<SEC-DOCUMENT>0000950170-22-003577.txt : 20220314
<SEC-HEADER>0000950170-22-003577.hdr.sgml : 20220314
<ACCEPTANCE-DATETIME>20220314161358
ACCESSION NUMBER:		0000950170-22-003577
CONFORMED SUBMISSION TYPE:	10-K
PUBLIC DOCUMENT COUNT:		102
CONFORMED PERIOD OF REPORT:	20211231
FILED AS OF DATE:		20220314
DATE AS OF CHANGE:		20220314

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Vor Biopharma Inc.
		CENTRAL INDEX KEY:			0001817229
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39979
		FILM NUMBER:		22736725

	BUSINESS ADDRESS:	
		STREET 1:		215 FIRST STREET
		STREET 2:		SUITE 430
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
		BUSINESS PHONE:		617-655-6580

	MAIL ADDRESS:	
		STREET 1:		215 FIRST STREET
		STREET 2:		SUITE 430
		CITY:			CAMBRIDGE
		STATE:			MA
		ZIP:			02142
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K
<SEQUENCE>1
<FILENAME>vor-20211231.htm
<DESCRIPTION>10-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2022-03-14T15:51:37.3035+00:00 --><!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:vor="http://vorbiopharma.com/20211231" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:utr="http://www.xbrl.org/2009/utr">
 <head>
  <title>10-K</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body>
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_b2ffa8ee-9529-4fd4-82fe-a6ca516756a7" name="dei:CurrentFiscalYearEndDate" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96">--12-31</ix:nonNumeric><ix:nonNumeric id="F_e50e96ba-4bb2-4a0a-bedc-b96d652fbac5" name="dei:EntityCentralIndexKey" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96">0001817229</ix:nonNumeric><ix:nonNumeric id="F_ddc30ae4-0085-4f3c-a71b-bd969e305524" name="dei:DocumentFiscalPeriodFocus" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96">FY</ix:nonNumeric><ix:nonFraction id="F_1a6782bb-9d03-4a11-a8d9-b5a47122f2f7" name="us-gaap:StockholdersEquityNoteStockSplitConversionRatio1" contextRef="C_e733f8c4-07b6-4b41-b024-5814fc24327f" unitRef="U_pure" decimals="4" scale="0" format="ixt:numdotdecimal">0.0735</ix:nonFraction><ix:nonNumeric id="F_9fe2e284-3d35-4fe3-b478-3dcd0820f887" name="us-gaap:AccountingStandardsUpdateExtensibleList" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201912Member</ix:nonNumeric><ix:nonFraction id="F_92740c7f-9a44-4bb2-be40-da3ce44d3337" name="us-gaap:PreferredStockValue" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" unitRef="U_USD" xsi:nil="true"></ix:nonFraction><ix:nonNumeric id="F_b08dbc5d-8945-4b44-ac31-66ad1c7b51b0" name="dei:AmendmentFlag" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonFraction id="F_d001c3a9-ea5b-45d4-bac4-d84b5bc72b37" name="us-gaap:PreferredStockValue" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" unitRef="U_USD" xsi:nil="true"></ix:nonFraction></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="vor-20211231.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_30c63602-288c-4405-a204-cdab859368e7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1e278196-1cfd-446f-8d91-9976d22c5883"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-15</xbrli:startDate><xbrli:endDate>2021-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2df3377e-ee22-43dc-b9ea-a3b6b9eb60c6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_8e0a26e9-728b-430b-b0fc-8bf930a218ab"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f421d89d-1fcd-44c9-b330-4181365acf97"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesATwoRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a552db48-79ee-4bc9-bd4d-b52fcf933430"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesATwoRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_69091247-915d-4997-8567-724c5a05de2f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesAOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_78d79139-f336-486b-8add-17be3536b350"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6db24f0b-fc32-481a-99b2-6949f632a61f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">vor:SecondLeaseAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-15</xbrli:startDate><xbrli:endDate>2021-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bb722967-b149-4749-9edf-a5242ac6397a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_26ff529e-e196-4005-ac31-d73430825eb5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vor:NationalInstitutesOfHealthLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_29752c48-fb53-41e4-b327-df9623f28225"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vor:TwoThousandFifteenStockIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f6546c5b-8293-41ca-b559-c79fcc889b89"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vor:ColumbiaLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">vor:AccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_52a58005-78a0-40c3-9da0-2ffe7154a555"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesATwoRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-02-05</xbrli:startDate><xbrli:endDate>2020-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fe5f0887-c938-4424-9f52-81c4c0ac9449"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7a2f1c59-42b8-4077-b849-32e1f00d5329"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_588f2dc9-7ea0-423b-baac-bf5e275504d3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2069f6af-4edc-49e3-bb9e-d18be8ade020"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vor:FurnitureAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4fcfa437-bee3-47fa-94e3-9caec72a5b95"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e733f8c4-07b6-4b41-b024-5814fc24327f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-29</xbrli:startDate><xbrli:endDate>2021-01-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5b680cd4-9558-44e6-9a54-c351f3ac168d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">vor:MaturingInOneYearOrLessMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_33213034-803c-4c95-bb92-7996ff3a4622"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vor:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_39aabd88-71ef-47fd-81c2-5989c3eb5180"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_01ae64e4-fcbc-4c77-945a-5a32dc371b12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a0646336-a18c-4b69-a90e-ca45d0ce7f71"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">vor:FirstLeaseAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_af4903d8-c8c6-44b2-ae8d-4dfc4cc09658"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">vor:CambridgeparkLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_125bd726-c0d2-4df7-b573-0ef9f71919e2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cbe610c1-c6d3-4428-b88d-d6ea1d66502f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vor:FurnitureAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d0fb8d89-6900-4a5d-85de-755eaa9cf227"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-06-29</xbrli:startDate><xbrli:endDate>2020-06-29</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d9da6ae7-78bc-43bf-aef8-9f17cd10c178"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">vor:SecondLeaseAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-15</xbrli:startDate><xbrli:endDate>2021-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_05cbe1e9-93ae-4c7c-8022-300abf600f9a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesAOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_627553ad-acf9-43fd-997b-9899cf109351"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_7ad90457-283a-44cd-b3db-1fbd4b5d6040"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0934599b-e63c-44b0-8f73-95ce8e66ed87"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesAOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4322025b-403f-47da-9dfb-69514ce849e6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_906ae667-10d4-461d-ab58-98924db96c28"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_715633f5-fcd9-4448-aad7-029e1308015e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vor:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4fad1b2e-548e-456c-a314-8f74671c228b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">vor:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_09163903-47da-4862-9c71-2100cb0e3e52"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e1887846-0919-4db3-aa01-c63b37f6dff8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">vor:MaturingInOneYearOrLessMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_1f0cde73-59e7-449b-80e5-547933529d26"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2bd29414-3bf3-467c-b8da-0f5c54c35d29"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vor:ColumbiaLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">vor:AccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2c77f565-f009-499e-a1b1-aa2bbba1d540"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vor:FurnitureAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f5ef1ea6-c3b7-451a-8872-9c63fc489bc3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_22f4bcb0-6708-4711-89d9-4dd150fabf2e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vor:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3c5cc129-6f72-442b-ba44-37460dc77415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_384191fb-9059-497b-a41e-c8f78ff3b67f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vor:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-05</xbrli:startDate><xbrli:endDate>2021-02-05</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fde2681f-7863-4672-ac2d-a2fe4bb678c4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d9365f15-4570-4863-b99d-75d5cc7c706b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesATwoRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b6f766ff-68c5-4b43-8d56-95a91d04de17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_2e62aa11-22e8-433f-b264-9531559a3726"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4f4bd222-f291-4cc2-a0d9-e0451c423659"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">vor:SeriesAOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5704eb75-6122-4803-bb26-449ab2867e41"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-10-01</xbrli:startDate><xbrli:endDate>2020-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8e667a03-9dc8-490a-98a3-a47136782d33"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_108d57ff-006a-4611-a4b0-e4181430ef77"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_3dacd509-2296-44c2-8572-ea922b845d9c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_ae930d22-cc83-471e-981d-8726a0b382a0"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e403d7c0-1f35-43a7-8fc0-3a59a8d342cd"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-09</xbrli:startDate><xbrli:endDate>2021-02-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_73eee50d-fc14-42b0-8920-b0a04312d39a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vor:NationalInstitutesOfHealthLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_86a506c8-d064-4dfe-9433-56efa7f9e3b1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4ca00470-3222-46a5-ba00-840824cc64ac"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f7e93cb2-5aad-42ef-867b-5b8e561d0399"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_38911f38-ed40-46e3-aae3-567d07cc6536"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d1a54bd6-087e-482f-9586-9f67436d0f3b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_17db07ca-1802-4fd6-af2a-3b044cdb439e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f74e35ab-8530-45d8-8610-4c43f69992db"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4efe06e3-c8a1-4df0-8cc2-32db822023b4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9ced81ea-4ae3-445d-910e-f3c298459ae8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e3549357-9b6b-45e4-b9a8-1215efcfd4cf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_715b82a7-0efe-414c-ba1e-c08acca496be"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">vor:MaturingAfterOneYearThroughFiveYearsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_4457893c-b88e-4779-ae3d-d3eaad39d858"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5fa63f3c-7a7e-49f4-b2a0-dffb9dcb0526"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5ce9a17a-6747-4e6a-b14b-931e7fbf6304"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_3e5b0b1c-0786-4be6-85c8-c47c2f2afe86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesATwoRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_88b36c70-a4c3-4733-99e7-acb53eff697f"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesATwoRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8f8c1246-f661-4230-b8d9-f954d3732f61"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vor:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_21f54f52-6262-4aae-b36b-d01ad52765ef"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1d853449-b848-41c9-8402-61ac0859b6c1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_f9decb30-9917-46ec-95f6-06ac473f5fb9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e1434930-9e6c-49c1-8a72-2f6ad390870c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_f35b7c7a-c532-4b88-bdc5-43c57c43318c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_4524d971-84fd-4763-928f-3714233d9b8d"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">vor:FirstLeaseAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-15</xbrli:startDate><xbrli:endDate>2021-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_6591cce2-facd-4d98-9f53-16294c8f698c"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-08</xbrli:startDate><xbrli:endDate>2021-01-08</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_fb525106-40af-41f1-abca-fd6a6fdc8870"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_bb19a2ae-ac5d-4f11-b032-62cb4dd2a453"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">vor:CambridgeparkLeaseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_e2969fd4-7d7c-435f-8e64-f416d48f96fe"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_c04daa76-85eb-4243-8001-dd530ab727ea"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_b03a92f2-8cde-4578-9ffb-def9727ae3e2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-06-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_522a671f-8013-49d5-9406-851e52363e90"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-02-09</xbrli:startDate><xbrli:endDate>2021-02-09</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_8cfcd4c1-10fe-467a-9e2b-cc68414f8f0e"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_5c1b58ed-1181-42ef-9936-9ee4e450ee86"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vor:ColumbiaLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-11-30</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d8baf95d-5eaa-4c79-8ad9-9d413c0de569"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_5e77fbcd-1b4f-4eb9-bc4a-1659f7452745"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_6c62975b-bbca-4e3d-9239-8d568106fa63"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesAOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_cc3d40e7-fe0d-4909-adf0-b9e10e622e8b"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">vor:RestrictedCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_e8956874-0a8e-44bd-8bfb-ee0b88501483"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">vor:RestrictedCashEquivalentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_a65d33bd-d9c2-4c72-bb24-f45f2ce91c39"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">vor:MaturingAfterOneYearThroughFiveYearsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_02d1981e-0b73-40f4-9bc3-8fdce9d391e3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesATwoRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-02-12</xbrli:startDate><xbrli:endDate>2019-02-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_0b13dbfb-af9b-4e36-b831-4dc9d2f387b8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_640a4a96-8eca-48d4-9211-924367454b36"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">vor:SecondLeaseAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-06-15</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_1a7d767a-18bf-417e-9a93-14efa9daffc7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vor:NationalInstitutesOfHealthLicenseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">vor:AccruedExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_d6d70c45-e42a-4ed6-8717-d4b764af1957"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a8aa8d2a-0cb5-4a21-b6ab-146b2c4adaa1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">vor:FirstLeaseAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-15</xbrli:startDate><xbrli:endDate>2021-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_965a7f16-b568-4209-8526-032c882c59d6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">vor:SecondLeaseAmendmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-15</xbrli:startDate><xbrli:endDate>2021-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_d172676c-6f5a-4c81-bda9-175f1b30bdaf"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_28790eaf-526a-4566-8f5d-38d463cd96fa"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">vor:SeriesATwoRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_830618a5-a622-44e4-a728-a9181a23c735"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_312b019a-fe59-4cdb-acae-11a1267c8c20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">vor:FirstLeaseAmendmentMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-06-15</xbrli:startDate><xbrli:endDate>2021-06-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_2d35f13a-de85-4de4-863e-43adb4567091"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="C_a4841187-5a01-4b8a-9f4b-2a8762ff5f9a"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_c2b57d58-2294-4b68-be37-2b25d3a08312"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-02-09</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="C_9b3fa813-9828-49c2-a538-31ae7b11c4b9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001817229</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vor:NationalInstitutesOfHealthLicenseAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-10-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="U_Vote"><xbrli:measure>vor:Vote</xbrli:measure></xbrli:unit><xbrli:unit id="U_pure"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="U_sqft"><xbrli:measure>utr:sqft</xbrli:measure></xbrli:unit><xbrli:unit id="U_Segment"><xbrli:measure>vor:Segment</xbrli:measure></xbrli:unit><xbrli:unit id="U_shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="U_UnitedStatesOfAmericaDollarsShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:unit id="U_USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit></ix:resources></ix:header></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="border-top:2.250pt double;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:16.0pt;font-family:Times New Roman;">UNITED STATES</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:16.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:16.0pt;font-family:Times New Roman;">SECURITIES AND EXCHANGE COMMISSION</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:16.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Washington, D.C. 20549</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.000pt solid;margin-right:40.0%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:Times New Roman;">FORM </span><span style="font-size:18.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_873c3753-b63f-49d9-91a5-fe004e43e789" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:DocumentType"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:Times New Roman;">10-K</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:18.0pt;font-family:Times New Roman;"> </span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.000pt solid;margin-right:40.0%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(Mark One)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"> </span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:4.0%;"></td>
    <td style="width:96.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.010in;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b08efb01-cecb-41cd-a345-4d9abcf85254" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:DocumentAnnualReport" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.010in;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">For the fiscal year ended </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b94d0211-2a4c-4d38-a716-ae7fadf3a079" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:DocumentPeriodEndDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">December 31, </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c0bef316-6778-45ee-bc89-81574a85de21" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:DocumentFiscalYearFocus"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2021</span></ix:nonNumeric></span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"></span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">OR</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:4.0%;"></td>
    <td style="width:96.0%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.010in;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:3.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4b022b3b-feae-47d7-9380-5520adba2887" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:DocumentTransitionReport" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;padding-left:0.010in;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:2.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM                      TO</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">                     </span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Commission File Number: </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8e6ba8c4-a030-45ad-b836-d31851be70c8" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:EntityFileNumber"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">001-39979</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.000pt solid;margin-right:40.0%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:3.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:22.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3f327089-4a96-4256-ae4e-9d9c4f9871b2" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:EntityRegistrantName"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:22.0pt;font-family:Times New Roman;">VOR BIOPHARMA INC.</span></ix:nonNumeric></span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(Exact name of registrant as specified in its charter)</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"> </span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.000pt solid;margin-right:40.0%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:3.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:3.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:50.0%;"></td>
    <td style="width:50.0%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5e1ff1a2-bad6-4f2d-84a1-5b2686978ddf" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7740b2cb-f27e-4bc7-a9c0-5c6a955ec253" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:EntityTaxIdentificationNumber"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">81-1591163</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(State or other jurisdiction of</span></p><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.75pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">incorporation or organization)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(I.R.S. Employer</span></p><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Identification No.)</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:3.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5e0fe894-996e-4210-8b3e-e02b02e5b091" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:EntityAddressAddressLine1"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">100 Cambridgepark Drive</span></ix:nonNumeric></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">, </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_11bf33dd-a600-4d4b-9206-e687d662fe5c" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:EntityAddressAddressLine2"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Suite 101</span></ix:nonNumeric></span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1e128b3e-295f-47fc-bcee-bd46c258b329" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:EntityAddressCityOrTown"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Cambridge</span></ix:nonNumeric></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">, </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b1586aa6-97a8-42e2-ba57-9a8956130058" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Massachusetts</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_19a3045e-5e9f-4670-99a2-9cc592396d0a" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:EntityAddressPostalZipCode"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">02140</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(Address of principal executive offices)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">Registrant&#x2019;s telephone number, including area code: </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">(</span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c4f4d85f-7e34-41d4-8f89-3848fd5d0688" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:CityAreaCode"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">617</span></ix:nonNumeric></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">) </span><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bae042fc-0f19-4d38-a285-ecad919aba2b" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:LocalPhoneNumber"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">655-6580</span></ix:nonNumeric></span></p>
  <p style="margin-left:40.0%;text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:1.000pt solid;margin-right:40.0%;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:2.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:3.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:Times New Roman;">Securities registered pursuant to Section 12(b) of the Act:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.5pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:39.989%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:18.003%;"></td>
    <td style="width:1.0%;"></td>
    <td style="width:40.007%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Title of each class</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Trading</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Symbol(s)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9a5a7526-78e2-4f27-9371-a74f8e6cc344" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:Security12bTitle"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Common Stock, $0.0001 par value per share</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1c7f1cd2-f04e-44e4-b689-1fa2ca0bfceb" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:TradingSymbol"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">VOR</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:9.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0e82c748-d386-42a8-a982-14335138d4c5" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Nasdaq Global Select Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Securities registered pursuant to Section 12(g) of the Act: </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">None</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes &#9744; </span><span style="font-size:7.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_71389703-eb1d-4d48-ad19-74ba410697cd" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:EntityWellKnownSeasonedIssuer"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">No</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"> &#9746;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act.  Yes &#9744; </span><span style="font-size:7.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3f127e6b-eb0d-49d9-92e0-c558dbbf8b81" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:EntityVoluntaryFilers"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">No</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"> &#9746;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  </span><span style="font-size:7.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_059f0203-f5bf-497c-b6b3-9610c1a26e75" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:EntityCurrentReportingStatus"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Yes </span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#9746; No &#9744;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).  </span><span style="font-size:7.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7532ffc3-5e30-42d6-b0a5-9bef7a3810d8" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:EntityInteractiveDataCurrent"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Yes</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"> &#9746; No &#9744;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#x201c;large accelerated filer,&#x201d; &#x201c;accelerated filer,&#x201d; &#x201c;smaller reporting company,&#x201d; and &#x201c;emerging growth company&#x201d; in Rule 12b-2 of the Exchange Act.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:18.34%;"></td>
    <td style="width:1.076%;"></td>
    <td style="width:55.891%;"></td>
    <td style="width:1.076%;"></td>
    <td style="width:20.492%;"></td>
    <td style="width:1.076%;"></td>
    <td style="width:2.05%;"></td>
   </tr>
   <tr style="height:10.8pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Large accelerated filer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#9744;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Accelerated filer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#9744;</span></p></td>
   </tr>
   <tr style="height:2.15pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_6dcb2259-b0aa-4100-a9b8-7eec35bba7dd" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Non-accelerated filer</span></ix:nonNumeric></span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#9746;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">  </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Smaller reporting company</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_08ba217d-f99b-41eb-8db7-5664eb43181e" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:EntitySmallBusiness" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:2.15pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Emerging growth company</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:7.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b50d4960-de6b-46c1-99f4-4a15adc981f1" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="font-size:7.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e35f506b-9294-4499-8a96-53de236e6233" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:EntityExTransitionPeriod" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant has filed a report on and attestation to its management&#x2019;s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.  </span><span style="font-size:7.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_84a9bda3-9434-43cd-83eb-5f07f864dcc5" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:IcfrAuditorAttestationFlag" format="ixt-sec:boolballotbox"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes &#9744;  No </span><span style="font-size:7.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_50c25b4c-9175-4421-9bce-e53d583c8e6c" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:EntityShellCompany" format="ixt:booleanfalse"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#9746;</span></ix:nonNumeric></span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">As of June 30, 2021, the last day of the registrant&#x2019;s most recently completed second fiscal quarter, the aggregate market value of the registrant's common stock, $0.0001 par value per share (&#x201c;Common Stock&#x201d;), held by non-affiliates of the registrant was approximately $</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fa9cfc47-a850-4c78-bc68-6de0129f445c" contextRef="C_b03a92f2-8cde-4578-9ffb-def9727ae3e2" name="dei:EntityPublicFloat" unitRef="U_USD" scale="0" decimals="2" format="ixt:numdotdecimal">351,650,244.65</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"> based upon the closing price of the Common Stock on June 30, 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">The number of shares of registrant&#x2019;s Common Stock outstanding as of  March 4, 2022 was </span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3102c86c-f73d-4a52-80c1-429459741ac4" contextRef="C_21f54f52-6262-4aae-b36b-d01ad52765ef" name="dei:EntityCommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">37,488,370</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">DOCUMENTS INCORPORATED BY REFERENCE</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">None.</span></p>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:2.250pt double;text-align:left;"><span style="white-space:pre-wrap;font-size:3.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Table of Contents</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:10.096%;"></td>
    <td style="width:82.821%;"></td>
    <td style="width:7.083%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Page</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#part_i"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">PART I</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 1.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1_business"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Business</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 1A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1a_risk_factors"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Risk Factors</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 1B.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_1b_unresolved_staff_comments"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Unresolved Staff Comments</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">109</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 2.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_2_properties"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Properties</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">109</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 3.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_3_legal_proceedings"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Legal Proceedings</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">109</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 4.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_4_mine_safety_disclosures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Mine Safety Disclosures</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">109</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#part_ii"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">PART II</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 5.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_5_market_for_registrants_common_equ"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Market for Registrant&#x2019;s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">110</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 6.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_6_selected_financial_data"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Selected Financial Data</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">110</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 7.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_7_managements_discussion_analysis_f"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">111</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 7A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_7a_quantitative_qualitative_disclos"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Quantitative and Qualitative Disclosures About Market Risk</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">122</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 8.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_8_financial_statements_supplementar"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Financial Statements and Supplementary Data</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">123</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 9.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9_changes_in_disagreements_with_acc"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Changes in and Disagreements with Accountants on Accounting and Financial Disclosure</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">123</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 9A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9a_controls_procedures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Controls and Procedures</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">123</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 9B.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9b_or_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Other Information</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">123</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 9C</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_9c_foreign_jurisdictions"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Disclosure Regarding Foreign Jurisdictions that Prevent Inspections</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">123</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#part_iii"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Part III</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 10.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_10_directors_officers"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Directors, Executive Officers and Corporate Governance</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">124</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 11.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_11_executive_comp"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Executive Compensation</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">127</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 12</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_12_security_ownership_matters"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">138</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 13</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_13_related_parties"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Certain Relationships and Related Transactions, and Director Independence</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">140</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 14</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_14_accounting_fees"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Principal Accountant Fees and Services</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">143</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#part_iv"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">PART IV</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(5,99,193,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 15.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_15_exhibits_financial_statement_sch"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Exhibits and Financial Statement Schedules</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">145</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;text-indent:6.85pt;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="margin-left:6.85pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Item 16</span></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#item_16_form_10k_summary"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Form 10-K Summary</span></a></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">147</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">i</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Note Regarding Company References</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Throughout this Annual Report on Form 10-K (&#x201c;Annual Report&#x201d;), the &#x201c;Company,&#x201d; &#x201c;Vor,&#x201d; &#34;Vor Bio,&#34; &#x201c;Vor Biopharma Inc.,&#x201d; &#x201c;we,&#x201d; &#x201c;us,&#x201d; and &#x201c;our,&#x201d; except where the context requires otherwise, refer to Vor Biopharma Inc. and its consolidated subsidiary, and &#x201c;our board of directors&#x201d; refers to the board of directors of Vor Biopharma Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Special Note Regarding Forward-Looking Statements and Industry Data</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This Annual Report contains forward-looking statements that involve substantial risks and uncertainties. All statements, other than statements of historical facts, contained in this Annual Report, including statements regarding our strategy, future operations, future financial position, future revenue, projected costs, prospects, plans, and objectives of management, are forward-looking statements. In some cases, you can identify forward-looking statements by terms such as &#x201c;may,&#x201d; &#x201c;will,&#x201d; &#x201c;should,&#x201d; &#x201c;expect,&#x201d; &#x201c;plan,&#x201d; &#x201c;anticipate,&#x201d; &#x201c;could,&#x201d; &#x201c;intend,&#x201d; &#x201c;target,&#x201d; &#x201c;project,&#x201d; &#x201c;estimate,&#x201d; &#x201c;believe,&#x201d; &#x201c;estimate,&#x201d; &#x201c;predict,&#x201d; &#x201c;potential&#x201d; or &#x201c;continue&#x201d; or the negative of these terms or other similar expressions intended to identify statements about the future. These statements speak only as of the date of this Annual Report and involve known and unknown risks, uncertainties and other important factors that may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our business, financial condition and results of operations. These forward-looking statements include, without limitation, statements about:</span></p>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the timing, progress and results of our preclinical studies and clinical trials of our product candidates, including statements regarding the timing of initiation, enrollment and completion of studies or trials and related preparatory work, the period during which the results of the trials will become available and our research and development programs;</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the timing of clinical trials and timing of expected clinical results for our current and future product candidates;</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the timing of any submission of filings for regulatory approval of, and our ability to obtain and maintain regulatory approvals for our product candidates for any indication;</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the COVID-19 pandemic, which could continue to adversely impact our business, including our preclinical studies and clinical trials;</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to identify patients with the diseases treated by our product candidates, and to enroll patients in trials;</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our expectations regarding the market acceptance and opportunity for and clinical utility of our product candidates, if approved for commercial use;</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our expectations regarding the scope of any approved indication for any product candidate;</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to successfully commercialize our product candidates;</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our estimates of our expenses, ongoing losses, future revenue, capital requirements and our need for or ability to obtain additional funding before we can expect to generate any revenue from product sales;</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to establish or maintain collaborations or strategic relationships;</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to identify, recruit and retain key personnel;</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our reliance upon intellectual property licensed from third parties and our ability to obtain such licenses on commercially reasonable terms or at all;</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to protect and enforce our intellectual property position for our product candidates, and the scope of such protection;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our financial performance;</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the period over which we estimate our existing cash, cash equivalents and investments will be sufficient to fund our future operating expenses and capital expenditure requirements;</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our competitive position and the development of and projections relating to our competitors or our industry;</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our estimates regarding future revenue, expenses and needs for additional financing;</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the impact of laws and regulations; and</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our expectations regarding the time during which we will be an emerging growth company under the Jumpstart Our Business Startups Act of 2012.</span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">You should read this Annual Report and the documents that we have filed as exhibits to this Annual Report completely and with the understanding that our actual future results may be materially different from what we expect. The forward-looking statements contained in this Annual Report are made as of the date of this Annual Report, and we do not assume any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have included important factors in this Annual Report, particularly in the &#34;Summary Risk Factors&#34; and &#x201c;Risk Factors&#x201d; sections, that could cause actual results or events to differ materially from the forward-looking statements that we make.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This Annual Report includes statistical and other industry and market data, which we obtained from our own internal estimates and research, as well as from industry and general publications and research, surveys, and studies conducted by third parties. Industry publications, studies, and surveys generally state that they have been obtained from sources believed to be reliable, although they do not guarantee the accuracy or completeness of such information. While we believe that each of these studies and publications is reliable, we have not independently verified market and industry data from third-party sources. While we believe our internal company research is reliable and the market definitions are appropriate, neither such research nor these definitions have been verified by any independent source.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Summary Risk Factors</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our business is subject to a number of risks that if realized could materially affect our business, financial condition, results of operations, cash flows and access to liquidity. These risks are discussed more fully in the &#x201c;Risk Factors&#x201d; section of this Annual Report. Our principal risks include the following:</span></p>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have incurred significant net losses since inception. We expect to incur net losses for the foreseeable future and may never achieve or maintain profitability.</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We will need substantial additional funding. If we are unable to raise capital when needed, we would be forced to delay, reduce or eliminate our research and product development programs or future commercialization efforts.</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have a limited operating history, have not yet completed any clinical trials and have no history of commercializing products, which may make it difficult to evaluate the success of our business to date and to assess our future viability.</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Engineered hematopoietic stem cells (</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">eHSCs</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) are a novel technology that is not yet clinically validated for human use. The approaches we are taking to create eHSCs are unproven and may never lead to marketable products.</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are substantially dependent on the success of our two most advanced product candidates, VOR33 and VCAR33. If we are unable to complete development of, obtain approval for and commercialize VOR33 or VCAR33 in a timely manner, our business will be harmed.</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may not be successful in our efforts to identify, develop or commercialize additional product candidates. If these efforts are unsuccessful, we may never become a commercial stage company or generate any revenues.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have not successfully tested our product candidates in clinical trials and any favorable preclinical results are not predictive of results that may be observed in clinical trials.</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Development of a product candidate such as VOR33, which is intended for use in combination or in sequence with an already approved therapy, will present increased complexity and more or different challenges than development of a product candidate for use as a single agent.</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If our product candidates, or the delivery modes we rely on to administer them, cause serious adverse events, undesirable side effects or unexpected characteristics, such events, side effects or characteristics could delay or prevent regulatory approval of the product candidates, limit their commercial potential or result in significant negative consequences following any potential marketing approval.</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We face significant competition in an environment of rapid technological change, and there is a possibility that our competitors may achieve regulatory approval before us or develop therapies that are safer or more advanced or effective than ours, which may harm our financial condition and our ability to successfully market or commercialize our product candidates, if approved.</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Adverse public perception of genetic medicines, and of genome engineering in particular, may negatively impact regulatory approval of, and/or demand for, our potential products.</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Genome engineering technology is subject to a number of challenges and risks. Because genome engineering technology is novel and the regulatory landscape that will govern our product candidates is uncertain and may change, we cannot predict the time and cost of obtaining regulatory approval, if we receive it at all, for our product candidates.</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Because we are developing product candidates using new technologies, as well as potential mechanisms of action for which there are few precedents, there is increased risk that the U.S. Food and Drug Administration, the European Medicines Agency or other regulatory authorities may not consider the endpoints of our clinical trials to provide clinically meaningful results and that these results may be difficult to analyze.</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We contract with third parties for the manufacture and supply of materials for development of our product candidates and advancement of our current clinical trial, as well as our research programs and preclinical studies, and we expect to continue to do so for future clinical trials and for commercialization of our product candidates. This reliance on third parties increases the risk that we will not have sufficient quantities of such materials, product candidates or any products that we may develop and commercialize, or that such supply will not be available to us at an acceptable cost, which could delay, prevent or impair our development or commercialization efforts.</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are highly dependent on intellectual property licensed from third parties and termination of any of these licenses could result in the loss of significant rights, which would harm our business.</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may not be successful in acquiring or in-licensing necessary rights to key technologies underlying our product candidates.</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Third-party claims of intellectual property infringement, misappropriation or other violations may prevent or delay our product discovery and development efforts and have a material adverse effect on our business.</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The COVID-19 pandemic has caused, and could continue to cause, severe disruptions in the United States, regional and global economies and could seriously harm our development efforts, increase our costs and expenses and have a material adverse effect on our business, financial condition and results of operations.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;" id="part_i"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">PAR</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">T I</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_1_business"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 1. Bu</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">siness.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Overview</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vor Bio is a clinical stage company with a vision to cure blood cancers through cell and genome engineering. Our mission is to change the standard of care for patients with blood cancer by engineering hematopoietic stem cells (&#x201c;HSCs&#x201d;) to enable the use of targeted therapies post-transplant.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Our initial focus is on patients suffering from acute myeloid leukemia (&#x201c;AML&#x201d;).  For many of these patients, hematopoietic stem cell transplant (&#x201c;HSCT&#x201d;) is the standard of care treatment and the only way to achieve durable remission or a cure. Despite undergoing HSCT, approximately 40% of patients experience a relapse of their cancer and subsequently face an extremely poor prognosis, with two-year survival rates of less than 20%.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The traditional tumor targeting approach to treating blood cancers such as AML focuses on cancer cells expressing a target antigen. However, very few targets are tumor-specific, as healthy cells usually express these same target antigens alongside cancer cells. While technologies may improve the specificity of target antigen binding or enhance potency, these approaches are subject to the same fundamental biological limitation of killing healthy cells expressing these targets, known as on-target toxicity. A number of targeted therapies have failed in clinical development, and those that have succeeded possess limited utility and narrow applicability, in part due to their on-target toxicity.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Vor Bio&#x2019;s proprietary platform aims to change the traditional target tumor approach by genetically engineering healthy cells by removing therapeutic targets, thereby enabling the use of targeted therapies post-transplant.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:Times New Roman;"><br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:18.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Changing the Thinking on Tumor Targeting</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img17388848_0.jpg" alt="img17388848_0.jpg" style="width:624px;height:271px;" />&#160;</p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Leveraging our expertise in HSC biology and genome engineering, we genetically modify HSCs to remove surface targets and then provide these cells as hematopoietic stem cell transplants to patients. Once these cells engraft into bone marrow, the patient&#x2019;s healthy cells should be protected because they no longer express the surface target, leaving only the cancerous cells exposed.  We believe this will unlock the potential of targeted therapies to selectively destroy cancerous cells while sparing healthy cells. As a result, our engineered HSCs (&#x201c;eHSCs&#x201d;) are</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">designed to limit the on-target toxicities associated with these targeted therapies, thereby enhancing their utility, and broadening their applicability.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are developing our lead eHSC product candidate, VOR33, which we believe has the potential to transform the treatment for AML and other blood cancers. CD33 is a clinically validated target for AML, and we use genome engineering technology to remove CD33 surface targets from HSCs to create VOR33. Data from preclinical studies from multiple independent laboratories, alongside data from human genetics databases, show that CD33 can be removed from HSCs without any deleterious impact on cell biology.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> We have initiated VBP101, a Phase 1/2a clinical trial in patients with CD33-positive AML who are at high risk of relapse. The primary goals of the trial are to evaluate tolerability and feasibility of the VOR33 stem cell transplant, with a focus on confirming that VOR33 can engraft normally. Following engraftment, patients will be eligible to be treated with Mylotarg, a CD33-directed antibody drug conjugate (&#x201c;ADC&#x201d;) therapy, in order to potentially prolong leukemia-free survival and provide evidence that VOR33 protects against the myelosuppression that typically accompanies treatment with Mylotarg.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Our proprietary eHSC technology is designed to confer advantages and address several limitations associated with existing cell therapy processes. Our manufacturing of eHSCs is a fast and elegant process that leads to a rapid vein-to-vein time of seven to ten days which we believe can easily integrate into existing standard of care. Additionally, preclinical studies of VOR33 demonstrated a high degree of genome engineering precision with highly reproducible results across multiple independent healthy donors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> We intend to pair future eHSC product candidates with targeted therapeutics such as our VCAR33 programs, chimeric antigen receptor (&#x201c;CAR&#x201d;)-T therapies designed to target CD33, as well as with potentially best-in-class targeted therapies from collaborators, to bring potentially transformative outcomes to patients and establish new standard of care Treatment Systems for blood cancers.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> We believe that the combination of VOR33 followed by treatment with VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, our in-house CD33-directed CAR-T program, in the post-transplant setting may transform patient outcomes and offer the potential for cures for patients that have limited treatment options, which we refer to as the VOR33 + VCAR33 Treatment System. The Treatment System would utilize the same healthy donor allogenic cell source for both VOR33 and VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.  Following ongoing discussions with the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) and alongside improved scientific understanding of the differences in T-cell sources, we plan to collect initial data on VOR33 from the VBP101 clinical trial and initial clinical data from the first-in-human trial studying the VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">program prior to the Investigational New Drug (&#x201c;IND&#x201d;) submission for the Treatment System. We believe this approach may allow for a more methodical development pathway for this novel-novel treatment combination.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> We are also pursuing our first multi-targeted Treatment System comprising the VOR33-CLL1 multiplex-edited eHSC therapy and the VCAR33-CLL1 multi-specific CAR-T therapy. These next-generation, multiplex-edited eHSCs may enable a wide range of treatment options post-transplant, including the use of multi-specific CAR-T therapies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> We believe our proprietary technology has broad applicability beyond CD33, including targets such as CD123, EMR2, and CD5. Leveraging our platform, we are rapidly advancing the creation and preclinical testing of multiplex-engineered eHSCs, in which multiple surface targets are removed, potentially obviating concern around tumor heterogeneity and potential escape mechanisms.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Acute Myeloid Leukemia Overview</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">AML is the most common type of acute leukemia in adults and is characterized by excessive proliferation of myeloid stem cells and their failure to properly differentiate into mature blood cells. There are an estimated 42,500 new diagnoses of AML each year in the United States, Europe and Japan. The median five-year survival rate for patients with AML is less than 30%, but there are significant differences in prognosis depending on several factors, including the age of the patient at diagnosis.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Current first-line treatments for patients with AML typically involve aggressive combination chemotherapy regimens with the goal of inducing disease remission long enough to allow the patient to undergo a potentially curative HSCT. The recommended treatment for AML for patients younger than 60 years and for older patients who can tolerate intensive chemotherapy is a regimen referred to as 7+3, involving seven days of continuous dosing with the chemotherapy agent cytarabine along with short infusions of the chemotherapy agent daunorubicin on days one</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">through three. These induction chemotherapy regimens are usually not curative, and without post-remission therapy such as HSCT, AML is likely to return within several months.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Following successful induction chemotherapy and prior to HSCT, patients undergo myeloablation, a procedure designed to eliminate more of the remaining tumor cells, but one that also leads to the destruction of the patient&#x2019;s HSCs. These HSCs are then replaced using cells from a matched healthy donor, resulting in reconstitution of the patient&#x2019;s hematopoietic system.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Over the past 20 years, there has been an increasing trend in HSCTs for AML patients with over 16,000 allogeneic HSCT procedures performed in the United States between 2013 and 2017. AML was the most common disease treated by allogeneic HSCT, representing over 35% of all allogeneic HSCT procedures performed during this time period.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Unfortunately, in approximately 40% of AML patients who undergo HSCT, some tumor cells persist, and the patient&#x2019;s cancer relapses. As shown in the figure below, AML patients treated with HSCT who were identified prior to HSCT as high risk of relapse, given presence of Minimal Residual Disease (&#x201c;MRD&#x201d;) biomarkers or active disease in bone marrow samples, or had MRD had an even higher relapse rate of 67%, with the vast majority of these patients relapsing within one year. Patients who had MRD negative disease, meaning that the number of tumor cells had been reduced to a level of approximately 0.1% of cells in a bone marrow sample, had a much lower and slower risk of relapse.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> Myeloid Cancer Unmet Need is Large and Increasing</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img17388848_1.jpg" alt="img17388848_1.jpg" style="width:624px;height:272px;" />&#160;</p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Following HSCT, patients have very few treatment options and generally receive no treatment despite being high risk of relapse, since anti-cancer therapies will compromise the integrity of the new HSCT. This includes the use of targeted therapies such as Mylotarg, where on-target toxicity may compromise the new bone marrow cells. Unfortunately, due in part to stagnant innovation in HSCT and limited post-transplant treatment options, the post-transplant survival for AML patients is approximately 44%, based on AML outcomes in the National Cancer Database from 1998 to 2011. Approximately 10,000 patients in the United States die from AML each year.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Our Strategy</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our mission is to change the standard of care for patients with blood cancer by engineering hematopoietic stem cells (HSCs) to enable use of targeted therapies post-transplant. Our strategy to accomplish this mission is as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.528%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Demonstrate VOR33 engrafts in patients and behaves like a typical HSCT. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">While extensive </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vitro </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">and animal experiments have studied the biological dispensability of CD33, the VBP101 Phase 1/2a clinical trial will be the first-time humans receive a stem cell transplant with CD33 surface targets </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:4.528%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;visibility:hidden;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;"></span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">deleted from the HSCs. Data showing robust engraftment of these cells will be important proof of concept for our platform. In addition, if successful, this will provide confidence that VOR33 could be combined with other targeted therapies such as VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, and that biological dispensability may also occur with additional targets Vor is studying including CD123, EMR2, and CD5.</span></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Demonstrate VOR33 and progeny cells are protected from Mylotarg.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> As a CD33-directed targeted therapeutic, Mylotarg almost universally causes bone marrow toxicity in the form of cytopenias, which are decreased counts of blood cells such as neutrophils and platelets, even at low doses. Patients enrolled in the VBP101 Phase 1/2a clinical trial will receive Mylotarg following their VOR33 transplant, and we expect that the VOR33 cells and their progeny will avoid the typical cytopenia effect as evidenced by robust peripheral cell counts, enabling repeat Mylotarg doses. We believe use of targeted therapies post-transplant will allow for longer relapse-free survival and potentially even cures.</span></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Advance in-house targeted therapies, including our wholly owned CAR-T therapy VCAR33 programs.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The VCAR33 programs are CAR-T therapy candidates designed to target CD33, a clinically validated target for AML. VCAR33 is made up of two programs with different cell sources.</span></div></div>
  <div style="margin-left:9.065%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.989278055754109%;">o</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">AUTO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> uses autologous cells from each patient and is being studied in an ongoing Phase 1/2 clinical trial sponsored by the National Marrow Donor Program (&#x201c;NMDP&#x201d;) in young adult and pediatric patients with relapsed/refractory AML in a bridge-to-transplant study. </span></div></div>
  <div style="margin-left:9.065%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.989278055754109%;">o</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">uses allogeneic healthy donor-derived cells. There has been an increasing appreciation for the value of cell phenotype in CAR-T approaches, and HLA-matched healthy donor cells are a potentially superior cell phenotype with improved persistence and in vivo expansion capability. VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> is a newly announced program. We plan to submit an IND for   this program in the first half of 2023 to support a Phase 1/2 clinical trial for patients with relapsed/refractory AML. </span></div></div>
  <p style="margin-left:9.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Clinical data generated from the VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">AUTO </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">and</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">programs may inform the development of important new therapies for patients with relapsed/refractory AML. In addition, these programs will collect important safety and efficacy data to inform the Treatment Systems discussed below.</span></p>
  <div style="margin-left:4.528%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Advance Treatment Systems comprising eHSCs and CAR-Ts, starting with the VOR33 + VCAR33 Treatment System.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> We intend to combine VOR33 and VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">as the VOR33 + VCAR33 Treatment System where patients first receive a VOR33 HSCT, then subsequently VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">generated from the same healthy donor source as VOR33. Such a Treatment System could result in long-lived CAR-T cells in the patient without major hematologic toxicities and enable prolonged remissions or cures in the post-transplant setting. We plan to develop the VOR33 + VCAR33 Treatment System by generating initial data on VOR33 from the VBP101 clinical trial, alongside initial clinical data from the VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> program, thereby de-risking the Treatment System prior to IND submission. </span></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Leverage our proprietary Vor Bio platform to discover and validate targets for additional eHSCs and CAR-Ts.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have applied expertise in HSC biology and genome engineering to focus on targets beyond CD33, including CD123, EMR2, and CD5. Additional targets may allow us to go beyond AML to other cancers, and also provide multiplexing opportunities that allow modification of more than one target simultaneously, potentially obviating concerns around tumor heterogeneity or tumor escape mechanisms, and allowing even more post-transplant treatment opportunities including multi-specific CAR-Ts. The VOR33-CLL1 + VCAR33-CLL1 Treatment System is the first of such programs consisting of a multiplex-edited eHSC and multi-specific CAR-T.</span></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Establish in-house cGMP cell therapy manufacturing.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">HSCs are unique cell types that require specialized genome engineering techniques as well as specific handling and manipulation processes. We have built considerable know-how manipulating genes of these cells and have also designed a highly efficient manufacturing process for VOR33 of approximately three days. We are investing in our know-how and manufacturing processes, including the build-out of our own in-house clinical manufacturing facility at our Cambridge, MA headquarters. The facility has been designed to support flexible clinical manufacturing for our eHSC and CAR-T product candidate pipeline and allow enhanced strategic control.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Our Approach&#x2014;Engineering Hematopoietic Stem Cells to Enable Targeted Therapies Post-Transplant.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our proprietary platform aims to change the traditional approach to tumor targeting by removing target expression from healthy cells, thereby engineering the patient&#x2019;s cells to improve the tumor specificity of targeted therapies. We accomplish this by genetically modifying healthy donor HSCs to remove select cell surface targets. By removing these targets, we make these donor HSCs and their progeny treatment-resistant to targeted therapies and enable these treatments to selectively destroy cancerous cells while sparing healthy cells. As a result, our eHSCs are designed to limit the on-target toxicities associated with these targeted therapies, thereby enhancing their utility and broadening their applicability. We believe that combining our eHSCs and targeted therapies, such as CAR-Ts, bispecific antibodies, and antibody-drug conjugates, has the potential to transform the treatment of blood cancers, such as AML.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Our Proprietary Vor Bio Platform</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have built a technology platform to realize our vision that allows for selective cancer targeting with highly potent targeted therapies by leveraging our expertise and recent advances in stem cell biology and genome engineering. Our approach is in stark contrast to conventional approaches that have focused solely on developing the therapeutic and have faced clinical limitations due to toxicities. The key components of our proprietary Vor Bio platform are the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.528%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Leveraging Stem Cell Biology and Manufacturing Expertise.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have built an extensive understanding of the biology of HSCs to enable our eHSCs to retain their cellular viability and functionality during manipulation. In addition, we have built process development expertise centered around HSCs, enabling us to process these cells quickly, precisely, reproducibly, and efficiently for patients. We are developing in-house clinical GMP manufacturing capabilities and facilities that allow us to leverage our expertise and to maintain strategic control over the manufacturing process. </span></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Applying Genome Engineering to Hematopoietic Stem Cells.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Recent developments in genome engineering allow permanent changes to DNA in cells and all their progeny. We have assembled a team with extensive experience in applying genome engineering technologies to HSCs, which display distinct DNA repair mechanisms compared to many other cell types. We possess expertise in a variety of genome engineering technologies including CRISPR-Cas9, CRISPR analog enzymes, and base editing, and we are capable of multiplex editing using a variety of techniques.</span></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Unlocking the Potential of Targeted Therapies.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe our eHSCs are a solution to the lack of tumor-specific targets and enable selective cancer targeting. Our solution allows for treatment with potent agents, such as CAR-T therapies, whose utility and applicability have previously been limited, in part, by on-target toxicity. We are designing and developing targeted therapies that are optimized for use with our eHSCs in the post-HSCT setting. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our goal is to replace the patient&#x2019;s HSCs with next-generation, treatment-resistant eHSCs that unlock the potential of highly potent targeted therapies by leveraging our platform and expertise. Our platform is adaptive and has the potential to engineer cells, whether autologous or allogeneic, whether collected from mobilized peripheral blood stem cells, bone marrow or cord blood-derived stem cells, and with any human leukocyte antigen (&#x201c;HLA&#x201d;) matching strategy, such as complete, incomplete or haploidentical matches. We also foresee no barriers to using our eHSCs with any specific conditioning regimen and believe our platform could be used with either myeloablative or reduced-intensity conditioning regimens.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Vor Bio&#x2019;s Vision and Platform</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img17388848_2.gif" alt="img17388848_2.gif" style="width:624px;height:267px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Advantages of Our eHSC Technology and Manufacturing Process</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our eHSC technology is designed to confer advantages and address limitations associated with existing cell therapy processes.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.528%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Speed&#x2014;Rapid Manufacturing Cycle and Vein-to-Vein Time.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> In contrast to other patient-specific cell therapies, such as CAR-T therapies and gene-modified allogeneic cell therapies, our eHSCs manufacturing is a rapid and elegant process that is completed in approximately three days, enabling a seven-to-ten day vein-to-vein time. The primary reason we can produce eHSCs so quickly is the lack of a need for cell expansion. Our approach to creating eHSCs also does not involve the insertion of new genetic material, thereby avoiding complications related to the use of delivery modalities necessary for gene insertion, such as the viral vectors used in CAR-T therapies. The relatively simple and streamlined process of creating our eHSCs provides significant advantages in the required manufacturing infrastructure and we are developing in-house clinical current manufacturing capabilities to support our planned clinical trials. We believe the efficiency and low capital expenditure of our manufacturing process should translate into higher scalability, a lower cost of goods, and easy integration into routine transplant practice.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Vor Bio eHSC Manufacturing Process</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><img src="img17388848_3.gif" alt="img17388848_3.gif" style="width:624px;height:280px;" />&#160;</p>
  <div style="margin-left:4.528%;display:flex;margin-top:12.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Investment in our own internal manufacturing facility.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  In June 2021, we announced the initiation of the build-out of an in-house clinical manufacturing facility in Cambridge, Massachusetts to support our development of potentially transformative eHSCs and CAR-T therapeutic candidates for patients with blood cancers. We anticipate that the facility, located in the same premises as our current headquarters, will be operational in 2022. The facility will provide us with end-to-end oversight over drug product for our planned clinical trials. With this new facility, we expect our manufacturing teams will be seamlessly integrated within our wider organization, a crucial component of our strategy as we begin our clinical studies. The facility has been designed to support clinical manufacturing for our cell therapy programs, including both eHSCs and CAR-T therapeutic candidates, and to be cGMP compliant. By integrating our internal research, process development, analytical development, manufacturing, and quality control testing capabilities under one roof, we aim to achieve flexible manufacturing capacity and to reduce the time and cost required to manufacture complex cell therapy clinical candidates. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Our Pipeline</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our pipeline of eHSC and CAR-T programs is shown below:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img17388848_4.jpg" alt="img17388848_4.jpg" style="width:624px;height:284px;" />&#160;</p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="border-top:0.750pt solid;margin-left:4.533%;padding-top:1.0pt;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;">.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">AML</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">: acute myeloid leukemia; </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">MDS</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">: myelodysplastic syndrome; </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">MPN</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">: myeloproliferative neoplasm</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">*The VCAR33 construct is being studied in a Phase 1/2 clinical trial sponsored by the NMDP, and timing of data release is dependent on the investigators conducting the trial.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Our Programs</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">VOR33 for the Treatment of Blood Cancers</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Overview</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> VOR33 is our lead eHSC product candidate created by genetically modifying healthy donor HSCs in order to remove the CD33 surface target. We intend to develop VOR33 as an HSCT product candidate to replace the standard of care in transplant settings. Once the VOR33 cells have engrafted, we believe that patients can be treated with anti-CD33 therapies, such as Mylotarg or our CAR-T therapy product candidates, with limited on-target toxicity.  We have initiated VBP101, a Phase 1/2a clinical trial in patients with CD33-positive AML who are at high risk of relapse.  The primary goals of the trial are to evaluate tolerability and feasibility of the VOR33 stem cell transplant, with a focus on confirming that VOR33 can engraft normally. Following engraftment, patients will be eligible to be treated with Mylotarg, a CD33-directed ADC therapy, in order to potentially prolong leukemia-free survival and provide evidence that VOR33 protects against the myelosuppression that typically accompanies treatment with Mylotarg.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">CD33 Targeted Therapies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A number of biologics investigated by third parties as potential therapeutics in AML and other hematopoietic malignancies have been based on targeting CD33, which, as shown in the figures below, is expressed, on average, in between approximately 85 to 90% of bulk AML patient samples and over 75% of leukemic stem cells.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Rate of expression in bulk AML patient samples and leukemic stem cells</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><img src="img17388848_5.jpg" alt="img17388848_5.jpg" style="width:624px;height:235px;" />&#160;</p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">CD33 is an attractive target for the development of AML therapeutics based on preclinical and clinical results from third parties demonstrating the ability of anti-CD33 directed therapies to deplete tumor cells. However, CD33-directed therapeutic approaches have had limited impact in improving the prognosis of patients with AML due in part to on-target toxicity. This on-target toxicity can have myelosuppressive effects, such as neutropenia, which is an abnormally low number of certain white blood cells, and thrombocytopenia, which is an abnormally low number of platelets. A summary of certain myelosuppressive effects observed in early-stage trials of selected CD33-directed therapies is shown below.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Third-party CD33-directed products and myelosuppressive effects</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><img src="img17388848_6.jpg" alt="img17388848_6.jpg" style="width:624px;height:393px;" />&#160;</p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The only CD33 targeted therapy approved by the FDA for the treatment of AML is gemtuzumab ozogamicin (&#x201c;GO&#x201d;), which is marketed by Pfizer under the brand name Mylotarg. Mylotarg is an ADC that targets CD33 on AML cells and is designed to deliver a potent cytotoxin directly to tumor cells. However, due to the expression of CD33 on a broad set of hematologic progenitor cells, Mylotarg not only attacks AML cells, but it also depletes healthy blood cells, including HSCs and other progenitor cells that express CD33. Primarily due to its toxicity profile, Mylotarg is currently used only in a limited setting, in both first line and relapsed/refractory disease. Without a solution to the problem of CD33 on-target toxicity, we expect all CD33-targeted therapies to produce thrombocytopenia and neutropenia which may result in the same limited clinical utility as Mylotarg.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe engineering the patient to remove CD33 is a unique approach designed to protect from on-target toxicity and unlock the potential of CD33 as a therapeutic target. By removing CD33 expression in healthy cells, we expect to render these cells and their progeny treatment resistant to CD33-directed therapies, thereby providing robust protection from these therapies&#x2019; cytotoxic effects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">VOR33 Preclinical Data</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Preclinical Proof of Concept</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In preclinical studies, we observed the resistance of our eHSCs to Mylotarg. As shown in the figure below, we used in vitro cytotoxicity assays to measure the effects of various concentrations of Mylotarg on HSCs and their progeny (collectively, &#x201c;HSPCs&#x201d;) that have differentiated into myeloid lineage cells. We tested both wild type cells whose CD33 surface targets had not been manipulated (&#x201c;CD33WT&#x201d;) and cells that we had genetically engineered to remove CD33 (&#x201c;CD33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">Del</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d;). We observed that CD33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">Del</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> cells had an approximately 70-fold increase in IC50 in comparison to CD33WT cells and, as expected, observed few differences in cell killing at extreme Mylotarg concentrations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Mylotarg Cytotoxicity on CD33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">WT</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> and CD33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">Del</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> HSPCs</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><img src="img17388848_7.jpg" alt="img17388848_7.jpg" style="width:527px;height:436px;" />&#160;</p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This was consistent with results from in vivo studies in which human HSPCs were engrafted for 16 weeks into 15 immune-compromised mice, with 15 mice used as a vehicle treated (&#x201c;Vh&#x201d;) control group. We investigated the impact of Mylotarg on CD14+ monocytes derived from these human HSPCs since CD14+ monocytes naturally express CD33 on their surface. As shown in the figure below, we observed that in the vehicle-treated groups, there was significant loss of CD14+ cells, while that population of cells was largely intact in the CD33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">Del</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> arm, leading to a 61-fold higher CD14+ cell frequency in the CD33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">Del</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> arm compared to the mock electroporated arm. These studies provide evidence of the resistance of CD33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">Del</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> eHSCs and progeny to anti-CD33 therapies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">CD33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">WT</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> and CD33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">Del </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">HSC survival after exposure to Mylotarg</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img17388848_8.jpg" alt="img17388848_8.jpg" style="width:501px;height:413px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Removal of CD33&#x2014;No Observed Impact on Biology</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Data from preclinical studies from multiple independent laboratories, alongside data from human genetics databases, show that CD33 can be removed from HSCs without any deleterious impact on cell biology.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The in vivo study below shows engraftment of human HSCs into 15 immune-compromised mice, with 15 mice used as a vehicle treated control group. Following 16 weeks of engraftment, CD33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">Del</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> eHSCs and CD33WT control cells differentiated into various classes of blood cells, which allowed detection of these cells and functional assays of differentiated cells. We observed statistically significant (p&lt;0.0001) lower rates of CD33 surface proteins, suggesting successful genome engineering in CD33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">Del</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> cells. As shown in the other figures below, we observed no statistically significant differences in the number of cells by cell type produced by the CD33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">WT</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and CD33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">Del </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">HSCs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">16-week xeno-transplant mouse model engraftment data of human CD33-engineered cells</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img17388848_9.jpg" alt="img17388848_9.jpg" style="width:624px;height:456px;" /><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In order to observe the in vitro functionality of differentiated immune cells derived from eHSCs, we compared the ability of cells differentiated from CD33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">WT</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and CD33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">Del</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> cells to phagocytose or produce cytokines. No differences in function were observed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Cells derived from CD33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">Del </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">eHSCs and CD33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">WT</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> HSCs demonstrate intact functionality</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img17388848_10.jpg" alt="img17388848_10.jpg" style="width:624px;height:187px;" />&#160;</p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to data generated by us, academic laboratories at Columbia University, the University of Pennsylvania, and the Fred Hutchinson Cancer Research Center have each conducted similar experiments in vitro and in vivo with very similar findings, showing that no deleterious effects can be observed from replacing existing blood cells with CD33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">Del</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> cells.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Preclinical Validation of CD33 Deletion in HSCs</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img17388848_11.jpg" alt="img17388848_11.jpg" style="width:624px;height:272px;" />&#160;</p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">While these preclinical data offer encouraging evidence of the non-essential nature of CD33, we believe the strongest support for our approach comes from existing human genetics data. We have found 65 individuals with homozygous loss of function mutations in the CD33 gene using the genetic database maintained by the Broad Institute. More recently, we identified 176 individuals with homozygous loss-of-function mutations in CD33 through the database maintained by the UK Biobank. This critical evidence suggests the non-essential nature of CD33 function in humans. We believe this finding of so-called &#x201c;null mutants&#x201d; among the adult human population, combined with the lack of discernable in vitro and in vivo effects observed with the removal of CD33, mitigates concerns associated with introducing CD33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">Del</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> eHSCs in humans.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">VBP101 Clinical Trial</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our IND application for VOR33 in patients with AML was accepted by the FDA in January 2021, and we have initiated VBP101, our first-in-human Phase 1/2a trial of VOR33 in combination with Mylotarg.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> VOR33 has received Fast Track designation for the treatment of AML from the FDA allowing for potential facilitated development and expedited review process and Orphan-drug designation (&#x201c;ODD&#x201d;), which is granted by the FDA to a drug or biologic intended to treat a rare disease or condition that affects fewer than 200,000 individuals in the U.S. ODD granted therapies entitle companies to development incentives including tax credits for clinical testing, prescription drug user fee exemptions, and seven-year marketing exclusivity in the event of regulatory approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The clinical strategy for VOR33 is to initially evaluate engraftment and tolerability, then assess clinical activity in subsequent clinical trials. The VBP101 trial is actively recruiting and w</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">e anticipate initial clinical data in the second half of 2022</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. If successful, this trial will provide important validating evidence of the potential of VOR33 and our broader eHSC approach.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The primary goals of the VBP101 trial are to evaluate tolerability and feasibility, with a focus on confirming that VOR33 can engraft in patients in a timely manner. Patients will then be eligible for subsequent treatment with Mylotarg. While this trial is not designed to evaluate the efficacy of the combination of VOR33 and Mylotarg, we may generate data on the incidence of the previously documented hematopoietic toxicities associated with Mylotarg. Any observed protection from such on-target toxicity in this Phase 1/2a trial would serve as an important proof of principle for our research and development platform.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The VBP101 clinical trial will enroll CD33-positive AML patients who are at a high risk of relapse. We will start our screening process with patients who have achieved morphologic remission, which means they have no detectable AML blasts in peripheral blood. As part of routine clinical practice, genetic profiling will also be used to identify those patients who have disease markers associated with a high risk of disease relapse, such as MRD status.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">After the primary disease in these patients is put into remission, we expect a substantial number of patients will have MRD or other disease markers showing high risk of relapse and therefore will be candidates for VOR33.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> To administer VOR33, HSCs from matched healthy donors will be isolated, engineered into VOR33 and then introduced into patients following myeloablative conditioning. We expect that engraftment of VOR33 will occur within 28 days of administration, which occurs in over 90% of standard HSCT procedures. As a safety measure, we will freeze and preserve a portion of the original donor cells to use in case of the failure of VOR33 to engraft. At day 60, we will re-evaluate patients for disease status. Those patients with successful VOR33 grafts who experience relapse of their AML will then become eligible to be treated with therapeutic doses of Mylotarg. Other patients will be treated with maintenance doses of Mylotarg once a month for four months to address any remaining MRD.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expect the key analytical and clinical read-outs of the VBP101 clinical trial to include the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:4.528%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Engraftment.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Hematologic cell counts will be assessed following transplant with the expectation that absolute neutrophil cell counts will be greater than or equal to 500/mm</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> by day 28 post-transplant for three consecutive days. </span></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Mylotarg Toxicities.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Patients receiving Mylotarg usually exhibit significant myelosuppression within one to two weeks following dosing. Patients will be monitored for neutrophil cell counts following Mylotarg dosing, and will be assessed for suitability for receiving repeat Mylotarg dosing.</span></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Clinical Activity Observations.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Following Mylotarg treatment, patients will be monitored for the presence of MRD, which are biomarkers in bone marrow indicating remaining presence of cancer. MRD positivity is a strong predictor of AML relapse, and change from MRD positive to negative status would be clinically meaningful. In addition, patients will be assessed for the incidence of relapse-free survival and overall survival. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">VBP101: VOR33+Mylotarg Phase 1/2a Clinical Trial</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img17388848_12.jpg" alt="img17388848_12.jpg" style="width:624px;height:278px;" />&#160;</p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">VOR33 with Other Targeted Therapies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Mylotarg is currently the only anti-CD33 therapy approved by the FDA. We believe that other anti-CD33 therapies that are not yet approved, such as our VCAR33 product candidates or bispecific antibodies, may ultimately be better targeted therapies due to higher expected potency and target specificity. Different therapeutics may also be more suitable in various clinical settings and disease states. We therefore plan to support research and development efforts studying the benefits of VOR33 and other eHSC approaches with several targeted therapies using different treatment modalities. This strategy is intended to optimize the potential for VOR33 and other eHSC programs to</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">eventually become a new standard of care in transplantation, unlocking the potential of multiple targeted therapies for patients with AML and other blood cancers.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">VOR33 and Myelodysplastic Syndrome and Myeloproliferative Neoplasm</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other blood cancers overexpress CD33, including myelodysplastic syndrome (&#x201c;MDS&#x201d;) and myeloproliferative neoplasms (&#x201c;MPNs&#x201d;). MDS consists of a spectrum of bone marrow cancers that are characterized by reduction in blood cell counts and an increase in immature blood cells in bone marrow. This condition evolves into AML in up to 30% of cases. Similarly, MPNs are a group of blood cancers such as chronic myelogenous leukemia, chronic neutrophilic leukemia, polycythemia vera, primary myelofibrosis and essential thrombocythemia where excessive fully differentiated blood cells are produced by the bone marrow, and these conditions may also evolve into more aggressive AML. Patients with these conditions can be segmented into different risk categories based on cell counts and cytogenetics, with intermediate- or high-risk patients often treated with HSCT, and together MDS and MPN are the most common indications for allogeneic HSCT outside of AML. Scientific evidence produced by third parties shows that blast cells responsible for MDS and MPN express CD33 and other myeloid cell surface targets. We believe VOR33 has the potential to provide a therapeutic window that enables anti-CD33 therapies to be effective in those settings, and we are exploring the potential use of VOR33 in combination with targeted therapies in these indications.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">VCAR33 for the Treatment of Blood Cancers</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Overview</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">VCAR33 is a CAR-T therapy designed to target CD33, a clinically-validated target for AML. VCAR33 uses a CAR moiety that recognizes CD33 on the outside of the cell surface using the huM195 CD33 binder. The same binder was used in lintuzumab, which is an agent that has been tested in clinical trials and demonstrated clinical activity. We licensed VCAR33 from the National Institutes of Health (&#x201c;NIH&#x201d;). We are studying VCAR33 with autologous and allogeneic cell sources.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <div style="margin-left:4.528%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">AUTO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> uses autologous cells from each patient, and is being studied in an ongoing Phase 1/2 clinical trial sponsored by the NMDP in young adult and pediatric patients with relapsed/refractory AML in a bridge-to-transplant study. We have received cross-reference rights for the IND for the NMDP program. Initial data from this study is expected in 2022, depending on the investigator&#x2019;s timing of data release.</span></div></div>
  <div style="margin-left:4.528%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:4.537%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.7521786492374725%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">uses allogeneic healthy donor-derived cells. There has been an increasing appreciation of the value of cell phenotype in CAR-T approaches, and the HLA-matched healthy donor cells are a potentially superior cell phenotype with improved persistence and in vivo expansion ability. VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">is a newly announced program. We plan to submit an IND for this program in the first half of 2023 to support a Phase 1/2 clinical trial for patients with relapsed/refractory AML.</span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Preclinical Proof of Concept</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The NIH conducted preclinical studies to assess the ability of various CAR-T constructs, including a construct using the huM195 binder, to clear human AML tumor cells implanted in mice. These CAR-T constructs, as well as a saline solution and untransduced T cells used as controls, were administered to mice that were then observed over the course of a 10-week period. As shown in the figure below, the constructs targeting the 4-1BB costimulatory domain were less active against the AML cells than those containing CD28. In addition, in other studies, the NIH noted toxicity signals in CAR constructs containing the hP67.6 binder, which is the same binder used in Mylotarg. As a result, the NIH choose to take the construct using the huM195 binder and CD28 into clinical development.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Tumor cell clearance of CAR constructs in mouse xenograft models</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img17388848_13.jpg" alt="img17388848_13.jpg" style="width:624px;height:509px;" />&#160;</p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;font-style:italic;">AUTO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Clinical Development</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">AUTO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> NMDP Phase 1/2 clinical trial is running in two phases: the first phase, which is expected to enroll approximately 12 patients, is designed to determine the maximum tolerated dose of VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">AUTO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> using a 3+3 trial design; the second phase, which is expected to enroll up to 16 patients, is an expansion phase designed to evaluate the rate of clinical response to treatment. VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">AUTO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> could cause bone marrow failure due to the elimination of normal hematopoiesis in the absence of an approach that limits on-target toxicity, and therefore, the clinical trial is studying VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">AUTO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> in the bridge-to-transplant setting, where bone marrow failure is manageable with subsequent transplant. Patients will be monitored for safety endpoints associated with CAR-T therapy including evidence of cytokine release syndrome, hepatotoxicity and neurotoxicity. Additional endpoints, such as graft versus host disease incidence, treatment-related mortality and time to engraftment, will be assessed post-HSCT to determine the safety of VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">AUTO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> in combination with the transplantation procedure.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Key clinical efficacy endpoints of the trial include reduction of the blast count in the bone marrow to achieve a morphologic remission, assessment of the elimination of MRD by flow cytometry or molecular methods and the percent of patients consequently able to proceed to a potentially curative HSCT. Standard transplant-related outcomes of the trial including overall survival, relapse rates and event-free survival will be measured. Exploratory objectives will assess VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">AUTO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> performance in patients including expansion and persistence within the blood and bone marrow.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The NMDP is responsible for all aspects of this trial, including the design of the trial, the manufacture of study product, the enrollment, dosing and follow-up of patients, the recording of trial data and the analysis of results. We also did not control the preclinical development of this program, which was conducted by the NIH, and we do not have rights under the license agreement to certain intellectual property, such as know-how, employed by the NMDP in manufacturing study product or conducting its clinical trial, however, the NMDP has permitted us to cross-reference its IND for this trial in future IND applications that we may submit with the FDA.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;font-style:italic;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> Clinical Development</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We plan to study VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> in a Phase 1/2 clinical trial in older patients in an otherwise similar design to the NIH&#x2019;s VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">AUTO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> clinical trial. The clinical trial will run in two phases: the first phase, which is expected to enroll approximately 12 patients, is designed to determine the maximum tolerated dose of VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> using a 3+3 trial design; the second phase, which is expected to enroll up to 12 patients, is an expansion phase designed to evaluate the rate of clinical response to treatment. VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> could cause bone marrow failure due to the elimination of normal hematopoiesis in the absence of an approach that limits on-target toxicity, and therefore, the clinical trial is studying VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">in the bridge-to-transplant setting, where bone marrow failure is manageable with subsequent transplant. Patients are monitored for safety endpoints associated with CAR-T therapy including evidence of cytokine release syndrome, hepatotoxicity and neurotoxicity. Since VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> uses T cells sourced from a healthy donor, there may be additional risk of these T cells attacking the patient called graft versus host disease, and incidence of this will be monitored in the trial. In addition, treatment-related mortality and time to engraftment, will be assessed post-HSCT to determine the safety of VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">in combination with the transplantation procedure. We plan to submit an IND for this clinical trial in the first half of 2023.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We anticipate the key clinical efficacy endpoints of the trial being the reduction of the blast count in the bone marrow to achieve a morphologic remission, assessment of the elimination of MRD by flow cytometry or molecular methods and the percent of patients consequently able to proceed to a potentially curative HSCT. Standard transplant-related outcomes of the trial including overall survival, relapse rates and event-free survival will be measured. Exploratory objectives will assess VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> performance in patients including expansion and persistence within the blood and bone marrow.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our Solution to Transform Patient Outcomes: The VOR33 + VCAR33 Treatment System</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe VOR33 could unlock the potential of anti-CD33 therapies that are much more potent than Mylotarg. We believe VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> could be a highly potent anticancer therapy that, when combined with VOR33, is not associated with severe myeloablative toxicities. We believe the VOR33 + VCAR33 Treatment System is a novel and comprehensive approach that has the potential to transform clinical outcomes and establish a new standard of care for patients suffering with AML.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">An attractive feature of this Treatment System is to use the same allogeneic source of cells for both the eHSC and CAR-T. In this scenario, the apheresis product from the healthy donor can be processed to serve as starting materials for both products. One advantage of this approach is that donor-derived T cells should not recognize CAR-T cells as foreign, potentially prolonging persistence. In addition, sourcing T cells from healthy donors may provide a healthier, more abundant cell source, allowing for optimizations and efficiencies in the manufacturing process that are not possible with autologous sources. Unlike autologous CAR-T therapies, the manufacturing of the CAR-T cells would not be rate limiting when combined with VOR33, as the CAR-T therapy would not be needed until 60 days after administration of VOR33.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Production of VOR33 + VCAR33 Treatment System from the same donor</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img17388848_14.jpg" alt="img17388848_14.jpg" style="width:471px;height:346px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">VOR33 + VCAR33 Treatment System&#x2014;Clinical Development</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We intend to submit an IND application with the FDA and conduct a clinical trial of the VOR33 + VCAR33 Treatment System after we obtain the initial results from our VOR33 Phase 1/2a clinical trial and our planned VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Phase 1/2 monotherapy clinical trial. We believe demonstration of disease clearance activity by VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">would provide a fundamental rationale for further development in a non-relapse/refractory population which is still high risk, including patients with poor prognostic molecular markers and/or MRD positivity. We would evaluate VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> in a post-VOR33 transplant setting to reduce the risk of recurrence or treat evidence of early relapse. Through use of VOR33, we believe VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> could be used in a post-transplant maintenance setting since CD33 negative hematopoiesis established by the VOR33 graft would be protected from eradication. The objective of this trial would be to assess the safety and initial clinical efficacy of the VOR33 + VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Treatment System.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Ongoing Preclinical Programs</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe our approach can extend beyond CD33 where targets fulfill three important criteria: firstly, these targets are expressed on cancer cells; secondly, these targets are expressed on cells of hematopoietic lineage (and therefore present a safety concern); and lastly there is evidence these protein targets are biologically dispensable. We have generated data exploring targets such as CD123, EMR2, and CD5 which all currently show promise fulfilling these criteria.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Other Myeloid Targets: CD123, CLL-1, EMR2</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">CD123, CLL-1, and EMR2 are targets expressed strongly in various myeloid blood cancers including AML. These targets are expressed both in bulk AML cells as well as leukemic stem cells. As shown in the figure below, we have the ability to genetically engineer HSCs in human cells to remove expression of these targets with good efficiency. As such, we continue to research these targets as potential target candidates for our eHSCs and CAR-T therapies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">High Editing Frequency Observed in Human CD34</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">+</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Cells for CD123, CLL-1 and EMR2</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">22</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><img src="img17388848_15.jpg" alt="img17388848_15.jpg" style="width:411px;height:247px;" />&#160;</p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Multiplex Engineering: The VOR33-CLL1 + VCAR33-CLL1 Treatment System</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Multiplex engineering is a strategy and method where multiple genetic targets are engineered within the same cells in the same manufacturing process. Multiplex engineering could allow removal or modification of two or more distinct genes, thus allowing for targeted therapies directed at two or more separate targets to be used in combination or in sequence, which could be particularly valuable to prevent escape mechanisms involving tumor cells down-regulating target expression.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have developed several techniques for multiplex engineering HSCs. One such technique is sequential Cas9 editing, where HSPCs are subject to a two separate Cas9 edits separated by a defined time period in order to allow the first edit to complete before applying the second edit. This separation is important to avoid translocations errors, which are gene repairs resulting in one DNA segment joining other DNA segments from different parts of the same chromosome or segments of other chromosomes. As seen in the chart below left, we can efficiently knock out expression of both CD33 and CLL-1 from HSPCs using this technique.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Another technique involves a technology called base editing, which involves converting a specific DNA base into another at a targeted genomic locus. As such, base editing does not require a cut, lowering the risk of translocation errors. As seen in the chart on the below right, we can efficiently knock out expression of both CD33 and CLL-1 from HSPCs using a single base editing step.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">23</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><img src="img17388848_16.jpg" alt="img17388848_16.jpg" style="width:624px;height:365px;" />&#160;</p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our expertise in multiplex engineering allowed us to make progress on a new program called the VOR33-CLL1 + VCAR33-CLL1 Treatment System. This Treatment System is made up of the VOR33-CLL1 multiplex-engineered eHSC, and the VCAR33-CLL1 multi-specific CAR-T.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In vitro proof of concept for this approach is shown below. In this experiment we compared the survival of wild type, CD33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">Del</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, CLL-1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">Del </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and CD33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">Del</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">+CLL-1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">Del</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> cell lines when simultaneously exposed to CD33 and CLL-1 CAR-T treatments. We observed statistically significant higher survival for cell lines with protein removals corresponding to the CAR-T targets, with the highest survival in the cell line lacking both CD33 and CLL-1 surface targets. These results suggest that the removal of these surface targets provided protection of the cell lines from the target-specific effects of the CAR-T therapy.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A multiplex approach may provide advantages in two areas. Firstly, target expression can vary in tumor cells from the same patient, a phenomenon known as tumor heterogeneity. Applying therapies such as a multi-specific CAR-T may reduce that concern. Secondly, it is theoretically possible for tumor cells to downregulate expression of a target to avoid being killed, a phenomenon known as tumor escape. Again, pursuing multiple targets simultaneously may reduce the effectiveness of the tumor escape mechanism.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Survival of CD33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">Del</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> and CLL-1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">Del</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> cells after exposure to</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">anti-CD33 and anti-CLL-1 CAR-T therapies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img17388848_17.jpg" alt="img17388848_17.jpg" style="width:624px;height:339px;" />&#160;</p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Beyond Myeloid Diseases: CD5</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As HSCs differentiate, there are two distinct lineages: myeloid and lymphoid. The lymphoid lineage differentiates into important immune cells such as T cells, B cells, and natural killer cells, which are important for fighting infection and preventing development of cancer. Lymphoid cells also have the potential to crease cancerous cells.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">CD5 is a cell surface protein that is ubiquitously expressed on T cells. CD5 is also expressed on the majority of T cell malignancies, and therefore could be an attractive target to eliminate cancer cells with two important concerns. Firstly, elimination of all cells expressing CD5 could result in decreased T cell counts which is called lymphopenia, which is not compatible with long-term survival. Secondly, since the CAR-T cells themselves express CD5, CAR-T cells attacking CD5 can also attack themselves, a phenomenon known as fratricide.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our approach may address both of these concerns. Elimination of CD5 from HSPCs would result in a lymphoid cell compartment lacking CD5 expression, therefore T cells may be protected from CD5-targeted therapies. Secondly, CAR-T cells can be made from CD5-deleted cell populations which may address the issue with fratricide. Preliminary data shows that CD5 may show similar biological dispensability characteristics to CD33. The chart below shows that we can delete CD5 expression from HSPCs with good efficiency.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">High Editing Frequency Observed in Human CD34</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">+</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> Cells for CD5</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img17388848_18.jpg" alt="img17388848_18.jpg" style="width:381px;height:320px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Commercial Strategy and Reimbursement Framework for Our eHSCs and CAR-T Product Candidate</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Given the potential value proposition of eHSCs enabling targeted therapies, our goal is to maximize the reach of our therapies, if approved, to all patients in the transplant setting suffering from blood cancers. Each year, approximately 42,500 new cases of AML are diagnosed across the United States (~20,000), Europe (~18,000) and Japan (~4,500). For the past 20 years, there has been an increasing trend in allogeneic transplants for AML. Currently, there are approximately 12,000 allogeneic HSCTs performed globally each year, with approximately 3,500 performed in the United States, 7,000 in Europe and 1,500 in Japan.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> We believe we will be able to commercialize our eHSCs and targeted therapies, if approved, with a focused footprint where we can leverage the existing logistical infrastructure of the NMDP and HSC transplants centers. HSCTs are performed at tertiary medical care hospitals with specialized HSC transplant centers. The United States, EU5 and Japan have approximately 200, 300 and 185 transplant centers, respectively. The transplant volumes are further concentrated with 15%, or approximately 30 U.S. transplant centers, performing 50% of U.S. transplants. Building on a concentrated network of transplant centers, we have the added advantage of a rapid manufacturing process of 7-10 days. This turn-around time for collecting cells and shipping is a critical component of a successful commercialization.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As shown below, we believe that our platform and approach gives us the ability to transform the treatment paradigm for patients suffering from AML at each significant step in their journey by increasing transplant eligibility, replacing the standard of care for transplants, and unlocking the potential of targeted therapies post-transplant.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Opportunity to Transform the Patient Journey</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><img src="img17388848_19.jpg" alt="img17388848_19.jpg" style="width:624px;height:283px;" />&#160;</p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> We believe multiple reimbursement pathways may be available in the United States to capture the value of eHSCs and targeted therapies, such as CAR-T. Effective for cost reporting periods beginning on or after October 1, 2020, under the Hospital Inpatient Prospective Payment System (&#x201c;IPPS&#x201d;), Medicare payment for HSCT will include a carve-out for the actual cost of stem cell acquisition and processing, and payment will instead be made on a reasonable cost basis. We believe this new rule may apply to innovative sources of donor stem cells like eHSCs. In addition, a new Medicare Severity Diagnosis-Related Group (&#x201c;MS-DRG&#x201d;) establishes a base payment rate of approximately $246,000 for CAR-T cases, with a base rate for clinical trial cases of approximately $42,000.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> A potential alternative reimbursement pathway for eHSC is Medicare New Technology Add-on Payment (&#x201c;NTAP&#x201d;) which, if approved, allows for temporary reimbursement for new cell therapies above the standard MS-DRG payment threshold. When certain criteria are met, the Centers for Medicare &amp; Medicaid Services (&#x201c;CMS&#x201d;), the federal agency responsible for administering the Medicare program, may provide incremental reimbursement for up to 65% of the cost of therapy in addition to the standard MS-DRG payment. For patients covered by commercial insurance, we believe that reimbursement will be based on a case rate methodology with provisions for separate payments for new therapies such as eHSC. Lastly, outcomes-based agreements or value-based purchasing models is another option that is becoming more common with novel cell and gene therapies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">27</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Potential Value Proposition and Reimbursement Pathways</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><img src="img17388848_20.jpg" alt="img17388848_20.jpg" style="width:624px;height:280px;" />&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">License Agreements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Exclusive License Agreement with Columbia University</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In April 2016, we entered into an exclusive license agreement with The Trustees of Columbia University in the City of New York (&#x201c;Columbia&#x201d;), which agreement was subsequently amended in February 2019 and November 2021 (the &#x201c;Columbia Agreement&#x201d;). Pursuant to the Columbia Agreement, we obtained a worldwide, exclusive license, with the right to grant sublicenses (subject to certain restrictions), under certain of Columbia&#x2019;s patents, know-how and materials to discover, develop, manufacture, have made, use, sell, offer to sell, have sold, import, export, distribute, rent or lease products that are covered by such patents or involve the use of or otherwise incorporate such know-how or materials, in each case for any and all uses. The foregoing license is subject to certain customary retained rights of Columbia, including the right to conduct academic research and publish know-how. We are also obligated to use commercially reasonable efforts to research, discover, develop and market licensed products for commercial sale and distribution, including by achieving one or more specified diligence milestones.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under the Columbia Agreement, we paid Columbia an upfront fee of $25,000 and issued to Columbia 91,911 shares of our common stock. We are also obligated to pay Columbia an annual fee in the low five digits, as well as royalties on net sales of products that are covered by the licensed patents ranging in the low single digits and on net sales of products that are not covered by the licensed patents but involve the use of or otherwise incorporate licensed know-how or materials ranging in the low single digits (which range is lower than the range for patented products), in each case with respect to such products sold by us but not our sublicensees. Royalties are payable on a patented product-by-patented product basis and country-by-country basis for such period as a valid claim covers such patented product in such country, which we expect to be until January 2040, absent any applicable patent term extensions, and, on an unpatented product-by-unpatented product and country-by-country basis for the longer of ten years from first commercial sale of such unpatented product in such country or expiration of any market exclusivity for such unpatented product in such country. If the royalty term for a patented product expires in a country and such product would otherwise qualify as an unpatented product in such country (and the applicable royalty term for such unpatented product has yet to expire in such country), then we are obligated to pay Columbia royalties for such unpatented product for the remainder of the royalty term in such country. Additionally, we are obligated to pay Columbia up to $4.45 million in the aggregate for certain clinical, regulatory and commercial milestones for the first two products, $2.0 million in the aggregate for certain commercial milestones for a single additional product incorporating certain of the intellectual property licensed to us under the Columbia Agreement and a mid-second decile percentage of consideration received from sublicensees, including royalties, provided that if such sublicensing income includes a milestone payment for which we are already obligated to make a milestone payment under the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">28</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Columbia Agreement, then Columbia shall only be entitled to the higher of our milestone payment and its portion of the sublicensing income.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Columbia Agreement expires on a country-by-country and product-by-product basis upon expiration of the applicable royalty term for such product in such country. Columbia may either terminate the Columbia Agreement or convert our license to a non-exclusive license in the case of our insolvency, or upon our uncured material breach of the agreement of certain specified provisions, including in the event that we fail to achieve one or more specified diligence milestone(s) and fail to mutually agree upon a revised plan for development of a licensed product. Additionally, we have the right to terminate the Columbia Agreement at any time upon specified written notice to Columbia.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Exclusive License Agreement with National Institutes of Health</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In October 2020, we entered into a patent license agreement (the &#x201c;Patent License&#x201d;) with the U.S. Department of Health and Human Services, as represented by National Cancer Institute (&#x201c;NCI&#x201d;) of the NIH. Pursuant to the Patent License, we hold an exclusive, worldwide license, sublicensable with the prior written consent of NIH, to certain intellectual property rights to develop, manufacture and commercialize licensed products, or to practice licensed processes, in each case, for use in the development of a CAR therapy mono-specific for CD33 for the prophylaxis or treatment of CD33-expressing hematological malignancies (but excluding CD33-specific logic-gated CAR-based immunotherapies) wherein the CAR is comprised of the CD33-binding domain referenced as Hu195 or hP67.6, is delivered via lentiviral transduction, and the T cells are derived from the patient or from an allogeneic source, which we collectively refer to as the field of use.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to the terms of the Patent License, we are required to pay NCI a license issue fee in the aggregate amount of $400,000. The terms of the Patent License also require us to pay NCI de minimis minimum annual royalties, which royalties are creditable against earned royalties on sales of licensed products or licensed processes. We must also pay NCI tiered royalties on net sales of licensed products at rates ranging in the low single digits if the product CAR-T cells are derived from the patient, and at a higher range of rates in the low single digits if the product CAR-T cells are derived from an allogeneic source. Such royalties are payable on a licensed product-by-licensed product and country-by-country basis, commencing on the date of first commercial sale of such licensed product in such country, until the date such licensed product ceases to be covered by a valid claim of a licensed patent in such country, which we expect to occur in March 2039, absent any applicable patent term extensions, and are subject to reduction for unblocking licenses from third parties, subject to a specified royalty floor.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are required to pay NCI one-time milestone payments upon successful completion of specified clinical and regulatory milestones relating to the licensed products. The aggregate potential milestone payments are $8.0 million. In addition, we are required to pay NCI one-time milestone payments following aggregate net sales of licensed products at certain net sales up to $2.0 billion. The aggregate potential amount of these milestone payments is $6.0 million. To the extent we enter into a sublicensing agreement relating to a licensed product, we are required to pay NCI a percentage of the non-royalty based consideration received from a sublicensee, with specified exclusions, which percentage ranges from the low single digits to low double digits, depending on the stage of development of the licensed product at the time of the sublicense. We are also required to reimburse NCI for its past patent expenses for the licensed patent rights, with such amounts being payable in three installments during the term of the Patent License, as well as our pro rata share of future patent expenses, in each case, in connection with NCI&#x2019;s prosecution or maintenance of the licensed patent rights. We have the right to surrender our license rights in any country and will not be required to pay NCI for patent prosecution or maintenance expenses for any licensed patents for which we exercise such right.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are required under the Patent License to use reasonable commercial efforts to bring the licensed products and licensed processes to practical application, which includes adhering to an agreed upon commercial development plan and meeting certain performance benchmarks. We are also required, commencing upon first commercial sale of a licensed product and for the remainder of the term of the Patent License, to use reasonable commercial efforts to make licensed products and licensed processes reasonably accessible to the U.S. public.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Patent License will expire upon expiration of the last valid claim of a licensed patent, unless terminated earlier as described below. NCI may terminate the Patent License in the event of a material breach, including if we do not use reasonable commercial efforts to execute the commercial development plan, or if we do not achieve the performance milestones by certain dates, following the expiration of a 90-day notice period during which we must ether cure the relevant breach or initiate corrective action to NCI&#x2019;s reasonable satisfaction. We may terminate the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">29</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Patent License, in its entirety or with respect to any license in any country, in our sole discretion at any time upon 60 days&#x2019; written notice to NCI. In addition, NCI has the right to require us to grant sublicenses under the licensed patent rights in any of the fields of use under specified conditions, if required by public health or safety concerns, or to terminate or modify the Patent License if deemed necessary to meet requirements for public use as specified by federal regulations, if NCI determines that we are not reasonably satisfying such requirements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We cannot assign the Patent License without NCI&#x2019;s prior written consent, other than to our affiliates. Upon NCI&#x2019;s approval of a proposed assignment, we must pay NCI a low-single digit percentage of the fair market value of any consideration we receive for such assignment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Sales and Marketing</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Given our stage of development, we have not yet established a commercial organization or distribution capabilities. We plan to build focused capabilities in the United States to commercialize our development programs focused on eHSCs and targeted therapies, where we believe the patient populations and medical specialists for the indications we are targeting are sufficiently concentrated to allow us to effectively promote our products, if approved for commercial sale, with a targeted sales team. In other markets for which commercialization may be less capital efficient where the patient populations and medical specialists are less concentrated we may selectively pursue strategic collaborations with third parties in order to maximize the commercial potential of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Manufacturing</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are currently building out our in-house clinical cGMP manufacturing facility in Cambridge, Massachusetts to support development of our eHSC and CAR-T therapeutic candidates for patients with blood cancers. We anticipate that the facility, located in the same premises as our headquarters, will be operational in 2022.  We have designed the facility to support clinical manufacturing for our cell therapy programs and to be cGMP compliant. By integrating our internal research, process development, analytical development, manufacturing, and quality control testing capabilities under one roof, we believe we can achieve flexible manufacturing capacity and reduce the time and cost required to manufacture our complex cell therapy clinical candidates. While this facility is in development, we continue to rely on third-party contract manufacturers for all of our required raw materials, manufacturing devices, active pharmaceutical ingredients and finished product for our research. We do not have long-term agreements with any of these third parties. We also do not have any current contractual relationship for the manufacture of material for clinical trials beyond Phase 1/2a or commercial supplies. We intend to enter into agreements with third-party contract manufacturers and one or more backup manufacturers for future production. Although we are developing certain in-house manufacturing capabilities for our current clinical needs, we continue to analyze the feasibility of building additional manufacturing capabilities for future development and commercial quantities of any products that we develop. Such products will need to be manufactured in facilities, and by processes, that comply with the requirements of the FDA and the regulatory agencies of other jurisdictions in which we are seeking approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Competition</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The biotechnology industry is characterized by intense and dynamic competition to develop new technologies and proprietary therapies. Any product candidates that we successfully develop and commercialize will have to compete with existing therapies and new therapies that may become available in the future. We believe that our technology platform and our scientific and clinical expertise may provide us with competitive advantages. However, we face potential competition from various sources, including larger and better-funded pharmaceutical, specialty pharmaceutical and biotechnology companies, as well as from academic institutions, governmental agencies and public and private research institutions. Prior to approval, these entities may compete with us in hiring scientific and management personnel, establishing clinical study sites, recruiting patients to participate in clinical trials and acquiring technologies complementary to, or necessary for, our programs. Furthermore, key competitive factors will affect the success of any product that may be approved by regulators, including the efficacy, safety profile, pricing, method of administration and level of promotional activity of such product.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the case of our lead eHSC product candidate, VOR33, we are not aware of any approved products or product candidates in development that apply gene engineering technology to donor HSCs in order to reduce the on-target toxicity of targeted cancer therapies. However, researchers at the University of Pennsylvania (&#x201c;UPenn&#x201d;) have</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">published the results of academic studies on gene engineering HSCs for this purpose, and UPenn has licensed intellectual property related to this approach to Tmunity Therapeutics Incorporated. We are also aware of a large number of companies that are attempting to address the problem of on-target toxicity through other treatment modalities, including many companies attempting to improve the specificity of targeted therapies, including CD33-directed targeted therapies, for AML and other hematological cancer cells. For example, Johnson &amp; Johnson and Amgen Inc. have CD33-directed bispecific antibodies in Phase 1 clinical development, 2seventy bio is studying a regulatable CD33 CAR-T and CRISPR Therapeutics AG has released data from preclinical studies for an allogeneic CAR-T program targeting CD33. If any of these companies successfully develop effective targeted therapies for hematological malignancies without significant on-target toxicity, we believe they could compete with our eHSCs, including VOR33.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the case of VCAR33, there are a number of companies exploring CAR-T therapies in early trials for relapsed/refractory AML. Some of these therapies are directed against targets that have approved monoclonal antibody competitors on the market already, while others have novel targets. For example, PersonGen BioTherapeutics (Suzhou) Co., Ltd. is studying a CAR-T therapy targeting tumor associated antigens, Precigen, Inc. is studying a CAR-T therapy targeting CD33 and Mustang Bio, Inc. and Cellectis S.A. are separately studying CAR-T therapies targeting CD123. Dual targeting CAR-T cell-based approaches have also recently begun clinical trials, including the ICG-144 program by iCell Gene Therapeutics, LLC, BG-NE1 by Guangzhou Bio-Gene and the LB1910 program from Legend Biotech Corporation, each of which target both CD33 and CLL-1.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Beyond CAR-T therapies, a number of small molecule and monoclonal antibody products have been approved in recent years for the treatment of AML, including Novartis International AG&#x2019;s Rydapt (midostaurin), Jazz Pharmaceuticals plc&#x2019;s Vyxeos (daunorubicin and cytarabine), Bristol-Myers Squibb Company&#x2019;s Idhifa (enasidenib), Pfizer Inc.&#x2019;s Mylotarg (gemtuzumab ozogamicin) and Daurismo (glasdegib), Agios Pharmaceuticals Inc.&#x2019;s Tibsovo (ivosidenib), Astella Pharma Inc.&#x2019;s Xospata (gilteritinib), and AbbVie Inc.&#x2019;s Venclexta (venetoclax). Other treatment modalities, such as bispecific antibodies and antibody-drug conjugates are also in development across a wide range of targets. In addition, marketed therapies are being studied in the relapsed/refractory setting, including Bristol-Myers Squibb Company&#x2019;s CC-486 oral formulation of azacitidine and AbbVie Inc.&#x2019;s venetoclax.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Many of our current or potential competitors have substantially greater financial, technical and human resources. Accordingly, our competitors may be more successful in developing or marketing products and technologies that are more effective, safer or less costly. Additionally, our competitors may obtain regulatory approval for their products more rapidly and may achieve more widespread market acceptance. Future collaborations and mergers and acquisitions may result in further resource concentration among a smaller number of competitors. Smaller or early-stage companies may also prove to be significant competitors, either alone or through collaborative arrangements with large and established companies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Intellectual Property</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Overview</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We strive to protect the proprietary product candidates and technologies that we believe are important to our business, including seeking and maintaining patent protection intended to cover the composition of matter of our product candidates, their methods of use, their methods of production, related technologies and other inventions. In addition to patent protection, we also rely on trade secrets to protect aspects of our business that are not amenable to, or that we do not consider appropriate for, patent protection, including certain aspects of technical know-how.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our commercial success depends in part upon our ability to obtain and maintain patent and other proprietary protection for commercially important technologies, inventions and know-how related to our business, defend and enforce our intellectual property rights, particularly our patent rights, preserve the confidentiality of our trade secrets and operate without infringing valid and enforceable intellectual property rights of others.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The patent positions for biopharmaceutical companies like us are generally uncertain and can involve complex legal, scientific and factual issues. In addition, the coverage claimed in a patent application can be significantly reduced before a patent is issued, and its scope can be reinterpreted and even challenged after issuance. As a result, we cannot guarantee that any of our product candidates will be protectable or remain protected by enforceable patents. We cannot predict whether the patent applications we are currently pursuing will issue as patents in any particular jurisdiction or whether the claims of any issued patents will provide sufficient proprietary</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">31</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">protection from competitors. Any patents that we hold may be challenged, circumvented or invalidated by third parties.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of February 28, 2022, our owned patent portfolio is composed of approximately 88 pending U.S. and foreign patent applications, approximately 22 pending U.S. provisional patent applications, and one granted U.S. patent. In addition, we have licensed seven granted U.S. and foreign patents, and approximately 46 pending patent applications in the United States and foreign jurisdictions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Patent Rights Relating to Our eHSC Programs</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The patent portfolio related to our lead eHSC product candidate, VOR33, includes three patent families that are exclusively licensed from Columbia. The first patent family licensed from Columbia is directed to compositions and methods for gene engineering lineage-specific cell surface antigens, such as CD33, in HSCs and use thereof, and includes seven granted U.S. and foreign patents, two pending U.S. applications and at least 13 pending foreign applications in Europe, Japan, Canada, China, Australia and other jurisdictions. Any patents that grant from applications claiming priority to this patent family would be expected to expire in 2036, absent any applicable patent term extensions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of February 28, 2022, the second patent family licensed from Columbia, directed to compositions and methods of use of HSCs containing a single nucleotide polymorphism in CD33, includes a pending U.S. application and two pending foreign applications in Europe and Japan. Any patents that grant from applications claiming priority to this patent family would be expected to expire in 2038, absent any applicable patent term extensions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of February 28, 2022, the third patent family licensed from Columbia, directed to compositions and methods for gene engineering CD33 in HSCs and use thereof, includes a U.S. patent  and at least 14 pending foreign applications in Europe, Japan, Canada,  China, Australia and other jurisdictions. Any patents that grant from applications claiming priority to this patent family would be expected to expire in 2040, absent any applicable patent term extensions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The patent portfolio related to VOR33 also includes three patent families that we own. As of February 28, 2022, the first family, directed to compositions and methods of engineering lineage-specific antigens in HSCs includes one pending patent application in the United States and 15 pending foreign applications in Europe, Japan, Canada, China, Australia and other jurisdictions. Any patents that grant from applications claiming priority to this patent family would be expected to expire in 2038, absent any applicable patent term extensions. As of February 28, 2022, the second family, directed to compositions and methods of engineering multiple lineage-specific antigens in HSCs, includes one U.S. patent, seven pending U.S. patent applications and at least 15 pending foreign patent applications. Any patents that grant from applications claiming priority to these provisional applications would be expected to expire in 2039, absent any applicable patent term extensions. As of February 28, 2022, the third family, directed to compositions and methods of treating a hematopoietic malignancy, includes a pending Patent Cooperation Treaty (&#x201c;PCT&#x201d;) patent application. Any patents that grant from applications claiming priority to this patent would be expected to expire in 2041, absent any applicable patent term extensions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We also own three patent families directed to compositions and methods of engineering specific antigens in HSCs, including CD33, CLL-1 and CD123. As of February 28, 2022, the first family, directed to compositions and methods for engineering CD33 in HSCs includes one pending U.S. application and eight pending foreign patent applications. As of February 28, 2022, the second family, directed to compositions and methods for engineering CLL-1 in HSCs includes one pending U.S. application and eleven pending foreign patent applications. As of February 28, 2022, the third family, directed to compositions and methods for engineering CD123 in HSCs includes one pending U.S. application and 11 pending foreign applications.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We also own eight patent families directed to compositions and methods of engineering additional target antigens in HSCs. Seven of these families include a pending PCT application each, and one of these families includes a pending U.S. provisional patent application. Any patents that grant from applications within these families would be expected to expire in 2041 or 2042, absent any applicable patent term extensions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Patent Rights Relating to Our Targeted Therapy Programs</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We own three patent families directed to compositions and methods of making and using CARs. As of February 28, 2022, each of these families includes at one pending PCT application, and any patents that grant from applications in these families would be expected to expire in 2041, absent any applicable patent term extensions.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have one patent family that is exclusively licensed from the NIH related to our VCAR33 program. As of February 28, 2022, the patent family licensed from NCI is directed to CARs targeting CD33, compositions containing cells expressing CARs, and methods of use thereof, and includes one pending U.S. application and at least 14 pending foreign applications in Europe, Japan, Canada, China, Australia and other countries. Any patents that grant from applications in this patent family would be expected to expire in 2039, absent any applicable patent term extensions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We own one patent family directed to compositions and methods of using single domain antibodies targeting CD33. As of February 28, 2022, this family includes one pending PCT patent application, and any patents that grant from applications in this family would be expected to expire in 2041, absent any applicable patent term extensions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Provisional Patent Applications</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As indicated above, many of our owned patent applications are provisional patent applications. Provisional patent applications are not eligible to become issued patents until, among other things, we file a non-provisional patent application within 12 months of filing of one or more of our related provisional patent applications. If we do not timely file any non-provisional patent applications, we may lose our priority date with respect to our provisional patent applications and any patent protection on the inventions disclosed in our provisional patent applications. While we intend to timely file non-provisional patent applications relating to our provisional patent applications, we cannot predict whether any such patent applications will result in the issuance of patents that provide us with any competitive advantage. Moreover, the patent application and approval process is expensive and time-consuming. We may not be able to file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Patent Term and Term Extensions</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The term of individual patents depends upon the legal term for patents in the countries in which they are obtained. In most countries in which we have filed, including the United States, the patent term is 20 years from the earliest filing date of a non-provisional patent application. In the United States, a patent&#x2019;s term may be lengthened by patent term adjustment, which compensates a patentee for administrative delays by the U.S. Patent and Trademark Office in examining and granting a patent, or may be shortened if a patent is terminally disclaimed over an earlier filed patent. The term of a patent that covers a drug or biological product may also be eligible for patent term extension when FDA approval is granted for a portion of the term effectively lost as a result of the FDA regulatory review period, subject to certain limitations and provided statutory and regulatory requirements are met. Any such patent term extension can be for no more than five years, only one patent per approved product can be extended, the extension cannot extend the total patent term beyond 14 years from FDA approval, and only those claims covering the approved drug, a method for using it, or a method for manufacturing it may be extended. We may not receive an extension if we fail to exercise due diligence during the testing phase or regulatory review process, fail to apply within applicable deadlines, fail to apply prior to expiration of relevant patents or otherwise fail to satisfy applicable requirements. Moreover, the length of the extension could be less than we request. In the future, if and when our product candidates receive approval from the FDA or foreign regulatory authorities, we expect to apply for patent term extensions on issued patents we may obtain in the future covering those products, depending upon the length of the clinical trials for each product and other factors. There can be no assurance that any of our pending patent applications will issue or that we will benefit from any patent term extension or favorable adjustment to the term of any of our patents.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As with other biotechnology and pharmaceutical companies, our ability to maintain and solidify our proprietary and intellectual property position for our product candidates will depend on our success in obtaining effective patent claims and enforcing those claims if granted. However, our owned and licensed pending patent applications, and any patent applications that we may in the future file or license from third parties may not result in the issuance of patents. We also cannot predict the breadth of claims that may be allowed or enforced in our patents. Any issued patents that we may receive in the future may be challenged, invalidated, infringed or circumvented. In addition, because of the extensive time required for clinical development and regulatory review of a product candidate we may develop, it is possible that, before any of our product candidates can be commercialized, any related patent may expire or remain in force for only a short period following commercialization, thereby limiting the protection such patent would afford the respective product and any competitive advantage such patent may provide. For more information, see the section entitled &#x201c;Risk Factors&#x2014;Risks Related to Intellectual Property.&#x201d;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">33</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Other IP Rights</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to patents, we rely upon unpatented trade secrets and know-how, continuing technological innovation and confidential information to develop and maintain our proprietary position and protect aspects of our business that are not amenable to, or that we do not consider appropriate for, patent protection, including our proprietary processes for generating and propagating eHSCs. However, trade secrets and know-how can be difficult to protect. We seek to protect our proprietary information, in part, by executing confidentiality agreements with our collaborators and scientific advisors, and non-competition, non-solicitation, confidentiality and invention assignment agreements with our employees and consultants. We have also executed agreements requiring assignment of inventions with selected scientific advisors and collaborators. The confidentiality agreements we enter into are designed to protect our proprietary information and the agreements or clauses requiring assignment of inventions to us are designed to grant us ownership of technologies that are developed through our relationship with the respective counterparty. We cannot guarantee, however, that we have executed such agreements with all applicable counterparties, such agreements will not be breached, or that these agreements will afford us adequate protection of our intellectual property and proprietary rights. In addition, our trade secrets may otherwise become known or be independently discovered by competitors. To the extent that our commercial partners, collaborators, employees and consultants use intellectual property owned by others in their work for us, disputes may arise as to the rights in related or resulting know-how and inventions. For more information, see the section entitled &#x201c;Risk Factors&#x2014;Risks Related to Our Intellectual Property&#x201d; in Part I, Item 1A of this Annual Report.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our commercial success will also depend in part on not infringing upon the proprietary rights of third parties. It is uncertain whether the issuance of any third-party patent would require us to alter our development or commercial strategies, or our drugs or processes, obtain licenses or cease certain activities. Our breach of any license agreements or failure to obtain a license to proprietary rights that we may require to develop or commercialize our future drugs may have an adverse impact on us. Since patent applications in the United States and certain other jurisdictions are maintained in secrecy for 18 months or potentially longer, and since publication of discoveries in the scientific or patent literature often lags behind actual discoveries, we cannot be certain of the priority of inventions covered by pending patent applications.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Trademarks</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We also aim to obtain and maintain registration for trademarks that we consider are relevant to our business. As of February 28, 2022, we have filed for registration of the trademarks for VOR BIOPHARMA, for VOR33, for VOR, and for Vor's &#34;V&#34; logo, for international class 5 (pharmaceuticals) under the Madrid Protocol, with more than 50 applications in the United States and foreign jurisdictions. We plan to register additional trademarks in connection with any future pharmaceutical products we may commercialize, if approved.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Government Regulation and Product Approval</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As a biopharmaceutical company that operates in the United States, we are subject to extensive regulation. Our cell product candidates will be regulated as biologics. With this classification, commercial production of our product candidates will need to occur in registered facilities in compliance with current good manufacturing practices (&#x201c;cGMP&#x201d;) for biologics. The FDA categorizes human cell- or tissue-based products as either minimally manipulated or more than minimally manipulated and has determined that more than minimally manipulated products require clinical trials to demonstrate product safety and efficacy and the submission of a Biologics License Application (&#x201c;BLA&#x201d;) for marketing authorization. Our product candidates are considered more than minimally manipulated and will require evaluation in clinical trials and the submission and approval of a BLA before we can market them.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The FDA and other government authorities in the United States (at the federal, state and local levels) and in other countries extensively regulate, among other things, the research, development, testing, manufacturing, quality control, approval, labeling, packaging, storage, record-keeping, promotion, advertising, distribution, post-approval monitoring and reporting, marketing and export and import of biopharmaceutical products such as those we are developing. Our product candidates must be approved by the FDA before they may be legally marketed in the United States and by the appropriate foreign regulatory agency before they may be legally marketed in foreign countries. Generally, our activities in other countries will be subject to regulation that is similar in nature and scope as that imposed in the United States, although there can be important differences. Additionally, some significant aspects of regulation in Europe are addressed in a centralized way, but country-specific regulation remains essential in many respects. The process for obtaining regulatory marketing approvals and the subsequent compliance with</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">34</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">appropriate federal, state, local and foreign statutes and regulations require the expenditure of substantial time and financial resources.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">U.S. Product Development Process</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the United States, the FDA regulates pharmaceutical and biological products under the Federal Food, Drug and Cosmetic Act, the Public Health Service Act (&#x201c;PHSA&#x201d;) and their implementing regulations. The process of obtaining regulatory approvals and the subsequent compliance with appropriate federal, state, local and foreign statutes and regulations require the expenditure of substantial time and financial resources. Failure to comply with the applicable U.S. requirements at any time during the product development process, approval process or after approval, may subject an applicant to administrative or judicial sanctions. FDA sanctions could include, among other actions, refusal to approve pending applications, withdrawal of an approval, a clinical hold, warning letters, product recalls or withdrawals from the market, product seizures, total or partial suspension of production or distribution injunctions, fines, refusals of government contracts, restitution, disgorgement or civil or criminal penalties. Any agency or judicial enforcement action could have a material adverse effect on us. The process required by the FDA before a biological product may be marketed in the United States generally involves the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">completion of nonclinical laboratory tests and animal studies according to FDA&#x2019;s good laboratory practices (&#x201c;GLPs&#x201d;) and applicable requirements for the humane use of laboratory animals or other applicable regulations; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">submission to the FDA of an IND application, which must become effective before human clinical trials may begin; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">approval by an independent Institutional Review Board (&#x201c;IRB&#x201d;) or ethics committee at each clinical site before the trial is commenced; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">performance of adequate and well-controlled human clinical trials according to the FDA&#x2019;s regulations commonly referred to as good clinical practices (&#x201c;GCPs&#x201d;) and any additional requirements for the protection of human research patients and their health information, to establish the safety and efficacy of the proposed biological product for its intended use; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">submission to the FDA of a Biologics License Application (&#x201c;BLA&#x201d;) for marketing approval that includes substantial evidence of safety, purity and potency from results of nonclinical testing and clinical trials; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">satisfactory completion of an FDA Advisory Committee review, if applicable; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">satisfactory completion of an FDA inspection of the manufacturing facility or facilities where the biological product is produced to assess compliance with cGMP, to assure that the facilities, methods and controls are adequate to preserve the biological product&#x2019;s identity, strength, quality and purity and, if applicable, the FDA&#x2019;s current good tissue practices (&#x201c;GTPs&#x201d;) for the use of human cellular and tissue products; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">potential FDA audit of the nonclinical study and clinical trial sites that generated the data in support of the BLA; and </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">FDA review and approval, or licensure, of the BLA to permit commercial marketing of the product for particular indications for use in the United States. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Before testing any biological product candidate, including our product candidates, in humans, the product candidate enters the preclinical testing stage. Preclinical tests, also referred to as nonclinical studies, include laboratory evaluations of product chemistry, toxicity and formulation, as well as animal studies to assess the potential safety and activity of the product candidate. The conduct of the preclinical tests must comply with federal regulations and requirements including GLPs. The clinical trial sponsor must submit the results of the preclinical tests, together with manufacturing information, analytical data, any available clinical data or literature and a proposed clinical protocol, to the FDA as part of the IND. Some preclinical testing may continue even after the IND is submitted. The IND automatically becomes effective 30 days after receipt by the FDA, unless the FDA raises concerns or questions regarding the proposed clinical trials and places the trial on a clinical hold within that 30-day time period. In such a case, the IND sponsor and the FDA must resolve any outstanding concerns before the clinical trial can begin. The FDA may also impose clinical holds on a biological product candidate at any time before or</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">35</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">during clinical trials due to safety concerns or non-compliance. If the FDA imposes a clinical hold, trials may not recommence without FDA authorization and then only under terms authorized by the FDA. Accordingly, we cannot be sure that submission of an IND will result in the FDA allowing clinical trials to begin, or that, once begun, issues will not arise that suspend or terminate such trials.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Supervision of human gene transfer trials includes evaluation and assessment by an Institutional Biosafety Committee (&#x201c;IBC&#x201d;), a local institutional committee that reviews and oversees research utilizing recombinant or synthetic nucleic acid molecules at that institution, as set forth in the NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules (&#x201c;NIH Guidelines&#x201d;). The IBC assesses the safety of the research and identifies any potential risk to public health or the environment, and such review may result in some delay before initiation of a clinical trial. While the NIH Guidelines are not mandatory unless the research in question is being conducted at or sponsored by institutions receiving NIH funding of recombinant or synthetic nucleic acid molecule research, many companies and other institutions not otherwise subject to the NIH Guidelines voluntarily follow them.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Clinical trials involve the administration of the biological product candidate to human subjects under the supervision of qualified investigators, generally physicians not employed by or under the trial sponsor&#x2019;s control. Clinical trials are conducted under protocols detailing, among other things, the objectives of the clinical trial, dosing procedures, subject selection and exclusion criteria, and the parameters to be used to monitor subject safety, including stopping rules that assure a clinical trial will be stopped if certain adverse events should occur. Each protocol and any amendments to the protocol must be submitted to the FDA as part of the IND. Clinical trials must be conducted and monitored in accordance with the FDA&#x2019;s regulations comprising the GCP requirements, including the requirement that all research patients provide informed consent. Further, each clinical trial must be reviewed and approved by an independent IRB at or servicing each institution at which the clinical trial will be conducted. An IRB is charged with protecting the welfare and rights of trial participants and considers such items as whether the risks to individuals participating in the clinical trials are minimized and are reasonable in relation to anticipated benefits. The IRB also approves the form and content of the informed consent that must be signed by each clinical trial subject or his or her legal representative and must monitor the clinical trial until completed. Certain clinical trials involving human gene transfer research also must be overseen by an IBC, a standing committee established specifically to provide peer review of the safety of research plans, procedures, personnel training and environmental risks of work involving recombinant DNA molecules. IBCs are typically assigned certain review responsibilities relating to the use of recombinant DNA molecules, including reviewing potential environmental risks, assessing containment levels, and evaluating the adequacy of facilities, personnel training and compliance with the NIH Guidelines. Some studies also include oversight by an independent group of qualified experts organized by the clinical study sponsor, known as a data safety monitoring board, which provides authorization for whether or not a study may move forward at designated check points based on access to certain data from the study and may halt the clinical trial if it determines that there is an unacceptable safety risk for subjects or other grounds, such as no demonstration of efficacy. There are also requirements governing the reporting of ongoing clinical studies and clinical study results to public registries.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For purposes of BLA approval, human clinical trials are typically conducted in three sequential phases that may overlap or be combined:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Phase 1.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The biological product candidate is initially introduced into healthy human subjects and tested for safety. In the case of some products for severe or life-threatening diseases, especially when the product may be too inherently toxic to ethically administer to healthy volunteers, the initial human testing is often conducted in patients. </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Phase 2.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> The biological product candidate is evaluated in a limited patient population to identify possible adverse effects and safety risks, to preliminarily evaluate the efficacy of the product candidate for specific targeted diseases and to determine dosage tolerance, optimal dosage and dosing schedule. </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Phase 3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Clinical trials are undertaken to further evaluate dosage, clinical efficacy, potency and safety in an expanded patient population at geographically dispersed clinical trial sites. These clinical trials are intended to establish the overall risk to benefit ratio of the product candidate and provide an adequate basis for product labeling. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Post-approval clinical trials, sometimes referred to as Phase 4 clinical trials, may be conducted after initial marketing approval. These clinical trials are used to gain additional experience from the treatment of patients in the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">36</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">intended therapeutic indication, particularly for long-term safety follow-up. These Phase 4 studies may be made a condition to approval of the BLA. During all phases of clinical development, regulatory agencies require extensive monitoring and auditing of all clinical activities, clinical data and clinical trial investigators. Annual progress reports detailing the results of the clinical trials must be submitted to the FDA. Written IND safety reports must be promptly submitted to the FDA, and the investigators for serious and unexpected adverse events, any findings from other studies, tests in laboratory animals or </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> testing that suggest a significant risk for human patients, or any clinically important increase in the rate of a serious suspected adverse reaction over that listed in the protocol or investigator brochure. The sponsor must submit an IND safety report within 15 calendar days after the sponsor determines that the information qualifies for reporting. The sponsor also must notify the FDA of any unexpected fatal or life-threatening suspected adverse reaction within seven calendar days after the sponsor&#x2019;s initial receipt of the information. Phase 1, Phase 2 and Phase 3 clinical trials may not be completed successfully within any specified period, if at all. The FDA or the sponsor or its data safety monitoring board may suspend or terminate a clinical trial at any time on various grounds, including a finding that the research patients are being exposed to an unacceptable health risk, including risks inferred from other unrelated immunotherapy trials. Similarly, an IRB can suspend or terminate approval of a clinical trial at its institution if the clinical trial is not being conducted in accordance with the IRB&#x2019;s requirements or if the biological product has been associated with unexpected serious harm to patients. In addition, some clinical trials are overseen by an independent group of qualified experts organized by the sponsor, known as a data safety monitoring board or committee. Depending on its charter, this group may determine whether a trial may move forward at designated check points based on access to certain data from the trial.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Gene therapy products are a new category of therapeutics. Because this is a relatively new and expanding area of novel therapeutic interventions, there can be no assurance as to the length of the trial period, the number of patients the FDA will require to be enrolled in the trials in order to establish the safety, efficacy, purity and potency of gene therapy products, or that the data generated in these trials will be acceptable to the FDA to support marketing approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Concurrently with clinical trials, companies usually complete additional studies and must also develop additional information about the physical characteristics of the biological product candidate as well as finalize a process for manufacturing the product candidate in commercial quantities in accordance with cGMP requirements. To help reduce the risk of the introduction of adventitious agents with use of biological products, the PHSA emphasizes the importance of manufacturing control for products whose attributes cannot be precisely defined. The manufacturing process must be capable of consistently producing quality batches of the product candidate and, among other things, the sponsor must develop methods for testing the identity, strength, quality, potency and purity of the final biological product candidate. Additionally, appropriate packaging must be selected and tested and stability studies must be conducted to demonstrate that the biological product candidate does not undergo unacceptable deterioration over its shelf life.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">U.S. Review and Approval Processes</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">After the completion of clinical trials of a biological product candidate, FDA approval of a BLA must be obtained before commercial marketing of the biological product. The BLA submission must include all relevant data of product development, laboratory and animal studies, human trials, information on the manufacture and composition of the product, proposed labeling and other relevant information. The testing and approval processes require substantial time and effort and there can be no assurance that the FDA will accept the BLA for filing and, even if filed, that any approval will be granted on a timely basis, if at all.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under the Prescription Drug User Fee Act, as amended (&#x201c;PDUFA&#x201d;), each BLA must be accompanied by a significant user fee. The FDA adjusts the PDUFA user fees on an annual basis. PDUFA also imposes an annual program fee for biological products. Fee waivers or reductions are available in certain circumstances, including a waiver of the application fee for the first application filed by a small business. Additionally, no user fees are assessed on BLAs for products designated as orphan drugs, unless the product also includes a non-orphan indication.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Within 60 days following submission of the application, the FDA reviews a BLA submitted to determine if it is substantially complete before the agency accepts it for filing. The FDA may refuse to file any BLA that it deems incomplete or not properly reviewable at the time of submission and may request additional information. In this event, the BLA must be resubmitted with the additional information. The resubmitted application also is subject to review before the FDA accepts it for filing. Once the submission is accepted for filing, the FDA begins an in-depth substantive review of the BLA. The FDA reviews the BLA to determine, among other things, whether the proposed</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">37</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">product is safe, potent and/or effective for its intended use and has an acceptable purity profile, and whether the product candidate is being manufactured in accordance with cGMP to assure and preserve the product candidate&#x2019;s identity, safety, strength, quality, potency and purity. The FDA may refer applications for novel biological product candidates or biological product candidates that present difficult questions of safety or efficacy to an advisory committee, typically a panel that includes clinicians and other experts, for review, evaluation and a recommendation as to whether the application should be approved and under what conditions. The FDA is not bound by the recommendations of an advisory committee, but it considers such recommendations carefully when making decisions. During the biological product candidate approval process, the FDA also will determine whether a Risk Evaluation and Mitigation Strategy (&#x201c;REMS&#x201d;) is necessary to assure the safe use of the biological product candidate. A REMS is a safety strategy to manage a known or potential serious risk associated with a medicine and to enable patients to have continued access to such medicines by managing their safe use, and could include medication guides, physician communication plans or elements to assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. If the FDA concludes a REMS is needed, the sponsor of the BLA must submit a proposed REMS. The FDA will not approve a BLA without a REMS, if required.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Before approving a BLA, the FDA will inspect the facilities at which the product candidate is manufactured. The FDA will not approve the product candidate unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product candidate within required specifications. For immunotherapy product candidates, the FDA also will not approve the product candidate if the manufacturer is not in compliance with GTPs, to the extent applicable. These are FDA regulations and guidance documents that govern the methods used in, and the facilities and controls used for, the manufacture of human cells, tissue and cellular and tissue based products (&#x201c;HCT/Ps&#x201d;), which are human cells or tissue intended for implantation, transplant, infusion or transfer into a human recipient. The primary intent of the GTP requirements is to ensure that cell and tissue based products are manufactured in a manner designed to prevent the introduction, transmission and spread of communicable disease. FDA regulations also require tissue establishments to register and list their HCT/Ps with the FDA and, when applicable, to evaluate donors through screening and testing. Additionally, before approving a BLA, the FDA will typically inspect one or more clinical sites to assure that the clinical trials were conducted in compliance with IND trial requirements and GCP requirements. To assure cGMP, GTP and GCP compliance, an applicant must incur significant expenditure of time, money and effort in the areas of training, record keeping, production and quality control.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Notwithstanding the submission of relevant data and information, the FDA may ultimately decide that the BLA does not satisfy its regulatory criteria for approval and deny approval. Data obtained from clinical trials are not always conclusive and the FDA may interpret data differently than we interpret the same data. If the agency decides not to approve the BLA in its present form, the FDA will issue a complete response letter that describes all of the specific deficiencies in the BLA identified by the FDA. The deficiencies identified may be minor, for example, requiring labeling changes, or major, for example, requiring additional clinical trials. Additionally, the complete response letter may include recommended actions that the applicant might take to place the application in a condition for approval. If a complete response letter is issued, the applicant may either resubmit the BLA, addressing all of the deficiencies identified in the letter, or withdraw the application.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If a product receives regulatory approval, the approval may be limited to specific diseases and dosages or the indications for use may otherwise be limited, which could restrict the commercial value of the product. Further, the FDA may require that certain contraindications, warnings or precautions be included in the product labeling. The FDA may impose restrictions and conditions on product distribution, prescribing or dispensing in the form of a risk management plan, or otherwise limit the scope of any approval. In addition, the FDA may require post marketing clinical trials, sometimes referred to as Phase 4 clinical trials, designed to further assess a biological product&#x2019;s safety and effectiveness, and testing and surveillance programs to monitor the safety of approved products that have been commercialized.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, under the Pediatric Research Equity Act (&#x201c;PREA&#x201d;), a BLA or supplement to a BLA must contain data to assess the safety and effectiveness of the product for the claimed indications in all relevant pediatric subpopulations and to support dosing and administration for each pediatric subpopulation for which the product is safe and effective. The FDA may grant deferrals for submission of data or full or partial waivers. Unless otherwise required by regulation, PREA does not apply to any product for an indication for which orphan designation has been granted. However, if only one indication for a product has orphan designation, a pediatric assessment may still be required for any applications to market that same product for the non-orphan indication(s).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">38</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Orphan Drug Designation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under the Orphan Drug Act, the FDA may grant orphan designation to a drug or biologic intended to treat a rare disease or condition, which is generally a disease or condition that affects fewer than 200,000 individuals in the United States, or more than 200,000 individuals in the United States and for which there is no reasonable expectation that the cost of developing and making available in the United States a drug or biologic for this type of disease or condition will be recovered from sales in the United States for that drug or biologic. Orphan drug designation must be requested before submitting a BLA. After the FDA grants orphan drug designation, the generic identity of the therapeutic agent and its potential orphan use are disclosed publicly by the FDA. The orphan drug designation does not convey any advantage in, or shorten the duration of, the regulatory review or approval process.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If a product candidate that has orphan drug designation subsequently receives the first FDA approval for the disease for which it has such designation, the product is entitled to orphan product exclusivity, which means that the FDA may not approve any other applications, including a full BLA, to market the same biologic for the same indication for seven years, except in limited circumstances, such as a showing of clinical superiority to the product with orphan drug exclusivity. Orphan drug exclusivity does not prevent FDA from approving a different drug or biologic for the same disease or condition, or the same drug or biologic for a different disease or condition. Among the other benefits of orphan drug designation are tax credits for certain research and a waiver of the BLA application user fee.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A designated orphan drug may not receive orphan drug exclusivity if it is approved for a use that is broader than the indication for which it received orphan designation. In addition, exclusive marketing rights in the United States may be lost if the FDA later determines that the request for designation was materially defective, if the second applicant demonstrates that its product is clinically superior to the approved product with orphan exclusivity, or if the manufacturer is unable to assure sufficient quantities of the product to meet the needs of patients with the rare disease or condition. Orphan drug designation may also entitle a party to financial incentives such as opportunities for grant funding towards clinical trial costs, tax advantages and user-fee waivers.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expedited Development and Review Programs</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The FDA has established certain programs intended to expedite or facilitate the process for developing, reviewing or approving new products that meet certain criteria, including fast track designation, breakthrough therapy designation, accelerated approval and priority review. Specifically, new product candidates are eligible for fast track designation if they are intended to treat a serious or life-threatening disease or condition and demonstrate the potential to address unmet medical needs for the disease or condition. Fast track designation applies to the combination of the product candidate and the specific indication for which it is being studied. Unique to a fast track product, the FDA may consider for review sections of the BLA on a rolling basis before the complete application is submitted, if the sponsor provides a schedule for the submission of the sections of the BLA and the payment of applicable user fees, the FDA agrees to accept sections of the BLA and determines that the schedule is acceptable, and the sponsor pays any required user fees upon submission of the first section of the BLA.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any product candidate submitted to the FDA for approval, including a product candidate with a fast track designation, may also be eligible for other types of FDA programs intended to expedite development and review, such as priority review and accelerated approval. A product candidate is eligible for priority review if it has the potential to provide safe and effective therapy where no satisfactory alternative therapy exists or a significant improvement in the treatment, diagnosis or prevention of a disease compared to marketed products. The FDA will attempt to direct additional resources to the evaluation of an application for a new product candidate designated for priority review in an effort to facilitate the review.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, a product candidate may be eligible for accelerated approval. Product candidates studied for their safety and effectiveness in treating serious or life-threatening diseases or conditions may receive accelerated approval upon a determination that the product candidate has an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit, or on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality, that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity or prevalence of the condition and the availability or lack of alternative treatments. As a condition of approval, the FDA may require that a sponsor of a drug or biological product candidate receiving accelerated approval perform adequate and well-controlled post-marketing clinical studies. The FDA may withdraw approval of a drug or indication approved under accelerated approval if, for example, the confirmatory trial fails to verify the predicted clinical benefit of the product. In addition, the FDA currently requires as a condition</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">39</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">for accelerated approval pre-approval of promotional materials, which could adversely impact the timing of the commercial launch of the product candidate.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, breakthrough therapy designation is intended to expedite the development and review of product candidates that treat serious or life-threatening conditions. The designation by FDA requires preliminary clinical evidence that a product candidate, alone or in combination with other drugs and biologics, demonstrates substantial improvement over currently available therapy on one or more clinically significant endpoints, such as substantial treatment effects observed early in clinical development. If the FDA designates a breakthrough therapy, it may take actions appropriate to expedite the development and review of the application, which may include holding meetings with the sponsor and the review team throughout the development of the therapy; providing timely advice to, and interactive communication with, the sponsor regarding the development of the drug to ensure that the development program to gather the nonclinical and clinical data necessary for approval is as efficient as practicable; involving senior managers and experienced review staff, as appropriate, in a collaborative, cross-disciplinary review; assigning a cross-disciplinary project lead for the FDA review team to facilitate an efficient review of the development program and to serve as a scientific liaison between the review team and the sponsor; and considering alternative clinical trial designs when scientifically appropriate, which may result in smaller trials or more efficient trials that require less time to complete and may minimize the number of patients exposed to a potentially less efficacious treatment. Breakthrough therapy designation comes with all of the benefits of fast track designation, which means that the sponsor may file sections of the BLA for review on a rolling basis if certain conditions are satisfied, including an agreement with FDA on the proposed schedule for submission of portions of the application and the payment of applicable user fees before the FDA may initiate a review. The breakthrough therapy designation is a distinct status from both accelerated approval and priority review, which can also be granted to the same product candidate if relevant criteria are met. If a product candidate is designated as breakthrough therapy, FDA will expedite the development and review of such product candidate.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Fast Track designation, priority review, accelerated approval, and breakthrough therapy designation do not change the standards for approval but may expedite the development or approval process. Even if a product qualifies for one or more of these programs, the FDA may later decide that the product no longer meets the conditions for qualification or that the time period for FDA review and approval will not be shortened.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Post-Approval Requirements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any products for which we receive FDA approvals are subject to continuing regulation by the FDA, including, among other things, continuing user fee requirements, record-keeping requirements, reporting of adverse experiences with the product, providing the FDA with updated safety and efficacy information, product sampling and distribution requirements, and complying with FDA promotion and advertising requirements, which include, among others, standards for direct-to-consumer advertising, restrictions on promoting products for uses or in patient populations that are not described in the product&#x2019;s approved uses (known as &#x201c;off-label use&#x201d;), limitations on industry-sponsored scientific and educational activities, and requirements for promotional activities involving the internet. Although a physician may prescribe a legally available product for an off-label use, if the physicians deems such product to be appropriate in his/her professional medical judgment, a manufacturer may not market or promote off-label uses. However, companies may share truthful and not misleading information that is otherwise consistent with a product&#x2019;s FDA-approved labeling. A company that is found to have promoted off-label use of its product may be subject to significant liability, including administrative, civil and criminal sanctions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, quality control and manufacturing procedures must continue to conform to applicable manufacturing requirements after approval to ensure the long-term stability of the product. cGMP regulations require among other things, quality control and quality assurance as well as the corresponding maintenance of records and documentation and the obligation to investigate and correct any deviations from cGMP. Manufacturers and other entities involved in the manufacture and distribution of approved products are required to register their establishments with the FDA and certain state agencies and are subject to periodic unannounced inspections by the FDA and certain state agencies for compliance with cGMP and other laws. Accordingly, manufacturers must continue to expend time, money and effort in the area of production and quality control to maintain cGMP compliance. Discovery of problems with a product after approval may result in restrictions on a product, manufacturer or holder of an approved BLA, including, among other things, recall or withdrawal of the product from the market. In addition, changes to the manufacturing process are strictly regulated and, depending on the significance of the change, may require prior FDA approval before being implemented. Other types of changes to</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">40</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the approved product, such as adding new indications and claims, are also subject to further FDA review and approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The FDA also may require post-marketing testing, known as Phase 4 testing, and surveillance to monitor the effects of an approved product. Discovery of previously unknown problems with a product or the failure to comply with applicable FDA requirements can have negative consequences, including adverse publicity, judicial or administrative enforcement, warning letters from the FDA, mandated corrective advertising or communications with doctors, and civil or criminal penalties, among others. Newly discovered or developed safety or effectiveness data may require changes to a product&#x2019;s approved labeling, including the addition of new warnings and contraindications, and also may require the implementation of other risk management measures. Also, new government requirements, including those resulting from new legislation, may be established, or the FDA&#x2019;s policies may change, which could delay or prevent regulatory approval of our products under development.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The FDA may withdraw approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the product reaches the market. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may result in revisions to the approved labeling to add new safety information; imposition of post-market studies or clinical studies to assess new safety risks; or imposition of distribution restrictions or other restrictions under a REMS program. Other potential consequences include, among other things:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">restrictions on the marketing or manufacturing of a product, complete withdrawal of the product from the market or product recalls; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">fines, warning letters or holds on post-approval clinical studies; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">refusal of the FDA to approve pending applications or supplements to approved applications, or suspension or revocation of existing product approvals; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">product seizure or detention, or refusal of the FDA to permit the import or export of products; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">consent decrees, corporate integrity agreements, debarment or exclusion from federal healthcare programs; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">mandated modification of promotional materials and labeling and the issuance of corrective information; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the issuance of safety alerts, Dear Healthcare Provider letters, press releases and other communications containing warnings or other safety information about the product; or</span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">injunctions or the imposition of civil or criminal penalties. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">U.S. Marketing Exclusivity</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Biologics Price Competition and Innovation Act (&#x201c;BPCIA&#x201d;) amended the PHSA to authorize the FDA to approve similar versions of innovative biologics, commonly known as biosimilars. A competitor seeking approval of a biosimilar must file an application to establish its molecule as highly similar to an approved innovator biologic, among other requirements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Biosimilarity, which requires that there be no clinically meaningful differences between the biological product and the reference product in terms of safety, purity, and potency, can be shown through analytical studies, animal studies, and a clinical study or studies. Interchangeability requires that a product is biosimilar to the reference product and the product must demonstrate that it can be expected to produce the same clinical results as the reference product in any given patient and, for products that are administered multiple times to an individual, the biologic and the reference biologic may be alternated or switched after one has been previously administered without increasing safety risks or risks of diminished efficacy relative to exclusive use of the reference biologic. Complexities associated with the larger, and often more complex, structures of biological products, as well as the processes by which such products are manufactured, pose significant hurdles to implementation of the abbreviated approval pathway that are still being worked out by the FDA.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under the BPCIA, an application for a biosimilar product may not be submitted to the FDA until four years following the date that the reference product was first licensed by the FDA. In addition, the approval of a biosimilar product may not be made effective by the FDA until 12 years from the date on which the reference product was first</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">licensed. During this 12-year period of exclusivity, another company may still market a competing version of the reference product if the FDA approves a full BLA for the competing product containing that applicant&#x2019;s own preclinical data and data from adequate and well controlled clinical trials to demonstrate the safety, purity and potency of its product. The BPCIA also created certain exclusivity periods for biosimilars approved as interchangeable products. At this juncture, it is unclear whether products deemed &#x201c;interchangeable&#x201d; by the FDA will, in fact, be readily substituted by pharmacies, which are governed by state pharmacy law.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The BPCIA is complex and continues to be interpreted and implemented by the FDA. In addition, recent government proposals have sought to reduce the 12-year reference product exclusivity period. Other aspects of the BPCIA, some of which may impact the BPCIA exclusivity provisions, have also been the subject of recent litigation. As a result, the ultimate impact, implementation, and impact of the BPCIA is subject to significant uncertainty.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pediatric exclusivity is another type of regulatory market exclusivity in the United States. Pediatric exclusivity, if granted, adds six months to existing exclusivity periods and patent terms. This six-month exclusivity, which runs from the end of other exclusivity protection or patent term, may be granted based on the voluntary completion of a pediatric trial in accordance with an FDA-issued &#x201c;Written Request&#x201d; for such a trial.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Other U.S. Healthcare Laws and Compliance Requirements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the United States, our activities are potentially subject to regulation by various federal, state and local authorities in addition to the FDA, including but not limited to, the CMS, other divisions of the U.S. Department of Health and Human Services (e.g., the Office of Inspector General), the U.S. Department of Justice (&#x201c;DOJ&#x201d;) and individual U.S. Attorney offices within the DOJ, and state and local governments. For example, our business practices, including our clinical research and any future sales, marketing and scientific/educational grant programs may be required to comply with the fraud and abuse provisions of the Social Security Act, the false claims laws, the data privacy and security provisions of the Health Insurance Portability and Accountability Act (&#x201c;HIPAA&#x201d;), federal transparency requirements and similar state laws, each as amended.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The federal Anti-Kickback Statute prohibits, among other things, any person or entity, from knowingly and willfully offering, paying, soliciting or receiving any remuneration (including any kickback, bribe or rebate), directly or indirectly, overtly or covertly, in cash or in kind, to induce or in return for, either the referral of an individual for, or the purchasing, leasing, ordering or arranging for the purchase, lease or order of any item or service reimbursable under Medicare, Medicaid or other federal healthcare programs. The term remuneration has been interpreted broadly to include anything of value. The federal Anti-Kickback Statute has been interpreted to apply to arrangements between pharmaceutical manufacturers on one hand and prescribers, purchasers and formulary managers on the other. There are a number of statutory exceptions and regulatory safe harbors protecting some common activities from prosecution. The exceptions and safe harbors are drawn narrowly and require strict compliance in order to offer protection. Practices that involve remuneration that may be alleged to be intended to induce prescribing, purchasing or recommending may be subject to scrutiny if they do not qualify for an exception or safe harbor. Failure to meet all of the requirements of a particular applicable statutory exception or regulatory safe harbor does not make the conduct per se illegal under the Anti-Kickback Statute. Instead, the legality of the arrangement will be evaluated on a case-by-case basis based on a cumulative review of all of its facts and circumstances. In addition, a person or entity does not need to have actual knowledge of the federal Anti-Kickback Statute or specific intent to violate it in order to have committed a violation. Rather, if &#x201c;one purpose&#x201d; of the remuneration is to induce referrals, the federal Anti-Kickback Statute is violated.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The federal civil monetary penalties statute imposes penalties against any person or entity who, among other things, is determined to have knowingly presented or caused to be presented a false or fraudulent claim to, among others, a federal healthcare program that the person knows or should know is for an item or service that was not provided as claimed or is false or fraudulent.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The federal civil False Claims Act prohibits, among other things, any person or entity from knowingly presenting, or causing to be presented, a false claim for payment to, or approval by, the federal government or knowingly making, using or causing to be made or used a false record or statement material to a false or fraudulent claim to the federal government in order to avoid, decrease or conceal an obligation to pay money to the federal government. As a result of a modification made by the Fraud Enforcement and Recovery Act of 2009, a claim includes &#x201c;any request or demand&#x201d; for money or property presented to the federal government. The federal civil False Claims Act can be enforced through private &#x201c;qui tam&#x201d; actions brought by individual whistleblowers in the name of</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">42</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the government. In addition, manufacturers can be held liable under the civil False Claims Act even when they do not submit claims directly to government payors if they are deemed to &#x201c;cause&#x201d; the submission of false or fraudulent claims. Pharmaceutical and other healthcare companies are being investigated or, in the past, have been prosecuted under these laws for, among other things, allegedly providing free product to customers with the expectation that the customers would bill federal programs for the product. In addition, pharmaceutical and other healthcare companies also have been prosecuted for causing false claims to be submitted because of the companies&#x2019; marketing of the product for unapproved, and thus non-reimbursable, uses and purportedly concealing price concessions in the pricing information submitted to the government for government priced reporting purposes. A claim that includes items or services resulting from a violation of the federal Anti-Kickback Statute also constitutes a false or fraudulent claim for purposes of the federal civil False Claims Act.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">HIPAA created additional federal criminal statutes that prohibit knowingly and willfully executing, or attempting to execute, a scheme or artifice to defraud or to obtain, by means of false or fraudulent pretenses, representations or promises, any money or property owned by, or under the control or custody of, any healthcare benefit program, including private third-party payors and knowingly and willfully falsifying, concealing or covering up by trick, scheme or device, a material fact or making any materially false, fictitious or fraudulent statement in connection with the delivery of or payment for healthcare benefits, items or services. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may be subject to data privacy and security regulations by both the federal government and the states in which we conduct our business. HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009 and its implementing regulations (which we collectively refer to as HIPAA), imposes requirements on certain types of individuals and entities, including covered entities (i.e., certain healthcare providers, health plans and healthcare clearinghouses), as well as their business associates that perform certain services on behalf of the covered entities and their covered subcontractors, relating to the privacy, security and transmission of individually identifiable health information. Entities that are found to be in violation of HIPAA as the result of a breach of unsecured protected health information, a complaint about privacy practices or an audit by the U.S. Department of Health and Human Services (&#x201c;HHS&#x201d;), may be subject to significant civil, criminal and administrative fines and penalties and/or additional reporting and oversight obligations if required to enter into a resolution agreement and corrective action plan with HHS to settle allegations of HIPAA non-compliance. Further, entities that knowingly obtain, use, or disclose individually identifiable health information maintained by a HIPAA covered entity in a manner that is not authorized or permitted by HIPAA may be subject to criminal penalties. In addition, state laws govern the privacy and security of health information in specified circumstances, many of which differ from each other in significant ways and may not have the same effect, thus complicating compliance efforts.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, the federal Physician Payments Sunshine Act created under the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, and its implementing regulations (collectively, the &#x201c;ACA&#x201d;), require that certain manufacturers of drugs, devices, biological and medical supplies for which payment is available under Medicare, Medicaid or the Children&#x2019;s Health Insurance Program (with certain exceptions) annually report information to CMS related to certain payments or other transfers of value made or distributed to physicians (currently defined to include doctors, dentists, optometrists, podiatrists and chiropractors), other healthcare professionals (such as physician assistants and nurse practitioners), and teaching hospitals, or to entities or individuals at the request of, or designated on behalf of, the physicians and teaching hospitals and to report annually certain ownership and investment interests held by physicians and their immediate family members.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Also, many states have similar fraud and abuse statutes or regulations similar to the aforementioned federal laws that apply to items and services reimbursed under Medicaid and other state programs, or, in several states, apply regardless of the payor. In order to distribute products commercially, we must comply with state laws that require the registration of manufacturers and wholesale distributors of drug and biological products in a state, including, in certain states, manufacturers and distributors who ship products into the state even if such manufacturers or distributors have no place of business within the state. Some states also impose requirements on manufacturers and distributors to establish the pedigree of product in the chain of distribution, including some states that require manufacturers and others to adopt new technology capable of tracking and tracing product as it moves through the distribution chain. Several states and local jurisdictions have enacted legislation requiring pharmaceutical and biotechnology companies to establish marketing compliance programs and comply with the pharmaceutical industry&#x2019;s voluntary compliance guidelines and the relevant compliance guidance promulgated by</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">43</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the federal government, file periodic reports with the state, make periodic public disclosures on sales, marketing, pricing, clinical trials and other activities, and/or register their sales representatives, as well as to prohibit pharmacies and other healthcare entities from providing certain physician prescribing data to pharmaceutical and biotechnology companies for use in sales and marketing, and to prohibit certain other sales and marketing practices. All of our activities are also potentially subject to federal and state consumer protection and unfair competition laws.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If our operations are found to be in violation of any of the federal and state healthcare laws described above or any other governmental regulations that apply to us, we may be subject to significant penalties, including without limitation, civil, criminal and/or administrative penalties, damages, fines, disgorgement, imprisonment, exclusion from participation in government programs, such as Medicare and Medicaid, injunctions, contractual damages, reputational harm, administrative burdens, diminished profits and future earnings, additional reporting requirements and/or oversight if we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws, and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Coverage, Pricing and Reimbursement</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Significant uncertainty exists as to the coverage and reimbursement status of any product candidates for which we obtain regulatory approval. In the United States and certain markets in other countries, sales of any products for which we receive regulatory approval for commercial sale will depend, in part, on the extent to which third-party payors provide coverage and establish adequate reimbursement levels for such products. No uniform policy for coverage and reimbursement exists in the United States, and coverage and reimbursement can differ significantly from payor to payor. As a result, the coverage determination process is often time-consuming and costly. In the United States, third-party payors include federal and state healthcare programs, private managed care providers, health insurers and other organizations. The process for determining whether a third-party payor will provide coverage for a product may be separate from the process for setting the price of a product or from establishing the reimbursement rate that such a payor will pay for the product. Third-party payors may limit coverage to specific products on an approved list, also known as a formulary, which might not include all of the FDA-approved products for a particular indication.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Third-party payors are increasingly challenging the price, examining the medical necessity and reviewing the cost-effectiveness of medical products, therapies and services, in addition to questioning their safety and efficacy. New metrics frequently are used as the basis for reimbursement rates, such as average sales price, average manufacturer price and actual acquisition cost. We may need to conduct expensive pharmaco-economic studies in order to demonstrate the medical necessity and cost-effectiveness of our products, in addition to the costs required to obtain the FDA approvals. Our product candidates may not be considered medically necessary or cost-effective. A payor&#x2019;s decision to provide coverage for a product does not imply that an adequate reimbursement rate will be approved. Further, one payor&#x2019;s determination to provide coverage for a product does not assure that other payors will also provide coverage for the product. Adequate third-party reimbursement may not be available to enable us to maintain price levels sufficient to realize an appropriate return on our investment in product development. We cannot predict at this time what third-party payors will decide with respect to the coverage and reimbursement for our product candidates including, for example, whether we will seek, and whether CMS would approve, an NTAP under the IPPS for our product candidates, once approved. NTAP will only be available for our products if we submit a timely and complete application and CMS determines that our product candidates meet the eligibility requirements of NTAP, including, among other criteria, demonstrating a substantial clinical improvement relative to services or technologies previously available.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, the containment of healthcare costs has become a priority of federal and state governments, and the prices of drugs have been a focus in this effort. The United States government, state legislatures and foreign governments have shown significant interest in implementing cost-containment programs, including price controls, restrictions on reimbursement and requirements for substitution of generic products. Adoption of price controls and cost-containment measures, and adoption of more restrictive policies in jurisdictions with existing controls and measures, could further limit our net revenue and results.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Different pricing and reimbursement schemes exist in other countries. In the EU, governments influence the price of pharmaceutical products through their pricing and reimbursement rules and control of national health care systems that fund a large part of the cost of those products to consumers. Some jurisdictions operate positive and negative list systems under which products may only be marketed once a reimbursement price has been agreed. To</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">44</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">obtain reimbursement or pricing approval, some of these countries may require the completion of clinical trials that compare the cost-effectiveness of a particular product candidate to currently available therapies. Other member states allow companies to fix their own prices for medicines, but monitor and control company profits. The downward pressure on health care costs has become very intense. As a result, increasingly high barriers are being erected to the entry of new products. In addition, in some countries, cross-border imports from low-priced markets exert a commercial pressure on pricing within a country. Accordingly, in markets outside the United States, the reimbursement for our products may be reduced compared with the United States and may be insufficient to generate commercially reasonable revenue and profits.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The marketability of any product candidates for which we receive regulatory approval for commercial sale may suffer if the government and third-party payors fail to provide coverage and adequate reimbursement. In addition, emphasis on managed care in the United States has increased and we expect will continue to increase the pressure on healthcare pricing. Coverage policies and third-party reimbursement rates may change at any time. These and other actions by federal and state governments and health plans may put additional downward pressure on pharmaceutical pricing and health care costs, which could negatively impact coverage and reimbursement for our products if approved, our revenue, and our ability to compete with other marketed products and to recoup the costs of our research and development. Even if favorable coverage and reimbursement status is attained for one or more products for which we receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Healthcare Reform</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the United States and some foreign jurisdictions, there have been, and continue to be, several legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay marketing approval of product candidates, restrict or regulate post-approval activities and affect the ability to profitably sell product candidates for which marketing approval is obtained. Among policy makers and payors in the United States and elsewhere, there is significant interest in promoting changes in healthcare systems with the stated goals of containing healthcare costs, improving quality and/or expanding access. In the United States, the pharmaceutical industry has been a particular focus of these efforts and has been significantly affected by major legislative initiatives.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For example, the ACA has substantially changed healthcare financing and delivery by both governmental and private insurers. Among the ACA provisions of importance to the pharmaceutical and biotechnology industries, in addition to those otherwise described above, are the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">an annual, nondeductible fee on any entity that manufactures or imports certain specified branded prescription drugs and biologic agents apportioned among these entities according to their market share in some government healthcare programs; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">an increase in the statutory minimum rebates a manufacturer must pay under the Medicaid Drug Rebate Program, to 23.1% and 13% of the average manufacturer price for most branded and generic drugs, respectively, and capped the total rebate amount for innovator drugs at 100% of the Average Manufacturer Price; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a Medicare Part D coverage gap discount program, in which manufacturers must now agree to offer 70% point-of-sale discounts off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a condition for the manufacturers&#x2019; outpatient drugs to be covered under Medicare Part D; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">extension of manufacturers&#x2019; Medicaid rebate liability to covered drugs dispensed to individuals who are enrolled in Medicaid managed care organizations; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">expansion of eligibility criteria for Medicaid programs by, among other things, allowing states to offer Medicaid coverage to additional individuals and by adding mandatory eligibility categories for individuals with income at or below 133% of the federal poverty level, thereby potentially increasing manufacturers&#x2019; Medicaid rebate liability; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">expansion of the entities eligible for discounts under the 340B Drug Discount Program; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">45</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in and conduct comparative clinical effectiveness research, along with funding for such research; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">expansion of healthcare fraud and abuse laws, including the False Claims Act and the Anti-Kickback Statute, new government investigative powers and enhanced penalties for noncompliance; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">requirements to report certain financial arrangements with physicians and teaching hospitals; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a requirement to annually report certain information regarding drug samples that manufacturers and distributors provide to physicians; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">establishment of a Center for Medicare and Medicaid Innovation at CMS to test innovative payment and service delivery models to lower Medicare and Medicaid spending, potentially including prescription drug spending; and </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">creation of a licensure framework for follow on biologic products.</span></div></div>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There have been executive, legal and political challenges to certain aspects of the ACA. For example, in</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 2017, Congress repealed the tax penalty for an individual&#x2019;s failure to maintain ACA -mandated health insurance as part of the Tax Cuts and Jobs Act of 2017 (the &#x201c;Tax Act&#x201d;), effective January 1, 2019. In addition, the 2020 federal spending package permanently eliminated, effective January 1, 2020, the ACA-mandated &#x201c;Cadillac&#x201d; tax on high-cost employer-sponsored health coverage and medical device tax and, effective January 1, 2021, also eliminated the health insurer tax. On June 17, 2021 the U.S. Supreme Court dismissed a challenge on procedural grounds that argued the ACA is unconstitutional in its entirety because the &#x201c;individual mandate&#x201d; was repealed by Congress. Thus, the ACA will remain in effect in its current form. Prior to the U.S. Supreme Court ruling, on January 28, 2021, President Biden issued an executive order that initiated a special enrollment period for purposes of obtaining health insurance coverage through the ACA marketplace. The executive order also instructed certain governmental agencies to review and reconsider their existing policies and rules that limit access to healthcare, including among others, reexamining Medicaid demonstration projects and waiver programs that include work requirements, and policies that create unnecessary barriers to obtaining access to health insurance coverage through Medicaid or the ACA. It is possible that the ACA will be subject to judicial or Congressional challenges in the future. It is unclear how such challenges and the healthcare reform measures of the Biden administration will impact the ACA and our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We anticipate that the Affordable Care Act, if substantially maintained in its current form, will continue to result in additional downward pressure on coverage and the price that we receive for any approved product and could seriously harm our business. Any reduction in reimbursement from Medicare and other government programs may result in a similar reduction in payments from private payors. The implementation of cost containment measures or other healthcare reforms may prevent us from being able to generate revenue, attain profitability or commercialize our products. Such reforms could have an adverse effect on anticipated revenue from product candidates that we may successfully develop and for which we may obtain regulatory approval and may affect our overall financial condition and ability to develop product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Further legislation or regulation could be passed that could harm our business, financial condition and results of operations. Other legislative changes have been proposed and adopted since the Affordable Care Act was enacted. For example, in August 2011, the Budget Control Act of 2011 was signed into law, which, among other things, included aggregate reductions to Medicare payments to providers of 2% per fiscal year and, due to subsequent legislative amendments to the statute, including the Infrastructure Investment and Jobs Act, will stay in effect through 2031, with the exception of a temporary suspension from May 1, 2020 through March 31, 2022, unless additional Congressional action is taken. Under current legislation the actual reduction in Medicare payments will vary from 1% in 2022 to up to 3% in the final fiscal year of this sequester. Further, in January 2013, the American Taxpayer Relief Act of 2012 was signed into law, which, among other things, further reduced Medicare payments to several types of providers, including hospitals, imaging centers and cancer treatment centers, and increased the statute of limitations period for the government to recover overpayments to providers from three to five years. <br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">46</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, there has been increasing legislative and enforcement interest in the United States with respect to specialty drug pricing practices. Specifically, there have been several recent U.S. Congressional inquiries and proposed and enacted federal legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drugs. At the federal level, the Trump administration used several means to propose or implement drug pricing reform, including through federal budget proposals, executive orders and policy initiatives. For example, on July 24, 2020 and September 13, 2020, the Trump administration announced several executive orders related to prescription drug pricing that attempted to implement several of the administration&#x2019;s proposals. As a result, the FDA concurrently released a final rule and guidance in September 2020, providing pathways for states to build and submit importation plans for drugs from Canada. Further, on November 20, 2020, HHS finalized a regulation removing safe harbor protection for price reductions from pharmaceutical manufacturers to plan sponsors under Part D, either directly or through pharmacy benefit managers, unless the price reduction is required by law. The implementation of the rule has been delayed by the Biden administration from January 1, 2022 to January 1, 2023 in response to ongoing litigation. The rule also creates a new safe harbor for price reductions reflected at the point-of-sale, as well as a safe harbor for certain fixed fee arrangements between pharmacy benefit managers and manufacturers, the implementation of which have also been delayed until January 1, 2023. On November 20, 2020, CMS issued an interim final rule implementing a Most Favored Nation executive order, which would tie Medicare Part B payments for certain physician-administered drugs to the lowest price paid in other economically advanced countries, effective January 1, 2021.  As a result of litigation challenging the Most Favored Nation model, on December 27, 2021, CMS published a final rule that rescinded the Most Favored Nation model interim final rule. In July 2021, the Biden administration released an executive order, &#x201c;Promoting Competition in the American Economy,&#x201d; with multiple provisions aimed at prescription drugs. In response to Biden&#x2019;s executive order, on September 9, 2021, HHS released a Comprehensive Plan for Addressing High Drug Prices that outlines principles for drug pricing reform and sets out a variety of potential legislative policies that Congress could pursue as well as potential administrative actions HHS can take to advance these principles. No legislation or administrative actions have been finalized to implement these principles. In addition, Congress is considering drug pricing as part of other reform initiatives. It is unclear whether these or similar policy initiatives will be implemented in the future. Individual states in the United States have also become increasingly active in passing legislation and implementing regulations designed to control pharmaceutical and biological product pricing, including price or patient reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing.  <br /></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Further, it is possible that additional governmental action is taken in response to the COVID-19 pandemic.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The Foreign Corrupt Practices Act</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Foreign Corrupt Practices Act (&#x201c;FCPA&#x201d;) prohibits any U.S. individual or business from paying, offering or authorizing payment or offering of anything of value, directly or indirectly, to any foreign official, political party or candidate for the purpose of influencing any act or decision of the foreign entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are listed in the United States to comply with accounting provisions requiring the company to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Additional Regulation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to the foregoing, state and federal laws regarding environmental protection and hazardous substances, including the Occupational Safety and Health Act, the Resource Conservancy and Recovery Act and the Toxic Substances Control Act, affect our business. These and other laws govern our use, handling and disposal of various biological, chemical and radioactive substances used in, and wastes generated by, our operations. If our operations result in contamination of the environment or expose individuals to hazardous substances, we could be liable for damages and governmental fines. We believe that we are in material compliance with applicable environmental laws and that continued compliance therewith will not have a material adverse effect on our business. We cannot predict, however, how changes in these laws may affect our future operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">47</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Europe/Rest of World Government Regulation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to regulations in the United States, we will be subject to a variety of regulations in other jurisdictions governing, among other things, clinical trials and any commercial sales and distribution of our products. Whether or not we obtain FDA approval of a product, we must obtain the requisite approvals from regulatory authorities in foreign countries prior to the commencement of clinical trials or marketing of the product in those countries. Certain countries outside of the United States have a similar process that requires the submission of a clinical trial application much like the IND prior to the commencement of human clinical trials. In the EU, for example, a clinical trial application must be submitted to each country&#x2019;s national health authority and an independent ethics committee, much like the FDA and IRB, respectively. Once the clinical trial application is approved in accordance with a country&#x2019;s requirements, clinical trial development may proceed. Because biologically sourced raw materials are subject to unique contamination risks, their use may be restricted in some countries.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The requirements and process governing the conduct of clinical trials, product licensing, pricing and reimbursement vary from country to country. In all cases, the clinical trials must be conducted in accordance with GCP and the applicable regulatory requirements and the ethical principles that have their origin in the Declaration of Helsinki.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To obtain regulatory approval of an investigational drug or biological product under EU regulatory systems, we must submit a Marketing Authorisation Application. The application used to file the BLA in the United States is similar to that required in the EU, with the exception of, among other things, country-specific document requirements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For other countries outside of the EU, such as countries in Eastern Europe, Latin America or Asia, the requirements governing the conduct of clinical trials, product licensing, pricing and reimbursement vary from country to country. In all cases, again, the clinical trials must be conducted in accordance with GCP and the applicable regulatory requirements and the ethical principles that have their origin in the Declaration of Helsinki.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we or our potential collaborators fail to comply with applicable foreign regulatory requirements, we may be subject to, among other things, fines, suspension or withdrawal of regulatory approvals, product recalls, seizure of products, operating restrictions and criminal prosecution.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Employees and Human Capital Resources</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our human capital is integral to helping us achieve our mission of developing transformative treatments for patients suffering from hematological malignancies. We have built a culture of high performance based on our core values:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Passion:    </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">enthusiastically driving our science toward innovative medicines. </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Fellowship</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">:    fostering genuine bonds of collaboration and mentorship. </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Humility:    </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">acting selflessly by putting the collective mission first. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our human capital objectives include, as applicable, identifying, recruiting, retaining, incentivizing and integrating our existing and additional employees. The principal purposes of our equity incentive plans are to attract, retain and motivate selected employees, consultants and directors through the granting of stock-based compensation awards.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of March 1, 2022, we had 135 full-time employees, 39 of whom held an M.D. or Ph.D. degree and 97 of whom are engaged in research and development activities. None of our employees are represented by a labor union or covered by a collective bargaining agreement. We consider our relationship with our employees to be good.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Corporate Information</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our principal executive offices are located at 100 Cambridgepark Drive, Suite 101, Cambridge, Massachusetts 02140 and our telephone number is 617-655-6580.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Available Information</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We maintain an internet website at www.vorbio.com and make available free of charge through our website our Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, Current Reports on Form 8-K and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">48</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">amendments to those reports filed or furnished pursuant to Sections 13(a) and 15(d) of the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;). We make these reports available through our website as soon as reasonably practicable after we electronically file such reports with, or furnish such reports to, the Securities and Exchange Commission (the &#x201c;SEC&#x201d;). You can review our electronically filed reports and other information that we file with the SEC on the SEC&#x2019;s web site at http://www.sec.gov. We also make available, free of charge on our website, the reports filed with the SEC by our executive officers, directors and 10% stockholders pursuant to Section 16 under the Exchange Act as soon as reasonably practicable after copies of those filings are provided to us by those persons. In addition, we regularly use our website to post information regarding our business, product development programs and governance, and we encourage investors to use our website, particularly the information in the section entitled &#x201c;Investors,&#x201d; as a source of information about us.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The information on our website is not incorporated by reference into this Annual Report and should not be considered to be a part of this Annual Report. Our website address is included in this Annual Report as an inactive technical reference only.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Investors and others should note that we announce material information to our investors using one or more of the following: SEC filings, press releases and our corporate website, including without limitation the &#x201c;Investors&#x201d; and &#x201c;Events and Presentations&#x201d; sections of our website. We use these channels, as well as social media channels such as LinkedIn, in order to achieve broad, non-exclusionary distribution of information to the public and for complying with our disclosure obligations under Regulation FD. It is possible that the information we post on our corporate website or other social media could be deemed to be material information. Therefore, we encourage investors, the media, and others interested in our company to review the information we post on the &#x201c;Investors&#x201d; and &#x201c;Events and Presentations&#x201d; sections of our corporate website and on our social media channels. The contents of our corporate website and social media channels are not, however, a part of this Annual Report.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">49</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;" id="item_1a_risk_factors"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 1A. Ris</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">k Factors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The following risk factors and other information included in this Annual Report on Form 10-K (&#x201c;Annual Report&#x201d;), including our financial statements and related notes thereto, should be carefully considered. The risks and uncertainties described below are not the only risks and uncertainties we face. Additional risks and uncertainties not presently known to us or that we presently deem less significant may also impair our business operations. Pl</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">ease see the discussion regarding some of the forward-looking statements that are qualified by these risk factors contained elsewhere in this Annual Report. If any of the following risks occur, our business, financial condition, results of operations and future growth prospects could be materially and adversely affected. Such risks may be amplified by the COVID-19 pandemic and its potential impact on our business and the global economy.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to Our Financial Position and Need for Additional Capital</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We have incurred significant net losses since inception. We expect to incur net losses for the foreseeable future and may never achieve or maintain profitability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since inception, we have not generated any revenue and have incurred significant operating losses. For the years ended December 31, 2021 and 2020, our net loss was $68.9 million and $43.3 million, respectively. As of December 31, 2021, we had an accumulated deficit of $130.1 million. We have financed our operations primarily through the sale of our capital stock. We have devoted all of our efforts to organizing and staffing our company, business and scientific planning, raising capital, acquiring and developing technology, identifying potential product candidates, undertaking studies of potential product candidates, developing manufacturing capabilities and evaluating a clinical path for our pipeline programs. We expect to continue to incur significant expenses and increasing operating losses for the foreseeable future. The net losses we incur may fluctuate significantly from quarter to quarter. We anticipate that our expenses will increase substantially if and as we:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">advance and complete clinical trials of our product candidate VOR33;  </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">initiate clinical development of our other product candidates; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">continue our current research programs and development of other potential product candidates from our current research programs; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">seek to identify additional product candidates and research programs; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">initiate preclinical testing and clinical trials for any other product candidates we identify and develop; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">maintain, expand, enforce, defend and protect our intellectual property portfolio and provide reimbursement of third-party expenses related to our patent portfolio; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">research, develop, acquire or in-license additional targeted therapies that could potentially be used in combination or sequence with VOR33 or other engineered hematopoietic stem cell (&#x201c;eHSC&#x201d;) product candidates; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">seek marketing approvals for any product candidates that successfully complete clinical trials; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ultimately establish a sales, marketing and distribution infrastructure to commercialize any products for which we may obtain marketing approval; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">adapt our regulatory compliance efforts to incorporate requirements applicable to marketed products; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">further develop our genome engineering capabilities; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">hire additional research and development and clinical personnel; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">hire commercial personnel and advance market access and reimbursement strategies; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">add operational, financial and management information systems and personnel, including personnel to support our product development; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">acquire or in-license product candidates, intellectual property and technologies; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">develop or in-license manufacturing and distribution technologies;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">build, maintain and validate our own manufacturing facility that is designed to comply with current Good Manufacturing Practices (&#x201c;cGMP&#x201d;); </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">should we decide to do so and receive approval for any of our product candidates, build and maintain, or purchase and validate, commercial-scale manufacturing facilities designed to comply with cGMP requirements; and </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">operate as a public company. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As a company, we have not completed clinical development of any product candidate and expect that it will be several years, if ever, before we have a product candidate ready for commercialization. To become and remain profitable, we must develop and, either directly or through collaborators, eventually commercialize a product or products with significant market potential. This will require us to be successful in a range of challenging activities, including identifying product candidates, completing preclinical testing and clinical trials of product candidates, obtaining marketing approval for these product candidates, manufacturing, marketing and selling those products for which we may obtain marketing approval and satisfying any post-marketing requirements. We may never succeed in these activities and, even if we do, may never generate revenues that are significant or large enough to achieve profitability. Our product candidates and research programs are currently only in the early stages of development. Because of the numerous risks and uncertainties associated with developing product candidates, we are unable to predict the extent of any future losses or when we will become profitable, if at all. If we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis. Our failure to become and remain profitable would decrease the value of our company and could impair our ability to raise capital, maintain our research and development efforts, expand our business or continue our operations. A decline in the value of our company could also cause our stockholders to lose all or part of their investments in us.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We will need substantial additional funding. If we are unable to raise capital when needed, we would be forced to delay, reduce or eliminate our research and product development programs or future commercialization efforts.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expect our expenses to increase in connection with our ongoing activities, particularly as we continue the clinical development of VOR33 in acute myeloid leukemia (&#x201c;AML&#x201d;), advance our VCAR33 programs through clinical development, initiate clinical development of the VOR33 in combination or in sequence with VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> as a targeted therapeutic, which we refer to as the VOR33 + VCAR33 Treatment System and otherwise continue to advance our research programs in support of our pipeline. In addition, if we obtain marketing approval for any of our product candidates, we expect to incur significant commercialization expenses related to product sales, marketing, manufacturing and distribution to the extent that such sales, marketing, manufacturing and distribution are not the responsibility of a collaborator. In addition, we expect to continue to incur significant additional costs associated with operating as a public company in 2022 and future years. Accordingly, we will need to obtain substantial additional funding in order to maintain our continuing operations. If we are unable to raise capital when needed or on attractive terms, we would be forced to delay, reduce or eliminate our research and product development programs or future commercialization efforts.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021, our cash, cash equivalents and investments were $207.5 million. We expect that our existing cash, cash equivalents and investments at December 31, 2021, will enable us to fund our operating expenses and capital expenditure requirements into the fourth quarter of 2023. However, our operating plan may change as a result of factors currently unknown to us, and we may need to seek funding sooner than planned. Our future capital requirements will depend on many factors, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the progress, results and costs of clinical trials for our product candidates, including any COVID-19-related delays or other effects on our development programs; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the costs of continuing to build our technology platform, including in-licensing additional genome engineering technologies for use in developing our product candidates; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the costs of researching, developing, acquiring or in-licensing additional targeted therapies to use in combination or in sequence with VOR33 and other eHSC product candidates; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the scope, progress, results and costs of discovery, preclinical development, formulation development and clinical trials for other product candidates;</span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the costs of expanding our facilities, including the ongoing development of our internal manufacturing capabilities at our headquarters; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">51</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the costs of preparing, filing and prosecuting patent applications, maintaining and enforcing our intellectual property and proprietary rights and defending intellectual property-related claims in the United States and internationally; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the costs, timing and outcome of regulatory review of any product candidates; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the costs of future activities, including product sales, medical affairs, marketing, manufacturing, distribution, coverage and reimbursement for any product candidates for which we receive regulatory approval; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to establish and maintain collaborations on favorable terms, if at all; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the success of our collaborations, including ones we may establish, and of our license agreements; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the achievement of milestones or occurrence of other developments that trigger payments under any collaboration agreements we enter; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the extent to which we acquire or in-license product candidates, intellectual property and technologies; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the extent to which we develop or in-license manufacturing and distribution technologies; and </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the costs of operating as a public company. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Conducting preclinical testing and clinical trials is a time-consuming, expensive and uncertain process that takes years to complete, and we may never generate the necessary data or results required to obtain marketing approval and achieve product sales. In addition, even if we successfully develop product candidates and those are approved, we may not achieve commercial success. Our commercial revenues, if any, will be derived from sales of products that we do not expect to be commercially available for several years, if at all. Accordingly, we will need to continue to rely on additional financing to achieve our business objectives.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any additional fundraising efforts may divert our management from their day-to-day activities, which may adversely affect our ability to develop and commercialize product candidates. We cannot be certain that additional funding will be available on acceptable terms, or at all. We have no committed source of additional capital and, if we are unable to raise additional capital in sufficient amounts or on terms acceptable to us, we may have to significantly delay, scale back or discontinue the development or commercialization of product candidates or other research and development initiatives. Our license agreements and any future collaboration agreements may also be terminated if we are unable to meet the payment or other obligations under the agreements. We could be required to seek collaborators for product candidates at an earlier stage than otherwise would be desirable or on terms that are less favorable than might otherwise be available or relinquish or license on unfavorable terms our rights to product candidates in markets where we otherwise would seek to pursue development or commercialization ourselves.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we are unable to obtain funding on a timely basis, we may be required to significantly curtail, delay or discontinue one or more of our research or development programs or the commercialization of any product candidate, or be unable to expand our operations or otherwise capitalize on our business opportunities, as desired, which could materially affect our business, financial condition and results of operations. Any of the above events could significantly harm our business, prospects, financial condition and results of operations and cause the price of our common stock to decline.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Raising additional capital may cause dilution to our stockholders, restrict our operations or require us to relinquish rights to our technologies or product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Until such time, if ever, as we can generate substantial product revenues, we expect to finance our cash needs through a combination of equity offerings, government or private party grants, debt financings, collaborations, strategic alliances and licensing arrangements. We do not currently have any committed external source of funds. To the extent that we raise additional capital through the sale of equity or convertible debt securities, our stockholders&#x2019; ownership interest will be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect rights of our common stockholders. Debt financing and preferred equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures, declaring dividends and possibly other restrictions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we raise funds through collaborations, strategic alliances or licensing arrangements with third parties, we may have to relinquish valuable rights to our technologies, future revenue streams, research programs or product</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">52</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">candidates, or we may have to grant licenses on terms that may not be favorable to us or commit to providing us with future payment streams. If we are unable to raise additional funds through equity or debt financings when needed, we may be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to develop and market product candidates that we would otherwise prefer to develop and market ourselves. Market volatility resulting from the COVID-19 pandemic or other factors may further adversely impact our ability to access capital as and when needed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We have a limited operating history, have not yet completed any clinical trials and have no history of commercializing products, which may make it difficult to evaluate the success of our business to date and to assess our future viability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are an early-stage company. We were founded in December 2015 and commenced operations in February 2016. Our operations to date have been limited to organizing and staffing our company, business planning, raising capital, acquiring and developing our platform and technology, identifying product candidates and undertaking studies. VOR33 is in the early stages of a Phase 1/2a clinical trial and we have not yet submitted an Investigational New Drug (&#x201c;IND&#x201d;) application for our VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> program and our other programs are still in the preclinical or research stage. The risk of failure for these activities is high. We have not yet demonstrated an ability to successfully complete any clinical trials, including large-scale, pivotal clinical trials, obtain marketing approvals, manufacture a commercial-scale product or arrange for a third party to do so on our behalf or conduct sales and marketing activities necessary for successful commercialization. Consequently, any predictions made about our future success or viability may not be as accurate as they could be if we had a longer operating history.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our limited operating history may make it difficult to evaluate our technology and industry and predict our future performance. Our short history as an operating company makes any assessment of our future success or viability subject to significant uncertainty. We expect to encounter risks and difficulties frequently experienced by early stage companies in new and rapidly evolving fields. If we do not address these risks and difficulties successfully, our business could suffer.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, as a new business, we may encounter other unforeseen expenses, difficulties, complications, delays and other known and unknown factors. We will need to transition from a company with a research focus to a company capable of supporting commercial activities. We may not be successful in such a transition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We have never generated revenue from product sales and may never become profitable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our ability to generate revenue from product sales and achieve profitability depends on our ability, alone or with collaborators, to successfully complete the development of, and obtain the regulatory approvals necessary to commercialize, product candidates. We do not anticipate generating revenues from product sales for the next several years, if ever. Our ability to generate future revenue from product sales depends heavily on our, or our current or future collaborators&#x2019;, ability to successfully:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">advance and complete clinical trials of our product candidate VOR33; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">initiate and complete clinical development of our other product candidates;</span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">complete research and preclinical and clinical development of any other product candidates we may identify; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">seek and obtain regulatory and marketing approvals for any product candidates for which we complete clinical trials; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">launch and commercialize any product candidates for which we obtain regulatory and marketing approval by establishing a sales force, marketing and distribution infrastructure or, alternatively, collaborating with a commercialization partner; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">qualify for coverage and adequate reimbursement by government and third-party payors for any product candidates for which we obtain regulatory and marketing approval; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">develop, maintain and enhance a sustainable, scalable, reproducible and transferable manufacturing process for our product candidates; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">53</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">establish and maintain supply and manufacturing relationships with third parties that can provide adequate, in both amount and quality, products and services to support clinical development and the market demand for any product candidates for which we obtain regulatory and marketing approval; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">obtain market acceptance of product candidates as viable treatment options; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">address competing technological and market developments; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">implement internal systems and infrastructure, as needed; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">negotiate favorable terms in any collaboration, licensing or other arrangements into which we may enter and performing our obligations in such arrangements; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">maintain, protect, enforce, defend and expand our portfolio of intellectual property rights, including patents, trade secrets and know-how, in the United States and internationally; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">avoid and defend against third-party interference, infringement and other intellectual property claims in the United States and internationally; and </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">attract, hire and retain qualified personnel. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Even if one or more of the product candidates we develop are approved for commercial sale, we anticipate incurring significant costs associated with commercializing any approved product candidate. Our expenses could increase beyond expectations if we are required by the U.S. Food and Drug Administration (the &#x201c;FDA&#x201d;), the European Medicines Agency (the &#x201c;EMA&#x201d;) or other regulatory authorities to perform clinical and other studies in addition to those that we currently anticipate. Even if we are able to generate revenues from the sale of any approved product candidates, we may not become profitable and may need to obtain additional funding to continue operations.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Even if we do achieve profitability, we may not be able to sustain or increase profitability on a quarterly or annual basis. Our failure to become and remain profitable would decrease the value of our company and could impair our ability to raise capital, maintain our research and development efforts, expand our business or continue our operations. A decline in the value of our company also could cause stockholders to lose all or part of their investment in us.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our ability to utilize our net operating loss carryforwards and certain other tax attributes to offset taxable income or taxes may be limited.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021, we had gross federal net operating loss carryforwards of  $119.3 million including $117.4 million that had an indefinite carryforward period and $1.9 million that were subject to expiration at various dates through 2037. Furthermore, we have state and local net operating loss carryforwards of $109.2 million which will expire at various dates through 2041. Portions of these net operating loss carryforwards could expire unused and be unavailable to offset future income tax liabilities. Under the legislation enacted in 2017, informally titled the Tax Cuts and Jobs Act (the &#x201c;Tax Act&#x201d;), as modified by the Coronavirus Aid, Relief, and Economic Security (the &#x201c;CARES Act&#x201d;) U.S. federal net operating losses incurred in taxable years beginning after December 31, 2017, may be carried forward indefinitely, but the deductibility of such federal net operating losses in taxable years beginning after December 31, 2020, may be limited. It is uncertain how various states will respond to the Tax Act and the CARES Act. For state income tax purposes, there may be periods during which the use of net operating loss carryforwards is suspended or otherwise limited, which could accelerate or permanently increase state taxes owed. In addition, under Sections 382 and 383 of the Internal Revenue Code of 1986, as amended (the &#x201c;Code&#x201d;), and corresponding provisions of state law, if a corporation undergoes an &#x201c;ownership change,&#x201d; which is generally defined as a greater than 50% change, by value, in its equity ownership over a three-year period, the corporation&#x2019;s ability to use its pre-change net operating loss carryforwards and other pre-change tax attributes to offset its post-change income or taxes may be limited. The completion of our initial public offering, together with private placements and other transactions that have occurred since our inception, may trigger such an ownership change pursuant to Section 382 of the Code. We have not yet completed a Section 382 analysis, and therefore, there can be no assurances that our net operating losses are not already limited. We may experience ownership changes as a result of subsequent shifts in our stock ownership, some of which may be outside of our control. If an ownership change occurs and our ability to use our net operating loss carryforwards is materially limited, it would harm our future operating results by effectively increasing our future tax obligations. There is a full valuation allowance for net deferred tax assets, including net operating loss carryforwards.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">54</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to Discovery, Development, Manufacturing and Commercialization</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">eHSCs are a novel technology that is not yet clinically validated for human use. The approaches we are taking to create eHSCs are unproven and may never lead to marketable products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are developing VOR33 and other eHSCs for transplant into the human body. Although there have been significant advances in the field of genome engineering in recent years, these technologies have rarely been applied to hematopoietic stem cells (&#x201c;HSCs&#x201d;), and our approach is new and largely unproven. The scientific evidence to support the feasibility of developing eHSCs is both preliminary and limited. Successful development of eHSCs by us will require solving a number of challenges, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">obtaining regulatory authorization from the FDA and other regulatory authorities, which have limited or no experience with regulating the development and commercialization of eHSCs, to proceed with clinical trials; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">identifying appropriate genetic targets for modification within HSCs; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">developing and deploying consistent and reliable processes for procuring cells from consenting third-party donors, isolating HSCs from such donor cells, inactivating genetic targets within such HSCs, storing and transporting the resulting eHSCs for therapeutic use and finally infusing these eHSCs into patients; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">utilizing these eHSC product candidates in combination or in sequence with targeted therapeutics, which may increase the risk of adverse side effects; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">avoiding potential complications of eHSC transplants, including failure to engraft, rejection by host or lack of functionality, any of which could result in serious side effects or death; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">educating medical personnel regarding the potential side effect profile of our product candidates, particularly those that may be unique to our eHSCs; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">understanding and addressing variability in the quality of a donor&#x2019;s cells, which could ultimately affect our ability to manufacture product in a reliable and consistent manner; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">developing processes for the safe administration of eHSC products, including long-term follow-up and registries, for all patients who receive these product candidates; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">relying on third parties to find suitable healthy donors; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">obtaining regulatory approval from the FDA and other regulatory authorities; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">manufacturing product candidates to our specifications and in a timely manner to support our clinical trials and, if approved, commercialization; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">sourcing clinical and, if approved by applicable regulatory authorities, commercial supplies for the materials used to manufacture and process product candidates; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">developing a manufacturing process and distribution network that can provide a stable supply with a cost of goods that allows for an attractive return on investment; and </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">establishing sales and marketing capabilities ahead of and after obtaining any regulatory approval to gain market acceptance, and obtaining coverage, adequate reimbursement and pricing by third-party payors and governmental healthcare programs. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have concentrated our research efforts to date on preclinical work to bring VOR33 into clinical development for the treatment of AML, and our future success is highly dependent on the successful development of eHSCs, such as VOR33, and the therapeutic applications of these cells. We may decide to alter or abandon our initial programs as new data become available and we gain experience in developing eHSCs. We cannot be sure that our programs will yield satisfactory products that are safe and effective, scalable or profitable in our initial indication or any other indication we pursue.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Moreover, actual or perceived safety issues, including as a result of adverse developments in our eHSC programs or in genome engineering programs undertaken by third parties or of the adoption of novel approaches to treatment, may adversely influence the willingness of subjects to participate in our clinical trials, or, if one of our product candidates is approved by applicable regulatory authorities, of physicians to subscribe to the novel treatment</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">55</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">mechanics or of patients to provide consent to receive a novel treatment despite its regulatory approval. The FDA or other applicable regulatory authorities may require specific post-market studies or additional information that communicates the benefits or risks of our products. New data may reveal new risks of our product candidates at any time prior to or after regulatory approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We are substantially dependent on the success of our two most advanced product candidates, VOR33 and VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;font-style:italic;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">. If we are unable to complete development of, obtain approval for and commercialize VOR33 or VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;font-style:italic;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> in a timely manner, our business will be harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our future success is dependent on our ability to timely advance and complete clinical trials, obtain marketing approval for and successfully commercialize our product candidates VOR33 and VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. We are investing significant efforts and financial resources in the research and development of these product candidates. Our IND application for VOR33 in combination with Mylotarg in patients with AML was accepted by the FDA in January 2021 and we are only in the early stages of advancing VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> through clinical development. VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">AUTO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, a CAR-T substantially similar to our VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">program that uses autologous cells from each patient, as opposed to using allogeneic healthy donor-derived cells like our VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">program, is also undergoing a multi-site, investigator-initiated Phase 1/2 clinical trial in relapsed AML patients as a monotherapy in a bridge-to-transplant setting. This trial is currently sponsored and overseen by the National Marrow Donor Program (&#x201c;NMDP&#x201d;). VOR33 and VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> will each require additional clinical development, evaluation of clinical, preclinical and manufacturing activities, marketing approval from government regulators, substantial investment and significant marketing efforts before we can generate any revenues from product sales. We are not permitted to market or promote VOR33, VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> or any other product candidate, before we receive marketing approval from the FDA and comparable foreign regulatory authorities, and we may never receive such marketing approvals.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The success of VOR33 and VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> will depend on several factors, including the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the acceptance of individual investigational review boards (&#x201c;IRBs&#x201d;) and scientific review committees at each clinical trial site as to the adequacy of the preclinical data package to support clinical development of VOR33 and their overall general agreement with the use of VOR33 in the intended patient population in the intended manner; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the willingness of clinical investigators to place patients in the clinical trials, and the willingness of patients to enroll in a clinical trial studying a first-in-human cell therapy; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the successful and timely completion of our Phase 1/2a clinical trial of VOR33, the development of our  VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> program and the ongoing Phase 1/2 clinical trial of VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">AUTO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">;</span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to incorporate the results of the ongoing Phase 1/2 clinical trial of VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">AUTO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for the treatment of AML into future regulatory filings;</span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the initiation and successful patient enrollment and completion of additional clinical trials of VOR33 and VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> on a timely basis; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">maintaining and establishing relationships with contract research organizations (&#x201c;CROs&#x201d;) and clinical sites for the clinical development of these programs both in the United States and internationally; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the frequency and severity of adverse events in the clinical trials; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the results of clinical trials conducted by third parties in hematopoietic stem cell transplant (&#x201c;HSCT&#x201d;) if such trials result in changes to the standard of care for HSCT or otherwise cause us to change our clinical trial protocols; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the efficacy, safety and tolerability profiles that are satisfactory to the FDA, European Medicines Agency (&#x201c;EMA&#x201d;) or any comparable foreign regulatory authority for marketing approval; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the timely receipt of marketing approvals for our programs from applicable regulatory authorities; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the extent of any required post-marketing approval commitments to applicable regulatory authorities; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the maintenance of existing or the establishment of new supply arrangements with third-party suppliers and manufacturers for clinical development of our programs;</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">56</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the maintenance of existing, or the establishment of new, scaled production arrangements with third-party manufacturers to obtain finished products that are appropriate for commercial sale of our programs, if either is approved;</span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">obtaining and maintaining patent protection, trade secret protection and regulatory exclusivity, both in the United States and internationally; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the protection of our rights in our intellectual property portfolio; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the successful launch of commercial sales following any marketing approval; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a continued acceptable safety profile following any marketing approval; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">commercial acceptance by patients, the medical community and third-party payors; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to obtain coverage and adequate reimbursement from third-party payors for our products and patients&#x2019; willingness to pay out-of-pocket in the absence of such coverage and adequate reimbursement; and </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to compete with other treatments. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We do not have complete control over many of these factors, including certain aspects of clinical development and the regulatory submission process, potential threats to our intellectual property rights and the manufacturing, marketing, distribution and sales efforts of any future collaborator. If we are not successful with respect to one or more of these factors in a timely manner or at all, we could experience significant delays or an inability to successfully commercialize VOR33 and/or VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, which would materially harm our business. If we do not receive marketing approvals for VOR33 and VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> we may not be able to continue our operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may not be successful in our efforts to identify, develop and commercialize additional product candidates. If these efforts are unsuccessful, we may never become a commercial stage company or generate any revenues.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The success of our business depends primarily upon our ability to identify, develop and commercialize additional product candidates based on, or complementary with, our technology platform. Other than VOR33, all of our other product development programs are still in the research or preclinical stage of development. Our research programs may fail to identify additional product candidates for clinical development for a number of reasons. Our research methodology may be unsuccessful in identifying potential product candidates, our potential product candidates may be shown to have harmful side effects in preclinical </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">in vitro</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> experiments or animal model studies, they may not show promising signals of efficacy in such experiments or studies or they may have other characteristics that may make the product candidates impractical to manufacture, unmarketable or unlikely to receive marketing approval. The historical failure rate for product candidates is high due to risks relating to safety, efficacy, clinical execution, changing standards of medical care and other unpredictable variables. In addition, although we believe our technology platform will position us to rapidly expand our portfolio of product candidates beyond our current product candidates, our ability to expand our portfolio may never materialize.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If any of these events occur, we may be forced to abandon our research or development efforts for a program or programs, which would have a material adverse effect on our business, financial condition, results of operations and prospects. Research programs to identify new product candidates require substantial technical, financial and human resources. We may focus our efforts and resources on potential programs or product candidates that ultimately prove to be unsuccessful, which would be costly and time-consuming.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If our product candidates, or the delivery modes we rely on to administer them, cause serious adverse events, undesirable side effects or unexpected characteristics, such events, side effects or characteristics could delay or prevent regulatory approval of the product candidates, limit their commercial potential or result in significant negative consequences following any potential marketing approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have not yet completed any human clinical trials of our product candidates and it is impossible to predict when or if our product candidates will prove safe in humans. Undesirable side effects caused by our product candidates could cause us or regulatory authorities to interrupt, delay or halt clinical trials and could result in a more restrictive label or the delay or denial of regulatory approval by the FDA or comparable foreign regulatory authorities. Results of our clinical trials could reveal a high and unacceptable severity and prevalence of side effects or unexpected characteristics.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">57</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There have been no clinical trials of eHSCs and a limited number of clinical trials of certain of the technologies we are using to engineer eHSCs and chimeric antigen receptor (&#x201c;CAR&#x201d;)-T cells, including the CRISPR/Cas9 method we are using in our VOR33 program. In the genetic medicine field, there have been several significant adverse events from genetically engineered treatments in the past, including reported cases of leukemia and death. There have also been recent studies suggesting that genome engineering using the CRISPR-Cas9 method may increase the risk that the modified cells themselves become cancerous or otherwise dysfunctional. There can be no assurance that our eHSCs or CAR-T cells and the genome engineering techniques that we may employ in their development will not cause undesirable side effects, as improper modification of a patient&#x2019;s DNA could lead to lymphoma, leukemia or other cancers, or other aberrantly functioning cells.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A significant risk in any genetically engineered product candidate is that &#x201c;off-target&#x201d; gene alterations may occur, which could cause serious adverse events, undesirable side effects or unexpected characteristics. Although we and others have demonstrated the ability to improve the specificity of gene alterations in a laboratory setting, we cannot be certain that off-target alterations will not occur in any of our planned or future clinical trials, and the lack of observed side effects in preclinical studies does not guarantee that such side effects will not occur in human clinical trials.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There is also the potential risk of delayed adverse events following exposure to genetically engineered cells due to the permanence of changes to DNA or due to other components of product candidates used to carry the genetic material. Further, because our genome engineering technology makes a permanent change, the treatment cannot be withdrawn, even after a side effect is observed. For example, our eHSCs are designed to permanently reconstitute the blood cells necessary for the survival of HSCT patients, and we cannot be certain that these changes will not induce adverse reactions in patients or impair the functionality of the resulting blood cells. The eHSC manufacturing process generally, and the removal of surface targets such as CD33 specifically, could have temporary or permanent harmful effects. The removal of CD33 from HSCs has never been studied in clinical trials. While we have discovered anonymous individuals in genome databases who lack CD33, we cannot be certain that these databases are accurate or complete or that the individuals who have contributed DNA to the database are healthy, as comprehensive health information is not included in the databases we have consulted. The removal of CD33 or other surface targets we remove from HSCs could have serious harmful effects, including the impairment of the ability of our eHSCs to migrate to patients&#x2019; bone marrow, survive and reconstitute properly functioning blood cells. These side effects may not be evident for years after transplant.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to side effects and adverse events that may be caused by our eHSCs, HSCT is itself a complicated and risky procedure. The conditioning, administration process or related procedures which may be used in HSCT can cause adverse side effects and adverse events. An HSCT patient is generally administered cytotoxic drugs to remove stem cells from the bone marrow to create sufficient space in the bone marrow for the modified stem cells to engraft and produce new cells. This procedure compromises the patient&#x2019;s immune system. In addition, the HSCs administered via transplant may fail to engraft in patients&#x2019; bone marrow, or could be rejected by the patient, either of which could result in serious side effects, including death. If in the future we are unable to demonstrate that such adverse events were caused by the elements of the HSCT process unrelated to our eHSCs, the FDA, the European Commission, the Competent Authorities of the Member States of the European Union, EMA or other regulatory authorities could order us to cease further development of, or deny approval of, our eHSCs for any or all target indications. Even if we are able to demonstrate that adverse events are not related to our product candidates, or are merely a feature of HSCT generally, such occurrences could affect patient recruitment, the ability of enrolled patients to complete the clinical trial, or the commercial viability of any product candidates that obtain regulatory approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Furthermore, in previous and ongoing clinical trials involving CAR-T or other cell-based therapies from other companies, patients experienced side effects such as neurotoxicity and cytokine release syndrome. There have been life threatening events related to severe neurotoxicity and cytokine release syndrome, requiring intense medical intervention such as intubation or pressor support, and in several cases, resulting in death. Severe neurotoxicity is a condition that is currently defined clinically by cerebral edema, confusion, drowsiness, speech impairment, tremors, seizures, or other central nervous system side effects, when such side effects are serious enough to lead to intensive care. In some cases, severe neurotoxicity was thought to be associated with the use of certain lymphodepletion regimens used prior to the administration of the CAR-T or other cell-based therapies. Cytokine release syndrome is a condition that is currently defined clinically by certain symptoms related to the release of cytokines, which can include fever, chills, low blood pressure, when such side effects are serious enough to lead to intensive care with mechanical ventilation or significant vasopressor support. The exact cause or causes of cytokine release syndrome</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">58</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">and severe neurotoxicity in connection with treatment of CAR-T or other cell-based therapies is not fully understood at this time. In addition, patients have experienced other adverse events in these trials, such as a reduction in the number of blood cells (in the form of neutropenia, thrombocytopenia, anemia or other cytopenias), febrile neutropenia, chemical laboratory abnormalities (including elevated liver enzymes) and renal failure.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The delivery modalities of certain of our product candidates may also cause serious adverse events. For example, in order to administer VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, we employ viral vectors, including lentiviruses, which are relatively new approaches used for disease treatment. In past clinical trials that were conducted by others with lentivirus vectors, several significant side effects were caused by gene therapy treatments, including reported cases of leukemia and death. Other potential side effects could include an immunologic reaction and insertional oncogenesis, which is the process whereby the insertion of a functional gene near a gene that is important in cell growth or division results in uncontrolled cell division, which could potentially enhance the risk of malignant transformation. If the vectors we use demonstrate a similar side effect, or other adverse events, we may be required to halt or delay further clinical development of VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and potential product candidates. Furthermore, the FDA has stated that lentiviral vectors possess characteristics that may pose high risks of delayed adverse events.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Undesirable side effects caused by VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">AUTO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> or other cell-based targeted therapeutics we may develop could cause us or regulatory authorities to interrupt, delay or halt clinical trials and could result in a more restrictive label or the delay or denial of marketing approval by the FDA or other comparable foreign regulatory authorities. In some cases, side effects such as neurotoxicity or cytokine release syndrome have resulted in clinical holds of ongoing clinical trials and/or discontinuation of the development of the product candidate. Results of our studies could reveal a high and unacceptable severity and prevalence of side effects or unexpected characteristics. Treatment-related side effects could also affect patient recruitment or the ability of enrolled patients to complete the trials or result in potential product liability claims. In addition, these side effects may not be appropriately recognized or managed by the treating medical staff, as toxicities resulting from T cell-based immunotherapies are not normally encountered in the general patient population and by medical personnel. Medical personnel may need additional training regarding T cell-based immunotherapy product candidates to understand their side effects. Inadequate training in recognizing or failure to effectively manage the potential side effects of T cell-based immunotherapy product candidates could result in patient deaths. Any of these occurrences may harm our business, financial condition and prospects significantly.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If any product candidates we develop are associated with serious adverse events, undesirable side effects or unexpected characteristics, we may need to abandon their development or limit development to certain uses or subpopulations in which the serious adverse events, undesirable side effects or other characteristics are less prevalent, less severe or more acceptable from a risk-benefit perspective, any of which would have a material adverse effect on our business, financial condition, results of operations, and prospects. Many product candidates that initially showed promise in early stage testing have later been found to cause side effects that prevented further clinical development of the product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, if we successfully develop a product candidate and it receives marketing approval, the FDA could require us to adopt a Risk Evaluation and Mitigation Strategy (&#x201c;REMS&#x201d;), to ensure that the benefits of treatment with such product candidate outweighs the risks for each potential patient, which may include, among other things, a medication guide outlining the risks of the product for distribution to patients, a communication plan to health care practitioners, extensive patient monitoring or distribution systems and processes that are highly controlled, restrictive and more costly than what is typical for the industry. Furthermore, if we or others later identify undesirable side effects caused by a product candidate, several potentially significant negative consequences could result, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">regulatory authorities may suspend or withdraw approvals of such product candidate; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">regulatory authorities may require additional warnings on the label or limit the approved use of such product candidate; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may be required to change the way the product is administered, or implement other changes to the labeling or handling of a product, if approved; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may be required to conduct additional clinical trials; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we could be sued and held liable for harm caused to patients; and </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">59</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our reputation may suffer. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any of these events could prevent us from achieving or maintaining market acceptance of product candidates and could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We have not successfully tested our product candidates in clinical trials and any favorable preclinical results are not predictive of results that may be observed in clinical trials.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have not successfully tested our product candidates in clinical trials, and there is a high failure rate for drugs and biologics proceeding through clinical trials. A number of companies in the pharmaceutical and biotechnology industries have suffered significant setbacks in later stage clinical trials even after achieving promising results in earlier stage clinical trials. Data obtained from preclinical and clinical activities are subject to varying interpretations, which may delay, limit or prevent regulatory approval. In addition, regulatory delays or rejections may be encountered as a result of many factors, including changes in regulatory policy during the period of product development. Any such adverse events may cause us to delay, limit or terminate planned clinical trials, any of which would have a material adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, the results of preclinical studies may not be predictive of the results of later-stage preclinical studies or clinical trials. To date, we have generated only limited preclinical study data and no clinical trial results, and any such data or results do not ensure that later preclinical studies or clinical trials will produce similar outcomes. Moreover, preclinical and clinical data are often susceptible to varying interpretations and analyses, and many companies that have believed their product candidates performed satisfactorily in preclinical studies and clinical trials have nonetheless failed to obtain marketing approval of their product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Furthermore, the IND for the T cell therapy candidate using the same CAR construct as VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, which we refer to as VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">AUTO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, is currently held, and this clinical trial is currently sponsored, by the NMDP. As such, the NMDP is responsible for all aspects of this trial, including the design of the trial, the manufacture of study product, the enrollment, dosing and follow-up of patients, the recording of trial data and the analysis of results. We also did not control the preclinical development of this T cell therapy candidate, which was conducted by the NIH, and we do not have rights under the license agreement to certain intellectual property, such as know-how, employed by the NMDP in manufacturing study product or conducting its clinical trial. We have received the right to cross reference the NMDP's IND for this T cell therapy candidate in any future IND application we may make with the FDA. In the event we cross-reference these trial results, we will be required to demonstrate that our VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> is comparable to the T cell therapy studied in the NMDP trial, which will require us to show that our manufacturing processes and construct release specifications are sufficiently comparable to those employed in the NMDP trial. While we do not believe that we need to demonstrate comparability of our VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> candidate since we intend to rely on initial clinical data from our VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> program, if the FDA disagrees, we may have to demonstrate comparability. If we have to determine comparability, we expect the FDA to evaluate whether and to what extent any changes in our process and specifications are likely to have an adverse effect on the quality, safety and efficacy of VCAR33 in comparison to the T cell therapy studied in the NMDP trial. We may be unable to establish the comparability of the product candidate investigated under the NMDP IND and our IND for VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> in the event of manufacturing changes, or the FDA or other regulatory authorities may otherwise disagree with the sufficiency of our right of reference to the preclinical, manufacturing or clinical data generated by the NMDP&#x2019;s trial or our interpretation of preclinical, manufacturing or clinical data from this trial. If so, regulatory authorities may require us to obtain and submit additional preclinical, manufacturing or clinical data before we may initiate further clinical trials and/or obtain any regulatory approvals. For example, we may be required to conduct additional preclinical toxicology studies, requalify manufacturing processes or conduct further clinical investigation of VCAR33 before advancing our VCAR33 program.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are also relying on NIH to have conducted its research and development efforts, and on the NMDP to conduct its clinical trial, in accordance with applicable protocol, legal, regulatory and scientific standards, to accurately report the results of preclinical studies and clinical trials, and to correctly collect and interpret the data from these studies and trials. To the extent any of these has not occurred or does not occur, the expected time and costs of developing our VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> program, as well as the VOR33 + VCAR33 Treatment System, may be increased, which could adversely affect our business. Furthermore we do not control the timing of the ongoing NMDP trial or the release of information about the trial, including trial results, all of which negatively affect our ability to accurately estimate the timing of anticipated trial milestones. As a result, our estimates may prove to be inaccurate. Additionally, our ability to conduct clinical development of VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> could be delayed or otherwise</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">60</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">adversely affected. The NMDP also may not publicize data from the trial in a manner that facilitates further clinical development by us, or at all. The NMDP may elect to publicize this data at a time or in a manner other than we desire or may interpret data from these trials in a manner differently than we do, any of which could harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Development of a product candidate such as VOR33, which is intended for use in combination or in sequence with an already approved therapy, will present increased complexity and more or different challenges than development of a product candidate for use as a single agent.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expect that our product candidate VOR33, and any other eHSC product candidates that we may develop, will be required to be used in combination or in sequence with existing or future therapies in order to demonstrate more anti-cancer efficacy than unmodified HSCs. In particular, our Phase 1/2a</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> clinical trial evaluates VOR33 in combination with Mylotarg and we anticipate conducting future trials of VOR33 with VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> as a Treatment System, and also potentially with other targeted therapies. Developing product candidates for use in combination or sequence with other therapies will present challenges. For example, the FDA may require us to use more complex clinical trial designs to evaluate the contribution of each product and product candidate to any observed effects. Moreover, following product approval, the FDA may require that products used in conjunction with each other be cross-labeled, which would require consent from the sponsoring company. To the extent that we do not have rights to already approved products, this may require us to work with another company to satisfy such a requirement. For example, we do not have and do not currently plan to enter into a cross-labeling agreement with Pfizer with respect to Mylotarg, and therefore any such cross-labeling requirement from the FDA would require us to negotiate such an agreement with Pfizer. In addition, developments related to the already approved therapies may impact our clinical trials for the combination as well as our commercial prospects should we receive marketing approval. Such developments may include changes to the approved therapy&#x2019;s safety or efficacy profile, changes to the availability of the approved therapy, changes to the standard of care and a decision by the sponsoring company to withdraw the therapy from the market. For example, Mylotarg was voluntarily withdrawn from the market in 2010 after post-approval testing indicated increased risks of hepatic veno-occlusive disease, or blockage of veins in the liver. Mylotarg was re-approved in 2017 with a lower recommended dose and for use in a new patient population. Also, while we do not currently require a license from or agreement with Pfizer to permit us to conduct clinical trials or, if approved, to commercialize VOR33 with Mylotarg as a targeted therapeutic, we do not have and do not plan to enter into a supply or license agreement with Pfizer that would require Pfizer to produce Mylotarg, or permit us to otherwise produce Mylotarg, for these purposes. If Mylotarg undergoes subsequent labeling changes, or if Mylotarg is again removed from the market due to renewed concerns about its safety profile, or for other reasons, our clinical trial of VOR33, and our prospects for commercializing VOR33, will be materially adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Furthermore, we will not be able to market and sell VOR33 or any product candidate we develop in combination with an unapproved cancer therapy, such as VCAR33 or other cell-based targeted therapeutics, for a combination indication, if that unapproved therapy does not ultimately obtain marketing approval either alone or in combination with our product. To our knowledge, the FDA has not previously approved combined cell therapies, and we cannot be certain whether the FDA will apply existing guidance to cell therapies product candidates, such as the VOR33 + VCAR33 Treatment System, or will otherwise apply existing guidance in novel ways. In addition, unapproved cancer therapies face the same risks described with respect to our product candidates currently in development and clinical trials, including the potential for serious adverse effects, delay in their clinical trials and lack of FDA approval. If the FDA, EMA or comparable foreign regulatory authorities do not approve these other drugs or revoke their approval of, or if safety, efficacy, quality, manufacturing or supply issues arise with, the drugs we choose to evaluate in combination with any product candidate we develop, we may be unable to obtain approval of or market such combination therapy.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any inability to develop targeted therapies for use with our product candidate, any failure to maintain or enter into new successful commercial relationships with respect to targeted therapies, or the expense of purchasing targeted therapies in the market, may delay our development timelines, increase our costs and jeopardize our ability to develop our current product candidates and any future product candidates as commercially viable therapies. If any of these occur, our business, financial condition, results of operations, stock price and prospects may be materially harmed.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">61</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we are unable to successfully develop our current programs into a comprehensive portfolio of product candidates, or experience significant delays in doing so, we may not realize the full commercial potential of our current and future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are developing VOR33 so that it can be used in combination or in sequence with other product candidates that we in-license or develop ourselves, and we are focused on a product development strategy that includes leveraging the synergies among a comprehensive portfolio of our product candidates. For example, if the initial clinical trials of VOR33 and VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> are each successful, we anticipate conducting clinical trials of the VOR33 + VCAR33 Treatment System, for the treatment of myeloid malignancies such as AML. Our success may depend, in part, on our ability to develop a complementary product portfolio with product candidates that will address a major limitation of existing therapies. Given our limited experience in developing product candidates that have received marketing approval, we may not be successful in developing some of our product candidates. The failure of one of our product candidates to obtain regulatory approval or market acceptance may affect our ability to expand our market opportunities for our other product candidates or programs. Although we may develop product candidates that ultimately obtain marketing approval, if we are unable to successfully develop our current programs into a comprehensive portfolio of product candidates, or experience significant delays in doing so, we may not realize the full commercial potential of our current and future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may expend our limited resources to pursue a particular product candidate or indication and fail to capitalize on product candidates or indications that may be more profitable or for which there is a greater likelihood of success.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Because we have limited financial and managerial resources, we focus on product candidates and research programs that we identify for specific indications among many potential options. As a result, we may forego or delay pursuit of opportunities with other product candidates or for other indications that later prove to have greater commercial potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitable market opportunities. Our spending on current and future product candidates and research and development programs for specific indications may not yield any commercially viable products. If we do not accurately evaluate the commercial potential or target market for a particular product candidate, we may relinquish valuable rights to that product candidate through collaboration, licensing or other royalty arrangements in cases in which it would have been more advantageous for us to retain sole development and commercialization rights to such product candidate. Any such event could have a material adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Even if a product candidate receives marketing approval, it may fail to achieve the degree of market acceptance by physicians, patients, healthcare payors and others in the medical community necessary for commercial success.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The commercial success of our product candidates, if approved, will depend upon their degree of market acceptance by physicians, patients, third-party payors and others in the medical community. Ethical, social and legal concerns about genetic medicines generally and genome engineering technologies specifically could result in additional regulations restricting or prohibiting the marketing of our product candidates. Even if any product candidate we develop receives marketing approval, it may nonetheless fail to gain sufficient market acceptance by physicians, patients, healthcare payors and others in the medical community. The degree of market acceptance of any product candidate we develop, if approved for commercial sale, will depend on a number of factors, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the efficacy and safety of such product candidate as demonstrated in clinical trials; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the efficacy and safety of other products that are used in combination or in sequence with our product; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the potential and perceived advantages of our product candidates compared to alternative treatments; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the limitation to our targeted patient population and limitations or warnings contained in approved labeling by the FDA or other regulatory authorities; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the ability to offer our products for sale at competitive prices; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">convenience and ease of administration compared to alternative treatments; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the clinical indications for which the product candidate is approved by the FDA, the EMA or other regulatory agencies; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">62</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">public attitudes regarding genetic medicine generally and genome engineering technologies specifically; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the willingness of the target patient population to try novel biologics and of physicians to prescribe these treatments, as well as their willingness to accept an intervention that involves the alteration of the patient&#x2019;s gene; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">product labeling or product insert requirements of the FDA, the EMA or other regulatory authorities, including any limitations or warnings contained in a product&#x2019;s approved labeling; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">relative convenience and ease of administration; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the timing of market introduction of competitive products; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">publicity concerning our products or competing products and treatments; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the strength of marketing and distribution support; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">availability of third-party coverage and sufficiency of reimbursement; and</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the prevalence and severity of any side effects. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Even if a product candidate is approved, such product may not achieve an adequate level of acceptance, we may not generate significant product revenues, and we may not become profitable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If, in the future, we are unable to establish sales and marketing capabilities or enter into agreements with third parties to sell and market our product candidates, we may not be successful in commercializing those product candidates if and when they are approved.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We do not have a sales or marketing infrastructure and have limited experience in the sale, marketing or distribution of pharmaceutical products. To achieve commercial success for any approved product for which we retain sales and marketing responsibilities, we must either develop a sales and marketing organization or outsource these functions to third parties. In the future, we may choose to build a focused sales, marketing and commercial support infrastructure to sell, or participate in sales activities with our collaborators for, some of our product candidates if and when they are approved.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There are risks involved with both establishing our own commercial capabilities and entering into arrangements with third parties to perform these services. For example, recruiting and training a sales force or reimbursement specialists is expensive and time consuming and could delay any product launch. If the commercial launch of a product candidate for which we recruit a sales force and establish marketing and other commercialization capabilities is delayed or does not occur for any reason, we would have prematurely or unnecessarily incurred these commercialization expenses. This may be costly, and our investment would be lost if we cannot retain or reposition our commercialization personnel.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Factors that may inhibit our efforts to commercialize our product candidates on our own include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our inability to recruit and retain adequate numbers of effective sales, marketing, reimbursement, customer service, medical affairs and other support personnel; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the inability of sales personnel to obtain access to physicians or educate adequate numbers of physicians on the benefits of prescribing any future products; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the inability of reimbursement professionals to negotiate arrangements for formulary access, reimbursement and other acceptance by payors; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">restricted or closed distribution channels that make it difficult to distribute our product candidates to segments of the patient population; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the lack of complementary products to be offered by sales personnel, which may put us at a competitive disadvantage relative to companies with more extensive product lines; and </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">unforeseen costs and expenses associated with creating an independent commercialization organization. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we enter into arrangements with third parties to perform sales, marketing, commercial support and distribution services, our product revenues or the profitability of these product revenues to us may be lower than if</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">63</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we were to market and sell products ourselves. In addition, we may not be successful in entering into arrangements with third parties to commercialize our product candidates or may be unable to do so on terms that are favorable to us. We may have little control over such third parties, and any of them may fail to devote the necessary resources and attention to sell and market our products effectively. If we do not establish commercialization capabilities successfully, either on our own or in collaboration with third parties, we will not be successful in commercializing our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We face significant competition in an environment of rapid technological change, and there is a possibility that our competitors may achieve regulatory approval before us or develop therapies that are safer or more advanced or effective than ours, which may harm our financial condition and our ability to successfully market or commercialize product candidates, if approved.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The development and commercialization of new drug and biologic products is highly competitive. Moreover, the genome engineering and oncology fields are characterized by rapidly changing technologies, significant competition and a strong emphasis on intellectual property. We will face competition with respect to our product candidates that we develop or commercialize in the future from major pharmaceutical companies, specialty pharmaceutical companies and biotechnology companies worldwide. Potential competitors also include academic institutions, government agencies and other public and private research organizations that conduct research, seek patent protection and establish collaborative arrangements for research, development, manufacturing and commercialization.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There are a number of large pharmaceutical and biotechnology companies that currently market and sell products or are pursuing the development of products for the treatment of the disease indications for which we have product candidates and research programs. Some of these competitive products and therapies are based on scientific approaches that are similar to our approach, and others are based on entirely different approaches.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any product candidates that we successfully develop and commercialize will compete with existing therapies and new therapies that may become available in the future that are approved to treat the same diseases for which we may obtain approval for our product candidates. This may include other types of therapies, such as small molecule, antibody and/or protein therapies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Many of our current or potential competitors, either alone or with their collaboration partners, may have significantly greater financial resources and expertise in research and development, manufacturing, preclinical testing, conducting clinical trials, obtaining regulatory approvals and marketing approved products than we do. Mergers and acquisitions in the pharmaceutical, biotechnology and gene therapy industries may result in even more resources being concentrated among a smaller number of our competitors. Smaller or early-stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trial sites and patient registration for clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs. Our commercial opportunity could be reduced or eliminated if our competitors develop and commercialize product candidates that are safer, more effective, have fewer or less severe side effects, are more convenient or are less expensive than our product candidates or that would render our product candidates obsolete or non-competitive. Our competitors also may obtain FDA or other regulatory approval for their product candidates more rapidly than we may obtain approval for ours, which could result in our competitors establishing a strong market position before we are able to enter the market. Additionally, technologies developed by our competitors may render our product candidates uneconomical or obsolete, and we may not be successful in marketing any product candidates against competitors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, as a result of the expiration or successful challenge of our patent rights, we could face more litigation with respect to the validity and/or scope of patents relating to our competitors&#x2019; products. The availability of our competitors&#x2019; products could limit the demand, and the price we are able to charge, for our product candidates, if approved.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Adverse public perception of genetic medicines, and genome engineering in particular, may negatively impact regulatory approval of, and/or demand for, our potential products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">VOR33, and future eHSCs and CAR-T or other cell-based targeted therapeutics we may develop will be, created by altering the human genome. The clinical and commercial success of our potential products will depend in part on public understanding and acceptance of the use of genome engineering for the prevention or treatment of human diseases. Public attitudes may be influenced by claims that genome engineering is unsafe, unethical or</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">64</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">immoral, and, consequently, our current or future product candidates may not gain the acceptance of the public or the medical community. Adverse public attitudes may adversely impact our ability to enroll clinical trials. Moreover, our success will depend upon physicians prescribing, and their patients being willing to receive, treatments that involve the use of product candidates in lieu of, or in addition to, existing treatments with which they are already familiar and for which greater clinical data may be available.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, genome engineering technology is subject to public debate and heightened regulatory scrutiny due to ethical concerns relating to the application of genome engineering technology to human embryos or the human germline. For example, in the United States, germline alteration for clinical application has been expressly prohibited since enactment of a December 2015 FDA ban on such activity. Prohibitions are also in place in the United Kingdom, across most of Europe, in China and many other countries around the world. In the United States, the National Institutes of Health has announced that the agency would not fund any use of gene engineering technologies in human embryos, noting that there are multiple existing legislative and regulatory prohibitions against such work, including the Dickey-Wicker Amendment, which prohibits the use of appropriated funds for the creation of human embryos for research purposes or for research in which human embryos are destroyed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Although we do not use our technologies to alter human embryos or the human germline, public debate about the use of genome engineering technologies in human embryos and heightened regulatory scrutiny could prevent or delay our development of product candidates. More restrictive government regulations or negative public opinion would have a negative effect on our business or financial condition and may delay or impair our development, commercialization and demand of product candidates. Adverse events in our preclinical studies or clinical trials or those of our competitors or of academic researchers utilizing genome engineering technologies, even if not ultimately attributable to product candidates we may identify and develop, and the accompanying publicity could result in increased governmental regulation, unfavorable public perception, potential regulatory delays in the testing or approval of potential product candidates we may identify and develop, stricter labeling requirements for those product candidates that are approved and a decrease in demand for any such product candidates. Use of genome engineering technology by a third party or government to develop biological agents or products that threaten U.S. national security could similarly result in such negative impacts to us.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Due to the novel nature of our eHSCs, the small patient population we are addressing and the potential for any of our product candidates to offer benefits in a single administration or limited number of administrations, we face additional uncertainty related to pricing, coverage and reimbursement for these product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The pricing and reimbursement of our product candidates, if approved, must be adequate to support the necessary commercial infrastructure. If we are unable to obtain adequate levels of reimbursement, our ability to successfully market and sell any such product candidates will be adversely affected. The manner and level at which reimbursement is provided for services related to a product candidate (e.g., for administration of our product candidates to patients) is also important. Inadequate reimbursement for such services may lead to physician and payor resistance and adversely affect our ability to market or sell any product candidate we develop.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are initially developing product candidates targeting rare diseases with small patient populations. For products that are designed to treat smaller patient populations to be commercially viable, the reimbursement for such products must be higher, on a relative basis, to account for the lack of volume. Accordingly, we will need to implement a coverage and reimbursement strategy for any approved product candidate with a smaller patient population that accounts for the smaller potential market size. Even if we obtain coverage for a given product by a third-party payor, the resulting reimbursement payment rates may not be adequate.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are also initially developing products that are designed to be used in a single administration. We expect the cost of a single administration of genetic treatments, such as those we are seeking to develop, to be substantial, when and if they achieve regulatory approval. We expect that coverage and reimbursement by governmental healthcare programs such as Medicare and Medicaid, private health insurers and other third-party payors will be essential for most patients to be able to afford these treatments. Accordingly, sales of any such product candidates will depend substantially, both domestically and abroad, on the extent to which the costs of any such product candidates will be paid by governmental healthcare programs, private health plans and other third-party payors. Payors may not be willing to pay high prices for a single administration. Coverage and reimbursement by a</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">65</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">third-party payor and physician utilization may depend upon several factors, including the third-party payor&#x2019;s determination that use of a product is:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">a covered benefit under its health plan; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">safe, effective and medically necessary; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">appropriate for the specific patient; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">cost-effective; and </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">neither experimental nor investigational. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There is significant uncertainty related to third-party coverage and reimbursement of eHSCs. For example, effective for cost reporting periods beginning on or after October 1, 2020, under the Medicare Hospital Inpatient Prospective Payment Systems (&#x201c;IPPS&#x201d;), Medicare payment to the hospital for hematopoietic stem cell acquisition, including the preparation and processing of stem cells derived from peripheral blood, will be made on a reasonable cost basis. We believe that this new rule may also apply to eHSC products. Alternatively, we may apply for Medicare&#x2019;s New Technology Add-on Payment (&#x201c;NTAP&#x201d;) designation for our eHSC product candidates, which, if approved, may allow for temporary reimbursement for new cell therapies above the standard Medicare Severity Diagnosis-Related Group (&#x201c;MS-DRG&#x201d;) payment amount under IPPS. NTAP will only be available for our product candidates, if approved, if we submit a timely and complete application and the Centers for Medicare &amp; Medicaid Services (&#x201c;CMS&#x201d;) determines that our product candidates meet the eligibility requirements of NTAP, including, among other criteria, demonstrating a substantial clinical improvement relative to services or technologies previously available. We also believe that, for patients covered by commercial insurance, reimbursement will be based on a case rate methodology with possible provisions for separate payments for new therapies, such as eHSC. However, we cannot be certain that our eHSCs would qualify for these carveouts or other reimbursement avenues for new therapies. We also may not be able to provide data sufficient to gain acceptance with respect to coverage and reimbursement. If coverage and reimbursement are not available, or are available only at limited levels, we may not be able to successfully commercialize a product candidate. Even if coverage is provided, the approved reimbursement amount may not be adequate to realize a sufficient return on our investment. Further, even if favorable coverage and reimbursement status is attained for one or more product candidates for which we receive regulatory approval, less favorable coverage policies and reimbursement rates may be implemented in the future. If we are unable to obtain adequate levels of reimbursement, our ability to successfully market and sell any product candidates will be harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may need to develop new reimbursement models to realize adequate value for our product candidates. Payors may not be able or willing to adopt such new models, and patients may be unable to afford that portion of the cost that such models may require them to bear. If we determine such new models are necessary but we are unsuccessful in developing them, or if such models are not adopted by payors, our business, financial condition, results of operations and prospects could be adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outside the United States, international operations are generally subject to extensive governmental price controls and other market regulations, and we believe the increasing emphasis on cost-containment initiatives in Europe and other countries has and will continue to put pressure on the pricing and usage of our products. In many countries, the prices of medical products are subject to varying price control mechanisms as part of national health systems. Other countries allow companies to fix their own prices for medical products but monitor and control company profits. Additional foreign price controls or other changes in pricing regulation could restrict the amount that we are able to charge for our products. Accordingly, in markets outside the United States, the reimbursement for our products may be reduced compared with the United States and may be insufficient to generate commercially reasonable revenue and profits.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our inability to promptly obtain coverage and profitable payment rates from both government-funded and private payors for any approved products we may develop could have a material adverse effect on our operating results, our ability to raise capital needed to commercialize products and our overall financial condition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The market for our product candidates, if approved, may be limited to those patients who are ineligible for or have failed, or are at risk of failing, prior treatments and who are able to tolerate the side effects of</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">66</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">co-administered or sequentially administered targeted therapies, and our projections regarding the size of the addressable market may be incorrect.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cancer therapies are sometimes characterized as first line, second line or third line, and the FDA often approves new therapies initially only for last line use. When blood cancers are detected, they are treated with first line of therapy with the intention of curing the cancer. This generally consists of chemotherapy, radiation, antibody drugs, tumor-targeted small molecules or a combination of these. In addition, for myeloid malignancies, HSCT is frequently added to the first line therapy after the combination chemotherapy is given. If the patient&#x2019;s cancer relapses, then they are given a second line or third line therapy, which can consist of more chemotherapy, radiation, antibody drugs, tumor-targeted small molecules or a combination of these, or HSCT. Generally, the higher the line of therapy, the lower the chance of a cure. If a patient relapses after HSCT, the goal of the therapy in the treatment of AML is to control the growth of the tumor and extend the life of the patient, as a cure is unlikely to happen.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are initially developing VOR33 for use in patients receiving HSCT who have been determined to be at high-risk for relapse of AML in the anticipation that VOR33 would enhance the utility and broaden the applicability of therapies subsequently deployed. VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> or any other targeted therapeutic we may develop is not guaranteed approval as an earlier line therapy or in settings other than bridge to transplant. In addition, we may have to conduct additional large randomized clinical trials prior to or post gaining approval for use VOR33 in patients who have not experienced relapse and/or in combination with an earlier line of therapy or of VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> as or in combination with a different line of treatment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our projections of both the number of people who have the cancers we are targeting, as well as the size of the patient population subset who are in a position to undergo HSCT, who are likely to relapse and who have the potential to benefit from treatment with eHSCs, or who are in a position to benefit from a targeted therapeutic, such as VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, are based on our estimates and data provided to us by third parties. These estimates have been derived from a variety of sources, including scientific literature, surveys of clinics, the NMDP, research facilities, patient foundations or market research and may prove to be incorrect. Further, new studies may change the estimated incidence or prevalence of these cancers. The number of patients may turn out to be fewer than expected.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Additionally, the potentially addressable patient population for our product candidates may be limited, or may not be amenable to treatment with our product candidates. The addressable patient population will ultimately depend upon, among other things, the diagnosis criteria included in the final label, the availability of alternative treatments and the safety, convenience, cost and efficacy of our product candidates relative to such alternative treatments, acceptance by the medical community and patient access, drug pricing and reimbursement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Even if we obtain significant market share for our product candidates, because the potential target populations are small, we may never achieve significant revenue without obtaining regulatory approval for additional indications or in connection with earlier lines of therapy.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If product liability lawsuits are brought against us, we may incur substantial liabilities and may be required to limit commercialization of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We face an inherent risk of product liability exposure related to the testing in human clinical trials of our product candidates and will face an even greater risk if we commercially sell any products that we may develop. For example, we may be sued if our product candidates cause, or are perceived to cause, injury or are found to be otherwise unsuitable during clinical trials, manufacturing, marketing or sale. Any such product liability claims may include allegations of defects in manufacturing, defects in design, a failure to warn of dangers inherent in the product, negligence, strict liability or a breach of warranties. Claims could also be asserted under state consumer protection acts. If we cannot successfully defend ourselves against claims that our product candidates or products caused injuries, we could incur substantial liabilities. Regardless of merit or eventual outcome, liability claims may result in:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the inability to commercialize any products that we may develop; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">decreased demand for our product candidates or products that we may develop; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">injury to our reputation and significant negative media attention; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">withdrawal of clinical trial participants; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">significant time and costs to defend the related litigation; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">67</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">substantial monetary awards to trial participants or patients; and </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">loss of revenue. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Insurance coverage is also increasingly expensive and we may not be able to maintain insurance coverage at a reasonable cost or in an amount adequate to satisfy any liability that may arise.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cell and genetic medicines are novel, and our product candidates are complex and difficult to manufacture. We could experience delays in satisfying regulatory authorities or production problems that result in delays in our development or commercialization programs, limit the supply of our product candidates, or otherwise harm our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our product candidates require processing steps that are more complex than those required for most chemical and other biological pharmaceuticals. Moreover, unlike chemical and other biological pharmaceuticals, the physical and chemical properties of a gene-engineered cell therapy, such as an eHSC or CAR-T or other cell-based targeted therapeutics we may develop, generally cannot be fully characterized. As a result, assays of the finished product candidate may not be sufficient to ensure that the product candidate will perform in the intended manner. Problems with the manufacturing process, even minor deviations from the normal process, could result in product defects or manufacturing failures that result in lot failures, product recalls, product liability claims, insufficient inventory or potentially delay progression of our potential IND filings or clinical trials. If we successfully develop product candidates, we may encounter problems achieving adequate quantities and quality of clinical-grade materials that meet FDA, EMA or other comparable applicable foreign standards or specifications with consistent and acceptable production yields and costs. In addition, our product candidates will require complicated delivery modalities, such as electroporation, which will introduce additional complexities in the manufacturing process. Any of the foregoing factors could limit our ability to replicate the vein-to-vein time achieved in our preclinical manufacturing of VOR33 in a clinical or, if approved, commercial setting.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our product candidates consist, and any other eHSC or CAR-T or other cell-based targeted therapeutics we may develop will consist, of genetically engineered human cells, and the process of manufacturing such product candidates is complex, concentrated with a limited number of suppliers, highly regulated and subject to numerous risks. Manufacturing such product candidates involves harvesting cells from a donor or from the patient, altering the cells </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">ex vivo </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">using genome engineering technology, cryopreservation, storage and eventually shipment and infusing the cell product into the patient&#x2019;s body. Our manufacturing process will be susceptible to product loss or failure, or product variation that may negatively impact patient outcomes, due to logistical issues associated with the collection of starting material from the donor, shipping such material to the manufacturing site, shipping the final product back to the clinical trial recipient, preparing the product for administration, infusing the patient with the product, manufacturing issues or different product characteristics resulting from the differences in donor starting materials, variations between reagent lots, interruptions in the manufacturing process, contamination, equipment or reagent failure, improper installation or operation of equipment, vendor or operator error, inconsistency in cell growth and variability in product characteristics. Our manufacturing process, like that of a number of other cell therapy companies, is also characterized by limited numbers of suppliers, and in some cases sole source suppliers, with the manufacturing capabilities and know-how to create or source the materials, such as donor marrow cells and electroporation machines, used in our cell manufacturing. While we pursue multiple sources for the critical components of our manufacturing process, we may not be successful in securing these additional sources at all or on a timely basis. Even minor deviations from normal manufacturing processes could result in reduced production yields, product defects and other supply disruptions. If microbial, viral or other contaminations are discovered in our product candidates or in any of the manufacturing facilities in which products or other materials are made, such manufacturing facilities may need to be closed for an extended period of time to investigate and remedy the contamination. In addition, because VOR33 and VCAR33 are manufactured for each particular patient, we will be required to maintain a chain of identity with respect to materials as they move from the donor or patient to the manufacturing facility, through the manufacturing process and back to the clinical trial recipient. Maintaining a chain of identity is difficult and complex, and failure to do so could result in adverse patient outcomes, loss of product or regulatory action, including withdrawal of our products from the market. Any failure in the foregoing processes could render a batch of product unusable, could affect the regulatory approval of such product candidate, could cause us to incur fines or penalties or could harm our reputation and that of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may make changes to our manufacturing process for various reasons, such as to control costs, achieve scale, decrease processing time, increase manufacturing success rate or for other reasons. For example, we are building and developing internal GMP manufacturing capabilities to produce supplies of our cell-based therapies for</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">68</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our clinical trials. Changes to our process made during the course of clinical development could require us to show the comparability of the product used in earlier clinical phases or at earlier portions of a trial to the product used in later clinical phases or later portions of the trial. Other changes to our manufacturing process made before or after commercialization could require us to show the comparability of the resulting product to the product candidate used in the clinical trials using earlier processes. Such showings could require us to collect additional nonclinical or clinical data from any modified process prior to obtaining marketing approval for the product candidate produced with such modified process. If such data are not ultimately comparable to that seen in the earlier trials or earlier in the same trial in terms of safety or efficacy, we may be required to make further changes to our process and/or undertake additional clinical testing, either of which could significantly delay the clinical development or commercialization of the associated product candidate, which would materially adversely affect our business, financial condition, results of operations and growth prospects</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, the FDA, the EMA and other regulatory authorities may require us to submit samples of any lot of any approved product together with the protocols showing the results of applicable tests at any time. Under some circumstances, the FDA, the EMA or other regulatory authorities may require that we not distribute a lot until the agency authorizes its release. Slight deviations in the manufacturing process, including those affecting quality attributes and stability, may result in unacceptable changes in the product that could result in lot failures or product recalls. Lot failures or product recalls could cause us to delay clinical trials or product launches, which could be costly to us and otherwise harm our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We also may encounter problems hiring and retaining the experienced scientific, quality control and manufacturing personnel needed to manage our manufacturing process, which could result in delays in our production or difficulties in maintaining compliance with applicable regulatory requirements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Given the nature of biologics manufacturing, there is a risk of contamination during manufacturing. Any contamination could materially harm our ability to produce product candidates on schedule and could harm our results of operations and cause reputational damage. Some of the raw materials that we anticipate will be required in our manufacturing process are derived from biologic sources. Such raw materials are difficult to procure and may be subject to contamination or recall. A material shortage, contamination, recall or restriction on the use of biologically derived substances in the manufacture of VOR33 could adversely impact or disrupt the commercial manufacturing or the production of clinical material, which could materially harm our development timelines and our business, financial condition, results of operations and prospects. Also, due to the short time between the collection of donor HSCs, the manufacturing of VOR33 and the shipment to a transplant center for use in HSCT, there are limited opportunities for sterility testing and we anticipate that final testing may occur just before or after the administration VOR33. Any delays in testing may delay administration of VOR33 and any administration prior to testing may result in positive bacterial tests and obligations to notify health authorities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any problems in our manufacturing process, including at either our planned in-house manufacturing or the facilities with which we contract could make us a less attractive collaborator for potential partners, including larger pharmaceutical companies and academic research institutions, which could limit our access to additional attractive development programs. Problems in internal or third-party manufacturing process or facilities, including our own facility that we are building, also could restrict our ability to ensure sufficient clinical material for any clinical trials we may be conducting or are planning to conduct and meet market demand for any product candidates we develop and commercialize.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The process for treating cancer patients using T cell therapy or other cell-based targeted therapies is subject to human and systemic risks.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The &#x201c;vein-to-vein&#x201d; cycle for treating cancer patients using T cell therapy or other cell-based targeted therapies typically takes approximately four to six weeks and involves a large number of steps and human participants. First, the patient&#x2019;s lymphocytes are isolated by apheresis at the clinical site and shipped to the manufacturing site. Under cGMP conditions at the manufacturing site, the patient&#x2019;s lymphocytes are thawed and washed and then enriched for CD33-positive T cells using specialized reagents. After overnight culture and T cell activation, the T cells are transduced using lentiviral vector transduction technology to introduce the CAR genetic construct into the enriched T cell population. At the completion of T cell transduction, the T cells are harvested, formulated into the final drug product and then cryopreserved for delivery to patients. Similar procedures may be used for other cell-based targeted therapies, such as a CAR natural killer cell therapy. In the United States, samples of the final product are subjected to several release tests which must fulfill specified criteria for the drug product to be released for infusion. These include sterility, identity, purity, potency and other tests. We are subject to stringent</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">69</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">regulatory and quality standards for the T cell therapy treatment process. We cannot offer assurances that our quality control and assurance efforts will be successful or that the risk of human or systemic errors in these processes can be eliminated.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Prior treatments can alter the cancer and negatively impact chances for achieving clinical activity with our CAR-T or other cell-based targeted therapies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Patients with hematological cancers typically receive highly toxic chemotherapy as their initial treatments that can impact the viability of the T cells collected from the patient and may contribute to highly variable responses to CAR-T or other cell-based targeted therapies. In certain instances, we may use the allogeneic derived T cell fraction from the leukapheresis of the HLA-matched normal healthy donors as the starting material. Like the patient derived T cells, these donor-derived T cells may also display variability that will impact responses to VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> or other cell-based targeted therapeutics we may develop. Patients could also have received prior therapies that target the same molecule on the cancer cells as cell-based targeted therapeutics we may develop and thereby these patients may have cancer cells with low or no expression of the target. As a result, VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> or any other cell-based targeted therapeutics we may develop may not recognize the cancer cell and may fail to achieve clinical activity. For example, AML patients could have received a BCMA-targeting antibody drug conjugate BCMA-ADC like GSK2857916, BCMA targeting T cell engagers like AMG-420 (Amgen) and CC-93269 (Bristol-Myers Squibb), or similar products or product candidates prior to receiving VCAR33 or any other cell-based targeted therapeutics we may develop. If any product candidates we develop do not achieve a sufficient level of clinical activity, we may discontinue the development of that product candidate, which could have an adverse effect on the value of our common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We and any third-party manufacturers and any third-party collaborators may be unable to successfully scale-up manufacturing of our product candidates in sufficient quality and quantity, which would delay or prevent us from developing such product candidates and commercializing approved products, if any.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In order to conduct clinical trials of our product candidates, we may need to work with third-party manufacturers to manufacture them in sufficient quantities if we are not able to produce sufficient quantities on our own. We, or our manufacturing partners or our third-party collaborators, may be unable to successfully increase the manufacturing capacity of our product candidates in a timely or cost-effective manner, or at all. We expect that each lot of VOR33 and VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> will need to be manufactured for a specific individual patient, and each lot will need to be individually tested and released for that patient. As a result, we may experience limited production capacity and be unable to meet the need of all patients who could benefit from treatment, if approved. In addition, quality issues may arise during scale-up activities. If we or our manufacturing partners or collaborators are unable to successfully scale up the manufacture of our current or future product candidates in sufficient quality and quantity, the development, testing and clinical trials of that product candidate may be delayed or infeasible, and marketing approval or commercial launch of any resulting product may be delayed or not obtained, which could significantly harm our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We have not yet developed a validated methodology for freezing and thawing large quantities of eHSCs or of VCAR33, which we believe will be required for the storage and distribution of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have not demonstrated that eHSCs or VCAR33, when manufactured for late stage clinical studies or at a commercial scale, can be frozen and thawed without damage in a cost-efficient manner and without degradation. We may encounter difficulties not only in developing freezing and thawing methodologies, but also in obtaining the necessary regulatory approvals for using such methodologies in treatment. If we cannot adequately demonstrate similarity of our frozen product to the unfrozen form to the satisfaction of the FDA, we could face substantial delays in our regulatory approvals. If we are unable to freeze eHSCs or VCAR33 or other cell-based targeted therapeutics we may develop for shipping purposes, our ability to promote adoption and standardization of our products, as well as achieve economies of scale by centralizing production facilities, will be limited. Even if we are able to successfully freeze and thaw eHSCs or VCAR33 at commercial scale, we will still need to develop a cost-effective and reliable distribution and logistics network, which we may be unable to accomplish. For these and other reasons, we may not be able to manufacture eHSCs, VCAR33 or other cell-based targeted therapeutics we may develop at commercial scale or in a cost-effective manner.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">70</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we or any contract manufacturers and suppliers that we engage fail to comply with environmental, health and safety laws and regulations, we could become subject to fines or penalties or incur costs that could have a material adverse effect on the success of our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We and any contract manufacturers and suppliers we engage are subject to numerous federal, state and local environmental, health and safety laws, regulations and permitting requirements, including those governing laboratory procedures; the generation, handling, use, storage, treatment and disposal of hazardous and regulated materials and wastes; the emission and discharge of hazardous materials into the ground, air and water; and employee health and safety. Our operations involve the use of hazardous and flammable materials, including chemicals and biological and radioactive materials. Our operations also produce hazardous waste. We generally contract with third parties for the disposal of these materials and wastes. We cannot eliminate the risk of contamination or injury from these materials. In the event of contamination or injury resulting from our use of hazardous materials, we could be held liable for any resulting damages, and any liability could exceed our resources. Under certain environmental laws, we could be held responsible for costs relating to any contamination at our current or past facilities and at third-party facilities. We also could incur significant costs associated with civil or criminal fines and penalties.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Compliance with applicable environmental laws and regulations may be expensive, and current or future environmental laws and regulations may impair our product development and research efforts. In addition, we cannot eliminate the risk of accidental injury or contamination from these materials or wastes. Although we maintain workers&#x2019; compensation insurance to cover us for costs and expenses, we may incur due to injuries to our employees resulting from the use of hazardous materials, this insurance may not provide adequate coverage against potential liabilities. We do not carry specific biological or hazardous waste insurance coverage, and our property, casualty and general liability insurance policies specifically exclude coverage for damages and fines arising from biological or hazardous waste exposure or contamination. Accordingly, in the event of contamination or injury, we could be held liable for damages or be penalized with fines in an amount exceeding our resources, and our clinical trials or regulatory approvals could be suspended, which could have a material adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, we may incur substantial costs to comply with current or future environmental, health and safety laws, regulations and permitting requirements. For example, our products are considered to contain genetically modified organisms or cells, which are regulated in different ways depending upon the country in which preclinical research or clinical trials are conducted. These current or future laws, regulations and permitting requirements may impair our research, development or production efforts. Failure to comply with these laws, regulations and permitting requirements also may result in substantial fines, penalties or other sanctions or business disruption, which could have a material adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any third-party contract manufacturers and suppliers we engage will also be subject to these and other environmental, health and safety laws and regulations. Liabilities they incur pursuant to these laws and regulations could result in significant costs or an interruption in operations, which could have a material adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to Regulatory Review</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If clinical trials of any of our product candidates fail to demonstrate safety and efficacy to the satisfaction of regulatory authorities or do not otherwise produce positive results, we may incur additional costs or experience delays in completing, or ultimately be unable to complete, the development and commercialization of such product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Before obtaining marketing approval from regulatory authorities for the sale of our product candidates, we must complete preclinical development and then conduct extensive clinical trials to demonstrate the safety and efficacy in humans. Clinical testing is expensive, difficult to design and implement, can take many years to complete and is uncertain as to outcome. A failure of one or more clinical trials can occur at any stage of testing. The outcome of preclinical testing and early clinical trials may not be predictive of the success of later clinical trials, and interim results of a clinical trial do not necessarily predict final results.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Moreover, preclinical and clinical data are often susceptible to varying interpretations and analyses. Many companies that have believed their product candidates performed satisfactorily in preclinical studies and clinical trials have nonetheless failed to obtain marketing approval of their product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">71</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We and our collaborators, if any, may experience numerous unforeseen events during, or as a result of, clinical trials that could delay or prevent our ability to receive marketing approval or commercialize any product candidates, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays in reaching a consensus with regulators on trial design; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">regulators, IRBs, independent ethics committees or scientific review boards may not authorize us or our investigators to commence a clinical trial or conduct a clinical trial at a prospective trial site; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays in reaching or failing to reach agreement on acceptable clinical trial contracts or clinical trial protocols with prospective CROs, and clinical trial sites; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">clinical trials of product candidates may produce negative or inconclusive results, and we may decide, or regulators may require us, to conduct additional clinical trials or abandon product development or research programs; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">difficulty in designing well-controlled clinical trials due to ethical considerations which may render it inappropriate to conduct a trial with a control arm that can be effectively compared to a treatment arm; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">difficulty in designing clinical trials and selecting endpoints for diseases that have not been well-studied and for which the natural history and course of the disease is poorly understood; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the number of patients required for clinical trials may be larger than we anticipate; enrollment of suitable participants in these clinical trials, which may be particularly challenging for some of the rare diseases we are targeting in our most advanced programs, may be delayed or slower than we anticipate; or patients may drop out of these clinical trials at a higher rate than we anticipate; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our third-party contractors may fail to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">regulators, IRBs or independent ethics committees may require that we or our investigators suspend or terminate clinical research or clinical trials for various reasons, including noncompliance with regulatory requirements, a finding of undesirable side effects or other unexpected characteristics, or that the participants are being exposed to unacceptable health risks or after an inspection of our clinical trial operations or trial sites; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the cost of clinical trials may be greater than we anticipate; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the supply or quality of product candidates or other materials necessary to conduct clinical trials may be insufficient or inadequate, including as a result of delays in the testing, validation, manufacturing and delivery of product candidates to the clinical sites by us or by third parties with whom we have contracted to perform certain of those functions; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">delays in having patients complete participation in a trial or return for post-treatment follow-up; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">clinical trial sites dropping out of a trial; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">selection of clinical endpoints that require prolonged periods of clinical observation or analysis of the resulting data; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">occurrence of serious adverse events associated with product candidates that are viewed to outweigh their potential benefits; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">occurrence of serious adverse events in trials of the same class of agents conducted by other sponsors; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes in regulatory requirements and guidance that require amending or submitting new clinical protocols; and </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">disruption in the supply or availability of Mylotarg or any future targeted therapeutics we use with our eHSCs. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we or our collaborators are required to conduct additional clinical trials or other testing of product candidates beyond those that we currently contemplate, if we or our collaborators are unable to successfully</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">72</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">complete clinical trials or other testing of product candidates, or if the results of these trials or tests are not positive or are only modestly positive or if there are safety concerns, we or our collaborators may:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">be delayed in obtaining marketing approval for any such product candidates or not obtain marketing approval at all; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">obtain approval for indications or patient populations that are not as broad as intended or desired; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">obtain approval with labeling that includes significant use or distribution restrictions or safety warnings, including boxed warnings; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">be subject to changes in the way the product is administered; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">be required to perform additional clinical trials to support approval or be subject to additional post-marketing testing requirements; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">have regulatory authorities withdraw or suspend their approval of the product or impose restrictions on its distribution in the form of a REMS or through modification to an existing REMS; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">be sued; or </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">experience damage to our reputation. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Product development costs will also increase if we or our collaborators experience delays in clinical trials or other testing or in obtaining marketing approvals. We do not know whether any clinical trials will begin as planned, will need to be restructured or will be completed on schedule, or at all. Significant clinical trial delays also could shorten any periods during which we may have the exclusive right to commercialize product candidates, could allow our competitors to bring products to market before we do and could impair our ability to successfully commercialize product candidates, any of which may harm our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Even if we complete the necessary clinical trials, we cannot predict when, or if, we will obtain regulatory approval to commercialize VOR33, VCAR33, the VOR33 + VCAR33 Treatment System or any other product candidate we may develop in the United States or any other jurisdiction, and any such approval may be for a more narrow indication than we seek.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We cannot commercialize a product candidate until the appropriate regulatory authorities have reviewed and approved the product candidate. Even if our product candidates meet their safety and efficacy endpoints in clinical trials, the regulatory authorities may not complete their review processes in a timely manner, or we may not be able to obtain regulatory approval. Additional delays may result if an FDA Advisory Committee or other regulatory authority recommends non-approval or restrictions on approval. In addition, we may experience delays or rejections based upon additional government regulation from future legislation or administrative action, or changes in regulatory authority policy during the period of product development, clinical trials and the review process.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Regulatory authorities also may approve a product candidate for more limited indications than requested or they may impose significant limitations in the form of narrow indications, warnings or a REMS. These regulatory authorities may require labeling that includes precautions or contra-indications with respect to conditions of use, or they may grant approval subject to the performance of costly post-marketing clinical trials. In addition, regulatory authorities may not approve the labeling claims that are necessary or desirable for the successful commercialization of our product candidates. Any of the foregoing scenarios could materially harm the commercial prospects for our product candidates and materially adversely affect our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Marketing approval by the FDA in the United States, if obtained, does not ensure approval by regulatory authorities in other countries or jurisdictions. In addition, clinical trials conducted in one country may not be accepted by regulatory authorities in other countries, and regulatory approval in one country does not guarantee regulatory approval in any other country. Approval processes vary among countries and can involve additional product candidate testing and validation and additional administrative review periods. Seeking foreign regulatory approval could result in difficulties and costs for us and require additional preclinical studies or clinical trials which could be costly and time-consuming. Regulatory requirements can vary widely from country to country and could delay or prevent the introduction of our product candidates in those countries. The foreign regulatory approval process involves all of the risks associated with FDA approval. We do not have any product candidates approved for sale in any jurisdiction, including international markets, and we do not have experience in obtaining regulatory</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">73</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">approval in international markets. If we fail to comply with regulatory requirements in international markets or to obtain and maintain required approvals, or if regulatory approvals in international markets are delayed, our target market will be reduced and our ability to realize the full market potential of our product candidates will be unrealized.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Genome engineering technology is subject to a number of challenges and risks. Because genome engineering technology is novel and the regulatory landscape that will govern our product candidates is uncertain and may change, we cannot predict the time and cost of obtaining regulatory approval, if we receive it at all, for our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Because our product candidates and technology platform involve genome engineering, we are subject to many of the challenges and risks that other genetically engineered biologics and gene therapies face, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">regulatory requirements or guidance regarding the requirements governing genome engineering products have changed and may continue to change in the future; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">to date, only a limited number of products that involve genome engineering have been approved globally; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">improper modulation of a gene sequence, including unintended alterations or insertion of a sequence into certain locations in a patient&#x2019;s chromosomes, could lead to cancer, other aberrantly functioning cells or other diseases, as well as death; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">transient expression of the Cas9 protein could lead to patients having an immunological reaction towards those cells, which could be severe or life-threatening; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">corrective expression of a missing protein, or deletion of an existing protein, in patients&#x2019; cells could result in the protein or cell being recognized as foreign, and lead to a sustained immunological reaction against the expressed protein or expressing cells, which could be severe or life-threatening; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">regulatory agencies may require extended follow-up observation periods of patients who receive treatment using genome engineering products including, for example, the FDA&#x2019;s recommended 15-year follow-up observation period for these patients, and we will need to adopt such observation periods for our product candidates if required by the relevant regulatory agency, which could vary by country or region; and </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the field of genome engineering is subject to a number of intellectual property disputes. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The regulatory requirements that will govern our novel genetically engineered product candidates are not entirely clear and may change. Within the broader genetic medicine field, we are aware of a limited number of gene therapy products that have received marketing authorization from the FDA and the EMA. Even with respect to more established products that fit into the categories of gene therapies or cell therapies, the regulatory landscape is still developing. Regulatory requirements governing gene therapy products and cell therapy products have changed frequently and will likely continue to change in the future. Moreover, there is substantial, and sometimes uncoordinated, overlap in those responsible for regulation of existing gene therapy products and cell therapy products. For example, in the United States, the FDA has established the Office of Tissues and Advanced Therapies (&#x201c;OTAT&#x201d;) within its Center for Biologics Evaluation and Research (&#x201c;CBER&#x201d;) to consolidate the review of gene therapy and related products, and the Cellular, Tissue and Gene Therapies Advisory Committee to advise CBER on its review. In addition to FDA oversight and oversight by IRBs under guidelines promulgated by the NIH, gene therapy clinical trials are also subject to review and oversight by an institutional biosafety committee (&#x201c;IBC&#x201d;), a local institutional committee that reviews and oversees research utilizing recombinant or synthetic nucleic acid molecules at that institution. Before a clinical study can begin at any institution, that institution&#x2019;s IRB and its IBC assesses the safety of the research and identifies any potential risk to public health or the environment. While the NIH guidelines are not mandatory unless the research in question is being conducted at or sponsored by institutions receiving NIH funding of recombinant or synthetic nucleic acid molecule research, many companies and other institutions not otherwise subject to the NIH guidelines voluntarily follow them. Moreover, serious adverse events or developments in clinical trials of gene therapy product candidates conducted by others may cause the FDA or other regulatory bodies to initiate a clinical hold on our clinical trials or otherwise change the requirements for approval of any of our product candidates. Although the FDA decides whether individual gene therapy protocols may proceed, the review process and determinations of other reviewing bodies can impede or delay the initiation of a clinical trial, even if the FDA has reviewed the trial and approved its initiation. Although the FDA decides whether individual</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">74</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">gene therapy protocols may proceed, the review process and determinations of other reviewing bodies can impede or delay the initiation of a clinical trial, even if the FDA has reviewed the trial and approved its initiation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The same applies in the European Union. The EMA&#x2019;s Committee for Advanced Therapies (&#x201c;CAT&#x201d;) is responsible for assessing the quality, safety and efficacy of advanced-therapy medicinal products. The role of the CAT is to prepare a draft opinion on an application for marketing authorization for a cell or gene therapy or other novel therapeutic medicinal candidate that is submitted to the Committee for Medicinal Products for Human Use (&#x201c;CHMP&#x201d;) before CHMP adopts its final opinion. In the European Union, the development and evaluation of an advanced therapeutic medicinal product must be considered in the context of the relevant European Union guidelines. The EMA may issue new guidelines concerning the development and marketing authorization for these medicinal products and require that we comply with these new guidelines. As a result, the procedures and standards applied to gene and cell therapy products may be applied to our product candidates, but that remains uncertain at this point.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Adverse developments in post-marketing experience or in clinical trials conducted by others of gene therapy products, cell therapy products or products developed through the application of a genome engineering technology may cause the FDA, the EMA and other regulatory bodies to revise the requirements for development or approval of our product candidates or limit the use of products utilizing genome engineering technologies, either of which could materially harm our business. In addition, the clinical trial requirements of the FDA, the EMA and other regulatory authorities and the criteria these regulators use to determine the safety and efficacy of a product candidate vary substantially according to the type, complexity, novelty and intended use and market of the potential products. The regulatory approval process for novel product candidates, such as VOR33, can be more expensive and take longer than for other, better known or more extensively studied pharmaceutical or other product candidates. Regulatory agencies administering existing or future regulations or legislation may not allow production and marketing of products utilizing genome engineering technology in a timely manner or under technically or commercially feasible conditions. In addition, regulatory action or private litigation could result in expenses, delays or other impediments to our product candidate development, research programs or the commercialization of resulting products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The regulatory review committees and advisory groups described above and the new guidelines they promulgate may lengthen the regulatory review process, require us to perform additional studies or trials, increase our development costs, lead to changes in regulatory positions and interpretations, delay or prevent approval and commercialization of these treatment candidates, or lead to significant post-approval limitations or restrictions. Currently, OTAT requires a 15-year follow-up for each patient who receives a genetically engineered cell or gene therapy. This applies to all patients treated in trials during clinical development prior to approval. Following approval, such prolonged follow-up could continue to be required. As we advance our product candidates and research programs, we will be required to consult with these regulatory and advisory groups and to comply with applicable guidelines. If we fail to do so, we may be required to delay or discontinue development of our product candidates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Because we are developing product candidates using new technologies, as well as potential mechanisms of action for which there are few precedents, there is increased risk that the FDA, the EMA or other regulatory authorities may not consider the endpoints of our clinical trials to provide clinically meaningful results and that these results may be difficult to analyze.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The FDA, EMA and other regulatory authorities typically assess the safety and efficacy of a product with sufficient data to justify marketing authorization. We expect that VOR33 and any other eHSC product candidates we develop will not, by themselves, provide any anti-tumor activity in patients that relapse after HSCT, and that our eHSCs could be effective after patients relapse only when administered in combination or sequence with other therapies. There are few precedents for product candidates with this potential mechanism of action. Furthermore, we are employing genome engineering technologies in the creation of our eHSCs that have not yet been clinically validated. During the regulatory review process, we will need to identify success criteria and endpoints such that the FDA, the EMA or other regulatory authorities will be able to determine the clinical efficacy and safety profile of our product candidates. As we are initially seeking to identify and develop product candidates to treat diseases using novel methods of action and new technologies, there is heightened risk that the FDA, the EMA or other regulatory authorities may not consider the clinical trial endpoints that we propose to provide clinically meaningful results (reflecting a tangible benefit to patients). In addition, the resulting clinical data and results may be difficult to analyze. Even if the FDA does find our success criteria to be sufficiently validated and clinically meaningful, we may not achieve the pre-specified endpoints to a degree of statistical significance. Further, even if we do achieve the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">75</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">pre-specified criteria, we may produce results that are unpredictable or inconsistent with the results of the non-primary endpoints or other relevant data. The FDA also weighs the benefits of a product against its risks, and the FDA may view the efficacy results in the context of safety as not being supportive of regulatory approval. Other regulatory authorities in the European Union and other countries may make similar comments with respect to these endpoints and data. Our product candidates are based on a novel technology that makes it difficult to predict the time and cost of development and of subsequently obtaining regulatory approval.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Interim &#x201c;top-line&#x201d; and preliminary results from our clinical trials that we may announce or publish from time to time may change as more patient data become available and are subject to audit and verification procedures that could result in material changes in the final data.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From time to time, we may publish interim top-line or preliminary results from our preclinical studies and clinical trials, which are based on a preliminary analysis of then-available data, and the results and related findings and conclusions are subject to change following a more comprehensive review of the data related to the particular study or trial. Interim results from clinical trials that we may complete are subject to the risk that one or more of the clinical outcomes may materially change as patient enrollment continues and more patient data become available. Preliminary or top-line results also remain subject to audit and verification procedures that may result in the final data being materially different from the preliminary data we previously published. As a result, interim and preliminary data should be viewed with caution until the final data are available. Differences between preliminary or interim data and final data could significantly harm our business prospects and may cause the trading price of our common stock to fluctuate significantly.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Further, others, including regulatory agencies, may not accept or agree with our assumptions, estimates, calculations, conclusions or analyses or may interpret or weigh the importance of data differently, which could impact the value of the particular program, the approvability or commercialization of the particular product candidate or product and our company in general. In addition, the information we choose to publicly disclose regarding a particular study or clinical trial is based on what is typically extensive information, and investors or others may not agree with what we determine is material or otherwise appropriate information to include in our disclosure, and any information we determine not to disclose may ultimately be deemed significant with respect to future decisions, conclusions, views, activities or otherwise regarding a particular product, product candidate or our business. If the interim, top-line or preliminary data that we report differ from actual results, or if others, including regulatory authorities, disagree with the conclusions reached, our ability to obtain approval for, and commercialize, our product candidates may be harmed, which could harm our business, operating results, prospects or financial condition.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we experience significant delays or difficulties in the enrollment of patients in clinical trials, the cost of developing product candidates could increase and our receipt of necessary regulatory approvals could be delayed or prevented.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Patient enrollment is a significant factor in the timing of clinical trials. The timing of our clinical trials depends, in part, on the speed at which we can recruit patients to participate in our trials. We or our collaborators may not be able to advance clinical trials for our product candidates if we are unable to locate and enroll a sufficient number of eligible patients to participate in these trials as required by the FDA, the EMA or other analogous regulatory authorities outside the United States, or as needed to provide appropriate statistical power for a given trial. Patients may be unwilling to participate in our clinical trials because of negative publicity from adverse events related to the biotechnology, gene therapy or genome engineering fields, competitive clinical trials for similar patient populations, clinical trials in competing products or for other reasons. As a result, the timeline for recruiting patients, conducting trials and obtaining regulatory approval of product candidates be delayed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Patient enrollment is also affected by other factors, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">severity of the disease under investigation; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">size of the patient population and process for identifying patients; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">design of the trial protocol; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">availability and efficacy of approved medications for the disease under investigation; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">availability of genetic testing for potential patients; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">76</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ability to obtain and maintain patient informed consent; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">risk that enrolled patients will drop out before completion of the trial; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">eligibility and exclusion criteria for the trial in question; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">perceived risks and benefits of the product candidate under trial; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">perceived risks and benefits of genome engineering as a treatment approach; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">perceived risks and benefits of the targeted therapeutics that may be administered in combination or in sequence with VOR33 or our other eHSC product candidates; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">efforts to facilitate timely enrollment in clinical trials; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">potential disruptions caused by the COVID-19 pandemic, including difficulties in initiating clinical sites, enrolling and retaining participants, diversion of healthcare resources away from clinical trials, travel or quarantine policies that may be implemented, and other factors; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">patient referral practices of physicians; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ability to monitor patients adequately during and after treatment; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">proximity and availability of clinical trial sites for prospective patients, especially for those conditions which have small patient pools; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the requirement for HSCT to be performed in centers that specialize in this procedure; and </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes to diagnostic technologies, methodologies or criteria used to identify HSCT patients at high risk for relapse. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Significant enrollment delays in our clinical trials may result in increased development costs for our product candidates, which would cause the value of our company to decline and limit our ability to obtain additional financing. If we or our collaborators have difficulty enrolling a sufficient number of patients to conduct our clinical trials as planned, we may need to delay, limit or terminate ongoing or planned clinical trials, any of which would have an adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we are unable to successfully identify patients who are likely to benefit from our product candidates, or experience significant delays in doing so, we may not realize the full commercial potential of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">VOR33 and any other eHSCs we may develop will require identification of patients that are likely to benefit from administration of our genetically engineered cells in combination with a targeted therapeutic. In addition, VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and any other targeted therapeutic we develop will require identification of patients with myeloid malignancies that express specific surface targets. If we, or any third parties that we engage to assist us, are unable to successfully identify such patients or experience delays in doing so, then:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to develop any product candidates may be adversely affected if we are unable to appropriately select patients for enrollment in our clinical trials; and </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may not realize the full commercial potential of any product candidates we develop that receive marketing approval if, among other reasons, we are unable to appropriately select patients who are likely to benefit from administration of our genetically engineered cells. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any product candidates we develop may require use of a companion diagnostic to identify patients who are likely to benefit from genetically engineered cell treatment. If safe and effective use of any of our product candidates depends on a companion diagnostic, we may not receive marketing approval, or marketing approval may be delayed, if we are unable to or are delayed in developing, identifying or obtaining regulatory approval or clearance for the companion diagnostic product for use with our product candidate. Identifying a manufacturer of the companion diagnostic and entering into an agreement with the manufacturer could also delay the development of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">77</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As a result of these factors, we may be unable to successfully develop and realize the commercial potential of our product candidates, and our business, financial condition, results of operations and prospects would be materially adversely affected.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may seek Fast Track designation for some or all of our product candidates. We may not receive such designation, and even for those product candidates for which we do, it may not lead to a faster development or regulatory review or approval process, and will not increase the likelihood that product candidates will receive marketing approval.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may seek Fast Track designation and review for some or all of our product candidates. If a drug or biologic is intended for the treatment of a serious or life-threatening condition or disease, and nonclinical or clinical data demonstrate the potential to address an unmet medical need, the product may qualify for FDA Fast Track designation, for which sponsors must apply. The FDA has broad discretion whether or not to grant this designation. Thus, even if we believe a particular product candidate is eligible for this designation, the FDA may decide not to grant it. Although we have received Fast Track designation for VOR33, we or our collaborators may not experience a faster development process, review or approval compared to conventional FDA procedures for VOR33 or any other product candidate for which we may receive Fast Track designation. In addition, the FDA may withdraw Fast Track designation if it believes that the designation is no longer supported by data from our clinical development program.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to Our Relationships with Third Parties</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We rely on third parties for some aspects of our research and preclinical testing, and we expect to rely on third parties to conduct our clinical trials, and those third parties may not perform satisfactorily, including failing to meet deadlines for the completion of such trials, research or testing.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We rely on third parties to conduct some aspects of our research and preclinical testing, and we expect to rely on third parties, such as CROs, clinical data management organizations, medical institutions such as HSCT centers, and clinical investigators, to conduct our clinical trials. Any of these third parties may terminate their engagements with us at any time under certain criteria. If we need to enter into alternative arrangements, it may delay our product development activities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our reliance on these third parties for research and development and clinical activities will reduce our control over these activities but will not relieve us of our responsibilities. For example, we will remain responsible for ensuring that each of our clinical trials is conducted in accordance with the general investigational plan and protocols for the trial. Moreover, the FDA, EMA and other regulatory authorities require us to comply with standards, commonly referred to as Good Clinical Practices, for conducting, recording and reporting the results of clinical trials to assure that data and reported results are credible and accurate and that the rights, integrity and confidentiality of trial participants are protected. In the United States, we also are required to register ongoing clinical trials and post the results of completed clinical trials on a government-sponsored database, ClinicalTrials.gov, within certain timeframes. Failure to do so can result in fines, adverse publicity and civil and criminal sanctions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Although we intend to design the future clinical trials for our product candidates, CROs will conduct some or all of the clinical trials. As a result, many important aspects of our development programs, including their conduct and timing, will be outside of our direct control. Our reliance on third parties to conduct future preclinical studies and clinical trials will also result in less direct control over the management of data developed through preclinical studies and clinical trials than would be the case if we were relying entirely upon our own staff. Communicating with outside parties can also be challenging, potentially leading to mistakes as well as difficulties in coordinating activities. Outside parties may:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">have staffing difficulties; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">fail to comply with contractual obligations; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">experience regulatory compliance issues; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">undergo changes in priorities or become financially distressed; or </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">form relationships with other entities, some of which may be our competitors. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">78</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These factors may materially adversely affect the willingness or ability of third parties to conduct our preclinical studies and clinical trials and may subject us to unexpected cost increases that are beyond our control. If the CROs and other third parties do not perform preclinical studies and future clinical trials in a satisfactory manner, breach their obligations to us or fail to comply with regulatory requirements, the development, regulatory approval and commercialization of our product candidates may be delayed, we may not be able to obtain regulatory approval and commercialize our product candidates, or our development programs may be materially and irreversibly harmed. If we are unable to rely on preclinical and clinical data collected by our CROs and other third parties, we could be required to repeat, extend the duration of or increase the size of any preclinical studies or clinical trials we conduct and this could significantly delay commercialization and require greater expenditures.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Moreover, principal investigators for our clinical trials may serve as scientific advisors or consultants to us from time to time and receive compensation in connection with such services. Under certain circumstances, we may be required to report some of these relationships to the FDA or comparable foreign regulatory authorities. The FDA or comparable foreign regulatory authority may conclude that a financial relationship between us and a principal investigator has created a conflict of interest or otherwise affected interpretation of the trial. The FDA or comparable foreign regulatory authority may therefore question the integrity of the data generated at the applicable clinical trial site and the utility of the clinical trial itself may be jeopardized. This could result in a delay in approval, or rejection, of our marketing applications by the FDA or comparable foreign regulatory authority, as the case may be, and may ultimately lead to the denial of marketing approval of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We also expect to rely on other third parties to store and distribute drug supplies for our clinical trials. Any performance failure on the part of our distributors could delay clinical development or marketing approval of our product candidates or commercialization of our products, producing additional losses and depriving us of potential product revenue.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We contract with third parties for the manufacture and supply of materials for development of our product candidates and advancement of our current clinical trial, as well as our research programs and preclinical studies, and we expect to continue to do so for future clinical trials and for commercialization of our product candidates. This reliance on third parties increases the risk that we will not have sufficient quantities of such materials, product candidates or any products that we may develop and commercialize, or that such supply will not be available to us at an acceptable cost, which could delay, prevent or impair our development or commercialization efforts.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Although we are building out an in-house manufacturing space in our headquarters, we do not have any active manufacturing facilities at the present time. We currently rely on third-party manufacturers, pharmaceutical companies and marrow donor programs, including certain single source suppliers, for the manufacture and supply of our materials for preclinical studies, and expect to continue to do so for future clinical testing and for commercial supply of our product candidates and for which we or our collaborators obtain marketing approval. We do not have a long-term agreement with many of these third-party manufacturers or suppliers, and we frequently purchase our required supply on a purchase order basis. We may be unable to establish any agreements with third-party manufacturers or suppliers or to do so on acceptable terms. Even if we are able to establish agreements with third-party manufacturers or suppliers, reliance on third-party manufacturers entails additional risks, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the possible breach of the manufacturing or supply agreement by the third party; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the possible termination or nonrenewal of the agreement by the third party at a time that is costly or inconvenient for us; and </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">reliance on the third party for regulatory compliance, quality assurance, safety and pharmacovigilance and related reporting. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Third-party manufacturers may not be able to comply with cGMP regulations or similar regulatory requirements outside the United States. Our failure, or the failure of our third-party manufacturers or suppliers, to comply with applicable regulations could result in sanctions being imposed on us, including fines, injunctions, civil penalties, delays, suspension or withdrawal of approvals, license revocations, seizures or recalls of product candidates or products, operating restrictions and criminal prosecutions, any of which could significantly and adversely affect supplies of our products and harm our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">79</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our product candidates may compete with other product candidates and products for access to manufacturing facilities and other supplies. There are a limited number of manufacturers that operate under cGMP regulations and that might be capable of manufacturing for us. Also, prior to the approval of our product candidates, we would need to identify a contract manufacturer that could produce our products at a commercial scale and that could successfully complete FDA pre-approval inspection and inspections by other health authorities. Agreements with such manufacturers or suppliers may not be available to us at the time we would need to have that capability and capacity.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any performance failure on the part of our existing or future manufacturers or suppliers, or any decision by a manufacturer or supplier to remove its products from the market or restrict access to its products, could delay clinical development or marketing approval. We do not currently have arrangements in place for redundant or guaranteed supply for many of the materials we currently use in our preclinical studies and expect to use in our clinical development programs, including for the supply of Mylotarg, donor blood cells, certain apheresis reagents and electroporation machines, and we may have difficulty or be unable to establish alternative sources of these materials. In addition, if any of the manufacturers with whom we have a contractual agreement cannot perform as agreed, we may be required to replace that manufacturer. Although we believe that there are several potential alternative manufacturers who could replace our contract manufacturers, we may incur added costs and delays in identifying and qualifying any such replacement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our current and anticipated future dependence upon others for the manufacture of our product candidates and the materials used in our clinical trials may adversely affect our future profit margins and our ability to commercialize any products that receive marketing approval on a timely and competitive basis.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We have and may enter into collaborations with third parties for the research, development and commercialization of our product candidates. If any such collaborations are not successful, we may not be able to capitalize on the market potential of those product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have and may seek third-party collaborators for the research, development and commercialization of certain our product candidates. If we enter into any such arrangements with any third parties in the future, we will likely have limited control over the amount and timing of resources that our collaborators dedicate to the development or commercialization our product candidates. Our ability to generate revenues from these arrangements will depend on our collaborators&#x2019; abilities to successfully perform the functions assigned to them in these arrangements. We cannot predict the success of collaborations that we have entered into or may enter into in the future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Collaborations involving our current or future product candidates or research programs pose numerous risks to us, including the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Collaborators have significant discretion in determining the efforts and resources that they will apply to these collaborations. </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Collaborators may not pursue development and commercialization of our product candidates or may elect not to continue or renew development or commercialization programs based on clinical trial results, changes in the collaborator&#x2019;s strategic focus or available funding or external factors such as an acquisition that diverts resources or creates competing priorities. </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Collaborators may delay clinical trials, provide insufficient funding for a clinical trial program, stop a clinical trial or abandon a product candidate, repeat or conduct new clinical trials or require a new formulation of a product candidate for clinical testing. </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Collaborators could independently develop, or develop with third parties, products that compete directly or indirectly with our product candidates if the collaborators believe that competitive products are more likely to be successfully developed or can be commercialized under terms that are more economically attractive than ours. </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Collaborators with marketing and distribution rights to one or more products may not commit sufficient resources to the marketing and distribution of such products. </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Collaborators may not properly obtain, maintain, enforce or defend our intellectual property or proprietary rights or may use our proprietary information in such a way as to invite litigation that could jeopardize or invalidate our proprietary information or expose us to potential litigation. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">80</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Disputes may arise between the collaborators and us that result in the delay or termination of the research, development or commercialization of our products or product candidates or that result in costly litigation or arbitration that diverts management attention and resources. </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may lose certain valuable rights under circumstances identified in our collaborations, including if we undergo a change of control. </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Collaborations may be terminated and, if terminated, may result in a need for additional capital to pursue further development or commercialization of the applicable product candidates. </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Collaboration agreements may not lead to development or commercialization of product candidates in the most efficient manner or at all. If a present or future collaborator of ours were to be involved in a business combination, the continued pursuit and emphasis on our product development or commercialization program under such collaboration could be delayed, diminished or terminated. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If our collaborations do not result in the successful development and commercialization of product candidates, or if one of our collaborators terminates its agreement with us, we may not receive any future research funding or milestone or royalty payments under the collaboration. If we do not receive the funding we expect under these agreements, our development of product candidates could be delayed, and we may need additional resources to develop product candidates. In addition, if one of our collaborators terminates its agreement with us, we may find it more difficult to find a suitable replacement collaborator or attract new collaborators, and our development programs may be delayed or the perception of us in the business and financial communities could be adversely affected. All of the risks relating to product development, regulatory approval and commercialization described in this Annual Report apply to the activities of our collaborators.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These relationships, or those like them, may require us to incur non-recurring and other charges, increase our near- and long-term expenditures, issue securities that dilute our existing stockholders, or disrupt our management and business. In addition, we could face significant competition in seeking appropriate collaborators, and the negotiation process is time-consuming and complex. Our ability to reach a definitive collaboration agreement will depend, among other things, upon our assessment of the collaborator&#x2019;s resources and expertise, the terms and conditions of the proposed collaboration, and the proposed collaborator&#x2019;s evaluation of several factors. If we license rights to our product candidates, we may not be able to realize the benefit of such transactions if we are unable to successfully integrate them with our existing operations and company culture.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we are not able to establish collaborations on commercially reasonable terms, we may have to alter our development and commercialization plans.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our product development and research programs and the potential commercialization of our product candidates will require substantial additional cash to fund expenses. For some of the product candidates, we may decide to collaborate with other pharmaceutical and biotechnology companies for the development and potential commercialization of those product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We would face significant competition in seeking appropriate collaborators. Whether we reach a definitive agreement for a collaboration will depend, among other things, upon our assessment of the collaborator&#x2019;s resources and expertise, the terms and conditions of the proposed collaboration, and the proposed collaborator&#x2019;s evaluation of a number of factors. Those factors may include the design or results of clinical trials, the likelihood of approval by the FDA, the EMA or similar regulatory authorities outside the United States, the potential market for the subject product candidate, the costs and complexities of manufacturing and delivering such product candidate to patients, the potential of competing products, the existence of uncertainty with respect to our ownership of technology, which can exist if there is a challenge to such ownership without regard to the merits of the challenge, and industry and market conditions generally. The collaborator may also consider alternative product candidates or technologies for similar indications that may be available to collaborate on and whether such a collaboration could be more attractive than the one with us.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may also be restricted under existing collaboration agreements from entering into future agreements on certain terms with potential collaborators. Collaborations are complex and time-consuming to negotiate and document. In addition, there have been a significant number of recent business combinations among large pharmaceutical companies that have resulted in a reduced number of potential future collaborators.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">81</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may not be able to negotiate collaborations on a timely basis, on acceptable terms, or at all. If we are unable to do so, we may have to curtail the development of the product candidate for which we are seeking to collaborate, reduce or delay its development program or one or more of our other development programs, delay its potential commercialization or reduce the scope of any sales or marketing activities, or increase our expenditures and undertake development or commercialization activities at our own expense. If we elect to increase our expenditures to fund development or commercialization activities on our own, we may need to obtain additional capital, which may not be available to us on acceptable terms or at all. If we do not have sufficient funds, we may not be able to develop product candidates or bring them to market and generate product revenue.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to Our Intellectual Property</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We are highly dependent on intellectual property licensed from third parties and termination of any of these licenses could result in the loss of significant rights, which would harm our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In April 2016, we entered into a license agreement with The Trustees of Columbia University in the City of New York (&#x201c;Columbia&#x201d;) pursuant to which we were granted an exclusive, worldwide license to certain intellectual property rights owned or controlled by Columbia, including patents, patent applications, proprietary information, know-how and other intellectual property related to the inhibition of lineage-specific antigens, to develop, commercialize and sell one or more products in any field of use, including related to eHSCs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, in October 2020, we entered into a license agreement with the National Cancer Institute (&#x201c;NCI&#x201d;), pursuant to which we were granted an exclusive, worldwide license to certain intellectual property rights owned or controlled by NCI, including patents, patent applications, proprietary information, know-how and other intellectual property related to anti-CD33 CAR-T therapies, to develop, commercialize and sell one or more products for the prophylaxis or treatment of CD33-expressing hematological malignancies, including AML and other myeloid malignancies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are dependent on the patents, know-how and proprietary technology, licensed from Columbia and NCI for the development and, if approved, commercialization of VOR33 and VCAR33, respectively. Any termination of these licenses, or a finding that such intellectual property lacks legal effect, could result in the loss of significant rights and could harm our ability to commercialize our current or future product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each of the Columbia license agreement and the NCI license agreement imposes certain obligations on us, including obligations to use diligent efforts to meet development thresholds and payment obligations. Non-compliance with such obligations may result in termination of the respective license agreement or in legal and financial consequences. If either Columbia or NCI terminates its respective license agreement, we may not be able to develop, commercialize or sell our product candidates covered by these agreements. Such an occurrence could materially adversely affect the value of the product candidate being developed under any such agreement or using rights granted under such agreement. Termination of our license agreements or reduction or elimination of our rights under them may result in our having to negotiate a new or reinstated agreement, which may not be available to us on equally favorable terms, or at all, which may mean we are unable to develop, commercialize or sell the affected product candidate or may cause us to lose our rights under the agreement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, our licensors may make decisions in prosecuting, maintaining, enforcing and defending any licensed intellectual property rights, for example, any licensed patents or patent applications, that may not be in our best interest. Moreover, if our licensors take any action with respect to any licensed intellectual property rights, for example, any licensed patents or patent applications, that results in a successful challenge to the licensed intellectual property by a third party, such patents may be invalidated or held to be unenforceable, and we may lose our rights under such patents, which could materially harm our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Further, the agreements under which we currently license intellectual property from third parties are complex, and certain provisions in such agreements may be susceptible to multiple interpretations. Accordingly, disputes may arise between us and our licensors regarding intellectual property subject to a license agreement, including those relating to:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the scope of rights, if any, granted under the license agreement and other interpretation-related issues; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">whether and the extent to which our technology and processes infringe on intellectual property of the licensor that is not subject to the license agreement; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">82</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">whether our licensor or its licensor had the right to grant the license agreement; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">whether third parties are entitled to compensation or equitable relief, such as an injunction, for our use of the intellectual property without their authorization; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our right to sublicense patent and other rights to third parties under collaborative development relationships; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">whether we are complying with our obligations with respect to the use of the licensed technology in relation to our development and commercialization of product candidates; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our involvement in the prosecution and enforcement of the licensed patents and our licensors&#x2019; overall patent prosecution and enforcement strategy; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the allocation of ownership of inventions and know-how resulting from the joint creation or use of intellectual property by our licensors and by us and any future partners or collaborators; and </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the amounts of royalties, milestones or other payments due under the license agreement. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be the scope of our rights to the relevant intellectual property or technology, or increase what we believe to be our financial or other obligations under the relevant agreement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If disputes over intellectual property that we have licensed prevent or impair our ability to maintain our current licensing arrangements on acceptable terms, or are insufficient to provide us the necessary rights to use the intellectual property, we may be unable to successfully develop and commercialize the affected product candidates.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we or any of our licensors fail to adequately protect this intellectual property, our ability to commercialize our products could suffer. Any disputes with our licensors or any termination of the licenses on which we depend could have a material adverse effect on our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our commercial success depends on our ability to obtain, maintain and protect our intellectual property and proprietary technology.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our commercial success depends in large part on our ability to obtain, maintain and protect intellectual property rights through patents, trademarks and trade secrets in the United States and other countries with respect to our proprietary product candidates. If we do not adequately protect our intellectual property rights, competitors may be able to erode, negate or preempt any competitive advantage we may have, which could harm our business and ability to achieve profitability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To protect our proprietary position, we own and have in-licensed certain intellectual property rights, including certain issued patents and patent applications, and have filed and may file provisional and non-provisional patent applications in the United States or abroad related to our product candidates that are important to our business. Provisional patent applications are not eligible to become issued patents until, among other things, we file a non-provisional patent application within 12 months of the filing of one or more of our related provisional patent applications. If we do not timely file non-provisional patent applications, we may lose our priority date with respect to our provisional patent applications and any patent protection on the inventions disclosed in our provisional patent applications. While we intend to timely file non-provisional patent applications relating to our provisional patent applications, we cannot predict whether any such patent applications will result in the issuance of patents that provide us with any competitive advantage. Moreover, the patent application and approval process is expensive and time-consuming. We may not be able to file and prosecute all necessary or desirable patent applications at a reasonable cost or in a timely manner.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The patent application, prosecution, and enforcement processes are subject to numerous risks and uncertainties, and there can be no assurance that we, our licensors, or any of our current or future collaborators will be successful in protecting our product candidates by obtaining, defending, and/or asserting patent rights. These risks and uncertainties include the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other provisions during the patent process. There are situations in which noncompliance can result in abandonment or lapse of a patent or patent application, resulting in </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">83</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;visibility:hidden;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;"></span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">partial or complete loss of patent rights in the relevant jurisdiction. In such an event, competitors might be able to enter the market earlier than would otherwise have been the case;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">patent applications may not result in any patents being issued; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">patents that may be issued or in-licensed may be challenged, invalidated, modified, revoked, circumvented, found to be unenforceable or otherwise may not provide any competitive advantage; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our competitors, many of whom have substantially greater resources and many of whom have made significant investments in competing technologies, may seek or may have already obtained patents that will limit, interfere with or eliminate our ability to make, use, and sell our potential product candidates; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">there may be significant pressure on the U.S. government and international governmental bodies to limit the scope of patent protection both inside and outside the United States for disease treatments that prove successful, as a matter of public policy regarding worldwide health concerns; and </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">countries other than the United States may have patent laws less favorable to patentees than those upheld by U.S. courts, allowing foreign competitors a better opportunity to create, develop and market competing product candidates. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In some instances, agreements through which we license intellectual property rights may not give us control over patent prosecution or maintenance, so that we may not be able to control which claims or arguments are presented, how claims are amended, and may not be able to secure, maintain, or successfully enforce necessary or desirable patent protection from those patent rights. We have not had and do not have primary control over patent prosecution and maintenance for certain of the patents and patent applications we license, including under our license agreements with Columbia and NCI, and therefore cannot guarantee that these patents and applications will be prosecuted or maintained in a manner consistent with the best interests of our business. We cannot be certain that patent prosecution and maintenance activities by our licensors have been or will be conducted in compliance with applicable laws and regulations or will result in valid and enforceable patents.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Moreover, some of our in-licensed patents and patent applications may be, and some of our future owned and licensed patents may be, co-owned with third parties. If we are unable to obtain an exclusive license to any such third-party co-owners&#x2019; interest in such patents or patent applications, such co-owners may be able to license their rights to other third parties, including our competitors, and our competitors could market competing products and technology. In addition, we may need the cooperation of any such co-owners of our patents in order to enforce such patents against third parties, and such cooperation may not be provided to us.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The patent protection we obtain for our product candidates may not be sufficient to provide us with any competitive advantage or our patents may be challenged.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our owned and licensed patents and pending patent applications, if issued, may not provide us with any meaningful protection or may not prevent competitors from designing around our patent claims to circumvent our patents by developing similar or alternative technologies or therapeutics in a non-infringing manner. For example, a third party may develop a competitive product that provides benefits similar to one or more of our product candidates but falls outside the scope of our patent protection or license rights. If the patent protection provided by the patents and patent applications we hold or pursue with respect to our product candidates is not sufficiently broad to impede such competition, our ability to successfully commercialize our product candidates could be negatively affected, which would harm our business. Currently, a significant portion of our patents and patent applications are in-licensed, though similar risks would apply to any patents or patent applications that we now own or may own or in-license in the future.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">It is possible that defects of form in the preparation or filing of our patents or patent applications may exist, or may arise in the future, for example with respect to proper priority claims, inventorship, claim scope, or requests for patent term adjustments. If we or our partners, collaborators, licensees, or licensors, whether current or future, fail to establish, maintain or protect such patents and other intellectual property rights, such rights may be reduced or eliminated. If our partners, collaborators, licensees, or licensors, are not fully cooperative or disagree with us as to the prosecution, maintenance or enforcement of any patent rights, such patent rights could be compromised. If there are material defects in the form, preparation, prosecution, or enforcement of our patents or patent applications, such patents may be invalid and/or unenforceable, and such applications may never result in valid, enforceable patents.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">84</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any of these outcomes could impair our ability to prevent competition from third parties, which may have an adverse impact on our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, the determination of patent rights with respect to clinical compositions of matter and treatment methods commonly involves complex legal and factual questions, which are dependent upon the current legal and intellectual property context, extant legal precedent and interpretations of the law by individuals. As a result, the issuance, scope, validity, enforceability and commercial value of our patent rights are characterized by uncertainty.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Changes in either the patent laws or interpretation of the patent laws in the United States and other countries may diminish the value of our patents or narrow the scope of our patent protection. In addition, the laws of foreign countries may not protect our rights to the same extent or in the same manner as the laws of the United States. For example, patent laws in various jurisdictions, including significant commercial markets such as Europe, restrict the patentability of methods of treatment of the human body more than U.S. law does. If these changes were to occur, they could have a material adverse effect on our ability to generate revenue.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pending patent applications cannot be enforced against third parties practicing the technology claimed in such applications unless and until a patent issues from such applications. Assuming the other requirements for patentability are met, currently, the first party to file a patent application is generally entitled to the patent. However, prior to March 16, 2013, in the United States the first party to invent was entitled to the patent. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are not published until 18 months after filing, or in some cases not at all. Therefore, we cannot be certain that we were the first to make the inventions claimed in our patents or pending patent applications, or that we were the first to file for patent protection of such inventions. Similarly, we cannot be certain that parties from whom we do or may license or purchase patent rights were the first to make relevant claimed inventions, or were the first to file for patent protection for them. If third parties have filed prior patent applications on inventions claimed in our patents or applications that were filed on or before March 15, 2013, an interference proceeding in the United States can be initiated by such third parties to determine who was the first to invent any of the subject matter covered by the patent claims of our applications. If third parties have filed such prior applications after March 15, 2013, a derivation proceeding in the United States can be initiated by such third parties to determine whether our invention was derived from theirs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Moreover, because the issuance of a patent is not conclusive as to its inventorship, scope, validity or enforceability, our owned and licensed patents or pending patent applications may be challenged in the courts or patent offices in the United States and abroad. There is no assurance that all of the potentially relevant prior art relating to our patents and patent applications has been found. If such prior art exists, it may be used to invalidate a patent, or may prevent a patent from issuing from a pending patent application. For example, such patent filings may be subject to a third-party submission of prior art to the U.S. Patent and Trademark Office (the &#x201c;USPTO&#x201d;), or to other patent offices around the world. Alternately or additionally, we may become involved in post-grant review procedures, oppositions, derivation proceedings, ex parte reexaminations, inter partes review, supplemental examinations, or interference proceedings or challenges in district court, in the United States or in various foreign patent offices, including both national and regional, challenging patents or patent applications in which we have rights, including patents on which we rely to protect our business. An adverse determination in any such challenges may result in loss of the patent or in patent claims being narrowed, invalidated or held unenforceable, in whole or in part, or in denial of the patent application or loss or reduction in the scope of one or more claims of the patent application, any of which could limit our ability to stop others from using or commercializing similar or identical technology and products, or limit the duration of the patent protection of our technology and products. In addition, given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such candidates might expire before or shortly after such candidates are commercialized.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Issued patents that we have or may obtain or license may not provide us with any meaningful protection, prevent competitors from competing with us or otherwise provide us with any competitive advantage. Our competitors may be able to circumvent our patents by developing similar or alternative technologies or products in a non-infringing manner. Our competitors may also seek approval to market their own products similar to or otherwise competitive with our products. Alternatively, our competitors may seek to market generic versions of any approved products, for example, by submitting a Section 351(k) BLA to the FDA, or pursue similar strategies in the United States or other jurisdictions, in which they claim that patents owned or licensed by us are invalid, unenforceable or not infringed. In these circumstances, we may need to defend or assert our patents, or both, including by filing lawsuits alleging patent infringement. In any of these types of proceedings, a court or other agency with jurisdiction</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">85</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">may find our patents invalid or unenforceable, or that our competitors are competing in a non-infringing manner. Thus, even if we have valid and enforceable patents, these patents still may not provide protection against competing products or processes sufficient to achieve our business objectives. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other parties have developed or may develop technologies that may be related to or competitive with our approach, and may have filed or may file patent applications and may have been issued or may be issued patents with claims that overlap or conflict with our patent applications, either by claiming the same materials, formulations or methods, or by claiming subject matter that could dominate our patent position. In addition, certain parts or all of the patent portfolios licensed to us are, or may be, licensed to third parties and such third parties may have or may obtain certain enforcement rights. If the scope of the patent protection we or our licensors obtain is not sufficiently broad, we may not be able to prevent others from developing and commercializing technology and products similar or identical to ours. The degree of patent protection we require to successfully compete in the marketplace may be unavailable or severely limited in some cases and may not adequately protect our rights or permit us to gain or keep any competitive advantage. We cannot provide any assurances that any of our licensed patents have, or that any of our pending owned or licensed patent applications that mature into issued patents will include, claims with a scope sufficient to protect our product candidates or otherwise provide any competitive advantage, nor can we provide any assurance that our licenses will remain in force.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we are unable to protect the confidentiality of our trade secrets, our business and competitive position may be harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to the protection afforded by patents, we rely upon trade secret protection, know-how and continuing technological innovation to develop and maintain our competitive position. We seek to protect our proprietary technology and processes, in part, by entering into confidentiality agreements with our contractors, collaborators, scientific advisors, employees and consultants and invention assignment agreements with our consultants and employees. However, we may not obtain these agreements in all circumstances, and individuals with whom we have these agreements may not comply with their terms. The assignment of intellectual property rights under these agreements may not be self-executing or the assignment agreements may be breached, and we may be forced to bring claims against third parties, or defend claims that they may bring against us, to determine the ownership of what we regard as our intellectual property. In addition, we may not be able to prevent the unauthorized disclosure or use of our technical know-how or other trade secrets by the parties to these agreements despite the existence of confidentiality agreements and other contractual restrictions. Monitoring unauthorized uses and disclosures is difficult and we do not know whether the steps we have taken to protect our proprietary technologies will be effective. If any of the contractors, collaborators, scientific advisors, employees and consultants who are parties to these agreements breaches or violates the terms of any of these agreements, we may not have adequate remedies for any such breach or violation. As a result, we could lose our trade secrets. Enforcing a claim against a third party that illegally obtained and is using our trade secrets, like patent litigation, is expensive and time-consuming and the outcome is unpredictable. In addition, courts outside the United States are sometimes less willing or unwilling to protect trade secrets. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Moreover, our trade secrets could otherwise become known or be independently discovered by our competitors or other third parties. Competitors and other third parties could attempt to replicate some or all of the competitive advantages we derive from our development efforts, willfully infringe our intellectual property rights, design around our protected technology or develop their own competitive technologies that fall outside of our intellectual property rights. If any of our trade secrets were to be lawfully obtained or independently developed by a competitor or other third party, we would have no right to prevent them, or those to whom they communicate it, from using that technology or information to compete with us. If our trade secrets are not adequately protected or sufficient to provide an advantage over our competitors, our competitive position could be adversely affected, as could our business. Additionally, if the steps taken to maintain our trade secrets are deemed inadequate, we may have insufficient recourse against third parties for misappropriating our trade secrets.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may not be successful in acquiring or in-licensing necessary rights to key technologies underlying our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We currently have rights to intellectual property, through licenses from third parties, to develop our product candidates, and we expect to seek to expand our intellectual property footprint related to our product candidate pipeline in part by in-licensing the rights to key technologies. The future growth of our business will depend in part</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">86</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">on our ability to in-license or otherwise acquire the rights to develop additional product candidates and technologies. Although we have succeeded in licensing technologies from third party licensors, including Columbia and NCI, in the past, we can give no assurance that we will be able to in-license or acquire the rights to other technologies relevant to our product candidates from third parties on acceptable terms or at all.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In order to market our product candidates, we may find it necessary or prudent to obtain licenses from such third party intellectual property holders. However, it may be unclear who owns the rights to intellectual property we wish to obtain, or we may be unable to secure such licenses or otherwise acquire or in-license intellectual property rights from third parties that we identify as necessary for our product candidates and technology we employ. For example, we employ a range of genome engineering technologies that are owned by third parties in our preclinical studies, as well as to manufacture the supply of eHSCs or other cell therapies used for clinical trials and, if approved, for commercialization of our product candidates. In particular, we rely on, and will continue to rely on, CRISPR-Cas9 genome engineering technology to create VOR33. We currently conduct our preclinical research and clinical trials under 35 U.S.C. &#167; 271(e)(1), which provides a safe harbor from patent infringement for uses of patented technology reasonably related to the development and submission of information under a federal law which regulates the manufacture, use, or sale of drugs. However, prior to commercializing any product candidates that rely on genome engineering technology owned by third parties, including VOR33, we will be required to obtain a license to that technology covering our field of use. While genome engineering technology licenses, including for the CRISPR-Cas9 technology, have a very limited history, we believe companies typically secure commercial licenses for these technologies in the later stages of clinical development, in anticipation of the expiration of the safe harbor under federal law. While we are aware of both exclusive and non-exclusive licenses being granted for these technologies, we are not aware of any exclusive licenses covering the engineering of eHSCs. However, it is possible that such licenses exist, or will be granted to third parties in the future, and we may be unable to secure a license for our field of use on commercially reasonable terms or at all.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Numerous patents and patent applications directed to genome engineering technology have been filed by third parties. For example, we are aware of a number of patents and patent applications by the University of California, the University of Vienna, and Emmanuelle Charpentier; the Broad Institute, Inc. (the &#x201c;Broad Institute&#x201d;); the Massachusetts Institute of Technology; the Presidents and Fellows of Harvard College; Sigma-Aldrich Co.; Novartis AG; Vilnius University; Agilent Technologies, Inc.; Cellectis; Sangamo Therapeutics, Inc; The Trustees of Princeton University; Miltenyi Biotec GmbH (&#x201c;Miltenyi&#x201d;); Amgen Research (Munich) GmbH; and the University of Pennsylvania, among others. The intellectual property space related to genome engineering, particularly with respect to CRISPR-Cas9, is highly complex and still unsettled. For example, certain CRISPR-Cas9 patents of various parties previously mentioned above are currently subject to interference proceedings before the USPTO and opposition proceedings before the European Patent Office. It is uncertain when and how the USPTO as well as the European Patent Office will decide in the various proceedings, and the decisions of the respective patent offices may significantly affect the scope or may deny the validity of the respective patents involved in these proceedings. At the time we attempt to obtain a license to genome engineering technology, including to CRISPR-Cas9 technology, it may be unclear which parties own the rights to this technology, and we may be required to obtain licenses from more than one party, or from different parties in different parts of the world. In certain scenarios, it may also be difficult or impossible, at least for a certain time, to identify whether a license, if available at all, would convey sufficient intellectual property rights to us that would allow us to avoid third-party claims of intellectual property infringement, misappropriation or other violations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The licensing or acquisition of third party intellectual property rights is a highly competitive area, and other companies may pursue strategies to license or acquire third party intellectual property rights that we may consider attractive or necessary. Such companies may have a competitive advantage over us, e.g., due to their size, capital resources and greater clinical development and commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. We also may be unable to license or acquire third party intellectual property rights on terms that would allow us to make an appropriate return on our investment or at all. If we are unable to successfully obtain rights to required third party intellectual property rights or maintain the existing intellectual property rights we have, we may have to abandon development of the relevant program or product candidate, which could have a material adverse effect on our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Even if we were able to obtain such a license, it could be non-exclusive, thereby giving our competitors and other third parties access to the same technologies licensed to us, and it could require us to make substantial licensing and royalty payments. If we are unable to obtain a necessary license to a third-party patent on</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">87</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">commercially reasonable terms, we may be unable to commercialize our product candidates or such commercialization efforts may be significantly delayed, which could in turn significantly harm our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Third-party claims of intellectual property infringement, misappropriation or other violations may prevent or delay our product discovery and development efforts and have a material adverse effect on our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our commercial success depends in part on our avoiding infringement, misappropriation and other violations of the patents and proprietary rights of third parties. There is a substantial amount of litigation involving patents and other intellectual property rights in the biotechnology and pharmaceutical industries, as well as administrative proceedings for challenging patents, including interference and reexamination proceedings before the USPTO or oppositions and other comparable proceedings in foreign jurisdictions. Recently, under U.S. patent reform, new procedures including </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">inter partes </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">review and post grant review have been implemented. This reform will bring uncertainty to the possibility of challenge to</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our patents in the future. Numerous U.S. and foreign issued patents and pending patent applications, which are owned by third parties, exist in the fields in which we are developing our product candidates, and third parties may allege they have patent rights encompassing our product candidates, technologies or methods. Third parties may assert that we are employing their proprietary technology without authorization and may file patent infringement claims or lawsuits against us, and if we are found to infringe such third-party patents, we may be required to pay damages, cease commercialization of the infringing technology or obtain a license from such third parties, which may not be available on commercially reasonable terms or at all.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are aware of several third-party patents and patent applications that if issued, may be construed to cover eHSC technology. For example, Miltenyi&#x2019;s European patent EP3025719 covers technology related to eHSC products. This patent was subject to opposition proceedings before the European Patent Office Opposition Division (the &#x201c;Opposition Division&#x201d;) and in March 2021, the Opposition Division revoked the patent.  However, this decision has been appealed and when or in what manner the Board of Appeals of the European Patent Office will act on the appeal is not clear. In addition, the University of Pennsylvania has filed patent applications and has been granted at least one U.S. patent covering eHSC technology. These or other third parties owning or controlling patent rights may seek to allege that our development and commercialization of our eHSC products, including VOR33, infringes such patent rights and file a patent infringement lawsuit against us in the future. While we believe that we have valid defenses against any such allegation or lawsuit, such defenses may ultimately be unsuccessful.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There may also be third-party patents of which we are currently unaware with patent rights to materials, formulations, methods of manufacture or methods of treatment related to the use or manufacture of our product candidates. Because patent applications can take many years to issue, there may be currently pending patent applications which may later result in issued patents that our product candidates may infringe. In addition, third parties may obtain patents in the future and claim that use of our technologies infringes upon these patents. Further, we or our licensors may fail to identify even those relevant third-party patents that have issued or may incorrectly interpret the relevance, scope or expiration of such patents. The scope of a patent claim is determined by an interpretation of the law, the written disclosure in a patent and the patent&#x2019;s prosecution history. Our interpretation of the relevance or scope of a patent or a pending application may be incorrect. If any third-party patents were held by a court of competent jurisdiction to cover the manufacturing process of our product candidates, materials used in or formed during the manufacturing process or any final product itself, the holders of any such patents may be able to block our ability to commercialize the product candidate unless we obtained a license under the applicable patents, or until such patents expire or they are finally determined to be held invalid or unenforceable. Similarly, if any third-party patent were held by a court of competent jurisdiction to cover aspects of our materials, formulations or methods, including without limitation, combination therapy or patient selection methods, the holders of any such patent may be able to block our ability to develop and commercialize the product candidate unless we obtained a license or until such patent expires or is finally determined to be held invalid or unenforceable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Parties making claims against us may seek and obtain injunctive or other equitable relief, which could effectively block our ability to further develop and commercialize our product candidates. Defense of these claims, regardless of their merit, would involve substantial litigation expense and would involve a substantial diversion of employee resources from our business. We may not have sufficient resources to bring these actions to a successful conclusion, which may result in significant cost and may impede our inability to pursue any affected products or product candidates. There could also be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of shares of our common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">88</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the event of a successful claim of infringement against us, we may have to pay substantial damages, including treble damages and attorneys&#x2019; fees for willful infringement, obtain one or more licenses from third parties, pay royalties or redesign our infringing products, which may be impossible or require substantial time and monetary expenditure.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Periodic maintenance fees on any issued patent are due to be paid to the USPTO and foreign patent agencies in several stages over the lifetime of the patent. The USPTO and various foreign governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. While an inadvertent lapse can in many cases be cured by payment of a late fee or by other means in accordance with the applicable rules, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. Noncompliance events that could result in abandonment or lapse of a patent or patent application include, but are not limited to, failure to respond to official actions within prescribed time limits, non-payment of fees and failure to properly legalize and submit formal documents. In such an event, our competitors might be able to enter the market earlier than would otherwise have been the case, which would have a material adverse effect on our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Some intellectual property that we have in-licensed may have been discovered through government funded programs and thus may be subject to federal regulations such as &#x201c;march-in&#x201d; rights, certain reporting requirements and a preference for U.S.-based companies. Compliance with such regulations may limit our exclusive rights and limit our ability to contract with non-U.S. manufacturers.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any of the intellectual property rights that we have licensed or we may license in the future and that have been generated through the use of U.S. government funding are subject to certain federal regulations. As a result, the U.S. government may have certain rights to intellectual property embodied in our current or future product candidates pursuant to the Bayh-Dole Act of 1980 (the &#x201c;Bayh-Dole Act&#x201d;). These U.S. government rights in certain inventions developed under a government-funded program include a non-exclusive, non-transferable, irrevocable worldwide license to use inventions for any governmental purpose. In addition, the U.S. government has the right to require us to grant exclusive, partially exclusive, or non-exclusive licenses to any such intellectual property rights to a third party if it determines that: (i) adequate steps have not been taken to commercialize the invention; (ii) government action is necessary to meet public health or safety needs; or (iii) government action is necessary to meet requirements for public use under federal regulations (also referred to as &#x201c;march-in rights&#x201d;). The U.S. government also has the right to take title to such intellectual property rights if we, or the applicable licensor, fail to disclose the invention to the government and fail to file an application to register the intellectual property within specified time limits. Intellectual property generated under a government funded program is also subject to certain reporting requirements, compliance with which may require us or the applicable licensor to expend substantial resources. We cannot be certain that our current or future licensors will comply with the disclosure or reporting requirements of the Bayh-Dole Act at all times, or be able to rectify any lapse in compliance with these requirements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, the U.S. government requires that any products embodying the subject invention or produced through the use of the subject invention be manufactured substantially in the United States. The manufacturing preference requirement can be waived if the owner of the intellectual property can show that reasonable but unsuccessful efforts have been made to grant licenses on similar terms to potential licensees that would be likely to manufacture substantially in the United States or that under the circumstances domestic manufacture is not commercially feasible. This preference for U.S. manufacturers may limit our ability to contract with non-U.S. product manufacturers for products covered by such intellectual property. To the extent any of our current or future intellectual property is generated through the use of U.S. government funding, the provisions of the Bayh-Dole Act may similarly apply.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may become involved in lawsuits to protect or enforce our patents or other intellectual property, which could be expensive, time-consuming and unsuccessful.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Competitors may infringe our patents, trademarks, copyrights or other intellectual property. To counter infringement or unauthorized use, we may be required to file infringement claims, which can be expensive and time-consuming and divert the time and attention of our management and scientific personnel. Any claims we assert</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">89</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">against perceived infringers could provoke these parties to assert counterclaims against us alleging that we infringe their patents, in addition to counterclaims asserting that our patents are invalid or unenforceable, or both. In any patent infringement proceeding, there is a risk that a court will decide that a patent of ours is invalid or unenforceable, in whole or in part, and that we do not have the right to stop the other party from using the invention at issue. There is also a risk that, even if the validity of such patents is upheld, the court will construe the patent&#x2019;s claims narrowly or decide that we do not have the right to stop the other party from using the invention at issue on the grounds that our patent claims do not cover the invention. An adverse outcome in a litigation or proceeding involving our patents could limit our ability to assert our patents against those parties or other competitors, and may curtail or preclude our ability to exclude third parties from making and selling similar or competitive products. Any of these occurrences could adversely affect our competitive business position, business prospects and financial condition. Similarly, if we assert trademark infringement claims, a court may determine that the marks we have asserted are invalid or unenforceable, or that the party against whom we have asserted trademark infringement has superior rights to the marks in question. In this case, we could ultimately be forced to cease use of such trademarks.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Even if we establish infringement, the court may decide not to grant an injunction against further infringing activity and instead award only monetary damages, which may or may not be an adequate remedy. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during litigation. There could also be public announcements of the results of hearings, motions or other interim proceedings or developments. If securities analysts or investors perceive these results to be negative, it could have a material adverse effect on the price of shares of our common stock. Moreover, there can be no assurance that we will have sufficient financial or other resources to file and pursue such infringement claims, which typically last for years before they are concluded. Even if we ultimately prevail in such claims, the monetary cost of such litigation and the diversion of the attention of our management and scientific personnel could outweigh any benefit we receive as a result of the proceedings. Any of the foregoing may have a material adverse effect on our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Changes to patent law in the United States and other jurisdictions could diminish the value of patents in general, thereby impairing our ability to protect our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As is the case with other biopharmaceutical companies, our success is heavily dependent on intellectual property, particularly patents. Obtaining and enforcing patents in the biopharmaceutical industry involves both technological and legal complexity, and is therefore costly, time-consuming and inherently uncertain. In addition, the United States has recently enacted and is currently implementing wide-ranging patent reform legislation. Recent U.S. Supreme Court rulings have narrowed the scope of patent protection available in certain circumstances and weakened the rights of patent owners in certain situations. In addition to increasing uncertainty with regard to our ability to obtain patents in the future, this combination of events has created uncertainty with respect to the value of patents, once obtained. Depending on decisions by the Congress, the federal courts, and the USPTO, the laws and regulations governing patents could change in unpredictable ways that would weaken our ability to obtain new patents or to enforce our existing patents and patents that we might obtain in the future. For example, in the case, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Assoc. for Molecular Pathology v. Myriad Genetics, Inc.,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> the Supreme Court held that certain claims to DNA molecules are not patentable. In addition, the case </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Amgen Inc. v. Sanofi</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> affects the way antibody claims are examined and litigated. While we do not believe that any of the patents owned or licensed by us will be found invalid based on these decisions, we cannot predict how future decisions by the courts, the Congress or the USPTO may impact the value of our patents.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We may not be able to protect our intellectual property rights throughout the world.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Filing, prosecuting, maintaining, defending and enforcing patents on our product candidates in all countries throughout the world would be prohibitively expensive, and our intellectual property rights in some countries outside the United States can be less extensive than those in the United States. In addition, the laws of some foreign countries do not protect intellectual property rights to the same extent as federal and state laws in the United States. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling or importing products made using our inventions in and into the United States or other jurisdictions. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own drugs and may export otherwise infringing drugs to territories where we have patent protection, but enforcement rights are not as strong as those in the United States. These drugs may compete with our product</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">candidates and our patents or other intellectual property rights may not be effective or sufficient to prevent them from competing.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Many companies have encountered significant problems in protecting and defending intellectual property rights in foreign jurisdictions. The legal systems of some countries do not favor the enforcement of patents and other intellectual property protection, which could make it difficult for us to stop the infringement of our patents generally. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial costs and divert our efforts and attention from other aspects of our business, could put our patents at risk of being invalidated or interpreted narrowly and our patent applications at risk of not issuing and could provoke third parties to assert claims against us. We may not prevail in any lawsuits that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Many countries have compulsory licensing laws under which a patent owner may be compelled under specified circumstances to grant licenses to third parties. In addition, many countries limit the enforceability of patents against government agencies or government contractors. In those countries, we may have limited remedies if patents are infringed or if we are compelled to grant a license to a third party, which could materially diminish the value of those patents. This could limit our potential revenue opportunities. Accordingly, our efforts to enforce our intellectual property rights around the world may be inadequate to obtain a significant commercial advantage from the intellectual property that we develop or license, which could adversely affect our business, financial condition, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Patent terms may be inadequate to protect our competitive position on our product candidates for an adequate amount of time.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Patents have a limited lifespan. In the United States, if all maintenance fees are timely paid, the natural expiration of a patent is generally 20 years from its earliest filing date of a non-provisional application to which the patent claims priority. Various extensions may be available, but the life of a patent, and the protection it affords, is limited. Even if patents covering our product candidates are obtained, once the patent life has expired for a product candidate, we may be open to competition from competitive medications, including generic medications. Given the amount of time required for the development, testing and regulatory review of new product candidates, patents protecting such product candidates might expire before or shortly after such product candidates are commercialized. As a result, our owned and licensed patent portfolio may not provide us with sufficient rights to exclude others from commercializing product candidates similar or identical to ours.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we do not obtain patent term extension and data exclusivity for VOR33 or any other product candidates, our business may be materially harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Depending upon the timing, duration and conditions of any FDA marketing approval of our product candidates, one or more of our U.S. patents may be eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Act of 1984, referred to as the Hatch-Waxman Amendments, and similar legislation in the European Union. The Hatch-Waxman Amendments permit a patent term extension of up to five years for a patent covering an approved product as compensation for effective patent term lost during product development and the FDA regulatory review process. However, we may not receive an extension if we fail to exercise due diligence during the testing phase or regulatory review process, fail to apply within applicable deadlines, fail to apply prior to expiration of relevant patents or otherwise fail to satisfy applicable requirements. Moreover, the length of the extension could be less than we request. Only one patent per approved product can be extended, the extension cannot extend the total patent term beyond 14 years from approval and only those claims covering the approved drug, a method for using it or a method for manufacturing it may be extended. If we are unable to obtain patent term extension or the term of any such extension is less than we request, the period during which we can enforce our patent rights for the applicable product candidate will be shortened and our competitors may obtain approval to market competing products sooner. As a result, our revenue from applicable products could be reduced. Further, if this occurs, our competitors may take advantage of our investment in development and trials by referencing our clinical and preclinical data and launch their product earlier than might otherwise be the case, and our competitive position, business, financial condition, results of operations, and prospects could be materially harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">91</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Third parties may assert that our employees or consultants have wrongfully used or disclosed confidential information or misappropriated trade secrets.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We employ individuals who were previously employed at universities or other biopharmaceutical companies, including our competitors or potential competitors. Although we try to ensure that our employees and consultants do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we or our employees, consultants or independent contractors have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other proprietary information, of a former employer or other third parties. We may also be subject to claims that patents and applications that we may file to protect inventions of our employees or consultants are rightfully owned by their former employers or other third parties. Litigation may be necessary to defend against these claims. If we fail in defending any such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel. Even if we are successful in defending against such claims, litigation could result in substantial costs and be a distraction to management and other employees. Any of the foregoing would harm our business, financial condition, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest and our business may be adversely affected.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our registered or unregistered trademarks or trade names may be challenged, infringed, circumvented or declared generic or determined to be infringing on other marks. We may not be able to protect our rights to these trademarks and trade names, which we need to build name recognition among potential partners or customers in our markets of interest. At times, competitors or other third parties may adopt trade names or trademarks similar to ours, thereby impeding our ability to build brand identity and possibly leading to market confusion. In addition, there could be potential trade name or trademark infringement claims brought by owners of other registered trademarks or trademarks that incorporate variations of our registered or unregistered trademarks or trade names. Over the long term, if we are unable to establish name recognition based on our trademarks and trade names, then we may not be able to compete effectively and our business may be adversely affected. Our efforts to enforce or protect our proprietary rights related to trademarks, trade secrets, domain names, copyrights or other intellectual property may be ineffective and could result in substantial costs and diversion of resources and could adversely affect our business, financial condition, results of operations and growth prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Intellectual property rights do not necessarily address all potential threats.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The degree of future protection afforded by our intellectual property rights is uncertain because intellectual property rights have limitations and may not adequately protect our business or permit us to maintain our competitive advantage. For example:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our product candidates may eventually become available in generic or biosimilar product forms; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">others may be able to make products that are similar to our product candidates or utilize similar technology but that are not covered by the claims of the patents that we license or own; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we, or our current or future licensors might not have been the first to make the inventions covered by the issued patent or pending patent application that we license or own; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we, or our current or future licensors might not have been the first to file patent applications covering certain of our or their inventions; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we, or our license partners or current or future collaborators, may fail to meet our obligations to the U.S. government regarding any in-licensed patents and patent applications funded by U.S. government grants, leading to the loss or unenforceability of patent rights; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">others may independently develop similar or alternative technologies or duplicate any of our technologies without infringing our owned or licensed intellectual property rights; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">it is possible that our pending, owned or licensed patent applications or those that we may own in the future will not lead to issued patents; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">it is possible that there are prior public disclosures that could invalidate our owned or in-licensed patents, or parts of our owned or in-licensed patents; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">92</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">it is possible that there are unpublished applications or patent applications maintained in secrecy that may later issue with claims covering our product candidates or technology similar to ours; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">it is possible that our owned or in-licensed patents or patent applications omit individual(s) that should be listed as inventor(s) or include individual(s) that should not be listed as inventor(s), which may cause these patents or patents issuing from these patent applications to be held invalid or unenforceable; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">it is possible that our pending owned or licensed patent applications or those that we may own or license in the future will not lead to issued patents; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">issued patents that we hold rights to may be held invalid or unenforceable, including as a result of legal challenges by our competitors; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the claims of our owned or in-licensed issued patents or patent applications, if and when issued, may not cover our product candidates; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the laws of foreign countries may not protect our proprietary rights or the proprietary rights of license partners or current or future collaborators to the same extent as the laws of the United States; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the inventors of our owned or in-licensed patents or patent applications may become involved with competitors, develop products or processes that design around our patents or become hostile to us or the patents or patent applications on which they are named as inventors; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our competitors might conduct research and development activities in countries where we do not have patent rights and then use the information learned from such activities to develop competitive products for sale in our major commercial markets; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we have engaged in scientific collaborations in the past and will continue to do so in the future and our collaborators may develop adjacent or competing products that are outside the scope of our patents; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may not develop additional proprietary technologies that are patentable; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any product candidates we develop may be covered by third parties&#x2019; patents or other exclusive rights; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the patents of others may harm our business; and </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we may choose not to file a patent in order to maintain certain trade secrets or know-how, and a third party may subsequently file a patent covering such intellectual property. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Should any of these events occur, they could harm our business, financial condition, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to Regulatory and Other Legal Compliance Matters</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Failure to obtain marketing approval in foreign jurisdictions would prevent product candidates from being marketed in such jurisdictions, which, in turn, would materially impair our ability to generate revenue.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In order to market and sell product candidates in the European Union and other foreign jurisdictions, we or our third-party collaborators must obtain separate marketing approvals (a single one for the European Union) and comply with numerous and varying regulatory requirements. The approval procedure varies among countries and can involve additional testing. The time required to obtain approval may differ substantially from that required to obtain FDA approval. The regulatory approval process outside the United States generally includes all of the risks associated with obtaining FDA approval. In addition, in many countries outside the United States, it is required that the product candidate be approved for reimbursement before the product candidate can be approved for sale in that country. We or these third parties may not obtain approvals from regulatory authorities outside the United States on a timely basis, if at all. Approval by the FDA does not ensure approval by regulatory authorities in other countries or jurisdictions, and approval by one regulatory authority outside the United States does not ensure approval by regulatory authorities in other countries or jurisdictions or by the FDA. We may not be able to file for marketing approvals and may not receive necessary approvals to commercialize our products in any jurisdiction, which would materially impair our ability to generate revenue.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Even if we, or any collaborators we may have, obtain marketing approvals for our product candidates, the terms of approvals and ongoing regulation of our product candidates could require the substantial expenditure of</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">93</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">resources and may limit how we, or they, manufacture and market our product candidates, which could materially impair our ability to generate revenue.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any product candidate for which we obtain marketing approval, along with the manufacturing processes, post-approval clinical data, labeling, advertising and promotional activities for such product, will be subject to continual requirements of and review by the FDA, EMA, the Competent Authorities of the Member States of the European Union and other regulatory authorities. These requirements include submissions of safety and other post-marketing information and reports, facility registration and drug listing requirements, cGMP requirements relating to quality control, quality assurance and corresponding maintenance of records and documents, and requirements regarding the distribution of samples to physicians and recordkeeping. Even if marketing approval of a product candidate is granted, the approval may be subject to limitations on the indicated uses for which the product may be marketed or to the conditions of approval, or contain requirements for costly post-marketing testing and surveillance to monitor the safety or efficacy of the product. The FDA and other regulatory authorities may restrict the use of our products to certain specialists and/or institutions and require formal reporting and approval of a REMS program. Such restrictions or requirements could deter use of our products by certain individuals or institutions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accordingly, assuming we, or any of our collaborators, receive marketing approval for one or more product candidates, we, such collaborators and our and their contract manufacturers will continue to expend time, money, and effort in all areas of regulatory compliance, including manufacturing, production, product surveillance and quality control. If we and such collaborators are not able to comply with post-approval regulatory requirements, we and such collaborators could have the marketing approvals for our products withdrawn by regulatory authorities and our, or such collaborators&#x2019;, ability to market any future products could be limited, which could adversely affect our ability to achieve or sustain profitability. Further, the cost of compliance with post-approval regulations may have a negative effect on our business, operating results, financial condition and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Any product candidate for which we obtain marketing approval could be subject to restrictions or withdrawal from the market, and we may be subject to substantial penalties if we fail to comply with regulatory requirements or if we experience unanticipated problems with our products, when and if any of them are approved.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The FDA, the EMA, the Competent Authorities of the Member States of the European Union and other regulatory agencies closely regulate the post-approval marketing and promotion of products to ensure that they are marketed only for the approved indications and in accordance with the provisions of the approved labeling. The FDA, the Competent Authorities of the Member States of the European Union and other regulatory agencies impose stringent restrictions on manufacturers&#x2019; communications regarding off-label use, and if we market our products for off-label use, we may be subject to enforcement action for off-label marketing by the FDA and other federal and state enforcement agencies, including the Department of Justice. While physicians may prescribe products for off-label uses as the FDA and other U.S. regulatory agencies do not regulate a physician&#x2019;s choice of drug treatment made in the physician&#x2019;s independent medical judgment, they do restrict promotional communications from companies or their sales force with respect to off-label uses of products for which marketing clearance has not been issued. Companies may only share truthful and not misleading information that is otherwise consistent with a product&#x2019;s FDA approved labeling. Violation of the Federal Food, Product, and Cosmetic Act and other statutes, including the False Claims Act and equivalent legislation in other countries relating to the promotion and advertising of prescription products may also lead to investigations or allegations of violations of federal and state and other countries&#x2019; health care fraud and abuse laws and state consumer protection laws. Even if it is later determined we were not in violation of these laws, we may be faced with negative publicity, incur significant expenses defending our actions and have to divert significant management resources from other matters.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, later discovery of previously unknown problems with our products, manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may yield various negative consequences, including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">restrictions on such products, manufacturers or manufacturing processes; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">restrictions on the labeling or marketing of a product; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">restrictions on the distribution or use of a product; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">requirements to conduct post-marketing clinical trials; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">receipt of warning or untitled letters; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">94</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">withdrawal of the products from the market; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">refusal to approve pending applications or supplements to approved applications that we submit; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">recall of products; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">fines, restitution or disgorgement of profits or revenue; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">restrictions on future procurements with governmental authorities; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">suspension or withdrawal of marketing approvals; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">suspension of any ongoing clinical trials; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">refusal to permit the import or export of our products; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">product seizure; and </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">injunctions or the imposition of civil or criminal penalties. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any government investigation of alleged violations of law could require us to expend significant time and resources in response and could generate negative publicity. The occurrence of any event or penalty described above may inhibit our ability to commercialize any of our product candidates, if approved, and adversely affect our business, financial condition, results of operations and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We expect the product candidates we develop will be regulated as biologics, and therefore they may be subject to competition sooner than anticipated.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Biologics Price Competition and Innovation Act of 2009 (the &#x201c;BPCIA&#x201d;), was enacted as part of the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act (collectively, the &#x201c;ACA&#x201d;) to establish an abbreviated pathway for the approval of biosimilar and interchangeable biological products. The regulatory pathway establishes legal authority for the FDA to review and approve biosimilar biologics, including the possible designation of a biosimilar as &#x201c;interchangeable&#x201d; based on its similarity to an approved biologic. Under the BPCIA, an application for a biosimilar product cannot be approved by the FDA until 12 years after the reference product was approved under a BLA. The law is complex and is still being interpreted and implemented by the FDA. As a result, its ultimate impact, implementation, and meaning are subject to uncertainty. While it is uncertain when processes intended to implement the BPCIA may be fully adopted by the FDA, any of these processes could have a material adverse effect on the future commercial prospects for our biological products.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe that any of the product candidates we develop that is approved in the United States as a biological product under a BLA should qualify for the 12-year period of exclusivity. However, there is a risk that this exclusivity could be shortened due to congressional action or otherwise, or that the FDA will not consider the subject product candidates to be reference products for competing products, potentially creating the opportunity for generic competition sooner than anticipated. Moreover, the extent to which a biosimilar, once approved, will be substituted for any one of the reference products in a way that is similar to traditional generic substitution for non-biological products is not yet clear, and will depend on a number of marketplace and regulatory factors that are still developing.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, the approval of a biologic product biosimilar to one of our products could have a material adverse impact on our business as it may be significantly less costly to bring to market and may be priced significantly lower than our products.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Disruptions at the FDA and other government agencies caused by funding shortages or global health concerns could hinder their ability to hire, retain or deploy key leadership and other personnel, or otherwise prevent new or modified products from being developed, approved or commercialized in a timely manner or at all, which could negatively impact our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The ability of the FDA to review and approve new products can be affected by a variety of factors, including government budget and funding levels, statutory, regulatory, and policy changes, the FDA&#x2019;s ability to hire and retain key personnel and accept the payment of user fees, and other events that may otherwise affect the FDA&#x2019;s ability to perform routine functions. Average review times at the agency have fluctuated in recent years as a result. In addition, government funding of other government agencies that fund research and development activities is subject</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">95</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">to the political process, which is inherently fluid and unpredictable. Disruptions at the FDA and other agencies may also slow the time necessary for new biologics or modifications to cleared or approved biologics to be reviewed and/or approved by necessary government agencies, which would adversely affect our business. For example, over the last several years, including for 35 days beginning on December 22, 2018, the U.S. government has shut down several times and certain regulatory agencies, such as the FDA, have had to furlough critical FDA employees and stop critical activities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Separately, in response to the COVID-19 pandemic, in March 2020 the FDA announced its intention to postpone most inspections of foreign manufacturing facilities and in July 2020 the FDA resumed certain on-site inspections of domestic manufacturing facilities subject to a risk-based prioritization system. The FDA intends to use this risk-based assessment system to identify the categories of regulatory activity that can occur within a given geographic area, ranging from mission critical inspections to resumption of all regulatory activities. Regulatory authorities outside the United States may adopt similar restrictions or other policy measures in response to the COVID-19 pandemic. If a prolonged government shutdown occurs, or if global health concerns continue to prevent the FDA or other regulatory authorities from conducting their regular inspections, reviews, or other regulatory activities, it could significantly impact the ability of the FDA or other regulatory authorities to timely review and process our regulatory submissions, which could have a material adverse effect on our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our relationships with healthcare providers, including physicians, and third-party payors will be subject to applicable anti-kickback, fraud and abuse, anti-bribery and other healthcare laws and regulations, which could expose us to criminal sanctions, civil penalties, contractual damages, reputational harm and diminished profits and future earnings.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Healthcare providers and third-party payors play a primary role in the recommendation and prescription of any product candidates for which we obtain marketing approval. Our current and future arrangements with healthcare providers, third-party payors and customers may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations that may constrain the business or financial arrangements and relationships through which we research as well as market, sell and distribute our products for which we obtain marketing approval. Restrictions under applicable federal and state healthcare laws and regulations, including certain laws and regulations applicable only if we have marketed products, include, but are not limited to, the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the federal healthcare program Anti-Kickback Statute, which prohibits, among other things, persons or entities from knowingly and willfully soliciting, receiving, offering, or providing any remuneration (including any kickback, bribe or certain rebates), directly or indirectly, in cash or in kind, to induce, or in return for, either the referral of an individual for, or the purchase, lease, order or recommendation of any item, good, facility, or service for which payment may be made, in whole or in part, under federal healthcare programs such as Medicare and Medicaid. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">federal false claims, including the False Claims Act that can be enforced through whistleblower actions, false statements and civil monetary penalties laws, which prohibit, among other things, any person or entity from knowingly presenting, or causing to be presented, a false or fraudulent claim for payment of government funds or knowingly making, or causing to be made, a false record or statement material to a false or fraudulent claim to get a false claim paid or to avoid, decrease, or conceal an obligation to pay money to the federal government. In addition, the government may assert that a claim including items and services resulting from a violation of the U.S. federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the False Claims Act; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the federal Health Insurance Portability and Accountability Act of 1996 (&#x201c;HIPAA&#x201d;), which, prohibits, among other things, executing, or attempting to execute, a scheme to defraud any healthcare benefit program or making false, fictitious, or fraudulent statements in connection with the delivery of, or payment for, healthcare benefits, items or services relating to healthcare matters. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act (&#x201c;HITECH&#x201d;), and their implementing regulations, also imposes obligations, including mandatory contractual terms, certain covered healthcare providers, health plans, and healthcare clearinghouses and their respective business associates and covered subcontractors that perform services for them that </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">96</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;visibility:hidden;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;"></span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">involve the use, or disclosure of, individually identifiable health information with respect to safeguarding the privacy, security and transmission of individually identifiable health information;</span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the federal Food, Drug, and Cosmetic Act, which among other things, strictly regulates drug marketing, prohibits manufacturers from marketing such products for off-label use and regulates the distribution of samples; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">federal laws that require pharmaceutical manufacturers to report certain calculated product prices to the government or provide certain discounts or rebates to government authorities or private entities, often as a condition of reimbursement under government healthcare programs; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the federal Physician Payments Sunshine Act, which requires certain manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid, or the Children&#x2019;s Health Insurance Program (with certain exceptions) to report annually to CMS within the U.S. Department of Health and Human Services, information related to payments or other transfers of value made during the previous year to physicians (defined to include doctors, dentists, optometrists, podiatrists and chiropractors), other healthcare professionals (such as physician assistants and nurse practitioners) and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members; and </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">analogous state and foreign laws and regulations, such as state anti-kickback and false claims laws, which may be broader in scope and apply to healthcare items or services that are reimbursed by non-governmental third-party payors, including private insurers. </span></div></div>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Some state laws also require pharmaceutical companies to comply with specific compliance standards, restrict financial interactions between pharmaceutical companies and healthcare providers or require pharmaceutical companies to report information related to payments to health care providers or marketing expenditures. Certain state laws also require the reporting of information related to drug pricing. Further, certain state and local laws require the registration of pharmaceutical sales representatives.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Efforts to ensure that our business arrangements with third parties will comply with applicable healthcare laws and regulations will involve substantial costs. Given the breadth of the laws and regulations and evolving government interpretations of the laws and regulations, governmental authorities may possibly conclude that our business practices, including certain of our advisory board arrangements with physicians, some of whom are compensated in the form of stock or stock options, may not comply with healthcare laws and regulations. If our operations are found to be in violation of any of the laws described above or any other government regulations that apply to us, we may be subject to significant penalties, including administrative, civil and criminal penalties, damages, fines, disgorgement, exclusion from participation in government health care programs, such as Medicare and Medicaid, imprisonment, integrity oversight and reporting obligations, contractual damages, reputational harm, diminished profits and future earnings, and the curtailment or restructuring of our operations, any of which could adversely affect our business, financial condition, results of operations, and prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The European Union has strict laws governing the provision of benefits or advantages to healthcare professionals in order to induce or encourage the prescription, recommendation, endorsement, purchase, supply, order, or use of medicinal products. Such laws and associated codes of practice set out the rules and requirements that the provision of hospitality, sponsorship, gifts and promotional items must meet before they can be accepted by healthcare professionals. The provision of benefits or advantages to healthcare professionals is also governed by the national anti-bribery laws of European Union Member States. Infringement of these laws could result in substantial fines and imprisonment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Payments made to healthcare professionals in certain European Union Member States may be publicly disclosed. Moreover, agreements with healthcare professionals often must be the subject of prior notification and approval by the healthcare professionals&#x2019; employer, his or her competent professional organization, and/or the regulatory authorities of the individual European Union Member States. These requirements are provided in the national laws, industry codes, or professional codes of conduct applicable in the European Union Member States. Failure to comply with these requirements could result in reputational risk, public reprimands, administrative penalties, fines or imprisonment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">97</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Healthcare and other reform legislation, may increase the difficulty and cost for us and any collaborators we may have to obtain marketing approval of and commercialize our product candidates, if approved, and affect the prices we, or they, may obtain.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the United States and some foreign jurisdictions, there have been and continue to be ongoing efforts to implement legislative and regulatory changes regarding the healthcare system. Such changes could prevent or delay marketing approval of our product candidates, restrict or regulate post-approval activities and affect our ability to profitably sell any product candidates for which we obtain marketing approval. Although we cannot predict what healthcare or other reform efforts will be successful, such efforts may result in more rigorous coverage criteria, in additional downward pressure on the price that we, or our future collaborators, may receive for any approved products or in other consequences that may adversely affect our ability to achieve or maintain profitability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Within</span><span style="background-color:rgba(0,0,0,0);color:rgba(255,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the United States, the federal government and individual states have aggressively pursued healthcare reform, as evidenced by the passing of the ACA. The ACA substantially changed the way healthcare is financed by both governmental and private insurers and contains a number of provisions that affect coverage and reimbursement of drug products and/or that could potentially reduce the demand for pharmaceutical products such as increasing drug rebates under state Medicaid programs for brand name prescription drugs and extending those rebates to Medicaid managed care and assessing a fee on manufacturers and importers of brand name prescription drugs reimbursed under certain government programs, including Medicare and Medicaid. Other aspects of healthcare reform, such as expanded government enforcement authority and heightened standards that could increase compliance-related costs, could also affect our business. There have been executive, judicial and Congressional challenges, to certain aspects of the ACA. For example, on June 17, 2021, the United States Supreme Court dismissed a challenge on procedural grounds that argued the ACA is unconstitutional in its entirety because the &#x201c;individual mandate&#x201d; was repealed by Congress. Thus, the ACA will remain in effect in its current form. It is possible that the ACA will be subject to judicial or Congressional challenges in the future. We cannot predict the ultimate content, timing or effect of any such challenges or changes to the ACA or other federal and state reform efforts. There is no assurance that federal or state health care reform will not adversely affect our future business and financial results, and we cannot predict how future federal or state legislative, judicial or administrative changes relating to healthcare reform will affect our business. For a more detailed discussion of U.S. healthcare reforms that may affect our business, see &#x201c;Business&#x2014;Healthcare Reform&#x201d; in Part I, Item 1 of this Annual Report.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Federal and state governments have shown significant interest in implementing cost-containment programs to limit the growth of government-paid healthcare costs, including price controls, waivers from Medicaid drug rebate law requirements, restrictions on reimbursement and requirements for substitution of generic products for branded prescription drugs. The private sector has also sought to control healthcare costs by limiting coverage or reimbursement or requiring discounts and rebates on products. We are unable to predict what additional legislation, regulations or policies, if any, relating to the healthcare industry or third party coverage and reimbursement may be enacted in the future or what effect such legislation, regulations or policies would have on our business. Any cost containment measures could significantly decrease the available coverage and the price we might establish for our potential products, which would have an adverse effect on our net revenues and operating results.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Legislative and regulatory proposals have been made to expand post-approval requirements and restrict sales and promotional activities for biotechnology products. We cannot be sure whether additional legislative changes will be enacted, or whether FDA regulations, guidance or interpretations for biological products will be changed, or what the impact of such changes on the marketing approvals of our product candidates, if any, may be.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our employees, principal investigators, consultants and commercial partners may engage in misconduct or other improper activities, including non-compliance with regulatory standards and requirements and insider trading.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are exposed to the risk of fraud or other misconduct by our employees, consultants and commercial partners, and, if we commence clinical trials, our principal investigators. Misconduct by these parties could include intentional failures to comply with FDA regulations or the regulations applicable in the European Union and other jurisdictions, provide accurate information to the FDA, the EMA and other regulatory authorities, comply with healthcare fraud and abuse laws and regulations in the United States and abroad, report financial information or data accurately or disclose unauthorized activities to us. In particular, sales, marketing and business arrangements in the healthcare industry are subject to extensive laws and regulations intended to prevent fraud, misconduct, kickbacks, self-dealing and other abusive practices. These laws and regulations restrict or prohibit a wide range of pricing, discounting, marketing and promotion, sales commission, customer incentive programs and other business arrangements. Such misconduct also could involve the improper use of information obtained in the course of clinical</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">98</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">trials or interactions with the FDA, the EMA or other regulatory authorities, which could result in regulatory sanctions and cause serious harm to our reputation. We have adopted a code of conduct applicable to all of our employees, but it is not always possible to identify and deter employee misconduct, and the precautions we take to detect and prevent this activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from government investigations or other actions or lawsuits stemming from a failure to comply with these laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a significant impact on our business, financial condition, results of operations, and prospects, including the imposition of significant fines or other sanctions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Laws and regulations governing any international operations we may have in the future may preclude us from developing, manufacturing and selling certain product candidates outside of the United States and require us to develop and implement costly compliance programs.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may be subject to numerous laws and regulations in each jurisdiction outside the United States in which we may operate. The creation, implementation and maintenance of international business practices compliance programs is costly and such programs are difficult to enforce, particularly where reliance on third parties is required.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Foreign Corrupt Practices Act (the &#x201c;FCPA&#x201d;) prohibits any U.S. individual or business from paying, offering, authorizing payment or offering of anything of value, directly or indirectly, to any foreign official, political party or candidate for the purpose of influencing any act or decision of the foreign entity in order to assist the individual or business in obtaining or retaining business. The FCPA also obligates companies whose securities are listed in the United States to comply with certain accounting provisions requiring the company to maintain books and records that accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an adequate system of internal accounting controls for international operations. The anti-bribery provisions of the FCPA are enforced primarily by the Department of Justice. The SEC is involved with enforcement of the books and records provisions of the FCPA.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Similarly, the U.K. Bribery Act 2010 has extra-territorial effect for companies and individuals having a connection with the United Kingdom. The U.K. Bribery Act prohibits inducements both to public officials and private individuals and organizations. Compliance with the FCPA and the U.K. Bribery Act is expensive and difficult, particularly in countries in which corruption is a recognized problem. In addition, the FCPA presents particular challenges in the pharmaceutical industry, because, in many countries, hospitals are operated by the government, and doctors and other hospital employees are considered foreign officials. Certain payments to hospitals in connection with clinical trials and other work have been deemed to be improper payments to government officials and have led to FCPA enforcement actions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Various laws, regulations and executive orders also restrict the use and dissemination outside of the United States, or the sharing with certain non-U.S. nationals, of information classified for national security purposes, as well as certain products and technical data relating to those products. Our expansion outside of the United States has required, and will continue to require, us to dedicate additional resources to comply with these laws, and these laws may preclude us from developing, manufacturing or selling certain product candidates outside of the United States, which could limit our growth potential and increase our development costs. The failure to comply with laws governing international business practices may result in substantial penalties, including suspension or debarment from government contracting. Violation of the FCPA can result in significant civil and criminal penalties. Indictment alone under the FCPA can lead to suspension of the right to do business with the U.S. government until the pending claims are resolved. Conviction of a violation of the FCPA can result in long-term disqualification as a government contractor. The termination of a government contract or relationship as a result of our failure to satisfy any of our obligations under laws governing international business practices would have a negative impact on our operations and harm our reputation and ability to procure government contracts. The SEC also may suspend or bar issuers from trading securities on U.S. exchanges for violations of the FCPA&#x2019;s accounting provisions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We or our partners may be subject to stringent privacy laws, information security laws, regulations, policies and contractual obligations related to data privacy and security and changes in such laws, regulations, policies or how they are interpreted or changes in contractual obligations could adversely affect our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There are numerous U.S. federal and state data privacy and protection laws and regulations that apply to the collection, transmission, processing, storage and use of personally-identifying information, which among other things, impose certain requirements relating to the privacy, security and transmission of personal information. The legislative and regulatory landscape for privacy and data protection continues to evolve in jurisdictions worldwide,</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">99</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">and there has been an increasing focus on privacy and data protection issues with the potential to affect our business. Failure to comply with any of these laws and regulations could result in enforcement action against us, including fines, imprisonment of company officials and public censure, claims for damages by affected individuals, damage to our reputation and loss of goodwill, any of which could have a material adverse effect on our business, financial condition, results of operations or prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we are unable to properly protect the privacy and security of health-related information or other sensitive or confidential information in our possession, we could be found to have breached our contracts. Further, if we fail to comply with applicable privacy laws, including applicable HIPAA privacy and security standards, we could face significant administrative, civil and criminal penalties. Enforcement activity can also result in financial liability and reputational harm, and responses to such enforcement activity can consume significant internal resources. In addition, state attorneys general are authorized to bring civil actions seeking either injunctions or damages in response to violations that threaten the privacy of state residents. In addition to the risks associated with enforcement activities and potential contractual liabilities, our ongoing efforts to comply with evolving laws and regulations at the federal and state level may be costly and require ongoing modifications to our policies, procedures and systems.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to COVID-19, Employee Matters, Managing Growth and Information Technology</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The COVID-19 pandemic has caused, and could continue to cause, severe disruptions in the U.S., regional and global economies and could seriously harm our development efforts, increase our costs and expenses and have a material adverse effect on our business, financial condition and results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The COVID-19 pandemic has caused widespread disruptions to the U.S. and global economy and has contributed to significant volatility and negative pressure in financial markets. The global impact of the pandemic is continually evolving and, as additional cases of the virus, and variants thereof, are identified, many countries, including the United States, have reacted by instituting quarantines, restrictions on travel and mandatory closures of businesses. Certain states and cities, including where we or the third parties with whom we engage operate, have also reacted by instituting quarantines, restrictions on travel, &#x201c;stay at home&#x201d; rules, restrictions on types of business that may continue to operate and restrictions on the types of construction projects that may continue.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The extent to which the COVID-19 pandemic impacts our business, financial condition and results of operations will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the scope, severity and duration of such pandemic, the actions taken to contain the pandemic or mitigate its impact, as well as the effect of any relaxation of current restrictions within the communities or regions in which we, our partners and proposed clinical sites are located, and the direct and indirect economic effects of the pandemic and containment measures, among others. The rapid development and fluidity of this situation precludes any prediction as to the full adverse impact of the COVID-19 pandemic. Nevertheless, the COVID-19 pandemic has adversely affected, and may continue to adversely affect, our business, financial condition and results of operations, and it has had, and may continue to have, the effect of heightening many of the risks described in these Risk Factors, including but not limited to, the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The COVID-19 pandemic has had, and will likely continue to have, an adverse impact on various aspects of our planned or ongoing preclinical studies and clinical trials. For example, we have experienced delays in the activation and readiness of clinical sites for our VOR33 Phase 1/2a clinical trial in part due to COVID-19 pandemic that have resulted in enrollment delays. Additionally, we may experience additional delays in clinical trials, investigators may be deployed to care for COVID-19 patients, IRBs may be backlogged with clinical trials related to the pandemic, patients may defer receiving HSCT, HSCT-donors may be less available to travel for stem cell mobilizations, hospital beds and resources normally dedicated to cancer patients may be redeployed to treat COVID-19 patients and there may be disruption in the supply of critical agents (such as Mylotarg) or other supportive care agents needed for our clinical trials or for HSCT. </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other potential impacts of the COVID-19 pandemic on our clinical trials include impacts on patient dosing and study monitoring, which may be paused or delayed due to changes in policies at various clinical sites; federal, state, local or foreign laws, rules and regulations, including quarantines or other travel restrictions; the prioritization of healthcare resources toward pandemic efforts, including diminished attention from physicians serving as our clinical trial investigators and reduced availability of site staff supporting the conduct of our clinical trials; and interruption or delays in the operations of the FDA, among other reasons related to the COVID-19 pandemic. If the COVID-19 pandemic continues, </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">100</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;visibility:hidden;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;"></span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">other aspects of our clinical trial will likely be adversely affected, delayed or interrupted, including, for example, site initiation, patient recruitment and enrollment, availability of clinical trial materials and data analysis. Some patients and clinical investigators may not be able to comply with clinical trial protocols and patients may choose to withdraw from our trials once initiated or we may choose to, or be required to, pause enrollment and or patient dosing in our clinical trials in order to preserve health resources and protect trial participants. It is unknown how long these pauses or disruptions would continue if they occur.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We currently rely on or expect to rely on third parties, including CROs, contract manufacturing organizations and other contractors and consultants to, among other things, conduct our preclinical studies and clinical trials, manufacture raw materials, manufacture and supply our product candidates, perform quality testing and supply other goods and services to run our business. If any such third party is adversely impacted by restrictions resulting from the COVID-19 pandemic, including staffing shortages, production slowdowns, disruptions in delivery systems or the ongoing global supply chain issues, our supply chain may be disrupted, which could limit our ability to manufacture our product candidates for our clinical trials and conduct our research and development operations. </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have in the past, and may again in the future, be required to establish a work-from-home policy for employees. Any increased reliance on personnel working from home may negatively impact productivity, or disrupt, delay or otherwise adversely impact our business, which includes research and development work that is dependent on a laboratory. In addition, this could increase our cyber security risk, create data accessibility concerns and make us more susceptible to communication disruptions, any of which could adversely impact our business operations or delay necessary interactions with local and federal regulators, ethics committees, manufacturing sites, research or clinical trial sites and other important agencies and contractors. </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our employees and contractors conducting non-business critical research and development activities may not in the future be able to, access our laboratory for an extended period of time as a result of work-from-home policies and the possibility that governmental authorities further modify current restrictions. This could delay timely completion of preclinical activities, including completing IND enabling studies or our ability to select future development candidates, and ongoing clinical trials for our other product candidates. </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Certain government agencies, such as health regulatory agencies and patent offices, within the United States or internationally have experienced, and may continue to experience, disruptions in their operations as a result of the COVID-19 pandemic. The FDA and comparable foreign regulatory agencies may have slower response times or be under-resourced to continue to monitor our clinical trials and, as a result, review, inspection and other timelines may be materially delayed. FDA has experienced delays in on-site inspections and this could have an impact on the timing for clearance and approvals of BLAs. Health Canada has extended their reviews of clinical trial applications due to resource issues during the pandemic and similar increases in review times of INDs by FDA could occur. Also, the ability of health authorities to meet with us and other companies involved in our research and clinical development activities may be delayed or otherwise adversely affected. It is unknown how long these disruptions could continue. Any elongation or de-prioritization of our clinical trials or delay in regulatory review resulting from such disruptions could materially adversely affect the development and study of our product candidates. For example, regulatory authorities may require that we not distribute a product candidate lot until the relevant agency authorizes its release. Such release authorization may be delayed as a result of the COVID-19 pandemic, which would likely result in delays to our ongoing clinical trials. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our future success depends on our ability to retain our Chief Executive Officer and other key executives and to attract, retain and motivate qualified personnel.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are highly dependent on Robert Ang, MBBS, MBA, our Chief Executive Officer, as well as the other principal members of our management and scientific teams. Dr. Ang and such other principal members are employed &#x201c;at will,&#x201d; meaning we or they may terminate the employment at any time. We do not maintain &#x201c;key person&#x201d; insurance for any of our executives or other employees. The loss of the services of any of these persons could impede the achievement of our research, development and commercialization objectives.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Recruiting and retaining qualified scientific and clinical personnel and, if we progress the development of our product candidates toward scaling up for commercialization, manufacturing and sales and marketing personnel</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">101</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">will also be critical to our success. We may not be able to attract and retain these personnel on acceptable terms given the competition among numerous pharmaceutical and biotechnology companies for similar personnel. We also experience competition for the hiring of scientific and clinical personnel from universities and research institutions. In addition, we rely on consultants and advisors, including scientific and clinical advisors, to assist us in formulating our research and development and commercialization strategy. Our consultants and advisors, including our scientific founder, may be employed by employers other than us and may have commitments under consulting or advisory contracts with other entities that may limit their availability to us. The inability to recruit, or loss of services of certain executives, key employees, consultants or advisors, may impede the progress of our research, development and commercialization objectives and have a material adverse effect on our business, financial condition, results of operations and prospects.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We expect to expand our development, regulatory and future sales and marketing capabilities, and as a result, we may encounter difficulties in managing our growth, which could disrupt our operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In connection with the growth and advancement of our pipeline and having become a public company, we expect to increase the number of our employees and the scope of our operations, particularly in the areas of drug development, regulatory affairs, manufacturing and, as our product candidates advance through later stages of clinical development, sales and marketing. To manage our anticipated future growth, we must continue to implement and improve our managerial, operational and financial systems, expand our facilities and continue to recruit and train additional qualified personnel. Due to our limited financial resources and the limited experience of our management team in managing a company with such anticipated growth, we may not be able to effectively manage the expected expansion of our operations or recruit and train additional qualified personnel. Moreover, the expected physical expansion of our operations may lead to significant costs and may divert our management and business development resources. Any inability to manage growth could delay the execution of our business plans or disrupt our operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As a growing biotechnology company, we are actively pursuing new platforms and product candidates in many therapeutic areas and across a wide range of diseases. Successfully developing product candidates for and fully understanding the regulatory and manufacturing pathways to all of these therapeutic areas and disease states requires a significant depth of talent, resources and corporate processes in order to allow simultaneous execution across multiple areas. Due to our limited resources, we may not be able to effectively manage this simultaneous execution and the expansion of our operations or recruit and train additional qualified personnel. This may result in weaknesses in our infrastructure, give rise to operational mistakes, legal or regulatory compliance failures, loss of business opportunities, loss of employees and reduced productivity among remaining employees. The physical expansion of our operations may lead to significant costs and may divert financial resources from other projects, such as the development of our product candidates. For example, in June 2021 we entered into amendments to our Cambridgepark lease to expand our office, laboratory and manufacturing space from approximately 33,000 square feet to approximately 73,000 square feet and we have only just begun occupying some of that space in the first quarter of 2022. If our management is unable to effectively manage our expected development and expansion, our expenses may increase more than expected, our ability to generate or increase our revenue could be reduced and we may not be able to implement our business strategy. Our future financial performance and our ability to compete effectively and commercialize our product candidates, if approved, will depend in part on our ability to effectively manage the future development and expansion of our company.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our insurance policies may be inadequate and potentially expose us to unrecoverable risks.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have limited director and officer insurance and commercial insurance policies. Any significant insurance claims would have a material adverse effect on our business, financial condition and results of operations. Insurance availability, coverage terms and pricing continue to vary with market conditions. We endeavor to obtain appropriate insurance coverage for insurable risks that we identify; however, we may fail to correctly anticipate or quantify insurable risks, we may not be able to obtain appropriate insurance coverage, and insurers may not respond as we intend to cover insurable events that may occur. We have observed rapidly changing conditions in the insurance markets relating to nearly all areas of traditional corporate insurance. Such conditions have resulted in higher premium costs, higher policy deductibles and lower coverage limits. For some risks, we may not have or maintain insurance coverage because of cost or availability.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our internal computer systems, or those of our third-party vendors, collaborators or other contractors or consultants, may fail or suffer security breaches, which could result in a material disruption of our product</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">102</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">development programs, compromise sensitive information related to our business or prevent us from accessing critical information, potentially exposing us to liability or otherwise adversely affecting our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our internal computer systems and those of our current and any future third-party vendors, collaborators and other contractors or consultants are subject to damage or interruption from computer viruses, computer hackers, malicious code, employee theft or misuse, denial-of-service attacks, sophisticated nation-state and nation-state-supported actors, unauthorized access, natural disasters, terrorism, war and telecommunication and electrical failures. While we seek to protect our information technology systems from system failure, accident and security breach, if such an event were to occur and cause interruptions in our operations, it could result in a disruption of our development programs and our business operations, whether due to a loss of our trade secrets or other proprietary information or other disruptions. For example, the loss of clinical trial data from future clinical trials could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. If we were to experience a significant cybersecurity breach of our information systems or data, the costs associated with the investigation, remediation and potential notification of the breach to counter-parties and data subjects could be material. In addition, our remediation efforts may not be successful. If we do not allocate and effectively manage the resources necessary to build and sustain the proper technology and cybersecurity infrastructure, we could suffer significant business disruption, including transaction errors, supply chain or manufacturing interruptions, processing inefficiencies, data loss or the loss of or damage to intellectual property or other proprietary information.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Although we take such steps to help protect confidential and other sensitive information from unauthorized access or disclosure, our information technology and infrastructure has been subject to in the past and may be vulnerable in the future to attacks by hackers or viruses, failures, or breaches due to third-party action, employee negligence or error, malfeasance, or other incidents or disruptions. For example, we could be the target of phishing attacks seeking confidential information regarding our employees. Furthermore, while we have implemented data privacy and security measures in an effort to comply with applicable laws and regulations relating to privacy and data protection, some health-related and other personal information or confidential information may be transmitted to us by third parties, who may not implement adequate security and privacy measures, and it is possible that laws, rules and regulations relating to privacy, data protection, or information security may be interpreted and applied in a manner that is inconsistent with our practices or those of third parties who transmit health-related and other personal information or confidential information to us.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To the extent that we or these third parties are found to have violated such laws, rules or regulations or that any disruption or security breach were to result in a loss of, or damage to, our or our third-party vendors&#x2019;, collaborators&#x2019; or other contractors&#x2019; or consultants&#x2019; data or applications, or inappropriate disclosure of confidential or proprietary information, we could incur liability including litigation exposure, penalties and fines, we could become the subject of regulatory action or investigation, our competitive position could be harmed and the further development and commercialization of our product candidates could be delayed. Any of the above could have a material adverse effect on our business, financial condition, results of operations or prospects.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Risks Related to the Ownership of Our Common Stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">An active trading market for our common stock may not be sustained.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our shares of common stock began trading on the Nasdaq Global Select Market on February 5, 2021. Given the limited trading history of our common stock, there is a risk that an active trading market for our shares will not be sustained, which could put downward pressure on the market price of our common stock and thereby affect the ability of our stockholders to sell their shares.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The market price of our common stock may be volatile.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our stock price is, and is likely to continue to be, volatile. For example, our stock traded within a range of a high price of $63.62 and a low price of $7.07 per share for the period of February 5, 2021, our first day of trading on the Nasdaq Global Select Market, through March 1, 2022. As a result of volatility, our stockholders may not be able to sell their common stock at or above the prices at which they purchased their shares. Some of the factors that may cause the market price of our common stock to fluctuate include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the success of existing or new competitive product candidates or technologies; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the timing and results of preclinical studies and clinical trials for our product candidates; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">103</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">failure or discontinuation of any of our product development and research programs; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">results of preclinical studies, clinical trials or regulatory approvals of product candidates of our competitors, or announcements about new research programs or product candidates of our competitors; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">developments or changing views regarding the use of genetic medicines, including those that involve genome engineering; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">commencement or termination of collaborations for our product development and research programs; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">regulatory or legal developments in the United States and other countries; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">developments or disputes concerning patent applications, issued patents or other proprietary rights; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the recruitment or departure of key personnel; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the level of expenses related to any of our research programs, product candidates or clinical development programs; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the results of our efforts to develop additional product candidates or products; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">actual or anticipated changes in estimates as to financial results, development timelines or recommendations by securities analysts; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">announcement or expectation of additional financing efforts; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">sales of our common stock by us, our insiders or other stockholders; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">variations in our financial results or those of companies that are perceived to be similar to us; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes in estimates or recommendations by securities analysts, if any, that cover our stock; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">changes in the structure of healthcare payment systems; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">market conditions in the pharmaceutical and biotechnology sectors; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">global or regional public health emergencies, including the COVID-19 pandemic, and political instability, including terrorist attacks, civil unrest and actual or threatened armed conflict; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">general economic, industry and market conditions; and </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the other factors described in this &#x201c;Risk Factors&#x201d; section. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In recent years, the stock market in general, and the market for pharmaceutical and biotechnology companies in particular, has experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to changes in the operating performance of the companies whose stock is experiencing those price and volume fluctuations. Broad market and industry factors may seriously affect the market price of our common stock, regardless of our actual operating performance. Following periods of such volatility in the market price of a company&#x2019;s securities, securities class action litigation has often been brought against that company. Because of the potential volatility of our stock price, we may become the target of securities litigation in the future, which could result in substantial costs and divert management&#x2019;s attention and resources from our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If securities analysts do not publish research or reports about our business or if they publish negative evaluations of our stock, the price of our stock could decline.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The trading market for our common stock will be influenced by the research and reports that industry or financial analysts publish about us or our business. If one or more of the analysts covering our business downgrade their evaluations of our stock, the price of our stock could decline. If one or more of these analysts cease to cover our stock, we could lose visibility in the market for our stock, which in turn could cause our stock price to decline.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">A significant portion of our total outstanding shares is restricted from immediate resale but may be sold into the market in the near future, which could cause the market price of our common stock to decline significantly, even if our business is doing well.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Sales of a substantial number of shares of our common stock in the public market could occur at any time. These sales, or the perception in the market that the holders of a large number of shares of common stock intend to</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">104</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">sell shares, could reduce the market price of our common stock. Our outstanding shares of common stock may be freely sold in the public market at any time to the extent permitted by Rules 144 and 701 under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), or to the extent such shares have already been registered under the Securities Act and are held by non-affiliates.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Moreover, holders of a substantial number of shares of our common stock have rights, subject to conditions, to require us to file registration statements covering their shares or to include their shares in registration statements that we may file for ourselves or other stockholders. We have also registered all shares of common stock that we may issue under our equity compensation plans or that are issuable upon exercise of outstanding options and will continue to register any additional shares that become available under such plans due to any annual, automatic increases under the terms of those plans. These shares can be freely sold in the public market upon issuance and once vested, subject to volume limitations applicable to affiliates. If any of these additional shares are sold, or if it is perceived that they will be sold, in the public market, the market price of our common stock could decline.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Insiders have substantial control over our company, which could limit the ability of our other stockholders to affect the outcome of key transactions, including a change of control.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our executive officers and directors, combined with our stockholders who own more than 5% of our outstanding common stock, and their affiliates, in the aggregate, beneficially own shares representing a substantial amount of our outstanding common stock. As a result, these stockholders, if they act together, may be able to influence our management and affairs and all matters requiring stockholder approval, including the election of directors and approval of significant corporate transactions, such as a merger or other sale of our company or its assets. This concentration of ownership may have the effect of delaying or preventing a change in control of our company or discouraging a potential acquirer from making a tender offer or otherwise attempting to obtain control, even if that change in control would benefit our other stockholders. This significant concentration of ownership may also adversely affect the trading price for our common stock because investors often perceive disadvantages in owning stock in companies with controlling stockholders.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">If we fail to establish and maintain proper and effective internal control over financial reporting, our operating results and our ability to operate our business could be harmed.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Ensuring that we have adequate internal financial and accounting controls and procedures in place so that we can produce accurate financial statements on a timely basis is a costly and time-consuming effort that needs to be re-evaluated frequently. Our internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with generally accepted accounting principles.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Implementing any appropriate changes to our internal controls may distract our officers and employees, entail substantial costs to modify our existing processes and take significant time to complete. These changes may not, however, be effective in maintaining the adequacy of our internal controls, and any failure to maintain that adequacy, or consequent inability to produce accurate financial statements on a timely basis, could increase our operating costs and harm our business. In addition, investors&#x2019; perceptions that our internal controls are inadequate or that we are unable to produce accurate financial statements on a timely basis may harm our common share price.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We are an &#x201c;emerging growth company&#x201d; and a &#x201c;smaller reporting company,&#x201d; and the reduced disclosure requirements applicable to emerging growth companies and smaller reporting companies may make our common stock less attractive to investors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are an &#x201c;emerging growth company,&#x201d; as defined in the Jumpstart Our Business Startups Act of 2012 (the &#x201c;JOBS Act&#x201d;). We will be an emerging growth company during this year and may remain an emerging growth company until 2026. For so long as we remain an emerging growth company, we are permitted and plan to rely on exemptions from certain disclosure requirements that are applicable to other public companies that are not emerging growth companies. These exemptions include not being required to comply with the auditor attestation requirements of Section 404 of </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the Sarbanes-Oxley Act of 2002 (&#x201c;SOX&#x201d;)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor&#x2019;s report providing additional information about the audit and the financial statements, reduced disclosure obligations regarding executive compensation, exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved, and being permitted to provide only two years of audited financial statements. As a result, the information we provide stockholders will be different than the information that is available with respect to other</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">105</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">public companies.</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For example, we did not include all of the executive compensation related information in this Annual Report that would be required if we were not an emerging growth company. We cannot predict whether investors will find our common stock less attractive if we rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock, and our stock price may be more volatile.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, the JOBS Act provides that an emerging growth company can take advantage of an extended transition period for complying with new or revised accounting standards. This allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have availed ourselves of this extended transition period and we cannot predict whether investors will find our common stock less attractive due to this election.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are also a &#x201c;smaller reporting company&#x201d; and we may continue to be a smaller reporting company if either (i) the market value of our stock held by non-affiliates is less than $250 million or (ii) our annual revenue is less than $100 million during the most recently completed fiscal year and the market value of our stock held by non-affiliates is less than $700 million. If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form 10-K and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We will incur increased costs as a result of operating as a public company, and our management will be required to devote substantial time to new compliance initiatives and corporate governance practices.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As a public company, and particularly after we are no longer an &#x201c;emerging growth company,&#x201d; we will incur significant legal, accounting and other expenses that we did not incur as a private company. The Sarbanes-Oxley Act of 2002, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the listing requirements of the Nasdaq Global Select Market and other applicable securities rules and regulations impose various requirements on public companies, including establishment and maintenance of effective disclosure and financial controls and corporate governance practices. We expect that we will need to continue to hire additional accounting, finance and other personnel in connection with our efforts to comply with the requirements of being, a public company, and our management and other personnel will need to continue to devote a substantial amount of time towards maintaining compliance with these requirements. These requirements have increased and will continue to increase our legal and financial compliance costs and make some activities more time-consuming and costly. These rules and regulations are often subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure and governance practices.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to SOX Section 404, we were required to furnish a report by our management on our internal control over financial reporting beginning with this Annual Report. However, while we remain an emerging growth or a smaller reporting company with less than $100 million in annual revenue, we will not be required to include an attestation report on internal control over financial reporting issued by our independent registered public accounting firm. To achieve compliance with SOX Section 404 within the prescribed period, we have and will be engaged in a process to document and evaluate our internal control over financial reporting, which is both costly and challenging. In this regard, we will need to continue to dedicate internal resources, potentially engage outside consultants, adopt a detailed work plan to assess and document the adequacy of internal control over financial reporting, continue steps to improve control processes as appropriate, validate through testing that controls are functioning as documented and implement a continuous reporting and improvement process for internal control over financial reporting. Despite our efforts, there is a risk that we will not be able to conclude, within the prescribed timeframe or at all, that our internal control over financial reporting is effective as required by SOX Section 404. If we identify one or more material weaknesses, it could result in an adverse reaction in the financial markets due to a loss of confidence in the reliability of our financial statements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our management team has broad discretion in the use of our cash reserves and may not use them effectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our management has broad discretion to use our cash reserves and could use our cash reserves in ways that do not improve our results of operations or enhance the value of our common stock. The failure by our management</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">106</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">to apply these funds effectively could harm our business, financial condition, results of operations and prospects. Pending their use, we may invest our cash reserves in a manner that does not produce income or that loses value.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">We do not expect to pay any dividends for the foreseeable future. Accordingly our stockholders must rely on capital appreciation, if any, for any return on their investment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have never declared or paid any cash dividends on our equity securities. We do not anticipate that we will pay any dividends to holders of our common stock in the foreseeable future. Instead, we plan to retain any earnings to maintain and expand our existing operations. In addition, any future credit facility that we enter into may contain terms prohibiting or limiting the amount of dividends that may be declared or paid on our common stock. As a result, capital appreciation, if any, of our common stock will be stockholders&#x2019; sole source of gain for the foreseeable future.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Unfavorable global economic conditions could adversely affect our business, financial condition or results of operations.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our results of operations could be adversely affected by general conditions in the global economy and in the global financial markets. A severe or prolonged economic downturn, or additional global financial crises, whether related to the ongoing COVID-19 pandemic or not, could result in a variety of risks to our business, including weakened demand for our product candidates, if approved, or our ability to raise additional capital when needed on acceptable terms, if at all. A weak or declining economy could also strain our suppliers, possibly resulting in supply disruption. Any of the foregoing could harm our business and we cannot anticipate all of the ways in which the current economic climate and financial market conditions could adversely impact our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Provisions in our certificate of incorporation and bylaws and under Delaware law could make a change in control of us, which may be beneficial to our stockholders, more difficult and may prevent attempts by our stockholders to replace or remove our current management.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Provisions in our amended and restated certificate of incorporation and our amended and restated bylaws may discourage, delay or prevent a merger, acquisition or other change in control of us that stockholders may consider favorable, including transactions in which our stockholders might otherwise receive a premium for their shares. These provisions also could limit the price that investors might be willing to pay in the future for shares of our common stock, thereby depressing the market price of our common stock. In addition, because our board of directors is responsible for appointing the members of our management team, these provisions may frustrate or prevent any attempts by our stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors. Among other things, these provisions:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">establish a classified board of directors such that not all members of the board are elected at one time; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">allow the authorized number of our directors to be changed only by resolution of our board of directors; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">limit the manner in which stockholders can remove directors from the board; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">establish advance notice requirements for stockholder proposals that can be acted on at stockholder meetings and nominations to our board of directors; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">require that stockholder actions must be effected at a duly called stockholder meeting and prohibit actions by our stockholders by written consent; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">limit who may call stockholder meetings; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">authorize our board of directors to issue preferred stock without stockholder approval, which could be used to institute a stockholder rights plan, or so-called &#x201c;poison pill,&#x201d; that would work to dilute the stock ownership of a potential hostile acquirer, effectively preventing acquisitions that have not been approved by our board of directors; and </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">require the approval of the holders of at least 66</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2044;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:bottom;font-size:6.7pt;font-family:Times New Roman;">3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the votes that all our stockholders would be entitled to cast to amend or repeal certain provisions of our charter or bylaws. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Moreover, because we are incorporated in Delaware, we are governed by the provisions of Section 203 of the Delaware General Corporation Law (the &#x201c;DGCL&#x201d;), which prohibits a person who owns in excess of 15% of our outstanding voting stock from merging or combining with us for a period of three years after the date of the transaction in which the person acquired in excess of 15% of our outstanding voting stock, unless the merger or</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">107</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">combination is approved in a prescribed manner. We have not elected to opt out of DGCL Section 203. These provisions could discourage potential acquisition proposals and could delay or prevent a change in control transaction. They could also have the effect of discouraging others from making tender offers for our common stock, including transactions that may be in our stockholders&#x2019; best interests. These provisions may also prevent changes in our management or limit the price that investors are willing to pay for our common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware and the federal district courts of the United States of America will be the exclusive forums for substantially all disputes between us and our stockholders, which could limit our stockholders&#x2019; ability to obtain a favorable judicial forum for disputes with us or our directors, officers or employees.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our amended and restated certificate of incorporation provides that the Court of Chancery of the State of Delaware is the exclusive forum for the following types of actions or proceedings under Delaware statutory or common law:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any derivative action or proceeding brought on our behalf; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any action asserting a breach of fiduciary duty; </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any action asserting a claim against us arising under the DGCL, our amended and restated certificate of incorporation or our amended and restated bylaws; and </span></div></div>
  <div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any action asserting a claim against us that is governed by the internal-affairs doctrine. </span></div></div>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This provision would not apply to suits brought to enforce a duty or liability created by the Securities Exchange Act of 1934, as amended. Furthermore, Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. Accordingly, both state and federal courts have jurisdiction to entertain such claims. To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, our amended and restated certificate of incorporation further provides that the federal district courts of the United States will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act. While the Delaware courts have determined that such choice of forum provisions are facially valid, a stockholder may nevertheless seek to bring a claim in a venue other than those designated in the exclusive forum provisions. In such instance, we would expect to vigorously assert the validity and enforceability of the exclusive forum provisions of our amended and restated certificate of incorporation. This may require significant additional costs associated with resolving such action in other jurisdictions and there can be no assurance that the provisions will be enforced by a court in those other jurisdictions.</span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These exclusive forum provisions may limit a stockholder&#x2019;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees, which may discourage lawsuits against us and our directors, officers and other employees. If a court were to find either exclusive-forum provision in our amended and restated certificate of incorporation to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving the dispute in other jurisdictions, which could seriously harm our business.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">108</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;" id="item_1b_unresolved_staff_comments"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 1B. Unresolve</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">d Staff Comments.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Not applicable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;" id="item_2_properties"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 2. Pr</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">operties.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our principal executive office is located at 100 Cambridgepark Drive, Suite 101 Cambridge, Massachusetts where we lease approximately 73,235 square feet of office, laboratory and manufacturing space pursuant to a lease that expires in August 2030. We believe that these facilities will be adequate for our near-term needs. If required, we believe that suitable additional or alternative space would be available in the future on commercially reasonable terms.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;" id="item_3_legal_proceedings"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 3. Legal </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Proceedings.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From time to time, we may become involved in legal proceedings arising in the ordinary course of our business. We are not currently subject to any material legal proceedings. Regardless of outcome, such proceedings or claims can have an adverse impact on us because of defense and settlement costs, diversion of resources and other factors, and there can be no assurances that favorable outcomes will be obtained.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;" id="item_4_mine_safety_disclosures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 4. Mine Saf</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ety Disclosures.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Not applicable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">109</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="part_ii"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">PAR</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">T II</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;" id="item_5_market_for_registrants_common_equ"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 5. Market for Registrant&#x2019;s Common Equity, Related Stoc</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">kholder Matters and Issuer Purchases of Equity Securities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Market Information</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our common stock trades on the Nasdaq Global Select Market under the symbol &#x201c;VOR&#x201d;. Trading of our common stock commenced on February 5, 2021 in connection with our initial public offering (&#x201c;IPO&#x201d;). Prior to that time, there was no established public trading market for our common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Holders</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of March 1, 2022, we had approximately 26 holders of record of our common stock. This number does not include beneficial owners whose shares were held in street name.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Dividend Policy</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have never declared or paid any cash dividends on our common stock. We currently intend to retain future earnings to fund the development and growth of our business. We do not expect to pay any cash dividends in the foreseeable future. In addition, the terms of any future debt agreements that we may enter into, may preclude us from paying dividends without the lenders&#x2019; consent or at all.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Use of Proceeds from Registered Securities</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On February 9, 2021, we closed our initial public offering of 11,302,219 shares of our common stock, including 1,474,202 shares of our common stock pursuant to the full exercise by the underwriters of an option to purchase additional shares, at a public offering price of $18.00 per share for aggregate offering proceeds of approximately $203.4 million. The offer and sale of all of the shares in the offering were registered under the Securities Act pursuant to a registration statement on Form S-1 (File No. 333-252175), which was declared effective by the SEC on February 4, 2021, and a registration statement on Form S-1 (File No. 333-252766), which was deemed effective on February 5, 2021. </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Goldman Sachs &amp; Co. LLC, Evercore Group L.L.C., Barclays Capital Inc. and Stifel, Nicolaus &amp; Company, Incorporated </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">acted as the lead book-running managers and representatives of the underwriters. The offering commenced on February 5, 2021 and did not terminate until the sale of all of the shares offered.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We received aggregate net proceeds from the offering of $186.3 million, after deducting underwriting discounts and commissions and other offering expenses payable by us. None of the underwriting discounts and commissions or other offering expenses were incurred or paid to directors or officers of ours or their associates or to persons owning 10% or more of our common stock or to any affiliates of ours.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021, we had not used any of the net proceeds from our initial public offering. We have invested the net proceeds from the offering in a variety of capital preservation investments, including short-term investment grade interest bearing instruments and U.S. government securities. There has been no material change in our planned use of the net proceeds from the offering as described in the final prospectus for our initial public offering filed with the SEC pursuant to Rule 424(b) under the Securities Act.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;" id="item_6_selected_financial_data"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 6. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">[</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Reserved]</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">110</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_7_managements_discussion_analysis_f"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 7. Management&#x2019;s Discussion and Analysis of</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> Financial Condition and Results of Operations</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">You should read the following discussion and analysis of our financial condition and results of operations together with our consolidated financial statements and related notes included elsewhere in this Annual Report on Form 10-K (the &#x201c;Annual Report&#x201d;). Some of the information contained in this discussion and analysis or set forth elsewhere in this Annual Report, including information with respect to our plans and strategy for our business, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, including those factors set forth in the section titled &#x201c;Risk Factors,&#x201d; our actual results could differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Overview</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are a clinical-stage cell and genome engineering company with a vision is to cure blood cancers through cell and genome engineering. Our mission is to change the standard of care for patients with blood cancer by engineering hematopoietic stem cells (&#x201c;HSCs&#x201d;) to enable the use of targeted therapies post-transplant. Leveraging our expertise in HSC biology and genome engineering, we genetically modify HSCs to remove surface targets and then provide these cells as hematopoietic stem cell transplants to patients. Once these cells engraft into bone marrow, the patient&#x2019;s healthy cells are protected because they no longer express the surface target, leaving only the cancerous cells exposed.  We believe this will unlock the potential of targeted therapies to selectively destroy cancerous cells while sparing healthy cells. As a result, our engineered HSCs (&#x201c;eHSCs&#x201d;) are designed to limit the on-target toxicities associated with these targeted therapies, thereby enhancing their utility, and broadening their applicability. We intend to pair future eHSC product candidates with targeted therapeutics such as our VCAR33 programs, chimeric antigen receptor (&#x201c;CAR&#x201d;)-T therapies designed to target CD33, as well as with potentially best-in-class targeted therapies from collaborators, to bring potentially transformative outcomes to patients and establish new standard of care Treatment Systems for blood cancers.</span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are developing our lead eHSC product candidate, VOR33, which we believe has the potential to transform the treatment for acute myeloid leukemia (&#x201c;AML&#x201d;) and other blood cancers. VOR33 is created by genetically modifying healthy donor HSCs in order to remove the CD33 surface target. We intend to develop VOR33 as an HSCT product candidate to replace the standard of care in transplant settings. Our investigational new drug (&#x201c;IND&#x201d;) application for VOR33 in patients with AML was accepted by the U.S. Food and Drug Administration (&#x201c;FDA&#x201d;) in January 2021, and we h</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ave initiated and are actively recruiting for VBP101, our first-in-human Phase 1/2a trial of VOR33 in combination with Mylotarg. We anticipate initial clinical data for this trial in the second half of 2022. If successful, this trial will provide important validating evidence of the potential of VOR33 and our broader eHSC approach.</span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The VCAR33 programs are CAR-T therapy candidate designed to target CD33, a clinically-validated target for AML that we have licensed from the National Institutes of Health (&#x201c;NIH&#x201d;). VCAR33 is made up of two programs with different cell sources. The first uses autologous cells from each patient and is being studied in an ongoing Phase 1/2 clinical trial sponsored by the National Marrow Donor Program (&#x201c;NMDP&#x201d;) in young adult and pediatric patients with relapsed/refractory AML in a bridge-to-transplant study, which we refer to as VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">AUTO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The second uses allogeneic healthy donor-derived cells that is our newly announced program that we refer to as VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. We plan to submit an IND for VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> in the first half of 2023 to support a Phase 1/2 clinical trial for patients with relapsed/refractory AML. The NMDP is currently evaluating VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">AUTO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> in a multi-site Phase 1/2 clinical trial in young adult and pediatric patients with relapsed/refractory AML, with initial monotherapy proof-of-concept data expected in 2022, depending on the investigator&#x2019;s timing of data release. The NMDP is responsible for all aspects of the VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">AUTO </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">trial, including the design of the trial, the manufacture of study product, the enrollment, dosing and follow-up of patients, the recording of trial data and the analysis of results. We also did not control the preclinical development of VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">AUTO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, which was conducted by the NIH, and we do not have rights under the license agreement to certain intellectual property, such as know-how, employed by the NMDP in manufacturing study product or conducting its clinical trial, however, the NMDP has permitted us to cross-reference its IND for this trial in future IND applications that we may submit with the FDA.</span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe that the combination of VOR33 followed by treatment with VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">in the post-transplant setting, which we refer to as the VOR33 + VCAR33 Treatment System, may transform patient outcomes and offer the potential for cures for patients that have limited treatment options. The VOR33 + VCAR33 Treatment System would utilize the same healthy donor allogenic cell source for both VOR33 and VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.  Following ongoing discussions with the FDA and alongside improved scientific understanding of the differences in T-cell sources, we</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">111</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">plan to collect initial data on VOR33 from the VBP101 clinical trial and initial clinical data from the VCAR33</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;vertical-align:top;font-size:6.7pt;font-family:Times New Roman;">ALLO </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">program prior to IND submission for the Treatment System. We believe this approach allows for a more methodical development pathway for this novel-novel treatment combination.</span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since our inception in December 2015, we have devoted substantially all of our resources to raising capital, organizing and staffing our company, business and scientific planning, conducting discovery and research activities, acquiring or discovering product candidates, establishing and protecting our intellectual property portfolio, developing and progressing our product candidates and preparing for clinical trials, establishing arrangements with third parties for the manufacture of our product candidates and component materials, building out our internal clinical manufacturing facility and providing general and administrative support for these operations. We do not have any product candidates approved for sale and have not generated any revenue from product sales. Through December 31, 2021, we funded our operations primarily through the sale of equity securities and debt financings and have received aggregate net proceeds from these transactions of approximately $344.0 million.</span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have incurred significant operating losses since inception, including net losses of $68.9 million and $43.3 million for the years ended  December 31, 2021 and 2020, respectively. As of December 31, 2021, we had an accumulated deficit of  $130.1 million.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021, we had cash, cash equivalents and investments of $207.5 million. In February 2021, we completed our initial public offering (</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">IPO</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) and sold 11,302,219 shares of our common stock, at a public offering price of $18.00 per share. We received net proceeds of $186.3 million from the IPO, after deducting underwriters&#x2019; discounts and commissions and other offering expenses paid by us. We expect that our existing cash, cash equivalents and investments at December 31, 2021 will enable us to fund our operating expenses and capital expenditure requirements into the fourth quarter of 2023.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Business Impact of the COVID-19 Pandemic</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The global COVID-19 pandemic continues to rapidly evolve, including with respect to the variants</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">of the virus, and we will continue to monitor the COVID-19 situation closely. To date our financial condition and operations have not been significantly impacted by the COVID-19 pandemic, but we have experienced delays in our Phase 1/2a trial for VOR33 in part due to the COVID-19 pandemic, including site activation and readiness delays, which has resulted in enrollment delays. We cannot, at this time, predict the specific extent, duration or full impact that the COVID-19 pandemic will have on our financial condition and operations, including our ongoing and planned preclinical and clinical trials. The extent of the impact of the COVID-19 on our business, operations and clinical development timelines and plans remains uncertain and will depend on certain developments, including the duration and subsequent waves of the outbreak, such as those related to variants of the virus, and its impact on our clinical trial enrollment, trial sites, contract research organizations (&#x201c;CROs&#x201d;), third-party manufacturers, and other third parties with whom we do business, as well as its impact on regulatory authorities and our key scientific and management personnel. To the extent possible, we are conducting business as usual, with necessary or advisable modifications to employee travel. We will continue to actively monitor the rapidly evolving situation related to COVID-19 and may take further actions that alter our operations, including those that may be required by federal, state or local authorities, or that we determine are in the best interests of our employees and other third parties with whom we do business. The development of our product candidates could be disrupted and materially adversely affected in the future by the COVID-19 pandemic, including due to the ongoing global supply chain issues that may limit our ability and service providers' ability to acquire the raw materials necessary to conduct our research, development, manufacturing and clinical activities. Our clinical trials also could be delayed due to government orders and site policies on account of the pandemic, and some patients may be unwilling or unable to travel to study sites, enroll in our trials or be unable to comply with clinical trial protocols if quarantines impede patient movement or interrupt healthcare services, which would delay our ability to conduct clinical trials or release clinical trial results and could delay our ability to obtain regulatory approval and commercialize our product candidates. Furthermore, COVID-19 could affect our employees or the employees of research sites and service providers on whom we rely, including CROs, as well as those of companies with which we do business, including our suppliers and contract manufacturing organizations (&#x201c;CMOs&#x201d;), thereby disrupting our business operations. Quarantines and travel restrictions imposed by governments in the jurisdictions in which we and the companies with which we do business operate could materially impact the ability of employees to access preclinical and clinical sites, laboratories, manufacturing site and office. These and other events resulting from the COVID-19 pandemic could disrupt, delay, or otherwise adversely impact our business.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">112</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Financial Operations Overview</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Revenue</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have not generated any revenue since our inception and do not expect to generate any revenue from the sale of products in the near future, if at all. If our development efforts for our product candidates are successful and result in marketing approval, or if we enter into collaboration or license agreements with third parties, we may generate revenue in the future from a combination of product sales or payments from such agreements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="margin-left:5.667%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research and Development Expenses</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development expenses consist primarily of external and internal expenses incurred in connection with our research and development activities, including our drug discovery efforts and the development of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">External expenses include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.657%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">research and development expenses incurred under agreements with CROs and other scientific development services; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">costs of consultants, including their fees and related travel expenses;</span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">costs related to compliance with quality and regulatory requirements; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">costs of laboratory supplies and acquiring and developing preclinical and clinical trial materials, including expenses associated with our CMOs; and </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">payments made under third party licensing agreements. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Internal expenses include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">personnel-related expenses, including salaries, bonuses, benefits and stock-based compensation expenses, for employees involved in research and development activities; and </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">facilities, depreciation and other allocated expenses, which include direct and allocated expenses for rent, insurance and other internal operating costs. </span></div></div>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expense research and development costs as incurred. We recognize external development costs based on an evaluation of the progress to completion of specific tasks using information provided to us by our vendors. Payments for these activities are based on the terms of the individual agreements, which may differ from the pattern of costs incurred, and are reflected in our consolidated financial statements as prepaid expenses or accrued research and development expenses. Nonrefundable advance payments for goods or services to be received in the future for use in research and development activities are deferred and capitalized, even when there is no alternative future use for the research and development. The capitalized amounts are expensed as the related goods are delivered or the services are performed.</span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A significant portion of our research and development costs have been external costs, which we track by stage of development, preclinical or clinical. However, we do not track our internal research and development expenses on a program specific basis because these costs are deployed across multiple projects and, as such, are not separately classified.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development activities are central to our business model. We expect that our research and development expenses will increase significantly for the foreseeable future as we continue to identify and develop product candidates, particularly as more of our product candidates move into clinical development and later stages of clinical development.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The successful development of our product candidates in the future is highly uncertain. Therefore, we cannot reasonably estimate or know the nature, timing and estimated costs of the efforts that will be necessary to complete the development and commercialization of any of our product candidates. We are also unable to predict when, if ever, material net cash inflows will commence from the sale of our product candidates, if approved. This is due to the numerous risks and uncertainties associated with developing product candidates, many of which are outside of our control, including the uncertainty of:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">113</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the timing and progress of preclinical and clinical development activities; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the number and scope of preclinical and clinical programs we decide to pursue; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to maintain our current research and development programs and to establish new ones; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">establishing an appropriate safety profile with IND-enabling studies; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the number of sites and patients included in the clinical trials; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the countries in which the clinical trials are conducted; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">per patient trial costs; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">successful patient enrollment in, and the initiation of, clinical trials, as well as drop out or discontinuation rates, particularly in light of the current COVID-19 pandemic environment; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the successful completion of clinical trials with safety, tolerability and efficacy profiles that are satisfactory to the FDA or any comparable foreign regulatory authority; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the number of trials required for regulatory approval; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the timing, receipt and terms of any regulatory approvals from applicable regulatory authorities; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our ability to establish new licensing or collaboration arrangements; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the performance of our current and future collaborators, if any; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">establishing commercial manufacturing capabilities or making arrangements with third-party manufacturers; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">significant and changing government regulation and regulatory guidance; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the impact of any business interruptions to our operations or to those of the third parties with whom we work, particularly in light of the current COVID-19 pandemic environment; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">obtaining, maintaining, defending and enforcing patent claims and other intellectual property rights; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">launching commercial sales of our product candidates, if approved, whether alone or in collaboration with others; and </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">maintaining a continued acceptable safety profile of the product candidates following approval. </span></div></div>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Any changes in the outcome of any of these variables could mean a significant change in the costs and timing associated with the development of our product candidates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">General and Administrative Expenses</span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative expenses consist primarily of personnel-related costs, including salaries, bonuses, benefits and stock-based compensation expenses for employees involved in our executive, finance, corporate, business development and administrative functions, as well as expenses for outside professional services, including legal, audit, accounting and tax-related services and other consulting fees, facility-related expenses, which include depreciation costs and other allocated expenses for rent and maintenance of facilities, insurance costs, recruiting costs, travel expenses and other general administrative expenses.</span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expect that our general and administrative expenses will increase significantly for the foreseeable future as our business expands and we hire additional personnel to support our continued research and development activities, including our future clinical programs. We also anticipate increased expenses associated with being a public company, including costs for legal, audit, accounting, investor and public relations, regulatory and tax-related services related to compliance with the rules and regulations of the Securities and Exchange Commission (the &#x201c;SEC&#x201d;), listing standards applicable to companies listed on a national securities exchange, director and officer insurance premiums and investor relations costs.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Other Income</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">114</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="margin-left:5.667%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Interest Income</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Interest income consists of interest income earned on our cash, cash equivalents and investments held in financial institutions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Results of Operations</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Comparison of Years Ended December 31, 2021 and 2020</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes our results of operations for the years ended December 31, 2021 and 2020 (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:56.789%;"></td>
    <td style="width:1.36%;"></td>
    <td style="width:1.371%;"></td>
    <td style="width:10.73%;"></td>
    <td style="width:0.91%;"></td>
    <td style="width:1.36%;"></td>
    <td style="width:1.371%;"></td>
    <td style="width:10.559%;"></td>
    <td style="width:0.91%;"></td>
    <td style="width:1.36%;"></td>
    <td style="width:1.371%;"></td>
    <td style="width:10.998%;"></td>
    <td style="width:0.91%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Change</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating expenses:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">47,529</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">31,618</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,911</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21,489</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11,748</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9,741</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total operating expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">69,018</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">43,366</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25,652</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Loss from operations</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(69,018</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(43,366</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(25,652</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other income:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Interest income</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">119</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">29</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total other income</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">119</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">29</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">90</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss and comprehensive loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(68,899</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(43,337</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(25,562</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
  </table>
  <p style="margin-left:5.667%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research and Development Expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes our research and development expenses incurred for the years ended December 31, 2021 and 2020 (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:56.51%;"></td>
    <td style="width:1.37%;"></td>
    <td style="width:1.37%;"></td>
    <td style="width:11.06%;"></td>
    <td style="width:0.696%;"></td>
    <td style="width:1.37%;"></td>
    <td style="width:1.37%;"></td>
    <td style="width:11.06%;"></td>
    <td style="width:0.696%;"></td>
    <td style="width:1.37%;"></td>
    <td style="width:1.37%;"></td>
    <td style="width:11.06%;"></td>
    <td style="width:0.696%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Change</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">External expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21,379</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18,189</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,190</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Internal expenses:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Personnel expenses (including stock-based compensation)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20,690</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,209</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,481</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Facilities and other expenses</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,460</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,220</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,240</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total research and development expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">47,529</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">31,618</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,911</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development expenses were $47.5 million  for the year ended December 31, 2021, compared to $31.6 million for the year ended December 31, 2020. The increase of $15.9 million was primarily due to increases of external clinical program costs of $1.4 million, preclinical studies, research consulting fees, and laboratory supplies costs of $1.8 million, personnel costs primarily attributable to an increase in employee headcount to support the growth of our research and development efforts of $10.5 million and in facilities and other expenses primarily due to increases in rent and depreciation expense of  $2.2 million.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">General and Administrative Expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative expenses were $21.5 million for the year ended December 31, 2021, compared to $11.7 million for  the year ended December 31, 2020. The increase of $9.8 million was primarily due to increases in personnel costs attributable to increased employee headcount of $4.6 million, in professional fees primarily attributable to increases in use of legal consultants and in insurance premiums of $4.3 million and in facilities and other expenses primarily due to increases in rent expense and purchases of office equipment and supplies of $0.9 million.</span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Other Income</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other income increased by $90 thousand for the year ended December 31, 2021, compared to the  year ended December 31, 2020. The increase in interest income was due to increases in interest received from our cash, cash equivalents and investments.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">115</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Liquidity and Capital Resources</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Sources of Liquidity</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Since our inception, we have not recognized any revenue and have incurred operating losses and negative cash flows from our operations. We have not yet commercialized any product and we do not expect to generate revenue from sales of any products for several years, if at all. We have funded our operations primarily through the sale of equity securities and debt financings and have received aggregate net proceeds from these transactions of approximately $344.0 million as of December 31, 2021, including net proceeds of $45.4 million from our sale of Series B preferred stock in January 2021 and $186.3 million from our IPO in February 2021, after deducting underwriters&#x2019; discounts and other offering expenses paid by us.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In order to fund our future operations, including our planned clinical trials, on March 14, 2022, we will file a universal shelf registration statement (the &#x201c;Shelf Registration Statement&#x201d;), which will provide for aggregate offerings of up to $350.0 million of common stock, preferred stock, debt securities, warrants or any combination thereof. The Shelf Registration Statement has not yet been declared effective by the Securities and Exchange Commission. We believe that our Shelf Registration Statement, once effective, will provide us with the flexibility to raise additional capital to finance our operations as needed.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may offer additional securities under our Shelf Registration Statement, when declared effective, from time to time in response to market conditions or other circumstances if we believe such a plan of financing is in the best interests of our stockholders. On March 14, 2022, we will enter into an open market sale agreement (the &#x201c;Sale Agreement&#x201d;), with Jefferies LLC, as the sales agent, pursuant to which we may, subject to the effectiveness of the Shelf Registration Statement, from time to time, issue and sell common stock with an aggregate value of up to $125.0 million in an at-the-market offering. Jefferies is acting as the sole sales agent for any sales made under the Sale Agreement for a commission up to 3% on gross proceeds. The common stock will be sold at prevailing market prices at the time of the sale, and, as a result, prices may vary. Unless otherwise terminated earlier, the Sale Agreement will continue until all shares available under the Sale Agreement have been sold.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cash Requirements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021, we had cash, cash equivalents and investments of $207.5 million. We will need to raise additional capital in the future to fund our future operations. However, we cannot guarantee that we will be able to obtain sufficient additional funding or that if we do obtain additional funding, that such funding, will be obtainable on terms satisfactory to us. In the event that we are unable to obtain sufficient additional funding, there can be no assurance that we will be able to continue as a going concern.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expect that our existing cash, cash equivalents and investments at December 31, 2021, will enable us to fund our operating expenses and capital expenditure requirements into the fourth quarter of 2023. We have based this estimate on assumptions that may prove to be wrong and we could exhaust our capital resources sooner than we expect.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">116</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We expect our expenses to increase substantially if, and as, we:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.657%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">continue research and preclinical and clinical development of our product candidates, including in particular the expenses associated with our clinical trials;</span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">incur third party manufacturing costs to support our preclinical studies and clinical trials of our product candidates and, if approved, their commercialization; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">seek to identify and develop additional product candidates; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">make investments in our platform, including the costs of developing internal manufacturing capabilities; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">seek regulatory and marketing approvals for our product candidates; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">establish a sales, marketing and distribution infrastructure to commercialize any approved product candidates; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">adapt our regulatory compliance efforts to incorporate requirements to applicable marketed products;</span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">acquire or in-license products, product candidates, technologies;</span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">maintain, expand, enforce, defend and protect our intellectual property;</span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">hire additional clinical, quality control, manufacturing and other scientific personnel;</span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">add operational, financial and management information systems and personnel;</span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">expand our office, laboratory and manufacturing facility; and</span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">experience any delays or encounter any issues with any of the above, including as a result of the ongoing COVID-19 pandemic. </span></div></div>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, we expect to incur additional costs associated with operating as a public company, including significant legal, audit, accounting, investor and public relations, regulatory, tax-related, director and officer insurance premiums, investor relations and other expenses that we did not incur as a private company. Developing pharmaceutical products, including conducting preclinical studies and clinical trials, is a time-consuming, expensive and uncertain process that takes years to complete, and we may never generate the necessary data or results required to obtain marketing approval for any product candidates or generate revenue from the sale of any product candidate for which we may obtain marketing approval. In addition, our product candidates, if approved, may not achieve commercial success. Our commercial revenues, if any, will be derived from sales of drugs that we do not expect to be commercially available for at least several years, if ever.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As a result, we will need substantial additional funding to support our continuing operations and pursue our growth strategy. Until such time as we can generate significant revenue from product sales, if ever, we expect to finance our operations through the public or private sale of our equity, government or private party grants, debt financings or other capital sources, including potential collaborations with other companies or other strategic transactions. To the extent that we raise additional capital through the sale of our equity or convertible debt securities, the ownership interest of our shareholders will be or could be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect the rights of our stockholders. Debt financing and equity financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. If we are unable to obtain additional funding, we could be forced to delay, reduce or eliminate some or all of our research and development programs, product portfolio expansion or any commercialization efforts, which could adversely affect our business prospects, or we may be unable to continue operations. If we raise funds through strategic collaborations or other similar arrangements with third parties, we may have to relinquish valuable rights to our platform technology, future revenue streams, research programs or product candidates or may have to grant licenses on terms that may not be favorable to us and/or may reduce the value of our common stock. Our ability to raise additional funds may be adversely impacted by potential worsening global economic conditions and disruptions to and volatility in the credit and financial markets in the United States and worldwide resulting from the ongoing COVID-19 pandemic or otherwise. Because of the numerous risks and uncertainties associated with product development, we cannot predict the timing or amount of increased expenses, and there is no assurance that we will ever be profitable or generate positive cash flow from operating activities.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">117</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We did not have during the periods presented, and we do not currently have, any off-balance sheet arrangements that, have or are reasonably likely to have a material current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, cash requirements or capital resources.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cash Flows</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table provides information regarding our cash flows for the periods presented (in thousands):</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.685%;"></td>
    <td style="width:1.531%;"></td>
    <td style="width:1.381%;"></td>
    <td style="width:12.782%;"></td>
    <td style="width:0.942%;"></td>
    <td style="width:1.552%;"></td>
    <td style="width:1.381%;"></td>
    <td style="width:12.804%;"></td>
    <td style="width:0.942%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash used in operating activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(69,144</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(36,292</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash used in investing activities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(91,651</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(4,161</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash provided by financing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">232,911</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">82,526</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net increase in cash, cash equivalents and restricted cash equivalents</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">72,116</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">42,073</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Operating Activities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash used in operating activities was $69.1 million for the year ended December 31, 2021, reflecting a net loss of $68.9 million, net cash use of $9.2 million for operating assets and liabilities, which were offset by non-cash charges of $9.0 million. The change in our net operating assets and liabilities was due to an increase in prepaid expenses and other current assets of $6.4 million, a decrease in operating lease liabilities of $2.5 million, an increase in accounts payable and accrued expense of $0.4 million and increase in other assets of $0.7 million. The non-cash charges primarily consisted of stock-based compensation expense of $4.3 million, non-cash lease expense of $3.0 million and depreciation expense of $1.4 million.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash used in operating activities was $36.3 million for the year ended December 31, 2020, reflecting a net loss of $43.3 million, partially offset by a net change of $4.3 million in our net operating assets and liabilities and non-cash charges of $2.7 million. The change in our net operating assets and liabilities was primarily due to increases in accounts payable and accrued expenses of $5.8 million, decreases in prepaid expenses and other current assets of $0.6 million, increases in operating lease liabilities of $0.4 million, partially offset by an increase other assets. The non-cash charges primarily consisted of stock-based compensation expense of $1.3 million, non-cash lease expense of $0.8 million and depreciation expense of $0.6 million.</span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The $32.8 million increase in net cash used in operating activities for the year ended December 31, 2021 compared to the year ended December 31, 2020 was primarily due to an increase in operating expenses as a result of our increased efforts identifying product candidates and advancing the development of VOR33, including increased personnel costs related to our increased headcount.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Investing Activities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash used in investing activities was $91.7 million for the year ended December 31, 2021, which consisted of purchases of $87.8 million of investments and $3.9 million of property and equipment. Net cash used in investing activities was $4.2 million for the year ended December 31, 2020, which consisted primarily of purchases of property and equipment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Financing Activities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net cash provided by financing activities was $232.9 million for the year ended December 31, 2021, which consisted of proceeds of $45.4 million received from the sale and issuance of shares of our preferred stock and IPO net proceeds of $187.0 million. Net cash provided by financing activities was $82.5 million for the year ended December 31, 2020, consisting primarily of proceeds from the sale and issuance of shares of our preferred stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Contractual Obligations and Other Commitments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Contractual obligations relate to future minimum lease payments for existing non-cancellable leases primarily relating to corporate office and laboratory real estate. The following table summarizes the payments due by period as of December 31, 2021 (in thousands):</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">118</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:25.367%;"></td>
    <td style="width:1.37%;"></td>
    <td style="width:12.897%;"></td>
    <td style="width:0.685%;"></td>
    <td style="width:1.37%;"></td>
    <td style="width:12.855%;"></td>
    <td style="width:0.685%;"></td>
    <td style="width:1.37%;"></td>
    <td style="width:12.855%;"></td>
    <td style="width:0.685%;"></td>
    <td style="width:1.37%;"></td>
    <td style="width:12.855%;"></td>
    <td style="width:0.685%;"></td>
    <td style="width:1.37%;"></td>
    <td style="width:12.897%;"></td>
    <td style="width:0.685%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Material Cash Requirements By Period </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:bold;font-size:6.7pt;font-family:Times New Roman;position:relative;">(1)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Less than 1 year</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">More Than 1 Year and Less Than 3 Years</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">More Than 3 Years and Less Than 5 Years</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">More Than 5 Years</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating lease obligation</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26,445</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,410</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,517</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,853</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11,665</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="border-top:0.750pt solid;margin-left:2.667%;padding-top:1.0pt;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Excluded from the table above is $30.1 million for lease payments associated with the Lease Amendments, as defined in Note 10 of our audited consolidated financial statements included elsewhere in this Annual Report, as the space leased has not commenced for accounting purposes as of  December 31, 2021. The commencement date is the date on which the asset is made available to us by the lessor.</span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other commitments include license and collaboration agreements we have entered into with certain parties. Such arrangements require ongoing payments, including payments upon the achievement of certain development, regulatory and commercial milestones, receipt of sublicense income, as well as royalties on commercial sales. Payments under these arrangements are expensed as incurred.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We also have agreements with certain vendors for various services, including services related to clinical operations and support, which we are not contractually able to terminate for convenience and avoid any and all future obligations to the vendors. Under such agreements, we are contractually obligated to make certain payments to vendors to reimburse them for their unrecoverable outlays incurred prior to cancellation. The exact amounts of such obligations are dependent on the timing of termination and the exact terms of the relevant agreement and cannot be reasonably estimated. We do not include these payments in this summary as they are not fixed and estimable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Critical Accounting Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our management&#x2019;s discussion and analysis of financial condition and results of operations is based on our consolidated financial statements. Our consolidated financial statements are prepared in accordance with generally accepted accounting principles in the United States. The preparation of our consolidated financial statements and related disclosures requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, costs and expenses, and the disclosure of contingent assets and liabilities in our consolidated financial statements. We base our estimates on historical experience, known trends and events and various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We evaluate our estimates and assumptions on an ongoing basis. Our actual results may differ from these estimates under different assumptions or conditions. During the year ending December 31, 2021, there were no material changes to these assumptions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">While our significant accounting policies are described in more detail in Note 2 to our audited consolidated financial statements included elsewhere in this Annual Report, we believe that the following accounting policies are those most critical to the judgments and estimates used in the preparation of our consolidated financial statements.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accrued Research and Development Expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As part of the process of preparing our consolidated financial statements, we are required to estimate our accrued research and development expenses as of each balance sheet date. This process involves reviewing open contracts and purchase orders, communicating with our applicable personnel to identify services that have been performed on our behalf and estimating the level of service performed and the associated cost incurred for the service when we have not yet been invoiced or otherwise notified of actual costs. The majority of our service providers invoice us in arrears for services performed, on a pre-determined schedule or when contractual milestones are met; however, some require advance payments. We make estimates of our accrued expenses as of each balance sheet date in the consolidated financial statements based on facts and circumstances known to us at that time. We periodically confirm the accuracy of the estimates with the service providers and make adjustments if necessary.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Determination of the Fair Value of Equity-Based Awards</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We measure stock options and other stock-based awards granted to directors, employees and non-employees based on their fair value on the date of the grant and recognize the corresponding compensation expense of those awards over the requisite service period, which is generally the vesting period of the respective award. We have only issued stock options and restricted share awards with service-based vesting conditions and record the expense for</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">119</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">these awards using the ratable method. We determine the fair value of restricted stock awards granted based on the fair value of our common stock. We estimate the fair value of stock option awards granted using the Black-Scholes option-pricing model, which uses as inputs the fair value of our common stock and subjective assumptions we make, including the expected stock price volatility, the expected term of the award, the risk-free interest rate and expected dividends.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Due to insufficient trade history of our common stock, we are unable to imply the future volatility of our share price and estimate our expected volatility from the historical volatility of a representative group of publicly traded companies for which historical information is available. The historical volatility is generally calculated based on a period of time commensurate with the expected term assumption. We use the simplified method to calculate the expected term for options granted to employees and directors. We utilize this method as we do not have sufficient historical exercise data to provide a reasonable basis upon which to estimate the expected term. For grants to non-employees, ASU 2018-07 allows entities to use the expected term to measure non-employee options or elect to use the contractual term as the expected term, on an award-by-award basis. The risk-free interest rate is based on a U.S. treasury instrument whose term is consistent with the expected term of the stock options. The expected dividend yield is assumed to be zero as we have never paid dividends and do not have current plans to pay any dividends on our common stock.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Prior to the IPO, as there had been no public market for our common stock, the estimated fair value of our common stock had been approved by our board of directors, with input from management, as of the date of each award grant, considering our most recently available independent third-party valuations of common stock, and our board of directors assessment, with input from management, of additional objective and subjective factors that we believed were relevant and which may have changed from the date of the most recent valuation through the date of the grant. These independent third-party valuations were performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants' Accounting and Valuation Guide, Valuation of Privately-Held-Company Equity Securities Issued as Compensation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Given the absence of a public trading market, our board of directors with input from management considered numerous objective and subjective factors to determine the fair value of common stock. The factors included, but were not limited to:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">contemporaneous valuations performed by an independent third-party valuation firm; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our stage of development and material risks related to our business; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the progress of our research and development programs, including the status and results of preclinical studies and clinical trials for our product candidates; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our business conditions and projections; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">sales of our redeemable convertible preferred stock; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the rights, preferences and privileges of our redeemable convertible preferred stock relative to those of our common stock; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">lack of marketability of our common and redeemable convertible preferred stock as a private company;</span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">our operating results and financial performance; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the likelihood of achieving a liquidity event, such as an initial public offering or sale of our company, in light of prevailing market conditions; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the trends, developments and conditions in the life sciences and biotechnology industry sectors; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">analysis of initial public offerings and the market performance and stock price volatility of similar public companies in the life sciences and biopharmaceutical sectors; and </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the economy in general.</span></div></div>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For our valuations performed through June 30, 2020, in accordance with the Practice Aid, we determined the Option Pricing Method (&#x201c;OPM&#x201d;) was the most appropriate method for determining the fair value of our common stock based on our stage of development and other relevant factors. The OPM uses a market approach to estimate our enterprise value. The OPM treats common stock and redeemable convertible preferred stock as call options on</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">120</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the total equity value of a company, with exercise prices based on the value thresholds at which the allocation among the various holders of a company&#x2019;s securities changes. Under this method, the common stock has value only if the funds available for distribution to stockholders exceeded the value of the redeemable convertible preferred stock liquidation preferences at the time of the liquidity event, such as a strategic sale or a merger. A discount for lack of marketability of the common stock is then applied to arrive at an indication of value for the common stock.</span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For our valuations performed after June 30, 2020 through December 31, 2020, in accordance with the Practice Aid, we determined the hybrid method was the most appropriate method for determining the fair value of our common stock based on our stage of development and other relevant factors. The hybrid method also uses a market approach to estimate our enterprise value. It is a probability-weighted expected return method (&#x201c;PWERM&#x201d;), where the equity value in one or more scenarios is calculated using an OPM. The PWERM is a scenario-based methodology that estimates the fair value of our common stock based upon an analysis of our future values, assuming various outcomes. The common stock value is based on the probability-weighted present value of expected future investment returns considering each of the possible outcomes available as well as the rights of each class of stock. The future value of the common stock under each outcome is discounted back to the valuation date at an appropriate risk-adjusted discount rate and probability weighted to arrive at an indication of value for the common stock.</span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The assumptions underlying these valuations represented management's best estimates, which involved inherent uncertainties and the application of management judgment. As a result, if factors or expected outcomes change and we used significantly different assumptions or estimates, our equity-based compensation expense could have been materially different.</span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Se</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">e Note 9 to ou</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">r audited consolidated financial statements included elsewhere in this Annual Report for information concerning certain of the specific assumptions we used in applying the Black-Scholes option pricing model to determine the estimated fair value of our stock options granted in the years ended December 31, 2021 and  2020.</span></p>
  <p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Following completion of the IPO on February 9, 2021, it is no longer necessary for our board of directors to estimate the fair value of our common stock in connection with our accounting for granted stock options and other such awards we may grant, as the fair value of our common stock will be determined based on the quoted market price of our common stock.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Recent Accounting Pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A description of recently issued accounting pronouncements that may potentially impact our financial position and results of operations is disclosed in Note 2 to our audited consolidated financial statements included in this Annual Report.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Emerging Growth Company and Smaller Reporting Company Status</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In April 2012, the JOBS Act was enacted. Section 107 of the JOBS Act provides that an &#x201c;emerging growth company&#x201d; can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act of 1933, as amended, for complying with new or revised accounting standards. Thus, an emerging growth company can delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We elected the extended transition period for complying with new or revised accounting standards, which delays the adoption of these accounting standards until they would apply to private companies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, as an emerging growth company, we may take advantage of specified reduced disclosure and other requirements that are otherwise applicable generally to public companies. These provisions include:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">being permitted to present only two years of audited consolidated financial statements in addition to any required unaudited interim consolidated financial statements, with correspondingly reduced disclosure in </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">121</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;visibility:hidden;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;"></span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the section titled &#x201c;Management&#x2019;s Discussion and Analysis of Financial Condition and Results of Operations&#x201d;;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">an exception from compliance with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act of 2002, as amended; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">reduced disclosure about our executive compensation arrangements in our periodic reports, proxy statements and registration statements; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">exemptions from the requirements of holding non-binding advisory votes on executive compensation or golden parachute arrangements; and </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">an exemption from compliance with the requirements of the Public Company Accounting Oversight Board regarding the communication of critical audit matters in the auditor&#x2019;s report on consolidated financial statements. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We may take advantage of these provisions until the last day of the fiscal year ending after the fifth anniversary of our initial public offering or such earlier time that we no longer qualify as an emerging growth company. We will cease to qualify as an emerging growth company on the date that is the earliest of: (i) the last day of our fiscal year following the fifth anniversary of the date of the completion of our initial public offering; (ii) the last day of the fiscal year in which we have more than $1.07 billion in total annual gross revenues; (iii) the date on which we are deemed to be a &#x201c;large accelerated filer&#x201d; under the rules of the SEC, which means the market value of our common stock that is held by non-affiliates exceeds $700 million as of the prior June 30th and we have been a public company for at least 12 months and have filed one annual report on Form 10-K; or (iv) the date on which we have issued more than $1.0 billion of non-convertible debt over the prior three-year period. We may choose to take advantage of some but not all of these reduced reporting burdens. We have taken advantage of certain reduced reporting requirements in this this Annual Report. Accordingly, the information contained herein may be different than you might obtain from other public companies in which you hold equity interests.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are also a &#x201c;smaller reporting company.&#x201d; If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company, we may choose to present only the two most recent fiscal years of audited consolidated financial statements in our Annual Report and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;" id="item_7a_quantitative_qualitative_disclos"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 7A. Quantitative and Qualitati</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ve Disclosures About Market Risk.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are a smaller reporting company, as defined in Rule 12b-2 under the Securities Exchange Act of 1934, as</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">amended, for this reporting period and are not required to provide the information required under this item.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">122</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;" id="item_8_financial_statements_supplementar"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 8. Financial Statement</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">s and Supplementary Data.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The financial statements required to be filed pursuant to this Item 8 are appended to this Annual Report on Form 10-K. An index of those financial statements is found in Item 15, Exhibits and Financial Statement Schedules, of this Annual Report on Form 10-K.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_9_changes_in_disagreements_with_acc"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 9. Changes in and Disagreements With Acco</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">untants on Accounting and Financial Disclosure.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;" id="item_9a_controls_procedures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 9A. Controls </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">and Procedures.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:13.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Evaluation of Disclosure Controls and Procedures</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures as of December 31, 2021. The term &#x201c;disclosure controls and procedures,&#x201d; as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the &#x201c;Exchange Act&#x201d;), means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission&#x2019;s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company&#x2019;s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Our management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and our management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of December 31, 2021, our Chief Executive Officer and Chief Financial Officer concluded that, as of such date, our disclosure controls and procedures were effective at the reasonable assurance level.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Management&#x2019;s Annual Report on Internal Control over Financial Reporting</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Management is responsible for establishing and maintaining adequate internal control over financial reporting, as such term is defined in Rule 13a-15(f) under the Exchange Act. Our management conducted an assessment of the effectiveness of our internal control over financial reporting based on the criteria set forth in &#x201c;Internal Control-Integrated Framework (2013)&#x201d; issued by the Committee of Sponsoring Organization of the Treadway Commission. Based on this assessment, management concluded that, as of December 31, 2021, our internal control over financial reporting was effective.<br /></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This Annual Report on Form 10-K does not include an attestation report of our independent registered public accounting firm on internal control over financial reporting due to an exemption established by the JOBS Act for &#x201c;emerging growth companies.&#x201d;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Changes in Internal Control over Financial Reporting.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There were no changes in our internal control over financial reporting that occurred during our most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_9b_or_information"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 9B. Other </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Information.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">None.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_9c_foreign_jurisdictions"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 9C. Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Not applicable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">123</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="part_iii"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">PART III</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;" id="item_10_directors_officers"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 10. Directors, Executive Officers and Corporate Governance</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">.</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table provides information regarding our current executive officers, other key employees and</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">directors, including their ages as of March 1, 2022:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:48.04%;"></td>
    <td style="width:1.624%;"></td>
    <td style="width:5.416%;"></td>
    <td style="width:1.624%;"></td>
    <td style="width:43.297%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Name</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Age</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Position(s)</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Executive Officers</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Robert Ang, M.B.B.S., M.B.A.</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">47</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;President, Chief Executive Officer and Director</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Tirtha Chakraborty, Ph.D.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">49</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;Chief Scientific Officer</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Nathan Jorgensen, Ph.D., M.B.A.</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">45</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;Chief Financial Officer</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Christopher Slapak, M.D.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">63</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;Chief Medical Officer</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Non-Employee Directors</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Matthew Patterson </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:normal;font-size:5.36pt;font-family:Times New Roman;position:relative;">(1)(2)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;Chair of the Board of Directors</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Daniella Beckman </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:normal;font-size:5.36pt;font-family:Times New Roman;position:relative;">(2)(3)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">43</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;Director</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">David C. Lubner </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:normal;font-size:5.36pt;font-family:Times New Roman;position:relative;">(2)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">57</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;Director</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Sven (Bill) Ante Lundberg, M.D. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:normal;font-size:5.36pt;font-family:Times New Roman;position:relative;">(3)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">58</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;Director</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Kush Parmar, M.D., Ph.D. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:normal;font-size:5.36pt;font-family:Times New Roman;position:relative;">(1)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;Director</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Joshua Resnick, M.D. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:normal;font-size:5.36pt;font-family:Times New Roman;position:relative;">(1)(3)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">47</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#xfeff;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;Director</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.750pt solid;margin-right:66.667%;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:2.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Member of the nominating and corporate governance committee.</span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Member of the audit committee. </span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(3)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Member of the compensation committee. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Executive Officers</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Robert Ang, M.B.B.S., M.B.A.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">has served as our Chief Executive Officer and a member of our board of directors since August 2019. Prior to that, Dr. Ang served as Chief Business Officer at Neon Therapeutics Inc., a biopharmaceutical company, from October 2015 until August 2019, and as Senior Vice President, Business Development at Bavarian Nordic A/S, an immuno-oncology and infectious disease vaccine company, from 2013 to 2015. Dr. Ang has served on the board of directors of Enara Bio Limited, a private biotechnology company, since September 2021 and the Alliance for Regenerative Medicine (</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ARM</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201d;</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">), an international advocacy organization representing the gene and cell therapy and broader regenerative medicine sector, since January 2022. Dr. Ang received an M.B.B.S. medical degree from the University of Western Australia and an M.B.A. from Columbia University. We believe that Dr. Ang is qualified to serve on our board of directors due to his service as our President and Chief Executive Officer and his experience in the field of medicine and biotechnology.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Tirtha Chakraborty, Ph.D</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> has served as our Chief Scientific Officer since November 2020 and previously as our Vice President, Head of Research starting in October 2019. From October 2018 to October 2019, Dr. Chakraborty served as Vice President of Cell Therapy Research at Sana Biotechnology, Inc., a biotechnology company. Prior to that, Dr. Chakraborty served as an Executive Director and Head of Hematology at CRISPR Therapeutics AG, a biotechnology company (</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x201c;CRISPR Therapeutics&#x201d;)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, from 2015 to October 2018. From 2011 to 2015, Dr. Chakraborty was responsible for building the therapeutic mNRA platform at Moderna, Inc., a biotechnology company pioneering messenger RNA therapeutics and vaccines. Dr. Chakraborty received a Ph.D. from Tata Institute of Fundamental Research and completed his post-doctoral associateship at Harvard Medical School.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Nathan Jorgensen, Ph.D.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> M.B.A.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, has served as our Chief Financial Officer since May 2020. From August 2016 to April 2020, Dr. Jorgensen led global healthcare investments for Qatar Investment Authority, the sovereign wealth fund for the State of Qatar. Dr. Jorgensen served as investment analyst at Calamos Investments, a global investment firm, from 2013 to August 2016. Dr. Jorgensen received a Ph.D. from the University of Minnesota and an M.B.A. from Cornell University Johnson Graduate School of Management.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Christopher Slapak, M.D.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, has served as our Chief Medical Officer since July 2020 and previously served in a consulting role as our Chief Medical Officer from July 2019 to July 2020. From January 2018 to July 2020, Dr. Slapak provided oncology consulting services to pharmaceutical companies, including Takeda Oncology and</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">124</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Translational Drug Development, Inc. From July 2018 to June 2019, Dr. Slapak served in a consulting role as Chief Medical Officer for Prelude Therapeutics, Inc., a precision oncology company. Dr. Slapak served in roles of increasing responsibility at Eli Lilly and Company from 1996 to December 2017, including most recently as Vice President, Early Phase Development Oncology. Dr. Slapak is also a clinical associate professor of medicine and clinical pharmacology at the Indiana University School of Medicine. Dr. Slapak received a B.S. in chemistry from The Ohio State University and an M.D. from the University of Chicago Pritzker School of Medicine.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Non-Employee Directors</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Matthew Patterson</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> has served as a member of our board of directors since October 2020 and as chairman since June 2021. Mr. Patterson is the co-founder of Audentes Therapeutics, Inc. (&#x201c;Audentes&#x201d;) and he served as Chief Executive Officer of Audentes from 2012 until its acquisition by Astellas Pharma, Inc. in January 2020. Mr. Patterson is the Executive Chairman at Remix Therapeutics, Inc. and Iris Medicine, Inc., each a private biotechnology company. He also serves on the board of directors of Homology Medicines, Inc., a public gene therapy company (&#x201c;Homology Medicines&#x201d;), and 5:01 Acquisition Corp, a public special purpose acquisition company, since January 2018 and October 2020, respectively, and as the executive chairman of the board of directors of Remix Therapeutics, Inc., a private biotechnology company, since March 2021. Mr. Patterson was a member of the board of directors of ARM since 2015 until 2020, including as a chair in 2019 and 2020. Mr. Patterson received a B.A. in Biochemistry from Bowdoin College. We believe that Mr. Patterson is qualified to serve on our board of directors due to his expertise in the fields of business, biotechnology and drug development.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Daniella Beckman</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> has served as a member of our board of directors since July 2020. Since September 2019, she has served as the Chief Financial Officer of Tango Therapeutics, a public targeted oncology biotechnology company. From November 2015 to September 2019, she provided consulting services and served as the Interim Chief Financial Officer for several early-stage biotechnology companies. Ms. Beckman has served on the board of directors and is a member of the audit committee of Translate Bio, Inc., a clinical-stage mRNA therapeutics company, since October 2017, on the board of directors of 5:01 Acquisition Corp, a public special purpose acquisition company, since October 2020 and on the board of directors of Blueprint Medicines Corp, a public, global precision therapy company, since December 2021. Ms. Beckman received a B.S. in business administration-accounting from Boston University. We believe that Ms. Beckman is qualified to serve on our board of directors due to her financial expertise and her experience in public accounting in the life sciences industry.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">David C. Lubner </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">has served as a member of our board of directors since July 2020. From January 2016 to June 2020, Mr. Lubner served as the Executive Vice President and Chief Financial Officer of Ra Pharmaceuticals, a biotechnology company acquired by UCB S.A. in April 2020. Mr. Lubner has served on the boards of directors of Dyne Therapeutics, Inc., a public biotechnology company, since March 2020, Gemini Therapeutics, Inc., a public precision medicine company, since April 2020, Arcellx Inc., a public biotechnology company, since August 2020, Point Biopharma, Inc., a public late-stage clinical precision oncology (&#x201c;Point Biopharma&#x201d;), since June 2021 and several private companies. Mr. Lubner previously served on the board of directors of Nightstar Therapeutics plc, a gene therapy company, from July 2017 until it was acquired by Biogen Inc in June 2019 and Therapeutics Acquisition Corp., a special purpose acquisition company, from May 2020 until June 2021 when it merged with Point Biopharma. Mr. Lubner received a B.S. in business administration from Northeastern University and an M.S. in taxation from Bentley University. Mr. Lubner is also a member of the American Institute of Certified Public Accountants and is a certified public accountant in Massachusetts. We believe Mr. Lubner is qualified to serve on our board of directors due to his financial and accounting experience and his service as a director and executive officer of other biotechnology companies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Sven (Bill) Ante Lundberg, M.D.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, has served as a member of our board of directors since March 2019. Since December 2019, he has served as President, Chief Executive Officer and Principal Financial Officer, and Executive Director of Merus N.V., a clinical-stage immune-oncology company. From 2015 to February 2018, Dr. Lundberg was Chief Scientific Officer of CRISPR Therapeutics. Dr. Lundberg received an M.D. from Stanford University and an M.B.A. from the University of Massachusetts. He completed post-doctoral training at the Whitehead Institute/MIT and clinical training in Medicine and Medical Oncology from Harvard and the Dana-Farber Cancer Institute. We believe that Dr. Lundberg is qualified to serve on our board of directors due to his experience in the field of medicine and clinical drug development as well as his leadership and business experience.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Kush Parmar, M.D., Ph.D.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">has served as a member of our board of directors since February 2019, the chairman of our board of directors from January 2021 until June 2021 and served as our interim President and Chief</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">125</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Executive Officer from February 2019 until August 2019. Dr. Parmar is currently a Member of 5AM Venture Management, LLC, where he has worked since 2010, and is Co-Chief Executive Officer and member of the board of directors of 5:01 Acquisition Corp, a public special purpose acquisition company, positions he has held since its inception in August 2020. Dr. Parmar has served on the boards of directors of Homology Medicines, Akouos, Inc., Rallybio Corporation, a public biotechnology company, and Entrada Therapeutics, Inc., a public biotechnology company, since December 2015, October 2017, April 2018 and December 2020, respectively, and previously served on the board of directors of Arvinas, Inc. from 2013 to November 2019, Audentes from 2013 to November 2018 and scPharmaceuticals, Inc. from March 2014 to July 2018. Dr. Parmar received an A.B. in molecular biology and medieval studies from Princeton University, a Ph.D. in experimental pathology from Harvard University and an M.D. from Harvard Medical School. We believe that Dr. Parmar is qualified to serve on our board of directors due to his extensive experience in the venture capital industry, medical and scientific background and training, and service on the boards of other public and private biopharmaceutical and biotechnology companies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Joshua Resnick, M.D.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">has served as a member of our board of directors since February 2019. Dr. Resnick currently serves as a Managing Director at RA Capital Management, a life sciences investment advisor, since October 2018. Dr. Resnick previously served as a Partner at SV Health Investors from January 2016 to September 2018 and as President and Managing Partner at MRL Ventures Fund, an early-stage therapeutics-focused corporate venture fund that he built and managed within Merck &amp; Co., from 2014 to January 2016. Dr. Resnick also has served on the board of directors of Aerovate Therapeutics, Inc., a public clinical stage biopharmaceutical company, since October 2018. Dr. Resnick is on staff in the Department of Emergency Medicine at Massachusetts General Hospital. Dr. Resnick has previously served on the boards of directors of Kalvista Pharmaceuticals, Inc. and Avrobio, Inc. from November 2016 to September 2018 and July 2016 to September 2018, respectively. Dr. Resnick received a B.A. in chemistry from Williams College, an M.D. from the University of Pennsylvania School of Medicine and an M.B.A. from The Wharton School of Business. We believe that Dr. Resnick is qualified to serve on our board of directors due to his experience as a biopharmaceutical and biotechnology public and private company investor.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Family Relationships</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">There are no family relationships among any of our directors or executive officers.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Audit Committee</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our audit committee consists of Daniella Beckman, David C. Lubner and Matthew Patterson, with Daniella Beckman serving as chair of the audit committee. Our board of directors has determined that each of these individuals meets the independence requirements of Rule 10A-3 under the Securities Exchange Act, as amended (the &#x201c;Exchange Act&#x201d;), and the Nasdaq Listing Rules. Each member of our audit committee can read and understand fundamental financial statements in accordance with Nasdaq audit committee requirements. Our board of directors has also determined that Daniella Beckman qualifies as an audit committee financial expert within the meaning of SEC regulations and meets the financial sophistication requirements of the Nasdaq Listing Rules. In arriving at these determinations, the board has examined each audit committee member&#x2019;s scope of experience and the nature of their prior and/or current employment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The functions of our audit committee include, among other things:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">helping our board of directors oversee our corporate accounting and financial reporting processes; </span></div></div>
  <div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">managing the selection, engagement, qualifications, independence and performance of a qualified firm to serve as the independent registered public accounting firm to audit our financial statements; </span></div></div>
  <div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">discussing the scope and results of the audit with the independent registered public accounting firm, and reviewing, with management and the independent accountants, our interim and year-end operating results;</span></div></div>
  <div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">developing procedures for employees to submit concerns anonymously about questionable accounting or audit matters; </span></div></div>
  <div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">reviewing related person transactions; and</span></div></div>
  <div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">approving or, as permitted, pre-approving, audit and permissible non-audit services to be performed by the independent registered public accounting firm. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">126</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We believe that the composition and functioning of our audit committee will comply with all applicable SEC and Nasdaq rules and regulations. We intend to comply with future requirements to the extent they become applicable to us.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Delinquent Section 16(a) Reports</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Section 16(a) of the Exchange Act requires our directors, executive officers and beneficial owners of more than 10% of our common stock to file reports of holdings and transactions in our common stock and other securities of our company with the Securities and Exchange Commission. Based solely on our review of copies of such forms that we have received, or written representations from reporting persons, we believe that during the fiscal year ended December 31, 2021, all executive officers, directors and greater than 10% stockholders complied with all applicable filing requirements under Section 16(a) of the Exchange Act.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Code of Business Conduct and Ethics</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have adopted a Code of Business Conduct and Ethics (the &#x201c;Code of Conduct&#x201d;) applicable to all of our employees, executive officers and directors. This includes our principal executive officer, principal financial officer and principal accounting officer or controller, or persons performing similar functions. A copy of the Code of Conduct is available on our website at </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">www.vorbio.com</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. We intend to post on our website all disclosures that are required by law or the listing standards of the Nasdaq Stock Market concerning any amendments to, or waivers from, any provision of the Code of Conduct.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Stockholder Communications with the Board of Directors</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our board of directors has adopted a formal process by which stockholders may communicate with the board or any of its directors. Stockholders who wish to recommend individuals for consideration to become nominees for election to the board at an annual meeting of stockholders must do so by delivering a written recommendation to the Nominating and Corporate Governance Committee c/o Vor Biopharma Inc., 100 Cambridgepark Dr., Suite 101, Cambridge, MA 02140, Attn: Corporate Secretary. Each submission must set forth: the name and address of the stockholder on whose behalf the submission is made; the number and class of our shares that are owned beneficially by such stockholder as of the date of the submission; the full name of the proposed candidate; a description of the proposed candidate&#x2019;s business experience for at least the previous five years; complete biographical information for the proposed candidate; and a description of the proposed candidate&#x2019;s qualifications as a director. Any such submission must be accompanied by the written consent of the proposed candidate to be named as a nominee and to serve as a director if elected. All written submissions received from stockholders that include the information described above will be reviewed by the committee at its next appropriate meeting.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;" id="item_11_executive_comp"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 11. Executive Compensation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our named executive officers for the year ended December 31, 2021 consist of our principal executive officer, Robert Ang, our President and Chief Executive Officer, and our next two most highly compensated executive officers Dr. Tirtha Chakraborty, our Chief Scientific Officer, and Dr. Christopher Slapak, our Chief Medical Officer.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Summary Compensation Table</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table provides information regarding the compensation provided to our named executive officers for the years ended December 31, 2021 and 2020.</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:22.775%;"></td>
    <td style="width:1.1%;"></td>
    <td style="width:5.555%;"></td>
    <td style="width:1.1%;"></td>
    <td style="width:10.02%;"></td>
    <td style="width:1.1%;"></td>
    <td style="width:10.02%;"></td>
    <td style="width:1.1%;"></td>
    <td style="width:10.02%;"></td>
    <td style="width:1.1%;"></td>
    <td style="width:11.302%;"></td>
    <td style="width:1.1%;"></td>
    <td style="width:11.302%;"></td>
    <td style="width:1.1%;"></td>
    <td style="width:11.302%;"></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Name and Principal Position</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Year</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Salary<br />($)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Bonus<br />($)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Option<br />Awards<br />($)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:bold;font-size:4.69pt;font-family:Times New Roman;position:relative;">(1)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Non-Equity<br />Incentive Plan<br />Compensation<br />($)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:bold;font-size:4.69pt;font-family:Times New Roman;position:relative;">(2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">All Other<br />Compensation<br />($)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Total<br />($)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Robert Ang, M.B.B.S.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Times New Roman;position:relative;">(3)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><br />&#160;&#160;&#160;President and Chief<br />&#160;&#160;&#160;Executive Officer</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">2021<br />2020</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">507,760<br />424,173</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Calibri;">&#x2014;<br />&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">919,080<br />1,619,356</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">218,705<br />211,200</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">17,992</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Times New Roman;position:relative;">(4)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><br />500,015</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Times New Roman;position:relative;">(5)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">1,663,537<br />2,754,744</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Tirtha Chakraborty, Ph.D. <br />&#160;&#160;&#160;Chief Scientific Officer</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">2021<br />2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">384,022<br />298,439</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;<br />47,600</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Calibri;position:relative;">(7)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;<br />718,008</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">138,701<br />111,784</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">17,915</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Times New Roman;position:relative;">(6)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><br />2,059 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Times New Roman;position:relative;">(8)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">540,638<br />1,177,890</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Christopher Slapak, M.D. <br />&#160;&#160;&#160;Chief Medical Officer</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">2021<br />2020</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">428,012<br />176,846</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Times New Roman;position:relative;">(10)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Calibri;">&#x2014;<br />&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;<br />627,356</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">150,593<br />136,800</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">12,043</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Times New Roman;position:relative;">(9)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><br />283,344</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Times New Roman;position:relative;">(11)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">590,648<br />1,224,346</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">127</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.750pt solid;margin-right:66.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:-3.52%;padding-left:3.4%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">This column reflects the full grant date fair value of stock awards and option awards granted during the year measured pursuant to Financial Accounting Standard Board Accounting Standards Codification Topic 718 (&#x201c;ASC 718&#x201d;), which is the basis for computing stock-based compensation in our financial statements. This calculation assumes that the named executive officer will perform the requisite service for the award to vest in full as required by SEC rules. These amounts do not reflect the actual economic value that will be realized by the named executive officer upon vesting of the stock options, the exercise of the stock options or the sale of the common stock underlying such stock options. See Note 9 to our consolidated financial statements appearing elsewhere in this Annual Report on Form 10-K (&#x201c;Annual Report&#x201d;). </span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">The amounts disclosed represent performance bonuses earned in the applicable year listed in the row. </span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(3)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Dr. Ang is also a member of our board of directors but did not receive any additional compensation in his capacity as a director. </span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(4)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Consists of $10,150 in defined benefit plan contributions, $4,000 health savings account contributions, $1,970 in aggregate for life insurance and disability insurance premiums paid by us on Dr. Ang's behalf and $1,872 for commuting expenses.</span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(5)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Consists of $497,920 resulting from our forgiveness of a loan to Dr. Ang, an aggregate of $1,645 in life insurance and disability insurance premiums paid by us on Dr. Ang&#x2019;s behalf and reimbursement of $450 in commuting expenses.</span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(6)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Consists of $10,150 in defined benefit plan contributions, $4,000 health savings account contributions, $1,893 in aggregate for life insurance and disability insurance premiums paid by us on Dr. Chakraborty&#x2019;s behalf and $1,872 for commuting expenses. </span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(7)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Dr. Chakraborty was awarded a one-time bonus in connection with his promotion to Chief Scientific Officer. </span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(8)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Consists of an aggregate of $1,609 in life insurance and disability insurance premiums paid by us on Dr. Chakraborty&#x2019;s behalf and reimbursement of $450 in commuting expenses in 2020.</span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(9)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Consists of $10,150 in defined benefit plan contributions and $1,893 in aggregate for life insurance and disability insurance premiums paid by us Dr. Slapak's behalf.</span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(10)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Dr. Slapak commenced employment with us as our Chief Medical Officer in July 2020. </span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(11)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Consists of $282,592 paid to Christopher Slapak Consulting LLC for Dr. Slapak&#x2019;s consulting services to us from January 2020 until his commencement of employment with us in July 2020 and an aggregate of $752 in life insurance and disability insurance premiums paid by us on Dr. Slapak&#x2019;s behalf in 2020. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Narrative to the Summary Compensation Table</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We review compensation annually for all employees, including our executive officers. In setting executive base salaries and bonuses and granting equity incentive awards, we consider compensation for comparable positions at peer companies in the market, the historical compensation levels of our executives, individual performance as compared to our expectations and objectives, our desire to motivate our employees to achieve short- and long-term results that are in the best interests of our stockholders and a long-term commitment to our company. We do not target a specific competitive position or a specific mix of compensation among base salary, bonus or long-term incentives.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our board of directors and compensation committee of our board of directors has historically determined our executive officers&#x2019; compensation and our committee has typically reviewed and discussed management&#x2019;s proposed compensation with our chief executive officer for all executives other than our chief executive officer. Based on those discussions and its discretion, our compensation committee approved the compensation of our executives other than our chief executive officer and our board of directors, upon recommendation from our compensation committee, then approved the compensation of our chief executive officer.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Annual Base Salary</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have entered into offer letters with each of our named executive officers that establish annual base salaries, which are generally determined, approved and reviewed periodically by our board of directors or compensation committee in order to compensate our named executive officers for the satisfactory performance of duties to our company. Annual base salaries are intended to provide a fixed component of compensation to our named executive officers, reflecting their skill sets, experience, roles and responsibilities. Base salaries for our named executive officers have generally been set at levels deemed necessary to attract and retain individuals with superior talent. See &#x201c;&#x2014;Offer Letters and Potential Payments Upon Termination or Change in Control.&#x201d;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Non-Equity Incentive Plan Compensation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In accordance with the terms of their offer letters, our named executive officers are eligible to receive discretionary annual bonuses of up to a percentage of each officer&#x2019;s gross base salary based on individual performance, company performance or as otherwise determined appropriate, as determined by our board of directors and our compensation committee. In 2021, our named executive officers were eligible to earn an annual target performance bonus of each executive&#x2019;s 2021 base salary based on achievement of certain corporate objectives. Dr. Ang was eligible to earn 50% of his 2021 base salary and Drs. Slapak and Chakraborty were each eligible to earn 40% of their 2021 base salaries.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">128</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Equity-Based Incentive Awards</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our equity-based incentive awards are designed to align our interests with those of our employees and consultants, including our executive officers. Our board of directors has historically been responsible for approving equity grants. Vesting of equity awards is generally tied to continuous service with us and serves as an additional retention measure. Our executives generally are awarded an initial new hire grant upon commencement of employment. We have also made true-up awards following certain financing events or promotions. Additional grants may occur periodically in order to specifically incentivize executives with respect to achieving certain corporate goals or to reward executives for exceptional performance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table provides information regarding the outstanding equity awards held by our named executive officers as of December 31, 2021.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Outstanding Equity Awards at December 31, 2021</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:19.392%;"></td>
    <td style="width:1.038%;"></td>
    <td style="width:6.796%;"></td>
    <td style="width:1.006%;"></td>
    <td style="width:0.46%;"></td>
    <td style="width:12.339%;"></td>
    <td style="width:0.46%;"></td>
    <td style="width:1.038%;"></td>
    <td style="width:0.46%;"></td>
    <td style="width:12.339%;"></td>
    <td style="width:0.46%;"></td>
    <td style="width:1.038%;"></td>
    <td style="width:0.899%;"></td>
    <td style="width:5.64%;"></td>
    <td style="width:0.46%;"></td>
    <td style="width:1.038%;"></td>
    <td style="width:6.753%;"></td>
    <td style="width:1.038%;"></td>
    <td style="width:13.057%;"></td>
    <td style="width:1.038%;"></td>
    <td style="width:0.46%;"></td>
    <td style="width:12.329%;"></td>
    <td style="width:0.46%;"></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="15" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;">Option Awards</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.0485pt;white-space:pre-wrap;font-weight:bold;font-size:4.355pt;font-family:Times New Roman;position:relative;">(1)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="4" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;">Stock Awards</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.0485pt;white-space:pre-wrap;font-weight:bold;font-size:4.355pt;font-family:Times New Roman;position:relative;">(1)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;">Name</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;">Grant<br />Date</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;">Number of<br />Securities<br />Underlying<br />Unexercised<br />Options<br />(#)<br />Exercisable</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;">Number of<br />Securities<br />Underlying<br />Unexercised<br />Options<br />(#)<br />Unexercis-<br />able</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;">Option<br />Exercise<br />Price<br />($)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;">Option<br />Expiration<br />Date</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;">Number of<br />Shares or Units<br />of Stock that<br />Have Not Vested (#)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:6.5pt;font-family:Times New Roman;">Market Value of<br />Shares or Units of<br />Stock that Have Not<br />Vested ($)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.0485pt;white-space:pre-wrap;font-weight:bold;font-size:4.355pt;font-family:Times New Roman;position:relative;">(2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">Robert Ang,<br />&#160;&#160;&#160;M.B.B.S.</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">08/05/19</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">  </span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">  </span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">  </span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">  </span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">152,549 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.0485pt;white-space:pre-wrap;font-weight:normal;font-size:4.355pt;font-family:Times New Roman;position:relative;">(3)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">1,772,619</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">03/10/20</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">66,773 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.0485pt;white-space:pre-wrap;font-weight:normal;font-size:4.355pt;font-family:Times New Roman;position:relative;">(4)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">80,521</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">2.18</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">03/09/30</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">  </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">  </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">08/21/20</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">230,947</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">421,139 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.0485pt;white-space:pre-wrap;font-weight:normal;font-size:4.355pt;font-family:Times New Roman;position:relative;">(5)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">1.90</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">08/20/30</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">  </span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">  </span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">02/05/21</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">11,701</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">39,359 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.0485pt;white-space:pre-wrap;font-weight:normal;font-size:4.355pt;font-family:Times New Roman;position:relative;">(5)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">18.00</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">02/04/31</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">  </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">  </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">Christopher Slapak,<br />&#160;&#160;&#160;M.D.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">08/21/20</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">51,029</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">102,059 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.0485pt;white-space:pre-wrap;font-weight:normal;font-size:4.355pt;font-family:Times New Roman;position:relative;">(5)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">1.90</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">08/20/30</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">  </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">  </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">08/25/20</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">92,509</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">60,610 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.0485pt;white-space:pre-wrap;font-weight:normal;font-size:4.355pt;font-family:Times New Roman;position:relative;">(6)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">1.90</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">08/24/30</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">  </span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">  </span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">Tirtha Chakraborty,<br />&#160;&#160;&#160;Ph.D.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">09/25/19</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">8,567</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">20,233 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.0485pt;white-space:pre-wrap;font-weight:normal;font-size:4.355pt;font-family:Times New Roman;position:relative;">(6)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">1.36</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">09/24/29</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">  </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">  </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">03/10/20</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">13,730</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">10,680 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.0485pt;white-space:pre-wrap;font-weight:normal;font-size:4.355pt;font-family:Times New Roman;position:relative;">(6)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">2.18</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">03/09/30</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">  </span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">  </span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">08/21/20</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">25,024</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">45,632 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.0485pt;white-space:pre-wrap;font-weight:normal;font-size:4.355pt;font-family:Times New Roman;position:relative;">(5)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">1.90</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">08/20/30</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">  </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">  </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:6.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:middle;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">11/18/20</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">32,858</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">88,465 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.0485pt;white-space:pre-wrap;font-weight:normal;font-size:4.355pt;font-family:Times New Roman;position:relative;">(6)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">6.53</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">11/17/30</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">  </span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;text-align:center;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">  </span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.750pt solid;margin-right:66.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <div style="margin-left:2.667%;display:flex;margin-top:12.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">All equity awards were granted under our 2015 Plan, the terms of which are described below under the subsection titled &#x201c;&#x2014;Equity Incentive Plans&#x2014;2015 Stock Incentive Plan,&#x201d; and our 2021 Equity Incentive Plan (the &#x201c;2021 Plan&#x201d; , the terms of which are described below under the subsection titled &#x201c;&#x2014;Equity Incentive Plans&#x2014;2021 Equity Incentive Plan.&#x201d;</span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">This column represents the fair market value of a share of our common stock of $11.62 as of December 31, 2021, which was the closing price of our common stock as reported on the Nasdaq Global Select Market on December 31, 2021, multiplied by the amount shown in the column &#x201c;Stock Awards&#x2014;Number of Shares or Units of Stock That Have Not Vested.&#x201d; </span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(3)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">The shares were acquired pursuant to the exercise of unvested options granted to Dr. Ang on August 5, 2019 and are subject to our right of repurchase upon Dr. Ang&#x2019;s termination of service. The shares will be released from our repurchase right in equal monthly installments on the fifth day of each month through August 5, 2023, subject to continuous service with us as of each such date. The restricted shares are subject to vesting acceleration, as described in more detail below under the subsection titled &#x201c;&#x2014;Offer Letters and Potential Payments Upon Termination or Change in Control.&#x201d; </span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(4)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Twenty-five percent of the shares subject to the option vest on the first anniversary of the vesting commencement date, and thereafter the remaining shares subject to the option vest in 36 equal monthly installments on each monthly anniversary thereafter, subject to continuous service with us as of each such vesting date. The option is exercisable immediately with respect to all shares subject to the option granted on such date, subject to a repurchase right in favor of us which lapses as the option vests. As a result, this reflects the number of shares subject to the option that were exercisable and vested as of December 31, 2021. The option is subject to vesting acceleration, as described in more detail below under the subsection titled &#x201c;&#x2014;Offer Letters and Potential Payments Upon Termination or Change in Control.&#x201d; </span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(5)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">The shares subject to the option vest in 48 equal monthly installments beginning on the vesting commencement date, subject to continuous service as of the vesting cliff date set forth in the table above and further subject to continuous service as of each such vesting date. </span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(6)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Twenty-five percent of the shares subject to the option vest on the first anniversary of the vesting commencement date, and thereafter the remaining shares subject to the option vest in 36 equal monthly installments on each monthly anniversary thereafter, subject to continuous service with us as of each such vesting date.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">401(k) Plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We maintain a defined contribution retirement plan that provides eligible U.S. employees, including our named executive officers, with an opportunity to save for retirement. The plan is intended to qualify as a tax-qualified 401(k) plan so that contributions to the 401(k) plan, and income earned on such contributions, are not taxable to participants until withdrawn or distributed from the 401(k) plan (except in the case of contributions under</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">129</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the 401(k) plan designated as Roth contributions). For more information regarding our 401(k) plan see Note 13 to our consolidated financial statements appearing elsewhere in this Annual Report.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Health and Welfare Benefits; Perquisites</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our named executive officers are eligible to participate in our other benefit programs on the same basis as all employees of our company. We generally do not provide perquisites or personal benefits except in limited circumstances.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Severance and Change in Control Benefits Plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In January 2021, we adopted our Executive Severance and Change in Control Benefits Plan (the &#x201c;Severance Plan&#x201d;), for certain of our employees, including each of our executive officers. Under the terms of the Severance Plan, if the employment of any of our officers or vice presidents is terminated by us without cause or by the officer for good reason prior to or more than 12 months following a change in control, each as defined in the Severance Plan, and subject to the employee&#x2019;s execution of a general release of potential claims against us and a non-competition agreement, we have agreed to continue to pay the employee&#x2019;s then-current base salary for a period of 12 months, in the case of our C-level officers, and six months, in the case of our vice presidents, and to pay premiums for continuation of health coverage under COBRA for up to 12 months, in the case of our C-level officers, and up to six months, in the case of our vice presidents.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Alternatively, if a covered employee&#x2019;s employment is terminated by us without cause or by the employee for good reason within one year following a change in control, and subject to the employee&#x2019;s execution of a general release of potential claims against us and a non-competition agreement, we have agreed, in the case of our chief executive officer, to pay a lump sum payment in an amount equal to 18 months of his then-current base salary, in the case of our other C-level officers, to pay a lump sum payment in an amount equal to 12 months of his or her then-current base salary and, in the case of our vice presidents, to pay a lump sum payment in an amount equal to six months of his or her then-current base salary; to pay premiums for continuation of health coverage under COBRA for up to 18 months, in the case of our chief executive officer, up to 12 months, in the case of our other C-level officers, and up to six months, in the case of our vice presidents; to pay a lump sum payment in an amount equal to 150%, in the case of our chief executive officer, 100%, in the case of our C-level officers, and 50%, in the case of our vice presidents, of the employee&#x2019;s target annual bonus as then in effect; and to accelerate the vesting of any outstanding equity grants in full.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, in the event any of the amounts provided for under the Severance Plan or otherwise would constitute a &#x201c;parachute payment&#x201d; within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended (the &#x201c;Code&#x201d;) and such payments would be subject to the excise tax imposed by Section 4999 of the Code, then such payments will either be (i) provided to the employee in full, or (ii) reduced to such lesser amount that would result in a smaller or no portion of such payments being subject to the excise tax, whichever amount, after taking into account all applicable taxes, including the excise tax, would result in the employee&#x2019;s receipt, on an after-tax basis, of the greatest amount of such payments.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Offer Letters and Potential Payments Upon Termination or Change in Control</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are party to offer letters with each of our named executive officers. The agreements generally provide for at-will employment without any specific term and set forth the named executive officer&#x2019;s initial base salary, eligibility for employee benefits and severance benefits upon a qualifying termination of employment or change in control of our company. Each of our named executive officers has executed our standard confidentiality, intellectual property assignment and non-solicitation agreement. The key terms of the offer letters with our named executive officers, including potential payments upon termination or change in control, are described below.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Dr. Robert Ang</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We entered into an offer letter with Robert Ang in June 2019 in connection with his appointment as our President and Chief Executive Officer. The offer letter provides for a base salary of $395,000 per year, a one-time signing bonus of $76,000 and a target annual bonus equal to 40% of Dr. Ang&#x2019;s annual base salary based on the achievement of goals established by our board of directors. Our board of directors has increased Dr. Ang's annual base salary, including most recently in February 2022, to $570,000 for 2022 and subsequent years. Additionally, in January 2021, our Board of directors approved an increase in Dr. Ang&#x2019;s target annual bonus to 50% of his annual salary. The offer letter further provided for the grant of stock options.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">130</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to benefits pursuant to the Severance Plan, as described above, Dr. Ang is also entitled to severance benefits pursuant to his offer letter. Pursuant to his offer letter, if we terminate Dr. Ang&#x2019;s employment without cause, or if Dr. Ang terminates his employment for good reason or due to death or disability, each as defined in Dr. Ang&#x2019;s offer letter, he will be entitled to (i) cash severance equal to continued base salary payments commencing on Dr. Ang&#x2019;s termination date until the first anniversary of such termination date (the &#x201c;Ang Severance Period&#x201d;), paid in equal monthly installments in accordance with our standard payroll policies and (ii) if he timely elects to continue health coverage through COBRA, direct payment of, or reimbursement for, COBRA premiums for Dr. Ang and his covered dependents for the Ang Severance Period or, if earlier, until Dr. Ang is eligible for healthcare coverage under another employer&#x2019;s plan. These severance benefits are conditioned upon Dr. Ang&#x2019;s resignation from all positions with us, execution of a release agreement, return of company property and compliance with his confidentiality, intellectual property assignment and non-solicitation agreement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Notwithstanding the foregoing, in the event we undergo a change in control, as defined in Dr. Ang&#x2019;s offer letter, Dr. Ang&#x2019;s then-outstanding equity awards granted pursuant to the offer letter will vest in full, subject to Dr. Ang&#x2019;s continued service through the date of such change in control.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Dr. Tirtha Chakraborty</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We entered into an offer letter with Tirtha Chakraborty in August 2019 in connection with his hiring as our Vice President of Research. The offer letter provides for a base salary of $285,000 per year and a target annual bonus equal to 30% of Dr. Chakraborty&#x2019;s annual base salary based on the achievement of goals established by our board of directors. Dr. Chakraborty&#x2019;s annual base salary was increased to $325,000 in connection with his appointment as our Chief Scientific Officer in November 2020. Additionally, in January 2021, our board of directors approved an increase in Dr. Chakraborty&#x2019;s annual base salary for 2021 and subsequent years to $390,200 and an increase of his target annual bonus to 40% of his annual salary. In January 2022, our compensation committee approved an increase in annual base salary for 2022 and subsequent years to $430,000. In addition, under the offer letter Dr. Chakraborty received a one-time signing bonus equal to $30,000, with an additional payment to cover all taxes resulting from the payment of the signing bonus. The offer letter further provided for the grant of stock options. Dr. Chakraborty is also eligible to receive benefits pursuant to the Severance Plan.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Dr. Christopher Slapak</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We entered into an offer letter with Christopher Slapak in July 2020 in connection with his hiring as our full-time Chief Medical Officer. The offer letter provides for a base salary of $380,000 per year and a target annual bonus equal to 30% of Dr. Slapak&#x2019;s annual base salary based on the achievement of goals established by our board of directors. Additionally, in January 2021, our Board of directors approved an increase in Dr. Slapak&#x2019;s annual base salary for 2021 and subsequent years to $432,600 and an increase of his target annual bonus to 40% of his annual salary. In January 2022, our compensation committee approved an increase in annual base salary for 2022 and subsequent years to $450,100. The offer letter further provided for the grant of stock options.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition to benefits pursuant to the Severance Plan, as described above, Dr. Slapak is also entitled to severance benefits pursuant to his offer letter. Pursuant to his offer letter, if we terminate Dr. Slapak&#x2019;s employment without cause, or if Dr. Slapak terminates his employment for good reason, each as defined in Dr. Slapak&#x2019;s offer letter, he will be entitled to (i) cash severance equal to continued base salary payments commencing on Dr. Slapak&#x2019;s termination date until the first anniversary of such termination date (the &#x201c;Slapak Severance Period&#x201d;), paid in equal monthly installments in accordance with our standard payroll policies and (ii) if he timely elects to continue health coverage through COBRA, direct payment of, or reimbursement for, COBRA premiums for Dr. Slapak and his covered dependents for the Slapak Severance Period or, if earlier, until Dr. Slapak is eligible for healthcare coverage under another employer&#x2019;s plan. These severance benefits are conditioned upon Dr. Slapak&#x2019;s resignation from all positions with us, execution of a release agreement, return of all company property and compliance with his confidentiality, intellectual property assignment and non-solicitation agreement.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dr. Slapak provided consulting services to us prior to the commencement of his full-time employment as our Chief Medical Officer and received consulting fees of $500 per hour. See &#x201c;Certain Relationships and Related Transactions, and Director Independence&#x2014;Consulting Agreement with Christopher Slapak Consulting LLC.&#x201d;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">131</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Equity Incentive Plans</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">2021 Equity Incentive Plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our board of directors adopted and our stockholders approved our 2021 Plan in February 2021. The 2021 Plan became effective on February 5, 2021, from which point no further grants were or will be made under our 2015 Plan, as described in &#x201c;&#x2014;Equity Incentive Plans&#x2014;2015 Stock Incentive Plan.&#x201d; Our 2021 Plan provides for the grant of stock options qualifying as incentive stock options (&#x201c;ISOs&#x201d;) within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (the &#x201c;Code&#x201d;), to our employees and for the grant of nonstatutory stock options (&#x201c;NSOs&#x201d;), restricted stock awards, restricted stock unit awards, stock appreciation rights, performance stock awards and other forms of stock compensation to our employees, consultants and directors. As of March 1, 2022, there were options to purchase 2,463,098 shares of our common stock outstanding under the 2021 Plan, at a weighted average exercise price of $11.51 per share, and 200 options to purchase shares of our common stock have been exercised. Our employees, officers, directors, consultants, and advisors are eligible to receive awards under the 2021 Plan; however, incentive stock options may only be granted to our employees.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Authorized Shares</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. As of March 1, 2022, the number of shares of our common stock reserved for issuance under our 2021 Plan is the sum of (i) 2,481,648 and (ii) the number of shares of our common stock subject to outstanding awards under our 2015 Plan that expire or are forfeited, canceled, withheld to satisfy tax withholding or to purchase or exercise an award, repurchased by us or are otherwise terminated. The number of shares of our common stock reserved for issuance under our 2021 Plan automatically increases on January 1 of each year, for a period of ten years, from January 1, 2022 continuing through January 1, 2031, by 4% of the total number of shares of our common stock outstanding on December 31 of the preceding calendar year, or a lesser number of shares as may be determined by our board of directors. The maximum number of shares that may be issued pursuant to the exercise of ISOs under the 2021 Plan is 23,742,528.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Administration</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Our board of directors, or a duly authorized committee thereof (referred to herein as the &#x201c;administrator&#x201d;), has the authority to administer our 2021 Plan. Our board of directors has delegated its authority to administer our 2021 Plan to our compensation committee under the terms of the compensation committee&#x2019;s charter. Our board of directors may also delegate to one or more of our officers the authority to (i) designate employees other than officers to receive specified stock awards and (ii) determine the number of shares of our common stock to be subject to such stock awards. Subject to the terms of our 2021 Plan, the administrator has the authority to determine the terms of awards, including recipients, the exercise price or strike price of stock awards, if any, the number of shares subject to each stock award, the fair market value of a share of our common stock, the vesting schedule applicable to the awards, together with any vesting acceleration, the form of consideration, if any, payable upon exercise or settlement of the stock award and the terms and conditions of the award agreements for use under our 2021 Plan.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The administrator has the power to modify outstanding awards under our 2021 Plan. Subject to the terms of our 2021 Plan, the administrator has the authority to reprice any outstanding option or stock award, cancel and re-grant any outstanding option or stock award in exchange for new stock awards, cash or other consideration, or take any other action that is treated as a repricing under generally accepted accounting principles, with the consent of any adversely affected participant.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Corporate Transactions</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The following applies to stock awards under the 2021 Plan in the event of certain specified corporate transactions, unless otherwise provided in a participant&#x2019;s stock award agreement or other written agreement with us or one of our affiliates or unless otherwise expressly provided by the plan administrator at the time of grant.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the event of a corporate transaction, any stock awards outstanding under the 2021 Plan may be assumed, continued or substituted for by any surviving or acquiring corporation (or its parent company), and any reacquisition or repurchase rights held by us with respect to the stock award may be assigned to our successor (or its parent company). If the surviving or acquiring corporation (or its parent company) does not assume, continue or substitute for such stock awards, then (i) with respect to any such stock awards that are held by participants whose continuous service has not terminated prior to the effective time of the corporate transaction, or current participants, the vesting (and exercisability, if applicable) of such stock awards will be accelerated in full (or, in the case of performance awards with multiple vesting levels depending on the level of performance, vesting will accelerate at 100% of the target level) to a date prior to the effective time of the corporate transaction (contingent upon the effectiveness of the corporate transaction), and such stock awards will terminate if not exercised (if applicable) at or prior to the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">132</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">effective time of the corporate transaction, and any reacquisition or repurchase rights held by us with respect to such stock awards will lapse (contingent upon the effectiveness of the corporate transaction), and (ii) any such stock awards that are held by persons other than current participants will terminate if not exercised (if applicable) prior to the effective time of the corporate transaction, except that any reacquisition or repurchase rights held by us with respect to such stock awards will not terminate and may continue to be exercised notwithstanding the corporate transaction.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the event a stock award will terminate if not exercised prior to the effective time of a corporate transaction, the plan administrator may provide, in its sole discretion, that the holder of such stock award may not exercise such stock award but instead will receive a payment equal in value to the excess (if any) of (i) the per share amount payable to holders of our common stock in connection with the corporate transaction, over (ii) any per share exercise price payable by such holder, if applicable. In addition, any escrow, holdback, earn out or similar provisions in the definitive agreement for the corporate transaction may apply to such payment to the same extent and in the same manner as such provisions apply to the holders of our common stock.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under the 2021 Plan, a significant corporate transaction is generally the consummation of (i) a sale or other disposition of all or substantially all of our consolidated assets; (ii) a sale or other disposition of at least 50% of our outstanding securities; (iii) a merger, consolidation or similar transaction following which we are not the surviving corporation; or (iv) a merger, consolidation or similar transaction following which we are the surviving corporation but the shares of our common stock outstanding immediately prior to such transaction are converted or exchanged into other property by virtue of the transaction.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Amendment or Termination</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Our board has the authority to amend, suspend, or terminate our 2021 Plan, provided that such action does not materially impair the existing rights of any participant without such participant&#x2019;s written consent. No ISOs may be granted after the tenth anniversary of the date our board of directors adopts our 2021 Plan.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">2015 Stock Incentive Plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The 2015 Plan was adopted by our board of directors and approved by our stockholders in December 2015. The 2015 Plan provides for the grant of ISOs, NSOs, restricted stock awards, restricted stock units, stock appreciation rights and other stock-based awards. Our employees, officers, directors, consultants and advisors are eligible to receive awards under the 2015 Plan; however, ISOs may only be granted to our employees. As of March 1, 2022, there were 3,216,311 shares of common stock issuable upon the exercise of stock options outstanding under the 2015 Plan at a weighted-average exercise price of $2.42 per share, and options to purchase 1,117,991 shares of our common stock had been exercised, including 573,128 restricted shares of common stock that were issued related to early exercise of unvested options. As of February 5, 2021, we ceased making grants of stock options or other awards under the 2015 Plan. However, any shares of common stock subject to awards under our 2015 Plan that expire, terminate, or otherwise are surrendered or canceled without being fully exercised, are forfeited (including as the result of shares of common stock subject to such award being repurchased by us at the original issuance price pursuant to a contractual repurchase right) or results in any common stock not being issued will become available for issuance under our 2021 Plan. Further, shares of common stock tendered to us by a participant to exercise an award shall be added to shares of common stock available for the grant of awards under the 2015 Plan.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Administration</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Our board of directors, or a committee appointed by our board, administers the 2015 Plan and, subject to any limitations set forth in the 2015 Plan, will select the recipients of awards, determine the number of shares of common stock to be subject to such stock awards and specify the other terms and conditions, including the exercise price or purchase price and vesting schedule, applicable to such stock awards. Our board of directors has delegated its authority to administer our 2021 Plan to our compensation committee under the terms of the compensation committee&#x2019;s charter Our board of directors has delegated its authority to administer our 2021 Plan to our compensation committee under the terms of the compensation committee&#x2019;s charter.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If a stock award granted under the 2015 Plan expires, terminates or otherwise is surrendered or canceled without being exercised in full, is forfeited in whole or in part (including as the result of shares of common stock subject to such award being repurchased by us at the original issuance price pursuant to a contractual repurchase right), or results in any common stock not being issued, the shares of our common stock not acquired pursuant to the stock award again will become available for subsequent issuance under the 2021 Plan. Further, shares of common stock tendered to us by a participant to exercise an award shall be added to shares of common stock available for the grant of awards under the 2021 Plan.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">133</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Changes to Capital Structure. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon the occurrence of any stock split, reverse stock split, stock dividend, recapitalization, combination of shares, reclassification of shares, spinoff, or other similar change in capitalization or event, or any dividend or distribution to holders of our common stock other than an ordinary cash dividend, under the terms of the 2015 Plan, we are required to equitably adjust (or make substitute awards, if applicable), in the manner determined by our board of directors or compensation committee:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the number and class of securities available under the 2015 Plan; </span></div></div>
  <div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the number and class of securities and exercise price per share of each outstanding option; </span></div></div>
  <div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the share and per-share provisions and the measurement price of each outstanding stock appreciation right; </span></div></div>
  <div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the number of shares subject to and the repurchase price per share subject to each outstanding restricted stock award; and </span></div></div>
  <div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the share and per-share-related provisions and the purchase price, if any, of each outstanding other stock-based award. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Reorganization Events</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Upon the occurrence of a merger or consolidation of our company with or into another entity as a result of which all of our common stock is converted into or exchanged for the right to receive cash, securities, or other property or is cancelled; any transfer or disposition of all of our common stock for cash, securities, or other property pursuant to a share exchange or other transaction; or a liquidation or dissolution of our company, our board of directors may, on such terms as our board of directors determines, take any one or more of the following actions pursuant to the 2015 Plan, as to some or all outstanding awards, other than restricted stock awards:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">provide that awards shall be assumed, or substantially equivalent awards shall be substituted, by the acquiring or succeeding corporation (or an affiliate thereof); </span></div></div>
  <div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">upon written notice to a plan participant, provide that the participant&#x2019;s unexercised awards will terminate immediately prior to the consummation of such transaction unless exercised by the participant (to the extent then exercisable) within a specified period; </span></div></div>
  <div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">provide that outstanding awards shall become exercisable, realizable or deliverable, or restrictions applicable to an award shall lapse, in whole or in part, prior to or upon such transaction; </span></div></div>
  <div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">in the event of a transaction under the terms of which holders of common stock will receive upon consummation thereof a cash payment for each share surrendered in the transaction, make or provide for a cash payment to a plan participant; </span></div></div>
  <div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">provide that, in connection with a liquidation of dissolution of the company, awards shall convert into the right to receive liquidation proceeds; or </span></div></div>
  <div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any combination of the foregoing. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our board of directors is not obligated under the 2015 Plan to treat all awards, all awards held by a participant, or all awards of the same type, identically.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon the occurrence of any corporate transaction described above, other than our liquidation or dissolution, our repurchase and other rights under each outstanding restricted stock award will continue for the benefit of our successor and will, unless our board of directors or compensation committee determines otherwise, apply to the cash, securities, or other property which our common stock was converted into or exchanged for in the transaction in the same manner and to the same extent as they applied to the common stock subject to the restricted stock award; provided, however, that our board of directors or the compensation committee may provide termination or deemed satisfaction of such repurchase or other rights under the restricted stock award agreement, either initially or by amendment, or provide for forfeiture of such restricted stock if issued at no cost. Upon our liquidation or dissolution, except to the extent specifically provided to the contrary in the restricted stock award agreement or any other agreement between the plan participant and us, all restrictions and conditions on all restricted stock awards then outstanding will automatically be deemed terminated or satisfied. Our board of directors or our compensation committee, in their sole discretion, may accelerate the exercisability of any option or time at which any restrictions shall lapse or be removed from any restricted stock award, as the case may be.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">134</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Amendment and Termination</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Our board of directors and the compensation committee has the authority to amend, suspend or terminate the 2015 Plan, provided that, if approval of our stockholders is required, our board of directors and compensation committee may not effect such modification or amendment without such approval. Unless otherwise specified, any amendment to the 2015 Plan shall apply to all outstanding awards, and be binding on holders of such awards, at the time the amendment is adopted, provided that our board of directors determines such amendment does not materially and adversely affect the rights of the holders. Unless terminated sooner by our board of directors or compensation committee, the 2015 Plan will automatically terminate on December 30, 2025. No stock awards may be granted under the 2015 Plan while it is suspended or terminated.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">2021 Employee Stock Purchase Plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our board of directors adopted and our stockholders approved our 2021 Employee Stock Purchase Plan (the &#x201c;ESPP&#x201d;) in February 2021. The ESPP became effective on February 5, 2021. The purpose of the ESPP is to secure the services of new employees, to retain the services of existing employees and to provide incentives for such individuals to exert maximum efforts toward our success. The ESPP includes two components. One component is designed to allow eligible U.S. employees to purchase common stock in a manner that may qualify for favorable tax treatment under Section 423 of the Code. In addition, purchase rights may be granted under a component that does not qualify for such favorable tax treatment when necessary or appropriate to permit participation by eligible employees who are foreign nationals or employed outside of the United States while complying with applicable foreign laws. The ESPP is intended to qualify as an &#x201c;employee stock purchase plan&#x201d; within the meaning of Section 423 of the Code.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Share Reserve</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The ESPP authorizes the issuance of shares of our common stock pursuant to purchase rights granted to our employees or to employees of any of our designated affiliates. The ESPP provides participating employees with the opportunity to purchase up to an aggregate of 745,754 shares of our common stock. The number of shares of our common stock reserved for issuance automatically increases on January 1 of each calendar year, from January 1, 2022 through January 1, 2031, by the lesser of (i) 1% of the total number of shares of our common stock outstanding on December 31 of the preceding calendar year, and (ii) 1,800,000 shares; provided, that prior to the date of any such increase, our board of directors may determine that such increase will be less than the amount set forth in clauses (i) and (ii). If purchase rights granted under the ESPP terminate without having been exercised, the shares of our common stock not purchased under such purchase rights will again become available for issuance under the ESPP.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Administration</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Our board of directors has delegated concurrent authority to administer the ESPP to our compensation committee. The ESPP is implemented through a series of offerings under which eligible employees are granted purchase rights to purchase shares of our common stock on specified dates during such offerings. Under the ESPP, we may specify offerings with durations of not more than 27 months, and may specify shorter purchase periods within each offering. Each offering will have one or more purchase dates on which shares of our common stock will be purchased for employees participating in the offering. An offering under the ESPP may be terminated under certain circumstances.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Corporate Transactions</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. In the event of certain significant corporate transactions, including (i) a sale of all or substantially all of our assets, (ii) the sale or disposition of more than 50% of our outstanding securities, (iii) the consummation of a merger or consolidation where we do not survive the transactions and (iv) the consummation of a merger or consolidation where we do survive the transaction but the shares of our common stock outstanding immediately prior to such transaction are converted or exchanged into other property by virtue of the transaction, any then-outstanding rights to purchase our stock under the ESPP may be assumed, continued or substituted for by any surviving or acquiring entity (or its parent company). If the surviving or acquiring entity (or its parent company) elects not to assume, continue or substitute for such purchase rights, then the participants&#x2019; accumulated payroll contributions will be used to purchase shares of our common stock within ten business days prior to such corporate transaction, and such purchase rights will terminate immediately.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Amendments or Termination</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Our board of directors and compensation committee has the authority to amend or terminate our ESPP, provided that except in certain circumstances such amendment or termination may not materially impair any outstanding purchase rights without the holder&#x2019;s consent.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of March 1, 2022, we have not made any offerings under our the ESPP.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Limitations on Liability and Indemnification Matters</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">135</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our amended and restated certificate of incorporation contains provisions that limit the liability of our current and former directors for monetary damages to the fullest extent permitted by Delaware law. Delaware law provides that directors of a corporation will not be personally liable for monetary damages for any breach of fiduciary duties as directors, except liability for:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any breach of the director&#x2019;s duty of loyalty to the corporation or its stockholders; </span></div></div>
  <div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law; </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">unlawful payments of dividends or unlawful stock repurchases or redemptions as provided in Section 174 of the Delaware General Corporation Law; or </span></div></div>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any transaction from which the director derived an improper personal benefit. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These limitations of liability do not apply to liabilities arising under federal securities laws and does not affect the availability of equitable remedies such as injunctive relief or rescission.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our amended and restated certificate of incorporation and our amended and restated bylaws provide that we are required to indemnify our directors to the fullest extent permitted by Delaware law. Our amended and restated bylaws will also provide that, upon satisfaction of certain conditions, we are required to advance expenses incurred by a director in advance of the final disposition of any action or proceeding, and permit us to secure insurance on behalf of any officer, director, employee or other agent for any liability arising out of his or her actions in that capacity regardless of whether we would otherwise be permitted to indemnify him or her under the provisions of Delaware law. Our amended and restated bylaws also provide our board of directors with discretion to indemnify our officers and employees when determined appropriate by the board.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have entered into indemnification agreements with each of our directors and executive officers. With certain exceptions, these agreements provide for indemnification for related expenses including, among other things, attorneys&#x2019; fees, judgments, fines and settlement amounts incurred by any of these individuals in any action or proceeding. We believe that these bylaw provisions and indemnification agreements are necessary to attract and retain qualified persons as directors and executive officers. We also maintain customary directors&#x2019; and officers&#x2019; liability insurance.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The limitation of liability and indemnification provisions in our amended and restated certificate of incorporation and amended and restated bylaws may discourage stockholders from bringing a lawsuit against our directors for breach of their fiduciary duty. They may also reduce the likelihood of derivative litigation against our directors and officers, even though an action, if successful, might benefit us and other stockholders. Further, a stockholder&#x2019;s investment may be adversely affected to the extent that we pay the costs of settlement and damage awards against directors and officers as required by these indemnification provisions. At present, there is no pending litigation or proceeding involving any of our directors, officers or employees for which indemnification is sought and we are not aware of any threatened litigation that may result in claims for indemnification.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Insofar as indemnification for liabilities arising under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;), may be permitted for our directors, executive officers or persons controlling us, we have been informed that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Rule 10b5-1 Sales Plans</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our directors and executive officers may adopt, and some have adopted, written plans, known as Rule 10b5-1 plans, in which they will contract with a broker to buy or sell shares of our common stock on a periodic basis. Under a Rule 10b5-1 plan, a broker executes trades pursuant to parameters established by the director or officer when entering into the plan, without further direction from them. The director or officer may amend a Rule 10b5-1 plan in some circumstances and may terminate a plan at any time. Our directors and executive officers also may buy or sell additional shares outside of a Rule 10b5-1 plan when they are not in possession of material nonpublic information subject to compliance with the terms of our insider trading policy.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">136</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Non-Employee Director Compensation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our board of directors adopted a non-employee director compensation policy in January 2021 that became effective on February 5, 2021 and is applicable to all of our non-employee directors. This compensation policy provides that each such non-employee director will receive the following compensation for service on our board of directors:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">an annual cash retainer of $35,000; </span></div></div>
  <div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">an additional annual cash retainer for service as Chair of board of directors in an amount to be determined by the Board each year and which has been set at $30,000 for 2021 and subsequent years; </span></div></div>
  <div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">an additional annual cash retainer of $7,500, $5,000 and $4,000 for service as a member of the audit committee, compensation committee and the nominating and corporate governance committee, respectively; </span></div></div>
  <div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">an additional annual cash retainer of $15,000, $10,000 and $8,000 for service as chair of the audit committee, compensation committee and the nominating and corporate governance committee, respectively; </span></div></div>
  <div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">an initial option grant to purchase 33,823 shares of our common stock on the date of each such non-employee director&#x2019;s appointment to our board of directors, with the shares vesting in 36 equal monthly installments, subject to continued service as a director through the vesting date; and </span></div></div>
  <div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">an annual option grant to purchase 16,911 shares of our common stock on the date of each of our annual stockholder meetings, beginning with our 2022 annual stockholder meeting, with the shares vesting on the earlier of the first anniversary of the date of grant or the next annual stockholders meeting, subject to continued service as a director though the applicable vesting date. </span></div></div>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We also will continue to reimburse our non&#x2011;employee directors for reasonable travel and other expenses incurred in connection with attending our board of director and committee meetings. We do not pay any compensation to our President and Chief Executive Officer in connection with his service on our board of directors. The compensation that we pay to our President and Chief Executive Officer is discussed earlier in this &#x201c;Executive Compensation&#x201d; section.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each of the option grants described above will be granted under our 2021 Plan, the terms of which are described in more detail above under the section titled &#x201c;Executive Compensation&#x2014;Employee Benefit Plans&#x2014;2021 Equity Incentive Plan.&#x201d; Each option awarded to directors under the non-employee director compensation policy will be subject to accelerated vesting upon a &#x201c;change in control&#x201d; (as defined in the 2021 Plan). The term of each option will be ten years, subject to earlier termination as provided in the 2021 Plan.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our board of directors approved a grant to each of our non-employee directors of an option to purchase 16,900 shares of our common stock effective on February 5, 2021 with an exercise price per share equal $18.00 per share, with the shares vesting in 36 equal monthly installments, subject to continued service through the vesting date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">2021 Director Compensation Table</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table sets forth information regarding the compensation earned for service on our board of directors in 2021 by our non-employee directors, including the outstanding equity awards held by our non-employee directors as of December 31, 2021. Robert Ang, our President and Chief Executive Officer, is also a member of our board of directors but did not receive any additional compensation for service as a director.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:51.135%;"></td>
    <td style="width:1.563%;"></td>
    <td style="width:0.557%;"></td>
    <td style="width:13.605%;"></td>
    <td style="width:0.557%;"></td>
    <td style="width:1.563%;"></td>
    <td style="width:0.557%;"></td>
    <td style="width:13.616%;"></td>
    <td style="width:0.557%;"></td>
    <td style="width:1.563%;"></td>
    <td style="width:0.557%;"></td>
    <td style="width:13.616%;"></td>
    <td style="width:0.557%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Name</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Fees<br />Earned or<br />Paid in<br />Cash ($)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Option<br />Awards<br />($)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;font-family:Times New Roman;position:relative;">(1)(2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Total ($)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Matthew Patterson</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">62,204</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">304,200</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">366,404</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Daniella Beckman</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">52,569</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">304,200</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">356,769</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">David C. Lubner</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">41,285</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">304,200</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">345,485</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Sven (Bill) Ante Lundberg, M.D.</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">39,028</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">304,200</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">343,228</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Kush Parmar, M.D., Ph.D.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">37,845</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">304,200</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">342,045</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Joshua Resnick, M.D.</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">44,236</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">304,200</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">348,436</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">137</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;border-bottom:0.750pt solid;margin-right:66.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Times New Roman;"> </span>&#160;</p>
  <p style="text-indent:-3.52%;padding-left:3.4%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:2.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">This column reflects the full grant date fair value of options granted during the year measured pursuant to ASC 718, which is the basis for computing stock-based compensation in our financial statements. See Note 9 to our consolidated financial statements appearing elsewhere in this Annual Report for information concerning certain of the specific assumptions we used in valuing options. </span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">The table below shows the aggregate number equity awards outstanding for each of our directors who is not a named executive officer, as of December 31, 2021.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Arial;"> </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.517%;"></td>
    <td style="width:1.616%;"></td>
    <td style="width:0.557%;"></td>
    <td style="width:14.012%;"></td>
    <td style="width:0.557%;"></td>
    <td style="width:1.616%;"></td>
    <td style="width:0.557%;"></td>
    <td style="width:14.012%;"></td>
    <td style="width:0.557%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Name</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Number of<br />Outstanding<br />Options</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Number of<br />Outstanding<br />Unvested<br />Stock</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Matthew Patterson</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">16,900</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">30,897</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Daniella Beckman</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">58,096</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">David C. Lubner</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">58,096</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">-</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Sven (Bill) Ante Lundberg, M.D.</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">37,862</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">9,198</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Kush Parmar, M.D., Ph.D.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">16,900</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">-</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Joshua Resnick, M.D.</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">16,900</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">-</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Compensation Committee Interlocks and Insider Participation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">None of our directors who serve as a member of our compensation committee is, or has at any time during the past year been, one of our officers or employees. None of our executive officers currently serves, or in the past year has served, as a member of the board of directors or compensation committee of any other entity that has one or more executive officers serving on our board of directors or compensation committee.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;" id="item_12_security_ownership_matters"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table sets forth information with respect to the beneficial ownership of our common stock, as of March 1, 2022 by:</span></p>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each person known by us to beneficially own more than 5% of our common stock;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">each of our directors;</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">each of our named executive officers; and</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All of our executive officers and directors as a group. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The column entitled &#x201c;Percentage of Shares Beneficially Owned&#x201d; is based on a total of 37,487,370 shares of our common stock outstanding as of March 1, 2022.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The number of shares beneficially owned by each stockholder is determined under rules issued by the Securities and Exchange Commission (the &#x201c;SEC&#x201d;) and includes voting or investment power with respect to securities. Under these rules, beneficial ownership includes any shares as to which the individual or entity has sole or shared voting power or investment power. In computing the number of shares beneficially owned by an individual or entity and the percentage ownership of that person, shares of common stock subject to options, warrants, or other rights held by such person that are currently exercisable or will become exercisable within 60 days after March 1, 2022 are considered outstanding, although these shares are not considered outstanding for purposes of computing the percentage ownership of any other person. Unless otherwise indicated, the address of all listed stockholders is 100 Cambridgepark Dr., Suite 101, Cambridge, Massachusetts 02140. Each of the stockholders listed has sole voting and investment power with respect to the shares beneficially owned by the stockholder unless noted otherwise, subject to community property laws where applicable.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Except as indicated by the footnotes below, we believe, based on information furnished to us, that each of the stockholders listed has sole voting and investment power with respect to the shares beneficially owned by the stockholder unless noted otherwise, subject to community property laws where applicable.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">138</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.756%;"></td>
    <td style="width:1.617%;"></td>
    <td style="width:0.557%;"></td>
    <td style="width:14.026%;"></td>
    <td style="width:0.557%;"></td>
    <td style="width:1.617%;"></td>
    <td style="width:14.872%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Name of Beneficial Owner</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Number of Shares Beneficially Owned</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Percentage of Shares Beneficially Owned</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Greater than 5% stockholders</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Entities affiliated with RA Capital Healthcare Fund, L.P. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:normal;font-size:5.36pt;font-family:Times New Roman;position:relative;">(1)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">11,120,973</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">29.7%</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Entities affiliated with 5AM Ventures VI, L.P. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:normal;font-size:5.36pt;font-family:Times New Roman;position:relative;">(2)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">6,361,723</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">17.0%</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">PureTech Health LLC </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:normal;font-size:5.36pt;font-family:Times New Roman;position:relative;">(3)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">3,207,200</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">8.6%</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Entities affiliated with FMR, LLC </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:normal;font-size:5.36pt;font-family:Times New Roman;position:relative;">(4)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">3,181,463</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">8.5%</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Named Executive Officer and Directors</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Robert Ang, M.B.B.S</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Times New Roman;position:relative;">(5)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">811,858</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2.2%</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Tirtha Chakraborty, Ph.D</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Times New Roman;position:relative;">(6)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">109,807</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">*</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Christopher Slapak, M.D</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Times New Roman;position:relative;">(7)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">173,888</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">*</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Matthew Patterson </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Times New Roman;position:relative;">(8)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">47,768</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">*</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Daniella Beckman </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Times New Roman;position:relative;">(9)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">24,594</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">*</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">David C. Lubner </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Times New Roman;position:relative;">(9)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">24,594</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">*</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Sven (Bill) Ante Lundberg, M.D. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Times New Roman;position:relative;">(10)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">45,174</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">*</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Kush Parmar, M.D., Ph.D</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Times New Roman;position:relative;">(11)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">6,368,295</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">17.0%</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Joshua Resnick, M.D.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Times New Roman;position:relative;">(12)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">6,572</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">*</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:5.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">All current executive officers and directors as a group (10 persons) </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.283pt;white-space:pre-wrap;font-weight:normal;font-size:4.69pt;font-family:Times New Roman;position:relative;">(13)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">7,748,708</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">20.7%</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:3.0pt;border-bottom:0.750pt solid;margin-right:66.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Arial;"> </span>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">* Represents beneficial ownership of less than one 1%.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Consists of (i) 9,295,647 shares of common stock held by RA Capital Healthcare Fund, L.P. (&#x201c;RA Healthcare&#x201d;) and (ii) 1,825,326 shares of common stock by RA Capital Nexus Fund, L.P. (&#x201c;Nexus Fund&#x201d;). RA Capital Healthcare Fund GP, LLC is the general partner of RA Healthcare and RA Capital Nexus Fund GP, LLC is the general partner of the Nexus Fund. The general partner of RA Capital Management, L.P. (&#x201c;RA Capital&#x201d;) is RA Capital Management GP, LLC, of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the controlling persons. RA Capital serves as investment adviser for the RA Healthcare and the Nexus Fund and may be deemed a beneficial owner, for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;), of any securities of the company held by the RA Healthcare or the Nexus Fund.  RA Healthcare and the Nexus Fund have delegated to RA Capital the sole power to vote and the sole power to dispose of all securities held in RA Healthcare&#x2019;s and the Nexus Fund&#x2019;s portfolio, including the shares of company&#x2019;s common stock. Because RA Healthcare and the Nexus Fund have divested themselves of voting and investment power over the reported securities they hold and may not revoke that delegation on less than 61 days&#x2019; notice, RA Healthcare and the Nexus Fund disclaim beneficial ownership of the securities they hold for purposes of Section 13(d) of the Exchange Act and therefore disclaim any obligation to report ownership of the reported securities under Section 13(d) of the Exchange Act. As managers of RA Capital, Dr. Kolchinsky and Mr. Shah may be deemed beneficial owners for purposes of Section 13(d) of the Exchange Act.  RA Capital, Dr. Kolchinsky, and Mr. Shah disclaim beneficial ownership of the securities other than for the purpose of determining their obligations under Section 13(d) of the Exchange Act. The address of the entities listed above is 200 Berkeley Street, 18th Floor, Boston, Massachusetts 02116. For information regarding RA Capital Management, L.P. and its affiliates, we have relied on a Schedule 13D filed by RA Capital Management, L.P. with the SEC on February 9, 2021.</span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Consists of (i) 4,595,089 shares of common stock held by 5AM Ventures VI, L.P.; and (ii) 1,766,634 shares of common stock held by 5AM Opportunities I, L.P. (collectively, the &#x201c;5AM Holdings&#x201d;). 5AM Partners VI, LLC is the general partner of 5AM Ventures VI, L.P. and may be deemed to have sole investment and voting power over the shares held by 5AM Ventures VI, L.P. Andrew Schwab and Kush Parmar are the managing members of 5AM Partners VI, LLC, and may be deemed to share voting and dispositive power over the shares held by 5AM Ventures VI, L.P. 5AM Opportunities I (GP), LLC is the general partner of 5AM Opportunities I, L.P. and may be deemed to have sole investment and voting power over the shares held by 5AM Opportunities I, L.P. Andrew Schwab and Kush Parmar are the managing members of 5AM Opportunities I (GP), LLC, and may be deemed to share voting and dispositive power over the shares held by 5AM Opportunities I, L.P. Dr. Parmar is also a member of our board of directors. The address of the above persons and entities is 501 2nd Street, Suite 350, San Francisco, California 94107. For information regarding 5AM Ventures VI, L.P. and its affiliates, we have relied on a Schedule 13D and Form 4 filed by 5AM Ventures VI, L.P. with the SEC on February 9, 2021 and November 18, 2021, respectively. </span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(3)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Voting and investment power over the shares held by PureTech Health LLC is exercised by its parent entity, PureTech Health plc. The board of directors of PureTech Health plc consists of Mr. Joichi Ito, Dr. Raju Kucherlapati, Dr. John LaMattina, Dr. Robert Langer, Dame Marjorie Scardino, Dr. Bennett Shapiro, Mr. Christopher Viehbacher, Ms. Daphne Zohar and Mr. Stephen Muniz. None of the members of the board of directors of PureTech Health plc or PureTech Health LLC has individual voting or investment power with respect to such shares. The address for PureTech Health LLC and the individuals listed above is c/o PureTech Health LLC, 6 Tide Street, Boston, Massachusetts 02210. </span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(4)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">FMR LLC reports sole voting power with respect to 611,457 shares and sole dispositive power with respect to 3,181,463 shares. Abigail P. Johnson is a director, the chair, the chief executive officer and the president of FMR LLC. Members of the Johnson family, including Abigail P. Johnson, are the predominant owners, directly or through trusts, of Series B voting common shares of FMR LLC, representing 49% of the voting power of FMR LLC. The Johnson family group and all other Series B shareholders of FMR LLC have entered into a shareholders&#x2019; voting agreement under which all Series B voting common shares will be voted in accordance with the majority vote of Series B voting common shares. Accordingly, through their ownership of voting common shares and the execution of the shareholders&#x2019; voting agreement, members of the Johnson family may be deemed, under the Investment Company Act of 1940, to form a controlling group with respect to FMR LLC. Neither FMR LLC nor Abigail P. Johnson has the sole power to vote or direct the voting of the shares owned directly by the various investment companies registered under the Investment Company Act of 1940 (the &#x201c;Fidelity Funds&#x201d;) advised by Fidelity Management &amp; Research Company, a wholly owned subsidiary of FMR LLC, which power resides with the Fidelity Funds&#x2019; Boards of Trustees. Fidelity Management &amp; Research Company carries out the voting of the shares under written guidelines established by the Fidelity Funds&#x2019; Boards of Trustees. The business address for each person and entity named in this footnote is 245 Summer Street, Boston, Massachusetts 02110. For information regarding FMR LLC, we have relied on a Schedule 13G/A filed by FMR LLC with the SEC on February 8, 2022.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">139</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(5)</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Consists of (i) 412,072 shares of common stock; and (ii) 472,255 shares of common stock issuable upon the exercise of outstanding options exercisable within 60 days of March 1, 2022.  </span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(6)</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Consists of (i) 3,534 shares of common stock; and (ii) 106,273 shares of common stock issuable upon the exercise of outstanding options exercisable within 60 days of March 1, 2022. </span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(7)</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Consists of 173,888 shares of common stock issuable upon the exercise of outstanding options exercisable within 60 days of March 1, 2022. </span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(8)</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Consists of (i) 41,196 shares of common stock and (ii) 6,572 shares of common stock issuable upon the exercise of outstanding options exercisable within 60 days of March 1, 2022. </span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(9)</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Consists of 24,594 shares of common stock issuable upon the exercise of outstanding options exercisable within 60 days of March 1, 2022. </span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(10)</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Consists of (i) 29,432 shares of common stock and (ii) 15,742 shares of common stock issuable upon the exercise of outstanding options exercisable within 60 days of March 1, 2022.</span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(11)</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Consists of (i) the 5AM Holdings and (ii) 6,572 shares of common stock issuable upon the exercise of outstanding options exercisable within 60 days of March 1, 2022. </span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(12)</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Consists of 6,572 shares of common stock issuable upon the exercise of outstanding options exercisable within 60 days of March 1, 2022. Under Dr. Resnick&#x2019;s arrangement with RA Capital, Dr. Resnick holds the foregoing shares for the benefit of the RA Healthcare and the Nexus Fund. Dr. Resnick is obligated to turn over to RA Capital any net cash or stock received from the foregoing shares underlying such option, which will offset advisory fees owed by the RA Healthcare and the Account to RA Capital. Dr. Resnick therefore disclaims beneficial ownership of the foregoing shares of common stock underlying the outstanding options held by him. </span></div></div>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(13)</span><div style="display:inline;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Consists of (i) 5AM Holdings, (ii) 515,503 shares of common stock and (iii) 1,023,440 shares of common stock issuable upon the exercise of outstanding options exercisable within 60 days of March 1, 2022.</span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Securities authorized for issuance under equity compensation plans</span></p>
  <p style="text-indent:6.773%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table contains information about our equity compensation plans as of December 31, 2021. As of December 31, 2021, we had three equity compensation plans. See &#x201c;Item 11. Executive Compensation&#x2014;Equity Incentive Plans&#x201d; for a description of the material terms of each of our equity compensation plans.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Equity Compensation Plan Information</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:34.344%;"></td>
    <td style="width:1.596%;"></td>
    <td style="width:0.546%;"></td>
    <td style="width:19.137%;"></td>
    <td style="width:0.546%;"></td>
    <td style="width:1.596%;"></td>
    <td style="width:1.124%;"></td>
    <td style="width:18.709%;"></td>
    <td style="width:0.546%;"></td>
    <td style="width:1.596%;"></td>
    <td style="width:0.557%;"></td>
    <td style="width:19.158%;"></td>
    <td style="width:0.546%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Plan category</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Number of securities to be issued upon exercise of outstanding options, warrants and rights</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Weighted-average exercise price of outstanding options, warrants and rights</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column(a))</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(a)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(b)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(c)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Equity compensation plans <br />&#160;&#160;&#160;approved by security holders</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">4,886,105</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">6.35</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2,643,187</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Equity compensation plans <br />&#160;&#160;&#160;not approved by security holders</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">200,687</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">1.90</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);text-indent:5.0pt;word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="margin-left:5.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">  </span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Total</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">5,086,792</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">6.17</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">2,643,187</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The table above does not include any amounts issuable under the ESPP because we have not made any offerings under such plan as of December 31, 2021.</span></p>
  <p style="text-indent:6.773%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> In addition, </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">we granted an option to purchase shares of our common stock to an advisor outside of any equity compensation plan approved by our stockholders, but subject to the terms and conditions of the 2015 Plan. The stock option award to purchase </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">294,117</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of our common stock had an exercise price of $28.29 per share, which was four times greater than the fair market value of our common stock on the date of grant, as determined contemporaneously by our board of directors, and is scheduled to vest over four years, with 25% of the shares scheduled to vest on October 21, 2021, and the remainder scheduled to vest ratably at the end of each subsequent month thereafter through October 21, 2024, subject to such advisor's continued service relationship with our company through the applicable vesting dates.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;" id="item_13_related_parties"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 13. Certain Relationships and Related Transactions, and Director Independence</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following is a description of transactions since January 1, 2020 to which we have been a participant in which the amount involved exceeded or will exceed $120,000, and in which any of our directors, executive officers or holders of more than 5% of our voting stock, or any members of their immediate family, had or will have a direct or indirect material interest, other than equity and other compensation, termination, change in control and other arrangements which are described under &#x201c;Executive Compensation.&#x201d;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Series B Preferred Stock Financing</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">140</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In June 2020, we entered into a preferred stock purchase agreement with certain investors, including beneficial owners of greater than 5% of our voting stock and affiliates of members of our board of directors, pursuant to which we issued and sold to such investors an aggregate of 124,519,220 shares of our Series B preferred stock in June 2020 at a purchase price of $0.52 per share for aggregate gross proceeds of $64.7 million, and an aggregate of 87,259,605 additional shares of our Series B preferred stock in January 2021 at a purchase price of $0.52 per shares for aggregate gross proceeds of $45.4 million.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The table below sets forth the aggregate number of shares of Series B preferred stock issued to our related parties:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.538%;"></td>
    <td style="width:1.616%;"></td>
    <td style="width:0.557%;"></td>
    <td style="width:14.001%;"></td>
    <td style="width:0.557%;"></td>
    <td style="width:1.616%;"></td>
    <td style="width:0.557%;"></td>
    <td style="width:14.001%;"></td>
    <td style="width:0.557%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Name</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Series B<br />Preferred<br />Stock<br />(#)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Aggregate<br />Purchase Price<br />($)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Entities affiliated with RA Capital Healthcare Fund, L.P. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:Times New Roman;position:relative;">(1)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">76,923,076</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">40,000,000</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Entities affiliated with FMR, LLC </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:Times New Roman;position:relative;">(2)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">37,259,615</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">19,375,000</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Entities affiliated with 5AM Ventures VI, L.P. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:Times New Roman;position:relative;">(3)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">38,461,536</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">19,999,999</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">PureTech Health LLC </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:Times New Roman;position:relative;">(4)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">1,923,076</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">1,000,000</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:3.0pt;border-bottom:0.750pt solid;margin-right:66.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Arial;"> </span>&#160;</p>
  <div style="margin-left:3.333%;display:flex;margin-top:2.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Joshua Resnick, a member of our board of directors, is a managing director at RA Capital Management. RA Capital Healthcare Fund, L.P. and its affiliates hold more than 5% of our voting stock. </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:2.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Entities affiliated with FMR, LLC collectively hold more than 5% of our voting stock. </span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:2.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">(3)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Kush Parmar, the chairman of our board of directors, is one of the managing members of 5AM Partners VI, LLC, the general partner of 5AM Ventures VI, L.P. and, as a result, may be deemed to share voting and investment power with respect to the shares held by 5AM Ventures VI, L.P.</span></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:2.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">(4)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Bharatt Chowrira, a former member of our board of directors, is the president and chief of business and strategy of PureTech Health LLC. PureTech Health LLC holds more than 5% of our voting stock. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In connection with the closing of our initial public offering on February 9, 2021, all outstanding shares of our Series B preferred stock were converted into shares of our common stock at a ratio of 13.6-for-1 and the foregoing amounts are listed on a pre-conversion basis.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Director Affiliations</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Some of our directors are affiliated with and serve on our board of directors as representatives of entities which beneficially own or owned 5% or more of our common stock, as indicated in the table below:</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:49.258%;"></td>
    <td style="width:1.485%;"></td>
    <td style="width:49.258%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Director</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Principal Stockholder</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Kush Parmar, M.D., Ph.D.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">5AM Ventures VI, L.P. and affiliates</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Joshua Resnick, M.D.</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">RA Capital Healthcare Fund, L.P. and its affiliates</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:13.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Participation in Initial Public Offering</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In our IPO, funds affiliated with RA Capital Healthcare Fund, L.P., 5AM Ventures VI, L.P. and FMR, LLC, each of whom was one of our 5% stockholders at the time of our IPO, purchased 3,222,222, 555,555 and 1,195,566 shares of our common stock, respectively. Such purchases were made through the underwriters at the initial public offering price of $18.00 per share for an aggregate purchase price of $89.5 million.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Promissory Note with Robert Ang</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In September 2019, we entered into a limited recourse promissory note with Dr. Ang, our President and Chief</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Executive Officer, pursuant to which we loaned him the principal amount of $497,920.10 to early exercise stock options. The note accrued interest at 1.5% compounding semi-annually and could be prepaid at any time without penalty. We forgave the principal amount and accrued interest under this promissory note in full in October 2020.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Consulting Agreement with Christopher Slapak Consulting LLC</span></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In July 2019, we entered into a consulting agreement with Christopher Slapak Consulting LLC, an entity</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">wholly owned by Christopher Slapak, who is now our Chief Medical Officer. Pursuant to the consulting agreement, Dr. Slapak agreed to provide services related to the customary job functions of a chief medical officer. In July 2020,</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">141</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dr. Slapak joined us as our full-time Chief Medical Officer, at which point the consulting agreement was terminated. During the length of the consulting agreement, we paid Christopher Slapak Consulting LLC an aggregate of $0.44 million for consulting services and reimbursement of certain expenses.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Investors&#x2019; Rights Agreement</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are a party to an amended and restated investors&#x2019; rights agreement, or the Investors&#x2019; Rights Agreement, dated as of June 30, 2020, with holders of our previously-outstanding preferred stock, including certain of our 5% stockholders and their affiliates and entities affiliated with certain of our officers and directors. This agreement provides these holders the right to demand that we file a registration statement or request that their shares be covered by a registration statement that we are otherwise filing.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Employment Arrangements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have entered into offer letter agreements with each of our executive officers. For more information regarding our employment agreements with our named executive officers, see &#x201c;Executive Compensation&#x2014;Offer Letters and Potential Payments and Benefits Upon Termination or Change in Control.&#x201d;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Indemnification Agreements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our amended and restated certificate of incorporation contains provisions limiting the liability of directors, and our amended and restated bylaws provide that we will indemnify each of our directors to the fullest extent permitted under Delaware law. Our amended and restated certificate of incorporation and amended and restated bylaws also provide our board of directors with discretion to indemnify our officers and employees when determined appropriate by the board.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In addition, we have entered into indemnification agreements with each of our directors and executive officers. For more information regarding these agreements, see &#x201c;Executive Compensation&#x2014;Limitations on Liability and Indemnification Matters.&#x201d;</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Related Person Transaction Policy</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have adopted a related person transaction policy that sets forth our procedures for the identification, review, consideration and approval or ratification of related person transactions, which policy became effective on February 4, 2021. For purposes of our policy only, a related person transaction will be a transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships, in which we and any related person are, were or will be participants in which the amount involved exceeds $120,000. Transactions involving compensation for services provided to us as an employee or director will not be covered by this policy. A related person will be any executive officer, director or beneficial owner of more than 5% of any class of our voting securities, including any of their immediate family members and any entity owned or controlled by such persons.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under the policy, if a transaction has been identified as a related person transaction, including any transaction that was not a related person transaction when originally consummated or any transaction that was not initially identified as a related person transaction prior to consummation, our management must present information regarding the related person transaction to our audit committee, or, if audit committee approval would be inappropriate, to another independent body of our board of directors, for review, consideration and approval or ratification. The presentation must include a description of, among other things, the material facts, the interests, direct and indirect, of the related persons, the benefits to us of the transaction and whether the transaction is on terms that are comparable to the terms available to or from, as the case may be, an unrelated third party or to or from employees generally. Under the policy, we will collect information that we deem reasonably necessary from each director, executive officer and, to the extent feasible, significant stockholder to enable us to identify any existing or potential related-person transactions and to effectuate the terms of the policy. In addition, under our code of business conduct and ethics, our employees and directors will have an affirmative responsibility to disclose any transaction or relationship that reasonably could be expected to give rise to a conflict of interest. In considering related person transactions, our audit committee, or other independent body of our board of directors, will take into account the relevant available facts and circumstances including:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the risks, costs and benefits to us; </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">142</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the impact on a director&#x2019;s independence in the event that the related person is a director, immediate family member of a director or an entity with which a director is affiliated; </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the availability of other sources for comparable services or products; and </span></div></div>
  <div style="margin-left:5.657%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4050538990704133%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the terms available to or from, as the case may be, unrelated third parties or to or from employees generally. </span></div></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The policy will require that, in determining whether to approve, ratify or reject a related person transaction, our audit committee, or other independent body of our board of directors, must consider, in light of known circumstances, whether the transaction is in, or is not inconsistent with, our best interests and those of our stockholders, as our audit committee, or other independent body of our board of directors, determines in the good faith exercise of its discretion.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">All of the transactions described in this section were entered into prior to the adoption of this policy. Although we have not had a written policy for the review and approval of transactions with related persons, our board of directors has historically reviewed and approved any transaction where a director or officer had a financial interest, including the transactions described above. Prior to approving such a transaction, the material facts as to a director&#x2019;s or officer&#x2019;s relationship or interest in the agreement or transaction were disclosed to our board of directors. Our board of directors took this information into account when evaluating the transaction and in determining whether such transaction was fair to us and in the best interest of all our stockholders.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Director Independence</span></p>
  <p style="text-indent:6.773%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Applicable Nasdaq rules (the &#x201c;Nasdaq Listing Rules&#x201d;) require a majority of a listed company&#x2019;s board of directors to be comprised of independent directors, as affirmatively determined by the board of directors. In addition, the Nasdaq Listing Rules require that, subject to specified exceptions, each member of a listed company&#x2019;s audit, compensation and nominating and corporate governance committees be independent and that audit committee members also satisfy independence criteria set forth in Rule 10A-3 under the Securities Exchange Act of 1934, as amended (the &#x201c;Exchange Act&#x201d;). The Nasdaq independence definition includes a series of objective tests, such as that the director is not, and has not been for at least three years, one of our employees, and that neither the director nor any of his or her family members has engaged in various types of business dealings with us. In addition, under applicable Nasdaq rules, a director will only qualify as an &#x201c;independent director&#x201d; if, in the opinion of the listed company&#x2019;s board of directors, that person does not have a relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director.</span></p>
  <p style="text-indent:6.773%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our board of directors has determined that all of our directors other than Robert Ang, by virtue of his employment with us, are &#x201c;independent directors&#x201d; as defined under applicable Nasdaq rules. In making such determination, our board of directors considered the current and prior relationships that each such director has with our company and all other facts and circumstances that our board of directors deemed relevant in determining his or her independence, including the beneficial ownership of our capital stock by each director and the transactions described in this section.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;" id="item_14_accounting_fees"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 14. Principal Accountant Fees and Services</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">.</span></p>
  <p style="text-indent:6.773%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes the fees of Ernst &amp; Young LLP, our independent registered public accounting firm, billed us for each of the last two fiscal years.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.342%;"></td>
    <td style="width:1.606%;"></td>
    <td style="width:1.124%;"></td>
    <td style="width:13.542%;"></td>
    <td style="width:0.557%;"></td>
    <td style="width:1.606%;"></td>
    <td style="width:1.124%;"></td>
    <td style="width:13.542%;"></td>
    <td style="width:0.557%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Calibri;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Category</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:middle;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:middle;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Audit Fees </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-4.6899999999999995pt;white-space:pre-wrap;font-weight:normal;font-size:6.7pt;font-family:Times New Roman;position:relative;">(1)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">815,623</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">870,000</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Audit-Related Fees</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Tax Fees </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:normal;font-size:5.36pt;font-family:Times New Roman;position:relative;">(2)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">62,500</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">All Other Fees</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Total</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">878,123</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">870,000</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;padding-bottom:1.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:3.0pt;border-bottom:0.750pt solid;margin-right:66.667%;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.0pt;font-family:Arial;"> </span>&#160;</p>
  <div style="margin-left:2.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Audit fees consist of fees billed for professional services by Ernst &amp; Young LLP for audit and quarterly review of our consolidated financial statements and review of the registration statement on Form S-1 for our initial public offering, and related services that are normally provided in connection with statutory and regulatory filings or engagements. The aggregate fees included in the Audit Fees are those fees billed for the fiscal year. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">143</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="margin-left:2.667%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;display:inline-flex;font-size:8.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Tax fees consist of fees billed or accrued for professional services by Ernst &amp; Young LLP for tax consulting. </span></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Pre-Approval Policies and Procedures</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The audit committee of our board of directors has adopted policies and procedures for the pre-approval of audit and non-audit services for the purpose of maintaining the independence of our independent auditor. We may not engage our independent auditor to render any audit or non-audit service unless either the service is approved in advance by the audit committee, or the engagement to render the service is entered into pursuant to the audit committee&#x2019;s pre-approval policies and  procedures.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From time to time, our audit committee may pre-approve services that are expected to be provided to us by the independent auditor during the following 12 months. At the time such pre-approval is granted, the audit committee must identify the particular pre-approved services in a sufficient level of detail so that our management will not be called upon to make a judgment as to whether a proposed service fits within the pre-approved services and, at each regularly scheduled meeting of the audit committee following such approval, management or the independent auditor shall report to the audit committee regarding each service actually provided to us  pursuant to such pre-approval.</span></p>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The audit committee has delegated to its chairman the authority to grant pre-approvals of audit or non-audit services to be provided by the independent auditor, provided, that such services are no more than $50,000 per calendar year. Any approval of services by the chairman of the audit committee is reported to the committee at its next regularly scheduled meeting.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">144</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="part_iv"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">PART</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> IV</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_15_exhibits_financial_statement_sch"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 15. Exhibits, Financ</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ial Statement Schedules.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">For a list of the financial statements included herein, see Index to the Consolidated Financial Statements on page F-1 of this Annual Report on Form 10-K, incorporated into this Item by reference. </span></div></div>
  <div style="display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">(2)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Schedules have been omitted since they are either not required or not applicable or the information is otherwise included herein.</span></div></div>
  <div style="display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.333%;">(3)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Exhibits </span></div></div>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:8.017%;"></td>
    <td style="width:1.006%;"></td>
    <td style="width:29.894%;"></td>
    <td style="width:1.006%;"></td>
    <td style="width:6.004%;"></td>
    <td style="width:1.006%;"></td>
    <td style="width:14.984%;"></td>
    <td style="width:1.017%;"></td>
    <td style="width:7.011%;"></td>
    <td style="width:1.006%;"></td>
    <td style="width:17.981%;"></td>
    <td style="width:1.006%;"></td>
    <td style="width:10.061%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="7" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Incorporated by Reference</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Exhibit</span></p><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Number</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Description</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Form</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">File No.</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Exhibit Number</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Filing Date</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Filed Herewith</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001817229/000119312521034387/d117998dex31.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Amended and Restated Certificate of Incorporation of the Registrant</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">8-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">001-39979</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">February 9, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001817229/000119312521034387/d117998dex32.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Amended and Restated Bylaws of the Registrant</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">8-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">001-39979</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">3.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">February 9, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001817229/000119312521023537/d942530dex41.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Form of Common Stock Certificate of the Registrant</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">S-1/A</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">333-252175</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">February 1, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1817229/000119312521023537/d942530dex42.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Amended and Restated Investors&#x2019; Rights Agreement, by and among the Registrant and certain of its stockholders, dated June  30, 2020</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">S-1/A</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">333-252175</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">February 1, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">4.3</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="vor-ex4_3.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Description of the Registrant&#x2019;s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934</span><span style="color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">X</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.1&#134;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001817229/000119312521010219/d942530dex103.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Patent License Agreement, by and between the Registrant and the U.S. Department of</span></a></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001817229/000119312521010219/d942530dex103.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Health and Human Services, as represented by the National Cancer Institute, dated</span></a></p><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001817229/000119312521010219/d942530dex103.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">October 30, 2020</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">S-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">333-252175</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.3</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">January 15, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.2&#134;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1817229/000119312521010219/d942530dex101.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Exclusive License Agreement, by and between the Registrant and The Trustees of Columbia University in the City of New York (&#x201c;Columbia&#x201d;), dated April 28, 2016</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">S-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">333-252175</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">January 15, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.3&#134;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001817229/000119312521010219/d942530dex102.htm"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">First Amendment to Exclusive License Agreement, by and between the Registrant and Columbia, dated February 12, 2019</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">S-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">333-252175</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">January 15, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.4&#134;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001817229/000095017021004072/vor-ex10_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Second Amendment to Exclusive License Agreement, by and between the Registrant and Columbia, dated November 8, 2021</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10-Q</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">001-39979</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">November 10, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">145</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:8.017%;"></td>
    <td style="width:1.006%;"></td>
    <td style="width:29.894%;"></td>
    <td style="width:1.006%;"></td>
    <td style="width:6.004%;"></td>
    <td style="width:1.006%;"></td>
    <td style="width:14.984%;"></td>
    <td style="width:1.017%;"></td>
    <td style="width:7.011%;"></td>
    <td style="width:1.006%;"></td>
    <td style="width:17.981%;"></td>
    <td style="width:1.006%;"></td>
    <td style="width:10.061%;"></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.5</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001817229/000119312521010219/d942530dex104.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Lease Agreement, by and between the Registrant and PPF Off 100 Cambridge Park Drive, LLC (&#x201c;Landlord&#x201d;), dated December 17, 2019</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">S-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">333-252175</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.4</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">January 15, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.6</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/1817229/000156459021033269/vor-ex101_8.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">First Amendment to Lease, by and between the Registrant and the Landlord, dated June 15, 2021</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">8-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">001-39979</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">June 17, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.7</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001817229/000156459021033269/vor-ex102_7.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Second Amendment to Lease, by and between the Registrant and the Landlord, dated June 15, 2021</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">8-K</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">001-39979</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.2</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">June 17, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.8+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001817229/000119312521010219/d942530dex105.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">2015 Stock Incentive Plan and Forms of Option Grant Agreements, Exercise Notices and Restricted Stock Agreement</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">S-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">333-252175</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.5</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">January 15, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.9+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001817229/000119312521023537/d942530dex106.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">2021 Equity Incentive Plan and Forms of Stock Option Grant Notice, Stock Option Agreement, Restricted Stock Unit Grant</span></a><a href="https://www.sec.gov/Archives/edgar/data/0001817229/000119312521023537/d942530dex106.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Notice and Restricted Stock Unit Award Agreement</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">S-1/A</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">333-252175</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.6</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">February 1, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.10+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001817229/000119312521023537/d942530dex107.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">2021 Employee Stock Purchase Plan</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">S-1/A</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">333-252175</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.7</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">February 1, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.11+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001817229/000119312521010219/d942530dex108.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Form of Indemnification Agreement with Executive Officers and Directors</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">S-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">333-252175</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.8</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">January 15, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.12+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001817229/000119312521010219/d942530dex109.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Offer Letter, by and between the Registrant and Robert Ang, dated June 28, 2019</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">S-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">333-252175</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.9</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">January 15, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.13+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001817229/000119312521010219/d942530dex1011.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Offer Letter, by and between the Registrant and Christopher Slapak, dated July 2, 2020</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">S-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">333-252175</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.11</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">January 15, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.14+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001817229/000119312521010219/d942530dex1012.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Offer Letter, by and between the Registrant and Nathan Jorgensen, dated March 20, 2020</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">S-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">333-252175</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.12</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">January 15, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.15+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001817229/000119312521010219/d942530dex1013.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Offer Letter, by and between the Registrant and Tirtha Chakraborty, dated August 28, 2019</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">S-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">333-252175</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.13</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">January 15, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.16+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001817229/000119312521023537/d942530dex1014.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Non-Employee Director Compensation Policy</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">S-1/A</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">333-252175</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.14</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">February 1, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.17+</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001817229/000119312521023537/d942530dex1015.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Executive Severance and Change in Control Benefits Plan</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">S-1/A</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">333-252175</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">10.15</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">February 1, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">21.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="https://www.sec.gov/Archives/edgar/data/0001817229/000119312521010219/d942530dex211.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Subsidiaries of the Registrant</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">S-1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">333-252175</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">21.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">January 15, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">23.1</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="vor-ex23_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Consent of Ernst &amp; Young LLP</span><span style="color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"> </span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">X</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">146</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:8.017%;"></td>
    <td style="width:1.006%;"></td>
    <td style="width:29.894%;"></td>
    <td style="width:1.006%;"></td>
    <td style="width:6.004%;"></td>
    <td style="width:1.006%;"></td>
    <td style="width:14.984%;"></td>
    <td style="width:1.017%;"></td>
    <td style="width:7.011%;"></td>
    <td style="width:1.006%;"></td>
    <td style="width:17.981%;"></td>
    <td style="width:1.006%;"></td>
    <td style="width:10.061%;"></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">31.1*</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="vor-ex31_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">X</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">31.2*</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="vor-ex31_2.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</span><span style="color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"> </span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">X</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:6.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">32.1*</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="vor-ex32_1.htm"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:9.0pt;font-family:Times New Roman;">Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</span><span style="color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:bold;font-size:9.0pt;font-family:Times New Roman;"> </span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">X</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">101.INS</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Inline XBRL Instance Document</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">X</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">101.SCH</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Schema Document</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">X</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">101.CAL</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">X</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">101.DEF</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">X</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">101.LAB</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Label Linkbase Document</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">X</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">101.PRE</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">X</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:9.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">104</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="11" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;line-height:1.1243750000000001;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">The cover page from the Company&#x2019;s Annual Report on Form 10-K for the year ended December 31, 2021, formatted in Inline XBRL.</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">+ Indicates management contract or compensatory plan.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#134; Portions of the exhibit have been omitted as the Registrant has determined that: (i) the omitted information is not material; and (ii) the omitted information is the type that the Registrant treats as private or confidential.</span></p>
  <p style="text-indent:-7.143%;padding-left:6.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">* </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">This certification will not be deemed &#x201c;filed&#x201d; for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;" id="item_16_form_10k_summary"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Item 16. Form</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> 10-K Summary</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">None.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">147</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:center;" id="signatures"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">SIGNAT</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">URES</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">.</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:48.972%;"></td>
    <td style="width:4.069%;"></td>
    <td style="width:0.985%;"></td>
    <td style="width:45.974%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">VOR BIOPHARMA INC.</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date: March 14, 2022</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Robert Ang</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Robert Ang, M.B.B.S., M.B.A.</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">President and Chief Executive Officer</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, this Report has been signed below by the following persons on behalf of the Registrant in the capacities and on the dates indicated.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:35.039%;"></td>
    <td style="width:1.015%;"></td>
    <td style="width:44.995%;"></td>
    <td style="width:1.015%;"></td>
    <td style="width:17.936%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Name</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Title</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Date</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Robert Ang</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">President, Chief Executive Officer and Director</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(Principal Executive Officer)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 14, 2022</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Robert Ang, M.B.B.S., M.B.A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Nathan Jorgensen</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Chief Financial Officer (Principal Financial Officer</span></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">and Principal Accounting Officer)</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 14, 2022</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Nathan Jorgensen, Ph.D., M.B.A.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Matthew Patterson</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Chairman of the Board</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 14, 2022</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Matthew Patterson</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Daniella Beckman</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 14, 2022</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Daniella Beckman</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ David C. Lubner</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 14, 2022</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">David C. Lubner</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Sven (Bill) Ante Lundberg</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 14, 2022</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Sven (Bill) Ante Lundberg, M.D.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Kush M. Parmar</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 14, 2022</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Kush M. Parmar, M.D., Ph.D.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Joshua Resnick</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Director</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 14, 2022</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Joshua Resnick, M.D.</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span>&#160;</p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">148</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">VOR BIOPHARMA INC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">INDEX TO FINANCIAL STATEMENTS</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:91.335%;"></td>
    <td style="width:8.665%;"></td>
   </tr>
   <tr style="height:12.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:12.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#report_independent_registered_public_acc"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Report of Independent Registered Public Accounting Firm</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">  </span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(PCAOB ID: </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_245dbc9c-bcee-4d99-a0ec-ba225c4e129f" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:AuditorFirmId"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">42</span></ix:nonNumeric></span></a><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Consolidated Balance Sheets</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#statements_operations_comprehensive_loss"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Consolidated Statements of Operations and Comprehensive Loss</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#consolidated_statements_redeemable_conve"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders&#x2019; Equity (Deficit)</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#statements_cash_flows"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Consolidated Statements of Cash Flows</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6</span></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><a href="#notes_to_financial_statements"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,255,1);white-space:pre-wrap;font-weight:normal;text-decoration:underline;font-size:10.0pt;font-family:Times New Roman;">Notes to Consolidated Financial Statements</span></a></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="report_independent_registered_public_acc"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">REPORT OF INDEPENDENT REGIST</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">ERED PUBLIC ACCOUNTING FIRM</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To the Board of Directors and Stockholders of Vor Biopharma Inc.</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Opinion on the Financial Statements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have audited the accompanying consolidated balance sheets of Vor Biopharma Inc. (the &#x201c;Company&#x201d;) as of December 31, 2021 and 2020, and the related consolidated statements of operations and comprehensive loss, redeemable convertible preferred stock and stockholders&#x2019; equity (deficit) and cash flows for the years then ended and the related notes (collectively referred to as the &#x201c;consolidated financial statements&#x201d;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December 31, 2021 and 2020, and the results of its operations and its cash flows for the years then ended, in conformity with U.S. generally accepted accounting principles.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Basis for Opinion</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These financial statements are the responsibility of the Company&#x2019;s management. Our responsibility is to express an opinion on the Company&#x2019;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (&#x201c;PCAOB&#x201d;) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#x2019;s internal control over financial reporting. Accordingly, we express no such op</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">inion.</span></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:14.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:14.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_64273416-47f2-49c6-b8d6-c23d4509ca73" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:AuditorName"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Ernst &amp; Young LLP</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We have served as the Company&#x2019;s auditor since 2020</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_454c9a6d-6723-4c18-ab85-0726ffee3fa4" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:AuditorLocation"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Boston, Massachusetts</span></ix:nonNumeric></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">March 14, 2022</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:1.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">VOR BIOPHARMA INC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="balance_sheets"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">CONSOLIDATED BALANCE </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">SHEETS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.899%;"></td>
    <td style="width:1.584%;"></td>
    <td style="width:1.124%;"></td>
    <td style="width:12.847%;"></td>
    <td style="width:0.963%;"></td>
    <td style="width:1.606%;"></td>
    <td style="width:1.124%;"></td>
    <td style="width:12.868%;"></td>
    <td style="width:0.985%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands, except share amounts)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Current assets:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Cash and cash equivalents</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e0f268fb-81e8-4a7e-b221-6206d78a4d08" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">119,801</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_88f91a38-11f5-4da4-9f12-c7498d6d0dbf" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">48,539</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Investments</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_91f2b0ec-9c32-4f56-8a3e-ec8fdf112897" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:ShortTermInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">87,668</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Prepaid expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_493bc673-62ac-4dba-b670-ccd349eea496" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:PrepaidExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,836</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_08d06321-a052-4ccb-95c0-0ba81e98b2e6" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:PrepaidExpenseCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">467</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Other current assets</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_da08be27-6aa2-4649-b560-610d3b5f822e" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:OtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,094</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d79929c0-ad31-4542-97b5-c9061c9e31bc" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:OtherAssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">100</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Total current assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0417a2cd-d2ae-41ea-9bb5-7f18848a309f" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">214,399</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_63c6325c-fdda-4157-8f7e-8041166e8d99" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:AssetsCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">49,106</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Restricted cash equivalents</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7f95d6f1-173a-44d3-a463-62889319ba1a" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:RestrictedCashEquivalentsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,413</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_096cc6bb-9001-4f19-a234-60a020792767" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,559</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Property and equipment, net</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1841c8a3-5847-440f-bf72-6771e9cc9d2c" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,853</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d18e5157-ca40-470a-bc09-36860c9c55e9" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,728</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Operating lease right-of-use assets</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f63b01bf-e676-4a13-b3b2-dfc2c7042a3b" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,670</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1272e15c-92a0-4076-9fa6-977f8c88f118" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,117</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Other assets</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b4401f55-6207-4c90-9b6c-f8b5fee7b001" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,255</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f3c9ad7f-8ac3-40ad-900e-fb92b1beaa76" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:OtherAssetsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,398</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Total assets</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c480474c-aa0b-476a-8e40-d1f5f615620c" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">242,590</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6e1ce71b-8c63-4306-a0ac-2bf06e461325" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:Assets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">75,908</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Liabilities, redeemable convertible preferred stock and stockholders&#x2019; equity (deficit)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Current liabilities:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Accounts payable</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a915bcd3-668c-4a81-9bd3-d9b99492db0b" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,545</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5caf1bfc-168f-4f10-b4a5-3a623b06c73d" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:AccountsPayableCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,361</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Accrued expenses</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2e52886a-e430-4491-97df-2ddecf5f11e9" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,335</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c27d601e-54f2-455d-81f3-995e1249bc87" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,260</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Operating lease liability</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_53f97be4-cb36-409e-a2f6-30f4992bbc1c" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,839</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d7e6ffef-8963-4c79-bc4b-974896e8e54c" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">863</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Other current liabilities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ebc93220-3d94-4b35-985c-529546fa96ac" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:OtherLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">434</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6fdee86e-e080-4ea2-afe6-babfee9f5411" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:OtherLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">723</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Total current liabilities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ec34cd78-cd3d-4c62-b655-57431ae01d40" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,153</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_80dfc7cd-dda8-49c8-b3b8-eb1f5e4ef98f" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:LiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">10,207</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Long-term liabilities:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Operating lease liabilities&#x2014;non-current</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7465d67a-57d0-4e04-959b-d850d7a99e42" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,174</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_295c88f1-ee17-4d3d-bf83-217e9e14b4c6" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,430</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Total liabilities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_615dd825-6656-4216-b1e0-e914aaaeb8ec" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">26,327</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e81ae38e-dd4d-4209-9ee8-d56ec0538ac4" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:Liabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">27,637</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series A-1 redeemable convertible preferred stock, $</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_97d7b653-5d9c-4b1c-8bcd-37ca07cbb8de" contextRef="C_0934599b-e63c-44b0-8f73-95ce8e66ed87" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF"><ix:nonFraction id="F_90c2302c-cbc9-435a-bdf5-2e7055422fc6" contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;par value; <br />&#160;&#160;&#160;</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_025ecd0c-535e-4056-bf48-e2bed34d1bfc" contextRef="C_0934599b-e63c-44b0-8f73-95ce8e66ed87" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_20570fdf-692e-4404-8b6e-2a9774a86b68" contextRef="C_0934599b-e63c-44b0-8f73-95ce8e66ed87" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_65b962d5-e553-4caf-b20f-3caa1bfed103" contextRef="C_0934599b-e63c-44b0-8f73-95ce8e66ed87" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;shares and </span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_59301fad-d35e-453a-b2df-a180bf83b14b" contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_c86affdc-e5a5-4d6c-927b-76929f675558" contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_1a9eeef9-561e-4235-810c-41573900cced" contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">20,000,000</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;shares authorized, issued, and outstanding as of <br />&#160;&#160;&#160;&#160;December 31, 2021 and December 31, 2020, respectively (liquidation <br />&#160;&#160;&#160;&#160;preference of $</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bfe1013b-9b7d-4204-8627-ed2e0e0a8584" contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;as of December 31, 2020)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a768bc36-7055-49ad-aa47-007c7e382794" contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series A-2 redeemable convertible preferred stock, $</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e7aad643-cdd5-4294-9ebe-c6db31213f7d" contextRef="C_a552db48-79ee-4bc9-bd4d-b52fcf933430" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF"><ix:nonFraction id="F_9bf107cc-73d6-4e03-963e-23b70c8cccf2" contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;par value;<br />&#160;&#160;&#160;</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a136d5f4-5455-4d67-931b-5bf20bdb0c70" contextRef="C_a552db48-79ee-4bc9-bd4d-b52fcf933430" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_40b9295d-fc4a-4d6a-96b7-d069d2cc564e" contextRef="C_a552db48-79ee-4bc9-bd4d-b52fcf933430" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_a5f6e5e8-3760-4453-a2a0-83d5dcbe0067" contextRef="C_a552db48-79ee-4bc9-bd4d-b52fcf933430" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;and </span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a498544f-7404-4792-a56f-d9734eba9d57" contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_dcf99733-d3fe-4abf-8e98-0f57c5ac6e6c" contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_46eca231-adfd-41f2-aa5c-c5cb539db04b" contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">107,194,866</ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;shares authorized, issued, and outstanding as of <br />&#160;&#160;&#160;December 31, 2021 and December 31, 2020, respectively <br />&#160;&#160;&#160;(liquidation preference of $</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b44fea04-91b0-4156-8c9d-1b86c4c40ed5" contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">42,878</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;as of December 31, 2020)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_357afd78-7908-4eb5-bcac-f619b543a8e8" contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">42,786</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Series B redeemable convertible preferred stock, $</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ef763627-b5dc-4e1f-9845-b02e0a7ee52c" contextRef="C_906ae667-10d4-461d-ab58-98924db96c28" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF"><ix:nonFraction id="F_668be7ea-387e-4773-a030-206cf5dd87a8" contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;par value; <br />&#160;&#160;&#160;</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8d4dfab6-1895-48eb-a406-699e99d6071d" contextRef="C_906ae667-10d4-461d-ab58-98924db96c28" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;shares and </span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2c399eeb-9855-4052-805f-1f3b8df761bd" contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">211,778,825</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;shares authorized as of December 31, 2021 <br />&#160;&#160;&#160;and December 31, 2020, respectively; </span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f0fadcb7-258b-4e5b-924e-9cc66aaed533" contextRef="C_906ae667-10d4-461d-ab58-98924db96c28" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_7de54af7-3279-49b2-a8d2-25d35099ef83" contextRef="C_906ae667-10d4-461d-ab58-98924db96c28" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;shares and </span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_00d2f561-ccd4-4f4d-b8a0-f512925ccb14" contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_fcb722f1-9695-48df-8529-09565924430c" contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">124,519,220</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;<br />&#160;&#160;&#160;shares issued and outstanding as of December 31, 2021 and <br />&#160;&#160;&#160;December 31, 2020, respectively (liquidation preference of<br />&#160;&#160;&#160;$</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_56a98ce7-bd77-47a8-a172-05d476d66876" contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">64,750</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;as of December 31, 2020)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cb0c3d11-a76c-4b80-9f1f-f1886f955d34" contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">64,548</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Stockholders&#x2019; equity (deficit):</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Preferred stock, $</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ad3c6d73-ef73-4190-b78f-f9dbdb725d8d" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF"><ix:nonFraction id="F_15991e24-0286-4ff9-bfb4-e7c3aeb7a919" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;par value; </span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c55fd881-03f0-4d1b-9444-68b1a45b1759" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;and </span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_54939038-5249-4a54-a434-619e203fe34e" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;shares <br />&#160;&#160;&#160;authorized as of December 31, 2021 and December 31, 2020, <br />&#160;&#160;&#160;respectively; </span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_591a07a6-80a4-44c9-8cdd-829d290a3d23" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_8d3ae97b-76d6-48c5-a670-ac835ce2a2ce" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_c1c4b63b-0b5d-4c53-b881-c5f867c8293f" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:PreferredStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_f3760de4-4a88-4cc2-8823-e7100e22c6f6" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;shares issued and outstanding as of December 31, <br />&#160;&#160;&#160;2021 and December 31, 2020</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_d001c3a9-ea5b-45d4-bac4-d84b5bc72b37;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_92740c7f-9a44-4bb2-be40-da3ce44d3337;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></span></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Common stock, $</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_24bc576b-8e80-4e75-82c0-1ff9f60c9ed7" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF"><ix:nonFraction id="F_8575b697-e06e-4769-a968-2b2f79fee24f" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;par value; </span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_53ac510c-69b3-4c94-8c2d-5180242f8b02" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">400,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;and </span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c95820ea-eff1-49f0-88ea-c0b456438572" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">420,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;<br />&#160;&#160;&#160;shares authorized as of December 31, 2021 and December 31, 2020 <br />&#160;&#160;&#160;respectively; </span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b47d0238-08db-4098-a3f8-a5ec6832b9a3" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">37,375,428</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;and </span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_712aa16e-5ad7-4ec3-aeb7-472764a2b025" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:CommonStockSharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">893,231</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;shares issued and <br />&#160;&#160;&#160;</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1380be29-505f-4d6b-a45b-14ec0ce5de37" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">37,174,741</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;and </span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8bd11139-e64d-40b9-8d7f-0adba65dc23c" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">505,074</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#160;outstanding as of December 31, 2021 and <br />&#160;&#160;&#160;December 31, 2020, respectively</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fe23dfac-7b1b-4349-98f8-12bb51fd7f7e" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f68a1b30-7ed5-427b-8900-d79c1cbdd6ed" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:CommonStockValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Additional paid-in capital</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bb95bf27-a0dc-4e3c-9086-b476e23e1cbc" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">346,382</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0116fe6e-8e75-4eba-b857-c4febca4eee7" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:AdditionalPaidInCapitalCommonStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,158</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Accumulated deficit</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e352a840-8a5a-405a-b4ec-0e91d9535dd2" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">130,123</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b991178e-d1bc-45d4-a715-477c18c08b1d" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:RetainedEarningsAccumulatedDeficit" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">61,224</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Total stockholders&#x2019; equity (deficit)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8cecc286-2772-4fcd-a5db-1c8e6cd9d5c1" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">216,263</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_05cfd18f-984a-4c29-b402-5fa2420fa6e2" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">59,065</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Total liabilities, redeemable convertible preferred stock and stockholders&#x2019; equity (deficit)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a88632e6-138f-452f-b215-830fd9923459" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">242,590</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_069f4470-25c9-4131-b683-14c8eae6363f" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:LiabilitiesAndStockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">75,908</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The accompanying notes are an integral part of these financial statements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">VOR BIOPHARMA INC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="statements_operations_comprehensive_loss"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">CONSOLIDATED STATEMENTS OF OPERATIONS</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> AND COMPREHENSIVE LOSS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:60.368%;"></td>
    <td style="width:1.895%;"></td>
    <td style="width:1.124%;"></td>
    <td style="width:16.144%;"></td>
    <td style="width:0.739%;"></td>
    <td style="width:1.895%;"></td>
    <td style="width:1.124%;"></td>
    <td style="width:15.973%;"></td>
    <td style="width:0.739%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands, except share and per share amounts)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Operating expenses:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Research and development</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_29bdf53d-75c4-4f79-a5eb-e3ec532de60a" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">47,529</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3f8dc17a-4470-40b8-9afc-ae67ba817d05" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:ResearchAndDevelopmentExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">31,618</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">General and administrative</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b9ead98d-48f3-4aa5-b436-2d59cb9c63e4" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">21,489</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f93d13bb-a90e-414c-bd99-138684ca5d2c" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:GeneralAndAdministrativeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,748</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Total operating expenses</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a349cebf-58ea-493a-b463-63c3f1ba4bcd" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">69,018</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4ba8b25b-5330-444f-bf12-d55cdedbf953" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:OperatingExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">43,366</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Loss from operations</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b08ed71a-0229-45ad-b4fd-52d01a286b2f" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">69,018</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e13d379d-c0f0-43c3-9122-12f6e39390d5" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:OperatingIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">43,366</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Other income:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Interest income</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2f521501-f307-4c76-a6b6-858326a3fe25" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">119</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_269efed8-1bdc-4ecc-9217-1e8ac4f0d9ea" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:InvestmentIncomeInterest" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">29</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Total other income</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0e595bc6-bb57-440d-9ab5-e9e566bff57c" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">119</ix:nonFraction></span></p></td>
    <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="border-top:0.500pt solid rgba(255,255,255,0.01);background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_98a06026-90c7-497c-afb2-af241dcd508e" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:NonoperatingIncomeExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">29</ix:nonFraction></span></p></td>
    <td style="border-top:0.500pt solid rgba(0,0,0,1);background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Net loss and comprehensive loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f81a340a-8d15-4397-8589-1acce62bdad1" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">68,899</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1d43e843-223e-4fe0-9066-03495d5b3a72" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">43,337</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Cumulative dividends on redeemable convertible<br />&#160;&#160;&#160;preferred stock</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_798e3693-8620-46e3-b216-8daf1134fa72" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:RedeemablePreferredStockDividends" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,228</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3adbce51-ba0a-4f0d-8c1b-6c618b7b0f4b" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:RedeemablePreferredStockDividends" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,925</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Net loss attributable to common stockholders</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f6862175-75e2-491e-8789-fadbb9f2d04f" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">70,127</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_30c477b5-3f0a-42b5-9f2d-3eaf7d8e5e6b" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">49,262</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Net loss per share attributable to common stockholders,<br />&#160;&#160;&#160;basic and diluted</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f61f9120-1431-4bd5-90c4-25b1473f8708" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-">2.10</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c59ba923-b6a3-4b7d-a926-834f11ead1b9" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-">230.57</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Weighted-average common shares outstanding, <br />&#160;&#160;&#160;basic and diluted</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_49c33897-323f-4f6f-9d38-5a11f346dc6c" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">33,433,214</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_13531512-edfa-47af-87d7-0fb25ad14f7c" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">213,658</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:2.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The accompanying notes are an integral part of these financial statements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Vor Biopharma Inc.</span><span style="text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="consolidated_statements_redeemable_conve"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">CONSOLIDATED Statements of Redeemab</span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">le Convertible Preferred Stock and</span><span style="text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Stockholders&#x2019; EQUITY (Deficit)</span><span style="text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:19.614%;"></td>
    <td style="width:1.059%;"></td>
    <td style="width:0.34%;"></td>
    <td style="width:5.827%;"></td>
    <td style="width:0.464%;"></td>
    <td style="width:1.059%;"></td>
    <td style="width:0.703%;"></td>
    <td style="width:4.25%;"></td>
    <td style="width:0.518%;"></td>
    <td style="width:1.005%;"></td>
    <td style="width:0.34%;"></td>
    <td style="width:5.827%;"></td>
    <td style="width:0.464%;"></td>
    <td style="width:1.059%;"></td>
    <td style="width:0.703%;"></td>
    <td style="width:4.25%;"></td>
    <td style="width:0.464%;"></td>
    <td style="width:1.059%;"></td>
    <td style="width:0.34%;"></td>
    <td style="width:5.827%;"></td>
    <td style="width:0.464%;"></td>
    <td style="width:1.059%;"></td>
    <td style="width:0.703%;"></td>
    <td style="width:4.25%;"></td>
    <td style="width:0.464%;"></td>
    <td style="width:0.85%;"></td>
    <td style="width:0.34%;"></td>
    <td style="width:4.969%;"></td>
    <td style="width:0.34%;"></td>
    <td style="width:1.059%;"></td>
    <td style="width:0.703%;"></td>
    <td style="width:4.343%;"></td>
    <td style="width:0.34%;"></td>
    <td style="width:1.059%;"></td>
    <td style="width:0.703%;"></td>
    <td style="width:6.213%;"></td>
    <td style="width:0.34%;"></td>
    <td style="width:1.059%;"></td>
    <td style="width:0.703%;"></td>
    <td style="width:6.09%;"></td>
    <td style="width:0.464%;"></td>
    <td style="width:1.059%;"></td>
    <td style="width:0.703%;"></td>
    <td style="width:6.09%;"></td>
    <td style="width:0.464%;"></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Series A-1 Preferred<br />Stock</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Series A-2 Preferred<br />Stock</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Series B Preferred<br />Stock</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Common<br />Stock</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Additional<br />Paid-In</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Accumulated</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Total<br />Stockholders&#x2019;<br />Equity</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(in thousands, except share amounts)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Shares</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Amount</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Shares</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Amount</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Shares</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Amount</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;border-left:0.500pt solid rgba(0,0,0,1);vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Shares</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Amount</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Capital</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Deficit</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(Deficit)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Balance, January 1, 2020</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_c4e42a40-aeee-40af-952f-954421fa62d4" contextRef="C_05cbe1e9-93ae-4c7c-8022-300abf600f9a" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">20,000,000</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_4745eb5e-7324-4006-997b-e1edb214b667" contextRef="C_05cbe1e9-93ae-4c7c-8022-300abf600f9a" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_dbcaddd2-60b8-4d98-a2c8-49b4952a07c8" contextRef="C_f421d89d-1fcd-44c9-b330-4181365acf97" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">62,819,866</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_85e2f1a1-0ec6-4280-9a37-ecca549e60be" contextRef="C_f421d89d-1fcd-44c9-b330-4181365acf97" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">25,067</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;border-left:0.500pt solid rgba(0,0,0,1);vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_d128e1a6-d8ce-4a44-b925-bfc8c122007b" contextRef="C_7ad90457-283a-44cd-b3db-1fbd4b5d6040" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">119,936</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_708023cd-d229-4007-9a08-e2a7c0b04b7b" contextRef="C_f7e93cb2-5aad-42ef-867b-5b8e561d0399" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">458</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">(</span><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_880604c0-89c4-4a00-b6c8-3ddaacb1dd61" contextRef="C_d8baf95d-5eaa-4c79-8ad9-9d413c0de569" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">17,887</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">(</span><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_e3158ceb-e422-4733-a006-a3d2858c2320" contextRef="C_09163903-47da-4862-9c71-2100cb0e3e52" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">17,429</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Issuance of Series A-2 Redeemable <br />&#160;&#160;&#160;Convertible Preferred Stock</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_7ae282ed-a48c-43b7-a874-9e4349a9a871" contextRef="C_88b36c70-a4c3-4733-99e7-acb53eff697f" name="vor:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">44,375,000</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_ef679081-8b79-4bc9-aea9-dc37a5a31f18" contextRef="C_88b36c70-a4c3-4733-99e7-acb53eff697f" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,719</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;border-left:0.500pt solid rgba(0,0,0,1);vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Issuance of Series B Redeemable <br />&#160;&#160;&#160;Convertible Preferred Stock</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_863c43e8-c905-4210-99b9-7829fc5423b7" contextRef="C_39aabd88-71ef-47fd-81c2-5989c3eb5180" name="vor:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">124,519,220</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_ae2043ea-2531-48d5-9787-21fe5e05fc54" contextRef="C_39aabd88-71ef-47fd-81c2-5989c3eb5180" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">64,548</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;border-left:0.500pt solid rgba(0,0,0,1);vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Issuance of common stock upon exercise<br />&#160;&#160;&#160;of stock options</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;border-left:0.500pt solid rgba(0,0,0,1);vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_4a45f5a4-feab-4327-823e-46a1b117f87f" contextRef="C_588f2dc9-7ea0-423b-baac-bf5e275504d3" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">385,138</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_2bf4e049-a122-484a-b188-c8ffef4bb630" contextRef="C_588f2dc9-7ea0-423b-baac-bf5e275504d3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_08fd001d-c089-48bc-b9a1-2fce54670233" contextRef="C_d1a54bd6-087e-482f-9586-9f67436d0f3b" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">358</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_32b060f2-34db-4074-9139-d1f1cf7681b8" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">359</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Stock-based compensation expense</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;border-left:0.500pt solid rgba(0,0,0,1);vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_f199ce87-c1c4-458a-8381-0df331a15ae8" contextRef="C_d1a54bd6-087e-482f-9586-9f67436d0f3b" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,342</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_b3676895-ef9b-415c-8baf-7c2ebe222726" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,342</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;border-left:0.500pt solid rgba(0,0,0,1);vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">(</span><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_5309ed90-8370-48d4-af0e-e5a5b96e90f1" contextRef="C_17db07ca-1802-4fd6-af2a-3b044cdb439e" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">43,337</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">(</span><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_50492e4e-8151-453f-ac39-763e080061a5" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">43,337</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Balance, December 31, 2020</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_d76099a1-0ab6-4782-8a17-b4f50f8c52c8" contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">20,000,000</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_6f0e30cf-55c3-4746-afe7-56ce6874d95d" contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_e8f9eb6a-f314-4cd8-8b9f-b912eb03433e" contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">107,194,866</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_00de7c20-d856-4c9d-855d-345f2ef11a11" contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">42,786</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_52f0406e-af29-417d-84ba-376d9c48ce5a" contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">124,519,220</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_25a70091-793a-44ac-9f84-1952312e9fca" contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">64,548</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;border-left:0.500pt solid rgba(0,0,0,1);vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_d7a365c9-7e97-447c-87d9-c07e6d40ebfa" contextRef="C_fde2681f-7863-4672-ac2d-a2fe4bb678c4" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">505,074</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_db994d59-438e-4da3-94d4-70dc426555dd" contextRef="C_fde2681f-7863-4672-ac2d-a2fe4bb678c4" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_9d481b92-6d4a-4366-ad5e-981a993b831f" contextRef="C_78d79139-f336-486b-8add-17be3536b350" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,158</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">(</span><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_28fc47e9-9c57-4eea-9840-ab4b6dff1ad7" contextRef="C_2df3377e-ee22-43dc-b9ea-a3b6b9eb60c6" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">61,224</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">(</span><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_c9b03d32-7dac-41fe-bdcd-070f87486c8a" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">59,065</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Issuance of Series B Redeemable <br />&#160;&#160;&#160;Convertible Preferred Stock</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_ddb7ce4e-cdbd-4537-9ab1-38363105ffae" contextRef="C_ae930d22-cc83-471e-981d-8726a0b382a0" name="vor:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">87,259,605</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_1cd7b6e7-480e-465b-abee-4b7d6a1c32bb" contextRef="C_ae930d22-cc83-471e-981d-8726a0b382a0" name="us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">45,375</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;border-left:0.500pt solid rgba(0,0,0,1);vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Conversion of redeemable convertible <br />&#160;&#160;&#160;preferred stock into common stock <br />&#160;&#160;&#160;upon closing of initial public offering</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">(</span><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_79e3e876-3847-40e4-bf7b-df8f6d29834b" contextRef="C_69091247-915d-4997-8567-724c5a05de2f" name="vor:TemporaryEquityStockConvertedDuringPeriodShares" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">20,000,000</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">(</span><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_4efc8180-7fa5-4d8a-8e10-ecba8cb7b4b7" contextRef="C_69091247-915d-4997-8567-724c5a05de2f" name="vor:TemporaryEquityStockConvertedDuringPeriodValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">(</span><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_15c605f5-199f-46b6-ad8b-c0f5361e862d" contextRef="C_3e5b0b1c-0786-4be6-85c8-c47c2f2afe86" name="vor:TemporaryEquityStockConvertedDuringPeriodShares" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">107,194,866</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">(</span><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_b4d97897-02ac-4f9e-b71b-e88f4dc9a128" contextRef="C_3e5b0b1c-0786-4be6-85c8-c47c2f2afe86" name="vor:TemporaryEquityStockConvertedDuringPeriodValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">42,786</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">(</span><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_480e140f-c5df-43ae-b5a6-2356e54a25d7" contextRef="C_ae930d22-cc83-471e-981d-8726a0b382a0" name="vor:TemporaryEquityStockConvertedDuringPeriodShares" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">211,778,825</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">(</span><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_f5fc2cb2-0d38-4694-aa5f-a8b74951af9c" contextRef="C_ae930d22-cc83-471e-981d-8726a0b382a0" name="vor:TemporaryEquityStockConvertedDuringPeriodValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">109,923</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;border-left:0.500pt solid rgba(0,0,0,1);vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_7f5c419c-5104-4df7-b130-7837c1468d85" contextRef="C_2e62aa11-22e8-433f-b264-9531559a3726" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">24,924,501</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_82548228-374f-472b-a835-ccffdaed9b51" contextRef="C_2e62aa11-22e8-433f-b264-9531559a3726" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_66380e2d-eda7-4650-b745-c7fdaf88fb85" contextRef="C_5fa63f3c-7a7e-49f4-b2a0-dffb9dcb0526" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">152,709</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_622f5c2b-df67-4646-ae10-0bb47f4d6496" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">152,711</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Issuance of common shares upon closing<br />&#160;&#160;&#160;of initial public offering, net of offering <br />&#160;&#160;&#160;costs and underwriter fees of $</span><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_14369cac-a9d8-404d-b0e3-00a400693777" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,132</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;border-left:0.500pt solid rgba(0,0,0,1);vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_e53e18ea-972a-4629-b69d-f15c3963742a" contextRef="C_2e62aa11-22e8-433f-b264-9531559a3726" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">11,302,219</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_2da31e84-e9f6-4ca7-ac71-ec2584095d0d" contextRef="C_2e62aa11-22e8-433f-b264-9531559a3726" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_13f7826a-edd4-44d1-8b32-8908a0d00a15" contextRef="C_5fa63f3c-7a7e-49f4-b2a0-dffb9dcb0526" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">186,307</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_7883a4c6-2a47-40d6-9fc2-85a8c2727842" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">186,308</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Issuance of common stock upon vesting<br />&#160;&#160;&#160;and exercise of stock options</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;border-left:0.500pt solid rgba(0,0,0,1);vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_9f4c9f26-3d69-47b1-860e-4c2cef7ab8ed" contextRef="C_2e62aa11-22e8-433f-b264-9531559a3726" name="vor:StockIssuedDuringPeriodSharesStockOptionsVestedAndExercised" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">442,947</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_32daab80-f9b4-433e-b0cb-a6b47efaaa8f" contextRef="C_5fa63f3c-7a7e-49f4-b2a0-dffb9dcb0526" name="vor:StockIssuedDuringPeriodValueStockOptionsVestedAndExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">894</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_1b41d6df-e2d0-4083-bf95-ab28ba58a132" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="vor:StockIssuedDuringPeriodValueStockOptionsVestedAndExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">894</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Stock-based compensation expense</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;border-left:0.500pt solid rgba(0,0,0,1);vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_13b73c4d-597d-498b-88cd-37ce389e8b79" contextRef="C_5fa63f3c-7a7e-49f4-b2a0-dffb9dcb0526" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,314</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_43ade168-2b31-4fe4-8eee-9fd08ed2f054" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,314</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:8.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:8.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;border-left:0.500pt solid rgba(0,0,0,1);vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">(</span><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_d1fab01d-90a1-43dc-910f-02b222134a1a" contextRef="C_e2969fd4-7d7c-435f-8e64-f416d48f96fe" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">68,899</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">(</span><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_defdac80-56c5-4ad9-b4a9-fa405f6d58dd" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">68,899</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:7.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Balance, December 31, 2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;border-left:0.500pt solid rgba(0,0,0,1);vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_4cffb4b5-550c-4bf1-941e-1c57e418a083" contextRef="C_f9decb30-9917-46ec-95f6-06ac473f5fb9" name="us-gaap:CommonStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">37,174,741</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_c05859e4-aa8b-49ab-9905-6aa187b96fe4" contextRef="C_f9decb30-9917-46ec-95f6-06ac473f5fb9" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_8468cef0-a96a-4ba8-94b5-58a9deaa17be" contextRef="C_3c5cc129-6f72-442b-ba44-37460dc77415" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">346,382</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">(</span><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_eedeb50b-d909-4057-bd44-d631164664b5" contextRef="C_fe5f0887-c938-4424-9f52-81c4c0ac9449" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">130,123</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:6.5pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;"><ix:nonFraction id="F_6844cd3e-8a50-46ac-b482-e1ba81ec3aef" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:StockholdersEquity" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">216,263</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:6.5pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:6.5pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;">The accompanying notes are an integral part of these financial statements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Vor Biopharma Inc.</span><span style="text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="statements_cash_flows"><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">CONSOLIDATED StatementS of</span><span style="background-color:rgba(0,0,0,0);text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> Cash Flows</span><span style="text-transform:uppercase;color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.342%;"></td>
    <td style="width:1.606%;"></td>
    <td style="width:1.124%;"></td>
    <td style="width:13.36%;"></td>
    <td style="width:0.739%;"></td>
    <td style="width:1.606%;"></td>
    <td style="width:1.124%;"></td>
    <td style="width:13.36%;"></td>
    <td style="width:0.739%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Cash flows from operating activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Net loss</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4f1ebaff-092d-442c-94c6-0874c3f96e71" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">68,899</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a028dfd3-6e91-40c5-8053-ce11173fe6a5" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:ProfitLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">43,337</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Adjustments to reconcile net loss to net cash used in operations:</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Depreciation expense</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e406f7be-d0cf-4916-9366-ec433bc620f0" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:Depreciation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,434</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d56c28ff-6454-4bc8-9610-74de42eb5981" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:Depreciation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">605</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Non-cash lease expense</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9442a6d2-7997-4369-9111-eeb03e3621df" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:OperatingLeaseExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,017</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f2ccbc99-316e-4435-94ab-6bc7411edf19" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:OperatingLeaseExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">782</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Stock-based compensation</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1a29607c-ec6f-4136-9c18-7f5a28cc0180" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,315</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_20022e9e-9b3c-4b95-aeca-1298aefe89f6" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:ShareBasedCompensation" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,342</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Other</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f8f1a71d-d1f1-408e-9af0-6b49144b12f4" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:OtherOperatingActivitiesCashFlowStatement" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">174</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Changes in operating assets and liabilities:</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Operating lease liability</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7c583631-bf8b-4489-b757-9c5eab44e9e3" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">2,559</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ac1c3046-4427-40d7-89b1-a013d4a772f3" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">393</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Prepaid expenses and other current assets</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_707fa695-6ff5-470e-8109-9237aa648215" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,363</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9810eb31-9ad2-4805-991c-1d56a18a459f" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">606</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Accounts payable and accrued expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_918aa6af-3855-40c8-b87e-390da30c9af1" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">405</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bfb8c25a-fb92-463c-bb30-30f236c3f0f3" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,820</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:30.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:30.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Other assets</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_73e540be-c0f1-4440-ae5b-391b0dd541b7" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">668</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_971e9df6-67c8-4bce-90fb-18bbdc476a83" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:IncreaseDecreaseInOtherOperatingAssets" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,503</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:40.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:40.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Net cash used in operating activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_55c8b200-56e8-4bf6-8d07-a0cc894c3f0e" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">69,144</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8b5e96a2-aba6-4cea-91f9-f4e5bc57db2f" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">36,292</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Cash flow from investing activities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Purchases of investments</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3d9d84ea-e097-4535-8ab9-2b47f71100ad" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:PaymentsToAcquireInvestments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">87,757</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Purchases of property and equipment</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3457ec53-5fb8-4141-b5c4-c0617a253aff" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,894</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_924c7f7b-9668-458f-8933-69535c9a65c4" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,161</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Net cash used in investing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_95feb9cd-3050-4cc8-9cbd-83725e85f078" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">91,651</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_de4b0672-8414-4ce2-8400-bebf8713e515" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">4,161</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Cash flow from financing activities</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Proceeds from issuance of redeemable convertible preferred stock</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1287a97d-d68c-485e-af9c-6c5eb30a28f2" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">45,375</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e5baec31-7bce-461d-93d2-08c9ee0db6c0" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">82,267</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Proceeds from the issuance of common stock upon closing of initial <br />&#160;&#160;&#160;public offering, net of underwriter fees</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9d798a5e-d94e-4ee7-87c8-311acd7c5d48" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">189,198</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Payment of initial public offering costs</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">(</span><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_059a2ee7-97dd-4584-9da1-91edc0fe0865" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:PaymentsOfStockIssuanceCosts" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,215</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">)</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Proceeds from stock option exercises</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ba510218-a7ea-4aec-8b6a-cfd8755bea6b" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">553</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_894f1d68-36e8-4859-94f1-b901f697ad76" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:ProceedsFromStockOptionsExercised" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">259</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Net cash provided by financing activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a32dbebd-d498-423f-906d-81694cf19f68" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">232,911</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_51f3c234-cbc5-4912-b1d5-8b5baf944bf6" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">82,526</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Net increase in cash, cash equivalents and restricted cash equivalents</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1f7ffd23-8e79-471f-a87c-b93f3539b086" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">72,116</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dadd4af9-3202-4be7-90af-0e3c7d735f54" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">42,073</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Cash, cash equivalents and restricted cash equivalents, <br />&#160;&#160;&#160;beginning of period</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d41885ab-60a3-49d9-8bc0-8d9ae2e4d13f" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50,098</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_74e64d4d-6a22-455b-8304-fd9697c59557" contextRef="C_09163903-47da-4862-9c71-2100cb0e3e52" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,025</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Cash, cash equivalents and restricted cash equivalents, end of period</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e573739c-c705-41f0-b17c-129b8778049b" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">122,214</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f75fa69e-59d3-4c76-89db-9ba6fcbad54d" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50,098</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Supplemental disclosure of non-cash activities</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Operating right-of-use assets and operating lease liability recorded<br />&#160;&#160;&#160;upon lease commencement</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_aa2e8b83-99ab-430b-bfda-f69c07d22bed" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="vor:OperatingRightOfUseAssetsAndOperatingLeaseLiabilityRecordedUponLeaseCommencement" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">35</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_26e512ae-f0b8-4bd7-a0a2-c310949400cb" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="vor:OperatingRightOfUseAssetsAndOperatingLeaseLiabilityRecordedUponLeaseCommencement" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,899</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Purchases of property and equipment in accounts payable</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8d6a8200-8917-40ff-a5a1-45f1f192374a" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">194</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_10a4646b-6fec-4930-994f-43a03e6d6d1a" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">444</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Conversion of redeemable convertible preferred stock to common<br />&#160;&#160;&#160;stock upon closing of the initial public offering</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f80af4c4-a1da-4a04-b04a-efcf0a94442c" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="vor:ConversionOfRedeemableConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">152,711</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Deferred offering costs in accounts payable and accrued expenses</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2300926a-9fe1-4a24-a607-b83fe7cebbff" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="vor:DeferredOfferingCostsInAccountsPayableAndAccruedExpenses" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">896</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">A reconciliation of the cash, cash equivalents and restricted cash reported within the consolidated balance sheets that sum to the total of the same amounts shown in the statements of cash flows is as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:66.353%;"></td>
    <td style="width:1.606%;"></td>
    <td style="width:1.124%;"></td>
    <td style="width:13.542%;"></td>
    <td style="width:0.557%;"></td>
    <td style="width:1.606%;"></td>
    <td style="width:1.124%;"></td>
    <td style="width:13.532%;"></td>
    <td style="width:0.557%;"></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">For the Year Ended December 31,</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Cash and cash equivalents</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6a42bee5-4674-4857-8996-3e646b742c0a" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">119,801</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a86a3fea-d998-4236-bfb4-94e95c390eec" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">48,539</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Restricted cash equivalents</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_11c19537-9576-4ca6-acb8-75f96eebee24" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:RestrictedCashEquivalentsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,413</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3b0c4f34-49d9-4e3b-b597-fbd31b8a102b" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,559</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
   <tr style="height:8.0pt;">
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">Total cash, cash equivalents and restricted cash equivalents as shown on the <br />&#160;&#160;&#160;statements of cash flows</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2e7f5bfe-cd0e-4a54-b249-512089219db1" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">122,214</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;">$</span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:8.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bb3339ee-06da-4511-b6d8-11588f46a00e" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">50,098</ix:nonFraction></span></p></td>
    <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The accompanying notes are an integral part of these financial statements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">VOR BIOPHARMA INC.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;" id="notes_to_financial_statements"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">NOTES TO CONSOLIDATED FINANC</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">IAL STATEMENTS</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a411c917-012f-4677-8e83-dd956c8b02ba" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:NatureOfOperations" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">1. Nature of the Business</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vor Biopharma Inc. (the &#x201c;Company&#x201d;) is a clinical-stage cell and genome engineering company that combines a novel patient engineering approach with targeted therapies to provide a single company solution for patients suffering from hematological malignancies. The Company&#x2019;s proprietary platform leverages its expertise in hematopoietic stem cell (&#x201c;HSC&#x201d;) biology, genome engineering and targeted therapy development to genetically modify HSCs to remove surface targets expressed by cancer cells. The Company is headquartered in Cambridge, Massachusetts. The Company was incorporated on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d173f96b-69d5-4711-bc4f-d1462494d128" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="dei:EntityIncorporationDateOfIncorporation" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 30, 2015</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Initial Public Offering</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On February 9, 2021, the Company completed an initial public offering (&#x201c;IPO&#x201d;) of its common stock. At the closing of the IPO, the Company sold </span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f12d6739-562e-493b-a7c3-097c04dfb319" contextRef="C_e403d7c0-1f35-43a7-8fc0-3a59a8d342cd" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">11,302,219</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of its common stock, at a public offering price of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_85b016f6-7e69-4e08-a961-6c5d2546cba7" contextRef="C_c2b57d58-2294-4b68-be37-2b25d3a08312" name="us-gaap:SaleOfStockPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">18.00</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share. The Company received net proceeds of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_421fe42b-8bc2-4188-8b35-a009c67d7348" contextRef="C_522a671f-8013-49d5-9406-851e52363e90" name="us-gaap:ProceedsFromIssuanceInitialPublicOffering" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">186.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million from the IPO, after deducting underwriters&#x2019; discounts and commissions and other offering expenses paid by the Company.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon closing of the IPO, all shares of the Company&#x2019;s Series A-1, A-2 and B redeemable convertible preferred stock then outstanding automatically converted into an aggregate of </span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_aff01fdc-a77f-4f8c-af35-98ced7e00f75" contextRef="C_522a671f-8013-49d5-9406-851e52363e90" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">24,924,501</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock. Upon conversion of the redeemable convertible preferred stock, the Company reclassified the carrying value of the redeemable convertible preferred stock to common stock and additional paid-in capital.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In connection with the IPO, the Company filed an amended and restated certificate of incorporation that amended and restated the Company&#x2019;s certificate of incorporation in its entirety to, among other things, authorize the Company to issue up to </span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e6ed8303-29de-4d24-a1cf-74021f4c7d15" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">400,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_efc4afe2-90ef-4986-93b2-92b4a5471e88" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.0001</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> par value per share, and </span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_10e64152-ace5-4576-ad07-d6e367979618" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of preferred stock, $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ee9ea95f-7762-4376-949d-fe88d8f19ccd" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="4">0.0001</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> par value per share, all of which shares of preferred stock are undesignated and the rights and preferences of such preferred stock may be established by the Company&#x2019;s board of directors from time to time.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Reverse Stock Split</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On January 29, 2021, the Company effected a </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cce73150-3d7a-404e-a148-566acb9ca65a" contextRef="C_2e62aa11-22e8-433f-b264-9531559a3726" name="us-gaap:StockholdersEquityReverseStockSplit"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_1a6782bb-9d03-4a11-a8d9-b5a47122f2f7;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13.6</span></span></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-for-1 reverse stock split</span></ix:nonNumeric></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of the Company&#x2019;s common stock. All shares, stock options, and per share information in the consolidated financial statements were previously adjusted to reflect the reverse stock split. There was no change in the par value and authorized number of shares of the Company&#x2019;s common stock.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Risks and Uncertainties</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is subject to a number of risks common to development stage companies in the biotechnology industry, including, but not limited to, risks of failure of preclinical studies and clinical trials, dependence on key personnel, protection of proprietary technology, reliance on third party organizations, risks of obtaining regulatory approval for any product candidate that it may develop, development by competitors of technological innovations, compliance with government regulations, the impact of the COVID-19 pandemic, including impacts related to the variants of the virus, and the need to obtain additional financing.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company anticipates that it will continue to incur significant operating losses for the next several years as it continues to develop its product candidates. The Company believes that its existing cash, cash equivalents and investments at December 31, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> will be sufficient to allow the Company to fund its current operations through at least a period of one year after the date the financial statements are issued.</span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_789f183a-29eb-47d3-ab82-8c4325bb1832" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:SignificantAccountingPoliciesTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2. Summary of Significant Accounting Policies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_02d5eae1-9beb-439c-a6f8-5acf7675048e" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Basis of Presentation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;). Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification (&#34;ASC&#34;) or an Accounting Standards Update (&#x201c;ASU&#x201d;) issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8d341bac-508f-4ca5-a299-d5d1b96b06aa" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:UseOfEstimates" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of the consolidated financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amount of expenses during the reporting period. Actual results could differ from those estimates. Management considers many factors in selecting appropriate financial accounting policies in developing the estimates and assumptions that are used in the preparation of the consolidated financial statements. Management must apply significant judgment in this process. Management&#x2019;s estimation process often may yield a range of potentially reasonable estimates and management must select an amount that falls within that range of reasonable estimates. Estimates are used in the following areas, among others: estimating the fair value of the Company&#x2019;s common stock (prior to the IPO); accrued expenses and related research and development expenses.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e2a0ddae-9c1d-4e9d-9375-27c2afd927ac" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Segments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating segments are defined as components of an enterprise for which separate and discrete information is available for evaluation by the chief operating decision-maker in deciding how to allocate resources and assess performance. The Company has </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_57411cbc-b28b-44be-bfc8-e7315a44d458" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:NumberOfOperatingSegments" unitRef="U_Segment" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> operating segment. The Company&#x2019;s chief operating decision maker, its Chief Executive Officer, manages the Company&#x2019;s operations on an aggregate basis for the purpose of allocating resources.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_333b78e7-73ef-4983-bc41-0079288324ce" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Foreign Currency Transaction Gains or Losses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Transactions denominated in foreign currencies are recorded in U.S. dollars on the date of those transactions. Adjustments arising from foreign currency transactions between the purchase and the settlement dates are reflected in the consolidated statement of operations and comprehensive loss as a component of other income.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d909251c-ef10-4abc-a2df-4ac01c350eca" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:CashAndCashEquivalentsPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cash and Cash Equivalents</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company considers highly-liquid investments purchased with an original maturity date of ninety days or less from the date of purchase to be cash equivalents. Cash and cash equivalents include cash held in banks and amounts held in money market funds. Cash equivalents are stated at cost, which approximates market value.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2be55f93-1620-4b95-ac66-e65d66c571ac" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:InvestmentPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Investments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Investments represent excess cash balances held in marketable debt securities and are classified as available-for-sale. Investments with maturities beyond one year may be classified as short-term based on their highly liquid nature and because such securities represent an investment of cash that is available for current operations.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Available-for-sale investments are reported at fair value at each balance sheet date. Changes in the market value of available-for-sale investments, excluding other-than-temporary impairments, are reflected as other comprehensive income, a component of stockholders&#x2019; equity. Realized gains and losses are determined using the specific identification method and are included in other income in our consolidated statements of operations and comprehensive loss.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Investments are evaluated for other-than-temporary impairment at the end of each reporting period. Impairment is evaluated considering numerous factors, and their relative significance varies depending on the situation. Factors considered include whether a decline in fair value below the amortized cost basis is due to credit-related factors or non-credit-related factors, the financial condition and near-term prospects of the issuer, and the Company's intent and ability to hold the investment to allow for an anticipated recovery in fair value. Once a decline in fair value is determined to be other-than-temporary, an impairment charge is recorded to other income (expense) and a new cost basis in the investment is established.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9c5a383f-2b12-451d-a581-921346d13752" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:DeferredChargesPolicyTextBlock" escape="true" continuedAt="F_9c5a383f-2b12-451d-a581-921346d13752_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Deferred Offering Costs</span></p></ix:nonNumeric></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span><ix:continuation id="F_9c5a383f-2b12-451d-a581-921346d13752_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company capitalizes certain legal, professional, accounting and other third-party fees that are directly associated with in-process equity issuances as deferred offering costs until such equity issuances are consummated. After consummation of the equity issuance, these costs are recorded as a reduction in the capitalized amount associated with the equity issuance. During the year ended December 31, 2020, the Company incurred $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f9321ed8-4dcf-4366-bd00-45f61d375d56" contextRef="C_108d57ff-006a-4611-a4b0-e4181430ef77" name="us-gaap:DeferredOfferingCosts" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million in deferred offering costs that are included in other assets on the consolidated balance sheet.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d3a7b631-81b2-4805-b6b3-f6b23feed432" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Restricted Cash</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company had </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_20e36763-b599-4baa-b76e-9a5aa2ffe0ff" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:RestrictedCashEquivalentsNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">2.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_500efcfa-47cc-49e6-87a8-55d3b97354a1" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:RestrictedCashEquivalentsNoncurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of restricted cash in the form of a letter of credit related to a lease at December 31, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_587ad30b-0f8a-4725-b50a-7c67210c467a" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Comprehensive loss</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Comprehensive loss includes net loss, as well as other changes in stockholders&#x2019; equity (deficit) that result from transactions and economic events other than those with stockholders. The Company&#x2019;s comprehensive loss was equal to net loss for the years ended December 31, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> .</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0fe60f06-a048-4d6e-af16-ca64e0090ca9" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Preferred Stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company applies the guidance enumerated in FASB ASC Topic 480, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Distinguishing Liabilities from Equity</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#x201c;ASC 480&#x201d;), when determining the classification and measurement of its preferred stock. Preferred stock subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. The Company classifies conditionally redeemable preferred stock (if any), which includes preferred stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s control, as temporary equity.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_707213a3-55c0-4f3c-967a-53d6cb22b7d6" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ConcentrationRiskCreditRisk" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Concentrations of Credit Risk</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash equivalents and investments. The Company maintains deposits in accredited financial institutions in excess of federally insured limits. The Company deposits its cash in financial institutions that it believes have high credit quality and has not experienced any losses on such accounts and does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#x2019;s investments consist of money market funds and marketable debt securities, including corporate bonds and U.S. Treasury securities. The Company&#x2019;s investments may include commercial paper and other debt securities of U.S. government agencies, corporate entities, and banks. The Company&#x2019;s investment policy limits instruments to investment grade securities with high credit quality issuers with the objective to preserve capital and to maintain liquidity until the funds can be used in business operations.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a9447132-da85-4b39-9dfb-19b6217fba81" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:FairValueMeasurementPolicyPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Fair Value Measurements</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 1&#x2014;Quoted prices in active markets for identical assets or liabilities. </span></div></div><div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 2&#x2014;Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. </span></div></div><div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 3&#x2014;Unobservable inputs that are supported by little or no market activity that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. </span></div></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument&#x2019;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments consist of cash and cash equivalents, restricted cash, accounts payable and accrued expenses. These financial instruments are stated at their respective historical carrying values which approximate fair value due to their short-term nature.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7e49b05e-6de7-4694-b4b5-f363f0c56ab3" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" escape="true" continuedAt="F_7e49b05e-6de7-4694-b4b5-f363f0c56ab3_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Property and Equipment, Net</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ddcfb97c-9eb3-4df7-8da2-a5be443eb2c0" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="vor:PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment, net is recorded at cost less accumulated depreciation. Depreciation expense is recorded using the straight-line method over the estimated useful life of the related asset, which are as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:50.0%;"></td>
          <td style="width:50.0%;"></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Estimated Useful Life</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Computer equipment</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c004a3ef-7c82-43ec-9658-1e37deaa5400" contextRef="C_8cfcd4c1-10fe-467a-9e2b-cc68414f8f0e" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3 years</span></ix:nonNumeric></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Furniture and equipment</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_691a1901-7de2-4213-b049-f720ff13895c" contextRef="C_2c77f565-f009-499e-a1b1-aa2bbba1d540" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5 years</span></ix:nonNumeric></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Laboratory equipment</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4d5d2862-8a3d-4465-a273-c4dd824bf387" contextRef="C_22f4bcb0-6708-4711-89d9-4dd150fabf2e" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5 years</span></ix:nonNumeric></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Leasehold improvements</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c010d363-2839-4c5f-bf44-cc7409c21622" contextRef="C_e3549357-9b6b-45e4-b9a8-1215efcfd4cf" name="us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Shorter of remaining lease term or useful life</span></ix:nonNumeric></span></p></td>
         </tr>
        </table></ix:nonNumeric></div></ix:nonNumeric></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><ix:continuation id="F_7e49b05e-6de7-4694-b4b5-f363f0c56ab3_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Purchased assets that are not yet in service are recorded to construction-in-process and no depreciation expense is recorded. Once they are placed in service, they are reclassified to the appropriate asset class. When assets are retired or otherwise disposed of, the assets and related accumulated depreciation are eliminated from the accounts and any resulting gain or loss is reflected in the Company&#x2019;s consolidated statements of operation and comprehensive loss. Expenditures for maintenance and repairs are expensed as incurred.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_93a53827-b665-4b26-b15a-180e92d9cae6" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" escape="true" continuedAt="F_93a53827-b665-4b26-b15a-180e92d9cae6_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Impairment of Long-Lived Assets</span></p></ix:nonNumeric></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span><ix:continuation id="F_93a53827-b665-4b26-b15a-180e92d9cae6_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Long-lived assets consist of property and equipment. The Company continually evaluates whether events or circumstances have occurred that indicate that the estimated remaining useful life of its long-lived assets may warrant revision or that the carrying value of these assets may not be recoverable. If circumstances require that a long-lived asset or asset group be tested for impairment, the Company first compares the estimated undiscounted future cash flows expected to result from the use or disposition of that asset or asset group to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment loss would be recognized to the extent the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market prices and third-party independent appraisals, as considered necessary.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e1d72b51-4380-48c9-9514-3be0e840f0f3" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:LesseeLeasesPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Leases</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease. Leases with a term greater than one year are recognized on the consolidated balance sheet as a right-of-use (&#x201c;ROU&#x201d;) asset and current and non-current lease liabilities, as applicable. The Company has made an accounting policy election, known as the short-term lease recognition exemption, which allows the Company to not recognize ROU assets and lease liabilities that arise from short-term leases (12 months or less); The Company has applied this election to all classes of underlying assets. The Company typically only includes an initial lease term in its assessment of a lease arrangement. Options to renew or options to cancel a lease are not included in the Company&#x2019;s assessment unless there is reasonable certainty that the Company will renew or will not cancel, respectively. The Company monitors its material leases on a quarterly basis.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating lease liabilities and their corresponding ROU assets are recorded based on the present value of future lease payments over the expected remaining lease term. Lease cost for operating leases is recognized on a straight-line basis over the lease term as an operating expense. Certain adjustments to the ROU asset may be required for items such as lease prepayments or incentives received. The interest rate implicit in lease contracts is typically not readily determinable. As a result, the Company utilizes its incremental borrowing rate, which reflects the fixed rate at which the Company could borrow on a collateralized basis the amount of the lease payments in the same currency, for a similar term, in a similar economic environment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has elected to account for the lease and non-lease components together for office, laboratory, and manufacturing real estate leases.</span></p></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_aeb77815-21a4-4158-acd8-484dddd8fadd" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ResearchAndDevelopmentExpensePolicy" escape="true" continuedAt="F_aeb77815-21a4-4158-acd8-484dddd8fadd_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research and Development</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development expenses include costs directly attributable to the conduct of the Company&#x2019;s research and development programs.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expenditures relating to research and development are expensed in the period incurred. Nonrefundable advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made. The cost of materials for a research and development activity that have an alternative future use is capitalized when the materials are acquired and recognized as expense as consumed. The costs of materials that were acquired for a particular research and development activity and have no alternative future use are expensed in the period acquired.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></ix:nonNumeric></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span><ix:continuation id="F_aeb77815-21a4-4158-acd8-484dddd8fadd_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Costs incurred in obtaining licenses are recognized as research and development expense as incurred if the license has no alternative use.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_fcfbf5ab-e668-44c1-9e25-1d248c635a8d" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="vor:AccruedResearchAndDevelopmentExpensesPolicyPolicyTextBlock" escape="true" continuedAt="F_fcfbf5ab-e668-44c1-9e25-1d248c635a8d_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accrued Research and Development Expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p></ix:nonNumeric></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span><ix:continuation id="F_fcfbf5ab-e668-44c1-9e25-1d248c635a8d_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has entered into various research and development related contracts, including contracts with third-party contract research organizations and contract manufacturing organizations. These agreements are cancelable, and related payments are recognized as research and development expenses as incurred. The Company records accrued liabilities for estimated ongoing research costs. When evaluating the adequacy of the accrued liabilities, the Company analyzes the progress of the studies, including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the accrued balances at the end of any reporting period. Actual results could differ from the Company&#x2019;s estimates. To date, the Company&#x2019;s historical accrual estimates have not been materially different from the actual costs.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9562e2b2-6da7-4dbe-9d55-c49e05ac49aa" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:CompensationRelatedCostsPolicyTextBlock" escape="true" continuedAt="F_9562e2b2-6da7-4dbe-9d55-c49e05ac49aa_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock-Based Compensation Expense</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company accounts for stock-based compensation under the provisions of ASC 718-10,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> Compensation&#x2014;Stock Compensation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#x201c;ASC 718-10&#x201d;), which requires all share-based payments to employees, non-employees and directors, including grants of stock options and restricted stock, to be recognized in the consolidated statements of operations and comprehensive loss based on their fair values on the date of grant over the requisite service period, which is generally the vesting period of the respective award. Forfeitures are accounted for as they occur. Generally, the Company issues awards with only service-based vesting conditions and records the expense for these awards using the ratable method. The Company classifies stock-based compensation expense in the same manner in which the award recipient&#x2019;s payroll or service provider&#x2019;s costs are classified. Share-based payments that contain performance conditions are recognized when such conditions are probable of being achieved.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The fair value of each restricted common stock award is estimated on the date of grant based on the fair value of the Company&#x2019;s common stock on that same date.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model, which requires inputs based on certain subjective assumptions, including the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Fair Value of Common Stock</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;See the discussion below. </span></div></div><div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expected Term</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;The expected term represents the period that the stock-based awards are expected to be outstanding. The Company uses the simplified method to determine the expected term, which is based on the average of the time-to-vesting and the contractual life of the options. </span></div></div><div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expected Volatility</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;Because the Company does not have sufficient trading history for its common stock as of December 31, 2021 , the expected volatility was estimated based on the average volatility for comparable publicly traded biotechnology companies over a period equal to the expected term of the stock option grants. The comparable companies were chosen based on the similar size, stage in life cycle or area of specialty. The Company will continue to apply this process until a sufficient amount of historical information regarding the volatility of its own stock price becomes available. </span></div></div><div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Risk-Free Interest Rate</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;The risk-free interest rate is based on the U.S. Treasury zero coupon issues in effect at the time of grant for periods corresponding with the expected term of the awards. </span></div></div><div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#x2022;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Dividend Yield</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;The Company has never paid dividends on its common stock and has no plans to pay dividends on its common stock. Therefore, the Company used an expected dividend yield of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_07651309-b4bb-480f-90b5-9fab50f340b5" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt-sec:numwordsen">zero</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. </span></div></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company began to use the closing common stock price as reported on the Nasdaq Global Select Market exchange as the fair value of common stock on the date of a grant subsequent to its IPO. Prior to the Company's IPO the estimated fair value of common stock was determined by the Company&#x2019;s board of directors as of the date of each</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_9562e2b2-6da7-4dbe-9d55-c49e05ac49aa_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">option grant, with input from management, considering third-party valuations of its common stock as well as the Company&#x2019;s board of directors&#x2019; assessment of additional objective and subjective factors that it believed were relevant and which may have changed from the date of the most recent third-party valuation through the date of the grant. These objective and subjective factors include: (i) prices paid for the Company&#x2019;s redeemable convertible preferred stock, and the rights, preferences, and privileges of the Company&#x2019;s redeemable convertible preferred stock and common stock; (ii) the Company&#x2019;s stage of development; (iii) the fact that the grants of stock-based awards related to illiquid securities in a private company; and (iv) the likelihood of achieving a liquidity event for the common stock underlying the stock-based awards, such as an initial public offering or sale of the Company, given prevailing market conditions. These third-party valuations were performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants&#x2019; Accounting and Valuation Guide, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Valuation of Privately Held Company Equity Securities Issued as Compensation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Each valuation methodology includes estimates and assumptions that require the Company&#x2019;s judgment. The methodology utilized to estimate the fair value of the Company&#x2019;s common stock was the option-pricing method (&#x201c;OPM&#x201d;) to back-solve the estimated value of the Company&#x2019;s equity and corresponding value of the Company&#x2019;s common stock.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_097b9d5e-428b-476f-bf6d-c6a0386935be" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:IncomeTaxPolicyTextBlock" escape="true" continuedAt="F_097b9d5e-428b-476f-bf6d-c6a0386935be_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Income Taxes</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p></ix:nonNumeric></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span><ix:continuation id="F_097b9d5e-428b-476f-bf6d-c6a0386935be_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company accounts for income taxes using the asset and liability approach. Deferred tax assets and liabilities represent future tax consequences of temporary differences between the financial statement carrying amounts and the tax basis of assets and liabilities and for loss carryforwards using enacted tax rates expected to be in effect in the years in which the differences reverse. A valuation allowance is established to reduce deferred tax assets to the amounts expected to be realized. The Company also recognizes a tax benefit from uncertain tax positions only if it is &#x201c;more likely than not&#x201d; that the position is sustainable based on its technical merits. The Company accounts for interest or penalties related to uncertain tax positions as part of its provision for income taxes. To date, the Company has </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c103a1a9-4437-4ffc-98a1-535ac994f5f1" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t incurred interest and penalties related to uncertain tax positions. Should such costs be incurred, they would be classified as a component of provision for income taxes.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_02c8fcc0-fb22-444e-a0f9-5b4135087b42" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:EarningsPerSharePolicyTextBlock" escape="true" continuedAt="F_02c8fcc0-fb22-444e-a0f9-5b4135087b42_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Net Loss Per Share</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss attributable to common stockholders is equal to the net loss for the period, as adjusted for cumulative dividends on redeemable convertible preferred stock, for the respective period.</span></p></ix:nonNumeric></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span><ix:continuation id="F_02c8fcc0-fb22-444e-a0f9-5b4135087b42_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the reporting period, without consideration for potentially dilutive securities. Diluted net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares and potentially dilutive securities outstanding during the period determined using the treasury-stock and if-converted methods. For purposes of the diluted net loss per share attributable to common stockholders calculation, redeemable convertible preferred stock, restricted stock and stock options considered to be potentially dilutive securities were excluded from the calculation of diluted net loss per share attributable to common stockholders because their effect would be anti-dilutive and therefore, basic and diluted net loss per share attributable to common stockholders were the same for all reporting periods presented.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0321c355-3e44-47dc-baac-9d700e9f49e3" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" escape="true" continuedAt="F_0321c355-3e44-47dc-baac-9d700e9f49e3_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recent Accounting Pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From time to time, new accounting pronouncements are issued and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#x2019;s consolidated financial statements upon adoption. Under the Jumpstart Our Business Startups Act of 2012, as amended (the &#x201c;JOBS Act&#x201d;), the Company meets the definition of an emerging growth company and has elected to take advantage of the extended transition period for complying with certain new or revised accounting standards pursuant to Section 107(b) of the JOBS Act. As noted below, certain new or revised accounting standards were early adopted.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recently Adopted Accounting Pronouncements</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In 2019, the FASB issued </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_9fe2e284-3d35-4fe3-b478-3dcd0820f887;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ASU No. 2019-12</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Income Taxes (Topic 740)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">: </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Simplifying the Accounting for Income Taxes (&#x201c;ASU 2019-12&#x201d;), which introduces a number of amendments that are designed to simplify the application of accounting for income taxes. Such amendments include removing certain exceptions for intraperiod tax allocation, interim reporting when a year-to-date loss exceeds the anticipated loss, reflecting the effect of an enacted change in tax laws or rates in the annual effective tax rate and recognition of deferred taxes related to</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude></ix:nonNumeric></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_0321c355-3e44-47dc-baac-9d700e9f49e3_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">outside </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">basis differences for ownership changes in investments. ASU 2019-12 also provides clarification related to when a step up in the tax basis of goodwill should be considered part of the business combination in which the book goodwill was originally recognized and when it should be considered a separate transaction. In addition, ASU 2019-12 provides guidance on the recognition of a franchise tax (or similar tax) that is partially based on income as an income-based tax and accounting for any incremental amount incurred as a non-income-based tax. The Company </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3105c361-0835-42ce-b4f4-2eea3cef98ab" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" format="ixt:booleantrue"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">adopted </span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> ASU 2019-12 effective </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e2a00bcb-30f0-4346-b4ea-0c1f5207c2c8" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" format="ixt:datemonthdayyearen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 1, 2021</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, and the adoption did </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4c55b092-dff4-4d41-a1c3-cb41d55bfb86" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" format="ixt:booleantrue"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t have a material impact on its consolidated financial statements.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c4f13434-a722-4847-b37c-8e286a64c605" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="vor:RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recently Issued Accounting Pronouncements Not Yet Adopted</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In June 2016, the FASB issued ASU 2016-13, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> which has been subsequently amended by ASU 2018-19, ASU 2019-04, ASU 2019-05, ASU 2019-10, ASU 2019-11 and ASU 2020-03 (&#x201c;ASU 2016-13&#x201d;). This standard significantly changes the impairment model for most financial assets and certain other instruments and will require immediate recognition of estimated credit losses expected to occur over the remaining life of many financial assets, which will generally result in earlier recognition of allowances for credit losses on loans and other financial instruments. The Company does not expect that this standard will have a material impact to the Company&#x2019;s consolidated financial statements and plans to adopt this standard on January 1, 2022.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_60c421b7-e62b-40a0-b67a-6b3c99de3234" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">3. Investments</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cf6ab898-1713-4fc8-9086-2d2940b841df" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The amortized cost and estimated fair value of investments, by contractual maturity are as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:48.999%;"></td>
        <td style="width:1.178%;"></td>
        <td style="width:1.371%;"></td>
        <td style="width:9.519%;"></td>
        <td style="width:0.685%;"></td>
        <td style="width:1.178%;"></td>
        <td style="width:1.371%;"></td>
        <td style="width:9.53%;"></td>
        <td style="width:0.685%;"></td>
        <td style="width:1.178%;"></td>
        <td style="width:1.371%;"></td>
        <td style="width:9.53%;"></td>
        <td style="width:0.685%;"></td>
        <td style="width:1.178%;"></td>
        <td style="width:1.371%;"></td>
        <td style="width:9.487%;"></td>
        <td style="width:0.685%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Amortized Cost</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Gross Unrealized Holding Gains</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Gross Unrealized Holding Losses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Fair Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Maturing in one year or less</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate debt</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e107077e-b7fb-4915-8b3d-1b9823e038a1" contextRef="C_5b680cd4-9558-44e6-9a54-c351f3ac168d" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,603</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f059402f-f2dd-4fb2-836f-d676f455e1a0" contextRef="C_5b680cd4-9558-44e6-9a54-c351f3ac168d" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,603</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. Treasuries</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a830e335-b66d-4641-983b-2b5d382834da" contextRef="C_e1887846-0919-4db3-aa01-c63b37f6dff8" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,119</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_927dc0d6-d33c-4872-a49c-d2e404e3a789" contextRef="C_e1887846-0919-4db3-aa01-c63b37f6dff8" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">30,119</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Maturing after one year through five years</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate debt</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0cabb277-3d09-43c0-b305-93cf92e73e8d" contextRef="C_a65d33bd-d9c2-4c72-bb24-f45f2ce91c39" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,006</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_78cdf13e-83ba-4a64-9013-5242c7d095a4" contextRef="C_a65d33bd-d9c2-4c72-bb24-f45f2ce91c39" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,006</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. Treasuries</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_addc93c9-aacc-43f7-a35d-feb1d975c70e" contextRef="C_715b82a7-0efe-414c-ba1e-c08acca496be" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">44,940</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_225cf31d-edf3-4ed2-b2ca-afd70454052e" contextRef="C_715b82a7-0efe-414c-ba1e-c08acca496be" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">44,940</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:15.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fb1237a2-5eb0-456c-ae1b-10cfc0eab5e5" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">87,668</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0d324bac-fd3b-4d81-bff3-c9efac1c2029" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:AvailableForSaleSecuritiesDebtSecurities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">87,668</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company held </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b0729d2a-b4f0-43d8-9ff2-a2577dcea8f5" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:Investments" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> investments at December 31, 2020.</span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_8616a410-8e06-45ec-96b0-6b8e27ebdb6b" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:FairValueDisclosuresTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">4. Fair Value Measurements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_817b4c64-e247-4958-8dcb-8aa68aadb446" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following tables present information about the Company&#x2019;s financial assets and liabilities measured at fair value on a recurring basis:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.143%;"></td>
        <td style="width:1.178%;"></td>
        <td style="width:1.371%;"></td>
        <td style="width:9.499%;"></td>
        <td style="width:0.685%;"></td>
        <td style="width:1.178%;"></td>
        <td style="width:1.371%;"></td>
        <td style="width:9.499%;"></td>
        <td style="width:0.685%;"></td>
        <td style="width:1.178%;"></td>
        <td style="width:1.371%;"></td>
        <td style="width:9.392%;"></td>
        <td style="width:0.685%;"></td>
        <td style="width:1.178%;"></td>
        <td style="width:1.371%;"></td>
        <td style="width:9.531%;"></td>
        <td style="width:0.685%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Level 1</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Level 2</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Level 3</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5caa9618-8b61-4083-8841-cf6f6f194f27" contextRef="C_30c63602-288c-4405-a204-cdab859368e7" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">95,339</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_949d1479-cbf6-4ac2-a4ba-be311264caa3" contextRef="C_8e0a26e9-728b-430b-b0fc-8bf930a218ab" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">95,339</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Investments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate bonds</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_45fa4e80-64cf-45f3-bdcf-e477532f8e48" contextRef="C_4efe06e3-c8a1-4df0-8cc2-32db822023b4" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,609</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_54356b5d-1250-4141-8e4a-316a479284d2" contextRef="C_c04daa76-85eb-4243-8001-dd530ab727ea" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">12,609</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. Treasuries</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d73ed43f-b216-4fb2-8bdf-be0533789d2d" contextRef="C_a4841187-5a01-4b8a-9f4b-2a8762ff5f9a" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">75,059</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_20a17827-1727-4dc3-962e-8c1f2c896a05" contextRef="C_4457893c-b88e-4779-ae3d-d3eaad39d858" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">75,059</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:15.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total investments</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c7c900d9-b827-4fc9-a1e1-057d9c43c6b1" contextRef="C_125bd726-c0d2-4df7-b573-0ef9f71919e2" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">87,668</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e031665c-dc5d-46d2-bc2e-4bd34430250d" contextRef="C_627553ad-acf9-43fd-997b-9899cf109351" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">87,668</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Restricted cash equivalents</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fcc3946b-a914-4e15-8c5e-843e5ccd951b" contextRef="C_cc3d40e7-fe0d-4909-adf0-b9e10e622e8b" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,413</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a7266c4e-cfd5-4693-abef-4014e536c63e" contextRef="C_e8956874-0a8e-44bd-8bfb-ee0b88501483" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,413</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fa581dd8-38fd-4923-a34f-9856bfdba767" contextRef="C_4fcfa437-bee3-47fa-94e3-9caec72a5b95" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">97,752</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2502d6e4-2221-483f-9e03-24b0374eeff1" contextRef="C_3dacd509-2296-44c2-8572-ea922b845d9c" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">87,668</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0f1e0439-8ae7-4e90-8da4-942c0ca5340d" contextRef="C_830618a5-a622-44e4-a728-a9181a23c735" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">185,420</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Level 1</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Level 2</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Level 3</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_939d9d9d-b52e-40e5-8dee-3324ffb25c7c" contextRef="C_b6f766ff-68c5-4b43-8d56-95a91d04de17" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">41,036</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_59393b27-81b6-4757-84ab-3133ea4f5542" contextRef="C_1d853449-b848-41c9-8402-61ac0859b6c1" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">41,036</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:15.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f1545196-81c6-48f9-9c0e-c02f656cbd59" contextRef="C_5e77fbcd-1b4f-4eb9-bc4a-1659f7452745" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">41,036</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5dc29c81-8396-4bb9-870d-fe02e2a7680a" contextRef="C_4322025b-403f-47da-9dfb-69514ce849e6" name="us-gaap:AssetsFairValueDisclosure" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">41,036</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The fair value of the Company&#x2019;s cash equivalents and restricted cash equivalents is based on quoted market prices in active markets with no valuation adjustment. The fair value of investments was determined based on observable market inputs. During the years ended December 31, 2021 and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b7e383d5-dc48-48e6-ad14-4dbbefc747a6" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="vor:FairValueAssetsLevel1ToLevel2TransferredAmount" unitRef="U_USD" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_f6b70458-d865-4e2c-8cb2-29cbd4c82662" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="vor:FairValueAssetsLevel2ToLevel1TransferredAmount" unitRef="U_USD" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_59e68c6d-f995-41cd-a1c4-cb4e693f8eb9" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" unitRef="U_USD" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_bf8e3d72-cc11-4335-bbc6-8e37ddfc1bce" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" unitRef="U_USD" decimals="INF" format="ixt:numdotdecimal">0</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, there were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_40f4e850-2ce8-4253-8aaa-99dcc5adc9ff" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="vor:FairValueAssetsLevel1ToLevel2TransferredAmount" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_1f481c30-1a31-40c1-8609-0014dbcb975f" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="vor:FairValueAssetsLevel2ToLevel1TransferredAmount" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_5aafb620-9b2e-4360-9087-d2c9b994c4ca" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_cf4693bb-1052-4a45-ae47-6b5f49f6acc8" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> transfers between levels.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4461e3ed-5302-4cb9-9703-5afa6543347f" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">5. Property and Equipment, Net</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_0a73fd34-d1bc-46e2-a7c7-5ab7be2e6bf0" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:PropertyPlantAndEquipmentTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment, net consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.149%;"></td>
        <td style="width:1.606%;"></td>
        <td style="width:1.37%;"></td>
        <td style="width:13.029%;"></td>
        <td style="width:0.921%;"></td>
        <td style="width:1.606%;"></td>
        <td style="width:1.37%;"></td>
        <td style="width:13.029%;"></td>
        <td style="width:0.921%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Furniture and equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5213052d-5754-4fd9-a4b2-19af058796f8" contextRef="C_2069f6af-4edc-49e3-bb9e-d18be8ade020" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">108</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cf0f6aff-b7e2-4aa3-92b1-ea740c74043b" contextRef="C_cbe610c1-c6d3-4428-b88d-d6ea1d66502f" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">40</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Laboratory equipment</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bb52efc3-9808-4242-a43e-648c280965f1" contextRef="C_8f8c1246-f661-4230-b8d9-f954d3732f61" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,457</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7bc8fe9a-4820-4ac1-8f5d-4828b2548b98" contextRef="C_715633f5-fcd9-4448-aad7-029e1308015e" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,247</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Leasehold improvements</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2fb9fcb3-873a-46f9-b4e3-fc28728ef692" contextRef="C_86a506c8-d064-4dfe-9433-56efa7f9e3b1" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">55</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Computer equipment</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_de5482aa-4d8b-44e1-9deb-f44f91171e57" contextRef="C_8e667a03-9dc8-490a-98a3-a47136782d33" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">317</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5489ffac-094f-4210-aa06-1f95a132f595" contextRef="C_d172676c-6f5a-4c81-bda9-175f1b30bdaf" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">167</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment, gross</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_979bad0f-9a64-4394-96d3-f8f34a6deb8a" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,937</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_79a311af-a0c7-4537-8c54-368103e95486" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:PropertyPlantAndEquipmentGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,454</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accumulated depreciation</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6b362842-8769-44e3-9cd0-03364163f11e" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,084</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8f5d4d2a-ec03-48d2-85b8-60697738172d" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">726</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6f510f8c-9920-4477-9b59-f096cda420b1" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,853</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f92924a5-5502-419c-824c-c3afc21de9ad" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:PropertyPlantAndEquipmentNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,728</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Depreciation expense for the years ended December 31, 2021 and 2020 was approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_588600fb-8f5c-4138-b5b8-713a8336ae87" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:Depreciation" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cc67763c-b80b-4f0b-8973-da19bfb8ef04" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:Depreciation" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_cb63d4a6-bf70-4a7c-bf08-18bd8609cd2e" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">6. Accrued Expenses and Other Current Liabilities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_841e102e-8762-4065-89cb-f153995cdf8b" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="vor:ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued expenses and other current liabilities consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.246%;"></td>
        <td style="width:1.606%;"></td>
        <td style="width:1.381%;"></td>
        <td style="width:12.996%;"></td>
        <td style="width:0.867%;"></td>
        <td style="width:1.606%;"></td>
        <td style="width:1.381%;"></td>
        <td style="width:13.221%;"></td>
        <td style="width:0.696%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Employee-related and other expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e54c94a0-bd7a-4e0a-a2b1-8ef82046eef8" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,178</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_08abc58a-0993-4a4b-8d96-f93d15602b18" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,727</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development expenses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f72f4aee-7735-452e-9af1-9b6d1bfac259" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="vor:AccruedResearchAndDevelopmentExpensesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">797</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_50b05274-a4d5-4415-9477-03b8d77f633e" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="vor:AccruedResearchAndDevelopmentExpensesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,924</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Professional fees</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3ff7aca8-9dc6-4980-87ad-46ed1dd56b69" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">743</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_79e61f7f-932e-4c46-a852-ed741eb5b746" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:AccruedProfessionalFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,097</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">License and milestone fees</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Calibri;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f9311743-1539-4858-9948-118fbb65c8ec" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="vor:AccruedLicenseAndMilestoneFeesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">450</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dce309ba-f93b-4abc-bd62-42da99ed1c10" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">617</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3d0240a3-9774-4e99-a35b-3c01c7278c9c" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:OtherAccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">62</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total accrued expenses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5c563b6e-bfde-4cc4-a94a-1b973a1a4110" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,335</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c15bdc7e-73fc-4cb4-a760-7f0052d5d7a6" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:AccruedLiabilitiesCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,260</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b1a5c3c1-250a-469a-ac77-8aa69369dd89" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="vor:RedeemableConvertiblePreferredStockTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">7. Redeemable Convertible Preferred Stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2020, the authorized capital stock of the Company included </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4b1e8ebc-9d17-4458-bf06-013209af4a31" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">338,973,691</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f36e85d1-27b2-4df4-a145-7657daf1a376" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:TemporaryEquityParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.0001</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> par value preferred stock, of which </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9e60fd03-b5e4-47aa-9362-5b8ff7cb6fbe" contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">20,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares were designated as Series A-1 redeemable convertible preferred stock (&#x201c;Series A-1&#x201d;); </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_849ba2d1-6fb4-4781-a9ed-2904999b3a3e" contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">107,194,866</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares were designated as Series A-2 redeemable convertible preferred stock (&#x201c;Series A-2&#x201d;) and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_da6ea549-58a2-491b-9ada-84ab2a158ca3" contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">211,778,825</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares were designated as Series B redeemable convertible preferred stock (&#x201c;Series B&#x201d;).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Series A-1 and Series A-2 Redeemable Convertible Preferred Stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On February 12, 2019, the Company entered into the Series A-2 Preferred Stock Purchase Agreement. Included in the terms of the Series A-2 were tranche rights. The tranche rights obligated the investors in the Series A-2 to purchase, and the Company to sell, an additional </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f0b689e5-8fbe-444c-926f-3deb0da647e8" contextRef="C_02d1981e-0b73-40f4-9bc3-8fdce9d391e3" name="vor:TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">44,375,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Series A-2 at a purchase price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_69a0e7bc-92bf-4e05-a78a-c7f5fe54d207" contextRef="C_02d1981e-0b73-40f4-9bc3-8fdce9d391e3" name="vor:TemporaryEquityIssuedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.40</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share upon achieving certain milestones related to the Company&#x2019;s research platform (&#x201c;Milestone Closing&#x201d;). The number of shares and issuance price for the Milestone Closing were fixed at inception, and the timing for the closing was dependent on whether the Company met certain research and development milestones or if an earlier closing is voted by the Series A-2 holders. The Series A-2 tranche obligation is an embedded feature that does not net settle and therefore, it did not meet the definition of an embedded derivative.</span></p><p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On February 5, 2020, the Company issued and sold </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_158f54a4-1598-411c-8c56-2af06bb46723" contextRef="C_52a58005-78a0-40c3-9da0-2ffe7154a555" name="vor:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">44,375,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Series A-2 for total gross cash proceeds of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_24b569aa-5008-40d9-8e74-447eb53978b9" contextRef="C_52a58005-78a0-40c3-9da0-2ffe7154a555" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">17.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million related to the Milestone Closing.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Series B Redeemable Convertible Preferred Stock Closing</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On June 29, 2020, the Company issued and sold </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0e78e802-dd44-4fb5-862a-2dfdc2792f6a" contextRef="C_d0fb8d89-6900-4a5d-85de-755eaa9cf227" name="vor:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">124,519,220</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of its Series B redeemable convertible preferred stock at a per share price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_06c86b50-7d6b-4fbb-8948-9feaabdec912" contextRef="C_d0fb8d89-6900-4a5d-85de-755eaa9cf227" name="vor:TemporaryEquityIssuedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.52</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#x201c;Original Purchase Price&#x201d;) for total gross proceeds of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_570ca836-5bb9-45ed-998b-359ef2ab9f23" contextRef="C_d0fb8d89-6900-4a5d-85de-755eaa9cf227" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">64.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million. The stock purchase agreement provided for a second closing obligating the investors in the Series B redeemable convertible preferred stock to purchase, and the Company to sell, an additional </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b74f8d3c-a9ac-40db-acdd-2ae51633509e" contextRef="C_d0fb8d89-6900-4a5d-85de-755eaa9cf227" name="vor:TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">87,259,605</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Series B redeemable convertible preferred stock at a per share price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9acbc3cd-aecc-4bf3-acb1-80a3815d8dff" contextRef="C_d0fb8d89-6900-4a5d-85de-755eaa9cf227" name="vor:TemporaryEquityIssuedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.52</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> upon the achievement of the second tranche milestone.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On January 8, 2021, upon achievement of the second tranche milestone, the Company issued and sold </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0f84fd90-0ad1-4fe1-bd03-78176aa9aaa3" contextRef="C_6591cce2-facd-4d98-9f53-16294c8f698c" name="vor:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">87,259,605</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Series B redeemable convertible preferred stock at a price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d194aa1d-5d0a-4d74-903d-d35659297b79" contextRef="C_6591cce2-facd-4d98-9f53-16294c8f698c" name="vor:TemporaryEquityIssuedPricePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.52</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share, for total gross and net proceeds of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_45117b06-60dc-4bf7-9333-e18eda69a828" contextRef="C_6591cce2-facd-4d98-9f53-16294c8f698c" name="us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">45.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On February 9, 2021, the Company completed its IPO. Upon closing of the IPO, all shares of Series A-1, A-2 and B redeemable convertible preferred stock then outstanding automatically converted into </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4b0b9a38-0d26-4571-8fbe-820d4a07ab83" contextRef="C_522a671f-8013-49d5-9406-851e52363e90" name="us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">24,924,501</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common shares. Upon conversion of the redeemable convertible preferred stock, the Company reclassified the carrying value of the redeemable convertible preferred stock to common shares and additional paid-in capital.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_faa1a38a-2767-4d1b-ad5c-8417e919eb59" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="vor:ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2020, redeemable convertible preferred stock consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:31.91%;"></td>
        <td style="width:0.706%;"></td>
        <td style="width:9.206%;"></td>
        <td style="width:0.706%;"></td>
        <td style="width:2.055%;"></td>
        <td style="width:0.706%;"></td>
        <td style="width:8.135%;"></td>
        <td style="width:0.706%;"></td>
        <td style="width:2.055%;"></td>
        <td style="width:1.381%;"></td>
        <td style="width:7.6%;"></td>
        <td style="width:0.706%;"></td>
        <td style="width:2.055%;"></td>
        <td style="width:1.381%;"></td>
        <td style="width:6.851%;"></td>
        <td style="width:0.706%;"></td>
        <td style="width:2.055%;"></td>
        <td style="width:1.381%;"></td>
        <td style="width:7.172%;"></td>
        <td style="width:0.706%;"></td>
        <td style="width:2.055%;"></td>
        <td style="width:0.706%;"></td>
        <td style="width:8.349%;"></td>
        <td style="width:0.706%;"></td>
       </tr>
       <tr style="height:7.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(in thousands, except share amounts)</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Preferred<br />Stock<br />Authorized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Preferred<br />Stock Issued<br />and<br />Outstanding</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Carrying<br />Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Liquidation<br />Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Cumulative<br />Undeclared<br />Dividends</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Common<br />Stock<br />Issuable<br />Upon Conversion</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:7.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Series A-1 redeemable<br />&#160;&#160;&#160;&#160;convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b3ad1bd5-86d4-4beb-873d-cbed47852c06" contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">20,000,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_604930ce-8a3e-478d-bce2-b408750e5fa0" contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_4dbc0514-b562-4c4c-9e2f-17f13e333d1b" contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">20,000,000</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b4717357-2b12-4af9-b8c0-88cc9ef1fc4d" contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0746f8c1-8cc4-461c-aec2-d5ccbf7a1a86" contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b2f8e86b-5cdd-4160-9acb-b2084641f28a" contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,470,588</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:7.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Series A-2 redeemable<br />&#160;&#160;&#160;&#160;convertible preferred stock</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_13786c4e-ca92-43cd-9d47-77ec6b8407ae" contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">107,194,866</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ce5b742f-70dd-41f8-a338-b5ebe44b885d" contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_2ed8098a-7103-43c2-aa62-9b1dc856a280" contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">107,194,866</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3d55e5b2-2bc3-480d-af67-6e1d487f33b4" contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">42,786</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d184acee-0282-43e1-af3d-7c291752fcca" contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">42,878</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d2f8e2b7-7859-4852-910c-592437df90e3" contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b" name="vor:TemporaryEquityCumulativeUndeclaredDividends" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,073</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c9d766f6-a485-4f18-a027-cebe936d4642" contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">7,881,965</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:7.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Series B redeemable<br />&#160;&#160;&#160;&#160;convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c1ac1f46-361c-49be-97bc-55e9b72c7937" contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">211,778,825</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_50fba24f-c353-48fa-be8a-08bff8901e8c" contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_39b2d646-8ff3-428e-9066-e67ee6c19833" contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">124,519,220</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7925ccdd-fe4e-4634-999a-c2a247bf5b5b" contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">64,548</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c49276c8-a6da-484b-aceb-5af9e8600f6c" contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">64,750</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_792a1c2f-db00-4ddb-b95d-1b1848202024" contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42" name="vor:TemporaryEquityCumulativeUndeclaredDividends" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,625</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8c2fece8-8fd8-4fe7-935e-031486a927ee" contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">9,155,810</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:7.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_35867926-57b2-48f5-8725-7f8ad92f0508" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:TemporaryEquitySharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">338,973,691</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b159ee19-a372-4eb4-a00b-3a3dc8b95d75" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:TemporaryEquitySharesIssued" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal"><ix:nonFraction id="F_4dc24527-a68a-4737-aad0-f388f4e2491f" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:TemporaryEquitySharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">251,714,086</ix:nonFraction></ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5cf412ff-67cd-4e19-bb48-eb9ea1902403" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:TemporaryEquityCarryingAmountAttributableToParent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">107,336</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_513f6d01-b95a-400f-8973-b90f0b5a5e2f" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:TemporaryEquityLiquidationPreference" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">111,628</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6e381559-3ac1-4c43-b47b-05fe4c050be7" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="vor:TemporaryEquityCumulativeUndeclaredDividends" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">7,698</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_216fa2c0-1155-48ff-9381-889f5c50420a" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">18,508,363</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_f387700d-d5a2-4a1f-ae82-2eb6adcac9ad" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">8. Stockholders' Equity</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Preferred Stock</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has authorized up to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_70a1500c-71a3-405a-b0d7-4433780594e2" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:PreferredStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">10,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of preferred stock, $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c99db922-452b-47f3-b538-85d1447e7133" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:PreferredStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.0001</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> par value per share, for issuance. The preferred stock will have such rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges, and liquidation preferences, as shall be determined by the Company&#x2019;s Board of Directors upon its issuance. At  </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 31, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, there were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9b99bc9a-f95a-4e9e-b7aa-3d5190046430" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:PreferredStockSharesOutstanding" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of preferred stock outstanding.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Common Stock</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the Company&#x2019;s authorized capital stock included </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0c312ac0-a58f-4a76-9145-bc180185c099" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">400,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4e307a0e-0b66-4910-b8af-4d1e4409b59d" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:CommonStockSharesAuthorized" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">420,000,000</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares, respectively, of its </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0c33dfd3-58d8-4c9c-a464-d75f16531f4e" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF"><ix:nonFraction id="F_e3065939-7ebc-4033-95e6-ffdfc7359713" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:CommonStockParOrStatedValuePerShare" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">0.0001</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> par value common stock.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_2791bdc0-0466-4c53-957c-4bfb06111a68" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:CommonStockVotingRights"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each share of common stock entitles the holder to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_16663531-e5c9-481f-90ff-19104f36aae3" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="vor:NumberOfCommonStockVotingRights" unitRef="U_Vote" decimals="INF" format="ixt-sec:numwordsen">one</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> vote</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> on all matters submitted to a vote of the Company&#x2019;s stockholders provided, however, that, except as otherwise required by law, holders of common stock shall not be entitled to vote on any amendment to the Company&#x2019;s Certificate of Incorporation, as amended (the &#x201c;Certificate of Incorporation&#x201d;), that relates solely to the terms of one or more outstanding series of preferred stock if the holders of such affected series are entitled, either separately or together with the holders of one or more other such series, to vote thereon pursuant to the Certificate of Incorporation or pursuant to the Delaware General Corporation Law. Common stockholders are entitled to receive dividends, as may be declared by the Company&#x2019;s board of directors, if any, subject to the preferential dividend rights of the preferred stock. </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3eb20ab4-4825-48db-8d84-236c2cf91e78" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:DividendsCommonStock" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_164ac04b-23aa-4827-b817-550c541b748c" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:DividendsCommonStock" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_2b72638f-2691-4523-a0fe-b3ac4a0bbc8a" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:PaymentsOfDividendsCommonStock" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_cb07c5ca-1b69-48a9-9734-e476227eba98" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:PaymentsOfDividendsCommonStock" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">No</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> dividends have been declared or paid as of and for either of the years ended  </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 31, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p></ix:nonNumeric></div>
  <div><ix:nonNumeric id="F_31d085a9-0b5f-4a73-9216-d58e2309ba75" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">9. Stock-Based Compensation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock Incentive Plans</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2015, the Company&#x2019;s board of directors adopted and approved the 2015 Stock Incentive Plan (as amended to date, the &#x201c;2015 Plan&#x201d;). The 2015 Plan provided for the granting of incentive stock options, non-statutory stock options, restricted stock awards and other stock-based awards to eligible employees, officers, directors, consultants and advisors as determined by the Company&#x2019;s board of directors.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In October 2020, the Company granted an option to purchase </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bfbe14de-dcd7-442f-afbb-8674738baa18" contextRef="C_5704eb75-6122-4803-bb26-449ab2867e41" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">294,117</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of its common stock to an advisor outside of the 2015 Plan, with a strike price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ed64ab9f-8a30-48e3-99b4-4631e5853dde" contextRef="C_4ca00470-3222-46a5-ba00-840824cc64ac" name="us-gaap:SharePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" decimals="INF">28.29</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share. Such grant was made outside of the 2015 Plan but is subject to the terms and conditions of such plan.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In February 2021, the Company&#x2019;s board of directors adopted and stockholders approved the 2021 Equity Incentive Plan (the &#x201c;2021 Plan&#x201d;). The 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Plan became effective on February 5, 2021, following which </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f0b59af9-a993-4068-9808-6135dab172bb" contextRef="C_29752c48-fb53-41e4-b327-df9623f28225" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> further grants were or will be made under the 2015 Plan. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The 2021 Plan provides for the grant of stock options, non-statutory stock options, restricted stock awards, restricted stock unit awards, stock appreciation rights, performance stock awards and other forms of stock compensation to our employees, consultants and directors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The number of shares of our common stock reserved for issuance under our 2021 Plan will automatically increase on January 1 of each year through January 1, 2031, by </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fe396d92-4ebf-48ec-9fe1-69dd3c8d7dcf" contextRef="C_384191fb-9059-497b-a41e-c8f78ff3b67f" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">4.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">of the total number of shares of common stock outstanding on December 31 of the preceding calendar year. Any grants that expire or are canceled, terminated,</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">forfeited, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">or fail to vest are allowed to be reissued under 2021 Plan. As of December 31, 2021, the Company had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8d3747b9-5564-48e5-b83d-64ae6d0bfe08" contextRef="C_33213034-803c-4c95-bb92-7996ff3a4622" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">2,643,187</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of its common stock available for future issuance under the 2021 Plan.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock Options</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#x2019;s stock options generally </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e60c2449-c75b-4165-a3bb-b1e5227bd390" contextRef="C_f74e35ab-8530-45d8-8610-4c43f69992db" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">vest over </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_29c4052e-fffd-45bf-b5c5-eb1adcedbce9" contextRef="C_2d35f13a-de85-4de4-863e-43adb4567091" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">48 months</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> with </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f362ffa2-346c-4808-845e-041bdc825a6c" contextRef="C_d6d70c45-e42a-4ed6-8717-d4b764af1957" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">25</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% vesting after </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7e633c75-80cb-49ce-97b7-b02c067c76fe" contextRef="C_d6d70c45-e42a-4ed6-8717-d4b764af1957" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">one year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> followed by ratable monthly vesting over</span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c6f8ac0b-aa4a-4a07-9482-93cb51405205" contextRef="C_1f0cde73-59e7-449b-80e5-547933529d26" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> three years</span></ix:nonNumeric></span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"></span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and have a contractual term of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_984acd9b-6361-4b36-9e88-0e146f5c872e" contextRef="C_2d35f13a-de85-4de4-863e-43adb4567091" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10 years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ed9080d9-df23-4d16-9d20-a65088b91211" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" escape="true" continuedAt="F_ed9080d9-df23-4d16-9d20-a65088b91211_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The weighted-average assumptions used principally in determining the fair value of options granted were as follows: </span></ix:nonNumeric></span><span style=""></span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_ed9080d9-df23-4d16-9d20-a65088b91211_1">
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.657%;"></td>
        <td style="width:1.595%;"></td>
        <td style="width:1.37%;"></td>
        <td style="width:11.905%;"></td>
        <td style="width:2.312%;"></td>
        <td style="width:1.595%;"></td>
        <td style="width:1.37%;"></td>
        <td style="width:11.883%;"></td>
        <td style="width:2.312%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Fair value of common stock</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0350c2a8-afcb-4ec8-87bb-478a2e9e0728" contextRef="C_2d35f13a-de85-4de4-863e-43adb4567091" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">23.63</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_37748b35-07d8-43ea-aafd-49e495781d59" contextRef="C_f74e35ab-8530-45d8-8610-4c43f69992db" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">4.29</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected term (in years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b66ce9ee-ae3d-4260-96e6-a1e299fc7be6" contextRef="C_2d35f13a-de85-4de4-863e-43adb4567091" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.0</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_26e66dba-e0bf-4310-be04-5338ed719d3c" contextRef="C_f74e35ab-8530-45d8-8610-4c43f69992db" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.0</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected volatility</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d6816667-2bd3-4ef1-8bb6-e64b9353886c" contextRef="C_2d35f13a-de85-4de4-863e-43adb4567091" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">78.4</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_acc964b6-bdbc-4be1-8ba3-da8e1a8cac5e" contextRef="C_f74e35ab-8530-45d8-8610-4c43f69992db" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">77.3</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Risk-free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1ab68277-0eac-49d4-8a07-c9cefa97dfae" contextRef="C_2d35f13a-de85-4de4-863e-43adb4567091" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.9</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_23a209fa-a947-4859-ac2c-bf29425f0a2f" contextRef="C_f74e35ab-8530-45d8-8610-4c43f69992db" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.4</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dividend yield</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_da31c0da-e9c7-4847-aaf6-bec1c9177130" contextRef="C_2d35f13a-de85-4de4-863e-43adb4567091" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5102cb12-ab76-4a58-99a4-18f0059ee476" contextRef="C_f74e35ab-8530-45d8-8610-4c43f69992db" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" unitRef="U_pure" scale="-2" decimals="2" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_92da1b4f-3d52-4072-bd15-93e2cc0adbd3" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes the Company&#x2019;s stock option activity for the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 31, 2021:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.095%;"></td>
        <td style="width:1.188%;"></td>
        <td style="width:0.685%;"></td>
        <td style="width:9.935%;"></td>
        <td style="width:0.91%;"></td>
        <td style="width:1.188%;"></td>
        <td style="width:1.37%;"></td>
        <td style="width:9.506%;"></td>
        <td style="width:0.685%;"></td>
        <td style="width:1.188%;"></td>
        <td style="width:0.707%;"></td>
        <td style="width:10.074%;"></td>
        <td style="width:0.685%;"></td>
        <td style="width:1.188%;"></td>
        <td style="width:1.37%;"></td>
        <td style="width:9.539%;"></td>
        <td style="width:0.685%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Weighted-<br />Average<br />Exercise Price</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Weighted-<br />Average<br />Remaining<br />Contractual Term<br />(in years)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Aggregate<br />Intrinsic<br />Value<br />(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding at December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8e1ea85a-f689-4885-a90a-38bb0a644264" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">5,084,679</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_07a5b32e-2998-4d8c-b27e-fba9624d7d40" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">3.79</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_40808ca1-28a7-4cdd-af42-8cc000668d05" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.42</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3541ab71-cc67-4772-874d-010f4e7a1e24" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">32,086</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dcc6d233-c1d8-430e-81fb-36350752a28d" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">730,884</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_68e24258-e059-4688-9a31-b22ad19c74d5" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">19.46</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vested and exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_76bd6714-7a22-4bea-a334-bfeabaa115d7" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="vor:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">442,947</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9df6063f-93fe-43ff-ab12-9aedce9d6476" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="vor:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">2.02</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Forfeited</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2673d6b1-2014-4e06-871f-9e152f4b5334" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">285,698</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_38283706-d7ef-454e-978a-4cb49ef71db8" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">4.10</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expired</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_eec57696-2aea-4f53-9a96-80e1d0758504" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">126</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a546c1b4-a617-47b3-803c-f2381eaa10be" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">18.00</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding at December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_47fed47f-fa22-4457-82ce-07c6e1400e98" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">5,086,792</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_540451a0-442b-4cc9-a920-2aa3845e816b" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">6.17</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_811e182e-6f43-45a2-a107-761449cd7272" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.00</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_20f0bd2b-15a7-4368-92c5-a12bff780cc0" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">38,000</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Exercisable at December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_252fb15a-2c99-4aed-8c1f-896f0dd6ecc2" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">1,669,852</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_90a28108-c80f-4891-beaf-773eac3f1315" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">4.15</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d3f00f06-3bd5-4b88-971b-da0107710d72" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.49</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9c7384b0-feb6-480e-89b5-fde3645e2cb7" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">14,384</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The aggregate intrinsic value of options is calculated as the difference between the exercise price of the stock options and the fair value of the Company&#x2019;s common stock for those stock options that had exercise prices lower than the fair value of the common stock as of the respective date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The weighted-average grant-date fair value of stock options granted during the years ended December 31, 2021 and 2020 was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_34c43ac2-b44c-458e-ba16-8486000dbc9e" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">13.14</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_30f06ea6-e2d3-4f8b-8771-4c5d608b00a9" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">2.19</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share, respectively. As of December 31, 2021, total unrecognized compensation expense related to stock options was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b89ced28-0e82-4639-8617-b414f8fb6ee9" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">13.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> which is expected to be recognized over a weighted-average period of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_292f5919-af11-4f96-866a-c734bd357cc1" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.51</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> years. The intrinsic value of stock options exercised was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3d9d4a9f-f3ad-49a9-a9af-155b4e345336" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">3.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for the year ended December 31, 2021.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">During the year ended December 31, 2020, options for </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5c66e760-c857-4c81-bbb1-753c410d894e" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">159,197</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares with a weighted-average exercise price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d0ae37b2-f23d-4620-b061-afb8d8785732" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">2.59</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and a weighted-average grant date fair value of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9ab3b62e-0685-42c8-b620-d3cf22c62eee" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="vor:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">1.90</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> were exercised but unvested at the time of exercise. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021 and 2020, options for </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_21490bd6-c811-4bab-b6f0-9a8b5eb6ebd5" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">200,687</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_25800103-df85-415d-a23d-0fcc15a0b74f" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" unitRef="U_shares" decimals="INF" format="ixt:numdotdecimal">388,157</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares with weighted average exercise prices of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8614a82d-7b35-4025-a64a-c2502319ee20" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="vor:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">1.90</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1baf71ab-ed3c-4794-9494-7e3e1a63a69b" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="vor:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2">1.86</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> were exercised and unvested, respectively. The underlying proceeds from the unvested exercises of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9f965858-6b30-4053-9307-b3cc8c9d807d" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:OtherLiabilitiesCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_64accfe7-122f-4485-ab7f-837220fdcf00" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:OtherLiabilitiesCurrent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.7</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> is recorded in other current liabilities as of December 31, 2021 and 2020, on the consolidated balance sheet.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock-Based Compensation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_118d5253-7439-4789-8dd7-3edcfc3e6342" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock-based compensation expense was allocated as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.253%;"></td>
        <td style="width:1.606%;"></td>
        <td style="width:1.381%;"></td>
        <td style="width:13.191%;"></td>
        <td style="width:0.696%;"></td>
        <td style="width:1.606%;"></td>
        <td style="width:1.381%;"></td>
        <td style="width:13.191%;"></td>
        <td style="width:0.696%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ad1713a7-eaa9-4be3-acac-906229cdc1d2" contextRef="C_e1434930-9e6c-49c1-8a72-2f6ad390870c" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,281</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_96471e15-cbaf-4d8c-9344-a218fac75f99" contextRef="C_01ae64e4-fcbc-4c77-945a-5a32dc371b12" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">665</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fae0995c-66e6-47a5-a85c-32cd3f23102e" contextRef="C_5ce9a17a-6747-4e6a-b14b-931e7fbf6304" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,034</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2bf04084-0dbb-4849-a0df-45c3ccb802d1" contextRef="C_f35b7c7a-c532-4b88-bdc5-43c57c43318c" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">677</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total stock-based compensation expense</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4a6b896a-d8f9-4541-9ff0-34e43bd36664" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,315</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_44746f0f-4012-432d-879f-3fee3c90a6a0" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:AllocatedShareBasedCompensationExpense" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,342</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3dd06878-62a9-4343-9311-ce5e267b024c" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:LesseeOperatingLeasesTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">10. Leases</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cambridgepark Lease</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2019, the Company entered into a lease agreement for its new corporate office and laboratory facility (the &#x201c;Cambridgepark Lease&#x201d;) in Cambridge, Massachusetts. The Cambridgepark Lease has a term of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_ae7dda8c-0964-46cb-b480-5563b0c68466" contextRef="C_af4903d8-c8c6-44b2-ae8d-4dfc4cc09658" name="us-gaap:LesseeOperatingLeaseTermOfContract" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10 years</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, beginning on the rent commencement date which is two months after the lease commencement date. There are </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_27ce9868-2573-4c60-818f-dedbf7970a18" contextRef="C_bb19a2ae-ac5d-4f11-b032-62cb4dd2a453" name="us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend" format="ixt:booleanfalse"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no options</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> to extend the lease. The lease commencement date, for accounting purposes, was deemed to be reached as of June 30, 2020.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On June 15, 2021, the Company entered into the first lease amendment (&#x201c;First Lease Amendment&#x201d;) and the second lease amendment (&#x201c;Second Lease Amendment&#x201d; and, together with the First Lease Amendment, the &#x201c;Lease Amendments&#x201d;) with PPF Off 100 Cambridge Park Drive, LLC (the &#x201c;Landlord&#x201d;). The Lease Amendments amended the Cambridgepark Lease with the Landlord in Cambridge, Massachusetts to add additional leased space in the same building (the &#x201c;Amended Cambridgepark Lease&#x201d;).</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The First Lease Amendment expanded the amount of space leased by the Company by an additional </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9be707db-e53e-437b-9ac9-93d8542de654" contextRef="C_a0646336-a18c-4b69-a90e-ca45d0ce7f71" name="vor:AdditionalSpaceLeased" unitRef="U_sqft" decimals="INF" format="ixt:numdotdecimal">10,262</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> square feet in exchange for aggregate total fixed rent payments of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c394f2e8-4c03-459a-aeb1-31c42af06236" contextRef="C_4524d971-84fd-4763-928f-3714233d9b8d" name="us-gaap:PaymentsForRent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">8.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million with the annual fixed rental payments escalating from $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2f2d27ea-4a96-4e19-a37b-a7e30c136a5f" contextRef="C_312b019a-fe59-4cdb-acae-11a1267c8c20" name="vor:IncreaseInAnnualFixedRentalPayments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d906e323-c8fc-45dd-b391-038d50da676a" contextRef="C_a8aa8d2a-0cb5-4a21-b6ab-146b2c4adaa1" name="vor:IncreaseInAnnualFixedRentalPayments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million during the term. The First Lease Amendment commenced during the </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_db7a9b40-b9ac-4deb-a4bc-c0e64d9b9ab9" contextRef="C_4524d971-84fd-4763-928f-3714233d9b8d" name="vor:OperatingLeaseCommencementPeriod"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">first quarter of 2022</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Second Lease Amendment expands the amount of space leased by the Company by an additional </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5d7f8e11-71d1-4360-93d7-30e2772d2639" contextRef="C_640a4a96-8eca-48d4-9211-924367454b36" name="vor:AdditionalSpaceLeased" unitRef="U_sqft" decimals="INF" format="ixt:numdotdecimal">30,175</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> square feet in exchange for aggregate total fixed ren</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t payments of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a7dba0ab-879b-4cd4-9bee-25a6a6e5df15" contextRef="C_d9da6ae7-78bc-43bf-aef8-9f17cd10c178" name="us-gaap:PaymentsForRent" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">21.9</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million with the annual fixed rental payments escalating from $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9d8aa706-f690-4a3c-9a3b-62de4a39a068" contextRef="C_965a7f16-b568-4209-8526-032c882c59d6" name="vor:IncreaseInAnnualFixedRentalPayments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.2</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0e5f845d-d591-410e-9004-f910259c0a64" contextRef="C_6db24f0b-fc32-481a-99b2-6949f632a61f" name="vor:IncreaseInAnnualFixedRentalPayments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">3.0</ix:nonFraction></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million during the term. The Second Lease Amendment&#x2019;s term is expected to commence during the </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c6fb2b13-317f-45ff-93c9-628ba5469270" contextRef="C_d9da6ae7-78bc-43bf-aef8-9f17cd10c178" name="vor:OperatingLeaseEstimatedToCommencePeriod"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">second quarter of 2022</span></ix:nonNumeric></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Payments associated with the Amended Cambridgepark Lease include fixed and variable payments. Variable payments relate to the Company&#x2019;s share of the Landlord&#x2019;s operating costs associated with the underlying assets and are recognized when the event on which those payments are assessed. The Amended Cambridgepark Lease does not contain a residual value guarantee. The Lease Amendments term end dates are coterminous with the Cambridgepark Lease.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In conjunction with the Amended Cambridgepark Lease, the Company was required to establish a </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f8253a67-6088-4852-aa74-1d3fd2469270" contextRef="C_1e278196-1cfd-446f-8d91-9976d22c5883" name="us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">2.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> irrevocable standby letter of credit for the benefit of the Landlord, which has been secured by money market investments and is presented as restricted cash equivalents.</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_83568097-1eca-4263-a7d2-fbb91eb873a6" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:LeaseCostTableTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The elements of lease expense were as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.231%;"></td>
        <td style="width:1.606%;"></td>
        <td style="width:1.381%;"></td>
        <td style="width:13.201%;"></td>
        <td style="width:0.696%;"></td>
        <td style="width:1.606%;"></td>
        <td style="width:1.381%;"></td>
        <td style="width:13.201%;"></td>
        <td style="width:0.696%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating lease cost</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_81bb31f8-2750-4a3f-9878-f65b83a0f15c" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,017</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c667fb76-e556-450c-98ce-886aa1af9762" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:OperatingLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,780</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Short-term lease cost</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5176242a-1142-4c2b-9fd4-ff8598ab15e3" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ShortTermLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">52</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_56852c43-42b6-410d-bfed-5f2a406e1a47" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:ShortTermLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">309</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Variable lease cost</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f88358eb-c3fa-434b-ac7c-748a1feffc3c" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:VariableLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,099</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_5fc56ba9-7178-4b28-88b2-5c1088b3ac09" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:VariableLeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">235</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total lease cost</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bf36f045-3ef7-48b6-86f6-21f6fca0bcfb" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,168</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_49c7c041-210c-44e0-b7cd-feb72477b8d5" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:LeaseCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,324</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e0332483-eae8-4064-8b43-765368155e01" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="vor:ScheduleOfOperatingLeaseAssetsAndLiabilitiesWeightedAverageLeaseTermAndDiscountRateTableTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Amounts reported in the consolidated balance sheets and the weight-average lease term and discount rate information were as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.61%;"></td>
        <td style="width:1.585%;"></td>
        <td style="width:1.37%;"></td>
        <td style="width:11.927%;"></td>
        <td style="width:2.313%;"></td>
        <td style="width:1.585%;"></td>
        <td style="width:1.37%;"></td>
        <td style="width:11.927%;"></td>
        <td style="width:2.313%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands except weighted-average amounts)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating right-of-use assets</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_87ac65d8-4978-436e-bc93-c2e391f9ec5e" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">15,670</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ed9194ec-550a-45a0-8a21-b3e22786b0f5" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:OperatingLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,117</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating lease liabilities, current</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8abfec8a-9a68-4448-a0b4-691512767e49" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,839</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a77f72c6-3d7a-440c-85fe-d6ac75b57e23" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:OperatingLeaseLiabilityCurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">863</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating lease liabilities, non-current</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e77a2c57-2ec8-4a52-b65d-c9297d4f7462" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">16,174</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e429fd5a-bccc-4f86-9fcc-adea17cacdfa" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:OperatingLeaseLiabilityNoncurrent" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,430</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total lease liabilities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_aa6dd1c4-9b76-463f-96a9-e6d990c610e3" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,013</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_03f4a521-1cc9-4161-9f3f-a0e7668cf35a" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,293</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Weighted Average Lease Term and Discount Rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average remaining lease term (years)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_00f403d4-bf15-4f5d-a218-4f9764298c40" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.64</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_a6b95568-1a7b-4bae-8477-e75c461b2255" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.55</span></ix:nonNumeric></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average discount rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6a67759f-c01c-48f6-b9b1-2d9dbb75c900" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">9.4</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f9b81021-122c-468c-9ff8-7503274f9a25" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">9.4</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18</span></p>
       <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_aad56a5d-fbab-4ccf-8e22-4ffeae299921" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="vor:ScheduleOfOtherLeaseActivityTableTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table represents other lease activity:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.224%;"></td>
        <td style="width:1.606%;"></td>
        <td style="width:1.381%;"></td>
        <td style="width:13.2%;"></td>
        <td style="width:0.696%;"></td>
        <td style="width:1.606%;"></td>
        <td style="width:1.381%;"></td>
        <td style="width:13.211%;"></td>
        <td style="width:0.696%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Cash Flow Information</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash paid for amounts included in the measurement of<br />&#160;&#160;&#160;lease liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating cash flows for operating leases</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_20c8201e-2ede-4358-aad9-8b7ce3e60b99" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,559</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_cc35f599-d201-4fa6-8c47-c79a56ebce15" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:OperatingLeasePayments" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">703</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Right-of-use assets obtained in exchange for lease obligations</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_24ebcd1f-f4f1-4f7b-8887-9625a2689d36" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">35</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c6ee902b-6f27-4287-8a82-c6a3a3699fd9" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">17,899</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9ec41060-a572-4963-92e5-dbd93ddc1734" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Future lease payments for noncancelable leases as of were as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:78.867%;"></td>
        <td style="width:1.916%;"></td>
        <td style="width:1.381%;"></td>
        <td style="width:16.915%;"></td>
        <td style="width:0.921%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,<br />&#160;2021 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;font-family:Times New Roman;position:relative;">(1)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_43d48545-a26e-4321-a066-d2e8bb0aa9cf" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,410</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2023</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b00d6e3d-efcb-46d1-9ec3-e9a1d1ab9091" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,718</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2024</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_da3673dd-723b-475d-92d9-3060378307a2" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,799</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2025</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_072473fc-4c23-4a7d-bd06-543f5c176d01" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,883</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2026</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_46fdc5d2-2cfd-4291-b627-0c87f7e4f799" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,970</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Thereafter</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8cb1ee7d-8977-4682-b756-ae9a36cc39bc" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,665</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total lease payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f36f905c-9d7c-4e38-a043-9dfe7d7ebe50" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">26,445</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Less: imputed interest</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_59a0857d-cd19-45ba-bece-99a582ef6dbe" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">8,432</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Present value of lease liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ee8b401c-3906-403d-b5af-9cf4b749c485" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:OperatingLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,013</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p><div style="border-top:0.750pt solid;margin-left:2.667%;padding-top:1.0pt;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;display:inline-flex;font-size:9.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Excluded from the table above are a portion of the Company's lease payments associated with the Lease Amendments, as the space leased has not commenced for accounting purposes as of December 31, 2021. The commencement date is the date on which the asset is made available to the Company by the lessor.</span><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></div></div></ix:nonNumeric></div></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_820763fe-ebc8-4cca-9602-b9ad21dfcb70" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="vor:SignificantAgreementsTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">11. Significant Agreements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has agreements with third parties in the normal course of business under which it has obtained licenses for certain developed technologies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Columbia License Agreement</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In April 2016 (and amended in February 2019 and November 2021), the Company entered into an exclusive license agreement (the &#x201c;Columbia Agreement&#x201d;) with The Trustees of Columbia University in the City of New York (&#x201c;Columbia&#x201d;). Under the Columbia Agreement, the Company has exclusively licensed the worldwide rights to key patents, technical information, and use of materials from Columbia.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is required to pay Columbia an annual license fee in the low five digits. The Company is also obligated to make milestone payments to Columbia of up to an aggregate of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d9cd4475-7219-4e96-b041-e428d6f922ec" contextRef="C_5c1b58ed-1181-42ef-9936-9ee4e450ee86" name="vor:LicenseAgreementPotentialMilestonePaymentsUponAchievementOfClinicalMilestones" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million upon the achievement of certain clinical milestones and milestone payments to Columbia of up to an aggregate of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d48534e5-b0cf-410e-b76e-49b3199fc8a7" contextRef="C_5c1b58ed-1181-42ef-9936-9ee4e450ee86" name="vor:LicenseAgreementPotentialMilestonePaymentsUponAchievementOfRegulatoryAndCommercialMilestones" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">6.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million for certain regulatory and commercial milestones for the first three products. In addition, the Company is required to pay Columbia escalating low single digits royalties on cumulative annual net sales of licensed products. As of  </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 31, 2021, and  2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the Company had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_7afe1214-b105-4447-be1d-feea14c9e713" contextRef="C_2bd29414-3bf3-467c-b8da-0f5c54c35d29" name="vor:LicenseFeeObligatedToPay" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> obligation and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a5e943a4-2cc0-4936-8d9a-71e760c9a4f3" contextRef="C_f6546c5b-8293-41ca-b559-c79fcc889b89" name="vor:LicenseAgreementPotentialMilestonePayments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million due, respectively, in milestone payments and this amount is included within accrued expenses balance on the consolidated balance sheet.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">National Institutes of Health License Agreement</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In October 2020, the Company entered into a patent license agreement (the &#x201c;Patent License&#x201d;) with the U.S. Department of Health and Human Services, as represented by National Cancer Institute (&#x201c;NCI&#x201d;) of the National Institutes of Health. Pursuant to the terms of the Patent License, the Company paid NCI a license issue fee in the aggregate amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6e60b808-af41-4fe1-a29c-8e5ff825e2f6" contextRef="C_1a7d767a-18bf-417e-9a93-14efa9daffc7" name="vor:LicenseFeeObligatedToPay" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The terms of the Patent License also require the Company to pay NCI de minimis minimum annual royalties, which royalties are creditable against earned royalties on sales of licensed products or licensed processes. The Company must also pay NCI tiered royalties on net sales of licensed products at rates in the low single digits. The Company is also required to pay NCI one-time milestone payments upon successful completion of specified clinical and regulatory milestones relating to the licensed products. The aggregate potential</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">milestone </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">payments are $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f4a81267-dc17-4782-b9ab-22a372d21173" contextRef="C_73eee50d-fc14-42b0-8920-b0a04312d39a" name="vor:LicenseAgreementPotentialMilestonePayments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">8.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million. In addition, the Company is required to pay NCI one-time milestone payments following aggregate net sales of licensed products at certain net sales up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_70a34b56-169a-47a6-ab0a-8237906a6ab7" contextRef="C_9b3fa813-9828-49c2-a538-31ae7b11c4b9" name="vor:LicenseAgreementMilestonePaymentsOnAggregateNetSales" unitRef="U_USD" scale="9" decimals="-8" format="ixt:numdotdecimal">2.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> billion. The aggregate potential amount of these milestone payments is $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_6daac0fc-961c-4fd9-b41f-150ca8db5f4e" contextRef="C_26ff529e-e196-4005-ac31-d73430825eb5" name="vor:LicenseAgreementPotentialMilestonePayments" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">6.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million. To the extent the Company enters into a sublicensing agreement relating to a licensed product, the Company is required to pay NCI a percentage of the non-royalty based consideration received from a sublicensee, with specified exclusions, which percentage ranges from the low single digits to low double digits. The Company is also required to reimburse NCI for its past patent expenses for the licensed patent rights, as well as the Company&#x2019;s pro rata share of future patent expenses, in each case, in connection with NCI&#x2019;s prosecution or maintenance of the licensed patent rights.</span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_4715c2ca-0c34-4693-b9b8-6d2a90381b28" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">12. Commitments and Contingencies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Legal Proceedings</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is not currently a party to any material legal proceedings. At each reporting date, the Company evaluates whether or not a potential loss amount or potential range of loss is probable and reasonably estimated under the provisions of the authoritative guidance that addresses accounting for contingencies. The Company recognizes expenses for its costs related to its legal proceedings, as incurred.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></ix:nonNumeric></div>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_1cc5c708-b047-4d37-9f8b-8f028d458d98" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">13. Defined Contribution Benefit Plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company maintains a defined contribution plan under Section 401(k) (the &#x201c;401(k) Plan&#x201d;) of the Internal Revenue Code, as amended (the &#x201c;Code&#x201d;). The 401(k) Plan covers all employees who meet defined minimum age and service requirements and allows participants to defer a portion of their annual compensation on a pretax basis, as well as Roth post tax deferrals. During 2021, the Company began to match </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_35532089-e109-41ab-8352-b0b423bb4d8b" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">100</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of compensation amounts deferred up to the first </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d41a6382-5ff9-4eae-86b0-2e2cc0400f54" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="vor:DefinedContributionPlanFirstPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of an employee's compensation plus </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3d948b3e-582f-4767-aee5-46fae2cd3197" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="vor:DefinedContributionPlanAdditionalPercentage" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">50</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of compensation amounts deferred between </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f19371e5-1571-4074-bbb0-1471f0a985b3" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="vor:Definedcontributionplanminimumannualcontributionsperemployeepercent" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b7738170-1296-4122-967d-24938b1b9f3c" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" unitRef="U_pure" scale="-2" decimals="INF" format="ixt:numdotdecimal">6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of an employee's compensation. All matching contributions are immediately vested. Expense recognized by the Company for matching contributions made in accordance with the 401(k) Plan was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c2eae9c5-8f0f-4de9-a54d-2ca7897d8775" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">0.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for the year ended December 31, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p></ix:nonNumeric></div>
  <div><ix:nonNumeric id="F_0aade2ac-96d7-477c-9775-f04f45c9e601" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:IncomeTaxDisclosureTextBlock" escape="true" continuedAt="F_0aade2ac-96d7-477c-9775-f04f45c9e601_1"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">14. Income Taxes</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company accounts for income taxes under FASB ASC 740 (&#x201c;ASC 740&#x201d;). For the years ended December 31, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the Company did not record a current or deferred income tax expense or benefit. </span><span><ix:nonNumeric id="F_7d6f2c40-b524-4f0c-921e-41f8ddbca014" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" escape="true" continuedAt="F_7d6f2c40-b524-4f0c-921e-41f8ddbca014_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table reconciles the federal statutory income rate to the Company&#x2019;s effective income tax rate: </span></ix:nonNumeric></span><span style=""></span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_7d6f2c40-b524-4f0c-921e-41f8ddbca014_1">
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.963%;"></td>
        <td style="width:1.627%;"></td>
        <td style="width:14.891%;"></td>
        <td style="width:1.627%;"></td>
        <td style="width:14.891%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Federal income tax rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dc5d7911-3aea-4c01-9ae3-08e202a717f5" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">21.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_317d809d-4bdb-47e9-8b20-22d6ee9ea7e1" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">21.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">State income tax benefit</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_eb46cb16-2b79-4377-99d1-c9007b230f76" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">6.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c081efac-773c-4d2c-8d05-ebe9f5c01e1c" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">6.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Permanent items</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_611dfbad-9511-49e8-978d-e1fe39c530dd" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">0.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) %</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research tax credits</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2a934d48-d05c-4af8-8ba5-d595a36462de" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">4.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_215f5631-18f3-4c69-a0f6-3d156c834807" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">5.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_880a9258-6db2-490c-a043-cb39f37438a4" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">0.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) %</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_174a5584-5c88-48a1-8c83-1c43f5acc803" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments" unitRef="U_pure" scale="-2" decimals="3" sign="-" format="ixt:numdotdecimal">0.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) %</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_21ca3aab-0d49-4d5a-afa7-5429ccc35b4b" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">30.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) %</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f0734c00-f9fb-4536-b046-6970efe7b424" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" unitRef="U_pure" scale="-2" decimals="3" format="ixt:numdotdecimal">32.6</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) %</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Effective income tax rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deferred </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">tax assets and liabilities reflect the net tax effects of net operating loss and tax credit carryforwards and temporary differences between the carrying amount of assets and liabilities for financial reporting and the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">amounts </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">used for tax purposes. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_10b2839a-8bf3-4524-8355-896af18f8a4b" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" escape="true" continuedAt="F_10b2839a-8bf3-4524-8355-896af18f8a4b_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Significant components of the Company&#x2019;s deferred tax assets and liabilities were as follows:</span></ix:nonNumeric></span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:continuation id="F_10b2839a-8bf3-4524-8355-896af18f8a4b_1">
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.163%;"></td>
        <td style="width:1.595%;"></td>
        <td style="width:1.371%;"></td>
        <td style="width:13.031%;"></td>
        <td style="width:0.921%;"></td>
        <td style="width:1.595%;"></td>
        <td style="width:1.371%;"></td>
        <td style="width:13.031%;"></td>
        <td style="width:0.921%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deferred tax assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued expenses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4225ce9b-c423-45e5-9c24-b7d9320905be" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">972</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d55dddee-f9ba-4e4a-88e0-58e836c49559" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">659</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Federal net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_92fef1ca-7b62-4a44-93cd-020d28875323" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">25,060</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ba698ba8-cf29-4900-81c3-8d085d482819" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">11,515</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">State net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_097f0d3e-b5af-4d3b-b7f6-c6e54ce21c62" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">6,913</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_20140975-90a8-4284-aa12-1ee004048b74" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">3,113</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Tax credits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4246b18a-7451-4bef-a440-7346062f2bd1" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,675</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_741fa593-7d41-4cbb-b235-2ef2e8e5c3ba" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwards" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">2,851</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock compensation</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1f59f427-95bc-4c72-96c3-8f01c8f996db" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">529</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_b37a48a3-b24c-46e8-9a45-b52edb86ac6d" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">177</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Amortization</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1472822c-7ed2-4d6c-b6d8-8d738dcc863e" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="vor:DeferredTaxAssetsAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">191</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Lease liability</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d4a911dd-6125-4ec0-98ff-5b1f75a69474" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="vor:DeferredTaxAssetsLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,675</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_8aec750e-f545-4675-86a7-0161064e1a99" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="vor:DeferredTaxAssetsLeaseLiability" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,941</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a32292bf-5a9e-4aed-acb0-531f9096ddd9" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">44,015</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_4eec0105-43c6-449b-82ad-24081307108e" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:DeferredTaxAssetsGross" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">23,256</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_f3e3c949-21b3-4491-961d-4d15c219b8ee" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">39,401</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_44b92285-2180-430b-a42e-24d17a280832" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">18,414</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net total deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0026dd37-af9f-46f7-90d1-8669984d5407" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,614</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0c2c10cc-36bf-4408-85fd-54ccee99dda6" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:DeferredTaxAssetsNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,842</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deferred tax liabilities:</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Lease right of use asset</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c3ccc747-1746-4308-ac1a-488f1e38fb3b" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="vor:DeferredTaxLiabilitiesLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,234</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_acbf7466-2235-43c7-ab2c-2ff54e431b72" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="vor:DeferredTaxLiabilitiesLeaseRightOfUseAsset" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,624</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Depreciation and amortization</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_3f84344d-71e4-49c3-8fe7-2260107c9593" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="vor:DeferredTaxLiabilitiesDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">380</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1fd52095-ceac-40e2-acf3-d8633e54f1c7" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="vor:DeferredTaxLiabilitiesDepreciationAndAmortization" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">218</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total deferred tax liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_78e5c9ff-976e-4bd6-8322-436f14aaefd2" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:DeferredTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,614</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c5deece7-e4ce-445c-82cb-fe6068326be8" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:DeferredTaxLiabilities" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">4,842</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net deferred tax assets</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d684345f-2023-4257-9944-6ad643de3a33" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_c504eb25-6dbf-4267-a535-3ed163c4f35f" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:DeferredTaxAssetsLiabilitiesNet" unitRef="U_USD" scale="3" decimals="-3" format="ixt:zerodash">&#x2014;</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:continuation></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has weighed the positive and negative evidence to assess the recoverability of its deferred tax assets. Realization of future tax benefits is dependent on many factors, including the Company&#x2019;s ability to generate taxable income. After this assessment, the Company determined it was more likely than not that the Company will not realize the benefit of its deferred tax assets. As a result, the Company has provided a full valuation allowance against its net deferred tax assets. The valuation allowance for deferred tax assets as of December 31, 2021 and 2020 was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_dd4b7df2-c19b-460e-93b7-de51b0391aa5" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">39.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_fb77c518-f3d4-4300-9938-c47685c6db47" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:DeferredTaxAssetsValuationAllowance" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">18.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively. For the years ended December 31, 2021 and 2020, the Company recorded an increase in the valuation allowance of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bf90fe6f-c766-4b01-b14e-e8844a720546" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">21.0</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_355cb323-34ca-4400-b6f1-d1433351e4dc" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">14.1</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively, primarily related to net operating losses and tax credits.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of  December 31, 2021, the Company had gross U.S. federal net operating loss carryforwards of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_2fa8e00f-ef29-4549-9ff2-86f1c00f6a86" contextRef="C_0b13dbfb-af9b-4e36-b831-4dc9d2f387b8" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">119.3</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> including </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_91e09ea8-f7e6-42af-a4bd-b671aa26a280" contextRef="C_0b13dbfb-af9b-4e36-b831-4dc9d2f387b8" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">117.4</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> that had an indefinite carryforward period and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d9b8cc9e-9e6e-4c27-86ae-58391ee578cd" contextRef="C_0b13dbfb-af9b-4e36-b831-4dc9d2f387b8" name="us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">1.9</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> that were subject to expiration at various dates through </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_bfe533c2-ac61-47e2-b17f-6d9424f4ab95" contextRef="C_9ced81ea-4ae3-445d-910e-f3c298459ae8" name="vor:OperatingLossCarryforwardsExpirationYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2037</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. As of December 31, 2021, the Company had state net operating loss carryforwards of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_36287536-1c24-44dc-a22c-0a8bed550f72" contextRef="C_7a2f1c59-42b8-4077-b849-32e1f00d5329" name="us-gaap:OperatingLossCarryforwards" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">109.2</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> which will expire at various dates through </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_318e8278-1151-4d3a-b309-41f96175c112" contextRef="C_fb525106-40af-41f1-abca-fd6a6fdc8870" name="vor:OperatingLossCarryforwardsExpirationYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2041</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. As of December 31, 2021, the Company had U.S. federal research and development tax credit carryforwards of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_e4ee14e2-44f0-42b4-a12b-28f0ab11b8b6" contextRef="C_0b13dbfb-af9b-4e36-b831-4dc9d2f387b8" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">3.5</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> which will expire at various dates through </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5e885d06-6d11-41ec-a005-1943d6c0d477" contextRef="C_9ced81ea-4ae3-445d-910e-f3c298459ae8" name="vor:TaxCreditCarryforwardsExpirationYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2041</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and state research and credit carryforwards of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_ad3f0f3a-87aa-4cfd-8d33-4151379ac979" contextRef="C_7a2f1c59-42b8-4077-b849-32e1f00d5329" name="us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch" unitRef="U_USD" scale="6" decimals="-5" format="ixt:numdotdecimal">2.8</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> which will expire at various dates through </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_c2cd4300-194e-4ee5-acb2-f690a4021d80" contextRef="C_fb525106-40af-41f1-abca-fd6a6fdc8870" name="vor:TaxCreditCarryforwardsExpirationYear"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2036</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The net operating loss and tax credit carryforwards are subject to review and possible adjustment by the Internal Revenue Service and state tax authorities.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net operating loss and tax credit carryforwards may become subject to an annual limitation in the event of certain cumulative changes in the ownership interest of significant shareholders over a </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_617cce49-80e8-4c20-b8db-7c477dc47591" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="vor:ConsideredPeriodOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards" format="ixt-sec:durwordsen"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">three-year</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> period in excess of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_22f09f15-9803-40ec-ad3a-d5b763880a05" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="vor:ConsideredPercentageOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards" unitRef="U_pure" scale="-2" decimals="2" format="ixt:numdotdecimal">50</ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%, as defined under Sections 382 and 383 of the Code, respectively, as well as similar state provisions. This could limit the amount of tax attributes that can be utilized annually to offset future taxable income or tax liabilities. The amount of the annual limitation is determined based on the value of the Company immediately prior to the ownership change. Subsequent ownership changes may further affect the limitation in future years. The Company has not determined whether an ownership change has occurred and as such, the Company&#x2019;s net operating losses may be limited. Any limitation may result in expiration of a portion of the net operating loss carryforwards or research development credit carryforwards before utilization.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has not, as yet, conducted a study of research and development credit carryforwards. Such a study, once undertaken by the Company, may result in an adjustment to the research and development credit carryforwards. However, a full valuation allowance has been provided against the Company&#x2019;s research and development credits and, if any adjustment is required, such adjustment would be offset by an adjustment to the valuation allowance. Thus, there would be no impact to the balance sheet or statement of operations if any adjustment is required.</span></p><ix:exclude><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21</span></p>
     <hr style="page-break-after:always;" /><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></ix:exclude><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021 and 2020, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the Company did </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_1e09cea4-9ee7-4626-9d0d-a3681b57e7ee" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_98924b3a-9636-4739-a04f-9545a8e30a86" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:UnrecognizedTaxBenefits" unitRef="U_USD" scale="3" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t have any unrecognized tax benefits. Any future interest and penalties related to income tax matters would be recognized in the provision for income tax. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 31, 2021 and 2020,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> the Company did </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_a3592bd8-2950-4526-af9b-54bc31f4ff5b" contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen"><ix:nonFraction id="F_77feef8f-5992-4a47-9064-5ee5cf82534b" contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6" name="us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" unitRef="U_USD" decimals="INF" format="ixt-sec:numwordsen">no</ix:nonFraction></ix:nonFraction></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t have a balance of accrued interest and penalties related to uncertain tax positions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In March 2020, the Coronavirus Aid, Relief, and Economic Security Act (the &#x201c;CARES Act&#x201d;) was signed into law. The CARES Act includes provisions relating to several aspects of corporate income taxes. The CARES Act did not have a significant impact on the Company&#x2019;s provision for income taxes.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company files income tax returns in the United States and various states. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_e5e0ee91-11c9-4872-baa3-d9cdeef6ebcc" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:IncomeTaxExaminationDescription"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 31, 2021 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, there were no income tax examinations in progress</span></ix:nonNumeric></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p></ix:nonNumeric></div>
  <p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span><ix:continuation id="F_0aade2ac-96d7-477c-9775-f04f45c9e601_1"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The tax years 2018 through present remain open to examination by major taxing jurisdictions to which the Company is subject, which are primarily in the United States. In addition, tax years prior to 2018 resulted in losses and the Company also generated research and development tax credits during those years. Since carryforward attributes generated in these years may be utilized in future years, years prior to 2018 may still be adjusted upon examination by the Internal Revenue Service or state tax authorities if they have or will be used in a future period.</span></ix:continuation></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
  <div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_884d618f-6ec3-42d8-a2e4-c7efca8a18ea" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:EarningsPerShareTextBlock" escape="true"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">15. Net Loss Per Share</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><ix:nonNumeric id="F_3cd691c5-5590-430d-b42b-62b9b416e2a8" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table sets forth the computation of the Company&#x2019;s basic and diluted net loss per share for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 31, 2021 and 2020:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.957%;"></td>
        <td style="width:1.595%;"></td>
        <td style="width:1.37%;"></td>
        <td style="width:13.253%;"></td>
        <td style="width:0.921%;"></td>
        <td style="width:1.595%;"></td>
        <td style="width:1.37%;"></td>
        <td style="width:13.018%;"></td>
        <td style="width:0.921%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands, except share and per share amounts)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Numerator:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_18b06889-1935-4619-8925-f160a0113d50" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">68,899</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_0e61da3a-b9b9-41d1-b40a-a546efba9075" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:NetIncomeLoss" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">43,337</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cumulative dividends on redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_bbc4669f-bc77-4642-912d-f122bb54f8a4" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:RedeemablePreferredStockDividends" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">1,228</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d0d0c4e3-374a-47dd-80a4-865388cad2b6" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:RedeemablePreferredStockDividends" unitRef="U_USD" scale="3" decimals="-3" format="ixt:numdotdecimal">5,925</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss attributable to common stockholders</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9e989ce0-faa4-456a-a83c-9ed279aac6e0" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">70,127</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_073b4dd7-2840-45bb-a720-acffaa57d5e2" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" unitRef="U_USD" scale="3" decimals="-3" sign="-" format="ixt:numdotdecimal">49,262</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Denominator:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average number of common shares outstanding, basic and diluted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_9073e201-46c4-4d33-abfe-b66c1581801d" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">33,433,214</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_d593e8e4-c661-4c44-877f-391dbd51d080" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">213,658</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss per share attributable to common stockholders, basic and diluted</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_eb3cd4f8-47a6-4a47-bc10-c90fbd8a3364" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-">2.10</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_39827f75-4ee5-4d84-b3be-91e4498194da" contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536" name="us-gaap:EarningsPerShareBasicAndDiluted" unitRef="U_UnitedStatesOfAmericaDollarsShare" scale="0" decimals="2" sign="-">230.57</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
      </table></ix:nonNumeric></div><div style="font-size:11.0pt;font-family:Calibri;"><ix:nonNumeric id="F_0492f24f-0ec8-4ed3-842c-5358a961a95a" contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" escape="true"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#x2019;s potentially dilutive securities were redeemable convertible preferred stock and stock options. Based on the amounts outstanding at </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 31, 2021 and 2020, the Company excluded the following potential common shares from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.417%;"></td>
        <td style="width:1.606%;"></td>
        <td style="width:0.696%;"></td>
        <td style="width:13.793%;"></td>
        <td style="width:0.696%;"></td>
        <td style="width:1.606%;"></td>
        <td style="width:0.696%;"></td>
        <td style="width:13.793%;"></td>
        <td style="width:0.696%;"></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">As of December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Series A-1 redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_144a09bb-b92a-4830-8346-6c36cc642b31" contextRef="C_4f4bd222-f291-4cc2-a0d9-e0451c423659" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">1,470,588</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Series A-2 redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_95900678-513d-4a1d-a2a6-db96762d2ab9" contextRef="C_28790eaf-526a-4566-8f5d-38d463cd96fa" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">7,881,965</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Series B redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2014;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_824384a4-17f6-478e-b6f9-27920a868855" contextRef="C_4fad1b2e-548e-456c-a314-8f74671c228b" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">9,155,810</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Options to purchase common stock</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_99606cb9-79a6-4128-b202-8f723716f1b5" contextRef="C_bb722967-b149-4749-9edf-a5242ac6397a" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">5,086,792</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"><ix:nonFraction id="F_74369652-acc6-4386-965b-5177c142569f" contextRef="C_f5ef1ea6-c3b7-451a-8872-9c63fc489bc3" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" unitRef="U_shares" decimals="0" format="ixt:numdotdecimal">5,084,679</ix:nonFraction></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></ix:nonNumeric></div></ix:nonNumeric></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">F-</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">22</span></p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>2
<FILENAME>vor-ex4_3.htm
<DESCRIPTION>EX-4.3
<TEXT>
<html>
 <head>
  <title>EX-4.3</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 4.3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">DESCRIPTION OF THE REGISTRANT&#x2019;S SECURITIES</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">REGISTERED PURSUANT TO SECTION 12 OF THE</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">SECURITIES EXCHANGE ACT OF 1934</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">The descriptions below of Vor Biopharma Inc.&#x2019;s (&#x201c;we,&#x201d; &#x201c;our&#x201d; or &#x201c;we&#x201d;) common stock and provisions of our amended and restated certificate of incorporation (&#x201c;Restated Certificate&#x201d;) and amended and restated bylaws (&#x201c;Bylaws&#x201d;) are summaries and are qualified by reference to our Restated Certificate and the Bylaws, which are filed as exhibits to this Annual Report on Form 10-K, and by the applicable provisions of the Delaware General Corporation Law (the &#x201c;DGCL&#x201d;).</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.05pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.05pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">General</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our authorized capital stock consists of 400,000,000 shares of common stock, $0.0001 par value per share, and 10,000,000 shares of preferred stock, $0.0001 par value per share, all of which shares of preferred stock will be undesignated. Our board of directors may establish the rights and preferences of the preferred stock from time to time.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Common Stock</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.5pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Voting Rights</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each holder of our common stock is entitled to one vote for each share on all matters submitted to a vote of the stockholders, including the election of directors. The affirmative vote of holders of at least 66</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the voting power of all of the then-outstanding shares of capital stock, voting as a single class, will be required to amend certain provisions of our Restated Certificate, including provisions relating to amending our Bylaws, the classified board, the size of our board, removal of directors, director liability, vacancies on our board, special meetings, stockholder notices, actions by written consent and exclusive forum.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.05pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Dividends</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Subject to preferences that may be applicable to any then-outstanding preferred stock, holders of common stock are entitled to receive ratably those dividends, if any, as may be declared from time to time by our board of directors out of legally available funds.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Liquidation</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In the event of our liquidation, dissolution or winding up, holders of common stock will be entitled to share ratably in the net assets legally available for distribution to stockholders after the payment of all of our debts and other liabilities and the satisfaction of any liquidation preference granted to the holders of any then-outstanding shares of preferred stock.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Rights, Preferences and Privileges</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Holders of common stock have no preemptive, conversion or subscription rights and there are no redemption or sinking fund provisions applicable to the common stock. The rights, preferences and privileges of the holders of common stock are subject to, and may be adversely affected by, the right of the holders of shares of any series of preferred stock that we may designate in the future.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Preferred Stock</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our board of directors have the authority under our Restated Certificate, without further action by our stockholders,</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">to issue up to 10,000,000 shares of preferred stock in one or more series, to establish from time to time the number of shares to be included in each such series, to fix the rights, preferences and privileges of the shares of each wholly unissued series and any qualifications, limitations or restrictions thereon, and to increase or decrease the number of shares of any such series, but not below the number of shares of such series then outstanding.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our board of directors may authorize the issuance of preferred stock with voting or conversion rights that could adversely affect the voting power or other rights of the holders of our common stock. The purpose of authorizing our board of directors to issue preferred stock and determine its rights and preferences is to eliminate delays associated with a stockholder vote on specific issuances. The issuance of preferred stock, while providing flexibility in connection with possible acquisitions and other corporate purposes, could, among other things, have the effect of delaying, deferring or preventing a change in control of us and may adversely affect the market price of our common stock and the voting and other rights of the holders of our common stock. It is not possible to state the actual effect of the issuance of any shares of preferred stock on the rights of holders of common stock until the board of directors determines the specific rights attached to that preferred stock.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Registration Rights</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We and the holders of our existing preferred stock have entered into an amended and restated investors&#x2019; rights agreement. The registration rights provisions of this agreement provide those holders with demand, piggyback and Form S-3 registration rights with respect to the shares of common stock currently held by them and issuable to them upon conversion of our preferred stock in connection with our initial public offering. An aggregate of 17,489,764 shares of common stock are entitled to these registration rights. These shares are collectively referred to herein as registrable securities.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Demand Registration Rights</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The holders of a majority of registrable securities then outstanding have the right to demand that we file a registration statement covering at least 40% of the registrable securities then outstanding (or a lesser percent if the aggregate offering price exceeds $15.0 million net of certain selling expenses). We are obligated to effect at most two registrations in response to these demand registration rights. These demand registration rights are subject to specified conditions and limitations, including the right of the underwriters, if any, to limit the number of shares included in any such registration under specified circumstances. Upon such a request, we are required to effect the registration as soon as practicable, but in any event no later than 60 days after the receipt of such request.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:4.2pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Piggyback Registration Rights</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">If we propose to register any of our securities under the Securities Act of 1933, as amended (the &#x201c;Securities Act&#x201d;) either for our own account or for the account of other stockholders, the holders of registrable securities will each be entitled to notice of the registration and will be entitled to include their shares of common stock in the registration statement. These piggyback registration rights are subject to specified conditions and limitations, including the right of the underwriters to limit the number of shares included in any such registration under specified circumstances, and do not apply to a registration relating to any equity incentive plan, stock purchase or similar plan, a transaction under Rule 145 of the Securities Act, a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the registrable securities or a registration related to common stock issued upon conversion of debt securities.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Registration on Form S-3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">At any time after we become eligible to file a registration statement on Form S-3, the holders of at least 15% of the registrable securities then outstanding will be entitled to request to have such shares registered by us on a Form S-3 registration statement. These Form S-3 registration rights are subject to other specified conditions and limitations, including the condition that the anticipated aggregate offering price, net of certain selling expenses, is at least $5.0 million. Upon receipt of this request, the holders of registrable securities will each be entitled to participate in this</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">registration. We will not be required to effect such a registration if, within any twelve month period, we have already effected two registrations on Form S-3 for the holders of registrable securities.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expenses of Registration</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are required to pay all expenses, including fees and expenses of one counsel to represent the selling stockholders, relating to any demand, piggyback or Form S-3 registration, other than underwriting discounts and commissions, stock transfer taxes and any additional fees of counsel for the selling stockholders, subject to specified conditions and limitations. We are not required to pay registration expenses if a demand registration request is withdrawn at the request of a majority of holders of registrable securities to be registered, unless holders of a majority of the registrable securities agree to forfeit their right to one demand registration.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The amended and restated investors&#x2019; rights agreement contains customary cross-indemnification provisions, pursuant to which we are obligated to indemnify the selling stockholders in the event of material misstatements or omissions in the applicable registration statement attributable to us, and the selling stockholders are obligated to indemnify us for material misstatements or omissions in the registration statement attributable to them, subject to certain limitations.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Termination of Registration Rights</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The registration rights granted under the investors&#x2019; rights agreement will terminate with respect to any particular stockholder upon the earlier of (i) the closing of a deemed liquidation event, as defined in our Restated Certificate &#x37e; (ii) with respect to each stockholder, at such time such stockholder is able to sell all of its shares pursuant to Rule 144 or another similar exemption under the Securities Act during a three-month period without registration&#x37e; and (iii) the fifth anniversary of February 5, 2021.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Anti-Takeover Provisions</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.5pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Section 203 of the DGCL</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">We are subject to Section 203 of the DGCL, which prohibits a Delaware corporation from engaging in any business combination with any interested stockholder for a period of three years after the date that such stockholder became an interested stockholder, with the following exceptions:</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">before such date, the board of directors of the corporation approved either the business combination or the transaction that resulted in the stockholder becoming an interested stockholder&#x37e;</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">upon completion of the transaction that resulted in the stockholder becoming an interested stockholder, the interested stockholder owned at least 85% of the voting stock of the corporation outstanding at the time the transaction began, excluding for purposes of determining the voting stock outstanding, but not the outstanding voting stock owned by the interested stockholder, those shares owned (i) by persons who are directors and also officers and (ii) employee stock plans in which employee participants do not have the right to determine confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer&#x37e; or</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">on or after such date, the business combination is approved by the board of directors and authorized at an annual or special meeting of the stockholders, and not by written consent, by the affirmative vote of at least 66</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of the outstanding voting stock that is not owned by the interested stockholder.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In general, Section 203 defines a &#x201c;business combination&#x201d; to include the following:</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any merger or consolidation involving the corporation or any direct or indirect majority-owned subsidiary of the corporation and the interested stockholder&#x37e;</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested stockholder (in one transaction or a series of transactions)&#x37e;</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">subject to certain exceptions, any transaction that results in the issuance or transfer by the corporation or by any direct or indirect majority-owned subsidiary of the corporation of any stock of the corporation or of such subsidiary to the interested stockholder&#x37e;</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any transaction involving the corporation or any direct or indirect majority-owned subsidiary of the corporation that has the effect of increasing the proportionate share of the stock or any class or series of the corporation beneficially owned by the interested stockholder&#x37e; or</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits by or through the corporation.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In general, Section 203 defines an &#x201c;interested stockholder&#x201d; as an entity or person who, together with the person&#x2019;s affiliates and associates, beneficially owns, or within three years prior to the time of determination of interested stockholder status did own, 15% or more of the outstanding voting stock of the corporation.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Restated Certificate and Amended and Restated Bylaws</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our Restated Certificate provides for our board of directors to be divided into three classes with staggered three-year terms. Only one class of directors will be elected at each annual meeting of our stockholders, with the other classes continuing for the remainder of their respective three-year terms. Because our stockholders do not have cumulative voting rights, stockholders holding a majority of the shares of common stock outstanding will be able to elect all of our directors. Our Restated Certificate and our Bylaws also provide that directors may be removed by the stockholders only for cause upon the vote of 66</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% or more of our outstanding common stock. Furthermore, the authorized number of directors may be changed only by resolution approved by a majority of the board of directors, and vacancies and newly created directorships on the board of directors may, except as otherwise required by law or determined by the board, only be filled by a majority vote of the directors then serving on the board, even though less than a quorum.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Under our Restated Certificate and Bylaws our stockholders do not have cumulative voting rights. Because of this, the holders of a majority of the shares of common stock entitled to vote in any election of directors can elect all of the directors standing for election, if they should so choose.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our Restated Certificate and Bylaws also provide that all stockholder actions must be effected at a duly called meeting of stockholders and will eliminate the right of stockholders to act by written consent without a meeting. Our Bylaws also provide that only the chair of our board, Chief Executive Officer or the board of directors pursuant to a resolution adopted by a majority of the total number of authorized directors may call a special meeting of stockholders.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our Bylaws provides that stockholders seeking to present proposals before a meeting of stockholders to nominate candidates for election as directors at a meeting of stockholders must provide timely advance notice in writing, and will specify requirements as to the form and content of a stockholder&#x2019;s notice.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our Restated Certificate and Bylaws provide that the stockholders cannot amend many of the provisions described above except by a vote of 66</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">2</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#x2215;</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:6.5pt;font-family:Times New Roman;">3</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% or more of our outstanding common stock.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As described in &#x201c;&#x2014;Preferred Stock&#x201d; above, our Restated Certificate gives our board of directors the authority, without further action by our stockholders, to issue up to 10,000,000 shares of preferred stock in one or more series, with any rights, preferences and privileges as they may designate, including the right to approve an acquisition or other change in control.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The combination of these provisions will make it more difficult for our existing stockholders to replace our board of</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">directors as well as for another party to obtain control of us by replacing our board of directors. Since our board of directors has the power to retain and discharge our officers, these provisions could also make it more difficult for existing stockholders or another party to effect a change in management. In addition, the authorization of undesignated preferred stock makes it possible for our board of directors to issue preferred stock with voting or other rights or preferences that could impede the success of any attempt to change our control.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These provisions are intended to enhance the likelihood of continued stability in the composition of our board of directors and its policies and to discourage coercive takeover practices and inadequate takeover bids. These provisions are also designed to reduce our vulnerability to hostile takeovers and to discourage certain tactics that may be used in proxy fights. However, such provisions could have the effect of discouraging others from making tender offers for our shares and may have the effect of delaying changes in our control or management. As a consequence, these provisions may also inhibit fluctuations in the market price of our stock that could result from actual or rumored takeover attempts. We believe that the benefits of these provisions, including increased protection of our potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure our company, outweigh the disadvantages of discouraging takeover proposals, because negotiation of takeover proposals could result in an improvement of their terms.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:4.2pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Choice of Forum</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our Restated Certificate provides that the Court of Chancery of the state of Delaware will be the exclusive forum for the following types of actions or proceedings under Delaware statutory or common law:</font></p>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any derivative action or proceeding brought on our behalf&#x37e;</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any action asserting a breach of fiduciary duty&#x37e;</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any action asserting a claim against us arising pursuant to the DGCL, our Restated Certificate, or our Bylaws&#x37e; or</font></div></div>
  <div style="margin-left:3.333%;display:flex;margin-top:0.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:12.0pt;min-width:3.333%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:3.447919145106397%;">&#x2022;</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">any action asserting a claim against us that is governed by the internal affairs doctrine.</font></div></div>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The provision would not apply to suits brought to enforce a duty or liability created by the Securities Exchange Act of 1934, as amended. Furthermore, Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all such Securities Act actions. Accordingly, both state and federal courts have jurisdiction to entertain such claims. To prevent having to litigate claims in multiple jurisdictions and the threat of inconsistent or contrary rulings by different courts, among other considerations, our Restated Certificate also provide that unless we consent in writing to the selection of an alternative forum, the federal district courts of the United States shall be the exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">While the Delaware courts have determined that such choice of forum provisions are facially valid, a stockholder may nevertheless seek to bring a claim in a venue other than those designated in the exclusive forum provisions. In such instance, we would expect to vigorously assert the validity and enforceability of the exclusive forum provisions of our Restated Certificate. This may require significant additional costs associated with resolving such action in other jurisdictions and there can be no assurance that the provisions will be enforced by a court in those other jurisdictions</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">These exclusive forum provisions may limit a stockholder&#x2019;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers, or other employees, which may discourage lawsuits against us and our directors, officers and other employees. If a court were to find either exclusive-forum provision in our Restated Certificate to be inapplicable or unenforceable in an action, we may incur further significant additional costs associated with resolving the dispute in other jurisdictions, all of which could seriously harm our business.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our Restated Certificate further provides that the federal district courts of the United States of America will be the</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act, subject to and contingent upon a final adjudication in the State of Delaware of the enforceability of such exclusive forum provision.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.05pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Transfer Agent and Registrar</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The transfer agent and registrar for our common stock is Computershare Trust Company, N.A. The transfer agent&#x2019;s address is 150 Royall Street, Canton, Massachusetts 02021.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.05pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Listing</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Our common stock is listed on the Nasdaq Global Select Market under the trading symbol &#x201c;VOR&#x201d;.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:5.45pt;line-height:1.2170833333333333;font-family:Times New Roman;margin-bottom:12.0pt;margin-right:0.787%;text-align:justify;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:10.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:7.0pt;font-family:Arial;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>3
<FILENAME>vor-ex23_1.htm
<DESCRIPTION>EX-23.1
<TEXT>
<html>
 <head>
  <title>EX-23.1</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:11.0pt;font-family:Times New Roman;">Exhibit 23.1</font></p>
  <p style="text-indent:6.667%;font-size:10.0pt;margin-top:10.8pt;line-height:1.15;font-family:Times New Roman;margin-bottom:10.0pt;text-align:right;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.8pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Times New Roman;">Consent of Independent Registered Public Accounting Firm</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:12.0pt;font-family:Times New Roman;"> </font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:9.0pt;font-family:Arial;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;">We consent to the incorporation by reference in the Registration Statement (Form S-8 No. 333-252908) pertaining to the 2015 Stock Incentive Plan, 2021 Equity Incentive Plan, 2021 Employee Stock Purchase Plan and Stock Option Awarded Outside of Any Plan of Vor Biopharma Inc. of our report dated March 14, 2022, with respect to the consolidated financial statements of Vor Biopharma Inc. included in this Annual Report (Form 10-K) for the year ended December 31, 2021.</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;">/s/ Ernst &amp; Young LLP</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;"> </font>&#160;</p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;">Boston, Massachusetts</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:12.0pt;font-family:Times New Roman;">March 14, 2022</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>4
<FILENAME>vor-ex31_1.htm
<DESCRIPTION>EX-31.1
<TEXT>
<html>
 <head>
  <title>EX-31.1</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 31.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">CERTIFICATIONS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">I, Robert Ang, certify that:</font></p>
  <div style="display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">I have reviewed this Annual Report on Form 10-K of Vor Biopharma Inc.;</font></div></div>
  <div style="display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div style="display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div style="display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a)     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b)     Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(c)     Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(d)     Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></p>
  <div style="display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a)      All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b)     Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></p>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.38%;"></td>
    <td style="width:3.002%;"></td>
    <td style="width:5.224%;"></td>
    <td style="width:46.395%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date: March 14, 2022</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Robert Ang</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Robert Ang</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">President and Chief Executive Officer</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Principal Executive Officer</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>5
<FILENAME>vor-ex31_2.htm
<DESCRIPTION>EX-31.2
<TEXT>
<html>
 <head>
  <title>EX-31.2</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Arial;">Exhibit 31.2</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">CERTIFICATIONS</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">I, Nathan Jorgensen, certify that:</font></p>
  <div style="display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">1.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">I have reviewed this Annual Report on Form 10-K of Vor Biopharma Inc.;</font></div></div>
  <div style="display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">2.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;</font></div></div>
  <div style="display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">3.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;</font></div></div>
  <div style="display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:10.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">4.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:</font></div></div>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a)     Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to</font></p>
  <p style="margin-left:9.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;</font></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b)     Designed such internal control over financial reporting, or caused such internal control over financial</font></p>
  <p style="margin-left:9.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="margin-left:9.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(c)     Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this</font></p>
  <p style="margin-left:9.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and</font><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font></p>
  <p style="margin-left:9.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(d)     Disclosed in this report any change in the registrant's internal control over financial reporting that</font></p>
  <p style="margin-left:9.067%;text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and</font></p>
  <div style="display:flex;margin-top:10.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.537%;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.537%;">5.</font><div style="display:inline;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):</font></div></div>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(a)      All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:10.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(b)     Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.</font></p>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.38%;"></td>
    <td style="width:3.002%;"></td>
    <td style="width:5.224%;"></td>
    <td style="width:46.395%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date: March 14, 2022</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Nathan Jorgensen</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Nathan Jorgensen</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Chief Financial Officer</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Principal Financial Officer</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>6
<FILENAME>vor-ex32_1.htm
<DESCRIPTION>EX-32.1
<TEXT>
<html>
 <head>
  <title>EX-32.1</title>
 </head>
 <body>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Exhibit 32.1</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">CERTIFICATION PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></p>
  <p style="text-indent:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In connection with the Annual Report on Form 10-K of Vor Biopharma Inc. (the &#x201c;Company&#x201d;) for the year ended December 31, 2021 as filed with the Securities and Exchange Commission on the date hereof (the &#x201c;Report&#x201d;), each of the undersigned officers of the Company hereby certifies, pursuant to 18 U.S.C. &#167; 1350, that to his knowledge:</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(1)	The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and</font></p>
  <p style="margin-left:4.533%;text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.</font></p>
  <p style="text-indent:-4.749%;padding-left:4.533%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Times New Roman;">&#160;</font></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:45.4%;"></td>
    <td style="width:3.996%;"></td>
    <td style="width:4.199%;"></td>
    <td style="width:46.405%;"></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date: March 14, 2022</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Robert Ang</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Robert Ang</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">President and Chief Executive Officer</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Principal Executive Officer</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Date: March 14, 2022</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:top;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">By:</font></p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;border-bottom:0.250pt solid rgba(0,0,0,1);padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">/s/ Nathan Jorgensen</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:middle;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Nathan Jorgensen</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Chief Financial Officer</font></p><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Principal Financial Officer</font><font style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</font></p></td>
   </tr>
   <tr style="height:10.0pt;">
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </font>&#160;</p></td>
    <td style="background-color:rgba(255,255,255,1);padding-top:0.010in;word-break:break-word;vertical-align:bottom;padding-right:0.010in;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p></td>
   </tr>
  </table>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:12.0pt;font-family:Arial;">&#160;</font></p>
  <p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><font style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>img17388848_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img17388848_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )N!98# 2(  A$! Q$!_\0
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MU&GW87/>O^%B^%O^@H/^_+_X4?\ "Q?"W_04'_?E_P#"O!:*/J-/NPN>]?\
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MZ_X6+X6_Z"@_[\O_ (4?\+%\+?\ 04'_ 'Y?_"O!:*/J-/NPN>]?\+%\+?\
M04'_ 'Y?_"C_ (6+X6_Z"@_[\O\ X5X+11]1I]V%SWK_ (6+X6_Z"@_[\O\
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M->!8'I1@>E'U*/<#WW_A)=#_ .@O9?\ ?Y?\:/\ A)=#_P"@O9?]_E_QKP+
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M +]M_A1_PE^A?\_P_P"_;?X5Y711]2I]V'MY'JG_  E^A?\ /\/^_;?X4?\
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M  E^A?\ /\/^_;?X4?\ "7Z%_P _P_[]M_A7E=%'U*GW8>WD>J?\)?H7_/\
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M%%% !1110 4444 %%%% !1110!ZW\'_^03J?_7RO_H KTBO-_@__ ,@G4_\
MKY7_ - %>D5XF*_C2*04445S@4=:_P"0%J'_ %[2?^@FOGI/N+]*^A=:_P"0
M%J'_ %[2?^@FOGI/N+]*]'!?"QCJ***[0"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *]A^&G_(
MI#_KXD_I7CU>P_#3_D4A_P!?$G]*Y<9_#^8'84445Y8@K'\5?\BQ?_\ 7/\
MK6Q6/XJ_Y%B__P"N?]:NG\:]29_"SR>BBBO;//"BBB@ HHHH **** "BBB@
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M-)N)+*0:U]8\->#-"TRVU+4+-EC  \N-F/F,1Z9I/BG&(O"VG1J<A+E%!]<
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M^,@Y/)[ 5%J/A_2]2T5M3T4;"H+%,G!QU&#T-:7B#3Y/$NB6L^GNCLIWA2<
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MWG=UQ6M)WC[TMF1-6>BZ&/111788!1110 4444 %%%% !1110 4444 %%%%
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M0_Z]I/\ T$U\])]Q?I7T+K7_ " M0_Z]I/\ T$U\])]Q?I7HX+X6,=1117:
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MEB>":2&08>-BK#T(.*95[6O^0[?_ /7P_P#.J-=R=U< HHHI@%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5[#\-/\ D4A_U\2?TKQZO8?AI_R*
M0_Z^)/Z5RXS^'\P.PHHHKRQ!6/XJ_P"18O\ _KG_ %K8K'\5?\BQ?_\ 7/\
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MM&]^Q_9/M4OV;&/*S\N.M5J4 LP4=2<"GRKL%V)15Z_T>_TR-'O+<Q*YPI+
MY/X4VPTJ^U0N+* RF/&[# 8S]:7/&U[Z!9WL4Z*E-O,+DVWEL9@VS8.3GTK6
M7PCK;1[_ +'C_9+C/\Z'.,=V-1;V1B45-<VL]G.8;F)HI!U5ABK%AH^H:GDV
MELTBCJW11^)IN22NWH*SO8HT5J7OAW5=/B,MQ:,(QU=2& _*LNB,E+5,&FMP
MHHJ[I^DWFJ>;]DC#F(98;@#BAM)78)-[%*B@@@D$8(X(HIB"BBB@ H/2B@]*
M /9-)_Y ]E_UP3_T$44:3_R![+_K@G_H(HKPY?$ST5L?/?B/_D9]6_Z_)?\
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M./Z5JZ7$]Q\%Y(XE+N8)/E R>')I*I54(S<MV@.-\(>#%\4VEW.UZUO]G8
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M[C;W*E&/O)+8RM-\&^?IZWNH7@M4<;E7 X'8DFGS>"!#I]Q=F_#K&I=-BY#
M#/K6MXP@GN_#UJUHC21*59E3GY<<4[2K>YMO DT=RK*WE2%5;J%QQ4^UFX\W
M-N]A\D;\MC*CM[X^ A-]N MO+)\CRATW=-U5-)\(MJVC+>QW6R1L@(5XX/K6
MO%_R3(?]<C_Z%4FB.T?P_E="0P23!%-SDD^7^8.5-J_8H-X&BEM'>SU-9IDZ
M@ ;2?3@\5AZ+H%SK-X\*'RDB_P!9(PSM]O<UT/P\)VWRYX^4XK0\'%/L^J*.
M7^U/N ZX[4Y59PYDW>UA*$969DS^!XGAD^P:DL\\8^:,XZ^G!XK#T;0;K6+U
M[=/W2Q']Z[#[OM]:Z[1[K38;VZ;3-(O?/7(FY]_<U8\,2QS7>LNL;QLUQDQM
M]X<?_KI>VJ1C*X_9Q;1C3>!XGBD%CJ2RSQCYHR!U].#Q6=H/A=M9CNC)<&"2
M!]A4IGGWKHM)N=-@U"Y.FZ3>_:5R)LGW]S5GPY*)+O6I5C>+,X.Q^H.WO2=:
MHHO7MV!0BVCF=9\*Q:581RI>F:Y:01^4%ZL?2KD7@>*.",W^I+!-)]U!C&?3
MD\UAZ/-YGBBUDG<D-<[CN/&<UVGB5M*6\MO[1L+FX<C$31DX!STX/6KG.I%J
M%Q1C%IRL<5K6@W.C7B0.1*LO^J=1][VQZUN1>!XX[-9+_45MY7'"X& ?3D\U
M?UZ\62ZTE9[*> )<J=TN,$?4&JWQ @N))+-T1WA 8?*,@-256<N6-[7!PBKO
M<T-;LVL/ CVK.',2JNY>A^:O-ST->C:NDT7P_"7&?-6) P/4<BO.3T-:87X7
MZDUMUZ'I%Q:SWO@&&"WC,DK0IA1WZ5D^%-#U*QUZ.>YM7CB","Q^E;,E]/IW
M@2"ZMF"RI"F"1FLSPSXDU/4M;CMKF5&B*,2 @'05SKGY)VM;4T?+S1ON2R-
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M\/\ WP*/LMM_S[P_]\"CZ]_= ^;]C_W&_P"^:-C_ -QO^^:^D/LMM_S[P_\
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M '&_[YHV/_<;_OFOI#[+;?\ /O#_ -\"C[+;?\^\/_? H^O?W0/F_8_]QO\
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MS8>0R(&V^BC-;7]EZ=_T#[7_ +\K_A7)+%Q3LD*YX)N'K1N'K7O?]EZ=_P!
M^U_[\K_A1_9>G?\ 0/M?^_*_X4OKB[!<\$W#UHW#UKWO^R]._P"@?:_]^5_P
MH_LO3O\ H'VO_?E?\*/KB[!<\$W#UHW#UKWO^R]._P"@?:_]^5_PH_LO3O\
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M5AT2O:P H    & !VID4$4)D,4:H9&WN5&-S>IJ2M*U9U978!11160!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $\
M'W3]:EJ*#[I^M2U#W*04444@$;[I^E5*MM]T_2JE5$3"BBBJ$%%%% !1110
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MG-SES,<8J*L@HHHJ1A1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% %M?NCZ44+]T?2BLRBL_WV^M-IS_ 'V^M-JR0HHH
MI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110!/!]T_6I:B@^Z?K4M0]RD%%%%(!&^Z?I52K;?=/T
MJI51$PHHHJA!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %6(?\ 5_C5>K$/^K_&I8T24445(PIL
MG^K-.ILG^K- %6BBBM"0HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"VOW1]**%^Z/I1691
M6?[[?6FTY_OM]:;5DA1113 **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"K$/^K_&J]6(?]7^-2QHDHHHJ1A39/\ 5FG4V3_5F@"K1116A(4444 %%%%
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MB'_5_C4L:)****D84V3_ %9IU-D_U9H JT445H2%%%% !1110 4444 %%%%
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M3]:EJ'N4@HHHI (WW3]*J5;;[I^E5*J(F%%%%4(**** "BBB@ HHHH ****
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M:P5'J,N+B*UA::=PB+U)KE[WQ9*S%;*,*O\ ?<9/Y5F:QJCZE=$@D0(<(O\
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M**S+)X/NGZU+44'W3]:EJ'N4@HHHI (WW3]*J5;;[I^E5*J(F%%%%4(****
M"BBB@ HHHH **** "N4\5H1>V[]BF/UKJZYWQ9&QM[>4#Y58@_C4RV+I_$<X
ME6$-5D-6$-9'6A;S_CV_X%5-#5RY^:V;VYJ@AXKLH? <U;XBP3B,TU337/[N
MFJ:T9D60:D!JNK5)NX-0T6BJ[98GWJ,F@FF&M$C,7-%)13$+11FB@ HHHS0
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ME6WBK7K;0H-'M=(N4OX@(UF\LD8'MBI/%FB:O<6^E:K<V_VVXB0"[BC7WSC
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M(^E^-YM3NM(EU/2[G+,L8)VD]>G<&M#P9;-=Z_+>VWAR+3[.)6\B:16$@)&
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MKM0=^G0<5#XI\,ZMJ7A;P_96ML)+BT4"9?,4;?E ZD\]*'&5GZ($UH=W:_\
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MR"M/Z=J7- $6:,TXJ#[4PJ>U,0$TA--(([4PF@!Y:FEJ8324"%+4WK2[:7%
M["4E.VGTI0A[T#&5)'$68 #+'H*>D19@JC+&MBTM! N3RYZGTH$W86TMA!'S
M]\]35D"EQ2$U21DW<":OZ9ICWLF]@1 IY/K["ETS2WO7\R3*PCJ?[WL*ZA$2
M) B*%51@ 5E4J6T1487U8JJJ($4 *!@ 4M%%<QL%%%% !1110 4444 %%%%
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M>Y2"BBBD C?=/TJI5MONGZ54JHB844450@HHHH **** "BBB@ HHHH ****
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MAV29DGO1LBZB/NWUII7)E)):E;1M&?49!+*"MLIY/][V%=I'&D,:QQJ%11@
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MX2-V/L,U=M]$U&X/RV[(/5^*8FTBB32HCRL$C1G8]E&:ZBQ\+QQL'NY/,/\
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MG7'7*FIL:*2844S)]#^5&ZD,?13-U #,<*I/T% #LTF:LPZ9?W!'EVLG/<C
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M8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@">#[I^M2U%!]T_6I:A[E(**
M**0"-]T_2JE6V^Z?I52JB)A1115""BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *L0_ZO\:KU8A_
MU?XU+&B2BBBI&%-D_P!6:=39/]6: *M%%%:$A1110 4444 %%%% !1110 44
M44 %(0#U -+10 PQ1D8,:8^E,^R6W_/O%_WP*FHI#(?LEM_S[Q?]\"GI%%&,
M)&B_1<4^B@ HHHIB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** +:_='THH
M7[H^E%9E%9_OM]:;3G^^WUIM62%%%%, HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** )X/NGZU+44
M'W3]:EJ'N4@HHHI (WW3]*J5;;[I^E5*J(F%%%%4(**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MJQ#_ *O\:KU8A_U?XU+&B2BBBI&%-D_U9IU-D_U9H JT445H2%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 6U^Z/I10OW1]**S**S_ 'V^M-IS_?;ZTVK)"BBBF 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% $\'W3]:EJ*#[I^M2U#W*04444@$;[I^E5*MM]T_2JE5$3"BB
MBJ$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 58A_U?XU7JQ#_J_P :EC1)1114C"FR?ZLTZFR?
MZLT 5:***T)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** +:_='THH7[H^E%9E%9_OM]:11
MN8#UI7^^WUHC_P!8OUJR23R/]JCR/]JIJ*F[*L0^1_M4>1_M5-11=A8A\C_:
MH\C_ &JFHHNPL0^1_M4>1_M5-11=A8A\C_:H\C_:J:BB["Q#Y'^U1Y'^U4U%
M%V%B'R/]JCR/]JIJ*+L+$/D?[5'D?[5344786(?(_P!JCR/]JIJ*+L+$/D?[
M5'D?[5344786(?(_VJ/(_P!JIJ*+L+$/D?[5'D?[5344786(?(_VJ/(_VJFH
MHNPL0^1_M4>1_M5-11=A8A\C_:H\C_:J:BB["Q#Y'^U1Y'^U4U%%V%B'R/\
M:H\C_:J:BB["Q#Y'^U1Y'^U4U%%V%B'R/]JCR/\ :J:BB["Q#Y'^U1Y'^U4U
M%%V%B'R/]JCR/]JIJ*+L+$/D?[5'D?[5344786(?(_VJ/(_VJFHHNPL0^1_M
M4>1_M5-11=A8A\C_ &J/(_VJFHHNPL0^1_M4>1_M5-11=A8KO%L7.<U'5B?[
MGXU7JD(G@^Z?K4M10?=/UJ6I>XT%%%%(!&^Z?I52K;?=/TJI51$QR+O;&:D\
MC_:IL/\ K!]*L4-@B'R/]JCR/]JIJ*5V.Q#Y'^U1Y'^U4U%%V%B'R/\ :H\C
M_:J:BB["Q#Y'^U1Y'^U4U%%V%B'R/]JCR/\ :J:BB["Q#Y'^U1Y'^U4U%%V%
MB'R/]JCR/]JIJ*+L+$/D?[5'D?[5344786(?(_VJ/(_VJFHHNPL0^1_M4>1_
MM5-11=A8A\C_ &J/(_VJFHHNPL0^1_M4>1_M5-11=A8A\C_:H\C_ &JFHHNP
ML0^1_M4>1_M5-11=A8A\C_:H\C_:J:BB["Q#Y'^U1Y'^U4U%%V%B'R/]JCR/
M]JIJ*+L+$/D?[5'D?[5344786(?(_P!JCR/]JIJ*+L+$/D?[5'D?[5344786
M(?(_VJ/(_P!JIJ*+L+$/D?[5'D?[5344786(?(_VJ/(_VJFHHNPL0^1_M4>1
M_M5-11=A8A\C_:H\C_:J:BB["Q#Y'^U3)(]F.<YJS4,_:FF)D-6(?]7^-5ZL
M0_ZO\:&")****D84V3_5FG4V3_5F@"K3XTWDC.*94L'WC]*MDB^1_M4>1_M5
M-14W95B'R/\ :H\C_:J:BB["Q#Y'^U1Y'^U4U%%V%B'R/]JCR/\ :J:BB["Q
M#Y'^U1Y'^U4U%%V%B'R/]JCR/]JIJ*+L+$/D?[5'D?[5344786(?(_VJ/(_V
MJFHHNPL0^1_M4>1_M5-11=A8A\C_ &J/(_VJFHHNPL0^1_M4>1_M5-11=A8A
M\C_:H\C_ &JFHHNPL0^1_M4>1_M5-11=A8A\C_:H\C_:J:BB["Q#Y'^U1Y'^
MU4U%%V%B'R/]JCR/]JIJ*+L+$/D?[5'D?[5344786(?(_P!JCR/]JIJ*+L+$
M/D?[5'D?[5344786(?(_VJ/(_P!JIJ*+L+$/D?[5'D?[5344786(?(_VJ/(_
MVJFHHNPL0^1_M4>1_M5-11=A8A\C_:H\C_:J:BB["Q#Y'^U1Y'^U4U%%V%B'
MR/\ :H\C_:J:BB["Q5D38<9S3:EG^\/I454A%M?NCZ44+]T?2BH&5G^^WUHC
M_P!8OUH?[[?6B/\ UB_6KZ$EJBBBH*"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@".?[GXU7JQ/\ <_&J
M]4MA,G@^Z?K4M10?=/UJ6D]QH****0"-]T_2JE6V^Z?I52JB)DD/^L'TJQ5>
M'_6#Z58I,$%%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5#/VJ:H9^U-;B9#5B'_5_C5>K$/^K_&FP1)1
M114C"FR?ZLTZFR?ZLT 5:E@^\?I452P?>/TJWL(GHHHJ!A1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<PQC8".N,GFCV4[VL!UU%4]*U2UUG3H;^S??!*,@D8(]C[U<J&FG9@%%%%(
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M:\4DFO7] (/">F_V7X:L[=AB0IYDG^\W)K&\>NL5SH$TA"QI>@LQZ#BNR
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MFM?:4^?F=]?Z^8C@_',6N0Z+"=9UBTD\R=-EI!$%R?7)YX_K6U<QI)\4=$+
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M8RNK =717&V_B/7+#7K/3]<LK=([T[8I(&)P?2I;WQ'JMYKEQI6@6D,IM?\
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M':TUW6-&=SA5!)/H*Y74?$VI3Z[+H_A^PBNI[=0;B:=]L<9/0?6C3O$MQ?\
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M[N=1;R[:_MU6*8_=!'8UW=075E:WT7E75O%,G7;(H854)*-[[,9PBZO::O\
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M<N54#<?4^M*==25OZW"-.QPEM>6\OP[N+5)09X8R9$[KEJZ"ZP/ S>GV(?\
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MM$?^L7ZU?0DM4445!04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M4;RA6 _.I.M !1110 5#/VJ:H9^U-;B9#5B'_5_C5>K$/^K_ !IL$24445(P
MILG^K-.ILG^K- %6I8/O'Z5%4L'WC]*M[")Z***@84444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%1F4"3':@"2BBB@ HHHH
M @G^\/I452S_ 'A]*BJUL)EM?NCZ44+]T?2BH&5G^^WUHC_UB_6A_OM]:0$@
MY%626Z*K>:_K1YK^M38=RS15;S7]:/-?UHL%RS15;S7]:/-?UHL%RS15;S7]
M:/-?UHL%RS15;S7]:/-?UHL%RS15;S7]:/-?UHL%RS15;S7]:/-?UHL%RS15
M;S7]:/-?UHL%RS15;S7]:/-?UHL%RS15;S7]:/-?UHL%RS15;S7]:/-?UHL%
MRS15;S7]:/-?UHL%RS15;S7]:/-?UHL%RS15;S7]:/-?UHL%RS15;S7]:/-?
MUHL%RS15;S7]:/-?UHL%RS15;S7]:/-?UHL%RS15;S7]:/-?UHL%RS15;S7]
M:/-?UHL%RS15;S7]:/-?UHL%RS15;S7]:/-?UHL%RS15;S7]:/-?UHL%RS15
M;S7]:/-?UHL%RPS!5)-522Q)-*SLW4TVJ2L!+"^#M/0U/5.G^:_K2:"Y9HJM
MYK^M'FOZTK!<EG^Y^-5Z<TC,,$TVJ0B>#[I^M2U%!]T_6I:E[E(****0"-]T
M_2JE6V^Z?I52JB)DD/\ K!]*L545BIR.M.\U_6AH"S15;S7]:/-?UI6"Y9HJ
MMYK^M'FOZT6"Y9HJMYK^M'FOZT6"Y9HJMYK^M'FOZT6"Y9HJMYK^M'FOZT6"
MY9HJMYK^M'FOZT6"Y9HJMYK^M'FOZT6"Y9HJMYK^M'FOZT6"Y9HJMYK^M'FO
MZT6"Y9HJMYK^M'FOZT6"Y9HJMYK^M'FOZT6"Y9HJMYK^M'FOZT6"Y9HJMYK^
MM'FOZT6"Y9HJMYK^M'FOZT6"Y9HJMYK^M'FOZT6"Y9HJMYK^M'FOZT6"Y9HJ
MMYK^M'FOZT6"Y9HJMYK^M'FOZT6"Y9HJMYK^M'FOZT6"Y9HJMYK^M'FOZT6"
MY9HJMYK^M'FOZT6"Y9HJMYK^M'FOZT6"Y9IKML7/?M4'FOZTUF+=33L%Q"<G
M)J:%_P"$_A4- .#D4VA%RBJWFOZT>:_K4V'<LU#/VIGFOZTC.6ZTT@N-JQ#_
M *O\:KU8A_U?XT,$24445(PILG^K-.ILG^K- %6I8/O'Z5%2JQ4Y%6R2W15;
MS7]:/-?UJ;#N6:*K>:_K1YK^M%@N6:*K>:_K1YK^M%@N6:*K>:_K1YK^M%@N
M6:*K>:_K1YK^M%@N6:*K>:_K1YK^M%@N6:*K>:_K1YK^M%@N6:*K>:_K1YK^
MM%@N6:*K>:_K1YK^M%@N6:*K>:_K1YK^M%@N6:*K>:_K1YK^M%@N6:*K>:_K
M1YK^M%@N6:*K>:_K1YK^M%@N6:*K>:_K1YK^M%@N6:*K>:_K1YK^M%@N6:*K
M>:_K1YK^M%@N6:*K>:_K1YK^M%@N6:*K>:_K1YK^M%@N6:*K>:_K1YK^M%@N
M6:*K>:_K1YK^M%@N6:*K>:_K1YK^M%@N6:*K>:_K1YK^M%@N6:*K>:_K1YK^
MM%@N32/M7CJ:K4K,6.32525@+$3[A@]14E5 2IR.M.\U_6DT%RS15;S7]:/-
M?UI6"XZ?[P^E14K,6.3252$6U^Z/I10OW1]**@HK/]]OK3:<_P!]OK3:LD**
M**8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 3P?=/UJ6HH/NGZU+4/<I!1112 1ONGZ54JVWW3
M]*J541,****H04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !5B'_ %?XU7JQ#_J_QJ6-$E%%%2,*
M;)_JS3J;)_JS0!5HHHK0D**** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH MK]T?2BA?NCZ45F
M45G^^WUIM3&'+$[NM'D'^]^E7="(:*F\@_WOTH\@_P![]*+H"&BIO(/][]*/
M(/\ >_2BZ AHJ;R#_>_2CR#_ 'OTHN@(:*F\@_WOTH\@_P![]*+H"&BIO(/]
M[]*/(/\ >_2BZ AHJ;R#_>_2CR#_ 'OTHN@(:*F\@_WOTH\@_P![]*+H"&BI
MO(/][]*/(/\ >_2BZ AHJ;R#_>_2CR#_ 'OTHN@(:*F\@_WOTH\@_P![]*+H
M"&BIO(/][]*/(/\ >_2BZ AHJ;R#_>_2CR#_ 'OTHN@(:*F\@_WOTH\@_P![
M]*+H"&BIO(/][]*/(/\ >_2BZ AHJ;R#_>_2CR#_ 'OTHN@(:*F\@_WOTH\@
M_P![]*+H"&BIO(/][]*/(/\ >_2BZ AHJ;R#_>_2CR#_ 'OTHN@(:*F\@_WO
MTH\@_P![]*+H"&BIO(/][]*/(/\ >_2BZ AHJ;R#_>_2CR#_ 'OTHN@(:*F\
M@_WOTH\@_P![]*+H"&BIO(/][]*/(/\ >_2BZ AHJ;R#_>_2CR#_ 'OTHN@(
M:*F\@_WOTH\@_P![]*+H"&BIO(/][]*/(/\ >_2BZ AHJ;R#_>_2CR#_ 'OT
MHN@%@^Z?K4M,C38",YS3ZEC"BBBD C?=/TJI5LC((J+R#_>_2J3$R&BIO(/]
M[]*/(/\ >_2G= 0T5-Y!_O?I1Y!_O?I1= 0T5-Y!_O?I1Y!_O?I1= 0T5-Y!
M_O?I1Y!_O?I1= 0T5-Y!_O?I1Y!_O?I1= 0T5-Y!_O?I1Y!_O?I1= 0T5-Y!
M_O?I1Y!_O?I1= 0T5-Y!_O?I1Y!_O?I1= 0T5-Y!_O?I1Y!_O?I1= 0T5-Y!
M_O?I1Y!_O?I1= 0T5-Y!_O?I1Y!_O?I1= 0T5-Y!_O?I1Y!_O?I1= 0T5-Y!
M_O?I1Y!_O?I1= 0T5-Y!_O?I1Y!_O?I1= 0T5-Y!_O?I1Y!_O?I1= 0T5-Y!
M_O?I1Y!_O?I1= 0T5-Y!_O?I1Y!_O?I1= 0T5-Y!_O?I1Y!_O?I1= 0T5-Y!
M_O?I1Y!_O?I1= 0T5-Y!_O?I1Y!_O?I1= 0T5-Y!_O?I1Y!_O?I1= 0T5-Y!
M_O?I1Y!_O?I1= 0T5-Y!_O?I1Y!_O?I1= 0T5-Y!_O?I1Y!_O?I1= 0T5-Y!
M_O?I1Y!_O?I1= 0T5-Y!_O?I1Y!_O?I1= 0T5-Y!_O?I1Y!_O?I1= 0U8A_U
M?XTWR#_>_2I$78N,YI-@AU%%%2,*;)_JS3J1AN4B@"I14WD'^]^E'D'^]^E7
M="(:*F\@_P![]*/(/][]*+H"&BIO(/\ >_2CR#_>_2BZ AHJ;R#_ 'OTH\@_
MWOTHN@(:*F\@_P![]*/(/][]*+H"&BIO(/\ >_2CR#_>_2BZ AHJ;R#_ 'OT
MH\@_WOTHN@(:*F\@_P![]*/(/][]*+H"&BIO(/\ >_2CR#_>_2BZ AHJ;R#_
M 'OTH\@_WOTHN@(:*F\@_P![]*/(/][]*+H"&BIO(/\ >_2CR#_>_2BZ AHJ
M;R#_ 'OTH\@_WOTHN@(:*F\@_P![]*/(/][]*+H"&BIO(/\ >_2CR#_>_2BZ
M AHJ;R#_ 'OTH\@_WOTHN@(:*F\@_P![]*/(/][]*+H"&BIO(/\ >_2CR#_>
M_2BZ AHJ;R#_ 'OTH\@_WOTHN@(:*F\@_P![]*/(/][]*+H"&BIO(/\ >_2C
MR#_>_2BZ AHJ;R#_ 'OTH\@_WOTHN@(:*F\@_P![]*/(/][]*+H"&BIO(/\
M>_2CR#_>_2BZ AHJ;R#_ 'OTH\@_WOTHN@(:*F\@_P![]*/(/][]*+H"&BIO
J(/\ >_2CR#_>_2BZ AHJ;R#_ 'OTH\@_WOTHN@)5^Z/I10!@ 45 S__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>img17388848_1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img17388848_1.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ;J#^(# 2(  A$! Q$!_\0
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MU#_P)?\ QK-HHY(]@-+_ (2+6_\ H,:A_P"!+_XT?\)%K?\ T&-0_P# E_\
M&LVBCDCV TO^$BUO_H,:A_X$O_C1_P )%K?_ $&-0_\  E_\:S:*.2/8#2_X
M2+6_^@QJ'_@2_P#C1_PD6M_]!C4/_ E_\:S:*.2/8#2_X2+6_P#H,:A_X$O_
M (T?\)%K?_08U#_P)?\ QK-HHY(]@-+_ (2+6_\ H,:A_P"!+_XT?\)%K?\
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MU#_P)?\ QK-HHY(]@-+_ (2+6_\ H,:A_P"!+_XT?\)%K?\ T&-0_P# E_\
M&LVBCDCV TO^$BUO_H,:A_X$O_C1_P )%K?_ $&-0_\  E_\:S:*.2/8#2_X
M2+6_^@QJ'_@2_P#C1_PD6M_]!C4/_ E_\:S:*.2/8#2_X2+6_P#H,:A_X$O_
M (T?\)%K?_08U#_P)?\ QK-HHY(]@-+_ (2+6_\ H,:A_P"!+_XT?\)%K?\
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MU#_P)?\ QK-HHY(]@-+_ (2+6_\ H,:A_P"!+_XT?\)%K?\ T&-0_P# E_\
M&LVBCDCV TO^$BUO_H,:A_X$O_C1_P )%K?_ $&-0_\  E_\:S:*.2/8#2_X
M2+6_^@QJ'_@2_P#C1_PD6M_]!C4/_ E_\:S:*.2/8#2_X2+6_P#H,:A_X$O_
M (T?\)%K?_08U#_P)?\ QK-HHY(]@-+_ (2+6_\ H,:A_P"!+_XT?\)%K?\
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MU#_P)?\ QK-HHY(]@-+_ (2+6_\ H,:A_P"!+_XT?\)%K?\ T&-0_P# E_\
M&LVBCDCV TO^$BUO_H,:A_X$O_C1_P )%K?_ $&-0_\  E_\:S:*.2/8#2_X
M2+6_^@QJ'_@2_P#C1_PD6M_]!C4/_ E_\:S:*.2/8#2_X2+6_P#H,:A_X$O_
M (T?\)%K?_08U#_P)?\ QK-HHY(]@-+_ (2+6_\ H,:A_P"!+_XT?\)%K?\
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MU#_P)?\ QK-HHY(]@-+_ (2+6_\ H,:A_P"!+_XT?\)%K?\ T&-0_P# E_\
M&LVBCDCV TO^$BUO_H,:A_X$O_C1_P )%K?_ $&-0_\  E_\:S:*.2/8#2_X
M2+6_^@QJ'_@2_P#C1_PD6M_]!C4/_ E_\:S:*.2/8#2_X2+6_P#H,:A_X$O_
M (T?\)%K?_08U#_P)?\ QK-HHY(]@-+_ (2+6_\ H,:A_P"!+_XT?\)%K?\
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MU#_P)?\ QK-HHY(]@-+_ (2+6_\ H,:A_P"!+_XT?\)%K?\ T&-0_P# E_\
M&LVBCDCV TO^$BUO_H,:A_X$O_C1_P )%K?_ $&-0_\  E_\:S:*.2/8#2_X
M2+6_^@QJ'_@2_P#C1_PD6M_]!C4/_ E_\:S:*.2/8#2_X2+6_P#H,:A_X$O_
M (T?\)%K?_08U#_P)?\ QK-HHY(]@-+_ (2+6_\ H,:A_P"!+_XT?\)%K?\
MT&-0_P# E_\ &LVBCDCV ^D:***\,04444 %%%% !1110 4444 %%%% 'CNM
M?\AW4/\ KYD_]"-4:O:U_P AW4/^OF3_ -"-4:]N'PH\][A1115""BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ J]HO\ R'=/_P"OF/\ ]"%4:O:+_P AW3_^OF/_
M -"%*7PL<=SV*BBBO#/0"BBB@ HHHH **** "BBB@ HHHH **** /$O'W_([
M:A_VS_\ 1:US==)X^_Y';4/^V?\ Z+6N;KVJ7\./HAA1116@!1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 ?2-%%%>"(**** "BBB@ HHHH **** "BBB@#Q
MW6O^0[J'_7S)_P"A&J-7M:_Y#NH?]?,G_H1JC7MP^%'GO<****H04444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %7M%_Y#NG_]?,?_ *$*HU>T7_D.Z?\ ]?,?_H0I
M2^%CCN>Q4445X9Z 4444 %%%% !1110 4444 %%%% !1110!XEX^_P"1VU#_
M +9_^BUKFZZ3Q]_R.VH?]L__ $6M<W7M4OX<?1#"BBBM "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH ^D:***\$04444 %%%% !1110 4444 %%%% 'CNM?
M\AW4/^OF3_T(U1J]K7_(=U#_ *^9/_0C5&O;A\*//>X44450@HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *O:+_R'=/_ .OF/_T(51J]HO\ R'=/_P"OF/\ ]"%*
M7PL<=SV*BBBO#/0"BBB@ HHHH **** "BBB@ HHHH **** /$O'W_([:A_VS
M_P#1:US==)X^_P"1VU#_ +9_^BUKFZ]JE_#CZ(84445H 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% 'TC1117@B"BBB@ HHHH **** "BBB@ HHHH \=UK_
M )#NH?\ 7S)_Z$:HU>UK_D.ZA_U\R?\ H1JC7MP^%'GO<****H04444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M45N7?A'6;1"YMA*HZF%MQ_+K6(058JP((."#VJXSC+X62TUN)1115""BBB@
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MK7-UTGC[_D=M0_[9_P#HM:YNO:I?PX^B&%%%%: %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110!](T445X(@HHHH **** "BBB@ HHHH **** /'=:_Y#NH?]
M?,G_ *$:HU>UK_D.ZA_U\R?^A&J->W#X4>>]PHHHJA!1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'L7]M:5_T$
M[/\ [_K_ (T?VUI7_03L_P#O^O\ C7CM%<?U*/<W]N^Q[='(DT:R1.KHPRK*
M<@CV--GGAMHC+/+'%&.KR,% _$U1\/?\B]8?]<5_E5'QI_R+,_\ OI_Z$*XE
M"]3E\SH<O=N:7]M:5_T$[/\ [_K_ (U3U?5]-DT6^CCU"T=VMY JK,I))4\
M9KRFBNU8.*=[G.Z[?0W/!_\ R--E_P #_P#0&KU2O*_!_P#R--E_P/\ ] :O
M5*QQG\1>AI0^$\G\4_\ (S7W^^/_ $$5CUT>L:9=ZKXNOH;2$NP<;FZ!1@<D
MUH0?#V=HP;C4(XW[JD9<#\2176JL(07,^A@X2E)V1QE%=5J'@2_MHS):S)=
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M4XY]".M94,,EQ,D,*,\CG"JHR2:TC)25T]"6FG9C**ZRR\!7\ZAKJ>*V!_A
MWL/KT'ZU:;X>,!\NI@GW@Q_[-63Q%).UR_93['$T5KZKX;U'2$\R>-7AXS+$
M<J"?7N/RK(K6,E)73(::T8445;T_3;O5+CR+2$R/C)[!1ZDTVTE=@E<J45V<
M'P^G9 9[^.-L=$C+8_45#>^ KZ"/?:7$=S@'*D;&/TY(_45C]8I7M<OV4^QR
M5%:VD^'KS6);B.%HHG@(#K,2I!.>. ?2KUWX)U*SLYKF2>T*1(78*[9( SQ\
MM6ZL$[-ZDJ$FKV.;HHKH[/P7J-]9PW44]J$E4,H9VS@^ORTY3C#63$HM['.4
M5M:OX8O=%M$N;F6W=&D$8$;,3D@GN!Z5BTXR4E= TUHPHK0TC2+C6KM[:V>)
M'6,R$R$@8! [ ^M;7_" :K_S\6?_ 'VW_P 34RJPB[-C4)/5(Y6BI)XF@N)(
M6(+1L5)'3(.*CJR0HK;TKPMJ6JQK-&BQ0-TDE.,CV'4UN#X>-MYU,!O00?\
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MJ04)^G4?J*Y:XMYK6=X)XVCE0X96'(JH5(3^%BE%QW(Z***LD**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "KVB_\AW3_ /KYC_\ 0A5&KVB_\AW3
M_P#KYC_]"%*7PL<=SV*BBBO#/0"BBB@ HHHH **** "BBB@ HHHH **** /$
MO'W_ ".VH?\ ;/\ ]%K7-UTGC[_D=M0_[9_^BUKFZ]JE_#CZ(84445H 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MOC_T$5UW@.V\K199RJ[II3@CJ5 P,_CFNFI-PH)KLC*,>:H=2JJBA5 "@8
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MG+A?+9N-JCL#Z&LGQ1X?_L6\5X-QM)L[,\[#W4G^7_UJP*[6HUH>1@FZ<CW
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M<KZ&UTXW1X_7KWA[_D7K#_KBO\J\AKU[P]_R+UA_UQ7^5=F-^%&%#=F/X_\
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M_P! ?4/_  &?_"L]T:-V1U*NIPRL,$'T-)-/8!M%%%, HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHJ:VM+F]E\JTMY9Y,9V1(6./7 H AHK2_X1W6_^@/J'_@,_^%9\D;PR
MO%*C)(C%61A@J1U!'8TDT]@&T444P"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7CG1I;I(=0MHF=HUV2A1D[>H./8D_G[5P%%'#TZD+W83JRB['JG_  F&@_\
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MS?&RAXV/7:<]??@UWW@W_D5[7ZO_ .A&L#XA.AN[&,$;UC9B,]B1C^1J_P"
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MA:Q#$\LNE7R1HI9G:W<!0.I)QP*J6]M/=RB*VADFD/1(T+$_@*5TP(J*Z)/
MOB62,.-,8#_:E0'\BV:R]0T;4M*?;?64T'. S+\I.,\-T/X&DIQ;LF!1IT<;
MRR+'&C.[D*JJ,DD] !3:V_#VDZC-JVFW<6GW3VWVF-O.6%BF XR=V,<8/Y4Y
M245<#J_#_P -&;;<:X^T=K6-N?\ @3#\>!^=9?Q*MX;7Q!:0V\211+9*%1%
M ^=^PKU^O,/B/I6HWWB&WEM+"ZN(Q:*I>&%G .]^,@=>17GT*TIU;R8CSVBI
MKJSNK&417=M-;R$;@DJ%#CUP:AKT=QA1110![_X=_P"19TK_ *\X?_0!7*_%
M/_D"V7_7Q_[*:XJW_P"$O^S1?9O[<^S[!Y7E>;MVXXVXXQCIBJFJ_P#"0>0G
M]K_VGY6[Y/M?F;=V.V[OBN&&'Y:G-S(1E445-;6ES>2^5:V\L\F,[(D+''T%
M=PR&BNAC\#>))%!72W (S\TJ+_-J27P/XDA7<VER$?[$B-_(FH]K#^9 <_14
MMQ;3VDIBN89(9!U21"I'X&HJL HHHH *]#^%/_'YJ?\ USC_ )FO/*]#^%/_
M !^:G_USC_F:PQ/\)@>G5\]ZO_R&K_\ Z^)/_0C7T)7SWJ__ "&K_P#Z^)/_
M $(US8+=B*5%6;33KZ_W_8[.XN=F-_DQ,^W/3.!QT-32Z'J\$32S:7>QQH,L
M[V[@*/4DBN_F6UQE"BIK:TN;R7RK6WEGDQG9$A8X^@K=7P)XE9=PTPX]YHP?
MRW4I3C'=@<Y15R_TK4-+DV7UG- <X!=" ?H>A_"J=4FGJ@"BBG(C2.J(I9V.
M%51DD^@H ;16[;>#/$5W&LD6ES!6Z>85C/Y,0:=/X)\1V\9=]+D( S^[=7/Y
M*2:CVD-KH# HI\D4D,C1RHR.O!5A@C\*95@%%6[72]0OD9[.QN;A%."T,+.
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MM_=21L,,KS,0?J,U4I4*3IQ:8ZD^=W"BBBMC,]>\/?\ (O6'_7%?Y51\:?\
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M5?\ H)WG_?\ ;_&JUQ=7%W()+F>69P,!I'+$#TR:BCAG3ES-E3JJ2L15Z-X
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M19G_ -]/_0A7E]6I]2O[F(Q3WMS+&>J22LP/X$U5HH4G3CRL52?,[G3>!?\
MD83_ -<6_F*]*KQ2"YGM9/,MYI(7QC=&Q4X^HJS_ &UJO_03O/\ O^W^-95L
M,ZDN9,NG5458-:_Y#NH?]?,G_H1J]X2U&'3==1YV"12H8F<G 7.""?Q _.L5
MW>21I)&9W8DLS'))/<FFUT."<.5F:E9W1[AU&14'V*T^TFY^S0^>>LOEC<?Q
MZUY39^(M6L(1#;WLBQCHK ,![#(.![5++XIUN92KZA( 1CY%5#^8 KA^IS3T
M9T>WCV*.IH(M5O(QT6=U_)C56E9F=RS,69CDDG))I*]%*R.9A5[1?^0[I_\
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MY &/G16/YD5Q2P;O>#.A5U;WD>HP6EM:C%O;Q0CTC0+_ "J'4M4M=)M6GNI
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 >\^%?^14TO_KW3^59OQ$_Y$ZY_P"ND?\ Z$*TO"O_ "*FE_\
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M^'?_ ")UM_UTD_\ 0C6EXJ_Y%35/^O=_Y5F_#O\ Y$ZV_P"NDG_H1K2\5?\
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M61#Z#.#^A_2LZ$Y4ZG(P/)M(_P"0U8?]?$?_ *$*^A*^>](_Y#5A_P!?$?\
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M@< _A3[FV@O+=[>XB66)QAD89!%>":%JDNCZU;7D<K1JK@2[?XDR-P([\5]
M4J]'V35F!X/XHT7^P=>GLU),/$D+'J4/3\N1^%>J> ?^1)T__MI_Z,:N3^*L
M:#4-.D"C>T3J6[D C _4_G7&Z%_R,&F_]?47_H8KL<76HIMC/H*BBO)/BC_R
M,UM_UYK_ .AO7#1I^TERW$-^)W_(T1?]>J?^A-7%T45Z]./)%1&%%%%4![_X
M=_Y%G2O^O.'_ - %<K\4_P#D"V7_ %\?^RFNJ\._\BSI7_7G#_Z *Y7XI_\
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M1176 5Z'\*?^/S4_^N<?\S7GE>A_"G_C\U/_ *YQ_P S6&)_A,#TZOGO5_\
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M6JYQL]T,].\ >$84M(]8U"%9)I/FMT89"+V;'J>H]!C\._DD2)"\CJBCJS'
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!](T445X(@HHHH **** "BBB@ HHHH **** /'=
M:_Y#NH?]?,G_ *$:HU>UK_D.ZA_U\R?^A&J->W#X4>>]PHHHJA!1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% 'HG@#_D#7'_ %\'_P!!6MS7?^0!J'_7N_\ Z":\PT_7=2TN%H;*Y\J-
MFW$;%;)QCN#Z5//XIUFYMY()KS='(I5E\I!D'KT%<4\-.53G1T1JQ4;&/111
M7:<X4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %=I\/?^/F^_W$_F:XNKNG:M?:4TC64_E&0 -\BMG'U!K.K!S@XHN$N65V>Q
MUXK=_P#'[/\ ]=&_G6M_PF&O?\_W_D%/_B:Q7=I'9V.68Y)]ZRP]&5.]RZM1
M3M8;111728A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %7M%_Y#NG_]?,?_ *$*HU>T7_D.Z?\
M]?,?_H0I2^%CCN>Q4445X9Z 4444 %%%% !1110 4444 %%%% !1110!XEX^
M_P"1VU#_ +9_^BUKFZZ3Q]_R.VH?]L__ $6M<W7M4OX<?1#"BBBM "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** />/"3A_">F$9_U"CGVXK/\ B&"?!UT1
MV>,G_OH4?#R=)?!UJBL"87D1@.QW%OY,*U?$>E'6M N[!#B21<H2<#<"",^V
M17D?#6U[B/ J*DN+>6UN)()XVCEC;:Z,,$&HZ]<9WWPK_P"0M?\ _7 ?^A5Z
MG7 ?##2YK:QN]0F0JMR56($8RJYR?H2?T-=[(ZQ1M([!44%F)[ 5Y.)=ZKL(
M^?\ 6R&U_42.ANI2/^^C6SX-\6'PY=O%<*SV,QRZKU1O[P]?I7.7,YN;N:X8
M8,KLY'U.:Z_2/AS=ZIIT%[_:%M'',@= JLQ /8].>H_"O0J<BA:IL,]1T[5K
M#5H1-8W<4Z]]IY'U'4?C5RO'_$'@BZ\,Z<NIPZ@TQ20*QCC*% >C9W'OQ^-9
MUCXV\0V. NHR3(#DK< 29_$\_K7']54U>G*Z$>TW5C:7T9CN[:&=",$2(&_G
M7!^)OAS ;>2[T5769?F-L3D,.^WT/M5[P?XXGU^^-A>6J)-L+K)#G:<=B#G'
MYUVU97J4)6 ^=;)0U];JP!4RJ"".",U]%5X%KJK:>)]0%LP BNW*8'W2&/'/
MH>/PKW:RNX[ZQ@NXC^[FC61?H1FM\9JHR 9=:987[J]Y8VUPRC"F:)7('MD5
M7_X1W1/^@/I__@,G^%<5\4]/E9;'45!,:9A?_9)Y']?TKS6E2P[G!24@/H>T
MTVPL"QL[*VMR_#&&)4S]<"IYEWPR+C.5(Q^%>):%X-U/Q!8O=VCVZ1J^S]\S
M*6/'3 /'-37_ (!US3[2:ZDC@>*%#(Y24< =>N.U)X>'-9SU_KS YBBBBO2&
M%=K\+P#XGGR>EH^/^^DKBJZ;P#?K8>+;8/PMP# 3GH6Z?J /QK*LKTVD![77
MSYK;,VO:BS?>-U*3]=QKZ#KQ/QUI,FE^)KE_+(@NF,T3=CG[P_!L\>A'K7%@
MFE)H1S5==\-RP\6IMS@PONX[<?UQ7(UZ'\+])F-Y<ZLX*P*AACR/OL2"<?3
M_/V-=F(:5-W&>G5X5XR55\7ZF%.1YN?QP,U[F[K&C.[!54$DGH!7SWJEY_:&
MK7=X-V)YGD&[J 22!^5<F"7O-B/3?A;_ ,B_=_\ 7T?_ $!:Z3Q-_P BOJO_
M %ZR?^@FN;^%O_(OW?\ U]'_ - 6ND\3?\BOJO\ UZR?^@FLJO\ '^8'@=%%
M%>L,**** "BBB@#V?X=_\B=;?]=)/_0C6EXJ_P"14U3_ *]W_E6;\._^1.MO
M^NDG_H1K2\5?\BIJG_7N_P#*O(G_ !GZB/!J***]<9O^"O\ D<=-_P"NA_\
M037N5>&^"O\ D<=-_P"NA_\ 037N5>;C?C7H(\<^)$PE\6N@(_=0(AP>G5O_
M &:N1KI/'W_([:A_VS_]%K7-UW45:G'T&6+"QN-2OH;.U3?-*VU1G%>H:3\,
M]-MXD?4Y)+J?;\Z*Y6,'VQAC^?X5D_"JUC>]U*Z909(D1%/H&))_]!%>FR/Y
M<;/@G:"<#O7'B:\E+DCH(J6FD:;8,6M+"V@8]6CB )_&K3S1QLJO(BEC@!F
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M>J,**** /?\ P[_R+.E?]></_H KE?BG_P @6R_Z^/\ V4UU7AW_ )%G2O\
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M_D:S_P!>[_S%=KFYX=R?89[!7@'B+_D9M5_Z_)O_ $,U[_7@'B+_ )&;5?\
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M'@U%%6[72]0OD9[.QN;A%."T,+. ?3@5Z[:6XRI16BV@:RB,[Z1?JJC))MG
M _*LZDFGL 44Z.-Y9%CC1G=R%55&22>@ K0_X1W6_P#H#ZA_X#/_ (4-I;@9
MM%3W5E=6,HBN[::WD*[@DT90D>N#VX-04]P"BK=KI6HWT1EM+"ZN(PVTO#"S
M@'TR!UY%2RZ%J\$3RRZ5?1QH"S.]NX"@=R<<4N9;7 SZ***8!1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110!](T445X(@HHHH **** "BBB@ HHHH
M**** /'=:_Y#NH?]?,G_ *$:HU>UK_D.ZA_U\R?^A&J->W#X4>>]PHHHJA!1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,LT,CQRH<JZ,05/L178Z;\2]8M $O(X;U!W8;'_,<?I7!4PDD^:F(ZV/X:Z
MEQYK"ZD3_GDTOR_H ?UKK(((;:!(8(DBB085$7  ]A7G1^*YQQHH!][K_P"P
MK U?Q]K>J(T22K9P'.5M\AB,\9;K^6,U'L*]1^^!TOC_ ,6QI;OHVGS))))E
M;F13G8/[GU/.?3IWX\QHHKNI4U3CRH9ZQ\+?^1?N_P#KZ/\ Z M=)XF_Y%?5
M?^O63_T$UY)H'C'4/#MG):VD-JZ22>83,K$YP!V8>E7K[XBZOJ%A<6<MM8K'
M/&T;%$<$ C''S5R3P\W5YEL!R%%%%=X!1110 4444 >S_#O_ )$ZV_ZZ2?\
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M*O9=D$S[H7;HKG@@GL#Q^/UKU1E5T9'4,K#!!&017S?74:-X]UG2(A"TBW<
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M_0WKB:U->UZZ\17R7=W'"DB1"("$$# )/<GGDUEUO2BXP46!ZW\+O^19N?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** .X^'?_,2_P"V7_L]=Q7#_#O_ )B7
M_;+_ -GKN*\G$_Q7_70[:7P(*.HP:\K_ .$PU[_G^_\ (*?_ !-21>--;C)+
M7"2^SQ+_ $ K3ZG4[HGV\3TB>QM+E2L]M#(#U#H#7#^)O"*6-N]]IP;R4YDA
M)+;1Z@]<>N:Z3PWXB77('5T$=S%C>HZ$'N*VV574JP!4C!!'!%9QG.C*S*<8
MS1XA15S5;3[!JMU:C[L<A"_3M^F*IUZR=U='&U8***N+I&IN,KIUVP]H&/\
M2AM+<+7*=%33V=U:_P#'Q;30\X_>(5Y_&H:$[B"BBB@ HI\<4DS[8HV=O11D
MU;&C:H1D:;>$?]<&_P *3:6X[-E&BII[.ZM0#<6TT0/0R(5S^=0TT[B"K5AI
MUUJ5P(+2%I'/7 X4>I/855KOOA]_QY7O_71?Y5G6FX0<D7"/-*Q)IG@RVL;9
MY[_;<W 0D+CY$X_7\?RKSVO;+C_CVE_W#_*O$ZPPLY3YG)FE:*C9(****ZS
M*O:+_P AW3_^OF/_ -"%4:DAFDMYXYXFVR1L'1L9P0<BE)75AK1GME%>5_\
M"8:]_P _W_D%/_B:/^$PU[_G^_\ (*?_ !->=]3J=T=7MXGJE%,A8O!&S')*
M@G\JY_QAJEYI5A;RV4WE.\NUCM#9&#Z@USP@Y2Y4:RE97.CK#\8?\BM>_P#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !5[1?^0[I__7S'_P"A"J-7M%_Y#NG_ /7S
M'_Z$*4OA8X[GL5%%%>&>@%%%% !1110 4444 %%%% !1110 4444 >)>/O\
MD=M0_P"V?_HM:YNND\??\CMJ'_;/_P!%K7-U[5+^''T0PHHHK0 HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;G=CDDUI0PTE+GF!'1117>,**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH ^D:***\$04444 %%%% !1110 4444
M %%%% 'CNM?\AW4/^OF3_P!"-4:O:U_R'=0_Z^9/_0C5&O;A\*//>X44450@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#N/AW_P Q+_ME_P"SUW%</\._^8E_VR_]
MGKN*\G$_Q7_70[:7P(\/HKT;_A -*_Y^+S_OM?\ XFI8? NCQ,2_VB8'L\F,
M?]\@5V_6Z9A[&1A^ +:5M2N;H#$*Q>63CJ20<?I_*O0:AM+2WL;=;>UB6*)>
MBJ/Y^I]ZKZOJ<6D:=+=2D$@81"<;V[#_ #VKAJ3=6=TCHA'DCJ>9^)G5_$E\
M5((\S&1Z@ ']:AT?1[C6;T6\ VJ.9)".$'K]?:J4LKS3/+(VYW8LQ]2>37J'
MA+3EL-!A8@>9< 3,1Z'[H_+'XYKOJU/8TU;<YH1YY%O2]!T_2(P+:$&3',K\
MN?Q[?05I5E>(=8&BZ6UPJJTS'9$K="WO].M>67E_=ZA+YMW<23-VW'@?0=!^
M%<=.A*M[S9O.HH:)'LSHLB%'4,IZ@C(-<?XA\&Q2QO=:6FR4<F ?=;_=]#[5
MC^&?$MU97T5M=3/+:2L$^<Y,9/ (SV]17I5*2GAY:,$XU4>'UM^&M!;6[XB3
M<MK%S(P[^BCW-6?&FFK8ZSY\8 CNAOVCLW\7^/XUT/@ #^PYSQG[2<_]\K7;
M5K?NN>/4PA#W^5G26EE;6$"P6L*Q1J.BC^9[U/6=KD%]<:1/'ITACN2 5(;:
M3SR >QKR[4+#4[61FOX+@$<%Y 2/^^NAKBI4?:ZN6IO.?)T/82 P(8 @]0:X
M?Q9X7A@MVU'3XM@3_70H.,?W@.V.X_'M6=X>\6S::\D=_)/<6[+E1G<RM[$G
MIC_/6M>Y\>V,L,D0T^:174J5=@ 01T/6M(TJM*?NZDN<)QU.:\+?\C-8_P"^
M?_037K%>)12R02K+#(\<B_==&((_$5Z#X&O+F[M+MKFXFF*R* 9'+8X]ZTQ=
M-OW^Q-"5O=.LJO?_ /(.N?\ KD_\C4DY(MY2#@A#@CZ5Y VL:FZE6U&\*D8(
M,[8(_.N:A1=35/8UJ5%$I4445ZQQ!1110 4444 >V6__ ![1?[@_E7*_$#_D
M%VO_ %V_]E-=5;_\>T7^X/Y5ROQ _P"07:_]=O\ V4UY-#^*CMJ? SSVBBBO
M6.([3X>_\?-]_N)_,UV>HP/=:9=V\>-\L+HN>F2I KC/A[_Q\WW^XG\S7>5Y
M>)=JK9V4O@*&DZ3;:/9K;VZ\]7<]7/J:FU&6&#3KF6XC$D21LS(P!# #I@US
MOB'Q@=+O&L[.!))D WO)G:IZXP.O'O6#JGC!]5T.2REM@DSLN61OEP#GH>>H
MHC0J3:D^H.I&*LC+T729M;U,0)\J?>E<#A%^GZ 5ZCI^EV6EP>5:0+&,89L9
M9OJ>IZUY[X:\16VA1SK):/(\K EU?L.V#]3^=;-]X]@DL)5LH9X[IAA&=5*K
MSR>OI[=:WQ$*LY<J6AG3<(J[W.UHKQ.2XFFE\V6:1Y!_&S$G\Z[GP'>WDXNH
M9Y)9(% ,;/DA3W /Y<5C4PKA'FN7"MS.UB;Q3X7M[BTEO[*(17,8+NJ# D'?
MCU[^]>>5[=(@DB=" 0RD$&O$:Z,)-RBT^AG7BD[H]&\ ?\@*?_KY;_T%:UM?
MTV35M+:SB94+NN6;^$ Y)]ZR? '_ " I_P#KY;_T%:Z>:5(())I#A(U+,?0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"KVB_P#(=T__ *^8_P#T(51J]HO_ "'=/_Z^8_\ T(4I?"QQW/8J***\,] *
M*** "BBB@ HHHH **** "BBB@ HHHH \2\??\CMJ'_;/_P!%K7-UTGC[_D=M
M0_[9_P#HM:YNO:I?PX^B&%%%%: %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!](T445X(@HHHH **** "BBB@ HHHH **** /'=:_Y#NH?]?,G_ *$:HU>U
MK_D.ZA_U\R?^A&J->W#X4>>]PHHHJA!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '<
M?#O_ )B7_;+_ -GKN*X?X=_\Q+_ME_[/7<5Y.)_BO^NAVTO@1RO_  G^E?\
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M_/C_ .1G_P#BJY3QEI%CI3V8LH/*$@??\[-G&,=2?6K_ /PL3_J%_P#DQ_\
M8UA>(?$/]O-;G[+Y'DAA_K-V<X]AZ4J,*RFG/;U'.5-Q]TQ****[3G/;+?\
MX]HO]P?RKE?B!_R"[7_KM_[*:ZJW_P"/:+_<'\JY7X@?\@NU_P"NW_LIKR:'
M\5';4^!GGM%%%>L<1VGP]_X^;[_<3^9KO*X/X>_\?-]_N)_,UWE>5BOXK.RC
M\"/&-1D\W5+N3^_,[?FQJM117JI65CC+FFZ9=ZK="WM(][=6). H]2:[:Q\
MV<1#7MQ)<$'[J#8OX]_U%6?!%G%!H"W*K^\N'8LQZX!*@?3@_F:UM9U,:1I<
MMX8_,*8"KG&23BO/K5YN?) ZH4XJ/-(9:^'])LPODV$.5.0SKO(/KDY-:0
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M%%%>@<P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5>T7_ )#NG_\ 7S'_ .A"J-7M
M%_Y#NG_]?,?_ *$*4OA8X[GL5%%%>&>@%%%% !1110 4444 %%%% !1110 4
M444 >)>/O^1VU#_MG_Z+6N;KI/'W_([:A_VS_P#1:US=>U2_AQ]$,****T *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@#Z1HHHKP1!1110 4444 %%%% !1
M110 4444 >.ZU_R'=0_Z^9/_ $(U1J]K7_(=U#_KYD_]"-4:]N'PH\][A111
M5""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** .X^'?_ #$O^V7_ +/7<5Y7X=\1?V!]
MI_T7S_.V_P#+3;MQGV/K6Y_PL3_J%_\ DQ_]C7GUZ%251RBM#JIU(J*39P]%
M%%>@<H4444 %=QX'UQ54Z3<.!R6@)]^J_GR/Q]JX>BHJ4U4CRLJ$G%W1[=)&
MDT;1R(KHPPRL,@CTKD;OP!:2REK6[D@4G[C)O _4&L33/&NHV,8BN MW&.GF
M'#C_ (%_B#6^GC_32HWVUVK=PJJ1_P"A"N!4J])^Z=//3GN:>C>&K'129(MT
MMP>#+)U ] .U:&H7\&FV4EU<-A$&<=V/8#W-<I>?$&((1963LQ!^:8@ 'MP,
MY_,5R&I:K>:M<>==R[R,[5 PJ#T _P FG'#U*DN:H)U8Q5HC=3U"75-0EO)N
M&D/"@\*.PKKO ^MQK&=*N'"MN+0$]\]5_/G\:X:E!*L&4D$'(([5VU*49PY#
M",W&5SVN>"*Y@>&9%>-QAE8<$5R-S\/K=Y,VU_)$O]UXP_ZY%9NF>.KRV18K
MV(7*C \P':^/?L?TK97Q_IF/FMKP'V53_P"S5PJG7I/W3H<Z<]RYHWA.RT>Y
M%TLDDTX!"L^ %SZ =\5LW=W!8VLES<2!(HQEB?\ /6N5N/B!:*A^S64[MV\P
MA1^F:Y/6-?O=:=?M#!8D.4B3A1[^YIJA5J2O,3J0BK1*FH7;7^HW%VV<RR%@
M#V'8?E76?#R11-J$18;V5& SR0-V?YBN*JUI^H7.F7B75J^V1>W9AW!'<5VU
M:?-3<$80E:7,SV5E#HRGHPP:XP^ +>,3.U[*ZA28T"!2/3)YSV["I;?X@631
M W%I<))W$>UA^9(IMS\0+/RV%O93NQ&!YA"C],UP0IUX.T4=$I4Y;G 4445Z
M9R!1110 4444 >V6_P#Q[1?[@_E7*_$#_D%VO_7;_P!E-4X_B#Y<2)_9>=H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >H>"
M_P#D68/]]_\ T(U:\3?\BW??]<_ZBN7\/>++#2='CM)X;EI%9B3&JD<G/<BI
MM8\9:=J&D7-I%#=+)*FU2ZJ!U[_-7FRI3]KS6TN=2G'DM?H</1117I'*%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 5>T7_ )#NG_\ 7S'_ .A"J-7M%_Y#NG_]?,?_
M *$*4OA8X[GL5%%%>&>@%%%% !1110 4444 %%%% !1110 4444 >)>/O^1V
MU#_MG_Z+6N;KI/'W_([:A_VS_P#1:US=>U2_AQ]$,****T **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@#Z1HHHKP1!1110 4444 %%%% !1110 4444 >.Z
MU_R'=0_Z^9/_ $(U1J]K7_(=U#_KYD_]"-4:]N'PH\][A1115""BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ J]HO_(=T_P#Z^8__ $(51J]HO_(=T_\ Z^8__0A2
ME\+''<]BHHHKPST HHHH **** "BBB@ HHHH **** "BBB@#Q+Q]_P CMJ'_
M &S_ /1:US==)X^_Y';4/^V?_HM:YNO:I?PX^B&%%%%: %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!](T445X(@HHHH **** "BBB@ HHHH **** /'=:_
MY#NH?]?,G_H1JC5[6O\ D.ZA_P!?,G_H1JC7MP^%'GO<****H04444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !3)H8YX7BE0/&XPRD<$4^B
M@#S;Q#X>DTF;S8@7M'/RMW0^A_QK#KV*:&.>%XI4#QN,,I'!%><^(?#TFDS>
M;$"]HY^5NZ'T/^-=]"OS>[+<YJE.VJ,.BBBNHQ"BBB@ HHHH *W/#WAZ35IO
M-E!2T0_,W=SZ#_&CP]X>DU:;S904M$/S-W<^@_QKT:&&."%(HD"1H,*H' %<
MM>OR^['<VIT[ZL(88X(4BB0)&@PJ@< 4^BBN Z0HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "E3[Z_6DI4^^OUI 6J***@H
M**** "BBB@ HHHH **** "BBB@ HHHH KR_ZPTRGR_ZPTRK1(4444P"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M** +=%%%9E!1110 4444 %%%% !1110 4444 57^^WUI*5_OM]:2K)"BBBF
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !3
M)H8YX7BE0/&XPRD<$4^B@#S;Q#X>DTF;S8@7M'/RMW0^A_QK#KV*:&.>%XI4
M#QN,,I'!%><^(?#TFDS>;$"]HY^5NZ'T/^-=]"OS>[+<YJE.VJ,.BBBNHQ"M
MSP]X>DU:;S904M$/S-W<^@_QH\/>'I-6F\V4%+1#\S=W/H/\:]&AAC@A2*)
MD:#"J!P!7+7K\ONQW-J=.^K"&&."%(HD"1H,*H' %/HHK@.D**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *5/OK]:2
ME3[Z_6D!:HHHJ"@HHHH **** "BBB@ HHHH **** "BBB@"O+_K#3*?+_K#3
M*M$A1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@"W1116904444 %%%% !1110 4444 %%%% %5_OM]:2E?[[?6DJR0HH
MHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %,FACGA>*5 \;C#*1P13Z* /-O$/AZ329O-B!>T<_*W=#Z'_&CP]X
M>DU:;S904M$/S-W<^@_QKT::&.>%XI4#QN,,I'!%$,,<$*11($C0850. *Z?
MK4N2W4Q]BN:_0(88X(4BB0)&@PJ@< 4^BBN8V"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I4^^OUI*5/OK]
M:0%JBBBH*"BBB@ HHHH **** "BBB@ HHHH **** *\O^L-,I\O^L-,JT2%%
M%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** +=%%%9E!1110 4444 %%%%
M !1110 4444 57^^WUI*5_OM]:2K)"BBBF 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %*GWU^M)2I]]?K2 M4445!04444 %%%% !1110 4444 %%%% !1110!7
ME_UAIE/E_P!8:95HD****8!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 6Z*
M**S*"BBB@ HHHH **** "BBB@ HHHH JO]]OK24K_?;ZTE62%%%%, HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *5/OK]:2E3[Z_6D!:HHHJ"@HHHH **** "BBB
M@ HHHH **** "BBB@"O+_K#3*?+_ *PTRK1(4444P"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH MT445F4%%%% !1110 4444 %%%% !1110!5?[[?6DI7^
M^WUI*LD****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4J??7ZTE*GWU^M("U1
M114%!1110 4444 %%%% !1110 4444 %%%% %>7_ %AIE/E_UAIE6B0HHHI@
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110!;HHHK,H**** "BBB@ HHHH **
M** "BBB@"J_WV^M)2O\ ?;ZTE62%%%%, HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***@OKR+3]/N;VX)$-
MO$TLA'95!)_04 5M7US2]!M?M.JWT%I$3A3(V"Q]%'4GZ5Q%U\;O"5NY6)=0
MN@#C=#  #[_.RG_]=>%>)O$NH>*M9EU+4)"68XCC!^6).RK[?SZUTVC?![Q5
MK%DET8[6RCD7<@O)&5B/]U5)'XXJ;]AV/4;+XU^$;IB)FOK,9ZSV^<_]\%J[
MVQO[/4[1+NPNH;FW?[LL+AE/KR*^8?$_PV\1>%+/[;>PPS6@.'GMG+*G( W9
M (R2,<4SP#XRN?!_B"*;S'.G3,$NX1R&7^\!_>7.1^7>B_<+'U312*P90RD%
M2,@CH:\G^+/Q!U?PUJ,.C:5Y<!FMA.]SC+@%G7"@\#[N<]?I3$>KB6,RM$'4
MR*H9DSR <X)'H<'\C3J\9^ UQ-=7'B6XN)I)II&MV>21BS,3YN22>2:]FH0!
M1113 **** "F>;'YHBWKYA7<$SSCIG'I7FGQ8\>:IX5-II^E+''+=1L[7##<
MR#IA1TSWR<_2N<^!]Y<ZAXGUNZO)Y)[B6W0O+*Q9F.[N32N,]QHHHIB"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHKYH\<_$C7=>O;S3A-]CTY)'B\
MB D&10<?.W5NG3@<]*3=AGTI'+',@>)U="2 RG(X.#^M/KE_AS_R3S1/^O8?
MS-=10(*R-?\ %&C>&((9M8O/LT<S%(SY3OD@9_A!K7KSGXN>%]9\3Z5IL.CV
M?VF2&=GD'FHF 5Q_$10P-'_A;?@?_H-_^2DW_P 11_PMOP/_ -!O_P E)O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2.:"9"K(P#*ZD<@CH017SK\:--L-*\86D&G65M9PM8(YCMXEC4MYD@SA0.<
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M;\2? ^MVJ6SWD%NA4+]FOHO+51C&"3\G3C@TMP/+_"OQCUS3+^./6YCJ%@S
M2%D EC'3*D8SZX/7VKZ#M+J"^M(;NUE66"9 \<BG(93R#7E,WP7T+6K^XU+3
M];"6%PY>&*TC5D0'!P&W$$=?3J/2O2/#NAP^&]"MM)@N)YX;<$(\Y!;!)..
M..>/04U<#4HHHJA',^.?&-OX,T$WLB":YE;R[> MC>W<GOM Z_@.]?/^J?$W
MQ=JMP\C:Q/;(Q.(K0^4J#G@8Y[]22?>O=?&WP]L_&TUK+=:A=VYMD942/:4Y
M().".IP!U["L_P +> _#WP^$]WJ&H6LUQ(P:.YO%2+RE7'W<DX.3DG/IZ<R[
MC/"X?&_BJWDWIXBU0G&,273N/R8D5Z;\.OBU?:AJUKH?B QRFX;RX;P *V\_
M=5@.#GH"!G.,YZUI?$CQCX)U3PU?6'VNWOK_ &E;=H8RY1QR"),8 SQP>03U
MYKQ'097@\1:9,AP\=W$RGW#@TM@/?OBYXHUGPQI6FS:/>?9I)IV20^4CY 7/
M\0-?.DTSW$\DTK;I)&+L<8R2<FOL6_TK3M51$U'3[6\1#E%N(5D"GU&X'%?(
M6JHL>L7R(H5%N) JJ, #<>!0P1U7AOXB>*K"33=)MM4V6*2)$L7V>(X4MR,E
M<]_6OI^N#^'_ (:T&X\$:+>3:)ILETT <S/:H7+9/.XC.?>N\JD 4444Q!7S
M!\6_^2G:Q_VQ_P#1*5]/U\P?%O\ Y*=K'_;'_P!$I4R&CT+X"?\ ($U?_KY3
M_P!!KUVO(O@)_P @35_^OE/_ $&O7::V!G!_%GQ%JOAGPK:WND77V:X>]2)G
M\M7RI1R1A@1U4?E7"?#OXB>*M=\=Z;INI:IY]I-YOF1_9XESB)V'*J#U [UU
M'QV_Y$BR_P"PDG_HN6O+_A)_R4[1_P#MM_Z)>D]P/=_B)J]]H7@34M2TV?R+
MN'RO+DV*V,RHIX8$=">U>/>&OB]XABUZ"37M4:XTU$D:6);>)2Y$;%0"%!SN
MV]Z]4^+?_),=8_[8_P#HY*^:]*L6U36+'3T.&NKB. 'T+,%_K0]P1UGB+XJ^
M)]<O7>WOI=-M<GR[>U?:5'NXP6/Z>@%5]$^)OBO1;E9!JL][%NR\-ZYE5O;)
M^8?@17TGI&@Z9H6G)8Z?9Q0PJ@1L(,R8'5C_ !'KR?6OF7XC:7:Z/X_U>RLX
MUBMUD5TC085=Z*Y '8 L<"DP/0O%'QOWZ=;Q>'(O+NIH0T\TRY^SL>J*",,1
MSR1CZ]O-&\<^*WG$Q\1:GN!R +EPO7/W0<?I7?\ P2\*V&IO?:U?VZ7#6SK#
M;I( 55B,LQ'<X*X].?;':?&/1;74/ MS?O"IN[%D>*3'S %U5AGTP<X]A3U
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M=3K%OQG:"<%L=\#G\*^L="\/:7X;TZ*QTRU2&-!@O@;Y#W9F[DX'Y#L!4J[
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M"%?8]*(V<5\6_P#DF.L?]L?_ $<E?/7A!0WC7058 J=1MP0>A_>+7T+\6_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M +=%%%9E!1110 4444 %%%% !1110 4444 57^^WUI*5_OM]:2K)"BBBF 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"^FCU")BYD#1X0ANJX).1U_PKIZ*+#/$M=^!$SW<DN@ZE L#-E8+O<-G/0,
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !5>]L+/4K<V]_:074!()CGC#KD=#@C
M%6** ,FV\+^'[.X2XM="TR">,Y22*TC5E/J"!D5K444@"BBBF 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M*GWU^M)2I]]?K2 M4445!04444 %%%% !1110 4444 %%%% !1110!7E_P!8
M:93Y?]8:95HD****8!1110 4444 %%%% !1110 4444 %%%% !1169KOB'2_
M#5@M[J]T+:W:01*^QGRQ!(&%!/0'\J0&G17%?\+;\#_]!O\ \E)O_B*OZ/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ I4^^OUI*5/OK]:0%JBBBH*"BBB@ HHHH
M**** "BBB@ HHHH **** *\O^L-,I\O^L-,JT2%%%%, HHHH **** "BBB@
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MR#G !/X5Y_\ &Y GB;P[.N1(59<CV=2/YFM+X]NPT#24S\INF)'N%_\ KF@
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M"T=OQ'(_45SGP1)/@%@22!>R >W"T^H'I%%%%,04444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!;
MHHHK,H**** "BBB@ HHHH **** "BBB@"J_WV^M)2O\ ?;ZTE62%%%%, HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *5/OK]:2E3[Z_6D!:HHHJ"@HHHH **** "
MBBB@ HHHH **** "BBB@"O+_ *PTRGR_ZPTRK1(4444P"BBB@ HHHH ****
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MHHH **** *K_ 'V^M)2O]]OK259(4444P"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ I4^^OUI*5/OK]:0%JBBBH*"BBB@ HHHH **** "BBB@ HHHH **** *\O
M^L-,I\O^L-,JT2%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#SS5_^2XZ!_UX-_Z#/7H=
M>>:O_P EQT#_ *\&_P#09Z]#I(84444Q!1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% %NBBBLR@HHHH **** "BBB@
MHHHH **** *K_?;ZTE*_WV^M)5DA1113 **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "E3[Z_6DI4^^OUI 6J***@H**** "BBB@ HHHH **** "BBB@ HHHH KR_
MZPTRGR_ZPTRK1(4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** //-7_ .2XZ!_UX-_Z#/7H
M=>>:O_R7'0/^O!O_ $&>O0Z2&%%%%,04444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4J??7ZTE*GWU^M("U1114%!1110 4444 %%%% !1110 4444 %%%
M% %>7_6&F4^7_6&F5:)"BBBF 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YYJ_P#R7'0/^O!O
M_09Z]#KSS5_^2XZ!_P!>#?\ H,]>ATD,****8@HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZPTRK1(4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** //-7_P"2XZ!_UX-_Z#/7H=>>:O\
M\EQT#_KP;_T&>O0Z2&%%%%,04444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:]LBQ^5YOE_>[YP?Y5=\.:Q_PD'AVQU;R/(^U1^9Y6_=M]LX&?RI :E%%%,
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44A8*,L0!ZFLF]\3:
M599#7(E<?P0_,?SZ?K3C%RV0FTMS7HKB+OQU*P*V=HJ<\-*<_H*P+S6M1OS_
M *1=R,O]Q3M7\AQ71'"S>^AFZT5L>C7>N:999\Z\B##^%3N/Y"N?O/'2 [;*
MT+?[<QQ^@_QKBJ*Z(X6"WU,G6D]C6N_$NJWF0UTT:G^&+Y/U'-9)))R3DFBB
MMU%1V1FVWN%%%%,04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 7=(_P"0U8?]?$?_ *$*]8KR?2/^0U8?]?$?_H0KUBN'%_$CIH;,
M****Y#8**** +=%%%9E!1110 4444 %%%% !1110 4444 57^^WUI*5_OM]:
M2K)"BBBF 4444 %%%% !1110!YY\;9[F#X6ZC]G+@221)*RYX0N,Y/8$X'XX
M[U!K5GI]A^S]/!I@3[)_9*,K(!\Y(!+''4DDDGU-=YK.DVFO:-=Z5?(7MKJ,
MQR =0#W'H0>1[BO!]6\&?$_PWHM]X:TQQK'AVX4QH%*%D0G. K$,I]0,K4L9
MZM\-TBE^%>AQW"(\+60619 "I4YR"#QC%<G\ I = UV*WD9]/CU-OLV[T*CU
MYZ;>O^-<EI_ASXM:YX<M_"KPII.C0Q>3(\I6,R)G.&(RY[]  1P:]L\(>%;'
MP;X<@T>PRRH2\LS !II#U8X^@ ]  .U" W:***H04444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5R7Q,_Y)[JG_ &R_
M]&I76UR7Q,_Y)[JG_;+_ -&I28&3\&_^10N_^O\ ?_T7'7H=>>?!O_D4+O\
MZ_W_ /1<=>AT+884444Q!1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MYKI]2OXM*TJ\U&=7:&U@>=U0 L552QQG'.!7BWQ,D\"ZGHAU#0KRPCU>"16
MM5V&92<$$  $C.<]>*['3=:G\0? Z]O[IR]R=+NHY6/5F177)]R #^-%P+47
MQ7\,MX>&LRR7%O&TK11V\B+YTA7&<*K$8^8<DBJ^D?&/PKJU\EH6N[)Y&"H]
MW&JH2?=6;'U.!7%?!;PCIFK17NM:E:+=&"400),H:,':"QP>I&1UZ9]>FO\
M&WP]IL/ANTU6VLX(+J.Y6$O&NW=&RL<$#KR!].?6E=@=EXH^(OA_PE<BTOYI
M9;LKN,%L@=E';.2 ,^F<\^E)X7^(_A[Q9<BUL9IHKP@D6]Q'M<@=<$$@\#/6
MLKX9^$M-B\*VFKWUK%>:GJ"^?+<7*B5L$G: 3G'&,^IZ]L<5X]TNUT#XN:!<
M:7&MJ;B2&5UB&T;_ #2"<>XZCZ^M 'JWC35M&T7P\]YKNG_;K$2*IA\E)<L>
MAVN0*N^'+VPU'P[8WFEVWV6QECW0P^6J;%]-J\#\*Y'XT_\ )/)?^OF+^9J[
MX26[?X06:V#;;PZ:X@.2,28;;T]\4^H#=>^*_A70;E[5[F:\N(V*R1VD>[81
MU!8D+^1[4S1?BYX3UFY2W^TS6,LAPHO(P@)_W@2H_$BO-/A=KGA#0Q=6_B.V
M2+46FVI/<6^]53 &WH2IR#GCN/2N_P!=\%>$?B%;QS:/>V,%Q$_[RXL51BRX
MQM=01_LX)Y'XTK@>BLP52S$!0,DGH*X#5?C)X2TR?R8YKJ_(X9K2(%0?JQ4'
M\,UH>,-.O[7X5W^G6,\US=0V2Q&5\EY47 ?..I*!OKFO/?A?XD\#:=HD=EJL
M5O;ZHSMYL]S &609)7#X.T 8&#CD4[@>A>'OB=X8\274=I;7;V]W)]R"Z386
M/H#DJ3[9S5_QIJVC:+X>>\UW3_MUB)%4P^2DN6/0[7(%<OJ_PZ\-^,KNUUC0
M=2@LF0YDETT*PD;.0WRD!6!SSU]>E3?&<$?#J0$EB+B+D]3R: .O\.7MAJ/A
MVQO-+MOLMC+'NAA\M4V+Z;5X'X5E^)?B!X>\*2B#4+LO=<$V\"[W4'H2.@_$
M]Q6=X7U1=%^#EGJ; '[+I[2@'HS#.!^)P/QKB_A)X3M?$1OO%.O(M_,]P4B6
M?YAOX9G8=">0!Z8/'2@#I[#XU^$[VY6&07]F&( DN(5VC/J59L5Z%;W$-W;Q
MW%O-'-#(H9)(V#*P/<$<$5@:_P"!] \0Z;+:W&G6T4C*1'<11*LD1[$$>_;H
M:X'X):G=6]QK/AFZ<L+1_-C'.$(;:X&>V=IQQW]: .QMOB7X?FU75["=I[0Z
M47%Q/<*HC)5]GRX8DY/08K%/QP\*"X$?DZD4)_UOD+M'_CV?TK@="\,VOBGX
MT:Y:7RL]I!>75Q*@;&\++@ ^Q+#..U>W7GA'P]?:<UA-HUB+<J5"I J%.,94
M@?*>>HI:@6]'UK3]?TV/4-,N4N+=_P")>JGN".H/L:OUXG\"9Y(=2U[3C*[1
M*$<+_#N!92<=B>/R]A7ME-""O'?#DI\=?&2_U>0>9I^C*4MN"5R"50^V3O?\
M*])\6Z@VE>$-7OHW9)8;20QLO4/M(4_F17#? FS2+PA>W>!YD]Z5)_V51<?J
M6_.@9W'C'_D2-?\ ^P;<?^BVKYHM].FL_"%EXHM-RS6VK/"S@_=(2-XSZ]0_
MZ5]+^,?^1(U__L&W'_HMJ\H\!:)_PD/P4\0:>J;IFO))(0%R?,6.)E ^I&/Q
MI,#V72-2BUC1[/4H,>5=0K*H!SC(SCZCI^%<;\8-=;1O TT$+E9]0<6P('\!
M!+_@5!7_ (%5#X(ZV=0\(3:9(Q,NG387VC?++^N_\A6?XH_XJWXU:/HB_/::
M2HFGQV;AVS['$:\>I_!] .3\/:)_PCOQ@T'3&&)8HHVE_P"NC0EF_4D?05Z/
M\:?^2>2_]?,7\S7+:G_R<A:?\ _]$&NI^-/_ "3R7_KYB_F:0%WX2?\ ),='
M_P"VW_HYZ[1E#*58 J1@@]#7@/@_Q9X^TSPK96>B>&XKS3H]_E3M:RN7R[%N
M5< X8D=.U2:C\7?'-C/]BO=(L-/N'X7SK:2,CGJ-[XQ[GBBX%?XIZ?:^&?B)
MIM]HJ)!<2JETT,?R@2!R P[#=C]">]>M_$;_ ))YK?\ U['^8KB/"OPXUC5O
M$B^*?&-Q%++N$L=NK+('( VDE<KM'8#T_/M_B-_R3S6_^O8_S% ',? G_D2+
MW_L)/_Z+BKTR6*.:-HY462-A@JPR#^%>9_ G_D2+W_L)/_Z+BKT^FM@/!/B=
MX<3P-XCTSQ+X>3[*DDI8QIPD4JX. !_"PS\O3@CH<5ZXVK:GJG@N#5?#\%N^
MH7,$4T,5UD)\Q4L&P0> 6[]17)_'((? D!;&1?QE>>^Q_P"F:W_AF7/PYT4O
MG/DD<C'&]L?IBEU \[\477CQ_%WA5M2L-'2_6:7[ D+-L=L)NWY8\?=Q@CO7
MI/AFX\:37DP\2V>E06PC_=FS+%B^1URQXQFIM=\+_P!M^(= U;[9Y/\ 9,DD
MGE>5N\W=MXSD;<;?0]:Z&G8#S#XPZ7+;V>G>+K ^7?:5,H9P,%HV88R1S@-Q
MC_;:N]\/ZS#X@T"RU6W_ -7<QAL?W6Z,/P((_"J/CFR74/ NMV[(&_T.1U!&
M?F4;E_517)? Z]:X\$3VS?\ +M>.J_[K*K?S+4=0/3:***8@HHHH **** "B
MBB@ HHHH **** "E3[Z_6DI4^^OUI 6J***@H**** "BBB@ HHHH **** "B
MBB@ HHHH KR_ZPTRGR_ZPTRK1(4444P"BBB@ HHHH **** "O,/'?C_58M='
MA3PE;M/JQ'[Z4)NV97.%SQD @ECP/SQZ?7D?PBACN_%?B_59=K79N=F0!P'=
MV;\"5'Y4F,],T(7ZZ#8+JBA;]8$6X ??EP,$Y[YZ_C7+?$2R\9SI8W?A.[\O
M[+O>:%' >4\8^4C:P&#P?7H:[FB@1P/PZ^(;>*O/TO4[<6NLVB_O$P0)0#@D
M*?ND' *^_'<#OJ\D\16\>F_'WP_<62JDMY"#<*O\6?,0L1_N@?\ ?.:];H0P
MHHHIB"BLOQ#X@L/#&C3:IJ+LL$6 %0 N['HJC(R3_B>@J+PQXEL_%FC+JEA%
M/' SL@6=0&R.O0D?K2 V:*BN;F"RM9;FYE2&")2\DCG"J!U)->>W7QN\)6]S
MY42ZA<I_SVB@ 7_QYE;]* /1Z*R?#_B;2/%%B;O2;M9T4@2+@J\9]&4\C^1Q
MQFM:@ HKAM=^+7A;0;V2S>:XO+B)]DBVD88(>^68@'\":T/#'Q"\/>+)?L]A
M<O'=X+?9KA=CD>HY(/X$]*+@=3117(>)?B9X;\+73V=W<2SWB8+V]M'O9<^I
M)"@]\9S^E '7T5QGASXH^&?$MXEG;SS6MW(<1PW:!"Y] 02N?;.379T %%%%
M, HHHH \\U?_ )+CH'_7@W_H,]>AUYYJ_P#R7'0/^O!O_09Z]#I(84444Q!1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?&6_MYG\G2;Z!Y%9Q@*I!<8^C*R _G6Q\';6;5+S7_%UVI\Z^N#''NYP,[V
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MBBH*"BBB@ HHHH **** "BBB@ HHHH **** *\O^L-,I\O\ K#3*M$A1113
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M <;XYU:]^(,FK7]D[1^']#0;&(.)W+!=V/4Y)'HH]37H7P6_Y)Y%_P!?,O\
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MIG\J2<;]J@E6//4EMV3[?6LO6"1^SGI@!(!D4'W_ 'K5Z+\-(EA^'.B*@P#
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *X/X@>$;_4KK3O$7AU$&NZ=
M("JE@@G3/W2<CIZ$@$%AZ5WE%("&TEEGM(99[=K:5T!>%F#&,]QE20<>HJ:B
MBF 4444 %%%% !1110 4444 %%%% !1110 4444 >?1^&-5U_P")C:]KEHL&
MF:: NFP-(K,[ Y#G:3CG+<\_=]#7H-%%( HHHI@%%%% !1110 4444 %%%%
M!1110 4J??7ZTE*GWU^M("U1114%!1110 4444 %%%% !1110 4444 %%%%
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M\:QPQ($C11@*H& ![ 4 24444Q!1110!YYJ__)<= _Z\&_\ 09Z]#KSS5_\
MDN.@?]>#?^@SUZ'20PHHHIB"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJA>ZS
MIVGY%S=QJXZH#N;\AS32;T0-I;E^BN/O/'2 [;*T+?[<QQ^@_P :YZ\\1:K>
MGY[MT7^[%\@_2MXX:;WT,G5BMCT6[U6PL!_I-U'&<9VYR?R'-<_>^.+=,K96
MSRGIOD.T?7'4_I7#$DG).2:*Z(X6"WU,W6D]C8O/$^JWA(-R8D/\$(VC\^OZ
MUD$ECEB2?4TE%=$8J.R,FV]PHHHIB"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "N>N?'/ARTNIK:?4=DT+F-U\
MB0X8'!&0OK70U\]>(_\ D:-6_P"OV;_T,UT8>C&JVI >O_\ "P?"_P#T%/\
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MP?"__04_\EY?_B:\-HH^I4^[ ]R_X6#X7_Z"G_DO+_\ $T?\+!\+_P#04_\
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MP/<O^%@^%_\ H*?^2\O_ ,31_P +!\+_ /04_P#)>7_XFO#:*/J5/NP/<O\
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M^M9?_"P?"_\ T%/_ "7E_P#B:Y[XM?\ 'KI?^_)_):\NKNH86%2"DVP/<O\
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M<=!SWK!_X6#X7_Z"G_DO+_\ $U+XZ_Y$O4O]Q?\ T-:\(KKP^'C5BVP/<O\
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M/IT'<YKT:O+_  ]\9K;7_$%EI2Z++"UU)Y8D-P&V\>FT5ZA30!1113$%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!YYJ_\ R7'0/^O!O_09Z]#K
MSS5_^2XZ!_UX-_Z#/7H=)#"BBBF(**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MO_\ %T?\+1UO_GUT_P#[]O\ _%T?4ZH>W@>MT5Y)_P +1UO_ )]=/_[]O_\
M%T?\+1UO_GUT_P#[]O\ _%T?4ZH>W@>MT5Y)_P +1UO_ )]=/_[]O_\ %T?\
M+1UO_GUT_P#[]O\ _%T?4ZH>W@>MT5Y)_P +1UO_ )]=/_[]O_\ %T?\+1UO
M_GUT_P#[]O\ _%T?4ZH>W@>MT5Y)_P +1UO_ )]=/_[]O_\ %T?\+1UO_GUT
M_P#[]O\ _%T?4ZH>W@>MT5Y)_P +1UO_ )]=/_[]O_\ %T?\+1UO_GUT_P#[
M]O\ _%T?4ZH>W@>MT5Y)_P +1UO_ )]=/_[]O_\ %T?\+1UO_GUT_P#[]O\
M_%T?4ZH>W@>MT5Y)_P +1UO_ )]=/_[]O_\ %T?\+1UO_GUT_P#[]O\ _%T?
M4ZH>W@>MT5Y)_P +1UO_ )]=/_[]O_\ %T?\+1UO_GUT_P#[]O\ _%T?4ZH>
MW@>MT5Y)_P +1UO_ )]=/_[]O_\ %T?\+1UO_GUT_P#[]O\ _%T?4ZH>W@>M
MT5Y)_P +1UO_ )]=/_[]O_\ %T?\+1UO_GUT_P#[]O\ _%T?4ZH>W@>MT5Y)
M_P +1UO_ )]=/_[]O_\ %T?\+1UO_GUT_P#[]O\ _%T?4ZH>W@>MT5Y)_P +
M1UO_ )]=/_[]O_\ %U7;XH:_N.([(#/01-_\51]3JEPJ1GL>QT5XW_PM#7_[
MEE_WZ/\ \51_PM#7_P"Y9?\ ?H__ !5'U.H6>R5QOCSQ1J'AO^S_ +"L)^T>
M9O\ -0M]W;C'(_O&N-_X6AK_ /<LO^_1_P#BJQ?$'BC4/$GV?[<L(^S[MGE(
M5^]C.>3_ '16E+"24TY[ ;7_  M#7_[EE_WZ/_Q5'_"T-?\ [EE_WZ/_ ,57
M& 9.*=Y9]179]7I_RDRG&.C9V/\ PM#7_P"Y9?\ ?H__ !59^H>.M?U"5'^V
MM;;5QMMB4!]SSUKGO+/J*/+/J*:H06JB3[6'<]!^'FN:IJ/B5H;S4+B>(6[M
MLDD)&<CFO5*^?M UFZ\/:B;VU2%Y#&8\2@D8./0CTKIO^%HZW_SZZ?\ ]^W_
M /BZY*^%G.=XK03KP1ZW17DG_"T=;_Y]=/\ ^_;_ /Q='_"T=;_Y]=/_ ._;
M_P#Q=8_4ZHO;P/6Z*\D_X6CK?_/KI_\ W[?_ .+H_P"%HZW_ ,^NG_\ ?M__
M (NCZG5#V\#UNBO)/^%HZW_SZZ?_ -^W_P#BZ/\ A:.M_P#/KI__ '[?_P"+
MH^IU0]O ];HKR3_A:.M_\^NG_P#?M_\ XNC_ (6CK?\ SZZ?_P!^W_\ BZ/J
M=4/;P/6Z*\D_X6CK?_/KI_\ W[?_ .+H_P"%HZW_ ,^NG_\ ?M__ (NCZG5#
MV\#UNBO)/^%HZW_SZZ?_ -^W_P#BZ/\ A:.M_P#/KI__ '[?_P"+H^IU0]O
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M_P#?M_\ XNC_ (6CK?\ SZZ?_P!^W_\ BZ/J=4/;P/6Z*\D_X6CK?_/KI_\
MW[?_ .+H_P"%HZW_ ,^NG_\ ?M__ (NCZG5#V\#UNBO)/^%HZW_SZZ?_ -^W
M_P#BZ/\ A:.M_P#/KI__ '[?_P"+H^IU0]O ];HKR3_A:.M_\^NG_P#?M_\
MXNC_ (6CK?\ SZZ?_P!^W_\ BZ/J=4/;P/6Z*\D_X6CK?_/KI_\ W[?_ .+H
M_P"%HZW_ ,^NG_\ ?M__ (NCZG5#V\#UNBO)/^%HZW_SZZ?_ -^W_P#BZ/\
MA:.M_P#/KI__ '[?_P"+H^IU0]O ];HKR3_A:.M_\^NG_P#?M_\ XNC_ (6C
MK?\ SZZ?_P!^W_\ BZ/J=4/;P/6Z*\D_X6CK?_/KI_\ W[?_ .+H_P"%HZW_
M ,^NG_\ ?M__ (NCZG5#V\#UNBO)/^%HZW_SZZ?_ -^W_P#BZ/\ A:.M_P#/
MKI__ '[?_P"+H^IU0]O ];HKR3_A:.M_\^NG_P#?M_\ XNC_ (6CK?\ SZZ?
M_P!^W_\ BZ/J=4/;P/6Z*\D_X6CK?_/KI_\ W[?_ .+H_P"%HZW_ ,^NG_\
M?M__ (NCZG5#V\#UNBO)/^%HZW_SZZ?_ -^W_P#BZ/\ A:.M_P#/KI__ '[?
M_P"+H^IU0]O ];HKR3_A:.M_\^NG_P#?M_\ XNC_ (6CK?\ SZZ?_P!^W_\
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M_P#/KI__ '[?_P"+H^IU0]O ];HKR3_A:.M_\^NG_P#?M_\ XNC_ (6CK?\
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MV\#UNBO)/^%HZW_SZZ?_ -^W_P#BZ/\ A:.M_P#/KI__ '[?_P"+H^IU0]O
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M )#L_P#U[-_Z$M:4O]WE_78F?\5%[XB?\PW_ +:_^R5P]=Q\1/\ F&_]M?\
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MX(H W@X'J5!/ZYK3#U)\SA/H35C&RDC'HHHKK, HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** +ND?\AJP_Z^(_\ T(5ZQ7D^
MD?\ (:L/^OB/_P!"%>L5PXOXD=-#9A1117(;!1110!;HHHK,H**** "BBB@
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M/_\ $4?\*NUO_GZT_P#[^/\ _$5ZW11]<JA["!Y)_P *NUO_ )^M/_[^/_\
M$4?\*NUO_GZT_P#[^/\ _$5ZW11]<JA["!Y)_P *NUO_ )^M/_[^/_\ $4?\
M*NUO_GZT_P#[^/\ _$5ZW11]<JA["!Y)_P *NUO_ )^M/_[^/_\ $4?\*NUO
M_GZT_P#[^/\ _$5ZW11]<JA["!Y)_P *NUO_ )^M/_[^/_\ $4?\*NUO_GZT
M_P#[^/\ _$5ZW11]<JA["!Y)_P *NUO_ )^M/_[^/_\ $4?\*NUO_GZT_P#[
M^/\ _$5ZW11]<JA["!Y)_P *NUO_ )^M/_[^/_\ $4?\*NUO_GZT_P#[^/\
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M?K3_ /OX_P#\11_PJ[6_^?K3_P#OX_\ \17K=%'URJ'L('DG_"KM;_Y^M/\
M^_C_ /Q%'_"KM;_Y^M/_ ._C_P#Q%>MT4?7*H>P@>2?\*NUO_GZT_P#[^/\
M_$4?\*NUO_GZT_\ [^/_ /$5ZW11]<JA["!Y)_PJ[6_^?K3_ /OX_P#\11_P
MJ[6_^?K3_P#OX_\ \17K=%'URJ'L('DG_"KM;_Y^M/\ ^_C_ /Q%'_"KM;_Y
M^M/_ ._C_P#Q%>MT4?7*H>P@>2?\*NUO_GZT_P#[^/\ _$4?\*NUO_GZT_\
M[^/_ /$5ZW11]<JA["!Y)_PJ[6_^?K3_ /OX_P#\11_PJ[6_^?K3_P#OX_\
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M?K3_ /OX_P#\11_PJ[6_^?K3_P#OX_\ \17K=%'URJ'L('DG_"KM;_Y^M/\
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MZXS5O&4]QNAT]3!&>#(?OGZ>E:4Z4I[$RFH[G6:GK5EI4>;B7]X1E8EY9O\
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M44 %%%% !1110 4444 %%%% %W2/^0U8?]?$?_H0KUBO)](_Y#5A_P!?$?\
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M"4#*3G'7H/>J'_"<^&O^@K'_ -\/_A7'_%K_ (^M+_W)/YK7G%=U'"PG!2;
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BJ-SK.FV>?/O85(ZJ&RWY#FL2^\;6D2$643S2=BXVJ/ZFKC2G+9
M$N<5NSI9IXK>(RS2+'&O5F. *Y+5O&@4F+3$W'H9G''_  $?X_E7+7^IW>IS
M>9=3%R.B] OT%5*[*>%2UEJ82K-[$US=3WD[37$K22-U9C4-%%=5K&(4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M *&*^A:^>O#G_(T:3_U^P_\ H8KZ%KS<=\2 ****X@"BBB@"W1116904444
M%%%% !1110 4444 %%%% %5_OM]:2E?[[?6DJR0HHHI@%%%% !1110 5YI\=
M_P#DF-Q_U\P_^A5Z77&_$[PQJ'B_P9)I.F&$7+S1N#,Y50%.3R :3 W/"W_(
MHZ+_ ->$'_HM:\JU;3[74OVF]/CNXEECCM%F",,C<L;%2?H<'Z@54MO!'QDL
M[6&V@\36R0PHL<:"Y/RJ!@#[GI5%OA?\4WU]-=;6[(ZHB;%N?M+;@N",?<]"
M:0SZ$HKP[_A$/C5_T-5O_P"!)_\ C=>@_#[2O%NEZ=>)XNU..^N'E!A9)"^U
M,<C[H[T[B.PHHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% '%_$CX?
M6_C[1(X!,MMJ%LQ>VN"FX<CE&[[3QTZ$ \]#P-O9?'+2[+^R8&MKF%5VI>M+
M"S*,=-S$,?J5)Y_+W*BE89YK\,?AB_A"2XUC6+E;S7+L?.^=PB!Y8!CRS$]6
M_P#KDZ/Q5TWQ3JGA>V@\(R72:@MZKR&VNQ;MY6QP<L67(R5XSZ>E=S1181A^
M#K;5+/P?I=OK;2MJ<< %P99?-<O[MDY^N37">/OA3>:GX@'BOPGJ'V#6P0SQ
MDE5D8#&X,/NG'!&"&]N<^KT46 \,O-.^-_B&Q;2+TVEG;2CRIK@20J9%/!)*
M98 ]]H'7&,<5Z-\/? MKX#T V,<WVB[G?S+FXVXWMC  '91V^I/>NMHHL 44
M44P"N2^)G_)/=4_[9?\ HU*ZVN2^)G_)/=4_[9?^C4I,#)^#?_(H7?\ U_O_
M .BXZ]#KSSX-_P#(H7?_ %_O_P"BXZ]#H6PPHHHIB"BBB@ HHHH **** "BB
MB@ HHHH **** "JNI.T>E7CHQ5E@<A@<$':>:M54U7_D#WO_ %[R?^@FG'="
M>QXA_P )5KW_ $%[O_OZ:/\ A*M>_P"@O=_]_3617H^B_#K3]3T6TO9+RY1Y
MXPY5=N 3^%>S4=*FKR7X'#%3EHF<?_PE6O?]!>[_ ._IH_X2K7B/^0M=_P#?
MPUWW_"K-,_Y_[O\ \=_PH_X59IG_ #_W?_CO^%9?6,/V_ OV54\JKV[P'_R)
M>G?23_T8U8W_  JS3/\ G_N__'?\*Z[1M+CT728-/AD>2.'.&?&3EB>WUK#%
M5X5()1[FE&G*,KLO4445PG0%%%% !1110!6U+_D%W?\ UQ?_ -!-?.%?0'BN
M]DT[POJ%U"J,ZQX <$CDA3T]C7S_ %Z.!7NM@>^>#?\ D3]+_P"N(_F:W*P_
M!O\ R)^E_P#7$?S-;E<%3XWZ@%%%%2 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"N2^)G_)/=4_[9?^C4KK:Y+XF?\ )/=4_P"V7_HU*3 R?@W_ ,BA=_\ 7^__
M *+CKT.O//@W_P BA=_]?[_^BXZ]#H6PPHHHIB"BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\\$5Z)10(\GL_@=:O>K/K7B"\U%5QA!'Y9(!S@L68X^F.]>H6%A:Z98PV5E
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-_X#?_957M<+Y?=_P!<E;^F<?>^+M=U&SDM+N_,D$@PZ>6@SSGL/:L2O2_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "E3[Z_6DI4^^OUI 6J***@H**** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG(]U 4_F*IT4[(I0BN@^2:68YED=R.[,33***904444 %%%% !1110 4444
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M$$8_"MBZM;>^M);6ZA2:WF0I)'(N5=3U!%>,W7P9\2:%?R3^!_%;V5O))O\
MLT\LD848[E0P?H.JCCUQRAGLM[=6UE8SW5[*D5K#&SRO)]U5 Y)_"O*O@ I?
MPYK=U%%Y-E-J3&"/^Z-JY'X J/P-9A^$GCCQ))#%XO\ &'FZ>'WO!!*\AR!Q
M@%54'MG!Q[YKU_0]%LO#NB6FDZ=&8[6U38@)R3SDD^Y))/N: -"BBBF(****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(.BJ, 55?$JK'EL ZBBBN4 HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'OQETG3]-D,]E8%1+*G*G8Q>1@P[8PH/3(XZ\]E\8]'EU7P%++ A>2PF6Z(
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M-B6# 9YP21[8%>F5YOXA^#NDZKJC:EIE]/I-R[%W$2[TW'G<!D%3SV./0"F
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BF2S101F2:1(T'5G8
M #\37/ZAXRL+4LELK7,@Z%>$S]?\!51A*7PH3DEN='6=?Z[IVFDK<7 \P#_5
MH-S?IT_&N"U#Q+J>HAD>;RHC_P LXAM'XGJ:R*ZH83^9F,JW8ZG4/&UU,&2R
MB6!3T=OF;'\A^M<W<7,]U)YEQ-)*_J[$G]:BHKJA3C#X48RDY;A1115DA111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 444A(52Q(  R2>PH 6CJ:S[K5[>#*QGSG]%/ _'_"L:YU"XN\AWPA_
M@7@?_7_&J46S6-*3W-VZU2VM<C=YD@_@0_S/:L:XU6ZG)VOY2?W4X_7K5&BJ
M44C>-.,0HHHJBPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#3\.?\ (T:3_P!?L/\ Z&*^
MA:^>O#G_ "-&D_\ 7[#_ .ABOH6O-QWQ( HHHKB **** +=%%%9E!1110 44
M44 %%%% !1110 4444 57^^WUI*5_OM]:2K)"BBBF 4444 %%%% !1110 44
MC,%4LQ 4#))[5Y!K_P"T#HNGWLEKHVEW&K&-B&F\T0QL ,DJ<,2![@=STZH#
MV"BO/M1^*MGI'@W0/$E]ITBPZJX5HHI0S0@@DD9 W8Q[=:[72M4L];TJVU/3
MYA-:7*!XW QD?0]#VQ0!<HHHI@%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %<E\3/^2>ZI_VR_P#1J5UM<E\3/^2>
MZI_VR_\ 1J4F!D_!O_D4+O\ Z_W_ /1<=>AUYY\&_P#D4+O_ *_W_P#1<=>A
MT+884444Q!1110 4444 %%%% !1110!RWQ#_ .1.NO\ ?C_]"%>.6W_'U#_O
MK_.O8_B'_P B==?[\?\ Z$*\<MO^/J'_ 'U_G7JX+^$_4XZ_QGT91117E'8%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M00..5/&:+@>NT4450@HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M//-7_P"2XZ!_UX-_Z#/7H=>>:O\ \EQT#_KP;_T&>O0Z2&%%%%,04444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MVB0P>1+?%'1L9[.V%0X/N>XQ7LOP^\&0^!O"T6EK(LUR[F:ZF7.'D( XSV
M ^F>I-" ZJBBBJ$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %<E\3/^2>ZI_VR_\ 1J5UM<E\3/\ DGNJ?]LO_1J4
MF!D_!O\ Y%"[_P"O]_\ T7'7H=>>?!O_ )%"[_Z_W_\ 1<=>AT+884444Q!1
M110 4444 %%%% !1110!RWQ#_P"1.NO]^/\ ]"%>.6W_ !]0_P"^O\Z]C^(?
M_(G77^_'_P"A"O'+;_CZA_WU_G7JX+^$_4XZ_P 9]&4445Y1V!1110 4444
M>=^-_&.K:%KRV=BT*Q&!7.^/<<DG_"IO GBS5?$&JW-O?O$8XX-ZA(PO.X#^
MM<S\4/\ D;$_Z]4_FU6OA1_R'KW_ *]?_9EKT'3A]7YK:V ]:HHHKSP"BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "E3[Z_6DI4^^OUI 6J***
M@H**** "BBB@ HHHH **** "BBB@ HHHH KR_P"L-,I\O^L-,JT2%%%%, HH
MHH **** "BBB@ HHHH \3T;Q!_PK#QQKFEZY!(NG7\QN(+B-20!DD''4@@X/
M7!7ZFN_;XG>#%@$QUZ#:1G 1RW3/W0N?TJQXSO\ PK9:4/\ A*1:R09S'%+'
MYCLW^PO7/;(_$UY5;ZC\&UNF)TB^"YX,AE9!VZ;R??FIV&:NF:LWQ%^*UGJU
MI;2Q:-HL;'SW &XX.">PR2..N%/3LZ'68?B!\8M*N=)65]-TF)F>X*$!NIS@
MC(!8J.>>IKTCP]<>'M3T!8]!>UDTW;Y9C@&T*".0R]0<>O-7=+T73-$MS!IE
MA;VD;'+"&,+N/J3W/UIV O4444Q!1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 >>:O\ \EQT#_KP;_T&>O0Z\\U?_DN.@?\ 7@W_ *#/7H=)#"BB
MBF(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBF2RQPQF2618T'5F. /QH
M?17.:AXRL+4LELK7,@Z%>$S]?\!7*ZAXGU+4!L:40Q_W(<KGZGK6\,/.7D9R
MJQ1WE_KNG::2MQ<#S /]6@W-^G3\:Y74/&US,I2RA$ _YZ,=S?ET'ZURI))R
M3DFBNJ&&A'?4QE5D]B:YN[B\E\RYF>5_5SFH:**Z$K&04444 %%%% !1110
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M/P?+$T%FCO=6K%29N0<;6'(P#T(/)QS6K\/O&</CGPM%JBQK#<HYANH5SA)
M >,]B""/KCJ#6OKGB#2_#FFRW^JWD5O"BE@'8!GQV4?Q'V'K7G?P%M9AX7U7
M43"8;6^U%WMH]NU=H !*CIC.5X_NFCJ!ZO1113$%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<E\3/^2>ZI_VR_\
M1J5UM<E\3/\ DGNJ?]LO_1J4F!D_!O\ Y%"[_P"O]_\ T7'7H=>>?!O_ )%"
M[_Z_W_\ 1<=>AT+884444Q!1110 4444 %%%% !7,^/SCP9?8]8__0UKIJYG
MX@?\B7??6/\ ]&+6E'^)'U1-3X6>*EB>I-26W_'U#_OK_.HT&74'H37MB^ O
M#:.&73R"#D'SY/\ XJO7K5XTK<W4XJ=-SV.DHHHKQ#O"BBJ]]<&ST^YN0H8P
MQ-(%)QG )Q0M0+%%>7?\+:G_ .@1'_W_ #_\31_PMJ?_ *!$?_?\_P#Q-='U
M6KV S/BA_P C8G_7JG\VJU\*/^0]>_\ 7K_[,M<SXEU]_$>JB^>W6 B,1[ V
M[H3SG\:Z;X4?\AZ]_P"O7_V9:[)Q<</9]@/6J***\L HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ I4^^OUI*5/OK]:0%JBBBH*"BBB@ HHHH
M**** "BBB@ HHHH **** *\O^L-,I\O^L-,JT2%%%%, HHHH **** "BBB@
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M_P#R7'0/^O!O_09Z]#KSS5_^2XZ!_P!>#?\ H,]>ATD,****8@HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BD9E12S,%4=23@"L+4/%NFV+&-&:YD':+&T'W/^&:J,)2=D
MA.26YO52OM7L-- ^U7"HQZ+U8_@.:X6_\6ZE>@I&XMH\](LAO^^O\,5A,S.Q
M9F+,>I)R373#"/[3,95ET.OU#QP[!DL+?9Z2RG)_[Y_^N:YB]U&[U"3?=SO*
M1TST'T X%5J*ZX4H0V1C*<I;A1115DA1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 44A(52S$!0,DGH*J3ZI:
M09_>AV](^?UZ4QJ+>Q<HK#GUV0Y$$2I_M.=Q^OI_.LZ>ZGN3^^E9AG.,\ _3
MI346:JBWN=#-J=I!UE#GCB/YOUZ?K5&;7FZ00@>[G/Z"L:BJY4:JE%%B>^N;
MD$2S,5/\(X7\AQ5>BBF:6L%%%%, HHHH **** "BBB@ HHHH **** "BBB@
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M/^S\S##=0HHHKSSI"J.M?\@'4?\ KUD_]!-7JHZU_P @'4?^O63_ -!-..Z
M^=:Z2S\":_?V<-W;VL;0S('0F91D'VS7-U] >%/^13TK_KU3^5>KB:LJ:3B!
MY5_PKGQ+_P ^<?\ W_3_ !KK/ /A75M!U6YN-0@2..2#8I$BMD[@>Q]J]!HK
MAGBISBXL HHHKG **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MM6OM2(^U7#.HZ+T4?@.*I445TI)*R,V[[A1110(**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***CFN(;90TTBH#TS
MU/X=:!I7V)**R)]=521;Q;O1GX'Y#_&LNXOKBY)\R5MI_@'"_E5*+-(T9/<W
MI]4M(,#S/,)[1\_KTK.GUR=^(8UB'')^8_X?I6515**-HTHHDEGEG.99&<CI
MN.<?3TJ.BBJ- HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH T_#G_(T:3_ -?L/_H8KZ%KYZ\.?\C1I/\ U^P_^ABOH6O-QWQ( HHHKB *
M*** +=%%%9E!1110 4444 %%%% !1110 4444 57^^WUI*5_OM]:2K)"BBBF
M 4444 %%%% !1110!Q?Q6L++4_A[J%K?7\%B&*&*><X02!LJ"<' .,9]ZY;P
M7\:_#1\/6-EKUV]CJ-M$L$K-$SQRE?EWJR C!'/. #GM@GTW6=$TWQ#IS:?J
MMHEU:LP8QL2!D<@\$&O-==T;X,>&K@V^JP:?#<*0K0I)-*Z'&?F5"2O'J/2D
M,Z;_ (6WX$_Z&*W_ ._<G_Q-;V@^)]&\3V\MQHM_'>10OLD9%8;3C..0*X5O
M"GPD32].U.2PLHK+46"6LTKS(LA.<#YB-O0]<5W'A_PSHGAJWECT.RCM89R'
M<([,&..#R3VH$;%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **X
M[XB^/[3P%HBW#Q^??W.Y;.W.<,PQEF/91D9[G('N//TOOCCJ=HFLVT=M;POB
M1=/\J%&*YZ8<%AQV+ X]Z5QGN-%>;?#+XGOXQGN='U>S%EKEHI9T52JR*"%;
M@\JP)P5/^./2:!!1113 **\8^+_Q7O/#M_%H7ANZ2*_C(>[G\M7\O(RJ ,",
MD')/;CWKU#PK>W&I>#]$O[N3S+FYL()IGV@;G:-2QP.!R3TI7 UZ***8!7)?
M$S_DGNJ?]LO_ $:E=;7)?$S_ ))[JG_;+_T:E)@9/P;_ .10N_\ K_?_ -%Q
MUZ'7GGP;_P"10N_^O]__ $7'7H="V&%%%%,04444 %%%% !1110 5S/Q _Y$
MN^^L?_HQ:Z:N9^('_(EWWUC_ /1BUI1_B1]434^%GBR?ZQ?J*^CZ^<$_UB_4
M5]'UV8_[/S,,-U"BBBO/.D*\0\1>)];76M6LAJ4XMA<31",'C9N(Q^5>WUPM
M_P##*SO]1NKQM1G1KB9Y2H08!8DX_6NC#3A!MS \AKZ \*?\BGI7_7JG\JY7
M_A4]C_T$[C_OA:[C3;%--TRVL8W9U@C6,,W4X&,UIBJT*D4H@6J***XP"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWOP?\*:AX8\(.^K;UU'49S=2QO\ ?C!  #'J6X)/INQU!H0'H-%%%4(****
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M5/\ P:K_ /'*SM=T7Q[::-<3ZU+?MIZ[?-$NH"1>6 &5WG/S8[4KC.^^#?\
MR*%W_P!?[_\ HN.O0Z\\^#?_ "*%W_U_O_Z+CKT.FM@"BBBF(**** "BBB@
MHHHH *YGX@?\B7??6/\ ]&+735S/Q _Y$N^^L?\ Z,6M*/\ $CZHFI\+/%D_
MUB_45]'U\X)_K%^HKZ/KLQ_V?F88;J%%%(S*BEF8*!W)Q7GG2+147VF#_GM'
M_P!]"I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!YYJ__ "7'0/\
MKP;_ -!GKT.O/-7_ .2XZ!_UX-_Z#/7H=)#"BBBF(**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &G
MX<_Y&C2?^OV'_P!#%?0M?/7AS_D:-)_Z_8?_ $,5]"UYN.^) %%%%<0!1110
M!;HHHK,H**** "BBB@ HHHH **** "BBB@"J_P!]OK24K_?;ZTE62%%%%, H
MHHH **** "L_6=;TWP]IS:AJMVEK:JP4R,"1D\ < FM"L[6M"TSQ%IYL-6M5
MNK4L',;,0"1TZ$4@.<_X6WX$_P"ABM_^_<G_ ,36/J_C'X2Z^P?5KK2[R0#
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M#'MZ4 6)H]*\;^$GC29YM+U*# DC!1F0]QN&1^(KAO\ A0'@S_GIJG_@0O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!2I]]?K24J??7ZT@+5%%%04%%%% !1110 4444 %%%% !1110 4444 5Y?\
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M8@9VG'#9'(8=??.:]"U[6[7P[HEUJMX3Y-NF[:" 7/91GN3Q1<1I45XEI?\
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M[NXNL>=*6 Z#H/R%045221M&$8[!1113*"BBB@ HHHH **** "BBB@ HHHH
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MY;XJ?\C@/^O9/YM6\:\G6=/H@.(HHHKJ$%%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BL7Q;X@_X1;PQ
M>:S]E^U?9MG[GS-F[<ZKUP<?>ST[5YG'\>)I5W1^$Y'&<96])_\ :5*X'LU%
M>-M\=;E5+-X1E  R2;P\?^0JZ3PE\6M%\3Z@FG202Z?>2$B)96#)(>RAN/F/
MH1^.>*+H9Z!1113$%%%% !1110 4444 %%9?B/6/^$?\.WVK>1Y_V6/S/*W[
M=WMG!Q^54O!?BC_A+_#R:M]C^R;I&C\KS?,^[WS@?RI =#1113 **** "BBL
MOQ'K'_"/^';[5O(\_P"RQ^9Y6_;N]LX./RI :E%<]X+\4?\ "7^'DU;[']DW
M2-'Y7F^9]WOG _E70T %%%%, HHHH **** "BBL7Q5XEL_">@S:K>Y8*0D<2
MD!I7/11^I]@">U(#:HK/T._N=4T2TOKNS%G-<1B0VXE\S8#T^; YQ@].,XKR
M_3?CO#>ZI:VMQH/V:&:98WG^V;O+!.-V/+&<=:+@>P4444P"BO*Y?C1"/%AT
M6#1#+%]L%JMR;O&[Y]N[;L/'?&:] \1ZQ_PC_AV^U;R//^RQ^9Y6_;N]LX./
MRI7 U**\9C^/$TJ[H_"<CC.,K>D_^TJ<WQUN54LWA&4 #))O#Q_Y"HNAV/9*
M*\X\+_&/1?$&H0Z?=6TNG7,QVQF1P\1;LN[@@GMD?TKT"\N/LEC<7.W?Y,;2
M;<XS@9QF@1/17C$?QZEFSY7A1WQUVWI./_(=.;X\2Q8,WA26-"<%C>'^L=%T
M.Q[+17%^$_B?H'BNY6RB:6TOV^[;W  \S'7:PX/TX/M7:4""BBBF 45RT?C-
M8O',OAC4K'[&[H)+*Y\W<ET/0?*-K=>.>01GIGJ:0!1113 **** "BBB@ HH
MHH **** "BBB@ I4^^OUI*5/OK]:0%JBBBH*"BBB@ HHHH **** "BBB@ HH
MHH **** *\O^L-,I\O\ K#3*M$A1113 **** "BBB@ HHHH *\2U.#4?BI\0
M]0T<7S6NAZ260^7R"P.W./XF+ X)X 'Y^VUX[\*;B/2_'GBS1;H^7=33;HU?
M@MY;OG'KPX/T!/2DQG8>([I/A_\ #29;&61VM(5M[5IF!?<QV@D@ <9ST[5Q
M7P[^&.E:YX=&N>(EFO+B_+/&IE9=@W$;B002Q()Y)&".*M_&[4&NH]%\,VF)
M+N[N!,8QG=W1!]"6;_OFO4M-LETW2K.P1MR6T"0J<8R%4#IVZ4NH'D/A:*?X
M?_%M_#"7+2:3J*%XE=_ND@E&/'WLJ4[9R#V%>T5X[JTZZ[^T)I<-H58:;$$F
M<'(RH=S^KA?K7L5- %<Q!X#TBW\9OXJ5[HZ@Q8E6D!C!9=N0,9Z9'7O73TV6
M6.&)Y976.-%+.[' 4#J2>PH$*S!5+,0% R2>@KPS2;A?%7[0#ZEIJB2RMF+/
M,F""J1>7NSW!; 'L1Z5=\5>/-2\::HWA/P8A>*;Y)KP97>O\6#_"GJ>IZ#KS
MWW@;P59^"]'^SQE9KV7YKFYVX+GL!Z*.P^I[TMQGG'Q#5M9^-&@Z7("T"&W1
MD]07+,?R_E7N%>)^+"UK^T!HLLBX60VX0DXR"2F?SS^5>V4T!XC\7=VE?$/P
MYK%NH6;"'(XW&.3//X,!]*VOCM>/%X4L+520L]WE_<*IX_,@_A61\;29?$WA
MN! 2^&Q[Y=0/Y5H_'J-SX>TF4*=BW3*6[ E#@?H?RI=P.^\&62Z=X*T6U"[2
MMG&6'^T5#-^I-<I\;;-+CP&+@H"]M=1N&QR <J?YC\J[;P_*+CPWI<RXQ)9Q
M.,'/5 >M<C\97"?#F[4YR\T2C_OH'^E-[ <_K>L7#_L\6<K,1)-#%:EN^U7V
M_J$_6NH^$EDME\.--.W#W!DF?W)<@'_OD+7$ZS!+_P ,YZ<=APC([8[*96P?
M_'A^=>@_#.43?#G17&,"$IP<_==A_2D@$^)MFE[\.]81D#&.(3*2/NE6#9'X
M _G67\&;R2Z^'D$<AR+:XEA0_P"SG=_[,:W?B XC^'^NL<X-HZ\>XQ_6N<^"
M*,O@ DC :\D(]QA1_2GU ]'HHHIB"BBB@#SS5_\ DN.@?]>#?^@SUZ'7GFK_
M /)<= _Z\&_]!GKT.DAA1113$%%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !115"\UO3;#(N+N-6'\*_,WY"FDWH@;2W+]%<=
M>^.D&5L;0D]GF.!^0_QKGKWQ#JE]N66Z94/&R/Y1CTXZ_C6\<--[Z&3K16QZ
M+=ZOI]B&^T742LO5-V6_(<U@7OCBW3*V5L\IZ;Y#M'UQU/Z5PQ))R3DFBNB.
M%@M]3-UI/8U[WQ-JM[D-<F)#_!#\H_/K^M9!))R3DFBBNB,5'1(R;;W"BBBF
M(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***;)(D2AI'
M5%/0L< T .HK.EUJUCX0/*<9X&!^O^%9UQK-S*2(L0ITPO)_/_#%5RLT5*3-
MZ:XAME#32*@/3/4_AUK+N-=4$K;Q;O1WZ?E_]>L4DL2222>23252B;1HQ6Y/
M/=W%UCSI2P'0=!^0J"BBF:[!1113 **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *],
M^$6EE[N^U5U.V-1;QG(P2>6]\@!?^^J\SKZ$\%Z,VA^%K2UD0+<,#+-@ ?,W
M.#CJ0,#/M7)C)\M.W<:."^*NM/\ V[8V-O*5-DHF8JW21CD9'J  1_O5Z1!)
M;^)?#",P_<W]MAA_=W+@CZ@_RK!U3X;:3K&IW&H75YJ!FG;<VUT '8 ?)T P
M/PKH-#T6#0-*CTZVEGDAC+%3,P)&3DC@#C)/YUPU)TW3BH[H9\YW5M)9W<UK
M,,2PR-&X]"#@_P J]A^$G_(J77_7\_\ Z!'7)?%+2%L/$B7L2[8KV/>?^NB\
M-^A4_C76_"3_ )%2Z_Z_G_\ 0(ZZ\1/GPZD(WM$O_-\1^(K%GRT-Q'( 2<A6
MB4?EE?UKSBS\.NOQ=-DRL(HKHW8(& $'[Q?PSM6N@TS4?LWQEU2U+X2[C"8[
M%EC5A^@;\Z[--%@3Q-+K0 \Z2U6W_)LD_C\H_"N;G]DWYQ0%:]U+9XOTK35*
M'S()I7&?F7& IQZ'YOR]JYCXN_\ (!L/^OG_ -E-$=Z;SXTLF/EMK4PK[_+N
M/ZL:/B[_ ,@&P_Z^?_9312CRU8+R_P P#X1?\@&__P"OG_V45RWQ4_Y' ?\
M7LG\VKJ?A%_R ;__ *^?_917+?%3_D<!_P!>R?S:MZ?^]2#H<11117H""BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCR68Y)KU3X3_ /(+U'_KLO\ Z#6>)7+0MZ'2>A4445Y8!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK4#2D9FN6A??*W<GY>!Z#M^9KI[#XA>%=3OH;*SUB*:YF;9'&L;Y8_BM4/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=LD3E6&1@X(YZ&I[S5M2U"-8[W4+NY13N59IF< ^H!-:2H7JJ:Z >J?"+_D
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M,J8F<%(PRG (."S],\#'?/:O6/"'A6Q\&^'(-'L,LJ$O+,P ::0]6./H /0
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M%>?.K*5TWH:A11168!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P )'P;X973YI(I;N21IIY(L[2QP !GG  '8=^*5M0//OBK_ ,E1\+?]L?\
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M)LOC&>U>#3;,%+?)XSMVJF>Y^8L<="?<"O:*$,****8@HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** //-7_Y+CH'_7@W_H,]>AUYYJ__ "7'0/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M:?AS_D:-)_Z_8?\ T,5]"U\]>'/^1HTG_K]A_P#0Q7T+7FX[XD 4445Q %%%
M% %NBBBLR@HHHH **** "BBB@ HHHH **** *K_?;ZTE*_WV^M)5DA1113 *
M*** "BBB@ HHHH X+XRZ9=ZI\,M2CLT>22%HYVC09+(K M^0^;\*W/ VIZ?J
MW@G2+G3#&+?[,B>7& !$RJ R$=B#D4_QAHFH^(/#\EAI>LSZ1=-(K+=0E@P
M/(^5@>?K7DMM^S_K%E,TUKXR:"5CEGB@=6)Z\D/2&>\45XK_ ,*9\7?]%%OO
MSE_^.5WG@+PIJOA.PN[;5->FU=II1(DDI;*#&"/F8T".NHHHI@%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<E\3/
M^2>ZI_VR_P#1J5UM<E\3/^2>ZI_VR_\ 1J4F!D_!O_D4+O\ Z_W_ /1<=>AU
MYY\&_P#D4+O_ *_W_P#1<=>AT+884444Q!1110 4444 %%%% %35/^03>_\
M7!__ $$U\\U]#:I_R";W_K@__H)KYYKTL!M(Y<3NCW?PE_R*>F?]<%K:K%\)
M?\BGIG_7!:VJ\^I\;]3HC\*"BBBI*"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M :?AS_D:-)_Z_8?_ $,5]"U\]>'/^1HTG_K]A_\ 0Q7T+7FX[XD 4445Q %%
M%% %NBBBLR@HHHH **** "BBB@ HHHH **** *K_ 'V^M)2O]]OK259(4444
MP"BBB@ HHHH *YOQUJ6OZ5X8ENO#5B+W4A(BK$8C)\I/)P"#7244@/!O^$[^
M,O\ T*8_\%\G_P 51_PG?QE_Z%,?^"^3_P"*KWFBBPSP;_A._C+_ -"F/_!?
M)_\ %5Z)\.=:\6:U87TGBS3?L%Q'*JPIY#1!EQR>2<\UVM%%@"BBBF(****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
MY+XF?\D]U3_ME_Z-2NMKDOB9_P D]U3_ +9?^C4I,#)^#?\ R*%W_P!?[_\
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M;:.1>JO*H(_#-))O8+EJBH(+RUNBPM[F&8KU\N0-C\JEDDCAC:25U1%&2S'
M'XT6>P#J*I?VOIG_ $$;3_O^O^-7%974,K!E89!!R"*&FMPNA:*@GOK2U8+<
M74$+$9 DD"DC\:;#J%E<R>7!>6\KXSM256/Y T[/<+HLT452_M?3/^@C:?\
M?]?\:23>P7+M%1PSQ7$8D@E26,]&1@P/XBDGNK>U4-<3Q0J3@&1PH)_&BSV
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M8-%;1H4X]#-U)/J37%Y<W1S<7$LISD;W)Q^=0T45JE8@**** "BBB@ HHHH
M**** "BBB@ HHHH **.IJ*6YA@SYLJ*1V+<_EUH&DWL2T5GR:U:(2%+R>A5>
M/UQ5*77I2?W4*(/]H[O\*=F6J4F;M,DECAQYLB)D9&]@,_3-<S)J-Y)]ZX<<
M8^4[?Y55JN4T5#NSI)-9LTQM9Y,C^!>GUSBJ<FO.1^ZMU4^K,6_EBL>BGRHM
M4HHMRZG>3=9BH]$^7^5522Q))))Y)-)13L:));!1113 **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS'5T5YKH%]>2:[9H]W.RF3!#2$@\5Z515I>S=A0GS*X45Y9J&H7JZE=*MY<
M"9P )3QR?>NN\%SS3Z;<--*\A$V 78G' ]:N=!PCS7%&IS.QTM%87BV62'0F
M>*1D<2+\RG!K@/[1OO\ G]N/^_K?XT4J#J1O<)U.5V/7*898P<&1 1[T^O,/
M$L;1>(;L,/O,&'T(%31I^T=KCG/E5SJ/&[*^B0E6!'VE>A_V6KA[/_C]M_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]!C'YU3DU6]D&//*CML 4C\1S5.BJLC10BMD*S,[%F8LQZDG)I***904444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MY+XF?\D]U3_ME_Z-2NMKDOB9_P D]U3_ +9?^C4I,#)^#?\ R*%W_P!?[_\
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MBFO3)$Z JF-RD>M=E152KMPY+"5.TN:X4445@:!1110 4444 %%%% !1110
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MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH \R\4WT>F_&+1;N169([
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#3\.?\
M(T:3_P!?L/\ Z&*^A:^>O#G_ "-&D_\ 7[#_ .ABOH6O-QWQ( HHHKB ****
M +=%%%9E!1110 4444 %%%% !1110 4444 57^^WUI*5_OM]:2K)"BBBF 44
M44 %%%% !7/^,_$Y\(>'GU8:?+?!)%0PQMM/S'&>AKH*BN+F"SMI+FYFC@@B
M4M)+*P544=22> *0'%ZSXUMX_AU9>*9M :\25HY!9/@M&Q) .2IY![X%<?\
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MVMREW"8F9P5!(.1CVJ[XDM)[W1)H+:,R2EE(4$#H16M12=1N?."BE'E/,/\
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M;!1113&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?_0!6G5/2;22PT:QLY2ID@MXXF*G@E5 ./;BKE>?+63*"BBBD 4444 %%%%
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M 4444 %%%% !1110 4444 %%%% %>7_6&F4^7_6&F5:)"BBBF 4444 %%%%
M!1110 4444 >-ZKXD\;>,?%FHZ5X1F6VT^PD,;SJ0%8@XR7(/4@X"]O7K1_P
MBWQ<_P"ACB_\"3_\14WA+6=/\"^,=?T?5[N"&UOI_M5G=ALQMR<JQ!.TX(ZX
M^Z<]1GTE/%'A^1 R:[IC*>A6[C(_G4C.#\.^'?B5;>(+*?5]=BFT]),SQB<G
M<N.F-M>HUGP:[H]U.L-OJMC+*YPJ1W",S?0 UH4Q!6+X@\*Z5XG-F-5A::.U
MD,B1[L*Q_P!K'4>U;5% 'CGQQM+>Q\,Z':VD,<$$4[*D<:[54;>@%>G^&O\
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M#_\ 75:2ZN)4V23RNO\ =9R145%.R*22V"BBBF,**** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>BV>EVN?)M8EC4GJV.K'W)R3[FKU%%@"BBBF 4444 >+?%C_ )'FQ_Z\%_\
M0Y*Y"NO^+'_(\V/_ %X+_P"AR5R%>E@?X;]?\AA1117:(**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "E3[Z_6DI4^^OUI 6J***@H**** "BBB@ H
MHHH **** "BBB@ HHHH KR_ZPTRGR_ZPTRK1(4444P"BBB@ HHHH **** "O
MFGQ%I]_8>)YKGQS9:U<633,T+QW (VYS@$[AC!7@$8Z?3Z6IKHDD;(ZAD8$,
MK#((/8TFAGG'@36/ALBH=$2UT^\P1B]PL_N-[$YSZ*W\JI3_ /)Q=M_UY'_T
M6U;_ (A^%'A?7B9%M3I]Q@_O+(! 3[KC!_#!Z\UP%Q\,?&/@_5H]6\,WD>H-
M A"-M59%7&"NQ\@C!(X.?84@/=J*\M\+_%+4Y]?L_#GB/0I;34)F""4 IDXX
M)1AT..H..>!7J5,04444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH \6^+'_(\V/\ UX+_ .AR5R%=?\6/^1YL?^O!?_0Y*Y"O2P/\-^O^0PHH
MHKM$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ I4^^OUI*5/OK]:0%JBBBH*"BBB@ HHHH **** "BBB@ HHHH ***
M* *\O^L-,I\O^L-,JT2%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Q;XL?\ (\V/_7@O
M_H<E<A77_%C_ )'FQ_Z\%_\ 0Y*Y"O2P/\-^O^0PHHHKM$%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 :?AS_D:-)_Z_8?_0Q7T+7SUX<_
MY&C2?^OV'_T,5]"UYN.^) %%%%<0!1110!;HHHK,H**** "BBB@ HHHH ***
M* "BBB@"J_WV^M)2O]]OK259(4444P"BBB@ HHHH **** //OC5:7=W\+]26
MU5F\MXY9E4]8U8$Y]0.#^&>U;'@;3M!'@O29=)L[46TMK&V]8EW.VWDL<<MG
M.<]\U;\8Z7K.K^'I;/0=233[YG4B=\XVY^8'@]1[5Y!IWP5\=Z.SG3/%T%CO
M;>RVT\T2L?<* #TI#/=OL5I_SZP_]^Q4D<4<*[8XU1<YPHQ7C/\ PKGXJ?\
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MABJFM?\ (>U'_KZD_P#0C7JOX_D9X;9GJWPO_P"13?\ Z^G_ )+7:5Q?PO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !2I]]?K24J??7ZT@+5%%%04%
M%%% !1110 4444 %%%% !1110 4444 5Y?\ 6&F4^7_6&F5:)"BBBF 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!XM\6/^1YL?^O!?_0Y*Y"NO^+'_(\V/_7@O_H<E<A7I8'^
M&_7_ "&%%%%=H@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M.;:-A]P%5)'Y%>,__7749ZU1115""BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "N2^)G_)/=4_[9?^C4KK:Y+XF?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ I4^^OUI*5/OK]:0%JBBBH*"BBB@ HHHH *
M*** "BBB@ HHHH **** *\O^L-,I\O\ K#3*M$A1113 **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH \6^+'_(\V/\ UX+_ .AR5R%=?\6/^1YL?^O!?_0Y*Y"O2P/\-^O^0PHH
MHKM$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MHK'.'CS@J,XW*00!GY17K7@WQ3:^,?"]IK-LNPRC;-%G)BD'#+^?0]P0>]"
MWJ***8@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KDOB9_P D]U3_ +9?^C4KK:Y+XF?\D]U3_ME_Z-2DP,GX-_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
MJ??7ZTE*GWU^M("U1114%!1110 4444 %%%% !1110 4444 %%%% %>7_6&F
M4^7_ %AIE6B0HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 5ROB?XB>'?"<_P!FO[F22\VAOLUNF]P#TST4?0D'D5J^
M)=7_ + \-:CJN%9K:!G16Z,^/E!]B<"O+O@]X8MM8AO?%.M1"]NY+ADA:X^?
MD#+/SP22V,GI@TAG6Z#\6?"VOWB6B33V<\C;8TO(PN\GH 5)'?N17<UYG\5/
M VE7GA:[U>SLX+;4+)/-WPH$$B#&X-@<_+T[\ =*VOA=KTOB#P+9S7#[[FV)
MM96R26*8P3GOM*Y]3DT =E1113$%%%% 'BWQ8_Y'FQ_Z\%_]#DKD*Z_XL?\
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M05R7Q,_Y)[JG_;+_ -&I76UR7Q,_Y)[JG_;+_P!&I28&3\&_^10N_P#K_?\
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MZPTRK1(4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M4[+^OF!\P?;(/[_Z&C[9!_?_ $-?3]%'UVIV7]?,#Y@^V0?W_P!#1]L@_O\
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M(/[_ .AH^V0?W_T-?3]9/BC_ )%+6?\ KQG_ /1;4?7:G9?U\P/G;[9!_?\
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MVIV7]?,1\P?;(/[_ .AH^V0?W_T-?3]%'UVIV7]?,#Y@^V0?W_T-'VR#^_\
MH:^GZ*/KM3LOZ^8'S!]L@_O_ *&C[9!_?_0U]/T4?7:G9?U\P/F#[9!_?_0T
M?;(/[_Z&OI^BCZ[4[+^OF!\P?;(/[_Z&C[9!_?\ T-?17BC_ )%+6?\ KQG_
M /1;4WPI_P B?HO_ %XP_P#H H^NU.R_KYC/G?[9!_?_ $-'VR#^_P#H:^GZ
M*/KM3LOZ^8CY@^V0?W_T-'VR#^_^AKZ?HH^NU.R_KY@?,'VR#^_^AH^V0?W_
M -#7T_11]=J=E_7S ^8/MD']_P#0T?;(/[_Z&OI^BCZ[4[+^OF!\P?;(/[_Z
M&C[9!_?_ $-?3]%'UVIV7]?,#Y@^V0?W_P!#1]L@_O\ Z&O<O WW_$W_ &';
MG_V6NMH^NU.R_KYC/F#[9!_?_0T?;(/[_P"AKZ?HH^NU.R_KYB/F#[9!_?\
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M[4[+^OF,\-^V0?W_ -#1]L@_O_H:^GZ*/KM3LOZ^8CY@^V0?W_T-'VR#^_\
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M>8_3CC"]/6A@>Y5Y)XE^*.MZ-XCO].M[73VAMY=B-)&Y8C'?#BO6Z*!'A_\
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MBBB@ HHHH **** "BBB@"O+_ *PTRGR_ZPTRK1(4444P"BBB@ HHHH ****
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M]TNT>))Y]FUI20HVNK'. 3T![5N444@"BBBF 4444 6Z***S*"BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I4^^OUI*5/OK]:0%JB
MBBH*"BBB@ HHHH **** "BBB@ HHHH **** *\O^L-,I\O\ K#3*M$A1113
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %<O\1+:>\\":E!;023S-Y6V.)"S'$J$X YZ5U%%(#YW\
M.>/-7\)6$VG6EM:,C3&5OM$;E@V I'##^Z*V/^%R>(?^?/2_^_4G_P 77N%%
M*PSP_P#X7)XA_P"?/2_^_4G_ ,71_P +D\0_\^>E_P#?J3_XNO<**+,#P_\
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M/_/GI?\ WZD_^+KW"BBS \/_ .%R>(?^?/2_^_4G_P 71_PN3Q#_ ,^>E_\
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MLP/#_P#A<GB'_GSTO_OU)_\ %T?\+D\0_P#/GI?_ 'ZD_P#BZ]PHHLP/#_\
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M#_SYZ7_WZD_^+KW"BBS \/\ ^%R>(?\ GSTO_OU)_P#%T?\ "Y/$/_/GI?\
MWZD_^+KW"BBS \/_ .%R>(?^?/2_^_4G_P 71_PN3Q#_ ,^>E_\ ?J3_ .+K
MW"BBS \/_P"%R>(?^?/2_P#OU)_\71_PN3Q#_P ^>E_]^I/_ (NO<**+,#P_
M_A<GB'_GSTO_ +]2?_%T?\+D\0_\^>E_]^I/_BZ]PHHLP/#_ /A<GB'_ )\]
M+_[]2?\ Q='_  N3Q#_SYZ7_ -^I/_BZ]PHHLP/#_P#A<GB'_GSTO_OU)_\
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M 'ZD_P#BZ/\ A<GB'_GSTO\ []2?_%U[A119@>'_ /"Y/$/_ #YZ7_WZD_\
MBZ/^%R>(?^?/2_\ OU)_\77N%%%F!X?_ ,+D\0_\^>E_]^I/_BZ/^%R>(?\
MGSTO_OU)_P#%U[A119@>'_\ "Y/$/_/GI?\ WZD_^+H_X7)XA_Y\]+_[]2?_
M !=>X4468'A__"Y/$/\ SYZ7_P!^I/\ XNC_ (7)XA_Y\]+_ ._4G_Q=>X44
M68'A_P#PN3Q#_P ^>E_]^I/_ (NC_A<GB'_GSTO_ +]2?_%U[A119@>'_P#"
MY/$/_/GI?_?J3_XNC_A<GB'_ )\]+_[]2?\ Q=>X4468'A__  N3Q#_SYZ7_
M -^I/_BZ/^%R>(?^?/2_^_4G_P 77N%%%F!X?_PN3Q#_ ,^>E_\ ?J3_ .+H
M_P"%R>(?^?/2_P#OU)_\77N%%%F!X?\ \+D\0_\ /GI?_?J3_P"+H_X7)XA_
MY\]+_P"_4G_Q=>X4468'A_\ PN3Q#_SYZ7_WZD_^+H_X7)XA_P"?/2_^_4G_
M ,77N%%%F!X?_P +D\0_\^>E_P#?J3_XNC_A<GB'_GSTO_OU)_\ %U[A119@
M>'_\+D\0_P#/GI?_ 'ZD_P#BZ/\ A<GB'_GSTO\ []2?_%U[A119@>'_ /"Y
M/$/_ #YZ7_WZD_\ BZ/^%R>(?^?/2_\ OU)_\77N%%%F!X?_ ,+D\0_\^>E_
M]^I/_BZ/^%R>(?\ GSTO_OU)_P#%U[A119@>'_\ "Y/$/_/GI?\ WZD_^+H_
MX7)XA_Y\]+_[]2?_ !=>X4468'A__"Y/$/\ SYZ7_P!^I/\ XNC_ (7)XA_Y
M\]+_ ._4G_Q=>X4468'A_P#PN3Q#_P ^>E_]^I/_ (NC_A<GB'_GSTO_ +]2
M?_%U[A119@>'_P#"Y/$/_/GI?_?J3_XNC_A<GB'_ )\]+_[]2?\ Q=>X5YYJ
M_P#R7'0/^O!O_09Z-0.2_P"%R>(?^?/2_P#OU)_\71_PN3Q#_P ^>E_]^I/_
M (NO<**+,#P__A<GB'_GSTO_ +]2?_%T?\+D\0_\^>E_]^I/_BZ]PHHLP/#_
M /A<GB'_ )\]+_[]2?\ Q='_  N3Q#_SYZ7_ -^I/_BZ]PHHLP/#_P#A<GB'
M_GSTO_OU)_\ %T?\+D\0_P#/GI?_ 'ZD_P#BZ]PHHLP/#_\ A<GB'_GSTO\
M[]2?_%T?\+D\0_\ /GI?_?J3_P"+KW"BBS \/_X7)XA_Y\]+_P"_4G_Q='_"
MY/$/_/GI?_?J3_XNO<**+,#P_P#X7)XA_P"?/2_^_4G_ ,71_P +D\0_\^>E
M_P#?J3_XNO<**+,#P_\ X7)XA_Y\]+_[]2?_ !='_"Y/$/\ SYZ7_P!^I/\
MXNO<**+,#P__ (7)XA_Y\]+_ ._4G_Q='_"Y/$/_ #YZ7_WZD_\ BZ]PHHLP
M/#_^%R>(?^?/2_\ OU)_\71_PN3Q#_SYZ7_WZD_^+KW"BBS \/\ ^%R>(?\
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M['9VD)DM[,@KUQC:G\(YY+'=QCGMWGP0_P"1"D_Z_9/_ $%*Z'XC?\D\UO\
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MR23@?*K8FX/_ 'T/SKMZ*0!1113 **** "BBB@ HHHH **** "BBB@ HHHH
M*5/OK]:2E3[Z_6D!:HHHJ"@HHHH **** "BBB@ HHHH **** "BBB@"O+_K#
M3*?+_K#3*M$A1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/EG8Y:1CU8^YK6IH04444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MUN1/"?Q_MM2N ([.]VMN[ .AB))]G!)KV^N9\:^";#QKID=M=2/!<0$M;W"
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !117G7Q:^(A\%:(MMI\J#6[P?N,KN\E,\R$$8/H >YSR 12 ]%
MHKA_A-X@U3Q-X%AU+6+K[3=M/(AD\M4X!XX4 ?I7<4 %%%%, HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **S=>UVP\-:)<ZMJ<ICM;=<L0,EB3@
M*!W)) KQRS\9_%3Q]++=^%K&#3-*!*QS2(A!Y_O2 [SP0=JX'?FE<#W6BO#M
M.^)WC#P=XGM=$^(-K$UO<. +Y552JDXWY3Y&4<9& 0/?@^X*P90RD%2,@CO0
M M%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 >)?M#:A/+;>'] MW'^ESO*Z#KE=JI^&7;
M\JZ74OB5X(^'=O#X=ADGF>P00&VLH@YCP!]YB54MW/.<YSS7!?M%M)#X@T":
M-G1E@D*.I((8.#P?4<5ZAX%^'^B^'/#ELLEC!<ZA/&LEW=3H'=W(R1DYPHZ
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M4444 %%%% !1110 4444 %%%% !2I]]?K24J??7ZT@+5%%%04%%%% !1110
M4444 %%%% !1110 4444 5Y?]8:93Y?]8:95HD****8!1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 6Z***S*"BBB@ HHHH **** "BBB@ HHHH JO\ ?;ZT
ME*_WV^M)5DA1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *CN($NK:6WDSY<J%&P<<$8-244 ?/?PLUR'X<>,=<\)>)+E+2-Y%
M,<\V%0.O0D]@Z,#DG P/6O3/'WQ$T;POX:N98[^&?4)HVCM8()@7+$8W<= .
MN?;'4UH>*_A]X<\9;'U:QS<QC:ES"VR4#T)'4>@.<?C7-Z3\"?!NEWD=S(E[
M?E#D1WDJLA^H55S]#4ZC*OP%\-RZ/X-FU.YC*3:K()$!')B4$(?Q)8_0UZM2
M*H50J@!0, #M2TQ!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* /#_BW\0KVYU;_A!_#LRQ2RD1WMRTGEX)_Y9[C@*,<LV>AQZYZ/X>^'_!?@
M;3D;^V](N=7D3%Q>&ZCSSC*)SPO'U/4^@BU+X#>%]4U2[U"XU'6?/NIGGDVS
M18W,Q8XS&3U-5O\ AG?PC_T$=;_[_P 7_P :J=1GI,'B+1+F=((-9T^65SM2
M..Z1F8^@ /-:5>:Z!\$?#7AW7;/5[2^U9[BTD\Q%FEC*$XQR!&#W]:]*IB"B
MBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >6?\* \&?\ /35/
M_ A?_B:YSQY\&_"_ASP1JFKV+ZA]JMHU:/S)@RY+J.1M]":]VK+\1:%:^)M
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MH)Y4]>,XS@\UW3*&4JP!4C!![UYQK?P.\&ZS>/<I!=:<[G+)82*B?@K*0/P
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M^HXYKZ*K&\-^%-%\):>;/1;)+>-B#(V2SR'U9CR>_L,\8K9H0@HHHI@%%%%
M!1110 4444 %%%% !1110 4J??7ZTE*GWU^M("U1114%!1110 4444 %%%%
M!1110 4444 %%%% %>7_ %AIE/E_UAIE6B0HHHI@%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!;HHHK,H**** "BBB@ HHHH **** "BBB@"J_WV^M)2O\
M?;ZTE62%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *5/OK]:2E3[Z_6D!:H
MHHJ"@HHHH **** "BBB@ HHHH **** "BBB@"O+_ *PTRGR_ZPTRK1(4444P
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH MT445F4%%%% !1110 4444 %%
M%% !1110!5?[[?6DI7^^WUI*LD****8!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !115/5=/_ +4TJYL?M5S:&9"HGM93'+&>S*PZ$4 7
M**\ \">,]>\'?$*Z\)^,M0NKE)Y!%'/=3F3RW/W&#,3\C COP2.G->_T@"BO
M*/C3\09O#FFQ:#H\\D>L7P!:2(D/!%G&01T9B,#'( )X.#75?#K0=7T/PM#_
M &]J5]?:K<XEG^U7+S>3D<1KDD# ZXZG/)&* .MHHHI@%%%% !1110 4444
M%%%% !1110 45SOC?Q;:^"O"]QK%RGFNI$<$&[!ED/1<_@2?8&O(M.@^+GQ(
MLQJL>LQZ-ITQW0B.5K<%<X^38"Y''\1Y]<4KC/?Z*\#U'P_\7?!-H^JV_B1]
M6MX 99HVG:<A1URLHY&/[ISU/&,UZ-\,_B!%X^T*2>2%+?4K1@EW"F=O(.UU
MS_"<'@G((/7@DN!VU%>9^,M'\;WGQ0\/WNB2WRZ!#]G^VK%?"*,XF8R;H]XW
M?(1G@Y''->F4""BBBF 4444 %%%% !1110 4444 %%>'_&_7M8TGQ3X>ATW5
M;ZSBE0F1+:X>-7^<#D*1FO<*0!117AW@#7M8O?CKXDTZZU:^GL89+T1VTMP[
M1IMF 7"DX&!P,=* /<:*YWQOXMM?!7A>XUBY3S74B."#=@RR'HN?P)/L#7D6
MG0?%SXD68U6/68]&TZ8[H1'*UN"N<?)L!<CC^(\^N*+C/?Z*\#U'P_\ %WP3
M:/JMOXD?5K> &6:-IVG(4=<K*.1C^Z<]3QC->C?#/X@1>/M"DGDA2WU*T8)=
MPIG;R#M=<_PG!X)R"#UX)+@=M17/^,O%^G>"M DU34-S\^7!"GWII""0H].A
M)/8#\*\BL;_XL_$MUO\ 3KE-#TAR1$Z-Y2$9Z@X+N>,9Z9].:+B/?:*\%N_!
MOQA\-Q/?:=XIFU0HNYH1=/,W'HDH*GZ#D^G2NL^%GQ3/C,RZ3JT*6^M0*7^1
M2J3(" 2 >C#/(_$=P"XSTZBO*O&'@'QWK?BJ]U#1O&,VGZ?-L\JU6\G0)A%4
M_*O RP)X]:\]\<:!\0O NBPZI?>.+^XBEN%MPD&H7&X$JS9Y(X^4T7 ^EZ*^
M?M$\ _$G7=#L=5@\?7<<5Y LR))J%QN4,,X.*]&^'?A/Q3X:FU!_$?B.75UG
M6,0*]Q++Y>-VX_/TSD=/2BX'=T444Q!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %*GWU^M
M)2I]]?K2 M4445!04444 %%%% !1110 4444 %%%% !1110!7E_UAIE/E_UA
MIE6B0HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!;HHHK,H**** "BB
MB@ HHHH **** "BBB@"J_P!]OK24K_?;ZTE62%%%%, HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH \L^-/@#_ (2;0O[9TZ#=JNGH
M25CCR]Q%W7CDD<D=>X[U2\!_%NU;X:WMYK4ROJ.C1A'0G:UR#Q%@]R2-IZXQ
MD]:]@KY7\>>$--MOC3;:%:A[>RU*YM]RH>8_-8!MN?<DCTSCI4L9V'PD\,WW
MB[Q-=?$/Q$ID+S%K0'.'D'&X _PH!M7W'^S7N5U=06-G/=W,JQ6\$;2RR-T1
M5&23] *2QLK;3;""QLXEAMK>-8XHUZ*H& *X'XX74EM\+=02/ $\L,3'OC>&
MX_[YQ]":>P'(?\+(\>>/M9N;;P'816VGVYP;F9$+8/ +%\J">H4 GKUIUSXR
M^*?@ I=^*]/M]5THN!)/&$4KG@ -&!MYQ]Y><XSZ87@+QKXP\,^$K6PTGP'>
M7UJ6>47:6\Q$Q8YW9"D=,#CTK4U_Q]X[\0:!?Z1<_#>^$5W T1;[).2A(X8#
M;U!P1[BD![5H6MV/B/1;;5M-E\RUN$W*3U4]U([$'((]J\FU7XJ^)O$OBF?0
M/AYI\%PD.X/>2 -NP<%P20BIGH3G/&.N*UO@58ZKIW@^_P!.UC3KVT*WA>-+
MR!H\HR+D -VR#^)-4Y_B!\-?AOJ5W9:)ISRW,C 7)T] R!A_"79@.,GA<@=.
M#0!DZCJ/QM\+VTFJW\MKJ%E;J9)D6*%E"CDE@@5\ #D@UZ/\./&Z^._#/]HO
M EO=PRF&XA1L@, "",\X((_4<XKS[4_C'K6OZ7=6^A^!KZ>WGMV5KB4.ZJK#
M!8A5QM'/);\JF_9R_P"1=UK_ *^T_P#0* ,[6?BIXKTCXFZUHMJ3J";C;:=9
M>2@"S-MVDL &(&6XSS[=1U?A%?BT/%-LWB62S.CRJSSJHAS%\IVH-F&SDCG)
M& >3WY'P]:Q7'[3VIO(N3 TTB>S>6%_DQKWZA >*WWQ(\9^,/$E_HO@&QMTM
M[1RCWTH4M@$C=\WRA20<#!)Q]15'4_%GQ<\!1IJ'B&"SU/32ZB20(F%R?NYC
M"E2>Q((R1UZ5ESZ'XZ^$&OZC=^&[#[=HUVXP5A,R[025#A3O4J&(SD YZ^FU
M9?'W2[XR:?XJ\-/%$6"2!,3*"#SOC<#&",]S[9'(!ZUX6\16OBOPW9:U9@K%
M<IDH>L;@X93]"",]^O>MBLSP_J&DZIH=K>:&T#:=(F8A"H55]1M'W2#G([&M
M.F(\V^-_A^^U_P  ?\2^)YI;*Y6Z>),DL@5E; [D;L_0&N?^'7QG\-V_AC3]
M'UMWTZYLH$@$GDL\4H7Y5(*Y(. "<@#.>:]<O]8TS2R@U#4;.T+_ '!<3K'N
MYQQDC/)%<[X@^&'A#Q(7DO-(BBN7Y-Q:_NGSZG;PQ_W@:!FYI7B/1-<7=I6K
M65YZK#,K,/J <C\:P_"'PWT/P3J%[>Z4]XTEV-K+-("J+G.%  X^N37G&M_L
MZQHCS^'M=E65 #%#>H#N;C_EHF,=_P"$]OK5SX0^.==?Q'>^"_$\TMQ=V^_R
M)IFS(K(?G1F/+^H)YX/48PO4"_X\\:>(-%^,'AG0M/U#R=-O?LOVB#R8VW[[
MAD;YBI894 <$5T?Q9\0:IX9\"S:EH]U]FNUGC02>6K\$\\,"/TKSWXH?\G >
M#/\ MQ_]*GKK_CO_ ,DQN/\ KYA_]"H Y72?'_Q%\<:=;6WA.RC1K:!4OM4N
MEC&^?;D[0?E'/8 GD$@ U!+\1/B)X UNUA\;VT5W83G'FHB#*YY9&C &0/X2
M/3IG->D_"BUBM/A?H21+@/ 9&]V9BQ_4UQ_[1:C_ (1#2FP,B_P#_P!LVHZ
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MCO79?\* \&?\]-4_\"%_^)KAOA)I\.D_'#7=-MMWD6BW<$>\Y;:DRJ,GUP*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** +=%%%9E!1110 4444 %%
M%% !1110 4444 57^^WUI*5_OM]:2K)"BBBF 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %?._Q!_P"3C- _Z^;#_P!&"OHBN=U#
MP+X;U7Q';^(+W3?-U2W:-XI_/D7:4.5^4,%.#ZBDQG15S'Q!\-MXL\#ZEI,(
M!N7026^2!^\4AE&3P,XQ^-=/10(\'^%GQ.L/#&EGPEXL\S3I[&9HX99(V( +
M$E'QDJ0Q//3!'3'/0>.OC7H>F:'<0^&]02]U>5=L3QQEHX<_QDL,$@9P.><9
M&*[G7O!'AKQ.Q?6-&MKF4@ S8*2X'0;U(;'MFJFB_#?P?X>NENM-T*VCN%(9
M)92TS(1T*ER=I]QBC49E^'9/&-_\*KVYUJ4G7KJTG:U00K&\>4(CW*!C<3ST
M[@8R#7E/P4\2^$?#C:@FOB*TU1I%,5W/$6P@XV X.PYR3TSQD\#'TI7*ZU\-
M_!_B&Z:ZU+0K:2X8EGEB+0LY/4L4(W'W.:+ <CXU^,.A?V/=Z3X;FDU75[N,
MP0K;1,50NN-V2,,1G.!G)X/?&/\ LWS;M)U^#*_)/$^._P RL/\ V7^=>IZ#
MX,\-^&6WZ/H]K:R[=GG!=TFWTWMEL<#O2:#X,T#PQ>7=WHUBUK+>?Z_;/(RO
MR2/E9BHQDXP.,GUH \E\,?\ )S6M_P"[-_Z"M>[.&:-@C;6((#8S@^M8=KX,
M\/V7B:?Q';V&S5I]WF7'G2'=D 'Y2VT=!VK>H0CQ+PG\8+S2_$6JZ+\0IQ;2
MQ2!(94M2J1D$Y!P-V""I4XZ<D\U<^)7CKX>ZEX2U"#S;35-0FA*6WDQ;GCD(
M(1]^!@*>3STXP<UZ+KW@[P[XGP=9TFVNG VB1@5D ] ZX;]:R].^%?@?2IUF
MMO#MJ9%.09V>< _20D4M1G._ 32;S3?A\\]W&\0OKMKB!6[Q[44-CMDJ?J,'
MI7J5%%,1Y7\</!5UXF\/6^I:; 9K[32Q,2+EY(FQNQZD8! ^N.>N?X,^.NCR
MZ=;V'BCS[+48AY<EQY9>.3' 8XRP8]\C&><^GLE<YK7@+PKXAE,NJ:':33')
M:55,;MGU9<$_B:+#,#4_C7X&T^V>2+5'O9@,K#;P/EOQ8!1^)KB?A'IFI>*?
MB!J?C^]M3;6DC2B =G=OEPI[A5R"<<G\<>BV/PF\"Z=/YL'AVV=O2X=YU_[Y
M=B/TKL41(HUCC5410%55&  .@ H \'^*'_)P'@S_ +<?_2IZZ_X[_P#),;C_
M *^8?_0JZW5/!?A_6O$%EKNH:?YVI66S[//YTB[-CEU^4,%.&)/(-6]>\/Z7
MXFTQM-UBU^TVC,',?F,G(Z<J0?UHL!B_##_DF?A__KT7^9KB?VB_^1.TO_L(
M#_T6]>L:7IEGHVF6^G:?#Y-I;ILBCW%MJ^F223^)JCXC\*Z+XLLXK36[+[5!
M%)YJ)YKIAL$9RI!Z$T=!'$:OX7G\6_ 32-/LQNO8],M+BW7. [K$OR_B"P'N
M16#\+?BKI.F:!'X;\2R'3+O3LPI)*C!74'[K=U8$D'([?6O9K&RM]-T^VL+2
M/R[:VB6&%-Q.U% "C)Y/ '6L/7? /A7Q+,9]6T6VGG.-TR[HW;ZLA!/YT6&>
M:?$SXJIJ45KX>\#WMQ<:C<3(7N;(LI'<1H1@L2<9QQCCG)Q=^)G@36-6^%^D
M;FEU'7=)0/<,&WM*&7][MSRW(4CN0O3.*]!\/^!?#'A:0RZ-H]O;3$8\XYDD
M [@.Y+ >V:Z&BP'DW@/XT>'K[0;6UUZ]73]3@C$<AE5MDNT8W!AD#(QD''.<
M9K-\=?&8SS6FD> 9VN]1EG"O,MMO!YP$0,/F)/?&,=#SD>@ZQ\-?!VO7)N-0
MT"V:8G+20EH2Q]6,97<?K5S0/!7AOPN=VC:/;6LF"OG8+R8)R1O8EL>V>PHU
M O:''J4>AV2ZQ,DVI>2IN710J^81D@ <8!X]\5H444"/G_X__P#(W^&?^N9_
M]&"OH"N?\0>"/#OBF\MKO6=/^TSVHQ"WG2)M&<]%8 \^M=!0,*^?OAO_ ,G#
M>*?^NM]_Z/%?0-<_IO@CP[I'B&ZU^QT[RM3NC(9I_.D;<7;<WREBHR>>!0Q'
M%_'#P5=>)O#UOJ6FP&:^TTL3$BY>2)L;L>I& 0/KCGKG^#/CKH\NG6]AXH\^
MRU&(>7)<>67CDQP&.,L&/?(QGG/I[)7.:UX"\*^(93+JFAVDTQR6E53&[9]6
M7!/XFBPS U/XU^!M/MGDBU1[V8#*PV\#Y;\6 4?B:XGX1Z9J7BGX@:GX_O;4
MVUI(TH@'9W;Y<*>X5<@G')_''HMC\)O NG3^;!X=MG;TN'>=?^^78C]*[%$2
M*-8XU5$4!551@ #H * /,?C1X!NO%VBV^H:6ADU'3@W[@=9HS@D#U8$ @=\G
MJ<5D^"_COI4FFQV7BTRV5_ H1[H1,Z3$#&2%&58]QC'N.@]FKG=:\">%O$4S
MSZKHEK<3N-K3;2CD?[RD'\<T6 Y?7/CCX.TNU+65U+JEP1E8K>-E&?\ :9@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ I4^^OUI*5/OK]:0%JBBBH*"BBB@ HHHH *
M*** "BBB@ HHHH **** *\O^L-,I\O\ K#3*M$A1113 **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@"W1116904444 %%%% !1110 4444 %%%% %5_OM]:2
ME?[[?6DJR0HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2I]]?K24J??7ZT@
M+5%%%04%%%% !1110 4444 %%%% !1110 4444 5Y?\ 6&F4^7_6&F5:)"BB
MBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% %NBBBLR@HHHH **** "BBB@
M HHHH **** *K_?;ZTE*_P!]OK259(4444P"BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ I4^^OUI*5/OK]:0%JBBBH*"BBB@ HHHH **** "BBB@ HHHH **** *
M\O\ K#3*?+_K#3*M$A1113 **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"W1
M116904444 %%%% !1110 4444 %%%% %5_OM]:2E?[[?6DJR0HHHI@%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !2I]]?K24J??7ZT@+5%%%04%%%% !1110 444
M4 %%%% !1110 4444 5Y?]8:93Y?]8:95HD****8!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 6Z***S*"BBB@ HHHH **** "BBB@ HHHH JO]]OK24K_?
M;ZTE62%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *5/OK]:2E3[Z_6D!:HH
MHJ"@HHHH **** "BBB@ HHHH **** "BBB@"O+_K#3*?+_K#3*M$A1113 **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@"W1116904444 %%%% !1110 4444
M %%%% %5_OM]:2E?[[?6DJR0HHHI@%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M10 4444 %%%% !1110 4444 -,:$Y(I/*3T_6GT47 9Y2>GZT>4GI^M/HHN
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ='(\4BR1NR.I
M#*RG!!'0@U] >#?$B>)=$2=B!=Q82X0#&&]1['K^?I7S[6[X2\0R>&]=BNP6
M-NWR7"#^)#U./4=145(<R ^AJ*9%*DT22Q,'C=0RL.A!Z&GUR %%%% !1110
M 4444 ?+E%%%=P!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!ZK\+_%.]/[ O)!N7+6K,>HZE/PZC\:].
MKYAMKF:SNHKFWD,<T3AT<=01R#7T-X8UZ'Q'HD-]&5$N-L\:_P #CJ/IW'L:
MYZL+.Z V****Q **** "BBB@#Y<HHHKN **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "NG\$>)V\-ZTIE
M9C8W&$G7T]&_#^6:YBBDU=68'U$"& (((/((I:\]^&/B<7VG_P!BW3G[3:KF
M$L?OQ^G_  '^6/2O0JXY1Y78 HHHI %%%% 'RY1117< 4444 %%%% !1110
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M^[^M2IQ;L@,"BBBJ **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HJ>RMOME_;VN_9YTJQ[L9QD@9Q^->E_P#"G?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MEO9V\<$*V\F$C4*!\IKYOKZ:U")Y]-NH8UW220NJC.,D@@5X:?AWXJ523I7
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M!:)<HH))MY Q&/\ 9."?P!KE71XI&CD5D=2596&"".H(III[ -HHHI@%%%%
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M&A'.H6,D<><"489#_P "''YUDU2=]@"OHCP?_P B?I/_ %[)_*OG>OHCP?\
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M5*I9M+  &23<Q<?^/4N9=P,/2'2+6K"21E1%N(V9F.  &&237T'_ ,)-H/\
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M6O7$FINEA #RN0\C#CH!P._4]NE>CZ)X+T/02LEM:"2X QY\_P [_49X7KV
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MZWOU4&2TFP6ST1^#^H6E2E:5@/'%5G8*H+,3@ #))KZ2T32X=%T:UT^$86)
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-\6_^14M?^OY/_0)*\P\+::NK^)]/L7 ,<DH+@C.57YF'Y U5)VA<#T7X?\
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M)A^\FZA/]E?;WZG]*XOX3Z-'=:I=:I*H(M0$B!Q]]LY/X ?K7K]*K/7E0 2
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M>R?RK6ML@)]=T.W\064=G=LPMQ,LCJIP6 SQGMFKA:STNR4,T%I:Q+M&2$1
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M0WJ.H/Y$5])UX5\2XEC\<7; G,D<;'/KL _I11>M@*?@/_D=]+_ZZ'_T$U]
MU\_> _\ D=]+_P"NA_\ 037T#16W Q1X9L9/$DVN7,8FN2%6$-TC &,X]3_A
M5VXUC3+2X%O<ZC:0SG&(Y)U5CG@<$YKEOB5XDGT31X;2S=X[F]+*)5."B+C=
MCT)R /QKQ-F9V+,2S$Y))R2:(TW)78'U""&4,I!!&01WJEK&DVNMZ9/8W:!H
MY5(#8Y0]F'N*\[^$FL3O)=Z/)(6B1//B4Y.WD!@/0<@X]<UZE6<DXNP'S+J%
ME)INI7-E-_K()6C;C&<'&:Z#P+X83Q+K++<[A96RB2;:<%LGA<]1GGGT!Z<4
MSXA((_'6IJ.[1G\XU/\ 6NT^$!A_LW4PH'G^<F\]]N#M_7=71*3Y+@>C0PQ6
M\*0PQK'%&H5$08"@= !5>[U33[#'VR^MK?)P/.F5.?Q-69%+1LJMM8@@-Z>]
M>$:QX"\26$\DC6DE\K,3YUO^\+DGJ1][/X5A"*ENP/<;2_LK]2UG=P7"CJ89
M X_0T^ZM8+VUDMKF)989%VNC#((KYNMKB_T/48[B/SK:YC(8!@5)P>A'<<<B
MO3IOB]8K IATNYEFP-P=U1<]\$;C^E5*DUL!Q'C7PQ_PC&LB&)F>TG7S(6;J
M!GE3]/ZBN;KJO%GC>;Q5;P0/8PVZ0N7!#%FSC&,\<?AVKE:Z(WMJ!]'^&?\
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M>A!R#7R_)(\TKRRNSR.2S,QR6)ZDGN:ZKP!XBN=&\0VUKYCM97<@BDBZ@,Q
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MHP_]!/YUZD0",$9%1)<D@/ERE56=@J@LQ.  ,DFM3Q)I?]C>([^P  2*4^6
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M#&?3D_0&OGBHHQZ@>B?#7PC'J4IUF_C#VT+;8(F'#N,?,?4#]3].?7P !@#
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M6/%7_(I:O_UYR_\ H)KD^T!\Z*S(P9258'((."#7TOIE_'JFEVM]#_J[B)9
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>,02.5MG(_0?UKL/BW_R*EK_ -?R?^@25P_PUN_LWC6U0J")T>(G/3Y=W\U
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M_P#7FG_H3UA2^(#A:]&^$/\ R&-1_P"O<?\ H5><UZ-\(?\ D,:C_P!>X_\
M0JVJ?"P/7:^?O'G_ ".^J?\ 70?^@BOH&OG[QY_R.^J?]=!_Z"*RH_$!Z'\)
M% \+W;8^8WK G_@"?XUWU>;_  AO%?2]1LOFWQS++[89<?\ LE>D5%3XF!\O
MRRO/,\TK%I)&+,Q[D\DTRM'7M-;2->OK!D*"&9@@)S\G53^*D'\:SJZT!K^%
M97A\6Z0T;%6-Y$I(]"P!'Y$U]&5X%X TPZGXQLAC*6S?:7YZ!<8_\>VU[[7/
M6W \M^,0&[1CW(G'_HNO+J](^+UXLFJ:;9@@M#"\A [;R!_[)7F]:T_A0!11
M15@:GAG_ )&O1_\ K^A_]#%?1]?.'AG_ )&O1_\ K^A_]#%?1]<];= >;?%^
MYV:=IEKC_63/)T_N@#_V>O):]0^,3'S-'7L!,?\ T"O+ZUI?"@+NCJ'UNP1A
ME6N8P1_P(5]+5\Q6=P;.]M[D*&,,BR!3WP<XKZ;1@Z*Z]&&16=;H!#>:?9:A
M&L=[:07**=RK-&' /J 15/\ X1G0?^@)IO\ X"1_X5S_ ,3)=1M?#D5WIUU<
M6_E3CS6@E*':01S@C(SC\Z\D_P"$FU[_ *#>I?\ @7)_C4P@Y*Z8'OB>'=#B
MD62/1M.1U(966U0$$="#BM.OGBQUCQ/J5[%9V>K:G+<2G"(+MQGC/=JT[JV^
M(%F0)GUXY[QSR2#\U)IND^K Z'XQ(!)H[]R)A^6S_&N8^'/_ "/FF_\ ;7_T
M4]8>HWVIW4HBU.ZO)I(<@+<R,Q3.,\-TZ"MSX<_\CYIO_;7_ -%/6EK0L![U
M7C/Q;_Y&NU_Z\4_]#DKV:O&?BW_R-=K_ ->*?^AR5C2^(#A(XWFE2*)&>1R%
M55&2Q/0 =S7H>C?">]N8TFU6[6T4\^3&-[X]ST!_.CX3:/'<ZG=ZI,@;[*H2
M+/9VSD_4 8_X%7KU:5*C3L@.4LOAQX9L]C&R:X=?XIY2V?J!@'\JZ"RTO3].
M7;96-O; ]?*B"Y^N.M>?Z]\539W\]II=C',(F*>?,QPQ''"C'&??GVKE+OXE
M>)KH_)>1VZ_W885_F<G]:CDG+<#W:N3^)/\ R(M]_O1?^C%K9\.S37'AK3)[
MAV>:6UC=W8Y+$J#FL/XF$CP1=<]9(_\ T(5$?B0'A=?1'@__ )$_2?\ KV3^
M5?.]?1'@_P#Y$_2?^O9/Y5M6V0%7Q_,\'@;4W3J41/P9U4_H37@-?26OV#:I
MX?O[*/'F30,J;NF[''ZXKYMHH[ %>R_"21F\+W2$DA;QMN>V46O&J]Q^&-@U
MEX.CD=65KJ9YL,,<<*/PPN?QJJOP@=BRAE*GH1BOEVOIO4+I;'3;J[<X6"%Y
M2<9P%!/]*^955G8*H+,3@ #))J*/4#V3P-X\MM1LXM.U2:."^B 1)'8*LXZ#
M!_O=!COV]!WU?.=KX6UZ]?;!I%X>,Y:(J/S.!6B=0\6^"9XK>6>>UW('2&1U
MD0KDC@9('3M@]/:B5--Z,#WNLJ_\,Z)J>3>:9;2,1MWA-K8_WA@UYM9?%W4H
M@!>Z=;7'7F-C&?\ V:NW\->.M+\2SFUA66"["EO*E ^8#K@CK^AK-PE'4#D/
M$GPK,,,EUH4KR;<L;64Y;'HAQS]#^?KYFRLC%6!5@<$$8(-?45>#_$:PCL/&
M=V8@JI<*L^T=BP^;\R"?QK6E-O1@>G_#D > ].([F4G_ +^M732Q1SQ/%*BR
M1NI5T<9# \$$=Q7)_#*Y6?P1;1KC,$DD;<]]Q;^3"NEU*&:YTJ\@MI6BGD@=
M(Y%."C%2 0>V#6,OB8%7_A&=!_Z FF_^ D?^%'_",Z#_ - 33?\ P$C_ ,*\
M%;Q)X@1BK:UJ:L#@@W4@(/YTG_"3:]_T&]2_\"Y/\:U]E+N!]%6UM;V=NL%K
M!%!"F=L<2!5&3DX XZFL;QK$LW@S558# @+<C/*D$?RKRO[%\0?LL=RLNM/%
M(@=2ET[$@C(X#9_#%9&H7_B:&)X-2N]72-QM:.YDD 8'L0QYI*GK>X&+1117
M0 4444 ?1_AG_D5-'_Z\8?\ T 5C?$MRO@>\ Z,\8/\ WV#_ $K9\,_\BIH_
M_7C#_P"@"J_C#3FU7PEJ-I&"9#%O0#J64A@/QQC\:XU\0'SQ11178![C\,)&
M?P7"IZ)-(H^F<_UKJK]!)IUTASAH7!Q]#7/_  ]LWLO!-@)4V/*&F(/HS$J?
MQ7!K6\0736/AS4KE,;XK:1ER,C=M./UKDEK(#P[P/&DOC72ED4,!-NP?4 D'
M\P*^@Z^<?#5Y]@\3:9<YPJ7";O\ =)P?T)KZ.JZVZ \H^,+$W>DKGY0DI ^I
M7_"O,Z]9^+NG22V.GZB@)2%VBDP,XW8(/MRI'XBO)JUI?"@"O=?AHQ;P/: G
M(5Y /;YR?ZUX57T%X(TV32_!^GV\H(E9#*X(P07);!'8@$#\*FM\(&S?*'T^
MY1AE6B8$?@:^9*^C_$E]_9OAO4;O<BM';OL+]-Q&%'YD"OG*.-Y7"1HSN>BJ
M,DTJ.S ]M\%^.K76[.*TOYTAU) $.\A1/_M+[^HKM*^=+3PIK][GR-(NR!W:
M,H/S;%:/]K^+/!=W'9S7,T!V*XMY765-G(  R0!P1Q@TI4TW[K ]Z(!&",BL
M?4/"FA:IO-WI=NSN!ND5=CG'3YEP>U>=67Q=U")<7VF6]P>QB<Q?GG=7=^&_
M&FE^)WDAM?-BN(UW&&8 $KQR""01S]:S<)1U X7Q/\+Y;*"2\T622XC0;FMG
MYDQ_LD=>.W7COTKSBOJ.OGWQQ9Q6/C34X(5"IY@DP">K*&/ZL:UI3;T8&C\,
M/^1UA_ZXR?RKW&O"OAI*L?CBT4@YDCD48]=A/]*]UJ*WQ >+?%C_ )&V'_KS
M3_T)ZX6NZ^+'_(VP_P#7FG_H3UPM;P^% >[^%?#^C7'A73)I](L)97MT9G>V
M1F8XZDD<UL?\(SH/_0$TW_P$C_PKS31_BE_9.CVFG_V-YOV>(1[_ +5MW8[X
MV'%7O^%Q?]0'_P G/_L*P<)W [W_ (1G0?\ H":;_P" D?\ A7C?Q%M+:Q\7
M2P6EO#;Q")"(XD"+G'H*Z?\ X7%_U ?_ "<_^PKAO$^O?\))K3ZC]F^S[D5?
M+\S?C QUP*NG&2>H'KWPV_Y$6Q_WI?\ T8U=!JW_ "![[_KWD_\ 037/?#5@
M? UD/[KR#_Q\UT.K?\@>^_Z]Y/\ T$UE+XF!\T5>T7_D/:=_U\Q_^A"J-7M%
M_P"0]IW_ %\Q_P#H0KK>P'TK7 _%J=H_#-M"IP);H;N.H"L?YXKOJ\X^+[D:
M1IR<8,['\E_^O7)3^) >1T445U@;&@>&=3\27!CL(1L0XDFD.$3ZG^@S7H^E
M_"738,/J5[-=MD_)&/+3&._4GUZBNM\,:/%H?AZTLTC19 @>8I_'(0-QSW_P
M I/$OB*V\,Z0U]<(TC%O+BB7@NY!(&>PX//\^E<\JDF[1 AL_!7ANR3;%H]L
M_.<S+YI_\?S6XJ*B[44*/0#%>.WGQ:UF9S]DM+2W0CC<#(P/UR!^E7? GBG7
M=<\5QP7]^\T"Q.[(%5!P,#A0,]:3IRM=@>KUX=\3_P#D=9O^N,?\J]QKP;XC
MLS>.]1!)(41  GH/+4_UHH_$!7\!_P#([Z7_ -=#_P"@FOH&OG[P'_R.^E_]
M=#_Z":^@:=;<#R7XOR$ZEID?987;KZD?X5YM7HWQ>_Y#&G?]>Y_]"KSFM:?P
MH#N_A.2/%LW/6S?_ -"2O:*\6^$__(VS?]>;_P#H25[36-7X@/!?B-_R/FI?
M]LO_ $4E5O"/B>7POJWVC89;:4!)XQU*^H]Q_P#6]ZL_$;_D?-2_[9?^BDKG
M[73KV]!-I9W$X!P3%$S8/X"MTDXI,#Z.TW5;'6+47.GW4<\1QDH>5/7!'4'V
M-7*\ MO"GBNSA;4+>PN[81QF0R+((W50,GC(;MTZU=T[XF^(K$*DLL-X@/\
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M\* ]'^$)/]KZB,G!@4X_X%7KE>1?"'_D,:C_ ->X_P#0J]=KGJ_$!\_>//\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<1DDUBU8#C$+^8?R7)KGBY1V ^>:^HZ^9+^2.74;F2$DQ/*S(3U*DG%>Y?\
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M[:_^BGKEJW_!>HVFD^+;&^OI?*MHO,WOM+8S&P' !/4BNB7PL#Z$KQ;XL?\
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MYI/_ 'SFO,_%OQ&N-<@>QTZ-[2Q?AV8_O)1Z''W1[ G/KVH493>H&1XVU_\
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M><_$75-%UO4;6_TJ]\^3R_*F3RW7&#E3\RCU(Z]A1234M4!4^'/_ "/FF_\
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MYHU_'>V,QBF3N.01W!'<5ZWHOQ2TB]C5-35[&?H3@O&3GL1R/Q'XUSSIM.Z
MQ=5^$=P;EWTF_A\EFRL=SD%!_O '/Y"ND\'^ H?#-PU[/<_:;QE* A=J1@]<
M=R>.OZ5N)XI\/N,C6]/_ !N4'\S5>\\:^&[)"TFKVSX&<0MYI/\ WSFI<IM6
M W7=8T9W8*JC)8G  ]:^?_&VO_\ "0>))YXV)M8OW4 SQM'?\3D_3%:_BWXC
M7&N0/8Z=&]I8OP[,?WDH]#C[H]@3GU[5PU:TX6U8'M'PIOX[CPO)9Y42VL[
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M'(KQGQC\19-:@?3]+62WLFXED;AY1Z<=%_4_F#W<?Q$\*K$@.J\A0#_H\O\
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MA<?7&?Q-8U%%=B5E8"]HO_(>T[_KYC_]"%?2M?,^ES1V^K6<\K;8XYT=VQG
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M+WQKX<L(M\FKVTG. L#>:?R7/YUYQK_Q-O=0OH/[-1K:R@E27:QP\I4YPQ'
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M\*\U^*NFV&G2Z4+&RMK4.LN_R(E3=C;C.!SUKM?^%C>%/^@K_P"2\O\ \37
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBNS^'/AK^V
M];^V3KFSLF5V!_C?JJ^XXR?_ *])NRN!W7PX\+_V+I/]H7* 7MXH8<GY(R 0
MI'KW/X#M7;445QR=W=@%%%%(#Y<HHHKN **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KJ?AS_R/FF_]M?\
MT4]<M74_#G_D?--_[:_^BGJ9?"P/>J\6^+'_ "-L/_7FG_H3U[37BWQ8_P"1
MMA_Z\T_]">L*7Q <+11172 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !7T1X/_ .1/TG_KV3^5?.]?1'@__D3])_Z]D_E6-;9
M1>./^1*U7_KC_45\^5]!^./^1*U7_KC_ %%?/E.CL 4445J 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!]'^&?^14T?\ Z\8?_0!6/\2?
M^1%OO]Z+_P!&+6QX9_Y%31_^O&'_ - %8_Q)_P"1%OO]Z+_T8M<B^,#PBBBB
MNL HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!)!<36LZ3V\TD,R'*R1L59?H16A_PDVO?]!O4O_ N3_&LNBBR **** "IK
M:[N;.7S;6XE@DQC=$Y4X^H^E0T4 :,GB#6I8S')J]^Z'C:URY'Y9K.HHHL 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% %K3=.N=6U&&QLX]\\S;57./<D^P )KZ(T/1[?0=
M(@TZUR4B!R[=78G))KCOACX8-A8G6;N+%Q<KB ''RQ$ [O8M_(#UKT*N:K.[
ML@"BBBL@"BBB@#Y<HHHKN **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ IR.\4BR1LR.I#*RG!!'0@TVB@#37Q)KJC"ZUJ('M=/_ (U4NKZ[
MOG#WEU/<..C32%R/SJO119 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M (1G7O\ H":E_P" DG^%?1]%'MGV ^</^$9U[_H":E_X"2?X4?\ ",Z]_P!
M34O_  $D_P *^CZ*/;/L!\X?\(SKW_0$U+_P$D_PH_X1G7O^@)J7_@))_A7T
M?11[9]@/G#_A&=>_Z FI?^ DG^%'_",Z]_T!-2_\!)/\*^CZ*/;/L!\X?\(S
MKW_0$U+_ ,!)/\*/^$9U[_H":E_X"2?X5]'T4>V?8#YP_P"$9U[_ * FI?\
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M'SA_PC.O?] 34O\ P$D_PH_X1G7O^@)J7_@))_A7T?11[9]@/G#_ (1G7O\
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M^BCVS[ ?.'_",Z]_T!-2_P# 23_"C_A&=>_Z FI?^ DG^%?1]%'MGV ^</\
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M (1G7O\ H":E_P" DG^%?1]%'MGV ^</^$9U[_H":E_X"2?X4?\ ",Z]_P!
M34O_  $D_P *^CZ*/;/L!\X?\(SKW_0$U+_P$D_PH_X1G7O^@)J7_@))_A7T
M?11[9]@/G#_A&=>_Z FI?^ DG^%'_",Z]_T!-2_\!)/\*^CZ*/;/L!\X?\(S
MKW_0$U+_ ,!)/\*/^$9U[_H":E_X"2?X5]'T4>V?8#YP_P"$9U[_ * FI?\
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M'SA_PC.O?] 34O\ P$D_PH_X1G7O^@)J7_@))_A7T?11[9]@/G#_ (1G7O\
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M^BCVS[ ?.'_",Z]_T!-2_P# 23_"C_A&=>_Z FI?^ DG^%?1]%'MGV ^</\
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M (1G7O\ H":E_P" DG^%?1]%'MGV ^</^$9U[_H":E_X"2?X4?\ ",Z]_P!
M34O_  $D_P *^CZ*/;/L!\X?\(SKW_0$U+_P$D_PH_X1G7O^@)J7_@))_A7T
M?11[9]@/G#_A&=>_Z FI?^ DG^%'_",Z]_T!-2_\!)/\*^CZ*/;/L!\X?\(S
MKW_0$U+_ ,!)/\*/^$9U[_H":E_X"2?X5]'T4>V?8#YP_P"$9U[_ * FI?\
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M'SA_PC.O?] 34O\ P$D_PH_X1G7O^@)J7_@))_A7T?11[9]@/G#_ (1G7O\
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M^BCVS[ ?.'_",Z]_T!-2_P# 23_"C_A&=>_Z FI?^ DG^%?1]%'MGV ^</\
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M (1G7O\ H":E_P" DG^%?1]%'MGV ^</^$9U[_H":E_X"2?X4?\ ",Z]_P!
M34O_  $D_P *^CZ*/;/L!\X?\(SKW_0$U+_P$D_PH_X1G7O^@)J7_@))_A7T
M?11[9]@/G#_A&=>_Z FI?^ DG^%'_",Z]_T!-2_\!)/\*^CZ*/;/L!\X?\(S
MKW_0$U+_ ,!)/\*/^$9U[_H":E_X"2?X5]'T4>V?8#YP_P"$9U[_ * FI?\
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M'SA_PC.O?] 34O\ P$D_PH_X1G7O^@)J7_@))_A7T?11[9]@/G#_ (1G7O\
MH":E_P" DG^%'_",Z]_T!-2_\!)/\*^CZ*/;/L!\X?\ ",Z]_P! 34O_  $D
M_P */^$9U[_H":E_X"2?X5]'T4>V?8#YP_X1G7O^@)J7_@))_A1_PC.O?] 3
M4O\ P$D_PKZ/HH]L^P'SA_PC.O?] 34O_ 23_"KVC^"]:U+5;>UFTV\MH'<>
M;-+ R!$[G+#&<=!7T#11[9@5[&S@TZQ@L[9=L,""-![ =_>K%%%8@%%%% !1
-110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>img17388848_2.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img17388848_2.gif
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MGVB+I2B+M0B+NZB+M\B+O^B+N4B+P4B,PTB*G"B,R6B,RXB,KMB+TK10^)9
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M^3B-]+@$H;F@T2X<^0\RH; &6Z5&ZK=R:CE%PIN7&Q-@:AK,89Q5\C^(-!,
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MO^C?O9C>MZ(+_\* [PVCL\!>"EA/YJZ\ZY->]A#@_UTK]Z0BY2.!$Y08VPN
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MBOC2.1U/RN7(-?';+<%(NTU<*IF@@,T(,+E3B)S3Q@F<-*%7@=R'G(S =##
M7)R#X92.,7&(NLWC #2<7'03O0$3+W&3Q 7D^*T(/I+'?K12+>U'1@K8NH$;
M.H((*KV(QL73+JD;=_^L'/,8RY28CQU2"\VQ'?KHY)OT'=DE5!T624\>RU=5
MU9& D!U:W4Q*"QXF8=I9R]*]STZ*59<D)0E=B1R2B4=5$ .!B8T-5%5"Y93!
MG%#:79'T"B NSTK%&)A12?.PW9@,"8\1Y4\F';/8U$[6'579X++P75;9F41%
M%3FB1"HRGV"U"ZH=)KJ,Q6$NS/7Y1+M06O#)%F&-5EP1S>R!XB3A8E!(S1#I
M#.5)IK@X7U4PYM+DQ"AJ36(>!VAPEK595FTMC&N]55Y=(FLMIM&XUM(@'A"%
MH_51C5CL7O.U%O-)']0@Y@])WP\!)[^HQB;62Q7)WFQ&S>4-)DK43MGTSCK_
M2E<$.I@L^8WLY(X(EIOA' ]UM0?_Q8W?!(YVT [^@=AYBLA[H@V:C !YH9=V
MH D>4 <<^)\)!$['9$@$N&"_L0T%RD4"#@Z(F0V#!L_Y45AW2N &/I<_HH[Z
MI:1YNIN\;5=ZYHAY2EB#+4X&JMQ**%#9<1F7I! ("5E65H]&\.']9%4.LE"7
M_62G*%WW2&'W?(^)O@D4?L_:S1"2#>(@QFC3E2'.?5D<4L]6+J&2^:4.[J@
M<=F3N!V7_.6>\51>YN@3$@N3P.%5\13_@.&+%N(&=90'-4N770^5\:!'=0\)
M6*=)G")CK1IM.5)G45%0O(NT)5]A4E]H,-_1!*KG_WWB%;U>6WS1;RV6ST!B
M(SI1:?QB3%Q>7.V:<3!:3!R2#O$$:BC2716:&FV6IH7B*68-[GT%)&D2H]X$
M<BBC)EH6$ED-HGJ&*,)1))&1\@6&71E6)TUJ9X3&(KZFI'6&4LBI280.A95D
M2BH<+J7(AKY;*TU<?#A3R74'*K%C?KG?1^I2/FD7+XTD2&('>[D;B%@'10:
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M08U9AIB;L8A%./YJ2@Z#5AJFN,8W5..6%3X6  >P "A,(<$0UI("WESA8_S
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M]K4"%$AP%@5S?;.% ,*>$G=C'X@Y!A>?[;4=ZP0D^6  ^3:#[+F%]+0F5N>
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MU#\)Y#\"]+]S$,$![+\&S#\0M, .+$ ,C$ %+$$._#\4%$ 2%$$4M$ 0Q,$
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MVK96$.6 FTK_;HOZLF:6W\WVVK(D[@?N'RPZJQ::9D [_RD9IB%DD2*5(11
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M@@]5*5^$R(GL;NML1]PJ9:IN+&)(0@<?9&8V1RYX!T+V([*6S;001+U^ZW_
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M7!JXUNV#>II4 S'0+U%'7KWOL.U%KHW%+N^O.HB G636<!K_M NP%Q9*^+1
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M\R)?3^9,@+)G0.50"W@Z-E-:J@8VFJ1]5&AJ&=E-9F0;9=0:RS4U";AJ6D:
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MF]]>JYO68YSQ*1.MO3G.A!5+,RZM]QFFMD,3';@^E7U+*D"IYQZXWJ+BT:C
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M_[ E@R;5\2?_POV3\CI6LK85YN.6 K$A>RH9<]H] F0A=^FQ8KD)F6L0G)/
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MA7R*(>1+"#]&)9'MZ5-5I/HG]RS2S_85) *8FE[V$.HK>?_:#R2[DAY'\O&
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M#!K63>P@6[0;JX6>4&G9>VA3M 6C.*70BGDC1G4+"K(:)X6)HL0:40S!-:S
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M;JO$',,[XP:*N!'V[ST;Q> 1Z(-6MAK@KO],HL%E(0M8$:2I2X$<06&Y5,A
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MN1PU<W+2\)$YQ&W_[L>]()K3G68U$<=>?EC@N5/B-XFZ!$[[VH[:VYG /"9
MIJN$J9]@=5#6[A:A(^X)9 VW:OGP),J(^991B&*PH<FW)ET7RGKDH2JG4 .]
M]K23U9GIL*KSJ"@(P=F_,5^5=2KZGZ9Q"E)WNDP 9<*2#CJK(<J:()%A.N0B
M+SVF2#_ZL##"D0L^A%<>0,FN3,J2:XUPI"/M%DU2)<\CFJF>I9&0>)Q(LD+#
M,ZQ&G#D]NZ-H,>:\U'Q"F,?SQ9J#.9*B^+GK7!+)1=>@F#ML(Z[XT"8]")^9
M?/F$S)G%7G*)HC$XC>7TY3&/FPZT@!?U^ T^7 !949O<SG.WFM*L8I[]_YAM
M=U?++%T8=3ZQQ@UKH86K7Z03MKN,G%#$[ENE[+BW=$*&+0>">9[8Q[= C34Z
M56O:RW>7M:#A[;Y=NE*)2G0ETXT.2#^24;V-Z<P:79=RF@/O=J_[.&.&]YDF
M2*]Z31==U+FW2B9R;HFL_=[[>LF^<.K04;Z! H@HMW8+\,XFC!0C?\X,+4J+
MMLQE>%0LB79H8[Y'P#8+?BJ0;WAO[Q;,+PX/V69O]3BFY-!&HD(KLE9/MOZL
MSOJH?<),L\!,ME#PJU;/ USB'(**6G8E)!Z"(6I*@H LR(20Z82,"(_,IB+"
M(1AB"2L QW[*(%BB(&""5KINRU H[&1HKLK'9R'FZ;>4AZ]4A8=$1K221RY^
M*/J:9MGR!L4*JD#F)\:,2XG_Y*,^%FU!7&[9Z@0.QZI=T /M^DDK)L4TJL,%
M]T2/_.D!23!>V(CR/N^P,F_3_,$VV"@2RR4 Q"( ["%G:,;R@*,(8@#:!$EL
M*.GND.]^F J*AJM.$LWT&J:),.HU1BD,$?#_8&,_#&8#X\,08RDJ7+&BC@)
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ML.]P\3/5&LMHL$B-"%#Q_QO0Q$"&-_O%YS)]HL^M9E4R_VC%4X6I&&9@!1Y
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M"X;U :^V)"4MD2L#XOH!-GR$A7SE!4=$8"Z2G+ "[')BNUXBK%^-D%XU><
M6E87!^K/;P6#F6ANN;#_59545]6<_O!8F,K69SP,4E1-&7- 7@HE8SE3I\SB
MHC[_@:=QQL1* C\V-YCQ"F\'6@OE/OB=N(1*9S[A&6I\5H06Q*8IGJ2:U$")
M&ZDU][E'0TYNEI,DK#GGE:ULCG2ZUH(R^*P>8G.4-F'_%A66E;9CA<PJ KFC
ML6'6SVZ-Q%!ZY=+-]<1M;WXIV!?3Z]/"R2V^Q(4<VA:4./C-=K1N\91G.^4Y
M0ZDW,>S]HH@^ Y2P+%@RD02?/)46SXI";SE9>NB4%&J\*L$NQ;;S)^Y^]#O=
M&2]+,<Y2/Y%78H.F($O.XY+K6N?CXNAFDZ=3$XLZH"84P0E\Z'. !L81'I7%
M]KQ@,>_(?(N^FC'XC!.."Q91-D[%D3:S!G:;XI(28,(1JFW^2Z^"*]B?D,U1
MN'(A\/\P)SFM^*TP"\3CP>K'P<VLC3,@&LH(;.*2E7C56"KLB+<J\BR!3$"M
M9HT6.A(R 1W:E25V[;1=8W)7_S9X0"/A6F$1*P#8<H4D73HTB4I4TI*74%%>
MC,7).:PBL;VT;9A:-BU=//;-7D]P1,!&'\!(N[C#$=>\GZ7CA;<RH!$QZL^+
M 8V#ON,4[VRF?8:IU1WW BFHDB>8#:.+?_3+9_OH6<]8-,UQL7/)U-1#D\UM
M7=6:AN]ZY^9%GX31<&QC.X9HS94#(?AT!M(<5U*G!>80F@MHZ9E!]9*<=%3/
MQ.^8(:#>U)H8^N5\UHW(?7T\G8!<;X1T!9XT9\HL,LO5HP"6GJ.J6[6P2N=D
MNG*?DX]YEYYQ4+IQ>5_Y2*4I<.J>T1U@ 7Z R74&!2B-^0E0VAUT2%#*$?)Z
MQ"-^3O\T#L+XD9"8(XSE^?-&7C*!ZR;JXQ<(N3<7+4[2DRZF%[6)16SBAYSL
MWF'P.2 :%+B94BW+8)R/DW[&-.;;^K:KP*!4*P-#I,4F=>QD6DKEE[*V 7,.
MFLI!/K(3$P]G*K34:0?PFF:!W.?-[51*#=)O--,F.,YA$[F>1%WJ*M=>E241
M:3'K6M+:EK4H4I*[LF18PH_K\'MXU^3'VB4/< &I>2&NC72$)(1%UPFO;Q+9
M)Y8!)Y")8^EU+Y-F)4\91[FLHKSNDN^I4A_C=DK_A2C_ ([CYI^4463NQT-F
M6;>L12 6_TLV;W,>Z99 \W5!UR8ZB_1KDJ4XSQ: 9-1F(!3_:+HB*<9E2<J5
M&;;Q;]"E;]65'%*C-"IR&Z=S75ZR2EP#$=[U70;@2BIX$,U1'>@P7D6P'5>!
M4OOC%>_U@.QQ<]OF?^R#7A.22S/S612V7PQC8(W4/H6V>I17>>W5-EU69U(8
MA'+#A)_5@V5$99NA7M562.95-A(H7[L6%"9  2:@2>]$&]E#/;=!/5NR)44B
MARH&)'0H)2YF KSS8L-#8[-C G$ ##00!R]&!($H#"9V.RDVAS 6.SOV8]13
M3QU0&Z>#9!M59"((/FT")VMC82\"9:R2;/JE-YN1.3>W:P769)WC6E@6*%$V
M;'GD3./1A0+DA )R>+2U92S'&6\1_X ^R!W\DVX LS=^DS;L-1J(IV5'P813
M!D<8-E\_D0(G "S"XBXII"QDI1$RA!#.L58&<6G1D@=LD!+%\@%.9(ZRUVG$
M)Q/KJ'P/$'T5@2P>@41(Q&KJ8A+M FOQ0B_[6$4O41B998,^!T%ZHHKXA6'Q
MLX"MR!5OI(P*1E_-"%_)ECZ!Y'][@V:&0TSRXQG:!C<BMQ_I@4X7]DMP(7.W
M)!@.@T<DYQ_35A@CMS*?!0[N=H'!D1NH-$\=6)-,8TJZ<37+$7 '(0U;0W L
M2)1%^4H'1Y35<1T^$PPQ$&R>ITA8=5]XDH,3LRAF5A^JXDC6A%G[DB>,XG,2
M9EI\DFU]@O]ZW@%-M1@@Y=9^:"-';805'_>%Z+,AAF(AA)19TD9.4-F2-GA'
MG (.$' -[K0FI;,BWA-BMK$E)B8ETL!06C>'O<-0^R0E16([!N6890 ,HT #
M-) ,94 $G-F9<="8P7,D!&50KK.8D=@Z(99TK:,FJ],B\G28:2(G2\9D <--
MZ!4?8)8JG7.0+X<R[&%_195443DR6*1_K9)5O)26:ID7==8?2T4H>X1LBH27
M-Q6+\E5R,I-QP+0IH?$9PO0GU-83F.<J[K%5[(@2M8=$'B$#*P1IV'(0*= M
M::40)9%]'A!7;-!I3E2.Q3=\7J5\\4)%'^ .&B$NRB(2>5 NZV+_CN>@CC"Q
M?3!P N!W$P,@/L^D6A.B.-VF&"C'A?7Q1]Y6%H"#>0K#E8 Y<7YSDJF72%"1
M'B&2,;<B&$J%99-3@%OF2.X32/_XBRNS1?^"34@HBUJ(;:(#ENC#,T-P@;9C
M.[&#=DZ#D]9%2K8AI5#Z+%HS< 6'<.B@ M2!@M[5!DCY+-_E-6 3&^"@'0K2
M&! $E;SD.:$2D7[A.89'AF5#:,86A776/UBFIWU:,Z&CIPX G0 R4XAS7LFF
MG%7)'NHS;*(#6ESD6:O'2+>%I/MR<Q/93A3@ N0#)RKR(O'T(F_(#],#/366
MAS2V(\"#.^9P8RZF)+#Z3T5"!#00B#30_PN!N)G"T $FIDI/QXA>UY,_MG22
MR%&I\R*26&3=4S0.,#XL E5+"&$UHX6ZU2"AF(#U44;F!3C"M#AR9GD$,T9P
MA(""NAZ*<ZAY<8L*>3*$I#<> YQ8=E]7>&#<EGB^"$*2!8Q6)A85E&4,EFR'
M-A.PQBY,)!)C-0$9T4)"=*8* :82$8YWY43$=WPE1'QT57QW55?Q(A,#X'WG
MH!%%5"ZI1A)+=(\H\6JQ!GOT4D4WX8X.Y&6"*H% &&7&F#8'R6X[6VTX8S*;
MFH614X! RUL(V7-&$6TEDY?K!W2+X6V0Q$%[HJ/(B496R6L"\V7EUISZ-6WQ
M%YXQV3-,V0(B,/\16B,MZ& [*9 "V04]C^BV73)BV06EVH6"1KDU!U$&0VD
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M-2*$DCE;0141< WC *K0JB8;!<VH>F+%>R-U2,TN9@X.Y2,OA@ZR\V*W\P*
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M<)"=V"A8I@)1IH6NZ(:<QT1)I@E'IH7.@H8^ XL<#2[ !B[ Z9K. M'P %8
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M(CX[-BH_IP2VCV*L'JI4S+,"#+E1-^^,\Z6!0[XTPDP935!!+B<"L-&&-ZK
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M%Y<#;A!/A9R?F, 2'Y9<)W5081A%2 ,VR^C&'7GX"VV.5)C$X.A#B$G,$/*
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MV0COM-6"3.5D?NNGQ:C3I>!:-762FY<V&?!>N!D-,$@SC& . SW$J* ,'JH
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M5+3-0BYLC*?Q0E\J)AAHL+M)5>TU553% NPM 50M 7W>YU%%558= '_6WG,
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M1,.8Y[<:1'(M4K!$9PKLRVR.TB2E7&VNT<B!"Q=9P<NY$1N,U[1<RP@P)Q'
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MG&"@PH,' QZ<:#9@ ):($.%0'%#B(42) S*6V,@1XL6,'S=B% G19,2*<$K
MP<+F XL/#]@\D,F #8,'YQXP@/$!!HP', 9\_SBQ$*F^ AH*4""AX9J&IQ2@
M0DWA#ZL#?UJU^L/G#]Q6<,O .0 7 6O9L&+3HL47MNO7LUC!;LUJ=V[=KU[#
MOJV+%ZW8P&_CJD5;EFY??_\8-V:,5:Y=KG#3ZLT:-L):<'N[JJ7[V:X_LF;)
M)HZ\&;*_S)?QUIU,UVQLUF$]4[X;N3/8$2VD!?#]^W<PW@:(&T!GX,HX"!"B
MS?B&9086"!BF0_CFW#F&;]9G0"".KLWW\,NCN1!Q4-H$$2)<M!=1@8T+%E8>
M0)@QHWCQ\ ;V[]<OGC\5P"-.!-Z .[ (%_9B:[74V$(,+*V^&FTMU[R*4#3$
M,NNJ0:T@C+#"KE+SD/_$$<%:C2NV/&0K-!0M7,LLQV2<D<8:S5*-LMALNU"L
MN&:3C4(0090MJR O1 TU'R'T#$7:.*,M-!)AE,P!KB)P@)\K^7%@! =>X&>$
M#D;X<DPQ7PA3&0I<>.%,-O69AX47AGA!! JNH0!/?4P8PAP7U'S!A#*^F2<:
M:<PI8\Y!HP&TC$#GC&.(.!@UX= 7]/DS4!-&N'/-,[^Y1IHQA[@33PI6&).?
M.J\9880(NJQ3&0NVM*#+#KB\LLLJ(^!G&0>NW*I*N_"Q0ID;5V3M1LXR?/*S
M('/\R\=CO]JK022)U+&K($M,;305*0.GQG#%;0PVVZ"\D*P)-:3M1ABG[)'_
MM1X1DTNK:N52-D0H/731MKWF!0L?!Z2B  )_ @ G'X0/SB< @QL:ZJ=S&/C@
M'#;.<>?B/"K8^+TASIO ( ,*>CBDDD-JI@2-0OJ(HY0KFN@BD%@*:>:)4%ZY
M98U:P@(+.'B"B048:CH'*(L9P,DGG1@8(*BAF%X(#X4-!JMAW^(A@:HND:17
MW[1$_$JK=$W\%C?+N 9X[+I*PVK#;V]DT;/0$%.KLQKU97<LOBY<,6YXA7S2
M <(\\^LR"1-#BV_)X%+LM;W>6N:SQR4[D2W!VQH2JQ<,/#"X%@YJXSCBVJ".
MN>NX&P>+[:B#[AOMKDL]C_P"-$"$[LI33STKK+@"_P+>EV.!!3:BL6*Y;_H+
M77;1D_^N.!4(;.$%SGW#QX4B^J+,<7;O,NPOP.>Z&\,*"?=K+L(*O[Y=P"JS
M4%X>C3V?1\6PKVO<^FE<?%NQG"5-;PB[>G]R4?):W]+GM;IHYC#_^Q;D!M@K
MO?EE,K()%JYTU257V:I+9#J3F<)4AA=@S04C:%2CTK2F.97!3U#!TPI>4 9S
MN$-.+KS4HDP@#4"M@ +1<&$-)_4"D;EP3H%2QCQ$,$(3O !/(AB3G"8PI@E0
M8!YV,M69QJ0J+X4I5?/0AZ]R]0(N52E7N?K5E7X5K*] 0!GXXPO_6D.^ ;KE
M0Z^17[*T=QKW'6Z VP,@!/_'<JYV'2:!B['?(!GC&2DA3C.=4:0 ==2KZ]%%
M+F[9WN40(Z)$XB]'BJG<@S $+:QH "H0\!]LZ*(3&"@-!A([AP<JYH$\N*,"
ML)Q !699$%L>9 (,8<A()I(2DN L91FY2$4D(LR'I.1E$#EF,EDB$9>TY '1
MD(E,9L(3%AQM)SWY2=-T<@*&$(4A(YB<LOP! :=H@!^:@5Q>).0V*'WHG2OR
M5XG>-A?^04E9*8(@9/KUK =-)C#)$N2,7K.A>%6FDO!#UY+41<JWF64OI4E2
M6L#&R6X=$$<L:M^/O$47@VI2++OIC?0"(!S_\(<XVUF.=:B# >A@IW4Q;=TX
M,(#_'^7EASSF48\+5FJ?E79G'#.(1C26,X-X-"\\ QJ0 <J05*?^9T B&$?T
M2%J$&+P--R%"6UXJJ9DHK2N ;3OHL9;%-JT>*8(7.IO<WH<:L[Y(CF(A)"$!
M2*%YDE*C%"+-W/:Z57I=%%O":HWAVNHX#$'T+G]9BY$.RQ4P5LE+ON+'"UP5
M 2^BJ@P<+.$1CVBI>;@@4^8P@0NB.(^HC,,$Z*!4HU[P#0J, U&,^H8&W'#$
M.<D)'42(U O,T=O8EO!01]S4GSRXQ#*DB53Z&(*9(E G"H@ILK :@:S$M*LO
M8NFQN[J2E8 %EG'H@T=_@5^' BA>M93MH@UJ34*MY58B_ZT&7U@U$;V^BI>Y
M#I)L>H176/1*4;!<]*VI^=96]]9)NDW.14?*Z(VJ%4"P&5*%,V#-M$!TCJ<I
M[0,4LY@K/>"""FCL/1\#&<@*8@"D*#-E%KE9SBB2XE\*$\4J8S$67!SCAS33
M)2[Y0$UB8I,'9)AH03YE4( R%",SQ"$CL..]P!&/J&A G&DE,+<2NIJ)$M:
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MK6]%.]K_ 24)1%E/UY1E8D$Y99 UO$J-Q9*6M!R".VYID(; 6"(I!HDR3S*
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M^3#=(@"Z6H6RBI!5* L)+<Y2U"107(M4BN@%I,%^\<18!\4* !A9*=-7-],
MB$#A*D5.QN1-\'-:S? %_$2*-. ;VF0=*SI5[J166H6"8U4/54Z[MD2[(*N[
M*HKK>)1YC>0MCT2<ES-)2UA(^K$N5D.LQ@T#/="KG,6="ZGS'/(WJ9HUF@2C
M&G$>#2Q09<]B.WE=J%(\Y\S.9D-BMP)DMTED&:!BYCICZC/N!L)E1XP_62P:
MC3'&0$(9]:YG<\:8_ YG04)G_ZT10J/IQWP,:85F8L[AE+3I YC&LH4"(BI
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M:D  2ILX6<./$;B&->D9@3*NX0(+]&8"ZQ0=!;Y1'>.,8'%#2(X5YJ,;=K[
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M6L)Y:M\-J%*N@\$7EE8MK?-#%:J<;U6-B348-<$UKB4[8:@VJ84Z77V4NRV
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M74,@V>2==AMA:1J0LA$E%7?=+33:11J9&>1%<])T%42WL11:GS$-Y< (#D3
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M;$ +S@I)R;]P3#*>M$QE@I89K6AF )A!TQFA]*_FG E@ZSKB^[HW+?KQ+SU
MX5MO^"6;*"Z/2'#"&T/8*+Y;AN0D4D18E,)HK[1I[9CS@IJ1N"4=5AJL;\KK
MTL,TDD>M5:TZ, G "%K B^$1#_\_J0N1Z?JCGP5!X 'QH)#N(."Y%VEN!AFP
MT()VUSL!:6B?^AE"YJP0#3;(<W8)RIV"+E2A"N63=_[9#XYB  YRSL=X$ N@
M5-0SQ"8Q36S4T8F6RH6TGJ /-QJMCKW>%R7J)4U^VI360+Y8/CWY2:,V+1)5
M(N*4:5'$:5&ZZ$R<-A6<P$8\"[.IU*XF+ZE(;#3@^ 8%!&+  ]ZPAL(B5J(F
M]4!'P9!3EXH I[+:*5,Y0%:SNI2IT#J"$K(J5Z"*% QAQ:D1OO568-V5#7V%
MJ475L(=4[>&QE!(L)RGEI]6*U]0$AJ5D_L]:>+QHQ(+RO*V1U"5+"MMSK#0D
MHLCT79__L=8NJ>@O0O&+BH.B5I?<PZ?G:7-KYUF2 (_VK3,^S#I2TI9T G .
MHH'2,AL+RSD>HY?$(!*3YW@DRH*;W)3M)2THB\O,-KDR2JJ%,9,92V6 IEVA
M!8TS(W"/E5(+)SR=]DD.6:SXL.<E0BE/<&$S;4NP]!1NFG2IU@1.\\06TY/H
M)&GJ8ZK5:/,]M040*65T'V;MEQJ;7)8FUQ,C&14F19E8]FD"01Q%@=>XR;7A
M<?P9@@L4)-"$<DY!):[0-S(P X9.8'(NUH^'U6D%$K%@' S*7(/B.;H)32BA
M&&B<Y#H,O!=0-  .:,'QE/(CK 1J:D-E+6@H_!IKWE+ JKWL_V%Y<AU!K0\[
M3B1P;**"O<ZZ2S: 2\V@JCRN/*67;VH48$QT4R3PQ)&I:+I(DUTIX%9:3S1#
MT( +F&) OSJ 4<'2*K$852L+E+71M1KAIS88PU==\%,3C*&CYQII%9K*JY4"
MZZ4NQ6A8.:J"DQK5#0NM*!="JECJV8A?I?I9O@D0;]MJ+ !7R40"<RF8H(V>
M::/RX#EA<<MA5LU-3$MF,L&W.,*<(YAY [W8N,_7]V5(0N(8Y?4MT;%CP_.?
MV$<]U.P-S6!Z" .XLA6,169GGDS+8]:B2;6T12UNT0LDY[V6Z.*,W_F^F<X^
MJ;$!:.6/%[O8"9J1\.\R#,]7!-(PT_]4-05G5(\D=:I[E#Q%62YQV-PF8T:9
M1*\](7&S-$&.<YYDX,-VU"'8@CAV]B4P=!UM:BIO.?7*/2>IR'RUWJ1(#&)0
MY !T #_J[##DU/F?"5RHG3T&78E%M] +?:-T,.[0AU3'S_V$& +18('FZJE0
M",&(0OB4D3KU4X8)X,<!13YR,%1NKG"]=\T/2=BYVWMNP<7IM<EIN7RQ9EJ,
MP/1([,EOP_:V[#%9#>/^$@_UHN=SI$J8/-N*+6+SA!OQF1=.T(D?'27^/G\$
M8!P42)14EW' 1O40J\&:JP,ZT.J]TNI1CLZJK=X*5Q*>.M*GGBNG,P5#6DWJ
MTY,"5E9G/ZS_1ADZ@8065@^3E3SI>0FEL%Z7RW%[18HT7%I+]5.=5E+X9[HQ
M89%O$I=FLG@Q/4M>N>YY<_!E'*/>=UK8A]BYO05-V3!-M6V29I)LF4!8B=^1
M5G&(S]!T10)FAF5(1F,,4G"IA7%-X%N@Q;TIU[TU5R85UR:-!63HC,9H3%<,
MW'8- -%P!AX<8(.-'FP@D49M%M5PAQS)'^<ET_PTSS0!3,%\"Q%5R\&(5$8E
ME2WUQ$*<C6-A$;91DW&0#7XE!5+81)8U'M5,Q),%4T6TGYUD&RYUG/+42=#5
MP] MSH:)"-+M4XAECM@M5.BLF-E)B.[,0(L)".1,#N2<CGY, !H^_\ ;TA.,
M'-34L:$5#,$^Q4 +$%F1F4 +F  76<2#69N2W=+^F!EN) 2<6(2_J%)OW-)R
M6-D42=:SB(OZ !L1SL]#K!]*>-O:'"&"]>!\L=FN:1/&H=G>,-G*J0DNB5%(
M$8>\"*! :, X?(8-L9ZRN-Y6G9JCE94%84H(D1 &E94&R94R;HH&E=6C11H+
MC=JC8 JC&6.B]9#LD= PIII4394/,=.<F5O@>$TT 5"U,9A^\1WTC)YMI$_^
M"& [3M;GM5*R]88I\A>!,5&XI5]PG-\J^L8\!E4K[A01>8^=/=D=(63<>$VY
M70W7]!2:M<0(J!L@E84"NMMU(0:\(5*^??\,<97%=%%@)LD;)>U,68C@6&PD
M("5@-IB29[36@PE>;R1A1D%B: ".WDS9$ZH43SBAE5"B$ZHCP7Q&;$R,'DU'
MKGW/*?(B<Y@7^D'+$S)$ 1Z@F6$ER E@M&Q)>62+2$&ANCCADID6-+$'1-0#
M+[2 VQ69/;0 -G18VFG=B-A.BG!.CTW=/;'A&%X=@-!E8/;3$(3=C-T.CU&=
MC&  BMF.C/!.V@%/, Q= $A#\*S62"G5T;QC>QP>R$'<5'83*WE4UJ0?G!G6
M0O#B89$7A2E$/YK$#)Y4ED36;T0-]LG+>A0.*6+BLV1?9;7967H3>LR:<[22
M.U# H2C%#@D+#C'_4%X5VJWLU:-,B@K!RJ+$%5=%)PP57Z)PFJ1P%3)FE:8X
M4*9TT%UM5:HIBZ,,!:.4BP$5!**X@%,!4,(\RU?R7!'174#BH(/95FV*'FU.
M'%(RB7LTA+F\W&N6!';85X5999;9(R^&"Q4.IYS(5VJ.)4=M9D7V6A;UB32U
MULQI5/M\GF],@#X(S5=81@G  (L*D@,Z1B%YS%E(8'")I$JB9 0&%UF,15H,
MDL"QJ(\&3;J!D@ER!L$-0 9\5]V-)4B)UDS4B4T%94>DHKT0E5->B9M52X->
MV[BT3T[M().DU$D5CA'2IM@0$P M19RTAT$T$4-2F_CH(&@MY:Z-E_8,_\[%
MA0^ L4N]# &&4=0+C$-^O!A_+%T\.<@?6L@*\%CH.%2'$6J V"&'L5,\80#4
M84"/64A?LI@@ZD=$O661Q8 ;2-FX[1D5PM+>]4L3-N'/,=EPJ%Q$ !/5R"JY
MB=M#^F![)"A)&*3$R5=3#DJXD8>TG:,Y'E&#I<W= )@=]8F$M9?^%*A Y,-[
MTI "!8NB0:>NK-H*)0I?Y1X+C="B29!8=1"IG5JX+AJFF- #F2>W=B=TKF<"
MJ1ISQNLX)J>LP1H%?$-D-=P2N>H5KH\=W0]%^@3]'$7 *LW]X$EK[EVV#:5!
M-&R8\92WZ6J93,UX-:&>J!XK=B&MQ8DV85F"$?_3WL@J%L)I_]B&2M'BK078
MWH@ "6@ "5B,NF6&(!&<CU+&OL$;C182)B62<!W2S%A729X%!%[7QF &95S,
MT,2D9F  !10 PTF<0*(&0J3CE^#405JDV%";@CEE__A-]Y#<#[EBG.(D:&G9
M%MW/*:X&;C8/A8H?:/J=QT*H9-7M4M66#J;E9]ZMB*)BVRJ'1L =90; XKB
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M642%^<T]K@8MVF+5!JP6QJJ=R)(]GIDH2C#?B![X_*9%?JR:.EMSM$_ /J1
MNK$?G[&IGJK=<)&5R8U ")JRZ%"JL1JW3@HX$@LX7ZLRQA"C6%JYBA5T9E $
MQ="WEB>WSA#Y*DHP:E4XAC-5;02Q2%]0N  %L$$ -/#H05%G\IT;C=83X6#!
M7HTLZ3%1V!HO[^)V: M-.;#;"/."330E'MO%R8U15H#TJH(F_B0LF.7QF>5M
M:709?C71@/6&/]3DK.;!-5  S)+ ",B"'ZU;1P921U)&8WC@8<@;8GB,)E4&
MO+TH8NRHT;:D$C?UD"*M3J];,\! ,PP 'HR !M TS":*DR)+LBYSM(%;G[W7
M+J^7$G412N7DMR$-M?&2F24SEV59;\(I0?^LK?]:$\SI;1C)(Y[J$J# U$W-
M25%9C:_>'Q8/TX)2"]<@3T&T)>F6;B(#2(A,KHM-P 2X@-D]+CRY0!RJSND<
M78!X]M'MQ^)N[AN:G2?73B7K!R$&0SX,[N(,!<@.8 ]B7R^;,9\$<)'D8Y1"
MAX5>!WC0'YZIHU=B,47/9U%(,&8QZ%&!Q-SUMF_:&6ZEH@B+!ZP*#)/ZBP!%
M*'[1UO:=EOS Q*&,X_6NIZ%M5:142J-]V@O%[PL]IS(F2K:B6O*M+_B.$'K;
MGNO%JWJ>=SG^]T&,  7\XDXJ]E+9H_5AJ =C!_H!S$$/3HCV'%#EKFPZMQE+
MCP179=V(G(83,-W_K69&=ZCUB?1JY5%5"LILK9QQWR"SL$!A^<,$D, +1_%W
M5<0Y %+&U#"+<J1OM:0@$9)9[!M1[^AAX P$(C7/1(98!$W&,/'/\)8I=09!
ME($&7 ,,%T *Z!(X,,O^/G@8@9]S/$3#_<2+=S$VL9FXC!9I.MO5W!0J,>NW
M[)1WE"F#I=FZ5'/R_*,:+:2W&5M.+6^$D5_!3EEZA<:S?6SU(=E$4:8#%&[C
MU"&'H-/DN,"!Q,,#1 -G4^X0)%T9:/*+_8>,K9CNY X[20B#*$BF"X@(!)TT
MO/8IN\'QS**6>BC#0,E++,\GVL\NU_(E#N4M3Q;[4+A9NQ?(>3%P8'32_P!R
M3C39^<ECLZEJ/1K1FNA/L#)P:W99PZFF@ZV@ [C#-^SS7]%0\]VS5B%?[.4W
M=HXK.'85J,CSJ/5*NX,C.((*/C=: \EKO#I?_7I$8 F6K$7#-_@@<0QEM:W7
M:63-:'*TF3"B>\6&Q( X+\.B26&B65*%Z#D 1C<8,)<;;[-C+S$,MM )R2D)
M,/V<'7^Y,BE8,O=4:Q$%!F0U!;@ W[C#-10 3=NTM'Y$NB5@BO+T"30@SXS%
MCG+,(.VHCWI@(6V,3W>%BX)%("'M933Q'VT&5WP71?Q9E6_U4)V#!G2]S$>\
MWMRQ"L?I0&*[F4W12[2C%G=L=T_'4= +3L+-%?]''-:@G!8A_*EZ60+WJM7D
MGT-'89R^[F>F]24B7DD!(6(I10"TI2D/+CJT )+UT^1(NHAX^N0G;HB$"-9M
MOHN!F.9X3H6 _C=$PU\28@P\=ABV0&#YID]5[7\*^GIMGL=F5(:2,%-*DUFJ
MDLIE,(7)8-\*3+M0+ .;U$?U'UC"O9RB67T6,,T=E6JD$?(040CGA(5RB[GP
M5$QHP HXA7H.A2R4][M>E569.WL78S!^U:7H=W[#7GU#"O/IM_SV%0,)"Z/(
MK^K-_ZO=;Y.=4>H*($ X\"?0 ;B!_@PN,UC07P1P# \.-'@0(D1__A3BNPA.
MXT.) B]V9#C28$>$#3W_4C3X<.')B2,1_I,YDV9-FS=E:A3(\6)!@@8='@0Z
MU"%!E$==!J6(T&10I48E7O1GDN=!I2AA3A4:52G+G@@5,@27AP*%:QHTL%@Y
M@42! B2NC=@H-MV# 2<>X+4+PRZ# 7QAG/C EP'@P84_%(9Q>'%C!@\*1X9,
MF/#?#Y/S?OB[=^^ !WGMGI.K%6$9#07.4C AT84&LVB'P/3H5:5/A!8/AFUY
MM>5&J3LC:I3*46#7D+][KK0(TF5RI$%?1@4.#J?RJ. B(,R.CV5VD#J7?H_.
M<IGVER7!E8\N?.G<].+!ACSO_&-TV\ %=E0_M>3 %B[J"4#  0DL,( 78OA/
M_P05#&C0P0;;<#!" R:L$,(')WQ00PTS;'"""5S X!L1182 A0D>= &;<8)Q
MP, 7!WRAA6"48\FH]%(23L?Z?@KJIY."LY&_(6]K3BRA=H+(JY2T<^Z[KW <
MSKNMXO,(IRNQG,DCB'2*SC?AGI0R(I^6S.^X)J.JLB#US&2(N_*V A-)_@K*
M[C:/A$OIR"07&F(>#'0J;B '(BB.GT(C*'0$!QPXU($7'%@T D<C>"%1?BR(
M5-,71NC@T0@Z?3142"$]E)]/#UW4TE!#;1114%U-=%)&":5U&0=NQ76@0@DR
M2B.3N*MO3M_0XV\_D':RL\?^AL1..ALG<K;)'%<*+O^Y8]/TZLT@59I6H"S!
MO<DZ-,G3:LTQY]-S(6?A8U;:)(<,%D_[[DS.MJCD)>U==&4KSX'6*"#!-8%9
MP&<"LPK0@(01 H"JHQ0\R\8SOAX K.(!!JNX8A@4&VRPQAJ;#.2,'X,!9(U+
MQ@N&S5:^^.*(!QB@@F8/PB>%TQ1>V!^ !7XM!:V<I9:TC^SU"EGK; NV2S+Y
MO--.(?.L-]B?RE-Z2V.?5>DI+W$"KZ*6>MN)JHY$F@AHYM+42"GPQF;J3N:,
M[E8A'X>RB&R,:-OSJVRE:4$:& 'G)Y@69FP#'0L-0(?"#1E7W  5'*<0\C8F
MG_Q"QSLT8 @4(T3Q01%<(%S_F@ !-Q"<P>6"EUB!=&NNVHOF-CNCK\I&;EU[
MORJJ6Q]QCX@GL6%?TNV?;AQ>NIC"35ZF>I6\3NW^>%H)O!J#+Z[:_H GVO>M
M;M]().]= @Y*9(UD'F\Y#1*! @AZ'90@7GE=-%9-"[54TQ$4U;2#26?-_U3Y
M%Q7 2$4@4_BSP*SD=RI&X6^ _/ 4H?Y'*/XML"&,\HY1&%6SK30/)+-C6D04
M,I>S@>U(W+.=]IZDNAU=37@I*<I$P/.4>@$-//I2GO)R,YL:<E!Z3A+*CD#B
ME;#XIFGB:XD1Q0*FN''%;$%\4O0J4B2.D$5A"DO-^D@@,-2DCGK"B< Y/&.7
M$^#E_RZ:X<L)SEBRSYC,9)/Y6,D^%D>3F5$S)?,+7S:#%SV")F9VL4L*3&*F
ME9CFBBPXS5G@@A8-#$%/SNF*1D)8E2=FA2$A'(Z<SH1!MTGE;59)2-ZB5;WY
MW.M[3"13=9)"FN]I"SD;89-\3I*?N 7+A%X"TKNZ0ZPA,2=9>Z/E;+CU(WD]
M,0(QB(&+2O<B:20H!B*01H/0P2 ,*<YP%*(F-1=G36DR3IK1M*:$&/>Y!,T(
MF<DL4-]$T# 2.@PYFOQ@S<Q&&VG)ZVG;<8^^Q)*=V>@N7L/QW;V@XJZLF,]*
M-PS7>.QY+O$!J4G F9X]B[24:CDQ/?V$%]6&-IL@3LE9M/\DD[^.AZ_AD,0?
M$)C':FC5D(:<ZE;^D)\%->4J1R405 \,X/YN&JG]I<I3CH*4 %,%05C!2J<P
ME12O7%4K6CF '-Y!:J\>$@$7<+1;M(Q/T^2D).^ ;:MK(A[V*CK,DP"K.>Y1
M%I*:&$JP#4T_]^R/00\:T5!^+T]P.U?<YMI*,NGS:%H;JP8C$E&)Z 9.LL2G
MV1J*-=(,X2S7R( _,(!(UVC@&CIK2=1F4P'0@*9E*P/,Q 80&8Q9K(TE,TP;
M <.QC;G,8BH#;5[">((!G&-K0/K)$"@KL&M0X#0K*$,!S$*""<"R7-J[FGF
M5EAF)2V>01GF]2A:)^<T$H4=_<W_>*HVGQT1$2=?"6+YADB]W^$MBFMJ(D._
M9[VRL9-),>Q-]%;(I:,T#6A( 9[93# C<)C30 Y8)N%<( (+0>YQWM00@QA4
MA@9MDT)EB)"#'1S-"4FS0Q,:0H1 -\Y@H",?_"V0 V+@!KII)9)MB]X+XP2D
M7]&./BET"?I(\R-XM0YOPQL7886TR1<"5(IP!9>,;WF<=1'O.M]-";/NQD*
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M5[[HBR:EN;I9LKG7/>E#PHSSE4A%TLG@7N#A_DHC="TP9H!%(.#%J1S#+3>
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M93Z.695F";ZHRX;#;G>V]-V\7E0#^0TRJ3F[JW1_F*5J*YUL$0654D>5[]F
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M/:VQ\2U;#)3@_<9;/"[I>+-+QJFOR_,[?"6.44>Y/%=LSM4:NY5,R@!T#+$
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M=8B R.^\X>KT;_;^TL1W2P^_AS!]%@JOKE-5Y=(5_ZG? 00^</X<@"NXS)_
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M1W$GQ/!.PPP:;SFO*3PX6DKWOJYWH0C9@.-]"9@W1C=OE7: LN@*A]29I7=
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M^!L1-=4#P/,"C*#!^JA]\&G[? U0EL$86,%!!CU2K#XA'Y]5:_==\/\0[6O
M"A'X=$$B0$U]N( "$Q[!^F^B_P1___@(YGT,,0$:@&P!$'_K508<]Q-YA6L3
M8("QY@_ IP%V51"[)Q 18 4.Y7W7! [I)Q#]IV".Y7[VAW\ .&$NEQ=IPF$&
MI#8&-2.1U6)&9T;/1DILQ5!!8%4+,037]%F61EKP1%KQ, '7H _\  %60(1&
M>(#15H0B\(.E-0(0< TDD%CU$ ]F)&US-0-4J ]/>"11.(55N! 1P(6P!$7C
MMA! *(54R&@8V(1>:&D2M771!EF,M0)MAX%F. /N(%+S!X=?"(8SP(9CB!,1
M (B\=H!FZ )0-%*E%0 BED;>5EK@4 \0,(C_8NB&BDB%?.B'"&(M/Z)=I!)Z
M55)R'] ,9(83_.1W H$'>L=UK,AW3@8.;/  RZ!'S0!;1X*+#S $<%!#<=9J
M%0 '6/"+93<"N&B, U&+MWA;NN@ SU4!8D9P%5%,X#",6( ' X&-J=A<U-=;
M!/%OX !0)8 %9&9P&>$/44:,'[ ,!3&,]B #[.B.PDB,RMAJN,@&]#B.'P .
M([!'?I13F(>/MZ6/AI&/]"A:%8!;YIA<O=6,N;ASZX@%[;B,MP5X ? !Y^"+
MS0!GB_<\QR5:"&F1 ;F-5T:1"?D3.)0OEQ(HRS%G*X!H.,&%,JE65(03LA<
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MUT]7.B)0*F9P6AZ .F8!$&5-RJ+]9A .$R<Y BC_ZN81@_,3BR9:$,!HAU8
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M!X%Y-V%,1+0I6JJ#>5!Y_E"D"^$!Q970%:%FD1>EYMO/#$'2#!%$(%IY6C8
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M&?\@UW.=AQWOX/G ;&84! F*1I]^1KRV\)8!1?K0;/>=W_3^\M27H #*G23
M\3/ :X1<]!I/"1(*$@F^$'_\FZ$5#BJWH$+"2L:'S&=&]#NW C#?MWTS+J-R
M/A0#,!YE4WR4$.N(;?)FYL!DHD6N95):O5XF70X !R9 [P. XR?]T2S:IS$J
M(&0JFQB= B, #J5[SSLMI/H+T@ZAI?#2TWL_I1'=SF:V>7BZ>':*X_ZP>4D*
M2.7A>;3%;X9WIC$Z$EX.HNV,]Q7]XZ\?O&8N^4$'!X*D>#MM$S*PI5?VD5J*
MTGL?T3%^^U\Z(N! >7_T ',F%WT6/X #1@8U9_DP46+_9P#B7NZ9GA$!"J]A
M'5H1_.M?7<I/K9-7F0+D?M73IVL8^.X_@0_IIX",*=;H3Q#Z8/]S';'D20$
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M0@=/%)'$B5*<,4+=FF'QI U1]+'$<S[[$+@!SHEQH0U#%!'*_, 9X</&-HR
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M; A7>YS>WKRU<*Q 'RYXJ7A,PF:CQ<0?BDDG"]1[MTUUF6^H@<QSM!B/Q<S
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M0TM9D !<Q5JTQ5N\M1"41)9YQ -Y"Y.A%%P4QF$D1K/0H9TB)@?_D)1%(4,
M*<9GA$9</!F=VZD![,5&Y$,9C,9MY,8M+*Y=(Z9>A,3EBT0_[,9S1,?N(\,0
M=$2Z^*FK.T%S3,=YI,?.8Y1['!UQ_(=71!!(48MZ!,B G#V<F\2VT$?T8YGE
M$\B%9$B[^\)?:T58E(M?([[E.\6&Q,B,I*E/O#J@:L<\5!!)+#*-),F2#)T4
MK,@D#$=Q!)"U*!F:,\F8E,D&6;*6_*&;2TCAT@M*G,F>),EDJLF\.,A?>T?W
M\\FCE$EFG!1(29"A%#WS0\JH-,EJG,9%64;T,S*CE,JM9$@ ^45&L<9'5$J*
M7 M-= "MR0\KV+/4Z)!884NNW,K5N<.5_^Q%B/R/XH/+O 1(E Q XPO+N0"\
MOJ@4;=3+PGS&A$0+96*+@Q3!$U1(1>PG.B2+>)B-CY@ X:,-P^Q)1\FI;XP4
M<0S,EY%'S21-5$Q&K?M"B1S'(BN9EBG-URS&E&S&OS3"7\.A>R3,(/2'N,F/
M56NN4H'-GE2=!"E%?=2I8&.+X%1.6V2+XDO)2<')>_1*N%K.ZC1+P!L=VB1!
M)$3,%%3$QY#,..$.L6N.T;1.=.Q(IO1'MV#,.\RION#)\Y3/#/Q&(AR0E<E*
M:DR+^>1/+@1+8!LN<5R4UD0FK90[%WBSXW@TYA@Q%H@5![!!K< :!["F:U T
MW@P $YBF;!*!#HYQ,]0 BE3ZF8T@- C-)KZ!&1N\AAG(Q/[\0TF\PU%D28(L
M+A>UT1F$4974SGT,O%DTT!L%4G6<2[!DS&4RP&"\/!>8@>/PIR&PIA7XLNO@
M!Q\<C,%PB2D=C P@ 9C(#8%XP9^YCM1@I\M(M. (D;/,LI\1-":%4MX+4E0T
MP=N\NJ%4$ !QE#?%4^L+$# ,_]"Z&$R2R:']S--!C;T4=(O6[$C55+]=6Z:W
MT+P\V)GUZ*9.&X&B"0"A*1NKR1<6"()T&0&/$0\H"[_*J!RQ$34&$9O5X)B"
MB<-KX8J;(=0_#$IXI,M'[$@4S+E8U=7_JT:TR+F;N\U*@91=)5:Y2\::7#(Z
M'4ROB\^D6PT*<9K, "?9, D6J!4@U(T@B">.&(*U4X:+"*< \ W5P,S(B Z3
ML *)\(=Y8H$R,,]B%5+<]"'&K-.7@==[U;M7_%-)<1DFNSI\!=BC:\Y2E-%K
M_$K[S$VE<X$@D%:FZ0Q[N+MZP1O!H+X9V KB0*=K\IK':8P/#8"[054(: LM
M_4'HN_^<DUJ,&^0;20M8_[//._Q((XS'B/R+EK79.LS/EMG1[(1' ;G9G_T<
MBD2]M&C/(M.Z=ZTI4<L,RM2;B_@.BD IH*,[AA(/FW&!G^.'S6"/V2!7A=@.
MVX#2=**$Q4BGD%J-=-I2H/6_CGQ/A"S:4OQ1M95;R5B0KZM)23E:Y[S(N>5;
MCI@4'$)!.CVR@4U89PT"3HNU;_@,5]4;S#C7P-F(K&BT &!<::&<RA :#QVE
MB-6/?!B!5'J!OJT^U(-(/!30U;G'LA3=U0T A$W4G4U=9/5.&WD!-\. [XN&
M0F1=%Z7(KQ-*EER^AV241Q6^X&@GU?BS>"&/FWB:,O@9B1#_EDSUEV$)$;$A
MJ.9 "MJP@@S@II*:CY"Z#(W:W<]+5&14BR)]F<?\G!&H #9@@ ]@@,0;7QM-
M0A]5U'@,WK@UBQ' @ J\H_":7Q>M2-*!3M#LR^++(<T3@2 @,SFS'(=26872
MI2^;&>3(@-S8T.@;C/60EH5PM9.R&1+M-,' 07M"BKNI8'JBCP#^/],31:/5
MQYR33?T%#'_XD@OQJK0*.18^SP#<PXXD17G]C_XP, J #!%P@<M8(Q=H5AXN
M3,\4S,4$7O.3SB:>0'K9J($2CJU98"A]0.\X6T##5@H=#$M[UBQ&XY=@(C$5
MLH5]WG6:" .HTD1T8LVSS6.4XEX<C*; #)D-\:H'\  \P(,* +AFD($Z7L[0
M^R&KQ$]'D=-&X8_^O29HZB\R*EQ$CDM )4HDZ\7!_:'CPF2;E5T W5'DJ]-C
M'4UQ RV3T)W]N>10[DE#?<F10> @[EDDS8\(@[U/^J+PA.6\)!W2*66_"]X%
M&>)?QM=I%*ZZ=4I4AD_^T!\QV=^"0^8GON5)_[R+72RR8P:,"-@8_1@"*=+=
M_OC<1/HSF(D&LQ,V@Q"/<):B>5@C"&A1S5M7*:(^&YEGDZ@'MGOE[HL&#0"W
M?485@08'@>Z0?*Z^\S,N137E;?Y;&JYF/.7+__15AO8[!6'&O."/&1D K<J/
MUWF@(F*#Q/J <?ZM'W&LD#F'E#:+E>[G8'+IO'OIO(MI7*MIFV;I6+GIHYMH
M9%H^4E3F$U24#-" F"B+["6C+J3 1%(CW%.:^YI<[O&QDLB("E0C-0I=Z_OG
M^T)HD] 9>_B<5^+":.@)LF@(A3AKAE")"5 &EHU MH7'F-W.EDG-?XWH8CW-
M>)1K]>-9G()HSB*V//^1'2DY/,=(K;$ZG@JP8GC#AX>S$7SPJ[* ;,%VNLG.
M.TZT/LO&-<W>;+^RD,_@[*0[5N'E9#$<RT3]:#7B,I,@%YS930JX9_U(F#@,
M 'L0 2GJ$%5A7(C14G"A &GPZEOI/@BX!K .IE>9Z3;$B80]%?($Z!T<3F!;
M"WT<6INLV;O>U;B64Z)ER9-Q3D?5#_!99;(XAV;PZ =HGF/[  J)@ ^)*L#P
MGV:PX@P\G[JCPN3>POHVNOKF/_U.NI%YR;P&UJ<<7L!@ 0W )[/HWVOPL/Y:
M8?T0EN*-8PV(PU1ZE0SIE.1(EXS07::8[[A[HIDR"K>VQ50RPQ"G"!:X!J3_
M_;SZ%$#T[<Y_Q.Y=W4.?;A3&'&UN!@P6FI.3L#;0RH/!:I%FH&Q\"VG].!)-
MC.RX*RQB7/);\RLM?/*CH^*X+NVYV"E@J^C\4(H'3PH)>QN$T(>RR%I1HA #
M.!@E<@$/.XY*]9P1* !O!A<*/PE5V3 6T <'V&J)L(>MAH!8&8(C6J[&^"Z%
M^;T/-.B%$.A\"&<)FR+N$?1/B94R+VJD*"4*  I^WC;Q\X=ZP((9N.VCX/1"
M_]3EBJ9#_[,Y)/-#_P:L"?0E[I!_UG,I&K^)>/5!MQ@(I75,FI7L$K_OLB,(
M"&<=) &CUCU #=:1,<Y$I65!G7%"-=0R?%GJ-D%R_]R/#[E"D1N 1C.!"SD)
M_1EOSFJK@H #!V A.%COZXDL*%EI*0&>"L ".  9YH$0!DDW%T&L>$<L<]N>
ME5Z&#XCWM^$(@'>J%)*)<C_W=(\?<#B'@/<.>G^1#F'XHB)X@3=WWO( $[(K
M.& #%S&V")H A$<LA1<RB!\"8;OIFO9C=*>0=!,1BG=XP(YW&A%R=).?AI?W
MAX>#>#]Y"7D\GK=W$OD0KX*2\\%YD*&KCW]OF1O"6<5)G5-,M.!)?4CSD\
M,:)M?=& 0ZDD'V,0%#=P6-$'SXF&%9@DJJ9SJT@BMOD&(=K (;CT#[SM=P:C
MDBBE"BP)L>Z8 "B#IGZ8,__2@'FH^QOI^A57%S#:"+VG7)68@2<P&*#(I)?
M)34"%TA:)$IJ.CB_(\,?FS42_ ]4<7*Y:A) BKD/_,$/ !8H@'BH0.B2"G%U
M(SG:HOMJEV^U=0TPZ=@3VG>D4[F\QV?7U1IO1&4$30"<Q/VXD*B>B!L> >#
MD3JAJI;VD<(Z[ N)@'SXD!(@$GSCD0HXA^HW@7,H 1RND11Y'<0^O,;P*^*1
M/QIY([)Z*MVE?O3O$!-A ,2NO#!!;->B./@'B %#P 5P,*#9@(0( P0XEW!
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M!%_@2D -RB0FQ"P^$$-\WT$]A''TVS#M(:$HTR\6E'?1"(E]D@<IW%J\B[J
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MXK(K%:9HJ/Y#WXQG""6NY"HNB3DLVAYL@UKNTWH(/V3 "N!MAY2!VQ'K?LS
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M=M0Q2?AJ!'RN_QJ,(0>(%<R (6/9"@RD(/,0"^B&56-$/O3Q"9. Y^JKK+J
M/OS$^JZRU.CKU>H&CLTO5^LKWE;&5K?U"MR355\M"<SU"I1L5_=,5@?K4RN'
M;@1!:61U6(\U"90U^]IU/TMN-?HL]):GY6R0+%624:33"2Q*9I.:I1JJ0C@*
M1W@V0:B$'B#$\7:VI3[80U17\3176YK.32-ENEII]X[%)B.PNLXV;T<IYV#R
MK=*J^KW(A^PMOSA -/!%*[^R8.@K79QSZ;Y5'OB#4P? ,A\655MW@-BQTK
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MD W1< C5$ S=T S+T ?A< SI, WQT Z3\ SS4+'"Z*>&YGM2S ]Q*8C>S97
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-KU1O](M -0H= 0$ .P$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>img17388848_3.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img17388848_3.gif
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M:[5[<U):0A"<UI2EUKUKK5+>(5*<(1F<<QG>(1F<(<4A&4I"0DHQ6G.<SO<
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M]P+2I1KZ! V\85TH<#W"L1KM-@2?< @?N (RZ"8QL &78 ;T] )#8 C[]X
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M)!FD 7R2*,%,#>@R*\&2+0$S"03-,&F3-2%-%R1-3<I 4/(3$80S.3$6/./
M?_J&;0$4/ZF35;(E%<Q-/E/#4TLS/OF63+F31;.G3D,UA*(F9MH673D&<0*F
M5SD&*4S.4TN5/2&G;U).*4RG2X@5<[J$0*""::K.0[.U50'.77LT7=.U3'F7
M-$0F-QDT5EJ$,0B"9TB#.=P3.>D3," 8C]*"5' $A*&VB@*#,<BVBD%0D+*8
M0BQ$CA$W<1L9!UT&DA&91CP)FR*L#5"#-KA'7IRY'" ,U,J)G""\B/B<$YT
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M1T.Q! 1(//C0L4DG@_\L<E<BEW3R6"NH3%$10JUU%%!^1U6[U+H[_K?OOD<
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M2FW7HC*YU6=\6FW_V6ZMQL)G*!YB<N8G**KGXTC6+=\R?\[5>9:;M>DB4*
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ML<2TIRM/=W0.<W7:3%Y-@&BMA'6N8<0)_(""@X%%_(48&,2#0\5??(M /(M
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MA2N9X8C<<Q9\2!>ZW.6N?<5K7OA*)4,\.>-TM7*6(.Y7P'SBRH=%+&(0,_U
M%I(!46)$Q]]<6<!X]DP=H(PC5XZR[$TRLRJW+"4AH8DR2U+E<'J,^$+N,DI\
MPA/DC],I7AC""S;BA8W ,PU/ X=5I,:6-'#S7!W@Q#[I>>=5K&(=?@9#)LY6
MZ+>P8?T&572B!<.7AO:%\/^0:&3PP+W&10]Z_+?H"D9M SS $#S  W( #SQ
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ME"Y0L*A1]B2\>)&]S N,1 4.-D53XNN]EI$YYLOL;B-7[LOM:$4:<V6/@"7
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M!_[H&TU4EPM)''V9D:S%11O)OH=9'4?!%1H F76A% )\DL!E\;S"F<4 FL6
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M #76L8I5,.%.@I*3H5(!!CN)@U&/>E0X_]!@J4I)"E.5TM2G/G4_[J@*""+
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M<8@5/;8!&[7Q<=KC<9-%!-USB<.!6<=A',BA'.>S'"D ':$%!2VG 5 @'<8
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M1Q!".2W61 2WUV?K,I:J8O\#(A-+)].55]DO6DDJ-E!.^U)8;D8J?>8OYR*
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MX%EEI*,9EU2E8E4)#GQB$I06!PY+B8DD@B0)+W8UJ4Z9A%>=2L$ ?N WDC2
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M#M^8'^+ RH.U'Z_L2N%@O;H 2X?='P:: YV<@P\:,.O0#EBXA!.Z!)(+ BT
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MB;%?!]=I)SKI*<]][*<="+7'/PE,CG<(:)_DY$<YSI$@>R 4P0M:,#[*84Z
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M0 +5&<$XFL_[E  FQ,9PS<9LO,8:+$(R_]A";(" +9S'<)#7<.#C;]@/='1
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M@T="?P>QT.(A7@FQ[M8M.G!UWBSP0>=Y08CT$*:67C,LPC,D@XA@N@V!@!8
MQ!F!8\ZD&I-&BY95F9:E B,0(BDG! 4F*6+O8I$R-LJ4X;&QC(^.]LJ0%#D2
M)4F59?ZU=/D29DR8 VA.P+,!3Y$($0;LC*#39U ?*RZL@(8"Q5&D2Y4B/;HB
MQ@JD0!KG-.!1E0?5!A.V=JV* D^,JU6Y<KT:)0J0J0R M# Q(2A-N31W,FB1
MHT44'_88X!FR8450P3^C\.#! .V*'"M:,#",(@<>%#YV3M I-P(#-3)*#<'#
M@R=='BL&X45\.(<+0RB*](R@EP=2RH-=H]A@B,?<G@Q4"_&MQH,00T!T%Y\[
M88+Q 5R!1%%.L\4*(&61=T5>'3O7!BU0@*:[DT?RY\;!,Y#: CV*%93'TYW
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M8";  P4I)PIO&4]TEC>7(TA%=KJ[7>V@88+;Y6YV_8E"A^;2  \$(1N'X-
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M: !5G&@"V\X0MT"HK>P^@ *J-&\KXP&""#CX'+1\D(?CFU\/42"$%SPW$4:
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M$TR@/E"(>Y+2,QSO?-(KCG&(=6YHO62@!#QC@LIR?"I9?=('?59@ V0@#"[
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M$J)606$,&BL5!B<4] !6%4</\H,BO_BR,!(C.0)9-5(CT_@?@J<!1" ,8F
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M$(A%$&$1T1S#,PJ5!C5S6INV6$4?S@ &4I!S4%IH9Z=4(*E0G8$4>LA$MS]
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M"/4"!'&7 T3C--<R54:P 6'@ 8&E=(8PDHN#<)G5 '<S :B"EHM3<0/)C%$
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MYFK*6[#-K-P@9T/-W?PF,M (#%*X_VR[TT(@RF+0 <A@)D'-3>3\,#%05B:
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M@<4A8\N!'!I@^-%Q0P?:8]21 E"0WB)89$7FWNJ1'DRF@DY&;RO !=" "@W
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M$ LD;2B_ ;B!+FF&_O.&,QF&'YN_',N2+F++!QBCZ>L1.=*1_@.R,M*1L!P
M+* R&P&'@+J!&^F2+&LR&!&3$8NC12B3* % QB2# 2 "1% 3 CRDRA2QO[2!
M%7D31>+, IRSX8LS.S&4.%L4$-,S.V.437(S(("4UJ04/A$E49&4&52T33E!
M6*( 5X$T6<I-. B!K*R4)I 5<!#.7,%!3CN!QTR!W"P57^D58 D68"E"9JF
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M ?" ( 72@J/%RO5=K4X#2*P94[P(%P "ISD#,WB)H7G22X!>:V"!JP*!$K"
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M)QP3S(HGH8("^JJ=G1*JP" #7(#GL=!&NBPX"H1[ +9U\I."MW9&^FV=&@S
MP $A^ G' ?FR,\ P=]0)3KX _WL NP ^94.^<. +!P7Y'N#4!0? 8<, /2A,
MP;X74$ !NQI30/$)!'O;< _\'D !'">004;()S@%!05-G! S.!2<<$(#+-],
M,0PWWUPR&2&<X("W_<R#33\AA&#TTO.$X#341/000@]26]V#!D1H@#76!AED
M3 I0$#21!@O=,)$Q%]T0]D057:3V#3]$)!(4&_T !3MWBY#_-TAS_A-(($&L
MA$5,'KQ4DQ UA2$$(W@<DTTVC(21$R.->.'%)6M8HX4UUH36PE,-#++6#T"@
M@((1+Z"P50YX] C6)VIX4,(&8VUPEEI[J?'"%FK-!5-=,&VP1NU[I4 73&T%
MP4);:[E1& M!% ;88;EO(/UBBSWSV/633<99&G!]_UA<QAFWAA9IF-'(;I=8
M<\D<W^A0 B?(6-#!]D,$P@(+F/"&R6_B$(CK8<9\QAE#*I"30 4RQSBD 04H
MO"..,ZB - S<3B8RT9WL("<)90C/D]SS'O? YSSRB0\/R&!"&ZPGA7Y[X4D&
M, &#&<Q*&P)3",?$)37I:(<^["&6_VC4(A[><$8'FD",2#2A+ZUIB3JTX970
M!"8BLJD%+G"=[*;R@D2$02Y <H$XA->6S'PBA&MJ$!IW2*,T*=&((;IAEJS$
MH@2%B8E 5",;J6BF.*:)0$7PP9,&8 ,8\N=.>@(4(ALP@"!0JU5PJ-8CM2&!
M 8#C 8R"%:Z4]2AM] D(@MJ MQZE0FVLBE23(D(6)$"Q4"K@")0DY:I@"2I8
MY0H+VNC' &Z025T62ANH5.53OI7)90T*ET!H52VW%02H,*L!$P"'-O9TAPW<
M )CM4H *^5$G1/))D'O*50KRI( Q>%,!4,AEG>I4*5[D*5<:L%.S!*F 2D5L
MF_:R09XDEO_/A>5+7D!P&$ !BK(>5'.5&H.#>4[ L'RA[&3LXL4!FD"Q?E!@
M"B.#0P@B8(.4-<PIRM@8Q680LB8<8&8FG0 9^I$R]_3C!. X04LI-@^7#8 <
M%4B:T9@6M:>%0&I/(\(\I(:%>6Q-:T0MB-<T +:QI:!L"BD;V<X&-XQ4A!TW
ML.I'Z@82OMTM)'SSFQ%6 C@JK*0E8(&)$+(!$\1Y@!'9" ,CA'$,N3+B&'/0
MG#764()GC&$%_LF!.#:P@A9P@0'"",+I8G !KKANL7BPAA'&@E:6Q(5(+[B$
M[SP0/"*QQ1JU0QY:YZ*&(3"O+6+4BQ#R,I>];  +0SH,8!8SE:G_7&8JDYD*
M9<H'E\Y0QCB928,6/-,^O6X!!-\ P?SLAPQ;#.&P_/,-<'P3"$RPX"Q&R Q2
MUC 8[3 '.:18H/F@DX0^Z*$ZY-'"=Y<3FFKHX3O028,XRJ "Y'S /6!Z#WX3
MA%_TG.<]]F$A>@CYP@$HDH8!:F.)4'2F)O)P3$!\,(/Y2" 0W?&'"_)2'L54
M)C)A6(H;CG"(YMC@ 5D1#X- 4A@V\(*UJ.5'8K&+2VKC@D &\4$V?J.#]QA$
M#Z<HCW'4L)A O,8T0E'(/1YQ@]K$  'Q0,#Z.20\RU6NB0U@'M"*IK52H*I#
M#>!.EWS4)#> "$(YZU*6#*4V"-S+6&[*_Y4&<]0#**8J+$/@ 8M0 *@<Q:@L
M/,!4K1H6GQ\ ATF^65"Y$G.KRHRG81'37-Z0 +2D!2@XH("&W+"3I+EY)XP^
MRTZ3)"9&O<$ /#GE!M!20,?NH(!/Z^E8(OL6ONHUKX'Q U\*$-@!*M4OB0%T
M82<@-( ND#(5UJS6)&T8QT8&#I"!HV,;FX?)-D8!:-N  B4;!L-:5M*2JJP!
M/E/AS5H*4XJEH!^Y(L<)YF&T&2B-:3H%ZD^KUH.@]@ +7!M(UY*Z$*?NVVQE
M"YO9I(H1M;%C$%:56T=&HG"MVNTC?@L<%8Q 5K(&S@@O$0(6V$H3FP@!KI*+
MPS'B8(L,)(-SGO]+@PMF&*JQH,!T0&AN"U"P@ABL+@8YB($)H'*)Q+U8LK<S
M"PM4B];CC64L+*@=XHXGA!04_07,0^MGQ2@$R&Y Z9M=[8H+DYC%+"(NLPU"
M8M(2ER#DCS+%^6T:$F&-XFSA$EO0+@M ((9OK,8"=J\-:?OW&\#%03=Q".L&
M%@$"6]B"$R0O@1:ZJWCDG,$X9ZB&=S(Q!CVH@ G>7: 6_*$'-( G.V5(PG:J
M,0 5VK<!"3(]>_3;0C*D<#WO<:&3Y10Z _O'C5T2L81_V,;<1S'#%>("\(,O
M?.![XTS#/SX7O'$@'S" !P-"_O!-OZ 810#ZPB_^#:T??.6'*4/:)_[_4R2T
MA_'OP0Y[L$3Y\V"'/'A@+(;P@%2"='Y&6((1YB?_^/N(__V37_E6XC__^=^&
M .#^89^:T,$V(* ")B #"J"!#, "(B #2J ,4<D"3N V,& %2D@$8B ";F"&
M1. F2* "QAY*Y$FY\ ,\(=(LX8FUX,DR-0 X( +%E LH'<*CY,JR/,HRV< G
MH5D#F,"<K0JM1,H \(((I$ 0S-*F3%(0P!*K/  3:@,9^. P>-(N_=E32$ 2
M]D,+/L"P]("@:(.S'-,P,4LG,8MY@,,CY<H R($(W$ SM* "K"$\[0F>. L^
MX0DX[0DN[>&^F)HXR4O$P $XB=,]*0 AZA,<_S2#1L6:(?&:P[ +PD"B)!Z
M&TK W81 QDA,0L$!/U" -C4!OL# R%" /0Q "%24MRC4/6V;0J4B3<&,MID4
MRB34S>2,T(0;-E!,#U0 .=24T(3 #,Q#!3Q-TC@-3\7;U6A-U0@$U@P$04AC
M4C$$OT65V%1$VU#5VUR51\0-.S#<1Y!$WKQ0($3<.5*!.@:!.I*5Q<%$QF$<
M3<SC6'B $83!,93 &X  $UB#+9A!*FP $'C#!*R 6+0<-*".$:! 0JY.8ET
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MJ5L(5$ %0 U/ 16\R=L\V%N@8LU1$14UCHU3+=5"_T15V9P-1:2-VU"$5=W
MWI"CWN3-133<2,!0< !.6$T<.P:!,%!!+I35!K#56JT52PA!4&H.$R!>XJW
M8.'!2S!6;:S Z31DKK8<$%Q"%L1 5^ !37P%3&3!"Q#/6:#5/,XC18J ""SK
MLN+!$+P 3<B.M5[K2B)=6'2D!S!=XKS T@D!$01&[L!68MRD6E!&_O0D3T;&
M,US&%@RE#+" Y1Q7*5S"<KU $#@=__P&< 1"WS7",:3%;BQ"&I#=NRZ"&)2
M=GSE!3'>&%P'&F1"628!$EB><G#0Y.G!(*A7-93!!(W!DY@>Z9F'>TP ?-A7
MZ_%EZY&G?BA"8Q9F=<*F(E[QD'-^YP:J)LT^!702R,T&IB)!IX4 9]!*"-&&
M7Q0TGX#\K";8P'GX /4Q;8$)[6'N;(T<+=4."-/:0!0 DHEXK=2"H,_N;-9&
M0-AZ2-CVK'):[6SN+-JR;7B2[88P_ZTFD&>Y),P*;MH=@(JW[,D&K!(T*4 -
MFDN[G*&@+-,Q^5(H22&!$0$G(8HN:8,B@>@#](-!"0JB!,&CN""O?"&C.)^J
M/  WY)*@*-*N5&Z!"5,M"1HG>8,9@HH,/D **)\GX4D#R*#MYFBSI"Z>G),W
MN,%^4HP@-H,W\$"YX!F!E4O![.$Y*8,XY9JW2 PXZ=,?JBA4 ,SRYDFL26*L
MR8L]7"+ A"(<D,$ 0('"A(#S12_&#( W]  _S /%*,/)$"*^3!0K'M0]A0S*
MS(Q[M*+--,S,_"_.!,U+!:.9WLPY#< 'P%0PVA0Q&B,R1C"?5@V]24V]$176
M:,VA?HW7^/^;!P<<585P..)-W43$2+##WIQP29ACX+#CQ!T6%0QLQ%%!I[*$
M$1".2MIC2UR<63R#+3"!%JP!_YC!,PBQ# AQV[% (#B=&>Q/(,@ :IC!;A"E
M$%/Q;>R&:;S/&BS""W3QOAK!&D@/J]HP2]R.$12E&9O%60A#<[&$:0@!"NBP
M&=_.2RR"Q='D6AR&$'#A;*5KNII!5OAD7/1D9,A (<^KTS5""2#7:B #2QK!
M_K! +BAQ;U3R_AC!):!#' 1!&H"#%ACL,Z #")2 6BX><I3R&3Q#=$B>62:!
M.&A#>F5L-8Q'R")'&7P ?0U(>J@'":V,RJ9'>IQ'?P68RZ($8";_)BK4T'!6
M)BJ4[3)')BJ\"-,F,Y9,<X<,P!YL0S8KX @R(&>.2#9O<P)V,P+6[(YT 8IX
M0SA/(#EO@PDL"-1>B#IK,SLOH G4T0.N,S<OH#-UICZ/,S]WB#>XPAZH @'N
MP6G"\_3Q@$'C'T$7]/@5YX5@LT$3=$5#]!Y(M(!0]!Y8=$=C-$'Z\T6/=$1+
MR0!  S1P04JCPDJG-!>([4:CM$IS 2JH=$VG-!P-P$RG-$_/]$NK[4;OM%"[
M=$[WM$L'7TJ[K'FF@;^(4]ZZH<$TP[8@"C35IZ <@C=XBJ#PYZ-TS.8BRG_P
MP.9"-8!<2JT,P &84JL\:.E:"H;.Z*9\_X"!W4JR..Z@>*BS_,<DC2BF-4 :
MX$FET= 1  I8^T<#;-,&*%_?YK5_N%*0UJCN*N\U?9HX,0J]R)K!?.^2WIJ3
MU@F[&"FO6>(! !N -"D_K))_%,'^.MN7#H!"F:+'0%LPI2D%$%H/I*E)P>()
M))3-M#: -,!-S8-3H-NZY2F?!A5/!54%/V.]-??6$$2^:0!"(,2^-02_-2K9
M3%5&6)5'&)S!H3#?T$W#*0,AL41P"$Y8B6H0!$(NO( [=FIPO$ 90]T.F[$0
M: 88I($:N$!;9!9- ')-M$3'[46*&4$)E-401-R^)GAMM%UF='%6.-TB0#%N
M"+$U-$)>N<]JE/^ :I2 AY? AJ_&:G2X^SA=YF1.45HXBF=QYR!%Y_B/AT-6
M('PXC7MX:]"X#LR/C;,&AX, <@T>.MC"'-C"-V3 @4\K__B/$@/',01"D_<&
M+ ".P9+=(@2!&?@X"%A#>)CR<HQ&)H""&:!!$B3!!20>=R&''GR "I3RY)5!
M<HB#+N\RZ06S"+D'@]CE>YQ',:,$@"@V@$0)[0V(BU!(H->>21<ZER!Z^!VZ
M@>'8B" Z@0 2BRCZ'%W8 ]+>1!,ZI$M(H&\T&P4("DB /?  "RT( YQZ"Z1Z
M"W3!B7@Z#6&)HN>THE_SK&MZH<,ZHCMSK-OZK7-ZGTM SA&8RVJO>6[_&C>9
M2V&3 3=L&9ZD(C1=$C+AYZ!PDB#](*R0$B(XQ1;>"2Q!=0-<@+,,Z:I1$NO>
M0;4P[K7+)XB24J[P4B:%#K@3F*K4$AH.P& OPBV!]07@TF 3BGG@H;?_ *.(
M.Q_ZAP0<[P$@ M_N80BLT@]4+_)"@?8J8O0:HIOJ4T;MX0%8;NC<@.MN+\!L
MK\3(2R7F2ZT=P,E;_%.0P05 F[>=C,KS"\ TC+SP LJDXBK6_+8E<+65% 7(
M2TK5# #[_,R  YOZ#!20+X$1MTC5*03WPS$68S(>(W)7\#Q0L+T-U31N_=<@
MA$&834.@#0@_:@AW(PEGE:;&C4<(V$JL-UD)_\YAM3U\H[?$48%[5]SUW/'/
MW?<:)% 0-D .\/<GQ  01 $5;,#IK("N6H4$H, %-((+U!RPMLXG^ @>'*M<
MU$3["8_%J<$B"($(Q "T6JNQFD'[M5_/O5AJ!4%H01V,V7%AF 5E=-VTH@5:
M6'E/O@4A[SYFF,%@!(%JZ)6/BP$Z?,,<6( U",,9$^532A?@'$,F4W(+9V40
M+((MS \(\%57=A=T<%#BB8-X#$(2A,,8H-<,*,=G)$&:N\$I@X*;(P>=FVQZ
MH!2+W&7IE=!<[GD,_8>T*!] >!LP<&"$ 1$,(CR8,$(1'CP2'I2HD"+#B1<K
M+M28D2%'BQTO8EQ8!/]A1),%17:$2!&ER9(O0YY\R?)D2HP?6RZ$F5'B009X
M\,3(D0.%#QX^AB9=D6,0BB(]>\JL"=7@1)D$JT;%&1'EQHU3LU;=RC4L5JM>
MNT;U"M;L6K!%@-@S:.-?7;MW\>:%<T !7SA]%8 +K(!P8<(/"FM3@!BQ L4/
M&!=&K WR8@6U(D/6K%D;A,V?(5,./7J1Y<J,3R\.;?JS:<O:X#0V+-GR;$2S
M<=_&O9NOX;^$>P-7\/MO\#O#>__="WSY ;X'>@RX<(<O..?5#^R][MRZ=C@4
M^&UWKGU\$_'9*8"C0.' >@K?V[MG#^=$_";\T@^3OOY$$PI-Z/OO! H&/.'_
M!/I. ,=  _LY89X30CBAP0CG":&""D/ L,)YB*BP!R(^[*$'+'K08$0-YC%1
M@Q59U. &#8QYT<497X0B!2A>O"'&&W#D\88;V/GQ!R '84<9=G[X 0HE?T"2
M'23SBK*N0(*@(H@@C!#F2BRI,,((*K$,@LI OC2"BD#0?.$%([#<P @A7@!#
MBS&B  *('-10PX,]\7B!BAA6 !2%%:!9P5!H8K FJ!A0R"&&&$3 (PN@7F#!
MB VR\$ -(3;== ,A6!#BAQR$R"(+0S+UX%0CS-C3U5?WS(*%%[)PP51357WU
M!3T]$,)77U/8E-,7?MU C0V&2#999!=)UHPAGHWV_UEH7QA"32H:N40,,4#0
M@04=+ADB$!98R(7<0"Y!,XY <@D$%A;4!7.118)89!802O "A#1(&</??__M
M=XPSSI@3C23T0$.%.?WM-PUQ/M!#A33\%<<'%?SUX2 R$.+8XPDXCH",!D0F
MB622BB!#RI57)LAE$TQH8( )=+II(X=(^N@JET#2>2V;?>;H+)JLRAEHHGOF
M@:2O4IJ)IIT]L@IJJ&_:Z>@(&/C$D$%<&"0''XI@( <\AB(;#Z]]Z-FEIM4>
M6NJ:H^99)Z2KAENJH2M:^^FV]9:[)+?<,J@(HP1GV?#QLN-GL.$(^VVWPF*#
M0S''7*OLL<H=4^QRQ!:!+/^VTRC3AC+*)ZM-M=-'IRPVTE>7C7+-#Z/<M=@?
MKWTWY7##'?+= ?.K=\:SRZ[WXI[[*X2!B,BN&9FA.("?O00[P+KMO',N/#C"
M"WZO[;/;"T#\]GKO /_X:<*Z$_!C#[P#T">PO?'5.R$%,@;HQ_WVZZO//P,1
M7'#!"0U4@7Y0:( .ZL<\!CB/"F2(""'X$(<>2*(/K>A$&L!"BS#H(F.L*$<:
MU-&/>+0C$((P2$%:DI'8 04G*4D$2S(<7JAD)2M5B0HSW!*;;B@F-)'I!4%0
MTPY[""HMG&$,+6  $ :1)Z[E209#P,,G& 4-+A@*4(RZ!!Y0\"@M7F %0(F!
M$=;_, 0UN$!20NA5I]3  C7$P 4;B-4;^Q0(%^3J5*G:4QJ#X(%/>" ;AO#
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MV-&'^DP^M5Z>X?I,%03TQ7][20=@80VF.LLV0& VX-/'0!S*8!#^]0<H)@0
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MCG!0<  X/#8!XPDY"MECCSSN>("02O:X)!Q+/IEDE"=0_P"DDA1,:>4)3I[
M)9?]G!#""?U4 *:8\X#9SSPSA#!/"&FFR6:;<A(Q#Q$]]&!G#UAHT(,&&NSI
M9Z :I&!,"C?X>6BB&MQ@S V).@III#>PX^@/-UB**3L_: H%=9Z2!,LEEP02
M2!"EFHIJJ52@:D00KAI1Z@NH!O%"J;&RH,49I'STD0MJJ-&K&6JX(,(@-[B
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MQ3>>&2H6F&I5ITJ5J6!E*U?1:INR*M4E<D407BGN5XHS@Q!$L#[=B*Y9WM@
M*B!B F^\I $-0 4]/;"((8A@-9\ 5[> L (S6(X+S\D*NU80A'=]"UEXRX((
M1*! ,VQ@70-;U[AB $ \,.NA!3M85H#0KX5-8  C7<D/-N"&#<1+HD.X6!HR
M-H072#0(+!A"">9@@3G,@66?<,4G6, R*E#A!2V;V<]J1C.7!8)G.S-#$,P
M E@03:I",]HL;#$'/B!-($G;P!B8-O^&-*0A)&@H@P_"&@*!;" -2?#!#TCA
MU0\<Q T\B$M$GH<7M#G&("$1R3(]M9((D(L%8=B-![8P!UN40%27L,9B&6L-
MQDK6L8Q=[&,?VUC+7@*S6QB"\#Q @L2!5K2A_5UI/? )R,E.!HV5K*A>\(D6
M2.!<#( &$%#@ 3-L=K>/U<%F'QM9&:A!@2X0!F5%A5E11;8$)="!;X>0 ]\\
MSRX\T.@:7I"#(N0E+@/@04!%Y5O-+I>WRI7L8GU+7LU>UK+,U4%RE8O9Q<I
MI>'S0/B$4#H/Y-=TD(M7WECW@N6B%[/CW:UK&1M>]I[7P(P-A =D>ZX6,. (
MZ'O!%ABL7N7_&N&C#+@MM5;@@1=X]H"&."T>)/=?R)UV RPX,(/-"]_,(O>W
MZ4TO>\F+WADW%P3,+8%?_TJ2.=((1S,LXX8<%$8=NB="4ARB$9M(Q/P(*(@
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MX"T9A$#A13A;+((''B:(,X()6E!CC4NHP(.!.QF<$\Y!7>2AA0VJ,B'(M3P
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M80C!Y;$%)G@&:V@?"4@0(!B$+! "%Z ,%ZB*0:",?-.*', #TL"#18@!"6
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MI8M3E@&(D1B8$2C1I7@A$J+3*!\I%<2(J#.))3HI)AR9 +EXJ@VRJ WBH+D
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MB2+86MFY=Y%N><8HC+(5H@,"#Z "#UB!(V0K^:2 P/%;QU-JLJE+_]O[@0&
M MS[JQ08@ O &")XT! Y B*XK&8X@AZY@-;SZ,]#F<BBS*%I!B-=VI%NAA;8
MD0L@Z<Q2@!NY@8Q!VFA'D@;X 89^FMT;\BK.++V,FGKGD090AN=3&]24/.3;
M:>=SS:-VF^T[@8#GD6&8!X8AKO [=L0%VNOKFY\%AQZ 4&(7G-^B/L4A',?5
M+L;I@0MX'/F; <W9',JAG/P[+_S;3O[SO\\-0($83P*L+P.\@12PB-O1'8P
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M'&V30'D;.Z73"?2(FI## (1 $31$#PP)%#Q/!+!#>YQ)"-B7/1C(,'A)-J:
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M.%"05[S.!]@+'BS"S:# %PF$9@S-"^3 #'E%#!2F!*&GPJ3+6H9=7;Q+Q>1
MOOP=61A- WC $$2,9 1,T<9+##Q?#A0F759>809,#!@!'JP -*P QBBFE7+!
M"H2!E<(+T3* Q!2,&IB!$-1L_\U>Y696#>S% 6YMS24<PPN\+=C,P6FNP>^U
M3=O +?'%C6O636T6;'!"EN<D@F\& 7!JP>0 YW^!UW_%3AI(3L&&'V^F 1I\
M@ TT0/YYCCB0@8"I@78X42]M! _ 3_S$C@O\0("Y08$-;'D\!!ZP@!=LP27$
MKA>LP8,EVDD4@4O,Y[UD3\  IN_&P =LZ99>J=&LC (Z3T*8$1214?>DX46
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MB*X^FP*@F_\GHJJ+!#B&F,XV$E)I-, B#4BJ"@F\X3>3P)NL-B*?VFJ0\,@
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MM6I9WUI19%K3K,7D:TSMJM+:I#0Z=Q2%*,C*5#GJI)X%62MJZX@''C""!X
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MI JC;=GZR$!>X!,DH-O 3?/&A%G@(*[RREO^:@#NS5L !@BP"MXJ!J@2YF@
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M$&[ $&Q#*X8@OA+!"Z%(+SP G7,@N<8@!Q@@"ZB6+ZJ3,F1@9Z?SH($ %1H
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M I-G]"T;,-%;-M!*@B"@P@3>0$7.P:JVL'H@*7&0G!%8< R4A"$,*PA##%;
M]!APP:[9<$4,7!$($)1.=%4A7598T(BH'.,L@<!$3T% ]DNPP'9G80ONVA($
M(XSV*U_YG1H8D 4R1 !K9&A THAF&#,<9@ Y<$$:F, $,)B!,Q5JP-U#C#6(
M#(0!,?BV:B@3!1<( ;J*GP :!>+&QP/GQG7T7^5S !L9A7Z[3VJP$U??Q VA
M:(+ZA2\55U0BZLP>@A1 '@N36%\24H87!!PA_SL\.)\+S'Z$JY& >6RXPO2
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MU;=]_\5]T0$']O$#S3%"Y I_ P #X-$<V:)^/J1^VG%])\!>VMH/U7<![:I
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M)J0Y+5M8)NW9+56&)ON,:NCD3K16+O!4AAV6:V@(;/A4 <3&G\6V3P*:;%A
M,'5HH-)V,%A@,1CM4)=;,7[(;0P5H9ZK7";#;H2XH2I5,R5UNBF5H2>5 8'
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M'E!@VY6AR-,A&PIB'MX'?,+7']!!&8X<(O\$XI:JI\<G< -.WP ]L"(]$)=
M4/;042';$7W1P0VK06#Y>F(/N[#BD93Y+?1)#\G;S??1P>$QC]W&$07TIK'+
M*JST-]WLDQFJF"%  #EX$,LI#F4 Q;):Z&KG!"UF_BS#@LZO\F>,-LY_HIQ_
M%H2R>2JD#RK)6?JCLDIHEDFM!)S 2?K&/&:> LZKA/IZDLR01BJ\KRN.1LZ[
M?RM0OBW:*9ZKAIUT$B?A";?(KVK9%"W=@IVFEF7M"4[@@D[7#]#IE$[9,B[S
M%/[N$D@'?9]_#FSWR4]PV)^.NVP":N@'TP/ L.@(]3".KE =O6T;HVV5_FT
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M,#(DB)$@9LPL'T)E"'+F7=-H&2*!!PHR-LC$4&/2Y!@>XL"<-],F"A 4_T"
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M'X-L#"X;*UA!-LR]GQ>*((8%FN$- ZQZ)D>( 2WA80X^\*@6")&'54%!"WP
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MFCA%LU(,5S3&H#""2T *K* )TY,@$KB<&U4<OGH*(0@"K(@)O@(]%'C4%]B
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MSF1V-5:CF"N<_88)S5,+J#>+%23OYG_*-;45J(_)F":H<I)A,U5)SX>BJ'[
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M\=\$/$S  !YXP*F&$!Z@8!V>U6FP9P]$S!-""'_V$X*#)U  3A.''G#" 4W
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MH'H##,( $QB%9"+/!'*0EPVH0;\Y\( :Z*2&/\XQBB@0QAJ$8 +L-.""/-V
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MJBQF4  SN@$XOI8V(BYKX -)Q]=1W7H4!+#0[1QV"P(O1*TN10M#(*C& BI
M) Q8BZH+5/N)M3TU)!O)FQ"P*C:-:"0&+YA(&+BP J"Z0B$:P=\&(N(2M64C
MPBX(0B.$T+8P&,$50H":!_]6((.)1"4.1C"$34'P5QUD9@XZ8(V]VQT7S :B
M:#\5F\<5X@%A#*$$0AU:6L<'BT9D(W4L4)O=PF (1C@-Y[+;2NUJ!P8M:($)
M';#%6$:K6%S\[AF!N 0FGL$"S,RA WR8!1]D2X,XS.*VE$&'&-"!CA*@8WS?
M8 UL0T.:2VP/[]\PS6W.9QL6+&(LS^#$&\*WOC.4W1;/"()NK4'XZ6: $R5(
MMW0^2, <*'"##OSOE1?X'1^(AP?[M3U^K*Q[(A]Y0.WIO7F"'Y\BY!#).< #
M?SX0!0; 4<DYD$9]__-[[+1@"![9\ # XX/C?T+*M%\!'N"8@Q^@  4'))":
M?%__IM^G,/@R;K_K[^A?^+#?BNT7/@?7BW_ULZ?^["=^C^$?[)&1_FW0!%S0
M(+C (.#7D^W'(' 9[_%7[)4'#S09"L0  Y0'&8 9(9$,QA !H.C3"3 (P, !
M.3&*@8P*.$T3IF"2I9Q+))%*I:F2I7T+ICS3*@43MNR2+:$*J?C@+1D:IO0@
MM023$;:*,&&++K42JGC2K.29)\D2,F%+I(G2*(E3,SF3"T:2-3%**%E3-HG+
M-#G2KL5+##9!KEG*NZ @&:X3(TV2"<Y+FLGA"?C+O)B@L W,"(J@D23,(>E3
MQ #40(6 GWS@Q?3 (6J;0GF,0C&40^V)RSS41*6,RU B_Q2H#.IEXLQX02.H
MCE=T(C*(P25(Q?C,52?J0%Y]0[Y=@NA #4,,!$S,W1K(Q<)Y@!"I39U,A-V4
MCD;@ 0E\ @F$00EXP$;@@5J\A2NL@##H  MX "IP01NL1<=U7#:  $V01$DP
M@I(=A0O\1%" GU$8T4=X00D4#4)\@@F@@A!P(@L8!@A0@5FUVR4$ L\8C4"P
MS2?031AP71A0P0O<%=0\UOC(P$]4';^Q7%W<C<?UX^R0'70E@AHD@CB8 1_(
M0'ULP!LPEF+,8U9$QC. 1MTAP]WI'2Y\ PV4 _6,ABT,7@FD%BX<P_3@UN.)
M#BS(P_>\@>^$%.5U1?K4AAE<E_\6/$,:6 ,3$&5PS!!O^4\R6(/_,($F"M $
MQ$ !I1> \%<$SA^!O-C\]9?N;65ZU=%Z.-&9K!A5ILF6M(&3B0>7;$D+>,<+
M2=\' 0&&:1AV3$ 4S)Y]A <#T-Y:XA>5K0< <B58GLF @=#KV5B5&9F00=!5
M1B!7%ME8DD?Z*>9@@F5E\M<$H, @&((+.)F3\0 #K, @X(%_N)YIYM]_Z5$,
M@)]_#( -@-D4G R?^(G$+%O#H)F[F)-N]EHD>4JBM*"J-0NFR-FF-8NO+ NT
MA(HWB8JN(,N>*=J>(>&>'2<R(0NE#4NKS-*W_%FQ7 MR0N&EA)*U3%JSC%*C
M>)JV&)/_K''+G*D3<$8*N903I%#3? 9G'9H+)!D*?,IAK!F*K]D+'9H@L 5;
M'BH,A#B;PO2#LCD;Q$B,0('@Q!SB!W;,MFT;%F ;MSGB(T[4N$UBS)B;)H9H
M=:P;B5["V<'"4[ 458Q/7MG"*NY5T;S<@D%-![P [&0$28"5P\G$"Y1.2&1$
MG&B$&L!"4KW%6K %6ZP $ @!9#@C*J!"##QC17"!(>A-,$85<J" #.$!6*PF
M6U0$5'F 6>T5 9G!362#RY5"T;&B%[B.$5#!,:B-0)R$VB"C1; %ZL0 'C"=
M1[U 8[$ 9B6$D5Z=11Q=#* .%RS$"\R.&4Q"[0R!"[@ 'B1"_P>801NTP 9T
MP/@DQCRR5MRQ &F)069XP3>$ 2[P@1?0@"YLSQQ<CVX5'BR4@RY$3_0DEOC
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M0E<!]?X*#:U;KPQP8LY,A5R] $:\Q?'&@%FIE# T BQX@1%\@_\V J&;.DS
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MPC!HA )*M!TN/O?)0B64/H^,/^\)%G H);Z,F!'TF'LN8[U  LL5'ES"')
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M5KF*X"$,L/" 2_! D1A@K2(K  D+PK 0E[0A!E)8&T2,X(&:.L0CE]B",&+
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MR/$$T_E1!XL$G1GT(SK."4%TGN3'$&RP EAJCG(.J24N?:E+C-3 /,HT#^(
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MM&F)]" R+\3;?O-FA#C_T:_?";QX*32A<.+ "0K\_#;Y>X "',#\P 7VV_C
M@<7\X$0.?)@PN .2'\/A1P&R9\+\#(OV'!E.Y@-P0J<.?%JTZL>O"7.&4_HQ
MZL^Y-2^F;1MSY]N14P/W2V'Q;;^F [,N;)AU\>('F@C^VW=O$W" "3M&;!@P
M8,9]_W9OC+CO]Q.(\8*[6]<]WGDGZ,Z+*[]?!;<59N0/X=9_B+;Z:VLM GO
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M>;D7IM,J5 RH%3"*AT#%ABJ*KFN)>'.!O>JD3H(L0V  ,MB<78R 7HP(%-B
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M_*(HE$(S"*;P#$\B-(,B_*(UB$+]A$"#&$']!$$6:,\HM ;^%-  A<! ,(-
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M=E-_3)<^1&5VT8^0)-<%$=N)= 2&4 1#F$05_\93N0G,AQZ$&I2>@>;=$7B
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M/.Y6$V3BM*8[=15R**T"D>8F':*HIF97C:ZUBI6IT";(HM$C_\9Q$*RA(TI
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MNQPI%O@[LB[ W EE&@J2 P/\NXVF:$AJWMH$/%Q342!0TE'Z%4>0 =V* A;
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MD9K9&0VS/=?)#TG+$0*T0@%A%'M(0ZG@ 7;8)490!$: !&B !(!",S:[@BM
ML:B0 */A!@CI'ZLYDP "M^[3C$5P&C1)O7N\L#ZYJP;Y-M3@DSJ;-&8B0 6I
M"OP3,^9C/G*XG5)# C3 '262 "F1G@MP 31;LW\"*'<\G-X8AH8LG>)YQKN:
MJ\=1/4'AO9?A1_19I8+<P!FI,&JLQI?I0.'AA9BZ'5 ;AC0$@L\ +F6XJ4R(
M1XZQ 32P 8D8D'EL-@>HLY?_L<IH#" K::A!H": ?#"7;)RK+$AI9)!KO !O
M&@:NC+0TZ4EV<("K^ 'XV1 )*$HE.L%I2P$LZ,8VDH Z^8%ZU!GSP<G\>)RJ
M'+P*@\1]T2S- B6'^)64JQ><"(P3@AAAZ<5]>45A&9:"Z*%=+ K*.(BOBPH\
M*$D?D:.*LSI01$,;*(,Q3,,T;,T&:,TBL ':M$W8Q$U]"$/:'$,@L(=UB8H+
MZ(H;=#EP4<R(0"**4ZYE7*$N4A:1L+F;NP"=$T2>RT%1BCOD8BY2BBW/XLS9
MPHRP0(&(^ZZF@Q-TPSJJ4T_:)(.\8$\>>,\&H$VZX %]<,_:I$_[W$3:]($L
M6$6E_XB!.MJB3M)#MOBY7$RXYR(7.>2(OSJ(RHP(#$I&0(HM8SF[SV+,4YHK
M>SR\/"&2SUBIT6,FH_D! :$GW$$"G,H$98!*X F%;( &RH,$2& $:!""=E0S
M-N.GWMA&_^"^POL %P'2VQO()VFU@93)"<3*O'JEQ)O!XBB-O@2FJAB&FDJ"
M+MO(CKR _TM1)1I*-.0,"8@^5&!'=NRG-+L" >E)_7LE/VDG"@-1!QFFWG.Q
MXM K/9'3=A(486*\]2!1WKB 4/#2,.2,(Y" C=S2_TN"^_D %,4I)'!%-<T^
M_;- ?60=5^JJ[VA ]EL\)HW3\['*W:-!!LC4ZM 3/4$#>/_R**BD"@F0'_T[
M F8"+A/\@4&(GQ0,0!NHF[^4@ "$RYZ! G%+OQ=DC0BK$=D0B[.XT,=4BY\S
ME2_J(AD0@0;5"\%HUMTJ"J3#+:++B>3RP;1P@2E4BC8<$(A00R\4PS.$3=E$
MPS*PN#!<37<-0WE]S7KE3?MTUV&0 UX0@?\< *X(%R>D0V2A#!3*3BNJ(E7!
MC(>P 2<"+I% "4"L3I[+3 4[MV0L%K#XP:#3EP9#H@A0NJC( 7^]"DU,SU(4
MQ2) 6:J;3Y1MSRV<STTT0U"D3=^TAQPPS^\*NSD4(FP-.A^$S$1).5U<((U-
M6+ @1(GH%IOH%S\ZH)3;NA9ZKG3_*]"=@+^OK+ ^P4EP.U((<QU[((>76LJH
MX(%Q0()10UM2,SXP4X%TS 95,,>A,00ND+Y_:@.Z_:?2A,N>HM.609_&"2"Q
MS#T\89D68Q#'H4GS.<S"S<9R(U%6=</<$<HQ[ PEJDCCDX N/-2ZO (V^Z=K
MD +0[2=_&B@!41\ZZ9-66T@'P0^$>AP^,0ZN!5P(Z5J5=+]R&P]@A:G=" 45
MZ#(@8 !$!2[@&K52JR5[X#1E&(=!&+6DS(0/,-TV6;6LE=W6R<GK(<NO-5QR
MH\ XY1.RQ+WK 5Q[,,$V&=L!@((4V)#^XP9NL#;UN0%V2,$5E,>UNM44Z($;
ML#_>^ '<_W#+UE5<G>R?T2BW(AV4='/$'](64#H[]!H7.?1!CN&CAO"(6B0(
M!>8(F[#,SR0B?GE,7X%:0HHAIG !S..-7[DX= U#4.Q"W91->*W7U7QA%[8!
M&GYAU8S-U@Q#0^4%7I" &R#/I2BYI#!.CFU.@VVNM0!-B% Y>R&#D5@BG$.)
MB>6YHYVYS_*53PJC1#$(E1DEW+*)+((N,K@ ?P7.Z[H,]7S9^.3$I[S/(J"Z
M]JS/JH/CU'SCIVQ/+CP_&Q"!G&6*'-BA9A6C1$&Y/O+BKO,DV?JL\!0[V?JB
M5?E@!JV,GDV6.=Q@,H!6&\3@4-*R4RW65N(]/%V\$&4EBH*G4__;#0G(O_TC
M7K--T9Q2HG0<FJ$)@[HMTY%L@S3E#>!H-N[[9/:[L$IMW6+MO7M,)8+D5#4A
MR+U2#<]84U^] -^=SC TC4.MFRVM2!4 @MFX@"30/T.XVW?LIVMXQ] %*$/X
M@:Z#LY<:CI8\9I<4OV$"JE.U4RH;R#B-/]>X1M6@D9X4 5]EBD852D0E/C%+
MWN(U/J:X@$R @BL=WN<K->CM#3*(G>U3$P.<0+SJU(324YLA5A"]O8(DY@<)
M'CH!Z %P5=P +KR,G_O%R[R$W&BSMOBM-BQ000))-956*07\4-MKTV$NCEP\
MB+183)T(8X((X^)\.6,1NJHU1&IE"R/_+!>4*12(*&&IZ*Z2W3HTW,+:7&$O
MI%<8!D76;%<9)L,QE-=X?5<Q'(F1X(5AX(4S7HHWU*S/L@S ,HHMMF -OE:C
M@,5EL;G +@GJI&(ILA>#HUKT4B[SZJ'CK.MZ6>)_#>*E&-FK. CU[$25?<I0
MA,_:M#J5[>Q-1%FOILU/'$6-XP%PM)JM80 &L(=!\&-6W-G#MA<(5LR*I;B^
M"IC;YN1O:3"_+I?E[&O:]KGP6DR.O=T9D;3"G-V[R48,,X[\^9$PZ[(:DYFC
M1%'&0<-95H0+Z-PTN^71S>4WXXUYA"?H=C&==.ZQQ,IK!-(&85V6Q)NKC)FN
M)0]XVLO@ZUW&_ZD@X1U>;"ZU_KL=*!"SZ#-G<>:G?OJ$*R@U9?"-OKPT*$ -
M:IRT\H.<K24WF600/NF^#+]=G0$WYU:U_*Z*F<+2>J*I%*6I3,@=&'""3%B*
M#^@TC03([E@^)!!4WV  .6.'0T5<P,T;!GE=$.6]Q$6H:I1=FU$I)0?5U)#N
MJ^ %N33!EV8K#:ARMKH!F^[&!H !:;.R'Q !:X,!(KB!\Y7'%J2S.-7)XL'3
M.IMPV!#:C%!8C;V7\CKL$*ZB?4%B.0]NJJT)XSK.C:US!0W-D?.Z$8:*K69A
M=.7-KJ;A==7ATG[-%_;J%Y;T=15#SG#K)I(#"6@B/)ALI1#."P89+?]J6I7#
MS*V[;7SAZ_,B8]^"%F>1V,*6(HT8=(4C4,HXB^,VT&O1B80MXUDAV8D@Q3A&
M0SF>NI=-PZG;[*NKX]MDX\]68V;W 7MH[=9F[=;^S=A6BAPXON:\9#PT(PL5
MBL CNBZ^:P(M[J6-1>9D1(2HHB)26%[_BO-ITXW.&P 24<)<4S-?"GO*N5M2
MA$,X5.D9-17(!'*P@> 5WARX@C7C)W(F9W/.9;V%RUZND6.5;P^%1H\&R O4
M1V5NI7L^9O;KT=V="A/G/NDAOMQ1AE!P 4.0>9EW@=Y=<7#.Y7(>YW*6 D-
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MIQ\UI0@V/XW-1>$SHZ/"Z"PYTBF!DN XD#:H;2$E#&&DEXD49&( 'PA%721
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M6GD,3_S02/*IR*O9AJ#$3&I57GNE#,J,#&A1X=<M'5'\!!@VDVF!(<(]GE&
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M>MU3C&80$1DGDA9OM0"$':>NX$JOY$H@MJ$9 >)U^05NKNLB:M=V>9$9*68
M 8D/]D@/!))SJE&PP,4* %<V&D7BN>:2.<M+V):/Y5"V/FQ.S$1]@:+_*-;*
M>(ZG.D(>H. ,T8EC-6(<'#62O>"+""QCWS5C?Z:L0SRC,A:H,FY,"Z !QYP8
MRQJH+XE,DXV=DB7+2ZPB1\A7A,++;FE3TR$<G[#,,R$+LI!=Y/G,"F$D\%S;
M^;0&XD!M6O @.R3AU/#1\=3%F,UH-I39F7$!^&&'I>'DL (DF;F "RCJY)!-
MV0PE@31 U*P%JV&FGTT9GY%D1+F&F@P</=J.K.5:UHX'&52-71R$/1R!6-G4
MF?53F:)-=Z!E#YR?ICI/5EIJ)F@J]'S U'!&40+/^KQ/K.7MYY$@7B8E^M#-
MGKF//90%.0R?UO+;!Y@EIG+9!X3*Q=B4@A0;_Q(T#_.4#0<Z00CT *;66?$T
MP'DHPP_DK6SL[4;23_Y 7](834G>1E-E:?IT1@\:JV](P+DE4(_8*A#8P$M2
MD*X280+%JKJM&Q9L@+I%)H%@5F;>8^N>T*HB'8.%J^4M7LLPG'72T,-EW?\Z
M"VDUV6[MULL(F=$:$1&]Q01D@0BDD<[MI@7?2LNQZV_VH<M]%P6'4:T0IW8]
M"09%R03I:I D$'?EBAS< -HET< Z"\P 6.,!#6N*W=(N<,9&Q;5 *JU '7Y=
M[-4M[28ZTN-)ZWEAG-<Y"FZ5G2P*BPL$GA3_I\H.GH!2,5<(*"X!:"T1J!7G
MTL7L4B]9Q"]-7-<)2O_/9!PT/<4.Y<S#$JT:AZ'+V)$UD02 2:@R>>$:IX2I
M8BF,^,U_&-_S:D681,VDU"D2@)I6D-$A?, /),'GI!F<U>1-EE\(>!DTF  T
M8('POFVP(4$*)('\5L1%TI51'1^9H(;\8"D+RD@ (E5<4>TP# \['+)FL&1=
M]"+C$L=AE,[L<4%-UB3D;@Z;]@";2@BS\:2E$D:F9D(HO(V7^-M\\&F6OO);
MZ95?_8=<J1JJLD?<V#*_H<%"+H^%3)>&8,@$G<Y+:>ZE]@ IN %7I<ZNF9/Y
M_''SF5!_U(B)HBA$P8?_*0T*D@D+[@8[3 "_\=J1'*%CV10WF)X%B0 &I<#_
M$;(OD1P)DA!!DAS)0??;;I#)1!V.\YV//9Q6>NF)&/97RR!*#L-QAEZHP7UK
M%2:Q@RX+;,IQ2.!!"X S17S"#[SK&*4K:#@GKMKKSJ7KNRYB5A"BO0[B&)$1
M /$/"D@ -)SP8?(K+WQ77^#!+%;$L#0QHT@2M%ICUJ%,3S0L#ND8(($G(/TP
MU0GQU:50,!DTC!D8CGDCCB&P1^Q6PG7B"KPP1=3B+&V,8"-CBA7V+#TC0S2C
MR29VQ8!Q,AIVANQGBMD#'HQQ180,*L*$C7GF.(+F@L48(_U)CMD$@_:774?H
M2H]$!-@ %#2,T#5 :BI>73OMSPY.[#SO:DAM^MRM_^(<JI?P0"B F@3@G89(
MP&',GG-@!V4L=W=L+A%D@0FT4UY  CXE<U6E)1+< !>0V;&:FM'8SE"U3_Z
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M7\2+L:+1MB9-Z!8"&[#-B%9+%)VOV)=]N?^UU47H&=Y0G6.A&LO+#.^,4US
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M*K-R3+Y2+,4/1[4L1V\4+,5OZLBRR-!O2J1%B5K .&7"B> 14NRQ0SSD!T1
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M'2I').8YB47"G):(B<"IB30:L.'(A@T:%V&RHHSWLSU+BC?JH.]S=*Q8)Q<
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M![=U+/= $\=MO>&9NC-9&D!R*X<CQ@&N(H<_1O@C9"P'C\B<1/+&#G0C,>M
M)*"U%Q$#*!!'\REOMB6?O/C$=U2X"4:U9*"?K&@C^XDG31M##)M<N-6.>DM7
MC **=/6T:Q*,1L1U9><J7I=%G]*AJL(J7S?*8<=V7!3*<%L4.<#'AO=&5YA&
M\2&&-[K$4)<HNU+)I[B&#^LFA117/92@"%HM?3M([\A5OV1_Z,',RB0>2L$-
M"]4 :6IZO! *@I$$_RY -*V$I4!Q!4/0P$8%#380+]D@J9_W"8,PF8*A:4E
M#LI@>@$9I;-[$;R@9>?;9+8F-GO*%&81PAE6I_((.I;'2,P$DP[@K=>\%P81
M ]M\J#W1$3+A!(F!@-]K3 L]F1"%48S1-S-!ODM*P7CZ2/DDI\-0&B;H:Z@J
MJC(H,0/]$+6[4!)P@-7I1$@U"%9YTX8Q-W)S:G'9DZF!@*AT%Y0Q4S*&!#O,
M'?:,&=6IOO''+5[%2" 9,IJ13S\<T(S$2VB@U!VG-A< .QY7',R1',KQL:-U
M<=+1 ]@1KRT2<J-E;=;!)#W #E])%_CK@/67@BH%4RH=L0+'5U>'RV\UCFJ
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M2)EW92J0(%&?"8G[]T0@,<H&"9HWXS9^#"<'6[;_NG9K#3;69/--M]ER2_#
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M<0B2,>"L3&#&_DD"<IBK^G$/#1PJ>X/!3<$0)3D(!FK"FWP<VIBM4'J)G9D
M;,K,3/25"1B W) MFG2>VK X/BL4W_*57_FD>V&E_U<DN2C*'FXHE91#E5*!
M%9<K.R+8@%&Y 9GC+MSPMNDAH/ 2P['P&46"EHZ0B48B)YVALYDH,WXD,X)4
MQB_+1)M1&TDTLZ2#NLF0)$I2EULJB(1A%X,P,'XQB+8[,(4Y)>H*.R)H+EJA
M(@U8+86Y.MGHE_LD3_-T".-H@(L!)Z58";W9,=Z#.NH\B2\3ID.REJ.I&S)X
MF2'B!0=@ PF]@&F<F9#1)HIJ&Z=P+R C+ZS(C $8LN/( ;#XO+SHO!25FK-
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M;)Z+3'<F SHIK/^ 2^,Q$NT.US1CMA2"= N<!(]\&J?E;6\D-O(#[Z<X;D3
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M!.=%3(1+YF2Z\1MG7@ W[!"IO"@61 D/04DH=N1KL2P4P( (_  *]&A)ND6
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M^MG/2'5J/UJF;3+O6":O\2ROD33O;([%*3Y>58C(!:#$]PS"!3354JV(!*
M--A #!R!\B75OJ+ /UG? /  &[#!?9"&F>"&!%C93^E:^9X3ZI:?XEFK[X;4
M<2+BR:K<_Y&I0:;<HAX*3QC+*DWD&B874SQE4Q*74!A7AC8*9661!_!LOGW
MJO""',#D1\)H:46)_\SL#;BDIEB*'+B* ^@0]L7LB\*H9P4I6JG*C7H 0$V
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M&O4X@#:[T^ZJLCT8L U47_A@03^ 0PHP58LP0!;TPPUP 33$ #@0@02,#_@
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M8JS>!?/N\PHL,^KG.O5..Y6ND%S%,OU&K-DV'=\>9V9S(1*W7 V1/9C(B9@
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M4)ETF/93:T0P;)II*_034*)0%I%F'H$"^1,#+<"6/?9CO/] =]Y@ BU +CG
M "'95QUY$G'4>)22LD(5AH-YHL/3(SE!IP(C*QY%!FT255@)&Q? I(I"IQS*
M=EIEI/$"DSVU(T?"*B_K)SBT;W2'1"[* #% +%Q:95*&IEG%H7AX52\!,'2%
M>.BB,,Y396O&/,PCLPU%5Q#1D %J8+RY8,)J.[6G7*.S>2W#>JO3:M@&6J&Y
M&>KWD.^G@;*UJ; I-<C$6$EC?@LV>J!%?;#UMI$U3XM4FP/:-%'#83;3%1!*
M7JWI89W)-\UEG*_3. UVGV];6<?X7L#E6:7C,0S8H-0%;//E *[!(5 0%QP"
M%ZAQ']A9.ICW,1@#-LI)F8>4@8__.3/S!X %-W^$ S&BX[NC"WP&6!@7H)_8
M=A:SL $=T $;@!3^V %KP )J< $$^0.V@+U\L %<D0%\, ?=^@$@T $$27"7
M< D$B0;?@ P$B12#T %\8 TE\ /1M;>W1UJKQ3B^X3TG:H=R"6)NA+0_BCQ%
MF#Q!6X(H2+1,EBI\J&9%&Q%>HG/J P0V<%(#8D9@ZBLZ*'2^<CD! B FT$,W
MZ<$B"Q&(*8)%A6+9PZ]H^H$_NB]AFQ.)TK53=U4VH+,Z2X6PD85LQF> -G(P
M]Q%$*1$W:J?9HU )G+"G @0YT"UX(@$]U,5>?+$%%"T%9 (,X,5F[$/&\BP,
M4*6!B$9[_RF"0!*Q8"3'1I5&<&QH7F0C@E:EA3@2.IK'- (O,TO'C7FE'G09
MNL1*\C9=P-1=\O8;NHF/K<I,R<2KR?%.SI9,O"@WT2$BK_@5D<B/VZ$=TGA(
MG<HZP5I:!.I=EK>HM<J=+O*NO>B*MW=QH3,[G"QMS%4<MW0;>Y2I>=2GZ146
M%$ALMY%JRFI-C!1K2W$:J%&[<-$:J?',T<PAJ.$ ]19/XK=(QR1O'L;(K&J:
MK)--A#L8%?(;W7DZT+5)%R &'6 !\(L,+! 8&3 $]C (]0L":F /68 ,:N"^
M'_ !R+ !]J ,[#L,SR $9: &)6 4X%L&&W )'_ #&: &1P&^]O_ T$N!#EF0
MT7,PK^D*&,*:,J/&.IYA%QV$DDR"12_7/0F;<C/7$D$R8E"'=# 7QX0F1X.,
ML#"V9S<B 11;)KSB/TU41"(P4KX"=!M;/A0;1$OT0^XSU%R<DGD%DH(8$CP]
MEVWV4%0":"=I45\&*7&4@E")9C<!=EY'Q#L[=B-GQ7 $@VF*U6 D06KG5PG#
M9$OB0R[ +"X@)GV=A@.!!^43 7560'@@!,ER+8K=+"20 U T$?UEUC!8I"KH
MQ_&R4%Z8M6B[QU5V,/XRV3F\PV![A Y,$:D#BW>C7!=2GP\F7@'*VJSYNYS+
M-*S%G9WIG0M(8:/5.N;WN,>77>HW?/#_ASN3^JS9";R[,YKY^%EU$[F@I9RS
M%UNR^;JER;P85H&+83;6E@^/53/$O<YK*WP<=GRYTT>UR,V+@YWX= &W*Q[B
ML1K/S"&M\1:K\0/T?0,&]YG0K8"8"XS*"=U7PZ"\6[?FC&&M%5K)Y=VPR8C(
M)P$(2355PS(_( 8*2;X?( (ED#$@D 4(>1;?4.$@,-$A?A@):>$D#L!B( +S
MA0X3DI N< GOD9"/BXRKN7SXE-ZT)48[FE@99$8\BC"R0L-VU=:05Z='2(9;
M!7DLAG0ZRE78 P1UA@(H -12C@(?,.6&@,+FLX/ELZ)57A<M4.5<; -"6"N0
MQR@]VD*(&3U8&GO'_ +7-M%";T>72^XD)4>V$R$!]+4I56F%_UD(0WD(I6=:
M1D_2QHNVLD\Z1I?VH03;5SKQZ"U&)"H:QO90PEL"A!<Q #J!$ 34*FVZ*'>(
MB"P9VH.NLC>7YE[=DC.F$6"XF%L81D?R(RT7>0NC3YY4R<7D2<,;(=*(R9R!
M>M.(&2(]S+M'3)[TBI$ACI&SS);D6OSHJ] QR]!VZ\A,CIM4J9=:2,I(FM>M
MC9V$7=6Q;HZHS<E^2L!12\*1":#I>R8"BKWXZX7[C<P!39O4>_/&'.SM&O0-
M%]QP 4$GL@V0GD P#$< 'FPQ"-:LD+NDS9"D;-P1;!27;J"<[-_,[84S[[QS
MC5#! +TI%B#@[[R&D!= <!F  BD@T?]0 ;X ?0$94!?3&]!B8 '( +^#T,[X
M2_,7\/%%\8_X:P$BH 8HCP;RJG'L04RGW(WH/19P'8-;!>=-JB1_>+*$KM)'
MR4 %Z]-;.$$L 89SY+"1AU>(%0$_5#XG7$!%UJ%4$LB/5RF0%J0+@]-:[_5[
M&(-]Q]565E$I)^HIJ0]6J2DW*W9=ML.#9Y?I0I=\Z94Z'49(1R1+PL 596.(
M-Q)CI2<I7-CBT@!J8 ++4R]1&1)GM.2F<C!#.Y>0=G)BYF9(-\ABV)4,=$'U
MLBI8G4+W0B];/7,W?4:ZLCPQ]&#"Z9F1Z[H4B6JJB=OXJGFWU]P\4S3YV#/M
ME9IQTW'R^7O_Z@V>T:UAPTF?C1LW$@A[UN<UJIUKOF%AYX?CL23;S>=\Z[R
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M_O_.AV8.0,400RP^PP1$$+SN+G,N,P>MV\TWY@8D;<+"=L,C!N0D FK#B&+
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M'GE'QRBDAB0D6\H-]G( 7G  -K@/.:@/^E(0ID.OD'D_]=LG'4&MEAPH8*K
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M_R1)Z$0GJ82ZUAJH?#*9HZ2Q%@6<"ZDM8J7/T@HH=+(!#BK/HIN0L2$9GJ3
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MO;RIK4KH2)F[/F$[T*/:];E-P.V69SE<BSG<@; %(7K5-=@ =.B -?B .>B
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M2P(?C8$%KIS1*%RC&F\H<$2.RJ6>EY(+?\\L$WZS*TU/.%W2YG^VF<UN3GA
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M'3,R'UEFN#QMTS:+U"P""L !#G@@(TQE9AJFTE*%#-B!!VS-(!I )6*"LMC
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M!W(42HO2'B] 2L%A'V.T)'XTEDG")M%Q&/BQ=3NH*"F@'SYE 'C@1TG9&W[
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MBB!";KH!M/=\*[(BPY<G=!5__T,%>, ;GC<?QM0> F00! ("^X-&-5= T&
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M$S @17-R+4F1?.G+8C=03$N1CE(47_W0*:G2*#;V$=D+#MLK*7=B8.E;2B>
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MFTIC":LWO( SD\/#:( +0"N_:+R/"C.. XZ6.<J3XK*_ BJO1*FE84NL5$,
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M#5Y)A((%&AD\APTHS%'23EOY?$AT3J,P[5<-X,4:"#&T*A7=3<\B-QE),]0
MVPW8HW4#/$0;$A!D+P6R4C$S]19O-TT.U>4QQ4S<RU#-G)3'-#M%^6TU#W#B
MA1QBN"!Z=NK9.GFI;F<GE8Z"IR=^X_%>8W:N#Z.GZ[C_+I[P5@I/?/#E)1^\
MH!'6'B#QRFO7H?._.TH\>:%J?V.&RR=ZO.W_OL/.O'^3 F]B\J]GK_OXY@]I
MZ/7')[@[^!WJ'OP/Z"0)?)%V3FD[%U@(^(@WOD<9R':G6MUW_(<B$E6/>@FT
M!T_4!*8RM8D=[&"3EZ#@D^DUSW[F*5ZBJI<J\"GP?MLQGNR6QYX6#<^!5](3
MB2R$'MDU+WHN+"#V-E0^&]F.?D&T4HT B#W>!<AZJKO>$=W'O"5>#W=@N4Y2
MW(*K*:XDBZ0[ETVJF!3!5(=TN2(-KUB0&.!LH&W>2-K2\C(XD R.#Q<PF]O8
M9H.0J L$4?#<1K1&N*?8<6=RPQM,!H"88 '2((#LP"$XPC>?H8!M*V!:XM"6
MM;H]+5@A,2/,]H('_\-9@&^&VXI$;A*!JUW2!HY!""3I"$A2V@0O,1.=3:PX
M =T@,HS>"$K*+L"+H+0LF$7AXJSZ9DSH"*<!,GA!7DPB S, H2\-, ,S]S4:
M%B@R!GQP#=%,LHAL;C-I/!!.-%'0FL_P8"(,:-QN#KFY?36 !<R,YSQM4; &
M?(.4($A,/!O' C,(1P8RR D(1, <?VU&*?+,R3\'T(*R1"PN33$7<KZ5N; !
M)XRW,=W&F$4YCDTD;*PZ'6^08U+?6#0"D *5]VJ4IP/USD=*JE&AB"A3)\$H
MB:E24:3"%R$19@^F,WW4A%I$J?S0CE!"!12*\/>AW07H5!SJD9*(ZM/WW/^0
M192:D:7NQ#NJXBBK0EUI[^1S5._\0 P6X,,&2F"-67Q@$!W@ S)8@-8YT-4#
M:)B%!>8PB!^ 0#['HNL/[/&#;VQ@KD/H$XM.!+VN3@E2"F)0^Z04'YZ0Z4OL
M$ &;R,23"S2UJY6B4Z>^:K^G+DE.^8OI@%K4HQ25$$.3S1&-RNHB1H&*0'4R
M(9686L+O2:JI^7&2B*+DV$WYKE3:0=&L0E*KE"H%-]]ZKE,Z.E+F/&5FU5E)
M3A!CDVB:P9L@B<'9R"L!D6A%(R  : -LL163X*$#9LB)<KS1FJ904SC_A(M9
MF*-,(1@GBQ?@PP?L]:ZPY !<&8GGM2;P&==D1)W_7B'#U;Z5$S*8,25-D0'"
ME/D"ALX7G9.)2VON*Q);+&V?37%OSO3"'+=PEV.;VZY>J&,#GI2L)R>[@!R$
MZ6/,X3(WG<,H0AB'AR#C@0\B ($:^-"!%Y"A::N,  ,LDA(S/&0.<F. 8ZIH
MAK4V;G =6"LROI(UN:%@KG-% :^XR\E;GHO+4W/6"[(RT)"6("MJ4!L9&+=6
M/.B (8:TRD 1DD86Q"0A"Q&)12X\ "Q#Q"W^HO+>VI*X01(STV2DI7-P]<67
MW?+3A/QH%UTU1CCORKKG,@X,E2H_37$O5$XTSZ-:VL#5/8C6+1T?$)^GO.W]
MNH?"#BJIP!.](=9/V/XK_V+KGOC;9+,/A23:7A-EVVL>_N=/Z<&0 9V]P_S-
M#D50\E.KX]?#Z:'A H&]P"RRL)UOI* ,@YB#"-# 9!.M&P1)NH M/H 6-91!
M!&>[P!P6^X,Y)*E#H5JA_.Y'H^XPP(1![!ZT;PVG71]*A#>,4?FXQT3_X2Y]
M\&-X]X0X*42Q3N(U9.+L=C<^D>=N=> VZL)[Q_#KM>>%[K/V@Y1G)[/J>G[-
MEE_^DD=,+_:FDT3&B]+_A;<88Y>0SJ%BS1*--S,(X5\1B*\08O5E/C2N(4XN
M<]>X9I4] R%B8OBD,8%0%H0,@ 6$Q@M'5L#'9AT2)B#; %VW*1:Q!\)I<GMT
M5O_.1N6G82:3?$<T&1\]A[D^I%BL&L B^LJ"WR0M*V4&5UPJ8A9P69EK#]DS
M#Z9^T=/_ICFMXJ,L\S:,G_ 2F#X6IK-HC-V8S5+3)X876ZHSE;; G5G-W!S3
M(\<6*]8X7U:,SL?:A4SET,Q9LFJ5L]C23.HC\_BW27VO0MI)E3@+F54TYA2O
MV%Q=&?-6DZ-B33+7_G,=)VSO?PE(>>7\+78T4ZC2S\8M)*6I[@ECP=3L9$]8
M855_H(?T]!:=(-$(65M2S8<#XL].G1#0+<JBT% $2B $:9O&,0J3"*"H0,KM
M1.!6[4<(A@H&QLBX32!2$8E,F8I0)2"3X,][&%:_\9O_"$30,(" ,@Q""9C0
MD8@'8'T OR7)!Y0 FMB"#@HAZT3@\\#@^/#';+%6;I6@$](<H3QA3OF.354*
M59%@C+S4;B4@2^U(<?5(G)3*:CD)6.G6?=A4IUR*A@R(&L94"K869"%1" 95
MA.#)3[U@CUB@@=3?%.&-<VW:C!&3%DE7@)6?_3&?K2A'^\7*1$17W_R&K5!?
MQ[1*=@E?MEB'8FS-] 5+[1T32%5?\MW%%*7BMUQ?4[@%*691]7$B=%0?*5K?
M\N4-%P%?+EZ %]S&<-@>QYB436C1Y30 +_72+_78[ 63*V).%:T$20$?TN&-
MX(FBTQEB3&".<?R&QFB,&W74_S2&E")F46B(6DS<GTXTA6ZHXSIF8["XX^7D
MC>C<!J>EXZW RD:=VD:5(_RI(SFZ"OM%&=5Y#"+="JK!&!DU#93$#G MS\Y!
M" WYC@B1D!/-6D0J#_MLG/G(&O&<R@R%G,^Q4!-1#\EIY+>%7 Q>SP.F$ O>
M#Z]Y9&0]$$?NS@-&R/G,%O!LI,OY"?UX)+;UW \QT>ZHVP<<29)( ,%AA06(
M0 J4P.RD6V 9EKX-PB48#PNHP0?H6U4F2:@T6YSH#DG&' EUF__13T5.G$W:
M6DTVD$-.6[*5Y,]=)/P\R,99Y+DUX*W=3U!%U@X"D Y%&\R=D$3ZY)YPR/JT
ME$,V6__1>2&I%.!,AM;KE"2H!1FI$9),H*.CW43N70Y+:.9 TH3SV=_HM$3F
M?":GO>,790& [4J0 1DMA5K5 =G+L I*$(<754TI%9+,8(XQ!1B[9&,7C>8[
M*F)TE0TC-<4+F$%M2I?\N>/&R.8_B@V.\<0OI8P#.&,P99=2_%YTQ8I2/!>I
M*9A&H)]X4DYWGLM)4$ZMT-AYEM\Q1>*WE*86(8?]30Z,Z=TDIM3HN-CE?-3T
MW>8V=E1_NA]]PMBIN:/(P)AQX)_I1$78@,Z!EE]U\0J-(!5+RN ;^DA4\<Y/
MSI1C,56>4!:=9-MH;=4@3B8$V4]I.=98Y:$&(N8.UM"3Q$?Z;GVHBLC@"07@
MP^5<98'A;BE@&0+@C'1HC80(&-;'N+&($![E,*25")0!#RJ#")2 %1IA518A
M.M0'")!)OU%0O[E63)VA3FT(GZR(:!D@8^D4BI:(]&"*CHHE_YG@8WU*F=Y'
M&R:1_JT(DW8H@LP.4L%@C[:6B"QI8^E(1<JA4>4I!V+@\QP7;.D6@F2<=HA,
M@:Y?*<(BQ\!$=,#BIB5'ITJ'+*Z:^_6*C$5'J/HGKX@,\T73M=18S)BB/Y(&
M2 VHWJG>YBS'KD9BKA)H_>$*K7 7K](GKV9.Z$R "\R5!7S8^YWC+0'K/M;$
M&$U=E#4 &_!"RNR8'/C$=O\&TW'FC6?2)FCN(W%0#F:*SDR<CJSZWL; YC<&
MAVW.(W#$$I'UWDM8G=6E:[@N9!5I5&]$9]/EBC%%XU3 &9P]9S3NH[X2[*?-
MIM,A'2*58^H5Z$SDC3=0&^]DH/+$Y0.1$/BPY,V9)5M.G$HN4%ZN5L9^W,@9
M2K3M4!25H?$DD/GXSP+5CNJD8+(IIL1E;+@%)6#"3TJ6B,R"ST>:6X 84?-$
M%O,X2 K^D'P0H1$.P[PEB1GXU3#8@A"\'KT1G C@VP?8FQH,PPV<#5>"%A':
M)65^;,W2SEN6V_=X[$]!"-'6I5H2+5W.K,<!#Q$AS\\JG,6-4-#"CD@";KFE
MI>__M \#J:6WV=!/R2S#!2H,M1!/MB3V.";'R:SN3&Y0NH>"A)'4X9)V)5IZ
M1B.$FBL?D8Y,Z 9L3H3H&JO5Y>:%=5&XOL5UG&.^'FN;,9TV%BOG?)KH<.86
M>>=I$E."GLM'(=)LKJYMJJ[>.0LN_><Q>::O4&R^:LY.. "V*J,O>6O+<-^N
M1BB%WJJP^.=TO,1R2$[O26*40:*N&FPPBJ:THN. ZJJ,+:1ZTDRM/N)MJ!_Z
M5=1\SA+"?J<;36,#0-UTF$ZT:M0QFF;39=3Q6H=4J*<V(H13(6F.=!5J96B&
M9."HI.F;RDB,5M6FX(@%OHBCHBB.<MN2J*!/5<BD,DA5_UEP:0EIK8W5&=*@
MD,JH@R#JDKSHG/)6:>$I!_<A^40M7%T*"SS$!JQ!%D!I!HR9&GC'&B"#&O#;
M$(I!5@P"E(KI !WJ"6U5G,;P7_J(62UJRA%1BH+;$RJ)H(H5H8[0!;/6AH2D
M$EEA<57)@:!/&9NAH335G;!IROEA!5*)]1A;!,$(3(4QE9PI!D[;_BT@;0T(
MP:IO G=,^^DF%DU10JYG)V,7^*9$A)ZOZ26'P<**.XKR%GE.12DD=&VCS.SJ
M\&;:Z56HI]ZNK*H:A9*&/E)'^&J:ZD%'=,Q$<-RF\5JH=;39Z2SE,GY6MW;O
M4<"N]1HO:,KNL0YC+/FC_)(G)?_CHT&2YRW9G^S.4G#,'V:RWNV>WV_>9BX1
M9*?.&.J2KC_Z2K@JZ /S+NDDJ'3B!.A$;W%^9@3T5 DET Q!86)V;D2VT,OR
M:%$J9LF>K$DN'$W&X1'Q)0GIT/ 44,[]E,S-;%*A7!S[SPJ[+0O"I$&;I+1I
M= 1]9+&-($\V,OS CD'?K$F;)0#9PTT'CZP=\DVSB W<-(GPM!GJCJQ!81H7
MI="ZSL%!'EUM\<?VI D5H-N^GA@D7!E> /_X90*J;?J$6\9.'$9RK,/A#K4M
MF^T$;>!&&\/QFMS:$/549!K;D$W'Y5'?Y KFCV 6Y910'$7_$.>@+CKJG82>
M+R[;*Z?_U5[>!*_&Y%ZI6>C=93-X,C8[5^SY!F=H=N.,<5]FDF[-M&\WW\3&
MI)XX_Z[Z/K8FP<HEZC,MFY*GV:8PD\$O8:>..8#)/+/+X&M^1O#"XI,(X 8Z
ML6\VBW(Y@8L$#$"5/<;4F51UG$0T;86O@( B"8MN ,%Y;<Z(W0T7\6]UK< <
M1 'T;5A6.)D%7!ZFDC93Z KZ06/2(3>GVJKZTO)D"Z-([:]N1]T48;<[,^!3
M+6D7CJGW1!9>6E;&6>"/4NJ=OI2#3&!E+;3_-8H?%W(&_P>?!D@,SHE]<$^B
M4CAM-8@+4HH@PI9L\2F>4&0CXQ1E<16+I&$<6T]$]\DA/YP$_Q;)TA:I(!O5
M4'=N7'K*4L4/H*" +: !3XL ,M3;(Q.<B$IR>SSI!]>'$.K(&%[5!=8@F0X7
MEB#(&8OA ?VW:$76E6 H%D9JXL80DA;J"=;6F>K("J&X7@=N]3S5 =(Q!WK'
M2$6H<$"=_AKP)XNN<FL:.B?'@GZS/1_ON>CC;GAC?&.F:],W>I)K?&_?INDG
MHYL4:=#78'O1 =>R[[Y?11D'R/ S%1UH29D..0-P+$_1C?52R91,;1^%/R_Z
M@XK.U9P+VZ3= >_B@.Z,:R >610.)8.Z7F!$M"@%1I3 063:V*#-H(L-XJFF
MU %L3,@Z(@6,]47 "PQ[Y$!=^O[F4O_,)CC'*F"C6C^.;FJK)F CDM49<ZU+
M^FO:)F>2 8\:YO=(D!_#)1"-I F)Y,Q)KD(S\LK6[?^P$$N']%$774?SK,8%
M+K)E[J&8]0L96U"6]...T%I_'-UN+$K/STSRD,-G-./*SU^F]+7MS@RZ-4MZ
M+%';^T=GG/^YD&'Q3P.IR]H"5O\PIM!>,;'Y'-JBG%L.G;\ST<VIM5^>M.)F
M[D_.+,"'Y8=6G$(/O,.!\+OO)4L;]0=/9$FJ/+W/($HK3VY8]KU>1^6X<^H6
MK_GYH[@6:&+WS;B/<W,4Z.>DJL**KW5-YS;_\^;PN3R?7C]S/<+:[J:)JW=>
MD?FE:B[KZ[/_KN-3 $7*'+[LJ7I1F&*FYNKT24?7*$4,9$ Z"2^N/L5F,$!&
M\%="1B\_LD;!G5$#N( 12,;IP5,I-\7F?\5]FFM](\1G%$%\QU-BY&8#Z$ .
M,/HT0NCZ#JN> S]]XP9R! ?@ZV-RDZ<L/O:P*@=R9AI35#@C>V@=8A5O:>CM
MG# <%G*&)FJ/QGB#/!"@[G"42U49#\F3*/EBCNE1N?B8TW#*Z;"Y=6C5VQ1R
MD;E^2+B!?SB. K*1 L2P81\$#D,S3((]A/8^V$N(\*# AA(5(C2X$**$B!8)
M7DPH86#!A@\+&GPX$N/$AS]T$ 3Y@86:83_FS+$@ @T("W,&"9S3_V$.P1\@
M-@ =(L$6T!\_OA$<U*$#GS7#+H"8&!$-R((D.V95R/5KP:P8MRJ<:%+AP9,"
MO;(%N?&LUY<B!2;L6A8DR;EK3YH-25&BV)<530X,NU'M7XI:+]8U2[BCQ;$/
M]88D,R%" S(#&D0@T_GR9C(1O('F3+ISZ<R9![#^['G":- 3O*WV%ILT9M"[
M3^_VW"#V[=RH5Y,1/GMT:-V]5W<N?EKUYMF_/9\NWF# Z]#(82<O'KIY\=O:
M8^/&GIIU:M^@/8-7?EE\;.3KKY.F#M_YY^RYI?^^X.""_P24PP%>_CD0P005
M7#!![3B3;;3RO$G.O @RLP4/[U"8 XC+%O_A(ZHH1@-B#F1 %((,(#+ XQMD
M.M@ "!"$,+$#/ 8P@H7:&L"#A<QDBX!$/&1H0+,7/"A!,Q*!ZD (%7]",0(6
M?F)A1! \B*K&"#\T443/0.!C#C4X7(TU,X3H+@(>RS,C*BJ!G ./I&K,; (V
MYV"A,R"^42/$Y$X[33H(BRO/Q_# ZPQ1"YUK0$<=!]51T$5#.[2Y'\D;QJ&(
M",I4,H$8J@O3O"R:RZ&0-/)T4Y!*Y92MD$H]M:ZLQHKH(U91+:G354\E*-7$
M F.LH%4)BDC7DE[=2%B(;B7UK8] M374:(W-:RQ=-6U5,4PCHRNP3Z/U]J)D
MM[IHV& I<]6E3VW_+1966)55E[%/3Y576FUQU0A?>Z?]5J,/0+@@4YHNR$FF
M0>8(\%^#8K(GA4L^N&".#>PQ^&&KT/!WX%FR*$.9.43XP1:7%E*UH8Y@=:C4
MP()-5ZM/-XU,Y)$;2]G4:&&VR-A>S45Y6WF1/3DR9",C>62L/MHH6GPY/79E
MCD+="&AIX675'LTBC'0_1"M,5+,(<+/4/+ C_;'K\0!MSVM+TRX4T>S*(X/L
MVBZ;$.VMR4:S:^QD8XY1O%O3[&\=H9M ;]=\;'0UW KMCVO/\,ZLT;DA'VT\
MX\)C&\V[+^M[;MG&,]2\80#D!<#2 ;R P=15_Z<[S(S#;,*WN=.L 1#P_V@.
M8A[(8.&%UDBXA$@0<K PBSEX. ($%(;Y1H(!)!#C$N*-CT$,'CIC002WDU,1
MCQ=X )*%"Z+G07CI>6 @^<]DZ#T"VR.08 YK+'3!^ 9X;PT/X!L0XTPR0)BC
M"'#;#0M0]+486$-]O2/#"UZ0H@P +TUSL$&4V,>[]V6 ?9!*U&M,L\'9/0X^
MFJO0=JKCF^'H;5'004]G .6ZSA@&9[1R3%X>DY*TE.0LA8'95WB8$;&XI51G
MH0Q#"",SN,!P5#TD25MJU2I>%0:)<X'A2)B8*:WD4(J-@2%8T.)#3?GE+N?"
MR!*U<JTC!HTDW&J+R-(HJUJ=*UU(Q)5(PK)#Q_^ 2B5C](M@(%.1'(Y%B$4,
MR5FZLA(Q+&D.?/B!/2[PC0L8!!U+"=DPN!$RAX#@!Q^8@S)F8I6J-.0"M@!8
MM$ PB$\V)HU Y(@?*P)(3#4FAR5I2Q=_M<96 FN67BE7JYR%-)/,<B%#HYG(
MT'A#;#D++]FZXT/DHABX?(6).*SAO4H5GM2XL#BM4UML&$<=X:@&A2#T#:6
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M-)>0RL^2,."HA_*M+75()Y7HEKQZ+0@NEB1^J/7:F%!"<^6()DZ6!0@.#4@
M&7(@)%:>1H+BVFC^)T2M)[H7+?DBXS=5*RY@%H+:(+@A*#S>?,<%XJW:E:>+
M5LLB4*%^LC77L)U^WEBWJ@$^,0"^)LFWKHTR6]*HM;0-A@@+OU_C\APG.B[O
MM]N7/K:=V8MS.>\J@9>S<>1&H.2V[K5XW(^-;';=/1\ZG<H.R_QU-O;#;MDW
MHOVWHB>][@78O]WC:T+CNPL$S,3LUAEDP*&;OOT[473_FE(H',(C!?]B^GYM
M8\D0O<:F[7X]G5+PFR4WL<%3W18'CY^I[-*O.)_5/5WS*?_H>4(65D/GZ7&P
M6,&](5IN\-O44"N+Y98C$,/B6+*(1L&B?./@-/D;4 BS15I39K&7*]"Q/%,G
MK$\[Q<H_?,VCKL.=)4WA=,"NQ8Y]*;FP'+*E_,J7G\C9V-PP><;]$" DV),P
MK"#!#P6'V4,XC"&:A!+0#)KSP9X]%FL,#F,1A,7#AB 0EK$WI(3 B!87AK1(
ML.7'A@41GDPX[*&]'R N,*PY3"#"@3P+/CSY(6?!A4<9$E08L>='I#$35EPZ
MT^?1IDP__I2)!BK"J5>=TF2:__#ASZ5EI=)L"C1KV+9 7P*%6C,BP;EWN0J%
M.7?G4[M/&Y"9X"U"@P%D# \P'(%Q@P:.!R>&+-FP9,03)D>8K#EQXLR9&T,^
M/!ES9<BA1V\FO#E"8=6J7\O>K#JU9L:269,&79C,@-"2O94>/+M!8<6?B[M.
MO=JW8,N9-;^VS-C;A-W"61N>;ITS8]S4(6\?3WH\<<GZ+O"ZX. "^_8.Y/R;
M3[^^_?OXYYMV37F ZL'+X<8<9:1!Y@UL_#D606C6*3B::91-D.!T9$2867>4
M"5CA:HXA-N%_$79&8'.,^:<@&0=NEN)_)&HVHF>I+39BB *22". &8I(FV@U
M@AC@AO\F'F:@@=$AN&)/]B YTU1)"F10DTG6%5.4=0'UU91K85D1EDZ6U1)-
M6QZ4Y$YB<AG4ED@*]:63#('%9D\P/;E7F@<%):63> 8U5)IM1AEFDFAT&2A,
M7T5Y4I2!CMG64 LABN= 5(8)4Z)RYMGEH08-JF6E;8EE9Z%K0:DFG7X"JI94
M34[:$SIJ1'D!.H/4].H@Z'QU@2T[71"21@7]@*N74**%9EV#MO0!KF/""::?
M#4':ZZ\[19NLF6HRBVJ5P"HIYYR:VHEELT[9]61+HE8DTZ)E+D5F7&P:.I"F
M:#+)*YJ7 M4NGW!^="A!$FZXX8L9UGC:C@#Z&Z2)*Y[8H8M'!%_HL',J9M8
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MS ]-FUC!AO'/V,FKQOK5+T].:)2402R'7B9)X&0L:@F3#&B[HVS#.7M!O9F
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M"G,#NL-M2G^XF)>L)+<S20AO \^[N0<;H3_$;6[*>-O!##Z8@YOK[FSZ.^
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M%GI=\*#&XSC7Q)*JJ[HSR4%<0E/%+=*/Q"''R?J]M=$1&'J_T"C2+C500;3
M(WQ2_C)1 ?0Y%9,X1\0__)M"&K72%[S!!+7!$&O#2,U2!+6N/:W#%'70]Q6R
M1+W3$5(R^YM#&310J1U1!7;$^@NY-YPW!^0W*M5* 8RO+F5)LZM?MZ7 '5S"
M(.S_TA\U4A.[VA]K-Q\#0PGVKBF-0##5,(]23/2%U(:E4!D\0@X5P(O[0 0N
M,$O4L@BD1)(+6@X\.88+5")ST14U8I5,F$8\87:KL:!=,3^,0KX<N@=E,*<T
M4$"54!8+LV0RQ#0;R8:LW_9%4C=0 5N5C17ZD3>#7>\3Q4^L(_>8F_A4O-YM
MU?B@U.Y;(SQRCN5(#G>-'%+:SN+\&>>=$3WK#>H,U1YZW6$\S<']U:8)H]U;
M7;S2MAR2JI<Y7"M1O5_KSGP$UZ/B&M?SF+ :D4OJHU/-F$AZD7#=1VV4HV7U
MI,_UF5C>H<C;$<'*92'A#%,CD4^.)"L2C\^#D)O4K:4L_SF$'3L:94+P.D"/
M#5J_/"4\U.+)X($!X('KL@?E0*8/Z(X!&( /6$ER1F=RCH /6,I,^&9R_@#N
M>N=RQM*B@TNH>Z]Y_@!^PEM32@)RGM..!"[!;&>NJU%JKDQF6B\7^^<!0(*2
MP\HK+CDDL(<+R(1Q(&<DX,BM_"5U<S"HA4"%Q%CT*K.<Q<B8I%E_6MF,G$N*
M=6(W:.AT'H +@+IONTP;& ![6-L+0&<]F%G>^C:8SF@E7<R#\39L?E@F+$J7
MS2\5R.BH13/,S 2*9H.NM>D&V^C\:]B[% >G=NB!PU?]HN@+4..,1L,-7>GC
MPK=[TSNR>\&N+..4S$NM^^@@,_]@E3S*A2M;S"S,R$ "=!PJS!M.5.:KMP%'
MW!ULJ'HD2HK5-4I.SK/ES[.TD/DJ>C3<_Q21RZ4S.KJ12Q)LXTALXMC/SBZ1
M7UN:_F #YW0 :,QD-)J<]4LB[\-L_LQ/_CS>),FLU$-&;8NA5O7CX=#5V,0^
M+XD/EV%%.A-D[RU5O?&\V!:9408;.497VJY.^QB^5MTB0P/NH8&]Y)Z &@WB
MJU.RNP;A,HWF#B8FZSI4#&S & QO#3:Q#P#H_,H$;Q@ !K@,")%I;Q@A^Y9I
M<K9H)YAG>&88G$YG-K!2GWM$3'1GF49P(U4RC';H";8EH@58,ZY1FE/1!DSO
M7_H!@#;_T1[>2\CH#IKVZB/\XC .X3#\4#)D6W>:.J,=PB L0/-^X27&X45U
M@@__[WC.)@1V IX>@&$(,1Y'YPNH8#*^#"''82Y\VV_"8'"3,)+S:HT&ZCD=
M;PBA:0AE2?7M09H#[P@\<1 V4".%$#1P@C$WXB_.AR$]:A"EKRNVOR;?TMY*
MI?V%WX#V,!*U.9(#P59:8[<)G&+]3SZSFRZ"G$0;#DBSSFC-(O93;K0AHL:N
M;L]#G#N^H\^33Q[:)/=<U6!T3<]:9%8&CNB%+?HHW=6NY+MJ;32:O=KM$)Q9
M/.1,D51V-45?DKS)-<X]3FP$Y.D5#Z7RD<1&&MD\-HQYCT>K_R$7J2IH"S;N
M[&6Y&:2ULK9M10T5.?9'D[8LR5QP/8VA%#JTI<NU!<*9Y;=[);RT?;>18VD,
M7B6OIFG+4 9R'@=_D.]RSH=\$'*==@)DNP!UVV8RJ"4M%W!N5I@BH.=O+@(\
M-+B_\R@(B>=A,'B,E$ A1X*QY-BIR[JS/MJ"G=>3ZDJK_+:&?NCWNB_V7MG(
MP&D]:.FNA#LK;$-_XJ>*W5"O_2[TS>8):TR73^EQQ^&C#+AO%GB.5$QSFV=[
M6*5MUFF>YN^:O7E_D' 5D.J4=[<2C,B>0^E]/3=\5<* 0WB+1NA6,C>:7$JH
MY;@HBZ>*#:],V.8M?S!Z#<K?6FNG%?][A*1,O*.O=/NVH N[EXM!HAM;@R7)
MO83KO[8-VJ1LQYHJK0)0MV*T5 :2+'$04TT^=M2C"LD16;Q.Y'Y\XB6D\HN9
M8Z,VWB9'Q8'6V!NVPK6T1S.U42XC,4K=5D^C8HRA\!N]*&FA3*NMZ6LUU4C6
M6ESD1)<;66XV]-B/[ YNVW(JC9$;JQH<3#M'X;-<P=F,Y<.9Y&4/4!I'T40-
M.VLA(9H GAS!#+S#(,QA,7;1\H7SJY-S [7G$S7BRM ';AZN;P[_3 #P"B7Y
M^L;W[ *(<0,:9'+BQHF_3#8&E#F8SQ]">P-L.,FD8L" <>*<Y-O8D6-!)T[$
MY0,ID6)"D?G_,KE!@[&!RP%("DK$R*,@Q@\?)=H3Z:9@)HS#>&"TQS+H@ \8
ME?E3T0"CMP\I,RD=6#434IW^DF $>@'C@)N9GH(5.*!@4[(1+B!$RJ:FC9 0
M5PHE:_0GQIA,59#!2.8"1)%?,<8-677 ,)%.G()%HYAQSI5N+F8,:?#HX(('
MT2+\.78 F;Z)\U%61KIKQ;8<JT:XNK%F6*R1:0[HF=#-PIXK^[+U=WC82B@8
M9^:L>?.@OXV9B(*="7G A967#>;>_)1-QYB(5RKKFLE;4KA8*TIGCI'K6<IL
M^I(9!QEMR\8<E1M,_7-DY_G3I8.L6)#D42(5Q-^ EEWVT68.091<_T4.><12
M:B(U148#$51(801D6+CA!!ANB&&' T7@387>=/B4AB:&UF&&*IYX8@0;5LAB
M:!5>"*.'%]J8(887BLC>B"6&>"$9'9K8XI CTKCCA3)FR*23-SXY)1DN:JAC
MABP2J66,6!:YH8H?%GEEAA_>B*$-%ZC)RP5LL,FF#?_(.2>===IY)YYU\LBE
MA63NJ"&7@(Z9Y: -^.D-F!8B6B2B#30*6I*A?4@HAV0*NF&?F-H(6IF&1J#E
ME:'V.0&3*H[I9Z>B@OKIE9!ZXR=H@\I8:)E\0BDJDZ%V2*J?K0[*I:?!6MHA
MF9F>22M"$9*76B8+"E@?2>1M%"VU$4:K&?^$F92D[;+<6C:MMB1MI%BV^52%
MQ$$Y.4$.:@U^=H$;$4#WGS]/\< L$H3! -1DA&E&61(508152<K]M"UEA258
MT&!@#><$;#:9&UM%X&DDK1-].3Q011J#E@EZ#G]@D'8.HROOR)FP*Y,_#4.U
MG,/H(>'/#QL/@,9/'H/%P\#WZ?R22.#YE8G+.?GCV\;>T.8P W1M#"]2(HM$
MF48=!5;10@P\N[" -@P#<T_B4#93)O*2$ZY/)3<'\<;W?G7O1AB-4Y\37!&4
M2;YGL<VT1<-E\G-8 FZ[$%B9U+PQSH%!Q)72BZ$VS,8]C>V$O!L7D2#6#G<G
M$V4V[PP1X6 Q,/#_M@:1GBQ0VWY$$D3CNK%22:E!]),;L[MKM> 1 G5M[ 0O
MBS%+3F6)Z*BX&IOJ\;3>V.BIDQJ+ZHRJ(CK!JY4JVB6E3 8*;)3/C_KHE8M:
M. "+83;IZ/C93QKL\->C2'WX8!K):I\BVMCJIO%KR*8##ES0O_\<P(8\$;"
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M! C26(5W!#!Z])'3.#!^X-1G] 2YP&?_7OB==QQ80I@%## (0HA#*) %4UR
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MO0N^+WKUJ]YQ(#C $*8PB$E\X@87^,+B?? X_LOA"DO8Q/)E+XSQ"V#]LIC
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MM<"F%,DG$[135%Y"0#.9\(+;RA(")Q*Q&.:E-RN*&'"L Y_N>$V')CK:<]
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M$)>4_]IQ^-O"'8@-?5" AB.P@5F'*J9[!1>3\ (LIE7\T5]?]N5]X1]MU56
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8ZDS)GHQ.U(T,PRMVB(=TR([B*\H%!  [

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>img17388848_4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img17388848_4.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" =H$$T# 2(  A$! Q$!_\0
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M:\NEF>/S-F(@"<G/J1Z5SG_"S]'_ .>&H?\ ?"?_ !=3?$S_ )%L_P#7TO\
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M_P!\)_\ %UY/11]2I!<]8_X6?H__ #PU#_OA/_BZ/^%GZ/\ \\-0_P"^$_\
MBZ\GHH^I4@N>L?\ "S]'_P">&H?]\)_\71_PL_1_^>&H?]\)_P#%UY/11]2I
M!<]8_P"%GZ/_ ,\-0_[X3_XNC_A9^C_\\-0_[X3_ .+KR>BCZE2"YZQ_PL_1
M_P#GAJ'_ 'PG_P 71_PL_1_^>&H?]\)_\77D]%'U*D%SUC_A9^C_ //#4/\
MOA/_ (NC_A9^C_\ /#4/^^$_^+KR>BCZE2"YZQ_PL_1_^>&H?]\)_P#%T?\
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MK'_"S]'_ .>&H?\ ?"?_ !='_"S]'_YX:A_WPG_Q=>3T4?4J07/6/^%GZ/\
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M#4/^^$_^+H_X6?H__/#4/^^$_P#BZ\GHH^I4@N>L?\+/T?\ YX:A_P!\)_\
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M_P +/T?_ )X:A_WPG_Q=>3T4?4J07/6/^%GZ/_SPU#_OA/\ XNC_ (6?H_\
MSPU#_OA/_BZ\GHH^I4@N>L?\+/T?_GAJ'_?"?_%T?\+/T?\ YX:A_P!\)_\
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M_GAJ'_?"?_%T?\+/T?\ YX:A_P!\)_\ %UY/16_U*D%SUC_A9^C_ //#4/\
MOA/_ (NC_A9^C_\ /#4/^^$_^+KR>BCZE2"YZQ_PL_1_^>&H?]\)_P#%T?\
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MT?\ YX:A_P!\)_\ %UY/16_U*D%SUC_A9^C_ //#4/\ OA/_ (NC_A9^C_\
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M?\+/T?\ YX:A_P!\)_\ %UY/11]2I!<]8_X6?H__ #PU#_OA/_BZ/^%GZ/\
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MPU#_ +X3_P"+H_X6?H__ #PU#_OA/_BZ\GHH^I4@N>L?\+/T?_GAJ'_?"?\
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MH?\ ?"?_ !='_"S]'_YX:A_WPG_Q=>3T4?4J07/6/^%GZ/\ \\-0_P"^$_\
MBZ/^%GZ/_P \-0_[X3_XNO)Z*/J5(+GK'_"S]'_YX:A_WPG_ ,71_P +/T?_
M )X:A_WPG_Q=>3T4?4J07/6/^%GZ/_SPU#_OA/\ XNC_ (6?H_\ SPU#_OA/
M_BZ\GHH^I4@N>L?\+/T?_GAJ'_?"?_%T?\+/T?\ YX:A_P!\)_\ %UY/11]2
MI!<]8_X6?H__ #PU#_OA/_BZ/^%GZ/\ \\-0_P"^$_\ BZ\GHH^I4@N>L?\
M"S]'_P">&H?]\)_\71_PL_1_^>&H?]\)_P#%UY/11]2I!<]8_P"%GZ/_ ,\-
M0_[X3_XNC_A9^C_\\-0_[X3_ .+KR>BCZE2"YZQ_PL_1_P#GAJ'_ 'PG_P 7
M1_PL_1_^>&H?]\)_\77D]%'U*D%SUC_A9^C_ //#4/\ OA/_ (NC_A9^C_\
M/#4/^^$_^+KR>BCZE2"YZQ_PL_1_^>&H?]\)_P#%T?\ "S]'_P">&H?]\)_\
M77D]%'U*D%SUC_A9^C_\\-0_[X3_ .+H_P"%GZ/_ ,\-0_[X3_XNO)Z*/J5(
M+GK'_"S]'_YX:A_WPG_Q='_"S]'_ .>&H?\ ?"?_ !=>3T4?4J07/6/^%GZ/
M_P \-0_[X3_XNC_A9^C_ //#4/\ OA/_ (NO)Z*/J5(+GK'_  L_1_\ GAJ'
M_?"?_%T?\+/T?_GAJ'_?"?\ Q=>3T4?4J07/6/\ A9^C_P#/#4/^^$_^+H_X
M6?H__/#4/^^$_P#BZ\GHH^I4@N>L?\+/T?\ YX:A_P!\)_\ %T?\+/T?_GAJ
M'_?"?_%UY/11]2I!<]8_X6?H_P#SPU#_ +X3_P"+H_X6?H__ #PU#_OA/_BZ
M\GHH^I4@N>L?\+/T?_GAJ'_?"?\ Q='_  L_1_\ GAJ'_?"?_%UY/11]2I!<
M]8_X6?H__/#4/^^$_P#BZ/\ A9^C_P#/#4/^^$_^+KR>BCZE2"YZQ_PL_1_^
M>&H?]\)_\71_PL_1_P#GAJ'_ 'PG_P 77D]%'U*D%SUC_A9^C_\ /#4/^^$_
M^+H_X6?H_P#SPU#_ +X3_P"+KR>BCZE2"YZQ_P +/T?_ )X:A_WPG_Q='_"S
M]'_YX:A_WPG_ ,77D]%'U*D%SUC_ (6?H_\ SPU#_OA/_BZ/^%GZ/_SPU#_O
MA/\ XNO)Z*/J5(+GK'_"S]'_ .>&H?\ ?"?_ !='_"S]'_YX:A_WPG_Q=>3T
M4?4J07/6/^%GZ/\ \\-0_P"^$_\ BZ/^%GZ/_P \-0_[X3_XNO)Z*/J5(+GK
M'_"S]'_YX:A_WPG_ ,71_P +/T?_ )X:A_WPG_Q=>3T4?4J07/6/^%GZ/_SP
MU#_OA/\ XNC_ (6?H_\ SPU#_OA/_BZ\GHH^I4@N>L?\+/T?_GAJ'_?"?_%T
M?\+/T?\ YX:A_P!\)_\ %UY/11]2I!<]8_X6?H__ #PU#_OA/_BZ/^%GZ/\
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MH_\ SPU#_OA/_BZ/^%GZ/_SPU#_OA/\ XNO)Z*/J5(+GK'_"S]'_ .>&H?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH ]/\9?\ )/=/_P"V'_H!KS"O3_&7
M_)/=/_[8?^@&O,*Y<)\#]6-A11174(**** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** .L^'7_(UK_P!<7_I5;QY_R.5__P!L_P#T6M6?AU_R-:_]<7_I5;QY_P C
ME?\ _;/_ -%K7*O]Y?I^HSG****ZA!1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5M>$O^1KTW_KL*Q:VO"7_ "->F_\
M785G4^!^@&Y\3O\ D8+7_KU'_H;5Q-=M\3O^1@M?^O4?^AM7$U&&_A1&%%%%
M;B"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** .E\ _\CC9_[LG_ * :]VL_^/<?4UX3X!_Y'&S_ -V3_P! ->[6?_'N
M/J:\G'?Q%Z#1P7Q,_P"1;/\ U]+_ .S5Y#7KWQ,_Y%L_]?2_^S5Y#75@OX7S
M!A11178(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ]/\ &7_)/=/_
M .V'_H!KS"O3_&7_ "3W3_\ MA_Z :\PKEPGP/U8V%%%%=0@HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ZSX=?\ (UK_ -<7_I5;QY_R.5__ -L__1:U9^'7
M_(UK_P!<7_I5;QY_R.5__P!L_P#T6M<J_P!Y?I^HSG****ZA!1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5M>$O^1KTW
M_KL*Q:VO"7_(UZ;_ -=A6=3X'Z ;GQ._Y&"U_P"O4?\ H;5Q-=M\3O\ D8+7
M_KU'_H;5Q-1AOX41A1116X@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@#I? /_ ".-G_NR?^@&O=K/_CW'U->$^ ?^
M1QL_]V3_ - ->[6?_'N/J:\G'?Q%Z#1P7Q,_Y%L_]?2_^S5Y#7KWQ,_Y%L_]
M?2_^S5Y#75@OX7S!A11178(**** "BBB@ HHHH **** "BBB@ HHHH ****
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MB&U\8:;/<31PPI(2TDC!57Y3U)KU7QCKVCW7A'4H+?5K"65XL+''<HS,<CH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MLMA:1W&NL[S.,_9HVVJGLQ')/TX^M8?@S3X+_P")ERS('CM99IU  (R&PI_
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MWWBFY<0L(+6+'FW#C(!] .Y]OUZ5L_%C_D;8?^O-/_0GKT_PGI::1X8L+55
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M]"^-(DF\&:JKC($!;\1R/U KYZKHPE652'O= 84445UB"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!TO@'_D<;/_=D_P#0#7NUG_Q[CZFO"? /
M_(XV?^[)_P"@&O=K/_CW'U->3COXB]!HX+XF?\BV?^OI?_9J\AKU[XF?\BV?
M^OI?_9J\AKJP7\+Y@PHHHKL$%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MWUY;Z?9R75TX2"/&]B,@ G&3[<TL8VJT6OZU!'S)7NGPSMW@\%6S."/-D>0
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M&\8) /!_$8-='\-;.6Y\:6LR*3';J\DC>@*E1^I%>I>(/!>C^)Y([FY$L<P
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M?_KFW\J,?\401\[>&?\ D:]'_P"OZ'_T,5[QXJ_Y%+5_^O.7_P!!->#^&?\
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M&/O$G.<'@>E<S\7K)Y=+TZ]4$K!*\;8[;P#S_P!\4J3C]83BK+_@ 2?"+_D
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M/ID"OG>\L[C3[R6TNX6AGB;:Z-U!_P ]Z],\%?$:)+9--UZ8JR +#=L"0PZ
M/[C^]Z=?4^@%-(UZV1V2RU"#.4)"2KD<<=?<5YE.<\*W&2NA[GAG@_P[<>(-
M=MHQ"S6<<@>XD(^4*.2N?4],>_IFO2O%WA'PQ:Z%>ZB]@MO)#"=A@?RP6_A&
M.G)([5U$]]H^@6H6:>TL85^ZF50?@H_I7D/CKQN/$;I9V(DCT^)BQW<&5NQQ
MV'H/?FKC.I7J)QT2 J?#G_D?--_[:_\ HIZ].^)/_(BWW^]%_P"C%KS'X<_\
MCYIO_;7_ -%/7IWQ)_Y$6^_WHO\ T8M/$?[S#Y?F!Y_\*_\ D<#_ ->S_P U
MKN/BE_R)K?\ 7Q'_ %KA_A7_ ,C@?^O9_P":UW'Q2_Y$UO\ KXC_ *TJW^]1
M^0'&_"3_ )&NZ_Z\7_\ 0XZZ;XN?\BU9_P#7X/\ T!JYGX2?\C7=?]>+_P#H
M<==-\7/^1:L_^OP?^@-3J?[T@Z'EOA__ )&72O\ K\A_]#%>_>)O^14UC_KQ
MF_\ 0#7@/A__ )&72O\ K\A_]#%>_>)O^14UC_KQF_\ 0#1C/XD01XEX#_Y'
M?2_^NA_]!->P^./^1*U7_KC_ %%>/> _^1WTO_KH?_037L/CC_D2M5_ZX_U%
M+%?QX?+\P1Q7P>E43ZO%_$RQ,/H"X_J*E^,,#E-(N I,:F5&/H3M(_D?RKA/
M"^O2>'-=@U!0SQC*31@_?0]1_(CW KW5O[&\7:*4W17EG, >#RI[>ZD?G17O
M2KJJUI_2 ^>+.UDOKZWM(<>;/(L29Z98X'\ZZ?5/ASKVDV4]W*+66&%2[M%+
MT ZGY@*]/T/P%HN@:B;ZV6>6<9\LS."(LY!VX [''.:YCXF>+;26P;0K&5)Y
M'8&X=#E4"G.W(_BR!GTQ6BQ,JE11IK3J ?"_PO:26)UR[B265G*6X;D(!P3C
MU)S^5=!XF^(&G>'+MK'R);J\50S(A"JN1D L>^,'@'K6-\*_$%L^F-HDTB1W
M,<C/""0/,4\D#GD@Y_#'O71Z[X&T7Q!>B\NHY8[CC?)"^TR = V00?KUX'-<
MU5KV[]ML!!X+\73^*S?O)9+;16Y01[6+9W;L@G Z8'YUR7Q@_P"/W2O^N<G\
MUKN=$DT#2KUO#FD^6L\<;3R(AW8Y .YO[W(X[#T&*XWXP6LA72[P+F)3)$S9
MZ$X('XX;\J='E^L)I67_   -3X2?\BI=?]?S_P#H$=<G\6/^1MA_Z\T_]">N
ML^$G_(J77_7\_P#Z!'7)_%C_ )&V'_KS3_T)ZUI_[TPZ'"T445Z(@HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *VO"7_ "->F_\
M785BUM>$O^1KTW_KL*SJ? _0#<^)W_(P6O\ UZC_ -#:N)KMOB=_R,%K_P!>
MH_\ 0VKB:C#?PHC"BBBMQ!1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% '2^ ?\ D<;/_=D_] ->[6?_ ![CZFO"? /_
M ".-G_NR?^@&O=K/_CW'U->3COXB]!HX+XF?\BV?^OI?_9J\AKU[XF?\BV?^
MOI?_ &:O(:ZL%_"^8,****[!!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@#T_QE_R3W3_ /MA_P"@&O,*]/\ &7_)/=/_ .V'_H!K
MS"N7"? _5C84445U""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** --?$6N*NU=9U +Z"Z?'\ZSY
M99)Y6EFD>21N69VR3]2:91244MD 4^*62"5989'CD7E61L$?0BF44P-/_A(]
M<V!/[9U':!@#[4^/YUG.[RR-)(S.[$LS,<DD]233:*2BEL 4444P"BBB@ HH
MHH **** "BBB@ J:VN[FSE\VUN)8),8W1.5./J/I4-%(#2D\0ZW,A276-0=#
MU5KER#^M9M%%"26P!6BNOZRD(A75[]8@,!!<N!CZ9K.HH:3W ****8!1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 =+X!_Y'&S_W9/\ T U[M9_\>X^I
MKPGP#_R.-G_NR?\ H!KW:S_X]Q]37DX[^(O0:."^)G_(MG_KZ7_V:O(:]>^)
MG_(MG_KZ7_V:O(:ZL%_"^8,****[!!1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% 'I_C+_DGNG_ /;#_P! ->85Z?XR_P"2>Z?_ -L/_0#7F%<N$^!^
MK&PHHHKJ$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MJ/\ T-JXFNV^)W_(P6O_ %ZC_P!#:N)J,-_"B,****W$%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 =+X!_P"1QL_]
MV3_T U[M9_\ 'N/J:\)\ _\ (XV?^[)_Z :]VL_^/<?4UY.._B+T&C@OB9_R
M+9_Z^E_]FKR&O7OB9_R+9_Z^E_\ 9J\AKJP7\+Y@PHHHKL$%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 >G^,O^2>Z?_VP_P#0#7F%>G^,O^2>Z?\
M]L/_ $ UYA7+A/@?JQL****ZA!1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!U
MGPZ_Y&M?^N+_ -*K>//^1RO_ /MG_P"BUJS\.O\ D:U_ZXO_ $JMX\_Y'*__
M .V?_HM:Y5_O+]/U&<Y11174(**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "MKPE_R->F_P#785BUM>$O^1KTW_KL*SJ?
M _0#<^)W_(P6O_7J/_0VKB:[;XG?\C!:_P#7J/\ T-JXFHPW\*(PHHHK<044
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445;TNPDU35+6P
MBSON)5C!"YVY/)QZ <_A2;LKL"I17O(^'/A0* =+)('4W$O/_CU>0>+-%.@>
M([NQ48A#;X><_NVY'Y=/PK"EB857:(S%HHHKH$%%%% !115W2M)O=:OTLK"
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M#T__ (0_P?\ ]!+_ ,FTH_X0_P '_P#02_\ )M*\PHH^KS_G8'I__"'^#_\
MH)?^3:4?\(?X/_Z"7_DVE>844?5Y_P [ ]/_ .$/\'_]!+_R;2C_ (0_P?\
M]!+_ ,FTKS"BCZO/^=@>G_\ "'^#_P#H)?\ DVE'_"'^#_\ H)?^3:5YA11]
M7G_.P/3_ /A#_!__ $$O_)M*/^$/\'_]!+_R;2O,**/J\_YV!Z?_ ,(?X/\
M^@E_Y-I1_P (?X/_ .@E_P"3:5YA11]7G_.P/3_^$/\ !_\ T$O_ ";2C_A#
M_!__ $$O_)M*\PHH^KS_ )V!Z?\ \(?X/_Z"7_DVE'_"'^#_ /H)?^3:5YA1
M1]7G_.P/3_\ A#_!_P#T$O\ R;2C_A#_  ?_ -!+_P FTKS"BCZO/^=@>G_\
M(?X/_P"@E_Y-I1_PA_@__H)?^3:5YA11]7G_ #L#T_\ X0_P?_T$O_)M*/\
MA#_!_P#T$O\ R;2O,**/J\_YV!Z?_P (?X/_ .@E_P"3:4?\(?X/_P"@E_Y-
MI7F%%'U>?\[ ]/\ ^$/\'_\ 02_\FTH_X0_P?_T$O_)M*\PHH^KS_G8'I_\
MPA_@_P#Z"7_DVE'_  A_@_\ Z"7_ )-I7F%%'U>?\[ ]/_X0_P '_P#02_\
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M)!D6X!"\>HXJM_PA_@__ *"7_DVE'P__ .1,U'_KO+_Z+6O,*QIPJ2E*/.]
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M_P"=@>G_ /"'^#_^@E_Y-I1_PA_@_P#Z"7_DVE>844?5Y_SL#T__ (0_P?\
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M\PHH^KS_ )V!Z?\ \(?X/_Z"7_DVE'_"'^#_ /H)?^3:5YA11]7G_.P/3_\
MA#_!_P#T$O\ R;2C_A#_  ?_ -!+_P FTKS"BCZO/^=@>G_\(?X/_P"@E_Y-
MI1_PA_@__H)?^3:5YA11]7G_ #L#T_\ X0_P?_T$O_)M*/\ A#_!_P#T$O\
MR;2O,**/J\_YV!Z?_P (?X/_ .@E_P"3:4?\(?X/_P"@E_Y-I7F%%'U>?\[
M]/\ ^$/\'_\ 02_\FTH_X0_P?_T$O_)M*\PHH^KS_G8'I_\ PA_@_P#Z"7_D
MVE'_  A_@_\ Z"7_ )-I7F%%'U>?\[ ]/_X0_P '_P#02_\ )M*/^$/\'_\
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M2C_A#_!__02_\FTKS"BCZO/^=@>G_P#"'^#_ /H)?^3:4?\ "'^#_P#H)?\
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M,**/J\_YV!Z?_P (?X/_ .@E_P"3:4?\(?X/_P"@E_Y-I7F%%'U>?\[ ]/\
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M#T__ (0_P?\ ]!+_ ,FTH_X0_P '_P#02_\ )M*\PHH^KS_G8'I__"'^#_\
MH)?^3:4?\(?X/_Z"7_DVE>844?5Y_P [ ]/_ .$/\'_]!+_R;2C_ (0_P?\
M]!+_ ,FTKS"BCZO/^=@>G_\ "'^#_P#H)?\ DVE'_"'^#_\ H)?^3:5YA11]
M7G_.P/3_ /A#_!__ $$O_)M*/^$/\'_]!+_R;2O,**/J\_YV!Z?_ ,(?X/\
M^@E_Y-I1_P (?X/_ .@E_P"3:5YA11]7G_.P/3_^$/\ !_\ T$O_ ";2C_A#
M_!__ $$O_)M*\PHH^KS_ )V!Z?\ \(?X/_Z"7_DVE'_"'^#_ /H)?^3:5YA1
M1]7G_.P/3_\ A#_!_P#T$O\ R;2C_A#_  ?_ -!+_P FTKS"BCZO/^=@>G_\
M(?X/_P"@E_Y-I1_PA_@__H)?^3:5YA11]7G_ #L#T_\ X0_P?_T$O_)M*/\
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MPA_@_P#Z"7_DVE>844?5Y_SL#T__ (0_P?\ ]!+_ ,FTH_X0_P '_P#02_\
M)M*\PHH^KS_G8'I__"'^#_\ H)?^3:4?\(?X/_Z"7_DVE>844?5Y_P [ ]/_
M .$/\'_]!+_R;2C_ (0_P?\ ]!+_ ,FTKS"BCZO/^=@>G_\ "'^#_P#H)?\
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M_P"=@>G_ /"'^#_^@E_Y-I1_PA_@_P#Z"7_DVE>844?5Y_SL#T__ (0_P?\
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M\PHH^KS_ )V!Z?\ \(?X/_Z"7_DVE'_"'^#_ /H)?^3:5YA11]7G_.P/3_\
MA#_!_P#T$O\ R;2C_A#_  ?_ -!+_P FTKS"BCZO/^=@>G_\(?X/_P"@E_Y-
MI1_PA_@__H)?^3:5YA11]7G_ #L#T_\ X0_P?_T$O_)M*/\ A#_!_P#T$O\
MR;2O,**/J\_YV!Z?_P (?X/_ .@E_P"3:4?\(?X/_P"@E_Y-I7F%%'U>?\[
M]/\ ^$/\'_\ 02_\FTH_X0_P?_T$O_)M*\PHH^KS_G8'I_\ PA_@_P#Z"7_D
MVE'_  A_@_\ Z"7_ )-I7F%%'U>?\[ ]/_X0_P '_P#02_\ )M*MZ9X8\,6>
MIV]Q9W^^XC?,:_:5;)^@ZUY+6UX2_P"1KTW_ *["HG0FHM\[ W/B<!_;]J>_
MV4?^A-7$UVWQ._Y&"U_Z]1_Z&U<36V&_A1 ****W$%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %>B_";1S/JESJTJ QVZ>5$2N?G;J0>Q
M"_\ H5>=5]">#-&.A>%[2U=0)V'FS8 'SMS@^I PN?:N3&5.6G;N-&C)JUK%
MK4.DL_\ I4T+3*./N@@<]^<G'^Z:X;XLZ+Y^G6VL11YDMSY4S#_GFQ^4GZ,<
M?\"KE-;\6-_PL8ZS;/YL-I*(HL8(:,#:V".H.6(/O7LM_9V^M://:NV8+J$K
MO7T(X(_0UQ<KP\H3[@?--;GAOPK?>*);B.REMXS H9O/9AG.>F ?2LBZMI+.
M[FM9AB6&1HW'H0<'^5>C?!__ (_=5_ZYQ_S:O2KS<*;E$1@W?PYUZUU*VL$6
MWN)9U+[H7.V-00"6+ 8ZUT4?P>D,8,FMHK]PML2/SW#^5=?XU\2GPQHXN8(D
M>[G<11!N@X)W'U ]/>N-\&_$#6+_ ,20V.I2QSP73%5^14,1P2,8 R.V#GM^
M/&JN(G#GCHD,Y+Q-X1U+PQ,GVH++;2$B.XCSM)]#Z''./R)Q7<_#;PG?Z==1
M:Y-+;-:W-H0B(S%QN*D9!&.WK74>/+1+SP7J2N!F.,2J?0J0?Z$?C7+_  V\
M67^HW46AS16RVMM:$HZ*P<[2H&23COZ4.M4JT&_O Z/QUX;O/$^D6]I9201R
M1SB4F9B!C:P[ \\UXGK6D7&A:O/IMT\3S0[=S1$E3E0PQD ]#Z5[9XZ\27GA
MC2+>[LHX))))Q$1,I(QM8]B.>*\3UK5[C7=7GU*Z2))IMNY8@0HPH48R2>@]
M:O!<_+K\(,[^'P9X[>"-D\2[4*@J/M\XP,?[M>:W"/'<RI*VZ17(9LYR<\FO
MIFS_ ./*#_KFO\J^>K336UCQ<NGJ&_?W95BI (7<2QY]!D_A3PM9RYN;H!=\
M.>!]6\21_:( D%INQY\V0&YYV@=<?EVS75GX.OL)&N+N]/LO'Y[Z[[5+ZV\,
M>&IKI8@(+.$+'$. 3PJK[9) S7DJ?%#Q&+_[0\MNT)/-MY(" >Q^]^IZU$:M
M>M>5/1 9_B;P5J7AG$LVV>T9MJSQ@X!]&':LS0;2]O\ 6[6UTZX^SW<C$1R[
MRFTX/=>1QFO6=2^(/A.^TB:VN)IIDGA*R11PMNY'0%@!D>OJ*\Y\"[1XYTS:
M25\UL$C!(VFMJ=2HZ<G-6: WM<\*>,;'1;JYU#7_ +1:1IF6+[9,^X9Z8(P?
MQKDO#^@77B/4OL-G)"DOEF3,Q(7 QZ ^M>W>./\ D2M5_P"N/]17F?PK_P"1
MP/\ U[/_ #6LZ-:3HRGU0%74_ASKNF&V4"WNI+B0QI';,Q.<$Y.Y0 ..N:WK
M7X/W3P!KO5XH9>Z10&0#\25_E7H?B+6(= T6XU26'S3" $08!9F( &>PSC/L
M*\F@^*/B&/41<3/!+;Y^:U$05<=\-]X'ZD_3M4TZN(JQO&RL!G>)_!6I>& L
MLQ2>T<[5GC!P#Z,.QKFZ^E,67B#0QN7S;.]@!P>"58?H?Y&O +:"UTKQ2MOJ
MH:2VM+HI.$4-N"-@C'H<<^U;8;$.HFI;H#?T+X::OJ]NEU</'8V[C*>8"SL.
MQVCH/J0:W&^#K!?DUP$^AM<?^SUK:Q\3M(ATB5](F$U[PL<<D3J![GC''IFL
M#PIX[\3:AXA@MYE-];32JDJI !Y*L<;LJ. .O.>!^-8\^)DG+9 <QXE\'ZEX
M8D5KH)+;.VV.>,\$\\$'D' S_4UW'PV\)W^G746N32VS6MS:$(B,Q<;BI&01
MCMZUU7CFV6Z\%:HC$@+%Y@(]5(8?RKE?AMXLO]1NHM#FBMEM;:T)1T5@YVE0
M,DG'?TI.M4JT&_O Z/QUX;O/$^D6]I9201R1SB4F9B!C:P[ \\UXGK6D7&A:
MO/IMT\3S0[=S1$E3E0PQD ]#Z5[9XZ\27GAC2+>[LHX))))Q$1,I(QM8]B.>
M*\D22X\;>-(6NA'%+>RHLGD@@*JJ 2,D\[5_.JP;FH7?P@R;PUX'U3Q*GGQ;
M;>SSCSY0<-Z[1W_E[UU3?!U]ORZXI;T-K@?GOKO=5OK7POX:FND@ @LX@L<*
M<#.0JK[#)'->3VWQ1\0Q:AY\[P3VY/-MY050/9A\P/U)^AI1JUZUY4]$!A:_
MX8U3PW<+'?PKL?\ U<T9W(_T/]" :QZ^C-8TZU\4>&Y+<,&BN8A)!)Z$C*-_
M*O(_AQHZ:EXN7[3&2EFAF967C<"  ?Q.?PK6EB>:FY2W0%O1/A;JFI6R7%]<
M)IZ.,JC(7DQ[KD8_//M4FK_"G4[&W,VGW4=_M&6CV>6Y_P!T9(/?N.G&:]%\
M8>(QX8T-KQ8UDN'<1PHQX+$$Y..P )_3C->:Z3\4=:MM05]2=+NT9OGC$:JR
M#_9(Q^N>G;K65.IB*BYXVMV ]>TL%=(L@001 @(/^Z*^==:_Y#VH_P#7S)_Z
M$:^E%8.H93E2,@^M?->M?\A[4?\ KYD_]"-3@=92!E&BBBO3$?4+L5C9AU )
MKG_%%LFO^!KSR"&$MN+B(C'.,.,'WQC\:WIR%MY&/0*2?RKG? 5X-0\$V&_Y
MC&A@8,<\*2!^F*\"%TN==&BCQ#1=..K:W96 W8GF5&*]0N?F/X#)KZ-GNHK:
M6UA=@K7$ABC&.I",V/R4UY9X'\/M;?$;4$>+$>F^9LRV<%CM3ZY4DUUVO7Y_
MX3SPSIRR< S3R)_P!E4_^AUV8I^TFHKHK_J)$GQ&_P"1#U+_ +9?^C4KQGPY
M97^HZ];6FEW7V6\DW>7-YC)MPI)Y7D< C\:]F^(W_(AZE_VR_P#1J5Y=\.?^
M1\TW_MK_ .BGJL*[4)/U_(&:?B3PQXMTW0I[K5-<^U6:%=\7VN5]V6 '##'7
M%+\)/^1KNO\ KQ?_ -#CKNOB3_R(M]_O1?\ HQ:X7X2?\C7=?]>+_P#H<=.-
M1SP\FP.F^+G_ "+5G_U^#_T!J\BM+.XO[N.UM(7FGE.U$09)->N_%S_D6K/_
M *_!_P"@-4/PHT2*'2YM9D4-<3N8HS_=0=<>Y.?R%%&K[+#\P&58_"&]E@5[
MW5(K>0CF..(R8_'(JKJ_PIU2QMS-I]S'?[<EHPGEO^ )(/Y_3-;7CWQ[J&DZ
ML=*TEEA>%5,TS(&.X@$  @C&".??MCG3^'WC*Z\1BXLM1\HW<"*ZN@VF5>A)
M'3(..F!\W08J?:8E0]J]@/%65D8JP*L#@@C!!K=\->$=2\3S-]E58[>,@23R
M?='L/4XYQ^>,BNB^*NBQV.LV^I0+M6]4^8 ./,7'/X@CCV)KT?P=;0VO@_28
MX -K6R2'!S\S#<WZDUK5Q5J2G'J%CB%^#K%?GUP ^@M<_P#L]8VN_#+5-(LW
MN[:=+Z*,%I B%7 ]0.<UK:]KWQ"T[49':W:&V#G8L%NLL94'^]@GIZX/L*M6
M7Q<M5TZ,7UA.UZ!A_)VB,GU&3D=JA2Q*M)-20'G_ (=\.W?B;4)+*RD@CD2(
MRDS,0, @=@>?F%?0ME"UM86T#D%HHE0D=,@ 5X+8^+9M(\27NL:7901?:0R^
M1,2ZH&8,<$;>XKWJRF:YL+:=P TL2N0.F2 :SQW/=7V!'BGB?P'JFC6UUJUQ
M/9M!YN=L;L6^9N."H'?UKDH8);F9(8(GEE<X5(U+,Q] !UKK?$_CS5-9MKK2
M;B"S6#S<;HT8-\K<<EB.WI74?"C08X[&;7)H\S2L8H">R#[Q'N3D?\!]ZZ?:
MSI4N:IN!CZ9\)M4NHO,U"\ALB0"$5?-8>N<$ ?@35B\^$%Y'"6L]5AGD'\,L
M1C!_$%JVO'GCR?0[H:7I83[7MW2S, PC!'  _O=#SQC'!SQE^#?B-J%UJ\.G
M:RZ3)<-LCG"A&5CT!Q@$'ITK%3Q+C[1;=@/.M0TZ[TJ]>SOH&@N$^\C?S!'!
M'N*M^'] NO$>I?8;.2%)?+,F9B0N!CT!]:]=^(^@Q:KX:FO%C'VNR7S4<#DH
M/O*?;&3]1]:X3X5_\C@?^O9_YK6T<0YT7-;H"MJ?PXUW36MD M[J2XD\M([=
MV)S@G)W* !QUS6];?!^X>!6NM8CBE(Y2. N ?KN'\J[_ ,3:TGA[0I]3,:R2
M1@)&A.-S,0,9].Y^E>9:+\2M=DU^W%[+%+:32+&T(C5 @) R"!GCW)_PQA5Q
M%6'-'H!E>)_ NI>&H_M+,EU9$A?.C!&T]MP[<^Y'YXKEJ^E-;M$O]"O[60 K
M+ Z\]C@X/X'FO#/!.BQZ[XIM;6<9MTS+*O\ >5>WXG /L36N'Q#E3<I] +_A
MSX=ZKKULEW(Z65HXRCR*2SCU"^GN2*W9O@],L3&#6HWDP=JR6Y0$]LD,<?E7
M;^+O$ \+^'WO(XE>9F$,"$?+N()&<=@ 3^&.*\YT+XFZRFKQ+JDT,]G+(JR;
MHPGE*3R5*@=,YYST[=:RC4Q%5.<-$!R6LZ'J&@WIM-0@,;XRK Y5QZ@]Q4.F
MZ;=ZO?Q65E$99Y#@ =!ZDGL!ZU[EX\T6/6?"UUE<W%JAGA8#)RHR1[Y&1^7I
M7,?""V@^S:G=;@;C>D97/*K@G/XG/_?-:1Q5Z+G;5!8J6WP@N7B5KK5XH7(!
M*QP%\'TSN%-N_A!>1PLUIJL,\@Z))"8P?QR?>NE\;WWB^RE1]!@W68C&]XHQ
M+('SS\ISQC'0'O\ ASFC?$^_TYYK;Q';2S.JY1DB$<@;KAEX&,'J!V[YS649
MXB4>>+3\@/.[RSN-/O);2[A:&>)MKHW4'_/>H*ZCQKXHM/%%[;7%M8O;M$A1
MG=@3(,Y P.F.>_>N7KO@Y.*<E9B"BBBK **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH Z7P#_R.-G_NR?\ H!KW:S_X]Q]37A/@'_D<;/\
MW9/_ $ U[M9_\>X^IKR<=_$7H-'!?$S_ )%L_P#7TO\ [-7D->O?$S_D6S_U
M]+_[-7D-=6"_A?,&%%%%=@@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** /3_ (?_ /(F:C_UWE_]%K7F%>G_  __ .1,U'_KO+_Z+6O,*Y:'\2?J
M,****ZA!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'I]E_R2)O
M^N$O_HQJ\PKT^R_Y)$W_ %PE_P#1C5YA7+AMY^K&%%%%=0@HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#T_P 9?\D]T_\ [8?^@&O,
M*]/\9?\ )/=/_P"V'_H!KS"N7"? _5C84445U""BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]Q7EU[UZ_(N@SIO^%<^%/^@5_P"3$O\ \571VEK#8VD-K;J4AA0)&I8MA0,
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MC%KA?A)_R-=U_P!>+_\ H<=31_W:7]=@.F^+G_(M6?\ U^#_ - :M;X<$?\
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MO1PLI2I)R$PHHHKH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 =+X!_Y'&S_W9/\ T U[M9_\>X^IKPGP#_R.-G_NR?\ H!KW:S_X]Q]3
M7DX[^(O0:."^)G_(MG_KZ7_V:O(:]>^)G_(MG_KZ7_V:O(:ZL%_"^8,****[
M!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 >G_#_P#Y$S4?^N\O
M_HM:\PKT_P"'_P#R)FH_]=Y?_1:UYA7+0_B3]1A11174(**** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH ]/LO^21-_UPE_\ 1C5YA7I]E_R2)O\
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M/E3U HT5VN@?#35M8MQ<W,B6$#C*>8I9VZ8.WC ^IS[5KW/P?N$A8VVL1RR
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M6P##'4JQY_(@?A6F&JU%4=*;N!N^"_!?A_5O"5C?7VG^;<R^9O?SI%SB1@.
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M"KWNI0VSGJB1&3'XY%74JPI_$Q'G%%>F3_!^=8F-OK,<C@':KVY0$^F0QQ7
MZMI%[HFHR6-_"8YDY'<,.S ]Q2IUJ=32+ HT5+;V\UW<QV]O$TLTC!411DL:
M] TWX27]S;++?ZA%:2-SY2Q^:5&.YR!GZ9^M.I5A3^)@>=45Z'J?PEU*U@,F
MGWL5ZPY,;)Y3'Z9)'YD5Y])&\,KQ2HR2(2K*PP5(Z@CL:*=6%3X6 VBBBM "
MBBB@ HHHH *VO"7_ "->F_\ 785BUM>$O^1KTW_KL*SJ? _0#<^)W_(P6O\
MUZC_ -#:N)KMOB=_R,%K_P!>H_\ 0VKB:C#?PHC"BBBMQ!1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% '1VGCOQ)8V<-I;:CY<$*!$3R(S@
M#IR5S6-J.HW>K7\M]?2^;<RXWOM S@ #@ #H!56BH4(Q=T@"GQ2O!,DT3%9(
MV#*P[$<@TRBK ZG_ (6-XK_Z"O\ Y+Q?_$UE:3XBU70YIY=-N1;O/CS,1(0<
M=.""!U[5ET5FJ<$K)(#7UCQ/K&OQ11ZG>>>D1+(/*1<$_P"Z!6?97EQI][%=
MVLGESPMN1\ X/T/%0452C%*R6@'17GCKQ)?V<UI<ZEYD$RE'7R(QD'W"YK#M
M+NXL;N*ZM96BGB;<CJ>0:AHH4(Q5D@.ZC^+'B!(PK06#G^^T39_1@/TKEM;U
MN\\0:B;Z^*&4J$ 1=H '^3^=9U%3&E"#O% =.GQ#\4QHJ+JF%48 ^SQ=/^^:
MYJ21I97D<Y=R68^I--HIQA&/PJP&OH?B;5?#TI;3[DHC'+Q,-R,<8Y%=+_PM
MG7]@7[-IV<?>\I\_^AUP=%3*C3D[R0&IK7B'5-?G\W4;II #E(QPB?11Q^/7
MWJI87]SIE]%>V<GEW$1RC[0V#C'0\=ZK45:BDN5+0#H;[QQXCU*REL[O4?,M
MY1M=/(C&1]0N:UOA7_R.!_Z]G_FM<171>"M?M?#FO&^O(YGB\EH\0@%LDCU(
M]*RJTTJ<HP0'J'Q+GEMO"?G02O%*ES&5>-BK*>>01TKA;?XJ^(88%C=+*=@,
M>9)$VX_]\L!^E7?&?C[2O$6@&PM+>\24RJ^9D4+@9]&->=5CAZ"]G:I$9J:U
MXBU3Q!.)=1NFD"YV1@;43Z*/Y]?>LQ69&#*2K Y!!P0:2BNQ125D(['3OB;X
MBL+80O);W@485[E"6 QZJ1GZG)K.U[QGK7B&/R;RX5+;.?(A7:A^O<_B37/T
M5FJ--/F2U Z<_$/Q2R%&U3*D8(-O%R/^^:YZTN[BQNXKJUE:*>)MR.IY!J&B
MJ4(QV0'=1_%CQ D85H+!S_?:)L_HP'Z5RVMZW>>(-1-]?%#*5" (NT #_)_.
MLZBE&E"#O% :^B^)M7\/L?[.NVCC9@SQ, R,?<'Z8R,'WKI#\6?$!0K]GT\'
M^]Y3Y_\ 0\5PE%*5&G)WD@-'6-=U+7KH7&HW33,N0B]%0>@ X';ZXK.HHK1)
M)60'3:'X\US0;86UO+%-;KPD5PI8)]""#^&:?K7Q!UW7+1K666*WMW!61+9"
MN\>A))./8'G/-<M16?L:?-S6U Z.T\>>);&TAM;?4MD$*!(U\B,X4# &2N:P
M)YI+B>2>5MTDC%W;&,DG)J.BK4(QU2 ****H#II?B#XHGA>&34]T<BE6'V>(
M9!X/\-<_:7<]C>0W=M(8YX7#HX[$?7K4-%0H1CHD!T=UX\\2WMI-:W&I;X9D
M,<B^1&,J1@C(7/2L6PO[G3+Z*]LY/+N(CE'VAL'&.AX[U6HH4(I62 W]1\:>
M(-6L);&^U#S;:7&]/)C7."".0H/4"LK3M1N])OXKZQE\JYBSL?:&QD$'@@CH
M356BFH12LEH!O:EXS\0:O8R65]?^;;R8+)Y,:YP<CD*#U%4-(UK4-"NVNM-N
M/(F=#&S;%;*D@XPP(Z@50HI*$4N5+0#9U?Q5K6NVR6^I7OGQ(^]5\I%PV",_
M*!V)K(CD>&5)8G9)$(964X*D="#V--HIJ*BK) =E8_$_Q'90B.22WN\=&N(_
MF ],J1G\>:9J?Q)\1:E;M")H;1&&&-JA5B/]XDD?ABN0HJ/84[WY4 5H:1K>
MHZ'=?:-.N7A<XW <JX'8CO6?16C2:LP.[C^+'B!$"M!I\A'\31-D_DP%96L>
M/=?UJ![>:Y2&WD7:\4";0P[Y/)Y],XKF:*S5"FG=1 *Z70?'6M>'K3[);/#+
M; Y2.="0G))Q@@\DUS5%7*$9JTE<#J]<^(.LZ]ILMA<QVD=O+MWB&,@G!##D
MD]P*Y569&#*2K Y!!P0:2BE"$8*T58#KM,^)'B+38%A,T5VB]/M2%CCTR""?
MQJ>\^*7B*ZA:./[);$C[\,1W#_OHFN*HJ/84[WY4 ^::6XF:6:1Y97.6=V+$
MGW)JWI6KWVB7GVO3I_)GVE-VQ6X/7A@1VJC16K2:LP-S5/%^NZU9&TU"^\Z
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110!Z?\/_\ D3-1_P"N\O\
MZ+6O,*]/^'__ ")FH_\ 7>7_ -%K7F%<M#^)/U&%%%%=0@HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MRJ1$A.#(^.%'^>!DUY6_Q9\0.,"WT]/=8G_JU<IJNMZEKDZS:E=R7#J,+NP
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MO_(>T[_KYC_]"%3+9@>L?\*DT'_G[U+_ +^1_P#Q%'_"I-!_Y^]2_P"_D?\
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MQFKQ=P"BBBK **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MU>#X4:%+;Q2-=ZCED#'$B=Q_N5Y=X@_Y&75?^OR;_P!#-=[#_P +3\B/RO\
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M2(1 0NH& 2>ZGGYC6?:_"SPY;N6E%W= _P ,TV /^^ IKSO_ (6-XK_Z"O\
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '2^ ?^1QL_P#=D_\
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M $ UPOCV^\SQ]X=L\86WDCD+9[O(/Z(/SKNO$W_(J:Q_UXS?^@&LG'E4//\
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M(U]&VR+)I\*,,JT0!'MBOG+6O^0]J/\ U\R?^A&OH^S_ ./*#_KFO\J6-^&
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M@YQTX'X5XK7I?A3X8I?6$5_K4DL8EP\=O$0#L_VSCOZ#D#OGHZ\(1I*,Y.R
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M4D8-[>H'WD<K&>5 ],C!/X>E<9\6/^1MA_Z\T_\ 0GKV&Q4)I]LBC"K$H _
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .E\ _\ (XV?^[)_
MZ :]VL_^/<?4UX3X!_Y'&S_W9/\ T U[M9_\>X^IKR<=_$7H-'!?$S_D6S_U
M]+_[-7D->O?$S_D6S_U]+_[-7D-=6"_A?,&%%%%=@@HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ J]HO\ R'M._P"OF/\ ]"%4:EM;A[2[AN8PI>&19%#=
M"0<C-)JZ ^F+S_CRG_ZYM_*OF*N[D^*^NRQ/&UIIV&4J<1OW_P"!UPE<F$HR
MI7YNHV%%%%=@CV#X1?\ (!O_ /KY_P#916+\7O\ D,:=_P!>Y_\ 0JYWPYXU
MU+PQ:36UE!:2)+)YC&9&)SC'&&'I57Q'XGO?$]S#/>Q6\;0H440JP!&<\Y)K
MCC1FL0ZG09E6T[VMU%<1XWQ.'7(XR#D5]%Z;?V?B70$N%"R6]U$5ECSG&1AD
M/YXKYOK7T+Q+JGAV=I-/GVHY!>)QN1_J/ZC!J\30]JDUN@.CU3X7:U;ZF8].
M1+JS9ODE:15*#_:!QT]LYQ^%>@^"?"8\+:=()G62]N"#,Z9V@#HHSZ9//O\
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M^-=N?BWKY'_'IIH_[9O_ /%UGB<-*HTX@C.UF]74/B>\ZCY?M\<8]]A5,_\
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M?Q7UV*)(UM-.PJA1F-^W_ ZX\71E5MR]!HY+6O\ D/:C_P!?,G_H1KZ/L_\
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MW>5LQSC'4UWOPB_Y -__ -?/_LHK%^+W_(8T[_KW/_H5<D:TWB'"^@S,\)>
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M:T?[% LP='^S21Y;!&,L2.A/Y54G4]JK/W0.-HHK6TOPQK6LIYEAITTT?:3
M5#]&; -;N2BKMB,FBNBNO GB:SA:672)BJ]?*99#^2DFN>961BK JP."",$&
MB,XR^%W 2BI;:VN+RX6"U@EGF?.V.)"S' R< <]!5B[T?4]/B$M[IUW;1EMH
M>:!D!/7&2.O!_*G=7L!2HKH++P/XDU"V2XM]*D,3C*EW2,D?1B#6?JFA:IHL
M@34;*6W)Z,PRI^C#@_G4JI!NR>H&?1115@%%%% !71^!/^1SL/\ MI_Z+:N<
MKH_ G_(YV'_;3_T6U95OX<O1@6?B+_R-3?\ 7!/ZUR==9\1?^1J;_K@G]:Y.
ME0_A1]!A1116P@HHHH [#PAX%_X2JPGNO[1^R^5+Y>WR-^> <YW#UKHO^%._
M]1[_ ,D__LZO?"+_ ) -_P#]?/\ [**N>//&.H>%[BRCLH;603HS-YZL<8(Z
M88>M>;.K6=9TX,9B_P#"G?\ J/?^2?\ ]G1_PIW_ *CW_DG_ /9UE?\ "V]>
M_P"?33?^_<G_ ,71_P +;U[_ )]--_[]R?\ Q=7RXOO^0:'%ZA:?8-2NK/?O
M\B9XM^,;MI(SCMTJM4]Y=/?7UQ=RA1)/(TK!>@+')Q[<U;E\/:W!$\LNCZA'
M&BEG=[9P% Y))QP*[;V2YA&;16MI7AC6=;C:33K"2:-3@OD*N?8L0#4NI^$=
M>T>#S[[398XAU=2KA?J5)Q^-+VD+\M]0,2BBIK:TN;V80VMO+/*>0D2%F/X"
MJ AHKIU^'GBIUR-*./>>,?S:LS4_#>L:,@DU#3YH8R<;R 5S]1D5"J0;LF@,
MNO4'^#VU&;^W<X&?^/3_ .SKR^OJ"7_4O_NFN;%U9T^7E>XT?+]%:VE>&=:U
MM"^G:?+-&#CS.%3/IN8@9IVJ^%=<T6+SM0TZ6*+O("'4=!R5) ZCK75SQORW
MU$8]=[X<^&O_  D&@VVJ?VMY'G[OW?V;=MVL5Z[AZ>E<%7O7PY_Y$/3?^VO_
M *->L,74E3@G%]1H\8\0Z1_8.NW6F>?Y_D%1YFS;NRH/3)QU]:['1_A;_:VC
MVFH?VSY7VB(2;/LN[;GMG>,U@_$'_D>M3_WD_P#1:UO:/XM\9V>CVEO9>'_/
MM8X@L4OV*9MR]CD'!_"E.55TXN#U XK6M-_LC6;O3_-\W[/(4\S;MW>^,G%4
M*OZU=7=[K-W<WT'D74DA:6+85VMZ8/(_&GQ>'M;GB26+1]0DC=0R.ELY# \@
M@XY%="=HKF8C-HK1TK0=4UMW33;*2XV#+$8"C\3@9]JOWW@CQ)IUN9[G2I1&
M.IC99,?4*2:'4@G9O4#GZ**='&\TJ11(SR.0JJHR6)Z #N:L!M%=)%X \430
M"9=)D"D;L/(BM_WR6SGVQ60VC:FM^; Z?=?; ,^0(F+X]<8SCWJ%4@]F!2HJ
M[=Z/J>GQ"6]TZ[MHRVT/- R GKC)'7@_E5*J33V ****8!1110!UGPZ_Y&M?
M^N+_ -*K>//^1RO_ /MG_P"BUJS\.O\ D:U_ZXO_ $JMX\_Y'*__ .V?_HM:
MY5_O+]/U&<Y11174(**** "BBB@ HHHH **** "BBB@ HHKU7PO\+O)DCO-?
M9793N6S0Y7I_&>_/8<<=3TK*K5C25Y 8OAOX:7&NZ.FH7%\;(2DF-#;[RR=F
M^\.O;VY[URNO:5_8FMW6F^=YWD,%\S;MW< ],G'7UKZ0141%2,*J*-H"C  '
M:O /'G_([ZI_UT'_ *"*Y<-7G5J-/89SM==X0\"R>*K2YNC??9(HI!&I\GS-
MYQD_Q#&,C\ZY&O=/ \":'\/XKJ55&Z-[N3!QD<D'/^Z%K;%5)4X>[NP1XUJ>
MF_8=<N=,MY'NFAF,"LL94NP.,!<GOQ78:1\*=4O;837]U'8;@"L>SS''^\,@
M#MW/OBI?A?8)JGB6^U>YPTEL-ZCG_62$_-U[ -U]<]J[CQIXM7PK81&.)9KR
MX+"%&SM&,98X[#(X[YK&M7J*:I4]P./N?@_<I$3;:Q%+)@X62 H"?J&/\JX#
M5=*O=%OWLK^!HIEYP>C#L0>XKUCP9\0I?$&I_P!FZA;0Q7#J6C>$D*Q')&"2
M>G/7L:?\5-.AN/#*WQ4>?;2KM?OM;@C^1_"E3KU85%3J]0/%Z***] 04444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!TO@'_D<;/_=D_P#0#7NUG_Q[CZFO"? /_(XV?^[)_P"@&O=K/_CW'U->
M3COXB]!HX+XF?\BV?^OI?_9J\AKU[XF?\BV?^OI?_9J\AKJP7\+Y@PHHHKL$
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %=[X"\=Q:#$=,U,-]A9BT<RKDQ$]00.J]^.1[YXX*BLZE.-2/+(#
MZ#FUSPGJL(%UJ&DW"#HMR\9Q^#?0?E4<OBSPIHMJ%BU"Q6,?*L=GA_T3.*\
MHKE^HQVYG8=SI/&?BIO%.J)*D;16D"[88WQGGJ3CN>/RKFZ**[(14(\JV$%%
M%%4 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 >G_  __ .1,U'_KO+_Z+6O,*]/^'_\ R)FH_P#7>7_T
M6M>85RT/XD_484445U""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ KWK2]3\(06\%W%<:);7)A4,RO$C
MC@9'8]OTKP6BL*U%54E>PSUWQM\0+!-,GTW2+@7%S.IC>:,_)&IZX;N2...G
MKQBO(J**JE1C2C:(@HHHK4 HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** /3[+_DD3?\ 7"7_ -&-7F%>
MGV7_ "2)O^N$O_HQJ\PKEPV\_5C"BBBNH04444 %%%% !1110 4444 %%%%
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M]X%;=(1G^(DD^O6N#^,7_,%_[;_^TZPP[C]87)HO^ !>^$7_ " ;_P#Z^?\
MV45B_%[_ )#&G?\ 7N?_ $*MKX1?\@&__P"OG_V45B_%[_D,:=_U[G_T*M8?
M[V_ZZ!T.@^$G_(J77_7\_P#Z!'7)_%C_ )&V'_KS3_T)ZZSX2?\ (J77_7\_
M_H$=<G\6/^1MA_Z\T_\ 0GIT_P#>F'0[/X;^&X=+T*+4I(P;V]0/O(Y6,\J!
MZ9&"?P]*3Q+\2;+0=1:P@M'O;B/B;]YY:H?3.#D_A^-==IT20:7:0QC"1PHJ
MCT 4 5\X:I(\NKWLDC%G>=V8GN2QK.A!5ZDI3 ]\\.:_I?B>%M0LEVW$8\J5
M' $B G(!QV.,C\>^:YCXN_\ (!L/^OG_ -E-8_P@D8:GJ<?\+0HQ^H8_XFMC
MXN_\@&P_Z^?_ &4TE35/$J*V R_A3IE@6N=5N)83=(_DP1N1E. 68 ^N0,_7
MUKHO$_Q&L_#VHMI\5G)=W,>TR_/Y:KD9QG!R<8[8YZ]J\S\*^#[[Q3._DL(+
M2+B2X=<@'LH'<_R[]1GT:P^%.AVP4W<UU=OMPP+A$)]0!R/S/6M*ZI*HY5'?
MR Z'PQXEMO$^FM=V\;Q%'*21OR5/4<]^,5Y_K\EAX0^*5MJ1MW6V:$SR)" 2
M6=70D D#KSUKTO2;#2]-MVM=+A@BC0C>L1!.<?Q'J3CUYKRCXM_\C7:_]>*?
M^AR5EAU&55Q6S0'K6E:E#J^EV^H6ZR+%.NY1( & ]\$UQ'C'QYI:VFK:$8+S
M[5L:#?L79NQZ[LX_"NC\#_\ (E:5_P!<?ZFO&?&?_(Y:M_U\-3P]*,JK3Z?Y
M@=!\)/\ D:[K_KQ?_P!#CKIOBY_R+5G_ -?@_P#0&KF?A)_R-=U_UXO_ .AQ
MUTWQ<_Y%JS_Z_!_Z U:U/]Z0=#E/ASX5AUW4)+Z^3?9VA&(STD?J ?8=2._'
MO7IGB/Q3IOA2SC\]=TC#$-M%@$@=_8"LSX81)'X+B91@R32,WN<X_D!7GWQ.
MGDF\;7".&"PQ1HF>XV[N/Q8U+7M\0XRV0'>>'/B58:Y?I8W-JUC/*=L1:0.C
MGC S@8)YQQ^.3BJWQ(\)07NG3:Y:ILO;==TP7I*@ZD^X'.?08YXQX_#-);SQ
MS1.4EC8.C#J"#D&OIF>-;BQECF1622(JZ,."".012K06'J1E #PSX<_\CYIO
M_;7_ -%/7M6KQZ?]D6\U)5,%B_VH%AD*RJ1G'?&3CWQ7BOPY_P"1\TW_ +:_
M^BGKT_XD$CP+?^[1?^C%IXI<U>*[V_,$8UK\6M/GU1()=/FAM'8*+AI 2N>[
M+C@?0GC\J[37-*@UK1KFQN$#+(AVG&2K8X8>X-?-E?4$1)B0GD[148JE&BXN
M (^7Z***]804444 %='X$_Y'.P_[:?\ HMJYRNC\"?\ (YV'_;3_ -%M65;^
M'+T8%GXB_P#(U-_UP3^M<G76?$7_ )&IO^N"?UKDZ5#^%'T&%%%%;""BBB@#
MV#X1?\@&_P#^OG_V45K^,/!7_"63VDG]H?9?LZLN/)W[LD?[0QTK(^$7_(!O
M_P#KY_\ 915SQYXQU#PO<64=E#:R"=&9O/5CC!'3##UKR)\_UE\F_P#P!F+_
M ,*=_P"H]_Y)_P#V=0W?PD^RV<]Q_;F[RHV?;]DQG SC[]4/^%MZ]_SZ:;_W
M[D_^+J.X^*FN7-M+ ]IIP65"A(C?.",?WZZ%'%WU?Y!H<-7T[=VL5[9SVDX)
MAGC:-P#C*L,']#7S%7U!*2(G(X.TU./^S\_T!' :G\3=,T6]_LRPTQIX;9O)
M9E<1*NWC"#!SCD=NE=KINH6FN:3#>V_SVURF=K@?0J1TR#D&OFFO>/AN2? M
MA[-+_P"C&J,5AX4X)QW!'D/BW38M(\5:A90#$22;D7T# ,!^&<5ZU\/=-L-,
M\-0/#+#)=72":=PPW#(R%/H%!Z>N3WKS3XC?\CYJ7_;+_P!%)5_PO\-[S7;.
M._O+@V=JY!C&S<\B]R.?E![$_7&,9WJI3H1YY6V Z2Z^+MC%?-';:;-/; D>
M<9 A/7D+@\=.I!YZ5W4,EGKNCI)L\VSNXL[7&-RL.A%<U9?#3PU8 23Q3715
MMVZYEX'X+@8^OK766B6T=K$EH(A;JH$8BQM ]L<5P572T]FF,^;M6M5L=9OK
M1!A8+B2(#.>%8C^E?2Q 92#T/!KYQ\3?\C7K'_7]-_Z&:^C9"5B<CJ 2*Z<:
M[QA_782."UGXDZ9H%U_9FG6'VH6W[L['$<:8XVKP<XZ=,5U6AZY8>)M*^U6O
MS1ME)8I ,J>ZL/\ .:^<F9G8LQ+,3DDG))KTSX/.1=:LG8I$3^!;_&JKX6$*
M7,MT%SF_'WA^+P_XB:.V0K:7">;$,'"\D%0>^",_0BO4?AS_ ,B'IO\ VU_]
M&O7+?&(#=HQ[GSQ_Z+KJ?AS_ ,B'IO\ VU_]&O45I.>&BWW_ ,P/*_B#_P C
MUJ?^\G_HM:]B\'_\B?I/_7LG\J\=^(/_ "/6I_[R?^BUKV+P?_R)^D_]>R?R
MIXG^!#Y?D!XIXS_Y'+5O^OAJ]R\,_P#(J:/_ ->,/_H KPWQG_R.6K?]?#5[
MEX9_Y%31_P#KQA_] %&+_A0_KH".4U;QQI/@MDT/3=.:<VJA64/Y:KD9ZX)+
M=">._7-=5X>UZU\1Z2E_:AE!8H\;]48=0<?4'Z$5X'XA)/B752>3]LF_]#->
MH_",G_A&KP=OMA_] 2E7P\(TE-;@<3\1M*@TKQ;(+9 D=Q$L^Q1@*22#C\5)
M_&NU^&'AJ&TTD:S<1[KJZSY6]?\ 5Q@XX]SUSZ8_'FOBW_R-=K_UXI_Z')7J
M'A=0GA/1P.GV*$_F@-.M4E]7BNX&'XI^(5GX<O18Q6S7ETN#*HDV+&",C)P>
M>G&*O^'=?TGQ:$OH8=EY:9&R3[\888X(ZJ?Z>U>(^(B6\3:J3U-Y,3_WV:ZK
MX3.R^*KA Q"M:-D=CAEQ55,+"-'F6X'5?%O_ )%2U_Z_D_\ 0)*\9KV;XM_\
MBI:_]?R?^@25XS6V"_A PHHHKK$%%%% '6?#K_D:U_ZXO_2JWCS_ )'*_P#^
MV?\ Z+6K/PZ_Y&M?^N+_ -*K>//^1RO_ /MG_P"BUKE7^\OT_49SE%%%=0@H
MHHH **** "BBB@ HHHH **** "O5/$OQ4C\IK;0%<N>#=R+@+T^ZIZ]^N/H:
M\KHK*=*-1IRZ ?0O@N1YO!^FRRNSR/&69F.2Q+'))[FO'/'G_([ZI_UT'_H(
MKV'P/_R)6E?]<?ZFO'O'G_([ZI_UT'_H(KBPO\>7S_,9@P0O<W$4$?WY'"+]
M2<"O</',\>B^ )K:+8NY([2(8P,< @#_ '0:\P\ 6)OO&FGJ5RD+&9CC.-H)
M!_[ZQ^==;\7]0&--TU6&?FGD7O\ W5/_ *'6M?WZ\(=M0/,[>\NK,L;:YF@+
M<,8G*Y_*GW>H7M^4-Y>7%QL!">=*S[<]<9/%5J[WP)X$;6'34]3C*Z>IS'&>
M#.?_ (G^==-2<*:YI"+GPL\-RRWQU^=2L,.Z.WR"-[$89A[ $CZD^E:?Q9UI
M(M-M]'C?]],XFE  .$&<9],M_P"@FMKQ7XPL/"=B+.T2)KX(%AMD&$B'8MCH
M!Z=3].:\0O+RXU"\EN[N9IIY6W.[=2?\]JXZ4)5JGMI;=!D%%%%>@(**** "
MBBB@ HHHH **** "BBB@ KT^P_Y)$_\ UPE_]&-7F%>GV'_)(G_ZX2_^C&KE
MQ6T?5#1YA11174(**** "BBB@ HHHH **** "BBB@ JU;:E?62[;6]N8%)W8
MBE91GUX-5:*32>X$MQ<SW<[3W,TDTS8W22,68X&!DGV %>Q_#+PY/I&E3:A=
MJ4FO0I2,]5C&<$^YSG'ICWK/\!_#]8%CU;6X TI&8+61<A!_><'OZ#MWYZ6/
M''Q!BT])=,T>8/>Y*2S+TA]0#W;^7UK@K5'5?L:?S&<Y\5-8CO\ 7H-/A.Y;
M%"'/^VV"1^ "_CFK'PBLO-UF_O2>((!&%QW<YSG_ ( ?SKSMF9V+,2S$Y))R
M2:]K^%UH+/P<;IVXN9GER1C 7Y?Q^Z35UTJ6'Y%Z <+\3KU;OQE+&HXM84AS
MZGEO_9L?A7&U<U:]_M+6+R]RV)YGD&[J 22!^54ZZ:<>6"B([SP3X!A\16']
MI7EW)' LQ00QJ,N!@YW9XZD8QVKTCQ!K5MX1\/AX[:1Q%&(H(T0E5P,+N/0#
MH/Y5X[I?C;7-&L;>RL+B.*WA8ML,2MOR<G<3S[<8KV#PIKD?BWPW]HN;>/=E
MH+B(C*,0!G@]B"./?'-<&*C44N>>L;C1X#//)<W$MQ,V^65R[MZL3DFHZZ+Q
MOH<>@>)Y[6#BWD FB7^ZK=NG8@@>V*YVO1A)2BFA!1115 %%%% !1110 444
M4 %%%% !6UX2_P"1KTW_ *["L6MKPE_R->F_]=A6=3X'Z ;GQ._Y&"U_Z]1_
MZ&U<37;?$[_D8+7_ *]1_P"AM7$U&&_A1&%%%%;B"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .E\ _P#(XV?^[)_Z
M :]VL_\ CW'U->$^ ?\ D<;/_=D_] ->[6?_ ![CZFO)QW\1>@T<%\3/^1;/
M_7TO_LU>0UZ]\3/^1;/_ %]+_P"S5Y#75@OX7S!A11178(**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@#T_X?_\ (F:C_P!=Y?\ T6M>85Z?\/\
M_D3-1_Z[R_\ HM:\PKEH?Q)^HPHHHKJ$%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME\\AFB\S?AL $YP.N,UW-U\73<6DT(T0H9$9 XN_NY&,_<K3$4:E2,$EM_P
M,/Q%X UC3M5E6PL9KJRDD_<O"-V >0".2,=,GBO0?AYX7N/#NF3RWJA+NZ92
MR YV* < ^_)KFO#_ ,5FMK06^MV\L[( %G@QN8?[0)'/N#^'>K&L?%N)K1DT
M:SE6=N!)= 84?[H)R?QJ:BQ$U[-KY@97Q8U1+O7K:PC8,+.(EB#T=R"1^07\
MZ[OX<_\ (AZ;_P!M?_1KUX3/-)<W$D\SEY96+NYZLQ.2:[GPY\2O^$?T&VTO
M^R?/\C=^\^T[=VYBW3:?7UJZU"7L53AK8#(^(/\ R/6I_P"\G_HM:]B\'_\
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M)C+O\_9C@#&-I]*TKTY3I<L5J!;^+?\ R-=K_P!>*?\ H<E=Q\.=8CU/PI!
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MR?:=N\DDDXV'U]:PQ"FX6I[L9ZIK5C>:CIDEI8ZA]@DDX:<1[V"]PO(P??\
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M3?\ KL*Q:VO"7_(UZ;_UV%9U/@?H!N?$[_D8+7_KU'_H;5Q-=M\3O^1@M?\
MKU'_ *&U<348;^%$84445N(**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH Z7P#_ ,CC9_[LG_H!KW:S_P"/<?4UX3X!
M_P"1QL_]V3_T U[M9_\ 'N/J:\G'?Q%Z#1P7Q,_Y%L_]?2_^S5Y#7KWQ,_Y%
ML_\ 7TO_ +-7D-=6"_A?,&%%%%=@@HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** /3_A__P B9J/_ %WE_P#1:UYA7I_P_P#^1,U'_KO+_P"BUKS"
MN6A_$GZC"BBBNH04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Z
M?9?\DB;_ *X2_P#HQJ\PKT^R_P"21-_UPE_]&-7F%<N&WGZL84445U""BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /3_&7_)/=/_[8
M?^@&O,*]/\9?\D]T_P#[8?\ H!KS"N7"? _5C84445U""BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!TO@'_D<;/_ '9/_0#7NUG_ ,>X^IKPGP#_ ,CC9_[LG_H!KW:S
M_P"/<?4UY.._B+T&C@_B2CR>'"J*S'[2O &?[U>2_9;C_GA+_P!\&OH.YD\D
MLV,_-BJWVX?\\S^=%#$2IPY5&X6/!?LMQ_SPE_[X-'V6X_YX2_\ ?!KWK[</
M^>9_.C[</^>9_.MOKLOY?Q"QX+]EN/\ GA+_ -\&C[+<?\\)?^^#7O7VX?\
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M@U[U]N'_ #S/YT?;A_SS/YT?79?R_B%CP7[+<?\ /"7_ +X-'V6X_P">$O\
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MW'_/"7_O@T?9;C_GA+_WP:]Z^W#_ )YG\Z/MP_YYG\Z/KLOY?Q"QX+]EN/\
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M?^^#1]EN/^>$O_?!KWK[</\ GF?SH^W#_GF?SH^NR_E_$+'@OV6X_P">$O\
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M?;A_SS/YT?79?R_B%CP7[+<?\\)?^^#1]EN/^>$O_?!KWK[</^>9_.C[</\
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MN'_/,_G1]N'_ #S/YT?79?R_B%CP7[+<?\\)?^^#1]EN/^>$O_?!KWK[</\
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M )X2_P#?!H^RW'_/"7_O@U[U]N'_ #S/YT?;A_SS/YT?79?R_B%CP7[+<?\
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MN'_/,_G1]N'_ #S/YT?79?R_B%CP7[+<?\\)?^^#1]EN/^>$O_?!KWK[</\
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M?;A_SS/YT?79?R_B%CP7[+<?\\)?^^#1]EN/^>$O_?!KWK[</^>9_.C[</\
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M )X2_P#?!KWK[</^>9_.C[</^>9_.CZ[+^7\0L>"_9;C_GA+_P!\&C[+<?\
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M +X-'V6X_P">$O\ WP:]Z^W#_GF?SH^W#_GF?SH^NR_E_$+'@OV6X_YX2_\
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M )YG\Z/MP_YYG\Z/KLOY?Q"QX+]EN/\ GA+_ -\&C[+<?\\)?^^#7O7VX?\
M/,_G1]N'_/,_G1]=E_+^(6/*? D$R>+[1GB=5"R<E2/X#7N5G_Q[CZFL:*Z$
ML@381GWK9LO^/?\ $UQXBJZDKM6&9&H?=;_?K.K1U#[K?[]9U*GL 4445H 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% %VT_P"/=_J?Y52J[:?\
M>[_4_P JI5$=V 44458!1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% %U?\ D'_@?YU2JZO_ "#_ ,#_ #JE40Z@%%%%6 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!=N/^/1/PJE5VX_X]$_"J51#8 H
MHHJP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J:U_X^%_'^50U-
M:_\ 'POX_P J4MF MY_K_P !4%3WG^O_  %04H[( HHHJ@"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** )[3_7CZ&DNO^/E_P /Y4MI_KQ]#277_'R_X?RJ
M/M@0T4458!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5=3_D'_@?YU2JZG_(/_ _SJ)]
M *5%%%6 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %20?Z]/K4=20?Z]/K2>P$M[_K5_
MW:K59O?]:O\ NU6I1V ****H HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@":U_X^%_'^5=%9_\>X^IKG;7_CX7\?Y5
MT5G_ ,>X^IK&IN!D:A]UO]^LZM'4/NM_OUG55/8 HHHK0 HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** +MI_Q[O]3_*J57;3_CW?ZG^54JB.[ **
M**L HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"[:?\>[_4_RJE5VT_X]
MW^I_E5*HCNP"BBBK **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M NK_ ,@_\#_.J575_P"0?^!_G5*HAU ****L HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@"SJ'_(-_[YK#K<U#_D&_]\UAU5'X3&IN
M%%%%;&84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !3XI#&^1T[BF44AIV-)6#J&4Y%+5"*4Q-ZCN*O A@"#
MP:RE&QO&5Q:***DH**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J
MZG_(/_ _SJE5U/\ D'_@?YU$^@%*BBBK **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "I
M(/\ 7I]:CJ2#_7I]:3V EO?]:O\ NU6JS>_ZU?\ =JM2CL 44450!1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $UK_
M ,?"_C_*NBL_^/<?4USMK_Q\+^/\JZ*S_P"/<?4UC4W R-0^ZW^_6=6CJ'W6
M_P!^LZJI[ %%%%: %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MI]E<M;P7$3-*8^&;G&,]A]*])M/^/*#_ *YK_*DG=V FHHHI@%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% $UK_Q\+^/\JZ*S_P"/<?4USMK_ ,?"_C_*NBL_^/<?4UC4
MW R-0^ZW^_6=6CJ'W6_WZSJJGL 4445H 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% %VT_X]W^I_E5*KMI_Q[O]3_*J51'=@%%%%6 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *L6\Q!"')!Z>U0 $G &2:NPPB,9/+&HFU;4N"=]"
M6BBBLC<**** "BBB@ HHHH **** "BBB@ HHHH **** "KJ?\@_\#_.J574_
MY!_X'^=1/H!2HHHJP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MB1<XR,X4>PR>>^34?$] .9^,W_()TS_KNW_H-;7@SQ#HEKX/TN"XUC3X9DA
M:.2Y164Y/4$\5B_&;_D$Z9_UW;_T&LWP_P#"RRUG0++49-2N(WN(]Y144@4:
M\V@'I/\ PE'A[_H.Z9_X%Q_XUS/Q!U[1KWP-J-O:ZM83SOY6V.*Y1F;$J$X
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MO=/@,5LWS+MAB52#TV^9R1],U0FC7Q5\9)+:[C#0)=/$R'H4B!X/UV_K7MH
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M .A-7:>#M+ATGPEIMO$FUFA664D<EV&YB?Q./H *AW;L!P$GC/Q7H*O9>++
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M"DG[UK@>?>-E\3K>VH\3NKS>6?)*^7]W//W!Z^M>G>#H_&ZZBIU^>-M-\@[
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[DN8HF>.-]N&(&<=._2O4Z*KD0'D'P>UHQ7MYHLC ),/M$0/]\8##\1@_P#
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 445;
MMX-H#L.>P]*3=BHQNQT$.P;F^\?TJ:BBL&[FZ5E8****!A1110 4444 %%%%
M !1110 4444 %%%% !1110 5=3_D'_@?YU2JZG_(/_ _SJ)] *5%%%6 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %20?Z]/K4=20?Z]/K2>P$M[_K5_W:K59O?]:O\
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MY5YYX?E\9^&8YETW0;Q3,07=]/=F..@SCI_C1)ZV ]1\'>!K+PM!YK%;C47
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** +MI_Q[O]3_*J57;3_CW?ZG^5
M4JB.[ ****L HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"ZO\
MR#_P/\ZI5=7_ )!_X'^=4JB'4 HHHJP"BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** +.H?\@W_OFL.MS4/^0;_WS6'54?A,:FX4445L
M9A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%6+>'<=[#CL/6DW8:5W8=!!T=Q]!5FBBL6[G0E9!1112&%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5=3_D'_@?YU2JZG_(/
M_ _SJ)] *5%%%6 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %20?Z]/K4=20?Z]/K2>P
M$M[_ *U?]VJU6;W_ %J_[M5J4=@"BBBJ **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH FM?^/A?Q_E716?_ ![CZFN=
MM?\ CX7\?Y5T5G_Q[CZFL:FX&1J'W6_WZSJT=0^ZW^_6=54]@"BBBM "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH NVG_'N_P!3_*J57;3_ (]W
M^I_E5*HCNP"BBBK **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MNK_R#_P/\ZI5=7_D'_@?YU2J(=0"BBBK **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!=/S/>NLH33V **9+*D$+RR':B*68XS@#DURW_"R_"/_ $%__):7_P")H;2
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M5*HCNP"BBBK **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **S-9\0Z7X>ABEU2Z^SI*Q5#Y;/DC_=!J'1O%6B^(9I8
MM+O?M#Q*&<>4Z8'3^("E=; ;-%%9.M>)=(\.^1_:MW]G\_=Y?[MWW;<9^Z#C
MJ* -:BLG1?$ND>(O/_LJ[^T>1M\S]VZ;=V<?> ST-:U !17(ZK\2O#6E2F$W
M3W<BY#+:IO _X$2%/X&L^'XN^')90CPZA"I_CDB4@?\ ?+$_I2YD!WU%4=*U
MG3M;MC<:;=QW$8."4/*GT(/(_&KU4 44A(52S$  9)/:N1U+XF>&=.F>(7;W
M;IU^RIO!]@V0I_ TFTMP.OHK@[?XN>&YI0DB7]NI(&^2$$#W^5B?TKLK#4;/
M5+1;JPN8KB!NCQMD XS@^AYZ'FA-/8"U1113 **** "BBB@ HHHH **** "B
MN5;XD^$D=E.KC(.#BWE(_,+S736\\5U;17$#AX94#HXZ,I&0?RI)I@2445F:
MSXATOP]#%+JEU]G25BJ'RV?)'^Z#3 TZ*Y/_ (67X1_Z"_\ Y+2__$TY?B3X
M2=@HU<9/K!*!^96ES+N!U5%4--UO3-8CWZ=?P7(QDB-P6 ]UZC\:OTP"BBLG
M6_$ND>'H@^I7L<3$96(?-(W7HHYQQUZ>](#6HK@)/B_X=1]JV^HR#^\L28_5
MQ6]H?C?0?$$@AL[T+<'I!,-CGZ9X;IV)I<R8'0T4450!1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 75_P"0?^!_G5*KJ_\
M(/\ P/\ .J51#J 44458!1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% %VX_X]$_"J57;C_CT3\*I5$-@"BBBK **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "IK7_CX7\?Y5#4UK_P ?"_C_ "I2V8"WG^O_
M  %05/>?Z_\  5!2CL@"BBBJ **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M GM/]>/H:2Z_X^7_  _E2VG^O'T-)=?\?+_A_*H^V!#1115@%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !5U/^0?^!_G5*KJ?\@_\#_.HGT I44458!1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 5)!_KT^M1U)!_KT^M)[ 2WO^M7_=JM5F]_UJ_P"[5:E'8 HH
MHJ@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** )K7_CX7\?Y5T5G_Q[CZFN=M?^/A?Q_E716?\ Q[CZFL:FX&1J'W6_
MWZSJT=0^ZW^_6=54]@"BBBM .3^(VBMK/@^Y$2;[BU(N(QW.W[P_[Y+<>N*\
M;\$ZE_97C'3+@N4C,PB<C^Z_RG/MSG\*^CR RE6 ((P0>]?,OB32CHGB._T[
M&%AE(3_</*_^.D5E45G<#Z;KE_B'JC:5X*OGC)$DX%NA'^WP?_'=U:'A75O[
M;\,6%^6#221 2_[Z\-^H->=?&/5M]U8:1&W$:FXE /<\+D>H ;_OJKD_=N!Q
MO@G1FUSQ98VIC+PH_G3=<!%Y.?KP/Q%>W^,O$B>&/#\MX &N7/E6Z'H7(."?
M88)_#'>N0^#FD^5I]]JSJ-TSB",]PJ\M^9(_[YK&^,=XTOB&QL\Y2"VWX]&=
MCG]%6H7NQN!Q,<>J^)M9V();V_N6)Y/)/7Z #\ *[ZR^#-Y) &O=8A@E/\$4
M)D _$E?Y5>^#FEP_8K_5F0-.9?LZ,?X0 &./KN'Y"O4J(P35V!\[^)_ FK^%
MXQ<3B.XLR0//A)(4GH&!Y'\O>ND^&/C*XM]0CT*_F:2VF^6V9R28G[*/]D^G
M8_4UZWJ%A;ZGI]Q8W2!X)T*./8]Q[CJ#ZU\O,LMG=LN=LT,F,CLP/^(I27([
MH#Z?U7_D$7O_ %PD_P#037R_!"UQ<10(0&D<(">F2<5],W%R+SPS+=*,+-9F
M0#/3*9_K7S582I#J-M+(<(DJ,QQG !&:=3H!W7_"G?$/_/YIG_?V3_XBL_6/
MAEX@T>PDO&%M=11@M(+9V9E [X*C/X9Z5ZC_ ,++\(_]!?\ \EI?_B:R/$/Q
M1T$:3=0Z=))>7,L;1IB)D0$C&26P<#V_^O0XP \[\">([G0/$=LJRD6=S*L5
MQ&>5()QNQZC.:]T\1:L-"\/WVI$!C!$2BGH7/"@^VXBOG?PYILVK^(;"R@0N
MTDR[O90<L3[  FOI.\L;34;<V][;17$)Y*2H&&?7![T4[V ^;;>WU7Q9KWEQ
M[[J^N6+$LW '4DD] *TO$?@+6O#%FEW=B":V9MK26[E@A/3=D C/KT_,5[?9
M^'="T&XGU*SL8K63R2LCQYQLSN/R].W8=J\Y^(7C[2M:T8Z5I323B216DF*%
M% '. #SG..W:DXI+4"?X2>)+B6:;0;F4O&L9EMBQ)*XP"H]NX'UKJ_B)XBF\
M/>&6:U?9=W3^3&PZH""2P]P.GN17&_"/P[=?VA+KD\;QVZQ&.#<I'F$D98>H
M !'U/M7J6HZ/INKQJFHV-O=!,[/-C#%<XS@]1T'3TJHWY0/GCP_X:U7Q7?2Q
M6*JQ3YYIIF(5<GC)Y.3S[\&E\1>%=5\*744=\J;9.8IX6)1B.N"0""/<5[PE
MKH/@O2[N[CB6QLRZO,RAW&20HXY/4C@5Y'\1?&-GXGN;2'3UD^S6NX^8ZXWE
ML=!U &*EQ27F!Z!\,?$<VN>'Y+>[<O<V+",N3DLA'RDGN>&'X"NWK@?A7X>N
MM&T6YO+R-HIKYU(B<$,J+G!(/0DLWX8KOJTC>VH!116;/XAT2UG>"XUC3X9D
M.&CDN45E/H03Q5 9WB?QIIWA26VCOH+J0W"LR>0BG&,9SEAZU>\/Z_:^)-*7
M4+..:.$NR;9@ V1]":\L^+>IV&I7>EM8WUM=!(Y Y@E5]N2N,X/%=%\,]<TF
MP\'QP7FJ65O,)I#Y<UPB-C/7!-0I>]8#T:BJ5GK&F:C(T=CJ-G=.HW,L$ZN0
M/4@&KM6 5XE\8O\ D;K3_KP3_P!&25[;7B7QB_Y&ZT_Z\$_]&25%38#@$:2&
M1)4)5@0R-]#U_,5]0Z7?+J>DV=^@PMS"DN/3< <5\\75A_Q16FZBH'%Y- YS
MS]U&7_V:O6OA5J0O?!R6Y=C)9RM$=WH3N&/;G'X5%/1V Y3XQZCYNKZ?IJE2
ML$)F8CKN<XP?P7/XUYH05)!!!'!![5TOB69_$?Q"NDB.XSWBVT7.,@$(,>F<
M9_&L_P 46T5GXJU6W@7;%'=2!%]!N/%3+5W ^@_"_P#R*.B_]>$'_HM:UJXJ
M\M[RX^$UFVGW-Q;W4.FP31O;R,K';&I(X()R,C'TKSSP/XOU2'Q=8IJ&J7EQ
M:SMY#I/.[J"W"G!.!\V.?3-:\UK(#WBBBO"_'OB[5'\7WD.GZG>6UM;$0!(9
MVC!9?O$A3UW9&?84Y2L!Z]XH_P"11UK_ *\)_P#T6U> ^#O^1ST?_K[C_G7L
M-M:7=K\*;W[?=W%S=3:;--(\\I=@6C)"Y/H,<>N:\>\'?\CGH_\ U]Q_SJ)[
MH#Z4HJKJ.H6^E:=/?7;[(($+N>OX#W[5X1X@\>Z[XDO/*MYI;6V9ML5K;$@M
MD\!B.6/3CIZ"KE)(#Z!HKYUG\%^*]/M6U&33;F-%!9G212X'4D@'<.GI70^"
MOB5>6-ZEEKMS)<V4A"B>0Y>$^I/4KZYZ?H94^X'LL[F*WED7&50L,^PKYY7Q
M'JOB'Q3ILNI7;R@7D12('$:?./NKT'UZ^IKT?XI?V]LTS^Q?[2V8F^T?8O,Q
MCY,;]O\ P+&?>O%X/.^T1?9_,\_>/+\O.[=GC&.<YJ9O6P'U717FOPS_ .$E
M_M&^_MS^UO*\E?+^W>9MSGG&_O5/XD^.KVSU%M$TFX:W,:C[3,G#$D9"JW;
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MO@WIR)I.H:D4'F2S"!6(Y"J 3@^A+?I[4/WI6 SD^#%R;?<^M0K/_<6 E?\
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M^J.= 4J*N^5:_P!X?]]4>5:_WA_WU1SH"E15WRK7^\/^^J/*M?[P_P"^J.=
M4J*N^5:_WA_WU1Y5K_>'_?5'.@*5%7?*M?[P_P"^J/*M?[P_[ZHYT!2HJ[Y5
MK_>'_?5'E6O]X?\ ?5'.@*5%7?*M?[P_[ZH\JU_O#_OJCG0%*BKOE6O]X?\
M?5'E6O\ >'_?5'.@*5%7?*M?[P_[ZH\JU_O#_OJCG0%*BKOE6O\ >'_?5'E6
MO]X?]]4<Z I45=\JU_O#_OJCRK7^\/\ OJCG0%*BKOE6O]X?]]4>5:_WA_WU
M1SH"E15WRK7^\/\ OJCRK7^\/^^J.= 4J*N^5:_WA_WU1Y5K_>'_ 'U1SH"&
MT_UX^AI+K_CY?\/Y5:B2!7S&06^N:)$MS(2Y&[O\U3S>]<#/HJ[Y5K_>'_?5
M'E6O]X?]]57.@*5%7?*M?[P_[ZH\JU_O#_OJCG0%*BKOE6O]X?\ ?5'E6O\
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M]4<Z I45=\JU_O#_ +ZH\JU_O#_OJCG0%*BKOE6O]X?]]4>5:_WA_P!]4<Z
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ME6O]X?\ ?5'E6O\ >'_?5'.@*5%7?*M?[P_[ZH\JU_O#_OJCG0%*BKOE6O\
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M@:B?-;4#W'P+_P B1I'_ %P'\S7SYJG_ "%KW_KN_P#Z$:^@_ O_ ")&D?\
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M_P @_P# _P ZI5$.H!1115@%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 7;C_CT3\*I5=N/^/1/PJE40V ****L HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *FM?^/A?Q_E4-36O_ !\+^/\ *E+9@+>?
MZ_\  5!4]Y_K_P !4%*.R ****H HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@">T_UX^AI+K_CY?\ #^5+:?Z\?0TEU_Q\O^'\JC[8$-%%%6 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %74_Y!_X'^=4JNI_R#_P/\ZB?0"E1115@%%%% !1110
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MP"J.LZ3;:YI-QIUVN8IEQD=5/9A[@X-7J*H#P"7X9>+8;EUBTX2*CD)*EQ&
MP!X898$9Z\\U[-I$5[J7AE+7Q%8B.Y>,PW,9=6$@Z;@5)ZC\0<^U;-%2HI >
M%^(_A?K.F73OID1O[-B2IC_UB#T*YR?J,].W2N?M_!WB2ZE$<>AWZL2!F2$Q
MC\VP*^E**ETT!PW@3P OAHF_OG2;477:H7E85/4#U/J?P'?/3>(-#M?$6CS:
M==#"N,HXZQN.C#Z?K6G15I)*P'SYK/PZ\1:3<ND=C)>P9.R:V&_</=1R#^'T
M)JKI_@7Q+J,XC32;F $X+W*&)1[_ #?TS7T;14>S0'.>#_"-KX4TTQ(PFNY<
M&>?&-Q[ >@%='115I6 ****8!1110 4444 %>6_$GPAKNO\ B*WNM,L?/@2T
M6-F\U%PP=SC#,#T(KU*BDU=6 YCP#I%YH?A2"ROX/)N1([.F\-U;CD$CIBO.
MO%/PZ\07/B?4+C3=-$EI-,9(V$\:@[N3PS CDFO;**3BFK <OX T&Y\/>%H[
M6\C$=U)*\LJ @[23@<@D'@"O//%?@+Q-J7BG4;VTTWS+>:8M&_GQC(QZ%LU[
M710XIJP&?H-M-9>'=,M;A-D\%I%'(N0=K*@!&1QU%)K^FPZOH-[87#JD<T1!
M=NB$<AOP(!_"K=U,UO9SSHGF-'&SA,XW$#.,UXUKOQ8O-6TB:PMM.2T,Z&.2
M7SBYP>NW@8[COUH;26H'G@!8@ $D\ #O7TQX9TA-"\.V6GJ@5XX@9<8YD/+'
MCWS7BGPZ\/2:YXG@E>,FSLV$TK%<J2#E5_$]O0&OH&HIKJ!GZ];37OAW4[6W
M3?//:2QQKD#<S(0!D\=37D'AKP!XGT_Q-IMY=:9Y<$-PCR/Y\1PH/)P&S7M]
M%6XIZ@0W5K#>VDMK<QB2"9"CH>C \$5XMXD^%>JZ?</-I"_;K,M\J @2H/0@
M]?J/R%>WT42BF!\[2Z3XVU!%LKBTUR:)>%CF64QC'^]QVKM_!'PREL[R+5-=
M"[XB'AM5.<-U!<^WI_\ JKU*BDH):@(0&4JP!!&"#WKY\UWP!KVEZE-';Z=<
M7=MN)BEMT,F4SQD#)!QVKZ$HIRBI >8_#2T\31:Q<3ZU%J(MFMBJ->.W#!EP
M-K<] ?RK'\;?#?4DU:XU'1K8W-I.QD:)"-\;$Y("\9&3QC/Z5[-12Y%:P'SW
MIWAOQK?Q?V;#;:I!:DC='<,\,0!XR0V >/0$UI:Q\*M;M);9-,B^W*809I/,
M1 LF3D ,0<8QS7N5%+V: Y[P19ZCIWA2TL=4M3;W-ON3;YBON7)(.5)'0X_"
MO);_ .'/BN;4;J6/2LH\KLI^T1#()./XJ][HJG%-6 BMD:.UB1AAE0 CWQ1<
MVT-Y;2VUQ&LD,JE'1APP/45+7.^-](N=;\*W5K9%OM2[9(@K8W%3T_$9_'%-
M[ >;:[\)=6MKQVT8QW=JQ)17D"2(/0YP#]<_@*30?A/J]S>QMK(6SM%.759%
M>1O88) SZ_I7+:9XDUK0=2CECN[D- ^'MY9&VG'!5ES7;7'QGNGMRMOHT44Q
M4@.\Y< ^N-H_+-8KEZ@>=ZM!';:S?6\*[8HKB1$7.< ,0!S7TW8((].MD&<+
M$@&?H*^=?#.AW7B?Q'#;A&DC:4274G.%3.6)(Z$\@>YKZ2JJ?5@%%%%:@%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %VT_X]
MW^I_E5*KMI_Q[O\ 4_RJE41W8!1115@%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% &=KFC6NOZ1/IMX#Y4HX9?O(PY##W!KQ+4_A[
MXHT*\,EI;RW*(<QW%F26_P"^1\P./_UFO?J*F44P/G@^&_&FOW$8NK+5)W7*
MJ]\64*.IYDZ"O7/!'@N'PG8NTCK-J$X'G2KT '\*YYQ_/\L=7124$M0.%^)G
MA[5/$.G6$6EVOVAXI69QYBI@$?[1%9_PS\*ZUX>U&^EU2R^SI+"JH?-1\G.?
MX2:]*HI\JO< KSWXG^&M7\1?V5_95I]H\CSO,_>(FW=LQ]XC/0UZ%13:NK >
M>_##PUJ_AW^U?[5M/L_G^3Y?[Q'W;=^?NDXZBNB\6^%+7Q7I8MYF\JXB):"<
M#)0GJ/<' R/8>E=!1245:P'SQJ7P\\3:;,Z'37N47D26O[P-]!][\Q5"/PEX
MBE?:NA:B#_M6SJ/S(KZ6HJ?9H#QKPK\*[ZXNXKK7D%O:H0_V?<"\G(.#C[H/
M?G/TKV1$6-%1%"JHP% P /2EHJE%+8#'\1^&[#Q/IIL[U"&7F*9?O1MZC^H[
MUY-J?PDU^T<_87M[Z/G&U_+;\0W'ZFO<:*'%,#P*U^%OBJXEV2V<-LO]^6X0
MC_QTL?TKTOP=\/K/PQ(+R:4W6HX*^9C"H#V4?U-=E124$@"BBBK **** "BB
MB@ HHHH \?\ '/A3Q9XB\3W%U!II>T0"*WS<1#Y!WP6!Y.3^-=M\/O#L_ASP
MTL%Y$([V:5I9E!!V]@,@D'@ _B:ZJBI44G< K*\2:/'KWAZ\TU^LL?R'^ZXY
M4_F!6K13 \(TKP-XUTC5;;4+?2?WL$@<?Z3#SZC[W<9%=[\2_#^J^(M-L(],
MM#-)'*S.ID1=H(]R!^5=U14J"2L!\^?\*T\7?] C_P F8O\ XJ@?#/Q<2 =*
M ![FYBX_\>KZ#HI>S0'CVA?""\DN%EUNYCB@4@^3 =SO[%NB]O7\*]<MK:&S
MMHK:WC6.&)0B(HX4#H*EHJE%+8!" RE6 ((P0>]>7^)/A(MU=2W>AW$4&\[O
MLLH(0'_989P.O&/TKU&BFTGN!\_-\,?%BRE!IJLN<;Q<1X^O+9_2NAT'X0W<
MDR3:Y<QQ0CDP0-N<\]"V,#\,U[!14JF@(;6UALK2*UMHQ'!"@1$'10. *FHH
MJP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M NK_ ,@_\#_.J575_P"0?^!_G5*HAU ****L HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@"[<?\>B?A5*KMQ_QZ)^%4JB&P!1115@%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !4UK_P ?"_C_ "J&IK7_
M (^%_'^5*6S 6\_U_P" J"I[S_7_ ("H*4=D 44450!1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% $]I_KQ]#277_'R_P"'\J6T_P!>/H:2Z_X^7_#^51]L
M"&BBBK **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "KJ?\@_\#_.J574_Y!_X'^=1/H!2
MHHHJP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ J2#_7I]:CJ2#_ %Z?6D]@);W_ %J_
M[M5JLWO^M7_=JM2CL 44450!1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% $UK_Q\+^/\JZ*S_X]Q]37.VO_ !\+^/\
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M?PE&X==(4D=-T\K#\BV*ZJBE9 5[*PL].@$%E:PV\0_@B0*/TJQ113 ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"[:
M?\>[_4_RJE5VT_X]W^I_E5*HCNP"BBBK **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH NK_ ,@_\#_.J575_P"0?^!_G5*HAU ****L HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"SJ'_(-_[YK#K<U#
M_D&_]\UAU5'X3&IN%%%%;&84444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH NVG_'N_U/\ *J57;3_CW?ZG^54JB.[ ****
ML HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"ZO_(/_  /\ZI5=
M7_D'_@?YU2J(=0"BBBK **** "BBB@ HHHH **** "BBB@ HHHH **** "BJ
M]U?V=BNZ[NX+<8SF60)QZ\FJ]OKVCW<HBMM6L)I"0 D=RC$D]L T@-"BBBF
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110!9U#_ )!O_?-8=;FH?\@W_OFL.JH_"8U-PHHHK8S"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH *56*,&4X-)10!?BE$JYZ'N*DK.1S&P85?C
MD$BY'XCTK&4;&\)7'4445)84444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !4UK_Q\+^/\JAJ:U_X^%_'^5*6S 6\_U_X"H*GO/]?^ J"E'9 %%%%4
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!/:?Z\?0TEU_Q\O^'\J6T_UX
M^AI+K_CY?\/Y5'VP(:***L HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *NI_R#_P/\ZI
M5=3_ )!_X'^=1/H!2HHHJP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J2#_ %Z?6HZD
M@_UZ?6D]@);W_6K_ +M5JLWO^M7_ ':K4H[ %%%%4 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!-:_P#'POX_RKHK
M/_CW'U-<[:_\?"_C_*NBL_\ CW'U-8U-P,C4/NM_OUG5HZA]UO\ ?K.JJ>P!
M1116@!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3ZTGL!+>_P"M7_=JM5F]_P!:O^[5:E'8 HHHJ@"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** )K7_CX7\?Y5T5G_P >
MX^IKG;7_ (^%_'^5=%9_\>X^IK&IN!D:A]UO]^LZM'4/NM_OUG55/8 HHHK0
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** +MI_Q[O\ 4_RJE5VT
M_P"/=_J?Y52J([L HHHJP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** +J_\@_\#_.J575_Y!_X'^=4JB'4 HHHJP"BBB@#D_B7_P D^U3_ +9?
M^C4K!^%ME%J/@'4[*<9BN+J6-OH8D%;WQ+_Y)]JG_;+_ -&I63\'?^11N_\
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M3\:YB;P5XU\..9K..X(5N'L)B2??:,-^E>[Q2QSPI-$P>-U#*PZ$'D&GTW!
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M.#O;Y5(^A.?PKC_ASI/V+P#J5^ZD27RR$?[B*0/UW51^)FM_VW:Z#I>GDO\
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M0 HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** +MI_Q[O]3_*J57;3
M_CW?ZG^54JB.[ ****L HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M=C)%I\1D&X],<(!]"V?PKVS5?^01>_\ 7"3_ -!-6Z*(QLK >+_!O_D8K_\
MZ]/_ &=:Z;XQ?\BC:?\ 7^G_ *+DKT*BDHZ6 XWX7?\ (B6G_727_P!#-=E1
M15)65@"BBBF!XC_S6[_M_P#Z5[=114I6 JZCI]OJNG3V-VF^"="CCI^(]^]?
M-WB+0[CP[K4^G7/)0Y1^SH>C?Y[YKZ;HHE'F J:5_P @BR_ZX1_^@BK=%%4
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@":U_P"/A?Q_E716
M?_'N/J:YVU_X^%_'^5=%9_\ 'N/J:QJ;@9&H?=;_ 'ZSJT=0^ZW^_6=54]@"
MBBBM "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH NVG_ ![O]3_*
MJ57;3_CW?ZG^54JB.[ ****L HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@"ZO_ "#_ ,#_ #JE5U?^0?\ @?YU2J(=0"BBBK **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH LZA_R#?\ OFL.MS4/^0;_
M -\UAU5'X3&IN%%%%;&84444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !5FWAS\[#CL*;!!O\ F;[OIZU<K.4NB-80ZL****S-0HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ J:U_P"/A?Q_E4-36O\ Q\+^/\J4
MMF MY_K_ ,!4%3WG^O\ P%04H[( HHHJ@"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** )[3_7CZ&DNO^/E_P_E2VG^O'T-)=?\ 'R_X?RJ/M@0T4458!111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 5=3_D'_@?YU2JZG_(/_ _SJ)] *5%%%6 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %20?Z]/K4=20?Z]/K2>P$M[_ *U?]VJU6;W_ %J_
M[M5J4=@"BBBJ **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH FM?^/A?Q_E716?_ ![CZFN=M?\ CX7\?Y5T5G_Q[CZF
ML:FX&1J'W6_WZSJT=0^ZW^_6=54]@"BBBM "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH NVG_'N_P!3_*J57;3_ (]W^I_E5*HCNP"BBBK ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH NK_R#_P/\ZI5=7_D'_@?
MYU2J(=0"BBBK **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH MW:![%5.<''2LW[)'ZM^=:EQ_QZ)^%4JFFVD)Q3W(/LD?JWYT?9(_5O
MSJ>BKYF+E1!]DC]6_.C[)'ZM^=3T4<S#E1!]DC]6_.C[)'ZM^=3T4<S#E1!]
MDC]6_.C[)'ZM^=3T4<S#E1!]DC]6_.C[)'ZM^=3T4<S#E1!]DC]6_.C[)'ZM
M^=3T4<S#E1!]DC]6_.C[)'ZM^=3T4<S#E1!]DC]6_.C[)'ZM^=3T4<S#E1!]
MDC]6_.@6L8/5C^-3T4<S#E0=****104444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %36O_ !\+^/\ *H:FM?\ CX7\?Y4I;,!;S_7_
M ("H*GO/]?\ @*@I1V0!1115 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M 3VG^O'T-)=?\?+_ (?RI;3_ %X^AI+K_CY?\/Y5'VP(:***L HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *NI_R#_P/\ZI5=3_D'_@?YU$^@%*BBBK **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "I(/]>GUJ.I(/\ 7I]:3V EO?\ 6K_NU6JS>_ZU?]VJU*.P
M!1115 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 36O_'POX_RKHK/_CW'U-<[:_\ 'POX_P JZ*S_ ./<?4UC4W R
M-0^ZW^_6=6CJ'W6_WZSJJGL 4445H 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% %VT_X]W^I_E5*KMI_P >[_4_RJE41W8!1115@%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 75_Y!_X'^=4JNK_ ,@_\#_.J51#
MJ 44458!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %
MVX_X]$_"J57;C_CT3\*I5$-@"BBBK **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "IK7_ (^%_'^50U-:_P#'POX_RI2V8"WG^O\ P%05/>?Z_P#
M5!2CL@"BBBJ **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH GM/]>/H:2Z_X
M^7_#^5+:?Z\?0TEU_P ?+_A_*H^V!#1115@%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!5U/^0?^!_G5*KJ?\@_\#_.HGT I44458!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
M)!_KT^M1U)!_KT^M)[ 2WO\ K5_W:K59O?\ 6K_NU6I1V ****H HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(#$HK;^SGU%'V<^HH]IY 8E%;?V<^HH^SGU%'M/(#$HK;^SGU%'V<^HH]IY
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@"";_6#Z5/4$W^L'TJ>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH @/_'Q^-3U ?^/C\:GH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** ((_P#7'\:GJ"/_ %Q_&IZ "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *9+_JS3Z9+_JS0 D/^K_&I*CA
M_P!7^-24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $<W^K_ !I8
MO]6*2;_5_C2Q?ZL4 /HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H#_ ,?'XU/4
M!_X^/QH GHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "FR?ZMOI3J;)_JV^E #(/
MN'ZU+44'W#]:EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** &2_ZLU8L_P#CW'U-5Y?]6:L6?_'N/J: *B_\
M?#_4U-4*_P#'P_U-34 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 03?ZP?2IZ@F_U@^E3T %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% $!_X^/QJ>H#_Q\?C4] !1110 4444 %%%% !1110 4444
M %%%% !1110 445'<3Q6MM+<3.$BB0N['^%0,D_E0!)17R9K$FH>*;C6O$[I
MF-+B/SN?N!]P0<G. $ _*OI+P/K_ /PDOA#3]2;B9D\N<?\ 31?E8_CC/T-
M'0T45XM\?_\ F7O^WG_VE0![317SY\&=2?2/&DFEW*B,:C; IGKN"^8G/H5+
M?F*^@Z "BBOE+Q_K0U_QOJ=ZC!H1+Y,)'0HGR@CZXS^- 'U;17(_##_DF^B_
M]<G_ /0VKR.Z_P"2_K_V%D_F* /HJBBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** ((_]<?QJ>H(_]<?QJ>@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "F2_ZLT^F2_P"K- "0_P"K_&I*CA_U?XU)0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 1S?ZO\:6+_5BDF_U?XTL7
M^K% #Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ J _\?'XU/4!_X^/QH GHHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "FR?ZMOI3J;)_JV^E #(/N'ZU+44'W#]:EH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** &2_P"K-6+/_CW'U-5Y?]6:L6?_ ![CZF@"HO\ Q\/]34U0K_Q\
M/]34U !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $$W^L'
MTJ>H)O\ 6#Z5/0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 0'_CX_&IZ@/_ !\?C4] !1110 4444 %%%% !1110 4444 %%%% !111
M0 5Y[\8M?;1_!36D$FRXU%_L_'7R\9?],*?]ZO0J^??B/=S^,/BC:^'[>7,%
MO(EHF.BNQ!D;\.A_W* .H^'_ (-2\^$5_;RHHGUE7=2>=NWB+/T9=WX_EA_
M_7#8ZU?>'[G<ANAYD2,,;9$!W#UR5_\ 0:]OL[2&PL;>SMUVP6\:Q1KZ*HP!
M^0KY\^(,$W@GXJ)J]@@1)62\B"J I)X=?3DAL_[U 'T57BWQ_P#^9>_[>?\
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MH **** "BBB@ HHHH **** &2_ZLU8L_^/<?4U7E_P!6:L6?_'N/J: *B_\
M'P_U-35"O_'P_P!34U !1110 45YY\81JEMX5AU32M1O+-[2<";[/.\>Y'^7
MG:><-MQGU/X^=_"_QGK)\=6=KJ.J7]Y;W:M 4N+AY K$95@&)YRH&?0F@#Z'
MHHK&\5ZR/#_A74M4SAX("8^ ?WA^5.O^T10!LT5\K:)KOBO6M<L=,B\2:N'N
MITBS]NE^4$\GKV'-?4-S<VVF:?+<W,OEVUM&7>1R6VJHY)/)/\S0!8HKYR\9
M_%K5]=N9;;2)I=.TP$J/+.V649ZLPY7Z ]^<UR']C>(=2B-Z--U2ZCV;C/Y$
MCC;Z[L=* /KRBOE'P_XX\1>%[H&TOYC"&_>6LY+QMR,C:?NDXQD8/O7TAX1\
M56?B_0H]2M1Y;YV30%LF)^ZYP,]0<^] &]117,?$+7V\.>"M0O89/+NF40VY
M'4.W&1[@9;\* .GHKY)3QGXHC=7'B/5B5((W7DA'X@G!KZB\.:S'XA\.V&K1
MJ%%S$'95;(5NC+GV8$?A0!J445XQ\:];U;2M8TM-.U2]LT>W8NMO</&&.[J=
MI&: /9Z*^1_^$Q\3_P#0QZO_ .!TO_Q5'_"8^)_^ACU?_P #I?\ XJ@#ZXHK
MY?TCXI>+=*N YU22\B+ O%=CS V.V3R/P(KZ'\+>)+3Q7H,.JV:LBN2LD;=8
MW'5<]_KZ$4 ;-%<3\1O'J>#-.B2VC2;4[G/DH^=J*.KGUP<#&1G/M7@U[X^\
M67]P9I=?OXR23M@F:)1^"8% 'U?17SAX5^+FOZ/>HFJ7+ZE8NP\Q9CF1!GDJ
MW7IV.1]*^B;2ZAOK."[MI!)!/&LL;@?>5AD'\C0!-17D/Q+^*=UH^H2:'H+(
MEQ$,7%TRY*,?X5!&,XQSSUQVKRD^-_%33F8^(M4W$YP+IPO_ 'SG'Z4 ?6E%
M>+_#GXKWMYJ=MHGB"19O/81P7>W#[S@*K #!STSZ]<]:]HH PO%7BS3?!^F)
M?:CYKH\@C2.$*78^P)' [UB^&?BGH/BK6DTJS@OH;B1&9#<(BJVT9(&')SC)
MZ=C7GOQCOKC7?&^G^'+(-(]NJH(QWFE(/_H.S\S6#XBL&^'/Q+LY+<DP6_D3
MQE5P9(\!7X]25<?CUH ^EZXN3XFZ+'XP'ADVM_\ ;3<"W\P1IY>X]\[\XY]*
M[&*1)HDEC8,CJ&5AW!Z&OGBZ_P"2_K_V%D_F* /HJHKF=;6UFN'!*1(SL%ZD
M 9XJ6J6L_P#(#U#_ *]I/_030!SOA+XBZ1XROY[/3K:^BDAB\UC<(B@C('&U
MCSS77UX%\!_^1IU+_KR_]G6O?: "N/\ $/Q-\,^'+I[2YNI+BZC)#PVJ;RA&
M."20 >>F>QIGQ0\1W'AKP5-<6;F.ZN9%MHI%ZH6!)(]]JMCT.#7 ?"7P#IVM
MV,VO:U$MVAE,<$+DE<C[S.._)&/H?:@#K++XU^$[NX$4HO[0$@>9/"NW_P <
M9C^E>@6MW;WUK'=6LT<T$J[DDC;*L/4&N0\3_#/P]K>D30VFF6MA>!28)K6)
M8\,.@(& 0>AS7G7P5\0W5CXBF\.7#,(+E7=(GX,<JC)P/=0<CV% 'O5%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 03?ZP?2IZ@
MF_U@^E3T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M7_;UK_SSF_(?XT?V]:_\\YOR'^-'LY]@YD:E%9?]O6O_ #SF_(?XT?V]:_\
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M%% !1110 4444 %%%% !39/]6WTIU-D_U;?2@!D'W#]:EJ*#[A^M2T %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_$.K,IZAKV0@_K0!V'QHL=(L?%D"Z=%#%</;A[J.+@!L_*2!P"0/Y'OD]?\
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MU+_KR_\ 9UKWVOECP'XT_P"$)U2YO?[/^V^?!Y6SSO+V_,#G.T^E=]_PO_\
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M%% !1110 4444 %%%% !1110 4444 03?ZP?2IZ@F_U@^E3T %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% $!_P"/C\:GJ _\?'XU/0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9>I_
M\>,_X?\ H0KG:Z+4_P#CQG_#_P!"%<[770^$QJ;A1116YF%%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5/:W4EI,)(S[$'H14%%)J^C&=?:W4=W")(S[$'J#4]<E97CV4XD7E3P
MRYZBNIAFCN(EDC;*FN.I3Y'Y&T97)****R+"BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH CF_P!7^-+%_JQ23?ZO\:6+_5B@
M!]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 5 ?^/C\:GJ _\?'XT 3T444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !39/]6WTIU-D_U;?2@!D'W#]:EJ*#[A^M2T %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% #)?]6:L6?_ ![CZFJ\O^K-6+/_ (]Q]30!47_CX?ZFIJA7_CX?ZFIJ
M "BBB@ KS?XU:)_:/@U=0C3,VG2B3(7)\MOE8?GM/_ :](JKJ5A#JFEW6GW
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MD[B,>K%N?3%>R?"/1/[(\!VTSIMGOV-T^5P=IX3ZC: ?^!&@#P+_ (3'Q/\
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MPR"*=7,:;J+6<FU\F%CR/3W%=,CK(@=2"K#(([UQ5(.#-XRN+1116904444
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MU.,X(4D5YK\(O&&O>*+O54UF^^TK!'&8QY*)M)+9^ZHST% 'JE%%% !1110
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M9I.GZ-:BVTVR@M8<YV1(%R?4^I^M7*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M ()O]8/I4]03?ZP?2IZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#Q?XZ^()%-AX?@E
M(1E^TW*C^+G" ^W#''T/I6+\(O MGXBFN-7U6(3V5J_E1P-]V23 )W>H (X]
M3^>9\8G9OB-> GA88@/8; ?ZUZK\&D1/AW;LF-SSRL_UW8_D!0!W#6-HUJUJ
MUK ;=N&B,8V'ZCIV%>'?$WX:S6^MVUUX9TF>2"\#>;!;1DI"XQV PJG/TR#T
MX%>\T4 ><?"'3O$6BZ1>:;K=A+;6Z.LMJ9&4_>SO7@Y'0'\37H]%9^NZO#H.
MA7NJSC=':Q-)MSC>>RY[9.!^- '@GQGU\:IXO&GPREK?3H_+(#9'FGEC]>@_
MX#7&:MH%]HUEI=U=(!'J-O\ :(<?W<D8/OC:?HPIVF65YXK\4P6H+276H7.9
M'Y)&XY=C[ 9)^E>Z_%OPQ!>^ UGM8MKZ0 T*KVBX5ASV  /_  &@"?X/^(1K
M7@N.SEEWW6FD0.#U\O\ Y9GZ8^7_ (!7H%?-?PA\0-HWC:&U=@+;4A]G?)QA
M^J$>^[Y?^!5]*4 ?-WQG_P"2A3?]>T7\J[WX2>'M$U+P+%<7^CZ?=3FXD!DG
MMD=L \#)&:X+XS_\E"F_Z]HOY5A:+X^\3>'M.%AI6I_9[4,7">1&_)Z\LI-
M'TD_@SPO(C(?#FD@,"#MLXP?P(&17SI\1]#T_P />-;NPTTD6X59!&6SY189
MV_3GC/."*FE^*GC69-CZXX'^Q!$A_,*#5+1/"?B/QCJ8:&VN9?.;?+>W&[8,
MGEF<]3WP,DT >W_!NXFG^'ENLQ)6&>6./)_ASG^9-=_65X<T*V\-:!::3:DM
M';I@N1R[$Y9C]22<=NE:M !6;>^'M$U*X-Q?:/I]U.0 9)[9'; Z#)&:TJ*
M/-_B?X;T+3_AWJMU9:+IMM<)Y.R6&U1'7,J X(&1P2/QKR/X86=KJ'Q$TJUO
M;:&YMW\[?%,@=&Q$Y&0>#R ?PKW#XM?\DQUC_MC_ .CDKQ7X2_\ )3M'_P"V
MW_HEZ /H3_A#O#'_ $+FD?\ @#%_\36I:VEM8VR6UI;Q6\$8PD42!%7OP!P*
MFHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** (#_ ,?'XU/4!_X^/QJ>@ HHHH ****
M"BBB@ HHHH **** "BBB@ JEK/\ R ]0_P"O:3_T$U=JEK/_ " ]0_Z]I/\
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M&KW<UG;R7,=MA)GB4NN#D88C(ZF@#RKX:?$72/!NC7EGJ-M?2R37'FJ;=$8
M;0.=S#GBOH**030I*H(5U##/7FO(?@EI6G:AX:U%[VPM;EUO,*TT*N0-B\#(
MKV&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,O4_^/&?\/_0A
M7.UT6I_\>,_X?^A"N=KKH?"8U-PHHHK<S"BBB@ HHHH **** "BBB@ HHHH
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MG&-K'TKS/X]?\AS2/^O9_P#T*IO@'_Q_ZY_URA_FU0_'K_D.:1_U[/\ ^A4
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MM[?R]C31N7.Z-6.2' ZL>U>B^#M:N?$/A+3]5NTB2>Y1F=8@0HPQ' ))[>M
M&[17BGBOXO\ B#0O%.HZ7:V>F/!;3%$:6*0L1COAP/TKU;PUJ<VL^&=-U*X6
M-9KJW25UC!"@D9XR2<?C0!JT444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M)4MXU1%D'S*< #D@G_OBK_P+\0;9;_0)Y3A@+BV4YXQPX';^Z?SH YKXS_\
M)0IO^O:+^5=Y\)_#>AZMX"274-'L+J9YY4,LMNK/C_>(R/SK@_C/_P E"F_Z
M]HOY5Z?\%_\ DGL7_7S+_,4 ><?%3X?P^%[F+5-*C*Z7<-L:/<6\F3DXY_A(
M''/7/M5SX6_$>ZT_48-"UBY,NGSD)!+*W,#GH,G^$]/;CMFO<=6TNUUK2;K3
M;Q"UO<QF-P.HSW'N#R/<5\G^)?#]WX8UZYTJ\!WQ-\DF,"5#]UA[$?D<CJ*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH *;)_JV^E.ILG^K;Z4 ,@^X?K4M10?</UJ6@ HHHH **** /
M;G_DXE?^OY/_ $6*]^KP&Y_Y.)7_ *_D_P#18KWZ@#R/X]?\@32/^OE__0:[
M7X=?\D]T3_KV'\S7%?'K_D":1_U\O_Z#7:_#K_DGNB?]>P_F: .GKB_BU_R3
M'6/^V/\ Z.2NTKB_BU_R3'6/^V/_ *.2@#G?@/\ \BOJ7_7[_P"R+7JU>4_
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M/^N4/\VJ'X]?\AS2/^O9_P#T*IO@'_Q_ZY_URA_FU0_'K_D.:1_U[/\ ^A4
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MZ\E\ ^/I? =Q<>'/$=M-';1RD@A<O;N>H([J>O'U&<T >_5\]^.%$OQU@CB
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M3?1?^N3_ /H;5X?\6O\ DIVL?]L?_1*5[A\,/^2;Z+_UR?\ ]#:@#P+XB_\
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M,W^G.X;[)<!D'=5<9Q],JQ_$T >JT444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110!!-_K!]*GJ";_ %@^E3T %%%% !1110 4444
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M%% !1110 4444 %%%% !1110 4444 %%%% $!_X^/QJ>H#_Q\?C4] !1110
M4444 %%%% !1110 4444 %%%% !3)H8[B"2&5=T<BE&&<9!&#3Z* ,#0?!7A
M[PS=2W.CZ?\ 9II4\MV\Z1\KD'&&8CJ!6_110 4444 (RAE*L 5(P0>AKF-1
M^'/A'5;CS[K0[?S"2286:')/4D(1D_6NHHH Q-&\'^'O#\GFZ7I5O;R[=OFX
M+.!Z;FR?UYK;HHH IZCI6GZO;&VU&R@NH3_!-&& ]QGH?<5S7_"JO!7G"7^P
MTW @X\^7;Q[;L5V-% %/3-)T_1K46VFV4%K#G.R) N3ZGU/UJY110!R=[\,O
M!NH7+7$^APB1NOE221+_ -\HP'Z5U%O!':VT5O""L42!$!). !@<GDU)10 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% &7J?_'C/^'_ *$*YVNB
MU/\ X\9_P_\ 0A7.UUT/A,:FX4445N9A1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !116W
MI6EX*W,Z^Z(?YFIG-15V-)MDNE::(5%Q,O[P\JI_A'^-:U%%<,I.3NSH2LK!
M1114C"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@".
M;_5_C2Q?ZL4DW^K_ !I8O]6* 'T444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4!_
MX^/QJ>H#_P ?'XT 3T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !39/]6WTIU-D_
MU;?2@!D'W#]:EJ*#[A^M2T %%%% !1110!@-X)\//XB_M]M/SJF\2>?YTGW@
M, [=VWI[5OT44 9&O^&-'\3P0PZQ9_:8X6+QCS73!(Q_"15W3M.M=)TZ"PL8
MO*M8%V1IN+;1]2235JB@ JEJVDV.NZ9-INI0>?:3;?,CWLN<,&'*D'J!WJ[1
M0!E:#X:TCPS:RVVCVGV:&5_,=?,=\MC&<L3V%:M%% !7'W/PM\&W=U-<SZ-O
MFF<R.WVJ898G). _K7844 <7_P *E\$?] 3_ ,FYO_BZ/^%2^"/^@)_Y-S?_
M !==I10!FZ'H&F>'+ V.DVWV>V+F0IYC/\QQDY8D]A5RZM+:^MGMKNWBN()!
MAXI4#JW?D'@U-10!Q[?"WP6\XF.A1[@<@":0+US]T-C]*Z>PTZRTNU6UL+2"
MU@4Y$<*!%SZX'?WJS10!0UC1=/U_37T_4[?S[5R"T>]ER0<CE2#UKFO^%2^"
M/^@)_P"3<W_Q==I10!Q?_"I?!'_0$_\ )N;_ .+I4^%'@F.1771<,I!!^U3=
M?^^Z[.B@ K#UKP=X>\0RB75=*@N)@,>;RCD>A92"?SXK<HH Y?3OASX1TJX\
M^UT.W\P$$&9FFP1T(#DX/TKIU4*H50 H& !T%+10 4444 9>N^'=*\36*66K
MVOVFW202JGF,F& (!RI!Z,?SJ71]%T_0--33],M_(M4)*Q[V;!)R>6)/6K]%
M &#K_@S0/$\\,VL6'VF2%2D9\Z1, G/\+"MN&&.W@CAB7;'&H11G. !@4^B@
M K(U_P +Z-XG@AAUBR%RD+%H_P!XR%21@\J0?PK7HH S]%T/3O#VG"PTJW^S
MVH8N$WL_)Z\L2:SM=\#^'/$U\E[J^G?:;A(Q$K^?(F%!) PK =6/YUT-% '%
M_P#"I?!'_0$_\FYO_BZD@^%O@NW;<FA1D_\ 32:1Q^3,:["B@""TL[6PMUM[
M.VAMH%^['"@11] .*GHHH **** *.J:-IFM6X@U.PM[N-3E1-&&VGU!['Z5S
MB?"KP4DPE&AH6!SAIY2OY%L5V-% %73]-LM)LTM-/M(;6W3I'$@49]>.I]ZM
M444 <UJOP_\ "FM3^?>Z);M*>2\1:(L?4[",GZU?TGPSHNA6SV^F:;!;)(NR
M0HOS./1F/S'\36M10!AZ!X/T'PO).^C6/V9IP!(?.=]P&<?>8XZFFZ_X,T#Q
M//#-K%A]IDA4I&?.D3 )S_"PK>HH Q=;\(^'_$9W:MI<%Q)@#S<%),#H-ZD-
MCVS3-%\%^'/#LOFZ7I,$$W:4Y=QZX9B2.O8UNT4 %<]=>!_#E[XA77KC3M^I
MK)'*)_/D'S)@*=H;;QM';M70T4 %<]KO@?PYXFODO=7T[[3<)&(E?SY$PH)(
M&%8#JQ_.NAHH *Q?$'A+0_%/V?\ MFQ^U?9MWE?O73;NQG[I&?NCKZ5M44 5
MTL;:/3ET]8\6JQ>2(]Q^YC;C/7I67H'@_0?"\D[Z-8_9FG $A\YWW 9Q]YCC
MJ:W** (KFV@O+=[>Z@CG@D&'CE0,K#T(/!KE+CX6^"[F8RR:%&&/:.:2,?DK
M 5V%% &5H_AO1?#ZN-*TVWM2XPS1K\S#T+'DC\:U:** ,'6/!?AO7I3+J6D6
MTTQSF4 H[?5E()_$U2L?AKX.T^82P:% 7!!'G.\H!'LY(KJZ* $50JA5 "@8
M '05@ZCX)\/:MK<>L7VG^;?QE"DOG2+@J<KP& X^E;]% !63K'AG1-?0KJFF
M6UR<8#NF' ]F'S#\#6M10!R5I\,?!EE+YD6A0,V0<32/*./9V(KJT18T5$4*
MB@!548 'H*=10!EZ[X=TKQ-8I9:O:_:;=)!*J>8R88 @'*D'HQ_.I])TFQT+
M3(=-TV#R+2'=Y<>]FQEBQY8D]2>]7:* &30QW$$D,J[HY%*,,XR",&L;0/!^
M@^%Y)WT:Q^S-. )#YSON SC[S''4UN44 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% #)?]6:L6?_ ![CZFJ\O^K-6+/_ (]Q]30!47_CX?ZFIJA7
M_CX?ZFIJ "BBB@#GO'G_ "(6N_\ 7E)_*O OA+_R4[1_^VW_ *)>OH[7=/\
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M?*?)QCJ<-GG_ &@/2@#S7XM?\E.UC_MC_P"B4KW#X8?\DWT7_KD__H;5X?\
M%K_DIVL?]L?_ $2E>X?##_DF^B_]<G_]#:@#P+XB_P#)0M;_ .OD_P A7N-B
M[1_ _>IPRZ$Y!]_)->'?$7_DH6M_]?)_D*^A?!<"7/PYT>"3.R6P1&P><%<&
M@#YU\!B(^/="\X@)]MCQG^]GY?UQ7UA7R3K6E:AX,\5R6Q+Q7%G.)+>;;]X
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M(****@84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% $<W^K_&EB_U8I)O]7^-+%_JQ0 ^BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH *@/_'Q^-3U ?\ CX_&@">BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *;)_JV^
ME.ILG^K;Z4 ,@^X?K4M10?</UJ6@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH 9+_JS5BS_X]Q]35>7_ %9J
MQ9_\>X^IH J+_P ?#_4U-4*_\?#_ %-34 %%%% !7S!\0]%F\*>/[A[9F1)9
M!>VKX^[DYP/]U@1] *^GZXCXF^#'\7>'P;)%;4[1M]N"0OF _>0L>F1R.V0*
M .D5K?Q-X9#13RQ6^HVO$D+ .JNO8D<'!].*X>#X'^%X+B*8W6J2B-PWER2Q
ME6P<X(\OH:T?A;IOB#0_#DFDZ[8?9A;R%K9O-1]RL22/E8XPV?3[WUKNJ "B
MBB@#!\6>$=-\8Z;%9:DTZ)%*)4D@*JX.",9(/!ST]A61X7^&.C^$M8&IZ=?:
MDTOEM&R32H493V(" ]0#UZ@5VM% '">(OA/H7B;7;G5[V[U*.XN-N]89$"#:
MH48!0GHH[UU6@Z+;>'M$M=*M'E>"V4JC2D%CDD\D #OZ5HT4 >?ZU\(/#^NZ
MS=:I=7FII/<OO=8I8PH/ME"?UKL])TR'1M(M--MVD:&UB6)&D(+$ 8YP ,_A
M5VB@#$\2>$M&\5VJPZK:B1D!\N53MDCSZ'^AXKS>Y^ 5NTN;7Q#+%'C[LMJ'
M/YAE_E7L=% ' >&/A'H'AZZ2\G,FHW4;!HVG "(1C!"COD=3FN_HHH \Y\4^
M/O!4]U>>'/$-M<2K#)MD#0Y4,.ZE3N!YZC!K+T3X6^ _$=I'JFE7VI36A8J4
M\T*-PZJ04W#KZ^E2?$WX877B&^;7-$*O?,JK/;.P7S<  ,I/ .  02!@?GY?
M;^'_ !]H3,MCI^OVA?[WV-90&^I2@#O/C#I^E>'_  CHVBZ;#';J+EI5C7JP
M"X+,>I/(Y--^ 4$GG:[<;2(]L*9(ZGYSQ]/ZBN,M/A_XW\270DN-/O V-IGU
M%BFT#_?^;'T!KWSP1X2@\'>'DTY)!-.[F6XF QO<X' [   ?AGO0!MWUC:ZG
M8S65[ D]M,NV2-QD,/\ /?M7EVJ? C2;B=GTW5;FR0_\LY8Q, <]N5./J3]:
M]9HH \KT;X&Z-97"3:IJ$^HA#GR@@A1OK@D_D17J444<,211(L<:*%1%& H'
M0 =A3J* ..\6?#;1O&.JQ:AJ%S?Q31P" +;R(J[0S-W4\Y8UK>%O"]EX1T@Z
M;82W$D)E:7=<,I;) '8 8X]*VZ* ,3Q3X7LO%VD#3;^6XCA$JR[K=E#9 ([@
MC'/I63X3^&VC>#M5EU#3[F_EFD@,!6XD1EVEE;LHYRHKL:* *]]8VNIV,UE>
MP)/;3+MDC<9##_/?M7EVJ? C2;B=GTW5;FR0_P#+.6,3 '/;E3CZD_6O6:*
M/*]&^!NC65PDVJ:A/J(0Y\H((4;ZX)/Y$5ZE%%'#$D42+'&BA411@*!T '84
MZB@#CO%GPVT;QCJL6H:A<W\4T< @"V\B*NT,S=U/.6-:WA;PO9>$=(.FV$MQ
M)"96EW7#*6R0!V &./2MNB@#,UWP_IGB33FL=4M5GASE2>&1L8W*>QKS&\^
MEG).6LM>F@B))"2VPD(&>!D,O\J]AHH \W\.?!G0M&NH[J_FDU.>,AE610D0
M([[ 3GZ$D5Z115>^EN(+"XEM;<W%PD;&*$,%WMC@9) &30!\]_&34CJGC[[%
M 3(+.%( J<Y<_,<>_P P'X5[AX/T(>&_">GZ4?\ 60QYE/K(Q+-^I(^@%>:>
M OAMK:^,9->\56BQ&)S<1JTRR&6=F)W?*Q^Z>>>^.O->ST %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4R7_ %9I],E_
MU9H 2'_5_C4E1P_ZO\:DH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** (YO\ 5_C2Q?ZL4DW^K_&EB_U8H ?1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %0'_CX_&IZ@/_'Q^- $]%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4V3_5M]*=
M39/]6WTH 9!]P_6I:B@^X?K4M !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 R7_5FK%G_P >X^IJO+_JS5BS
M_P"/<?4T 5%_X^'^IJ:H5_X^'^IJ:@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@"";_6#Z5/4$W^L'TJ>@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *9+_ *LT^F2_
MZLT )#_J_P :DJ.'_5_C4E !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!'-_J_QI8O\ 5BDF_P!7^-+%_JQ0 ^BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *@/_ !\?C4]0'_CX_&@">BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *;)_J
MV^E.ILG^K;Z4 ,@^X?K4M10?</UJ6@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 9+_JS5BS_P"/<?4U7E_U
M9JQ9_P#'N/J: *B_\?#_ %-35"O_ !\/]34U !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% $$W^L'TJ>H)O]8/I4] !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110! ?^/C\:GJ _P#'Q^-3T %%%% !
M1110 4444 %>6^(O@GIVKZK/?6&IR:>9W,DD1A$J!B<G;RN!GMS^7 ]2HH Y
M&U\$O;_#E_"+ZGYF8WC%WY&,!G+?=W=LXZT> O __"$6-Y;?VC]M^T2"3=Y'
ME[<#&,;CFNNHH *\T\1_!?1=9O9;S3[J33)93N:-(P\6<\D+D$=^ <>PKTNB
M@#R6Q^!5DDL9U/7;J\BC/$<<0B&/3)9L=NG_ ->M+Q1\']*UM+!-+FBTA+2-
MHV$=MYGF@D$9.X$D<\DDG->D44 9E[I<NH>%[G2)[L&:XLFMI+D1]69"I?;G
MU.<9_&N>\ > /^$&_M'_ (F?VW[9Y?\ RP\K9LW?[1SG=^E=I10 5P$7PS\O
MXBGQ9_:^<SM-]E^S>JE<;]_OZ5W]% %/5-+L=:TZ6PU&V2XM91AXW[^X(Y!]
MQS7E^H_ ;39IBVG:S<VJ$YV30B;'L""OZYKURB@#RK1_@9I%G<QS:GJ4]^J'
M)B6,1(WH#R3CZ$5ZA;6T%G:Q6UM$D,$2A(XT&%4#H *EHH ^<]&T^TU7X[7M
MC?0+/;3:A?K)&W1AB6NMO_@)8RW!;3]=GMX3_!-;B4C\0R_RK+\-Z#K,'QTF
MU";2;^.Q-_>N+E[9Q&599=IW$8P<C![Y%>YT <?X0^'&B>$)3=6PDN;X@C[3
M.02H/4*!P/Y\GG'%='K&G_VMHE_IOF^5]KMI(/,V[MF]2N<9&<9Z9J[10!QW
M@'P)_P (/!?1?VE]M^U,C9\CR]NT'_:.>M2^,/A]HWC+9+=B2WO(UVI<PX#8
M]&!^\/Y5UE% 'CL7P&56*/XFF-L228DM=I/ISO(].W:ND/PC\/1>%[O2;5-E
MU<JH.H3())5((.1TP..@QGOFN^HH YCP-X3E\&Z+)ICZD+Z,S&6-O(\LID $
M?>.1D9_$UB?\*P_XN%_PE?\ ;'_+SY_V7[-[8QOW_KBO0J* "N+\?^ /^$Y_
ML[_B9_8OL?F?\L/-W[]O^T,8V_K7:44 5=-L_P"S]+M++S/,^SP)%OQC=M4#
M..W2N$\8?"/3O%&K2:I;W\FGW<V/.Q$)$<@ 9VY!!P.>>>O7.?1:* .8\"^$
M7\%Z+-IIU#[:KW!F5_)\O;E5&,;C_=S^-=/110 4444 %%%% !1110!!'_KC
M^-3U!'_KC^-3T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4R7_5FGTR7_ %9H 2'_ %?XU)4</^K_ !J2@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH CF_U?XTL7^K%)-_J_QI8O]6* 'T444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !4!_X^/QJ>H#_ ,?'XT 3T444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !39/\ 5M]*=39/]6WTH 9!]P_6I:B@^X?K4M !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 R7_ %9J
MQ9_\>X^IJO+_ *LU8L_^/<?4T 5%_P"/A_J:FJ%2!</D]S4NY?[P_.@!:*3<
MO]X?G1N7^\/SH 6BDW+_ 'A^=&Y?[P_.@!:*3<O]X?G1N7^\/SH 6BDW+_>'
MYT;E_O#\Z %HI-R_WA^=&Y?[P_.@!:*3<O\ >'YT;E_O#\Z %HI-R_WA^=&Y
M?[P_.@!:*3<O]X?G1N7^\/SH 6BDW+_>'YT;E_O#\Z %HI-R_P!X?G1N7^\/
MSH 6BDW+_>'YT;E_O#\Z %HI-R_WA^=&Y?[P_.@!:*3<O]X?G1N7^\/SH 6B
MDW+_ 'A^=&Y?[P_.@!:*3<O]X?G1N7^\/SH 6BDW+_>'YT;E_O#\Z %HI-R_
MWA^=&Y?[P_.@!:*3<O\ >'YT;E_O#\Z %HI-R_WA^=&Y?[P_.@!:*3<O]X?G
M1N7^\/SH 6BDW+_>'YT;E_O#\Z %HI-R_P!X?G1N7^\/SH 6BDW+_>'YT;E_
MO#\Z %HI-R_WA^=&Y?[P_.@!:*3<O]X?G1N7^\/SH 6BDW+_ 'A^=&Y?[P_.
M@!:*3<O]X?G1N7^\/SH 6BDW+_>'YT;E_O#\Z %HI-R_WA^=&Y?[P_.@!:*3
M<O\ >'YT;E_O#\Z %HI-R_WA^=&Y?[P_.@!:*3<O]X?G1N7^\/SH 6BDW+_>
M'YT;E_O#\Z %HI-R_P!X?G1N7^\/SH 6BDW+_>'YT;E_O#\Z %HI-R_WA^=&
MY?[P_.@!:*3<O]X?G1N7^\/SH 6BDW+_ 'A^=&Y?[P_.@!:*3<O]X?G1N7^\
M/SH 6BDW+_>'YT;E_O#\Z %HI-R_WA^=&Y?[P_.@!:*3<O\ >'YT;E_O#\Z
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M'YT +12;E_O#\Z-R_P!X?G0 M%)N7^\/SHW+_>'YT +12;E_O#\Z-R_WA^=
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M^= "T4FY?[P_.C<O]X?G0 M%)N7^\/SHW+_>'YT +12;E_O#\Z-R_P!X?G0
MM%)N7^\/SHW+_>'YT +12;E_O#\Z-R_WA^= "T4FY?[P_.C<O]X?G0 M%)N7
M^\/SHW+_ 'A^= "T4FY?[P_.C<O]X?G0 M%)N7^\/SHW+_>'YT 0Q_ZX_C4]
M01D"4DFIMR_WA^= "T4FY?[P_.C<O]X?G0 M%)N7^\/SHW+_ 'A^= "T4FY?
M[P_.C<O]X?G0 M%)N7^\/SHW+_>'YT +12;E_O#\Z-R_WA^= "T4FY?[P_.C
M<O\ >'YT +12;E_O#\Z-R_WA^= "T4FY?[P_.C<O]X?G0 M%)N7^\/SHW+_>
M'YT +12;E_O#\Z-R_P!X?G0 M%)N7^\/SHW+_>'YT +12;E_O#\Z-R_WA^=
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M3<O]X?G1N7^\/SH 6BDW+_>'YT;E_O#\Z %HI-R_WA^=&Y?[P_.@!:*3<O\
M>'YT;E_O#\Z %HI-R_WA^=&Y?[P_.@!:*3<O]X?G1N7^\/SH 6BDW+_>'YT;
ME_O#\Z %HI-R_P!X?G1N7^\/SH 6BDW+_>'YT;E_O#\Z %HI-R_WA^=&Y?[P
M_.@!:*3<O]X?G1N7^\/SH 6BDW+_ 'A^=&Y?[P_.@!:*3<O]X?G1N7^\/SH
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M_;C_ ,\Q^='VX_\ /,?G52BCDB!;^W'_ )YC\Z/MQ_YYC\ZJ44<D0+?VX_\
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M"W]N/_/,?G1]N/\ SS'YU4HHY(@6_MQ_YYC\Z/MQ_P">8_.JE%')$"W]N/\
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M"W]N/_/,?G1]N/\ SS'YU4HHY(@6_MQ_YYC\Z/MQ_P">8_.JE%')$"W]N/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!=M/^/9
M_J?Y52J[:?\ 'L_U/\JI5$=V 44458!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% %U?^/#\#_.J575_P"/#\#_ #JE40Z@%%%%6 4444 %%%%
M!12.ZQHSNP55&2Q. !65_P )1X>_Z#NF?^!<?^-(#6HK)_X2CP]_T'=,_P#
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M  _E2V?^O_ TEU_Q\O\ A_*H^V!#1115@%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5
MU/\ D'_@?YU2JZG_ "#_ ,#_ #J)] *5%%%6 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %26_\ KT^M1U);_P"O3ZTGL!+>_P"M7_=JM5F]_P!:O^[5:E'8 HHHJ@"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* )K7_CX7\?Y5T5G_P >X^IKG;7_ (^%_'^5=%9_\>X^IK&IN!D:A]UO]^LZ
MM'4/NM_OUG5=/8 HHHJP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH NVG_'L_U/\JI5=M/^/9_J?Y52J([L HHHJP"BBB@ HHHH **** "BBB@
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M+)Y6^1P.K8/"KTZC\1G%4Y) >M45Y%<:Y\3=!B:\U&V$UN@R^^*)U4>I\K!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@"[:?\>S_4_RJE5VT_X]G^I_E5*HCNP"BBBK **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 3V?\ K_P-)=?\?+_A_*EL_P#7_@:2Z_X^7_#^51]L"&BBBK ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "KJ?\@_\#_.J574_Y!_X'^=1/H!2HHHJP"BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ J2W_UZ?6HZDM_]>GUI/8"6]_UJ_[M5JLWO^M7_=JM
M2CL 44450!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?3.HWT6F:;<WTYQ%;Q-(W/7 S@>YZ4Z;TU \@^(T\WB/Q[::':,&\G; OS9
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M>SAA<@LB!21TJ>BB4W+<(KEV(;F$S6DT2D!G1E&>F2*YO_A&KW_GK!_WT?\
M"NJHHA-QV"2YMSE?^$:O?^>L'_?1_P *Z.T@-O9PPN061 I(Z5/11*;EN$5R
M[$-S"9K2:)2 SHRC/3)%<W_PC5[_ ,]8/^^C_A75440FX[!)<VYRO_"-7O\
MSU@_[Z/^%=':0&WLX87(+(@4D=*GHHE-RW"*Y=B&YA,UI-$I 9T91GIDBN;_
M .$:O?\ GK!_WT?\*ZJBB$W'8)+FW.5_X1J]_P">L'_?1_PKH;&W:VLHH7(+
M(N"5Z59HHE-R5F$8\NQ%/$9;>6-<99"HS[BN:_X1J]_YZP?]]'_"NJHHA-QV
M"2YMSE?^$:O?^>L'_?1_PKH;&W:VLHH7(+(N"5Z59HHE-R5F$8\NQ%/$9;>6
M-<99"HS[BN:_X1J]_P">L'_?1_PKJJ*(3<=@DN;<Y7_A&KW_ )ZP?]]'_"NA
ML;=K:RBA<@LBX)7I5FBB4W)681CR[$4\1EMY8UQED*C/N*YK_A&KW_GK!_WT
M?\*ZJBB$W'8)+FW.5_X1J]_YZP?]]'_"NBTR&2QM(8V*F1 02.1U-6**)S<U
M9BC%1U0EQNG1P2-S*0*Y;_A&KW_GK!_WT?\ "NJHHA-PV')<VYRO_"-7O_/6
M#_OH_P"%=!I]LUK8Q02$%D!!*].M6J*)5')68HQ4=41RQ[XG0=64@9KF?^$:
MO?\ GK!_WT?\*ZJBB$W'8<ES;G*_\(U>_P#/6#_OH_X5T&GVS6MC%!(060$$
MKTZU:HHE4<E9BC%1U1'+'OB=!U92!FN9_P"$:O?^>L'_ 'T?\*ZJBB$W'8<E
MS;G*_P#"-7O_ #U@_P"^C_A6_IUH]I8102%2ZYR5/'))JW13E4<E9BC%1=T-
M9-R,!W&*Y?\ X1J]_P">L'_?1_PKJJ*4)N&PY+FW.5_X1J]_YZP?]]'_  K?
MTZT>TL(H)"I=<Y*GCDDU;HIRJ.2LQ1BHNZ&LFY& [C%<O_PC5[_SU@_[Z/\
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MBK6 \<^&EEKFA>*GAO-)OX;6YC:*1WMV"*R\J2V,=B,_[57_ !QX'U2+7?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M9!Y+NA;^!PI*L#V(-97PT_Y)]I?_ &U_]&O70ZI_R"+W_K@__H)JTO= \O\
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M!9ZI>V\(AC(CAN'1<X] :X__ (2CQ#_T'=3_ / N3_&NA^*W_([R_P#7"/\
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M6****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MBBB@ JZG_(/_  /\ZI5=3_D'_@?YU$^@%*BBBK **** "BBB@ HHHH ****
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M)3.!^.!744523[@?,MOK;_\ "1?VSJ-NFH2F0RM',<*S=LCT'8=. .G%=O\
M\+FU#_H$VO\ W\:O8Z*E0:Z@>.?\+FU#_H$VO_?QJ]:T^Z-[IEK=LH4SPI(5
M!SC< <?K5FBJ2:W8'DOA;QGX@U+XA1:7=W_F632SJ8_)C'"HY'(7/4#O7K5%
M%"5@"LGQ1_R*.M?]>$__ *+:M:BJ \A^"_\ Q^ZO_P!<XOYM6Y\8O^11M/\
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M_AB+PKHBV8<2W$C>9/*!PS8Q@>PQ@?GWK?HH4;.[ \2\1?\ );H?^O\ L_\
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MD;F)S(WIC) S]?2IE9M(#U".-(HTC10J( J@=@*=116@!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% $UK_ ,?"_C_*NBL_^/<?4USMK_Q\+^/\JZ*S_P"/
M<?4UC4W R-0^ZW^_6=6CJ'W6_P!^LZKI[ %%%%6 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% %VT_X]G^I_E5*KMI_Q[/\ 4_RJE41W8!1115@%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 >!?%$D^.[L$DXCB ]OD%>D_"O9_P@UOMZ^=)N^N[_
M  Q7$_%_2VM_$-MJ*@^7=P[2?]M.#^A7]:V?@_KD)LKK1)I5699/.@5CRZD?
M,!],9_'VK):3 ]1HHKSSXB>.;GP]=VECI4T7VK!DN RA@JG[H/N>3^ ]:T;L
MK@>AUF>(M6&A>'[[4B Q@B)13T+GA0?;<16%X"\6W_BNUNY;RRAA6!E021,<
M.QR2,'.,<=^]<S\8M:&RRT6&7DDSSJ#^" _^/''TI.6EP//- TN;Q'XDM;+)
M9KB7,K>B]7;\LU[1\1]$CU'P9<-'&HDL1Y\0' 55^\./]G/Y"O"+2]NK"<3V
M=S-;S $"2&0HV/J*NOXFU^1&1]<U)E88*F[D((_.L5))6 U_AWK9T7Q=:[Y
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MV,91M*X4444Q!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !7DVE:;;:Q\5/%6GWB;X)[616'<?/%@CW!P1[BO6:\Q\
M+?\ )9_$7_7"3_T..HGNBEU&^!M0N?"OB*X\&ZLX"%R]G*1@.3R .V&'('KD
M=:=XI_Y+/X=_ZX1_^AR5M?$3PLVMZ6NH6(*ZI8CS(W5B&9!R5&._<>_UK@K#
MQ$WB;X@^%[V48N8XDAN,# +AI#D?4$'VSCM4O3W1K74Z/Q]_R4;PC_UWB_\
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MW<;Z1IVEQG?>370E2)>6*A67H/4L /7MWJ/XI0_9M(\/09SY<X3/T4"AZ)I
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MHH **** "BBB@ HHHH *DM_]>GUJ.I+?_7I]:3V EO?]:O\ NU6JS>_ZU?\
M=JM2CL 44450!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !..NTC@_P _:DI)@=-117.^)O&FD^%T"W;M+=,,K;PX+XYP3D\#C_ZQIMV
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M%% %VT_X]G^I_E5*KMI_Q[/]3_*J51'=@%%%%6 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!D
M^(_#]IXET>33[LE03OCD7K&XZ,/S(^A-> ZQX?UKPIJ7[^*:$QOF*[BR%;'0
MJPZ']17TI2.BR(R.H96&"I&0142C<#YW7XA>*TMA;C6)=@&,F-"W_?17=^M4
M=(T'6/%%^4M(9)Y&),D\A.T>I9C_ /KKZ#/AK06D\PZ)II?KN-JF?SQ6E'&D
M48CC141> JC %3R/JP,KP_HEKX9T&*QB8;(@7EE8XW,>68^W] *^??$VL-KW
MB*]U(Y"2R?NP>R#A1^0%?2\D:2QM'(BNC@JRL,A@>H(K,'ACP^I!&AZ8".01
M:1\?I52C=60$/A#2?[$\*Z?9,NV58@\HQ@[V^9@?H3C\*VZ**I: >3_&+16)
ML=:B3*@?9YR.W=#_ .A#/TJI\']:6WU.ZT>5CBZ'FPCC&]0=P_$?^@UZ[=6=
MM?0&"[MX;B%B"8YD#J<=.#Q52W\/Z+:3I/;:180S(<K)';(K+]"!D5/+[UT!
MXQ\5O^1WE_ZX1_RKT'X4_P#(D1_]=Y/YUU%WH>DW\YGO-+LKB8@ R36Z.V/J
M15BTLK6P@$%G;0V\()/EPQA%S]!0HVE<!;JUAO;26UN8Q)!,A1T/1@>"*^<?
M%?AV;PQKLUA)EH3\\$A_CC/0_4=#[BOI2JE[I>GZEL^WV%K=>7G9Y\*OMSC.
M,CCH/RIRCS <5\+?%!U72#I-U)NO+)?D)/+Q= ?^ D@?3%>@5GVNA:18SB>T
MTJQMYER!)#;HC#/7D#-:%-)I:@%%%%,#D_B7_P D^U3_ +9?^C4KRCX:?\E!
MTO\ [:_^BGKWZYM;>]MVM[J"*>!\;HY4#*V#D9!XZ@54MM!T:RN%N+72;""=
M,[9(K9%9<C!P0,]":AQN[@:%%%%6 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 75_P"/
M#\#_ #JE5U?^/#\#_.J51#J 44458!1110 4444 %?/WAW6Y? 'BN]6ZLWEV
MAK>2/=M8?,"&!QST^A!KZ!JG>:5IVHE3?:?:W17A3/"KX^F14R5]@.8UK68O
M$'PLOM4AC:-)[=\(QR1A]O\ 2L7X,_\ ((U/_KNO_H->AIIEA'8FQ2QMELVR
M#;K$HC.>3\N,466FV.FHR6-E;6JN<LL$2H&/O@46UN :G9C4=)O+$L5%S \)
M8=MRD9_6O$/"^N7/P\\0W=MJUA)LD 295'SC&=K+DX8'/X^M>\U7N["SU",1
MWMI!<H/X9HPX_(CV'Y42C?5 <%=_%_2?)4:?I][<7+\+'(H09[9()[^@KS;Q
M+%KL>K0ZMK]N\=Q>8F16POR@@;<=5P,<'FOH&TT?3+!]]GIUG;-US# J'T["
MG7NEZ?J6S[?86MUY>=GGPJ^W.,XR..@_*I<6]V!2\2R)+X-U>1&#(^GS,I'<
M&,UY_P#!7_F.?]L/_:E>I_9;?[)]D\B+[-Y?E>3L&S9C&W;TQCC%0V6EZ?IN
M_P"P6%K:^9C?Y$*INQG&<#GJ?SJFM;@6Z\6M_P#DN9_Z^W_] ->TU2&CZ6+[
M[<--LQ>9W?:! OF9Z9W8SFB2N!Q_Q/\ "T^N:7!?6$3RWEGD&)!DR1GK@=R"
M,@#U/M6!X<^*RZ;I\6GZU8W#O;*(A-#@L0. &5B.1CKGFO7*IWFD:;J#!KW3
MK2Y8=#-"KD?F*3B[W0'DOBWX@GQ99?V%HVG7&VY=0QD ,CX((4*,XY YSVKO
MO 'A^;P[X7CMKKBYFD,\J?W&( V_@%%;UIIEAIXQ96-M;=OW,2I_(5:IJ.MV
M!\[7BZBWQ(U Z2K-?QZA<2PJ@R25=FZ=^ >.]=]:?&/3Q9@7^F7:7@X=(=I0
MGUR2"._&#CU-<[X=_P"2W3?]?]Y_Z#)7K]WHFE7\OFWFF65S)TWS6ZN?S(J(
MI] /'=FL?%3Q)%,UN;73H!L+C)6)<Y(R?O.<C].PKU;Q#!%:^"=5MX$$<,6G
M3(B#HJB,@#\JV(XTBC$<:*B+P%48 I)8HYX7AFC62*12KHXRK \$$'J*M1L!
MYA\%_P#CSU?_ *Z1?R:L3QS87_AGQXOB"* R6TDRW$3L,KO&,JV.G/Z'ZU['
M9:98::'%A8VUJ'P7$$2INQTS@<U8DC26,QR(KHW!5AD&ERZ6 \_3XP:";8.]
MI?K-CF,(I&?8[NGOQ]*XWQ;JNO>,M/DU1=.DMM#LL%=Q^\2=N[/&X\]N /S/
ML2>'=#BF\V/1M/23D[UM4!Y]\5=FMH+BW:WG@CE@8;6B= RD>A!XH<6]V!QW
MPIG67P/$BD9BGD1OKG=_)A7#_P#-;O\ M_\ Z5[)9:;8Z:C)8V5M:JYRRP1*
M@8^^!4?]C:7]N^W?V;9_:]V[S_(7S,^N[&<T<NB0%ZO)_C5_S _^V_\ [3KU
MBJE[I>GZEL^WV%K=>7G9Y\*OMSC.,CCH/RIR5U8"+0?^1=TS_KTB_P#0!7B^
MH7T_@SXIWFH2VS2#[1),$)QYB29.0<?[7YC%>[1QI%&L<:*B( JJHP% Z "H
M+S3[+44"7MG;W*+R%GB5P/S%#C<#,\*^)8/%6E27\$#P*DQA*.<G( /_ +-6
MY5:STZRTZ-H[&SM[5&.YE@B5 3ZD 59IKS ****8!1110 4444 &KZI!IUO;
MK,DC&3D; #TQZGWHAE6:".500KJ&&>N",UD^,?\ 5Z?]'_\ 9:T=/_Y!MK_U
MQ3^0JXQ2IJ7<PE)N;18HHHI %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %<QI?A#^S/&>H^(?MWF?;(V3R/)QLR5.
M=V[G[OH.M=/10U<+A7$?\*XMX_&J>(;:^,2";SFM?)R"W?#;A@$\]*[>BAI/
M<$[',:_X0_MSQ'I&K_;O(_LZ17\KR=WF8<-C.X8Z8Z&M#Q-H,7B709],DE,/
MF%664+NV,""#C(SZ?C6O12LAW,;PMX>B\,:%%IL<OG%69WEV[=[$]<9..,#\
M*J:3X3_LOQ;J>N_;?-^W*1Y'E;=G(/WLG/3T%=)119"N<'K?P[NM3\47.N6?
MB*;3IIPH AA.Y0$5?O!QUVU7/PXUJ4A;GQQJ<T6?F0A^?SD/\J]$HI<B'S,P
M/#/@_2O"L+BQ1WGDXDGE(+L/3@  >P_'-5_&GA#_ (2^SM8/MWV3R)"^[R?,
MW9&,?>&*Z>BGRJU@N[W"BBBF(**** .&O_APG]KS:CH6L7.C23#]XD"Y0G/.
M &''MTS5G1/ ,6GZO'J^IZI=:MJ,61'+.<*O7H"2>,\<X%=A12Y4.[/+_B'9
M0:CX]\-65RI:"?\ =NH)&07YY%7V^&5S*GV.?Q7J4FE@C%J>N/3<6(_\=Q73
M:IX7LM6US3M6GEN%N+ @Q+&RA3SGY@03^1%;=3R)MMCOV*FF:99Z/I\5C8PB
M*WB&%4<_4D]S7)W_ ,.8?[2EU'0M6NM&N)L^8L S&?8*",<\XSCT KMZ*IQ3
M%=G':!\/K32M3&J:A>SZKJ P5FN>BGU )//U)Q5WQ=X3_P"$JBLH_MOV7[+-
MYN?*W[O;J,5TE%'*K6"[W"N;\,>$_P#A'-1UB[^V_:/[1E$NWRMGEX+G&<G/
MW_;I7244[".)U?X=0W6L/JNCZI<:/=R?ZPVZ_*QSDG (Z]QG%/TOX?)!J\&J
MZSK%WJ]Y;D&$S?*B$'(."2>#SUQFNSHI<J'=F'XF\*:;XJLT@OE99(SF*>+
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MD5K:!XVT/Q),8+*Y9;D9/D3+M8@=QV/X&CF0&CKUS-9>'=3NK=]D\%I+)&V
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M!D:A]UO]^LZM'4/NM_OUG5=/8 HHHJP*.M7C:=H6H7J,%>"VDD4GU"DC]:\
M\#6[7OCG24/S$3^:<G^X"^?_ !VO<?&7_(F:Q_UZ2?RKQCX:?\E!TO\ [:_^
MBGK*?Q(#Z#K*\2ZPN@>'KS4F +1)\BG^)R<*/S(K5KR?XQ:TP-CHL3X4C[1.
M!W[(/_0CCZ5<G9 >?^'-*E\0>);.R(:032AIFY)V9RQ)^F?QKU7XM:&EWX<A
MU.),2V#@';C_ %;8!_([<>G->1Z/K>H:#>-=Z;.()V0QE_+5_E)!/# CL*U;
MSQ_XFU"RFL[K4A+;S(4D0V\7(/T7CZUDFDK ;7PGULV'B1]-=@(+],#)QB10
M2OYC</?(KW"OE6VN)+2ZAN86*RPNLB,.S Y!KZ=TC4X=9TBUU&#(CN(PX4]5
M/<'Z'(_"KIO2P'S]XZ_Y'?5_^NY_D*]R\&_\B9H__7I'_*O#?'7_ ".^K_\
M7<_R%>Y>#?\ D3-'_P"O2/\ E2A\3 \]^-'_ !^Z1_USE_FM6?A19QZCX7UV
MQF9EBN6\ERAPP#(0<9[\U5^,[ W^DKGYA%(2/J1_A6E\&?\ D$:G_P!=U_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** +MI_Q[/]3_ "JE5VT_X]G^I_E5*HCNP"BBBK **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW.QP!L89_2GR2["YD7J**KW5[;V04W$FP-T^4G/Y4DK[#+%%9W]NZ;_S\_\
MCC?X4^+5[&>58HY]SL< ;&&?TI\DNPN9%ZBBJ]U>V]D%-Q)L#=/E)S^5)*^P
MRQ16=_;NF_\ /S_XXW^%/BUBPFE6..?+L< ;&Y/Y4^2787,B]114%U>V]FJM
M<2; QP."?Y4DK[#)Z*SO[=TW_GY_\<;_  I\6L6$TJQQSY=C@#8W)_*GR2["
MYD7J**@NKVWLU5KB38&.!P3_ "I)7V&3T5G?V[IO_/S_ ..-_A3XM8L)I5CC
MGR[' &QN3^5/DEV%S(O445!=7MO9JK7$FP,<#@G^5)*^PR>BL[^W=-_Y^?\
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M(=ED^YVZO@C;^?>C0K":'==3,R^8.$]?<U;A:-WH*+O*R-LG-%%%8G0%%%%
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M/LT/V;[4X\GRQLQL/&WI79_"-77P8Y<#:UVY3'IA1S^(-<E;_P#)<S_U]O\
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M6E36EP"BBBM "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** +MI_Q[/]
M3_*J57;3_CV?ZG^54JB.[ ****L HHHH **** "BBB@ HHHH **** "BBB@
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M?Z98ZI#Y-_9P7,?.!*@;&?3/3\*F4;ZH#EI/BEX52U\U;N:1\9\E8&W_ $Y
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MB^'-*\/),FEVQMUF(+KYKN"1G'WB<=>U"B[W U:***L HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@":U_X^%_'^5=%
M9_\ 'N/J:YVU_P"/A?Q_E716?_'N/J:QJ;@9&H?=;_?K.K1U#[K?[]9U73V
M****L KG?&GA=?%6AM:*ZQW4;>9;R/G:&[@X[$9'Z]JZ*BDU<#E/ F@:OX;T
MJ;3]2GM98A)O@,#,=N?O Y4=^>_4UU=%%"5M "BBBF 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5YCXQ^%SZC?R:CHDD4<DK%I;:4D*6
M/5E/;)['CKSVKTZBDTGN!\_2?#+Q:CE5TQ7 Z,MQ'@_FP-;&C_"'5;B57U:X
MAM( ?F2-M\A'M_"/S_"O::*GV: @L[.#3[*&TMHQ'!"@1%'8"IZ**L HHHH
M**** "BBB@ HHHH **** "N$\?\ A+7/%=Q:QV5Q916=NI.V9V#,YZGA3Q@#
MOZUW=%)J^@&=H6C6^@:-;:;;8*0KAGQ@NW=C]36C113 **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** +MI_P >S_4_RJE5VT_X]G^I_E5*HCNP
M"BBBK **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH NK_P >'X'^
M=4JNK_QX?@?YU2J(=0"BBBK **** "BBB@ HHHH **** "BBB@ HHHH *\A^
M+NKF[U&QT&WW,T7[V10>"[<(/J!G_OJO6YIH[>"2>5@L<:EW8]@!DFOG1M7U
M'5/&4NO6=B]S<+<"X2$HT@0 _(#MYX  [=*SF]+ >\^'=(71?#=CIA )AA"R
M=P6/+?ADFO';0CP#\3_*D9A:))L)(ZPN.#R>V1SG^&MG_A8GCC_H78O_  "G
M_P#BJY+Q9J.M:[=1ZCJVD_9&1!%O2"2-6&21G<3SR:4FK: ?1=>3_&K_ )@?
M_;?_ -IUV7@+7/[>\)VLTD@:YA_<S^NY>A_$8/XUQOQJ_P"8'_VW_P#:=5)W
MB WQKI/VKX8>'M211YEE:P!C_L.BC_T+;^9KN_!6K?VUX1T^[9BTHC\J4GKO
M7Y2?QQG\:9INGIJWPZL=/DX6XTN*//H3$,'\#S7%_"'4'M;O5-!N/DD5O.5#
MU# [''I_=_(TEH_4#0^+VJF#1+32HB?,O)=SJIY*)VQ[L5_[YK$^(6E#1/ O
MAW3L8:%B'_WRN6_\>)J:Z_XJSXRI!@O:::<,"N0!'R<CWD./Q_"KWQF_Y!&F
M?]=V_P#0:3U38'3_  ]_Y$/2O^N;?^AM7F5Q_P EJ'_823^8KTWX>_\ (AZ5
M_P!<V_\ 0VKS*X_Y+4/^PDG\Q1+9 >YT445J 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% %VX_X]$_#^54JNW'_ !Z)^'\JI5$-@"BBBK ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "IK7_CX7\?Y5#4UK_P ?"_C_
M "I2V8#KS_7_ ("J]6+S_7_@*KTH[( HHHJ@"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** )[/_ %_X&DNO^/E_P_E2V?\ K_P-)=?\?+_A_*H^V!#1115@
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !5U/^0?^!_G5*KJ?\@_\#_.HGT I44458!1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5);_ .O3ZU'4EO\ Z]/K2>P$M[_K5_W:K59O
M?]:O^[5:E'8 HHHJ@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *\[\+> M4T/QC+J]S<6;V[^;A8G8O\QXX*@?K7HE%)JX
M!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KSO5? 6
MJ7WQ%C\0Q7%F+1;FWF*,[>9B,(#QMQGY3CFO1**35P"BBBF 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 36O_'POX_RKHK/_
M (]Q]37.VO\ Q\+^/\JZ*S_X]Q]36-3<#(U#[K?[]9U:.H?=;_?K.JZ>P!11
M15@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!=M/^/9_J?Y52J[
M:?\ 'L_U/\JI5$=V 44458!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% %U?^/#\#_.J575_P"/#\#_ #JE40Z@%%%%6 4444 %%%% !1110 44
M44 %%%% !1110!Q7Q0ULZ5X3>VC;$]^WD#GD)C+G\N/^!52^$FBK9>'I=4D4
M^=?/A2<<1J2!CTR=WUP*WO$W@K3_ !7/;RW]U>Q^0I5$@=0O)Y."IYX'Y"MO
M3[&#3-.M[&V!$-O&L:9ZX QD^_K46]ZX%FLKQ+HZZ_X>O--8@-*GR,?X7!RI
M_,"M6BJ \4^$VL/I_B.?2)\JEXIPK9&V1,G&.V1N_(5I_&K_ )@?_;?_ -IU
MT\WPVT:37SK,=Q?6]R9Q.%AD0('SG@%2>3[]ZT/%'@[3_%GV7[?-=1_9M^SR
M&49W;<YRI_NBHY7RV M^%_\ D4=%_P"O"#_T6M>5^*Y)O!7Q._M>VCS'<*9P
MG16W JX/K\V6_$?6O8K"SCT[3K6QA9FBMHDA0N<L0H &<=^*Q_$_@[3?%8MO
MM[W$;6^[8\#!3@XR#D'T%.2N@.2^$&FM]CU'6I_FEN9?*1CUP.6/XDC_ +YH
M^,W_ ""-,_Z[M_Z#7?Z-I-MH>DV^FVA<P0 A2Y!8Y)))P!W)JAXF\*6/BNV@
M@OI;F-87+J8&4$DC'.0:.7W; 5OA[_R(>E?]<V_]#:O+=1N8;/XPO<W$BQPQ
M:@KN['A0,9->U:-I4&AZ3;Z;;/(\, (5I2"QR2>< #OZ5S&K?##1-8U6YU"X
MNM06:X?>RQR(%!]LH:'%V0&I_P )UX8_Z#5K^9_PH_X3KPQ_T&K7\S_A7/?\
M*=\/?\_FI_\ ?V/_ .(H_P"%.^'O^?S4_P#O['_\11>0'<V&H6FJ6:7=C.D\
M#DA70\'!P:LUF:#H=MX=TF/3;1YGAC9F#3$%N3D] !^E:=4@"BBBF 4444 %
M%%% !1110 4444 %%%% !1110!=N/^/1/P_E5*KMQ_QZ)^'\JI5$-@"BBBK
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "IK7_CX7\?Y5#4UK_Q\
M+^/\J4MF Z\_U_X"J]6+S_7_ ("J]*.R ****H HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@">S_U_X&DNO^/E_P /Y4MG_K_P-)=?\?+_ (?RJ/M@0T44
M58!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 5=3_ )!_X'^=4JNI_P @_P# _P ZB?0"
ME1115@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !4EO_ *]/K4=26_\ KT^M)[ 2WO\
MK5_W:K59O?\ 6K_NU6I1V ****H HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@":U_X^%_'^5=%9_\ 'N/J:YVU_P"/
MA?Q_E716?_'N/J:QJ;@9&H?=;_?K.K1U#[K?[]9U73V ****L HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** +MI_Q[/]3_*J57;3_CV?ZG^54JB.
M[ ****L HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM;7DK[T>2OO1[1@8OV:;^Y^M'V:;^Y^M;7DK[T>2OO1[1@9]O&R0,K#!)/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!!-_K!]*GJ";_6#Z5/0 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 0'_CX_&IZ@/\ Q\?C4] !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110!!'_ *X_C4]01_ZX_C4] !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %,E_U9I],E_U9H 2'_5_C4E1
MP_ZO\:DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (YO]7^-+%_
MJQ23?ZO\:6+_ %8H ?1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %0'_ (^/QJ>H
M#_Q\?C0!/1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %-D_U;?2G4V3_ %;?2@!D
M'W#]:EJ*#[A^M2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% #)?]6:L6?\ Q[CZFJ\O^K-6+/\ X]Q]30!4
M7_CX?ZFIJA7_ (^'^IJ:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@"";_6#Z5/4$W^L'TJ>@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH @/_'Q^-3U ?^/C\:GH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** ((_P#7'\:GJ"/_ %Q_&IZ "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *9+_JS3Z9+_JS0 D/
M^K_&I*CA_P!7^-24 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $<
MW^K_ !I8O]6*2;_5_C2Q?ZL4 /HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H#_
M ,?'XU/4!_X^/QH GHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "FR?ZMOI3J;)_
MJV^E #(/N'ZU+44'W#]:EH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%)X']U_J"?R)H ^EKRX^R6-Q<[=_DQM)MSC.!G&:\=_X7_\ ]2S_ .3_ /\
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M@3685#/<22QD,J XX!ZDDX_/TKJ_B'\*K#POX?\ [7TN^N72)U2:*Z*L2&.
M5*@=#C@COUXP0#V[1]9T_7]-CU#3+E+BW?\ B7JI[@CJ#[&KLLL<,3RRNL<:
M*6=V. H'4D]A7@7P.UBXM_%%QI6]FM;J!I-F3A9%Q\V.G3(/X>E=W\8KK5%\
M)I8Z7:WDINI,7#V\3L$B4<ABHXR2HYZC- %'7/CAHVGW+P:98S:EL.#+Y@BC
M/T."3^51Z/\ '32;R[2'4]-GT]'./.603*IS_%P#CW /TK@OAY\-V\77-W)J
M,LUI96C!'" "1W/.T9'&!R21W'X-^)7P_@\%3V<ME=R3V=UN55FQYB,H&<D
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MI-(CT@WKQ1HTDGVGR]K,,[<;6[%3GWKHO WBR7QEHLFIOIHL8Q,8HU\_S"^
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M!] * .]HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@"";_6#Z5/4$W^L'TJ>@ HHHH **** "BBB@ HHHH ****
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M4_MZZ_YYP_D?\:/[>NO^></Y'_&LNBCV<.P<S-3^WKK_ )YP_D?\:/[>NO\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J _\
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M-;M?$6AVFJV;9BN$#;<\HW\2GW!R/PJ76?\ D!ZA_P!>TG_H)H Y'P%\1_\
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M%O<S0P3J[+A6'S '(Y/YUJ_#F3P=:^#M+MYKG1/[1F7,J2R1>:SLQP""<YY
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MNWUXS6OX[\8?\(5HD.I?8?MGFW*P>7YWEXRK-G.T_P!WICO7E/@__DO^H_\
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M&: +E%-BECFB26)UDC=0R.IR&!Z$'N*=0 4444 %%%% !1110 4444 %%%%
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MKA[;X>:W(A()MS'P>S$*?T)KDO@9HGV3P[>:Q(F)+V7RXR5_Y9IQD'W8L/\
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M_'Q^-3U ?^/C\:GH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** ,O4_\ CQG_  _]"%<[71:G_P >,_X?^A"N=KKH?"8U-PHH
MHK<S"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** 'Q2O!*LD;%67H:ZBQOH[V+(XD'WE]*Y2
MI()Y+:998SAA^M9U*:FO,N,K'9457L[N.\A$B'D?>7N#5BN)IIV9ON%%%%(
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MY%?3?^OW_P!D:NO^'7_)/=$_Z]A_,T >4_&G_DHNE?\ 7E#_ .C9*]C\8_\
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MFU>PZY$D^@:E#* 8Y+656#=,%2#FO'O@'_Q_ZY_URA_FU 'N%%%% 'SM\4O
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ME_U'_K]OOYO77?'7_D2++_L))_Z+EKD?!_\ R7_4?^OV^_F]==\=?^1(LO\
ML))_Z+EH Z'X8?\ )-]%_P"N3_\ H;5Y7XCU_6_BCXM_X1[1W\O34=@JA\(Z
MJ>99".HZ$#MQCD\^@^%)Y+;X'+/""98M-N73;UR-Y&*Y#X!VL;WVN794>;%%
M#$IQR Q8GG_@ _*@#9B^ ^B"SVS:MJ#W6/\ 6($5,_[I!/\ X]7'+<:_\'?%
MD=K+<&[TN7YO+!PD\>>6"Y^1Q_G(//T17DOQYA1O#^E3G.]+ID'T*$G_ -!%
M &C\7+2'7?AQ'JMIF9('CNHI$'6-QC.,9QA@?PJY\']7;5/ -O%(^Z2QD:V/
MKM&&7]& _"K'@:T36?A+I]C=DO%<6<D#9_NDLH_(?RK@O@C?/IWB76-!N699
M'3<$S\H>-BK#ZX;_ ,=^E %OXY7T]W?:)X?M0\DLA,QA3DNS'9'@>OWQ^-7?
M@/JGG:'JFEL26MKA9ER?X77&!]"A/_ JS;0'Q1^T'/)MQ#IC,2!@_P"J&S_T
M,C^55O W_%+_ !LU+1B%6&Y,T**APBC_ %J<?[JX_'% '2_'+5?LGA.TTY)"
MLE[<@LHZ-&@R<_\  BE7-)T4:%\#KRW90)I=*N+B;_>>-FY]P,#\*XSQYGQ7
M\9=.T-")88&B@=5&<#_62'W(4G/^[[5Z[XQ_Y$C7_P#L&W'_ *+:@#S?X!_\
M>.N?]=8?Y-6'\:[@VGQ#TNX50QBL8G /?$LAK<^ ?_'CKG_76'^35SWQU_Y'
M>R_[!J?^C): -C2/A=JGC-5\0>+-8G26[7>D"+EU4\KDMP@Y/R@=^HZ5SOCG
MX?WGP_EM-8TK4)I+;S JS9V2PR<D=.Q //X'MGZ+1%CC5$&%4  >@%>??&@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#\.8?!$][<'4/MT]RJHK^1Y?EJ"21C<<Y./RH R/^%%>&/\ G_U?_O\ 1?\
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M@TC[7]J\IG;S?+V9W,3TR?7UK>H **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 1S?ZO\ &EB_U8I)O]7^-+%_JQ0
M^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *@/\ Q\?C4]0'_CX_&@">BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH *;)_JV^E.ILG^K;Z4 ,@^X?K4M10?</UJ6@ HH
MHH Q?&/_ ")&O_\ 8-N/_1;5Y3\ _P#C_P!<_P"N4/\ -J]CUC3_ .UM$O\
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MEA^JT >S4444 >._'S_CQT/_ *ZS?R6O2/!W_(D:!_V#;?\ ]%K61X^\"?\
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MDB\/Z79*Q"3W+.X'?8O /_?7Z>U<W\";!)O$^H7K#)MK78OL78<_DI'XUO\
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M 8=<$$C&0>./=J "BO%/%?Q?\0:%XIU'2[6STQX+:8HC2Q2%B,=\.!^E8_\
MPO7Q/_SX:1_WYE_^.4 ?0=<Q\1?^2>ZW_P!>Q_F*W["=KK3K6X< /+"CL%Z
MD \5@?$7_DGNM_\ 7L?YB@#Y[^'7_)0M$_Z^1_(U]5U\J?#K_DH6B?\ 7R/Y
M&OJN@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH @
M/_'Q^-3U ?\ CX_&IZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KR#
MX[:XL6FZ?H<;CS)W-S,HZA%R%_ DM_WQ7K]?+_B'Q)I^L_$^36+P23Z5'=(
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MKG:ZZ'PF-3<****W,PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_P#R4F_^(K3\<:%=>)O!U_I%E)#'<7'E[&F)"#;(K') )Z*>U>._\**\3_\
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MV# T :]%%% !1110 4444 %%%8'C;5[K0?!NIZG9%!<P1@QEUR 2P7./;.:
M-QI8T=$9U5W)"*3@M@9./7BGU\Z_#+5]1UKXIV5WJ5Y-=3F*;YI6SCY#P!T
M]A7T50 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 03?ZP?2IZ@F_U@^E3T %%%%
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M_P D/_ME</X^\ S>!Y[(&]^VP72MME\GR\,I&5QN/8@Y_P *^H:Y7X@>$?\
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M* "BBB@ HHHH **** (#_P ?'XU/4!_X^/QJ>@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MAS[UZ)XQ_P"1(U__ +!MQ_Z+:@#(^&.N:CXA\&QW^JW'VBZ,\B%]BIP#QPH
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MXL;^V<@]4=#W!!_(@_C7T[X!\4GQ=X5AU&5%2Y1VAN%3[N]<<CV((..V?QH
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M"O&?A#72EMI5M!IUZ%XM&@6)L#^Z5X(Y/ .>O JW\3_^2;ZU_P!<D_\ 0UH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!!-_K!]*GJ";_6#Z5/0 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 0'_CX_&IZ@/_'Q
M^-3T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% &7J?\ QXS_ (?^A"N=KHM3_P"/&?\ #_T(5SM==#X3&IN%%%%;F84444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !110 20 ,DT *JL[!5!+$X '>NFTW35LTWOAIB.3Z>PJ/2M-
M^S+YTH_?$<#^Z/\ &M.N2K5OHC:$;:L****P- HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** (YO]7^-+%_JQ23?ZO\:6+_5B
M@!]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5 ?^/C\:GJ _P#'Q^- $]%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4V3_ %;?2G4V3_5M]* &0?</UJ6HH/N'ZU+0
M 4444 <+\6[^\TWP++<6%W/:SBXC D@D*-@GD9!S4WPJOKO4? -G<WUU/=3M
M)*#+/(78X<XY/-4?C1_R3V7_ *^8OYFIO@]_R3BQ_P"NLW_H9H \\U?QSJ?A
MSXL:C--?WUQ86TLH6R-R_E,3$0HVYP!N(/3BK_\ 9WQ9\7*+]KR32X'^:*)9
MS; #/3:OS?\ ?7/Z5B7EI%??'MK>=%>)M34LC#(8#!P1W'%?1= 'SY8>//&'
M@7Q(-,\22SW5NC 2QW#;V*'^-'ZGU[YQC@]/==1N V@W=Q;R'!MG>-U.#]TD
M$&O(?C]$JSZ!,!\[K.A^@,9'_H1KTRU);X>0LQ))TI22>_[J@#SWX):UJNK7
MNL+J.IWEXL<<107$[2!<ELXW$XKFOBQH&O:9>-?ZEK#7EA=WLS6MN9Y&\@$D
M@!6X& <<>E:_P#_X_P#7/^N4/\VK4^/7_($TC_KY?_T&@!OPZ\)>*8VT36)?
M$DKZ.8A(+'[1*1L*':NS[O!(JA\7-=U?3?'FFVUAJM]:P/:1,T4%PZ*Q,L@)
M(!P3@ ?A7IG@/_D0M"_Z\H_Y5Y'\:?\ DHNE?]>4/_HV2@#W6^O8-.L+B]NG
M"001M)(Q[*!DUXD?&OC?XA:U-9>%_P#0+*/G*D*RKV:1^2"<'A?UQFO;KVRM
MM1LI;.\A6:WE7;)&W1AZ5QZZQX!^'HN+2"[MK-Y)-TL$+/,^\#&"!N*\#O@?
MG0!PUSX'^*EE;?:8O$D]TZC/D1:G*6Z>C@*?SK3^%_Q(U+5M6_X1W7LRW15O
M(G*A7RH)*..,G //7@YSUK2O?C?X8MP1;07]VV."L01?Q+$']*\W\&ZH-7^-
M%KJ<41MQ=WDTOEAL[=RN2,\9ZT >H_&C_DGLO_7S%_,U-\'O^2<6/_76;_T,
MU#\:/^2>R_\ 7S%_,U-\'O\ DG%C_P!=9O\ T,T =Y1110!X%\6-/N/#/Q!L
MO$EFH5+ADG1A@ 31D;@1[C:??)]Z]STW4+?5M,MM0M'WV]S&LL9[X(SSZ'U%
M<C\5_#[:[X'N6A4&XL3]J3CDA0=XS_NDG'<@5E_!+6C?^$)M-D8F73IL+[1O
MEE_7?^0H [+Q=KJ^&_"NH:J=I>&/]T#WD)VJ/S(KR_X&:*TUQJ?B&Y4NW_'O
M#(^22Q^:0Y/?[O/N:F^.>N;X]-\.6Q9YI'^TS(F<XY5![Y.XX]AZBO2/!VA_
M\(YX2T[2V55EAB!FVG(\QOF?GOR30!SOQBU)M/\ A[<1HS*UY-';!E)!QDN1
MQV(0CZ&LSX&Z9';^$KK4"B>?=73+O'78H  /XEC^-2_'.-W\#6S*I(CU"-F/
MH-D@S^9'YU<^#4HD^'=NHQF.>53S_M9_K0!Z!1110!X[\>=*1K#2M850'25K
M5SGJ&!9?RVM^==G\,=5?5_A_IDLI)E@0V[$_[!VK_P".[:P?CE.L?@FUB/+2
MWR8^@1R3_+\ZO?!N)H_AU:LPXDGE9?<;L?S!H \ST'_DOTO_ &%KO^<E?1=?
M+=_HLOB+XK:II,,J127.J7*AW!(7#N>WTKK'^ VK!&*:S9,^#M#(X!/N><4
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ML8M2<N_VA0SR;689.8VP,EN]>D?$?POJ_B[1;;3-,GM((_/$L[7#,"0 0 ,
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M!'4 'K[^U=[\";6>+PMJ%Q(KK%-=_N]PP&VJ 2/7GC\/:N$\.?![Q'JUXO\
M:4']F60/SR2D%V'HJCO[G ^O2OH/2=+M-$TJVTVPB$5M;IL1?U)/J2<DGU-
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M#O[U!JGP,T&YRVG7UY8N>BMB5!^!P?\ QZN%\2_"#Q#HUV\NDQMJ-F&S&T1
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MD<B;@VU@.1D<'\* -FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH @F_U@^E3U!-_K!]*GH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** (#_Q\?C4]0'_ (^/QJ>@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH SKV&2>VFBB7<[8
MP,X[BLC^R+[_ )X?^/K_ (UT,?\ KC^-3UI"JX*R)E!,Y?\ LB^_YX?^/K_C
M1_9%]_SP_P#'U_QKJ**OV\B?9HY?^R+[_GA_X^O^-']D7W_/#_Q]?\:ZBBCV
M\@]FCE_[(OO^>'_CZ_XT?V1??\\/_'U_QKJ**/;R#V:.7_LB^_YX?^/K_C1_
M9%]_SP_\?7_&NHHH]O(/9HY?^R+[_GA_X^O^-']D7W_/#_Q]?\:ZBBCV\@]F
MCE_[(OO^>'_CZ_XT?V1??\\/_'U_QKJ**/;R#V:.7_LB^_YX?^/K_C1_9%]_
MSP_\?7_&NHHH]O(/9HY?^R+[_GA_X^O^-']D7W_/#_Q]?\:ZBBCV\@]FCE_[
M(OO^>'_CZ_XT?V1??\\/_'U_QKJ**/;R#V:.7_LB^_YX?^/K_C1_9%]_SP_\
M?7_&NHHH]O(/9HY?^R+[_GA_X^O^-']D7W_/#_Q]?\:ZBBCV\@]FCE_[(OO^
M>'_CZ_XT?V1??\\/_'U_QKJ**/;R#V:.7_LB^_YX?^/K_C1_9%]_SP_\?7_&
MNHHH]O(/9HY?^R+[_GA_X^O^-']D7W_/#_Q]?\:ZBBCV\@]FCE_[(OO^>'_C
MZ_XT?V1??\\/_'U_QKJ**/;R#V:.7_LB^_YX?^/K_C1_9%]_SP_\?7_&NHHH
M]O(/9HY?^R+[_GA_X^O^-']D7W_/#_Q]?\:ZBBCV\@]FCE_[(OO^>'_CZ_XT
M?V1??\\/_'U_QKJ**/;R#V:.7_LB^_YX?^/K_C1_9%]_SP_\?7_&NHHH]O(/
M9HY?^R+[_GA_X^O^-']D7W_/#_Q]?\:ZBBCV\@]FCE_[(OO^>'_CZ_XTATF]
M49,''^^O^-=33)?]6:/;R#V:.972KUAD0\?[Z_XTO]D7W_/#_P ?7_&NDA_U
M?XU)1[>0>S1R_P#9%]_SP_\ 'U_QH_LB^_YX?^/K_C7444>WD'LT<O\ V1??
M\\/_ !]?\:/[(OO^>'_CZ_XUU%%'MY![-'+_ -D7W_/#_P ?7_&C^R+[_GA_
MX^O^-=111[>0>S1R_P#9%]_SP_\ 'U_QH_LB^_YX?^/K_C7444>WD'LT<O\
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M7+KP_P"!KV[L7,=TY6&.1>J;C@D>^,X]#BO-OA;\.](\3:1/K.M>;<_OVB2
M2%%X"DLQ'))SCK^>>/9M>T6V\1:'=Z3>;A!<IM)7JI!!!'N" ?PKQNS\"?$?
MP5>S'PU<17$,I 8QO& X'0LDO /TYYZT >K6?A#PMHBFY@T;3X/*&\SR1@E
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M7X)+?+M_[["_]]]Z]SKP/QE\+?$;^*]2G\/V#2Z=>-YG%Q'&,L0S*06' <9
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!!
M-_K!]*GJ";_6#Z5/0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 0'_CX_&IZ@/\ Q\?C4] !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!!'_ *X_C4]01_ZX_C4] !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %,E_U9I],E_U9H 2'_5_C4E1P_ZO
M\:DH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (YO]7^-+%_JQ23
M?ZO\:6+_ %8H ?1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %0'_ (^/QJ>H#_Q\
M?C0!/1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %-D_U;?2G4V3_ %;?2@!D'W#]
M:EJ*#[A^M2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% #)?]6:L6?\ Q[CZFJ\O^K-6+/\ X]Q]30!47_CX
M?ZFIJA7_ (^'^IJ:@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@"";_6#Z5/4$W^L'TJ>@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH @/_'Q^-3U ?^/C\:GH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** &2_ZLU8L_P#CW'U-5Y?]6:L6?_'N/J:
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M20&OD>M&1ZUD?;A_</YT?;A_</YT<D@-?(]:,CUK(^W#^X?SH^W#^X?SHY)
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M20&OD>M&1ZUD?;A_</YT?;A_</YT<D@-?(]:,CUK(^W#^X?SH^W#^X?SHY)
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M20&OD>M&1ZUD?;A_</YT?;A_</YT<D@-?(]:,CUK(^W#^X?SH^W#^X?SHY)
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@"[:?\>[_4_RJE5VT_X]W^I_E5*HCNP"BBBK **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH NK_ ,@_\#_.J575_P"0?^!_G5*H
MAU ****L HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M"[<?\>B?A5*KMQ_QZ)^%4JB&P!1115@%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !4UK_P ?"_C_ "J&IK7_ (^%_'^5*6S 6\_U_P" J"I[S_7_
M ("H*4=D 44450!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $]I_KQ]#27
M7_'R_P"'\J6T_P!>/H:2Z_X^7_#^51]L"&BBBK **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "KJ?\@_\#_.J574_Y!_X'^=1/H!2HHHJP"BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ J2#_7I]:CJ2#_ %Z?6D]@);W_ %J_[M5JLWO^M7_=JM2CL 44450!1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $
MUK_Q\+^/\JZ*S_X]Q]37.VO_ !\+^/\ *NBL_P#CW'U-8U-P,C4/NM_OUG5H
MZA]UO]^LZJI[ %%%%: %%96M>(]*\/)"^J7)MUF)"-Y3N"1C/W0<=>]0:/XP
MT'7KQK33;\3SJAD*>4Z?*" >64#N*5T!N444CNL:,[L%51DL3@ >M,!:*Y/_
M (67X1_Z"_\ Y+2__$UU:,'16&<,,C((/Y'I233V 6BLK6?$FD>'XU;4[V.
ML,JG+.WT4<URTOQ>\.1OM6#4)1_>2)<?JP-#DD!WU%<GI?Q'\-:K.(%O3;2-
M]T72^6#_ ,"Z?F>]=90FGL 44R65((7ED.U$4LQQG ')KEO^%E^$?^@O_P"2
MTO\ \30VD!UE%<G_ ,++\(_]!?\ \EI?_B:DB^(OA.4X76$'^_#(O\UHYEW
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M9!Y;IC.<?> ST/2E=; :]%%07EY;Z?937EU*(K>%"\CGL!].OTI@3T5R]O\
M$3PM=7,5O!J9DFE<(B"VERS$X ^[ZUU%)-, HK%USQ7HOAX :C>HDIY$*?-(
M??:.0..IP*YIOB_X=64H+?467.-XB3'UY?/Z4.20'?T5A:%XQT/Q$0EA>+Y_
M_/O*-DG?H#UZ=LXK=HO< HHJKJ.HVFE6$M]?3"&VB +N03C)P.!R>2*8%JBN
M:L_'_A>_O8;2VU0//,X2-3#(NYCT&2H%=+233 ***P=6\9^']#OC9:CJ'DW
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MBN(6W12H'1L$94C(/-*Z8$E%%%, HHHH **** "BBB@ HHHH **** "BBB@
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M6 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!=N/^/1
M/PJE5VX_X]$_"J51#8 HHHJP"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ J:U_X^%_'^50U-:_\ 'POX_P J4MF MY_K_P !4%3WG^O_  %04H[(
M HHHJ@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** )[3_7CZ&DNO^/E_P /
MY4MI_KQ]#277_'R_X?RJ/M@0T4458!1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5=3_D
M'_@?YU2JZG_(/_ _SJ)] *5%%%6 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %20?Z]/
MK4=20?Z]/K2>P$M[_K5_W:K59O?]:O\ NU6I1V ****H HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@":U_X^%_'^5=
M%9_\>X^IKG;7_CX7\?Y5T5G_ ,>X^IK&IN!D:A]UO]^LZM'4/NM_OUG55/8
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M>"="CCV/<>XZ@^M?+S++9W;+G;-#)C([,#_B*4ER.Z ^G]5_Y!%[_P!<)/\
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M,?:(%/Y.!_XZ<?4U$/==F!ZQ7@WQ6_Y'>7_KA'_*O>:\&^*W_([R_P#7"/\
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M;B;RFDVY91M)XST/'6O-?A=_R/EG_P!<Y?\ T U!XW_M[^VK_P#M'^TO[/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!/:?Z\?0TEU_P ?+_A_*EM/]>/H:2Z_X^7_  _E
M4?; AHHHJP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ JZG_ "#_ ,#_ #JE5U/^0?\
M@?YU$^@%*BBBK **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "I(/]>GUJ.I(/]>GUI/8"
M6]_UJ_[M5JLWO^M7_=JM2CL 44450!1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP]_S^:G_ -_8_P#XBM;4O!D!\ 2>'+%Y'\M2]N\S#=OWE^2 !U)'3H:+2:U
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M4_\ K@O_ *%5OXU?\P/_ +;_ /M.JGP9_P"0OJ?_ %P7_P!"J]\:4)CT63C
M,P_/9_A5?8 ?\%_^//5_^ND7\FKK/B%_R(>J_P#7-?\ T-:X[X,7,0_M:U+8
MF/ER!?51N!/X$C\ZZ3XHZC#9^"KFW:15FNV2.)>[88,W'T'ZCVIKX /+_AI_
MR4'2_P#MK_Z*>O5_B7_R3[5/^V7_ *-2O*/AI_R4'2_^VO\ Z*>O5_B7_P D
M^U3_ +9?^C4I1^%@>6_"[_D?+/\ ZYR_^@&NV^,G_(O6'_7W_P"R-7$_"[_D
M?+/_ *YR_P#H!KMOC)_R+UA_U]_^R-27P,#)^#'_ !^ZO_USB_FU>O5Y!\&&
M O\ 5ES\QBC('T)_QKU^KA\('RM:_P#'Y!_UT7^=?2?BC_D4=:_Z\)__ $6U
M?-EK_P ?D'_71?YU])^*/^11UK_KPG_]%M4T]F!\^>%["/4_%&FV<V/*EN%#
M@C.5!R1^.,5], !5"J  !@ =J^8=#U#^R=>L+\@E;>=)& /50>1^6:^F[>XA
MNK>.XMY%EAD4,CH<A@>X-%,#Q#XM6$-GXM2>%0OVJW61P.[@E2?R _6N]^%5
MS)<>"(DD)(@GDC3/IPW_ +,:\\^*6K0ZGXN,=O*LD=I"(2R\C=DEN>^,X_"O
M1OA;:/:^![=W# SRR2@,,<9VC_T'-$?C8'C/BC_D;M:_Z_Y__1C5[+X@NC9_
M"-Y5SEM/ABX_VPJ?^S5XUXH_Y&[6O^O^?_T8U>TZU9/J'PH:WC4L_P#9T4@4
M=3L"OQ_WS2CU \9\*ZE8Z/XEL]1U&&2:WMV+E(U#,6VG:0"0.&P?PKU3_A<7
MA[_GSU/_ +]1_P#Q=>6>$X]*G\36<&LQA[&5BCYD* $@[22",#..]>S2_#GP
M;!"\TNEA(T4LS&YEP .2?O40O;0#PF[G@&JSW&GJ\4'GL]N&^\B[LKGW Q7T
M]97'VNPM[G@>;$LG!XY&:\EM[CX5W$RQ?V;=(6;:"QG.?P5R?TS7KD4<-E:)
M$F(X((PJY;A54>I]A505@/&_BEX273+T:W9H%M;J3;,BC&R0C.?HV"?8CW%<
M+86EQK&IVMC&^Z69UA0NW '0=>P]*Z#Q_P"*SXFUPB!S_9]KE+<8QO\ 5_QQ
MQ[ =\UAZEI&I:%/;B]@DMY)8UFB.>H/(((Z$>G45G*U] /HW0=%MO#^CV^G6
MH&V)?G?;@R-W8^YK+\9^+O\ A$;2UG^P_:_/D*;?-\O;@9S]TYJ'P#XK7Q-H
M@69O^)A:@)< _P ?'#_C@_B#[5?\3>%+'Q7;P07TMS&L+EU,#*"21CG(-;;K
M0#A/^%U?]2__ .3G_P!KI^M>.&\2_#G5YEL3:,)HK? FWY!()_A'8$?C6G_P
MIWP]_P _FI_]_8__ (BH?$7@:TT+X?:M;Z;)<S?,ERWG,&(V$9QM _AR?PJ/
M>Z@>;^#=8T_0?$<6HZC!+-%$C;%B0,P<C /) ]:],D^+WAR6)XY+'4V1P58&
M*/D'_@=>;>"+;2+WQ/;VFMQ"2UG5D7=(4 ?JN2"#SC'U(KURZ^'W@JRM);JY
MTT1P0H7=S<S84#DG[U*%[: >%PW8LM5CO+0,HAG$L08\C#9&?R%>J?&:Z/\
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5U/^0?\
M@?YU2JZG_(/_  /\ZB?0"E1115@%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4D'^O3Z
MU'4D'^O3ZTGL!+>_ZU?]VJU6;W_6K_NU6I1V ****H HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ?\ Q5?0=%+V: XGX::!J?A_1KRWU2V^SRR7&]5\Q7R-H&?E)]*[:BBK2LK
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M4LWME1RI_3T-7](\%^*_$]S FMRW\-A$>6O)&+*,<A%8]3P.F/RQ7N-%1[-
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M ,Z]<OH6ETRY@A4;FA9$4<<E2 *LT4U%(#P2P^'/BN'4;:632L(DJ,Q^T1'
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M2Z_X^7_#^5+:?Z\?0TEU_P ?+_A_*H^V!#1115@%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !5U/^0?^!_G5*KJ?\@_\#_.HGT I44458!1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5)!_KT^M1U)!_KT^M)[ 2WO\ K5_W:K59O?\ 6K_NU6I1V ****H HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"
M:U_X^%_'^5=%9_\ 'N/J:YVU_P"/A?Q_E716?_'N/J:QJ;@9&H?=;_?K.K1U
M#[K?[]9U53V ****T **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **CGN(
M;:(RW$T<48ZO(P4#\36>OB;0'8*FN::S'H!=QD_SI :E%(CK(BNC!E89# Y!
M'K2TP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M +MI_P >[_4_RJE5VT_X]W^I_E5*HCNP"BBBK **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ IDL4<\+PS1K)%(I5T<95@>""#U%/HH S8?#NAVT
MR30:-I\4J'<CI:HK*?4$#BM*BB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HK.E\0:+!-Y,VKV$<O38]R@;\B:N
MP7$-S$);>:.6,]'C8,#^(I 24444P"BBB@ HHHH **** "BF2RQP1F2618T'
M5G. /QK./B705D\LZWIH?IM-TF?RS2 U**;'(DL8DC=71N0RG(/XTZF 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!?C1LTP+GQ+F?7?%VC^&[=AP07/HSD#GZ*,_C5CXOPQV^@Z1!$H6..4HBCL
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ME59BD;AE7/)&7QD#UKV2J4D]@"BN%^('CFZ\*SV5K816TL\RM)()P3M7.%P
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M7ID%S#)#,B,&CE0JR_.W4'D5Y9XBTSQ#;?$"\U33]'OI3'=>;#(MJ[H2,8/
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M_P /Y4MI_KQ]#277_'R_X?RJ/M@0T4458!1110 4444 %%%% !1110 4444
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M8S7BVAZS?>&=:2ZMW:-XWVS1YX=0>5([]*]Q\?NLG@#4W4Y5HD(/MO6J333
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M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** +MI_Q[O\
M4_RJE5VT_P"/=_J?Y52J([L HHHJP"BBB@ HHHH **** "O)_C5_S _^V_\
M[3KUBO)_C5_S _\ MO\ ^TZB?P@8OA/3?[0^'/BE0"679(H'7,8+?CWXI_PB
MU#[-XIFLVQMNX"!DX.Y?F'UXW5T'P=C271-6CD4,CS*K ]P5KS"7S] UZXCB
M8>=:320Y//0E3_6L]K,#0G+>*O'K=UOK[:,'.$+8'/LO\JT/BC_R/EY_USB_
M] %2_"O3_MOC6.9E4K:0O,=PSS]T8]\MG\*;\4TV^.K@YSOBC/T^7']*/LW
M]/\ AI_R3[2_^VO_ *->O$O%'_(W:U_U_P __HQJ]M^&G_)/M+_[:_\ HUZ\
M3\5 KXNUH$$'[=,>?]\TY_"@/HC0?^1=TS_KTB_] %>3_&3_ )&*P_Z]/_9V
MKU?0"&\.:6000;2(@CO\@KR3XPS*_BFTB'6.S7)]R[?Y_&JG\('5?!W_ )%&
M[_Z_W_\ 1<=<]\9O^0OIG_7!O_0JZ'X._P#(HW?_ %_O_P"BXZY[XS?\A?3/
M^N#?^A4G\ &O\(K>&Z\+ZE!<0QS0O=8:.10RL-B]0>M</\1[2VL?&EU!:6\5
MO"J1D1PH$4909X'%=Y\&_P#D7K__ *^__9%KB?BC_P CY>?]<XO_ $ 4G\"
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MPI=RW,.H74[RQ^6R, J$9SDCU]#GN?6NMKFM#\=Z'XAO5LK*6;[2RE@DD1'
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MAA+JIAO]1N[?^SR=VRWDWM)[9'"C\<^PZU[/%%'!"D,2A(T4*JCH . *\!\
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M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "KJ?\ (/\
MP/\ .J574_Y!_P"!_G43Z 4J***L HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *D@_UZ
M?6HZD@_UZ?6D]@);W_6K_NU6JS>_ZU?]VJU*.P!1115 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 36O_ !\+^/\
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MG^54JNVG_'N_U/\ *J51'=@%%%%6 4444 %%%% !1110 5Y/\:O^8'_VW_\
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MJP'@WPI_Y'>+_KA)_*O>:**48V5@"BBBJ **** "BBB@ HHHH **** +J_\
M(/\ P/\ .J575_Y!_P"!_G5*HAU ****L HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110!/:?Z\?0TEU_P ?+_A_*EM/]>/H:2Z_X^7_  _E4?;
MAHHHJP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ JZG_ "#_ ,#_ #JE5U/^0?\ @?YU
M$^@%*BBBK **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "I(/]>GUJ.I(/]>GUI/8"6]_U
MJ_[M5JLWO^M7_=JM2CL 44450!1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% $UK_P ?"_C_ "KHK/\ X]Q]37.VO_'P
MOX_RKHK/_CW'U-8U-P,C4/NM_OUG5HZA]UO]^LZJI[ %%%%: %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!YMK/PE35=9N]0363!]IE:4Q_
M9=V"3D\[A6UX8^'FD^&KD7@>2[O ,++*  G^ZO8^_-=?14\JW ****H HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH NVG_'N_U/\ *J57;3_C
MW?ZG^54JB.[ ****L HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "I(/\ 7I]:CJ2#_7I]:3V
MEO?]:O\ NU6JS>_ZU?\ =JM2CL 44450!1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\.?]!.U_[^T>]V8$U%0_V_X<_P"@G:_]_:/[?\.?]!.U_P"_M'O=F!-14/\
M;_AS_H)VO_?VC^W_  Y_T$[7_O[1[W9@345#_;_AS_H)VO\ W]H_M_PY_P!!
M.U_[^T>]V8$U%0_V_P"'/^@G:_\ ?VC^W_#G_03M?^_M'O=F!-14/]O^'/\
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M/^@G:_\ ?VC^W_#G_03M?^_M'O=F!-14/]O^'/\ H)VO_?VC^W_#G_03M?\
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M\.?]!.U_[^T>]V8$U%0_V_X<_P"@G:_]_:/[?\.?]!.U_P"_M'O=F!-14/\
M;_AS_H)VO_?VC^W_  Y_T$[7_O[1[W9@345#_;_AS_H)VO\ W]H_M_PY_P!!
M.U_[^T>]V8$U%0_V_P"'/^@G:_\ ?VC^W_#G_03M?^_M'O=F!IVG_'N_U/\
M*J5$?B'0%C(35;,+W!F']34/]O\ AS_H)VO_ ']J4I)O1@345#_;_AS_ *"=
MK_W]H_M_PY_T$[7_ +^U7O=F!-14/]O^'/\ H)VO_?VC^W_#G_03M?\ O[1[
MW9@345#_ &_X<_Z"=K_W]H_M_P .?]!.U_[^T>]V8$U%0_V_X<_Z"=K_ -_:
M/[?\.?\ 03M?^_M'O=F!-14/]O\ AS_H)VO_ ']H_M_PY_T$[7_O[1[W9@34
M5#_;_AS_ *"=K_W]H_M_PY_T$[7_ +^T>]V8$U%0_P!O^'/^@G:_]_:/[?\
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M5#_;_AS_ *"=K_W]H_M_PY_T$[7_ +^T>]V8$U%0_P!O^'/^@G:_]_:/[?\
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MG_03M?\ O[1_;_AS_H)VO_?VCWNS FHJ'^W_  Y_T$[7_O[1_;_AS_H)VO\
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M)]1,#_*F?V_X<_Z"=K_W]H7,ELP)J*A_M_PY_P!!.U_[^T?V_P"'/^@G:_\
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M &_X<_Z"=K_W]H_M_P .?]!.U_[^T>]V8$U74_Y!_P"!_G69_;_AS_H)VO\
MW]J8>(= $&!JMGL]/.&?YYJ9*3Z, HJ'^W_#G_03M?\ O[1_;_AS_H)VO_?V
MJ][LP)J*A_M_PY_T$[7_ +^T?V_X<_Z"=K_W]H][LP)J*A_M_P .?]!.U_[^
MT?V_X<_Z"=K_ -_:/>[,":BH?[?\.?\ 03M?^_M']O\ AS_H)VO_ ']H][LP
M)J*A_M_PY_T$[7_O[1_;_AS_ *"=K_W]H][LP)J*A_M_PY_T$[7_ +^T?V_X
M<_Z"=K_W]H][LP)J*A_M_P .?]!.U_[^T?V_X<_Z"=K_ -_:/>[,":BH?[?\
M.?\ 03M?^_M']O\ AS_H)VO_ ']H][LP)J*A_M_PY_T$[7_O[1_;_AS_ *"=
MK_W]H][LP)J*A_M_PY_T$[7_ +^T?V_X<_Z"=K_W]H][LP)J*A_M_P .?]!.
MU_[^T?V_X<_Z"=K_ -_:/>[,":BH?[?\.?\ 03M?^_M']O\ AS_H)VO_ ']H
M][LP)J*A_M_PY_T$[7_O[1_;_AS_ *"=K_W]H][LP)J*A_M_PY_T$[7_ +^T
M?V_X<_Z"=K_W]H][LP)J*A_M_P .?]!.U_[^T?V_X<_Z"=K_ -_:/>[,":BH
M?[?\.?\ 03M?^_M']O\ AS_H)VO_ ']H][LP)J*A_M_PY_T$[7_O[1_;_AS_
M *"=K_W]H][LP)JD@_UZ?6JO]O\ AS_H)VO_ ']IR>(/#H<%=3M <\9EI/FM
MLP+M[_K5_P!VJU-E\0^'V8>9JEH3CM,#_*H_[?\ #G_03M?^_M$5)+9@345#
M_;_AS_H)VO\ W]H_M_PY_P!!.U_[^T_>[,":BH?[?\.?]!.U_P"_M']O^'/^
M@G:_]_:/>[,":BH?[?\ #G_03M?^_M']O^'/^@G:_P#?VCWNS FHJ'^W_#G_
M $$[7_O[1_;_ (<_Z"=K_P!_:/>[,":BH?[?\.?]!.U_[^T?V_X<_P"@G:_]
M_:/>[,":BH?[?\.?]!.U_P"_M']O^'/^@G:_]_:/>[,":BH?[?\ #G_03M?^
M_M']O^'/^@G:_P#?VCWNS FHJ'^W_#G_ $$[7_O[1_;_ (<_Z"=K_P!_:/>[
M,":BH?[?\.?]!.U_[^T?V_X<_P"@G:_]_:/>[,":BH?[?\.?]!.U_P"_M']O
M^'/^@G:_]_:/>[,":BH?[?\ #G_03M?^_M']O^'/^@G:_P#?VCWNS FHJ'^W
M_#G_ $$[7_O[1_;_ (<_Z"=K_P!_:/>[,":BH?[?\.?]!.U_[^T?V_X<_P"@
MG:_]_:/>[,":BH?[?\.?]!.U_P"_M']O^'/^@G:_]_:/>[,":BH?[?\ #G_0
M3M?^_M']O^'/^@G:_P#?VCWNS FHJ'^W_#G_ $$[7_O[1_;_ (<_Z"=K_P!_
M:/>[,":BH?[?\.?]!.U_[^T?V_X<_P"@G:_]_:/>[,":BH?[?\.?]!.U_P"_
MM']O^'/^@G:_]_:/>[,":BH?[?\ #G_03M?^_M']O^'/^@G:_P#?VCWNS FH
MJ'^W_#G_ $$[7_O[1_;_ (<_Z"=K_P!_:/>[,":BH?[?\.?]!.U_[^T?V_X<
M_P"@G:_]_:/>[,":BH?[?\.?]!.U_P"_M']O^'/^@G:_]_:/>[,":BH?[?\
M#G_03M?^_M']O^'/^@G:_P#?VCWNS FHJ'^W_#G_ $$[7_O[1_;_ (<_Z"=K
M_P!_:/>[,":BH?[?\.?]!.U_[^T?V_X<_P"@G:_]_:/>[,":BH?[?\.?]!.U
M_P"_M']O^'/^@G:_]_:/>[,":BH?[?\ #G_03M?^_M']O^'/^@G:_P#?VCWN
MS FHJ'^W_#G_ $$[7_O[1_;_ (<_Z"=K_P!_:/>[,":BH?[?\.?]!.U_[^T?
MV_X<_P"@G:_]_:/>[,":BH?[?\.?]!.U_P"_M']O^'/^@G:_]_:/>[,":BH?
M[?\ #G_03M?^_M']O^'/^@G:_P#?VCWNS FHJ'^W_#G_ $$[7_O[1_;_ (<_
MZ"=K_P!_:/>[,":BH?[?\.?]!.U_[^T?V_X<_P"@G:_]_:/>[,":BH?[?\.?
M]!.U_P"_M']O^'/^@G:_]_:/>[,":BH?[?\ #G_03M?^_M']O^'/^@G:_P#?
MVCWNS FHJ'^W_#G_ $$[7_O[1_;_ (<_Z"=K_P!_:/>[,":BH?[?\.?]!.U_
M[^T?V_X<_P"@G:_]_:/>[,":BH?[?\.?]!.U_P"_M']O^'/^@G:_]_:/>[,"
M:BH?[?\ #G_03M?^_M']O^'/^@G:_P#?VCWNS FHJ'^W_#G_ $$[7_O[1_;_
M (<_Z"=K_P!_:/>[,":BH?[?\.?]!.U_[^T?V_X<_P"@G:_]_:/>[,":BH?[
M?\.?]!.U_P"_M']O^'/^@G:_]_:/>[,":BH?[?\ #G_03M?^_M']O^'/^@G:
M_P#?VCWNS FHJ'^W_#G_ $$[7_O[1_;_ (<_Z"=K_P!_:/>[,":BH?[?\.?]
M!.U_[^T?V_X<_P"@G:_]_:/>[,":BH?[?\.?]!.U_P"_M']O^'/^@G:_]_:/
M>[,":BH?[?\ #G_03M?^_M']O^'/^@G:_P#?VCWNS FHJ'^W_#G_ $$[7_O[
M1_;_ (<_Z"=K_P!_:/>[,":BH?[?\.?]!.U_[^T?V_X<_P"@G:_]_:/>[,":
MBH?[?\.?]!.U_P"_M']O^'/^@G:_]_:/>[,":BH?[?\ #G_03M?^_M']O^'/
M^@G:_P#?VCWNS FHJ'^W_#G_ $$[7_O[1_;_ (<_Z"=K_P!_:/>[,":BH?[?
M\.?]!.U_[^T?V_X<_P"@G:_]_:/>[,":BH?[?\.?]!.U_P"_M']O^'/^@G:_
M]_:/>[,":BH?[?\ #G_03M?^_M']O^'/^@G:_P#?VCWNS FHJ'^W_#G_ $$[
M7_O[1_;_ (<_Z"=K_P!_:/>[,":BH?[?\.?]!.U_[^T?V_X<_P"@G:_]_:/>
M[,":BH?[?\.?]!.U_P"_M']O^'/^@G:_]_:/>[,"Y:_\?"_C_*NBL_\ CW'U
M-<S9:OHMU=+#9WT$L[9VHDF2>.?TKIK+_CW_ !-8U+WU0'!?$S_D6S_U]+_[
M-7D->O?$S_D6S_U]+_[-7D->I@OX7S$PHHHKL$%%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 =+X!_Y'&S_ -V3_P! ->[6?_'N
M/J:\)\ _\CC9_P"[)_Z :]VL_P#CW'U->3COXB]!HX+XF?\ (MG_ *^E_P#9
MJ\AKU[XF?\BV?^OI?_9J\AKJP7\+Y@PHHHKL$%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ML>,[S;.!CUSBAM+<#.HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MG*DK@PHHHKI$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M [35?"'B'P;:)>Z3J=S.I)$ZVRE-G P2,G<.O..,"K/A#QOXIU+5K6R:);Z
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M!)&<-P,X[&O4OAS_ ,B'IO\ VU_]&O7A^HZA<ZKJ$U]>2>9<3-N=L8]@/H
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M%<G\1O%6C^(+.S@TV>29XI69F\LJN,8[X/\ DTL+[2G+D<=P9UOPM_Y$U?\
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M[CZFO"? /_(XV?\ NR?^@&O=K/\ X]Q]37DX[^(O0:."^)G_ "+9_P"OI?\
MV:O(:]>^)G_(MG_KZ7_V:O(:ZL%_"^8,****[!!1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW_V=>H;1Z"C:/04?6ZW?\@L>7_\ "K#_ -!G_P EO_LZ/^%6'_H,_P#DM_\
M9UZAM'H*-H]!1];K=_R"QY?_ ,*L/_09_P#);_[.C_A5A_Z#/_DM_P#9UZAM
M'H*-H]!1];K=_P @L>7_ /"K#_T&?_);_P"SH_X58?\ H,_^2W_V=>H;1Z"C
M:/04?6ZW?\@L>7_\*L/_ $&?_);_ .SH_P"%6'_H,_\ DM_]G7J&T>@HVCT%
M'UNMW_(+'E__  JP_P#09_\ );_[.C_A5A_Z#/\ Y+?_ &=>H;1Z"C:/04?6
MZW?\@L>7_P#"K#_T&?\ R6_^SH_X58?^@S_Y+?\ V=>H;1Z"C:/04?6ZW?\
M(+'E_P#PJP_]!G_R6_\ LZ/^%6'_ *#/_DM_]G7J&T>@HVCT%'UNMW_(+'E_
M_"K#_P!!G_R6_P#LZ/\ A5A_Z#/_ )+?_9UZAM'H*-H]!1];K=_R"QY?_P *
ML/\ T&?_ "6_^SH_X58?^@S_ .2W_P!G7J&T>@HVCT%'UNMW_(+'E_\ PJP_
M]!G_ ,EO_LZ/^%6'_H,_^2W_ -G7J&T>@HVCT%'UNMW_ ""QY?\ \*L/_09_
M\EO_ +.C_A5A_P"@S_Y+?_9UZAM'H*-H]!1];K=_R"QY?_PJP_\ 09_\EO\
M[.C_ (58?^@S_P"2W_V=>H;1Z"C:/04?6ZW?\@L>7_\ "K#_ -!G_P EO_LZ
M/^%6'_H,_P#DM_\ 9UZAM'H*-H]!1];K=_R"QY?_ ,*L/_09_P#);_[.C_A5
MA_Z#/_DM_P#9UZAM'H*-H]!1];K=_P @L>7_ /"K#_T&?_);_P"SH_X58?\
MH,_^2W_V=>H;1Z"C:/04?6ZW?\@L>7_\*L/_ $&?_);_ .SH_P"%6'_H,_\
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M?_PJP_\ 09_\EO\ [.C_ (58?^@S_P"2W_V=>H;1Z"C:/04?6ZW?\@L>7_\
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M_P *L/\ T&?_ "6_^SH_X58?^@S_ .2W_P!G7J&T>@HVCT%'UNMW_(+'E_\
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M,_\ DM_]G7J&T>@HVCT%'UNMW_(+'E__  JP_P#09_\ );_[.C_A5A_Z#/\
MY+?_ &=>H;1Z"C:/04?6ZW?\@L>7_P#"K#_T&?\ R6_^SH_X58?^@S_Y+?\
MV=>H;1Z"C:/04?6ZW?\ (+'E_P#PJP_]!G_R6_\ LZ/^%6'_ *#/_DM_]G7J
M&T>@HVCT%'UNMW_(+'E__"K#_P!!G_R6_P#LZ/\ A5A_Z#/_ )+?_9UZAM'H
M*-H]!1];K=_R"QY?_P *L/\ T&?_ "6_^SH_X58?^@S_ .2W_P!G7J&T>@HV
MCT%'UNMW_(+'E_\ PJP_]!G_ ,EO_LZ/^%6'_H,_^2W_ -G7J&T>@HVCT%'U
MNMW_ ""QY?\ \*L/_09_\EO_ +.C_A5A_P"@S_Y+?_9UZAM'H*-H]!1];K=_
MR"QY?_PJP_\ 09_\EO\ [.C_ (58?^@S_P"2W_V=>H;1Z"C:/04?6ZW?\@L>
M7_\ "K#_ -!G_P EO_LZ/^%6'_H,_P#DM_\ 9UZAM'H*-H]!1];K=_R"QY?_
M ,*L/_09_P#);_[.C_A5A_Z#/_DM_P#9UZAM'H*-H]!1];K=_P @L>7_ /"K
M#_T&?_);_P"SH_X58?\ H,_^2W_V=>H;1Z"C:/04?6ZW?\@L>7_\*L/_ $&?
M_);_ .SH_P"%6'_H,_\ DM_]G7J&T>@HVCT%'UNMW_(+'E__  JP_P#09_\
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ME_\ PJP_]!G_ ,EO_LZ/^%6'_H,_^2W_ -G7J&T>@HVCT%'UNMW_ ""QY?\
M\*L/_09_\EO_ +.C_A5A_P"@S_Y+?_9UZAM'H*-H]!1];K=_R"QY?_PJP_\
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M9_\ );_[.C_A5A_Z#/\ Y+?_ &=>H;1Z"C:/04?6ZW?\@L>7_P#"K#_T&?\
MR6_^SH_X58?^@S_Y+?\ V=>H;1Z"C:/04?6ZW?\ (+'E_P#PJP_]!G_R6_\
MLZ/^%6'_ *#/_DM_]G7J&T>@HVCT%'UNMW_(+'E__"K#_P!!G_R6_P#LZ/\
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M_P!!G_R6_P#LZ/\ A5A_Z#/_ )+?_9UZAM'H*-H]!1];K=_R"QY?_P *L/\
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MW_V=>H;1Z"C:/04?6ZW?\@L>7_\ "K#_ -!G_P EO_LZ/^%6'_H,_P#DM_\
M9UZAM'H*-H]!1];K=_R"QY?_ ,*L/_09_P#);_[.C_A5A_Z#/_DM_P#9UZAM
M'H*-H]!1];K=_P @L>7_ /"K#_T&?_);_P"SH_X58?\ H,_^2W_V=>H;1Z"C
M:/04?6ZW?\@L>7_\*L/_ $&?_);_ .SH_P"%6'_H,_\ DM_]G7J&T>@HVCT%
M'UNMW_(+'E__  JP_P#09_\ );_[.C_A5A_Z#/\ Y+?_ &=>H;1Z"C:/04?6
MZW?\@L>7_P#"K#_T&?\ R6_^SH_X58?^@S_Y+?\ V=>H;1Z"C:/04?6ZW?\
M(+'E_P#PJP_]!G_R6_\ LZ/^%6'_ *#/_DM_]G7J&T>@HVCT%'UNMW_(+'E_
M_"K#_P!!G_R6_P#LZ/\ A5A_Z#/_ )+?_9UZAM'H*-H]!1];K=_R"QY?_P *
ML/\ T&?_ "6_^SH_X58?^@S_ .2W_P!G7J&T>@HVCT%'UNMW_(+'E_\ PJP_
M]!G_ ,EO_LZ/^%6'_H,_^2W_ -G7J&T>@HVCT%'UNMW_ ""QY?\ \*L/_09_
M\EO_ +.C_A5A_P"@S_Y+?_9UZAM'H*-H]!1];K=_R"QY?_PJP_\ 09_\EO\
M[.C_ (58?^@S_P"2W_V=>H;1Z"C:/04?6ZW?\@L>7_\ "K#_ -!G_P EO_LZ
M/^%6'_H,_P#DM_\ 9UZAM'H*-H]!1];K=_R"QY?_ ,*L/_09_P#);_[.C_A5
MA_Z#/_DM_P#9UZAM'H*-H]!1];K=_P @L>7_ /"K#_T&?_);_P"SH_X58?\
MH,_^2W_V=>H;1Z"C:/04?6ZW?\@L>7_\*L/_ $&?_);_ .SH_P"%6'_H,_\
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M?_PJP_\ 09_\EO\ [.C_ (58?^@S_P"2W_V=>H;1Z"C:/04?6ZW?\@L>7_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&DB#6Z3HTF ZM]W.>P-8?PF?PA8^%6GU6ZT>/499WW&\EB$BIP !NY"\9^M
M'IWAC7/^$D\.6>K_ &5[47(8B)VR0 Q4'.!UQG\:UZCMXH8;>..V2-(54!%C
M "@>P'&*J7VMZ3IC!=0U2RM&/07%PD9/YD4 7Z*JV6I6&I(SV%[;72+C+02J
MX&>G0U:H **H3ZWI-K?I87&J645Y(5"6\EPBR,6X "DY.>U)=:[I%C=+:W>J
MV-O<,0%BFN$1SGI@$Y[B@#0HJI>ZII^FVR7-_?6MK [!5EGF5%8D$@ DX)P"
M?PJ2.^M)K);R*Z@>U9=PG60%"/7=TQ0!/16=9>(-%U*?R;#5["ZEQG9!<H[?
MD#6@S!5+,0% R2>@H 6BLR#Q'H=S=_9(-9TZ6YW;?)CND9\YQC:#G-:= !11
M10 445!=WEKI]J]U>W,-M;IC?+,X1%R<#)/ Y('XT 3T54L-4T_58FETZ^M;
MR-&VL]O,L@!]"5)YJQ--%;P23SR)%#&I=Y'8*JJ!DDD] !WH ?15'3]:TK5F
M==.U.SO&C +BWG60KGIG:3BKU !16?9:[I&I7+VUAJMC=3HI9HH+A'90" 20
M#D#) _&M"@ HK*E\4>'X+@V\VNZ9'.IP8WNXPP/I@G-::.LB*Z,&1@"K*<@C
MU% #J*** "BBHKBY@M(3-<SQPQ#J\CA5'XF@"6BL9/%OAJ1PJ>(=)9CT"WL9
M/_H5:Z.LB*Z,&1@"K*<@CU% #J*KWM_9Z;;FXO[N"U@! ,D\@1<GH,DXJ'^V
MM*&G+J/]IV?V%B0MSYZ^4<$@X;..H/Y&@"]15:RU&QU*'SK"\M[J+.-\$JNO
MY@U.[K&C.[!44$LS'  ]30 ZBLJ+Q1X?GN!;PZ[IDD[' C2[C+$^F <UJT %
M%%% !114%Y?6FGVYGO;J"VA!P9)I BC\3Q0!/16?8Z[I&J2-'I^JV-VZC)6W
MN$D(_ $UH4 %%9=WXDT+3[I[6]UK3;:X3&^*:Z1'7(R,@G(X(/XUJ4 %%5+_
M %33]*B674;ZULXW;:KW$RQ@GT!8CFEM=2L+ZS-Y:7MM<6HSF:*5708Z_,#C
MB@"U15+3]8TO5O,_LW4K.\\K'F?9IUDV9SC.TG&<'\JKMXG\/I.(&UW3%F8X
M$9NXPQ.<8QGUH U:Q?%OB#_A%O#%YK/V7[5]FV?N?,V;MSJO7!Q][/3M6RK!
ME#*05(R".AKC/BU_R3'6/^V/_HY* -#P1XL_X3+06U3[%]CQ.T7E^;YG0 YS
M@>OI725YO\$?^1"?_K]D_P#05KTB@ HK*F\3:!;3^1/KFFQ39QY;W<:M^1.:
MT8+B&Z@6:WFCFB<95XV#*WT(H DHHK/L==TC4VD6PU6QNS&NYQ!<))M'J<'@
M4 :%<!XB^)G]@>-;?P[_ &1Y_G-$OVC[3MQO./N[#T^M=?:Z[I%]=-:VFJV-
MQ<*2&BAN$=QCKD Y[&L#6M&\#77BB&[U>6Q76E:,QK+?F-\@_)A-XSS[<T =
M?145S<P6=N]Q=3QP01C+R2N%51ZDG@5%8:E8:I T^GWMM=PJVPR6\JR*&P#C
M()YP1Q[T 6J*RO\ A)_#_P!H^S_V[IGGYQY?VN/=GTQG-:BL&4,I!4C((Z&@
M!:**I7^L:7I>W^T-2L[3=T^T3K'GKZD>A_*@"[15>UO[.^MOM-I=P7%O_P ]
M8I Z_F#BH=/UK2M69UT[4[.\:, N+>=9"N>F=I.* +U%%% !116;>>(M$T^;
MR;W6-/MI?[DURB-^1- &E15*QUC2]4)&GZE9W9 R1;SK)@=,\$U=H **9)+'
M#&TDKK&BC)9C@#\:SK?Q)H5W<BVMM:TZ:X)P(H[I&8GTP#F@#E?&GQ+_ .$0
M\1VND_V1]K^T0)+YOVGR]NYV7&-IS]W/7O7?5X%\:?\ DHNE?]>4/_HV2O?:
M "BH+J\M;&'SKNYAMXLXWRN$7/IDU6L==TC5)&CT_5;&[=1DK;W"2$?@": .
M0B^)GF?$4^$_[(QB=H?M7VGT4MG9L]O6NE\6^(/^$6\,7FL_9?M7V;9^Y\S9
MNW.J]<''WL].U>-VW_)Q+?\ 7\__ *+->U>(K71[W0KFWUYH5TQ]OG&:;RDX
M8%<MD8^8+WH S_!'BS_A,M!;5/L7V/$[1>7YOF= #G.!Z^E7=>\3Z1X;@234
M[M(FD.(H@<R2'./E7J>O7H*A\,VGAS2]%=/#LMM_9JR,[O#<^<@; W98L<<
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MTV*;./+>[C5OR)S6C!<0W4"S6\T<T3C*O&P96^A% $E%-=UC1G=@J*"69C@
M>IJGI^M:5JS.NG:G9WC1@%Q;SK(5STSM)Q0!>HHK/;7M&34?[/?5K!;W<$^S
M&Y02;CT&W.<^U &A14%W>6NGVKW5[<PVUNF-\LSA$7)P,D\#D@?C4":UI4NG
MG4(]3LGLE)!N%G4QC'7YLXH O5POC3XHZ7X0O/[/%O)?:@%#/"CA%C!&1N;G
M!(P< 'C\,]-_PDV@?9/M?]N:;]FWA/.^UQ[-QR0-V<9X/'L:\#BGTC5?C=-/
MJEU92Z4][*[33R*86558IDD[2#A1Z'WH ],\$_%1?&.N?V9_8S6C^4TOF?:1
M( !C_9'K7HE96D3>'[QY)]&DTR=XQL>2S:-BH/."5Z9QT]JT9[B&U@::XFCA
MB099Y&"JOU)H DHK&_X2WPUYGE_\)#I._.-OVV/.?3[U:T<L<T:R1.LB,,AE
M.0?QH ?115>\O[/3H?.O;N"VB_OSR!!^9- %BBL^RU[1]2E$5CJUA=2'.$@N
M4<\=> :T* "BBLNZ\3:!97#07>N:;!,IPT<MW&K#Z@G- &I13(Y8YHUDB=9$
M89#*<@_C3Z "BBJM_J5AI<"SZA>VUI"S;!)<2K&I;!.,DCG /'M0!2C\3Z1/
MXA.A6]VDVH*C/)''\PC"D ACV.3TZUKU\[_#35-/L/B;J%W>7UM;VSQSA9II
ME1#EP1AB<<U] V=]::C;+<V-U!=0,2!+!('4XZ\CB@">BHKBY@M(3-<SQPQ#
MJ\CA5'XFLM/%OAJ1PJ>(=)9CT"WL9/\ Z%0!LT4U'61%=&#(P!5E.01ZBJ]_
MJ5AI<"SZA>VUI"S;!)<2K&I;!.,DCG /'M0!:HJC+K6E0V"7\NIV4=G(,I</
M.HC;Z-G!J>SOK34+<3V5U!<PDX$D,@=3^(XH GHJ*XN8+2$S7,\<,0ZO(X51
M^)JI8Z[I&J2-'I^JV-VZC)6WN$D(_ $T :%%4)=;TF#45T^75+*.^8@+;/<(
M)"3T 7.>:OT %%0W5W;65NT]W<16\*\M)*X11]2>*J67B#1=2G\FPU>PNI<9
MV07*.WY T :-5K_4+/2[.2\O[J*VMXQ\TDK!0/\ Z_M5FO)?C?JNG7'A>WL(
M+^UEO(=00R6Z3*TB 1R DJ#D=1^8H ],T?5K77=*@U*Q9FMIP3&S+M) )&<?
MA5ZN!^&6O:,G@C1=/?5K!;[:R?9C<H)-Q=L#;G.?:N^H **R9/%/AZ*7RI->
MTM)"<;&O(P?RS6G'+'-&LD3K(C#(93D'\: 'T444 %%%4K[6-+TL@:AJ5G:$
MC(%Q.L>1TSR10!=HJG8ZKIVIJ6T_4+6[4=3;S+(!^1-7* "BL^37=(BU$:=)
MJMBE\6"BV:X02Y(R!MSG)!'YUH4 %%4]0U?3=)6-M1U&TLQ(2$-Q,L>['7&X
MC-6(+B&ZMX[BWFCFAD4,DD;!E8'N"."* )**:[K&C.[!44$LS'  ]366/%/A
MYIQ NO:692<",7D>X_AF@#6KB_'_ (__ .$&_L[_ (EGVW[9YG_+?RMFS;_L
MG.=WZ5V:L&4,I!4C((Z&O%_C_P#\R]_V\_\ M*@#US1]0_M;1+#4O*\K[7;1
MS^7NW;-ZAL9P,XSUQ5VN?\,7=M9> ="GN[B*WA73;<M)*X11^Z7J3Q6A9:]H
M^I2B*QU:PNI#G"07*.>.O - &A1110 4444 %%95QXH\/VDQAN==TR&4=4DN
MXU(_ FK=EJ5AJ2,]A>VUTBXRT$JN!GIT- %JBBJ]Y?V>G0^=>W<%M%_?GD"#
M\R: +%%9]EKVCZE*(K'5K"ZD.<)!<HYXZ\ UH4 %%%% !7FWB?XRZ+HEQ)::
M;"VIW*'#,CA8@?\ >YS^ Q[U6^,_BZ72-*AT.QFV7-\I:<J2&2'..#GC<<CZ
M!J/A=\.;+3M)M];U6V6;4;A?,B25<B!#C;\I_B[Y[9P/4@'-'XS>,'_?Q:#9
M_92<@FWF/'^]NQ^.*Z+PO\;-/U*XCM-<M1I\C<"Y5]T.??/*^G?\*]5KRKXM
M^ [2\T6XU_3;6.*^MB9;GRUQYZ?Q,>V1][/H#[4 >J*P90RD%2,@CH:\^\=_
M$_\ X0K6X=-_L?[9YMLL_F?:?+QEF7&-A_N]<]Z/A#JNJWOA=[+5;6Z1K%@D
M,\Z,/,0YP 2.=N,>PQ7GWQU_Y'>R_P"P:G_HR6@#:_X7_P#]2S_Y/_\ VNI(
M?C["TF)_#DB)CK'>!S^10?SKU&RT?2_L%O\ \2VS_P!4O_+!?0>U)>>&-!U"
M'RKO1K"5.VZW7(^AQD?A0!F>%/'VA>+P8["9X[M5W/:SKM<#.,CLP^A/49Q7
M45\[?$+PA+\/M=L]9T&:6"TDDS 0V6MY!SMR>2",]>V0<]_;?"'B!/$_A>RU
M12/,D3;,HZ+(.&'YT ;E07EY;Z?937EU*L5O ADD=NBJ!DFLOQ5XIL/"&C_V
MEJ E:-I!%&D2Y9W() ]!PIY->#>*O&'B3X@BX^RVDT.CVB&62&$G8%'.Z5N
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MC3Q1_P (AX>?5?L?VO;(L?E>;Y?WN^<'^57;KQ)H5C,T-WK6G6\JD@I+=(C
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MGIMN;B_NX+6 $ R3R!%R>@R3BBWO[.[LA>VUW!-:$$B>.0,A )!.X''&#^5
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M^)/^16U?_KRF_P#0#7D7P#_X_P#7/^N4/\VH A^/7_(<TC_KV?\ ]"J_X?\
MA?\ \)GIG_"1^)M3O/MNHCSHU@VJ$4YP3E3D$8( P *H?'K_ )#FD?\ 7L__
M *%7L^B(L>@:<BC"K:Q #VVB@"CX1\,6OA'04TNU<R@2/(\I7:9&)ZD>H&T?
M\!K=HHH \]^-'_)/9?\ KYB_F:\X\#>&M7^(&G6VGW=]):^'=*)3$0YE=F+D
M#/!;YNIS@;>.37H_QH_Y)[+_ -?,7\S5GX06\</PVTZ1!AIWFD?W/F,O\E%
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M Q/(Q_M'O7#?##X?:+XOT2\N]3:Z$L-QY:^3(%&-H/.0?6O6?B+_ ,D]UO\
MZ]C_ #%<A\!_^17U+_K]_P#9%H H_%/P#HVGZ%J/B. W/VYI8^&D!098+TQG
MI[UG_#KX9Z#XH\*)J>H/>"=IG3$4H5<#IQM-=Q\8?^2<7W_76'_T,5#\%_\
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MQ3J.4[D$#J/0^_-=A\&O$5UK7A>>TO99)IK"4(LCG),;#*C/M@CZ8KK?&/\
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M2Q*;73YD'RL2#SDYYZY["@#Z:HJ.!G>WC>1=KLH+#&,''-24 <[XW\4IX/\
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MP,X')_$Y) /6:G\#;*&W,^@ZM>Q7T7SP_:&4@L.1\RA2O..><5K_  4B6/P
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MVX)7/3)"GI[4 :'C?X5GPEIO]N>']1O'6W91(CD>:NX[=RLH'<@8QWZUZ?\
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M[ :::0Q*PS]]COD_FGYG\0#F/&__ "74_P#7[9_^@15[]K/_ " ]0_Z]I/\
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MA ?R'N: /"O!_P#R7_4?^OV^_F]==\=?^1(LO^PDG_HN6N1\'_\ )?\ 4?\
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M7_7[:?\ HJ.O0?@]_P DXL?^NLW_ *&:\^U__DXJ+_K]M/\ T5'0!Z3\6O\
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M >*_ ?\ Y&G4O^O+_P!G6O?:\"^ _P#R-.I?]>7_ +.M>^T ?/?C[_DN%O\
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M]HSG/.<YZT >$_#_ %^Z^'_C.Z\.ZVPAM99?+FR"1')CY''^RPQSZ$'M6_\
M&#QC+-.GA#227EE*_:RF<DDC;$/KP3]0/6I?CKI>F?V;8:HS+'J7F>2H"\S)
M@DY_W?7WQWKG_@K::=J/BR\O-0D:;4X8_-MUEYR2?GDR>2PR/^^B>O0 ]/\
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M!UKQ'H5U>W/AW1?[2E=%CE/V62;RQDD?<(QG'?TKNO\ A8OQ._Z$W_RF7/\
M\50!CV.HZY\(?%T6EW]RUSHTQ#,!NV%">70'HPYR!UZ>AKZ 5@RAE(*D9!'0
MU\W^+[CQSXU:S;4?"=W$UJ'"&VTZ=2V[;G.[/]WCZFO>/"0NAX/T=;V.2.Z2
MSB2595(<,% ^8'G/'.: -FLSQ#K4'AW0+W5KE2T=M'NV XW,3A5SVR2!^-:=
M>:_'"=HO D*#I-?1H?IM=O\ V6@#A-%T7Q!\7M:N-2U.]>WTR%]I*Y*1G'"1
MKTSC&3[Y.2:ZK4_@1I36;_V3JEY'= ?+]J*NA]CM4$?7FN2\&^*_&^A^'8K7
M0_#'VRQ9WD6X^PSR;R3@_,K '&,?A6__ ,+%^)W_ $)O_E,N?_BJ )/A?XQU
M:S\0R>#?$#R/(I=+=YB2Z.O)0D]5(!(^@ X(QK?'7_D2++_L))_Z+EKSZ&V\
M8:I\1K+Q#=^'+^UF>\@>7RK&9(U"E5/7) ('.3W->@_'7_D2++_L))_Z+EH
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M!'Q/>ZA;WNB7LS3+:HLMNSMEE4G!7U(SC'IGZ5ZXRAE*L 5(P0>AKP/X#_\
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M,;QHO-E<@$$,<@D<],@#TKI/#6DMX3\*PZ?=7XNH[)'/G^24.S);E<MT!Q^
MH \;^%VOIX)\5ZCHFO$V27&V-GEX6.5"<9ST4AC\W3IVY'NUSJEA9V/VVYO;
M>*UQGSGD 0_0]#TK@]3T#P3\4W>[L+__ $Z)5WSVV5?;R%#JPYZ>@/ YQQ6+
M:_ 2SCN5:ZUZ:: ,"8X[8(Q'INW'\\4 >?>-O$\7BSQV+^W#"UC:."#=U**W
M7';))./>O>_B+_R3W6_^O8_S%>,>,M#L+7XH:;H&CVRQPQ&V@\L,22S-N)8G
MG.&!S7O7B/1_[?\ #U]I7G^1]JC\OS=F[;[XR,_G0!Y[\!_^17U+_K]_]D6N
M1^)__)7K7_MV_G7K/@/P7_PA.EW-E_:'VWSYO-W^3Y>WY0,8W'TK(\4?##_A
M)/%\6O?VQ]G\OR_W'V;?G8?[V\=?I0!Z%7F'QU_Y$BR_["2?^BY:]/KF/'?@
M_P#X371(=-^W?8_*N5G\SR?,SA67&-P_O=<]J *7P\M8[[X5:;:39\J>VEB?
M:<'#,X./SKRSP#JA^'?C^]TO7=UO#,/L\DC#"JP;*2?[I&>?]K->X>%]#_X1
MOPW9:1]H^T?9E*^;LV;LL3TR<=?6N2U+3? _Q58_9;X/J$$>1/;@I(J=@RL/
MF7)'49'8C)H [I]2L$L?MSWMLMIC/V@RJ(\>N[..U?-?Q/\ %EOXK\5&6R)-
MC:QB"%SQYG)+/CMDG'T ^E=Y%\ [47&Z;Q!,\']Q+4*W_?18C]*Y#XFZ!IVD
M^*=+\/Z%;","V0$;BS/*[L,L3U.-OZ#M0!]%67_'A;?]<E_D*GIJ(L<:H@PJ
M@ #T IU ')_$G09O$7@>^M+5&DNH]L\**,EF4Y('N1N ]\5P/P=\;6-A9OX;
MU6=;602L]M)*=JG/5"3T.>1ZY(ZXS[57">*OA1H/B:\FOPTUC?2\O)!@H[>K
M*>I^A'K0!U^H:MI^E637E_>P6]N%W>9(X (]O4^PZUX!;R3_ !+^+J7EO#(M
MDDR.>.4@C(Y/H6Q[X+=\5U%M\ K=9<W7B&66/'W8K4(?S+-_*O2_#OAC2O"V
MG_8]*MA&K',DC'+R'U9N_P#(=J .0^-EG+=> EDC5B+:\CF?"DX7:R_ARPJ'
MX0>*-)?P9:Z1+>P07MH\BF*60*SAG9PR@]?O8XST]Z](N;:"\M9;:YB2:"52
MDD;C*L#U!%>5ZK\"-+N9_,TS5KBR0\F.6(3 ?0Y4X^N: -CXE^.-+TKPQ?Z?
M;WL4VI7<1@2*%PQ0-PS,1]W S[YQ]1R'P#_X_P#7/^N4/\VKL/#/PCT3P\_V
MJ262^OPN$FF4!(VQC<J#OSW)QQC'6K'@'X=_\(/<7TO]J?;?M2HN/L_E[=I/
M^T<]: .!^/7_ "'-(_Z]G_\ 0J]IT;_D!Z?_ ->T?_H(KD?'OPX_X3>^L[G^
MUOL7V>,Q[?L_F;LG.<[ABNTL[?[)8V]MNW^3&L>[&,X&,XH GHHHH \]^-'_
M "3V7_KYB_F:Y[X,^,["+2F\.7\\=O/'(SVS2$*LBMR5R?X@<_4'V-=#\:/^
M2>R_]?,7\S7)>"/AYH_C+X?VT]V9;>\CGE5;B C)7/W6!X(Y^OO0!ZQX@\3:
M5X9L'NM2NXXB%)CB+?/*1V4=37COPETZ\\1>/KWQ5= B.!I)&?'#32@C:/HK
M,?;Y?45M6'P$L8K@-J&NSW$(_@AMQ$3^)9OY5ZGI>EV.BZ=%8:=;);VL0PD:
M=O<D\D^YYH \B^/_ /S+W_;S_P"TJ]/\'?\ (D:!_P!@VW_]%K6+X_\  '_"
M<_V=_P 3/[%]C\S_ )8>;OW[?]H8QM_6NGT?3_[)T2PTWS?-^R6T<'F;=N_8
MH7.,G&<=,T <-\9?#\^L>$8[NUC:2;3Y?-9%&28R,-COQ\I^@-5/A-XZT^\\
M/V^A7US';W]HNR(2L%$R9XVD]2!QCT&?7'J->;^(O@SH.L7$UU8SS:;<2MN(
MC4/%D]<)QCGT('M0!V>N^(M*\-Z?)>:G=QPHJY6/<-\A]%7J3_GI7B7P[M;S
MQC\49_$<T+);PS/=2$=%9LA$SQ_]<*?6NCL?@)8Q3!K[79[B,$'9#;B(D=QD
MLU>H:/HVGZ!IL>GZ9;);VZ?PKU8]R3U)]S0!YE\>O^0)I'_7R_\ Z#6G\)O&
M=AJ?ANUT6>>.'4K)?*$3$+YJ#[I7UXX(]L]ZS/CU_P @32/^OE__ $&H=*^%
MFC^+/!&C:@)I;'4&M0&EB 99#T!93U(QV(H [KQKXST_PKHUR[W<0U$Q'[-;
MA@79SP#CL ><GCBO/_@7H-P)=0\13AA'(GV6$MG]Y\P9S] 0HSZY]*OZ3\"=
M*M;D2ZIJL]_&I!$4<?D*WLQRQQ]"#[UZI;6T%G:Q6UM$D,$2A(XT&%4#H *
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MW4;V&" *64LPR^.RCJQZ<#UKF?%WPOT7Q9<M>EI+*_; :>$ A\?WEZ$].>O
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M5EQC</[W7/:@"E\)?^28Z/\ ]MO_ $<]:7CK0G\1^#=1TZ($SM'OA .,NI#
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M0T/POX-T\P65_:27$@_?74DR;Y#Z=>%]!_,\UP__  H#_J9O_)#_ .V4?\*
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M7,#1J3T5L?*?P.#^%<?_ ,*P_P"+A?\ "5_VQ_R\^?\ 9?LWMC&_?^N*]"H
M^5[3Q5<Z7X%U?PLXD5[BZ1AVV*,^8,_5$&/=OQ^@_ &B_P!@>"-,LG4K,8O.
MF!ZAW^8C\,X_"N5U3X-6FI>,)=;.J;+::Z%Q+9FVW;N077=N'WCGMQGO7I]
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MMT6_1XKF($17,. ZCT.>JY['\,9K@X_@,L<S8\33"W8_-&MKABOH3OQ^GX4
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M2=A#+*WW8Y$+;2>/NG<>>G(/3D>\W.J6%G8_;;F]MXK7&?.>0!#]#T/2N?\
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MX(\)_P#"&Z"VE_;?MF9VE\SRO+Z@#&,GT]:@\:^ M.\;6\ NI9+:ZM\^5/$
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M#.:\=^&7B9? WB>_T370+6&X<1R2.#^YE3(&?]DY(S]#P,FO>=+MC9:396K
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M^'GTK[9]DW2+)YOE>9]WMC(_G1X+\+_\(AX>32OMGVO;(TGF^5Y?WNV,G^=
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M!.E6TZR:GJL]\@))CCB\D,,< \D_D17JEM;06=K%;6T20P1*$CC0850.@ H
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M7%^ / '_  @W]H_\3/[;]L\O_EAY6S9N_P!HYSN_2NTH \!MO^3B6_Z_G_\
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M1DD[3P*N44 >,?!31-6TK6-4?4=+O;-'MU"-<6[QACNZ#<!FO9Z** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#DOB#X+7QIH26T<RP7MN_F6\CYVY(
MP5;'8\<CD8'T/FFEZE\4O!5N-,71)KZVB&V)7MVN%0=1M:,YQ[$\=.*]XHH
M\(OK;XF?$7RK&_L#IVGE]SB2(V\8QT+!B7;V'/8^]>M^$O#%KX2\/PZ7;-YA
M4EY9MNTRR'JQ&3CH!CT K<HH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ JMJ-A!JFFW-A=*6@N8FBD .#M88./>K-% '@B>%O'WPX
MU6XE\/H]_8R=3"GF+(!G&Z/[P8>H]>#UJ[<>+?BOK<)LK;P])8-)\GFQV4D3
M#/\ M2DA?KQCU%>W44 ><_#7X<2>%'DU7598YM4GCVA5Y$ )RPW=V/&3VP0"
M0:]&HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M[44 <YX)\(VW@W01I\4@FG=S)//MV^8Q]LG  P /J>YKHZ** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@!DO^K-6+/_ (]Q]35>7_5FK%G_ ,>X^IH J+_Q\/\ 4U-4
M*_\ 'P_U-34 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !574=1M=)TZ>_OI?*M8%WR/
MM+;1] "35JN8^(O_ "3W6_\ KV/\Q0!H:!XGT?Q/!--H]Y]ICA8)(?*=,$C/
M\0%:]>1_ 7_D":O_ -?*?^@UZY0 4444 %%%% !1110 4444 %%%% !1110
M4444 %4M6U:QT+3)M2U*?R+2';YDFQFQE@HX4$]2.U7:XOXM?\DQUC_MC_Z.
M2@#H-"\1:5XFL7O=(NOM-NDAB9_+9,, "1A@#T8?G6I7F'P*_P"1(O?^PD__
M *+BKT^@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** (+R[@T^QN+VZ?R[>WC:65\$[549)P.3P.U9N@>*M%\41SOHU[]I6
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MQTSCTI]>&_!G4[[5_&VK7FHW4MS</9?-)*V3_K%X'H/8<"@#W*BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L#2O&WA[6]6ETO3M0\
MZ]B#%XO)D7 4X/+*!U]ZWZ\!^%/_ "5C4O\ KG<?^C!0![]1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;F"$F*"Y=%)+-DX!Q7N=?/?QA_Y*7:?]>\/_ *&U 'M7C'_D2-?_ .P;<?\
MHMJ\W^ ?_'CKG_76'^35Z1XQ_P"1(U__ +!MQ_Z+:O-_@'_QXZY_UUA_DU '
M&_$[0-?T6\M)=:UAM0CNI)VMD,\DGD@%<@;NGWEZ>E>B?#WPEXJL+O3=5U#Q
M))<Z8UJ&2S^T2N &3Y1M/RC&?TK&^/\ _P R]_V\_P#M*O5O#?\ R*VD?]>4
M/_H H \D\>:[J]G\7;"RM=5OH+1I+8-!%<.J'+#.5!QS7I?CVYGL_ NL7%K/
M)!/';DI)$Y5E.1R".17DGQ$_Y+5IW_72T_\ 0A7J_P 1?^2>ZW_U['^8H \>
M\,>.?%]_HY\.:.]W>ZQ<W#R-=W$ID,4.Q1@%C\O(8Y/ R,<FMZ^\&_%'3(3J
M-OXGEO98E+-;Q7<K$X'\*,-K?3],U=^ VF1)HNJ:J54S2W M@V.555#$ ^A+
MC\AZ5Z[0!YG\,_B3-XEE?1]9"+JD:[HY%7:)P/O9'0,.O'!]!BF?'7_D2++_
M +"2?^BY:XKQ1&/#WQU@N;9@BRWD$Y P.'($@/URW/O7:_'7_D2++_L))_Z+
MEH Z'X8?\DWT7_KD_P#Z&U<O\0/BC=:=JG_"/^&(Q-J6_P J6;R_,*.> D:_
MQ-GU!';!/3H_AS.MK\+=,N&&5BMY'/T#L:\/\">)]-T'Q;+KFNPW-TY1V0PQ
MHS>:Q&6.X@#C=T]: .V3P7\5;V+[?+XD>"9AO^SMJ$B$''3:@V#Z9Q4N@?$G
MQ!X:\1+H7CA#Y>0GVED >/L&)'#I[]>^3C%;/_"]?#'_ #X:O_WYB_\ CE>?
M_$WQOH7C1-/DTZSO(;JV+J\EQ&B[D.,#*L2<$=^F3ZT ?1]%<[X"OY-3\":-
M=3',AME1CZE?ES^.VNBH Q/%OB.'PIX<N=5FC,AC 6./D;W/ &>P]Z\DTU?B
M=\083JEMJW]GV,C,L929K=.#R%" L0#QDYZ$9XKTGXD^';GQ-X+N;*R4/=QN
ML\*$XWE3R/J03CWQ7D?A'XG:GX'M1H6HZ49;>WD/[MRT4T.XY88(]23@@=3S
MZ %_5;CXF?#I([N\U3[?9,VTR/(;B/<>S%P''UX^M>O^$O$<7BOPW:ZM%$83
M+E9(B<['4X(SZ=Q[$5Q\'Q.\$^+M/?3-9$EK'/@/#=@A&P0P^=3P,@=<=*[?
M0-,T;2]+6/0H8([&8^:I@;<KD@#<#DYR .?:@#R;6]=U>+X\Q:='JM\EB;NV
M4VRW#B+!C0D;<XP23^=>VUX%K_\ R<5%_P!?MI_Z*CKWV@#RGXVZOJ6DV>C-
MIVHW=F9))0YMYFCW8"XSM(S7<^"[B:Z\$Z-<7$TDTTEI&SR2,69B1U)/)->=
M?'S_ (\=#_ZZS?R6O0? ?_(A:%_UY1_RH \/TWQSXHL?%.I6UG>WM_=7+O:V
M<,\[2)&YE7#!6.,X! ],^G%=98>$/BG!?6=S+XCDV2S*9T^VF0PKGDE6!0]^
M!D=*YSX:V\<_Q@D:1<F%[F1/][D?U-?1% 'S1\0O#/B7P_!8-KVO/J:3,XB#
M7$DGED 9^_TSD=/2NW\$>#/&"_V#JLGBF4Z5Y<,XLQ<S$>45!$>W[N,8&.E-
M^/G_ !XZ'_UUF_DM>D>#O^1(T#_L&V__ *+6@#COB5\2IO#-PFCZ/&DFINH:
M21UW"('H .['KSP!CKGCGHO"'Q7UE!=W/B)[)W^;RGO9(B,_[,2D#Z=J]%US
M1/"%MJ4?B+6H;.WNXI%E6ZFF,9+H!M[C<0%&!@]*R;SXQ>#K4XCO9[HCKY-N
MW_LV* /.+GQ%\0/AQJUO'K-U+=V\F65;B;SDG4$;MKGY@1G\,CC!Y]WT?4X-
M:T:SU.W!$-U$LJJW5<CH?<=/PKP'XD_$;3_&=C;6=C87$*6\WFB6<J&/RD$;
M03CD^O:O5_A_<O;?"C3KD#>T-K*X#'KM9L#]* .6\??$[4(-;/AOPJ@>\5_)
MEG5-[>8>-D8Z9'0D]^.,9K-'@OXKR0&];Q#*DYY^RG47W?3 ^3]:I_!*T&I>
M,-3U>[ EGAA+!V XDD;EAZ' 8?\  C7O= 'CO@/XD:Q'XD'ACQ9CSS)Y,<\B
MA9%DZ!&QPP/8]<GJ<\>C>*_%-CX1T1]1OLL<[(85^]*^.%'ITY/8?E6?K7PZ
MT'7O$(UJ]6Y^U!47$<NU25/#=,YZ#KV%>:?'F^=]=TK3]YV16S3;?=V*Y_\
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M /IB*1)HDEC8,CJ&5AW!Z&OFGPQXZ\6B6XTZRO+_ %'4M0"P6OGW#2"(YR6
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M'_8-M_\ T6M<5\=?^1(LO^PDG_HN6N[\-VD^G^%M(LKI/+N+>RABE3(.UE0
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M4G## ^8<9P0".I(]:]N\":7>:-X)TS3]0A\FZ@1A)'N#;278]02.A%<UX_\
MA5;^*KA]3TV=+35& #B0?NIL<9; R&QWYZ=.] '6_P#"'>&/^A<TC_P!B_\
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MUU_V\_SKZ$KQSP)X'\1Z-\1I]5U#3O)L6\_$OGQMG<>. Q/Z5['0!X[\?/\
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M]/7/"<-];>$]*MM2MS;WD%LD,L9=7.4&W.5)!R #U[T >*_ K_D=[W_L&O\
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MFI^-+XE 5+Q"7?(XY.S(X09]/4X]:]HMX(K6VBM[>-8X8D"1HHP%4#  ]@*
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M-.\FQ;S\2^?&V=QXX#$_I7L= 'SW_P W"?\ <2_]EKZ$KQS_ (0?Q'_PN/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% #)?]6:L6?\ Q[CZFJ\O
M^K-6+/\ X]Q]30!47_CX?ZFIJA7_ (^'^IJ:@ HHHH **** "BBB@ HHHH *
M*** "BBB@"EK/_(#U#_KVD_]!->+? 7_ )#FK_\ 7LG_ *%7NCHLB,CJ&1@0
MRL,@CT-4K#1-)TIW?3M+LK-W&':WMTC+#T.T#- %^BBB@#SWXT?\D]E_Z^8O
MYFCX+_\ )/8O^OF7^8KNKVPL]2MS;W]I!=0$@F.>,.N1T.",465A9Z;;BWL+
M2"U@!)$<$81<GJ< 8H L4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %<Q\1?^2>ZW_P!>Q_F*Z>HKFV@O+=[>Z@CG@D&'CE0,K#T(/!H \H^
MO_($U?\ Z^4_]!KURJEAI6G:4CIIUA:V:.<NMO"L88^IV@9JW0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !7AGCZRU_P3X[;Q7IHD?3YY
M5F;!8QA\!620#UYP??CD5[G2,H92K %2,$'H: /*[?X\:$UL&N=*U&.XQRD>
MQUS_ +Q8']*X[5+_ %WXQ^(K:WL+!K;3+1L;C\RPAB-SNW +$#A1Z<=S7M[^
M%?#LDQF?0-+:4G)=K.,MGUSBM."WAM8%AMX8X8D&%2-0JK] * &6-G%I]A;6
M4 (AMXEBC![*H 'Z"IZ** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH 9+_ *LU8L_^/<?4U7E_U9JQ
M9_\ 'N/J: *B_P#'P_U-35"O_'P_U-34 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% #)?]6:L6?_ ![CZFJ\O^K-6+/_
M (]Q]30!47_CX?ZFIJA7_CX?ZFIJ "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!YWF$< @YP.N?3M73UX7\&+MM'\9:OX?N'96D5@%(QF2)B",=0<%OR^E>Z4
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M+4K#4D9["]MKI%QEH)5<#/3H:M4 %%4)];TFUOTL+C5+**\D*A+>2X19&+<
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M>@!]%07E]::?;F>]NH+:$'!DFD"*/Q/%5K'7=(U21H]/U6QNW49*V]PDA'X
MF@#0HHJEJ&L:7I/E_P!I:E9V?FY\O[3.L>_&,XW$9QD?G0!=HJC>:UI6GQ1R
MWNIV5M'* 8WFG5 ^>F"3S3+GQ!HMG!!-=:O8013@F%Y;E%63'7:2><9'3UH
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M;BYV[_)C:3;G&<#.,UQW@'XB?\)Q<7T7]E_8OLJHV?M'F;MQ/^R,=*ZO6?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MC>>!P2 ,9ZGGU_XM?\DQUC_MC_Z.2L+X$HH\&7S@?,=0<$^PCCQ_,T 96K_
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ML:7J-S+#YHC8L-KQ-@D-N7L<8Z#!QUS6EHUGXC^+Z1G4M0>TT>P1(G*#/GS
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M5?-LQ)!SG$C@!1QZ,1GZ'I7$_ W0Y4M=1\0W(+/=-Y,+MRQ4'+G/7EL?]\T
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MS]R2>782?]Q0<CKW% $'B3X'V=MI%Q=:)J%VUQ!&9!#<[6$N!G:"H7!].O\
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M \;^$OC'48]7F\(:V\KRQ[EMC*<O&R9W1$]P #CTVD=,8L?'K_D":1_U\O\
M^@US&K+'9?M"QBW!*MJ-N3MYY=4W?JQKI_CU_P @32/^OE__ $&@#N_ ?_(A
M:%_UY1_RKQZY;7_BOXZDTV26:QTV(&01.I410@X#%#C<YR/S]!7L/@/_ )$+
M0O\ KRC_ )5SGBCXP:)X?O)K&U@EU&[A;:XC8+$I[C?SR/8'OZ4 9_\ PHCP
M_P#9MO\ :>I^?C[^Z/;G_=VY_6N"LSJ_PM^(T6GB\\RV:2,2=DGA<CG:3P1S
M]".I'7J$^+GB[5G(T3PFL@/*_NY9\#CJ5V^O7W%<%XLF\1W'BVTE\40B*_9(
MBJ *,1[CMX4\=^O/K0![_P#$7_DGNM_]>Q_F*\,\$:7K_B^QE\,:?>&STI)C
M=7LO.T[@J@$#[Q^0D*2 <$]J]S^(O_)/=;_Z]C_,5Q'P$11H^L/CYC<1@GV"
MG_$T 17WP'M5TN0V&KSO?JN4\Y%$;GT..1GUR<5G_!KQ!J5EXCN/"]Z[M 5<
MI$[9\F1.H'M@'@>F?6O<Z\"\&J%^/NH*H 47E\ !T'+T =3\7O!VF2Z'J7BE
MFN/[0B2%%&\>7CS%3IC/1CWKG_AA\.]#\2^'AJVH&Z-Q'=L@6.0*I"A2,C&>
M_K7H'Q:_Y)CK'_;'_P!')67\$?\ D0G_ .OV3_T%: -/XE^-7\&Z'&;15;4+
MQF2WW<A !\SX[XR./4CZ5Y]X2^%MYXPMAKWBC4;Q5N@'B"MF:13G#%F!P#P1
MP<CTXJO\=YV;Q;IUO_"EB''U:1Q_[**T+;Q[\2K2UAMH?!F(H46-!_9ESP ,
M#^*@!/%'P@E\/63ZSX8U*\,UHIE,;M^]P.I1D Y')QBNR^%GC:;Q;HDT-^0=
M2L2JR.!CS4(^5_KP0<>@/?%<DWQ#^)K*5;P8"I&"#I=S@_\ CU5/@YHVO:1X
MPG:^TG4+2UELW1FN+=XT+;E(Y( SP?UH T/BWXRU(:Q#X4T69XG<)]H:%MKN
MS_=CSG@8()]<CMUFTGX$:?\ V<IU?4[LWK+EA:E5C0XZ?,I+8]>*Y_3\7G[1
M#^<P&V_FP3_L(VT?^.@5[_0!\S>.O#6L>";6+1);XW6C7,WVJ [< 2*"IX_A
M.&YP>>/2O:_AA_R3?1?^N3_^AM6+\;;6.;P(D[*/,@NXV1L<C(((S^/Z5M?#
M#_DF^B_]<G_]#:@#KJ*** /E/3I-;'CBZ@\/-(NI7,\L,9CX8 L2Q![< Y/8
M9KTVS^ ]F;;=J&MW+W3#+&&,!0W?KDGGOQGVKF?ABBM\7[@D<J;DCV.2/ZU]
M"T ?-NGMJ_PN^(D5@]R7MVD190#A)XF.-V.Q'/N"/2OH;5M3@T;2+O4KDGR;
M:)I&QU.!T'N>E>'?&G_DHNE?]>4/_HV2O0/C'.T7PYO$7I--$C?3>&_FHH \
MVL+7Q#\8_$DTUW<M:Z3;L"5!)CA'94'0N1U)_P !76WOP'T=K)A8:K?QW>/E
M:<HZ$X[@*".??\ZXGP/XG\9:!H<D'A_PW]NM)9VD:?[%-+EL $;D('&!Q73?
M\+%^)W_0F_\ E,N?_BJ &?#SQ5K'AOQ<W@KQ!(\B&0Q1-(Q8Q/C*[2>2C#&/
MJ#QS75?&C_DGLO\ U\Q?S->5ZI%XUU_Q=;Z]=>&;^WNDDB.;>PF11L(P><G/
M'7->J?&C_DGLO_7S%_,T ><>"O#>M?$#2;?3)K^2S\/Z7N7"@D22LS/P.A8;
MNIZ C'6KOC;X1Q^&?#SZSIFHW$YMBIFCD09P2!N4CI@D<8/'.>*[CX*QHGP_
M5E4 R74K,?4\#/Y ?E6[\1?^2>ZW_P!>Q_F* /(_#L_BGXFV5KX<?4)(--L(
M_P#3;K)+2@D[ W3<<# !./ER<D5I^*/@K!I?AZYU#2]2GFGM8S,\<ZC#JHRV
MW X.!QU]/>M/X"@?V+K#8&3<("?^ FO4-9_Y >H?]>TG_H)H \W^"/B*YU+1
MK[2KN:29K)U>%W.2(WS\N?0%3_WU[55^+OBC6X]0MO#FCBXA295\Z:(%3(S'
M"QANPZ9]<@=.N=\ _P#C_P!<_P"N4/\ -J]+\6^.='\&P1G4'DDN)1F.VA +
ML/7D@ >Y_#- '#Z5\"-,%G&=6U.\:Y*Y=;8HBJ?0;E;-<EX[^'UQ\/VM-:TC
M4IWM_/V*Y^66%\$KR.N0#S@?K71/\<-3OI7CTCPQYA'3=(TI]B0JC';C/XUS
MGCC6O'FM^'4GU_2EL-*$Z@+Y/E$R8..')?U]J /8/"U^?&_PZADU$_-?6TMO
M<F+"GJT;$>A(&?QKP_Q9X2T[0_B/::%:M.UG*\ ;S'!;#D X( KU_P"#W_).
M+'_KK-_Z&:\]^(G_ "6K3O\ KI:?^A"@#UCPIX%T?P=)=/IAN6:Y"AS-(&P%
MSC& /6O(_$>OZW\4?%O_  CVCOY>FH[!5#X1U4\RR$=1T(';C')Y]N\23R6W
MA;5YX03+%93.FWKD(2,5Y'\ [6-[[7+LJ/-BBAB4XY 8L3S_ , 'Y4 ;,7P'
MT06>V;5M0>ZQ_K$"*F?]T@G_ ,>KCEN-?^#OBR.UEN#=Z7+\WE@X2>//+!<_
M(X_SD'GZ(KR7X\PHWA_2ISG>ETR#Z%"3_P"@B@#T>^NH;[PO<W=M()()[)I8
MW ^\K(2#^1KR+X!_\?\ KG_7*'^;5V_@R1Y?@]:,[%B+"5<GT&\#] *XCX!_
M\?\ KG_7*'^;4 ;7Q;\>WNB-%H&CR&*\N(Q)-<1M\\:DD!5QT8XZ]0,8ZY&;
MX<^!\=S8)=>([^ZBN95W&WMBH,9/]YB&R?7 Z]S6'JB?VI^T"L5TNY!J$2['
M&0515P,>AQ^O>OH2@#Y_\7?#W4_AXL?B'P]JEP8(6 E?(22+) &<<,I. 1CN
M,@BO5OA_XO7QCX;2\D54O86\JZC4' ;L1[$8/MR.U:7BR!+GP?K,,F=K64V<
M'_8->4_ *5_M6N1;CY92%MOOEQF@"+XA^(]7\6^,U\&Z#,ZP*Y@E1'VB:09+
M[R/X% Z?[)//&-JW^ ^CBQ"W.K7S7F.9(PBQY_W2"?\ QZN6^"S-?_$2^N[@
M[IC9RS$_[32(#_Z$:^@J /E[QMIFN^%-GA?4+QKK34<7-FYSC'S+\N2=O4Y7
MUY[Y/T!X#_Y$+0O^O*/^5<%\>XD.CZ/,0/,6XD53WP5!/\A7>^ _^1"T+_KR
MC_E0!Y'\!_\ D:=2_P"O+_V=:[?XM>-KGPQI4%AIKF._O@W[X=8HQP2/1B3@
M'M@]\5Q'P'_Y&G4O^O+_ -G6HOBF%N_BU9V]RV8-MO&01D!"V2,?B?SH U/"
M_P &GUFPCU7Q-J%W'/=#S!!&1Y@!&079@?F/ICCN<\#)\9^ K[X<R6^OZ#JE
MP8%EV;SA9(2>@)'# C(/ 'J.:^A*ANK2VO;=K>[MXKB%B"T<J!U.#D9!XX(!
M_"@#%\%>)$\5^%K34PH28@QSH/X9%X/X'@CV(KH*C@MX;:/RX(8XDSG;&H4?
MD*DH Q?&/_(D:_\ ]@VX_P#1;5\]>"++7O$B3^&-*NC:6<[&>]F&<;0-H#8Z
MCK\O?//2OH7QC_R)&O\ _8-N/_1;5Y;\ 8T,NORE1O5;=0WH#YF1^@_*@"75
M_@7;0:1/-IVJW,MY%&SK')&")"!D*,<@GIWKD/"/B'Q7JU@G@O2;MT^TR@I<
M%R#;Q $NN[J%Z'CT('WJ^EJ^>_@6H/CB\) )&G2$9[?O(Z .DG^ MD-/80:U
M<&]"<-)&HC9L>@Y S[G'O61\&M:OM-\5W7AFZDD,#K)MB+96.5#SCTR V?H*
M]WKP+P?_ ,E_U'_K]OOYO0!Z5\3/$U_X:\,[]+B=KVY?RDD5"PB&.6^O0#/<
MUY[X0^%#^*M,37O$.IW8>\_>($8-(Z_WF=L]1TKV76];T_P]I<NHZG<"&WCX
MSU+'LJCN3Z5Y9>_'99+CR='\/S3[N$:>7#$\_P "@^W>@"GXN^"UKIFB76I:
M)?W,C6L1E>"YVL75>6PR@8..V#G%;_P6\3WVM:1?:=?SF=K Q^3(YRY1MW!/
M?!7]0/2N>U#QC\2/$6DWJV_A];.P,#F64V[)^ZVG=AI#@\ ]!FE^ ?\ Q_ZY
M_P!<H?YM0!#\>O\ D.:1_P!>S_\ H5>Q7?\ R*D__7BW_H%>._'K_D.:1_U[
M/_Z%7L5W_P BI/\ ]>+?^@4 >1_ /_C_ -<_ZY0_S:M?XP>-;S36M_#FCS21
MW=PHDN)(3\X4G"HI'()(.>^,>M9'P#_X_P#7/^N4/\VK-O':_P#VA$\\[MFH
MQA?8(HV_^@B@#H-%^!=M+IHEU[4KH7\@W&.V*A8R>Q)!W'W&/QZUR_C3PMK/
MP\LI[:RU"2YT#4_W3JXP%?A@&'3=A>&'7!%?15<3\6XHY?AIJC.!F,PLA/8^
M:@_D2/QH S?@C_R(3_\ 7[)_Z"M><?$#4;K2?C+?WUBNZ[B:$PC;N^<P(!QW
MY/2O1_@C_P B$_\ U^R?^@K7!>+463]H&)'&5;4+$$>H*Q4 =!IOP6N-5C.H
M^)];N&O[@!W2+YF4_P"T[9R<8&,#&.IKC_%/AK5OA;XBL[[3;]S%)EK>X7@D
MC&Y'7IW'L1^./I6O(OCT!_8NCM@9%PX!_P" B@#TO3-634/#=IK!0JD]HERR
M)\Q7*AB!ZD=*\,M[7Q!\6_&$\5_<365A;_O#$0=L"9P $)Y<\\^Q[ "O9/ ?
M_(A:%_UY1_RKE?$?QHT31KN6ST^UEU.:)MK.CA(L]P'Y)Q[#'O0!5D^!&@FV
M98M4U);C'#L8V4?\!V@_K7%>&+G5_AU\34T"2YW6TUU'!.O_ "SD5\;9,=B
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M7;^&?C3I.KW<%EJEH^G3RD*)=X>'=[G@KD^Q'/)[T >GT444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MEWJ&N3K);!Q%;,(50NP^^> ,@<#ZY]*]#J*VMH+.UBMK:)(8(E"1QH,*H'0
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M2PU*XCM#>+&8Y)FV+N0ME23P"=W<CICO7LFL^+="T*P:[OM1@"A=R(CAGD]
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M?QF\:V%_:P^'M-N$N"DHFNI8F!52 0$R."<G)], >N.R^#W_ "3BQ_ZZS?\
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MV"Y'<#'"CCH/Q)K;UC3_ .UM$O\ 3?-\K[7;20>9MW;-ZE<XR,XSTS0!Y'\
M/^9A_P"W;_VK7M-<7X \ ?\ "#?VC_Q,_MOVSR_^6'E;-F[_ &CG.[]*[2@#
MP&V_Y.);_K^?_P!%FNJ^-_AZ;4="M-7MHWD:P9A,J\XC;&6Q[%1^!-:L7PS\
MOXBGQ9_:^<SM-]E^S>JE<;]_OZ5U&OZ_HNAV\2ZW<QPP79,2B6,LK\<@X!&,
M>O% ',?##QEI^M>&+'3I+J--3LXE@>"1P&<+PK+_ '@1C/H>O8G1\=>-M/\
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M?9MGBE^R_9L_<55QOW=]OIWH M?%K_DF.L?]L?\ T<E8GP*_Y$B]_P"PD_\
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M/PMX)T7PA ZZ9 QFD&)+B8AI&'IG P/8 "@#RSXSZ/=Z;XHL?$UJC>5(J!I
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M7C;22GD8ZF3<" /R.?;-87P0T!K'PY<ZQ,@$FH2;8B0,^4F1GVRQ;C_9!]*
M/4Z*** "OG2*>;X8?%F:2[B)LY';+!/O6\AR&7W&/S4BOHNL3Q+X3T?Q99?9
MM4M@[*#Y<Z?++$3_ '6_H<@\9% %_3=5L-8M$N].O(;J!P"'B<'\_0^QYKR_
MXD_%&73;NVTSPM?1O=(^ZYFC595'81C(()YYQR, 9ZBJ]Q\ H&F)MO$4D<79
M9+0.?S#C^5=/X4^%&B>&+U+]WDO[V,YBDF "QGCD*._7DYQGVS0!U7AYM3D\
M/V,FL[?[1>(/.%7:%8\[<>H! _"O%/AW_P EJU'_ *Z7?_H1KWZN \._#/\
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MM-AF#:CK-S=(#G9#"(<^Q)+?IBO4-+TNQT73HK#3K9+>UB&$C3M[DGDGW/-
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MU0Y[L@.1]2I8#W(K8\+Z'_PC?ANRTC[1]H^S*5\W9LW98GIDXZ^M:S,%4LQ
M4#))Z"@#Y:D\37>I^ ]*\)1!WE2^<J P&Y3C8OO\SOUXX'X?2'AG1UT#PSIV
MEJ!FV@57(& 7ZL?Q8D_C7AGPY\/VVK_%&>YLEWZ3IUQ)/&S <KN(B_'H?^ U
M]$T %%%% 'F7QS1F\#VI R%U",GV'ER#^HK1^%FLZ;+X!TJU%];BYC#1/"TJ
MAPV]L#&<\Y!'UKJ?$&@V/B719]*U!6,$V/F0X9"#D,I[$?YXKSG2_@D-)UZS
MU.W\0L1:W"3K&]IRVU@=I8..N,=* ,+X]?\ (<TC_KV?_P!"KVG1O^0'I_\
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M &AC&W]:Z?1]/_LG1+#3?-\W[);1P>9MV[]BA<XR<9QTS0!B_$7_ ))[K?\
MU['^8KD/@/\ \BOJ7_7[_P"R+7H7B/1_[?\ #U]I7G^1]JC\OS=F[;[XR,_G
M61X#\%_\(3I=S9?VA]M\^;S=_D^7M^4#&-Q]* .'C^)6MZ+\2IM)\320PZ8L
MSQ_)$ %4Y,;YY)&-O?H?45ZRMS87]@TZSVUS9LN3('5XRO7.>F*P?%G@#0_&
M 62_BDBNT7:EU VUP/0YR"/J/IBN!?X Q&8E/$;B+/"M9@MCZ[Q_*@#C?']O
MI-U\08K3PC'$,B./%F $\_<?N;>.A7IW!KV3XM?\DQUC_MC_ .CDH\)?#+0O
M"<XNXQ)>7P/RW%QC]WU'R@<#COR?Y4?%K_DF.L?]L?\ T<E '"?!CQG8:?;W
M'A_4IX[;S)?.MI9"%5B0 R$G@'@$>N2/05Z]K.O:7X?LGN]4O8K>)1P&;YF/
M/"KU)X/ ]*\:^'/@/2/&7@*Y^W"2*ZBU"017,) 91Y<?RG.05R<X_45JVOP#
MLTN=UWK\\MO_ '(K81M_WT68?I0!@_#VUN_&?Q3N?$DR,MO;RO<N3T!.1''G
MU Q^"FNC^/7_ "!-(_Z^7_\ 0:],T;1-/\/Z;'I^F6RP6R9.T<EB>I)/)/N:
MP?'O@?\ X3>QL[;^T?L7V>0R;O(\S=D8QC<,4 1Z$]U'\'[9['/VM=')@VG!
MW^6=N/QQ7E7P6BT2;Q/<+J:P/>>6/L23#(+9)8KGC< !COUQWKW;0=+_ +$T
M"QTOSO.^RPK%YFW;NP,9QDX_.N%\1_!?1=9O9;S3[J33)93N:-(P\6<\D+D$
M=^ <>PH ]#O;^STVV:YOKJ&V@7K)*X4?F:^9/''B>W\4>.SJ5ME;-#'%$SC!
M*J?O'TR23]*])L?@59)+&=3UVZO(HSQ''$(ACTR6;';I_P#7K2\4?!_2M;2P
M32YHM(2TC:-A';>9YH)!&3N!)'/)))S0!T/Q%_Y)[K?_ %['^8KBO@+_ ,@3
M5_\ KY3_ -!KT+6-#EUGPE/HL]Z!-/;B&2Z$6<MQEMN[N1TS^-9?@+P/_P (
M18WEM_:/VW[1()-WD>7MP,8QN.: .NKP+P?_ ,E_U'_K]OOYO7OM<#H_PT_L
MGQ_<>*?[7\WSIYY?LWV;;CS-W&[<>F[TYQ0!;^*Z,_PSU@*,G$1_ 3(37.?!
M76=-A\'SV<]];PW$=V[&.6558J57# $].H_"O3=0L+;5-.N+"\C$EO<1F.13
MW!&/P/O7DUQ\!(/M)>S\130Q Y19+4.R_P# @R_R% !\== GGM;#785+16X,
M$^!]P,<JQ/IG(^I'K76_#_QWIWB;1;:&2YABU6) DUL3M+$<;E!Z@^W3./2N
MPFMXKJU>WNHHIXI%VR(Z HX[@@YX]J\PUGX&Z->W#S:7J$^G!SGRB@F1?ID@
M_F30!V7C#QAIWA'2)KFYGC-X4/V:UW?/*W;CKMSU/;ZX%<K\)O$?BCQ.E[=:
MS<+-8P@1Q.850O(3DX*@# '_ *$*S]-^ ^G03J^HZS/=Q@Y,<4(AR,=,[F[U
MZI8V-KIEC#964"06T*[8XT& H_SW[T >$>/[.?P5\5+;Q&D!DM)YENE X!88
M$B9]>I_X$*]LT7Q!I?B#35O].NXY8"NYN<-'[,.JG@]?2GZWHFG^(=+ET[4[
M<36\G..A4]F4]B/6O+;OX!VLEP[6>ORP1%B526U$A [#(9<_E0!0^-/C&PU*
M*UT#3;E+CR9?.N9(F!0, 0J9'4\DGTX[]/0_AA_R3?1?^N3_ /H;5SDWP1T?
M^P7L;2^D2\DE61KV>(2,% /R*H*[0<YZYX^F.Z\+Z'_PC?ANRTC[1]H^S*5\
MW9LW98GIDXZ^M &O1110!\]_##_DKUU_V\_SKZ$KSWPO\,/^$;\7RZ]_;'VC
MS/,_<?9MF-Y_O;ST^E>A4 >!?&G_ )*+I7_7E#_Z-DKUOQUH<OB+P7J6FP8\
M^2,/%D=61@P'X[<?C6'XT^&G_"7^([75O[7^R?9X$B\K[-YF[:[-G.X8^]CI
MVKOJ /#/@_XUL]%%SX<UB1+17E,L$LOR@/P&1CVZ C/N,]!7M5SJ-E96)O;F
M[@AM0N[SGD 3'8YKD/%GPMT'Q3.UX ]A?MDM/;@8D.>KKT)Z\C!YY)KDH_@%
M")\R>(Y&BR?E6S"M[<[S_*@!EA\1O$7BCXDII^@3!=(>4#:\"DK"OWY"2,C/
M)&3W4=:Z;XT?\D]E_P"OF+^9KHO"O@[2/"%F\&FQ'S),>=/(<O(0.Y[#V'')
MI/&GA?\ X2_P\^E?;/LFZ19/-\KS/N]L9'\Z .>^"_\ R3V+_KYE_F*V_B+_
M ,D]UO\ Z]C_ #%3>"_"_P#PB'AY-*^V?:]LC2>;Y7E_>[8R?YU=\1Z/_;_A
MZ^TKS_(^U1^7YNS=M]\9&?SH \W^ O\ R!-7_P"OE/\ T&O3]9_Y >H?]>TG
M_H)KGO 7@?\ X0BQO+;^T?MOVB02;O(\O;@8QC<<UT]Y;_:[&XMMVSSHVCW8
MSC(QG% 'BWP#_P"/_7/^N4/\VKG_ !H87^-$H\0$K8"ZA$F[./(PN.G8CKCU
M/>O6/ /P[_X0>XOI?[4^V_:E1<?9_+V[2?\ :.>M7/&'P^T;QELENQ);WD:[
M4N8<!L>C _>'\J .DM$LK>QC^Q+;QV@0-'Y( CV8X(QQC&/PKQGXS^,].U"T
M@\/Z=.ER\<PFN)8R&12 0$![GG)QTQCU%7(O@,JL4?Q-,;8DDQ):[2?3G>1Z
M=NU=(?A'X>B\+W>DVJ;+JY50=0F022J00<CI@<=!C/?- #O@Z0?AQ9 $$B64
M'V^<UYU\3I5LOB_974YVQ)]FE+?[(;D_H:]:\#>$Y?!NBR:8^I"^C,QEC;R/
M+*9 !'WCD9&?Q-5?&_PZT[QJ89YIY+2^A0QI/&H8%>H#*>H!)/!'4T =%]HT
M[6[&:W@O(+F*>$JQ@E5_D88SQGL:\"\$:P_PV\>7FG:VCQ6\G^CS/M/RX.4D
M [K_ $->H^ OARW@>^N[@:O]M2YC"%/LWEX(.0<[SGOV[UL>*O ^B^,(XAJ<
M4BS1 B.X@8+(H],D$$=\$'^= &W%J%E/9_;(;N"2U(SYR2 ICUW XKP?XK>*
M8O%^O6&A:%_ID=NY4/%AA-,V!A3W QUZ')[ &ML_ *'[1D>(Y!#N^X;,%L>F
M[?C/OBNW\(_#K1/"#FXMD>YOB,&YGP64>BCHO\_>@"[::5_8?P_73"VYK;3V
MC<^K;#N/YYKS#X!_\?\ KG_7*'^;5[3>6_VNQN+;=L\Z-H]V,XR,9Q7'> ?A
MW_P@]Q?2_P!J?;?M2HN/L_E[=I/^T<]: /.OBKI]YX:^(=KXGMHR8IGBF1\?
M*)8\ J<>H4'WR:]B\-^*])\4:;%=Z?<H68?/ S 21MW#+^!]CVJ]JNE66MZ;
M-I^H0+/;3+AD;]"#V([&O+]1^ VG37&_3M:N+6(DDQS0B;'L""O'US0!K?%3
MQQI^D^'+O1[:XCFU&]1K=HXV#>4AX<MZ<9 '7GVJM\$= GTSPU=:I<(T;:E(
MIC5AUB0':WXEF_  ]ZDT#X*:%I=TESJ-S+J;(.(W0)$3ZE1DGZ9Q]:]+50JA
M5 "@8 '04 ?.\#-\,?BX\EY'*-.>1P'P3N@DSAAZ[3C..ZD5[];:I87EC]MM
MKVWEM<9\Y) 4'U/0=:Y'6T\$_$"\?0;J[634[61T7RLQS1,I(<*2,$?*<CD=
M_0URI^ 5M]H!'B&7R>Z?91N_[ZW8_2@#F_C!XRL_$6J6NG:9,L]I8[B\Z-E9
M)&Q]WU  Z]\GM@GV;P'_ ,B%H7_7E'_*O&OBIX9T;PAIVB:9I<1\Z3S9;B9V
MR\F H4GMCEL 8 Y]:]O\*VC6'A'1K5UVR164*N/1M@S^N: /&?@/_P C3J7_
M %Y?^SK5SXX:-<6NM:=XBMD81L@ADD4?<D4DJ3]0>/\ =KL_ ?PT_P"$)U2Y
MO?[7^V^?!Y6S[-Y>WY@<YW'TKMKZQM=3L9K*]@2>VF7;)&XR&'^>_:@#&\(^
M+M.\6Z1%=6LR"Y"XGMR</&PQGC/W<G@^_K7-?%7QO%H6A/IVG7YCUBX90OD-
M\\*!LL21]W.,>O)]*S-5^!&EW,_F:9JUQ9(>3'+$)@/H<J<?7-7?#_P4T+2K
MA+C4KF75)$SB-T$<1^JY)/YX]J -SX9_VW)X.AN=>N9Y[FYD,L1G^\L1 "C\
M<%O^!5V%(JA5"J % P .@I: ,7QC_P B1K__ &#;C_T6U>8? #_F8?\ MV_]
MJUZYK&G_ -K:)?Z;YOE?:[:2#S-N[9O4KG&1G&>F:YCP!X _X0;^T?\ B9_;
M?MGE_P#+#RMFS=_M'.=WZ4 =I7SY\"O^1WO?^P:__HR*OH.O/? GPP_X0K6Y
MM2_MC[9YMLT'E_9O+QEE;.=Y_N],=Z /0J\"\'_\E_U'_K]OOYO7OM<#H_PT
M_LGQ_<>*?[7\WSIYY?LWV;;CS-W&[<>F[TYQ0!R/Q\:Z\_1$.[['ME(P>#)E
M<Y_#&/J?>O0?AW#HB^#-.?15@*F%1/)&OS&7 W[SUW9]>V,<8K5\0^'-,\4:
M6VGZI!YD1.Y64X>-O53V->9R? =$G9[+Q+/ A& &M=S?F'7^5 '4?$GQKIFA
M>&[VP%S'+J5W"\$<$;!F3<""S#L!D]>I_''$? ,C^T=;7(R8HB!^+5V?ASX1
M^'-!G^TSQMJ=P#\INE!1?HG0GW.?;%'@KX:MX+UVYOX-8^T6\\;1FW:VVX&X
M%3NWGD8QT[F@#A_CU_R'-(_Z]G_]"KV*[_Y%2?\ Z\6_] KF/'OPX_X3>^L[
MG^UOL7V>,Q[?L_F;LG.<[ABNQFL_-TJ2Q\S&^ P[\=,KC.* /&?@'_Q_ZY_U
MRA_FU4OBEIUWX8^(EIXGMXG:":2*=6_A$J8RA..,A0?Q/I7HO@'X=_\ "#W%
M]+_:GVW[4J+C[/Y>W:3_ +1SUJ]XDU/PCJ5PWA;7KF SR["()0RG<QPI5\8!
M^AH U="\1:5XDT^.\TR[CF1ERT>X;XSZ,O4'_/2O,OC'XVT^71_^$=T^Y2YF
MF=7N'B<,L:J<A21U)(!QVQ[BG77P#LGN ;37KB*'/*36ZR-C_>!4?I6=XV\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% #)?]6:L6?_ ![CZFJ\O^K-6+/_ (]Q]30!
M47_CX?ZFIJA7_CX?ZFIJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@!DO^K-6+/_ (]Q]35>7_5FK%G_ ,>X^IH J+_Q
M\/\ 4U-4*_\ 'P_U-34 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_P!X?G1]DG_O#\Z** #[)/\ WA^='V2?^\/SHHH /LD_]X?G1]DG_O#\Z**
M#[)/_>'YT?9)_P"\/SHHH /LD_\ >'YT?9)_[P_.BB@ ^R3_ -X?G1]DG_O#
M\Z** #[)/_>'YT?9)_[P_.BB@ ^R3_WA^='V2?\ O#\Z** #[)/_ 'A^='V2
M?^\/SHHH /LD_P#>'YT?9)_[P_.BB@ ^R3_WA^='V2?^\/SHHH /LD_]X?G1
M]DG_ +P_.BB@ ^R3_P!X?G1]DG_O#\Z** #[)/\ WA^='V2?^\/SHHH /LD_
M]X?G1]DG_O#\Z** #[)/_>'YT?9)_P"\/SHHH /LD_\ >'YT?9)_[P_.BB@
M^R3_ -X?G1]DG_O#\Z** #[)/_>'YT?9)_[P_.BB@ ^R3_WA^='V2?\ O#\Z
M** #[)/_ 'A^='V2?^\/SHHH /LD_P#>'YT?9)_[P_.BB@ ^R3_WA^='V2?^
M\/SHHH /LD_]X?G1]DG_ +P_.BB@ ^R3_P!X?G1]DG_O#\Z** #[)/\ WA^=
M'V2?^\/SHHH /LD_]X?G1]DG_O#\Z** #[)/_>'YT?9)_P"\/SHHH /LD_\
M>'YT?9)_[P_.BB@ ^R3_ -X?G1]DG_O#\Z** #[)/_>'YT?9)_[P_.BB@ ^R
M3_WA^='V2?\ O#\Z** #[)/_ 'A^='V2?^\/SHHH /LD_P#>'YT?9)_[P_.B
MB@ ^R3_WA^='V2?^\/SHHH /LD_]X?G1]DG_ +P_.BB@ ^R3_P!X?G1]DG_O
M#\Z** #[)/\ WA^='V2?^\/SHHH /LD_]X?G1]DG_O#\Z** #[)/_>'YT?9)
M_P"\/SHHH /LD_\ >'YT?9)_[P_.BB@ ^R3_ -X?G1]DG_O#\Z** #[)/_>'
MYT?9)_[P_.BB@ ^R3_WA^='V2?\ O#\Z** #[)/_ 'A^='V2?^\/SHHH /LD
M_P#>'YT?9)_[P_.BB@ ^R3_WA^='V2?^\/SHHH /LD_]X?G1]DG_ +P_.BB@
M ^R3_P!X?G1]DG_O#\Z** #[)/\ WA^='V2?^\/SHHH /LD_]X?G1]DG_O#\
MZ** #[)/_>'YT?9)_P"\/SHHH /LD_\ >'YT?9)_[P_.BB@ ^R3_ -X?G1]D
MG_O#\Z** #[)/_>'YT?9)_[P_.BB@ ^R3_WA^='V2?\ O#\Z** #[)/_ 'A^
M='V2?^\/SHHH /LD_P#>'YT?9)_[P_.BB@ ^R3_WA^='V2?^\/SHHH /LD_]
MX?G1]DG_ +P_.BB@ ^R3_P!X?G1]DG_O#\Z** #[)/\ WA^='V2?^\/SHHH
M/LD_]X?G1]DG_O#\Z** #[)/_>'YT?9)_P"\/SHHH /LD_\ >'YT?9)_[P_.
MBB@ ^R3_ -X?G1]DG_O#\Z** #[)/_>'YT?9)_[P_.BB@ ^R3_WA^='V2?\
MO#\Z** #[)/_ 'A^='V2?^\/SHHH /LD_P#>'YT?9)_[P_.BB@ ^R3_WA^='
MV2?^\/SHHH /LD_]X?G1]DG_ +P_.BB@ ^R3_P!X?G1]DG_O#\Z** #[)/\
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G* #[)/\ WA^='V2?^\/SHHH 0V<V.H/XU;MHVBBVMC.>U%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>img17388848_5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img17388848_5.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" D7&"@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHI:!"4HI**!BTE%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M)2T4 (*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "EI** "DI:* "BBBD 4444P"BBB@ HHHH
M**** "BBB@ HHHH **** "@T44 )2T44 %%%%( HI**8"T444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 % HHH
M6DHHH **** "BBB@ HHHH **** "BBB@ HHHH **** %HI** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBE% "44M)0 M%)10 M%)10 4444 %%%%( HI*
M6F 4444 %%%% "TAHS10 4444 %%%% !1110 4444 %**2BD M)110 4444P
M"BBB@ HHI: $HH-% !2TE&: %H-)10 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 HHI** "BBB@ HHHH **** %H-)10 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E+10 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4HI*44 .HHHI#.+HHHK4[ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H7ZU-
M4+]:: T=+_UBUZ5X?Z+7FNE_ZQ:]*\/]%KDQ&PT=[9?<%7:I67W!5VO+>XPH
MHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!4NONFN5U7H:ZJ
MZ^Z:Y75>AK>CN9S./O?O&J2]:NWOWC5)>M>G'8Y&24444P"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *7-)10 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% "T4E% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444@"BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %+249H ***
M*0!1BBEI@)1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 8HI:#0 E%%% !112T )12TE !1110 4444 %%%% !1110 9HHHH 3
M-+24M !29I:2@!:*** "BBBD F*6BBF 4444 %%%% "4M%% !1110 4444 %
M%%% !1110 4444 %%%% !112T )12TE !2TE% @HHHH&%)2T8H **** "BBB
M@ HHHH **** "BBB@ HI110 E%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %+249H *,T4E "T444 %%%% !1110 44
M8HH **** "EQ24M "44M)0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %**2E% #J***0SBZ***U.P**
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ J%^M35"_6F@-'2_]8M>E>'^BUYKI?\ K%KT
MKP_T6N3$;#1WME]P5=JE9?<%7:\M[C"BBBD 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% %2Z^Z:Y75>AKJKK[IKE=5Z&MZ.YG,X^]^\:I+UJ[>_
M>-4EZUZ<=CD9)1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH 6D-%%( HHHI@%)12T  HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH$%%%)0,*!2T4 %%%% !
M0:**0 **** "BBBF 4444 %%%% !1110 4444 %%%%( HH-)3 6BBB@!**6B
M@ HHHH **** "BBB@ HHHH **** "BBB@ I*6C% !1124@%HHHIB"BBB@844
M44 %%%% !1110 4444 %%%% !1110 E%+1B@ %%%%( HHHI@%)2T4  HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!*
M*6B@ I*=24  I:2B@ HI:*!"4444#"BBB@ HHHH **** "BBB@ HHH- !124
MM !1110 4444@"BBBF 4444 %+244@ T444P"BBB@ HHHH **** "BBEH 2B
ME-)0 4M)10 M)110 "EI** "DI:*0""EHHH ****8!110* "BEI*0"4"EHI@
M%%%)0 Z@TE% !1110 4444 %%%% !2TE% !1110 4444 +2&BBD 4444P"BB
MBD 4444P"BEI* $H%+24 +124M !1110 "EI** "BBB@!:*2B@ HHHH ****
M "BBB@ HHHH **** $HI:*!A1110(***6D VE%%%, HHHH 6DHHH **** "B
MBB@!:*2B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *44E** '4444AG%T445J=@4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !4+]:FJ%^M- :.E_ZQ:]*\/\ 1:\UTO\ UBUZ5X?Z+7)B-AH[
MVR^X*NU2LON"KM>6]QA1112 **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@"I=?=-<KJO0UU5U]TURNJ]#6]'<SF<?>_>-4EZU=O?O&J2]:]..QR,
MDHHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 444&@ HIII.:+ /HIF31DT .I:9S1DT"'T4W)I10,6BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "C%%% !12&DYH =131
M3J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *,444 %%%% !12
M4G- #J*;3J "BBB@ HHHH **** "BBB@ HHHH *7-)10 4G%!I,T .HIHIU(
M HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% A:2EI*!A1110 44AI
M,F@!U%-%.H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BC%% !112&@!<T4SFE!- #J*04M "YI,T44 %%%% !1110 4444 %%%
M% !1110 444TT +2TPDTF30!)13 33A0 M)FEI* %HI#2<T .HIF31DT /HI
MF32Y- #J*04M !11FB@ HI<4TT +13>:3)H ?1FFBG4 %%%% !12XI* "BBF
MF@!U%-R:44"%HHHH&%%%%(0M)2TE,84444 +FDHHH **0TW)H$/I*9DTN30,
M?1313J "BBB@ HIII,F@0^BF<T<T#'T4WFB@!U% HH **** "BBFF@!U%,YI
M>: '44@I: "BBB@!<TE(:3)H =24WFEH 6EI*6@ HHHH **** "BBB@ HHHH
M *,TTTA)H$/HJ/)I030,?124M !11FB@ HHHH **** "BBBD 49HIII@.HIN
M32B@!:*#330 [-%-R:44 +1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4HI*44 .H
MHHI#.+HHHK4[ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "H7ZU-4+]:: T=+_UBUZ5
MX?Z+7FNE_P"L6O2O#_1:Y,1L-'>V7W!5VJ5E]P5=KRWN,****0!1110 4444
M %%%% !1110 4444 %%%% !1110 4444 5+K[IKE=5Z&NJNONFN5U7H:WH[F
M<SC[W[QJDO6KM[]XU27K7IQV.1DE%%%, HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "E S3":L6R;V%)Z "P$]J=]F/
MI6Y::>7 XJY_91Q]VLG52-%"YR_V8^E'V8^E=/\ V4?[M+_91_NTO:H.1G+_
M &8^E'V8^E=0-*/]V@Z2?[M'M4'(SE3 1VIC1XKI9M-*CI65<V^S/%5&=R7&
MQF'BBB3@TT-6I(ZBDS2T %%%)F@!:*3-+0 449I,T +11FDS0 M%)FC- "T4
M44 %%&:3- "T4F:,T +129I: "BBDS0 M%)FC- "T49HH **** "BDS1F@!:
M*3=1F@!:*** "BBB@ HI,T9H 6BDS1F@!:.M(33D&30 X)FGB GM5RVM]Y'%
M:T6FEESBLI5+%*-SG&A([5&1@UOW=B8U/%85P-K8JHRYA-6&44U33ZL0E%!-
M)F@!:*3-+F@ HHHH ***3- "T49I,T +129HS0 M%+FD- !124M !12&E3DT
M ."9J00$]JLV\&\BM:#3BR]*SE.Q2C<P# 1VJ)ABNBN=/**>*PKE-C&B,N83
M5B&BF!J=FM!"T4F:,T +129HS0 M%%% !1110 444F>: '!<T_R2>U6+6'S"
M*UH].)7.*SE-(J*N8!B(II&*VKBR* \5ERQ[2:<97$U8@HI#UI15B"BBB@ H
MHHH **3-&: %HI,TM !1110 44F:,T +11FB@ HHI,T +1BDS3AS0 JIFI!
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M$BU&YSGV8^E'V8^E=1_91_NT?V2?[M3[5#Y#E3;D=J8T9':NJ;23_=JK-I+
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M%% !1110 4444 %%%% !1110 4444 %%%% !1110 E%+28H *6C%% !1110
M4444P"BBBD 4444 %%)FEI@%%%%( HHHH **** "BBB@ HHHH **** "BDS2
MT %%%% !1110 44E+0 4444 %%%)0 M%%% !129I: "BBB@ HHHH **** "B
MBBF 4444 %%%%( HHHH **** "BBBF 4444@"EI*,T %%%% !1113 ****0!
M1110 4444 %)2T4 )2T44 %%%% !1110 4444 +124$T %%)2T %%%% !111
M0 4444 %%%% !112XH 2BBB@ HHHH ****!A1110 4444""BBB@ HI,TM !1
M110 4444 %%%% !1110 4444 %%)10 M+249H **** "DI:3% "T444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 5"_6IJA?K30&CI?\ K%KTKP_T6O-=+_UBUZ5X?Z+7)B-AH[VR^X*NU2LO
MN"KM>6]QA1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"I=?
M=-<KJO0UU5U]TURNJ]#6]'<SF<?>_>-4EZU=O?O&J2]:]..QR,DHHHI@%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MP**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "DI:* "BBB@ HHHH **0T"@!:*** "BBB@ HHHH **** "BE%% "4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% "4M%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %)2T4 )2T44 %%%% !1110 E+FBDH 6BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** #-%)2B@ HHHH ****
M "BBB@ HHHH ***!18 HI:2@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MI@%%%%( HHHH 2EHHH ,T9I,44 +1110 4444 %%%% !1113 ****0"4M%%
M!1110 4444 &**6D- !1110 9I***  4M HH 2EHHH ***#0 9I,T44 +111
M0 4444 %%%% !1110 4444 %%%% !1113 ****0!1110 4444#"BBB@04444
M &:*2E% !BBEI* "BBB@ HHHH **** "BBB@ HHHH **** $I:** "BBB@ H
MHHH **** "BBB@ I:2BF 4444@"BBB@ HHHI@%%%%( HHHH **** $I:** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI:#0 E%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM-%.JR0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "E%)2B@!U%%%(9Q=%%%:G8%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !24M% ""EHHH *7-)29I@*:*3-)F
MD N:,TE%,!<TN:;FEI **6D%% !1110P"BB@T %)12TP 4444@"DI:,4 %+3
M:44P%I***0!2TE%  :***8!1112 *0TM% "4M%% !112T (:2E-&*8!1112
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M*6@ HHI* %S129H% "T4M(: "EI*,T %%%%, HHHI +129HS0 4444 %%%%
M!1110 44E%,!:***0!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !4+]:FJ%^M- :.E_P"L6O2O#_1:\UTO_6+7I7A_HM<F(V&C
MO;+[@J[5*R^X*NUY;W&%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** *EU]TURNJ]#7577W37*ZKT-;T=S.9Q][]XU27K5V]^\:I+UKTX['(
MR2BBBF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MEKJ=$EH<3,\OF=ZTM-DDW#.:T7TV,MT%6+:R2-A6\JB:,E%W-.W4O%S6%K<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %**2E% #J***0SBZ***U.P**** "BBB@
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MT@S@?+3<T@.;\I_2C:1793>'V2/.VL*\LC"3Q2512 RJ*<XVFHP:T =1110
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M3U.CNQ^X./2O/->#[FQ7HN!+#CVKG=3TGS2>*SH347J.HKH\W@$OG]^M=UH
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M112&<71116IV!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M LVT)=QQ79Z+I?F ';6-I-@9'7BO2]"TW8BY6N.O4LAI&->Z4([<G;VKSK7
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MY$ZJ:KM;M'U%4FF E%'2BF 4444@"BBB@ HHHH **** "BBB@ HHHH ****
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MXU27K7IQV.1DE%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** (F'-:>F/LD%9Y'-6+=]A%*2NAIZGH^DWJK& 36H;
MU&[BO/;;4C&/O5:&L'^]7#*A=W.A5-#M3-$WI29B/I7&#6C_ 'J=_;9_O5/L
M&/VB.PS#[4$Q>U<?_;9_O4'6S_>H]A(7M$=+<&+:>E<WJ(0DXJ"36"P^]5&:
M]\P]:UITVB923+5F )1]:ZRQG1(QR*X:*YVMG-7EU0HN-U.I3<A1E8Z;4-15
M5.#7+76I$R'FJUUJ+29YK*DE+-G-53I61,IW.ITW42'&3766]^KQ $UYE;W!
MC(YK7@U4JN-U34HWV*C.QT6J.CJ>E<C<J/.XJY/J1=3S68TV^6JIP<4*3N='
MH@^9:[:%L0BN-T),E:ZTDK!^%<M?61K3V([F9<\U4'EL>U9FH7A1SS6;_:I4
M_>IQINV@.9UL9B7GBF3WJ1J<$5RW]LG'WJIW.K%@?FJE0;8O:(OZIJ(;(!KE
MYIM\G6BXO#(3S54-DUUPI\J,92N;VF2A6%=E97RK&.:\[MY_+/6M2+4RJXW5
ME5I\Q4)6.DU:\5XSS7!:B=TIK4N=0,B]:QYVWMFKHPY13E<KQC%7;:<HPYJJ
M!3E.#6[U,UH=EI>H;< FNDBO$D3DBO,X+LQ$<UK6^KL/XJY*E&[NC:-0[1DB
M<YXI5BB7TKFH]7./O4Y]7./O5C[.1?.CH)I8U0]*YG59U;.#56XU=B#\U9,]
MZ9">:VITFG<SE,:7_>9K=TRX QDUS)?G-68+LQD<UO*%T0I69Z+;7$;(,D5)
M*(G':N*M]69<?-5]-6)'WJY'1:9LIHWUCC![5:2=(AU%<S_:?'6H)M5(!^:E
M[)L.=(Z*^U-0A -<=J5WYCGFHKG4F?/S5FR3%S713I<IG.=RW:RXD%=7IMRN
M!DUQ"2;3FK]OJ!CQS55*?,*,K'HB2Q.G:H)8XR>U<M#K!Q]ZK2ZKG^*N;V31
MKSIG01"-.>*L&]2->M<PVJ8'6J5QJQP?FI>Q;#VB1L:IJ092 :Y*>??*3FFW
M%\TA/-50^3FNJG3Y492E<Z#2YPK#)KL+6^41#FO.[>X\O'-:4>IE5QNK*I2Y
MBX3L;^KW:NC<UPUZ_P"])%:=S?F0'FLB<[VS6M*'*1.5R[IUT8V'-=EINIC
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MD<"GI7"JTF[ <Y;Z#$#RHJ^/#T3+PHJF^N1128W"M33];BF(&X4Y.>X&1?\
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M,/K29)IE** #%%%%, HHHH 7)%+O([TTTE(!Y<GO3<TE+3 4,12^8?6F&BD
M[<324E+3 *4.124E(!QD)[TF<TE% "T444P"BBB@!0<4X2$4RDH E,I]:3S3
MZU'12L%R3S3ZT>:?6HZ* N2>:?6FEB:;10 &F\BGT4P%20KWJ<7! ZU6I,FE
M8+EAYR>]0LQ--S2BC8!N#3L4N**8#<4Y6(HI* )UG([T-,3WJO12L%P8DFG*
MY'>DHI@/WDTW.:2EH 4$BE\P^M-I*0#BY/>DI*6F E.#D=Z2DH E$AQUIK-F
MF44K -8$TJDJ:=24P)TG*]Z>;@D=:J9-&32L%R21RW>H<&GTM,!!3@Q%)24
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MU@N-P:<*6BF 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4HI*44 .HHHI#.+HHHK4[ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ<=CD9)1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ Q1110(****!AB
M@<&EH- %J&X*=ZLF^;&,UEYHW5+BAW+4LY?O59CFDW44TK"N)BEHHI@%%%%
M!1110 4444 %%%% !1110 8HQ110 4444 %%%% !1BBB@ Q1110 4444 %%%
M% !1BBB@ Q1110 4444@"BBBF 4444 %%%% !1BD)I-U #L44 T4 %%)FC-
MA:**3- QU!IN:6D 44F:3=3 =129I: "C% I: &TX4E% "FDHHH **** "BB
MBD 4444P"BBB@ HHHH **** "BBB@ HI"U)NH =12 TM @HHHI#"BBBF 444
M4 %)BEHH ,4"BBD M)113 **** #%%%% !1110 M)110 4M)10 444A- "T4
MW=2YH 6BBEH 2BEI* #%&*** "BBB@ HHHH **** "BBDS0 M%-W4;Z!#J*9
MOI=U Q:6DS2T@"BBB@ HHHS3 **** "BBBD(,48HHIC"BBB@0444M Q**4TE
M !1110 M(:**0!BC%%%,04=Z**!A1112 *6DHI@%%%% @HHI,T#%HINZDWT6
M ?13=]&Z@!U%(#2T )WI<444 %%%+0 E%*:2@ HHHH **3-)NH =12!J6D 4
M4A-)NI@.HI V:6@ HHHH **!2T )12TE !1129H 7%&*;NI=U "T4F:,T"%H
MI,T9H&+129HW4 !%% -+0 4444 %%%% !1110 4444 &*,444 %%%% !1110
M 4444 &**** "BBB@ HHHH **** "BBB@ HHHH *,444 &**** "BBB@ HHH
MH **** #%&*** "BBB@ HHHH **** "BBB@ HHHH **** #%&*** #%%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4HI*44 .HHHI#.+HHHK4[ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVU;34G4G%<7>:"/,/RUT4*UE81P5I8N9!P:]$\,V+(5)%,L=" <?+79:78)
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MKQOMC/+-9^^U<M-]^NJUH_.U<K/]XUZM+80BTZF)3ZT&%%%% @HHHH ****
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MF<SC[W[QJDO6KM[]XU27K7IQV.1DE%%%, HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4HI*44 .HHHI#.+HHHK4[ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E+110 4444 %%%%
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MUT,R#R#]*\^I)J1T16AY[J\(0FN=8_-75:Z,,U<J1ES7=2^$PGN+DXHR:G2
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MP9.IJ$KDT@7%/%&P ORU()RO>HZ811N!9^UMZTUIRW>J^TTH%%D \G-&***
M&[:4-M-+32* +$=XR=ZG&IN!UK-*FDV&CE0&B^I,W>J[S%^]5MAIX&*+) +C
M-!7-.%% #0-IJ>.Y,?>H2*85HL!HKJ;KWI3JKD?>K+V&C8:7*@+LEZS]Z@9M
MU1!33P*:2 -M&VG44 *CE#UJPE^R=ZJ$4PJ:+)@:?]JO_>--;4G8=:S=AH"&
MCE0%IYR_>H2N:0#%/%,!!\M2K.5[U$::12 M?:V]:8TY;O5?::<!19 *PW4W
M9BGB@T *DA3O5A+]D[U4(IA4T63 TO[4?^]43WS/WJAL-."FCE0$KL7--"T
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M:;2<"N3O[<*QP*Z:56YE.%C%'%%.D&#3!709A4T7WA45"OAA28'8:(1E:[:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ Q28I:* 'QMM;-:UKJ
M!B YK&SBFF0BDXW Z.35BRXW5E7%QYA/-4/-:G!B:2@D YN:;BEHJ@"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "DQ2T4 )BEHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DQ2T4 %%%% !1110 4
M444 )BBEHH **** "BBB@ HHHH 7-)110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 +FDHHH **** "BBB@ -(.*6B@"Q#-
ML-:EOJ9C'WJPLD4TR,*3BF!T<VJEUQNK'NI?-8U4\UC3@<TE!(!H7FGXHHJ@
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH&%%%% @HHHH **** "BBB@ HHHH 7-)110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !4+]:FJ%^M- :.E_ZQ:]*\/\ 1:\UTO\ UBUZ5X?Z+7)B-AH[
MVR^X*NU2LON"KM>6]QA1112 **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@"I=?=-<KJO0UU5U]TURNJ]#6]'<SF<?>_>-4EZU=O?O&J2]:]..QR,
MDHHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1112 ****8!1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4M)2T )10:* $-.09-,-2Q=:&"-?2X_G
M6N\TY<0BN+TI?G6NXLAB$?2N#$,Z*:,[67Q&:\_OWS*:[O6S\C5P%Z?WIK7#
MK0BJR*,XJW%<%>]4EI=Q%=+5S(TOMAQUJ)[@MWJCO-+N)HY4.Y<2<J>M3_;3
MMQFLS)I"YI.*87+4LY?O38>9!5<$FI[?[XHM9!<[#1.U=9_RQ_"N4T3^&NK_
M .6/X5YU;XCJAL<MK'4UR-U]XUUNLGEJY&Z/S&NNCL8SW*AZTHIA/-+FN@R!
MZGLUW2"JYYJ]8+F04I:(%N=EHMN"%XKIM@CBK'T11L6MN=?W7%>74=Y'7%:&
M!J%UM) K(%V?,ZUHW\#,QK-%J0V:WA:QG*]S;L+G( )K4D19(S6!:(4(K:CD
M_=\UC-:Z&D7H<OK-L 6.*P[4;9Q]:Z36G!#5SD'_ !\?C773?NF,MSN-)QY8
MJS?X\LU3TG_5BK5^?W9KD?Q&RV.,U3[QK"'^LK<U3[QK"'^LKOI['-+<ZC1/
MO+7:PX\G\*XC13\RUVL)_<_A7'7W.BGL<[K>.:Y=?]=^-=/K7>N87_7?C6]+
MX3.>YT^DG&VNG1=\6*Y;2OX:ZVU_U=<M;<U@9EQI^]LXJ6WM!$.E:I4'J*:R
M#:<"L^=[%<J,:_NA%&17$ZKJ&6(S74ZTK!6Q7GVI!_,-=F'@GJ856QJR&5ZW
M]+M=S XKG;(9<9KM='C!VUM6=D135V='80A(QQ2WLP1#BK$*XCXJC?(64UYZ
MUD=+T1SMU>$/UJ:QO27'-5[JT8L:6TMV1Q74[<IEK<["V<21#-8^L0*5/%7+
M639&,U4U*8,IKGBK2-&]#DFAQ-^-=%I"@8K'< RULZ9P1714=XF4=SJ(\"*L
M/5+P1YYK6+8A_"N/UZ5ANP:YZ4;R-9NR*K:I^]QFMK3+SS".:\^:9O.ZUU6A
MN25KKJ4THF,)W9W\+ Q@UF:E<K&IJU"Q\G\*Y[6Y2%:N*$;R-Y/0RKK4\28S
M5_2[[>PYKB[J9O.//>MK1)&+K7;.FE$YXSU/18F#Q?A6!K,8VMQ6Q:-F$?2L
MK6/NFN2&DC>6QPMRN)S]:Z#0OO+6%=_ZX_6MS0_O+7;4^ PCN=LF/(_"N<U<
M YKH$/[C\*Y_4^2:XJ?Q&\]CFO)S-T[UU.C6X !Q6'$@,M=5IB (*WJRT(@M
M2_/(L4/X5R^HZEM8C-;6J.5B.*X#5)V\P\U%"%QU)6-%-4^?K6M:ZL-H^:N#
M$S ]:L1WCKWKIE13,5.QVUSJ2NIYKG;V<.36>U\Y'6H6G+4X4N4)3N,EY-,4
M4X\T5L0%1D<U)3U3=0!):SM&PKI=/U4I@9KGDMB>@JPD3Q\\UE-*146T=W:Z
MHKXR:TTNHW'45YW%>O%U-:$&L$8^:N25#L;1J=SM]L<@[54N+%'' K%AUH<?
M-6K:ZDLN!FLG"43123,J]TG*D@5S-[8&,GBO3"B2Q=*YS5[(88@5K2JN]F1.
M!PJ.8Y*Z?2+G)'-<Y>1%)36EH[G>*ZJB3C<QB[,]!M9,QBJFHW&U3S3[,_N1
M]*S=68A37GQC[QTMZ&!>WF7(S3+/]ZXK,O'/FFM/1QN<9KO:M$YT[LZO3[<!
M0<5=N)!&E+9H/*%17B$@UPMWD=&R.?OKHASS45K>G>.:?=VS,QJM#;,KBNA6
ML9:W.LL91(@S46J0JT9XJ"P)11FI;^<&,\USVM+0TZ'%7<.)S]:U=(7!6J5U
MAI?QK1TP8(KJD_=,DM3KK; B%4-2N1&IJS"V(OPK!UJ0A3S7+"-Y&LG9&5<:
MEB0C-7].OM[#FN-NI6\X\UK:/(Q=:[)4THF*EJ>C6KAD!J"^F6-33;$GR16?
MK$A$;5Q1C>1NWH8M]J85R,TEAJ.^0<US.I3MYIYJ72)6,HYKN]DN4Y^?4]1L
MY!)$*H:M&"AJ32F)A6C5/]6:XDK2.AZQ."U!,.:QY.#6[J/WC6'+]XUZ-/8Y
M)#10O6D%*M:"+]H/G%=IHP&!7$VK8<5V>BMG%<U=:&M/<Z*7_4_A7':P3N:N
MS<9A_"N0UE.6KFH[FM38Y*?[QJOWJQ<##&JF>:]%'*R2F-GM3UYJ>. N>E.]
M@L4#OI8]V[FM?[ 2N<57-J4?I2YTPY67-/AWD<5V>E6P4 XKFM+C&X5VM@@"
M"N.O(WIHMN1'%7.:C=%2<&M^Y!*&N<O[=F)K&E:YI,HPWQ\SK72Z;.'49KE4
MM&#YK?TX&,#-:5$K:$0O<U;^)7A/%</J=N!*<"NRN9QY6,URVH$,YI4;H=0J
M:<FV05VVFG]V*X^S&)!77Z=_JQ3KZBID&L?ZIJX&\_UY^M=]K'^J-<#>_P"O
M/UJ\/L*H:NC_ 'EKN+3_ %'X5P^C_>6NXM/]365?<JF8.N]#7+P8^T<^M=5K
MH^5JXTR^7/\ C6U'6)$]SOM(">6*UI44IQ7(:7J6T 9KH8;T2KUKFJ0:=S6,
ME8I7D7)K.W-&U= \8E%4Y;#.2!3C)=0:,UK\HO6LN\U$L#S6I<Z<YS@5BW>G
MR+G@UO#E,I7,F>;>U,CDVT3PF,G-5=^#74EH8EYY^.M5F<DTS<313M8"5'Q4
MPG(%5:3)HL%R=Y2PZU6?DT[-(:$AW);;AA73Z6_(KF(/O5T6EGYA6578J.YV
M5L-T59&LQX0UM67,0K,UH?NVKB@_>-Y;'GE]Q(:KI5C4/]::KQUZ2V.5[DE%
M%% !12XI*8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %**2E% #J***0SBZ***U.P*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I"N:6B
M@!NVEQ2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 &*;MIU% #=HIP%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %0OUJ:H7ZTT!HZ7_K%KTKP
M_P!%KS72_P#6+7I7A_HM<F(V&CO;+[@J[5*R^X*NUY;W&%%%%( HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** *EU]TURNJ]#7577W37*ZKT-;T=S
M.9Q][]XU27K5V]^\:I+UKTX['(R2BBBF 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 TU+%UJ(T]#@TF!T.E'YUKN+$YA'TK@-+D_>"N[TYMT(^E<-='139G:V
M/D->?WH_>FO1-93,;5P%^F)36N'>A%4I+3L4@&*6NHR#%&*6B@ Q2$4M!H$-
M J>W^^*A%30??%)[#1V.A_PUU?\ RQ_"N4T0<K77I&3#7FUOB.N&QR>L+DFN
M2N4.XUWFIV9?/%<[/IC$GBNBE-)&4XG,&,YIPC/I6X=*;/W:<-*;^[6_M$9\
MK, IBKEAQ(*NSZ:RC.*JPQF*49HYE)!:S.[T4_*M=!(/W=<MHMP %&:Z-I=T
M7%>=57O'5!Z&/>NJL<UF-<)GM4^IAR3BN>;S?,[UO"%T9REJ=!#,I/%7#-A*
MQ[*.0@9S5Z3*IS4RCJ-,R-6FSGFLBTYG%7-2DR35&S;]\*Z8JT3)O4[O21^[
M%6KY?W9JGI$@V"M.ZC\R+BN&6DC=;' ZKPS5AI\TM=3JUB[,<"L:'3W$O(KO
MIR7*823N;>BQ'*UV4:XA_"L#1K7;CBNF*8A_"N*M*\C>"T.2UKO7,K_KJZ;6
MAR:YE1^^KII?"8SW.FTD9Q750MLCKF='7.*Z*4%(,US5=6;0V&37X1L9J2&]
M60=:Y#5+UHY3S1IVJ9< M3]C[MQ<^IT>HP"5#7#ZM8;6)Q7>P.)XZRM5T_<A
M(%.E/E=A3C=7//X4\N4?6NNT9_NUSUU;&*4\=ZU-)FV, 3754]Z)E#1G>0<Q
MBJUV0H.:6SG#1CFH-1W%#BN!+WCIOH9%Q.@:FQ3(3QBLJ\$OF'&:6U64D9S7
M5R:&/-J=$LWR<5FWTQYYJS$C;.:SM0.T&HBM1R>A2#Y>MW3>HKF4DS)72Z4,
MXJZBLB8;F^3^Y_"N0USG=78,I\FN0UP8W5E1^(TJ;'(%?WWXUU6ACE:Y8_Z[
M\:ZK0ADK776^$PAN=K%_J/PKFM<Z-731*?(_"N;UP8#5Q4OB.B>QPER/WWXU
MNZ(/F6L.Y_UWXUNZ(,LM=U3X3FCN=Y:?ZD?2LK6#\IK7M%/DCZ5E:PI"FN"'
MQ'3+8X>Z_P!=^-;FA_>%8=W_ *\_6MW0AEEKLJ? 81W.Q3_4?A6!J?!-=$B'
MR/PKG=6&-U<E/XC>6QD1/^]KJM+.4%<2)MLU=3H]R, 9K6K'0B#U+^IQYB-<
M!JD6)#7I-RHEBXKD-5TYF8D"E0E9CJ*YQP3)Q5J&S9^@J]'I;^9]VNBT[2,@
M96NF=5)&,87.7.FOCI4$EHR=17H,NFHD?2N=U&%4SBHA6YF5*%CF&&TTW-27
M/#'%0@UTHR'*>:MP#)%4QUJU;OAA2D".AL+02 <5I/I8\O(6J^D2#BNJBC62
M.N&I-IG1"*://M0M&B)P*QFE>-J]$U/3/,!P*Y6ZT=@Q^6MJ55-:D2@S%2]D
M##DUTFCW3LZ\FLI=(??]VNBTG36C()%.K*-A03N=99,6B&:JZI&"AJY;CRH^
M:S-5N0$(S7!'XM#H>QQ&IH!*:FTD?O!574)@TIJSI)_>"O0?P',OB.ZLA^Y'
MTK.U8?*:T['F(55U.W+H<"N*+M(Z'L>?W@_>FM71CAUJO?63"0G%3:<#$XS7
M:W>)@E9G>V7,0I+K !S56PN04 S4MX2T9(K@M[QTWT,>ZF12<U62="U4]0$F
M\XS5:W64OWKI4-#%RU.DBE&WBJM],=II;=&VC-5[_A#4):E-Z&-))F2MC3#D
MBN?=_P![6]I/.*VFO=(B]3IX_P#55@ZS]TUT$:GRJY_61\IKGI_$:2V.)N5_
M>FM?1Q\ZUE7/^N-:^CCYUKMG\)A'<[NQ_P!2/I6;K7^K-:EBI\D5F:TN(S7!
M#XSH>QYWJ0_>GZU8T<?O14&HC]Z:LZ./WHKT7\!S+<]%TK_4BDU3_5FGZ4I\
MD4FJ*?+->;]LZ?LG"ZE]XUAR]36[J0^8UAR_>KT:>QS2&"EH6@]*T))89,.*
MZ_1)N5YKB5.&KH=)N=C#FLJL;HN#LST:+YXJPM6M-VXXJ_I]XK(!FK5S$LR&
MO/3<9'2]4>:7]J58\5D%"&KO-2TTMG"US[Z4WF?=KOIU58YI09G6\!<CBM^P
MTTOCBGV.EMD?+756%B$49%95:MMBX0,HZ6%BSMK"O[81L>*[VZ")$>E<5J\@
MWMBLZ4FV5-)(@TYL2"NST\Y05P%G/ME'-=GI=R"HYIUXBILV)N%K#O)44G-;
M$[;H^*Y74Q)N.,UE25V:28\3QENU7891CBN:C$I?O6S:(^!FM9Q2(BRS<S'8
M:P;F3+FMBZ&$-<]=2?/54T*;+ED<R"NPT[_5BN,TXYD%=MIJGRQ6=;0=,JZQ
M_JS7 WO^N/UKO]94B-JX"]_UY^M:8?854U='^^*[BT_U(KA]&&7%=U:*?('T
MK*ON53,/7/N-7"7()F./6N[UT$*U<64#3\^M;T-(D5-RQ8[QBM^UG9 ,FJUA
M:!E'%79;4JO J9R3=@BFB]'J*KU-7(;Z-^,BN/N/-1N,TZTGFWCK4.BFKE*;
M.ZCCCF["JM_IR&,D"H],E? S6E<R#R37.[QD:Z-'G&L6PB9L"N<;[]==KK L
MU<DX^<UZ=%^Z<DUJ/ XI:04M:$BTA%%%  !36IU-:@"6'[U=#I?WA7/VXRPK
MI-,3D5E5V+@=A9'$0K-UH_NVK0M3MBK)UB3*-7#!>^;RV.#U#_6FJ\=6+[F0
MU72O26QRO<DI1244P%I*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *44E** '44
M44AG%T445J=@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !4+]:FJ%^M- :.E_ZQ:]*\
M/]%KS72_]8M>E>'^BUR8C8:.]LON"KM4K+[@J[7EO<84444@"BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH J77W37*ZKT-=5=?=-<KJO0UO1W,YG
M'WOWC5)>M7;W[QJDO6O3CL<C)****8!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0S)Y'7M7,Z[(I5L5636\1XW5EW^H^<#S7)3I-2N;2FFC"N?]=^-;VAL ZYK
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MUL<PZBBB@84M)2YH 2BBBF(****!A1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2BDI10 ZBBBD,XN
MBBBM3L"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4+]:FJ%^M- :.
ME_ZQ:]*\/]%KS72_]8M>E>'^BUR8C8:.]LON"KM4K+[@J[7EO<84444@"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH J77W37*ZKT-=5=?=-<KJO
M0UO1W,YG'WOWC5)>M7;W[QJDO6O3CL<C)****8!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ I124HH =1112&<71116IV!1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I:2B@ -)2T4 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1112 ****8!1110 4444@"BBBF 4444 %%%% !1110 4
M444 %%%% !24M% "4M%% "TE%% !1110 4444 +2444 %%%% !1110 4444"
M"EI**!A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444@"BBB@ HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 M
M)110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444@"B
MBBF 4444 %%%%( HHHI@%%%%( HHHI@%%%% "44M% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !2BDI10 ZBBBD,XNFDT[K32A-:G8&Z
MC=2>6:7RS3 3=1NH\LT>6: %#4;J3RS2[#0 ;J-U&PTFPT@%W4;J3RS2^6:8
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
M!NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+- !NHW4>6:/+-
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MFC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@
MS1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF
M@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-IH
MVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-
MIHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&
M:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #
M-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC::
M #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC
M:: #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9HV
MFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9
MHVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,
MT9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH
M ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-
MIH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC:
M:-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1F
MC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S
M1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@
M S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHV
MF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-I
MHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:
M-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-
M&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC::
M#-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC:
M: #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVF
MC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9H
MVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH ,T
M9HVFC:: #-&:-IHVF@ S1FC::-IH ,T9HVFC:: #-&:-IHVF@ S1FC::-IH
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MM_=H_LUO[M>C?V!_LT?V!_LT?6$!YS_9K?W:/[-;^[7HW]@?[-']@?[-'UA
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M[-;^[7HW]@?[-']@?[-'UA ><_V:W]VC^S6_NUZ-_8'^S1_8'^S1]80'G/\
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M"/R4]*/)3TJ2BBX$?DIZ4>2GI4E%%P(_)3TH\E/2I**+@1^2GI1Y*>E2447
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M+V.Y'<CH**!T%%>4,****0!1113 **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MMZ1G(H0_ZRNHTOH*Y>'_ %E=1I?05I5V)@;%%%%<AL%%&:* $HI:* "BBBD
M4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***,T %%%% !1110
M E+24M  >E<UK?W6KI3TKFM;^ZU:TOB(GL>>:G_K#11J9_>&BO6AL<;W.'T/
M_7+]:]G\*_<2O&-#_P!<OUKV?PK]Q*QQ>QW([D=!10.@HKRAA1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5SFO?=:NCKG->^ZU73^(#@KC_7_C6YH_45AW'^O_&MS1^HKLG\
M(D=I9?=%:%9]E]T5H5PRW&%%%%( HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** *5WT-<W?\ 4UTEWT-<W?\ 4UO2,Y%"'_65U&E]!7+P_P"LKJ-+
MZ"M*NQ,#8HHHKD-A*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "DI:* "BBB@ HHHH ****  ]*YK6_NM72GI7-:W]UJUI
M?$3/8\[U3[[44:I]]J*]:&QQ/<XC0_\ 7+]:]G\*_<2O&-#_ -<OUKV?PK]Q
M*QQ>QW([D=!10.@HKRAA1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 5SFO?=:NCKG->^ZU73^
M(#@KC_7_ (UN:/U%8=Q_K_QK<T?J*[)_")':67W16A6?9?=%:%<,MQA1112
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"E=]#7-W_4UTEWT-<W
M?]36](SD4(?]974:7T%<O#_K*ZC2^@K2KL3 V****Y#8**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M****  ]*YK6_NM72GI7-:W]UJUI?$3/8\[U3[[44:I]]J*]:&QQ/<XC0_P#7
M+]:]G\*_<2O&-#_UR_6O9_"OW$K'%['<CN1T%% Z"BO*&%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ****  ]*YK6_NM72GI7-:W]UJUI?$3/8\
M[U3[[44:I]]J*]:&QQ/<XC0_]<OUKV?PK]Q*\8T/_7+]:]G\*_<2L<7L=R.Y
M'044#H**\H84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH ****  ]*YK6_NM72GI7-:W]UJUI?$3/8\[U3[[4
M4:I]]J*]:&QQ/<XC0_\ 7+]:]G\*_<2O&-#_ -<OUKV?PK]Q*QQ>QW([D=!1
M0.@HKRAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 5SFO?=:NCKG->^ZU73^(#@KC_7_ (UN
M:/U%8=Q_K_QK<T?J*[)_")':67W16A6?9?=%:%<,MQA1112 **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@"E=]#7-W_4UTEWT-<W?]36](SD4(?]
M974:7T%<O#_K*ZC2^@K2KL3 V****Y#8**** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****  ]*YK6_
MNM72GI7-:W]UJUI?$3/8\[U3[[44:I]]J*]:&QQ/<XC0_P#7+]:]G\*_<2O&
M-#_UR_6O9_"OW$K'%['<CN1T%% Z"BO*&%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7.:]]
MUJZ.N<U[[K5=/X@."N/]?^-;FC]16'<?Z_\ &MS1^HKLG\(D=I9?=%:%9]E]
MT5H5PRW&%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *5WT
M-<W?]3727?0US=_U-;TC.10A_P!974:7T%<O#_K*ZC2^@K2KL3 V****Y#8*
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH ****  ]*YK6_NM72GI7-:W]UJUI?$3/8\[U3[[44:I]]J
M*]:&QQ/<XC0_]<OUKV?PK]Q*\8T/_7+]:]G\*_<2L<7L=R.Y'044#H**\H84
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<YKWW6KHZYS7
MONM5T_B X*X_U_XUN:/U%8=Q_K_QK<T?J*[)_")':67W16A6?9?=%:%<,MQA
M1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"E=]#7-W_ %-=
M)=]#7-W_ %-;TC.10A_UE=1I?05R\/\ K*ZC2^@K2KL3 V****Y#8**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH ****  ]*YK6_NM72GI7-:W]UJUI?$3/8\[U3[[44:I]]J*]:&QQ
M/<XC0_\ 7+]:]G\*_<2O&-#_ -<OUKV?PK]Q*QQ>QW([D=!10.@HKRAA1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 5SFO?=:NCKG->^ZU73^(#@KC_7_ (UN:/U%8=Q_K_QK
M<T?J*[)_")':67W16A6?9?=%:%<,MQA1112 **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@"E=]#7-W_4UTEWT-<W?]36](SD4(?]974:7T%<O#_K
M*ZC2^@K2KL3 V****Y#8**** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH ****  ]*YK6_NM72GI7-:W]U
MJUI?$3/8\[U3[[44:I]]J*]:&QQ/<XC0_P#7+]:]G\*_<2O&-#_UR_6O9_"O
MW$K'%['<CN1T%% Z"BO*&%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7.:]]UJZ.N<U[[K5=
M/X@."N/]?^-;FC]16'<?Z_\ &MS1^HKLG\(D=I9?=%:%9]E]T5H5PRW&%%%%
M( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *5WT-<W?]3727?0U
MS=_U-;TC.10A_P!974:7T%<O#_K*ZC2^@K2KL3 V****Y#8**** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH ****  ]*YK6_NM72GI7-:W]UJUI?$3/8\[U3[[44:I]]J*]:&QQ/<XC0_
M]<OUKV?PK]Q*\8T/_7+]:]G\*_<2L<7L=R.Y'044#H**\H84444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %<YKWW6KHZYS7ONM5T_B X*X_
MU_XUN:/U%8=Q_K_QK<T?J*[)_")':67W16A6?9?=%:%<,MQA1112 **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@"E=]#7-W_ %-=)=]#7-W_ %-;
MTC.10A_UE=1I?05R\/\ K*ZC2^@K2KL3 V****Y#8**** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M*  ]*YK6_NM72GI7-:W]UJUI?$3/8\[U3[[44:I]]J*]:&QQ/<XC0_\ 7+]:
M]G\*_<2O&-#_ -<OUKV?PK]Q*QQ>QW([D=!10.@HKRAA1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 5SFO?=:NCKG->^ZU73^(#@KC_7_ (UN:/U%8=Q_K_QK<T?J*[)_")':
M67W16A6?9?=%:%<,MQA1112 **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@"E=]#7-W_4UTEWT-<W?]36](SD4(?]974:7T%<O#_K*ZC2^@K2KL3
MV****Y#8**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH ****  ]*YK6_NM72GI7-:W]UJUI?$3/8\[U3
M[[44:I]]J*]:&QQ/<XC0_P#7+]:]G\*_<2O&-#_UR_6O9_"OW$K'%['<CN1T
M%% Z"BO*&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !7.:]]UJZ.N<U[[K5=/X@."N/]?^-;
MFC]16'<?Z_\ &MS1^HKLG\(D=I9?=%:%9]E]T5H5PRW&%%%%( HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** *5WT-<W?]3727?0US=_U-;TC.10A
M_P!974:7T%<O#_K*ZC2^@K2KL3 V****Y#8**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BDI: "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG->^ZU='7.
M:]]UJNG\0'!7'^O_ !K<T?J*P[C_ %_XUN:/U%=D_A$CM++[HK0K/LONBM"N
M&6XPHHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!2N^AKF[_
M *FNDN^AKF[_ *FMZ1G(H0_ZRNHTOH*Y>'_65U&E]!6E78F!L4445R&P4444
M %%%% #6<+UIOG)GK52^F,8-8O\ :)$F,T =0"".*6L^QO%D49-7]Z^HH 6B
MDW#U%+0 4444 %%%% !1110 4444 %%%% !124M !1110 444E "T444 %%%
M% !1110 4444 %%%% !1110 444E "T444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1124 +1110 4444
M %%%% !1110 4444 %%%)0 M%%% !1110 4444 %%%% !1110 4444 %%%%
M!1124 +124M !1110 4444 %%%% !1110 44E+0 4444 %%%% !124M !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%)0 M%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH **** "BBB@04444#$Q2T44 %%%% !24M% "4N:2B@!:*** "BBB@ HHHH
M**** "BBB@ I*6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "DI:2@!110** "BBB@ HHHH **** "BBB@ HHHH **** "DI:* $I:**
M"BBB@ HHHH **** "BBB@!,44M)0 N:*2B@!:*** $I:** "BBB@ HHHH **
M** "C-%)0 M% HH ****0!0:*#3 2ES244 +24M% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%)0 N:*2EH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ I,4M% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 !Z5S6M_=:NE/2N:UO[K5K2^(F>QYWJGWVHHU3[[45ZT-CB>YQ&A
M_P"N7ZU[/X5^XE>,:'_KE^M>S^%?N)6.+V.Y'<CH**!T%%>4,**** "D+ 4M
M5KA]JF@"&[N553S7+:G,LF0#4^K7I3/-<T;PRRXS0!0O=/,Y.!6<-#<-G;7>
MZ;8"YP2,UMC0$P/E% 'FUMI<B8^4U>\F6)>]=Z-"0?PBH+K1%V\+0!Q]I-()
M "37:Z/(65<UC#2=DF<5T&FP>6!Q2 UZ***8!1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %!HHH 2EHHH **"<5&TZ+U- $E%0BYC/0U('#=* '
M444AH 6BD%+0 4444 %%%% !1110 4444 %%%% !1124 +124M !1124 +10
M** "BBB@ HHHH **** "BBB@ HI#10 M)2T4  HHHH **** $I1110 4444
M%%%% !1110 4444 %%%% !1110 44E** "BBB@ HHHH **** "BBB@ HHHH
M**** $I1110 &DI:* "BBB@!#12T4 %)2T4 )12T4 )2T44 %%%% !1110 4
M444 %%%% !1110 44E% "T4@I: "BDI10 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444@"BBBF 4444 %%%% !
M1110 4444 %%%% !1110 4E+10 "BBB@!*6BB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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ML3 V****Y#8**** "BBB@"O<SB)3FN9U.]1\C-7=?NC"C8->?7&J,]P5SWH
MEO[3[03@5C-H;E\[:[/2+;[6!D9S71IH"%02HH&>;6NDNA'RFK<MO+$G ->A
MKH2#^$56O-#4KPM C@;2659@.:[[0G9E7-8XT39+G;71Z7;>2!Q0!LT444 %
M%%% !0:** $I:** "BBB@ HHHH *2EHH 04M%% !1110 4444 %%%% !1112
M ****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%&:3(]: %HI,BEH **#24 +1110 4444 %%%% "4"EHH **** "BBB
M@ HHHH **** "@T44 )2T44 %%%% !1110 4E+10 E+110 44E+0 4444 %%
M%% !1110 4444 %%%% !112$@=: %HIAE0=Z!*A[T /HI P-+0 4444 %%%%
M !1110 4444 %%-,BCJ:02J>] #Z*0'-+0 4444 %%%)0 M%%% !1110 444
M4 %%%% !1110 44E% "T444 %(:6B@!*6BB@ HHHH **#24 +24M%  ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>0'IOVB+^\*/M$7]ZO,_^$J/]^C_ (2H_P!^CZO(#TS[1%_>H^T1?WA7F?\
MPE1_OT?\)4?[]'U>0'IGVB+^\*/M$7]X5YG_ ,)4?[]'_"5'^_1]7D!Z;Y\?
M]X4X2(>C"O,!XK.?O_K5RV\4[B/G_6D\/) >B9![TM<S8ZV)L?-6];SB51S6
M4HN.X%BC%%%2 4444 %%%% !1BBB@ HHHH *3%+10 E+24M !1110 4444 %
M%%% !1110 4444 %%%% !1110 5SFO?=:NCKG->^ZU73^(#@KC_7_C6YH_45
MAW'^O_&MS1^HKLG\(D=I9?=%:%9]E]T5H5PRW&%%%%( HHHH **** "BBB@
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M44 %%%% !1110 4444 %%%% !BBBB@ HHHH$%%%% PHHHH **** $I:3%+0
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M0.:MUD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 !Z5S6M_=:NE/2N:UO[K5K2^(F>QYWJGWVHHU3[[45ZT-
MCB>YQ&AC]\OUKV?PK]Q*\9T/_7+]:]F\*_<2L<9L=R.Y'044#H**\H84444
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M"RUIWN!\QZT70W3DCV>VN1, 0:MURFAWV^-<FNE6Y0CK1<BS)J*8LBMTI],
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M&:KV-CY\@R*].G%00BDD4\G/-2"TG]#7?:;X>5XP2M:?_"-I_<J7B$F!Y?\
M9)_0THLYSV->G_\ "-+C[E-;P^B_PBE]80'FHLI_0TALI_0UZ,VCQ+_"*0:1
M$W\(H^L(1YP;2<=C2?9)_0UZ<OAY'Z**>?#2#^ 4?6$,\J:VG'8TB/-"><UZ
M?+X;3!^05SFL:((%)"U4:REH%BAI6K,CJ"U>AZ+J/FJO->/EC;SX]Z[7PY?$
M[1FHKTTU<#U)'W#-/JA8R[XQ5^O.:L,***:SA!S2 =159KZ)3R:5+R)SP:!V
M+%%(K!AD4M @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *YS7ONM71USFO?=:KI_$!P5Q_K_ ,:W-'ZBL.X_U_XUN:/U%=D_A$CM
M++[HK0K/LONBM"N&6XPHHHI %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!2N^AKF[_J:Z2[Z&N;O^IK>D9R*$/^LKJ-+Z"N7A_UE=1I?05I5V)@
M;%%%%<AL%%%% "$X%5Y;D1CK4[_=-8>I2%5;% &?KFH*589KSW4+@-*<5L:Q
M<N2W)KFMK224 3PR/VJ?S9!W-7+"P+@<5H/IF%Z4 9EO?/&PR374:3J18J,U
MS,U@ROP*U-*MY%D'!H ]&LI?,CS5JJ&F B(9]*OT %%)2T %!.!FFLP4<U2N
M[Y8U/-("P]P%.,TY)@]<K<:J/,X:KECJ(;O3 W9IQ$,UFR:PJ-C(JOJ%WF(X
M-<7?7LBRGDTKC/08=464]16@D@=<UYGIVIL'&6KL++40T8YJF2C4N+L0CK5
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M5>QQH 2*UAJ,)[TKHI4Y]BY15=;R-^AJ97#=*+B<6MQU)2T4Q ***8T@3K0
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M2BBBF2%%%% !1244 +1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MCH=HO^E)ZUFWVF%06Q6CHQR!FM#453R#TZ5<%H9RW..MF,,P%=WH<N]5KA9
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MJ:;YR>M [,DHIH=3T(IU @HIC2*O>F?:4]:+CLR:BHQ,C=#3P0>E K"T444
M%%%% !129I: "BBB@ HI,TM !1110 4444 %%%% !1110 4444 %%%% !129
MHS0 M%%% !1110 4444 %%%5[F81J>:!I7=B?>H[TF]?45SEUJXC)^:J\6MJ
MS8W5G[1'4L'-JYUF0>]+63:7PEQS6HARH-6G<YYP<'9CJ***9 4444 %%%%
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M^:HE443JI86=38[+[1'_ 'J'N(U&=U>>?\)+\WW_ -:D;Q%N7[_ZU'MD=/\
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M HHHI %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBDH
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M8J,')V18>Y"GK0ERK'K7)W>KA6/S5%;ZV"X&ZLO:JYW+!2<;G<*X84ZL6RU
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MV5<YQ4@A %2T4 5Y+57[54DTF-ST%:=% &=%I:1G.!5U(0JXJ2B@"K+9K+U
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MF=>*]%\/:6R[3MK!\/6 )7<*]0T>VBCC7I6].!Y&-Q-E9&K80^5"*MTT,N,
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M68E<<5FPL9&%=7HUN69>*R6K.^H_9P-S1]* VG;786=N(E'%5=+MPJ#BM8#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M")':67W16A6?9?=%:%<,MQA1112 **** "BBB@ HHHH **** "BBB@ HHHH
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M.M8V=MR[HVEJVWY:ZN&Q2,#@5G:,  *W:M12.:=><]V-5 HXIU%%48A1110
MA.*H:A.%0U:F?:IKEM9OMBMS43E9'3AZ3G(Q-8NP=W-<7?R;R:O:IJ&YSS6&
M\V\]:\ZI*[/L<'A^2-RJ5R]:-DH#"J>.:L0R;#4+0ZJEVK'::5(B[<XKL=/N
M8P!R*\KAU/RL<UMV&N_,!NKIIU$CQL7@IS5SU>*967@U,#FN3TO5/- YKI8)
M0ZBNR,KGS=:@Z;LR>BBBJ,".?_5&N,UR(G=Q7:N,J16)J5EYBGBLZBNCKPE1
M0GJ>5:A$0QKG+QBI-=[K-EY>[BN$U),.:\Z<;,^PP]53AH.TR0>:,UZ9X?\
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M597?F@<UJ#H*V3N>?.#B[,6BBBF0%%%% !1110 4444 %%%% !1110 4444
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MEISHPXKI;.$H!F@#34Y%+35&!3J "BBB@ HHHH **** "BBB@ HHHH ****
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M<]ZLX<AZ+HUT61<FNEB;<*YG1[9E5>*Z:)=J5VPV/F,1;FT)****LYPHHHH
M**** "BBB@ HHHH **2B@!:,T4E "T4"B@ HHHH CE0.A%8=[I8E)^6N@I"H
M/44FKEPJ.&QR"Z$-^=M:EIIHBQ\M;6Q?[HI=H':I4$C25>4MQD2;%Q4E%%68
M!1110 4444 %%%% !1110 4444 %)BEHI %%%%, HHHH **** "BBB@ HHHH
M **** "BBB@ HHHI %%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHQC;&!3Z!P**Z#R HHHH **** "BBB@ KG->^ZU='7.:]]UJNG\0'!7'^O\
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M6BK2L<TI-N["BBBF2%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQO)@!C-:8OI\]30!WL,L1/&*TH64CBN%L+J5F&<UU=C(S*,T :XZ4M-3I3J
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M9E;3HMTHKTOPY8*^W(K@-*A)F7ZUZGX<3:%ITUJ1C:BY=#LK.R2*%>*N  #
MIL)S$M/KL1\W)MO4****9)'*<(:Y'7G^1JZR?[IKC]>!V-43V.K#+WCR_7,&
M1JYLJ-U=#K8(D:N<+8:N&6Y]71^ <W%,#X-(S4T#)H$UJ2E\BEBY>F[#BGPC
M#BD:+8Z;1U^=:]-T(?*M>:Z.1O6O2M#(VK6](\?';'90_P"J%25'!_JA4E=9
MX#W$/ -8NHWPA!YK9?[C?2N%\23L@;!J)NR-\/3YY6*E[KH5R-U16VNY8?-7
M!ZA?N)3R:BM]3*G[U<WM-3WOJ2Y#UF/608_O5C:KJP93\U<BFLD)]ZJ5WJI<
M'YJT]KH<?]G^]<GO[OS'/-8[VYE;@4PW.]^M;FE6HG9>*YW[S/5IQ]C$DT33
MF\Q3BO5= @,:+FLG1=&&%.VNQM+00J.*Z:4+'C8[$J;L7.U%%%;GDA61JL1>
M-JUZ@GA\P4F7"7*[GDNNZ4TSMA:Y9_#;LQ.PU[5<Z2LC$D54?1HE4DJ*YI4K
ML]JCF'+&R/%+G0VA&2M4!#Y+XKU#7;.*-6P!7GE^H64X]:EPL;0Q3FR[IUSY
M9'-=AI>K[2HW5Y_;L16K92OY@QFH4K,ZIT5.-V>QZ7J'G <UT*'* UY_X=D<
M[<UWT/\ JEKL@[H^<Q4%"5D2444'I5G*12RA$-<CKFH[%;FNAOF(0XKSWQ#*
MWS5G.5D=V$IJ4CE-9U$R.PS7+7/[PFKNHR'S#5 '-<3=V?34H<L="&*+#5N6
M#A"*RUP#4\<VRA!)\QVUC?K&!S73Z?K*C'S5Y-_:1C/6K]GK3!A\U:1G8XZN
M$YT>Z66JK( -U:L<PD'%>5:+JS.5^:O0=+G,BK73"=SQ,1A_9FS1116AQ!11
M10 A&1BLV]LQ*#Q6G2,H:DU<J,G%W1QMSH:NQ.VFVVB*C#Y:Z]H%/:D6W4=J
MCD1T?6I6L4[&Q$0'%:04#I0 %&*7(JTK'/*3D[L****9(4AZ&EHH YW6-VUL
M5YQK+.&;K7J]_;>:AXKA=;TDMNPM85(L]7!58K1GF5Y=,C'FH[35760?,:T=
M3TB3<?E-9<>FNCYP:Y-4SZ&+A*)VFE:LQ49:MB356$?WJXVS!B S5R6Z^3&:
MT4G8X9T(N6A/?ZTX8_-4%GK3F4?-6-=DR,:=86SF0&H<G<Z%1@H:GJN@Z@9
MN37:VTFY!7G7A^)E"UWUEG8*[*;T/G<9%*6A>HHHK4X2.5-Z$5A7^F++GY:Z
M"F-$&I-7-(3<'H<%-H(WYVU<L='",/EKJVM%)Z"G):JIZ5FJ:.B6*DU8BM+9
M8D'%3M.L8YHG<11US&J:J(L_-5M\IC"#J,Z!M1C!QD4]+U'/&*\TF\0_O,;Z
MU-+UGS&'S5"J)LZ98*45<] 5@PS2U0LKD2(.:OYS6J.&2L[!112&@0M%)2T
M%%%% !1110 4444 %%%% !1110 44E H 6BD) IIF1>IH ?14/VF+^]3UE1N
MAH'9CZ*,YHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !12&B@!:*** "BFF15ZFHS=1+U:@=F345 +N(]&
MJ19%;H: LQ]%%% @HHHH **** "BBB@ HHHH **** "BBB@!**6B@!**6B@
MI*6B@!I0'K3#;H>U2T4#NR(0(.@J0#;2T4"N)2BBBD 4444P"DI:* $I:**
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M(D=I9?=%:%9]E]T5H5PRW&%%%%( HHHH **** "BBB@ HHHH **** "BBB@
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MB&?2M>JEG#Y2BK=>A%61\C5ES3;"BBBF9A1110 A.*:9 *9*V!6;<W8C!YH
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M7DNGZPSN/FKN=)O#(J\U5.KS&>+P'LCJP<TM0P-E14U=!Y#5F%%%% @HHHH
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MZ%VBBBMCS HI"<"J\MP$[T#2N6:*RGU%0<;JF@O!(>M*Y3IM*Y?I&8*,FD#
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M%%%,04444 %%%% !1110 4444 %%%% !1110 4444 )1FBB@!:*** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M4FK$=M L:#BK/2@#%%:'*W<****!!1110 4444 %%%% !1110 4444 %%%%
M!12"EH Y[6H2ZMBO-]8T]V<\5Z]<VPE!XKG[[11)GY:QJ0N>CA,2J9Y/%IK"
M3[M=3HUBRLO%;BZ!A_NULV&DB/'RUG&G9G97QJE$LZ9"445MK]T5## (U%3U
MTI6/%G+F=PHI#2TR HHHH *9+]RGTUQE: 1S6L.51L5YIKEXZ,W)KU/5;<O&
MW%><ZWI3.S86N:JF>U@)1OJ<3_:,GG=3UKL_#MV[LN2:YU=#<S9VGK79:!I3
M1E<K6--.YZ6*G3Y-#T72&+0@GTK3JAID?EQ >U7Z[EL?+5/B84444R HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *BG&8B*EI&&1B@$<1K=DT@;BN#OM
M'8R$[:]DN;(2@\5B7.BJS$[:PG3N>KAL9R*QYK9Z0P<?+7;:-8-'MXK1@T95
M;[M;EI8+&!Q2A3L/$XSF1-9H545<IJH%IU="/*;N[A1110(**** "BBB@ HH
MHH **2@4 +1110 4444 %%%%( HHHI@%%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %(:6B@!*6BB@"&Z_U)K@=>ZM7?77^H-<!KW5JWH;@<<_^O_&N
MK\/]5KDW_P!=75:"<%:[*GPDL[M!FW_"N,\1PL=W%=Q:KN@'TK%UJQ\U6XKR
M*JNSNPE3E9XSJ2%7-8<LK*W%=UK.ED,QVUQ]U:%'.17&U9GTE*2G$S7NI/4T
MD<[NW-3-;Y-6[/3B[# I79;IQ2N:6C1EY%R*]7\-V@PA(KB=$TI@RG;7I>BV
MYB5>*WIH\?'25K(Z%450 !6-XBXMOPK;K$\1?\>WX5VT_B/$9Y!J_P#Q\-]:
MT= 'SK6?JW_'R?K6EH0PPKTI? 2>CZ=*$C6K\FI+&O45S\-QY<7X5D:GJA0'
MYJ\FK+E9V4,/[1FAK6M_*P#5YMK>I22%L-5B_P!2:5R,UERQ&<&N252Y[-#!
M*GJSFIKB1I#R:OZ<KR2#K4[:43)TK?T;2<.N5J8IMF]64(QL=-X:M'^3(KTV
MQB\N 5RNC6R0*N1740W<80#-=<+)'S^(NY%RBHUE5^E259RA0:*1NE %*^N/
M+B/-<+J^JF-C\U=;JV?+;%>9:^7#-6%65CU,#24GJ.772'^]4_\ :QD7[U</
M)<,LAYJQ#?$8YK&%34]3$85<FAUZW.\]:>[EDKG[>]Z<UJ0W2L.M;2E='ET:
M#C,IW=J9">*BM=+8R [:W(@DC5N:?IZN0<5BH79Z,L0X1L,T2Q:/;Q7=V2[8
M@/:J-EIZQJ#BM5%VC%=4(V/$Q%;VC'T4459RA1110 4444 %<YKWW6KHZYS7
MONM5T_B X*X_U_XUN:/U%8=Q_K_QK<T?J*[)_")':67W16A6?9?=%:%<,MQA
M1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"E=]#7-W_ %-=
M)=]#7-W_ %-;TC.10A_UE=1I?05R\/\ K*ZC2^@K2KL3 V****Y#8**** "B
MBB@#$UN'?&U>9:S;LCL17JVI$;#FN#UB%9&;% '!O?20$C)I(M9E+@;C6C=:
M2TA.%JI%H<@DSM- SH-)NI)F7DUWVE1N54FN-T:S\EEW"N^TUT5 .*!&O",+
M4E,1@1Q3Z "@T44 )2T44 %%%% !1110 4444 %%%% !1110 4444 9^I_ZH
M_2N/N?\ 7'ZUV&I_ZH_2N/N?]<?K0!K:5U%=/%]P5S&E=173Q?<% #Z*** "
MBBB@ HHHH **** "BBB@ HHHH #TK)O[?S%/%:U,:,-UI-7+A/E=SSC5M(+E
MOEKCK[2&5C\M>UW.GK(#Q7.:CHH8'"URU*%SWL'F?+HSR463*W2KMO9%B.*Z
M>ZT;8Q.VHH;98FY%<ZA9GK3Q7M(W14M]*+ <5,^AEA]VMJVEB7 .*V+58I<=
M*U4$SSYXJI3=SD[/0F60';7;Z/9&%5R*NVUA&<$ 5IQ6ZQCBMZ=+E/-Q6.=5
M69(@PHIU%%;GE!1110 4A4'J*6B@#!UBU0J3BN7%HIGZ=ZZS6),*:Y=9AY_X
MT60U.:ZG2Z38H%!Q6VL:J.!69I+Y05JTK) Y-[A1113$%)2T4  HHHH *AN1
MNA(%34C+N&* .(U6Q>1S@&LJ#39%DS@UZ')9)(><5&--B![4!8Q]-@=,9%=%
M#]RF):JG3%3 8% "T444 %%%% !1110 'D5S.N6?FHW%=-52YMQ*IXJ9JZ-J
M%3DG<\8UC2CYC';69:V&V0#%>G:QI8()VUS*V(6;IWKB=#4^FIYFO9V+VAV'
MW>*[RQM_+0<5C:':@!>*ZE(PH%=-.%D>'C,3[20\=****V//"BBB@ IK*&'-
M.I#0!G7=N@4G%<IJTD<8(XKI]2D(0XKS_7))#NQFLJMDCOP3E*6ISVIW"LQQ
M6!)+\]6;MG+G-54B,CUP2=V?74*:C&[+, :0C%=+H]DY=3BJVD:4TC+E:]#T
M?10JJ2M73I-NYQXS'1A%Q-#18#&BY%;]006XA4"IZ[XJR/DZT^>5PHHHJC(*
M*** "LS4>AK3K+U,X4T <](?WE:MAVK%EDQ+6II\PXH Z&+H*EJ"%\@5/0 4
M444 %%%% !2,,KBEHH Q=1LA*IXKBM3T4LQ(6O3'C#]:IW.GI(IX%93I*1WX
M?&NB>2KI1CEY6NHT>U4%>*MW]@L;DXING_)(!2A142J^8RJJUSK;.!4B!Q5O
MI5>T;,(JQ6QY[;>K"BBB@0444E "T444 %9^J']UCVK0K.U/_5GZ4 <1?1>9
M*:GTW35=@<4LXS-6[I$0.*EP3-X8B42Y::>J <5J)&$&*55"BG4TK$3J.;U"
MBBBF9A1103B@!"<"JMRZLN*9>70C4\US]SJZJQ&ZHE-(ZJ%"4W=$>J6:R@\5
MQMYI@$N<5U;ZDDB]:S)W21ZQY5)GH.I4HQL-T2UV2+Q7HE@FV 5R&E1C>*[.
MV&(16\8V/+K5W4>I-1115&(4444 %%%% !WHHHH S=1N/*4\UQ>I:SY;$;JZ
M37F(1L5Y7K=PXD;FN2O4<3W\LPT:FYO0ZX6D^]74:5J7F;>:\BM+ES*.>]=U
MH4K';65*JVSOQV#C&.AZ9#-O45/698$E!FM(=*[TSY2I&SL+1113("BBB@ H
MHI* %HH%!H **2EH ****  TE+10 4444 ,:-6ZBHFLXF[58HI6&I-;%=;.)
M>@J58U4<"GT4[ Y-[C&B1NHJ)K.)NU6,T46!2:V*RV<:G@5,L:KT%/HI6!R;
MW"BBBF(**** "BF-(J]:A:]C4\FE<:BWL6:*KK=QMT-3*X;I1<'%K<=13&D5
M>M0F]C4\FBXU%O8LT576[C;H:F5PW2BXG%K<=1113$%5KB;8AJP>AK,OR=AJ
M9.QI3C=G/ZMJ.S/-<K-K163[W>KNN.P+5Q%W*WFFN"K4:9]5@<)&43OM,UG>
MP&ZNTTVZ\U1S7D&CR.9%ZUZ=H1;8N:VH3;.',\/&&QT]%)D 4GF+76?/V'44
M@8&CK0 M% HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M #24M% !1110 4&BB@!*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ ICN
M$%*S;165?W@C4\TF[%P@Y.R+3WRH>HI$OU8]17%7VL;7/S5#:ZWEP-U8>VU/
M267MQN>B),&J4<USVGZ@)0.:WHFW)FMHRN>?5I.#LQ])2T51D)2T44 %%%%
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M1!NU244 1+" >E2@8HHH&W<****!!1110 4444 %%%% !1110 4444 %%%%
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M\A<UQ&D63Y7(->@Z/;E N1713/'QLET.DA&(Q4E-0804ZND\1A1110 4444
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***3-
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MY?2[U"5R:[&QN%9!0!HQ)M6I*:AR*=0 4444 %%%% !24M% "4M%% !1110
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M:(SN*MAW V9) HZU3DOE4]:R[_5 BGFN8NM<PY^:B4[!2PTIG=QWRL>M78Y
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MBN[TZ,JHKKHMG@YBHWT-@=**0=!2UTGBA1110 4444 )@>E&!Z4M% !1110
M49HI* %S124HH **** (;EML)-<+KU^8]W-=S>#,!KS?Q'$Q+8K"LVD>IEL(
MRGJ<C=ZDS3'FM71[LEUYKF+B%Q/^-;FC1MO6N&,G<^HKT::IZ'J>CW.8UYK>
M1LBN7T9&"+731#BO1IO0^-Q44INQ)1116ARA1110 4QG"TYCA2:Q[^^$(/-)
MNQI3@YNR+TETJ]ZR=2OE*D9K#NM; )&ZL>ZU;?GYJQ=97/16 ERW-$R!YNM=
M1HRC KSZ"^!D'-=;I.IJH'S5JIHX*F&FGH=A16>FI(W<592Y5^AIW1#IR6Z)
MZ*0'(I:9 4444 9U_;>:IXKAM9TK[QVUZ2RAAS6+JUDK1DXK&K"Z._!XETY)
M'C5];^2QXK.CFVR5U6O6>UVP*Y%T*2&O.E>+/L:+5:GJ==H^H>7CFND.L@18
MW5YS;W)C[U;;4&VXS6JK.QQ3RZ+E<Z*ZU<ES\U6=/U<EQ\U<4URSMUK4TS>9
M!UI1J.YI4PD%#4]4TR\\T#FM]3E0:Y#0U;:N:ZZ/[@KOINZ/D\7!1G9#J2EH
MK0Y HHHH *3 ]*6B@!-H]!2X%%% !1110 4E+10 4444 %&:*2@!:*04M !1
M110 4444 %%%% !1110 45#).$ZU1FU58\\BDY)%QIREL/U4 PGZ5Y[JD960
MFNFOM91@1N%<KJ-XDF>14\ZL:K"SYM2O:WQ@;DULP>( N!NKB;JYVDX-9IU&
M19.IKBJ5VF?283+(SA=GL=AK(E(&ZNCMI?,4&O(= OW=UR:]1TAR\0^E=%&I
MS'DYCA51>AJT445T'DA56\3<AJU367<*&.+L[G#:Q9LP;BN+N[!O,/%>M7MD
M)%/%<[<Z.&<_+7)4I7/>P>.459G&V-@V\<5U5E8-L'%7+/2 K#Y:Z&VL55.E
M%.E86*QU]CDKZR;8>*Y"_L6+GBO6;NQ#*>*YVYT<,_W:*E*Y6#QRCN<-8:<_
MF#BN^T2U:,+D4EGHX5A\M=%:6@B XITJ5B,=CE45B]&,1BGT@&!2UU'A,***
M* # I-H]!2T4 &!Z50U!/W1Q5^H;E-\9%)K0N#M),\O\0AP6QFO/KHR>=WZU
MZ_K&F&7=\M<C-X>9I<[.]>=5IML^PR_%TXPU,[0!(77.:]9T('RESZ5Q^DZ*
M8F'RUWNF0>5&/I6^'@X[GEYKB(U/A-&BBBNL\ **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6B@!*6BB@ HHHH **0L!3
M/-7- [,DI* <BEH$)2T44 %%%% !1110 8S5.ZMQ(IXJY2$ ]:35RHR<7='*
M76D!V/RU';Z,%;.VNM,2'J*00H.U1[-'4L9-*Q0M;,1@<5HH,#%*% Z4M6E8
MYIS<G=A1113("C-!I* %S124M !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %-D_P!6WTIU-D_U;?2@#S?Q5]YZX:+_ (^?QKN?%7WG
MKAHO^/G\:].C\(F=]H'W5KNK+[@^E<-X?'RK7<VAVQUQUMP1;I"0!DU6ENUC
MZFLVZU=0"-U<SDD;0HRELBKK=T%5N:\\U+4-LAYK>UG4?,#8-<)J$C.YKCJU
M.Q]+E^$5O>-JQU8JX^:NPTS61@9:O+('96K9M+]H\<UG"JT=6)P,)+0]=AU1
M7 ^:M"&Y$G>O+[76BN/FKI])U7S2!NKIC6N>%7P#@KHZ+53FU->0^(A_I#?6
MO5[V3S+0_2O*_$8_?M]:]7!ZGD37*[%?0Q^]%=W#/Y< ^E<-H?\ K!79;"UO
MQZ56,V+PVL]3.U'4V7(S6'_:C>9]ZK&J1/D\&N;F9HVKYVI)\Q]IA:$'#0[.
MTU<A/O57U#4O,4\URL=ZR]Z26\9AUIJLTB9Y=&4KE_[6!+G-=%I-ZC$ FN >
M=MU;6C7#F1>:%5NRZF 4(7/6]-5)0#Q6['"J 8%<UX?9F1<UU(Z5Z%/5'R.*
MNIV"BBBK.41C@9K+O;ORU/-:4OW#7-:L6"MBHF[(Z,/!2EJ8^H:MM8_-6:FN
M[6Y:LO5I'#-7,373J_!-<,ZK3/J</@8R@=]-KZF/[U<]?:HLK'FN=>[E8=34
M(>1FYS6]*:DM3R\;AY497B:NX2FE%F6/2FV2$D9KI+*R$F.*FI33V-<'C:D5
M[Q2L-/;<.*[32;-EV\4:=I0X^6NFM+(1@<4Z5*Q&-QO,K%BT0JHJW354*.*=
M74CP9.[N%)0:*8A:*!10 'I7-:W]UJZ4]*YK6_NM6M+XB9['G>J??:BC5/OM
M17K0V.)[G$:'_KE^M>S^%?N)7C&A_P"N7ZU[/X5^XE8XO8[D=R.@HH'045Y0
MPHHHH K7)(0UR&L7+Q[L$UV<J;E-<SJU@9 W% 'GU]J,N\C)JHDTDQYS6S>Z
M2=Y.*;:V"JPR* *2V+R+G%1/82(W -=I9V<94<"K+Z5&_0"@#DK!94<=:[72
MG?"YS4=OHBA@0M;EKIWE@<4 7[<Y2IJ9&FP8I] !1110 444$X% !14+SA.I
MJ(WT8/44 6Z*JB^C/<4\749[T 3T5%]H3UIC7:#O0!8HJL+I2>M3+(&H ?11
M10 5AZOT-;E8>KC@T <Y'_KOQKJ]*^X*Y1!^^_&NKTL?(* -2BBB@ HHHH 2
MEHHH **** "BBB@ HHHH *2EHH !1110 4444 %%%% !1124 +1112 *:RYI
MU%,#,OK,2(>*Y>\T4.Y^6NY9=PQ5=K16/2HE%,Z*5=P.+M=!"OG972Z?8B$#
MBM!+55[5.J!:(P2'4Q$IAD*.::9T'>J=[<B)3S7.76M"-C\U-R2(IT7/8ZX3
MH>]/# ]*XRWUL.V-U=!97@E YH4DQU*$H;FK12 Y&:6J, HHIKMM4F@ +@=3
M2>:OK61>Z@(L\UF?VVH?&ZH<D;QH2DKG5,%D&*@:R1CG K/L]463'-;$;AUR
M*K1D24H$*6B)TQ4N508I)95B7)-8=[JRH3\U#:01C*;-T2J>].!!Z5RL.LJS
MXW5MVEX) .:2DF.=%Q-"BD5MPI:HR"L/7'*QMBMRLG6(/-C;Z5,MC6B[35SR
M/7KQUD;DURKZDX8_,:[C7M)=V8@5Q5WI,BL?E-<4D[GU.&<'$8NK,/XJ<=4+
M#[U9[:?*#T-)]BE]#4W9O*-,MO?$]ZC^V-V--2PE;L:NPZ1(W\)HLR5*")=/
MNY#*.37I?AJ5FVY-<1IVBN'!VFO1?#]@8@N16E).YPXZ<''0[:V_U(J6F0KM
MB I]=I\V]PICQAQ3Z*!'-:O9*RMQ7G>LV**S<5ZAJQ^1J\[UMN6KGJ(]?!29
MP-["%)P*RW7DUMWQ^8UDN,YKF9[L4VBO']\5TVCP[W7BN<C0F45VOAVV+.O%
M..K)K/E@=SH-G@*<5W%HFR,"L;1;3;&IQ70(NT5V05CY?$U.:0ZBBBM#E"BB
MB@ %(WW3]*6D;[I^E ''Z[U:L.Q/^D#ZUN:[U:L*R_X^!]: ._TMLVX'M5^L
M_2O]0/I6A0 4444 %%%% !2-]TTM% '$>)T)1Z\?UJ$^<W'>O<=?MMZ-Q7E.
MN6)$C'%<M5'OY=425CC$3!J913YHO+8U#NKG/8>I/&0'%=;H&"ZUQBL=XKL?
M#8)D6JAN8U]('J^B)^[6NB P*Q=#3]ROTK;KNCL?*5W>;"BBBJ,0HHHH @NL
M^4<5Y_XCM'E#8%>BNFY<5E7>E"?/RTI*YI2GR.Y\_:OICK(QVFLA$:%Z]A\0
M: %#';7G.HZ?Y<A %<TJ=CVJ&,YM&/TW4#%CFNSTO7,%1NKSV.)DJ_93ND@Y
M-9<[3.YX=5(W/;-*U$3!>:Z-&W(#7FOARY9BF37HMH<P UUTY71\_BZ7)(GH
MHHK0XPHHHH 9(VU:Y[6+O9&W-;MR2$-<9KK-M:HF['3AX*3U..U;42)6YJ'3
M=8*RCYJR]6+&1JS;,R"<8SUKE<W<]Z&&@XGLVCZEYJKS760-NC!KS3PXS_+G
M->D66?(&:Z:;NCQ<934):%BBBBM#B"BBB@ I&&5(I:* ,N\L1*#Q7/W6AAFS
MMKLR :C:%3VJ'%,WIUY0.,@T ;ONUMVNAH@!*BM=(D4]!4N10H)#J8F4BFFG
M1IT JPD(3I4M%58Q<F]PHHHIDA124M %:Z3<AKA]?LFD#8%=^Z[A65>:>)@>
M*B<;HZ</5Y)7/$[[1W>4_*>M.L]&=<'::]1?PZ'?.W]*<?#RQIG;7.J.IZ\L
MQ7)8XJRM3$PR*[71FV[:R[BR$+]*T-+X<"NJ"LCQ*\_:2N=A&<H#3JC@_P!4
M*DIF04444 %%%% "$9%5+BT$@/%7**35QIM;'+7FC*Y/RUE/X?4M]S]*[MHU
M;M49ME/85#@CIAB911PX\/+_ '*>/#J_W/TKM?LR^@I1;KZ4<B*>+D<C#X?5
M6!V5LV6FB''RUKB)1VIX4#H*:@D93KREN-C7:N*?115F 4444 -9<U0O+(2*
M>*T:0C(I6N-2:>AQ5]I"Y)VUCR6<<1.0*[G4HPJ$XKS_ %J\\DMS6,TD>IAI
MRJ:#LQ XXJ18(Y3P!7'MK1\W&ZM_2+XS,O-9*2;.ZI1E!7.BL]*5F!VUTUCI
MRQ@<57TI-Z*<5O(NU<5T0BCQZ]:3=AJ1A.E2445H<@4444 %%%% &?>VPE!X
MKE-1T8.3\M=RR[A5:6T#]JB4;G12K.!YPNAX?[M;^F:5LQ\M=!_9JYSMJU#:
MB/M4JG8VJ8MR5AMM;B-1Q5L=*0# I:U.)NX4444""BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH #0*** "HY^(FJ2F2C,;"@:W//_$<[)NP:\VO[UQ,>3UKU+Q!9
M-(&P*\YU#2',Q.T]:XZJ=SZ/ 2ARZDNCW;,XYKO;*9C".>U<3H^F.LB\5W]A
M9'R1QVITDS/&RC?0Q-7N756Y-<5=WC^:>:]"U?3F9#Q7#7NE/YIX-*HF:X24
M+!IUVQ<<FN_T2=F"\UP^FZ8XD'!KT+1;(HJY%.DF98V4;:'4VA)05:J"W3:H
MJ>NI'@2W"BBBF(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH ANO]2:X'7NK5WUS_J37 Z]U:MZ&X'&O_KJZ;0_O+7,2?Z_\:Z?
M0OO+794^$1Z)I_\ J!]*N54T\?N!5NO->XPJE==#5VJ5R.#2 Q+KJ:A@^_4U
MSU-0P??H WK+H*T*H6705?H *P_$/_'N?I6Y6'XA_P"/<_2KA\0'D&K_ /'R
M?K6EX?\ ]8OUK.U<?Z0WUK0\/_ZQ:]*7P"/4--C#0#Z53UJP\R)L"KNE-^Z6
MM&X@$R8Q7EU5<THS<)7/#];T9FE;"USKZ+(/X37N-YH*RL3MK*N/#:JI.S]*
MXG2U/?I9@E&QXX=*<-]TU<M='=R/E-=W<Z,L;_=JUIVF1[QD"J5$B68ZZ'.6
M/AYFP2GZ5UFEZ!L()2NFLM-A5 <"M6&VC3H!5QII')6QTI*Q6T^Q$*CBM0#
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M^-;FC]179/X1([2R^Z*T*S[+[HK0KAEN,****0!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 4KOH:YN_P"IKI+OH:YN_P"IK>D9R,^'_65U.E]!
M7+P_ZRNHTOH*TJ[$P-BBBBN0V"BBB@!K_<-<YJTCJ&Q72,,C%9=]9>:IXH \
MQU:_EC9N36 =0EE?&379:YHY^8XKF$TW9-R.] $MK:O.,X-7?[,=1G%;FD6<
M>P9%;AL(V7H* .'2*6)N,UOZ3+*&4'-:G]C*YX6M"TT;RR#MH U=/8F,9]*N
MU#!%Y2XJ:@ HHHH *2EHQ0 "BBB@ HI"RCJ:;YJ?WA0 ^BF"5#_$*<&4]#0
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M9OO_ *UI6VO"3'S4*282H2CN=3167#J D YJS]IXZU1B6Z*SVO<'K2K>9[T
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M^7.: +5%9CWX5L9J6*[W]Z +U%4I;O8.M0+J +8S0!J454%SE<YJ"2^"G&:
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MWH T**H?;/>D^V^] &A15#[9[T?;/>@"_16?]M]Z47GO0!?HJA]L]Z3[;[T
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M9CSJR+5LNR("IJJB8+QFI%ER*Z$>,W=W)J*@:;'>D6;-,18HJ(R8%()@3UH
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M.J.,U3C=BN5N+GRY*[C4+(NK'%<5JE@R.>*GD1O]:E:Q=TO4PKKS7?Z1J(=
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MK=JP-6TU0#Q0!P<*OYO?K77Z0'VK69'8@3=.]=9I5D-HXH L*K;:@F#5M"V
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MNU="=SR)KE=C!MPX:M AO+JRMD%;I4_V<%<8ID'+WH<$]:P+ZY>-3R:[R[L
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MZ;4>E,^Q#/2@#.B#8IDP:M=;4 =*1K0'M0!C1!]U6F#;*O+9@'I3S;#'2@#
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MG:EX^E<N]AMFR1WKT"XC5D.:Y?4U6(DBB(2+>C+'&5'%=Q8.I08KRNTU$I,
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M4D56DB):IX(R!0 Z>4@57CF._K4\\9(JM'$=] %\2?)5668AJL!#LJI+&2U
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MKG44B?\ &BR&JLT=-I: **UR^T5F:6I*"M1XSB@3;>XP2FG^8<5$(SFG^6:
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M2-*:18SBD>,T *LIS4GF<5"L9S4FPXH >DAW4MQ(?)-,5#FG7"?N32Z@>?\
MB-LEJX^+_CX_&NO\1KAFKD(O^/C\:]2C\(CN="/RK76+*5BKD]"&0M=44)B_
M"N2N"^(PM9U HC<UYYJNHEG;FNTUV!V#8!K@;ZRD:0\&O(JMW/JLMA"UV8=Q
M.68U):C>PITM@X/2KFFV3>8,BL8Q;9[%6K"$=#9TRPWD<5V.G::%P<57T/3\
MJN1786]EM4<5VTZ1\OC,:V[)A9PB,#BM6-_EQ5=(2O:IE4BM[6/'E)R=V9>L
MRGR6%>5:XV9F^M>IZRA,3'VKRO7!B9J[<(2R/1SB85Z5H\A\M:\TT<9F%>E:
M0G[M:O$@CH5D^6H9#N:I40[:C9#FN 9%);JT9XKD]9M%R>*[-@1&:Y76CR:!
M6,"QM5\X<=Z[K3+=5B'%<;8Y\\?6NZTX'RA0,F=MAXI\4I-,F0DTL2$4 /ED
M(%0+,=U2RH2*KK&=U %U7RM5Y92#4ZH=M5KA<<T 2Q3>].E*LO-93W0B[U7E
MU95&-U0Y)&T*,Y:H3484(-<])"!)5ZZU(.#S6>)O,>FFF3.-2&YK:<@#"NIM
M1\HKFM.0D@UTUO\ *@S561ES29+*Q JF)#OZU)<SA1UK-^V*).M%T-0D]C<C
M)*U6N)"II+>Z5DZTR?YSQ1=!9K<=;RDM6K$<K61;1D/6O$,)0!)1110 =JYK
M6_NM72GI7-:W]UJUI?$1/8\[U3_6&BDU3_6&BO6AL<4MSB=#_P!<OUKV?PK]
MQ*\8T/\ UR_6O9_"OW$K'%['>CN1T%% Z"BO*&%%%% !37QM-.JI<3; : .6
M\1+E6Q7""!WNOQKN]6?S<BL>TL5:X!([T :VB696($BK.H7AM:V=-MD6 #CI
M67KECY@)% %"RUS=* 37407"7,0KSI;9H)\^]=-I5V1@$T ;3V*LV0*LV]OY
M?:I;=P\8-34 %%%% !37^X:=37&5- &)?DG(K!EMC(_2NIGM]YJNMC\W2I2L
MRF]#.T^QVD'%;I3RXOPI]O;A!TJ:9,IBM),A'):K.4)Q7/OJKHV,UUFHZ<9<
MX%<[+H+F3.TUF65DF:[.*V].TLDAL4:=HS1L,K75VELL:#BM%HC,6SA\E *M
M445)05C:N1@ULUAZOT- '/)CSOQKJ]+QL%<E'_KOQKJ]+^X* -2BBB@ HHHH
M KSP"12,5BW6BK*3\M=%12<4S2%64=CDX_#RJV=E:MKIJPX^6M>BDHI%2KSE
MN,C38N*?115&(4444 %(QPI-+4<QQ$: 1F7UX(@>:Y2_U\1L0&JYKMPRJV#7
MFNK7<AD/)KFJ3L>S@\,I[G:VWB+>^-U=)8ZH)%'S5XW97,GF#DUVNEW;A!S2
MA49MB<)&*T.YN+\*A.:YN_UWRV/S5%=7;&(\UQFKW,FX\FG.;1EAL*I/4ZRW
M\1[I -]=/INIB8#YJ\4MKJ43#D]:[[P_=.VW)J:=1LUQ6$C&-T>G0N'3-2U2
MTYMT(^E7:ZD>#)6844=Z*8@HHHH **** "BBB@ HHI* %HI*6@ HHHH ",C!
MKD_$4 9&P*ZRLK4K3SU/%3)71M0GRSN>&:[9N9&P*Y:2SE#'@U[5J'AWS6)V
M5C2>$\G[E<;I.Y])1Q\%&QYK8VLOF#(->@>'[1B5R*N6_A4JX.S]*Z?2]%\D
MCY:J%-IF6)QL91T-G2+<*B\5N@8&!56T@\M *MUUQ5D?/5)<TKA1113,PHHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *S;^Y\N-JT6^Z:YW6&(C;%3)Z&M*-Y'%^(=0^9N:Y./5=D_P![O5_Q
M"[[FKBW=_.[]:Y9S:9]!A\+%Q/6]!UG=M&ZN_P!/N/.0<UXGX<DDWKUKUS0F
M)C7-:4I7.#'4(PV-ZBBBN@\D**** "BDI: "H+DXCJ>HYDWH10!R&JR'FN:8
MLTW3O7;WNG&0GBLL:(=^=M%@4FA=%!W+D5V,7^K6L;3]/\DCBMM1A0* O<6B
MBB@ HHHH I7X_=GZ5Y[XA7AJ]#OAF,UP6O1DAJQJ'H8)ZGF&H)^]/UI;"(;Q
M5K4(B)#Q4%JVQQ7)U/I8N\#IK6-0@J:241BJ$%T @YIES<Y4\UU1?NGS^(IM
MU1+O4R@(S68NI%I?O53OI"<XK.A=O.%<LV[GNX6BE3/2M!O"67FO2-+GW1BO
M)O#FYF6O5-(C/EK732/%S"*3-T'(I:11@4M=!XX4444 %5[P?N35BH+O_4F@
M#C[X?O3]:O:2/F%4KXCSC5_22NX<T".F7[H^E+2#[HI:!A1110 4444 %%%%
M #77<I%<KKEAY@;BNLJK>0+(G(I-7-*53DE<\6U7129"=M0:=I)64?+WKT34
M=.4D\5GVU@JRCCO6'LM3U/KSY;&GH%CM5>*Z^./8N*SM)B5$%:M;15CRZE1S
M=PHHHJC,**** "BB@D"@ J*X_P!0WTIQD4=ZK75P@B(S2N-)L\Z\4Q[B]>8W
MENYG.!WKU;7=LK,*YI-($\OW:PJ1N>M@ZWL]SEK*TE)'!KN="M7#+D5=L?#8
MP#LKI+#2/)(^6LX4W<Z\3C8RC9&OI*;4%:U5;6+RP*M5UI61X%1WE<****9
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M1G.HY;A1113("BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH AN?\ 4FN!U[JU=]=?
MZDUP.O=6K>AN!QKC]]^-=/H0&Y:YA_\ 75TVA_>6NRI\(CT6P_U JW5/3_\
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M ',ZFI5&KSW6RQ+5ZCJ5MO0X%<#K5@WS<5R5DSWLME!/4\^FD*2=:UM*OBK
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MD>U'D>U6J* *OD>U'D>U6J* *WD>U)Y'M5JB@"L(*##5FB@"KY'M3A#BK%%
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M1(HYIJ5R:E)PW+E% YHJC$**** "BBB@ HHHH **** "BBB@ HHHH **2@4
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M%%)0 M%)2T %%%% !1110 4444 %%%% !1124 +1110 4444 %%%% "44M%
M!1110 4444 %%%% !1110 4444 )2T44 %%%% !1110 4444 %%%% !24M%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%(: %HI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ANO]2:X'7NK
M5WUU_J#7 :]]YJWH;@<<_P#K_P :Z;0_O+7,/_KOQKI]#^\M=E3X0/1-/_U
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MK=1O$N6.VH+"W8R@@=ZI:=!+,PW UVFF:<  2* -72U*Q 'TK1J*&,1KBI:
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M516"V38F*GI ,"EK='F-W=PHHHH$%%%% !1110 4444 %%%% !1110 4444
M%5[EL*:L5!<+E3294-SB]>F(5J\VU.X82'FO3==MBRMQ7G&I6;&0\5P5DSZW
M*YTTM2KIMXXE')ZUZ5X?N&<)DUY]IFFL91QWKT?0K-HPN1103N/-)TW'0[2
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MM%=#10!RO_"++_=I!X64'.S]*ZNB@#%M-%6 CY:UXT"+BGT4 %%%% !1110
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MDFRYD>M+61_:29^]5F*\5^]*Y3IM%ZBFHP84ZF0%%%% !1110 4444 %%%%
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MK<5U[#(JA<V@E!XJ)QN=.'J^SE<\@U+37,AX-5K/3'\T<&O3+G0Q(Q.VF0Z
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M:] TA]RK7GVC63AUR#7I&D0%47BMZ%SR\T<%L;L?W!3J11@4M=I\XPHH[T4
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MH'E,#MKM-/MA#&.*G^S1H,@4GGJAQFG&*B9U:\JI8HJ)9@W>I0<U9SA1110
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M@1*O04^K2L<U2HYN["BBBF9A11WJ*24)UH!()Y!&F37,ZOJZQH1FKNJWX$9
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M4"@!:*** (;K_4FN!U[JU=]=?ZDUP.O=6K>AN!QK_P"O_&NGT(?,M<P_^O\
MQKJ=!'*UV5/A$>@V'$ IUQ<"('FH[9ML ^E8FM7_ ):MS7EU)69O1I\[+$^L
MK&V-U+!K*R-C=7G%_K#"0X:FV.LMY@^:N?VNIZ?U#W;GL%O.DHZBK& >PKD-
M(U(R!>:ZJWD\Q :WB[GEU:;@R38O]T4H51T I:*HR"L/Q#_Q[GZ5N5A^(?\
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M_P!<?K0!K:5U%=/%]P5S&E=173Q?<% #Z*** "BBB@ HHHH 2EI*6@ HHH-
M!FBDI: "BBB@ HHHH **** "DI:* "DI:* "BBBD 49HI*8"YHI*44 %%%%
M!1110 4444 %%%% !1110(****0PI#2T&F E+FDHH 6BBB@ HHHH CF&4KF-
M8C;:V*ZIAD5E7]KYB'BHFKHZ<-/EEJ>2:P'#MUK"3S#+WKT/5-',C'Y:R8M
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M0:* $I:** "BBB@ IDIVQDT^HKC_ %)H8UN<GK-\8@W-<3>:RPD(W5T7B/<
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MV1=T?.UH<DK!1115&04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%+&SIJR.4L='\HCY:Z6T@$:CBIQ"@Z"G@ =*J,%$QK8B57<6BBBK.<.]%%%
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M6"/RTQ7535CP\544I:$M%%%:'&%8?B'_ (]S]*W*P_$/_'N?I5P^(#R'5_\
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MZH_2N/N/]=^-=AJ7^J/TKC[C_7?C0!MZ/VKI!TKF]'[5T@Z4 %%%% !1110
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M]: .GTJV 0<5KJNVJ>FC]T/I5Z@ HHHH **** "BBB@ HHHH **** "BBB@
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M:A&(EJ2FH,*!3JZCPV%%%% "8HI:* "BBB@!I13U%,,"'M4M% [D0@0=JD
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MJN0:!'6PMN7-2U!;+M2IZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M[:RI5G)G?C\NA3C='IUN^]!4]4+!LQBK]=ZV/E)JTK!24M%,@**** "BC-%
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M110 4444 %%%% !1110 4444 %%%% !1110 4444 %)FEI* %HH%% !1110
M4444 %%%% !1110 4444 )FEI*6@ HHHH *3-+24 +1110 4444 )BEHHH *
MCDB5QTJ2B@%H4OLBYZ5/' J#I4U%*Q3FV&****"0HHHI@%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;I.J>:!\U=5!+O05Y?X=E<[:]%L"3&*ZJ<KH^?Q=)1EH:-% Z45J<0E%+10
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M9WGH%%%%49!1110 5BZMT-;58VK+P: .:7_7?C74Z5]P5RZC]]^-=3I0^04
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M5>J.--JBI*ZTK'STG=W"BBBF2%%%% "4HHHH :PRIKE]8B&375'H:YG6.IH
MQ+.(></K79Z<@$0^E<A:?ZX?6NRL/]2/I0!;HHHH **** "BBB@ H)Q14<K;
M5H&E<H:I,%B/TKB[J\59NM;>MW>U&YKSS4-0*RGFL)U>4]/#9>ZR/0-'U!<C
MFNHCN%D Q7C^E:N1(!NKO])O_-5>:(5>8,3E[HHZ@'(HID9R@-/K<\L****
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MR:RC4=SOJ82"@>Q6-WYH'-:R'*UR&B2L57-=;"<QBNN+NCY^O#ED28HHHJC
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MT?J*P[C_ %_XUN:/U%=D_A$CM++[HK0K/LONBM"N&6XPHHHI %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!2N^AKF[_ *FNDN^AKF[_ *FMZ1G,
MH0_ZRNGTOH*YB'_65T^E]!6E78F!LT445R&P4444 %%%% '/ZU-L1JXFXE66
M8CWKJO$I*HV*\^\]A=<^M '56&C+<@';5L^&57)VU9\/72!%W5NW%Y$L9Z=*
M .)N+06;<<8JQI^H$2!<U#K%P)'.VJ&GJYG!YH ](T^7S8P:NUF:0"(1GTK3
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#/U/_5'Z5Q]S_KC]
M:[#4_P#5'Z5Q]S_KC]: -;2NHKIXON"N8TKJ*Z>+[@H ?1110 4444 %%%%
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M78F$%J86G;Q,.O6O2O#Q;"YKF-,T@M(#MKOM(TXQ*O%%&#3'F6*A..ATMO\
MZD5+3(AM0"GUWH^5>X449HH$%%%% !1110!5N <&L.\!R:Z&7&TYK#O=N33)
MYBG;CYZZ&R'R5@V^/,KHK3'E#%*P7+%%%%!04444 %%%% !1110!6O?]2:XV
M_P#]::[*]_U)KC;_ /UIH O:3]X5U:?<%<II/WA75I]P4 .HHHH **** "BB
MB@ H/0T4'H: .:UCO6+;?Z[\:V]8[UB6W^N_&@#L--_U0^E7ZHZ;_JA]*O4
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M6+*(0*N5T)6/)J3<G=A@"CO113,PHHHH **** #%9FJ(#&?I6G6=JA_=GZ4
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M-<;?_P"M-=E>_P"I-<;?_P"M- %[2?O"NK3[@KE-)^\*ZM/N"@!U%%)0 M%
MHH **** "@]#10>AH YO6.]8EM_KOQK;UCO6);?Z[\: .QTW_5#Z5>JCIO\
MJA]*O4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !39/]6WTIU-D_P!6WTH \W\5?>>N&B_X^?QKN?%7WGKAHO\
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M6*;&NU<4ZNH\-N["BBB@0E%+1B@ HHHH **** "BBB@ HHHH **** "BB@T
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MNA_Z\?6O5-&_U2UY7H?^O'UKU31O]4M7B1(Z)/NTZFI]VG5P#"BBB@ HHHH
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M&Y15*"]$V,&K@.1FJN9--;BT444""BBB@ HHHH **** "BBB@ HHHH ****
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MT?J*P[C_ %_XUN:/U%=D_A$CM++[HK0K/LONBM"N&6XPHHHI %%%% !1110
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MXKE);8+-T[T ;F@@C;791?ZL5R>C)C%=9%]P4 /HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH #TK.O+?S >*T
M:0J#U%)JY4)<KN<'J>CF0GY:PCH!W_<_2O49K1)!TJK_ &:F[[M82HIL]6CF
M4HQL<EIFC&,CY:ZVQMO*4<5:BLTC[58"@=!6D*:B<F(Q4JKU%HHHK0XPHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRUN0:;F3&*Z.RT4,@.VI]BSI>9HY*STE@X^6NUT:P*;>*NP:.%8?+6Y9V0C
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $I:** "BBB@ HHHH
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2T4
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MU"Q+QVKC= L0-IQ7HFGH$B ]JZJ4;'S^/K<VB+@4"EHHKH/)"BBB@ H[TE%
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M&IE8,.*XBRU%W< FNLL7+Q@F@"Y110:!A1244 +1110 4444 %%%% !1110
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M<4 5ETR)>PIW]GQ^U6!/$W1Q3PRGH10!66Q1?2I5@5:EHH 0#%+110 4444
M%%%% !3''RFGTA&128'+ZSN"MBO/-4\\N<9KUN[L1.#Q6%<>&UE8G;0M!L\R
MM;6:209!KK=-T@L@)6M^W\,K&V=M;=MIJQ*!BG85SC+[3S%&<"N4O8IC(0 :
M]<NM.$JD8K&E\-J[YVT(5CA-+LY#*"0:](T*$QHN:CM= 6(@[:W+:V$('%,"
MU2;12T4AF;J<8\HUQ]RF)C]:[/4C^Z/TKC[D_OC]: -321@BNHB^X*YC2NHK
MIXON"@!]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $5P<1YKD
M]7NS&&YKJ[D9CKCM;@9E;%95-COP23EJ<5J&K,LA^:H+35V,@^:J^IV4AD/!
MJM9V4@E'!KSG*7,?71I4O9GH^C7S2;>:[2S;=&#7!:%;LNW(KN[$8B'TKOHM
MVU/E<PC%2T+=%%%;GF!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110(****!A1110 4444
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M%!#"I<UY5:>,,$#?^M='9>)/. ^:@#LJ*S+;4!*!S6@C;A0 ^BBB@ HHS10
M4444 %%%% !1110 4444 %%%% !6'J_0UN5AZOT- '.1_P"N_&NKTK[@KE(_
M]=^-=7I7W!0!J4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !FBDHH 6C%%% !1110 4444 )FEI*6@!#TK/N[L1 \U??A#]*Y'7;
MHQJV#4R=D;48<\K#;S71$2-]5H?$(9P-_P"M<#JNJ/YA&35.SU&0R#DUS.KJ
M>W' +DN>T6.HB8#YJV8WW"O.-"OV;;DUW=C+O45O"5SR<11Y&:%%%%:'(%%%
M% !1110 55OD#0FK55[S_4F@#AM1MP9CQ5G2;5=XXI;X?O35[2E&X4K%^T>Q
MT5O"$0<5/2+]T?2EID7N%%%% !1110 4R7_5M]*?39!E"* 1P?B120V!7ENJ
MHXF. :]IU:P,P;BN&U'0&9R=M<E6+9[^!KQ@M3AK.-S(,UWF@6V2N16;#HIC
M<?+74Z1;>41Q12@T&-Q,6M#K]+MU5%XK7 P*H:?]P5?KJ1X4G=A1113)"BBB
M@ HHHH *CG_U1J2HY_\ 5&@#D-3_ -8:-,_U@I=3_P!8:33/]8* .NM_]4*E
MJ*W_ -4*EH **** "BBB@!",BJ\MNK \59HH&G8YG4(0@/%<=J<^QC7H6H6Q
MD4XKBM7TQB6.*7*-U78YV+4_+DZUT%CXA"*/FKD+VTDB8\&L]KF6(=34SERG
M1AJ'M6>F#Q*"WW_UK5L=9$Q'S5XTFI2>9U-=5HFH.67)K!5;L]*I@5&-SUVV
MF$B@YJQ6!I5T70<UNH<BNE.YX]2'*[#J***9F%5+R$.AXJW377<*!IVU.!UO
M3MP;Y:\^U73BK-\M>TW]D)%/%<;JFD!MWRU#IIG53QDHGD[6C"7I70Z1 0R\
M5>GTC;)]VM/3-.PXXI*FD5/'2:.FT2+"KQ796HP@K"TJSVH.*Z"%=JU:5CDE
M4<MR6BBBF2%)FEI* "EHHH *S=4_U9^E:59VJ?ZL_2@#D9?]=^-=#I'05S\O
M^N_&N@TCH* -ZBBB@ HHHH **2B@!:*** (Y_P#4M7":U_K#7=S_ .I:N$UK
M_6&@"'2/]<*[ZT_U K@=(_UPKOK3_4"@">DI:2@!:*2EH ,4444 %%%% &7J
M-SY2GFN*U36PA(W5O^(92B-BO(M>OI!(V":PJ3L>M@L,JFYTT.MAY?O5U^BW
MHDV\UXG87LAF')ZUZ;X:G9MF:BG4NS?%X.,(Z'IT3;D!I]5K-LPBK-=2/#:L
MPHHHH$%%%% !110: "BH9)-HJE+?A#UH TZ*RX]0#G&:OQ2;QF@"7%&*** "
MBBB@ HHHH **** *>H3B&+-<C=:[LE(W5OZ[GR3CTKS6^$AN#UZT"L=WIFJ^
M>1DUTT+AT!KS_P /Q.2N:[NV4J@H"Q9HHHH&%%%% !1110 44'BHFF"]Z L5
M+VWWJ>*Y34+,[CQ77R3H5/-8&HRQ\\BE<?(S(L8=DHKM=.P(17$+>)')UK>T
M_5%P!NHYD4J,MSIJ*IPW8D[U;4Y%%R6FMQ<48HHIB"BBB@ HHJM<S>4I- TK
MLF>54')JH]ZH/6L#4=9$61NK ?Q!E_O5FZB1UT\)*2N>AQ7*OWJSG-<-I^M!
MV'S5U%I>>:HYJHR3,JM"4&:-%(IR,TM48!1110 4444 (>E4;NW\Q3Q5^D(!
M%)H<79G":KI1?/RUR5UH!9S\E>N7%HK@\5FR:4K'[M8RIW/1HXQQ1Y8/#A/\
M'Z5?LO#Q1P=GZ5Z&NDI_=J>+3$4_=I*D:RQ[:,O1]/\ )"\5U42[4 J&&W6/
MM5FMHJQYM6ISNX44451D%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $-U_J37 Z]U:N^N
MO]2:X'7NK5O0W XU_P#75TVA_>6N9D_UU=-H?WEKLJ?"(]$T_P#U ^E7*IZ?
M_J!]*N5YKW&%%%%( HHHH **** "L/Q#_P >Y^E;E8?B'_CW/TJX?$!Y#J__
M !\-]:T- ^^*S]7_ ./AOK6AH'WQ7I2^ 1Z9I?W%K=7[HK"TK[BUNK]T5YL]
MQBT445 !1110 4444 %%%% !1110 4444 %&*** "BBB@ HHHH **** "BBB
M@ HHHH **** "N<U[[K5T=<YKWW6JZ?Q <%<?Z_\:W-'ZBL.X_U_XUN:/U%=
MD_A$CM++[HK0K/LONBM"N&6XPHHHI %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110!2N^AKF[_J:Z2[Z&N;O^IK>D9R*$/^LKJ-+Z"N7A_P!974:7
MT%:5=B8&Q1117(;!1110 4444 9FISF)#BN-OM<DB<X8UV6IP&53BN+U#17D
M8D"@!EMXB<MRQKH+#61(1EJXM]+D@R<&JYU%[-N3C% 'KMO=1RJ/F&:LY![U
MY-:>+2C %_UKH;3Q0) /FH [BBL.TU838^:M:&7S * )J*** "BC-% !1110
M 4444 %%%% !1BBB@ HHHH **** ,_4_]4?I7'W/^N/UKL-3_P!4?I7'W/\
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MBBB@ HHHH **** "BBB@ HHHH **** "BBC- !12;AZT9![T +1110 4444
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MNUU(\.2L[!1113)"BC-% !1110 4449H **** "BBB@ HHHH **** "BBB@
MHHHH **** "FR?ZMOI3J;)_JV^E 'F_BK[SUPT7_ !\_C7<^*OO/7#1?\?/X
MUZ='X1'?^'S\JUW-KS&/I7"Z!]U:[JR^X*Y*VX(2YMA(IXK$N=&$C?=KIZ3:
M/05RN"9T4Z\H;'*PZ($;.VMNTLQ$!Q5_:OH*6DH)!4Q$Y[B 8%+115F 4444
M 9^K_P#'H?I7C_B+_7M]:]@U?_CT/TKQ_P 1?Z]OK79A=Q,KZ'_KQ]:]4T;_
M %2UY7H?^O'UKU31O]4M7B01T2?=IU-3[M.K@&%%%% !1110 4444 %)2TE
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M78:G_JC]*X^Y_P!<?K0!JZ5U%=/#]P5S.E=173Q?<% #Z*** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB@T %
M%)2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 )0*6B@ HHHH **** "BBB@ HS124 +1110 4444 )0*6B@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM4=EE-2Z-*QE%+D1JZ\VK7._M8U$0-6:KV9S;BK%48WN%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4C=*6B@#&U0'RS7FNO;MS5ZM?0[XC7"ZQ
MI9D9OEKFKQ;/:RRM&,M3S0[_ #^_6NO\/AMRU -#)ESMKIM'THQ%?EKEI4WS
M'MXS%0=.R.QTG/DC/I6G52QC\N("K=>DMCXZJ[R;"@T44S,2EHHH ****  T
ME+10 4444 %%%% !1110 4444 %%%% !1110 4444 %-D_U;?2G4V3_5M]*
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 &DI:3% "T444 %
M%%% !1110!5NY-B$UQVKZJ82WS5U>HY\HUYGXC+@OC-<]:32/7RVC&I+4K3>
M(RLF-_ZUL:1KIE9?FKRVZ:;SSUZUT?AYY=ZYS7%"K+F/H\3@*:I7/63.9K?K
MVK@_$MN[;L UVVF(9( #Z57U32//4_+77.+E$\'"UHT*IXF]G+]HZ'K77>'K
M:177(-;3^&OWF=GZ5LZ;HODL/EKFIT6F>SBLRA.G8Z+1D(B7-;54K*'RT J[
M7HQ5D?'UI<TVPHHHJC(**** $894BLNZT\3$\5JT4 <Z-% ;.VK]O8^5VK3H
MH 9&NT4^BB@ HHHH ***,T %1NFX5)10!FSV7F \5@ZAI60>*["J%\J[3Q0!
MY])IF).E;&EZ=AAQ4TZKYM:FFJN1Q0!HVUMY:CBK@&!2CI10 4444 %%%% !
M114<K;5H >6 ')KFM8F3)YJW>WQB4\UQFJZH2QYH T;25?.'/>NQL)%,(&:\
MJMM2(E'-=CI.IEE S0!V&:*JVTOF 5:H **** "D[TM% !4,\>]34U!Y% T[
M,XS7+0E6XKSK4;0F4\5Z_J\ :(\=JX.]L@TQX[URU*7,>W@L=[-:G/Z9IK-(
M.*]#T2R,:KD50TC31N!VUV-I:B-1Q13I<H\;C_:JR+L0VQ@4^D' I:ZCPV%%
M%% @J&>/>IJ:B@:=G<X[6;#<K'%><:Q9,C-Q7M-[:B1#Q7%:QHV_<0M<E:G?
M8]_+<8HNS/)9(F#]*55-=->Z08V)VUCRV_EGI7'RM'U$:T9K0JA*LV\)9A30
ME:NG6V]QQ2M=DSGRJYIZ58%F4XKT#1[/RU7BLK1-/!"G%=E:VPC4<5W4:=M3
MY;,,7S.Q;C&$ IU Z45U'A,#TJC>P[D-7J9(NY<4GJ5"7*[GG&NV3-NP*XV7
M39#*>#UKUZ_TX39XK'.@ OG;7'4HW9]'A,Q5.-F</;:8Z@?*:U+2W,;C(KJF
MT<1Q_=K,E@$4E:TJ?*<6/QGM3<T?@+73+]T5R>ES!2.:Z:.X4H.:Z&SQU%[D
M]%,$JGO3@0: L+1110 4444 %!Z&B@]#0!S>L=ZQ+;_7?C6WK'>L2V_UWXT
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M:5%)12+E7G+<:B[1BG4451B%%%% !1110 4444 %%%% !1110 4444 %%%%
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M^\EKJ=,AZ4 =):$F.K-06ZX2IZ "BBB@ I*6B@ %%%% !1110 4444 %%%%
M!1110 5AZOT-;E8>K]#0!SD?^N_&NKTK[@KE(_\ 7?C75Z5]P4 :E%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !5:YA#J>*LTA&:!IV./U+2?-)^6L4>'_P!YG97HSVZ/U%1_8HL]
M*S=-,ZX8N458YC3M($6/EKIK6'RP*E6!%Z"I  *J,;&-2JY[BT4451B%)2T4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1FJ3N8RBXNS%HHHIDA1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M (UN:/U%=D_A$CM++[HK0K/LONBM"N&6XPHHHI %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2U%/_JC0!R.IGYS3--_U@^M/U/[YIFF_ZP?6@#L+;_4BIJAMO]2*FH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **1CM&:K27J1]2* +
M5%4!J<9.,BITNE?I0!8HI <C-+0 4444 %%%% !1110 4444 %%%% !1110
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M]OM4<4Z#2Q'CY:THH-@Z4 2QC"T^D'%+0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %8>K]#6Y6'J_0T <Y'_KOQKJ]*^X*Y2/_ %WXUU>E?<% &I11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M4E+0 4AI:* $I:,44 %%%% !1110 4444 %!HHH 2EHQ10 4E+2&@ I:2EH
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MW?+7H+J&%4+BQ$F>*B4;G30KN#/'[S2S&Q.*@@<6[5W.MZ<$5B%KS[4MT4A
MKDFN4][#U?;*QT$.M;(\;JKS:KYKXW5RGVA\=3217#^:.354YLRQF%BE<](T
M,B5Q7>V]HK0#(KSCPO+EES7J%L0;=,>E=:U1X$KQ=B#[ F<\5/';B.IJ*+"<
MFPZ4E+24R1:*2EH IWL6Z,UY_P"(+!GW8%>DR+N7%8][I@F!^6LYQN=>&K>S
M9X;>Z:ZR'(JMY&P<UZ/K6C"/<=M<'J0$+$5R2CRL^AI5_:QT,YXPU+!8L[C
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M3%,O2NKTRP"*.*S[<#?716>-E)02+EB9RT9.D844^BBJ,6[A1110 E**,44
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MM0!DQ:E(9,9-='IURSXR:YR"Q/F]*Z;3;8J!Q0!T4!S&*EJ* 82I: "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *;)_JV^
ME.ILG^K;Z4 >;^*OO/7#1?\ 'S^-=SXJ^\]<-%_Q\_C7IT?A$=]H'W5KNK/[
M@KA= ^ZM=U9_<%<E;<9;HHHKG **** "BBB@ HHHH S]6_X]3]*\?\1?\?#?
M6O8-6_X]#]*\?\1?Z]OK79A=P9!H9_?CZUZGHXS$M>5Z'_KQ]:]5T;_5+5XD
M2-EK82+R*J/I",V<"M1?NBEKSW%,UC5E'9F;%IBQ]A5C[*,8Q5JBBR$ZDGN8
M-_IX<'BN=GT3>_W:[R2,..E5S:*3TK.5-,ZZ.+E!')V>AA&!VUTEE9B$#BKD
M=NJ]JG"@4XP2(K8J53<4=****T.0**** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ /2N:UO[K5TIZ5S6M_=:M:7Q$SV/.]4^^U%&J??:BO6AL<3W.(
MT/\ UR_6O9_"OW$KQC0_]<OUKV?PK]Q*QQ>QW([D=!10.@HKRAA1124 +1@4
M44 &!Z48HIDCA%S0 ^BLR?5EA/)%5/\ A($SC<* -ZBLF+6%D[BKL5T)!UH
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MV,^#051@=M;ME9"$#BA+R(G@BKD4JMTHBDAU:DY;DXZ44459S!1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MKK]-O=X'-<-:63IC@UT^EHZD9H [6!]RU-56RSY=6J "BBB@ I*6B@ %%%%
M!1110 4444 %%%% !1110 5AZOT-;E8>K]#0!SD?^N_&NKTK[@KE(_\ 7?C7
M5Z5]P4 :E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMBYKL5^Z*[H.Z/F<1%1GH+1115& E+2$A14$EVB=2*5QI-EBLS4F^4T]]2C
M^\*Q]0U%6!PU"DANG*QSNIQF1CBN9N],>0' -=67662K\&GQR+R!45(\QUX2
MLZ3/*WT23S,[36]HVF/&Z\5VDNCQ9^Z*LV>EHK#"UA&E9GIU<=S1L6-(A9$6
MNCB^[56VM1&HXJZHP*ZHJQXE6?,[BT444S(*1E##!I:* ,K4-/65#Q7$:OHP
M);Y:]*<;E(K%U"T# \5$H7.BE7<#RA]'VR_=KH]%TX*R\5=N;,*YXJ_IL6UQ
MQ4QIV-:F+<E8Z73[8)".*O 8J*V_U(J:M3C;N%%%%(04444P(YSB%C7!>(+\
MQ;L&N[N>8&KS?Q-"S%L5E5>AW8%)SU.0NM;<2$;C5=M6=Q]XUGW<#"4U!C:*
MXU)W/I'3I\A>?4&SUIT.JNI^\:RV/O1&NXU4FS"E3IW.NL-9<L!N-=QHM^9-
MO->8Z?;L7&*]"T"!EVYS5TFSGQL():'H%LVZ(&IJ@M!B$5/78CYV6X4444"$
M(S3&A4U)10%RK+:H8VXKCM;A";L5W,AQ&Q]JXG7GRS"@3;N<1=%@YQ6;<&3'
M>NA%KYTG2GS:(S)G;7-539[6 JQCN<G 7\P5V.AE\K6;'HS++]VNLT73"N/E
MK.G%W.S%UHN)TVG$[!FM<=*J6MOY:#BKE=B/G9N["B@T4R HHHH K7$ D!S7
M/W^EHV3MKIW.!69>,,&E9,:G*.QR0TQ%DZ5OZ7:A,<54=AOK5T\]*.5(IU)/
M<V%&%%+0.E%,@**** "FLVT&G56NGVJ:!I79E:I>^4AYKBK[7&20_-6OKER0
MK<UYWJ=P?,/-<M2=CV\%AU):G3P>(">-U2RZGYHZUPL%PV[K6K#,Q7K2IU&S
M3&8:,5=&R]]L.<TG]NM&,;JQII&Q65<SLIZTZLVC/!8>,GJ=Q9Z^SN!NKLM)
MOO. YKQC3[H^:.>]>E^&[C<%YI4IMEX[#QBM#T!3E0:6HX3NB!J2NL\!A112
M-PIH BDG6,<U0GU1$!^:J>JW1B!YKB=2UED+#=64YV.[#X;VAO:KJZLI&ZN6
MDU!3-G-8%_K9;/S5D_VH2^=U9JJ=<\ SU/2=55 /FKHDUM-H^:O'+36&0?>J
M\NOOD#?3=8<,NNCU^#5%D/WJTXI0ZUY;H^K-*Z_-7H.ES&2,5I"=SAQ.']F:
MU%%%:'&%'2BHY7V+0 -*J=:A:^B4\FL?4M1$2GYJY*[\0%9"-_ZUG*I8[*6%
ME4/1#>QLIP:Y'Q!+O5L5G6FO;^"]2W4XN4/.:%+F02H.E*[//=45S*>M4(8V
MSWKK[O3/-8D+4,6BG/W:YZD&>KA<1%(HZ<CB0=:]$T$, N:Q-/T4A@=M=EIE
MCY0'%73@T8XVO&2LC=B_U8I](HPH%+72>(%%%% $,D"R=:KOIL9YP*O57NIQ
M#&32:1<7*]D8FIVD,<1X'2N%OQ&)B..M;VOZUM5ANKSVZU;?.?F[UDZB1WT\
M+.:N=OHMO'(XX%=O;Z=%Y8.!7F7A_4_G7FO3--O1)$HS51DF8UJ4Z9<2T1.E
M3JNVE!R,T5H<C;>X4444""BBB@ J.5 Z$'TJ2D/0T </K]F"6XKEHM,#S].]
M=WK*@DUB6L(,PX[U#A<Z88AQ5C2T;2PBJ=M=7!'Y:8JIIL0$0XK0IJ-C.I4<
M]PHHHJC(**** "BBB@ HHHH **** "BBB@ I*6B@ %%)10 M%%% !3&C#=:?
M10!5>QC?J!48TV('.!5ZBE9%<\B&.V6/I4H&*6BF)NX4444""BBB@ HHHH *
M*** "BBB@ HHHH ANO\ 4FN!U[JU=]=?ZDUP.O=6K>AN!QK_ .NKIM#^\M<R
M_P#KJZ;0_O+794^$1Z)I_P#J!]*N53T__4#Z5<KS7N,****0!1110 4444 %
M8?B'_CW/TK<K#\0_\>Y^E7#X@/(=7_X^&^M:&@??%9^K_P#'PWUK0T#[XKTI
M? (],TK[BUNCH*PM*^XM;HZ"O-GN,9,^Q,US>IZD(@>:W;\D0'%>>:],X+8)
MK"H[([,+34Y:E6\UTB0@-4^GZT6<9:N'NI7,IY-7-.D<2#DURJ;N>W+"QY#V
M#3;X2*.:VT;<N:X31)6(6NUM#F.NN#NCP<13Y9%BD%+15G,%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %<YKWW6KHZYS7ONM5T_B X*X_
MU_XUN:/U%8=Q_K_QK<T?J*[)_")':67W16A6?9?=%:%<,MQA1112 **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@"E=]#7-W_ %-=)=]#7-W_ %-;
MTC.90A_UE=1I?W17+P_ZRNHTOH*TJ[$P-BBBBN0V"BBD;I0 UI O6H6O(U-5
MKN0@'%<_=74BMP30!U:7*.>#3;QL0Y%<Y87C%ADUK7-TIM^O:@#DM9U!HF;F
MN:;5G+GYC6EKC;Y&Q6#%9L[]* -2#57W#)-=+I>HERHS7(BP<$<&MS2875UR
M#0!Z'9OOC!JU5'301$,^E7J "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH S]3_U1^E<?<_ZX_6NPU/_ %1^E<?<_P"N/UH UM*ZBNGB^X*YC2NH
MKIXON"@!]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !32
MP%#G:N:R[N^$6>:3=BX0<W9&D9D'>@3*:Y2;65#8W58M-4$C#YJCVB.EX225
MSIP<T5!;S"1.M3UHCD:L[!1110(***2@!:*** "BBB@ HHHH **** "BBB@
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MXUW/BK[SUPT7_'S^->G1^$1WV@?=6NZL_N"N%T#[JUW5G]P5R5MQENBBBN<
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR0>:PKCQ (VQNH ZRBN2M_$(D;&ZMRVO1*N<T :-%9MU?B%<YK$F\1*CXWT
M=;17,6VNB4@;JW+6X\X#F@"W1110!GZG_JC]*X^Y_P!<:[34 #":X^Z \X_6
M@#2TKJ*Z>+[@KF=+ZBNFB^X* 'T444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M10 4444 %!Z&B@]#0!S>L=ZQ+;_7?C6WK'>L2V_UWXT =CIO^J'TJ]5'3?\
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MEG5!UK'O;Y #S0%S.9/WE:^GITK :]0R=16QIUTIQS0!OT4U7##BG4 %%%%
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MKC]!X=:[1/N#Z4TK"E-R'444E,@6B@44 %%%% !2'H:6D/0T <UJ_4UD6O\
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M:']Y:[*GPB/1-/\ ]0/I5RJ>G_Z@?2KE>:]QA1112 **** "BBB@ K#\0_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-<++</OZFKUC<OD<F@#TBVO0P'-7ED#5R6GS,<5T=LQ(% %VB@=** "BBB@
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M;NE78H%0=* (;&W$*]*NT  44 %(5I:* $'%+124 +1110 4R0[4)I]17/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M],8/-3)V-:=/G=B[>:NB \BN4U/6U)(W5BZGJ[ M\U<I>ZJQ8_-6$JNIZU+
MW1UL>HJ\G6NFTN6.0#I7DEOJ9#CYJ[#0]7)91NH52XIX-Q6AZA!;HX! J['
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M^HKLG\(D=I9?=%:%9]E]T5H5PRW&%%%%( HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** *5WT-<W?]3727?0US=_U-;TC.9GP_P"LKJ-+Z"N7A'[R
MNITOH*TJ[$P-BBBBN0V"D897%+10!GSV?F9XK)N=/QGBNFJ":$..E '&2Z?N
M/2I+;2L-G;72&R!/2K$5J%[4 5K"U\H#BM.D50HXI: "DQ2T4 %%%% !1110
M 4444 %(:6HIFVJ32 K7ERL(.37+ZCJ\?(W"F>(]1:)6P:\NU/79?.(W'K26
MI6QVS7*3R<$5J6,*MBO.=+U1Y'&2:[O3+H[%-4T3<W'TY'3D"L'4+&.')P*V
M)-1V1]:Y;5]5+9 --; +;7"Q3  UW&BW'F*O->66D[R7 Z]:])\-JQ5<TD#.
MI=-Z5GSZ?YF>*U1TI:!(X?5='^4_+7,G3=D_3O7INIQJ8R<5Q]R@$Q^M(9>T
M.'9MKL(O]6*YC2AC%=/%]P4 /HHHI@&****0!1113 **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ Q1110 4444 %%%% !1110 4
M444 %&*** "BBB@#%UP$Q-CTKR?7XY"[8S7L>H0>:A&*XK5-%,K$[:Y:\'(]
MS*\1&EN>6P02>=WZUVV@QNI7.:?'H!63[M=%I>E&,CY:YZ=)IGK8S'0G"R.B
MTS.P5L#H*IV<'EJ,U::15')KT(Z(^2JOFEH/HJN;E<]:E217[U5S-Q:'T444
M""HKC_4M4M-D&Y"*3&MSSSQ%"S;L5YS?V[B0GFO:=2TWSE;BN%U;1BA8[:X:
MU-O4^JRW&1BN4XF%VB/6KXOCLQFJ][;-$QXJHBN3BN9.VA[CC&HN8GN&:6H;
M>U<R@X-:ME9F4C(KHK#0MY!VU2IN1C4Q4:2L6?#4+*RY%>FV?_'NM<UI6D^2
M =M=3 FR,"O0HQ<4?(9C656=T24445L>:%%%% !37.%)IU,E_P!6:!K<Q-2O
M/*5N:X#6-3)<\UUFN;MK8KS75]_F&N*M-H^DRW#0GN6;342)AS7=:+J)95&:
M\JMM_FBN[T#?\M9TJC;.O'X2$8Z'I%K)O45:K/T[.P9K0KT(['R516D%%%%,
M@2EI,4M !1110!0U,9A/TKBKJ(&;IWKMM2_U1^E<A<?Z[\:+7&IN.QIZ- ..
M*ZA%"@5@:.!Q70T6L#DY;A24II,4""EQ110 4444 %%%':@"O,>#6-=D9-;$
MYX-8EX1DT"L0P$;ZW[/[E<[ 1OKH;+[HH"Q<HHHH&%%%% !1110 4444 5[S
M_4&N"UN0HS5W]UCR&S7GWB!<EL4GL53UD<M)J)C<\TW^W&4XW5F7J/O.*RW2
M7?WKS:TVF?:9?AH2AJ>@:3JYD<?-7H6DS&1!7C^@QR>8N<UZUH2D1+GTK?#R
M;W/*S>E&&QNT445V'SP445%,VQ<T#2N.:55ZFJ5S?(BGFLO4-1\K/-<M?ZX1
MD;JQG52/0P^"E4U+VKZBI)YK&@O@)>M85[JID8_-5%+\ALYKG=8]F&5^[J>L
MZ5J(*@9KHX)1(!S7E.C:DQ91FO1=)G,B"MZ53F/)QN$]D;%%%%;GEA129I:
M"H9)@@ZU*>AK"U2[,0/-3)V1K2I\\K$USJ"IGFLU]67/WJY;4=78,1NK(;5F
M+?>KFE6U/;IY;>%SO6O5E'6J-Q )LUSMIJ98CFN@LIQ+C-;0ES(\W$4'1E=%
M,Z,)&^[5RVT$ CY:Z&T@5P.*U([=5'2ATD$,=-*QCV>EB/'%;4,7E@5*% Z"
MEJXQ2.:I5E-ZA1115&0R0X6N?U:9@AKH'&16)JEL60\5$]CIPS7/J>;ZO<-O
M;FL6.[</U-=#J]DQ=N*R(M-<OTKS9IW/L</.G[/4GBF>11DTKVQD'2K<-@R
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M=P97T/\ UX^M>J:-_JEKRO0_]>/K7JFC?ZI:O$B1T2?=IU-C^[3JX!A1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M^T>^6)QDUUL>KQ[!DBE=%*G)FK15!-2C<\$5;CD#CBBX.+6Y)1113)"BBB@
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MB@ HHHH **** (;K_4FN!U[JU=]=?ZDUP.O=6K>AN!QK_P"NKIM#^\M<R_\
MKJZ;0_O+794^$1Z)I_\ J!]*N53T_P#U ^E7*\U[C"BBBD 4444 %%%% !6'
MXA_X]S]*W*P_$/\ Q[GZ5</B \AU?_CX;ZUH:!]\5GZO_P ?#?6M#0/OBO2E
M\ CTS2ON+6ZOW16%I7W%K=7[HKS9[C%HHHJ "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N<U[[K5T=<YKWW6JZ?Q
M <%<?Z_\:W-'ZBL.X_U_XUN:/U%=D_A$CM++[HK0K/LONBM"N&6XPHHHI %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!2N^AKF[_J:Z2[Z&N;O^
MIK>D9R*$/^LKJ-+Z"N7A_P!974:7T%:5=B8&Q1117(;!1110 4444 &**AFN
M%A!)K.EUR*,XR* ->BL$^((ST84#7D_O"@#>HK'CUE'_ (JN17@DZ&@"Y135
M;<*=0 4444 %%%% !4-PI9#4U(0#2:!'":_ISSJV :\\O?#,TDI.PU[M)9QR
M_>%5VT:V8Y*C\J:T!NYX]I?AN6-@2AKL;+2WC0<&NR32;=.@'Y5,ME$O04 <
M3=V$A0@ USMUHTLCGY37JSV,;=A4)TF(GD"BXK'FVG:"ZR E37?:-:>0J\5?
M338DZ 5:2)4Z4 /HHHH&4-2_U1KC[G_7&NPU+_5FN/N?]<?K0!JZ5U%=/%]P
M5S&E=173Q?<% #Z*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH :R!NM59;)'[5<HI6*4FMC).FIN^[5J"T5.U6\"EI<J*=6313N)A IKG[[6
MA&2-U7=9E*(V*\VUJ_=';DUA5J<IZF7X15=SJ1KP+_>K8L-5$F/FKR&+4W\S
MK76Z)>,Y7FL:=9MGHXK+E"-ST^&?S *LCI6+ILA9!6R.@KNB[H^;JPY96%HH
MHIF0UD5@016%JFFK(IPM;],DC$@P:F4;HTI5'"5T>5:IHA+'"UB_V04;[M>M
MW>FJ^?EK!N]+523MKFE0U/<I9HU&QS.FV05AD5V^EVB;1Q6'% (Y.E='IC8
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MI* %HHHH *P]7Z&MRL/5^AH YR/_ %WXUU>E?<%<HG^N_&NKTK[@H U****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &.FX5C:C8B13
MQ6Y4<D8<=*35RX3<6><7^C;G/RU6MM"Q(#MKT&6P5SG%)'IRJ?NUE[/4[UC6
MHV,K3--\D#BNEA7;&!3(X @Z5..!6D58XJE1S=V%%%%49!1110 E+1BB@!&&
M5(KG=7L?-!XKHZ@FA$G:DU<TISY'<\LO]"WN3MI+'0RCCY:]$ETQ7/W:2/2U
M4_=K'V6IZ/UY\MBEI-AY:CBNB1-H%100",=*L5K%6/.J3<W<****HS"BDI:
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MS2*09 KL],DC2,#(JH0L98G$NIL7X;<1 5-3=ZGN*7(/>M3SQ:*** "BBB@
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M4HN&Y=HHHJC$**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ]S_ *XT :VE=173Q?<%<QI745T\7W!0 ^BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH ****  TE+1B@ HHI* %HI** "EHQ10 4444 %%%% !1110 4
M444 %%%% !1110 4444 %!HHH 2EHQ10 44E+0!AZO"9$:O.-;TUG9L"O6KB
M#S >*P[O1A*3\M<]6GS'K8'&*B>01Z5()>AKK]#L&0KD5T(\.@-G96I9Z2(<
M?+6-.A9GH8G,U.-BUIT6Q!6J.E0PQ;!BIZ[4K(^=J2YG<****9F%%%% ",,B
MLN^B&T\5JFL^^==IH%>QS,J[9:UM-/2LN=AYE:6FGD4 ="OW12TB_=%+0,**
M** "BBB@ HHHH 0G )KFM9F&370W#;8S7#Z[<$,U,3$LYE\X?6NRT]PT(%>9
MV-R3..>]>@:1+NB7Z4"1L4444B@HHHH *.]%% !4,[;5-357N?N&DRH[G*ZY
M=%4;FO.]1OB)3S7<Z\IVM7FVJ*?,-<-:31]7EE"$EJ:>EZJPD'S=Z]#T6^,J
MKS7D>FQOYP^M>F>'48!,TJ$FV/-*%.,=#O8CF,&GU'!_JEJ2O0/DGN%%%% @
MHHHH **** (9(0]5FT]6/2K]% %%+!5/2K<<804^B@ HHHH **** $/0UEZA
MDH<5JGI56X@WJ:F2T-*4DI79YMKD;,6KB[B!_,/6O5=4TPOGBN=?0BS_ ':X
M:M-MGU6"QD(Q.5M8I!CK6YIX8.,UIC0RBYVTU+3RI.E:48-'#F6)C4V.KT5N
M%KI1T%<MHYQBNI3[HKL/G4M1:***"@HHHH *0C(I:* *TMJ).HJE-I"."=HK
M6IDL@1"34N*-(U)K8X?4]+CC).!65$J12=JW-=O5 ;FN&NM5V2GFLI3C$]&C
MAZU8] L+N-%'(K5CU-.FZO*H]?VC[U6K?Q 7<#?67MT=CRN3C=GK$-VLG0U:
M!R*XW1M0,VWFNN@;=&#73"7,CQL11]E*Q+1115G.%,:,-3Z* N4I+%7Z@55D
MTI,9VUKTU_NTN5&GM9I:,YR:S$?:JH7#5KWA'-91^_3M8S<G+<T;(]*VH_N"
ML6S'(K:C^X* '4444 %%%% #7X%8NIW!C0\UM/\ =KG=90E&Q43V.G#).:N<
M5JVKM&[?-6/'K[;\;J-<@D,C8S7/16LOF]#7F3G+F/L\-AZ3IW9V$>J--CFM
MC37WN#7)V<#KC-=5I (9:[J#;6I\SFD(QE[IW6F#""M*L_3?N#Z5H5T'D+8*
M**2@8M%%% !2%@.M+6?>7(B!YI-V*C%R=D73*@[U#/<(L9YKFKG60C'YJSY]
M=!4C=6?M5<Z_J,W&Y8U68.QK >V\TGBDFU(2O]ZKEDZR$54O>1E3;H3,>ZTD
ML,A:99Z4PE'%=JEFDJ]*G@TM0P(6N;V&MSVHYI[EAFC6.Q5XKJ(H]JBJUI;"
M,#BKM=,(V1XN(JNI*X44459SA1110!5NB=AKA=?+$-7?RQ[U-<GK5EN#<5C5
MBVCT,#4C">IY+J2N9#4NDJ_FBMN]TLM(?EJSIFD%7!VUP^R?,?52QL/96.K\
M/;@JUVD7W!7/:/9^6J\5T:C"XKT*:LCY#&34IW0M%%%:'(%%%% !110>E "$
M@5#/*JQGFFS2;0:QK^\*H1F@#-U.=?,/-,TV9?,'-86H7Q,AYHT^]/F#F@#T
MVVE#1"I^M8.FW1= ,UMQ'*T /HHHH #24M&* "BB@]* *]Q,$4\UQ^N7X ;F
MM[4Y2J'%>?:W<,6;FN>K.R/6P&&4WJ4'U#$_7O73:)J?W1NKSR61O,K:T:X<
M.O-<T*KN>YB,##V>AZ]9W D4<U?KF]%E+(N:Z,=!7=!W1\I7AR3L+1115F 4
M444 %13G"U+3)%W"@#F=4E<*V*X;4[F0.W)KTG4+,/&3BN'U6P =N*3=BHP<
MMCF8[N7S.IK>L+J4XY-4(K%?,KHM.TX''%"DF7*C*)KZ;,YQFNFM22HS6996
M&Q0<5KQ)L%,R):*** "BDI: "BBB@ HHIKG H &=5ZFH6NXUZFJ%]=^4IYKD
MM0USRF/S5E.HHG;0PDJNQW8O8CWJ59T;H:\MC\2YDQOKI-+U?S\?-4QK*1M6
MRZ=-7.Q!S2U#;/OCS4U;GFM6=@HHHH$%%%% !1110 4444 %-D_U;?2G4V3_
M %;?2@#S?Q5]YZX:+_CY_&NY\5?>>N&B_P"/G\:].C\(COM ^ZM=U9_<%<+H
M'W5KNK/[@KDK;C+=%%%<X!1110 44E+0 4444 9^K?\ 'H?I7C_B+_7M]:]@
MU;_CT/TKQ_Q'_KV^M=F%W$ROH?\ KQ]:]4T;_5+7EFA_Z\?6O4]&_P!4M7B0
M.B3[M.IJ?=IU< PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ /2N:UO[K5TIZ5S6M_=:M:7Q$SV/.]4^^U%&J??:BO
M6AL<3W.(T/\ UR_6O9_"OW$KQC0_]<OUKV?PK]Q*QQ>QW([D=!10.@HKRAA1
M110 54N8]RFK=-90RD4 <3K&8]QKE'U,12\FNYUVS+HV!7F6K6<D<C$ T =?
MIVOQJ!\PK2_X2&//WA7E,=Q-$<9-7+>ZF=QR: /5K;65D(P:V[:Y$@%>=:.L
MKE<YKO-.B8(": -=3D4M-48%.H **** "BBB@ HHHH **** "BBB@ I*6B@
MHHHH *P]7Z&MRL/5^AH YQ/]=^-=7I7W!7*1_P"N_&NKTK[@H U**** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[,O%=YH=FR[<BJI7N98WEL=M:MNB!J>H;5=L0%35V(^>>X4444""BBD8X&:
M([@XA:O/]=F D/-=AJ-WLA(S7F>OW_SMS42E8Z*-!S-#2;D"8<]Z]"T^=7A
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MGB^X* 'T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2T
M4 )12T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M "4M%% !28![4M% ";5]!1@#M2T4 %%%% !1110 4444 0SOM6N?U&[*@\UN
MW0RIKF]1@9LT!8Q'NBTO7O70:0^XBL 6;>9TKI-)@*8HN%FCHE^Z*6D'04M
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M),]/'XBE*G9'>Z:<VXJY56Q39"!5JO36Q\54^)A1113("BBB@ HHHH ****
M"FR?ZMOI3J;)_JV^E 'F_BK[SUPT7_'S^-=SXJ^\]<-%_P ?/XUZ='X1'?:!
M]U:[JS^X*X70/NK7=6?W!7)6W&6Z***YP"BBB@!*6BB@ HHHH S]6_X]#]*\
M?\1_Z]OK7L&K?\>A^E>/^(_]>WUKLPNX$&A_Z\?6O5-&_P!4M>5:'_KQ]:]4
MT;_5+5XD1T2?=IU-3[M.K@&%%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHKS9[C%HHHJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M!<Y3RAY_XUU.D1@**YK/[_\ &NHTD_**+(.9LUZ*** $HI:* "BBB@ HHHH
MH:E%OA/TKS;7[(L[<5ZE<KNB-<CJ=F'8\5C4AS'?@\5[!W/,%TIC/]VNQT'3
MRA7BK4.E R9VUT>GV C XK&%"SN>CB,V]I&QL:<FR$5=J*!-B8J6NM*R/!D[
MNX4444R0I"<"EJ.8XC- T5KJ[$:'FN7U'5@K'YJMZM.RJW-<%JEVVYN:YJM2
MQ[6 PBGJSH(M<_>?>KH-/U590!NKR47KB3J:Z+2=18%<FLJ=6[.[%X"*A='J
M"A9T]:IW&EK)_#533-1#*,FM^*19 *[.521\XZDJ<K(PTT1-V=HK2M].6+'%
M:  %+0H)!/$3ENQJ+M&*=1251B+10** "DI:* "BBB@ HHHH *;)_JV^E.IL
MG^K;Z4 >;^*OO/7#1?\ 'S^-=SXJ^\]<-%_Q\_C7IT?A$=]H'W5KNK/[@KA=
M ^ZM=U9_<%<E;<9;HHHKG **** "BBB@ HHHH S]6_X]#]*\?\1_Z]OK7L&K
M?\>A^E>/^(_]>WUKLPFXF5]#_P!>/K7JFC?ZI:\KT/\ UX^M>J:-_JEJ\2".
MB3[M.IJ?=IU< PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ /2N:UO[K5TIZ5S6M_=:M:7Q$SV/.]4^^U%&J??:BO6
MAL<3W.(T/_7+]:]G\*_<2O&-#_UR_6O9_"OW$K'%['<CN1T%% Z"BO*&)2TE
M+0 52NR=IJ[4,\>]: .)U8,Q-8]I%^_&?6NLU2TX)Q7-2,(),T =II21B$9Q
M46K1QE#C%<[;ZZL2XW43ZVLW&Z@"E/$1*<5IZ:6#"JL(%P^1WK?LK' !Q0!M
M61)C%6Z@MDV+BIZ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K#U?H:
MW*P]7Z&@#G(_]=^-=7I7W!7*1_Z[\:ZO2ON"@#4HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ7 V&L+:@#=C%7CXE5U*[_UH I:W'AVVUE6 <3CKUK5EE%XWKFKECIGS!L4
M='H^?)&?2M2J=C%Y4>*N4 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!GZG_JC]*X^Y_P!<?K78:G_JC]*X^Y_UQ^M &MI745T\7W!7,:5U%=/%
M]P4 /HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH YWQ A:-L5Y)KUO(9&P#7MFHV_G*>*X
MW4=!\YB=M<E>FY'O97BXTMSRRRMI1,.#7H?AZ!QMS1!X:*29V?I73Z7I?DXX
MK*C2:9Z&/Q\*D+(WK!,1"KU10)L3%2UWK8^3F[NX4444R0HHHH *#THHH KS
M0AP>*R;G2A(?NUO48'I4N*9K"K*&QS,>BA6SMK6MK,1@<5?P/04M"@D5/$3G
MN-5<"G4451@%%%% !1110 444QVVBD XD#J::9D'\595[?B('FN>N-?"-]ZH
ME42.NEA)U-CMA*AZ,*=D'O7#VWB .V-U=!9:@)@.:(U$PJX2=/<V:*:ARH-.
MK0Y!*44F*6@ IKG IU-<9% (P=7E(1L5YIK<K[VP37J&I6Y=#Q7!ZQIK,6XK
MCKQ;/H,KJ0B]3A#<R!SR:=]I<CK5Z?3&5C\M56LW4]*X[-'U"G"6PZ%#*170
MZ;IA=@=M4=,M"7&17?Z+IXPN16M*',SS,=BO9K0?I>E;0/EKI[:W\L#BI;:V
M6-1Q5G%>A&"1\G7Q$JC$'2EHHJSF$<94U@:I:EU/%=!5>>$.IXJ9*Z-:-3DE
M<\KU:P8,W%82VY63I7I6K6 .3BN.O+?RG/%<%2G9GU.#Q7-&PEHN *N,X K)
M6Z$9QFG_ &P..M:4II'-C</*H[DT]V4!P:Q[F^<MUJW+EZHR6A9NE95FV]#M
MR^E&G'WBQ87;F0<FN^T6Z8JN37$Z?8-O'%=UI%FRA>*NBF89E*#1U5N^Y15F
MJUNA515FNY'RT]PHHHIDA4%Q)L0U.>E9>H2%8S2;LBZ<>:5CF-<O-I;FN5&J
M;)OO=ZO:_.V6KB+B=Q*:X*E9IGU6"RZ$X79ZGI&L;@!NKKK.X\T#FO'-#NWW
MJ,FO4=#D+(N:WHU'(\W,L(J.QOT445TGB!11FB@ HHIC.%% #S52YB5EILMX
MJ=ZI2:BIXS2YD:*C)ZF=>VH.>*ROL?S]*W))UD[U"%4M36IFXN.XVQM,$<5T
M5O#M454LD7(K4' H$F &!2T44#"BBB@ HHS10 444A.!0!BZR 5:N$O;02RG
MBNSUJ; -<KY@>?\ &DU<NG-P=T5(-#\P?=JY%X<PP.RNGTFW611Q6X+1!V%8
M.BFSTHYE.,;'.Z;I7DD?+730)L0"E6%5Z"I.E:QCRG!6K.H[L****LQ"J=U<
MB('FK;'"FN8UNZ,:M@U,W9&U"GSSL.N-85"?FJC/KBLA&ZN*U'57$AYK.74W
M8_>-<;KZV/H8Y6O9\QU[W@EDZUOZ0ZY!S7GMM>$L"3726&I",#FNJ,]+GB5\
M,U.R/1DD78.12^<F>M<8WB (N-U-BU\._P!ZI]JBU@*EKG;A@>AI:Q;&_P#-
M YK71MPK5.YR3IN#LQ]%%%,S"BD)P*KRW 0=:+C2;V)I &0@UQ^O6P8-BMF;
M5%3/S5@ZA?I-D9K*;35CNPT)TY<QP&HV!:0X%2Z7IS"0<5O-;+,_2M;3M- (
M.*YE1UN>U+,;0Y32T.U**O%=4@PH%9]A;B-1Q6E77"-D?.XBI[2=PHHHJS *
M*** "BBB@ J*?_5&I:BG_P!4: .1U/\ UAIFF_ZP4_4_OFF:;_K!]: .PMO]
M2*FJ&V_U(J:@ HHHH ***,T %%%%( K&U?[IK9K&U?[II@<O_P M_P :ZG2/
MNBN6_P"6_P"-=3I'W10!L4444 %%%% !1110 4444 ,E_P!6:Y^^*[C6[<MM
MB-<AJET$8\TG*Q4:3J;%F!DWUMVI7 Q7#0ZB!)UKI-.O0X'-+VB93PDX:LZ1
M>E.J*!MR9J6J,[6"BBB@ ID@RA%/HZT <WJMH75N*\_U>Q<.W%>M7, D4\5S
ME_I E8_+7-5IW/9P&,]F]3RU-/D:3H:U[:T>)0<&NMBT$!L[:ENM)$<73M6=
M.C9G;C,Q4HV1C6%VT; 9KM=*N/,45PY@*3?C76Z'G"UVI61\S4ES2N=+1110
M 48HHH **** "BBB@ HHHH **** "FR?ZMOI3J;)_JV^E 'F_BK[SUPT7_'S
M^-=SXJ^\]<-%_P ?/XUZ='X1'?:!]U:[JS^X*X70/NK7=6?W!7)6W&6Z***Y
MP"BBB@ HHHH **** ,_5O^/0_2O'_$?^O;ZU[!JW_'H?I7C_ (C_ ->WUKLP
MFXF5]#_UX^M>J:-_JEKRO0_]>/K7JFC?ZI:O$@CHD^[3J:GW:=7 ,**** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH #TK
MFM;^ZU=*>E<UK?W6K6E\1,]CSO5/OM11JGWVHKUH;'$]SB-#_P!<OUKV?PK]
MQ*\7T/\ UZ_6O:/"O^K2L<7L=R.Y'044#H**\H84A.!FEIDGW#0!!)=A#UJ,
M7JMWK,OF8,<53C>3- %S5;A?+/TKSW6+W:[8-==J&]XSUKB=2LI)'/!H PY-
M3D!.":?;:E(T@R33SH\AYVFFIICQN.* .TT*YWE<FO0+$JT(KS+18W1EKT+3
M"WEC- &R !2TU>E.H **** "BBB@ HHHH **** "BBB@ HHHH **** "L/5^
MAK<K#U?H: .<C_UWXUU>E?<%<I'_ *[\:ZO2ON"@#4HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MPGRM7GFK2F-FP:[_ %>Y4JW->>ZN/,9L5$]CHPL??U.:NM5DC)PQI+'69&E
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M5-4-M_J14U "4HHHH *2EHH **** "LG5E^0UIM(J=:Q-7O4"D9H Y_;^_\
MQKJ-)7Y0:X[[8OG]>]=1I-\FT#- &_14:S*W2GT +1110 4444 %!HI&Z4 4
M=0FVPGFO.==O2K-S7=ZKGRS7F>OJQ9JY:\FCW,KI1D]3'75")OO=ZZ_0]1+E
M>:\Y,;^?^-=AX>5@RUS4YNY[F-P]-4[H]8T^3?$*NUF:3GR1]*TZ]*.Q\755
MIM!1124S,6DI:* #&:88D;J*?10"9%Y$8[5EZJR+&1QTJ[>70A0\UQFLZO\
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MAZOT-;E8>K]#0!SD?^N_&NKTK[@KE(_]=^-=7I7W!0!J4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZBNR?PB1VEE]T5H5GV7W16A7#+<84444@"BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB01T2?=IU-3[M.K@&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK=7[HKS9[C%HHHJ "BBB@ HHHH **2@4 +1110 4444 %%%% !1110 4444
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M^D:*R,IVUJ:99Q,%X%=19VD2 <"NB%,\G$8Q[#]*M3"@XK5J-"BK@$4[>O\
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MJ&W R*L[U]17FO<8ZBF[U_O"C>O]X4@'44F]?44;E]10 M%-WK_>%&]?[PH
M=6)XA'^CD^U;.]?45C>()5^RD9[5</B \@U<?Z0WUK1\/CYQ6?K# W+?6M#P
M^P#C->E+X!'INE*=BUMC@5BZ5,@1>:V=ZG^(5YL]QCJ*;O7^\*-Z_P!X5 #J
M*3<OJ*-R^HH 6BF[U_O"C>O]X4 .HIN]?[PHWK_>% #J*;O7^\*-Z_WA0 ZB
MF[U_O"C>O]X4 .HIN]?[PI=Z^HH 6BDW+ZBC>OJ* %HIN]?[PHWK_>% #J*;
MO7^\*-Z_WA0 ZBF[U_O"C>O]X4 .HI-P/<4M !1110 5SFO?=:NCKG->^ZU7
M3^(#@KC_ %_XUN:/U%85Q_K_ ,:W='ZK79/X1([2R^Z*T*S[+[HK0KAEN,**
M**0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 4KOH:YN_ZFNDN^
MAKF[_J:WI&<BA#_K*ZC2^@KEX?\ 65U&E]!6E78F!L4445R&P4444 %%%% &
M9J0&TYKDKR&.1R.*Z76YO+1JX6XU#;.<GO0!<33D'S8%3K,ML<9Q4,-^K1=:
MQM2O&W':: .KM[U)B!FMNTMD;! %>9Z=J#K*,FN_TC4 Z+DT =)%&$7BI*CB
M<.N14E !1110 4444 )0**!0 M%%% "4M%,D<*A-%P&27"1]35<ZG"#R16%K
M&H&(-@UQ=YK\B2'YC26HV>JI?POT-3I(K]*\MTS7GD< M7>:3=&91DU5B39H
MHI,CUI#*.I#,1KC[E?WQ^M=CJ,JB$C-<?<RIYQYH UM*4\5TT8P@KFM)G0$<
MBND65&4$,* 'T4W>O]X4;U_O"@!U%-WK_>%&]?[PH =13=Z_WA1O7^\* '44
MW>O]X4;U_O"@!U%-WK_>%&]?[PH =13=Z_WA1O7^\* '44W>O]X4;U_O"@!U
M%-WK_>%&]?[PH =13=Z_WA2[U_O"@!:*3>O]X4F]?[PH =13=Z_WA1O7^\*
M'44W>O\ >%&]?[PH =13=Z_WA1O7^\* '44WS$_O"C>O]X4 .HIN]?[PHWK_
M 'A0 ZBF[U_O"C>O]X4 .HIN]?[PHWK_ 'A0 ZBF[U_O"C>O]X4 .HIN]?[P
MHWK_ 'A0 ZBF[U_O"C>O]X4 .HI-Z_WA1O7^\* %HIN]?[PHWK_>% #J*;O7
M^\*-Z_WA0 ZBF[U_O"C>O]X4 .HIN]?[PHWK_>% #J*;O7^\*-Z_WA0 ZBF[
MU_O"EWK_ 'A0 M%-WK_>%&]?[PH =13?,3^\*-Z_WA0 ZBF[U_O"C>O]X4 .
MHIN]?[PHWK_>% #J*;O7^\*-Z_WA0 ZBDWK_ 'A1O7^\* %HIN]?[PHWK_>%
M #J*;O7^\*-Z_P!X4 .HIN]?[PHWK_>% #J*;O7^\*-Z_P!X4 .HIN]?[PHW
MK_>% #J*3>O]X4F]?[PH =13=Z_WA1O7^\* '44W>O\ >%&]?[PH =13=Z_W
MA1O7^\* '44W>O\ >%&]?[PH =13=Z_WA1O7^\* '44W>O\ >%&]?[PH =13
M=Z_WA1O7^\* '44W>O\ >%&]?[PH =13=Z_WA1O7^\* '44W>O\ >%&]?[PH
M =13=Z_WA1O7^\* '44F]?[PI-Z_WA0 ZBF[U_O"C>O]X4 .HIN]?[PHWK_>
M% #J*;O7^\*-Z_WA0 ZBF[U_O"C>O]X4 .I"0*:TJ*,EA6?<Z@B$_-2;L7"#
MD]#1WKZT[.:P%U1=WWJOV]^C_P 0I*29<J$HFA13%E1APPI=Z_WA5&(ZBF[U
M_O"CS$_O"@!U%-WK_>%(TB*,EA0 /($&369=:@J$\U#J6HI&I^:N+U+6\,<-
M6-2IRGHX7!NIJ=E%JBEOO5H1WJNO6O*HM=P_WJW[#6PP W5G&M<ZZV6N*N=/
MJ%T0A(-</JNJ/&S?-6]<7BRQ'FN+UD@EL&HJS?0Z<!0A>TA(M;?S0-QKK-'U
M%I=O->9)D3=>]=KX?D *Y-8TIRN=^.P]-0NCTZR8M'GVJU5#394,(&1TJ[O7
M^\*]*.Q\=45I,=13=Z_WA1O7^\*9 XG YJ)KB->IJM>WB0QGYA7):AKPC8X:
MLYU%$ZJ&%E5V.T%U$3]ZI5D5NAKS:#Q'NDQOKI]+U99<9:IC54C6M@9TU=CM
M<M6E1L"O+]:T>1Y&PIKV>41SQ]16+=Z3%*2<"HK4N8Z\OQRH:,\>LM$D68':
M>M>B>'M/>/;D5IQ:)$C9VBMJSM8X<=*SI4.5G3CLS56-D:%NFR("I::'3'WA
M1O7^\*[3YUN[N.HIN]?[PH,B ?>% A20.M,,R#J:HWM^D8.&%<[=:V%8_-6<
MII'52PTJFQV F0]#3B ZD5QEKK@9Q\U=+97R2J,L*<9J0JV&E2U97O=,$P/%
M<]<Z "Y.VNWWH1]X5&ZQ-Z4I4TRJ.+G3T.0M-$V,/EKH[.P$2CBK:+$I[5+O
M7U%$8)"K8J50%4**=3=Z_P!X4;U_O"M#E'44W>O]X4;U_O"@!U-?[AHWK_>%
M,EE18V.X=*!K<YC6;TPAN:X>]UUDD(W&NB\27 PV#7F6H2DS'GO7GUZC3T/K
M<LPM.<;L[73=::1Q\U=[I-R95&37CNC2XD7)KU#0;A0BY-50FWN89IAX07NG
M7CI14:2HRCYA3MZ_WA7<?,#J*;O7^\*-Z_WA0 ZD9=PQ2;U_O"C>O]X4 9M[
M8"0'BN>NM)0$DJ*ZZ:>-4.6%<UJFH1H#@BL:B1Z&$J5&[(YV\M8XE/ KF;Z0
M(3BM'5-7!) :N:N+OS2>:YG-+8]V&%G/5B_:R&ZU8BO7R,$UE=6K0M(MS"L)
M2;9Z5*C&G'4ZS1;EW=>37H^E9,0)]*\_T.W52I->AZ>R+"!D=*[*%^I\WFCC
M?0O44W>O]X4;U_O"NH\0=13=Z_WA1O7^\* '4AZ&DWK_ 'A4%Q=)&A^84#2N
M['*^(IMN[FN/BO=MQU[UN>(KM7W8-<,]SMGSGO7/*LDSU:&6RJ1N>J:+?!D4
M9KJ(GWKFO+="U( J"U>AZ;>)+&!N%:0J<QRXG".CN:=%-WK_ 'A1O7^\*T.,
M=13=Z_WA1O7^\* '57N0=AQ4V]?[PIKLA4@D4,<79G#:]N :O-M48^8:]3\0
M!-K8KR[5@/-:O.K[GV&523B9<;$-5^"\:/'-4$'-2$<5@FT>K4A&3U->/670
M@;JZ/2-7>1U&ZO/R#O%=)H38D7)JX3E<YL1AJ:IW/7=*F,J+S6S7.Z',@C7)
MKH/,4_Q"O2AL?%8E)5&D.HIN]?[PHWK_ 'A5G..HIN]?[PHWK_>% #JAD@63
MK4F]?[PI=Z_WA18:=C-ETE)#T%1+H:*<X%:^Y?44;AZBIY$:*O-*URI#8K%Z
M5:50HI=R^HI-Z_WA32L0Y.6XZBF[U_O"C>O]X4R1U%-WK_>%&]?[PH =6#K,
MK1JV*W-Z_P!X5S^NNK(V#43V.G"I.HKG :IJCH[#<:P9=7<D_,:O:R@+M7-2
MC!/->9.3N?;8>C2=,T!J+%NM7(-59/XJYX'FI0WO5*H[$/!P<KV.D.ON.-YK
M3TS6GDD W5PCL<]:V-%?$JY-3&I*YI6PE)4[GLNCSF5%.:W:Y7P].HC7)KJ!
M(I&=PKTZ;NCXC%Q4:C2'44W>O]X4;U_O"K.8<3@54N;Q8E/-+=W20Q'YA7#Z
MUK80L U9SGRG7A<,ZTC3U#6%7.&KF+W62Q/S5@7>M&1B-U9LEX7/6N.5:[/I
M:&6J*U1KW.HEL\UFRWA;O54R[N]1L:RE-L[J6&A O6TN9!DUVNB2H"N<5Y['
M+L.<UKV&L>4X&ZBG*S(Q6'<XV1[182HR#%:%<'H>MK)M!:NUMYTEB!W"O1IR
MYD?'XJ@Z4M2>BF[U_O"C>O\ >%:'(96I2F-37#:MJ;HQ^:NRU>52C8-><:UR
MS8-<E=M;'OY93A+<@367\S[QK>L=6+J,M7!G(DZUK6-SL YKFA4=SV<3A8.&
MAUT]SO7.:R9[SRR2#4+7@V]:S+NXW9YKLE/W3YZEA7[;4FGUMTXW4^RUIWD'
MS&N9N26;K5G3 1*,FO/YY<Q]2L+35+4]9T2Z:4+S761?<!KAO#SJJKDUV\,J
M&,?,*]*B[H^/Q\5&>A-13=Z_WA1O7^\*V//&7"[H6%>>>([4L6XKT21TV'YA
M7)ZVJ.&K&JKH]'+ZG),\DO;8K(:HE=IKI=5B4,:YZ; :O.:LS[6E/G@$;D59
M6<@=:J+4@Z4-L2IQ3+<-PV\<UV>@2,S+7#6X!D%=YX="AES5T;W.3,.54ST3
M3@?*!-7JJV;((!R*L;U_O"O36Q\14=Y,=13=Z_WA1O7^\*9 ZBF[U_O"C>O]
MX4 ,N!F(UQFKL5=J[*:5%B;)%<9K#J6;FDW8N$')Z&1!,?-'-=3ICE@M<?&Z
MB7K74:5.HQS24TRY4)1.KA^X*DJ&&5&C'(J3>O\ >%48CJ*;O7^\*-Z_WA0
MZBF[U_O"CS$'\0H =2$@5!+=1H.HK.GU-%/WA4N21I"E*1K;E]:S]3*F,UG_
M -KK_>%4[[559#\U+VB-7A)&7<%1-6SI-PB8R:Y&[OQO)S38=:\K^*E*JD72
MP,IL]1%[%CK3ENHW/!KS$^)3G&^M?3-=$KC+5FJZ;.FIEDX1N=Z#D9%+5.RN
MTEC'S"K6]?[PK=.YYDH\KLQU%-WK_>%&]?[PIDCJ*;O7^\*-Z_WA0 ZBF[U_
MO"C>O]X4 .HIN]?[PHWK_>% #J:XRC#VHWK_ 'A2-(@0G<.E 'G7BI<%ZX:(
M?Z3^-=UXKD5F?!KA(F'VG\:].C\(CO\ P^IVK7=6BX3-<-X?E4*N37<VLR&,
M#(KCK;C+-%-WK_>%&]?[PK !U%-WK_>%+O7^\* %HIN]?[PHWK_>% #J*;O7
M^\*-Z_WA0!2U49M&KQ[Q&/W[?6O8=3E06;#(KQ_Q&P,[8]:[,+N)E?0Q^_'U
MKU71E/E+7E6A,!./K7JVBS((EYJ\2".@486EIHD0C(84;U_O"N 8ZBF[U_O"
MC>O]X4 .HI-Z_P!X4F]?[PH =13=Z_WA1O7^\* '44W>O]X4;U_O"@!U%-WK
M_>%&]?[PH =13=Z_WA1O7^\* '44W>O]X4;U_O"@!U%-WK_>%&]?[PH =13=
MZ_WA1O7^\* '44W>O]X4;U_O"@!U%-WK_>%+N![B@!:***  ]*YK6_NM72GI
M7-:W]UJUI?$3/8\[U3[[44:I]]J*]:&QQ/<XC0_]<OUKV?PK]Q*\9T/_ %R_
M6O9O"OW$K'%['<CN1T%% Z"BO*&%%%% !5.YFV U<K/NT+9Q0!A7TADR*Y;4
MK?@FNFO 8R<USU_.K B@#E+AW5R!4UG9M<,":F>V\R3.*V-,A6+&10 ^TL#!
M@XKH].N60A<U6RCK@58M+<F0$"@#JK23>@JS52R4J@S5N@ HHHH 3%&:6DH
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M>@#J#KO^U33KI_O5RZI(3WJS':ROV- &_P#VZ?[U+_;I]:QQ82^AI?L$OH:
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M^W6_O4?VZW]ZLC^SY?0T?V?+Z&@#7_MUO[U']NG^]61_9\OH:/L$OH: -?\
MMT_WJ/[=;^]61]@E]#1_9\OH: -?^W3_ 'J=_;W^U6'+92HN<&L^02*V.: .
MK.NG^]2?VZ?[U<W!%))ZU<%A+CH: -C^W6_O4?VZW]ZLC^SY?0T?V?+Z&@#7
M_MT_WJ/[=/\ >K(^P2^AH^P2^AH U_[=/]ZC^W6_O5D?V?+Z&C^SY?0T :_]
MNM_>H_MT_P!ZLC^SY?0T&PEQT- &R-=/]ZE_M[_:KE;F.2+/6JT<DCOC)I =
MB==/]ZD_MQO[U8<%G+(N<&I?[/E]#3 UO[=/]ZE_MT_WJQ_[/E]#1_9\OH:
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M_P!NM_>H_MUO[U9']GR^AH_L^7T- &O_ &ZW]ZC^W6_O5D?V?+Z&C^SY?0T
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M  D)_O4?\)"?[U8)T^8=C2?8)O0T ;__  D)_O4?\)"?[U8'V";T-'V";T-
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M)_O4?\)"?[U8'V";T-'V";T- &__ ,)"?[U'_"0G^]6!]@F]#1]@F]#0!O\
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M2?\ "0M_>KFH;660=ZL?V=-CH: -W_A(3_>H_P"$A/\ >K ^P3>AH^P3>AH
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M,<4FK'5V^OD1 ;JE/B$_WJY]-/F48P:4V$WH:[#YEN[-[_A(3_>H_P"$A/\
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MZ;3_ ! R(!NK27Q$3_%7+Q:9,O8U973YAV->G#8^(Q#3F['0_P#"0G^]2?\
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M16H.E %+^S8O04?V;%Z"KM% %+^S8O04?V;%Z"KM% %+^S8O04?V;%Z"KM%
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M_JQ3Z *7]FQ>@H_LV+T%7:* *7]FQ>@H_LV+T%7:* *7]FQ>@H_LV+T%7:*
M*!TN$]0*P]:T:,1DA175UF:N<P$>U*Q2DX['F$NGJMQC'>NMT#2T<+E165-
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M%:+2XE09 J3^S8O05=HK8\YZE+^S8O04?V;%Z"KM% %+^S8O04?V;%Z"KM%
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MNC]5K#N/]?\ C6YH_45V3^$2.TLONBM"L^R^Z*T*X9;C"BBBD 4444 %%%%
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M1=@*TTX0?2G4TDB)3E+<RO['C_NBC^R(_P"Z*U:*9!E?V/'Z"E&D1^@K4HH
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MGWJQ[W4 A)S0G<-C>T\I'CD5KAU;H:\Z37PCXW5T.F:MYY W55A'344R-MR
MT^D 4444 %%%1ROM% $F132ZCO6;/>[,\UG3ZL%S\U),#<E9&SR*H2JF>U<]
M-X@"D_/^M5QKZNWWJ8SJ8=H:M2)@5X-<;!JH/.ZM6VU,'C=36I)T-%5;>?S!
MUJU2&%%%% !111VH *,CUK/N[OR<\UD2ZV%;&Z@#I6VE2"16?+:([9XK'&N
M_P 5*-:!_BH W;>!(S5S-<TFK@GK6C;7OF8YHL!J44U#E<TZ@ HHHH ***AG
MD\M,T 2Y'K1N'J*YR]U?R2?FK(D\3%3]ZE<=CKKN&.;KBJL-C$CYXKEQXGSU
M:@^*%7^*F([Q-JJ "*?FN'M?$XD<#?\ K726%\+@#FG8#4HH%%( HHHH ***
MAEEV T 2E@.IJO/.H7&:R;W4Q%GYJQ9=;RV-U+<-C=FE#'K38@I-82ZANYS3
MAJ@0]:>P;G76X08JW7*6VL D#=6U;7HD YIV$:-%-0[AFG4AA24M% !114-S
M)Y<>: )#(HZFF&XC'\5<OJ.M" D;JPSXFS)C?^M*X['=7*I/5(:>H;.*RM/U
MD38RU:TFH((LY%58FY?MRL0Q5E9 W2N1EUI1+@-6OIM[Y^.:DHVJ***8@HHH
MH ***H7EWY(/- %_(]::2I&"17'7OB+RB1OJ@GBDE\;_ -:5PL==<V44C9 %
M+;P1P,.E8,/B!73):JMSXA"GAJ8CN%E0]#3P<UQ6GZT9W W5UMH_F1 T 6**
M**!A1110 4$XI&.!5&YNA&IYI-V&D6GG5>]"W$;=Q7*7NK["?FK);Q(4?&^A
M:B9W\L<<J]C5)K% V0*PM.U\3$ M71)=(T><BFW82B20!8JLB0'I6!=:BJ/@
M-4]E>^:1S3'L;5%(O*BEI %%%% !2%@.II:S-0N_(4G- &@94'5J3S8R/O"N
M%O?$0B8C?4%MXE,C@;_UH [*YLXYCG I+>SCA;.!52QU-94!)IUYJ21KPPJB
M;&TLB8P"*<"#TKE(-7#RXW5T5G+YJ9J2BU1110 4444 %-WJ.])*VU":PKS4
M#$QYI-CL;X8'H14-Q"LR8(KG8=9^;!:MBVU!) ,L*:)9!_9J*^[ K1@\N)-H
M(%5+V^CCC)!%<Q<^(-DNT-1<+6.WWJ>AI<YKG-+U,W..:Z).5!IC'4444@"B
MBB@ HJ.1MHJA/>^7WI7 T\CUJ*148<U@2ZT%/WJA_MP'^*F!M-:H3VJ2*!%K
M!_ML9^]4\6K!CUH Z)< <4M9T%WYF.:OHV118!U%%% !1110 4A('4TDC;4)
MK!U#51 2-U &U)<(HZUEWDPE!&:YY]=WMC=3EOR_.: +BVJM)FMVPC2-17-"
M_"<YJ:+6E4@;J!'7T5DV>H"?'-:JG*@T#%I*6B@ HHHI %&1ZU!/+Y8)S6+=
MZN(L_-1<=CH"1CDBLB]LXIF)XKGYO$NTD;Z@_P"$F4]6IB.CM+&*)P>*V49=
MH (KS]O%"J?OU>L?$(F<#?32%<[6BJEE<><@.:MTAA1110 4444 %&1ZTR5P
MB$U@:CJ_V?/S4KA8Z$E>Y%59HHF]*XI_%6U\;_UI?^$I4K]_]:8'7"*('M5J
M'8.E<(OB4,_WJV+#6!+CYJ:U%L=515:WN!(HYJS2L%PHHHS0,****0!29'J*
MK7<_DJ3FN:OO$ @)^:BX'7;E'<5A:I#',3TKEW\7?-C?^M.3Q )CRU,#4M;%
M$ESBNIM=JQ  UQ2:JJ\YK0M-:#,!NIV$=9152TN/.4'-6Z0PHHHH ***0G -
M "T9'K69=WPA!YK"N?$(C)&^E<+'4W.QXBK$5ST]A$TN<"L=_$V3]^F'7P1G
M=3$T==IZQ0@=!6H'4]"*\]C\0 -C=6WI^K>=CYJ8+0ZBBH8)-Z@U-2&%%%%
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MFO[&(W52&N[S]ZF!T[[':K-O$@.:Y(:S@_>JY;ZV"1\U CLEQM&*=6+::D)
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MB73%9\XJ6SU%9<9:KLMS&L9.10]!+4KVL20>U7?-3L:Y/4-;$+D!J;8:R9W
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M <T["-&BBBD,**** "BBJ=U<B('F@"YD>M,=EVD$BN9N]<$1/S5ER^)N?O\
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MR-U=9<:.(K?A>U<#K]I(&8 &GS6T%RW,L:RTESC=WKT+PO<F4+DUY;:V$AN
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M@#7<W8S 17!ZQ9O(YXJ9%1.2GGEF<X)IJ6D[\\UN6NE9D^85U%EHL;(/E%.
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M!;F/;D59)UXZ"EI!T%+4C"BBB@ KFM=N3$K8-=+7*Z_ T@;%)C1Y_J5^[2$
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M=?+-<_\ :E\['O1:Q-[G1Z5$(U&*U:RM+?<HK5H&)WI:** "D(R#2TC'"DT
M9UW9I*#D5@W.B0LQ.T5L7U^(<Y-<]<ZZH8C=4C)(M-BA;.!5\/&B8XKG)=;S
MG!JC+K;#^*J0F=)-'%*_:KVGVJ*00!7#Q:[F3!:NLT;4!-MYIV"YUT2[4%/I
MD1S&#3Z0!1110 4UQD4ZHIGVB@"I=0*R&N5U:U7!P*Z"ZO H(S7/7]TK@\U.
M^PSB-0@Q(>*KVHVR"M:]"NQJE'& ]4GW!KL=+I2A@,UUUC:H5!Q7%6$WE8YK
MJ+#4A@#-5Z$G20Q!!Q4]4[6<2 5<J6,**** "@]**#T- %&Y13G-9S11!NU&
MJWWD \UR-UX@V.1NI#.WMWB0]JT!<Q;?O"O,U\1'^]4B^(V/&ZF2>@S7T8X!
MJ**Y#MUKBX=5>9AS70:=(SD$T[#N=(ARM.J.'[E24@"BBB@ I"0!S2U4OI?*
MCS0 L]XD0//-8T^K@/UK&U'52'*[JR_M#RG.34WL.QW%GJR,,,:BU:\BEA(!
M%<+-J3VHZD53;Q"TK;=U5N+8O3P![@D>M=/H<&T#BN=T[-PX.,UVVEP;5'%$
M58).YKQC"BGT@&!2T,2"BBB@8=JIW" CFKAZ5G7LP1328T9-W&F3FLM_+0]J
M9J>I;">:YFXU=BW!HBPDCJTF0\ U.D(E-<K8WS2,.:['2B'VYJ^4FY-!IFXY
MQ6I!8",#BKL*J$&*DI -1=HQ2TM&*0Q*6BB@ J&Y0/'@U-4%T^R+- &!<V,9
MD)(%7+'R8,=*Q-4U40L>:P6\2$/@-23&T>C7%Q$\1&17*:E91S$GBLI/$#./
MO4/JY(Y-.UQ7L.@TF-9,X%=9I-L(@,"N1M]3#2 9KKM)N!(!3$;]%%%(8444
M4 !Z5Q_B)6(;%=A61J-D)P>* /)+EY8YCC/6FO?S^7CFNWN/#JR,3MJE-X:4
M+]VIL.YYQ=S3/(3S5_2;V:*0=:Z.?PZH8_+3K;0 '!VU:8F='HVHR2*H)KLK
M1RT8)KEM*TSRL<5U=LFR,"ADDU%%%(H**** &N,BJ5Q;J5)(JZ[;16;>7@1"
M,U+*1D7$*(_:K=A<1QD<BN?U'4<,<&LH:TT;?>JDR6CTB::&6+&17+:EI\4K
M$@"L0^)2!C?2)KIF;&:EK4:98BTU4DX%=/I<.S%9-@WGD'%=/9P;0#BK6Q+-
M%?NBEI!TI:0PHHHH *S;ZT\X'BM*D8J!S0!S4>E+')N*UMVSQQ1A<@56O;J*
M)3R*Y:_U\0DX:DF-HZK41#/$1D&N UC3(V<D 5&_BO+;=_ZTZ+4?MC#G.::0
MFR'2[ QS# [UZ1I";( /:N=TRRW$-BNLM(_+3%-B18HHHI#"BBB@"*X.V(FN
M5U&\=2P&:ZJ9=Z8K#NM-\UB<4F-'+-"]VV",YIZ^$_M W%/TKJ+/2U1@2*W$
M1(T   IK839YM<>'5LEW;<8JE'J?V.7;G&*[?Q%-&(& QG%>3Z@SM=G;GK23
M'8],T;5?M!'-=9&<H#7F?A4."N<UZ5!_J5JB22BBBD,2E%&** #-5;O8R8-%
MQ-Y8/-85[J>S/-*X[#I+>+S,\5I63Q1 <BN.GUDJQYJJ?$17^*F)GI!NH1_&
M*@EOH\8!KS9_$[YP'JW9ZP\[#DT =NMQN;BKT!R*Q-/S( 36Y$NT4VA7):**
M*0PHHHH :XRN*R;RTC?)(%:LK;4)KF-5U3R,\TF-$$T$439XJ+[2B<9%<[>:
M\68@-6>^JNQSF@&=LL\<O&15J&TBD.>*X6WU5PPY-=#IVK$D FJ1)U]K:)'@
M@5H@8 K*L;OS5'-:HY I#%HHHH **** .>\0KF-J\NU-FCG)]Z]:UF/?&U>:
MZQ99D;BHD6C*M]7>(8S2W&MNZ]35%[-@341LV-5$ED$^I.S]:V=$NF>5>:Q7
MTYBW2M[0[!UD7BJM<5SU#0OFC6NB P*P]#B*1KFMVAB0444E(8M,E&8R*?2,
M,B@#EM4MR<D"N4O)9("<9KT6ZM?,4\5SM]H9E)PM0EJ6WH>;ZCJ$SY'-8JS3
M>9GFO19O";.Q^3]*B'@]O^>?Z5HV9K0YRPU&9% R:UX;EYV&:O?\(LT0SL_2
MG1Z:8'Y%$1R-G1HN0:[* 8B%<MI8"D"NJA_U8IR)B24445)04444 4[J(.#F
MLEK2(/D@5I:A-Y2$UQ]_K?DN1NI)C.OM##$.U6VNH@/O"O-E\2G^]2/XB<_Q
M&F([FZDBGSTJFEC&7R *Y2'7'9N6K=T_4_,(R:$@;.FM(1$!BK=5+23>HJW0
M 4444 %(PR"*6D8X!- &;=6BR9)%4UM(HVS@5/?7HA!YKG+O6]I(#4AG507$
M40QD4^>]B9",BN DUU@?O57?Q V/O4Q'3W:Q2N>E2V-JFX$"N/CUPN_WJZ;2
M+\2$<T[!<ZR"(*@J>HH'#QBI:0!1110 444UFP* %) ZFJLYB/7%5KN\$8/-
M<U?ZT8\_-2W'L;5P(<'I6!>I%N.,5BW'B0AB-U46UHS-UI;!N=)9!%E%=GIT
MB^4!7G%C=L6!KK=-OL #-:;D['4T56MYO, YJS4C"DI:,4 )2T8HH K36PD[
M56%@BG)%:#.JC)-9=_J<<2G#"D,NQ&*(8R!3GNX5&=PK@]1\2^43A_UK%/BQ
MG;&_]:=Q6/0[G45)X--MKDNU<;9:BUTPYSFNLTV)B 3185S?B.4I],C&$ I]
M PHHHH *I:@2(N/2KM5;U-\6* .#U2X97/-9<5]\^":VM8LV)8@5Q]R)(')Y
MJ&6CK+<QS 9(IMU91%21BN2AUIX#@FK@\0;Q@M6B6AF]S4AB"2\5UVD,0!7%
M6-T)Y <UW.D)E120WL;R'*BGTU1@4ZFQ(****0PJ*2+>*EHH RKFP#@\5@WF
MFJ,\5UL\JHAR17,:KJ"(&Y%3>Q6Y@S6D:'H*8FQ3CBL[4-6 )P:S8M5+28S3
M6HGH==%&KD5M6%M@@XKG=*G,I6NUT^+*@XJ[6)O<T+==J5-35&!3JD84444
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MJX&'Q <?>I)M>8]&I[B.[^V(QX-3HP8<5PEAJCRR#FNQL)"\8)HL%R[1110
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M** &R#*$5S]_:H[$D5T#G"&N8U:]$.[FDQH+6.*%\\5JF\C\O&17G]QKVQR
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ME(YW6=6,2MS7 ZEK32N0#74:[:22;L UQTFDRM-R#4VT'L4R)+CGFI;:Q?S
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M(M*D]#7;6NBJ%&5J^FE1J/NBK9*.1LM/D1AP:ZO3HBBC-65L$7L*L)$$Z47
MEH-%%(89HI*6@ KE/$$I4-BNKKDO$*Y#4 <%<.\DQ&3UJS#8/(F:9@+<<^M;
MEK/$L7.*A[E]#F[NQ=,UGI _F5TVH7$1SC%8HF3S*V^R8]3=T5"K+7H.FO\
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MTDBY-<Q<Z-)]HSM/6NL\,V#0R+D4;C/3[0YMU-35#:C%NHJ:@04444 %%%%
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M3+:[$S4AO0R(O#R>9G;6[::-&J8VBK?"KG%(EZ%;&:JQ*=P&CQ^@JQ'IJQ]
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MD<@4K7'L<]=V(,AP*ELK;RW&16M#:-,<XJ:2Q:,9"U5K"W-/3-F #726T*,
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M6BB@!K+N%4;RP65#QFM"HY)%53DBDP. UC1E.X[:X>^TK:YXKU?4W1\UR-]
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MJ2*%7)KLM.NGEQS7$6UBT4P&.]=SHL("KFF@9T-MG S5JHXU '%24AA1110
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M*** "BBB@ HHHH **** "BBB@"&Z_P!0:X'7NK5WUU_J37 Z]U:MZ&X'&O\
MZ[\:ZK0!RM<J_P#KJZK0.JUV5/A$=Y VV ?2L+5IR<C-;<0S!^%<]JJD,:\J
M?Q%Q,40&:2MW3=-48)%8\4ZQOS6K;ZO'&!S6T;6,Y;FZVGH8\8%8>HZ:$R0*
MN#74(^]5:]U2.6,\BL);EIZ&$)#!)C-=)I%T7*C-<I,_F3<>M=#H:'<M=/V3
M'J=B.0*Q?$/_ !['Z5M+]T?2L7Q%_P >Q^E1#XD:GD&K_P#'PWUK1\/_ .L6
ML[5_^/AOK6CX?_UBUZ4O@$>H:4O[H&I-1N_(C--TH_N1]*AUB!I8CCTKRZFX
MT<K>^(3'*1NIMOX@+_Q5C:EI<QF) -,M-.F4C(-3'4;.J362>]6X=4W'DUAP
M:?(<<&M&'3I 1P:HDZ"UNP^*UXCN6L"RM70C-;T"[5H8$M&:*2D,6BDI: &2
M#*$5@ZG:LZD@5T-130K(A!%)H:9Y1JEJZN>M9L%H\DF.:[[5].4L3BL:"U6.
M7D4T)E>WT1I$!Q5J+071LX-=-IQBV@'%;"01,,@"@##TVQ:+&170Q#"8I5B1
M>@IX&*=Q!1112&%%%% !1110 4444 %<YKWW6KHZYS7ONM5T_B X*X_U_P"-
M;FC]16'<?Z_\:W-'ZBNR?PB1VEE]T5H5GV7W16A7#+<84444@"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH I7?0US=_U-=)=]#7-W_4UO2,Y%"'
M_65U&E]!7+P_ZRNHTOH*TJ[$P-BBBBN0V"BBB@ HHHH Q-;MA,C5P%YHV9B<
M5Z)JLPC4YKDIKR-I<9% &?::<T8Z5:DLF9:U[01NN>*6X:.,=J .5GTHL>E1
MQZ25;I6\UQ&S8XJU;1I(1Q0!6TVT:,CBNPL%*J*IVMF  <5JPQ[!0!/1110
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M64D1P.*T(.?BT-E8'%;EA8F$C(K92.,J" #4@51T I7"PB#"@4ZBBD,****
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MKFT%LK$F0'%=GI<7EH*@L-/ 4$BM:*(1BK;(2):***DH**** (Y0/+-<EK)
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M_K_QK<T?J*P[C_7_ (UN:/U%=D_A$CM++[HK0K/LONBM"N&6XPHHHI %%%%
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M* .;T^X\E@*ZRRN]ZCFN3^S%):W-/)&* .FC;<*?4%N<K4] !1110 8HHHH
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M&\TGY:SCX<Y^[7;8'I28'H*5@.+7P[AONUK66E"$CBM[ ]!2X'I57%89$@1
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M]!D.#1ILQ:04H[E26AWMB^4%:2G(K'T[)05KKTJY&:'4445)0444A.* ()X
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MH9<FM;3]1"8!-53)F=M$JK&  *HZA:1R*3@5!!J(*=:ANM34(>:4PB<_>PK
MYQ4NGW9#@9JE?W7FN<4[3HV,@-.(,[NQ??%FK54]/&(1]*N4 %%%% !56^.(
M"15JH+I/,B(I,#S;7[R2-FP37(/JLPDQDUZ-JVBFX)XKG)/"C;B=M"*,>#47
M;&36A'()1S4%SH[6O;I5'[28&P:=T38Z>RM%9P:[32( BK7 :5J(9AS7H&D3
M;U6J:)-VBBBI*"BBB@ HHHH **** "BBB@ HHHH ANO]2:X'7NK5WUU_J37
MZ]U:MZ&X'&O_ *_\:ZG01\RURS_Z_P#&NKT#JM=E3X1'=P-LM_PK+U"^V@C-
M:*#-O^%<UJP8.:\J;]XN*&I()I*Z#38E !Q7(VDA609KK=-F4J.:UBM#*3LS
M6FA62,C%<SJ5DJ$MBNIW#;G-86L2KL;!K&3U-$<XEY]GDQFNATR_\[ S7$W3
M,9SCUKH-!#;ES6Z7ND=3MAT%8OB+_CV/TK:7[H^E8OB'_CV/TI0^(H\@U?\
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M4X(Y8SD#-<E<VBQR$@5>NM:&#\U9,E\)WP#6:W+Z&C8W!1@,UU%C*745RUA
M78&NIL8RBBMGL9IZEZBBBH*"BBB@"&Y.(2:X#Q#J+PEL$UZ#.NZ(BN+UO1VN
M=V!28T><S>()EEQN-7+77'?&2:L3^$I#(3MJM)HCVHSCI3$S5BO1*!DU;@4.
MXQ7+><T#8-:VFWVYP,TT)G>Z3'C%=.GW!7+Z/+N"UU"?<%#!#J***0Q****
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M;7E)<UCZ? #.,^M;>O'!8US45]Y4W7O20'HVG6\8@&<4Z^MHS W2N:M=?"Q
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MHHHI#"BB@T (0#33$AZBG4M $7V:(_PTGV6+^[4U% $/V:+^[3A#&.BU)10
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M8A6A67HYS"/I6I0 4444 %%%% !1110 4444 %%%% !1110 4E+10 @I:**
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MB9>E+0**0PHHHH *J7B;HS5NF2+N0TFKC1P.K0$.3BJ5E=?9Y!DUT^J66\'
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MIQ7+W):&0YI=1]#I+38V.E;<  7BN+T^^^8#-==8R>9&#5LE%NBBBI&%%%%
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MZ*\A*YS5+2M'68@D5V-AI*PXXI(;-:Q)V"M =*KP1!% JQ38D%%%%(84444
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M=M%MHA1@=M-"96LM.,Q!(KH;33!$ =M3V5F(@,BM"FQ#8UV+BG444AA1110
M51U)ML.?:KU9NK']P?I0!PFKWA5VP:Q([^7?P36CJ:>9,1[T^PTD2#)%39CN
M/L]3E4C)-=7INHE\ FN;GT];<9JSIDX24 FM$R6=]$V] :?5:SD5X!@U9J1A
M1110 44F:6@ HHHH BGB$BXK(N=&68GY:W**+ <L?#:DYV5/#H"QD';7144
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MQ_Q%_P ?#?6O8=6_X]#]*\?\1?\ 'PWUKLPFXF0Z&/WP^M>BV,NR$5YWH?\
MK17>V^?)%5BQQ-6.\.<9J:6XW)6.C$/S5TR*(^37!#5A4T,R[DR]6M-3>169
M>3+YG6M31YDR,FG+04-35G/E19K'.HD38S6QJ$B& X/:N/E)^T\>M$=1L[;3
M;CS5'-:E8&B9VC-;]-@%%%%( J.8XC-25',,Q-]*3!'':Q-M<\U2TZX!F'UI
MVO[@[8K&T^9EG&?6B(V>H61#6XIMY&ODL<51TR\7R ":DU"]40, >U-B1QVJ
M2K',:GT>Y#2#FL+6+AGG./6KGA\L95S4JY1Z5;',(-35!:?\>ZU/5$A1110
M4444 %%%%  >E<UK?W6KI3TKFM;^ZU:TOB)GL>=ZI]]J*-4^^U%>M#8XGN<1
MH?\ KE^M>S^%?N)7C&A_ZY?K7L_A7[B5CB]CN1W(Z"B@=!17E#"F2#<A%/HH
M YC5--\[/%<E>: Y8X6O46B1NHJ%K*%NJT >/S>')6_A-0#PO+G[A_*O9#IM
MN?X:/[,M_P"[0!Y"/#<H'W33?^$;E+?=->P?V;;_ -W]*/[,M_[M 'FNG: Z
M,"5-=IIM@8E&16RMC"O1:F6)5Z"@!(EVK4E%% !1110 4444 %%%% !1110
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MQA1112 **** "BBB@ K#\0_\>Y^E;E87B'_4'Z5</B \BU?_ (^&^M:/A_\
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M<>*L4@ '2EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MC=VK"U&]$LAYJ; 7M'8^:*[6'_5+7$:+S(*[>'_5+3 DHHHH **** $I:**
M"BBB@ HHHH *;)_JV^E.ILG^K;Z4 >;^*OO/7#1?\?/XUW/BK[SUPT7_ !\_
MC7IT?A$=]H'W5KNK/[@KA= ^ZM=U9_<%<E;<9;HHHKG **** "BBB@ HHHH
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M#X;A/\*UO44 8L6@Q1G( K1AM5A' JS10 4444 %%%% !1110 4444 %%%%
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M=% T"('.T5M44 4(=-2'H!5Q$"C%/HH **** "BBB@ -)2T4 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *J7P_=&K=07*;XR*30T
M>>:T2':N>68K)7;ZIIK2DX%8+:&^[[IHZ 5([UE%7(-38$<T?V-(/X33TTB0
M'[IIK03U-JQU-F(YKI;.X,@%<G9Z>Z,.#73V$10#--B1J4444AA1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MQ]:ILE(]1LFWVX-6*J:>,6JU;I#"BBB@ HHHH **** "BC-% !1110 4444
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M% !1110 4444 %%%% !7.:]]UJZ.N<U[[K5=/X@."N/]?^-;FC]16'<?Z_\
M&MS1^HKLG\(D=I9?=%:%9]E]T5H5PRW&%%%%( HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** *5WT-<W?]3727?0US=_U-;TC.10A_P!974:7T%<O
M#_K*ZC2^@K2KL3 V****Y#8**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "D/(I:#TH PM5A#*>*XV\T]7<\5W5^A8&N:N8]KG
M-)#9@?V:B#.*KR-' >U:UU*%C-<AJ4[ESMS0V)(Z"UOH]P&175:7,KXQ7E]@
M9FE'6O0M#5\+G-6MB6=O;',=3U7M!^[JQ4E"&BEHH *BG&8S4M(PW#% '(:M
M;L^<"N4NM)>0GY37ITMBLG456.CH>PJ;#N>.WN@,23MI+#3OLLH)&,5ZO=:&
MA!^6N8U+2O)R56JN*QJ:%J20*JDUU4%\DW3%>41230S8&>M=EH4[OMW9I[AL
M=@.112+]T4M( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBBD 4A&12T4P(7M8WZBHC80
MGM5NB@"I_9\/I1_9\/I5NB@"LMG&O05,L87I3Z* "BBB@ HHHH 0T4M% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 12G"
MFN9UB8JK5T\HRIKEM:B)5JCJ5T.&U'4#&YYJM::NS.!NIFKVSES@5FV5M()A
MP>M:R5T9Q=F=W9#[2@/6HK^'R02!5S1(\1C-3:M#OC.*478<E<QM/O6$X&>]
M>A:1)YD(/M7G-G:,+D''>O1-%0K",^E#!&K1112&%%%% !1110 4444 %%%%
M !1110 4E+10 "BBB@ IK(''-.HH KFSC)SBI4B5!P*?10!&\2OU%-%L@.<5
M-10 @  P**6B@ %%%% !1110!6NDW1FN+UNU9MV!7=NNY<5DWE@)<\5-K#/'
MK[3)&E/RFKFDZ?)%(I(->@-H"NV=M/70UBY"U>XBG:@K ![5FWMJTLG2NB%J
M5XQ4L>GASDBI0V9.C6;1N"17:0C$2BJ5M8B+!Q5\# Q5,D6BBBD,**** "BB
MB@ HHHH **** "FR?ZMOI3J;)_JV^E 'F_BK[SUPT7_'S^-=SXJ^\]<-%_Q\
M_C7IT?A$=]H'W5KNK/[@KA= ^ZM=U9_<%<E;<9;HHHKG **** "BBB@ HHHH
M S]6_P"/0_2O'_$7^O;ZU[!JW_'H?I7C_B+_ (^&^M=F$W$R#0Q^^'UKU#29
M D(SZ5YEH@_>BN_M9"L(QZ56*'$T]0E5XR*Y::P\Z?..]:DMP2<$U+;!&8$U
MP1U8Y:$^E:.NP96GZEHJE.%K:L2H4 5:E577!IR0HL\Y.G>1-G'>M_39EC &
M:75HTC)(K#BNRLV >]*(,[ZWE#J,58K&TB8R*,ULTV 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 'I7-:W]UJZ4]*YK6_NM6M+XB9['G>
MJ??:BC5/OM17K0V.)[G$:'_KE^M>S^%?N)7C&A_ZY?K7L_A7[B5CB]CN1W(Z
M"B@=!17E#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBC- !1110 444
M4 %)U%+2=J *\L(8<UC7UI'@YQ6O=3B)"<UQ>MZZ(0PW5+921G:I'&F[&*Y:
MZ3S&(%)?:\9I" :BMI&E8&G%"9:L-%$T@.*[K1=%6(*<5A:7*$(R*[+3[M<"
MK(-NV@$:@5;JM#+N JP.E)C0M%%%(84444 %%%% $<T0D7&*R+G2A*3\M;=%
M*P'(R>'P3G;4]MHWE,/EKI\#TI,#T%,"M:P^4 *M444 )2TE+0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%&: "BBB@ HHHH 2EI** %HHS10 8HHHH **** "BBB@ I*6DH 6BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H[T4=Z $89%9.
MHVOF*>*UZCEC#BE89P-YH_FN?EJ"#0-C9VUW1LU)Z4\6: =*:8FCFK>V,  Q
M4DD)F&,5L2V?/ HAM,'D4@,FVTK#YVUT5I#Y28J2.%5'2I:H04444AA1110
M4444 %%%% !1110 4444 %%%% !1110 4E+24 +1112 ****8!1110 4444
M)2TE+0 4TH#3J* &A .U#(&'2G44 5&M@3TJ:*(*.E2T4 %%%% !1110 444
M4 %%%% !1110 4444 %-D_U;?2G4V3_5M]* /-_%7WGKAHO^/G\:[GQ5]YZX
M:+_CY_&O3H_"([[0/NK7=6?W!7"Z!]U:[JS^X*Y*VXRW1117. 4444 %%%%
M!1110!GZM_QZ'Z5X_P"(O^/AOK7L&K?\>A^E>/\ B+_7M]:[,+N)D>AG]Z*]
M"LXM\(^E>=Z&?WP^M>H:2@:%?I58H<3,NX&3)J@EX8I,9KK+RSWH<"N3U"R:
M-R0*\^.C'+4Z#3M2! R:T9=14)]ZN!CO'MSC-2'5'DXS52U)6AKZG>^:2 :R
MK>%GF!J2!&N&&>:W['3> <4XJP,T=&C**,UMU4M(?+ XJW0QH****0!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 !Z5S6M_=:NE/2N:UO[K5K2^
M(F>QYWJGWVHHU3[[45ZT-CB>YQ&A_P"N7ZU[/X5^XE>,:'_KE^M>S^%?N)6.
M+V.Y'<CH**!T%%>4,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !24M% @%%%% PHHHH *#112 2EHHI@%%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !BBBB@!"H/:@*!VI:* "BBB@ HI*!0 M%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !39/]6WTIU-D_U;?2@#S?Q5]YZX:+
M_CY_&NY\5?>>N&B_X^?QKTZ/PB.^T#[JUW5G]P5PN@?=6NZL_N"N2MN,MT44
M5S@%%%% !1110 4444 9^K?\>A^E>/\ B/\ U[?6O8-6_P"/0_2O'_$?^O;Z
MUV83<3*^A_Z\?6O5M%_U2UY3H?\ KQ]:]5T8_NEJ\2!OF,,N*QM1T\.#@5MH
M<J*1XPXYKSVBD><WNE/N.%JM!I4F\9!KT9]/B<\@4U=,B4]!36@F8&FZ=MQD
M5TT$"QH.*6.V2/I4U-B$  I:**0PHHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ /2N:UO[K5TIZ5S6M_=:M:7Q$SV/.]4^^U%&J??:BO6AL
M<3W.(T/_ %R_6O9_"OW$KQC0_P#7+]:]G\*_<2L<7L=R.Y'044#H**\H8444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5#<\0FIJ@NO
M]0: .+UB?8S<UA)?E9.M:>M@EVK!AMF>2I6Y;V-V+4VV]:E.HOCK4%MIS%1Q
M5K^S6QTJV9(:FH.3UK5L[MF(YK.336!Z5J6EF5QQ20S:MG+ 5='2J=O'M JX
M.E (6BBB@84444@"BBBF 4444@"BBBF 4444 %%%%( HHHI@%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1112 ****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 )12XHH **** "BBB@ HHHH **** "
MBBB@ HHHH 2@4N** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@"&Z_U)K@=>ZM7?77^H-<!KW5JWH;@<<_\ KJZ?0A\RUR['
M$_XUU.@L-RUV5/A$>AZ>,0"K=5K$@VXQ5FO->XPHHHI %%%% !1110 5B>(1
M_HY^E;=8WB!@+4_2JA\0'CVK_P#'PWUK0T _.*S]8(-RV/6K^@?ZQ:]1_ 2>
MFZ5]Q:W5^Z*P=*'R+6\OW17F3W*%HHHJ "BBB@ HHHH ****!!1110,****
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MBBB@84444 %%%% !1110 4444 %%%% !1110 4444 %)2T4 (*6BB@ HHHH
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M*>E<UK?W6K6E\1,]CSO5/OM11JGWVHKUH;'$]SB-#_UR_6O9_"OW$KQC0_\
M7+]:]G\*_<2L<7L=R.Y'044#H**\H84444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***2D M%%%, H
MHHH **** "BBB@ HHHH **** "BBB@ I*6B@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *YS7ONM71USFO?
M=:KI_$!P5Q_K_P :W-'ZBL.X_P!?^-;FC]179/X1([2R^Z*T*S[+[HK0KAEN
M,****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 4KOH:YN_P"I
MKI+OH:YN_P"IK>D9R*$/^LKJ-+Z"N7A_UE=1I?05I5V)@;%%%%<AL%%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M )BEHHH *3%+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% "4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 F*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ /2N:UO[K5TIZ5S6M_=:M:7Q$SV/.]4^^U%&J??:B
MO6AL<3W.(T/_ %R_6O9_"OW$KQC0_P#7+]:]G\*_<2L<7L=R.Y'044#H**\H
M84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 AHI:* "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2BEHH **** "BBB@ H
MHHH **** "B@TE "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %<YKWW6KHZYS7ONM5T_B X*X_U_XUN:/U%8
M=Q_K_P :W-'ZBNR?PB1VEE]T5H5GV7W16A7#+<84444@"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH I7?0US=_U-=)=]#7-W_4UO2,Y%"'_ %E=
M1I?05R\/^LKJ-+Z"M*NQ,#8HHHKD-@HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **#24 +1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%( HHHI@%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  >E<UK?W
M6KI3TKFM;^ZU:TOB)GL>=ZI]]J*-4^^U%>M#8XGN<1H?^N7ZU[/X5^XE>,:'
M_KE^M>S^%?N)6.+V.Y'<CH**!T%%>4,**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH *2EI,4 +1110 4444 %%%%( HHHI@%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 E+24M "4M%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5SF
MO?=:NCKG->^ZU73^(#@KC_7_ (UN:/U%8=Q_K_QK<T?J*[)_")':67W16A6?
M9?=%:%<,MQA1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"E
M=]#7-W_4UTEWT-<W?]36](SD4(?]974:7T%<O#_K*ZC2^@K2KL3 V****Y#8
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "C%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%%( HHHI@%%%% !1110 4444 %%%
M% !1110 4444 %%%%( HHHI@%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 'I7-:W]UJZ4]*YK6_NM6M+XB9['G>J??:BC5/
MOM17K0V.)[G$:'_KE^M>S^%?N)7C&A_ZY?K7L_A7[B5CB]CN1W(Z"B@=!17E
M#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N<U[[K5T=<Y
MKWW6JZ?Q <%<?Z_\:W-'ZBL.X_U_XUN:/U%=D_A$CM++[HK0K/LONBM"N&6X
MPHHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!2N^AKF[_J:Z
M2[Z&N;O^IK>D9R*$/^LKJ-+Z"N7A_P!974:7T%:5=B8&Q1117(;!1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 'I7-:W]UJZ4]*YK6_NM6M+XB9['G>J??:BC5/OM17K0V.)[
MG$:'_KE^M>S^%?N)7C&A_P"N7ZU[/X5^XE8XO8[D=R.@HH'045Y0PHHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH *YS7ONM71USFO?=:KI_$!P5Q_K_P :W-'ZBL.X_P!?^-;F
MC]179/X1([2R^Z*T*S[+[HK0KAEN,****0!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 4KOH:YN_P"IKI+OH:YN_P"IK>D9R*$/^LKJ-+Z"N7A_
MUE=1I?05I5V)@;%%%%<AL%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  >E<UK?W6KI3TKFM;^
MZU:TOB)GL>=ZI]]J*-4^^U%>M#8XGN<1H?\ KE^M>S^%?N)7C&A_ZY?K7L_A
M7[B5CB]CN1W(Z"B@=!17E#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 !Z5S6M_=:NE/2N:UO[K5K2^(F>QYWJGWVHHU3[[45ZT-CB>YQ&A_
MZY?K7L_A7[B5XQH?^N7ZU[/X5^XE8XO8[D=R.@HH'045Y0PHHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH *YS7ONM71USFO?=:KI_$!P5Q_K_QK<T?J*P[C_7_ (UN:/U%=D_A
M$CM++[HK0K/LONBM"N&6XPHHHI %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!2N^AKF[_J:Z2[Z&N;O^IK>D9R*$/\ K*ZC2^@KEX?]974:7T%:
M5=B8&Q1117(;!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 'I7-:W]UJZ4]*YK6_NM6M+XB9[
M'G>J??:BC5/OM17K0V.)[G$:'_KE^M>S^%?N)7C&A_ZY?K7L_A7[B5CB]CN1
MW(Z"B@=!17E#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ KG->^ZU='7.:]]UJNG\0'!7'^O
M_&MS1^HK#N/]?^-;FC]179/X1([2R^Z*T*S[+[HK0KAEN,****0!1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 4KOH:YN_ZFNDN^AKF[_J:WI&<B
MA#_K*ZC2^@KEX?\ 65U&E]!6E78F!L4445R&P4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 !Z
M5S6M_=:NE/2N:UO[K5K2^(F>QYWJGWVHHU3[[45ZT-CB>YQ&A_ZY?K7L_A7[
MB5XQH?\ KE^M>S^%?N)6.+V.Y'<CH**!T%%>4,**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MN<U[[K5T=<YKWW6JZ?Q <%<?Z_\ &MS1^HK#N/\ 7_C6YH_45V3^$2.TLONB
MM"L^R^Z*T*X9;C"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% %*[Z&N;O\ J:Z2[Z&N;O\ J:WI&<BA#_K*ZC2^@KEX?]974:7T%:5=B8&Q
M1117(;!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 'I7-:W]UJZ4]*YK6_NM6M+XB9['G>J??
M:BC5/OM17K0V.)[G$:'_ *Y?K7L_A7[B5XQH?^N7ZU[/X5^XE8XO8[D=R.@H
MH'045Y0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 !Z5S6M_=:NE/2N:UO[K5K2^(F>QYWJGWVHHU3[[45
MZT-CB>YQ&A_ZY?K7L_A7[B5XQH?^N7ZU[/X5^XE8XO8[D=R.@HH'045Y0PHH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH *YS7ONM71USFO?=:KI_$!P5Q_K_QK<T?J*P[C_7_C
M6YH_45V3^$2.TLONBM"L^R^Z*T*X9;C"BBBD 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% %*[Z&N;O^IKI+OH:YN_ZFMZ1G(H0_ZRNHTOH*Y>'_
M %E=1I?05I5V)@;%%%%<AL%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  >E<UK?W6KI3TKFM;
M^ZU:TOB)GL>=ZI]]J*-4^^U%>M#8XGN<1H?^N7ZU[/X5^XE>,:'_ *Y?K7L_
MA7[B5CB]CN1W(Z"B@=!17E#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KG->^ZU='7.:]]U
MJNG\0'!7'^O_ !K<T?J*P[C_ %_XUN:/U%=D_A$CM++[HK0K/LONBM"N&6XP
MHHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!2N^AKF[_ *FN
MDN^AKF[_ *FMZ1G(H0_ZRNHTOH*Y>'_65U&E]!6E78F!L4445R&P4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "N<U[[K5T=<YKWW6JZ?Q <%<?Z_P#&MS1^HK#N/]?^-;FC
M]179/X1([2R^Z*T*S[+[HK0KAEN,****0!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 4KOH:YN_ZFNDN^AKF[_J:WI&<BA#_K*ZC2^@KEX?]974
M:7T%:5=B8&Q1117(;!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 'I7-:W]UJZ4]*YK6_NM6M
M+XB9['G>J??:BC5/OM17K0V.)[G$:'_KE^M>S^%?N)7C&A_ZY?K7L_A7[B5C
MB]CN1W(Z"B@=!17E#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "N<U[[K5T=<YKWW6JZ?Q <%<?Z_\:W-'ZBL.X_U_XUN:/U%=D_A$CM++
M[HK0K/LONBM"N&6XPHHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110!2N^AKF[_J:Z2[Z&N;O^IK>D9R*$/^LKJ-+Z"N7A_P!974:7T%:5=B8&
MQ1117(;!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 'I7-:W]UJZ4]*YK6_NM6M+XB9['G>J?
M?:BC5/OM17K0V.)[G$:'_KE^M>S^%?N)7C&A_P"N7ZU[/X5^XE8XO8[D=R.@
MHH'045Y0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *YS7ONM71USFO?=:KI_$!P5Q_K_P :
MW-'ZBL.X_P!?^-;FC]179/X1([2R^Z*T*S[+[HK0KAEN,****0!1110 4444
M %%%% !1110 4444 %%%% !1110 4444 4KOH:YN_P"IKI+OH:YN_P"IK>D9
MR*$/^LKJ-+Z"N7A_UE=1I?05I5V)@;%%%%<AL%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  >
ME<UK?W6KI3TKFM;^ZU:TOB)GL>=ZI]]J*-4^^U%>M#8XGN<1H?\ KE^M>S^%
M?N)7C.A_ZY?K7LWA7[B5CB]CN1W(Z"B@=!17E#"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****0!1113
M*YS7ONM71USFO?=:KI_$!P5Q_K_QK<T?J*P[C_7_ (UN:/U%=D_A$CM++[HK
M0K/LONBM"N&6XPHHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!2N^AKF[_J:Z2[Z&N;O^IK>D9S*$/\ K*ZC2^@KEX?]974:7T%:5=B8&Q11
M17(;!1110 4E+10 E+24M !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% "4M)2T !Z5S6M_=:NE/2N:UO[K5K2^(F>QYWJG
MWVHHU3[[45ZT-CB>YQ.A_P"N7ZU[-X5^XE>,:%S.OUKVOPFN42L,9L=R.U'0
M4445Y8PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "4M%%  >E<UK
M?W6KI:YW7%^5JUI?$3/8\XU3_6-11JG^L-%>M#8XGN<+HC[9E^M>P^%[Y41,
MFO(+&U>-P<5VNE7;PJ.348F*DCN/7QJ,6.HH_M*+U%>?C57V_>--.K/_ 'C7
M![ +GH/]I1>HI?[2B]17GO\ :K_WC1_:S_WC1[ +GH7]I1>HH_M*+U%>>_VL
M_K1_:S^M'L N>A?VE%ZBC^THO45Y[_:S_P!XT?VL_P#>-'L N>A?VE%ZBC^T
MHO45Y[_:S_WC1_:S_P!XT>P"YZ%_:47J*/[2B]17GO\ :S_WC1_:S_WC1[ +
MGH7]I1>HH_M*+U%>>_VL_P#>-']K/_>-'L N>A?VE%ZBC^THO45Y[_:S_P!X
MT?VL_P#>-'L N>A?VE%ZBC^THO45Y[_:S_WC1_:S_P!XT>P"YZ%_:47J*/[2
MB]17GO\ :S_WC1_:S_WC1[ +GH7]I1>HH_M*+U%>>_VL_P#>-']K/_>-'L N
M>A?VE%ZBC^THO45Y[_:S_P!XT?VL_P#>-'L N>A?VE%ZBC^THO45Y[_:S_WC
M1_:S_P!XT>P"YZ%_:47J*/[2B]17GO\ :S_WC1_:S_WC1[ +GH7]I1>HH_M*
M+U%>>_VL_P#>-']K/_>-'L N>A?VE%ZBC^THO45Y[_:S_P!XT?VL_P#>-'L
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M+U%>>_VL_P#>-']K/_>-'L N>A?VE%ZBC^THO45Y[_:S_P!XT?VL_P#>-'L
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M+U%>>_VL_P#>-']K/_>-'L N>A?VE%ZBC^THO45Y[_:S_P!XT?VL_P#>-'L
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M+U%>>_VL_P#>-']K/_>-'L N>A?VE%ZBC^THO45Y[_:S_P!XT?VL_P#>-'L
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M+U%>>_VL_P#>-']K/_>-'L N>A?VE%ZBC^THO45Y[_:S_P!XT?VL_P#>-'L
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M+U%>>_VL_P#>-']K/_>-'L N>A?VE%ZBC^THO45Y[_:S_P!XT?VL_P#>-'L
MN>A?VE%ZBC^THO45Y[_:S_WC1_:S_P!XT>P"YZ%_:47J*/[2B]17GO\ :S_W
MC1_:S_WC1[ +GH7]I1>HH_M*+U%>>_VL_P#>-']K/_>-'L N>A?VE%ZBC^TH
MO45Y[_:S_P!XT?VL_P#>-'L N>A?VE%ZBC^THO45Y[_:S_WC1_:S_P!XT>P"
MYZ%_:47J*/[2B]17GO\ :S_WC1_:S_WC1[ +GH7]I1>HH_M*+U%>>_VL_P#>
M-']K/_>-'L N>A?VE%ZBC^THO45Y[_:S_P!XT?VL_P#>-'L N>A?VE%ZBC^T
MHO45Y[_:S_WC1_:S_P!XT>P"YZ%_:47J*/[2B]17GO\ :S_WC1_:S_WC1[ +
MGH7]I1>HH_M*+U%>>_VL_P#>-']K/_>-'L N>A?VE%ZBC^THO45Y[_:S_P!X
MT?VL_P#>-'L N>A?VE%ZBC^THO45Y[_:S_WC1_:S_P!XT>P"YZ%_:47J*/[2
MB]17GO\ :S_WC1_:S_WC1[ +GH7]I1>HH_M*+U%>>_VL_P#>-']K/_>-'L N
M>A?VE%ZBC^THO45Y[_:S_P!XT?VL_P#>-'L N>A?VE%ZBC^THO45Y[_:S_WC
M1_:S_P!XT>P"YZ%_:47J*/[2B]17GO\ :S_WC1_:S_WC1[ +GH7]I1>HH_M*
M+U%>>_VL_P#>-']K/_>-'L N>A?VE%ZBC^THO45Y[_:S_P!XT?VL_P#>-'L
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M+U%>>_VL_P#>-']K/_>-'L N>A?VE%ZBC^THO45Y[_:S_P!XT?VL_P#>-'L
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M+U%>>_VL_P#>-']K/_>-'L N>A?VE%ZBC^THO45Y[_:S_P!XT?VL_P#>-'L
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MC^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\
ML]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8
MXO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:
M/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_L
MP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_
M=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3
M^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW
M]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2
MC^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\
ML]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8
MXO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:
M/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_L
MP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_
M=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3
M^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW
M]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2
MC^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\
ML]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8
MXO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:
M/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_L
MP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_
M=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3
M^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW
M]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2
MC^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\
ML]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8
MXO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:
M/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_L
MP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_
M=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3
M^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW
M]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2
MC^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\
ML]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8
MXO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:
M/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_L
MP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_
M=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3
M^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW
M]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2
MC^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\
ML]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8
MXO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:
M/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_L
MP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_
M=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3
M^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW
M]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2
MC^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\
ML]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8
MXO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:
M/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_L
MP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_
M=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3
M^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW
M]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2
MC^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\
ML]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8
MXO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:
M/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_L
MP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_
M=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3
M^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW
M]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2
MC^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\
ML]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8
MXO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:
M/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_L
MP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_
M=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3
M^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW
M]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2
MC^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\
ML]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8
MXO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:
M/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_L
MP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_
M=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3
M^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW
M]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2
MC^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\
ML]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8
MXO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:
M/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_L
MP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_
M=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3
M^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW
M]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2
MC^SW]*[3^S!_=H_LP?W:/;!8XO\ L]_2C^SW]*[3^S!_=H_LP?W:/;!8XO\
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MTIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44
M-\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*
M/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G
M44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WR
MU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M
M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10
M WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7T
MH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*
M=10 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?
M+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CR
MU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU%
M #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?
M2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+7T
MIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44 -
M\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/
M+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G4
M4 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU
M]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?
M2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10
MWRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH
M\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=
M10 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+
M7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU
M]*=10 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU%
M#?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2
MCRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TI
MU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44 -\
MM?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+
M7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44
M -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]
M*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2
MG44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10 W
MRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\
MM?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=1
M0 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7
MTH\M?2G44 -\M?2CRU]*=10 WRU]*/+7TIU% #?+7TH\M?2G44 -\M?2CRU]
M*=10 WRU]*/+7TIU% #=B^E+@4M% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4F!2T9H 3:/2DV#TIU% #=@]*-@]*=10 W8/2
MC8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@
M]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -
MV#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10
M W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU
M% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2
MG44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@
M]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#TH
MV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/
M2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=
M@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44
M-V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=1
M0 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TI
MU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/
M2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-
M@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#T
MHV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8
M/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #
M=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44
M -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=
M10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#T
MIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8
M/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*
M-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#
MTHV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W
M8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU%
M#=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G4
M4 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*
M=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#
MTIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C
M8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]
M*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V
M#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10
MW8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU%
M #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G
M44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]
M*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV
M#TIU% #=@]*-@]*=10 W8/2C8/2G44 -V#THV#TIU% #=@]*-@]*=10 W8/2
MC8OI3J* &[!Z4;!Z4ZB@!NP>E&Q?2G44 -V#THV#TIU% #=@]*7:/2EHH 3:
M**6B@ HHHH **** "C%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** $I:2EH **** "BBB@ HHHS0 449HH ***
M*0!1110 4444P"BBB@ HHHH **** "BBB@ HHHH **** "DI:2@!:*** "BB
MB@ HHHH **** $I:2EH **** "BC-% !1110 4444 %%%% !111F@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *2EI* "EI*6@ HHHH **** "B
MBB@ HHHH ****0!1113 **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!*6DI: "BB
MC- !1110 4444@"BBBF E+24M !1110 4449H **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **,T4 %%%%( HHHI@%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 (:*6B@!*6BB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M 2E%%% !1110 4444 %%%%( I*6BF E+110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%)0 M%%% !1110 4444 %%%% !1110 4444 %%%%
M!124HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **0T4
M +1110 44E H 6BBB@ HHQ10 4444 %%%%(!#12T4P"BBB@ HHHH **** "B
MBB@ HHHH *2EHH !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% "4"EHH ***2@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHHH **** $HI:* "DI:,4 %%%0R3!.] $U%5%N03UJRC;A0 ZBBB@ HHI,T
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M2 36S:W8FQS7G373)-C/>NJT2<N%R:F<-!G45!<3")<YI)+@1KDUS>L:N!N
M:LXQN!<NM8"<;JJ1ZKYC_>KCKK46DD.#5O39'=QUK;V=D([ZTFW@5/</M2J.
MF@[!5RY0E*Q:U&8US=E6/-4VOR.]37-LS,>*H3VKHI.*U20$K:EM'6JK:SAO
MO5C7DS1DC-9Z.\LG&:T4$([S3M3,K 9KJ+9M\>:X31K>0%20:[FS!$(!K"HD
M@18HHHK,84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 )2T44 %%%% $<QQ&37+ZI<;2>:Z>X.(37"ZW-M
M9N:TIJ[ H-*KR<UJV"1Y!XKDOM1\S@UIVMZZ@<UO*(COK=XDC'(I+J:)H&&1
M7(G59%3J:JOJ\C KDUDJ; J:Y$'F8KZTNAIY4H)IYC>Y.2*FBB-MSC%;=+ =
MDEX!;8![5SVI73ESM)J*/4<_+FK4-NMR<^M9)<HS(2>;.>:T+:_=&&2:U3I"
M"/.*P=0B\ASBJNF(ZS3KX2 #-:,\VV/-<;HUR3(!FNBNY?\ 12?:LI1LQF+J
M>J>6Q&ZLA=1>1^#6=JUPS7!&>]7-&M#.P)%;\J2N(U[>>0@')J6:]:->36BF
MF[(LXK"U52@(%9JS8R"756+$!J8;R1ER":RHXVDGQ[UTEGI9>')%6[(#%?4)
M$?J:WM'OVD89-8^I6'E.>*FT?*R"AI-"/0(I<Q9K*U&X(S@U/'+M@_"LJZD#
MN036,5J,R+NXE).":S#=3*_4UTZV*RBJESI:KDXK520$%A?N&&375V-X&4<U
MQ9C\E^*U=/N2"!FE*-Q':H^X4ZJEDY=!5NN=C"L'78BZ-BMZJMU )@13B[,#
MRN[M'\\G'>M;20L9&ZMG4-* )(6N?N-]L3CBNE2YD([6VNHM@&11<117 XQ7
M IJ\J/C)K=T[5RY 8U#@UJ!JKI"[\A:O16_DKTJQ97*2J.14]P!LR*S;8S*N
M;@JIYK O+F0YP36I>N Q%5$MUF-7'01SLUS,&ZFK5E>R!ADFM6?2DVYQ6>]J
M(FXK2Z8'3:;?9 R:VOM2;,YKA8KDP]ZLC5CC&ZLG"XS4U2]P#@URT]Y(SG!-
M7Y)C<G .:EMM),QR5JU:*U P9KJ4+R35-;UC)@FNIU'13'"3M[5Q-U&8;G'O
M6D+,1UNF#S<&N@7$,>:YK09,J,UL7]R$BX-9RWL,9=7YY -9%Q<RDD@FHTG\
MV;&>];4&GK+'DBGI$##@NY5D&2:ZC3;P[1DUF3Z:(VR!2PL812E9@='<7H\O
MK7.WDWFN1FH;J_(&,U4AG\V3K1&-@+D%KN;.*UX?W25':190'%.F<)Q4MW$5
M;ZX<@X-<]/<3!^IKI5B6;BFR:2C#.*I-(9@VMY*K#)-=)IVH= 361<6*PYP*
MK1SF)\9IM*0'H$=T&CZUC:G)D&JMG?$J!FDO9-Z&LU&S S%FVR=:U(K[;'UK
MGIF*N:%NCC&:T<;B->ZU G.#6:]U(QX)HC1IVK7M](+IDK1H@,3[=(AY)K5T
M_4RS $U3U33_ " 3BLRRE*7 &>].R: ],L9?,0'VJY63HK[H1]*UJYGN,*KW
M$XC!YJ<G KGM:O/+4X-$5=@0WVH]0#7/75U*Y.":JR7QEFQGO6S8V2W"@D5T
M)<HC%CN)A)SFNBTV\88W&B;2%09 JF5\@\4FU(9U/VT&/K7,ZY<LR, :5;P]
M,U#<IYZFE&-F(X>Z5WG[]:Z;PZC*RU"VF;I<XKH]&T_81Q6LY*PK'561/EKF
MK=0P1[$%35QLH;(<(:P[^X*YYK9G;;&:YJ_D!<C-7! 9%U<R$G!-9<MU,K=3
M6_%;+,:CNM+4+G%;)I",ZPOWWC)-=98WF4&37(B 12<5IV\Y1>M*23"YT%U>
M#81FN9OAYSFI)KPGC-11'S6I1C8!^GVF) <5V=@FR+'M6+86_0XKH(%VI43=
MQDM%%%9@%(2!2U!</L4T 4=4N L1 ->>:I,SS$#UKKM3N-P(S7+20>;-GWKH
MIJPB;1;+SI!D5W-MIB)&IP*Q-#MO+9>*ZY?NCZ5%26HT5OL:XQ@54N-*5P3@
M5JT5G=@<I+IFQ^!5RSB,=:\L*L<XJI(!'FKYK@5[R8K&<&N5OKB7><$UT=Q(
M'XS6>;%9FZ54;(#GTN)@<Y-6[?471@":U)=*58R<5S=\OD2\5HFI".WTR]\P
M#FM"ZGV1$YKCM#NR6 S6]J,_^C'GM64HZC,:_P!6VR$!JIK?O(.":P[V9WNB
M,]ZW=(LC-&"16W*DA%6:\E5NIJ[IU^Y<9-3WNEA5SBJ=O;^7)2NF@.UL;L;!
MDU+<WR*A -<T+HPQ]:SY]6+-MW5ER78RWJ5ZQSM-<_)=3%^IK8@B-W[YJ^OA
M_<,[:T341&/974@(R3746%[@#)K/.CF'^&JT[M; ]J3M(#JI-07R^M<]J5XS
M9VFL=M7.[:6JS;N+H\G-)0L,SI)YB_>K5M=2H1N)K<BT='7.*JWU@(%) JN9
M/01?T_4<D FM];@-'G/:O.8KIHIL9KJ+*]+0=>U9S@,75K_R@>:X^YU9VD(#
M5H:].3D USUI;-//^-:PBK7$;5C<RNP.376Z:[$#-9^F:-^Z#;:W[:S\H#BL
MIR0R[']VE9PH- &%JA>3[ >:S2N!A:]<\-@UQ>&FN,>]='JC^:Q%9]G:9F!Q
M73#1"-[0],#JI(KI([!4'05!H\?EQ#CM6I6$I-L93>Q5QT%9EWI(Y(%;]-90
MRX-2I- <K'9>4^<5K0SB*/K4EW$J)NKF[S4/*8C-:+W@+FI7I(.#7-RW$S2<
M$U;2X%RV,YK2M]+64 XJU:(&-#<RIU)K9L-1^8 FH[[3UA0D"L)9VBGP#WIV
M4A'HT=P)(.O:N/\ $*Y)K4TV[+P@$UGZV-ZFH@K2 P-,^6X'UKK]P-K^%<=:
M_)/^-=+'-F#'M5S P+^'=<?C6_X?BVE:SY8O,ESCO6_H\.S'%*3T Z1?NCZ4
MM(.@I:YQE:[3>A%<]<:5YDA.*ZAES4?E*.2*I.P&-::6(QTJ#4H45#6W-.D2
M'I7*:Q?9R :J-VP,MHU,O%74!CCR*S+5FEF'UKHUM<V^<=JUD[".>NKYE;!-
M3V ^U.,\UFZK&4F-:/AXYE7/K5->[<#KK/2E$0) INJ68CMS@=JV81B)?I5'
M6#BU-<Z;N,\WNQMN?QKJ- /RBN5OF_TH_6NF\.G.T5O/X1&UJ+L(CBN"U:20
MR'K7I5Q:^:F,5R6MZ5LR<5G3D@.-A4O)S75:1:9VG%8"1>7/CWKM-#CW*M:S
M>@(WK*'8HJZT888I(TV@5)7*V,J/:+U(K.U&%%A/2M.\G$4=<M?ZF&)7-5%-
M@<WJ4&Z4@58TC2_,D!(JW%!]IDSC-=)IEB(L'%;2G9 6[/35BC4XK21=BXI0
M, "EKG;N 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MDM-F,DH!KOM*A'EJ<43T W[%=L=6ZIQ2A!C-3K*&%<S&-EDVU$MRN>34=T2
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!@3@5VK)N7%9M[8"0'BIA*P'GJ-)'+WKI--U$HHR:BN]*VL2!5$Q/$>*V=I
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "DHHH *6BB@ HHHH **** "BBB@ HHHH **** # HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *2BB@!:*** $S2T44 %%%% "9I
M:** "BBB@ HHHH **** "BBB@ HHHH **** $I:** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ P**** "B
MBB@ HHHH **** "BBB@ HHHH ****!!1110,**** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2@444 +1112 ****8!11
M10 4444 %%%% "9I:** "BBB@ I,T44 +1110 4444 )FEHHH **** "BBB@
M HHHH **** $HHHH !2T44 %%%%( HHHI@%%%% !1110 4E%% "T444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
#?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>img17388848_6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img17388848_6.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (K W(# 2(  A$! Q$!_\0
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M=!QU'6MJO%_VA/\ CPT'_KK-_)* /6M(UBPU[2X=2TRX%Q:39V2!2N<$@\$
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MN3D@#('4]<5B>*O$_P 3?!>AP_VM?6;R74@,5Y;QQLT1 .8V4H%.1SD#MUH
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MT#39-1U2Z6VM(\!I&!/).   "2?H*73M9T_5='CU:SN5>PD0NLS H-H)!)W
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M&O\ PE,OG-,ME#+;1F0B.,R.A+;>A;:V,G/%>EV/_(/MO^N2_P A0!8HHHH
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M.N3U&&!&<X/-=IXT\#Z+>:U/XK\4ZG/)I-K $^QA&"Q] ,,AW<L2< =3UP*
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MDUK;W-J]K/!%+;NNQHG0,C+Z$'@CVJ*PTVQTNW^SZ?96UI 6+>7;Q+&N3WP
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M_P"]^E %JBJOG/\ WOTI5E<N 3W]* +-%%% !1110 455\Y_[WZ4><_][]*
M+5%5?.?^]^E'G/\ WOTH M455\Y_[WZ4><_][]* +5%5?.?^]^E'G/\ WOTH
M M455\Y_[WZ4><_][]* +5%5?.?^]^E'G/\ WOTH M455\Y_[WZ4><_][]*
M+5%5?.?^]^E'G/\ WOTH M455\Y_[WZ4><_][]* +5%5?.?^]^E'G/\ WOTH
M M455\Y_[WZ4><_][]* +5%5?.?^]^E'G/\ WOTH M455\Y_[WZ4><_][]*
M+5%5?.?^]^E'G/\ WOTH M455\Y_[WZ4><_][]* +5%5?.?^]^E'G/\ WOTH
M M455\Y_[WZ4><_][]* +5%5?.?^]^E'G/\ WOTH M455\Y_[WZ4><_][]*
M+5%5?.?^]^E'G/\ WOTH M455\Y_[WZ4><_][]* +5%5?.?^]^E'G/\ WOTH
M M455\Y_[WZ4><_][]* +5%5?.?^]^E'G/\ WOTH M455\Y_[WZ5:H ****
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MHHH **** "BBB@ IR??7ZBFTY/OK]10!;HHHH **** *5%%% !1110 4444
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M@HK'\.:_#X@T\S*HCGC.V6/.=I[$>Q_QK8H **** "LSQ)_R*VK_ /7E-_Z
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M*** "BBB@ HHHH *\T^),4HU>TF(/E-!M4_[08D_S%>EUGZQI-IK-@UM> A
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MMJ/_ (,;C_XNC^PK/_GMJ/\ X,;C_P"+K3HJN>7<#,_L*S_Y[:C_ .#&X_\
MBZ/["L_^>VH_^#&X_P#BZTZ*.>7<#,_L*S_Y[:C_ .#&X_\ BZ/["L_^>VH_
M^#&X_P#BZTZI6FK6-]>7-I;SAY[8[94VD;3G'<<].U-2F^K A_L*S_Y[:C_X
M,;C_ .+H_L*S_P">VH_^#&X_^+J=]5LH]4CTQIQ]LD3>L6TGCGOC Z&KE#E-
M;M@9G]A6?_/;4?\ P8W'_P 71_85G_SVU'_P8W'_ ,75RVNX+OSO(??Y,AB?
M@C##J.:E=UCC:1V"HH)8GL!1S3[@9W]A6?\ SVU'_P &-Q_\71_85G_SVU'_
M ,&-Q_\ %U?@FCN;>.>%MT4BAT;U!&0:DI<\NX&9_85G_P ]M1_\&-Q_\71_
M85G_ ,]M1_\ !C<?_%UIT4<\NX&9_85G_P ]M1_\&-Q_\71_85G_ ,]M1_\
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MTZYB$%U-"#D1NRY]<'%;'@^S^V^*+-2,K$QE;_@/(_7%9>H_\A.[_P"NS_\
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M.X^8PP.1C/0=ZZ>ZT&"XO&NX;FZLYG0)(ULX7>!TSD'IZBBW\/6-M<V4T0D
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M?UW8%FWUVY\VT^WZ:;6&[8+#()@^&(R P &"?QK8EFB@C,DTB1H" 6=@!DG
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M?;;=L1*(DFMV?RA@;MI#@9/<XSVZ4<D8Z@;E%%%8 %%%,EWB%S&,OM.WZ]J
M/&?%%Y]N\2WTP;*B0HOT7Y?Z5JV%GY7PYU:[(^:>:-0?]E77^I-<JX?S6#AO
M,W$,".<UZ5JUB=.^&'V9E*NL<;.#V8R*2/S-(9YG1110,WO!?_(W6'U?_P!
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MR((<GV+'_ "O3J\:\7&8^*K\S AMXVY_NX&/TQ0-&AX&L_-N]0NB.(+5@/\
M>8?X URE>E^"K%K;PG>7+J5:YWL,CJH7 _7->:4@"K%A_P A&V_ZZI_,57JQ
M8?\ (1MO^NJ?S% S=\=6?V7Q1,X&%N$64?E@_J#6W\-+SF^LBW]V51^C?^RU
M+\2;%GMK.^1"1&6CD8#H#@C/MD'\ZQ?A\)O^$EW1J3'Y+"4]@.,?J!0+H>JT
M444Q!1110 4444 %7:I5=H **** "BBB@ HHHH **** &3?ZHU5JU-_JC56@
M HHHH **** "BBB@ K.U_P#Y%W4_^O63_P!!-:-9VO\ _(NZG_UZR?\ H)H
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M -#6@#R6U :[A! (,B@@_6NZ^(=C9VEE9-;6L$):1@3'&%SQ[5PUI_Q^P?\
M71?YUZ#\2_\ CPL/^NK?RI#.6\%_\C=8?5__ $!J]=N+:"ZB,5Q#'-&3DI(H
M8?D:\B\%_P#(W6'U?_T!J]BI@R.&"&VB$4$211KT1%"@?@*DHHH$%%%% !11
M10 4Y/OK]13:<GWU^HH MT444 %%%% %*BBB@ HHHH **** "BBB@ KPC4?^
M0G=_]=G_ /0C7N]>$:C_ ,A.[_Z[/_Z$:!H]$T7_ ))?/_U[7'\VKS*O3=%_
MY)?/_P!>UQ_-J\RI >\6'_(.MO\ KDG\A5BJ]A_R#K;_ *Y)_(58IB"BBB@
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M:SM;)"EK;0P*3DB) H/Y5/13$%%%% !1110 4444 %7:I5=H **** "BBB@
MHHHH **** &3?ZHU5JU-_JC56@ HHHH **** "BBB@ K.U__ )%W4_\ KUD_
M]!-:-9VO_P#(NZG_ ->LG_H)H \0KTWQ=_R(=K](?Y5YE7IOB[_D0[7Z0_RI
M#9P&B_\ (=T__KYC_P#0A7N5>&Z+_P AW3_^OF/_ -"%>Y4P84444""BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KGO''_(HWOUC
M_P#0UKH:Y[QQ_P BC>_6/_T-: /)K3_C]@_ZZ+_.O0?B7_QX6'_75OY5Y]:?
M\?L'_71?YUZ#\2_^/"P_ZZM_*D,Y;P7_ ,C=8?5__0&KV*O'?!?_ "-UA]7_
M /0&KV*F#"BBB@04444 %%%% !3D^^OU%-IR??7ZB@"W1110 4444 4J***
M"BBB@ HHHH **** "O"-1_Y"=W_UV?\ ]"->[UX1J/\ R$[O_KL__H1H&CT3
M1?\ DE\__7M<?S:O,J]-T7_DE\__ %[7'\VKS*D![Q8?\@ZV_P"N2?R%6*KV
M'_(.MO\ KDG\A5BF(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M** "BH[B1H;:65(VE=$++&O5B!T'UKSSX;?$'6/&6I:E;:EI45M';#<LD2N
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MRJS%%<'('!!P#CIFN@\1WMU!\2/!5K#<S1V]Q]N\^%)"$EVP@KN X.#R,]*
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MVE9;==Y$\87>N<;EP3QG'7!]JZRL30O"&@>&IKB;1]-BM9+C_6,K,Q(]!DG
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M7#/#(&X=&X!VD8YQD8KO:* .<TVW\73:M'<ZQ>:;;642$&TL%:3SF/0L[J"
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M126[X&16'H/_ ")_PS_["3?REH [%_&>IWEYJ::%X<;4K;39WMIY6O%A9I4
M+*B%26QGN1FG^*=9FG^'LD\%O<6EYJ:):06\Z%94DF8)@CL1N)_"N/U?_A&/
M[>U6:^N=3\)ZXD[8DM)G_P!-4?=D4!</N]!SZ]:T="N=8U^Z\'66N*_VRVBF
MU2Z#H$8A28X"R]F.\G'M]< '56.K1:?XJMO!D-IB*WT=;I+CS.BJXB";<>@S
MG/X5!>>(OMNH^)]!^R[/[/L1)Y_F9\SS(R<;<<8^IKG]:UVQ\/\ QKANM1D:
M*VD\/B)IMI*QDW!(+8' XQGU(JIHNJV^M^+O'6H68D-K+IL/DR.A7S%$;#<
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MUTP^ O&^JZ=<ZU>?;(HTDO-250MQY8P&CPJD@ X)([#%;?Q _P"22VGULO\
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MGNO[6$F/O[VW;_\ @..M %WP7XL\WX96'B'Q+J,:L_F^=<2*J XE=5&% &<
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M110 4444 %%%% !1110 4444 %%%% !1110!A_\ "._\5U_PDWVK_F&?V?\
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M>X=0LCI*\9D Z!]A&X?7-;-K:V]C:Q6MK#'#!$H6..-0JJ!V %344 <7XO\
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M<0.[O&QR3PA)"\DGY0*32O!?A[1;Q+RQT\+<HI6.26:24Q@]EWL=OX8K?HH
M0@$$$ @]0:YGPQH<VCV.H:!=6RRZ3'*QLW<JP>"3+&-EZY4EAR,$$8[UT]%
M'-6?P^\+6-Y%=0:2GF0MOB5Y7=(V]51F*J?H*NZUX6T7Q!)#+J=BLTT(Q',K
MM'(H] Z$-CVS6Q10!EZ;X;T?2--FT^PL8X+:?/FJI.Z3(P2S$[B<=R<TV/PQ
MHL?AU= &GQOI:KM%O(2X SGJQ)SDYSFK%GJ7VR_OK3[%>P?9&5?.GBVQS9&<
MQMGY@.A]ZO4 8NC^$M#T&Y>YTZP$=PZ[#-)(\K[?[H9R2!["K]YIMIJ$MK)=
M1>8UK,)X06("N 0&P#@XR<9SCK5NLZ36;9->@T95DDNY(6N&V ;8HP< N2>,
MG@8SG!["@!FL^'-)U\1?VE:>:T.?+=9&C=01@C<I!P>XS@U3\0Z9='PHVBZ#
M;I#YZK:*RD*MM"W#/C/.%S@#G)'N:Z"B@"MI]A;Z7IMM86B;+>VC6*-?10,"
MJ&L^%M%\02PS:E9"6:$$1RI(\;J#U&Y"#CVSBHO$/BRP\.RVEM-%=7E_>$BW
MLK*+S)I<?>(&0 !W)(%-T#Q=8>(+JZLD@O+'4;0!I[*^B\N5%/1L D%3Z@D4
M 6-'\+:)H NETO3X[=;O;YR*6*OM&!P20.">G7O6?%\//"D-RDZ:1'F-_,2)
MI9&B5O41EM@_*J$OQ1T6,RW L=6DTB*8PR:O':[K16!P3NSN*@\;@I'O6YK_
M (HT_P .V=O/<">YDNI!':VUI'YLMPQ&<(O?CG.0/>@"UK6B:=XATR33M5MA
M<6DA!:,LR\@Y'*D$<CL:LR6=M-9-92P1O:LGEM$RY4KC&"/3%8^@>+;+7[NZ
ML1:WMAJ-J%::ROX?+E"-T<8)#*<'D$UOT <W9> ?#&GWD-W;Z6OFP'=#YDTD
MBQ'U568JOX"M>#2;&WU&^U"* "ZOEC6Y<L3Y@0$*,$X& 3T'/>KM% '-0_#[
MPK;WJ74>CQ!XY/-1#(YB1_41D[ ?H*S->\'_ -O_ !$M+V_T];C2$TQH6D,@
M4I-YFY=N"'!QW'YUTFO:]:^'K2WN;N.9TGNHK51$ 2'D8*I.2.,GFDLM?M;_
M ,0:KHL4<PN=,6!IF8#8PE#%=ISD_=.<@?C0 _1_#^E:!;26^F6:0)(VZ0Y+
M-(?5F8DM^)K);X=^$VN#*='CP7\PQ>;)Y);U\O=L_2NHK-U'6K;3=0TNQE2:
M2?4IFAA6-0<;49V9LD84!>V>HXH ;K'AW2=?MHH-2LDF2%M\1#,C1GU5E(*_
M@:@TCPAH.@WSWNF:>MO<O%Y+R"1V+KNW<Y)R<]SS[UMUB>)/%%EX6ATZ6^BN
M)%O[Z.QB\A5)$CYP6R1\ORG.,GVH VZ**S;#6[74-3U'3D62*[L'598I0 2K
M#*R+@G*GD ^JD$#% &E1110 4444 %%%% !1110 4444 <Y/H%W+\1+7Q LD
M/V2+3GM&0L?,+E]V0,8QCWIFKZ9XDCUX:KH5_;R1O (9=/OY)!""#D2(5SM;
ML>.:Z:B@#G?#'AVYTF?4=3U.ZCNM6U*17N)(E*QHJC"1H#SM SR>M33:-<7O
MBZ#5+N2,V5C"5LX58D^:^0\C#&,A<*O)ZMZUN44 <#>>"-4G;4=*CN;(:%J.
MIC49V;=]H4[U=HP,;2"RC#9&,]#7?444 <W8> _#UC?OJ#67VR^=BQN;UC,X
M.<\;N%QGL!72444 8/B?PROB"*TFANGLM3L9/-L[Q%W&)CP01_$I'!%9SQ_$
M*6'R!-X<@)X-V@F=A[B,C&?JQ%=?10!P\7@.73_#OA?1[&[25-'U-+R66?*F
M109"VT 'G,G /8=:O>*O#>HZEK.C:YH\]JNH:6TFV*\#>5(LBX;)4$J>."!7
M544 </#X8\1W/C?2?$FJ7FGL+6.:*2UM]X6)67 *$C+DDG).WC&*9:>&/%&@
M17FE:!?::FD3R/) ]RK^=9[SE@H48< DD9(]\UW=% 'G>F_#[4K#P9H%I'?6
MT&O:+-+-!.@9X6WNQ9&R =I5@#QD8KH-/M_&$^K0SZM>:9:V,0.ZVL%:0SD]
M-SR*"H'7"_G7244 5[^U:]T^XM5N);=IHV030MM>,D?>4^HZUQ5QX?\ &]_H
M3>'KW5=+-E)']GFU!1(US+%T.4/R[B."=Q[UWM% %>QLX=.T^VL;=2L%M$L,
M8)SA5  _05B>'- NM'UKQ%>7$D+1ZE>">$1L254+C#9 P?IFNCHH X&W^']R
M_AC4=-N;R*&\DU:34[*Y@RWDON#(2"!D\$$>_6M."V\<W-W:I?7VCV=K$X:>
M2R1Y)9P/X<2+M0'N1D^E=710!QUSH'B'3O%FIZSH$^FR1ZHD0N(+\R+Y;QKM
M#*4!SQU!Q]:S['P#J2>&/%.E7^HPS7&LSO,EPH/WF4<LN./F!X&<#O7H-% '
M&1^'-=NG\+2Z@VG)+I$[&46\CE73RMBE<KUSU!X]ZM^(/#FH7&NV?B'0KFWA
MU6VA:W>.Z!,5Q"3G8Q7E<'D$5U%% '*:1X=U67Q.WB/Q#<6C7<=N;:UMK(-Y
M4*$Y9MS8+,>G0<?IQ7P]L_&%Y\,[*VTV^TN.PNEF59IUD\^V'F.K!0/E?H2,
MD8SWQ7L%06=E:Z=:I:V5M#;6Z9V0PQA$7)R< <#DD_C0!R5SX&DL;/07\.W4
M=O?Z*ACA:Y4M'.C#YUD YY/.1T-:6EV_BR75ENM9O-.@LTC*BRL%9Q(Q_B9W
M4$8[!<>]=%10!R_A/PW>:%X;O-.NI('FGN)Y5:)B5 <DC.0#GUXK&T[P+JEG
MI/@VUDGLS)HER\MR5=L.#NQL^7D\CKBO0:* .%L/#7BCP]?ZO%HEUI+6&HWC
MW@ENUD,T#O\ >X48<#'&2*TO OAJ\\+:7?65Y<QW)EOI;B.92=SHV,%Q@8;@
MY R/>NHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH Q_%<FJQ>%=2DT-"^IK"3   3GO@'J<9P/7%<#X;U;2Y];T
MV&#Q?KMGJ@<?:M.UHNWVC(P4 ?"JQ/3:?PKT;7=.GU;1+NQMKZ:PGF3$=S Q
M#QMG((P0>W//3-<G>^&/$WB273(/$$NC):V5REPTUFKM-,4Z ;@!&#WP30!S
M\_BK3M8\6:Y%KGBVZT>ST^X-I:6MI<- S%>'D9@,MST'2HT\3ZI?^#-1OK+5
M)KV7PWJ:R"YA<H+ZU!R1(!@'Y2<\?PUU[>'_ !!HFMZE>^&Y].EM=2E^T36E
M^701S8PSHR _>P,@BMC2=.U,Z3<0>(KZ&^FN2^](8@D4:,,>6O<C&>6YYH P
M]0U.;6_''A[3M-O)DLX[=M4NVA<J)(S\L2M@\@DDD'J!7&:7XLTSQ''>:IK7
MCB[TJXDG<6=I:W!B2WC!PI90,.3U.[]*[7P!X,N_"L=\^HW45U<S,D,,B$G;
M;1KMC4Y P>3G''3K45CX>\4^&5N;'P]<:3/I<DSRVZ7YD5[;><E1L!#KDDC.
M#[T <U/XFUCQ'X%\+S6^HRVM_<:['83W5HVT2+B0%L="" &P1C(Z5?\ %^H'
MPHVB^'8_$-]:6^HSR2W>I7<YEFBB0#*J[9QN/ ]#]:Z*_P##>L7^G^'8[K4H
MKR\T_4XKVZGD01!U4."J*HQ_$ ,^G)JUXG\.W6JW&FZGI=U':ZMIDC/;O*I:
M-U<8=' YP0!R.1B@#C]%\46%CXWTO2]&\2W&M:=J2R)-%=3F:2WD5=RLKL,X
M/(()-=GXXN)[3P-K=Q;320SQV<C))&Q5E('!!'(-1Z;;^+IM6CN=8O--MK*)
M"#:6"M)YS'H6=U! 'HOXFKOBC2Y];\+:GIELT:3W5N\2-(2%!(P,X!./PH \
M\UJ'5M!^'EKXQ3Q'JTVI11VUQ)%)<9MY [("GE] ,-UZ\=:M>*O$]O+X^;0M
M2\12Z)I5G:K+(UO*8I+B5N0N\#(4*0>/_P!6_P")/"E]K'PP_P"$9MY;9;W[
M-;Q;Y&81YC9">0"<?*<<>E3:MX?U:'Q-_P )#X>N+1;J6 6]W;7FX13*IRK;
ME!*L,XZ$8H Y71O%/F?\)3H]AKLNJV=MICWEE>M(3-%\I#(S\$D-@@]?>M?4
M]0O8_@<FH)>7"WIT>"3[2LK"3>40EMV<Y.3S6U9:7K]];:G'XBU"U,=Y"8([
M6QC_ '<"D$$[V&YF.>^![5S%SX.\977@MO"CZCI"V44 ACN4\SS957[BL""$
M' !(W<#WH IZGI8U+X@^#'FO]11[G3I'=HKIT*E8U/RD'C/\7KWK1T'3[[7?
M%WB22[US5DM+#4@MM;P73(F=JL0>Y7H-O3D]S6EJGAC6/[2\-ZKI4EBUWI5N
M]O+%=,ZQR!D52595)!&#U'/M6IX=T.YTC4M>N+AX634+XW,0C))5=BKAL@<Y
M!Z9H YCP]:7_ ([L[O7;S7M5LDDN)8K*WL+@PI"B,5!8#[[$C)SQ63=^(/$&
MH>#+.V74G@UJT\2)I$MU%\HD96(!8#@@Y7(Z'%=):>'/$_AM[VU\.7.E2:9<
MS//%'?\ F![5F.6"[ 0ZYY ./K7/^+?#<GASP)H^GV]\S7TNNP327I0<SNS$
MOM]CCCVH UM3@O\ P3K'A^Z@UO4K^VU"_CTZ[@OIS*&,@.V1,_<((Z#CVK"_
MX2K3==\0ZVVN>+[K1[:SNGM+*TL[AH"0G!E8@9;)Z \<'BNL_P"$>\0ZWK&F
M7'B6XTU;/3)A<Q06 <^=, 0KN7QMQG( SUZT+X?\1:!JNI3^&YM-FL=1G-U)
M:WY=/)F;[S(R Y!P#@B@#C;CQAJFH_#Z8VNKLUY8ZW'91ZC =OVB/<-KD#&<
M@\CH<>]=!JEI?>$?$/AN:VU[5;Q-0OA9W<-[<>:CAE/S =$((_AQ5_6/"WB'
M6O"L-C?:I:W6H_;X[IW,?E11HK9V)M!)P.A;D]S6GXHT"[UN^\/SVTD*+IVH
MI=S"1B"R $$+@')Y[XH P+/5=135OB#MU-(OL;1?9GO9&,-MF(DG'.!GG '-
M<AJOB%]+\.KK6D:SXKO[ZW,3RW4R2"PERX# JX"A3G P,]/<UVE]X!N=33QG
M!<7<44.N/"]N\9):,Q@??&!_$!P">*J>(/"?C3Q1X5?1;Z]T6U1$7:+7S")V
M4C&\E?D7C. #R!0!Z17$^ G.HZGXJUJ7F6?57M4/I%" J#VZDXKM5W%1N #8
MY .0#]:XWPO&=#\8^(M%E^5+V?\ M6T)_C5\"4#_ '6 X_VA0!R\/CG6?&NN
MW.BV6I67A2&&0Q,+LAM0F_ZYHV%4$9YY(ZUZ-X>T"V\.::;*VGN[C=(999[N
M8RR2.0 69C]!TXI=;\-Z+XCMOL^L:9;7L8'R^;&"R_[K=5/N"*3P_P"'[3PU
MIIT^QFNGMA(7C6YF,IC! &U2>=HQP/<T ,U*UT/3;]_%.H^5!/:VC0-=R.0$
MAW;B,9QG(ZXSV[XK@K1K[7KWQ+\05BDLK+^PY;'2@XVR31KF3SR.P+#Y?;]=
M#Q[X2\4^)?$>F7%D=%N-&L5\P6.H2RJLL^3\SA%(8 8P"?7UKH-%3QA/<30^
M)K?P^-/>%E T^29G+$@8(=0-NW=[]* ,7PU:6S_ FTMI%5;>30V\P=OFC)8\
M^Y)KF/",LMYXA^&HNLMY/A^9XPW\)PJ;OJ5 K;C\%^,;3PY+X0L]6TP:"X:!
M+V19#>16[9R@4#86 ) ;(X[5LZWX,F$6@77AJ>"TU#05,5HMR"T4L)0(T;XY
MY '(S@T 5-8_<_&SPS)$/WD^F7<4^.OEJ59<^VZM3XAZ_>>'/!MU>:=L^WR/
M';VQ?HKR.%#?ADG\*BT+PYJ[^*9O$WB2>R:_%M]DM;:QWF*WCW;F.YL%F8XY
MP, 5J>+/#D'BOPU>:-/*T(G *3)UC=2&5A]"!QWH PHO!VN:5=:;>:9XIU&Z
MN$F7^T(]3N&DAN(C]_8F,1M_=VX'KFN)M_&&E>(]9UNY\0^.;O18[>]DM;"Q
ML[HV^R-.!*V!\Y8YX;(Z\>G;KI'CG4YK"WU?5M.M+*UF26:?2VE6>\V]%;(
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N2TW3K+Q%J6
MLRZW:07LMM?-;Q07,8D2"-54J54\ L#NW=3GT KK:S+[0-/U"Z^U3)/'<;0A
MFMKF6W=E'(#-&REA[&@#/\-LT&K:YID+,]A9S1BWRV[RBR!FC!] <$#MNQT
MKHZK6-A:Z;:+:V<"PPJ20J]R3DDGJ23R2>35F@ KR3P]X:/B3X>726TOD:G:
M:M<W%A< X,4JOD<^AZ'_ .M7K=4=*T>PT2U>VTZ#R87E:9EWLV78Y8Y8D]:
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MNW$D[CP.3G&.* /.K3_DA_BC_KYNO_1@K=^($$=M\.M)@V[=.CNK-+H8^40
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M\R%M\2O-(Z1MZJC,5'X"@#)TV*-OC3KDC(I=-,@"L1R,GG'Y"N=O0$@^+"*
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MW5+QEMI*LP & #@8[Z5UJFOV&FWU[>Z5IT<5M:RS#R+^25F95) VF%.#CUH
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M;/MSC.!G% ')V'A37;+PW!H \0VJV,<0@,D.G,LYC[X=I64,1D9V'&>E:_\
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M?,C.H5]DF\  X[J2!T/>G6?@^]TCR9=(U>*WN38PV=TTMH94F\I=J2*N\%7
MR.K#!Z<5%K?Q&TW2O%.F^'K9/MU[=726]QL?:MKN( +'!!;G[OL<XXSV5 ''
M6'@>;2;?3)-/U?;J5BLT1N9[?S$GBDD,A1T# \$@@AAR/0XK?T?3;G3XIVO-
M1FOKFXE,LCME8TST2-,G8H Z9)ZDDFH-9UR33K[3]-L[1;K4+_S#"DDOE1A8
MP"[,^&(QN' 4DY],D0+KVH0IJ$>I:9!8S6L0F2>2[/V.13_TW*#:00<@ID<'
MD&@#H**S[S7=)TP0C4M4L+-IES&)[E$W^NW<1D<U:2[MI+J6U2XB:XB56DB5
MP70'."1U .#CZ4 345GS:[H]M9F[GU6QBMA*83-)<(J>8,Y3<3C<,'CKP:=+
MK6E06<-Y-J=E':S#,4SSJ$D&"V58G!X!/'84 7J*RI/$V@1- LFN::C7"!X0
MUW&#*I) *\\@D$9'I5S4+O[!IMU>;-_D0O+LSC=M!.,]NE %FBN9TS6O$FK:
M39ZC!HFDK#=P)/&LFJR!@KJ& .+<C.#ZU?L-<-[XCU;2#;",Z=';N91)GS/-
M#'&,#&-OJ<Y[4 :]%%07E[:Z=:O=7MS#;6Z8WS3R!$7)P,D\#D@?C0!/17/:
MWXSTC2- CU=+RUNK>69(8FCN4VN2X4X;)!V\DXZ!36]#-%<0QS0R))%(H='1
M@592,@@CJ#0 ^BL^QU[1]4N'M]/U:QNYT!9X[>X21E .,D D@9(%0>&-;_X2
M3PU8ZQ]G^S_:H]_E;]^WDC&<#/3TH UZ*S/$6LIX>\/7VK/%YHM8BXCW;=YZ
M!<X.,D@=.]9C^(M7L+K3$U?1[6"#4+A;97MKYIGCD925#*T2<?*02"<4 =-1
M6%8^*+.>#5+J]>"PL[&^>S$\\X57*X!.3@+\Q*XR>E:4>J:?+IIU*.^MGL0I
M<W*S*8MHSD[LXP,'G/:@"W1573]3T_5H&GTZ^MKR%6V&2WE610V <94D9P1Q
M[UD7'C#36GTN+2[BUU,WU[]E)MKE6$8",[,2N<X"CCCJ* .AHHKF8?&EC=^,
M8_#UE$\Y\N5I;H9$:/&5!C4XPY&><'Y>!R<@ '345R<WC&YV:G?6FD?:-(TN
M5HKFX^T[96*?ZPQQ[2&"^[+G!QGO,_BBZO=3N;+0-,BU 6D,<T\LMUY"YD7<
MB)\C;F*\\[0,CGG@ Z:BN5C\9C5)--M] L1>7-[;&\*W,WV=((@=IWD*YW;_
M )=H!Z,<X'.CI7B2SU"R66Y9+&Y%TUC);SRKE;@=8U/1\]1CJ"#@<@ &S17)
MS>,;G9J=]::1]HTC2Y6BN;C[3ME8I_K#''M(8+[LN<'&>]J\\0:B99CI&C"\
MMH;=;AKB><VZ2AAN"Q'8V\X'.=H&0,]< '145@#Q5;W-CHLVGPM/-K&UK:&1
MO+(3;N=G.#@*OUR2!WS4%YXULH/%NG^';>)[FXN)6BGE7(CMR(R^"V,%B /E
M!X')[9 .FHKF;SQK90>+=/\ #MO$]S<7$K13RKD1VY$9?!;&"Q 'R@\#D]LZ
M4.M*=>N])NHE@EBA%S"WF9$T.<%N@VE6X(YZJ<\\ &I16->ZW,4L?[$LTU0W
MNXI.LVVV1%&2S2JK8SP  "2?H2,Y?&@.GOG3V_M5;\Z:MDLH*M.%W<28^YM(
M8MC(';/% '545A6^K:W,][:2Z'##?0!'B)NG-K.C=<3>5D,,'*E/[O8Y%&W\
M4ZE_PD5QI=[I5FD=I:_:;RXM;YYA I!VJ08ERS8)QGH,^F0#JZ*Y/3_&%U<2
M:-->Z2MKI^LY%E,EUYD@)4N@D3: NY 3\K-@X!]:W]6OWTS3)KN*RN+V5 !'
M;VZY>1B< >PR>2> ,F@"[17-+XK>QO;VTUZSBL9+:R:_\RWN#/&T*G#<E$(8
M''&WG(P33['7M6FNK WF@/!97^[RIHIS,\)QN7ST" (",\AF ; /7- '145Q
M\?C>=X+?4VTE5T.>]^QI<_:<S9+F,.8MN-N\8^_NP<X[5=\6^+[;PK;VI>!K
MFYNIECC@5MN%+*K.3@X4;A]20.] '1T45RWBCQA+H>J:?H^FZ1+JVKWP9X[9
M9EA544<LSMP.^/H>1QD ZFBN>\(>*H_%>F37'V22SNK6=K:ZMG;<8I%ZC=QD
M<]<5IZSJUMH6C7>J7F_[/:Q&1Q&,L0.P'J>E %ZBN>CUK7(9;-K_ ,/QK;74
MBQE[*[-P\!;H9%\M0%'=E9@/<<T[1/%VEZX^K""ZME73IVC=OM"ME%4$RG'1
M<EAGI\O7L #?HK+&OZ;=:7=WVFZEIMW';J2T@O%$2$#/SNN[:/?!P.U$WB/1
MK.,&^U?3;9]J%@]V@ W E>21P0#@X&0#0!J44U'26-9(V5T8!E93D$'H0:Y7
M1O$FO:]8&^L=$TT6_G21+Y^IR*YV.4)($! Y7UH ZRBN5O?&+:7XHTO0[_3P
MKWL D>:&?>D+EQ&%Y52068#/'4<5:\1>*8] OM)LQ:M<2ZA=1P</M$2LZIO/
M![L,#O@\C% '04451U#6])TEXTU+4[*S:7/EK<W"1E\=<;B,]: +U%85UXJT
M^U\6VGAZ2:%;BX@>7+3*I5@5"IMZEFR2/]WOVUKR]M=.M7NKVYAMK=,;YIY
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M3:Q+;1U.,C..F:[.B@#BOB7<6G]CZ9IU[<I;VNH:G!%<.\HB B4^8Y+9&.$
MSZD5EW5SH<6O:1=>']1?4VM)))KUVOGOX[>V$;;FW2,_E/D*!M*D\CD9KTFB
M@#R?PX8-+NO#5YXBDBM;.33IKV*:Y<)"+R:7><D\!_+;C/;=BF';)K":Q?1F
MV\)ZAK9N29EV1-M@"QS2 ]$>0!@6X)VD]17K=% 'DOB24:OJ.J:U9 GPY(+*
MROKN('9<QK.3,ZD?>55.PL,\9&2 <:XU+1=3^)EE=V=Q;?8=(TF2:2\1@(,,
MVQ0'^Z0H\SD' RPZ@@>AT4 -1TEC62-E=& 964Y!!Z$&N3U/_DJF@?\ 8.N_
M_0HZZZB@#RO6)H;6S\3Z/8:J;5KN:8#2)+4&[FED'6 A^8W)!R4; W<KCBTC
MP>%M2EA.M1Z/<G3[9;I;RV$BW9CCV!K8[P2X VD8;G;\I[^E44 >4:-9CPM9
M>'7NM0&B:B;&9'N=3A#V\D;2F00R'>A64;@PY'1NO0='X%V:=IM_=WUYA=7U
M>6:TDNL1-<;@JJ54X^]L+*O7;BNTJK>V$5\UJ96<+;SK.%4@!V . WL"0W&.
M5';((!YKK$T-K9^)]'L-5-JUW-,!I$EJ#=S2R#K 0_,;D@Y*-@;N5QQMW]YX
M?MM!3PSXGNIM/2UL8PTCW#6Z72B/:PC9&!D R04.><<'BNYHH \W\+'45\2^
M''UN$PW$FASQ0H\0C(99D.-HP%;R]A(P,8/3I6SXJ_Y'+P9_U^3_ /HAJZ'4
MM*@U(VSR/)%/:S":">(@/&W0@9!&&4E2".03WP1>H Y#Q5_R.7@S_K\G_P#1
M#4_6F#?$3PT(R \-M>2SG^[%M09)[#=M_*NLJC;Z5!;ZK=ZD7DENKE53=(0?
M+C7HB8 PN23W))Y/ P 9^J>(M'BMK475TRZ;J"LJZC#/L@3 X!F5@4)YP0>H
MZYQ7G#V41FBNXO-E\'V.M,5G&3OBDA(F=GZR1>82I<YRK'D@5[+10!Q/A86"
M^+M6?PZ81X>^RQ>9]EQ]E^U9.3'CY<[-N[;WQGFF>%!=OX!U+7;6/SM5U;[3
M?1JXSN8Y$2?0*J#%=S10!Y3I!TN-O"QT*\^U:TLP%W:LV_[-&P(G/D]+;:3C
MY G]WD&NXGO=4T*QN-0UB>&_MH@,IIVGNDB#(!<@RON4#D@#. 3STK>HH \E
MUZSAUJ^UF#PC<_VE'>:3+]OE6<W*^8"&A1923AC\XV!L8.=HX-7;5]&GU7PU
M+X7*'63,3J1C/[WR=A\T7??=OVXW\[NG->FT4 >.VLEJ=!M)5GSXT_M!96TK
M/"S[_G_T7[B@)N;S0H/\6_)R;GC?3M=MM/U34;VUTZ9KF^MDBG6\?=%"LZ^7
M&$\K &3ECNZDGG %>K44 5K:\CF<VTDMN+Z.-'N+>*;>8BP^@.,@X) SCI7#
M?$_Q^?"EO;:78RQQ:G?CBXE!*6L><&0@ DGK@ 'H3@X /H5% 'G?@K7/!GA[
MPG"+'67NHYKT6\][);RA[B[D&[D%<C(''8 #))Y/8>))&B\.WKKI?]J@1X>R
M[S(2 P P<G;D@8YQCO6I10!Y9&VE:;<:9)X%\1W5Q))+#$-%%T;F%8"P,A:-
M\O"0.2Q(QC'&<54U8M+I/B2S1XV,/B1;J^MVC,K"T_=DNT2D,Z< D#&0#S7K
MU% 'D>O3?VD-?OX=8LM2,>@W$5Q-IEGL@(/**\AF?+C!( &0"<XSSM^$;>&7
MQMJKR1([#1["/+*#\K*VX?0X&?H*]!HH Y;X;DGX>Z-D](2!] [8KD?!LWA1
M-!8:IXB^QW?VNYWP_P!NRVVW]\^/W:RJ!D8/3GK7J]% 'F>M6<&O>*OLVF72
MSJ_AF4VEPDWFYD2XC,;;R3N(=5.<D\>M5KR];7]/T?Q(\;1_;==TZ*&-@04C
MC?!'/_31I?PQ7JM% $,%Y;733+;W$,S0.8Y1&X8QN.=K8Z'D<&O.+RZ?2?&G
MB675-5TC38[M(_);4[-I1<6XC *1GS4!PV[* $DG/.17H=G8164EW(CR.]U.
M9Y&<Y^;:J@#'0!54#Z5:H \R\.I_8^O^$H;^::('1[BWA-]&('8^;&4CVEFP
MP7 "[B<#MTK;\<WJV=_X>>0V=LOVN0C4;Y6>"T81-M)4.@+-G +' Y[UV5%
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M=S8A2R=90.P\PRD9'&3LY]!6C10 4444 %%%% !1110 4444 %%%% !1110
M4R5#)"\8D:,LI =,;ESW&<C-/J.>(3P20EG02*5+1L589&,@CD'WH \_N-*M
M/#?BGPZEE8RV$0N##<:O(5)OV=.(W*DL[.YSND"@,OR\D5SM[=Z?IOA'5-0N
MY$7QW:W4LSOUNT<2?+C^+R/*V]/DV&N]7PMJ%S+IL>K:V+ZQTZ99X8Q;;)97
M0_NVEDWG=M_V57)Y/I1-X4OKN%]-N]<>XT5[CSG@DA+7#+NW^49B_*;N/NYV
M_+GO0!R0$GB:3Q/?W/A^+51;74ELLD]P(WMXXUX6V^1L/U8ME,EEY../1M!N
MH+WP_IUS;3SW$$MM&R37&/,<;1R^/XCW]\UD7'A>^CNM4;2=8%E;:HWF7,4E
MMYK(Y7:SQ-N7:6 &=P89&0.U;NFZ?;Z5IEKI]JI6WMHEAC!.3M48&?4\4 6J
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
=HH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>img17388848_7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img17388848_7.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &T @\# 2(  A$! Q$!_\0
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M)55DG1XB&&>2,C]13?L^1SBDPU*?_":^)/\ H,7/_?5)_P )MXC_ .@S<_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%8DG_(\0?]@Z3_T8E;=8DG_(\0?]@Z3_ -&)5PZ^@!X0_P"10TK_ *]UK;K$
M\(?\BAI7_7NM;=%3XWZ@%%%%0 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5B2?\ (\0?]@Z3_P!&)6W6))_R/$'_ &#I/_1B5<.OH >$/^10TK_K
MW6MNL3PA_P BAI7_ %[K6W14^-^H!1114 %%175U;V5K+=74T<,$2EI))&"J
MH'<DU!?:MIVF6 OKZ^M[:U.,32R!5.>G)]: +E%4I-8TR+2O[4DO[9=/VA_M
M)E'EX/?=TJ6QO[34[1+NQN8;FW?[LL+AE/XB@"Q1110 4444 %%%% !1110
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MX)UO5]6DUJWUDVOVBPO/L_\ HRD)]T'C/)Z]ZZRN*\"_\AWQE_V%V_\ 0%H
M[6BL6Y\6Z):7,EO/>A)8VVNOEN<'\!47_":^'_\ H(#_ +]/_A6?MJ:^TOO(
MYX]S?HI 00".AI:T+"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MM)!+.>@Z=#7I\(D$$8F(,H4;R.A..:?10 4444 %%%% !1110 4444 %%%%
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MRGD$'(- #JXKP+_R'?&7_87;_P! 6NUKBO O_(=\9?\ 87;_ - 6@#M:***
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MNBZRV1_=AF_IU_(^U;OEJ1Y8O5:K_(1Z'1117*,**** "BBB@ HHHH ****
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M%!J,%C?:BK$W,T@06\(^_)SU;LH]3[5U]5+S3+"_(-W96\[!=H:6)6('MD4
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ME7#KZ 'A#_D4-*_Z]UK;K$\(?\BAI7_7NM;=%3XWZ@8>JZIJ.E7RN+>"[L7
M'E1R!+A3W*ACAQ[#!^M<OX6L[J[UN.[AO8G:"61KN8W,OG3!LX1X&XCQD?3;
MQ6OXB\'2:UJ<UU'/9[;B!8'^U6WFM" 3\T1R-IY_, UO?V-8M<6MU) LEW:J
M%CN#_K,8QR1U^AXJ +]%%% !1110 5Q7@7_D.^,O^PNW_H"UTFMZE<:5IQNK
M73+G49 P7R+?&\@]^?2N3^&US)>7OBJYEMI+6275"S02XW1DHO!QWH [VBBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J"[O+>PM7N
M;J410QC+.>@J>D95=2KJ&4]01D4G>V@'$Z_XET:[NM'>#4(G6"]664C/RJ >
M>E=+I^OZ5JL[06-['/*J[BJYX'3/2KGV2V_Y]XO^^!3D@BC.8XD0^JJ!6483
M4FVUKY?\$S49)W;)****V- HHHH BGMH+J(Q7$22QG@JZ@BO-O&WAN#2V@N]
M/MC';/E90N2%;M]!7IU9?B3_ )%K4_\ KVD_]!-88BE&<'?<SJP4HNYY_P"%
M-1O=!BFOGTZXGT^8A7D0?=([CUZUZ'I>N:=K$6^RN5<XY0\,/J*?HH']@Z>,
M<?9H_P#T$5F:GX/TZ_D^T6^ZRNP<B:#CGW%9TJ=2G!<KNNQ,(RA%6U.AHKC?
M[1\2>'.-2M_[3LE_Y>(?OJ/<?X_G6_I7B#3=93-G<J7[Q-\KC\*VC6C)V>C[
M,M33=NIIT445J6<!\1X3ILNF>(;%_+U.&<0( /\ 7!L_*?7O^=4+"[\0^![J
M&;6(K:33]4NR\YA^]#*_7^73D<5V'B_P\WB31#:Q2B&YBD$T$AZ!QTS7G.J:
MAXEUFWBNM5LHY]-TB]V726A^9W3&2>O'N..:[J+4X*+MY_I81[)16?H^M6&O
M6"7FGSB2-NH_B0^A'8UH5Q--.S&%%%%( HHHH **** "BBB@ HHHH **** "
MBBB@ K$D_P"1X@_[!TG_ *,2MNL23_D>(/\ L'2?^C$JX=?0 \(?\BAI7_7N
MM;=8GA#_ )%#2O\ KW6MNBI\;]0"BBBH **** "BBB@ KBO O_(=\9?]A=O_
M $!:[6N*\"_\AWQE_P!A=O\ T!: .UHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHKSU?%OBO6UOM0\-Z78RZ9:2M
M$BW#-YUR5^]M X'MF@#T*BL*X\56&EZ+9W^N$Z;)<*/]&D&Z0/CE0%R3BE/C
M#0!H:ZS_ &C&=/:01>< 3M<G&",9!^M &Y7.WOABYO6G#Z_?B&8MF$;=H4_P
M].E1CQYH$VGZE=6EZ)_[/B,DL81E)'8C(Y!/&:IZ7\1]%G\.6>J:E<I9M.61
MH]K,%=1DJ#CG@BIG",U9BE%2W+T/A>\@6-$\1ZB(XP J#;C [=*Z2N;N_'OA
MJQBM9+C4E07,8EC7RV+;#T8@#*CZTS4?%$D/B/PW96/V>>RU82LTW).%4$%2
M#CO2C",-A1BH['3U@ZKX1TS4W\]$:TNNHG@^4Y]2.];U%.4(S5I(;BI*S.-^
MU>)O#?%W$-5L5_Y:Q_ZQ1[_Y/UK<TGQ'IFLJ!;7 $O>&3Y7'X=_PK6K#U;PI
MIFK,96B-O<]1/#\K9]3ZUER3A\#NNS_S(Y91^%W)-0UV2QO&@72-1N0 #YD$
M093GWS7)^$]=>UCUD#1M1G$NIS2'RH@VS./E;GJ.]0ZKKGBGPBTMJ\3W]J0%
MAO)%Z$C..O)&.]8OA'Q;JVEWMS =,GOA>SO-Y:%5<R-U(/X5M#G<6F[-VZQ_
MS)YG>S=ON.DO_#-_IDR^(_"<;VT\BA[C39!A9!U(V]C[?E70>&?%EEXD@95!
MM[Z+B>UDX9#WQZBMFSGDN;*&>6W>WDD0,T+D;D)[''<5S7B?P:FJ3KJFE3?8
M=9B^9)TX$GLW^/\ .NA24URU-^_^9J=917'^&_&+W%Y_8NO0_8M9C^7#<)-[
MK[GT_*NPK.<'!V8PHHHJ "BBB@ HHHH **** "BBB@ HHHH *Q)/^1X@_P"P
M=)_Z,2MNL23_ )'B#_L'2?\ HQ*N'7T /"'_ "*&E?\ 7NM;=8GA#_D4-*_Z
M]UK;HJ?&_4 HHHJ "N<\6:;;7D4%UJNK266C68>2ZB25HA-Q\NYU(( YX'4D
M5T=<OXM\)7'B>XT^2/5VLX[)S*(3;K-'))_"S*W!QVSZYH X^P;4;O3-!T>>
MXU"'3-6U6<P^=*RW!LD0NB,V=PW8]<XQ75>#FEL]8\1:%Y\TUIIUS$;8S2%V
M1)(P^S<>2 <XSZU+<^%=0O\ 3K=;[7Y)=3M+K[3:7ZVJ(8CC&TH.&4@D'US6
MAX>T#^Q([N2:[>]O[V;S[JY= F]L  !1P    * ,W4/&5Y8ZA/:IX2UVY6)R
MHGAA4I)[J<]*S?AO<M>WOBJZ>WEMFEU0N8)AAX\HO##UKO:XKP+_ ,AWQE_V
M%V_] 6@#M:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *\SL+/QAX0LK_0])T>.^AFF>2ROA.JB(/\ WU/I7IE% ' Z
MOH_B&WU/P[K_ -GBUB\L('BNX$98]S,/OIGCC_"L2Z\':[<^%=4=M/1+S4]7
MBO/L,<BD0QAAG)SC..3BO6:* .'NO#VH3>-M;NXK4+:76C_98I=R@&3IC&<_
MI6)IOA[7)['P9;7FC/"-(NF%QOE1@4 &'QGIGM[5ZG10!YYJFDZWI'BG6M0T
M_14U:WU:V2%?WJH8&"[<,&_A[\5%IOA#5=+N? \31B9-,6X^URJXVQEQD 9Y
M(R<<>E>D44 %%%% !1110!EZY9Z?JMB]C>SI'G#*=X#(>Q&:XC0_"VEW<=\;
MK4"DD-P\,3+(J_=QA_?-=Q>^'=(U&Y-S>6$,TQ !=AS@=*KGP?X?/72K?\C7
M+4HN<^9I?U\C&=-RE>R,9;GQ%X;4&4?VQIHZ2I_K%7^OZ_6N@TGQ#INM)_HD
MX\P?>B?AQ^%:$$$5K;QP0($BC4*BCH .U8NK>$M.U1_/16M+L<K/!\IS[CO5
M*%2'PNZ[/]'_ )CY91VU'^(_"]AXELQ%=*4G3F&X3AXS['T]JYO3/$VH^%[]
M-%\5DM$3MMM2'W7'8,?Z]?7UJZ-1\0^&L+J<']I6(_Y>8OOJ/?\ ^O\ G6MY
M^A>,=,DMF:.YB<?-$W#H?7'4$>M=-'$QE^[G]W5>A2FF[=3;5E=0RL&5AD$'
M((I:\W275_AQ<".X,NH>&V;"2 9DML]C[?I]*[F+6]+FTZ/4%O[<6DG"RO(%
M4GTY[^U:3I..JU3++]%9W_"0:+_T%]/_ / E/\:L6NH65_O^QWEO<;,;O)E#
M[<^N#6;BUN@+-%%%( HHHH **** "BBB@ K$D_Y'B#_L'2?^C$K;K$D_Y'B#
M_L'2?^C$JX=?0 \(?\BAI7_7NM;=8GA#_D4-*_Z]UK;HJ?&_4 HHHJ "BBB@
M HHHH *XKP+_ ,AWQE_V%V_] 6NEUG5?[&T\W?V&\O<,%\JTB\R0Y[X]*Y+X
M;W7VZ]\57?D30>=JA?RIUVNF47AAV- '>T444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !U&#7.ZIX/L;V7[59LUA>@Y$T'&3[BNBHJ9PC-6DB
M914M&<6^K:SH:-;>(;(7]@PVFYB7=D?[0_QQ7,W^D0:?!-JWAO[-J>CD^;=:
M7<#>L9 ^\%/(Q^8]Q7K) 92K $'J#7(>)?!UE+87EY8;[2X$+EA"<+(,'((]
M_:E2G4H/1WCU3(M*.VJ//I$NY;2'Q4/"^E)I,&Y# D>!(#QO8=\'H:].\(VA
MAM'N1IFFV45RJ21FR&/,&"?F_/\ 4UY</%5ZO@P>%?L2[F!03[N#'G.,>OO6
MCINLZYI,$5O8>(+>6.-0HMKZ$IM [ ^GXUV5YTY63J)=M=&N@^>-UJ>QT5YW
M;_$/5+9<ZGH#2(.LUC()%^N.?YUM6'Q%\-WS;&O3:R=TN4*$?CTK/V,[72NO
M+4NZ9U5%0V]U;W:;[>>*9/[T;AA^E35D,**** "BBB@ K$D_Y'B#_L'2?^C$
MK;K$D_Y'B#_L'2?^C$JX=?0 \(?\BAI7_7NM;=8GA#_D4-*_Z]UK;HJ?&_4
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M&YSU8XZD^M2T44 %%%% !65XDT5/$6@W.DR2!(K@H)"5SE P+#\0"/QK5HH
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M YV@* ,D\D]\"MN@ Z4444 %%%% !6))_P CQ!_V#I/_ $8E;=8DG_(\0?\
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MTACR)-X?YGQN9=PZ&M6^\,11Z3XE587U ZL6F:U9Q'EM@7:K=ONC!/0UT]%
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M4?\ "-K_ -!C6/\ P,/^%%% !_PC:_\ 08UC_P ##_A1_P (VO\ T&-8_P#
MP_X444 '_"-K_P!!C6/_  ,/^%'_  C:_P#08UC_ ,##_A110 ?\(VO_ $&-
M8_\  P_X4?\ "-K_ -!C6/\ P,/^%%% !_PC:_\ 08UC_P ##_A1_P (VO\
MT&-8_P# P_X444 '_"-K_P!!C6/_  ,/^%'_  C:_P#08UC_ ,##_A110 ?\
M(VO_ $&-8_\  P_X4?\ "-K_ -!C6/\ P,/^%%% !_PC:_\ 08UC_P ##_A1
M_P (VO\ T&-8_P# P_X444 '_"-K_P!!C6/_  ,/^%'_  C:_P#08UC_ ,##
M_A110 ?\(VO_ $&-8_\  P_X4?\ "-K_ -!C6/\ P,/^%%% !_PC:_\ 08UC
M_P ##_A1_P (VO\ T&-8_P# P_X444 '_"-K_P!!C6/_  ,/^%'_  C:_P#0
M8UC_ ,##_A110 ?\(VO_ $&-8_\  P_X4?\ "-K_ -!C6/\ P,/^%%% !_PC
M:_\ 08UC_P ##_A1_P (VO\ T&-8_P# P_X444 '_"-K_P!!C6/_  ,/^%'_
M  C:_P#08UC_ ,##_A110 ?\(VO_ $&-8_\  P_X4?\ "-K_ -!C6/\ P,/^
M%%% !_PC:_\ 08UC_P ##_A1_P (VO\ T&-8_P# P_X444 '_"-K_P!!C6/_
M  ,/^%'_  C:_P#08UC_ ,##_A110 ?\(VO_ $&-8_\  P_X4?\ "-K_ -!C
M6/\ P,/^%%% !_PC:_\ 08UC_P ##_A1_P (VO\ T&-8_P# P_X444 '_"-K
M_P!!C6/_  ,/^%'_  C:_P#08UC_ ,##_A110 ?\(VO_ $&-8_\  P_X4?\
M"-K_ -!C6/\ P,/^%%% !_PC:_\ 08UC_P ##_A1_P (VO\ T&-8_P# P_X4
M44 '_"-K_P!!C6/_  ,/^%'_  C:_P#08UC_ ,##_A110 ?\(VO_ $&-8_\
M P_X4?\ "-K_ -!C6/\ P,/^%%% !_PC:_\ 08UC_P ##_A1_P (VO\ T&-8
M_P# P_X444 '_"-K_P!!C6/_  ,/^%36&A06%^;W[5>W$_E&(&YF+X4D$X_$
)"BBIF_=8'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>img17388848_8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img17388848_8.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &= ?4# 2(  A$! Q$!_\0
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M^H?]_E_^)H_X5-X>_P">^H?]_E_^)H^NT@L>+T5[1_PJ;P]_SWU#_O\ +_\
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M'_"IO#W_ #WU#_O\O_Q-'UVD%CQ>BO:/^%3>'O\ GOJ'_?Y?_B:/^%3>'O\
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M*5M5BZ/_ ,AK7O\ KZC_ /1*5M43W^[\@"BBBH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@#$TW_D:-=^EO_Z :*--_P"1HUWZ6_\ Z :*N>_R7Y +H_\
MR&M>_P"OJ/\ ]$I6U6+H_P#R&M>_Z^H__1*5M43W^[\@"BBBH **** ,G7=3
MOM.BMDTW2WO[JXE\M1O\N.,8)+2/@[1QZ')K$C\=//I$$D&F;M5GOWTY+,SC
M894SO/F ?< !.<>V,UJ^)KB]@M(1#I#:I8RL8[Z"(_O1&5(R@) ;G&1GI7%Z
M?H6JZ996.I6^D7"6EAJ\EQ:Z5N4S16CQ["!SC.XE]N>AQF@#M_#VNMK45W'<
M6OV2^LIS;W,&_>%; (*M@94@@@X%;-<QX1LKQ;C6M7O;62T;4[L2QV\N-Z1J
M@1=V"0"<$X[9%9NJ>(/%V@3VUQJ=IHSZ=->1VW^CO)YN';:IYX^M '<T444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% &)IO_(T:[]+?_T T4:;_P C1KOTM_\ T T5<]_DOR 71_\
MD-:]_P!?4?\ Z)2MJL71_P#D-:]_U]1_^B4K:HGO]WY %%%%0 4444 %%%%
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MY_\ 9:ZNM:FT?3]6 4445D 4444 %%%% !1110 4444 %%%% !1110 4444
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M,BI\)T-%%%:EA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% '*:I_P E*\/_ /7I<_\ LM=77*:I_P E*\/_ /7I<_\
MLM=76M3:/I^K ****R **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@#$TW_D:-=^EO_Z :*--_P"1HUWZ6_\ Z :*N>_R7Y +H_\ R&M>_P"OJ/\
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M,BO:P[G5T5R\?C[1994B476YV"C,7<G'K745<*D9_"[E1DI;,****LH****
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MS"BBBO1.H**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KSOXO?\
M(!T__K[_ /9&KT2O._B]_P @'3_^OO\ ]D:M\+_&B)GD%%%%>X2%%%% !7;?
M"K_D<F_Z])/YK7$UVWPJ_P"1R;_KTD_FM8XC^%+T&CVVBBBO"*"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@#$TW_ )&C7?I;_P#H!HHTW_D:-=^EO_Z
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M** "BBB@ HHHH **** "BBB@ KSOXO?\@'3_ /K[_P#9&KT2O._B]_R =/\
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M5>EUPWQ%L[6#1].EBMH8Y#JUKEUC /\ K/6@#N:*** .9\>_\BK-_P!=8_\
MT(5Y17J_CW_D59O^NL?_ *$*\HKR,=_%^1PXCXPHHHKB, HHHH GLO\ D(6O
M_79/_0A7NU>$V7_(0M?^NR?^A"O=J]/+]I'7A=F%%%%>B=04444 %%%% !11
M10 4444 %%%% !03@9/2N7\0>.=.\.^)M&T2Z1C+J;%?,# "$9PI;ZMQ6QKB
MZ?)H=Y#JEQ';V4L+1RR22! JD8/)Z4 8]W\0O#=KKEMHT=]]KOYY1%Y5HAE\
MO/=R. /6G^)?'.E>&+F&SGCN[R_F4NEG90F67:.K$#H/>O)O 0\46L]_X0\/
M1Z/9W5E*6N-5E3=(\3'Y"J_Q C!!Z8(Z5VGB'2?$FA^/K;Q=I&G#6$FLA9WE
MLCB-P0<AESVS0!@7OB;3(O&.C?$'1I6_LR^?^R]61UVM$W\)<=B./^^:YV>W
MT6SM_%OA[Q+I\LOB2ZNGET^[$+/)<[O]5L;L,_A@GTKO_#WP]EU+1/$B^)K5
M;/\ M^[%P;2WD!-L <KANF[)[5Z%::?;VEM:P*N_[-&(XY)?F< #'WCSF@#$
M\ OK#>#-/BUZTDMM0@3R760@EPO"MQZC%8'Q>_Y .G_]??\ [(U>B5YK\9;N
MVMM!T\33HA^U9VD\D;&[=:WPS2JIL3/)J1F5%+.P51U).!6)/K[2/Y5C SL>
MC,/Z4Q=*OK]A)?3E%_N]3^705Z;Q";M35_R^\5BS=:_;P_+ #,_J.%JIY6K:
MK_K&\B$]ONC\NIK6M=-M;3!CB!?^^W)JW2]C.?\ $E\D!FVNB6EMAG'G/ZOT
M_*O2/A2 /&) & +23@?5:XFNV^%7_(Y-_P!>DG\UIU:<849**MH![;1117BE
M'D?Q@_Y"^E_]<'_]"%><5Z/\8/\ D+Z7_P!<'_\ 0A7G%>WA?X,26%%%%= @
MHHHH ]/^#O\ K=8^D/\ [/7JE>5_!W_6ZQ](?_9Z]4KQ<7_&?]="D%%%%<PP
MHHHH **** ,33?\ D:-=^EO_ .@&BC3?^1HUWZ6__H!HJY[_ "7Y +H__(:U
M[_KZC_\ 1*5M5BZ/_P AK7O^OJ/_ -$I6U1/?[OR *Y'QO<.TNBZ2=0>PM-0
MNF2ZGCE\M_+6-GVA_P"'<0!D<XKKJY/QL8[@Z3I2Z38:A=WUR5A%_'OBA55+
M.Y'4G P .YJ ,"_L-&\+W.FZCX<U:19FOH8+BV^WF9+B-VVME68\C.01Z5Z7
M7 ZYHNE^&=4TO4K7PYHAT[[1'!.5M56>)W<*DB-TP"1D=>]=]0 4444 %<9\
M2O\ D!Z;_P!A>T_]&5V=<9\2O^0'IO\ V%[3_P!&4 =G1110!S/CW_D59O\
MKK'_ .A"O**]7\>_\BK-_P!=8_\ T(5Y17D8[^+\CAQ'QA1117$8!1110!/9
M?\A"U_Z[)_Z$*]VKPFR_Y"%K_P!=D_\ 0A7NU>GE^TCKPNS"BBBO1.H****
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M -"%>45Y&._B_(X<1\84445Q& 4444 3V7_(0M?^NR?^A"O=J\)LO^0A:_\
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MAGPL%>RT]9;H?\O5Q^\D_ GA?P KJZ** "BBB@ HHHH **** "BBB@ HHHH
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M * U=E6CKU+)7 X/3;KQCI5BEG;^$$:),D&;65D;DYY8C-6_[<\<?]"=;?\
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M_0G6W_@T3_XFM/1-1\1WEX\>L:##I\ 3*RI>+,6;(XP!QQGGVK>HJ0"BBB@
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MVK<1% W]QNJM^!P?PK1HH XM/!EZ? .H:-/>PRZKJ#-+=7>T['E9@2<=<8
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M^'_^>NJ_^#&7_P"*H_X5CX?_ .>NJ_\ @QE_^*KLZ* .,_X5CX?_ .>NJ_\
M@QE_^*H_X5CX?_YZZK_X,9?_ (JNSHH XS_A6/A__GKJO_@QE_\ BJU-#\'Z
M7X>O)+JR>]:1X_+/GW3RC&0>C$C/'6M^B@ HHHH **** ,33?^1HUWZ6_P#Z
M :*--_Y&C7?I;_\ H!HJY[_)?D NC_\ (:U[_KZC_P#1*5M5BZ/_ ,AK7O\
MKZC_ /1*5M43W^[\@"BBBH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_9NN_P#0PC_P"3_&C^S==_Z&$?\ @$G^-'*NZ_'_ " VZ*Q/[-UW_H81_P"
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#'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>img17388848_9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img17388848_9.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"!&J&"@# 2(  A$! Q$!_\0
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M!M^>*//%8GVOWH^U^]'(!M^>*//%8GVOWH^U^]'(!M^>*//%8GVNE^U^]/D
MVO/%'GBL7[7[TGVOWI<@7-OSQ1YXK$^U^]'VOWHY -OSQ1YXK$^U^]'VOWHY
M -OSQ1YXK$^U^]'VOWHY -OSQ1YXK$^U^]'VOWHY -OSQ1YXK$^U^]'VOWHY
M -OSQ1YXK$^U^]'VOWHY -OSQ1YXK$^U^]'VOWHY -OSQ1YXK$^U^]'VOWHY
M -OSQ1YXK$^U^]'VOWHY -OSQ1YXK$^U^]'VOWHY -OSQ1YXK$^U^]'VOWHY
M -OSQ1YXK$^U^]'VOWHY -OSQ1YXK$^U^]'VOWHY -OSQ1YXK$^U^]'VOWHY
M -OSQ1YXK$^U^]'VOWHY -OSQ1YXK$^U^]'VOWHY -OSQ1YXK$^U^]'VOWHY
M -OSQ1YXK$^U^]'VOWHY -OSQ1YXK$^U^]'VOWHY -OSQ1YXK$^U^]'VOWHY
M -OSQ1YXK$^U^]'VOWHY -OSQ1YXK$^U^]'VOWHY -O[0*7[0*P_M?O1]K/K
M3Y -S[0*0W K$^UGUH^UGUI<@&W]H%,><>M8_P!K/K4;W9]::I@=%:SC>*ZW
M29 <5YQ9W9+CFNWT.;=MK"K&R ]#L3E16H.E8^G-E!6N.@KSI;C%HHHJ0"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** ,^^^X:X+7^C5WM]]PUP.O\ 1JZ:&XCSG4O]8U9R=:T-2_UAK/3K7JQV
M$34444P"BDI: "BBB@ HHHH 2@4M% !1113 ***2D M% HH **** "BBB@ H
MHHH **** "BBB@ HHI* '"BD%% "TE%% !1110 4444 %%)2T %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44M% "4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %!HHI@)2T44@"BBB@ HHHH **** "BBB@ HHHH **** "DI:
M*  4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M "TE%% !1110 4444 %%%%, HHHI %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5Y>M6*KR]:
M: UM%_URU[#X9_U:UX]HO^N6O8?#/^K6N+%[#1V Z44#I17F#"BBB@ HHHH
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M-.Q1B@!N31DT[%&* &Y-&33L48H ;DT9-.Q1B@!N31DT[%&* &Y-&33L48H
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M:=BC% #<FC)IV*,4 -R:,FG8HQ0 W)HR:=BC% #<FC)IV*,4 -R:,FG8HQ0
MW)HR:=BC% #<FC)IV*,4 -R:C<FIB*BD%" GLB?,%=]H!/RUP=B/G%=[H/\
M#7/7V&>BZ9]P5LCH*QM,^XM;(Z"O)GN,6BBBI **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH H7WW#7 >(.C5W]
M]]PUP'B#HU=-#<1YQJ7^L-9Z=:T-2_UAK/3K7K1V$34444 )BEHHH **** "
MBBB@ HHHH **** "DI:* "BBB@ HHHH **** "BBB@ HHHH **** "DQ2T4
M%%%% !1110 4444 %%%% "8I:** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **,T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444P"BBBD 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !24M% "4M)2T %%%%, HHHI %%%%,!:0T44@$HI
M:* "BBB@ HHHH **** "BBB@ HHHH **** "BD-% "T444 %%&:,T %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444P"BBBD 4444 %%%%, HHI*0"T4"B@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BC-%, HHHI %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 &HI*EJ*2F@+%C]\5
MWN@_PUP5E]\5WN@_PUSU]AGHNF?<6MD=!6-IGW%K9'05Y,MQBT445(!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% %"^^X:X#Q!T:N_OON&N \0=&KIH;B/.-2_UAK/CZUH:E_K#6?'UKUH[")J
M*** "BBB@ HHHI@%%%%( HHHH **** "BDI10 44II* "BBB@ HHHH ****
M"BBB@ HHHH **** "BDHH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** $I1110 4444 %%%% !1110 44E+0 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44O:DH 2B
MBEH **** "@T44 )2T44 %%%% !1110 4444 %%%% !1110 4444 %%)10 M
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%, HHHI %%
M%% !1110 4444 %(:6B@!*6BB@ HI*!0 &B@T4 +1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 57EZU8JO+UI
MH#6T7_7+7L/AG_5K7CVB_P"N6O8?#/\ JUKBQ>PT=@.E% Z45Y@PHHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"
M.;_5FN2UO[K5ULW^K-<EK?W6K6EN!YOK'WFKEIOOUU.L?>:N7F^]7KTMA G2
MGTQ.E.JQ :*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** %I*6D- !1FD-1L318"7(I#4(+$U(J,>U,!:7-+Y38Z5&RL
M.U(!^12YJOELU(I-,"2BD%+2 **** "BBBF 4444@"BBB@ HHHH **** "BB
MB@ HHHH *2EI* %HHH- PI,TTDTWYCVH$/HI5C8]J4QL!TH 3-&13&#"F$M3
M FR*7-5<MGI4B$]Z+ 344"BD 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1FD-,)-,"2BHU)J04@%I
M":#43DT 29%&158EJ>A:G8">DQ2BBD 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%-
M- #LTAIAW4JJQ[4P%I:7RV]*858=J 'T4T9IU( HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **,44 %125+44E- 6+(?O!7>
M:#_#7"67^L%=YH/\-<]?89Z+IGW%K9'05C:9]Q:V1T%>3/<8M%%%2 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!0OON&N \0=&KO[[[AK@/$'1JZ:&XCSC4O]8:STZUH:G_K#68N<UZT=A%C(
MHR*A):D#-3L!8HJ-2:>*0"T44M,!*,TQB:C+-0!-FEJ %JE7-*P#J*** #%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 48HHH **** "BBFF@!<
MT9J)BU-RU.P6+&:*C4FGBD M%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4E+10 E%%% "T44&@!":3--;-1$MFG8"QFEJ!2U3+0 M%%%( H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DS2FHF)I@29%&:
MKY:GJ6HL!-12+2T@"BBB@!,TM)2T %%%% !1110 4444 %%%% !1110 4444
M )BC%+10 44PDT FF ^BD%+2 **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "DR*:Q-1$M3L!/D4M0 M4BYHL ^BBBD 4444 %)FD;-0DM3 GS2U7!:I5S
M0 ^BEI*0"8I:** "C%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 57EZU8JO+UIH#6T7_ %RU[#X9_P!6
MM>/:+_KEKV'PS_JUKBQ>PT=@.E% Z45Y@PHHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@".;_5FN2UK[K5ULW^K-
M<EK7W6K6EN!YOK/WVKEYOOUU&L_>:N7F^_7KTMB03I3J:G2G5H 4444@"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)AY;8IBMFIM3&V8X]:JQ'BN];")J*3-(6I .HIF^CS!0 ^BF;Z<#F@!:***
M"BBFEJ '44W?1NH =13=U)OH ?13-]*&S0 ZBBB@ HHHH **** "BBB@ HHI
MI:@!U%,WT>8* 'T4S?3@U "T44QCBF \<U+'"7/2H8CN-;^EVGFN.*F3L!%:
MZ0TN/EK7A\-N0/D_2NOT71595)6NK72HHXQE17#4Q-G8=CRX^&6V_<K.N]!:
M('Y:];FB@12.*YS55A*MC%*%>386/*KFT,)/%4RV#BNAU<*&;%<U)]^NZ#NA
M$@.:6FKTIU4 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MFZ@!U%-W4N: %HII;%)OH ?13=U+F@!:*** "BBDS0 M%-WTF^@!]%-#4N:
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M;ZQ]YJY>;[]=1K'WVKEIOOUZ]+80J=*=3$Z4^K$%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 AII;%2!<T];5G[47 K>90'S5S^SW/8TUK-D[470$ -.I2F
MVDH *#1F@#- $9;%)YE65M6?H*?_ &<X[470%4-FGBI&MF3J*81BBX"4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !32V*<!
MFGK 7[4 5S)2A\U;&GN>U(UDR=J+H" &EI2A6DH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "D)Q1FG!=U $1?%-\RKBV3/
MVIW]FN.<470%16S3ZD:V:/J*C/%%P"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M:0C!V$48K9N--9!]VJ:V;[\8I*28%+RF:C[.WI716NELX'RU>_L0[?NTG52
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M7ZU[#X9_U:UQ8K8:.P'2B@=**\P84444 %%%% !1110 4444 %%%% !1110
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M<=M>OHL=PG:L?5])5HV(6M*=9IV8K'AMS:F)SQ20#YP*ZC7-.\IVXKFXTVS
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MKD]5T(QY.VO7(XTECSC-8VMZ<AA+ 44ZS3L!X;>VQA8\5FALOBNK\06XCD;
MKF[:W+W X[UZD)75R33TZP,Y'%=II?AXL 2E,\.:7NV$K7I%C81Q0@D#I7%7
MKV=D,P+70U11E:EFTM N,"MFZN(X%/(K"N-7C#$;A7.I2EJ,Q[O15D)PM0P>
M'/FSMK:AOXI6Y(K=LEBD QBK=244(YI=#")]VL?4],"*?EKTQ[9"AP*Y;78
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 TT
MJTAH!Q0!MZ0/WJUZMX=_U:UY+I,@$JUZOX;?*)7%B=@1U<_^H/TKS[Q%_%7H
MDJY@/TK@/$<1P]<M!^\,\OU/_6&LZ/K6EJHQ(U9<9&:]>.PBQ2$4@84]1NH
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M!JV+MY(SZ5F:V T;5M11A$XK$UEOW;5R0^(9Y=K;>7*WUK/L+TB8#/>KVO\
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M%>3/<8M%%%2 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MG83':#_KE^M>Q^&?N+7CNB#$RU[#X8^XM3B]AH[(=**.U%>8,**** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %;5X[K/^O;ZU[%XH_U;UXYK/^O;ZUV8383,^&IZ@AJ>NUB"J\O6K%02#FA
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MTKUC2O\ 4#Z5RXK<$4M=/[IOI7CWB3[[5[!KO^J;Z5Y!XD^^]7A 9Q\8_?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $<W^K-<EK?W6
MKK9O]6:Y+6_NM6M+<#S?6/O-7+S?>KJ-8^\U<O-]ZO7I;"!.E.IJ=*=5B"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** (YO]6:Y+6_NM76S?ZLUR6M_=:M:6X'F^L?>:N7F^]74:Q]YJY>;
M[U>O2V$"=*=34Z4ZK$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "'I41^]4IZ5'_
M !4P-;3?OBO1?#O5:\ZTW[XKT;PZI)6N3$;#1W2_\>_X5P_B<?*U=TB'[/\
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MN#LOOBN\T'^&N>OL,]%TS[BULCH*QM,^XM;(Z"O)GN,6BBBI **** "BBB@
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M=:7/S5S]U=-*3S5'S'/>G D]:VC!1$1NA8YJY9R>2P-1 4A..E4]0.KL==,
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@!*4444 %)BEHH ;M%&T4ZB@!NT4;!3@*6@!FT4N*6B@ HHHH *,444 )M
M%)M%.HH ;M%&T4[%%,!NT4N*6BD 4444 )C-&P4M% ";12T44 %&,T44 -VB
MC:*=10  48H%+3 ;M!I-@IU%(! H%+110 4FT&EHI@-V"E"@4M%( I"HI:*
M&;13@HHI: #%%+24 %)@&BEH ;L%&T4II10 "BEI* $*@TFP4ZB@!-HI:**
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M $VBEHHI %(1FEHH ;L%*%%+10 4444 )M%)M%.HHN VBEQ1BF ;11M%+10
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M12[12T4@#%5Y>M6*KR]:: UM%_URU[#X9_U:UX]HO^N6O8?#/^K6N+%[#1V
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M** "BBB@ HHHH *2EHH 2EHHH **** "BBB@ HI*6@ H-%%,!*,4N**0#<4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "DI:* "BBB@ I*6B@!,44M)0 M%(*6@ HHHH *
M*** "BBB@ HHHH 0T4&B@!:*0G%-W4 *3498U/'&7-:$&EM+CY:')(#)7<>U
M3I"S=JZ2V\.N_P# ?RK4A\--C[E92K10'%_9VQTJ%XV7M7H+>&FQ]S]*HS^&
MWP?D_2I5:(SA26!IRDUT-SH3QG[M9DUDT7:ME-,15%+2-\M,5\G%4 XYIN&S
MTK3M+,SXP*UXO#[N,[*B4T@.5PWI1AO2NO'AM_[A_*G#PRY_@/Y5/MH@<=AO
M2FG=Z5VG_",/_</Y4QO##_W#^5'MH@<82WI0&:NLD\-./X#^549]%>+^$U2J
M18&,I-/J6:W,1Y%09YJKW =0:3- YH :2:C);-7HK8R'I6E;Z(\O\-)S2 P5
M#'M3BK#M77Q>&7(SL/Y5(WAE\?</Y5G[:('$DL#2J372W/A]X\G8?RK*GL6B
M/2K4TP*8-+05VFFYJ@'&F,33QS4T5N9#P*+V I9:G*&/:MVVT1Y<?*:U(O#+
MD?</Y5#JQ0''D-CI3<MZ5VK>&7Q]P_E5"X\/O'GY#256+ YI2:D%79[!HC]V
MJC+M-:)I@)129I: "BBC- !36I0W-6(;<RG@4; 46+4@+>E=#!HCR]%J=_#S
MJN=A_*I]I$#FU)J2M"XT]H.HJ@PVG%-.X"4444P"BBB@!:*2B@ I*6B@ HHH
MH **** "BBB@ HHHH ,T4E** "EI** %I,T4E "T4@I: "BBB@ HHHH ****
M "BBB@ I:2B@ I:2B@ HHHH 6DHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ J*2I:BDIH"S9??%=YH/\-<'9??%=YH/\-<]?89Z+IGW%K9'05C:9]Q:
MV1T%>3/<8M%%%2 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110!0OON&N \0=&KO[[[AK@/$'1JZ:&XCSC4O]8:S
MX^M:&I?ZPUGQ]:]:.PB:BBB@ HHHH **** "BBB@ HHHH *6DHH **** "BE
M%% "4444 %%%% !1110 4444 %%%% !1110 4M)10 4444 %%%% !1110 44
M44 %)2T4 %&:*2@!:*04M !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%+0 F**6DH ,4F!2T4 )BEQ110 4444 %%% H ,44M)0 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %&:*2F M%)VH#<T@&L343,U:$%J9CP*T8M!>09"G\J3DEN!SJLU3*<UNRZ
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MF_U9KDM;^ZU:TMP/-]8^\U<O-]ZNHUC[S5R\WWJ]>EL($Z4ZFITIU6(****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MII.* '45&7Q3?-I@345#YM'FT6 FHJ'S*/,I 2TM1>93@V:8#Z*0&EH ,T4E
M+2 ****0!1113 **** "BBB@ HHHH **** "BBB@ HHHH *2EHH **** "BB
MFEL4 .HJ(R8H$F:8$M%(#FD)Q0 ZC-1&3%()*!DU%(IS2TA!1110 4444 %%
M-)IADQ3 EI*A,U EHL!.*,4Q7S3P: #%)3J2D 4444 %%%% !1113 **** "
MBBBD 4444 %&:** "BBB@ I:2B@ I*6B@!I)%,,C"I,4FT&F!'YT@[T>?)ZF
MI-@I/+%&@#//D]32B5C3M@I0HH 0,33Z3%+2 **** "BBBBP!1FBDH *6D%+
M0 M)110 444HH 2BEI* "BBB@ HQ0*6@!*2EHH **** "BBB@ HHHI@%%%%(
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MEI*,T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444TG%  U$4
M9=J<@W&MC3; RNO%)NR ETS3#*P^6NZTG0 P7*T_0M&X4E:[>TM4MT&0.E>?
M6K=$,H6VB1HHRHJQ]AA3L*DO-2C@4C(KF[SQ"JL<-7/%2D,Z#[-">,"E.EQ2
M#H*Y.'Q("_WJZ#3]:23 +42A*(%;4/#ZE20M<3J^AE-Q"UZTLB31YR"#6+J^
MGI)$2 *JG6:>H'A6H6AB)XK*BSYV/>N\\06 0MQ7%&/9<?C7JTY\R).T\.6J
MRLN17INGZ+&T )45YWX5;#)7K>GMNM5KSL3)IC14_L6$=A33I<*_PBM.:41(
M6-<]?:TL1/-<\>:0R[_9\/H*7^RX3V%<\/$:[OO5;A\0(?XJMPF!IR:)$PX4
M5B:EH"[3A:W;75TEQR*OG9<)VJ5.47J!XUJ^BE"Q"UREQ:M$YR*]TU71UDC)
MVUYMKNE^4S86N^A6YM!'$LV#BK5I$96 Q52Y0K+BMW0H0\BYKJD[*XC<TC1C
M*5.VNYTW0%502OZ4N@V<8120*Z9Y8[>+M7EU:K;LBBFNEPHHRHI?[.A;C K,
MO]>2-B-U5K7Q KR ;JCDG:XB]?:)&Z'"BN)UC1-FXA:],M+A;I/6J>IZ8LL3
M';3IU7%V8SPN]LS$QXK)=MK8KO/$5AY)?BN N?EGQ[UZE*7,B2_:Q&5ABNKT
MG1FE*G;6+H,0D=<UZMH-E&$4D"L*]3E&A-,T!0H)6ML:5#&HRHJZTD=O%VK"
MO]=2-B U<%Y38S1_LZ%N,"J-]H<;J<**HVOB!7D W5TEI<K=(.]#4H@>:ZQH
MFS<0M<5?69B8\5[IJ>FK)$QVUYCXBL/*9N*ZZ%:^@F<*>&Q3QTILR[9#0IXK
MO$.IIZ4ZFL.*0$:GYZZ/2(!(RY%<VG^LKJM".'6IJ;#/0=$TA)57*BMJZT*,
M0DA1TIGAYQL6MZY8"!J\B<Y<PSR/Q#8K"6P*X:X&)#7H_BE@2]><W7^M->E0
M=T(@IPIM.%= @HHHI %%+2$T %-+4IYIOEENE, WBCS!1]F<]C1]ED]*- #>
M*4-FD^SN.U'ED=: 'T4G2ES2 *3-+FD(S0 A84F\4>4S=*/LTA[&GH >8*-X
MH^R2>E'V9QV-&@"AJ4&F^4PZTX<4 +11FD-( +8IN\4NPFD^SN>@I@'F"CS!
M1]ED]#1]ED]#1H N\4H--\AQU%*%(H =12"EI %%%% !1110 4444 %%%% !
M1244 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5%)4M124T!9LOOBN\T'^&N#LO
MOBN\T'^&N>OL,]%TS[BULCH*QM,^XM;(Z"O)GN,6BBBI **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH H7WW#7
M>(.C5W]]]PUP'B#HU=-#<1YQJ7^L-9\?6M#4O]8:SX^M>M'81-1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2$XI:0
MJ30 FZC=2>4U'ED4P';J3>*-A-'DL>U ";Q2AJ/L[^E)Y3+UH =F@FDZ4;2>
ME !O%)O%'D.>U'V=_2C0!=U.S3/+(IP&* %HHS24@#-)N%!&:;Y3&F N\4;Z
M/L[^E'V=_2C0!=XI<TWR6%*!B@!](: :*0#2:-U!0FD\IJ8#MU)NI-AH\IC0
M ;Q2AJ3R']*41,* %S2;J78:0Q,: #=1NI/+(H\LF@ WBEW4GD/Z4HA84 +F
MEI,$49I &:3>*",TGDL: #>*-XH^SOZ&CR'':GH NZG9IGED=:<.* %I":7K
M2%": $W4;J0Q-2^610 ZBD'%+0 F:3=05)H\EC0 ;J=3?*(I0,4 +29I::5)
MI &\4!J3R6-*(F%,!U%&,44@"BBB@ HHI,T &:3>*-I-)Y+&F ;Q1O%'V=_2
MCR'':C0!=U.S3?+(ZTHXI +11FC- !2%J,YI-A/2@!-XHWT>0Y[4?9W]*>@"
M[@:44WRF%+C% "MTJ)#^\%2,?EJ%/]8*$!UNA6PE9<BO2M)T2.2,$J.E>?>&
MS\Z5ZYHK P >U>=B9-;#1DZKH<:0DA1TKS#7;812L *]IU=@+4CVKR#Q(?WS
M4L+)MZ@S%TV(/,![UZ1H>D)*BDK7GND_\? ^M>L^'& C6M,3)I: .N]"C6 G
M:.E>>Z_9+"S8%>OWSC[.?I7EOB9LNU88>3;!G S##&H<\U//]\U 1S7J(0X4
MC' I1TIDG2F Z)LMBM[3+3S6'%8%JA:45WGAVTW%<BLJKLAG1:-H@<*2M=7'
MHT4<0)45)I-L(X@<59O[D0Q&O*G-RD,SIK6!$/ KF-6BAPV,4:MKAC+#=7+7
M>MF7(W5O3IRW$9FJJJLV*YN5OF-:U[.9B:RGA8MFO0@K( 5N*=N%-$9 I?*8
MU8@WBE#9I/(?TI1$PZT .HS2=*0\T@ M2;Q1Y;'I1]G?TIZ &\4NZD^SN.QI
M?+(ZT: .HI.E.S2 2B@T9H ,TTM0>:3RR>E, WBE#"D^SOZ&CR6':C0!VZDW
M4>6:3RR: %W4H.:;Y34X*10 M(6Q2TTH32 -U*&S3?*:G!"*8"T4"EI -S2;
MJ4J33?*:F NZG"FB-A3@"* %I*,TAYI )NI-XH\LGI1]G<]J8!O%+N%)]G?T
MH\IA1H [-+31Q3LT@"D)Q2TA4F@!-U&ZD\IJ/+(I@.W4FZC8:3RF- !O%*'%
M)]G?TH\EAUHT =FEIH&*6D M%%&: $S32U*>:3RF;I3 -XHWBC[._I1]G?TH
MT 7=2@TWRF%*.* '4A.*7.:0H32 3>*-U)Y+4HC(I@.HI ,4M( I,TIINPF@
M W4NZD\IJ7RR*8"T48Q12 **** "BBB@ I:2B@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "J\O6K%5Y>M- :VB_ZY:]A\,_ZM:\>T7_7+7L/A
MG_5K7%B]AH[ =**!THKS!A1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% $<W^K-<EK?W6KK9O]6:Y+6_NM6M+<#S
M?6/O-7+S?>KJ-8^\U<O-]ZO7I;"!.E.IJ=*=5B"BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M5KIM+\/;P#MKI8-$6)1E:Y)XA(9PJ:#Q]VAM!./NUZ$;&-1T%*+"-NPK+V[
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M4=J*\P84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110!'-_JS7):W]UJZV;_5FN2UO[K5K2W \WUC[S5R\WWJZC6/
MO-7+S?>KUZ6P@3I3J:G2G58@HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*\F>XQ:***D HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRQ)",XJ>\U2*)3@BN%MM781@!JJWNHS2 X)KD]C=ZCN=1-KR;\;A5JRU996
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\-J=RUZ99#_1Q]*\W$;C1B:Y]UJX>=,S&NXUOHU<7*1YU71V W-#0!UKOK,
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M#-<=++O8UWT(60F5@OS5,!Q3<<T[M72(,4444@"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ JO+UJQ5>7K30&KHO^N6O7_#/W%KR
M#1?]<M>O^&?N+7%B]AH[(=!2T@Z"EKS!A1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% $<W^K-<EK?W6KK9O]6:Y
M+6_NM6M+<#S?6/O-7+S?>KJ-8^\U<O-]ZO7I;"!.E.IJ=*=5B"BBB@ HHHH
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MN(G+&0YKU/6]'9@QVUP6HZ>87/%>G0FK"9C"G4V3Y3BA3D5TB'4F:#TIH/-
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MTX&^/%>/4^(H\]\0V!D+<5PUQHS&0_+7LU_IXESQ6*^AJ6/RUTTJ_*A'EO\
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MU$'<,UYWJ4_F.>:[<.F#,5OOU*O2HV'S5(.E=PA:***0!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 5%)4M124T!9LOOBN\T'^&N#LOOBN\T
M'^&N>OL,]%TS[BULCH*QM,^XM;(Z"O)GN,6BBBI **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8\FN3N=3\MB,UK3BVM -G;$I[5?M+M(B,&N/75=YQNJY#=,_0U;IOJ([)]7
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MBO,QXF/]_P#6C_A)C_?_ %J/JS&>F?;(O44JWL7J*\R_X28_W_UI1XG/]_\
M6CZLQ'I<EY%CJ*P]2N8RC8(KD&\3$C[]4[C7O,!^:JCAV@(]9=69L5S\=R8I
M<@]ZL7=YYN>:RWR6S7="-E9B.YT77#'M!:NZTW6E=0"U>*VMPT1'-;UGK;18
M^:N>K03V&>RK=0RCDBG@P8SQ7F$/BC:!\_ZU9_X2SC[_ .M<SP\@N>A27<40
M."*PM3UI54@-7'S^*"X/S_K6->:TTN?FJX8=WU"Y=UC62Y8;JY*>Y,DA.:?<
MSM(3S50*<UW0@HH1I65V87!S7;:-X@,>T;J\Z&15RVNFB8<TJE-20'M]CK23
M( 6%77DAF'.*\BL]=,6/FK8B\4[1]_\ 6N&6':>@[G?&T@//%.588>F*X?\
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MX:\_U_HU=5#<#SO4?]8:STZU?U'[YJ@G6O5CL234444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !2'I2TF* (,?O!79>&9A'(F
M:Y+;\V:U+"\^SL#FIJ+F5@/=-+U"(6X!(Z55UN_C:(@$5YU;>)3&@&^H[OQ$
M9E(W?K7GK#/FN.Y6UV4.[8KDC_KJU+R[\XGFLTCY\UWPC9".R\-3"-US7J>F
MZA&L !(Z5X?87OV<CG%=%!XD,: ;ZYJU%R8ST#6[]&C;!%>7ZU*&=L5:N_$!
MF4C=7/W=UYQ/-51I.(%('][79^')U1ER:XO^+-:EC?\ D$<UM4CS*P'MMCJ$
M8@ R.E9.MWJ,C8(KB(?$A1,;JK7FO&93\U<<<.U*X!?7@68X-:&CZIMD7+5R
M%Q=&1B<TZUO#$P.:Z73NK"/<M+U)'B )'2KL_DS#M7DMAXB,0 W5L1^*^/O_
M *UQ2P\D]!W.RFLX.N!5"4Q0-QBN<D\5 K]^LJZ\1[R?FJHT9=0/0;/540XW
M"M";4HW@(W"O(TU\JV=U6O\ A)24QO\ UH>&=PN:WB&5)"V#7#. )\^]7[W5
M_/S\U8[SY?-==.#BK".Z\.7*QLN37HEOJ,8MQ\PZ5XE8ZF8".:W$\3%4QO\
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M-\"JC->+VER8V'-=QH&J[64%JY,13NAGJ<[>;"<>E<+XAM7;<0#76:?>I-$
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M[+7K[.X9K@[Y][FO4P\+(11CZU/4*#FIJZF(****0!24M&* $%+110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_7+7K_AG[BUY!HO^N6O7_#/W%KBQ>PSLAT%+2#H*6O,&%%%% !1110 4444
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M*3-&: %HI,T9H 6BDS1F@!:*3-&: %HI,T9H 6BDS1F@!:*3-&: %HI,T9H
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M6F=::%YIXK8 HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]%6/(;TH\AO2BX%>BK'D-Z4>0WI1<"O15CR&]*/(;THN!7HJQY#>E'D-Z47
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M2 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC^R(_04?60/*_P#A'V_N4?\ "/M_<KU3^R(_04?V1'Z"CZR!Y7_PC[?W*/\
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M[E>J?V1'Z"C^R(_04?60/*_^$?;^Y1_PC[?W*]4_LB/T%']D1^@H^L@>5_\
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MC^R(_04?60/*_P#A'V_N4?\ "/M_<KU3^R(_04?V1'Z"CZR!Y7_PC[?W*/\
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M[E>J?V1'Z"C^R(_04?60/*_^$?;^Y1_PC[?W*]4_LB/T%']D1^@H^L@>5_\
M"/M_<H_X1]O[E>J?V1'Z"C^R(_04?60/*_\ A'V_N4?\(^W]RO5/[(C]!1_9
M$?H*/K('E?\ PC[?W*/^$?;^Y7JG]D1^@H_LB/T%'UD#RO\ X1]O[E'_  C[
M?W*]4_LB/T%']D1^@H^L@>5_\(^W]RC_ (1]O[E>J?V1'Z"C^R(_04?60/*_
M^$?;^Y1_PC[?W*]4_LB/T%']D1^@H^L@>5_\(^W]RC_A'V_N5ZI_9$?H*/[(
MC]!1]9 \K_X1]O[E'_"/M_<KU3^R(_04?V1'Z"CZR!Y7_P (^W]RC_A'V_N5
MZI_9$?H*/[(C]!1]9 \K_P"$?;^Y1_PC[?W*]4_LB/T%']D1^@H^L@>5_P#"
M/M_<H_X1]O[GZ5ZI_9$?H*3^R(_04?60/+/^$?;^Y1_PC[?W*]3_ +'C]!1_
M8\?H*/K+ \L_X1]O[E'_  C[?W*]3_L>/T%+_9$?H*/K('EO_"/M_=JC>Z(T
M:D[:]@_LB/T%8VMZ4B1$A>U5'$78'D*VIBEZ5UVA#E:R[ZW$<YX[UKZ(/F%;
MU)7B%CO]-^X*V1T%8^G?<%; Z5YL]P%HHHJ0"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,Z_^X:X#7QPU>@7P
M^0UP6OC[U=-!ZBL>=7\1>0U#!IK2=JUV@\R?&.]=-I&CB51\M>@ZO*@L<;_8
M[X^[2?V0_P#=->I_\(^NW[M1G0%S]VLOK(6/,/[(?^Z?RH_LA_[M>G?V /[M
M']@#^[1]9"QYC_9#_P!TTG]D/_=KT_\ L ?W:/[ 7^[1]9"QYA_9#_W:7^R'
M_NFO3O[ 7^[1_8 _NT?60L>8_P!D/_=/Y4?V0_\ =/Y5Z=_8 _NT?V /[M'U
ME!8\Q_LA_P"Z?RH_LA_[I_*O3O[ ']VC^P!_=H^LH+'F/]D/_=/Y4?V0_P#=
M/Y5Z=_8 _NT?V /[M'UE!8\Q_LA_[I_*C^R'_NG\J]._L ?W:/[ ']VCZR@L
M>8_V0_\ =/Y4?V0_]T_E7IW]@#^[1_8 _NT?64%CS'^R'_NG\J/[(?\ NG\J
M]._L ?W:/[ ']VCZR@L>8_V0_P#=/Y4?V0_]T_E7IW]@#^[1_8 _NT?64%CS
M'^R'_NG\J/[(?^Z?RKT[^P!_=H_L ?W:/K*"QYC_ &0_]T_E1_9#_P!T_E7I
MW]@#^[1_8 _NT?64%CS'^R'_ +I_*C^R'_NG\J]._L ?W:/[ ']VCZR@L>8_
MV0_]T_E1_9#_ -T_E7IW]@#^[1_8 _NT?64%CS'^R'_NG\J/[(?^Z?RKT[^P
M!_=H_L ?W:/K*"QYC_9#_P!T_E1_9#_W3^5>G?V /[M']@#^[1]906/,?[(?
M^Z?RH_LA_P"Z?RKT[^P!_=H_L ?W:/K*"QYC_9#_ -T_E1_9#_W3^5>G?V /
M[M']@#^[1]906/,?[(?^Z?RH_LA_[I_*O3O[ ']VC^P!_=H^LH+'F/\ 9#_W
M3^5']D/_ '3^5>G?V /[M']@#^[1]906/,?[(?\ NG\J/[(?^Z?RKT[^P!_=
MH_L ?W:/K*"QYC_9#_W3^5']D/\ W3^5>G?V /[M']@#^[1]906/,?[(?^Z?
MRH_LA_[I_*O3O[ ']VC^P!_=H^LH+'F/]D/_ '3^5']D/_=/Y5Z=_8 _NT?V
M /[M'UE!8\Q_LA_[I_*C^R'_ +I_*O3O[ ']VC^P!_=H^LH+'F/]D/\ W3^5
M']D/_=/Y5Z=_8 _NT?V /[M'UE!8\Q_LA_[I_*C^R'_NG\J]._L ?W:/[ ']
MVCZR@L>8_P!D/_=/Y4?V0_\ =/Y5Z=_8 _NT?V /[M'UE!8\Q_LA_P"Z?RH_
MLA_[I_*O3O[ ']VC^P!_=H^LH+'F/]D/_=/Y4?V0_P#=/Y5Z=_8 _NT?V /[
MM'UE!8\Q_LA_[I_*C^R'_NG\J]._L ?W:/[ ']VCZR@L>8_V0_\ =/Y4?V0_
M]T_E7IW]@#^[1_8 _NT?64%CS'^R'_NG\J/[(?\ NG\J]._L ?W:/[ ']VCZ
MR@L>8_V0_P#=/Y4?V0_]T_E7IW]@#^[1_8 _NT?64%CS'^R'_NG\J/[(?^Z?
MRKT[^P!_=H_L ?W:/K*"QYC_ &0_]T_E1_9#_P!T_E7IW]@#^[1_8 _NT?64
M%CS'^R'_ +I_*C^R'_NG\J]._L ?W:/[ ']VCZR@L>8_V0_]T_E1_9#_ -T_
ME7IW]@#^[1_8 _NT?64%CS'^R'_NG\J/[(?^Z?RKT[^P!_=H_L ?W:/K*"QY
MC_9#_P!T_E1_9#_W3^5>G?V /[M']@#^[1]906/,?[(?^Z?RH_LA_P"Z?RKT
M[^P!_=H_L ?W:/K*"QYC_9#_ -T_E1_9#_W3^5>G?V /[M']@#^[1]906/,?
M[(?^Z?RH_LA_[I_*O3O[ ']VC^P!_=H^LH+'F/\ 9#_W3^5']D/_ '3^5>G?
MV /[M']@#^[1]906/,?[(?\ NG\J/[(?^Z?RKT[^P!_=H_L ?W:/K*"QYC_9
M#_W3^5']D/\ W3^5>G?V /[M']@#^[1]906/,?[(?^Z?RH_LA_[I_*O3O[ '
M]VC^P!_=H^LH+'F/]D/_ '3^5']D/_=/Y5Z=_8 _NT?V /[M'UE!8\Q_LA_[
MI_*C^R'_ +I_*O3O[ ']VC^P!_=H^LH+'F/]D/\ W3^5']D/_=/Y5Z=_8 _N
MT?V /[M'UE!8\Q_LA_[I_*C^R'_NG\J]._L ?W:/[ ']VCZR@L>8_P!D/_=/
MY4?V0_\ =/Y5Z=_8 _NT?V /[M'UE!8\Q_LA_P"Z?RH_LA_[I_*O3O[ ']VC
M^P!_=H^LH+'F/]D/_=/Y4?V0_P#=/Y5Z=_8 _NT?V /[M'UE!8\Q_LA_[I_*
MC^R'_NG\J]._L ?W:/[ ']VCZR@L>8_V0_\ =/Y4?V0_]T_E7IW]@#^[1_8
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M]906/,?[(?\ NG\J/[(?^Z?RKT[^P!_=H_L ?W:/K*"QYC_9#_W3^5']D/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 1S?ZLUR
M6M_=:NMF_P!6:Y+6_NM6M+<#S?6/O-7+S?>KJ-8^\U<M.?FKUZ6PA4Z4ZHU8
M8IV\5H(=13=U&Z@!U%-W4;J '44W=1NI .HINZC=0 ZBF[J-U #J*;NHW4 .
MHINZC=0 ZBF[J-U #J*;NHW4 .HINZC=0 ZBF[J-U #J*;NHW4 .HINZC=0
MZBF[J-U #J*;NHW4 .HINZC=0 ZBF[J-U #J*;NHW4 .HINZC=0 ZBF[J-U
M#J*;NHW4 .HINZC=0 ZBF[J-U #J*;NHW4 .HINZC=0 ZBF[J-U #J*;NHW4
M .I*3=1N% #J*9N% :@!]%-W4;J %H%)N%&X4 .HIN\4;J '44W=1NH =13=
MU!:@!U)3=U+N% #A13=PHWB@!U%-W4;J '44W=1NH =13=U&Z@!U%-W4;Q0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MLJ^E6:*+L"M]E7TI?LJ^E6**+L"M]E7TH^RKZ59HHNP*WV5?2C[*OI5FBB[
MK?95]*/LJ^E6:*+L"M]E7TH^RKZ59HHNP*WV5?2C[*OI5FBB[ K?95]*/LJ^
ME6:*+L"M]E7TH^RKZ59HHNP*WV5?2C[*OI5FBB[ K?95]*/LJ^E6:*+L"M]E
M7TH^RKZ59HHNP*WV5?2C[*OI5FBB[ K?95]*/LJ^E6:*+L"M]E7TH^RKZ59H
MHNP*WV5?2C[*OI5FBB[ K?95]*/LJ^E6:*+L"M]E7TH^RKZ59HHNP*WV5?2C
M[*OI5FBB[ K?9E]*/LJ^E6:*+L"M]E7TH^RKZ59HHNP*WV5?2C[*OI5FBB[
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MUTU_A [$=**!THKSP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]VCVB YCRFH\IJZ?^QS_ ':/['/]VCVJ YCRFH\IJZ?^QS_=H_L<_P!VCVJ
MYCRFH\IJZ?\ L<_W:/['/]VCVJ YCRFH\IJZ?^QS_=H_L<_W:/:H#F/*:CRF
MKI_['/\ =H_L=O[M'M4!S'E-1Y35T_\ 8[?W:7^QS_=H]H@.7\IO2CRFKI_[
M';^[1_8Y_NT>T0SF/*:CRFKI_P"QS_=H_L<_W:/:H1S'E-1Y35T_]CG^[1_8
MY_NT>U0',>4U'E-73_V.?[M']CG^[1[5 <QY34>4U=/_ &.?[M']CG^[1[5
M<QY34>4U=/\ V.?[M']CG^[1[5 <QY34>4U=/_8Y_NT?V.?[M'M4!S'E-1Y3
M5T_]CG^[1_8Y_NT>U0',>4U'E-73_P!CG^[1_8Y_NT>U0',>4U'E-73_ -CG
M^[1_8Y_NT>U0',>4U'E-73_V.?[M']CG^[1[5 <QY34>4U=/_8Y_NT?V.?[M
M'M4!S'E-1Y35T_\ 8Y_NT?V.?[M'M4!S'E-1Y35T_P#8Y_NT?V.?[M'M4!S'
ME-1Y35T_]CG^[1_8Y_NT>U0',>4U'E-73_V.?[M']CG^[1[5 <QY34>4U=/_
M &.?[M']CG^[1[5 <QY34>4U=/\ V.?[M']CG^[1[5 <QY34>4U=/_8Y_NT?
MV.?[M'M4!S'E-1Y35T_]CG^[1_8Y_NT>U0',>4U'E-73_P!CG^[1_8Y_NT>U
M0',>4U'E-73_ -CG^[1_8Y_NT>U0',>4U'E-73_V.?[M+_8[?W:/:H#E_*:C
MRFKJ/[';^[2?V.?[M'M4!S'E-1Y35U']CM_=H.CM_=H]J@.7\IJ<$(KHGTD@
M?=JG-9%.U-33 R\45+(FTT50RWIWWQ7H.@_PUY]IWWQ7H6@_PUR5]BCO+'[@
MK1[5G6/W!6CVKS9;B"BBBI *#110 E+110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%!I* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBD- "T4E+0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1124 +10** "BBB@ HHHH *
M*** "BBDH 6BD%+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 07!^0UPGB/HU=W<?<-<)XCZ-6U'<#BHO\ CZ_&
MO1O#/W5KSF+_ (^OQKT;PS]U:ZJ_P@=B.E% Z45YX!1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $<W^K-<IK X
M:NKF_P!6:Y75^C5K2W X'44S(:-/LA)(.*FO1F4UI:+$&D7BNYRM$#9LM&!C
M!VU:;11_=KHM/MU%N#BK?D)Z5Q.J[@<A_8B_W:/[$7^[77>0GI1Y">E+VK Y
M'^Q!_=H_L0?W:Z[R$]*/(3TH]JP.1_L0?W:/[$7^[77>0GI1Y">E'M6!R/\
M8B_W:/[$7^[77>0GI1Y">E'M6!R/]B+_ ':/[$7^[77>0GI1Y">E'M6!R/\
M8B_W:/[$7^[77>0GI1Y">E'M6!R/]B+_ ':/[$7^[77>0GI1Y">E'M6!R/\
M8B_W:/[$7^[77>0GI1Y">E'M6!R/]B+_ ':/[$7^[77>0GI1Y">E'M6!R/\
M8B_W:/[$7^[77>0GI1Y">E'M6!R/]B+_ ':/[$7^[77>0GI1Y">E'M6!R/\
M8B_W:/[$7^[77>0GI1Y">E'M6!R/]B+_ ':/[$7^[77>0GI1Y">E'M6!R/\
M8B_W:/[$7^[77>0GI1Y">E'M6!R/]B+_ ':/[$7^[77>0GI1Y">E'M6!R/\
M8B_W:/[$7^[77>0GI1Y">E'M6!R/]B+_ ':/[$7^[77>0GI1Y">E'M6!R/\
M8B_W:/[$7^[77>0GI1Y">E'M6!R/]B+_ ':/[$7^[77>0GI1Y">E'M6!R/\
M8B_W:/[$7^[77>0GI1Y">E'M6!R/]B+_ ':/[$7^[77>0GI1Y">E'M6!R/\
M8B_W:/[$7^[77>0GI1Y">E'M6!R/]B+_ ':/[$7^[77>0GI1Y">E'M6!R/\
M8B_W:/[$7^[77>0GI1Y">E'M6!R/]B+_ ':/[$7^[77>0GI1Y">E'M6!R/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M"DI:* $I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH @N/N&N$\1
M]&KN[C[AKA/$?1JVH[@<5%_Q]?C7HWAG[JUYS%_Q]?C7HWAG[JUU5_A [$=*
M*!THKSP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** (YO\ 5FN5U?HU=5-_JS7*ZOT:M:6X'$7O^M/UK4T0_O%K
M*O?]:?K6GHO^L6NR7P@>DV!S;BK54]._U JY7GO< HHHI %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110!3O6^0UP>O'(:NYO?N&N$UWHU=%'<#SS4O\ 6&BC4OOF
MBO4CL,;IWWQ7H6@_PUY[IWWQ7H6@_P -85]@.\L?N"M'M6=8_<%:/:O,EN(*
M***D HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "C-!I* %S124M !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 9HI*6@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD
MH 6BDI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "L/7_P#4GZ5N5AZ__J3]*N'Q
M >8:C_Q\'ZUIZ)]X5F:C_P ?!^M:>B?>%=\OA&>@:=]P5L#I6/IWW!6P.E>?
M/<04445(!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+6=IUX);=>:T <B@0M%%% !1110 4444 %%)10 M%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44F0>]+0 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %8>O_ZD_2MRL/7_ /4GZ5</B \PU'_CX/UK
M3T3[PK,U'_CX/UK3T3[PKOE\(ST#3ON"M@=*Q].^X*V!TKSY[B"BBBI ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH HWOW#7!Z_P#Q5WE[]PUP>O\ \5=%'<#E;?\ X^1]:]*\-?<6O-;?_CY'
MUKTKPU]Q:WK_  @=51117  4444 %%%% !1110 4444 %%%% !1110 4444
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M04 6**K_ &VW_P">@H^VV_\ ST% %BBJ_P!MM_\ GH*/MMO_ ,]!0!8HJO\
M;;?_ )Z"G"YA;HXH FHIHD4]#3J "BBB@ HHHH **** "BBB@ HHHH ****
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M%-T(JZL@;I7EOA_6'E"Y8UZ%83^8@YH$:5%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 07'W#7">(^C5W=Q]PUPGB/HU;4=P.*B_P"/K\:]&\,_
M=6O.8O\ CZ_&O1O#/W5KJK_"!V(Z44#I17G@%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 1S?ZLURNK]&KJIO]
M6:Y75^C5K2W X>]_UI^M:>B_ZQ:S+W_6GZUIZ+_K%KLE\('H^G?Z@5<JGIW^
MH%7*\][@%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *%[]PUPFN]&KN[W[
MAKA-=Z-711W \\U+[YHHU+[YHKU([#&Z=]\5Z%H/\->>Z=]\5Z%H/\-85]@.
M\L?N"M'M6=8_<%:/:O,EN(****D HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***K7%T
ML2GF@"S1FN8O?$"PY^>L6;QBJ-CS/UH ]!HKS^W\8+(P&_\ 6MZRUU)\?-0!
MT5%0P3K*HP:FH **AN)?*3-85WKJP$C=0!T=%<6WBE ?OTG_  E*_P!^@#M:
M*X@^*E_OU:M?$2S,!OH ZVBJ=G<^> <U<H **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHK/O+]8,_-0!H45SZZVI?&ZM.VO5E YH
MNT4 Y%% !15*\O5@'6LL:VN_&Z@#H:*H6M\LN.:O @C(H 6BBJEY=K O6@"W
M17/G6U#XW5?M=067'S4 :-%(K!AD4M !15>ZN%@3)-8[ZTH?&Z@#H**S+745
MEQ\U:2L&&10 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6O2O#7W%KS6W_P"/D?6O2O#7W%K>O\('54445P %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *%[]PUPFN]&
MKN[W[AKA-=Z-711W \\U+[YHHU+[YHKU([#&Z=]\5Z%H/\->>Z=]\5Z%H/\
M#6%?8#O+'[@K1[5G6/W!6CVKS);B"BBBI **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***1C@
M4 5[FX$49.:X;7_$(@##=70ZW<&.%L'M7BGBO4)#*X!- #]3\2M(Y >L";4Y
MY&R":SK6.6ZG[GFNLLO#KRQ!MAYH&8MOJLT; EC74:/XD*NH+UE:EH#V\9;:
M17*O<O:7&,D8- CZ*T+6Q.JC=78QN)$#"O!/"&M,SH"U>V:3="6U!)[4 1ZY
M/Y-L3GM7COB/7FAE8!^]>G^*[D+;-@]J^>_%-V6N7 />@"V/$<C/]^IQKDI_
MB-<KIMM)</P":Z>'1)60'::!@VN2Y^\:W=#UB22506-8C:#*3]TUN:)HLL<J
MDJ: /7?#DQEC7/I71USGAR Q1J"*Z.@04444 %%%% "&BEHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "L/7_P#4GZ5N5AZ__J3]*N'Q >8:C_Q\'ZUIZ)]X5F:C
M_P ?!^M:>B?>%=\OA&>@:=]P5L#I6/IWW!6P.E>?/<04445(!1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %&]^
MX:X/7_XJ[R]^X:X/7_XJZ*.X'*V__'R/K7I7AK[BUYK;_P#'R/K7I7AK[BUO
M7^$#JJ***X "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ J.8XB-25%/_ *LT >8^-3^[>O%;K_C^/UKVGQJ?
MW;UXK='_ $X_6@:/3_ W6.O:;3_CV3Z5XMX&/*5[1:?\>R4".?\ $BYC>O$_
M$ZXD:O===B+QMQ7B_BRV*LYQ0!RND-B['UKW'P<-T*5X)82B*]&?6O;?!E^H
MA3F@9W&K+BT/TKPSQH?WCU[)K.HI]D/S#I7B'BZZ665\&@1R^CC-^/K7MV@1
M9L!QVKQO0(=]\I]Z]UT"#&GCCM0!YUXWCP6KA-).+X?6O2?','W^*\TLSY5\
M,^M SW?P9S$E=MJ*?Z&?I7F_@W4%5$!-=W?Z@ALC\PZ4"/(/&;8E>N&LSNN?
MQKJ?&=X&F< ]ZY?2%\VZ'UH&>D^'8-RKQ75S:7YMO]WM69X7L_D3BO0[>Q4P
M#(H$>.ZMX5\YR=GZ5C+X-PW^K_2O>)-'BD/(%1?V##Z"@#Q$>#S_ ,\_TIW_
M  AY_P">?Z5[:-"A]!2_V'#Z"@#PY_"&!_J_TK'U'PUY2$[*^AI="B*'"BN/
M\1:.D<+_ "]J /G>]T\0S'BM[PVH$RCWIWB&W$=PV!WIOA_BX7ZT#/;O# _=
MI7?VO^KK@O"_^J2N^MO]70(FHHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.EPJ[CUKVSP9J1N F30!Z:.E%(G*+]*6@04444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% $%Q]PUPGB/HU=W<?<-<)XCZ-6U'<#BHO^/K\:]&\,_=6O.8O
M^/K\:]&\,_=6NJO\('8CI10.E%>> 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!'-_JS7*ZOT:NJF_U9KE=7Z-
M6M+<#A[W_6GZUIZ+_K%K,O?]:?K6GHO^L6NR7P@>CZ=_J!5RJ>G?Z@5<KSWN
M 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\(ST#3ON"M@=*Q].^X*V!TKSY[B"BBBI **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 07'W#7">(^C5W=Q]PUPGB/HU;4=P.*B_P"/
MK\:]&\,_=6O.8O\ CZ_&O1O#/W5KJK_"!V(Z44#I17G@%%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***0G% "T5"\P7O5<WJ
M ]: +U%5X[N-Q]X4DUW&B_>H L9'K2UBOJJ!L;JLVVHQR?Q"@#1HIJR*XX-.
MH ***BDG2,<D4 2YI,CUK'N=41"?FJHNLKN^]0!TE%9EKJ,<F/FK15U<9!%
M#J*** "BBB@ HHI* %HI,TM !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5AZ__J3]*W*P
M]?\ ]2?I5P^(#S#4?^/@_6M/1/O"LS4?^/@_6M/1/O"N^7PC/0-.^X*V!TK'
MT[[@K8'2O/GN(****D HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@""X^X:X3Q'T:N[N/N&N$\1]&K:CN!Q47_ !]?C7HW
MAG[JUYS%_P ?7XUZ-X9^ZM=5?X0.Q'2B@=**\\ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@".;_5FN5U?HU=5
M-_JS7*ZOT:M:6X'#WO\ K3]:T]%_UBUF7O\ K3]:T]%_UBUV2^$#T?3O]0*N
M53T[_4"KE>>]P"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4E+2$X&: %IDCB-"2:@FO$A!R17,ZSXC2%&&\
M?G0 [7-<6W#?/7(?\)4&GQO[UQWBKQ3N9P'_ %KC[#69)KL?,>M 'TCH>I_:
M0O.:ZM#E :\M\%W#2*F37J,7^J7Z4 /K/O[Y;9"<XJU-,(U)-<#XJUCRXW :
M@!-7\6K 2-_ZURLWC?YS^\_6N"US6)9IF"L>M9,45U-\PW4#/7++QL"X!D_6
MNTTCQ(MR%&^OFXO<VL@)R*[+PQKCK*H9C0(^B[>431!@:E)P,USOAW4A/;C)
MSQ6Y/*%@8^U %2\U%8%.37':MXJ6$M\_ZU5\4:SY&\!J\HU;6)9Y&"L: .UN
M?'&UR/,_6K>G^-1(PS)^M>.3"YD;(W5/:2W$# G- 'TAI7B)9POSUT]O="8
M@U\^:#KSQNJEJ];\.ZG]H5>: .QHI <@&EH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBDH 6BBB@ HHHH
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M(FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBDH 6BDI: "BBB@ HHHH *
M*** "BDI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"
M"X^X:X3Q'T:N[N/N&N$\1]&K:CN!Q47_ !]?C7HWAG[JUYS%_P ?7XUZ-X9^
MZM=5?X0.Q'2B@=**\\ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@".;_5FN5U?HU=5-_JS7*ZOT:M:6X'#WO\
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M3_'0!8HJ$7,1Z-4@D5NAH =1110 44E% "T444 %%%% !1110 4444 %%%%
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ME! %<;;^+-Y +5U6BZTDS+\U CT32(?*0 5M5CZ3<+(BX-;% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% %"]^X:X37>C5W=[]PUPFN]&KHH[
M@>>:E]\T4:E]\T5ZD=AC=.^^*]"T'^&O/=.^^*]"T'^&L*^P'>6/W!6CVK.L
M?N"M'M7F2W$%%%%2 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %)2T4 )12T4 %13OL3-2U7NU+1'% '&>)=
M29(G ->%^*[Z621\$U[;KU@\X8 &O.=5\*R3NWR'\J!GC+/*9\D'K71:7>-$
M!73/X'DW9\L_E4B^#ID'"'\J (H?$+Q(,-4T/BF4R ;C3'\*W 'W#^5-M_"M
MP) =A_*@#NM"UV28*"QKL5#74'U%<5H.AS0E<J:],TFQQ$ PH$>:>)-'E*L0
M#7F-]'/9W!/(P:^F]5T=)HC\O:O+O$/A0N[%4_2@#B])\3RVH +$8K2NO&4D
MB;=YK+N/"]Q&YVH?RJNGANY9^5/Y4#(Y[J34).YS70^'M!:256*U9T;PK)N4
MLA_*O3="T!854E*!&EX9T[[/&O&*ZRJUK;B%!@59H **** "BBB@ K@/&A/E
MR5W]>?\ C3_5R?2@#P+Q#_Q\M]:D\.?Z]?K4?B'_ (^6^M2>'/\ 7K]:!GO/
M@[[B5Z .E<!X/^Y'7?\ :@04444 )2T44 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4E+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 5AZ__ *D_2MRL/7_]2?I5P^(#S#4?^/@_6M/1/O"LS4?^
M/@_6M/1/O"N^7PC/0-.^X*V!TK'T[[@K8'2O/GN(****D HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"C>_<-<
M'K_\5=Y>_<-<'K_\5=%'<#E;?_CY'UKTKPU]Q:\UM_\ CY'UKTKPU]Q:WK_"
M!U5%%%< !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !24M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!'-_JS7$^)?\ 4O\ 2NVF_P!6:XGQ+_J7
M^E 'AOB7_CX;ZU7\/_\ 'ROUJQXE_P"/AOK5?P__ ,?*_6@9[AX7_P!4E=];
M?ZNN!\+_ .J2N^MO]70(FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DI:*
M $I:** "BBB@ HHHH **** $I:** "BBB@ HHHH *,T4E "T4"B@ S124M !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 07'W#7">(^C5W=Q]PUPGB/HU;4=P.*B_X^OQKT
M;PS]U:\YB_X^OQKT;PS]U:ZJ_P ('8CI10.E%>> 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!'-_JS7*ZOT:N
MJF_U9KE=7Z-6M+<#A[W_ %I^M:>B_P"L6LR]_P!:?K6GHO\ K%KLE\('H^G?
MZ@5<JGIW^H%7*\][@%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ J&Y7?"14U!&: .$U;0S<2$[<U0@\-B,9*
M5Z,88VZK4,]M'Y+$+CB@#QGQ39)#"PQ7F2C;?<>M>N>-UVJXKR,?\?\ ^- S
MV7P(>(Z]77[@^E>3^!.D=>L+]P?2@1P7B]L*]>+:LV;D_6O9_&/W7KQ;5/\
MCY/UH&;?AA09E^M>T:*,6H^E>->%_P#6K7LVC_\ 'J/I0(Q/%(S$WTKQW51B
MX/UKV+Q3_J6^E>.ZM_Q\'ZT#-'09")%KN6E)LOPK@M#_ -8M=R?^//\ "@1Y
MOXE.;D_6M+P<H-PGUK+\1_\ 'P?K6MX-_P!>GUH&>\Z(@^R+]*P/&"#R'^E=
M%HG_ !Z+]*Y_QA_J'^E CP'6U_TYOK75^#_E937+:U_Q_-]:ZKPET6@9Z8-3
M-O;#GH*YZ_\ %YA8C?4VHA_LIQZ5YGK:S^8V,T".OD\=$'_6?K3!X[/_ #T_
M6O+)EN<]ZA"W/O0,]:_X3H_\]/UH_P"$[/\ ST_6O*-MS[TOEW)_O4 >J_\
M"=G_ )Z?K4T7CK<?]9^M>.SFYC'>JBZA.C\DT ?0ECXN$S ;_P!:[/2M4^T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %"]^X:X37>C5W=
M[]PUPFN]&KHH[@>>:E]\T4:E]\T5ZD=AC=.^^*]"T'^&O/=.^^*]"T'^&L*^
MP'>6/W!6CVK.L?N"M'M7F2W$%%%%2 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4C*&&#2T4
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M;U]10 ZBF[U]11O7U% #J*;O7U%&]?44 .HIN]?44;U]10 ZBF[U]11O7U%
M#J*;O7U%&]?44 .HIN]?44;U]10 ZBF[U]11O7U% #J*;O7U%&]?44 .HIN]
M?44;U]10 ZBF[U]11O7U% #J*;O7U%&]?44 .HIN]?44;U]10 ZBF[U]11O7
MU% #J*;O7U%&]?44 .HIN]?44;U]10 ZBF[U]11O7U% #J*;O7U%&]?44 .H
MIN]?44;U]10 ZBF[U]11O7U% #J*;O7U%&]?44 .HIN]?44;U]10 ZBF[U]1
M1O7U% #J*;O7U%&]?44 .HIN]?44;U]10 ZBF[U]11O7U% #J*;O7U%&]?44
M .HIN]?44;U]10 ZBF[U]11O7U% #J*;O7U%&]?44 .HIN]?44;U]10 ZBF[
MU]12[U]: %HI,@T&@!:*2EH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *P]?_P!2?I6Y
M6'K_ /J3]*N'Q >8:C_Q\'ZUIZ)]X5F:C_Q\'ZUIZ)]X5WR^$9Z!IWW!6P.E
M8^G?<%; Z5Y\]Q!1114@%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 4;W[AK@]?_BKO+W[AK@]?_BKHH[@<K;_
M /'R/K7I7AK[BUYK;_\ 'R/K7I7AK[BUO7^$#JJ***X "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $I
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!!<?<-<)XCZ-
M7=W'W#7">(^C5M1W XJ+_CZ_&O1O#/W5KSF+_CZ_&O1O#/W5KJK_  @=B.E%
M Z45YX!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% $<W^K-<KJ_1JZJ;_5FN5U?HU:TMP.'O?\ 6GZUIZ+_ *Q:
MS+W_ %I^M:>B_P"L6NR7P@>CZ=_J!5RJ>G?Z@5<KSWN 4444@"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J
M&Y;$+?2IJKW?^J;Z4 >3>.#E7KR-?^/_ /&O6O'!PKUY&K#[?^- T>S>!.D=
M>L+]P?2O)O A^6.O64^XOTH$<'XO7*O7BVKKBX/UKW3Q1 9$?BO%]?MC',QQ
M0!;\,/\ OE^M>UZ(NZU'TKP;P_=K#<J">]>UZ!JD7V1?F'2@"AXL^6%OI7C>
MJ/FY;ZUZIXPU.,Q, PKR*YD$UV<>M S>T"+<Z\5WCPD673M7->&+$N5.*[V>
MS*V)X[4"/%_$PVW!^M:/@U_](7ZU7\6P%;AN.]0^%KD0W*Y/>@9]$Z(W^B+]
M*Y[Q@_[A_I4VCZS$MJH+#I6#XKU6.2%P&% CQS6G_P!.;ZUU_@X;RHKBM2;S
M;TX]:]!\#6Q+IQ0,] ;3O.MAQVKF-0\,B5R=GZ5Z=:V8-LN1VH?3$;M0(\:D
M\( G_5_I3!X/'_//]*]C.CH?X11_8R?W10!X]_PAX_YY_I4B^#QC_5_I7KO]
MCI_=%.&D)C[HH \(UCPJ(8R=GZ5Y[J.GB"4C%?2WBC2D2U)"]J\#\2PB.X8>
M] RKH$8\]?K7MWA)<*E>)Z ?](7ZU[=X3^XE CTJ#_4K]*DJ.'_4K]*DH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M I*6B@ %%%% !1110 E I:* "H+K_5U/44XRE 'GOBF,M$]>):S:,;P\=Z^@
MM<LS+&PQ7FFHZ SW).WO0.Y!X&MRDZ<=Z]\LN+.+Z5Y9X7T@P2J=M>K6PVVZ
M#VH$9GB-=VG$?6OGOQ3:LUV_'>OHO6(_-LRM>2Z[HAEG8[: .)\/6K+,O'>O
M6-*A80#CM7,:/HACE'RUZ-I>GXB (H Y+71*L38S7F6H7ES%<'D]:]\U+1!/
M$?EKSO6O"GSL0GZ4 <YH^LR)C<QKHGUD/#C=VKFGTB2V8X4TT13 XP: *>O
MW1;'.:Q]+T9WN@=IZUU\&E/<,,J:ZK1O#(#*Q3]* -#PAI9BC3*UZ1;1[(P*
MS-)TT6\8XK9 P,4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M%"]^X:X37>C5W=[]PUPFN]&KHH[@>>:E]\T4:E]\T5ZD=AC=.^^*]"T'^&O/
M=.^^*]"T'^&L*^P'>6/W!6CVK.L?N"M'M7F2W$%%%%2 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !7 >-/]7)7?UP'C3_5R4 > >(?^/EOK4OAS_7K]:B\0_\ 'RWUJ7PY_KU^
MM SWKP=]R.N_[5P'@[[D==_VH$%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )BHI9-@J8]*R]1
MF,<9- $-UJ2Q9RU9DFOHIQO'YUR/B'6F@W?-7G]YXL=)2-Y_.@#VT:_&?XQ^
M=+_;Z?WZ\-C\6N1]\U)_PEC_ -^@#V[^WX_[XH_M^/\ OC\Z\1_X2Q_[YH_X
M2Q_[YH ]N_M]/[]']OI_?KQ'_A+'_OT?\)8_]^@#V[^WT_OT?V^G]^O$?^$L
M?^_1_P )8_\ ?H ]N_M]/[]']OI_?KQ'_A+'_OT?\)8_]^@#V[^WT_OT?V^G
M]^O$?^$L?^_1_P )8_\ ?H ]N_M]/[]']OI_?KQ'_A+'_OT?\)8_]^@#V[^W
MT_OT?V^G]^O$?^$L?^_1_P )8_\ ?H ]N_M]/[]']OI_?KQ'_A+'_OT?\)8_
M]^@#V[^WT_OT?V^G]^O$?^$L?^_1_P )8_\ ?H ]N_M]/[]']OI_?KQ'_A+'
M_OT?\)8_]^@#V[^WT_OT?V^G]^O$?^$L?^_1_P )8_\ ?H ]N_M]/[]']OI_
M?KQ'_A+'_OT?\)8_]^@#V[^WT_OT?V^G]^O$?^$L?^_1_P )8_\ ?H ]N_M]
M/[]']OI_?KQ'_A+'_OT?\)8_]^@#V[^WT_OT?V^G]^O$?^$L?^_1_P )8_\
M?H ]N_M]/[]']OI_?KQ'_A+'_OT?\)8_]^@#V[^WT_OT?V^G]^O$?^$L?^_1
M_P )8_\ ?H ]N_M]/[]']OI_?KQ'_A+'_OT?\)8_]^@#V[^WT_OT?V^G]^O$
M?^$L?^_1_P )8_\ ?H ]N_M]/[]']OI_?KQ'_A+'_OT?\)8_]^@#V[^WT_OT
M?V^G]^O$?^$L?^_1_P )8_\ ?H ]N_M]/[]']OI_?KQ'_A+'_OT?\)8_]^@#
MV[^WT_OT?V^G]^O$?^$L?^_1_P )8_\ ?H ]N_M]/[]']OI_?KQ'_A+'_OT?
M\)8_]^@#V[^WT_OT?V^G]^O$?^$L?^_1_P )8_\ ?H ]N_M]/[]']OI_?KQ'
M_A+'_OT?\)8_]^@#V[^WX_[XH_M^/^^*\1_X2Q_[YH_X2Q_[YH ]N_M^/^_1
M_;Z?WQ^=>(_\)8_]^D_X2Q_[YH"Q[?\ V_'_ 'Q^=']OQ_WQ^=>(#Q8_]XTO
M_"6/_?- 6/:V\01C^,?G4T&NI(P&\?G7@TOBYQ_&?SK1T?Q4\LRC<>M 'T':
M70F P:OUQ?AB_-Q&A)KM!TH ,4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8>O\
M^I/TK<K#U_\ U)^E7#X@/,-1_P"/@_6M/1/O"LS4?^/@_6M/1/O"N^7PC/0-
M.^X*V!TK'T[[@K8'2O/GN(****D HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@"C>_<-<'K_P#%7>7OW#7!Z_\
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M757^$#L1THH'2BO/ **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MOTJ2@04444 %%%% !1110 4444 %%%% !1110 4444 )2TE+0 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MVCW#3'"GK7TCJ&AK<9RM8$W@^-VSL'Y4 >$1:/<8^Z:E_L>X_NFO<5\'1C^
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M_<-<'K_\5=%'<#E;?_CY'UKTKPU]Q:\UM_\ CY'UKTKPU]Q:WK_"!U5%%%<
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 1S?ZLUQ/B7_4O]*[:;_5FN)\2_P"I?Z4 >&^)?^/A
MOK5?P_\ \?*_6K'B7_CX;ZU7\/\ _'ROUH&>X>%_]4E=];?ZNN!\+_ZI*[ZV
M_P!70(FHHHH **** "BBB@ HHHH **** "BB@T %%)2T %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M!THKSP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 44E+0 44&DH 6BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** *%[]PUPFN]&KN[W[AKA-=Z-711W \\U+[YHHU+[YHKU(
M[#&Z=]\5Z%H/\->>Z=]\5Z%H/\-85]@.\L?N"M'M6=8_<%:/:O,EN(****D
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M^X*V!TKSY[B"BBBI **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH HWOW#7!Z_\ Q5WE[]PUP>O_ ,5=%'<#E;?_
M (^1]:]*\-?<6O-;?_CY'UKTKPU]Q:WK_"!U5%%%< !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M 1S?ZLUQ/B7_ %+_ $KMIO\ 5FN)\2_ZE_I0!X;XE_X^&^M5_#__ !\K]:L>
M)?\ CX;ZU7\/_P#'ROUH&>X>%_\ 5)7?6W^KK@?"_P#JDKOK;_5T")J*** "
MBBB@ HHHH **** "BBB@ HHHH ,4444""BBB@84444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "DI:* $I:** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH H7OW#7":[T:N[O?N&N$UWHU=%'<#SS4OOFBC4
MOOFBO4CL,;IWWQ7H6@_PUY[IWWQ7H6@_PUA7V [RQ^X*T>U9UC]P5H]J\R6X
M@HHHJ0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MS_7K]:!GO7@[[D==_P!JX#P=]R.N_P"U @HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI*6@ HHHH **** "BBB@
MHHHH *2EHH !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %8>O\ ^I/TK<K#U_\ U)^E7#X@/,-1_P"/
M@_6M/1/O"LS4?^/@_6M/1/O"N^7PC/0-.^X*V!TK'T[[@K8'2O/GN(****D
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@"C>_<-<'K_P#%7>7OW#7!Z_\ Q5T4=P.5M_\ CY'UKTKPU]Q:\UM_
M^/D?6O2O#7W%K>O\('54445P %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!'-_JS7$^)?\ 4O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (YO]6:XGQ+_J
M7^E=M-_JS7$^)?\ 4O\ 2@#PWQ+_ ,?#?6J_A_\ X^5^M6/$O_'PWUJOX?\
M^/E?K0,]P\+_ .J2N^MO]77 ^%_]4E=];?ZN@1-1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=%WU[=X=N_/B7F@1T5%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!0O?N&N$UWHU=W>_<-<)KO1JZ
M*.X'GFI??-%&I??-%>I'88W3OOBO0M!_AKSW3OOBO0M!_AK"OL!WEC]P5H]J
MSK'[@K1[5YDMQ!1114@%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5P'C3_ %<E=_7 >-/]7)0!
MX!XA_P"/EOK4OAS_ %Z_6HO$/_'RWUJ7PY_KU^M SWKP=]R.N_[5P'@[[D==
M_P!J!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8>O
M_P"I/TK<K#U__4GZ5</B \PU'_CX/UK3T3[PK,U'_CX/UK3T3[PKOE\(ST#3
MON"M@=*Q].^X*V!TKSY[B"BBBI **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH HWOW#7!Z__%7>7OW#7!Z__%71
M1W Y6W_X^1]:]*\-?<6O-;?_ (^1]:]*\-?<6MZ_P@=51117  4444 %%%%
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MN*M65BTLRX% 'H'@:,B6.OH70ABR'TKQ7P7IC(Z$K7N.E1^7:*/:@DO4444
M%%%% !1110 444E "T444 4=4;;:-]*\+\=3',E>Z:HNZT:O"?'41W24 >-W
MKYN3]:?",K45XA%P?K4T)PM!1+BFN.*=FFN>* *?24?6O0/!\N)4KS_&91]:
M[[PA&3*E CZ"\,REH$'M76CI7(^&(R(4/M77#I0(**** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!#
M12T4 %%%% !1110 4444 (0",&JTMC%+U%6J* ,MM#MF.2H_*@:';#^$?E6I
M10!2CTV&+H!5M$"# IU% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 07'W#7">(^C5W=Q]PUPG
MB/HU;4=P.*B_X^OQKT;PS]U:\YB_X^OQKT;PS]U:ZJ_P@=B.E% Z45YX!111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDV1T%+110 4444 %%!I* %HI*6@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *P]?_U)^E;E8>O_ .I/TJX?$!YAJ/\ Q\'ZUIZ)]X5F:C_Q\'ZUIZ)]X5WR
M^$9Z!IWW!6P.E8^G?<%; Z5Y\]Q!1114@%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 4;W[AK@]?\ XJ[R]^X:
MX/7_ .*NBCN!RMO_ ,?(^M>E>&ON+7FMO_Q\CZUZ5X:^XM;U_A ZJBBBN  H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** (YO]6:XGQ+_ *E_I7;3?ZLUQ/B7_4O]* /#?$O_ !\-
M]:K^'_\ CY7ZU8\2_P#'PWUJOX?_ ./E?K0,]P\+_P"J2N^MO]77 ^%_]4E=
M];?ZN@1-1110 4444 %%%% !1110 5%<)YD+"I:",B@#S3Q1HGGJY"UXUX@T
M!XG8A/TKZ>OK%9T(Q7":YX7$^[$?Z4 ?,]U:RQN1@U7\F4]C7L6H>"6+DB/]
M*SQX*;./+_2@9YO9VDLD@&#7H/AO06E9"4_2MK3O!+"0'R_TKT/0?#0MPN4_
M2@"?PYH@@13MKN8$\N(+45I:K#&!BK5 @HHHH **"0!DU1NKY(0?F% %[-&:
MY:X\0)&2-_ZTR'Q$CMC?^M '645FVFHI-CYA6B&##(- "T444 07B;[=A[5X
MYXUT]GWX%>T.-R$5Q^O:.+E&.W- 'R[JNGND[''>LT(4X->M^(/#15F(3]*\
M^U'3'A8_*:!F0#33DU(8'!Z&K-I9O*X&TT#*EO:/)*..]>F^#=.<2(2M9VB^
M'6E=24_2O5_#7A[R0I*?I0([30;?R[5>.U;E5K.+RH N*LT""BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ I*6B@ HHHH *2EI* %HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH @N/N&N$\1]&KN[C[AKA/$?1JVH[@<5%_P ?7XUZ-X9^ZM><Q?\ 'U^-
M>C>&?NK757^$#L1THH'2BO/ **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$V+?ZO\ 2M32/"S)*IV=_2@1VOA!2$3(KU2P_P!6*XGP[I)A5?EKNK6/8H%
MBU1110 4444 %&*** #%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K#
MU_\ U)^E;E8>O_ZD_2KA\0'F&H_\?!^M:>B?>%9FH_\ 'P?K6GHGWA7?+X1G
MH&G?<%; Z5CZ=]P5L#I7GSW$%%%%2 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110!1O?N&N#U_^*N\O?N&N#U_^
M*NBCN!RMO_Q\CZUZ5X:^XM>:V_\ Q\CZUZ5X:^XM;U_A ZJBBBN  HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** (YO\ 5FN)\2_ZE_I7;3?ZLUQ/B7_4O]* /#?$O_'PWUJOX?\
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ME_*GQZ' AR * ./T+PXL6W*?I7=6=C'!&.*DAM$AZ 58H  ,=**** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BHI)TC&2:S;K6XH0?F H UBP7
MJ:02*3UKCKGQ1$&QO%10^*(]WWZ .XHK"L_$$,P + UK1722C*F@">BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH @N/N&N$\1]&KN[C[AKA/$?1JVH[@<5%_Q]?C7HWAG[JUYS%_
MQ]?C7HWAG[JUU5_A [$=**!THKSP"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** (YO]6:Y75^C5U4W^K-<KJ_1J
MUI;@</>_ZT_6M/1?]8M9E[_K3]:T]%_UBUV2^$#T?3O]0*N53T[_ % JY7GO
M< HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M7[B!=V2*\YU*ZAWG&*9XC\2EF;#UP=SK+R.?FH&=3]JCSU%5KJXC*'&*Y?\
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M$/\ Q\M]:E\.?Z]?K47B'_CY;ZU+X<_UZ_6@9[UX.^Y'7?\ :N \'?<CKO\
MM0(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *:[A!DTZL
MS5KGR(B<]J ,[6M66"-OFKRGQ%XL,;, _P"M7_%6ND;QOKR#6[]YY&PU &M<
M^+'=S\Y_.JW_  DSYSO/YUQQ\POG)IV'QWH&>@V7BQT8?.?SKN=!\5F1E!?]
M:\&621".372Z!J3I,N6- 'U+HFI"X1>:Z'.:\H\(ZKN1 6KTRTG$J YH$6Z*
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *P]?\ ]2?I6Y6'K_\ J3]*N'Q
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M!!Z&EK L-4$^/FK<C;<@- #Z*** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MVMA N *L444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%(2!U.
M* %HJ)KF).K"F"\B)QN% #+JT\Y"*XW6O#GG[OEKNUD5Q\K TDD22## 4 >*
MW'@K>Y/E_I6;>^#3'&2$_2O<FT^,G[HJG>:3')&1M% 'R]K6A20,V%/Y5S$E
MK(CG(-?1FO\ AE'#'9^E>:ZOX=$+,0E [GGFPCK36.*VKK3VC8X6LFYA9.U
M#[4;W KL='TC[1M^6N1TM<S#/K7L'A&S20)D4 %GX3\Q =GZ5>_X0S(_U?Z5
MZ;IFFP^4N5%:HL( /NB@1XP_@H_\\_TJ,^""?^6?Z5[4;" _PBE%A /X10!X
MQ;^!") ?+_2NST/PT;0J=F/PKN%M85Z1BI0BKT4"@"*VB\J(+4U%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% %"]^X:X37>C5W=[]PUPFN]&KHH[@>>:E]\T4:E]\T5ZD=AC=.^^*]"T'^&
MO/=.^^*]"T'^&L*^P'>6/W!6CVK.L?N"M'M7F2W$%%%%2 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 &DI:* $I:*
M* "BBB@ HHHH ,TE%** $I:** "BBB@ HHHH **** "BBB@ I*6B@ HHHH *
M*** "BBB@ K@/&G^KDKOZX#QI_JY* / /$/_ !\M]:E\.?Z]?K47B'_CY;ZU
M+X<_UZ_6@9[UX.^Y'7?]JX#P=]R.N_[4""BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "N7\5RF.!\>E=17)>,/^/=_I0!X'XKOV\YQFN'>
M4R.<UU7BM3]H?ZUQZCYC0,DV#-."B@4X4#*\RC%6=-<I,M03=*EL#^]% 'K?
MA.\9=@S7L>BW!>)>>U>(>%@24KV700?+7Z4$G5CD"EI%^Z*6@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "L/7_P#4GZ5N5AZ__J3]*N'Q >8:C_Q\'ZUIZ)]X
M5F:C_P ?!^M:>B?>%=\OA&>@:=]P5L#I6/IWW!6P.E>?/<04445(!1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BD-% "T444 %%%% #)'V+FN)\57A6%\&NSN%S$:\[\5J?+>@#Q'Q7=
M,TS\]ZXM6+2'-==XF7]Z]<FHPYH&6508I"@IPZ4M R)CLY%:6CW[)<* >]9D
MWW:?I8/VI?K0!]">![QI%CR:];B.8E/M7C7@!21'7LL0Q$@]J"1]%%'2@ HJ
MC<ZC';@Y(XK#N_%$<9(WB@#J=P]12@@]#7 R>,(PW^L_6IK?Q=&Q'[P?G0!W
M%%8-IX@BGQ\P-;$%PLPR* )J*** "BBB@ HHHH **** "BBB@ HHHH ****
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MX^6^M2^'/]>OUH&>]>#ON1UW_:N \'?<CKO^U @HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ KG/$T!E@; [5T=4K^V\^,C% 'SCXKTIO-
M<[:\]N8/)<Y%?0_B?0MZN0M>->(-'DBD?"F@:.4\T9I_FBH7M)5<\&@V\GH:
M!BRN&J[I4)DF7CO5>&QED(X-=?X=T1VE4E30!W/A'3R=G%>OZ3;>7$O%<IX4
MTGRT3*UZ!!"(U Q023CI1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6'K_
M /J3]*W*P]?_ -2?I5P^(#S#4?\ CX/UK3T3[PK,U'_CX/UK3T3[PKOE\(ST
M#3ON"M@=*Q].^X*V!TKSY[B"BBBI **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH HWOW#7!Z_\ Q5WE[]PUP>O_
M ,5=%'<#E;?_ (^1]:]*\-?<6O-;?_CY'UKTKPU]Q:WK_"!U5%%%< !1110
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M1MR@UXOX0UTR[ 6KU_3YA+; YH$6Z*** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *P]?_P!2?I6Y6'K_ /J3]*N'Q >8:C_Q\'ZUIZ)]X5F:C_Q\
M'ZUIZ)]X5WR^$9Z!IWW!6P.E8^G?<%; Z5Y\]Q!1114@%%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *P]?\
M]2?I6Y6'K_\ J3]*N'Q >8:C_P ?!^M:>B?>%9FH_P#'P?K6GHGWA7?+X1GH
M&G?<%; Z5CZ=]P5L#I7GSW$%%%%2 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110!1O?N&N#U_\ BKO+W[AK@]?_
M (JZ*.X'*V__ !\CZUZ5X:^XM>:V_P#Q\CZUZ5X:^XM;U_A ZJBBBN  HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M:8MPC<"N"UWPPK;B$_2@#YVFL&B.,5#]G8CI7IFJ>&6#G"?I62OAM]WW#^5
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "FM&K=:=10! UI&W44S[!#Z
M5:HH J_8(?2@6,/I5JD9@BY)H J2V40C)Q7#>)!%&C]*Z?5]:CMXF 8"O)O%
M'B(/O :@#A_$DJF9L>M9VBNHN5SZU1U2^,\Q.:ALKHQ2 YH&?0/A*2)HT!Q7
MHMO:Q21 X%> >&/$/E,@W5[#H.OI-&H+#F@1T?V&'TH^PQ>E3)*DB@J:?0!C
M:GI<<D!VKVKRGQ1H^W>0M>VNNY"*XSQ)I?FQ.0M 'S7K$/DR-Q7/F;Y\5Z'X
MJT=UD?"UP$MA(DIR#0,<KY%,DDP*D6%@.E,DMF?H*!BVK[I *[[PW9F5T.*X
M[2],D><?*>M>P^$-%;Y"5H$=OX:L3&B'%=W",1 5F:78B&%>*U@,#% A:***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M7^E=K-_JS7$^)?\ 4O\ 2@#PWQ+_ ,?#?6J_A_\ X^5^M6/$O_'PWUJOX?\
M^/E?K0,]P\+_ .J2N^MO]77 ^%_]4E=];?ZN@1-1110 4444 %%%% !1110
M449I* %JG=V:3J?E%7** .2N_#B2L3L_2J8\*(#GR_TKN<48'I0!RUIX?2(C
MY/TK?M;585'%6J* "BBB@ Z5G7]V(8R<U>E;;&37%^(M0\N-AF@#EO%6O>6'
M ?\ 6O(-8UMII6&ZM[Q3J+2.X#5YS=.S2GZT#18ED,QS3(SY9S38NG-.D'RT
M#-G3-7:"5?FKU3PMXA+; 7_6O"49EEXKM?#=\\4B<T"9]-:5J GB7GM6VIW#
M->:^&-2+H@S7H=I)YD0- BQ1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+0 4444 %%%% '-^+/\ CT/TKYU\5?\ 'R_UKZ,\5_\ 'D?I7SIXK_X^7^M
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%(0",$4M% &;>:<DP/RBN:U/PTLJ$[/TKMZ:R*ZX(H \*UKPM@MB/]*XJ\\/
M.KGY/TKZ/U+2$FSA17+77AA78G9^E [GBUOH#L?N?I5J7PZRQD[/TKUR#PNJ
MG[GZ5-<^&U\D_)^E 7/G74]/>!C\IK%PRMS7L?B/PT1N(3]*\VU+2W@=OE-
M&6",4[-5WWHV,4Y"30,FI::*=0 'I569L&K)-4Y\[J -[P^OF3*/>O;_  KI
M2S1I\M>*^%T)N4X[U]'>"H!Y2$B@3+TGAU&3&S]*P]0\(JX/[O\ 2O2,"FM&
MCC#**!'A6I>#MI)$?Z5@R^%2&QY?Z5] 7FEQR@X45C2: A;[E 'D5CX2)<9C
M_2NWT;PJ$*DQ_I77VNB(A'RBMRWM(XE'RB@#.T_2UMU'RXK94;5 I:* "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MIMUN/I7D/A2V(*<5Z_I2[;<?2@1?HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MBBB@ HHHH ****  4444 <IXA5BC8KR#Q!&WF-FO<M5M/-1N*\L\4:;LWG%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** *%[]PUPFN]&KN[W[AKA-=Z-711W \\U+[YHHU+[YHKU(
M[#&Z=]\5Z%H/\->>Z=]\5Z%H/\-85]@.\L?N"M'M6=8_<%:/:O,EN(****D
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "L/7_\ 4GZ5N5AZ_P#ZD_2KA\0'
MF&H_\?!^M:>B?>%9FH_\?!^M:>B?>%=\OA&>@:=]P5L#I6/IWW!6P.E>?/<0
M4445(!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% %&]^X:X/7_XJ[R]^X:X/7_XJZ*.X'*V_P#Q\CZUZ5X:^XM>
M:V__ !\CZUZ5X:^XM;U_A ZJBBBN  HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBDS0 M%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!'-_JS7$^)?
M]2_TKMIO]6:XGQ+_ *E_I0!X;XE_X^&^M5_#_P#Q\K]:L>)?^/AOK5?P_P#\
M?*_6@9[AX7_U25WUM_JZX'PO_JDKOK;_ %= B:BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** &2KNC(KC/$.G^;&V!7;$9%9][:":,C% 'SC
MXITQD9SMKSFZA9)3Q7T3XIT+>'(6O(-:T5HI&.V@9RT7 ISG(I9HS$<4V(&0
MXH&11Q,\G2NU\-Z<TDB_+6;I6DM-(ORUZKX6T#;L)2@1TOAK33&B$K7H5HFR
M("LW3-/$,2\5L*-HQ0(=1110 4444 %)2T8H 2EI.E% "T444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9
M>KW'D1$YQQ6I7-^)W*P-CTH \T\4ZT1O&ZO)-9NS<.W-=5XKN6\UQGO7 S2%
MW.:!E$Q$OFG^0:G YIXQ0,IE"E;&BW;1S+SWK-F'%26&5E'UH ]X\(:H<("U
M>KZ?<B6,'-> >%;AE*<U[-H-P6C7F@DZEAN%<YXCL?,MC@=JZ1>5%5[V 3PE
M<4 ?-/B[27\UR%->>2V3QR'(-?2WB/PV)@QV?I7E&N>'S S'9^E S@,8XIK9
MJY=P&*0C%1PPF1@*!D<-LTK 8KKO#^BL\JG;1H>BF9U^6O5O#GAL*%)3]*!&
MOX3TXP*F17H:#" >U96GZ>+=1Q6N.E B"ZD\N/-<3XAU?RHV&ZNKU:39 ?I7
MD/BN]8;QF@#B_$VKF1W :O/KJ5I9#S6UJ\S22-S6%CYZ!D9MRW-*(S'5Q.E,
ME'% R_I%\T,J_-7KGA36C\@+5XE;960&N[\-W;(Z<T"9]&:5?>=&O-;BG*@U
MY_X9NRZ)S7>PG,2F@1)1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 07'W#7">(^C5W=Q]PUPGB/HU;4=P.*B_P"/K\:]&\,_=6O.8O\ CZ_&
MO1O#/W5KJK_"!V(Z44#I17G@%%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 1S?ZLURNK]&KJIO]6:Y75^C5K2W
MX>]_UI^M:>B_ZQ:S+W_6GZUIZ+_K%KLE\('H^G?Z@5<JGIW^H%7*\][@%%%%
M( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'[U:]H\)?=2O%]".9E^M>T^$Q\J4 >EP?ZE?I4E1P?ZE?I4E @HHHH ****
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M6B8E*!'M&C3EXEYKH!TKF="0B-<UTPZ"@04444 %%%% !1110 4444 %%%%
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M-*?X/TI$\-*&SL_2O0?L\?\ =H^SQ_W: .4LM&$1'RUT=G;B-1Q5D0H.@IX
M'2@!KQJXP16+J.DI,#\HK=I"H;J* /-[WPT&8X2JD/A?$F=GZ5Z<UM$W5:06
MD(_AH Y?3-#6''R5U-O L*  4]8U7H*?0 4444 %%%% !1110 5P'C3_ %<E
M=_7 >-/]7)0!X!XA_P"/EOK4OAS_ %Z_6HO$/_'RWUJ7PY_KU^M SWKP=]R.
MN_[5P'@[[D==_P!J!!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %8>O_P"I/TK<K#U__4GZ5</B \PU'_CX/UK3T3[PK,U'_CX/UK3T
M3[PKOE\(ST#3ON"M@=*Q].^X*V!TKSY[B"BBBI **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH HWOW#7!Z__%7>
M7OW#7!Z__%711W Y6W_X^1]:]*\-?<6O-;?_ (^1]:]*\-?<6MZ_P@=51117
M  4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@""X^X:X3Q'T:N[N/N&N$\1]&K:CN!
MQ47_ !]?C7HWAG[JUYS%_P ?7XUZ-X9^ZM=5?X0.Q'2B@=**\\ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M6CVK.L?N"M'M7F2W$%%%%2 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% "44M&* $%+110 4444 %<!XT_U<E=_7 >-/
M]7)0!X!XA_X^6^M2^'/]>OUJ+Q#_ ,?+?6I?#G^O7ZT#/>O!WW(Z[_M7 >#O
MN1UW_:@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6
M'K_^I/TK<K#U_P#U)^E7#X@/,-1_X^#]:T]$^\*S-1_X^#]:T]$^\*[Y?",]
M T[[@K8'2L?3ON"M@=*\^>X@HHHJ0"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** *-[]PUP>O\ \5=Y>_<-<'K_
M /%711W Y6W_ ./D?6O2O#7W%KS6W_X^1]:]*\-?<6MZ_P ('54445P %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0![1#XG3=]_]:Z#3?$43D N/SKYP3Q,ZG.\_G6QI?B]UF4>9^M ['TU%=Q3
M%6KF/%LFZ!\>E8/ASQ']HC7+_K5[7[Q9K9CGM0(\.\4G]^WUK+T,_P"DK]:U
M/%',[?6LO1!_I*_6@9[SX)?"I7I0Y%>9>"?NI7IB_='TH$+1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !4%S")4(Q4]% 'GOB311*CD+7B_B3075W(
M0_E7TY>V:SH1BN'UKPPLX8[/TH&?,LFER)(<J:463],&O7=0\([7.$_2LAO#
M#!_N?I0!Y]'I<DA'RFNGT#P_(95)0_E78Z;X4W,,I^E=UHWA58]IV?I0%QWA
M/2/*1,K7H,4(C4 54L+!;91QBM"@04R601IDT^LC6[L06YY[4 9FM:VL$;#=
M7DOB7Q#O+@/^M2^+/$#*S@/7F%_JK7$C?-0!'J5Z9IB<U#:7)B<'-56RYS2=
M*"CTOPWX@,3(-]>O^']>65%!>OF6PO&A<'->A^'/$)1T&_\ 6@1]%0W"2H"#
M4U<=X?U7[2B_-FNP4Y4'VH$,EC$B$5QOB+2A+$Q"UVU4[VU$T9&* /F?Q5HC
MK(^%->?S6#QRG(-?3/B#PV)PYV?I7FFK>%BCL0GZ4#/,Q&5'-(]NS]!73SZ%
M(KXVFK5EX>>1AE/TH YS2M*DDF7Y37L/A#12 A*U#H7A3YE)3]*]/T31EMD7
MY: 9JZ79"*%>.U:H&!BDC0(H IU @HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** (+C[AKA/$?1J[NX^X:X3Q'T:MJ.X'%1?\?7XUZ-X9^ZM>
M<Q?\?7XUZ-X9^ZM=5?X0.Q'2B@=**\\ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@".;_5FN5U?HU=5-_JS7*Z
MOT:M:6X'#WO^M/UK3T7_ %BUF7O^M/UK3T7_ %BUV2^$#T?3O]0*N53T[_4"
MKE>>]P"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MDNQ)J]?3-<.235-%P:0#PF*<5HR*7-,96F&*T]"N3%<+D]ZH2+NIUMF*0$4
M?0G@O7(XDCW./SKTI-=M60$L,GWKY;TO7Y+0##$8]ZWU\:RA0/,/YT$GT-_;
MEG_?'YTV35+:=-H8'-?.[^.)0?\ 6'\ZU](\8R32*"Y_.@=CU#4]*AO 2%!S
M7&:CX5&XD1_I76Z)J/VM%R<YKHCIRSIDKUH$>*GPN?,_U?Z5MZ;X5!89C_2O
M2#H*;L[:NVVEI$1\M &%I/AI(@IV#\JZFVM5@4 #I4R($7 %.H **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M:PK[ =Y8_<%:/:LZQ^X*T>U>9+<04445(!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4E%% "T444 %%%% !1110 4444 %%%% "9I:2EH *X#QI
M_JY*[^N \:?ZN2@#P#Q#_P ?+?6I?#G^O7ZU%XA_X^6^M2^'/]>OUH&>]>#O
MN1UW_:N \'?<CKO^U @HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 4449H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !24N:* $I:*IW=R(D;F@#/UG4A;1M\V*\NU_P 6^6S 2?K6OXMU<A'
M:O#O$.I2/,V&- SH;WQ0TS']X?SK(FU8R$Y:N32ZD9N2:G$K'O0%C5GN1)WJ
M*.(2-5)7)-7K60 C- %M;$;<XJG<P"/-:HN%V=:S;R0-G% &:QYJ&3=VJ8CF
MEV@T#*\<TD39R:ZG0-8=)5!8]:YB90!4FFR%)U^M 'TAX2U8R(F6KTNVE\R,
M'->"^#KUAL&:]GTBYWPKSVH)-JBD!R*6@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M73H%'2G?8(?2K5% %7[!#Z4JV42]!5FB@!BQ*O2GT44 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 E+110 5S.NW!CC;!KINU<IXBC+1O0!Y'XHO2Q<9KR
M[4_WDC&O1O$\1#/7F]^<.:!HHQQ@&IPE11L":GH& &*7S"E-+@4@7S.!0 XW
MC#C-)YY>E%B[<XI#;F/J*!!UIU1[P*/-% QDW2EL<></K4<SAAQ5C3(2\Z_6
M@#U'PCG*5[1H8/E+7E/@VQ)V'%>RZ3;>7"O%!)KK]T4M X%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %"]
M^X:X37>C5W=[]PUPFN]&KHH[@>>:E]\T4:E]\T5ZD=AC=.^^*]"T'^&O/=.^
M^*]"T'^&L*^P'>6/W!6CVK.L?N"M'M7F2W$%%%%2 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M7 >-/]7)7?UP'C3_ %<E '@'B'_CY;ZU+X<_UZ_6HO$/_'RWUJ7PY_KU^M S
MWKP=]R.N_P"U<!X.^Y'7?]J!!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %8>O_ .I/TK<K#U__ %)^E7#X@/,-1_X^#]:T]$^\*S-1
M_P"/@_6M/1/O"N^7PC/0-.^X*V!TK'T[[@K8'2O/GN(****D HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"C>_
M<-<'K_\ %7>7OW#7!Z__ !5T4=P.5M_^/D?6O2O#7W%KS6W_ ./D?6O2O#7W
M%K>O\('54445P %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110!'-_JS7$^)?]2_TKMIO]6:XGQ+_J
M7^E 'AOB7_CX;ZU7\/\ _'ROUJQXE_X^&^M5_#__ !\K]:!GN'A?_5)7?6W^
MKK@?"_\ JDKOK;_5T")J*** "BBB@ HHHH **** "BBB@ HHHH *1AD4M% &
M3J5D)86XKQWQCI#?/A:]V=0R$'O7(:[H@N@WRYH ^6-3TZ1)C\IK/\AU[&O:
MM9\('>Q$?Z5R5WX99&/R&@9P+1N1TI]G;2/,!@UV4?AQF.-E;>E>$&:53Y?Z
M4!<7POI#R*I*UUEYI'E6Q.WM73^'_#8MXERE6/$%HL-LPQVH$>'ZNGERD5EH
MW-;/B'BX;ZUA1G)H M&X*CK5"[N&;/-3NK$<50G5AG- RC)RU"BE;K0*!B/]
MVJ@4^;5MNE5U_P!90!V7AF0I(G->X>&+HE$&:\+\/ F1<5[1X75MJ4$L]+M7
MWQ@U/56R&(A]*M4 %%%% "4M)2T %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !11FB@ HHHH **** "BBB@ HHHH **** "B
MBB@ J"ZA$T14BIZ* //O$/AT3*QV5Y/K_A_R&<A*^D;J!986R*\U\4Z8I5R%
MH ^>KZW,4A&*CMX3(P&*W]?M/+G;CO5/28-\ZC'>@9OZ#HIF=?EKUGP[X="A
M24K)\):2K*AVUZMIUFD,0.*!#;*P$"@8Q6D.!110 E+24M !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $%Q]P
MUPGB/HU=W<?<-<)XCZ-6U'<#BHO^/K\:]&\,_=6O.8O^/K\:]&\,_=6NJO\
M"!V(Z44#I17G@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 1S?ZLURNK]&KJIO]6:Y75^C5K2W X>]_P!:?K6G
MHO\ K%K,O?\ 6GZUIZ+_ *Q:[)?"!Z/IW^H%7*IZ=_J!5RO/>X!1112 ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@#FO%G_ !Z'Z5\[>*_^/E_K7T3XL_X]#]*^=O%?_'R_UH&B
MAH'_ !\#ZU[?X3^ZE>(:!_Q\#ZU[?X3^ZE ,]*A_U*_2I*CA_P!2OTJ2@044
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK#P:=P_=_I7<:+X4$14E/TH M^$])\I$RM>C01B- *S=+T\6Z@8K8H$%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% %"]^X:X37>C5W=[]PUPFN]&KHH[@>>:E]\T4:E]\T5ZD=AC=.^^*
M]"T'^&O/=.^^*]"T'^&L*^P'>6/W!6CVK.L?N"M'M7F2W$%%%%2 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !7 >-/]7)7?UP'C3_5R4 > >(?^/EOK4OAS_7K]:B\0_\ 'RWU
MJ7PY_KU^M SWKP=]R.N_[5P'@[[D==_VH$%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5AZ_P#ZD_2MRL/7_P#4GZ5</B \PU'_ (^#
M]:T]$^\*S-1_X^#]:T]$^\*[Y?",] T[[@K8'2L?3ON"M@=*\^>X@HHHJ0"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** *-[]PUP>O_ ,5=Y>_<-<'K_P#%711W Y6W_P"/D?6O2O#7W%KS6W_X
M^1]:]*\-?<6MZ_P@=51117  4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@#FO%G_'H?I7SMXK_X^7^M?1/BS_CT/TKYV\5_\?+_
M %H&BAH'_'P/K7M_A/[J5XAH'_'P/K7M_A/[J4 STJ'_ %*_2I*CA_U*_2I*
M!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %"
M]^X:X37>C5W=[]PUPFN]&KHH[@>>:E]\T4:E]\T5ZD=AC=.^^*]"T'^&O/=.
M^^*]"T'^&L*^P'>6/W!6CVK.L?N"M'M7F2W$%%%%2 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!7 >-/\ 5R5W]<!XT_U<E '@'B'_ (^6^M2^'/\ 7K]:B\0_\?+?6I?#G^O7
MZT#/>O!WW(Z[_M7 >#ON1UW_ &H$%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 5AZ__ *D_2MRL/7_]2?I5P^(#S#4?^/@_6M/1/O"L
MS4?^/@_6M/1/O"N^7PC/0-.^X*V!TK'T[[@K8'2O/GN(****D HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"C>
M_<-<'K_\5=Y>_<-<'K_\5=%'<#E;?_CY'UKTKPU]Q:\UM_\ CY'UKTKPU]Q:
MWK_"!U5%%%< !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 1S?ZLUR
MNK]&KJIO]6:Y75^C5K2W X>]_P!:?K6GHO\ K%K,O?\ 6GZUIZ+_ *Q:[)?"
M!Z/IW^H%7*IZ=_J!5RO/>X!1112 **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#FO%G_ !Z'Z5\[
M>*_^/E_K7T3XL_X]#]*^=O%?_'R_UH&BAH'_ !\#ZU[?X3^ZE>(:!_Q\#ZU[
M?X3^ZE ,]*A_U*_2I*CA_P!2OTJ2@04444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44F:* %H%&** "
MBBDH 6BBB@ HHHH *2EHQ0 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110!0O?N&N$UWHU=W>_<-<)KO1JZ*.X'G
MFI??-%&I??-%>I'88W3OOBO0M!_AKSW3OOBO0M!_AK"OL!WEC]P5H]JSK'[@
MK1[5YDMQ!1114@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 5P'C3_5R5W]<!XT_P!7)0!X!XA_
MX^6^M2^'/]>OUJ+Q#_Q\M]:E\.?Z]?K0,]Z\'?<CKO\ M7 >#ON1UW_:@044
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M  B+#_EG^E+_ ,(DW_//]* /.RDH[&F$SCIFO1_^$2?_ )Y_I2'P@W_//]*
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M'8CI10.E%>> 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!'-_JS7*ZOT:NJF_U9KE=7Z-6M+<#A[W_ %I^M:>B
M_P"L6LR]_P!:?K6GHO\ K%KLE\('H^G?Z@5<JGIW^H%7*\][@%%%%( HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** .:\6?\ 'H?I7SMXK_X^7^M?1/BS_CT/TKYV\5_\?+_6@:*&
M@?\ 'P/K7M_A/[J5XAH'_'P/K7M_A/[J4 STJ'_4K]*DJ.'_ %*_2I*!!111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% "44M% !1110 4E+10 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!0O?N&N
M$UWHU=W>_<-<)KO1JZ*.X'GFI??-%&I??-%>I'88W3OOBO0M!_AKSW3OOBO0
MM!_AK"OL!WEC]P5H]JSK'[@K1[5YDMQ!1114@%%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5P'C
M3_5R5W]<!XT_U<E '@'B'_CY;ZU+X<_UZ_6HO$/_ !\M]:E\.?Z]?K0,]Z\'
M?<CKO^U<!X.^Y'7?]J!!1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %8>O\ ^I/TK<K#U_\ U)^E7#X@/,-1_P"/@_6M/1/O"LS4?^/@
M_6M/1/O"N^7PC/0-.^X*V!TK'T[[@K8'2O/GN(****D HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"C>_<-<'K
M_P#%7>7OW#7!Z_\ Q5T4=P.5M_\ CY'UKTKPU]Q:\UM_^/D?6O2O#7W%K>O\
M('54445P %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110!'-_JS7$^)?\ 4O\ 2NVF_P!6:XGQ+_J7
M^E 'AWB7_CX;ZU7T#_CY7ZU8\2_\?#?6J^@?\?*_6@9[?X7_ -4E=];?ZNN!
M\+_ZI*[ZV_U= B:BBB@ HHHH **** "BBB@ J*2$/UJ6B@#.ETF*3J!5<Z!
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% %"]^X:X37>C5W=[]PUPFN]&KHH[@>>:E]\T4:E]\T5
MZD=AC=.^^*]"T'^&O/=.^^*]"T'^&L*^P'>6/W!6CVK.L?N"M'M7F2W$%%%%
M2 4444 %%%% !1110 4444 %)2TE "T4E+0 4444 1L^VH6N5!ZU%?3"-3S7
M,7FKB-R-U '6I<ACUJPIR*Y#3]465P-U=9 P:($4 24444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !7 >-/\ 5R5W]<!XT_U<E '@'B'_ (^6^M2^'/\ 7K]:B\0_
M\?+?6I?#G^O7ZT#/>O!WW(Z[_M7 >#ON1UW_ &H$%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5AZ__ *D_2MRL/7_]2?I5P^(#S#4?
M^/@_6M/1/O"LS4?^/@_6M/1/O"N^7PC/0-.^X*V!TK'T[[@K8'2O/GN(****
MD HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@"C>_<-<'K_\5=Y>_<-<'K_\5=%'<#E;?_CY'UKTKPU]Q:\UM_\
MCY'UKTKPU]Q:WK_"!U5%%%< !1110 4444 %%%% !1110 4444 %%%% !111
M0!#)*$ZU!]M7.,U2UB[6W4G-<@VO@7&W?WH ]$BE#]*EK$T.\%RH.<\5MT %
M%%% !1110 4449H **** "BBB@ HHHH **** "BBB@ HHHH ***,T %%%% !
M1110 4449H **** "BBB@ HHHH **** (YO]6:XGQ+_J7^E=M-_JS7$^)?\
M4O\ 2@#P[Q+_ ,?#?6J_A_\ X^5^M3^)?^/AOK5?P_\ \?*_6@9[AX7_ -4E
M=];?ZNN!\+_ZI*[ZV_U= B:BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ KC/%_P#JWKLZXSQ?_JWH \!\3_ZYOK69HG_'ROUK3\3_
M .N;ZUF:)_Q\K]:!GN_@G[J5Z8OW1]*\S\%?=2O3%^Z/I0(6BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHS0 4444 %%%% "$!A@CBL75=,AE4Y K4N;A8$))K
ME-5\11PA@7'YT <OJV@0EFPHKG&\/1^;]T5LWWB>%W(WC\ZRSX@AWYW"@#=T
M;08E9<J*]"TK3H8HQA17FEAXEA4CYQ^==AI?B..0* XH [,*%& ,4M5+2[%P
MHP<U;H KW1Q&:\Y\5.WEO7H]PNY2*X+Q7:GRG.* / _$A)E;-<JG^L-=9XH0
MI*_%<@A/F&@9='2EI%Z4$XH&13_=HTQF^U+]:27YA5K2;=FN5X[T >W_  _9
MOW>:]JB_U2?2O'? <!41\5[%%_JD^E!)F:[G[+QZ5XEXL5M[U[IJD?F6Y%>3
M>*M/)WG% 'BU_GS&S68?O5MZW"8I&XKG?,.^@9;'2FO2*<BF2M@4#)8?O"NK
MT(,9%Q7'VCEI0*]#\,69D=#B@1ZEX4#83->F6_\ J%KBO#EB4C0XKMXAB,"@
M0^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3]:T]%_UBUV2^$#T?3O]0*N53T[_ % JY7GO< HHHI %%%% !1124 +124M
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!0O?N&
MN$UWHU=W>_<-<)KO1JZ*.X'GFI??-%&I??-%>I'88W3OOBO0M!_AKSW3OOBO
M0M!_AK"OL!WEC]P5H]JSK'[@K1[5YDMQ!1114@%%%% !1110 4444 %%%% !
M1110 4444 1RR"-<FLJ[UN.!3R!5O4V*PG'I7F/B*[F0O@F@#4U?Q0F& ?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %8>O_P"I/TK<K#U__4GZ5</B \PU
M'_CX/UK3T3[PK,U'_CX/UK3T3[PKOE\(ST#3ON"M@=*Q].^X*V!TKSY[B"BB
MBI **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MO$<F]\.?SKHO%6L$%QNKRG5;DSR-S0,AFU^9I#\Q_.HSK4W]XUFF'+YJ3R*
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@".;_5FN5U?HU=5-_JS7*ZOT:M:6X'#WO\
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M^I7Z5)4</^I7Z5)0(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKCO&A_T=_I78UROBV$RP-@=J /F?Q83]I?ZURT/+5WOBS36\]SCO7$-%Y+G-
M R84M0B84OFB@9#<]*NZ(?\ 25^M4I3OZ5KZ!9LUPIQWH ]R\#D[(Z]:MO\
M4K7F7@BS*)'D>E>HQKM0#VH)'4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% %"]^X:X37>C5W=[]PUPFN]&KHH[@>>:E]\T4:E]\T5ZD=AC=.
M^^*]"T'^&O/=.^^*]"T'^&L*^P'>6/W!6CVK.L?N"M'M7F2W$%%%%2 4444
M%%%% !1110 4444 )2TF*6@ HHHH KW47FIBN/UG0//#';7<5')$LBD$4 >'
M:IX7*ECMKC[W0F20C;7T#J=@C _**XC4-)4R'Y: /-[#P\TT@&VO0_#WA,IM
M;95S2=*195RM>B:9:QQ0 A1F@"'2]/\ LJ@8QBM:BB@ HHHH ,4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 5P'C3_ %<E=_7 >-/]7)0!X!XA_P"/EOK4OAS_ %Z_6HO$/_'R
MWUJ7PY_KU^M SWKP=]R.N_[5P'@[[D==_P!J!!1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M]"T'^&L*^P'>6/W!6CVK.L?N"M'M7F2W$%%%%2 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %8>O_ZD_2MRL/7_ /4GZ5</B \PU'_CX/UK3T3[
MPK,U'_CX/UK3T3[PKOE\(ST#3ON"M@=*Q].^X*V!TKSY[B"BBBI **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
MHWOW#7!Z_P#Q5WE[]PUP>O\ \5=%'<#E;?\ X^1]:]*\-?<6O-;?_CY'UKTK
MPU]Q:WK_  @=51117  4444 %%%% !1110 4444 %%%% !0>!137.$)H @FN
MA'WK/FUE4R-PK/UB\,2MS7GVJ:^8Y"-] '=7EZMT",YS5*'21+)NVURVD:P;
MF4 MFO3-'C5X Q]* )=,LQ;1@XQBI+S4DML\CBDO[U+6!N0*\T\1^)@A<!Z
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **2E% !6-KD'G0MQVK9J"XB$J$4 >#^*]).
M7.VO*M4A,$C<5]+>(M%$L;$+7C?B3PZX=R$H&CS7SCNJ42<5?ET61)#\II/[
M-<?PT#,V20FM#2(S),O'>K$6C22$?+74:!X;D\U24H$=IX0TXML.*]=TNT\J
M->*YCPKH_DHF5KO4B"  4")!T%5KR<0PDYJP6VBN<\27WE6[8/:@#E_$?B(0
MJP#_ *UY)KVOM.[ /5GQ=K#^8X#&O/);UII3DT#)+F=I9"2:;'*8R"#3 ,\T
M,*!G5:'K+PR+\U>M^&O$>0@+_K7S]!.8F!S76Z!K;1RJ-U CZ=L-0%Q&O.:U
M!R*\Y\)ZD9T0;LUZ(AS&I]J!#J*** "BBB@ HHHH **** "BBB@ HHHH **0
MT4 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% $%Q]PUPGB/HU=W<?<-<)X
MCZ-6U'<#BHO^/K\:]&\,_=6O.8O^/K\:]&\,_=6NJO\ "!V(Z44#I17G@%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M\JJQ>'8P_P!P?E7:M&K=12"% >E &-9:+'&!\HK8BMTB& *D  Z4M !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %"]^X:X37>C5W=
M[]PUPFN]&KHH[@>>:E]\T4:E]\T5ZD=AC=.^^*]"T'^&O/=.^^*]"T'^&L*^
MP'>6/W!6CVK.L?N"M'M7F2W$%%%%2 4444 %%%% !1110 4444 %%%% !111
M0!#<2>6F:X_7M8$,;#=72:Q+Y5N3[5X_XIU,Y<;J ,+Q#XA<LP5ZX>?4[B67
M@FK]PK7<Y'7)K8TOPJUS@[<_A0,QK+49XR"2:VXO$TD2X+FM*[\)/!"2$[>E
M<9JEA+;N0 : -NX\1R3C&\UES>==GC)S5'3[.664 YKT;P_X:-P%RN: /.I-
M%G8YVFJ[V<]J<X(KWX>"@5'[OMZ5SOB/P?Y$1(3''I0!YUHVKRP3*"QZU['X
M4UKS50%J\5NK%K2YZ8P:[/PI?-&R#- 'T#:3B6('-6:YK1+PR1+S72+RHH$*
M:*** "BDHH 6BBB@ HHI&95&20* $9P@R37.:YK*6Z$!@,4_6M9CMT;##CWK
MR'Q3XGRS@/\ K0!T4WB?-Q@/WKI]"U0W&WYLUX!;:P\UT/F[UZUX.G+A,F@9
MZQ"VZ,&I*@M#F$5/0(J7TWE19KC-3UX0,1NKHO$=QY-L>>U>&>*-;9)G ;O0
M,[9O%2[OO_K3/^$I']_]:\>76)I'X8U8%]<$=30!ZP?%(_O_ *UHZ=XB$S@;
MZ\4:]N<]ZZ+P_=SM,N2:!'T#I=SYZ@YK4KE_"[LT2Y]*ZB@ HHHH **** "N
M \:?ZN2N_K@/&@_=R4 > >(?^/EOK4OAS_7K]:C\0_\ 'RWUJ3PY_KU^M SW
MKP=]R.N_[5P'@[[D==_VH$%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5AZ_P#ZD_2MRL/7_P#4GZ5</B \PU'_ (^#]:T]$^\*S-1_
MX^#]:T]$^\*[Y?",] T[[@K8'2L?3ON"M@=*\^>X@HHHJ0"BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *-[]PU
MP>O_ ,5=Y>_<-<'K_P#%711W Y6W_P"/D?6O2O#7W%KS6W_X^1]:]*\-?<6M
MZ_P@=51117  4444 %%%% !1110 4444 %%%% !3)?\ 5M3Z9+_JF^E '!^)
M92JO7CFO7;+.>>]>O>*/N/7BGB$'SV^M S;\*W3/<KSWKW31YBED#[5X#X/X
MN4SZU[K8RJFG#G^&@1SGB[6C CJ&KQG5]4DNIF 8G)KM?'5V3(X!K@=/M&NK
MKGG)H J1:9+=/G!.:U8?"\C+G8:]"T+PP)$4E/TKL[?PLHC'R?I0,\&N/#DL
M*DA36:HFM)NXP:^@]0\**8&.S]*\Q\0>'_(D8A<4 2>&-:='4%J]BT/4_.B3
MYJ^?K &VN />O4_#%\2$&: 9ZO$VY,T^J>GOO@!JY0(**** "BBB@ HHHH Y
MSQ!)MC>O'/$\VYG&:]=\2G$;UXIXFDP[T <S%@7&?>N^\/:FMNJ\UYG]IQ+6
M[IUS)@8S0,]:;Q(/+ W5'!J<=S)R0:\[DN)@O>BVUA[>09- CV_2(89 #Q6S
M=(J63X]*\R\.>* Q52WZUWGV\7%B>>HH \?\=2GS'&:X'3?GO1]:[OQR,R/7
M#Z0O^FCZT#/;O!48"(<5WM^1]B(]JXKP:H\M/I7::A_QZ'Z4"/$/&L8:5ZXO
M3ALNA]:[OQB/WCUPUMQ<_C0!ZQX7N,*G->E6=Z@A&XUY#X?F**O-=1/JS06Y
MY[4 =K/K$$1QN%5_^$@@_O"O&M:\6O$Y&\_G6$OC60M_K#^= ['T)_;\']X4
MX:] ?XA7S^/&<G]\_G3AXSD_OG\Z!6/>9]>AV'#"N.\0ZO%)"^&'2O-7\92$
M??/YUF7WB9YD(W_K0%BOXAN%DN&P>])X>&;A?K7/W-Z9YN371^'!F53[T#/;
M/#'^J2N^MO\ 5UP/AD_NTKO;7_5T")Z*** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "N,\7_P"K>NSKC?%X_=O0!X!XG_US?6LS1/\
MCY7ZUI^)_P#7-]:S-$_X^5^M SW?P5]U*],7[H^E>9^"1\J5Z8OW1]*!"T44
M4 %%%!('6@!"0.M,,\:]6K.U'44@4_-TKC-2\3K$QP_ZT >A?:H?[XI1<Q'H
MPKR)O&6&_P!9^M7;+Q:)' W_ *T >J!@W0TM<WI6LI.!\U=$DBR*"#0 ZBBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M;I?K0![_ . YRPCYKV*'F%/I7BW@!"!'FO:8/]0GTH))**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (+C
M[AKA/$?1J[NX^X:X3Q'T:MJ.X'%1?\?7XUZ-X9^ZM><Q?\?7XUZ-X9^ZM=5?
MX0.Q'2B@=**\\ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M)3[4"'T444 %%%% !1110 4444 %%%% !1110 449HH **** "BBB@ HHHH
M**** "BBB@ HHHH **** .:\6?\ 'H?I7SMXK_X^7^M?1/BS_CT/TKYV\5_\
M?+_6@:*&@?\ 'P/K7M_A/[J5XAH'_'P/K7M_A/[J4 STJ'_4K]*DJ.'_ %*_
M2I*!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M%"]^X:X37>C5W=[]PUPFN]&KHH[@>>:E]\T4:E]\T5ZD=AC=.^^*]"T'^&O/
M=.^^*]"T'^&L*^P'>6/W!6CVK.L?N"M'M7F2W$%%%%2 4444 %%%% !1110
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M6O.8O^/K\:]&\,_=6NJO\('8CI10.E%>> 4444 %%%% !1110 4444 %%%%
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M2OTJ2@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M13L54]:314GAG7KUKV+5?"HF<G9^E9,'A'RI0=GZ4#N:?AN:0H@.:[VVC#Q
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MI7?=JX'P?_JTKONU @HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "L/7_P#4GZ5N5AZ__J3]*N'Q >8:C_Q\'ZUIZ)]X5F:C_P ?!^M:
M>B?>%=\OA&>@:=]P5L#I6/IWW!6P.E>?/<04445(!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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ME;YJ\KUWQ22[ /\ K0!UVI>* K'#_K66OBKYO]9^M>7WNOO(Y^:J7]LN.=U
M['O.F>*%9@"_ZUVFFZTDRCYA7S!8>(GCD'SG\Z]#\/>*"2@+_K0![PDRN 0:
MDKE=&U87"+\U=/&VY :!#ZCDE5%)-/8X4FN?U;4!#&W- &7X@UD0JV&KR'Q'
MX@,C.-_ZUK>*]:)W@-7E&I7[2RGF@:&:C=&9R<U7LYC'(#4?WZ,;:!GH'A[7
M#"ZC=7KOAW71,%!:OFNSO&BE'->C^%M:*L@+4"/HNWN%EB4YJQ7(:%J@FB0;
MJZR)MZ T"*^HMMM&->'>.KH@R<U[=JO-FU>#>.E.Z2@#R&_F+W!Y[TD2Y%17
M:XN3]:GA^Z*"AVRD=.*DI'Z4 4U;;,/K7HO@VX(E3FO.2/WHKO/""GS4H$?1
M?AJ?= @SVKIJX_PN"(4^E=>.E A:*** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $H%+
M10 4R1!(N#3Z* .9UG1$FC8[0:\G\2Z"(RY"5[U,H:)@:\_\3V2LCG% 'SIJ
M=J8I2,5#9P>9(!BNC\26H29N.]9^C0[[A1CO0,Z_PUHGFLAVUZ]H&AK&BDK7
M/^$=.4QH=M>FVD(BB&!0(6*V6(#%3T44 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $%Q]PUPGB/HU=W
M<?<-<)XCZ-6U'<#BHO\ CZ_&O1O#/W5KSF+_ (^OQKT;PS]U:ZJ_P@=B.E%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX^OQKT;PS]U:\YB_X^OQKT;PS]U:ZJ_P@=B.E% Z45YX!1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M-P)S7H7ASP\0R,4H$=;X,T[RHTR*]&0;4 ]JQ-$L1;QKQBMV@ HHHH ****
M"N#\:M^[DKO*X'QH?W<E '@'B+_CY;ZU)X<_UZ_6H_$/_'RWUJ3PY_KU^M S
MWKP=]R.N_P"U<!X.^Y'7?]J!!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %8>O_ .I/TK<K#U__ %)^E7#X@/,-1_X^#]:T]$^\*S-1
M_P"/@_6M/1/O"N^7PC/0-.^X*V!TK'T[[@K8'2O/GN(****D HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"C>_
M<-<'K_\ %7>7OW#7!Z__ !5T4=P.5M_^/D?6O2O#7W%KS6W_ ./D?6O2O#7W
M%K>O\('54445P %%%% !1110 4444 %%%% !1110 4R7B-OI3Z9+S&WTH X7
MQ'>-$&P:\LU?7WBD;YC7J/B6T:17P*\=\0:9*'8X- RC)XH<-]\_G3X_$DC?
MQFN1O+>2)SD&F6\Q5@": .Z7793_ !&E.NR@?>-8-F/-P!6LFE/*O - $5QK
MDC _,:Q;K4&DSDFMF?0Y0"=IK&N]/>(G(- %(7;*V<UKZ=K$D;C#&L86Y+8K
M5T_2I)7& : .\T;6I'*Y8UZ1H5XT@7)KS/1M'D0KE37I6A6C1A<B@1W-H=T0
M-6*KV@Q$!5B@ HHHH **** "BBB@ HHHH 1E##D5 ]G$_5:L44 4_P"S;?/W
M:E2TB3HM3T4 (  ,"EHHH *:R!AR*=10!6>RA?JM,&FP#^']*N44 0I;1IT%
M2@ =*6B@ -)2T4 %%%)0 M%)2T 1S?ZLUQ/B7_4O]*[:;_5FN)\2_P"I?Z4
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M&: +-SXH2(GYZJ?\)E&#_K/UKR?7M7FA=OF-<C)XHE63&\T#/HG_ (3- /\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM+80Q@8JU110 C'"DU@:KJ8MU/S5MW#;8&/M7EWC#5#"' :@#/U[Q4$+#?\
MK7GNI^*/,<_/6)KFKO),PW=ZYN2620YR:!G4'7"3G=5NS\1F-Q\U<6"^*0,Z
MG.30,]IT7Q;\R@O^M>E:+KHN%7YLU\NZ?J4D,J_,:]8\'ZPSL@+4"/>[>3S(
M@:EK,T:?S;8<]JTZ!!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4E+24 %+110 C-M&:HW5ZL0.34UY)
MY<9-<)K^JM$&P: -6\UY(R?G'YUFGQ,F?]8/SKR_6/$4JNWS&N=;Q+-O^\:
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M 9Z5#_J5^E25'#_J5^E24""BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** *%[]PUPFN]&KN[W[AKA-=Z-711W \\U+[YHHU+[YHK
MU([#&Z=]\5Z%H/\ #7GNG??%>A:#_#6%?8#O+'[@K1[5G6/W!6CVKS);B"BB
MBI **** "BBB@ HHHH **** "BBDH 6BD%+0!6O(O-BQ7 >(]$\V-R%KT<@'
MK5*]L4GB(Q0!\TZQHTD4[$*>M2:+'-%.HYZUZQK'AI97)"5E6OA8I*#LH&;G
MAMW*(#7=P(OE#(KFM)TTVX7BNGB^6, T"';%_NBE  Z"C</6ER#0!POBVX:-
M'P:\,\0W$TTS $]:]]\2V#7*M@9KS6[\*M+.24/7TH \_P!(TJ6><$J>M>P^
M$]%,:H2M1:)X5$14E*]#TK3%MU7Y<4#+]E;B*,<5<I  !Q2T""BBB@ HHHH
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M_6G?\)BO_/3]:\5;4YD_B-1G6I1_$: L>W?\)BO_ #T_6C_A,5_YZ?K7A_\
M;DO]XT?VY+_>- 6/</\ A,5_YZ?K0?&*_P#/3]:\/_MR7^\:4:W*W\1H"Q[8
M?&0'_+3]:8?&@_YZ?K7CJ:C._0FI/M%P>YH"QZVWC4?\]/UJ:#QH"W^L_6O&
MFGN,]35BVGN-PZT!8]^TWQ6)B!OKL=/U 7"CFO _#\DY=<YKV'PV7*+NH$=A
M10.@HH **2EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ K#U__4GZ5N5AZ_\ ZD_2KA\0'F&H_P#'
MP?K6GHGWA69J/_'P?K6GHGWA7?+X1GH&G?<%; Z5CZ=]P5L#I7GSW$%%%%2
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110!1O?N&N#U_P#BKO+W[AK@]?\ XJZ*.X'*V_\ Q\CZUZ5X:^XM>:V_
M_'R/K7I7AK[BUO7^$#JJ***X "BBB@ HHHH **** "BDI10 4444 %%%% !1
M110 THK=5!K.U#2XIXCA16G1UH \IUWPUOW%4KSS4]#G@=B%(KZ0FL89@01U
MKE=9\.1.K$** /GB=Y[8D'-9]SJ;XP2:])U[PSAFVI7#7OAN8N<(: N5M'NS
M)<K]:]W\#N=D=>1:%X:F6924/6O;?"6G-;HF10!W@Z"BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* (YO]6:XGQ+_J7^E=M-_JS7$^)?]2_TH \-\2_\?#?6J_A__CY7ZU8\2_\
M'PWUJOX?_P"/E?K0,]P\+_ZI*[ZV_P!77 ^%_P#5)7?6W^KH$34444 %%%%
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M!F5* /HKPS<;K=>>U=,#D5R'AA2($^E=>OW10(6BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/*!/I6_@>E9&DIY*@5K[AZT &T>@HVCTI:* $VCTHVCTI:* # HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"A>_<-<)KO1
MJ[N]^X:X37>C5T4=P//-2^^:*-2^^:*]2.PQNG??%>A:#_#7GNG??%>A:#_#
M6%?8#O+'[@K1[5G6/W!6CVKS);B"BBBI **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@"C>_<-<'K_P#%7>7OW#7!Z_\ Q5T4=P.5M_\ CY'UKTKP
MU]Q:\UM_^/D?6O2O#7W%K>O\('54445P %%%% !1110 4444 %%%% !1110
M4444 %%%5;NZ6%#DT 3M*B=6JO)J-O'U>N0UCQ&L ;Y_UK@M4\:E6($GZT >
MP2Z_;1YPP_.LRZU^"7(W"O$)O&DC,?WA_.H/^$ME)^^?SH ]8NYK>X)R16?_
M &=:RMG"UYROBQ\\N?SJU%XP*GE_UH"QZCI^EVR," M=?I\4<2C;BO&M.\9@
ML 7_ %KN]'\2).%^<?G0!WU%4[2\29!S5R@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (YO]6:XGQ+
M_J7^E=M-_JS7$^)?]2_TH \-\2_\?#?6J_A__CY7ZU8\2_\ 'PWUJOX?_P"/
ME?K0,]P\+_ZI*[ZV_P!77 ^%_P#5)7?6W^KH$34444 %%%% !1110 4444 %
M%%% !1110 4444 %0R744?WC3Y3MC8^U<%XDUEK7=AL8H [%M7ME/+#\ZC_M
MNV_O#\Z\*OO&DD<I'F'KZU3_ .$WD_YZ'\Z!V/H(:U;'^(?G3CK%M_>'YU\^
M+XWD_P">A_.I/^$X?_GH?SH$>\3ZY B'##\Z\]\5:TDJ/AJX67QNS*1YGZUA
M:AXB:Y!^?.?>@9E>(+CS)6P>]4=(EV3@GUJ*[E,S$YJ*W;RGS0![?X1U980F
M6KU*SUV%HAEA^=?,>G:ZUMCYL5T=OXU9%QYGZT ?0@UBV_O#\Z<NKVI/WQ^=
M> ?\)R__ #T_6D'CF0'_ %A_.@1[QJ&JVXMF <'(KQCQM=1RF3!%9D_C>21"
M/,/YUR^JZR]YGYB<T#.7O\>>3[U&C@"I)X))')P:C^R2CL: '^8*:T@(J-X)
M .AIL5O*[XP:!CHX3)*,"O2O!FGMYB'%<YHFBO-(N4->P^%=!\H(2E CT'P]
M;;+5<CM6^.!533X?*@ Q5N@04444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %<!XT_U<E=_7 >-/]7)0!X!XA_X^6^M2^'/]>OUJ+Q#_P ?+?6I?#G^
MO7ZT#/>O!WW(Z[_M7 >#ON1UW_:@04444 %%%% !1110 49HI* %HI!2T %%
M%% !1110 4444 %%%% !7+>+U'V5C[5U-<[XFB,MNP]J /FSQ8I^T/\ 6N.7
M.[FO2?%FGMYKG;7GEQ&8G/% PHJ%9,FI>U R.6K&G_ZT54F;%6M*RTP'O0!Z
MAX64DI7LV@(/+7(KRKPA9E]AQ7L.DVYBC7CM02;@&!10.E% !1124 +124M
M!1FBDH 6B@44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "J]Y.((BV:G8X%<YXBO?+MFP
M>U '->(O$@A##?7EFM>)6E9@'I/%VKOYC@-7G<M\\LAR:!FG=:I*\A.XU'%J
MDJG[QK.SNYIK<4#.[T77WC=<O7J?AWQ(&"@O7SO;W31,"#78>'];995&Z@1]
M-6&H"X4<UJCD5YWX4U$SHF37H2'**?:@0ZBBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@""X^X:X3Q'T:N[
MN/N&N$\1]&K:CN!Q47_'U^->C>&?NK7G,7_'U^->C>&?NK757^$#L1THH'2B
MO/ **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M!RMO_P ?(^M>E>&ON+7FMO\ \?(^M>E>&ON+6]?X0.JHHHK@ **** "BBB@
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M_P!2_P!* /#?$O\ Q\-]:K^'_P#CY7ZU8\2_\?#?6J_A_P#X^5^M SW#PO\
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M 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M2E%%% !1110!S7BS_CT/TKYV\5_\?+_6OHGQ9_QZ'Z5\[>*_^/E_K0-%#0/^
M/@?6O;_"?W4KQ#0/^/@?6O;_  G]U* 9Z5#_ *E?I4E1P_ZE?I4E @HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"A>_<-<)KO1
MJ[N]^X:X37>C5T4=P//-2^^:*-2^^:*]2.PQNG??%>A:#_#7GNG??%>A:#_#
M6%?8#O+'[@K1[5G6/W!6CVKS);B"BBBI **** "BBB@ HHHH **** "BBB@
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MDS2TE "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !6'K_\ J3]*W*P]?_U)^E7#
MX@/,-1_X^#]:T]$^\*S-1_X^#]:T]$^\*[Y?",] T[[@K8'2L?3ON"M@=*\^
M>X@HHHJ0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@GYJQK.X,ER#[T#/7O!OWDKUN#_4)]*\E\%CE*]:@_U"?2@1)1BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH YKQ9_P >A^E?.WBO_CY?ZU]$^+/^/0_2OG;Q7_Q\O]:!HH:!_P ? ^M>
MW^$_NI7B&@?\? ^M>W^$_NI0#/2H?]2OTJ2HX?\ 4K]*DH$%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %<!XT_U<E=_7 >-/\ 5R4
M> >(?^/EOK4OAS_7K]:B\0_\?+?6I?#G^O7ZT#/>O!WW(Z[_ +5P'@[[D==_
MVH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5/4
MCBS:KE4]3_X\VH \(\<GYY*\R@_X_/QKTSQS]^2O,X/^/S\:!GK/@\\)7LFC
MG]P/I7C7@_HE>R:/_J!]*!&I1110 444E "T444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !6'K_\ J3]*W*P]?_U)^E7#X@/,-1_X^#]:T]$^\*S-1_X^#]:T]$^\
M*[Y?",] T[[@K8'2L?3ON"M@=*\^>X@HHHJ0"BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *-[]PUP>O_Q5WE[]
MPUP>O_Q5T4=P.5M_^/D?6O2O#7W%KS6W_P"/D?6O2O#7W%K>O\('54445P %
M%%% !1110 4444 %%%% !1110 4R;_5-]*?39!E"* /-_%4)97KQS6[5O,;
MKWS7+$S!N*\]U+PZTKGY/TH&>/RI+&W&:5+NX3H37H4WA%V/^K_2H?\ A#7_
M .>9_*@+G#?;[GU-'VZX]37<'P>P_P"6?Z4?\(@W_//]*!'#_;KGU-*+^Y'<
MUV__  B#?\\_TI1X/8_\L_TH'<X5[VY88)-0(LLLG.:]"_X0Q\?ZL_E2Q^$'
M1O\ 5_I0%S$T.T;S%)%>N^&82JIQ7.:9X>:)A\GZ5WVC6!B"\4 =;8C$(JU4
M%LNV/%3T""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@".;_5FN)\2_P"I?Z5VTW^K-<3XE_U+_2@#PWQ+_P ?
M#?6J_A__ (^5^M6/$O\ Q\-]:K^'_P#CY7ZT#/</"_\ JDKOK;_5UP/A?_5)
M7?6W^KH$34444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44E
M** &M&K]156;389>H%7** ,630(6/W12)X?@4_=%;=% %&+2X(NPJVD2)T%/
MHH ***2@!:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH ***2@!:*** "BBB@!*6BB@ HHHH
M **** "BBB@ J.6,2)@U)10!R6M:(LZ-\M>7Z_X3+,Q5/TKWF2)9!@BLVYT2
M*?.0* /EZZ\(2^8<1G\J;%X0ER/W9_*OH^;PE"YSL%1IX1B!_P!6/RH'<\=T
M/PDZNI*?I7JGA_01"JY6M^V\/0PX^45K06RPC@"@006ZQ( !4]%% "$X%4;Z
M]6&%N:L74GEQYKAO$6K>5&XW4 8_B7Q#Y8<!J\JUCQ*[.V'/YU/XFUAG=QNK
M@;B=I9#DT#L7I]>F+_>-7+#Q#,KC+FL'R-W-(4\OD4!8]<\/>)SO4%_UKUK0
M-9$R+\U?+NE:@T4R_-7K?A/6C\@+4 >[1RB0 BI#6#I-\)HUYK=4Y4&@0M%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!!<?<-<)XCZ-7=W'W
M#7">(^C5M1W XJ+_ (^OQKT;PS]U:\YB_P"/K\:]&\,_=6NJO\('8CI10.E%
M>> 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'9^E '5>#H"H3BO48?\ 5+]*XKP_8& +Q7;1C$:CVH$.HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .:
M\6?\>A^E?.WBO_CY?ZU]$^+/^/0_2OG;Q7_Q\O\ 6@:*&@?\? ^M>W^$_NI7
MB&@?\? ^M>W^$_NI0#/2H?\ 4K]*DJ.'_4K]*DH$%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ K#U__ %)^E;E8>O\ ^I/TJX?$!YAJ/_'P?K6GHGWA
M69J/_'P?K6GHGWA7?+X1GH&G?<%; Z5CZ=]P5L#I7GSW$%%%%2 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MT5B6FK)(1\U;$<JR*"IH ?1110 4444 %%%% !1110 4444 %%%% &;J\FR
M_2O(?%=Z07&:]8UW/V<X]*\5\5AM[T >:ZO*9)&Y[UA;#OK8OP?,;-9IQNH*
M'KP*CE&14@Z4U^E #+92) :[OPW=&-UYKB(?O"NKT(-YBXH$>Z^&;LNB#-=[
M"<Q UYEX4#83->F6_P#J%H$2T444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% $%Q]PUPGB/HU=W<?<-<)XCZ-6U'<#BHO\ CZ_&O1O#/W5KSF+_
M (^OQKT;PS]U:ZJ_P@=B.E% Z45YX!1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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ME1P_ZE?I4E @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MYC2?V@_J:!GL^G>+,,,R?K7;:/XI67:-X_.OFB+5Y(R/F-=7X?\ $+B507-
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!!<?<-<)XCZ-7=W'W#7">(^C5M1W
MXJ+_ (^OQKT;PS]U:\YB_P"/K\:]&\,_=6NJO\('8CI10.E%>> 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "L/7_\ 4GZ5N5AZ_P#ZD_2KA\0'F&H_\?!^M:>B?>%9FH_\?!^M:>B?>%=\
MOA&>@:=]P5L#I6/IWW!6P.E>?/<04445(!1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** *%[]PUPFN]&KN[W[AKA-=Z-711W \\U+[YHHU+[YHKU([#&Z=]
M\5Z%H/\ #7GNG??%>A:#_#6%?8#O+'[@K1[5G6/W!6CVKS);B"BBBI ****
M"BBB@ HHHH **** "BBB@ HHHH 9(@=<&N7U[21-$WRUU=0SPB5""* /G/Q3
MX?97<JGZ5P,D4UG-T(P:^F];\/+<*QV?I7F.N^$<,Q"?I0-'"V?B&:W !<C\
M:VK?Q:X',A_.L6_\/2Q,<*:S&TRY3H#0!VQ\7MC_ %GZU6F\7.0<2'\ZX_[!
M=>C4Y=,N7/0T :UWXCEF) <UG$S7C]SFK=IX>GD894UVNA^$6=ERGZ4 8WA[
MP_))*K%#7M?A;1_(1,K3="\*K"JDI^E=E:VBVR@ 4")TC"# I]%!H **2EH
M**** "BBB@ HHHH **** "BBB@ HHHH **** $H%+10 4444 %%%%  :2EHH
M **** "O/_&G^KD^E>@5P'C3_5R4 > ^(?\ CY;ZU)X<_P!>OUJ/Q#_Q\M]:
MD\.?Z]?K0,]Z\'?<CKO^U<!X.^Y'7?\ :@04444 %%%% !1110 4444 %133
M"-"34M8>LW/DQMS0!S?B?6/*C?#5XCXDU^0RN Y_.NT\5:D6WC=7DFKL996.
M:!HK-J;R.<L:4W+'G-4(XB&JSLXH&/-^Z'@UNZ)K<B2KECUKF9(LFK%D#&X-
M 'T!X6UTN$!?]:].TZ[$T8YKYU\,Z@4=!NKVOPU=F5$YH).RHH'04$@=: "L
M[5;I8[1QFI[N[2&,G-<'XCUY4C=0U 'GOC>X#O)@UYK"X%Y^-=-XCU+[0[\U
MQHDQ/GWH&>Q>$+D#8,U[/HTH> <]J^<O#.J>4R9->S>'=;1HU&X4".\HJ"WN
M5F4$&IZ (ION&N!\6 ^4]>@LNX8KC_%5INA? [4 ?./BC_7/]:Y*/'F5W/BV
MS99GX[UPX0I(<T#+J]**8L@Q09!0,9/]VDT__CX'UHE(<<59TJT9[A<#O0(]
M@\#@_NZ]MTO/D+GTKR+P/8LHCR*]ELX_+@7Z4"+%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M91S7I?A;6RK("WZT ?15O<++&#FK'6N1T/4_.B7YJZJ%MZ9H$24444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110!!<?<-<)XCZ-7=W'W#7">(^C5M1W XJ+_CZ_&O1O#/W5KSF+_CZ_&O1
MO#/W5KJK_"!V(Z44#I17G@%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 1S?ZLURNK]&KJIO]6:Y75^C5K2W X>
M]_UI^M:>B_ZQ:S+W_6GZUIZ+_K%KLE\('H^G?Z@5<JGIW^H%7*\][@%%%%(
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO1]!\-B +E/TH M^&=*^SHGRUW2#" >U4K.T6%!Q5Z@04444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8>O_ZD
M_2MRL/7_ /4GZ5</B \PU'_CX/UK3T3[PK,U'_CX/UK3T3[PKOE\(ST#3ON"
MM@=*Q].^X*V!TKSY[B"BBBI **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\USB@;JV=,)$BXH$>V^%;XD(,UZEI[[X0?:O%O";-E*]DT@YMQ]*!&C1110
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M_P ? ^M>W^$_NI7B&@?\? ^M>W^$_NI0#/2H?]2OTJ2HX?\ 4K]*DH$%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 4+W[AKA-=
MZ-7=WOW#7":[T:NBCN!YYJ7WS11J7WS17J1V&-T[[XKT+0?X:\]T[[XKT+0?
MX:PK[ =Y8_<%:/:LZQ^X*T>U>9+<04445(!1110 4444 %%%% !1110 4444
M %%%% !1110 5#+.L0YJ8]*Y[6;SR4;F@"IK6OB!& ;%>:ZSXN978"3]:9XF
MUEB7 :O-=0N);B4X)H Z:7Q?(6/[P_G48\62Y^^?SKEH-.GF.<&KJZ+/_=-
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M*S*"#7SGX?\ $D@=0SG\Z]=\/ZT)D7+4 =M144,PE4$5+0 4444 %%%% !7
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M6O*-0T]XYCP>M T5XVR*5VP*1$*#FE9=PXH&0K+\^*Z;0X3+(O%8%O8O)*,
MUZ-X5T9F="5H$=WX5L" AQ7JFFIL@ ]JYOP_I@BB3BNMB38F*!$E%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !24M%  **** "BBB@ HHHH **** "BBB@ HHHH ,T444 %%%% !1110
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M2M(F69<J:!'LOAK4#.%YKO8CF-3[5YQX5M7C"9!KT>+B)?I0 ^BBB@ HHHH
M**** "BBB@ HHHH **2EZ4 %%0O<QQ]335O8F. : +%%-5PW2G4 %%%1/<(G
M4T 2T54.HP ]?UIR7L3]#0!9HI%8,,BEH **** "BBB@ HHHH YKQ9_QZ'Z5
M\[>*_P#CY?ZU]$^+/^/0_2OG;Q7_ ,?+_6@:*&@?\? ^M>W^$_NI7B&@?\?
M^M>W^$_NI0#/2H?]2OTJ2HX?]2OTJ2@04444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K#U_\ U)^E;E8>
MO_ZD_2KA\0'F&H_\?!^M:>B?>%9FH_\ 'P?K6GHGWA7?+X1GH&G?<%; Z5CZ
M=]P5L#I7GSW$%%%%2 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP<RE4YKT*Z*_83]*!'BGCECYCUPNDC-Z/K7<>.3^\>N)T?\ X_1]:"CW3P8
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M$%Q]PUPGB/HU=W<?<-<)XCZ-6U'<#BHO^/K\:]&\,_=6O.8O^/K\:]&\,_=6
MNJO\('8CI10.E%>> 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!'-_JS7*ZOT:NJF_U9KE=7Z-6M+<#A[W_6GZ
MUIZ+_K%K,O?]:?K6GHO^L6NR7P@>CZ=_J!5RJ>G?Z@5<KSWN 4444@"BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% $%Q]PUPGB/HU=W<?<-<)XCZ-6U'<#BHO\ CZ_&O1O#/W5K
MSF+_ (^OQKT;PS]U:ZJ_P@=B.E% Z45YX!1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M10 4444 4;W[AK@]?_BKO+W[AK@]?_BKHH[@<K;_ /'R/K7I7AK[BUYK;_\
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MK7K5A:#R0,=J!'E?BC26(8[:\XD@-K<Y(QS7T1KVCB6%CM[5X]XDT=H7<JM
M%WPSKBV[*"V*[BY\2Q/9$;QTKP5KF>SEXR,5<&NW#Q;=QH'8U?$]^+FX;:<Y
M-1^&K-I;A3CO6-&DU[<#()R:]+\'Z*0R$K0!WOARR,<2'%=M$,1 5G:=9"&!
M>*TP,#% A:*** "BBB@!&;:I-<;XFES"_P!*Z^;_ %9KB?$O^I?Z4 >(>)VS
M<-]:J>'_ /CY7ZU8\2_\?#?6J_A__CY7ZT#/</"_^J2N^MO]77 ^%_\ 5)7?
M6W^KH$34444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10!!<?<-<)XCZ-7=W'W#7">(^C5M1W XJ+_CZ_&O1O#/W5KSF+_CZ_&O1O#/
MW5KJK_"!V(Z44#I17G@%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M%I<_;OQKUCP)GY*\UELV^V].]>H^"8"FSB@9Z_;?\>Z?2LK6K?S(VXK4M?\
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MFVOB\M*!O_6@#W>WOUEZ&M%&W#->:>'M;-QM^;K7H=C)OC!H MT444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@""X^X:X3Q'T:N[N/N
M&N$\1]&K:CN!Q47_ !]?C7HWAG[JUYS%_P ?7XUZ-X9^ZM=5?X0.Q'2B@=**
M\\ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@".;_5FN5U?HU=5-_JS7*ZOT:M:6X'#WO\ K3]:T]%_UBUF7O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *%[]PU
MPFN]&KN[W[AKA-=Z-711W \\U+[YHHU+[YHKU([#&Z=]\5Z%H/\ #7GNG??%
M>A:#_#6%?8#O+'[@K1[5G6/W!6CVKS);B"BBBI **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8>
MO_ZD_2MRL/7_ /4GZ5</B \PU'_CX/UK3T3[PK,U'_CX/UK3T3[PKOE\(ST#
M3ON"M@=*Q].^X*V!TKSY[B"BBBI **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH HWOW#7!Z_P#Q5WE[]PUP>O\
M\5=%'<#E;?\ X^1]:]*\-?<6O-;?_CY'UKTKPU]Q:WK_  @=51117  4444
M%%%% !1110 4444 %%!I* %IDW$34^F2C,;"@#B]:O#$S<UA0>(1#+RU;/B&
MV9@Q KR[5Q/!(2N: /7K#Q5"5 +BMN#6(9\8(KYT@UBYA<#<:['1/$+Y7<]
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M_P!70(FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@""X^X:X3Q'T:N[N/N&N$\1]&K:CN!Q47_'U^->C>&?NK7G,7_'U^->C>&?
MNK757^$#L1THH'2BO/ **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *P]?_U)^E;E8>O_ .I/
MTJX?$!YAJ/\ Q\'ZUIZ)]X5F:C_Q\'ZUIZ)]X5WR^$9Z!IWW!6P.E8^G?<%;
M Z5Y\]Q!1114@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% $%Q]PUPGB/HU=W<?<-<)XCZ-6U'<#BHO\
MCZ_&O1O#/W5KSF+_ (^OQKT;PS]U:ZJ_P@=B.E% Z45YX!1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&>E0_P"I7Z5)4</^I7Z5)0(**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]*\+\#@_NZ]NTS/V=<^E!)?HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH *P]?_P!2?I6Y6'K_ /J3]*N'Q >8
M:C_Q\'ZUIZ)]X5F:C_Q\'ZUIZ)]X5WR^$9Z!IWW!6P.E8^G?<%; Z5Y\]Q!1
M114@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 4;W[AK@]?_BKO+W[AK@]?_BKHH[@<K;_ /'R/K7I7AK[BUYK
M;_\ 'R/K7I7AK[BUO7^$#JJ***X "BBB@ HHHH **** "BBB@ HHHH ***1C
MA2: &22B,9-9=WKD=MG)%5=6U(0(WS5YKK^N,2P5J .YN/&D2$C>*J'Q=;RG
MEQ7BE]J5T[G:6JJFH7B\Y:@#W-M6M+@8RO-9]W:17*DH!S7EMAK5R) &8UZ%
MH%_]H"AS0!AZIH4IR44USCV%U;R=&KWFWTJ&[B!*@Y%9NI>%(BI(0?E0!Y=I
MVHSVI&XGBNNTWQ@8< O^M9>KZ"T&[:M<9=17,$AQF@9[E9>,$F !8&MVVU5;
M@#!%?/>F:A<1R@$FO2O#VI,X0$T"/2T;<,TZJMB^^$&K5 !0:** $I:** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH CF_
MU9KB?$O^I?Z5VTW^K-<3XE_U+_2@#PWQ+_Q\-]:K^'_^/E?K5CQ+_P ?#?6J
M_A__ (^5^M SW#PO_JDKOK;_ %=<#X7_ -4E=];?ZN@1-1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110!S7BS_ (]#]*^=O%?_ !\O]:^B?%G_ !Z'Z5\[>*_^/E_K0-%#0/\
MCX'UKV_PG]U*\0T#_CX'UKV_PG]U* 9Z5#_J5^E25'#_ *E?I4E @HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"A>_<-<)KO1J
M[N]^X:X37>C5T4=P//-2^^:*-2^^:*]2.PQNG??%>A:#_#7GNG??%>A:#_#6
M%?8#O+'[@K1[5G6/W!6CVKS);B"BBBI **** "BBB@ I*6B@!*6C%% !1110
M 4444 8OB&4Q6I(]*\0\1:FQN&7=WKVKQ.A:S./2O O$MO(+IC@]: )-,MEO
M7&><UU</A6*2/=M%<9H=V;>0;J[^TUU!" 2.E &!J?AZ. $A16+ BVTXQV-=
M#K6L*Z-@UQ_VII;GCUH&>I>&M0V[1FO2;&Z\V( UY%X8C=MAYKU32XRJ+F@1
M;N[)9P>*YG4?"ZS@_)^E=E10!Y)>^#0A)"?I5*#16MI>%KV"XMDE0_*,UBSZ
M0K/D+0!G:&C)M!KL8_N"LBSL/*(XK8484"@!:*** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N \:?ZN2N_K@/&
MG^KDH \ \0_\?+?6I?#G^O7ZU%XA_P"/EOK4OAS_ %Z_6@9[UX.^Y'7?]JX#
MP=]R.N_[4""BBB@ HHHH **** "BBB@ I&8*,DTM9FHW7DHW- &3X@U401MA
MNU>.>)/%#*[ /^M=-XKU8E7 :O%]>N7EE;GO0,L7&OO,Y^>JAU%B<[JPDW[J
MLC.*!FNFLO$P^8UU.@^)F$B@OW]:\XE#9J]IDKQ2 Y/6@1],>&]<$R)EJ[VU
MG$J#FOGWPKJK*4&ZO9=!O?.C7F@1TU9>KV_G1$8[5J#I4<J!UQ0!XMXIT,OO
M(6O(]9TMX9&^4U]2:KHZSQM\M>8^(_"_WR$_2@9X6(V1^:F!XK=U;2C;2-\N
M,5AA?WFV@9&T#2'@5MZ%I<CSK\IJ[I&DFY9?ES7IOASPIRK>7^E C7\'Z255
M"5KT^VMQ$@&.U9>CZ6+55&W&*W:!"$9&*Y#Q7:%X6P.U=A67K%MY\!X[4 ?,
M'BVR<3/QWKB%B*2'(KW3Q5H!<N=E>5ZGI;6[M\N*!F2#Q1FHWRK8I"30,)5W
M#BK.E6;O<+QWI]G;-,X&*[OP[X>,CJVS]* .R\#V+*(\BO9+2/9 OTKC_#6D
M?9T3Y<5VZC" 4$BT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %8>O_P"I/TK<K#U__4GZ5</B \PU'_CX/UK3
MT3[PK,U'_CX/UK3T3[PKOE\(ST#3ON"M@=*Q].^X*V!TKSY[B"BBBI ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-G;6Q#'L7% $U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!S7BS_ (]#]*^=O%?_ !\O]:^B?%G_ !Z'
MZ5\[>*_^/E_K0-%#0/\ CX'UKV_PG]U*\0T#_CX'UKV_PG]U* 9Z5#_J5^E2
M5'#_ *E?I4E @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@"A>_<-<)KO1J[N]^X:X37>C5T4=P//-2^^:*-2^^:*]2.PQNG??%
M>A:#_#7GNG??%>A:#_#6%?8#O+'[@K1[5G6/W!6CVKS);B"BBBI **** "BB
MB@ HHHH **** "BBB@ HHHH S]5@\^ C':O+O$/AXR,S!/TKU]E##!K-OM+2
M9#\H- 'S[/I,ELY(4U&'F3CFO5M4\/AB<)7,S>'3O/R4#.)FCEGXYJSIFBR2
M3 E379VWAPDC*5TNF>'E0@E*!$/AO23$JY6N\MHMB 5!8V*P*.*O@8H 6BBB
M@ I, ]J6B@!,#TI:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ K@/&G^KDKOZX#QI_JY* / /$/\ Q\M]
M:E\.?Z]?K47B'_CY;ZU+X<_UZ_6@9[UX.^Y'7?\ :N \'?<CKO\ M0(****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L/7_P#4GZ5N5AZ_
M_J3]*N'Q >8:C_Q\'ZUIZ)]X5F:C_P ?!^M:>B?>%=\OA&>@:=]P5L#I6/IW
MW!6P.E>?/<04445(!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% %&]^X:X/7_XJ[R]^X:X/7_XJZ*.X'*V__'R/
MK7I7AK[BUYK;_P#'R/K7I7AK[BUO7^$#JJ***X "BBB@ HHHH **** "BBB@
M I*6B@ IDHW1D4^CK0!Q.O:1]H5CMS7FVJZ"T;DA:]XEMDE4@BN;U71$D!PM
M 'AS0RP-@9H9YF7'-=]?^'<N<)5)/#C9^Y0!Q$=A+-*.#79>']$8,I*UM6'A
MP!@2E=CI>CK$!\M $FE6'DQKQVK?0;5Q38XE10 *D[4 %%%% !@&DVCT%+10
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% $<W^K-<3XE_U+_2NVF_U9KB?$O^I?Z4 >&^)?^/AOK5?P
M_P#\?*_6K'B7_CX;ZU7\/_\ 'ROUH&>X>%_]4E=];?ZNN!\+_P"J2N^MO]70
M(FHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 4+W[AKA-=Z-7=WOW#7":[T:NBCN!YYJ7WS11J7WS17J1V&-T[[XKT
M+0?X:\]T[[XKT+0?X:PK[ =Y8_<%:/:LZQ^X*T>U>9+<04445(!1110 4444
M %%%% !1110 4444 %%%% !0>1110!6ELTEZ@54;1XV.<"M2B@#-32HT["K<
M=LL?05/10  8%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M$%Q]PUPGB/HU=W<?<-<)XCZ-6U'<#BHO^/K\:]&\,_=6O.8O^/K\:]&\,_=6
MNJO\('8CI10.E%>> 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!'-_JS7*ZOT:NJF_U9KE=7Z-6M+<#A[W_6GZ
MUIZ+_K%K,O?]:?K6GHO^L6NR7P@>CZ=_J!5RJ>G?Z@5<KSWN 4444@"BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MUXUX'MS^[XKVBP39 ![4$ENBBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH CF_U9KB?$O\
MJ7^E=M-_JS7$^)?]2_TH \-\2_\ 'PWUJOX?_P"/E?K5CQ+_ ,?#?6J_A_\
MX^5^M SW#PO_ *I*[ZV_U=<#X7_U25WUM_JZ!$U%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 07'W#7">(^C5W=Q]PUPGB/HU;4
M=P.*B_X^OQKT;PS]U:\YB_X^OQKT;PS]U:ZJ_P ('8CI10.E%>> 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!
M'-_JS7*ZOT:NJF_U9KE=7Z-6M+<#A[W_ %I^M:>B_P"L6LR]_P!:?K6GHO\
MK%KLE\('H^G?Z@5<JGIW^H%7*\][@%%%%( HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBDH 6BDI: "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#FO%G_
M !Z'Z5\[>*_^/E_K7T3XL_X]#]*^=O%?_'R_UH&BAH'_ !\#ZU[?X3^ZE>(:
M!_Q\#ZU[?X3^ZE ,]*A_U*_2I*CA_P!2OTJ2@04444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110!0O?N&N$UWHU=W>_<-<)KO1JZ*.
MX'GFI??-%&I??-%>I'88W3OOBO0M!_AKSW3OOBO0M!_AK"OL!WEC]P5H]JSK
M'[@K1[5YDMQ!1114@%%%% !1110 4444 %%%% !1110 AHI:* "BBB@ HHHH
M **** "BBB@ HHHH 2E%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %<!XT_U<E=_7 >-/\ 5R4
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M])B79&![5FZ=IRVZ+@8K5H$%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% $%Q]PUPGB/HU=W<?<-<)XCZ-6U'
M<#BHO^/K\:]&\,_=6O.8O^/K\:]&\,_=6NJO\('8CI10.E%>> 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!'-
M_JS7*ZOT:NJF_P!6:Y75^C5K2W X>]_UI^M:>B_ZQ:S+W_6GZUIZ+_K%KLE\
M('H^G?Z@5<JGIW^H%7*\][@%%%%( HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .:\6?\>A^E?.W
MBO\ X^7^M?1/BS_CT/TKYV\5_P#'R_UH&BAH'_'P/K7M_A/[J5XAH'_'P/K7
MM_A/[J4 STJ'_4K]*DJ.'_4K]*DH$%%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 4+W[AKA-=Z-7=WOW#7":[T:NBCN!YYJ7WS1
M1J7WS17J1V&-T[[XKT+0?X:\]T[[XKT+0?X:PK[ =Y8_<%:/:LZQ^X*T>U>9
M+<04445(!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %<!XT_P!7)7?UP'C3_5R4 > >(?\ CY;Z
MU+X<_P!>OUJ+Q#_Q\M]:E\.?Z]?K0,]Z\'?<CKO^U<!X.^Y'7?\ :@04444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHJ.29(QR10!)16>^H(#]ZI(KU'_BH N44BL&&0<TM "4M%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5AZ_P#Z
MD_2MRL/7_P#4GZ5</B \PU'_ (^#]:T]$^\*S-1_X^#]:T]$^\*[Y?",] T[
M[@K8'2L?3ON"M@=*\^>X@HHHJ0"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** *-[]PUP>O_ ,5=Y>_<-<'K_P#%
M711W Y6W_P"/D?6O2O#7W%KS6W_X^1]:]*\-?<6MZ_P@=51117  4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% '->+/^/0_2OG;Q7_Q\O]:^B?%G_'H?I7SMXK_X^7^M T4-
M _X^!]:]O\)_=2O$- _X^!]:]O\ "?W4H!GI4/\ J5^E25'#_J5^E24""BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MS& _Z9^- SUCP? I"<>E>R:1$JP X[5X[X/;A*]CTALP#Z4"-*BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% $%Q]PUPGB/HU=W<?<-<)XCZ-6U'<#BHO^/K\:]&\,_=6
MO.8O^/K\:]&\,_=6NJO\('8CI10.E%>> 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!'-_JS7*ZOT:NJF_U9KE
M=7Z-6M+<#A[W_6GZUIZ+_K%K,O?]:?K6GHO^L6NR7P@>CZ=_J!5RJ>G?Z@5<
MKSWN 4444@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH YKQ9_QZ'Z5\[>*_^/E_K7T3XL_X]#]*
M^=O%?_'R_P!:!HH:!_Q\#ZU[?X3^ZE>(:!_Q\#ZU[?X3^ZE ,]*A_P!2OTJ2
MHX?]2OTJ2@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!0O?N&N$UWHU=W>_<-<)KO1JZ*.X'GFI??-%&I??-%>I'88W3OOBO0
MM!_AKSW3OOBO0M!_AK"OL!WEC]P5H]JSK'[@K1[5YDMQ!1114@%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 5P'C3_5R5W]<!XT_P!7)0!X!XA_X^6^M2^'/]>OUJ+Q#_Q\M]:E
M\.?Z]?K0,]Z\'?<CKO\ M7 >#ON1UW_:@04444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %5-2_X\WJW6;J]RD=HP)&<4 >'>.OOR5Y
ME ?],_&O1_&\ZN[X->9QOB\_&@9Z]X//"5[+I _< ^U>(^#KA1LR:]LT:9'M
M@ 1G% C4H[T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 5[QBMLQ':O)O%^K&'>-U>KZ@P6RD)]*\#\
M>W.'DP: //\ 6=2:>5ANKG)8R[9I]Q*S7!Y[U(G(H**ZP'%(82!5P"FN/EH
MBLY6CF'/>O4O"&HE63YJ\JC'[VNX\,R%9$YH!GT5H5]YL"#-=*AW+FO//#,Y
M,:<UWUJVZ,4$D]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !6'K_^I/TK<K#U_P#U)^E7#X@/,-1_X^#]:T]$^\*S-1_X^#]:
MT]$^\*[Y?",] T[[@K8'2L?3ON"M@=*\^>X@HHHJ0"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *-[]PUP>O\
M\5=Y>_<-<'K_ /%711W Y6W_ ./D?6O2O#7W%KS6W_X^1]:]*\-?<6MZ_P (
M'54445P %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!'-_JS7$^)?]2_TKMIO]6:XGQ+_J7^E 'A
MOB7_ (^&^M5_#_\ Q\K]:L>)?^/AOK5?P_\ \?*_6@9[AX7_ -4E=];?ZNN!
M\+_ZI*[ZV_U= B:BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** (+C[AKA/$?1J[NX^X:X3Q'T:MJ.X'%1?\ 'U^->C>&?NK7G,7_
M !]?C7HWAG[JUU5_A [$=**!THKSP"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_CY7ZT#/</"_^J2N^MO]77 ^%_\ 5)7?6W^KH$34444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110!!<?<-<)XCZ-7=W'W#7">(^C5M
M1W XJ+_CZ_&O1O#/W5KSF+_CZ_&O1O#/W5KJK_"!V(Z44#I17G@%%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 1
MS?ZLURNK]&KJIO\ 5FN5U?HU:TMP.'O?]:?K6GHO^L6LR]_UI^M:>B_ZQ:[)
M?"!Z/IW^H%7*IZ=_J!5RO/>X!1112 **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#FO%G_'H?I7S
MMXK_ ./E_K7T3XL_X]#]*^=O%?\ Q\O]:!HH:!_Q\#ZU[?X3^ZE>(:!_Q\#Z
MU[?X3^ZE ,]*A_U*_2I*CA_U*_2I*!!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% $%Q]PUPGB/HU=W<?<-<)XCZ-6U'<#BHO^/K\:]&
M\,_=6O.8O^/K\:]&\,_=6NJO\('8CI10.E%>> 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!'-_JS7*ZOT:NJF
M_P!6:Y75^C5K2W X>]_UI^M:>B_ZQ:S+W_6GZUIZ+_K%KLE\('H^G?Z@5<JG
MIW^H%7*\][@%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** .:\6?\>A^E?.WBO\ X^7^M?1/
MBS_CT/TKYV\5_P#'R_UH&BAH'_'P/K7M_A/[J5XAH'_'P/K7M_A/[J4 STJ'
M_4K]*DJ.'_4K]*DH$%%%% !1110 44E+0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MBB@ HHHH *2EHH 3-+24M !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %8>O_ZD
M_2MRL/7_ /4GZ5</B \PU'_CX/UK3T3[PK,U'_CX/UK3T3[PKOE\(ST#3ON"
MM@=*Q].^X*V!TKSY[B"BBBI **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH HWOW#7!Z_P#Q5WE[]PUP>O\ \5=%
M'<#E;?\ X^1]:]*\-?<6O-;?_CY'UKTKPU]Q:WK_  @=51117  4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 1RR;%S7+:YK MXV^:MG5)_*C:O*/%NIN%< T 9>N>*6W
ML _ZUS#ZU+.QPQK"O)9KFY(YZUT&B:'+< $J>:!E5M1F1LY-:FG>(WA< L:T
M+OPO(L6[8>E<?J-I)9R'@C% 'LOA[Q+YNP%Z]$L;L31@YKYJ\-:HZ7**6/6O
M=?#UX7M%)/:@1N:C?"WC)SCBO-/$?B/87 >M[Q3J7E0M@]J\9UK4'GG8 ]Z
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (+C[AK
MA/$?1J[NX^X:X3Q'T:MJ.X'%1?\ 'U^->C>&?NK7G,7_ !]?C7HWAG[JUU5_
MA [$=**!THKSP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH'_'P/K7M_A/[J4 STJ'_4K]*DJ.'_4K]*DH$%%%% !1110 F*6BB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^X*V!TKSY[B"BBBI **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJ^M<O=^(8XB1O%4AXGBS]\?G0!VOFKZT>8OK7&?\)-'_ 'Q^=.'B:+^^/SH
MZV:50AYKB_$LH,+\]J?-XEB*GYQ^=<KKNN))$V&% 'FOB5LW#?6J_A__ (^5
M^M0ZW="6=L'O5CP\,SJ?>@9[=X7_ -4E=];?ZNN!\,?ZI*[VV_U8H$3T444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!!<?<-<)XC
MZ-7=W'W#7">(^C5M1W XJ+_CZ_&O1O#/W5KSF+_CZ_&O1O#/W5KJK_"!V(Z4
M4#I17G@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MD6/3'%9_AG1!# I*UT]] $L6P.@H \/\<OEW%<1I S>CZUV7C@GS7KC='/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (+C[AK
MA/$?1J[NX^X:X3Q'T:MJ.X'%1?\ 'U^->C>&?NK7G,7_ !]?C7HWAG[JUU5_
MA [$=**!THKSP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<>M>D>!7*E*!GN43 Q*<]J=D>HK&%\([9>>@K(NO$2Q,1OH$=AN'J*-P]17
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M0![SX/\ ]6E=]VK@/!_W$KO^U @HHHH **** "BBB@ HHHH 0T4&B@!:***
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M/O"N^7PC/0-.^X*V!TK'T[[@K8'2O/GN(****D HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"C>_<-<'K_ /%7
M>7OW#7!Z_P#Q5T4=P.5M_P#CY'UKTKPU]Q:\UM_^/D?6O2O#7W%K>O\ "!U5
M%%%< !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 44AHH 6BBB@ HHHH *IWUT+>(DG%3RS+&"37$^*=;$43@
M-0!D>)O$8174/^M>2ZMJ3WD[ -G)I/$FOL\S#?6)IMT)[@%CWH&=!HNA/=SJ
M2N<FO8?#/A58D1BE<GX7>WCV$XKTZSUNUMX%&Y:!&_;6R6T010*CU 9LI/I5
M*+Q!;2G 89^M69[E)[1]O<4 >"^.D/G25Q&E';>CZUZ9XVLBSN<5YK$OV>[R
M>.:!GN7@I@8TKN]04?8B?:O(_".M)"$!:N[O?$$;61^<=*!'F'C5]LK_ %KB
M+ [[H?6M[Q?J2S3O@YYK(T"$S7(..] 'IWAFWW*G%=[%IPD@&1VKGO#-@5C0
MXKOK>$+$ 10!QM[X=25C\@K/'A9,_<'Y5Z*UNC=J;]EC]* //_\ A%T_N?I3
MAX83^X/RKOOLJ>E+]F3TH \\E\,(%^X/RKF=:T%8HV^2O99;5"AP*XOQ);*(
M7XH ^?\ 6+013GCO5SP\<3J/>I?$B!;AOK4/A_\ X^5^M SV_P ,#]VE=[;?
MZL5P?AC_ %25WMM_JQ0(FI#2T4 )2T44 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MO_"/3_W#2_\ "/S_ -P_E0 R\UZ252"QK#DN#,^2:UKK0YHER5-9#P-$^"*
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MZ* .%_X06/\ YYBC_A!8_P#GF*[JB@#A?^$&C_YYC\J/^$'C_P">8_*NZHH
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MR-_RT/YU7;Q1(3]\UQF']:4!_>@#M%\4R+_&?SJ0>+I /]8?SKA\/ZTF']:
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M]+\--+(I*&O3O#F@BW"G;0!TNB6(B@7CM6Z!@8J.WC$<0 J6@04444 %%%%
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M@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 1S?ZLURNK]&KJIO]6:Y75^C5K2W X>]_P!:?K6GHO\ K%K,O?\
M6GZUIZ+_ *Q:[)?"!Z/IW^H%7*IZ=_J!5RO/>X!1112 **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "@T44 )
M2T8HH **** $+ =37/:_JJVT38;H*N:E>>0I.:\M\6ZZ2K@/0!A>)_$I9G4/
M7#I.U[<<G.35/5+QYYS\W>KFB1_O%)H&=_X7T5'=&9:]@TBPAMX$X%>8:'?)
M;*O(KL(?$:", .*!'<M(HC.#7"^+(]\+D>E:=IJXN,#=46M0>?:L<=J /GK7
M8]EX?K75>")PLJ<]ZR/%=DT=RQQWJ'PU=FWG7)QS0,^D=/O4%D.>U<+XTNU:
M-^:9:^( EJ!O[5RGB/5OM"L V:!' 7S;KXX]:]+\"1EBE>;K"TUX#CO7K?@6
MS*%"10,]*&G":V4$=JR[CPLDS$[!73Q#$2CVI] CBCX+C/\ RS'Y4G_"%1_\
M\Q^5=M10!Q/_  A<?_/,?E1_PA<?_/,?E7;44 >6^(O":06Y(0=/2O%]?LQ;
M3L .AKZ<\4E?[/.>N#7SCXMQ]J?'K0-&?H#9G7ZU[=X3'RI7B&@?\? ^M>W^
M$_NI0#/2H?\ 4K]*DJ.'_4K]*DH$%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF"W9OEKBKA0)",5ZUXRM@CO@5Y1>C$S4#*F!3@!32:<.E PP*-HI:* $VBC
MI:*!$4@ J2S4/*!4,YP*DTQLW"_6@9Z)X>TL3A?EKO[+PNKH#L_2L?P5;"01
MY%>R:?81I I*CI02<GI_AU86!V?I77V%J(5 Q5P01CHM/"@=* %HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *P]?_P!2?I6Y
M6'K_ /J3]*N'Q >8:C_Q\'ZUIZ)]X5F:C_Q\'ZUIZ)]X5WR^$9Z!IWW!6P.E
M8^G?<%; Z5Y\]Q!1114@%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 4;W[AK@]?_BKO+W[AK@]?_BKHH[@<K;_
M /'R/K7I7AK[BUYK;_\ 'R/K7I7AK[BUO7^$#JJ***X "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DI:* "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[5+65IDI>%?I6J.E @HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BDI: "BBB@ HHHH **** "BBB@ I*6C%  ***"0
M.M !5>\4O;.!4V]1_$*1G1E(R#0!X_XOTUG+G;7CNL69AE;(KZ<U[3%GC8@9
MKQ;Q7H3*SE4H \JDD"MBGI(#4E[ILR2GY3426LBCD&@HD#9IPI@C8=:?B@!"
MV*890*<8RW2H'MI"> : "1@XP*T-&M&>X4@=ZAL]-EE<#::[_P ->'F+H2E
M'?\ @>T*+'D5ZY ,0H/:N-\-:9]G1/EKM5&% H)%HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BC%% !1110 4444 %%%% !1110 4444 %%%% $
M<W^K-<3XE_U+_2NVF_U9KB?$O^I?Z4 >&^)?^/AOK5?P_P#\?*_6K'B7_CX;
MZU7\/_\ 'ROUH&>X>%_]4E=];?ZNN!\+_P"J2N^MO]70(FHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!!<?<-<)XCZ-7=W'W#7">(^C5M1W
MXJ+_ (^OQKT;PS]U:\YB_P"/K\:]&\,_=6NJO\('8CI10.E%>> 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!'
M-_JS7*ZOT:NJF_U9KE=7Z-6M+<#A[W_6GZUIZ+_K%K,O?]:?K6GHO^L6NR7P
M@>CZ=_J!5RJ>G?Z@5<KSWN 4444@"BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110!0O?N&N$UWHU=W>_<-<)KO1JZ*.X'GFI??
M-%&I??-%>I'88W3OOBO0M!_AKSW3OOBO0M!_AK"OL!WEC]P5H]JSK'[@K1[5
MYDMQ!1114@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1124 +1110 44&DH 6BBB@ K@/&G^KDKOZX#QI_JY* / /$/_'RW
MUJ7PY_KU^M1>(?\ CY;ZU+X<_P!>OUH&>]>#ON1UW_:N \'?<CKO^U @HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH R-7M_.1ABO*?%&C$[SMKVF2(2#F
MN9U_2!+$V%[4 ?,.M61AD;BN=,FUZ]<\3^'F+/A*\\O-!F5S\IH&9'VD4UI-
M]66T>;=]TU=M="E=AE30,72+4RRKQ7K7A;1R=AVUSOASPX^]24KV3PWHXB1<
MK0)FQH]GY*+Q6_44<(C'%2T"*.IP>="1CM7F/B3P]YP<A*]:=0PP:S;W3$GC
M/ - 'S%K/AUHW8A*YF32W1S\IKZ-UGPRK[B$KA[[PJ0YPGZ4#/)_[/8]JNVN
MBO*P^4UWR>%VWCY*Z'2?"OS#*?I0*YROA_PRWF*=GZ5[)X:TK[.BY7%2:1X=
M2)5.P5T]O:K !@4 6%4* *6BB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH)Q43W$<
M?WFH D) &37/Z[J:PPL W:GZIKL,,9 8"O,_$GB,.' >@#G?%NO-N<!Z\QO-
M6DDF/S&MC6KTW#MS7,/%E\T#+(NV8<FD:[91P:C2/ H>/(H&7+#5Y(YA\QZU
MZEX3\0L&0%_UKQZ.':^:Z;1KXV\B\T"/J?0]36YMU!.>*M:I"LD!/M7EGA?Q
M($507KM)?$,<EOC>.E CSKQE;A0]>1SKB\_&O5_%M\DRO@UY3.P-YGWH!'IG
M@2$,\=>\Z?"L=HG'.*\(\"2!72O=;&Y0VB9/04 7:*@-Y"/XJ!=PGHU $]%-
M616Z&G4 %%%(S!>IH 6BH6NHEZM3?ML/]Z@"Q142W$;=&J0$'I0 M%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5AZ__ *D_2MRL/7_]2?I5
MP^(#S#4?^/@_6M/1/O"LS4?^/@_6M/1/O"N^7PC/0-.^X*V!TK'T[[@K8'2O
M/GN(****D HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@"C>_<-<'K_\5=Y>_<-<'K_\5=%'<#E;?_CY'UKTKPU]
MQ:\UM_\ CY'UKTKPU]Q:WK_"!U5%%%< !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 1S?ZLUQ/B
M7_4O]*[:;_5FN)\2_P"I?Z4 >&^)?^/AOK5?P_\ \?*_6K'B7_CX;ZU7\/\
M_'ROUH&>X>%_]4E=];?ZNN!\+_ZI*[ZV_P!70(FHHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@""X^X:X3Q'T:N[N/N&N$\1]&K:
MCN!Q47_'U^->C>&?NK7G,7_'U^->C>&?NK757^$#L1THH'2BO/ **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH C
MF_U9KE=7Z-753?ZLURNK]&K6EN!P][_K3]:T]%_UBUF7O^M/UK3T7_6+79+X
M0/1]._U JY5/3O\ 4"KE>>]P"BBBD 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '->+/^/0_2OG
M;Q5_Q\O]:^B?%G_'H?I7SKXJ_P"/E_K0-%'0/^/@?6O;_"?W4KQ#0/\ CX'U
MKV_PG]U* 9Z5#_J5^E25'#_J5^E24""BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@""X^X:X3Q'T:N[N/N&N$\1]&K:CN!Q47_ !]?C7HW
MAG[JUYS%_P ?7XUZ-X9^ZM=5?X0.Q'2B@=**\\ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M:!_Q\#ZU[?X3^ZE>(:!_Q\#ZU[?X3^ZE ,]*A_U*_2I*CA_U*_2I*!!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %"]^X:X37>
MC5W=[]PUPFN]&KHH[@>>:E]\T4:E]\T5ZD=AC=.^^*]"T'^&O/=.^^*]"T'^
M&L*^P'>6/W!6CVK.L?N"M'M7F2W$%%%%2 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7 >-/\
M5R5W]<!XT_U<E '@'B'_ (^6^M2^'/\ 7K]:B\0_\?+?6I?#G^O7ZT#/>O!W
MW(Z[_M7 >#ON1UW_ &H$%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )12T4 %%%)0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %&]^X:X/7_XJ
M[R]^X:X/7_XJZ*.X'*V__'R/K7I7AK[BUYK;_P#'R/K7I7AK[BUO7^$#JJ**
M*X "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH CF_P!6:XGQ+_J7^E=M-_JS7$^)?]2_TH \-\2_
M\?#?6J_A_P#X^5^M6/$O_'PWUJOX?_X^5^M SW#PO_JDKOK;_5UP/A?_ %25
MWUM_JZ!$U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 07'W#7">(^C5W=Q]PUPGB/HU;4=P.*B_X^OQKT;PS]U:\YB_X^OQKT;P
MS]U:ZJ_P@=B.E% Z45YX!1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% $<W^K-<KJ_1JZJ;_ %9KE=7Z-6M+<#A[
MW_6GZUIZ+_K%K,O?]:?K6GHO^L6NR7P@>CZ=_J!5RJ>G?Z@5<KSWN 4444@"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH YKQ9_QZ'Z5\[>*_P#CY?ZU]$^+/^/0_2OG;Q7_ ,?+
M_6@:*&@?\? ^M>W^$_NI7B&@?\? ^M>W^$_NI0#/2H?]2OTJ2HX?]2OTJ2@0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!0O?N
M&N$UWHU=W>_<-<)KO1JZ*.X'GFI??-%&I??-%>I'88W3OOBO0M!_AKSW3OOB
MO0M!_AK"OL!WEC]P5H]JSK'[@K1[5YDMQ!1114@%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5P
M'C3_ %<E=_7 >-/]7)0!X!XA_P"/EOK4OAS_ %Z_6HO$/_'RWUJ7PY_KU^M
MSWKP=]R.N_[5P'@[[D==_P!J!!1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M="\.B';E/TH M>'=&$4:G;VKMK:$1J*CLK188QQ5S&*!!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5AZ_\ ZD_2MRL/7_\ 4GZ5</B \PU'_CX/
MUK3T3[PK,U'_ (^#]:T]$^\*[Y?",] T[[@K8'2L?3ON"M@=*\^>X@HHHJ0"
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** *-[]PUP>O_P 5=Y>_<-<'K_\ %711W Y6W_X^1]:]*\-?<6O-;?\
MX^1]:]*\-?<6MZ_P@=51117  4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $<W^K-<3XE_U+_2NV
MF_U9KB?$O^I?Z4 >&^)?^/AOK5?P_P#\?*_6K'B7_CX;ZU7\/_\ 'ROUH&>X
M>%_]4E=];?ZNN!\+_P"J2N^MO]70(FHHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@""X^X:X3Q'T:N[N/N&N$\1]&K:CN!Q47_'U
M^->C>&?NK7G,7_'U^->C>&?NK757^$#L1THH'2BO/ **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH CF_P!6:Y75
M^C5U4W^K-<KJ_1JUI;@</>_ZT_6M/1?]8M9E[_K3]:T]%_UBUV2^$#T?3O\
M4"KE4]._U JY7GO< HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110!S7BS_CT/TKYV\5_\?+_
M %KZ)\6?\>A^E?.WBO\ X^7^M T4- _X^!]:]O\ "?W4KQ#0/^/@?6O;_"?W
M4H!GI4/^I7Z5)4</^I7Z5)0(**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH H7OW#7":[T:N[O?N&N$UWHU=%'<#SS4OOFBC4OOF
MBO4CL,;IWWQ7H6@_PUY[IWWQ7H6@_P -85]@.\L?N"M'M6=8_<%:/:O,EN(*
M***D HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "N \:?ZN2N_K@/&G^KDH \ \0_P#'RWUJ7PY_
MKU^M1>(?^/EOK4OAS_7K]:!GO7@[[D==_P!JX#P=]R.N_P"U @HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 07'W#7"
M>(^C5W=Q]PUPGB/HU;4=P.*B_P"/K\:]&\,_=6O.8O\ CZ_&O1O#/W5KJK_"
M!V(Z44#I17G@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 1S?ZLURNK]&KJIO]6:Y75^C5K2W X>]_UI^M:>B_
MZQ:S+W_6GZUIZ+_K%KLE\('H^G?Z@5<JGIW^H%7*\][@%%%%( HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** .:\6?\>A^E?.WBO_ (^7^M?1/BS_ (]#]*^=O%?_ !\O]:!HH:!_
MQ\#ZU[?X3^ZE>(:!_P ? ^M>W^$_NI0#/2H?]2OTJ2HX?]2OTJ2@04444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!0O?N&N$UWHU
M=W>_<-<)KO1JZ*.X'GFI??-%&I??-%>I'88W3OOBO0M!_AKSW3OOBO0M!_AK
M"OL!WEC]P5H]JSK'[@K1[5YDMQ!1114@%%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5P'C3_5R5
MW]<!XT_U<E '@'B'_CY;ZU+X<_UZ_6HO$/\ Q\M]:E\.?Z]?K0,]Z\'?<CKO
M^U<!X.^Y'7?]J!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M$%Q]PUPGB/HU=W<?<-<)XCZ-6U'<#BHO^/K\:]&\,_=6O.8O^/K\:]&\,_=6
MNJO\('8CI10.E%>> 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!'-_JS7*ZOT:NJF_U9KE=7Z-6M+<#A[W_6GZ
MUIZ+_K%K,O?]:?K6GHO^L6NR7P@>CZ=_J!5RJ>G?Z@5<KSWN 4444@"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH YKQ9_QZ'Z5\[>*_^/E_K7T3XL_X]#]*^=O%?_'R_P!:!HH:
M!_Q\#ZU[?X3^ZE>(:!_Q\#ZU[?X3^ZE ,]*A_P!2OTJ2HX?]2OTJ2@04444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!0O?N&N$UW
MHU=W>_<-<)KO1JZ*.X'GFI??-%&I??-%>I'88W3OOBO0M!_AKSW3OOBO0M!_
MAK"OL!WEC]P5H]JSK'[@K1[5YDMQ!1114@%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4E+10 E+110 4444 %<!XT_
MU<E=_7 >-/\ 5R4 > >(?^/EOK4OAS_7K]:B\0_\?+?6I?#G^O7ZT#/>O!WW
M(Z[_ +5P'@[[D==_VH$%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:0"&,#%6*!!1110 4E+10 @I:** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "L/7_P#4GZ5N5AZ__J3]*N'Q >8:C_Q\'ZUIZ)]X5F:C_P ?!^M:>B?>
M%=\OA&>@:=]P5L#I6/IWW!6P.E>?/<04445(!1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %&]^X:X/7_XJ[R]^
MX:X/7_XJZ*.X'*V__'R/K7I7AK[BUYK;_P#'R/K7I7AK[BUO7^$#JJ***X "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBDH 6B@
M44 %%%% !1110 4444 1S?<-<5XE_P!2_P!*[2?[E<7XD_U+_2@#PSQ+_P ?
M#?6J_A__ (^5^M6?$W_'PWUJMX?_ ./E?K0,]P\+_P"J2N^MO]77 ^%_]4E=
M];?ZN@1-1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% $%Q]PUPGB/HU=W<?<-<)XCZ-6U'<#BHO^/K\:]&\,_=6O.8O^/K\:]&\,
M_=6NJO\ "!V(Z44#I17G@%%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 1S?ZLURNK]&KJIO]6:Y75^C5K2W X>]
M_P!:?K6GHO\ K%K,O?\ 6GZUIZ+_ *Q:[)?"!Z/IW^H%7*IZ=_J!5RO/>X!1
M112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@#FO%G_ !Z'Z5\[>*_^/E_K7T3XL_X]#]*^=O%?
M_'R_UH&BAH'_ !\#ZU[?X3^ZE>(:!_Q\#ZU[?X3^ZE ,]*A_U*_2I*CA_P!2
MOTJ2@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0!0O?N&N$UWHU=W>_<-<)KO1JZ*.X'GFI??-%&I??-%>I'88W3OOBO0M!_AK
MSW3OOBO0M!_AK"OL!WEC]P5H]JSK'[@K1[5YDMQ!1114@%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 5Y_XU.(Y*] KSOQPV(Y* / _$#?Z2WUJ?PV?WZ_6J'B"3_2F^M7/#)S,
MOUH&>^^#O]6E=_VK@/!_^K2N_P"U @HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH #24M)B@!:*** "BBB@ HQ110 4444 %%%&: "BBB@ HH
MHH BG_U9KB?$K?N7^E=K<']V:X3Q,_[IZ /%/$IS<-]:K^'_ /CY7ZT_Q$V;
MAOK3?#__ !\+]:!GM_A?_5)7?6W^KK@?#'^J2N^MO]70(FHHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!0O?N&N$UWHU=W>_<-<)KO1JZ*.X'
MGFI??-%&I??-%>I'88W3OOBO0M!_AKSW3OOBO0M!_AK"OL!WEC]P5H]JSK'[
M@K1[5YDMQ!1114@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5YOX[_ -5)^->D5YOX[_U4GT-
M'SQKY_TIOK6CX6_UR?6L[7Q_I3?6M'PM_KD^M SZ \'_ .K3Z"N^[5P/@_\
MU:?05WW:@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:X3Q'T:MJ.X'%1?\?7XUZ-X9^ZM><Q?\?7XUZ-X9^ZM=5?X0.Q'2B@=**\\
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@".;_5FN5U?HU=5-_JS7*ZOT:M:6X'#WO^M/UK3T7_ %BUF7O^M/UK
M3T7_ %BUV2^$#T?3O]0*N53T[_4"KE>>]P"BBBD 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% ',
M>+O^/1OI7SAXL/\ I3_6OH_Q?_QZ-]*^</%G_'T_UH&BGX=/^DK]:]T\)?<2
MO"O#O_'ROUKW7PE]Q* 9Z5#_ *I?I4E1P_ZE?I4E @HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MGWA69J/_ !\'ZUIZ)]X5WR^$9Z!IWW!6P.E8^G?<%; Z5Y\]Q!1114@%%%%
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MZX+PQ_JDKO;;_5T")J*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH @N/N&N$\1]&KN[C[AKA/$?1JVH[@<5%_P ?7XUZ-X9^ZM><
MQ?\ 'U^->C>&?NK757^$#L1THH'2BO/ **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH CF_U9KE=7Z-753?ZLURN
MK]&K6EN!P][_ *T_6M/1?]8M9E[_ *T_6M/1?]8M=DOA ]'T[_4"KE4]._U
MJY7GO< HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E**,44 %%%% !112$
MX&:  D#K43W42?>:L_4-06!#S7 ZWXH\DMA_UH ](.J6HZR"E74;9^CBO +O
MQQ*LA D/YU=TSQJ\CC,A_.@#WE9D?[K5)7":)XA$X7+UV-K<K*@P: +5%%%
M!1110 4444 <QXO_ ./1OI7SAXL_X^G^M?1_B_\ X]&^E?.'BS_CZ?ZT#12\
M._\ 'ROUKW7PE]Q*\*\._P#'ROUKW7PE]Q* 9Z5#_J5^E25'#_J5^E24""BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!1O?N&N#U_^*N\O?N&N#U_^*NBCN!RMO_Q\CZUZ5X:^XM>:V_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!!<?<-<)XCZ-7=W'W#7">(^C5M1W XJ+_CZ_&O1O#/W5KSF+_CZ_&O
M1O#/W5KJK_"!V(Z44#I17G@%%%% !1110 4444 %%%% !1110 4444 %%%%
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MPSPV,W*_6O>O"$642@&>AP_ZE?I4E(HVJ!Z"EH$%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 4+W[AKA-=Z-7=WOW#7":[T:NB
MCN!YYJ7WS11J7WS17J1V&-T[[XKT+0?X:\]T[[XKT+0?X:PK[ =Y8_<%:/:L
MZQ^X*T>U>9+<04445(!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 !I*6B@ HHHH
M *Y7Q++LC:NJKC/%;8C>@#QWQ-<;I&&:P-)@$ET#[UH^(6S,WUJ#01FY7ZT
M>R>$;)?)3CM6]K5@IM&X[50\)X$*?2M_6"#:M]* /G[Q;:B.9^.]<_HLI6\4
M9[UUOC0?O'^M<7I/_'Z/K0,^AO!,NZ)/I7<,X49->?>"&Q"GTKL[^4QP$^U
MATNIPQ?>(JJWB&U4\L/SKSSQ%KKVY?#$8KSR^\92I*1YA_.@#Z%'B*T/\0_.
ME_X2&U_O#\Z^<X_&DI_Y:'\ZD'C.7_GH?SH'8^B/^$AM?4?G7 ^-M;BGC<*P
MKS;_ (3*7_GH?SK)U+Q#)=@@N3F@+&%KLHDN6(]:T/#5P(IE)]:Q+G=,Y-36
M<C6[ B@+'T5X3UV*&-,L*[7_ (2&U]1^=?,UCXDDM@ '(Q6E_P )E+_ST/YT
M!8^A_P#A(;7U'YT?\)#:_P!X?G7SQ_PF4O\ ST/YT?\ "9R_\]#^= 6/H?\
MX2&U_O#\Z/\ A(;7^\/SKYX_X3.7_GH?SH_X3.7_ )Z'\Z L?0__  D-K_>'
MYT?\)#:_WA^=?/'_  F<O_/0_G1_PF<O_/0_G0%CZ'_X2&U_O#\Z/^$AM?[P
M_.OGC_A,Y?\ GH?SH_X3.7_GH?SH"Q]#_P#"0VO]X?G1_P )#:_WA^=?/'_"
M9R_\]#^='_"9R_\ /0_G0%CZ'_X2&U_O#\Z/^$AM?[P_.OGC_A,Y?^>A_.C_
M (3.7_GH?SH"Q]#_ /"0VO\ >'YT?\)#:_WA^=?/'_"9R_\ /0_G1_PF<O\
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M^=?/'_"9R_\ /0_G1_PF<O\ ST/YT!8^A_\ A(;7^\/SH_X2&U_O#\Z^>/\
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M^>A_.C_A,Y?^>A_.@+'T/_PD-K_>'YT?\)#:_P!X?G7SQ_PF<O\ ST/YT?\
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M_A,Y?^>A_.C_ (3.7_GH?SH"Q]#_ /"0VO\ >'YT?\)#:_WA^=?/'_"9R_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M/YT!8^A_^$AM?[P_.C_A(;7^\/SKYX_X3.7_ )Z'\Z/^$SE_YZ'\Z L?0_\
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M!8^A_P#A(;7^\/SH_P"$AM?[P_.OGC_A,Y?^>A_.C_A,Y?\ GH?SH"Q]#_\
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M_P#/0_G0%CZ'_P"$AM?[P_.C_A(;7^\/SKYX_P"$SE_YZ'\Z/^$SE_YZ'\Z
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M_P )G+_ST/YT!8^A_P#A(;7^\/SH_P"$AM?[P_.OGC_A,Y?^>A_.C_A,Y?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M$)P*Y;Q+/MMG&>U=/(<(:XKQ0_[A_I0!X=XHDWW;?6KGA&W#W"<=ZS?$)S>-
M]:W/!@_?I]:!GM6BV"FU7CM6#XML56!^.U=EH@'V1?I7/^, /(?Z4"/GO5HM
MEZ?K7<>!Y=LB5QVN#_36^M=3X-.)%H&>[Z;< VRY/:IY+^*+J16'93E+4<]J
MY[7=6:!6PU CLGUZV0\D?G3/^$BM#_$/SKP?5?%TL4A D/YUEIXTE)_UA_.@
M=CZ-_P"$AM?4?G1_PD-KZC\Z^>/^$SE_YZ'\Z/\ A,Y?^>A_.@+'LWBG7X)+
M,JK#&/6OGSQ1<K-<N0>]:-]XIEN4*ER?QKE+V9KAR3S0!H:!.([A23WKVKPM
MK4<*)EA7@=J[0N#7166OR6X&'(H"Q].1^(K4Q@EAG'K3O^$AM?[P_.OG9?&4
MH&/,/YT[_A,Y?^>A_.@+'T/_ ,)#:_WA^='_  D-K_>'YU\\?\)G+_ST/YT?
M\)G+_P ]#^= 6/H?_A(;7^\/SH_X2&U_O#\Z^>/^$SE_YZ'\Z/\ A,Y?^>A_
M.@+'T/\ \)#:_P!X?G1_PD-K_>'YU\\?\)G+_P ]#^='_"9R_P#/0_G0%CZ'
M_P"$AM?[P_.C_A(;7^\/SKYX_P"$SE_YZ'\Z/^$SE_YZ'\Z L?0__"0VO]X?
MG1_PD-K_ 'A^=?/'_"9R_P#/0_G1_P )G+_ST/YT!8^A_P#A(;7^\/SH_P"$
MAM?[P_.OGC_A,Y?^>A_.C_A,Y?\ GH?SH"Q]#_\ "0VO]X?G1_PD-K_>'YU\
M\?\ "9R_\]#^='_"9R_\]#^= 6/H?_A(;7^\/SH_X2&U_O#\Z^>/^$SE_P">
MA_.C_A,Y?^>A_.@+'T/_ ,)#:_WA^='_  D-K_>'YU\\?\)G+_ST/YT?\)G+
M_P ]#^= 6/H?_A(;7^\/SH_X2&U_O#\Z^>/^$SE_YZ'\Z/\ A,Y?^>A_.@5C
MZ'_X2*U_O#\Z7_A(;4_Q#\Z^=O\ A,I?^>A_.E'C24?\M#^= ['T3_;]K_>'
MYT?V_:_WA^=?/'_";R?\]#^='_";2'_EH?SH"Q]"_P#"0VO]X?G1_P )#:_W
MA^=?/'_":2G_ ):'\Z/^$RE_YZ'\Z L?0_\ PD-K_>'YT?\ "0VO]X?G7SQ_
MPF<O_/0_G1_PF<O_ #T/YT!8^A_^$AM?[P_.C_A(;7^\/SKYX_X3.7_GH?SH
M_P"$SE_YZ'\Z L?0_P#PD-K_ 'A^='_"0VO]X?G7SQ_PF<O_ #T/YT?\)G+_
M ,]#^= 6/H?_ (2&U_O#\Z/^$AM?[P_.OGC_ (3.7_GH?SH_X3.7_GH?SH"Q
M]#_\)#:_WA^='_"0VO\ >'YU\\?\)G+_ ,]#^='_  F<O_/0_G0%CZ'_ .$A
MM?[P_.C_ (2&U_O#\Z^>/^$SE_YZ'\Z/^$SE_P">A_.@+'T/_P )#:_WA^='
M_"0VO]X?G7SQ_P )G+_ST/YT?\)G+_ST/YT!8^A_^$AM?[P_.C_A(;7^\/SK
MYX_X3.7_ )Z'\Z/^$SE_YZ'\Z L?0_\ PD-K_>'YT?\ "0VO]X?G7SQ_PF<O
M_/0_G1_PF<O_ #T/YT!8^A_^$AM?[P_.C_A(;7^\/SKYX_X3.7_GH?SH_P"$
MSE_YZ'\Z L?0_P#PD-K_ 'A^='_"0VO]X?G7SQ_PF<O_ #T/YT?\)G+_ ,]#
M^= 6/H?_ (2&U_O#\Z/^$AM?[P_.OGC_ (3.7_GH?SH_X3.7_GH?SH"Q]#_\
M)#:_WA^='_"0VO\ >'YU\\?\)G+_ ,]#^='_  F<O_/0_G0%CZ'_ .$AM?[P
M_.C_ (2&U_O#\Z^>/^$SE_YZ'\Z/^$SE_P">A_.@+'T/_P )#:_WA^='_"0V
MO]X?G7SQ_P )G+_ST/YT?\)G+_ST/YT!8^A_^$AM?[P_.C_A(;7^\/SKYX_X
M3.7_ )Z'\Z/^$SE_YZ'\Z L?0_\ PD-K_>'YT?\ "0VO]X?G7SQ_PF<O_/0_
MG1_PF<O_ #T/YT!8^A_^$AM?[P_.C_A(;7^\/SKYX_X3.7_GH?SH_P"$SE_Y
MZ'\Z L?0_P#PD-K_ 'A^='_"0VO]X?G7SQ_PF<O_ #T/YT?\)G+_ ,]#^= 6
M/H?_ (2&U_O#\Z/^$AM?[P_.OGC_ (3.7_GH?SH_X3.7_GH?SH"Q]#_\)#:_
MWA^='_"0VO\ >'YU\\?\)G+_ ,]#^='_  F<O_/0_G0%CZ'_ .$AM?[P_.C_
M (2&U_O#\Z^>/^$SE_YZ'\Z/^$SE_P">A_.@+'T/_P )#:_WA^='_"0VO]X?
MG7SQ_P )G+_ST/YT?\)G+_ST/YT!8^A_^$AM?[P_.C_A(;7^\/SKYX_X3.7_
M )Z'\Z/^$SE_YZ'\Z L?0_\ PD-K_>'YT?\ "0VO]X?G7SQ_PF<O_/0_G1_P
MF<O_ #T/YT!8^A_^$AM?[P_.C_A(;7^\/SKYX_X3.7_GH?SH_P"$SE_YZ'\Z
M L?0_P#PD-K_ 'A^='_"0VO]X?G7SQ_PF<O_ #T/YT?\)G+_ ,]#^= 6/H?_
M (2&U_O#\Z/^$AM?[P_.OGC_ (3.7_GH?SH_X3.7_GH?SH"Q]#_\)#:_WA^=
M'_"0VO\ >'YU\\?\)G+_ ,]#^='_  F<O_/0_G0%CZ'_ .$AM?[P_.C_ (2&
MU_O#\Z^>/^$SE_YZ'\Z/^$SE_P">A_.@+'T/_P )#:_WA^='_"0VO]X?G7SQ
M_P )G+_ST/YT?\)G+_ST/YT!8^A_^$AM?[P_.C_A(;7^\/SKYX_X3.7_ )Z'
M\Z/^$SE_YZ'\Z L?0_\ PD-K_>'YT?\ "0VO]X?G7SQ_PF<O_/0_G1_PF<O_
M #T/YT!8^A_^$AM?[P_.C_A(;7^\/SKYX_X3.7_GH?SH_P"$SE_YZ'\Z L?0
M_P#PD-K_ 'A^='_"0VO]X?G7SQ_PF<O_ #T/YT?\)G+_ ,]#^= 6/H?_ (2&
MU_O#\Z/^$AM?[P_.OGC_ (3.7_GH?SH_X3*7_GH?SH"Q]#_\)#:_WA^=*/$%
MK_>'YU\[_P#"9RC_ ):'\Z4>-I!_RT/YT!8^B/[?M?[P_.D_X2"U_O#\Z^>?
M^$WD_P">A_.D/C64_P#+0_G0%CZ&_P"$AM?[P_.C_A(;7^\/SKYX_P"$SE_Y
MZ'\Z/^$SE_YZ'\Z L?0__"16O]X?G1_PD5K_ 'A^=?.__"9R_P#/0_G1_P )
MG+_ST/YT!8^B/^$AM?[P_.C_ (2&U_O#\Z^=_P#A,I?^>A_.C_A,I?\ GH?S
MH"Q]$?\ "0VO]X?G1_PD-K_>'YU\\?\ "9R_\]#^='_"9R_\]#^= 6/H?_A(
M;7^\/SH_X2&U_O#\Z^>/^$SE_P">A_.C_A,Y?^>A_.@+'T/_ ,)#:_WA^='_
M  D-K_>'YU\\?\)G+_ST/YT?\)G+_P ]#^= 6/H?_A(;7^\/SH_X2&U_O#\Z
M^>/^$SE_YZ'\Z/\ A,Y?^>A_.@+'T/\ \)#:_P!X?G1_PD-K_>'YU\\?\)G+
M_P ]#^='_"9R_P#/0_G0%CZ'_P"$AM?[P_.C_A(;7^\/SKYX_P"$SE_YZ'\Z
M/^$SE_YZ'\Z L?0__"0VO]X?G1_PD-K_ 'A^=?/'_"9R_P#/0_G1_P )G+_S
MT/YT!8^A_P#A(;7^\/SH_P"$AM?[P_.OGC_A,Y?^>A_.C_A,Y?\ GH?SH"Q]
M#_\ "0VO]X?G1_PD-K_>'YU\\?\ "9R_\]#^='_"9R_\]#^= 6/H?_A(;7^\
M/SH_X2&U_O#\Z^>/^$SE_P">A_.C_A,Y?^>A_.@+'T/_ ,)#:_WA^='_  D-
MK_>'YU\[_P#"92_\]#^='_"92_\ /0_G0%CZ(_X2&U_O#\Z/^$BM?[P_.OGC
M_A,Y?^>A_.D_X3.7_GH?SH"Q]$?\)#:_WA^='_"0VO\ >'YU\[CQG+_ST/YT
MO_"9R_\ /0_G0%CZ'_X2&U_O#\Z0^(K4?Q#\Z^>/^$RE_P">A_.HY?&DH'^L
M/YT!8^C%\16K' 8?G5R'48I_ND5\U6/C.5Y@/,/7UKU+PKK+W03+9S0(].!R
M,TM16[;H5-2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!0O?N
M&N$UWHU=W>_<-<)KO1JZ*.X'GFI??-%&I??-%>I'88W3OOBO0M!_AKSW3OOB
MO0M!_AK"OL!WEC]P5H]JSK'[@K1[5YDMQ!1114@%%%% !1110 4444 %%%%
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M1_SS_2C_ (1$?\\_TH \6_LFX]#1_9-QZ&O:?^$1'_//]*/^$1'_ #S_ $H
M\6_LFX]#1_9-QZ&O:?\ A$1_SS_2C_A$1_SS_2@#Q;^R;CT-']DW'H:]I_X1
M$?\ //\ 2C_A$1_SS_2@#Q;^R;CT-']DW'H:]I_X1$?\\_TH_P"$1'_//]*
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M#7W%K>O\('54445P %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1_9-QZ&O:?\ A$1_SS_2C_A$1_SS_2@#Q;^R;CT-']DW'H:]I_X1$?\ //\
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MFX]#1_9-QZ&O:?\ A$1_SS_2C_A$1_SS_2@#Q;^R;CT-']DW'H:]I_X1$?\
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M1_SS_2C_ (1$?\\_TH \6_LFX]#1_9-QZ&O:?^$1'_//]*/^$1'_ #S_ $H
M\6_LFX]#1_9-QZ&O:?\ A$1_SS_2C_A$1_SS_2@#Q;^R;CT-']DW'H:]I_X1
M$?\ //\ 2C_A$1_SS_2@#Q;^R;CT-']DW'H:]I_X1$?\\_TH_P"$1'_//]*
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MM9L1"Y&*H:?;"28#'>@"&"PFD' -61I,_H:]"T3P\)XU.S]*Z5/"(*C]W^E
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M#7M/_"(C_GG^E'_"(C_GG^E 'BW]DW'H:/[)N/0U[3_PB(_YY_I1_P (B/\
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MF[*:]G_X1+_IG^E)_P (B/\ GG^E 7/%?[)G]#1_9-QZ&O:?^$1'_//]*/\
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MG]DW'H:]I/A$?\\_TH_X1$?\\_TH"YXM_9-QZ&C^R;CT->T_\(B/^>?Z4?\
M"(C_ )Y_I0!XM_9-QZ&C^R;CT->T_P#"(C_GG^E'_"(C_GG^E 'BW]DW'H:/
M[)N/0U[3_P (B/\ GG^E'_"(C_GG^E 'BW]DW'H:/[)N/0U[3_PB(_YY_I1_
MPB(_YY_I0!XM_9-QZ&C^R;CT->T_\(B/^>?Z4?\ "(C_ )Y_I0!XM_9-QZ&C
M^R;CT->T_P#"(C_GG^E'_"(C_GG^E 'BW]DW'H:/[)N/0U[3_P (B/\ GG^E
M'_"(C_GG^E 'BW]DW'H:/[)N/0U[3_PB(_YY_I1_PB(_YY_I0!XM_9-QZ&C^
MR;CT->T_\(B/^>?Z4?\ "(C_ )Y_I0!XM_9-QZ&C^R;CT->T_P#"(C_GG^E'
M_"(C_GG^E 'BW]DW'H:/[)N/0U[3_P (B/\ GG^E'_"(C_GG^E 'BW]DW'H:
M/[)N/0U[3_PB(_YY_I1_PB(_YY_I0!XM_9-QZ&C^R;CT->T_\(B/^>?Z4?\
M"(C_ )Y_I0!XM_9-QZ&C^R;CT->T_P#"(C_GG^E'_"(C_GG^E 'BW]DW'H:/
M[)N/0U[3_P (B/\ GG^E'_"(C_GG^E 'BW]DW'H:/[)N/0U[3_PB(_YY_I1_
MPB(_YY_I0!XM_9-QZ&C^R;CT->T_\(B/^>?Z4?\ "(C_ )Y_I0!XM_9-QZ&C
M^R;CT->T_P#"(C_GG^E'_"(C_GG^E 'BW]DW'H:/[)N/0U[3_P (B/\ GG^E
M'_"(C_GG^E 'BW]DW'H:/[)N/0U[3_PB(_YY_I1_PB(_YY_I0!XM_9-QZ&C^
MR;CT->T_\(B/^>?Z4?\ "(C_ )Y_I0!XM_9-QZ&C^R;CT->T_P#"(C_GG^E'
M_"(C_GG^E 'BW]DW'H:/[)N/0U[3_P (B/\ GG^E'_"(C_GG^E 'BW]DW'H:
M/[)N/0U[3_PB(_YY_I1_PB(_YY_I0!XM_9-QZ&C^R;CT->T_\(B/^>?Z4?\
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MFX]#1_9-QZ&O:?\ A$1_SS_2C_A$1_SS_2@#Q;^R;CT-']DW'H:]I_X1$?\
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M^Q0_W:/L4/\ =JQ10!7^Q0_W:/L4/]VK%% %?[%#_=H^Q0_W:L44 5_L4/\
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M!P][_K3]:T]%_P!8M9E[_K3]:T]%_P!8M=DOA ]'T[_4"KE4]._U JY7GO<
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M^Q0_W:/L4/\ =JQ10!7^Q0_W:/L4/]VK%% %?[%#_=H^Q0_W:L44 5_L4/\
M=H^Q0_W:L44 5_L4/]VC[%#_ ':L44 5_L4/]VC[%#_=JQ10!7%E"/X:D6%%
MZ"I** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** *%[]PU
MPFN]&KN[W[AKA-=Z-711W \\U+[YHHU+[YHKU([#&Z=]\5Z%H/\ #7GNG??%
M>A:#_#6%?8#O+'[@K1[5G6/W!6CVKS);B"BBBI **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** $HI:* "C%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 -D^X:Y#Q!_JWKKY/N
M&N0\0?ZIZ /#_%7^M?ZUBZ)_Q]K]:VO%?^M;ZUBZ&?\ 2U^M SW?P?\ ZE/I
M7H,7W!7GW@__ %*5Z#%]P4"'T444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $%Q]PUPGB/HU=W<?<-
M<)XCZ-6U'<#BHO\ CZ_&O1O#/W5KSF+_ (^OQKT;PS]U:ZJ_P@=B.E% Z45Y
MX!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% $<W^K-<KJ_1JZJ;_5FN5U?HU:TMP.'O?]:?K6GHO^L6LR]_UI^M
M:>B_ZQ:[)?"!Z/IW^H%7*IZ=_J!5RO/>X!1112 **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "F2IOC*T^B@#C-<T-;A6.VO--9\.F)F*I7O4L*R*
M017-ZGHBSYPM 'SW=:=,CX -6;#2I96 (->I7/A+>Y.S]*LV/A81,"4_2@9@
M:%X<R5)2O2M(TT6R+QBGZ;I:P*/EK950HP!0(6BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HQ110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !7G'C?[DE>CUYQXX^Y)0!X+K7_'TWUK7\,?ZU/K6/K1_TIOK6QX8_UJ?6
M@9[MX4_U:5VE<7X4_P!6E=I0(**** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH S-;_P"/%OI7SUXW_P!>]?0N
MM_\ 'BWTKYZ\;_ZY_K0-'&:7_P ?@^M>T>$?NI7B^EG_ $L?6O:/"/W4H ]7
MT_\ X]Q5RJFG_P#'N*MT""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *#110 E+28I: "BBB@ HHHH
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M*P='A,<2C':MX=!0(6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH ****  TE+10 4444 %(45NH!I:* (6M86ZH*;]AM\_ZL58HH B6WB3H
M@J0 #H*6B@ HHHH ****  TE+10 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M:/:LZQ^X*T>U>9+<04445(!1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44E+0 44
M49'K0 44FY?44;U_O#\Z %HI-R^HI<T %%%% !1110 4444 %%%% !24M)0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI* %HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***3<OJ* %HIN]?[P
M_.C>O]X?G0 ZBDW*>XI: "BBB@ HHHH ****!!1110,**** "BBB@ HHI* %
MK+U#3Q<@Y&<UJ44 <3/X4CD?.P?E4]IX:2$@A/TKK\#THP* *%G:" # J_11
M0 4444 %%%% !1110 4444 %!HH- "4M)2T %%%% !1110 4444 %%%% !12
M9'J*-P]10 M%&110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 44E+0 4444 %%%%  :2EHQ0
M 4444 %%)D>HHW#U'YT +129'K2T %%%% !11D>M)N'J* (YXO-C*US5_P"'
M4N6)*?I74Y'J*6@#AX?"4:/G9^E;UEI"P 87%;6!10 R--BXI])N [BDWK_>
M'YT .HIN]/[P_.EWK_>'YT +129![BEH **** "BBB@ HHS2;E]1^= "T4W>
MG]X?G1O7^\/SH =12;@>XI: "BBB@ HHHH **** "BBB@!*448HH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@"A>_<-<)KO1J[N]^X:X37>C5T4=P//-2^^:*-2^^:*]2.PQNG??%>
MA:#_  UY[IWWQ7H6@_PUA7V [RQ^X*T>U9UC]P5H]J\R6X@HHHJ0"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ [T45GWNHK;*<G&* +5Q.L*$D\USM_KJPD_.*Y[
M7/%:Q[@'_6O/-5\5&1VP_P"M 'I$_BT(3\_ZU5'C(;O]9^M>0RZS+*>&-0_V
ME,#G)H ]PM_%@<CYZZ"PUI)\?.*^=8==EB898UU&C^+"C*"_ZT ?0,4BR*"#
M3ZX+1/%"S!1O_6NRM+L7 !!ZT 6Z*** "BBB@ HHHH *3%+10 4444 %%%%
M!1110 4444 %%%% !137;:A-8&HZVMMD%L4 ;[2*HY(J$S@G@UQ9\4([[0_Z
MUK6-^+C!!H Z-&W4^H+<Y7-3T %%%% !1110 4444 %)BEHH **** "BBB@
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M <UX7HNMM).HW=Z]:\/W!EB4YH ZBFO(L:DDTR601QYKE-;U];=&&Z@#3O\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWP*: -2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MH'2BO/ **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH CF_U9KE=7Z-753?ZLURNK]&K6EN!P][_K3]:T]%_UBUF7
MO^M/UK3T7_6+79+X0/1]._U JY5/3O\ 4"KE>>]P"BBBD 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %(S!1DFHYIA$N37.ZOKR01GYJ +U_JB0 _,*YF\\5+$3\
M_P"M<=KOBKE@'_6N'O->DF<X8T >HR^-MK?ZS]::GCC)_P!9^M>//=W$AR":
MC:[N$YR: />K+Q:LI&9/UKJ+#5TG ^85\TV>O2P,,L:[?0O%OS*"_P"M 'O"
M2*ZY!I]<AHNO+<(OS5U4,HD4&@"6BBB@ HHHH **** "BBB@ HHHH *2EHH
M**** "BBB@ HHHH *:SJHR35._O1:J23BN2O_%*(Q7?^M '727BAL U)%-OK
M@[;71<2<-76:7+YH!S0!LT444 %%%% !1110 F*6BB@ HHHH **** "BBB@
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MM'M6=8_<%:/:O,EN(****D HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MH **** *-[]PUP>O_P 5=Y>_<-<'K_\ %711W Y6W_X^1]:]*\-?<6O-;?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MWI;'R5!H$;-%(.E+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZN!)9MSVH$>+>-Q\[UYU:?\ 'X/K7H_C899Z\XM?^/W\:!H]A\(?<2O4M/\
M]6*\M\(?<2O4M/\ ]6*!%^BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "D)P,TM074GEPDT 4=1
MOU@C8YKS?Q#XG\HL ]:7B;6/*1QNKQS7-3>XG8!N] &E>>)))I" QJJ;Z>3G
MFJ6CZ:]Y*,C.:]#L?"!DMPVV@9Q*:G/"<DFMS2_%3QR*"]:.J^$6AMRP6O/;
M^&2RN>XP: /?O#_B$7*H"]=JL@EM\^U?/?A'6&61 6KV;3-1$MJ.>U CG/&
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M!^M:>B?>%=\OA&>@:=]P5L#I6/IWW!6P.E>?/<04445(!1110 4444 %%%%
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MUJ5[QH?_ ![K]*\'\&?ZY*]XT/\ X]U^E F;%%%% !1110 E+24M "4M)2T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!'-_JS7*ZOT:N
MJF_U9KE=7Z-6M+<#A[W_ %I^M:>B_P"L6LR]_P!:?K6GHO\ K%KLE\('H^G?
MZ@5<JGIW^H%7*\][@%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M(!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MG_ZL5Y;X0^XE>I:?]P4 R_1110(**** "BBB@ HHI* %HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ K#U__ %)^E;E8>O\ ^I/TJX?$!YAJ/_'P
M?K6GHGWA69J/_'P?K6GHGWA7?+X1GH&G?<%; Z5CZ=]P5L#I7GSW$%%%%2 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110!1O?N&N#U_^*N\O?N&N#U_^*NBCN!RMO\ \?(^M>E>&ON+7FMO_P ?
M(^M>E>&ON+6]?X0.JHHHK@ **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** .1\9#-L_
MTKYS\4C%R_UKZ2\61[[=OI7SWXLMB)G..] T8OA]L7*_6O>?!QRL=?/NDR>5
M=#ZU[CX)O0?+&: /74X1?I2TR%P\2D>E/H$%1M*J]:=(<(37-ZGJHMR<MB@#
M?^U)GK4B2*_2O.W\4(LF-_ZUNZ1KB7&/FH T]>EV6AQZ5X/XPU!A(XS7MNNR
M>;9G'I7@/C($3O\ 6@#DK<&YN^>>:]7\&Z0CE"5%>6:0!]J&?6O;O!F,1XH&
M>E6>EP1VR H,XHO-,@DMV 49J]#_ *E/I1+_ *IOI0(\<\6Z,BAR%%>.:E$;
M>[...:^@/%F/+?->%:^%^U-]:!G6>";UA*@S7M%M/OL1SVKPGP=_KTQ7M5D3
M]B'TH$<)XSY#UY!<KF\Q[UZ[XP^Z]>33C_3/QH&CT/P/IZ321Y%>[6&F01VD
M8*#.*\9\ \/'7NEO_P >\?\ NT S(UO3XC9$A17AGBZS59'P*]]UIMMB:\-\
M7<R/0(\\M%V78^M>P^"SD)7D<"_Z6/K7K?@L?<H ]7CA#V?([5YKXTM$".<"
MO3(6Q:?A7G'C1_D>@#Q&^C O"/>N]\$VJ221Y%<)?'-Z?K7H7@8GS(Z!GM^F
MV<<=FGRCI6;XEC5;0X':MJQ_X\X_I61XG_X]#]*!'SWXP7,K_6N.T^VWW8X[
MUVGBP9G?ZUSNDQ W0^M SU;P3I4;E,J*]>ATRW2)!L&0*\W\&#9Y?X5ZHARB
MGVH$9FI6D4=J65<8KR+Q;>&(. :]AUIMMD:\,\8L2ST ><7<QN+L@GO7>^"]
M+2:5"5KST ?;.?6O6? N-\= SU_2M)@ALTR@R15N;38)(RH45/:?\>L?TJ:@
M1YQXGT.,1.0HKQ'Q!9BWN6P,<U]&>)<>0^:\$\6;?M#T#1'X7NS'.HSWKVK1
MKPM;+SVKPGP]_P ?*_6O9="S]G7Z4"(_$S[X6^E>,ZP/]+/UKV+Q#_J&^E>/
M:Q_Q]GZT#.H\&?ZY*]XT/_CW7Z5X/X,_UR5[QH?_ ![+]*!,V**** "B@44
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MM#<J,]ZW_& 'G/7*Z5_Q]CZT#/H/PE>F2! 36IXB^:S8^U<WX+SY25TFO_\
M'DWTH$>#>)QBZ;ZU#X?_ ->OUJ;Q1_Q]-]:B\/\ ^O7ZT#/;/"GW4KT%?NCZ
M5Y_X4^ZE>@+]T?2@0M%%% !1110 &DI:* "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** &OPA^E<5XDNC'&X!KM9/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 4;W[AK@]?\ XJ[R]^X:X/7_
M .*NBCN!RMO_ ,?(^M>E>&ON+7FMO_Q\CZUZ5X:^XM;U_A ZJBBBN  HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH Q=>@\V%ACM7B?B[2F)<[:]]NH?-4BN'\2Z&)
M8F.V@#YP:%K:ZYXYKT/PAK A= 6K!\1:0\$S$+6#97LMG,.2,&@9]4:-K44L
M"@N.E;@N82,B05\Z:1XN>%5!?]:Z1/'!V#]Y^M K'KFH:A#!;,=XR17DGBOQ
M"J%]K_K6;JOC9I(2 _;UKSC6=8EO)& ).:!EV?Q'(UU@.>OK7H/@W5)973+&
MO)--TV:ZN <'DU[+X,T1XMA*F@1Z'.#-8_A7C7C6Q;S'.*]VBM/]%VD=J\]\
M7Z/YBN0M 'A=FQ@NQGUKU_P9J:*4!85Y;JM@]M<$@'K5S0]9DM)5!)&*!GU5
M:7<4MLC;QTI;N[BBMV.\=*\?T[QDPMU4O^M/O_&!:W(W_K0(L>+M5C*N PKQ
M;593/=G'/-;FMZY)=.P#$YK'L;*2[N02"<F@9UW@JT8RH<5[5:P;;$9':N(\
M&Z*8PA*UZ1)%Y5ICVH$>4>,\ /7DLS#[9^->L>-<D/BO'Y@WVW\: /6O 1&^
M/\*]UMO^/:/_ ':\&\  [X\^U>\6O_'K'_NT 4==_P"/(UX;XM/SO7N.O?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!'-_JS7*ZOT:NJF_U9KE=7Z-6M+<#A[W_6GZUIZ+_K%K,O?]:?
MK6GHO^L6NR7P@>CZ=_J!5RJ>G?Z@5<KSWN 4444@"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+!XKAB%[T#1T_@W4DB= 6KVS1]4BD@4%ATKY9TO49+28<D8KT;1O%;(B@O\
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M-#>.5F"T#-/PEK7E,@+5[=X>UJ*6)0SCD5\MVUQ+92]QBNUT/Q=) %!<\>]
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M'H^G?Z@5<JGIW^H%7*\][@%%%%( HHHH **** "BBB@ HHHH **** "BBB@
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MN:\4PF2%@!VKJ*S-4M_/0C% 'S_KND-)<,=O>DT31V293MKTZ^T 2N3MHLM
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M3Z!!1110 4444 %&:#24 +24M% "4M%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110!0O?N&N$UWHU=W>_<-
M<)KO1JZ*.X'GFI??-%&I??-%>I'88W3OOBO0M!_AKSW3OOBO0M!_AK"OL!WE
MC]P5H]JSK'[@K1[5YDMQ!1114@%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M $9&*J3622]0*MT4 9#Z)&_85&- B!^Z*VZ* ,N/2(T["KL5LL705/10 444
M4 %%%% #)(ED&"*H3:3'+V%:5% &&?#\1.=HJ2/1(T.<"MBB@"O#:)#T JQ1
M10 4QD#4^B@"G)8K)U IBZ:@.<"K]% $,=N(^E3=J** &/&&JK)8(_4"KM%
M%!=-13G JW%$(^E244 %12P+(.:EHH S)=(CD/(%0C0HP<[16S10!GQZ:D?8
M5-]D7'05:HH HMIR-V%":<B'.!5ZB@!B($&!3Z** "BBB@!&4,,&J,VFI+U
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M!^Z*VJ* ,Z+2XX^PJ['$L8X%244 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %8>O_P"I/TK<K#U__4GZ5</B \PU'_CX/UK3T3[PK,U'_CX/UK3T3[PK
MOE\(ST#3ON"M@=*Q].^X*V!TKSY[B"BBBI **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH HWOW#7!Z__%7>7OW#
M7!Z__%711W Y6W_X^1]:]*\-?<6O-;?_ (^1]:]*\-?<6MZ_P@=51117  44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M** "BBB@ J.2)9!R*DHH SWTR-ST%1_V/'Z"M2B@"A'ID:'H*N1Q+&.!3Z*
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@""X^X:X3Q'T:N[N/N&N
M$\1]&K:CN!Q47_'U^->C>&?NK7G,7_'U^->C>&?NK757^$#L1THH'2BO/ **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH CF_P!6:Y75^C5U4W^K-<KJ_1JUI;@</>_ZT_6M/1?]8M9E[_K3]:T]
M%_UBUV2^$#T?3O\ 4"KE4]._U JY7GO< HHHI %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 $9&*K2V:2=0*LT4 9C:1&QS@4+I$8["M.B@"K%9)'T JR
M,"EHH **** "BBB@".6%9!R*I2:5&YZ"M&B@#)_L://058AT](NPJ]10 BJ%
M&!2T44 %1O$'ZU)10!4-BA/04Y+14Z 59HH :J!:4]*6B@"%X0_45$;%#V%6
MZ* ($ME3H*F Q2T4 !&:ADMUDZBIJ* ,U]*C8YP*5-+1#T%:-% %9+55'2G-
M;J14]% %3[$F<X%2I;JG2IJ* $ Q2T4E "T444 1R1+(.15.32XW/05H44 9
M/]BQYZ"IXM.2+L*OT4 -50BX%.HHH *8\8?K3Z* *K62-V%"V2+V%6J* (UB
M"]*DHHH **** "BBB@ HHHH 2E%&** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "FN@<8-.HH H3::DG857_ +%C
MSG K7HH SH]+2/L*NQQ+&.*DHH *",BBB@"N]JK]14?V!,]!5RB@"!+94Z"I
ME&!2T4 %%%% $3P!^M0&Q0GH*N44 5TM57L*F5 M.HH **** ();5).H%5'T
MJ-NPK2HH R?[&CST%2)I4:]A6E10!!%;)%T J>BB@ I#2T4 %%%% #64,,&J
MLM@DG85<HH RSH\9/04Y=*C7L*TJ* *\5JD?0"K%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110!0O?N&N$UWHU=W>_<-<)KO1JZ*.X'GFI??-%
M&I??-%>I'88W3OOBO0M!_AKSW3OOBO0M!_AK"OL!WEC]P5H]JSK'[@K1[5YD
MMQ!1114@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E+110 4444 %%%% "
M8I:** "BBB@ HHHH **** "C-%)0 M%%% !1110 4444 (:*** %HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6B@!,4M%% !1110 44
M44 %%%% !1FBDH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@!**6DH 6BB@T &:*2EH **** "BBB@ HHHH
M**** "BBB@ HHHH **** $Q2T44 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5AZ__ *D_2MRL
M/7_]2?I5P^(#S#4?^/@_6M/1/O"LS4?^/@_6M/1/O"N^7PC/0-.^X*V!TK'T
M[[@K8'2O/GN(****D HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@"C>_<-<'K_\5=Y>_<-<'K_\5=%'<#E;?_CY
M'UKTKPU]Q:\UM_\ CY'UKTKPU]Q:WK_"!U5%%%< !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %&:#24 +1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !28I:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***2@!:*2EH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH @N/N&N$\1]&KN[C[AKA/$?1JVH[@<5%_Q]?C7HWAG[JU
MYS%_Q]?C7HWAG[JUU5_A [$=**!THKSP"BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** (YO]6:Y75^C5U4W^K-<K
MJ_1JUI;@</>_ZT_6M/1?]8M9E[_K3]:T]%_UBUV2^$#T?3O]0*N53T[_ % J
MY7GO< HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444E "T4E+0 44
M44 %%%% !1110 9HI** %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH ,T4E+0 4E+10 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 49H-)
M0 M%%% !1244 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %"]^X:X37>C
M5W=[]PUPFN]&KHH[@>>:E]\T4:E]\T5ZD=AC=._U@KT/0%SMKSO3F D%>@Z#
M<*NW)K"OL!Z%8I^[%7:S+*^C\L D5=^U0_WJ\QIW$345#]JA_OT?:H?[U*P$
MU%0_:H?[U'VJ'^]19@345#]JA_O4?:H?[U%F!-14/VJ'^]1]JA_O468$U%0_
M:H?[U'VJ'^]19@345#]JA_O4?:H?[U%F!-14/VJ'^]1]JA_O468$U%0_:H?[
MU'VJ'^]19@345#]JA_O4?:H?[U%F!-14/VJ'^]1]JA_O468$U%0_:H?[U'VJ
M'^]19@345#]JA_O4?:H?[U%F!-14/VJ'^]1]JA_O468$U%0_:H?[U'VJ'^]1
M9@345#]JA_O4?:H?[U%F!-14/VJ'^]1]JA_O468$U%0_:H?[U'VJ'^]19@34
M5#]JA_O4?:H?[U%F!-14/VJ'^]1]JA_O468$U%0_:H?[U'VJ'^]19@345#]J
MA_O4?:H?[U%F!-14/VJ'^]1]JA_O468$U%0_:H?[U'VJ'^]19@345#]JA_O4
M?:H?[U%F!-14/VJ'^]1]JA_O468$U%0_:H?[U'VJ'^]19@345#]JA_O4?:H?
M[U%F!-14/VJ'^]1]JA_O468$U%0_:H?[U'VJ'^]19@345#]JA_O4?:H?[U%F
M!-14/VJ'^]1]JA_O468$U%0_:H?[U'VJ'^]19@345#]JA_O4?:H?[U%F!-14
M/VJ'^]1]JA_O468$U%0_:H?[U'VJ'^]19@345#]JA_O4?:H?[U%F!-14/VJ'
M^]1]JA_O468$U%0_:H?[U'VJ'^]19@345#]JA_O4?:H?[U%F!-14/VJ'^]1]
MJA_O468$U%0_:H?[U'VJ'^]19@345#]JA_O4?:H?[U%F!-14/VJ'^]1]JA_O
M468$U%0_:H?[U'VJ'^]19@345#]JA_O4?:H?[U%F!-14/VJ'^]1]JA_O468$
MU%0_:H?[U'VJ'^]19@345#]JA_O4?:H?[U%F!-14/VJ'^]1]JA_O468$U%0_
M:H?[U'VJ'^_19@345#]JA_O4?:H?[U%F!-14/VJ'^]1]JA_O468$U%0_:H?[
MU'VJ'^]19@345#]JA_O4?:H?[U%F!-14/VJ'^]1]JA_O468$U%0_:H?[U'VJ
M'^]19@345#]JA_O4?:H?[U%F!-14/VJ'^]1]JA_O468$U%0_:H?[U'VJ'^]1
M9@345#]JA_O4?:H?[U%F!-14/VJ'^]1]JA_O468$U%0_:H?[U'VJ'^]19@34
M5#]JA_O4?:H?[U%F!-14/VJ'^]1]JA_O468$U%0_:H?[U'VJ'^]19@345#]J
MA_O4?:H?[U%F!-14/VJ'^]1]JA_O468$U%0_:H?[U'VJ'^]19@345#]JA_O4
M?:H?[U%F!-14/VJ'^]1]JA_O468$U%0_:H?[U'VJ'^]19@345#]JA_O4?:H?
M[U%F!-14/VJ'^]1]JA_O468$U%0_:H?[U'VJ'^]19@345#]JA_O4?:H?[U%F
M!-14/VJ'^]1]JA_O468$U%0_:H?[U'VJ'^]19@345#]JA_O4?:H?[U%F!-14
M/VJ'^]1]JA_O468$U%0_:H?[U'VJ'^]19@345#]JA_O4?:H?[U%F!-14/VJ'
M^]1]JA_O468$U%0_:H?[]'VJ'^]19@345#]JA_O4?:H?[U%@)J*A^U0_WJ/M
M4/\ >HLP)J*A^U0_WJ/M4/\ >HLP)J*A^U0_WJ/M4/\ >HLP)J*A^U0_WJ/M
M4/\ >HLP)J*A^U0_WJ/M4/\ >HLP)J*A^U0_WJ/M4/\ >HLP)J*A^U0_WJ/M
M4/\ >HLP)J*A^U0_WJ/M4/\ >HLP)J*A^U0_WJ/M4/\ >HLP)J*A^U0_WJ/M
M4/\ >HLP)J*A^U0_WJ/M4/\ >HLP)J*A^U0_WJ/M4/\ >HLP)J*A^U0_WJ/M
M4/\ >HLP)J*A^U0_WJ/M4/\ >HLP)J*A^U0_WJ/M4/\ >HLP)J*A^U0_WJ/M
M4/\ >HLP)J*A^U0_WJ/M4/\ >HLP)J*A^U0_WJ/M4/\ >HLP)J*A^U0_WJ/M
M4/\ >HLP)J*A^U0_WJ/M4/\ >HLP)J*A^U0_WJ/M4/\ >HLP)J*A^U0_WZ/M
M4/\ ?HL!-14/VJ'^]1]JA_O468$U8VO)F GVK3^U1?WJQM=O(_((##I503N!
MYIJ0Q<'ZUI:)]X5EZC*&N#CUK3T0_,*[Y?",]!T[[@K8'2L;3ON+6R.E>?/<
M04445(!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZ&C[#+Z&CDB!O_\ "1/_ 'J/^$B?^]6!]AE]#1]AE]#1R1 W_P#A(G_O4?\
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MD3_WJP/L,OH:/L,OH:.2(&__ ,)$_P#>H_X2)_[U8'V&7T-'V&7T-')$#?\
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MZ&C[#+Z&CDB!O_\ "1/_ 'J/^$B?^]6!]AE]#1]AE]#1R1 W_P#A(G_O4?\
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M_P#>K ^PR^AH^PR^AHY(@;__  D3_P!ZC_A(G_O5@?89?0T?89?0T<D0-_\
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M$_\ >K ^PR^AH^PR^AHY(@;_ /PD3_WJ/^$B?^]6!]AE]#1]AE]#1R1 W_\
MA(G_ +U'_"1/_>K ^PR^AH^PR^AHY(@;_P#PD3_WJ/\ A(G_ +U8'V&7T-'V
M&7T-')$#?_X2)_[U'_"1/_>K ^PR^AH^PR^AHY(@;_\ PD3_ -ZC_A(G_O5@
M?89?0T?89?0T<D0-_P#X2)_[U'_"1/\ WJP/L,OH:/L,OH:.2(&__P )$_\
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M)_[U8/V&7T-'V&7T-') #?\ ^$B?^]1_PD3_ -ZL#[#+Z&C[#+Z&CDB!O_\
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MB"BBBI **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#+Z&CDB!O_\ "1/_ 'J/^$B?^]6!]AE]#1]AE]#1R1 WO^$B?^]1_P )"_\
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MD3_WJP/L,OH:/L,OH:.2(&__ ,)$_P#>H_X2)_[U8'V&7T-'V&7T-')$#?\
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MZ&C[#+Z&CDB!O_\ "1/_ 'J/^$B?^]6!]AE]#1]AE]#1R1 W_P#A(G_O4?\
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M^AHY(@;_ /PD3_WJ/^$B?^]6!]AE]#1]AE]#1R1 W_\ A(G_ +U'_"1/_>K
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M_P )$_\ >K ^PR^AH^PR^AHY(@;_ /PD3_WJ/^$B?^]6!]AE]#1]AE]#1R1
MW_\ A(G_ +U'_"1/_>K ^PR^AH^PR^AHY(@;_P#PD3_WJ/\ A(G_ +U8'V&7
MT-'V&7T-')$#?_X2)_[U'_"1/_>K ^PR^AH^PR^AHY(@;_\ PD3_ -ZC_A(G
M_O5@?89?0T?89?0T<D0-_P#X2)_[U'_"1/\ WJP/L,OH:/L,OH:.2(&__P )
M$_\ >H_X2)_[U8'V&7T-'V&7T-')$#?_ .$B?^]1_P )$_\ >K ^PR^AH^PR
M^AHY(@;_ /PD3_WJ/^$B?^]6!]AE]#1]AE]#1R1 W_\ A(G_ +U'_"1/_>K
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M$B?^]6#]AE]#1]AE]#1R1 WO^$A?^]1_PD3_ -ZL'[#+Z&C[#+Z&CDB(W_\
MA(G_ +U'_"1/_>K ^PR^AH^PR^AHY(C-_P#X2)_[U'_"1/\ WJP/L,OH:/L,
MOH:.2(&__P )$_\ >H_X2)_[U8'V&7T-'V&7T-')$#?_ .$B?^]1_P )$_\
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MR^AHY(@;W_"1/_>H_P"$A?\ O5@_89?0T?89?0T<D -[_A(G_O4O_"1/_>K
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MPR^AHY(@;_\ PD3_ -ZC_A(G_O5@?89?0T?89?0T<D0-_P#X2)_[U'_"1/\
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M@<K_ &,O]VC^QE_NUU7D+1Y"T>T8'*_V,O\ =H_L9?[M=5Y"T>0M'M&!RO\
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M]C+_ ':/[&7^[75>0M'D+1[1@<K_ &,O]VC^QE_NUU7D+1Y"T>T8'*_V,O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (Y%W"LVYM ^>
M*UL4TH#33L!R\VDAB?EJ'^QE_NUU9A4T>0M:>T8'*_V,O]VC^QE_NUU7D+1Y
M"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>U8'*_
MV,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^Q
ME_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+
M1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'
M*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC
M^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7
MD+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T
M8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]
MVC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NU
MU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T
M>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,
MO]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_
MNUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y
M"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_
MV,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^Q
ME_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+
M1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'
M*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC
M^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7
MD+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T
M8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]
MVC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NU
MU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T
M>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,
MO]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_
MNUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y
M"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_
MV,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^Q
ME_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+
M1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'
M*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC
M^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7
MD+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T
M8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]
MVC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NU
MU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T
M>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,
MO]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_
MNUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y
M"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_
MV,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^Q
ME_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+
M1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'
M*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC
M^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7
MD+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VC^QE_NUU7D+1Y"T>U
M8'*_V,O]VC^QE_NUU7D+1Y"T>T8'*_V,O]VFG1E_NUUGD+1Y"T>U8'-V^E!&
M'RUMVD'E@<5:$*BGA0*F4VP%HHHJ "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M]C+_ ':/[&7^[75>0M'D+1[1@<K_ &,O]VC^QE_NUU7D+1Y"T>T8'*_V,O\
M=H_L9?[M=5Y"T>0M'M&!RO\ 8R_W:/[&7^[75>0M'D+1[1@<K_8R_P!VC^QE
M_NUU7D+1Y"T>T8'*_P!C+_=H_L9?[M=5Y"T>0M'M&!RO]C+_ ':/[&7^[75>
M0M'D+1[1@<K_ &,O]VC^QE_NUU7D+1Y"T>T8'*_V,O\ =H_L9?[M=5Y"T>0M
M'M&!RO\ 8R_W:/[&7^[75>0M'D+1[1@<K_8R_P!VC^QE_NUU7D+1Y"T>T8'*
M_P!C+_=H_L9?[M=5Y"T>0M'M&!RO]C+_ ':/[&7^[75>0M'D+1[1@<K_ &,O
M]VC^QE_NUU7D+1Y"T>T8'*_V,O\ =H_L9?[M=5Y"T>0M'M&!RO\ 8R_W:/[&
M7^[75>0M'D+1[1@<K_8R_P!VC^QE_NUU7D+1Y"T>T8'*_P!C+_=H_L9?[M=5
MY"T>0M'M&!RO]C+_ ':/[&7^[75>0M'D+1[1@<K_ &,O]VC^QE_NUU7D+1Y"
MT>T8'*_V,O\ =H_L9?[M=5Y"T>0M'M&!RO\ 8R_W:/[&7^[75>0M'D+1[1@<
MK_8R_P!VC^QE_NUU7D+1Y"T>T8'*_P!C+_=H_L9?[M=5Y"T>0M'M&!RO]C+_
M ':/[&7^[75>0M'D+1[1@<K_ &,O]VC^QE_NUU7D+1Y"T>T8'*_V,O\ =H_L
M9?[M=5Y"T>0M'M&!RO\ 8R_W:/[&7^[75>0M'D+1[1@<K_8R_P!VC^QE_NUU
M7D+1Y"T>T8'*_P!C+_=H_L9?[M=5Y"T>0M'M&!RO]C+_ ':/[&7^[75>0M'D
M+1[1@<K_ &,O]VC^QE_NUU7D+1Y"T>T8'*_V,O\ =H_L9?[M=5Y"T>0M'M&!
MRO\ 8R_W:/[&7^[75>0M'D+1[1@<K_8R_P!VC^QE_NUU7D+1Y"T>T8'*_P!C
M+_=H_L9?[M=5Y"T>0M'M&!RO]C+_ ':/[&7^[75>0M'D+1[1@<K_ &,O]VC^
MQE_NUU7D+1Y"T>T8'*_V,O\ =H_L9?[M=5Y"T>0M'M&!RO\ 8R_W:/[&7^[7
M5>0M'D+1[1@<K_8R_P!VC^QE_NUU7D+1Y"T>T8'*_P!C+_=H_L9?[M=5Y"T>
M0M'M&!RO]C+_ ':/[&7^[75>0M'D+1[1@<K_ &,O]VC^QE_NUU7D+1Y"T>T8
M'*_V,O\ =H_L9?[M=5Y"T>0M'M&!RO\ 8R_W:/[&7^[75>0M'D+1[1@<K_8R
M_P!VC^QE_NUU7D+1Y"T>T8'*_P!C+_=H_L9?[M=5Y"T>0M'M&!RO]C+_ ':/
M[&7^[75>0M'D+1[1@<K_ &,O]VC^QE_NUU7D+1Y"T>T8'*_V,O\ =H_L9?[M
M=5Y"T>0M'M&!RO\ 8R_W:/[&7^[75>0M'D+1[1@<K_8R_P!VC^QE_NUU7D+1
MY"T>T8'*_P!C+_=H_L9?[M=5Y"T>0M'M&!RO]C+_ ':/[&7^[75>0M'D+1[1
M@<K_ &,O]VC^QE_NUU7D+1Y"T>T8'*_V,O\ =H_L9?[M=5Y"T>0M'M&!RO\
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M]C+_ ':/[&7^[75>0M'D+1[1@<K_ &,O]VC^QE_NUU7D+1Y"T>T8'*_V,O\
M=H_L9?[M=5Y"T>0M'M&!RO\ 8R_W:/[&7^[75>0M'D+1[1@<K_8R_P!VC^QE
M_NUU7D+1Y"T>T8'*_P!C+_=H_L9?[M=5Y"T>0M'M&!RO]C+_ ':/[&7^[75>
M0M'D+1[1@<K_ &,O]VC^QE_NUU7D+1Y"T>T8'*_V,O\ =H_L9?[M=5Y"T>0M
M'M&!RO\ 8R_W:7^QU_NUU/D+1Y"T>T8'+_V0/[M%=1Y"T4O:,"6BBBLP"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBDS0 M%&:* "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HI*6@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **2EH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH #24M!H 2EI*6@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH 2EHHH **** "BBB@ HHHH ****0!1113 **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@!*4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %!HHH 2EHQ10 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 )0*6B@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HS124@%S1244P%HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M;_\ M4>P8'H7V^/U%'V^/U%>>_V__M4?V_\ [5'L&!Z%]OC]11]OC]17GO\
M;_\ M4?V_P#[5'L&!Z%]OC]11]OC]17GO]O_ .U1_;_^U1[!@>A?;X_44?;X
M_45Y[_;_ /M4?V__ +5'L&!Z%]OC]11]OC]17GO]O_[5']O_ .U1[!@>A?;X
M_44?;X_45Y[_ &__ +5']O\ ^U1[!@>A?;X_44?;X_45Y[_;_P#M4?V__M4>
MP8'H7V^/U%'V^/U%>>_V_P#[5']O_P"U1[!@>A?;X_44?;X_45Y[_;_^U1_;
M_P#M4>P8'H7V^/U%'V^/U%>>_P!O_P"U1_;_ /M4>P8'H7V^/U%'V^/U%>>_
MV_\ [5']O_[5'L&!Z%]OC]11]OC]17GO]O\ ^U1_;_\ M4>P8'H7V^/U%'V^
M/U%>>_V__M4?V_\ [5'L&!Z%]OC]11]OC]17GO\ ;_\ M4?V_P#[5'L&!Z%]
MOC]11]OC]17GO]O_ .U1_;_^U1[!@>A?;X_44?;X_45Y[_;_ /M4?V__ +5'
ML&!Z%]OC]11]OC]17GO]O_[5']O_ .U1[!@>A?;X_44?;X_45Y[_ &__ +5'
M]O\ ^U1[!@>A?;X_44?;X_45Y[_;_P#M4?V__M4>P8'H7V^/U%'V^/U%>>_V
M_P#[5']O_P"U1[!@>A?;X_44?;X_45Y[_;_^U1_;_P#M4>P8'H7V^/U%'V^/
MU%>>_P!O_P"U1_;_ /M4>P8'H7V^/U%'V^/U%>>_V_\ [5']O_[5'L&!Z%]O
MC]11]OC]17GO]O\ ^U1_;_\ M4>P8'H7V^/U%'V^/U%>>_V__M4?V_\ [5'L
M&!Z%]OC]11]OC]17GO\ ;_\ M4?V_P#[5'L&!Z%]OC]11]OC]17GO]O_ .U1
M_;_^U1[!@>A?;X_44?;X_45Y[_;_ /M4?V__ +5'L&!Z%]OC]11]OC]17GO]
MO_[5']O_ .U1[!@>A?;X_44?;X_45Y[_ &__ +5']O\ ^U1[!@>A?;X_44?;
MX_45Y[_;_P#M4?V__M4>P8'H7V^/U%'V^/U%>>_V_P#[5']O_P"U1[!@>A?;
MX_44?;X_45Y[_;_^U1_;_P#M4>P8'H7V^/U%'V^/U%>>_P!O_P"U1_;_ /M4
M>P8'H7V^/U%'V^/U%>>_V_\ [5']O_[5'L&!Z%]OC]11]OC]17GO]O\ ^U1_
M;_\ M4>P8'H7V^/U%'V^/U%>>_V__M4?V_\ [5'L&!Z%]OC]11]OC]17GO\
M;_\ M4?V_P#[5'L&!Z%]OC]11]OC]17GO]O_ .U1_;_^U1[!@>A?;X_44?;X
M_45Y[_;_ /M4?V__ +5'L&!Z%]OC]11]OC]17GO]O_[5']O_ .U1[!@>A?;X
M_44?;X_45Y[_ &__ +5']O\ ^U1[!@>A?;X_44?;X_45Y[_;_P#M4?V__M4>
MP8'H7V^/U%'V^/U%>>_V_P#[5']O_P"U1[!@>A?;X_44?;X_45Y[_;_^U1_;
M_P#M4>P8'H7V^/U%'V^/U%>>_P!O_P"U1_;_ /M4>P8'H7V^/U%'V^/U%>>_
MV_\ [5']O_[5'L&!Z%]OC]11]OC]17GO]O\ ^U1_;_\ M4>P8'H7V^/U%'V^
M/U%>>_V__M4?V_\ [5'L&!Z%]OC]11]OC]17GO\ ;_\ M4?V_P#[5'L&!Z%]
MOC]11]OC]17GO]O_ .U1_;_^U1[!@>A?;X_44?;X_45Y[_;_ /M4?V__ +5'
ML&!Z%]OC]11]OC]17GO]O_[5']O_ .U1[!@>A?;X_44?;X_45Y[_ &__ +5'
M]O\ ^U1[!@>A?;X_44?;X_45Y[_;_P#M4?V__M4>P8'H7V^/U%'V^/U%>>_V
M_P#[5']O_P"U1[!@>A?;X_44?;X_45Y[_;_^U1_;_P#M4>P8'H7V^/U%'V^/
MU%>>_P!O_P"U1_;_ /M4>P8'H7V^/U%'V^/U%>>_V_\ [5']O_[5'L&!Z%]O
MC]11]OC]17GO]O\ ^U1_;_\ M4>P8'H7V^/U%'V^/U%>>_V__M4?V_\ [5'L
M&!Z%]OC]11]OC]17GO\ ;_\ M4?V_P#[5'L&!Z%]OC]11]OC]17GO]O_ .U1
M_;_^U1[!@>A?;X_44?;X_45Y[_;_ /M4?V__ +5'L&!Z%]OC]11]OC]17GO]
MO_[5']O_ .U1[!@>A?;X_44?;X_45Y[_ &__ +5']O\ ^U1[!@>A?;X_44?;
MX_45Y[_;_P#M4?V__M4>P8'H7V^/U%'V^/U%>>_V_P#[5']O_P"U1[!@>A?;
MX_44?;X_45Y[_;_^U1_;_P#M4>P8'H7V^/U%'V^/U%>>_P!O_P"U1_;_ /M4
M>P8'H7V^/U%'V^/U%>>_V_\ [5']O_[5'L&!Z%]OC]11]OC]17GO]O\ ^U1_
M;_\ M4>P8'H7V^/U%'V^/U%>>_V__M4?V_\ [5'L&!Z%]OC]11]OC]17GO\
M;_\ M4?V_P#[5'L&!Z%]OC]11]OC]17GO]O_ .U1_;_^U1[!@>A?;X_44?;X
M_45Y[_;_ /M4?V__ +5'L&!Z%]OC]11]OC]17GO]O_[5']O_ .U1[!@>A?;X
M_44?;X_45Y[_ &__ +5']O\ ^U1[!@>A?;X_44?;X_45Y[_;_P#M4?V__M4>
MP8'H7V^/U%'V^/U%>>_V_P#[5']O_P"U1[!@>A?;X_44?;X_45Y[_;_^U1_;
M_P#M4>P8'H7V^/U%'V^/U%>>_P!O_P"U1_;_ /M4>P8'H7V^/U%'V^/U%>>_
MV_\ [5']O_[5'L&!Z%]OC]11]OC]17GO]O\ ^U1_;_\ M4>P8'H7V^/U%'V^
M/U%>>_V__M4?V_\ [5'L&!Z%]OC]11]OC]17GO\ ;_\ M4?V_P#[5'L&!Z%]
MOC]11]OC]17GO]O_ .U1_;_^U1[!@>A?;X_44?;X_45Y[_;_ /M4?V__ +5'
ML&!Z%]OC]11]OC]17GO]O_[5']O_ .U1[!@>A?;X_44?;X_45Y[_ &__ +5'
M]O\ ^U1[!@>A?;X_44?;X_45Y[_;_P#M4?V__M4>P8'H7V^/U%'V^/U%>>_V
M_P#[5']O_P"U1[!@>A?;X_44?;X_45Y[_;_^U1_;_P#M4>P8'H7V^/U%'V^/
MU%>>_P!O_P"U1_;_ /M4>P8'H7V^/U%'V^/U%>>_V_\ [5']O_[5'L&!Z%]O
MC]11]OC]17GO]O\ ^U1_;_\ M4>P8'H7V^/U%'V^/U%>>_V__M4?V_\ [5'L
M&!Z%]OC]11]OC]17GO\ ;_\ M4?V_P#[5'L&!Z%]OC]11]OC]17GO]O_ .U1
M_;_^U1[!@>A?;X_44?;X_45Y[_;_ /M4?V__ +5'L&!Z%]OC]11]OC]17GO]
MO_[5']O_ .U1[!@>A?;X_44?;X_45Y[_ &__ +5']O\ ^U1[!@>A?;X_44?;
MX_45Y[_;_P#M4?V__M4>P8'H7V^/U%'V^/U%>>_V_P#[5']O_P"U1[!@>A?;
MX_44?;X_45Y[_;_^U1_;_P#M4>P8'H7V^/U%'V^/U%>>_P!O_P"U1_;_ /M4
M>P8'H7V^/U%'V^/U%>>_V_\ [5']O_[5'L&!Z%]OC]11]OC]17GO]O\ ^U1_
M;_\ M4>P8'H7V^/U%'V^/U%>>_V__M4?V_\ [5'L&!Z%]OC]11]OC]17GO\
M;_\ M4?V_P#[5'L&!Z%]OC]11]OC]17GO]O_ .U1_;_^U1[!@>A?;X_44?;X
M_45Y[_;_ /M4?V__ +5'L&!Z%]OC]11]OC]17GO]O_[5']O_ .U1[!@>A?;X
M_44?;X_45Y[_ &__ +5']O\ ^U1[!@>A?;X_44?;X_45Y[_;_P#M4?V__M4>
MP8'H7V^/U%'V^/U%>>_V_P#[5']O_P"U1[!@>A?;X_44?;X_45Y[_;_^U1_;
M_P#M4>P8'H7V^/U%'V^/U%>>_P!O_P"U1_;_ /M4>P8'H7V^/U%'V^/U%>>_
MV_\ [5']O_[5'L&!Z%]OC]11]OC]17GO]O\ ^U1_;_\ M4>P8'H7V^/U%'V^
M/U%>>_V__M4?V_\ [5'L&!Z%]OC]11]OC]17GO\ ;_\ M4?V_P#[5'L&!Z%]
MOC]11]OC]17GO]O_ .U1_;_^U1[!@>A?;X_44?;X_45Y[_;_ /M4?V__ +5'
ML&!Z%]OC]11]OC]17GO]O_[5']O_ .U1[!@>A?;X_44?;X_45Y[_ &__ +5'
M]O\ ^U1[!@>A?;X_44?;X_45Y[_;_P#M4?V__M4>P8'H7V^/U%'V^/U%>>_V
M_P#[5']O_P"U1[!@>A?;X_44?;X_45Y[_;_^U1_;_P#M4>P8'H7V^/U%'V^/
MU%>>_P!O_P"U1_;_ /M4>P8'H7V^/U%'V^/U%>>_V_\ [5']O_[5'L&!Z%]O
MC]11]OC]17GO]O\ ^U1_;_\ M4>P8'H7V^/U%'V^/U%>>_V__M4?V_\ [5'L
M&!Z%]OC]11]OC]17GO\ ;_\ M4?V_P#[5'L&!Z%]OC]11]OC]17GO]O_ .U1
M_;_^U1[!@>A?;X_44?;X_45Y[_;_ /M4?V__ +5'L&!Z%]OC]11]OC]17GO]
MO_[5']O_ .U1[!@>A?;X_44?;X_45Y[_ &__ +5']O\ ^U1[!@>A?;X_44?;
MX_45Y[_;_P#M4?V__M4>P8'H7V^/U%'V^/U%>>_V_P#[5']O_P"U1[!@>A?;
MX_44?;X_45Y[_;_^U1_;_P#M4>P8'H7V^/U%'V^/U%>>_P!O_P"U1_;_ /M4
M>P8'H7V^/U%'V^/U%>>_V_\ [5']O_[5'L&!Z%]OC]11]OC]17GO]O\ ^U1_
M;_\ M4>P8'H7V^/U%'V^/U%>>_V__M4?V_\ [5'L&!Z%]OC]11]OC]17GO\
M;_\ M4?V_P#[5'L&!Z%]OC]11]OC]17GO]O_ .U1_;_^U1[!@>A?;X_44?;X
M_45Y[_;_ /M4?V__ +5'L&!Z%]OC]11]OC]17GO]O_[5']O_ .U1[!@>A?;X
M_44?;X_45Y[_ &__ +5']O\ ^U1[!@>A?;X_44?;X_45Y[_;_P#M4?V__M4>
MP8'H7V^/U%'V^/U%>>_V_P#[5']O_P"U1[!@>A?;X_44?;X_45Y[_;_^U1_;
M_P#M4>P8'H7V^/U%'V^/U%>>_P!O_P"U1_;_ /M4>P8'H7V^/U%'V^/U%>>_
MV_\ [5']O_[5'L&!Z%]OC]11]OC]17GO]O\ ^U1_;_\ M4>P8'H7V^/U%'V^
M/U%>>_V__M4?V_\ [5'L&!Z%]OC]11]OC]17GO\ ;_\ M4?V_P#[5'L&!Z%]
MOC]11]OC]17GO]O_ .U1_;_^U1[!@>A?;X_44?;X_45Y[_;_ /M4?V__ +5'
ML&!Z%]OC]11]OC]17GO]O_[5']O_ .U1[!@>A?;X_44?;X_45Y[_ &__ +5'
M]O\ ^U1[!@>A?;X_44?;X_45Y[_;_P#M4?V__M4>P8'H7V^/U%'V^/U%>>_V
M_P#[5']O_P"U1[!@>A?;X_44?;X_45Y[_;_^U1_;_P#M4>P8'H7V^/U%'V^/
MU%>>_P!O_P"U1_;_ /M4>P8'H7V^/U%'V^/U%>>_V_\ [5']O_[5'L&!Z%]O
MC]11]OC]17GO]O\ ^U1_;_\ M4>P8'H7V^/U%'V^/U%>>_V__M4?V_\ [5'L
M&!Z%]OC]11]OC]17GO\ ;_\ M4?V_P#[5'L&!Z%]OC]11]OC]17GO]O_ .U1
M_;_^U1[!@>A?;X_44?;X_45Y[_;_ /M4?V__ +5'L&!Z%]OC]11]OC]17GO]
MO_[5']O_ .U1[!@>A?;X_44?;X_45Y[_ &__ +5']O\ ^U1[!@>A?;X_44?;
MX_45Y[_;_P#M4?V__M4>P8'H7V^/U%'V^/U%>>_V_P#[5']O_P"U1[!@>A?;
MX_44?;X_45Y[_;_^U1_;_P#M4>P8'H7V^/U%'V^/U%>>_P!O_P"U1_;_ /M4
M>P8'H7V^/U%'V^/U%>>_V_\ [5']O_[5'L&!Z%]OC]11]OC]17GO]O\ ^U1_
M;_\ M4>P8'H7V^/U%'V^/U%>>_V__M4?V_\ [5'L&!Z%]OC]11]OC]17GO\
M;_\ M4?V_P#[5'L&!Z%]OC]11]OC]17GO]O_ .U1_;_^U1[!@>A?;X_44?;X
M_45Y[_;_ /M4?V__ +5'L&!Z%]OC]11]OC]17GO]O_[5']O_ .U1[!@>A?;X
M_44?;X_45Y[_ &__ +5']O\ ^U1[!@>A?;X_44?;X_45Y[_;_P#M4?V__M4>
MP8'H7V^/U%'V^/U%>>_V_P#[5']O_P"U1[!@>A?;X_44?;X_45Y[_;_^U1_;
M_P#M4>P8'H7V^/U%'V^/U%>>_P!O_P"U1_;_ /M4>P8'H7V^/U%'V^/U%>>_
MV_\ [5']O_[5'L&!Z%]OC]11]OC]17GO]O\ ^U1_;_\ M4>P8'H7V^/U%'V^
M/U%>>_V__M4?V_\ [5'L&!Z%]OC]11]OC]17GO\ ;_\ M4?V_P#[5'L&!Z%]
MOC]11]OC]17GO]O_ .U1_;_^U1[!@>A?;X_44?;X_45Y[_;_ /M4?V__ +5'
ML&!Z%]OC]11]OC]17GO]O_[5']O_ .U1[!@>A?;X_44?;X_45Y[_ &__ +5'
M]O\ ^U1[!@>A?;X_44?;X_45Y[_;_P#M4?V__M4>P8'H7V^/U%'V^/U%>>_V
M_P#[5']O_P"U1[!@>A?;X_44?;X_45Y[_;_^U1_;_P#M4>P8'H7V^/U%'V^/
MU%>>_P!O_P"U1_;_ /M4>P8'H7V^/U%'V^/U%>>_V_\ [5']O_[5'L&!Z%]O
MC]11]OC]17GO]O\ ^U1_;_\ M4>P8'H7V^/U%'V^/U%>>_V__M4?V_\ [5'L
M&!Z%]OC]11]OC]17GO\ ;_\ M4?V_P#[5'L&!Z%]OC]11]OC]17GO]O_ .U1
M_;_^U1[!@>A?;X_44?;X_45Y[_;_ /M4?V__ +5'L&!Z%]OC]11]OC]17GO]
MO_[5']O_ .U1[!@>A?;X_44?;X_45Y[_ &__ +5']O\ ^U1[!@>A?;X_44?;
MX_45Y[_;_P#M4?V__M4>P8'H7V^/U%'V^/U%>>_V_P#[5']O_P"U1[!@>A?;
MX_44?;X_45Y[_;_^U1_;_P#M4>P8'H7V^/U%'V^/U%>>_P!O_P"U1_;_ /M4
M>P8'H7V^/U%'V^/U%>>_V_\ [5']O_[5'L&!Z%]OC]11]OC]17GO]O\ ^U0=
M?_VJ/8,#T+[?'ZB@7T9[BO//[?\ ]JI(M=W,/FH]@P/1$N%?I4P.17+Z9J'F
MXYKI8CNC!K&4>4!]%%%2 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !BBBB@ HHHI %5[PXA-6*
MK7O^H-4MP.$UVX*%N:X2]OF#GFNP\1$_-7GE^3O->G05T2/;4&SUI1J#>M8[
M$[J<K&NKD0&O_:#>M']H-ZUD[C1N-'(@-;^T&]:/[0;UK)W&C<:.1 :W]H-Z
MT?V@WK63N-&XT<B UO[0;UH_M!O6LG<:-QHY$!K?V@WK1_:#>M9.XT;C1R(#
M6_M!O6C^T&]:R=QHW&CD0&M_:#>M']H-ZUD[C1N-'(@-;^T&]:/[0;UK)W&C
M<:.1 :W]H-ZT?V@WK63N-&XT<B UO[0;UH_M!O6LG<:-QHY$!K?V@WK1_:#>
MM9.XT;C1R(#6_M!O6C^T&]:R=QHW&CD0&M_:#>M']H-ZUD[C1N-'(@-;^T&]
M:/[0;UK)W&C<:.1 :W]H-ZT?V@WK63N-&XT<B UO[0;UH_M!O6LG<:-QHY$!
MK?V@WK1_:#>M9.XT;C1R(#6_M!O6C^T&]:R=QHW&CD0&M_:#>M']H-ZUD[C1
MN-'(@-;^T&]:/[0;UK)W&C<:.1 :W]H-ZT?V@WK63N-&XT<B UO[0;UH_M!O
M6LG<:-QHY$!K?V@WK1_:#>M9.XT;C1R(#6_M!O6C^T&]:R=QHW&CD0&M_:#>
MM']H-ZUD[C1N-'(@-;^T&]:/[0;UK)W&C<:.1 :W]H-ZT?V@WK63N-&XT<B
MUO[0;UH_M!O6LG<:-QHY$!K?V@WK1_:#>M9.XT;C1R(#6_M!O6C^T&]:R=QH
MW&CD0&M_:#>M']H-ZUD[C1N-'(@-;^T&]:/[0;UK)W&C<:.1 :W]H-ZT?V@W
MK63N-&XT<B UO[0;UH_M!O6LG<:-QHY$!K?V@WK1_:#>M9.XT;C1R(#6_M!O
M6C^T&]:R=QHW&CD0&M_:#>M']H-ZUD[C1N-'(@-;^T&]:/[0;UK)W&C<:.1
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *KWO^H-6*K7O^H--;@>=^(1]ZO/;X?.:]"\0]6KSV^^^
M:]2AL29C#FE44C=:<M=8!BC%+12 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,
M48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH
M3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:*
M $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6
MB@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1B
MEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,4
M8I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3
M%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:*
M$Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B
M@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BE
MHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48
MI:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%
M&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $
MQ1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@
M!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEH
MH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I
M:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&
M*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q
M1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!
M,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH
M 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:
M* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*
M6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1
MBEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,
M48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH
M3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:*
M $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6
MB@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1BEHH 3%&*6B@!,48I:* $Q1B
MEHH 3%(13J0T -Q5BT'[T5!5BT_UH^M$M@/1?# Y2O3;3_CW6O,_#'5:],M/
M^/=:\G$;C1/1117,,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JU[_J#5FJU[_J
M#36X'G?B'JU>>WWWS7H7B'^*O/K[[YKU*&Q)EMUIRTUNM.6NL!:***0!1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !2&EI#0 E6+3_ %H^M5ZLVG^M%#V ]%\,=5KTRT_X]UKS/PSU2O3;
M7_CW6O)Q&XT34445S#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JO>?Z@U8JO>?
MZ@TUN!YWXA_BKSV^^^:]"\0_Q5Y[???->I0V),MNM.6FMUIRUU@+1112 ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *0TM(: $JS:?ZT56JQ:?ZT?6A[ >C>&>J5Z;:_ZA:\R\,]5KTRT
M_P"/=:\G$?$-$]%%%<PPHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *KWG^H-6*KW
MG^H--;@>=^(?XJ\]OOOFO0O$/\5>>WWWS7J4-B3+;K3EIK=:<M=8"T444@"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "D-+2&@!*L6G^M'UJO5BT_UH^M$M@/1O#'5:],M/\ CW6O,_#'
M5:],M/\ CW6O)Q&XT3T445S#"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JO>?Z@
MU8JO>?Z@TUN!YWXA_BKSV^^^:]"\0_Q5Y[???->I0V),MNM.6FMUIRUU@+11
M12 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *0TM(: $JQ:?ZT?6J]6+3_6CZT2V ]&\,=5KTRT_X]UKS
M/PQU6O3+3_CW6O)Q&XT3T445S#"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JO>?
MZ@U8JO>?Z@TUN!YWXA_BKSV^^^:]"\0_Q5Y[???->I0V),MNM.6FMUIRUU@+
M1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *0TM(: $JQ:?ZT?6J]6+3_6CZT2V ]&\,=5KTRT_P"/
M=:\S\,=5KTRT_P"/=:\G$;C1/1117,,**** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"J]Y_J#5BJ]Y_J#36X'G?B'^*O/;[[YKT+Q#_%7GM]]\UZE#8DRVZTY::W6G
M+76 M%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ I#2TAH 2K%I_K1]:KU8M/]:/K1+8#T;PQU6O3+
M3_CW6O,_#'5:],M/^/=:\G$;C1/1117,,**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "J]Y_J#5BJ]Y_J#36X'G?B'^*O/;[[YKT+Q#_%7GM]]\UZE#8DRVZTY::W
M6G+76 M%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 3-&:0TF: '9I:;N
MI0: %HHHH *3-*::30 N:6FTHH 6BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHI@%%%%(!,T9HI,T +FEI*6@ HHHH **6DH *
M*** "BBB@ HHHH **** "BBB@ HHHH **6D- !1110 4444 %%%% !1110 4
M444 %%%% !1110,****!!1110 4444 %%%% !1110 4444 %%%% !29H--H
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M*** "BBB@ HHHH **** "BBB@ S1FDHH 6BBB@ HHHH&%%%% @HHHH ****
M"BBB@ HHHH **** "BEH- "4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(:6
MD- "58M/]:/K5>K%I_K1]:); >C>&.JUZ9:?\>ZUYGX8ZK7IEI_Q[K7DXC<:
M)Z***YAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 57O/]0:L57O/]0::W \[\0_
MQ5Y[???->A>(?XJ\]OOOFO4H;$F6W6G+36ZTY:ZP%HHHI %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 444C&@!1S3UC+5&G)K6L;?S&'%*3L!52R=^@IQTR3'W37;Z9HHE
M ^6MU?#(*9V5S2Q"3&>2O9.G45"R%>M>BZKH'E*V%KB=2M3"QXK6G44A&=N%
M&:AR0U#/S6U@+*(7/%6DT]W' J328?.D KT'2] $L8.VL*E7D \\;3G4=*KO
M 4ZBO4K[P\(XR=M<7JMB(2>*4*RD,YL\&BFS?*^*%.:W$.HHHS0 449HS0 4
M49HH&%%%% @HHHH **** "BBB@ HI,T9H 6BC-&: "BC-(30 9IZJ6J('FKU
MI%O84/0!B6C/T%3?V;)C.#74Z5I0FQ\M=(/#@\K.SM7/*NDQGEKVC)U%5V4B
MNWU?21!GY:Y&ZCV,16D)\PBK136-*#6@"T49HH **** "BBC- !129HS0 M%
M&:,T %%%% !111F@ HHS10 444<4 %%&:* %HI** "BBB@!**,T TP%HHS10
M M(:,T9I %% I: $HHHH **,T9H **,T4P"BBBD 444E "T9S32:1#EJ )TB
M+]*L)ISOT4U>TVV$K#(KMM+T1)5&5K&I5Y0//FTR11G::K20&/J*]8O/#Z)$
M3MKA-:LQ S8%33K<PSG**:QPQI<UT"%HH!HXH ***,T %%&:* "BBB@ HHHH
M&%%%)0(6C% -&: "BC-% !11FC- !11FB@ HHHH **,TF: %I:;FES0 &BEI
M.* "BBB@ HHHH ***,T %%%% !1110 449HS0 449HH *!S36-21#)% #TA+
M=!4ZZ>[#@5I:=9^:PXKLK#0!)&#MK"=7E \[;3W7L:@>$I7IE_H CC)VUQ>I
M6GE,1BB%7F PCQ24^08-1@UN HI:2ES0,*2ES13$)2T44@#-*HS4;'%3VJ[V
M%# >EJS]!5@:9(1G::Z'2=/68KD5V%MX>1H@=M<TZ_*QGE4E@\?4569"AP:]
M(UC1DA1B%K@M0C\N0BM*=3G I44T&ES6HA:**3- "TJJ6.*86J[81^9(!2>B
M 1+%W' J0Z;(!G::[C2-$$Z [:UY_#86+.RN:6(2=AGE+VS)U%0L,5U^JZ8(
M=W%<G=+L<UO"7,(BS2U&IR:DJP"BBB@ HHHH ***,T %%)FC- "T4F:6@ HH
MHH ****!A11FC- @HHS10 4A.*6H7;!H&6$0N>*MII[N. :?I,/G2 5Z'I?A
M\31 [:RJ55 1YTVFR*,X-5G@*'D5ZK?>'1'$3MKA]6LO)<C%33K*0'/JA)Q5
MF.Q=^@J6UAWR@5VNCZ()U7Y:JI4Y0.).F2 9VFJTELT?45ZU-X:"Q$[*XO7-
M.%N6XJ*==2=AG)$X-+44K8DQ3U.172(6EHQ2'@4@%S2;"W2F!OFQ6MI]IY[#
MBANP%.&R=STK3@TEV'W:ZS2] \P [*Z6V\/*JC*URSQ"0SS<Z,^/NU2GTUX^
MJU[ =#B"G*BN=U?2XXU; %1#$78'F,D10\U%TK:U& (YQ6+)P:ZXNX@HIH-.
MS5 %%&:,T %%%% !11FC- !11FC- !1113 ****0!129HS0 M%&:,T %%%&:
M "BC-% !1110 449H- !124M !24M)0 4M)2T %%%% !111F@ Q129I<T %%
M%% !1110 44<44 %%)FC- "T49HS0,*,444""BBB@ HHHS0 449HS0 44F:6
M@ HHHH **,T9I@%%%%( HI*6@ HHS10 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %(:6D- "58M/]:/K5>K%I_K1]:); >C>&.JUZ9:?\>ZUYGX8ZK7IEI_
MQ[K7DXC<:)Z***YAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 57O/\ 4&K%5[S_
M %!IK<#SOQ#_ !5Y[???->A>(?XJ\]OOOFO4H;$F6W6G+36ZTY:ZP%HHHI %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2TAH 2K%I_K1]:K
MU8M/]:/K1+8#T;PQU6O3+3_CW6O,_#'5:],M/^/=:\G$;C1/1117,,**** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "J]Y_J#5BJ]Y_J#36X'G?B'^*O/;[[YKT+Q#_
M !5Y[???->I0V),MNM.6FMUIRUU@+1112 **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IK4
MZFM0 1?>KH]*^^M<[%]ZNBTG[ZU%389Z/H71:[.$XB%<?H0^5:ZDR;(J\BKN
M,L[QTJE?6BS0GBJAOP),9K1BG$L>*BS6H'F'B33,;R%KS/4+8QSGCO7OFN:>
M)HV.VO*->TPQRL=O>O2PU7H)E;PWQ*M>T>'SF!?I7C6B)Y=PH]Z]B\.G]POT
MK/%@B]JW^I/TKR[Q"?F:O4=7_P!0?I7E7B%OG:L\-N-G"W8)E-6+*T:0CBG^
M099NG>NMT/1S)M.VO0G/E1)#IFC,^/EKK++01@96MS3-'6- 2M:Y2.!>U>?4
MKMO0=C"31$"_=%,DT1"/NBM.748T.,BB&^CD/45ES2&<I?Z#\IPM<AJ6C-&3
M\M>S>3'<)T%8^J:(KQDA:UIUVGJ!XC-;-$QR*@SBNPUO2O)+86N0G0I(17H0
MGS(D4<T4U>E.JP"BBFYYH #4T$!D88%-2,N171:1IQE=>*F4K(!-.TEI"/EK
MKM/T'@96MG1]% 125KH?L\=O'T KSZE=MV0[&#'HJ!>5I6T:,C[HJ]/J$<9Q
MD4R'44=L9%97EN,PK[005.%KD=4T-DR0M>NQ^7.O:LS5=,C:)CM%73K-/41X
M7/9M%(<BKFGG#@5NZ[8K$[8%85J-LX'O7H*7-$#T7P\?NUW2#=!^%<#X>/"U
MZ!9C="/I7FU]QG+ZQ9&0GBL*+2LR<K7H-W;*R$D5@7'EPL>E.%1VLA%6WT="
MH^45,^A(R\+4D&H(&QD5MVDZ3 =*F4I(9PNI:%M4D+7%ZGIYB)XKW"]L5EC)
MQ7G_ (@TT*&(6MZ%:[L(\OD!5\5/#"9" *EOH-DQX[U>TB$/(H-=[EI<1;T[
M1WE(^6NPT[0/E&5K1T.PBV*2!74*D,,?:O/JUW>R'8P8]%15Y6I/[(CQ]T5;
MN=1CCR 156/5$9L9K*\F,K3:(C#A:P=1T/:I(6N]M9$G%)>V"R1DXHC5:>HC
MQ#4K Q$\5@D%9,5Z;X@TT+NXKSZ[AV3GZUZ5*IS(1IZ3 )6'%=I9Z.)(P=M<
MMH S(M>J:-;!XEXKGKS<1HYB?0N/NU1;1"&^[7I<M@I7.*S;BUCCSD"N>-9@
M<K9Z. 1E:W8-&C9?NBF-<1Q-C(J_9Z@C$#(I2E)Z@9=YH*E20M<GJFBE,D+7
MK*(D\=96IZ2K0L=M*G6:>HSP^[M3$QXK-9L-BNU\06(A9N*XF13YV/>O4IRY
ME<DMV\)E(P*Z'3=(:0CY:AT.Q,K+Q7IFBZ,H125K"M5Y1HRM.T 8!*ULC18U
M3E16^MO';Q]!Q6==Z@D>1D5P^TE)Z#.:O](7!PM8QT0E_NUU37D<K8R*NVMO
M'*0<"M%4E%"L<Q;Z%QRM%UHP1"=M=['9*%X%4=1M@L9XJ56;8'DNJ6@BSQ7,
M3J=^!7<>(%"LU<FL'FSXQWKT*4M+B$L;)I6'%=?I>BEL96I=!T??M.VN^L=+
M6&,$K6%:O;1#L8MKH:A1E:OC1H]OW16E/+' .U43J\0;&X5R<TF,SKK1%(.%
MKF=3T0J"0M>@P745QQD47>G)-&2 *N-5Q>H'B-]8M$QXK,*E37I&N:1L+$+7
M#WEJ8W/%=].IS(DHBEIK'!I16H W2F(?FIS=*9']^F!O:;%N85VVEV.]1Q7)
MZ,F76O3-#M@R+Q7#7E89EWNG[8CQ7#ZM#L<BO7=3M0+<\=J\OUZ/;*U3AY78
M,P[.'?(!BNOTW2Q(H^6N;TU<S#ZUZ-H<(*KQ6E:;0&;<:$#'PM8LNAE9/NUZ
MK]B5XAD5F7MA&G.!7-&NPL<CI^D 8RM;\6C(R?=%1^;' V.*T;34$8@9%$I2
M>H&=<: I4X6N7U71=@;"UZG%LFC[5DZMIRO&3M[5,*S3U&>'W]H8V/%9P!!K
MN-<T_8S<5R$\6QSQ7ITY\R$19HIN>:<*T$!I*#24 30#<X%=;H]@)L<5R=I_
MK17HGAJ,-MXK"M*R&73H0,6=M9LVA$-]VO2H;-6@7BJUU8(J9Q7 J[N!PMKH
MX!&5K;@T="H^6IY&CA;M4]M?ID#(IRG)@4YM#4KPM<YJ6A=<+7HL3I,M)-IB
MS#[M3&LXO49XX=%<2?=K>TO2 ",K78W&C)'SM%4OW=LW:MG6<EH(?#HT;(/E
M%17&@J5.%K1M;]#@9%;4(29*P<Y(9Y5J^C>6"0M<C+:E)L8[U[7K6FJT1.*\
MUU.R\J<\=ZZZ-6Z$PT:S$A&1780Z(KQ9VUSFB.$D4&O1]-VR0CZ5E6FTP."U
M;1Q&I.VN$U*'RG/%>VZU9!HF(%>4>(+39(W%;8>I<#F8SDUH6T.]AQ5"-<28
MKH])MO,=>*Z9NR$;&DZ5YN/EKH?[$58LE:T]"T\!%)6M>^C6* \=J\Z=5\UA
MV/,]5LUBSQ7*3Q;I"!78Z[./,8"L"VMO/FZ5UTW978F06&G-*XXKL=-T+<H)
M6KFB:+G:2M=E!9)!&,@"L*M?HAHP[?1$ &5%22:/'C[HK1N+Z*#C(JHNJQ.^
M-PK#FD]1F+>:&"IPM<EJFCLF?EKU:+R[A.W-9VJ:0LD9(6KA6:>HK'A]W:M&
MYXHMAAA76:WI7ELQVUS)3RY,5Z$9\R ZC1#\ZUZ?H_\ J5^E>6Z$<R+7J>C_
M .I'TKAQ(PUC_4M]*\LUX_O&KU/6/]2WTKRK7QF1J,,)G+RC<QJQ9:>TKCBG
M6UN99<8KN= T7S-I*UV5*BB@*.F:$S8RM=5::" HRM=#9Z2D**2HJ>9XX!CB
MO/G6<GH!BKHL?]T5%/H2E>%K1;4HU;&15F"\CEXR*CFD@.%U#0< X6N2U#2V
MC)^6O;9;..=. #7*ZSH@VL0M;TJ^MF!XY/$4:IK0985L:OIQB<\5F6R;9 *]
M!2NA'3Z5;[RO%=A;:=F+I6#X?C#,M>B6=H# ..U>?6G9C.#U>RV(W%<!J*[9
M#7K?B* +&W%>5ZHF9B/>M\/*Z SH(R[8KH-.TMI2/EJMI-D9''%>DZ%HX(4E
M:NM5Y1&?I^@Y RM;L>AHJ\J*Z&&S2!.0*IW=['%D9%>>ZLI/0HYR^TA,'"BL
MJ+2-LP(7O70R7Z2-C(JW9QQR,#Q6G/)+4";1K8Q*,BM6].("/:I+>%448J"_
M_P!6:YF[R \]\0_Q5YWJ/^L->A^(/XJ\\U'_ %AKU,/L)E).M2U%'UJ6N@04
MA.*6HW- #P-U7+6Q:5AQ45C$99 ,5WFA:/YFTE:SJ3Y4!2TS0V;&5KJ[30E"
MC*UOV.D)%&"5%6)FC@7M7GSK.3T&8ZZ-'_=%1SZ&C#A:MMJ:*V,BK=O>QR\9
M%1S26H'%ZAH!P2%KD=1TIHB?EKVR6VBFC/ KD-=TY K$ 5M2KN]F%CR.>(QM
M@TD:E^*U=5MMLAP*BTZU,DH&*[^;2XB6QTUI6'%=?IFA$A<K6AH.BAPI*UV<
M&GQV\8) KBJU];(9@P:(BIRM3'1XR/NBM&YO(X01D52358R^-PK"\GJ,RKW0
MP5.%KD=3T5D)(6O4X9([A>QJKJ&D)+&2%JH5G%ZBL>'W-HT1.169*</7H&O:
M5Y18A:X"]C*3$>]>E2GS(1TGALYF7ZU[3H'^H7Z5XIX9_P!<M>U>'_\ 4+]*
MXL6-%S5_^/<_2O)?$7^L:O6M7_X]S]*\E\1?ZQJSPNXS$T[_ (^!]:]5\,_<
M6O*M/_X^!]:]5\,_<6ML3L(ZJZ_X]S]*\L\6]7KU.Z_X]S]*\L\6]7KFPWQ
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MZ28C<CUH^;]ZNOT+5?,*_-7D,<[^8.:[;PW.V]>:VK4E8#U^&02P_A7+^(8
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MC1=HDLZWPS8C*DBO2[)%A@'TKD/#D "KQ772?)!QZ5Q5Y7D-&7J^I+"C &N
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M 93TJPW2CCO7INA6:QQJ2*Y31;8%UXKOK*/9 /I2KSOH");RZ6"+Z"N)U?7
MK, U:OB"Z:.-L&O+-8OW,C<T8>E?4&:EQX@(<_-5[2_$69 "U><7-RY)Y-3:
M9=2"8<FNYT%81] Z1J2W"+S6G>6JSQ=.U>?>&+QB$!->D6[;X%)]*\NK'DD4
M>9>)=-"EB!7!.GEW&/>O8/%%N-C'%>47R;;H_6NW#SO$3.K\-'++7J%CC[./
MI7EGAK[RUZA9'_1A]*YL1N!S?B8C8U>6WL>^Y/UKT[Q,?D:O.77==?C6^'^$
M#:\/6.64XKT[3+=8H@<5QWAN ?+Q7>HFRWX]*Y\1*[L",_5;]8(VYKSW5M=Q
M(P#5N^)[ED1\&O*-4O',S<UMAZ2>H'1IK?S_ 'JZ;1]:#,HW5Y,MRX/4UOZ+
M>OYJC-=%2BK"/<["Z$R#!I]\N8B:P_#TQ>)<FM^\'^CGZ5YDERR*/./$'\5>
M=ZC_ *PUZ+XBZM7G6H_ZPUZ>'V$RC'UJ:H8^M3=JZ6(0FDV[C2$\U/ NYA28
M&OHMKNF7BO6/#]HJQJ2*\_T& &1>*]1TF/9"/I7GXF0T:5Q,L,/X5Q.LZN$+
M -70:S.4A.#7EVN73%VYK*A3YF,=<:X1)]ZK^FZ_\PRU>?7,[ESS3[6\=&')
MKO=%-"/:[774:+EJS=6U))$/-<#;ZPZ+C<:2?5VDXW5@L/9@2W^)I3BK^B66
MZ5>*QX)?-D&:[+081N4XK2H^6-A'<:-;K%"IQ4NJW?DQ'%36*8A %4]4M6E4
M@5YV\M1G ZOJ[AV )K$36)1)U-='?Z#)*Y^4UG#PS)NSM-=T90L!M:%JS.R@
MFN[@<3P<^E<1I&BO"XR*[NQM_+A -<E;EOH".1\2609&(%>2:O:;)SQWKW77
M(%:)J\EU^W"RM]:Z<+,&4_#HVSK]:]H\/']POTKQK1!MN%^M>Q^'3^X7Z4L6
M"+^K_P#'N?I7DOB+_6-]:]:U?_CW/TKR7Q%_K&K/"[@S$T[_ (^!]:]5\,_=
M6O*M/_X^!]:]4\,GY5K;$[ CJ[K_ (]S]*\L\6]7KU.Z_P"/<_2O+/%O5ZYL
M-\0,\SN/]<?K4D?W:CN/]<?K4D?W:]?H(5AFA/E.:=37X6@#6T_4?)=1FO1O
M#VJ>:%&:\:61EE&*]!\)RL73FN>O37+<9[';/OB!K.U6X\H'FKFG'-L*Q?$+
M$(V*\N*]ZPSD=7UG9N&ZN/N-1\Z;&>]/UV9P[<USL$K-<<GO7J4Z:2N2>B>'
M1OD4UZGIPQ:BO+?"_)6O4;$X@'TKAQ.XT.O9Q#$<FN(UC6Q$6PU;^O7!6-L&
MO*-?NWW-S3P]/F M7/B0ER-_ZTV/4/M1QG.:X":YD,_4]:Z307:1US7?*DHJ
MXCO]&LA*ZG%=]9VRP0 X[5SGAZ$;5.*ZYE_<X'I7F5I7=AHY?7]1,*-@UYOJ
M.N2><0&->B:WI[W ; KA[KPS(\I.TUT4'!+4"#3=8D9QDFO0-%OS*J@FN/LO
M#DD; [379:/IK1$9%*LXO8#=N(1- 3CM7G/B:S"[L"O4UC BVGTKA/%,*_-6
M-"5I >5FVW7&,=Z[?PW8<J<5S\=N#<].]=_X=MP O%=E:?NB1UMA$L,(..U4
M=6U%8$;G%:;#9;\>E<%XFNF0-@UPTX\TBC+U/7?G.&K,CUW$GWJYC4+QVE/-
M9_VEPW6O3C15B3V#1M:5RHW5W%E.)HQ7AGA^]<RJ,GK7K^@REX5SZ5Q8BGRC
M3+NJ*/)8^U>6^(_OM7JNJ?Z@_2O*O$?^L:C#;C.<L_\ CX'UKT_PQC"UY?9_
M\? ^M>G^&.BUOB?A$=N_^I/TKSCQ;T>O1G_X]_PKS?Q9T>N/#_$,\DU'_CX/
MUJ_I7WA5#4/]>?K5[2OO"O8E\))Z3X>ZI7HUKC[./I7F_A\\I7HMJ?\ 1Q]*
M\FON4<SXE(V-7EU_%ON#]:]-\2GY6KSR1 UQ^-=.'T0F:7A^PS(IQ7J.E6ZQ
M0@XKC/#\ &WBN]M5_<@"L,1*[!%#6+WR8CBO.=5UF3S" 37?ZM9M,I KB;WP
M_))(3M-.ARK<#$M]7D\P<FNST/5&<J":Y^+PW(K9VFNCTC1WA89%:57!H#L4
M(FM^G:N*\2V8*L0*[JUAV0@&N?\ $$*E&KEIRM(&>*:A;E;@\=ZW/#PQ(M1:
MO;A9CQWJ?0QB9:]*4KP$>NZ#CR!]*U)Y!'$2:R-".(5^E6-6E*P''I7ER5Y%
M'+ZWJ8CW<UQ%YK^V0_-5SQ%<MEN:\[O[A_-/)KTJ%%-"/2M&USS)%&ZO2M(N
M!-&O->!>'KAS,O)KVKPU(3&OTKGQ5-1!&[J$2M 3BO+O$L85FKU:\YMVKRWQ
M/]YJSPSU&<5'%ON,>]>@>&M/#;3BN)L4#7(^M>J^&(!L7BNG$2LA(Z6V@6&'
MIVK#US4Q C<UT5P=L#8]*\S\5W+ /@UQ48\TAF-J'B ^:1NHLM=)<?-7"WUR
MYG/)ZT^UNG7!S7J>Q5A'L>G:ZNT9:KMWK$;PGYATKRBVU5TQ\QJVVM.RXW&N
M:6'U"Y?UVY61FP:RM.FV7 /O5*YO#*>34=O/MD!S71&%HV$>Q>&[T;%&:ZF?
M;+;GZ5Y;X=U AE&ZO2;27S;<<]J\ZM#ED4<!XHM<[\"O,;NU/V@\=Z]J\0VF
M]6XKSJ[T[]^?E[UUX>I9"'>&[4^8O%>NZ)"$A4XK@/#]EMD7BO1[1?*MQ]*P
MQ,KL8S5[I8X2,]J\L\170<M@UV'B*^V*PS7F>J7?F.W-7AH=1&!<<RFG1CBA
MQEJ5>E>CT$.HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4AI:0T )5BT_UH^M5ZL6G
M^M'UHEL!Z-X8ZK7IEI_Q[K7F?ACJM>F6G_'NM>3B-QHGHHHKF&%%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !5>\_U!JQ5>\_U!IK<#SOQ#_%7GM]]\UZ%XA_BKSV
M^^^:]2AL29;=:<M-;K3EKK 6BBBD 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !36IU-:@
MB^]71Z3]]:YR+[U='I/WUJ*FPST[0/N+6QJ(S;GZ5D: /D6MF_'[@_2O)G\8
MSR_Q#\KL:YRUO3'..>]='XE'S/7%%MLV?>O2I*\23U;PYJ9(4%J[=2MQ"/I7
MC6AZCY3J-U>EZ/J(E11FN*O3L[H:-/[ N_.*N1Q>6E31X9 :<1\IKE;;&86J
MG]VU>9ZY_K37IFJC]VU>8:\<2FNS#B9+H&//7ZUZQI/_ !ZCZ5X]H4VVX7GO
M7KNBRA[4#/:EBD"*FO9\IJ\E\0'YFS7LVL0>; <>E>4>([!MS<4\*T#/.Y2/
M-/UJU;GI39[-Q,>.]7+.S9B.*]-M6$=)H!/F+7K&BY\E?I7G6@:<V]3BO3=-
M@,4 R.U>7B6FQH9JW^I/TKS#7OO-7HNMW 2(C->8:U<AG;FGAD,Y.Z^^:BCJ
M6X.YC4:C%>FMB1QZ5!_'4YZ5!CYZ!G4:!_K%KUOP]]Q:\?T23:ZUZOX=N1M4
M9KS\4@1TUY_Q[-]*\G\6]7KUFX&^ X[BO-/%5BS[^*PPSM(9Y)<?ZXU/%TJ>
M[L'68\5-:V3,0,5Z_,K$D:1LW2IOL[D=#70:?HS28^6MG_A'R(\[:PE528S@
M&A96Y%:-@N'%:6H:=Y)/%4[8;90*KFYD([WP[_#7<#_CW_"N'\/?PUW '^C_
M (5YE;XBCB?$IX:O,[\9E->F>)1PU>:7_P#K379AMA%*)1O%=IX<'SK7&Q??
M%=IX<^^M:UOA!'J.F_Z@?2L[73^Z:M'3A^X'TK-UW_5M7F1^(&>7ZSS*U95M
M:&64<5LZJN9C]:LZ+9B25>*])2M$1IZ/HNX E:ZRVTR.)1E15_2=.580<=J7
M5#]G0XK@E4<I6*(C]GB'.*K/=VZG (KD=5UIXF8!C6&-<EDEQN-:QH-JXKGJ
MEG=1LPP16NS!HN*X#0;J24KDFNYAR8.?2N>I'E8SE?$'W&KS#5#^_/UKU'Q$
M,(U>6:I_KV^M=F&V$:&@_P"M6O7-!_U2_2O(] _URUZYH(_=+48H$7M4.(#]
M*\E\4\EZ]:U4?N#]*\F\4#EZC"[@SSF9!]H_&NCT1?F6N?F_X^/QKHM%^\M>
MG4^$1ZEX<X"UV,W_ ![?A7'^'1PM=A,/]&_"O&J_$4>:>*/OM7)V?_'R/K76
M^*!\S5QEO+LN?QKNI? 2>H^'3\JUT]QS!^%<9X<N00O-=ICS(./2N*JK2&CS
M;Q.#EJ\XO.)&KUOQ'8,X8@5YMJ&FN)&XKNP\E81S4G+5TWAM?WR5E#39&D'R
MUUWAW2G6125KHJR7*!ZAX>&(%J_JW_'N?I4&C0F*)0:FU8_N#]*\9OWRCRS7
M_P#6M]:KZ'_Q\+]:F\0'$K?6JNAR8N%^M>@O@)/7]&_X]1]*N3, .:H:)(&M
M@/:I=38K&2/2O.:]XHIW$L )SBJ1FM<]JYG6-2DA9N37+2>(91)C<:ZH4&T(
M]3CN[=.F*M)K$48X(KRJWUJ:3^(U?6]G9<Y-#P_<#T&[UV,PD!A7G?B.^6;=
M@U#<WLX4Y)KGKVX=R<DUK1HJ+N!CW(S*32QC ISC+4 <5W"&OTIL7WQ3WZ4R
M+[] '6:)]]:]2T'_ %:UY;HGWUKU+01^[6O.Q(T:6J?\>[?2O*/$/^M:O6-4
M'^CGZ5Y1XA_US5&%W!F7I?\ KQ]:]/T#_5K7F.E_Z\?6O3]!'[M:TQ (V+__
M %!^E>8^(S\S5Z=J _T<_2O,/$8^9JSP^X,XB<9<U-8K^]%13??-3V/^M%>B
M]@/2?#(X6N\7_4?A7">&NBUWBC]Q^%>56^(9QGB$\-7F^I_?->D>(1PU>;ZG
M]\UV8?8DQ3]ZGCI4;?>J0=*[  TE*:2@"Q9_ZX5Z5X7Z+7FMG_K17I?A?HM<
MN(V!'H<9_P!'_"N,\1GAJ[.,?Z/^%<;XC'#5P4OB*/,-5&9&JG8J//'UJ[JG
M^L-5+'_7#ZUZJ^$1Z9X9'"UW8_X]_P *X7PR.%KNP/W'X5Y=;XAG$^(SPU>:
MZB,R'ZUZ5XC'#5YMJ'^L/UKLP^PB/3U'G"O3/#8X6O-+#_7"O3/#8X6GB-@.
MS;_CW_"N$\2]'KO&'^C_ (5P?B4??KCH_$#/-[IB+@_6NC\/76R1>:YR\7$Q
M/O5S2[GRI!S7HS5XB/;-(N0\*C/:EU:V$T1XKG= O]RJ,UV"KY\/X5Y<URR*
M/,[[2C]H)V]ZZ/P_9&, XK3N=-#29VU>L[40ITJYU;QL V_G\FW//:O+_$M_
MEV&:[OQ!=;(6&:\@U^[+2MSWK;"PN[B*]L_F7.?>O3_"JX"UY/ICYF!]Z]4\
M,3 !:VQ*T!'HT?\ JU^E5+IT .ZK$+;H0?:L#6YWB5B*\V*N[#$FGMMW.*8E
MQ:CIMKSW4]:FBD/S'K5&'Q!*QQN-=:P[L(]82_@CZ$5,-<B48R*\RBU6:0<$
MU(]W<$9R:GV'<+G5Z]K22QL PKS3491+.2/6K-_>3$')-8IE+2<UU4:?*@.A
MT,8E6O4='_U(KS#0^9%KU'1Q^Y%<^)&0ZU_JFK@KK_7GZUW^M+^Z:O/;UMDY
M^M*AL)G0Z)C<M=Q!_J/PKSS1;H!U&:[ZRD\R$8]*SK+4:.8\2YV-7E&JY\YJ
M]DUZS:2-N*\NU?3F$C<5TX:2L(Y&;%2Z>1YHJ2YM&!/%3:;8N91Q7<VK"/0O
M#).4KU&QS]F7->?>&;%E"$BO18%$<"@^E>/B'>0T<]XG_P!4U>1ZC_Q]'ZUZ
MEXHN1L89KRF]?=='ZUTX9: SJ?#7WEKTZQ_X]Q]*\Q\-#YEKT^R'^C#Z5AB-
MQHY?Q-]QJ\[/_'W^->B^)A\C5YO*VVZ_&M\/\(F=]X:Z+7<_\N_X5Y[X;N -
MO-=_$_F6_P"%<M9>\,X+Q5]QZ\GU'_7GZU[+XELVD1^*\IU2P83'CO7;AI*P
MF8@K:T;_ %R_6L];1B<8KH-%TY_-4XKIG)6$>G^&O]4M=-=_\>Y^E8.@6QCC
M7(K=O.(#]*\>H[R*/.?$75J\ZU'_ %AKT7Q#U:O.M1_UAKTL/L)E&/K4W:H8
M^M2]JZ6(8>M6[7[PJJ1S4\#;6%)[ =OH&-ZUZ;IO^H'TKRC0;@"1>:]2TB3?
M"OTKS,2M1HJZYGRFKRS6OOM7KVKVQ>$\=J\QUVQ8.W%5AFAG"7!&XTV+D\59
MN[1@YXJ6PL'=QQ7HW21(1PNPXH:VDST-=AI^A%T!*U8NM"\M<[:P=97L,Y:Q
MB*N,UWFA#!6N7-N().E=%HLX#J,UG5=T!Z)8_P"K%.N'0#YJAL6W0C%9^L2O
M&A(KSTKR&.EFM]QSBHO/MO:N'U#5Y8G/S&LHZ_+NQN-=*H-H1ZC'>V\?0BIO
M[;B12 PKS"+5II.A-3F[N"O4T>P[A<Z[5-921&^:O.=;NA(YP:GN[N8 Y)KF
MKVY9GY-=-&ER@:^B<W"_6O9/#H_<+]*\:\/'=.OUKV?P^/W"_2L<6"+FK_\
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M/]<M>S^&A^[6N?%C1TEY_P >[5Y;XG^^U>I7G_'NU>6^)Q\[5S8;<9R^G_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !5>\_U!JQ5>\_U!IK<#SOQ#_%7GM]]\UZ%XA_BKSV^^^:]2AL29;=:<
MM-;K3EKK 6BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M 4AI:0T )5BT_P!:/K5>K%I_K1]:); >C>&.JUZ9:?\ 'NM>9^&.JUZ9:?\
M'NM>3B-QHGHHHKF&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5>\_U!JQ5>\_U!
MIK<#SOQ#_%7GM]]\UZ%XA_BKSV^^^:]2AL29;=:<M-;K3EKK 6BBBD 4444
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MG4W/&XTWAU<9T>I:B)<\US%TV]C0UTS]341.:UC#E$,44^C%)5@+2$44M "
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 57O/\ 4&K%5[S_ %!IK<#SOQ#_ !5Y
M[???->A>(?XJ\]OOOFO4H;$F6W6G+36ZTY:ZP%HHHI %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %(12T4 1E,TT1U-13 8%Q3Z*2D M(:6B@!C+FHS&:GI,4[@1"
M,U(JXIU%%P"D/-+12 C*YIGEFIL4M.X%?RJ/*JQ11<"$1T\+BG4M%P"BBBD
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MG0;=V!5UK43([<US$S;V)J:ZG,C$YJL.:]*$>5"&J,4^DQ2U8!1112 ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *0TM(: $JQ:?ZT?6J]6+3_6CZT2V ]&\,=5KT
MRT_X]UKS/PQU6O3+3_CW6O)Q&XT3T445S#"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ JO>?Z@U8JO>?Z@TUN!YWXA_BKSV^^^:]"\0_Q5Y[???->I0V),MNM.6F
MMUIRUU@+1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6B@!*6
MBB@ HQ12TP$HH-%( HHHH **!0: "BBB@!*6BB@ HHHH&%%%% @HHI#3 ***
M,4@%HHHH **** "BBB@ HHHH **** "BBB@ I:2B@849HI*!"T4E+0 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *0TM(: $JQ:?ZT?6J]6+3_6CZT2V ]&\,=5KTRT_X]UKS/PQU6O3+3_CW
M6O)Q&XT3T445S#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JO>?Z@U8JO>?Z@TU
MN!YWXA_BKSV^^^:]"\0_Q5Y[???->I0V),MNM.6FMUIRUU@+1112 **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHI@%%%%( I
M:2B@!:2BB@ HHHH **** "BBB@ HHHH *6DHS0 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%%, H-%%(!*6BB@!"*3;3J*8#=E&VG44@$Q2T44 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1113
M **** "BBBD 4444 %%%% "4"EHH **** "BBB@ HHHH **** #%-VTZB@!N
MVEQ2T4 %%%% !1113 ****0!1110,**** "BBB@04444#"BBB@04444 %)2T
M4P$%+112 **** "BBB@ HHHH ****  4M)10 4444 %%%% !1110 4444 %%
M%%, HHHI %%%% !1110 4444 %%%% !2&EHH 2EHHH **** "BBB@ HHHH *
M!110 M)110 4444P"BBBD 4444 (:*6B@ HHHH *#110 E+110 4444 %%%%
M !24M% "44M% !1110 4444 %%%% !1110 4444 %%%% !1110 E&*6B@!,4
M8I:* "BBB@ HHHH **** "BBB@ HHHH **** "@T44 )2T44 %%%% !1110
M4444 %%%% !1113 ****0!1110 4444 %%%% !1110 4444 -(HVTZB@!N*7
M%+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4AI:0T )5BT
M_P!:/K5>K%I_K1]:); >C>&.JUZ9:?\ 'NM>9^&.JUZ9:?\ 'NM>3B-QHGHH
MHKF&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !5>\_U!JQ5>\_U!IK<#SOQ#_%7G
MM]]\UZ%XA_BKSV^^^:]2AL29;=:<M-;K3EKK 6BBBD 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4AI:0
MT )5BT_UH^M5ZLVG^M%$M@/1?#'5:],M/^/=:\S\,]5KTRT_X]UKR<1N-$]%
M%%<PPHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *KWG^H-6*KWG^H--;@>=^(?XJ\
M]OOOFO0O$/\ %7GM]]\UZE#8DRVZTY::W6G+76 M%%%( HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I#2
MTAH 2K-G_K15:K-I_K10]@/1O#/5:],M?]0M>9>&>JUZ9:?\>ZUY.(^(:)Z*
M**YAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 57O/\ 4&K%5[S_ %!IK<#SOQ#_
M !5Y[???->A>(?XJ\]OOOFO4H;$F6W6G+36ZTY:ZP%HHHI %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M(:6D- "58M/]:/K5>K%H?WH^M$M@/1O#'5:],M/^/=:\R\,'E:]-M/\ CW6O
M)Q&XT3T445S#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JO>?Z@U8JO>?Z@TUN!
MYWXA_BKSV^^^:]"\0_Q5Y[???->I0V),MNM.6FMUIRUU@+1112 **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *0TM(: $J>T_UHJ"IK7_6BB6P'HWACJE>G6G_ ![K7F'A?JM>GVG_ ![K
M7D8C<:)Z***YQA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 57O/]0:L57O/]0::W
M \[\0_Q5YY?GYS7H?B'^*O.[\'>U>I0V),QF&:4.*8Z,32"-_2NL"7>*-XJ/
MRG]*/+>@"3>*-XJ/RWH\MZ )-XHWBH_+>CRWH DWBC>*C\MZ/+>@"3>*-XJ/
MRWH\MZ )-XHWBH_+>CRWH DWBC>*C\MZ/+>@"3>*-XJ/RWH\MZ )-XHWBH_+
M>CRWH DWBC>*C\MZ/+>@"3>*-XJ/RWH\MZ )-XHWBH_+>CRWH DWBC>*C\MZ
M/+>@"3>*-XJ/RWH\MZ )-XHWBH_+>CRWH DWBC>*C\MZ/+>@"3>*-XJ/RWH\
MMZ )-XHWBH_+>CRWH DWBC>*C\MZ/+>@"3>*-XJ/RWH\MZ )-XHWBH_+>CRW
MH DWBC>*C\MZ/+>@"3>*-XJ/RWH\MZ )-XHWBH_+>CRWH DWBC>*C\MZ/+>@
M"3>*-XJ/RWH\MZ )-XHWBH_+>CRWH DWBC>*C\MZ/+>@"3>*-XJ/RWH\MZ )
M-XHWBH_+>CRWH DWBC>*C\MZ/+>@"3>*-XJ/RWH\MZ )-XHWBH_+>CRWH DW
MBC>*C\MZ/+>@"3>*-XJ/RWH\MZ )-XHWBH_+>CRWH DWBC>*C\MZ/+>@"3>*
M-XJ/RWH\MZ )-XHWBH_+>CRWH DWBC>*C\MZ/+>@"3>*-XJ/RWH\MZ )-XHW
MBH_+>CRWH DWBC>*C\MZ/+>@"3>*-XJ/RWH\MZ )-XHWBH_+>CRWH DWBC>*
MC\MZ/+>@"3>*-XJ/RWH\MZ )-XHWBH_+>CRWH DWBC>*C\MZ/+>@"3>*-XJ/
MRWH\MZ )-XHWBH_+>CRWH DWBC>*C\MZ/+>@"3>*-XJ/RWH\MZ )-XHWBH_+
M>CRWH DWBC>*C\MZ/+>@"3>*-XJ/RWH\MZ )-XHWBH_+>CRWH DWBC>*C\MZ
M/+>@"3>*-XJ/RWH\MZ )-XHWBH_+>CRWH DWBC>*C\MZ/+>@"3>*-XJ/RWH\
MMZ )-XHWBH_+>CRWH DWBC>*C\MZ/+>@"3>*-XJ/RWH\MZ )-XHWBH_+>CRW
MH DWBC>*C\MZ/+>@"3>*-XJ/RWH\MZ )-XHWBH_+>CRWH DWBC>*C\MZ/+>@
M"3>*-XJ/RWH\MZ )-XHWBH_+>CRWH DWBC>*C\MZ/+>@"3>*-XJ/RWH\MZ )
M-XHWBH_+>CRWH DWBC>*C\MZ/+>@"3>*-XJ/RWH\MZ )-XHWBH_+>CRWH DW
MBC>*C\MZ/+>@"3>*-XJ/RWH\MZ )-XHWBH_+>CRWH DWBC>*C\MZ/+>@"3>*
M-XJ/RWH\MZ )-XHWBH_+>CRWH DWBC>*C\MZ/+>@"3>*-XJ/RWH\MZ )-XHW
MBH_+>CRWH DWBC>*C\MZ/+>@"3>*-XJ/RWH\MZ )-XHWBH_+>CRWH DWBC>*
MC\MZ/+>@"3>*-XJ/RWH\MZ )-XHWBH_+>CRWH DWBC>*C\MZ/+>@"3>*-XJ/
MRWH\MZ )-XHWBH_+>CRWH DWBC>*C\MZ/+>@"3>*-XJ/RWH\MZ )-XHWBH_+
M>CRWH DWBC>*C\MZ/+>@"3>*-XJ/RWH\MZ )-XHWBH_+>CRWH DWBC>*C\MZ
M/+>@"3>*-XJ/RWH\MZ )-XHWBH_+>CRWH DWBC>*C\MZ/+>@"3>*-XJ/RWH\
MMZ )-XHW"H_*?TI1&XH DS1FD"D4%32 7<*3>*:48TWRG]*8$F\4;Q4?E/Z4
M>6] $F\4;Q4?EO1Y;T 2;Q1O%1^6]'EO0!)O%&\5'Y;T>6] $F\4;Q4?EO1Y
M;T 2;Q1O%1^6]'EO0!)O%&\5'Y;T>6] $F\4;Q4?EO1Y;T 2;Q1O%1^6]'EO
M0!)O%&\5'Y;T>6] $F\4;Q4?EO1Y;T 2;Q1O%1^6]'EO0!)O%&\5'Y;T>6]
M$F\4;Q4?EO1Y;T 2;Q1O%1^6]'EO0!)O%&\5'Y;T>6] $F\4;Q4?EO1Y;T 2
M;Q1O%1^6]'EO0!)O%&\5'Y;T>6] $F\4;Q4?EO1Y;T 2;Q1O%1^6]'EO0!)O
M%&\5'Y;T>6] $F\4;Q4?EO1Y;T 2;Q1O%1^6]'EO0!)O%&\5'Y;T>6] $F\4
M;Q4?EO1Y;T 2;Q1O%1^6]'EO0!)O%&\5'Y;T>6] $F\4;Q4?EO1Y;T 2;Q1O
M%1^6]'EO0!)O%&\5'Y;T>6] $F\4;Q4?EO1Y;T 2;Q1O%1^6]'EO0!)O%&\5
M'Y;T>6] $F\4;Q4?EO1Y;T 2;Q1O%1^6]'EO0!)O%&\5'Y;T>6] $F\4;Q4?
MEO1Y;T 2;Q1O%1^6]'EO0!)O%&\5'Y;T>6] $F\4;Q4?EO1Y;T 2;Q1O%1^6
M]'EO0!)O%&\5'Y;T>6] $F\4;Q4?EO1Y;T 2;Q1O%1^6]'EO0!)O%&\5'Y;T
M>6] $F\4;Q4?EO1Y;T 2;Q1O%1^6]'EO0!)O%&\5'Y;T>6] $F\4;Q4?EO1Y
M;T 2;Q1O%1^6]'EO0!)O%&\5'Y;T>6] $F\4;Q4?EO1Y;T 2;Q1O%1^6]'EO
M0!)O%&\5'Y;T>6] $F\4;Q4?EO1Y;T 2;Q1O%1^6]'EO0!)O%&\5'Y;T>6]
M$F\4;Q4?EO1Y;T 2;Q1O%1^6]'EO0!)O%&\5'Y;T>6] $F\4;Q4?EO1Y;T 2
M;Q1O%1^6]'EO0!)O%&\5'Y;T>6] $F\4;Q4?EO1Y;T 2;Q1O%1^6]'EO0!)O
M%&\5'Y;T>6] $F\4;Q4?EO1Y;T 2;Q1O%1^6]'EO0!)O%&\5'Y;T>6] $F\4
M;Q4?EO1Y;T 2;Q1O%1^6]'EO0!)O%&\5'Y;T>6] $F\4;Q4?EO1Y;T 2;Q1O
M%1^6]'EO0!)O%&\5'Y;T>6] $F\4;Q4?EO1Y;T 2;Q1O%1^6]'EO0!)O%&\5
M'Y;T>6] $F\4;Q4?EO1Y;T 2;Q1O%1^6]'EO0!)O%&\5'Y;T>6] $F\4;Q4?
MEO1Y;T 2;Q1O%1^6]'EO0!)O%&\5'Y;T>6] $F\4;Q4?EO1Y;T 2;Q1O%1^6
M]'EO0!)O%&\5'Y;T>6] $F\4;Q4?EO1Y;T 2;Q1O%1^6]'EO0!)O%&\5'Y;T
M>6] $F\4;Q4?EO1Y;T 2;Q1O%1^6]'EO0!)O%&\5'Y;T>6] $F\4;Q4?EO1Y
M;T 2;Q1O%1^6]'EO0!)O%&\5'Y;T>6] $F\4;Q4?EO1Y;T 2;Q1O%1^6]'EO
M0!)O%&\5'Y;T>6] $F\4;Q4?EO1Y;T 2;Q1O%1^6]'EO0!)O%&\5'Y;T>6]
M$F\4;Q4?EO1Y;T 2;Q1O%1^6]'EO0!)O%&\5'Y;T>6] $F\4;Q4?EO1Y;T 2
M;Q06%1^4_I1Y;^E #MPJ>U/[T56V-5BT4^:*4M@/1_"_5:]/M/\ CW6O,/"X
MY2O3[3_CW6O)Q'Q#1/1117,,**** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/1117. 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]*?10
MSRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]% #/*7TH
M\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]*?
M10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]% #/*
M7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE
M]*?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]%
M#/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2
MCRE]*?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI
M]% #/*7TH\I?2GT4 -\M:HZG$/LQ.*T*I:F<6IIQW \OUI<2M]:IZ:O[T?6K
MVMG]ZU4=-/[X5Z*^$9WND1@JM=-%$ @KG-'/RK73QG*"N&IN(3RUH\I?2GT5
MF SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]% #/*7
MTH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]
M*?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]% #
M/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2C
MRE]*?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]
M% #/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I
M?2CRE]*?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7
MTI]% #/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]% #/*7TH\I?2GT4
M,\I?2CRE]*?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*
M/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]% #/*7TH\I?2G
MT4 ,\I?2CRE]*?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]*?10 SR
ME]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]% #/*7TH\I
M?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]*?10
M SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]% #/*7T
MH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]*
M?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]% #/
M*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CR
ME]*?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]%
M #/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?
M2CRE]*?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7T
MI]% #/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,
M\I?2CRE]*?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/
M*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE]*/*7TI]% #/*7TH\I?2GT
M4 ,\I?2CRE]*?10 SRE]*/*7TI]% #/*7TH\I?2GT4 ,\I?2CRE]*?10 SRE
M]*/*7TI]% #/+6HKB(&,U8J.<XC-- <AK$8"M7#7:XF/UKO-8/RM7"WA_?GZ
MUVT=AFYH'WUKT>S_ ./=:\XT#[ZUZ/:?\>ZUC7W$3T44E<X"T4E+0 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1112 *K7O\ J#5FJU[_ *@U2W X+6?O-6!%_K:W]:^^U8$7
M^MKOA\('6:/U%=G;?ZH5QFC]179VW^J%<M7<":BBBL0"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ JCJG_'L?I5ZJ.J?\>Q^E..X'F.M_P"M:J6F_P"M%7=;_P!:U4M-
M_P!:*])?",[[2/NK741?ZL5R^D?=6NHB_P!6*X*FXA]%%%9@%%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !4-Q]PU-4-Q]PT(#D]8^ZU<->?Z\_6NYUC[K5PUW_KS]:[J
M.P&[H'^L6O1[3_CW6O.- ^^M>CVG_'NM8U]P)Z,445S@%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !5:]_U!JS5:]_U!IK<#@M:^\U<_%_K:Z#6OO-7/Q?ZVN^'P
MC.MT?M79VW^J%<9H_P##79VW^J%<M7<1-1116(!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 51U3_CV/TJ]5'5/^/8_2G'<#S'6_]:U4M-_UH^M7=;_UK52TW_6CZUZ2
M^ 9WVD?=6NHB_P!6*Y?2/NK741?ZL5P5-Q#Z***S **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "H;C[AJ:H;C_5FA <GK'W6KAKO_7'ZUW.L?=:N&O/]<?K7=1V&;N@?
M?6O1[3_CW6O.- ^^M>CVG_'NM8U]Q$]%%%<X"&BEHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBDS0 M%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4=
M4_X]C]*O51U3_CV/TIQW \QUO_6M5+3?]:/K5W6_]:U4M-_UH^M>DO@&=]I'
MW5KJ(O\ 5BN7TC[JUU$7^K%<%3<0^BBBLP"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MJ&X_U9J:H;C[AH0')ZQ]UJX:\_UQ^M=SK'W6KAKS_7'ZUW4=AF[H'WUKT>S_
M ./=:\XT#[ZUZ/9_\>ZUCB-Q$]%%%<X!24M)0 M%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %5KW_4&K-5KW_4&FMP."UK[S5S\?\ K:Z#6OO-7/Q_ZVN^'PC.MT;M79VW
M^J%<9HW:NSMO]4*Y:NXB:BBBL0"BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH ***2@!:*04M !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %0W'W#4U0W'W#0@.3UC[K5PUY_KC]:[G6/NM7#7G^N/UKNH[#-W0/
MOK7H]G_Q[K7G&@??6O1[/_CW6L<1N(GHHHKG **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "JU[_J#5FJU[_J#36X'!:U]YJY^/\ UM=!K7WFKGX_];7?#X1G6Z-V
MKL[;_5"N,T;M79VW^J%<M7<1-1116(!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !13'E1.IJK)J,:G&10!=HJE'>I(>#5Q3N&: %HHHH **0NJ]2!5>6^
MACZL* +-%9PU6$MC<*M1W44@X84 3T4@(/0TM !1124 +1110 44E% "T44E
M "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !24M% "4
MM%% !1110 4444 %%%% !1244 +124M !24M% "4M%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 51U3_CV/TJ]5'5/^/8_2G'<#S'6_\ 6M5+3?\ 6CZU=UO_ %K52TW_ %H^
MM>DO@&=]I'W5KJ(O]6*Y?2/NK741?ZL5P5-Q#Z***S **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "H;C[AJ:H;C[AH0')ZQ]UJX:\_UQ^M=SK'W6KAKS_7'ZUW4=AF[H
M'WUKT>S_ ./=:\XT#[ZUZ/9_\>ZUCB-Q$]%%%<X!1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 56O?]0:LU6O?]0::W X+6OO-7/Q_P"MKH-:^\U<_'_K:[X?",ZW
M1NU=G;?ZH5QFC=J[.V_U0KEJ[B)J***Q **** "BBB@ HHHH **** "BBB@
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M%% !1110 4444 %4=4_X]C]*O51U3_CV/TIQW \QUO\ UK52TW_6CZU=UO\
MUK52TW_6CZUZ2^ 9WVD?=6NHB_U8KE](^ZM=1%_JQ7!4W$/HHHK, HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH *AN/N&IJAN/N&A <GK'W6KAKS_ %Q^M=SK'W6KAKS_
M %Q^M=U'89NZ!]]:]'L_^/=:\XT#[ZUZ/9_\>ZUCB-Q$]%%%<X!1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MAQQ4E8ND77G(O-;5 !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 51U3_ (]C
M]*O51U3_ (]C]*<=P/,=;_UK52TW_6CZU=UO_6M5+3?]:/K7I+X!G?:1]U:Z
MB+_5BN7TC[JUU$7^K%<%3<0^BBBLP"BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J&X^X
M:FJ&X^X:$!R>L?=:N&O/]<?K7<ZQ]UJX:\_UQ^M=U'89NZ!]]:]'L_\ CW6O
M.- ^^M>CV?\ Q[K6.(W$3T445S@%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M4U4]-.;45<H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG_'L?I5ZJ.J?\>Q^E..X'F.M_P"M:J6F_P"M'UJ[K?\ K6JEIO\ K1]:])?
M,[[2/NK741?ZL5R^D?=6NHB_U8K@J;B'T445F 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111F@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *AN/N&IJAN/N&A <GK'W6KAKS_7'ZUW.L?=:N&O/]<?K7=1V&;N@??6O
M1[/_ (]UKSC0/OK7H]G_ ,>ZUCB-Q$]%%%<X!1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH #24M% !1110 4444 %%%% "4444 +1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !4-Q]PU-4-Q]PT(#D]8^ZU<->?ZX_6NY
MUC[K5PUY_KC]:[J.PS=T#[ZUZ/9_\>ZUYQH'WUKT>S_X]UK'$;B)Z***YP"B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "DI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *A
MN/N&IJAN/N&A <GK'W6KAKS_ %Q^M=SK'W6KAKS_ %Q^M=U'89NZ!]]:]'L_
M^/=:\XT#[ZUZ/9_\>ZUCB-Q$]%%%<X!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M56O?]0:LU6O?]0::W X+6OO-7/Q_ZVN@UK[S5S\?^MKOA\(SK=&[5V=M_JA7
M&:-VKL[;_5"N6KN(FHHHK$ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@!K#(Q5&>P27JM:%% &5%I$0;.T5HQQ) GR
MC&*>S!5R:P]8UE+: @,!Q0!#K^K)#;.NX5X+XLU(3W+ '/-=)XG\3ERZA_UK
MSN0R7]UGDY- &MX;MC-<*<=Z]0M[(I: X[5@>#]".48K7HL]D(K/&.U 'E?B
M E-PKE;4!KH?6NK\4C:[URECS=#ZT >O>#8P$2NYOT!LS]*XGP?]Q*[B]/\
MHA^E 'C'C&,!W-<'9-B\ ]Z[_P 9GEZ\\LO^/\?6@#W#P4V(D-=AJ.KBTC)+
M8KC?!_%JI]J3QA=/%;,03TH MW'CE(G*^9^M,7QTA'^M_6O!-6UJX6Z8!CUJ
M"'6[@C[QH'8^A/\ A.4_YZ_K1_PG*?\ /7]:\!_MJX_O&C^VKC^\: /?O^$Y
M3_GK^M'_  G*?\]?UKP'^VKC^\:ADUV=?XC0%CZ)B\;(Y_U@_.M6T\2K.1\_
MZU\SV?B&;>!O/YUWGA[6))'3+&@1[U:W@F .:O#I7):!<&1%R:ZQ?NB@!:**
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "HYI/+3-252U1]EH30!EW>N+ Q&ZH(_$:,
M?OC\Z\Z\2ZN\$K?-WKG+;Q,WF8W_ *T >SS^(E12=]94_C)8SCS/UKSY]9DG
MCX8U@ZA=7')!- 'L%OXR21L>9^M;]CK:W&/FKYP@U>>&498UW/AWQ"2R O\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ JM>_Z@U9JM>_Z@TUN!P6M?>:N?C_UM=!K
M7WFKGX_];7?#X1G6Z-VKL[;_ %0KC-&[5V=M_JA7+5W$34445B 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHI*6@ HHHH *2EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *HZI_Q['Z5>JCJG
M_'L?I3CN!YCK?^M:J6F_ZT?6KNM_ZUJI:;_K1]:])? ,[[2/NK741?ZL5R^D
M?=6NHB_U8K@J;B'T445F 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(6"]32UD:E?K
MK<T ,U?5$MHF ;I7E'BCQ$6#*KU:\4^) N\!Z\QN]2-Y.1NSDT 17#S7UP<9
M.375^&?#3S2HS)3?#FDI<.K,,UZ_X?TN"W5"0*!ES0-#6U@4E0.*M:S'Y=N0
M/2ME2@4!2,5F:T0UN1[4"/$O%0^=ZY&Q;%T/K7;^*X#ESBN"@;R[P9]:!GM/
M@[F-*[>_!%F?I7 ^";I-B9/:NZU*[C%F>1TH$>/>,S\SUY_8C_3A]:[CQ?<+
M)(X!KC].A+78(]:!GLW@X9ME'M5KQ3IQN+9@!VJ/P9$1&@]J[.\T\7"8Q0(^
M:]4\+/)<L=G>HHO"L@'W*]ZF\+)(Y.S]*:/"J#^"@9X9_P (M)_<-'_"+/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!4-Q]PU-4-Q]PT(#D]8^ZU<->?ZX_6NYUC[K5PUY_KC]:[J.PS=T#[ZUZ/9_
M\>ZUYQH'WUKT>S_X]UK'$;B)Z***YP"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !4-Q]PU-4-Q]PT(#D]8^ZU<->?ZX_6NYUC[K5PUY_KC]:[
MJ.PS=T#[ZUZ/9_\ 'NM><:!]]:]'L_\ CW6L<1N(GHHHKG **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "JU[_J#5FJU[_J#36X'!:U]YJY^/_6UT&M?>:N?C_P!;
M7?#X1G6Z-VKL[;_5"N,T;M79VW^J%<M7<1-1116(!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% "444"@!:S=;_ ./%OH:TJH:LF^T(]J / /%T9-P_'>L/
M18R+D<=Z[KQ+I32S,0O>LC2M&=+@':>M 'HWA88B2NON/^/<_2N=\/6QBC7(
MKIITS#CVH \O\5KG?7F,L1^V?C7L/B.Q:7=Q7 R:,_VG.T]: .E\'QX"5V.K
M%ULSM]*P_"]BT6W(KMI]/$]J01VH \)UV^N([EAD]:;I.KN'&\UV/B+PQN=V
M"5P]SI<MHYVJ: .\M=5A>'!(Z5S^ORPS*V,5SJ75Q'\O-*6GN" <T 8[V'FW
M' [UV_AG265D.VH=(T5II%++7IVA:&(T4[:!FMH4!B1<BN@JO;VXA P*L4""
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ J&X^X:FJ&X^X:$!R>L?=:N&O/\
M7'ZUW.L?=:N&O/\ 7'ZUW4=AF[H'WUKT>S_X]UKSC0/OK7H]G_Q[K6.(W$3T
M445S@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !5:]_U!JS5:]_U!IK<#@M:^\U<
M_'_K:Z#6OO-7/Q_ZVN^'PC.MT;M79VW^J%<9HW:NSMO]4*Y:NXB:BBBL0"BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** ,W6_P#CP;\:^?/&_P#KI/K7T'K?_'@WXU\^>-_]
M=)]:!HX*Q_X_!]:]B\'?\LZ\=L?^/P?6O8O!W_+.@&>R:;_QZBKE4]-_X]15
MR@04444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4=4_P"/8_2K
MU4=4_P"/8_2G'<#S'6_]:U4M-_UH^M7=;_UK52TW_6CZUZ2^ 9WVD?=6NHB_
MU8KE](^ZM=1%_JQ7!4W$/HHHK, HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $/0UYWXV_U3_2O1
M#T->=^-O]4_TH \"UG_C\;ZUT/A3_6)7/:S_ ,?C?6NA\*?ZQ*!GN'AW_5I7
M8+]T?2N/\._ZM*[!?NCZ4"%HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &;K?\ QX-^-?/GC?\
MUTGUKZ#UO_CP;\:^?/&_^ND^M T<%8_\?@^M>Q>#O^6=>.V/_'X/K7L7@[_E
MG0#/9--_X]15RJ>F_P#'J*N4""BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ JCJG_ !['Z5>JCJG_ !['Z4X[@>8ZW_K6JEIO^M'UJ[K?^M:J
M6F_ZT?6O27P#.^TC[JUU$7^K%<OI'W5KJ(O]6*X*FXA]%%%9@%%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %)12B@!*6BB@ HHHH **** "BBB@ HHHH *
M*** "BBB@!#T->=^-O\ 5/\ 2O1#T->=^-O]4_TH \"UG_C\;ZUT/A3_ %B5
MSVL_\?C?6NA\*?ZQ*!GN'AW_ %:5V"_='TKC_#O^K2NP7[H^E A:*** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH-)0 M%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5#<?<-35#<?<-" Y/
M6/NM7#7G^N/UKN=8^ZU<->?ZX_6NZCL,W= ^^M>CV?\ Q[K7G&@??6O1[/\
MX]UK'$;B)Z***YP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JM>_P"H-6:K7O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ JCJG_'L?I5ZJ.J?\>Q^E..X'F.M_ZUJI:;_K1]:NZW_K6JEI
MO^M'UKTE\ SOM(^ZM=1%_JQ7+Z1]U:ZB+_5BN"IN(?11168!1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 (>AKSOQM_JG^E>B'H:\[\;?ZI_I0!X%K/_ !^-]:Z'PI_K$KGM9_X_
M&^M=#X4_UB4#/</#O^K2NP7[H^E<?X=_U:5V"_='TH$+1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %0W'W#4U0W'W#0@.3UC[K5PUY_
MKC]:[G6/NM7#7G^N/UKNH[#-W0/OK7H]G_Q[K7G&@??6O1[/_CW6L<1N(GHH
MHKG **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "JU[_J#5FJU[_J#36X'!:U]YJY^
M/_6UT&M?>:N?C_UM=\/A&=;HW:NSMO\ 5"N,T;M79VW^J%<M7<1-1116(!11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% &;K?_'@WXU\^>-_]=)]:^@];_X\&_&OGSQO_KI/
MK0-'!6/_ !^#ZU[%X._Y9UX[8_\ 'X/K7L7@[_EG0#/9--_X]15RJ>F_\>HJ
MY0(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J.J?\>Q^E7J
MHZI_Q['Z4X[@>8ZW_K6JEIO^M'UJ[K?^M:J6F_ZT?6O27P#.^TC[JUU$7^K%
M<OI'W5KJ(O\ 5BN"IN(?11168!1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (>AKSOQM_JG^E>B'
MH:\[\;?ZI_I0!X%K/_'XWUKH?"G^L2N>UG_C\;ZUT/A3_6)0,]P\._ZM*[!?
MNCZ5Q_AW_5I78+]T?2@0M%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 49H-)0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 5#<?<-35#<?<-" Y/6/NM7#7G^N/UKN=8^ZU<->?ZX_6NZC
ML,W= ^^M>CV?_'NM><:!]]:]'L_^/=:QQ&XB>BBBN< HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M9NM_\>#?C7SYXW_UTGUKZ#UO_CP;\:^?/&_^ND^M T<%8_\ 'X/K7L7@[_EG
M7CMC_P ?@^M>Q>#O^6= ,]DTW_CU%7*IZ;_QZBKE @HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH *HZI_Q['Z5>JCJG_'L?I3CN!YCK?^M:J6
MF_ZT?6KNM_ZUJI:;_K1]:])? ,[[2/NK741?ZL5R^D?=6NHB_P!6*X*FXA]%
M%%9@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 AZ&O._&W^J?Z5Z(>AKSOQM_JG^E '@6L_\?C?
M6NA\*?ZQ*Y[6?^/QOK70^%/]8E SW#P[_JTKL%^Z/I7'^'?]6E=@OW1]*!"T
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 &**** #% HHH **2EH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H;C[AJ:
MH;C[AH0')ZQ]UJX:\_UQ^M=SK'W6KAKS_7'ZUW4=AF[H'WUKT>S_ ./=:\XT
M#[ZUZ/9_\>ZUCB-Q$]%%%<X!1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56O?]0:
MLU6O?]0::W X+6OO-7/Q_P"MKH-:^\U<_'_K:[X?",ZW1NU=G;?ZH5QFC=J[
M.V_U0KEJ[B)J***Q **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !5'5/^/8_2KU4=4_X]C]*<=P/,=;_UK52TW_6CZU=UO_6M5+3?
M]:/K7I+X!G?:1]U:ZB+_ %8KE](^ZM=1%_JQ7!4W$/HHHK, HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** $/0UYWXV_U3_2O1#T->=^-O]4_TH \"UG_ (_&^M=#X4_UB5SVL_\
M'XWUKH?"G^L2@9[AX=_U:5V"_='TKC_#O^K2NP7[H^E A:*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **JW%TL())KG]0\1I!GYZ .G>5$ZL*B^V1YQD5YM>^-$4D>9^M4%\:+N_UG
MZT >O+(KC@BG5YI8^,T8@>9^M=9I^NI<@?-UH WZ*9'()%R*?0 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %0W'W#4U0W'W#0@.3UC[K5PUY_KC]:[G6/NM7#7G^N/UKNH[#-W0/OK7
MH]G_ ,>ZUYQH'WUKT>S_ ./=:QQ&XB>BBBN< HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *K7O\ J#5FJU[_ *@TUN!P6M?>:N?C_P!;70:U]YJY^/\ UM=\/A&=
M;HW:NSMO]4*XS1NU=G;?ZH5RU=Q$U%%%8@%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9N
MM_\ '@WXU\^>-_\ 72?6OH/6_P#CP;\:^?/&_P#KI/K0-'!6/_'X/K7L7@[_
M )9UX[8_\?@^M>Q>#O\ EG0#/9--_P"/45<JGIO_ !ZBKE @HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5ZW8OYELIH$6:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "H;C[AJ:H;C[AH0')ZQ]UJX:\_UQ^M=SK'W
M6KAKS_7'ZUW4=AF[H'WUKT>S_P"/=:\XT#[ZUZ/9_P#'NM8XC<1/1117. 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZUW4=AF[H'WUKT>S_P"/=:\XT#[ZUZ/9_P#'NM8XC<1/1117. 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %5KW_ %!JS5:]_P!0::W X+6OO-7/Q_ZVN@UK[S5S
M\?\ K:[X?",ZW1NU=G;?ZH5QFC=J[.V_U0KEJ[B)J***Q **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***:TBKU- #J*B$Z'O4@8-
MTH 6BBB@ HHHH **** "BBB@#-UO_CP;\:^?/&_^ND^M?0>M_P#'@WXU\^>-
M_P#72?6@:."L?^/P?6O8O!W_ "SKQVQ_X_!]:]B\'?\ +.@&>R:;_P >HJY5
M/3?^/45<H$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5'5/
M^/8_2KU4=4_X]C]*<=P/,=;_ -:U4M-_UH^M7=;_ -:U4M-_UH^M>DO@&=]I
M'W5KJ(O]6*Y?2/NK741?ZL5P5-Q#Z***S **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!#T->=^-
MO]4_TKT0]#7G?C;_ %3_ $H \"UG_C\;ZUT/A3_6)7/:S_Q^-]:Z'PI_K$H&
M>X>'?]6E=@OW1]*X_P ._P"K2NP7[H^E A:*** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K-U: 2V[<=JTJBG
M3?$10!X)XTTPDN=OK7D&H6C0SGCO7T[XDT7[0K_+FO(M>\,N'8A/TH&>:"8J
M,4&?BM>ZT*5'/RFH!HTI'W30,SXY2YQ6]I.G&>53M[TVQT"5I1\AKTCPSX;8
M%"4_2@5S>\'Z08MAVUZ]8)LME%<_HFDB"-?EKIXUV(!0(?1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5
M#<?<-35#<?<-" Y/6/NM7#7G^N/UKN=8^ZU<->?ZX_6NZCL,W= ^^M>CV?\
MQ[K7G&@??6O1[/\ X]UK'$;B)Z***YP"BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M JM>_P"H-6:K7O\ J#36X'!:U]YJY^/_ %M=!K7WFKGX_P#6UWP^$9UNC=J[
M.V_U0KC-&[5V=M_JA7+5W$34445B 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !2%@.II'.U<UAZGJ0@1OFH OW.HQP@_,*P;OQ!&I(WBN)
MU[Q08RP#_K7#7?BB620@.: /8T\1Q[OOUK66NQ/CYQ7S^-?F7G<:T=.\5R+(
M 7- 'T3!>1S#@U9SFO,_#_B/SPH+UWUE="9 <T 7J*** "BBB@ HHHH S=;_
M ./!OQKY\\;_ .ND^M?0>M_\>#?C7SYXW_UTGUH&C@K'_C['UKV+P=_RSKQV
MQ_X^Q]:]B\'?\LZ 9[)IO_'J*N53TW_CU%7*!!1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 51U3_ (]C]*O51U3_ (]C]*<=P/,=;_UK52TW
M_6CZU=UO_6M5+3?]:/K7I+X!G?:1]U:ZB+_5BN7TC[JUU$7^K%<%3<0^BBBL
MP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J&X^X:FJ&X^X:$!R>L?=
M:N&O/]<?K7<ZQ]UJX:\_UQ^M=U'89NZ!]]:]'L_^/=:\XT#[ZUZ/9_\ 'NM8
MXC<1/1117. 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M ^]>P>#OX*\BTX9G4UZYX/ZI0![-IO\ QZBKE4],_P"/1:N4""BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 AZ&O._&W^J?Z5Z(>AKSOQM_JG^E
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "H;C[AJ:H;C[AH0')ZQ]UJ
MX:\_UQ^M=SK'W6KAKS_7'ZUW4=AF[H'WUKT>S_X]UKSC0/OK7H]G_P >ZUCB
M-Q$]%%%<X!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 56O?]0:LU6O?]0::W X+6
MOO-7/Q_ZVN@UK[S5S\?^MKOA\(SK=&[5V=M_JA7&:-VKL[;_ %0KEJ[B)J**
M*Q **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@""ZD\N$M7GW
MB/6UB#+NKN-9;98L17@WC'4'69P": ,[5KT7DK '.:K6/AMKQP0F<UFZ7(UQ
M=C/K7M/@_2HI$0L!0!P4G@IUASY9Z>E8%QH[6,N2N,5]+7&DVYMB HR!7D_C
M'3TB+E10!S^@ZL+:15)QBO6-$UD3P*-U?/)N'@N\ ]Z]+\&WSR% 30!V7B*W
M:YMV('45XEXCT29YVPIZU]%FT%Q:#(ZBN6U'PTLTA.S]* /GZ'09P?NFK7]A
M3_W37M">$U'_ "S_ $J3_A%5_N?I0!XG_8<_]TTY="G/\)KVK_A%5_N?I3T\
M+)_<_2@#PV?1)D!)4UDSVK0L<BO>]4\,JENS;/TKRGQ%8BWD;C% S"TX_OEK
MUSP?]Y*\AL#_ *2![UZ_X.ZI0![+IG_'H*N53TW_ (]15R@04444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %4=4_X]C]*O51U3_CV/TIQW \QU
MO_6M5+3?]:/K5W6_]:U4M-_UH^M>DO@&=]I'W5KJ(O\ 5BN7TC[JUU$7^K%<
M%3<0^BBBLP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH 0]#7G?C;_5/]*]$/0UYWXV_U3_2@#P+
M6?\ C\;ZUT/A3_6)7/:S_P ?C?6NA\*?ZQ*!GN'AW_5I78+]T?2N/\._ZM*[
M!?NCZ4"%HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0G K!UVZ\NV89K=
M?[IKCO$LA$3_ $H \;\9WS&1\&O+YYW>8\UW?BUR97KS]N9C0,F7)%*P.*D0
M?+2D4#(%9D.:VM'U%XYE&X]:R9  M)9N5N!]: /H/P7J!EV9->N6YW0(?:O
MO UR5V9->PQ:NL-HOS=!02=#TIN]?[PKA=1\8I#D>9^M9'_"<(6_UGZT >I
M@]"*6O.K7QFCL!YGZUTNGZZER!\U '044R-Q(@(I] !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %0W'W#4U0W'W#0@.3UC[K5PUY_KC]:[G6/NM7#7G^N/UKNH
M[#-W0/OK7H]G_P >ZUYQH'WUKT>S_P"/=:QQ&XB>BBBN< HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *K7O^H-6:K7O^H--;@<%K7WFKGX_];70:U]YJY^/_ %M=
M\/A&=;HW:NSMO]4*XS1NU=G;?ZH5RU=Q$U%%%8@%%%% !1110 4444 %%%%
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MGIO_ !ZBKE @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M )2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %0W'W#4U0W'W#0@.3UC[K5PUY_KC]:[G6
M/NM7#7G^N/UKNH[#-W0/OK7H]G_Q[K7G&@??6O1[/_CW6L<1N(GHHHKG ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "JU[_J#5FJU[_J#36X'!:U]YJY^/\ UM=!
MK7WFKGX_];7?#X1G6Z-VKL[;_5"N,T;M79VW^J%<M7<1-1116(!1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JCJG_'L?I5
MZJ.J?\>Q^E..X'F.M_ZUJI:;_K1]:NZW_K6JEIO^M'UKTE\ SOM(^ZM=1%_J
MQ7+Z1]U:ZB+_ %8K@J;B'T445F 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%!H 3-
M+24M !1110 4444 %%%% !1110 4444 %%%% !24M)0 M%%% "'H:\[\;?ZI
M_I7HAZ&O._&W^J?Z4 >!:S_Q^-]:Z'PI_K$KGM9_X_&^M=#X4_UB4#/</#O^
MK2NP7[H^E<?X=_U:5V"_='TH$+1110 4444 %%%% !1110 4444 %%%% !11
M10 4R9/,C*T^B@#CM<T$7"L=M>8ZYX6VLQ"5[Y)&LBD,*P-4T9)@?EH ^:K[
M0G1SA*K0Z)(Q^Z:]PO/"8D<G9^E00^$ K?ZO]* /-M+\.,7!*5V-MH7E09*]
MJ[.Q\-K$1\E7KK3%B@.%[4 >+^([3RD;BO,K_(F//>O8?&$6P/Q7C^I$B<_6
M@:&P]*E/2H8.E3F@9$1S3HI"D@YH-,529!B@#T;PA=,94&>]?0'AIMUL/I7S
MOX0C;SDX[U]#>& 1:C/I02=!1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %)2TE "T444 %%%% !1110 4444 %%&:* "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H;C
M[AJ:H;C[AH0')ZQ]UJX:\_UQ^M=SK'W6KAKS_7'ZUW4=AF[H'WUKT>S_ ./=
M:\XT#[ZUZ/9_\>ZUCB-Q$]%%%<X!1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 56O
M?]0:LU6O?]0::W X+6OO-7/Q_P"MKH-:^\U<_'_K:[X?",ZW1NU=G;?ZH5QF
MC=J[.V_U0KEJ[B)J***Q **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH 0@'J*888SU45)10!%]FB_N"G"%%Z**?10  8Z4444 %%%%
M!1110 4444 9NM_\>#?C7SYXW_UTGUKZ#UO_ (\&_&OGSQO_ *Z3ZT#1P5C_
M ,?@^M>Q>#O^6=>.V/\ Q^#ZU[%X._Y9T SV33?^/45<JGIO_'J*N4""BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JCJG_'L?I5ZJ.J?\>Q^
ME..X'F.M_P"M:J6F_P"M'UJ[K?\ K6JEIO\ K1]:])? ,[[2/NK741?ZL5R^
MD?=6NHB_U8K@J;B'T445F 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %!HHH 2EHHH *
M*0D"C<* %HHS10 4444 %%%% !1110 4@I:* "BBB@!*6D%+0 AZ&O._&W^J
M?Z5Z(>AKSOQM_JG^E '@6L_\?C?6NA\*?ZQ*Y[6?^/QOK70^%/\ 6)0,]P\.
M_P"K2NP7[H^E<?X=_P!6E=@OW1]*!"T444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !2%0>HHI: (S!&>JBD^SQ#^ 5+10 P1(.BBJU] 'A.!5RD9=
MRD4 >+^,[ D2<5XCK-JT<[<=Z^H/$NE>>CX6O&_$'AIM[$)^E T>7HY2I/.X
MK8NM#DC8_*:JC2I/[IH&9OG$MBM;3;8SR+Q20Z)*\@^4UW/AOPXY=24_2@#=
M\)Z00R';7M6B0^3;@>U<UX?T40QK\M=K;Q"- *"2:BBD- "T4E+0 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%!I*
M"E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !4-Q]PU-4-Q]PT(#D]8^ZU<->?ZX_6NYUC[K5PUY_KC]:[
MJ.PS=T#[ZUZ/9_\ 'NM><:!]]:]'L_\ CW6L<1N(GHHHKG **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "JU[_J#5FJU[_J#36X'!:U]YJY^/_6UT&M?>:N?C_P!;
M7?#X1G6Z-VKL[;_5"N,T;M79VW^J%<M7<1-1116(!1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%)2T %%%)0 M%%% !1110 4444 %%%%
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MX)C_ $KM-*\-)  =@KH[;3DCQ\HJ^J*HP!0!7MK185 Q5JBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI"0.I% "T5$]
MQ$G5A40OH2<;A0!:HJ-)HWZ,*DH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J&X^X:FJ&X^X:
M$!R>L?=:N&O/]<?K7<ZQ]UJX:\_UQ^M=U'89NZ!]]:]'L_\ CW6O.- ^^M>C
MV?\ Q[K6.(W$3T445S@%%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M?0>M_P#'@WXU\^>-_P#72?6@:."L?^/P?6O8O!W_ "SKQVQ_X_!]:]B\'?\
M+.@&>R:;_P >HJY5/3?^/45<H$%%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !5'5/^/8_2KU4=4_X]C]*<=P/,=;_ -:U4M-_UH^M7=;_ -:U
M4M-_UH^M>DO@&=]I'W5KJ(O]6*Y?2/NK741?ZL5P5-Q#Z***S **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "J=U<B)2<U;/"FN3U^^\E6YH KZOXB$"M\U>6^*/%C.K@
M/^M3:YJ,DS,%)K@-6@GER2#0,S)]4DN+K.X]:[SPB[ETS7G-O;E)QN'>O3/"
M2@,E ,]IT(DQ+73C[HKFM"'[I?I72C[HH$96OR^78-]*^>?&EZYG< ]Z]X\4
MS[;1AGM7SQXJDWW3_6@#F;2":ZF[\FNEM_#DTJ [34/AY(S.NX"O4]-BM_*7
M('2@9YT/"\_]TUM:1X?FBE4E37HMO9VTI PM;=GHL)P0HH%<A\,VC0HN1785
M4MK-8 ,"K)<"@!U%1>>OK1YZ^M $M%1^<OK1YR^M $E>>>-@/*>N^:90I.:\
M[\:3 Q/S0!X/K7_'XWUKH/"G^L2N>U@YNV^M=#X4_P!8E SW#P[_ *M*[!?N
MCZ5Q_AW_ %:5V"_='TH$+1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 49HI* %HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHJ.9]D1- $%S=+"I.:YC4_$B6^
M?G_6JOB+6A;HPW8KR#Q#XF9G<!_UH [R]\;JK$>9^M45\;C/^L_6O%+S6YGD
M.'-5UU>;'WC0.Q]$6'C578#S/UKLM,UY;D#YJ^5=.UR991ES^=>G^&/$;90,
M_P"M 6/?HI!(@(-/KF=%U=9XU^:ND1MZYH$.HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *AN/N&IJAN/
MN&A <GK'W6KAKS_7'ZUW.L?=:N&O/]<?K7=1V&;N@??6O1[/_CW6O.- ^^M>
MCV?_ ![K6.(W$3T445S@%%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5:]_U!JS5:
M]_U!IK<#@M:^\U<_'_K:Z#6OO-7/Q_ZVN^'PC.MT;M79VW^J%<9HW:NSMO\
M5"N6KN(FHHHK$ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@#-UO_CP;\:^?/&_^ND^M?0>
MM_\ '@WXU\^>-_\ 72?6@:."L?\ C\'UKV+P=_RSKQVQ_P"/P?6O8O!W_+.@
M&>R:;_QZBKE4]-_X]15R@04444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M+PAK!E*#=7KM@^^V4U\]>!)B9(^:^@-(.;%:!%^BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J&X^X:FJ
M&X^X:$!R>L?=:N&O/]<?K7<ZQ]UJX:\_UQ^M=U'89NZ!]]:]'L_^/=:\XT#[
MZUZ/9_\ 'NM8XC<1/1117. 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 51U3_CV/TJ]5'5/^/8_2G'<#S'6_\ 6M5+3?\ 6CZU=UO_ %K5
M2TW_ %H^M>DO@&=]I'W5KJ(O]6*Y?2/NK741?ZL5P5-Q#Z***S **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M/;/#G^K2NR7[H^E<=X=_U:5V*_='TH$+1110 F*6BB@ HHHH **** "BBB@
MHHHH **** "DQ2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (PR*YOQ!"3 V/2N
MEK.U6#S;=N.U 'SEXRB8._%>8S9$Y^M>X^,]*+%R%KQ_4K%H9F^6@:((C\M/
M)%4_,9.*#,<4#++G*U!#"S3C [TD3L[8KH]&TQIY5.V@1W'@2!EDCR*^@-(&
M+%:\L\(Z,8MAVUZS8ILME% BS1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5#<?<-35#<?<-" Y/6/NM7
M#7G^N/UKN=8^ZU<->?ZX_6NZCL,W= ^^M>CV?_'NM><:!]]:]'L_^/=:QQ&X
MB>BBBN< HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *K7O^H-6:K7O^H--;@<%K7W
MFKGX_P#6UT&M?>:N?C_UM=\/A&=;HW:NSMO]4*XS1NU=G;?ZH5RU=Q$U%%%8
M@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 9NM_P#'@WXU\^>-_P#72?6OH/6_^/!OQKY\
M\;_ZZ3ZT#1P5C_Q^#ZU[%X._Y9UX[8_\?@^M>Q>#O^6= ,]DTW_CU%7*IZ;_
M ,>HJY0(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J.J?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MA7S2Q"?I7K) (YJK<6<<JGY10!X#<>%WB<X3]*J'0)&.-IKVR[T1')P@_*J
M\/KO^Y^E 'G&F>%F9P2GZ5Z#HOAM8@I*5N66CI%CY16Y%"L2@ 4 5[2T$
MJY110 4444 %%%% "'H:\[\;?ZI_I7HAZ&O._&W^J?Z4 >!:S_Q^-]:Z'PI_
MK$KGM9_X_&^M=#X4_P!8E SW#P[_ *M*[!?NCZ5Q_AW_ %:5V"_='TH$+111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !00#UHHH K2VB2=J@&G(&SMK0HH BB@6,< 5+110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !4-Q]PU-4-Q]PT(#D]8^ZU<->?ZX_6NYUC[K5PUY_KC]:[J.P
MS=T#[ZUZ/9_\>ZUYQH'WUKT>S_X]UK'$;B)Z***YP"BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ JM>_Z@U9JM>_Z@TUN!P6M?>:N?C_UM=!K7WFKGX_];7?#X1G6
MZ-VKL[;_ %0KC-&[5V=M_JA7+5W$34445B 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!F
MZW_QX-^-?/GC?_72?6OH/6_^/!OQKY\\;_ZZ3ZT#1P5C_P ?@^M>Q>#O^6=>
M.V/_ !^#ZU[%X._Y9T SV33?^/45<JGIO_'J*N4""BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\*?ZQ*!GN'AW_5I78+]T?2N/\._ZM*[!?NCZ4"%HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "H;C[AJ:H;C[AH0')ZQ]UJX:\_UQ^M=
MSK'W6KAKS_7'ZUW4=AF[H'WUKT>S_P"/=:\XT#[ZUZ/9_P#'NM8XC<1/1117
M. 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %5KW_ %!JS5:]_P!0::W X+6OO-7/
MQ_ZVN@UK[S5S\?\ K:[X?",ZW1NU=G;?ZH5QFC=J[.V_U0KEJ[B)J***Q **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH S=;_X\&_&OGSQO_KI/K7T'K?\ QX-^-?/GC?\
MUTGUH&C@K'_C\'UKV+P=_P LZ\=L?^/P?6O8O!W_ "SH!GLFF_\ 'J*N53TW
M_CU%7*!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 51U3_CV
M/TJ]5'5/^/8_2G'<#S'6_P#6M5+3?]:/K5W6_P#6M5+3?]:/K7I+X!G?:1]U
M:ZB+_5BN7TC[JUU$7^K%<%3<0^BBBLP"BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ K.U2(2QXQ6C44D>^@#AYM(W2YVUJZ=8^3CBMO[(N[)%$OEP(>E
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JM>_Z@U9J
MM>_Z@TUN!P6M?>:N?C_UM=!K7WFKGX_];7?#X1G6Z-VKL[;_ %0KC-&[5V=M
M_JA7+5W$34445B 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%(S;1F@!:*KM=*IZTJ7"OWH GHI <BEH ,T4E** "BBB@ HHHH
M **** "BBB@ S124HH **** "BBB@ HHHH ,T4E+0 4444 %%%% !1110 44
M44 9NM_\>#?C7SYXW_UTGUKZ#UO_ (\&_&OGSQO_ *Z3ZT#1P5C_ ,?@^M>Q
M>#O^6=>.V/\ Q^#ZU[%X._Y9T SV33?^/45<JGIO_'J*N4""BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ JCJG_'L?I5ZJ.J?\>Q^E..X'F.M
M_P"M:J6F_P"M'UJ[K?\ K6JEIO\ K1]:])? ,[[2/NK741?ZL5R^D?=6NHB_
MU8K@J;B'T445F 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% $-S*
M(HRQKB=?\0K K#=70^(;GR+4\]J\)\5ZT_FNH:@ U[Q.SLP5_P!:XNXU:>5S
M@FFJ);V7N<UMV/AF2;!V&@#G_/N']:7[3<)W-=]#X0;;_JZ9<>$7"G$?Z4 <
MA9:U-"XRQKO- \5E64%_UKD;_P .RVX)V&L>*:6SN ,D8- 'TSH6NBY11NSF
MNMB;?&&KP?P;K#,Z M7MFES^;:J?:@"_1110 4444 )2T44 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% "'H:\[\;?ZI_I7HAZ&O
M._&W^J?Z4 >!:S_Q^-]:Z'PI_K$KGM9_X_&^M=#X4_UB4#/</#O^K2NP7[H^
ME<?X=_U:5V"_='TH$+1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% "44M% !1110 4444 %%%% "4M%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MH!GLFF_\>HJY5/3?^/45<H$%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %% HR!0 5&\Z)U-5KN^2%#S7)ZIXB2+.'H ZYM0A7J?UI%U&%
MCP:\GN_%F&.'_6F6OBS<XR_ZT >QI.C]#4E<)I7B-)-N7'YUUUI?QSH.10!=
MHI 01D4M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5KW_4&K-5KW_4&
MFMP."UK[S5S\?^MKH-:^\U<_'_K:[X?",ZW1NU=G;?ZH5QFC=J[.V_U0KEJ[
MB)J***Q **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *@G?
M:I-3U7N5W(: .5UG5VME;!KS3Q%XLE*,N\_G7H.O:=).K8!KRWQ#X=GPS;30
M!P]]J\D\Q.X]:O:/KDEO(/F-9%WI\D,I!!ZU=TO2I9Y!A30,]0T?Q7*0J[S^
M==WI.LO/C+5YGHWAV<!3M->A:+IDD.W(- CN+23S$S5FJMDA2, U:H ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *K7O^H-6:K7O
M^H--;@<%K7WFKGX_];70:U]YJY^/_6UWP^$9UNC=J[.V_P!4*XS1NU=G;?ZH
M5RU=Q$U%%%8@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%(0#UI:* ()+2*3[PK%UO0H)K-BJC.*Z&HKE-\#+ZT ?/^N^'@+IL)WK5\+^
M'E,B[DKMM1T7SIB=O>K>D:5]G<';0!K6&B6\4"Y49Q6BEG%']T5,@P@'M3J
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M<^U>0^,[LIO&:]=O/^/9_I7C7C:,DR4 >/ZM=&29@3WK'9 QS6AJ<96=OK5
M' H&"H!2LHQ3AS0W2@"N(QO%='HDGER+BN=W#?6]I W2+B@#V/PM>M\@S7JN
MER;X0?:O(/"L)RAKUW2%VPCZ4"-.BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *H
MZI_Q['Z5>JCJG_'L?I3CN!YCK?\ K6JEIO\ K1]:NZW_ *UJI:;_ *T?6O27
MP#.^TC[JUU$7^K%<OI'W5KJ(O]6*X*FXA]%%%9@%%%% !1110 4444 %%%%
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M0,]P\._ZM*[!?NCZ5Q_AW_5I78+]T?2@0M%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 5#<?<-35#<?<-" Y/6/NM7#7G^N/UKN=8^ZU
M<->?ZX_6NZCL,W= ^^M>CV?_ ![K7G&@??6O1[/_ (]UK'$;B)Z***YP"BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ JM>_Z@U9JM>_Z@TUN!P6M?>:N?C_UM=!K7
MWFKGX_\ 6UWP^$9UNC=J[.V_U0KC-&[5V=M_JA7+5W$34445B 4444 %%%%
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M44 %%%% !1110 4444 %%%% $5P-T#"O,?%NGF4.0*]1<90BN?U73!<(W&:
M/F;7--9)6.VN7E0HQ!KVWQ/H&-Y"5Y1K&FO%(V%H&C)1Q3F88JI(DB'H:2(2
M.<8- QVTM(,5U_ARR>25.*R=-TQYI%^4UZEX5T @H2OZ4 =?X7TXJJ$BO1[*
M/RXP*R-'TX0PKQ6^B[1B@D=1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %4=4_X]
MC]*O51U3_CV/TIQW \QUO_6M5+3?]:/K5W6_]:U4M-_UH^M>DO@&=]I'W5KJ
M(O\ 5BN7TC[JUU$7^K%<%3<0^BBBLP"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBH99-@H FHK#NM4$6?FK.?Q"H.-_ZT =;17(CQ"I_C_6E_X2%?[_ .M
M'6T5R7_"0K_?_6E_X2%?[_ZT =917)_\)"O]_P#6D_X2%?[_ .M '6T5R)\0
MKC[_ .M(OB)2V-_ZT =?16'9ZJ)R/FS6U&VY : '4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (>AKSOQM_JG
M^E>B'H:\[\;?ZI_I0!X%K/\ Q^-]:Z'PI_K$KGM9_P"/QOK70^%/]8E SW#P
M[_JTKL%^Z/I7'^'?]6E=@OW1]*!"T444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !4-Q]PU-4-Q]PT(#D]8^ZU<->?ZX_6NYUC[K5PUY_K
MC]:[J.PS=T#[ZUZ/9_\ 'NM><:!]]:]'L_\ CW6L<1N(GHHHKG **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "JU[_J#5FJU[_J#36X'!:U]YJY^/_6UT&M?>:N?C
M_P!;7?#X1G6Z-VKL[;_5"N,T;M79VW^J%<M7<1-1116(!1110 4444 %%%%
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M*D_ZS]:E_P"$O7^_^M 'JO\ :*>M.6_0_P 0KRC_ (2]?[_ZU+'XO7_GI^M
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H;C[AJ:H;C[AH
M0')ZQ]UJX:\_UQ^M=SK'W6KAKS_7'ZUW4=AF[H'WUKT>S_X]UKSC0/OK7H]G
M_P >ZUCB-Q$]%%%<X!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MX0@$DZ<5[GHNGJ;93CM7B_@E?WB&O>=&Q]D7Z4"+"6:KV%6%0**=10 4444
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MX/\ O)7D6GG]^![UZ[X/ZI0![+IG_'H*NU3TS_CU%7*!!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 51U3_CV/TJ]5'5/^/8_2G'<#S'6_\
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MP7[H^E<?X=_U:5V"_='TH$+1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !129I: "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ J&X^X:FJ&X^X:$!R>L?=:N&O/]<?K7<ZQ]UJX:\_UQ^M=
MU'89NZ!]]:]'L_\ CW6O.- ^^M>CV?\ Q[K6.(W$3T445S@%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !4-Q]PU-4-Q]PT(#D]8^ZU<->?ZX_6NYUC[K5PUY_KC]:[J.PS
M=T#[ZUZ/9_\ 'NM><:!]]:]'L_\ CW6L<1N(GHHHKG **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****  TE+10
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M ';^']=DFD4%C7K6A3F:)2?2O'O#VC2Q2+E37K^@0F*%0?2@1NT444 %%%%
M!BBBB@ HHHH **** &21K(,$5E7>E)+GY16Q10!R;: I;.RKEKHZ1D?**W\#
MT%+@4 0P0+$HP*FHHH **,T4 %%%% !1110!FZW_ ,>#?C7SYXW_ -=)]:^@
M];_X\&_&OGSQO_KI/K0-'!6/_'X/K7L7@[_EG7CMC_Q]CZU[%X._@H!GLFF_
M\>HJY5/3?^/45<H$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 )FEI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ JCJG_'L?I5ZJ.J?\>Q^E..X'F.M_ZUJI:;_K1]:NZW_K6JEIO^M'UKTE
M\ SOM(^ZM=1%_JQ7+Z1]U:ZB+_5BN"IN(?11168!1110 4444 %%%% !1110
M 4444 %%%% !65J<I2(D5JUF:E"9(F ':@#RSQ)K+P%L,:X&X\5R)*07/YUW
M/BS2I'#D*:\:UJQG@F8X- SL(_%K$?ZS]:&\52'HYKSF&2;?MYK>L;*6X X-
M '2GQ3+_ 'S2?\)1-_?-4TT"9QPIJ0>&Y\?<- %C_A*)O[Y_.D_X2F;^^:KG
MPY/_ '32?\(Y/_=- $[^*9@OWS4$7BN8S ;SUIK^')ROW#4$/AJ<3 [#UH ]
M/\):S)<.F6->OV+;[537C?@_29('3(->R6"[;510(LT444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (>AKSOQM_
MJG^E>B'H:\[\;?ZI_I0!X%K/_'XWUKH?"G^L2N>UG_C\;ZUT/A3_ %B4#/</
M#O\ JTKL%^Z/I7'^'?\ 5I78+]T?2@0M%%% !1110 4444 %%%% !1110 44
M44 %%%% &'XAS]G;'I7AOBHS>:^,U[YJL'G1$8[5YSK7AMKAV.R@#PV8W&\]
M:C_TCWKU%_!;%O\ 5_I3?^$*;_GF?RH&>9?Z1[TH^T>]>F_\(6W_ #S_ $I1
MX+;_ )Y_I0!YB3<#UJ-KB5.I->G7'@UDB+>7^E<5K.DFU9OEQ0!A_;9/[QIP
MN96Z$U5V'S<>]=%I.DFY*_+G- &6&N#ZTO\ I'O7HMGX/:6,'R_TJS_PA;?\
M\_TH \P/VC'>H6^T;N]>J?\ "%M_SS_2F'P2V?\ 5G\J . TXW&\9S7I?AHR
MY7.:2U\',C#]W^E=;I&@F K\M CK-%)\M<UNUFZ?;^4H&*TJ "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ J&X^X:FJ&X^X:$!R>L?=:N&O/]<?K7<ZQ]UJX:\_UQ^M=
MU'89NZ!]]:]'L_\ CW6O.- ^^M>CV?\ Q[K6.(W$3T445S@%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !5:]_P!0:LU6O?\ 4&FMP."UK[S5S\?^MKH-:^\U<_'_
M *VN^'PC.MT;M79VW^J%<9HW:NSMO]4*Y:NXB:BBBL0"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH ***2@!::R*W6G"B@#$U;2DGC/R]:\M\4>&
M 5=@GZ5[6RAQ@UB:UI23VS84'B@#Y7U'2/L]P?E[UK: L:R*"!77^)M (D<A
M.]<I:V<MO<C /6@9Z?H]C!/&O KI(O#43KG8/RKF?"K.2@.:]3LHQ]G4D4".
M4/AB+^X/RI/^$7B_N#\J[3RU]*/+7TH XK_A%XO[@_*G#PQ$#]P?E79^4OI1
MY2^E '-VFAI"1A16]:PB)0 *G" 4H&* %HHH- !124M !1110 4444 %%%%
M!1110 4444 %!HHH 2EHHH **** "BBB@#-UO_CP;\:^?/&_^ND^M?0>M_\
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MGM9_X_&^M=#X4_UB4#/</#O^K2NP7[H^E<?X=_U:5V"_='TH$+1110 4444
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M* "BBB@ HHHH **** "BBB@ HHI* %HI*44 %%%% !1110 444AH 6BDI10
M4444 %%%)0 M%%% !1110 444E "T4@I: "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH *AN/N&IJAN/N&A <GK'W6KA
MKS_7'ZUW.L?=:N&O/]<?K7=1V&;N@??6O1[/_CW6O.- ^^M>CV?_ ![K6.(W
M$3T445S@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M+0 4444 %%%% !BBBB@!*44F*6@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** ,W6_\ CP;\:^?/&_\ KI/K7T'K?_'@WXU\^>-_]=)]:!HX*Q_X
M_!]:]B\'?\LZ\=L?^/P?6O8O!W_+.@&>R:;_ ,>HJY5/3?\ CU%7*!!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 51U3_CV/TJ]5'5/^/8_2
MG'<#S'6_]:U4M-_UH^M7=;_UK52TW_6CZUZ2^ 9WVD?=6NHB_P!6*Y?2/NK7
M41?ZL5P5-Q#Z***S **** "BBB@ HHHH **** "BBB@ HHHH **** "H;B$3
M)C%344 <7K.@"<-\GZ5R)\+[)\[._I7K\BHRG>!BL6[C@5B>* ,G0+(6NWCI
M78JP91@URXNXHCP14R:P@XWB@#I**Q8M61C]X5H0WD<@^\* +5%("#T.:6@
MHHHH 2EI*44 %%%% !1110 E%+10 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 AZ&O._&W^J?Z5Z(>AKSOQM_JG^E '@6L_\ 'XWUKH?"
MG^L2N>UG_C\;ZUT/A3_6)0,]P\._ZM*[!?NCZ5Q_AW_5I78+]T?2@0M%%% !
M1110 4444 %%%% !1110 4444 %%%% !24M)B@!:*** "BBB@"KJ'_'F_P!*
M\,\;_?>O<]0_X\W^E>&>-_OO0!Y>/^/S\:]-\(?>2O,A_P ?GXUZ;X0^\E S
MVW1?^/4?2M.LS1?^/4?2M.@04444 %%%% !1110 4E+28H 6BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HQ110 8HHHH **** "BBB@ HHHH 3%+110 E%+10 48HHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH *AN/N&IJAN/N&A <GK'W6KAKS_7'ZUW.L?=:N&O/]<?K7=1V
M&;N@??6O1[/_ (]UKSC0/OK7H]G_ ,>ZUCB-Q$]%%%<X!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'KG6BLZQU!9XAR#6@#D9H *6BB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@!#T->=^-O]4_TKT0]#7G?C;_5/]*
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MZB@"[15+^T8O44?VC%ZB@"[15+^T8O44HU&,]Q0!<HJ%+E7Z&I@<B@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H;
MC[AJ:H;C[AH0')ZQ]UJX:\_UQ^M=SK'W6KAKS_7'ZUW4=AF[H'WUKT>S_P"/
M=:\XT#[ZUZ/9_P#'NM8XC<1/1117. 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M.1\V:Z^VG$D8.:\(\*7\S,F2:]AT:9GB7- C>HI!TI: "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC?6N@\*?ZQ*!GN'AW_5I78+]T?2N/\._ZM*[!?NCZ4"%HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#BO&!_=/7S_XG8^>_UKZ(\50&6)\"
MO"/$^G,)7.*!HX _>I0.:DGC\ICFH589H&2]JK3U8SQ5>;DT 7M) \Y?K7L7
MA$D!*\BT2$O.OUKVSPA9':G% CT_223&M;59VG0;(UK1H$%%%% !1110 444
ME "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9VI']V:T:S=
M3/[MJ /(O&1X>O*6_P"/S\:]5\9'AZ\J;_C\_&@:/3_!A^Y7LFEG]TOTKQKP
M8?N5['I9_=+0(U**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ J&X^X:FJ&X^X:$!R>L?=:N&O/\
M7'ZUW.L?=:N&O/\ 7'ZUW4=AF[H'WUKT>S_X]UKSC0/OK7H]G_Q[K6.(W$3T
M445S@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M+XD0_P 8_.O$M3\4R)<L-QZU#%XJD(^^: /=?^$C3^^/SH_X2)/[X_.O#_\
MA*9/[Q_.C_A*9/[QH"Q[B?$2;3\XKB/%.L+-&P#5PQ\528^\:R=0UUYP06H
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %9>I?ZMJU*R]2_U;4 >1>,>CUY6W_'Y^->J
M>,>CUY6W_'Y^- STWP;_  5[%I?^J6O'?!O\%>Q:7_JEH$:U%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 5#<?<-35#<?<-" Y/6/NM7#7G^N/UKN=8^ZU<->?ZX_6NZCL,W= ^^
MM>CV?_'NM><:!]]:]'L_^/=:QQ&XB>BBBN< HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M HHHH **** "BBB@ HHHH *HZI_Q['Z5>JCJG_'L?I3CN!YCK?\ K6JEIO\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5#<?<-35#<?<-" Y/
M6/NM7#7G^N/UKN=8^ZU<->?ZX_6NZCL,W= ^^M>CV?\ Q[K7G&@??6O1[/\
MX]UK'$;B)Z***YP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ JM>_P"H-6:K7O\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"J.J?\>Q^E7JHZI_Q['Z4X[@>8ZW_K6JEIO^M'UJ[K?^M:J6F_ZT?6O27P#.
M^TC[JUU$7^K%<OI'W5KJ(O\ 5BN"IN(?11168!1110 4444 %%%% !1110 4
M444 %%%% #7^Z:Y;Q#(1"_TKJ7^Z:YO7H"T#GVH \$\62$SMGUJGX9@62[7(
M[UH>+X2D[G%9/AV[$5VN3WH&?0_A6PB%LIP.E=6$51@"N+\):DK0(,]J[16#
M+D4"%HHHH *CEA21""!4E,E?9&6H X;Q1I\?DN<"O!_$4 CNFP.]>Z>*=058
M7&:\*\07(ENFQZT C6\'2$7*#WKZ%\//NLU^E?/G@Z/=<(?>OH/P^FVT7Z4
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M7G&@??6O1[/_ (]UK'$;B)Z***YP"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ J&X^X:FJ&X^X:$!R>L?=:N&O/]<?K7<ZQ]UJX:\_UQ^M=U'89
MNZ!]]:]'L_\ CW6O.- ^^M>CV?\ Q[K6.(W$3T445S@%%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MHH **** "BJ]S<K I)-9$NOHCXW"@#?HK(MM66<\-6I&^\9H ?1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ JCJG_'L?I5ZJ.J?\>Q^E..X'
MF.M_ZUJI:;_K1]:NZW_K6JEIO^M'UKTE\ SOM(^ZM=1%_JQ7+Z1]U:ZB+_5B
MN"IN(?11168!1110 4444 %%%% !1110 4444 %%%% !FCJ*2EH R[^Q6=2,
M9K@/$'AD2AB$_2O4B >M5;FRCG4\"@#YHUKPQ)&S%4/Y5RD^FW$#' -?2^J^
M'8Y<_(/RKCK_ ,'AR<1_I0,\1S<H?XJ7S[GI\U>IR>""2?W?Z5#_ ,(,V?\
M5_I0!Y>3<N?XJL6^FW%PPR":]/B\#'/,?Z5O:;X*56&8_P!* N>>Z+X6DD=2
MR'\J]4\/>&A"%)3]*Z72O#$4*@E0,>U=)#:10* JB@16LK)8$ QBM # HHH
M**** "BBB@!,4M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 AZ&O._&W^J?Z5Z(>AKSOQM_JG^E '@6L_\?C?6NA\*?ZQ*Y[6
M?^/QOK70^%/]8E SW#P[_JTKL%^Z/I7'^'?]6E=@OW1]*!"T444 %%%% !11
M10 4444 %%%% !1110 444&@ JM>PB: C%6:0C(P: /*O%'A_P _>0GZ5Y)K
M/AYH78A/TKZ@OM/2=#Q7!:[X9$N["?I0!\W7=O)$Q&#44$4CMC!KU;4?!;O(
M<1_I5>V\%.&&8S^5 [G"QZ>[+G::9)9F,\BO5U\)&. DIT]JY/6],^S%OEH
MYRR7$@%>A^'+592G%>>P';< >]>F^$1N9* ._L-#22 '9V]*E;PVI;[GZ5T^
MCQ*+0'':M#RT_NB@1RMGH*1D?(/RKH+6R2)1\HJV$4= *6@  QTHHHH ****
M $I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBD8X4F@!:P]
M;NTCC;FG:CJZVR-\U>=>(?$RD, _ZT <WXOO@Q<9KS?S,W6?>MC7=5\]V^:N
M967$F:!GJ_@^Y52G->T:+.KQ+SVKYL\/ZMY#K\U>O^'-?5E0%J!,].HK/M;]
M9E&#5]3D9H 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ J&X^X:FJ&X^X:$!R>L?=:N&O/\ 7'ZUW.L?
M=:N&O/\ 7'ZUW4=AF[H'WUKT>S_X]UKSC0/OK7H]G_Q[K6.(W$3T445S@%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !5:]_U!JS5:]_U!IK<#@M:^\U<_'_K:Z#6
MOO-7/Q_ZVN^'PC.MT;M79VW^J%<9HW:NSMO]4*Y:NXB:BBBL0"BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 8\:OU%5Y+")A
MG JT2%&36-J>L);*>0* '2VENG4"JC):K_=KC]5\8",L _ZUR]QXV.XXD_6@
M#U<-:#^[4J7-LG0BO'!XU8_\M*#XS<_\M* /:TUB",8R*=_;MOZC\Z\,;QBY
M/^L_6A/%KEO]90![Q'JL,G0BKD<HD'%>0:+X@:=U&ZO3-'N#-&#GM0!KT444
M %%%% !124HH **** "BBB@ J&>80IDFIB<=:YKQ%J0MXFPW2@#(\1:\L*L
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J.
MJ?\ 'L?I5ZJ.J?\ 'L?I3CN!YCK?^M:J6F_ZT?6KNM_ZUJI:;_K1]:])? ,[
M[2/NK741?ZL5R^D?=6NHB_U8K@J;B'T445F 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% $;PJ_457DL(F&<"K,D@C7)K#U/74MT/S 4 2RVELG4
M"JI6T!_AKBM6\8A&8!_UKF9?&S;C^\_6@#UP-:#^[4J7=M'T(KQO_A-'/_+3
M]:0^,G/_ "TH ]M&LP(,;A1_;UMG&17ALGC!\?ZS]:KQ^,':4#S/UI ?04.I
M13?=(JZK;AD5Y3X9UUKEERV:]0LVWVZFF!/1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 AZ&O._&W^J?Z5Z(>
MAKSOQM_JG^E '@6L_P#'XWUKH?"G^L2N>UG_ (_&^M=#X4_UB4#/</#O^K2N
MP7[H^E<?X=_U:5V"_='TH$+1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ J&X^X:FJ&X^X:$!R>L?=:N&O/]<?K7<ZQ
M]UJX:\_UQ^M=U'89NZ!]]:]'L_\ CW6O.- ^^M>CV?\ Q[K6.(W$3T445S@%
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8CY_UKJ[#4UN /FH UJ*0'(S2T %%%% !BBBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M HHHH **,T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% "'H:\[\;?ZI_I7HAZ&O._&W^J?Z4 >!:S_Q^-]:Z'PI_K$KGM9_X_&^
MM=#X4_UB4#/</#O^K2NP7[H^E<?X=_U:5V"_='TH$+1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110!5U#_CS?Z5X9XW^^]>YZA_QYO]
M*\,\;_?>@#R\?\?GXUZ;X0^\E>9#_C\_&O3?"'WDH&>VZ+_QZCZ5IUF:+_QZ
MCZ5IT""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M&!'\?ZUYW]GN/0TX6]SZ&@#N+_Q89(R-]<3JFH?:7/.:AF@N .0:SY$<$[J
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MS_O?K2#Q!9$XW?K0!I+!&O1 *D Q5*'4[>;[K?K5Q6##(H 6BBDH 6@T@I:
M$I:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!
M#T->=^-O]4_TKT0]#7G?C;_5/]* / M9_P"/QOK70^%/]8E<]K/_ !^-]:Z'
MPI_K$H&>X>'?]6E=@OW1]*X_P[_JTKL%^Z/I0(6BBB@ HHHH **** "BBB@
MHHHH **** "BB@T %%)2T %%%% !1110!5U#_CS?Z5X9XW^^]>YZA_QYO]*\
M,\;_ 'WH \O'_'Y^->F^$/O)7F0_X_/QKTWPA]Y*!GMNB_\ 'J/I6G69HO\
MQZCZ5IT""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *K7O^H-6:K7O^H--;@<%K7WFKGX_];70:U]YJY^/_ %M=
M\/A&=;HW:NSMO]4*XS1NU=G;?ZH5RU=Q$U%%%8@%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %9U_,8T)K1K)U-"T;8H X77M:>#=AC7GF
MH^+Y8Y" Y_.NP\36<CA\ UY7JNDSM(V : -4>,Y74CS#^=9%]K+W))+&L^+1
MI]W0U<31Y<<J:!E)+YXWSDUKVOB26' WFJK:+)C[IJ(Z+-G[IH Z*/QA,!]\
M_G4O_"8S?WS^=<TNCS#^$U(-)EQT- &__P )C-_?/YU)'XPF+#YS^=<W_94F
M>AJ2/2I-PX- 'I6@^(Y)W4%C7JVB7!GB4D]J\1\-Z=(DJ9!KVCP]&4A7/I0(
MWZ*** "BBB@ HHHH *#THI#T- '.^(9RENX!KP7Q;=/YS\FO=O$,9>)@*\4\
M3:9))*Q"F@#B;*=O/!)[UVVFZGY,8YKE8=,D27.TUJI;RJG0T#-?4M<+Q$;N
MU<+?W7F3$Y[UJ7J2 '.:YVXSN- '2:!J9AE7FO8_#FL&6-5W5X%I:N9ABO7?
M":R?)G- ,]$N;3[;">,Y%<?J7@\3R$[/TKT;3(MT(R.U7FLXVZJ*!'C:>!P/
M^6?Z5)_PA0_YY_I7KWV&/^Z*/L,?]T4 >1?\(4/^>?Z5+'X)!_Y9_I7K'V&/
M^Z*>EI&O\(H \7U/P:(HB=G;TKS;7--^RNPQBOI[7;.,V;$*.E> ^,X@DSX%
M '$6!Q< >]>O>#NJ5X_8_P#'V/K7L/@X?ZN@9[+IO_'J*N53TW_CU%7*!!11
M10 4444 %%%% !1110 4444 %%%% !1110!'.VV(FN%\0ZN;8-\U=O=_\>[5
MY-XR$A#XS0!SM]XQ:.4CS._K5=/&C'_EI^M<#JJ7'GMC/6J4:7'O0!Z7)XR8
MH1YGZUSVI^(VGS\_ZUS#)<8[U5ECG[YH&3W=V9F/-42N31M<'FGB@ 48I6Y%
M%% R Q_-FM&QN# P.:J9%)ACTH [?3O$C0 #?^M;L?C)@O\ K/UKS!(Y\\9J
M<)<8[T"/3!XS;_GI^M6[7Q>SN!YGZUY2$N,]ZTK!+CS1UH$>\Z%K9N"OS5Z!
M92>9"#7B_A-9-R9S7L6E9^RC/I0!?I*6DH *6DI: "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M*6C%% !1110 4444 5=0_P"/-_I7AGC?[[U[GJ'_ !YO]*\,\;_?>@#R\?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %0W'W#4U0W'W#0@.3UC[K5PUY_KC]:[G6/NM7#7G^N/UKNH[#-W0/OK7
MH]G_ ,>ZUYQH'WUKT>S_ ./=:QQ&XB>BBBN< HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH *K7O\ J#5FJU[_ *@TUN!P6M?>:N?C_P!;70:U]YJY^/\ UM=\/A&=
M;HW:NSMO]4*XS1NU=G;?ZH5RU=Q$U%%%8@%%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %5;F+>IJU2$ ]: .2U+21-GY:YFZ\*B1B?+_2O
M4#"C=13#:0G^&@#RE?"(!_U?Z5(/"@'_ "S_ $KU'['#_=H^QP_W: /+O^$4
M']S]*1O"BJ.4_2O4OL</]VJ6H0Q0QDX'2@#RRYT".('Y16+=6<<1/ KL-:U"
M)"P!%<9>78E8X- %/8F_&!6C9V<<C#@5D_-OS6E978B89- ';Z+IB J<"N^T
MZ$1H,>E>?Z+JT9*C<*[[3KA94&#VH T:**.] !1110 4444 %(>E+10!F7]M
MYRD8KC-3\/>>Q.RO1"@;K4;6L;=10!Y(?"?S9V?I2MX7(4_)7J_V&'^[2-80
ME2-M '@&OZ(8(V.VO-;Z-DG*X[U]*>*M&5XGPO:O&]2\.N;LX0]:!HSO#6GF
M>5?EKVCPWI!C1#MKEO".@^6RY2O8-,L%BA7B@3+5E%Y<8%6Z0 #I2T %%%%
M!1110!G:S_QX-7SYXW_UTE?06M'%@U?/GC?_ %TGUH&C@K'_ (_!]:]B\'?\
MLZ\=L?\ C\'UKV+P=_RSH!GLFF_\>HJY5/3?^/45<H$%%%% !1110 4444 %
M%%% !1110 4444 %%%% $<Z[HB*XG7M'-R&^7-=T1D5"]M')]X4 >&WG@UI)
M"?+_ $JNO@IA_P L_P!*]T.F6YZK2?V7;?W: /#6\%MC_5_I67?>$6C4GR_T
MKZ&.EVQ'W:R=3T")XSM44 ?+VIZ4UL3\M<[*Q1\5[CXG\-??PE>5ZKHKPRM\
MIH&8L;9%.8X%!C,7!IR+YAP*!E;>2^*WM)T]KI@-N<U%9:.\\@PIKTWPIX9.
MY"R4",_3_"#3(#Y?Z5I#P4V/]7^E>OZ1H4,4"EE'2M3^R[;^[0(\-'@IL_ZO
M]*M6W@YD<'R_TKVC^R[;^[2C3;<?PT </HFAFW*_+7=V<?EP@4Y+2).@J8
M<4 +24M% "4N:#24 +1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MQO%C<9- '>^'M.2/:0!7H%NNV%17G^A:DAVC(KN[6X$D0P: +5%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MPOUH&>C>&- 6;82M>MZ-H:6\:G:!7*^#X%"IQ7I<8 C4#TH$"*$4*.U.HHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ JCJG_ !['Z5>JCJG_ !['Z4X[@>8Z
MW_K6JEIO^M'UJ[K?^M:J6F_ZT?6O27P#.^TC[JUU$7^K%<OI'W5KJ(O]6*X*
MFXA]%%%9@%%%% !1110 4444 %%%% !1110 &DI:,4 &<"F&55ZFB0X6L>^N
M3&#S0!J_:8@?O4]94?H:X6XUDQORU6]/UU&< O0!V5%5;>]AG0$.,U8#J>C"
M@!2< GTKSGQCK!MP^&KT5_N-]*\?\>PR,9, T <!=ZX\]P5W=ZT["!KI0>N:
MY.*V?[9\V>M>D>'88Q$N[% RA/IK1QYQ7/74SV\O?K7IE['#Y!QCI7GNM6ZF
M4[: -3P[J[>:H+5Z]H=WYL2\UX;H4#"=<>M>Q>'0RQ+F@1VB'*TZHX?N5)0
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 AZ&O._&W^J?Z5Z(>AKSOQM_JG^E '@6L_P#'XWUKH?"G^L2N>UG_ (_&
M^M=#X4_UB4#/</#O^K2NP7[H^E<?X=_U:5V"_='TH$+1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110!5U#_ (\W^E>&>-_OO7N>H?\
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M]:]'L_\ CW6O.- ^^M>CV?\ Q[K6.(W$3T445S@%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M)0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M%% !1110 4444 %%%% !1110 AZ&O._&W^J?Z5Z(>AKSOQM_JG^E '@6L_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_JU^E AU%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 444UI%7J: '457:]@3JXJ(ZI;#^,4
M7:*IKJ5LW1Q4R743]&H FHI P/0TM !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !5'5/^/8_2KU4=4_X]C]*<=P/,=;_UK52TW_6C
MZU=UO_6M5+3?]:/K7I+X!G?:1]U:ZB+_ %8KE](^ZM=1%_JQ7!4W$/HHHK,
MHHHH **** "BBB@ HHHH **** "BBB@ I",BEHH @DM(I/O"J4^AVTP/ S]*
MT'FC3[S 55EU:UBZN* .5U7PO&%)5!7":OH+Q;MBUZE<Z[;2<;EK)G>UNNZG
M- 'B\]G=0R' :K=A=3PN Q->DW6AV\P)517-ZAH0BR46@"]IFK1X4.:ZBSNK
M28#)6O)+II[5OER*=9Z_<0N 6- 'M]O96DQ& M:46D6ZX.T5YEHOBELKO?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M3KD'K7JWAR-HT4&@#L**:IR*=0 4444 %%%% !1110 E+24M !1110 4444
M%%%% !1110 4444 %%%% &;K?_'@WXU\^>-_]<_U-?0>M_\ '@WXU\^>-_\
M7/\ 4T#1P5E_Q]CZU[#X./W*\>LO^/P?6O8?!W\% 'LNF_\ 'J*N53TW_CU%
M7*!!1110 4444 %%%% !1110 4444 %%%% "4M)BEH **** "DI:2@ I:2EH
M *X_QI_Q[/\ 2NPKC_&G_'L_TH ^<_$W_'T_UIOAO_CX7ZT[Q-_Q]/\ 6F^&
M_P#CX7ZT#/=O"7W$KT:/_5K]*\Y\)?<2O1H_]6OTH$.HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI"0HR30 M&1ZUEWNI)#
MGYJPYO$:(V-] '89'K17)0^(D<CYZV+34TFQ\U &K1358.,@TZ@ HHJ.5]BY
MH 6201H6)KE=8UM;<-\U6-7U40PL-U>2^*-?.7 >@#6U+QGY;,!)^M<]-X\8
M-_K/UKSG4]6DED;#&L66XF8YR: /:+3QTS,/WGZUUVD>*Q,R@O\ K7S=;WDL
M9'S&NLT+6WCD7+F@#ZATO45N$'/6MBO)_"^N[U0%Z](L[P3(#F@#0HI <BEH
M **** "BBB@ HHS10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5'5/^/8_2KU
M4=4_X]C]*<=P/,=;_P!:U4M-_P!:/K5W6_\ 6M5+3?\ 6CZUZ2^ 9WVD?=6N
MHB_U8KE](^ZM=1%_JQ7!4W$/HHHK, HHHH **** "BBB@ HHHH **** "BBB
M@ J.9PD9-/8X6L?4[O9"PS0!SOB#7?LP;#8Q7FVJ>,)1(0'/YUI>*+MI&< U
MPO\ 9TEW/W.30!>?Q;<$_>/YU:L_%\P<;F/YT^T\&23H#M-+=>$);5"VTC%
MSJ-,\4>=@,U=- J:A&.AS7CB&2QG )(P:]*\'ZCYK(K'- &A>>$/M +!/TKE
MM0\(O Q(0_E7M\*J85X&"*H:EIL<Z$A10(\#F@FL2<9&*9!XCGMY -Q_.O1=
M8\-&0-M2N%O?"LRS$A#0!T^A>)))BH+&O2-+N_.C!)KR+1M)FMY%R#7INC!D
M10: .H'(I:9$<J*?0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 AZ&O._&W^J?Z5Z(>AKSOQM_JG^E '@6L_\?C?6
MNA\*?ZQ*Y[6?^/QOK70^%/\ 6)0,]P\._P"K2NP7[H^E<?X=_P!6E=@OW1]*
M!"T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 5=0_X
M\W^E>&>-_OO7NE__ ,><GTKPSQQ]^2@#RX?\?GXUZ;X0^\E>9#_C\_&O3O!_
M5*!GMFB_\>H^E:=9NC?\>H^E:5 @HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOH/6_P#CP;\:^?/&_P#KI/K0-'!6/_'X/K7L7@[_ )9UX[8_\?@^M>Q>#O\
MEG0#/9--_P"/45<JGIO_ !ZBKE @HHHH **** "BBB@ HHHH **** "BB@T
M%%)2T %%%% !1110 4444 %<?XT_X]G^E=A7'^-/^/9_I0!\Y^)O^/I_K3?#
M?_'POUIWB;_CZ?ZTWPW_ ,?"_6@9[MX2^XE>C1_ZM?I7G/A+[B5Z-'_JU^E
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'->E^&?$1!0%_P!: 9]"0SB50<U-7)Z'JPG1?FKJ8VW(#0(?1110 &DI324
M+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %0W'W#4U0W'W#0@.3UC[K5PUY_KC]:[G6/NM7#7G^N/UKNH[#-W0/OK7H
M]G_Q[K7G&@??6O1[/_CW6L<1N(GHHHKG **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRSH!GLFF_P#'J*N53TW_ (]15R@04444 %%%% !1110 4444 %%%% !1110
M4444 %!HHH 2EHQ10 4444 %<=XT_P"/=_I78UQWC3_CW?Z4 ?.GB;_CZ?ZT
MWPY_Q\+]:=XF_P"/I_K3?#G_ !\+]:!GNWA+[B5Z-'_JU^E><^$ON)7HT?\
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M]U:ZB+_5BN7TC[JUU$7^K%<%3<0^BBBLP"BBB@ HHHH **** "BBB@ HHHH
M**** "F2IO0BGT4 <IJ^A+<AOEKA]1\(C<2$_2O8F4,,$52N;!)!]T4 >'S>
M&&4X"4^U\+EG&4_2O6)=&5C]T4^#1U0CY: ./TGPJ%()3]*[73](6W4?+BM*
MWM4B7H*LT (HVJ!2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 (>AKSOQM_JG^E>B'H:\[
M\;?ZI_I0!X%K/_'XWUKH?"G^L2N>UG_C\;ZUT/A3_6)0,]P\._ZM*[!?NCZ5
MQ_AW_5I78+]T?2@0M%%% !1110 4444 %%%% $-P<1FN$\2W[0(^#7=W S&:
MX#Q/9M*CX% 'D^M>)IHIF <_G6/'XLG)^^?SJ]KF@S23,0IK&B\.3 _=- S3
M_P"$JG_OG\Z/^$JG_OG\ZJ?\(]-_=-'_  CTW]TT 6_^$IG_ +Y_.C_A*I_[
MY_.JG_".S?W31_PCTW]TT 6_^$JG_OG\Z/\ A*I_[Y_.JO\ PCTW]TT?\(]-
M_=- %K_A*IO[Y_.G+XKG'\9_.J7_  CTW]TTX>'9C_": +$WBF>1<%S^=8EY
MJ;W!.2:T)?#TR#.TUE7-@\).10!2WG=FM&TU)X,8-9VSYL5=M[%Y<8% S=@\
M3S1@ .?SJ<^+)S_&?SK.BT"9QD*:E/AV8?PF@19_X2J?^^?SH_X2J;^^?SJI
M_P (]-_=-'_"/3?W30!;_P"$JF_OG\Z/^$JF_OG\ZJ?\(]-_=-'_  CTW]TT
M 6_^$JF_OG\Z/^$JF_OG\ZJ?\(]-_=-'_"/3?W30!;_X2J?^^?SJ*7Q7.!]\
M_G4/_"/3?W344OAV8C[IH V-)\4323J"YZ^M>R^$;]KA4R:\0TCP_,DZDJ>M
M>U^#K-H%3(H$>ACH*6D'04M !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %)2T4 %%%% !1110 4444 %%%% !6=JTW
MEVS?2M&N?\0S@0, >U 'C_C742"X#5Y!?W;2SGGO7H?C20L[\UY?-GSS]:!D
MR(2,T\IQ2Q?=IYH @52IS6UI.HF"51NK)?A:@AD99QCUH&?0'@[53*4&ZO8+
M%M]JIKY[\!S$R1Y/I7T#I9!L4H)+E%%% !1110 4444 %%%% !1110 4444
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MW%XD .2*P;[Q+'%D;Q^= '2/,B]Q35N4)ZBO/+KQ<@8_/^M01>+TW??_ %H
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M^M T<%8_\?@^M>Q>#O\ EG7CMC_Q^#ZU[%X._P"6= ,]DTW_ (]15RJ>F_\
M'J*N4""BBB@ HHHH **** "BBB@ J*:98XV)/:G2':A-<YK&H^3$W- &'XDU
MSR ^&KR;6_%3B1@)/UK4\6:N6+@-7E.HW+2RGGO0-&O<>)I68_.?SJ./Q)*#
M]\_G7.^6S4&%@*!G<:;XID$JYD/YUZAX8\2&0H&?]:^?+;='(#FNW\/:JT+J
M-U CZ?TV_2>$<]JT0<BO,_#.M^8B#=7HMI*)80:!$]%%% !7'>-/^/9_I78U
MQ_C3_CV?Z4 ?.?B;_CZ?ZTWPW_Q\+]:=XF_X^G^M-\-_\?"_6@9[MX2^ZE>C
M1_ZM?I7G/A+[B5Z-'_JU^E AU%%% !69J%\L$9R:T7.U"?:O//%FJ^0CX:@#
M)\2>)1&' ?\ 6O*]7\4R&1L2'\ZB\0ZVTLK#=7'W#-,Q.:!FR?$DI/WS^=.A
M\32J_P!\_G7."%J/)8'- SU+0_%;;U!D_6O5?#VOB<*-]?,=I=M;R#FO2_"6
MM-YB M0)GT;:3":('-6:YSP]>B:%<GM71YH$%%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 (:*6B@ HHHH **** (;A-T9KSWQ79DQ.
M<5Z.PR,5SGB&Q\VW;CM0!\Q^)K<I,_%<HIVO7JOBS16,CD+7G%UITD<A^4T#
M(A(,4>8*C\EP>AH\ESVH&2;P:4#=2P6DCMT-;%KI$C@?*: ,CRCZ4GE'TKIA
MH<F/NFC^PY/[IH$<SY1I5B(/2NE_L.3^Z:4:'(?X30!B02M$016I;Z[) .&(
MJ=]!E"YV&LVZTN2/.0: -<>+9@,>8?SI?^$NF_YZ'\ZY&6!T/>F+$Q- '9CQ
M=,/^6A_.HY/%DKC&\_G7+"W;'>HWB9: -FZUAY\Y;-9KR%VS58 U(* )XYS'
MWJR-28#&:SB*;M- %J:X,O4U5,>3FG 4Z@!@2F2)D5-37Z4#(8(\2 UW'ARY
M,4B<UQ<1&^NIT129%Q0(]R\,WQ=$&:]"MFW0@UY9X51@$KU&RXMQ0(L4444
M%%!I* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MY_VJ-MS_ +5>L?\ "$_],_TH_P"$)_Z9_I0!Y/MN?]JD9;G'\5>L_P#"$_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %5KW_4&K-5KW_4&FMP."UK[S5S\?^MKH-:^
M\U<_'_K:[X?",ZW1NU=G;?ZH5QFC=J[.V_U0KEJ[B)J***Q **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $I:
M2B@!:*** "BBB@ HHH- "9I:2EH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH S=;_ ./!OQKY\\;_ .ND^M?0>M_\>#?C7SYXW_UTGUH&
MC@K'_C\'UKV+P=_RSKQVQ_X_!]:]B\'?\LZ 9[)IO_'J*N53TW_CU%7*!!11
M10 4444 %%%% !1110!!=G; 37G/BB[*JX!KT2]_X]S7E_BI6P] 'DOB&Y9Y
M&YKC)LF0UU>N*1(U<M+]^@:'1CBG,!BD3I3C0,B P:OV,[1RCFJ>*?&VUP:
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M HHHH **** "BBB@ HHHH **** "BBC- !1110 4444 %%%% !1110 4444
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M_=%7 01D4M %+^SX_P"Z*46$?]T5<HH JFQBQ]T5E:C8QB-OE%;]9VI#]V:
M/'/%MLH#X%>576([D_6O8/%J\/7CFK'9.WUH&CI]#U%80,FNI'B2.-!\PKR:
MVO60<&G3ZE*1PQH ]1/BZ,'&\5>L_%,4C#+"O#WOYMWWC5VSU66-AEC0!](:
M5JL-QCD5V%E##,H.!7SWX=\0,'4%_P!:]D\.:P)D7YJ!'5G3XO[HI/[/C_NB
MK,4@D7(J2@"E_9\?]T4?V?'_ '15VB@"E_9\?]T4X6,8_A%6Z* (5@5>@J4#
M%+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4-Q]PU-4
M-Q]PT(#D]8^ZU<->?ZX_6NYUC[K5PUY_KC]:[J.PS=T#[ZUZ/9_\>ZUYQH'W
MUKT>S_X]UK'$;B)Z***YP"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M6?\ C\;ZUT'A3_6)0,]P\._ZM*[!?NCZ5Q_AW_5I78+]T?2@0M%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %74/\ CS?Z5X9XW^^]
M>YZA_P >;_2O#/&_WWH \O'_ !^?C7IOA#[R5YD/^/S\:]-\(?>2@9[;HO\
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M.-7/SC\Z9;^(T+#YQ^= ';45D6>M0R@ L*TDGCD'RF@"6BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "H;C[AJ:H;C[AH0')ZQ]UJX:
M\_UQ^M=SK'W6KAKS_7'ZUW4=AF[H'WUKT>S_ ./=:\XT#[ZUZ/9_\>ZUCB-Q
M$]%%%<X!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 56O?]0:LU6O?]0::W X+6OO
M-7/Q_P"MKH-:^\U<_'_K:[X?",ZW1NU=G;?ZH5QFC=J[.V_U0KEJ[B)J***Q
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M9H R])TA;55^7&*W>E'2B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "JU[_J
M#5FJU[_J#36X'!:U]YJY^/\ UM=!K7WFKGX_];7?#X1G6Z-VKL[;_5"N,T;M
M79VW^J%<M7<1-1116(!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4E+10 E+110 4444 %%%% %6\B\Q"*X#Q
M+I6^-CMKT@J&'-9>JZ>L]N<#M0!\Q>)+ Q2/\M<6ZE9#7N?BOPZS%R$KRK4M
M(:"1OEH&8RGBF.>*=)^[;%.CB,W H&+:*9) ,5WWAO23*Z';6)H>B/+*IVU[
M)X5\/[%0E:!-F[X;TGRD0E:[B.-40#'056LK-8(@,<U<H$)@#M2T44 %%%!H
M **2EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MVZ$&O*O"JG"5ZEI_^H'TH$7**** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ J&X^X:FJ&X^X:$!R>L?=:N&O/]<?K7<ZQ]UJX:\_UQ^M=U'89N
MZ!]]:]'L_P#CW6O.- ^^M>CV?_'NM8XC<1/1117. 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %5KW_4&K-5KW_4&FMP."UK[S5S\?\ K:Z#6OO-7/Q_ZVN^'PC.
MMT;M79VW^J%<9HW:NSMO]4*Y:NXB:BBBL0"BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!G>'M/:%5R*[NT7:@JE::>(0.*U(UVB@!]%%% !1110 4444 %%%% !1110
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MO.- ^^M>CV?_ ![K6.(W$3T445S@%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB@ HHHH **** "C ]*** $P/04;1Z"EHH 3:/04;1Z"EHH 3:/04;1Z"EHH
M3:/04;1Z"EHH 3 ]!1@>@H)P,U1O-06"-CG!H R?$1A2-NE>+>*+B/<X&*[7
MQ1KWRN-]>/ZYJ9ED;YJ!HP-18,YQ46G/MF&?6F3-YA-,A.QLT#/4_#=Q'\@)
M%>DV-O%<Q 8'->$Z/JAAD4;J]9\+ZR)-@+4"-B_\,+.A(3]*YNY\%EF.(_TK
MUW3Q%<0#.#5HV$!ZH*!'B]KX+*N#Y?Z5UVD>&EA*Y3]*[H6%N.B"I5@C3HM
M%.RT^.%!\HJ^%4= *7I10 F!Z"C:/04M% ";1Z"C ]!2T4 &**** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M &NV!5"XO1$#S5JY;:IKCM<OC$K<T 6[WQ$L(/S_ *USE[XS5,_O/UKA-?\
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MHH **** "BBB@ HHHH **** *NH?\>;_ $KPSQO]]Z]UOAFSD^E>&>.5Q(]
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MN=8^ZU<->?ZX_6NZCL,W= ^^M>CV?_'NM><:!]]:]'L_^/=:QQ&XB>BBBN<
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M,:SGCZ@U[U=>!TC!/E_I7*:QX;C@5OEH \J>22+J341OF'>M?6+,1,P KF9
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M/13%E1NC T^@ ICRHG4TR>Y2%"2:Y+6-?2(-AQ0!U#:C O5J0:E >C5Y%?\
MB[8YQ)^M0VOB\L_^L_6@#UZ]O8_LCX/:O$O&TH=WQ72MXF#VY!?M7 >)-0$Y
M;F@#BP/]+_&O3/"'WDKS6+YKG/O7I?A$89*!GMFB_P#'J/I6G69HO_'J/I6G
M0(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6B@ %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1124 +1110
M52N[!;A2"!5VB@#A=6\*K*&(0?E7%W_@\ACB/]*]K<H5PV*SI[>W<G(% 'BR
M>$7W_P"K_2KT?A78F2E>J"SM@>@JO=Q0)&< 4 >(Z_HP@C;Y:XE$\N[Q[UZO
MXN9 KXKRMSF\_&@9Z=X.;.RO8-,_U2UX[X,_@KV+2_\ 5+0(UJ#110 4444
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MH **** "BBB@ JCJG_'L?I5ZJ.J?\>Q^E..X'F.M_P"M:J6F_P"M'UJ[K?\
MK6JEIO\ K1]:])? ,[[2/NK741?ZL5R^D?=6NHB_U8K@J;B'T445F 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !110
M: $S2TE+0 4444 (>AKSOQM_JG^E>B'H:\[\;?ZI_I0!X%K/_'XWUKH?"G^L
M2N>UG_C\;ZUT/A3_ %B4#/</#O\ JTKL%^Z/I7'^'?\ 5I78+]T?2@0M%%%
M!1110 4444 %%%% !2%@HR:6LW5+L6\9.<4 1:CJ20*?FKB=6\6K 6P_3WK*
M\2^)?+W@/^M>4:UKTDS-AS^= ST2;Q[AR/,_6EA\>98?O/UKP^74)C(?F-+#
MJ,P8?,: L?36B^+!<LH+_K78Q:HC0[MPZ5\S>'M=>)UW.:]"@\5XML>9V]:!
M'7>(?$2P*P#_ *UY7K7B<R,P#_K5?Q%X@:;=A_UK@;F\DDD/)H'8U+S57D<G
M<:CM]3=6SN-8^\M1N(H ZQ=<<)C=6==ZB9B>:Q#,U-61B>:!FQ:-NF!KU#PD
M/G2O+-/YD6O5/"7WDH$SVG1O^/4?2M.LS1O^/4?2M.@04444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1FBDH 6BBB@ HHHH **** "BBB@ HHHH
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M&;N@??6O1[/_ (]UKSC0/OK7H]G_ ,>ZUCB-Q$]%%%<X!1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M<<4#&PR9D KLO#\)DD3BN2LK-Y)A@=Z]0\)Z0Q9"5H$ST/PO:%50XKTBU7;
M!7.Z%I_E1+Q73HNU0*!#J*** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *HZI
M_P >Q^E7JHZI_P >Q^E..X'F.M_ZUJI:;_K1]:NZW_K6JEIO^M'UKTE\ SOM
M(^ZM=1%_JQ7+Z1]U:ZB+_5BN"IN(?11168!1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 (>AKSOQ
MM_JG^E>B'H:\[\;?ZI_I0!X%K/\ Q^-]:Z'PI_K$KGM9_P"/QOK70^%/]8E
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MH[#-W0/OK7H]G_Q[K7G&@??6O1[/_CW6L<1N(GHHHKG **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M HHHH ***J7=TL*GF@"UN [BDWK_ 'A^=<?J'B-8"?G_ %KG;GQL(R?WGZT
M>I;T_O#\Z4,#T(KR>'QR';'F_K6]I_BA9V \S]: .[KBO&D"_9W..U=38W:W
M$8(.:P?&(#6C?2@#YJ\3)BY?ZU'X=CS<+]:M>*1BZ?ZU'X;_ ./A?K0,]R\'
MQ*%3BO24 "*!Z5YWX1^XE>B)]Q?I0(=1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MFL*CB@1+:P"*,#%6:** $I:3%+0 4444 %%%% !1110 4444 %%%% !1110
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M4M)B@!11110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2TF*
M%HHHH **** "D;[I^E+2'H: .$\40LR/BO%?$=NRR-Q7T/K%CYT;<5Y!XLTH
MIO(6@:/'[KY7.:A1A5C5HGCF88[UG1%J!EW(HR*ARU(=U !*1FM+1O\ 7+]:
MQY-V:V-$_P!<N?6@#V;PB.$KUO2P?*6O*?"&W:E>M:<R"$<CI02:%%)D>HI<
MT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !4-Q]PU-4-Q]PT(#D]8^ZU<->?ZX_6NYUC[K5PUY_KC]:
M[J.PS=T#[ZUZ/9_\>ZUYQH'WUKT>S_X]UK'$;B)Z***YP"BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ JM>_Z@U9JM>_Z@TUN!P6M?>:N?C_UM=!K7WFKGX_];7?#
MX1G6Z-VKL[;_ %0KC-&[5V=M_JA7+5W$34445B 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0]#7G?C
M;_5/]*]$/0UYWXV_U3_2@#P+6?\ C\;ZUT/A3_6)7/:S_P ?C?6NA\*?ZQ*!
MGN'AW_5I78+]T?2N/\._ZM*[!?NCZ4"%HHHH **** "BBB@ HHHH *SM3M1/
M&1CM6C2,H88- 'E.O^&O.W'9^E>;ZIX396;"?I7TE=6$<L9X%<7K&FPKNX%
M'@3^&V5ONT+X:=V'RUZ9=6L*R'@4^TM(6<<"@9R6C^$VWJ=GZ5Z?X?\ #@C"
MY3]*T-'TV$[< 5V-I9I"@(% BM#I,8A VCI6)J^@I*C86NPJ.2)9!R* /%]0
M\);Y"0GZ5!:^$2K\Q_I7LSZ9"YY IJZ5 O0#\J /,SX9"6Y.SH/2N$\2:<+<
MMQ7T+=V,8M'P!TKQ7QO$$9\"@#RJ23RY35J'4#&!@UE7KXG/UJ(2G% S>?6Y
M N QJHVM3;OO&LLMFFE: .GT[7I%=<N?SKT'1/$Y5!E_UKQE'*'(-:EKJKQ
M88T!8]@U;Q();<C?V]:\E\0WQGE;GO3YM9=TP6-8MS-YS9- 6*<8W-S5@1C%
M-10*FH&1&,4*WEG(IYJ*2@#J/#^HLLZ#/>O>?!MT943)KYTT('[0OUKZ \#
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MN/UKNH[#-W0/OK7H]G_Q[K7G&@??6O1[/_CW6L<1N(GHHHKG **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !56\CWQFK5-==PH \R\4V!9'.*\2\1VC)*_%?2^O
M6(>W8X[5XEXKT]5=^* /*0A5ZL#I4]U"$D-5B0*!BDU)$-QJ!FJW8 -(*!EV
M&R9QTJ5[ J.E=)IEHCQC(J:]LT6,X% CA9HBIJ6SAWN!5F^C <TVQ(604 ;U
MK8J$!Q4=W/\ 9AQ5Z"=1#U[5A:O+NS@T 5Y-98'&ZH3JSG^*L:0,7-*%.* -
MD:R\?.ZMO1_$[K*HW]ZX>56Q4EB724'/>@9](^%M?\X)EZ]+L[E9H@<U\X^%
M-2,3("U>T:!J7FQ*,T$G844R([HP:?0 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !5'5/^/8_2KU4=4_X]C]*<=P/,=;_UK52TW_6CZU=U
MO_6M5+3?]:/K7I+X!G?:1]U:ZB+_ %8KE](^ZM=1%_JQ7!4W$/HHHK, HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "H;C[AJ:H;C[AH0')ZQ]UJX:\_UQ^M=SK'
MW6KAKS_7'ZUW4=AF[H'WUKT>S_X]UKSC0/OK7H]G_P >ZUCB-Q$]%%%<X!11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 56O?]0:LU6O?]0::W X+6OO-7/Q_ZVN@U
MK[S5S\?^MKOA\(SK=&[5V=M_JA7&:-VKL[;_ %0KEJ[B)J***Q **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %0W'W#4U0W'W#0@.3UC[K5PUY_KC]:[G6/NM7#7
MG^N/UKNH[#-W0/OK7H]G_P >ZUYQH'WUKT>S_P"/=:QQ&XB>BBBN< HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH *K7O^H-6:K7O^H--;@<%K7WFKGX_];70:U]YJ
MY^/_ %M=\/A&=;HW:NSMO]4*XS1NU=G;?ZH5RU=Q$U%%%8@%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M:])? ,[[2/NK741?ZL5R^D?=6NHB_P!6*X*FXA]%%%9@%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 AZ&O._&W^J?Z5Z(>AKSOQM_JG^E '@6L_\?C?6NA\*?ZQ*Y[6?^/QOK70
M^%/]8E SW#P[_JTKL%^Z/I7'^'?]6E=@OW1]*!"T444 %%%% !1110 4444
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M_P >ZUYQH'WUKT>S_P"/=:QQ&XB>BBBN< HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH *K7O^H-6:K7O^H--;@<%K7WFKGX_];70:U]YJY^/_ %M=\/A&=;HW:NSM
MO]4*XS1NU=G;?ZH5RU=Q$U%%%8@%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 9NM_\>#?C
M7SYXW_UTGUKZ#UO_ (\&_&OGSQO_ *Z3ZT#1P5C_ ,?@^M>Q>#O^6=>.V/\
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M;B\#!6_U?Z5T>E>$5A93Y?Z5Z/\ 8(,YVBI4AC3HHH R],TU;91\M;%& **
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "J.J?\>Q
M^E7JHZI_Q['Z4X[@>8ZW_K6JEIO^M'UJ[K?^M:J6F_ZT?6O27P#.^TC[JUU$
M7^K%<OI'W5KJ(O\ 5BN"IN(?11168!1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M/L8Q5^LW1C_HH^E:5 @HHHH *3-+24 +1110 48HHH ,4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH *K7O^H-6:K7O^H--;@<%K7WFKGX_];70:U]YJY^/_ %M=
M\/A&=;HW:NSMO]4*XS1NU=G;?ZH5RU=Q$U%%%8@%%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M0W$>],5Q/B+2O-C<[:[LC-4;ZS6:$\4 ?-'B?1V1W.VN!GMVAD.17T;XD\/>
M:'PGZ5Y9K'A>0.Q"'\J!HX S[>*3S=]:]QX=G#_</Y5+;>')R1E#^5 %33K5
MII!Q7I'AK1"S(=M4]!\,OO7*?I7K?AW0A$JY6@#2T#3O(1>*Z]!A /:J\%JL
M2C JS0(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ JCJG_'L?I5ZJ.J?\>Q^E..X'F.M_ZUJI:;_K1]:NZW_K6JEIO^
MM'UKTE\ SOM(^ZM=1%_JQ7+Z1]U:ZB+_ %8K@J;B'T445F 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %(:6B@!*6BB@ I&^Z?I2TA^Z: ."\4@['KQ3Q$#
MYC5[WX@M#*C<5XWXGTUE9SB@9YE<_>-1QU8U"/RY#5..0 T#+%(:9YHI=X-
M"XS4D3;#FF"EH T(]1>(<-1)KDH'WC6:>:C:/- BVVN3[OO&K-MK\RL/G-9!
MM\TQH]E ST_P]XD<R("]>R^&M7$J)EJ^8=(NC%,O/>O8?">K$;!NH$SW".4.
M,BI*Q-*N_-C7FMH=!0(6BBB@ HHH- !124M !124HH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "H;C[AJ:H;C[AH0')ZQ]UJX:\_UQ^M=SK'W6
MKAKS_7'ZUW4=AF[H'WUKT>S_ ./=:\XT#[ZUZ/9_\>ZUCB-Q$]%%%<X!1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 56O?]0:LU6O?]0::W X+6OO-7/Q_P"MKH-:
M^\U<_'_K:[X?",ZW1NU=G;?ZH5QFC=J[.V_U0KEJ[B)J***Q **** "BBB@
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M^5=G4$]U%$IW,* //)?!43-_JQ^5.A\%Q*?]6/RKK)M6MU;&14EOJEN[#D4
M9-CX82$@A!^5=':6:VZC@5/'-'(H*L*DH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *HZI_Q['Z5>JCJG_'L
M?I3CN!YCK?\ K6JEIO\ K1]:NZW_ *UJI:;_ *T?6O27P#.^TC[JUU$7^K%<
MOI'W5KJ(O]6*X*FXA]%%%9@%%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 4;JT$RGBO./%>B[D<A:]5K&U;3EN4(QUH ^6=?TB1)6P
MIKF&LI5)X-?1.M>$?-9CL_2N0N?!A#']W^E [GD8M9<]#5F*RE/8UZ4O@X[O
M]7^E6D\(E5SL_2@+GF7V1U'(-0LI6N^U/0OLZ'Y:XK4(_*<B@"GFEJ-6R:EH
M *BE&:EJ&4T#)++B05Z/X8F963FO.;($R"O1?#,+%DXH$SVCP[,6C7FNQ3[@
MKC?#L16-<UV2?<% AU%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5#<?<-35#<?<-" Y/6/NM7#7G^N/UKN=8^ZU<->?
MZX_6NZCL,W= ^^M>CV?_ ![K7G&@??6O1[/_ (]UK'$;B)Z***YP"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ JM>_Z@U9JM>_Z@TUN!P6M?>:N?C_UM=!K7WFKG
MX_\ 6UWP^$9UNC=J[.V_U0KC-&[5V=M_JA7+5W$34445B 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110!FZW_QX-^-?/GC?_72?6OH/6_\ CP;\:^?/&_\ KI/K0-'!6/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH I7\OEQD^U><>)]4(1QNKOM:
M)$)^E>.^*I6R_- 'G7B*Z,TC\UR#1DR5OZHQ,C9K&_BH*$6+BFO#FK(Z4C4
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M<#<.E6)-8C!^\*!&Y169;:I%)P6%:"2HXRK"@!^**** "BBB@ HHHH ****
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M **** "BDI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J&X^X:
MFJ&X^X:$!R>L?=:N&O/]<?K7<ZQ]UJX:\_UQ^M=U'89NZ!]]:]'L_P#CW6O.
M- ^^M>CV?_'NM8XC<1/1117. 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %5KW_4
M&K-5KW_4&FMP."UK[S5S\?\ K:Z#6OO-7/Q_ZVN^'PC.MT;M79VW^J%<9HW:
MNSMO]4*Y:NXB:BBBL0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,W6_\ CP;\:^?/&_\
MKI/K7T'K?_'@WXU\^>-_]=)]:!HX*Q_X_!]:]B\'?\LZ\=L?^/P?6O8O!W_+
M.@&>R:;_ ,>HJY5/3?\ CU%7*!!1110 4444 %%%% !1110 4444 %%%% !5
M>\&;9JL5'.NZ(B@#R+Q?"QW\5X[K$++*W%?0_B+3/-C<[:\:\2Z88F<[: //
M9.&IR=*9>9CD(J%)N*"BT>E1@_-49FXIL3EI * -K3HV:1<5ZGX2@8,G%<+X
M>L#/(O%>R^&=(*(IVT"9WVB@BV&?2M2JEA'Y<('M5N@04444 %%%% !1110
M4444 &:*2E% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M' )I:KWDHB@))H S[_4UMU/S5Q.K^*UBW#?^M5?%6N>2' :O'M;\0/)(P#T
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M< HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH *K7O^H-6:K7O^H--;@<%K7WFKGX_]
M;70:U]YJY^/_ %M=\/A&=;HW:NSMO]4*XS1NU=G;?ZH5RU=Q$U%%%8@%%%%
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MP# HHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ JCJG_'L?I5ZJ.J?\>Q^E..X'F.M_ZUJI:;_K1]:NZW_K6JEIO^
MM'UKTE\ SOM(^ZM=1%_JQ7+Z1]U:ZB+_ %8K@J;B'T445F 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5#<?<-35#<?<-"
MY/6/NM7#7G^N/UKN=8^ZU<->?ZX_6NZCL,W= ^^M>CV?_'NM><:!]]:]'L_^
M/=:QQ&XB>BBBN< HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@@5FSZ8CG[HK5HH QX]*16SM%:,-ND2\*,U/10 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4UXU<8(%.HH I/8QL?NBGQV4:'.T5:HH 0*%& ,4M%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 449HH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU<->?ZX_6NZCL,W= ^^M>CV?_'NM><:!]]:]'L_^/=:QQ&XB>BBBN< HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M^ECZU[/X-_@KQC3O^/L?6O9O!O\ !0![)IO_ !ZK5RJ>F_\ 'J*N4""BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2E%%% !10:2@!:*** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *HZI_Q['Z5>JCJG_'L
M?I3CN!YCK?\ K6JEIO\ K1]:NZW_ *UJI:;_ *T?6O27P#.^TC[JUU$7^K%<
MOI'W5KJ(O]6*X*FXA]%%%9@%%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 AZ&O/O&?\ J7^E>@GH
M:\^\9_ZE_I0!\\^)CBX?ZU6\/S,+E>>]6?$__'P_UJGX?7_25^M SW_P7*66
M.O4HO]4OTKROP2/ECKU2+_5+]*!#Z*** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M#_6JOA__ (^5^M SWSP5]V.O4XO]4OTKRSP5]V.O4XO]4OTH$/HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@!" >HI B@]!3J* "BBB@ HH
MHH *;L4]A3J*   #I1110 4444 %%%% !24M&* "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "D8;E(I:* .?U31EN4;Y<UYWKGA498A/TKV0@$8-9
MM]IR3J?EH ^<-1\.,KG"5G+X?<M]RO>+WPTLK$[*I)X44-]S]* /,-*\,%G&
M4KT?0?#80*2GZ5O6/AY8B/DKI;2S2%1\M $%GIRP*.*TE&T8I:* "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BDS2T %%%% !1110 4444 %%%% !111
M0 4444 %0W'W#4U0W'W#0@.3UC[K5PUY_KC]:[G6/NM7#7G^N/UKNH[#-W0/
MOK7H]G_Q[K7G&@??6O1[/_CW6L<1N(GHHHKG **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "JU[_J#5FJU[_J#36X'!:U]YJY^/\ UM=!K7WFKGX_];7?#X1G6Z-V
MKL[;_5"N,T;M79VW^J%<M7<1-1116(!1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !24M% "4M%% #7;:N:Y_6-4$,+#=6S?/LMR:\L\5:H8]XW4 <WXHUU
MF9PK?K7GEQ+/=3'!)S5_4;IKFX(SGFMWP[HHNG4E<T <I]AN57=@U8T^^FM9
M@&)&#7JUSX71;,G8.GI7G&MZ=]DG; Q@T#/1_"FO;@@+5ZC8WPFB7FOF_P /
MZ@T,JC=WKV3PWJ)E1!F@1WP.1FEID1S$II] !1110 4444 <_P")?^/9OI7S
MWXR_US_6OHCQ''FS8^U?//C1<3O]:!HXO3O^/L?6O9O!O\%>,Z=_Q]CZU[3X
M,3.R@&>PZ;_QZBKE5K!=MJM6:!!1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 51U3_CV/TJ]5'5/^/8_2G'<#S'6_]:U4M-_UH^M7=;_UK52T
MW_6CZUZ2^ 9WVD?=6NHB_P!6*Y?2/NK741?ZL5P5-Q#Z***S **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH *K7O^H-6:K7O^H--;@<%K7WFKGX_];70:U]YJY^/_ %M=\/A&
M=;HW:NSMO]4*XS1NU=G;?ZH5RU=Q$U%%%8@%%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110!0U9MMDQKP[QA<$2.,U[?K1Q8-7S_XSD(G>@#E+
M9?.NQ]:]:\'V(PAQ7DVDG==CZU[;X/4>6E SJKNT7[&1CM7C_BZR D<XKV^[
MQ]E/TKR/Q@HR] CSBS;RKH?6O6?"%P3LYKR('%W^->H>#F/R&@9[);RJ+=23
MVH:]@7JU8%S?^19YST%<#J_BXV\K#S,?C0(];_M"W_OTOV^W_OUXA'XW)/\
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M7C?_  F7_33]:/\ A,O^FGZT >R?;H/[]'VZ#^_7C?\ PF7_ $T_6C_A,O\
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M2B/^^/SIP\3(?XQ^=>%CQ#./XC4B^)9!U<T >X_\)(G]\4A\2H/XQ^=>)?\
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M\: L>Y?\)1'_ '_UH_X2B/\ O_K7AO\ PD,_]XT?\)#/_>- 6/<O^$HC_O\
MZT?\)1'_ '_UKPW_ (2&?^\:/^$AG_O&@+'N7_"41_W_ -:/^$HC_O\ ZUX;
M_P )#/\ WC1_PD,_]XT!8]R_X2B/^_\ K1_PE$?]_P#6O#?^$AG_ +QH_P"$
MAG_O&@+'N7_"41_W_P!:/^$HC_O_ *UX;_PD,_\ >-'_  D,_P#>- 6/<O\
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M_A*(_P"_^M>&_P#"0S_WC1_PD,_]XT!8]R_X2B/^_P#K1_PE$?\ ?_6O#?\
MA(9_[QH_X2&?^\: L>Y?\)1'_?\ UH_X2B/^_P#K7AO_  D,_P#>-'_"0S_W
MC0%CW+_A*(_[_P"M'_"41_W_ -:\-_X2&?\ O&C_ (2&?^\: L>Y?\)1'_?_
M %H_X2B/^_\ K7AO_"0S_P!XT?\ "0S_ -XT!8]R_P"$HC_O_K1_PE$?]_\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_E1_PA\G_/,_E0!P_P!KN/4T?:[CU-=Q_P (?)_SS/Y4?\(?)_SS/Y4 </\
M:[CU-'VNX]37<?\ "'R?\\S^5'_"'R?\\S^5 '#_ &NX]31]KN/4UW'_  A\
MG_/,_E1_PA\G_/,_E0!P_P!KN/4T?:[CU-=Q_P (?)_SS/Y4?\(?)_SS/Y4
M</\ :[CU-'VNX]37<?\ "'R?\\S^5'_"'R?\\S^5 '#_ &NX]31]KN/4UW'_
M  A\G_/,_E1_PA\G_/,_E0!P_P!KN/4T?:[CU-=Q_P (?)_SS/Y4?\(?)_SS
M/Y4 </\ :[CU-'VNX]37<?\ "'R?\\S^5'_"'R?\\S^5 '#_ &NX]31]KN/4
MUW'_  A\G_/,_E1_PA\G_/,_E0!P_P!KN/4T?:[CU-=Q_P (?)_SS/Y4?\(?
M)_SS/Y4 </\ :[CU-'VNX]37<?\ "'R?\\S^5'_"'R?\\S^5 '#_ &NX]31]
MKN/4UW'_  A\G_/,_E1_PA\G_/,_E0!P_P!KN/4T?:[CU-=Q_P (?)_SS/Y4
M?\(?)_SS/Y4 </\ :[CU-'VNX]37<?\ "'R?\\S^5'_"'R?\\S^5 '#_ &NX
M]31]KN/4UW'_  A\G_/,_E1_PA\G_/,_E0!P_P!KN/4T?:[CU-=Q_P (?)_S
MS/Y4?\(?)_SS/Y4 </\ :[CU-'VNX]37<?\ "'R?\\S^5'_"'R?\\S^5 '#_
M &NX]31]KN/4UW'_  A\G_/,_E1_PA\G_/,_E0!P_P!KN/4T?:[CU-=Q_P (
M?)_SS/Y4?\(?)_SS/Y4 </\ :[CU-'VNX]37<?\ "'R?\\S^5'_"'R?\\S^5
M '#_ &NX]31]KN/4UW'_  A\G_/,_E1_PA\G_/,_E0!P_P!KN/4T?:[CU-=Q
M_P (?)_SS/Y4?\(?)_SS/Y4 </\ :[CU-'VNX]37<?\ "'R?\\S^5'_"'R?\
M\S^5 '#_ &NX]31]KN/4UW'_  A\G_/,_E1_PA\G_/,_E0!P_P!KN/4T?:[C
MU-=Q_P (?)_SS/Y4?\(?)_SS/Y4 </\ :[CU-'VNX]37<?\ "'R?\\S^5'_"
M'R?\\S^5 '#_ &NX]Z/M=QZFNY_X0]_^>9_*FOX0<+GRS^5 '#F^G'<TG]I2
MC^(UT5]X=>%2=GZ5R][;&%R,4 3?VE*?XC2_;IST)J&RMC,X&*ZRP\-/.@.S
M]* .:^UW'J:/M=QZFNX'@^3'^K/Y4?\ "'O_ ,\S^5 '#_:[CU-'VNX]37<?
M\(?)_P \S^5'_"'O_P \S^5 '#_:[CU-'VNX]37<?\(?)_SS/Y4?\(?)_P \
MS^5 '#?:[CU-'VNX]37<_P#"'O\ \\S^5'_"'O\ \\S^5 '#_:[CU-'VNX]3
M7<?\(?)_SS/Y4?\ "'R?\\S^5 '#_:[CU-'VNX]37<?\(?)_SS/Y4?\ "'R?
M\\S^5 '#_:[CU-'VNX]37<?\(?)_SS/Y4?\ "'R?\\S^5 '#_:[CU-'VNX]3
M7<?\(?)_SS/Y4?\ "'R?\\S^5 '#_:[CU-'VNX]37<?\(?)_SS/Y4?\ "'R?
M\\S^5 '#_:[CU-'VNX]37<?\(?)_SS/Y4?\ "'R?\\S^5 '#_:[CU-'VNX]3
M7<?\(?)_SS/Y4?\ "'R?\\S^5 '#_:[CU-'VNX]37<?\(?)_SS/Y4?\ "'R?
M\\S^5 '#_:[CU-'VNX]37<?\(?)_SS/Y4?\ "'R?\\S^5 '#_:[CU-'VNX]3
M7<?\(?)_SS/Y4?\ "'R?\\S^5 '#_:[CU-'VNX]37<?\(?)_SS/Y4?\ "'R?
M\\S^5 '#_:[CU-'VNX]37<?\(?)_SS/Y4?\ "'R?\\S^5 '#?:Y_4TV2[N-O
M4UW?_"'R?\\S^5-?P<Y'^K/Y4 <%;7=QYXY/6O6O!$TC,F[-<_!X-=90?+/Y
M5Z%X7T-K5ERN* /2[#_CT3Z59J&U79;J*FH$%%%% !1110 4444 %%%% !11
M10 4444 %4=4_P"/8_2KU4=4_P"/8_2G'<#S'6_]:U4M-_UH^M7=;_UK52TW
M_6CZUZ2^ 9WVD?=6NHB_U8KE](^ZM=1%_JQ7!4W$/HHHK, HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH *P?$/^I;Z5O5AZ^N86^E 'B?B<?O'KE[
M#_CZ'UKK?%"89ZX^S?%V/K0![+X0^XE=M>G_ $0_2N)\&$-&E=SJ"@69^E '
MC/C,\O7GMC_Q_#ZUW_C)OG<5P=BF;T?6@9[9X/YM5^E,\96TDEJVW/2I?!BY
MA0>U=-J^FBX@(VYXH$?+NK:7<-=MP>M10:3/M^Z:]KO/"2R3$^7^E,3PBH'^
MK_2@=SQ[^R9_[II/[)FS]TU[+_PB8_YY_I1_PB8_YY_I0%SQO^R9O[IIPTF4
M]5->Q?\ ")#_ )Y_I1_PB8_YY_I0!Y&FBNW\-68] =OX/TKU5/"P!_U?Z5?@
M\, 8RGZ4!<\D3PU*1PA_*I/^$8F_N'\J]J@\-H!R@_*K0\-Q8^X/RH"YX5_P
MC$W]PTO_  C$W]T_E7NA\-Q?W!^5)_PC<?\ <'Y4"/"_^$8F_N'\J/\ A&)O
M[AKW3_A&X_[@_*C_ (1N/^X/RH \,_X1B;^Z?RH_X1B;^Z?RKW/_ (1N/^X/
MRH_X1N/^X/RH \,_X1B;^Z?RH_X1B;^Z?RKW/_A&X_[@_*C_ (1N/^X/RH \
M,_X1B;^Z?RH_X1B;^Z?RKW/_ (1N/^X/RH_X1N/^X/RH \,_X1B;^Z?RH_X1
MB;^Z?RKW/_A&X_[@_*C_ (1N/^X/RH \,_X1B;^Z?RH_X1B;^Z:]S_X1N/\
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MNG_"-Q_W!^5'_"-Q?W!^5 [GA?\ PC$W]PTO_",3?W3^5>Y_\(W'_<'Y4?\
M"-Q_W!^5 KGAG_",3?W3^5'_  C$W]T_E7N?_"-Q_P!P?E1_PC<?]P?E0!X9
M_P (Q-_=/Y4?\(Q-_=/Y5[G_ ,(W'_<'Y4?\(W'_ '!^5 'AG_",3?W3^5'_
M  C$W]T_E7N?_"-Q_P!P?E1_PC<?]P?E0!X9_P (Q-_=/Y4?\(Q-_=/Y5[G_
M ,(W'_<'Y4?\(W'_ '!^5 'AG_",3?W3^5'_  C$W]T_E7N?_"-Q_P!P?E1_
MPC<?]P?E0!X9_P (Q-_=/Y4?\(Q-_=/Y5[G_ ,(W'_<'Y4?\(W'_ '!^5 'A
MG_",3?W3^5'_  C$W]T_E7N?_"-Q_P!P?E1_PC<?]P?E0!X9_P (Q-_=/Y4?
M\(Q-_=/Y5[G_ ,(W'_<'Y4?\(W'_ '!^5 'AG_",3?W3^5'_  C$W]T_E7N?
M_"-Q_P!P?E1_PC<?]P?E0!X9_P (Q-_=/Y4?\(Q-_=/Y5[G_ ,(W'_<'Y4?\
M(W'_ '!^5 'AG_",3?W3^5'_  C$W]T_E7N?_"-Q_P!P?E1_PC<?]P?E0!X9
M_P (Q-_=/Y4?\(Q-_=/Y5[G_ ,(W'_<'Y4?\(W'_ '!^5 'AG_",3?W3^5'_
M  C$W]T_E7N?_"-Q_P!P?E1_PC<?]P?E0!X9_P (Q-_=/Y4?\(Q-_=/Y5[G_
M ,(W'_<'Y4?\(W'_ '!^5 'AG_",3?W3^5'_  C$W]T_E7N?_"-Q_P!P?E1_
MPC<?]P?E0!X9_P (Q-_=/Y4?\(Q-_=/Y5[G_ ,(W'_<'Y4?\(W'_ '!^5 'A
MG_",3?W3^5'_  C$W]T_E7N?_"-Q_P!P?E1_PC<?]P?E0!X9_P (Q-_=/Y4?
M\(Q-_=/Y5[G_ ,(W'_<'Y4?\(W'_ '!^5 'AG_",3?W3^5'_  C$W]T_E7N?
M_"-Q_P!P?E1_PC<?]P?E0!X9_P (Q-_=/Y4?\(Q-_=/Y5[G_ ,(W'_<'Y4?\
M(W'_ '!^5 'AG_",3?W3^5'_  C$W]T_E7N?_"-Q_P!P?E1_PC<?]P?E0!X9
M_P (Q-_=/Y4?\(Q-_=/Y5[G_ ,(W'_<'Y4?\(W'_ '!^5 'AG_",3?W3^5'_
M  C$W]T_E7N?_"-Q_P!P?E1_PC<?]P?E0!X9_P (Q-_=/Y4?\(Q-_=/Y5[G_
M ,(W'_<'Y4?\(W'_ '!^5 'AG_",3?W3^5'_  C$W]T_E7N?_"-Q_P!P?E1_
MPC<?]P?E0!X9_P (Q-_=/Y4?\(Q-_=/Y5[G_ ,(W'_<'Y4?\(W'_ '!^5 'A
MG_",3?W3^5'_  C$W]T_E7N?_"-Q_P!P?E1_PC<?]P?E0!X9_P (Q-_=/Y4?
M\(Q-_=/Y5[G_ ,(W'_<'Y4?\(W'_ '!^5 'AG_",3?W3^5'_  C$W]T_E7N?
M_"-Q_P!P?E1_PC<?]P?E0!X9_P (Q-_=/Y4?\(Q-_=/Y5[G_ ,(W'_<'Y4?\
M(W'_ '!^5 'AG_",3?W3^5'_  C$W]T_E7N?_"-Q_P!P?E1_PC<?]P?E0!X9
M_P (Q-_=/Y4?\(Q-_=/Y5[G_ ,(W'_<'Y4?\(W'_ '!^5 'A?_",3?W#3O\
MA%YO[A_*O<O^$;B_N#\J>/#<6/N#\J!W/!9/#4RC[IK*O=)EA!X-?0=WX=C5
M3\@_*N%\1Z0D2-A:!7/&95D1\<U=L;22<CK5F_MU6X(QWKH_#5BLLB\4#*=O
MX>ED4'::LCPQ,?X3^5>MZ5H$;Q*=@_*ME?#<6/N#\J!'A9\,3?W3^5'_  C$
MW]T_E7NA\-Q?W!^5)_PC<?\ <'Y4 >&?\(Q-_=/Y4?\ ",3?W3^5>Y_\(W'_
M '!^5'_"-Q_W!^5 'AG_  C$W]T_E1_PC$W]T_E7N?\ PC<?]P?E1_PC<?\
M<'Y4 >&?\(Q-_=/Y4?\ ",3?W3^5>Y_\(W'_ '!^5'_"-Q_W!^5 'AG_  C$
MW]T_E1_PC$W]T_E7N?\ PC<?]P?E1_PC<?\ <'Y4 >&?\(Q-_=/Y4?\ ",3?
MW3^5>Y_\(W'_ '!^5'_"-Q_W!^5 'AG_  C$W]T_E1_PC$W]T_E7N?\ PC<?
M]P?E1_PC<?\ <'Y4 >&?\(Q-_=/Y4?\ ",3?W3^5>Y_\(W'_ '!^5'_"-Q_W
M!^5 'AG_  C$W]T_E1_PC$W]T_E7N?\ PC<?]P?E1_PC<?\ <'Y4 >&?\(Q-
M_=/Y4?\ ",3?W3^5>Y_\(W'_ '!^5'_"-Q_W!^5 'AG_  C$W]T_E1_PC$W]
MT_E7N?\ PC<?]P?E1_PC<?\ <'Y4 >&?\(Q-_=/Y4?\ ",3?W3^5>Y_\(W'_
M '!^5'_"-Q_W!^5 'AG_  C$W]T_E1_PC$W]T_E7N?\ PC<?]P?E1_PC<?\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M8%MZ#\JUJ* ,G^P+;T'Y4?V!;>@_*M:B@#)_L"V]!^5']@6WH/RK6HH R?[
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M'Y4?V!;>@_*M:B@#)_L"V]!^5']@6WH/RK6HH R?[ MO0?E1_8%MZ#\JUJ*
M,G^P+;T'Y4?V!;>@_*M:B@#)_L"V]!^5']@6WH/RK6HH R?[ MO0?E1_8%MZ
M#\JUJ* ,G^P+;T'Y4?V!;>@_*M:B@#)_L"V]!^5']@6WH/RK6HH R?[ MO0?
ME1_8%MZ#\JUJ* ,G^P+;T'Y4?V!;>@_*M:B@#)_L"V]!^5']@6WH/RK6HH R
M?[!MO0?E4<V@6YC.%&?I6U37;:A- 'F7B/18XXWPHZ5XSX@MA'<, .]>^>)Y
M08G^E>%>)#FY;ZT 1>';827"@CO7N/AK0XI($)4=*\6\,'%RGUKZ \*RC[.G
MTH&:@T"W Y _*E_L&V]!^5:U% C(_L"V]!^5']@6_H/RK7HH R?[ MO0?E1_
M8%MZ#\JUJ* ,C^P+;T'Y4?V!;>@_*M>B@#)_L"V]!^5']@6WH/RK6HH R?[
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M44 %%%% !1110 4444 %%%% !1110 51U3_CV/TJ]5'5/^/8_2G'<#S'6_\
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M ,\I:/*6GT4 ,\I:/*6GT4 ,\I:/*6GT4 ,\I:/*7TI]% #/*7TH\I?2GT4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5[GJ'_'F_P!*\+\<']Y)0!Y@/^/O\:]-\(?>2O, ?],_&O3O!_5*!GMVB_\
M'J/I6G69HO\ QZCZ5IT""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** *=]_JS]*\R\6_P"J>O3;_P#U9^E>
M8^+C^Z>@#QG4_P#C[/UKKO!_^M3ZUQVID_:S]:Z_P>?WJ?6@9[IHG^H7Z5OC
MH*Y_0_\ 4+]*Z =!0(6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHS10 4449H **** "BBB@ HHHH **** "H;C[AJ:H;C[AH0')ZQ]UJX:\_U
MQ^M=SK'W6KAKS_7'ZUW4=AF[H'WUKT>S_P"/=:\XT#[ZUZ/9_P#'NM8XC<1/
M1117. 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %5KW_ %!JS5:]_P!0::W X+6O
MO-7/Q_ZVN@UK[S5S\?\ K:[X?",ZW1NU=G;?ZH5QFC=J[.V_U0KEJ[B)J***
MQ **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****  TE+10 4444 1O"C_
M 'A5=],MGZH*N44 4/['M1_ /RJ5-/MX_NI5JB@!JQJGW13J*3O0 M)2T4 %
M%%% !1110 444E "T4@I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH I7_ /JVKRGQD^$>O5KX9C->8>+K5I$? H&>$ZS+
MBX;ZU?\ #4N9U^M&KZ3(UPWRGK5[P[I4B3+E3UH ]K\(-E$KTB/_ %:_2O//
M"ENT:)D5Z''_ *M?I0(=1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %17'^J-2U%.,Q&@#@?$[8B?Z5X9XDEQ<-]
M:]W\20%XGP*\4\0Z7(\[84]: *OAB7-ROUKZ \*G-NGTKPSPWIDB7*DJ>M>[
M^&(2D" ^E V=>OW12TU?NBG4""BBB@ HHHH 2BEHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *HZI_Q['Z5>JCJG_'L?I3CN!YC
MK?\ K6JEIO\ K1]:NZW_ *UJI:;_ *T?6O27P#.^TC[JUU$7^K%<OI'W5KJ(
MO]6*X*FXA]%%%9@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4$9ZT44 1M!&W5:;]EB'\-344 ,6-%Z"GT44 %%%!H **2EH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@"KJ'_'F_P!*\-\;J2[U[I>+NMF%>2^*]*:=WPM 'B@0_;.G>O3?" .Y
M*YW_ (1V3[3G8>M=[X:TIX2F5H ]2T7_ (]1]*TZH:4FRW ]JOT %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 4[[_ %9^E>:>+$)C>O3KM=R&N'\0V!F1L"@#P/4X";L\=ZZ[PA$1*G'>
MI+[P\[7!.SO70^'-&:%URM STK1!B!?I6^.@K)TN'RXE%:XZ4""BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@!*4444 !I*6B@ HHHH **** "BBB@
M HHHH *AN/N&IJAN/N&A <GK'W6KAKS_ %Q^M=SK'W6KAKS_ %Q^M=U'89NZ
M!]]:]'L_^/=:\XT#[ZUZ/9_\>ZUCB-Q$]%%%<X!1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 56O?]0:LU6O?]0::W X+6OO-7/Q_ZVN@UK[S5S\?^MKOA\(SK=&[
M5V=M_JA7&:-VKL[;_5"N6KN(FHHHK$ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBDS0 M%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** &NNX5GW.G"<'BM*B@#
MF)/#2NV=E6K70E@(^7%;M% $,4/EJ!4U%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M E+28I: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *AN/N&IJA
MN/N&A <GK'W6KAKS_7'ZUW.L?=:N&O/]<?K7=1V&;N@??6O1[/\ X]UKSC0/
MOK7H]G_Q[K6.(W$3T445S@%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5:]_U!JS
M5:]_U!IK<#@M:^\U<_'_ *VN@UK[S5S\?^MKOA\(SK=&[5V=M_JA7&:-VKL[
M;_5"N6KN(FHHHK$ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6B@!*6
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ I*6B@ HHHH **** "BFNX1<F
MLJ^UF.W0_,!0!H7%RL(Y-9,^M)&3\U<AJ_BQ%W /^M<;>^+-S'#_ *T >JMX
MD0'[X_.I(O$*.?OC\Z\1D\3N3]_]:EM_%3*>7_6@#WJWU1)<?,*TD<.N0:\6
MTOQ:"1E_UKN])\1I*%^<4 =A156"]28#!%6@<C- !1110 4444 &:,T44 %%
M%% !1FBB@ I*6B@ HHHH **** "BBB@ HJI<WJP DD5E2>(HU;;N% '0=*3-
M9-MJBW!X:M*,[AF@"6BBB@ HHHH **** "BBDH 6BBB@ HHHH **** $)Q5:
M:Y$8Y-32MA37,:U?^2C<T :;:LJMC=4\.H+)_%7E5UXBV3$;^_K6WHFL^>P^
M:@#TA'W"GU0LI=\8-7Z "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH ***2@!:*!10 9HI*6@ HHHH *
M*** "H9)@@ZU*W"FL;4;GRT;F@":74EC/WJ8FK*QQNK@=7UWR7(W5GV/B+S)
M@-_?UH ]<AN!(.M6 <BN8T:^\Y%YKI(CE: )*CDDV"I*S-0F\M3S0 Z;4%C_
M (JKC5T+8W5QNLZSY);YJYZ+Q)F;&_OZT >P078EQS5RN*T'4OM 7FNSC.8U
M/M0 ZF2RK&N2:KW=ZMNI)-<?K'BA(MPW_K0!T5SJZ19^85GOXC0'[_ZUYIJ/
MBS<QP_ZUB/XE=F^_^M 'LJ^)$)^_^M7[?64EQ\PKPE?$KJWWZUK#Q;M89?\
M6@#W6&X64<$5-7G.D>*4EVC?^M=G8ZDMPHYS0!IT4BMN&:6@ HJ.658ER:P]
M2U^.W4C<!0!J7-ZD(/S"LJ;7D0D;_P!:X?5O%R@L _ZUR5UXJ+,</^M 'KA\
M2)G[X_.K,.O))_'7AA\3/G[_ .M7+3Q8589?]: />K>_27'S5=!!&17DFD^+
M%8KE_P!:[G3-=291\PH Z.BH8KA9!D5-0 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M4=4_X]C]*O51U3_CV/TIQW \QUO_ %K52TW_ %H^M7=;_P!:U4M-_P!:/K7I
M+X!G?:1]U:ZB+_5BN7TC[JUU$7^K%<%3<0^BBBLP"BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\6C<,O\ K0![4CAUR#3JXW2?$R2A1O'YUT]O>I.!@B@"W1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5#<?<-35#<?<-" Y/6/NM7#7G^N/UKN=8^
MZU<->?ZX_6NZCL,W= ^^M>CV?_'NM><:!]]:]'L_^/=:QQ&XB>BBBN< HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH *K7O^H-6:K7O^H--;@<%K7WFKGX_P#6UT&M
M?>:N?C_UM=\/A&=;HW:NSMO]4*XS1NU=G;?ZH5RU=Q$U%%%8@%%%% !1110
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M>(Y(I5!?O7KWA?7_ #@@+5X/+I-Q;7/"GK7?>$7GC= <T ?0=C<"6,'-7"P
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M>8ZW_K6JEIO^M'UJ[K?^M:J6F_ZT?6O27P#.^TC[JUU$7^K%<OI'W5KJ(O\
M5BN"IN(?11168!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MN6KN(FHHHK$ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]8E<;J8_TP_6NR\&_P"L2@9[=HW^I7Z5NCI6%HW^I7Z5NCI0(**** "BBB@
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MASN[5PVBZ3*@4X-;MVCP6YSGI0(IZOXB\@GY_P!:P4\9[9,>9^M<UXHOG4L
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M-S_K75Z=X@MY\984 <Y9>#/)E!$?Z5WVBZ<;1!QC%6[.:VF QBM0(JH=H[4
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ JM>_Z@U9JM>_Z@TUN!P6M?>:N?C_UM=!K7WFKGX_];7?#X1G6
MZ-VKL[;_ %0KC-&[5V=M_JA7+5W$34445B 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH 1CA2:\R\;7QC1\&O2;@XA8UY#XZ?*R4
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ JCJG_'L?I5ZJ.J?\>Q^E..X'F.M_ZUJI:;_K1]:NZW_K
M6JEIO^M'UKTE\ SOM(^ZM=1%_JQ7+Z1]U:ZB+_5BN"IN(?11168!1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M5:\_U)JS5>[&8C0!YMXJ/[MZ\4ULYNF^M>X^*8"8GXKQ'7H]ERWUH!&GX5'[
M]*]X\-C]PGTKP'PQ.$N%Y[U[OX9N T*<]J 9V:?=%.IL9R@-.H ***J7-ZD
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MK7G&@??6O1[/_CW6L<1N(GHHHKG **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M'\.W01U!KUS0KF)HUSB@1GMX<PO*U0F\-QD\J*[>[O(8XLY%<EJ&O11.1D4
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M#+=C [U[7X)M&*IQ0#.OOH#+:'CM7D/BW3R'<XKWIK+=#MQVKSKQAI'RN0M
MCQ2T/D78SQS7L'@S5E54!:O(]5MWMK@D#&#6IH.N/;.H+8Q0,^H[&]CGB7YA
MG%7<CUKR'0_%GRJ"_P"M=2OB=2N=_P"M CK[FX2&,DD9KAM?U];=6P_ZU3U?
MQ4!&</\ K7EGB7Q&\NX!OUH WKKQD1.0)._K6_H/B1[AU^?/XUX.EU/<774]
M:]2\%VDSLA(- SV_3+DRQJ2:V%Z5BZ3;F.%,^E;2]*!"T444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 5#<?<-35#<?<-" Y/6/NM7#7G^N/UKN=8^ZU<->?
MZX_6NZCL,W= ^^M>CV?_ ![K7G&@??6O1[/_ (]UK'$;B)Z***YP"BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,'(2O'=9\/O!,Q"=Z^IM0TY;A#QFN USPNLFXA* /#+.::S;'(Q71V?B&1
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M9*F^,BN*U_1A<*_RYKN*@EMDE!!H ^=/$'AED=F"5QTMG+:2< C%?2VL>'TF
M5OEKSK6/"HW,0E SS^RU:6  %C6G_P )#)LQN-%UX<DC8X0U4_L2;.-IH J7
MVK2SY 8\UC_8I;R49!.:ZJ#PY([C*&NLT;PGEE)2@#G/#7AAC(C%/TKVWPQI
M"V\:Y7I46C^'4@53LKJ[> 0)@"@0YH4*$8[5Y]XKT8SJ^%KT:J5Y8)<(<C-
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_MQ?[U<)]JD]31]JD]31[% =W_;B_P!ZC^W%_O5PGVJ3U-'VJ3U-'L4!W?\
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M_MQ?[U<)]JD]31]JD]31[% =W_;B_P!ZC^W%_O5PGVJ3U-'VJ3U-'L4!W?\
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M?VXO]ZN$^U2>IH^U2>IH]B@.[_MQ?[U']N+_ 'JX3[5)ZFC[5)ZFCV* [O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MS#TI/LWM5NBB[ J?9O:C[-[5;HHNP*GV;VH^S>U6Z*+L"I]F]J/LWM5NBB[
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M, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
9HH **** "BBB@ HHHH **** "BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>img17388848_10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img17388848_10.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" <_&"\# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4QNM/IC=: )K?[
MPKJM%^^M<K;_ 'A75:+]]:RJ[%(],T/[JUTO:N:T/[JUTO:O(J?$,****@ H
MHHH **** "BBB@ KC_%/W&KL*X_Q3_JVK6E\0'C>L_Z]OK6;%6EK/^O;ZUG0
MU[,?A))A2T44Q!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %,;K3ZC;K0!/;_>%
M=5HOWUKE(/O"NKT7[ZUE5V*1Z9H?W5KI>U<UH?W5KI>U>14^(84445 !1110
M 4444 )2BBB@ KC_ !3_ *MJ["N/\4_ZMJUI?$!XWK/^O;ZUG0UHZS_KV^M9
MT->S'X22>BBBF(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IC=:?3&ZT 36_WA
M75:+]]:Y6W^\*ZK1?OK6578I'IFA_=6NE[5S6A_=6NE[5Y%3XAA1114 %%%%
M !1110 4444 %<?XI_U;5V%<?XI_U;5K2^(#QO6?]>WUK.AK1UG_ %[?6LZ&
MO9C\))/2TE+3$)1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 44A-(7Q0 ZBH_,%'F"@"2
MBH_,%'F"@"2BF>8*4-F@!U% -% !12$XIN^@!]%-#YI<T +1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%)FC- "T44
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !111F@ HII;%)Y@H ?130
MV:=0 4444 %%%% !1110 4444 %%%% !1110 4449H **:6Q3?,% $E%,#YI
MP.: %HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH *8W6GTQNM $UO]X5U6B_?6
MN5M_O"NJT7[ZUE5V*1Z9H?W5KI>U<UH?W5KI>U>14^(84445 !1110 4444
M%%%% !7'^*?]6U=A7'^*?]6U:TOB \;UG_7M]:SH:T=9_P!>WUK.AKV8_"23
MT444Q!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#NCSMK.511&<+]G9>HI=I%=5?Z3Y(/RUS]Q%L8TXS4@*M%-8X- -6(=1110
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M[&NFT_2C-CY:W8_#F4SLK*59(9Y[]F=>HHVE:[.^T,Q G;7,WEN8F/%5&HI
M4\T4S=S3QTJQ!1110 449HS0 449HH ****!A1110(**,T9H **3-+F@8G>E
MHHH$%%%% !11FC- !11FB@ HHHH **3-+F@84444""BBBF 4444@"BBB@!:0
MT9HH .]%%% PHHHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!3&ZT^F-UH FM_O"NJT7[ZURMO\ >%=5HOWUK*KL4CTS0_NK72]JYK0_NK72
M]J\BI\0PHHHJ "BBB@ HHHH **** "N/\4_ZMJ["N/\ %/\ JVK6E\0'C>L_
MZ]OK6=#6CK/^O;ZUG0U[,?A))Z***8@HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "EI** "BBB@ IK' IU,
M;F@ 0[FQ6QI^G&=AQ6=90%Y1Q7HGAW3 VTE:RJSY4%B32- R%)6NNM-+2%1D
M"M"SLTAA!P*K7]\D"D BO-E4<V4AQ,47I2BYA/&17':AKNUCAJSHO$!,GWJI
M46U<#T81Q3+VK-O]&2520M9VFZT'QEJZ>WNHYHQDBLVI08'FFL:#Y>3MKBKZ
MV\ECQ7M.MQ1M&Q&*\MUR$>8V*[</4;W!G*%CFG!C5R.R+MTJQ_9K!<XKLYD2
M9P)IPJS):E.U5V&VB]QBU&Q-.!R:F2 OVHV$4BYS4\"F0XJT-.9CTK5T[2F+
MC*U+FD@':9I9E8?+760:'B'.VKVB:4 5RM=>+!1!T[5PU:^I5CR36K+R5;BN
M,G8B4BO6_$>G95L"O,M0L624\5TT)IH3*<9R*<:9C92J=QK<0A)IA8U?AM#)
MVJZFCLP^[2YD@,/<U.#&MPZ*X'W:KRZ:T?\ #1SIC,W/% ZU)+&4J!6^:J$:
M=FN7%=WH%N'*Y%<+8_?%>B>&QRM<M=Z#.I-BGV?..U<-XCMPF[ KTHK_ *-^
M%>>^*.K5R4&^89YS<\2&JS$U:N>931%:F3M7IIZ$E/<:7)Q6JNF,1G%,DL"@
MZ4<R&5;7_6BN^\/[<+FN%BCV2"NNT68J%K&MJ@1VTH3R/PKC-:V[FQ7027)\
MFN5U64DM7/25F,YJ[^\:H$G-:$PWL:2.R+]J[D[$E($TN35]K!E'2F+:$G&*
M.9 42QI-QK9CTIG_ (:D;1G SMHYT,Q 33P:O2V#1]JJM&5/2G=,0VBD)Q2;
MJ %)IC,:E52QJW%8M)VHND!F;FH#&MY=%=A]VFR:.R#[M3SH9C FGBK,MJ8^
MU5CQ57$+129I: "D;I2TC=* (E/SUTNC1AG6N97[]=7H0^=:BIL,]"T>S5D7
MBNA2Q0+T%9NAK\BUNSMLBS7DU&[E&=-%&G856W19QQ6;JVJ>23S7.G7_ -YC
M=6D*;:$=W''$_I2RZ8DJG %<O9:Z"1\U=3IVH+, ,U,HRB,YS5-"!1B%K@]6
MTXPLW%>X7%NDMN3BO._$MB!NP*VH57>S$SR^4;6(IN3BKMW;XE/%,2V+=J]&
MZL25-QHR:TAI[$9Q338L#C%+F0&<6-*&-:L>F,_\-.?2V09VT<R RP:4U-+"
M8^U09R<4P&L33"QJ[%;&3M5V/26;^&DY)#,3<U.#&M[^Q'Q]VJ\NF-'_  T<
MZ S 33Q3Y(C&>E19IB'44F:,T (:C9C5J.(N>E6X],:0?=I<R0&,&;=6K89+
M"K(T5P<[:MVNGM&XXJ9330'6>'[</MR*[![%/L^<=JYOP]'M917:2#_1?PKS
M:K?,4CS#Q) $+8%<'/Q(:]$\4_>>O/Y8]TIKNH/W1,JEC0&-7X[(N.E/.GLH
MSBMN9"**FG5))%Y=1 Y.*8"$TPDU:2$O5A=/9ATHYDAF<":>*N/8E>U5Y$V4
M7N(8::::7YJ1%+F@"(DTW<:TXK!I.U6ET9F'W:3FD!A!FIX)K:?1G4?=JI-8
MM'VH4TQE+-*!NIK@JU6;6/S&%-B+5A9F5QQ78V&A%XP=M5]!T[>ZY%>EZ=IJ
MK ,CM7#7K6&CS74]*\A#\M<3?@I(17M6OZ<#$V!7E>L:>5F;BM,/4YMP9GZ8
M<R#->A:.%V#-<!91F.05V6ES%5%56U!'27(3RNU<;K 7YJZ&>X)CKEM4D+9K
M*DM1LY:Y^_3%Z4ZY/SFHXSFNU;$CB33"QJW%;F3M5R/2V?\ AI<R0S'W&E#&
MM[^Q'Q]VH9=*9/X:.= 90)IPJ:6 Q]J@)Q3 =36- ;FIXX3)VH$5<FER:T?L
M#$9Q4;69!Z4<R HDFD+&M..P9^U6%T=F'W:7,@,3<:<":UWTEE'W:J26AC[4
M<R8%84M##;29I@+1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;MY/2N5U6,J6KTZ:P M^G:N#U^WV,W%<]&=V,Y%$W2XKIM+TP2J.*P8$_?\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M#-ZTU8^:/F[UWFA7_F!<FO'+.5O-'->B^&I6)6KKTTD)'H5SMDMC]*\N\51
M,QKTLL3;?A7G7BO^*N;#Z2&S@$F\J?\ &NFTW6?*4<UR4J,TYQZUKV%E+)C
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M.3\3W@&X UYO=W.^0\UU'B6Z+,W-<.[DR&N^A"T1,D/-**1>E.K<0N*2EI*
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "F-UI],;
MK0!-;_>%=5HOWUKE;?[PKJM%^^M95=BD>F:']U:Z7M7-:']U:Z7M7D5/B&%%
M%%0 4444 %%%% !1110 5Q_BG_5M785Q_BG_ %;5K2^(#QO6?]>WUK.AK1UG
M_7M]:SH:]F/PDD]%%%,04444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 1O5BS^^*KO5BS.'%#V
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MW>M3Q'>$1L :\]:Z9KKKWHHT[JX-GI^D7OF8YKHS)^YS7"^'9"P6NT8_Z/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH *8W6GTQNM $UO\ >%=5HOWUKE;?[PKJM%^^M95=BD>F:']U:Z7M7-:'
M]U:Z7M7D5/B&%%%%0 4444 %%%% !1110 5Q_BG_ %;5V%<?XI_U;5K2^(#Q
MO6?]>WUK.AK1UG_7M]:SH:]F/PDD]%%%,04444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M(_\ 5-6IHZ'R!]*S_$:'R6^E>9'XRCS"X.+K\:Z_PZ_W:XN^;9<GZUT/AZ\
M91FNVHKQ$>I6O,0^E4-2D55.:GL)P\ P>U9.N;_+;;7!%>\48ES>0K(<D4Z"
M^B)X(KDM1:X$IQGK3K SLPSFNWV:L([Q+L$<&J=[='8>:AM8Y/+!.:IZDY13
M62BK@<]JT^XMS7*7'+FMG4)LL>:QI#EJ[J:LA#4I6Z4+0W2M!$*_?KJM"^^M
M<JO^LKJ]!&76HJ_",]1T,?(M:UZY2$GVK,T)"8UK2U)#Y!^E>3+XBCSOQ!J;
MQ,V&-<<^O2^8?F/YUN^* 0[UP;_ZVO2HP3B2= =;E(^\:KR:O*W\1K-49%&R
MM>2($\EZ[]34.\L>:;LI5&#5V0B_:#YQ7H/AKJM>?VGWQ7H7AI<E:Y<1L-'>
M#_CV_"N"\3G[U=_L/V;\*\_\3@@M7%0^(;/.KP RFH80%<5/=_ZPU3WX<5ZJ
MV)/0/#+C>M>H68W6P^E>.^'+K9(O->LZ1=*\"C/:O.Q*=RD8'B2W)5CBO+M5
MCVR-Q7MNL6@GB.!VKS36]%<NV%J\-42W!GG<JYDQ73^&[<F5>*KC0I3+]TUV
M/A[16C925KJJU%RB1W>B1E;=?I3M5?;&:M6B"" 9]*P==O@JMS7EI<TAG/W4
MP\WK6QHL@+"N*N=0!FZ]ZZ#0;P%UYKJG!\HCO9EW6OX5YEXJ@.YSBO3H6$MO
MCVKDO$6EM,&(6L*,N60SQF9=LQ^M:VF+N=:LWNAR><3M/6M#2-)=9%RIKTI3
M7*([3PW ?E.*["X7;;'Z5EZ!9;$7BMN^CQ;''I7EU)7D4>6^)#^\:N>L!^_'
MUKH?$@Q(U<W92 7 ^M=U/X!'I_AX?(M;6IC_ $8_2L#P[*"JUTEY$9;8X]*X
M9_&,\<\5??>N+@/^D?C7I7B72GD9L*:XZ+1)1<9VGK7IT9KE):.J\-+NV5Z=
M81GR!]*X7PWI[1E<BO1[.+; /I7!B):C1S7B$8B:O,;S_C[/UKU+Q&G[MJ\K
MU#Y;DGWK;#; SM?"S?=KOV&ZV_"O+O#=X$91FO2[.<36X&>U85TU*X(XKQ'"
M?FXKS'5!B0U[/KM@948@5YEJNC2&4X4UTX::L)G+V\>]L 5KP:4\JC"U?TS0
MI#*,J:[_ $KP\/+!9:UJUE$$>:2Z-(@SM-11VIC<9%>I:II$<41^45PU]&L4
MI I0K<P6-'0EQ(M>F:=_Q[#Z5YEHKCS5KTS2_F@ ]JY<0-&#XF_U35Y!K'_'
MPWUKVGQ#:-)$V!7DVLZ9(L['::VPLE8&5=$_UJ_6O6- _P!6M>7Z1;LDRY'>
MO5- 0^6M&)8(VKS_ %!^E>;^(/\ 6-7I5ZA\@_2O-?$0(=JPP^X,IZ(P%ROU
MKUC2#NMA]*\:TNX\NY&3WKU70+Y6A49JL3%@AOB"$M&U>5ZW$59N*]HU& 7$
M)Q7G&OZ.[%L+1AII:,&>6S@>;^-=)X?BS(O%02Z%*9ONGK74^']&='7*UW5*
MBY1'<Z!$1&M;5^VVW/TJ#3;?R(1D=JJZU>K'$PS7DOWI%' >(WS*U5-!_P"/
MA?K5;6[P23L,]ZM>'1NG4^]>A:T"3U73/^/8?2L;Q ?D:MS38S]F'TK$\0(=
MC5P0^,9Y?JXR[5CP+^^%;6KC#M6/!_KA]:]2'PB/0_# ^[7H(_X]OPK@/"ZD
M[:]""'[+^%>=7^(:.!\2]6KSR[^^:]%\3+@M7G5Y_K#79A]A,I'K2BD/6E%=
M(A:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 0]*A_CJ<U'M^:F!NZ.
M0'6O4?#LR +DUY'8S>6PKK]+UH0@?-7)7@Y#1ZQ<3Q_9R<CD5Y=XND5B^*TY
M?$H:+&_]:X_6M1^T9YS6%"DXRN-G'SC]^?K4J=*25<R$T]1Q7I="1:7M1BBD
M VG)]\4F*5>&H&=GX9<"1<UZO87"?9AR.E>):3>>0P.:[*V\1!(L;ZX*]-R>
M@T;'B29&5L&O+-3(,Q^M=/JNLB=3\U<A=R^8Y-:T(.*$QUD<2"O1O#4J@KDU
MYG;OM<&NITK5/(Q\U56CS(#U][B,VG4=*\U\4.ID;!JZ?$8\G&_]:Y76-1\\
MDYKFHTG&0QNEW0CN!SWKTW1=01HE!->+PW)27.:ZO2M;\H*-U;5J7,@1ZK.D
M=Q'VKFM0T6-V)P*AM?$2E!EJDFUV-A]X5R1C.+T K6VDQPR X%=;I@CB0#(K
MAYM>13PPI8?$P4_?_6KE3E) =UJ<T9@(R.E>7>(L%F(K7NO$8D0_/7*ZG?"<
MGFKHTW%@S&BG,<_![UVV@:B05!-<.(]TF16_I>Z,@UTU(IH2/6;.Y2:( D4M
MQ90S#) KDK34VB0<U-)XBV#EJX/9N^@S7DTR!3D 4Z!8X6&,5S;^)0YQNJ>U
MU,SN.:?)*VH'<P2AD%<]XD&Z)OI6IISEH\GTK,\0D>2WTK*"M,9X]K3;)V/O
M3M&U QR#FHO$'^N;'K61:2%'SFO74;P)/:M#U8,B@M749BN8^<5XQIFKF CY
MJZ^Q\2@* 7_6N"K0=[H=SI;G1(9FSM%1P:##&P.T57B\0QL!EA3W\01@?>%9
MVGL!M1PQ6T?85BZOJJQ(P#5EWOB5=I >N0U36C,3AJJG1;=V%R+6M3,KM\U8
M"3$29S3+B9I&)S4&37HQ@DK".WT+5/+906KTC2]02:, D5X;9W1B8<UU^E:]
MY6 6_6N:O1OJ@3/3;JSBN%Z#FLLZ!"7SM%4+;Q(C*,N/SJX/$$>/O"N3EG'0
M9IVFGPV^#@5->7D4,1 (Z5SEQXC0*<,/SKG=2\1;P0'_ %IQI2D]0#Q'J2ON
M ->=WDV^8_6M74;\SD\U@R@L^:]*E#E0F:-C+L8<UWN@7O*C->;0;PPXKK]
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M:N)OCYCDUVX>+BM1,JV[;#71:1>[9%&:YA@PZ5>TQG\X=>M=$U= >T^'KCS
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB;N3S&-:&JWADD;FL@L6KU:<.5$C%7!J2D I:T$%%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4QNM/IC=: )K?[PKJM
M%^^M<K;_ 'A75:+]]:RJ[%(],T/[JUTO:N:T/[JUTO:O(J?$,****@ HHHH
M**** "BBB@ KC_%/^K:NPKC_ !3_ *MJUI?$!XWK/^O;ZUG0UHZS_KV^M9T-
M>S'X22>BBBF(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "F-UI],;K0!-;_>%=5HOWUKE;?[PKJM%^^M95=BD>F:'
M]U:Z7M7-:']U:Z7M7D5/B&%%%%0 4444 %%%% !1110 5Q_BG_5M785Q_BG_
M %;5K2^(#QO6?]>WUK.AK1UG_7M]:SH:]F/PDD]%%%,04444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 )2T44 %%%% !1110 F:6DH% Q:***!!FBDI: $)II)I])B@!FXTX9I<
M4N* $%.I** %I*** "BBB@84444 %%%% !1124 +FDS110 M%%% @HHHH **
M** "BBB@ HHHH **** "BBB@ I:2B@!:2BB@ HHHH 2BEHH&%&**6@0E%!HH
M *6DHH **** "BBB@ HHHH **** %I*** "BBB@ HHHH **** "BBB@ HHHH
M ****0!1113 ,44M(: "C%%+0 E%%% !1110 4444 %%%% "4M%% "TE%% !
M2TE% !1112 ****8!1113 ***0T@%HI!3J $HH-% !1110 4444 %%%% !11
M10 4444 )2T44 &:*2@4 +1110 4444 %%%% !1110 E%+10 4M)10 9HI*!
M0 M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1129H 6BDW"C<* %HI-P
MHW"@!:*3<*-PH 6BDW"C<* %HI-PHW"@!:*3<*-PH 6BDW"C<* %HI-PHW"@
M!:*3<*-PH 6BDW"C<* %HI-PHW"@!:*3<*-PH 6BDW"C<* %HI-PHW"@!:*3
M<*-PH 6BDW"C<* %HI-PHW"@!:*3<*-PH 6BDW"C<* %HI-PHW"@!:*3<*-P
MH 6BDW"C<* %HI-PHW"@!:*3<*-PH 6BDW"C<* %HI-PHW"@!:*3<*-PH 6B
MDW"C<* %HI-PHW"@!:*3<*-PH *!29%&X4 .I*3<*,B@!:44W(I=PH 6BDW"
MC<*8"T4FX4;A2 **-PI,B@!:6FY%+NH 6BDW"C<* %HI-PHW"@!:6F[A1N%
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M;A0 M%)N%&X4 +12;A1N% "T4FX4;A0 M%)N%&X4 +12;A1N% "T4FX4;A0
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MC<* %HI-PHW"@!:*3<*-PH 6BDW"C<* %HI-PHW"@!:*3<*-PH 6BDW"C<*
M%HI-PHW"@!:*3<*-PH 6BDW"C<* %HI-PHW"@!:*3<*-PH 6BDW"C<* %HI-
MPHW"@!:*3<*-PH 6BDW"C<* %HI-PHW"@!:*3<*-PH 6BDW"C<* %HI-PHW"
M@!:*3<*-PH 6BDW"C<* %HI-PHW"@!:*3<*-PH 6BDW"C<* %HI-PHW"@!:*
M3<*-PH 6BDW"C<* %HI-PHW"@!:*3<*-PH 6BDW"C<* %HI-PHW"@!:*3<*-
MPH 6BDW"C<* %HI-PHW"@!:*3<*-PH 6BDW"C<* %HI-PHW"@!:*3<*-PH 6
MBDW"C<* %HI-PHW"@!:*3<*-PH 6BDW"C<* %HI-PHW"@!:*3<*-PH 6BDW"
MC<* %HI-PHW"@!:*3<*-PH 6BDW"C<* %HI-PHW"@!:*3<*-PH 6BDW"C<*
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M4NZ@!:*;N%&X4 +12;A1NH&+12;A1N% A:*3<*-U "T4FX4;A0 M%)N%&X4
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M);^[1[1 <]M;THVM70_V2W]VC^R6_NT<Z YW:U+M;TKH?[);^[1_9+?W:.=
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M>T0'/;6]*-K>E=#_ &2W]VC^R6_NT>T0'/;6]*-K>E=#_9+?W:/[);^[1[1
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M:/:(#GMK>E&UO2NA_LEO[M']DM_=H]H@.>VMZ4;6]*Z'^R6_NT?V2W]VCVB
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MQ_=H_L,?W:[3[*GM1]E3VH]LP.+_ +#']VC^PQ_=KM/LJ>U'V5/:CVS XO\
ML,?W:/[#']VNT^RI[4?94]J/;,#B_P"PQ_=I?[#']VNS^RIZ"C[*GH*/;,#B
M_P"PQ_=H_L,?W:[3[*GM1]E3VH]LP.+_ +#']VC^PQ_=KM/LJ>U'V5/:CVS
MXO\ L,?W:/[#']VNT^RI[4?94]J/;,#B_P"Q!_=H_L0?W:[3[*GM1]E3VH]L
MP.+_ +#']VC^PQ_=KM/LJ>U'V5/:CVS XO\ L,?W:/[#']VNT^RI[4?94]J/
M;,#B_P"PQ_=H_L,?W:[3[*GM1]E3VH]LP.+_ +#']VC^PQ_=KM/LJ>U'V5/:
MCVS XO\ L,?W:/[#']VNT^RI[4?94]J/;,#B_P"PQ_=H_L,?W:[3[*GM1]E3
MVH]LP.+_ +#']VC^PQ_=KM/LJ>U'V5/:CVS XO\ L,?W:/[#']VNT^RI[4?9
M4]J/;,#B_P"PQ_=H_L,?W:[3[*GM1]E3VH]LP.+_ +#']VC^PQ_=KM/LJ>U'
MV5/:CVS XO\ L,?W:/[#']VNT^RI[4?94]J/;,#B_P"PQ_=H_L,?W:[3[*GM
M1]E3VH]LP.+_ +#']VC^PQ_=KM/LJ>U'V5/:CVS XO\ L,?W:/[#']VNT^RI
M[4?94]J/;,#B_P"PQ_=H_L,?W:[3[*GM1]E3VH]LP.+_ +#']VC^PQ_=KM/L
MJ>U'V5/:CVS XO\ L,?W:/[#']VNT^RI[4?94]J/;,#B_P"PQ_=H_L,?W:[3
M[*GM1]E3VH]LP.+_ +#']VC^PQ_=KM/LJ>U'V5/:CVS XO\ L,?W:/[#']VN
MT^RI[4?94]J/;,#B_P"PQ_=H_L,?W:[3[*GM1]E3VH]LP.+_ +#']VC^PQ_=
MKM/LJ>U'V5/:CVS XO\ L,?W:/[#']VNT^RI[4?94]J/;,#B_P"PQ_=H_L,?
MW:[3[*GM1]E3VH]LP.+_ +#']VC^PQ_=KM/LJ>U'V5/:CVS XO\ L,?W:/[#
M']VNT^RI[4?94]J/;,#B_P"PQ_=H_L,?W:[3[*GM1]E3VH]LP.+_ +#']VC^
MPQ_=KM/LJ>U'V5/:CVS XO\ L,?W:/[#']VNT^RI[4?94]J/;,#B_P"PQ_=H
M_L,?W:[3[*GM1]E3VH]LP.+_ +#']VC^PQ_=KM/LJ>U'V5/:CVS XO\ L,?W
M:/[#']VNT^RI[4?94]J/;,#B_P"PQ_=H_L,?W:[3[*GM1]E3VH]LP.+_ +#'
M]VC^PQ_=KM/LJ>U'V5/:CVS XO\ L,?W:/[#']VNT^RI[4?94]J/;,#B_P"P
MQ_=H_L,?W:[3[*GM1]E3VH]LP.+_ +#']VC^PQ_=KM/LJ>U'V5/:CVS XO\
ML,?W:/[#']VNT^RI[4?94]J/;,#B_P"PQ_=H_L,?W:[3[*GM1]E3VH]LP.+_
M +#']VC^PQ_=KM/LJ>U'V5/:CVS XO\ L,?W:/[#']VNT^RI[4?94]J/;,#B
M_P"PQ_=H_L,?W:[3[*GM1]E3VH]LP.+_ +#']VC^PQ_=KM/LJ>U'V5/:CVS
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MC^[1_88_NUVGV5/:C[*GM1[9@<7_ &&/[M']AC^[7:?94]J/LJ>U'MF!Q?\
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M@"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH ***2@!:*** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **2EH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HI,TM !1110 4444 %%%% !129I: "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHI,T +111
M0 4444 %%%% !1110 4444 %%%% !1110 449HH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***3- "T444
M%%%% !67J3?NS6F>E9.H_<-5'<#S[7CRU<'>_P"L-=WKO5JX2\_UAKU*.PR;
M3OOBO0="_AKS[3OOBO0="_AI5]A'>6/W!6CVK.L?N"M'M7F2W ****D HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L
MC5?NFM>LC5?NFJCN!P>J?>-4+3_6CZUH:I]XUGVG^M'UKOC\(([K0^BUU Z5
MR^A]%KJ!TKBJ;@%%%%9@&:*2E% !1110 4444 %<=XH^ZU=C7'>*/NM6M+X@
M/.)/^/K\:[3P]T6N*D_X^OQKM?#W1:[:OP@=U:_<%6JJVOW!]*M5YS **#12
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "DI:* "BBB@ HHHH ****
M"BBB@ HHHH **** "@T44 )2T44 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 E+110 4444 %%%% !24M% "4N:#24 +24M% "4M%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 E**2E% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !24M% !111
M0 4444 (>E9.H_<-:QZ5DZC]PU4=P//==ZM7"7G^L-=WKO5JX2\_UAKU*.PR
M;3O]8*]"T'^&O/=._P!8*]"T+^&E7V$=Y8_<%:':L^Q/R"M#M7F2W ****D
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "LC5?NFM>LC5?NFJCN!P>J?>-4+3_6CZU?U3[QJA:?ZT5W1^$#NM#Z+74#
MI7+Z'T6NH'2N.IN 4445F 4444 %%%% !1110 5QWBC[K5V-<=XH^ZU:TOB
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M](UV>0#+&NHCU:019+&@#T%M7C3JPIBZY"6QN%>4ZGXD:$'Y_P!:PX?&+?:
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M$4PD&17C&@>(FN)5&\G\:]1TFY,L2G- &Z.E%(OW:6@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !61JOW36O61JOW351W X/5
M/O&J%I_K15_5/O&J%I_K1]:[H_"!W6A]%KJ!TKE]#Z+74#I7'4W ****S **
M** "BBB@ HHHH *X[Q1]UJ[&N.\4?=:M:7Q ><2?\?7XUVGA[HM<7)_Q]?C7
M:>'NBUVU?A [JU^X*M55M?N"K5><P"BBBD 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@#(U-]L;5Y+XNO&CWX->KZM_JF^E>,
M^,VY>@#F=-U%VO0-QZU[/X;G+6BDGM7@6E.?[0'UKW3PN?\ 0E^E $/BB[,:
M-@UYN^IO]I(W'K7<>+V(1Z\L>0_:_P : /3_  [>,Y7)KU'2FW0@^U>.>%V)
M9*]@T;_CW'TH U**** "BBB@ HHHH *Q]8OQ:QMSC%:SMM7->?>--0,<;X-
M'.Z[XF^9E#_K7&7-_)=L<$G-8VI:@\UV1D]:WM!L#<[21F@"B+:8_-S2?;9K
M1AR>*[Y=#41?=K$U#PZTC':M $_AWQ#(TBJ6->P:'=&X@4D]J\?T7P[+%.IV
MGK7KF@6[00J#Z4 ;E%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<HK)?5E5L;JL6]Z)N] %ZB@<BB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH 0]*R=1^X:UCTK)U'[AJH[@>>Z[U:N$O/]8:[O7>K5PEY_K#7J4=
MADVG??%>@Z%_#7GVG??%>@Z%_#2K[".\L?N"M'M6=8_<%:/:O,EN 4445(!1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %9&J_=-:]9&J_=-5'<#@]4^\:H6G^M'UJ_JGWC5"T_UH^M=\?A [K0^BUU
MZ5R^A]%KJ!TKBJ;@%%%%9@%%%% !1110 4444 %<=XH^ZU=C7'>*/NM6M+X@
M/.)/^/K\:[3P]T6N+D_X^OQKM/#W1:[:OP@=U:_<%6JJVOW!5JO.8!1112 *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M >BV$A?!K<C^X*R=,AQ&IK748% "T444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M )8' [5\^>*_^/M_K0"+/A-OWRCWKW/0!F!?I7A7A/\ X^%^M>\^'ES;K]*
M.@+A%&:S[_4%CB(!Q3]0F\J(GVK@]8U@ABNZ@!VIZDSN<-6=!++(^>:K6[F[
ME'?FNLTO1PZ@E: &63.J@G-27VI^3&>:U9K 0Q<"N'\0S-&& - $<NO$SXW=
MZZK0+XS[>:\A69VNNIZUZ7X1R=F: /14^X/I3J1?NCZ4M !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 AZ5DZC]PUK'I63J/W#51W \]UWJU<)>?
MZPUW>N]6KA+S_6&O4H[#)M.^^*]!T+^&O/M.^^*]!T+^&E7V$=Y8_<%:/:LZ
MQ^X*T>U>9+< HHHJ0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH *R-5^Z:UZR-5^Z:J.X'!ZI]XU0M/]:/K5_5/O&J%
MI_K1]:[X_"!W6A]%KJ!TKE]#Z+74#I7%4W ****S **** "BBB@ HHHH *X[
MQ1]UJ[&N.\4?=:M:7Q ><2?\?7XUVGA[HM<7)_Q]?C7:>'NBUVU?A [JU^X*
MM55M?N"K5><P"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M6L2E(F%=G<(&C/%<9KT)VMQ0!YSJ&9+D_6NI\*18D2N8O 5N3GUKK?"Q&]:
M/381B%/I7.>*X ;4MCM71Q$>4OTKF?%=RHM2N>U 'B.KJ1>D#UKL?!<)=UKD
M-2_>7Q^M>@>"(P&3- 'IMK%LB7CM5BD7[HQZ4A/- #J*04M !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110!BZM_JF^E>-^,NKU[)JW^J;Z5XWXRZO0!PFEG_3Q]:]
MR\,?\>2_2O#-+_X_Q]:]S\,?\>2_2@9E>+_N/7EC_P#'V?K7J?B_[C5Y:_\
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ML8DH&>FQG*YI]1P?ZL5)0(**** "BBB@ HQ110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MSWH Q+>PW7 ..]>D>%[;RPO%<CIB+)(#7H&C(J!: .G'04M-1@5%.H ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !61JOW36O61JOW351W X/5/O&J%I_K1]
M:OZI]XU0M/\ 6CZUWQ^$#NM#Z+74#I7+Z'T6NH'2N*IN 4445F 4444 %%%%
M !1110 5QWBC[K5V-<=XH^ZU:TOB \XD_P"/K\:[3P]T6N+D_P"/K\:[3P]T
M6NVK\('=6OW!5JJMK]P5:KSF 4444@"BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M< X[5C:)X=:.0$I^E>@V.G>7"!CM0!P_B>,^2P]J\\LX3_:(X[U[#K^EM*C
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ K(U7[IK7K(U7[IJH[@<'JGWC5"T_UH^M7]4^\:H6G^
MM'UKOC\('=:'T6NH'2N7T/HM=0.E<53< HHHK, HHHH **** "BBB@ KCO%'
MW6KL:X[Q1]UJUI?$!YQ)_P ?7XUVGA[HM<7)_P ?7XUVGA[HM=M7X0.ZM?N"
MK55;7[@JU7G, HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 4;JR$^<BLQO#Z%L[170T4 9%OI
M*PXPM:447EU+10 5!/ )<\5/10!C2Z.LASMI(]%5#G;6U10!5@MA#VJU110!
M%/")5P:R;C0TF).T5MT4 <]'X>1&SM%:MO9B%< 5<HH IW%F)EP168^@HS9V
MBM^B@#(@TA8NBUHQ0B,5-10 4444 %(1D8I:* *%QIZS=JI-HBD_=K<HH Y]
MM"4_PT1Z"JG.VN@HH S%TM0N,54GT)9#G;6]10!B6NC"!@<5L1)L3%/HH **
M** "BBB@ HHI,T +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 5KB'S%(KFM2T);G.5S778II13U
M% 'GT'A58YMVS]*ZFPT\01@8K7\I/[M."@=!0!@:EI8N%(VURUUX165R=GZ5
MZ05!ZBF^4G]T4 >5OX)4_P#+/]*C/@9?^>?Z5ZOY,?\ =%'DQ_W10!Y.? JX
M^Y^E1CP&H?/E_I7KGD1_W11Y$?\ =% '!:3X7%JP.S&*[>RA\F+;4XC0=!3P
M,4 %%%% !4<L8D7!J2B@# U'0TN%/RUQ^H^#ED)^3]*]/J-X$?J!0!XX/!(#
MY\O]*V=/\(*K#*?I7H?V*//W14\<"1C@"@##T_0DMU'RUNQ1B-,"GT4 %%%%
M !1110 4E+1B@!!2T44 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[RQ^X*T>U9UC]P5H]J\R6X!1114@%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 5D:K]TUKUD:K]TU4=P.#U3[QJA:?Z
MT?6K^J?>-4+3_6CZUWQ^$#NM#Z+74#I7+Z'T6NH'2N*IN 4445F 4444 %%%
M% !1110 5QWBC[K5V-<=XH^ZU:TOB \XD_X^OQKM/#W1:XN3_CZ_&NT\/=%K
MMJ_"!W5K]P5:JK:_<%6J\Y@%%%%( HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "DI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** $/2LG4?N&M8]*R=1^X:J.X'GNN]6KA+S_6&
MN[UWJU<)>?ZPUZE'89-IWWQ7H.A?PUY]IWWQ7H.A?PTJ^PCO+'[@K1[5G6/W
M!6CVKS);@%%%%2 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !13&E5>IJ,W<0_BH GHJJU]
M$.A%0G44S]X4 :%%5HKR.0=:GWJ>XH =136D5>IJO)>(O<4 6LT5FG4%SUJ>
M*]C8<L* +=%,$J-T84_.: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "LC5?NFM>LC5?NFJCN!P>J?>-4+3_6
MCZU?U3[QJA:?ZT?6N^/P@=UH?1:Z@=*Y?0^BUU Z5Q5-P"BBBLP"BBB@ HHH
MH **** "N.\4?=:NQKCO%'W6K6E\0'G$G_'U^-=IX>Z+7%R?\?7XUVGA[HM=
MM7X0.ZM?N"K55;7[@JU7G, HHHI %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 444E "T444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 AZ5DZC]PUK'I63J/W#51W \]UWJU<)>?ZPU
MW>N]6KA+S_6&O4H[#)M.^^*]!T+^&O/M.^^*]!T+^&E7V$=Y8_<%:/:LZQ^X
M*T>U>9+< HHHJ0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9&J_=-:]9&J_=-5'
M<#@]4^\:H6G^M'UJ_JGWC5"T_P!:/K7?'X0.ZT/HM=0.E<OH?1:Z@=*XJFX!
M11168!1110 4444 %%%% !7'>*/NM78UQWBC[K5K2^(#SB3_ (^OQKM/#W1:
MXN3_ (^OQKM/#W1:[:OP@=U:_<%6JJVOW!5JO.8!1112 **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HQ11
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "LC5?NFM>LC5?NFJCN!P>J?
M>-4+3_6CZU?U3[QJA:?ZT?6N^/P@=UH?1:Z@=*Y?0^BUU Z5Q5-P"BBBLP"B
MBB@ HHHH **** "N.\4?=:NQKCO%'W6K6E\0'G$G_'U^-=IX>Z+7%R?\?7XU
MVGA[HM=M7X0.ZM?N"K55;7[@JU7G, HHHI %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 45&[[155[L+WH O9'K2;U]16+<:FJ
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MVKS);@%%%%2 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !12$X%4KJ_6 'F@"ZS
M!1R:A-RH.,US%YXC1"1O%9H\1JS??H [U) XX-/KDK/7T)'S5T%MJ"3J,$4
M7:*B>947)K'OM=C@!&X"@#8>95/6E24/WKAYO$R%_OU-:>)$+#+T =M167::
MO'.!R#6DC!UR* '4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110!7EMEDZBHUL44YP*N44 -1 @P*
M4C(Q2T4 59+-9#R*$LHTYQ5JB@"(V\9&,52N-.1L\5I4$9H P/[- ;I5VVT]
M!R15_P M:< !TH 8L*(.%J3&*** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "LC5?NFM>LC5?NFJCN!P>J?>
M-4+3_6CZU?U3[QJA:?ZT?6N^/P@=UH?1:Z@=*Y?0^BUU Z5Q5-P"BBBLP"BB
MB@ HHHH **** "N.\4?=:NQKCO%'W6K6E\0'G$G_ !]?C7:>'NBUQ<G_ !]?
MC7:>'NBUVU?A [JU^X*M55M?N"K5><P"BBBD 4444 %%%% !1110 4444 %%
M%% !1110 4444 %-9PO4U!<72PH237,WWB)(W(WT =6)5/>G@YKDK#7%G< -
M746S^9$&H FHIDCB--QK&OM<CM\C<!0!L/*J=Z1)E8]:X>?Q0A?&^IK3Q&A8
M?/0!V]%9=EJL<Z@;@:T1("N: 'TQY @Y-4[O4DMU.2!7.7GB- Q&\4 =:LZL
M<9J6N!C\3('^_6Y8>((Y@!N% '145##.LJY%)-<K$I)H E9@HR:8)USC-<]J
M&NI'D;JQ6\3HC_?H [\$$<&EKD+'Q+'*0-XKH[2]6<#!H N44C,%&365?:HD
M /S=* -,R*.]()5/>N*NO%$:,1O%-M_$Z.X^>@#N\YHK%L=728#YJUDE5QQ0
M!)1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !13))1&,FLR]UB.",\@&@"W<WBP]ZK)JBNV-U<'K'BE1(0'J'2=
M;,\P^;O0!ZG$_F+FGU2TR3S+8&K,T@CC+&@!DUPL8/-9L^L+&<;JQ-9UH0[A
MNKBKSQ 7D(#4 >G0ZTLC8W5JP3"5<@UY!9:TP8$M7::/K:OM!:@#L::S!1DU
M#'<J\>ZLG5-56W4_-0!<N=26'/-4UUQ2V-U<-J7B#>Y >LM-9</G=0!Z_;WJ
MS <U<!S7FVD^(02 7KM["^6= <T :55+F[6$'FFW=ZL$9.:XS5]<&6 :@#HV
MUQ5;&ZK-OJBR_P 5>3W&M.')W5?TSQ#\X!>@#UJ.0..*?7/:3JBS*OS5LM=(
MHS0 Z>81+DFLN;65C.-U9NLZNJA@&KA=1UM@YPU 'I<6M*YQNK3M[D38YKQJ
MRU]O-&6KNM%U<2;<M0!V=-D<(N34"WB%0<UG:IJ2QQG![4 37&J+%GYJJC75
M+8W5PFK:[M8X:L:'7F,OWJ /9+:_6;'-7J\YT?6LE<M7;VE^DL0YH O$X&:J
M3WJQ#K3+V\6.(G-<1K.O",D!J .I?7%5L;JL6VJ+,1\U>2MKK/)PU;&F:V58
M9:@#U5&#KD4ZN>TW6%E4#=6]%()%R* 'T444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%)2T %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1TIKN$&361J.KI;J?F
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M-]3VGB)'8?/0!VU%9EGJB3*.0:T$D#]* 'T444 %%%% !1110 4444 %%%%
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M04 ;RG(I::@P*=0 &DI:* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M- ST8<@4M1Q2*T2G(Z4IEC7JX% A]%1^?%_?%+YT?]\4 /HIGG1_WQ1YL?\
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M4_O4O]M1_P!X4 =#N'K2YKGAK4>?O"K$6K1L?O"@#9HJM#=)(.#5F@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB@=** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MU&;3\*X?Q$#]H/UH V_!X#S+GUKU1[6,V6<#I7E7@S_7)7K1_P"/'\* //\
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M@#A-")_M$?6O<M#F,=BOTKP[01_Q,1]:]PT6(O8#'I0!B^(M7:%FP:Y ^(9
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &7J-T(%))KC]0UX*Q
M:M7Q5<&*)\&O)+S4G>[*Y/6@#KWU)YCD$U#]ME1^2:;H5J;E 2,UIWVE&-<X
MH NZ5J9W+DUU]MJ2"(;B*\T@8P2?2KTFJM'%@-0!V5_K*!2%85RE_>O*3M-<
M_+JLDDF-QK4L&68#<: *GF3B3/-;6FW;J1DFI&MH=N>*@PL;?+0!V>GW@90"
M:U5<-TKB["X8,!74V3E@,T 7:*** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M#.<"M:B@"C%ID470"KB($&!3J* "BDI10 4444 %%%% !1110 4444 %%%%
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M-C;7L\UC%(/NBJ+:5'N^Z* /.;/PN6892NST?0Q; ';BMZWL(X^=HJZ%51@
M"@"A<68>$KCM7#:WX9\]F.RO2:BD@CD'*B@#Q1_"S1L<)5FV\+LSC*5ZE-I<
M9;.T5);Z;&AR5% '+Z/X=$!4[*[*UB$406I5C1!@ 4Z@ HHHH *Q-?\ ]2?I
M6W6%K_\ J6^E 'B?B[J]>9M_Q\_C7I?BX\O7FC?\?/XT#/0/"7WTKVW0O]2O
MTKQ+PE]]*]MT+_4K]*!'3)]T4ZFI]T4Z@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M!*?I7IGEI_='Y4!%'11^5 &1IFG"V4#&*V"H*X[4N ** .=U;2!<@X6N,O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M5+M<H:XO6K=FW8%=U*NX&L>\L/-SQ0!Y1=V<F\\&LVX22)3UKTRYT7.3MKE]
M:TSRXV^6@#A)+QP^,FM&P:28CK69<VY%P1CO75^&]/\ -9>* )X+&0@'!KH]
M(MG1US6O!HP"#Y:T;;3O+(^6@#5TY2(JNU#;IL7%34 %%%% !1110 44E+0
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M*'KA(=7^;[U;5GJJG&6I@=+15*/48F7DU(+Z(]Z0RS142SHW2I <T +1110
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M=@L!>/D50GT_+YQ0!6T6(JXXKMH1B)?I7/:?:>6PXKHH^$% #J*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "L
MC5?NFM>LC5?NFJCN!P>J?>-4+3_6CZU?U3[QJA:?ZT?6N^/P@=UH?1:Z@=*Y
M?0^BUU Z5Q5-P"BBBLP"BBB@ HHHH **** "N.\4?=:NQKCO%'W6K6E\0'G$
MG_'U^-=IX>Z+7%R?\?7XUVGA[HM=M7X0.ZM?N"K55;7[@JU7G, HHHI %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MFMZ(Y6L/3;4JHXK=C7:,4ADE%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %077^J-3U%.,H: //?$L997Q7D6N0-YC<5[KK-H)%;BO,M>
MTP L<4 >47J$ U0M/^/@?6NAUBW$>[BL"V&+D?6@H]8\%]4KW#1O]0OTKP[P
M6?F2O<=&/[A?I02S8HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ I*6B@!**,48H *6DQ2T %%%% %6XMA*#D5G
MG2%WYVUM44 5+:U$('%321[ABI:* ,Z2P#'I48TU0>E:M% &4^FAEQBLRZ\/
MB7/RUU%% '$?\(F-V=E7K7PZL1'RUU-% %*VLEB XJX  *6B@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %86O_P"J;Z5NUA:__JF^E 'B7B[J]>:-_P ?/XUZ7XNZ
MO7FC?\?/XT#/0/"7WTKVW0O]2OTKQ+PE]]*]MT+_ %*_2@1TZ?=%+2)]T4M
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **0T4 +1110 4444 %%%% !1110 4
M444 &:*2EH **** "BBB@ HHHH ***2@!:*** "BBB@ HHHH **** "BBB@
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MFBDI: "BBB@ HHHH **** "BBB@ S1110 4444 %%%% !1110 4444 %%%%
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M(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M** "BBB@!*448HH **** "BBB@ HHHH **** $I1110 4E+10 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %9&J_=-:]9&J_
M=-5'<#@]4^\:H6G^M'UJ_JGWC5"T_P!:/K7?'X0.ZT/HM=0.E<OH?1:Z@=*X
MJFX!11168!1110 4444 %%%% !7'>*/NM78UQWBC[K5K2^(#SB3_ (^OQKM/
M#W1:XN3_ (^OQKM/#W1:[:OP@=U:_<%6JJVOW!5JO.8!1112 **** "BBB@
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MJP]2LEVGB@#QZ_T_RL\5EQVQ,F*[C6K8 MQ7/06^9^G>@#2TC2/-Q\M=;:Z
M% .VG^'+,$+Q7:I:*H'% &+8Z:(B.*Z"!=J8I%A"GI4H&* %HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "H
MYAE,5)2,,B@#E]6LC*K<5YOK^CL-QVU[/+$C YQ7*^(K.$1,<#I0!\[ZW:&(
MMQ7-VXQ<CZUW_BN)%9\5P47_ !]?C0,]5\%_>CKW'1?]0OTKPWP7]Z.O<=%_
MU"_2@1LT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 44A8#K4+W4:=30!/153^T(?44OV^'^]0!:HJK]OA_O"C[
M?#_>% %JBJXO(CWJ595;H: 'T444 %%%% !1110 4444 %%%,:14ZF@!]%5F
MO85ZM2?;X?[U %JBJWV^'^]2?;X?[U %JBJPOH3_ !5(MS&W1J ):*0,&Z4M
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %-89
M%.ICG H S[NR28'(KFM7T*W-NQ*C-;][>^4#S7':WX@VQLNZ@#S/Q1IT4)?:
M!7F=RH6ZP/6O0?$>I^>7YKSV=MUUGWH&CN_!Q_>I7T!X:_U"?2OG_P '#]ZE
M?0'AK_4)]* 9U%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ KD?%/^J>NNKD?%/\ JGH \*\3_P"M?ZUP]Q]XUW'B?_6O]:X>
MX^\:0RN.M25&.M24QA1110 4444 %%%% $<O2DL_]>/K2R]*2S_UX^M 'J?A
M'[R5[7H7^J7Z5XIX1^\E>UZ%_JE^E!)TJ_=%0WG_ !ZO4R_=%0WG_'J] 'DG
MB[J]>/:O_K6KV+Q=U>O'=7_UK4#1@2'YJ=&NZH9CAJN:>GF.!0,>EDS]!3_[
M-?\ NFNNTS2Q*HXK=3P^I7[M!)YK_9C_ -TT?V9)_=->F?\ "/K_ '?TIP\/
M+_=_2@=SS Z:X_A-1-:,G:O3I] 55/RUS^H:8(L\4 <8R%:J2?>K8NXMA-8T
MQP] SH_#W^N3ZU[CX3^XE>&^'?\ 7+]:]S\)_<2@3/2K/_5BK=5+/_5BK= @
MHHHH **2EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@!#T
MK)U'[AK6/2LG4?N&JCN!Y[KO5JX2\_UAKN]=ZM7"7G^L->I1V&3:=]\5Z#H7
M\->?:=]\5Z#H7\-*OL([RQ^X*T>U9UC]P5H]J\R6X!1114@%%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %86O_
M .J;Z5NUA:__ *IOI0!XEXNZO7FC?\?/XUZ7XNZO7FC?\?/XT#/0/"7WTKVW
M0O\ 4K]*\2\)??2O;="_U*_2@1TZ?=%+2)]T4M !1110 4444 %%%% !1110
M 4444 !Z5YAXY'WZ]/KS+QU@>90!YG8 ?;Q]:]M\( ?9U^E>(6+ :@/K7MW@
M]@;=.>U '6T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4C
M<*:6J]Q-LC- &%K$RJK5P6I3@N:Z77;K[W-<1<N7D-,16D.33 *L+"2,T>5@
MT 5^<U/!)M84\09[5&T90T =;HLXW+7H&GN&B'TKRG2IRCKS7H.D7>47F@9T
M5%,1]U/I %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1FBDH 6BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K(U7[IK7K(U7[
MIJH[@<'JGWC5"T_UH^M7]4^\:H6G^M'UKOC\('=:'T6NH'2N7T/HM=0.E<53
M< HHHK, HHHH **** "BBB@ KCO%'W6KL:X[Q1]UJUI?$!YQ)_Q]?C7:>'NB
MUQ<G_'U^-=IX>Z+7;5^$#NK7[@JU56U^X*M5YS ****0!1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?&__ $T_6D'C?G_6?K7BAU2;^\:0:G-G[QH"Q[G'XUR?]9^M;FF^*A,P&_\
M6OGB/5901\QKH=(UUXW7+4"/I[2]02=!\W6M7(]:\5T7Q>(D&9/UKH!XYCP!
MY@_.@#TK<OJ*,BN%L?%*W###_K74V5X)U!S0!I44BG(I: "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "HYONFI*:XR* .6U=6*MBO,_$$<N6Z
MU[!>6OF \5QVMZ-NC9MM 'A6JHXW9KEI/^/C\:]&\1V'DE^*\\N%VW7XT#.\
M\'?ZU*^@/#7^H3Z5\_>#_P#6I7T!X:_U"?2@&=11110(**** "BBB@ HHHH
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MK[C3U8T ,NT38>*XW657YJZV[8[#7'ZP>&H X?4?O-7.S_ZRNAU#[QKGI_\
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M$!!%70<C->6^&->,ZH"U>D64_FQ Y[4"+=%%% !1110 4444 %%%% !1110
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MB)UQ4?\ :,>>HKD[K4B2<&J0U!]_4T =_'<I)TJ>N.LM3P1DUT=K?QRJ 2*
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M-/60-7.R7W[S&:T;&?S,4 :E%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 5D:K]TUKUD:K]TU4=P.#U3
M[QJA:?ZT?6K^J?>-4+3_ %H^M=\?A [K0^BUU Z5R^A]%KJ!TKBJ;@%%%%9@
M%%%% !1110 4444 %<=XH^ZU=C7'>*/NM6M+X@/.)/\ CZ_&NT\/=%KBY/\
MCZ_&NT\/=%KMJ_"!W5K]P5:JK:_<%6J\Y@%%%%( HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "D9@HR:6H+HXCH BFU".'[U9USXEMX8VY&
M0/6L#7+J1 VTFO--;U6Y0L 30!H>-?$"70<!@:\1U8^;=$CUK?U/4)Y7.XFN
M?F^9\F@9TOA%<3)]:^CO!O\ J4KYV\+#$Z5]$>#?]2E CM**** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHS1D4 %%%%
M $4XS$:XO6QPU=I<'$1KB];;AJ .&NO]<:W]!'[Q:P+H_OC]:WM!;]XM 'I5
M@,6PJU56P.;<5:H **,T4 %%%% "4HHHH **0L!U--,R#^*@!]%1^?'_ 'J/
M/C_O4 25FZDF4)J]YT?]ZL[4KI-A&: .!UQ/O5SENO\ I ^M=#KEPIW<USEO
M,OV@?6@#TGPTF0M=?7&^&KE5"\UUWG1_WJ )**C\Z/\ O4>?'_>H DHJ/SX_
M[U.#J>AH =1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !113'D5/O'%
M #Z*@^UPYQOJ19%;H: 'T44TNJ]30 ZBH'O(4ZO3!J-L3]\4 6J*B2YB?[K5
M("#TH 6BC.*B>XC3[S4 2T55.HVPZN*<M[ _1Z +%%-5U;H:=0 44QI43[QQ
M4+7UNO5Q0!9HJLM_;MT<5*DR/]ULT 2444C,%')H 6BH&O($ZO3!J-L?^6@H
M M45$ES$_P!UJE!STH **"<5$UQ&GWFQ0!+154ZA;@X+BG+?0/T>@"Q135D5
MNAIU !3)!E<4ZC&: ,+4+ 3*>*\_\0:& &.VO6FB#"N;\16:^2QQVH ^=-?L
MA"6XKDX!BY'UKT3Q=$$9Z\]C'^E_C0,]4\%_>C_"O<=%_P!0OTKPWP7]Z.O<
M=%_U"_2@1LT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 (W"FN7UF^\D-S73R?ZMOI7G?BN<HK\T 8.H>(C&Y&_P#6LJ3Q0>F_
M]:X[6]1996YKG)-5?)^:@+'IS>(!+U:J\E['+U(KSB/5W'\56%UIA_%0.QVD
MK0D'I6)?^6<XQ6.=:8C[U5I=1,G>@+%R-$\RNCTXQ*HSBN*%V0<YJU%JS1C[
MU 'HBW$2#J*ECU=8>C5YX=<8C[U1-K#'^*@+'I;>*=@QO_6K5CXG,D@&_P#6
MO'YM6?\ O5H:/JC-.OS=Z L?1FB:GYX7FNQMFW(*\G\(W1=4YKU.Q.8A0(N5
ME:TY2W)'I6K61KPS;'Z4 >.^*=4DB9\,:\VOO$$RN?G/YUW/BZ/+R5Y;?P?O
M&H&B9]?F8XWG\ZB?47F'+5FF'YJF2+% Q[_.>::(Q4@6C;0!'Y8H\L5)MH*T
M ,"@5+',8CD&F;:"F: +@UJ6%>&--3Q+/Y@&\_G6=)#D542W/G#ZT >K>%M:
MEED3+&O;?#MP9(ER:^?_  C#B1*][\,KB%*"3LX_NT^F1_=I] !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MQJA:?ZT?6N^/P@=UH?1:Z@=*Y?0^BUU Z5Q5-P"BBBLP"BBB@ HHHH ****
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MPH_->0ZQKC1RL-U 'IG_  DZ_P!_]:!XG7^_^M>,_P#"0OG[_P"M \0M_?\
MUH ]H_X29?[_ .M9U[XC#*?GKRO_ (2%L??_ %J"77F8?>_6@#K]3U@29^:L
M>'4@)<YKF9]4+_Q576_(;.:!GKVC:\(@/FKI1XF7;]_]:\,MM9:/'S5>'B%L
M??\ UH$>R'Q,O]_]::WBA0/O_K7CA\0O_?\ UJ*7Q"X'W_UH ]IA\3J[ ;_U
MKH=.U03X^:OGFP\0NTP&_P#6O4O"VHF;9S0!ZI"VY<U)56Q;="#[5:H ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHH **** "BBB@ HHHH **** "BBB@ HHHH ,4444 %%%&: "DI:2@ I:2EH
M**** "HIVPAJ6HIEW(: .1UW4WMT;!KRS7_%,X++N/YUZGKNF/<*V!7F&N^%
M)G#-L- 'GFHZQ)<ELDUSKMNGS[UTVIZ+):EL@US3ILN,>] SO_!P_>)7T!X:
M_P!0GTKY_P#!Q_>)7T!X:_U"?2@&=/1110(**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M'PQKW'Q2,QO]*\(\41 R/0!Q5SJ\P<_,:K#6)\_>-%S -YJL(!F@HM_VS/\
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M_>-9Y%+B@#HM.OF9QS7?:/*75<UYIIG^L%>C:']Q: .CHHHI#"BBB@ HHHH
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M;5^$#NK7[@JU56U^X*M5YS ****0!1110 4444 %%%% !1110 4444 %%%%
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M"9"=E>(:6G^D+]:]N\$+C90)GM&F_P#'NOTJ[5+3?^/=?I5V@04444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %9^I9:(@>E7STJ"2/S.#0!Y3XGLIG#E0:\AUG3YEG
M)8'K7U'?:+'<1-E1TKRCQ;H4<+,0HH&C@/#T.V=<CO7N'A;Y8T^E>0:="([L
M >M>N^&CB): 9TVJ3[;0\]J\5\6W#-.PSWKUS5G_ -&(]J\?\1C=<-]:!#O"
M=J)[A=P[UZ/?Z1$NG$[1TKB?!T>)U^M>EZ@/^):?I0!XAJD?D:@=OK7;>&KL
MK;#GM7*:Y'_I[?6MS1&VV_X4 ,\6:DP4@&N<T%OM-X W/-6?%,A)-4_"?-ZO
MUH ]5AT>-[ ':.E</K-@L%R<#O7J5DF=.'TKA?$,7[]OK0!2TB<Q+UIVK:HR
MH1NJO:_*M9>LR<&@86ER;B?!.>:Z^STQ)H02O:N$T<YN1]:]2TA,VX^E CG+
M[2DB)(6LX/Y!XKK=5C^4UR%Y\K&@";^U&7C=4;7AFZFL:20[JM6K984 :UM9
M+.PR,ULIH\:Q9VCI4&EIDBNE,>+?\* .!U9!;,<<4W1]2990-U2>)!@M6#ID
MF+@?6@9W]Y>&2T//:N%N4,U[SZUU#/NM?PK"6/-X/K0([7PWI$;VX)4=*Q_&
M5BEO&Q48KL_#<>+0?2N;\=+^[>@#SC1;AEU$#/>O=O#5[ML@2>U>"Z4N-1'U
MKV'1Y2MD,>E SJ+G7D@)RPJF/%4><;Q^=<-KUY*C-@FN6.J3ANIH$>T+XEC;
M^(5D:[KR20D!AT]:\R.NRQKRQ_.LV^\2,ZD%_P!:!V*WBJ\$K/@UPD)S=?C6
MKJE^9\\UC6IS<#ZT >L>"Q\T=>XZ+_J%^E>(>"Q\T?X5[?HW^H7Z4 ;-%%%
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M??DKS"_^^U T8Y_UE=-H:AG6N9/^LKI]".'6@#TK2+=3&O%;8M4QT%8^D/\
MNUK<#\4Q#/LJ>E2"T3'2D\PU().* ,C4+90AXKAM8B +5WFHO\AKA-9;EJ .
M-O1@FLI/]?\ C6M>]362G^O_ !I%'H7A+[Z5[MX:_P!2E>$^$OOI7NWAK_4I
M0)G8Q_=I],C^[3Z!!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%&<4 %%
M)N%&10 M%%% !13#*H/6E5PW2@!U%%% !1133(J]30 ZBF"13WI] !1110 4
M4$XIAE4=Z 'TE(KANE.H **** "BFLZKU-()5)ZT /HHHH *.M(:* &/!&_W
MEK.U'2[>6U;Y!D5JU4U%]EHWO0!X7XTL8XC)M KQZ\&V\(]Z]G\;R9,E>,WO
M_'X?K0-';^#O]:E?0'AG_4)]*^?_  =_K4KZ!\,_ZA/I0)G3T444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %<CXI_U3UUU<CXI
M_P!4] 'A7B?_ %K_ %KA[C[QKN/$_P#K7^M</<?>-(97'6I*C'6I*8PHHHH
M**** "BBB@".7I26?^O'UI9>E)9_Z\?6@#U/PC]Y*]KT+_5+]*\4\(_>2O:]
M"_U2_2@DZ5?NBH;S_CU>IE^Z*AO/^/5Z /)?%W5Z\=U?_6M7L7B[J]>.ZO\
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MTHI)3M?%*IS0!K:9_K!7HVA_<6O.=,_U@KT;0_N+0P.BHHHI#"BBB@ HHHH
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M%^#?]2E?.OA0_OT^M?17@W_4I0([.BBB@ HHHH **** "BBB@ HHHH ****
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MW'TJ[0(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\1R2RD!CU]:NVVMR)@EC0![?;7T<JCYA5L,#T->6:1XDW,JE_P!:[_2KP7*
MYS0!JT444 %4=5_X\VJ]5+5/^/-J /#_ !KUDKQV\_X_#]:]C\:]9*\<O/\
MC\/UH&CM_!W^M2OH#PS_ *A/I7S_ .#O]:E?0'AG_4)]* 9U%%%% @HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KD?%/^J>NNKD?%
M/^J>@#PKQ/\ ZU_K7#W'WC7<>)_]:_UKA[C[QI#*XZU)48ZU)3&%%%% !111
M0 4444 1R]*2S_UX^M++TI+/_7CZT >I^$?O)7M>A?ZI?I7BGA'[R5[7H7^J
M7Z4$G2K]T5#>?\>KU,OW14-Y_P >KT >2^+NKUX[J_\ K6KV+Q=U>O'=7_UK
M4#1S<_WJT=)_UBUG3_>K1TG_ %BT#/2]#^XM=7%]T5RFA_<6NKB^Z*9(^G+3
M:<M $%W]PUQ^L=&KL+O[AKC]8Z-0!P^H?>-<]/\ ZRNAU#[QKGI_]92&='X<
M_P!:OUKW+PG]Q*\-\.?ZU?K7N7A/[B4 STNS_P!6*MU4L_\ 5BK= @HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K-U)25-:55[B+S!0!P
M&I0,6/%4;2W<2CCO7:W&E^8>E0Q:/M?.V@";2T(B&:H:_$6C.*Z&VMO+7&*@
MOK+SE(Q0!Y>MFYN<X/6NDMH6C@Z=JU5T/$F=M7QIN(\8H X+4[B2-CC-9T.I
M3 XR:[6_T S$_+69_P (RRG[M '*WUU+*IZUEP6TLLW(/6N^;PR6_A_2K%IX
M9V.#L_2@"GH&FL-I(KO;&W\M!Q5:PTX0 <5KHH44 .HHI,T +1110 4444 %
M%%% !1110 4444 (>E9.H_<-:QZ5DZC]PU4=P//==ZM7"7G^L-=WKO5JX2\_
MUAKU*.PR;3OOBO0="_AKS[3OOBO0="_AI5]A'>6/W!6CVK.L?N"M'M7F2W *
M***D HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Q
MM8OA;(3G%:SOM%<1XKN3Y;X- &;+XJ"3[=_?UK8M/$(FB^_VKQJ_N)A=DY/6
MMO2M1<1@%C0!UFO:YL#$-7$R>*VCGQO[^M2:S.\T9P:X*\CF$Y(SUH ]AT+Q
M/YS*-_ZUZ5I-W]HC4YKYT\.22I*N2>M>W^&+@F),GM0!V5%-5MPIU !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6%K_^J;Z5NUA:_P#Z
MIOI0!XEXNZO7FC?\?/XUZ7XNZO7FC?\ 'S^- ST#PE]]*]MT+_4K]*\2\)??
M2O;="_U*_2@1TZ?=%+2)]T4M !1110!RGBC_ %;_ $KPSQ/_ *QZ]S\4?ZM_
MI7AGB?\ UCT <!>]ZS[7_CY'UK0O>]4+7_CY'UH*/7_ T:LT>:]ZT>&-;-2
M,XKP3P.V&CKWK1')M5'M02:6Q?[HHV+_ '13J* &[%_NBO-/'<*+YF *]-/2
MO,/'3D[Z /-+! =0'UKV_P (01_95.!G%>'V!_T\?6O;O"#G[.H]J .KV+_=
M%&Q?[HIU% #=B_W16/XBA0V+' SBMJL/Q(Q%D1[4 ?/7C-0LSXKSN3_6&O0_
M&1S,_P!:\\?[YH&,3_6BO2O!7^MC^M>:I_K17I7@K_6Q_6@#Z&\/_P#'DOTK
M8K'\/_\ 'DOTK8H$%%%% !5>\_U)JQ5>\_U)H X'7.K5QUQ]\UV.N=6KCKC[
MYIB*4GWJVM% ,BYK%?[U;6B_ZQ: /4-$B3R@<=JV=J^@K&T1OW0K:I#$V+Z"
MC:OH*6B@#/U2)3;$X%>=Z@@%P?K7HFJG%N1[5YWJ!_T@_6F!O>'XU8KFNT5%
M"@8%<5X?;!6NV0Y0?2D ;5]!1M7T%+10!'+&K1L,#I7!>(T5=V*[V8XB:N!\
M1G.Z@#@+G_6FECI+G_6FE2F(V-,_U@KT;0_N+7G.F?ZP5Z-H?W%H8'14444A
MA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5%
M+$''2I:* .>O],$@/RUS%YH)).%KT9HU;J*@>SC?M0!Y>V@L#]W]*=%H#%ON
MUZ,VF(3]T4Y--C'4"@#D++0]I&5KI;*P$8'%::VL:=!4H4#H* $10JXIU%%
M!5"\MA*#Q5^D(!ZT <1J>E=2%KGGB>WD[C%>G75JLB'BN7U'2\DX6@#*L]7:
M  $UHMXBRF-U8%QI\JDX!JLMG/NZ&@"WJ%TUV3CG-0:=I<CS!L'K6G8:8[D;
MEKK=.TM$ )6@""SLS';X([5S>O6I))Q7H)A4(0!6!J=AYH/% 'GEL3!-GWKI
M+76#&@&:K7&DL&)"U5-A*O0&@#9?6BP^]5">]:;C-5UL93V-7;73G+#(- &:
M-.:XDSBNFTC2?*P=M:.GZ8!C*UNQVZ1J !0!C7]L3;D =JX/4+.19RV#UKU6
M6$.N,5@:AI2N"0M '*Z;?O:@ GI6M)X@+)MW5F7FFNA.T&J"V4Q?&#0!?FD-
MV?7-2VNC%VW;:M:;I[$C<*ZVSLD2,$B@#GETYHXN!6%J,4D;$\UZ.]NA0@"N
M>U/30X.!0!RUEJ+V[<FM"?6C)'C=5"YTUU<X!J!+&4M@@T *VZXDS6[I>GDX
M)%1Z?IAR"5KK+&T6-1Q0 MI!Y8'%7Z0*!TI: "BBB@ HHHH *,T&DH 6BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "LC5?NFM>LC5?NFJCN!P>J?>-4+3_ %H^M7]4^\:H6G^M
M'UKOC\('=:'T6NH'2N7T/HM=0.E<53< HHHK, HHHH **** "BBB@ KCO%'W
M6KL:X[Q1]UJUI?$!YQ)_Q]?C7:>'NBUQ<G_'U^-=IX>Z+7;5^$#NK7[@JU56
MU^X*M5YS ****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %-<9%.HH S+BUWYXK$U#20\3?+VKK2H-130JT3#':@#Y_\ %VG"'?Q7D&I_
M+<D>]>_^/(0JR<5X!K/%VWUH&=+X2.9T^M?1G@W_ %*5\X^$/]<E?1W@W_4I
M0([2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M K,UO_CS/TK3K,UO_CS/TH \%\:?ZR2O+KD?O3]:]1\:?ZR2O+[C_6GZT#(J
M<*2E% Q:*** "BBB@ HHHH 1ONU4/^M%6V^[51O]:* .[\'_ .N3ZU]"^%O]
M0GTKYZ\'_P"N3ZU]"^%O]0E F=71VHH[4"///&?^K>O!/$)_?M7O7C/_ %<E
M>">(?]>WUH YJ2EM/]:/K22=*6T_UP^M ST7PV/NUZ':@>4*\[\.?PUZ%:G]
MT*8F2.!FFJ!FASS2*>: 'R@>6:Y76A\K5U$I_=FN6UD_*U ' ZG]\USMUWKH
M=2^^:Y^Z[TAH=I7_ !\+]:]M\$]$_"O$M*_X^%^M>V^">D= ,]GTW_CW'TJ[
M5+3?^/<?2KM @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $;[I^E>=^+K0R
MEN*]%/0USVK6'GYXH \=M]*87>=O>O3_  Q;F-%R*J1Z&!+G;WKIM-M/) XH
M TKF,26Y'M7F/BG1#,6(6O5,97%9E_IJ3H<C- '@JZ8]I/G:1S5R5Y'BV<UW
MNIZ -Q(7]*R$T)C)]V@#D;'17GN0Q4]:]3\.Z7Y,"@KVI-*T%4VDK^E=;:VB
MPH!B@#E=?T?SXC\M><W>C-;3E@M>Z3VR2H017*ZMHJMN(6@#RJX,BQE>:H6^
MG23W )!ZUW,^@L9/NUH:;X>"L"4_2@!OAO22B+E:Z*\T<21$;:U--T]85'%:
MIB0CD4 >0:KHAB=B%KF+R*2/( ->TZMI:R*2%KB;_02SG"T >?06\DDHX-=I
MH>E,^W*U8LO#Q$@)3]*[32-*$6WY: *L6C#RQ\M8^KZ,50X6O11"@&,52U"Q
M66,X% 'A&IV+QN< U2MTDWXYKTW5=!\QCA:QHO#Q63[GZ4 9>GZ<T[+E:[O1
MM%\M 2M.TC1@A7*UV%O;)%&!B@#GM4TW=;$ =J\KU[1'$[,%/6O=YX%D0C%<
MQJNB+*"=M 'C]G');<8-6);9[LXP3767.@%9#A>_I5O3]")<97]* ,/0/#Y6
M96*=_2O6=(M_(M0,=JJ:=I*1*#MK:1 BX% #JKWB@V[9%6*K7IQ ?I0!Y'XU
MC&V2O#=93_2&^M>Y^-&^62O#]9;_ $AOK0,R@/EJ6R_UX^M1D_+4EE_KQ]:
M/7?!?6.O;]&_U"_2O$/!?6.O;M&_U"_2@#9HHHH$%%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^^E>[>&O]2E F=C']VGTR/[M/H$%)2T4 %%%% !1110 4444 %%%% !1110
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M6AHWF6\@SFNZU728U0G:*Y:2%89#B@5SL=.U7RX@"W:H-4U4R1D!JY@7AC7
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MEV?^K%6ZJ6?^K%6Z!!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 F!Z4;1Z"EHH ,48'I110 FT>@HP/2EHH :44]5%(88S_"*?10
M!'Y$8_A%.$:#HHIU% !@#M1110 4E+10 4444 %%%% !1110 4444 %%%% "
M'I63J/W#6L>E9.H_<-5'<#SW7>K5PEY_K#7=Z[U:N$O/]8:]2CL,FT[[XKT'
M0OX:\^T[[XKT'0OX:5?81WEC]P5H]JSK'[@K1[5YDMP"BBBI **** "BBB@
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M5XE8#_3Q]:]M\( _9T^E '74444 %87B7_CT/TK=K"\2_P#'H?I0!\]>,?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[2BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M3(T.<"K<<*Q]*DHH *1AN&#2T4 5);%).H%0C2HP<X%:-% %>*U6+I5BBB@
MJ.2%7'-244 4'TR-SG IT6GQQG@"KM% "*H48%+110 55OO]0?I5JJ]V,PF@
M#R+QHI*R5XCK,9\]OK7O_BNT,BOQ7C>M::PE8[: ./*D+4EE_KQ]:L7%N4!X
MJ"S&+@?6@9ZYX+ZQU[?HW^H7Z5X?X+ZQU[AHW^H7Z4"-BBBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !52>R6<<BK=% '%>(M"C$)8*.E>6:C:B"X( [U[?XA<"T(/I7C.
MMN#=-]: +V@']XM>GZ?_ ,>P^E>7^'R#*M>IZ:N;8?2@#A?&W^J>O+]/_P"0
MF/\ >KU;QO"3$]>46?[O4QG^]0,]S\,?\>*_2L/Q:>6K2\-WL:6*@D=*P/%E
M]&[, PH YZQ.9JEU<?Z.?I4.E?O)N*T]4M&:V/':@#@8/^/W\:]9\+G]POTK
MR];8QWN2.]>D>';I(H%!/:@&;FKG]T?I7#W9S(:ZG5M1B,9&X5R<D@ED.#0(
MJ24Q.M7OLC.,@5&UJR')% %S3_OBNUT\_N?PKA;698G&3756&I1",#<* *'B
M8_NFKS.3_C[_ !KT;Q!<)-&V"*X/[*TEUD#O0!T.F?Z@?2DG_P!<*N6%HR6X
MR.U4;UO+FYH&=OX7/RBK'BT_Z$WTK)\,7\:@ L*N^*;R.2R8 CI0(\<N/^0F
M?]ZO4O"V1:KCTKRZ52^I9']ZO7O!=J9($!':@9E^*)IUC;;GI7F%U<W@F/WN
MM?0FI>&Q=@C;FN8N_ *G+>7^E 'C_P#:UU"O+-56?Q+-T+G\Z[C7O"?V9&PF
M/PKS#5K%H)&'O0 ZYU5K@'+5E;MTV?>FJI -"?ZT4#/1?!P_>)7O_AK_ %"?
M2O /!W^L2O?_  U_J$^E F=/1110(**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M1A^=3)<QOT->4VFNR.X^8UU>EWSRA<F@#L P/2EJM;,6459H **** "BBB@
MHHHH *:7 ZTK?=-9=W=>7GF@#1,R#O2>>GK7,3:KM/WJKG6@/XJ .P\Y/6CS
MT]:X\:ZO][]:#K@_O4 =?]H3UI1,I[UQHUH$_>K0M-2\PCF@#I00:6JMO)O
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MH$=,GW12TB?=%+0 4444 <IXH_U;_2O#/$_^L>O<_%'^K?Z5X9XG_P!8] '
M7O>J%K_Q\CZU?O>]4+7_ (^1]:"CUWP1]Z.O>-#_ ./9?I7@_@C[T=>]:&/]
M$'TH)-6BB@G R: "O-/';)\_-=AJ6L):JWS 5Y'XPU]9F<!Z .=L&7^T!]:]
MP\(,GV51D9Q7SG;ZF$N]V>]>J^$_$ZHB+O\ UH&SV"BLK3]52Z ^8'-:O6@0
M5@^)?^/0_2MZL/Q*/]"/TH ^>/&/^M>O/7^^:]"\9?ZY_K7GK_?- QB?ZT5Z
M5X*_UL?UKS5/]:*]*\%?ZV/ZT ?0WA__ (\E^E;%8_A__CR7Z5L4""BBB@ J
MO>?ZDU8JO>?ZDT <#KG5JXZX^^:['7.K5QUQ]\TQ%)_O5M:-_K%K%?[U;6C?
MZQ: /3M$_P!6M;E8FB?ZM:VZ0PHHJ*681CK0!6U3'V8YKSK4,?:3]:[#5]0'
ME$9[5PEY<!IR<]Z8'5>'L96NS'W17G.BWPC8<UVUM?K(J\T@-&BFHP89%.H
MCG_U+5P/B+^*N^G_ -2U<!XB_BH X&Y_UII4HN?]::6.F(U],_U@KT;0_N+7
MG6F?ZP5Z+H?W5H8'14444AA1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MNWAK_4I7A/A+[Z5[MX:_U*4"9V,?W:?3(_NT^@04444 %%%% !1110 4444
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M_O6^M ',%<$U"/\ 7"I2^2:B7_6B@H]$\'?ZQ*^@/#0_<)]*^?\ P=_K$KZ
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MU>:^';VX<KN)KK+V5VLSG/2@1Y%XP.97^M>>R#YS7H'BOF1ZX&3[YH&B)/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5D:K]TUKUD:K]TU4=P
M.#U3[QJA:?ZT?6K^J?>-4+3_ %H^M=\?A [K0^BUU Z5R^A]%KJ!TKBJ;@%%
M%%9@%%%% !1110 4444 %<=XH^ZU=C7'>*/NM6M+X@/.)/\ CZ_&NT\/=%KB
MY/\ CZ_&NT\/=%KMJ_"!W5K]P5:JK:_<%6J\Y@%%%%( HHHH **** "BBB@
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M2R'&:DM%FC()S776NB+-@[:L7.AK#$2%H S]*U)XG4%J])T'4?."C=7D<_\
MH\^!QS7:>%K[YER: /5T.4!IU9T.H1K "Q'2J<_B"&-L;Q0!NTR7_5/]*PH_
M$4+'[X_.G7.NQ>0V&'2@#SGQ[]V2OG[6?^/MOK7M_C34%F5\&O$-6^:Z)]Z!
MG1^$/]<GUKZ/\&_ZE*^<?"(Q,GUKZ.\&_P"I2@1V=%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !69K?\ QYGZ5IUF:W_QYGZ4
M >"^-/\ 625Y?<?ZT_6O4/&G^LDKR^X_UI^M T1THI*44#%HHHH **** "BB
MB@!&^[50_P"M'UJVWW:J'_6CZT =WX/_ -<GUKZ%\+?ZA/I7SUX/_P!<GUKZ
M%\+?ZA/I0)G5T=J*.U CSSQG_JWKP3Q!_KVKWOQG_JWKP3Q!_KVH YF2EM/]
M:/K224MI_K1]:"CT3PYT6O0K7_5"O/?#G1:]"M?]4*:)8K]:1>M*_6D7K0 Z
M7_5FN6UG[K5U,O\ JS7+:S]UJ . U/[[5SUUWKH=3^^U<]==Z0T/TK_CX7ZU
M[=X)Z1_A7B.E?\?"_6O;O!/2/\* 9[-IW_'NOTJ[5+3O^/=?I5V@04444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5!=+NB-
M3TUP"O- 'FWB>QEF#[0:\CUO1;D2,=K5]&WL$#YWXKBO$-E:;&("YH ^>KRS
MDB!W U1M!BX'UKM?$D,2%MN*XV$8NOQH&>K^"SS'7N&C?ZA?I7AW@O[T=>X:
M+_J%^E C9HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH ;)_JV^E>:^+ONO7I4G^K;Z5YKXN^Z] 'B>N_ZUJYB7J:Z?7?\ 6M7,
M2]30,8M/IBT^@84444 %%%% !1110!7FK1T7_7K]:SIJT=%_UZ_6@#V_P=]V
M.O6K#_5+]*\E\'?=CKUJP_U2_2@DNUDZY_Q['Z5K5DZY_P >Q^E 'B7BS[\E
M>87_ -]J]/\ %GWY*\PO_OM0-&.?]973:']]:YD_ZRNFT/[ZT >EZ1_JUK;'
M2L32/]6M;8Z4Q!4@Z5'4@Z4 9FH?<-<-K'5J[G4/N&N&UCJU ''7O4UE)_K_
M ,:U;WJ:RD_U_P"-(H]"\)??2O=O#7^I2O"?"7WTKW;PU_J4H$SL8_NT^F1_
M=I] @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** (Y8A(,&J;Z7&YR0*T** *
M,>G1QG@"K21A!@5)10 UD#=:J3Z=%,#P*NT4 <]+X?B9ON#\J?!X>A0Y*"MZ
MB@"K!8Q0@;0*L@ #%+10!!-:I,,$5E3Z%%(3\@K<HH YY/#4(;.P5H6^E108
MP!6C10 U$"+@4.@<8-.HH S;C2(ILY K/?PU"6SL'Y5T5% &+;Z'%$1\HK4A
MMTB& *FHH 0@$8-5)]/BF'(%7** ,"?P["QR$%-AT")&^X*Z&B@"G!I\4(Z"
MK2H%Z4ZB@ J"Y_U9J>HIQE#0!YOXK0E'KP[Q% WFMQWKZ$\06OFHW%>2>(-)
M)9CMH \O,97-1+_K16Y>67E$\5BD8GQ[T%'H7@[_ %B?6O?_  U_J$^E?/\
MX._UB5] >&O]0GTH$SIZ***!!1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MGVG??%>@Z%_#2K[".\L?N"M'M6=8_<%:/:O,EN 4445(!1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 5#<MMB)J:H;A=\9% '">(=8>V
M#8)XKRS7/%<S.R[C7JOB#17N@V%)S7EVN^$9E9FV'\J!G":CJ;7())K)M6W7
M(^M;&I:6]MD$&L>U7;<CZT#/6?!8^:.O<-&_U"_2O#_!9^:.O<-%_P!0OTH)
M-BBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M_P!?^-(H]"\)??2O=O#7^I2O"?"7WTKW;PU_J4H$SL8_NT^F1_=I] @HHHH
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M@ HHHH CEZ4EG_KQ]:67I26?^O'UH ]3\(_>2O:]"_U2_2O%/"/WDKVO0O\
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MP5Z-H?W%H8'14444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M=*_X^%^M>W>">D?X4 SV;3O^/=?I5VJ6G?\ 'NOTJ[0(**** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT/[BUYSIG^L%>C:']Q:&!T5%%%(84444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M#J2DG8/RK#D\'H[_ '/TKT<@'J*3RT_NB@#B+'PDD+ [!^5=38V"VP'&,5H
M =!10 C*&4BL74-'6Y!^7K6W10!Y]=^#TE8G8/RIEMX/2-@=@_*O0RH/4"DV
M+Z"@#!T_15@ ^6MN*$1C J7I10 5#<?<J:H+DXC- '+ZMC!K@=9VX:NUUJ7:
M&KSC6[HC=0!Q6M;=S8KC;K_6UTNJSEG:N:GYDH&=3X4_UZ?6OHKP;_J4KYU\
M*_Z]/K7T5X-_U*4".SHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MW@GI'^% ,]FT[_CW7Z5=JEIW_'NOTJ[0(**** "BBB@ HHHH **** "BBB@
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M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #9/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M#.C\.?ZU?K7N7A/[B5X;X<_UJ_6O<O"?W$H!GI=G_JQ5NJEG_JQ5N@04444
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M[RQ^X*T>U9UC]P5H]J\R6X!1114@%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !3)2H3YJ?6-K%\+>(\XXH J:G>0Q!LD5QFH>(H8
M&.&%9NOZ^Q9E#?K7#7DMQ=L=I)S0!VR^-55\!_UK;T_Q2ER0"U>/'3KO=NPU
M:-C-/:,-Q(H&>^Z=<PS@'(KH(0NWBO'_  _KYRJE_P!:].TF]%Q&.<T"-:BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K"U__ %3?
M2MVL+7_]4WTH \2\7=7KS1O^/G\:]+\7=7KS1O\ CY_&@9Z!X2^^E>VZ%_J5
M^E>)>$OOI7MNA?ZE?I0(Z=/NBEI$^Z*6@ HHHH Y3Q1_JW^E>&>)_P#6/7N?
MBC_5O]*\,\3_ .L>@#@+WO5"U_X^1]:OWO>J%K_Q\CZT%'KO@C[T=>\:'_Q[
M+]*\'\$?>CKWC0_^/9?I02:]%%% !1110 4444 %%%% !6#XE_X]#]*WJP?$
MO_'H?I0!\]^,?]:]>>2??->A^,?]:]>>2??- R-/]:/K7I?@K_6Q_6O-$_UH
M^M>E^"O];']: 9]#>'_^/)?I6Q6/X?\ ^/)?I6Q0(**** "J]Y_J35BJ]Y_J
M30!P.N=6KCKC[YKL=<ZM7'7'WS3$4W^]6SHW^L6L5_O5M:-_K%H ].T3_5K6
MY6'HG^K6MRD,**** $P/2C:OH*6B@!-H]!2XHHH **** (Y_]2U<#XB_BKOI
M_P#4M7 ^(OXJ . N?]::5*2Y_P!::5*8C8TS_6"O1M#^XM><Z9_K!7HVA_<6
MA@=%1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% #)/NUQWB7_ %+UV,GW:X[Q+_J7H \)\6?ZQZX!_P#6_C7?^+/]8]<
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MJ%>>^'.BUZ%:_P"J%-$L5^M(O6E?K2+UH =+_JS7+:S]UJZF7_5FN6UG[K4
M<!J?WVKGKKO70ZG]]JYZZ[TAH?I7_'POUKV[P3TC_"O$=*_X^%^M>W>">D?X
M4 SV;3O^/=?I5VJ6G?\ 'NOTJ[0(**** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M<4 5[*U\D#BM&DP/2EH *3-+24 +1110 4444 %%%% !1BBB@ HHHH ****
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M/I02;-4M0_U3?2KM4M0_U3?2@#R7QC]U_P :\/UO_7M]:]P\8_=?\:\/UO\
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ME CIT^Z*6D3[HI: "BBB@#E/%'^K?Z5X9XG_ -8]>Y^*/]6_TKPSQ/\ ZQZ
M. O>]4+7_CY'UJ_>]ZH6O_'R/K04>N^"/O1U[QH?_'LOTKP?P1]Z.O>-#_X]
ME^E!)KT444 %%%% !1110 4444 %8/B7_CT/TK>K!\2_\>A^E 'SWXQ_UKUY
MY)]\UZ'XQ_UKUYY)]\T#(T_UH^M>E^"O];']:\T3_6CZUZ7X*_UL?UH!GT-X
M?_X\E^E;%8_A_P#X\E^E;% @HHHH *KWG^I-6*KWG^I- ' ZYU:N.N/OFNQU
MSJU<=<??-,12?[U;6C?ZQ:Q7^]6UHW^L6@#T_1/]6M;=8FB?ZM:VZ0PHHHH
M**** "BBB@ HHHH CG_U+5P/B+^*N^G_ -2U<#XB_BH X"Y_UII4I+G_ %II
M4IB-C3/]8*]&T/[BUYSIG^L%>C:']Q:&!T5%%%(84444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M,Q9MV:Y:X_UG- SI_"0Q.GUKZ,\&_P"I2OG7PI_KT^M?17@W_4I0([.BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M5H$8E]8F*T/':O/[VX^SWG/K7M>L:=_HQ ':O'?$FER+.S*IZT#.HT#Q&D<
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MT_1/]6M;=8FB?ZM:VZ0PHHHH **** "BBB@ HHHH CG_ -2U<#XB_BKOI_\
M4M7 ^(OXJ . N?\ 6FE2DN?]::5*8C8TS_6"O1M#^XM><Z9_K!7HVA_<6A@=
M%1112&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %9&J_=-:]9&J_=-5'<#@]4^\:H6G^M'UJ_
MJGWC5"T_UH^M=\?A [K0^BUU Z5R^A]%KJ!TKBJ;@%%%%9@%%%% !1110 44
M44 %<=XH^ZU=C7'>*/NM6M+X@/.)/^/K\:[3P]T6N+D_X^OQKM/#W1:[:OP@
M=U:_<%6JJVOW!5JO.8!1112 **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M;)_JV^E>:^+ONO7I4G^K;Z5YKXN^Z] 'B>N_ZUJYB7J:Z?7?]:U<Q+U- QBT
M^F+3Z!A1110 4444 %%%% %>:M'1?]>OUK.FK1T7_7K]: /;_!WW8Z]:L/\
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M>F)L49K!MECC(Z5L07L<8'(H WJ*RAJ<?]X5(NH(Q^\* -&BJ\=P'[U.#D4
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M1110 R3[M<=XE_U+UV,GW:X[Q+_J7H \)\6?ZQZX!_\ 6_C7?^+/]8]< _\
MK?QH&6%^[3J:OW:=0,**** "BBB@ I#TI:0]* &]ZM6O^L%5>]6K7_6"@#TG
MPC_K$KW;P_\ \>H^E>$^$?\ 6)7NWA__ (]1]*"39JEJ'^J;Z5=JEJ'^J;Z4
M >2^,?NO^->'ZW_KV^M>X>,?NO\ C7A^M_Z]OK0-&?:]:Z+3OO"N=M>M=%IW
MWA0@.[T?HM=9;_<%<GH_1:ZRW^X*8AS=:0=:5NM(.M "3_ZLUP_B'HU=Q/\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M2OHGP;_J4H$=G1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MOBH!R-_ZT >E:IJ:R0D!NU>;:TKS2-@TW_A)1(,%_P!:B.I12G)(H&84UE*
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MY9#JCLW4UTNEWC.5YH [Z*;>*FK,L7+**TATH 6BBB@ HHHH **** "BBD+
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M]J\R6X!1114@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M[WJA:_\ 'R/K04>N^"/O1U[QH?\ Q[+]*\'\$?>CKWC0_P#CV7Z4$FO1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MC\UTPO\ &>]>K^")2ZI7CLYSJ''K7KO@0?*E 'I-%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4UUW#%.HH S;G2UG!R!6+>>$XI4<[1TKK*1ONGZ4 ?/WC#P^EH
M'(7%>.:I^ZN2OO7T1\0&!62OG?6_^/QOK0,Z7PBV9DKZ-\&_ZE*^</!_^N3Z
MU]'^#?\ 4I0([.BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ K,UO_ (\S]*TZS-;_ ./,_2@#P7QI_K)*\ON/]:?K7J'C3_62
M5Y?<?ZT_6@:(Z44E**!BT444 %%%% !1110 C?=JH?\ 6CZU;;[M5#_K1]:
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M6]5XH I6FG.6!P:ZO2K-DQQ6K9Z(,#Y:U[?31'CB@"2RCVJ*TATJ**+8*FH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH ***:[;10 ZD?[C?2J,]\(N]9%YX@6.-QN[4 <+X_(VR<^M?/6M?\
M'XWUKV;QCJXN XW5XSJGSW)/O0,Z/P?_ *Y/K7T?X-_U*5\Y>$1B=/K7T;X-
M_P!2E CLZ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M8E#;JY^V_P"/D?6@:/6/!?WHZ]QT7_4+]*\.\%_>CKW'1?\ 4+]*!&Q1110
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M%  !@44E+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6%K_\
MJF^E;M86O_ZIOI0!XEXNZO7FC?\ 'S^->E^+NKUYHW_'S^- ST#PE]]*]MT+
M_4K]*\2\)??2O;="_P!2OTH$=.GW12TB?=%+0 4444 <IXH_U;_2O#/$_P#K
M'KW/Q1_JW^E>&>)_]8] ' 7O>J%K_P ?(^M7[WO5"U_X^1]:"CUWP1]Z.O>-
M#_X]E^E>#^"/O1U[QH?_ ![+]*"37HHHH **** "BBB@ HHHH *P?$O_ !Z'
MZ5O5@^)?^/0_2@#Y[\8_ZUZ\\D^^:]#\8_ZUZ\\D^^:!D:?ZT?6O2_!7^MC^
MM>:)_K1]:]+\%?ZV/ZT SZ&\/_\ 'DOTK8K'\/\ _'DOTK8H$%%%% !5>\_U
M)JQ5>\_U)H X'7.K5QUQ]\UV.N=6KCKC[YIB*3_>K:T;_6+6*_WJVM&_UBT
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MJUS8Q1)D@4@/,VT/9_#49TM1VKK-0DBB)Z5ARW<>X\B@#,.G+Z4UM+4]JO\
MVE,]12_:H_44 +INEJL@.VO0]%@$:+@5QFGW2%QR*[C27#*,4 ;-%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M=:NIE_U9KEM9^ZU ' :G]]JYZZ[UT.I_?:N>NN](:'Z5_P ?"_6O;O!/2/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** &R?ZMOI7FOB[[KUZ5)_JV^E>:^+ONO0!XGKO^M:N8EZF
MNGUW_6M7,2]30,8M/IBT^@84444 %%%% !1110!7FK1T7_7K]:SIJT=%_P!>
MOUH ]O\ !WW8Z]:L/]4OTKR7P=]V.O6K#_5+]*"2[63KG_'L?I6M63KG_'L?
MI0!XEXL^_)7F%_\ ?:O3_%GWY*\PO_OM0-&.?]973:']]:YD_P"LKIM#^^M
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M5B0X[4 =M&<H*?38QA13J "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "L+7_]4WTK=K"U_P#U3?2@#Q+Q=U>O-&_X^?QKTOQ=U>O-&/\
MI/XT#/0/"7WTKVW0O]2OTKQ+PE]]*]MT+_4K]*!'3I]T4M(GW12T %%%% '*
M>*/]6_TKPSQ/_K'KW/Q1_JW^E>&>)_\ 6/0!P%[WJA:_\?(^M7[WO5"U_P"/
MD?6@H]=\$?>CKWC0_P#CV7Z5X/X(^]'7O&A_\>R_2@DUZ*** "BBB@ HHHH
M**** "L'Q+_QZ'Z5O5@^)?\ CT/TH ^>_&/^M>O/)/OFO0_&/^M>O/)/OF@9
M&G^M'UKTOP5_K8_K7FB?ZT?6O2_!7^MC^M ,^AO#_P#QY+]*V*Q_#_\ QY+]
M*V*!!1110 57O/\ 4FK%5[S_ %)H X'7.K5QUQ]\UV.N=6KCKC[YIB*3_>K:
MT;_6+6*_WJVM&_UBT >GZ)_JUK;K$T3_ %:UMTAA1110 4444 %%%% !1110
M!'/_ *EJX'Q%_%7?3_ZEJX'Q%_%0!P%S_K32I27/^M-*E,1L:9_K!7HVA_<6
MO.=,_P!8*]&T/[BT,#HJ***0PHHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K(U7[IK7K(U7[IJ
MH[@<'JGWC5"T_P!:/K5_5/O&J%I_K1]:[X_"!W6A]%KJ!TKE]#Z+74#I7%4W
M ****S **** "BBB@ HHHH *X[Q1]UJ[&N.\4?=:M:7Q ><2?\?7XUVGA[HM
M<5)_Q]?C7:^'CPM=M7X0.ZM/NBK55;3[HJU7G/<!DCA$)-<KKNJB*-L&N@OV
M(0X]*\]\1%V#4@.1UG7V\Q@&K%CU665^II;RR>:<_6M;1_#IE89% %1;J4C/
M-(UU+GO7;)X4^0?+2-X3Y^[0!@:1<RF5<YKU'P^Y9%S7-6/AKRG!VUV>EV?V
M=0,4 :]%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4449H **,T4
M %%%% !1110 4444 %%%% !1110 4444 %%%% !2,,BEHH K20!NU4+O3U>)
MOE[5L4R0 Q-GTH \,\;60C#G%>(:M\MT1[U]!>/E 62OG[6?^/QOK0,Z/PB<
MSI]:^CO!O^I2OG#PA_KD^M?1_@W_ %*4".SHHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M -6*MT""BBB@ HHHH **** "BBB@ HHHH 9)]VN.\2_ZEZ[&3[M<=XE_U+T
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M?:=]\5Z#H7\-*OL([RQ^X*T>U9UC]P5H]J\R6X!1114@%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%%  1FL36[$7$38'45MTR2,.N#
M0!XCK_AMW=F537'SZ)<0L< U]!ZC8P%26 KC=2M[1"<[: /)/[/NMW1JMV^A
MW$S#*DUVNVT\S'RUNZ9;6KD8"T 8/A_PVZ,I*5ZKHUF+>(#':F:?90A 5 K7
MC0(N!0 ^BBB@ HHHH **** "BBB@ HHI"P% "T5&9E'>E$BF@!]%%(S!1DT
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>1@ PK?L[A)0-M>$Z-J-RTJY)KUOPW*\B+NH ZFBBB@ HHHH **** "BBB@
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M(_PKQ'2O^/A?K7MW@GI'^% ,]FT[_CW7Z5=JEIW_ ![K]*NT""BBB@ HHHH
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MBB@ HHHH **** "BBB@ HHHH I7W^K->8^+/NO7IU]_JS7F/BS[KT >):_\
MZYOK7/Q_>KH-?_US?6N?C^]0,LCI10.E% PHHHH **** "FMTIU-;I0 D7WJ
MZ;1?]:M<S%]ZNFT7_6K0(]B\)]$KU2T_X]UKROPGT2O5+3_CW6@1))_JS7'^
M(/\ 5M]*["3_ %9KC_$'^K;Z4 >+>*OO/7F=Y_KC]:],\5?>>O,[S_7'ZT#1
M;L.HKL](ZK7&6'45V>D=5H!G;Z?]T5KK]VLC3_NBM=?NTQ#::U.IK4 96H_<
M->>ZYU:O0M1^X:\]USJU (XR;_6_C6GIWWEK,F_UOXUIZ=]Y:0STCPQ]]*]I
M\._ZM*\6\,??2O:?#O\ JTH$=+1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !4<IPIJ2HI_N&@#F-8G"*V:\TU^_3+<UW_B!'*MBO)/
M$$,VYN#0!RNJW*N6Q7+2'-Q^-;5['(N<YK#8?OQ]:!GH/@[_ %J5] ^&/]0G
MTKY_\'?ZU*^@?#/^H3Z4 =+61K'^H;Z5KUDZQ_J&^E CQ3QEU>O']0_UY^M>
MP>,NKUX_J'^O/UH&AD72I:BBZ5+0,**** "BBB@ HHHH 8>M/3K3#UIZ=: .
ML\.?ZY:]X\'_ '$KP?PY_KEKWCP?]Q*"3NZKW?\ JZL57N_]7^% 'G7BH#8]
M>&>)4'FO]:]T\5?<>O#?$O\ K7H&CD5C&^K2Q BJZG]Y6A"FZ@9$+<'M3Q:>
MU:UM9%\<5I1Z26'W:!',?9CZ4?9CZ5U9T@_W:;_9!_NT!<Y7[)[4TVV.U=:=
M(./NU2N=.,8/% '-O$ *C5!NJY=)L)JHARU S8TM!YJUZWX049CKR;3/]:M>
MM>$.L= CV33/^/45=JEIG_'J*NT""BBB@ HHHH **** "BBB@ HHHH *Y'Q3
M_JGKKJY'Q3_JGH \*\3_ .M?ZUP]Q]XUW'B?_6O]:X>X^\:0RN.M25&.M24Q
MA1110 4444 %%%% $<O2DL_]>/K2R]*2S_UX^M 'J?A'[R5[7H7^J7Z5XIX1
M^\E>UZ%_JE^E!)TJ_=%0WG_'J]3+]T5#>?\ 'J] 'DOB[J]>.ZO_ *UJ]B\7
M=7KQW5_]:U T<W/]ZM'2?]8M9T_WJT=)_P!8M STO0_N+75Q?=%<IH?W%KJX
MONBF2/IRTVG+0!!=_<-<?K'1J["[^X:X_6.C4 </J'WC7/3_ .LKH=0^\:YZ
M?_64AG1^'/\ 6K]:]R\)_<2O#?#G^M7ZU[EX3^XE ,]+L_\ 5BK=5+/_ %8J
MW0(**** "BBB@ HHHH **** "BBB@!DGW:X[Q+_J7KL9/NUQWB7_ %+T >$^
M+/\ 6/7 /_K?QKO_ !9_K'K@'_UOXT#+"_=IU-7[M.H&%%%% !1110 4AZ4M
M(>E #>]6K7_6"JO>K5K_ *P4 >D^$?\ 6)7NWA__ (]1]*\)\(_ZQ*]V\/\
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M]IWWQ7H.A?PTJ^PCO+'[@K1[5G6/W!6CVKS);@%%%%2 4444 %%%% !1110
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M;WJ:RD_U_P"-(H]"\)??2O=O#7^I2O"?"7WTKW;PU_J4H$SL8_NT^F1_=I]
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MTKVGP[_JTKQ;PQ]]*]I\._ZM*!'2T444 %%%% !1110 4444 %%%% !1110
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MH \)\6?ZQZX!_P#6_C7?^+/]8]< _P#K?QH&6%^[3J:OW:=0,**** "BBB@
MI#TI:0]* &]ZM6O^L%5>]6K7_6"@#TGPC_K$KW;P_P#\>H^E>$^$?]8E>[>'
M_P#CU'TH)-FJ6H?ZIOI5VJ6H?ZIOI0!Y+XQ^Z_XUX?K?^O;ZU[AXQ^Z_XUX?
MK?\ KV^M T9]KUKHM.^\*YVUZUT6G?>%" [O1^BUUEO]P5R>C]%KK+?[@IB'
M-UI!UI6ZT@ZT )/_ *LUP_B'HU=Q/_JS7#^(>C4 >;:C_K34,'45-J/^M-0P
M=12*.ET3_7+7MW@WHE>(Z)_KEKV[P;T2@D]/B_U2_2GTR+_5+]*?0 AZ5DZC
M]PUK'I63J/W#51W \]UWJU<)>?ZPUW>N]6KA+S_6&O4H[#)M.^^*]!T+^&O/
MM.^^*]!T+^&E7V$=Y8_<%:/:LZQ^X*T>U>9+< HHHJ0"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** $I:!10!',<1FO-_%\S!'Q7H\XRAKS
M_P 66Q:-SB@#R(YDON?6O6O!&FQ2*A8"O*KC_1[PD^M=[X4\21VFT%@,4 >M
M?98-FWRUQ7G'CG3HH@Y4"NA_X32WZ96N'\6>(H[S=A@<T >>Q%H[_ ]:]A\&
MRL8DS7DMHGGW@(]:]@\)6Q6).* .]0Y44ZFQ_<%.H **** "BBB@ JM=W @C
MR34DDP3K7->(-2"QL >U &%XGUX!&4-7CVM7;W,[$$]:Z77+QYI&&:PHK$S-
MDB@"GHZ2"<$YZUZ[X;FV1+DUP=G8")@<5V.DOY:@"@#9U^\/V5L'M7CVJ/)-
M?$9/6O2M:E+0'Z5P7DB2^Y]: -S0=+:2 $CM5'Q)9-;@D#%>A^&;%/LHX[5A
M^-+151N* .$\/73I>J"3UKW/P_>_Z&,GM7A&EKLOA]:]3TR],-H.>U ';2ZF
MJ?Q5#_;*?WJ\YU?Q)Y+'YZPAXO\ F^_0,]E_M=<?>K$UO55:)OF[5YZ/%OR_
M?K.OO$_FJ1OH I>*;H.7YKS[=FY_&MO5]2\[=S7/0ONN/QH ](\)??2O;-"_
MU*_2O%?"0^9*]JT+_5+]*!'3)]T4ZFI]T4Z@ HHHH Y3Q1_JW^E>&>)_]8]>
MY^*/]6_TKPSQ/_K'H X"][U0M?\ CY'UJ_>]ZH6O_'R/K04>N^"/O1U[QH?_
M ![+]*\'\$?>CKWC0_\ CV7Z4$FO1110 4444 %%%% !1110 5@^)?\ CT/T
MK>K!\2_\>A^E 'SWXQ_UKUYY)]\UZ'XQ_P!:]>>2??- R-/]:/K7I?@K_6Q_
M6O-$_P!:/K7I?@K_ %L?UH!GT-X?_P"/)?I6Q6/X?_X\E^E;% @HHHH *KWG
M^I-6*KWG^I- ' ZYU:N.N/OFNQUSJU<=<??-,12?[U;6C?ZQ:Q7^]6UHW^L6
M@#T_1/\ 5K6W6)HG^K6MND,**** "BBB@ HHHH **** (Y_]2U<#XB_BKOI_
M]2U<#XB_BH X"Y_UII4I+G_6FE2F(V-,_P!8*]&T/[BUYSIG^L%>C:']Q:&!
MT5%%%(84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 5D:K]TUKUD:K]TU4=P.#U3[QJA:?ZT?6K
M^J?>-4+3_6CZUWQ^$#NM#Z+74#I7+Z'T6NH'2N*IN 4445F 4444 %%%% !1
M110 5QWBC[K5V-<=XH^ZU:4OB \WD_X^OQKM?#W1:XJ3_CZ_&NU\.C(6NZM\
M('=6OW15JJUL-L8-17&H+!U-><]P+K %3FN,\2;1&V*TY]?3[H85SFJW/VM&
MP<YI >7ZU.4G;'K5?3M8:)^M;FIZ*]PY(6LR/PU,&R%- &W%XE8)C=2-XE;/
MWJSAX?N /NFF-H%QG[II#.GTS7S+(!NKT;0[KSD7FO)])T:>.525->I^'K=H
MD7-,1TM%%!H ,T4E+0 4444 %%%% !1110 4444 %%%% !1110 5',VR,FI*
MANAF$XH Y'7M3,:, :\HUZ_DFD;!->CZ]:22EL UP5[I3>825H XY1*9@>>M
M=_X4+;TS7/M8!&Z5U'AQ LJT#/3[5MMH#[5Q'BK4#'N -=G$<6/X5Y?XPG(E
M89[T 8 E>YE(SGFI+C29'CW8-)H*B:X&?6O0XM,C>U!P.E 'EL5E)!-T/6NN
MTF]:!!DT_4;!(G.!64\GE#B@1T\^LGR\;JYO4+EK@G!K/EO6+8S5BT_>L,T
M9K:=),^<&IDTR2)<X-=GI^G)( 2*LWVG)' 2!VH XRUN7MY0":]#\-WYDV@F
MO-=0_=7/'K74>%[LJR\T >Q0N&B!SVI&F53UK &K"*WY;M6!>>*DCD(WT =\
M)T/>FW$JB!N>U>?1>+4)^_4MQXI1H2-_:@#FO'<H99.:\#UGF[;ZUZSXJU87
M ?#9KR74OGN"?>@:.D\(?ZY/K7T=X-_U*5\Y^$AB9/K7T9X-_P!2E CLZ***
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LS6_\
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M@KT;0_N+0P.BHHHI#"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !69K?\ QYGZ5IUF:W_QYGZ4 >"^-/\ 625Y?<?Z
MT_6O4/&G^LDKR^X_UI^M T1THI*44#%HHHH **** "BBB@!&^[50_P"M'UJV
MWW:J'_6CZT =WX/_ -<GUKZ%\+?ZA/I7SUX/_P!<GUKZ%\+?ZA/I0)G5T=J*
M.U CSSQG_JWKP3Q!_KVKWOQG_JWKP3Q!_KVH YF2EM/]:/K224MI_K1]:"CT
M3PYT6O0K7_5"O/?#G1:]"M?]4*:)8K]:1>M*_6D7K0 Z7_5FN6UG[K5U,O\
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M]OT;_4+]*"38HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MCPQ]]*]I\._ZM*\6\,??2O:?#O\ JTH$=+1110 4444 %%%% !1110 4444
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ML57N_P#5T >=^*ON/7AGB;_6/7N?BK[CUX9XF_UKT CDH_\ 6UO:?U6L%/\
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MYKT/QC_K7KSR3[YH&1I_K1]:]+\%?ZV/ZUYHG^M'UKTOP5_K8_K0#/H;P_\
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M\3%FQOK;T_5S,1\U>70+-Y@ZUV.AK)E<YH$>A6\N]0:LU1L0?+&:O4 %%%%
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M)]VN.\2_ZEZ[&3[M<=XE_P!2] 'A/BS_ %CUP#_ZW\:[_P 6?ZQZX!_];^-
MRPOW:=35^[3J!A1110 4444 %(>E+2'I0 WO5JU_U@JKWJU:_P"L% 'I/A'_
M %B5[MX?_P"/4?2O"?"/^L2O=O#_ /QZCZ4$FS5+4/\ 5-]*NU2U#_5-]* /
M)?&/W7_&O#];_P!>WUKW#QC]U_QKP_6_]>WUH&C/M>M=%IWWA7.VO6NBT[[P
MH0'=Z/T6NLM_N"N3T?HM=9;_ '!3$.;K2#K2MUI!UH 2?_5FN'\0]&KN)_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MHH *R-2N/*!YK7KG-;5BK8H YZ]U?8Y&ZLY]=V_Q51U"*4R-P:P[R.5$)YH
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M'^J7Z5Y+X.^['7K5A_JE^E!)=K)US_CV/TK6K)US_CV/TH \2\6??DKS"_\
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MTP]:>G6@#K/#G^N6O>/!_P!Q*\'\.?ZY:]X\'_<2@D[NJ]W_ *O\*L57N_\
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M8FB?ZM:VZ0PHHHH **** "BBB@ HHHH CG_U+5P/B+^*N^G_ -2U<#XB_BH
MX"Y_UII4I+G_ %II4IB-C3/]8*]&T/[BUYSIG^L%>C:']Q:&!T5%%%(84444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_6&O4H[#)M.^^*]!T+^&O/M.^^*]!T+^&E7V$=Y8_<%:/:LZQ^X*T>U>9+<
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MH2-N&:=5:R??$#5F@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI^N?,,M0!ZFCAUR*=7.Z9JZNH!:MZ*990"* )**** "J6IG%FU7:I:F,V;4
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MTZ?=%+2)]T4M !1110!RGBC_ %;_ $KPSQ/_ *QZ]S\4?ZM_I7AGB?\ UCT
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M &WH/B<LRAGKT_1[\740YSFOG*QG>VNPN3UKVGP9=&6-,F@1W5%%% !1110
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MX+',=>X:-_J%^E>'>"S\T=>X:+_J%^E,1LT444 %%%% !1110 4444 %%%%
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MQ^Z_XUX?K?\ KV^M>X>,?NO^->'ZW_KV^M T9]KUKHM.^\*YVUZUT6G?>%"
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M=O>MZRT<10@8H X;6&-M$<>E><ZIJ3F4C/>O7_$6D-*C "O.+OPO*\Y.T]:
M*6ANTLRGWKV3PS"?+2N'T'PVT3J2M>J:)9""-<CM0!L1#"BI*,8HH *,T4E
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>P>,NKUX_J'^O/UH&AD72I:BBZ5+0,**** "BBB@ HHHH 8>M/3K3#UIZ=:
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MA/[B5X;X<_UJ_6O<O"?W$H!GI=G_ *L5;JI9_P"K%6Z!!1110 4444 %%%%
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M "BBB@ HHHH *AG=57YJFKGM>O\ [-&QS0!)<7MO"<DBJ;^(K>,8W"O+M?\
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M#@+G_6FE2DN?]::5*8C8TS_6"O1M#^XM><Z9_K!7HVA_<6A@=%1112&%%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !0:** $I
M:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MX-_U*5\X^$!B9/K7T=X-_P!2E CLZ*** "BBB@ HHHH **** "BBB@ HHHH
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M'7N&C?ZA?I7AW@L_-'7N&B_ZA?I0)FS1110(***#0 44E+0 444E "T4E+0
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M_J$^E F=+63K'^H;Z5K5DZQ_J&^E CQ7QEU?\:\>U'_7M]:]@\9=7KQ_4/\
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MAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M\&_ZE*^=?"AS.GUKZ*\&_P"I2@D[.BBB@ HHHH **** "BBB@ HHHH ****
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M$=*_X^%^M>W>">D?X4 SV;3O^/=?I5VJ6G?\>Z_2KM @HHHH **** "BBB@
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M[#Z5?H$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !29I:2@!:*!10 49Q3)9!&F2:P-1UI8 ?FH Z R(/XA0
M'4]#7G[>*5,F-_?UK>TK51=$<T =)12#D"J.HW@MD)SB@"]D>HI-Z?WA7 :E
MXM%N2-_ZUD)XX#28\S]: /5PP/0BEKA--\3B<CY_UKKK*\6X0<T 7:,U!<SB
M)"<URNJ>)5M<C?0!UYD0=6% =3T85Y;+XU&_&_\ 6KEEXN$C#+_K0!Z116!8
M:RMP!\U;<3^8N: )****  @'J*YSQ';IY+' Z5T=87B/_CW/TH \"\7QA6?
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M?W#7'ZQT:@#A]0^\:YZ?_65T.H?>-<]/_K*0SH_#G^M7ZU[EX3^XE>&^'/\
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M8*]&T/[BT,#HJ***0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHIK.%
MZT .HJ!KN)>IJ,ZC /XJ +=%4O[3M_[WZU*EW%)T- %BBD!!&12,ZIU- #J*
MK/>Q)U-1_P!J6^?O?K0!=HJJE]"_0U8616Z4 .HHI* %HI*6@ HHHH ****
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MTH \%\:?ZR2O+[C_ %I^M>H>-/\ 625Y?<?ZT_6@:(Z44E**!BT444 %%%%
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M%5FZU9M/O"@#O/#7^L2O;/#'W$KQ/PU_K$KVSPQ]Q*"3LJ@N?]74]07/^KH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ J&XY0U-44OW30!P_B* NC<
M5Y!X@T]M['%>Y:NBE6S7FVOP1_-P* /(+NU,>>*R2,3BNNU:-06Q7)R?\?'X
MT#/0/!W^L2OH'PS_ *A/I7S[X._UJ5] ^&/]0GTH!G35DZQ_J&^E:U9.L?ZA
MOI0(\4\9=7KQ_4/]>?K7L'C+J]>/ZA_KS]:!H9%TJ6HHNE2T#"BBB@ HHHH
M**** &'K3TZTP]:>G6@#K/#G^N6O>/!_W$KP?PY_KEKWCP?]Q*"3NZKW?^K_
M  JQ5>[_ -7^% 'G?BK[CUX9XF_UK_6O<_%7W'KPSQ-_K7^M T<DG^MK>T_J
MM8*?ZVM[3^JT =MH_P##796?W17&Z/\ PUV5G]T4Q%MJ93VIE  WW37-ZW_J
MVKI&^Z:YO6_]6U 'F6L_ZQJQ8OOUM:S_ *QJQ8OOTBC?TS_6+7K7A'K'7DNF
M?ZQ:]:\(]8Z!'L>F?\>HJ[5+3/\ CU%7:!!1110 4444 %%%% !1110 4444
M %<CXI_U3UUU<CXI_P!4] 'A7B?_ %K_ %KA[C[QKN/$_P#K7^M</<?>-(97
M'6I*C'6I*8PHHHH **** "BBB@".7I26?^O'UI9>E)9_Z\?6@#U/PC]Y*]KT
M+_5+]*\4\(_>2O:]"_U2_2@DZ5?NBH;S_CU>IE^Z*AO/^/5Z /)?%W5Z\=U?
M_6M7L7B[J]>.ZO\ ZUJ!HYN?[U:.D_ZQ:SI_O5HZ3_K%H&>EZ']Q:ZN+[HKE
M-#^XM=7%]T4R1].6FTY: (+O[AKC]8Z-787?W#7'ZQT:@#A]0^\:YZ?_ %E=
M#J'WC7/3_P"LI#.C\.?ZU?K7N7A/[B5X;X<_UJ_6O<O"?W$H!GI=G_JQ5NJE
MG_JQ5N@04444 %%%% !1110 4444 %%%% #)/NUQWB7_ %+UV,GW:X[Q+_J7
MH \)\6?ZQZX!_P#6_C7?^+/]8]< _P#K?QH&6%^[3J:OW:=0,**** "BBB@
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MBBB@ HHHH **** "BBB@ HHHH *2EI,4 ##*D5E7FGK-G(K5Z"J-W>)"I)-
M'+7NAQ9)(%9,FDVZGD"K6M^(XX=WS"N#O_&860X:@#M(M*MV/05?B\/0R#A1
M7GEAXRWN,O\ K7=Z)XECFVY84 6V\)(W1/TJ)O!JD_<_2NSLKN.X0;2,U<H
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1129H 6BBB@!#T-9&HWGDJ>:UW^X:XSQ)<&-&P: ,S4-?V,0&K'DU^1LX8U
MSEY=O+<E<]ZUM-TN2Z0'!YH D_X2"8/RQKH]'UII6&6KG+O09(N=IJ33D:W<
M9[4 >IVUZIB!)K/U+54C!PU<X^K&&'&[M7-WVM/*Y&30!M7^NN"=K5C'7I_,
M^\:BMH6NSSWK0302V#B@#0TS5Y9&&2:[73KDR*,FN+M--\@BNFT]O+ % '2
MY%+4$#[EJ>@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5;7[@JU7G, HHHI %%%% !1BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHJ.5MJYH >64=34<DT:HQ+#I6'?ZB80>:Y74?$S1*PW?K0!D>/KA'63
M!'>OGS6N;ML>M>F>)M=-R7&ZO,K_ />3D^] T=)X0_UR?6OH_P &_P"I2OG/
MPFN)T^M?1G@W_4I0([.BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MX)Z1_A0#/9M._P"/=?I5VJ6G?\>Z_2KM @HHHH **** "BBB@ HHHH ****
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M* "BBB@ HHHH **** "BBB@ HHHH ;)_JV^E>:^+ONO7I4G^K;Z5YKXN^Z]
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M5[O_ %?X58JO=_ZO\* /._%7W'KPSQ-_K7^M>Y^*ON/7AGB;_6O]:!HY)/\
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M:** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K"U_\ U3?2MVL+7_\
M5-]* /$O%W5Z\T;_ (^?QKTOQ=U>O-&_X^?QH&>@>$OOI7MNA?ZE?I7B7A+[
MZ5[;H7^I7Z4".G3[HI:1/NBEH **** .4\4?ZM_I7AGB?_6/7N?BC_5O]*\,
M\3_ZQZ . O>]4+7_ (^1]:OWO>J%K_Q\CZT%'KO@C[T=>\:'_P >R_2O!_!'
MWHZ]XT/_ (]E^E!)KT444 %%%% !1110 4444 %8/B7_ (]#]*WJP?$O_'H?
MI0!\]^,?]:]>>2??->A^,?\ 6O7GDGWS0,C3_6CZUZ7X*_UL?UKS1/\ 6CZU
MZ7X*_P!;']: 9]#>'_\ CR7Z5L5C^'_^/)?I6Q0(**** "J]Y_J35BJ]Y_J3
M0!P.N=6KCKC[YKL=<ZM7'7'WS3$4G^]6UHW^L6L5_O5M:-_K%H ]/T3_ %:U
MMUB:)_JUK;I#"BBB@ HHHH **** "BBB@".?_4M7 ^(OXJ[Z?_4M7 ^(OXJ
M. N?]::5*2Y_UII4IB-C3/\ 6"O1M#^XM><Z9_K!7HVA_<6A@=%1112&%%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !24M% !1110 V3[AKA/%()1J[J7[AKBO$@!1J /
M,EA+7O([UZ?X7LT,*Y%< B#[9^->D>'#MA6@"WJ]E&(B0!TKB[E!'(<5W>JO
MF(_2N%OO]8: *4P:52!5#^S)&?<0:V("N?FK27R2G:@9DV>+0#=VK0_MN%!C
M(JG?P,P.P5S-U;7(<D!J!':QZQ'(W!%;5A.)",&O+K>2:%QNS78:+J0RH)H
M]'M/NBK59VFSB5!BM&@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M4 %%(3B@$&@!:*** "BBD) H 6BFA@:=0 4444 %%%% !1110 4444 %%%%
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M4 =YX:_UB5[9X8^XE>)^&O\ 6)7MGAC[B4$G95!<_P"KJ>H+G_5T >?^*?\
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MQ#;F.1CBO8O*#6X'M7 ^)],+AR%H \U@U'[/-U[UU-EKX,&-W:N,U.PEBF)
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M78[2XE P#6A9V*M.!CO7;Z3HD<BKE10!QNGZ5<;QD&N\T2PECVY!KHK+P]$
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M2^^E>[>&O]2E F=C']VGTR/[M/H$%%%% !1110 4444 %%%% !1110!2OO\
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MI^$?O)7M>A?ZI?I7BGA'[R5[7H7^J7Z4$G2K]T5#>?\ 'J]3+]T5#>?\>KT
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MVG6GV=1Q6C0 4444 %%%)0 M%%% !1110 4444 %%%% !1110 4444 %%%%
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M7E]Q_K3]:!HCI124HH&+1110 4444 %%%% "-]VJA_UH^M6V^[50_P"M'UH
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M,0!-6?M$?]ZO-+;Q(JJ/G_6K0\3+_?\ UH ]!^T1_P!ZC[1'_>KST^)U_O\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MP^H?>-<]/_K*Z'4/O&N>G_UE(9T?AS_6K]:]R\)_<2O#?#G^M7ZU[EX3^XE
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M+_4K]*!'3I]T4M(GW12T %%%% '*>*/]6_TKPSQ/_K'KW/Q1_JW^E>&>)_\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MEO\ <%<GH_1:ZRW^X*8AS=:0=:5NM(.M "3_ .K-</XAZ-7<3_ZLUP_B'HU
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M8*]&T/[BT,#HJ***0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H-%% "4M%% !1110 4444
M%%)2T %%%% !1110 4444 %%%)0 M%%% !1110 4444 %%%% !24M%  ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LC5?NFM>LC5?NFJCN!
MP>J?>-4+3_6CZU?U3[QJA:?ZT?6N^/P@=UH?1:Z@=*Y?0^BUU Z5Q5-P"BBB
MLP"BBB@ HHHH **** "N.\4?=:NQKCO%'W6K6E\0'G$G_'U^-=IX>Z+7%R?\
M?7XUVGA[HM=M7X0.ZM?N"K55;7[@JU7G, HHHI %%%% !1110 4444 %%%%
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MQ;U>O*=0_P!<?K7JWBWJ]>4ZA_KC]:!HBBZ5+4472I:!A1110 4444 %%%%
M$;=:LVGWA59NM6;3[PH [SPU_K$KVSPQ]Q*\3\-?ZQ*]L\,?<2@D[*H+G_5U
M/4%S_JZ //\ Q3_JWKPWQ/\ ZUZ]R\4_ZMZ\-\3_ .M>@$<8O^NK<L.HK#7_
M %U;EAU%!1VNC_PUVEE]T5Q>C_PUVEE]T4R2ZW2F4]NE,H 8_P!VN<UG[C5T
M;_=KG-9^XU CS76?OM6''_K*W-9^^U8<?^LI%'0Z5_K%KUGPGU2O)M*_UBUZ
MSX3ZI0![!I7_ ![#Z5?JAI7_ ![#Z5?H$%%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%!I* %HHHH **** "BBB@
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MM/3OO+69-_K?QK3T[[RTAGI'AC[Z5[3X=_U:5XMX8^^E>T^'?]6E CI:***
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M^M-0P=12*.ET3_7+7MW@WHE>(Z)_KEKV[P;T2@D]/B_U2_2GTR+_ %2_2GT
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MYE.H3=,Y-=%I.AF,!MM S1NYC]@P3VKSVZB,M_\ C7>ZHIAMR/:N-3#7P^M
M'<^&=/!M02.U8_C&RV(V!7:^&47[(/I6#XU1=C4"/-=%W1WP^M>T:'?>59C)
M[5X[IP O>/6O1+.9DM!CTH W[W7Q$3\]9X\3C/\ K/UKAM>U.1&;!-<T-8FW
M_>- 'L8\2C'W_P!:R=5\0B2,C?\ K7G2ZO-M^\:J7.J2L#DF@"3Q#?\ F[N:
MXQ&W7'XU>U"Z9P<FLRV;,X^M STOPD/G2O;-"_U*_2O%?"0^9*]JT/\ U2_2
M@1TR?=%+34^Z*=0 4444 <IXH_U;_2O#/$_^L>O<_%'^K?Z5X9XG_P!8] '
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M7F U;I" : .9N=,WD_+3+?2]CYVUTQB4]J!"H[4 5;:#8F,52U*R\Y3Q6T%
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M;ZUVVA*S;:XK1=*F9U+*:]2T'3=B+D4 ;EBI"C-:%1I$$Z5)0 4444 %%%%
M!6;J&I+:H3G%7)YA'&37GGBS5C&C@-0!2\1>*,AE#_K7G5Q<RWMR<$G)K.U3
M5WEN""QZUI:$4D=6:@#K/#>E%V4LM>D6NFHMN/E'2N1TJ[A@"\BNQL=12:,
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M0(Z9/NBG4B?=%+0 4444 <IXH_U;_2O#/$_^L>O<_%'^K?Z5X9XG_P!8] '
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M 444E "T8S110 FT>E+110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !69K?\ QYGZ5IUF:W_QYGZ4 >"^-/\ 625Y?<?Z
MT_6O4/&G^LDKR^X_UI^M T1THI*44#%HHHH **** "BBB@!&^[50_P"M'UJV
MWW:J'_6CZT =WX/_ -<GUKZ%\+?ZA/I7SUX/_P!<GUKZ%\+?ZA/I0)G5T=J*
M.U CSSQG_JWKP3Q!_KVKWOQG_JWKP3Q!_KVH YF2EM/]:/K224MI_K1]:"CT
M3PYT6O0K7_5"O/?#G1:]"M?]4*:)8K]:1>M*_6D7K0 Z7_5FN6UG[K5U,O\
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M^J7Z5Y+X.^['7K5A_JE^E!)=K)US_CV/TK6K)US_ (]C]* /$O%GWY*\PO\
M[[5Z?XL^_)7F%_\ ?:@:,<_ZRNFT/[ZUS)_UE=-H?WUH ]+TC_5K6V.E8FD?
MZM:VQTIB"I!TJ.I!TH S-0^X:X;6.K5W.H?<-<-K'5J ..O>IK*3_7_C6K>]
M364G^O\ QI%'H7A+[Z5[MX:_U*5X3X2^^E>[>&O]2E F=C']VGTR/[M/H$%%
M%% !1110 4444 %%%% !1110!2OO]6:\Q\6?=>O3K[_5FO,?%GW7H \2U_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBF/*J=30
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M_2@1TZ?=%+2)]T4M !1110!RGBC_ %;_ $KPSQ/_ *QZ]S\4?ZM_I7AGB?\
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M;=(84444 %%%% !1110 4444 1S_ .I:N!\1?Q5WT_\ J6K@?$7\5 ' 7/\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MM;AWAJ\XUNPSNXH \HO(R'-9[\-72ZI:[';BN:G^62@9U7A;_7I]:^B?!O\
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M]4H ]@TK_CV'TJ_5#2O^/8?2K] @HHHH **** "BBB@ HHHH **** "BBB@
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M.OO]6:\Q\6?=>@#Q+7_]<WUKGX_O5T&O_P"N;ZUS\?WJ!ED=**!THH&%%%%
M!1110 4UNE.IK=* $B^]73:+_K5KF8OO5TVB_P"M6@1[%X3Z)7JEI_Q[K7E?
MA/HE>J6G_'NM B23_5FN/\0?ZMOI782?ZLUQ_B#_ %;?2@#Q;Q5]YZ\SO/\
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M7,O!-:,<TD #$F@#V33=4211EJV4D5QD5XYI7B K(%+_ *UZ7HE]]I1><\4
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M>X^\:0RN.M25&.M24QA1110 4444 %%%% $<O2DL_P#7CZTLO2DL_P#7CZT
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M=]\5Z#H7\->?:=]\5Z#H7\-*OL([RQ^X*T>U9UC]P5H]J\R6X!1114@%%%%
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M HHHH **** "BBB@ HHHH *2EHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBUZSX3ZI0![!I7_'L/I5^J&E?\>P^E7Z!!1110 4444 %%%% !1110 4444
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MBKGBJU5+-L#M0(\E@O'BOMN3UKV7P9=EXDR>U>'S?+J1_P!ZO6_!TVV!#[4
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MI?@K_6Q_6@&?0WA__CR7Z5L5C^'_ /CR7Z5L4""BBB@ JO>?ZDU8JO>?ZDT
M<#KG5JXZX^^:['7.K5QUQ]\TQ%)_O5M:-_K%K%?[U;6C?ZQ: /3]$_U:UMUB
M:)_JUK;I#"BBB@ HHHH **** "BBB@".?_4M7 ^(OXJ[Z?\ U+5P/B+^*@#@
M+G_6FE2DN?\ 6FE2F(V-,_U@KT;0_N+7G.F?ZP5Z-H?W%H8'14444AA1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4AI:* $I
M:** "D89%+10!4ELUDZ@50N-&1@3M%;5% '#:CHX4'"UR5_I;*3A:];N+590
M>*Q;[1E9"=M,1Y*]HR-R*:+8L< 5U&IZ>(G/%5;*S\R4#% %&STUV(XKJ-.T
MC.,K6QINB@J#MK?M]/6+'% %"ST50 2HK3CTY(^@%754*N!2TAD:1!!4E%%
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M-]VJA_UH^M6V^[50_P"M'UH [OP?_KD^M?0OA;_4)]*^>O!_^N3ZU]"^%O\
M4)]*!,ZNCM11VH$>>>,_]6]>">(/]>U>]^,_]6]>">(/]>U ',R4MI_K1]:2
M2EM/]:/K04>B>'.BUZ%:_P"J%>>^'.BUZ%:_ZH4T2Q7ZTB]:5^M(O6@!TO\
MJS7+:S]UJZF7_5FN6UG[K4 <!J?WVKGKKO70ZG]]JYZZ[TAH?I7_ !\+]:]N
M\$](_P *\1TK_CX7ZU[=X)Z1_A0#/9M._P"/=?I5VJ6G?\>Z_2KM @HHHH *
M*** "BBB@ HHHH **** $;[IKG-:_P!4U=&WW37.:U_JFH \:\6]7KRG4/\
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M_P >P^E7ZH:5_P >P^E7Z!!1110 4444 %%%% !1110 4444 %%%% !1110
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METW[PKFK7[PKI=-^\* .ZTCHM=5;_<KE=(Z+756_W*8A[=::*<W6FB@!L_\
MJS7%:_\ =:NUG_U9KBM?^ZU (\WU+_6FJ]OU%6-2_P!::KV_44BCJ=$_UR_6
MO:O"'1*\5T3_ %R_6O:O"'1*!'I\/^I3Z4^F0_ZE/I3Z!!1110 4444 %%%%
M !1110 4444 -D_U;?2O-?%WW7KTJ3_5M]*\U\7?=>@#Q/7?]:U<Q+U-=/KO
M^M:N8EZF@8Q:?3%I] PHHHH **** "BBB@"O-6CHO^O7ZUG35HZ+_KU^M 'M
M_@[[L=>M6'^J7Z5Y+X.^['7K5A_JE^E!)=K)US_CV/TK6K)US_CV/TH \2\6
M??DKS"_^^U>G^+/OR5YA?_?:@:,<_P"LKIM#^^M<R?\ 65TVA_?6@#TO2/\
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M;ZT#()KYI0<FJ(.Z8?6F(#2I_K10,]%\'?ZQ*^@/#/\ J$^E?/\ X._UB5]
M^&?]0GTH)9TM9.L?ZAOI6M63K'^H;Z4 >*>,NKUX_J'^O/UKV#QEU>O']0_U
MY^M T,BZ5+4472I:!A1110 4444 %%%% ##UIZ=:8>M/3K0!UGAS_7+7O'@_
M[B5X/X<_URU[QX/^XE!)W=5[O_5_A5BJ]W_J_P * /._%7W'KPSQ-_K7^M>Y
M^*ON/7AGB;_6O]:!HY)/];6]I_5:P4_UM;VG]5H [;1_X:[*S^Z*XW1_X:[*
MS^Z*8BVU,I[4R@ ;[IKF];_U;5TC?=-<WK?^K:@#S+6?]8U8L7WZVM9_UC5B
MQ??I%&_IG^L6O6O"/6.O)=,_UBUZUX1ZQT"/8],_X]15VJ6F?\>HJ[0(****
M "BBB@ HHHH **** "BBB@ KD?%/^J>NNKD?%/\ JGH \*\3_P"M?ZUP]Q]X
MUW'B?_6O]:X>X^\:0RN.M25&.M24QA1110 4444 %%%% $<O2DL_]>/K2R]*
M2S_UX^M 'J?A'[R5[7H7^J7Z5XIX1^\E>UZ%_JE^E!)TJ_=%0WG_ !ZO4R_=
M%0WG_'J] 'DOB[J]>.ZO_K6KV+Q=U>O'=7_UK4#1S<_WJT=)_P!8M9T_WJT=
M)_UBT#/2]#^XM=7%]T5RFA_<6NKB^Z*9(^G+3:<M $%W]PUQ^L=&KL+O[AKC
M]8Z-0!P^H?>-<]/_ *RNAU#[QKGI_P#64AG1^'/]:OUKW+PG]Q*\-\.?ZU?K
M7N7A/[B4 STNS_U8JW52S_U8JW0(**** "BBB@ HHHH **** "BBB@!DGW:X
M[Q+_ *EZ[&3[M<=XE_U+T >$^+/]8]< _P#K?QKO_%G^L>N ?_6_C0,L+]VG
M4U?NTZ@84444 %%%% !2'I2TAZ4 -[U:M?\ 6"JO>K5K_K!0!Z3X1_UB5[MX
M?_X]1]*\)\(_ZQ*]V\/_ /'J/I02;-4M0_U3?2KM4M0_U3?2@#R7QC]U_P :
M\/UO_7M]:]P\8_=?\:\/UO\ U[?6@:,^UZUT6G?>%<[:]:Z+3OO"A =WH_1:
MZRW^X*Y/1^BUUEO]P4Q#FZT@ZTK=:0=: $G_ -6:X?Q#T:NXG_U9KA_$/1J
M/-M1_P!::A@ZBIM1_P!::A@ZBD4=+HG^N6O;O!O1*\1T3_7+7MW@WHE!)Z?%
M_JE^E/ID7^J7Z4^@!#TK)U'[AK6/2LG4?N&JCN!Y[KO5JX2\_P!8:[O7>K5P
MEY_K#7J4=ADVG??%>@Z%_#7GVG??%>@Z%_#2K[".\L?N"M'M6=8_<%:/:O,E
MN 4445(!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 444E "T4E+0 4444 %%%% !1110
M 4444 %%%% !1110 5A:_P#ZIOI6[6%K_P#JF^E 'B7B[J]>:-_Q\_C7I?B[
MJ]>:-_Q\_C0,] \)??2O;="_U*_2O$O"7WTKVW0O]2OTH$=.GW12TB?=%+0
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M5_Q\+]:]N\$](_PH!GLVG?\ 'NOTJ[5+3O\ CW7Z5=H$%%%% !1110 4444
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MA]*OT""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M@:.23_6UO:?U6L%/];6]I_5: .VT?^&NRL_NBN-T?^&NRL_NBF(MM3*>U,H
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M\$?>CKWC0_\ CV7Z5X/X(^]'7O&A_P#'LOTH)->BBB@ HHHH **** "BBB@
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M** "BBB@ HHHH **** "BBB@ HHHH *R-5^Z:UZR-5^Z:J.X'!ZI]XU0M/\
M6CZU?U3[QJA:?ZT?6N^/P@=UH?1:Z@=*Y?0^BUU Z5Q5-P"BBBLP"BBB@ HH
MHH **** "N.\4?=:NQKCO%'W6K6E\0'G$G_'U^-=IX>Z+7%R?\?7XUVGA[HM
M=M7X0.ZM?N"K55;7[@JU7G, HHHI %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4R096GTR4X6@#*NH%<G-<_J=A&8V.!6]=SA,\USFJ:BJ
MQL,T >6^*K5$WX%>4ZC\MP?K7J7BF\$F_FO+=0^:<GWH&=-X2.9TKZ-\&?ZE
M/I7SEX2&)T^M?1G@S_4I]*!'9UD:O]QOI6O61J_W&^E 'DOBM<AZ\>UJ,>:U
M>Q^*NCUY!K/^M:@9A1Q#=5@1BHX_O58H&1^4*41@4^B@!,4A7-+2B@"/RQ1Y
M0J2B@"%XQBEMXQO%.?I2V_WQ0!U^@(/,6O9O"RX5*\<T#_6+7LGA?[J4"/1[
M?_4K]*2Y.(&I8/\ 4K]*;<_ZAJ!'G_B2<HK\UX]XAU)T=\$UZYXF7*O7B_B.
M/+O0-'+SZO)YA^8TY-7DQ]XUFSQ?O#3DAR*!FC_;$@_B-!UF0\;C5'[,30+1
MO2@"RU\TG4T@N2ISFHUMF':E-NQ[4 3KJTB=&-._MF4_Q&J1M&/:D^RD4 7O
M[7DQ]XU$=7EW?>-5C 0*A:+YJ .DTW59"X^8UZ9X8O6<IDUY)ID7[P5ZEX53
M!2@1[1H;EHU^E;M8&@C$:_2M^@04444 %%%% !1110 4444 %%%% !69K?\
MQYGZ5IUF:W_QYGZ4 >"^-/\ 625Y?<?ZT_6O4/&G^LDKR^X_UI^M T1THI*4
M4#%HHHH **** "BBB@!&^[50_P"M'UJVWW:J'_6CZT =WX/_ -<GUKZ%\+?Z
MA/I7SUX/_P!<GUKZ%\+?ZA/I0)G5T=J*.U CSSQG_JWKP3Q!_KVKWOQG_JWK
MP3Q!_KVH YF2EM/]:/K224MI_K1]:"CT3PYT6O0K7_5"O/?#G1:]"M?]4*:)
M8K]:1>M*_6D7K0 Z7_5FN6UG[K5U,O\ JS7+:S]UJ . U/[[5SUUWKH=3^^U
M<]==Z0T/TK_CX7ZU[=X)Z1_A7B.E?\?"_6O;O!/2/\* 9[-IW_'NOTJ[5+3O
M^/=?I5V@04444 %%%% !1110 4444 %%%% "-]TUSFM?ZIJZ-ONFN<UK_5-0
M!XUXMZO7E.H?ZX_6O5O%O5Z\IU#_ %Q^M T11=*EJ*+I4M PHHHH **** "B
MBB@"-NM6;3[PJLW6K-I]X4 =YX:_UB5[9X8^XE>)^&O]8E>V>&/N)02=E4%S
M_JZGJ"Y_U= 'G_BG_5O7AOB?_6O7N7BG_5O7AOB?_6O0".,7_75N6'45AK_K
MJW+#J*"CM='_ (:[2R^Z*XO1_P"&NTLONBF276Z4RGMTIE #'^[7.:S]QJZ-
M_NUSFL_<:@1YKK/WVK#C_P!96YK/WVK#C_UE(HZ'2O\ 6+7K/A/JE>3:5_K%
MKUGPGU2@#V#2O^/8?2K]4-*_X]A]*OT""BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH :5!IA@4]JEHH Q=<LT-@Q KP+Q3$$O6QZU]"ZVVW3GKY[\6R#[:_UH&C5
M\&-^]6O8X!FR'TKQCP6X,ZU[99)NLA]*!' >)UQNKA[=\7H^M>B^*K8[7.*\
MR9_)O>?6@#V'PTV;0?2N;\='$;5:\-ZQ$EL 6'2L7QGJ"7",%.: .#TH@ZB/
M]ZO8-(B9[(8]*\BT:!GU ''>O=_#-EOLAD=J .%U^RF=FP#7)2Z=<*2<&O=K
MG0(YSRHK,O/"D8A)"#\J / M1>>W!ZUS%UJDFX@L:]3\7:,L"OA:\?U.+RYR
M/>@8DMTTJG)I+(YG'UJNH^6K%C_KQ]:!GKO@OK'^%>XZ+_J%^E>'>"_O1_A7
MN.B_ZA?I02:U<WXC_P!0_P!*Z2N;\1_ZA_I0!X+XQ_UCUYI+_KC7I?C'_6/7
MFDO^N- T6$^[3J:GW:=0,**** "BBB@ H-%!H 9WJ:#[XJ'O4T'WQ0!Z%X3_
M -:E>]^&O^/9?I7@GA/_ %J5[WX:_P"/9?I02;]9^H_ZMJT*S]1_U;4 >3^+
M_NO7B6N?Z]OK7MOB_P"Z]>):Y_KV^M T9EK]X5TNF_>%<U:_>%=+IOWA0!W6
MD=%KJK?[E<KI'1:ZJW^Y3$/;K313FZTT4 -G_P!6:XK7_NM7:S_ZLUQ6O_=:
M@$>;ZE_K35>WZBK&I?ZTU7M^HI%'4Z)_KE^M>U>$.B5XKHG^N7ZU[5X0Z)0(
M]/A_U*?2GTR'_4I]*?0(**** "BBB@ HHHH **** "BBB@!LG^K;Z5YKXN^Z
M]>E2?ZMOI7FOB[[KT >)Z[_K6KF)>IKI]=_UK5S$O4T#&+3Z8M/H&%%%% !1
M110 4444 5YJT=%_UZ_6LZ:M'1?]>OUH ]O\'?=CKUJP_P!4OTKR7P=]V.O6
MK#_5+]*"2[63KG_'L?I6M63KG_'L?I0!XEXL^_)7F%_]]J]/\6??DKS"_P#O
MM0-&.?\ 65TVA_?6N9/^LKIM#^^M 'I>D?ZM:VQTK$TC_5K6V.E,05(.E1U(
M.E &9J'W#7#:QU:NYU#[AKAM8ZM0!QU[U-92?Z_\:U;WJ:RD_P!?^-(H]"\)
M??2O=O#7^I2O"?"7WTKW;PU_J4H$SL8_NT^F1_=I] @HHHH **** "BBB@ H
MHHH **** *5]_JS7F/BS[KUZ=??ZLUYCXL^Z] 'B6O\ ^N;ZUS\?WJZ#7_\
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M44 %%%% !1110 4444 %%%% !1110 4444 !&1BJTEE%*?F%6:* *::="AR
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M_6&O4H[#)M.^^*]!T+^&O/M.^^*]!T+^&E7V$=Y8_<%:/:LZQ^X*T>U>9+<
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MOF@9&G^M'UKTOP5_K8_K7FB?ZT?6O2_!7^MC^M ,^AO#_P#QY+]*V*Q_#_\
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M:OP@=U:_<%6JJVOW!5JO.8!1112 **** "BBB@ HHHH **** "BBB@ HHHH
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M]&8S(Y7O7M&AP>3: 8[5A:1H8MPORUUEO'Y<>* ):BN2! ^?2I:K7W^H/TH
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M4=3HG^N7ZU[5X0Z)7BNB?ZY?K7M7A#HE CT^'_4I]*?3(?\ 4I]*?0(****
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MG6/]0WTH$>*>,NKUX_J'^O/UKV#QEU>O']0_UY^M T,BZ5+4472I:!A1110
M4444 %%%% ##UIZ=:8>M/3K0!UGAS_7+7O'@_P"XE>#^'/\ 7+7O'@_[B4$G
M=U7N_P#5_A5BJ]W_ *O\* /._%7W'KPSQ-_K7^M>Y^*ON/7AGB;_ %K_ %H&
MCDD_UM;VG]5K!3_6UO:?U6@#MM'_ (:[*S^Z*XW1_P"&NRL_NBF(MM3*>U,H
M &^Z:YO6_P#5M72-]TUS>M_ZMJ /,M9_UC5BQ??K:UG_ %C5BQ??I%&_IG^L
M6O6O"/6.O)=,_P!8M>M>$>L= CV/3/\ CU%7:I:9_P >HJ[0(**** "BBB@
MHHHH **** "BBB@ KD?%/^J>NNKD?%/^J>@#PKQ/_K7^M</<?>-=QXG_ -:_
MUKA[C[QI#*XZU)48ZU)3&%%%% !1110 4444 1R]*2S_ ->/K2R]*2S_ ->/
MK0!ZGX1^\E>UZ%_JE^E>*>$?O)7M>A?ZI?I02=*OW14-Y_QZO4R_=%0WG_'J
M] 'DOB[J]>.ZO_K6KV+Q=U>O'=7_ -:U T<W/]ZM'2?]8M9T_P!ZM'2?]8M
MSTO0_N+75Q?=%<IH?W%KJXONBF2/IRTVG+0!!=_<-<?K'1J["[^X:X_6.C4
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MB@04444 %5[S_4FK%5[S_4F@#@=<ZM7'7'WS78ZYU:N.N/OFF(I/]ZMK1O\
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M.T>[,A7)KKXCF,&D,?1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !61JOW36O61JOW351W
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M?"?5*\FTK_6+7K/A/JE 'L&E?\>P^E7ZH:5_Q[#Z5?H$%%%% !1110 4444
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M *#10: &=ZF@^^*A[U-!]\4 >A>$_P#6I7O?AK_CV7Z5X)X3_P!:E>]^&O\
MCV7Z4$F_6?J/^K:M"L_4?]6U 'D_B_[KUXEKG^O;ZU[;XO\ NO7B6N?Z]OK0
M-&9:_>%=+IOWA7-6OWA72Z;]X4 =UI'1:ZJW^Y7*Z1T6NJM_N4Q#VZTT4YNM
M-% #9_\ 5FN*U_[K5VL_^K-<5K_W6H!'F^I?ZTU7M^HJQJ7^M-5[?J*11U.B
M?ZY?K7M7A#HE>*Z)_KE^M>U>$.B4"/3X?]2GTI],A_U*?2GT""BBB@ HHHH
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M8^+/NO0!XEK_ /KF^M<_']ZN@U__ %S?6N?C^]0,LCI10.E% PHHHH ****
M"FMTIU-;I0 D7WJZ;1?]:M<S%]ZNFT7_ %JT"/8O"?1*]4M/^/=:\K\)]$KU
M2T_X]UH$22?ZLUQ_B#_5M]*["3_5FN/\0?ZMOI0!XMXJ^\]>9WG^N/UKTSQ5
M]YZ\SO/]<?K0-%NPZBNSTCJM<98=179Z1U6@&=OI_P!T5KK]VLC3_NBM=?NT
MQ#::U.IK4 96H_<->>ZYU:O0M1^X:\]USJU (XR;_6_C6GIWWEK,F_UOXUIZ
M=]Y:0STCPQ]]*]I\._ZM*\6\,??2O:?#O^K2@1TM%%% !1110 4444 %%%%
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M,Z/PY_K5^M>Y>$_N)7AOAS_6K]:]R\)_<2@&>EV?^K%6ZJ6?^K%6Z!!1110
M4444 %%%% !1110 4444 ,D^[7'>)?\ 4O78R?=KCO$O^I>@#PGQ9_K'K@'_
M -;^-=_XL_UCUP#_ .M_&@987[M.IJ_=IU PHHHH **** "D/2EI#TH ;WJU
M:_ZP55[U:M?]8* /2?"/^L2O=O#_ /QZCZ5X3X1_UB5[MX?_ ./4?2@DV:I:
MA_JF^E7:I:A_JF^E 'DOC'[K_C7A^M_Z]OK7N'C'[K_C7A^M_P"O;ZT#1GVO
M6NBT[[PKG;7K71:=]X4(#N]'Z+766_W!7)Z/T6NLM_N"F(<W6D'6E;K2#K0
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M::5*2Y_UII4IB-C3/]8*]&T/[BUYSIG^L%>C:']Q:&!T5%%%(84444 %%%%
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M.Q0 AS4UKGS!41J:V_U@H [G0.JUW<'^J6N$T \K7=P?ZI:0R2BBB@ HHHH
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MO;O!/2/\*\1TK_CX7ZU[=X)Z1_A0#/9M._X]U^E7:I:=_P >Z_2KM @HHHH
M**** "BBB@ HHHH **** $;[IKG-:_U35T;?=-<YK7^J:@#QKQ;U>O*=0_UQ
M^M>K>+>KUY3J'^N/UH&B*+I4M11=*EH&%%%% !1110 4444 1MUJS:?>%5FZ
MU9M/O"@#O/#7^L2O;/#'W$KQ/PU_K$KVSPQ]Q*"3LJ@N?]74]07/^KH \_\
M%/\ JWKPWQ/_ *UZ]R\4_P"K>O#?$_\ K7H!'&+_ *ZMRPZBL-?]=6Y8=104
M=KH_\-=I9?=%<7H_\-=I9?=%,DNMTIE/;I3* &/]VN<UG[C5T;_=KG-9^XU
MCS76?OM6''_K*W-9^^U8<?\ K*11T.E?ZQ:]9\)]4KR;2O\ 6+7K/A/JE 'L
M&E?\>P^E7ZH:5_Q[#Z5?H$%%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 5!='$1J>H+H9B- 'G/BB7:KUY!K=P?-:O7_
M !1"65\"O'];MF\UN* .5NWW U3L_P#CX'UJY=QE0:IVG%P/K04>N>"^L=>X
MZ+_Q[K]*\-\%GF.O<M%_X]U^E!)K5S?B/_4/]*Z2N;\1_P"H?Z4 >"^,?]8]
M>:2_ZXUZ7XQ_UCUYI+_KC0-%A/NTZFI]VG4#"BBB@ HHHH *#10: &=ZF@^^
M*A[U-!]\4 >A>$_]:E>]^&O^/9?I7@GA/_6I7O?AK_CV7Z4$F_6?J/\ JVK0
MK/U'_5M0!Y/XO^Z]>):Y_KV^M>V^+_NO7B6N?Z]OK0-&9:_>%=+IOWA7-6OW
MA72Z;]X4 =UI'1:ZJW^Y7*Z1T6NJM_N4Q#VZTT4YNM-% #9_]6:XK7_NM7:S
M_P"K-<5K_P!UJ 1YOJ7^M-5[?J*L:E_K35>WZBD4=3HG^N7ZU[5X0Z)7BNB?
MZY?K7M7A#HE CT^'_4I]*?3(?]2GTI] @HHHH **** "BBB@ HHHH **** &
MR?ZMOI7FOB[[KUZ5)_JV^E>:^+ONO0!XGKO^M:N8EZFNGUW_ %K5S$O4T#&+
M3Z8M/H&%%%% !1110 4444 5YJT=%_UZ_6LZ:M'1?]>OUH ]O\'?=CKUJP_U
M2_2O)?!WW8Z]:L/]4OTH)+M9.N?\>Q^E:U9.N?\ 'L?I0!XEXL^_)7F%_P#?
M:O3_ !9]^2O,+_[[4#1CG_65TVA_?6N9/^LKIM#^^M 'I>D?ZM:VQTK$TC_5
MK6V.E,05(.E1U(.E &9J'W#7#:QU:NYU#[AKAM8ZM0!QU[U-92?Z_P#&M6]Z
MFLI/]?\ C2*/0O"7WTKW;PU_J4KPGPE]]*]V\-?ZE*!,[&/[M/ID?W:?0(**
M** "BBB@ HHHH **** "BBB@"E??ZLUYCXL^Z]>G7W^K->8^+/NO0!XEK_\
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M#2K[".\L?N"M'M6=8_<%:/:O,EN 4445(!1110 4444 %%%% !1110 4444
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M.C4I'ZDTOVACSF@9VFF:J("/FKH8_%&Q<!_UKRHWKIT--.J2#N: /6#XL/\
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MYEKT33VS$*0R[1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !61JOW36O61JOW351W X/5/O
M&J%I_K1]:OZI]XU0M/\ 6CZUWQ^$#NM#Z+74#I7+Z'T6NH'2N*IN 4445F 4
M444 %%%% !1110 5QWBC[K5V-<=XH^ZU:TOB \XD_P"/K\:[3P]T6N+D_P"/
MK\:[3P]T6NVK\('=6OW!5JJMK]P5:KSF 4444@"BBB@ HHHH **** "BBB@
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MZ5B:1_JUK;'2F(*D'2HZD'2@#,U#[AKAM8ZM7<ZA]PUPVL=6H XZ]ZFLI/\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MU'TH)-FJ6H?ZIOI5VJ6H?ZIOI0!Y+XQ^Z_XUX?K?^O;ZU[AXQ^Z_XUX?K?\
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MQ7#:!%RM=_:IMB6D,L4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5D:K]TUKUD:K]TU4=P
M.#U3[QJA:?ZT?6K^J?>-4+3_ %H^M=\?A [K0^BUU Z5R^A]%KJ!TKBJ;@%%
M%%9@%%%% !1110 4444 %<=XH^ZU=C7'>*/NM6M+X@/.)/\ CZ_&NT\/=%KB
MY/\ CZ_&NT\/=%KMJ_"!W5K]P5:JK:_<%6J\Y@%%%%( HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "D)Q2U#<-M2@!'NDCZFJD^KP1QM\PS
MBL+5KUXPV#7!:OKDT>X!C0 SQSJD<RR ,*\)U?Y[MB/6NSUO59)V8$FN+NOG
MER:!G2^$!B9/K7T=X,_U*?2OG7PH,3I]:^BO!G^I3Z4".SK(U;[C5KUD:O\
M<:@#R?Q5T>O(-9_UK5Z_XJZ/7D&L_P"M:@9C1_>JQ5>/[U6*!A1110 4444
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M7>NAU/[[5SUUWI#0_2O^/A?K7MW@GI'^%>(Z5_Q\+]:]N\$](_PH!GLVG?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4C+N&*6B@"E/IT<X^
M;%<YK/A6&2!G"@UV%5;^58[1\D<B@#YW\5:*EJ7PN*\ON4V76/>O:_&\JL9,
M5XO>G-X?K0-';^#S^]2OH+PQ_J$^E?/G@_\ UJ?6OH/PQ_J$^E '35DZQ_J&
M^E:U9.L?ZAOI0(\4\9=7KQ_4/]>?K7L'C+J]>/ZA_KS]:!H9%TJ6HHNE2T#"
MBBB@ HHHH **** &'K3TZTP]:>G6@#K/#G^N6O>/!_W$KP?PY_KEKWCP?]Q*
M"3NZKW?^K_"K%5[O_5_A0!YWXJ^X]>&>)O\ 6O\ 6O<_%7W'KPSQ-_K7^M T
M<DG^MK>T_JM8*?ZVM[3^JT =MH_\-=E9_=%<;H_\-=E9_=%,1;:F4]J90 -]
MTUS>M_ZMJZ1ONFN;UO\ U;4 >9:S_K&K%B^_6UK/^L:L6+[](HW],_UBUZUX
M1ZQUY+IG^L6O6O"/6.@1['IG_'J*NU2TS_CU%7:!!1110 4444 %%%% !111
M0 4444 %<CXI_P!4]==7(^*?]4] 'A7B?_6O]:X>X^\:[CQ/_K7^M</<?>-(
M97'6I*C'6I*8PHHHH **** "BBB@".7I26?^O'UI9>E)9_Z\?6@#U/PC]Y*]
MKT+_ %2_2O%/"/WDKVO0O]4OTH).E7[HJ&\_X]7J9?NBH;S_ (]7H \E\7=7
MKQW5_P#6M7L7B[J]>.ZO_K6H&CFY_O5HZ3_K%K.G^]6CI/\ K%H&>EZ']Q:Z
MN+[HKE-#^XM=7%]T4R1].6FTY: (+O[AKC]8Z-787?W#7'ZQT:@#A]0^\:YZ
M?_65T.H?>-<]/_K*0SH_#G^M7ZU[EX3^XE>&^'/]:OUKW+PG]Q* 9Z79_P"K
M%6ZJ6?\ JQ5N@04444 %%%% !1110 4444 %%%% #)/NUQWB7_4O78R?=KCO
M$O\ J7H \)\6?ZQZX!_];^-=_P"+/]8]< _^M_&@987[M.IJ_=IU PHHHH *
M*** "D/2EI#TH ;WJU:_ZP55[U:M?]8* /2?"/\ K$KW;P__ ,>H^E>$^$?]
M8E>[>'_^/4?2@DV:I:A_JF^E7:I:A_JF^E 'DOC'[K_C7A^M_P"O;ZU[AXQ^
MZ_XUX?K?^O;ZT#1GVO6NBT[[PKG;7K71:=]X4(#N]'Z+766_W!7)Z/T6NLM_
MN"F(<W6D'6E;K2#K0 D_^K-</XAZ-7<3_P"K-</XAZ-0!YMJ/^M-0P=14VH_
MZTU#!U%(HZ71/]<M>W>#>B5XCHG^N6O;O!O1*"3T^+_5+]*?3(O]4OTI] "'
MI63J/W#6L>E9.H_<-5'<#SW7>K5PEY_K#7=Z[U:N$O/]8:]2CL,FT[[XKT'0
MOX:\^T[[XKT'0OX:5?81WEC]P5H]JSK'[@K1[5YDMP"BBBI **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "DHHH 6BBB@ HHHH **** "BBB@ K"U
M_P#U+?2MVL+7_P#4M]* /$?%W5Z\U;_CY_&O2O%W5Z\U;_CY_&@9Z#X2^^E>
MVZ%_J5^E>)>$?OI7MNA?ZE?I0(Z9/NBEI$^Z*6@ HHHH Y3Q1_JW^E>&>)_]
M8]>Y^)_]6_TKPWQ/_K'H&CS^]ZFJ%K_Q\CZU?O>IJA:_\?(^M SUWP1]Z.O>
M-#_X]E^E>#^"/O1U[QH?_'LOTH)->BBB@ HHHH **** "BBB@ K!\2_\>A^E
M;U8/B7_CT/TH ^>_&/\ K7^M>>/]\UZ'XQ_UK_6O/'^^:!HC3_6BO2_!7^MC
M^M>:+_K17I?@K_6Q_6@&?0WA_P#X\E^E;%8_A_\ X\E^E;% @HHHH *KWG^I
M-6*KWG^I- ' ZYU:N.N/OFNQUSJU<=<??-,12D^]6SHW^L6L:3[U;.C?ZQ:
M/4-$_P!6M;=8FB?ZM:VZ0PHHHH **** "BBB@ HHHH CG_U+5P/B+^*N^G_U
M+5P/B+^*@#@+G_6FE2DN?]::5*8C8TS_ %@KT;0_N+7G.F?ZP5Z-H?W%H8'1
M4444AA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !5#5?\
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M4Z>6<4 ,-2VP_>"JX.:LVO\ K!0!W&@#E:[N#_5+7"Z#U6NZ@_U2TADE%%%
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MZ/7D&L_ZUJ"C&C^]5BJ\?WJL4 %%%% !1110 4444 ,?I2V_WQ2/TI;?[XH
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MEM/]:*22EM/]:*"CT3PY_#7H5K_JA7GOAS^&O0K7_5"J)8K]:1>M*_6D7K2
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MKPAT2O%=$_UJ_6O:O"'1*!'I\/\ J4^E/ID/^I3Z4^@04444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MY:_ZP532KEK_ *P4 =SH/5:[J#_5+7"Z#U6NZ@_U2TADE%%% !1110 4444
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MUUWI#0[2O^/A?K7M_@G^"O$=*_X^%^M>W>"?X/PH!GLVF_\ 'N/I5VJ6F_\
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M::T].^\M9DW^MK3T[[RTAGI'AC[Z5[3X=_U:5XMX8^^E>T^'?]6E CI:***
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M_K5^M>Y>$_N)0)GI=G_JQ5NJEG_JQ5N@04E+10 4444 %%%% !1110 4444
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MX!1114@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU_U@H [G0>JUW4'^J6N%T#JM=U!_JEI#)**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *R-
M5^Z:UZR-5^Z:J.X'!ZI]XU0M/]:/K5_5/O&J%I_K1]:[X_"!W6A]%KJ!TKE]
M#Z+74#I7%4W ****S **** "BBB@ HHHH *X[Q1]UJ[&N.\4?=:M:7Q ><2?
M\?7XUVGA[HM<7)_Q]?C7:>'NBUVU?A [JU^X*M55M?N"K5><P"BBBD 4444
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M *VD-&QI?WUKU'POU2O+=+^^*]2\+]4H ]BT+_5K6]6#H7^K7Z5O4""BBB@
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M/A?K7MW@GHGX4 SV;3?^/<?2KM4M._X]Q]*NT""BBB@ HHHH **** "BBB@
MHHHH 1ONFN<UK_5-71M]TUSFM?ZIJ /&O%O5Z\IU#_7'ZUZMXMZO7E.H?ZX_
M6@:(HNE2U%%TJ6@84444 %%%% !1110!&W6K-I]X56;K5FT^\* .\\-?ZQ*]
ML\,?<2O$_#7^L2O;/#'W$H).RJ"Y_P!74]0W/^KH \^\4_ZMZ\-\3_ZUZ]S\
M4#]V]>&>)_\ 6O0".,7_ %U;EAU%8:_ZZMRPZB@H[71_X:[2R^Z*XO1_X:[2
MR^Z*9)=;I3*>W2F4 ,?[M<YK/W&KHW^[7.:S]QJ!'FNL_?:L./\ UE;FL_?:
ML./_ %E(HZ'2O]8M>L^$^J5Y-I7^L6O6?"?5* /8-*_X]A]*OU0TK_CV'TJ_
M0(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHIKN$0L3@"
M@!20.I%&]?[PKE]4UY+=B XK/MO$8EDQOH [C(/>EK*LKWSE!S6FAR* '4A&
M12T4 020!QTKEO$5@HB8X[5V%8?B(#[,?I0!\^>+( C/Q7 1<77XUZ1XR^^]
M>;Q_\??XT#/5/!?WHZ]TT3_CW7Z5X7X+^_'7NNB_\>Z_2@1JUS?B/_4-]*Z2
MN<\1_P"H?Z4 >">,?]8]>:2_ZXUZ7XR_UCUYI+_KC0-%A/NTZFI]VG4#"BBB
M@ HHHH *#10: &=ZF@^^*A[U-!]\4 >A>$_]:E>]^&O^/8?2O!/"7^M2O?/#
M7_'L/I02;U9^H_ZMJT*H:B/W34 >3>+_ +KUXEKG^N;ZU[=XO^Z]>(ZY_KF^
MM T9EK]^NETW[PKFK7[U=+IOWA0!W6D=%KJK?[E<MI'1:ZJW^X*8AS=::*>W
M6F]Z &3_ .K-<5K_ -UJ[6;_ %9KB_$'W6H!'FVI?ZTU7M^HJQJ7^M-5[?J*
M11U&B?ZU:]J\(=$KQ;1/]<OUKVKPAT2@D]/A_P!2GTI],B_U2_2GT %%%% !
M1110 4444 %%%% !1110 V3_ %;?2O-?%WW7KTJ3_5M]*\V\7_=>@#Q+7?\
M6M7,2]373Z[_ *UOK7,2CDT#&+3Z8M/H&!I*6DQ0 M%%% !1110!!-6CHO\
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M$0:7&^@#L\@]Z6LBQOO/4'-:J'(H =1110 55U @6;YJU5+5/^/-J /$_&[
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MCL,FT[[XKT'0OX:\^T[[XKT'0OX:5?81WEC]P5H]JSK'[@K1[5YDMP"BBBI
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M/;?WEH C\3H# Q]J\(\4@"1Z]5\1>(XI8V <5X[XAO5FD;!H&<5?=36?:_\
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M??\ ";R?\]#1_P )O)_ST-<#]AN?1J/L-SZ-0!W_ /PF\G_/0TA\;R?\]#7
M_8;GT:C[!<^AH [[_A-Y/^>GZTH\;R?\]#^=>?\ V"Y]#2_8;GT- '?-XVD8
M8\PU1N/$[3=7KCQ8W/H:>MC<>AH$;[:T2<[J4:T1_%6%]BG]#1]BG]#0!T,>
MOE#G=6A#XO>+'[PUQILKCT-,-C<>AH&=[_PG$G_/0_G1_P )O(?^6AK@/L%S
MZ-1]@N?0T".^_P"$WD_YZ&C_ (3>3_GH:X'[#<^C4?8;GT:@#OO^$WD_YZ&C
M_A-Y/^>AK@?L-SZ-1]AN?1J!G??\)O)_ST-'_";R?\]#7 _8;GT:C[#<^C4
M=]_PF\G_ #T-'_";R?\ /0UP/V&Y]&H^PW/HU '??\)O)_ST-'_";R?\]#7
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M%'F"H?LTOH:/LTOH: )O,%'F"H?LTOH:/LTOH: )O,%'F"H?LTOH:/LTOH:
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MZ&D^S2^AH E,@Q4>X9S2?9I?0T?99?0T :VG7XMV!S786'BHPJ 'KSH6\PZ
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MW30!2S1FKO\ 9LO]TT?V;+_=- BEFC-7?[-E_NFC^S9?[IH&4LT9J[_9LO\
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MZ_8K?_GF*/L5O_SS% 'A7_" _P#3.C_A ?\ IG7NOV*W_P">8H^Q6_\ SS%
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M!_Z9T?\ " _],Z]U^Q6__/,4?8K?_GF* /"O^$!_Z9T?\(#_ -,Z]U^Q6_\
MSS%'V*W_ .>8H \*_P"$!_Z9T?\ " _],Z]U^Q6__/,4?8K?_GF* /"O^$!_
MZ9T?\(#_ -,Z]U^Q6_\ SS%'V*W_ .>8H \*_P"$!_Z9T?\ " _],Z]U^Q6_
M_/,4?8K?_GF* /"O^$!_Z9T?\(#_ -,Z]U^Q6_\ SS%'V*W_ .>8H \*_P"$
M!_Z9T?\ " _],J]U^Q6__/,4?8K?_GF* /"O^$!/_/.E'@(_\\_TKW3[#;_\
M\Q1]BM_^>8H \,_X0(_\\Z3_ (0(_P#/.O=/L5O_ ,\Q1]BM_P#GF* /"_\
MA 3_ ,\J3_A 3_SSKW7[%;_\\Q1]BM_^>8H'<\*_X0$_\\Z/^$!_Z9U[K]BM
M_P#GF*/L5O\ \\Q0(\*_X0'_ *9T?\(#_P!,Z]U^Q6__ #S%'V*W_P">8H \
M*_X0'_IG1_P@)_YY5[K]BM_^>8H^Q6__ #S% 'A7_" G_GE^E'_" _\ 3.O=
M?L5O_P \Q1]BM_\ GF* /"O^$!_Z94O_  @)_P">?Z5[I]BM_P#GF*/L5O\
M\\Q0!X7_ ,($?^>='_"!'_GG7NGV*W_YYBC[%;_\\Q0%SPO_ (0(_P#//]*/
M^$!/_/.O=/L5O_SS%'V*W_YYB@=SPEO 1"D^5^E<MK?AO[&&^3&*^GGL+=D(
MV#D5Y3X\LHX@^ *!'AHM?WVW'>NJTCPW]K ^3.:R%0?;\>]>O^"[*.1$R!0,
MYR'P(74'R_TJ;_A 3_SRKVZWTZ!(UR@/%3?8K?\ YYB@5SPO_A 3_P \Z/\
MA C_ ,\Z]T^Q6_\ SS%'V*W_ .>8H \+_P"$"/\ SSH_X0$_\\J]T^Q6_P#S
MS%'V*W_YYB@#PK_A ?\ IG1_P@/_ $SKW7[%;_\ /,4?8K?_ )YB@#PK_A ?
M^F='_" _],Z]U^Q6_P#SS%'V*W_YYB@#PK_A ?\ IG1_P@/_ $SKW7[%;_\
M/,4?8K?_ )YB@#PK_A ?^F='_" _],Z]U^Q6_P#SS%'V*W_YYB@#PK_A ?\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M'^Z* /!?^$);_GG^E'_"$M_SS_2O>O["A_NBC^PH?[HH \%_X0EO^>?Z4?\
M"$M_SS_2O>O["A_NBC^PH?[HH \%_P"$);_GG^E'_"$M_P \_P!*]Z_L*'^Z
M*/["A_NB@#P7_A"6_P">?Z4?\(4W_/.O>O["A_NBC^PH?[HH'<\%_P"$*?\
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MDM68*.E 'S/=V)AE*XK2TK13=D?+G-:&N6ZI>L .]==X*L$F=,B@9EP>"6=
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M $SKV;[)!_<%'V2#^X* /&?^$(_Z9T?\(1_TSKV;[)!_<%'V2#^X*!W/&?\
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M0?\ Z9U[/]D@_N"C[)!_<% 'C'_"#_\ 3.E_X0?_ *9U[-]D@_N"C[)!_<%
M[GC/_"$?],Z/^$(_Z9U[-]D@_N"C[)!_<% KGC/_  @__3.D_P"$'_Z9U[/]
MD@_N"C[)!_<% 'C'_"##_GG1_P (,/\ GG7L_P!D@_N"C[)!_<% 7/&/^$&'
M_/.C_A!A_P \Z]G^R0?W!1]D@_N"@=SQC_A!O^F?Z4?\(,/^>=>S_9(/[@H^
MR0?W!0%SQC_A!A_SSH_X08?\\Z]G^R0?W!1]D@_N"@+GC'_"##_GG1_P@P_Y
MYU[/]D@_N"C[)!_<% 7/&/\ A!A_SSH_X0;_ *9U[/\ 9(/[@H^R0?W!0%SQ
MC_A!O^F?Z4?\(/\ ],Z]G^R0?W!1]D@_N"@+GC/_  @__3.C_A!_^F=>S?9(
M/[@H^R0?W!0(\9_X0?\ Z9T?\(1_TSKV;[)!_<%'V2#^X*!W/&?^$(_Z9TG_
M  A'_3.O9_LD']P4?8X/[@H$>,_\(1_TSH_X0C_IG7LWV.#^X*/LD']P4 >,
M_P#"$?\ 3.D_X0C_ *9U[/\ 9(/[@H^R0?W!0!XS_P (1_TSH_X0C_IG7LWV
M2#^X*/LD']P4 >%W?@WRU/[NN9O_  _Y)/R5]#:KI\7EDA1TKS?7K1%9L 4#
M/,8-'#28VUU6E^$_/ ^2I+*W0W X[UZEX8L(F125'2@#@_\ A"/^F='_  A'
M_3.O9OLD/]P4?9(/[@H$>,_\(1_TSH_X0?\ Z9U[-]D@_N"C[)!_<% 'C'_"
M#_\ 3.C_ (0?_IG7L_V.#^X*/L<']P4 >,?\(/\ ],_TI?\ A!_^F?Z5[-]D
M@_N"C[)!_<% 7/&?^$'_ .F='_"#_P#3.O9OLD']P4?9(/[@H \9_P"$(_Z9
MT?\ "$?],Z]F^R0?W!1]D@_N"@#QG_A!_P#IG2?\(/\ ],Z]G^R0?W!1]D@_
MN"@#QC_A!A_SS_2F'P+S_J_TKVK[)!_<%'V.#^X* /';?P3L(_=UTFF>'/((
M^2N_%I"/X!3A!&.BT 4-/M?)4#%:=(% Z"EH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** $I:** "BBB@ I&
M^Z?I2TC_ '&^E 'E?C;J]><6A/VW\:]+\91ER]>?6ELWVP''>@#U'PL?W2?2
MNV*[XL>U<9X9C*QK7<0#Y* .:U/2C/GBN>D\-DN3LKTDQ(W44W[/%_=H \Y7
MPX0/N4]?#AS]RO0_L\7]VC[/%_=H X!O#89?N5BZAX0\P'"5ZUY$?]T4QK2%
MNJT >#3^!BS']W4'_"!M_P \OTKWLZ;;G^&D_LRV_N"@#P7_ (0,_P#/+]*7
M_A S_P \_P!*]Y_LRV_N"E_LRV_NT >#?\((?^>?Z4?\((W_ #SKWG^S+;^[
M2?V9;?W: /!_^$$;_GG1_P ((W_/.O>/[,MO[M']F6W]V@#P?_A!&_YYT?\
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MMO[M '@W_""'_GG^E)_P@A_YY_I7O7]F6W]VC^S+;^[0!X-_P@A_YY_I2?\
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M &9;?W!1_9EM_<% '@W_  @9_P">7Z4?\(&?^>7Z5[S_ &9;?W!1_9EM_<%
M'@W_  @9_P">7Z4?\(&?^>7Z5[S_ &9;?W!1_9EM_<% '@W_  @9_P">7Z4?
M\(&?^>5>\_V9;?W!2_V9;?W: /!O^$#/_//]*/\ A!&_YYU[S_9EM_=H_LRV
M_NT >#?\((W_ #SH_P"$$;_GG7O/]F6W]VC^S+;^[0!X-_P@C?\ /.C_ (01
MO^>=>\_V9;?W:/[,MO[M '@W_""-_P \Z/\ A!&_YYU[S_9EM_=H_LRV_NT
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** &N=J,?05Y)X_FR)*]:E_U3?2O(O'D3.'Q0!X\DO_$P_&O9/!$W
MR)7CBVC_ &_IWKV#P7$RHF10-GK-K)OB7-3U4LN(Q5N@04444 %%)2B@ HHH
MH **** "BDHH 6BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH *R-5^Z:UZR-5^Z:J.X'!ZI]XU0M/]:/K5_5/O&J%I_K1]:[X_"!W6A]%
MKJ!TKE]#Z+74#I7%4W ****S **** "BBB@ HHHH *X[Q1]UJ[&N.\4?=:M:
M7Q ><2?\?7XUVGA[HM<7)_Q]?C7:>'NBUVU?A [JU^X*M55M?N"K5><P"BBB
MD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[I]*EH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% #)O]4U<+K[?>
MKN9O]4U<-KZ$[J //KQ_WY^M;F@-^\6L2\A8S=.];>@QD2+0!ZGI1S;#Z5?K
M/TG_ (]A]*T* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "H;E=T)%34C#(Q0!PFKZ7YS
MD[:S[/1MDH.VN_EL5D/2F)IRJ<XH I:=:^6HXK;C&%J..$(.E2@8H 6BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 9*VU":X
M[Q'/^[:NOG&4KC/$,3-&V!0!Y3J<_P#I1^M=9X/G_>I7)ZE92&Z/!ZUU7A&V
M=)%R* /8+=MT"'VJ2H;48MD^E34 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% #)FVPN?:O'_ !I/^]>O7KCFW?Z5Y!XRMG>1\"@#CM*G_P!,'UKV
M3PS.?)6O'=+L9!=@X/6O7O#<3+$N: .S5MR@TZHXONU)0 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 444E "T4"B@ HHHH **** ,C5IL(17F?B"?YFKTC5E+*U>;:];.Q;
MH Y^RG_TD?6O5O"TWR+7E5E9R"Y'!ZUZEX7B*(N: .QHHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *1ON
MGZ4M% '$>(=/,Y;BN5@T,K<9V]Z]4N+(3=155=(4-G;0!FZ-9F)%XKI8AA:A
MAM1$.!5D#% "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !TK&UB7]RWTK8;H:P]74F%OI0!Y#XFE_?-]:K>')?]*7ZU9\2V
M[-,V!5;P[;LMRO'>@9[CH;[K%:TZRM!&+(?2M6@04444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M"_=JK;0"-0,5;'2@ HHHH **** "BBB@ I*6B@ HHHH **** "BBB@ HHHH
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M5KG]6LS*A&*Z.HI8%D'(H \IN]"+3D[>];^@Z9Y#+\M=+)IJ%L[14]O9B(C
MH NQ#$:CVI](!@4M !1110 4444 %%%% !1110 4444 %%%% !1110 AZ5DZ
MC]PUK'I61J/W#51W \^UWJU<)>?ZPUW>N]6KA+S_ %AKU*.PR;3OOBO0="_A
MKS[3OOBO0="_AI5]A'>6/W!6CVK.L?N"M'M7F2W ****D HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M ****0!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M5XC5B 7KM;#4$G0<YH T:*0$&EH **** "BBB@ HHHH **** "BBB@ HHHH
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %!HHH 2
MEHHH **** "BBB@ HHHH ***#0 44E+0 E(S;13JK73[4- $%QJ*PYR167/X
MGBB)!85SOB+4V@#8:O,=2\0RF5@'/6@#V8^,(A_&*1?&$1.-XKQ."_NI^06J
MRLMVIR=U 'N-OXDBF(^85JP7Z3 8(KPFSUF6!QN8UVVA^(!(54O0!Z6K;AFE
MJGI\XGB!![5<H **C:9%ZFF"ZC)ZT 3T4Q9%;H:?0 444QI%3J: 'T5!]KCS
MUIRSHW0T 2T4@.12T %%(6"]:B:X1>IH FHJ$7,9[U*K!AQ0 ,VT9K/N=26#
MJ:MW)VQ$UYYXEU1K<MAJ .O37(W;&X5IV\XF7(KQ2PUYWN@NX]:]4\.W!G@!
M)[4 ;U%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%  3
M@52N;Y8 <FK<APA-<+XGU$VZM@XH Z$:]&6QN%:-M=BX P:\/C\1.;O;O/6O
M3O"UX;F-,G- '64444 -=]HJC/J*PYR:EO9-B&N%UW4VB#8- '23>)(HNK"J
MI\80@_>%>1:GKLN]@&-92ZI<R-PQH ]R'B^$G[PJY;^(HYR,,*\'%_=+R2U;
M.DZU*L@#,: /=K>Y6<<&K!.!FN(T36@RKEJZ";5D\GAATH GNM22W!R16-/X
MLBB.-XKF/$&M$!MK5YU?ZI<2RG:QH ]D'C2'/WQ5NW\4Q3' 85X*+F\ZY:M/
M3=5GCE 9C0![_;7ZS@8(J\#D5YWX>U8N%!:N\MYQ)$#F@"Q11UHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***#TH BDF"#FL^?5TA
MSDBFZE/Y:-S7G>OZNT6[#4 =K+XIBC/WA5<^,(O[XKQ:\UZ9I" QID5]=2C(
M+4@/;5\81$XWBKMOXBCF(^85X8MS=H<DM6E9:W+"XW,:8'N\%XLPX(JSD8S7
MGN@:\)MH+5V8NQY&[/:@"6XO5A!)-9%QXECA)&X5@>(-<$6X!J\_OM6FF<[6
M- 'JZ>+8F;&X5IVNM1W&,$5X&-0N8Y,DFNJT'76WJ&:@#V:.02+D4^L?1KT3
MQ#GM6Q0 54NKU;8')%2SW"PH23TKSOQ5XA$.\!Z .M_X2"+?MW"M&VO5G P:
M\(M_$KRW> YZUZ=X;OC+&I)H [1F"KFLVZU5+?.2*2]OUCA//:O/M>UALL%:
M@#K)?%<4;8W"GP>*(I3@,*\2OM4N#*<,:LZ9JDX<;F- 'OEMJ"S@8(JZ#D9K
MSC0]8X4,U=S97BS(.: +]%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4E+10 @I:** $I:** "BBB@ HHHH **** "BBB@ HHHH *0G%+4,[
M;5H 9+=+&.35&768X^XK)U>_\E3S7!:EK[*Y >@#TH^(HQ_$*3_A(X\_>%>1
MIK$LIX8U8%]/UR: /78=;CE/WA6C#<K*.#7C]IK#Q,-S&NKTOQ K8!>@#O**
MHV5XMPHP:O4 %%%)D4 +1110 F!Z48'I2T4 %%)N% .: %HHHH **** "BDR
M*6@!"<57ENECZFII>%)KE]9OO)#<T ;7]IINQD59AN1+TKS#^W#Y^-W>NPT*
M\\\+S0!TPI:** "BBB@ HHHH **** "BBB@ HHHH ***2@!:#2"EH 2EHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "LC5?NF
MM>LC5?NFJCN!P>J?>-4+3_6CZU?U3[QJA:?ZT?6N^/P@=UH?1:Z@=*Y?0^BU
MU Z5Q5-P"BBBLP"BBB@ HHHH **** "N.\4?=:NQKCO%'W6K6E\0'G$G_'U^
M-=IX>Z+7%R?\?7XUVGA[HM=M7X0.ZM?N"K55;7[@JU7G, HHHI %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !5>\.(#5BJM__P >YH \[\1717=S7GUY>,92,UVOB;.7KSNYSY_XT :U
MB#*16P;8B/-96DD9%=%(5\C\*!G.7,S0OP:M:;J[K(!N-9VI'+G%,TV$M**
M/6=!U!I0N379)*OE@DXK@- B*1J:VM0U)K:#KT% CHWNX8^KBH3J4.>&%>4Z
MEXM>.0C>:J1>+&;DO0![*E["_P#%4ZR(W1A7CT'B_#@;_P!:[#1==%T!\V:
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MSN4T"/3-,E,D8)K1K,TE-L0^E:= !1110 4444 %%%% !1110 4444 %%%%
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M?LUD/I6+KNL&+*[J!&A>ZL QPU9HUK#\M7,'4C,Q^:J-Y?&+G=0!Z98ZPLA
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M]M '/Z9K;)=A=W>O6M#U$RV@.>U?/]BDIU 8SUKVSPM&YLU!]*!D'B?4WC!
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MZB/08(USM% 'G6GZ7+!@D&M]+LV\6":VK^UBMT. *XG5KS86 - BKKNIM(K
M-7$R6<UW/QDY-:T\YEEP:Z3P[IL=Q(N0*!G+1:!.(=VT]*SI;>:TGYR,&O?!
MX?A%G]T9Q7FGBK3TMYFP!0!+X8U%D"@M6WK5\)+4\]JXC2)RDF!6KJ-PQMSS
MVH$<[(0][^-=MHHQ /I7"1-NNOQKO='_ -0/I0!!J[D USB2MYW7O71ZN.#7
M.(/WWXT =EH+DE:]#T__ %(^E>>:$.5KT/3_ /4CZ4 7:*** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "LC5?NFM>LC5?NFJCN!P>J?>-4+3_6
MCZU?U3[QJA:?ZT?6N^/P@=UH?1:Z@=*Y?0^BUU Z5Q5-P"BBBLP"BBB@ HHH
MH **** "N.\4?=:NQKCO%'W6K6E\0'G$G_'U^-=IX>Z+7%R?\?7XUVGA[HM=
MM7X0.ZM?N"K55;7[@JU7G, HHHI %%%% !1110 4444 %%%% !1110 4444
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MM+Z>WN "3UKT[POJS,$!:@1ZY&P8<4^LW3KCS4'-:5 "4M%% !1110 4444
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MO3O!GW4KS&<_Z;^->G>"SPE 'HM%%% !FBDI: "BBB@ HHHH **** "BBB@
MHHHH 2BEHH **** "BBB@ KG_%7_ !XGZ5T%<]XJ_P"/$_2@#YY\0C_3V^M=
M=X%'[U*Y#Q$?]/;ZUUO@5OWJ4#/<['_CT3Z58JM8'-JGTJS0(BN/]2:X/Q"/
ME>N[N3B(UPGB(_(] 'E6L2;)B?>FZ7JPAD'-1ZZ"96Q6/:P2M*, ]:!GI"Z^
M&@QN[5AWMP;J0XYS45IIMP\8X-:]EHDC.,J: *NF:29I =M>@:3H>(QE:DT7
M1 @4E:Z<>7:Q\X% CD]8T 20D!>U>::MX9=)F(7O7LUWJ4#94D5BW$,%T3@
MYH \HM[26T/0C%:MKJ7E, QKJK_0@4)5:X?5K&2V<D B@9W>D:U%E06%=QI^
MHQRH,$5\]6>I2P3@9/6O1O#>K-)L!:@1ZQ$P9<BI*HZ;+YD(/M5Z@!**6B@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ K(U7[IK7K(U7[IJH[@<'JGWC
M5"T_UH^M7]4^\:H6G^M'UKOC\('=:'T6NH'2N7T/HM=0.E<53< HHHK, HHH
MH **** "BBB@ KCO%'W6KL:X[Q1]UJUI?$!YQ)_Q]?C7:>'NBUQ<G_'U^-=I
MX>Z+7;5^$#NK7[@JU56U^X*M5YS ****0!1110 4444 %%%% !1110 4444
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M)0?E6]%X8AC/W15_1R!!CVK3H SK?2XX,8 JKK;M! =OI6W6=JMM]HB(QVH
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M''>O;_"*[;9?I7F]II#+> [>]>I>'8?*@ ]J!F]1110(**** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH 9+_JF^E>7^-HBZ/7J,G*&N&\3V1F
M1N* / 9XFCOL^]>B>%-2\A%&:PM1T1A.2%[U/802P <$4#/2QK@VCYJFAU@-
M_%7!":7@<U>M99<CK0([&XO_ #$ZURFL*9 U:D =QSFBXL6D7I0!Y^;$O/T[
MUVOAO2%8KE:KC2B)<[:[#0+;RBN10,VX-'C6->!TJY%8I'V%6AT%+0(BF&V
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MCI7F4=I+:7.<'@UNQ:A+Y.W)H BU&)/M!QZUKZ*N,5CA))Y<D&NCTJU=0.*
M-=HPT=5OLD9/(%:'DL(^E9=Y*\.<4 1W-O BGI6!<W"1O\IJ/4=2EY S6,C3
M7$O>@9NV]^^>#6@NHS*.IJ#2=)>7&5KH3X?/EYVT",0ZLXZDU+%J*R'DU6U/
M3'AS@&L O-%)CF@#LI/*DB)XKE]1B02G%6K>ZE:/!S56YCDE?H: -/0.'%=-
MJ(_T,_2L30+1PRDBNEOK5FM<8[4 >;SC_3?QKT[P6.$KA)]/?[9G'>O1/"-N
M8PF10!WE%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MM)+*0D C% 'HC7<'V+&1TKA]3='N#M]:HS:Q.J;,FHK0RW4P)SR: -RPC9D
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA/TKT\@'J*88(VZH* /%'\&2;N$/Y5/:^#75P2A_*O8OLD'_ #S% M81TC%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH ***2@!:*04M !1110 4444 %%%% !124H
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH ***2@!:2EHH 2EHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DI:* "BBB@
M HHHH **** "BBB@ I*6B@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M***#0 44E+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%!H **2EH
M **** "BBB@ HHHH **** "BBB@ HHHH **,44 %%%% !1110 4444 %%%%
M!1110 4&BB@!*6BB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "C-%%  **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "B@TE "T444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 )12T4 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %(:6B@!*6BB@ HHHH
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M=P"Y_.O0M$UG[0%RU>)QZ;/:3=#Q7=>';F2/;DF@#V&*0/&#FI,US%MJFV(
MFKL.IAC]Z@#:HJ""<2#K4Y.!F@ HR/6LZZO5BSS6<VLC/WJ -2_NU@0\USDF
MN*)<;JSM<UG$38:O/9]>;[5C=WH ]LTS4%GQS6Q7F/A;5C(4RU>D6\HDC!H
MFHR/6H9YUB0Y-85UK(C)^:@#HLCUI:Y6'70[8W5N6=ZLP'- %ZL+7;[[+&QS
MC%;M<-XWE,<,F#VH XO6?&+02,!)^M88\:S.>'/YUQNN3RRWC $]:O:'H<UY
MC@G- SIE\7S[OOG\ZUK'Q;(6&YS^=9@\'3A-VP]*S+O39K%CD$8H ]<T?Q )
M]N6KLK2<31@@U\_Z-J[PS*I8UZSX>U7S8ERU CL**CBDWBI* $I:2EH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ K(U7[IK7K(U7[IJH[@<'JGWC5"T_U
MH^M7]4^\:H6G^M'UKOC\('=:'T6NH'2N7T/HM=0.E<53< HHHK, HHHH ***
M* "BBB@ KCO%'W6KL:X[Q1]UJUI?$!YQ)_Q]?C7:>'NBUQ<G_'U^-=IX>Z+7
M;5^$#NK7[@JU56U^X*M5YS ****0!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%&:* "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ Q1110 4444 %%%% !1110 4444 %%%% !24M)0 M%%% !1110 4444 %%
M%% !1110 4444 %)2TF* %HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** #%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %)2TE "TE+24 %%
M%+0 8HHHH **** "BBB@ HHHH **** "BBB@ HHJO-.(^] %BBLA]253]ZF?
MVJO]Z@#:HK%_M5?[U+_:B_WJ -FBL;^U%_O4?VHO]Z@#9HK&_M1?[U']J+_>
MH V:*QO[47^]1_:B_P!Z@#9HK%_M5?[U)_:J_P!Z@#;HK&75%)^]5R&Z$G>@
M"[12 Y%+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M&*** "BBB@ HHHH **** $I:2EH **** "BC-% !24M)0 M%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% "
M4444 +1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4E+24 %+24M !
M1110 4444 %%%% !1110 4444 (>E9&H_<-:YZ5DZC]PU4=P//==ZM7"7G^L
M-=WKO5JX2\_UAKU*.PR;3OOBO0="_AKS[3OOBO0="_AI5]A'>6/W!6CVK.L?
MN"M'M7F2W ****D HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?8ZB@#V'3I_,0<UIUSVB2%D6NAH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !2,<#-+44YVQ$T 5YKY8NIJD^MHI^\*P=;OS#NYKB;S7F5S\_P"M
M 'J']OQ_WA2_V\G]X5X^WB)L_?\ UI1XB;^_0!Z__;R?WA1_;R?WA7D/_"1-
M_?\ UH_X2)O[_P"M 'KW]O)_>%']O)_>%>0_\)$W]_\ 6C_A(F_OT >N_P!O
M)_>%']O)_>%>1?\ "1-_?I#XB;'WZ /71KZ9^\*GBUE)#]X5XN/$;;_O_K6Y
MI>N-(P^:@#UJ*Z$G>K*G(KE]*NS(J\UTD)RM $M%%% !1110 4E+10 E+110
M 4444 %%%% !1110 4444 %%%)0 M%%% !1110 4444 %%%% !1110 4444
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M HHHH **** $I1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M[31(BB+FNAJE9V_E*.*NT""BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "LC5?NFM>LC5?NFJCN!P>J?>-4+3_6CZU?U3[QJA:?ZT?6N^/P@=UH?1:Z
M@=*Y?0^BUU Z5Q5-P"BBBLP"BBB@ HHHH **** "N.\4?=:NQKCO%'W6K6E\
M0'G$G_'U^-=IX>Z+7%R?\?7XUVGA[HM=M7X0.ZM?N"K55;7[@JU7G, HHHI
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 44$XJ":=44\T 2EU'>@.IZ&L2XU##<&EM[_<PR: -RBHHIE=1S4M !111
M0 44E+0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 44FX>M&X>M "T4F:6@ HHHH **** "DW#UILK;5JB]QANM &
MAD&EJI#+NJT.E "T444 %%%% !1110 4444 %)D5&[8J R\T 6\BEJJLU+)<
M!5ZT 3EU'4TGF)ZU@W6H[2<&H(M2+-UH Z<,#WI:S;>XW@5?0Y% #Z***  T
ME+1B@ HHHH **** "BBB@ H-%% "4M&*"<4 %%-WKZTH8'H: "EHHH *,BFN
M<+FJCW(4]: +N:*JQ3ACUJR.E "T444 %%%% !1110 4444 %%%,=PHH <2!
MWI-Z^M9UQ>A,\U2_M'+=: -\$'I2U0M;H/CFKX.: "BBB@ H) HZ52N;D)GF
M@"WO7UI0P/>L%]1PW6K%O?!SUH UZ*CB<.M.=@HR: %) [TF]?6J$]V%SS6?
M)J.#UH W]Z^M+D5A0WY8]:T8ILB@"YD>M&15*2XV]Z6*Y#'K0!=HI%.1FEH
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ML*S-4O/LZGFN.O?$AC<@/^M 'H7VJ'^^*/M4/]\5YFOB.1NC4_\ X2"3^\:
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M#0FU( ]:K'4P3]ZN4GU)BQYI(KIV/6@#KEU'WJU!J2YY:N1$KXS4,E^\7<T
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 5D:K]TUKUD:K]TU4=P.#U3[Q
MJA:?ZT?6K^J?>-4+3_6CZUWQ^$#NM#Z+74#I7+Z'T6NH'2N*IN 4445F 444
M4 %%%% !1110 5QWBC[K5V-<=XH^ZU:TOB \XD_X^OQKM/#W1:XN3_CZ_&NT
M\/=%KMJ_"!W5K]P5:JK:_<%6J\Y@%%%%( HHHH **** "BBB@ HHHH ****
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M9MKTQD9-;=M?AP!FN.O)# WI5G2[TM(!F@#ND.Y0:5CA<U%:G= #2W#;82:
M*EQ>! >:P[R]W$X-0:E>E6(S6='(9VH 26Y;=UJS9WC!ADTC6#,N<5$+9HFZ
M4 =1:WHV#)HN=0 7K7.?;#$N,U1N=4/(W4 ;,][N)YJF9"QZUC"_RW6K45V#
MCF@#<M 2PK<B!$=<]87"LPYKI( 'BX]* ,R\G*FF6EWE^34NH6Q.3BLE"89.
M: .RMY R#FIZP;*]& ,ULPR;US0!)12T&@ HI*6@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ J"[_P"/=JGJ"[_X]VH \R\4?QUY=J/^L:O4?%'\
M=>7:C_K&H RGZT+0_6E6@!:*** "BBB@ IK=*=2-TH A7[]=3H7WUKEE^_74
MZ%]]: /6/#_W%KMK7[@KB?#_ -U:[>V^X* )Z*** .4\4,1&^*\CU2YD2X/)
MZUZ]XF&8VKQ_6D_?-]: -+0M1?S%!:O4M#N/,5>:\9T<D3#ZUZOX;?A<T =I
M5'4I-D?X5>'(K(UIL1'Z4 <)K]^5W &N+^VN]SU/6MOQ!(=S5S5J-UQ^- 'I
M/A9V8IFO14^XOTKS[PN@4*:[:2\6&,9/:@"U+($7)-47O@&ZUCWNM*6(#5G-
M?EN<T ==#=!^]6PP8<5Q,.J[&P6K;LM4$F.: -RBH%N%*YS5:YOUC7K0!9EG
M"=ZJ&^ ;K6'=ZL,D!JHC4"S9S0!VD$X?O5;4F'EG!K"@U7RQR:;=:PLBD;J
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH 0]*R=1^X:UCTK)U'[AJH[@>
M>Z[U:N$O/]8:[O7>K5PEY_K#7J4=ADVG??%>@Z%_#7GVG??%>@Z%_#2K[".\
ML?N"M'M6=8_<%:/:O,EN 4445(!1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%)0 M%)2T %%%% !3'C#C!IW>EH HR:;'(>0*C&D1 YP*
MTJ* *T5FD?0"K   P*6B@#$U=VV-BO+_ !(\[%@,UZ[=VOG C%<U?>&Q<$_+
M0!X@+2XEN.0>M=[X9T=B5++721>#563.S]*Z/3=&6U ^7% %C3;$0QKQ6M34
M4*H IU #64.,&JSV,;]0*MT4 45TZ-3D 59CA$?2I:* &/&'&#5.73(Y#R!5
M^B@#-32(E.<"KD5NL705-10 4QT#]:?10!4>QC?J!41TN(]A6A10!G#2HP>@
MJQ'9I'T JS10 @&!@4M%)0 M% HH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH *R-5^Z:UZR-5^Z:J.X'!ZI]XU0M/]:/K5_5/O&J%I_K1]:[X_"!
MW6A]%KJ!TKE]#Z+74#I7%4W ****S **** "BBB@ HHHH *X[Q1]UJ[&N.\4
M?=:M:7Q ><2?\?7XUVGA[HM<7)_Q]?C7:>'NBUVU?A [JU^X*M55M?N"K5><
MP"BBBD 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M7H.BG,(^E &M1110 44E+0 4444 %%%% !1110 4444 %%%% !1110 4444
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M'XL^X] 'C.M?ZYOK6(>E;>M?ZYOK6(U #[;_ %@KL-&_AKC[;_6"NPT<@;:
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ I*6B@ HHHH **** "BBB@ HHHH ***2@!<4F!Z44M !@4444 %%%
M% !1110 4444 %%%% !1110 4449H *2EI* #-+244 +1BBB@ HHHH ****
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M<Q"UK6CNT1,5BZI<>;D+0 MIJ'[S;FNDM1YZ UQ5A;R-,#@]:[_28"(AD=J
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M>[4 >9>*/XZ\NU'_ %C5Z?XI/WZ\LU)CYC4 9S]:%J)V.:%8T 3T5%N-&XT
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M=%KMJ_"!W5K]P5:JK:_<%6J\Y[@%%!HI %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !2
M4M%  **** *-_%YBD5S[:=F7.*ZQT#5#]E7.<4 4;*WV)C%0W]KY@Z5L+$%%
M(\(:@#F[:PVR9Q716R;(P*%ME!SBI@,#% !@&C:*6B@!-HHP*6B@"&XCWIBN
M;U"PW9(%=21D5!);*_:@#S^6SD1N :=%:2.W(-=H^EHQZ"A-+13T% &7ING[
M<$BM>:+9#QZ59B@6/I1.FY,4 <5J)?S3C-6](+;QFKMS8;WSBI[&S\LCB@#:
M3[B_2H+R/?'BK"\**1EW"@#EY;#=)G%:-E;>6!Q6D;92>E/6(+0!#)'E<51E
MMLGI6L5S33$#0!@R6>>U49[-AG KJC #4;V:MVH X::"4'@&HDL7D;D&NV;2
MT8]!2IIB*>@H PM/TH*02M=-;0B-,8I8[=4Z"I@,"@ P#1M%+10 FT5'*@(J
M6@\T 9-Q;;L\54%G\W2MUH@:;Y H K6T6Q>E,O(=Z$5?5 *&C#4 <L=-W2Y*
MU?BTU5C^[6L+90<XJ4( ,4 <?J-FPSM%<^]M-YG0UZ/-9++U JF=&0G.!0!S
M&G6CDC<#736]@"G(JS#IR1= *NHH48% &%=Z:,'"UC263(_ KM7C#CFJKV"L
M>@H Q+"-U(S720_ZH5!'9JAZ5:4;1B@!DPS&:YO4;=F)P*Z<C(Q5>2T63J*
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M/3R^>^*NZJ7+'%4;*!GE&10!9LK'+!L5T]G'Y:8J*SM0L8.*NJNT4 .HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !124"@!:*** $/2LG4?N&M8]*R=1^X:J.X'
MGNN]6KA+S_6&N[UWJU<)>?ZPUZE'89-IWWQ7H.A?PUY[IQ^<5Z%H7\-*OL([
MRQ^X*T>U9UC]P5H]J\R6X!24M)BI 44444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !61JOW36O61JOW350W X/5/OFJ%I
M_K15_5/OFJ%I_K17?'X0.ZT/HM=0.E<OH?1:Z@=*XJGQ %%%%9@%%%% !111
M0 8HHHH *X[Q1]UJ[&N.\4?=:M:7Q ><2?\ 'U^-=IX>Z+7%R?\ 'S^-=IX>
MZ+7;5^$#NK7[@JU56U^X*M5YSW ****0!1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4C#(I:* (&A!/2
MG)$%[5+10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 A&0:R[RP\_/%:M
M% '*/H +9VU*FB@#[M=-@>E)@>@H P(]' .=M:=M:"+'%7:* "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** &2+N0BLJXTX2-G%;%&* ,6'30AZ58-B".E:6** ,V.P56SBM!$"
M+@4ZB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "D894BEHH R;FP\ULXI+?3Q&V<5KX%&* &HNU *=110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !2,,C%+10!2FLQ)VJD^D*
MQ^[6U10!@_V,O]VC^QE_NUO44 8/]C+_ '11_8R_W:WJ* ,'^QE_NT?V,O\
M=%;U% &#_8R_W11_8R_W16]10!@?V*N?NU/'I:I_#6Q10!4BMPG:K2C I:*
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MX>Z+7%R?\?7XUVOAT<+7;6^$#N;7[@JU5:U'R"K->:]P"BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *2EHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *,"BB@!-H]*
M-J^E+10 FU?2C:OI2T4 )M7THVKZ4M% ";5]*-J^E+10 FU?2C:OI2T4 )M7
MTHVKZ4M% ";1Z48'I2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M8&KD49%97]H+_>H_M!?[U'*P-7(HR*RO[07^]1_:"_WJ.5@:N11D5E?V@O\
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MH+_>H_M!?[U'*P-7(HR*RO[07^]1_:"_WJ.5@:N11D5E?V@O]ZC^T%_O4<K
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M>JE<ZSO!^:N,^W/ZFD-XY/4T*BD!ORWGF-UJ]IK;I!7,0S%B*Z/2#EUHG&R
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MU^M']O?[7ZUP7VY_4T?;G]31[! =[_;W^U^M']O?[7ZUP7VY_4T?;G]31[!
M=[_;W^U^M']O?[7ZUP7VY_4T?;G]31[! =[_ &]_M?K1_;W^U^M<%]N?U-'V
MY_4T>P0'>_V]_M?K1_;W^U^M<%]N?U-'VY_4T>P0'>_V]_M?K1_;W^U^M<%]
MN?U-'VY_4T>P0'>_V]_M?K1_;W^U^M<%]N?U-'VY_4T>P0'>_P!O?[7ZT?V]
M_M?K7!?;G]31]N?U-'L$!WO]O?[?ZT?V]_M?K7 _;G]30+Y_4T>P0'??V]_M
M?K1_;W^U^M<%]N?U-'VY_4T>P0'>_P!O?[7ZT?V]_M?K7!?;G]31]N?U-'L$
M!WG]O?[5']O?[=<$;Y_4TGVY_4T>P0'?_P!O?[7ZT?V]_M?K7!?;G]31]N?U
M-'L$!WO]O?[7ZT?V]_M?K7!?;G]31]N?U-'L$!WO]O?[7ZT?V]_M?K7!?;G]
M31]N?U-'L$!WO]O?[7ZT?V]_M?K7!?;G]31]N?U-'L$!WO\ ;W^U^M']O?[7
MZUP7VY_4T?;G]31[! =[_;W^U^M']O?[7ZUP7VY_4T?;G]31[! =[_;W^U^M
M']O?[7ZUP7VY_4T?;G]31[! =[_;W^U^M']O?[7ZUP7VY_4T?;G]31[! =[_
M &]_M?K1_;W^U^M<%]N?U-'VY_4T>P0'>_V]_M?K1_;W^U^M<%]N?U-'VY_4
MT>P0'>_V]_M?K1_;W^U^M<%]N?U-'VY_4T>P0'>_V]_M?K1_;W^U^M<%]N?U
M-'VY_4T>P0'>_P!O?[?ZTG]O?[=<%]N?U-'VY_4T>P0'>_V]_M4O]O?[7ZUP
M(OG]32_;G]31[! =[_;W^U^M']O?[7ZUP7VY_4T?;G]31[! =[_;W^U^M']O
M?[7ZUP7VY_4T?;G]31[! =[_ &]_M?K1_;W^U^M<%]N?U-'VY_4T>P0'>_V]
M_M?K1_;W^U^M<%]N?U-'VY_4T>P0'>_V]_M?K1_;W^U^M<%]N?U-'VY_4T>P
M0'>_V]_M?K1_;W^U^M<%]N?U-'VY_4T>P0'>_P!O?[7ZT?V]_M?K7!?;G]31
M]N?U-'L$!WO]O?[7ZT?V]_M?K7!?;G]31]N?U-'L$!WO]O?[7ZT?V]_M?K7!
M?;G]31]N?U-'L$!WO]O?[7ZT?V]_M?K7!?;G]31]N?U-'L$!WO\ ;W^U^M']
MO?[7ZUP7VY_4T?;G]31[! =[_;W^U^M']O?[7ZUP7VY_4T?;G]31[! =[_;W
M^U^M']O?[7ZUP7VY_4T?;G]31[! =[_;W^U^M']O?[7ZUP7VY_4T?;G]31[!
M =[_ &]_M?K1_;W^U^M<%]N?U-'VY_4T>P0'>_V]_M?K1_;W^U^M<%]N?U-'
MVY_4T>P0'>_V]_M?K1_;W^U^M<%]N?U-'VY_4T>P0'>_V]_M?K1_;W^U^M<%
M]N?U-'VY_4T>P0'>_P!O?[7ZT?V]_M?K7!?;G]31]N?U-'L$!WO]N_[=']O?
M[7ZUP?VU_4TGVY_4T>P0'>_V]_M?K1_;W^W^M<%]N?U-'VY_4T>P0'>_V]_M
M?K1_;W^U^M<%]N?U-'VY_4T>P0'>_P!O?[7ZT?V]_M?K7!?;G]31]N?U-'L$
M!WO]O?[7ZT?V]_M?K7!?;G]31]N?U-'L$!WO]O?[7ZT?V]_M?K7!?;G]31]N
M?U-'L$!WO]O?[7ZT?V]_M?K7!?;G]31]N?U-'L$!WO\ ;W^U^M']O?[7ZUP7
MVY_4T?;G]31[! =[_;W^U^M']O?[7ZUP7VY_4T?;G]31[! =[_;W^U^M']O?
M[7ZUP7VY_4T?;G]31[! =[_;W^U^M']O?[7ZUP7VY_4T?;G]31[! =[_ &]_
MM?K1_;W^U^M<%]N?U-'VY_4T>P0'>_V]_M?K1_;W^U^M<%]N?U-'VY_4T>P0
M'>_V]_M?K1_;W^U^M<%]N?U-'VY_4T>P0'>_V]_M?K1_;W^U^M<%]N?U-'VY
M_4T>P0'>_P!O?[7ZTG]O?[7ZUP?VY_4TAOG]31[! =[_ &]_MT?V]_M?K7 _
M;G]32_;G]31[! =]_;W^U^M)_;O^U7!_;G]30+U_4T>P0'>?V[_M4O\ ;W^U
M^M<%]M?U-'VY_4T>P0'>_P!O?[7ZT?V]_M?K7!?;G]31]N?U-'L$!WO]O?[7
MZT?V]_M?K7!?;G]31]N?U-'L$!WO]O?[7ZT?V]_M?K7!?;G]31]N?U-'L$!W
MO]O?[7ZT?V]_M?K7!?;G]31]N?U-'L$!WO\ ;W^U^M']O?[7ZUP7VY_4T?;G
M]31[! =[_;W^U^M']O?[7ZUP7VY_4T?;G]31[! =[_;W^U^M']O?[7ZUP7VY
M_4T?;G]31[! =[_;W^U^M']O?[7ZUP7VY_4T?;G]31[! =[_ &]_M?K1_;W^
MU^M<%]N?U-'VY_4T>P0'>_V]_M?K1_;W^U^M<%]N?U-'VY_4T>P0'>_V]_M?
MK1_;W^U^M<%]N?U-'VY_4T>P0'>_V]_M?K1_;W^U^M<%]N?U-'VY_4T>P0'>
M_P!O?[7ZT?V]_M?K7!?;G]31]N?U-'L$!WO]O?[7ZT?V]_M?K7!?;G]31]N?
MU-'L$!WO]O?[7ZT?V]_M?K7!?;G]31]N?U-'L$!WO]O?[7ZT?V]_M?K7!?;G
M]31]N?U-'L$!WO\ ;W^U^M']O?[7ZUP7VY_4T?;G]31[! =[_;W^U^M']O?[
M7ZUP7VY_4T?;G]31[! =[_;W^U^M']O?[7ZUP7VY_4T?;G]31[! =[_;W^U^
MM']O?[7ZUP7VY_4T?;G]31[! =[_ &]_M?K1_;W^U^M<%]N?U-'VY_4T>P0'
M>_V]_M?K1_;W^U^M<%]N?U-'VY_4T>P0'>_V]_M?K1_;W^U^M<%]N?U-'VY_
M4T>P0'>_V]_M?K1_;W^U^M<%]N?U-'VY_4T>P0'>_P!O?[7ZT?V]_M?K7!?;
MG]31]N?U-'L$!WO]O?[7ZT?V]_M?K7!?;G]31]N?U-'L$!WO]O?[7ZT?V]_M
M?K7!?;G]31]N?U-'L$!WO]O?[7ZT?V]_M?K7!?;G]31]N?U-'L$!WO\ ;W^U
M^M']O?[7ZUP7VY_4T?;G]31[! =[_;W^U^M']O?[7ZUP7VY_4T?;G]31[! =
M[_;W^U^M']O?[7ZUP7VY_4T?;G]31[! =[_;W^U^M']O?[7ZUP7VY_4T?;G]
M31[! =[_ &]_M?K1_;W^U^M<%]N?U-'VY_4T>P0'>_V]_M?K1_;W^U^M<%]N
M?U-'VY_4T>P0'>_V]_M?K1_;W^U^M<%]N?U-'VY_4T>P0'>_V]_M?K1_;W^U
M^M<%]N?U-'VY_4T>P0'>_P!O?[7ZT?V]_M?K7!?;G]31]N?U-'L$!WO]O?[7
MZT?V]_M?K7!?;G]31]N?U-'L$!WO]O?[7ZT?V]_M?K7!?;G]31]N?U-'L$!W
MG]O?[7ZT?V]_M_K7!?;G]32?;G]31[! =]_;W^U^M+_;W^U^M<#]N?U-+]N?
MU-'L$!WO]O?[7ZT?V]_M?K7!?;G]31]N?U-'L$!WO]O?[7ZT?V]_M?K7!?;G
M]31]N?U-'L$!WO\ ;W^U^M']O?[7ZUP7VY_4T?;G]31[! =[_;W^U^M']O?[
M7ZUP7VY_4T?;G]31[! =[_;W^W^M']O?[7ZUP7VY_4T?;G]31[! =[_;W^U^
MM']O?[7ZUP7VY_4T?;G]31[! =[_ &]_M?K1_;W^U^M<%]N?U-'VY_4T>P0'
M>_V]_M?K1_;W^W^M<%]N?U-)]N?U-'L$!WW]O?[7ZT?V[_M?K7!?;G]31]M?
MU-'L$!WO]N_[7ZT?V]_M?K7!&^?U-'VY_4T>P0'>_P!O?[7ZT?V]_M?K7!?;
MG]31]N?U-'L$!WO]O?[7ZTG]N_[7ZUP?VY_4T?;7]31[! =Y_;O^U^M+_;W^
MU^M<%]M?U-'VY_4T>P0'>_V]_M?K1_;W^U^M<%]N?U-'VY_4T>P0'>_V]_M?
MK1_;W^W^M<%]N?U-)]N?U-'L$!WW]O?[7ZT?V]_M?K7!?;G]31]N?U-'L$!W
MO]O?[7ZT?V]_M?K7!?;G]31]N?U-'L$!WO\ ;W^U^M']O?[7ZUP7VY_4T?;G
M]31[! =[_;W^U^M']O?[7ZUP7VY_4T?;G]31[! =[_;W^U^M']O?[7ZUP7VY
M_4T?;G]31[! =[_;W^U^M']O?[7ZUP7VY_4T?;G]31[! =[_ &]_M?K1_;W^
MU^M<%]N?U-'VY_4T>P0'>_V]_M?K1_;W^W^M<%]N?U-)]N?U-'L$!WW]O?[7
MZT?V]_M?K7!?;G]31]N?U-'L$!WO]O?[7ZT?V]_M?K7!?;G]31]N?U-'L$!W
MO]O?[7ZT?V]_M?K7!?;G]31]N?U-'L$!WO\ ;W^U^M']O?[7ZUP7VY_4T?;G
M]31[! =[_;W^U^M']O?[7ZUP7VY_4T?;G]31[! =[_;W^U^M']O?[7ZUP7VY
M_4T?;G]31[! =[_;W^U^M)_;W^W7!_;G]33?MS^IH]@@.^_M[_;H_MW_ &OU
MK@A?/ZFE^VOZFCV" [W^WO\ :_6C^WO]K]:X+[<_J:/MS^IH]@@.]_M[_:_6
MC^WO]K]:X+[<_J:/MS^IH]@@.\_M[_:_6C^WO]NN"-\_J:3[<_J:/8(#OO[>
M_P!K]:7^WO\ :_6N!^W/ZFE^W/ZFCV" [W^WO]K]:/[>_P!K]:X+[<_J:/MS
M^IH]@@.]_M[_ &OUH_M[_:_6N"^W/ZFC[<_J:/8(#O?[>_VOUH_M[_:_6N"^
MW/ZFC[<_J:/8(#O?[>_VOUH_M[_:_6N"^W/ZFC[<_J:/8(#O?[>_VOUH_M[_
M &OUK@OMS^IH^W/ZFCV" [W^WO\ :_6C^WO]K]:X+[<_J:/MS^IH]@@.]_M[
M_:_6C^WO]K]:X+[<_J:/MS^IH]@@.]_M[_:_6C^WO]K]:X+[<_J:/MS^IH]@
M@.]_M[_:_6C^WO\ :_6N"^W/ZFC[<_J:/8(#O?[>_P!K]:/[>_VOUK@OMS^I
MH^W/ZFCV" [W^WO]K]:/[>_VOUK@OMS^IH^W/ZFCV" [W^WO]K]:/[>_VOUK
M@OMS^IH^W/ZFCV" [W^WO]K]:/[>_P!K]:X+[<_J:/MS^IH]@@.]_M[_ &OU
MH_M[_:_6N"^W/ZFC[<_J:/8(#O?[>_VOUH_M[_:_6N"^W/ZFC[<_J:/8(#O?
M[>_VOUH_M[_:_6N"^W/ZFC[<_J:/8(#O?[>_VOUH_M[_ &OUK@OMS^IH^W/Z
MFCV" [W^WO\ :_6C^WO]K]:X+[<_J:/MS^IH]@@.]_M[_:_6C^WO]K]:X+[<
M_J:/MS^IH]@@.]_M[_:_6C^WO]K]:X+[<_J:/MS^IH]@@.]_M[_:_6C^WO\
M:_6N"^W/ZFC[<_J:/8(#O?[>_P!K]:/[>_VOUK@OMS^IH^W/ZFCV" [W^WO]
MK]:/[>_VOUK@OMS^IH^W/ZFCV" [W^WO]K]:/[>_VOUK@OMS^IH^W/ZFCV"
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A<_J:47;GN:%12 V;R[\W/-9$HW-FE$I;K3L9K1*P'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>img17388848_11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img17388848_11.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (.!+4# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>.(Q'M(?"E:_?6_76W:_F+11161B%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 0W9Q:R8[@ _G7F?B*XB>_M04>1(X6.UGXR3\W'>O464.
MI5AE2,$5P?BCP_<+(MS$C2QHQ=2@R5/<?0U<5S*RW-<-6A0KJI4^&S5^W_ .
M698KR$LP:-$7)4C& ?3%:/PUGGC6]EMX6G"Q'RDS@D;^,_K5(:)K&NR^1'%(
MD62"R@@%?0D]*])\->'X?#VFBW0AIGP9''3CH!["M%%TXOFW?0Z,?C*6(A&E
M1?-9W;6RLGL^K=^G3<HK-JOB&%K.>T%K:LV)GPP)4$':,@=?6NG "@*HPH&
M/:BBL6[]#@C%I:NX4444B@HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHJC?:O8Z<=MQ. _\
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M\O\ ]^6_PH_X2G1_^?E_^_+?X47 V**IV&J66IK(;.;S/*(5P5(*D].#5R@
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M,^_O75ZI$\NGRB/=N )&#[5Y)X@=GCMUP0J+CD]ZN"-J44R(ZZYF8K FP?P
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M2%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ KE/$EVUWJ$>FH2(X\-)_M$]!^%=77!ZC(
M8O$UX7Z[P1],5M05Y-]B)O0N2-86EN$FACD;'1AG%9IN=+W';:(I]0*S;BX:
M>0L3WJ$FNN-+NS)U.Q;NO)D.Z$]/TJCN8L2>2:C:?9,JCJ>M;NA6$=T))92
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M6&63V.:F2NK%1=F0;=VH[O1:F3F21O<"FHO^DR-[ 4].A/J34Q0Y,=1116A
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M2%%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH ****  @$8(R#VKD=7\(,\C3::5 ;
MDPL< 'V-==15PJ2@[HF45+<\NE\.:MNVFPG_  P16EI?@BZD=7O,01]QG+G_
M  KO\T5J\5-K0A4D16UM#:6Z00($C08 %2T45S[FH4444 %%%% !1[T44@$
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MI16916?[Y^M)2O\ ?/UI*LD****8!1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M1_PG-_\ \^MM_P"/5R]%'L*?8/:2[G4?\)S?_P#/K;?^/4?\)S?_ //K;?\
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M*/84^P>TEW.H_P"$YO\ _GUMO_'J/^$YO_\ GUMO_'JY>BCV%/L'M)=SJ/\
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M',K+(O#*W4'WK2DW[25V1.W*K#:***Z#,**** "BBB@ HHHH **** "BBB@
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M/FZ0;5?:.!]*C.JWIU/^T3-_I><[]H^G2N@_X0#4?^?JW_6C_A -1_Y^K?\
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M6_ZT?\(!J/\ S]6_ZT?6*7</9R[')T5UG_" :C_S]6_ZT?\ " :C_P _5O\
MK1]8I=P]G+L<G176?\(!J/\ S]6_ZT?\(!J/_/U;_K1]8I=P]G+L<G176?\
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M[F=N@K>48+WI(S3D]$1R:K>RZ:FG/-FU3&U-HXQTYJ>V\1:I:6'V**XQ!@J
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M),PM.UJ_TII#:3;/,.7! ()]:JW-S+>7,EQ.VZ60Y9L8R:Z?_A -1_Y^K?\
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MN< <?A5:NL_X0#4?^?JW_6C_ (0#4?\ GZM_UJU7I)63)]G-]#DZ#TKK/^$
MU'_GZM_UH_X0#4?^?JW_ %H^L4NX>SEV.R\/_P#(O6'_ %P7^5%3Z7:O8Z7;
M6LC!GBC"$KT)%%>3-WDV=BV+=%<S<?$#PU:W,MO-J&V6)RCKY3G!!P>U1?\
M"Q_"W_02_P#(+_X57L:G\K&=717*?\+'\+?]!+_R"_\ A1_PL?PM_P!!+_R"
M_P#A3]C4_E?W =717*?\+'\+?]!+_P @O_A1_P +'\+?]!+_ ,@O_A1[&I_*
M_N ZNBN4_P"%C^%O^@E_Y!?_  H_X6/X6_Z"7_D%_P#"CV-3^5_<!U=%<I_P
ML?PM_P!!+_R"_P#A1_PL?PM_T$O_ ""_^%'L:G\K^X#JZ*Y3_A8_A;_H)?\
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M^5_<!U=17-O%=VTEO,H:.12K ^E<S_PL?PM_T$O_ ""_^%'_  L?PM_T$O\
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ML?PM_P!!+_R"_P#A1[&I_*_N ZNBN4_X6/X6_P"@E_Y!?_"C_A8_A;_H)?\
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M]P'5T5RG_"Q_"W_02_\ (+_X4?\ "Q_"W_02_P#(+_X4>QJ?RO[@.KHKE/\
MA8_A;_H)?^07_P */^%C^%O^@E_Y!?\ PH]C4_E?W =717*?\+'\+?\ 02_\
M@O\ X4?\+'\+?]!+_P @O_A1[&I_*_N ZNBN4_X6/X6_Z"7_ )!?_"C_ (6/
MX6_Z"7_D%_\ "CV-3^5_<!U=%<I_PL?PM_T$O_(+_P"%'_"Q_"W_ $$O_(+_
M .%'L:G\K^X#JZ*Y3_A8_A;_ *"7_D%_\*/^%C^%O^@E_P"07_PH]C4_E?W
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M]M)-/OI[.8KYL+E&VG(R/2G=7L!!1113 **** "BBB@ HHHH **** "BBB@
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MI5W6-(N]#OOL=\JK/L5RJG. >U%U>P%"BBDR*8"T444 %%%% !1110 4444
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MVKB=)+F9/+<.N5V]@!VQ45SXLU.ZT^]L7\A8+R;SY0B8(;CIZ=!0J$T[KR_
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M'K&KPK#?ZA-/$IR$)P,^X'6K/_"%^)?^@-<_D*/^$+\2_P#0&N?R%'-2O>Z
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MH_X0OQ+_ - :Y_(4>TAW0&%16[_PA?B7_H#7/Y"C_A"_$O\ T!KG\A1[2'=
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M_P (7XE_Z US^0H_X0OQ+_T!KG\A23I+M^ %5_$.KR/=.]_*6NE"3G _> =
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MZY/)XY%>JUC724M "BBBL0"BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M?>J&HPKX<^(VG7EL-EOJN8IT7H6]?SP:MQYU[RL]T!W=%%%<P!1110 4444
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M7KE'48[5=.HX.Z&>7> O"%U-&;_408[*3!CA/#2'U]A7IZ(D:*D:A448"@8
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M&_/_ +-'S_[-16]]:7;RI;7,4S1';($;)0^AJ>@!OS_[-'S_ .S3J* &_/\
M[-'S_P"S1)+'#$TLKJD:#+,QP /4TRWN8+N!9[:9)H6^ZZ'(- #_ )_]FCY_
M]FHKF^M+,QBZN8H3(=J"1L;CZ"IZ &_/_LT?/_LTZB@!OS_[-'S_ .S3J* &
M_/\ [-'S_P"S3J* &_/_ +-'S_[-.HH ;\_^S1\_^S3J* &_/_LT?/\ [-.H
MH ;\_P#LT?/_ +-.HH ;\_\ LT?/_LTZB@!OS_[-'S_[-.HH ;\_^S1\_P#L
MTZB@!OS_ .S1\_\ LTZB@!OS_P"S1F3U6G44 -S(.A44?/\ [-.HH ;\_P#L
MT?/_ +-.HH ;\_\ LT?/_LTZB@!OS_[-'S_[-.HH ;\_^S1\_P#LTZB@!OS_
M .S1\_\ LTZB@!OS_P"S1\_^S3J* &_/_LT?/_LTZB@!OS_[-'S_ .S3J* &
M_/\ [-'S_P"S3J* &_/_ +-'S_[-.HH ;\_^S1\_^S3J* &_/_LT?/\ [-.H
MH ;\_P#LT?/_ +-.HH ;\_\ LT?/_LTZB@!OS_[-'S_[-.HH ;\_^S1\_P#L
MTZB@!OS_ .S1F3&,K3J* &_O/]FCY_\ 9IU% #?G_P!FCY_]FG44 -^?_9H^
M?_9IU% #?G_V:/G_ -FG44 -^?\ V:/G_P!FG44 -^?_ &:/G_V:=10 WY_]
MFCY_]FG44 -^?_9H^?\ V:=10 WY_P#9H^?_ &:=10 WY_\ 9H^?_9IU% #?
MG_V:/G_V:=10 WY_]FCY_P#9IU% #?G_ -FCY_\ 9IU% #?G_P!FCY_]FG44
M -^?_9H^?_9IU% #?G_V:,R8QE<4ZB@!O[S&,KBCY_\ 9IU% #?G_P!FCY_]
MFG44 -^?_9H^?_9IU% #?G_V:/G_ -FG44 -^?\ V:/G_P!FG44 -^?_ &:/
MG_V:=10 WY_]FCY_]FG44 -^?_9H^?\ V:=10 WY_P#9H^?_ &:=10 WY_\
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MXF%NV.)3QTK/M%\4V7@S_A'O[ F8W"E4ES]Q2>0P[&GH!I^)]<LM0L?#=_\
MV?%<I=3 H)6(,1R,XQ[UM:]K7B"VU9K32],A\A4W-=W;[$8^@-<]K'A?4;;1
M?#%C;6TER]I*&G,8R$R03^%'B#3-3D\:W%Q?:-<:QI\BXMHDDQ&I[9_'K2L@
M.E\'^)I/$EC<O<0)#<6TGEN(SE6]Q71UQ'P[TO4-)&K17]A):F297CR/E(]
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M0 4444 %%%% %M?NCZ44+]T?2BLRBJ_WS]:2E?[Y^M)5DA1113 ***4?>%
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MY4?(B=^:[/2M.ATC2K;3X/\ 5P(%SZGN:F5XT[2W;N!<HHHK  HHHH ****
M"BBB@ HHHH MK]T?2BA?NCZ45F457^^?K24K??/UI*LD****8!2CJ*2B@#R[
M3-7@\&^,]:35XY8X;IR\<BID?>R/J.:M>%YSKWC_ %37+:*1;+R2JNXQDXP*
M]"FMH+D 3P12@=/,0-C\Z?'%'#&(XHTC0?PHH JN89YSX$1&\.^)V*J29'!.
M.V&XK$!'_"F7.?\ F(?U6O8$ABC5E2*-0WW@J  _6D^SP>7Y7D1>7G.SRQMS
M].E'/K<+G!>+K*2/PQHFO6PQ<:<L3$C^Z0/ZTWPEIMSJ/A[7-9<?Z;J@D$9_
MV?;\?Y5Z"8T9-A12F,;2,C'TI518U"HJJHZ!1@"CFTL!X=:7-O#X8DTV]U6^
MA?S2KZ9' "6.>H)KH=2LTB\1>"[20.RK"!B88;&[(R/6O3&M;9IA,UM"91_&
M8QG\Z>T4;NKO&C.OW6902/H:?.%SA?B(NF_:-.^VK=VK@GR[Z!?DBYY#?SK.
M\'ZGJ#^(KJQCU#^U=/%NY:[,>,';QR>:]+DBCF0I+&DB'JKJ"*;%;PVZ%(88
MXE/4(@ /Y4N;2P'E&BJTGPQ\2A%+'[0> ,UNZ:MGXK^&;Z9;-OGM80"-N-L@
MR17=K#%&K(D4:JW550 'ZBLO6-/U!M-\GP_+;6,Y;YF,8 *]^G>CFN%S@/!;
M7/B3Q/97%XI,>D6H0 _WAP/QKU:L#PEX:_X1K3)(9)1-=3R>9-*HP"?05OTI
M.[T ****0@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K"
MU7P=H6LR&6ZL5$QZRQ'8Q_*MVBG&3B[I@<M9_#SPW9S"4VCW# Y'GR%@*Z=$
M2.-8XT5$4855& !3J*<IRE\3N 4445(!1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !6#JO@S0=
M8E,US8A)SUEA.QC^5;U%.,G%W3 YBP^'_ARPF$HLVG=>5-PY?%=, %4*H  &
M  , 4M%.4Y2^)W ****D HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH *YS4? GA[4YC-)9>3*>2\#;,UT=%.,
MI1UB[ <WIW@/P[ILPFCLO.E7D-.V_%=)VP.@HHHE.4M9.X!1112 **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"EJ6D:?K$'
MDZA:1W"#IN'(^AKG?^%9^&O,W>3<[?\ GGYQV_E77T5<:DXZ18%/3M*L-(M_
M(T^UCMX^^P<GZGO5RBBH;;U8!1110 4444 %%%% !1110 4444 6U^Z/I10O
MW1]**S**;H-[<MU]:38/5OSI[_?/UI*LD;L'JWYT;!ZM^=.HH ;L'JWYT;!Z
MM^=.HH ;L'JWYT;!ZM^=.HH ;L'JWYT;!ZM^=.HH ;L'JWYT;!ZM^=.HH ;L
M'JWYT;!ZM^=.HH ;L'JWYT;!ZM^=.HH ;L'JWYT;!ZM^=.HH ;L'JWYT;!ZM
M^=.HH ;L'JWYT;!ZM^=.HH ;L'JWYT;!ZM^=.HH ;L'JWYT;!ZM^=.HH ;L'
MJWYT;!ZM^=.HH ;L'JWYT;!ZM^=.HH ;L'JWYT;!ZM^=.HH ;L'JWYT;!ZM^
M=.HH ;L'JWYT;!ZM^=.HH ;L'JWYT;!ZM^=.HH ;L'JWYT;!ZM^=.HH ;L'J
MWYT;!ZM^=5=4U2TT;3Y+Z]DV0I^;'L![UQL.H^,O%(\_34BTG3V_U<D@R[CU
MK2%-R5]D!WFP>K?G1L'JWYUP\ECX^TE?/AU.#5%7EH77!(]LUM^&?%,'B&.2
M)XC:ZA!Q-;/U'N/:G*DTN9.Z W=@]6_.C8/5OSIU%9 -V#U;\Z-@]6_.G44
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M8/5OSIU% #=@]6_.C8/5OSIU% #=@]6_.C8/5OSIU% #=@]6_.C8/5OSIU%
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MRNCZGXEN=5ABU'PW;VEJV=\RD$KQQWKGHY/$>O>,=8TRSUN6TM[=]P/7:!C
M%/E ]+HKRJ]\17E]KE[:R>()]-M[(>7"8HRQE<<$MCU-7(_&VIK\/[F\<_\
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M\-^!].2"_::YU%U6%W'_ ![IC[HK>TO1?%6F:U:R-K']H6+@&Y6<\J?]FAQ
MV=,\0V6JZG?:?;K*)K(XE+K@'G'%:M>5Z3I^I:EXQ\1PZ?J36"ARTLB#+-SP
M!Z<UTGP]U>_U/3;V'4)S/+:3^4)6ZD>]#C;8#L****D04444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110!PGB.+^W_ !_IFARDFSMH_M,J?WC_
M ) 'XUW84*H55 4#  ' %<+KLHT/XD:;JT_RVEW#]G>0]%/O^E2>)-"\0IJ[
MZEX>O7/VQ1%/$S\(,8W+[5T2CS**O96_'J!/K_BNY758M#\/1I<ZDS#S7(RD
M0]_\\50\7PG1/$.B^(8=J3/((+O9P'_SS71>&?#-MX<L2B'S;N7F>X;JY]![
M5S_CF4:MKFB^'[<[Y3.)I@/X%]_PS54W'G48[:W\P.\HHHKE **** "BBB@
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MOZ4;U]?TIU% #=Z^OZ4;U]?TIU% #=Z^OZ4;U]?TIU% #=Z^OZ4;U]?TIU%
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MQ-+XGL;BXEMD@,4@0!&)SQGO70K+&[%4D1F'4*P)%)JV@AU%->1(P#)(B G
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M(OARYBXFE)C?'=<X_J:>K_=R=W;[F!W-%!ZT5R@%%%% !1110 4444 %%%%
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'1]**S*/_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>img17388848_12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img17388848_12.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" )^!98# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M\^EY_P!\K_C7EU(:/J=(7MYGJ7_"SM)_Y]+S_OE?\:/^%G:3_P ^EY_WRO\
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MO_\ "V-&_P"?.^_[Y7_&C_A;&C?\^=]_WRO^->044?4:(?6)GK__  MC1O\
MGSOO^^5_QH_X6QHW_/G??]\K_C7D%%'U&B'UB9Z__P +8T;_ )\[[_OE?\:/
M^%L:-_SYWW_?*_XUY!11]1HA]8F>O_\ "V-&_P"?.^_[Y7_&C_A;&C?\^=]_
MWRO^->044?4:(?6)GK__  MC1O\ GSOO^^5_QH_X6QHW_/G??]\K_C7D%%'U
M&B'UB9Z__P +8T;_ )\[[_OE?\:/^%L:-_SYWW_?*_XUY!11]1HA]8F>O_\
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M(_K$SUW_ (6KH_\ SYWW_?*_XT?\+5T?_GSO?^^5_P :\CI:/J5$/K$SUO\
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M?\^EY_WRO^-'_"R=*_Y]+S_OE?\ &O,**/J=(/;S/3_^%DZ5_P ^EY_WRO\
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MY]+S_OE?\:\R(*DA@01U!IN*?U.D'MYGIW_"S-*_Y]+S_OE?\:3_ (6;I/\
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MO[5G77B32;K6++59-/,DQC,=]"Z#8_&-R^]1S:QHNG:3?6FBQ73R7I D:YP
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MJ\=U<7<\L'F$O$6R"I[ 4M]JUA)I%]8VD<RK->">/>H "XY!YKFC"<?=]/\
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M_P!0]G;=G)T4N**W("BEHI %%+10 ^&&2XF2&%&>1SA54<DUH_\ "-ZU_P!
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M"S*M(:M?V???\^5Q_P!^C33IU]_SY7'_ 'Z/^%%UW"S*II#5K^SK[_GRN?\
MOTW^%)_9U]_SY7/_ 'Z;_"GS+N%F5:2K?]G7W_/E<_\ ?HTG]FW_ /SY7/\
MWZ;_  HYEW"S+4&KK#X:N]),)+7$RRB3/ QVQ39=663PS;Z0(2&BN&F\S/!S
MVQ5;^S;_ /Y\;G_OTU(=-O\ _GQN?^_35-H?J.[.J/C73Y+BQO9],N'O+1%1
M%$^(N/XMOK63J/B2*]T_4[5+5T^VW@N@Q8';QTK*.FW_ /SXW/\ WZ;_  IO
M]FW_ /SXW/\ WZ;_  J%2IIW7YC<Y,VX?%%LC:4)]-6XAL[4V\B2$'?G^)?0
MU;_X26UN4T[1["VGBMA>I*SW$V]AST'H*YC^S+__ )\;G_OTW^%']FZAGBQN
ML_\ 7)O\*'3IL.:1V>O>(M,TOQ'JLUEIC?VFVZ SM+E!D8+ >IK,TWQFFG_V
M0/L3.+&!X)#OP7W=U]*Y5B2QW$[L\YZYIAIJA#EL]0=25[HZRY\4Z8-$U#2[
M/3KE1=D,TTT^]BP.>>.E5Y?%4<GC&TUW[(X2!$4Q;ADX7;UKFJ2J5&"$YR.@
M7Q!:2>'[[2[JSD?SKEKF&1'QL8^OK5?PSK<6@ZE)<SV[7$<D#0LBMM.&]ZQJ
M*KV<;-=Q<[NF=;;^*M)TF*9]$T1K>\D0H+B:;>4!]!573/$=JFB'2-6M)KFW
M$IFCDAEV.C'K]17.45/L8!SLZQ?&4,.M?:(-+C33S;&V>VW<R(>Y;UH3Q1I=
MA]AATO26BM[>Y%S*TCAI)"/X0<<#FN<33KZ1%>.RN'1AD,L1((I?[+U#_GPN
MO^_3?X4O94_Z8^>1T4'BC2Y//^VZ7+O:Z:YBGMY=D@R<[6/<4M_XV-\=7)M#
M&;V.*.(A\^6$.03ZFN<_LO4/^?"Z_P"_3?X4?V7J'_/A=?\ ?IO\*/94[W_4
M.>1U \8Z6]_#K$VC,VKQ(%WB7$;,!@,1CK6-?Z\VH:"-/EC/GFZ>Y>7/!+=L
M50_LO4/^?"Z_[]-_A1_9>H?\^%U_WZ;_  HC3IIW0.4F7?$&M+K=S:RI T0@
MMTA(+9SCO615K^R]0_Y\+K_OTW^%']EZA_SX77_?IO\ "M(\L59$N[=V5:*M
M?V7J'_/A=?\ ?IO\*/[+U#_GPNO^_3?X4^9=Q695HJU_9>H?\^%U_P!^F_PH
M_LO4/^?"Z_[]-_A1S+N%F5:*M?V7J'_/A=?]^F_PH_LO4/\ GPNO^_3?X4<R
M[A9E6BK7]EZA_P ^%U_WZ;_"C^R]0_Y\+K_OTW^%',NX695HJU_9>H?\^%U_
MWZ;_  H_LO4/^?"Z_P"_3?X4<R[A9E6BK7]EZA_SX77_ 'Z;_"C^R]0_Y\+K
M_OTW^%',NX695HJU_9>H?\^%U_WZ;_"C^R]0_P"?"Z_[]-_A1S+N%F5:*M?V
M7J'_ #X77_?IO\*/[+U#_GPNO^_3?X4<R[A9E6BK7]EZA_SX77_?IO\ "C^R
M]0_Y\+K_ +]-_A1S+N%F5:*M?V7J'_/A=?\ ?IO\*/[+U#_GPNO^_3?X4<R[
MA9E6BK7]EZA_SX77_?IO\*/[+U#_ )\+K_OTW^%',NX695HJU_9>H?\ /A=?
M]^F_PH_LO4/^?"Z_[]-_A1S+N%F5:*M?V7J'_/A=?]^F_P */[+U#_GPNO\
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MU?\ KH#<8EZVT6+3KV^>)O/C-FK0&11G,G S[U'?>#X[2PN6$MP;FVB\QG=
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M<GX_F,.DVA'>X _\=-<@GSQ@UU?Q$_Y!%E_U\C_T$URT _<CZ5V8=Z&%5:E>
M1:IN,-6C(M49A@UUHQ9W/@#[G_;0_P!*]<C_ -6OTKR/P!]S_MH?Z5ZY'_JU
M^E>%B/XLO4]"E\"'4445B:!1110!Y)XF_P"1EO\ _KI_05E5J^)O^1EO_P#K
MI_05E5[=/X%Z'GR^)FMHND6VJ+,;C48[3RR  X'S9SZD5TT.E3FW%G:^*U8$
M82,8Y]NN:X/&:U- U"STN^:YNK4SLJYBP?NMZUG5A)W:?RLBH22T:*-W;2V=
MW+;3#$D;%6J&K.H7CZA?S7;@*TK;L#M5:ME>VI#WT"BBBF(*MZ9I\NJ7R6L.
M 6Y9CT4=R:J5TUE)9:)HFZZ\QKF_7I"P#)&/?WJ*DFEIN5%7>IFC1)CX@.D!
MU\P/MWXXQC.:2WT2XN=<?2T(\Q'*L^. !WKHI)(HM:N]7C< "P$L>2,[B,8^
MM:$,]K9:G)<QR(9KN+[1*V1\B!1@?4FN=UI6T[?B:JFCC)M(>&TO;DS*4MIQ
M#T^^?:LVNJ;3[R_\+6B6JH[S3O<3 R*N">G4UBZ?8.^O6]E* &$P5\'.,=>:
MVA4NG=[&<HZJQ3DM;F*/S);>5$SC<R$"FM;7"PB9H)1$>CE#M/XUV]\\Y>_&
MIW<8M;N9(K9-X8*-WW@.V!4VJMY6DZIYC, RK%$'G5@1D?,%'"UFJ[TT+=,Y
M$Z#<1R6:W+B$7,;2 LI.P#UK.-M/Y)F$,AA!QYFP[?SKN+^9H+S4)YYMT,%F
MD,.7SG=@%A[U-J-Q';6=S( !9?9A% //!23(P,(._O25>6F@W31P"VERZ;TM
MIF3&[<$)&/6IVTJZ72DU$H?*DD\M!@Y)]?I77PWKVVJV]DEQML[+3R\B!N'8
MKT/KR:CMFN1;:"L-Q%L2)Y=LLGRR29R$Z\''2J=:7;^M1<B.)F@FMV"S0R1$
M\@.I&?SJ5;%GL%N58L[2^6L04DMQR16_XOD?RK)'E;<P:1H)'$C1$GIN';VJ
M_IS1646EDNG^B64MVPR/OMP/QJG5?(I$\BO8XJ6WG@"F:&2,-]TNI&?I45='
MK%[-<>%]-^U3F:XGFDG)8Y*CICV%<Y6L).2NR9*S$-(:4TAJR1IKK?!O_'M>
M?[Z_R-<D:ZWP;_Q[7G^^O\C65?\ ALNG\1TU%%%<!T!1110 4454L]2M-0EN
MH[67S'M9?)F&TC:^,XYZT 6Z**@O;R#3K&:]NG\NWA7=(^"<#Z"@">BF12I/
M!'-&=T<BAU/J",BGT %%,FECMX'FF<1Q1J6=V. H'>JQU2S%Q90>=F2]4O;X
M4D. ,DYZ#CUH N4444 %%%% !1110 4J_>%)2K]X4 >#0_\ ']=?]=G_ /0C
M5RJ</_']=?\ 79__ $(UHVUM->W45M;H7FE8*BCN37J4_A..7Q&MX5\/2^(]
M82WPPMD^:>0=E]/J:].U2ZB"QV%FH2TMP%55Z'%-M+&'PIH,>FVY!NY1NGE'
M4GO_ ("L^OSGBO.O:R^J47HM_P#+_,^CRK!<B]K/?H203R6\RRQG#J<BLOX@
M>'5U>P'B338\W,2XNHUZLH[_ %'\JT*O:9??8YRKC=!)\LBGIBO&R#-Y8#$)
M2?N2W\O/_,[,=A%7IZ;H\51@Z@@TZNE\<^&/^$<U9;FU&=,O#NB(Z(W4K]/2
MN:K]@I5(U(J43Y"<7%V9Z[X=_P"1<T[_ *X+6E6;X=_Y%S3O^N"UI5YD_B9U
MQV04445(PHHHH **** "BBB@ HK'U;Q3H^B3K;WMT1<,-PBC1I'QZD ' JUI
M6L6&MVGVK3KE9X@=I(X*GT(/(-%UL%B]1110 4444 %%17-Q%9VLMS.VR*)"
M[MC. .2:JV^LV%W<6T$,Q:2YM_M,0V$!H_7...O3K1<"_1574-1M=+MTGO)?
M+C>18E.TG+,< <5:Q0 45#/=V]M)"D\RH\[[(E)Y=NN!3+;4+:[N;JW@D+2V
MKA)@5(VGKU/7\* +-%%% !1110 4444 %%%% !1110 4444 >6?$K_D:+/\
MZ]1_Z$U82_=%;OQ*_P"1HL_^O4?^A-6$OW17HX;X#EJ[GL?@3_D3[/ZO_P"A
M&NCKG/ G_(GV?U?_ -"-='7F5?XDO4ZX?"CQCXG?\CS'_P!>D?\ -JA\)?\
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M$&"Y"EN2<#@4 6:*** "BBB@ KQ[Q#_R.VJ?]=?_ &45[#7CWB'_ )';5/\
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MQ;Z9X6NX[^^6[U&58;N43MF1&4DCVZ8JZSR^&;KQC:Z8\H@M;**X@1W+^6[
MY(S^=/F%8]%HKRJSMM3L?[%U&VL9;6:66/SKN?4E=;M6Z@J3R3VQ5V+1(=9E
M\7W=W<W9:TNI1;*DS*L1"!L@#O1S>06.\N=3MK74;.PE8_:+PL(E _NC)S5R
MO,XK6+6-2\#W-]OEGGMG\Q_,(+%5R#P?7\Z],IIW!JP4444Q'(?$/_D$6?\
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MV X4>]=->R06/A'[/%;H?M5U)M<DYVH3AOK4>C2Q6'A>[FFMEN#=W"0QQL2
MV.><=J?M':Z76P<NMCG(K>6X+^3&S[%+M@= .IJ'M7<C1+0W^I1PJ8%9X;90
MKD!6?!8#U[\&H)+32YM/U?R]($7V5Q!;REFR[$[>?>DJZ[![-G(S6\T C,L;
M()%WIN'WAZBHC7>ZJNGW4VH6<EFI_LVQ51<;CN#@#  Z=ZX&KI5.=;$RCRL0
MUUO@W_CVO/\ KHO\C7)&NM\&_P#'M>?]=%_D:5?^&QT_B.FHHHK@.@**** %
M'45YJ][=:=H?C:ZLI3%<1ZE\CCL3M%>D]#7/3>$;2;3]7LVN9PFJ7'GRL,90
M\<+[<4I)O8:,Q?[6T+Q%HBW.L3WT6I!UN(I5&U6"[@4QTK%U)=6U[P)JFOOJ
M\T2OY@2R4#RA$K8VGOGCK7>WNCPWNH:7>/*ZOIS%HU7&'RNWFL2\\"07,%W9
MQ:K?6VFW3&22SB*[ QY."1D#/.*EQ8TQVBWMRWBRST_S6^R?V-%*(NV[(&?R
MK&'B+53I-['%=_Z5<:X;"&9QGR4)[?05T=]X56XNK*\M-3NK&[MK<6WG0[29
M(_0@C%00>!].AT.XTLW%S(DMS]J69F_>1R]=P/UHLPNC+U_1]6L=%UB&37YK
MFQ:S9PLQ'G!QUQQ]PTMK<W6DOX3MQ=S3PR64TT@DP2V(]P7IT':M:'P?"TEW
M/J6H76H7-S;FV\Z7 \N,]E &,^]26/A5+5]*DGU"XNWTU9$B,H7YD<8VG ["
MBS"YS0N-=?P<_C#^VYEG"FX%GM'D>6#]S'7..]71)JOB+Q5-:0:M<:?8_8(;
MC9 !N#,,X!/2KW_"#6_E-9#4[T:.TGF'3LC9USMSC.W/;-;-KHT%IK=QJD3L
M'FA2#RN-JJO3%"BPNC/\%:C>:EX?+WTOG7$%Q+;F7&"X0X!/O70UFZ)HT.AV
M<MM!+)(LD[SDOC(+')'':M*K6VI+"BBB@ I5^\*2E7[PH \&B_X_KG_KL_\
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M:5>5/XF=D=D%%%%2,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M5]B&DJ;[+/\ \\7_ "I/LL__ #Q?\J.>/<7*^Q":2IOLMQ_SQ?\ *C[+<?\
M/%_^^:.>/<.5]B TE3_9;C_GB_Y4GV2X_P">$G_?-'/'N'*^Q :::L&TN?\
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MT>TAW0<LNQ5HJU_9M[_SZS?]\FC^S;W_ )]9O^^31[2'=!RR[%6BK7]FWO\
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MT>TAW0<LNQ5HJU_9M[_SZS?]\FC^S;W_ )]9O^^31[2'=!RR[%6BK7]FWO\
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MI_L-W_S[2_\ ?-+]AN_^?>7_ +YI>TAW'ROL04M3_8;O_GWD_P"^:7[#=?\
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M .^:7[+<?\\7_*CGCW#E?8BI:D^RS_\ /%_RI?LT_P#SQ?\ *CGCW#E?8C%
MJ7[-/_SQ?\J/LT__ #Q?\J.>/<.5]B.EJ3[-/_SR?\J7[-/_ ,\G_*CGCW'R
MOL1TM2?9YO\ GD_Y4?9YO^>3_E2YX]PY7V&"@5(+>;_GD_Y4OV>;_GDWY4<\
M>X<K[$=+3_(F_P">3_E2^1-_SR;\J.>/<.5]AE**?Y$O_/-ORH\B7_GFWY4N
M>/<.5]AM ZT_R)?^>;?E2B&7_GFWY4<\>X<K[#:6G>3+_P \V_*E\F3_ )YM
M^5'/'N/E?8;13_*D_N-^5'E2?W&_*CGCW%ROL,HI_E2?W&_*CRI/[C?E1SQ[
MAROL,HI_E2?W&_*CRI/[C?E1SQ[AROL,HI_E2?W&_*CRI/[C?E1SQ[AROL,H
MI_E2?W&_*CRI/[C?E1SQ[AROL,HI_E2?W&_*CRI/[C?E1SQ[AROL,HI_E2?W
M&_*CRI/[C?E1SQ[AROL,HI_E2?W&_*G+;RMT0_C2=2"W8<LNQ%5JSMFGE7 [
M\58M-)FF<?*379Z+X?$.UY!S7'7Q2:Y8&].C9WD7?#^G?9H S#DUO4U$$:A1
M3JX#I"BBB@ HHHH **** (9;:.8890:SY="MI#G8*UJ* ,+_ (1NV_NBC_A&
M[;^Z*W:* ,+_ (1NV_NBC_A&[;^Z*W:* ,+_ (1NV_NBC_A&[;^Z*W:* ,+_
M (1NV_NBC_A&[;^Z*W:* ,+_ (1NV_NBC_A&[;^Z*W:* ,+_ (1NV_NBC_A&
M[;^Z*W:* ,+_ (1NV_NBC_A&[;^Z*W:* ,+_ (1NV_NBC_A&[;^Z*W:* ,+_
M (1NV_NBC_A&[;^Z*W:* ,+_ (1NV_NBC_A&[;^Z*W:* ,+_ (1NV_NBC_A&
M[;^Z*W:* ,/_ (1NW_NBC_A&[?\ NBMRB@##_P"$;M_[HH_X1NW_ +HK<HH
MP_\ A&[?^Z*/^$;M_P"Z*W** ,/_ (1NW_NBC_A&[?\ NBMRB@##_P"$;M_[
MHH_X1NW_ +HK<HH P_\ A&[?^Z*/^$;M_P"Z*W** ,/_ (1NW_NBC_A&[?\
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MV_\ =%'_  C=O_=%;E% &'_PC=O_ '11_P (W;_W16Y10!A_\(W;_P!T4?\
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MW;_W16Y10!A_\(W;_P!T4?\ "-V_]T5N44 8?_"-V_\ =%'_  C=O_=%;E%
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ML;5O^?:T_P"^6_QH_P"%C:M_S[6G_?+?XT?7:0?6('IU%>8_\+&U;_GVM/\
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M_P"^6_QH_P"%C:M_S[6G_?+?XT?7:0?6('IU%>8_\+&U;_GVM/\ OEO\:/\
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M-2&.3_GF_P#WR::8Y/\ GF__ 'R:+"&44[RI/^>;_P#?)H\J3_GF_P#WR:+
M-HIWE2?\\W_[Y-'E2?\ /-_^^318!M%.\J3_ )YO_P!\FCRI/^>;_P#?)HL
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MJL"VZ"WV^5CY=O2IZ\O!8=8>BH)W/9;N8WBO_D5[_P#ZY_U%>8Z.?^)U9_\
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M>X_Z[G^0KBO$]R3XSU&+L'7_ -!%=MX$_P"01<?]=S_(5P7B;_D?-3_WU_\
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M%\>1:;_:=Y>6UW8/.ZW,F[;(K 97T'/2AQMU%8ZVZNH+&UENKJ58H(E+/(W
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M0M*!3L4N*=@$ IP%*!2@4[  %. H I0*H0H%**,4M,8HI112TP%%.%(!3A3
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MF_\ (PZ9_P!>Y_\ 0J;X5_Y&&Q_WS_(T_P")O_(PZ9_U[G_T*F^%O^1@L?\
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MEK_HX^E7C7E3W.&6YWG@O[L?TKD_C8/^)YI/_7L__H0KK/!?W8_I7*_&L?\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MV /-<_6WI%]9_89M-OPXAD;>'09P:QH-*>K,Z=N;4F\0)?"SCD>^6[M';AE
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M)_PD7B?_ *";_P#?M?\ "C_A(O$__03?_OVO^%'MHA[2)ZW17DG_  D7B?\
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MZ[GU/5KJ*?4KEIWC7:I*@8'X"M*UGFLY4F@?9*G*MCI45*B=121,Y)RN>O\
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M;'B3_H(O_P!\+_A2_P!L>)/^@B__ 'PO^%'MHA[1'I1 (P0"/3% &    !T
M%>:_VOXD_P"@B_\ WPO^%+_:_B/_ *"+_P#?"_X4>VB'M(GI(4#.% SUP.M
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M_L1X@\4@"!P#P/3V%>.XI=H]*3P]VW<9UNC7D$'P_O$EF02#4X)!&6^8J.I
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M;,G0D>E:E%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MR%D&!M7;Q5,5F[7T(=N@HIP%(*=2  !Z4H H%.% !@>E*%% IU !@>E+@>E
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MWZ@=7C P**SM*US3]9C+6<X9E^_&PVNGU4\BM&LFFG9@%%%%( HHHH ****
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M,48IV*,46 ;BEQ3@OM3@A- #,4X+FI5B]JE6+VI7 A6.ITCJ58_:IDB]JER
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M]GT:^OM8TV>P>R.UXR0XDSTV,.&S0!TE%<M9^+;G^TK.TU?2'T\7V1:R&99
MQQG:V/NG%:OB*[N;/P_?7%E%YMQ'"Q4!PN.#\V?;K0!J45YCX?URX\.>'=*8
MZ5=WE_J[G:&N]YE8*#NY^Z#GIVKHY?%FH-<QZ?9Z&\^I+")KJ W"HL /0%CU
M)]J .KHKE?\ A.K-]!AOX;6:2ZFN/LB6? ?SNZD].,9SZ59T?Q++>:M)I&I:
M>UAJ"Q><D?FB19$SC(8>A[4 =#16%XE\2+X?CLT2V-Q<WDOE01F01J3C/+'@
M53D\77%IX>U/4;_1Y[::PQOA+@K("1@HXX(YH ZFBL>_UY;'4-'M3 SG4G9
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M:1*UU*F]H\J.%%<;?^(]4U*%8;B<>6&#[40*"?4XZT^'Q-JL5U-<"X4O. )
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M5']FV_\ <'Y4?4J0?5X'C_\ 8MY_='ZT?V+>?W1^M>P?V;;_ -P?E1_9MO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M?\+0\,?\_$__ 'Y:CV%7^5@=E17&_P#"T/#'_/Q/_P!^6H_X6AX8_P"?B?\
M[\M1["K_ "L#LJ*XW_A:'AC_ )^)_P#ORU'_  M#PQ_S\3_]^6H]A5_E8'94
M5QO_  M#PQ_S\3_]^6H_X6AX8_Y^)_\ ORU'L*O\K [*BN-_X6AX8_Y^)_\
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M?\+0\,?\_$__ 'Y:CV%7^5@=E17&_P#"T/#'_/Q/_P!^6H_X6AX8_P"?B?\
M[\M1["K_ "L#LJ*XW_A:'AC_ )^)_P#ORU'_  M#PQ_S\3_]^6H]A5_E8'94
M5QO_  M#PQ_S\3_]^6H_X6AX8_Y^)_\ ORU'L*O\K [*BN-_X6AX8_Y^)_\
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M_?3?XT?\(#X7_P"@3%_WTW^-=)11[6I_,_O YO\ X0'PO_T"8O\ OIO\:/\
MA ?"_P#T"8O^^F_QKI**/:U/YG]X'-_\(#X7_P"@3%_WTW^-'_" ^%_^@3%_
MWTW^-=)11[6I_,_O YO_ (0'PO\ ] F+_OIO\:/^$!\+_P#0)B_[Z;_&NDHH
M]K4_F?W@<W_P@/A?_H$Q?]]-_C1_P@/A?_H$Q?\ ?3?XUTE%'M:G\S^\#F_^
M$!\+_P#0)B_[Z;_&C_A ?"__ $"8O^^F_P :Z2BCVM3^9_>!S?\ P@/A?_H$
MQ?\ ?3?XT?\ " ^%_P#H$Q?]]-_C7244>UJ?S/[P.;_X0'PO_P! F+_OIO\
M&C_A ?"__0)B_P"^F_QKI**/:U/YG]X'-_\ " ^%_P#H$Q?]]-_C1_P@/A?_
M *!,7_?3?XUTE%'M:G\S^\#F_P#A ?"__0)B_P"^F_QH_P"$!\+_ /0)B_[Z
M;_&NDHH]K4_F?W@<W_P@/A?_ *!,7_?3?XT?\(#X7_Z!,7_?3?XUTE%'M:G\
MS^\#F_\ A ?"_P#T"8O^^F_QH_X0'PO_ - F+_OIO\:Z2BCVM3^9_>!S?_"
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M?\(#X7_Z!,7_ 'TW^-=)11[6I_,_O YO_A ?"_\ T"8O^^F_QH_X0'PO_P!
MF+_OIO\ &NDHH]K4_F?W@<W_ ,(#X7_Z!,7_ 'TW^-'_  @/A?\ Z!,7_?3?
MXUTE%'M:G\S^\#F_^$!\+_\ 0)B_[Z;_ !H_X0'PO_T"8O\ OIO\:Z2BCVM3
M^9_>!S?_  @/A?\ Z!,7_?3?XT?\(#X7_P"@3%_WTW^-=)11[6I_,_O YO\
MX0'PO_T"8O\ OIO\:/\ A ?"_P#T"8O^^F_QKI**/:U/YG]X'-_\(#X7_P"@
M3%_WTW^-'_" ^%_^@3%_WTW^-=)11[6I_,_O YO_ (0'PO\ ] F+_OIO\:/^
M$!\+_P#0)B_[Z;_&NDHH]K4_F?W@<W_P@/A?_H$Q?]]-_C1_P@/A?_H$Q?\
M?3?XUTE%'M:G\S^\#F_^$!\+_P#0)B_[Z;_&C_A ?"__ $"8O^^F_P :Z2BC
MVM3^9_>!S?\ P@/A?_H$Q?\ ?3?XT?\ " ^%_P#H$Q?]]-_C7244>UJ?S/[P
M.;_X0'PO_P! F+_OIO\ &C_A ?"__0)B_P"^F_QKI**/:U/YG]X'-_\ " ^%
M_P#H$Q?]]-_C1_P@/A?_ *!,7_?3?XUTE%'M:G\S^\#F_P#A ?"__0)B_P"^
MF_QK:T_3[72[-+2RA$,"9VH"<#)S5JBIE.4M&P"BBBI **** "BBB@ HHHH
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MO>:A9Z?&)+V[@MT)P&FD" _G0!8HJ*WN8+R%9K:>.:)NCQL&!_$5+0 4444
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M$$OF-=*!@*%(^7/>NT>XACFCA>5%EESY:,P!;'7 [T33Q6T+2SRI%&OWG=@
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MBM;B?1WWFWNO]7<;AAPQ]2>0:E\/^$)9+^_DU70=(T_3KB 0+96P#L_.27<
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M10 4444 <;\0/'L?@6TLIGT^2\-U*4PK;0H R><=?:NKL;H7MA;W:HR">)9
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MX0UNXM;?P=HB)&;>ZTDRNY^\"H&,?G5'QCK^IZCX=\;64)AA33'BC5\'<R,
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M)9))HF&JS&2(+GY 4V_-6';>!]8TO2O#LVFWEH-8TB%X'$H8PSQL3E>.1]:
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M14LH9&":;+-_I4L8."PYX/<#%=#I^@>+Y;G3;?5M6M$T[3^OV,,'N\# $F>
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M@"OX=8Z5\0-?T-#BTECCU"!.R%R0X'L2,UVM<9X=1M5\=Z[KZC-FB)I]N_\
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M0@N9ET5G$T,6Q44/W'>N3U*>5=!'B+3SKTUPMRK+K-Q.(HI 9,86+<?E[=*
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M=T33].N;ZU79J-Q;6Z@,8E^X""1@9_E4GP[U*:S\2:WX>N;&XL(Y)#J%E!<
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M'5/&<][J6H*MC<M]DBAN&18F"9W8'7FH)M5?6O#?A&"_N-5O;JZMFEDL-/\
MD>YQQN=\C:H_6E[*'8KZ[7_F_K^MUL^IUVOZ9I6@:')J3RW<,<"XN9+8CS+A
M2<$-GKDGKU%:"^&=.G:*6'S(;)U5Y+-.(Y2!P6'\_7O7EB3W4?@_QUI4HN8K
M>SEA\BVN9O-> ,02N[)S^=>R*)&T("+_ %AML)]=O%/V4.POKF(_G?\ 7]:=
MNAP%SK7A^'5;NWL]/U?6K.T8K)!:0>9;VSG[V.1D^W;M6[X?L-#\1Z.;^UNY
M[V-_W<,DQQ):[3]P?W2#^-5_A,]N? %I'%M%Q')*MT/XA+O.[/O6;XBUG0'\
M/7$6CW5Q:++JGV>9=-A_>74O\:*<@<]VH]E#L'US$?SO^OZU[]3J_P#A%K?[
M/N%W<?VANW?;\CS<]/IC';I6KI]A!IMHMM #M&268Y9V/5B>Y->4Z"]SI7B[
M4]/AMM1TZTFT>2X^R7EUYS!P2-X.3M_.J=OIL^G^ -"\6+JVH/JS3P[G>X8H
M49]I3;TQBFH1B[I$5,15J+EG*Z_K^K=#VRBO./[-7QIXJ\21:G?W<,.F.D%K
M%!.8A'E=QD.#R<^O%8VKWUY?:OH'AY;F\UZP%@\\KV4RP-=LK;02VX<#N >M
M48GL%%>+WD^M67@;Q+9/)=6D4%S ++S;I9)X%=@"K%23QVSVKT_PWX?@\/:>
MT$-S=7!E;S'>YE+DL1SC/0>U $EEX@M+_7M0T>)91<V"HTI90%.[I@YK5KRF
M\E>'Q#\1)8W9'6QB*LIP0=IJHNFSZ%I?A'Q!#JNH2ZA>7,$5TTLY9)4<<KMZ
M "@#V&L74;S2M1O+C0)RTERMN+ED0'*+GA@?7(XKS'Q!#=VVKZSJFHMJ=S;I
M<;K?5=*N]XLD&/D:+..._6M6TLK.\^*=SJ44TTA.BQW,<@D8!B01DC/3';IF
MDU?1CC)Q:E%V:-B!-(ELM-DN)]1M]5U*<I;75PF+C>H/7L%P.G2MN3PE9>5&
M+>>XMY@"LT\3X>=3]X.>^?7MVKS"UL4UFU^'\U]-<22RWD\;OYS D#<1T/7C
MK77Z'>3&?X@"2X<K;W3"/<Y_=CR1T]*CV4.QT_7<1_-_7^7EL:FH:7H5AJVG
M6;2R6Z7[;!91#]W<,@SEOH.OK5Y/"FGK<L7+R6?)CLG.8HV/4@?T[=J\SMM/
MBUA/AK<7LMQ)+.DBNXF8$A5+#H>N>])))J7B74=?NIK#5[B2TN7M[22UO5AC
MM HX)4L,GN2<T_9P["^N8BUN=_U^OGO;0]5TS0(--N&G\^>X<#9"9VW>3'_=
M7V]^M1W.MV$NI7NDR0FX^RVWVBZ^4,B+U"G/<XSBF>#;O4+[PGI\^J%&O3'B
M5D<,&(XSD<<US'@\FYT/Q?J$O-Q<7ER')Z@*N /H!5**BK(RJ59U)<TW=G3>
M$_%FF>,-*>^TP2K%'*86250K*1[ FJEOX^T>ZO->MH1<,VB(7NF"#:<9R%.>
M>GM7FWA755\#Z9#>'B#5](\^)?[UU&2N![G(J?2M);18O%UI)S.?#ZS3GUD=
M79OU-,S.QC^*6F_98[RXT;7+6QD ;[7-9_NPIZ$D$\5T>H>(K'3[6PO')DLK
MR5(EN(\%$W_=)]B>,^]9VA2VT/PSL9+TH+9=-4R[SQMV<URFAVK3_ &:.Y!4
M?8YI(BW55#%D/X8!H ]/AABMXQ'#&D<8Z*B@"I*RO#-U+>^%]+N9\^;+:QL^
M?7:*U: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *SH=#L
M8-?N-;1&%[<0K!(VXX**<CBM&B@#+D\/Z?-KIUF2)FO&MC:$ECM,9.2,5SY^
M%WAMK7[)(M[)9JVZ*W:[<QPG.<JN>*[2B@#G-5\$:1JUREU(;N"Y6$0--;7#
M1/)&/X6(ZU/8^$=&TVYL)[.U\IK"!X( &. K<MD=R?4UN44 <W_P@F@_V5=Z
M8;:0V=S<&Y,7FMB.3.=R?W>>>*73/!&D:9/<W*_:;FZN(3 ]Q=3M*XC/\()Z
M"NCHH PY/"6DR^';70FBD^P6S(T2^8<@J<CGZU2U/P!HFJ:C<WLAO()+L 72
M6UR\:3XX^< \\5U-% '-W_@;1KV2RE1;BSELH?L\+V<[1,(_[I(ZBDL_ 7AZ
MRL-1L8K-FM=1*M<QR2,VY@/O9)R#WSZUTM% '+6?P_T.S>XD(N[F6:W:U\RY
MN&D9(B,%5)^[5JX\':1<1:6OERQOI:>7:RQR%75=NW!/<8[&M^B@#'A2Q\*:
M+:6L<<HLH<1;_O; 3]YCZ9ZFLK3;[0--US4I[82HFH2AY[YVS \H7&T-T''X
M5U;HLB,CJ&1A@J1D$5 =.LFL19&UA-J!@0[!MQ]*B2E?1G13E04;5(MOR?\
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M@"AI6C6>C1W$=FC*L\[3R;F)R[<FG:MI%AKFFRZ?J5NL]M*/F1OT(/8U=HH
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-** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>img17388848_13.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img17388848_13.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" +Z Z<# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MI=;OEC5<A3]: /9L@TM87A8S_P!F8GN&G(/RNQR2*W: "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!7O)6@
MM9)%Y*C(KE_ OB2\\1+J9NU1?LUQY:;1VKI=3_Y!TW^[7 _";[FN_P#7Z: /
M2:*** "BBB@ HHHH **** "BBB@ HHHH **** "BF2/Y<;/C.!G%9.CZ_!J]
MU=V\0VO:MM<9H V:*YC4_&ECIFO1Z7+C?(!AL^M:FLZQ#HVG/=R#=@9"YZT
M:=%5K&Z%[8PW*C D4-CTJS0 445'+((HFD/11F@"2BLG2=<AU::XBC7!A.#6
MM0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MEV\*1IZ+5FB@"&*VAA+&.,*6ZX'6FPVD%NS-%$J,QR2.]6** "BBB@ HHHH
M**** "BFE@JDDX [U734;*23RTN8V?\ NAN: +5%)2T %%%% !1110 4444
M%%%% !1110 45''-%*2$D5B#@X/2FSW4%LNZ>5(QZL<4 345%#<0W";H9%=?
M53FI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M-:9XV5B#@[3Q7'Z/"OA[QQ/9V+^;%(%#$G)% 'J%%%% !1110 4444 %%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'G'CRUN
M(-4AU*6#[19J5S'MW8Q[5!)K'A/Q18FQ%L]G(XP)#%L*_B:V-?\ $5UHOB("
MZCW:6Z@;F' />L;Q=J'A35='F^R7$%Q>,/D2%L$F@#H]3OYO#V@6Z:=_I#_*
MB%^1BL*[\3>)M(F@EOH[+R)&^<(X) K,U+4-5TSPY9P,_D1NR#S)!P%]*S_$
ML&DBT@E@NTO)^K-&WW?K0!T6L7(O/&^C7('$EJS?J*NP>(I(_$>K0):0*;:U
M602!?F;V-8\WS>(_#Y'3[$?Z4D8/_"7>(N.M@O\ 6@"[8^)_%FN6\DVGVEML
MB^\6.*U-$\;&\\.7%_>*J3PN\94=,K2^!5VZ#-QCY/Z5QNE:?-?>%=12)22E
MW*Q [C)H W(_%7B6YT\ZI!'9?92-R@N-V/I79>'M;CUW3O/7&]3M<#H&KS#3
M8?#L?AU&N[I$N57YK<OAOI7>^!;:VM](D^RVKV\;ON <YW>] '5=J^8?&G_(
MU7W_ %U-?3W:OF'QI_R-5]_UU- &"*0Q[F!SBG"G** +]M<,L>#SCO4%S*TT
MBCHHZU):IN#'<!@'K4&>:ZO:-1)6YV%IXEM(+".W%I$S*!DE.:?<>*8;BU>V
M6WC0,, A<<UR,,BQMENF,4A^]S4N=T.[N;]IJK:7A&5)4DY(;G%7SXGM(?+C
M2TB8%LDE*Y(8)'-6+G&U'"$$'K1&3L)RZ"Z_>)>ZB[QQJB@\ #%8[U=N91-M
M;&&[GUJH]<[UW*/3O@M_R$+[_=%>VGI7BGP7'_$POO\ =%>UGI0!\Z_%#_D=
M[G_<6N/ KL?B?_R.]S_N+7'9H = XANTE/\ "0:]4T77M(U*U1+F)=ZCEBO-
M>6#FM#3GV.<$BFI-/0#OM:U/1(--;[&N^3?R"M=)X.UG3QIR2;MDAZCI7B[3
MR1W#,I[]*NV&HS"\0EC@GI5.5]P/8?$>JZ=>VKI)-V/ -<CX0\706$K64A)C
MW';D>]<->7,WVUV$AZ^M+9R%M0A?ON%+F8'MMQXLT_>$:7:<=*\8\<WZ:CKY
MEA'R!0,BDUJ5Y+Z3YB #62P).3S4@0'[M>J_!L8NY/QKRTBO4_@[_P ?<GXT
M >T=J^<?B+_R,TO^\:^CNU?./Q%_Y&67_>- ')"GIGSTP<>],I>M.]A-75CT
M#2-6M+F-+>1LNHZFK.HZS#':S1V[+O4>M>>VF[S,*Q!I;C?YC!F.:R]DF[LR
M:=K'4Z1XB54=;H_Q=JO7WB:U@0B(9/N*X6%<..>,BKNHHHEPO3 K=1@9^P3=
MRU!XBG&H&4_=)Z5OGQ/ (-Y4Y^G%<4%QBK\H_P")6H_VJIN+&\.F0:QJD]].
M3G$9/ K,;H*F9*C=:S?D;PBHJQW?PH_Y#Y^HKZ"KY^^%''B!OJ*^@:104444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MPZ/^7^'_ +ZI/^%D^'?^?^'_ +ZKYXU[2!97")TRN>*RX++S9E3/4TP/IO\
MX63X=_Y_X?\ OJG#XC^'CTOX?^^J^?-:T'[%#;L!@.F2:Q8K0MT8T ?4*?$#
M07Z7T/\ WU5F/QCH\GW;N(_C7SMJ&DM:Z7:3IE2Z9)%8OVJZA<A9GSCUH ^G
MY?'&BPG#WD0/^]5W2?$FG:RY6SG20C^Z:^3)+N[=?G8D_6O6_@KN^U.6Z\T
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MJBS9X%<DTDSKI2<E<[KX3K_Q4!QZBOH2OGWX4#'B!OJ*^@JS- HHHH ****
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M*K_=/K55==TY[G[.+E?-SC;0!I457N;VWLX?-GD")ZFH;+5K+4,_99UDQZ4
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MHK,FU[38+CR)+E5DSC%:".LB!T.5(R#0 \U\P^-/^1JOO^NIKZ=[5\Q>-/\
MD:K[_KJ: ,%:C<;Y%6I5IA)28-MW =JJ+LQ'3V$!"(A(&0/O5>O=1FM-/GL4
M"-&RXW 5DP:FD@42Q8P/6G:CJUN]OY,$ !Q@MGK7HJLN74R5-WN6]$-K:0M]
MIW'>"04]:?%+"RR+.)7!!V8-5+-K>6UP7 E]*DBD9&*!N:UA*+0FM22SU&:Q
M\R*)5V,<X85'?7"SID##=340<378C)V]>:1;JVA\]9\-\IVY]:'.*0U=NQS.
M2U[*?>GN*9'S<.^.":E>O*D[NYL>G?!7_D(7_P#NBO;CTKQ/X+#_ (F%]_NB
MO;.U0!\Y_%'_ )'BY_W%KCLUV/Q1/_%<7/\ N+7'4 *,>8F>F:]Q\&ZOIT&B
MV\)D5'V\[C7AH($R9Z9KT?1=#L[R""4WH3=R5Q6U-1:U [3QBD$FB.ZD,#SD
M53^&=Q!)8^2D>&CY)Q6/XMN4MM&$4-WN5< CUJ3X?:[800A %24_>.>M#22"
MQV7C34;>TT::-P=S#C%>>?#*T@-S<2.AW,3U^M=/XO\ $6BR:?*DCI)*. /2
ML7P#J=C!;@2!5EWDYSVS4)JP'I#6:")MD2J<=A7SKXUC,/BJ52,<5]#S:M!&
MH?S!M(]:^?/'5Y'?>*GECQMVXX]:BX&">@KU?X,_\?;_ (UY01QQ7K'P9_X^
MI/QH ]JKYR^(O_(RR_[QKZ.KYQ^(Q_XJ67_>- ''DX(IS(9B$'4TW&34MNVV
MZC(]:8I-I':Z=X?EBLE,;8)&>M07^FW\<#@L2,>M=7I-W ;6,-@_*.:FO+FU
M6&1G"[0*R6(DG8\]KJ<'8:!.ML]P1R36_8Z1_HN)689[ U-9ZU9W&Z-95 #8
MQ5^:Y@3!\P"NCVTK:&<VVSGM/T#R-6DF;(7=Q72/;Q^05)8DUGV^K0W%PZ;P
M-IP#ZUH$[4#!LBE[6:W,Y1YGJ><^)M+:WO/-_A)R#6&>#79>+;^WD3R58&3I
MQVKC6'2AR<M6>EA[\NIW_P */^0^?J*^@J^?/A.?^*@;ZBOH.H-PHHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /._&_R
M^)K!CP-O7\17<7! TEB>GE#^58?C#PW)KMD&M91%=1D%7QZ=JY^1_%MQ9G3B
MLBDKL\[;QB@#(T@NNE>)F1BNZX7!!]JO:1X:BF\(7EU/<SO,H=E8MDBMRV\)
M267A::T#[[J?!D<#J:TM-TF:V\+W%BV?,=6 _&@#SV]1KKX.W#3R/(\,/#,<
MDU9\3VOV'X8Z2EM(\9FFAW%3@\D5N#PE=2^ +K1F)$LL>T'%5+W0-6U3PA9Z
M;.K"2VN8R"1U52* - ^';31_#5P[7DX,T(W.7^8?0UR-]?Z/_8H@MH[\W"D?
MOF7K^->A^)M"FU;0!;Q/MD1,#WKF_P"SM>O=#32%A:W\M0/-9!SB@#)U"XN+
MWP5I(,\BL]TR;@W..*N>*O#\>E>!_P"T8+B87407#[N3SZU?7PK?-X<TVS;/
MFP7)D8X[5N>*]&GU7P;+IL.?-8#H* .8\3I?S:9IMV'9X!%&71223P,\4S0+
M_1KS7K9X'O+:<-S$_P JM^'>M_4M+U>WLK.6PF^:*-%:/;G. ,UFQZ%J6O>(
MK#4;N)K9+1]Q4KC=0!7\,6(\5:GJ=Y>S2$6\[0H@/&/7%4]%TM=)\>:Y#'*[
MH(%P6.3UK9_L35?#>IS2Z6&DM[ABS1H/XCWI/#OAS5!XEU#4]2<M]IC"X(QB
M@"QX%EDD76M[LVV8XR<XXK#@U&>V;5W25BPB;;ST-7;;2M>T"_U".T#RPWDA
M<%5^[QBIM"\'WB0WT=_-O:Y1@&(QC- ">&_"T&K>%(+RYN)3<7*;F?=T/L:Q
MO%]U-H^GP::;J9XO.4EXVRQ&>E:UM9>(]'T\:-;;WB0;8Y0O"BI[[P3=3:/&
M4N!]M602ER,YQSB@#EM4U&Q2UBETR+4([J(94LA 8^]:;2W'B'Q3I%A=2R1P
MO:;Y%4XRPQ6HT?B35&BM&0VZ*</(T8PPJQK/AF^@U"TUC3Y<W5O%Y1"CEO6@
M#G_%OAV'2/$^@7$,KE9+H+L)X&!Z5ZU7F5[HNO:[K.EWMT72&WF#F)EZ>]>F
MT <5\2/^03:_]=Q70>'/^0#:_P"Y5#QAI$VL6$$,.<I)N./2M72+9K32X('^
M\BX- #-<N6M-(N94^]Y;8]N*XGPEX<BUOPU]NO+B5KBXR"V[[O/:N_OK5;VR
MFMV_Y:(5S]17 VFG^(?#UF^DV@>2'D1R*O"Y[T 9WBR:;0-#.GI=2R(TBG>C
M98#TK.OM0TX:;"UE%J"748W!BA&X^Y]*ZNY\%75WH3AK@?;G=9-Y'3':HF3Q
M)>1PV/EF$(0&F,8PPH SKZXFNK[PQ/<#$KVY+ ^N:GL$DD\6WZ1-MD:S(4YQ
M@XK9U+PY=3:EH\@?>+6,J[ =3FBU\.W<?B"ZN@VU9+<QJV.AQ0!PT<\.G12V
MFN)=O*W'G0J3CWS7I_A5K9M)!M9Y)H_60Y(KEGM?$-K:R:9)$URA&U9@@XKI
M/!^@OH&FR1R/N>9_,/M0!T?:OF'QI_R-5]_UU-?3W:OF'QI_R--]_P!=30!@
MBG@4P4X'% %JVY)P!T[U'QGI1$"6.#VI,\FJ;T NZ>5%T">!BG7%RR7I=.1^
ME4E#,<+UI[=:T3?*1RZW)))B\IDSM.>U0R#=UYJ:W19)0K<BF3*%<@=*ASTL
M4D5RH X J)Q4[#BHF%0,]-^"_P#R$+[_ '1_.O;.U>*?!C_D(7W^Z*]K/2@#
MYT^*/_([W/\ N+7'8XKL/BA_R/%S_N+7'@]J %V\AO3FMC2+RX&H1?O&50?N
M@\5DC%7-.DV7L9SWH GNKN26XECFD9D). 33-,=X[I!&Q7GM5:X;=<2'W-3Z
M8V+^+/K0 R_#2W$@=V/S>M/TV62VNHBKL!NZ9I+X_P"FR^FZHHVVR*?>@#9U
M?6+N2;:L[A1P &KG)H_-E,C$ECZU=N3ODS59A0! 1@5ZK\&_^/N0?6O+&&:]
M4^#G_'W)^- 'M/:OG#XC?\C++_O&OH_M7SA\1O\ D99?]XT <D*:4)(()!]J
M<*6@#5TJ_N8G*+(3Q_$:2\U2Z?S(G<X/!JI9MMF^M+=D?:6H5C/V2(K=GC<;
M6(R>HK2OYI1C$KXQZUFKPP^M7;SYHU(JD[#=.)5265'R'8<]C6G/?W*VBXF?
M_OJLL#I5J8_Z"O\ O4U(3IQ9G3@R2"5G9F/)S4;#BIV&:B?@5+=S1:*R.Z^%
M _XJ!OJ*^@Z^??A3_P C ?J*^@J0!1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;_OFE_LZ]_Y])?\ OF@!HFPFT=:;OJ0:=??\^DO_ 'S2_P!G7O\ SZ3?]\T
M,WT\R[D"^E*-/O?^?2;_ +YIWV"]_P"?2;_OF@",/BG-+D"G?8+W_GTF_P"^
M:0Z?>_\ /I-_WS0!$9:C9]U3G3[W_GTF_P"^:8VG7W_/I-_WS0!WGPE/_%0-
M]17T-7SY\)[2ZAU]C+!(@R.6%?0= !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M ,^B4G_".Z5_SYI6GD>M&1ZT 4K;2+&T??!;JC>HJ]2 @]Z6@ HHHH ****
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MHCC62:^;8>0=HK0MOBAJ.TB6_P"?I4>LZ&L7ABW<1_,(_FXKSR6)&N"N .*
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MC!)QUKU4BL/5?">E:O<?:+FW!FQ@L&QQ0!RFC+&?'MV=-Q]G\P;]GW<>U/\
M$6=:\?VNC$YA6+SB.V178Z1H&GZ(C+90!"WWCG.:>NC6*:J-3$(^UA"F_/:@
M"Z-D$ R0JJ.OI7)^.D36?"<\5JZRE9%+;#G&*ZN:%+B%XI!E'&"*IV6CV5A#
M+#!%M24Y<$YS0!QFG#01X'F5_L_FJC#YL;\UI?#U9ET@[MWD\>5N]*LR> M"
M><R?9< G)&\UT5K:0V=LEO;H$C084#M0!P/Q%FAANM/:8#9YZ=>@YJ?QY?V=
MYH7V6UECEN)%Q&$.2#75:MX?T[6XU2_MQ*H.1SBL^S\$Z+97:7$=K\\9RF6)
MVT <>$>+QGHZ29WKIV#GZ5I>$(T_X3C5VVC=Y2\_C783:)83ZDE_) #<HFQ6
MST%.M-&LK*]ENX(0DTH =L]: //+F)Y/%ERL/#G>>._%:7@74+"V\,7,-Q)'
M%()I-T;G!/-=@NB6"7QO%A G.<MGUK,NO!&B7=T;A[7YV^\0Q&: /.[=?MVE
M^+!8#(>12@6K.B6"OH3[M12)54AXS)@DXYXKTC2_#>EZ,DRV5L(UF^^,YS6;
M-X"T*69I/LF QW, YY- '#S6=M#X"U VYD,31\;^G7M7HGAV2"T\*Z=)(R1I
MY*\GBK!\/::=*_LW[./LN,;,U%JVDQ2Z(EA%"6B3 5 >F* -:*5)HP\;AE/0
M@UY]XGT;Q/>^(8+VR^S-#"" DF<'ZBNUT>Q.G:<EN6SCFM#% 'BEK+XH'Q//
MG+:"Z\A X&=H3VKMM4T7Q'=7KRVUQ$L;'@%B.*Z0:+8C5VU3R!]K9 A?/:M&
M@"E913P6"I<$&0+R0?:N-\(_\C]X@_W%_G7?$9&/6J%IH]E97\][!#MGG $C
M9ZT >;Z[%92_%C3TOG1(?L[Y+D =JL^+]/\ #T>F>?8W$;7B9,0B8$[JZ[6/
M!FB:Y=I=7UIYDR#"MN(XJM;?#WPW:S+-'8_.IR"7)H XG7F:X\.Z VHG:[0?
MO"_KFM^^TSPL^@DFZM_,$&1M<9SBNIU7PSI>M0)#>VPD1!A1G&!62GPV\,*0
M?L'3I^\- %+X:23G2#$V\VZ#]T7ZFN[JM965OI]JEM;1B.)!@**LT ':OF+Q
MG_R-5]_UU-?3O:OF+QG_ ,C3??\ 74T 80IP--%*#0!IZ:>),C/RFJ7!)JWI
MS "3_=-4@W)H GAYD'&:DNL>>0.F*;:-B;.,\&FROOD+5:F[6%RZW$[BKMU+
MFS2/L#5 ')J69R2![5 RNPJN]66%0L* /3/@O_R$+[_=%>V&O%/@Q_R$+[_=
M%>UGI0!\Z_$__D=[G_<6N0%=?\4/^1WN?]Q:X^@!XJ_ILICN !W-9X-6+-O]
M)0^] "S?Z]R?6K.EN$U"$YP-U4I3F5R?6G0-MG0CUH LW[YOIF4G!8]*K D'
M.34EQGS2?6HJ +][(S6MN-QX6LQQN')S]:O77^H@_P!VJ34 1$ 5ZG\'?^/R
M3\:\M88KU+X._P#'W)^- 'M':OG'XC?\C++_ +QKZ.[5\X_$;_D99?\ >- '
M(BG=.>])2T 3VSD7$9R<[A5O4)G%^YW$CTJA"?WR?459OS_I;4 0N%+!E&/6
MM,.PTA%!ZDY%9>:T8?GT\C^[S3NP,]<KP"<'K5F",-$Y/857S5FV;]VX]J?,
MPL4",U$XXJP<5$])L#N?A1_R,!^HKZ"KY_\ A3_R'V^HKZ I %%%% !1110
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MH \TWXHW5Z9_PI75O^?RW_.C_A2NK?\ /Y;_ )T >9%R:0OQ7IO_  I75_\
MG]M_SI/^%*:O_P _MO\ G0!Y>SUZS\&#F[D_&JA^">KG_E\M_P Z[;P#X$O?
M"DS/<SQR9S]V@#T(U\T_$I\>)Y1_M&OI8UY'XM^%FI:_K#WD-U"B,2<-0!XH
M'HWUZ;_PI'6/^?VW_.E_X4EK'_/[;_G0!YHDI0DBC?DY->F#X):O_P _MO\
MG2CX)ZO_ ,_MO^= 'F>ZG"0[<=J]*_X4IJ__ #^6_P"=*/@IJ_\ S^6_YT >
M:;SZTTO[UZ=_PI35_P#G\M_SIO\ PI/5_P#G]M_SH \R+U&TGO7J!^">KX_X
M_;?\Z:?@CK!_Y?;>@"E\)#GQ WU%?0]>6^"/AKJ'AG4S=7%S$ZG'"UZE0 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 445R=]\0-&T^[DMIG;S$.#B@#K**XK_A9^
M@9P78?E1_P +/T#./,;]* .UI*XQ?B;H+' =SGZ4Z3XE:'&V'9P: .RHKB_^
M%G:#V=_TI6^)>AKR6<9^E '9T5Q8^)V@GH[?I4G_  L?0\9WL >YQ0!V%%<H
MGQ"T-_\ EOCZD4U_B+H2?\M\_B* .MI*P]$\5Z=KTLD=F^XH.>:W30 45SFH
M^--*TO4&LKAR)5 )J/\ X3K1]N?,_44 =/17)/\ $/1$ZR'\Q41^)6A#_EHW
MZ4 =E17&'XFZ"/\ EHWZ4G_"S] _YZ-^8H [2BN+'Q.T$_\ +1OS%*/B9H)_
MY:-^E '9T5R*?$71)/NNWZ5;C\:Z5+]US0!T=%<O-X\TB X=V_.KNC>)[#7)
M"EHQ)'K0!MT45S5_XVTK3;PVT[D2#CK0!TM%<ROCG2&7<'./K4+_ !"T5#@N
M?SH ZRBN./Q)T(=9&_2F'XG:"/\ EHWYB@#M**XO_A9V@?\ /1OS%'_"SM _
MYZ-^8H [2BN,'Q-T$])&_2GI\1]#?H[?I0!U]+7-1^.-)EQM9N:;-XZTB#[[
MM0!T]%<_I7C#3-7N3!;,2X]:WSQ0 M%<SJGCC2=)O&M;AF$B\G%43\3=!!^^
M_P"E ':45Q7_  L_02<!V_2GI\2M#=@ SDGZ4 =E17(S_$71;<@.S\C/:HA\
M3-";H[_I0!V=%<C)\1-%B569G (R*A_X6;H7]]_TH [2BN0/Q&T01ARS[3]*
MB_X6=H /WW_2@#M**XK_ (6AH&/]8WYBMG1/%.GZ^3]C8G'K0!N445SNJ^,M
M+T>Z6WNF8.: .BHKEU\>Z,RY$OZBHW^(6B)UE/YB@#K**XYOB3H2]93^8II^
M)F@C_EHWZ4 =G17%?\+.T#_GHWYBE_X6=H'_ #T;]* .THKC!\3=!/\ &WZ4
M]?B/H;]':@#L**YF+QSI,WW7-$WCG28?O.: .FHKG-.\::7J=V+:W8ER<5T=
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MO^0A?_[H_G7N!Z4 ?.'Q2##QY<LK$?(M<<TUV1Q.<5V7Q2_Y'>Y_W%KBQD4
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MTKY^^%/_ ",!^HKZ!;[I^E 'SE\2?^1PN/\ =%<D*ZWXD_\ (X3_ .Z*Y-:
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M@@RT$>X5K5S7C_\ Y$;5O^N)H O:-K,5]I-I<S2JLDT8;:357Q;K<VB::L\
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M_,P'UKQ:^UO3=/T[[78:[/+>1#=L\LCS#Z5J:]J>HZG!I7V>ZD@>>)2Y4^M
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M/QKRZ2,(Q7.<5ZG\'!B[?\: /:>U?./Q&_Y&67_>-?1U?.'Q%/\ Q4LO^\:
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M^U2<X'Y4N* .,\(:5/;ZQ?W]RA$DX R1[UT.M7=Q9:>9K9"\FX# &:TL"C%
M'$^*M&NM:T^PO8E N+23S=I'6LC5K_4_%VGC119RPL^!*\D9"Y![&O3<"D"J
M.BC\J *VGVOV/3[>W[QQJI_ 5Y]J<6J:7XRN-3@@:2VWY<*N21[5Z728!["@
M#SJWM;_Q3XB349H&AM(HRNR1=K9[4U-$NUNM?/EG;-;!$XZG->C@ = !2X'I
M0!S'AFQFM/#1@E4A_*(P?I7+Z+X5NY/!TUO(NRXCNI98PW'4\5Z?@48'I0!Y
M9=ZKK%SX<.B+92B[ VF0QG83]:EN_"=[?>%;==B_:895E8,."!7INU?0?E2X
M'I0!YC+J=W?VZV%KHJQW1^4R26^$_.K^JZ->R7NFL8UW1Q@2;!QFN^VKZ#\J
M"!Z4 <[KNMS:/-I<*)D7$@C;CIQ71#YE&>]5;O3[>]>%YXPS0MN0GL:MT <!
MXAT74=,\0GQ!I04LRA)$QDD#K@53U#Q%K>OVC:?8V<UO-(,&26,J!^->ED ]
M12;5'8?E0!YIXJ\-WL/@JVMHM\]RMPDK_P 7(.3BI;?Q5K*6B6\-A,) , M$
M<5Z.0#U%)M7^Z/RH X3PYH%]8B[UC4,/>R9:,)S@$5R5G+JBZW-J.I6-Q-*3
MA5$9*@ \<5[3BDVK_='Y4 <7'-=>*M%NK*6V>WZ;=Z;:R+/5]2TC39M(FL)I
M)FW*CQQDICMDUZ6 !T %&U?[H_*@#E?!6BW.FV;3W>!/.,L!T%=7110 =J^8
M/&G_ "-5]_UU-?3_ &KY@\:?\C5??]=30!@@T\4P&C=B@"9/F< =2:DE0QR%
M#U%16Y_?)]:LWK9NW-7SNU@L%IS..,XJ:^8-<D@ <=JALWV39_V34;N7<L:7
M-I85M;CP0&'UJ;4&WS@C^Z!Q57/(J6=LL/I2N,KN"1@DGTJ%Q5@]*A<<&D!Z
M=\%A_P 3"^_W17MAZ5XG\%C_ ,3"^_W17MAZ4 ?.GQ0_Y'>Y_P!Q:X\5U_Q1
M_P"1XN?]Q:X[)H D%7]-;;<"LX''>KFGM^_'UH 1I7BN9"K8R34UC,4F//6J
M<I_?O]:D@.) : 'S-F9S[TD8W2KGN:9(W[QOK2H^)%/H: +-Z?F5,_=X%4V)
MQC-6+E]SJ?6J[T 0MS7J?P<_X_'_ !KRQC7JGP<_X^G_ !H ]H/2OG#XB_\
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MJ )@W-2.V157-.,F: )"W%1.V::[5$SX% 'JWP6.=1O_ /=%>VGI7A_P3/\
MQ,;_ /W1_.O<#TH ^<?BB?\ BN+G_<6N.W5UOQ4./'-R/]A:XT-0!-NS5JQ?
M;,*H@U-!*$?- #I&S,_UI\388569LN3ZFG*V* )V;+FD#8J+=S1NH OW(VPP
MMZBJC'BI;B4-#",\@559Z %9J]5^#9_TN3\:\D+>M>L?!DYNY/QH ]L[5\W_
M !&./$TO^\:^D*^:_B2V/$\O^\: .4W4FZH@]+OH GC?$B_6I+E\SL:J*_S
MT^20/(30!9@?#T2M\YJNDFUA3F?<V: +-L^V92:EOV!N,^PJBLFUP:?<3;Y
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MIA_RRD_[Y-?4O_"':+_SZBC_ (0[1O\ GV% 'RWY4W_/)_\ OFE\J;_GD_\
MWR:^H_\ A#]&_P"?44?\(=HW_/L* /ESRIO^>3_]\TOE3?\ /)_^^:^H_P#A
M#M&_Y]A1_P (?HW_ #["@#Y>,<V/]4_'^R:C,4W_ #R?_ODU]2_\(?HW_/J*
M3_A#M%_Y]10!\L&&;_GD_P#WS7K7P91UNY-R,.O45Z;_ ,(=HO\ SZBKNG:)
M8Z6Q-K$$)H TJ^:/B5'*WB>8K&Q&X]!7TO6/>>&=,OIC+/ &<]Z /D\13_\
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M(Y&\97!6-R-@Y KCQ#-_SRD_[YKZLO/#6F7UP9[B -(>IJ#_ (0_1O\ GU%
M'R\(9O\ GD__ 'S2^3-_SR?_ +YKZ@_X0_1O^?44O_"':-_S["@#Y>\F;_GD
M_P#WS2B*;_GD_P#WS7U!_P (?HW_ #[+1_PA^C?\^PH ^8!%-_SR?_OFCRIO
M^>3_ /?-?3__  B&C_\ /L/RH_X0_1O^?84 ?+YBF_YY/_WS3#%-_P \I/\
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MTGX9>+M4\1%_M[(<$_=% 'IM%%% !1110 4444 %%%% !1110 4444 %%%%
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M]^7ZFO)FKUGX-_?E^IKC*/9:*** "BBB@ HHHH **** "BBB@ HHHH ****
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MC@#@<]ZO AAD$$>U>=^,AK5SKEJ(;,362 [T)X8YXS0!B^'KK4KKXD337TC
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MU=<)\-KN5].DL68O%;C".?XJ[N@ [5\P^-/^1JOO^NIKZ>[5\P^-/^1JOO\
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M%;JH/U%.HH PW\-6C^(6U?;^^*!/;BMRBB@!",J1ZUD:=H%MINKWFHQ9\VY
M#Y/I6Q10!R&O^!+/7-6BU%WD2:-2H*.1UJI%\--.,Z27,]S($.0IE)&?>NZH
MH YS7/"-EK5A%:.&2.)=J[3C%8H^&=DRA)+FZ,8XP)CTKO:* ,[1]%M-#L4M
M+12$48R>2?QK1HHH .U?,/C3_D:K[_KJ:^GNU?,'C4_\55??]=30!@@TX$4P
M$49H TK+'EO]#50'K4]B_P KC_9-5,\FG<"4'FG]JBW<U(QP*?,[ 6+0XN!S
MVID[!I2:;!DR<&FL?F-2 C=*@>I6;BH7- 'J'P7_ .0A??[HKVL]*\3^"_\
MR$;[_=%>V'I0!\Y_%$_\5Q<_[BUQ^<"NN^*1_P"*YN?]Q:X_=Q0!(#4UN^&(
MJL#FGQ-@F@!['+&K-@?]+C^M4MV2:GM)-MTA]Z );IO]*E_WJ9"V)D/O3;EL
MW#GU--0X<?6@"S=G,I;UJJ:EN'R14!:@!C"O5/@Y_P ?;_C7E3&O5?@V<W<G
MXT >TGI7SC\1O^1EE_WC7T::^<?B-_R,LO\ O&@#D@:6FYHS0!;LFQ/^%%T<
MW+U':G]]GVI)WS.QH ?#_K5^M6;]]UT?H*J0MB1:EO&S<$^U ")RXJ;4&_?C
M_=%5D?YAS4MZV9A_NB@" ]*C>GGI4,AQ0!WOPI_Y&!OJ*^@&^Z?I7S[\*#GQ
M"WU%?03?=/TH ^<OB3_R.%Q_NK7)K75_$D_\5C<?[HKD@U $E.W&HMU.#4 2
MBIK5L7,9]ZK!JEA;$R?6@"S>',Y/K5;BI;I\R5!NH N9_P!#:J1Z5:W?Z,15
M0G - $3UZO\ !S_62?4UY.YKU?X.']Y+]30![+1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !VKY<\;-CQ7??\ 74U]15\L^.&Q
MXLO_ /KJ: ,/=2[^:AR30#0!?M9=I8^U0!SDU$KXZ&EW4 3A^14KN&48ZU3W
MT\-Q0!9278I'<TF^J^^D+T 3%^*B9\TTOD5&S4 >L?!1LZC?_P"Z/YU[<>E>
M'?!$YU&__P!T?SKW(T ?-OQ4./'5S_N+7&;Z[#XK'_BN[D?["UQE $P;BG*W
M6H0W%/20*K9Y]* ';N:DA8B53[U6W\TY7PP([4 67;]ZWUI%;YA4)?)R32!^
M>M %F5\M49:HBV3UII>@![M7JWP9_P"/M_QKR-FKUKX+G-V_XT >W&OFWXD-
MCQ-+_O&OI*OFCXEM_P 5/+_O&@#E=]&ZJX:G;J +MJW[P_2F2.#(34$<I0DC
MTIN[- %F-\.*?++NDS57=3M_O0!85OF%27$FZ0'VJGOYSFD:0GO0!-OJ-VS4
M9>F,] 'HGPF_Y&%OJ*^@V^Z?I7SS\)#GQ WU%?0S_=/TH ^;OB6<>,KC_=%<
M@&YKJ_B:<>,[C_=%<>&H GS2[C40;BE!H F#4^-L2*<]ZK[L4H?O0!;D?+YS
M4>ZH=]&^@"X),1$$U S5"S^],+T /=N*]9^#1S)+]37CY>O7?@N<R2_4T >U
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Y!K
M_P *;G5M9N;Q7P)'+#YJ]?HH \-_X4O=_P#/3_QZG?\ "F+K_GI_X]7N%% '
MA_\ PIFZ_P">G_CU'_"F;K_GI_X]7N%% 'A__"F;K_GI_P"/4O\ PIJZ_P">
MG_CU>WT4 >(_\*:NO^>G_CU'_"FKK_GI_P"/5[=10!X@?@S='_EI_P"/4A^#
M-T?^6G_CU>WTM 'GW@'P+-X5NKB61LB4 =:] /2EI* /*_&'PRN/$7B*744?
M"NH&,^E88^#%W_ST_P#'J]QHH \/_P"%,77_ #T_\>H_X4S=?\]/_'J]PHH
M\/\ ^%,77_/3_P >I?\ A3-UC_6?^/5[?10!XA_PIFZ_YZ?^/4?\*:NO^>G_
M (]7M]% 'B!^#5U_ST_\>I#\&;K_ )Z?^/5[A10!X<?@Q=8_UG_CU=GX$\#3
M>%YF>1LYSWKOJ* $KRKQ5\,;C7=6>[1\!B3UKU:B@#PW_A2]U_ST_P#'J!\%
M[K_GI_X]7N5% 'A__"F+K_GI_P"/4?\ "F;K_GI_X]7N%% 'B ^#-U_ST_\
M'J/^%,W7_/3_ ,>KV^B@#Q#_ (4S=?\ /3_QZD_X4S=?\]/_ !ZO;Z6@#P__
M (4Q=?\ /3_QZFGX+W9_Y:?^/5[E10!YCX+^'-QX;U(W#OD<=\UZ:>012T4
M>5>*_AE<:]KLM\CX5U ZUB?\*9NO^>G_ (]7N%% 'B'_  IJ[_YZ?^/4O_"F
M[K_GI_X]7MU% 'B/_"F[K_GI_P"/4O\ PIR[_P">G_CU>VT4 >(CX-W7_/3_
M ,>I?^%.77_/3_QZO;:* /$?^%-W7_/3_P >I/\ A35T?^6G_CU>WT4 >'GX
M,77_ #T_\>KM/ G@B7PNSF1LY/K7>44 %%%% !11FB@ HHHH **** "BBB@
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MM<;J).QQ]]:BSU*> '.UL5 ]27+22ZE<-*"'+<YIK+Q7')6=BSU[X*_>O/\
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MI74>,-)W6";<_NQQ3_A9(A@DA*@NQ/)%=YK>D*-#N"R@G;Q0!X3H^GO>ZFD
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MJ_:S;R?8<\-L.<5T=QK(&EI?VPWQD!FSV% &Q15/3=0AU2PCNX#F.09&:N4
M':OF#QI_R-5]_P!=37T_VKYA\9_\C7??]=30!@K3HH?/N50MM![T 4D:227
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M7D#BVFN=P8*2>E &GINM:IINJW^B:C<":2&W,JR 8'/054N/$6I1>"-4ODE
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M52H TEGD.ER*7.,>M93.2,'FKJG%BXJ@>M $3UZO\&_]9+]37E#]Z]7^#?\
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MT4 -5%0850H]AB@QHS;BBD^I%.HH :Z*XVNH8'L1FF);01G,<,:GU50*EHH
M8\4<@Q(BL/1AFFQV\$1S'#&A_P!E0*EHH *A-K;ODM!$2>N4'-344 ,6*.-=
MJ1JJ^@&!1Y,14KY:;3U&T8-/HH ;L7;MVC;Z8XI!&@38$4)_=QQ3Z* (19VP
MY%O$#[(*>T4;+M9%*^A'%/HH B2UMXVW)!$I]50"G^6F_?L7=ZXYIU% &;-I
M,-QJ$-Y*N9(3E".U:5%% $;PQ2C$D:./]I0:2.UMXCF.")#ZJ@%2T4 ,DABE
M&)(T?_>4&HQ9VRG*V\0/L@J>B@!IC1EVLBD>A%1?8K7_ )]H?^_8J>B@"-(8
MHU*I&BJ>H50!3?L=MNW?9XL^NP5-10 @  P!BJ&L::NIZ=) 0-^T[">QK0HH
M RM M+BPTJ&UN'#O&N-WK6D8HR^\QJ6_O8YI]% !44EO!*<R0QO_ +R@U+10
M!%'!#%_JX8T_W5 IRQHA)5%4GJ0.M/HH 0J&&" 1Z&F""(  1)@=!M'%244
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MS5ZQ\&SF27ZF@#V:OG_XJ_\ (P1_0U] 5\__ !6/_%01_0T <&,TX4S-*&H
MT]*E$=PV>ZD56N/EG85##(5E4@]ZDNWS<DT (#C%7)GS:I]:S]U67?-FGU-
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M7:2B@#-NM"TV]G,UQ9PR2'@LR@FHO^$8T;'_ "#[?_OV*UZ* ,G_ (1C1O\
MH'V__? H_P"$7T;_ *!]O_WP*UJ* ,G_ (1C1O\ H'V__? H_P"$8T;_ *!]
MO_WP*UJ* ,G_ (1C1O\ H'V__? H_P"$8T?_ *!]O_WP*UJ* ,C_ (1C1_\
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M 'P*U:* ,G_A&='_ .@?!_WP*/\ A&-'_P"@?!_WP*UZ* ,G_A&-&_Z!]O\
M]\"C_A&-'_Z!]O\ ]\"M:B@#*_X1K1_^@?!_WP*/^$9T?_H'V_\ WP*U:* ,
MG_A&='_Z!\'_ 'P*/^$8T;_H'V__ 'P*UJ* ,ZWT+3;20206<4;CNJ 5I4E%
( "T4E% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>img17388848_14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img17388848_14.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %: =<# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HJ*XG2UMY)Y,[47)QW]JIQV#78$VHY=SR(<_)'[8[GW- &@"&Z$'Z4
MM4FTFSX:*/R)!T>$[2/RZ_C2V<\IDDM;D@SQ8.\# D4]&QVZ$'W% %RBBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH ***CGF2W@DFD.$12Q^@H CNKN.U"A@SR/PD:#+-]!_6H?\
MB9S'(\BV7T(,C?S _G2V%NP!NK@?Z5,,M_L#L@]A^II]Q?16\@A >6=AD11C
M+8]3Z#W- $,ME=W 5)[Q&C#JS*L.,X.<9S[5+J:W3:9<K9'%R4/EGWJ+SM4?
ME+.WC'I),2?T%&_5_P#GA9_]_6_^)H R?",6KQ)<_P!H^<(R1Y:S'+9[X]JV
M[BTEDNTN8)Q$X0QG<FX$$@^H]*BWZO\ \\+/_OZW_P 31YFK#_EWLS["9O\
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MR\U5LD@;9)#DCJ/PKIX?%VG(CAKZ_?R]0CN%\Q,M,@ !!Q@#N<>PIT?BG1;
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M!FA($B=QD9%3UP*SR+<M>)<N]WO^_M&2V -N !D'CBNYMGEDMHWGC$4K*"Z
MYVGTS2G#E Q/&.D2:WH)LXIDB;S4?<X)''TK@/\ A7-Y_P!!*V_[]M7JU_\
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M6A_ZX/\ ^A+5NJC_ /(6A_ZX/_Z$M6ZX "BBB@ HHHH **** "BBB@ HHHH
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MOT46 I'2+!I7D:V4E]V02=O/!P.@)]JFM;."S5U@0KO.6)8L6.,<D\]*GHH
M='_K4_WA6W6)'_K4_P!X5MU,@#%%%%0 8S6=8Z1#9WES=EC)/,Y;<W\"G^$>
ME:-%--H JIJ'^JB_Z[Q_^A"K=5-0_P!5%_UWC_\ 0A2 R_$IQ)8G_:?^0KSB
MZ$\-E+IJ%A-#.TH4'!EC;.&'KUKT;Q-]^R_WG_D*YZYL[:\0)<P)*!TW#D?0
M]1750=D!YZ!*]Q&D<;F0MA1CDGT%=A<P'9I>C-(1'(N)F4XW*@&1]"2/PJW'
M:Z9I9WJL$#-P'D?YC^+'-&H6LEU'!<6CI]H@;?$2?E<'@J3Z'U]A6TI\S R=
M0UVWBC:UT^WA$0^7#1@@CWINAM!J$=Q82PAK4J)5C)_U9R00IZ@9&1Z9K+NM
M.NFN&\FSN49CGRC$3@^S#@C\:Z/0-(?38'>;!N)< @'.U1VSW.22:J2BHZ /
M_P"$?L68&0SRJ/X))20?KW-;5@ NIV*J  )0  , <&H<8J:Q_P"0I9?]=?Z&
ML)N\6!U+_P#(6A_ZX/\ ^A+5NJC_ /(6A_ZX/_Z$M6ZY "BBB@ HHHH ****
M "BBB@ HHJ&YN8K6+?*3R<*H&2Q] .YH FHJD)[^0;EM(XU["67YOT!Q2QWQ
M$RP74)@D;A"3N1_8'U]C0!<HHHH **** "LGQ'SI/_;5/_0A6M63XC_Y!/\
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M^-?SIIN8A_%GZ"J%%/E%S%MKP?PH3]:A>XD?O@>U1446"[-#0.M]_P!=A_Z
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 5UOK1[@VZW4!G!P8Q(-P_#K5BO/YK&26YOK:/2KC[?)JPFAN_
MLY"I'E?F\STP#Q5R!M8M/LM_/)J4R-?R+-"%+;8OG"84#.,[>?I0!TK:/9-K
M2ZL8O],6+R@^>-OT]?>LYM"T'3;N.YFD$($ADBBFN"(E?NRH3C//ZUR5[J>M
M6VG(UU=:A#,MEO0)@$/YA!,H//3&*Z3Q!IUUJ6IZ((8XSM2;?)/!YL:Y5?O#
MU/:@9HQ^'=*:VLEC1BEKN,+K(<E6SN!/<'/2HD\(Z6D+1K]I#$J1+]H?S$VY
MVA6SD 9/'O6*NDZQI;36>GW5VR6=@&MP!MCEF);(QT_#/I5=)M<\AMCZN=/\
MZ'S))(\7(&#YFT8SMSM[>N* .UTZWM+2QCMK';]GBRJ[6W<YYR?7.<U:KSNR
M;6=-TUE2WU(>=!="-5B);SB^49AV..]:$1U:?498;I]65W4+$(E A\LQ\EB>
MC;L^^>U CLU8,H92"#T(-+6)X1B>'PO8Q2K<)(B;76=2&4CJ!GMZ5MT %%%%
M !1110 4444 4K#_ %]]_P!=_P#V5:YZV_U ^K?^A&NAL?\ CXOQW\__ -E6
ML'88+FXMVX,<A(]U)R#^OZ5<-R)[#J***U,PHHHH **** -#0.M]_P!=A_Z"
M*NZ9_P >*_[[_P#H9JMH$9%B\Y&/M$AD7_=X _09_&K.E\V"D="[_P#H9K![
MFRV+,D:R8R2,>AJO/&(H]X9LY Y-6ZJWYQ;?\"7^=1)*S8/86T;<9/8C^56:
MHZ><M-]1_*KU$-4$=@HHHJAA1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %6YTRQO)HYKFS@FEC
M^X\D88K^)JU110 44=:* "BBB@ HHHH **** "BBB@ HHHH H%OLNK'=Q%=*
M &])%[?B/Y4S5--:Z*W%N56YC&!NZ.O]T_T/:KMQ;QW4#12C*GT."#V(/8U4
M$]U9#;<QO<1CI-$N6Q_M+_44 8+3K$^RX5K>3NLO'Y'H?PIWFQ?\]8_^^A6\
MVI:=*FV2:,CNKK_0BFP6^DW6[R+>TDV_>VQKQG\*TYR.0Q!)&>DB''HPI/-C
M_P">J?\ ?0K<N+"S1H0EI NZ0*V(P,CT-3'3; #)LK;_ +]+_A1SBY#FVN8$
M^]-&/;<,U9M=/FU%AO1X;3^(L,-(/0#L/>M.*YT>$[X6M4/JB@?RJ0ZI$YVV
ML<MRY_N*0H^K'@4G-L:BD27LXL[,^6HWG"1(.['@#_/:I+2#[-:109R44 GU
M/<U#;VLK3BZNV5I@"(T7[L8/IZGU-7*@L*IZF<6G_ U_G5RJ6J_\>7_ U_G4
MS^%DRV9'I9RUQ]5_E6C69I)RUS_O+_*M.E3^$(;!1115E!1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M)X)]#4R-9?VK(\5M(]K]FE6>!(662/Y@3N/\18YQ3L%C971].GG^U(SN-S,
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% 'GEY8M-
M=ZO;QZ7<-J,VHK);7(MR BC;\WF8P!P>]7TDUBV9;^:;49(_[2=)(0F0(!D
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
EHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>img17388848_15.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img17388848_15.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #W 9L# 2(  A$! Q$!_\0
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MW I?V/I?_0-L_P#OPO\ A1_8^E_] VS_ ._"_P"%7:*.9]P*7]CZ7_T#;/\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M9H@)"98P(_OG>/D^OI^-4];Y\/:F1T^QS?\ H!H&9O@'_DG?AOC_ )AL'_H
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MOQ'=6]KX=U%KFXBA#VLJ*97"[F*'@9ZFBP%+P#_R3OPWSG_B6P?^@"NAKGO
M7_)._#?_ &#8/_0!70T(04444P"BBB@ HHHH **** //O' ']NQ\?\L%_F:Y
MK ]!72^-_P#D.Q_]<%_F:YNO5H_PT<=3XF)@>E&!Z"EHK0@3 ]!78> AB>__
M -Q/YFN0KL/ 7^OO_P#<3^9K'$?PV:4OC1VM%%'>O,.LY2ZO;I;N95N)  Y
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M7S2>E?2UO_QZP_\ 7-?Y"L:O03)****R)"BBB@ HHHH **** "BBB@ HHHH
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M^@RW_@)/_P#$4?\ "T_!?_09;_P$G_\ B* .PHKC_P#A:?@O_H,M_P" D_\
M\11_PM/P7_T&6_\  2?_ .(H SO&_P#R'8_^N"_S-8FGVZ7>H0V\K,J.V&9>
MH&,\5#XK\=>'-0U9)K2_DEC$(4L+64<Y/JM87_"6:+_S]2_^ TO_ ,37I4IQ
M]FE<Y9Q?->QV3:?IBJ6:\>/?$LD:NPSR,X/!SS5JQM+&XDM-EH-SVA;:^7!<
M/@LP&#TSTZ5P3>+M$12SW<BJ.I-O* /_ !VE'BS1>"+J7_P&E_\ B:;E%KXQ
M)/\ E.CU".&'4KF*W;="DK*ASG@'BNG\!?Z^_P#]Q/YFO-?^$KT7_GYE_P#
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M/@<G.,XS7%PQ:UJ^L7-O(+J^2TD$UU!/-^XN"MP2$56X0[!]TX!VC/')TI]
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
***** "BBB@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>img17388848_16.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img17388848_16.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" &- J<# 2(  A$! Q$!_\0
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M7[R$R.BBBO3$%%%% !1110 4444 %%%% !6EX>FCM_$FF33.L<4=U&SNQP%
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MPSI<\^D64DLEK&SNT()8E1DFK=]H'A'3;8W-]INF6\((!DEC51D].:M^%/\
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MB5[?2Y-2NQ"T;#$T^[.R3T&,X'<BO2!TJ:CG!VY@.>_X07PS_P! F+_OMO\
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M_C1_P@OAG_H$Q?\ ?;?XUT-%'M)]V!Y_XR\*Z'I?A>ZN[+3XX9T*!7#,2,L
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M439G53<;([4:BD@\O8(EQNQNW,26'3'3KW]:P=1U2.*.0RVT0M0P;[3.<(X
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MDF XE=+9V1#@'E@,="*T8IHYHDEC=7C<!E8'(8'IBL"#4X=-U/5DGBNFDDN
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M:1"._2ULI7D\N=%"(-K *K#E\[N/0>];^SA;<RYI'0ZCJ5MI5J)[IRJ,ZQJ
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MEW ?,1SGBG44 %5=/_X\U_WF_P#0C5JJNG_\>:_[S_\ H1H M4444 %&***
M$Q1BEHH ,4444 %%%% !1110 4444 <Q\0?^1+O?]Z/_ -#6BCX@_P#(EWO^
M]'_Z&M%>CA/@?J!?\*?\BEI'_7G%_P"@BMBL?PI_R*6D?]><7_H(K8K@G\3
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M_P"VO/UKHY(R[#YR$[I@8;ZUSWCR,#P1JFP!"43) ZX=:=[@;BC9)(AD=L
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M1110 C?=/TK+\-?\BSIO_7NG\JU&^Z?I67X:_P"19TW_ *]T_E3Z :M%%%(
MKR2TO_"^H:>]WKFMWT6O2-(S2K-.C6S;CM5%7Y0  .,<]\UZW7GMCKNG2>%+
M^/7?$\EGJ;RR-=*;D1S6KAN$C7K@ #  .[WS0!U?A:]N-1\*Z5>79)N)K6-Y
M"5P2Q R<=JUZR_#EQ>W?AO3;C4D*WLENC3 KM.XCN.Q]NU:E &7(=WB6W DB
M(6VDW*/O@[DQGVK250HP  ,YXK/>*%?$4,@M0LK6[[IP -PRORD]3_*K[L4
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MQ-_R*VK?]><O_H)JH_$@-&#_ (]X_P#<'\JDJ.#_ (]X_P#<'\JDJ0"BBB@
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MM*LB+'N0_NVV;SCY?GV]QUJCHEA<:O;6\^KM>,]I<B6#SE\MF8(I)8 #@.7
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M!U*_NC+(UDVC3Q?+#);2+.01T;<<>N05JOX8M6M'UJ/[.88SJ3F)=FT%/+C
M*CTX/3TH WZCFABN87AFC62)P5=&&0P/8U)10!#!:6]JTC001QF0@N44#<0,
M#/X5-110 55DTZREF,TEK"\I96+L@)ROW3^&35JB@ HHHH JR:=933&:2UA>
M4LK%V0$DK]T_ADXJU110 4444 %%%% !1110 4444 8.KPY\2^'Y^ZRS)GZQ
M$_TK>KG]8G'_  EGAZW!Y+SR$>PC(_K7054ME_74 HHHJ0"BBB@ K*\3?\BM
MJW_7G+_Z":U:RO$W_(K:M_UYR_\ H)JH_$@-&#_CWC_W!_*I*C@_X]X_]P?R
MJ2I **** "BBB@!&^Z?I67X:_P"19TW_ *]T_E6HWW3]*R_#7_(LZ;_U[I_*
MGT U:***0!7F_C'4;/2/BKX3O]1N8[6TCMKI7GE.U 2H !/O7I%5;W3;'4HU
MCOK.WNHU.Y5GB#@'U - &%_PL;P9_P!#-IG_ '_%'_"QO!G_ $,VF?\ ?\5H
M?\(KX=_Z .F?^ D?^%'_  BOAW_H Z9_X"1_X4 9_P#PL;P9_P!#-IG_ '_%
M(?B-X- )'B73#[>>*T?^$5\._P#0!TS_ ,!(_P#"D/A3PZ5(_L+3!D=1:1_X
M4 9OA?XB>'?%N(K"\$=Y@YM)_DDX]!T8?3-/\1SW5SX@T70XKR:RM[Q9Y9Y8
M&VR.(PN$5OX<ELDCG J?PYX)T#PK%C2["-)C]ZX<;I6_X$?Y# K0U;1+'6H8
MH[R-RT+^9#+%(T<D3=,JRD$<'% '+W+7FC7^EV$>NS7B-K$:,DC!I8XFA=O+
MD;JP)&X$\XQUK8N;NY7Q_I]FLSBV?3IY'B!^4L'C )]P"?SIK>"=$:P6T\JX
M&+G[69UN9!,TV"N\R9W$X)'7I22>"=)E%N7EU'S( ZQS"_F$FUR"P+;LD9 X
M- %V?6H)KVYTBQN8QJR1EE26)RBG ()( !'(X!JEX)N+VY\/LVH7;7=REY<1
M-,RA=VV5E& .@P.G:MVTMDL[2*VC:1DC4*K2N78CW8\D^YJ.PTZVTRW:"U0I
M&TKRD%B?F=BS'GW)H M4444 %%%% !1110 4444 %%%% !1110 4444 %(P#
M @C(/!%+39'$<;.WW5!)_"@#%\'Q^3X7M(O[C2K^4C"MRL'P7(9O"5C*?^6G
MF/\ G(QK>JI_$P"BBBI **** .8^(/\ R)=[_O1_^AK11\0?^1+O?]Z/_P!#
M6BO1PGP/U O^%/\ D4M(_P"O.+_T$5L5C^%/^12TC_KSB_\ 015+QW<7%KX9
M9[:6XCD-Q"N;=]LA!< A3ZD<5Q./-4MY@=+17#66HG0M-O;Y[7Q TFZ*&*'5
M9P1([M@;>3CD\FJU]JVHP7?B$WQF3R?L06&VNB%7<V"4;' /?CGI35)MZ?U_
M5P/0J*XF3Q9?:;=^(9;Z.&2VLYXH+=$<@[G P"<=#G)/;H :FB\:O-:E8K))
M+UKQ+2-4E/DR%QN#!RH.T '/&<BE[*8'845S/A2[O;G4?$"WK-NBO0JQF0NL
M8V+PI]._0=:Z:HE'E=@"BBBD 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%07EU%96<UU,<1Q(78^PH YEW^V?$>$CE;2!D'L=
MN3_Z&HKK:Y#PI!+)JUW=3C]Z(@9/:21M[#\ $'X5U]:5=&EV0!11168!1110
M 5E>)O\ D5M6_P"O.7_T$UJUE>)O^16U;_KSE_\ 0351^) :,'_'O'_N#^52
M5'!_Q[Q_[@_E4E2 4444 %%%% "-]T_2LOPU_P BSIO_ %[I_*M1ONGZ5E^&
MO^19TW_KW3^5/H!JT55U-VCTF\=&*NL#E6!P0=IYKA/"<\OE6=_=KXF.VU,T
MDUS.&MGPF2<9R0>W%5&%XM@>BT5P@UW4K_5]"N9(6M+2[MKF9(X[@G>OEY7>
M,###KWZTW2_$>H>?H:C']G2:6]W,)IC)*0N,DMMY([=,YYJO8R_K^O(#O:*X
MJR^(,,\$\\]H%B6T>[3R9"Y 7^!\J K'(Z$BIM/U'5+KQK:I>Q_9HI-+,P@C
MG+H27&">!\P!Q2]E)7N!U]%%%9@%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !63XEN3;>'[LJ</*ODI]7.W^N?PK6KC_ !?=--*M
MG$<_9T\Q@/\ GH_R1CZ\D_E5TU>2 V/"T(@\+Z?&!@>4& ^IS_6MBHK6!;:T
MAMU^[$BH/H!BI:F3NVP"BBBD 4444 <Q\0?^1+O?]Z/_ -#6BCX@_P#(EWO^
M]'_Z&M%>CA/@?J!?\*?\BEI'_7G%_P"@BK.KZ3;:WI[65WYGE,RM^[<JP*G(
M((]Q5;PI_P BEI'_ %YQ?^@BMBN"3:FV@,"+PAIR6US;2RWUS%<*%9;B[>3;
M@Y!7)^4@]Q0?"&F-%=I(;J4WGE&=Y)V9G,9RIR:WZ*.>7<#&N/#.FW5Q>S2I
M*?MH7SD$I"EEQM<#LPP.12'POI[V+VLAN9"TPG,[SL91(.C!NH(Z5M57OKH6
M5A<717<(8VD(SC.!GK1S2[@5=*T6TT<W)M?-+7,GFRM+(7+-@#.3]*M7=_:V
M$:O=3K$KMM4MW.,X'Y&L,ZA>:UJ,<6GO]G2SF1Y]YXE1ATX_/'?@TV[U&_\
M^$KT^TGTORK19)7CN5FWF0")N-H7@\^O:DVWJP-/_A(=)_Y_$_[Y/^%'_"0Z
M3_S^)_WR?\*R[/Q>MW'&YM%0/);@'SP0%F)"YX^^,<K[]:Z>D!F?\)#I/_/X
MG_?)_P */^$ATG_G\3_OD_X5IT4 9G_"0Z3_ ,_B?]\G_"C_ (2'2?\ G]3_
M +Y/^%:+,J#+, ,XR34:,?,(95W[?F*GISP/7UH I?\ "0Z3_P _B?\ ?)_P
MH_X2'2?^?Q/^^3_A6BK%LY4K@XY[^]+N7=MW#=C.,\XH RAXFT4RF(:A$9%
M8ISN /0XQTX/Y4__ (2'2?\ G\3_ +Y/^%4+4G_A8FIC_J&6W_HR:N@+8=5P
MQSW X'UH SO^$ATG_G\3_OD_X4?\)#I/_/XG_?)_PK3HH S/^$ATG_G\3_OD
M_P"%'_"0Z3_S^)_WR?\ "M.J.KZB-*L#<F/S#YB1JI;:,LP4$GL,GDT 1?\
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M. !0!%J%]#IMC+=SD[(Q]T=6/91[D\5R>GVLMWK-M'<\S-(;^[QT!'"+] <
M?[E27=\VI3?VA=@PV%L"\$3C!Z?ZQAZXZ#M]36QX<LI(K62]N$*W-XPD*GJB
M?P+^ Y/N36Z7LXMO=BZFU1116 PHHHH **** .8^(/\ R)=[_O1_^AK11\0?
M^1+O?]Z/_P!#6BO1PGP/U O^%/\ D4M(_P"O.+_T$5L5C^%/^12TC_KSB_\
M016Q7!/XF 4445(!01D8-%% "  =!7/ZD\+>,-&4.AF3S<KO3< 8V[?>_+BN
MAK%U%U'B31T\Y S/(?*V?,P$;<[O0>GO0!A_VGY6EO=_V79?;WN667;;'8VS
M.&&/O$G"AO5O:NBTJ[OKN>^-RD:P1S>7 51E8X'S9R><'C(ZX-:E% #=Z[]F
M?FQG'M0F\K\^-W^STIU% $:B0'#E67UQ@YS_ (4V)23YAE9ADX!7;QZ'Z4Z;
M_5,>3M^; .,XYZU$DZ/$I2=7&[:S?7MQT/2F!,[9RB,HDQD \X]\4%6+*0P
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M** "LKQ-_P BMJW_ %YR_P#H)K5K*\3?\BMJW_7G+_Z":J/Q(#1@_P"/>/\
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MK5K*\3?\BMJW_7G+_P"@FJC\2 T8/^/>/_<'\JDJ.#_CWC_W!_*I*D HHHH
M**** $;[I^E9?AK_ )%G3?\ KW3^5:C?=/TK+\-?\BSIO_7NG\J?0#5HHHI
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M ?XB#SC@YQQTZ\U;NU9@O(D_L]#]G;8A#8WD ;M^<^_3'KVIUZ=\-TD47E[
M2PSM);J<8/4BH+.]66<1Q/)(@4H7.2",Y)))ZG!&!TXK26-&0MROEO\ ,_\
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M);GY2Q Q@=0.O//6I%VQ.(DC.&!8M_B>YKC8M1\3ZE*^S0]+D,&421]3;DD
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M4\+3L%DB<.IP .HJMIEM!<V5N)(893@-O*+R1Z8P>OJ*T+!%0W*HJJHG/"C
MZ"N"2L[&Q;HHHJ0"BBB@ HHHH **** "BBB@ HHHH **** .8^(/_(EWO^]'
M_P"AK11\0?\ D2[W_>C_ /0UHKT<)\#]0+_A3_D4M(_Z\XO_ $$5L5C^%/\
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M:71;R&XM1#$DJ^2B<2<E@PR&_&M2G9&L84YI.R$4!5    X %+113-0HHHH
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MY,C8P<$@E5Y&,\<&KUE/<3>#IG,@279-&CS2\+AF5<M^7-+Y&$'"]G"SM?\
M+R\S0L]$L["<2PK+E01&KRLRQ@]0H)P*M26T4EU#<L#YL(8(<]-V,_R%<Q::
M=-:^?I:P6XF*13EH7?$J!L%&W$X)P>>^:?8Z@;.X5;OS)%MU**4.50%\%CGK
M@E5'^Z:+E1JQ22<;(V6T*P:&6+RV5'F,XVN08W/5D(^[^'J:FL=,MM/+M$)'
MEDQOEE<N[8Z9)["K@I:JQT*G!.Z04444%A1110!S'Q!_Y$N]_P!Z/_T-:*/B
M#_R)=[_O1_\ H:T5Z.$^!^H%_P *?\BEI'_7G%_Z"*V*Q_"G_(I:1_UYQ?\
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M"K-%% TDE9!1110,**** "LKQ-_R*VK?]><O_H)K5K*\3?\ (K:M_P!><O\
MZ":J/Q(#1@_X]X_]P?RJ2HX/^/>/_<'\JDJ0"BBB@ HHHH 1ONGZ5E^&O^19
MTW_KW3^5:C?=/TK+\-?\BSIO_7NG\J?0#5HHHI %>?Z1_P EQ\2?]@JU_F:]
M KS_ $C_ )+CXD_[!5K_ #- &OJOB*ZLM2U"S2:S7ROLNQW!_<B5F5FD&[D#
M /;J*GT6UDU"\M?$T[B*2>Q6,P*F  <-DDGGD'' Z\YK=:V@=G9H8V+C:Y*
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M3_P)E_\ BJ- -JBL7_A%-&_Y]I/_  )E_P#BJ/\ A%-&_P"?:3_P)E_^*HT
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MR?\ @1)_\51_PC.D_P#/O)_X$2?_ !5&@&O161_PC.D_\^\G_@1)_P#%4?\
M",Z3_P ^\G_@1)_\51H!KT5D?\(SI/\ S[R?^!$G_P 51_PC.D_\^\G_ ($2
M?_%4: :]%9'_  C.D_\ /O)_X$2?_%4?\(SI/_/O)_X$2?\ Q5&@&O161_PC
M.D_\^\G_ ($2?_%4?\(SI/\ S[R?^!$G_P 51H!KT5D?\(SI/_/O)_X$2?\
MQ5'_  C.D_\ /O)_X$2?_%4: :]%9'_",Z3_ ,^\G_@1)_\ %4?\(SI/_/O)
M_P"!$G_Q5&@&O161_P (SI/_ #[R?^!$G_Q5'_",Z3_S[R?^!$G_ ,51H!KT
M5D?\(SI/_/O)_P"!$G_Q5'_",Z3_ ,^\G_@1)_\ %4: :]%9'_",Z3_S[R?^
M!$G_ ,51_P (SI/_ #[R?^!$G_Q5&@&O161_PC.D_P#/O)_X$2?_ !5'_",Z
M3_S[R?\ @1)_\51H!KT5D?\ ",Z3_P ^\G_@1)_\51_PC.D_\^\G_@1)_P#%
M4: :]%9'_",Z3_S[R?\ @1)_\51_PC.D_P#/O)_X$2?_ !5&@&O161_PC.D_
M\^\G_@1)_P#%4?\ ",Z3_P ^\G_@1)_\51H!KT5D?\(SI/\ S[R?^!$G_P 5
M1_PC.D_\^\G_ ($2?_%4: :]%9'_  C.D_\ /O)_X$2?_%4?\(SI/_/O)_X$
M2?\ Q5&@&O161_PC.D_\^\G_ ($2?_%4?\(SI/\ S[R?^!$G_P 51H!G_$'_
G )$N]_WH_P#T-:*O2>%-%F0I+9F1#U5YI"#^!:BNFCB(TXV8'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>img17388848_17.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img17388848_17.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %X K0# 2(  A$! Q$!_\0
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M]03??_"FMP9'1115DA1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!/#_J_QJ2H
MX?\ 5_C4E9LH**** "H)OO\ X5/4$WW_ ,*:W!D=%%%62%%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MIZ***8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M;-ZL271UNZ\Y86+(&RN=I(!(^HKK:YCP5]SQ%_V';O\ FM SIZ***8@HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"*Z_X\KC_KD_\
MZ":^:U^X/I7TI=?\>5Q_UR?_ -!-?-:_<'TK6EU&A:***U&%%%% !1110 Z/
M_6I_O#^=?2U?-,?^M3_>'\Z^EJRJ]!,****R$%%%% !1110 4444 %%%% !1
M110!/#_J_P :DJ.'_5_C4E9LH**** "H)OO_ (5/4$WW_P *:W!D=%%%62%%
M%% !1139$66-XW&4=2K#U!ZT <;XJLK?4]2\B'PI+?WR(,7XF%JL8/3]\#N.
M/0"M#PCI.NZ5;7"ZUJXOO,8&&(,7^SCNOF$ MVZCM61XB\,&.[%XFAZ;J&GQ
M0)&(Y+M[>:-5&,!B=A'UQ^-6O =_X<OH[\:#836<L3*MU'(2PSSC#9*L.O0T
MAG8T444Q!1110 4444 %<QX*^YXB_P"P[=_S6NGKF/!7W/$7_8=N_P":T@.G
MHHHI@%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 177
M_'E<?]<G_P#037S6OW!]*^E+K_CRN/\ KD__ *":^:U^X/I6M+J-"T445J,*
M*** "BBB@!T?^M3_ 'A_.OI:OFF/_6I_O#^=?2U95>@F%%%%9""BBB@ HHHH
M **** "BBB@ HHHH GA_U?XU)4</^K_&I*S904444 %03??_  J>H)OO_A36
MX,CHHHJR0HHHH **** //=>FT$>.+F/Q+:7%S;K!$]J-DLL*MSNW(OR@]".*
MZO0M7TC4H7BTA#'%;X!3[,T*KGI@$#]*R/$,FCKJ["]\8WNE3;%S;17:QJ!V
M."#UJ+P-=^?J.MPP:U>ZS8PO&(+NXDW+D@ED!P 2#U/N*0SLZ***8@HHHH *
M*** "N8\%?<\1?\ 8=N_YK73US'@K[GB+_L.W?\ -:0'3T444P"BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** (KK_CRN/\ KD__ *":
M^:U^X/I7TI=?\>5Q_P!<G_\ 037S6OW!]*UI=1H6BBBM1A1110 4444 .C_U
MJ?[P_G7TM7S3'_K4_P!X?SKZ6K*KT$PHHHK(04444 %%%% !1110 4444 %%
M%% $\/\ J_QJ2HX?]7^-25FR@HHHH *@F^_^%3U!-]_\*:W!D=%%%62%%%%
M!4=Q.MM:S7#@E8HVD8#K@#)J2D95=61E#*P(8'H0:0' OJVJW>@Z7<2+I_\
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M?\]$_P"^!3]GY!S>9I_VC?\ _0+?\S_A6FA+1JS#:Q&2/2N9_MN^_P">B?\
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M^\/YU]+5\TQ_ZU/]X?SKZ6K*KT$PHHHK(04444 %%%% !1110 4444 %%%%
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M_P"AGTG_ ,"EJIX!N8+VRURZM9DFMYM;NGCEC.5=25P0>XKIOL=I_P ^EO\
M]^E_PKG?!"JD7B%54*HUV[  & .5H&=11113$%%%% !1110 4444 %%9^M:D
M=(TJ6^$7FF,J-A;&<D#K7*_\+%;_ *!:_P#?[_ZU85,13INTF1*I&+LSMGGA
MB;;)-&AZX9P#3?M=M_S\P?\ ?P?XUYIJGB#3M9N5N+W1W:14V K=%>,Y_N^]
M4?M6A_\ 0%E_\##_ /$US2QROI8S===#UG[7;?\ /S!_W\'^-'VNV_Y^8/\
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MQG_R*MU_O)_Z$*\KKU3QG_R*MU_O)_Z$*\KKQLP_BKT./$?$%%%%<!@%%%%
M!1113 Z7P)_R,P_ZX/\ TKTVO,O G_(S#_KA)_2O3:]G ?P?F=N'^ ****[C
M8I:Q_P @2_\ ^O=_Y&O)QTKUC6/^0)?_ /7N_P#(UY..E=V$V9SU]T%%%%=9
M@%%%% !1110!9T[_ )"EG_UW3_T(5ZZ>IKR+3O\ D*6?_7=/_0A7KIZFN'%_
M$CHH;,2BBBN0W*&L_P#(*E^J_P ZY:NIUG_D%2_5?YURU=-'X3*>X4445J0%
M%%% !1110!>TC_D*P?4_R-=57*Z1_P A6#ZG^1KJJYJWQ&L-@HHHK(LBNO\
MCRN/^N3_ /H)KYK7[@^E?2EU_P >5Q_UR?\ ]!-?-:_<'TK6EU&A:***U&%%
M%% !1110 Z/_ %J?[P_G7TM7S3'_ *U/]X?SKZ6K*KT$PHHHK(04444 %%%%
M !1110 4444 %%%% $\/^K_&I*CA_P!7^-25FR@HHHH *@F^_P#A4]03??\
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MX4?\*ZT__H-^(?\ P8G_  KL**+L#C_^%=:?_P!!OQ#_ .#$_P"%'_"NM/\
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MR0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"C-%% !DTN3ZTE% !45S;QWEK+;3!C%*A1PK%3@^A'(^HJ6B@#.&@Z8-#711
M:@:>JA1"&(Z'=USDG/.<\UHDYHHH "2>IHHHH **** "BBB@ R?6ER?4TE%
M!DCH: 2.AHHH **** "BBB@ HHHH *,XZ444 &3G.:7)]3244@%))ZFDHHI@
M%%%% !1110 49.<YYHHH 4DGJ:3)QC-%% !DXQFBBB@ HR?6BB@!<GU-&3ZF
MDHH **** "BBB@ HHHH **** "BBB@ HHHH **** )X?]7^-25'#_J_QJ2LV
M4%%%% !4$WW_ ,*GJ";[_P"%-;@R.BBBK)"BBB@ HHHH ***S=:UVQT"UBN+
M[SRLL@BC6"!I79B"<!5!/8T@-*BL2P\5Z9J$5W*B7\$5I$997N[*6 !1U(+
M9^@IMMXNTJZET^*(7WFWX+0QM9R*P4'&]P1\BYZ$\&@#=HI2".HJ*ZN(;*UE
MN;F0101(7D=NBJ.I- $E%(A$B*Z<JP# X[&G8)&0#0 E%';/:N?UCQGI.A7A
MM;Y-1#@J-\5A+(A+= &48)]J .@HJGI6I0ZQ8B[M8KE(BQ7%Q;O"^1_LL :N
MX.,X.* $HI2".H-(WRJ6;A0,DGTH **BM;J"]M(KJVD$L$RAXW7HRGH14M,
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MTJ2M&AD0$*Y494'K@]LT^@ HHHI@%%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 3P_ZO\:D
MJ.'_ %?XU)6;*"BBB@ J";[_ .%3U!-]_P#"FMP9'1115DA1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110!/#_J_P :DJ.'_5_C4E9LH**** "H)OO_ (444UN#
M(Z***LD**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** )X?]7^-2445FR@HHHH _
"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>img17388848_18.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img17388848_18.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" %  7T# 2(  A$! Q$!_\0
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M,3?*/?CBFQ6UQ.CO#!+(B?>9$+!?J15W0$5%.ECDA8K+&\; 9VNI4_D:[)O
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M1O%UE8:5'97VAQW9B?>LL<QB9SG(WX^]^-1+#.*7+KM^O^8$GQ/_ .1UN/\
MKA'_ "KH_$6O0Z+H?AM9M&LM0,MD"&N5R4P%Z<=\UY_K^M3>(-9GU*=%C:7
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M_P#GP3_O\O\ C7M]%'UVIV0'B'_"NO$__/@G_?Y?\:/^%=>)_P#GP3_O\O\
MC7M]%'UVIV0'B'_"NO$__/@G_?Y?\:/^%=>)_P#GP3_O\O\ C7M]%'UVIV0'
MB'_"NO$__/@G_?Y?\:/^%=>)_P#GP3_O\O\ C7M]%'UVIV0'B'_"NO$__/@G
M_?Y?\:/^%=>)_P#GP3_O\O\ C7M]%'UVIV0'B'_"NO$__/@G_?Y?\:/^%=>)
M_P#GP3_O\O\ C7M]%'UVIV0'B'_"NO$__/@G_?Y?\:/^%=>)_P#GP3_O\O\
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M(_Y FG_]>L7_ * *;=Z?8_8;C_0;7_5/_P L5_NGVIVD?\@33_\ KUB_] %
M%RBBBF(**** "BBB@ HHHH **** .!^*/_'EI?\ UUD_]!%>;5Z3\4?^/+2_
M^NLG_H(KS:O3PW\-%(****W&%%%% %BP_P"0G9_]=X__ $(5] -]\_6OG^P_
MY"=G_P!=X_\ T(5] -]\_6N'&;H3$HHHKC)"BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@#$\1Z7+J4,#16<-TT);,;W#P.588(61>
MF>X/!IEI<Z[*8;:+08-,MHL+YEQ<K)M0<81$]N.2*T]3D$.E74AGFMPL1/FP
M)O=/=5P<GVP:YG2M=\2AM][I+7>G;T5;D*(;G#'&YH 6X'7.5..U(9V-%!ZT
M4Q!1110!#=_\>-S_ -<7_P#034.D?\@33_\ KUB_] %37?\ QXW/_7%__034
M.D?\@33_ /KUB_\ 0!2Z@7****8!1110 4444 %%%% !1110!P/Q1_X\M+_Z
MZR?^@BO-J])^*/\ QY:7_P!=9/\ T$5YM7IX;^&BD%%%%;C"BBB@"Q8?\A.S
M_P"N\?\ Z$*^@&^^?K7S_8?\A.S_ .N\?_H0KZ ;[Y^M<.,W0F)1117&2%%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &9XBCBF\-:
ME'/=BTB:W</<-TC&.IQV_P :YSPK=?VGXA-ZR6UN\-D+=8K6VGC61 1@LTB*
M/EQA0,D9-;WBLP#PEJQN1)Y/V9MWEXW?4$\#G')Z=:P/!NIZK-J9M-4U.6[<
MPRE5\R-T4QR;"<JBGN,$\'GTJ>HSMZ**P_&$MW#X9N'LV*/YD2R/DC9&74.<
MKR %SDCG&:8C=P>>#Q25YG)>S-IH$MQ<1I'!<C3GAFD*SW"R (4).6&,;58G
MC/4<UZ279(-\BL6"994&23CD =Z+C&7?_'C<_P#7%_\ T$U#I'_($T__ *]8
MO_0!5.[UJ,V5Q_H&J<Q/ULG]#5S2/^0)I_\ UZQ?^@"@"Y1113$%%%% !111
M0 4444 %%%% ' _%'_CRTO\ ZZR?^@BO-J])^*/_ !Y:7_UUD_\ 017FU>GA
MOX:*04445N,**** +%A_R$[/_KO'_P"A"OH!OOGZU\_V'_(3L_\ KO'_ .A"
MOH!OOGZUPXS="8E%%%<9(4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 5-594TF[9YQ HB;=*8?-"#'79_%]*XWP3#!:>(+B#2Y+>Y
ML9+8R2RP:3]DV2!AM!; W9!. .F#76Z]!=77A_4(+*3R[EX&$;B380<=F_A/
MOVKD/#NGPZOK,=W ^K16-M -R7&L--YDNX88!)&RO# D\'TJ>HSOZ***H044
M44 0W?\ QXW/_7%__034.D?\@33_ /KUB_\ 0!4UW_QXW/\ UQ?_ -!-0Z1_
MR!-/_P"O6+_T 4NH%RBBBF 4444 %%%% !1110 4444 <#\4?^/+2_\ KK)_
MZ"*\VKTGXH_\>6E_]=9/_017FU>GAOX:*04445N,**** +%A_P A.S_Z[Q_^
MA"OH!OOGZU\_V'_(3L_^N\?_ *$*^@&^^?K7#C-T)B4445QDA1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!C>+3"/"&KFX>2.$6KE
MWC4,P'K@XS[CTS7/>";.(:I)<_VOH5RZQ2".'23_  22!R6&<X!X4=LFMGQ'
MJ;:9J.E/*)VL)!.MPL4#2ACL&S<H![U%X/U>VU'3K6-[9XM4%LK71:Q: ;N_
M.T \]A2ZC.FHHHIB"BLMO$FBK;6]R=1A\FX+"*09(;:VTG@< 'C)X]ZU*0$-
MW_QXW/\ UQ?_ -!-0Z1_R!-/_P"O6+_T 5-=_P#'C<_]<7_]!-0Z1_R!-/\
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M$LC#9E0Q!/3BD!'=_P#'C<_]<7_]!-0Z1_R!-/\ ^O6+_P! %+=W5M]AN/\
M28?]4_\ RT7^Z?>H=)NK;^Q=/_TF'_CUB_Y:#^X/>CJ,T:*B^U6W_/S!_P!_
M%_QH^U6W_/S!_P!_%_QH$2T5%]JMO^?F#_OXO^-'VJV_Y^8/^_B_XT 2T5%]
MJMO^?F#_ +^+_C1]JMO^?F#_ +^+_C0!+147VJV_Y^8/^_B_XT?:K;_GY@_[
M^+_C0!+147VJV_Y^8/\ OXO^-'VJV_Y^8/\ OXO^- '#?%'_ (\M+_ZZR?\
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M!_W\7_&C[5;?\_,'_?Q?\:XB26BFHZ2+N1U=?53D4ZF 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% %:[TZROWA>\M(9VA;=
M&9$!V'V_(?E5AU6165U#*PP589!'O2T4@*7]CZ7_ - RQ_\  9/\*/['TO\
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MZ=*OZAJ=GI<227<NSS&V1JJ%W=L9PJJ"3QZ"J$GBS1(HX9#>EDEB,RE(7?"
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G HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>img17388848_19.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img17388848_19.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" *)!98# 2(  A$! Q$!_\0
M'P   04! 0$! 0$           $" P0%!@<("0H+_\0 M1   @$# P($ P4%
M! 0   %] 0(#  01!1(A,4$&$U%A!R)Q%#*!D:$((T*QP152T? D,V)R@@D*
M%A<8&1HE)B<H*2HT-38W.#DZ0T1%1D=(24I35%565UA96F-D969G:&EJ<W1U
M=G=X>7J#A(6&AXB)BI*3E)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&
MQ\C)RM+3U-76U]C9VN'BX^3EYN?HZ>KQ\O/T]?;W^/GZ_\0 'P$  P$! 0$!
M 0$! 0        $" P0%!@<("0H+_\0 M1$  @$"! 0#! <%! 0  0)W  $"
M Q$$!2$Q!A)!40=A<1,B,H$(%$*1H;'!"2,S4O 58G+1"A8D-.$E\1<8&1HF
M)R@I*C4V-S@Y.D-$149'2$E*4U155E=865IC9&5F9VAI:G-T=79W>'EZ@H.$
MA8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4
MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#W.*+%650"
ME50*=0 4444 %%%% !1110 4444 %%%% !1110 45GZYJ\6A:/<:E/&\D< !
M*IU.2!_6N,_X6[I7_0/O/_'?\:TA1G-7BK@>AT5YY_PMW2O^@?>?^._XT?\
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M !H^K5?Y0N>AT5YY_P +=TK_ *!]Y_X[_C5O3/B=INJ:I;6$5E=(\[A%9MN
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MST.BO//^%NZ5_P! ^\_\=_QH_P"%NZ5_T#[S_P =_P :/JU7^4+GH=%>>?\
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M?^._XT?\+=TK_H'WG_CO^-'U:K_*%ST.BO//^%NZ5_T#[S_QW_&C_A;NE?\
M0/O/_'?\:/JU7^4+GH=%>>?\+=TK_H'WG_CO^-'_  MW2O\ H'WG_CO^-'U:
MK_*%ST.BO//^%NZ5_P! ^\_\=_QH_P"%NZ5_T#[S_P =_P :/JU7^4+GH=%>
M>?\ "W=*_P"@?>?^._XT?\+=TK_H'WG_ ([_ (T?5JO\H7/0Z*\\_P"%NZ5_
MT#[S_P =_P :/^%NZ5_T#[S_ ,=_QH^K5?Y0N>AT5YY_PMW2O^@?>?\ CO\
MC1_PMW2O^@?>?^._XT?5JO\ *%ST.BO//^%NZ5_T#[S_ ,=_QH_X6[I7_0/O
M/_'?\:/JU7^4+GH=%<!;_%?2[FZB@6PNPTCA 3MP,G'K7?UG.G.'Q*PPHHHJ
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#F/B)_
MR(FI_P"ZG_HQ:\#KWSXB?\B)J?\ NI_Z,6O Z]; ?PWZDL****[1!1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5M>$/^1PTK
M_KX'\C6+6UX0_P"1PTK_ *^!_(U%3X'Z#/HFBBBOGR@HHHH \+^)O_(\W/\
MUQB_E7(5U_Q-_P"1YN?^N,7\JY"O>H?PH^A+"BBBM1!1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 5[)\)/\ D6[G_KY/\A7C
M=>R?"3_D6[G_ *^3_(5R8W^$-'?T445XY05A^,O^1,UC_KU?^5;E8?C+_D3-
M8_Z]7_E5T_C7J!\\4445] 0%%%% !1110 4444 %%%% !1110 4444 %%%%
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M3Q# EPRX&GV\?ROQWSD_C6=9*J_&*^V@#=8Y..YRM0L5+6ZZ7'8\OC\+:]+
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MF[^%M>CDDC;2;H-&-S?(>!ZYK:T>VTUO!%_+/HUS/>*7V72QY1/3)SQBNR\
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M?]#QG;M^?[VWIGU]ZR_#MOX3\3>*)([+22EK%9EFCE&,OO49X)[&GQ?\D/\
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M,AQ-=RQY(*K_  \XP!S70SR0W?P\U@?VK_:PCAE!N"H'S!<X'THEB)QE9I=
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M/2N?HI^RCR<G0#TE_B7I,CL[^%X6=CDL64D_^.UFKX\M(?%,&L6VC+!'%;-
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MHHKR"@K#\9?\B9K'_7J_\JW*P_&7_(F:Q_UZO_*KI_&O4#YXHHHKZ @****
M-+0M:N?#^JQW]K@NN0RMT93U!KO?^%I:6THNG\/@W@'$F5S_ -]8S7F%%93H
MPF[R0[G17OBVYU'Q9:ZY<Q BVD5D@4X 4'.,_P!:/$7B===\20:LMJ81$J#R
MR^<[23UQ[USM%-4H)II;: =S>?$)+KQ7I^M#3F46D3QF+S<EMW?..*SO^$UN
M8/&-QK]I"(Q/@/ [9!7 &,_A7+T5*H4UTZ6"YZ4WQ0L8C)=6GA^*/4)%PTQ*
M\_4@9-<[H?CC4-(UJZU"4"Y%V<SQL<9],>F.E<O10L/32:MN%ST.\^)=NEA/
M!H^C1V4UP#OD&!R>IP!R:Q6\8!O X\._9&#@Y^T>9_M;NF*Y:BA4*:V7F%SK
MM3\:KK/A6'2;^Q,EU"!LNO,Z$<9QCTX-<C115PA&"M$#J] \9+HGAN]TDV1F
M-R7(D$F-NX8Z8IG@WQ>WA5[E'M?M%M<8WJ&P01W'YUR]%2Z,&FFMPN>C6_Q+
ML+&.>VLO#T<%K(#\L;A22>I/%8?_  F$8\$OX=6Q8;B<3>9T&[=TQ7*T4EAZ
M:Z!<[WX8C5!>WCZ;-;%0H\VWG)&\=B" <5Z)HEUJ!O;PW>B0Z7:(I8NK F5\
M\G( XQFO!;.]NM/N!<6=Q)!*.CQL0:T;SQ5KU_ 8+G5+EXF&&7=@$>^.M8UL
M,ZDF]-03-S2/'+Z)>:G;R6J7NG7-Q(_EL<=6/3V(I=<\=V]YHC:1I.DQV%L_
M#'C..^ !Q7%45M["'-S6"YWFG?$&U@\,1:1?Z.MWY*;4+,-I]#@C@BF:3\0(
M8M%BTK6M*34((<!&8C.!TR"*X:BE]7IZZ!<ZOQ)XWN-:GM/LELMC#:.'B5/O
M;AT.?;TK<?XGVUQ##-=:##-J$(_=S,00I]1QD5YQ13>'IM)6V"YT_C#Q</%3
M6C?9#;F!2#E]VXG'MQ7,445I""@N6.P'5IXR5? O_"-_8CNP1Y_F<?>W=,?U
MJKX/\3+X6U.>\:U-P)8?*VA]N/F!ST/I7/45/LH6<;;@='HOBA=(\67.MFT,
MHF:1O*#XQO)/7':M#3?B!<:=KFHWBV@DL[Z3>]LS=#C'!Q_2N,HI2HPEN@.[
MU/X@6K:-/IVC:-%8+.#O88XSUP .OO6;=^+UN?!4'A_[$5:(C]]YG!P<],5R
MU%)4(+IYA<Z_PGXV7P]IUQIMW8B[LYF+%<X(R,$<]0<5I2?$>R_LB[TN#04@
MLY8VC1(I NT,""3QS7GU%$J%.3YF@N>S#64T/X9:7<S6:7<+(D<D+]&4YKC?
M$GCT:MHPTC3;!;"R. ZJ1R.N  .!FN7EU;4)[!+&6\F>TCQMA9OE&/:J=13P
MT8OFEO>X7.MUCQL=2\/Z5IL-HT$M@T;+-YF=Q1=O3''K6S'\3+*X$$^J:#%<
M7T ^28$<'VR.*\YHJWAZ;5K!<["/X@WR>*'UC[/%L:/RC;]MF<]?7WK6'Q)T
MRTDGN].\/)#?3CYY2PP3[X'-><T4GAZ;Z!<FNKF6\NYKF9MTLKEV/N:AHHK8
M04444P+>E_\ (7LO^NZ?S%?3':OF?2_^0O9?]=T_F*^F.U>9C]XE(****\\8
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 <Q\1/\
MD1-3_P!U/_1BUX'7TOJFF6VL:;-87BEK>8 .%.#P0>OU%<U_PK'PS_S[3?\
M?XUW8;$PI0<9":/#:*]R_P"%8^&?^?:;_O\ &C_A6/AG_GVF_P"_QKI^O4O,
M5CPVBO<O^%8^&?\ GVF_[_&C_A6/AG_GVF_[_&CZ]2\PL>&T5[E_PK'PS_S[
M3?\ ?XT?\*Q\,_\ /M-_W^-'UZEYA8\-HKW+_A6/AG_GVF_[_&C_ (5CX9_Y
M]IO^_P :/KU+S"QX;17N7_"L?#/_ #[3?]_C1_PK'PS_ ,^TW_?XT?7J7F%C
MPVBO<O\ A6/AG_GVF_[_ !H_X5CX9_Y]IO\ O\:/KU+S"QX;17N7_"L?#/\
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M/KU+S"QX;17N7_"L?#/_ #[3?]_C1_PK'PS_ ,^TW_?XT?7J7F%CPVBO<O\
MA6/AG_GVF_[_ !H_X5CX9_Y]IO\ O\:/KU+S"QX;6UX0_P"1PTK_ *^!_(UZ
MQ_PK'PS_ ,^TW_?XU8L?A[X?TZ^AO+>"430MO0F4D U,\;3<6M1V.IHHHKRA
MA1110!X7\3?^1YN?^N,7\JY"OH#5_ ^B:YJ+W][#(T[*%)60@8'3BJ/_  K'
MPS_S[3?]_C7IT\93C!1=]!6/#:*]R_X5CX9_Y]IO^_QH_P"%8^&?^?:;_O\
M&M/KU+S%8\-HKW+_ (5CX9_Y]IO^_P :/^%8^&?^?:;_ +_&CZ]2\PL>&T5[
ME_PK'PS_ ,^TW_?XT?\ "L?#/_/M-_W^-'UZEYA8\-HKW+_A6/AG_GVF_P"_
MQH_X5CX9_P"?:;_O\:/KU+S"QX;17N7_  K'PS_S[3?]_C1_PK'PS_S[3?\
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MQX;17N7_  K'PS_S[3?]_C1_PK'PS_S[3?\ ?XT?7J7F%CPVBO<O^%8^&?\
MGVF_[_&C_A6/AG_GVF_[_&CZ]2\PL>&T5[E_PK'PS_S[3?\ ?XT?\*Q\,_\
M/M-_W^-'UZEYA8\-HKW+_A6/AG_GVF_[_&O+_&7AE_#6LM"@8VDOSP,?3N/J
M*TI8F%1\J"QSM%%>C^!OA_;:MIK:CK"2&.7B"-6*G']XUI4JQIQYI ><45[E
M_P *Q\,_\^TW_?XT?\*Q\,_\^TW_ '^-<_UZEYA8\-HKW+_A6/AG_GVF_P"_
MQH_X5CX9_P"?:;_O\:/KU+S"QX;17N7_  K'PS_S[3?]_C1_PK'PS_S[3?\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110!SOC'PU'XET5X5PMW%EX'/8^GT->4>#_",^MZ^T%W&T=M:/_I.
M1W'\/X_RKWFHXK>&!I&BB1&E;<Y48W'U-=%+$RIP<$*PZ.-(HUCC4*BC"J.@
M%.HHKG&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% 'B_Q'\*'2=0.J6<?^AW+?.JC_5N?Z&NS^'GA0:'I
MGVZZ3_3[E<G/_+-.R_XUV,]O#<Q^7/$DB9!VL,C(Z5)73/$RE34!6"BBBN88
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 5B^*?#\/B/19;-P!*/FA<_POVK:HIQDXNZ \%\+>$+G5O$KV-W"\
M<-H_^E9[8/W?QKW>*)((DBB0)&@"JH'  I(X(HI))(XU5Y#EV Y8^]25M7KN
MJ[L204445@,**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BH+B9HIK95QB23:V?3:3_2IZ "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M1;^!5GACMV"W+LQ .T_,>3T(H ^D**** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M+_KL?_0&JW0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M44 %%%% !1110 4444 %%%% !1110 4A (((R#VI:* $5510J@ #H *6BB@
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MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ IKNL:,[L%51DDG
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M&%%%%( HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MHY6!UE%>4^$/B%K-S-%875C)J.<#S85PX^O;^5>J@Y )!&>Q[42BXNS 6@G
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MLY7>('Y68$8)KJ*YV[U6:+QWIVEB*$PS6LLK.5^<$=@?2JB!T5%%%2 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !4<\$=S;R02C='(I5AG&0:D
MHH J6&F66EVX@L;:.",#HBXS]?6K=%% !2,,J12T4 5**EDC_B'XU%5IDA11
M13 **** "BBB@ HHHH **** *FJ)=RZ5=QV!07;Q,L)D.%#$<9->>^'?@WHL
M.C*OB*W%WJCLS2RQ3N%&3P!@C/Y5Z;12 \>/PP\1IX.O_#L=S8M";Y;FS9I&
MX0'D-\O!QBM&^\&^-_$]M:Z9XAU/3(=)B93)'9ABT@7H#D5ZA1189P7B?P+>
MRZQIVN^%KJ&SU&QB$ CF!,<D8& #^'%1:+X2\47?BD^(?$NIPQSQPF*"WLB=
MB<<$@\<9SWKT*BBPCQK5/AGXGU?=;7BZ)(YFW_VJJ&.?;GH54 $UZ]8VWV.P
MM[7S#)Y,:Q[VZM@8S4]%%@"BBBF 4444 %%%% !1110 4444 %%%2QQY.3TI
M 21C:@%.HHJ"@HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHIDN\0OY?W]IVY]>U ',>+_&D'@^[TMKZ!FL;N1HI9E_Y9'C!^E8&O_%NP
MAO(M,\-6[ZQJ$K 9B!,:#USWKG]8MOBOK=C<:??:/IL]I+D%7V=.Q'/!]ZR?
M"7A7XE^#WD&FZ59A9V'F-(T;,!['.: /?8BS1(7&&*@D>AIU-CW&)-_W]HW?
M6G4 %,EECAC,DLBH@ZLQP!3Z\X\</=ZCXVTC1H]-3481:R7(MII=D3/G&7/.
M0!VQWH ]#,\2P^<TJ"+&=Y8;<?6D:Y@2#SWFC6'&?,+ +CZUY5IL=IJ0T'09
M+26"S&H7(O+&63>JR1@$(#W3YL@5(FD7,UQKNB:=:QW=AINIPW$=A*^U'1DR
MT8)X !YP>* /4C<0K&DC31A'(",6&&)Z8]:DKRK3;R'3KC3[+5%=H-(D<^3;
MJ90;E]S!%QU$:'KVKTZRO(-0LH;RV??!,@=&]0: ([S_ (^;+_KL?_0&JW52
M\_X^;+_KL?\ T!JMT %%%% !1110 4444 <E\11GPRO_ %\)_(UY3MKU?XAC
M/AI?^OA/Y&O+,5Z>$_AB9'MHVU)BC%=(B/;1MJ3%&* (]M&VI,48H CVT;:D
MQ1B@#;\&Z>NH>)K9) "D696![XZ?J16G?:X\/Q&-UNQ'#+]G([;>A_7FH/ 4
MZ0>)T5SCS8FC7Z\'^E9GB6W:W\2Z@C#&9F8?0\BN=KFJM/L,Z?QEH9O/%&GR
M1K\EZ0C$>W7]*N^*)([S7]'T$ >0KAY4['T'Y#]:V/#=]#JGA^TNKC:9;<$,
MS=5(&,_E7G%WK;R^*FU< D+-N5<_PCC'Y5C34I/E?V;@=#X]UJ]M;^'3[2=[
M>%(PQ\H[23]1VK%NO&%Y>Z!_9=U$DQ(P9G.6Z\'ZUU>M:':^,4@U'3KV-90N
MU@W(Q[^AJCK.C:1I.@Q::J17&JRL%C<<-N)ZGV^M.G*G:,6M0$\#6J:7HU]K
MMP,#:0F?0?XGBIO%T::]X3M-9A7YHP&8#LIX(_ UHZIJUOX1T:QL5MDN25VE
M"V!QU/?O2Z!XBMO$D5WI\EFEL/+/R!LA@>#V%9MR<O:VZ_@!4\&0SS^";F&V
MD\N=WD"/G&#V.:L>'M)U[2;M[G5]6$MJ(R"C2L_/KSTJ#2+=]-\':M;%MLD+
MRJ"#SQTJIX-UT:C;R:)JK^<'7$9D.=P[J33DF^9K:X&1=^*3IWBK4;[3(X7C
MFPFYEZX[CZFNNL8[RS\+WUQ=W;ZA+/&9/+7YMF1]T5SMKX6TRW\1W&G:G(PC
M<;[1@^T,/0^];NAZ2/",.H7-]>QM _W%![#/KW-.JX62COI\P./T+6]0-LFA
M6LD5LL[D>?R&3/).:Z7QH)+7PA:V;M)=MN4-<D9''<GU-96C>']+U_2+AX)O
M*U/>Q"L^ .<CCTQ6IK"Q:#X&&E75RDUTXPJ@Y[YX]A53<?:*V]]OU IW\?\
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M2 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MFZG&OFE9KJS8*A;/)"FMR70O '@[2M+\46MO<ZW#<7*QPEYQA6Y.2,=1CH:
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MJ12O]HW)DC!'_+-?E4UU5,BB2")(HE"1HH55'0 4^N*<N:5S4****D HHHH
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M.AGP^O\ UW7^1KSC;7I/C@9T!1_TW7^1KSK8?2N_#? )D>VC;4FP^E&P^E=
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MQ6V-2\^[U5@_E6]PCLL9. 6R,?C1I&GA/WEQ=QQQ,BR"(R[/-(/ -4YM+4#
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M !1110 4444 %%%% &#XMN([;1A)(&*^:H^7Z&N(_M>U_N2_D/\ &NN\>?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\_Y%Y?\ KNO\C7FM>I@_X9R5OB"BBBNHQ"BBB@ HHHH **** "BBB@ HHHH
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M:UZ5X\_Y%Y?^NZ_R->:UZF#_ (9R5OB"BBBNHQ"BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** +%
MA_R$K3_KLG_H0KVFO%]/_P"0G:?]=T_]"%>T5Y^-W1TT-F<WXMZZ5_U^)_,5
MTE<WXMZZ5_U^)_,5TE<T_@C\S5?$PHHHK(L**** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBHIKB"VC+SS1Q(.K.P _6@"6BN2U+XB:)8ED@=[N0=HA\O
MYG^E<=JGQ*U>\!2RCCLXS_$!N?\ ,\?I6\,-4ETL%SUF>X@MHS)/-'$@ZL[
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M(!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M;I=UM2_BDM'/\7WE_3FNQM;VUO8A+:W$4R'HT; UQSISA\2&3T445 !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4R4.87$9PY4[
M2>Q[4^B@#RR_T_XEVN@*TGB73;>Y6Y=GGE*JGE$#:N2G7.:S?L7Q4AOK:WG\
M7:0LDWS)$60-(O?:-G-7/C9C;X>^W-,NC?;/]+,6>!Q_3.*P/B9KWA?7(=%?
MP]?O<ZW;S1QVWD[OE3WSWSCWH ]VC#") YRX W'WIU1V^_[-%YGW]@W?7'-2
M4 %<]XFN=8@\C[!=6>GV2JSW5]<X;R\= %)'7UKH:Y[Q'-K4$]N]EI46JZ<R
MLES:Y59,_P + L<$>HH P+7Q;K&JZ/HL%L;>+4-2GEC%UL+1^7'G,BJ3W&,#
MWJ*X\7:O!:7>FW-U;VU]::A':S:@(OW:Q.-PDVG@'MZ5%9>&M<TFSL-4AT]'
MN+:^FN!IB2J/+AE&"BL>,C /I6_X9TB[C;6=7U:S6.?4YA)]C)#[$1<*I(X)
M[T 4](\1ZEK":-:K-&D[EY[R94&#"C%5(!Z;R!^&:[>O,K_PYJ+V<.IW&F3W
MDMW<O+>64+A61-A6%!R!A>"1GJ2:[KPY;7=GX<T^WOV+7<<"K*2VXYQZ]Z +
M%Y_Q\V7_ %V/_H#5;JI>?\?-E_UV/_H#5;H **** "BBB@ HHHH YCQY_P B
M\O\ UW7^1KS6O2O'G_(O+_UW7^1KS6O4P?\ #.2M\04445U&(4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110!9T__D)VG_7=/_0A7M%>+Z?_ ,A.T_Z[I_Z$*]HKS\;NCIH;,YOQ
M;UTK_K\3^8KI*YOQ;UTK_K\3^8KI*YI_!'YFJ^)A1116184444 %%%% !111
M0 4444 %%%% !117,^.=5O-(T 3V,OE2M*J;L X!SZU4(N4E% =#/<P6R%YY
MDB0=2[ "N8U/XA:+8ED@=[N0=HA\OYG^E>375[=WTA>ZN99F/=V)JOBN^&#B
MOB8KG8ZG\2=6NP4LHX[-#_$!N?\ ,\5R=W?7E\Y>[N99F/=V)J+%&*ZH4X0^
M%"&8]J,4_%&*L!F*,4_%&* &8HQ3\48H 9BC%/Q1B@!F*,4_%&* $CB>618X
MT+.QPJCJ377I\-M9>V$C26R2E<B%GY^E9O@\1_\ "6:=YN-OF<9]<<5Z)JDE
MC%XNA=K35IKX*#'Y)'E$?B1^-<U:K*,N6(SE?A[926WBN[MKN#;+'"0R.,X.
M:R=7TF^;Q9<NEC.8C=@@K&<8R*[C2IQ<_$6[E^RS6[&T 9)0 V<]>":R=0\?
M:O:^()K&..U,27'E E#G&0/6LU.;J-Q71 7_ !E86ESXA\/VTZ*D$LA5\#&1
MZ5I:U?W^@RQ1Z=H"7%@%&]XQR/; JAXWT_\ M;6=%LS.(#*7VR8S@\8J"XU;
MQ3X;ODLGA.J6^!Y<OEG+>V1W^M917-&/7R PO%KZ-K>IV0TE3'>2N(YD\HIU
MZ$@CJ*Z/5M2T_P !6=I966GQ37,B[F9N,XZDGKUI_B\6MM+HNLRP+#=+<)O!
MZ[>X/KBL_P"(ND75]<6>HV<+SP^7L;RQG'.0?I5Q:GR1>VH%;6]=\.^(O#1E
MN$6UU1<^6BH2VX>X'0^]>?X]JZX^")H?##ZM>W'V6106\EUZCM^)KE,5U4>5
M)J# 9BC%/Q1BM1#,48I^*,4 ,Q1BGXHQ0 S%&*?BC% #,48I^*,4 :&G^(=7
MTM@;2^E11_ 3N7\C78Z=\4)EVIJ5DK^KPG!_(UY]BC%9SHPGNAGN&F>+]$U4
M 0WBQR'_ )9S?(WZ\'\*W%8, 5((/<5\YXK3T[Q!JVEN#:7TJ+G[A.Y3^!XK
MDG@E]EA<]ZHJ&UD:6S@D?[SQJQ^I%35P#"BBB@ HHHH **** "BBB@ HHHH
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M_P"1>7_KNO\ (UYK7J8/^&<E;X@HHHKJ,0HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@"SI_P#R
M$[3_ *[I_P"A"O:*\7T__D)VG_7=/_0A7M%>?C=T=-#9G-^+>NE?]?B?S%=)
M7-^+>NE?]?B?S%=)7-/X(_,U7Q,****R+"BBB@ HHHH **** "BBB@ HHHH
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M:>@VUI:^-]4CL@JPB%?E7H#GD"FZ1X7N[#Q=/J4KI]E^=E8-RV:J55W?O6T
MJ^"K.73UUVTF_P!9$=IQWX-8.@Z!IE[9W%]JFH+!$CD"-6&[CN1UKKM#N([O
M4O$4\)!C9@ 1WPN*I>&-+MQX<EOK6T@N]1+-@2\@$'I[4<[7,]F[ 8^O>%=/
MMO#_ /;&E7,DD0P2K]QTS5V7P7HUKIUK?WFHRP0NBM)NQR2.@K;U]+V3P)=?
M;5C%SLRZQ=%&>E97C<9\+Z0.WR_^@40J3E97ZL#/UKPCI^G_ &&\ANW.GSR*
MLC,0=H/0@UT'C.RTZ;1+59;DQO&,6JCI(V  *S]>'_%NM.SV,=7/%>ES:IHF
MFS0,@C@4/(Y/W5VCFES-N+D^K SV\%Z-IMO -4N[@2RCED7Y%/UQQ^-<MX@T
MJVTK4/)M+Q+J%EW!E()7V.*]+MWUNTM[5%%OJENZ@-(IV$#U[@\5R?CZRL+?
M4+<VL:1SNI,JH,#V)'K54:LG.S=_Z_ #BL48J;91LKLN(AQ1BIME&RBX$.*,
M5-LHV47 AQ1BIME&RBX$.*,<CZU-LI0G(HN,]SL?^0?;?]<E_D*L5!9?\>%O
M_P!<E_D*GKQ7N,****0!1110 4444 %%%% !1110 4444 %%%% '/^-O^12O
MO]T?S%>,8KV?QK_R*=[]!_,5XWBO2P?P/U$QF*,4_%&*ZQ#,48I^*,4 ,Q1B
MGXHQ0 S%&*?BC% #,48K<\.MHJ7$QUM&:+9^[V@GG/M7:MHWA%-%&K&V?[(?
MXLMGKCI6,ZR@[-,9Y=@48KT/2M+\,ZUK;164#M;I 68,2/FS7*7FA7ZSW,D%
MA<&U21@K!"1@&G&JF[; 8^*,5-#!+<2K%#&\DC' 5!DFK%WI=_8*K7=G-"K=
M&=2 ?QK2ZO81N:/XVN-,TQ=/GLXKNW084.<<>GO4.N>,+K6;%;%+>*UM002D
M??'0?2LF'2M0N(4FALIY(W.%=4)!/UIQT?41=_9/L,_VC&[R]ASCUK+DIJ7-
MU&9^*,5?N])U"P0/=V<T*'C<ZD#\Z$TG4)(XY$L;ADE^XPC)#?2M.9;W$4,4
M8JY=Z?>6#*MW;2PENF]2,_2MW7++3(- L9K6TGBN'QYDCHP5N.Q/%)S2MYC.
M6Q1MK0M]'U*[@\^WL;B2+^\J$@_2JHAD,OE"-C)G;LQSGTQ5<R$0XHQ6G-H6
MJP0F:73[A8P,EBAXK/Q0I)[ ,Q1BGXHQ3 9BC%/Q1B@!F*,4_%&* &8HQ3\4
M8H :H^=?]X?SKZ$C_P!4GT%?/RCYU_WA_.OH&/\ U:?05PXW[(T.HHHK@&%%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5Q?
MCO7=5LFM=+TNSU#_ $H$W%]:VC3>0GHH ^^>WI7:44 >;I!;Z?!X?U/2]*U3
M[%IT\T=PDULPG/F*,R%2,MSU-7M"T:'6)/$6J:OI[+8ZC<(\,%RA5]D:X#D=
M02<^]=U10!Y3):W-E;V^K@7EA97DK1JMG$2]M;HI\I,8)&YOF/UKT/P[+>S>
M'=/DU$,+QH%,P88.['<=C6G10!4O/^/FR_Z['_T!JMU4O/\ CYLO^NQ_] :K
M= !1110 4444 %%%% ',>//^1>7_ *[K_(UYK7I7CS_D7E_Z[K_(UYK7J8/^
M&<E;X@HHHKJ,0HHHH **** "B@ DX R:4JPZJWY4 )1110!:TVZ%EJ5M<L,K
M'(&/TKH=3\-W6IZI+>Z>\,MK<MY@DW@;<]<URE*&8 @,0#U -1*#;YHO4I-6
MLSL;>VL535-'TRX#3RQ( [.,2,.H!J?2X6TFSL-/O7474EZ)$BW E%Q^E<-T
MZ4I))R22?7-9NBWI<I3\CJ[:9_MGB9O,.3&W.?\ :J]X=.=.T$9Y^T3?R-<+
M5S2M0;2]1BO%3S#'GY2<9R,43HWB[?UI8(SU.ECL9]$BUBZU!T$4\;1QC?GS
M6/3%:D-Q$MVELWE&:?346-9&P'.3\N:\]EE:61G)/+$XSTS3/QI.AS;L:J6V
M1VUTTECID,-S;6=D)+E&$*,2W!^]UXJ_Y9BU'6+=HX9);S$L"2/@2KZ9KSMB
MQPS%CGH32D/@,0V!T)S1[#S#VGD=5X@:6V\/PV<]O:VK-+O6WB)++[]:Y.G8
M=SGYF/KUI"".H(^HK6G'E5B).[$HHP?2EP<9P<>M62)15V;2+^WLQ=RVSK <
M'<<<9Z9':J5)-/8;36X4444Q!1110 4444 6=/\ ^0G:?]=T_P#0A7M%>+Z?
M_P A.T_Z[I_Z$*]HKS\;NCIH;,YOQ;UTK_K\3^8KI*YOQ;UTK_K\3^8K<OH9
MKBPN(;>;R9I(V5),?<8C@_A7-/X(_,U7Q,L5PWBOQU?Z3XCM?#VB:/\ VCJ4
MT)G(>38JH/YUD'X<>*[!Q)I7CJ\WR#$PNE+#/<KS^E<UXKL(I?'^B^']6UMM
M/BL]-.=6+!))GQW8GOSQ619U$OQ89O :>((-,"W"WZ64UO))D*Q)!(8#GI7H
M*:I9&>*V>[MUNY$#" R#><C/3K7SF]Y))\%KBUCCC*VFN1I#.JX\_DD,?4UV
MGPO46/C75;+Q)%N\32(LL=Q(V[?$0.$].W2@#V2BBB@ HHHH **** "BBB@
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M(PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** *EY_Q\V7_78_^@-5NJEY_P ?-E_UV/\ Z U6Z "BBB@
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MQ,****R+"BBB@ HHHH **** "BBB@ HHHH *PO%8SI*_]=5K=K&\3#.F*/\
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MGZRN-.8_[0K9V>U9NNKC2W/^T*[:;]Y$3^%G*4445WG"%%%% !1110 4444
M%%%% !1110 445?73"VAR:GYH"I*(O+QUSWS2;2W&E<H45?M-,-WIE[>B4*+
M4 E<?>S6@GAR".&$W^JPVDTRADB*EC@],GM4NI%;C46S HK6_P"$=OCK)TU=
MAD W>9GY=O\ >SZ5;_X1F"<21V&JPW5U&"3"%VYQUP>])U8+J'(SGJ*Z'3O#
M=MJ&R--6B6X*DM#Y9RN.HJ)M,TJTN$\S4?M8.1Y4*[26[#)Z4>UC>P<CW,.B
MM37].CTR_2*(,H>)9"C'.TGMGO675QDI*Z$U9V"BBBF(**** "BBB@ HHHH
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M?8YNBND_X1";_G[3_ODT?\(A-_S]I_WR:/;T^X>RGV.;HKI/^$0F_P"?M/\
MODT?\(A-_P _:?\ ?)H]O3[A[*?8YNBND_X1";_G[3_ODT?\(A-_S]I_WR:/
M;T^X>RGV.;HKI/\ A$)O^?M/^^31_P (A-_S]I_WR:/;T^X>RGV.;HKI/^$0
MF_Y^T_[Y-'_"(3?\_:?]\FCV]/N'LI]CFZ*Z3_A$)O\ G[3_ +Y-'_"(3?\
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MYT<K OT50_M-?^>1_.C^TU_YY'\Z.5@7Z*H?VFO_ #R/YT?VFO\ SR/YT<K
MOT50_M-?^>1_.C^TU_YY'\Z.5@7Z9(,KBJ?]IK_SR/YT?VFO_/(_G1RL"?RZ
MP/&28\.2G_IHM;']II_SR/YUF:Z/[8TM[1/W99@=QYZ5I2NIILF:O%I'F%%=
M)_PB$W_/VG_?)H_X1";_ )^T_P"^37I^WI]SD]E/L<W172?\(A-_S]I_WR:/
M^$0F_P"?M/\ ODT>WI]P]E/L<W172?\ "(3?\_:?]\FC_A$)O^?M/^^31[>G
MW#V4^QS=%=)_PB$W_/VG_?)H_P"$0F_Y^T_[Y-'MZ?</93['-T5TG_"(3?\
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M>WI]P]E/L<W172?\(A-_S]I_WR:/^$0F_P"?M/\ ODT>WI]P]E/L<W172?\
M"(3?\_:?]\FC_A$)O^?M/^^31[>GW#V4^QS=%=)_PB$W_/VG_?)H_P"$0F_Y
M^T_[Y-'MZ?</93['-U+;?\?<'_71?YBM_P#X1";_ )^T_P"^33XO"<T<T<AN
MD.Q@V-OH:'6I]P]E/L>B&/DTGEU7_M-?^>1_.C^TU_YY'\Z\FTCM+Q947+$
M#N3BJE[<0&QN )H\^6W\0]*K7=S;7UL]M<6Y>)QAEW8S^59/]AZ!_P! UO\
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MHH H:G]R/ZFLVM+4_N1_4UFUM#8 HHHJ@"BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !02 "3T%%(P#*5/0C!H
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ME[I4,.LVUL\L*QL=K8'/?L.0<UG_  <OM7F%W');B2PDD:26Z=B7\W'2CFU
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_//]16S11SL#&^PW/_//]11]AN?^>?ZBMFBCG8&-]AN?^>?ZBC[#<_\ //\
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IE% "T4E% "T4E% "T4E% "T4E% "T4E% "T4E% "T4E% "T4E% '_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>img17388848_20.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img17388848_20.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" (I!- # 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M_ 9_\*!XPT?/,LZCU:W< ?I4\LOY/S T-.U>RU1&-K+EDX>-AM=#Z$'D5>K
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M*P+M%4O[23_GFWYBC^TD_P">;?F*.5@7:*I?VDG_ #S;\Q1_:2?\\V_,4<K
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M\Q5N-Q)&K@8R.E#30#J***0!45S_ ,>LO^X?Y5+45S_QZR_[A_E36X'/V/\
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MV%A! Y&"RKS^=:=&1ZT9'K0VV[L HHR/6C(]:0!11D>M&1ZT %%&1ZT9'K0
M449'K1D>M !11D>M&1ZT %%&1ZT9'K0 449'K1D>M !11D>M&1ZT %%&1ZT9
M'K0 449'K1D>M !11D>M&1ZT %%&1ZT9'K0 449'K1D>M !11D>M&1ZT %%&
M1ZT9'K0 449'K1D>M !11D>M&1ZT %%&1ZT9'K0 449'K10 4449% !11D>M
M&1ZT %%&1ZT9'K0 449'K1D>M !11D>M&1ZT %%&1ZT9'K0 449'K1D>M !1
M1D>M&1ZT %%&1ZT9'K0 449'K1D>M !11D>M&1ZT %%&1ZT9'K0 449'K1D>
MM !11D>M&1ZT %%&1ZT9'K0 449'K1D>M !11D>M&1ZT %%&1ZT9'K0 449'
MK1D>M !11D>M&1ZT %%&1ZT9'K0 449'K1D>M !11D>M% !111D>M !11D>M
M&1ZT %%&1ZT9'K0 449'K1D>M !11D>M&1ZT %%&1ZT9'K0 449'K1D>M !1
M1D>M&1ZT %%&1ZT9'K0 449'K1D>M !11D>M&1ZT %%&1ZT9'K0 449'K1D>
MM !11D>M&1ZT %%&1ZT9'K0 449'K1D>M !11D>M&1ZT %%&1ZT9'K0 449'
MK1D>M !11D>M&1ZT %%&1ZT9'K0 449'K1D>M !11D>M% %6_P#^/;_@0J6U
M_P"/:/Z5%?\ _'M_P(5+:_\ 'M']*K[($M%%%2 4444 8>J:7=1WPU;261;P
M*%FA<_)<(.Q]#Z&N<>Q\,WMV[W?VK1[N1LR0/(8P6[D=C^%=_44]M!<ILGAC
ME7T=0:UA5:"QQP\,^'",C6Y<?]?HJS%X)TF>,20ZA>2(>C)<Y'YBMH^'-%)R
M=+M<_P#7(5G0Z5J^B&6'1OL<EE)(9%BN"RF(GJ 1U%:>U;VD_F+E78Q=2\(V
M=MJNE6Z75Z4N)75\S'. I/%:A\!Z:!DW=]C_ *[FJ&K7/B$:UHXGMM/$PE<Q
M!9&P3M(.>/2M6XM/$>JVTEG=-86D$HVR20%G?;W SC'UJW*I97D%D46\):#'
M]_5[A?K> 54N=#\*VZYFUJ=NVU;K<3[ #FNEC\+:'&BK_9MNVT 99<D_6KEM
MI.GV;;K:RMXF]4C -1[9_P S"R.:L],?4[2/3[.SDTW0E.9-XQ-<^V.P/<GD
MUU\<:11K'&H5% "J!P!3J*QG-R&%9>I$BX7D_=K4K*U+_CX7_=HAN!4R?4_G
M1D^I_.DHK4!<GU/YT9/J?SI** %R?4_G1D^I_.DHH 7)]3^=&3ZG\Z2B@!<G
MU/YT9/J?SI** %R?4_G1D^I_.DHH 7)]3^=&3ZG\Z2B@!<GU/YT9/J?SJ.26
M.%-\LB1KZNP IL-S!<9\F>*3'78X/\J+ 39/J?SHR?4_G244 +D^I_.C)]3^
M=)10 N3ZG\Z,GU/YTE% "Y/J?SHR?4_G4;31(X1Y45VZ*6 )I] "Y/J?SHR?
M4_G244 +D^I_.C)]3^=)10 N3ZG\Z,GU/YTE% "Y/J?SHR?4_G244 +D^I_.
MC)]3^=)10 N3ZG\Z,GU/YTE% "Y/J?SHR?4_G244 +D^I_.C)]3^=)10 N3Z
MG\Z,GU/YTE% "Y/J?SJUIY/VL<G[IJI5K3O^/L?[II2V UZPIR?/DY/WCWK=
MK"G_ ./B3_>-9PW 9D^I_.C)]3^=)16H"Y/J?SHR?4_G244 +D^I_.C)]3^=
M)10 N3ZG\Z,GU/YTE% "Y/J?SHR?4_G244 +D^I_.C)]3^=)10 N3ZG\Z,GU
M/YTE% "Y/J?SHR?4_G5<WMH#@W4 (_Z:"I4DCE7=&ZNOJIR*+ /R?4_G1D^I
M_.DHH 7)]3^=&3ZG\Z2COCO0 N3ZG\Z,GU/YTE% "Y/J?SHR?4_G24=!DT +
MD^I_.C)]3^=)10 N3ZG\Z,GU/YTE,6:)I#&LJ%QU4,,C\* ),GU/YT9/J?SI
M** %R?4_G1D^I_.DHH 7)]3^=&3ZG\Z2B@!<GU/YT9/J?SI** %R?4_G1D^I
M_.DHH 7)]3^=&3ZG\Z2B@!<GU/YT9/J?SI** %R?4_G6EIA)A?)_B_I696GI
MG^I?_>_I4SV LW'_ ![R?[IK$R?4_G6W<?\ 'M)_NFL.IAL N3ZG\Z,GU/YT
ME%: +D^I_.C)]3^=)10 N3ZG\Z,GU/YTE% "Y/J?SHR?4_G244 +D^I_.C)]
M3^=)10 N3ZG\Z,GU/YTE% "Y/J?SHR?4_G244 +D^I_.C)]3^=)4,EY:POLE
MN84?^ZT@!HL!/D^I_.C)]3^=-!#*&4@@]".]+0 N3ZG\Z,GU/YTE% "Y/J?S
MHR?4_G244 +D^I_.C)]3^=1O+'$F^21$7^\S "G*P90RD$'D$=Z '9/J?SHR
M?4_G244 +D^I_.C)]3^=)10 N3ZG\Z,GU/YTE% "Y/J?SHR?4_G244 +D^I_
M.C)]3^=)10 N3ZG\Z,GU/YTE% "Y/J?SHR?4_G244 +D^I_.C)]3^=)10 N3
MZG\Z,GU/YTE% "Y/J?SK;MO^/6+_ '16'6Y:_P#'K%_NBHGL!%?_ /'M_P "
M%2VO_'M']*BO_P#CV_X$*EM?^/:/Z5'V0):***D HHHH **** "BBB@#FM?1
MCXDT$@<><_\ Z":Z6FLB,RLR@LO*DCI3JJ4KI+L 4445(!1110 5E:E_Q\+_
M +M:M96I?\?"_P"[5PW IT445J 4444 %%%% !1110 4444 %%%% !1110!Y
MKXTDSXMMX]4:==," J(_3N13['1[.37+:Z\+ZK&JIS)#+(0WN ,<C%:.NZ]'
M!XD&F:U8V[Z6PRDK(2PR.N?KZ5S.M1:-!J]C_P (W+(TQ<9"$D YXP3S7?"[
MBH[:?(1WVO>*;?1KF.T2WDNKR3D0Q]0*-"\46^LSRVKP26EY$,M#+UQZUQVM
MI<VOC\RRWOV RJ"ER4W!>,?SS5G0TCE\9/=#57O[F&-F=UM\(X"_WL_TK/V4
M>2_E<#5N/'BBYN$L=+N+J& D/*O &._3@5:D\:VH\.+K$5M)(OFB)HBP!5OK
M7)QZO<:Q:ZA-=:RFG1)G%K"FUI?0<=?3O5",C_A75R.XODX_"K]A#2ZZH+G8
M2?$&WCFB9M.N19R' N#P#ZXXYQ3CX_MUO(E?3[B.SE;:ER_ 8>H&.E9GC)$3
MP3HRJ  -N /]VE\>*J^&M&   &,8[?**F,*;MIO<"3Q6<^.-$(/!VD8[_-6W
MK7B^'3=2_L^UM);V['+)%_#_ (U@>)/^1O\ #W_7./\ G6?<">U\?ZB&U,:8
M\C,4G=-P*GD#VS0H*2C?HOU [+3?%]A?Z?=7+K) ]HNZ:%AE@/;UK+_X3]A$
MMT=%NA9,V!-G@_I6)I2V#3ZU=7%[<7T1A87!CM]N[)&&!SZUG*3I^G?;=+UX
M&(-D6DG#]>Z\@TU1A=Z?F%ST+5?%=EIFFVUVJO.;H9AC48+?7TJI8^,Q-JD5
MA?Z9<64DV/++\@YZ=JP]=N[/4_#FD3:L)[>[E4F.:&/Y!S@Y&?H:I6E_J&C:
MS8P6^K1:G%,ZKL!WX4GW^[4QHQ<=M=0N>I4445R#"BBB@ HHHH **** "BBB
M@ HHHH **** "K6G?\?8_P!TU5JUIW_'V/\ =-*6P&O6%/\ \?$G^\:W:PI_
M^/B3_>-9PW CHHHK4 HHHH **** "BBB@ HHHH **** "@_=/THH/W3]* /)
MO#^CZ?K&JZFFHW+0K&Y*$2!<G<?6KOAK&F>/3I^GW;7-F^59LY!&.OIQZU7\
M,Z!9Z]J^J)=F0")R5V-CJQKOM%\-:9H<IDLXCYK\&1SDX]!Z5W5:BC=-]-A&
M!-\0XHYIX(],FDFBD*!5;.0#R>E7]5\96^FBWA%K)->S(K_9T/*9' )]:Q_
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M0 5IZ9_J7_WOZ5F5IZ9_J7_WOZ5,]@+-Q_Q[2?[IK#K<N/\ CVD_W36'2AL
M44458!1110 4444 %%%% !1110 4444 %%%% &)XLU631_#\]S"<3,1'&?0G
MO7,Z'X'M]4TA+_4;J=KFY&]2K?=SW/J:Z#QKITNI>&ID@4M)$PE"CJ0.HK+\
M.>,M*M_#\,%[,89[9-A0J27QTQ73#F5*\-[B)]#L]4\*Z5J$E_(L]I"I>&-7
M)88/OTS6II_B%+_PY+K"V[(D88^66R3CWK M-<U'Q'X?UPR6R+;I$PA90<M[
M>^!6=HNN:?:_#^ZM);A1<G>JQ?Q'/3%-TW*[DM;H#HT\8Q/X9?6OL;A%E\OR
MMXS]<XJ+3/'$6I7RQ+82QP;&=YF;A=HR>W-<O#Q\+)O^OL?SKK]+G&F^ (;J
M. 2-';%PF.IHG3A%/3K8#/;X@Y5YX='N9+-&P9LX'\L"H/%_B9Y] M&T[SHX
MKL;FF7C:.04/O6#<7\VI>'9[J\UQ8R20NGPH%#'/<#M5B[Y^%MCCG%TV?;EJ
MU5*$6G;K8#0O-3M[[P%#]NL[J.*"2.(;6VLY"_>!(Z5L:=XG@AOM/T8VDL:R
M0(8I7<'(*Y';\*QM?O;:\^'=F+>99#"T22 ?PMM/%.\26,@\,Z+K%OQ-9QQY
M(ZXX(/X'^=1RQ:L^K8'27WB5+3Q%;Z-':O--+C+*V F?;Z<U1U#QO%;ZA+:6
M-A/?-!GS6CZ+CKV/YUG>"HIM7UF_U^Y'+'RX\]B>N/H,"L#13<65]J,$FM#2
MYE8[]\6[S,$]_P#/6DJ4+M/H%STG1-;M==L?M-MD8.UT;JA]*TJXKX?00I%?
M36]S),CL V^'8 >>G)SUKM:PJQ49M(84445F 4444 %%%% !1110 4444 %%
M%% !1110 5N6O_'K%_NBL.MRU_X]8O\ =%1/8"*__P"/;_@0J6U_X]H_I45_
M_P >W_ A4MK_ ,>T?TJ/L@2T445(!1110 4444 %!('4T5YO\7G=--T[:S+^
M^;H<?PUI2I^TFH]P/2*3('<5@^"26\&:66)),/4_4UYO\0))%^(L0$C@;8.
MQ]:NG0YZCA?8#V>BBBL "BBB@ K*U+_CX7_=K5K*U+_CX7_=JX;@4Z***U *
M*** "BBB@ HHHH **** "BBB@ HHJ*YN([2UEN921'$I=B!G@4 1WNG6>HQA
M+RVCG4=-ZYQ5>ST'2M/E$MK8PQR#HX&2/QJ32M5M=9L_M5FS-%N*99<<BKM4
MW)>Z!5O=-LM1C"7EM'.J]-ZYQ]*2QTNQTQ&6RM8X0W78.3]34EW>6]A;/<74
MR11(,EF.*EC=98DD0Y1U#*?4$9%*[MY 9Q\/:.;HW)TZW,I.2Q7OZXIW]@Z2
M+=[?^SX/)=@[)LX)'>M&BGS2[@5+C3+&[MX[>XM8I88_N(RY"_2BZTRQO88X
M;JUBECC^XKKD+]*MT4KL"I-IEC<7$4\UK$\L( C=EY7'3%)?:38:GC[;:13%
M> 6'(_&KE%',^X%:TTZSL;=H+6VBBB;[RJO!^OK5+_A&-$\[S?[,M]^<_=X_
M*K4>J64TMS%#.LCVR[I@G.W_ .OQ4>DZU9ZW!)-9.S)&VQMRXYJO?5V!9N+*
MUN[?[/<6\<L/9&7(%5;/0=*T^;S;6QACD'1@O(^E:-%3S.UK@%%%%( HHHH
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M3Z'I;WWVUK&$W.=WF;><^OUK0HHYGO<#/O="TO4)O.N[&&63NY7DU;@MH+6
M000I'$.B*,"LC4/%VDZ7?-9W4LBS+C("$CFKVI:O9Z38+>74A6%B "HR23TJ
MFIV28$/_  C>B_://_LVW\S.<[.,_2K=[IUGJ, AN[>.:,<A6'3Z57TC6[+6
MX9);)V9(VVMN7'-:-)N2>NX%'^Q=,-DMD;&$VRG(C*\ ^M+8Z/IVF%FLK.*%
MFX+*.3^-7:*7,]K@4+S1=-U"59;NRAFD'1F7FI+?2[&TN&N+>TBBF9=A=%P2
M/3]!5NBCF=K7 ****0!1110 4444 %%%% !1110 4444 %%%% !6GIG^I?\
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M@8X&.E97AV6ZTC5=4LIK"X+76Y P7A<;CFIM!T2ZU#P9JED8VBG:</&)!C)
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M:'[Z''J.12@P(J***T **** "BBB@ HHHH **** "BBB@ HHHH **** &O\
MZM_]T_RKS?P;<26MKXBN(B!)&A921W!->D/_ *MO]TUYQX9M+F/3?$BO;RJ7
MC.P%2-W)Z5T4K<DK^7YB9+8Z[XKU719KZW>W6.VR78K\TG? 'L*34=9U#7?
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M0O3>7K# ;& *Z:BBB4G)W8!1114@%%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MX$*EM?\ CVC^E1]D"6BBBI **** "BBB@ KAOBI<74'A9$@++%+.$F(_NX)
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M ,,,1D20Q1F1!A'*#*CT![50UC3)KW3[A-/N%L;Z4#%RD8)..S<?,.V*TJ*
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MWZU(883+YIBC,NW;O*#=CTSUQ[4^BF!#;VEM:*RVUO# K'<PB0*"?7BIJ**
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M\>L7^Z*PZW+7_CUB_P!T5$]@(K__ (]O^!"I;7_CVC^E17__ ![?\"%2VO\
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M#%P.N>:[G:N<[5SG/3O7.:MX:U"YUB34M+UV;3Y)HUCEC,8D0XZ, >C>]%K
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M\.)>7(Q>:D[7EP3ZOR!^ Q4_B'P[-XA>"&34I8-.!!N+5%'[_!! )[#BMX
M    < "A*S ****H HHHH **** "BBB@ HHHH **** )H;J6#A3E?[IZ5J6M
MQ]HC+%=I!Q6+6GIG^I?_ 'OZ5$TK7 N2/Y<;.1G S69+J,CC" (/7O6A<?\
M'M)_NFL.E!)@*26)).2>YI***T **** "BBH+ZZ6RL+BZ896&-G(^@H6H"7=
M_:6$?F7ES% GJ[8J&RUK3-28K97\$[>B-S^58^@Z-'?0QZUJJBZO;D>8H<96
M)3T"CZ5'JEOI.KZL-,MK4_;8U+-=VP"_9CVR1UY[5KR1O81U5%8_AK49]0TQ
MA=X-U;2M!*P_B*]ZQ_$VH:W_ ,)9I.C:3J$5FMU#+([R0B3E<5G)<KLQG845
MPTFI^(_#OB/1[/4]3L]2MM2F,&U(!')&<9W<=16YJ'C'0-+OGL[N_5)H\>8%
M1F$>?[Q P/QJ;@;M%<U<ZW./&^DV$$\;:?=6<L[$ '<1C!!]*=_PG?AO[4L'
M]I+EG\L2>6WEELXQNQBBZ Z.BL/4O%^AZ3>R65Y>[;J,!FB5&9L'G. .E27'
MBG1;;2K?4Y+]#:W)VPL@+&0^@ YS[470&Q1658^)='U'3[B_MK^,V]OGSV?Y
M?*_W@>E0Z7XMT/6;L6ME?!YRNY$9"A<>JY'/X470&W169X@U>/0]#NM0D/,:
M'9\I.7P< X]ZY+PWXYM8-$CO?$6O1R370WI&+<IY?'*CCYOK1= >@45S]SXV
M\/6B0/+J _?Q"9%2-F;8>C$ <#ZU=N/$.DVND1ZK+?Q"QDQLE!R'ST QU/M1
M= :=%9FD>(-+UT2_V?<B1HB/,1E*LF>F0>:=J^O:;H4<;ZA<>5YIVQJ%+,Y]
M@.33N!HT5C0>*]$N+".]BOT:!YQ; X((E/12.H-79]4L[;4(;&68+<S(TD:8
M^\J]31<"Y17,Q?$'PO-*(X]5C9C@9VM@9.!DX]2*U]1U6TL)(;::Y6*YNE?R
M 1G)49)^@ZTKH"_16#H&NVUY;V5G+J45YJ$MOY^^.,H)5R1N JQ/XET>V6^:
M:^C1;%E2X)SA&/0>YHN!K45SL7B_2M2MKY--N\WD%NTHCDC*-@#@X(Y%6_"U
M_<:IX6TV^NV#7$\(>1@, GZ47 UZ***8!1110 4444 %%%% !1110 5N6O\
MQZQ?[HK#K<M?^/6+_=%1/8"*_P#^/;_@0J6U_P"/:/Z5%?\ _'M_P(5+:_\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ JUIW_ !]C_=-5:M:=_P ?8_W32EL!KUA3
M_P#'Q)_O&MVL*?\ X^)/]XUG#<".BBBM0"BBB@ HHHH **** "BBB@ HHHH
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M?[QK=K"G_P"/B3_>-9PW CHHHK4 HHHH **** "BBB@ HHHH **** "BBB@
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ML\/_ #R3_OD54^T7G_/(_P#?)H^T7G_/(_\ ?)HLP+?V>'_GDG_?(H^SP_\
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MC[1>?\\C_P!\FBS M_9X?^>2?]\BE6*-#E44'U JG]HO/^>1_P"^31]HO/\
MGD?^^319@7ZC,$1))B0D_P"S53[1>?\ /(_]\FC[1>?\\C_WR:.5@6_L\/\
MSR3_ +Y%'V>'_GDG_?(JI]HO/^>1_P"^31]HO/\ GD?^^319@6_L\/\ SR3_
M +Y%'V>'_GDG_?(JI]HO/^>1_P"^31]HO/\ GD?^^319@6_L\/\ SR3_ +Y%
M'V>'_GDG_?(JI]HO/^>1_P"^31]HO/\ GD?^^319@6_L\/\ SR3_ +Y%'V>'
M_GDG_?(JI]HO/^>1_P"^31]HO/\ GD?^^319@6_L\/\ SR3_ +Y%'V>'_GDG
M_?(JI]HO/^>1_P"^31]HO/\ GD?^^319@6_L\/\ SR3_ +Y%'V>'_GDG_?(J
MI]HO/^>1_P"^31]HO/\ GD?^^319@6_L\/\ SR3_ +Y%'V>'_GDG_?(JI]HO
M/^>1_P"^31]HO/\ GD?^^319@6_L\/\ SR3_ +Y%'V>'_GDG_?(JI]HO/^>1
M_P"^31]HO/\ GD?^^319@6_L\/\ SR3_ +Y%'V>'_GDG_?(JI]HO/^>1_P"^
M31]HO/\ GD?^^319@6_L\/\ SR3_ +Y%'V>'_GDG_?(JI]HO/^>1_P"^31]H
MO/\ GD?^^319@6_L\/\ SR3_ +Y%'V>'_GDG_?(JI]HO/^>1_P"^31]HO/\
MGD?^^319@6_L\/\ SR3_ +Y%'V>'_GDG_?(JI]HO/^>1_P"^31]HO/\ GD?^
M^319@6_L\/\ SR3_ +Y%'V>'_GDG_?(JI]HO/^>1_P"^31]HO/\ GD?^^319
M@6_L\/\ SR3_ +Y%'V>'_GDG_?(JI]HO/^>1_P"^31]HO/\ GD?^^319@6_L
M\/\ SR3_ +Y%'V>'_GDG_?(JI]HO/^>1_P"^31]HO/\ GD?^^319@6_L\/\
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MN;CPK8#X<VVL003/J,C*/E8G.6(Z5R$VF7]M,D,]E<1RO]Q&C(+?2E"I&5[
M5:*G-E="Y%L;:47!Z1;#N_*C['=?:?LWV:7[1_SRVG=Z]*NZ$0459CTZ^FN6
MMH[.=YU^]&J$L/J*6YTR_LY%CNK.>%W.%5T(R?:BZ JT5-<6MQ:,%N8)(6(R
M!(I&:<]A>1",R6LRB7_5DH?F^GK1= 5Z*NSZ-J=K#YUQI]S%%_?:,@52H33V
M ****8!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 :WA?_D:M+_Z^4_G7T;7SEX7_P"1JTO_ *^4
M_G7T;7EX_P")%(****X!A1110!\V^(?^1EU7_K\E_P#0S6=6CXA_Y&75?^OR
M7_T,UG5]##X40%%%%4 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M^%/^?"/_ +^'_&CZ]3[,+'@]%>\?\*_\*?\ /A'_ -_#_C1_PK_PI_SX1_\
M?P_XT?7J?9A8\'HKWC_A7_A3_GPC_P"_A_QH_P"%?^%/^?"/_OX?\:/KU/LP
ML>#T5[Q_PK_PI_SX1_\ ?P_XT?\ "O\ PI_SX1_]_#_C1]>I]F%CP>BO>/\
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M_"G_ #X1_P#?P_XT?\*_\*?\^$?_ '\/^-'UZGV86/!Z*]X_X5_X4_Y\(_\
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M7_A3_GPC_P"_A_QH_P"%?^%/^?"/_OX?\:/KU/LPL>#T5[Q_PK_PI_SX1_\
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M^%/^?"/_ +^'_&CZ]3[,+'@]%>\?\*_\*?\ /A'_ -_#_C1_PK_PI_SX1_\
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M]_&_QH^TW'_/Q-_W\;_&HJ*+ 2_:;C_GXF_[^-_C1]IN/^?B;_OXW^-1446
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M_P"_C?XU%118"7[3<?\ /Q-_W\;_ !H^TW'_ #\3?]_&_P :BHHL!+]IN/\
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MY Z5[M7@WQ&_Y'>]_P!U/Y5Y^!_B/T&SFOM-Q_S\3?\ ?QO\:/M-Q_S\3?\
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MIN/^?B;_ +^-_C1]IN/^?B;_ +^-_C45%%@)?M-Q_P _$W_?QO\ &C[3<?\
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MB0HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M,7_?@_XT?\*DG_Z#,7_?@_XT_K5+N(\XHKT?_A4D_P#T&8O^_!_QH_X5)/\
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M .%23_\ 09B_[\'_ !H_X5)/_P!!F+_OP?\ &CZU2[@><8HP*]'_ .%23_\
M09B_[\'_ !H_X5)/_P!!F+_OP?\ &CZU2[C/.,48![5Z/_PJ2?\ Z#,7_?@_
MXT?\*DG_ .@S%_WX/^-'UJEW$><4F!Z5Z1_PJ2?_ *#,7_?@_P"-'_"I)_\
MH,Q?]^#_ (T?6J7<#SC ]**]'_X5)/\ ]!F+_OP?\:/^%23_ /09B_[\'_&C
MZU2[@><8Q1@>E>C_ /"I)_\ H,Q?]^#_ (T?\*DG_P"@S%_WX/\ C1]:I=P/
M.,#THKT?_A4D_P#T&8O^_!_QH_X5)/\ ]!F+_OP?\:/K5+N!YO@>E+7H_P#P
MJ2?_ *#,7_?@_P"-'_"I)_\ H,Q?]^#_ (T?6J7<#SBBO1_^%23_ /09B_[\
M'_&C_A4D_P#T&8O^_!_QH^M4NX'G%%>C_P#"I)_^@S%_WX/^-'_"I)_^@S%_
MWX/^-'UJEW \XHKT?_A4D_\ T&8O^_!_QH_X5)/_ -!F+_OP?\:/K5+N!YQ1
M7H__  J2?_H,Q?\ ?@_XT?\ "I)_^@S%_P!^#_C1]:I=P/.**]'_ .%23_\
M09B_[\'_ !H_X5)/_P!!F+_OP?\ &CZU2[@><45Z/_PJ2?\ Z#,7_?@_XT?\
M*DG_ .@S%_WX/^-'UJEW \XHKT?_ (5)/_T&8O\ OP?\:/\ A4D__09B_P"_
M!_QH^M4NX'G%%>C_ /"I)_\ H,Q?]^#_ (T?\*DG_P"@S%_WX/\ C1]:I=P/
M.**]'_X5)/\ ]!F+_OP?\:/^%23_ /09B_[\'_&CZU2[@><45Z/_ ,*DG_Z#
M,7_?@_XT?\*DG_Z#,7_?@_XT?6J7<#SBBO1_^%23_P#09B_[\'_&C_A4D_\
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M^-'_  J2?_H,Q?\ ?@_XT?6J7<#SBBO1_P#A4D__ $&8O^_!_P :/^%23_\
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M^_!_QH^M4NX'G%%>C_\ "I)_^@S%_P!^#_C1_P *DG_Z#,7_ 'X/^-'UJEW
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MV;F[E1Z>AH W:***8!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MB7294.HM"4<N0<1+D9/K7H=   P  /:@9Y'!KEK;7/@G7I([G^SK.Q>RN9!
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M:HHY!)'4],#TJMHOB"V\.^#G\,7VCS76L0S/'_9[6Y9+@LY(;=@@J<YS7JH
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M5BJ\O^L-)#8RBBBJ$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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ME/B_U@I 6*KR_P"L-6*KR_ZPTD-C****H04444 %%%% !1110 4444 %%%%
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MFHPPW<\MY(88+)(CY[R#JFT],>O2I=/\:6%U#?F_@N=*N-/C\ZYMKQ<.D?\
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MXZKUR<'C/2N$>UDO=5\.75I#XENVAO(VO;F^5A'%D8(5.G4]1QBM$ZG>^&O
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M$D"K6JZU%XU;0-*T>RNUN;>[BN+GS;=HUM53[P)(QGM@4 :.A^+DT[2=<O\
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MV2J'"?(,9]* -*R\<Z+=Z5J&H2/-:)IS!;J*YC*21D]!M]^U&D^-M-U74HK
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M7E_UAJQ5>7_6&DAL91115""BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "CI110 $D]32Y.,9I** #)]:7)QC-)10  D=#1FBB@ HR<YS11
M0 9)ZFE))ZDTE% !1DGO110 N3ZF@$]B:2N%UK4KF7Q!K=O-KDFDPZ?9)-:A
M&"B1B&)<Y^\ 0!CWI =UD]:"2>IKB?"MUJNMZU->7NHW$4=O;VS?8D "%Y(R
M6+=^O:NVI@+D^II*** %W'.<FN*N?AIID[W$2:CJ<&FW,IEFTZ*;$+L3EO<
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MM[1V\JTO)OW]PB]P >,]A56YU36-5\=^$[ZT:VB@N=/><12%B%! +YQU..E
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MA?5H9/GM+B!HA=H1RF#PWUKT:[U[2K2WN)GO[9O(C:1T296;"C)& <YH$:&
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MBG;&_NFC8W]TT -HIVQO[IHV-_=- #:*=L;^Z:-C?W30 VBG;&_NFC8W]TT
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
..HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>28
<FILENAME>vor-20211231_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2022-03-14T15:51:45.4861+00:00 -->
<!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:href="vor-20211231.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="vor-20211231.xsd#StatementConsolidatedBalanceSheets" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:href="vor-20211231.xsd#StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="vor-20211231.xsd#StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" xlink:href="vor-20211231.xsd#StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" xlink:href="vor-20211231.xsd#StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="vor-20211231.xsd#StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical" xlink:href="vor-20211231.xsd#StatementConsolidatedStatementsOfCashFlowsParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusiness" xlink:href="vor-20211231.xsd#Role_DisclosureNatureOfBusiness" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:href="vor-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestments" xlink:href="vor-20211231.xsd#Role_DisclosureInvestments" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurements" xlink:href="vor-20211231.xsd#Role_DisclosureFairValueMeasurements" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNet" xlink:href="vor-20211231.xsd#Role_DisclosurePropertyAndEquipmentNet" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities" xlink:href="vor-20211231.xsd#Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStock" xlink:href="vor-20211231.xsd#DisclosureRedeemableConvertiblePreferredStock" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockholdersEquity" xlink:href="vor-20211231.xsd#DisclosureStockholdersEquity" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensation" xlink:href="vor-20211231.xsd#Role_DisclosureStockBasedCompensation" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeases" xlink:href="vor-20211231.xsd#Role_DisclosureLeases" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSignificantAgreements" xlink:href="vor-20211231.xsd#Role_DisclosureSignificantAgreements" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies" xlink:href="vor-20211231.xsd#DisclosureCommitmentsAndContingencies" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureDefinedContributionBenefitPlan" xlink:href="vor-20211231.xsd#DisclosureDefinedContributionBenefitPlan" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxes1" xlink:href="vor-20211231.xsd#DisclosureIncomeTaxes1" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShare" xlink:href="vor-20211231.xsd#Role_DisclosureNetLossPerShare" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:href="vor-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:href="vor-20211231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsTables" xlink:href="vor-20211231.xsd#Role_DisclosureInvestmentsTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" xlink:href="vor-20211231.xsd#Role_DisclosureFairValueMeasurementsTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetTables" xlink:href="vor-20211231.xsd#Role_DisclosurePropertyAndEquipmentNetTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:href="vor-20211231.xsd#Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockTables" xlink:href="vor-20211231.xsd#DisclosureRedeemableConvertiblePreferredStockTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" xlink:href="vor-20211231.xsd#Role_DisclosureStockBasedCompensationTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesTables" xlink:href="vor-20211231.xsd#Role_DisclosureLeasesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables" xlink:href="vor-20211231.xsd#DisclosureIncomeTaxesTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareTables" xlink:href="vor-20211231.xsd#Role_DisclosureNetLossPerShareTables" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails" xlink:href="vor-20211231.xsd#Role_DisclosureNatureOfBusinessAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="vor-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfPropertyAndEquipmentDetails" xlink:href="vor-20211231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfPropertyAndEquipmentDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails" xlink:href="vor-20211231.xsd#Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails" xlink:href="vor-20211231.xsd#DisclosureInvestmentsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="vor-20211231.xsd#Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:href="vor-20211231.xsd#Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails" xlink:href="vor-20211231.xsd#Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetails" xlink:href="vor-20211231.xsd#Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:href="vor-20211231.xsd#Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails" xlink:href="vor-20211231.xsd#DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails" xlink:href="vor-20211231.xsd#DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" xlink:href="vor-20211231.xsd#DisclosureStockholdersEquityAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:href="vor-20211231.xsd#Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedPrincipallyInDeterminingFairValueOfOptionsGrantedDetails" xlink:href="vor-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedPrincipallyInDeterminingFairValueOfOptionsGrantedDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails" xlink:href="vor-20211231.xsd#DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" xlink:href="vor-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails" xlink:href="vor-20211231.xsd#Role_DisclosureLeasesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseExpenseDetails" xlink:href="vor-20211231.xsd#Role_DisclosureLeasesSummaryOfLeaseExpenseDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfAmountsReportedInConsolidatedBalanceSheetsAndWeightaverageLeaseTermAndDiscountRateInformationDetails" xlink:href="vor-20211231.xsd#DisclosureLeasesSummaryOfAmountsReportedInConsolidatedBalanceSheetsAndWeightaverageLeaseTermAndDiscountRateInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOtherLeaseActivityDetails" xlink:href="vor-20211231.xsd#DisclosureLeasesSummaryOfOtherLeaseActivityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails" xlink:href="vor-20211231.xsd#DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails" xlink:href="vor-20211231.xsd#DisclosureSignificantAgreementsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureDefinedContributionBenefitPlanAdditionalInformationDetails" xlink:href="vor-20211231.xsd#DisclosureDefinedContributionBenefitPlanAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeRateToEffectiveIncomeTaxRateDetails" xlink:href="vor-20211231.xsd#DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeRateToEffectiveIncomeTaxRateDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="vor-20211231.xsd#DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="vor-20211231.xsd#DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails" xlink:href="vor-20211231.xsd#Role_DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:href="vor-20211231.xsd#Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalYearFocus" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentFiscalPeriodFocus" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CurrentFiscalYearEndDate" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityWellKnownSeasonedIssuer" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityVoluntaryFilers" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCurrentReportingStatus" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityInteractiveDataCurrent" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFilerCategory" order="22" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntitySmallBusiness" order="23" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="24" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="25" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCommonStockSharesOutstanding" order="26" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityPublicFloat" order="27" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_IcfrAuditorAttestationFlag" order="28" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityShellCompany" order="29" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentAnnualReport" order="30" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentTransitionReport" order="31" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="32" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="33" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="34" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock" order="35" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorName" order="36" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorLocation" order="37" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AuditorFirmId" order="38" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesAOneRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesAOneRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesATwoRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesATwoRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesBRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesAOneRedeemableConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesATwoRedeemableConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_RestrictedCashEquivalentsNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesBRedeemableConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OtherAssetsCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesAOneRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesAOneRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesATwoRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesATwoRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesBRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesAOneRedeemableConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesATwoRedeemableConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesBRedeemableConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreference" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingGainsLossesAbstract" xlink:label="us-gaap_NonoperatingGainsLossesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockDividends" xlink:label="us-gaap_RedeemablePreferredStockDividends"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingGainsLossesAbstract" xlink:to="us-gaap_InvestmentIncomeInterest" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingExpensesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NonoperatingGainsLossesAbstract" xlink:to="us-gaap_NonoperatingIncomeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_OperatingIncomeLoss" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NonoperatingGainsLossesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpenses" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLoss" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_RedeemablePreferredStockDividends" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesAOneRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesAOneRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesATwoRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesATwoRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesBRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TemporaryEquityStockConvertedDuringPeriodValue" xlink:label="vor_TemporaryEquityStockConvertedDuringPeriodValue"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TemporaryEquityStockConvertedDuringPeriodShares" xlink:label="vor_TemporaryEquityStockConvertedDuringPeriodShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_StockIssuedDuringPeriodValueStockOptionsVestedAndExercised" xlink:label="vor_StockIssuedDuringPeriodValueStockOptionsVestedAndExercised"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_StockIssuedDuringPeriodSharesStockOptionsVestedAndExercised" xlink:label="vor_StockIssuedDuringPeriodSharesStockOptionsVestedAndExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity_18"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding_19"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_20"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_21"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesAOneRedeemableConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesATwoRedeemableConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesBRedeemableConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="vor_TemporaryEquityStockConvertedDuringPeriodValue" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="vor_TemporaryEquityStockConvertedDuringPeriodShares" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="vor_StockIssuedDuringPeriodValueStockOptionsVestedAndExercised" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="vor_StockIssuedDuringPeriodSharesStockOptionsVestedAndExercised" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity_18" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding_19" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_20" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_21" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_OperatingRightOfUseAssetsAndOperatingLeaseLiabilityRecordedUponLeaseCommencement" xlink:label="vor_OperatingRightOfUseAssetsAndOperatingLeaseLiabilityRecordedUponLeaseCommencement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="us-gaap_PaymentsToAcquireInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ConversionOfRedeemableConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering" xlink:label="vor_ConversionOfRedeemableConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses" xlink:label="vor_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_5"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_Depreciation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="vor_OperatingRightOfUseAssetsAndOperatingLeaseLiabilityRecordedUponLeaseCommencement" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquireInvestments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ProfitLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OperatingLeaseExpense" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_ShareBasedCompensation" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="vor_ConversionOfRedeemableConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_OtherOperatingActivitiesCashFlowStatement" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="vor_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_RestrictedCashEquivalentsNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusiness" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NatureOfOperations" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestments" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurements" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNet" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStock" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_RedeemableConvertiblePreferredStockTextBlock" xlink:label="vor_RedeemableConvertiblePreferredStockTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="vor_RedeemableConvertiblePreferredStockTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockholdersEquity" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeases" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSignificantAgreements" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SignificantAgreementsAbstract" xlink:label="vor_SignificantAgreementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SignificantAgreementsTextBlock" xlink:label="vor_SignificantAgreementsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="vor_SignificantAgreementsAbstract" xlink:to="vor_SignificantAgreementsTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureDefinedContributionBenefitPlan" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxes1" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShare" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="us-gaap_InvestmentPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock" xlink:label="us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:label="us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_AccruedResearchAndDevelopmentExpensesPolicyPolicyTextBlock" xlink:label="vor_AccruedResearchAndDevelopmentExpensesPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" xlink:label="vor_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_UseOfEstimates" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_InvestmentPolicyTextBlock" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_DeferredChargesPolicyTextBlock" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ConcentrationRiskCreditRisk" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="vor_AccruedResearchAndDevelopmentExpensesPolicyPolicyTextBlock" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_IncomeTaxPolicyTextBlock" order="18" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock" order="19" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" order="20" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="vor_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" order="21" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock" xlink:label="vor_PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="vor_PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock" xlink:label="vor_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="vor_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock" xlink:label="vor_ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="vor_ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ScheduleOfOperatingLeaseAssetsAndLiabilitiesWeightedAverageLeaseTermAndDiscountRateTableTextBlock" xlink:label="vor_ScheduleOfOperatingLeaseAssetsAndLiabilitiesWeightedAverageLeaseTermAndDiscountRateTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ScheduleOfOtherLeaseActivityTableTextBlock" xlink:label="vor_ScheduleOfOtherLeaseActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeaseCostTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="vor_ScheduleOfOperatingLeaseAssetsAndLiabilitiesWeightedAverageLeaseTermAndDiscountRateTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="vor_ScheduleOfOtherLeaseActivityTableTextBlock" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareTables" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_NatureOfBusinessLineItems" xlink:label="vor_NatureOfBusinessLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_NatureOfBusinessTable" xlink:label="vor_NatureOfBusinessTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="dei_EntityIncorporationDateOfIncorporation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="vor_NatureOfBusinessTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="vor_NatureOfBusinessTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="vor_NatureOfBusinessTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="vor_NatureOfBusinessTable" xlink:to="vor_NatureOfBusinessLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="us-gaap_OtherAssetsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherAssetsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_DeferredOfferingCosts" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_RestrictedCashEquivalentsNoncurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_AccountingStandardsUpdateExtensibleList" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfPropertyAndEquipmentDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_FurnitureAndEquipmentMember" xlink:label="vor_FurnitureAndEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_LaboratoryEquipmentMember" xlink:label="vor_LaboratoryEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="vor_FurnitureAndEquipmentMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="vor_LaboratoryEquipmentMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueDomain"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_MaturingInOneYearOrLessMember" xlink:label="vor_MaturingInOneYearOrLessMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_MaturingAfterOneYearThroughFiveYearsMember" xlink:label="vor_MaturingAfterOneYearThroughFiveYearsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:to="vor_MaturingInOneYearOrLessMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FinancingReceivablesPeriodPastDueAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:to="us-gaap_FinancingReceivablesPeriodPastDueDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:to="vor_MaturingAfterOneYearThroughFiveYearsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments" xlink:label="us-gaap_Investments"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_Investments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsMember" xlink:label="us-gaap_CashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:label="us-gaap_InformationByCategoryOfDebtSecurityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:label="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsMember" xlink:label="us-gaap_InvestmentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_RestrictedCashEquivalentsMember" xlink:label="vor_RestrictedCashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CashEquivalentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:to="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:to="us-gaap_InvestmentsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MoneyMarketFundsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="vor_RestrictedCashEquivalentsMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_InvestmentTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_InformationByCategoryOfDebtSecurityAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByAssetClassAxis" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FinancialInstrumentAxis" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_FairValueAssetsLevel1ToLevel2TransferredAmount" xlink:label="vor_FairValueAssetsLevel1ToLevel2TransferredAmount"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_FairValueAssetsLevel2ToLevel1TransferredAmount" xlink:label="vor_FairValueAssetsLevel2ToLevel1TransferredAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="vor_FairValueAssetsLevel1ToLevel2TransferredAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="vor_FairValueAssetsLevel2ToLevel1TransferredAmount" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_FurnitureAndEquipmentMember" xlink:label="vor_FurnitureAndEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_LaboratoryEquipmentMember" xlink:label="vor_LaboratoryEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="vor_FurnitureAndEquipmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="vor_LaboratoryEquipmentMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_Depreciation" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_AccruedResearchAndDevelopmentExpensesCurrent" xlink:label="vor_AccruedResearchAndDevelopmentExpensesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_AccruedLicenseAndMilestoneFeesCurrent" xlink:label="vor_AccruedLicenseAndMilestoneFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="vor_AccruedResearchAndDevelopmentExpensesCurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="vor_AccruedLicenseAndMilestoneFeesCurrent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesAOneRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesAOneRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesATwoRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesATwoRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesBRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TemporaryEquityIssuedPricePerShare" xlink:label="vor_TemporaryEquityIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues" xlink:label="vor_TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesAOneRedeemableConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesATwoRedeemableConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesBRedeemableConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="vor_TemporaryEquityIssuedPricePerShare" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="vor_TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DebtConversionOriginalDebtAmount1" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesAOneRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesAOneRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesATwoRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesATwoRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesBRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TemporaryEquityCumulativeUndeclaredDividends" xlink:label="vor_TemporaryEquityCumulativeUndeclaredDividends"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesAOneRedeemableConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_ScheduleOfStockByClassTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesATwoRedeemableConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ClassOfStockLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesBRedeemableConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreference" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="vor_TemporaryEquityCumulativeUndeclaredDividends" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_NumberOfCommonStockVotingRights" xlink:label="vor_NumberOfCommonStockVotingRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock" xlink:label="us-gaap_DividendsCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_PreferredStockSharesAuthorized" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_PreferredStockSharesOutstanding" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_CommonStockSharesAuthorized" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_CommonStockVotingRights" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="vor_NumberOfCommonStockVotingRights" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_DividendsCommonStock" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_PaymentsOfDividendsCommonStock" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TwoThousandFifteenStockIncentivePlanMember" xlink:label="vor_TwoThousandFifteenStockIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TwoThousandTwentyOneEquityIncentivePlanMember" xlink:label="vor_TwoThousandTwentyOneEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue" xlink:label="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice" xlink:label="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="vor_TwoThousandFifteenStockIncentivePlanMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_PlanNameDomain" xlink:to="vor_TwoThousandTwentyOneEquityIncentivePlanMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharePrice" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedPrincipallyInDeterminingFairValueOfOptionsGrantedDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriod" xlink:label="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriodWeightedAverageExercisePrice" xlink:label="vor_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_12"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriod" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_5" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="vor_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriodWeightedAverageExercisePrice" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_12" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" order="13" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" order="14" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" order="15" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" order="16" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" order="17" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandbyLettersOfCreditMember" xlink:label="us-gaap_StandbyLettersOfCreditMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_FirstLeaseAmendmentMember" xlink:label="vor_FirstLeaseAmendmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SecondLeaseAmendmentMember" xlink:label="vor_SecondLeaseAmendmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_AdditionalSpaceLeased" xlink:label="vor_AdditionalSpaceLeased"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_CambridgeparkLeaseMember" xlink:label="vor_CambridgeparkLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="us-gaap_PaymentsForRent"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_IncreaseInAnnualFixedRentalPayments" xlink:label="vor_IncreaseInAnnualFixedRentalPayments"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_OperatingLeaseCommencementPeriod" xlink:label="vor_OperatingLeaseCommencementPeriod"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_OperatingLeaseEstimatedToCommencePeriod" xlink:label="vor_OperatingLeaseEstimatedToCommencePeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:label="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_StandbyLettersOfCreditMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_RangeAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="vor_FirstLeaseAmendmentMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LesseeLeaseDescriptionTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="vor_SecondLeaseAmendmentMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LeaseContractualTermAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_CreditFacilityAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="vor_AdditionalSpaceLeased" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="vor_CambridgeparkLeaseMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_PaymentsForRent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="vor_IncreaseInAnnualFixedRentalPayments" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="vor_OperatingLeaseCommencementPeriod" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="vor_OperatingLeaseEstimatedToCommencePeriod" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseExpenseDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost" xlink:label="us-gaap_ShortTermLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseCost" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_ShortTermLeaseCost" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_VariableLeaseCost" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeaseCost" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfAmountsReportedInConsolidatedBalanceSheetsAndWeightaverageLeaseTermAndDiscountRateInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityAbstract" xlink:label="us-gaap_OperatingLeaseLiabilityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_OperatingLeaseWeightedAverageLeaseTermAndDiscountRateAbstract" xlink:label="vor_OperatingLeaseWeightedAverageLeaseTermAndDiscountRateAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_OperatingLeaseAssetsAbstract" xlink:label="vor_OperatingLeaseAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="vor_OperatingLeaseWeightedAverageLeaseTermAndDiscountRateAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="vor_OperatingLeaseAssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="vor_OperatingLeaseAssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="vor_OperatingLeaseWeightedAverageLeaseTermAndDiscountRateAbstract" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="vor_OperatingLeaseWeightedAverageLeaseTermAndDiscountRateAbstract" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilityAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOtherLeaseActivityDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:label="vor_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_LeasesAbstract" xlink:to="vor_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="vor_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_OperatingLeasePayments" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="vor_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiability" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseMember" xlink:label="us-gaap_LicenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_AccruedExpensesMember" xlink:label="vor_AccruedExpensesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfClinicalMilestones" xlink:label="vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfClinicalMilestones"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ColumbiaLicenseAgreementMember" xlink:label="vor_ColumbiaLicenseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_NationalInstitutesOfHealthLicenseAgreementMember" xlink:label="vor_NationalInstitutesOfHealthLicenseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfRegulatoryAndCommercialMilestones" xlink:label="vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfRegulatoryAndCommercialMilestones"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_LicenseAgreementPotentialMilestonePayments" xlink:label="vor_LicenseAgreementPotentialMilestonePayments"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_LicenseFeeObligatedToPay" xlink:label="vor_LicenseFeeObligatedToPay"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_LicenseAgreementMilestonePaymentsOnAggregateNetSales" xlink:label="vor_LicenseAgreementMilestonePaymentsOnAggregateNetSales"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_LicenseMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="vor_AccruedExpensesMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfClinicalMilestones" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="vor_ColumbiaLicenseAgreementMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_RangeAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="vor_NationalInstitutesOfHealthLicenseAgreementMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfRegulatoryAndCommercialMilestones" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_BalanceSheetLocationAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="vor_LicenseAgreementPotentialMilestonePayments" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="vor_LicenseFeeObligatedToPay" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="vor_LicenseAgreementMilestonePaymentsOnAggregateNetSales" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureDefinedContributionBenefitPlanAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_DefinedContributionPlanFirstPercentage" xlink:label="vor_DefinedContributionPlanFirstPercentage"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_DefinedContributionPlanAdditionalPercentage" xlink:label="vor_DefinedContributionPlanAdditionalPercentage"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_Definedcontributionplanminimumannualcontributionsperemployeepercent" xlink:label="vor_Definedcontributionplanminimumannualcontributionsperemployeepercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:label="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="vor_DefinedContributionPlanFirstPercentage" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="vor_DefinedContributionPlanAdditionalPercentage" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="vor_Definedcontributionplanminimumannualcontributionsperemployeepercent" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeRateToEffectiveIncomeTaxRateDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_EffectiveIncomeTaxRateReconciliationPermanentItems" xlink:label="vor_EffectiveIncomeTaxRateReconciliationPermanentItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="vor_EffectiveIncomeTaxRateReconciliationPermanentItems" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_DeferredTaxLiabilitiesLeaseRightOfUseAsset" xlink:label="vor_DeferredTaxLiabilitiesLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:label="vor_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_DeferredTaxAssetsAmortization" xlink:label="vor_DeferredTaxAssetsAmortization"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_DeferredTaxAssetsLeaseLiability" xlink:label="vor_DeferredTaxAssetsLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="vor_DeferredTaxLiabilitiesLeaseRightOfUseAsset" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="vor_DeferredTaxLiabilitiesDepreciationAndAmortization" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_DeferredTaxLiabilities" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedTotalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="vor_DeferredTaxAssetsAmortization" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="vor_DeferredTaxAssetsLeaseLiability" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsGross" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_DeferredTaxAssetsNet" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_OperatingLossCarryforwardsExpirationYear" xlink:label="vor_OperatingLossCarryforwardsExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TaxCreditCarryforwardsExpirationYear" xlink:label="vor_TaxCreditCarryforwardsExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ConsideredPeriodOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards" xlink:label="vor_ConsideredPeriodOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ConsideredPercentageOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards" xlink:label="vor_ConsideredPercentageOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="us-gaap_IncomeTaxExaminationDescription"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_OperatingLossCarryforwardsTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="srt_RangeAxis" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" order="4" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="vor_OperatingLossCarryforwardsExpirationYear" order="5" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" order="6" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="vor_TaxCreditCarryforwardsExpirationYear" order="7" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="vor_ConsideredPeriodOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards" order="8" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="vor_ConsideredPercentageOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards" order="9" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" order="10" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" order="11" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_IncomeTaxExaminationDescription" order="12" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="us-gaap_NetIncomeLossAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockDividends" xlink:label="us-gaap_RedeemablePreferredStockDividends"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLoss" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_NetIncomeLossAbstract" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_RedeemablePreferredStockDividends" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedAbstract" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:presentationLink xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesAOneRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesAOneRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesATwoRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesATwoRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesBRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="vor_SeriesAOneRedeemableConvertiblePreferredStockMember" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" order="0" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="vor_SeriesATwoRedeemableConvertiblePreferredStockMember" order="1" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="vor_SeriesBRedeemableConvertiblePreferredStockMember" order="2" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" order="3" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>29
<FILENAME>vor-20211231_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2022-03-14T15:51:45.9076+00:00 -->
<!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="vor-20211231.xsd#StatementConsolidatedBalanceSheets" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails2" xlink:href="vor-20211231.xsd#DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails2" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:href="vor-20211231.xsd#StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" xlink:href="vor-20211231.xsd#StatementConsolidatedStatementsOfCashFlows" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical" xlink:href="vor-20211231.xsd#StatementConsolidatedStatementsOfCashFlowsParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails" xlink:href="vor-20211231.xsd#Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:href="vor-20211231.xsd#Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseExpenseDetails" xlink:href="vor-20211231.xsd#Role_DisclosureLeasesSummaryOfLeaseExpenseDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfAmountsReportedInConsolidatedBalanceSheetsAndWeightaverageLeaseTermAndDiscountRateInformationDetails" xlink:href="vor-20211231.xsd#DisclosureLeasesSummaryOfAmountsReportedInConsolidatedBalanceSheetsAndWeightaverageLeaseTermAndDiscountRateInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails" xlink:href="vor-20211231.xsd#DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:href="vor-20211231.xsd#DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails" xlink:href="vor-20211231.xsd#Role_DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails" xlink:type="simple"/>
  <link:calculationLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_PreferredStockValue" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_Liabilities" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_LiabilitiesCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccountsPayableCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_AssetsCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_CommonStockValue" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_RestrictedCashEquivalentsNoncurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_ShortTermInvestments" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_StockholdersEquity" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_Assets" xlink:to="us-gaap_OtherAssetsNoncurrent" order="4" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails2">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_OperatingLeaseLiability" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLoss" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_InvestmentIncomeInterest" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_ResearchAndDevelopmentExpense" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingExpenses" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_GeneralAndAdministrativeExpense" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_RedeemablePreferredStockDividends" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NonoperatingIncomeExpense" order="2" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockDividends" xlink:label="us-gaap_RedeemablePreferredStockDividends"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ProfitLoss" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquireInvestments" order="0" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_Depreciation" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OperatingLeaseExpense" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts" order="2" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_ProceedsFromStockOptionsExercised" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_ShareBasedCompensation" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_OtherOperatingActivitiesCashFlowStatement" order="7" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" order="8" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" order="9" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" order="10" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets" order="11" weight="-1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="us-gaap_PaymentsToAcquireInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_RestrictedCashEquivalentsNoncurrent" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" order="1" weight="-1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="vor_AccruedResearchAndDevelopmentExpensesCurrent" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="vor_AccruedLicenseAndMilestoneFeesCurrent" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent" order="4" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_AccruedResearchAndDevelopmentExpensesCurrent" xlink:label="vor_AccruedResearchAndDevelopmentExpensesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_AccruedLicenseAndMilestoneFeesCurrent" xlink:label="vor_AccruedLicenseAndMilestoneFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseExpenseDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_OperatingLeaseCost" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_ShortTermLeaseCost" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_VariableLeaseCost" order="2" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost" xlink:label="us-gaap_ShortTermLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfAmountsReportedInConsolidatedBalanceSheetsAndWeightaverageLeaseTermAndDiscountRateInformationDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" order="1" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" order="5" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsNet" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="vor_DeferredTaxLiabilitiesLeaseRightOfUseAsset" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsGross" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxLiabilities" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" order="1" weight="-1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="vor_DeferredTaxLiabilitiesDepreciationAndAmortization" order="1" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" order="2" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" order="3" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" order="4" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="vor_DeferredTaxAssetsAmortization" order="5" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="vor_DeferredTaxAssetsLeaseLiability" order="6" weight="1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_DeferredTaxLiabilitiesLeaseRightOfUseAsset" xlink:label="vor_DeferredTaxLiabilitiesLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:label="vor_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_DeferredTaxAssetsAmortization" xlink:label="vor_DeferredTaxAssetsAmortization"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_DeferredTaxAssetsLeaseLiability" xlink:label="vor_DeferredTaxAssetsLeaseLiability"/>
  </link:calculationLink>
  <link:calculationLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails">
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLoss" order="0" weight="1" use="optional"/>
    <link:calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_RedeemablePreferredStockDividends" order="1" weight="-1" use="optional"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockDividends" xlink:label="us-gaap_RedeemablePreferredStockDividends"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>30
<FILENAME>vor-20211231_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2022-03-14T15:51:44.7119+00:00 -->
<!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_AccruedResearchAndDevelopmentExpensesPolicyPolicyTextBlock" xlink:label="vor_AccruedResearchAndDevelopmentExpensesPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TemporaryEquityStockConvertedDuringPeriodShares" xlink:label="vor_TemporaryEquityStockConvertedDuringPeriodShares"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_MaturingInOneYearOrLessMember" xlink:label="vor_MaturingInOneYearOrLessMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorLocation" xlink:label="dei_AuditorLocation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpensesAbstract" xlink:label="us-gaap_OperatingExpensesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingIncomeLoss" xlink:label="us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentPolicyTextBlock" xlink:label="us-gaap_InvestmentPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureAbstract" xlink:label="us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:label="us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriodWeightedAverageExercisePrice" xlink:label="vor_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_DeferredTaxLiabilitiesLeaseRightOfUseAsset" xlink:label="vor_DeferredTaxLiabilitiesLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ConsideredPercentageOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards" xlink:label="vor_ConsideredPercentageOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsGross" xlink:label="us-gaap_DeferredTaxAssetsGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsNet" xlink:label="us-gaap_DeferredTaxAssetsNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityAbstract" xlink:label="us-gaap_OperatingLeaseLiabilityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementAbstract" xlink:label="us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ColumbiaLicenseAgreementMember" xlink:label="vor_ColumbiaLicenseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TwoThousandTwentyOneEquityIncentivePlanMember" xlink:label="vor_TwoThousandTwentyOneEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpense" xlink:label="us-gaap_GeneralAndAdministrativeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SignificantAgreementsAbstract" xlink:label="vor_SignificantAgreementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Investments" xlink:label="us-gaap_Investments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock" xlink:label="vor_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock" xlink:label="vor_ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_AccruedResearchAndDevelopmentExpensesCurrent" xlink:label="vor_AccruedResearchAndDevelopmentExpensesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UseOfEstimates" xlink:label="us-gaap_UseOfEstimates"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="us-gaap_PaymentsForRent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine2" xlink:label="dei_EntityAddressAddressLine2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CurrentFiscalYearEndDate" xlink:label="dei_CurrentFiscalYearEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseCost" xlink:label="us-gaap_OperatingLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:label="vor_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:label="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_AccruedExpensesMember" xlink:label="vor_AccruedExpensesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_FairValueAssetsLevel1ToLevel2TransferredAmount" xlink:label="vor_FairValueAssetsLevel1ToLevel2TransferredAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsMember" xlink:label="us-gaap_InvestmentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_NatureOfBusinessTable" xlink:label="vor_NatureOfBusinessTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_StockIssuedDuringPeriodSharesStockOptionsVestedAndExercised" xlink:label="vor_StockIssuedDuringPeriodSharesStockOptionsVestedAndExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeasesAbstract" xlink:label="us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:label="vor_DeferredTaxLiabilitiesDepreciationAndAmortization"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_LicenseFeeObligatedToPay" xlink:label="vor_LicenseFeeObligatedToPay"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_OperatingLeaseEstimatedToCommencePeriod" xlink:label="vor_OperatingLeaseEstimatedToCommencePeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ConsideredPeriodOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards" xlink:label="vor_ConsideredPeriodOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingExpenses" xlink:label="us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCost" xlink:label="us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareAbstract" xlink:label="us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:label="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_MaturingAfterOneYearThroughFiveYearsMember" xlink:label="vor_MaturingAfterOneYearThroughFiveYearsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk" xlink:label="us-gaap_ConcentrationRiskCreditRisk"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="dei_DocumentFiscalPeriodFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="us-gaap_IncomeTaxExaminationDescription"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingPoliciesAbstract" xlink:label="us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProfitLoss" xlink:label="us-gaap_ProfitLoss"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SignificantAgreementsTextBlock" xlink:label="vor_SignificantAgreementsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_DeferredTaxAssetsLeaseLiability" xlink:label="vor_DeferredTaxAssetsLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_AccruedLicenseAndMilestoneFeesCurrent" xlink:label="vor_AccruedLicenseAndMilestoneFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseCostTableTextBlock" xlink:label="us-gaap_LeaseCostTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VariableLeaseCost" xlink:label="us-gaap_VariableLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue" xlink:label="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityInteractiveDataCurrent" xlink:label="dei_EntityInteractiveDataCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_CambridgeparkLeaseMember" xlink:label="vor_CambridgeparkLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SecondLeaseAmendmentMember" xlink:label="vor_SecondLeaseAmendmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_RestrictedCashEquivalentsMember" xlink:label="vor_RestrictedCashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RedeemablePreferredStockDividends" xlink:label="us-gaap_RedeemablePreferredStockDividends"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeasePayments" xlink:label="us-gaap_OperatingLeasePayments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_OperatingLeaseWeightedAverageLeaseTermAndDiscountRateAbstract" xlink:label="vor_OperatingLeaseWeightedAverageLeaseTermAndDiscountRateAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntitySmallBusiness" xlink:label="dei_EntitySmallBusiness"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockVotingRights" xlink:label="us-gaap_CommonStockVotingRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TaxCreditCarryforwardsExpirationYear" xlink:label="vor_TaxCreditCarryforwardsExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_OperatingLeaseAssetsAbstract" xlink:label="vor_OperatingLeaseAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TemporaryEquityCumulativeUndeclaredDividends" xlink:label="vor_TemporaryEquityCumulativeUndeclaredDividends"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesBRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfRegulatoryAndCommercialMilestones" xlink:label="vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfRegulatoryAndCommercialMilestones"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLossAbstract" xlink:label="us-gaap_NetIncomeLossAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredChargesPolicyTextBlock" xlink:label="us-gaap_DeferredChargesPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingGainsLossesAbstract" xlink:label="us-gaap_NonoperatingGainsLossesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityAbstract" xlink:label="us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_OperatingLeaseCommencementPeriod" xlink:label="vor_OperatingLeaseCommencementPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Depreciation" xlink:label="us-gaap_Depreciation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_EffectiveIncomeTaxRateReconciliationPermanentItems" xlink:label="vor_EffectiveIncomeTaxRateReconciliationPermanentItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_OperatingLossCarryforwardsExpirationYear" xlink:label="vor_OperatingLossCarryforwardsExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_Definedcontributionplanminimumannualcontributionsperemployeepercent" xlink:label="vor_Definedcontributionplanminimumannualcontributionsperemployeepercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensation" xlink:label="us-gaap_ShareBasedCompensation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_LicenseAgreementMilestonePaymentsOnAggregateNetSales" xlink:label="vor_LicenseAgreementMilestonePaymentsOnAggregateNetSales"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TemporaryEquityStockConvertedDuringPeriodValue" xlink:label="vor_TemporaryEquityStockConvertedDuringPeriodValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_NationalInstitutesOfHealthLicenseAgreementMember" xlink:label="vor_NationalInstitutesOfHealthLicenseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriod" xlink:label="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentAbstract" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract" xlink:label="us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityWellKnownSeasonedIssuer" xlink:label="dei_EntityWellKnownSeasonedIssuer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandbyLettersOfCreditMember" xlink:label="us-gaap_StandbyLettersOfCreditMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentIncomeInterest" xlink:label="us-gaap_InvestmentIncomeInterest"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SupplementalCashFlowElementsAbstract" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_DefinedContributionPlanFirstPercentage" xlink:label="vor_DefinedContributionPlanFirstPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice" xlink:label="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_NatureOfBusinessLineItems" xlink:label="vor_NatureOfBusinessLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NonoperatingIncomeExpense" xlink:label="us-gaap_NonoperatingIncomeExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxLiabilities" xlink:label="us-gaap_DeferredTaxLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCurrentReportingStatus" xlink:label="dei_EntityCurrentReportingStatus"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ScheduleOfOperatingLeaseAssetsAndLiabilitiesWeightedAverageLeaseTermAndDiscountRateTableTextBlock" xlink:label="vor_ScheduleOfOperatingLeaseAssetsAndLiabilitiesWeightedAverageLeaseTermAndDiscountRateTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_OperatingRightOfUseAssetsAndOperatingLeaseLiabilityRecordedUponLeaseCommencement" xlink:label="vor_OperatingRightOfUseAssetsAndOperatingLeaseLiabilityRecordedUponLeaseCommencement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityVoluntaryFilers" xlink:label="dei_EntityVoluntaryFilers"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentsIncorporatedByReferenceTextBlock" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfDividendsCommonStock" xlink:label="us-gaap_PaymentsOfDividendsCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorFirmId" xlink:label="dei_AuditorFirmId"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AuditorName" xlink:label="dei_AuditorName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="us-gaap_OtherAssetsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_DeferredTaxAssetsAmortization" xlink:label="vor_DeferredTaxAssetsAmortization"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:label="us-gaap_OtherOperatingActivitiesCashFlowStatement"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentAnnualReport" xlink:label="dei_DocumentAnnualReport"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFilerCategory" xlink:label="dei_EntityFilerCategory"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock" xlink:label="us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentFiscalYearFocus" xlink:label="dei_DocumentFiscalYearFocus"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesAOneRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesAOneRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_FirstLeaseAmendmentMember" xlink:label="vor_FirstLeaseAmendmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxDisclosureTextBlock" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityExTransitionPeriod" xlink:label="dei_EntityExTransitionPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresAbstract" xlink:label="us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermLeaseCost" xlink:label="us-gaap_ShortTermLeaseCost"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TwoThousandFifteenStockIncentivePlanMember" xlink:label="vor_TwoThousandFifteenStockIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_FurnitureAndEquipmentMember" xlink:label="vor_FurnitureAndEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PayablesAndAccrualsAbstract" xlink:label="us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseExpense" xlink:label="us-gaap_OperatingLeaseExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_LicenseAgreementPotentialMilestonePayments" xlink:label="vor_LicenseAgreementPotentialMilestonePayments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_AdditionalSpaceLeased" xlink:label="vor_AdditionalSpaceLeased"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:label="us-gaap_InformationByCategoryOfDebtSecurityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock" xlink:label="vor_PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseMember" xlink:label="us-gaap_LicenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsMember" xlink:label="us-gaap_CashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsOfStockIssuanceCosts" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues" xlink:label="vor_TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiability" xlink:label="us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent" xlink:label="us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityPublicFloat" xlink:label="dei_EntityPublicFloat"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:label="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" xlink:label="vor_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_DocumentTransitionReport" xlink:label="dei_DocumentTransitionReport"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_FairValueAssetsLevel2ToLevel1TransferredAmount" xlink:label="vor_FairValueAssetsLevel2ToLevel1TransferredAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised" xlink:label="us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_DefinedContributionPlanAdditionalPercentage" xlink:label="vor_DefinedContributionPlanAdditionalPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:label="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense" xlink:label="us-gaap_ResearchAndDevelopmentExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_LaboratoryEquipmentMember" xlink:label="vor_LaboratoryEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfClinicalMilestones" xlink:label="vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfClinicalMilestones"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DividendsCommonStock" xlink:label="us-gaap_DividendsCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ScheduleOfOtherLeaseActivityTableTextBlock" xlink:label="vor_ScheduleOfOtherLeaseActivityTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract" xlink:label="us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NatureOfOperations" xlink:label="us-gaap_NatureOfOperations"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses" xlink:label="vor_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsToAcquireInvestments" xlink:label="us-gaap_PaymentsToAcquireInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_StockIssuedDuringPeriodValueStockOptionsVestedAndExercised" xlink:label="vor_StockIssuedDuringPeriodValueStockOptionsVestedAndExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityCommonStockSharesOutstanding" xlink:label="dei_EntityCommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityShellCompany" xlink:label="dei_EntityShellCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_IcfrAuditorAttestationFlag" xlink:label="dei_IcfrAuditorAttestationFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesATwoRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesATwoRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EarningsPerShareTextBlock" xlink:label="us-gaap_EarningsPerShareTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_NumberOfCommonStockVotingRights" xlink:label="vor_NumberOfCommonStockVotingRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_IncreaseInAnnualFixedRentalPayments" xlink:label="vor_IncreaseInAnnualFixedRentalPayments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ConversionOfRedeemableConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering" xlink:label="vor_ConversionOfRedeemableConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TemporaryEquityIssuedPricePerShare" xlink:label="vor_TemporaryEquityIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_RedeemableConvertiblePreferredStockTextBlock" xlink:label="vor_RedeemableConvertiblePreferredStockTextBlock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock" xlink:label="us-gaap_FairValueDisclosuresTextBlock"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_AccruedResearchAndDevelopmentExpensesPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued Research and Development Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_AccruedResearchAndDevelopmentExpensesPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Research and Development Expenses, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_AccruedResearchAndDevelopmentExpensesPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued research and development expenses, policy.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Segments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting rights description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Operating Loss Carryforwards, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Preferred Stock Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable convertible preferred stock, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TemporaryEquityStockConvertedDuringPeriodShares_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Conversion of redeemable convertible preferred stock into common stock upon closing of initial public offering, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TemporaryEquityStockConvertedDuringPeriodShares_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Conversion of convertible notes to Redeemable Convertible Preferred Stock, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TemporaryEquityStockConvertedDuringPeriodShares_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity stock converted during period shares.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TemporaryEquityStockConvertedDuringPeriodShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Stock Converted During Period Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_MaturingInOneYearOrLessMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Maturing in one year or less.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_MaturingInOneYearOrLessMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maturing In One Year or Less [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_MaturingInOneYearOrLessMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maturing in One Year or Less</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorLocation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpensesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating expenses:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Class [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Income (Loss)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Loss from operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Loss from operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instrument [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancialInstrumentAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Instrument</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Prepaid Expense and Other Assets, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Prepaid expenses and other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares available for future issuance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Property, Plant, and Equipment, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of property and equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, $0.0001 par value; 400,000,000 and 420,000,000 shares authorized as of December 31, 2021 and December 31, 2020, respectively; 37,375,428 and 893,231 shares issued and 37,174,741 and 505,074 outstanding as of December 31, 2021 and December 31, 2020, respectively</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Value, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Common Stock, Value, Issued, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Common Stock, Value, Issued, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Value, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Liabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity stock issued during period shares new issues.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Stock Issued During Period Shares New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of redeemable convertible preferred stock, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Redeemable convertible preferred stock, issued and sold</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Risk-free interest rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity, Reverse Stock Split</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityReverseStockSplit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' equity, reverse stock split</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Note, Redeemable Preferred Stock, Issue, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common Stock Issuable Upon Conversion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Convertible Preferred Stock, Shares Issued upon Conversion</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average common shares outstanding, basic and diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted-average number of common shares outstanding, basic and diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Exercise Price, Vested and exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangements by Share Based Payment Award Options Vested and Exercised in Period Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangements by share based payment award options vested and exercised in period weighted average exercise price.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, estimated useful lives</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Estimated Useful Lives</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Defined contribution benefit plan, matching contributions amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan, Employer Discretionary Contribution Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and Administrative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_DeferredTaxLiabilitiesLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Lease right of use asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_DeferredTaxLiabilitiesLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Lease Right of Use Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_DeferredTaxLiabilitiesLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax liabilities, lease right of use asset.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ConsideredPercentageOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Considered percentage of ownership for annual limitation of net operating loss and tax credit carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ConsideredPercentageOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Considered Percentage of Ownership for Annual Limitation of Net Operating Loss and Tax Credit Carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ConsideredPercentageOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Considered percentage of ownership for annual limitation of net operating loss and tax credit carryforwards.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Remaining Contractual Term, Exercisable at December 31, 2021</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Exercisable (in years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Accounting Policies [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SignificantAccountingPoliciesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Significant Accounting Policies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Outstanding liability for unvested shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Liabilities, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Weighted-Average Assumptions Used Principally in Determining Fair Value of Options Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable convertible preferred stock, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net total deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net of Valuation Allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">US Treasury Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_USTreasurySecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">U.S. Treasuries</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Adopted [true false]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, adopted [true false]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Exercise Price, Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Potential Dilutive Securities Excluded from Computation of Diluted Net Loss Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common shares upon closing of initial public offering, net of offering costs and underwriter fees, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock shares sold</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-sale</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Debt Securities, Available-for-sale, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Basis of Presentation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, immaterial effect [true false]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Conversion of Convertible Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of redeemable convertible preferred stock into common stock upon closing of initial public offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ColumbiaLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Columbia License Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ColumbiaLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Columbia license agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TwoThousandTwentyOneEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2021 Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TwoThousandTwentyOneEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Two Thousand Twenty One Equity Incentive Plan [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TwoThousandTwentyOneEquityIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand twenty one equity incentive plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in investing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchases of property and equipment in accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares reserved for issuance increase percentage of total number of shares of common stock outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforward, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee-related and other expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Employee-related Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Employee-related Liabilities, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">General and Administrative Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">General and administrative</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_GeneralAndAdministrativeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">General and Administrative Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Net, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Net, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property and equipment, net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Common Stock, Shares, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_SignificantAgreementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Significant agreements.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_SignificantAgreementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Agreements [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Investments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Investments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Investments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Investments, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-sale, Amortized Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Amortized Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Right-of-Use Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease right-of-use assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating right-of-use assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of accrued expenses and other current liabilities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule Of Accrued Expenses And Other Current Liabilities Table [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Accrued Expenses and Other Current Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss attributable to common stockholders</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value assets, transfers out of level 3</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Redeemable Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of Redeemable Convertible Preferred Stock [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_AccruedResearchAndDevelopmentExpensesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_AccruedResearchAndDevelopmentExpensesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued research and development expenses current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_AccruedResearchAndDevelopmentExpensesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Research And Development Expenses Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeCategorizationMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UseOfEstimates_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Use of Estimates</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating lease liabilities, current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementClassOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Adjustments to reconcile net loss to net cash used in operations:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Potential dilutive securities excluded from computation of diluted net loss per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForRent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments for Rent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsForRent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate total fixed rent payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VestingAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Vesting [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VestingAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CurrentFiscalYearEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Current Fiscal Year End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net increase in cash, cash equivalents and restricted cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cash paid for amounts included in the measurement of lease liabilities.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Paid For Amounts Included In The Measurement Of Lease Liabilities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash paid for amounts included in the measurement of lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Other Operating Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Other Operating Assets, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Other assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Existence of Option to Extend [true false]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Shares, Conversion of Convertible Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of redeemable convertible preferred stock into common stock upon closing of initial public offering, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Common stock shares issued for conversion of redeemable convertible preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value assets, transfers into level 3</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2022</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accounts Payable, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_AccruedExpensesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_AccruedExpensesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued expenses.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research tax credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StateAndLocalJurisdictionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">State and Local Jurisdiction [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments, Debt and Equity Securities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_FairValueAssetsLevel1ToLevel2TransferredAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value assets level1 to level2 transferred amount.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_FairValueAssetsLevel1ToLevel2TransferredAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets Level1 to Level2 Transferred Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_FairValueAssetsLevel1ToLevel2TransferredAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value assets, level 1 to level 2 transfers amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid in Capital, Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Additional Paid in Capital, Common Stock, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Additional Paid in Capital, Common Stock, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional paid-in capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_NatureOfBusinessTable_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Nature of business.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_NatureOfBusinessTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nature Of Business [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_NatureOfBusinessTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nature Of Business [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VestingDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Vesting [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VestingDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DomesticCountryMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Domestic Tax Authority [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, $0.0001 par value; 10,000,000 and 0 shares authorized as of December 31, 2021 and December 31, 2020, respectively; 0 shares issued and outstanding as of December 31, 2021 and December 31, 2020</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Value, Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Value, Issued, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Value, Issued, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Preferred Stock, Value, Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease liabilities&#8212;non-current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Operating lease liabilities, non-current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock Options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeStockOptionMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Options to Purchase Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_StockIssuedDuringPeriodSharesStockOptionsVestedAndExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period shares stock options vested and exercised.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_StockIssuedDuringPeriodSharesStockOptionsVestedAndExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Shares Stock Options Vested And Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_StockIssuedDuringPeriodSharesStockOptionsVestedAndExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon vesting and exercise of stock options, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Remaining Contractual Term, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted-Average Remaining Contractual Term, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other current assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Incorporation date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationDateOfIncorporation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, Date of Incorporation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic and Diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss per share attributable to common stockholders, basic and diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Earnings Per Share, Basic and Diluted, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDiluted_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net loss per share attributable to common stockholders, basic and diluted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeasesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leases [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_DeferredTaxLiabilitiesDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Depreciation and amortization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_DeferredTaxLiabilitiesDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Depreciation and Amortization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_DeferredTaxLiabilitiesDepreciationAndAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax liabilities, depreciation and amortization.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_LicenseFeeObligatedToPay_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License fee obligated to pay</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_LicenseFeeObligatedToPay_lbl" xlink:role="http://www.xbrl.org/2003/role/label">License Fee Obligated to Pay</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_LicenseFeeObligatedToPay_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License fee obligated to pay.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Shares, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common stock, shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_OperatingLeaseEstimatedToCommencePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease estimated to commence period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_OperatingLeaseEstimatedToCommencePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Estimated To Commence Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_OperatingLeaseEstimatedToCommencePeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease estimated to commence period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Accumulated depreciation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Shares, Forfeited</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ConsideredPeriodOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Considered period of ownership for annual limitation of net operating loss and tax credit carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ConsideredPeriodOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Considered Period of Ownership for Annual Limitation of Net Operating Loss and Tax Credit Carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ConsideredPeriodOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Considered period of ownership for annual limitation of net operating loss and tax credit carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total operating expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">IPO [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IPOMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">IPO</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Instruments [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Instruments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common shares upon closing of initial public offering, offering costs and underwriter fees</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Gross Unrealized Holding losses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Weighted-Average Exercise Price, Outstanding at December 31, 2020</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Weighted-Average Exercise Price, Outstanding at December 31, 2021</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flows from operating activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounting standards update [Extensible list]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Amortized Cost and Estimated Fair Value of Investments by Contractual Maturity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Future Lease Payments for Noncancelable Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Gross Unrealized Holding Gains</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2023</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net loss and comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Reconciliation of Federal Statutory Income Rate to Effective Income Tax Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Line of Credit Facility, Increase (Decrease), Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in irrevocable line of credit facility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Line of Credit Facility, Increase (Decrease), Net, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued Expenses and Other Current Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_MaturingAfterOneYearThroughFiveYearsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Maturing after one year through five years.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_MaturingAfterOneYearThroughFiveYearsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maturing After One Year Through Five Years [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_MaturingAfterOneYearThroughFiveYearsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maturing after One Year through Five Years</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ConcentrationRiskCreditRisk_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Concentrations of Credit Risk</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average discount rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Period Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Stock Issued During Period, Value, New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of redeemable convertible preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income tax examination, description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxExaminationDescription_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Examination, Description</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccountingPoliciesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Policies [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Restricted cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash Equivalents, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Intrinsic value of stock options exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Shares, Outstanding at December 31, 2020</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Shares, Outstanding at December 31, 2021</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total current liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProfitLoss_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_SignificantAgreementsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Significant Agreements.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_SignificantAgreementsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Significant Agreements [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_SignificantAgreementsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Significant Agreements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value, Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductsAndServicesDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product and Service [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Carrying Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Carrying Amount, Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable convertible preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_DeferredTaxAssetsLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_DeferredTaxAssetsLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_DeferredTaxAssetsLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets, lease liability.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance Initial Public Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from the issuance of common stock upon closing of initial public offering, net of underwriter fees</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Net proceeds from issuance of IPO</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash used in operating activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash, cash equivalents and restricted cash equivalents, end of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash, cash equivalents and restricted cash equivalents, beginning of period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total cash, cash equivalents and restricted cash equivalents as shown on the statements of cash flows</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_AccruedLicenseAndMilestoneFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">License and milestone fees</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_AccruedLicenseAndMilestoneFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Accrued license and milestone fees current.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_AccruedLicenseAndMilestoneFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued License And Milestone Fees Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Components [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementEquityComponentsAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Components</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease, Cost [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseCostTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Lease Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current assets:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Variable Lease, Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_VariableLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Variable lease cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted-average grant date fair value exercised but unvested at the time of exercise</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share-based compensation arrangement by share-based payment award options vested and expected to vest exercisable weighted average grant date fair value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityInteractiveDataCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Interactive Data Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_CambridgeparkLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cambridgepark Lease</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_CambridgeparkLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cambridgepark Lease Member</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_CambridgeparkLeaseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Cambridgepark lease.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected term (in years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flow from investing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_SecondLeaseAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Second lease amendment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_SecondLeaseAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Second Lease Amendment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_SecondLeaseAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Second Lease Amendment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Less: imputed interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Less: imputed interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total stockholders' equity (deficit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Attributable to Parent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_RestrictedCashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Restricted cash equivalents.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_RestrictedCashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Restricted Cash Equivalents [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_RestrictedCashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Cash Equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Unrecognized benefit at end of year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized tax benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefits_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Unrecognized Tax Benefits, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RedeemablePreferredStockDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Redeemable Preferred Stock Dividends</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RedeemablePreferredStockDividends_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Cumulative dividends on redeemable convertible preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of shares converted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion, Converted Instrument, Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeasePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating cash flows for operating leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Comprehensive loss</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Preferred Stock, Shares Issued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_OperatingLeaseWeightedAverageLeaseTermAndDiscountRateAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted Average Lease Term and Discount Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_OperatingLeaseWeightedAverageLeaseTermAndDiscountRateAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Lease Term and Discount Rate [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_OperatingLeaseWeightedAverageLeaseTermAndDiscountRateAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease, weighted average lease term and discount rate.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets, Fair Value Disclosure</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AssetsFairValueDisclosure_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statistical Measurement [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_RangeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statistical Measurement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntitySmallBusiness_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Small Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Preferred Stock, Shares Outstanding, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Preferred Stock, Shares Outstanding, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credits</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Credit Carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Tax Credit Carryforwards, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeasesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Leases [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Strike price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">APIC, Share-based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CreditFacilityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Credit Facility [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CreditFacilityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit Facility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Significant Components of Deferred Tax Assets and Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Deferred Tax Assets and Liabilities [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Impairment of Long-Lived Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and Development Tax Credit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research Tax Credit Carryforward [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Tranche Two [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche Two</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockVotingRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock, Voting Rights</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, estimated useful life</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Useful Life</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Location [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TaxCreditCarryforwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tax credit carryforwards expiration year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TaxCreditCarryforwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Tax Credit Carryforwards Expiration Year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TaxCreditCarryforwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Tax credit carryforwards expiration year.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_OperatingLeaseAssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease assets.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_OperatingLeaseAssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Assets [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_OperatingLeaseAssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Measurement, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TemporaryEquityCumulativeUndeclaredDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cumulative Undeclared Dividends</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TemporaryEquityCumulativeUndeclaredDividends_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity cumulative undeclared dividends.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_SeriesBRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series B redeemable convertible preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_SeriesBRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series B Redeemable Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_SeriesBRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series B Redeemable Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_SeriesBRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series B</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfRegulatoryAndCommercialMilestones_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Aggregate potential milestone payments upon achievement of regulatory and commercial milestones</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfRegulatoryAndCommercialMilestones_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement potential milestone payments upon achievement of regulatory and commercial milestones.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Income (Loss) Attributable to Parent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetIncomeLossAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Numerator:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred Offering Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredChargesPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Charges, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Exercise Price, Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Preferred Stock Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesIssued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable convertible preferred stock, shares issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingGainsLossesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other income:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingGainsLossesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Gains (Losses) [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Exercise Price, Expired</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_OperatingLeaseCommencementPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating lease, commencement period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_OperatingLeaseCommencementPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease Commencement Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_OperatingLeaseCommencementPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating lease commencement period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Thereafter</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Plan Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Plan Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Lease, Description [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee Lease Description [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Class of Stock [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ClassOfStockLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Class Of Stock [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Components of Deferred Tax Assets [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Depreciation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Depreciation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Depreciation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Depreciation, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Term of Contract</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Prepaid Expense, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Prepaid expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PrepaidExpenseCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Prepaid Expense, Current, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in deferred tax asset valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State income tax benefit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_EffectiveIncomeTaxRateReconciliationPermanentItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Permanent items</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_EffectiveIncomeTaxRateReconciliationPermanentItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation Permanent Items</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_EffectiveIncomeTaxRateReconciliationPermanentItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Effective income tax rate reconciliation permanent items.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common shares upon closing of initial public offering, net of offering costs and underwriter fees of $17,132</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_OperatingLossCarryforwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards expiration year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_OperatingLossCarryforwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards Expiration Year</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_OperatingLossCarryforwardsExpirationYear_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating loss carryforwards expiration year.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_Definedcontributionplanminimumannualcontributionsperemployeepercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Defined contribution benefit plan, minimum percentage of employee's compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_Definedcontributionplanminimumannualcontributionsperemployeepercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">DefinedContributionPlanMinimumAnnualContributionsPerEmployeePercent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_Definedcontributionplanminimumannualcontributionsperemployeepercent_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Defined contribution plan minimum annual contributions per employee percent.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-based compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensation_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Share-based Payment Arrangement, Noncash Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock Option Activity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredOfferingCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Offering Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Other Adjustments, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares, Exercisable at December 31, 2021</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net cash provided by financing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Right-of-use assets obtained in exchange for lease obligations</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_LicenseAgreementMilestonePaymentsOnAggregateNetSales_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Milestone payments on aggregate net sales</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_LicenseAgreementMilestonePaymentsOnAggregateNetSales_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement milestone payments on aggregate net sales.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TemporaryEquityStockConvertedDuringPeriodValue_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel">Conversion of redeemable convertible preferred stock into common stock upon closing of initial public offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TemporaryEquityStockConvertedDuringPeriodValue_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Conversion of convertible notes to Redeemable Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TemporaryEquityStockConvertedDuringPeriodValue_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary equity stock converted during period value.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TemporaryEquityStockConvertedDuringPeriodValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Stock Converted During Period Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_Assets_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel2Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 2</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_NationalInstitutesOfHealthLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">National Institutes of Health License Agreement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_NationalInstitutesOfHealthLicenseAgreementMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">National institutes of health license agreement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Leases [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeasesTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leases</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Shares, Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of stock options, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued interest and penalties related to uncertain tax positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Shares, Vested and exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement by Share Based Payment Award Options Vested and Exercised in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options vested and exercised in period.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_BalanceSheetLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Balance Sheet Location [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfCashFlowsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Cash Flows [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Paid-in Capital [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AdditionalPaidInCapitalMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional Paid-In Capital</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards subject to expiration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Asset, Aging [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Asset, Period Past Due</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel3Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 3</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityWellKnownSeasonedIssuer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Well-known Seasoned Issuer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Loss Carryforwards [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StandbyLettersOfCreditMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Standby Letters of Credit [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StandbyLettersOfCreditMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Standby Letters of Credit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Vesting percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Hierarchy and NAV</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Shares, expired</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Contractual term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Income, Interest</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentIncomeInterest_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Supplemental Cash Flow Elements [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SupplementalCashFlowElementsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Supplemental disclosure of non-cash activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Accounts Payable and Accrued Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accounts payable and accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_DefinedContributionPlanFirstPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Defined contribution benefit plan, first percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_DefinedContributionPlanFirstPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan First Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_DefinedContributionPlanFirstPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Defined contribution plan, first percentage.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Property and Equipment, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueInputsLevel1Member_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Level 1</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Share based compensation arrangement by share based payment award options unvested exercised in period weighted average exercise price.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Exercised In Period Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted average exercise price of options exercised and unvested</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_NatureOfBusinessLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Nature of business.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_NatureOfBusinessLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nature Of Business [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_NatureOfBusinessLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nature Of Business [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2025</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Net deferred tax assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total other income</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NonoperatingIncomeExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nonoperating Income (Expense)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Corporate Debt Securities [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CorporateDebtSecuritiesMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Corporate Debt</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedTotalLabel">Total deferred tax liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Liabilities, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Liabilities, Net, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liquidation Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquityLiquidationPreference_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable convertible preferred stock, liquidation preference</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Shares, Granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Stock options granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCurrentReportingStatus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Current Reporting Status</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ScheduleOfOperatingLeaseAssetsAndLiabilitiesWeightedAverageLeaseTermAndDiscountRateTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Amounts Reported in Consolidated Balance Sheets and Weight-average Lease Term and Discount Rate Information</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ScheduleOfOperatingLeaseAssetsAndLiabilitiesWeightedAverageLeaseTermAndDiscountRateTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Operating Lease Assets and Liabilities, Weighted Average Lease Term and Discount Rate [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ScheduleOfOperatingLeaseAssetsAndLiabilitiesWeightedAverageLeaseTermAndDiscountRateTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of operating lease assets and liabilities, weighted average lease term and discount rate.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Investment Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InvestmentTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investment Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_OperatingRightOfUseAssetsAndOperatingLeaseLiabilityRecordedUponLeaseCommencement_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Operating right-of-use assets and operating lease liability recorded upon lease commencement.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_OperatingRightOfUseAssetsAndOperatingLeaseLiabilityRecordedUponLeaseCommencement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Right Of Use Assets And Operating Lease Liability Recorded Upon Lease Commencement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_OperatingRightOfUseAssetsAndOperatingLeaseLiabilityRecordedUponLeaseCommencement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Operating right-of-use assets and operating lease liability recorded upon lease commencement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityVoluntaryFilers_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Voluntary Filers</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">State net operating loss carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, State and Local</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Money Market Funds [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_MoneyMarketFundsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Money Market Funds</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Documents Incorporated by Reference [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentsIncorporatedByReferenceTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Documents Incorporated by Reference</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-sale [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Securities Available For Sale [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividends paid</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfDividendsCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Ordinary Dividends, Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerSharePolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Defined contribution benefit plan, matching percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Stock-Based Compensation Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retirement Benefits [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Computer Equipment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComputerEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Computer Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorFirmId_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Firm ID</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Statement Location [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeStatementLocationDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Statement Location</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Tranche One [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Tranche One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AuditorName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Auditor Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Shares Authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockSharesAuthorized_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, shares authorized</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other Assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-Average Exercise Price, Exercisable at December 31, 2021</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Interest and penalties related to uncertain tax positions</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Minimum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MinimumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Minimum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon exercise of stock options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_DeferredTaxAssetsAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amortization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_DeferredTaxAssetsAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets Amortization</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_DeferredTaxAssetsAmortization_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred tax assets amortization.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherOperatingActivitiesCashFlowStatement_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherOperatingActivitiesCashFlowStatement_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Operating Activities, Cash Flow Statement</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentAnnualReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Annual Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax assets valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Valuation allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Valuation Allowance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Deferred Tax Assets, Valuation Allowance, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash flow from financing activities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Foreign Currency Transaction Gains or Losses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFilerCategory_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Filer Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Fiscal Year Focus</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of shares exercised but unvested at the time of exercise</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Weighted-average grant-date fair value of stock options granted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value of common stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings (Accumulated Deficit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Retained Earnings (Accumulated Deficit), Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Retained Earnings (Accumulated Deficit), Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Retained Earnings (Accumulated Deficit), Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_SeriesAOneRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A - one redeemable convertible preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_SeriesAOneRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A One Redeemable Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_SeriesAOneRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A-1 Redeemable Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_FirstLeaseAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">First lease amendment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_FirstLeaseAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">First Lease Amendment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_FirstLeaseAmendmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">First Lease Amendment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Income Taxes</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number unvested options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-term Lease, Cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermLeaseCost_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Short-term lease cost</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Maximum [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_MaximumMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Maximum</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Restricted Cash</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TwoThousandFifteenStockIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">2015 Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TwoThousandFifteenStockIncentivePlanMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Two thousand fifteen stock incentive plan.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_FurnitureAndEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Furniture and equipment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_FurnitureAndEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Furniture And Equipment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_FurnitureAndEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Furniture and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PayablesAndAccrualsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payables and Accruals [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Non-cash interest expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Non-cash lease expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and Cash Equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Equity Component [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EquityComponentDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Equity Component</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Preferred stock, par value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Expected volatility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_LicenseAgreementPotentialMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Aggregate potential milestone payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_LicenseAgreementPotentialMilestonePayments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement potential milestone payments.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and Equipment, Net</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders' equity, stock split, conversion ratio</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Note, Stock Split, Conversion Ratio</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_AdditionalSpaceLeased_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Additional space leased.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_AdditionalSpaceLeased_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional Space Leased</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_AdditionalSpaceLeased_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Additional space leased</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncomeTaxAuthorityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Income Tax Authority [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized share based compensation expense, recognition period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net operating loss carryforwards not subject to expiration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InformationByCategoryOfDebtSecurityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Security Category [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_InformationByCategoryOfDebtSecurityAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Debt Security Category</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Change in Accounting Principle, Accounting Standards Update, Adoption Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Change in accounting principle, accounting standards update, adoption date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Leasehold Improvements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseholdImprovementsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Leasehold Improvements [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Estimated Useful Life of Property and Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property Plant and Equipment Expected Useful Life [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Property plant and equipment expected useful life.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LicenseMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Licensed Products</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Weighted-average exercise price exercised but unvested at the time of exercise</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Statement [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Weighted-average remaining lease term (years)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash Equivalents [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashEquivalentsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash Equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Lease, Description [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lessee Lease Description [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retained Earnings [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_RetainedEarningsMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accumulated Deficit</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Payment of initial public offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Payment of initial public offering costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsOfStockIssuanceCosts_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments of Stock Issuance Costs</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal net operating loss carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Operating Loss Carryforwards, Domestic</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Additional stock issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary Equity Additional Stock Issued During Period Shares New Issues</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Current [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesCurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Current liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Denominator:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Commitments and Contingencies</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Present value of lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Operating Lease, Liability</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OperatingLeaseLiability_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Total lease liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Common Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CommonStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment, Gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Property, Plant and Equipment, Gross, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Property, Plant and Equipment, Gross, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property and equipment, gross</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentGross_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Property, Plant and Equipment, Gross, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Professional fees</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AccruedProfessionalFeesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Accrued Professional Fees, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityPublicFloat_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Public Float</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Shares, Expired</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CreditFacilityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Credit Facility [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CreditFacilityDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Credit Facility</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Asset Class [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByAssetClassAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Asset Class</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development tax credit carryforwards</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Credit Carryforwards, Research</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Issuance of Redeemable Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from issuance of redeemable convertible preferred stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Gross proceeds from stock issued</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred tax liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Components of Deferred Tax Liabilities [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Preferred Stock Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Ending Balance, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Beginning Balance, Shares</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TemporaryEquitySharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable convertible preferred stock, shares outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Property Plant And Equipment [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of operating segment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NumberOfOperatingSegments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number of Operating Segments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recently Issued Accounting Pronouncements Not Yet Adopted</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Recently Issued Accounting Pronouncements Not Yet Adopted, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Recently issued accounting pronouncements not yet adopted, policy.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-Lived Tangible Asset</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAccruedLiabilitiesCurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Accrued Liabilities, Current</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentTransitionReport_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Transition Report</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_FairValueAssetsLevel2ToLevel1TransferredAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Fair value assets level2 to level1 transferred amount.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_FairValueAssetsLevel2ToLevel1TransferredAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Assets Level2 to Level1 Transferred Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_FairValueAssetsLevel2ToLevel1TransferredAmount_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair value assets, level 2 to level 1 transfers amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Proceeds from Stock Options Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ProceedsFromStockOptionsExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Proceeds from stock option exercises</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_DefinedContributionPlanAdditionalPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Defined contribution benefit plan, additional percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_DefinedContributionPlanAdditionalPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan Additional Percentage</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_DefinedContributionPlanAdditionalPercentage_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Defined contribution plan, additional percentage.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Convertible notes value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Conversion, Original Debt, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Defined contribution benefit plan, maximum percentage of employee's compensation</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Research and Development Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Research and development</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ResearchAndDevelopmentExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Research and Development Expense, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_LaboratoryEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Laboratory equipment.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_LaboratoryEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Laboratory Equipment [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_LaboratoryEquipmentMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Laboratory Equipment</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfClinicalMilestones_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Aggregate potential milestone payments upon achievement of clinical milestones</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfClinicalMilestones_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">License agreement potential milestone payments upon achievement of clinical milestones.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DividendsCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividends declared</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DividendsCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Dividends, Common Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DividendsCommonStock_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Dividends, Common Stock, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Total stock-based compensation expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ScheduleOfOtherLeaseActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Summary of Other Lease Activity</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ScheduleOfOtherLeaseActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Other Lease Activity [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ScheduleOfOtherLeaseActivityTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Schedule of other lease activity.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StatementOfFinancialPositionAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Statement of Financial Position [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Expected dividend yield</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Dividend yield</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseContractualTermAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Contractual Term [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseContractualTermAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2026</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Federal income tax rate</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_StockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stockholders&#8217; equity (deficit):</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NatureOfOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Nature of Operations [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NatureOfOperations_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Nature of the Business</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseContractualTermDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lease Contractual Term [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LeaseContractualTermDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Lease Contractual Term</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Deferred offering costs in accounts payable and accrued expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Deferred offering costs in accounts payable and accrued expenses.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Deferred Offering Costs In Accounts Payable And Accrued Expenses</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Stock-Based Compensation Expense</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Compensation Related Costs, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Purchases of investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Purchases of investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Payments to Acquire Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PaymentsToAcquireInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Payments to Acquire Investments, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule of Computation of Basic and Diluted Net Loss Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Financial Asset, Aging [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Financial Asset, Period Past Due</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Changes in operating assets and liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_StockIssuedDuringPeriodValueStockOptionsVestedAndExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Stock issued during period value stock options vested and exercised.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_StockIssuedDuringPeriodValueStockOptionsVestedAndExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Stock Issued During Period Value Stock Options Vested And Exercised</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_StockIssuedDuringPeriodValueStockOptionsVestedAndExercised_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Issuance of common stock upon vesting and exercise of stock options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">2024</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Common Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCommonStockSharesOutstanding_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Common Stock, Shares Outstanding</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Measurement Frequency [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Measurement Frequency</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Award Type [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AwardTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Award Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityShellCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Shell Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock, Price Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SaleOfStockPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Public offering price per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Debt Securities, Available-for-sale [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Available For Sale Securities [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities and Equity [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Defined Contribution Benefit Plan</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Retirement Benefits [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_IcfrAuditorAttestationFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">ICFR Auditor Attestation Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_SeriesATwoRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Series A - two redeemable convertible preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_SeriesATwoRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Series A Two Redeemable Convertible Preferred Stock [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_SeriesATwoRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Series A-2 Redeemable Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_SeriesATwoRedeemableConvertiblePreferredStockMember_lbl" xlink:role="http://www.xbrl.org/2003/role/verboseLabel">Series A-2</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Earnings Per Share [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EarningsPerShareTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Net Loss Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_NumberOfCommonStockVotingRights_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Number of common stock voting rights</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_NumberOfCommonStockVotingRights_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Number Of Common Stock Voting Rights</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_NumberOfCommonStockVotingRights_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Number Of Common Stock Voting Rights</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Liabilities, Noncurrent [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Long-term liabilities:</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Schedule of Stock by Class [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ScheduleOfStockByClassTable_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Schedule Of Stock By Class [Table]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="srt_ProductOrServiceAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Product and Service [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Short-term Investments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_ShortTermInvestments_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Short-term Investments, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel">Cash and Cash Equivalents, at Carrying Value, Ending Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel">Cash and Cash Equivalents, at Carrying Value, Beginning Balance</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cash and cash equivalents</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Cash and Cash Equivalents, at Carrying Value, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Recent Accounting Pronouncements and Recently Adopted Accounting Pronouncements</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_IncreaseInAnnualFixedRentalPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Increase in annual fixed rental payments.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_IncreaseInAnnualFixedRentalPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Increase In Annual Fixed Rental Payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_IncreaseInAnnualFixedRentalPayments_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Increase in annual fixed rental payments</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xlink:role="http://www.xbrl.org/2009/role/negatedLabel">Permanent items</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Permanent items</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Unrecognized compensation expense related to stock options</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value, Recurring [Member]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueMeasurementsRecurringMember_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value, Recurring</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ConversionOfRedeemableConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Conversion of redeemable convertible preferred stock to common stock upon closing of the initial public offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ConversionOfRedeemableConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Conversion Of Redeemable Convertible Preferred Stock To Common Stock Upon Closing Of Initial Public Offering</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_ConversionOfRedeemableConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Conversion of redeemable convertible preferred stock to common stock upon closing of initial public offering.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TemporaryEquityIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Temporary Equity issued price per share.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TemporaryEquityIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Temporary Equity Issued Price Per Share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_TemporaryEquityIssuedPricePerShare_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Redeemable convertible preferred stock, price per share</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_RedeemableConvertiblePreferredStockTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Redeemable Convertible Preferred Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="vor_RedeemableConvertiblePreferredStockTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/documentation">Redeemable convertible preferred stock.</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Antidilutive Securities, Name [Domain]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Antidilutive Securities, Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Property, Plant and Equipment [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Property Plant And Equipment [Line Items]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Other Assets, Noncurrent</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Other assets</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_OtherAssetsNoncurrent_lbl" xlink:role="http://www.xbrl.org/2003/role/totalLabel">Other Assets, Noncurrent, Total</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_TypeOfArrangementAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Collaborative Arrangement and Arrangement Other than Collaborative [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Aggregate Intrinsic Value, Exercisable at December 31, 2021</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Exercisable at December 31, 2020</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Sale of Stock [Axis]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_SubsidiarySaleOfStockAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Sale of Stock</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Fair Value Disclosures [Text Block]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="us-gaap_FairValueDisclosuresTextBlock_lbl" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Fair Value Measurements</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_AccruedResearchAndDevelopmentExpensesPolicyPolicyTextBlock" xlink:to="vor_AccruedResearchAndDevelopmentExpensesPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="us-gaap_SegmentReportingPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwards" xlink:to="us-gaap_OperatingLossCarryforwards_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesAuthorized" xlink:to="us-gaap_TemporaryEquitySharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_TemporaryEquityStockConvertedDuringPeriodShares" xlink:to="vor_TemporaryEquityStockConvertedDuringPeriodShares_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_MaturingInOneYearOrLessMember" xlink:to="vor_MaturingInOneYearOrLessMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorLocation" xlink:to="dei_AuditorLocation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpensesAbstract" xlink:to="us-gaap_OperatingExpensesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingIncomeLoss" xlink:to="us-gaap_OperatingIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="us-gaap_IncreaseDecreaseInOperatingLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentPolicyTextBlock" xlink:to="us-gaap_InvestmentPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureAbstract" xlink:to="us-gaap_IncomeTaxDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_FinancialInstrumentAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockValue" xlink:to="us-gaap_CommonStockValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Liabilities" xlink:to="us-gaap_Liabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:to="vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityReverseStockSplit" xlink:to="us-gaap_StockholdersEquityReverseStockSplit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy" xlink:to="us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="us-gaap_ClassOfStockDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriodWeightedAverageExercisePrice" xlink:to="vor_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount" xlink:to="us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpenseMember" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_DeferredTaxLiabilitiesLeaseRightOfUseAsset" xlink:to="vor_DeferredTaxLiabilitiesLeaseRightOfUseAsset_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_ConsideredPercentageOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards" xlink:to="vor_ConsideredPercentageOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="us-gaap_SignificantAccountingPoliciesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherLiabilitiesCurrent" xlink:to="us-gaap_OtherLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsGross" xlink:to="us-gaap_DeferredTaxAssetsGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsNet" xlink:to="us-gaap_DeferredTaxAssetsNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_USTreasurySecuritiesMember" xlink:to="us-gaap_USTreasurySecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="us-gaap_BasisOfAccountingPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementAbstract" xlink:to="us-gaap_IncomeStatementAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_ColumbiaLicenseAgreementMember" xlink:to="vor_ColumbiaLicenseAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_TwoThousandTwentyOneEquityIncentivePlanMember" xlink:to="vor_TwoThousandTwentyOneEquityIncentivePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="us-gaap_CapitalExpendituresIncurredButNotYetPaid_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="us-gaap_EmployeeRelatedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_GeneralAndAdministrativeExpense" xlink:to="us-gaap_GeneralAndAdministrativeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentNet" xlink:to="us-gaap_PropertyPlantAndEquipmentNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesIssued" xlink:to="us-gaap_CommonStockSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_SignificantAgreementsAbstract" xlink:to="vor_SignificantAgreementsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Investments" xlink:to="us-gaap_Investments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock" xlink:to="vor_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeMember" xlink:to="srt_RangeMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock" xlink:to="vor_ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_AccruedResearchAndDevelopmentExpensesCurrent" xlink:to="vor_AccruedResearchAndDevelopmentExpensesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_InvestmentTypeCategorizationMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedLiabilitiesCurrent" xlink:to="us-gaap_AccruedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesAuthorized" xlink:to="us-gaap_CommonStockSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UseOfEstimates" xlink:to="us-gaap_UseOfEstimates_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsForRent" xlink:to="us-gaap_PaymentsForRent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock" xlink:to="us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CurrentFiscalYearEndDate" xlink:to="dei_CurrentFiscalYearEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseCost" xlink:to="us-gaap_OperatingLeaseCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" xlink:to="vor_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOtherOperatingAssets" xlink:to="us-gaap_IncreaseDecreaseInOtherOperatingAssets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:to="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:to="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3" xlink:to="us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableCurrent" xlink:to="us-gaap_AccountsPayableCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_AccruedExpensesMember" xlink:to="vor_AccruedExpensesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StateAndLocalJurisdictionMember" xlink:to="us-gaap_StateAndLocalJurisdictionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract" xlink:to="us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_FairValueAssetsLevel1ToLevel2TransferredAmount" xlink:to="vor_FairValueAssetsLevel1ToLevel2TransferredAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalCommonStock" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsMember" xlink:to="us-gaap_InvestmentsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="us-gaap_ResearchAndDevelopmentExpensePolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_NatureOfBusinessTable" xlink:to="vor_NatureOfBusinessTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_VestingDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock" xlink:to="us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DomesticCountryMember" xlink:to="us-gaap_DomesticCountryMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockValue" xlink:to="us-gaap_PreferredStockValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrent" xlink:to="us-gaap_AssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeStockOptionMember" xlink:to="us-gaap_EmployeeStockOptionMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_StockIssuedDuringPeriodSharesStockOptionsVestedAndExercised" xlink:to="vor_StockIssuedDuringPeriodSharesStockOptionsVestedAndExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsCurrent" xlink:to="us-gaap_OtherAssetsCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationDateOfIncorporation" xlink:to="dei_EntityIncorporationDateOfIncorporation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="us-gaap_EarningsPerShareBasicAndDiluted_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeasesAbstract" xlink:to="us-gaap_LeasesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_DeferredTaxLiabilitiesDepreciationAndAmortization" xlink:to="vor_DeferredTaxLiabilitiesDepreciationAndAmortization_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_LicenseFeeObligatedToPay" xlink:to="vor_LicenseFeeObligatedToPay_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockSharesOutstanding" xlink:to="us-gaap_CommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_OperatingLeaseEstimatedToCommencePeriod" xlink:to="vor_OperatingLeaseEstimatedToCommencePeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_ConsideredPeriodOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards" xlink:to="vor_ConsideredPeriodOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingExpenses" xlink:to="us-gaap_OperatingExpenses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IPOMember" xlink:to="us-gaap_IPOMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCost" xlink:to="us-gaap_LeaseCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="us-gaap_AccountingStandardsUpdateExtensibleList_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_OperatingLossCarryforwardsTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareAbstract" xlink:to="us-gaap_EarningsPerShareAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLoss" xlink:to="us-gaap_NetIncomeLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock" xlink:to="us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:to="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock" xlink:to="us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_MaturingAfterOneYearThroughFiveYearsMember" xlink:to="vor_MaturingAfterOneYearThroughFiveYearsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ConcentrationRiskCreditRisk" xlink:to="us-gaap_ConcentrationRiskCreditRisk_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxExaminationDescription" xlink:to="us-gaap_IncomeTaxExaminationDescription_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccountingPoliciesAbstract" xlink:to="us-gaap_AccountingPoliciesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:to="us-gaap_RestrictedCashEquivalentsNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrent" xlink:to="us-gaap_LiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProfitLoss" xlink:to="us-gaap_ProfitLoss_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_SignificantAgreementsTextBlock" xlink:to="vor_SignificantAgreementsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductsAndServicesDomain" xlink:to="srt_ProductsAndServicesDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_DeferredTaxAssetsLeaseLiability" xlink:to="vor_DeferredTaxAssetsLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInOperatingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations" xlink:to="us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_AccruedLicenseAndMilestoneFeesCurrent" xlink:to="vor_AccruedLicenseAndMilestoneFeesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_StatementEquityComponentsAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseCostTableTextBlock" xlink:to="us-gaap_LeaseCostTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_VariableLeaseCost" xlink:to="us-gaap_VariableLeaseCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue" xlink:to="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="us-gaap_StockholdersEquityNoteDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityInteractiveDataCurrent" xlink:to="dei_EntityInteractiveDataCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_CambridgeparkLeaseMember" xlink:to="vor_CambridgeparkLeaseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_SecondLeaseAmendmentMember" xlink:to="vor_SecondLeaseAmendmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquity" xlink:to="us-gaap_StockholdersEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_RestrictedCashEquivalentsMember" xlink:to="vor_RestrictedCashEquivalentsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefits" xlink:to="us-gaap_UnrecognizedTaxBenefits_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RedeemablePreferredStockDividends" xlink:to="us-gaap_RedeemablePreferredStockDividends_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeasePayments" xlink:to="us-gaap_OperatingLeasePayments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesIssued" xlink:to="us-gaap_PreferredStockSharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_OperatingLeaseWeightedAverageLeaseTermAndDiscountRateAbstract" xlink:to="vor_OperatingLeaseWeightedAverageLeaseTermAndDiscountRateAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AssetsFairValueDisclosure" xlink:to="us-gaap_AssetsFairValueDisclosure_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_RangeAxis" xlink:to="srt_RangeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntitySmallBusiness" xlink:to="dei_EntitySmallBusiness_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesOutstanding" xlink:to="us-gaap_PreferredStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwards_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="us-gaap_LesseeLeasesPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharePrice" xlink:to="us-gaap_SharePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock" xlink:to="us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchMember" xlink:to="us-gaap_ResearchMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockVotingRights" xlink:to="us-gaap_CommonStockVotingRights_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_TaxCreditCarryforwardsExpirationYear" xlink:to="vor_TaxCreditCarryforwardsExpirationYear_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_OperatingLeaseAssetsAbstract" xlink:to="vor_OperatingLeaseAssetsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementPolicyPolicyTextBlock" xlink:to="us-gaap_FairValueMeasurementPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_TemporaryEquityCumulativeUndeclaredDividends" xlink:to="vor_TemporaryEquityCumulativeUndeclaredDividends_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_SeriesBRedeemableConvertiblePreferredStockMember" xlink:to="vor_SeriesBRedeemableConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfRegulatoryAndCommercialMilestones" xlink:to="vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfRegulatoryAndCommercialMilestones_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetIncomeLossAbstract" xlink:to="us-gaap_NetIncomeLossAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredChargesPolicyTextBlock" xlink:to="us-gaap_DeferredChargesPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesIssued" xlink:to="us-gaap_TemporaryEquitySharesIssued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingGainsLossesAbstract" xlink:to="us-gaap_NonoperatingGainsLossesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityAbstract" xlink:to="us-gaap_EquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_OperatingLeaseCommencementPeriod" xlink:to="vor_OperatingLeaseCommencementPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PlanNameDomain" xlink:to="us-gaap_PlanNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LesseeLeaseDescriptionTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ClassOfStockLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxAssetsAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxAssetsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Depreciation" xlink:to="us-gaap_Depreciation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PrepaidExpenseCurrent" xlink:to="us-gaap_PrepaidExpenseCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_EffectiveIncomeTaxRateReconciliationPermanentItems" xlink:to="vor_EffectiveIncomeTaxRateReconciliationPermanentItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_OperatingLossCarryforwardsExpirationYear" xlink:to="vor_OperatingLossCarryforwardsExpirationYear_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_Definedcontributionplanminimumannualcontributionsperemployeepercent" xlink:to="vor_Definedcontributionplanminimumannualcontributionsperemployeepercent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensation" xlink:to="us-gaap_ShareBasedCompensation_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredOfferingCosts" xlink:to="us-gaap_DeferredOfferingCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_LicenseAgreementMilestonePaymentsOnAggregateNetSales" xlink:to="vor_LicenseAgreementMilestonePaymentsOnAggregateNetSales_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_TemporaryEquityStockConvertedDuringPeriodValue" xlink:to="vor_TemporaryEquityStockConvertedDuringPeriodValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_Assets" xlink:to="us-gaap_Assets_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel2Member" xlink:to="us-gaap_FairValueInputsLevel2Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_NationalInstitutesOfHealthLicenseAgreementMember" xlink:to="vor_NationalInstitutesOfHealthLicenseAgreementMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="us-gaap_LesseeOperatingLeasesTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriod" xlink:to="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_BalanceSheetLocationDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfCashFlowsAbstract" xlink:to="us-gaap_StatementOfCashFlowsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AdditionalPaidInCapitalMember" xlink:to="us-gaap_AdditionalPaidInCapitalMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:to="us-gaap_FinancingReceivablesPeriodPastDueDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel3Member" xlink:to="us-gaap_FairValueInputsLevel3Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityWellKnownSeasonedIssuer" xlink:to="dei_EntityWellKnownSeasonedIssuer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StandbyLettersOfCreditMember" xlink:to="us-gaap_StandbyLettersOfCreditMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentIncomeInterest" xlink:to="us-gaap_InvestmentIncomeInterest_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SupplementalCashFlowElementsAbstract" xlink:to="us-gaap_SupplementalCashFlowElementsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities" xlink:to="us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_DefinedContributionPlanFirstPercentage" xlink:to="vor_DefinedContributionPlanFirstPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueInputsLevel1Member" xlink:to="us-gaap_FairValueInputsLevel1Member_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice" xlink:to="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="vor_NatureOfBusinessLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsLiabilitiesNet" xlink:to="us-gaap_DeferredTaxAssetsLiabilitiesNet_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NonoperatingIncomeExpense" xlink:to="us-gaap_NonoperatingIncomeExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CorporateDebtSecuritiesMember" xlink:to="us-gaap_CorporateDebtSecuritiesMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxLiabilities" xlink:to="us-gaap_DeferredTaxLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquityLiquidationPreference" xlink:to="us-gaap_TemporaryEquityLiquidationPreference_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCurrentReportingStatus" xlink:to="dei_EntityCurrentReportingStatus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_ScheduleOfOperatingLeaseAssetsAndLiabilitiesWeightedAverageLeaseTermAndDiscountRateTableTextBlock" xlink:to="vor_ScheduleOfOperatingLeaseAssetsAndLiabilitiesWeightedAverageLeaseTermAndDiscountRateTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_OperatingRightOfUseAssetsAndOperatingLeaseLiabilityRecordedUponLeaseCommencement" xlink:to="vor_OperatingRightOfUseAssetsAndOperatingLeaseLiabilityRecordedUponLeaseCommencement_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityVoluntaryFilers" xlink:to="dei_EntityVoluntaryFilers_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_MoneyMarketFundsMember" xlink:to="us-gaap_MoneyMarketFundsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentsIncorporatedByReferenceTextBlock" xlink:to="dei_DocumentsIncorporatedByReferenceTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfDividendsCommonStock" xlink:to="us-gaap_PaymentsOfDividendsCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="us-gaap_EarningsPerSharePolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent" xlink:to="us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationAndRetirementDisclosureAbstract" xlink:to="us-gaap_CompensationAndRetirementDisclosureAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComputerEquipmentMember" xlink:to="us-gaap_ComputerEquipmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorFirmId" xlink:to="dei_AuditorFirmId_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_IncomeStatementLocationDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AuditorName" xlink:to="dei_AuditorName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockSharesAuthorized" xlink:to="us-gaap_PreferredStockSharesAuthorized_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsMember" xlink:to="us-gaap_OtherAssetsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MinimumMember" xlink:to="srt_MinimumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_DeferredTaxAssetsAmortization" xlink:to="vor_DeferredTaxAssetsAmortization_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherOperatingActivitiesCashFlowStatement" xlink:to="us-gaap_OtherOperatingActivitiesCashFlowStatement_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentAnnualReport" xlink:to="dei_DocumentAnnualReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsValuationAllowance" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFilerCategory" xlink:to="dei_EntityFilerCategory_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxPolicyTextBlock" xlink:to="us-gaap_IncomeTaxPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_SeriesAOneRedeemableConvertiblePreferredStockMember" xlink:to="vor_SeriesAOneRedeemableConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_FirstLeaseAmendmentMember" xlink:to="vor_FirstLeaseAmendmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="us-gaap_IncomeTaxDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresAbstract" xlink:to="us-gaap_FairValueDisclosuresAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermLeaseCost" xlink:to="us-gaap_ShortTermLeaseCost_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_MaximumMember" xlink:to="srt_MaximumMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_TwoThousandFifteenStockIncentivePlanMember" xlink:to="vor_TwoThousandFifteenStockIncentivePlanMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_FurnitureAndEquipmentMember" xlink:to="vor_FurnitureAndEquipmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PayablesAndAccrualsAbstract" xlink:to="us-gaap_PayablesAndAccrualsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseExpense" xlink:to="us-gaap_OperatingLeaseExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsPolicyTextBlock" xlink:to="us-gaap_CashAndCashEquivalentsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_EquityComponentDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_LicenseAgreementPotentialMilestonePayments" xlink:to="vor_LicenseAgreementPotentialMilestonePayments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_AdditionalSpaceLeased" xlink:to="vor_AdditionalSpaceLeased_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_IncomeTaxAuthorityDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:to="us-gaap_InformationByCategoryOfDebtSecurityAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseholdImprovementsMember" xlink:to="us-gaap_LeaseholdImprovementsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock" xlink:to="vor_PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LicenseMember" xlink:to="us-gaap_LicenseMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashEquivalentsMember" xlink:to="us-gaap_CashEquivalentsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_RetainedEarningsMember" xlink:to="us-gaap_RetainedEarningsMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="us-gaap_PaymentsOfStockIssuanceCosts_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues" xlink:to="vor_TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="us-gaap_EarningsPerShareBasicAndDilutedAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OperatingLeaseLiability" xlink:to="us-gaap_OperatingLeaseLiability_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CommonStockMember" xlink:to="us-gaap_CommonStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentGross" xlink:to="us-gaap_PropertyPlantAndEquipmentGross_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AccruedProfessionalFeesCurrent" xlink:to="us-gaap_AccruedProfessionalFeesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityPublicFloat" xlink:to="dei_EntityPublicFloat_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_CreditFacilityDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueByAssetClassAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract" xlink:to="us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TemporaryEquitySharesOutstanding" xlink:to="us-gaap_TemporaryEquitySharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="us-gaap_StatementOfStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NumberOfOperatingSegments" xlink:to="us-gaap_NumberOfOperatingSegments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" xlink:to="vor_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="us-gaap_OtherAccruedLiabilitiesCurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentTransitionReport" xlink:to="dei_DocumentTransitionReport_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_FairValueAssetsLevel2ToLevel1TransferredAmount" xlink:to="vor_FairValueAssetsLevel2ToLevel1TransferredAmount_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ProceedsFromStockOptionsExercised" xlink:to="us-gaap_ProceedsFromStockOptionsExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_DefinedContributionPlanAdditionalPercentage" xlink:to="vor_DefinedContributionPlanAdditionalPercentage_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DebtConversionOriginalDebtAmount1" xlink:to="us-gaap_DebtConversionOriginalDebtAmount1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent" xlink:to="us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ResearchAndDevelopmentExpense" xlink:to="us-gaap_ResearchAndDevelopmentExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_LaboratoryEquipmentMember" xlink:to="vor_LaboratoryEquipmentMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfClinicalMilestones" xlink:to="vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfClinicalMilestones_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DividendsCommonStock" xlink:to="us-gaap_DividendsCommonStock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_ScheduleOfOtherLeaseActivityTableTextBlock" xlink:to="vor_ScheduleOfOtherLeaseActivityTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementOfFinancialPositionAbstract" xlink:to="us-gaap_StatementOfFinancialPositionAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities" xlink:to="us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NatureOfOperations" xlink:to="us-gaap_NatureOfOperations_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="us-gaap_LeaseContractualTermDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses" xlink:to="vor_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CompensationRelatedCostsPolicyTextBlock" xlink:to="us-gaap_CompensationRelatedCostsPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PaymentsToAcquireInvestments" xlink:to="us-gaap_PaymentsToAcquireInvestments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:to="us-gaap_FinancingReceivablesPeriodPastDueAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_StockIssuedDuringPeriodValueStockOptionsVestedAndExercised" xlink:to="vor_StockIssuedDuringPeriodValueStockOptionsVestedAndExercised_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCommonStockSharesOutstanding" xlink:to="dei_EntityCommonStockSharesOutstanding_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_AwardTypeAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityShellCompany" xlink:to="dei_EntityShellCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SaleOfStockPricePerShare" xlink:to="us-gaap_SaleOfStockPricePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock" xlink:to="us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_IcfrAuditorAttestationFlag" xlink:to="dei_IcfrAuditorAttestationFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_SeriesATwoRedeemableConvertiblePreferredStockMember" xlink:to="vor_SeriesATwoRedeemableConvertiblePreferredStockMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EarningsPerShareTextBlock" xlink:to="us-gaap_EarningsPerShareTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_NumberOfCommonStockVotingRights" xlink:to="vor_NumberOfCommonStockVotingRights_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_ScheduleOfStockByClassTable_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductOrServiceAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_ShortTermInvestments" xlink:to="us-gaap_ShortTermInvestments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_IncreaseInAnnualFixedRentalPayments" xlink:to="vor_IncreaseInAnnualFixedRentalPayments_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense" xlink:to="us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueMeasurementsRecurringMember" xlink:to="us-gaap_FairValueMeasurementsRecurringMember_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_ConversionOfRedeemableConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering" xlink:to="vor_ConversionOfRedeemableConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_TemporaryEquityIssuedPricePerShare" xlink:to="vor_TemporaryEquityIssuedPricePerShare_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="vor_RedeemableConvertiblePreferredStockTextBlock" xlink:to="vor_RedeemableConvertiblePreferredStockTextBlock_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentLineItems_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_OtherAssetsNoncurrent" xlink:to="us-gaap_OtherAssetsNoncurrent_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_TypeOfArrangementAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SubsidiarySaleOfStockAxis_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_FairValueDisclosuresTextBlock" xlink:to="us-gaap_FairValueDisclosuresTextBlock_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>31
<FILENAME>vor-20211231_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2022-03-14T15:51:45.6825+00:00 -->
<!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" xlink:type="simple"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" xlink:href="vor-20211231.xsd#StatementConsolidatedBalanceSheets" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" xlink:href="vor-20211231.xsd#StatementConsolidatedBalanceSheetsParenthetical" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" xlink:href="vor-20211231.xsd#StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails" xlink:href="vor-20211231.xsd#Role_DisclosureNatureOfBusinessAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:href="vor-20211231.xsd#Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfPropertyAndEquipmentDetails" xlink:href="vor-20211231.xsd#DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfPropertyAndEquipmentDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails" xlink:href="vor-20211231.xsd#Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:href="vor-20211231.xsd#Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails" xlink:href="vor-20211231.xsd#Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails" xlink:href="vor-20211231.xsd#DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails" xlink:href="vor-20211231.xsd#DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:href="vor-20211231.xsd#Role_DisclosureStockBasedCompensationAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedPrincipallyInDeterminingFairValueOfOptionsGrantedDetails" xlink:href="vor-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedPrincipallyInDeterminingFairValueOfOptionsGrantedDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" xlink:href="vor-20211231.xsd#Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails" xlink:href="vor-20211231.xsd#Role_DisclosureLeasesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails" xlink:href="vor-20211231.xsd#DisclosureSignificantAgreementsAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" xlink:href="vor-20211231.xsd#DisclosureIncomeTaxesAdditionalInformationDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:href="vor-20211231.xsd#Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" xlink:type="simple"/>
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd#eedm" xlink:type="simple"/>
  <link:definitionLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityAbstract" xlink:label="us-gaap_StockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockValue" xlink:label="us-gaap_PreferredStockValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:label="us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract" xlink:label="us-gaap_LiabilitiesCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract" xlink:label="us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:label="us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountsPayableCurrent" xlink:label="us-gaap_AccountsPayableCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsAbstract" xlink:label="us-gaap_AssetsAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrentAbstract" xlink:label="us-gaap_AssetsCurrentAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:label="us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesAOneRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesAOneRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShortTermInvestments" xlink:label="us-gaap_ShortTermInvestments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockValue" xlink:label="us-gaap_CommonStockValue"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesATwoRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesATwoRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent" xlink:label="us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent" xlink:label="us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Liabilities" xlink:label="us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PrepaidExpenseCurrent" xlink:label="us-gaap_PrepaidExpenseCurrent"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesBRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalCommonStock" xlink:label="us-gaap_AdditionalPaidInCapitalCommonStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset" xlink:label="us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsCurrent" xlink:label="us-gaap_OtherAssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit" xlink:label="us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity" xlink:label="us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsCurrent" xlink:label="us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsNoncurrent" xlink:label="us-gaap_OtherAssetsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LiabilitiesCurrent" xlink:label="us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_Assets" xlink:label="us-gaap_Assets"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_PreferredStockValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesCurrentAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccountsPayableCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AssetsAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_AssetsCurrentAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_CashAndCashEquivalentsAtCarryingValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesAOneRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_RestrictedCashEquivalentsNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_ShortTermInvestments" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_CommonStockValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_LiabilitiesNoncurrentAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesATwoRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquityAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_AccruedLiabilitiesCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OperatingLeaseLiabilityCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="us-gaap_Liabilities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_PrepaidExpenseCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesBRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_AdditionalPaidInCapitalCommonStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquityAbstract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OperatingLeaseRightOfUseAsset" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_OtherLiabilitiesCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_OtherAssetsCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_RetainedEarningsAccumulatedDeficit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_LiabilitiesAndStockholdersEquity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsCurrentAbstract" xlink:to="us-gaap_AssetsCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_OtherAssetsNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LiabilitiesCurrentAbstract" xlink:to="us-gaap_LiabilitiesCurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StockholdersEquityAbstract" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AssetsAbstract" xlink:to="us-gaap_Assets" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesAOneRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesAOneRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesATwoRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesATwoRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesBRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesIssued" xlink:label="us-gaap_PreferredStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesOutstanding" xlink:label="us-gaap_PreferredStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesIssued" xlink:label="us-gaap_CommonStockSharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesAOneRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesATwoRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesBRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreference" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_PreferredStockSharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementLineItems" xlink:label="us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementTable" xlink:label="us-gaap_StatementTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesAOneRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesAOneRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquity" xlink:label="us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesATwoRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesATwoRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesOutstanding" xlink:label="us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember" xlink:label="us-gaap_AdditionalPaidInCapitalMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesBRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RetainedEarningsMember" xlink:label="us-gaap_RetainedEarningsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:label="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TemporaryEquityStockConvertedDuringPeriodValue" xlink:label="vor_TemporaryEquityStockConvertedDuringPeriodValue"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TemporaryEquityStockConvertedDuringPeriodShares" xlink:label="vor_TemporaryEquityStockConvertedDuringPeriodShares"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_StockIssuedDuringPeriodValueStockOptionsVestedAndExercised" xlink:label="vor_StockIssuedDuringPeriodValueStockOptionsVestedAndExercised"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_StockIssuedDuringPeriodSharesStockOptionsVestedAndExercised" xlink:label="vor_StockIssuedDuringPeriodSharesStockOptionsVestedAndExercised"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:label="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NetIncomeLoss" xlink:label="us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StatementTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesAOneRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockholdersEquity" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesATwoRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_CommonStockSharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_AdditionalPaidInCapitalMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_StatementTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesBRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_RetainedEarningsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="vor_TemporaryEquityStockConvertedDuringPeriodValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="vor_TemporaryEquityStockConvertedDuringPeriodShares" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodValueNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="vor_StockIssuedDuringPeriodValueStockOptionsVestedAndExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="vor_StockIssuedDuringPeriodSharesStockOptionsVestedAndExercised" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_StatementLineItems" xlink:to="us-gaap_NetIncomeLoss" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_NatureOfBusinessLineItems" xlink:label="vor_NatureOfBusinessLineItems"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_NatureOfBusinessTable" xlink:label="vor_NatureOfBusinessTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd#dei_EntityIncorporationDateOfIncorporation" xlink:label="dei_EntityIncorporationDateOfIncorporation"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SubsidiarySaleOfStockAxis" xlink:label="us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockNameOfTransactionDomain" xlink:label="us-gaap_SaleOfStockNameOfTransactionDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IPOMember" xlink:label="us-gaap_IPOMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:label="us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SaleOfStockPricePerShare" xlink:label="us-gaap_SaleOfStockPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceInitialPublicOffering" xlink:label="us-gaap_ProceedsFromIssuanceInitialPublicOffering"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockSharesAuthorized" xlink:label="us-gaap_CommonStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockParOrStatedValuePerShare" xlink:label="us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockSharesAuthorized" xlink:label="us-gaap_PreferredStockSharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PreferredStockParOrStatedValuePerShare" xlink:label="us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityReverseStockSplit" xlink:label="us-gaap_StockholdersEquityReverseStockSplit"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" xlink:label="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="vor_NatureOfBusinessTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="dei_EntityIncorporationDateOfIncorporation" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_SubsidiarySaleOfStockAxis" xlink:to="us-gaap_SaleOfStockNameOfTransactionDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="us-gaap_IPOMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vor_NatureOfBusinessTable" xlink:to="us-gaap_SubsidiarySaleOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="vor_NatureOfBusinessTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="us-gaap_SaleOfStockPricePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="us-gaap_ProceedsFromIssuanceInitialPublicOffering" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="us-gaap_CommonStockSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="us-gaap_CommonStockParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="us-gaap_PreferredStockSharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="us-gaap_PreferredStockParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="us-gaap_StockholdersEquityReverseStockSplit" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="vor_NatureOfBusinessLineItems" xlink:to="us-gaap_StockholdersEquityNoteStockSplitConversionRatio1" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:label="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_NumberOfOperatingSegments" xlink:label="us-gaap_NumberOfOperatingSegments"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherAssetsMember" xlink:label="us-gaap_OtherAssetsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredOfferingCosts" xlink:label="us-gaap_DeferredOfferingCosts"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_RestrictedCashEquivalentsNoncurrent" xlink:label="us-gaap_RestrictedCashEquivalentsNoncurrent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" xlink:label="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdateExtensibleList" xlink:label="us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_NumberOfOperatingSegments" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="us-gaap_BalanceSheetLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="us-gaap_OtherAssetsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_DeferredOfferingCosts" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_RestrictedCashEquivalentsNoncurrent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_AccountingStandardsUpdateExtensibleList" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfPropertyAndEquipmentDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:label="us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_FurnitureAndEquipmentMember" xlink:label="vor_FurnitureAndEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" xlink:label="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_LaboratoryEquipmentMember" xlink:label="vor_LaboratoryEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentUsefulLife" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="vor_FurnitureAndEquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="vor_LaboratoryEquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:label="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:label="us-gaap_DebtSecuritiesAvailableForSaleTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueDomain"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_MaturingInOneYearOrLessMember" xlink:label="vor_MaturingInOneYearOrLessMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:label="us-gaap_FinancingReceivablesPeriodPastDueDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_MaturingAfterOneYearThroughFiveYearsMember" xlink:label="vor_MaturingAfterOneYearThroughFiveYearsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" xlink:label="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AvailableForSaleSecuritiesDebtSecurities" xlink:label="us-gaap_AvailableForSaleSecuritiesDebtSecurities"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_DebtSecuritiesAvailableForSaleTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:to="vor_MaturingInOneYearOrLessMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FinancingReceivablesPeriodPastDueAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:to="us-gaap_FinancingReceivablesPeriodPastDueDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueAxis" xlink:to="us-gaap_FinancingReceivablesPeriodPastDueDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_DebtSecuritiesAvailableForSaleTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FinancingReceivablesPeriodPastDueDomain" xlink:to="vor_MaturingAfterOneYearThroughFiveYearsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems" xlink:to="us-gaap_AvailableForSaleSecuritiesDebtSecurities" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:label="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AssetsFairValueDisclosure" xlink:label="us-gaap_AssetsFairValueDisclosure"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:label="us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:label="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel1Member" xlink:label="us-gaap_FairValueInputsLevel1Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeAxis" xlink:label="us-gaap_InvestmentTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentTypeCategorizationMember" xlink:label="us-gaap_InvestmentTypeCategorizationMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CashEquivalentsMember" xlink:label="us-gaap_CashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:label="us-gaap_InformationByCategoryOfDebtSecurityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:label="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:label="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_InvestmentsMember" xlink:label="us-gaap_InvestmentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByAssetClassAxis" xlink:label="us-gaap_FairValueByAssetClassAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:label="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_MoneyMarketFundsMember" xlink:label="us-gaap_MoneyMarketFundsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FinancialInstrumentAxis" xlink:label="us-gaap_FinancialInstrumentAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:label="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CorporateDebtSecuritiesMember" xlink:label="us-gaap_CorporateDebtSecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis" xlink:label="us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain" xlink:label="us-gaap_FairValueMeasurementFrequencyDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember" xlink:label="us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_USTreasurySecuritiesMember" xlink:label="us-gaap_USTreasurySecuritiesMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_RestrictedCashEquivalentsMember" xlink:label="vor_RestrictedCashEquivalentsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel2Member" xlink:label="us-gaap_FairValueInputsLevel2Member"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_FairValueInputsLevel3Member" xlink:label="us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="us-gaap_AssetsFairValueDisclosure" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="us-gaap_FairValueMeasurementsFairValueHierarchyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel1Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InvestmentTypeAxis" xlink:to="us-gaap_InvestmentTypeCategorizationMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="us-gaap_CashEquivalentsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:to="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_InformationByCategoryOfDebtSecurityAxis" xlink:to="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain" xlink:to="us-gaap_InvestmentsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByAssetClassAxis" xlink:to="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain" xlink:to="us-gaap_MoneyMarketFundsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FinancialInstrumentAxis" xlink:to="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_CorporateDebtSecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByMeasurementFrequencyAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="us-gaap_FairValueMeasurementFrequencyDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="us-gaap_FairValueMeasurementsRecurringMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="us-gaap_USTreasurySecuritiesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_InvestmentTypeCategorizationMember" xlink:to="vor_RestrictedCashEquivalentsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByFairValueHierarchyLevelAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel2Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="us-gaap_FairValueInputsLevel3Member" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_InvestmentTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_InformationByCategoryOfDebtSecurityAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FairValueByAssetClassAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="us-gaap_FinancialInstrumentAxis" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems" xlink:label="us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:label="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:label="us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:label="us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross" xlink:label="us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_FurnitureAndEquipmentMember" xlink:label="vor_FurnitureAndEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_LaboratoryEquipmentMember" xlink:label="vor_LaboratoryEquipmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:label="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseholdImprovementsMember" xlink:label="us-gaap_LeaseholdImprovementsMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet" xlink:label="us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ComputerEquipmentMember" xlink:label="us-gaap_ComputerEquipmentMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="us-gaap_PropertyPlantAndEquipmentByTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="us-gaap_PropertyPlantAndEquipmentTypeDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="vor_FurnitureAndEquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="vor_LaboratoryEquipmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_LeaseholdImprovementsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="us-gaap_PropertyPlantAndEquipmentNet" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="us-gaap_ComputerEquipmentMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EquityComponentDomain" xlink:label="us-gaap_EquityComponentDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CommonStockMember" xlink:label="us-gaap_CommonStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementEquityComponentsAxis" xlink:label="us-gaap_StatementEquityComponentsAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesAOneRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesAOneRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityParOrStatedValuePerShare" xlink:label="us-gaap_TemporaryEquityParOrStatedValuePerShare"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesATwoRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesATwoRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesBRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" xlink:label="vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TemporaryEquityIssuedPricePerShare" xlink:label="vor_TemporaryEquityIssuedPricePerShare"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues" xlink:label="vor_TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionOriginalDebtAmount1" xlink:label="us-gaap_DebtConversionOriginalDebtAmount1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DebtConversionConvertedInstrumentSharesIssued1" xlink:label="us-gaap_DebtConversionConvertedInstrumentSharesIssued1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" xlink:label="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" xlink:label="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EquityComponentDomain" xlink:to="us-gaap_CommonStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementEquityComponentsAxis" xlink:to="us-gaap_EquityComponentDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesAOneRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquityParOrStatedValuePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementEquityComponentsAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesATwoRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesBRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="vor_TemporaryEquityIssuedPricePerShare" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="vor_TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DebtConversionOriginalDebtAmount1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_DebtConversionConvertedInstrumentSharesIssued1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockLineItems" xlink:label="us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfStockByClassTable" xlink:label="us-gaap_ScheduleOfStockByClassTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ClassOfStockDomain" xlink:label="us-gaap_ClassOfStockDomain"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesAOneRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesAOneRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesAuthorized" xlink:label="us-gaap_TemporaryEquitySharesAuthorized"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesATwoRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesATwoRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesIssued" xlink:label="us-gaap_TemporaryEquitySharesIssued"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesBRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquitySharesOutstanding" xlink:label="us-gaap_TemporaryEquitySharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityCarryingAmountAttributableToParent" xlink:label="us-gaap_TemporaryEquityCarryingAmountAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TemporaryEquityLiquidationPreference" xlink:label="us-gaap_TemporaryEquityLiquidationPreference"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TemporaryEquityCumulativeUndeclaredDividends" xlink:label="vor_TemporaryEquityCumulativeUndeclaredDividends"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" xlink:label="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ScheduleOfStockByClassTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesAOneRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquitySharesAuthorized" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfStockByClassTable" xlink:to="us-gaap_StatementClassOfStockAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_ClassOfStockDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesATwoRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquitySharesIssued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockDomain" xlink:to="vor_SeriesBRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquitySharesOutstanding" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquityCarryingAmountAttributableToParent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_TemporaryEquityLiquidationPreference" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="vor_TemporaryEquityCumulativeUndeclaredDividends" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ClassOfStockLineItems" xlink:to="us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TwoThousandFifteenStockIncentivePlanMember" xlink:label="vor_TwoThousandFifteenStockIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameAxis" xlink:label="us-gaap_PlanNameAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PlanNameDomain" xlink:label="us-gaap_PlanNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingAxis" xlink:label="us-gaap_VestingAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_VestingDomain" xlink:label="us-gaap_VestingDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheOneMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheOneMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TwoThousandTwentyOneEquityIncentivePlanMember" xlink:label="vor_TwoThousandTwentyOneEquityIncentivePlanMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationAwardTrancheTwoMember" xlink:label="us-gaap_ShareBasedCompensationAwardTrancheTwoMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharePrice" xlink:label="us-gaap_SharePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue" xlink:label="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice" xlink:label="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OtherLiabilitiesCurrent" xlink:label="us-gaap_OtherLiabilitiesCurrent"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="vor_TwoThousandFifteenStockIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_PlanNameAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_PlanNameAxis" xlink:to="us-gaap_PlanNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_VestingAxis" xlink:to="us-gaap_VestingDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheOneMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_PlanNameDomain" xlink:to="vor_TwoThousandTwentyOneEquityIncentivePlanMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_VestingAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_VestingDomain" xlink:to="us-gaap_ShareBasedCompensationAwardTrancheTwoMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="13" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="14" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="15" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="16" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="17" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_OtherLiabilitiesCurrent" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedPrincipallyInDeterminingFairValueOfOptionsGrantedDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:label="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AwardTypeAxis" xlink:label="us-gaap_AwardTypeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:label="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:label="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:label="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="us-gaap_AwardTypeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AwardTypeAxis" xlink:to="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:label="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:label="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember" xlink:label="us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationAxis" xlink:label="us-gaap_IncomeStatementLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeStatementLocationDomain" xlink:label="us-gaap_IncomeStatementLocationDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense" xlink:label="us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_GeneralAndAdministrativeExpenseMember" xlink:label="us-gaap_GeneralAndAdministrativeExpenseMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_ResearchAndDevelopmentExpenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="us-gaap_IncomeStatementLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeStatementLocationAxis" xlink:to="us-gaap_IncomeStatementLocationDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="us-gaap_AllocatedShareBasedCompensationExpense" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeStatementLocationDomain" xlink:to="us-gaap_GeneralAndAdministrativeExpenseMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems" xlink:label="us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable" xlink:label="us-gaap_LesseeLeaseDescriptionTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract" xlink:label="us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MinimumMember" xlink:label="srt_MinimumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_FirstLeaseAmendmentMember" xlink:label="vor_FirstLeaseAmendmentMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityAxis" xlink:label="us-gaap_CreditFacilityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CreditFacilityDomain" xlink:label="us-gaap_CreditFacilityDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StandbyLettersOfCreditMember" xlink:label="us-gaap_StandbyLettersOfCreditMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermAxis" xlink:label="us-gaap_LeaseContractualTermAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LeaseContractualTermDomain" xlink:label="us-gaap_LeaseContractualTermDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" xlink:label="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SecondLeaseAmendmentMember" xlink:label="vor_SecondLeaseAmendmentMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_AdditionalSpaceLeased" xlink:label="vor_AdditionalSpaceLeased"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_CambridgeparkLeaseMember" xlink:label="vor_CambridgeparkLeaseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_PaymentsForRent" xlink:label="us-gaap_PaymentsForRent"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_IncreaseInAnnualFixedRentalPayments" xlink:label="vor_IncreaseInAnnualFixedRentalPayments"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_OperatingLeaseCommencementPeriod" xlink:label="vor_OperatingLeaseCommencementPeriod"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_OperatingLeaseEstimatedToCommencePeriod" xlink:label="vor_OperatingLeaseEstimatedToCommencePeriod"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" xlink:label="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeLeaseDescriptionTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseTermOfContract" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MinimumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="vor_FirstLeaseAmendmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_CreditFacilityAxis" xlink:to="us-gaap_CreditFacilityDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CreditFacilityDomain" xlink:to="us-gaap_StandbyLettersOfCreditMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_LeaseContractualTermAxis" xlink:to="us-gaap_LeaseContractualTermDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_LeaseContractualTermAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="vor_SecondLeaseAmendmentMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="vor_AdditionalSpaceLeased" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LeaseContractualTermDomain" xlink:to="vor_CambridgeparkLeaseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_LesseeLeaseDescriptionTable" xlink:to="us-gaap_CreditFacilityAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_PaymentsForRent" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="vor_IncreaseInAnnualFixedRentalPayments" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="vor_OperatingLeaseCommencementPeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="vor_OperatingLeaseEstimatedToCommencePeriod" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:label="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:label="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ColumbiaLicenseAgreementMember" xlink:label="vor_ColumbiaLicenseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfArrangementAxis" xlink:label="us-gaap_TypeOfArrangementAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:label="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationDomain" xlink:label="us-gaap_BalanceSheetLocationDomain"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_AccruedExpensesMember" xlink:label="vor_AccruedExpensesMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_BalanceSheetLocationAxis" xlink:label="us-gaap_BalanceSheetLocationAxis"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfClinicalMilestones" xlink:label="vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfClinicalMilestones"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_LicenseMember" xlink:label="us-gaap_LicenseMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductOrServiceAxis" xlink:label="srt_ProductOrServiceAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_ProductsAndServicesDomain" xlink:label="srt_ProductsAndServicesDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_NationalInstitutesOfHealthLicenseAgreementMember" xlink:label="vor_NationalInstitutesOfHealthLicenseAgreementMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfRegulatoryAndCommercialMilestones" xlink:label="vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfRegulatoryAndCommercialMilestones"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_LicenseAgreementPotentialMilestonePayments" xlink:label="vor_LicenseAgreementPotentialMilestonePayments"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_LicenseFeeObligatedToPay" xlink:label="vor_LicenseFeeObligatedToPay"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_LicenseAgreementMilestonePaymentsOnAggregateNetSales" xlink:label="vor_LicenseAgreementMilestonePaymentsOnAggregateNetSales"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="vor_ColumbiaLicenseAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TypeOfArrangementAxis" xlink:to="us-gaap_ArrangementsAndNonarrangementTransactionsMember_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_TypeOfArrangementAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_BalanceSheetLocationDomain" xlink:to="vor_AccruedExpensesMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_BalanceSheetLocationAxis" xlink:to="us-gaap_BalanceSheetLocationDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfClinicalMilestones" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_ProductsAndServicesDomain" xlink:to="us-gaap_LicenseMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="srt_ProductOrServiceAxis" xlink:to="srt_ProductsAndServicesDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_ArrangementsAndNonarrangementTransactionsMember" xlink:to="vor_NationalInstitutesOfHealthLicenseAgreementMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfRegulatoryAndCommercialMilestones" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="us-gaap_BalanceSheetLocationAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="vor_LicenseAgreementPotentialMilestonePayments" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="vor_LicenseFeeObligatedToPay" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable" xlink:to="srt_ProductOrServiceAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems" xlink:to="vor_LicenseAgreementMilestonePaymentsOnAggregateNetSales" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsLineItems" xlink:label="us-gaap_OperatingLossCarryforwardsLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwardsTable" xlink:label="us-gaap_OperatingLossCarryforwardsTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DomesticCountryMember" xlink:label="us-gaap_DomesticCountryMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityAxis" xlink:label="us-gaap_IncomeTaxAuthorityAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxAuthorityDomain" xlink:label="us-gaap_IncomeTaxAuthorityDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsValuationAllowance" xlink:label="us-gaap_DeferredTaxAssetsValuationAllowance"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeMember" xlink:label="srt_RangeMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_MaximumMember" xlink:label="srt_MaximumMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd#srt_RangeAxis" xlink:label="srt_RangeAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ResearchMember" xlink:label="us-gaap_ResearchMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardAxis" xlink:label="us-gaap_TaxCreditCarryforwardAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TaxCreditCarryforwardNameDomain" xlink:label="us-gaap_TaxCreditCarryforwardNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_StateAndLocalJurisdictionMember" xlink:label="us-gaap_StateAndLocalJurisdictionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" xlink:label="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_OperatingLossCarryforwards" xlink:label="us-gaap_OperatingLossCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" xlink:label="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_OperatingLossCarryforwardsExpirationYear" xlink:label="vor_OperatingLossCarryforwardsExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" xlink:label="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_TaxCreditCarryforwardsExpirationYear" xlink:label="vor_TaxCreditCarryforwardsExpirationYear"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ConsideredPeriodOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards" xlink:label="vor_ConsideredPeriodOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_ConsideredPercentageOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards" xlink:label="vor_ConsideredPercentageOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefits" xlink:label="us-gaap_UnrecognizedTaxBenefits"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" xlink:label="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_IncomeTaxExaminationDescription" xlink:label="us-gaap_IncomeTaxExaminationDescription"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwardsTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_DomesticCountryMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_IncomeTaxAuthorityAxis" xlink:to="us-gaap_IncomeTaxAuthorityDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_IncomeTaxAuthorityAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_DeferredTaxAssetsValuationAllowance" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="srt_RangeMember" xlink:to="srt_MaximumMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="srt_RangeAxis" xlink:to="srt_RangeMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TaxCreditCarryforwardNameDomain" xlink:to="us-gaap_ResearchMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_TaxCreditCarryforwardAxis" xlink:to="us-gaap_TaxCreditCarryforwardNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_IncomeTaxAuthorityDomain" xlink:to="us-gaap_StateAndLocalJurisdictionMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="us-gaap_TaxCreditCarryforwardAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_OperatingLossCarryforwards" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_OperatingLossCarryforwardsTable" xlink:to="srt_RangeAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="4" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="5" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="vor_OperatingLossCarryforwardsExpirationYear" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="6" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="7" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="vor_TaxCreditCarryforwardsExpirationYear" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="8" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="vor_ConsideredPeriodOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="9" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="vor_ConsideredPercentageOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="10" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefits" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="11" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="12" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_OperatingLossCarryforwardsLineItems" xlink:to="us-gaap_IncomeTaxExaminationDescription" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:label="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain" xlink:label="us-gaap_AntidilutiveSecuritiesNameDomain_default"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesAOneRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesAOneRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:label="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesATwoRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesATwoRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="vor-20211231.xsd#vor_SeriesBRedeemableConvertiblePreferredStockMember" xlink:label="vor_SeriesBRedeemableConvertiblePreferredStockMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_EmployeeStockOptionMember" xlink:label="us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="us-gaap_AntidilutiveSecuritiesNameDomain_default" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="vor_SeriesAOneRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="1" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="vor_SeriesATwoRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="2" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="vor_SeriesBRedeemableConvertiblePreferredStockMember" priority="2" use="optional"/>
    <link:definitionArc xlink:type="arc" order="3" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="us-gaap_EmployeeStockOptionMember" priority="2" use="optional"/>
  </link:definitionLink>
  <link:definitionLink xlink:type="extended" xlink:role="http://fasb.org/us-gaap/role/eedm/ExtensibleEnumerationLists">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_TypeOfAdoptionMember" xlink:label="us-gaap_TypeOfAdoptionMember"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd#us-gaap_AccountingStandardsUpdate201912Member" xlink:label="us-gaap_AccountingStandardsUpdate201912Member"/>
    <link:definitionArc xlink:type="arc" order="0" xbrldt:closed="false" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="us-gaap_TypeOfAdoptionMember" xlink:to="us-gaap_AccountingStandardsUpdate201912Member" priority="2" use="optional"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>32
<FILENAME>vor-20211231.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2022-03-14T15:51:42.4201+00:00 -->
<!-- Copyright (c) 2022 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://vorbiopharma.com/20211231" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:vor="http://vorbiopharma.com/20211231" xmlns:dei="http://xbrl.sec.gov/dei/2021q4" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" namespace="http://fasb.org/srt/2021-01-31"/>
  <xsd:import schemaLocation="https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd" namespace="http://xbrl.org/2020/extensible-enumerations-2.0"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" namespace="http://fasb.org/us-gaap/2021-01-31"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd" namespace="http://xbrl.sec.gov/dei/2021q4"/>
  <xsd:import schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" namespace="http://www.xbrl.org/dtr/type/2020-01-21"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vor-20211231_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vor-20211231_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vor-20211231_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:title="Definition link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="vor-20211231_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:title="Calculation link" xlink:type="simple"/>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets" id="StatementConsolidatedBalanceSheets">
        <link:definition>100010 - Statement - CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails2" id="DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails2">
        <link:definition>100020 - Disclosure - Leases - Summary of Future Lease Payments for Noncancelable Leases (Details) 2</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical" id="StatementConsolidatedBalanceSheetsParenthetical">
        <link:definition>100030 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss" id="StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss">
        <link:definition>100040 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit" id="StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit">
        <link:definition>100050 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical" id="StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical">
        <link:definition>100060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows" id="StatementConsolidatedStatementsOfCashFlows">
        <link:definition>100070 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical" id="StatementConsolidatedStatementsOfCashFlowsParenthetical">
        <link:definition>100080 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusiness" id="Role_DisclosureNatureOfBusiness">
        <link:definition>100090 - Disclosure - Nature of the Business</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPolicies">
        <link:definition>100100 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestments" id="Role_DisclosureInvestments">
        <link:definition>100110 - Disclosure - Investments</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurements" id="Role_DisclosureFairValueMeasurements">
        <link:definition>100120 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNet" id="Role_DisclosurePropertyAndEquipmentNet">
        <link:definition>100130 - Disclosure - Property and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities" id="Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities">
        <link:definition>100140 - Disclosure - Accrued Expenses and Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStock" id="DisclosureRedeemableConvertiblePreferredStock">
        <link:definition>100150 - Disclosure - Redeemable Convertible Preferred Stock</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockholdersEquity" id="DisclosureStockholdersEquity">
        <link:definition>100160 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensation" id="Role_DisclosureStockBasedCompensation">
        <link:definition>100170 - Disclosure - Stock-Based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeases" id="Role_DisclosureLeases">
        <link:definition>100180 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSignificantAgreements" id="Role_DisclosureSignificantAgreements">
        <link:definition>100190 - Disclosure - Significant Agreements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies" id="DisclosureCommitmentsAndContingencies">
        <link:definition>100200 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureDefinedContributionBenefitPlan" id="DisclosureDefinedContributionBenefitPlan">
        <link:definition>100210 - Disclosure - Defined Contribution Benefit Plan</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxes1" id="DisclosureIncomeTaxes1">
        <link:definition>100220 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShare" id="Role_DisclosureNetLossPerShare">
        <link:definition>100230 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies">
        <link:definition>100240 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables" id="DisclosureSummaryOfSignificantAccountingPoliciesTables">
        <link:definition>100250 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsTables" id="Role_DisclosureInvestmentsTables">
        <link:definition>100260 - Disclosure - Investments (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables" id="Role_DisclosureFairValueMeasurementsTables">
        <link:definition>100270 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetTables" id="Role_DisclosurePropertyAndEquipmentNetTables">
        <link:definition>100280 - Disclosure - Property and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables" id="Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables">
        <link:definition>100290 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockTables" id="DisclosureRedeemableConvertiblePreferredStockTables">
        <link:definition>100300 - Disclosure - Redeemable Convertible Preferred Stock (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables" id="Role_DisclosureStockBasedCompensationTables">
        <link:definition>100310 - Disclosure - Stock-Based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesTables" id="Role_DisclosureLeasesTables">
        <link:definition>100320 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables" id="DisclosureIncomeTaxesTables">
        <link:definition>100330 - Disclosure - Income Taxes (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareTables" id="Role_DisclosureNetLossPerShareTables">
        <link:definition>100340 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails" id="Role_DisclosureNatureOfBusinessAdditionalInformationDetails">
        <link:definition>100350 - Disclosure - Nature of the Business - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" id="Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
        <link:definition>100360 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfPropertyAndEquipmentDetails" id="DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfPropertyAndEquipmentDetails">
        <link:definition>100370 - Disclosure - Summary of Significant Accounting Policies - Estimated Useful Life of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails" id="Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails">
        <link:definition>100380 - Disclosure - Investments - Summary of Amortized Cost and Estimated Fair Value of Investments by Contractual Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails" id="DisclosureInvestmentsAdditionalInformationDetails">
        <link:definition>100390 - Disclosure - Investments - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails" id="Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails">
        <link:definition>100400 - Disclosure - Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails" id="Role_DisclosureFairValueMeasurementsAdditionalInformationDetails">
        <link:definition>100410 - Disclosure - Fair Value Measurements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails" id="Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails">
        <link:definition>100420 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment, Net (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetails" id="Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetails">
        <link:definition>100430 - Disclosure - Property and Equipment, Net - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails" id="Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails">
        <link:definition>100440 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails" id="DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails">
        <link:definition>100450 - Disclosure - Redeemable Convertible Preferred Stock - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails" id="DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails">
        <link:definition>100460 - Disclosure - Redeemable Convertible Preferred Stock - Schedule of Redeemable Convertible Preferred Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails" id="DisclosureStockholdersEquityAdditionalInformationDetails">
        <link:definition>100470 - Disclosure - Stockholders' Equity - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails" id="Role_DisclosureStockBasedCompensationAdditionalInformationDetails">
        <link:definition>100480 - Disclosure - Stock-Based Compensation - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedPrincipallyInDeterminingFairValueOfOptionsGrantedDetails" id="Role_DisclosureStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedPrincipallyInDeterminingFairValueOfOptionsGrantedDetails">
        <link:definition>100490 - Disclosure - Stock-Based Compensation - Summary of Weighted-Average Assumptions Used Principally in Determining Fair Value of Options Granted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails" id="DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails">
        <link:definition>100500 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails" id="Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails">
        <link:definition>100510 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails" id="Role_DisclosureLeasesAdditionalInformationDetails">
        <link:definition>100520 - Disclosure - Leases - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseExpenseDetails" id="Role_DisclosureLeasesSummaryOfLeaseExpenseDetails">
        <link:definition>100530 - Disclosure - Leases - Summary of Lease Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfAmountsReportedInConsolidatedBalanceSheetsAndWeightaverageLeaseTermAndDiscountRateInformationDetails" id="DisclosureLeasesSummaryOfAmountsReportedInConsolidatedBalanceSheetsAndWeightaverageLeaseTermAndDiscountRateInformationDetails">
        <link:definition>100540 - Disclosure - Leases - Summary of Amounts Reported in Consolidated Balance Sheets and Weight-average Lease Term and Discount rate Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOtherLeaseActivityDetails" id="DisclosureLeasesSummaryOfOtherLeaseActivityDetails">
        <link:definition>100550 - Disclosure - Leases - Summary of Other Lease Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails" id="DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails">
        <link:definition>100560 - Disclosure - Leases - Summary of Future Lease Payments for Noncancelable Leases (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails" id="DisclosureSignificantAgreementsAdditionalInformationDetails">
        <link:definition>100570 - Disclosure - Significant Agreements - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureDefinedContributionBenefitPlanAdditionalInformationDetails" id="DisclosureDefinedContributionBenefitPlanAdditionalInformationDetails">
        <link:definition>100580 - Disclosure - Defined Contribution Benefit Plan - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeRateToEffectiveIncomeTaxRateDetails" id="DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeRateToEffectiveIncomeTaxRateDetails">
        <link:definition>100590 - Disclosure - Income Taxes - Schedule of Reconciliation of Federal Statutory Income Rate to Effective Income Tax Rate (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails" id="DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails">
        <link:definition>100600 - Disclosure - Income Taxes - Schedule of Significant Components of Deferred tax Assets and Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails" id="DisclosureIncomeTaxesAdditionalInformationDetails">
        <link:definition>100610 - Disclosure - Income Taxes - Additional Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails" id="Role_DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails">
        <link:definition>100620 - Disclosure - Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType roleURI="http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails" id="Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails">
        <link:definition>100630 - Disclosure - Net Loss Per Share - Potential Dilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
  <xsd:element id="vor_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" name="CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="vor_OperatingLeaseAssetsAbstract" name="OperatingLeaseAssetsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="vor_OperatingLeaseWeightedAverageLeaseTermAndDiscountRateAbstract" name="OperatingLeaseWeightedAverageLeaseTermAndDiscountRateAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="vor_SignificantAgreementsAbstract" name="SignificantAgreementsAbstract" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="vor_AccruedLicenseAndMilestoneFeesCurrent" name="AccruedLicenseAndMilestoneFeesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="vor_AccruedResearchAndDevelopmentExpensesCurrent" name="AccruedResearchAndDevelopmentExpensesCurrent" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="vor_AdditionalSpaceLeased" name="AdditionalSpaceLeased" type="dtr-types:areaItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="vor_ConsideredPercentageOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards" name="ConsideredPercentageOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="vor_ConsideredPeriodOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards" name="ConsideredPeriodOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards" type="xbrli:durationItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_ConversionOfRedeemableConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering" name="ConversionOfRedeemableConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="vor_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses" name="DeferredOfferingCostsInAccountsPayableAndAccruedExpenses" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="vor_DeferredTaxAssetsAmortization" name="DeferredTaxAssetsAmortization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="vor_DeferredTaxAssetsLeaseLiability" name="DeferredTaxAssetsLeaseLiability" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="vor_DeferredTaxLiabilitiesDepreciationAndAmortization" name="DeferredTaxLiabilitiesDepreciationAndAmortization" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="vor_DeferredTaxLiabilitiesLeaseRightOfUseAsset" name="DeferredTaxLiabilitiesLeaseRightOfUseAsset" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="vor_DefinedContributionPlanAdditionalPercentage" name="DefinedContributionPlanAdditionalPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_DefinedContributionPlanFirstPercentage" name="DefinedContributionPlanFirstPercentage" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_Definedcontributionplanminimumannualcontributionsperemployeepercent" name="Definedcontributionplanminimumannualcontributionsperemployeepercent" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_EffectiveIncomeTaxRateReconciliationPermanentItems" name="EffectiveIncomeTaxRateReconciliationPermanentItems" type="dtr-types:percentItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_FairValueAssetsLevel1ToLevel2TransferredAmount" name="FairValueAssetsLevel1ToLevel2TransferredAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="vor_FairValueAssetsLevel2ToLevel1TransferredAmount" name="FairValueAssetsLevel2ToLevel1TransferredAmount" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="vor_IncreaseInAnnualFixedRentalPayments" name="IncreaseInAnnualFixedRentalPayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="vor_LicenseAgreementMilestonePaymentsOnAggregateNetSales" name="LicenseAgreementMilestonePaymentsOnAggregateNetSales" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="vor_LicenseAgreementPotentialMilestonePayments" name="LicenseAgreementPotentialMilestonePayments" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfClinicalMilestones" name="LicenseAgreementPotentialMilestonePaymentsUponAchievementOfClinicalMilestones" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfRegulatoryAndCommercialMilestones" name="LicenseAgreementPotentialMilestonePaymentsUponAchievementOfRegulatoryAndCommercialMilestones" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="vor_LicenseFeeObligatedToPay" name="LicenseFeeObligatedToPay" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="vor_NumberOfCommonStockVotingRights" name="NumberOfCommonStockVotingRights" type="xbrli:integerItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="vor_OperatingLeaseCommencementPeriod" name="OperatingLeaseCommencementPeriod" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_OperatingLeaseEstimatedToCommencePeriod" name="OperatingLeaseEstimatedToCommencePeriod" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_OperatingLossCarryforwardsExpirationYear" name="OperatingLossCarryforwardsExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_OperatingRightOfUseAssetsAndOperatingLeaseLiabilityRecordedUponLeaseCommencement" name="OperatingRightOfUseAssetsAndOperatingLeaseLiabilityRecordedUponLeaseCommencement" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriod" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriod" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false"/>
  <xsd:element id="vor_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriodWeightedAverageExercisePrice" name="ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriodWeightedAverageExercisePrice" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_StockIssuedDuringPeriodSharesStockOptionsVestedAndExercised" name="StockIssuedDuringPeriodSharesStockOptionsVestedAndExercised" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_StockIssuedDuringPeriodValueStockOptionsVestedAndExercised" name="StockIssuedDuringPeriodValueStockOptionsVestedAndExercised" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="vor_TaxCreditCarryforwardsExpirationYear" name="TaxCreditCarryforwardsExpirationYear" type="xbrli:gYearItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues" name="TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_TemporaryEquityCumulativeUndeclaredDividends" name="TemporaryEquityCumulativeUndeclaredDividends" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="instant" nillable="true" abstract="false" xbrli:balance="credit"/>
  <xsd:element id="vor_TemporaryEquityIssuedPricePerShare" name="TemporaryEquityIssuedPricePerShare" type="dtr-types:perShareItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_TemporaryEquityStockConvertedDuringPeriodShares" name="TemporaryEquityStockConvertedDuringPeriodShares" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_TemporaryEquityStockConvertedDuringPeriodValue" name="TemporaryEquityStockConvertedDuringPeriodValue" type="xbrli:monetaryItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false" xbrli:balance="debit"/>
  <xsd:element id="vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" name="TemporaryEquityStockIssuedDuringPeriodSharesNewIssues" type="xbrli:sharesItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_NatureOfBusinessLineItems" name="NatureOfBusinessLineItems" type="xbrli:stringItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="vor_AccruedExpensesMember" name="AccruedExpensesMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="vor_CambridgeparkLeaseMember" name="CambridgeparkLeaseMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="vor_ColumbiaLicenseAgreementMember" name="ColumbiaLicenseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="vor_FirstLeaseAmendmentMember" name="FirstLeaseAmendmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="vor_FurnitureAndEquipmentMember" name="FurnitureAndEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="vor_LaboratoryEquipmentMember" name="LaboratoryEquipmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="vor_MaturingAfterOneYearThroughFiveYearsMember" name="MaturingAfterOneYearThroughFiveYearsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="vor_MaturingInOneYearOrLessMember" name="MaturingInOneYearOrLessMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="vor_NationalInstitutesOfHealthLicenseAgreementMember" name="NationalInstitutesOfHealthLicenseAgreementMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="vor_RestrictedCashEquivalentsMember" name="RestrictedCashEquivalentsMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="vor_SecondLeaseAmendmentMember" name="SecondLeaseAmendmentMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="vor_SeriesAOneRedeemableConvertiblePreferredStockMember" name="SeriesAOneRedeemableConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="vor_SeriesATwoRedeemableConvertiblePreferredStockMember" name="SeriesATwoRedeemableConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="vor_SeriesBRedeemableConvertiblePreferredStockMember" name="SeriesBRedeemableConvertiblePreferredStockMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="vor_TwoThousandFifteenStockIncentivePlanMember" name="TwoThousandFifteenStockIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="vor_TwoThousandTwentyOneEquityIncentivePlanMember" name="TwoThousandTwentyOneEquityIncentivePlanMember" type="dtr-types:domainItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="vor_NatureOfBusinessTable" name="NatureOfBusinessTable" type="xbrli:stringItemType" substitutionGroup="xbrldt:hypercubeItem" xbrli:periodType="duration" nillable="true" abstract="true"/>
  <xsd:element id="vor_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock" name="ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_AccruedResearchAndDevelopmentExpensesPolicyPolicyTextBlock" name="AccruedResearchAndDevelopmentExpensesPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock" name="PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" name="RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_RedeemableConvertiblePreferredStockTextBlock" name="RedeemableConvertiblePreferredStockTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_ScheduleOfOperatingLeaseAssetsAndLiabilitiesWeightedAverageLeaseTermAndDiscountRateTableTextBlock" name="ScheduleOfOperatingLeaseAssetsAndLiabilitiesWeightedAverageLeaseTermAndDiscountRateTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_ScheduleOfOtherLeaseActivityTableTextBlock" name="ScheduleOfOtherLeaseActivityTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock" name="ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
  <xsd:element id="vor_SignificantAgreementsTextBlock" name="SignificantAgreementsTextBlock" type="dtr-types:textBlockItemType" substitutionGroup="xbrli:item" xbrli:periodType="duration" nillable="true" abstract="false"/>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034244330696">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Document and Entity Information - USD ($)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Mar. 04, 2022</div></th>
<th class="th"><div>Jun. 30, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-K<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Dec. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">FY<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">VOR BIOPHARMA INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001817229<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityWellKnownSeasonedIssuer', window );">Entity Well-known Seasoned Issuer</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityVoluntaryFilers', window );">Entity Voluntary Filers</a></td>
<td class="text">No<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39979<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">81-1591163<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">100 Cambridgepark Drive<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Cambridge<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">MA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">02140<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">617<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">655-6580<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes <span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">37,488,370<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityPublicFloat', window );">Entity Public Float</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 351,650,244.65<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_IcfrAuditorAttestationFlag', window );">ICFR Auditor Attestation Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentAnnualReport', window );">Document Annual Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">VOR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorName', window );">Auditor Name</a></td>
<td class="text">Ernst & Young LLP<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorLocation', window );">Auditor Location</a></td>
<td class="text">Boston, Massachusetts<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AuditorFirmId', window );">Auditor Firm ID</a></td>
<td class="text">42<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorFirmId">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>PCAOB issued Audit Firm Identifier</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorFirmId</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:nonemptySequenceNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorLocation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorLocation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AuditorName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AuditorName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:internationalNameItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentAnnualReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an annual report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentAnnualReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityPublicFloat">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityPublicFloat</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityVoluntaryFilers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityVoluntaryFilers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityWellKnownSeasonedIssuer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityWellKnownSeasonedIssuer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_IcfrAuditorAttestationFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-K<br> -Number 249<br> -Section 310<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Number 249<br> -Section 220<br> -Subsection f<br><br>Reference 3: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 40-F<br> -Number 249<br> -Section 240<br> -Subsection f<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_IcfrAuditorAttestationFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034244347736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 119,801<span></span>
</td>
<td class="nump">$ 48,539<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermInvestments', window );">Investments</a></td>
<td class="nump">87,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseCurrent', window );">Prepaid expenses</a></td>
<td class="nump">4,836<span></span>
</td>
<td class="nump">467<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsCurrent', window );">Other current assets</a></td>
<td class="nump">2,094<span></span>
</td>
<td class="nump">100<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">214,399<span></span>
</td>
<td class="nump">49,106<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted cash equivalents</a></td>
<td class="nump">2,413<span></span>
</td>
<td class="nump">1,559<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">6,853<span></span>
</td>
<td class="nump">4,728<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets</a></td>
<td class="nump">15,670<span></span>
</td>
<td class="nump">17,117<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">3,255<span></span>
</td>
<td class="nump">3,398<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">242,590<span></span>
</td>
<td class="nump">75,908<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,545<span></span>
</td>
<td class="nump">2,361<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued expenses</a></td>
<td class="nump">6,335<span></span>
</td>
<td class="nump">6,260<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liability</a></td>
<td class="nump">1,839<span></span>
</td>
<td class="nump">863<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other current liabilities</a></td>
<td class="nump">434<span></span>
</td>
<td class="nump">723<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">10,153<span></span>
</td>
<td class="nump">10,207<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-term liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities&#8212;non-current</a></td>
<td class="nump">16,174<span></span>
</td>
<td class="nump">17,430<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">26,327<span></span>
</td>
<td class="nump">27,637<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">107,336<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity (deficit):</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockValue', window );">Preferred stock, $0.0001 par value; 10,000,000 and 0 shares authorized as of December 31, 2021 and December 31, 2020, respectively; 0 shares issued and outstanding as of December 31, 2021 and December 31, 2020</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common stock, $0.0001 par value; 400,000,000 and 420,000,000 shares authorized as of December 31, 2021 and December 31, 2020, respectively; 37,375,428 and 893,231 shares issued and 37,174,741 and 505,074 outstanding as of December 31, 2021 and December 31, 2020, respectively</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapitalCommonStock', window );">Additional paid-in capital</a></td>
<td class="nump">346,382<span></span>
</td>
<td class="nump">2,158<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(130,123)<span></span>
</td>
<td class="num">(61,224)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders' equity (deficit)</a></td>
<td class="nump">216,263<span></span>
</td>
<td class="num">(59,065)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)</a></td>
<td class="nump">$ 242,590<span></span>
</td>
<td class="nump">75,908<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=vor_SeriesAOneRedeemableConvertiblePreferredStockMember', window );">Series A-1 Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-term liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=vor_SeriesATwoRedeemableConvertiblePreferredStockMember', window );">Series A-2 Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-term liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,786<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=vor_SeriesBRedeemableConvertiblePreferredStockMember', window );">Series B Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-term liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,548<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapitalCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapitalCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 15: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6787-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6387103&amp;loc=d3e6435-108320<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section 05<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123349782&amp;loc=d3e5879-108316<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120413209&amp;loc=SL6242269-115581<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(1)(g))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=vor_SeriesAOneRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=vor_SeriesAOneRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=vor_SeriesATwoRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=vor_SeriesATwoRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=vor_SeriesBRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=vor_SeriesBRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034244790712">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Redeemable convertible preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Redeemable convertible preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">338,973,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable convertible preferred stock, shares issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,714,086<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Redeemable convertible preferred stock, shares outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,714,086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Redeemable convertible preferred stock, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 111,628<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">400,000,000<span></span>
</td>
<td class="nump">420,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued</a></td>
<td class="nump">37,375,428<span></span>
</td>
<td class="nump">893,231<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding</a></td>
<td class="nump">37,174,741<span></span>
</td>
<td class="nump">505,074<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=vor_SeriesAOneRedeemableConvertiblePreferredStockMember', window );">Series A-1 Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Redeemable convertible preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Redeemable convertible preferred stock, shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable convertible preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Redeemable convertible preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Redeemable convertible preferred stock, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=vor_SeriesATwoRedeemableConvertiblePreferredStockMember', window );">Series A-2 Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Redeemable convertible preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Redeemable convertible preferred stock, shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">107,194,866<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable convertible preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">107,194,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Redeemable convertible preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">107,194,866<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Redeemable convertible preferred stock, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,878<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=vor_SeriesBRedeemableConvertiblePreferredStockMember', window );">Series B Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Redeemable convertible preferred stock, par value</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Redeemable convertible preferred stock, shares authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">211,778,825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Redeemable convertible preferred stock, shares issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">124,519,220<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Redeemable convertible preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">124,519,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Redeemable convertible preferred stock, liquidation preference</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,750<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=vor_SeriesAOneRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=vor_SeriesAOneRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=vor_SeriesATwoRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=vor_SeriesATwoRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=vor_SeriesBRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=vor_SeriesBRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034244268232">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">$ 47,529<span></span>
</td>
<td class="nump">$ 31,618<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GeneralAndAdministrativeExpense', window );">General and administrative</a></td>
<td class="nump">21,489<span></span>
</td>
<td class="nump">11,748<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">69,018<span></span>
</td>
<td class="nump">43,366<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(69,018)<span></span>
</td>
<td class="num">(43,366)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingGainsLossesAbstract', window );"><strong>Other income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Total other income</a></td>
<td class="nump">119<span></span>
</td>
<td class="nump">29<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss and comprehensive loss</a></td>
<td class="num">(68,899)<span></span>
</td>
<td class="num">(43,337)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemablePreferredStockDividends', window );">Cumulative dividends on redeemable convertible preferred stock</a></td>
<td class="num">(1,228)<span></span>
</td>
<td class="num">(5,925)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (70,127)<span></span>
</td>
<td class="num">$ (49,262)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share attributable to common stockholders, basic and diluted</a></td>
<td class="num">$ (2.10)<span></span>
</td>
<td class="num">$ (230.57)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted-average common shares outstanding, basic and diluted</a></td>
<td class="nump">33,433,214<span></span>
</td>
<td class="nump">213,658<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingGainsLossesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingGainsLossesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemablePreferredStockDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dividends paid to preferred stock holders that is redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemablePreferredStockDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034247027992">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Series A-1 Redeemable Convertible Preferred Stock</div></th>
<th class="th"><div>Series A-2 Redeemable Convertible Preferred Stock</div></th>
<th class="th"><div>Series B Redeemable Convertible Preferred Stock</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2019</a></td>
<td class="num">$ (17,429)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 458<span></span>
</td>
<td class="num">$ (17,887)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance, Shares at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">119,936<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Beginning Balance at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 25,067<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Beginning Balance, Shares at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">62,819,866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,719<span></span>
</td>
<td class="nump">$ 64,548<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of redeemable convertible preferred stock, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,375,000<span></span>
</td>
<td class="nump">124,519,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options</a></td>
<td class="nump">359<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">358<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Issuance of common stock upon exercise of stock options, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">385,138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">1,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,342<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(43,337)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(43,337)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2020</a></td>
<td class="num">$ (59,065)<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">2,158<span></span>
</td>
<td class="num">(61,224)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance, Shares at Dec. 31, 2020</a></td>
<td class="nump">505,074<span></span>
</td>
<td class="nump">505,074<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Ending Balance at Dec. 31, 2020</a></td>
<td class="nump">$ 107,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 42,786<span></span>
</td>
<td class="nump">$ 64,548<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending Balance, Shares at Dec. 31, 2020</a></td>
<td class="nump">251,714,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">107,194,866<span></span>
</td>
<td class="nump">124,519,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues', window );">Issuance of redeemable convertible preferred stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,375<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Issuance of redeemable convertible preferred stock, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,259,605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_TemporaryEquityStockConvertedDuringPeriodValue', window );">Conversion of redeemable convertible preferred stock into common stock upon closing of initial public offering</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (2)<span></span>
</td>
<td class="num">$ (42,786)<span></span>
</td>
<td class="num">$ (109,923)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_TemporaryEquityStockConvertedDuringPeriodShares', window );">Conversion of redeemable convertible preferred stock into common stock upon closing of initial public offering, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(20,000,000)<span></span>
</td>
<td class="num">(107,194,866)<span></span>
</td>
<td class="num">(211,778,825)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities', window );">Conversion of redeemable convertible preferred stock into common stock upon closing of initial public offering</a></td>
<td class="nump">$ 152,711<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">152,709<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Conversion of redeemable convertible preferred stock into common stock upon closing of initial public offering, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,924,501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common shares upon closing of initial public offering, net of offering costs and underwriter fees of $17,132</a></td>
<td class="nump">186,308<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">186,307<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common shares upon closing of initial public offering, net of offering costs and underwriter fees, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,302,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_StockIssuedDuringPeriodValueStockOptionsVestedAndExercised', window );">Issuance of common stock upon vesting and exercise of stock options</a></td>
<td class="nump">894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">894<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_StockIssuedDuringPeriodSharesStockOptionsVestedAndExercised', window );">Issuance of common stock upon vesting and exercise of stock options, Shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">442,947<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation expense</a></td>
<td class="nump">4,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,314<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(68,899)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(68,899)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 216,263<span></span>
</td>
<td class="nump">$ 4<span></span>
</td>
<td class="nump">$ 346,382<span></span>
</td>
<td class="num">$ (130,123)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance, Shares at Dec. 31, 2021</a></td>
<td class="nump">37,174,741<span></span>
</td>
<td class="nump">37,174,741<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Ending Balance, Shares at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=122142933&amp;loc=d3e11178-113907<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123468992&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The gross value of stock issued during the period upon the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of new stock classified as temporary equity issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_StockIssuedDuringPeriodSharesStockOptionsVestedAndExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period shares stock options vested and exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_StockIssuedDuringPeriodSharesStockOptionsVestedAndExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_StockIssuedDuringPeriodValueStockOptionsVestedAndExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Stock issued during period value stock options vested and exercised.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_StockIssuedDuringPeriodValueStockOptionsVestedAndExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_TemporaryEquityStockConvertedDuringPeriodShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity stock converted during period shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_TemporaryEquityStockConvertedDuringPeriodShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_TemporaryEquityStockConvertedDuringPeriodValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity stock converted during period value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_TemporaryEquityStockConvertedDuringPeriodValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity stock issued during period shares new issues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034245858600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfStockholdersEquityAbstract', window );"><strong>Statement of Stockholders' Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts', window );">Issuance of common shares upon closing of initial public offering, offering costs and underwriter fees</a></td>
<td class="nump">$ 17,132<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfStockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfStockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034250429576">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProfitLoss', window );">Net loss</a></td>
<td class="num">$ (68,899)<span></span>
</td>
<td class="num">$ (43,337)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operations:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">1,434<span></span>
</td>
<td class="nump">605<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseExpense', window );">Non-cash lease expense</a></td>
<td class="nump">3,017<span></span>
</td>
<td class="nump">782<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">4,315<span></span>
</td>
<td class="nump">1,342<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherOperatingActivitiesCashFlowStatement', window );">Other</a></td>
<td class="nump">174<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liability</a></td>
<td class="num">(2,559)<span></span>
</td>
<td class="nump">393<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="num">(6,363)<span></span>
</td>
<td class="nump">606<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities', window );">Accounts payable and accrued expenses</a></td>
<td class="nump">405<span></span>
</td>
<td class="nump">5,820<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets', window );">Other assets</a></td>
<td class="num">(668)<span></span>
</td>
<td class="num">(2,503)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(69,144)<span></span>
</td>
<td class="num">(36,292)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flow from investing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireInvestments', window );">Purchases of investments</a></td>
<td class="num">(87,757)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(3,894)<span></span>
</td>
<td class="num">(4,161)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(91,651)<span></span>
</td>
<td class="num">(4,161)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flow from financing activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Proceeds from issuance of redeemable convertible preferred stock</a></td>
<td class="nump">45,375<span></span>
</td>
<td class="nump">82,267<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Proceeds from the issuance of common stock upon closing of initial public offering, net of underwriter fees</a></td>
<td class="nump">189,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of initial public offering costs</a></td>
<td class="num">(2,215)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock option exercises</a></td>
<td class="nump">553<span></span>
</td>
<td class="nump">259<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">232,911<span></span>
</td>
<td class="nump">82,526<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net increase in cash, cash equivalents and restricted cash equivalents</a></td>
<td class="nump">72,116<span></span>
</td>
<td class="nump">42,073<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash equivalents, beginning of period</a></td>
<td class="nump">50,098<span></span>
</td>
<td class="nump">8,025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Cash, cash equivalents and restricted cash equivalents, end of period</a></td>
<td class="nump">122,214<span></span>
</td>
<td class="nump">50,098<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowElementsAbstract', window );"><strong>Supplemental disclosure of non-cash activities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_OperatingRightOfUseAssetsAndOperatingLeaseLiabilityRecordedUponLeaseCommencement', window );">Operating right-of-use assets and operating lease liability recorded upon lease commencement</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">17,899<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Purchases of property and equipment in accounts payable</a></td>
<td class="nump">194<span></span>
</td>
<td class="nump">444<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_ConversionOfRedeemableConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering', window );">Conversion of redeemable convertible preferred stock to common stock upon closing of the initial public offering</a></td>
<td class="nump">$ 152,711<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses', window );">Deferred offering costs in accounts payable and accrued expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 896<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating lease expense. Excludes sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918638-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherOperatingActivitiesCashFlowStatement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherOperatingActivitiesCashFlowStatement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireInvestments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the purchase of all investments (debt, security, other) during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireInvestments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProfitLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3000-108585<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=123454820&amp;loc=SL4569616-111683<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 23: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 31: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4J<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591551-111686<br><br>Reference 32: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 55<br> -Paragraph 4K<br> -URI http://asc.fasb.org/extlink&amp;oid=120409616&amp;loc=SL4591552-111686<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProfitLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowElementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowElementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_ConversionOfRedeemableConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Conversion of redeemable convertible preferred stock to common stock upon closing of initial public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_ConversionOfRedeemableConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred offering costs in accounts payable and accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_OperatingRightOfUseAssetsAndOperatingLeaseLiabilityRecordedUponLeaseCommencement">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating right-of-use assets and operating lease liability recorded upon lease commencement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_OperatingRightOfUseAssetsAndOperatingLeaseLiabilityRecordedUponLeaseCommencement</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034246139240">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 119,801<span></span>
</td>
<td class="nump">$ 48,539<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted cash equivalents</a></td>
<td class="nump">2,413<span></span>
</td>
<td class="nump">1,559<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations', window );">Total cash, cash equivalents and restricted cash equivalents as shown on the statements of cash flows</a></td>
<td class="nump">$ 122,214<span></span>
</td>
<td class="nump">$ 50,098<span></span>
</td>
<td class="nump">$ 8,025<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3044-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120413209&amp;loc=SL6242269-115581<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034251698632">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of the Business<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NatureOfOperations', window );">Nature of the Business</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">1. Nature of the Business</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vor Biopharma Inc. (the &#8220;Company&#8221;) is a clinical-stage cell and genome engineering company that combines a novel patient engineering approach with targeted therapies to provide a single company solution for patients suffering from hematological malignancies. The Company&#8217;s proprietary platform leverages its expertise in hematopoietic stem cell (&#8220;HSC&#8221;) biology, genome engineering and targeted therapy development to genetically modify HSCs to remove surface targets expressed by cancer cells. The Company is headquartered in Cambridge, Massachusetts. The Company was incorporated on </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 30, 2015</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Initial Public Offering</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On February 9, 2021, the Company completed an initial public offering (&#8220;IPO&#8221;) of its common stock. At the closing of the IPO, the Company sold </span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11,302,219</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of its common stock, at a public offering price of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18.00</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share. The Company received net proceeds of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">186.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million from the IPO, after deducting underwriters&#8217; discounts and commissions and other offering expenses paid by the Company.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Upon closing of the IPO, all shares of the Company&#8217;s Series A-1, A-2 and B redeemable convertible preferred stock then outstanding automatically converted into an aggregate of </span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24,924,501</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock. Upon conversion of the redeemable convertible preferred stock, the Company reclassified the carrying value of the redeemable convertible preferred stock to common stock and additional paid-in capital.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In connection with the IPO, the Company filed an amended and restated certificate of incorporation that amended and restated the Company&#8217;s certificate of incorporation in its entirety to, among other things, authorize the Company to issue up to </span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">400,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common stock, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.0001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> par value per share, and </span><span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of preferred stock, $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.0001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> par value per share, all of which shares of preferred stock are undesignated and the rights and preferences of such preferred stock may be established by the Company&#8217;s board of directors from time to time.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Reverse Stock Split</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On January 29, 2021, the Company effected a </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_1a6782bb-9d03-4a11-a8d9-b5a47122f2f7;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13.6</span></span></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">-for-1 reverse stock split</span></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of the Company&#8217;s common stock. All shares, stock options, and per share information in the consolidated financial statements were previously adjusted to reflect the reverse stock split. There was no change in the par value and authorized number of shares of the Company&#8217;s common stock.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Risks and Uncertainties</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is subject to a number of risks common to development stage companies in the biotechnology industry, including, but not limited to, risks of failure of preclinical studies and clinical trials, dependence on key personnel, protection of proprietary technology, reliance on third party organizations, risks of obtaining regulatory approval for any product candidate that it may develop, development by competitors of technological innovations, compliance with government regulations, the impact of the COVID-19 pandemic, including impacts related to the variants of the virus, and the need to obtain additional financing.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company anticipates that it will continue to incur significant operating losses for the next several years as it continues to develop its product candidates. The Company believes that its existing cash, cash equivalents and investments at December 31, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> will be sufficient to allow the Company to fund its current operations through at least a period of one year after the date the financial statements are issued.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NatureOfOperations">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -URI http://asc.fasb.org/topic&amp;trid=2134479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NatureOfOperations</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034245810664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">2. Summary of Significant Accounting Policies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Basis of Presentation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification ("ASC") or an Accounting Standards Update (&#8220;ASU&#8221;) issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of the consolidated financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amount of expenses during the reporting period. Actual results could differ from those estimates. Management considers many factors in selecting appropriate financial accounting policies in developing the estimates and assumptions that are used in the preparation of the consolidated financial statements. Management must apply significant judgment in this process. Management&#8217;s estimation process often may yield a range of potentially reasonable estimates and management must select an amount that falls within that range of reasonable estimates. Estimates are used in the following areas, among others: estimating the fair value of the Company&#8217;s common stock (prior to the IPO); accrued expenses and related research and development expenses.</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Segments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating segments are defined as components of an enterprise for which separate and discrete information is available for evaluation by the chief operating decision-maker in deciding how to allocate resources and assess performance. The Company has </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> operating segment. The Company&#8217;s chief operating decision maker, its Chief Executive Officer, manages the Company&#8217;s operations on an aggregate basis for the purpose of allocating resources.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Foreign Currency Transaction Gains or Losses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Transactions denominated in foreign currencies are recorded in U.S. dollars on the date of those transactions. Adjustments arising from foreign currency transactions between the purchase and the settlement dates are reflected in the consolidated statement of operations and comprehensive loss as a component of other income.</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cash and Cash Equivalents</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company considers highly-liquid investments purchased with an original maturity date of ninety days or less from the date of purchase to be cash equivalents. Cash and cash equivalents include cash held in banks and amounts held in money market funds. Cash equivalents are stated at cost, which approximates market value.</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Investments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Investments represent excess cash balances held in marketable debt securities and are classified as available-for-sale. Investments with maturities beyond one year may be classified as short-term based on their highly liquid nature and because such securities represent an investment of cash that is available for current operations.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Available-for-sale investments are reported at fair value at each balance sheet date. Changes in the market value of available-for-sale investments, excluding other-than-temporary impairments, are reflected as other comprehensive income, a component of stockholders&#8217; equity. Realized gains and losses are determined using the specific identification method and are included in other income in our consolidated statements of operations and comprehensive loss.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Investments are evaluated for other-than-temporary impairment at the end of each reporting period. Impairment is evaluated considering numerous factors, and their relative significance varies depending on the situation. Factors considered include whether a decline in fair value below the amortized cost basis is due to credit-related factors or non-credit-related factors, the financial condition and near-term prospects of the issuer, and the Company's intent and ability to hold the investment to allow for an anticipated recovery in fair value. Once a decline in fair value is determined to be other-than-temporary, an impairment charge is recorded to other income (expense) and a new cost basis in the investment is established.</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Deferred Offering Costs</span></p></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company capitalizes certain legal, professional, accounting and other third-party fees that are directly associated with in-process equity issuances as deferred offering costs until such equity issuances are consummated. After consummation of the equity issuance, these costs are recorded as a reduction in the capitalized amount associated with the equity issuance. During the year ended December 31, 2020, the Company incurred $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million in deferred offering costs that are included in other assets on the consolidated balance sheet.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Restricted Cash</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company had </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of restricted cash in the form of a letter of credit related to a lease at December 31, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Comprehensive loss</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Comprehensive loss includes net loss, as well as other changes in stockholders&#8217; equity (deficit) that result from transactions and economic events other than those with stockholders. The Company&#8217;s comprehensive loss was equal to net loss for the years ended December 31, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> .</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Preferred Stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company applies the guidance enumerated in FASB ASC Topic 480, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Distinguishing Liabilities from Equity</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#8220;ASC 480&#8221;), when determining the classification and measurement of its preferred stock. Preferred stock subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. The Company classifies conditionally redeemable preferred stock (if any), which includes preferred stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control, as temporary equity.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Concentrations of Credit Risk</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash equivalents and investments. The Company maintains deposits in accredited financial institutions in excess of federally insured limits. The Company deposits its cash in financial institutions that it believes have high credit quality and has not experienced any losses on such accounts and does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#8217;s investments consist of money market funds and marketable debt securities, including corporate bonds and U.S. Treasury securities. The Company&#8217;s investments may include commercial paper and other debt securities of U.S. government agencies, corporate entities, and banks. The Company&#8217;s investment policy limits instruments to investment grade securities with high credit quality issuers with the objective to preserve capital and to maintain liquidity until the funds can be used in business operations.</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Fair Value Measurements</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 1&#8212;Quoted prices in active markets for identical assets or liabilities. </span></div></div><div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 2&#8212;Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. </span></div></div><div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 3&#8212;Unobservable inputs that are supported by little or no market activity that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. </span></div></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument&#8217;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments consist of cash and cash equivalents, restricted cash, accounts payable and accrued expenses. These financial instruments are stated at their respective historical carrying values which approximate fair value due to their short-term nature.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Property and Equipment, Net</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment, net is recorded at cost less accumulated depreciation. Depreciation expense is recorded using the straight-line method over the estimated useful life of the related asset, which are as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:50.0%;"/>
          <td style="width:50.0%;"/>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Estimated Useful Life</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Computer equipment</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Furniture and equipment</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Laboratory equipment</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Leasehold improvements</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Shorter of remaining lease term or useful life</span></span></p></td>
         </tr>
        </table></div></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Purchased assets that are not yet in service are recorded to construction-in-process and no depreciation expense is recorded. Once they are placed in service, they are reclassified to the appropriate asset class. When assets are retired or otherwise disposed of, the assets and related accumulated depreciation are eliminated from the accounts and any resulting gain or loss is reflected in the Company&#8217;s consolidated statements of operation and comprehensive loss. Expenditures for maintenance and repairs are expensed as incurred.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Impairment of Long-Lived Assets</span></p></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Long-lived assets consist of property and equipment. The Company continually evaluates whether events or circumstances have occurred that indicate that the estimated remaining useful life of its long-lived assets may warrant revision or that the carrying value of these assets may not be recoverable. If circumstances require that a long-lived asset or asset group be tested for impairment, the Company first compares the estimated undiscounted future cash flows expected to result from the use or disposition of that asset or asset group to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment loss would be recognized to the extent the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market prices and third-party independent appraisals, as considered necessary.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Leases</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease. Leases with a term greater than one year are recognized on the consolidated balance sheet as a right-of-use (&#8220;ROU&#8221;) asset and current and non-current lease liabilities, as applicable. The Company has made an accounting policy election, known as the short-term lease recognition exemption, which allows the Company to not recognize ROU assets and lease liabilities that arise from short-term leases (12 months or less); The Company has applied this election to all classes of underlying assets. The Company typically only includes an initial lease term in its assessment of a lease arrangement. Options to renew or options to cancel a lease are not included in the Company&#8217;s assessment unless there is reasonable certainty that the Company will renew or will not cancel, respectively. The Company monitors its material leases on a quarterly basis.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating lease liabilities and their corresponding ROU assets are recorded based on the present value of future lease payments over the expected remaining lease term. Lease cost for operating leases is recognized on a straight-line basis over the lease term as an operating expense. Certain adjustments to the ROU asset may be required for items such as lease prepayments or incentives received. The interest rate implicit in lease contracts is typically not readily determinable. As a result, the Company utilizes its incremental borrowing rate, which reflects the fixed rate at which the Company could borrow on a collateralized basis the amount of the lease payments in the same currency, for a similar term, in a similar economic environment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has elected to account for the lease and non-lease components together for office, laboratory, and manufacturing real estate leases.</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research and Development</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development expenses include costs directly attributable to the conduct of the Company&#8217;s research and development programs.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expenditures relating to research and development are expensed in the period incurred. Nonrefundable advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made. The cost of materials for a research and development activity that have an alternative future use is capitalized when the materials are acquired and recognized as expense as consumed. The costs of materials that were acquired for a particular research and development activity and have no alternative future use are expensed in the period acquired.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Costs incurred in obtaining licenses are recognized as research and development expense as incurred if the license has no alternative use.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accrued Research and Development Expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has entered into various research and development related contracts, including contracts with third-party contract research organizations and contract manufacturing organizations. These agreements are cancelable, and related payments are recognized as research and development expenses as incurred. The Company records accrued liabilities for estimated ongoing research costs. When evaluating the adequacy of the accrued liabilities, the Company analyzes the progress of the studies, including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the accrued balances at the end of any reporting period. Actual results could differ from the Company&#8217;s estimates. To date, the Company&#8217;s historical accrual estimates have not been materially different from the actual costs.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock-Based Compensation Expense</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company accounts for stock-based compensation under the provisions of ASC 718-10,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> Compensation&#8212;Stock Compensation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#8220;ASC 718-10&#8221;), which requires all share-based payments to employees, non-employees and directors, including grants of stock options and restricted stock, to be recognized in the consolidated statements of operations and comprehensive loss based on their fair values on the date of grant over the requisite service period, which is generally the vesting period of the respective award. Forfeitures are accounted for as they occur. Generally, the Company issues awards with only service-based vesting conditions and records the expense for these awards using the ratable method. The Company classifies stock-based compensation expense in the same manner in which the award recipient&#8217;s payroll or service provider&#8217;s costs are classified. Share-based payments that contain performance conditions are recognized when such conditions are probable of being achieved.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The fair value of each restricted common stock award is estimated on the date of grant based on the fair value of the Company&#8217;s common stock on that same date.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model, which requires inputs based on certain subjective assumptions, including the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Fair Value of Common Stock</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;See the discussion below. </span></div></div><div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expected Term</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;The expected term represents the period that the stock-based awards are expected to be outstanding. The Company uses the simplified method to determine the expected term, which is based on the average of the time-to-vesting and the contractual life of the options. </span></div></div><div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expected Volatility</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;Because the Company does not have sufficient trading history for its common stock as of December 31, 2021 , the expected volatility was estimated based on the average volatility for comparable publicly traded biotechnology companies over a period equal to the expected term of the stock option grants. The comparable companies were chosen based on the similar size, stage in life cycle or area of specialty. The Company will continue to apply this process until a sufficient amount of historical information regarding the volatility of its own stock price becomes available. </span></div></div><div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Risk-Free Interest Rate</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;The risk-free interest rate is based on the U.S. Treasury zero coupon issues in effect at the time of grant for periods corresponding with the expected term of the awards. </span></div></div><div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Dividend Yield</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;The Company has never paid dividends on its common stock and has no plans to pay dividends on its common stock. Therefore, the Company used an expected dividend yield of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">zero</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. </span></div></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company began to use the closing common stock price as reported on the Nasdaq Global Select Market exchange as the fair value of common stock on the date of a grant subsequent to its IPO. Prior to the Company's IPO the estimated fair value of common stock was determined by the Company&#8217;s board of directors as of the date of each</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">option grant, with input from management, considering third-party valuations of its common stock as well as the Company&#8217;s board of directors&#8217; assessment of additional objective and subjective factors that it believed were relevant and which may have changed from the date of the most recent third-party valuation through the date of the grant. These objective and subjective factors include: (i) prices paid for the Company&#8217;s redeemable convertible preferred stock, and the rights, preferences, and privileges of the Company&#8217;s redeemable convertible preferred stock and common stock; (ii) the Company&#8217;s stage of development; (iii) the fact that the grants of stock-based awards related to illiquid securities in a private company; and (iv) the likelihood of achieving a liquidity event for the common stock underlying the stock-based awards, such as an initial public offering or sale of the Company, given prevailing market conditions. These third-party valuations were performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants&#8217; Accounting and Valuation Guide, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Valuation of Privately Held Company Equity Securities Issued as Compensation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Each valuation methodology includes estimates and assumptions that require the Company&#8217;s judgment. The methodology utilized to estimate the fair value of the Company&#8217;s common stock was the option-pricing method (&#8220;OPM&#8221;) to back-solve the estimated value of the Company&#8217;s equity and corresponding value of the Company&#8217;s common stock.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Income Taxes</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company accounts for income taxes using the asset and liability approach. Deferred tax assets and liabilities represent future tax consequences of temporary differences between the financial statement carrying amounts and the tax basis of assets and liabilities and for loss carryforwards using enacted tax rates expected to be in effect in the years in which the differences reverse. A valuation allowance is established to reduce deferred tax assets to the amounts expected to be realized. The Company also recognizes a tax benefit from uncertain tax positions only if it is &#8220;more likely than not&#8221; that the position is sustainable based on its technical merits. The Company accounts for interest or penalties related to uncertain tax positions as part of its provision for income taxes. To date, the Company has </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t incurred interest and penalties related to uncertain tax positions. Should such costs be incurred, they would be classified as a component of provision for income taxes.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Net Loss Per Share</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss attributable to common stockholders is equal to the net loss for the period, as adjusted for cumulative dividends on redeemable convertible preferred stock, for the respective period.</span></p></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the reporting period, without consideration for potentially dilutive securities. Diluted net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares and potentially dilutive securities outstanding during the period determined using the treasury-stock and if-converted methods. For purposes of the diluted net loss per share attributable to common stockholders calculation, redeemable convertible preferred stock, restricted stock and stock options considered to be potentially dilutive securities were excluded from the calculation of diluted net loss per share attributable to common stockholders because their effect would be anti-dilutive and therefore, basic and diluted net loss per share attributable to common stockholders were the same for all reporting periods presented.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recent Accounting Pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From time to time, new accounting pronouncements are issued and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#8217;s consolidated financial statements upon adoption. Under the Jumpstart Our Business Startups Act of 2012, as amended (the &#8220;JOBS Act&#8221;), the Company meets the definition of an emerging growth company and has elected to take advantage of the extended transition period for complying with certain new or revised accounting standards pursuant to Section 107(b) of the JOBS Act. As noted below, certain new or revised accounting standards were early adopted.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recently Adopted Accounting Pronouncements</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In 2019, the FASB issued </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_9fe2e284-3d35-4fe3-b478-3dcd0820f887;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ASU No. 2019-12</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Income Taxes (Topic 740)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">: </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Simplifying the Accounting for Income Taxes (&#8220;ASU 2019-12&#8221;), which introduces a number of amendments that are designed to simplify the application of accounting for income taxes. Such amendments include removing certain exceptions for intraperiod tax allocation, interim reporting when a year-to-date loss exceeds the anticipated loss, reflecting the effect of an enacted change in tax laws or rates in the annual effective tax rate and recognition of deferred taxes related to</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p></div><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">outside </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">basis differences for ownership changes in investments. ASU 2019-12 also provides clarification related to when a step up in the tax basis of goodwill should be considered part of the business combination in which the book goodwill was originally recognized and when it should be considered a separate transaction. In addition, ASU 2019-12 provides guidance on the recognition of a franchise tax (or similar tax) that is partially based on income as an income-based tax and accounting for any incremental amount incurred as a non-income-based tax. The Company </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">adopted </span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> ASU 2019-12 effective </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 1, 2021</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, and the adoption did </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t have a material impact on its consolidated financial statements.</span></span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recently Issued Accounting Pronouncements Not Yet Adopted</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In June 2016, the FASB issued ASU 2016-13, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> which has been subsequently amended by ASU 2018-19, ASU 2019-04, ASU 2019-05, ASU 2019-10, ASU 2019-11 and ASU 2020-03 (&#8220;ASU 2016-13&#8221;). This standard significantly changes the impairment model for most financial assets and certain other instruments and will require immediate recognition of estimated credit losses expected to occur over the remaining life of many financial assets, which will generally result in earlier recognition of allowances for credit losses on loans and other financial instruments. The Company does not expect that this standard will have a material impact to the Company&#8217;s consolidated financial statements and plans to adopt this standard on January 1, 2022.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123372394&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034245936808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock', window );">Investments</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">3. Investments</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The amortized cost and estimated fair value of investments, by contractual maturity are as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:48.999%;"/>
        <td style="width:1.178%;"/>
        <td style="width:1.371%;"/>
        <td style="width:9.519%;"/>
        <td style="width:0.685%;"/>
        <td style="width:1.178%;"/>
        <td style="width:1.371%;"/>
        <td style="width:9.53%;"/>
        <td style="width:0.685%;"/>
        <td style="width:1.178%;"/>
        <td style="width:1.371%;"/>
        <td style="width:9.53%;"/>
        <td style="width:0.685%;"/>
        <td style="width:1.178%;"/>
        <td style="width:1.371%;"/>
        <td style="width:9.487%;"/>
        <td style="width:0.685%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Amortized Cost</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Gross Unrealized Holding Gains</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Gross Unrealized Holding Losses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Fair Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Maturing in one year or less</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate debt</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,603</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,603</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. Treasuries</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30,119</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30,119</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Maturing after one year through five years</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate debt</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,006</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,006</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. Treasuries</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">44,940</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">44,940</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:15.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">87,668</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">87,668</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company held </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> investments at December 31, 2020.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for  investments in certain debt and equity securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2209399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2324412<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -URI http://asc.fasb.org/topic&amp;trid=2196928<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 320<br> -URI http://asc.fasb.org/subtopic&amp;trid=2176304<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher SEC<br> -Name Regulation S-K (SK)<br> -Number 229<br> -Section 1403<br> -Paragraph (b)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034245817176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">4. Fair Value Measurements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following tables present information about the Company&#8217;s financial assets and liabilities measured at fair value on a recurring basis:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.143%;"/>
        <td style="width:1.178%;"/>
        <td style="width:1.371%;"/>
        <td style="width:9.499%;"/>
        <td style="width:0.685%;"/>
        <td style="width:1.178%;"/>
        <td style="width:1.371%;"/>
        <td style="width:9.499%;"/>
        <td style="width:0.685%;"/>
        <td style="width:1.178%;"/>
        <td style="width:1.371%;"/>
        <td style="width:9.392%;"/>
        <td style="width:0.685%;"/>
        <td style="width:1.178%;"/>
        <td style="width:1.371%;"/>
        <td style="width:9.531%;"/>
        <td style="width:0.685%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Level 1</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Level 2</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Level 3</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">95,339</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">95,339</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Investments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate bonds</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12,609</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12,609</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. Treasuries</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">75,059</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">75,059</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:15.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total investments</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">87,668</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">87,668</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Restricted cash equivalents</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,413</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,413</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">97,752</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">87,668</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">185,420</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Level 1</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Level 2</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Level 3</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41,036</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41,036</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:15.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41,036</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41,036</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The fair value of the Company&#8217;s cash equivalents and restricted cash equivalents is based on quoted market prices in active markets with no valuation adjustment. The fair value of investments was determined based on observable market inputs. During the years ended December 31, 2021 and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, there were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> transfers between levels.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034245921832">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">5. Property and Equipment, Net</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment, net consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.149%;"/>
        <td style="width:1.606%;"/>
        <td style="width:1.37%;"/>
        <td style="width:13.029%;"/>
        <td style="width:0.921%;"/>
        <td style="width:1.606%;"/>
        <td style="width:1.37%;"/>
        <td style="width:13.029%;"/>
        <td style="width:0.921%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Furniture and equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">108</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">40</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Laboratory equipment</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,457</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,247</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Leasehold improvements</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">55</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Computer equipment</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">317</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">167</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment, gross</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,937</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,454</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accumulated depreciation</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,084</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">726</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,853</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,728</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Depreciation expense for the years ended December 31, 2021 and 2020 was approximately </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI http://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034245976216">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock', window );">Accrued Expenses and Other Current Liabilities</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">6. Accrued Expenses and Other Current Liabilities</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued expenses and other current liabilities consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.246%;"/>
        <td style="width:1.606%;"/>
        <td style="width:1.381%;"/>
        <td style="width:12.996%;"/>
        <td style="width:0.867%;"/>
        <td style="width:1.606%;"/>
        <td style="width:1.381%;"/>
        <td style="width:13.221%;"/>
        <td style="width:0.696%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Employee-related and other expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,178</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,727</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development expenses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">797</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,924</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Professional fees</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">743</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,097</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">License and milestone fees</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Calibri;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">450</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">617</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">62</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total accrued expenses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,335</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,260</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034245937928">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_RedeemableConvertiblePreferredStockTextBlock', window );">Redeemable Convertible Preferred Stock</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">7. Redeemable Convertible Preferred Stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2020, the authorized capital stock of the Company included </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">338,973,691</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.0001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> par value preferred stock, of which </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">20,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares were designated as Series A-1 redeemable convertible preferred stock (&#8220;Series A-1&#8221;); </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">107,194,866</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares were designated as Series A-2 redeemable convertible preferred stock (&#8220;Series A-2&#8221;) and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">211,778,825</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares were designated as Series B redeemable convertible preferred stock (&#8220;Series B&#8221;).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Series A-1 and Series A-2 Redeemable Convertible Preferred Stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On February 12, 2019, the Company entered into the Series A-2 Preferred Stock Purchase Agreement. Included in the terms of the Series A-2 were tranche rights. The tranche rights obligated the investors in the Series A-2 to purchase, and the Company to sell, an additional </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">44,375,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Series A-2 at a purchase price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.40</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share upon achieving certain milestones related to the Company&#8217;s research platform (&#8220;Milestone Closing&#8221;). The number of shares and issuance price for the Milestone Closing were fixed at inception, and the timing for the closing was dependent on whether the Company met certain research and development milestones or if an earlier closing is voted by the Series A-2 holders. The Series A-2 tranche obligation is an embedded feature that does not net settle and therefore, it did not meet the definition of an embedded derivative.</span></p><p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On February 5, 2020, the Company issued and sold </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">44,375,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Series A-2 for total gross cash proceeds of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million related to the Milestone Closing.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Series B Redeemable Convertible Preferred Stock Closing</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On June 29, 2020, the Company issued and sold </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">124,519,220</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of its Series B redeemable convertible preferred stock at a per share price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.52</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#8220;Original Purchase Price&#8221;) for total gross proceeds of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">64.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million. The stock purchase agreement provided for a second closing obligating the investors in the Series B redeemable convertible preferred stock to purchase, and the Company to sell, an additional </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">87,259,605</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Series B redeemable convertible preferred stock at a per share price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.52</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> upon the achievement of the second tranche milestone.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On January 8, 2021, upon achievement of the second tranche milestone, the Company issued and sold </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">87,259,605</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of Series B redeemable convertible preferred stock at a price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.52</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share, for total gross and net proceeds of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">45.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On February 9, 2021, the Company completed its IPO. Upon closing of the IPO, all shares of Series A-1, A-2 and B redeemable convertible preferred stock then outstanding automatically converted into </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">24,924,501</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of common shares. Upon conversion of the redeemable convertible preferred stock, the Company reclassified the carrying value of the redeemable convertible preferred stock to common shares and additional paid-in capital.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2020, redeemable convertible preferred stock consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:31.91%;"/>
        <td style="width:0.706%;"/>
        <td style="width:9.206%;"/>
        <td style="width:0.706%;"/>
        <td style="width:2.055%;"/>
        <td style="width:0.706%;"/>
        <td style="width:8.135%;"/>
        <td style="width:0.706%;"/>
        <td style="width:2.055%;"/>
        <td style="width:1.381%;"/>
        <td style="width:7.6%;"/>
        <td style="width:0.706%;"/>
        <td style="width:2.055%;"/>
        <td style="width:1.381%;"/>
        <td style="width:6.851%;"/>
        <td style="width:0.706%;"/>
        <td style="width:2.055%;"/>
        <td style="width:1.381%;"/>
        <td style="width:7.172%;"/>
        <td style="width:0.706%;"/>
        <td style="width:2.055%;"/>
        <td style="width:0.706%;"/>
        <td style="width:8.349%;"/>
        <td style="width:0.706%;"/>
       </tr>
       <tr style="height:7.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(in thousands, except share amounts)</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Preferred<br/>Stock<br/>Authorized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Preferred<br/>Stock Issued<br/>and<br/>Outstanding</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Carrying<br/>Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Liquidation<br/>Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Cumulative<br/>Undeclared<br/>Dividends</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Common<br/>Stock<br/>Issuable<br/>Upon Conversion</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:7.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Series A-1 redeemable<br/>&#160;&#160;&#160;&#160;convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">20,000,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">20,000,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">4,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">1,470,588</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:7.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Series A-2 redeemable<br/>&#160;&#160;&#160;&#160;convertible preferred stock</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">107,194,866</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">107,194,866</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">42,786</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">42,878</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">5,073</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">7,881,965</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:7.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Series B redeemable<br/>&#160;&#160;&#160;&#160;convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">211,778,825</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">124,519,220</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">64,548</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">64,750</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">2,625</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">9,155,810</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:7.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">338,973,691</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">251,714,086</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">107,336</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">111,628</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">7,698</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">18,508,363</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_RedeemableConvertiblePreferredStockTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Redeemable convertible preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_RedeemableConvertiblePreferredStockTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034250547000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">8. Stockholders' Equity</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Preferred Stock</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has authorized up to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of preferred stock, $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.0001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> par value per share, for issuance. The preferred stock will have such rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges, and liquidation preferences, as shall be determined by the Company&#8217;s Board of Directors upon its issuance. At  </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 31, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, there were </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of preferred stock outstanding.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Common Stock</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the Company&#8217;s authorized capital stock included </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">400,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">420,000,000</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares, respectively, of its </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.0001</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> par value common stock.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Each share of common stock entitles the holder to </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> vote</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> on all matters submitted to a vote of the Company&#8217;s stockholders provided, however, that, except as otherwise required by law, holders of common stock shall not be entitled to vote on any amendment to the Company&#8217;s Certificate of Incorporation, as amended (the &#8220;Certificate of Incorporation&#8221;), that relates solely to the terms of one or more outstanding series of preferred stock if the holders of such affected series are entitled, either separately or together with the holders of one or more other such series, to vote thereon pursuant to the Certificate of Incorporation or pursuant to the Delaware General Corporation Law. Common stockholders are entitled to receive dividends, as may be declared by the Company&#8217;s board of directors, if any, subject to the preferential dividend rights of the preferred stock. </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">No</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> dividends have been declared or paid as of and for either of the years ended  </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 31, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034251712776">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Stock-Based Compensation</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">9. Stock-Based Compensation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock Incentive Plans</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2015, the Company&#8217;s board of directors adopted and approved the 2015 Stock Incentive Plan (as amended to date, the &#8220;2015 Plan&#8221;). The 2015 Plan provided for the granting of incentive stock options, non-statutory stock options, restricted stock awards and other stock-based awards to eligible employees, officers, directors, consultants and advisors as determined by the Company&#8217;s board of directors.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In October 2020, the Company granted an option to purchase </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">294,117</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of its common stock to an advisor outside of the 2015 Plan, with a strike price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">28.29</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share. Such grant was made outside of the 2015 Plan but is subject to the terms and conditions of such plan.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In February 2021, the Company&#8217;s board of directors adopted and stockholders approved the 2021 Equity Incentive Plan (the &#8220;2021 Plan&#8221;). The 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> Plan became effective on February 5, 2021, following which </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> further grants were or will be made under the 2015 Plan. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The 2021 Plan provides for the grant of stock options, non-statutory stock options, restricted stock awards, restricted stock unit awards, stock appreciation rights, performance stock awards and other forms of stock compensation to our employees, consultants and directors.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The number of shares of our common stock reserved for issuance under our 2021 Plan will automatically increase on January 1 of each year through January 1, 2031, by </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">of the total number of shares of common stock outstanding on December 31 of the preceding calendar year. Any grants that expire or are canceled, terminated,</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">forfeited, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">or fail to vest are allowed to be reissued under 2021 Plan. As of December 31, 2021, the Company had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,643,187</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares of its common stock available for future issuance under the 2021 Plan.</span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock Options</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#8217;s stock options generally </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">vest over </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">48 months</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> with </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% vesting after </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">one year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> followed by ratable monthly vesting over</span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> three years</span></span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"/></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and have a contractual term of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10 years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The weighted-average assumptions used principally in determining the fair value of options granted were as follows: </span></span><span style=""/></p><div style="font-size:10.0pt;font-family:Times New Roman;">
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.657%;"/>
        <td style="width:1.595%;"/>
        <td style="width:1.37%;"/>
        <td style="width:11.905%;"/>
        <td style="width:2.312%;"/>
        <td style="width:1.595%;"/>
        <td style="width:1.37%;"/>
        <td style="width:11.883%;"/>
        <td style="width:2.312%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Fair value of common stock</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">23.63</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.29</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected term (in years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.0</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.0</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected volatility</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">78.4</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">77.3</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Risk-free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.9</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.4</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dividend yield</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes the Company&#8217;s stock option activity for the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 31, 2021:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.095%;"/>
        <td style="width:1.188%;"/>
        <td style="width:0.685%;"/>
        <td style="width:9.935%;"/>
        <td style="width:0.91%;"/>
        <td style="width:1.188%;"/>
        <td style="width:1.37%;"/>
        <td style="width:9.506%;"/>
        <td style="width:0.685%;"/>
        <td style="width:1.188%;"/>
        <td style="width:0.707%;"/>
        <td style="width:10.074%;"/>
        <td style="width:0.685%;"/>
        <td style="width:1.188%;"/>
        <td style="width:1.37%;"/>
        <td style="width:9.539%;"/>
        <td style="width:0.685%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Weighted-<br/>Average<br/>Exercise Price</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Weighted-<br/>Average<br/>Remaining<br/>Contractual Term<br/>(in years)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Aggregate<br/>Intrinsic<br/>Value<br/>(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding at December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,084,679</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.79</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.42</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32,086</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">730,884</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19.46</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vested and exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">442,947</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.02</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Forfeited</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">285,698</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.10</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expired</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">126</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18.00</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding at December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,086,792</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.17</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.00</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">38,000</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Exercisable at December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,669,852</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.15</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.49</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,384</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The aggregate intrinsic value of options is calculated as the difference between the exercise price of the stock options and the fair value of the Company&#8217;s common stock for those stock options that had exercise prices lower than the fair value of the common stock as of the respective date.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The weighted-average grant-date fair value of stock options granted during the years ended December 31, 2021 and 2020 was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13.14</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.19</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> per share, respectively. As of December 31, 2021, total unrecognized compensation expense related to stock options was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">13.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> which is expected to be recognized over a weighted-average period of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.51</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> years. The intrinsic value of stock options exercised was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for the year ended December 31, 2021.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">During the year ended December 31, 2020, options for </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">159,197</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares with a weighted-average exercise price of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.59</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and a weighted-average grant date fair value of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.90</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> were exercised but unvested at the time of exercise. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021 and 2020, options for </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">200,687</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">388,157</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> shares with weighted average exercise prices of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.90</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.86</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> were exercised and unvested, respectively. The underlying proceeds from the unvested exercises of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.7</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> is recorded in other current liabilities as of December 31, 2021 and 2020, on the consolidated balance sheet.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock-Based Compensation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock-based compensation expense was allocated as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.253%;"/>
        <td style="width:1.606%;"/>
        <td style="width:1.381%;"/>
        <td style="width:13.191%;"/>
        <td style="width:0.696%;"/>
        <td style="width:1.606%;"/>
        <td style="width:1.381%;"/>
        <td style="width:13.191%;"/>
        <td style="width:0.696%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,281</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">665</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,034</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">677</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total stock-based compensation expense</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,315</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,342</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034245849368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">10. Leases</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cambridgepark Lease</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In December 2019, the Company entered into a lease agreement for its new corporate office and laboratory facility (the &#8220;Cambridgepark Lease&#8221;) in Cambridge, Massachusetts. The Cambridgepark Lease has a term of </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10 years</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, beginning on the rent commencement date which is two months after the lease commencement date. There are </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no options</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> to extend the lease. The lease commencement date, for accounting purposes, was deemed to be reached as of June 30, 2020.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">On June 15, 2021, the Company entered into the first lease amendment (&#8220;First Lease Amendment&#8221;) and the second lease amendment (&#8220;Second Lease Amendment&#8221; and, together with the First Lease Amendment, the &#8220;Lease Amendments&#8221;) with PPF Off 100 Cambridge Park Drive, LLC (the &#8220;Landlord&#8221;). The Lease Amendments amended the Cambridgepark Lease with the Landlord in Cambridge, Massachusetts to add additional leased space in the same building (the &#8220;Amended Cambridgepark Lease&#8221;).</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The First Lease Amendment expanded the amount of space leased by the Company by an additional </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">10,262</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> square feet in exchange for aggregate total fixed rent payments of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million with the annual fixed rental payments escalating from $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million during the term. The First Lease Amendment commenced during the </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">first quarter of 2022</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Second Lease Amendment expands the amount of space leased by the Company by an additional </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30,175</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> square feet in exchange for aggregate total fixed ren</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t payments of approximately $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21.9</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million with the annual fixed rental payments escalating from $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.2</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.0</span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million during the term. The Second Lease Amendment&#8217;s term is expected to commence during the </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">second quarter of 2022</span></span><span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Payments associated with the Amended Cambridgepark Lease include fixed and variable payments. Variable payments relate to the Company&#8217;s share of the Landlord&#8217;s operating costs associated with the underlying assets and are recognized when the event on which those payments are assessed. The Amended Cambridgepark Lease does not contain a residual value guarantee. The Lease Amendments term end dates are coterminous with the Cambridgepark Lease.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In conjunction with the Amended Cambridgepark Lease, the Company was required to establish a </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> irrevocable standby letter of credit for the benefit of the Landlord, which has been secured by money market investments and is presented as restricted cash equivalents.</span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The elements of lease expense were as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.231%;"/>
        <td style="width:1.606%;"/>
        <td style="width:1.381%;"/>
        <td style="width:13.201%;"/>
        <td style="width:0.696%;"/>
        <td style="width:1.606%;"/>
        <td style="width:1.381%;"/>
        <td style="width:13.201%;"/>
        <td style="width:0.696%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating lease cost</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,017</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,780</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Short-term lease cost</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">52</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">309</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Variable lease cost</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,099</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">235</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total lease cost</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,168</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,324</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Amounts reported in the consolidated balance sheets and the weight-average lease term and discount rate information were as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.61%;"/>
        <td style="width:1.585%;"/>
        <td style="width:1.37%;"/>
        <td style="width:11.927%;"/>
        <td style="width:2.313%;"/>
        <td style="width:1.585%;"/>
        <td style="width:1.37%;"/>
        <td style="width:11.927%;"/>
        <td style="width:2.313%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands except weighted-average amounts)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating right-of-use assets</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,670</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17,117</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating lease liabilities, current</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,839</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">863</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating lease liabilities, non-current</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16,174</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17,430</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total lease liabilities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18,013</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18,293</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Weighted Average Lease Term and Discount Rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average remaining lease term (years)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.64</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.55</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average discount rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.4</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.4</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table represents other lease activity:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.224%;"/>
        <td style="width:1.606%;"/>
        <td style="width:1.381%;"/>
        <td style="width:13.2%;"/>
        <td style="width:0.696%;"/>
        <td style="width:1.606%;"/>
        <td style="width:1.381%;"/>
        <td style="width:13.211%;"/>
        <td style="width:0.696%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Cash Flow Information</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash paid for amounts included in the measurement of<br/>&#160;&#160;&#160;lease liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating cash flows for operating leases</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,559</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">703</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Right-of-use assets obtained in exchange for lease obligations</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">35</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17,899</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Future lease payments for noncancelable leases as of were as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:78.867%;"/>
        <td style="width:1.916%;"/>
        <td style="width:1.381%;"/>
        <td style="width:16.915%;"/>
        <td style="width:0.921%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,<br/>&#160;2021 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;font-family:Times New Roman;position:relative;">(1)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,410</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2023</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,718</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2024</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,799</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2025</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,883</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2026</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,970</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Thereafter</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11,665</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total lease payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26,445</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Less: imputed interest</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,432</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Present value of lease liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18,013</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p><div style="border-top:0.750pt solid;margin-left:2.667%;padding-top:1.0pt;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;display:inline-flex;font-size:9.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Excluded from the table above are a portion of the Company's lease payments associated with the Lease Amendments, as the space leased has not commenced for accounting purposes as of December 31, 2021. The commencement date is the date on which the asset is made available to the Company by the lessor.</span><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></div></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034250571864">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Significant Agreements<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_SignificantAgreementsAbstract', window );"><strong>Significant Agreements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_SignificantAgreementsTextBlock', window );">Significant Agreements</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">11. Significant Agreements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has agreements with third parties in the normal course of business under which it has obtained licenses for certain developed technologies.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Columbia License Agreement</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In April 2016 (and amended in February 2019 and November 2021), the Company entered into an exclusive license agreement (the &#8220;Columbia Agreement&#8221;) with The Trustees of Columbia University in the City of New York (&#8220;Columbia&#8221;). Under the Columbia Agreement, the Company has exclusively licensed the worldwide rights to key patents, technical information, and use of materials from Columbia.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is required to pay Columbia an annual license fee in the low five digits. The Company is also obligated to make milestone payments to Columbia of up to an aggregate of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million upon the achievement of certain clinical milestones and milestone payments to Columbia of up to an aggregate of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million for certain regulatory and commercial milestones for the first three products. In addition, the Company is required to pay Columbia escalating low single digits royalties on cumulative annual net sales of licensed products. As of  </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 31, 2021, and  2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the Company had </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> obligation and $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million due, respectively, in milestone payments and this amount is included within accrued expenses balance on the consolidated balance sheet.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">National Institutes of Health License Agreement</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In October 2020, the Company entered into a patent license agreement (the &#8220;Patent License&#8221;) with the U.S. Department of Health and Human Services, as represented by National Cancer Institute (&#8220;NCI&#8221;) of the National Institutes of Health. Pursuant to the terms of the Patent License, the Company paid NCI a license issue fee in the aggregate amount of $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million. </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The terms of the Patent License also require the Company to pay NCI de minimis minimum annual royalties, which royalties are creditable against earned royalties on sales of licensed products or licensed processes. The Company must also pay NCI tiered royalties on net sales of licensed products at rates in the low single digits. The Company is also required to pay NCI one-time milestone payments upon successful completion of specified clinical and regulatory milestones relating to the licensed products. The aggregate potential</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">milestone </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">payments are $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million. In addition, the Company is required to pay NCI one-time milestone payments following aggregate net sales of licensed products at certain net sales up to $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> billion. The aggregate potential amount of these milestone payments is $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million. To the extent the Company enters into a sublicensing agreement relating to a licensed product, the Company is required to pay NCI a percentage of the non-royalty based consideration received from a sublicensee, with specified exclusions, which percentage ranges from the low single digits to low double digits. The Company is also required to reimburse NCI for its past patent expenses for the licensed patent rights, as well as the Company&#8217;s pro rata share of future patent expenses, in each case, in connection with NCI&#8217;s prosecution or maintenance of the licensed patent rights.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_SignificantAgreementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Significant agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_SignificantAgreementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_SignificantAgreementsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Significant Agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_SignificantAgreementsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034245954712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">12. Commitments and Contingencies</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Legal Proceedings</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company is not currently a party to any material legal proceedings. At each reporting date, the Company evaluates whether or not a potential loss amount or potential range of loss is probable and reasonably estimated under the provisions of the authoritative guidance that addresses accounting for contingencies. The Company recognizes expenses for its costs related to its legal proceedings, as incurred.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034337110968">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined Contribution Benefit Plan<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock', window );">Defined Contribution Benefit Plan</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">13. Defined Contribution Benefit Plan</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company maintains a defined contribution plan under Section 401(k) (the &#8220;401(k) Plan&#8221;) of the Internal Revenue Code, as amended (the &#8220;Code&#8221;). The 401(k) Plan covers all employees who meet defined minimum age and service requirements and allows participants to defer a portion of their annual compensation on a pretax basis, as well as Roth post tax deferrals. During 2021, the Company began to match </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">100</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of compensation amounts deferred up to the first </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of an employee's compensation plus </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of compensation amounts deferred between </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% and </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">% of an employee's compensation. All matching contributions are immediately vested. Expense recognized by the Company for matching contributions made in accordance with the 401(k) Plan was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> for the year ended December 31, 2021</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for retirement benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 55<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=123450688&amp;loc=d3e4179-114921<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section S99<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=21916913&amp;loc=d3e273930-122802<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (o)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (p)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 70<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=49170846&amp;loc=d3e28014-114942<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -URI http://asc.fasb.org/topic&amp;trid=2235017<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 60<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6414203&amp;loc=d3e39689-114964<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iv)(03)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (q)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (l)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 715<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (r)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123447040&amp;loc=d3e1928-114920<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034250574712">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">14. Income Taxes</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company accounts for income taxes under FASB ASC 740 (&#8220;ASC 740&#8221;). For the years ended December 31, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, the Company did not record a current or deferred income tax expense or benefit. </span><span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table reconciles the federal statutory income rate to the Company&#8217;s effective income tax rate: </span></span><span style=""/></p><div style="font-size:10.0pt;font-family:Times New Roman;">
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.963%;"/>
        <td style="width:1.627%;"/>
        <td style="width:14.891%;"/>
        <td style="width:1.627%;"/>
        <td style="width:14.891%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Federal income tax rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">State income tax benefit</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Permanent items</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) %</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research tax credits</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) %</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) %</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) %</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) %</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Effective income tax rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
       </tr>
      </table></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deferred </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">tax assets and liabilities reflect the net tax effects of net operating loss and tax credit carryforwards and temporary differences between the carrying amount of assets and liabilities for financial reporting and the</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">amounts </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">used for tax purposes. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Significant components of the Company&#8217;s deferred tax assets and liabilities were as follows:</span></span></p><div style="font-size:10.0pt;font-family:Times New Roman;">
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.163%;"/>
        <td style="width:1.595%;"/>
        <td style="width:1.371%;"/>
        <td style="width:13.031%;"/>
        <td style="width:0.921%;"/>
        <td style="width:1.595%;"/>
        <td style="width:1.371%;"/>
        <td style="width:13.031%;"/>
        <td style="width:0.921%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deferred tax assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued expenses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">972</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">659</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Federal net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25,060</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11,515</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">State net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,913</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,113</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Tax credits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,675</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,851</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock compensation</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">529</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">177</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Amortization</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">191</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Lease liability</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,675</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,941</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">44,015</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">23,256</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">39,401</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18,414</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net total deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,614</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,842</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deferred tax liabilities:</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Lease right of use asset</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,234</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,624</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Depreciation and amortization</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">380</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">218</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total deferred tax liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,614</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,842</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net deferred tax assets</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has weighed the positive and negative evidence to assess the recoverability of its deferred tax assets. Realization of future tax benefits is dependent on many factors, including the Company&#8217;s ability to generate taxable income. After this assessment, the Company determined it was more likely than not that the Company will not realize the benefit of its deferred tax assets. As a result, the Company has provided a full valuation allowance against its net deferred tax assets. The valuation allowance for deferred tax assets as of December 31, 2021 and 2020 was </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">39.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively. For the years ended December 31, 2021 and 2020, the Company recorded an increase in the valuation allowance of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively, primarily related to net operating losses and tax credits.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of  December 31, 2021, the Company had gross U.S. federal net operating loss carryforwards of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">119.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> including </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">117.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> that had an indefinite carryforward period and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.9</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> that were subject to expiration at various dates through </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2037</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. As of December 31, 2021, the Company had state net operating loss carryforwards of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">109.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> which will expire at various dates through </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2041</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. As of December 31, 2021, the Company had U.S. federal research and development tax credit carryforwards of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> which will expire at various dates through </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2041</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and state research and credit carryforwards of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> which will expire at various dates through </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2036</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. The net operating loss and tax credit carryforwards are subject to review and possible adjustment by the Internal Revenue Service and state tax authorities.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net operating loss and tax credit carryforwards may become subject to an annual limitation in the event of certain cumulative changes in the ownership interest of significant shareholders over a </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">three-year</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> period in excess of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">50</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%, as defined under Sections 382 and 383 of the Code, respectively, as well as similar state provisions. This could limit the amount of tax attributes that can be utilized annually to offset future taxable income or tax liabilities. The amount of the annual limitation is determined based on the value of the Company immediately prior to the ownership change. Subsequent ownership changes may further affect the limitation in future years. The Company has not determined whether an ownership change has occurred and as such, the Company&#8217;s net operating losses may be limited. Any limitation may result in expiration of a portion of the net operating loss carryforwards or research development credit carryforwards before utilization.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has not, as yet, conducted a study of research and development credit carryforwards. Such a study, once undertaken by the Company, may result in an adjustment to the research and development credit carryforwards. However, a full valuation allowance has been provided against the Company&#8217;s research and development credits and, if any adjustment is required, such adjustment would be offset by an adjustment to the valuation allowance. Thus, there would be no impact to the balance sheet or statement of operations if any adjustment is required.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2021 and 2020, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">the Company did </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t have any unrecognized tax benefits. Any future interest and penalties related to income tax matters would be recognized in the provision for income tax. As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 31, 2021 and 2020,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> the Company did </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t have a balance of accrued interest and penalties related to uncertain tax positions.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In March 2020, the Coronavirus Aid, Relief, and Economic Security Act (the &#8220;CARES Act&#8221;) was signed into law. The CARES Act includes provisions relating to several aspects of corporate income taxes. The CARES Act did not have a significant impact on the Company&#8217;s provision for income taxes.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company files income tax returns in the United States and various states. </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 31, 2021 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, there were no income tax examinations in progress</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">.</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The tax years 2018 through present remain open to examination by major taxing jurisdictions to which the Company is subject, which are primarily in the United States. In addition, tax years prior to 2018 resulted in losses and the Company also generated research and development tax credits during those years. Since carryforward attributes generated in these years may be utilized in future years, years prior to 2018 may still be adjusted upon examination by the Internal Revenue Service or state tax authorities if they have or will be used in a future period.</span><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI http://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034245986360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">15. Net Loss Per Share</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 31, 2021 and 2020:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.957%;"/>
        <td style="width:1.595%;"/>
        <td style="width:1.37%;"/>
        <td style="width:13.253%;"/>
        <td style="width:0.921%;"/>
        <td style="width:1.595%;"/>
        <td style="width:1.37%;"/>
        <td style="width:13.018%;"/>
        <td style="width:0.921%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands, except share and per share amounts)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Numerator:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">68,899</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">43,337</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cumulative dividends on redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,228</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,925</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss attributable to common stockholders</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">70,127</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">49,262</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Denominator:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average number of common shares outstanding, basic and diluted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">33,433,214</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">213,658</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss per share attributable to common stockholders, basic and diluted</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.10</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">230.57</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
      </table></div><div style="font-size:11.0pt;font-family:Calibri;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#8217;s potentially dilutive securities were redeemable convertible preferred stock and stock options. Based on the amounts outstanding at </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 31, 2021 and 2020, the Company excluded the following potential common shares from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.417%;"/>
        <td style="width:1.606%;"/>
        <td style="width:0.696%;"/>
        <td style="width:13.793%;"/>
        <td style="width:0.696%;"/>
        <td style="width:1.606%;"/>
        <td style="width:0.696%;"/>
        <td style="width:13.793%;"/>
        <td style="width:0.696%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">As of December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Series A-1 redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,470,588</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Series A-2 redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,881,965</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Series B redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9,155,810</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Options to purchase common stock</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,086,792</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,084,679</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034250528664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Basis of Presentation</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#8220;GAAP&#8221;). Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification ("ASC") or an Accounting Standards Update (&#8220;ASU&#8221;) issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;).</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of the consolidated financial statements in conformity with GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amount of expenses during the reporting period. Actual results could differ from those estimates. Management considers many factors in selecting appropriate financial accounting policies in developing the estimates and assumptions that are used in the preparation of the consolidated financial statements. Management must apply significant judgment in this process. Management&#8217;s estimation process often may yield a range of potentially reasonable estimates and management must select an amount that falls within that range of reasonable estimates. Estimates are used in the following areas, among others: estimating the fair value of the Company&#8217;s common stock (prior to the IPO); accrued expenses and related research and development expenses.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segments</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Segments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating segments are defined as components of an enterprise for which separate and discrete information is available for evaluation by the chief operating decision-maker in deciding how to allocate resources and assess performance. The Company has </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">one</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> operating segment. The Company&#8217;s chief operating decision maker, its Chief Executive Officer, manages the Company&#8217;s operations on an aggregate basis for the purpose of allocating resources.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency Transaction Gains or Losses</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Foreign Currency Transaction Gains or Losses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Transactions denominated in foreign currencies are recorded in U.S. dollars on the date of those transactions. Adjustments arising from foreign currency transactions between the purchase and the settlement dates are reflected in the consolidated statement of operations and comprehensive loss as a component of other income.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock', window );">Cash and Cash Equivalents</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Cash and Cash Equivalents</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company considers highly-liquid investments purchased with an original maturity date of ninety days or less from the date of purchase to be cash equivalents. Cash and cash equivalents include cash held in banks and amounts held in money market funds. Cash equivalents are stated at cost, which approximates market value.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentPolicyTextBlock', window );">Investments</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Investments</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Investments represent excess cash balances held in marketable debt securities and are classified as available-for-sale. Investments with maturities beyond one year may be classified as short-term based on their highly liquid nature and because such securities represent an investment of cash that is available for current operations.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Available-for-sale investments are reported at fair value at each balance sheet date. Changes in the market value of available-for-sale investments, excluding other-than-temporary impairments, are reflected as other comprehensive income, a component of stockholders&#8217; equity. Realized gains and losses are determined using the specific identification method and are included in other income in our consolidated statements of operations and comprehensive loss.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Investments are evaluated for other-than-temporary impairment at the end of each reporting period. Impairment is evaluated considering numerous factors, and their relative significance varies depending on the situation. Factors considered include whether a decline in fair value below the amortized cost basis is due to credit-related factors or non-credit-related factors, the financial condition and near-term prospects of the issuer, and the Company's intent and ability to hold the investment to allow for an anticipated recovery in fair value. Once a decline in fair value is determined to be other-than-temporary, an impairment charge is recorded to other income (expense) and a new cost basis in the investment is established.</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredChargesPolicyTextBlock', window );">Deferred Offering Costs</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Deferred Offering Costs</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company capitalizes certain legal, professional, accounting and other third-party fees that are directly associated with in-process equity issuances as deferred offering costs until such equity issuances are consummated. After consummation of the equity issuance, these costs are recorded as a reduction in the capitalized amount associated with the equity issuance. During the year ended December 31, 2020, the Company incurred $</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million in deferred offering costs that are included in other assets on the consolidated balance sheet.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Restricted Cash</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company had </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.4</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> and </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> million</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> of restricted cash in the form of a letter of credit related to a lease at December 31, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, respectively.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive loss</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Comprehensive loss</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Comprehensive loss includes net loss, as well as other changes in stockholders&#8217; equity (deficit) that result from transactions and economic events other than those with stockholders. The Company&#8217;s comprehensive loss was equal to net loss for the years ended December 31, 2021 and 2020</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> .</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy', window );">Preferred Stock</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Preferred Stock</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company applies the guidance enumerated in FASB ASC Topic 480, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Distinguishing Liabilities from Equity</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#8220;ASC 480&#8221;), when determining the classification and measurement of its preferred stock. Preferred stock subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. The Company classifies conditionally redeemable preferred stock (if any), which includes preferred stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#8217;s control, as temporary equity.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentrations of Credit Risk</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Concentrations of Credit Risk</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash equivalents and investments. The Company maintains deposits in accredited financial institutions in excess of federally insured limits. The Company deposits its cash in financial institutions that it believes have high credit quality and has not experienced any losses on such accounts and does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#8217;s investments consist of money market funds and marketable debt securities, including corporate bonds and U.S. Treasury securities. The Company&#8217;s investments may include commercial paper and other debt securities of U.S. government agencies, corporate entities, and banks. The Company&#8217;s investment policy limits instruments to investment grade securities with high credit quality issuers with the objective to preserve capital and to maintain liquidity until the funds can be used in business operations.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock', window );">Fair Value Measurements</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Fair Value Measurements</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 1&#8212;Quoted prices in active markets for identical assets or liabilities. </span></div></div><div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 2&#8212;Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. </span></div></div><div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Level 3&#8212;Unobservable inputs that are supported by little or no market activity that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. </span></div></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument&#8217;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Financial instruments consist of cash and cash equivalents, restricted cash, accounts payable and accrued expenses. These financial instruments are stated at their respective historical carrying values which approximate fair value due to their short-term nature.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment, Net</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Property and Equipment, Net</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><div style="font-size:10.0pt;font-family:Times New Roman;"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment, net is recorded at cost less accumulated depreciation. Depreciation expense is recorded using the straight-line method over the estimated useful life of the related asset, which are as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:50.0%;"/>
          <td style="width:50.0%;"/>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Estimated Useful Life</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Computer equipment</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Furniture and equipment</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Laboratory equipment</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Leasehold improvements</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Shorter of remaining lease term or useful life</span></span></p></td>
         </tr>
        </table></div><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Purchased assets that are not yet in service are recorded to construction-in-process and no depreciation expense is recorded. Once they are placed in service, they are reclassified to the appropriate asset class. When assets are retired or otherwise disposed of, the assets and related accumulated depreciation are eliminated from the accounts and any resulting gain or loss is reflected in the Company&#8217;s consolidated statements of operation and comprehensive loss. Expenditures for maintenance and repairs are expensed as incurred.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Impairment of Long-Lived Assets</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Impairment of Long-Lived Assets</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Long-lived assets consist of property and equipment. The Company continually evaluates whether events or circumstances have occurred that indicate that the estimated remaining useful life of its long-lived assets may warrant revision or that the carrying value of these assets may not be recoverable. If circumstances require that a long-lived asset or asset group be tested for impairment, the Company first compares the estimated undiscounted future cash flows expected to result from the use or disposition of that asset or asset group to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment loss would be recognized to the extent the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market prices and third-party independent appraisals, as considered necessary.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Leases</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease. Leases with a term greater than one year are recognized on the consolidated balance sheet as a right-of-use (&#8220;ROU&#8221;) asset and current and non-current lease liabilities, as applicable. The Company has made an accounting policy election, known as the short-term lease recognition exemption, which allows the Company to not recognize ROU assets and lease liabilities that arise from short-term leases (12 months or less); The Company has applied this election to all classes of underlying assets. The Company typically only includes an initial lease term in its assessment of a lease arrangement. Options to renew or options to cancel a lease are not included in the Company&#8217;s assessment unless there is reasonable certainty that the Company will renew or will not cancel, respectively. The Company monitors its material leases on a quarterly basis.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating lease liabilities and their corresponding ROU assets are recorded based on the present value of future lease payments over the expected remaining lease term. Lease cost for operating leases is recognized on a straight-line basis over the lease term as an operating expense. Certain adjustments to the ROU asset may be required for items such as lease prepayments or incentives received. The interest rate implicit in lease contracts is typically not readily determinable. As a result, the Company utilizes its incremental borrowing rate, which reflects the fixed rate at which the Company could borrow on a collateralized basis the amount of the lease payments in the same currency, for a similar term, in a similar economic environment.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has elected to account for the lease and non-lease components together for office, laboratory, and manufacturing real estate leases.</span></p><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Research and Development</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development expenses include costs directly attributable to the conduct of the Company&#8217;s research and development programs.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expenditures relating to research and development are expensed in the period incurred. Nonrefundable advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made. The cost of materials for a research and development activity that have an alternative future use is capitalized when the materials are acquired and recognized as expense as consumed. The costs of materials that were acquired for a particular research and development activity and have no alternative future use are expensed in the period acquired.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Costs incurred in obtaining licenses are recognized as research and development expense as incurred if the license has no alternative use.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_AccruedResearchAndDevelopmentExpensesPolicyPolicyTextBlock', window );">Accrued Research and Development Expenses</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Accrued Research and Development Expenses</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company has entered into various research and development related contracts, including contracts with third-party contract research organizations and contract manufacturing organizations. These agreements are cancelable, and related payments are recognized as research and development expenses as incurred. The Company records accrued liabilities for estimated ongoing research costs. When evaluating the adequacy of the accrued liabilities, the Company analyzes the progress of the studies, including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the accrued balances at the end of any reporting period. Actual results could differ from the Company&#8217;s estimates. To date, the Company&#8217;s historical accrual estimates have not been materially different from the actual costs.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationRelatedCostsPolicyTextBlock', window );">Stock-Based Compensation Expense</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Stock-Based Compensation Expense</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company accounts for stock-based compensation under the provisions of ASC 718-10,</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> Compensation&#8212;Stock Compensation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> (&#8220;ASC 718-10&#8221;), which requires all share-based payments to employees, non-employees and directors, including grants of stock options and restricted stock, to be recognized in the consolidated statements of operations and comprehensive loss based on their fair values on the date of grant over the requisite service period, which is generally the vesting period of the respective award. Forfeitures are accounted for as they occur. Generally, the Company issues awards with only service-based vesting conditions and records the expense for these awards using the ratable method. The Company classifies stock-based compensation expense in the same manner in which the award recipient&#8217;s payroll or service provider&#8217;s costs are classified. Share-based payments that contain performance conditions are recognized when such conditions are probable of being achieved.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The fair value of each restricted common stock award is estimated on the date of grant based on the fair value of the Company&#8217;s common stock on that same date.</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model, which requires inputs based on certain subjective assumptions, including the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Fair Value of Common Stock</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;See the discussion below. </span></div></div><div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expected Term</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;The expected term represents the period that the stock-based awards are expected to be outstanding. The Company uses the simplified method to determine the expected term, which is based on the average of the time-to-vesting and the contractual life of the options. </span></div></div><div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Expected Volatility</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;Because the Company does not have sufficient trading history for its common stock as of December 31, 2021 , the expected volatility was estimated based on the average volatility for comparable publicly traded biotechnology companies over a period equal to the expected term of the stock option grants. The comparable companies were chosen based on the similar size, stage in life cycle or area of specialty. The Company will continue to apply this process until a sufficient amount of historical information regarding the volatility of its own stock price becomes available. </span></div></div><div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Risk-Free Interest Rate</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;The risk-free interest rate is based on the U.S. Treasury zero coupon issues in effect at the time of grant for periods corresponding with the expected term of the awards. </span></div></div><div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;">&#8226;</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Dividend Yield</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;The Company has never paid dividends on its common stock and has no plans to pay dividends on its common stock. Therefore, the Company used an expected dividend yield of </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">zero</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. </span></div></div><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company began to use the closing common stock price as reported on the Nasdaq Global Select Market exchange as the fair value of common stock on the date of a grant subsequent to its IPO. Prior to the Company's IPO the estimated fair value of common stock was determined by the Company&#8217;s board of directors as of the date of each</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">option grant, with input from management, considering third-party valuations of its common stock as well as the Company&#8217;s board of directors&#8217; assessment of additional objective and subjective factors that it believed were relevant and which may have changed from the date of the most recent third-party valuation through the date of the grant. These objective and subjective factors include: (i) prices paid for the Company&#8217;s redeemable convertible preferred stock, and the rights, preferences, and privileges of the Company&#8217;s redeemable convertible preferred stock and common stock; (ii) the Company&#8217;s stage of development; (iii) the fact that the grants of stock-based awards related to illiquid securities in a private company; and (iv) the likelihood of achieving a liquidity event for the common stock underlying the stock-based awards, such as an initial public offering or sale of the Company, given prevailing market conditions. These third-party valuations were performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants&#8217; Accounting and Valuation Guide, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Valuation of Privately Held Company Equity Securities Issued as Compensation</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Each valuation methodology includes estimates and assumptions that require the Company&#8217;s judgment. The methodology utilized to estimate the fair value of the Company&#8217;s common stock was the option-pricing method (&#8220;OPM&#8221;) to back-solve the estimated value of the Company&#8217;s equity and corresponding value of the Company&#8217;s common stock.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Income Taxes</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company accounts for income taxes using the asset and liability approach. Deferred tax assets and liabilities represent future tax consequences of temporary differences between the financial statement carrying amounts and the tax basis of assets and liabilities and for loss carryforwards using enacted tax rates expected to be in effect in the years in which the differences reverse. A valuation allowance is established to reduce deferred tax assets to the amounts expected to be realized. The Company also recognizes a tax benefit from uncertain tax positions only if it is &#8220;more likely than not&#8221; that the position is sustainable based on its technical merits. The Company accounts for interest or penalties related to uncertain tax positions as part of its provision for income taxes. To date, the Company has </span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t incurred interest and penalties related to uncertain tax positions. Should such costs be incurred, they would be classified as a component of provision for income taxes.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Loss Per Share</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Net Loss Per Share</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss attributable to common stockholders is equal to the net loss for the period, as adjusted for cumulative dividends on redeemable convertible preferred stock, for the respective period.</span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the reporting period, without consideration for potentially dilutive securities. Diluted net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares and potentially dilutive securities outstanding during the period determined using the treasury-stock and if-converted methods. For purposes of the diluted net loss per share attributable to common stockholders calculation, redeemable convertible preferred stock, restricted stock and stock options considered to be potentially dilutive securities were excluded from the calculation of diluted net loss per share attributable to common stockholders because their effect would be anti-dilutive and therefore, basic and diluted net loss per share attributable to common stockholders were the same for all reporting periods presented.</span><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Pronouncements and Recently Adopted Accounting Pronouncements</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recent Accounting Pronouncements</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">From time to time, new accounting pronouncements are issued and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#8217;s consolidated financial statements upon adoption. Under the Jumpstart Our Business Startups Act of 2012, as amended (the &#8220;JOBS Act&#8221;), the Company meets the definition of an emerging growth company and has elected to take advantage of the extended transition period for complying with certain new or revised accounting standards pursuant to Section 107(b) of the JOBS Act. As noted below, certain new or revised accounting standards were early adopted.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recently Adopted Accounting Pronouncements</span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In 2019, the FASB issued </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="-sec-ix-hidden:F_9fe2e284-3d35-4fe3-b478-3dcd0820f887;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">ASU No. 2019-12</span></span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Income Taxes (Topic 740)</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">: </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Simplifying the Accounting for Income Taxes (&#8220;ASU 2019-12&#8221;), which introduces a number of amendments that are designed to simplify the application of accounting for income taxes. Such amendments include removing certain exceptions for intraperiod tax allocation, interim reporting when a year-to-date loss exceeds the anticipated loss, reflecting the effect of an enacted change in tax laws or rates in the annual effective tax rate and recognition of deferred taxes related to</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">outside </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">basis differences for ownership changes in investments. ASU 2019-12 also provides clarification related to when a step up in the tax basis of goodwill should be considered part of the business combination in which the book goodwill was originally recognized and when it should be considered a separate transaction. In addition, ASU 2019-12 provides guidance on the recognition of a franchise tax (or similar tax) that is partially based on income as an income-based tax and accounting for any incremental amount incurred as a non-income-based tax. The Company </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">adopted </span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> ASU 2019-12 effective </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">January 1, 2021</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">, and the adoption did </span><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">no</span></span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">t have a material impact on its consolidated financial statements.</span><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock', window );">Recently Issued Accounting Pronouncements Not Yet Adopted</a></td>
<td class="text"><p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Recently Issued Accounting Pronouncements Not Yet Adopted</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">In June 2016, the FASB issued ASU 2016-13, </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> which has been subsequently amended by ASU 2018-19, ASU 2019-04, ASU 2019-05, ASU 2019-10, ASU 2019-11 and ASU 2020-03 (&#8220;ASU 2016-13&#8221;). This standard significantly changes the impairment model for most financial assets and certain other instruments and will require immediate recognition of estimated credit losses expected to occur over the remaining life of many financial assets, which will generally result in earlier recognition of allowances for credit losses on loans and other financial instruments. The Company does not expect that this standard will have a material impact to the Company&#8217;s consolidated financial statements and plans to adopt this standard on January 1, 2022.</span><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationRelatedCostsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationRelatedCostsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123345438&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredChargesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for deferral and amortization of significant deferred charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredChargesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32847-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32840-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL116659661-227067<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32639-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e32280-109318<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for investment in financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(3)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for redeemable preferred stock issued. This disclosure may include the accounting treatment for the difference, if there is any, between the carrying value and redemption amount. For example, describe whether the issuer accretes changes in the redemption value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 05<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=123467743&amp;loc=d3e20905-112640<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_AccruedResearchAndDevelopmentExpensesPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued research and development expenses, policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_AccruedResearchAndDevelopmentExpensesPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Recently issued accounting pronouncements not yet adopted, policy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034245934568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock', window );">Estimated Useful Life of Property and Equipment</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment, net is recorded at cost less accumulated depreciation. Depreciation expense is recorded using the straight-line method over the estimated useful life of the related asset, which are as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
        <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
         <tr style="visibility:collapse;">
          <td style="width:50.0%;"/>
          <td style="width:50.0%;"/>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Estimated Useful Life</span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Computer equipment</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Furniture and equipment</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Laboratory equipment</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5 years</span></span></p></td>
         </tr>
         <tr style="height:10.0pt;">
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Leasehold improvements</span></p></td>
          <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Shorter of remaining lease term or useful life</span></span></p></td>
         </tr>
        </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Property plant and equipment expected useful life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034245920168">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Investments (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock', window );">Summary of Amortized Cost and Estimated Fair Value of Investments by Contractual Maturity</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The amortized cost and estimated fair value of investments, by contractual maturity are as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:48.999%;"/>
        <td style="width:1.178%;"/>
        <td style="width:1.371%;"/>
        <td style="width:9.519%;"/>
        <td style="width:0.685%;"/>
        <td style="width:1.178%;"/>
        <td style="width:1.371%;"/>
        <td style="width:9.53%;"/>
        <td style="width:0.685%;"/>
        <td style="width:1.178%;"/>
        <td style="width:1.371%;"/>
        <td style="width:9.53%;"/>
        <td style="width:0.685%;"/>
        <td style="width:1.178%;"/>
        <td style="width:1.371%;"/>
        <td style="width:9.487%;"/>
        <td style="width:0.685%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Amortized Cost</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Gross Unrealized Holding Gains</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Gross Unrealized Holding Losses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Fair Value</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Maturing in one year or less</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate debt</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,603</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,603</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. Treasuries</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30,119</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30,119</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Maturing after one year through five years</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate debt</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,006</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,006</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. Treasuries</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">44,940</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">44,940</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:15.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">87,668</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">87,668</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121590138&amp;loc=SL82922954-210456<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27290-111563<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124269663&amp;loc=SL82922888-210455<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034245801800">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock', window );">Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following tables present information about the Company&#8217;s financial assets and liabilities measured at fair value on a recurring basis:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.143%;"/>
        <td style="width:1.178%;"/>
        <td style="width:1.371%;"/>
        <td style="width:9.499%;"/>
        <td style="width:0.685%;"/>
        <td style="width:1.178%;"/>
        <td style="width:1.371%;"/>
        <td style="width:9.499%;"/>
        <td style="width:0.685%;"/>
        <td style="width:1.178%;"/>
        <td style="width:1.371%;"/>
        <td style="width:9.392%;"/>
        <td style="width:0.685%;"/>
        <td style="width:1.178%;"/>
        <td style="width:1.371%;"/>
        <td style="width:9.531%;"/>
        <td style="width:0.685%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Level 1</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Level 2</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Level 3</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Cash equivalents</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">95,339</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">95,339</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Investments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Corporate bonds</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12,609</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">12,609</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">U.S. Treasuries</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">75,059</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">75,059</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:15.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total investments</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">87,668</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">87,668</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Restricted cash equivalents</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,413</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,413</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">97,752</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">87,668</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">185,420</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Level 1</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Level 2</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Level 3</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Money market funds</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41,036</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41,036</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:15.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41,036</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">41,036</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034251762616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, Net</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment, net consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.149%;"/>
        <td style="width:1.606%;"/>
        <td style="width:1.37%;"/>
        <td style="width:13.029%;"/>
        <td style="width:0.921%;"/>
        <td style="width:1.606%;"/>
        <td style="width:1.37%;"/>
        <td style="width:13.029%;"/>
        <td style="width:0.921%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Furniture and equipment</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">108</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">40</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Laboratory equipment</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,457</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,247</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Leasehold improvements</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">55</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Computer equipment</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">317</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">167</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment, gross</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,937</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,454</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accumulated depreciation</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,084</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">726</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Property and equipment, net</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,853</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,728</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034245882408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock', window );">Schedule of Accrued Expenses and Other Current Liabilities</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued expenses and other current liabilities consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.246%;"/>
        <td style="width:1.606%;"/>
        <td style="width:1.381%;"/>
        <td style="width:12.996%;"/>
        <td style="width:0.867%;"/>
        <td style="width:1.606%;"/>
        <td style="width:1.381%;"/>
        <td style="width:13.221%;"/>
        <td style="width:0.696%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Employee-related and other expenses</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,178</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,727</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development expenses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">797</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,924</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Professional fees</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">743</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,097</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">License and milestone fees</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Calibri;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">450</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">617</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">62</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total accrued expenses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,335</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,260</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of accrued expenses and other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034251758312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock', window );">Schedule of Redeemable Convertible Preferred Stock</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">As of December 31, 2020, redeemable convertible preferred stock consisted of the following:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:31.91%;"/>
        <td style="width:0.706%;"/>
        <td style="width:9.206%;"/>
        <td style="width:0.706%;"/>
        <td style="width:2.055%;"/>
        <td style="width:0.706%;"/>
        <td style="width:8.135%;"/>
        <td style="width:0.706%;"/>
        <td style="width:2.055%;"/>
        <td style="width:1.381%;"/>
        <td style="width:7.6%;"/>
        <td style="width:0.706%;"/>
        <td style="width:2.055%;"/>
        <td style="width:1.381%;"/>
        <td style="width:6.851%;"/>
        <td style="width:0.706%;"/>
        <td style="width:2.055%;"/>
        <td style="width:1.381%;"/>
        <td style="width:7.172%;"/>
        <td style="width:0.706%;"/>
        <td style="width:2.055%;"/>
        <td style="width:0.706%;"/>
        <td style="width:8.349%;"/>
        <td style="width:0.706%;"/>
       </tr>
       <tr style="height:7.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">(in thousands, except share amounts)</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Preferred<br/>Stock<br/>Authorized</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Preferred<br/>Stock Issued<br/>and<br/>Outstanding</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Carrying<br/>Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Liquidation<br/>Value</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Cumulative<br/>Undeclared<br/>Dividends</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;">Common<br/>Stock<br/>Issuable<br/>Upon Conversion</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:7.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Series A-1 redeemable<br/>&#160;&#160;&#160;&#160;convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">20,000,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">20,000,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">2</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">4,000</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">1,470,588</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:7.0pt;">
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Series A-2 redeemable<br/>&#160;&#160;&#160;&#160;convertible preferred stock</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">107,194,866</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">107,194,866</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">42,786</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">42,878</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">5,073</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">7,881,965</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:7.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Series B redeemable<br/>&#160;&#160;&#160;&#160;convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">211,778,825</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">124,519,220</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">64,548</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">64,750</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">2,625</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">9,155,810</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:7.0pt;">
        <td style="background-color:rgba(255,255,255,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;"><p style="margin-left:4.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">Total</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">338,973,691</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">251,714,086</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">107,336</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">111,628</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">7,698</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;">18,508,363</span></p></td>
        <td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of Redeemable Convertible Preferred Stock [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034246120152">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Summary of Weighted-Average Assumptions Used Principally in Determining Fair Value of Options Granted</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The weighted-average assumptions used principally in determining the fair value of options granted were as follows: </span>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.657%;"/>
        <td style="width:1.595%;"/>
        <td style="width:1.37%;"/>
        <td style="width:11.905%;"/>
        <td style="width:2.312%;"/>
        <td style="width:1.595%;"/>
        <td style="width:1.37%;"/>
        <td style="width:11.883%;"/>
        <td style="width:2.312%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Fair value of common stock</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">23.63</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.29</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected term (in years)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.0</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.0</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expected volatility</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">78.4</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">77.3</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Risk-free interest rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.9</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.4</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Dividend yield</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Summary of Stock Option Activity</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table summarizes the Company&#8217;s stock option activity for the year ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 31, 2021:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:49.095%;"/>
        <td style="width:1.188%;"/>
        <td style="width:0.685%;"/>
        <td style="width:9.935%;"/>
        <td style="width:0.91%;"/>
        <td style="width:1.188%;"/>
        <td style="width:1.37%;"/>
        <td style="width:9.506%;"/>
        <td style="width:0.685%;"/>
        <td style="width:1.188%;"/>
        <td style="width:0.707%;"/>
        <td style="width:10.074%;"/>
        <td style="width:0.685%;"/>
        <td style="width:1.188%;"/>
        <td style="width:1.37%;"/>
        <td style="width:9.539%;"/>
        <td style="width:0.685%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Shares</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Weighted-<br/>Average<br/>Exercise Price</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Weighted-<br/>Average<br/>Remaining<br/>Contractual Term<br/>(in years)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Aggregate<br/>Intrinsic<br/>Value<br/>(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding at December 31, 2020</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,084,679</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3.79</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.42</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32,086</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Granted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">730,884</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">19.46</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Vested and exercised</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">442,947</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.02</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Forfeited</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">285,698</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.10</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Expired</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">126</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18.00</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Outstanding at December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,086,792</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.17</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.00</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">38,000</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Exercisable at December 31, 2021</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,669,852</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.15</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7.49</span></span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">14,384</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of Stock-Based Compensation Expense</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock-based compensation expense was allocated as follows:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.253%;"/>
        <td style="width:1.606%;"/>
        <td style="width:1.381%;"/>
        <td style="width:13.191%;"/>
        <td style="width:0.696%;"/>
        <td style="width:1.606%;"/>
        <td style="width:1.381%;"/>
        <td style="width:13.191%;"/>
        <td style="width:0.696%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research and development</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,281</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">665</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">General and administrative</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,034</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">677</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total stock-based compensation expense</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,315</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,342</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034250726488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Summary of Lease Expense</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The elements of lease expense were as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.231%;"/>
        <td style="width:1.606%;"/>
        <td style="width:1.381%;"/>
        <td style="width:13.201%;"/>
        <td style="width:0.696%;"/>
        <td style="width:1.606%;"/>
        <td style="width:1.381%;"/>
        <td style="width:13.201%;"/>
        <td style="width:0.696%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating lease cost</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,017</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,780</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Short-term lease cost</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">52</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">309</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Variable lease cost</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,099</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">235</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total lease cost</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,168</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,324</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_ScheduleOfOperatingLeaseAssetsAndLiabilitiesWeightedAverageLeaseTermAndDiscountRateTableTextBlock', window );">Summary of Amounts Reported in Consolidated Balance Sheets and Weight-average Lease Term and Discount Rate Information</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Amounts reported in the consolidated balance sheets and the weight-average lease term and discount rate information were as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.61%;"/>
        <td style="width:1.585%;"/>
        <td style="width:1.37%;"/>
        <td style="width:11.927%;"/>
        <td style="width:2.313%;"/>
        <td style="width:1.585%;"/>
        <td style="width:1.37%;"/>
        <td style="width:11.927%;"/>
        <td style="width:2.313%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands except weighted-average amounts)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31, 2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating right-of-use assets</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">15,670</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17,117</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating lease liabilities, current</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,839</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">863</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating lease liabilities, non-current</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">16,174</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17,430</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total lease liabilities</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18,013</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18,293</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Weighted Average Lease Term and Discount Rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average remaining lease term (years)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8.64</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.55</span></span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average discount rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.4</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9.4</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">%</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_ScheduleOfOtherLeaseActivityTableTextBlock', window );">Summary of Other Lease Activity</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table represents other lease activity:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.224%;"/>
        <td style="width:1.606%;"/>
        <td style="width:1.381%;"/>
        <td style="width:13.2%;"/>
        <td style="width:0.696%;"/>
        <td style="width:1.606%;"/>
        <td style="width:1.381%;"/>
        <td style="width:13.211%;"/>
        <td style="width:0.696%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;">Cash Flow Information</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cash paid for amounts included in the measurement of<br/>&#160;&#160;&#160;lease liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Operating cash flows for operating leases</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,559</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">703</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Right-of-use assets obtained in exchange for lease obligations</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">35</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">17,899</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Summary of Future Lease Payments for Noncancelable Leases</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Future lease payments for noncancelable leases as of were as follows:</span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:78.867%;"/>
        <td style="width:1.916%;"/>
        <td style="width:1.381%;"/>
        <td style="width:16.915%;"/>
        <td style="width:0.921%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,<br/>&#160;2021 </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;font-family:Times New Roman;position:relative;">(1)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2022</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,410</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2023</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,718</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2024</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,799</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2025</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,883</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2026</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,970</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Thereafter</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11,665</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total lease payments</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">26,445</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Less: imputed interest</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">8,432</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Present value of lease liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18,013</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></p><div style="border-top:0.750pt solid;margin-left:2.667%;padding-top:1.0pt;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;display:inline-flex;font-size:9.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;">(1)</span><div style="display:inline;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;">Excluded from the table above are a portion of the Company's lease payments associated with the Lease Amendments, as the space leased has not commenced for accounting purposes as of December 31, 2021. The commencement date is the date on which the asset is made available to the Company by the lessor.</span><span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;">&#160;</span></div></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_ScheduleOfOperatingLeaseAssetsAndLiabilitiesWeightedAverageLeaseTermAndDiscountRateTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of operating lease assets and liabilities, weighted average lease term and discount rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_ScheduleOfOperatingLeaseAssetsAndLiabilitiesWeightedAverageLeaseTermAndDiscountRateTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_ScheduleOfOtherLeaseActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule of other lease activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_ScheduleOfOtherLeaseActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034250125656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock', window );">Schedule of Reconciliation of Federal Statutory Income Rate to Effective Income Tax Rate</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table reconciles the federal statutory income rate to the Company&#8217;s effective income tax rate: </span>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.963%;"/>
        <td style="width:1.627%;"/>
        <td style="width:14.891%;"/>
        <td style="width:1.627%;"/>
        <td style="width:14.891%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Federal income tax rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;%</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">21.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">State income tax benefit</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6.0</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Permanent items</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) %</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Research tax credits</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4.1</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;%</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5.8</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#160;%</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Other</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.3</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) %</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">0.2</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) %</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">30.5</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) %</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">32.6</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">) %</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Effective income tax rate</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock', window );">Schedule of Significant Components of Deferred Tax Assets and Liabilities</a></td>
<td class="text"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Significant components of the Company&#8217;s deferred tax assets and liabilities were as follows:</span>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.163%;"/>
        <td style="width:1.595%;"/>
        <td style="width:1.371%;"/>
        <td style="width:13.031%;"/>
        <td style="width:0.921%;"/>
        <td style="width:1.595%;"/>
        <td style="width:1.371%;"/>
        <td style="width:13.031%;"/>
        <td style="width:0.921%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deferred tax assets:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Accrued expenses</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">972</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">659</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Federal net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">25,060</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">11,515</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">State net operating loss carryforwards</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">6,913</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">3,113</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Tax credits</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,675</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2,851</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Stock compensation</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">529</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">177</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Amortization</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">191</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Lease liability</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,675</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,941</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">44,015</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">23,256</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Valuation allowance</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">39,401</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">18,414</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net total deferred tax assets</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,614</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,842</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Deferred tax liabilities:</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Lease right of use asset</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,234</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,624</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Depreciation and amortization</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">380</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">218</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Total deferred tax liabilities</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,614</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">4,842</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net deferred tax assets</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034245800392">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Computation of Basic and Diluted Net Loss Per Share</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The following table sets forth the computation of the Company&#8217;s basic and diluted net loss per share for the years ended </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 31, 2021 and 2020:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:65.957%;"/>
        <td style="width:1.595%;"/>
        <td style="width:1.37%;"/>
        <td style="width:13.253%;"/>
        <td style="width:0.921%;"/>
        <td style="width:1.595%;"/>
        <td style="width:1.37%;"/>
        <td style="width:13.018%;"/>
        <td style="width:0.921%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">Year Ended December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">(in thousands, except share and per share amounts)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Numerator:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">68,899</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">43,337</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Cumulative dividends on redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,228</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,925</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss attributable to common stockholders</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">70,127</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">49,262</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Denominator:</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Weighted-average number of common shares outstanding, basic and diluted</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">33,433,214</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">213,658</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"><p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Net loss per share attributable to common stockholders, basic and diluted</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">2.10</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">$</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">(</span><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">230.57</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">)</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Potential Dilutive Securities Excluded from Computation of Diluted Net Loss Per Share</a></td>
<td class="text"><p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company&#8217;s potentially dilutive securities were redeemable convertible preferred stock and stock options. Based on the amounts outstanding at </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">December 31, 2021 and 2020, the Company excluded the following potential common shares from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect:</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
      <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
       <tr style="visibility:collapse;">
        <td style="width:66.417%;"/>
        <td style="width:1.606%;"/>
        <td style="width:0.696%;"/>
        <td style="width:13.793%;"/>
        <td style="width:0.696%;"/>
        <td style="width:1.606%;"/>
        <td style="width:0.696%;"/>
        <td style="width:13.793%;"/>
        <td style="width:0.696%;"/>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">As of December 31,</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:8.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2021</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;">&#160;</span></p></td>
        <td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;">2020</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"><p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Series A-1 redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">1,470,588</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Series A-2 redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">7,881,965</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Series B redeemable convertible preferred stock</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">&#8212;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">9,155,810</span></p></td>
        <td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
       <tr style="height:10.0pt;">
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Options to purchase common stock</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,086,792</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">5,084,679</span></p></td>
        <td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;">&#160;</span></p></td>
       </tr>
      </table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034244476264">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of the Business - Additional Information (Details)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Feb. 09, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th"><div>Jan. 29, 2021</div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_NatureOfBusinessLineItems', window );"><strong>Nature Of Business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationDateOfIncorporation', window );">Incorporation date</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">Dec. 30,  2015<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Net proceeds from issuance of IPO | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 189,198<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000,000<span></span>
</td>
<td class="nump">420,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value | $ / shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_NatureOfBusinessLineItems', window );"><strong>Nature Of Business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock shares sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,302,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering', window );">Net proceeds from issuance of IPO | $</a></td>
<td class="nump">$ 186,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Common stock shares issued for conversion of redeemable convertible preferred stock</a></td>
<td class="nump">24,924,501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,924,501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityReverseStockSplit', window );">Stockholders' equity, reverse stock split</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">13.6-for-1 reverse stock split<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1', window );">Stockholders' equity, stock split, conversion ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.0735<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember', window );">IPO | Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_NatureOfBusinessLineItems', window );"><strong>Nature Of Business [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Common stock shares sold</a></td>
<td class="nump">11,302,219<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SaleOfStockPricePerShare', window );">Public offering price per share | $ / shares</a></td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationDateOfIncorporation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date when an entity was incorporated</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationDateOfIncorporation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceInitialPublicOffering">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow associated with the amount received from entity's first offering of stock to the public.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceInitialPublicOffering</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteStockSplitConversionRatio1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB TOPIC 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteStockSplitConversionRatio1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityReverseStockSplit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SAB Topic 4.C)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187143-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityReverseStockSplit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_NatureOfBusinessLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Nature of business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_NatureOfBusinessLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=us-gaap_IPOMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034244694088">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Segment</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segment | Segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RestrictedCashEquivalentsNoncurrent', window );">Restricted cash</a></td>
<td class="nump">$ 2,413,000<span></span>
</td>
<td class="nump">$ 1,559,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted', window );">Change in accounting principle, accounting standards update, adopted [true false]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate', window );">Change in accounting principle, accounting standards update, adoption date</a></td>
<td class="text">Jan.  01,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect', window );">Change in accounting principle, accounting standards update, immaterial effect [true false]</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting standards update [Extensible list]</a></td>
<td class="text">us-gaap:AccountingStandardsUpdate201912Member<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Expected dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense', window );">Interest and penalties related to uncertain tax positions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember', window );">Other Assets</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredOfferingCosts', window );">Deferred offering costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,600,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(1)<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(2)<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(01)<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)(3)(iii)(03)<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether accounting standards update was adopted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 65<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121483254&amp;loc=SL120254523-199619<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120254519-210437<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123341672&amp;loc=SL120154346-209984<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 33: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Date accounting standards update was adopted, in YYYY-MM-DD format.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S65<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124359872&amp;loc=SL124427846-239511<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124434974&amp;loc=SL124442142-165695<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120320025-210437<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL122642865-165497<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122150657&amp;loc=SL122150809-237846<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123341672&amp;loc=SL120154346-209984<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 20<br> -Section 65<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121483254&amp;loc=SL120254523-199619<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120154821&amp;loc=SL120154904-197079<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL121967933-165497<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL120254519-210437<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=123597120&amp;loc=SL120254526-165497<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 848<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Publisher FASB<br> -Subparagraph (a)<br><br>Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21930-107793<br><br>Reference 35: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 45<br> -Paragraph 23<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124436220&amp;loc=d3e21914-107793<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether effect from applying amendment to accounting standards is immaterial.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section S99<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=122038215&amp;loc=d3e31010-122693<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=124402435&amp;loc=SL124402458-218513<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (e)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123459177&amp;loc=SL121830611-158277<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredOfferingCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 340<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 5.A)<br> -URI http://asc.fasb.org/extlink&amp;oid=122040515&amp;loc=d3e105025-122735<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredOfferingCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCashEquivalentsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL116631458-115580<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120413209&amp;loc=SL6242269-115581<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6812-107765<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=123431023&amp;loc=SL98516268-108586<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 210<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=120413173&amp;loc=SL6242262-115580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCashEquivalentsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=us-gaap_OtherAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034244464296">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Estimated Useful Life of Property and Equipment (Details)<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2021</div></th></tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful life</a></td>
<td class="text">3 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=vor_FurnitureAndEquipmentMember', window );">Furniture and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=vor_LaboratoryEquipmentMember', window );">Laboratory Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Property and equipment, estimated useful life</a></td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives', window );">Property and equipment, estimated useful lives</a></td>
<td class="text">Shorter of remaining lease term or useful life<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 35<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123364984&amp;loc=d3e1205-110223<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=vor_FurnitureAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=vor_FurnitureAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=vor_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=vor_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034246949320">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Summary of Amortized Cost and Estimated Fair Value of Investments by Contractual Maturity (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost</a></td>
<td class="nump">$ 87,668<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">87,668<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivablesPeriodPastDueAxis=vor_MaturingInOneYearOrLessMember', window );">Maturing in One Year or Less | Corporate Debt</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost</a></td>
<td class="nump">7,603<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">7,603<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivablesPeriodPastDueAxis=vor_MaturingInOneYearOrLessMember', window );">Maturing in One Year or Less | U.S. Treasuries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost</a></td>
<td class="nump">30,119<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">30,119<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivablesPeriodPastDueAxis=vor_MaturingAfterOneYearThroughFiveYearsMember', window );">Maturing after One Year through Five Years | Corporate Debt</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost</a></td>
<td class="nump">5,006<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">5,006<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinancingReceivablesPeriodPastDueAxis=vor_MaturingAfterOneYearThroughFiveYearsMember', window );">Maturing after One Year through Five Years | U.S. Treasuries</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems', window );"><strong>Schedule Of Available For Sale Securities [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis', window );">Debt Securities, Available-for-sale, Amortized Cost</a></td>
<td class="nump">44,940<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities', window );">Fair Value</a></td>
<td class="nump">$ 44,940<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AvailableForSaleSecuritiesDebtSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(6))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124258926&amp;loc=SL82898722-210454<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124260329&amp;loc=d3e26610-111562<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 320<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (aa)<br> -URI http://asc.fasb.org/extlink&amp;oid=123581744&amp;loc=d3e27161-111563<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AvailableForSaleSecuritiesDebtSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivablesPeriodPastDueAxis=vor_MaturingInOneYearOrLessMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivablesPeriodPastDueAxis=vor_MaturingInOneYearOrLessMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancingReceivablesPeriodPastDueAxis=vor_MaturingAfterOneYearThroughFiveYearsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancingReceivablesPeriodPastDueAxis=vor_MaturingAfterOneYearThroughFiveYearsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034250565432">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Investments - Additional Information (Details)<br></strong></div></th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract', window );"><strong>Investments, Debt and Equity Securities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Investments', window );">Investments</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Investments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all investments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.1(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Investments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034241074088">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - Fair Value, Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">$ 185,420<span></span>
</td>
<td class="nump">$ 41,036<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">41,036<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">87,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Investments | Corporate Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">12,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Investments | U.S. Treasuries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">75,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Cash Equivalents | Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">95,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Restricted Cash Equivalents | Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">2,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">97,752<span></span>
</td>
<td class="nump">41,036<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 41,036<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | Cash Equivalents | Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">95,339<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 1 | Restricted Cash Equivalents | Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">2,413<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">87,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Investments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">87,668<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Investments | Corporate Debt</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">12,609<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level 2 | Investments | U.S. Treasuries</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsFairValueDisclosure', window );">Total</a></td>
<td class="nump">$ 75,059<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByAssetClassAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_InvestmentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InformationByCategoryOfDebtSecurityAxis=us-gaap_InvestmentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_CorporateDebtSecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_USTreasurySecuritiesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=us-gaap_CashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=us-gaap_CashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentTypeAxis=vor_RestrictedCashEquivalentsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentTypeAxis=vor_RestrictedCashEquivalentsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034250072664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_FairValueAssetsLevel1ToLevel2TransferredAmount', window );">Fair value assets, level 1 to level 2 transfers amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_FairValueAssetsLevel2ToLevel1TransferredAmount', window );">Fair value assets, level 2 to level 1 transfers amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3', window );">Fair value assets, transfers into level 3</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3', window );">Fair value assets, transfers out of level 3</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123874694&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_FairValueAssetsLevel1ToLevel2TransferredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value assets level1 to level2 transferred amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_FairValueAssetsLevel1ToLevel2TransferredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_FairValueAssetsLevel2ToLevel1TransferredAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value assets level2 to level1 transferred amount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_FairValueAssetsLevel2ToLevel1TransferredAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034244799272">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property and Equipment, Net - Schedule of Property and Equipment, Net (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 8,937<span></span>
</td>
<td class="nump">$ 5,454<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Accumulated depreciation</a></td>
<td class="num">(2,084)<span></span>
</td>
<td class="num">(726)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net</a></td>
<td class="nump">6,853<span></span>
</td>
<td class="nump">4,728<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=vor_FurnitureAndEquipmentMember', window );">Furniture and Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">108<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=vor_LaboratoryEquipmentMember', window );">Laboratory Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">8,457<span></span>
</td>
<td class="nump">5,247<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold Improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember', window );">Computer Equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property Plant And Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property and equipment, gross</a></td>
<td class="nump">$ 317<span></span>
</td>
<td class="nump">$ 167<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=vor_FurnitureAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=vor_FurnitureAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=vor_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=vor_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ComputerEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034251568664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property and Equipment, Net - Additional Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation expense</a></td>
<td class="nump">$ 1,434<span></span>
</td>
<td class="nump">$ 605<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034244825128">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Employee-related and other expenses</a></td>
<td class="nump">$ 4,178<span></span>
</td>
<td class="nump">$ 2,727<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_AccruedResearchAndDevelopmentExpensesCurrent', window );">Research and development expenses</a></td>
<td class="nump">797<span></span>
</td>
<td class="nump">1,924<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional fees</a></td>
<td class="nump">743<span></span>
</td>
<td class="nump">1,097<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_AccruedLicenseAndMilestoneFeesCurrent', window );">License and milestone fees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">450<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">617<span></span>
</td>
<td class="nump">62<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Total accrued expenses</a></td>
<td class="nump">$ 6,335<span></span>
</td>
<td class="nump">$ 6,260<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_AccruedLicenseAndMilestoneFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued license and milestone fees current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_AccruedLicenseAndMilestoneFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_AccruedResearchAndDevelopmentExpensesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued research and development expenses current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_AccruedResearchAndDevelopmentExpensesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034241185784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 09, 2021</div></th>
<th class="th"><div>Jan. 08, 2021</div></th>
<th class="th"><div>Jun. 29, 2020</div></th>
<th class="th"><div>Feb. 05, 2020</div></th>
<th class="th"><div>Feb. 12, 2019</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Redeemable convertible preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">338,973,691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Redeemable convertible preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Gross proceeds from stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,375<span></span>
</td>
<td class="nump">$ 82,267<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities', window );">Common stock shares issued for conversion of redeemable convertible preferred stock</a></td>
<td class="nump">24,924,501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,924,501<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=vor_SeriesAOneRedeemableConvertiblePreferredStockMember', window );">Series A-1 Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Redeemable convertible preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Redeemable convertible preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=vor_SeriesATwoRedeemableConvertiblePreferredStockMember', window );">Series A-2 Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Redeemable convertible preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">107,194,866<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Redeemable convertible preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Redeemable convertible preferred stock, issued and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,375,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_TemporaryEquityIssuedPricePerShare', window );">Redeemable convertible preferred stock, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.40<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues', window );">Additional stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">44,375,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Gross proceeds from stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 17,800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=vor_SeriesBRedeemableConvertiblePreferredStockMember', window );">Series B Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Redeemable convertible preferred stock, shares authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="nump">211,778,825<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityParOrStatedValuePerShare', window );">Redeemable convertible preferred stock, par value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues', window );">Redeemable convertible preferred stock, issued and sold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,259,605<span></span>
</td>
<td class="nump">124,519,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,259,605<span></span>
</td>
<td class="nump">124,519,220<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_TemporaryEquityIssuedPricePerShare', window );">Redeemable convertible preferred stock, price per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.52<span></span>
</td>
<td class="nump">$ 0.52<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues', window );">Additional stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">87,259,605<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock', window );">Gross proceeds from stock issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 45,400<span></span>
</td>
<td class="nump">$ 64,700<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued during the period as a result of the conversion of convertible securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1E<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123466505&amp;loc=SL123495348-112611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=122040564&amp;loc=d3e177068-122764<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (27)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity Additional Stock Issued During Period Shares New Issues</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_TemporaryEquityIssuedPricePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary Equity issued price per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_TemporaryEquityIssuedPricePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity stock issued during period shares new issues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementEquityComponentsAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=vor_SeriesAOneRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=vor_SeriesAOneRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=vor_SeriesATwoRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=vor_SeriesATwoRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=vor_SeriesBRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=vor_SeriesBRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034241191016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Redeemable Convertible Preferred Stock - Schedule of Redeemable Convertible Preferred Stock (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Preferred Stock Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">338,973,691<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Preferred Stock Issued</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,714,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Preferred Stock Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">251,714,086<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 107,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">111,628<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_TemporaryEquityCumulativeUndeclaredDividends', window );">Cumulative Undeclared Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,698<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Common Stock Issuable Upon Conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18,508,363<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=vor_SeriesAOneRedeemableConvertiblePreferredStockMember', window );">Series A-1 Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Preferred Stock Authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Preferred Stock Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Preferred Stock Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
<td class="nump">20,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
<td class="nump">$ 2<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Common Stock Issuable Upon Conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,470,588<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=vor_SeriesATwoRedeemableConvertiblePreferredStockMember', window );">Series A-2 Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Preferred Stock Authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">107,194,866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Preferred Stock Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">107,194,866<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Preferred Stock Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">107,194,866<span></span>
</td>
<td class="nump">62,819,866<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 42,786<span></span>
</td>
<td class="nump">$ 25,067<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_TemporaryEquityCumulativeUndeclaredDividends', window );">Cumulative Undeclared Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,073<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Common Stock Issuable Upon Conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,881,965<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=vor_SeriesBRedeemableConvertiblePreferredStockMember', window );">Series B Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesAuthorized', window );">Preferred Stock Authorized</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">211,778,825<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesIssued', window );">Preferred Stock Issued</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">124,519,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquitySharesOutstanding', window );">Preferred Stock Outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">124,519,220<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent', window );">Carrying Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 64,548<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TemporaryEquityLiquidationPreference', window );">Liquidation Value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">64,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_TemporaryEquityCumulativeUndeclaredDividends', window );">Cumulative Undeclared Dividends</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,625<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion', window );">Common Stock Issuable Upon Conversion</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,155,810<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares issued for each share of convertible preferred stock that is converted.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496180-112644<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21506-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityCarryingAmountAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityCarryingAmountAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquityLiquidationPreference">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquityLiquidationPreference</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TemporaryEquitySharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TemporaryEquitySharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_TemporaryEquityCumulativeUndeclaredDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Temporary equity cumulative undeclared dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_TemporaryEquityCumulativeUndeclaredDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=vor_SeriesAOneRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=vor_SeriesAOneRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=vor_SeriesATwoRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=vor_SeriesATwoRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=vor_SeriesBRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=vor_SeriesBRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>79
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034246097672">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Additional Information (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($) </div>
<div>Vote </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized</a></td>
<td class="nump">10,000,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, shares authorized</a></td>
<td class="nump">400,000,000<span></span>
</td>
<td class="nump">420,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value | $ / shares</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockVotingRights', window );">Common Stock, Voting Rights</a></td>
<td class="text">Each share of common stock entitles the holder to one vote<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_NumberOfCommonStockVotingRights', window );">Number of common stock voting rights | Vote</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DividendsCommonStock', window );">Dividends declared | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsOfDividendsCommonStock', window );">Dividends paid | $</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 405<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6957935&amp;loc=d3e64057-112817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfDividendsCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfDividendsCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_NumberOfCommonStockVotingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Common Stock Voting Rights</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_NumberOfCommonStockVotingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034241228584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Additional Information (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Feb. 05, 2021</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">294,117<span></span>
</td>
<td class="nump">730,884<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharePrice', window );">Strike price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 28.29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant-date fair value of stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13.14<span></span>
</td>
<td class="nump">$ 2.19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense related to stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 13,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Unrecognized share based compensation expense, recognition period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 6 months 3 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of stock options exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber', window );">Number of shares exercised but unvested at the time of exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">159,197<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Weighted-average exercise price exercised but unvested at the time of exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2.59<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue', window );">Weighted-average grant date fair value exercised but unvested at the time of exercise</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.90<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares', window );">Number unvested options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">200,687<span></span>
</td>
<td class="nump">388,157<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price of options exercised and unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1.90<span></span>
</td>
<td class="nump">$ 1.86<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Outstanding liability for unvested shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 434<span></span>
</td>
<td class="nump">$ 723<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights', window );">Vesting rights description</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">vest over 48 months with 25% vesting after one year followed by ratable monthly vesting over three years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">48 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Contractual term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted-average grant-date fair value of stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 23.63<span></span>
</td>
<td class="nump">$ 4.29<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember', window );">Tranche One | Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage', window );">Vesting percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">25.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember', window );">Tranche Two | Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vor_TwoThousandFifteenStockIncentivePlanMember', window );">2015 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for future issuance</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=vor_TwoThousandTwentyOneEquityIncentivePlanMember', window );">2021 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant', window );">Number of shares available for future issuance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,643,187<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum', window );">Shares reserved for issuance increase percentage of total number of shares of common stock outstanding</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6911-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Price of a single share of a number of saleable stocks of a company.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of vesting of award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of non-vested options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options unvested exercised in period weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share-based compensation arrangement by share-based payment award options vested and expected to vest exercisable weighted average grant date fair value</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VestingAxis=us-gaap_ShareBasedCompensationAwardTrancheTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=vor_TwoThousandFifteenStockIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=vor_TwoThousandFifteenStockIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=vor_TwoThousandTwentyOneEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=vor_TwoThousandTwentyOneEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034244468360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Weighted-Average Assumptions Used Principally in Determining Fair Value of Options Granted (Details) - $ / shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value of common stock</a></td>
<td class="nump">$ 13.14<span></span>
</td>
<td class="nump">$ 2.19<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock Options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share Based Compensation Arrangement By Share Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Fair value of common stock</a></td>
<td class="nump">$ 23.63<span></span>
</td>
<td class="nump">$ 4.29<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Expected term (in years)</a></td>
<td class="text">6 years<span></span>
</td>
<td class="text">6 years<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Expected volatility</a></td>
<td class="nump">78.40%<span></span>
</td>
<td class="nump">77.30%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">0.90%<span></span>
</td>
<td class="nump">0.40%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034241004872">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Stock Option Activity (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Oct. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares, Outstanding at December 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,084,679<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Shares, Granted</a></td>
<td class="nump">294,117<span></span>
</td>
<td class="nump">730,884<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriod', window );">Shares, Vested and exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(442,947)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Shares, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(285,698)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod', window );">Shares, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(126)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Shares, Outstanding at December 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,086,792<span></span>
</td>
<td class="nump">5,084,679<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber', window );">Shares, Exercisable at December 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,669,852<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Outstanding at December 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.79<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">19.46<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriodWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Vested and exercised</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2.02<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Forfeited</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.10<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Expired</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Outstanding at December 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6.17<span></span>
</td>
<td class="nump">$ 3.79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice', window );">Weighted-Average Exercise Price, Exercisable at December 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4.15<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-Average Remaining Contractual Term, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">8 years<span></span>
</td>
<td class="text">9 years 5 months 1 day<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1', window );">Weighted-Average Remaining Contractual Term, Exercisable at December 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 5 months 26 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate Intrinsic Value, Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38,000<span></span>
</td>
<td class="nump">$ 32,086<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1', window );">Aggregate Intrinsic Value, Exercisable at December 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 14,384<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangement by share based payment award options vested and exercised in period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Share based compensation arrangements by share based payment award options vested and exercised in period weighted average exercise price.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>83
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034244465336">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 4,315<span></span>
</td>
<td class="nump">$ 1,342<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and Development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">2,281<span></span>
</td>
<td class="nump">665<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember', window );">General and Administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation expense</a></td>
<td class="nump">$ 2,034<span></span>
</td>
<td class="nump">$ 677<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=122041274&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_GeneralAndAdministrativeExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>84
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034241041368">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Jun. 15, 2021 </div>
<div>USD ($) </div>
<div>ft&#178;</div>
</th>
<th class="th"><div>Dec. 31, 2019</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember', window );">Standby Letters of Credit</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet', window );">Increase in irrevocable line of credit facility</a></td>
<td class="nump">$ 2.4<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=vor_FirstLeaseAmendmentMember', window );">First Lease Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_AdditionalSpaceLeased', window );">Additional space leased | ft&#178;</a></td>
<td class="nump">10,262<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Aggregate total fixed rent payments</a></td>
<td class="nump">$ 8.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_OperatingLeaseCommencementPeriod', window );">Operating lease, commencement period</a></td>
<td class="text">first quarter of 2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=vor_SecondLeaseAmendmentMember', window );">Second Lease Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_AdditionalSpaceLeased', window );">Additional space leased | ft&#178;</a></td>
<td class="nump">30,175<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsForRent', window );">Aggregate total fixed rent payments</a></td>
<td class="nump">$ 21.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_OperatingLeaseEstimatedToCommencePeriod', window );">Operating lease estimated to commence period</a></td>
<td class="text">second quarter of 2022<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseContractualTermAxis=vor_CambridgeparkLeaseMember', window );">Cambridgepark Lease</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Lease term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend', window );">Lessee, Operating Lease, Existence of Option to Extend [true false]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | First Lease Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_IncreaseInAnnualFixedRentalPayments', window );">Increase in annual fixed rental payments</a></td>
<td class="nump">$ 0.9<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Second Lease Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_IncreaseInAnnualFixedRentalPayments', window );">Increase in annual fixed rental payments</a></td>
<td class="nump">1.2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | First Lease Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_IncreaseInAnnualFixedRentalPayments', window );">Increase in annual fixed rental payments</a></td>
<td class="nump">1.1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Second Lease Amendment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee Lease Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_IncreaseInAnnualFixedRentalPayments', window );">Increase in annual fixed rental payments</a></td>
<td class="nump">$ 3.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates (true false) whether lessee has option to extend operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) of the credit facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsForRent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash payments to lessor's for use of assets under operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (g)<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsForRent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_AdditionalSpaceLeased">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Additional space leased.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_AdditionalSpaceLeased</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:areaItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_IncreaseInAnnualFixedRentalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase in annual fixed rental payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_IncreaseInAnnualFixedRentalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_OperatingLeaseCommencementPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease commencement period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_OperatingLeaseCommencementPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_OperatingLeaseEstimatedToCommencePeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease estimated to commence period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_OperatingLeaseEstimatedToCommencePeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CreditFacilityAxis=us-gaap_StandbyLettersOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=vor_FirstLeaseAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=vor_FirstLeaseAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=vor_SecondLeaseAmendmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=vor_SecondLeaseAmendmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseContractualTermAxis=vor_CambridgeparkLeaseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseContractualTermAxis=vor_CambridgeparkLeaseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>85
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034249289304">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Summary of Lease Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease cost</a></td>
<td class="nump">$ 3,017<span></span>
</td>
<td class="nump">$ 1,780<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShortTermLeaseCost', window );">Short-term lease cost</a></td>
<td class="nump">52<span></span>
</td>
<td class="nump">309<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_VariableLeaseCost', window );">Variable lease cost</a></td>
<td class="nump">1,099<span></span>
</td>
<td class="nump">235<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total lease cost</a></td>
<td class="nump">$ 4,168<span></span>
</td>
<td class="nump">$ 2,324<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShortTermLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term lease cost, excluding expense for lease with term of one month or less.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShortTermLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>86
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034250413336">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Summary of Amounts Reported in Consolidated Balance Sheets and Weight-average Lease Term and Discount rate Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_OperatingLeaseAssetsAbstract', window );"><strong>Assets</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating right-of-use assets</a></td>
<td class="nump">$ 15,670<span></span>
</td>
<td class="nump">$ 17,117<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityAbstract', window );"><strong>Liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities, current</a></td>
<td class="nump">1,839<span></span>
</td>
<td class="nump">863<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">16,174<span></span>
</td>
<td class="nump">17,430<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total lease liabilities</a></td>
<td class="nump">$ 18,013<span></span>
</td>
<td class="nump">$ 18,293<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_OperatingLeaseWeightedAverageLeaseTermAndDiscountRateAbstract', window );"><strong>Weighted Average Lease Term and Discount Rate</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining lease term (years)</a></td>
<td class="text">8 years 7 months 20 days<span></span>
</td>
<td class="text">9 years 6 months 18 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Weighted-average discount rate</a></td>
<td class="nump">9.40%<span></span>
</td>
<td class="nump">9.40%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_OperatingLeaseAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_OperatingLeaseAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_OperatingLeaseWeightedAverageLeaseTermAndDiscountRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating lease, weighted average lease term and discount rate.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_OperatingLeaseWeightedAverageLeaseTermAndDiscountRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>87
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034247315288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Summary of Other Lease Activity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash flows for operating leases</a></td>
<td class="nump">$ 2,559<span></span>
</td>
<td class="nump">$ 703<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use assets obtained in exchange for lease obligations</a></td>
<td class="nump">$ 35<span></span>
</td>
<td class="nump">$ 17,899<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash paid for amounts included in the measurement of lease liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>88
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034246095640">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Summary of Future Lease Payments for Noncancelable Leases (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Lessee, Operating Lease, Liability, Payment, Due [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2022</a></td>
<td class="nump">$ 3,410<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2023</a></td>
<td class="nump">2,718<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2024</a></td>
<td class="nump">2,799<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2025</a></td>
<td class="nump">2,883<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2026</a></td>
<td class="nump">2,970<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">11,665<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total lease payments</a></td>
<td class="nump">26,445<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: imputed interest</a></td>
<td class="num">(8,432)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of lease liabilities</a></td>
<td class="nump">$ 18,013<span></span>
</td>
<td class="nump">$ 18,293<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123408670&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>89
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034247360056">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Significant Agreements - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Nov. 30, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Oct. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=vor_ColumbiaLicenseAgreementMember', window );">Columbia License Agreement | Accrued Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_LicenseAgreementPotentialMilestonePayments', window );">Aggregate potential milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_LicenseFeeObligatedToPay', window );">License fee obligated to pay</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=vor_ColumbiaLicenseAgreementMember', window );">Columbia License Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfClinicalMilestones', window );">Aggregate potential milestone payments upon achievement of clinical milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfRegulatoryAndCommercialMilestones', window );">Aggregate potential milestone payments upon achievement of regulatory and commercial milestones</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 6,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=vor_NationalInstitutesOfHealthLicenseAgreementMember', window );">National Institutes of Health License Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_LicenseAgreementPotentialMilestonePayments', window );">Aggregate potential milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=vor_NationalInstitutesOfHealthLicenseAgreementMember', window );">National Institutes of Health License Agreement | Licensed Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_LicenseAgreementPotentialMilestonePayments', window );">Aggregate potential milestone payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">6,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=vor_NationalInstitutesOfHealthLicenseAgreementMember', window );">National Institutes of Health License Agreement | Accrued Expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_LicenseFeeObligatedToPay', window );">License fee obligated to pay</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">400,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TypeOfArrangementAxis=vor_NationalInstitutesOfHealthLicenseAgreementMember', window );">National Institutes of Health License Agreement | Maximum | Licensed Products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems', window );"><strong>Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_LicenseAgreementMilestonePaymentsOnAggregateNetSales', window );">Milestone payments on aggregate net sales</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000,000,000.0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_LicenseAgreementMilestonePaymentsOnAggregateNetSales">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License agreement milestone payments on aggregate net sales.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_LicenseAgreementMilestonePaymentsOnAggregateNetSales</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_LicenseAgreementPotentialMilestonePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License agreement potential milestone payments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_LicenseAgreementPotentialMilestonePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfClinicalMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License agreement potential milestone payments upon achievement of clinical milestones.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfClinicalMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfRegulatoryAndCommercialMilestones">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License agreement potential milestone payments upon achievement of regulatory and commercial milestones.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfRegulatoryAndCommercialMilestones</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_LicenseFeeObligatedToPay">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>License fee obligated to pay.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_LicenseFeeObligatedToPay</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=vor_ColumbiaLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=vor_ColumbiaLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BalanceSheetLocationAxis=vor_AccruedExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BalanceSheetLocationAxis=vor_AccruedExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TypeOfArrangementAxis=vor_NationalInstitutesOfHealthLicenseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TypeOfArrangementAxis=vor_NationalInstitutesOfHealthLicenseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_LicenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_LicenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>90
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034240740344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Defined Contribution Benefit Plan - Additional Information (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th">
<div>Dec. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CompensationAndRetirementDisclosureAbstract', window );"><strong>Retirement Benefits [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent', window );">Defined contribution benefit plan, matching percentage</a></td>
<td class="nump">100.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_DefinedContributionPlanFirstPercentage', window );">Defined contribution benefit plan, first percentage</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_DefinedContributionPlanAdditionalPercentage', window );">Defined contribution benefit plan, additional percentage</a></td>
<td class="nump">50.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_Definedcontributionplanminimumannualcontributionsperemployeepercent', window );">Defined contribution benefit plan, minimum percentage of employee's compensation</a></td>
<td class="nump">1.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent', window );">Defined contribution benefit plan, maximum percentage of employee's compensation</a></td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount', window );">Defined contribution benefit plan, matching contributions amount</a></td>
<td class="nump">$ 0.6<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CompensationAndRetirementDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CompensationAndRetirementDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of discretionary contributions made by an employer to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_DefinedContributionPlanAdditionalPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined contribution plan, additional percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_DefinedContributionPlanAdditionalPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_DefinedContributionPlanFirstPercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined contribution plan, first percentage.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_DefinedContributionPlanFirstPercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_Definedcontributionplanminimumannualcontributionsperemployeepercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Defined contribution plan minimum annual contributions per employee percent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_Definedcontributionplanminimumannualcontributionsperemployeepercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>91
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034250693160">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Schedule of Reconciliation of Federal Statutory Income Rate to Effective Income Tax Rate (Details)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate', window );">Federal income tax rate</a></td>
<td class="nump">21.00%<span></span>
</td>
<td class="nump">21.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes', window );">State income tax benefit</a></td>
<td class="nump">6.00%<span></span>
</td>
<td class="nump">6.00%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense', window );">Permanent items</a></td>
<td class="num">(0.30%)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch', window );">Research tax credits</a></td>
<td class="nump">4.10%<span></span>
</td>
<td class="nump">5.80%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments', window );">Other</a></td>
<td class="num">(0.30%)<span></span>
</td>
<td class="num">(0.20%)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(30.50%)<span></span>
</td>
<td class="num">(32.60%)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of domestic federal statutory tax rate applicable to pretax income (loss).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 6.I.Fact.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32687-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>92
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034244800872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Income Taxes - Schedule of Significant Components of Deferred tax Assets and Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract', window );"><strong>Deferred tax assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities', window );">Accrued expenses</a></td>
<td class="nump">$ 972<span></span>
</td>
<td class="nump">$ 659<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic', window );">Federal net operating loss carryforwards</a></td>
<td class="nump">25,060<span></span>
</td>
<td class="nump">11,515<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal', window );">State net operating loss carryforwards</a></td>
<td class="nump">6,913<span></span>
</td>
<td class="nump">3,113<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards', window );">Tax credits</a></td>
<td class="nump">5,675<span></span>
</td>
<td class="nump">2,851<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost', window );">Stock compensation</a></td>
<td class="nump">529<span></span>
</td>
<td class="nump">177<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_DeferredTaxAssetsAmortization', window );">Amortization</a></td>
<td class="nump">191<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_DeferredTaxAssetsLeaseLiability', window );">Lease liability</a></td>
<td class="nump">4,675<span></span>
</td>
<td class="nump">4,941<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsGross', window );">Total deferred tax assets</a></td>
<td class="nump">44,015<span></span>
</td>
<td class="nump">23,256<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Valuation allowance</a></td>
<td class="num">(39,401)<span></span>
</td>
<td class="num">(18,414)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsNet', window );">Net total deferred tax assets</a></td>
<td class="nump">4,614<span></span>
</td>
<td class="nump">4,842<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract', window );"><strong>Deferred tax liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_DeferredTaxLiabilitiesLeaseRightOfUseAsset', window );">Lease right of use asset</a></td>
<td class="num">(4,234)<span></span>
</td>
<td class="num">(4,624)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_DeferredTaxLiabilitiesDepreciationAndAmortization', window );">Depreciation and amortization</a></td>
<td class="num">(380)<span></span>
</td>
<td class="num">(218)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxLiabilities', window );">Total deferred tax liabilities</a></td>
<td class="num">(4,614)<span></span>
</td>
<td class="num">(4,842)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsLiabilitiesNet', window );">Net deferred tax assets</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxAssetsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxAssetsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsLiabilitiesNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsLiabilitiesNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=d3e31931-109318<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_DeferredTaxAssetsAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets amortization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_DeferredTaxAssetsAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_DeferredTaxAssetsLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax assets, lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_DeferredTaxAssetsLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_DeferredTaxLiabilitiesDepreciationAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities, depreciation and amortization.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_DeferredTaxLiabilitiesDepreciationAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_DeferredTaxLiabilitiesLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Deferred tax liabilities, lease right of use asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_DeferredTaxLiabilitiesLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>93
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034243373384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes - Additional Information (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsValuationAllowance', window );">Deferred tax assets valuation allowance</a></td>
<td class="nump">$ 39,401,000<span></span>
</td>
<td class="nump">$ 18,414,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount', window );">Change in deferred tax asset valuation allowance</a></td>
<td class="nump">$ 21,000,000.0<span></span>
</td>
<td class="nump">14,100,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_ConsideredPeriodOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards', window );">Considered period of ownership for annual limitation of net operating loss and tax credit carryforwards</a></td>
<td class="text">3 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_ConsideredPercentageOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards', window );">Considered percentage of ownership for annual limitation of net operating loss and tax credit carryforwards</a></td>
<td class="nump">50.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefits', window );">Unrecognized tax benefits</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued', window );">Accrued interest and penalties related to uncertain tax positions</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExaminationDescription', window );">Income tax examination, description</a></td>
<td class="text">As of December 31, 2021 , there were no income tax examinations in progress<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember', window );">Federal</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 119,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration', window );">Net operating loss carryforwards not subject to expiration</a></td>
<td class="nump">117,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration', window );">Net operating loss carryforwards subject to expiration</a></td>
<td class="nump">$ 1,900,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_OperatingLossCarryforwardsExpirationYear', window );">Net operating loss carryforwards expiration year</a></td>
<td class="text">2037<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credit carryforwards</a></td>
<td class="nump">$ 3,500,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_TaxCreditCarryforwardsExpirationYear', window );">Tax credit carryforwards expiration year</a></td>
<td class="text">2041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember', window );">State</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwardsLineItems', window );"><strong>Operating Loss Carryforwards [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLossCarryforwards', window );">Net operating loss carryforwards</a></td>
<td class="nump">$ 109,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_OperatingLossCarryforwardsExpirationYear', window );">Net operating loss carryforwards expiration year</a></td>
<td class="text">2041<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch', window );">Research and development tax credit carryforwards</a></td>
<td class="nump">$ 2,800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_vor_TaxCreditCarryforwardsExpirationYear', window );">Tax credit carryforwards expiration year</a></td>
<td class="text">2036<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32632-109319<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32621-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredTaxAssetsValuationAllowance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredTaxAssetsValuationAllowance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExaminationDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExaminationDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32559-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLossCarryforwardsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLossCarryforwardsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unrecognized tax benefits.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10B<br> -URI http://asc.fasb.org/extlink&amp;oid=123427490&amp;loc=SL37586934-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=SL6600010-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32718-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32537-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_ConsideredPercentageOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Considered percentage of ownership for annual limitation of net operating loss and tax credit carryforwards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_ConsideredPercentageOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_ConsideredPeriodOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Considered period of ownership for annual limitation of net operating loss and tax credit carryforwards</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_ConsideredPeriodOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_OperatingLossCarryforwardsExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating loss carryforwards expiration year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_OperatingLossCarryforwardsExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_vor_TaxCreditCarryforwardsExpirationYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tax credit carryforwards expiration year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">vor_TaxCreditCarryforwardsExpirationYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>vor_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_DomesticCountryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxAuthorityAxis=us-gaap_StateAndLocalJurisdictionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>94
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034244464344">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (68,899)<span></span>
</td>
<td class="num">$ (43,337)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RedeemablePreferredStockDividends', window );">Cumulative dividends on redeemable convertible preferred stock</a></td>
<td class="num">(1,228)<span></span>
</td>
<td class="num">(5,925)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss attributable to common stockholders</a></td>
<td class="num">$ (70,127)<span></span>
</td>
<td class="num">$ (49,262)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted-average number of common shares outstanding, basic and diluted</a></td>
<td class="nump">33,433,214<span></span>
</td>
<td class="nump">213,658<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Net loss per share attributable to common stockholders, basic and diluted</a></td>
<td class="num">$ (2.10)<span></span>
</td>
<td class="num">$ (230.57)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123482062&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=123367319&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=123570139&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124509347&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI http://asc.fasb.org/extlink&amp;oid=124359900&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=123359005&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RedeemablePreferredStockDividends">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Dividends paid to preferred stock holders that is redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=125511455&amp;loc=d3e1377-109256<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=123467817&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RedeemablePreferredStockDividends</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>95
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140034244398376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Potential Dilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vor_SeriesAOneRedeemableConvertiblePreferredStockMember', window );">Series A-1 Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potential dilutive securities excluded from computation of diluted net loss per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,470,588<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vor_SeriesATwoRedeemableConvertiblePreferredStockMember', window );">Series A-2 Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potential dilutive securities excluded from computation of diluted net loss per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">7,881,965<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vor_SeriesBRedeemableConvertiblePreferredStockMember', window );">Series B Redeemable Convertible Preferred Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potential dilutive securities excluded from computation of diluted net loss per share</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">9,155,810<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Options to Purchase Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potential dilutive securities excluded from computation of diluted net loss per share</a></td>
<td class="nump">5,086,792<span></span>
</td>
<td class="nump">5,084,679<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vor_SeriesAOneRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vor_SeriesAOneRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vor_SeriesATwoRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vor_SeriesATwoRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vor_SeriesBRedeemableConvertiblePreferredStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=vor_SeriesBRedeemableConvertiblePreferredStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>96
<FILENAME>vor-20211231_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021q4"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2021-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31"
  xmlns:utr="http://www.xbrl.org/2009/utr"
  xmlns:vor="http://vorbiopharma.com/20211231"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="vor-20211231.xsd" xlink:type="simple"/>
    <context id="C_30c63602-288c-4405-a204-cdab859368e7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_1e278196-1cfd-446f-8d91-9976d22c5883">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CreditFacilityAxis">us-gaap:StandbyLettersOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-15</startDate>
            <endDate>2021-06-15</endDate>
        </period>
    </context>
    <context id="C_2df3377e-ee22-43dc-b9ea-a3b6b9eb60c6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_8e0a26e9-728b-430b-b0fc-8bf930a218ab">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">us-gaap:CashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_f421d89d-1fcd-44c9-b330-4181365acf97">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesATwoRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_a552db48-79ee-4bc9-bd4d-b52fcf933430">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesATwoRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_69091247-915d-4997-8567-724c5a05de2f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesAOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_78d79139-f336-486b-8add-17be3536b350">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_6db24f0b-fc32-481a-99b2-6949f632a61f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">vor:SecondLeaseAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-15</startDate>
            <endDate>2021-06-15</endDate>
        </period>
    </context>
    <context id="C_bb722967-b149-4749-9edf-a5242ac6397a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_26ff529e-e196-4005-ac31-d73430825eb5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vor:NationalInstitutesOfHealthLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="C_29752c48-fb53-41e4-b327-df9623f28225">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vor:TwoThousandFifteenStockIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-05</instant>
        </period>
    </context>
    <context id="C_f6546c5b-8293-41ca-b559-c79fcc889b89">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">vor:AccruedExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vor:ColumbiaLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_52a58005-78a0-40c3-9da0-2ffe7154a555">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesATwoRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-02-05</startDate>
            <endDate>2020-02-05</endDate>
        </period>
    </context>
    <context id="C_fe5f0887-c938-4424-9f52-81c4c0ac9449">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_7a2f1c59-42b8-4077-b849-32e1f00d5329">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_588f2dc9-7ea0-423b-baac-bf5e275504d3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_2069f6af-4edc-49e3-bb9e-d18be8ade020">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vor:FurnitureAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_4fcfa437-bee3-47fa-94e3-9caec72a5b95">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_e733f8c4-07b6-4b41-b024-5814fc24327f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-29</startDate>
            <endDate>2021-01-29</endDate>
        </period>
    </context>
    <context id="C_5b680cd4-9558-44e6-9a54-c351f3ac168d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">vor:MaturingInOneYearOrLessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_33213034-803c-4c95-bb92-7996ff3a4622">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vor:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_39aabd88-71ef-47fd-81c2-5989c3eb5180">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_01ae64e4-fcbc-4c77-945a-5a32dc371b12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_a0646336-a18c-4b69-a90e-ca45d0ce7f71">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">vor:FirstLeaseAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-15</instant>
        </period>
    </context>
    <context id="C_af4903d8-c8c6-44b2-ae8d-4dfc4cc09658">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">vor:CambridgeparkLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_125bd726-c0d2-4df7-b573-0ef9f71919e2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_cbe610c1-c6d3-4428-b88d-d6ea1d66502f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vor:FurnitureAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_d0fb8d89-6900-4a5d-85de-755eaa9cf227">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-06-29</startDate>
            <endDate>2020-06-29</endDate>
        </period>
    </context>
    <context id="C_d9da6ae7-78bc-43bf-aef8-9f17cd10c178">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">vor:SecondLeaseAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-15</startDate>
            <endDate>2021-06-15</endDate>
        </period>
    </context>
    <context id="C_05cbe1e9-93ae-4c7c-8022-300abf600f9a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesAOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_627553ad-acf9-43fd-997b-9899cf109351">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_7ad90457-283a-44cd-b3db-1fbd4b5d6040">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_0934599b-e63c-44b0-8f73-95ce8e66ed87">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesAOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_4322025b-403f-47da-9dfb-69514ce849e6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_906ae667-10d4-461d-ab58-98924db96c28">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_715633f5-fcd9-4448-aad7-029e1308015e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vor:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_4fad1b2e-548e-456c-a314-8f74671c228b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">vor:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_09163903-47da-4862-9c71-2100cb0e3e52">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_e1887846-0919-4db3-aa01-c63b37f6dff8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">vor:MaturingInOneYearOrLessMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_1f0cde73-59e7-449b-80e5-547933529d26">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheTwoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_2bd29414-3bf3-467c-b8da-0f5c54c35d29">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">vor:AccruedExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vor:ColumbiaLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_df21a856-8ac4-4f90-a160-369dd5bc8faf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_2c77f565-f009-499e-a1b1-aa2bbba1d540">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vor:FurnitureAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_f5ef1ea6-c3b7-451a-8872-9c63fc489bc3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_22f4bcb0-6708-4711-89d9-4dd150fabf2e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vor:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_3c5cc129-6f72-442b-ba44-37460dc77415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_384191fb-9059-497b-a41e-c8f78ff3b67f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">vor:TwoThousandTwentyOneEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-05</startDate>
            <endDate>2021-02-05</endDate>
        </period>
    </context>
    <context id="C_fde2681f-7863-4672-ac2d-a2fe4bb678c4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_d9365f15-4570-4863-b99d-75d5cc7c706b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesATwoRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_14003f5b-14c6-46bb-a63b-569af36a4ed6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_b6f766ff-68c5-4b43-8d56-95a91d04de17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_2e62aa11-22e8-433f-b264-9531559a3726">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_4f4bd222-f291-4cc2-a0d9-e0451c423659">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">vor:SeriesAOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_5704eb75-6122-4803-bb26-449ab2867e41">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
        </entity>
        <period>
            <startDate>2020-10-01</startDate>
            <endDate>2020-10-31</endDate>
        </period>
    </context>
    <context id="C_8e667a03-9dc8-490a-98a3-a47136782d33">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_108d57ff-006a-4611-a4b0-e4181430ef77">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">us-gaap:OtherAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_3dacd509-2296-44c2-8572-ea922b845d9c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_ae930d22-cc83-471e-981d-8726a0b382a0">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_e403d7c0-1f35-43a7-8fc0-3a59a8d342cd">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-09</startDate>
            <endDate>2021-02-09</endDate>
        </period>
    </context>
    <context id="C_73eee50d-fc14-42b0-8920-b0a04312d39a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vor:NationalInstitutesOfHealthLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="C_86a506c8-d064-4dfe-9433-56efa7f9e3b1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_4ca00470-3222-46a5-ba00-840824cc64ac">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="C_f7e93cb2-5aad-42ef-867b-5b8e561d0399">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_38911f38-ed40-46e3-aae3-567d07cc6536">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_d1a54bd6-087e-482f-9586-9f67436d0f3b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_17db07ca-1802-4fd6-af2a-3b044cdb439e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_f74e35ab-8530-45d8-8610-4c43f69992db">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_4efe06e3-c8a1-4df0-8cc2-32db822023b4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_9ced81ea-4ae3-445d-910e-f3c298459ae8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_e3549357-9b6b-45e4-b9a8-1215efcfd4cf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_715b82a7-0efe-414c-ba1e-c08acca496be">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">vor:MaturingAfterOneYearThroughFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_4457893c-b88e-4779-ae3d-d3eaad39d858">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_5fa63f3c-7a7e-49f4-b2a0-dffb9dcb0526">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_5ce9a17a-6747-4e6a-b14b-931e7fbf6304">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_3e5b0b1c-0786-4be6-85c8-c47c2f2afe86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesATwoRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_88b36c70-a4c3-4733-99e7-acb53eff697f">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesATwoRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_8f8c1246-f661-4230-b8d9-f954d3732f61">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">vor:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_21f54f52-6262-4aae-b36b-d01ad52765ef">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
        </entity>
        <period>
            <instant>2022-03-04</instant>
        </period>
    </context>
    <context id="C_1d853449-b848-41c9-8402-61ac0859b6c1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_f9decb30-9917-46ec-95f6-06ac473f5fb9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_e1434930-9e6c-49c1-8a72-2f6ad390870c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_f35b7c7a-c532-4b88-bdc5-43c57c43318c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:GeneralAndAdministrativeExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_4524d971-84fd-4763-928f-3714233d9b8d">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">vor:FirstLeaseAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-15</startDate>
            <endDate>2021-06-15</endDate>
        </period>
    </context>
    <context id="C_6591cce2-facd-4d98-9f53-16294c8f698c">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesBRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-08</startDate>
            <endDate>2021-01-08</endDate>
        </period>
    </context>
    <context id="C_fb525106-40af-41f1-abca-fd6a6fdc8870">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:StateAndLocalJurisdictionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_bb19a2ae-ac5d-4f11-b032-62cb4dd2a453">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">vor:CambridgeparkLeaseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-12-31</endDate>
        </period>
    </context>
    <context id="C_e2969fd4-7d7c-435f-8e64-f416d48f96fe">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_c04daa76-85eb-4243-8001-dd530ab727ea">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_b03a92f2-8cde-4578-9ffb-def9727ae3e2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
        </entity>
        <period>
            <instant>2021-06-30</instant>
        </period>
    </context>
    <context id="C_522a671f-8013-49d5-9406-851e52363e90">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-02-09</startDate>
            <endDate>2021-02-09</endDate>
        </period>
    </context>
    <context id="C_8cfcd4c1-10fe-467a-9e2b-cc68414f8f0e">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_5c1b58ed-1181-42ef-9936-9ee4e450ee86">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vor:ColumbiaLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-11-30</instant>
        </period>
    </context>
    <context id="C_d8baf95d-5eaa-4c79-8ad9-9d413c0de569">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="C_5e77fbcd-1b4f-4eb9-bc4a-1659f7452745">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_6c62975b-bbca-4e3d-9239-8d568106fa63">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesAOneRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_cc3d40e7-fe0d-4909-adf0-b9e10e622e8b">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">vor:RestrictedCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_e8956874-0a8e-44bd-8bfb-ee0b88501483">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByAssetClassAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InvestmentTypeAxis">vor:RestrictedCashEquivalentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_a65d33bd-d9c2-4c72-bb24-f45f2ce91c39">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:CorporateDebtSecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancingReceivablesPeriodPastDueAxis">vor:MaturingAfterOneYearThroughFiveYearsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_02d1981e-0b73-40f4-9bc3-8fdce9d391e3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">vor:SeriesATwoRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-02-12</startDate>
            <endDate>2019-02-12</endDate>
        </period>
    </context>
    <context id="C_0b13dbfb-af9b-4e36-b831-4dc9d2f387b8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeTaxAuthorityAxis">us-gaap:DomesticCountryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_640a4a96-8eca-48d4-9211-924367454b36">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">vor:SecondLeaseAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-06-15</instant>
        </period>
    </context>
    <context id="C_1a7d767a-18bf-417e-9a93-14efa9daffc7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:BalanceSheetLocationAxis">vor:AccruedExpensesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vor:NationalInstitutesOfHealthLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <context id="C_d6d70c45-e42a-4ed6-8717-d4b764af1957">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VestingAxis">us-gaap:ShareBasedCompensationAwardTrancheOneMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_a8aa8d2a-0cb5-4a21-b6ab-146b2c4adaa1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">vor:FirstLeaseAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-15</startDate>
            <endDate>2021-06-15</endDate>
        </period>
    </context>
    <context id="C_965a7f16-b568-4209-8526-032c882c59d6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">vor:SecondLeaseAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-15</startDate>
            <endDate>2021-06-15</endDate>
        </period>
    </context>
    <context id="C_d172676c-6f5a-4c81-bda9-175f1b30bdaf">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ComputerEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="C_28790eaf-526a-4566-8f5d-38d463cd96fa">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">vor:SeriesATwoRedeemableConvertiblePreferredStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="C_830618a5-a622-44e4-a728-a9181a23c735">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_312b019a-fe59-4cdb-acae-11a1267c8c20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LeaseContractualTermAxis">vor:FirstLeaseAmendmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-06-15</startDate>
            <endDate>2021-06-15</endDate>
        </period>
    </context>
    <context id="C_2d35f13a-de85-4de4-863e-43adb4567091">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="C_a4841187-5a01-4b8a-9f4b-2a8762ff5f9a">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:USTreasurySecuritiesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:InformationByCategoryOfDebtSecurityAxis">us-gaap:InvestmentsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="C_c2b57d58-2294-4b68-be37-2b25d3a08312">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">us-gaap:IPOMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-02-09</instant>
        </period>
    </context>
    <context id="C_9b3fa813-9828-49c2-a538-31ae7b11c4b9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001817229</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:LicenseMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:TypeOfArrangementAxis">vor:NationalInstitutesOfHealthLicenseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-10-31</instant>
        </period>
    </context>
    <unit id="U_Vote">
        <measure>vor:Vote</measure>
    </unit>
    <unit id="U_pure">
        <measure>pure</measure>
    </unit>
    <unit id="U_sqft">
        <measure>utr:sqft</measure>
    </unit>
    <unit id="U_Segment">
        <measure>vor:Segment</measure>
    </unit>
    <unit id="U_shares">
        <measure>shares</measure>
    </unit>
    <unit id="U_UnitedStatesOfAmericaDollarsShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="U_USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:CurrentFiscalYearEndDate
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_b2ffa8ee-9529-4fd4-82fe-a6ca516756a7">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:EntityCentralIndexKey
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_e50e96ba-4bb2-4a0a-bedc-b96d652fbac5">0001817229</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalPeriodFocus
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_ddc30ae4-0085-4f3c-a71b-bd969e305524">FY</dei:DocumentFiscalPeriodFocus>
    <us-gaap:StockholdersEquityNoteStockSplitConversionRatio1
      contextRef="C_e733f8c4-07b6-4b41-b024-5814fc24327f"
      decimals="4"
      id="F_1a6782bb-9d03-4a11-a8d9-b5a47122f2f7"
      unitRef="U_pure">0.0735</us-gaap:StockholdersEquityNoteStockSplitConversionRatio1>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_9fe2e284-3d35-4fe3-b478-3dcd0820f887">http://fasb.org/us-gaap/2021-01-31#AccountingStandardsUpdate201912Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:PreferredStockValue
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      id="F_92740c7f-9a44-4bb2-be40-da3ce44d3337"
      unitRef="U_USD"
      xsi:nil="true"/>
    <dei:AmendmentFlag
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_b08dbc5d-8945-4b44-ac31-66ad1c7b51b0">false</dei:AmendmentFlag>
    <us-gaap:PreferredStockValue
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      id="F_d001c3a9-ea5b-45d4-bac4-d84b5bc72b37"
      unitRef="U_USD"
      xsi:nil="true"/>
    <dei:DocumentType
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_873c3753-b63f-49d9-91a5-fe004e43e789">10-K</dei:DocumentType>
    <dei:DocumentAnnualReport
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_b08efb01-cecb-41cd-a345-4d9abcf85254">true</dei:DocumentAnnualReport>
    <dei:DocumentPeriodEndDate
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_b94d0211-2a4c-4d38-a716-ae7fadf3a079">2021-12-31</dei:DocumentPeriodEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_c0bef316-6778-45ee-bc89-81574a85de21">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentTransitionReport
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_4b022b3b-feae-47d7-9380-5520adba2887">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_8e6ba8c4-a030-45ad-b836-d31851be70c8">001-39979</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_3f327089-4a96-4256-ae4e-9d9c4f9871b2">VOR BIOPHARMA INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_5e1ff1a2-bad6-4f2d-84a1-5b2686978ddf">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_7740b2cb-f27e-4bc7-a9c0-5c6a955ec253">81-1591163</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_5e0fe894-996e-4210-8b3e-e02b02e5b091">100 Cambridgepark Drive</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_11bf33dd-a600-4d4b-9206-e687d662fe5c">Suite 101</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_1e128b3e-295f-47fc-bcee-bd46c258b329">Cambridge</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_b1586aa6-97a8-42e2-ba57-9a8956130058">MA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_19a3045e-5e9f-4670-99a2-9cc592396d0a">02140</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_c4f4d85f-7e34-41d4-8f89-3848fd5d0688">617</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_bae042fc-0f19-4d38-a285-ecad919aba2b">655-6580</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_9a5a7526-78e2-4f27-9371-a74f8e6cc344">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_1c7f1cd2-f04e-44e4-b689-1fa2ca0bfceb">VOR</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_0e82c748-d386-42a8-a982-14335138d4c5">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityWellKnownSeasonedIssuer
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_71389703-eb1d-4d48-ad19-74ba410697cd">No</dei:EntityWellKnownSeasonedIssuer>
    <dei:EntityVoluntaryFilers
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_3f127e6b-eb0d-49d9-92e0-c558dbbf8b81">No</dei:EntityVoluntaryFilers>
    <dei:EntityCurrentReportingStatus
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_059f0203-f5bf-497c-b6b3-9610c1a26e75">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_7532ffc3-5e30-42d6-b0a5-9bef7a3810d8">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_6dcb2259-b0aa-4100-a9b8-7eec35bba7dd">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_08ba217d-f99b-41eb-8db7-5664eb43181e">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_b50d4960-de6b-46c1-99f4-4a15adc981f1">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_e35f506b-9294-4499-8a96-53de236e6233">false</dei:EntityExTransitionPeriod>
    <dei:IcfrAuditorAttestationFlag
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_84a9bda3-9434-43cd-83eb-5f07f864dcc5">false</dei:IcfrAuditorAttestationFlag>
    <dei:EntityShellCompany
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_50c25b4c-9175-4421-9bce-e53d583c8e6c">false</dei:EntityShellCompany>
    <dei:EntityPublicFloat
      contextRef="C_b03a92f2-8cde-4578-9ffb-def9727ae3e2"
      decimals="2"
      id="F_fa9cfc47-a850-4c78-bc68-6de0129f445c"
      unitRef="U_USD">351650244.65</dei:EntityPublicFloat>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="C_21f54f52-6262-4aae-b36b-d01ad52765ef"
      decimals="INF"
      id="F_3102c86c-f73d-4a52-80c1-429459741ac4"
      unitRef="U_shares">37488370</dei:EntityCommonStockSharesOutstanding>
    <dei:AuditorFirmId
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_245dbc9c-bcee-4d99-a0ec-ba225c4e129f">42</dei:AuditorFirmId>
    <dei:AuditorName
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_64273416-47f2-49c6-b8d6-c23d4509ca73">Ernst &amp; Young LLP</dei:AuditorName>
    <dei:AuditorLocation
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_454c9a6d-6723-4c18-ab85-0726ffee3fa4">Boston, Massachusetts</dei:AuditorLocation>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_e0f268fb-81e8-4a7e-b221-6206d78a4d08"
      unitRef="U_USD">119801000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_88f91a38-11f5-4da4-9f12-c7498d6d0dbf"
      unitRef="U_USD">48539000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:ShortTermInvestments
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_91f2b0ec-9c32-4f56-8a3e-ec8fdf112897"
      unitRef="U_USD">87668000</us-gaap:ShortTermInvestments>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_493bc673-62ac-4dba-b670-ccd349eea496"
      unitRef="U_USD">4836000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:PrepaidExpenseCurrent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_08d06321-a052-4ccb-95c0-0ba81e98b2e6"
      unitRef="U_USD">467000</us-gaap:PrepaidExpenseCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_da08be27-6aa2-4649-b560-610d3b5f822e"
      unitRef="U_USD">2094000</us-gaap:OtherAssetsCurrent>
    <us-gaap:OtherAssetsCurrent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_d79929c0-ad31-4542-97b5-c9061c9e31bc"
      unitRef="U_USD">100000</us-gaap:OtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_0417a2cd-d2ae-41ea-9bb5-7f18848a309f"
      unitRef="U_USD">214399000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_63c6325c-fdda-4157-8f7e-8041166e8d99"
      unitRef="U_USD">49106000</us-gaap:AssetsCurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_7f95d6f1-173a-44d3-a463-62889319ba1a"
      unitRef="U_USD">2413000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_096cc6bb-9001-4f19-a234-60a020792767"
      unitRef="U_USD">1559000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_1841c8a3-5847-440f-bf72-6771e9cc9d2c"
      unitRef="U_USD">6853000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_d18e5157-ca40-470a-bc09-36860c9c55e9"
      unitRef="U_USD">4728000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_f63b01bf-e676-4a13-b3b2-dfc2c7042a3b"
      unitRef="U_USD">15670000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_1272e15c-92a0-4076-9fa6-977f8c88f118"
      unitRef="U_USD">17117000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_b4401f55-6207-4c90-9b6c-f8b5fee7b001"
      unitRef="U_USD">3255000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_f3c9ad7f-8ac3-40ad-900e-fb92b1beaa76"
      unitRef="U_USD">3398000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_c480474c-aa0b-476a-8e40-d1f5f615620c"
      unitRef="U_USD">242590000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_6e1ce71b-8c63-4306-a0ac-2bf06e461325"
      unitRef="U_USD">75908000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_a915bcd3-668c-4a81-9bd3-d9b99492db0b"
      unitRef="U_USD">1545000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_5caf1bfc-168f-4f10-b4a5-3a623b06c73d"
      unitRef="U_USD">2361000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_2e52886a-e430-4491-97df-2ddecf5f11e9"
      unitRef="U_USD">6335000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_c27d601e-54f2-455d-81f3-995e1249bc87"
      unitRef="U_USD">6260000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_53f97be4-cb36-409e-a2f6-30f4992bbc1c"
      unitRef="U_USD">1839000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_d7e6ffef-8963-4c79-bc4b-974896e8e54c"
      unitRef="U_USD">863000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_ebc93220-3d94-4b35-985c-529546fa96ac"
      unitRef="U_USD">434000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_6fdee86e-e080-4ea2-afe6-babfee9f5411"
      unitRef="U_USD">723000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_ec34cd78-cd3d-4c62-b655-57431ae01d40"
      unitRef="U_USD">10153000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_80dfc7cd-dda8-49c8-b3b8-eb1f5e4ef98f"
      unitRef="U_USD">10207000</us-gaap:LiabilitiesCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_7465d67a-57d0-4e04-959b-d850d7a99e42"
      unitRef="U_USD">16174000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_295c88f1-ee17-4d3d-bf83-217e9e14b4c6"
      unitRef="U_USD">17430000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_615dd825-6656-4216-b1e0-e914aaaeb8ec"
      unitRef="U_USD">26327000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_e81ae38e-dd4d-4209-9ee8-d56ec0538ac4"
      unitRef="U_USD">27637000</us-gaap:Liabilities>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_0934599b-e63c-44b0-8f73-95ce8e66ed87"
      decimals="INF"
      id="F_97d7b653-5d9c-4b1c-8bcd-37ca07cbb8de"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63"
      decimals="INF"
      id="F_90c2302c-cbc9-435a-bdf5-2e7055422fc6"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_0934599b-e63c-44b0-8f73-95ce8e66ed87"
      decimals="INF"
      id="F_025ecd0c-535e-4056-bf48-e2bed34d1bfc"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_0934599b-e63c-44b0-8f73-95ce8e66ed87"
      decimals="INF"
      id="F_20570fdf-692e-4404-8b6e-2a9774a86b68"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_0934599b-e63c-44b0-8f73-95ce8e66ed87"
      decimals="INF"
      id="F_65b962d5-e553-4caf-b20f-3caa1bfed103"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63"
      decimals="INF"
      id="F_59301fad-d35e-453a-b2df-a180bf83b14b"
      unitRef="U_shares">20000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63"
      decimals="INF"
      id="F_c86affdc-e5a5-4d6c-927b-76929f675558"
      unitRef="U_shares">20000000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63"
      decimals="INF"
      id="F_1a9eeef9-561e-4235-810c-41573900cced"
      unitRef="U_shares">20000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63"
      decimals="-3"
      id="F_bfe1013b-9b7d-4204-8627-ed2e0e0a8584"
      unitRef="U_USD">4000000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63"
      decimals="-3"
      id="F_a768bc36-7055-49ad-aa47-007c7e382794"
      unitRef="U_USD">2000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_a552db48-79ee-4bc9-bd4d-b52fcf933430"
      decimals="INF"
      id="F_e7aad643-cdd5-4294-9ebe-c6db31213f7d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b"
      decimals="INF"
      id="F_9bf107cc-73d6-4e03-963e-23b70c8cccf2"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_a552db48-79ee-4bc9-bd4d-b52fcf933430"
      decimals="INF"
      id="F_a136d5f4-5455-4d67-931b-5bf20bdb0c70"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_a552db48-79ee-4bc9-bd4d-b52fcf933430"
      decimals="INF"
      id="F_40b9295d-fc4a-4d6a-96b7-d069d2cc564e"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_a552db48-79ee-4bc9-bd4d-b52fcf933430"
      decimals="INF"
      id="F_a5f6e5e8-3760-4453-a2a0-83d5dcbe0067"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b"
      decimals="INF"
      id="F_a498544f-7404-4792-a56f-d9734eba9d57"
      unitRef="U_shares">107194866</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b"
      decimals="INF"
      id="F_dcf99733-d3fe-4abf-8e98-0f57c5ac6e6c"
      unitRef="U_shares">107194866</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b"
      decimals="INF"
      id="F_46eca231-adfd-41f2-aa5c-c5cb539db04b"
      unitRef="U_shares">107194866</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b"
      decimals="-3"
      id="F_b44fea04-91b0-4156-8c9d-1b86c4c40ed5"
      unitRef="U_USD">42878000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b"
      decimals="-3"
      id="F_357afd78-7908-4eb5-bcac-f619b543a8e8"
      unitRef="U_USD">42786000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_906ae667-10d4-461d-ab58-98924db96c28"
      decimals="INF"
      id="F_ef763627-b5dc-4e1f-9845-b02e0a7ee52c"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42"
      decimals="INF"
      id="F_668be7ea-387e-4773-a030-206cf5dd87a8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_906ae667-10d4-461d-ab58-98924db96c28"
      decimals="INF"
      id="F_8d4dfab6-1895-48eb-a406-699e99d6071d"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42"
      decimals="INF"
      id="F_2c399eeb-9855-4052-805f-1f3b8df761bd"
      unitRef="U_shares">211778825</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_906ae667-10d4-461d-ab58-98924db96c28"
      decimals="INF"
      id="F_f0fadcb7-258b-4e5b-924e-9cc66aaed533"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_906ae667-10d4-461d-ab58-98924db96c28"
      decimals="INF"
      id="F_7de54af7-3279-49b2-a8d2-25d35099ef83"
      unitRef="U_shares">0</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42"
      decimals="INF"
      id="F_00d2f561-ccd4-4f4d-b8a0-f512925ccb14"
      unitRef="U_shares">124519220</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42"
      decimals="INF"
      id="F_fcb722f1-9695-48df-8529-09565924430c"
      unitRef="U_shares">124519220</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42"
      decimals="-3"
      id="F_56a98ce7-bd77-47a8-a172-05d476d66876"
      unitRef="U_USD">64750000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42"
      decimals="-3"
      id="F_cb0c3d11-a76c-4b80-9f1f-f1886f955d34"
      unitRef="U_USD">64548000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="INF"
      id="F_ad3c6d73-ef73-4190-b78f-f9dbdb725d8d"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="INF"
      id="F_15991e24-0286-4ff9-bfb4-e7c3aeb7a919"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="INF"
      id="F_c55fd881-03f0-4d1b-9444-68b1a45b1759"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="INF"
      id="F_54939038-5249-4a54-a434-619e203fe34e"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="INF"
      id="F_591a07a6-80a4-44c9-8cdd-829d290a3d23"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="INF"
      id="F_8d3ae97b-76d6-48c5-a670-ac835ce2a2ce"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="INF"
      id="F_c1c4b63b-0b5d-4c53-b881-c5f867c8293f"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="INF"
      id="F_f3760de4-4a88-4cc2-8823-e7100e22c6f6"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="INF"
      id="F_24bc576b-8e80-4e75-82c0-1ff9f60c9ed7"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="INF"
      id="F_8575b697-e06e-4769-a968-2b2f79fee24f"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="INF"
      id="F_53ac510c-69b3-4c94-8c2d-5180242f8b02"
      unitRef="U_shares">400000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="INF"
      id="F_c95820ea-eff1-49f0-88ea-c0b456438572"
      unitRef="U_shares">420000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="INF"
      id="F_b47d0238-08db-4098-a3f8-a5ec6832b9a3"
      unitRef="U_shares">37375428</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="INF"
      id="F_712aa16e-5ad7-4ec3-aeb7-472764a2b025"
      unitRef="U_shares">893231</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="INF"
      id="F_1380be29-505f-4d6b-a45b-14ec0ce5de37"
      unitRef="U_shares">37174741</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="INF"
      id="F_8bd11139-e64d-40b9-8d7f-0adba65dc23c"
      unitRef="U_shares">505074</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_fe23dfac-7b1b-4349-98f8-12bb51fd7f7e"
      unitRef="U_USD">4000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_f68a1b30-7ed5-427b-8900-d79c1cbdd6ed"
      unitRef="U_USD">1000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_bb95bf27-a0dc-4e3c-9086-b476e23e1cbc"
      unitRef="U_USD">346382000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:AdditionalPaidInCapitalCommonStock
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_0116fe6e-8e75-4eba-b857-c4febca4eee7"
      unitRef="U_USD">2158000</us-gaap:AdditionalPaidInCapitalCommonStock>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_e352a840-8a5a-405a-b4ec-0e91d9535dd2"
      unitRef="U_USD">-130123000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_b991178e-d1bc-45d4-a715-477c18c08b1d"
      unitRef="U_USD">-61224000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_8cecc286-2772-4fcd-a5db-1c8e6cd9d5c1"
      unitRef="U_USD">216263000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_05cfd18f-984a-4c29-b402-5fa2420fa6e2"
      unitRef="U_USD">-59065000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_a88632e6-138f-452f-b215-830fd9923459"
      unitRef="U_USD">242590000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_069f4470-25c9-4131-b683-14c8eae6363f"
      unitRef="U_USD">75908000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_29bdf53d-75c4-4f79-a5eb-e3ec532de60a"
      unitRef="U_USD">47529000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_3f8dc17a-4470-40b8-9afc-ae67ba817d05"
      unitRef="U_USD">31618000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_b9ead98d-48f3-4aa5-b436-2d59cb9c63e4"
      unitRef="U_USD">21489000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:GeneralAndAdministrativeExpense
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_f93d13bb-a90e-414c-bd99-138684ca5d2c"
      unitRef="U_USD">11748000</us-gaap:GeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_a349cebf-58ea-493a-b463-63c3f1ba4bcd"
      unitRef="U_USD">69018000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_4ba8b25b-5330-444f-bf12-d55cdedbf953"
      unitRef="U_USD">43366000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_b08ed71a-0229-45ad-b4fd-52d01a286b2f"
      unitRef="U_USD">-69018000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_e13d379d-c0f0-43c3-9122-12f6e39390d5"
      unitRef="U_USD">-43366000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_2f521501-f307-4c76-a6b6-858326a3fe25"
      unitRef="U_USD">119000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_269efed8-1bdc-4ecc-9217-1e8ac4f0d9ea"
      unitRef="U_USD">29000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_0e595bc6-bb57-440d-9ab5-e9e566bff57c"
      unitRef="U_USD">119000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_98a06026-90c7-497c-afb2-af241dcd508e"
      unitRef="U_USD">29000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_f81a340a-8d15-4397-8589-1acce62bdad1"
      unitRef="U_USD">-68899000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_1d43e843-223e-4fe0-9066-03495d5b3a72"
      unitRef="U_USD">-43337000</us-gaap:NetIncomeLoss>
    <us-gaap:RedeemablePreferredStockDividends
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_798e3693-8620-46e3-b216-8daf1134fa72"
      unitRef="U_USD">1228000</us-gaap:RedeemablePreferredStockDividends>
    <us-gaap:RedeemablePreferredStockDividends
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_3adbce51-ba0a-4f0d-8c1b-6c618b7b0f4b"
      unitRef="U_USD">5925000</us-gaap:RedeemablePreferredStockDividends>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_f6862175-75e2-491e-8789-fadbb9f2d04f"
      unitRef="U_USD">-70127000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_30c477b5-3f0a-42b5-9f2d-3eaf7d8e5e6b"
      unitRef="U_USD">-49262000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="2"
      id="F_f61f9120-1431-4bd5-90c4-25b1473f8708"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-2.10</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="2"
      id="F_c59ba923-b6a3-4b7d-a926-834f11ead1b9"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-230.57</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="0"
      id="F_49c33897-323f-4f6f-9d38-5a11f346dc6c"
      unitRef="U_shares">33433214</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="0"
      id="F_13531512-edfa-47af-87d7-0fb25ad14f7c"
      unitRef="U_shares">213658</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_05cbe1e9-93ae-4c7c-8022-300abf600f9a"
      decimals="INF"
      id="F_c4e42a40-aeee-40af-952f-954421fa62d4"
      unitRef="U_shares">20000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_05cbe1e9-93ae-4c7c-8022-300abf600f9a"
      decimals="-3"
      id="F_4745eb5e-7324-4006-997b-e1edb214b667"
      unitRef="U_USD">2000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_f421d89d-1fcd-44c9-b330-4181365acf97"
      decimals="INF"
      id="F_dbcaddd2-60b8-4d98-a2c8-49b4952a07c8"
      unitRef="U_shares">62819866</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_f421d89d-1fcd-44c9-b330-4181365acf97"
      decimals="-3"
      id="F_85e2f1a1-0ec6-4280-9a37-ecca549e60be"
      unitRef="U_USD">25067000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_7ad90457-283a-44cd-b3db-1fbd4b5d6040"
      decimals="INF"
      id="F_d128e1a6-d8ce-4a44-b925-bfc8c122007b"
      unitRef="U_shares">119936</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_f7e93cb2-5aad-42ef-867b-5b8e561d0399"
      decimals="-3"
      id="F_708023cd-d229-4007-9a08-e2a7c0b04b7b"
      unitRef="U_USD">458000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_d8baf95d-5eaa-4c79-8ad9-9d413c0de569"
      decimals="-3"
      id="F_880604c0-89c4-4a00-b6c8-3ddaacb1dd61"
      unitRef="U_USD">-17887000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_09163903-47da-4862-9c71-2100cb0e3e52"
      decimals="-3"
      id="F_e3158ceb-e422-4733-a006-a3d2858c2320"
      unitRef="U_USD">-17429000</us-gaap:StockholdersEquity>
    <vor:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_88b36c70-a4c3-4733-99e7-acb53eff697f"
      decimals="INF"
      id="F_7ae282ed-a48c-43b7-a874-9e4349a9a871"
      unitRef="U_shares">44375000</vor:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="C_88b36c70-a4c3-4733-99e7-acb53eff697f"
      decimals="-3"
      id="F_ef679081-8b79-4bc9-aea9-dc37a5a31f18"
      unitRef="U_USD">17719000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <vor:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_39aabd88-71ef-47fd-81c2-5989c3eb5180"
      decimals="INF"
      id="F_863c43e8-c905-4210-99b9-7829fc5423b7"
      unitRef="U_shares">124519220</vor:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="C_39aabd88-71ef-47fd-81c2-5989c3eb5180"
      decimals="-3"
      id="F_ae2043ea-2531-48d5-9787-21fe5e05fc54"
      unitRef="U_USD">64548000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="C_588f2dc9-7ea0-423b-baac-bf5e275504d3"
      decimals="INF"
      id="F_4a45f5a4-feab-4327-823e-46a1b117f87f"
      unitRef="U_shares">385138</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_588f2dc9-7ea0-423b-baac-bf5e275504d3"
      decimals="-3"
      id="F_2bf4e049-a122-484a-b188-c8ffef4bb630"
      unitRef="U_USD">1000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_d1a54bd6-087e-482f-9586-9f67436d0f3b"
      decimals="-3"
      id="F_08fd001d-c089-48bc-b9a1-2fce54670233"
      unitRef="U_USD">358000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_32b060f2-34db-4074-9139-d1f1cf7681b8"
      unitRef="U_USD">359000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_d1a54bd6-087e-482f-9586-9f67436d0f3b"
      decimals="-3"
      id="F_f199ce87-c1c4-458a-8381-0df331a15ae8"
      unitRef="U_USD">1342000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_b3676895-ef9b-415c-8baf-7c2ebe222726"
      unitRef="U_USD">1342000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="C_17db07ca-1802-4fd6-af2a-3b044cdb439e"
      decimals="-3"
      id="F_5309ed90-8370-48d4-af0e-e5a5b96e90f1"
      unitRef="U_USD">-43337000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_50492e4e-8151-453f-ac39-763e080061a5"
      unitRef="U_USD">-43337000</us-gaap:NetIncomeLoss>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63"
      decimals="INF"
      id="F_d76099a1-0ab6-4782-8a17-b4f50f8c52c8"
      unitRef="U_shares">20000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63"
      decimals="-3"
      id="F_6f0e30cf-55c3-4746-afe7-56ce6874d95d"
      unitRef="U_USD">2000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b"
      decimals="INF"
      id="F_e8f9eb6a-f314-4cd8-8b9f-b912eb03433e"
      unitRef="U_shares">107194866</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b"
      decimals="-3"
      id="F_00de7c20-d856-4c9d-855d-345f2ef11a11"
      unitRef="U_USD">42786000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42"
      decimals="INF"
      id="F_52f0406e-af29-417d-84ba-376d9c48ce5a"
      unitRef="U_shares">124519220</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42"
      decimals="-3"
      id="F_25a70091-793a-44ac-9f84-1952312e9fca"
      unitRef="U_USD">64548000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_fde2681f-7863-4672-ac2d-a2fe4bb678c4"
      decimals="INF"
      id="F_d7a365c9-7e97-447c-87d9-c07e6d40ebfa"
      unitRef="U_shares">505074</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_fde2681f-7863-4672-ac2d-a2fe4bb678c4"
      decimals="-3"
      id="F_db994d59-438e-4da3-94d4-70dc426555dd"
      unitRef="U_USD">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_78d79139-f336-486b-8add-17be3536b350"
      decimals="-3"
      id="F_9d481b92-6d4a-4366-ad5e-981a993b831f"
      unitRef="U_USD">2158000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_2df3377e-ee22-43dc-b9ea-a3b6b9eb60c6"
      decimals="-3"
      id="F_28fc47e9-9c57-4eea-9840-ab4b6dff1ad7"
      unitRef="U_USD">-61224000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_c9b03d32-7dac-41fe-bdcd-070f87486c8a"
      unitRef="U_USD">-59065000</us-gaap:StockholdersEquity>
    <vor:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_ae930d22-cc83-471e-981d-8726a0b382a0"
      decimals="INF"
      id="F_ddb7ce4e-cdbd-4537-9ab1-38363105ffae"
      unitRef="U_shares">87259605</vor:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues
      contextRef="C_ae930d22-cc83-471e-981d-8726a0b382a0"
      decimals="-3"
      id="F_1cd7b6e7-480e-465b-abee-4b7d6a1c32bb"
      unitRef="U_USD">45375000</us-gaap:TemporaryEquityStockIssuedDuringPeriodValueNewIssues>
    <vor:TemporaryEquityStockConvertedDuringPeriodShares
      contextRef="C_69091247-915d-4997-8567-724c5a05de2f"
      decimals="INF"
      id="F_79e3e876-3847-40e4-bf7b-df8f6d29834b"
      unitRef="U_shares">20000000</vor:TemporaryEquityStockConvertedDuringPeriodShares>
    <vor:TemporaryEquityStockConvertedDuringPeriodValue
      contextRef="C_69091247-915d-4997-8567-724c5a05de2f"
      decimals="-3"
      id="F_4efc8180-7fa5-4d8a-8e10-ecba8cb7b4b7"
      unitRef="U_USD">2000</vor:TemporaryEquityStockConvertedDuringPeriodValue>
    <vor:TemporaryEquityStockConvertedDuringPeriodShares
      contextRef="C_3e5b0b1c-0786-4be6-85c8-c47c2f2afe86"
      decimals="INF"
      id="F_15c605f5-199f-46b6-ad8b-c0f5361e862d"
      unitRef="U_shares">107194866</vor:TemporaryEquityStockConvertedDuringPeriodShares>
    <vor:TemporaryEquityStockConvertedDuringPeriodValue
      contextRef="C_3e5b0b1c-0786-4be6-85c8-c47c2f2afe86"
      decimals="-3"
      id="F_b4d97897-02ac-4f9e-b71b-e88f4dc9a128"
      unitRef="U_USD">42786000</vor:TemporaryEquityStockConvertedDuringPeriodValue>
    <vor:TemporaryEquityStockConvertedDuringPeriodShares
      contextRef="C_ae930d22-cc83-471e-981d-8726a0b382a0"
      decimals="INF"
      id="F_480e140f-c5df-43ae-b5a6-2356e54a25d7"
      unitRef="U_shares">211778825</vor:TemporaryEquityStockConvertedDuringPeriodShares>
    <vor:TemporaryEquityStockConvertedDuringPeriodValue
      contextRef="C_ae930d22-cc83-471e-981d-8726a0b382a0"
      decimals="-3"
      id="F_f5fc2cb2-0d38-4694-aa5f-a8b74951af9c"
      unitRef="U_USD">109923000</vor:TemporaryEquityStockConvertedDuringPeriodValue>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_2e62aa11-22e8-433f-b264-9531559a3726"
      decimals="INF"
      id="F_7f5c419c-5104-4df7-b130-7837c1468d85"
      unitRef="U_shares">24924501</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_2e62aa11-22e8-433f-b264-9531559a3726"
      decimals="-3"
      id="F_82548228-374f-472b-a835-ccffdaed9b51"
      unitRef="U_USD">2000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_5fa63f3c-7a7e-49f4-b2a0-dffb9dcb0526"
      decimals="-3"
      id="F_66380e2d-eda7-4650-b745-c7fdaf88fb85"
      unitRef="U_USD">152709000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_622f5c2b-df67-4646-ae10-0bb47f4d6496"
      unitRef="U_USD">152711000</us-gaap:StockIssuedDuringPeriodValueConversionOfConvertibleSecurities>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_14369cac-a9d8-404d-b0e3-00a400693777"
      unitRef="U_USD">17132000</us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_2e62aa11-22e8-433f-b264-9531559a3726"
      decimals="INF"
      id="F_e53e18ea-972a-4629-b69d-f15c3963742a"
      unitRef="U_shares">11302219</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_2e62aa11-22e8-433f-b264-9531559a3726"
      decimals="-3"
      id="F_2da31e84-e9f6-4ca7-ac71-ec2584095d0d"
      unitRef="U_USD">1000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_5fa63f3c-7a7e-49f4-b2a0-dffb9dcb0526"
      decimals="-3"
      id="F_13f7826a-edd4-44d1-8b32-8908a0d00a15"
      unitRef="U_USD">186307000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_7883a4c6-2a47-40d6-9fc2-85a8c2727842"
      unitRef="U_USD">186308000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <vor:StockIssuedDuringPeriodSharesStockOptionsVestedAndExercised
      contextRef="C_2e62aa11-22e8-433f-b264-9531559a3726"
      decimals="0"
      id="F_9f4c9f26-3d69-47b1-860e-4c2cef7ab8ed"
      unitRef="U_shares">442947</vor:StockIssuedDuringPeriodSharesStockOptionsVestedAndExercised>
    <vor:StockIssuedDuringPeriodValueStockOptionsVestedAndExercised
      contextRef="C_5fa63f3c-7a7e-49f4-b2a0-dffb9dcb0526"
      decimals="-3"
      id="F_32daab80-f9b4-433e-b0cb-a6b47efaaa8f"
      unitRef="U_USD">894000</vor:StockIssuedDuringPeriodValueStockOptionsVestedAndExercised>
    <vor:StockIssuedDuringPeriodValueStockOptionsVestedAndExercised
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_1b41d6df-e2d0-4083-bf95-ab28ba58a132"
      unitRef="U_USD">894000</vor:StockIssuedDuringPeriodValueStockOptionsVestedAndExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_5fa63f3c-7a7e-49f4-b2a0-dffb9dcb0526"
      decimals="-3"
      id="F_13b73c4d-597d-498b-88cd-37ce389e8b79"
      unitRef="U_USD">4314000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_43ade168-2b31-4fe4-8eee-9fd08ed2f054"
      unitRef="U_USD">4314000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:NetIncomeLoss
      contextRef="C_e2969fd4-7d7c-435f-8e64-f416d48f96fe"
      decimals="-3"
      id="F_d1fab01d-90a1-43dc-910f-02b222134a1a"
      unitRef="U_USD">-68899000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_defdac80-56c5-4ad9-b4a9-fa405f6d58dd"
      unitRef="U_USD">-68899000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="C_f9decb30-9917-46ec-95f6-06ac473f5fb9"
      decimals="INF"
      id="F_4cffb4b5-550c-4bf1-941e-1c57e418a083"
      unitRef="U_shares">37174741</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="C_f9decb30-9917-46ec-95f6-06ac473f5fb9"
      decimals="-3"
      id="F_c05859e4-aa8b-49ab-9905-6aa187b96fe4"
      unitRef="U_USD">4000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_3c5cc129-6f72-442b-ba44-37460dc77415"
      decimals="-3"
      id="F_8468cef0-a96a-4ba8-94b5-58a9deaa17be"
      unitRef="U_USD">346382000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_fe5f0887-c938-4424-9f52-81c4c0ac9449"
      decimals="-3"
      id="F_eedeb50b-d909-4057-bd44-d631164664b5"
      unitRef="U_USD">-130123000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_6844cd3e-8a50-46ac-b482-e1ba81ec3aef"
      unitRef="U_USD">216263000</us-gaap:StockholdersEquity>
    <us-gaap:ProfitLoss
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_4f1ebaff-092d-442c-94c6-0874c3f96e71"
      unitRef="U_USD">-68899000</us-gaap:ProfitLoss>
    <us-gaap:ProfitLoss
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_a028dfd3-6e91-40c5-8053-ce11173fe6a5"
      unitRef="U_USD">-43337000</us-gaap:ProfitLoss>
    <us-gaap:Depreciation
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_e406f7be-d0cf-4916-9366-ec433bc620f0"
      unitRef="U_USD">1434000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_d56c28ff-6454-4bc8-9610-74de42eb5981"
      unitRef="U_USD">605000</us-gaap:Depreciation>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_9442a6d2-7997-4369-9111-eeb03e3621df"
      unitRef="U_USD">3017000</us-gaap:OperatingLeaseExpense>
    <us-gaap:OperatingLeaseExpense
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_f2ccbc99-316e-4435-94ab-6bc7411edf19"
      unitRef="U_USD">782000</us-gaap:OperatingLeaseExpense>
    <us-gaap:ShareBasedCompensation
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_1a29607c-ec6f-4136-9c18-7f5a28cc0180"
      unitRef="U_USD">4315000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_20022e9e-9b3c-4b95-aeca-1298aefe89f6"
      unitRef="U_USD">1342000</us-gaap:ShareBasedCompensation>
    <us-gaap:OtherOperatingActivitiesCashFlowStatement
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_f8f1a71d-d1f1-408e-9af0-6b49144b12f4"
      unitRef="U_USD">174000</us-gaap:OtherOperatingActivitiesCashFlowStatement>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_7c583631-bf8b-4489-b757-9c5eab44e9e3"
      unitRef="U_USD">-2559000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_ac1c3046-4427-40d7-89b1-a013d4a772f3"
      unitRef="U_USD">393000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_707fa695-6ff5-470e-8109-9237aa648215"
      unitRef="U_USD">6363000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_9810eb31-9ad2-4805-991c-1d56a18a459f"
      unitRef="U_USD">-606000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_918aa6af-3855-40c8-b87e-390da30c9af1"
      unitRef="U_USD">405000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_bfb8c25a-fb92-463c-bb30-30f236c3f0f3"
      unitRef="U_USD">5820000</us-gaap:IncreaseDecreaseInAccountsPayableAndAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_73e540be-c0f1-4440-ae5b-391b0dd541b7"
      unitRef="U_USD">668000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:IncreaseDecreaseInOtherOperatingAssets
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_971e9df6-67c8-4bce-90fb-18bbdc476a83"
      unitRef="U_USD">2503000</us-gaap:IncreaseDecreaseInOtherOperatingAssets>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_55c8b200-56e8-4bf6-8d07-a0cc894c3f0e"
      unitRef="U_USD">-69144000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_8b5e96a2-aba6-4cea-91f9-f4e5bc57db2f"
      unitRef="U_USD">-36292000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquireInvestments
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_3d9d84ea-e097-4535-8ab9-2b47f71100ad"
      unitRef="U_USD">87757000</us-gaap:PaymentsToAcquireInvestments>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_3457ec53-5fb8-4141-b5c4-c0617a253aff"
      unitRef="U_USD">3894000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_924c7f7b-9668-458f-8933-69535c9a65c4"
      unitRef="U_USD">4161000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_95feb9cd-3050-4cc8-9cbd-83725e85f078"
      unitRef="U_USD">-91651000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_de4b0672-8414-4ce2-8400-bebf8713e515"
      unitRef="U_USD">-4161000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_1287a97d-d68c-485e-af9c-6c5eb30a28f2"
      unitRef="U_USD">45375000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_e5baec31-7bce-461d-93d2-08c9ee0db6c0"
      unitRef="U_USD">82267000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_9d798a5e-d94e-4ee7-87c8-311acd7c5d48"
      unitRef="U_USD">189198000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_059a2ee7-97dd-4584-9da1-91edc0fe0865"
      unitRef="U_USD">2215000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_ba510218-a7ea-4aec-8b6a-cfd8755bea6b"
      unitRef="U_USD">553000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_894f1d68-36e8-4859-94f1-b901f697ad76"
      unitRef="U_USD">259000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_a32dbebd-d498-423f-906d-81694cf19f68"
      unitRef="U_USD">232911000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_51f3c234-cbc5-4912-b1d5-8b5baf944bf6"
      unitRef="U_USD">82526000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_1f7ffd23-8e79-471f-a87c-b93f3539b086"
      unitRef="U_USD">72116000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_dadd4af9-3202-4be7-90af-0e3c7d735f54"
      unitRef="U_USD">42073000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_d41885ab-60a3-49d9-8bc0-8d9ae2e4d13f"
      unitRef="U_USD">50098000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_09163903-47da-4862-9c71-2100cb0e3e52"
      decimals="-3"
      id="F_74e64d4d-6a22-455b-8304-fd9697c59557"
      unitRef="U_USD">8025000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_e573739c-c705-41f0-b17c-129b8778049b"
      unitRef="U_USD">122214000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_f75fa69e-59d3-4c76-89db-9ba6fcbad54d"
      unitRef="U_USD">50098000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <vor:OperatingRightOfUseAssetsAndOperatingLeaseLiabilityRecordedUponLeaseCommencement
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_aa2e8b83-99ab-430b-bfda-f69c07d22bed"
      unitRef="U_USD">35000</vor:OperatingRightOfUseAssetsAndOperatingLeaseLiabilityRecordedUponLeaseCommencement>
    <vor:OperatingRightOfUseAssetsAndOperatingLeaseLiabilityRecordedUponLeaseCommencement
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_26e512ae-f0b8-4bd7-a0a2-c310949400cb"
      unitRef="U_USD">17899000</vor:OperatingRightOfUseAssetsAndOperatingLeaseLiabilityRecordedUponLeaseCommencement>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_8d6a8200-8917-40ff-a5a1-45f1f192374a"
      unitRef="U_USD">194000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_10a4646b-6fec-4930-994f-43a03e6d6d1a"
      unitRef="U_USD">444000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <vor:ConversionOfRedeemableConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_f80af4c4-a1da-4a04-b04a-efcf0a94442c"
      unitRef="U_USD">152711000</vor:ConversionOfRedeemableConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering>
    <vor:DeferredOfferingCostsInAccountsPayableAndAccruedExpenses
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_2300926a-9fe1-4a24-a607-b83fe7cebbff"
      unitRef="U_USD">896000</vor:DeferredOfferingCostsInAccountsPayableAndAccruedExpenses>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_6a42bee5-4674-4857-8996-3e646b742c0a"
      unitRef="U_USD">119801000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_a86a3fea-d998-4236-bfb4-94e95c390eec"
      unitRef="U_USD">48539000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_11c19537-9576-4ca6-acb8-75f96eebee24"
      unitRef="U_USD">2413000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_3b0c4f34-49d9-4e3b-b597-fbd31b8a102b"
      unitRef="U_USD">1559000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_2e7f5bfe-cd0e-4a54-b249-512089219db1"
      unitRef="U_USD">122214000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_bb3339ee-06da-4511-b6d8-11588f46a00e"
      unitRef="U_USD">50098000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations>
    <us-gaap:NatureOfOperations
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_a411c917-012f-4677-8e83-dd956c8b02ba">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;1. Nature of the Business&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Vor Biopharma Inc. (the &#x201c;Company&#x201d;) is a clinical-stage cell and genome engineering company that combines a novel patient engineering approach with targeted therapies to provide a single company solution for patients suffering from hematological malignancies. The Company&#x2019;s proprietary platform leverages its expertise in hematopoietic stem cell (&#x201c;HSC&#x201d;) biology, genome engineering and targeted therapy development to genetically modify HSCs to remove surface targets expressed by cancer cells. The Company is headquartered in Cambridge, Massachusetts. The Company was incorporated on &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;December 30, 2015&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Initial Public Offering&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On February 9, 2021, the Company completed an initial public offering (&#x201c;IPO&#x201d;) of its common stock. At the closing of the IPO, the Company sold &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11,302,219&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of its common stock, at a public offering price of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;18.00&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; per share. The Company received net proceeds of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;186.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million from the IPO, after deducting underwriters&#x2019; discounts and commissions and other offering expenses paid by the Company.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Upon closing of the IPO, all shares of the Company&#x2019;s Series A-1, A-2 and B redeemable convertible preferred stock then outstanding automatically converted into an aggregate of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;24,924,501&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of common stock. Upon conversion of the redeemable convertible preferred stock, the Company reclassified the carrying value of the redeemable convertible preferred stock to common stock and additional paid-in capital.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In connection with the IPO, the Company filed an amended and restated certificate of incorporation that amended and restated the Company&#x2019;s certificate of incorporation in its entirety to, among other things, authorize the Company to issue up to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;400,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of common stock, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.0001&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; par value per share, and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of preferred stock, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.0001&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; par value per share, all of which shares of preferred stock are undesignated and the rights and preferences of such preferred stock may be established by the Company&#x2019;s board of directors from time to time.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Reverse Stock Split&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On January 29, 2021, the Company effected a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_1a6782bb-9d03-4a11-a8d9-b5a47122f2f7;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;13.6&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;-for-1 reverse stock split&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of the Company&#x2019;s common stock. All shares, stock options, and per share information in the consolidated financial statements were previously adjusted to reflect the reverse stock split. There was no change in the par value and authorized number of shares of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Risks and Uncertainties&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company is subject to a number of risks common to development stage companies in the biotechnology industry, including, but not limited to, risks of failure of preclinical studies and clinical trials, dependence on key personnel, protection of proprietary technology, reliance on third party organizations, risks of obtaining regulatory approval for any product candidate that it may develop, development by competitors of technological innovations, compliance with government regulations, the impact of the COVID-19 pandemic, including impacts related to the variants of the virus, and the need to obtain additional financing.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company anticipates that it will continue to incur significant operating losses for the next several years as it continues to develop its product candidates. The Company believes that its existing cash, cash equivalents and investments at December 31, 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; will be sufficient to allow the Company to fund its current operations through at least a period of one year after the date the financial statements are issued.&lt;/span&gt;&lt;/p&gt;</us-gaap:NatureOfOperations>
    <dei:EntityIncorporationDateOfIncorporation
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_d173f96b-69d5-4711-bc4f-d1462494d128">2015-12-30</dei:EntityIncorporationDateOfIncorporation>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="C_e403d7c0-1f35-43a7-8fc0-3a59a8d342cd"
      decimals="INF"
      id="F_f12d6739-562e-493b-a7c3-097c04dfb319"
      unitRef="U_shares">11302219</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:SaleOfStockPricePerShare
      contextRef="C_c2b57d58-2294-4b68-be37-2b25d3a08312"
      decimals="INF"
      id="F_85b016f6-7e69-4e08-a961-6c5d2546cba7"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">18.00</us-gaap:SaleOfStockPricePerShare>
    <us-gaap:ProceedsFromIssuanceInitialPublicOffering
      contextRef="C_522a671f-8013-49d5-9406-851e52363e90"
      decimals="-5"
      id="F_421fe42b-8bc2-4188-8b35-a009c67d7348"
      unitRef="U_USD">186300000</us-gaap:ProceedsFromIssuanceInitialPublicOffering>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_522a671f-8013-49d5-9406-851e52363e90"
      decimals="INF"
      id="F_aff01fdc-a77f-4f8c-af35-98ced7e00f75"
      unitRef="U_shares">24924501</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="INF"
      id="F_e6ed8303-29de-4d24-a1cf-74021f4c7d15"
      unitRef="U_shares">400000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="INF"
      id="F_efc4afe2-90ef-4986-93b2-92b4a5471e88"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="INF"
      id="F_10e64152-ace5-4576-ad07-d6e367979618"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="4"
      id="F_ee9ea95f-7762-4376-949d-fe88d8f19ccd"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:StockholdersEquityReverseStockSplit
      contextRef="C_2e62aa11-22e8-433f-b264-9531559a3726"
      id="F_cce73150-3d7a-404e-a148-566acb9ca65a">13.6-for-1 reverse stock split</us-gaap:StockholdersEquityReverseStockSplit>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_789f183a-29eb-47d3-ab82-8c4325bb1832">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;2. Summary of Significant Accounting Policies&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Basis of Presentation&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;). Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification ("ASC") or an Accounting Standards Update (&#x201c;ASU&#x201d;) issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The preparation of the consolidated financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amount of expenses during the reporting period. Actual results could differ from those estimates. Management considers many factors in selecting appropriate financial accounting policies in developing the estimates and assumptions that are used in the preparation of the consolidated financial statements. Management must apply significant judgment in this process. Management&#x2019;s estimation process often may yield a range of potentially reasonable estimates and management must select an amount that falls within that range of reasonable estimates. Estimates are used in the following areas, among others: estimating the fair value of the Company&#x2019;s common stock (prior to the IPO); accrued expenses and related research and development expenses.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Segments&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Operating segments are defined as components of an enterprise for which separate and discrete information is available for evaluation by the chief operating decision-maker in deciding how to allocate resources and assess performance. The Company has &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;one&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; operating segment. The Company&#x2019;s chief operating decision maker, its Chief Executive Officer, manages the Company&#x2019;s operations on an aggregate basis for the purpose of allocating resources.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Foreign Currency Transaction Gains or Losses&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Transactions denominated in foreign currencies are recorded in U.S. dollars on the date of those transactions. Adjustments arising from foreign currency transactions between the purchase and the settlement dates are reflected in the consolidated statement of operations and comprehensive loss as a component of other income.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company considers highly-liquid investments purchased with an original maturity date of ninety days or less from the date of purchase to be cash equivalents. Cash and cash equivalents include cash held in banks and amounts held in money market funds. Cash equivalents are stated at cost, which approximates market value.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Investments&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Investments represent excess cash balances held in marketable debt securities and are classified as available-for-sale. Investments with maturities beyond one year may be classified as short-term based on their highly liquid nature and because such securities represent an investment of cash that is available for current operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Available-for-sale investments are reported at fair value at each balance sheet date. Changes in the market value of available-for-sale investments, excluding other-than-temporary impairments, are reflected as other comprehensive income, a component of stockholders&#x2019; equity. Realized gains and losses are determined using the specific identification method and are included in other income in our consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Investments are evaluated for other-than-temporary impairment at the end of each reporting period. Impairment is evaluated considering numerous factors, and their relative significance varies depending on the situation. Factors considered include whether a decline in fair value below the amortized cost basis is due to credit-related factors or non-credit-related factors, the financial condition and near-term prospects of the issuer, and the Company's intent and ability to hold the investment to allow for an anticipated recovery in fair value. Once a decline in fair value is determined to be other-than-temporary, an impairment charge is recorded to other income (expense) and a new cost basis in the investment is established.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Deferred Offering Costs&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company capitalizes certain legal, professional, accounting and other third-party fees that are directly associated with in-process equity issuances as deferred offering costs until such equity issuances are consummated. After consummation of the equity issuance, these costs are recorded as a reduction in the capitalized amount associated with the equity issuance. During the year ended December 31, 2020, the Company incurred $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million in deferred offering costs that are included in other assets on the consolidated balance sheet.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Restricted Cash&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company had &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of restricted cash in the form of a letter of credit related to a lease at December 31, 2021 and 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Comprehensive loss&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Comprehensive loss includes net loss, as well as other changes in stockholders&#x2019; equity (deficit) that result from transactions and economic events other than those with stockholders. The Company&#x2019;s comprehensive loss was equal to net loss for the years ended December 31, 2021 and 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; .&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Preferred Stock&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company applies the guidance enumerated in FASB ASC Topic 480, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Distinguishing Liabilities from Equity&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (&#x201c;ASC 480&#x201d;), when determining the classification and measurement of its preferred stock. Preferred stock subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. The Company classifies conditionally redeemable preferred stock (if any), which includes preferred stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s control, as temporary equity.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash equivalents and investments. The Company maintains deposits in accredited financial institutions in excess of federally insured limits. The Company deposits its cash in financial institutions that it believes have high credit quality and has not experienced any losses on such accounts and does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company&#x2019;s investments consist of money market funds and marketable debt securities, including corporate bonds and U.S. Treasury securities. The Company&#x2019;s investments may include commercial paper and other debt securities of U.S. government agencies, corporate entities, and banks. The Company&#x2019;s investment policy limits instruments to investment grade securities with high credit quality issuers with the objective to preserve capital and to maintain liquidity until the funds can be used in business operations.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 1&#x2014;Quoted prices in active markets for identical assets or liabilities. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 2&#x2014;Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 3&#x2014;Unobservable inputs that are supported by little or no market activity that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument&#x2019;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Financial instruments consist of cash and cash equivalents, restricted cash, accounts payable and accrued expenses. These financial instruments are stated at their respective historical carrying values which approximate fair value due to their short-term nature.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Property and Equipment, Net&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Property and equipment, net is recorded at cost less accumulated depreciation. Depreciation expense is recorded using the straight-line method over the estimated useful life of the related asset, which are as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:50.0%;"/&gt;
          &lt;td style="width:50.0%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Estimated Useful Life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Furniture and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Laboratory equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Shorter of remaining lease term or useful life&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Purchased assets that are not yet in service are recorded to construction-in-process and no depreciation expense is recorded. Once they are placed in service, they are reclassified to the appropriate asset class. When assets are retired or otherwise disposed of, the assets and related accumulated depreciation are eliminated from the accounts and any resulting gain or loss is reflected in the Company&#x2019;s consolidated statements of operation and comprehensive loss. Expenditures for maintenance and repairs are expensed as incurred.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Long-lived assets consist of property and equipment. The Company continually evaluates whether events or circumstances have occurred that indicate that the estimated remaining useful life of its long-lived assets may warrant revision or that the carrying value of these assets may not be recoverable. If circumstances require that a long-lived asset or asset group be tested for impairment, the Company first compares the estimated undiscounted future cash flows expected to result from the use or disposition of that asset or asset group to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment loss would be recognized to the extent the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market prices and third-party independent appraisals, as considered necessary.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Leases&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease. Leases with a term greater than one year are recognized on the consolidated balance sheet as a right-of-use (&#x201c;ROU&#x201d;) asset and current and non-current lease liabilities, as applicable. The Company has made an accounting policy election, known as the short-term lease recognition exemption, which allows the Company to not recognize ROU assets and lease liabilities that arise from short-term leases (12 months or less); The Company has applied this election to all classes of underlying assets. The Company typically only includes an initial lease term in its assessment of a lease arrangement. Options to renew or options to cancel a lease are not included in the Company&#x2019;s assessment unless there is reasonable certainty that the Company will renew or will not cancel, respectively. The Company monitors its material leases on a quarterly basis.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Operating lease liabilities and their corresponding ROU assets are recorded based on the present value of future lease payments over the expected remaining lease term. Lease cost for operating leases is recognized on a straight-line basis over the lease term as an operating expense. Certain adjustments to the ROU asset may be required for items such as lease prepayments or incentives received. The interest rate implicit in lease contracts is typically not readily determinable. As a result, the Company utilizes its incremental borrowing rate, which reflects the fixed rate at which the Company could borrow on a collateralized basis the amount of the lease payments in the same currency, for a similar term, in a similar economic environment.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has elected to account for the lease and non-lease components together for office, laboratory, and manufacturing real estate leases.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Research and Development&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Research and development expenses include costs directly attributable to the conduct of the Company&#x2019;s research and development programs.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expenditures relating to research and development are expensed in the period incurred. Nonrefundable advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made. The cost of materials for a research and development activity that have an alternative future use is capitalized when the materials are acquired and recognized as expense as consumed. The costs of materials that were acquired for a particular research and development activity and have no alternative future use are expensed in the period acquired.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Costs incurred in obtaining licenses are recognized as research and development expense as incurred if the license has no alternative use.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Accrued Research and Development Expenses&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has entered into various research and development related contracts, including contracts with third-party contract research organizations and contract manufacturing organizations. These agreements are cancelable, and related payments are recognized as research and development expenses as incurred. The Company records accrued liabilities for estimated ongoing research costs. When evaluating the adequacy of the accrued liabilities, the Company analyzes the progress of the studies, including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the accrued balances at the end of any reporting period. Actual results could differ from the Company&#x2019;s estimates. To date, the Company&#x2019;s historical accrual estimates have not been materially different from the actual costs.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Stock-Based Compensation Expense&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company accounts for stock-based compensation under the provisions of ASC 718-10,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; Compensation&#x2014;Stock Compensation&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (&#x201c;ASC 718-10&#x201d;), which requires all share-based payments to employees, non-employees and directors, including grants of stock options and restricted stock, to be recognized in the consolidated statements of operations and comprehensive loss based on their fair values on the date of grant over the requisite service period, which is generally the vesting period of the respective award. Forfeitures are accounted for as they occur. Generally, the Company issues awards with only service-based vesting conditions and records the expense for these awards using the ratable method. The Company classifies stock-based compensation expense in the same manner in which the award recipient&#x2019;s payroll or service provider&#x2019;s costs are classified. Share-based payments that contain performance conditions are recognized when such conditions are probable of being achieved.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The fair value of each restricted common stock award is estimated on the date of grant based on the fair value of the Company&#x2019;s common stock on that same date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model, which requires inputs based on certain subjective assumptions, including the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Fair Value of Common Stock&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;See the discussion below. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Expected Term&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;The expected term represents the period that the stock-based awards are expected to be outstanding. The Company uses the simplified method to determine the expected term, which is based on the average of the time-to-vesting and the contractual life of the options. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Expected Volatility&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;Because the Company does not have sufficient trading history for its common stock as of December 31, 2021 , the expected volatility was estimated based on the average volatility for comparable publicly traded biotechnology companies over a period equal to the expected term of the stock option grants. The comparable companies were chosen based on the similar size, stage in life cycle or area of specialty. The Company will continue to apply this process until a sufficient amount of historical information regarding the volatility of its own stock price becomes available. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Risk-Free Interest Rate&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;The risk-free interest rate is based on the U.S. Treasury zero coupon issues in effect at the time of grant for periods corresponding with the expected term of the awards. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Dividend Yield&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;The Company has never paid dividends on its common stock and has no plans to pay dividends on its common stock. Therefore, the Company used an expected dividend yield of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;zero&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company began to use the closing common stock price as reported on the Nasdaq Global Select Market exchange as the fair value of common stock on the date of a grant subsequent to its IPO. Prior to the Company's IPO the estimated fair value of common stock was determined by the Company&#x2019;s board of directors as of the date of each&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;option grant, with input from management, considering third-party valuations of its common stock as well as the Company&#x2019;s board of directors&#x2019; assessment of additional objective and subjective factors that it believed were relevant and which may have changed from the date of the most recent third-party valuation through the date of the grant. These objective and subjective factors include: (i) prices paid for the Company&#x2019;s redeemable convertible preferred stock, and the rights, preferences, and privileges of the Company&#x2019;s redeemable convertible preferred stock and common stock; (ii) the Company&#x2019;s stage of development; (iii) the fact that the grants of stock-based awards related to illiquid securities in a private company; and (iv) the likelihood of achieving a liquidity event for the common stock underlying the stock-based awards, such as an initial public offering or sale of the Company, given prevailing market conditions. These third-party valuations were performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants&#x2019; Accounting and Valuation Guide, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Valuation of Privately Held Company Equity Securities Issued as Compensation&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. Each valuation methodology includes estimates and assumptions that require the Company&#x2019;s judgment. The methodology utilized to estimate the fair value of the Company&#x2019;s common stock was the option-pricing method (&#x201c;OPM&#x201d;) to back-solve the estimated value of the Company&#x2019;s equity and corresponding value of the Company&#x2019;s common stock.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company accounts for income taxes using the asset and liability approach. Deferred tax assets and liabilities represent future tax consequences of temporary differences between the financial statement carrying amounts and the tax basis of assets and liabilities and for loss carryforwards using enacted tax rates expected to be in effect in the years in which the differences reverse. A valuation allowance is established to reduce deferred tax assets to the amounts expected to be realized. The Company also recognizes a tax benefit from uncertain tax positions only if it is &#x201c;more likely than not&#x201d; that the position is sustainable based on its technical merits. The Company accounts for interest or penalties related to uncertain tax positions as part of its provision for income taxes. To date, the Company has &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;t incurred interest and penalties related to uncertain tax positions. Should such costs be incurred, they would be classified as a component of provision for income taxes.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Net Loss Per Share&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net loss attributable to common stockholders is equal to the net loss for the period, as adjusted for cumulative dividends on redeemable convertible preferred stock, for the respective period.&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the reporting period, without consideration for potentially dilutive securities. Diluted net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares and potentially dilutive securities outstanding during the period determined using the treasury-stock and if-converted methods. For purposes of the diluted net loss per share attributable to common stockholders calculation, redeemable convertible preferred stock, restricted stock and stock options considered to be potentially dilutive securities were excluded from the calculation of diluted net loss per share attributable to common stockholders because their effect would be anti-dilutive and therefore, basic and diluted net loss per share attributable to common stockholders were the same for all reporting periods presented.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;From time to time, new accounting pronouncements are issued and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#x2019;s consolidated financial statements upon adoption. Under the Jumpstart Our Business Startups Act of 2012, as amended (the &#x201c;JOBS Act&#x201d;), the Company meets the definition of an emerging growth company and has elected to take advantage of the extended transition period for complying with certain new or revised accounting standards pursuant to Section 107(b) of the JOBS Act. As noted below, certain new or revised accounting standards were early adopted.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In 2019, the FASB issued &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_9fe2e284-3d35-4fe3-b478-3dcd0820f887;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;ASU No. 2019-12&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Income Taxes (Topic 740)&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;: &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Simplifying the Accounting for Income Taxes (&#x201c;ASU 2019-12&#x201d;), which introduces a number of amendments that are designed to simplify the application of accounting for income taxes. Such amendments include removing certain exceptions for intraperiod tax allocation, interim reporting when a year-to-date loss exceeds the anticipated loss, reflecting the effect of an enacted change in tax laws or rates in the annual effective tax rate and recognition of deferred taxes related to&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;outside &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;basis differences for ownership changes in investments. ASU 2019-12 also provides clarification related to when a step up in the tax basis of goodwill should be considered part of the business combination in which the book goodwill was originally recognized and when it should be considered a separate transaction. In addition, ASU 2019-12 provides guidance on the recognition of a franchise tax (or similar tax) that is partially based on income as an income-based tax and accounting for any incremental amount incurred as a non-income-based tax. The Company &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;adopted &lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; ASU 2019-12 effective &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;January 1, 2021&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, and the adoption did &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;t have a material impact on its consolidated financial statements.&lt;/span&gt;&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In June 2016, the FASB issued ASU 2016-13, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; which has been subsequently amended by ASU 2018-19, ASU 2019-04, ASU 2019-05, ASU 2019-10, ASU 2019-11 and ASU 2020-03 (&#x201c;ASU 2016-13&#x201d;). This standard significantly changes the impairment model for most financial assets and certain other instruments and will require immediate recognition of estimated credit losses expected to occur over the remaining life of many financial assets, which will generally result in earlier recognition of allowances for credit losses on loans and other financial instruments. The Company does not expect that this standard will have a material impact to the Company&#x2019;s consolidated financial statements and plans to adopt this standard on January 1, 2022.&lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_02d5eae1-9beb-439c-a6f8-5acf7675048e">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Basis of Presentation&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The accompanying consolidated financial statements have been prepared in conformity with accounting principles generally accepted in the United States of America (&#x201c;GAAP&#x201d;). Any reference in these notes to applicable guidance is meant to refer to the authoritative GAAP as found in the Accounting Standards Codification ("ASC") or an Accounting Standards Update (&#x201c;ASU&#x201d;) issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;).&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_8d341bac-508f-4ca5-a299-d5d1b96b06aa">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Use of Estimates&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The preparation of the consolidated financial statements in conformity with GAAP requires the Company&#x2019;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the consolidated financial statements and the reported amount of expenses during the reporting period. Actual results could differ from those estimates. Management considers many factors in selecting appropriate financial accounting policies in developing the estimates and assumptions that are used in the preparation of the consolidated financial statements. Management must apply significant judgment in this process. Management&#x2019;s estimation process often may yield a range of potentially reasonable estimates and management must select an amount that falls within that range of reasonable estimates. Estimates are used in the following areas, among others: estimating the fair value of the Company&#x2019;s common stock (prior to the IPO); accrued expenses and related research and development expenses.&lt;/span&gt;&lt;/p&gt;</us-gaap:UseOfEstimates>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_e2a0ddae-9c1d-4e9d-9375-27c2afd927ac">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Segments&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Operating segments are defined as components of an enterprise for which separate and discrete information is available for evaluation by the chief operating decision-maker in deciding how to allocate resources and assess performance. The Company has &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;one&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; operating segment. The Company&#x2019;s chief operating decision maker, its Chief Executive Officer, manages the Company&#x2019;s operations on an aggregate basis for the purpose of allocating resources.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NumberOfOperatingSegments
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="INF"
      id="F_57411cbc-b28b-44be-bfc8-e7315a44d458"
      unitRef="U_Segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_333b78e7-73ef-4983-bc41-0079288324ce">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Foreign Currency Transaction Gains or Losses&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Transactions denominated in foreign currencies are recorded in U.S. dollars on the date of those transactions. Adjustments arising from foreign currency transactions between the purchase and the settlement dates are reflected in the consolidated statement of operations and comprehensive loss as a component of other income.&lt;/span&gt;&lt;/p&gt;</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:CashAndCashEquivalentsPolicyTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_d909251c-ef10-4abc-a2df-4ac01c350eca">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Cash and Cash Equivalents&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company considers highly-liquid investments purchased with an original maturity date of ninety days or less from the date of purchase to be cash equivalents. Cash and cash equivalents include cash held in banks and amounts held in money market funds. Cash equivalents are stated at cost, which approximates market value.&lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsPolicyTextBlock>
    <us-gaap:InvestmentPolicyTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_2be55f93-1620-4b95-ac66-e65d66c571ac">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Investments&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Investments represent excess cash balances held in marketable debt securities and are classified as available-for-sale. Investments with maturities beyond one year may be classified as short-term based on their highly liquid nature and because such securities represent an investment of cash that is available for current operations.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Available-for-sale investments are reported at fair value at each balance sheet date. Changes in the market value of available-for-sale investments, excluding other-than-temporary impairments, are reflected as other comprehensive income, a component of stockholders&#x2019; equity. Realized gains and losses are determined using the specific identification method and are included in other income in our consolidated statements of operations and comprehensive loss.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Investments are evaluated for other-than-temporary impairment at the end of each reporting period. Impairment is evaluated considering numerous factors, and their relative significance varies depending on the situation. Factors considered include whether a decline in fair value below the amortized cost basis is due to credit-related factors or non-credit-related factors, the financial condition and near-term prospects of the issuer, and the Company's intent and ability to hold the investment to allow for an anticipated recovery in fair value. Once a decline in fair value is determined to be other-than-temporary, an impairment charge is recorded to other income (expense) and a new cost basis in the investment is established.&lt;/span&gt;&lt;/p&gt;</us-gaap:InvestmentPolicyTextBlock>
    <us-gaap:DeferredChargesPolicyTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_9c5a383f-2b12-451d-a581-921346d13752">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Deferred Offering Costs&lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company capitalizes certain legal, professional, accounting and other third-party fees that are directly associated with in-process equity issuances as deferred offering costs until such equity issuances are consummated. After consummation of the equity issuance, these costs are recorded as a reduction in the capitalized amount associated with the equity issuance. During the year ended December 31, 2020, the Company incurred $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million in deferred offering costs that are included in other assets on the consolidated balance sheet.&lt;/span&gt;</us-gaap:DeferredChargesPolicyTextBlock>
    <us-gaap:DeferredOfferingCosts
      contextRef="C_108d57ff-006a-4611-a4b0-e4181430ef77"
      decimals="-5"
      id="F_f9321ed8-4dcf-4366-bd00-45f61d375d56"
      unitRef="U_USD">1600000</us-gaap:DeferredOfferingCosts>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_d3a7b631-81b2-4805-b6b3-f6b23feed432">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Restricted Cash&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company had &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; of restricted cash in the form of a letter of credit related to a lease at December 31, 2021 and 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-5"
      id="F_20e36763-b599-4baa-b76e-9a5aa2ffe0ff"
      unitRef="U_USD">2400000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:RestrictedCashEquivalentsNoncurrent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-5"
      id="F_500efcfa-47cc-49e6-87a8-55d3b97354a1"
      unitRef="U_USD">1600000</us-gaap:RestrictedCashEquivalentsNoncurrent>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_587ad30b-0f8a-4725-b50a-7c67210c467a">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Comprehensive loss&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Comprehensive loss includes net loss, as well as other changes in stockholders&#x2019; equity (deficit) that result from transactions and economic events other than those with stockholders. The Company&#x2019;s comprehensive loss was equal to net loss for the years ended December 31, 2021 and 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; .&lt;/span&gt;&lt;/p&gt;</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:StockholdersEquityNoteRedeemablePreferredStockIssuePolicy
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_0fe60f06-a048-4d6e-af16-ca64e0090ca9">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Preferred Stock&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company applies the guidance enumerated in FASB ASC Topic 480, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Distinguishing Liabilities from Equity&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (&#x201c;ASC 480&#x201d;), when determining the classification and measurement of its preferred stock. Preferred stock subject to mandatory redemption (if any) are classified as liability instruments and are measured at fair value. The Company classifies conditionally redeemable preferred stock (if any), which includes preferred stock that features redemption rights that are either within the control of the holder or subject to redemption upon the occurrence of uncertain events not solely within the Company&#x2019;s control, as temporary equity.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteRedeemablePreferredStockIssuePolicy>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_707213a3-55c0-4f3c-967a-53d6cb22b7d6">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Concentrations of Credit Risk&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Financial instruments that potentially expose the Company to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash equivalents and investments. The Company maintains deposits in accredited financial institutions in excess of federally insured limits. The Company deposits its cash in financial institutions that it believes have high credit quality and has not experienced any losses on such accounts and does not believe it is exposed to any unusual credit risk beyond the normal credit risk associated with commercial banking relationships.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company&#x2019;s investments consist of money market funds and marketable debt securities, including corporate bonds and U.S. Treasury securities. The Company&#x2019;s investments may include commercial paper and other debt securities of U.S. government agencies, corporate entities, and banks. The Company&#x2019;s investment policy limits instruments to investment grade securities with high credit quality issuers with the objective to preserve capital and to maintain liquidity until the funds can be used in business operations.&lt;/span&gt;&lt;/p&gt;</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:FairValueMeasurementPolicyPolicyTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_a9447132-da85-4b39-9dfb-19b6217fba81">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Fair Value Measurements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Certain assets and liabilities are carried at fair value under GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize the use of observable inputs and minimize the use of unobservable inputs. Financial assets and liabilities carried at fair value are to be classified and disclosed in one of the following three levels of the fair value hierarchy, of which the first two are considered observable and the last is considered unobservable:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 1&#x2014;Quoted prices in active markets for identical assets or liabilities. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 2&#x2014;Observable inputs (other than Level 1 quoted prices), such as quoted prices in active markets for similar assets or liabilities, quoted prices in markets that are not active for identical or similar assets or liabilities, or other inputs that are observable or can be corroborated by observable market data. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:5.602%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.403652619758893%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Level 3&#x2014;Unobservable inputs that are supported by little or no market activity that are significant to determining the fair value of the assets or liabilities, including pricing models, discounted cash flow methodologies and similar techniques. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;To the extent that the valuation is based on models or inputs that are less observable or unobservable in the market, the determination of fair value requires more judgment. Accordingly, the degree of judgment exercised by the Company in determining fair value is greatest for instruments categorized in Level 3. A financial instrument&#x2019;s level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair value measurement.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Financial instruments consist of cash and cash equivalents, restricted cash, accounts payable and accrued expenses. These financial instruments are stated at their respective historical carrying values which approximate fair value due to their short-term nature.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueMeasurementPolicyPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_7e49b05e-6de7-4694-b4b5-f363f0c56ab3">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Property and Equipment, Net&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Property and equipment, net is recorded at cost less accumulated depreciation. Depreciation expense is recorded using the straight-line method over the estimated useful life of the related asset, which are as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:50.0%;"/&gt;
          &lt;td style="width:50.0%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Estimated Useful Life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Furniture and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Laboratory equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Shorter of remaining lease term or useful life&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;&lt;/div&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Purchased assets that are not yet in service are recorded to construction-in-process and no depreciation expense is recorded. Once they are placed in service, they are reclassified to the appropriate asset class. When assets are retired or otherwise disposed of, the assets and related accumulated depreciation are eliminated from the accounts and any resulting gain or loss is reflected in the Company&#x2019;s consolidated statements of operation and comprehensive loss. Expenditures for maintenance and repairs are expensed as incurred.&lt;/span&gt;</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <vor:PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_ddcfb97c-9eb3-4df7-8da2-a5be443eb2c0">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Property and equipment, net is recorded at cost less accumulated depreciation. Depreciation expense is recorded using the straight-line method over the estimated useful life of the related asset, which are as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
        &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
         &lt;tr style="visibility:collapse;"&gt;
          &lt;td style="width:50.0%;"/&gt;
          &lt;td style="width:50.0%;"/&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Estimated Useful Life&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Furniture and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Laboratory equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5 years&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
         &lt;tr style="height:10.0pt;"&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
          &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Shorter of remaining lease term or useful life&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
         &lt;/tr&gt;
        &lt;/table&gt;</vor:PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_8cfcd4c1-10fe-467a-9e2b-cc68414f8f0e"
      id="F_c004a3ef-7c82-43ec-9658-1e37deaa5400">P3Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_2c77f565-f009-499e-a1b1-aa2bbba1d540"
      id="F_691a1901-7de2-4213-b049-f720ff13895c">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="C_22f4bcb0-6708-4711-89d9-4dd150fabf2e"
      id="F_4d5d2862-8a3d-4465-a273-c4dd824bf387">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives
      contextRef="C_e3549357-9b6b-45e4-b9a8-1215efcfd4cf"
      id="F_c010d363-2839-4c5f-bf44-cc7409c21622">Shorter of remaining lease term or useful life</us-gaap:PropertyPlantAndEquipmentEstimatedUsefulLives>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_93a53827-b665-4b26-b15a-180e92d9cae6">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Impairment of Long-Lived Assets&lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Long-lived assets consist of property and equipment. The Company continually evaluates whether events or circumstances have occurred that indicate that the estimated remaining useful life of its long-lived assets may warrant revision or that the carrying value of these assets may not be recoverable. If circumstances require that a long-lived asset or asset group be tested for impairment, the Company first compares the estimated undiscounted future cash flows expected to result from the use or disposition of that asset or asset group to its carrying amount. If the carrying amount of the long-lived asset or asset group is not recoverable on an undiscounted cash flow basis, an impairment loss would be recognized to the extent the carrying value exceeds its fair value. Fair value is determined through various valuation techniques including discounted cash flow models, quoted market prices and third-party independent appraisals, as considered necessary.&lt;/span&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_e1d72b51-4380-48c9-9514-3be0e840f0f3">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Leases&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;At the inception of an arrangement, the Company determines whether the arrangement is or contains a lease. Leases with a term greater than one year are recognized on the consolidated balance sheet as a right-of-use (&#x201c;ROU&#x201d;) asset and current and non-current lease liabilities, as applicable. The Company has made an accounting policy election, known as the short-term lease recognition exemption, which allows the Company to not recognize ROU assets and lease liabilities that arise from short-term leases (12 months or less); The Company has applied this election to all classes of underlying assets. The Company typically only includes an initial lease term in its assessment of a lease arrangement. Options to renew or options to cancel a lease are not included in the Company&#x2019;s assessment unless there is reasonable certainty that the Company will renew or will not cancel, respectively. The Company monitors its material leases on a quarterly basis.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Operating lease liabilities and their corresponding ROU assets are recorded based on the present value of future lease payments over the expected remaining lease term. Lease cost for operating leases is recognized on a straight-line basis over the lease term as an operating expense. Certain adjustments to the ROU asset may be required for items such as lease prepayments or incentives received. The interest rate implicit in lease contracts is typically not readily determinable. As a result, the Company utilizes its incremental borrowing rate, which reflects the fixed rate at which the Company could borrow on a collateralized basis the amount of the lease payments in the same currency, for a similar term, in a similar economic environment.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has elected to account for the lease and non-lease components together for office, laboratory, and manufacturing real estate leases.&lt;/span&gt;&lt;/p&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_aeb77815-21a4-4158-acd8-484dddd8fadd">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Research and Development&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Research and development expenses include costs directly attributable to the conduct of the Company&#x2019;s research and development programs.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expenditures relating to research and development are expensed in the period incurred. Nonrefundable advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made. The cost of materials for a research and development activity that have an alternative future use is capitalized when the materials are acquired and recognized as expense as consumed. The costs of materials that were acquired for a particular research and development activity and have no alternative future use are expensed in the period acquired.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Costs incurred in obtaining licenses are recognized as research and development expense as incurred if the license has no alternative use.&lt;/span&gt;</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <vor:AccruedResearchAndDevelopmentExpensesPolicyPolicyTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_fcfbf5ab-e668-44c1-9e25-1d248c635a8d">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Accrued Research and Development Expenses&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has entered into various research and development related contracts, including contracts with third-party contract research organizations and contract manufacturing organizations. These agreements are cancelable, and related payments are recognized as research and development expenses as incurred. The Company records accrued liabilities for estimated ongoing research costs. When evaluating the adequacy of the accrued liabilities, the Company analyzes the progress of the studies, including the phase or completion of events, invoices received and contracted costs. Significant judgments and estimates are made in determining the accrued balances at the end of any reporting period. Actual results could differ from the Company&#x2019;s estimates. To date, the Company&#x2019;s historical accrual estimates have not been materially different from the actual costs.&lt;/span&gt;</vor:AccruedResearchAndDevelopmentExpensesPolicyPolicyTextBlock>
    <us-gaap:CompensationRelatedCostsPolicyTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_9562e2b2-6da7-4dbe-9d55-c49e05ac49aa">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Stock-Based Compensation Expense&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company accounts for stock-based compensation under the provisions of ASC 718-10,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; Compensation&#x2014;Stock Compensation&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (&#x201c;ASC 718-10&#x201d;), which requires all share-based payments to employees, non-employees and directors, including grants of stock options and restricted stock, to be recognized in the consolidated statements of operations and comprehensive loss based on their fair values on the date of grant over the requisite service period, which is generally the vesting period of the respective award. Forfeitures are accounted for as they occur. Generally, the Company issues awards with only service-based vesting conditions and records the expense for these awards using the ratable method. The Company classifies stock-based compensation expense in the same manner in which the award recipient&#x2019;s payroll or service provider&#x2019;s costs are classified. Share-based payments that contain performance conditions are recognized when such conditions are probable of being achieved.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The fair value of each restricted common stock award is estimated on the date of grant based on the fair value of the Company&#x2019;s common stock on that same date.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The fair value of each option grant is estimated on the date of grant using the Black-Scholes option pricing model, which requires inputs based on certain subjective assumptions, including the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="margin-left:5.667%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.4053088526814586%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Fair Value of Common Stock&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;See the discussion below. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Expected Term&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;The expected term represents the period that the stock-based awards are expected to be outstanding. The Company uses the simplified method to determine the expected term, which is based on the average of the time-to-vesting and the contractual life of the options. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Expected Volatility&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;Because the Company does not have sufficient trading history for its common stock as of December 31, 2021 , the expected volatility was estimated based on the average volatility for comparable publicly traded biotechnology companies over a period equal to the expected term of the stock option grants. The comparable companies were chosen based on the similar size, stage in life cycle or area of specialty. The Company will continue to apply this process until a sufficient amount of historical information regarding the volatility of its own stock price becomes available. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Risk-Free Interest Rate&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;The risk-free interest rate is based on the U.S. Treasury zero coupon issues in effect at the time of grant for periods corresponding with the expected term of the awards. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;div style="margin-left:5.731%;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:6.0pt;min-width:2.269%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;display:inline-flex;font-size:10.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:2.406941836658923%;"&gt;&#x2022;&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Dividend Yield&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;The Company has never paid dividends on its common stock and has no plans to pay dividends on its common stock. Therefore, the Company used an expected dividend yield of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;zero&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company began to use the closing common stock price as reported on the Nasdaq Global Select Market exchange as the fair value of common stock on the date of a grant subsequent to its IPO. Prior to the Company's IPO the estimated fair value of common stock was determined by the Company&#x2019;s board of directors as of the date of each&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;option grant, with input from management, considering third-party valuations of its common stock as well as the Company&#x2019;s board of directors&#x2019; assessment of additional objective and subjective factors that it believed were relevant and which may have changed from the date of the most recent third-party valuation through the date of the grant. These objective and subjective factors include: (i) prices paid for the Company&#x2019;s redeemable convertible preferred stock, and the rights, preferences, and privileges of the Company&#x2019;s redeemable convertible preferred stock and common stock; (ii) the Company&#x2019;s stage of development; (iii) the fact that the grants of stock-based awards related to illiquid securities in a private company; and (iv) the likelihood of achieving a liquidity event for the common stock underlying the stock-based awards, such as an initial public offering or sale of the Company, given prevailing market conditions. These third-party valuations were performed in accordance with the guidance outlined in the American Institute of Certified Public Accountants&#x2019; Accounting and Valuation Guide, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Valuation of Privately Held Company Equity Securities Issued as Compensation&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. Each valuation methodology includes estimates and assumptions that require the Company&#x2019;s judgment. The methodology utilized to estimate the fair value of the Company&#x2019;s common stock was the option-pricing method (&#x201c;OPM&#x201d;) to back-solve the estimated value of the Company&#x2019;s equity and corresponding value of the Company&#x2019;s common stock.&lt;/span&gt;</us-gaap:CompensationRelatedCostsPolicyTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="2"
      id="F_07651309-b4bb-480f-90b5-9fab50f340b5"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_097b9d5e-428b-476f-bf6d-c6a0386935be">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Income Taxes&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company accounts for income taxes using the asset and liability approach. Deferred tax assets and liabilities represent future tax consequences of temporary differences between the financial statement carrying amounts and the tax basis of assets and liabilities and for loss carryforwards using enacted tax rates expected to be in effect in the years in which the differences reverse. A valuation allowance is established to reduce deferred tax assets to the amounts expected to be realized. The Company also recognizes a tax benefit from uncertain tax positions only if it is &#x201c;more likely than not&#x201d; that the position is sustainable based on its technical merits. The Company accounts for interest or penalties related to uncertain tax positions as part of its provision for income taxes. To date, the Company has &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;t incurred interest and penalties related to uncertain tax positions. Should such costs be incurred, they would be classified as a component of provision for income taxes.&lt;/span&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="INF"
      id="F_c103a1a9-4437-4ffc-98a1-535ac994f5f1"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_02c8fcc0-fb22-444e-a0f9-5b4135087b42">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Net Loss Per Share&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net loss attributable to common stockholders is equal to the net loss for the period, as adjusted for cumulative dividends on redeemable convertible preferred stock, for the respective period.&lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Basic net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares outstanding during the reporting period, without consideration for potentially dilutive securities. Diluted net loss per share attributable to common stockholders is computed by dividing the net loss attributable to common stockholders by the weighted-average number of common shares and potentially dilutive securities outstanding during the period determined using the treasury-stock and if-converted methods. For purposes of the diluted net loss per share attributable to common stockholders calculation, redeemable convertible preferred stock, restricted stock and stock options considered to be potentially dilutive securities were excluded from the calculation of diluted net loss per share attributable to common stockholders because their effect would be anti-dilutive and therefore, basic and diluted net loss per share attributable to common stockholders were the same for all reporting periods presented.&lt;/span&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_0321c355-3e44-47dc-baac-9d700e9f49e3">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Recent Accounting Pronouncements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;From time to time, new accounting pronouncements are issued and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#x2019;s consolidated financial statements upon adoption. Under the Jumpstart Our Business Startups Act of 2012, as amended (the &#x201c;JOBS Act&#x201d;), the Company meets the definition of an emerging growth company and has elected to take advantage of the extended transition period for complying with certain new or revised accounting standards pursuant to Section 107(b) of the JOBS Act. As noted below, certain new or revised accounting standards were early adopted.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Recently Adopted Accounting Pronouncements&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In 2019, the FASB issued &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="-sec-ix-hidden:F_9fe2e284-3d35-4fe3-b478-3dcd0820f887;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;ASU No. 2019-12&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Income Taxes (Topic 740)&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;: &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Simplifying the Accounting for Income Taxes (&#x201c;ASU 2019-12&#x201d;), which introduces a number of amendments that are designed to simplify the application of accounting for income taxes. Such amendments include removing certain exceptions for intraperiod tax allocation, interim reporting when a year-to-date loss exceeds the anticipated loss, reflecting the effect of an enacted change in tax laws or rates in the annual effective tax rate and recognition of deferred taxes related to&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;outside &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;basis differences for ownership changes in investments. ASU 2019-12 also provides clarification related to when a step up in the tax basis of goodwill should be considered part of the business combination in which the book goodwill was originally recognized and when it should be considered a separate transaction. In addition, ASU 2019-12 provides guidance on the recognition of a franchise tax (or similar tax) that is partially based on income as an income-based tax and accounting for any incremental amount incurred as a non-income-based tax. The Company &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;adopted &lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; ASU 2019-12 effective &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;January 1, 2021&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, and the adoption did &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;t have a material impact on its consolidated financial statements.&lt;/span&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      id="F_3105c361-0835-42ce-b4f4-2eea3cef98ab">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      id="F_e2a00bcb-30f0-4346-b4ea-0c1f5207c2c8">2021-01-01</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate>
    <us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      id="F_4c55b092-dff4-4d41-a1c3-cb41d55bfb86">true</us-gaap:ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect>
    <vor:RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_c4f13434-a722-4847-b37c-8e286a64c605">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Recently Issued Accounting Pronouncements Not Yet Adopted&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In June 2016, the FASB issued ASU 2016-13, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; which has been subsequently amended by ASU 2018-19, ASU 2019-04, ASU 2019-05, ASU 2019-10, ASU 2019-11 and ASU 2020-03 (&#x201c;ASU 2016-13&#x201d;). This standard significantly changes the impairment model for most financial assets and certain other instruments and will require immediate recognition of estimated credit losses expected to occur over the remaining life of many financial assets, which will generally result in earlier recognition of allowances for credit losses on loans and other financial instruments. The Company does not expect that this standard will have a material impact to the Company&#x2019;s consolidated financial statements and plans to adopt this standard on January 1, 2022.&lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</vor:RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock>
    <us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_60c421b7-e62b-40a0-b67a-6b3c99de3234">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;3. Investments&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The amortized cost and estimated fair value of investments, by contractual maturity are as follows:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:48.999%;"/&gt;
        &lt;td style="width:1.178%;"/&gt;
        &lt;td style="width:1.371%;"/&gt;
        &lt;td style="width:9.519%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
        &lt;td style="width:1.178%;"/&gt;
        &lt;td style="width:1.371%;"/&gt;
        &lt;td style="width:9.53%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
        &lt;td style="width:1.178%;"/&gt;
        &lt;td style="width:1.371%;"/&gt;
        &lt;td style="width:9.53%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
        &lt;td style="width:1.178%;"/&gt;
        &lt;td style="width:1.371%;"/&gt;
        &lt;td style="width:9.487%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Gross Unrealized Holding Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Gross Unrealized Holding Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Maturing in one year or less&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Corporate debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,603&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,603&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;U.S. Treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;30,119&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;30,119&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Maturing after one year through five years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Corporate debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;U.S. Treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;44,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;44,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:15.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;87,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;87,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="margin-left:4.533%;text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company held &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; investments at December 31, 2020.&lt;/span&gt;&lt;/p&gt;</us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock>
    <us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_cf6ab898-1713-4fc8-9086-2d2940b841df">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The amortized cost and estimated fair value of investments, by contractual maturity are as follows:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:48.999%;"/&gt;
        &lt;td style="width:1.178%;"/&gt;
        &lt;td style="width:1.371%;"/&gt;
        &lt;td style="width:9.519%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
        &lt;td style="width:1.178%;"/&gt;
        &lt;td style="width:1.371%;"/&gt;
        &lt;td style="width:9.53%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
        &lt;td style="width:1.178%;"/&gt;
        &lt;td style="width:1.371%;"/&gt;
        &lt;td style="width:9.53%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
        &lt;td style="width:1.178%;"/&gt;
        &lt;td style="width:1.371%;"/&gt;
        &lt;td style="width:9.487%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Amortized Cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Gross Unrealized Holding Gains&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Gross Unrealized Holding Losses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Fair Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Maturing in one year or less&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Corporate debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,603&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,603&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;U.S. Treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;30,119&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;30,119&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Maturing after one year through five years&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Corporate debt&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,006&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;U.S. Treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;44,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;44,940&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:15.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;87,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;87,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_5b680cd4-9558-44e6-9a54-c351f3ac168d"
      decimals="-3"
      id="F_e107077e-b7fb-4915-8b3d-1b9823e038a1"
      unitRef="U_USD">7603000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_5b680cd4-9558-44e6-9a54-c351f3ac168d"
      decimals="-3"
      id="F_f059402f-f2dd-4fb2-836f-d676f455e1a0"
      unitRef="U_USD">7603000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_e1887846-0919-4db3-aa01-c63b37f6dff8"
      decimals="-3"
      id="F_a830e335-b66d-4641-983b-2b5d382834da"
      unitRef="U_USD">30119000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_e1887846-0919-4db3-aa01-c63b37f6dff8"
      decimals="-3"
      id="F_927dc0d6-d33c-4872-a49c-d2e404e3a789"
      unitRef="U_USD">30119000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_a65d33bd-d9c2-4c72-bb24-f45f2ce91c39"
      decimals="-3"
      id="F_0cabb277-3d09-43c0-b305-93cf92e73e8d"
      unitRef="U_USD">5006000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_a65d33bd-d9c2-4c72-bb24-f45f2ce91c39"
      decimals="-3"
      id="F_78cdf13e-83ba-4a64-9013-5242c7d095a4"
      unitRef="U_USD">5006000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_715b82a7-0efe-414c-ba1e-c08acca496be"
      decimals="-3"
      id="F_addc93c9-aacc-43f7-a35d-feb1d975c70e"
      unitRef="U_USD">44940000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_715b82a7-0efe-414c-ba1e-c08acca496be"
      decimals="-3"
      id="F_225cf31d-edf3-4ed2-b2ca-afd70454052e"
      unitRef="U_USD">44940000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_fb1237a2-5eb0-456c-ae1b-10cfc0eab5e5"
      unitRef="U_USD">87668000</us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis>
    <us-gaap:AvailableForSaleSecuritiesDebtSecurities
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_0d324bac-fd3b-4d81-bff3-c9efac1c2029"
      unitRef="U_USD">87668000</us-gaap:AvailableForSaleSecuritiesDebtSecurities>
    <us-gaap:Investments
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="INF"
      id="F_b0729d2a-b4f0-43d8-9ff2-a2577dcea8f5"
      unitRef="U_USD">0</us-gaap:Investments>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_8616a410-8e06-45ec-96b0-6b8e27ebdb6b">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;4. Fair Value Measurements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following tables present information about the Company&#x2019;s financial assets and liabilities measured at fair value on a recurring basis:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.143%;"/&gt;
        &lt;td style="width:1.178%;"/&gt;
        &lt;td style="width:1.371%;"/&gt;
        &lt;td style="width:9.499%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
        &lt;td style="width:1.178%;"/&gt;
        &lt;td style="width:1.371%;"/&gt;
        &lt;td style="width:9.499%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
        &lt;td style="width:1.178%;"/&gt;
        &lt;td style="width:1.371%;"/&gt;
        &lt;td style="width:9.392%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
        &lt;td style="width:1.178%;"/&gt;
        &lt;td style="width:1.371%;"/&gt;
        &lt;td style="width:9.531%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;95,339&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;95,339&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Corporate bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;12,609&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;12,609&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;U.S. Treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;75,059&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;75,059&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:15.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;87,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;87,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Restricted cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,413&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,413&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;97,752&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;87,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;185,420&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;41,036&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;41,036&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:15.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;41,036&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;41,036&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The fair value of the Company&#x2019;s cash equivalents and restricted cash equivalents is based on quoted market prices in active markets with no valuation adjustment. The fair value of investments was determined based on observable market inputs. During the years ended December 31, 2021 and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;20&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, there were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; transfers between levels.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_817b4c64-e247-4958-8dcb-8aa68aadb446">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following tables present information about the Company&#x2019;s financial assets and liabilities measured at fair value on a recurring basis:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.143%;"/&gt;
        &lt;td style="width:1.178%;"/&gt;
        &lt;td style="width:1.371%;"/&gt;
        &lt;td style="width:9.499%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
        &lt;td style="width:1.178%;"/&gt;
        &lt;td style="width:1.371%;"/&gt;
        &lt;td style="width:9.499%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
        &lt;td style="width:1.178%;"/&gt;
        &lt;td style="width:1.371%;"/&gt;
        &lt;td style="width:9.392%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
        &lt;td style="width:1.178%;"/&gt;
        &lt;td style="width:1.371%;"/&gt;
        &lt;td style="width:9.531%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;95,339&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;95,339&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Corporate bonds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;12,609&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;12,609&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;U.S. Treasuries&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;75,059&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;75,059&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:15.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total investments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;87,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;87,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Restricted cash equivalents&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,413&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,413&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:15.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;97,752&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;87,668&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;185,420&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="14" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Level 1&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Level 2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Level 3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Money market funds&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;41,036&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;41,036&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:15.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:15.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;41,036&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;41,036&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_30c63602-288c-4405-a204-cdab859368e7"
      decimals="-3"
      id="F_5caa9618-8b61-4083-8841-cf6f6f194f27"
      unitRef="U_USD">95339000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_8e0a26e9-728b-430b-b0fc-8bf930a218ab"
      decimals="-3"
      id="F_949d1479-cbf6-4ac2-a4ba-be311264caa3"
      unitRef="U_USD">95339000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_4efe06e3-c8a1-4df0-8cc2-32db822023b4"
      decimals="-3"
      id="F_45fa4e80-64cf-45f3-bdcf-e477532f8e48"
      unitRef="U_USD">12609000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_c04daa76-85eb-4243-8001-dd530ab727ea"
      decimals="-3"
      id="F_54356b5d-1250-4141-8e4a-316a479284d2"
      unitRef="U_USD">12609000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_a4841187-5a01-4b8a-9f4b-2a8762ff5f9a"
      decimals="-3"
      id="F_d73ed43f-b216-4fb2-8bdf-be0533789d2d"
      unitRef="U_USD">75059000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_4457893c-b88e-4779-ae3d-d3eaad39d858"
      decimals="-3"
      id="F_20a17827-1727-4dc3-962e-8c1f2c896a05"
      unitRef="U_USD">75059000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_125bd726-c0d2-4df7-b573-0ef9f71919e2"
      decimals="-3"
      id="F_c7c900d9-b827-4fc9-a1e1-057d9c43c6b1"
      unitRef="U_USD">87668000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_627553ad-acf9-43fd-997b-9899cf109351"
      decimals="-3"
      id="F_e031665c-dc5d-46d2-bc2e-4bd34430250d"
      unitRef="U_USD">87668000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_cc3d40e7-fe0d-4909-adf0-b9e10e622e8b"
      decimals="-3"
      id="F_fcc3946b-a914-4e15-8c5e-843e5ccd951b"
      unitRef="U_USD">2413000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_e8956874-0a8e-44bd-8bfb-ee0b88501483"
      decimals="-3"
      id="F_a7266c4e-cfd5-4693-abef-4014e536c63e"
      unitRef="U_USD">2413000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_4fcfa437-bee3-47fa-94e3-9caec72a5b95"
      decimals="-3"
      id="F_fa581dd8-38fd-4923-a34f-9856bfdba767"
      unitRef="U_USD">97752000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_3dacd509-2296-44c2-8572-ea922b845d9c"
      decimals="-3"
      id="F_2502d6e4-2221-483f-9e03-24b0374eeff1"
      unitRef="U_USD">87668000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_830618a5-a622-44e4-a728-a9181a23c735"
      decimals="-3"
      id="F_0f1e0439-8ae7-4e90-8da4-942c0ca5340d"
      unitRef="U_USD">185420000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_b6f766ff-68c5-4b43-8d56-95a91d04de17"
      decimals="-3"
      id="F_939d9d9d-b52e-40e5-8dee-3324ffb25c7c"
      unitRef="U_USD">41036000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_1d853449-b848-41c9-8402-61ac0859b6c1"
      decimals="-3"
      id="F_59393b27-81b6-4757-84ab-3133ea4f5542"
      unitRef="U_USD">41036000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_5e77fbcd-1b4f-4eb9-bc4a-1659f7452745"
      decimals="-3"
      id="F_f1545196-81c6-48f9-9c0e-c02f656cbd59"
      unitRef="U_USD">41036000</us-gaap:AssetsFairValueDisclosure>
    <us-gaap:AssetsFairValueDisclosure
      contextRef="C_4322025b-403f-47da-9dfb-69514ce849e6"
      decimals="-3"
      id="F_5dc29c81-8396-4bb9-870d-fe02e2a7680a"
      unitRef="U_USD">41036000</us-gaap:AssetsFairValueDisclosure>
    <vor:FairValueAssetsLevel1ToLevel2TransferredAmount
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="INF"
      id="F_b7e383d5-dc48-48e6-ad14-4dbbefc747a6"
      unitRef="U_USD">0</vor:FairValueAssetsLevel1ToLevel2TransferredAmount>
    <vor:FairValueAssetsLevel2ToLevel1TransferredAmount
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="INF"
      id="F_f6b70458-d865-4e2c-8cb2-29cbd4c82662"
      unitRef="U_USD">0</vor:FairValueAssetsLevel2ToLevel1TransferredAmount>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="INF"
      id="F_59e68c6d-f995-41cd-a1c4-cb4e693f8eb9"
      unitRef="U_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="INF"
      id="F_bf8e3d72-cc11-4335-bbc6-8e37ddfc1bce"
      unitRef="U_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <vor:FairValueAssetsLevel1ToLevel2TransferredAmount
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="INF"
      id="F_40f4e850-2ce8-4253-8aaa-99dcc5adc9ff"
      unitRef="U_USD">0</vor:FairValueAssetsLevel1ToLevel2TransferredAmount>
    <vor:FairValueAssetsLevel2ToLevel1TransferredAmount
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="INF"
      id="F_1f481c30-1a31-40c1-8609-0014dbcb975f"
      unitRef="U_USD">0</vor:FairValueAssetsLevel2ToLevel1TransferredAmount>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="INF"
      id="F_5aafb620-9b2e-4360-9087-d2c9b994c4ca"
      unitRef="U_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="INF"
      id="F_cf4693bb-1052-4a45-ae47-6b5f49f6acc8"
      unitRef="U_USD">0</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_4461e3ed-5302-4cb9-9703-5afa6543347f">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;5. Property and Equipment, Net&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Property and equipment, net consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.149%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:1.37%;"/&gt;
        &lt;td style="width:13.029%;"/&gt;
        &lt;td style="width:0.921%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:1.37%;"/&gt;
        &lt;td style="width:13.029%;"/&gt;
        &lt;td style="width:0.921%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Furniture and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;108&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;40&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Laboratory equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8,457&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,247&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;317&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;167&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Property and equipment, gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8,937&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,454&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accumulated depreciation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,084&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;726&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,853&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,728&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Depreciation expense for the years ended December 31, 2021 and 2020 was approximately &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million, respectively.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_0a73fd34-d1bc-46e2-a7c7-5ab7be2e6bf0">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Property and equipment, net consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.149%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:1.37%;"/&gt;
        &lt;td style="width:13.029%;"/&gt;
        &lt;td style="width:0.921%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:1.37%;"/&gt;
        &lt;td style="width:13.029%;"/&gt;
        &lt;td style="width:0.921%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Furniture and equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;108&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;40&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Laboratory equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8,457&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,247&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Leasehold improvements&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;55&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Computer equipment&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;317&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;167&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Property and equipment, gross&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8,937&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,454&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accumulated depreciation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,084&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;726&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Property and equipment, net&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,853&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,728&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_2069f6af-4edc-49e3-bb9e-d18be8ade020"
      decimals="-3"
      id="F_5213052d-5754-4fd9-a4b2-19af058796f8"
      unitRef="U_USD">108000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_cbe610c1-c6d3-4428-b88d-d6ea1d66502f"
      decimals="-3"
      id="F_cf0f6aff-b7e2-4aa3-92b1-ea740c74043b"
      unitRef="U_USD">40000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_8f8c1246-f661-4230-b8d9-f954d3732f61"
      decimals="-3"
      id="F_bb52efc3-9808-4242-a43e-648c280965f1"
      unitRef="U_USD">8457000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_715633f5-fcd9-4448-aad7-029e1308015e"
      decimals="-3"
      id="F_7bc8fe9a-4820-4ac1-8f5d-4828b2548b98"
      unitRef="U_USD">5247000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_86a506c8-d064-4dfe-9433-56efa7f9e3b1"
      decimals="-3"
      id="F_2fb9fcb3-873a-46f9-b4e3-fc28728ef692"
      unitRef="U_USD">55000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_8e667a03-9dc8-490a-98a3-a47136782d33"
      decimals="-3"
      id="F_de5482aa-4d8b-44e1-9deb-f44f91171e57"
      unitRef="U_USD">317000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_d172676c-6f5a-4c81-bda9-175f1b30bdaf"
      decimals="-3"
      id="F_5489ffac-094f-4210-aa06-1f95a132f595"
      unitRef="U_USD">167000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_979bad0f-9a64-4394-96d3-f8f34a6deb8a"
      unitRef="U_USD">8937000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_79a311af-a0c7-4537-8c54-368103e95486"
      unitRef="U_USD">5454000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_6b362842-8769-44e3-9cd0-03364163f11e"
      unitRef="U_USD">2084000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_8f5d4d2a-ec03-48d2-85b8-60697738172d"
      unitRef="U_USD">726000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_6f510f8c-9920-4477-9b59-f096cda420b1"
      unitRef="U_USD">6853000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_f92924a5-5502-419c-824c-c3afc21de9ad"
      unitRef="U_USD">4728000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Depreciation
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-5"
      id="F_588600fb-8f5c-4138-b5b8-713a8336ae87"
      unitRef="U_USD">1400000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-5"
      id="F_cc67763c-b80b-4f0b-8973-da19bfb8ef04"
      unitRef="U_USD">600000</us-gaap:Depreciation>
    <us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_cb63d4a6-bf70-4a7c-bf08-18bd8609cd2e">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;6. Accrued Expenses and Other Current Liabilities&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued expenses and other current liabilities consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.246%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:12.996%;"/&gt;
        &lt;td style="width:0.867%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:13.221%;"/&gt;
        &lt;td style="width:0.696%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Employee-related and other expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,178&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,727&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Research and development expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;797&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,924&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Professional fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;743&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,097&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;License and milestone fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Calibri;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;450&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;617&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,335&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,260&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock>
    <vor:ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_841e102e-8762-4065-89cb-f153995cdf8b">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued expenses and other current liabilities consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.246%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:12.996%;"/&gt;
        &lt;td style="width:0.867%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:13.221%;"/&gt;
        &lt;td style="width:0.696%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Employee-related and other expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,178&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,727&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Research and development expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;797&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,924&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Professional fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;743&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,097&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;License and milestone fees&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Calibri;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;450&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;617&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;62&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,335&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,260&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</vor:ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_e54c94a0-bd7a-4e0a-a2b1-8ef82046eef8"
      unitRef="U_USD">4178000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_08abc58a-0993-4a4b-8d96-f93d15602b18"
      unitRef="U_USD">2727000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <vor:AccruedResearchAndDevelopmentExpensesCurrent
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_f72f4aee-7735-452e-9af1-9b6d1bfac259"
      unitRef="U_USD">797000</vor:AccruedResearchAndDevelopmentExpensesCurrent>
    <vor:AccruedResearchAndDevelopmentExpensesCurrent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_50b05274-a4d5-4415-9477-03b8d77f633e"
      unitRef="U_USD">1924000</vor:AccruedResearchAndDevelopmentExpensesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_3ff7aca8-9dc6-4980-87ad-46ed1dd56b69"
      unitRef="U_USD">743000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_79e61f7f-932e-4c46-a852-ed741eb5b746"
      unitRef="U_USD">1097000</us-gaap:AccruedProfessionalFeesCurrent>
    <vor:AccruedLicenseAndMilestoneFeesCurrent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_f9311743-1539-4858-9948-118fbb65c8ec"
      unitRef="U_USD">450000</vor:AccruedLicenseAndMilestoneFeesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_dce309ba-f93b-4abc-bd62-42da99ed1c10"
      unitRef="U_USD">617000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_3d0240a3-9774-4e99-a35b-3c01c7278c9c"
      unitRef="U_USD">62000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_5c563b6e-bfde-4cc4-a94a-1b973a1a4110"
      unitRef="U_USD">6335000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_c15bdc7e-73fc-4cb4-a760-7f0052d5d7a6"
      unitRef="U_USD">6260000</us-gaap:AccruedLiabilitiesCurrent>
    <vor:RedeemableConvertiblePreferredStockTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_b1a5c3c1-250a-469a-ac77-8aa69369dd89">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;7. Redeemable Convertible Preferred Stock&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of December 31, 2020, the authorized capital stock of the Company included &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;338,973,691&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.0001&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; par value preferred stock, of which &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;20,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares were designated as Series A-1 redeemable convertible preferred stock (&#x201c;Series A-1&#x201d;); &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;107,194,866&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares were designated as Series A-2 redeemable convertible preferred stock (&#x201c;Series A-2&#x201d;) and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;211,778,825&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares were designated as Series B redeemable convertible preferred stock (&#x201c;Series B&#x201d;).&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Series A-1 and Series A-2 Redeemable Convertible Preferred Stock&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On February 12, 2019, the Company entered into the Series A-2 Preferred Stock Purchase Agreement. Included in the terms of the Series A-2 were tranche rights. The tranche rights obligated the investors in the Series A-2 to purchase, and the Company to sell, an additional &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;44,375,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Series A-2 at a purchase price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.40&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; per share upon achieving certain milestones related to the Company&#x2019;s research platform (&#x201c;Milestone Closing&#x201d;). The number of shares and issuance price for the Milestone Closing were fixed at inception, and the timing for the closing was dependent on whether the Company met certain research and development milestones or if an earlier closing is voted by the Series A-2 holders. The Series A-2 tranche obligation is an embedded feature that does not net settle and therefore, it did not meet the definition of an embedded derivative.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.733%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On February 5, 2020, the Company issued and sold &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;44,375,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Series A-2 for total gross cash proceeds of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;17.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million related to the Milestone Closing.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Series B Redeemable Convertible Preferred Stock Closing&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On June 29, 2020, the Company issued and sold &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;124,519,220&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of its Series B redeemable convertible preferred stock at a per share price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.52&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; (&#x201c;Original Purchase Price&#x201d;) for total gross proceeds of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;64.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million. The stock purchase agreement provided for a second closing obligating the investors in the Series B redeemable convertible preferred stock to purchase, and the Company to sell, an additional &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;87,259,605&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Series B redeemable convertible preferred stock at a per share price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.52&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; upon the achievement of the second tranche milestone.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On January 8, 2021, upon achievement of the second tranche milestone, the Company issued and sold &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;87,259,605&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of Series B redeemable convertible preferred stock at a price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.52&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; per share, for total gross and net proceeds of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;45.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On February 9, 2021, the Company completed its IPO. Upon closing of the IPO, all shares of Series A-1, A-2 and B redeemable convertible preferred stock then outstanding automatically converted into &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;24,924,501&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of common shares. Upon conversion of the redeemable convertible preferred stock, the Company reclassified the carrying value of the redeemable convertible preferred stock to common shares and additional paid-in capital.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of December 31, 2020, redeemable convertible preferred stock consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:31.91%;"/&gt;
        &lt;td style="width:0.706%;"/&gt;
        &lt;td style="width:9.206%;"/&gt;
        &lt;td style="width:0.706%;"/&gt;
        &lt;td style="width:2.055%;"/&gt;
        &lt;td style="width:0.706%;"/&gt;
        &lt;td style="width:8.135%;"/&gt;
        &lt;td style="width:0.706%;"/&gt;
        &lt;td style="width:2.055%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:7.6%;"/&gt;
        &lt;td style="width:0.706%;"/&gt;
        &lt;td style="width:2.055%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:6.851%;"/&gt;
        &lt;td style="width:0.706%;"/&gt;
        &lt;td style="width:2.055%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:7.172%;"/&gt;
        &lt;td style="width:0.706%;"/&gt;
        &lt;td style="width:2.055%;"/&gt;
        &lt;td style="width:0.706%;"/&gt;
        &lt;td style="width:8.349%;"/&gt;
        &lt;td style="width:0.706%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:7.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"&gt;(in thousands, except share amounts)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"&gt;Preferred&lt;br/&gt;Stock&lt;br/&gt;Authorized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"&gt;Preferred&lt;br/&gt;Stock Issued&lt;br/&gt;and&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"&gt;Liquidation&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"&gt;Cumulative&lt;br/&gt;Undeclared&lt;br/&gt;Dividends&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"&gt;Common&lt;br/&gt;Stock&lt;br/&gt;Issuable&lt;br/&gt;Upon Conversion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:7.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;Series A-1 redeemable&lt;br/&gt;&#160;&#160;&#160;&#160;convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;20,000,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;20,000,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;4,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;1,470,588&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:7.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;Series A-2 redeemable&lt;br/&gt;&#160;&#160;&#160;&#160;convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;107,194,866&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;107,194,866&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;42,786&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;42,878&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;5,073&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;7,881,965&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:7.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;Series B redeemable&lt;br/&gt;&#160;&#160;&#160;&#160;convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;211,778,825&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;124,519,220&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;64,548&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;64,750&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;2,625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;9,155,810&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:7.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="margin-left:4.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;338,973,691&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;251,714,086&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;107,336&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;111,628&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;7,698&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;18,508,363&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</vor:RedeemableConvertiblePreferredStockTextBlock>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="INF"
      id="F_4b1e8ebc-9d17-4458-bf06-013209af4a31"
      unitRef="U_shares">338973691</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquityParOrStatedValuePerShare
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="INF"
      id="F_f36e85d1-27b2-4df4-a145-7657daf1a376"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:TemporaryEquityParOrStatedValuePerShare>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63"
      decimals="INF"
      id="F_9e60fd03-b5e4-47aa-9362-5b8ff7cb6fbe"
      unitRef="U_shares">20000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b"
      decimals="INF"
      id="F_849ba2d1-6fb4-4781-a9ed-2904999b3a3e"
      unitRef="U_shares">107194866</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42"
      decimals="INF"
      id="F_da6ea549-58a2-491b-9ada-84ab2a158ca3"
      unitRef="U_shares">211778825</us-gaap:TemporaryEquitySharesAuthorized>
    <vor:TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_02d1981e-0b73-40f4-9bc3-8fdce9d391e3"
      decimals="INF"
      id="F_f0b689e5-8fbe-444c-926f-3deb0da647e8"
      unitRef="U_shares">44375000</vor:TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues>
    <vor:TemporaryEquityIssuedPricePerShare
      contextRef="C_02d1981e-0b73-40f4-9bc3-8fdce9d391e3"
      decimals="INF"
      id="F_69a0e7bc-92bf-4e05-a78a-c7f5fe54d207"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.40</vor:TemporaryEquityIssuedPricePerShare>
    <vor:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_52a58005-78a0-40c3-9da0-2ffe7154a555"
      decimals="INF"
      id="F_158f54a4-1598-411c-8c56-2af06bb46723"
      unitRef="U_shares">44375000</vor:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="C_52a58005-78a0-40c3-9da0-2ffe7154a555"
      decimals="-5"
      id="F_24b569aa-5008-40d9-8e74-447eb53978b9"
      unitRef="U_USD">17800000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <vor:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_d0fb8d89-6900-4a5d-85de-755eaa9cf227"
      decimals="INF"
      id="F_0e78e802-dd44-4fb5-862a-2dfdc2792f6a"
      unitRef="U_shares">124519220</vor:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <vor:TemporaryEquityIssuedPricePerShare
      contextRef="C_d0fb8d89-6900-4a5d-85de-755eaa9cf227"
      decimals="INF"
      id="F_06c86b50-7d6b-4fbb-8948-9feaabdec912"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.52</vor:TemporaryEquityIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="C_d0fb8d89-6900-4a5d-85de-755eaa9cf227"
      decimals="-5"
      id="F_570ca836-5bb9-45ed-998b-359ef2ab9f23"
      unitRef="U_USD">64700000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <vor:TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_d0fb8d89-6900-4a5d-85de-755eaa9cf227"
      decimals="INF"
      id="F_b74f8d3c-a9ac-40db-acdd-2ae51633509e"
      unitRef="U_shares">87259605</vor:TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues>
    <vor:TemporaryEquityIssuedPricePerShare
      contextRef="C_d0fb8d89-6900-4a5d-85de-755eaa9cf227"
      decimals="INF"
      id="F_9acbc3cd-aecc-4bf3-acb1-80a3815d8dff"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.52</vor:TemporaryEquityIssuedPricePerShare>
    <vor:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues
      contextRef="C_6591cce2-facd-4d98-9f53-16294c8f698c"
      decimals="INF"
      id="F_0f84fd90-0ad1-4fe1-bd03-78176aa9aaa3"
      unitRef="U_shares">87259605</vor:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues>
    <vor:TemporaryEquityIssuedPricePerShare
      contextRef="C_6591cce2-facd-4d98-9f53-16294c8f698c"
      decimals="INF"
      id="F_d194aa1d-5d0a-4d74-903d-d35659297b79"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.52</vor:TemporaryEquityIssuedPricePerShare>
    <us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock
      contextRef="C_6591cce2-facd-4d98-9f53-16294c8f698c"
      decimals="-5"
      id="F_45117b06-60dc-4bf7-9333-e18eda69a828"
      unitRef="U_USD">45400000</us-gaap:ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock>
    <us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities
      contextRef="C_522a671f-8013-49d5-9406-851e52363e90"
      decimals="INF"
      id="F_4b0b9a38-0d26-4571-8fbe-820d4a07ab83"
      unitRef="U_shares">24924501</us-gaap:StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities>
    <vor:ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_faa1a38a-2767-4d1b-ad5c-8417e919eb59">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of December 31, 2020, redeemable convertible preferred stock consisted of the following:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:31.91%;"/&gt;
        &lt;td style="width:0.706%;"/&gt;
        &lt;td style="width:9.206%;"/&gt;
        &lt;td style="width:0.706%;"/&gt;
        &lt;td style="width:2.055%;"/&gt;
        &lt;td style="width:0.706%;"/&gt;
        &lt;td style="width:8.135%;"/&gt;
        &lt;td style="width:0.706%;"/&gt;
        &lt;td style="width:2.055%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:7.6%;"/&gt;
        &lt;td style="width:0.706%;"/&gt;
        &lt;td style="width:2.055%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:6.851%;"/&gt;
        &lt;td style="width:0.706%;"/&gt;
        &lt;td style="width:2.055%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:7.172%;"/&gt;
        &lt;td style="width:0.706%;"/&gt;
        &lt;td style="width:2.055%;"/&gt;
        &lt;td style="width:0.706%;"/&gt;
        &lt;td style="width:8.349%;"/&gt;
        &lt;td style="width:0.706%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:7.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"&gt;(in thousands, except share amounts)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"&gt;Preferred&lt;br/&gt;Stock&lt;br/&gt;Authorized&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"&gt;Preferred&lt;br/&gt;Stock Issued&lt;br/&gt;and&lt;br/&gt;Outstanding&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"&gt;Carrying&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"&gt;Liquidation&lt;br/&gt;Value&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"&gt;Cumulative&lt;br/&gt;Undeclared&lt;br/&gt;Dividends&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:7.0pt;font-family:Times New Roman;"&gt;Common&lt;br/&gt;Stock&lt;br/&gt;Issuable&lt;br/&gt;Upon Conversion&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:7.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;Series A-1 redeemable&lt;br/&gt;&#160;&#160;&#160;&#160;convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;20,000,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;20,000,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;2&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;4,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;1,470,588&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:7.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;Series A-2 redeemable&lt;br/&gt;&#160;&#160;&#160;&#160;convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;107,194,866&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;107,194,866&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;42,786&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;42,878&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;5,073&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;7,881,965&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:7.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;Series B redeemable&lt;br/&gt;&#160;&#160;&#160;&#160;convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;211,778,825&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;124,519,220&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;64,548&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;64,750&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;2,625&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;9,155,810&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:7.0pt;"&gt;
        &lt;td style="background-color:rgba(255,255,255,1);text-indent:4.0pt;word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="margin-left:4.0pt;text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;Total&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;338,973,691&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;251,714,086&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;107,336&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;111,628&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;7,698&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:7.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:7.0pt;font-family:Times New Roman;"&gt;18,508,363&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(255,255,255,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:7.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:7.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</vor:ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63"
      decimals="INF"
      id="F_b3ad1bd5-86d4-4beb-873d-cbed47852c06"
      unitRef="U_shares">20000000</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63"
      decimals="INF"
      id="F_604930ce-8a3e-478d-bce2-b408750e5fa0"
      unitRef="U_shares">20000000</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63"
      decimals="INF"
      id="F_4dbc0514-b562-4c4c-9e2f-17f13e333d1b"
      unitRef="U_shares">20000000</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63"
      decimals="-3"
      id="F_b4717357-2b12-4af9-b8c0-88cc9ef1fc4d"
      unitRef="U_USD">2000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63"
      decimals="-3"
      id="F_0746f8c1-8cc4-461c-aec2-d5ccbf7a1a86"
      unitRef="U_USD">4000000</us-gaap:TemporaryEquityLiquidationPreference>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="C_6c62975b-bbca-4e3d-9239-8d568106fa63"
      decimals="INF"
      id="F_b2f8e86b-5cdd-4160-9acb-b2084641f28a"
      unitRef="U_shares">1470588</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b"
      decimals="INF"
      id="F_13786c4e-ca92-43cd-9d47-77ec6b8407ae"
      unitRef="U_shares">107194866</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b"
      decimals="INF"
      id="F_ce5b742f-70dd-41f8-a338-b5ebe44b885d"
      unitRef="U_shares">107194866</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b"
      decimals="INF"
      id="F_2ed8098a-7103-43c2-aa62-9b1dc856a280"
      unitRef="U_shares">107194866</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b"
      decimals="-3"
      id="F_3d55e5b2-2bc3-480d-af67-6e1d487f33b4"
      unitRef="U_USD">42786000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b"
      decimals="-3"
      id="F_d184acee-0282-43e1-af3d-7c291752fcca"
      unitRef="U_USD">42878000</us-gaap:TemporaryEquityLiquidationPreference>
    <vor:TemporaryEquityCumulativeUndeclaredDividends
      contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b"
      decimals="-3"
      id="F_d2f8e2b7-7859-4852-910c-592437df90e3"
      unitRef="U_USD">5073000</vor:TemporaryEquityCumulativeUndeclaredDividends>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="C_d9365f15-4570-4863-b99d-75d5cc7c706b"
      decimals="INF"
      id="F_c9d766f6-a485-4f18-a027-cebe936d4642"
      unitRef="U_shares">7881965</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42"
      decimals="INF"
      id="F_c1ac1f46-361c-49be-97bc-55e9b72c7937"
      unitRef="U_shares">211778825</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42"
      decimals="INF"
      id="F_50fba24f-c353-48fa-be8a-08bff8901e8c"
      unitRef="U_shares">124519220</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42"
      decimals="INF"
      id="F_39b2d646-8ff3-428e-9066-e67ee6c19833"
      unitRef="U_shares">124519220</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42"
      decimals="-3"
      id="F_7925ccdd-fe4e-4634-999a-c2a247bf5b5b"
      unitRef="U_USD">64548000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42"
      decimals="-3"
      id="F_c49276c8-a6da-484b-aceb-5af9e8600f6c"
      unitRef="U_USD">64750000</us-gaap:TemporaryEquityLiquidationPreference>
    <vor:TemporaryEquityCumulativeUndeclaredDividends
      contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42"
      decimals="-3"
      id="F_792a1c2f-db00-4ddb-b95d-1b1848202024"
      unitRef="U_USD">2625000</vor:TemporaryEquityCumulativeUndeclaredDividends>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="C_0e890eb4-5b3b-4c19-bc64-899ed7328e42"
      decimals="INF"
      id="F_8c2fece8-8fd8-4fe7-935e-031486a927ee"
      unitRef="U_shares">9155810</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:TemporaryEquitySharesAuthorized
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="INF"
      id="F_35867926-57b2-48f5-8725-7f8ad92f0508"
      unitRef="U_shares">338973691</us-gaap:TemporaryEquitySharesAuthorized>
    <us-gaap:TemporaryEquitySharesIssued
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="INF"
      id="F_b159ee19-a372-4eb4-a00b-3a3dc8b95d75"
      unitRef="U_shares">251714086</us-gaap:TemporaryEquitySharesIssued>
    <us-gaap:TemporaryEquitySharesOutstanding
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="INF"
      id="F_4dc24527-a68a-4737-aad0-f388f4e2491f"
      unitRef="U_shares">251714086</us-gaap:TemporaryEquitySharesOutstanding>
    <us-gaap:TemporaryEquityCarryingAmountAttributableToParent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_5cf412ff-67cd-4e19-bb48-eb9ea1902403"
      unitRef="U_USD">107336000</us-gaap:TemporaryEquityCarryingAmountAttributableToParent>
    <us-gaap:TemporaryEquityLiquidationPreference
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_513f6d01-b95a-400f-8973-b90f0b5a5e2f"
      unitRef="U_USD">111628000</us-gaap:TemporaryEquityLiquidationPreference>
    <vor:TemporaryEquityCumulativeUndeclaredDividends
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_6e381559-3ac1-4c43-b47b-05fe4c050be7"
      unitRef="U_USD">7698000</vor:TemporaryEquityCumulativeUndeclaredDividends>
    <us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="INF"
      id="F_216fa2c0-1155-48ff-9381-889f5c50420a"
      unitRef="U_shares">18508363</us-gaap:ConvertiblePreferredStockSharesIssuedUponConversion>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_f387700d-d5a2-4a1f-ae82-2eb6adcac9ad">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;8. Stockholders' Equity&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Preferred Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has authorized up to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of preferred stock, $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.0001&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; par value per share, for issuance. The preferred stock will have such rights, preferences, privileges and restrictions, including voting rights, dividend rights, conversion rights, redemption privileges, and liquidation preferences, as shall be determined by the Company&#x2019;s Board of Directors upon its issuance. At  &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;December 31, 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, there were &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of preferred stock outstanding.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Common Stock&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of December 31, 2021 and 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, the Company&#x2019;s authorized capital stock included &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;400,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;420,000,000&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares, respectively, of its &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.0001&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; par value common stock.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Each share of common stock entitles the holder to &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;one&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; vote&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; on all matters submitted to a vote of the Company&#x2019;s stockholders provided, however, that, except as otherwise required by law, holders of common stock shall not be entitled to vote on any amendment to the Company&#x2019;s Certificate of Incorporation, as amended (the &#x201c;Certificate of Incorporation&#x201d;), that relates solely to the terms of one or more outstanding series of preferred stock if the holders of such affected series are entitled, either separately or together with the holders of one or more other such series, to vote thereon pursuant to the Certificate of Incorporation or pursuant to the Delaware General Corporation Law. Common stockholders are entitled to receive dividends, as may be declared by the Company&#x2019;s board of directors, if any, subject to the preferential dividend rights of the preferred stock. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;No&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; dividends have been declared or paid as of and for either of the years ended  &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;December 31, 2021 and 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="INF"
      id="F_70a1500c-71a3-405a-b0d7-4433780594e2"
      unitRef="U_shares">10000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="INF"
      id="F_c99db922-452b-47f3-b538-85d1447e7133"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="INF"
      id="F_9b99bc9a-f95a-4e9e-b7aa-3d5190046430"
      unitRef="U_shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="INF"
      id="F_0c312ac0-a58f-4a76-9145-bc180185c099"
      unitRef="U_shares">400000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="INF"
      id="F_4e307a0e-0b66-4910-b8af-4d1e4409b59d"
      unitRef="U_shares">420000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="INF"
      id="F_0c33dfd3-58d8-4c9c-a464-d75f16531f4e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="INF"
      id="F_e3065939-7ebc-4033-95e6-ffdfc7359713"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockVotingRights
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_2791bdc0-0466-4c53-957c-4bfb06111a68">Each share of common stock entitles the holder to one vote</us-gaap:CommonStockVotingRights>
    <vor:NumberOfCommonStockVotingRights
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="INF"
      id="F_16663531-e5c9-481f-90ff-19104f36aae3"
      unitRef="U_Vote">1</vor:NumberOfCommonStockVotingRights>
    <us-gaap:DividendsCommonStock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="INF"
      id="F_3eb20ab4-4825-48db-8d84-236c2cf91e78"
      unitRef="U_USD">0</us-gaap:DividendsCommonStock>
    <us-gaap:DividendsCommonStock
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="INF"
      id="F_164ac04b-23aa-4827-b817-550c541b748c"
      unitRef="U_USD">0</us-gaap:DividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="INF"
      id="F_2b72638f-2691-4523-a0fe-b3ac4a0bbc8a"
      unitRef="U_USD">0</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:PaymentsOfDividendsCommonStock
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="INF"
      id="F_cb07c5ca-1b69-48a9-9734-e476227eba98"
      unitRef="U_USD">0</us-gaap:PaymentsOfDividendsCommonStock>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_31d085a9-0b5f-4a73-9216-d58e2309ba75">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;9. Stock-Based Compensation&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Stock Incentive Plans&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In December 2015, the Company&#x2019;s board of directors adopted and approved the 2015 Stock Incentive Plan (as amended to date, the &#x201c;2015 Plan&#x201d;). The 2015 Plan provided for the granting of incentive stock options, non-statutory stock options, restricted stock awards and other stock-based awards to eligible employees, officers, directors, consultants and advisors as determined by the Company&#x2019;s board of directors.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In October 2020, the Company granted an option to purchase &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;294,117&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of its common stock to an advisor outside of the 2015 Plan, with a strike price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;28.29&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; per share. Such grant was made outside of the 2015 Plan but is subject to the terms and conditions of such plan.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In February 2021, the Company&#x2019;s board of directors adopted and stockholders approved the 2021 Equity Incentive Plan (the &#x201c;2021 Plan&#x201d;). The 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; Plan became effective on February 5, 2021, following which &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; further grants were or will be made under the 2015 Plan. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The 2021 Plan provides for the grant of stock options, non-statutory stock options, restricted stock awards, restricted stock unit awards, stock appreciation rights, performance stock awards and other forms of stock compensation to our employees, consultants and directors.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The number of shares of our common stock reserved for issuance under our 2021 Plan will automatically increase on January 1 of each year through January 1, 2031, by &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;of the total number of shares of common stock outstanding on December 31 of the preceding calendar year. Any grants that expire or are canceled, terminated,&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;forfeited, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;or fail to vest are allowed to be reissued under 2021 Plan. As of December 31, 2021, the Company had &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,643,187&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares of its common stock available for future issuance under the 2021 Plan.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Stock Options&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company&#x2019;s stock options generally &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;vest over &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;48 months&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; with &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;25&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% vesting after &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;one year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; followed by ratable monthly vesting over&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; three years&lt;/span&gt;&lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"/&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and have a contractual term of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10 years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The weighted-average assumptions used principally in determining the fair value of options granted were as follows: &lt;/span&gt;&lt;/span&gt;&lt;span style=""/&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.657%;"/&gt;
        &lt;td style="width:1.595%;"/&gt;
        &lt;td style="width:1.37%;"/&gt;
        &lt;td style="width:11.905%;"/&gt;
        &lt;td style="width:2.312%;"/&gt;
        &lt;td style="width:1.595%;"/&gt;
        &lt;td style="width:1.37%;"/&gt;
        &lt;td style="width:11.883%;"/&gt;
        &lt;td style="width:2.312%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Fair value of common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;23.63&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4.29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;78.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;77.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table summarizes the Company&#x2019;s stock option activity for the year ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;December 31, 2021:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.095%;"/&gt;
        &lt;td style="width:1.188%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
        &lt;td style="width:9.935%;"/&gt;
        &lt;td style="width:0.91%;"/&gt;
        &lt;td style="width:1.188%;"/&gt;
        &lt;td style="width:1.37%;"/&gt;
        &lt;td style="width:9.506%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
        &lt;td style="width:1.188%;"/&gt;
        &lt;td style="width:0.707%;"/&gt;
        &lt;td style="width:10.074%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
        &lt;td style="width:1.188%;"/&gt;
        &lt;td style="width:1.37%;"/&gt;
        &lt;td style="width:9.539%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,084,679&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3.79&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9.42&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;32,086&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;730,884&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;19.46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Vested and exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;442,947&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;285,698&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4.10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;126&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;18.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,086,792&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8.00&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;38,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Exercisable at December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,669,852&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4.15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7.49&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;14,384&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The aggregate intrinsic value of options is calculated as the difference between the exercise price of the stock options and the fair value of the Company&#x2019;s common stock for those stock options that had exercise prices lower than the fair value of the common stock as of the respective date.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The weighted-average grant-date fair value of stock options granted during the years ended December 31, 2021 and 2020 was &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;13.14&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.19&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; per share, respectively. As of December 31, 2021, total unrecognized compensation expense related to stock options was &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;13.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; which is expected to be recognized over a weighted-average period of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.51&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; years. The intrinsic value of stock options exercised was &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; for the year ended December 31, 2021.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;During the year ended December 31, 2020, options for &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;159,197&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares with a weighted-average exercise price of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.59&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and a weighted-average grant date fair value of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.90&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; were exercised but unvested at the time of exercise. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of December 31, 2021 and 2020, options for &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;200,687&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;388,157&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; shares with weighted average exercise prices of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.90&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.86&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; were exercised and unvested, respectively. The underlying proceeds from the unvested exercises of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.7&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; is recorded in other current liabilities as of December 31, 2021 and 2020, on the consolidated balance sheet.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Stock-Based Compensation&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Stock-based compensation expense was allocated as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.253%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:13.191%;"/&gt;
        &lt;td style="width:0.696%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:13.191%;"/&gt;
        &lt;td style="width:0.696%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,281&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;665&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,034&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;677&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,315&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,342&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_5704eb75-6122-4803-bb26-449ab2867e41"
      decimals="INF"
      id="F_bfbe14de-dcd7-442f-afbb-8674738baa18"
      unitRef="U_shares">294117</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:SharePrice
      contextRef="C_4ca00470-3222-46a5-ba00-840824cc64ac"
      decimals="INF"
      id="F_ed64ab9f-8a30-48e3-99b4-4631e5853dde"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">28.29</us-gaap:SharePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_29752c48-fb53-41e4-b327-df9623f28225"
      decimals="INF"
      id="F_f0b59af9-a993-4068-9808-6135dab172bb"
      unitRef="U_shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum
      contextRef="C_384191fb-9059-497b-a41e-c8f78ff3b67f"
      decimals="INF"
      id="F_fe396d92-4ebf-48ec-9fe1-69dd3c8d7dcf"
      unitRef="U_pure">0.040</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
      contextRef="C_33213034-803c-4c95-bb92-7996ff3a4622"
      decimals="INF"
      id="F_8d3747b9-5564-48e5-b83d-64ae6d0bfe08"
      unitRef="U_shares">2643187</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights
      contextRef="C_f74e35ab-8530-45d8-8610-4c43f69992db"
      id="F_e60c2449-c75b-4165-a3bb-b1e5227bd390">vest over 48 months with 25% vesting after one year followed by ratable monthly vesting over three years</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_2d35f13a-de85-4de4-863e-43adb4567091"
      id="F_29c4052e-fffd-45bf-b5c5-eb1adcedbce9">P48M</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage
      contextRef="C_d6d70c45-e42a-4ed6-8717-d4b764af1957"
      decimals="2"
      id="F_f362ffa2-346c-4808-845e-041bdc825a6c"
      unitRef="U_pure">0.25</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_d6d70c45-e42a-4ed6-8717-d4b764af1957"
      id="F_7e633c75-80cb-49ce-97b7-b02c067c76fe">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="C_1f0cde73-59e7-449b-80e5-547933529d26"
      id="F_c6f8ac0b-aa4a-4a07-9482-93cb51405205">P3Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="C_2d35f13a-de85-4de4-863e-43adb4567091"
      id="F_984acd9b-6361-4b36-9e88-0e146f5c872e">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_ed9080d9-df23-4d16-9d20-a65088b91211">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The weighted-average assumptions used principally in determining the fair value of options granted were as follows: &lt;/span&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.657%;"/&gt;
        &lt;td style="width:1.595%;"/&gt;
        &lt;td style="width:1.37%;"/&gt;
        &lt;td style="width:11.905%;"/&gt;
        &lt;td style="width:2.312%;"/&gt;
        &lt;td style="width:1.595%;"/&gt;
        &lt;td style="width:1.37%;"/&gt;
        &lt;td style="width:11.883%;"/&gt;
        &lt;td style="width:2.312%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Fair value of common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;23.63&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4.29&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expected term (in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.0&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expected volatility&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;78.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;77.3&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Risk-free interest rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.9&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Dividend yield&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_2d35f13a-de85-4de4-863e-43adb4567091"
      decimals="2"
      id="F_0350c2a8-afcb-4ec8-87bb-478a2e9e0728"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">23.63</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_f74e35ab-8530-45d8-8610-4c43f69992db"
      decimals="2"
      id="F_37748b35-07d8-43ea-aafd-49e495781d59"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.29</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_2d35f13a-de85-4de4-863e-43adb4567091"
      id="F_b66ce9ee-ae3d-4260-96e6-a1e299fc7be6">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="C_f74e35ab-8530-45d8-8610-4c43f69992db"
      id="F_26e66dba-e0bf-4310-be04-5338ed719d3c">P6Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_2d35f13a-de85-4de4-863e-43adb4567091"
      decimals="3"
      id="F_d6816667-2bd3-4ef1-8bb6-e64b9353886c"
      unitRef="U_pure">0.784</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="C_f74e35ab-8530-45d8-8610-4c43f69992db"
      decimals="3"
      id="F_acc964b6-bdbc-4be1-8ba3-da8e1a8cac5e"
      unitRef="U_pure">0.773</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_2d35f13a-de85-4de4-863e-43adb4567091"
      decimals="3"
      id="F_1ab68277-0eac-49d4-8a07-c9cefa97dfae"
      unitRef="U_pure">0.009</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="C_f74e35ab-8530-45d8-8610-4c43f69992db"
      decimals="3"
      id="F_23a209fa-a947-4859-ac2c-bf29425f0a2f"
      unitRef="U_pure">0.004</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_2d35f13a-de85-4de4-863e-43adb4567091"
      decimals="2"
      id="F_da31c0da-e9c7-4847-aaf6-bec1c9177130"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="C_f74e35ab-8530-45d8-8610-4c43f69992db"
      decimals="2"
      id="F_5102cb12-ab76-4a58-99a4-18f0059ee476"
      unitRef="U_pure">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_92da1b4f-3d52-4072-bd15-93e2cc0adbd3">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table summarizes the Company&#x2019;s stock option activity for the year ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;December 31, 2021:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:49.095%;"/&gt;
        &lt;td style="width:1.188%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
        &lt;td style="width:9.935%;"/&gt;
        &lt;td style="width:0.91%;"/&gt;
        &lt;td style="width:1.188%;"/&gt;
        &lt;td style="width:1.37%;"/&gt;
        &lt;td style="width:9.506%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
        &lt;td style="width:1.188%;"/&gt;
        &lt;td style="width:0.707%;"/&gt;
        &lt;td style="width:10.074%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
        &lt;td style="width:1.188%;"/&gt;
        &lt;td style="width:1.37%;"/&gt;
        &lt;td style="width:9.539%;"/&gt;
        &lt;td style="width:0.685%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Shares&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Exercise Price&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Remaining&lt;br/&gt;Contractual Term&lt;br/&gt;(in years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Aggregate&lt;br/&gt;Intrinsic&lt;br/&gt;Value&lt;br/&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Outstanding at December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,084,679&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3.79&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9.42&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;32,086&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Granted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;730,884&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;19.46&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Vested and exercised&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;442,947&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.02&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Forfeited&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;285,698&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4.10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Expired&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;126&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;18.00&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Outstanding at December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,086,792&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.17&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8.00&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;38,000&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Exercisable at December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,669,852&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4.15&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7.49&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;14,384&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="INF"
      id="F_8e1ea85a-f689-4885-a90a-38bb0a644264"
      unitRef="U_shares">5084679</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="2"
      id="F_07a5b32e-2998-4d8c-b27e-fba9624d7d40"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">3.79</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      id="F_40808ca1-28a7-4cdd-af42-8cc000668d05">P9Y5M1D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_3541ab71-cc67-4772-874d-010f4e7a1e24"
      unitRef="U_USD">32086000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="INF"
      id="F_dcc6d233-c1d8-430e-81fb-36350752a28d"
      unitRef="U_shares">730884</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="2"
      id="F_68e24258-e059-4688-9a31-b22ad19c74d5"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">19.46</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <vor:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriod
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="INF"
      id="F_76bd6714-7a22-4bea-a334-bfeabaa115d7"
      unitRef="U_shares">442947</vor:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriod>
    <vor:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriodWeightedAverageExercisePrice
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="2"
      id="F_9df6063f-93fe-43ff-ab12-9aedce9d6476"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.02</vor:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="INF"
      id="F_2673d6b1-2014-4e06-871f-9e152f4b5334"
      unitRef="U_shares">285698</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="2"
      id="F_38283706-d7ef-454e-978a-4cb49ef71db8"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.10</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="INF"
      id="F_eec57696-2aea-4f53-9a96-80e1d0758504"
      unitRef="U_shares">126</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="2"
      id="F_a546c1b4-a617-47b3-803c-f2381eaa10be"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">18.00</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="INF"
      id="F_47fed47f-fa22-4457-82ce-07c6e1400e98"
      unitRef="U_shares">5086792</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="2"
      id="F_540451a0-442b-4cc9-a920-2aa3845e816b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">6.17</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_811e182e-6f43-45a2-a107-761449cd7272">P8Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_20f0bd2b-15a7-4368-92c5-a12bff780cc0"
      unitRef="U_USD">38000000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="INF"
      id="F_252fb15a-2c99-4aed-8c1f-896f0dd6ecc2"
      unitRef="U_shares">1669852</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="2"
      id="F_90a28108-c80f-4891-beaf-773eac3f1315"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">4.15</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_d3f00f06-3bd5-4b88-971b-da0107710d72">P7Y5M26D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_9c7384b0-feb6-480e-89b5-fde3645e2cb7"
      unitRef="U_USD">14384000</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="2"
      id="F_34c43ac2-b44c-458e-ba16-8486000dbc9e"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">13.14</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="2"
      id="F_30f06ea6-e2d3-4f8b-8771-4c5d608b00a9"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.19</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-5"
      id="F_b89ced28-0e82-4639-8617-b414f8fb6ee9"
      unitRef="U_USD">13100000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_292f5919-af11-4f96-866a-c734bd357cc1">P2Y6M3D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-5"
      id="F_3d9d4a9f-f3ad-49a9-a9af-155b4e345336"
      unitRef="U_USD">3100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="INF"
      id="F_5c66e760-c857-4c81-bbb1-753c410d894e"
      unitRef="U_shares">159197</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="2"
      id="F_d0ae37b2-f23d-4620-b061-afb8d8785732"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">2.59</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <vor:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="2"
      id="F_9ab3b62e-0685-42c8-b620-d3cf22c62eee"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.90</vor:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="INF"
      id="F_21490bd6-c811-4bab-b6f0-9a8b5eb6ebd5"
      unitRef="U_shares">200687</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="INF"
      id="F_25800103-df85-415d-a23d-0fcc15a0b74f"
      unitRef="U_shares">388157</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares>
    <vor:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="2"
      id="F_8614a82d-7b35-4025-a64a-c2502319ee20"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.90</vor:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice>
    <vor:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="2"
      id="F_1baf71ab-ed3c-4794-9494-7e3e1a63a69b"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">1.86</vor:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-5"
      id="F_9f965858-6b30-4053-9307-b3cc8c9d807d"
      unitRef="U_USD">400000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-5"
      id="F_64accfe7-122f-4485-ab7f-837220fdcf00"
      unitRef="U_USD">700000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_118d5253-7439-4789-8dd7-3edcfc3e6342">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Stock-based compensation expense was allocated as follows:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.253%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:13.191%;"/&gt;
        &lt;td style="width:0.696%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:13.191%;"/&gt;
        &lt;td style="width:0.696%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Research and development&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,281&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;665&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;General and administrative&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,034&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;677&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,315&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,342&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_e1434930-9e6c-49c1-8a72-2f6ad390870c"
      decimals="-3"
      id="F_ad1713a7-eaa9-4be3-acac-906229cdc1d2"
      unitRef="U_USD">2281000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_01ae64e4-fcbc-4c77-945a-5a32dc371b12"
      decimals="-3"
      id="F_96471e15-cbaf-4d8c-9344-a218fac75f99"
      unitRef="U_USD">665000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_5ce9a17a-6747-4e6a-b14b-931e7fbf6304"
      decimals="-3"
      id="F_fae0995c-66e6-47a5-a85c-32cd3f23102e"
      unitRef="U_USD">2034000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_f35b7c7a-c532-4b88-bdc5-43c57c43318c"
      decimals="-3"
      id="F_2bf04084-0dbb-4849-a0df-45c3ccb802d1"
      unitRef="U_USD">677000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_4a6b896a-d8f9-4541-9ff0-34e43bd36664"
      unitRef="U_USD">4315000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_44746f0f-4012-432d-879f-3fee3c90a6a0"
      unitRef="U_USD">1342000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_3dd06878-62a9-4343-9311-ce5e267b024c">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;10. Leases&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Cambridgepark Lease&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In December 2019, the Company entered into a lease agreement for its new corporate office and laboratory facility (the &#x201c;Cambridgepark Lease&#x201d;) in Cambridge, Massachusetts. The Cambridgepark Lease has a term of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10 years&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, beginning on the rent commencement date which is two months after the lease commencement date. There are &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no options&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; to extend the lease. The lease commencement date, for accounting purposes, was deemed to be reached as of June 30, 2020.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;On June 15, 2021, the Company entered into the first lease amendment (&#x201c;First Lease Amendment&#x201d;) and the second lease amendment (&#x201c;Second Lease Amendment&#x201d; and, together with the First Lease Amendment, the &#x201c;Lease Amendments&#x201d;) with PPF Off 100 Cambridge Park Drive, LLC (the &#x201c;Landlord&#x201d;). The Lease Amendments amended the Cambridgepark Lease with the Landlord in Cambridge, Massachusetts to add additional leased space in the same building (the &#x201c;Amended Cambridgepark Lease&#x201d;).&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The First Lease Amendment expanded the amount of space leased by the Company by an additional &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;10,262&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; square feet in exchange for aggregate total fixed rent payments of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million with the annual fixed rental payments escalating from $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million during the term. The First Lease Amendment commenced during the &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;first quarter of 2022&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Second Lease Amendment expands the amount of space leased by the Company by an additional &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;30,175&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; square feet in exchange for aggregate total fixed ren&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;t payments of approximately $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;21.9&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million with the annual fixed rental payments escalating from $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.2&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3.0&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million during the term. The Second Lease Amendment&#x2019;s term is expected to commence during the &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;second quarter of 2022&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(255,255,255,1);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Payments associated with the Amended Cambridgepark Lease include fixed and variable payments. Variable payments relate to the Company&#x2019;s share of the Landlord&#x2019;s operating costs associated with the underlying assets and are recognized when the event on which those payments are assessed. The Amended Cambridgepark Lease does not contain a residual value guarantee. The Lease Amendments term end dates are coterminous with the Cambridgepark Lease.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In conjunction with the Amended Cambridgepark Lease, the Company was required to establish a &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; irrevocable standby letter of credit for the benefit of the Landlord, which has been secured by money market investments and is presented as restricted cash equivalents.&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The elements of lease expense were as follows:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.231%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:13.201%;"/&gt;
        &lt;td style="width:0.696%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:13.201%;"/&gt;
        &lt;td style="width:0.696%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Operating lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,017&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,780&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Short-term lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;309&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Variable lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,099&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;235&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,168&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,324&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Amounts reported in the consolidated balance sheets and the weight-average lease term and discount rate information were as follows:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.61%;"/&gt;
        &lt;td style="width:1.585%;"/&gt;
        &lt;td style="width:1.37%;"/&gt;
        &lt;td style="width:11.927%;"/&gt;
        &lt;td style="width:2.313%;"/&gt;
        &lt;td style="width:1.585%;"/&gt;
        &lt;td style="width:1.37%;"/&gt;
        &lt;td style="width:11.927%;"/&gt;
        &lt;td style="width:2.313%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands except weighted-average amounts)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Operating right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15,670&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;17,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,839&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;863&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Operating lease liabilities, non-current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;16,174&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;17,430&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;18,013&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;18,293&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted Average Lease Term and Discount Rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8.64&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9.55&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table represents other lease activity:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.224%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:13.2%;"/&gt;
        &lt;td style="width:0.696%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:13.211%;"/&gt;
        &lt;td style="width:0.696%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Cash Flow Information&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Cash paid for amounts included in the measurement of&lt;br/&gt;&#160;&#160;&#160;lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,559&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;703&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Right-of-use assets obtained in exchange for lease obligations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;35&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;17,899&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Future lease payments for noncancelable leases as of were as follows:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:78.867%;"/&gt;
        &lt;td style="width:1.916%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:16.915%;"/&gt;
        &lt;td style="width:0.921%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;br/&gt;&#160;2021 &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;font-family:Times New Roman;position:relative;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,410&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,718&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,799&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,883&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,970&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11,665&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;26,445&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8,432&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;18,013&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="border-top:0.750pt solid;margin-left:2.667%;padding-top:1.0pt;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;display:inline-flex;font-size:9.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;"&gt;(1)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Excluded from the table above are a portion of the Company's lease payments associated with the Lease Amendments, as the space leased has not commenced for accounting purposes as of December 31, 2021. The commencement date is the date on which the asset is made available to the Company by the lessor.&lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="C_af4903d8-c8c6-44b2-ae8d-4dfc4cc09658"
      id="F_ae7dda8c-0964-46cb-b480-5563b0c68466">P10Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend
      contextRef="C_bb19a2ae-ac5d-4f11-b032-62cb4dd2a453"
      id="F_27ce9868-2573-4c60-818f-dedbf7970a18">false</us-gaap:LesseeOperatingLeaseExistenceOfOptionToExtend>
    <vor:AdditionalSpaceLeased
      contextRef="C_a0646336-a18c-4b69-a90e-ca45d0ce7f71"
      decimals="INF"
      id="F_9be707db-e53e-437b-9ac9-93d8542de654"
      unitRef="U_sqft">10262</vor:AdditionalSpaceLeased>
    <us-gaap:PaymentsForRent
      contextRef="C_4524d971-84fd-4763-928f-3714233d9b8d"
      decimals="-5"
      id="F_c394f2e8-4c03-459a-aeb1-31c42af06236"
      unitRef="U_USD">8200000</us-gaap:PaymentsForRent>
    <vor:IncreaseInAnnualFixedRentalPayments
      contextRef="C_312b019a-fe59-4cdb-acae-11a1267c8c20"
      decimals="-5"
      id="F_2f2d27ea-4a96-4e19-a37b-a7e30c136a5f"
      unitRef="U_USD">900000</vor:IncreaseInAnnualFixedRentalPayments>
    <vor:IncreaseInAnnualFixedRentalPayments
      contextRef="C_a8aa8d2a-0cb5-4a21-b6ab-146b2c4adaa1"
      decimals="-5"
      id="F_d906e323-c8fc-45dd-b391-038d50da676a"
      unitRef="U_USD">1100000</vor:IncreaseInAnnualFixedRentalPayments>
    <vor:OperatingLeaseCommencementPeriod
      contextRef="C_4524d971-84fd-4763-928f-3714233d9b8d"
      id="F_db7a9b40-b9ac-4deb-a4bc-c0e64d9b9ab9">first quarter of 2022</vor:OperatingLeaseCommencementPeriod>
    <vor:AdditionalSpaceLeased
      contextRef="C_640a4a96-8eca-48d4-9211-924367454b36"
      decimals="INF"
      id="F_5d7f8e11-71d1-4360-93d7-30e2772d2639"
      unitRef="U_sqft">30175</vor:AdditionalSpaceLeased>
    <us-gaap:PaymentsForRent
      contextRef="C_d9da6ae7-78bc-43bf-aef8-9f17cd10c178"
      decimals="-5"
      id="F_a7dba0ab-879b-4cd4-9bee-25a6a6e5df15"
      unitRef="U_USD">21900000</us-gaap:PaymentsForRent>
    <vor:IncreaseInAnnualFixedRentalPayments
      contextRef="C_965a7f16-b568-4209-8526-032c882c59d6"
      decimals="-5"
      id="F_9d8aa706-f690-4a3c-9a3b-62de4a39a068"
      unitRef="U_USD">1200000</vor:IncreaseInAnnualFixedRentalPayments>
    <vor:IncreaseInAnnualFixedRentalPayments
      contextRef="C_6db24f0b-fc32-481a-99b2-6949f632a61f"
      decimals="-5"
      id="F_0e5f845d-d591-410e-9004-f910259c0a64"
      unitRef="U_USD">3000000.0</vor:IncreaseInAnnualFixedRentalPayments>
    <vor:OperatingLeaseEstimatedToCommencePeriod
      contextRef="C_d9da6ae7-78bc-43bf-aef8-9f17cd10c178"
      id="F_c6fb2b13-317f-45ff-93c9-628ba5469270">second quarter of 2022</vor:OperatingLeaseEstimatedToCommencePeriod>
    <us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet
      contextRef="C_1e278196-1cfd-446f-8d91-9976d22c5883"
      decimals="-5"
      id="F_f8253a67-6088-4852-aa74-1d3fd2469270"
      unitRef="U_USD">2400000</us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_83568097-1eca-4263-a7d2-fbb91eb873a6">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The elements of lease expense were as follows:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.231%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:13.201%;"/&gt;
        &lt;td style="width:0.696%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:13.201%;"/&gt;
        &lt;td style="width:0.696%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Operating lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,017&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,780&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Short-term lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;52&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;309&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Variable lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,099&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;235&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total lease cost&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,168&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,324&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_81bb31f8-2750-4a3f-9878-f65b83a0f15c"
      unitRef="U_USD">3017000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_c667fb76-e556-450c-98ce-886aa1af9762"
      unitRef="U_USD">1780000</us-gaap:OperatingLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_5176242a-1142-4c2b-9fd4-ff8598ab15e3"
      unitRef="U_USD">52000</us-gaap:ShortTermLeaseCost>
    <us-gaap:ShortTermLeaseCost
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_56852c43-42b6-410d-bfed-5f2a406e1a47"
      unitRef="U_USD">309000</us-gaap:ShortTermLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_f88358eb-c3fa-434b-ac7c-748a1feffc3c"
      unitRef="U_USD">1099000</us-gaap:VariableLeaseCost>
    <us-gaap:VariableLeaseCost
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_5fc56ba9-7178-4b28-88b2-5c1088b3ac09"
      unitRef="U_USD">235000</us-gaap:VariableLeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_bf36f045-3ef7-48b6-86f6-21f6fca0bcfb"
      unitRef="U_USD">4168000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_49c7c041-210c-44e0-b7cd-feb72477b8d5"
      unitRef="U_USD">2324000</us-gaap:LeaseCost>
    <vor:ScheduleOfOperatingLeaseAssetsAndLiabilitiesWeightedAverageLeaseTermAndDiscountRateTableTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_e0332483-eae8-4064-8b43-765368155e01">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Amounts reported in the consolidated balance sheets and the weight-average lease term and discount rate information were as follows:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.61%;"/&gt;
        &lt;td style="width:1.585%;"/&gt;
        &lt;td style="width:1.37%;"/&gt;
        &lt;td style="width:11.927%;"/&gt;
        &lt;td style="width:2.313%;"/&gt;
        &lt;td style="width:1.585%;"/&gt;
        &lt;td style="width:1.37%;"/&gt;
        &lt;td style="width:11.927%;"/&gt;
        &lt;td style="width:2.313%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands except weighted-average amounts)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31, 2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31, 2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Operating right-of-use assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;15,670&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;17,117&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Operating lease liabilities, current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,839&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;863&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Operating lease liabilities, non-current&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;16,174&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;17,430&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;18,013&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;18,293&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted Average Lease Term and Discount Rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8.64&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9.55&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted-average discount rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9.4&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;</vor:ScheduleOfOperatingLeaseAssetsAndLiabilitiesWeightedAverageLeaseTermAndDiscountRateTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_87ac65d8-4978-436e-bc93-c2e391f9ec5e"
      unitRef="U_USD">15670000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_ed9194ec-550a-45a0-8a21-b3e22786b0f5"
      unitRef="U_USD">17117000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_8abfec8a-9a68-4448-a0b4-691512767e49"
      unitRef="U_USD">1839000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_a77f72c6-3d7a-440c-85fe-d6ac75b57e23"
      unitRef="U_USD">863000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_e77a2c57-2ec8-4a52-b65d-c9297d4f7462"
      unitRef="U_USD">16174000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_e429fd5a-bccc-4f86-9fcc-adea17cacdfa"
      unitRef="U_USD">17430000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_aa6dd1c4-9b76-463f-96a9-e6d990c610e3"
      unitRef="U_USD">18013000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_03f4a521-1cc9-4161-9f3f-a0e7668cf35a"
      unitRef="U_USD">18293000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      id="F_00f403d4-bf15-4f5d-a218-4f9764298c40">P8Y7M20D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      id="F_a6b95568-1a7b-4bae-8477-e75c461b2255">P9Y6M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="3"
      id="F_6a67759f-c01c-48f6-b9b1-2d9dbb75c900"
      unitRef="U_pure">0.094</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="3"
      id="F_f9b81021-122c-468c-9ff8-7503274f9a25"
      unitRef="U_pure">0.094</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <vor:ScheduleOfOtherLeaseActivityTableTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_aad56a5d-fbab-4ccf-8e22-4ffeae299921">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table represents other lease activity:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.224%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:13.2%;"/&gt;
        &lt;td style="width:0.696%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:13.211%;"/&gt;
        &lt;td style="width:0.696%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;Cash Flow Information&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Cash paid for amounts included in the measurement of&lt;br/&gt;&#160;&#160;&#160;lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Operating cash flows for operating leases&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,559&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;703&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Right-of-use assets obtained in exchange for lease obligations&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;35&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;17,899&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</vor:ScheduleOfOtherLeaseActivityTableTextBlock>
    <us-gaap:OperatingLeasePayments
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_20c8201e-2ede-4358-aad9-8b7ce3e60b99"
      unitRef="U_USD">2559000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_cc35f599-d201-4fa6-8c47-c79a56ebce15"
      unitRef="U_USD">703000</us-gaap:OperatingLeasePayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_24ebcd1f-f4f1-4f7b-8887-9625a2689d36"
      unitRef="U_USD">35000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_c6ee902b-6f27-4287-8a82-c6a3a3699fd9"
      unitRef="U_USD">17899000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_9ec41060-a572-4963-92e5-dbd93ddc1734">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Future lease payments for noncancelable leases as of were as follows:&lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:78.867%;"/&gt;
        &lt;td style="width:1.916%;"/&gt;
        &lt;td style="width:1.381%;"/&gt;
        &lt;td style="width:16.915%;"/&gt;
        &lt;td style="width:0.921%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;br/&gt;&#160;2021 &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);top:-3.752pt;white-space:pre-wrap;font-weight:bold;font-size:5.36pt;font-family:Times New Roman;position:relative;"&gt;(1)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2022&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,410&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2023&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,718&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2024&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,799&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2025&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,883&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2026&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,970&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Thereafter&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11,665&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total lease payments&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;26,445&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Less: imputed interest&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8,432&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Present value of lease liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;18,013&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:0.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;div style="border-top:0.750pt solid;margin-left:2.667%;padding-top:1.0pt;display:flex;margin-top:6.0pt;line-height:1.15;justify-content:flex-start;align-items:baseline;margin-bottom:0.0pt;min-width:4.667%;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;display:inline-flex;font-size:9.0pt;font-family:Times New Roman;justify-content:flex-start;min-width:4.794879434518611%;"&gt;(1)&lt;/span&gt;&lt;div style="display:inline;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:Times New Roman;"&gt;Excluded from the table above are a portion of the Company's lease payments associated with the Lease Amendments, as the space leased has not commenced for accounting purposes as of December 31, 2021. The commencement date is the date on which the asset is made available to the Company by the lessor.&lt;/span&gt;&lt;span style="white-space:pre-wrap;font-size:9.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/div&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_43d48545-a26e-4321-a066-d2e8bb0aa9cf"
      unitRef="U_USD">3410000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_b00d6e3d-efcb-46d1-9ec3-e9a1d1ab9091"
      unitRef="U_USD">2718000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_da3673dd-723b-475d-92d9-3060378307a2"
      unitRef="U_USD">2799000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_072473fc-4c23-4a7d-bd06-543f5c176d01"
      unitRef="U_USD">2883000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_46fdc5d2-2cfd-4291-b627-0c87f7e4f799"
      unitRef="U_USD">2970000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_8cb1ee7d-8977-4682-b756-ae9a36cc39bc"
      unitRef="U_USD">11665000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_f36f905c-9d7c-4e38-a043-9dfe7d7ebe50"
      unitRef="U_USD">26445000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_59a0857d-cd19-45ba-bece-99a582ef6dbe"
      unitRef="U_USD">8432000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_ee8b401c-3906-403d-b5af-9cf4b749c485"
      unitRef="U_USD">18013000</us-gaap:OperatingLeaseLiability>
    <vor:SignificantAgreementsTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_820763fe-ebc8-4cca-9602-b9ad21dfcb70">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;11. Significant Agreements&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has agreements with third parties in the normal course of business under which it has obtained licenses for certain developed technologies.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Columbia License Agreement&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In April 2016 (and amended in February 2019 and November 2021), the Company entered into an exclusive license agreement (the &#x201c;Columbia Agreement&#x201d;) with The Trustees of Columbia University in the City of New York (&#x201c;Columbia&#x201d;). Under the Columbia Agreement, the Company has exclusively licensed the worldwide rights to key patents, technical information, and use of materials from Columbia.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company is required to pay Columbia an annual license fee in the low five digits. The Company is also obligated to make milestone payments to Columbia of up to an aggregate of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million upon the achievement of certain clinical milestones and milestone payments to Columbia of up to an aggregate of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million for certain regulatory and commercial milestones for the first three products. In addition, the Company is required to pay Columbia escalating low single digits royalties on cumulative annual net sales of licensed products. As of  &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;December 31, 2021, and  2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, the Company had &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; obligation and $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million due, respectively, in milestone payments and this amount is included within accrued expenses balance on the consolidated balance sheet.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;National Institutes of Health License Agreement&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In October 2020, the Company entered into a patent license agreement (the &#x201c;Patent License&#x201d;) with the U.S. Department of Health and Human Services, as represented by National Cancer Institute (&#x201c;NCI&#x201d;) of the National Institutes of Health. Pursuant to the terms of the Patent License, the Company paid NCI a license issue fee in the aggregate amount of $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million. &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The terms of the Patent License also require the Company to pay NCI de minimis minimum annual royalties, which royalties are creditable against earned royalties on sales of licensed products or licensed processes. The Company must also pay NCI tiered royalties on net sales of licensed products at rates in the low single digits. The Company is also required to pay NCI one-time milestone payments upon successful completion of specified clinical and regulatory milestones relating to the licensed products. The aggregate potential&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;milestone &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;payments are $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;8.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million. In addition, the Company is required to pay NCI one-time milestone payments following aggregate net sales of licensed products at certain net sales up to $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; billion. The aggregate potential amount of these milestone payments is $&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million. To the extent the Company enters into a sublicensing agreement relating to a licensed product, the Company is required to pay NCI a percentage of the non-royalty based consideration received from a sublicensee, with specified exclusions, which percentage ranges from the low single digits to low double digits. The Company is also required to reimburse NCI for its past patent expenses for the licensed patent rights, as well as the Company&#x2019;s pro rata share of future patent expenses, in each case, in connection with NCI&#x2019;s prosecution or maintenance of the licensed patent rights.&lt;/span&gt;&lt;/p&gt;</vor:SignificantAgreementsTextBlock>
    <vor:LicenseAgreementPotentialMilestonePaymentsUponAchievementOfClinicalMilestones
      contextRef="C_5c1b58ed-1181-42ef-9936-9ee4e450ee86"
      decimals="-5"
      id="F_d9cd4475-7219-4e96-b041-e428d6f922ec"
      unitRef="U_USD">200000</vor:LicenseAgreementPotentialMilestonePaymentsUponAchievementOfClinicalMilestones>
    <vor:LicenseAgreementPotentialMilestonePaymentsUponAchievementOfRegulatoryAndCommercialMilestones
      contextRef="C_5c1b58ed-1181-42ef-9936-9ee4e450ee86"
      decimals="-5"
      id="F_d48534e5-b0cf-410e-b76e-49b3199fc8a7"
      unitRef="U_USD">6300000</vor:LicenseAgreementPotentialMilestonePaymentsUponAchievementOfRegulatoryAndCommercialMilestones>
    <vor:LicenseFeeObligatedToPay
      contextRef="C_2bd29414-3bf3-467c-b8da-0f5c54c35d29"
      decimals="INF"
      id="F_7afe1214-b105-4447-be1d-feea14c9e713"
      unitRef="U_USD">0</vor:LicenseFeeObligatedToPay>
    <vor:LicenseAgreementPotentialMilestonePayments
      contextRef="C_f6546c5b-8293-41ca-b559-c79fcc889b89"
      decimals="-5"
      id="F_a5e943a4-2cc0-4936-8d9a-71e760c9a4f3"
      unitRef="U_USD">100000</vor:LicenseAgreementPotentialMilestonePayments>
    <vor:LicenseFeeObligatedToPay
      contextRef="C_1a7d767a-18bf-417e-9a93-14efa9daffc7"
      decimals="-5"
      id="F_6e60b808-af41-4fe1-a29c-8e5ff825e2f6"
      unitRef="U_USD">400000</vor:LicenseFeeObligatedToPay>
    <vor:LicenseAgreementPotentialMilestonePayments
      contextRef="C_73eee50d-fc14-42b0-8920-b0a04312d39a"
      decimals="-5"
      id="F_f4a81267-dc17-4782-b9ab-22a372d21173"
      unitRef="U_USD">8000000.0</vor:LicenseAgreementPotentialMilestonePayments>
    <vor:LicenseAgreementMilestonePaymentsOnAggregateNetSales
      contextRef="C_9b3fa813-9828-49c2-a538-31ae7b11c4b9"
      decimals="-8"
      id="F_70a34b56-169a-47a6-ab0a-8237906a6ab7"
      unitRef="U_USD">2000000000.0</vor:LicenseAgreementMilestonePaymentsOnAggregateNetSales>
    <vor:LicenseAgreementPotentialMilestonePayments
      contextRef="C_26ff529e-e196-4005-ac31-d73430825eb5"
      decimals="-5"
      id="F_6daac0fc-961c-4fd9-b41f-150ca8db5f4e"
      unitRef="U_USD">6000000.0</vor:LicenseAgreementPotentialMilestonePayments>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_4715c2ca-0c34-4693-b9b8-6d2a90381b28">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;12. Commitments and Contingencies&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt;Legal Proceedings&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company is not currently a party to any material legal proceedings. At each reporting date, the Company evaluates whether or not a potential loss amount or potential range of loss is probable and reasonably estimated under the provisions of the authoritative guidance that addresses accounting for contingencies. The Company recognizes expenses for its costs related to its legal proceedings, as incurred.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_1cc5c708-b047-4d37-9f8b-8f028d458d98">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;13. Defined Contribution Benefit Plan&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company maintains a defined contribution plan under Section 401(k) (the &#x201c;401(k) Plan&#x201d;) of the Internal Revenue Code, as amended (the &#x201c;Code&#x201d;). The 401(k) Plan covers all employees who meet defined minimum age and service requirements and allows participants to defer a portion of their annual compensation on a pretax basis, as well as Roth post tax deferrals. During 2021, the Company began to match &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;100&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of compensation amounts deferred up to the first &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of an employee's compensation plus &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;50&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of compensation amounts deferred between &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% and &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;% of an employee's compensation. All matching contributions are immediately vested. Expense recognized by the Company for matching contributions made in accordance with the 401(k) Plan was &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; for the year ended December 31, 2021&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.&lt;/span&gt;&lt;/p&gt;</us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock>
    <us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="INF"
      id="F_35532089-e109-41ab-8352-b0b423bb4d8b"
      unitRef="U_pure">1</us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent>
    <vor:DefinedContributionPlanFirstPercentage
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="2"
      id="F_d41a6382-5ff9-4eae-86b0-2e2cc0400f54"
      unitRef="U_pure">0.01</vor:DefinedContributionPlanFirstPercentage>
    <vor:DefinedContributionPlanAdditionalPercentage
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="2"
      id="F_3d948b3e-582f-4767-aee5-46fae2cd3197"
      unitRef="U_pure">0.50</vor:DefinedContributionPlanAdditionalPercentage>
    <vor:Definedcontributionplanminimumannualcontributionsperemployeepercent
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="2"
      id="F_f19371e5-1571-4074-bbb0-1471f0a985b3"
      unitRef="U_pure">0.01</vor:Definedcontributionplanminimumannualcontributionsperemployeepercent>
    <us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="INF"
      id="F_b7738170-1296-4122-967d-24938b1b9f3c"
      unitRef="U_pure">0.06</us-gaap:DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent>
    <us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-5"
      id="F_c2eae9c5-8f0f-4de9-a54d-2ca7897d8775"
      unitRef="U_USD">600000</us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_0aade2ac-96d7-477c-9775-f04f45c9e601">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;14. Income Taxes&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company accounts for income taxes under FASB ASC 740 (&#x201c;ASC 740&#x201d;). For the years ended December 31, 2021 and 2020&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, the Company did not record a current or deferred income tax expense or benefit. &lt;/span&gt;&lt;span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table reconciles the federal statutory income rate to the Company&#x2019;s effective income tax rate: &lt;/span&gt;&lt;/span&gt;&lt;span style=""/&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.963%;"/&gt;
        &lt;td style="width:1.627%;"/&gt;
        &lt;td style="width:14.891%;"/&gt;
        &lt;td style="width:1.627%;"/&gt;
        &lt;td style="width:14.891%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Federal income tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;21.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;21.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;State income tax benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Permanent items&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;) %&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Research tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;) %&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;) %&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;30.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;) %&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;32.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;) %&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Effective income tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Deferred &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;tax assets and liabilities reflect the net tax effects of net operating loss and tax credit carryforwards and temporary differences between the carrying amount of assets and liabilities for financial reporting and the&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;amounts &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;used for tax purposes. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Significant components of the Company&#x2019;s deferred tax assets and liabilities were as follows:&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.163%;"/&gt;
        &lt;td style="width:1.595%;"/&gt;
        &lt;td style="width:1.371%;"/&gt;
        &lt;td style="width:13.031%;"/&gt;
        &lt;td style="width:0.921%;"/&gt;
        &lt;td style="width:1.595%;"/&gt;
        &lt;td style="width:1.371%;"/&gt;
        &lt;td style="width:13.031%;"/&gt;
        &lt;td style="width:0.921%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Deferred tax assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;972&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;659&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Federal net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;25,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11,515&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;State net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,913&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,113&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,675&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,851&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Stock compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;529&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;177&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;191&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Lease liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,675&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,941&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;44,015&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;23,256&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;39,401&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;18,414&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,614&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,842&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Lease right of use asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,234&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,624&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;380&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;218&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,614&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,842&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has weighed the positive and negative evidence to assess the recoverability of its deferred tax assets. Realization of future tax benefits is dependent on many factors, including the Company&#x2019;s ability to generate taxable income. After this assessment, the Company determined it was more likely than not that the Company will not realize the benefit of its deferred tax assets. As a result, the Company has provided a full valuation allowance against its net deferred tax assets. The valuation allowance for deferred tax assets as of December 31, 2021 and 2020 was &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;39.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;18.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively. For the years ended December 31, 2021 and 2020, the Company recorded an increase in the valuation allowance of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;21.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;14.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, respectively, primarily related to net operating losses and tax credits.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of  December 31, 2021, the Company had gross U.S. federal net operating loss carryforwards of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;119.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; including &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;117.4&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; that had an indefinite carryforward period and &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1.9&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; that were subject to expiration at various dates through &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2037&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. As of December 31, 2021, the Company had state net operating loss carryforwards of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;109.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; which will expire at various dates through &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2041&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. As of December 31, 2021, the Company had U.S. federal research and development tax credit carryforwards of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; which will expire at various dates through &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2041&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; and state research and credit carryforwards of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; million&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; which will expire at various dates through &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2036&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;. The net operating loss and tax credit carryforwards are subject to review and possible adjustment by the Internal Revenue Service and state tax authorities.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net operating loss and tax credit carryforwards may become subject to an annual limitation in the event of certain cumulative changes in the ownership interest of significant shareholders over a &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;three-year&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; period in excess of &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;50&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;%, as defined under Sections 382 and 383 of the Code, respectively, as well as similar state provisions. This could limit the amount of tax attributes that can be utilized annually to offset future taxable income or tax liabilities. The amount of the annual limitation is determined based on the value of the Company immediately prior to the ownership change. Subsequent ownership changes may further affect the limitation in future years. The Company has not determined whether an ownership change has occurred and as such, the Company&#x2019;s net operating losses may be limited. Any limitation may result in expiration of a portion of the net operating loss carryforwards or research development credit carryforwards before utilization.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company has not, as yet, conducted a study of research and development credit carryforwards. Such a study, once undertaken by the Company, may result in an adjustment to the research and development credit carryforwards. However, a full valuation allowance has been provided against the Company&#x2019;s research and development credits and, if any adjustment is required, such adjustment would be offset by an adjustment to the valuation allowance. Thus, there would be no impact to the balance sheet or statement of operations if any adjustment is required.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of December 31, 2021 and 2020, &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;the Company did &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;t have any unrecognized tax benefits. Any future interest and penalties related to income tax matters would be recognized in the provision for income tax. As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;December 31, 2021 and 2020,&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; the Company did &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;no&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;t have a balance of accrued interest and penalties related to uncertain tax positions.&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;In March 2020, the Coronavirus Aid, Relief, and Economic Security Act (the &#x201c;CARES Act&#x201d;) was signed into law. The CARES Act includes provisions relating to several aspects of corporate income taxes. The CARES Act did not have a significant impact on the Company&#x2019;s provision for income taxes.&lt;/span&gt;&lt;/p&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:6.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company files income tax returns in the United States and various states. &lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;As of &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;December 31, 2021 &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;, there were no income tax examinations in progress&lt;/span&gt;&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;.&lt;/span&gt;&lt;/p&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The tax years 2018 through present remain open to examination by major taxing jurisdictions to which the Company is subject, which are primarily in the United States. In addition, tax years prior to 2018 resulted in losses and the Company also generated research and development tax credits during those years. Since carryforward attributes generated in these years may be utilized in future years, years prior to 2018 may still be adjusted upon examination by the Internal Revenue Service or state tax authorities if they have or will be used in a future period.&lt;/span&gt;</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_7d6f2c40-b524-4f0c-921e-41f8ddbca014">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table reconciles the federal statutory income rate to the Company&#x2019;s effective income tax rate: &lt;/span&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.963%;"/&gt;
        &lt;td style="width:1.627%;"/&gt;
        &lt;td style="width:14.891%;"/&gt;
        &lt;td style="width:1.627%;"/&gt;
        &lt;td style="width:14.891%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="3" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Federal income tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;21.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;21.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;State income tax benefit&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6.0&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Permanent items&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;) %&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Research tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4.1&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5.8&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;%&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Other&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.3&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;) %&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;0.2&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;) %&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;30.5&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;) %&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;32.6&lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;) %&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Effective income tax rate&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="3"
      id="F_dc5d7911-3aea-4c01-9ae3-08e202a717f5"
      unitRef="U_pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="3"
      id="F_317d809d-4bdb-47e9-8b20-22d6ee9ea7e1"
      unitRef="U_pure">0.210</us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="3"
      id="F_eb46cb16-2b79-4377-99d1-c9007b230f76"
      unitRef="U_pure">0.060</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="3"
      id="F_c081efac-773c-4d2c-8d05-ebe9f5c01e1c"
      unitRef="U_pure">0.060</us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes>
    <us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="3"
      id="F_611dfbad-9511-49e8-978d-e1fe39c530dd"
      unitRef="U_pure">0.003</us-gaap:EffectiveIncomeTaxRateReconciliationNondeductibleExpense>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="3"
      id="F_2a934d48-d05c-4af8-8ba5-d595a36462de"
      unitRef="U_pure">0.041</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="3"
      id="F_215f5631-18f3-4c69-a0f6-3d156c834807"
      unitRef="U_pure">0.058</us-gaap:EffectiveIncomeTaxRateReconciliationTaxCreditsResearch>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="3"
      id="F_880a9258-6db2-490c-a043-cb39f37438a4"
      unitRef="U_pure">-0.003</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="3"
      id="F_174a5584-5c88-48a1-8c83-1c43f5acc803"
      unitRef="U_pure">-0.002</us-gaap:EffectiveIncomeTaxRateReconciliationOtherAdjustments>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="3"
      id="F_21ca3aab-0d49-4d5a-afa7-5429ccc35b4b"
      unitRef="U_pure">0.305</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="3"
      id="F_f0734c00-f9fb-4536-b046-6970efe7b424"
      unitRef="U_pure">0.326</us-gaap:EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance>
    <us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_10b2839a-8bf3-4524-8355-896af18f8a4b">&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Significant components of the Company&#x2019;s deferred tax assets and liabilities were as follows:&lt;/span&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.163%;"/&gt;
        &lt;td style="width:1.595%;"/&gt;
        &lt;td style="width:1.371%;"/&gt;
        &lt;td style="width:13.031%;"/&gt;
        &lt;td style="width:0.921%;"/&gt;
        &lt;td style="width:1.595%;"/&gt;
        &lt;td style="width:1.371%;"/&gt;
        &lt;td style="width:13.031%;"/&gt;
        &lt;td style="width:0.921%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Deferred tax assets:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Accrued expenses&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;972&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;659&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Federal net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;25,060&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;11,515&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;State net operating loss carryforwards&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;6,913&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;3,113&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Tax credits&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,675&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2,851&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Stock compensation&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;529&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;177&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;191&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Lease liability&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,675&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,941&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;44,015&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;23,256&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:20.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Valuation allowance&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;39,401&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;18,414&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net total deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,614&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,842&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Deferred tax liabilities:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Lease right of use asset&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,234&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,624&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Depreciation and amortization&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;380&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;218&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:20.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:20.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Total deferred tax liabilities&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,614&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;4,842&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net deferred tax assets&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_4225ce9b-c423-45e5-9c24-b7d9320905be"
      unitRef="U_USD">972000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_d55dddee-f9ba-4e4a-88e0-58e836c49559"
      unitRef="U_USD">659000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_92fef1ca-7b62-4a44-93cd-020d28875323"
      unitRef="U_USD">25060000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_ba698ba8-cf29-4900-81c3-8d085d482819"
      unitRef="U_USD">11515000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsDomestic>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_097f0d3e-b5af-4d3b-b7f6-c6e54ce21c62"
      unitRef="U_USD">6913000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_20140975-90a8-4284-aa12-1ee004048b74"
      unitRef="U_USD">3113000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_4246b18a-7451-4bef-a440-7346062f2bd1"
      unitRef="U_USD">5675000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwards
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_741fa593-7d41-4cbb-b235-2ef2e8e5c3ba"
      unitRef="U_USD">2851000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwards>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_1f59f427-95bc-4c72-96c3-8f01c8f996db"
      unitRef="U_USD">529000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_b37a48a3-b24c-46e8-9a45-b52edb86ac6d"
      unitRef="U_USD">177000</us-gaap:DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost>
    <vor:DeferredTaxAssetsAmortization
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_1472822c-7ed2-4d6c-b6d8-8d738dcc863e"
      unitRef="U_USD">191000</vor:DeferredTaxAssetsAmortization>
    <vor:DeferredTaxAssetsLeaseLiability
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_d4a911dd-6125-4ec0-98ff-5b1f75a69474"
      unitRef="U_USD">4675000</vor:DeferredTaxAssetsLeaseLiability>
    <vor:DeferredTaxAssetsLeaseLiability
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_8aec750e-f545-4675-86a7-0161064e1a99"
      unitRef="U_USD">4941000</vor:DeferredTaxAssetsLeaseLiability>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_a32292bf-5a9e-4aed-acb0-531f9096ddd9"
      unitRef="U_USD">44015000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsGross
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_4eec0105-43c6-449b-82ad-24081307108e"
      unitRef="U_USD">23256000</us-gaap:DeferredTaxAssetsGross>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_f3e3c949-21b3-4491-961d-4d15c219b8ee"
      unitRef="U_USD">39401000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_44b92285-2180-430b-a42e-24d17a280832"
      unitRef="U_USD">18414000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_0026dd37-af9f-46f7-90d1-8669984d5407"
      unitRef="U_USD">4614000</us-gaap:DeferredTaxAssetsNet>
    <us-gaap:DeferredTaxAssetsNet
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_0c2c10cc-36bf-4408-85fd-54ccee99dda6"
      unitRef="U_USD">4842000</us-gaap:DeferredTaxAssetsNet>
    <vor:DeferredTaxLiabilitiesLeaseRightOfUseAsset
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_c3ccc747-1746-4308-ac1a-488f1e38fb3b"
      unitRef="U_USD">4234000</vor:DeferredTaxLiabilitiesLeaseRightOfUseAsset>
    <vor:DeferredTaxLiabilitiesLeaseRightOfUseAsset
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_acbf7466-2235-43c7-ab2c-2ff54e431b72"
      unitRef="U_USD">4624000</vor:DeferredTaxLiabilitiesLeaseRightOfUseAsset>
    <vor:DeferredTaxLiabilitiesDepreciationAndAmortization
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_3f84344d-71e4-49c3-8fe7-2260107c9593"
      unitRef="U_USD">380000</vor:DeferredTaxLiabilitiesDepreciationAndAmortization>
    <vor:DeferredTaxLiabilitiesDepreciationAndAmortization
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_1fd52095-ceac-40e2-acf3-d8633e54f1c7"
      unitRef="U_USD">218000</vor:DeferredTaxLiabilitiesDepreciationAndAmortization>
    <us-gaap:DeferredTaxLiabilities
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_78e5c9ff-976e-4bd6-8322-436f14aaefd2"
      unitRef="U_USD">4614000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxLiabilities
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_c5deece7-e4ce-445c-82cb-fe6068326be8"
      unitRef="U_USD">4842000</us-gaap:DeferredTaxLiabilities>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-3"
      id="F_d684345f-2023-4257-9944-6ad643de3a33"
      unitRef="U_USD">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsLiabilitiesNet
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-3"
      id="F_c504eb25-6dbf-4267-a535-3ed163c4f35f"
      unitRef="U_USD">0</us-gaap:DeferredTaxAssetsLiabilitiesNet>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="-5"
      id="F_dd4b7df2-c19b-460e-93b7-de51b0391aa5"
      unitRef="U_USD">39400000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:DeferredTaxAssetsValuationAllowance
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="-5"
      id="F_fb77c518-f3d4-4300-9938-c47685c6db47"
      unitRef="U_USD">18400000</us-gaap:DeferredTaxAssetsValuationAllowance>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-5"
      id="F_bf90fe6f-c766-4b01-b14e-e8844a720546"
      unitRef="U_USD">21000000.0</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-5"
      id="F_355cb323-34ca-4400-b6f1-d1433351e4dc"
      unitRef="U_USD">14100000</us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_0b13dbfb-af9b-4e36-b831-4dc9d2f387b8"
      decimals="-5"
      id="F_2fa8e00f-ef29-4549-9ff2-86f1c00f6a86"
      unitRef="U_USD">119300000</us-gaap:OperatingLossCarryforwards>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration
      contextRef="C_0b13dbfb-af9b-4e36-b831-4dc9d2f387b8"
      decimals="-5"
      id="F_91e09ea8-f7e6-42af-a4bd-b671aa26a280"
      unitRef="U_USD">117400000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration>
    <us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration
      contextRef="C_0b13dbfb-af9b-4e36-b831-4dc9d2f387b8"
      decimals="-5"
      id="F_d9b8cc9e-9e6e-4c27-86ae-58391ee578cd"
      unitRef="U_USD">1900000</us-gaap:DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration>
    <vor:OperatingLossCarryforwardsExpirationYear
      contextRef="C_9ced81ea-4ae3-445d-910e-f3c298459ae8"
      id="F_bfe533c2-ac61-47e2-b17f-6d9424f4ab95">2037</vor:OperatingLossCarryforwardsExpirationYear>
    <us-gaap:OperatingLossCarryforwards
      contextRef="C_7a2f1c59-42b8-4077-b849-32e1f00d5329"
      decimals="-5"
      id="F_36287536-1c24-44dc-a22c-0a8bed550f72"
      unitRef="U_USD">109200000</us-gaap:OperatingLossCarryforwards>
    <vor:OperatingLossCarryforwardsExpirationYear
      contextRef="C_fb525106-40af-41f1-abca-fd6a6fdc8870"
      id="F_318e8278-1151-4d3a-b309-41f96175c112">2041</vor:OperatingLossCarryforwardsExpirationYear>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_0b13dbfb-af9b-4e36-b831-4dc9d2f387b8"
      decimals="-5"
      id="F_e4ee14e2-44f0-42b4-a12b-28f0ab11b8b6"
      unitRef="U_USD">3500000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <vor:TaxCreditCarryforwardsExpirationYear
      contextRef="C_9ced81ea-4ae3-445d-910e-f3c298459ae8"
      id="F_5e885d06-6d11-41ec-a005-1943d6c0d477">2041</vor:TaxCreditCarryforwardsExpirationYear>
    <us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch
      contextRef="C_7a2f1c59-42b8-4077-b849-32e1f00d5329"
      decimals="-5"
      id="F_ad3f0f3a-87aa-4cfd-8d33-4151379ac979"
      unitRef="U_USD">2800000</us-gaap:DeferredTaxAssetsTaxCreditCarryforwardsResearch>
    <vor:TaxCreditCarryforwardsExpirationYear
      contextRef="C_fb525106-40af-41f1-abca-fd6a6fdc8870"
      id="F_c2cd4300-194e-4ee5-acb2-f690a4021d80">2036</vor:TaxCreditCarryforwardsExpirationYear>
    <vor:ConsideredPeriodOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_617cce49-80e8-4c20-b8db-7c477dc47591">P3Y</vor:ConsideredPeriodOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards>
    <vor:ConsideredPercentageOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="2"
      id="F_22f09f15-9803-40ec-ad3a-d5b763880a05"
      unitRef="U_pure">0.50</vor:ConsideredPercentageOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="INF"
      id="F_1e09cea4-9ee7-4626-9d0d-a3681b57e7ee"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefits
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="INF"
      id="F_98924b3a-9636-4739-a04f-9545a8e30a86"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefits>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="C_df21a856-8ac4-4f90-a160-369dd5bc8faf"
      decimals="INF"
      id="F_a3592bd8-2950-4526-af9b-54bc31f4ff5b"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
      contextRef="C_14003f5b-14c6-46bb-a63b-569af36a4ed6"
      decimals="INF"
      id="F_77feef8f-5992-4a47-9064-5ee5cf82534b"
      unitRef="U_USD">0</us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued>
    <us-gaap:IncomeTaxExaminationDescription
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_e5e0ee91-11c9-4872-baa3-d9cdeef6ebcc">As of December 31, 2021 , there were no income tax examinations in progress</us-gaap:IncomeTaxExaminationDescription>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_884d618f-6ec3-42d8-a2e4-c7efca8a18ea">&lt;p style="text-indent:0.0%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt;15. Net Loss Per Share&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;&lt;div style="font-size:10.0pt;font-family:Times New Roman;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table sets forth the computation of the Company&#x2019;s basic and diluted net loss per share for the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;December 31, 2021 and 2020:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.957%;"/&gt;
        &lt;td style="width:1.595%;"/&gt;
        &lt;td style="width:1.37%;"/&gt;
        &lt;td style="width:13.253%;"/&gt;
        &lt;td style="width:0.921%;"/&gt;
        &lt;td style="width:1.595%;"/&gt;
        &lt;td style="width:1.37%;"/&gt;
        &lt;td style="width:13.018%;"/&gt;
        &lt;td style="width:0.921%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands, except share and per share amounts)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Numerator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;68,899&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;43,337&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Cumulative dividends on redeemable convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,228&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,925&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;70,127&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;49,262&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Denominator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted-average number of common shares outstanding, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;33,433,214&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;213,658&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net loss per share attributable to common stockholders, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;230.57&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;&lt;div style="font-size:11.0pt;font-family:Calibri;"&gt;&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company&#x2019;s potentially dilutive securities were redeemable convertible preferred stock and stock options. Based on the amounts outstanding at &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;December 31, 2021 and 2020, the Company excluded the following potential common shares from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.417%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:0.696%;"/&gt;
        &lt;td style="width:13.793%;"/&gt;
        &lt;td style="width:0.696%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:0.696%;"/&gt;
        &lt;td style="width:13.793%;"/&gt;
        &lt;td style="width:0.696%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Series A-1 redeemable convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,470,588&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Series A-2 redeemable convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,881,965&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Series B redeemable convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9,155,810&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Options to purchase common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,086,792&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,084,679&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_3cd691c5-5590-430d-b42b-62b9b416e2a8">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The following table sets forth the computation of the Company&#x2019;s basic and diluted net loss per share for the years ended &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;December 31, 2021 and 2020:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:65.957%;"/&gt;
        &lt;td style="width:1.595%;"/&gt;
        &lt;td style="width:1.37%;"/&gt;
        &lt;td style="width:13.253%;"/&gt;
        &lt;td style="width:0.921%;"/&gt;
        &lt;td style="width:1.595%;"/&gt;
        &lt;td style="width:1.37%;"/&gt;
        &lt;td style="width:13.018%;"/&gt;
        &lt;td style="width:0.921%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;Year Ended December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;(in thousands, except share and per share amounts)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Numerator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net loss&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;68,899&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;43,337&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Cumulative dividends on redeemable convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,228&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,925&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net loss attributable to common stockholders&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;70,127&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;49,262&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Denominator:&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Weighted-average number of common shares outstanding, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;33,433,214&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;213,658&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);text-indent:10.0pt;word-break:break-word;vertical-align:top;"&gt;&lt;p style="margin-left:10.0pt;text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Net loss per share attributable to common stockholders, basic and diluted&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;2.10&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;$&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(0,0,0,1);text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;(&lt;/span&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;230.57&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;border-bottom:2.250pt double rgba(255,255,255,0.01);"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;)&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_18b06889-1935-4619-8925-f160a0113d50"
      unitRef="U_USD">-68899000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_0e61da3a-b9b9-41d1-b40a-a546efba9075"
      unitRef="U_USD">-43337000</us-gaap:NetIncomeLoss>
    <us-gaap:RedeemablePreferredStockDividends
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_bbc4669f-bc77-4642-912d-f122bb54f8a4"
      unitRef="U_USD">1228000</us-gaap:RedeemablePreferredStockDividends>
    <us-gaap:RedeemablePreferredStockDividends
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_d0d0c4e3-374a-47dd-80a4-865388cad2b6"
      unitRef="U_USD">5925000</us-gaap:RedeemablePreferredStockDividends>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="-3"
      id="F_9e989ce0-faa4-456a-a83c-9ed279aac6e0"
      unitRef="U_USD">-70127000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="-3"
      id="F_073b4dd7-2840-45bb-a720-acffaa57d5e2"
      unitRef="U_USD">-49262000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="0"
      id="F_9073e201-46c4-4d33-abfe-b66c1581801d"
      unitRef="U_shares">33433214</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="0"
      id="F_d593e8e4-c661-4c44-877f-391dbd51d080"
      unitRef="U_shares">213658</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      decimals="2"
      id="F_eb3cd4f8-47a6-4a47-bc10-c90fbd8a3364"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-2.10</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="C_38911f38-ed40-46e3-aae3-567d07cc6536"
      decimals="2"
      id="F_39827f75-4ee5-4d84-b3be-91e4498194da"
      unitRef="U_UnitedStatesOfAmericaDollarsShare">-230.57</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96"
      id="F_0492f24f-0ec8-4ed3-842c-5358a961a95a">&lt;p style="text-indent:5.667%;font-size:10.0pt;margin-top:12.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:12.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;The Company&#x2019;s potentially dilutive securities were redeemable convertible preferred stock and stock options. Based on the amounts outstanding at &lt;/span&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;December 31, 2021 and 2020, the Company excluded the following potential common shares from the computation of diluted net loss per share attributable to common stockholders because including them would have had an anti-dilutive effect:&lt;/span&gt;&lt;span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt; &lt;/span&gt;&lt;/p&gt;
      &lt;table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;"&gt;
       &lt;tr style="visibility:collapse;"&gt;
        &lt;td style="width:66.417%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:0.696%;"/&gt;
        &lt;td style="width:13.793%;"/&gt;
        &lt;td style="width:0.696%;"/&gt;
        &lt;td style="width:1.606%;"/&gt;
        &lt;td style="width:0.696%;"/&gt;
        &lt;td style="width:13.793%;"/&gt;
        &lt;td style="width:0.696%;"/&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="6" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;As of December 31,&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:8.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2021&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:11.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:11.0pt;font-family:Calibri;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td colspan="2" style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(0,0,0,1);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:8.0pt;font-family:Times New Roman;"&gt;2020&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;border-bottom:0.500pt solid rgba(255,255,255,0.01);text-align:left;"&gt;&lt;p style="text-indent:0.0pt;font-size:8.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"&gt;&lt;span style="white-space:pre-wrap;font-size:8.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Series A-1 redeemable convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;1,470,588&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Series A-2 redeemable convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;7,881,965&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Series B redeemable convertible preferred stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;&#x2014;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;9,155,810&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(207,240,252,1);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
       &lt;tr style="height:10.0pt;"&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:top;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;Options to purchase common stock&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,086,792&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;text-align:center;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"&gt;&lt;span style="font-size:10.0pt;font-family:Times New Roman;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"&gt;5,084,679&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
        &lt;td style="background-color:rgba(0,0,0,0);word-break:break-word;vertical-align:bottom;"&gt;&lt;p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;line-height:1.05;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"&gt;&lt;span style="white-space:pre-wrap;font-size:10.0pt;font-family:Times New Roman;"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;
       &lt;/tr&gt;
      &lt;/table&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_4f4bd222-f291-4cc2-a0d9-e0451c423659"
      decimals="0"
      id="F_144a09bb-b92a-4830-8346-6c36cc642b31"
      unitRef="U_shares">1470588</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_28790eaf-526a-4566-8f5d-38d463cd96fa"
      decimals="0"
      id="F_95900678-513d-4a1d-a2a6-db96762d2ab9"
      unitRef="U_shares">7881965</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_4fad1b2e-548e-456c-a314-8f74671c228b"
      decimals="0"
      id="F_824384a4-17f6-478e-b6f9-27920a868855"
      unitRef="U_shares">9155810</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_bb722967-b149-4749-9edf-a5242ac6397a"
      decimals="0"
      id="F_99606cb9-79a6-4128-b202-8f723716f1b5"
      unitRef="U_shares">5086792</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="C_f5ef1ea6-c3b7-451a-8872-9c63fc489bc3"
      decimals="0"
      id="F_74369652-acc6-4386-965b-5177c142569f"
      unitRef="U_shares">5084679</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>97
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( +F!;E0'04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    " "Y@6Y4)BM^V.X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+!
M2L0P$(9?17)O)VW40^CFHGA2$%Q0O(5D=C?8-"$9:??M3>MN%]$'\)B9/]]\
M ].9*$U(^)Q"Q$0.\]7D^R%+$S?L0!0E0#8']#K7)3&4YBXDKZD\TQZB-A]Z
MC]!R?@L>25M-&F9@%5<B4YTUTB34%-();\V*CY^I7V#6 /;H<: ,3=T 4_/$
M>)SZ#BZ &4:8?/XNH%V)2_5/[-(!=DI.V:VI<1SK42RYLD,#;T^/+\NZE1LR
MZ<%@^96=I&/$#3M/?A5W]]L'IEK>MA4757.];;ELA!0W[[/K#[^+L _6[=P_
M-CX+J@Y^W87Z E!+ P04    " "Y@6Y4F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M +F!;E3H0_256P8  $$;   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MI9EK;]LV%(8_=[^",(IA!>I8-U_2)08<.UF]YN+9:8INV =:HFTADNB15)S\
M^QW*LI@&])&&?4DD6>?5HT/R/21UMN/B46X84^0Y33)YWMHHM?W4Z<APPU(J
M3_B69?#+BHN4*C@5ZX[<"D:C(BA-.I[C]#HIC;/6\*RX-A/#,YZK),[83!"9
MIRD5+Q<LX;OSEMLZ7)C'ZXW2%SK#LRU=LP537[<S 6>=2B6*4Y;)F&=$L-5Y
M:^1^F@1%0'''0\QV\M4QT:^RY/Q1GTRC\Y:CB5C"0J4E*/Q[8F.6)%H)./XI
M15O5,W7@Z^.#^E7Q\O R2RK9F"??XDAMSEN#%HG8BN:)FO/=9U:^4%?KA3R1
MQ5^RV]\;!"T2YE+QM P&@C3.]O_I<YF(UP'>D0"O#/#>!+C'GN"7 ?[;@/Z1
M@* ,"(K,[%^ER,.$*CH\$WQ'A+X;U/1!D<PB&EX_SG2[+Y2 7V.(4\,)#W-H
M1D5H%I'+3,7JA4RS?7_2[=(F7Q<3\LO[#V<=!8_309VPE+[82WM'I%V/W/!,
M;23H1BSZ4: #G!6L=X"]\%#%"0M/B.]^))[CN1:@,1Y^0\4)<8(BW+.$3_#P
MW_,,GN[8GO[#V_A5ZOU"SS^B-^9/3)"_1DNI!'3_OQ')H)(,"LF@KC7O7[;,
MUF)XN.NTOR 4W8JBB\J, "$J,*X2NK9AX/$KFDB&</0JCEZS;,R8B+GNWA&!
M06)-3(U2V?%^>O>NIO'[%5N_&=M5+$.:D.^,"G(%%Z6-#M>J01I42(/_A%1F
M[2@4KG;U'4$ZK9!.49%Q+L3;)&&MB*NUVZ[7]K%4N8ZQ30?5*JURSM:Q'K[
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M.I<Z1*;^/- I+0H=2>'XM@TZV(VI'=O7S]'_;":O)G.7"3IEQ3_Y0J[.!LD
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M8(H& ]L.#]4M_M\,G*#!&]""6.NSGXJ@8BT@0++,0@<?JX$Z)0*HND_!5CG
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M13.4T4U2Y]4W_O*)M@'Y:KZ4YU+_12^MK3-#:2TK7K2# 4'!RN8W^=TFXF@
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M**QNK?5"T+5N-DLJ9.O2TTR^1I@I@#Q/*16?"]6_VO<M^ =02P,$%     @
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M;W)K<VAE971S+W-H965T,3 N>&ULU5UMC]M&DOZ^OX*8/=S9@"3/C)V7LY,
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MGU^\(@QR9!X,8#Z1ZW,T<#WV8'9\C"681-'6)'75,-*0M'AR!(YF'-NZ(!F
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M*DXPN&">3PPON=& B+"A_=3Z!5(PSR;8'F@#5@=P"-N-P(7B4V(L OF]SP6
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MFS9C3.140WD.NBG04"$+ON74$DK'-:)XE%6ATP/I/XX3^U!Z2,L]2@H[YS]
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MX&8 MU+8"ZV4&F7]X?!-M^TPMN%?U57)XKX3P)6C9EU!*?TB1AYH.>E+SWM
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M, R]YU<07C&L@!%_Q$ZR+@G0CPT;L Y!BVV'80?%9F*ALN1*<M/\^U%RDB;
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MH7%_E >@.]7K#*L:KS0+94FW_+:B'P5JYT#W2Z7LSG )]K^>V1]02P,$%
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M00LPOU;HAMH74M#_R'/Z/U!+ P04    " "Y@6Y4K6BMUH($  #W"@  &0
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M;)Y EF;S$WAG0YYG >_L#;R8&?QUO7+>DA3^/H&Y&# 7 7/Q/VMW&N5\"L>
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M_*R*.5@TOA:RS.AB)")>W*B0Z4R4QJ, 4V,S(9&4UJK2"S!%]BO<9!W5A'I
MOW"*7L]5J1;:#]FDA<G1 '2YQ*IYKIA?F>H<MI"XA8(],A?.2U]Y8[<-3RL]
M&)NN3F19?/$"IBP6BJNZJP 17 _^#5M#4NZ9.F!3R<S!^UKB :E(XN%(_+7^
M&]QY>M994QLESGD5_PX^*O2'DIRBO2J<>"9&P[%XCO>L:O)B<*L<%$I7S"*%
MRS2".AG&6#(=7H+%/V&?[1#254)7@]]E7LG0P<B#LDP5WHY'PVF]<)P,SWGE
MNV/N:-1H_]\V@:,5TCD%;2C^N99SG6NO$15T1VJ=[/@2TX&#RQ*<, M^A-$
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M.:]!:"X%45 LO,MHMAI9>2?P!X>M/AH3Z\E:RGL[^35?>*$E!!5DQB(P_'N
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M=G?H&<H!E<!5.E@\L*%=PTJQ"DH,'#%4C5&39?H_:'U<9\(:."1*H=4;C/Z
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MZX5@@OV@&L-$TM#@6%9U=^:=;Q_3 >U:<!3'OYUQ'!#"*U@?/$48*&RZ!8W
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M&E6R$I()9_$[>"=Z2;XZ.2G'9'>3GID7?T<TS3MC]')7DY\C1O8.Z]' IG"
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MY\1^<!(GG*H33J7C=.@X,>KECE7F6)T/J,!89:C[(@_><4E^56T(U[R'3WA
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M(I<0"LRL0V#T><8K%,(!41I/&\Q@1^D"]_=;]!NOG;0LF,$K)7[SW!:38!A
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M&>;P&\0D;H#UM1!Z/T$#W8_5XC]02P,$%     @ N8%N5$9,LT$W!   UPD
M !D   !X;"]W;W)K<VAE971S+W-H965T,S,N>&ULC5;;;N,V$'W75PS<M$@
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MKSF03!986V@6,39R1(/1>*A,3@Q>)\]YV"-+C8FGGWZ(:33YI&U>M]S2EIM
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M!<NH,##+,KD6AHD2'B1G&4,-'V&6Y\Q=/N5P)YI/R(7B_0T:RKC^,(Z-I>2
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M^@M!93?0\YF4YGEB#\;%?\W@#U!+ P04    " "Y@6Y4-GCE[N(!  #7 P
M&0   'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6R%4U]OFS 0_RH6VD,G=3&!
M99TJ@I243<O#I*A1MX=I#PY<@E5C4_L([;??V1 43>OZ C[[?G_NSLYZ8Q]=
M#8#LN5':+:,:L;WEW)4U-,+-3 N:3@[&-@(IM$?N6@NB"J!&\22./_%&2!WE
M6=C;VCPS'2JI86N9ZYI&V)<U*-,OHWETWKB7QQK]!L^S5AQA!_C0;BU%?&*I
M9 /:2:.9A<,R6LUOUZG/#PD_)/3N8LU\)7MC'GVPJ991[ V!@A(]@Z#?">Y
M*4]$-IY&SFB2],#+]9G]:ZB=:MD+!W=&_905ULOH<\0J.(A.X;WIO\%8S\+S
ME4:Y\&7]D+L@Q;)S:)H13'$C]? 7SV,?+@#):X!D!"3!]R 47!8"19Y9TS/K
MLXG-+T*I 4WFI/9#V:&E4TDXS#?Z! ZIR^C8![:J*NF;)13;Z&'BOG57!:"0
MRKW/.)*F1_)RY%\/_,DK_ 64,Y;.KUD2)_'#KF!7[_YBX>1XLIU,MI- F[YM
M^YH5L$<F=,6^/'427]@.RLY2'>#8K]7>H:71__Z/:#J)ID'TX]NB_VK$ +X)
M8/\63GF<\=.E'K^8D[_RWX4]2NV8@@-AXMG-(F)VN$9#@*8-H]L;I(L0EC6]
M/+ ^@<X/QN Y\+=A>LOY'U!+ P04    " "Y@6Y409.(M$@$  !V&0  &0
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M!.X44E74X%2M0[U10','JG@8]WK#L*),!.G8K5VK="QKPYF :T5T7554/<V
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M2V5I:/RRHF<-M7.@\Y52=FNX ,-#F?\&4$L#!!0    ( +F!;E2F$J[HR0(
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M2KM?<9[_2CC/W[OV<5/63Z=]XM?<"/4"GPP:MO9^Q8'^B=N>'!'^<+7&5%A
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M/E'9 'J_E-(<!O8#33L[^0%02P,$%     @ N8%N5'$-OZQJ!   81$  !D
M  !X;"]W;W)K<VAE971S+W-H965T-3 N>&ULK5C?<YLX$/Y7-)X^M#.)03(&
MG'$\X]CM71\ZR21-^G!S#S*L;2: 7$F.X_^^DB#@&%!\R;TD(/;;_?:'=B6/
M=XP_BC6 1,]9FHO+WEK*S87CB&@-&15]MH%<?5DRGE&I7OG*$1L.-#:@+'6(
MZ_I.1I.\-QF;M1L^&;.M3),<;C@2VRRC?'\%*=M=]G#O9>$V6:VE7G FXPU=
MP1W(^\T-5V].I25.,LA%PG+$87G9F^*+.3$ (_&0P$X</"/MRH*Q1_WR/;[L
MN9H1I!!)K8*J?T\P@S35FA2/WZ727F53 P^?7[1_,\XK9Q94P(REOY)8KB][
M80_%L*3;5-ZRW=]0.C34^B*6"O,7[4I9MX>BK9 L*\&*09;DQ7_Z7 ;B *#T
MM -("2!' -(%&)2 P3%@T 'P2H!G(E.X8N(PIY).QISM$-?22IM^,,$T:.5^
MDNN\WTFNOB8*)R=WDD6/YU<J<C&:L4R5DZ F(>?HKB@%Q);(2*'KC?DRU:E*
MY!Y]GH.D22J^*.'[NSGZ_.D+^H0<)-:4@T!)CN[S1(HSM:B>?Z[95M \%F-'
M*N+:O!.5)*\*DJ2#)$8_6"[7 GW-8XA;\+,W\,2BP%$1J\)&7L)V1:P:KR/9
M1P-\AHA+W#9"=O@<H@J.6^#ST^&NQ9M!500#HV_0500Z8>>+9A%,.:?Y"M0^
MEVBQ1X=R-W1OEJ<[RN.SLC94KJ^W4DB5YB1?H7]N69HBM3^US+\6HEY%U#-$
M/1O1(R-4(A4/R!; K1DI- ^-9MT-GR9#-_3\8#1VGEHH#2M*PY,H_:4B)5N+
M\VK8L$Q&'L9!9;@@V!0+!FX8>NW\_(J??Q*_!Q"*'E)!0_ ,/$I$^T[R&RS.
M/4_Q#=II!!6-X"0:JAB6D+0':A8T;9-PZ(_"=MMA93L\R?;7YTW"VRV'3<N8
M^.UF1Y79T?]1K&W[?S9J*U95J^1US<Q;Y;J+&KOU6'!/C)FI%;I(X63RI>I#
M5MA761R2#E8'PPI;6?TR8QSB\^D3<'4L>:$'Z(8G$;RO,90V_0.Z@WYG!$G-
ME7R,:W?'F)6J=2#K$([Z7D=%XKK1X\''2)W:)DH[KQB2OMN5X;K!8WN'?Y.@
MM8&4RE^Q\OJX@U3=XK&]Q[])RM)9<+.MXXY^ANN>CNU-_:/[H'W;^LW@^?WC
M,34OQ4[<+O5\P/8!<4*,W]&)@@9750[##J[U/,'V@=+@>@OZBJ6#/5/G3*XN
M,UN:HI_ LU>I:*5H-Q6B/5#>=F:>OX$<%4@T1%EQ]L4HIGO+(0S7@PW;)]M_
M\O]=>;/;#XY=([[V3=@.]O7D(_;)-UVM.*RH!/1=N9*H&VZ$'FBZA3=362H.
M#G=&Z+KNT09J$R-JNK=7):F'([$/1POQ]^2@M'9($WN#QG'4.;A[9L!7Y@XO
M4,2VN2SN4]5J]3O!U-R.C]9G^&)>W/9K-<6/#S\H7REW4 I+I=+M!ZJ9\N(^
M7[Q(MC$WW 63ZKYL'M= 8^!:0'U?,B9?7K2!ZE>5R1]02P,$%     @ N8%N
M5-9(3_/F @  [ @  !D   !X;"]W;W)K<VAE971S+W-H965T-3$N>&ULS59=
M;]HP%/TK5M2'5EJ;+[Y: 5*!;JNT:@C:[6':@TDNQ*IC,]M NU^_:R>D*06T
METI](;9SS_&Y]P1?=S=2/>H,P)"GG O=\S)CEE>^KY,,<JHOY!($OIE+E5.#
M4[7P]5(!31THYWX4!"T_ITQX_:Y;&ZM^5ZX,9P+&BNA5GE/U/  N-STO]+8+
M$[;(C%WP^]TE7< 4S,-RK'#F5RPIRT%H)@51,.]YU^'5, PLP$7\8+#1M3&Q
MJ<RD?+23V[3G!581<$B,I:#X6,,0.+=,J.-/2>I5>UI@?;QE_^R2QV1F5,-0
M\I\L-5G/ZW@DA3E=<3.1FZ]0)M2T?(GDVOV231D;>"19:2/S$HP*<B:*)WTJ
M"U$#A*T#@*@$1+N Q@% 7 )BEVBAS*4UHH;VNTINB++1R&8'KC8.C=DP86V<
M&H5O&>),?VID\G@^P$*D9"AS_#HT=?4])]/"62+GY&#4S9,= SD=@:&,ZS/$
M/4Q'Y/3DC)P0)LA])E>:BE1W?8-R[:9^4DH;%-*B ]+"B-Q)83)-;D0*Z6L"
M'_.LDHVVR0ZBHXPC2"Y(''XB41"%>P0-_Q\>')$35[6/'5]\@.\F7W+Y#$"F
MH-8LP6=&%9 ]9;[F7";%\/N<3""1"\'^8M08%),V6!M-?GW##<BM@5S_/B*O
M4<EK.'F- _+NI:&<:&?]S&E*ZIJ@L'Z?KP5OV_':<V3=;\1AL^NOZ[5^&Q3&
MC:@*>B6Y64EN'I4\ 0U4)1G!+XZ,8(VGU!+/''.D&JV*NO41S6I7\MKO9%;!
MVZSY$$6=<,>LMT&M5G._5YU*<>>HXB\@0*%F:]5UBD<;TT91>Z@?*<=E17[Y
M$=T*@Y=C-W@GOTKB^A\G"N+&CF%[HEKM]HYC?JUOY* 6KIUJ5+(2ICA5J]6J
M95^[1K6S/K"MW/6C%YKB'G!'U8()33C,D3*X:.,WI(K66DR,7+KN-),&>YT;
M9G@= 64#\/U<2K.=V VJ"T[_'U!+ P04    " "Y@6Y4L0*[*S$$  ",$0
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MA''0^TO.U6YA K1/6_H74$L#!!0    ( +F!;E39Y= G%@,  &<)   9
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M6E9/6-71HK"OP$QH?%-L<XW//DBS .>70NA=QSPLS1^)X5]02P,$%     @
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M$B3-5%?U5.S 5)213TK:S) ?90KIMH, <;?@V3/X*^;U> W)*8GH"6$AHWL
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MSO%T?$3_Z+6CEC4SL%#BD>>VF :C@.2P896PW]7A$S1Z!@XO4\+X7W)H;*.
M9)6QJFR<D4')9?W/?C=Q.'&(TU<<:.- SQWZKS@DC4/BA=;,O*PELVPVT>I
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M4G4S6$^,+%T_=2\-=F=NF&$##<H>P/V5Q/PV$^N@;<G'?P%02P,$%     @
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M'A)1KUJ/O\'VNG%[6+6QN$S9DJ7C>JIGDVH8V(&-6E_@L(O<5I<?P7P<YD<
MP^)@"C ?YX7%^9_VTT?WXS!,6]^+]%&?/NKCO'S(N/I@<?P^B;W\.TV2*(IC
M+*/CL5?!&,M;',./GPW3!AY8'(CT9[G&JXUWR/X^P&JZKT.PG>*=B.T4SS4@
M_KR!1Y+XJXW% 0^L"ECO0'Q_'.@IOT\4054Q;=@3C"-)@B'0B_X>C6,D.S%\
M_/7!GI(H2A(_ IA?011A"#R-.((I  T8$D75>W#G?10V[ZEP_5^^T6]02P,$
M%     @ N8%N5)>*NQS     $P(   L   !?<F5L<R\N<F5L<YV2N6[#, Q
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M07DBTV1A1?E1OPL1Q>6VY;9(TQ&4S?,;(S>'5Q8/KUM^_P502P,$%     @
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M8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ N8%N5)E<G",0!@  G"<  !,
M             ( !S $  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4
M" "Y@6Y4Z$/TE5L&  !!&P  &               @($-"   >&PO=V]R:W-H
M965T<R]S:&5E=#$N>&UL4$L! A0#%     @ N8%N5&#9H,HC!@  L!H  !@
M             ("!G@X  'AL+W=O<FMS:&5E=',O<VAE970R+GAM;%!+ 0(4
M Q0    ( +F!;E0)?V# B00  / 8   8              " @?<4  !X;"]W
M;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4    " "Y@6Y4-/H<&_\#  ":
M#   &               @(&V&0  >&PO=V]R:W-H965T<R]S:&5E=#0N>&UL
M4$L! A0#%     @ N8%N5(HKL4%+!@  F!X  !@              ("!ZQT
M 'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4 Q0    ( +F!;E1Y*1EH
MG@(  !P%   8              " @6PD  !X;"]W;W)K<VAE971S+W-H965T
M-BYX;6Q02P$"% ,4    " "Y@6Y4I*KK?UT&  !X&   &
M@(% )P  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL4$L! A0#%     @ N8%N
M5,J*3T:> @  ZP8  !@              ("!TRT  'AL+W=O<FMS:&5E=',O
M<VAE970X+GAM;%!+ 0(4 Q0    ( +F!;E2[HE? R <  $(2   8
M      " @:<P  !X;"]W;W)K<VAE971S+W-H965T.2YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( +F!;E36:BH>OP(  !H&   9              "
M@85D  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL4$L! A0#%     @ N8%N
M5 MCW4AH!@  \!$  !D              ("!>V<  'AL+W=O<FMS:&5E=',O
M<VAE970Q-2YX;6Q02P$"% ,4    " "Y@6Y4K6BMUH($  #W"@  &0
M        @($:;@  >&PO=V]R:W-H965T<R]S:&5E=#$V+GAM;%!+ 0(4 Q0
M   ( +F!;E0N3B+YBP@  -85   9              " @=-R  !X;"]W;W)K
M<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @ N8%N5!@\;AH)"   PQ0
M !D              ("!E7L  'AL+W=O<FMS:&5E=',O<VAE970Q."YX;6Q0
M2P$"% ,4    " "Y@6Y45OY#(V<&  #L$   &0              @('5@P
M>&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4 Q0    ( +F!;E0^"'XF
MT@(  %(&   9              " @7.*  !X;"]W;W)K<VAE971S+W-H965T
M,C N>&UL4$L! A0#%     @ N8%N5)*^9!)G P  NP<  !D
M ("!?(T  'AL+W=O<FMS:&5E=',O<VAE970R,2YX;6Q02P$"% ,4    " "Y
M@6Y4_.3%0DD*  "7'   &0              @($:D0  >&PO=V]R:W-H965T
M<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( +F!;E2G?^C@"@0  )$)   9
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M970R-RYX;6Q02P$"% ,4    " "Y@6Y4M_.C3,8"  #W!0  &0
M    @(&VS   >&PO=V]R:W-H965T<R]S:&5E=#(X+GAM;%!+ 0(4 Q0    (
M +F!;E0Q[?/9S@(  /T%   9              " @;//  !X;"]W;W)K<VAE
M971S+W-H965T,CDN>&UL4$L! A0#%     @ N8%N5 5<7QL3 P  ; 8  !D
M             ("!N-(  'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6Q02P$"
M% ,4    " "Y@6Y4%%*(J&$$   D"@  &0              @($"U@  >&PO
M=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0    ( +F!;E2A+6 \-04
M &0-   9              " @9K:  !X;"]W;W)K<VAE971S+W-H965T,S(N
M>&UL4$L! A0#%     @ N8%N5$9,LT$W!   UPD  !D              ("!
M!N   'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q02P$"% ,4    " "Y@6Y4
MB4(9)SX$  !Y"@  &0              @(%TY   >&PO=V]R:W-H965T<R]S
M:&5E=#,T+GAM;%!+ 0(4 Q0    ( +F!;E2W)O.^" 0  /$.   9
M      " @>GH  !X;"]W;W)K<VAE971S+W-H965T,S4N>&UL4$L! A0#%
M  @ N8%N5%7TT$BV P  K@L  !D              ("!*.T  'AL+W=O<FMS
M:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " "Y@6Y4RS(1K]$"  "<"0
M&0              @($5\0  >&PO=V]R:W-H965T<R]S:&5E=#,W+GAM;%!+
M 0(4 Q0    ( +F!;E18%DKU/P,  .,,   9              " @1WT  !X
M;"]W;W)K<VAE971S+W-H965T,S@N>&UL4$L! A0#%     @ N8%N5#9XY>[B
M 0  UP,  !D              ("!D_<  'AL+W=O<FMS:&5E=',O<VAE970S
M.2YX;6Q02P$"% ,4    " "Y@6Y409.(M$@$  !V&0  &0
M@(&L^0  >&PO=V]R:W-H965T<R]S:&5E=#0P+GAM;%!+ 0(4 Q0    ( +F!
M;E294IX_B (  %8'   9              " @2O^  !X;"]W;W)K<VAE971S
M+W-H965T-#$N>&UL4$L! A0#%     @ N8%N5!CQTS83 P  F@L  !D
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M=#0V+GAM;%!+ 0(4 Q0    ( +F!;E3\QF4$2 ,  *@*   9
M  " @6H3 0!X;"]W;W)K<VAE971S+W-H965T-#<N>&UL4$L! A0#%     @
MN8%N5)19!0NJ!0  ?1@  !D              ("!Z18! 'AL+W=O<FMS:&5E
M=',O<VAE970T."YX;6Q02P$"% ,4    " "Y@6Y46@IY&E@#  #:"@  &0
M            @('*' $ >&PO=V]R:W-H965T<R]S:&5E=#0Y+GAM;%!+ 0(4
M Q0    ( +F!;E1Q#;^L:@0  &$1   9              " @5D@ 0!X;"]W
M;W)K<VAE971S+W-H965T-3 N>&UL4$L! A0#%     @ N8%N5-9(3_/F @
M[ @  !D              ("!^B0! 'AL+W=O<FMS:&5E=',O<VAE970U,2YX
M;6Q02P$"% ,4    " "Y@6Y4L0*[*S$$  ",$0  &0              @($7
M* $ >&PO=V]R:W-H965T<R]S:&5E=#4R+GAM;%!+ 0(4 Q0    ( +F!;E1T
M#A%ID@(  .8&   9              " @7\L 0!X;"]W;W)K<VAE971S+W-H
M965T-3,N>&UL4$L! A0#%     @ N8%N5-GET"<6 P  9PD  !D
M     ("!2"\! 'AL+W=O<FMS:&5E=',O<VAE970U-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( +F!;E1&I+&9V@(   T)   9              "
M@3H_ 0!X;"]W;W)K<VAE971S+W-H965T-3DN>&UL4$L! A0#%     @ N8%N
M5-!E-K?) P  50T  !D              ("!2T(! 'AL+W=O<FMS:&5E=',O
M<VAE970V,"YX;6Q02P$"% ,4    " "Y@6Y43SEA5H($  #.$0  &0
M        @(%+1@$ >&PO=V]R:W-H965T<R]S:&5E=#8Q+GAM;%!+ 0(4 Q0
M   ( +F!;E0L6W,$/ ,  - (   9              " @01+ 0!X;"]W;W)K
M<VAE971S+W-H965T-C(N>&UL4$L! A0#%     @ N8%N5((]C18B P  G@L
M !D              ("!=TX! 'AL+W=O<FMS:&5E=',O<VAE970V,RYX;6Q0
M2P$"% ,4    " "Y@6Y4L)8I"3(#  #R$P  #0              @ '040$
M>&PO<W1Y;&5S+GAM;%!+ 0(4 Q0    ( +F!;E27BKL<P    !,"   +
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4!08     1P!' &@3  "I7P$    !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>98
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>99
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>100
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>116</ContextCount>
  <ElementCount>404</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>46</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>100010 - Statement - CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>100030 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>100040 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>100050 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>100060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>100070 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>100080 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical</Role>
      <ShortName>CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>100090 - Disclosure - Nature of the Business</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusiness</Role>
      <ShortName>Nature of the Business</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>100100 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>100110 - Disclosure - Investments</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestments</Role>
      <ShortName>Investments</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>100120 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>100130 - Disclosure - Property and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNet</Role>
      <ShortName>Property and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>100140 - Disclosure - Accrued Expenses and Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>100150 - Disclosure - Redeemable Convertible Preferred Stock</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStock</Role>
      <ShortName>Redeemable Convertible Preferred Stock</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>100160 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>100170 - Disclosure - Stock-Based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensation</Role>
      <ShortName>Stock-Based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>100180 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>100190 - Disclosure - Significant Agreements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSignificantAgreements</Role>
      <ShortName>Significant Agreements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>100200 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>100210 - Disclosure - Defined Contribution Benefit Plan</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureDefinedContributionBenefitPlan</Role>
      <ShortName>Defined Contribution Benefit Plan</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>21</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>100220 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxes1</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>22</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>100230 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>23</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>100240 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>100250 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>100260 - Disclosure - Investments (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsTables</Role>
      <ShortName>Investments (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestments</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>100270 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurements</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>100280 - Disclosure - Property and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetTables</Role>
      <ShortName>Property and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNet</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>100290 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>100300 - Disclosure - Redeemable Convertible Preferred Stock (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockTables</Role>
      <ShortName>Redeemable Convertible Preferred Stock (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStock</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>100310 - Disclosure - Stock-Based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables</Role>
      <ShortName>Stock-Based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensation</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>100320 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeases</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>100330 - Disclosure - Income Taxes (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables</Role>
      <ShortName>Income Taxes (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxes1</ParentRole>
      <Position>33</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>100340 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShare</ParentRole>
      <Position>34</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>100350 - Disclosure - Nature of the Business - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails</Role>
      <ShortName>Nature of the Business - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>100360 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>100370 - Disclosure - Summary of Significant Accounting Policies - Estimated Useful Life of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfPropertyAndEquipmentDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Estimated Useful Life of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>100380 - Disclosure - Investments - Summary of Amortized Cost and Estimated Fair Value of Investments by Contractual Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails</Role>
      <ShortName>Investments - Summary of Amortized Cost and Estimated Fair Value of Investments by Contractual Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>100390 - Disclosure - Investments - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails</Role>
      <ShortName>Investments - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>100400 - Disclosure - Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>100410 - Disclosure - Fair Value Measurements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails</Role>
      <ShortName>Fair Value Measurements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>100420 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment, Net (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails</Role>
      <ShortName>Property and Equipment, Net - Schedule of Property and Equipment, Net (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>100430 - Disclosure - Property and Equipment, Net - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetails</Role>
      <ShortName>Property and Equipment, Net - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>100440 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>100450 - Disclosure - Redeemable Convertible Preferred Stock - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails</Role>
      <ShortName>Redeemable Convertible Preferred Stock - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>100460 - Disclosure - Redeemable Convertible Preferred Stock - Schedule of Redeemable Convertible Preferred Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails</Role>
      <ShortName>Redeemable Convertible Preferred Stock - Schedule of Redeemable Convertible Preferred Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>100470 - Disclosure - Stockholders' Equity - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails</Role>
      <ShortName>Stockholders' Equity - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>100480 - Disclosure - Stock-Based Compensation - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails</Role>
      <ShortName>Stock-Based Compensation - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>100490 - Disclosure - Stock-Based Compensation - Summary of Weighted-Average Assumptions Used Principally in Determining Fair Value of Options Granted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedPrincipallyInDeterminingFairValueOfOptionsGrantedDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Weighted-Average Assumptions Used Principally in Determining Fair Value of Options Granted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>100500 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Stock Option Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>100510 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>100520 - Disclosure - Leases - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails</Role>
      <ShortName>Leases - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>100530 - Disclosure - Leases - Summary of Lease Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseExpenseDetails</Role>
      <ShortName>Leases - Summary of Lease Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>100540 - Disclosure - Leases - Summary of Amounts Reported in Consolidated Balance Sheets and Weight-average Lease Term and Discount rate Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfAmountsReportedInConsolidatedBalanceSheetsAndWeightaverageLeaseTermAndDiscountRateInformationDetails</Role>
      <ShortName>Leases - Summary of Amounts Reported in Consolidated Balance Sheets and Weight-average Lease Term and Discount rate Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>100550 - Disclosure - Leases - Summary of Other Lease Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOtherLeaseActivityDetails</Role>
      <ShortName>Leases - Summary of Other Lease Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>100560 - Disclosure - Leases - Summary of Future Lease Payments for Noncancelable Leases (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails</Role>
      <ShortName>Leases - Summary of Future Lease Payments for Noncancelable Leases (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>100570 - Disclosure - Significant Agreements - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails</Role>
      <ShortName>Significant Agreements - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>100580 - Disclosure - Defined Contribution Benefit Plan - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureDefinedContributionBenefitPlanAdditionalInformationDetails</Role>
      <ShortName>Defined Contribution Benefit Plan - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>100590 - Disclosure - Income Taxes - Schedule of Reconciliation of Federal Statutory Income Rate to Effective Income Tax Rate (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeRateToEffectiveIncomeTaxRateDetails</Role>
      <ShortName>Income Taxes - Schedule of Reconciliation of Federal Statutory Income Rate to Effective Income Tax Rate (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>100600 - Disclosure - Income Taxes - Schedule of Significant Components of Deferred tax Assets and Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails</Role>
      <ShortName>Income Taxes - Schedule of Significant Components of Deferred tax Assets and Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>100610 - Disclosure - Income Taxes - Additional Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails</Role>
      <ShortName>Income Taxes - Additional Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>100620 - Disclosure - Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="vor-20211231.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>100630 - Disclosure - Net Loss Per Share - Potential Dilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share - Potential Dilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-K" original="vor-20211231.htm">vor-20211231.htm</File>
    <File>vor-20211231.xsd</File>
    <File>vor-20211231_cal.xml</File>
    <File>vor-20211231_def.xml</File>
    <File>vor-20211231_lab.xml</File>
    <File>vor-20211231_pre.xml</File>
    <File>vor-ex23_1.htm</File>
    <File>vor-ex31_1.htm</File>
    <File>vor-ex31_2.htm</File>
    <File>vor-ex32_1.htm</File>
    <File>vor-ex4_3.htm</File>
  </InputFiles>
  <SupplementalFiles>
    <File>img17388848_0.jpg</File>
    <File>img17388848_1.jpg</File>
    <File>img17388848_10.jpg</File>
    <File>img17388848_11.jpg</File>
    <File>img17388848_12.jpg</File>
    <File>img17388848_13.jpg</File>
    <File>img17388848_14.jpg</File>
    <File>img17388848_15.jpg</File>
    <File>img17388848_16.jpg</File>
    <File>img17388848_17.jpg</File>
    <File>img17388848_18.jpg</File>
    <File>img17388848_19.jpg</File>
    <File>img17388848_2.gif</File>
    <File>img17388848_20.jpg</File>
    <File>img17388848_3.gif</File>
    <File>img17388848_4.jpg</File>
    <File>img17388848_5.jpg</File>
    <File>img17388848_6.jpg</File>
    <File>img17388848_7.jpg</File>
    <File>img17388848_8.jpg</File>
    <File>img17388848_9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="534">http://fasb.org/us-gaap/2021-01-31</BaseTaxonomy>
    <BaseTaxonomy items="39">http://xbrl.sec.gov/dei/2021q4</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>103
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "vor-20211231.htm": {
   "axisCustom": 0,
   "axisStandard": 23,
   "contextCount": 116,
   "dts": {
    "calculationLink": {
     "local": [
      "vor-20211231_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "vor-20211231_def.xml"
     ]
    },
    "inline": {
     "local": [
      "vor-20211231.htm"
     ]
    },
    "labelLink": {
     "local": [
      "vor-20211231_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "vor-20211231_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "vor-20211231.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/dei/2021q4/dei-2021q4.xsd"
     ]
    }
   },
   "elementCount": 488,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2021-01-31": 4,
    "http://xbrl.sec.gov/dei/2021q4": 4,
    "total": 8
   },
   "keyCustom": 49,
   "keyStandard": 355,
   "memberCustom": 16,
   "memberStandard": 26,
   "nsprefix": "vor",
   "nsuri": "http://vorbiopharma.com/20211231",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100100 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100110 - Disclosure - Investments",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestments",
     "shortName": "Investments",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100120 - Disclosure - Fair Value Measurements",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100130 - Disclosure - Property and Equipment, Net",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNet",
     "shortName": "Property and Equipment, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100140 - Disclosure - Accrued Expenses and Other Current Liabilities",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities",
     "shortName": "Accrued Expenses and Other Current Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "vor:RedeemableConvertiblePreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100150 - Disclosure - Redeemable Convertible Preferred Stock",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStock",
     "shortName": "Redeemable Convertible Preferred Stock",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "vor:RedeemableConvertiblePreferredStockTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100160 - Disclosure - Stockholders' Equity",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100170 - Disclosure - Stock-Based Compensation",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensation",
     "shortName": "Stock-Based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100180 - Disclosure - Leases",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "vor:SignificantAgreementsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100190 - Disclosure - Significant Agreements",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSignificantAgreements",
     "shortName": "Significant Agreements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "vor:SignificantAgreementsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_df21a856-8ac4-4f90-a160-369dd5bc8faf",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100010 - Statement - CONSOLIDATED BALANCE SHEETS",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets",
     "shortName": "CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_df21a856-8ac4-4f90-a160-369dd5bc8faf",
      "decimals": "-3",
      "lang": null,
      "name": "us-gaap:ShortTermInvestments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100200 - Disclosure - Commitments and Contingencies",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100210 - Disclosure - Defined Contribution Benefit Plan",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureDefinedContributionBenefitPlan",
     "shortName": "Defined Contribution Benefit Plan",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100220 - Disclosure - Income Taxes",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxes1",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100230 - Disclosure - Net Loss Per Share",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShare",
     "shortName": "Net Loss Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100240 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "vor:PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100250 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "vor:PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100260 - Disclosure - Investments (Tables)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsTables",
     "shortName": "Investments (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100270 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100280 - Disclosure - Property and Equipment, Net (Tables)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetTables",
     "shortName": "Property and Equipment, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "vor:ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100290 - Disclosure - Accrued Expenses and Other Current Liabilities (Tables)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables",
     "shortName": "Accrued Expenses and Other Current Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "vor:ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "vor:RedeemableConvertiblePreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_14003f5b-14c6-46bb-a63b-569af36a4ed6",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquityParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100030 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
     "shortName": "CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_df21a856-8ac4-4f90-a160-369dd5bc8faf",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:PreferredStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "vor:RedeemableConvertiblePreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "vor:ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100300 - Disclosure - Redeemable Convertible Preferred Stock (Tables)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockTables",
     "shortName": "Redeemable Convertible Preferred Stock (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "vor:RedeemableConvertiblePreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "vor:ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100310 - Disclosure - Stock-Based Compensation (Tables)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables",
     "shortName": "Stock-Based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100320 - Disclosure - Leases (Tables)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100330 - Disclosure - Income Taxes (Tables)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables",
     "shortName": "Income Taxes (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100340 - Disclosure - Net Loss Per Share (Tables)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareTables",
     "shortName": "Net Loss Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:NatureOfOperations",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityIncorporationDateOfIncorporation",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100350 - Disclosure - Nature of the Business - Additional Information (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails",
     "shortName": "Nature of the Business - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:NatureOfOperations",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:EntityIncorporationDateOfIncorporation",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_Segment",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100360 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
     "shortName": "Summary of Significant Accounting Policies - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:SegmentReportingPolicyPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:NumberOfOperatingSegments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_Segment",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "vor:PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_8cfcd4c1-10fe-467a-9e2b-cc68414f8f0e",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100370 - Disclosure - Summary of Significant Accounting Policies - Estimated Useful Life of Property and Equipment (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfPropertyAndEquipmentDetails",
     "shortName": "Summary of Significant Accounting Policies - Estimated Useful Life of Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "vor:PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentPolicyTextBlock",
       "div",
       "us-gaap:SignificantAccountingPoliciesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_8cfcd4c1-10fe-467a-9e2b-cc68414f8f0e",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentUsefulLife",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "div",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_df21a856-8ac4-4f90-a160-369dd5bc8faf",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100380 - Disclosure - Investments - Summary of Amortized Cost and Estimated Fair Value of Investments by Contractual Maturity (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails",
     "shortName": "Investments - Summary of Amortized Cost and Estimated Fair Value of Investments by Contractual Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
       "div",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_df21a856-8ac4-4f90-a160-369dd5bc8faf",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_14003f5b-14c6-46bb-a63b-569af36a4ed6",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:Investments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100390 - Disclosure - Investments - Additional Information (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails",
     "shortName": "Investments - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_14003f5b-14c6-46bb-a63b-569af36a4ed6",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:Investments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100040 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
     "shortName": "CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ResearchAndDevelopmentExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_830618a5-a622-44e4-a728-a9181a23c735",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100400 - Disclosure - Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
     "shortName": "Fair Value Measurements - Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
       "div",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_830618a5-a622-44e4-a728-a9181a23c735",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AssetsFairValueDisclosure",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "vor:FairValueAssetsLevel1ToLevel2TransferredAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100410 - Disclosure - Fair Value Measurements - Additional Information (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails",
     "shortName": "Fair Value Measurements - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:FairValueDisclosuresTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "vor:FairValueAssetsLevel1ToLevel2TransferredAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_df21a856-8ac4-4f90-a160-369dd5bc8faf",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100420 - Disclosure - Property and Equipment, Net - Schedule of Property and Equipment, Net (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails",
     "shortName": "Property and Equipment, Net - Schedule of Property and Equipment, Net (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_df21a856-8ac4-4f90-a160-369dd5bc8faf",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:Depreciation",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100430 - Disclosure - Property and Equipment, Net - Additional Information (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetails",
     "shortName": "Property and Equipment, Net - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "vor:ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_df21a856-8ac4-4f90-a160-369dd5bc8faf",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100440 - Disclosure - Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails",
     "shortName": "Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses and Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "vor:ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock",
       "div",
       "us-gaap:AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_df21a856-8ac4-4f90-a160-369dd5bc8faf",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EmployeeRelatedLiabilitiesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "vor:RedeemableConvertiblePreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_14003f5b-14c6-46bb-a63b-569af36a4ed6",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100450 - Disclosure - Redeemable Convertible Preferred Stock - Additional Information (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
     "shortName": "Redeemable Convertible Preferred Stock - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "vor:RedeemableConvertiblePreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_52a58005-78a0-40c3-9da0-2ffe7154a555",
      "decimals": "INF",
      "lang": null,
      "name": "vor:TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "vor:RedeemableConvertiblePreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_14003f5b-14c6-46bb-a63b-569af36a4ed6",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:TemporaryEquitySharesAuthorized",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100460 - Disclosure - Redeemable Convertible Preferred Stock - Schedule of Redeemable Convertible Preferred Stock (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails",
     "shortName": "Redeemable Convertible Preferred Stock - Schedule of Redeemable Convertible Preferred Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "vor:ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock",
       "div",
       "vor:RedeemableConvertiblePreferredStockTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_14003f5b-14c6-46bb-a63b-569af36a4ed6",
      "decimals": "-3",
      "lang": null,
      "name": "vor:TemporaryEquityCumulativeUndeclaredDividends",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_df21a856-8ac4-4f90-a160-369dd5bc8faf",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:PreferredStockSharesAuthorized",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100470 - Disclosure - Stockholders' Equity - Additional Information (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
     "shortName": "Stockholders' Equity - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:CommonStockVotingRights",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_5704eb75-6122-4803-bb26-449ab2867e41",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100480 - Disclosure - Stock-Based Compensation - Additional Information (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
     "shortName": "Stock-Based Compensation - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_4ca00470-3222-46a5-ba00-840824cc64ac",
      "decimals": "INF",
      "lang": null,
      "name": "us-gaap:SharePrice",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "2",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
      "reportCount": 1,
      "unitRef": "U_UnitedStatesOfAmericaDollarsShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100490 - Disclosure - Stock-Based Compensation - Summary of Weighted-Average Assumptions Used Principally in Determining Fair Value of Options Granted (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedPrincipallyInDeterminingFairValueOfOptionsGrantedDetails",
     "shortName": "Stock-Based Compensation - Summary of Weighted-Average Assumptions Used Principally in Determining Fair Value of Options Granted (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_2d35f13a-de85-4de4-863e-43adb4567091",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_09163903-47da-4862-9c71-2100cb0e3e52",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100050 - Statement - CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit",
     "shortName": "CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_09163903-47da-4862-9c71-2100cb0e3e52",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:StockholdersEquity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_14003f5b-14c6-46bb-a63b-569af36a4ed6",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100500 - Disclosure - Stock-Based Compensation - Summary of Stock Option Activity (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails",
     "shortName": "Stock-Based Compensation - Summary of Stock Option Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "INF",
      "lang": null,
      "name": "vor:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100510 - Disclosure - Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails",
     "shortName": "Stock-Based Compensation - Summary of Stock-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "div",
       "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_1e278196-1cfd-446f-8d91-9976d22c5883",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100520 - Disclosure - Leases - Additional Information (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails",
     "shortName": "Leases - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_1e278196-1cfd-446f-8d91-9976d22c5883",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "us-gaap:LineOfCreditFacilityIncreaseDecreaseForPeriodNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100530 - Disclosure - Leases - Summary of Lease Expense (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseExpenseDetails",
     "shortName": "Leases - Summary of Lease Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LeaseCostTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_df21a856-8ac4-4f90-a160-369dd5bc8faf",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100540 - Disclosure - Leases - Summary of Amounts Reported in Consolidated Balance Sheets and Weight-average Lease Term and Discount rate Information (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfAmountsReportedInConsolidatedBalanceSheetsAndWeightaverageLeaseTermAndDiscountRateInformationDetails",
     "shortName": "Leases - Summary of Amounts Reported in Consolidated Balance Sheets and Weight-average Lease Term and Discount rate Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "vor:ScheduleOfOperatingLeaseAssetsAndLiabilitiesWeightedAverageLeaseTermAndDiscountRateTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_df21a856-8ac4-4f90-a160-369dd5bc8faf",
      "decimals": null,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "vor:ScheduleOfOtherLeaseActivityTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100550 - Disclosure - Leases - Summary of Other Lease Activity (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOtherLeaseActivityDetails",
     "shortName": "Leases - Summary of Other Lease Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "vor:ScheduleOfOtherLeaseActivityTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_df21a856-8ac4-4f90-a160-369dd5bc8faf",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100560 - Disclosure - Leases - Summary of Future Lease Payments for Noncancelable Leases (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails",
     "shortName": "Leases - Summary of Future Lease Payments for Noncancelable Leases (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "div",
       "us-gaap:LesseeOperatingLeasesTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_df21a856-8ac4-4f90-a160-369dd5bc8faf",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "vor:SignificantAgreementsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_f6546c5b-8293-41ca-b559-c79fcc889b89",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "vor:LicenseAgreementPotentialMilestonePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100570 - Disclosure - Significant Agreements - Additional Information (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails",
     "shortName": "Significant Agreements - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "vor:SignificantAgreementsTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_f6546c5b-8293-41ca-b559-c79fcc889b89",
      "decimals": "-5",
      "first": true,
      "lang": null,
      "name": "vor:LicenseAgreementPotentialMilestonePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100580 - Disclosure - Defined Contribution Benefit Plan - Additional Information (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureDefinedContributionBenefitPlanAdditionalInformationDetails",
     "shortName": "Defined Contribution Benefit Plan - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "INF",
      "first": true,
      "lang": null,
      "name": "us-gaap:DefinedContributionPlanEmployerMatchingContributionPercent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100590 - Disclosure - Income Taxes - Schedule of Reconciliation of Federal Statutory Income Rate to Effective Income Tax Rate (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeRateToEffectiveIncomeTaxRateDetails",
     "shortName": "Income Taxes - Schedule of Reconciliation of Federal Statutory Income Rate to Effective Income Tax Rate (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "3",
      "first": true,
      "lang": null,
      "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_pure",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100060 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_df21a856-8ac4-4f90-a160-369dd5bc8faf",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100600 - Disclosure - Income Taxes - Schedule of Significant Components of Deferred tax Assets and Liabilities (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails",
     "shortName": "Income Taxes - Schedule of Significant Components of Deferred tax Assets and Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_df21a856-8ac4-4f90-a160-369dd5bc8faf",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_df21a856-8ac4-4f90-a160-369dd5bc8faf",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:DeferredTaxAssetsValuationAllowance",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100610 - Disclosure - Income Taxes - Additional Information (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
     "shortName": "Income Taxes - Additional Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "us-gaap:IncomeTaxDisclosureTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "-5",
      "lang": null,
      "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100620 - Disclosure - Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails",
     "shortName": "Net Loss Per Share - Schedule of Computation of Basic and Diluted Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_4f4bd222-f291-4cc2-a0d9-e0451c423659",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100630 - Disclosure - Net Loss Per Share - Potential Dilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Details)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails",
     "shortName": "Net Loss Per Share - Potential Dilutive Securities Excluded from Computation of Diluted Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "div",
       "us-gaap:EarningsPerShareTextBlock",
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_4f4bd222-f291-4cc2-a0d9-e0451c423659",
      "decimals": "0",
      "first": true,
      "lang": null,
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_shares",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100070 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:ProfitLoss",
      "reportCount": 1,
      "unique": true,
      "unitRef": "U_USD",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "p",
       "td",
       "tr",
       "table",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_df21a856-8ac4-4f90-a160-369dd5bc8faf",
      "decimals": "-3",
      "first": true,
      "lang": null,
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "U_USD",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "100080 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical",
     "shortName": "CONSOLIDATED STATEMENTS OF CASH FLOWS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": null
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "100090 - Disclosure - Nature of the Business",
     "role": "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusiness",
     "shortName": "Nature of the Business",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "body",
       "html"
      ],
      "baseRef": "vor-20211231.htm",
      "contextRef": "C_0a2eada5-35e5-43d1-bfee-b4a982cf6b96",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NatureOfOperations",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 46,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_AuditorFirmId": {
     "auth_ref": [
      "r548",
      "r549",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PCAOB issued Audit Firm Identifier",
        "label": "Auditor Firm ID"
       }
      }
     },
     "localname": "AuditorFirmId",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "nonemptySequenceNumberItemType"
    },
    "dei_AuditorLocation": {
     "auth_ref": [
      "r548",
      "r549",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "localname": "AuditorLocation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_AuditorName": {
     "auth_ref": [
      "r548",
      "r549",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "localname": "AuditorName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "internationalNameItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentAnnualReport": {
     "auth_ref": [
      "r548",
      "r549",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an annual report.",
        "label": "Document Annual Report"
       }
      }
     },
     "localname": "DocumentAnnualReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "verboseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r551"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "auth_ref": [
      "r546"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Documents incorporated by reference.",
        "label": "Documents Incorporated by Reference [Text Block]",
        "terseLabel": "Documents Incorporated by Reference"
       }
      }
     },
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date when an entity was incorporated",
        "label": "Entity Incorporation, Date of Incorporation",
        "terseLabel": "Incorporation date"
       }
      }
     },
     "localname": "EntityIncorporationDateOfIncorporation",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityPublicFloat": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.",
        "label": "Entity Public Float"
       }
      }
     },
     "localname": "EntityPublicFloat",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "monetaryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "verboseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_EntityVoluntaryFilers": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.",
        "label": "Entity Voluntary Filers"
       }
      }
     },
     "localname": "EntityVoluntaryFilers",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "auth_ref": [
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.",
        "label": "Entity Well-known Seasoned Issuer"
       }
      }
     },
     "localname": "EntityWellKnownSeasonedIssuer",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_IcfrAuditorAttestationFlag": {
     "auth_ref": [
      "r548",
      "r549",
      "r550"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "localname": "IcfrAuditorAttestationFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r544"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021q4",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r221",
      "r234",
      "r282",
      "r283",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r472",
      "r501",
      "r503",
      "r541",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r221",
      "r234",
      "r282",
      "r283",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r472",
      "r501",
      "r503",
      "r541",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r147",
      "r261",
      "r262",
      "r474",
      "r500",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r147",
      "r261",
      "r262",
      "r474",
      "r500",
      "r502"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r221",
      "r234",
      "r263",
      "r282",
      "r283",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r472",
      "r501",
      "r503",
      "r541",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r221",
      "r234",
      "r263",
      "r282",
      "r283",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r472",
      "r501",
      "r503",
      "r541",
      "r542"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r88",
      "r89",
      "r90",
      "r91",
      "r151",
      "r152",
      "r172",
      "r173",
      "r174",
      "r175",
      "r177",
      "r178",
      "r209",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r355",
      "r356",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r402",
      "r403",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r438",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting standards update [Extensible list]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable, accrued expenses, and other liabilities that are classified as current at the end of the reporting period.",
        "label": "Accounts Payable, Accrued Liabilities, and Other Liabilities Disclosure, Current [Text Block]",
        "terseLabel": "Accrued Expenses and Other Current Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAccruedLiabilitiesAndOtherLiabilitiesDisclosureCurrentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r37",
      "r441"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable",
        "totalLabel": "Accounts Payable, Current, Total"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued expenses",
        "totalLabel": "Total accrued expenses"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r39"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r35",
      "r197"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedLabel": "Accumulated depreciation",
        "periodEndLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Ending Balance",
        "periodStartLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Beginning Balance",
        "totalLabel": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment, Total"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalCommonStock": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.",
        "label": "Additional Paid in Capital, Common Stock",
        "periodEndLabel": "Additional Paid in Capital, Common Stock, Ending Balance",
        "periodStartLabel": "Additional Paid in Capital, Common Stock, Beginning Balance",
        "terseLabel": "Additional paid-in capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r83",
      "r84",
      "r85",
      "r321",
      "r322",
      "r323",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r285",
      "r287",
      "r327",
      "r328"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation expense",
        "totalLabel": "APIC, Share-based Payment Arrangement, Increase for Cost Recognition, Total"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts": {
     "auth_ref": [
      "r249",
      "r257"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration.",
        "label": "Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs",
        "terseLabel": "Issuance of common shares upon closing of initial public offering, offering costs and underwriter fees"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementCondensedConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficitParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operations:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r287",
      "r313",
      "r326"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potential dilutive securities excluded from computation of diluted net loss per share"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ArrangementsAndNonarrangementTransactionsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Domain]"
       }
      }
     },
     "localname": "ArrangementsAndNonarrangementTransactionsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r79",
      "r133",
      "r141",
      "r145",
      "r168",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r367",
      "r371",
      "r401",
      "r439",
      "r441",
      "r480",
      "r493"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r8",
      "r10",
      "r45",
      "r79",
      "r168",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r367",
      "r371",
      "r401",
      "r439",
      "r441"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsFairValueDisclosure": {
     "auth_ref": [
      "r391"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Fair Value Disclosure",
        "terseLabel": "Total"
       }
      }
     },
     "localname": "AssetsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax": {
     "auth_ref": [
      "r157"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized gain in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax",
        "terseLabel": "Gross Unrealized Holding Gains"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax": {
     "auth_ref": [
      "r158"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before tax, of unrealized loss in accumulated other comprehensive income (AOCI) on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax",
        "negatedLabel": "Gross Unrealized Holding losses"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleDebtSecuritiesAmortizedCostBasis": {
     "auth_ref": [
      "r155",
      "r185"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amortized cost of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale, Amortized Cost",
        "totalLabel": "Amortized Cost"
       }
      }
     },
     "localname": "AvailableForSaleDebtSecuritiesAmortizedCostBasis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AvailableForSaleSecuritiesDebtSecurities": {
     "auth_ref": [
      "r154",
      "r156",
      "r185",
      "r484"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale",
        "terseLabel": "Fair Value",
        "totalLabel": "Debt Securities, Available-for-sale, Total"
       }
      }
     },
     "localname": "AvailableForSaleSecuritiesDebtSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r288",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedPrincipallyInDeterminingFairValueOfOptionsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location on balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Axis]"
       }
      }
     },
     "localname": "BalanceSheetLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BalanceSheetLocationDomain": {
     "auth_ref": [
      "r375",
      "r376"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the balance sheet (statement of financial position).",
        "label": "Balance Sheet Location [Domain]"
       }
      }
     },
     "localname": "BalanceSheetLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r71",
      "r72",
      "r73"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Purchases of property and equipment in accounts payable"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r6",
      "r32",
      "r69"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical": {
       "order": 0.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "periodEndLabel": "Cash and Cash Equivalents, at Carrying Value, Ending Balance",
        "periodStartLabel": "Cash and Cash Equivalents, at Carrying Value, Beginning Balance",
        "terseLabel": "Cash and cash equivalents",
        "totalLabel": "Cash and Cash Equivalents, at Carrying Value, Total"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsPolicyTextBlock": {
     "auth_ref": [
      "r17",
      "r70"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.",
        "label": "Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash and Cash Equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r17",
      "r70",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances.  Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents [Abstract]"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": {
     "auth_ref": [
      "r63",
      "r69",
      "r74"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations",
        "periodEndLabel": "Cash, cash equivalents and restricted cash equivalents, end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash equivalents, beginning of period",
        "totalLabel": "Total cash, cash equivalents and restricted cash equivalents as shown on the statements of cash flows"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r63",
      "r411"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net increase in cash, cash equivalents and restricted cash equivalents"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsMember": {
     "auth_ref": [
      "r17"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash Equivalents [Member]",
        "terseLabel": "Cash Equivalents"
       }
      }
     },
     "localname": "CashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted": {
     "auth_ref": [
      "r0",
      "r1",
      "r83",
      "r84",
      "r87",
      "r151",
      "r152",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r209",
      "r317",
      "r318",
      "r319",
      "r353",
      "r378",
      "r380",
      "r381",
      "r402",
      "r404",
      "r405",
      "r406",
      "r409",
      "r410",
      "r419",
      "r438",
      "r475",
      "r476",
      "r504",
      "r505",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates (true false) whether accounting standards update was adopted.",
        "label": "Change in Accounting Principle, Accounting Standards Update, Adopted [true false]",
        "terseLabel": "Change in accounting principle, accounting standards update, adopted [true false]"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdopted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate": {
     "auth_ref": [
      "r0",
      "r1",
      "r83",
      "r84",
      "r95",
      "r151",
      "r152",
      "r169",
      "r170",
      "r171",
      "r172",
      "r173",
      "r209",
      "r317",
      "r318",
      "r319",
      "r353",
      "r378",
      "r380",
      "r381",
      "r382",
      "r385",
      "r402",
      "r404",
      "r405",
      "r406",
      "r409",
      "r410",
      "r419",
      "r438",
      "r475",
      "r476",
      "r504",
      "r505",
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Date accounting standards update was adopted, in YYYY-MM-DD format.",
        "label": "Change in Accounting Principle, Accounting Standards Update, Adoption Date",
        "terseLabel": "Change in accounting principle, accounting standards update, adoption date"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateAdoptionDate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "dateItemType"
    },
    "us-gaap_ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect": {
     "auth_ref": [
      "r88",
      "r100",
      "r153",
      "r176",
      "r324",
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates (true false) whether effect from applying amendment to accounting standards is immaterial.",
        "label": "Change in Accounting Principle, Accounting Standards Update, Immaterial Effect [true false]",
        "terseLabel": "Change in accounting principle, accounting standards update, immaterial effect [true false]"
       }
      }
     },
     "localname": "ChangeInAccountingPrincipleAccountingStandardsUpdateImmaterialEffect",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r76",
      "r79",
      "r104",
      "r105",
      "r106",
      "r109",
      "r111",
      "r118",
      "r119",
      "r120",
      "r168",
      "r210",
      "r214",
      "r215",
      "r216",
      "r219",
      "r220",
      "r232",
      "r233",
      "r237",
      "r241",
      "r401",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class Of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]"
       }
      }
     },
     "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r203",
      "r204",
      "r205",
      "r206",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureCommitmentsAndContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r83",
      "r84",
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, shares authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r26"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued",
        "totalLabel": "Common Stock, Shares, Issued, Total"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r26",
      "r249"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending Balance, Shares",
        "periodStartLabel": "Beginning Balance, Shares",
        "terseLabel": "Common stock, shares outstanding"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r26",
      "r441"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "periodEndLabel": "Common Stock, Value, Issued, Ending Balance",
        "periodStartLabel": "Common Stock, Value, Issued, Beginning Balance",
        "terseLabel": "Common stock, $0.0001 par value; 400,000,000 and 420,000,000 shares authorized as of December 31, 2021 and December 31, 2020, respectively; 37,375,428 and 893,231 shares issued and 37,174,741 and 505,074 outstanding as of December 31, 2021 and December 31, 2020, respectively",
        "totalLabel": "Common Stock, Value, Issued, Total"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommonStockVotingRights": {
     "auth_ref": [
      "r250"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of voting rights of common stock. Includes eligibility to vote and votes per share owned. Include also, if any, unusual voting rights.",
        "label": "Common Stock, Voting Rights"
       }
      }
     },
     "localname": "CommonStockVotingRights",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CompensationAndRetirementDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Retirement Benefits [Abstract]"
       }
      }
     },
     "localname": "CompensationAndRetirementDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CompensationRelatedCostsPolicyTextBlock": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for salaries, bonuses, incentive awards, postretirement and postemployment benefits granted to employees, including equity-based arrangements; discloses methodologies for measurement, and the bases for recognizing related assets and liabilities and recognizing and reporting compensation expense.",
        "label": "Compensation Related Costs, Policy [Policy Text Block]",
        "terseLabel": "Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "CompensationRelatedCostsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Assets [Abstract]",
        "terseLabel": "Deferred tax assets:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxAssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComponentsOfDeferredTaxLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Components of Deferred Tax Liabilities [Abstract]",
        "terseLabel": "Deferred tax liabilities:"
       }
      }
     },
     "localname": "ComponentsOfDeferredTaxLiabilitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ComputerEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems.",
        "label": "Computer Equipment [Member]",
        "terseLabel": "Computer Equipment"
       }
      }
     },
     "localname": "ComputerEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfPropertyAndEquipmentDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r124",
      "r491"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentrations of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConvertiblePreferredStockSharesIssuedUponConversion": {
     "auth_ref": [
      "r24",
      "r25",
      "r244",
      "r250",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued for each share of convertible preferred stock that is converted.",
        "label": "Convertible Preferred Stock, Shares Issued upon Conversion",
        "verboseLabel": "Common Stock Issuable Upon Conversion"
       }
      }
     },
     "localname": "ConvertiblePreferredStockSharesIssuedUponConversion",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CorporateDebtSecuritiesMember": {
     "auth_ref": [
      "r264",
      "r278",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt securities issued by domestic or foreign corporate business, banks and other entities with a promise of repayment.",
        "label": "Corporate Debt Securities [Member]",
        "terseLabel": "Corporate Debt"
       }
      }
     },
     "localname": "CorporateDebtSecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CreditFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Axis]",
        "terseLabel": "Credit Facility"
       }
      }
     },
     "localname": "CreditFacilityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CreditFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.",
        "label": "Credit Facility [Domain]",
        "terseLabel": "Credit Facility"
       }
      }
     },
     "localname": "CreditFacilityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": {
     "auth_ref": [
      "r71",
      "r73"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.",
        "label": "Debt Conversion, Converted Instrument, Shares Issued",
        "terseLabel": "Number of shares converted"
       }
      }
     },
     "localname": "DebtConversionConvertedInstrumentSharesIssued1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_DebtConversionOriginalDebtAmount1": {
     "auth_ref": [
      "r71",
      "r73"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.",
        "label": "Debt Conversion, Original Debt, Amount",
        "terseLabel": "Convertible notes value"
       }
      }
     },
     "localname": "DebtConversionOriginalDebtAmount1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleTable": {
     "auth_ref": [
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).",
        "label": "Debt Securities, Available-for-sale [Table]",
        "terseLabel": "Debt Securities Available For Sale [Table]"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock": {
     "auth_ref": [
      "r161",
      "r186",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of fair value of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale), in unrealized loss position, without allowance for credit loss. Includes beneficial interest in securitized financial asset.",
        "label": "Debt Securities, Available-for-sale, Unrealized Loss Position, Fair Value [Table Text Block]",
        "terseLabel": "Summary of Amortized Cost and Estimated Fair Value of Investments by Contractual Maturity"
       }
      }
     },
     "localname": "DebtSecuritiesAvailableForSaleUnrealizedLossPositionFairValueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredChargesPolicyTextBlock": {
     "auth_ref": [
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for deferral and amortization of significant deferred charges.",
        "label": "Deferred Charges, Policy [Policy Text Block]",
        "terseLabel": "Deferred Offering Costs"
       }
      }
     },
     "localname": "DeferredChargesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DeferredOfferingCosts": {
     "auth_ref": [
      "r44",
      "r192"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific incremental costs directly attributable to a proposed or actual offering of securities which are deferred at the end of the reporting period.",
        "label": "Deferred Offering Costs",
        "terseLabel": "Deferred offering costs"
       }
      }
     },
     "localname": "DeferredOfferingCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsGross": {
     "auth_ref": [
      "r343"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Gross",
        "totalLabel": "Total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsLiabilitiesNet": {
     "auth_ref": [
      "r345"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.",
        "label": "Deferred Tax Assets, Net",
        "totalLabel": "Net deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsLiabilitiesNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsNet": {
     "auth_ref": [
      "r345"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.",
        "label": "Deferred Tax Assets, Net of Valuation Allowance",
        "totalLabel": "Net total deferred tax assets"
       }
      }
     },
     "localname": "DeferredTaxAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": {
     "auth_ref": [
      "r350",
      "r351"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic",
        "terseLabel": "Federal net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are not subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration",
        "terseLabel": "Net operating loss carryforwards not subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": {
     "auth_ref": [
      "r350",
      "r351"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local",
        "terseLabel": "State net operating loss carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards that are subject to expiration dates.",
        "label": "Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration",
        "terseLabel": "Net operating loss carryforwards subject to expiration"
       }
      }
     },
     "localname": "DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwards": {
     "auth_ref": [
      "r348",
      "r350",
      "r351"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before allocation of a valuation allowances, of deferred tax assets attributable to deductible tax credit carryforwards including, but not limited to, research, foreign, general business, alternative minimum tax, and other deductible tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards",
        "terseLabel": "Tax credits",
        "totalLabel": "Deferred Tax Assets, Tax Credit Carryforwards, Total"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxCreditCarryforwardsResearch": {
     "auth_ref": [
      "r348",
      "r350",
      "r351"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards.",
        "label": "Deferred Tax Assets, Tax Credit Carryforwards, Research",
        "terseLabel": "Research and development tax credit carryforwards"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxCreditCarryforwardsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": {
     "auth_ref": [
      "r350",
      "r351"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost",
        "terseLabel": "Stock compensation"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": {
     "auth_ref": [
      "r350",
      "r351"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.",
        "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities",
        "terseLabel": "Accrued expenses"
       }
      }
     },
     "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r344"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.",
        "label": "Deferred Tax Assets, Valuation Allowance",
        "negatedLabel": "Valuation allowance",
        "terseLabel": "Deferred tax assets valuation allowance",
        "totalLabel": "Deferred Tax Assets, Valuation Allowance, Total"
       }
      }
     },
     "localname": "DeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredTaxLiabilities": {
     "auth_ref": [
      "r334",
      "r345"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting.",
        "label": "Deferred Tax Liabilities, Net",
        "negatedTotalLabel": "Total deferred tax liabilities",
        "totalLabel": "Deferred Tax Liabilities, Net, Total"
       }
      }
     },
     "localname": "DeferredTaxLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerDiscretionaryContributionAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of discretionary contributions made by an employer to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Discretionary Contribution Amount",
        "terseLabel": "Defined contribution benefit plan, matching contributions amount"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerDiscretionaryContributionAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureDefinedContributionBenefitPlanAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DefinedContributionPlanEmployerMatchingContributionPercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of employees' gross pay for which the employer contributes a matching contribution to a defined contribution plan.",
        "label": "Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay",
        "terseLabel": "Defined contribution benefit plan, matching percentage"
       }
      }
     },
     "localname": "DefinedContributionPlanEmployerMatchingContributionPercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureDefinedContributionBenefitPlanAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum percentage of employee gross pay the employee may contribute to a defined contribution plan.",
        "label": "Defined Contribution Plan, Maximum Annual Contributions Per Employee, Percent",
        "terseLabel": "Defined contribution benefit plan, maximum percentage of employee's compensation"
       }
      }
     },
     "localname": "DefinedContributionPlanMaximumAnnualContributionsPerEmployeePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureDefinedContributionBenefitPlanAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r67",
      "r195"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation expense",
        "totalLabel": "Depreciation, Total"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r329"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Stock-Based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DividendsCommonStock": {
     "auth_ref": [
      "r257",
      "r490"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash, stock and payment-in-kind (PIK).",
        "label": "Dividends, Common Stock",
        "terseLabel": "Dividends declared",
        "totalLabel": "Dividends, Common Stock, Total"
       }
      }
     },
     "localname": "DividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DomesticCountryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of the government that is entitled to levy and collect income taxes from the entity in its country of domicile.",
        "label": "Domestic Tax Authority [Member]",
        "terseLabel": "Federal"
       }
      }
     },
     "localname": "DomesticCountryMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r110"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic and Diluted",
        "terseLabel": "Net loss per share attributable to common stockholders, basic and diluted",
        "totalLabel": "Earnings Per Share, Basic and Diluted, Total",
        "verboseLabel": "Net loss per share attributable to common stockholders, basic and diluted"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "verboseLabel": "Denominator:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r112",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r112",
      "r113",
      "r114",
      "r116"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": {
     "auth_ref": [
      "r80",
      "r335",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).",
        "label": "Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent",
        "terseLabel": "Federal income tax rate"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeRateToEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": {
     "auth_ref": [
      "r335",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.",
        "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent",
        "negatedLabel": "Valuation allowance"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeRateToEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpense": {
     "auth_ref": [
      "r335",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible expenses.",
        "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent",
        "negatedLabel": "Permanent items",
        "terseLabel": "Permanent items",
        "totalLabel": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent, Total"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeRateToEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": {
     "auth_ref": [
      "r335",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.",
        "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeRateToEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes": {
     "auth_ref": [
      "r335",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations applicable to state and local income tax expense (benefit), net of federal tax expense (benefit).",
        "label": "Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent",
        "terseLabel": "State income tax benefit"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeRateToEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EffectiveIncomeTaxRateReconciliationTaxCreditsResearch": {
     "auth_ref": [
      "r335",
      "r359"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to research tax credit.",
        "label": "Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent",
        "terseLabel": "Research tax credits"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationTaxCreditsResearch",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeRateToEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r39"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Employee-related and other expenses",
        "totalLabel": "Employee-related Liabilities, Current, Total"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r314"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized share based compensation expense, recognition period"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r314"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense related to stock options"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock Options",
        "verboseLabel": "Options to Purchase Common Stock"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedPrincipallyInDeterminingFairValueOfOptionsGrantedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r2",
      "r49",
      "r50",
      "r51",
      "r83",
      "r84",
      "r85",
      "r89",
      "r97",
      "r99",
      "r117",
      "r175",
      "r249",
      "r257",
      "r321",
      "r322",
      "r323",
      "r355",
      "r356",
      "r388",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r506",
      "r507",
      "r508",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r391",
      "r392",
      "r393",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": {
     "auth_ref": [
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Class of asset.",
        "label": "Asset Class [Domain]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByAssetClassAxis": {
     "auth_ref": [
      "r391",
      "r399"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of asset.",
        "label": "Asset Class [Axis]",
        "terseLabel": "Asset Class"
       }
      }
     },
     "localname": "FairValueByAssetClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r222",
      "r225",
      "r226",
      "r264",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r278",
      "r392",
      "r445",
      "r446",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r391",
      "r392",
      "r394",
      "r395",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r222",
      "r264",
      "r266",
      "r271",
      "r278",
      "r392",
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r222",
      "r225",
      "r226",
      "r264",
      "r266",
      "r271",
      "r278",
      "r392",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level 2"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r222",
      "r225",
      "r226",
      "r264",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r278",
      "r392",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level 3"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for fair value measurements of financial and non-financial assets, liabilities and instruments classified in shareholders' equity. Disclosures include, but are not limited to, how an entity that manages a group of financial assets and liabilities on the basis of its net exposure measures the fair value of those assets and liabilities.",
        "label": "Fair Value Measurement, Policy [Policy Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueMeasurementPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3": {
     "auth_ref": [
      "r397"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Transfers Into Level 3",
        "terseLabel": "Fair value assets, transfers into level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": {
     "auth_ref": [
      "r397"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3",
        "terseLabel": "Fair value assets, transfers out of level 3"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r222",
      "r225",
      "r226",
      "r264",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r278",
      "r445",
      "r446",
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r398",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r159",
      "r160",
      "r164",
      "r165",
      "r166",
      "r179",
      "r180",
      "r181",
      "r182",
      "r183",
      "r186",
      "r187",
      "r188",
      "r189",
      "r224",
      "r247",
      "r379",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivablesPeriodPastDueAxis": {
     "auth_ref": [
      "r149",
      "r181",
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by period in which financial asset is past due or not past due.",
        "label": "Financial Asset, Aging [Axis]",
        "terseLabel": "Financial Asset, Period Past Due"
       }
      }
     },
     "localname": "FinancingReceivablesPeriodPastDueAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinancingReceivablesPeriodPastDueDomain": {
     "auth_ref": [
      "r149",
      "r181",
      "r184"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which financial asset is past due or not past due. For past due, element name and standard label in Financial Asset, [numeric lower end] to [numeric higher end] [date measure] Past Due [Member] or Financial Asset, Greater than [low end numeric value] [date measure] Past Due [Member] or Financial Asset, Less than [high end numeric value] [date measure] Past Due [Member] formats.",
        "label": "Financial Asset, Aging [Domain]",
        "terseLabel": "Financial Asset, Period Past Due"
       }
      }
     },
     "localname": "FinancingReceivablesPeriodPastDueDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r418"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency Transaction Gains or Losses"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r54"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.",
        "label": "General and Administrative Expense",
        "terseLabel": "General and administrative",
        "totalLabel": "General and Administrative Expense, Total"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeneralAndAdministrativeExpenseMember": {
     "auth_ref": [
      "r53"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing general and administrative expense.",
        "label": "General and Administrative Expense [Member]",
        "terseLabel": "General and Administrative"
       }
      }
     },
     "localname": "GeneralAndAdministrativeExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IPOMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First sale of stock by a private company to the public.",
        "label": "IPO [Member]",
        "terseLabel": "IPO"
       }
      }
     },
     "localname": "IPOMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r193",
      "r200"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Impairment of Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r199",
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r202"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxAuthorityAxis": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by tax jurisdiction.",
        "label": "Income Tax Authority [Axis]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxAuthorityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Agency, division or body classification that levies income taxes, examines tax returns for compliance, or grants exemptions from or makes other decisions pertaining to income taxes.",
        "label": "Income Tax Authority [Domain]"
       }
      }
     },
     "localname": "IncomeTaxAuthorityDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r80",
      "r336",
      "r341",
      "r347",
      "r358",
      "r360",
      "r361",
      "r362",
      "r363"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxes1"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExaminationDescription": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A brief description of status of the tax examination, significant findings to date, and the entity's position with respect to the findings.",
        "label": "Income Tax Examination, Description",
        "terseLabel": "Income tax examination, description"
       }
      }
     },
     "localname": "IncomeTaxExaminationDescription",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r48",
      "r332",
      "r333",
      "r341",
      "r342",
      "r346",
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.",
        "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities",
        "terseLabel": "Accounts payable and accrued expenses",
        "totalLabel": "Increase (Decrease) in Accounts Payable and Accrued Liabilities, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r66",
      "r430"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liability"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssets": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating assets classified as other.",
        "label": "Increase (Decrease) in Other Operating Assets",
        "negatedLabel": "Other assets",
        "totalLabel": "Increase (Decrease) in Other Operating Assets, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets",
        "terseLabel": "Prepaid expenses and other current assets",
        "totalLabel": "Increase (Decrease) in Prepaid Expense and Other Assets, Total"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InformationByCategoryOfDebtSecurityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by category of debt security, either available-for-sale or held-to-maturity.",
        "label": "Debt Security Category [Axis]",
        "terseLabel": "Debt Security Category"
       }
      }
     },
     "localname": "InformationByCategoryOfDebtSecurityAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r55",
      "r132"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_NonoperatingIncomeExpense",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentPolicyTextBlock": {
     "auth_ref": [
      "r167",
      "r499"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for investment in financial asset.",
        "label": "Investment, Policy [Policy Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentTypeAxis": {
     "auth_ref": [
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of investments.",
        "label": "Investment Type [Axis]",
        "terseLabel": "Investment Type"
       }
      }
     },
     "localname": "InvestmentTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentTypeCategorizationMember": {
     "auth_ref": [
      "r518",
      "r519",
      "r520",
      "r521",
      "r522",
      "r523",
      "r524",
      "r525",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531",
      "r532"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asset obtained to generate income or appreciate in value.",
        "label": "Investments [Domain]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentTypeCategorizationMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Investments": {
     "auth_ref": [
      "r497"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all investments.",
        "label": "Investments",
        "terseLabel": "Investments",
        "totalLabel": "Investments, Total"
       }
      }
     },
     "localname": "Investments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureInvestmentsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentsDebtAndEquitySecuritiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investments, Debt and Equity Securities [Abstract]"
       }
      }
     },
     "localname": "InvestmentsDebtAndEquitySecuritiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r163",
      "r478",
      "r488",
      "r533",
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for  investments in certain debt and equity securities.",
        "label": "Investments in Debt and Marketable Equity Securities (and Certain Trading Assets) Disclosure [Text Block]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsInDebtAndMarketableEquitySecuritiesAndCertainTradingAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestments"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InvestmentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets held for their financial return, rather than for the entity's operations.",
        "label": "Investments [Member]",
        "terseLabel": "Investments"
       }
      }
     },
     "localname": "InvestmentsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseContractualTermAxis": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Axis]",
        "terseLabel": "Lease Contractual Term"
       }
      }
     },
     "localname": "LeaseContractualTermAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LeaseContractualTermDomain": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contractual term of lease arrangement.",
        "label": "Lease Contractual Term [Domain]",
        "terseLabel": "Lease Contractual Term"
       }
      }
     },
     "localname": "LeaseContractualTermDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r434",
      "r436"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total lease cost"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r434"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Summary of Lease Expense"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold Improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfPropertyAndEquipmentDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee Lease Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee Lease Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r424"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseExistenceOfOptionToExtend": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates (true false) whether lessee has option to extend operating lease.",
        "label": "Lessee, Operating Lease, Existence of Option to Extend [true false]"
       }
      }
     },
     "localname": "LesseeOperatingLeaseExistenceOfOptionToExtend",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "booleanItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Summary of Future Lease Payments for Noncancelable Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r435"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails2": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r435"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r435"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r435"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r435"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r435"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r435"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r435"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails2": {
       "order": 0.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedLabel": "Less: imputed interest",
        "terseLabel": "Less: imputed interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r425"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Lease term"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r38",
      "r79",
      "r142",
      "r168",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r368",
      "r371",
      "r372",
      "r401",
      "r439",
      "r440"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r31",
      "r79",
      "r168",
      "r401",
      "r441",
      "r481",
      "r495"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r40",
      "r79",
      "r168",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r368",
      "r371",
      "r372",
      "r401",
      "r439",
      "r440",
      "r441"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Long-term liabilities:"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LicenseMember": {
     "auth_ref": [
      "r262"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right to use intangible asset. Intangible asset includes, but is not limited to, patent, copyright, technology, manufacturing process, software or trademark.",
        "label": "Licensed Products"
       }
      }
     },
     "localname": "LicenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet": {
     "auth_ref": [
      "r78"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) of the credit facility.",
        "label": "Line of Credit Facility, Increase (Decrease), Net",
        "terseLabel": "Increase in irrevocable line of credit facility",
        "totalLabel": "Line of Credit Facility, Increase (Decrease), Net, Total"
       }
      }
     },
     "localname": "LineOfCreditFacilityIncreaseDecreaseForPeriodNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money Market Funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NatureOfOperations": {
     "auth_ref": [
      "r121",
      "r130"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the nature of an entity's business, major products or services, principal markets including location, and the relative importance of its operations in each business and the basis for the determination, including but not limited to, assets, revenues, or earnings. For an entity that has not commenced principal operations, disclosures about the risks and uncertainties related to the activities in which the entity is currently engaged and an understanding of what those activities are being directed toward.",
        "label": "Nature of Operations [Text Block]",
        "terseLabel": "Nature of the Business"
       }
      }
     },
     "localname": "NatureOfOperations",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusiness"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flow from financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r63"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flow from investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r63",
      "r65",
      "r68"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r5",
      "r46",
      "r47",
      "r51",
      "r52",
      "r68",
      "r79",
      "r88",
      "r93",
      "r94",
      "r95",
      "r96",
      "r98",
      "r99",
      "r107",
      "r133",
      "r140",
      "r143",
      "r144",
      "r146",
      "r168",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r390",
      "r401",
      "r485",
      "r498"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      },
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss and comprehensive loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss) Attributable to Parent [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "NetIncomeLossAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r93",
      "r94",
      "r95",
      "r96",
      "r102",
      "r103",
      "r108",
      "r111",
      "r133",
      "r140",
      "r143",
      "r144",
      "r146"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "totalLabel": "Net loss attributable to common stockholders"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r86",
      "r88",
      "r89",
      "r90",
      "r91",
      "r92",
      "r95",
      "r101",
      "r115",
      "r151",
      "r152",
      "r172",
      "r173",
      "r174",
      "r175",
      "r177",
      "r178",
      "r209",
      "r317",
      "r318",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r353",
      "r354",
      "r355",
      "r356",
      "r380",
      "r381",
      "r382",
      "r383",
      "r384",
      "r385",
      "r386",
      "r387",
      "r388",
      "r389",
      "r390",
      "r402",
      "r403",
      "r405",
      "r406",
      "r407",
      "r408",
      "r409",
      "r410",
      "r438",
      "r475",
      "r476",
      "r477",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514",
      "r515",
      "r563",
      "r564",
      "r565",
      "r566",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Pronouncements and Recently Adopted Accounting Pronouncements"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingGainsLossesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Nonoperating Gains (Losses) [Abstract]",
        "terseLabel": "Other income:"
       }
      }
     },
     "localname": "NonoperatingGainsLossesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r56"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "totalLabel": "Total other income"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r131"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segment"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r133",
      "r140",
      "r143",
      "r144",
      "r146"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "terseLabel": "Loss from operations",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r427",
      "r436"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseExpenseDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseExpense": {
     "auth_ref": [
      "r422"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating lease expense. Excludes sublease income.",
        "label": "Operating Lease, Expense",
        "terseLabel": "Non-cash lease expense",
        "verboseLabel": "Non-cash interest expense"
       }
      }
     },
     "localname": "OperatingLeaseExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r421"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfAmountsReportedInConsolidatedBalanceSheetsAndWeightaverageLeaseTermAndDiscountRateInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails2": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Present value of lease liabilities",
        "totalLabel": "Total lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfAmountsReportedInConsolidatedBalanceSheetsAndWeightaverageLeaseTermAndDiscountRateInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfFutureLeasePaymentsForNoncancelableLeasesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Lease, Liability [Abstract]",
        "terseLabel": "Liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfAmountsReportedInConsolidatedBalanceSheetsAndWeightaverageLeaseTermAndDiscountRateInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r421"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfAmountsReportedInConsolidatedBalanceSheetsAndWeightaverageLeaseTermAndDiscountRateInformationDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liability",
        "verboseLabel": "Operating lease liabilities, current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfAmountsReportedInConsolidatedBalanceSheetsAndWeightaverageLeaseTermAndDiscountRateInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r421"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfAmountsReportedInConsolidatedBalanceSheetsAndWeightaverageLeaseTermAndDiscountRateInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      },
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities\u2014non-current",
        "verboseLabel": "Operating lease liabilities, non-current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfAmountsReportedInConsolidatedBalanceSheetsAndWeightaverageLeaseTermAndDiscountRateInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r423",
      "r430"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash flows for operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOtherLeaseActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r420"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets",
        "verboseLabel": "Operating right-of-use assets"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfAmountsReportedInConsolidatedBalanceSheetsAndWeightaverageLeaseTermAndDiscountRateInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r433",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Weighted-average discount rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfAmountsReportedInConsolidatedBalanceSheetsAndWeightaverageLeaseTermAndDiscountRateInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r432",
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining lease term (years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfAmountsReportedInConsolidatedBalanceSheetsAndWeightaverageLeaseTermAndDiscountRateInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OperatingLossCarryforwards": {
     "auth_ref": [
      "r348"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.",
        "label": "Operating Loss Carryforwards",
        "terseLabel": "Net operating loss carryforwards",
        "totalLabel": "Operating Loss Carryforwards, Total"
       }
      }
     },
     "localname": "OperatingLossCarryforwards",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLossCarryforwardsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Operating Loss Carryforwards [Line Items]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLossCarryforwardsTable": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting pertinent information, such as tax authority, amounts, and expiration dates, of net operating loss carryforwards, including an assessment of the likelihood of utilization.",
        "label": "Operating Loss Carryforwards [Table]"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r13",
      "r14",
      "r15",
      "r39"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsCurrent": {
     "auth_ref": [
      "r44",
      "r441"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current assets classified as other.",
        "label": "Other Assets, Current",
        "terseLabel": "Other current assets"
       }
      }
     },
     "localname": "OtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsMember": {
     "auth_ref": [
      "r375",
      "r377"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing other assets.",
        "label": "Other Assets [Member]",
        "terseLabel": "Other Assets"
       }
      }
     },
     "localname": "OtherAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r36"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets",
        "totalLabel": "Other Assets, Noncurrent, Total"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r12",
      "r13",
      "r39",
      "r441"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other current liabilities",
        "totalLabel": "Other Liabilities, Current, Total",
        "verboseLabel": "Outstanding liability for unvested shares"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherOperatingActivitiesCashFlowStatement": {
     "auth_ref": [],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other cash or noncash adjustments to reconcile net income to cash provided by (used in) operating activities that are not separately disclosed in the statement of cash flows (for example,  cash received or cash paid during the current period for miscellaneous operating activities, net change during the reporting period in other assets or other liabilities).",
        "label": "Other Operating Activities, Cash Flow Statement",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherOperatingActivitiesCashFlowStatement",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain": {
     "auth_ref": [
      "r162"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Provides the categories of debt securities, available-for-sale or held-to-maturity, on which an entity may recognize other than temporary impairments (OTTI) for which a portion related to credit losses has been recognized in earnings and a portion related to all other factors has been recognized in other comprehensive income.",
        "label": "Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments [Domain]",
        "terseLabel": "Other than Temporary Impairment, Credit Losses Recognized in Earnings, Categories of Investments"
       }
      }
     },
     "localname": "OtherThanTemporaryImpairmentCreditLossesRecognizedInEarningsCategoriesOfInvestmentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsForRent": {
     "auth_ref": [
      "r64"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash payments to lessor's for use of assets under operating leases.",
        "label": "Payments for Rent",
        "terseLabel": "Aggregate total fixed rent payments"
       }
      }
     },
     "localname": "PaymentsForRent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfDividendsCommonStock": {
     "auth_ref": [
      "r60"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow in the form of ordinary dividends to common shareholders of the parent entity.",
        "label": "Payments of Ordinary Dividends, Common Stock",
        "terseLabel": "Dividends paid"
       }
      }
     },
     "localname": "PaymentsOfDividendsCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r61"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedLabel": "Payment of initial public offering costs",
        "terseLabel": "Payment of initial public offering costs"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireInvestments": {
     "auth_ref": [
      "r58"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the purchase of all investments (debt, security, other) during the period.",
        "label": "Payments to Acquire Investments",
        "negatedLabel": "Purchases of investments",
        "terseLabel": "Purchases of investments",
        "totalLabel": "Payments to Acquire Investments, Total"
       }
      }
     },
     "localname": "PaymentsToAcquireInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r57"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchases of property and equipment",
        "totalLabel": "Payments to Acquire Property, Plant, and Equipment, Total"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PensionAndOtherPostretirementBenefitsDisclosureTextBlock": {
     "auth_ref": [
      "r263",
      "r265",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r284"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for retirement benefits.",
        "label": "Retirement Benefits [Text Block]",
        "terseLabel": "Defined Contribution Benefit Plan"
       }
      }
     },
     "localname": "PensionAndOtherPostretirementBenefitsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureDefinedContributionBenefitPlan"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r288",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r25",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r25",
      "r232"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued",
        "totalLabel": "Preferred Stock, Shares Issued, Total"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r25"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "periodEndLabel": "Preferred Stock, Shares Outstanding, Ending Balance",
        "periodStartLabel": "Preferred Stock, Shares Outstanding, Beginning Balance",
        "terseLabel": "Preferred stock, shares outstanding"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValue": {
     "auth_ref": [
      "r25",
      "r441"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 0.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Preferred Stock, Value, Issued",
        "periodEndLabel": "Preferred Stock, Value, Issued, Ending Balance",
        "periodStartLabel": "Preferred Stock, Value, Issued, Beginning Balance",
        "terseLabel": "Preferred stock, $0.0001 par value; 10,000,000 and 0 shares authorized as of December 31, 2021 and December 31, 2020, respectively; 0 shares issued and outstanding as of December 31, 2021 and December 31, 2020",
        "totalLabel": "Preferred Stock, Value, Issued, Total"
       }
      }
     },
     "localname": "PreferredStockValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseCurrent": {
     "auth_ref": [
      "r7",
      "r9",
      "r190",
      "r191"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits within a future period of one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense, Current",
        "terseLabel": "Prepaid expenses",
        "totalLabel": "Prepaid Expense, Current, Total"
       }
      }
     },
     "localname": "PrepaidExpenseCurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceInitialPublicOffering": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.",
        "label": "Proceeds from Issuance Initial Public Offering",
        "terseLabel": "Proceeds from the issuance of common stock upon closing of initial public offering, net of underwriter fees",
        "verboseLabel": "Net proceeds from issuance of IPO"
       }
      }
     },
     "localname": "ProceedsFromIssuanceInitialPublicOffering",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock": {
     "auth_ref": [
      "r59"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from issuance of callable preferred stock which is identified as being convertible to another type of financial security at the option of the issuer or the holder.",
        "label": "Proceeds from Issuance of Redeemable Convertible Preferred Stock",
        "terseLabel": "Proceeds from issuance of redeemable convertible preferred stock",
        "verboseLabel": "Gross proceeds from stock issued"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r59",
      "r316"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from stock option exercises"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProfitLoss": {
     "auth_ref": [
      "r5",
      "r46",
      "r47",
      "r51",
      "r62",
      "r79",
      "r88",
      "r98",
      "r99",
      "r133",
      "r140",
      "r143",
      "r144",
      "r146",
      "r168",
      "r210",
      "r211",
      "r212",
      "r214",
      "r215",
      "r216",
      "r217",
      "r218",
      "r219",
      "r220",
      "r366",
      "r369",
      "r370",
      "r373",
      "r374",
      "r390",
      "r401",
      "r486"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 0.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.",
        "label": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest",
        "terseLabel": "Net loss",
        "totalLabel": "Net Income (Loss), Including Portion Attributable to Noncontrolling Interest, Total"
       }
      }
     },
     "localname": "ProfitLoss",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r35",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfPropertyAndEquipmentDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r201",
      "r538",
      "r539",
      "r540"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentEstimatedUsefulLives": {
     "auth_ref": [
      "r194"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment).",
        "label": "Property, Plant and Equipment, Estimated Useful Lives",
        "terseLabel": "Property and equipment, estimated useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentEstimatedUsefulLives",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r34",
      "r196"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "periodEndLabel": "Property, Plant and Equipment, Gross, Ending Balance",
        "periodStartLabel": "Property, Plant and Equipment, Gross, Beginning Balance",
        "terseLabel": "Property and equipment, gross",
        "totalLabel": "Property, Plant and Equipment, Gross, Total"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property Plant And Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfPropertyAndEquipmentDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r18",
      "r19",
      "r198",
      "r441",
      "r489",
      "r496"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "periodEndLabel": "Property, Plant and Equipment, Net, Ending Balance",
        "periodStartLabel": "Property, Plant and Equipment, Net, Beginning Balance",
        "terseLabel": "Property and equipment, net",
        "totalLabel": "Property and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r33",
      "r198",
      "r538",
      "r539"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r18",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r18",
      "r196"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfPropertyAndEquipmentDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Property and equipment, estimated useful life"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfPropertyAndEquipmentDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RedeemablePreferredStockDividends": {
     "auth_ref": [
      "r103",
      "r249",
      "r257"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      },
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Dividends paid to preferred stock holders that is redeemable solely at the option of the issuer.",
        "label": "Redeemable Preferred Stock Dividends",
        "negatedLabel": "Cumulative dividends on redeemable convertible preferred stock"
       }
      }
     },
     "localname": "RedeemablePreferredStockDividends",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r330",
      "r473",
      "r543"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss": {
       "order": 0.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development",
        "totalLabel": "Research and Development Expense, Total"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchMember": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Research tax credit carryforwards arising from certain qualifying expenditures incurred to develop new products and processes.",
        "label": "Research Tax Credit Carryforward [Member]",
        "terseLabel": "Research and Development Tax Credit"
       }
      }
     },
     "localname": "ResearchMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCashEquivalentsNoncurrent": {
     "auth_ref": [
      "r11",
      "r20",
      "r74",
      "r534",
      "r535",
      "r536"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash equivalents restricted as to withdrawal or usage, classified as noncurrent. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Restricted Cash Equivalents, Noncurrent",
        "terseLabel": "Restricted cash",
        "verboseLabel": "Restricted cash equivalents"
       }
      }
     },
     "localname": "RestrictedCashEquivalentsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlowsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r28",
      "r257",
      "r324",
      "r441",
      "r494",
      "r510",
      "r515"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "periodEndLabel": "Retained Earnings (Accumulated Deficit), Ending Balance",
        "periodStartLabel": "Retained Earnings (Accumulated Deficit), Beginning Balance",
        "terseLabel": "Accumulated deficit",
        "totalLabel": "Retained Earnings (Accumulated Deficit), Total"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r2",
      "r83",
      "r84",
      "r85",
      "r89",
      "r97",
      "r99",
      "r175",
      "r321",
      "r322",
      "r323",
      "r355",
      "r356",
      "r388",
      "r506",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r431",
      "r436"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use assets obtained in exchange for lease obligations"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOtherLeaseActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction.",
        "label": "Sale of Stock, Price Per Share",
        "terseLabel": "Public offering price per share"
       }
      }
     },
     "localname": "SaleOfStockPricePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r112"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Potential Dilutive Securities Excluded from Computation of Diluted Net Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAvailableForSaleSecuritiesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Securities, Available-for-sale [Line Items]",
        "terseLabel": "Schedule Of Available For Sale Securities [Line Items]"
       }
      }
     },
     "localname": "ScheduleOfAvailableForSaleSecuritiesLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]"
       }
      }
     },
     "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": {
     "auth_ref": [
      "r345"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.",
        "label": "Schedule of Deferred Tax Assets and Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Significant Components of Deferred Tax Assets and Liabilities"
       }
      }
     },
     "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r111"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Computation of Basic and Diluted Net Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.",
        "label": "Schedule of Effective Income Tax Rate Reconciliation [Table Text Block]",
        "terseLabel": "Schedule of Reconciliation of Federal Statutory Income Rate to Effective Income Tax Rate"
       }
      }
     },
     "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r287",
      "r312",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Schedule Of Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r287",
      "r312",
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Summary of Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock": {
     "auth_ref": [
      "r391",
      "r392"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets and liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).",
        "label": "Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Summary of Financial Assets and Liabilities Measured at Fair Value on Recurring Basis"
       }
      }
     },
     "localname": "ScheduleOfFairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r35",
      "r198"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Schedule Of Property Plant And Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfPropertyAndEquipmentDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r288",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule Of Share Based Compensation Arrangements By Share Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedPrincipallyInDeterminingFairValueOfOptionsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r293",
      "r300",
      "r303"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Summary of Stock Option Activity"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r306"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Summary of Weighted-Average Assumptions Used Principally in Determining Fair Value of Options Granted"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r41",
      "r76",
      "r118",
      "r119",
      "r227",
      "r230",
      "r231",
      "r232",
      "r233",
      "r234",
      "r235",
      "r237",
      "r241",
      "r247",
      "r250",
      "r251",
      "r252",
      "r254",
      "r255",
      "r256",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule Of Stock By Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r139",
      "r148"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r66"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation",
        "totalLabel": "Share-based Payment Arrangement, Noncash Expense, Total"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of service or performance condition required to be met for earning right to award under share-based payment arrangement. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights",
        "terseLabel": "Vesting rights description"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingRights",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r309"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield",
        "verboseLabel": "Expected dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedPrincipallyInDeterminingFairValueOfOptionsGrantedDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r308"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "terseLabel": "Expected volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedPrincipallyInDeterminingFairValueOfOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedPrincipallyInDeterminingFairValueOfOptionsGrantedDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share Based Compensation Arrangement By Share Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedPrincipallyInDeterminingFairValueOfOptionsGrantedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant",
        "terseLabel": "Number of shares available for future issuance"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number",
        "terseLabel": "Shares, Exercisable at December 31, 2021"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted-Average Exercise Price, Exercisable at December 31, 2021"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r302"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "terseLabel": "Intrinsic value of stock options exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod": {
     "auth_ref": [
      "r299"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options or other stock instruments for which the right to exercise has lapsed under the terms of the plan agreements.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period",
        "negatedLabel": "Shares, Expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r298"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedLabel": "Shares, Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Shares, Granted",
        "verboseLabel": "Stock options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r301"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Fair value of common stock",
        "verboseLabel": "Weighted-average grant-date fair value of stock options granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedPrincipallyInDeterminingFairValueOfOptionsGrantedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r315"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Outstanding",
        "terseLabel": "Aggregate Intrinsic Value, Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r295",
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Shares, Outstanding at December 31, 2021",
        "periodStartLabel": "Shares, Outstanding at December 31, 2020"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r294"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Weighted-Average Exercise Price, Outstanding at December 31, 2021",
        "periodStartLabel": "Weighted-Average Exercise Price, Outstanding at December 31, 2020"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r305"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Weighted-average exercise price exercised but unvested at the time of exercise"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Number of shares exercised but unvested at the time of exercise"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum number of shares that may be issued in accordance with the plan as a proportion of outstanding capital stock.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum",
        "terseLabel": "Shares reserved for issuance increase percentage of total number of shares of common stock outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r286",
      "r291"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedPrincipallyInDeterminingFairValueOfOptionsGrantedDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options of the plan that expired.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-Average Exercise Price, Expired"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-Average Exercise Price, Forfeited"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Weighted-Average Exercise Price, Granted"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche One [Member]",
        "terseLabel": "Tranche One"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheOneMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationAwardTrancheTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second portion of award under share-based payment arrangement differentiated by vesting feature, including, but not limited to, performance measure or service period.",
        "label": "Share-based Payment Arrangement, Tranche Two [Member]",
        "terseLabel": "Tranche Two"
       }
      }
     },
     "localname": "ShareBasedCompensationAwardTrancheTwoMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Price of a single share of a number of saleable stocks of a company.",
        "label": "Strike price"
       }
      }
     },
     "localname": "SharePrice",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage of vesting of award under share-based payment arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage",
        "terseLabel": "Vesting percentage"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period",
        "terseLabel": "Contractual term",
        "verboseLabel": "Shares, expired"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r307",
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Expected term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationSummaryOfWeightedAverageAssumptionsUsedPrincipallyInDeterminingFairValueOfOptionsGrantedDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1": {
     "auth_ref": [
      "r315"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable.",
        "label": "Exercisable at December 31, 2020",
        "terseLabel": "Aggregate Intrinsic Value, Exercisable at December 31, 2021"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for vested portions of options outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Exercisable (in years)",
        "terseLabel": "Weighted-Average Remaining Contractual Term, Exercisable at December 31, 2021"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of non-vested options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares",
        "periodEndLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Ending Balance",
        "periodStartLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested, Number of Shares, Beginning Balance",
        "terseLabel": "Number unvested options"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r304"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Weighted-Average Remaining Contractual Term, Outstanding",
        "terseLabel": "Weighted-Average Remaining Contractual Term, Outstanding"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShortTermInvestments": {
     "auth_ref": [
      "r21",
      "r482",
      "r483",
      "r492"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of investments including trading securities, available-for-sale securities, held-to-maturity securities, and short-term investments classified as other and current.",
        "label": "Short-term Investments",
        "terseLabel": "Investments",
        "totalLabel": "Short-term Investments, Total"
       }
      }
     },
     "localname": "ShortTermInvestments",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShortTermLeaseCost": {
     "auth_ref": [
      "r428",
      "r436"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.",
        "label": "Short-term Lease, Cost",
        "terseLabel": "Short-term lease cost"
       }
      }
     },
     "localname": "ShortTermLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r75",
      "r82"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StandbyLettersOfCreditMember": {
     "auth_ref": [
      "r207",
      "r208",
      "r365",
      "r517"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An irrevocable undertaking (typically by a financial institution) to guarantee payment of a specified financial obligation.",
        "label": "Standby Letters of Credit [Member]",
        "terseLabel": "Standby Letters of Credit"
       }
      }
     },
     "localname": "StandbyLettersOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StateAndLocalJurisdictionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Designated tax department of a state or local government entitled to levy and collect income taxes from the entity.",
        "label": "State and Local Jurisdiction [Member]",
        "terseLabel": "State"
       }
      }
     },
     "localname": "StateAndLocalJurisdictionMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r24",
      "r25",
      "r26",
      "r76",
      "r79",
      "r104",
      "r105",
      "r106",
      "r109",
      "r111",
      "r118",
      "r119",
      "r120",
      "r168",
      "r210",
      "r214",
      "r215",
      "r216",
      "r219",
      "r220",
      "r232",
      "r233",
      "r237",
      "r241",
      "r249",
      "r401",
      "r552"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r2",
      "r43",
      "r49",
      "r50",
      "r51",
      "r83",
      "r84",
      "r85",
      "r89",
      "r97",
      "r99",
      "r117",
      "r175",
      "r249",
      "r257",
      "r321",
      "r322",
      "r323",
      "r355",
      "r356",
      "r388",
      "r412",
      "r413",
      "r414",
      "r415",
      "r416",
      "r417",
      "r506",
      "r507",
      "r508",
      "r567"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r83",
      "r84",
      "r85",
      "r117",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r42",
      "r223",
      "r249",
      "r250",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.",
        "label": "Stock Issued During Period, Shares, Conversion of Convertible Securities",
        "terseLabel": "Conversion of redeemable convertible preferred stock into common stock upon closing of initial public offering, Shares",
        "verboseLabel": "Common stock shares issued for conversion of redeemable convertible preferred stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r25",
      "r26",
      "r249",
      "r257"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common shares upon closing of initial public offering, net of offering costs and underwriter fees, Shares",
        "verboseLabel": "Common stock shares sold"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r25",
      "r26",
      "r249",
      "r257",
      "r297"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedLabel": "Shares, Exercised",
        "terseLabel": "Issuance of common stock upon exercise of stock options, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": {
     "auth_ref": [
      "r43",
      "r249",
      "r257"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.",
        "label": "Stock Issued During Period, Value, Conversion of Convertible Securities",
        "terseLabel": "Conversion of redeemable convertible preferred stock into common stock upon closing of initial public offering"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r25",
      "r26",
      "r249",
      "r257"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common shares upon closing of initial public offering, net of offering costs and underwriter fees of $17,132"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r43",
      "r249",
      "r257"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Issuance of common stock upon exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r26",
      "r29",
      "r30",
      "r79",
      "r150",
      "r168",
      "r401",
      "r441"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total stockholders' equity (deficit)"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity (deficit):"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r77",
      "r233",
      "r236",
      "r237",
      "r238",
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r245",
      "r246",
      "r248",
      "r257",
      "r260"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityNoteRedeemablePreferredStockIssuePolicy": {
     "auth_ref": [
      "r22",
      "r23",
      "r229"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for redeemable preferred stock issued. This disclosure may include the accounting treatment for the difference, if there is any, between the carrying value and redemption amount. For example, describe whether the issuer accretes changes in the redemption value.",
        "label": "Stockholders' Equity Note, Redeemable Preferred Stock, Issue, Policy [Policy Text Block]",
        "terseLabel": "Preferred Stock"
       }
      }
     },
     "localname": "StockholdersEquityNoteRedeemablePreferredStockIssuePolicy",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StockholdersEquityNoteStockSplitConversionRatio1": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Ratio applied to the conversion of stock split, for example but not limited to, one share converted to two or two shares converted to one.",
        "label": "Stockholders' Equity Note, Stock Split, Conversion Ratio",
        "terseLabel": "Stockholders' equity, stock split, conversion ratio"
       }
      }
     },
     "localname": "StockholdersEquityNoteStockSplitConversionRatio1",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "us-gaap_StockholdersEquityReverseStockSplit": {
     "auth_ref": [
      "r259"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Description of the reverse stock split arrangement. Also provide the retroactive effect given by the reverse split that occurs after the balance sheet date but before the release of financial statements.",
        "label": "Stockholders' Equity, Reverse Stock Split",
        "terseLabel": "Stockholders' equity, reverse stock split"
       }
      }
     },
     "localname": "StockholdersEquityReverseStockSplit",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplementalCashFlowElementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Elements [Abstract]",
        "terseLabel": "Supplemental disclosure of non-cash activities"
       }
      }
     },
     "localname": "SupplementalCashFlowElementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardAxis": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by specific tax credit related to an unused tax credit.",
        "label": "Tax Credit Carryforward [Axis]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TaxCreditCarryforwardNameDomain": {
     "auth_ref": [
      "r349"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name of the tax credit carryforward.",
        "label": "Tax Credit Carryforward, Name [Domain]"
       }
      }
     },
     "localname": "TaxCreditCarryforwardNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": {
     "auth_ref": [
      "r210",
      "r214",
      "r215",
      "r216",
      "r219",
      "r220"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Carrying Amount, Attributable to Parent",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "terseLabel": "Redeemable convertible preferred stock",
        "verboseLabel": "Carrying Value"
       }
      }
     },
     "localname": "TemporaryEquityCarryingAmountAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityLiquidationPreference": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate liquidation preference (or restrictions) of stock classified as temporary equity that has a preference in involuntary liquidation considerably in excess of the par or stated value of the shares. The liquidation preference is the difference between the preference in liquidation and the par or stated values of the share. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Liquidation Value",
        "terseLabel": "Redeemable convertible preferred stock, liquidation preference"
       }
      }
     },
     "localname": "TemporaryEquityLiquidationPreference",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TemporaryEquityParOrStatedValuePerShare": {
     "auth_ref": [
      "r16",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.",
        "label": "Temporary Equity, Par or Stated Value Per Share",
        "terseLabel": "Redeemable convertible preferred stock, par value"
       }
      }
     },
     "localname": "TemporaryEquityParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_TemporaryEquitySharesAuthorized": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Authorized",
        "terseLabel": "Redeemable convertible preferred stock, shares authorized",
        "verboseLabel": "Preferred Stock Authorized"
       }
      }
     },
     "localname": "TemporaryEquitySharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesIssued": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Issued",
        "terseLabel": "Redeemable convertible preferred stock, shares issued",
        "verboseLabel": "Preferred Stock Issued"
       }
      }
     },
     "localname": "TemporaryEquitySharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquitySharesOutstanding": {
     "auth_ref": [
      "r22"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.",
        "label": "Temporary Equity, Shares Outstanding",
        "periodEndLabel": "Ending Balance, Shares",
        "periodStartLabel": "Beginning Balance, Shares",
        "terseLabel": "Redeemable convertible preferred stock, shares outstanding",
        "verboseLabel": "Preferred Stock Outstanding"
       }
      }
     },
     "localname": "TemporaryEquitySharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TemporaryEquityStockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of new stock classified as temporary equity issued during the period.",
        "label": "Temporary Equity, Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of redeemable convertible preferred stock"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r159",
      "r160",
      "r164",
      "r165",
      "r166",
      "r224",
      "r247",
      "r379",
      "r442",
      "r443",
      "r444",
      "r445",
      "r446",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556",
      "r557",
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TypeOfArrangementAxis": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.",
        "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]"
       }
      }
     },
     "localname": "TypeOfArrangementAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_USTreasurySecuritiesMember": {
     "auth_ref": [
      "r81",
      "r264",
      "r278",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This category includes information about debt securities issued by the United States Department of the Treasury and backed by the United States government. Such securities primarily consist of treasury bills (short-term maturities - one year or less), treasury notes (intermediate term maturities - two to ten years), and treasury bonds (long-term maturities - ten to thirty years).",
        "label": "US Treasury Securities [Member]",
        "terseLabel": "U.S. Treasuries"
       }
      }
     },
     "localname": "USTreasurySecuritiesMember",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UnrecognizedTaxBenefits": {
     "auth_ref": [
      "r331",
      "r340"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unrecognized tax benefits.",
        "label": "Unrecognized Tax Benefits",
        "periodEndLabel": "Unrecognized benefit at end of year",
        "periodStartLabel": "Unrecognized Tax Benefits, Beginning Balance",
        "terseLabel": "Unrecognized tax benefits"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefits",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": {
     "auth_ref": [
      "r337"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued",
        "terseLabel": "Accrued interest and penalties related to uncertain tax positions",
        "totalLabel": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": {
     "auth_ref": [
      "r337"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.",
        "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense",
        "terseLabel": "Interest and penalties related to uncertain tax positions",
        "totalLabel": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense, Total"
       }
      }
     },
     "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r122",
      "r123",
      "r125",
      "r126",
      "r127",
      "r128",
      "r129"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": {
     "auth_ref": [
      "r345"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.",
        "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount",
        "terseLabel": "Change in deferred tax asset valuation allowance"
       }
      }
     },
     "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VariableLeaseCost": {
     "auth_ref": [
      "r429",
      "r436"
     ],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.",
        "label": "Variable Lease, Cost",
        "terseLabel": "Variable lease cost"
       }
      }
     },
     "localname": "VariableLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesSummaryOfLeaseExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_VestingAxis": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Axis]",
        "terseLabel": "Vesting"
       }
      }
     },
     "localname": "VestingAxis",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VestingDomain": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Vesting schedule of award under share-based payment arrangement.",
        "label": "Vesting [Domain]",
        "terseLabel": "Vesting"
       }
      }
     },
     "localname": "VestingDomain",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "terseLabel": "Weighted-average common shares outstanding, basic and diluted",
        "verboseLabel": "Weighted-average number of common shares outstanding, basic and diluted"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2021-01-31",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerShareScheduleOfComputationOfBasicAndDilutedNetLossPerShareDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss"
     ],
     "xbrltype": "sharesItemType"
    },
    "vor_AccruedExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued expenses.",
        "label": "Accrued Expenses"
       }
      }
     },
     "localname": "AccruedExpensesMember",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vor_AccruedLicenseAndMilestoneFeesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued license and milestone fees current.",
        "label": "Accrued License And Milestone Fees Current",
        "terseLabel": "License and milestone fees"
       }
      }
     },
     "localname": "AccruedLicenseAndMilestoneFeesCurrent",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vor_AccruedResearchAndDevelopmentExpensesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued research and development expenses current.",
        "label": "Accrued Research And Development Expenses Current",
        "terseLabel": "Research and development expenses"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopmentExpensesCurrent",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vor_AccruedResearchAndDevelopmentExpensesPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued research and development expenses, policy.",
        "label": "Accrued Research and Development Expenses, Policy [Policy Text Block]",
        "terseLabel": "Accrued Research and Development Expenses"
       }
      }
     },
     "localname": "AccruedResearchAndDevelopmentExpensesPolicyPolicyTextBlock",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "vor_AdditionalSpaceLeased": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additional space leased.",
        "label": "Additional Space Leased",
        "terseLabel": "Additional space leased"
       }
      }
     },
     "localname": "AdditionalSpaceLeased",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "areaItemType"
    },
    "vor_CambridgeparkLeaseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cambridgepark lease.",
        "label": "Cambridgepark Lease Member",
        "terseLabel": "Cambridgepark Lease"
       }
      }
     },
     "localname": "CambridgeparkLeaseMember",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vor_CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash paid for amounts included in the measurement of lease liabilities.",
        "label": "Cash Paid For Amounts Included In The Measurement Of Lease Liabilities [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities"
       }
      }
     },
     "localname": "CashPaidForAmountsIncludedInTheMeasurementOfLeaseLiabilitiesAbstract",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfOtherLeaseActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vor_ColumbiaLicenseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Columbia license agreement.",
        "label": "Columbia License Agreement"
       }
      }
     },
     "localname": "ColumbiaLicenseAgreementMember",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vor_ConsideredPercentageOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Considered percentage of ownership for annual limitation of net operating loss and tax credit carryforwards.",
        "label": "Considered Percentage of Ownership for Annual Limitation of Net Operating Loss and Tax Credit Carryforwards",
        "terseLabel": "Considered percentage of ownership for annual limitation of net operating loss and tax credit carryforwards"
       }
      }
     },
     "localname": "ConsideredPercentageOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vor_ConsideredPeriodOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Considered period of ownership for annual limitation of net operating loss and tax credit carryforwards",
        "label": "Considered Period of Ownership for Annual Limitation of Net Operating Loss and Tax Credit Carryforwards",
        "verboseLabel": "Considered period of ownership for annual limitation of net operating loss and tax credit carryforwards"
       }
      }
     },
     "localname": "ConsideredPeriodOfOwnershipForAnnualLimitationOfNetOperatingLossAndTaxCreditCarryforwards",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "vor_ConversionOfRedeemableConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Conversion of redeemable convertible preferred stock to common stock upon closing of initial public offering.",
        "label": "Conversion Of Redeemable Convertible Preferred Stock To Common Stock Upon Closing Of Initial Public Offering",
        "terseLabel": "Conversion of redeemable convertible preferred stock to common stock upon closing of the initial public offering"
       }
      }
     },
     "localname": "ConversionOfRedeemableConvertiblePreferredStockToCommonStockUponClosingOfInitialPublicOffering",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vor_DeferredOfferingCostsInAccountsPayableAndAccruedExpenses": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred offering costs in accounts payable and accrued expenses.",
        "label": "Deferred Offering Costs In Accounts Payable And Accrued Expenses",
        "terseLabel": "Deferred offering costs in accounts payable and accrued expenses"
       }
      }
     },
     "localname": "DeferredOfferingCostsInAccountsPayableAndAccruedExpenses",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vor_DeferredTaxAssetsAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets amortization.",
        "label": "Deferred Tax Assets Amortization",
        "terseLabel": "Amortization"
       }
      }
     },
     "localname": "DeferredTaxAssetsAmortization",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vor_DeferredTaxAssetsLeaseLiability": {
     "auth_ref": [],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_DeferredTaxAssetsGross",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax assets, lease liability.",
        "label": "Deferred Tax Assets, Lease Liability",
        "terseLabel": "Lease liability"
       }
      }
     },
     "localname": "DeferredTaxAssetsLeaseLiability",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vor_DeferredTaxLiabilitiesDepreciationAndAmortization": {
     "auth_ref": [],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities, depreciation and amortization.",
        "label": "Deferred Tax Liabilities, Depreciation and Amortization",
        "negatedLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesDepreciationAndAmortization",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vor_DeferredTaxLiabilitiesLeaseRightOfUseAsset": {
     "auth_ref": [],
     "calculation": {
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails": {
       "order": 0.0,
       "parentTag": "us-gaap_DeferredTaxLiabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred tax liabilities, lease right of use asset.",
        "label": "Deferred Tax Liabilities, Lease Right of Use Asset",
        "negatedLabel": "Lease right of use asset"
       }
      }
     },
     "localname": "DeferredTaxLiabilitiesLeaseRightOfUseAsset",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfSignificantComponentsOfDeferredTaxAssetsAndLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vor_DefinedContributionPlanAdditionalPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined contribution plan, additional percentage.",
        "label": "Defined Contribution Plan Additional Percentage",
        "terseLabel": "Defined contribution benefit plan, additional percentage"
       }
      }
     },
     "localname": "DefinedContributionPlanAdditionalPercentage",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureDefinedContributionBenefitPlanAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vor_DefinedContributionPlanFirstPercentage": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined contribution plan, first percentage.",
        "label": "Defined Contribution Plan First Percentage",
        "terseLabel": "Defined contribution benefit plan, first percentage"
       }
      }
     },
     "localname": "DefinedContributionPlanFirstPercentage",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureDefinedContributionBenefitPlanAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vor_Definedcontributionplanminimumannualcontributionsperemployeepercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Defined contribution plan minimum annual contributions per employee percent.",
        "label": "DefinedContributionPlanMinimumAnnualContributionsPerEmployeePercent",
        "terseLabel": "Defined contribution benefit plan, minimum percentage of employee's compensation"
       }
      }
     },
     "localname": "Definedcontributionplanminimumannualcontributionsperemployeepercent",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureDefinedContributionBenefitPlanAdditionalInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vor_EffectiveIncomeTaxRateReconciliationPermanentItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective income tax rate reconciliation permanent items.",
        "label": "Effective Income Tax Rate Reconciliation Permanent Items",
        "terseLabel": "Permanent items"
       }
      }
     },
     "localname": "EffectiveIncomeTaxRateReconciliationPermanentItems",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesScheduleOfReconciliationOfFederalStatutoryIncomeRateToEffectiveIncomeTaxRateDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "vor_FairValueAssetsLevel1ToLevel2TransferredAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value assets level1 to level2 transferred amount.",
        "label": "Fair Value Assets Level1 to Level2 Transferred Amount",
        "terseLabel": "Fair value assets, level 1 to level 2 transfers amount"
       }
      }
     },
     "localname": "FairValueAssetsLevel1ToLevel2TransferredAmount",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vor_FairValueAssetsLevel2ToLevel1TransferredAmount": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value assets level2 to level1 transferred amount.",
        "label": "Fair Value Assets Level2 to Level1 Transferred Amount",
        "terseLabel": "Fair value assets, level 2 to level 1 transfers amount"
       }
      }
     },
     "localname": "FairValueAssetsLevel2ToLevel1TransferredAmount",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vor_FirstLeaseAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "First lease amendment.",
        "label": "First Lease Amendment [Member]",
        "terseLabel": "First Lease Amendment"
       }
      }
     },
     "localname": "FirstLeaseAmendmentMember",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vor_FurnitureAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Furniture and equipment.",
        "label": "Furniture And Equipment [Member]",
        "terseLabel": "Furniture and Equipment"
       }
      }
     },
     "localname": "FurnitureAndEquipmentMember",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfPropertyAndEquipmentDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vor_IncreaseInAnnualFixedRentalPayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase in annual fixed rental payments.",
        "label": "Increase In Annual Fixed Rental Payments",
        "terseLabel": "Increase in annual fixed rental payments"
       }
      }
     },
     "localname": "IncreaseInAnnualFixedRentalPayments",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vor_LaboratoryEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory equipment.",
        "label": "Laboratory Equipment [Member]",
        "terseLabel": "Laboratory Equipment"
       }
      }
     },
     "localname": "LaboratoryEquipmentMember",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesEstimatedUsefulLifeOfPropertyAndEquipmentDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosurePropertyAndEquipmentNetScheduleOfPropertyAndEquipmentNetDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vor_LicenseAgreementMilestonePaymentsOnAggregateNetSales": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License agreement milestone payments on aggregate net sales.",
        "label": "Milestone payments on aggregate net sales"
       }
      }
     },
     "localname": "LicenseAgreementMilestonePaymentsOnAggregateNetSales",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vor_LicenseAgreementPotentialMilestonePayments": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License agreement potential milestone payments.",
        "label": "Aggregate potential milestone payments"
       }
      }
     },
     "localname": "LicenseAgreementPotentialMilestonePayments",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfClinicalMilestones": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License agreement potential milestone payments upon achievement of clinical milestones.",
        "label": "Aggregate potential milestone payments upon achievement of clinical milestones"
       }
      }
     },
     "localname": "LicenseAgreementPotentialMilestonePaymentsUponAchievementOfClinicalMilestones",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vor_LicenseAgreementPotentialMilestonePaymentsUponAchievementOfRegulatoryAndCommercialMilestones": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License agreement potential milestone payments upon achievement of regulatory and commercial milestones.",
        "label": "Aggregate potential milestone payments upon achievement of regulatory and commercial milestones"
       }
      }
     },
     "localname": "LicenseAgreementPotentialMilestonePaymentsUponAchievementOfRegulatoryAndCommercialMilestones",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vor_LicenseFeeObligatedToPay": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "License fee obligated to pay.",
        "label": "License Fee Obligated to Pay",
        "terseLabel": "License fee obligated to pay"
       }
      }
     },
     "localname": "LicenseFeeObligatedToPay",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vor_MaturingAfterOneYearThroughFiveYearsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maturing after one year through five years.",
        "label": "Maturing After One Year Through Five Years [Member]",
        "terseLabel": "Maturing after One Year through Five Years"
       }
      }
     },
     "localname": "MaturingAfterOneYearThroughFiveYearsMember",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vor_MaturingInOneYearOrLessMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maturing in one year or less.",
        "label": "Maturing In One Year or Less [Member]",
        "terseLabel": "Maturing in One Year or Less"
       }
      }
     },
     "localname": "MaturingInOneYearOrLessMember",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureInvestmentsSummaryOfAmortizedCostAndEstimatedFairValueOfInvestmentsByContractualMaturityDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vor_NationalInstitutesOfHealthLicenseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "National institutes of health license agreement.",
        "label": "National Institutes of Health License Agreement"
       }
      }
     },
     "localname": "NationalInstitutesOfHealthLicenseAgreementMember",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSignificantAgreementsAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vor_NatureOfBusinessLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature of business.",
        "label": "Nature Of Business [Line Items]",
        "terseLabel": "Nature Of Business [Line Items]"
       }
      }
     },
     "localname": "NatureOfBusinessLineItems",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vor_NatureOfBusinessTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Nature of business.",
        "label": "Nature Of Business [Table]",
        "terseLabel": "Nature Of Business [Table]"
       }
      }
     },
     "localname": "NatureOfBusinessTable",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNatureOfBusinessAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vor_NumberOfCommonStockVotingRights": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Common Stock Voting Rights",
        "label": "Number Of Common Stock Voting Rights",
        "terseLabel": "Number of common stock voting rights"
       }
      }
     },
     "localname": "NumberOfCommonStockVotingRights",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "vor_OperatingLeaseAssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease assets.",
        "label": "Operating Lease Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "OperatingLeaseAssetsAbstract",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfAmountsReportedInConsolidatedBalanceSheetsAndWeightaverageLeaseTermAndDiscountRateInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vor_OperatingLeaseCommencementPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease commencement period.",
        "label": "Operating Lease Commencement Period",
        "terseLabel": "Operating lease, commencement period"
       }
      }
     },
     "localname": "OperatingLeaseCommencementPeriod",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vor_OperatingLeaseEstimatedToCommencePeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease estimated to commence period.",
        "label": "Operating Lease Estimated To Commence Period",
        "terseLabel": "Operating lease estimated to commence period"
       }
      }
     },
     "localname": "OperatingLeaseEstimatedToCommencePeriod",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vor_OperatingLeaseWeightedAverageLeaseTermAndDiscountRateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating lease, weighted average lease term and discount rate.",
        "label": "Operating Lease, Weighted Average Lease Term and Discount Rate [Abstract]",
        "terseLabel": "Weighted Average Lease Term and Discount Rate"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageLeaseTermAndDiscountRateAbstract",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureLeasesSummaryOfAmountsReportedInConsolidatedBalanceSheetsAndWeightaverageLeaseTermAndDiscountRateInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "vor_OperatingLossCarryforwardsExpirationYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating loss carryforwards expiration year.",
        "label": "Operating Loss Carryforwards Expiration Year",
        "terseLabel": "Net operating loss carryforwards expiration year"
       }
      }
     },
     "localname": "OperatingLossCarryforwardsExpirationYear",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "vor_OperatingRightOfUseAssetsAndOperatingLeaseLiabilityRecordedUponLeaseCommencement": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating right-of-use assets and operating lease liability recorded upon lease commencement.",
        "label": "Operating Right Of Use Assets And Operating Lease Liability Recorded Upon Lease Commencement",
        "terseLabel": "Operating right-of-use assets and operating lease liability recorded upon lease commencement"
       }
      }
     },
     "localname": "OperatingRightOfUseAssetsAndOperatingLeaseLiabilityRecordedUponLeaseCommencement",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vor_PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Property plant and equipment expected useful life.",
        "label": "Property Plant and Equipment Expected Useful Life [Table Text Block]",
        "terseLabel": "Estimated Useful Life of Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentExpectedUsefulLifeTableTextBlock",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "vor_RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recently issued accounting pronouncements not yet adopted, policy.",
        "label": "Recently Issued Accounting Pronouncements Not Yet Adopted, Policy [Policy Text Block]",
        "terseLabel": "Recently Issued Accounting Pronouncements Not Yet Adopted"
       }
      }
     },
     "localname": "RecentlyIssuedAccountingPronouncementsNotYetAdoptedPolicyPolicyTextBlock",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSummaryOfSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "vor_RedeemableConvertiblePreferredStockTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable convertible preferred stock.",
        "label": "Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "RedeemableConvertiblePreferredStockTextBlock",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStock"
     ],
     "xbrltype": "textBlockItemType"
    },
    "vor_RestrictedCashEquivalentsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Restricted cash equivalents.",
        "label": "Restricted Cash Equivalents [Member]",
        "terseLabel": "Restricted Cash Equivalents"
       }
      }
     },
     "localname": "RestrictedCashEquivalentsMember",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureFairValueMeasurementsSummaryOfFinancialAssetsAndLiabilitiesMeasuredAtFairValueOnRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vor_ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of accrued expenses and other current liabilities.",
        "label": "Schedule Of Accrued Expenses And Other Current Liabilities Table [Text Block]",
        "terseLabel": "Schedule of Accrued Expenses and Other Current Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedExpensesAndOtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureAccruedExpensesAndOtherCurrentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "vor_ScheduleOfOperatingLeaseAssetsAndLiabilitiesWeightedAverageLeaseTermAndDiscountRateTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of operating lease assets and liabilities, weighted average lease term and discount rate.",
        "label": "Schedule of Operating Lease Assets and Liabilities, Weighted Average Lease Term and Discount Rate [Table Text Block]",
        "terseLabel": "Summary of Amounts Reported in Consolidated Balance Sheets and Weight-average Lease Term and Discount Rate Information"
       }
      }
     },
     "localname": "ScheduleOfOperatingLeaseAssetsAndLiabilitiesWeightedAverageLeaseTermAndDiscountRateTableTextBlock",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "vor_ScheduleOfOtherLeaseActivityTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of other lease activity.",
        "label": "Schedule of Other Lease Activity [Table Text Block]",
        "terseLabel": "Summary of Other Lease Activity"
       }
      }
     },
     "localname": "ScheduleOfOtherLeaseActivityTableTextBlock",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "vor_ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of Redeemable Convertible Preferred Stock [Table Text Block]",
        "label": "Schedule of Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "ScheduleOfRedeemableConvertiblePreferredStockTableTextBlock",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "vor_SecondLeaseAmendmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Second lease amendment.",
        "label": "Second Lease Amendment [Member]",
        "terseLabel": "Second Lease Amendment"
       }
      }
     },
     "localname": "SecondLeaseAmendmentMember",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureLeasesAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vor_SeriesAOneRedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A - one redeemable convertible preferred stock.",
        "label": "Series A One Redeemable Convertible Preferred Stock [Member]",
        "terseLabel": "Series A-1 Redeemable Convertible Preferred Stock"
       }
      }
     },
     "localname": "SeriesAOneRedeemableConvertiblePreferredStockMember",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "vor_SeriesATwoRedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series A - two redeemable convertible preferred stock.",
        "label": "Series A Two Redeemable Convertible Preferred Stock [Member]",
        "terseLabel": "Series A-2 Redeemable Convertible Preferred Stock",
        "verboseLabel": "Series A-2"
       }
      }
     },
     "localname": "SeriesATwoRedeemableConvertiblePreferredStockMember",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "vor_SeriesBRedeemableConvertiblePreferredStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Series B redeemable convertible preferred stock.",
        "label": "Series B Redeemable Convertible Preferred Stock [Member]",
        "terseLabel": "Series B Redeemable Convertible Preferred Stock",
        "verboseLabel": "Series B"
       }
      }
     },
     "localname": "SeriesBRedeemableConvertiblePreferredStockMember",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureNetLossPerSharePotentialDilutiveSecuritiesExcludedFromComputationOfDilutedNetLossPerShareDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheets",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedBalanceSheetsParenthetical",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "domainItemType"
    },
    "vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award options unvested exercised in period weighted average exercise price.",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award Options Unvested Exercised In Period Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price of options exercised and unvested"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsUnvestedExercisedInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangement by share based payment award options vested and exercised in period.",
        "label": "Share Based Compensation Arrangement by Share Based Payment Award Options Vested and Exercised in Period",
        "negatedLabel": "Shares, Vested and exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriod",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "vor_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based compensation arrangement by share-based payment award options vested and expected to vest exercisable weighted average grant date fair value",
        "label": "Weighted-average grant date fair value exercised but unvested at the time of exercise"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageGrantDateFairValue",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "vor_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share based compensation arrangements by share based payment award options vested and exercised in period weighted average exercise price.",
        "label": "Share Based Compensation Arrangements by Share Based Payment Award Options Vested and Exercised in Period Weighted Average Exercise Price",
        "terseLabel": "Weighted-Average Exercise Price, Vested and exercised"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsVestedAndExercisedInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureStockbasedCompensationSummaryOfStockOptionActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "vor_SignificantAgreementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant agreements.",
        "label": "Significant Agreements [Abstract]"
       }
      }
     },
     "localname": "SignificantAgreementsAbstract",
     "nsuri": "http://vorbiopharma.com/20211231",
     "xbrltype": "stringItemType"
    },
    "vor_SignificantAgreementsTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Significant Agreements.",
        "label": "Significant Agreements [Text Block]",
        "terseLabel": "Significant Agreements"
       }
      }
     },
     "localname": "SignificantAgreementsTextBlock",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureSignificantAgreements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "vor_StockIssuedDuringPeriodSharesStockOptionsVestedAndExercised": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period shares stock options vested and exercised.",
        "label": "Stock Issued During Period Shares Stock Options Vested And Exercised",
        "terseLabel": "Issuance of common stock upon vesting and exercise of stock options, Shares"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsVestedAndExercised",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "vor_StockIssuedDuringPeriodValueStockOptionsVestedAndExercised": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock issued during period value stock options vested and exercised.",
        "label": "Stock Issued During Period Value Stock Options Vested And Exercised",
        "terseLabel": "Issuance of common stock upon vesting and exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsVestedAndExercised",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vor_TaxCreditCarryforwardsExpirationYear": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tax credit carryforwards expiration year.",
        "label": "Tax Credit Carryforwards Expiration Year",
        "terseLabel": "Tax credit carryforwards expiration year"
       }
      }
     },
     "localname": "TaxCreditCarryforwardsExpirationYear",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureIncomeTaxesAdditionalInformationDetails"
     ],
     "xbrltype": "gYearItemType"
    },
    "vor_TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity Additional Stock Issued During Period Shares New Issues",
        "label": "Additional stock issued"
       }
      }
     },
     "localname": "TemporaryEquityAdditionalStockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "vor_TemporaryEquityCumulativeUndeclaredDividends": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity cumulative undeclared dividends.",
        "label": "Cumulative Undeclared Dividends"
       }
      }
     },
     "localname": "TemporaryEquityCumulativeUndeclaredDividends",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockScheduleOfRedeemableConvertiblePreferredStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vor_TemporaryEquityIssuedPricePerShare": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary Equity issued price per share.",
        "label": "Temporary Equity Issued Price Per Share",
        "terseLabel": "Redeemable convertible preferred stock, price per share"
       }
      }
     },
     "localname": "TemporaryEquityIssuedPricePerShare",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "vor_TemporaryEquityStockConvertedDuringPeriodShares": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity stock converted during period shares.",
        "label": "Temporary Equity Stock Converted During Period Shares",
        "negatedLabel": "Conversion of convertible notes to Redeemable Convertible Preferred Stock, Shares",
        "negatedTerseLabel": "Conversion of redeemable convertible preferred stock into common stock upon closing of initial public offering, Shares"
       }
      }
     },
     "localname": "TemporaryEquityStockConvertedDuringPeriodShares",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "vor_TemporaryEquityStockConvertedDuringPeriodValue": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity stock converted during period value.",
        "label": "Temporary Equity Stock Converted During Period Value",
        "negatedLabel": "Conversion of convertible notes to Redeemable Convertible Preferred Stock",
        "negatedTerseLabel": "Conversion of redeemable convertible preferred stock into common stock upon closing of initial public offering"
       }
      }
     },
     "localname": "TemporaryEquityStockConvertedDuringPeriodValue",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "monetaryItemType"
    },
    "vor_TemporaryEquityStockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Temporary equity stock issued during period shares new issues.",
        "label": "Temporary Equity Stock Issued During Period Shares New Issues",
        "terseLabel": "Issuance of redeemable convertible preferred stock, Shares",
        "verboseLabel": "Redeemable convertible preferred stock, issued and sold"
       }
      }
     },
     "localname": "TemporaryEquityStockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/DisclosureRedeemableConvertiblePreferredStockAdditionalInformationDetails",
      "http://vorbiopharma.com/20211231/taxonomy/role/StatementConsolidatedStatementsOfRedeemableConvertiblePreferredStockAndStockholdersEquityDeficit"
     ],
     "xbrltype": "sharesItemType"
    },
    "vor_TwoThousandFifteenStockIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand fifteen stock incentive plan.",
        "label": "2015 Plan"
       }
      }
     },
     "localname": "TwoThousandFifteenStockIncentivePlanMember",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "vor_TwoThousandTwentyOneEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two thousand twenty one equity incentive plan.",
        "label": "Two Thousand Twenty One Equity Incentive Plan [Member]",
        "terseLabel": "2021 Plan"
       }
      }
     },
     "localname": "TwoThousandTwentyOneEquityIncentivePlanMember",
     "nsuri": "http://vorbiopharma.com/20211231",
     "presentation": [
      "http://vorbiopharma.com/20211231/taxonomy/role/Role_DisclosureStockBasedCompensationAdditionalInformationDetails"
     ],
     "xbrltype": "domainItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6801-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31010-122693"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1448-109256"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1377-109256"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1252-109256"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1278-109256"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e2626-109256"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=SL5780133-109256"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6812-107765"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125511455&loc=d3e1337-109256"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=125512782&loc=d3e3842-109258"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6911-107765"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "275",
   "URI": "http://asc.fasb.org/topic&trid=2134479"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8672-108599"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8736-108599"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8864-108599"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e8933-108599"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9031-108599"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=123577603&loc=SL6953401-111524"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e7018-107765"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)(1)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=124402435&loc=SL124402458-218513"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=124260329&loc=d3e26610-111562"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(aa)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27161-111563"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27232-111563"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(27)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=SL120269820-111563"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27290-111563"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=123581744&loc=d3e27340-111563"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "320",
   "URI": "http://asc.fasb.org/topic&trid=2196928"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "321",
   "URI": "http://asc.fasb.org/extlink&oid=123583765&loc=SL75117539-209714"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL120254519-210437"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL120320025-210437"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "80",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124267575&loc=SL82922355-210448"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124258926&loc=SL82898722-210454"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=123349782&loc=d3e5879-108316"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=6387103&loc=d3e6435-108320"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.A)",
   "Topic": "340",
   "URI": "http://asc.fasb.org/extlink&oid=122040515&loc=d3e105025-122735"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=123364984&loc=d3e1205-110223"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "http://asc.fasb.org/topic&trid=2155823"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=124440162&loc=d3e12021-110248"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=123408193&loc=d3e12803-110250"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S65",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359872&loc=SL124427846-239511"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442526-122756"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=124359900&loc=SL124442552-122756"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1E",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1I",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467743&loc=d3e20905-112640"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21553-112644"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496158-112644"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496171-112644"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496180-112644"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=SL123496189-112644"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21463-112644"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21475-112644"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21484-112644"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21488-112644"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21506-112644"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21521-112644"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=123467817&loc=d3e21538-112644"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 4.C)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.C)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187143-122770"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123351226&loc=SL49130545-203045"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=123410239&loc=SL49130690-203046-203046"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(l)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(o)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(p)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(q)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(1)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(r)(2)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "60",
   "Subparagraph": "(c)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "70",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "715",
   "URI": "http://asc.fasb.org/topic&trid=2235017"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=123468992&loc=d3e4534-113899"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f(1))",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11149-113907"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=122142933&loc=d3e11178-113907"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=SL37586934-109318"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=SL6600010-109319"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=123459177&loc=SL121830611-158277"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 6.I.Fact.4)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "http://asc.fasb.org/topic&trid=2144680"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "808",
   "URI": "http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "15",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116873149&loc=d3e923-111674"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123454820&loc=SL4569616-111683"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4J",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4K",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=125515794&loc=SL5624163-113959"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "182",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123421605&loc=SL5629052-113961"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121483254&loc=SL120254523-199619"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123477628&loc=d3e90205-114008"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=123482062&loc=SL123482106-238011"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19207-110258"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=d3e19279-110258"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "http://asc.fasb.org/extlink&oid=124434974&loc=SL124442142-165695"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=123874694&loc=SL6742756-110258"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL120254526-165497"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL121967933-165497"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=123597120&loc=SL122642865-165497"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123341672&loc=SL120154346-209984"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918638-209977"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918666-209980"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918673-209980"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918686-209980"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123408670&loc=SL77918701-209980"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "http://asc.fasb.org/extlink&oid=122150657&loc=SL122150809-237846"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.8)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "http://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669619-108580"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122625-111746"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124509347&loc=SL7669625-108580"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=125521744&loc=d3e122739-111746"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=123353855&loc=SL119991595-234733"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "http://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "940",
   "URI": "http://asc.fasb.org/subtopic&trid=2176304"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(4))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(5))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(6))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "320",
   "Subparagraph": "(b)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123599081&loc=d3e62557-112803"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "942",
   "URI": "http://asc.fasb.org/subtopic&trid=2209399"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "405",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=123345438&loc=d3e61044-112788"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(1)(g))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.1(h))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(3)(b))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117783719-158441"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124504033&loc=SL117819544-158441"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=124508989&loc=d3e19393-158473"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=66023616&loc=SL35737432-115832"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5D",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column A))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(4))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column B))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column C))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-15(Column D))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "320",
   "Topic": "946",
   "URI": "http://asc.fasb.org/subtopic&trid=2324412"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL6242262-115580"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413173&loc=SL116631458-115580"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "210",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=120413209&loc=SL6242269-115581"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=SL120174063-112916"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "http://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "http://asc.fasb.org/extlink&oid=123360121&loc=d3e27327-108691"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r544": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r545": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r546": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r547": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r548": {
   "Name": "Form 10-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "310"
  },
  "r549": {
   "Name": "Form 20-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "220",
   "Subsection": "f"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r550": {
   "Name": "Form 40-F",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "240",
   "Subsection": "f"
  },
  "r551": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r552": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402"
  },
  "r553": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(1)"
  },
  "r554": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)"
  },
  "r555": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(3)"
  },
  "r556": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(i)"
  },
  "r557": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(ii)"
  },
  "r558": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(c)",
   "Publisher": "SEC",
   "Section": "1402",
   "Subparagraph": "(2)(iii)"
  },
  "r559": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(b)",
   "Publisher": "SEC",
   "Section": "1403"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227"
  },
  "r560": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r561": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r562": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r563": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848"
  },
  "r564": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848"
  },
  "r565": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848"
  },
  "r566": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848"
  },
  "r567": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3213-108585"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3255-108585"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3291-108585"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3000-108585"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3521-108585"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3536-108585"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3602-108585"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123570139&loc=d3e3044-108585"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4273-108586"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4304-108586"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4313-108586"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=d3e4332-108586"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=123431023&loc=SL98516268-108586"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=123372394&loc=d3e18726-107790"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(ii)(A))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=124098289&loc=d3e6787-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>104
<FILENAME>0000950170-22-003577-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-22-003577-xbrl.zip
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MDV$.XF+'9/)1W23U&=HQ#T6F/,TC)KW=[UH=5G",.-F!U2&*Y+R0H!BQ0+$
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MCJ/.LGN3LSNMNQ9?ANRM"WJG'?2ZGI79@0,&255FD2:@]GV7,*K1R& C>6?
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MF1C"JYN)I_;XK:*[+<O&;DPQ)+Q6ET%15G?NJ$G#DPKJO'1=CHQ;:=<W]PG
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M$S/3B+\5YU\D7$;X)&L8[L7NO9OJ=9#7.H!TTA?&TUFGVNC)=8*# 3WTAH^
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ML358 ]Z=A")OS^6)&5JO)$6)5VO\K:J$_9.Y!<'TA7-&-14#8L?&[BD&45"
MN=% SPQ<$0 5B5KZ 97*L<S_5K%I*BZ0#MV"/-MI'71 #:9;G1\P:29WMD-
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M7ME \J_7BL@U%01;6RM\$,A.O.E63&O;=*F)!1_S3?*#GD2P(.>8D%5U=8T
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M7;EOWAPVKG?=6'RHM'2P 7$=FCA"^T=1 H$]#QTVV$#3O$5D<9&U8V7OM$+
M+?A0+46^HJ]5 .DL/LB3T6W(X,\*%DY?D?-$"9M76B=,X+(GD#+HCY^X==BH
MJA/3?Z]_D.+.N^FS%+C[E>M"0PH$?0-SW[ RGZGB8YP8IX+P$=-FE(&)IDFF
MX;*KB8'^'+=RC\PKU 9JB4*YN$E2.UDS27)/K<O'N<# <#R,=UD/;?%UZDV;
M!I4L0QC#:U!J3X;%H'A!HBLZ.C6U&@8;^?MLX1O!-% -(TK>@D$ V?CU0FXL
M*HSO>@[6"@P@6UI([0IP@G#':6BIJ$J#1#5HW+C]0/NIKPA\&Z]I2_+R0D08
MT8$YM,+KAI'I=.D37]T*N<O7Z3ZBFF'J/=EB^E^2.I+VI9FDI[:2H5T^/QZ\
M))CF818<=U:5$?]R>U_2[K=3M6Q9$PYGYJ35/J<G"6;4!/M#.9A=13"/\QG5
MXU'B_9&H"V4OR<6/D)YK"?##[1=3] JUBO(^+-\^7?!OPM07%HVM!*@6%JTD
M^UU6QMNR D0UMXTABWJWN(9CW22/5A]0:JUN1AK*RV39^U+,@3@#9J!A6P5[
MQIX2H1\4W+Y*"KZ,EVSG>^/HW\XW3!!ES-R*7O&:L;=7N; 4A74//[3-6E:5
MR1KDH3T4GE=_C%J1NQU0V)RV:284A9V;5QHM<^T/E,^L?S]S=)6CQI>!4+J.
M#<JV\/*FI!(W#A/IJ?*SOK+Q)J^COC&3^B-^7NG'?>TJS(9A39S5_-T:VDI=
M9][SL:8_@."21SZ30I_%LV=WCGV^R0&C/PS-WW7E3CBS"+D[_\0%YCMHQ;+#
M<@88X=_<DZ..QVBIM>I8Z?+0WF,@ZZHHNJ<$2NQES.>DK)&V+&VKE]HOO1RG
MP>@(N^5D_*[]SIJ]-7:@+BC]/4;^>*'\X2<8>#_HL^W#TR7LN $\5XD&'3&J
M!GQE/Z+5UYW.9UZC0Z7N-(HR'(/T75FSV^"I^/MH5XWZO'@,H'MJ_UWMS)O1
M6_,=DG\ =IY&'/8NX*2^P3O #4_/4X;]%U,RY6M/G.P;5<]6C2(]CF@)4F?)
M]M?W;9O3\2IXTW .2:>C\09L_$H7:9?%SI^3(Y<C>ZCNABE^RY'L?87F?9Q"
M#V9KO\F12E6YXLZ0=*Z<3V(Q!9-^(043]-YK*XAMCXG1)SGCVE'0J56]0+M$
MZ1Z2-JED,Q:U8:6C[?19Z9L/D:]WC7-IGV?B0-*UWWLWD.T;!],?P,EDVZP>
M>+E=F_]^W/#QY>2%!:^9P$=E8QK=5WZ3NS$PAP@H?S$7M)4M8?GZ![!)P@/1
M6Z-<Y/CGRF-_ %7;VGT4V3P"YSW[!!ZT%X,_ML)Q9ZNSL3'*"HJ%H?@ >64Y
M+3B.!U*E_!H4!A!I["5;RGS.#$I+Z5NW5,)L4F,^N >:PI_TS2(_=]-)7<DF
M&)=+-?96Y0%[_A;QD____AWDW[:)4.N&O:+863H>P^>6]YN/G\];:MV:5]WC
M^8@KY].5E+/GXQ<KR2B/ $Z*$N$(/+P$HC]3N&SZO>3 J6N?_Q@N'TI!N&PY
MJJF-)1.T&^2BN=3V>A7:E&T\OO]0.\3?\9JH:,:]!/]?AJ0G5).N#HYSBSJ3
M-Z8CWVS*L*1/6!;_B G9=9-)A^AIVYPZX$\CG>JNQ&$*7UHM;-LCB743,UMT
MI"7'V\T27Y<BKPRATHCE1=3X4I7RUT4;<D;0K'$]O\J.]P&>C+X'FT];L!^Z
M8<UC\I-<DWE=8Z:]W"[^!R?CNV]ERNSF..HG0?8:0L_J>NT*N_NSG )WUY%S
M]\>)=04-C20&R=\MCQ%KI3]79WV!EII[C+O^'Y>8%GQ/EGP32"EM?P#'E\Q]
MIWS7M;\]O;7A:9/5R/2E+JH\-DSMNP>C1.XBKK29?'2W&@)<N/'K+9[9O$_B
M:D\WD:U3CAJ78:@S439Y!T37P9VN97>%Y[(_=92'1*UG-5]8HQ'-":5R@N'.
M?:HZ5SGT*!@<%;$A8>\8&-C/HF2D^[:RGI9C\/;XPF?JO<F/24^NIG-"7O(K
MMY-3BRB"U[(<#KBOIO/V!:YK4,G@6@M$*<6TVE&=7**J>?&1(P#=2<[]*^!E
M!O.D^0ZFEP99N["LN>DO%7?5/*TS;OK0;OR^$S@RE2[HOQ!#:>]1R\P2P-^H
MG9]9KMX_I*;$$8?MRYNI<-JP^]1:_DNL[:1L.GC) ]J11GP802O5[3,;B/F:
M5T=L'.>>> <^[21%W(\&WS2*#I0_F+?SH9TL'CW0()Y^9M ^F'Y_G)XLZ)*M
M6[=NG#PM$5GM+0UAGM*M2A9=[?]PK,W+,W^"&=)<+PHN"G,;M%PT_05W<'+7
M-N,:B593Z%![\QL_)_$'$,?2EKT3<T9N[]+!S$!Z*4OUL@BO/?A8AS.Q?(+I
MQ)714)[O^Q !_]JT_1!1TZ8=H7K99H_&X5AQ0T^.URDI.X^,%.IA_P? [/X'
M<-#KFR273LLH%3W-:1%BJ.]35U1EI!DK9F@] A'WHXP']PZC+<LAQO!N&C]/
MC#>($H;R"VF(HIO:.F3[]/:GLT]FZ3WM2HF49W=.JY<_MC7,)06CO./7RW,O
M%.9J[G]+O@&*'!2Q]L&D%]39.%'<V?CO'M]"#[B*\7A(ON5H-)=>VJV/A3I)
MHZ]2^"7=P$"BH@I'HE.(0< MM"?1VBVW%KKS5-B-"9V[9%NMU--:(MJ]+"_#
MG#2E[&%6MD*X(6^M=B'E%O0G^E2.S[2/0JB4U:B!BBAZ1^;]JTMO"HOV\U)#
MH5B=4:S*?9!M BBMB,U% \*-$E,D!V'57AB^F+CF(L^7MJM)BL5>Y9,J*,B+
M;<>W$.1$YU?V-+Z^DB?"YKX4QK)N>&9KS6%$&("\7PT>]WYZ3;/!=[U$E%JS
MA1&["2I5J/CLUWX4LP>V6</Z8O\ T(EO,3Z*7MG(M=*LZMV=?&-U'%25-CSG
M7_TO%7_6#]68M,M/6(_SCY^NFU^HXI@=EN\JM.M:P3]V6789HD-0/4A?/WIW
M99\"Z*V.CH)8NA4A$86)+X.B%['!R$)$3EZ2@+3AIR5W68P-680VUA%E=_EA
MO['0UC*Q#O*]K]'$NQ3S,B0\@7)3XG)/S2[/RS^ IRQ1'JX&]S!>J2ES-.-"
MKO3542&2S_X 8)M'L2>G*Q4.Y\S%TU\3H)///X3<?.,DW,V<Z6EDKWJ?@F:
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M7"SG!I6ZO]Z\E@GT-Y7X$KA7:E3<EHX7@D\=LBHVRN.EV:S\B(^?(OQMX/"
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M36X*F@\OX@]&0M4[IGW,RT^'E'U.@2ZBO!.T(5+H/N&+".9=U>A2JD64/#T
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M 5M')E9"#TQCWVF )J?F#"M(>-ACA;3-- HX+2]-#FC*AS(_CK/O-O[(U#Q
MAZ+5[CP&T*=.M.N-PI_5(J&9E:-9%6-QTV;A5T75-^XYT 5E1N0"DQ[9I,1\
M;.^#"S0=! =NJ[:E[Y</L1+;8>UZ <_3$%'#3?--SY:M'T1_=\<H=LVQVW)\
M<?A8H(WMB BM43P?CH"--28SS(;F9U6B.0N>L8V,ZFKFK">06Q\YXO4O8>\J
M\EPI:WYJ$7D=5_Z+\WNT ?_'8,E@ 1V26T#0Q>,X'>X]QZ8*-W^,Y9:/"?6
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M^#R^JYF."E)<.\+.E6*\VX\UZ4.&ST/$+NB![!]X4*_.M^3\&O#-K9^EI]#
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M)CAM \/.P**V6B_\N)G0M>D'AGG*-VX'XLA(L?GU58@&ENDI^8<F8:.W=<*
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MC]^ROW28(GNY@=L&&)_.U9E5<\90E!(EX7AD/7)RL=*W'+NE5*#(H6JUWU%
M-%](U;>84GJY#S$$Z4+N(]0XYN4D9.ML-BL@C),X^<FXK=*(_?"O59W*GXIM
M:JM]UWDVPLTKJORW+B?_4(EB7.FT);#39=_Y[C2Z#3-+L)PG=U!$E4E6P-%
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MQ$2RR1Q,919T/P_ G*AH&;8)"EHS?LSG9*CF%'M$NFGCP-)RX_ 5&A"*_ZI
MM;(I$/)A!+:<&[YX?@TFT[W;+!BZ.%565Y;97;Z;M?<R](/L#4E^:E%(H6W*
M3YG42))07K'V@UTN_4;D!M'%,JG$ORV3'L*%=[/\J$,Z<K18,K@?C(EREB$6
M/*QA+),[CZ<?&=B9NU@(L5+ZAW1FVM4(8-*5<Y^,9@=:Q*XW5;2/G[[DNB2L
MMH2*2:3,5.U848X3NN?"X&;4@'031\V@5.8<-F/1P.[FK;,WIZK?IM*, ]9L
M8']O<2V4UI .ESUTX^7GJL<]H)9&>A=5_+T;9E37?12-6[CHG$%-3GFEO&GZ
M6[Y+I-I)?'*7J>GET +'T5W?($X_3.1A0:%LB^NK..M^F3UIEO/%0+OPUU%7
MS-\HD*R;#I[WC2BC <YG36EK"-]06O7>C<VHC9I'3-]G5(F^9FPKQ@N.J?H(
M$S[=E?^0U_OI\9XDM_%KVR)<I(3DNA9;WIJ*%XL$#IT/J_>@T*U<<0\+!QOZ
M^P5*;'Y.EI8X_//AHS6(Y4(R"=WYJD(^QKKY]EJQE_&.-0X6-V+>WC?$[O=R
M/EJ&^-E#"6'S2V?GS:A7.<Z+HKM$=+4L"NMJ*!HTT-9S?!:(['$<=FJ:.I(4
M4LG[MF44^BIPWJIZ37F^?P2_1U9NYSQ#FK6 T[N</\(PY2.J+%,76J17GUF@
M_9U[2V[18-G+:S=\^62,D2:NU-&-<CB%5OA*6ZN@W,%7#BXIZC#BIQ\Q3WQ$
MD>:PG"]P0KC*3M+9](GGK9@*:2).[IM1-D-0;Q+G$,&LJC0YEC#Y[H5:H]2L
M).>*V/GKVIS?ZR(1*$GXC%F /T_I2%F&O]ZA(CQ^_JR1J&U.JNBX)79NOLG)
MH!KC-A('VL7;YDQJ']#,0#73@T][ENB/DC$W<S!B(3B4L/51(5J]S68"8"A*
MRE^D='>K],9%Q:P4;/) _G.IHK=>G<HA/O?%;<9^ !61P=^F:C7H-R(L(:*N
M(."^RV*!VOGA/FTX,8A4R#(;++@OT_'PTA.E(MRV%9C@0&VI/V)0UMR7D#C8
M!YIS#!>$X:Q7N^\J8-ETKLS&I%D[1MA>HR3176\6H?47H^X9:;XGX5BJ?TWD
M/4E-4^[#P<B4,E--D^[AURGRPTPE$8MIME6'U.%S]\W%FC291\LX[CT6KQ5S
M]W4B7ST953Z^J2,_I$ GS9I84M7!NU)_N?SZ"CN?RR)3MG[; >^0KB7Q]G!K
MHG+F@GVD.!4GFR)MAMG]O'0 KZEA-RS:@#.X.\KIN?_UG-N>]%XPO!IXAQUI
M@/WK^<@MO,U'UQFJ;M_@[ .B3]3BT,#+M8:#J[5HH($ 1=+V.,3812YA."$L
M4OCYTU&V,N=X68&*#7X'NJL-BLI(R53)@F\/1A0=R+H5PI'V9Q1SR(?&^::(
MPXPVA5KU+M^(]Q\D1F>BVQZ-[<#E<W,A!CPSG6^6PVO#"=/*W&5?ER?3U@5R
M5W1/]YV)\AT6Y!W2GD894ZHZ@L#Z_3]J&/U7VE^L%RPVLAQH%"!;%\5'KB;K
M="<@Y_9S2QX/^=Z;O+U)3EAB/GN-G>F[M'%<$S-*:4%WO115V5];<4Q%]8ZZ
M^2O&7F_5]MX. BLGSE8%&A#U$$,#&"G(NP(,-9@/@NPC:Y5X;.GH4EDZF["(
MAHGDLOYUO4C*C&:I8<_>REIER7TZX"*B\4QXVWZ<L9!>@TD:M&*XPQ=(J].3
M6079: ^!W1X)L+$0SLAB?6_H_VB$_G&&YY5WQN2O&\'AS@/22NGZRP+3I%\.
MPI/YGG6N6R[<%\;A7WC>,$M]<7J2, <VPXT&_!1XW+P3Q$UA7Q]>G(^$7)R/
M!%D0'O37JZAVMZY8D&3^9BXS&O!UNCAE*0(R2*\^%+%=6R5YJ:+XL_]8DW!!
M(G*$2/8A%4M.!U._:@"2KGKZ'..0$'D%MI,QH05JJ>!@Y&# '+0U8>Z"MX7+
M8X1+4RE<R7M9N/%?VL-8B'/ _M(D2KTT?SETF*MZLNHJX>-K B0DHW$YZFEU
MBZ$]U9R-IJF&6 C;NW;L19=EP"#Y53^58%G\R;VOO8-N/HF?_+E.$#//IBHN
MU?T/P\(J_/.&'9YHA1>4XL3/_S=7#.(G!I>.]%@&?V@LM#H^\0L3MF:^1,$J
MBR*:LD)Y(0)0F- 35?>_MF6FT[]MT2![D4O]B#J4?NC;E0%QXG]M@/X+G$N9
M&!3B="O4%.XI+5\)OA,22.[=#AQACQ;^P^7OA'RLC1^9MC)CQ3T#XNJ?2Z-0
M1Y3J08$,%GGJNRFN S5FTKI!:PVS  C6YOI09U8HQD^'%BP>-/L;%824(OWC
M(5'W/3^Z*DL4T&^2/O>-+20V2:LH;<"=7AME=<(:[:*\ 42^I[GV$%/^8A]5
M<[0KW96@%7@M9<[J$==4%V^^Y(VM%R'-* B[7:F$37RM.G_97^>-A7_B>I*M
M*7ML?2@$;.7Q3WPPYV0()?X!#4R#(ZL6#9EW[QU#0B,7#Q3%7=N(JF9 7DCQ
MNF$&AL!4RU.+.8&B)!(N.(S7R%K,TCST;=VU:@CN NHNF(+CS\YWP>@.:BL,
M)P:S>H\'Z@3,$>(&8QY0;U>JP9,/ZS] D!/IVH2JA.\5P"#@-7B$B%.]\\OY
M!G]7\G<F6HH&PO<%,Y'<B3MB>2>AF ;L-_T0ARC1L:RQL)6QZ?&)EL+QVVRV
M! LAR&S_<URX/M9U' 'L5)(LK@?QAOV>F^%WQ@:&FBF\[**7BY&X[>><&B,3
MSI./$S:95"H>[W[VOJ\8E7'5$F$ B;%QF)0P>R9')L\NG9!\7<**6&/&_H?"
MIPGS$=;@'7D_]IH'V0Z4$MTU=R3(^(6U$(1H0,61^VGL3NW@)_5YI6Z%%ZQ]
M+=(R60%R)"9K+E;!;T68Z^BRGL'F@W7@/B UU'AS?GQ!F5Q:4QVMRO"#TSB7
MVO5HO)(ONT*\%S6$^/,$VUAS0<O*!MX&*RMM&K#('U*R_=P!=]@0G"J(BV=8
MK!6S#R>:$%9XQMHVKD&5?U?UN0_.ERLAE,<4>.L_GD[MF-W:%2ZYJD_R#9Q4
M>ICF(<NL$&ZF? 77&E<ZO:YN^_%5*_H]R4]MZYLZ4W9S"TER!";Y3_9@/\^9
M(PKOA3OO=>H,:YC@G-#/&Q4'W*%U-#I3;Z[CZ'.='4$[8((KA93]>G0LEB/D
M57/#QCMU*XK1OE O!\;:K+JBM1\/:S0L%LFEGZ5[X+2XW,M-TS/E_JS]^(<Z
ME"T/5P*BMRJ+S6M,-!9<U[UV),= P4[1RD?F4!&J[GH]K79>=&=J--^%4@Z_
M[=7]K:T,;#WQPSZXV:'(FTO9Y#R;Q()$9AL+_^N=[]=\.YY[+$CC$K5$T%:4
MV"?8&$C:5^1T0W7M?MM/I ]]:Z$U(Z!Y8 7 VO%@B%.K\\OFO>8#M1AHX#;H
M\NN+#0<D1;5Z.]W,2(FVM[ %W08T4,2.S&\W'ZL5NUBG0@/G-E:+NF**/B<:
M*L=@9E/3]Q9.2CP^EK:P@'S@7C9;N#ICN.>\PNHAA%]P?V&2Z6P0LL)Z2[H6
MU3=B81D^%2:J=?X##629?QN)Z1>,4/%_1-UB^])</D&[AE+)U[!,R%SQ4]S3
MAMA>VRRI]@ZQ"%N,^?V\5;KFV7E'26IR>1RXV*Z5?^8(.<=KGP1?G:* T/ER
M83309[9_NIE=_J+D"_U3-RD_A74MQ;P\R>[ +RWQ$["@0_,KBD=OA,3RY/8]
MZR27=:,SUW#S3#_IMF8^">Z,3LJ@(CH-VLLGN/5LV.A)15E$/AKHDE"Z3J@]
MEK>JZ6KJ:DAJ,NEKWF5 3K^0TCW&R/Y<M7QI6+MZP]CYZ[BE$*^M%&4:*VWT
MMS=O$#=U-713YK4R*W8VBK?N+#N(MXTQ'9 LD91?0_4MB</>'JV@@1%XO]K-
MW9LH_8:C,31@6#3X?6F"UG4#TEG9]_;%YE "-M".BP;JS:,)D,I6:C/&!+I^
M.^"L/G+2.YQ$ T8DRV4K>F"D+MQR0 ,Z#4>*.I7P6>[D\%9[BC&D5QDAXB@:
M]&K>BV;JK^^3\6>-QJ9H4F<:3DE?H &/BT:5TD_1"/DYI']>MN)&0?L.>=!
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M:M(L"1\J/#(EG[>M,Z*S3Q75S>&R<D1L-!D_CGC.\,EG/8C@MZ6Y/^18)?T
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MK2+5LP75Q0L7WE^A&)7))K6?!WPSQK,Y*TUW$DS_NK9\HF6\-^N9"'+Q-P'
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MR.DCQEXKOP>FMTMB1]R^(U(],QJ7,=#9G^GSV$9^7?X;%J*L3(<'DCD-E)>
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MEJIOPK#/RC&)>K!6XU%7-3V%C*-=V]8Z8?5J/;"\/Z?N_!$C<9*.;M\N/7W
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M/F6/W((RZV!?6IQ7RN"((Z^"6*T5.#5XF>(28-=P]*(K>OYM&;UM($JER9_
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M1.FN_;F XI)L382_PE34&-NIIA<*AWB>+W4TWOOO+\H(I9\=@T,+GZXVSUW
MZSC;_A9D^(]10:?YAK 62UM]N81Y1>;SES;BON8)9+2^CC"RM)&D'!]P?^E&
M7VG(<J7I1*R58]>'WP#^DY5LSU_P^2^*S6?9J+$L\FN?*J197P"3#PXDYZNU
M3A#G/.-\B8?W1(")XR/]1536$H"##$<^+YT8C_.6 :A.\9B>0OVOWW&&KK%G
M%MYD_N<I!8B3':W1#&\WD(WM BF]D2&L= IV+:IVN<H+11[LZ#,X:3G%A'VN
M#3Q$7\TP7'UQ^FO\;5EU\!R ^^X'U2D^,D]$.Y8Z"J>QDCA2<P[#<J6Q1N0+
M=EW[(XBXWM?,^5H,VOV%S_-Z>(2X:./]=GRKX0@_K2[H^"$J!!FWO2VB+A,B
M@_\PP%]A6T4\I1=B/65$4Y#759)ZVU?6.L\XB=G_3#PB@B&ATP@CVF^/Z&TJ
M:JUD8WULB,\FNBK-M$K$D(Q05#SYE#<V$>)@MU WT=1A8(YEODYN/_/%"#Y?
MND5!??;2J7,L*[42XP_\5;GPK!98S53UHV301]",*8"I+&A*QTF4:W'6(DUA
MN0S4*!CIK8:R%Y]8Z[YV;&Y,X??N#"770"E8IBK9:^K(&W]_$><>'RR]_SQZ
M;/K:8YG@79OP7$SN6QV-B.NWHB +*:M^E)> ]F6<*</AX.LJ3EC+/0;&ZJCE
M;6*/)9FQZMO-CK_DG%5>PG_!YRX!=Z9/[!6F?SVF[P$XB"JT\0_A>Z$T\[HT
M/9]&'(>=5M<XG.@_G<&<X3CB\=8EX*1ZWM9QV%(9TTAU$.DS953Q#YVF2>'+
MLU?E^M-G='SK$FZPX1W(QQAK GR>,H@F#'7P46 F]Z0D>H7/'9=E);(1YPNB
M*\LDI+/E(,]<<$L4C*7AXR')<B?XC@-PHK5ZIL0GB)Z!;KHM<F+ B\.?'1*=
MF(U>'XF%(HAT!741G9$^<@IB=LL;;VTK;-HA;!/2G0GP5?H%.]*?.RO3?;%+
M\6ZACFSHV<C67/'[=@>62GO#<@,GPKR#5N>1'_/<=XP\XM9%$6;!CVZ#Z-K(
M 6F+AX6V!T_R'K-PME&JR>HR7 +F9DZI79%G^Q\N 5)471B-JQ*]I*L2O6]5
M!=PA9ZV1D759VJ.L(HRZ'TLDY=4"X)^15'#D2;,J^D&A]G',!*/<^<\@7?J%
M![_/4#?$Q1<T/FTR5@275>QBRZC6 P<N.F/<+"0@*']()=*YI*Y\^,U\36F"
M9:!T@N4E0!QH>SI>YNI 8>M%$E1H?RN3OO:E,),OY)"JG(E\2] @XG#*ZF>U
M4)6CO?TKU\I7P8G4XRK?(,]\T9J;?@]6J9T)/;Y5/WI'+ODRX.0Q(!H!37TW
M7];T]1[=2W5)4=X>5:M5Z9R&5G>FQ8&/P"/$%;4-6]8LONE<5"?CI<C7%I0<
M)$O+G H M6)<YHD.MZR)7T_9O*DWM+O8QRB=[())CO//^B+*OCCSD[9L4%5M
MD.#95J#B5/I3G72IZH&DFS,"%33_KCKVQ[\7O%&MKRN$E(2U_YC#AEMP8HC!
M)0!N!,9>-%P"[AFZ]6RYN0DV^S/H</WTLDA%Z\[E=GWV:?1B^U?I;!W9!E9\
M^1* L,,4--=*S(?OD/KF;#H9=!Y%UF"6S".KVG@@QY%O.M%B^G%"SZ$Y<P&$
M% VPDP=6!N2BP\[/1*K_'C/-L\N!&N3:W[Z.%G$C'7JXDK+ME0Z7TXGS4;M"
MOPEL+0J'?E[@?Y"(+ZBR#22%"<O4I&-6Z.T0(FD\0/QDFJ=@ZX?F7W>78TCZ
M#VU*E<RFSQAA;W^[ =L^Y&(:#'6JUZH3$$7F#Y92,^0-W;;)'2'F)N*C4?&(
M=7WF-D7B;^%@SZ<%OM(+Z T#G>9S)>U9;Z&*.24VXT<[#T$B-'=EWM9+G -;
MZ(HR/9CD!KAN]/!VBJ\[QQGRF,&E , H?L/LAE:#A)>&:VKRT\4]JGXR='KU
MH)<=3:2, CZ.QLZ-P*]JAFGMMY.X5=08PKV][7+TNMW=V5OQS3EZL9Z2(W-^
M3*,FQJ,K]8\2^?=:(D=478&H=26NLGDE%9,8P<W32&5MRCG*!5H\U.39J)+;
MJUULGTYEG]:)WE6&8.:O#(&LF_%5N,KJ*EPEVG" 9RS]U:-9=7>IL/S(<>*I
M_'GG)]W4!1QYU [::?$U.VN;'S2 4M"C!5YJ 1_R_&SO1:6T?6-P+N@IQXO&
M$;Q:LOVYE=#YH6Q?]B.CF)?GZ6]7$1X/TQK1)Q?0$5JM@=AAON\_\2TH3(11
M:ID>QWJ#C+=+P]T!-)IP9N1 -=;SJ-4)U2PJ:6U/Z.F^NR)57;6?P,79YFP>
M_/()A@CGZ!@1)&6-68^:C39=H]2;]&0N/F3>4W)41!L%1H[SL%7=$\&]$7MP
M)EI,LRJDW=*!-,VKWJ<-^#+"+_B[*[1/P6Z=*1<]$\8TZ'H\M)5%<#;W]DNA
M="C14N7.VNF%3TK76J'#UG;_]=T7);D273&P;(C X.3+(26F3E#JCYH[NN?Q
M+Q'KFEHB>Q%GC$UG,QK%P7NC4KM=-1^CIMLG71GSH&GWAWRD[Q0=0+RNW]']
MA3)IQ[@8@[^>%&CL[L="'WK08/H5NN YZ6=^92/(5G?B?>LN@V'#63\#:)BN
M;4S"+-.W01_B#)N[A6N427=!]A <V*N\ 0"V4+1%Y][=W@W"F_O,]2^#GPC1
M;SE%1",9:\-U3SX4K#O5WL8O"6A8B65!1P4U--[JV[T$A+N1D\F*:X<Z,+[\
M&=:3-1O]D@)U=LN!5-UVSRM@U>3.5HK#K5!*IQM-8DZ_ QMZ@SS_O0TL"M\)
M24%DF@M^:4U+Z^\)HL%W=+H$^*(>&0D\$1ER3.[+>(.T*[LO@MABT3.-L=2#
M]1&.EPC""5;'EWY6504-S@73Z1K82'YZ</.XU9,Z<IY313JF+/*GIGE2:/"B
M0RXVHWI5$F3(?LTIJY5I(9Z^E<#O/=VRA^WWA+60U7]O,_->Z_;_N)V;R1SO
M?\/S!T;'65*)5OH28+L"/G^,,-=#)_Y R+VJ_&)6(?'*WT[[;$_A[&[4$U_C
M,IQK9=XN^3#:>-2_W&XTL7NI;68&W#(3C;?;YU7VMV&!V>D;[D\)TH\F9$(7
M?VO<"90CDR Z0(QIE+$111R?[9)3P#IZKRH:%F?.:!'Q?R<\5<03.?7UE34?
M'\=YZFL3]U.+BAPM%S>K?1&:]-^1_),)U#VM!39C6>IV)^/K4E5%DP'3SO$1
M5M^(#HMF_@'RO^H97#['4;0,X+PS_C6Z?6#8#/KT&PPE"D[.-]DM=6LX/1RZ
M!.S@&#_:+6B>'&?*X^09]A[?;B(R89'_Y81BQOFJ).)S@JQ,?(/K!O<[[+_:
ME33-]9^''3N0;Y2/8Y,>3))DO+PF(+5_WQTX"VTNG>+;UZZE3N0Y_1&CRS5;
M2U8;=\->WP/:6JW4455:4A5L23-U-T]$HE(\;()"^>Y #6]:LV^.WKJJIW#Y
M@ J-Z'797^2Y!X**RKNCX5G@SU8YS?3^<<QO:KAIYI+C1 Z08'@[]O'@XKG$
M14*U8D2 .$E61&QL()^(^+DV:_&"!%0_I%FB,>PZSX"4$,$&JFIC2.0(83V7
MO^6+[TV=5# .O>G$$G\:*\W[ON,I+^ .)'<%6::-UL-K2DEG)C]X2W\! LYE
M2>H$">^?3WSP\PO 48^&A5 ?.,$Z9\22EE.JFQMPM'A)K:BK)F#N<+V!&+Q(
M[/U7:\UC)#OBG10Z.'VN6\]N<Z[<-?8X'N<YMXGQ'"!?U-+/=05[2UZE5C_W
MG<U>G66"3 .5P.>-?S@Y<'#;F5++/):/W _DO5A?L.49SE:2-.7^LQEHE?UT
M<'!I<^=A=<03#PL]2N%GTAU]2T8?_D'9E'&$66#^3\*\$5JDY&U<C:;:,YIJ
MOR4?2^3__C;/38G.E7@]M[K'E3]E S:N.BOUKCHKVW#H>*<:^&?)#9*EW\<J
M]^1MZQ;GHS*/:8TG_*"[<8#-YJ@;1O4GX07KU/>HG2=T"UW:!HIE'*68Z'U&
M.L7%IXPMRQH7'V>$[?R7#&__GR/8U^@>9]12_-N6^[^=\Z%I>_2W\YK5D/;
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M:S$RJC0Q(NN$X-I>95QVK5.S@^07WW3/1C74+,3XJ'XMN^NKKB@0))QK3=O
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M#<S%NR[G4N?JI_[#UG@>[R3G6HOX]-D323F;.8(DYK9\.I$\?I)LM\?U?=[
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MF_J9[HW]O666B.H%VHT&^_QBKY-$KQ8SD&6XRZOT,/:L8\QF-WK:UA6%CRC
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MH$N<>D@('44E3"A2R0:'J;KRY5<!)C,E9X#F3F+B5I1';B&E=U@7-]FF+H%
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M#FNZ3?;&OW04!4%Z"PH(B$@3Z41$NH@@O:J @#3IG5"D=Q!0!** %*DBO?>
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MH#[_8576SMRG1_$[+B.ZPEC@0B?.,DG=QGF9P5A@,0\+O%YZB 4RZ"#'K5@
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MHFEH%W5#SACV,@]T?4Q0FA JE6YAIM1CQ (!!Q17ULNF9JS'!I6^/7"G?%#
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M(KL8 ''G-YVN$0J2^G^I3=!&$>'EEVN0GAAZ],EV)D;IYH@(K43,A1K"JOH
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M3>(7ONG%CM??RBO_W":](]0-@^L8X'-MVQ('!O#M:C'<IZY ?:-J<;ZWP>P
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M'C)4\T*R=<7AX):,BP"XSBLI)EU,):FETT(\T30S3]M<>6G.<(HL)M#5% .
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MK?J=.!<HVF=X^F@(_*>7AL4P4Z4[[I_4YZ0D,$#DB/))&P9(&:Y515_=!F&
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M<.=I6B]YF;2Z,YW%5O,FD_IYWH@F^/142VL\N8TO3"R"JT>*4IXD,ZA&-].
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M\?"CP90A7;$N><BGRBZ!I$J:H]5HC?Q]4/"-W==6<T3*.)$UA7JVE?-?O&)
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M]W-@08NY*Y?! 7,,L"?I$'O0>Y*=**$-9II8>1;A]IM\Z.UNCOG7@ !=FFO
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M#_(,&DC1P\T.='2WE^C]!6C=%_ID7G@^ES'Y4%]_S,[I_Q(6H,N^07J#47U
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M+GNS.^5@K!X"$:.P,]5\Y;AJ+')U.S:@*)">8KRH99^L93GEME@NLSEN][.
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M!,J<13ZYW 8A0S6'PV'46T$Y!Z5MT5?Z5V*>(#U>^HNVB^ +H5KV:X#QVIN
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M^W#>[4RL%D_S-6^Y*"R/A,TOL?-NIRD2M*KTVY+]BJGT4W$&"UHI*X$PT+H
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M)$."^SP@'"T/+Y)W5=I 4Z/1UBLG_M*O?"%O"Q>T^T8&[?%ZRI:DE0#TIZ7
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MRU[]Z;#79@9V.CJH$0FLD#%\QW_!BP]CA?BU0?K7HX!E7ZNK1/6P3DW<5X,
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MX=TR!)1K\_RT.X::)C)\%)GF1 !^]+J"""_R)H71/ FWSHX_?8U0%$!/Y$<
M7"A\I4O;']<^.#E^?VAK)I;$;;;NV+]LY[_1H)][DC]MKOV7<NR_]4_1_M9*
M=6^&0%GIS\'UWU"YP:^0HV+2W=L"]9R7?[(("]@W"M'LU#@;Q&J:_4']+EQT
MF+,3'1W*B/)#64\3QMJ.BCQ()#:FI4, UIE:Y_I #W3[1H&P*QJVE[TVJ]7G
M9/XD-Q")CNTZ"Z*7=]D\C>7WBJ9S<+A0WB=B?[P06]&Y9(* T9"()\J/;GB#
MY*?!8[X1@OK!#2&W$O/&ZS!R%_I%C,O0)W]+)13J."_XFDT0_<[C!3Q0Q.OI
MG_;1Y_UI8<#?(T"#_9O9WA?Z>E)/^B2W.T'BRU7LPK9O'SZ?960CJZ:V@K?
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M":)T[/*?$_"A9T,IUQ+SUVW5H,WK#PZ2S<E6JS,;1# K3XK&'UUO9%_.*)4
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M8_A@O!72=G\) SSSJ;.".0ISPBSL#67C>[ZSC+2:&Z>.\$QH4=\D7%:J3)6
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M;?CP\_*J227;ATEZWJ*._(R8BZ'N[H<JR/@GA.^?%7\BY4QG,!44CAD6FE:
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M-H ?E&ZIH8 +!;/=@4>,7HQ/]U6:B4.IYHFF*H.G7U_C"ZI5K<GP>) !/.
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M 8[QGROL_ZBI#NQF'E;?7!Z-L<[G]>=[&2J/^SG;IQ1\T/-'SE3A7LW[V<V
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M<JX9C \N+JK9V  ]=.)6?DK>RL#"04: MYV]*FFYU_68.M>;U\\)4[QR8--
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M$1E;LQ[4&P7XHJD"2"/5\:^K.^.1G_;^\#)[*%"@^/TI3FFE9[,AW'EJ^D9
MD%)A<G2XF7@M<9T]<WS\,X,:.B4Z+N,A;E:).-1XV<XK!P&\GA.^5,I?)^W>
M[]Y" &CPE\<ETL7"<K_%-YG_[%Z(04@&C L^,;S+3[R;PKE+<D/ *]YY]G3@
M(!$94^*YP#,6SMD0P,\Q#_DSC.]O2Y!A:( H E#;A\4@@%^;?_[IM'0/)V[8
M(.M/?S@NKK5D>/HFR@U\5;Y^E4P1;_;3>:]EX%%SJ'BFA^\&GYK,R[^[^BRY
M??O3YG%J*5/+^_/J<5&?/',?*K\\IB,VJ%3VP6/_-UJW35GI6@ZG.<L/;'S
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M79_7X+4OQX3'O\ 7XTGR#IRIXFVA[,6JUR-20B\]E+/FW^^3?]!;>.EB# B
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MYX>ML/AAN9I#79:SU)5C6ZA 6R3@ PVRS-@]'&Y#.>2E5D+.7$,VR![>4H,
MNIILBW/@Y(.A"&"3' '$7'_7B2GY%U'[<F!IM@4]=57H=[6*VH\&G&2!3O;8
MW50MXL(,26[\[[;AMR:..67JQ@H;@O4[+.8M!%[ZV06P'&.7YJ=&:TJ2J>D_
MB%D$W=S>+),Q795N9U+T_\;07K*E5%&-D9A>WPZ)-\1@VE&6:--" ,N<Q"\A
MFHWILH>S4^4S.7??*I]@4/5V,WI\O'>O\P0C)3V4PX>]2(FF/;$Z6&S_5[TA
MJ&=FW?M R_K7RC[)IJ4J3/1 /8_MZ2)!RG%P,S1?6<$)(SX]I[RL;NR!YOS
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M0<Z*1LS2TB%R*=! Y>H8R]ZE2M#=J;6ZL2IN_M5 KVI>=XEXXZ:ZBA'G\'6
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M65D6X(2*#FEYGMK:NF"TP)XO_0_FWCNJJ6\+%PV"!!")-*4'I*E(EUX"*EU
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M0X!@EWNW=.5*PC0A_&?\I5FR"Y%1\0AC4X/(,RVBA]PM:,4[\K(]Q8+=J:!
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MZZT]\TIFW55*Q5HMOOB&[*830HKMQM'?,FR?L^+\5B6FH-GM]4C*U"/<U?:
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MZ;((UL\J<A=O&7)0V@#%(: Q)N$+CA]F8N^*_-GAPG4-B#F$'0KU:1@:E.X
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M:.SU!,KOP#AXX4C:TOBL#\>>V74.(D-6#YJ*SL(_Z5O(*"TS*J,C<8QU\KP
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M2DG"]P(THKDRWLIH:=X(PVT120[B)7:^&19HSS)(S^2EM$\#DQW$W%HO?'W
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M]P39NJ^J5R,\'[@MG,F/WE#P'-+NH8<L/>-O(\1EM1\>X[M;58[;AOV_&_]
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M*8U0M,XY(*I@#%.+W9*>1-?,H31GL:XU!891Z#D'M(Y]14N/EIZYM-[4LZ@
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M\K'16:&G]^]*-G:D_'3W5);%XR3F^$LJ2=DGQ0X C(T34TJAF#FKR#+&U,>
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MY#("WKP@L,J\1,#QD!+16P.VK]DQIQ3@$-NM,C#YW.Q$UXI.]WS:%G=4*4E
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ML19!OZ^= ALM9]S_O(VMN.&WJ$'V]S-/BTE#("L"$T+@=R"7.O@0M:R@1</
M$TEQYP4AHQVD"3+I^1C>=\/ U46YK&*XHD^@-(CV^!9QD0J@2U<C1'TXICR%
M7%G&\B*VPHM48BUKU;A9WF5DMS:^UKA$>Z+ZO"'BU>"6;>HY0,/^5B>!?53_
M:7CLGK@'5;.>E$(8_G9;2VS9%W(CH4FXZ.-#QF34S;SOW-_?K0FT>KX<I7N!
MZ"\)\OETC"[9+'28.^5 0RI@-U"Q>3=4V_CPK)X+*BQYV/;]@$J B;KC:GW@
MV >P@3LM0>\:+&[0@AROX:@ID@F*.1T(IPB8O^?545E0O3)+5V/!4\"L=2=6
M7N21%*FR@>"Z>_Y*&)1A*[2=,Z9RB6R:;%HC?^V?'XF)K9=N^[2->)--TWW^
MJ_0<S\W0^_@Q!D$ CBR(:<)<"6AY=,-#O&_2ED;^"I7E4U)=%_;PA@P;]F!/
M"3BSSM Y@.XCZ,>(1Q\MRJ;KNMSW*0E\^^MNV!A]3CC'(5X=U^GOIVCU4&1Y
MPSG@&D$0>Y(@VRC?C.2#]H$YI##XN7I#B#>S+B12/#R1;E*S@>0'U(UC7^@T
M;?QVLOY(RS\*H .(3(QHQ/4NL]A;D[V-V6*Q-H\[QNS0W-4F)!F:)L^:@&5[
M60%B3UP6\I5MK>VZGTX8V43S917MBS?('_*P+X("RH3&O.9+XFVT19,_@Q!\
MU5"Q4W4GQIVW!*RY:.;J4QW!&"^"B?'H6TN%;PX["<3/P+03B+D6.CVV0]$9
MJ26]G[=MP@5T&<6#MNT@63%M^J"@Z^4569'_R-0==0V")#BG\DAM4_"CU:E/
MGP=*P?35E%CV-^X?I(I$]Y,JP,"HRJ^(F7AXQCS-21K43V8!%*C]"LCP_@9$
M.8K/Z&YHW^TJI]['W;[C\"17M*42.:JFN7K'?\?JMMK99N9:@SW'\?"28TD5
M-=KB*2__."D#+,OJ7\42ZXU@SN6H@ 7SK==/1^YU^Y =NKG#SR8'BVU&KY#^
M3<R1>QCML7AV71O1HVUQ-/MVY8UUD@(,5W@IFV(Y]E6,\O"58(Y\P,7IP*&M
MWPG:91)T^+P8FJ&U:F[:Y=K5R;R>X&&_J3?\U\B2SF(9IMBWKR,;$8^!L7L"
MB<OMR6X4,^D_B9&"2]B8XWA+OR05K3Y48$2V>5\@H='QKJ6^()J >;UOM&I#
MU:7ZBC\,$3:[J/4V!!4M:)5.!0CS'7+M G]&#=.Z-'.7\"<J*;]C(H@MOQH$
M4L<E0 BLW7<M:1DB+KC(H1USSP$/%-B#:\&W**TM&]^=3?D9'^,J)'G@I%E
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MQSE.+M!Y43%Q"4DYR)6K\@J*&C<TM;1U=/7,S"TLH5;6,*?;SBZN;NX(/_^
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MH"E*EVL"F*C)$8[(5<A@GT;<8X*JXA]6@7_C?S)R\MTHONF6['%U6'18=;X
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M=@:0X4"+\.2KV*5R7F#/MZ8V$NU9)U,J&.LFGA]1*N+,K'?7@+HHIQL=Z :
M<(F66ESP@0K6NRN9^$>.+KHMSG2V@Z6_-;TM;.4/+,\7L+_O_@I2?3%K\B>
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M"\_.S^=8V4/URS=6Z_0(;E>$7.'@R0M-WG4/6G"N,%P3M3ULTZW &?%Z3N@
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MDGLKK^4JI,_6B*2!OSM94B,:HI)7&ST :R[9I6R27YKO3&)XQ=96?6\^;6?
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MJJR"<S.K[2E]@]LV*\UL @VWEND/;C$E67;NC9S8UVI]FG^'L12VU_9:A/T
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M"3JH:S <Q-QQ-WW)R8L(;NH<"_H(RT);"@\!EQ3C"\]Y0F3/<B<BU;"#/1?
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ME(\J=MX2EH?X"E!>6?E2]Z (TJ=YPCVKDC^(KZ17<S!I^#XX#P*[87_#6],
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M>YVLX8#DE'%AFO?]A<"3]:W"RS?1* KQX#9363LMU>G*YQ0N]>(JBO%,.M1
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M@H0%+8((R^?V*JHWYAS>=?:T[46'H955M5[BNSZKU=9(N- ES]Y/>"=1MJ[
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M*@CKC]3!YK:,F>>:2"BLZ<]TYM(YL6S7.,-?X+(P4M!M@O4I9CL='N$YW-^
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M=3J7D0"SP+/(HBGY19ZCG:255)2DR"[WN-)[8YO'?^8F%@']9T*-'@?U^K]
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M8.!)E1^>Z=#\*F)@.1K.'41!WU>+>Y1QZ01L$&WZ4=0+ E2A/B@8""NB5CW
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MCK25V(\^[KG&9S[:L/!IT$F$^1N&F #NZ=NU7CE/.^;-C+D&T_U OW% 9)9
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M?_94[;^$"%BUO8I1[MRA2'KQ;=#\;MEN]BXX;+NMP@,P[?11;G"=K*7HH63
M#*=%5BKZD[YVVB+>!M)II>(K0,88#I =#WU%+T#F7C5ONQDCR(P:=JL)4D!>
M=Z<8_ J@!ZQ_!9"/\,6_0VIV/W6ZL >.<#,,OH^\VU4[,>S%1J#U<X-3O!&Z
M"F5P#--[58IN<]\*!Q$PVOI+,2Y5C=LFQTDN&#QHVT^TLE-J,X7H^[>YR*OK
MCW1:D;5WRUO@!Y4F[0]W>Y5"Y1E3@:\-R6X8NQ2#*,A+PER* .ICHY1ONSD2
M0)_IF;K*_93$"UK6C<D_T,R[I*(68(15TJ?\YZ08XOX"QN>O2'HU7P&1+DC@
MJJ65!!#-[3/QL>##OA;>J!3S-<1YS[XZ4$?6EY;O)C&V^8.!+N,5HA]LN53'
M_3)?KSS8.\]*6##J*2ZPX'QY$PFKOL*C\IAY8YTBT,:WQ.BA!BNX\:PT9Y(Y
MRDT]=.GCP(H7%"VF[A.$8VR6'CXL\P!\^:CT[*/ N+TAL;^1>BGWM?/YE2E1
M7#>!=^JC3U3>%.WDFXTDI;8"2\1'3^#77VVR<C,_%$N<N^W-Q5(%.>&V./1N
M\]6[!</:Q\FAV6KV6Q82O=ZHP6TU*:=TBALI02\DE5=9&!47^7S5'CIC]MU8
MX&[(T%[0!_,^7R%K4?6$Z8E:_66G99(V,:G/DO%Z*_!G#@8(J06CK;&/ET8_
MYS=)C_L-KR;O4_$B7%C>5QS(-JS=GEQDI=TX,:A;&*200.A>%L9?;A*AEL]&
MT+1H,XEZAM]X%Y/O)@OFTJ!#LJ)KG=U<=C&FGYX&\%W82J?(6-_Q''*60-N\
M+!'@-#NY7J1_ M?Y6E7E7^*>8:X4; >^)0LH"G<QQ>E90,F7UL]$%@0LC2,<
MKF"\CADC<\<\%4<G;].^RG!CU90&:C*'-%,+&XE[(WXIHX]/)U/&0#_RXWO&
M[8*#W13PNFNJ9+X"M$I(YF*70IPO'73),N6K 3AI$YWS"B^OZ4B6);H(:A K
MR-V7SC\IBG[EAC_#C^<0\L[KMFYQ9>&=D>"J3L)Y-L8_"\EZ'2/9_SOT^TA6
MH0\YG^:&/JV^D;E@N+HMM50B$6HH-6?P.K +FLL$#,G^A-4=LU_,I__>@SFN
MGPY_\6!.KZ#]+LVW[1W_ D_3_ZDG\#@ 1*$,6+-E?*M<XP;'3I15)?4W(QF]
M!H!-B*^ B94#"X+*E:>?X _I@B_RX"T:@<;4/R%-.@_'#]@('"K2S@@N]3\$
MJQF4!4>^7<>;V/VR'%\07?5RA(*V?X&Q=52_-:)?V3Z$R)[H7>;3"ZX(3 .X
M&1UW)B2EA&S"3K\C=:#PIGV8!G'>P,(C1?REQ5NPR50'GC;[3?H!^5/ZI5=[
MZ2Q$-M/EJ;EP0-.X7G(>/&>D$T'_V;2OYDX]ZQ9P/?VT! ?+;-$ZDKS/^,&0
M%W1X7_LK@#E\'4F\2N3=V[^13D;&HO/EEJ/A]-/Q2';BCEU,M/Y.\KDV*RD;
M@548D<?X=DN8[0%D(RU$K(]%<L%(B'G&=14LG9F\A7"48A[*@7B[,?9EO7H2
M"6J<O3E?\*QO:G'D@V,'Y(06VOG>>59GQ[;<DF5?*(-!;U*KE/B\-9Y::Z;8
MM*^ *769&-K/964#U#5D>>HNL2UDQGE!VZI0J@G AL%?K82'ZJPEW2MH0VP(
M1#A456&DQ_82RIVQ9G2VE/IL7=';PT^%*;R,\MFHWKL:^%U_ 3W[+R"\T *?
M?%NX&R:LA=OHP[?CT;#*&H"=OOY70.,;W.C@DNQ,G#-B@G\%M&SO8BK<3'%X
M0*HU[6QD=,'[2>/UVN8:<--7@/W"A\M84/-J(YU\N7XB[GLL"GPKQKT54^,C
M_Q6@(1%'TOO-,X7/W)BWP%?F> IQ>8=NXMLSZCGTH&CWO?Z144;-_5KX]!4#
MLQJZKX#;C^ME7B#95[T&W[,0^8I5@EFLWVT@I5>:AC6;*RY5]ZU&#BHQHRJR
M#%7S 6T$XF[S44\(+F65590E-RLBA05=&1QCU=1LH.;G3=BH%F%.=&V/\#%*
MMO09GJB)URRK2JZZW+N8?,NS&=, QT%?T"^6@M.[C\?0#V-$?^]0/-S=)]C=
M#*E>B[W%9DCN5>X1"&!MX6V#*!B4IS^9"LPMEQ0N' KUX4,1L&][\#&]/X .
M.#WLX&AU'*PN4T5]@1/38A1R@SB+4WOQN(.=59<8"H*N+5+3>Y?EN[^,KGR:
M^3S9+YVT1JN%Y"9[*HM:8K[X0C:Z<-7FIBA8$L[U845\EF!$C,OQ?JURVZKM
M;NFN[E? :<8![NY<M[*#.UYL5).)QJN;."2JO0RW!_]T3"!./6GVY@#85&TB
M,"R\A;1Z>BCF<VK5EB%,>1V?MUHXC[/F_>06TJ+3\S:-!AN7B >F36^+F_$K
M@%T<FH7JX](D.I]+%)G!)68."!N+ Z=MIS5&#V?Z?IH9J?YB"%D,$ 1I62[9
MW"&V;\._6,,"J;KL&&LX\ZAD^C;E>,4!JUR,N\Y+V,;H:8M4Y8M J?8916..
M3H(Y,/T<S1=(6$RHBK?;>(6X2J,EZ6/; PNJ8:]224UEKJ@(,O<2;PX9GSYO
MU'/K<=HHOUJL44ZYI_IIO.)YYGGX%#2[--YF=025T1-O9\=&T.%L2Y8Q2,<F
MX@&.6NA3L75Z0^IHK+@= $@@)D!Y[HS7;N_Y% %")<[8CK)M(1T[B>X:P]W
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M*+7MD%=JS0MWT1@Z0^'PD1<X]NJX'77&W+:]1:FZ*:_H8W[4S6PL7S=7126
M%GG*;#>D>OPN42QXVG'FIX9O%% -?0WCVBN]%:]IT1U1'Q=66Y59JX[F15_2
MUZ_O#!=X)4;(N<]830T,.PWK2.JJ@V/IW(G<_+#VA4*7('TV&YDH@+184JQH
M)@HT@Q&WFBSZP$722? &H[HA)@H%(M1_FEGUJB+@2R-<%?"TFK7>F/O C:7.
M%L>_TZQ'=5U%A?FM"N5S#\_23#G,R?>@H4&%N6T<<M]:37VW^-Q.D>+.)QC7
MUVK7B)<6+^,>,ADH(1>QN!$[*BD0,BIF[D1-"8KD)-+T7H]R4*-X,OZ.B6SW
M\<D)QX7(#'U+Y[UY:[./RD7%WFSYD42L,I;\R54-(/AWO4L&>F3]L'_6JH(3
M[\JT/?=B<^<<4A>A%]^F;D[XVK^WZ2.S0%&J"K,7\TC8J'7;(B*3/X-7+$=2
M\B*KR&.'0.^?YU2%J./B;@QK2MP;3L&/[O)_-O&-D^3_[-  !#Q>/G^N)Q!^
MH6BEQC.SJ+5KU456L?C>D$,"Z2;_-H9N^Y.OIURN]-,;7MV2U^MBC-QX"7BQ
M<T)-S""!YYX=;TY;YL:T+;9#%T8\(Y[9?,?U:KY3AG%T>@HY%5P6&@+8-1"_
M6_SISTF0013-I.L65Q]N\U%7TOG*M.PZL,PW"M(V+8(CA[9'M5HH%9V24Q-[
M>[3M/YJ?K5D8J9(B*09E;F'N//1YQ.N1#/WH=]=,@D11W.-&TG)K=?%S=8A5
M3H#%&;Q^/8HT5RSN/%"9IC)[?AUN76C%4\8="$]"%A'/Y@3V2?CY",W+O2L,
M)>15W4J&EF7Z^74#+@U%D0^W? GD8=%Z5#>G/IV2>BJ<@C<96-C$AG4'+4PM
MC<FWLJU9+4V--WTS?D>"Q:9'Y0ID,_G<TCL"4-</-V#LWB8.WRJL)YE#D:V'
M4S]?WAJ^_6,]U]* -V0=0R>L$0')2<@LW.O[HTN%_C$X?\X'2ENEWZ:TCCGY
M5;#D$?0&W?<'2EPZTE?]]"AS69B]<L+##7Z]5O4G0LC<EFF%3=B9*@:$A"**
M<?N"R?ZPPI5[KW]N;Y 9I3>=AR&+$L9V=[8U.)+U3*VH?D:!MHT98H9]!U8U
M)]%2A4X4(O^2B]@9FDX7:\I:'(_[2LC+[+4SVXI)9DHP8/JWJ*N4L?FC%IOC
MSVD*UM07SJV9PMF?&80@L_;*>B<Q],4]N@B%K6V<YK[1WD H\L4VAKZNY_KD
M"R[=@+FLH<?<A%PW7_-C(=^F<MZ':SDS@^;%B,](%M\:C"/$DWXK/2B$\*[R
M>*"\(P"9@0!66@H"!\.H,G$&7'JS=B,$'*:$4AM Z>OG%,V$&_S[_ETS=OP$
M%/_+H_Y'>@:C_;8"1"B6!_'Z;[F8=]O_Q39XPO^6;? >_;(-WF#SQ)GJFK\=
MUB$/SMTU^5E6\&_98/P:K.!BC6G?BW[W?2.B3)'5JV+ D2SNH4\FK6X$GG<D
M2.OM'#IDNW\G^0O\9A-TMO9Y/*[':P1]L]#/T#3P48+(9$.5>O W#>V@S<_>
M2I[V#?OJP97"B@6@O>Z^>T-/ N&Q.RG6WDEH6ZO(Z< NV/OTX1GVM]#N?NXM
M$.>5DLUW+]LJLH?F(LD3#!>5N"2!5F3P757I)PG1>I)>S9/GQ'@+ [;\Q,(1
M7WJ1NYLWZQW%[BTT! Q'9-;I<G[#J#"<7LEC>@-U=RMY[W&^F3VM-<5YLY2J
M ;[^Y1G1DTS5D8US[_X&[>Q(^H/IDPK;!NU81^0/3O&QY/&Q&@XU]K$=ANLP
M[LULI-*=4OYO18AOI>=5FTVX8P)LRSF_X=Q:]LHNP7W(S@_Y5"5]H,3Y;NJ_
MU%&&VFH_PMMOO\,6X^F2JR:J".#+6S&>=YXKVXXT.#2G%CZ%OH?'TPEA<5>\
MH:.+5:J3XMUDBDHK^L;A>.3F$7 *12MSJTBSV^[91FV-^1+=(+=7*K"P37?;
M5JB9W3>CJ(N3J0T70Y'O3"KF^4!'YN ">-<*5+PI$+&*S+7>[:PG1C7S(;HH
M/:P>3#T^G%.6HMVZU<%,X#2 W,CGRQ5*ABY_UCN_91029/V)N=$[]!,SL">4
M_O/9O^P("-(#+^;0YV<R_V-;@_YK2*RX_7]R9?];=XK_3\"3%]2(>U.5F1C:
M"8.U]S&EJ&X%E1*UL#>VENG%?+*W+ 3*\Q4ZVYE!"^RQY1"+4Z;;N/RW\)A+
M[Q(F:T2LM1SS+W*M9*X')+VD:@""*;*DG2,'TK 3)UQB&9!Q*LYF8@-E!]K>
M-RY)PK@]IK6-HW%@N+SC@,7[2>QRIT/-501Q_5O\_&5^/8ERU765VMQ!:&74
MK)#K=AUVJ5$[4Y9DY3PH);/3&T >V)-2Y%^)_D*RR'CL8Q]]F4YK_7!#VL:!
M8..'N\['[0CF'B-]^2+^U!_K3[(4^3Y#<-A!MKSWE) GA@;GS.A>=$-2^@]7
M%JQ;/O@80"S:01E*F!=>)/C]R'2^-<0P4O>:SH*5%*E8 ,[>$"B;;7$?7O!$
M8GW<X;[^Q3]$7E]0Z_8<$W 5H_2?#^,H'Z^[7I?:IOE<Y(M'PD@#M\C%KK*>
MR>'6Y;%;4;,O[F(<;DUA]1(M"-YGQ]I33LK7P2FRY1Y0J!<O\ZNJ+I.K%ZS0
M246#3;@ZZS'I2&P]5K'=:GMHS"G=^=PT6H[UH".W%SKB6/OX9I5 \:23DME%
M%T.8S?'DEB7@)QC2"+;+8S4^YZ!>&6,75&6,F"S8ZOIX8S/ENQ92[XT)2::C
M$#1@26^LWU9PV?&"N3-F1:BC35V5BO$Z1S;<@O3@\%4L$I'4$Q+D*  /0D4,
MI=OIQNJ;$4.6"^>XMP=T?>]4KHS5.)&TOEO'@&E.V*6D(S\.-N31>UARQV2'
M?.9J*&9HE<[[R$FK1YD<ABO7*JYK"!B)N_K2F3X0WI/.4WTK*%MQ9;)>1F:/
M??8;YN8--2XG&3S6WLJZQ+K5[-.X>D8#C$OT6 =.K5@LCACN#[T>US\"_(X)
M?77 P'S-%/9F1KUP"Z+"^2>K2!6ND%$_]WDX]7>*)?V!"_!?0ZJ=\;*3^0-H
M?+"G+14E^K3AD F_+'1N4FB#,2Z$NXJ0MD1=2DY,V,DRLZA" ,'XAY.:;V32
M":M*M/6214RH!>T+%I/1/UO.L;)$29)@O1KVU"=Q5*V(,K02>^W^>)PHD]=8
M_;'"$#!QIR.3X[II]7SAG/B*#N'UBYA1J %1"U6,>[E2%MZL(B+C0H*-7FNW
M],L%RO#JZ]^PW^Y;$/S:"D^;3=CFT?F&T+WF%Q0(XTXHMMZ5GBL?JW^-V*#Q
M[\K<)\*GY0<J;Z8/S\I($-HP<,5%<N2[ FW>9/)AQI)NVN9+ 43#W$6!Z2'I
MR>%([**+FY"\!ZSG_=O:<0VC,_AK/_IH7%Y\P[.N]SOR@Z%CELL1\EJN)%BX
M)='=E!+'H3=\)[A%O&";#O;1@K&NP;Q\0/NC?YL7C+-_.%^]<6/%,B426LB6
M*,G>T;@^HZKIDN]424*=(T5=5XS3'6I"WZDSIK.%TW#<*DZ.-+[<&C-1++UO
M)#GKFL<;6U728599AH/O([QD)J&O+\37*=7DX2,^'(P[LMG>')ZCK;&UBLM:
MX4A21F[JKGZK6&!M=31%VE."?<@43=8,>1SX98X_8%IQC1Y'5(R;2#0=#QX_
M/(UZSM  W'IIY2^PWU9YB:!NV\0_X-3(Y63N.]90X#@_PCG#3+M8X1*4;"QB
M%9-C&9S)/%]/UK:164>3OKW:>*IF\[96^M")5<><CU0>VA*8'^*[?>#%//_"
MPXW=@=U'AU/'+POR?CGH;PBMOWH%\&%.BRS(_5UG+:VEWD%>M2)"9!55-WR%
M?9H VDP%>@9+E%]PWL7#!FU.NLJ2+"+2XJ3@'G=^9*]CZ.$M3R*ZO:09R:L/
M4"4;# %S)-VUGSM1+5VCJFHG>-82(GNZ*'S$I<\?0)2FSL#/]5&Q<J.\OLXG
M6O5TW]/VU5]4E^T1)HR@GVQ& =CL3LU"Y):B@-V'>N*+BWN2G^$JN4BZ)#8,
MPS436ME\8SHE6][HX;W?-5;]YZQD@]?$!; ?T['3X^A85'UM#6-FMSLW?YT9
M2X0C^+W8W*F//%B+P6T]9NJ('^]P#O(W U)[E9^)DO*>O/?4$J5S7ORVK\9;
M:O< RS$_PU*>8UUH4Y/'9VOD*?+P&XY3,/!',*I\*".X3&FX_?P1H,.#@ 7@
M(\[IOJ*7-Z&*F8+%A%GR1%"ZG%TRY9:98D<KC&MQN+4IHH8JQC?='(^52HI3
M^Z%L,*J/E.ETJ4U1*$S3; ,%:W'#!?G-?0_>-*Y7R;50(Z%1299,*Z$32,J[
MX+;>PTT=:PZ9[RNQ[%PC2DL% @-?;K,U8>A7=SZ$_7B55[&!VP4V(>_<$'[*
M*T:K!+;DST'M6)#M,AV5U5GY$&>BAXO8<U;HYQ#:(<MH?R@I0&'_\\]=KVY'
M46G\\;FV_Q'DU5%8I/K<0<K<8U;HHPC6-#)E/CCF+%9")UJHBD+X1M0FP?#G
MR-2<N&/C 5CCW] Q7QM*GH0TQZ77XTD#W//)\KLL>ZG ]VZQEGL60=M$,^N2
M3CE\>D7PG7ZBB%7&U*%MUPD:/:H<B"M;;E&EP6X\V*0 P(6:57\-][*D\.2^
MX%FP!>K\A!*08^@V7!H;O0OV\;C2T'PRC3(CVZ(FR1_#X#S@&C1GA;*ON4K7
M80:'CNB12[Z;PWK6CN3/08*&ZXK>SV7NP9_OQ.X<O&$'HK3=TZ)=URQ#(_%:
MX_[X<U$.3U?P =L,)PK?)L"X(Y06<PM28?'A)*.+PR:\_A@Z#4A&Z"GA(X"%
M/^0\7'8"QD7'HCIVZ- .#4!3"POE,HIJW^DM*;D1,P0J5_'*;A'6D3':6$$>
M :TP]DW."[>L+59[H4YK]Q\WE5BJ7E/&G*#8W11/_33HL"G>[0'J?;E#A&=7
M,A\+*\<BR4^7KF/AVL:69:G 2%96A+6XET$?R.)+^=TYROE:OCXBP[2_1@2&
MEN.E5D6.?4[8I'[J0OR8YHM HE/6!_^R0EZT\*YNE*[0YF0M?C4^-C%CE&\
M??E<S*;YF<P(X3&GS$"CMT2;)1B+JX 0VWR-MLY!!!^T'REG!&U!DE?DH7GH
MFCL.40:"EBD*PR("?>_.3=>A+"_Y7X\= G5J]5)!:1']C]Z(6-+C\UP>/H&$
M-3Z8?C$S@E8\JS$<M$HW/'ACOX_]*XEZ*HDHT,"@F^%MFPH,9#WAC$+\]\C)
M8?ERVC-U86V5W6+#4@X8U%(+B *^3CC ',+&7?RY:_+2 K/C)QLSAUQX X64
MK(8_-TI5F7[Y!&X ))O\S)[ JY9(C\]OX>G6PXX #6ML8$1&]Y,]/2JA:7]U
M6DA/9V3]PD@#5<O,&CPC_$?*3I_D0#W$A>V^'7T2O.U)UK@2%?+UE/4VWY+1
M :JU_%"0<<9#7%LS;@V>LU1U<5_AF(4-^P^]_FR\&."94<J0"Y93]'\\D8'U
M^4'Y0%-4Q6/OT]F;*Y;Y8340&%=Z'7FHC0)]TFR5QX/7LEPK1$+_#W1(TFQ*
MY*'"H2-COYF&2>\Z3JP%3NN@\!W7-F0_N([C:8$=8@X=P6Y-GQ7>9R"V;Q*B
M1QW N?[P\*O$"P']1T <SUNTPA%@\L# *\SX]I.L#3@A?'_&[/UW1S:KY;GR
MD<?2DS-0BC[Y(G.&[7MH>2Z)"395%<202[R-+%>1(N1+5'EA:,%5#7+_MH)Q
M47I%%&:]>TK5"O5R>/?8T/NPONK<<COLY6%;HPLILKL/?K' ;RGK2<QVJ&'9
M<U(U5:Y_97FV)1OK R2YK[[?3L:NDPF\W99G!?+.KKPV7(ZR_(N8*&^O %JQ
M8&<]M%<CE8<+<OEP+FA?H$S6K1YI"JT)CWO6)\^CX]0H9'Z/<F]E5;2Q#S/?
MZ+[>6,[7B2[#^ZXW-"7SO\/<U/]=O8G0<<=NXZ?;>ML8FD036R0R&VN48F7:
M.XFA6X9D/&XY08H9+G8)* =U ^99L<,&TZ1;5*E E8I--S['@:-(:H-)O&T9
M6"PHZ8"JI#18Q\*FT?PYN7] :%]2Y0(@PDPM"!2XGO8<&KIOCY;;?WR:CQLB
MO:]!=N9"(-QVKI!D1!!,6>WR&$,KG&V5?LR);86O5X_[OD80-Z*FX26AM!E;
MK7M]5#5+5(<G0Y*Z=U[&LM=JL]J_"TGJV<F\C(5Q>PC2>?5B[RJQ/J+&LS1]
M5!K'M]6%TFB=L'($&[9L%+QRIA^>&GO4EN6Q8C4U;=^=$ QI<2->>70\IMO4
M*,=J\Y*QSV9-3?$DU_W#1(^Q\H,;OHJ XXXJ5(9F&Z_V.B:T/(ZKN.N 1\#U
M[(I52L$+IYQ]/:JX%23%QM[(2-2L^<:2*?OLZZ55Q970:P;?9I9@K-Q"\8^@
MAF]M?9871O!^14R2K?KK^6>+MS$.5:,W\G4Y?8\7E;C@B\]W<9/=;P8C%8O#
M-V@_O78-[.-]4#96;Z)3SN>%J+2^,N);SM@T'?9\3V["4W+%*C_G1MZ$I_PQ
MO8%4S@:C!K>> U6<WS#7H:9/A*:K5]:28B$EP_8="L0+=S?%,;2/^%V&D<./
M+W=?Y[]Y5Z/,M4X-0Y^M$:/.AGO6DN&P-%9C*:K%:"F32LL5J$?%,*W'7 E)
MJHA_T#YCJ?OPQ^WAKM$;6H?R?9)YCQZA'0;2G-$?H_>&'J;9' C7,Y%J>1#D
M 29QU,%//,:J,S@+0&66R8\%I</3A]MV/L\AT++:)S)(C-MXS[YY\0_X@7IY
M99X-<1[$=[HSO-_ W(F@Q],BEIGV33C83@2L?1XZN!.IF6SO#+;PWF-^GU#1
M1Y&\(2DXMUSG5QW^XU7-2\2DN7M U QN;4[]Q#N,0]$1\-8Z;M<)?JG^5BU,
MH7/#ME SKA[9DU&DN1#W;!MS*5@>L_+:<7S3ONZQ65!'$_[D^IW-FCB!!KQ:
M<)_80!B[]^^1&)!8\??+^86(2?*&[1KLS&*)/S3I^O>B\[C"8S[!46$2W(AY
M-9/:F,\G!5086MX3$BAWA1I'*O11YK+TAKZ%I975XL:7BT7ECLF(4'RU3[?2
M'Y:GPUAC:"8ST@9SAUBEZNOJPSA%OL0.+,SA%3:L[M^&7T!-QM0[%!%I9M)D
M1ZC.^6(8R%^%OVL$<ZV,'YSY5*V;ZS<;==I@9G]XY<=)N3"E1-#(\E=&YY"D
MN2N;R<_+CV=W"<.6[19>F'B5*#."YII:9,&=Y6L(,*N,=IJ@FL#+K4\= 6K6
MV #ST [Y'V 8M]@,Q4F_#]O%5@S/(CF'W=A"V\>#D;HG[EGH219O<+:,<@?"
MTT8/]C"]WXO[ZJ^=>'558W/E]+'!(OYC&PATB'#I+SG+1[CE]VH"+$WAK<1Z
MK,8H]DQX'@<0R.2XY&?3HJJ*==Y^V!PK,@W%%1+<0WI"$FEG;R<VK"D1EJW8
M'EE1=."%T:%Y/Z KW&>/ +V*$W7%B#:^B^!<C^_43->C2-NAVS>7+%2(>\TP
M9E=7-GBX$=_+5!UMLUHJRH*W#&DP+OL$]L:/4<NVA+AWBU?@XMFA=#YE&1_[
MJ$2P;078, OGA%>]36N6>77?$=5.RL>6%CNEJUE/5[A /C6W<FJ^G9(RW/8(
M,!5D)"Z:E"6RL5!%W;Y1>2SH[BKOWRO:P?]0-%^"<6MQQMP$[P^O<C.^:'?-
M5RQN#YV_< 20X2W67R43]!0%V;!8O^C10ODR"^?)JW<2XR3P.WEOG?0KPZW,
M_;,M'ST:&P(M;NSLQ'<ER6XL'@'I2;.&XQ/FA3TH]@7#=";5&1CWQA%P<OH(
MZ-5(YN$LOLSML&*M0.?JML9>AL)U7>"1.UZ+*GE^\:YJNRO8BK0>F)>UTLY-
MN#\7"/F=CMI-@F*!0"9=\#L:TVU#Q'-$KH(;FNF0/E%L2Q&*;$WKHRXSJ'MI
M(UX0-]#%P[=>DN8BF[W TF?>6JEP3-'PF7(XSQ'*S=J[N 7#5Q(+45WA&A !
MWSZ*4,&'H=3MU4]:15&O4#P3MBR]RU?,R_BI@0BBJ6D"^;#E=7,S$# L5#':
M)$M9^%)TZM,31] 9U>J4V.W!Q6^B&B^,%2&J[F]>$>_F.:VPTT8!Y?EO;953
M^_**'G :%OR>1MZ?,!BN%W L0KW&FE\5WZX?-Z^V(258%1<B=@O\\- -@1?O
MJ\-@G-O1\0HSOE>(+H[)K^_T<D'>7WB*<MKII:P4@=;<E_=T9%UCT8JO<R[!
M,W1]_0CJ16AK=C<FU'2[^<%ON$%-L8";Q9NV=GY?W!G_H,=?@E%$,>^/IHRQ
MP[.-YU\]A>39,!PKN(L1A(*!(;+FW-M^[4;J26CH.R?B)BS-TRGU_J#E"T]'
MMC/1M"DS*U;]&*=I<^,.DM6M*:Q0]UMQJVW2'MWK)$<)>3T^T;5FQMZG>L:,
MGS]X_2B!WU6ER@4\;)O62<>$&<)@NE[BH=IN@]<K40R^^=2/!..1]TM04WM\
M"Q5A[IYR-28@_S'Z/3%5YB H PM6!#<MH'(#0^X? 376N7ZA]R-[DDBU)PX[
MCTV"(;$)YHJA_:R7?WQ:]7\ )SYY'T(>;W#UQYBGDCB^\.2ZAP@^>F[-#)JK
MG5OR9[6O46]_UD)4+GG['@)76G":1Y\_%67-#TX-J,X5%8>12[+F<!*#IU!?
M[913-]\\R&'%?7I;*I,:@58<O)$07*HT7&RZ1Y9$8-O"'IN;<1LR$P&KD)@-
M\5T$6@%O&!FTL&)2\5B"2T=8/6M3E&&DJN(]IZ LAC[M6JB@B"]C)YLRCHFM
ML:<Y=:)\*%R0#7/2IVJ7O1YO?>%E\2!42&$Q%M+K4W?;+%80_+ST/D?8-MYP
M?>#$#&(S\,;7!1[$%AW3YTO74X&EM35R]_1 .%MP0;D:#)I?-'&:#2 JDJOZ
M[VYC3LPF.\S:/Z<MSXZ>K^/@(M<\=<%)]$")U^(!AGI/>]>R+L;''2E>82M0
M_V,J)BW@=F:<E;!'+5H^6%>/@I[.XTK,Q^@%\N'<(;J.-B^#YOS@W/(HX&VL
M^KLU^*V:) 9^HC9#9$07J2@E53PNJP_LO$8#G"P^RZ-@7S ^5N\V@-/^VMH-
MV*I=TTPEE@Z=D6I#/1_"W7?V+ZDFW.,?/_Z9XI7-<[O:RG9?I;*Q#DZO.-[*
M]:!*![<PS-*"8$/=WD1).%+P]M<4%A& *A-WMI7FR? $=U+KSK,@+(R3G/\"
M48GPR1'>SX]Z"NG&Y0C)M6.M7PW=46$]-L[<]G5X]&]^RU'*JN_=1P3Y2/47
MZ]858A@,-!<S,EGXU'#U\(REO6A<,S_1T$G^"FT?.0*S2^<ADW,R%E4Q%/<E
MQO\;7LB,7A",Z7?E@[/QUCUTRV(4X\OU(\7LYX13UJH1U+5L$X[MW_S TS!_
MEC=(;8XNC]B*_0D=DVL2J--=R68UO0A@4:K@"/ 3M^QY4<*(2NP388MZ"JFK
MK!IEWX"=^;E]^CG6?T?D]T^[G353F.:O%-5XR-PE.G*L,62C_M.2VS8^=*C-
MV8[E,S>TXFZM)V@%QA+$(RB#VL;[#Z3X/-R#A_M=&[A1IQ4^THCN/Z8>CP(6
M!M!R8LSF7-$>5F8^8O%W>[&!<0]7Z]\;P$A6?-/R0GS5MX]'Z1EOOO+1HPUT
M2W^GRDB=](&REV4AU6?U&RDZ]?5=#^B S6P?GW#G:>GL%Z$L <DO;ZNFRY(L
M0B,K(@.3;C>LC(A('5:>LR6 %=Q:REAQC]H#QM9=LTHE9H<:10>>=;2(>":K
MFLO)=F 83(C0ZK&.F.9<_[2/C]9V%)?$MMER'[MJP_M)=U)7Q:FP9(I@[4H)
MLRV21>0C[Z^O$J*VZ1ATK]H!L<-QTRYG \IH8'R1ZT-OQ^[TLGSJQK4E/_MX
M!9ZN6)'\]"F(1>>[_@N!CZF4KI^0*,6FIEYH0"?XBCOD8:FDKKMD.F$YG7/P
M?5L-,RC</^\R6ZM#UN'+W1F6I>^IER\[N"$_0]^?O5])079I=$7H# A9=A?+
M7W:*@^#?/=&UW@'K5G>ZJY!#I@V6%KTY)BJAB"I;K\Q(L8A:\"ZF>CD4;Y4R
M=7CU';4'+&8JIY5?F)4^Z7GHE+F_+;\@=)"A5BEQU/22/5HAW')]2)_R+?4F
MG9NFZ6@I9%(!)A,Q79]O57G)/(K2_TYW 5S!V)9[A*4NU-6XER5.L%F/RGC*
MI&5I&Y\5Q.Y%#>])/\.S=/+X53W;CUQ!QK'?,;\!9/)-5U1A'WZ^8#G$G+&V
MUN76MS<A2?-7NON92GL#@(%@TTH8LJ>V-FGOM)&SIO8YEI%1Q\8@FR02C+,%
M_K1EEY^HFX,R%68KBBC+>6QTD16GHZB,J1EC" "^/2.P^'FE#_>BKB2_^8#L
M'EB;-*52+)8W37HDAZ'=?[QTYPE)X"5-SXF+4K7.0I>R?;QC'*B;XZ. <.T&
M'YN3N%Z=C"[];G?A&UY3P:C2?LY76,#;Z#?[SD!/$.3X.U+7WR <F_>ATBW7
MJNC*TR_H."2P(<;&,]E@Z^=X!.2)C=1:GS%5>%I)8;L3JO-4GG!!%P%\:P!<
M7UGGVN\\[:O7@F%C0-*FN&!A%XTA;=>#8RN-8GCF\L?3L=O9F!6(ZYLSQ8T7
M!YY)/B&\T1 5R9/MF ]+3RE>4?="&DG[X4Z8I:61WCBDBN159U![68:$9[/9
MF=S!T+VDT1:R5[(:[O%[U9]XO*X"Z:14G"GEX2+3,7S=JN<=&1<:.1K.I/!Y
MM$,GK?WNR91"JKWQ4O45J3V>1HS=U]Q$[3@D',DT%_9-,&H+ @W@9FG^<7IY
M.$_VTE,+G9+. "+.+U3[*T:_B@"XIT,&'I^71ST=.+MZ%YU^&35&F#BG?7(W
M$)Z,'#,?Z^PJ4@%\G*9/S+P:K_;&R1L./>A^=[Q<(WU\W&OT4RVE)U&/FFP"
M^J@<LL;9]#Q,?"RY4B5\1Q8BO-_R66!]9!!7&FIV _4D6[,)TN6ST5Z6%(VO
MDC=L"&9$[P0:<6,<V-!_^C:E(^.P)4I=T@8J0;ZO/O.">-;.]<(S!^@2-\?@
MF';: _ Y=LDK"RXFZ2U-[UB63<:$GU'""5Y[WQ+*.&A@L6Q0D//!"Y-$Q)Z$
MRX1%>A5YO]H'RC)L;O6F1S?@"Q]X_,JCQVG,]4G/9U*>8^53"XDOE T0U7ZJ
MY),(8$[4>Y/EM<[P.PO-;X$OTN7P-L,5I>?.B2&_NC$Z?;T)8:%$7Q'A:3G)
M>5Z3/BEA6G.NGAS\@LC!_/W4NPK[RDO3J22TC3:XM)8NG&/8^2[>>WV[\A*,
MC^ ^R=.WWM&*&I1:#$ISKS@1ZR(L5!MF5M7('?GN-K,W+BJSUJ62M(5AH-V(
M37Y2\HQE>J]"V>'6FM7N3$3G.ZO3)7%;$7M]4G<>-B'2VQ1TE"I:>41T[:Z&
M*%70;K^FH&5=^>AMN/]@#QZY<\F+*S#D\8_,D$0FY_[?-X<>E%(P<8+Y*2IN
M"/JY!(8<WC!NBKK8A.>O'WKYI7-V&T/?L'WQV>QIO<-*HQ#UO$63O#D0'_28
M0K$293$TM29Y=T6U?;Z-/3T1,0WI/F=+GJ'1(%#4WXH> HU:KP@R/[AED7NX
MTJDS:'%06_)4/::-<(G-'NR!H4ZWF];:-$>XC!>R">2@''T7HL)I.((J0*-+
MW\,2R5#&%C(:TZNBK)=9AD;E;"1A9_\(D?*W$$SXQFQU6#OA;M*;G2\"?M9D
M: 51I\AO*0?4#9%OL+7\>)[4-FL2Y^=M_*UUYDN/6'G1\I8Z9-]:; G^5Q_Q
MBJNULY"\8/S1T;YXT8V(]$]R9&@Y+@X#4U%5W8"M"T0^%*TK%Z3MXFESBZ<2
M<EB4I88M_<?T1%H%W<LU=;(+J>/K/ID7="!4JZ\L/Y(I*Q"S=W0UQ86?5H!X
M'I(8/L1Q%;_//NS)33A<_JX8T-Q5<8Y^>)8=]VQ]HIQ"T1'<=W"UA-\$=H8+
M0M.R]U9CEA*'Y!C%3HTGF)U-.?VQ]^,FC$LI.FC)#]NMJ2OFK"-OXG:_Q/*Y
M)O66F3=>8O#+-PP#2^!UNDFU-<O*R,(+]>=.&T,;N+*3GHEX#;P7>?5$0I!Q
M=#EUU37'E>5>"MFT#IVGY"==_NIWN,?-Z^\D<<H8^YQ4_R0)"@?UV[>#XJUB
M;'/\G]#BD5W#6U[L3\^$<4Z\G!Z/3X@:U0Y0?/81$C-\QMS7V;ZT]6!:RZY/
MLFY(+/DS)^=\F4%'MRBLP'M-^O,Q_0_F49.P2<+0^GE_B[TT7?!12V1VOH%I
M06W4U;VAN/O@I@N_SK@RYN;UK)5X#%":[Q=NI/G8$T2R0KGY*TC,"!!&ILT3
M@=D^"L%,">M9^NW51MK*+L$3)*O '"<1_LY6U,B!#&I6M=X70\?QDILC;!-D
M6A5RJLJFZQ3[BM/34M-W4J#I'P+KJWI\MU3\YAOL>9/07"N+UF=EQ1O\KC[<
M??ZC@G;V_O54-:+SV_QV1,S-M<B?T< F[".FQK#U<7OR/7CO)#U/@\8>N/GZ
M]Y-;F)NZ_]E]$<^080(K=/*>SGTKQ,&-AM@O'=]SH:$IKE;!H4S%5O_$O97B
MC-1X!=@;SR'0,L\88T"4TU F5ZM_Q@'__5 NJ9T':=E]5'E'@-,-OPZ,)F=C
MTGS92JSN)/90S-B)U:Z/RB9YV;]5ZQ0H*JK'6N+2<!3PZ#-\1>O,0SK3+#3O
MU[.L!?REL3H8XTY!L'B%HWEI'AT][0(9H0!#+>X4K])'7?WPE(UA 88L2N-W
MMJG_E-VN*-7"B"P]R#U8M<DN*B_O%<2'&32SEW+_O=QYB-)5VEII:6)YMRUS
M^)>HK#&CP,9%#(-<^7J-/9O&ZE8PK3G@.UV%7>6+>YF%>V#,"E #F1[VW$S5
M) OIJJD,Q6>K>/6"G'MR5,*"X%:>M]T<G!?,*M?K)*-S Q+'+.Z45Q@E[SD[
M>AKI48EE[WC#C%9QG2/GF961QC&G;$ ZOYYB&?0(V+ZX9.[S '\$%+KE GX9
MCVL;_--"VWMGK%*F9WYUROR0HMUB.!F\A7?I>SV$'ZC7?&L=#!GW%MN&'$]X
MK0QOP\+"[__@[5)_7W0S Y%/4"]&2@Z&7"$Y1<3+)YDW8-SGI[E$$LMHK(*#
MP6T+X=:PE0#!Y^8T5G>+=IRJGC*A%2:,EZ[5R.+*ZI4Z0^:4&!@D97<%P6=U
MR_PM_?#JZSW)>ID0_<4?'.<*A:S"<IUX6:R3T=(5U0?5P+?B;6:A,O&?B0_6
MCWKI+/.1TPH&?DA@V@;VW3K&-_E,]NKG&8)'I<5$'#;@3#IZ+"X7\ K(B3@#
M-6DW:@ZK+?&+T4CFK5[\@I#;^XYAT+HW0V+<[KZS7&G^Y(6A%$>XH!X*TUA%
M=RS_]:B>=Y]-NCIC>29>Z .$SU"[BHJ;4)RMJA$%O/9/0;@^/[49]CVW40DQ
M=.5.AV38&HS[L0U0R5HHFBA%%S^&&;2 ELXG[[D_*>T&_#\];!MQAM-ORJ;A
M T@^WS?9RBS"$>7:+_0HYY_,1<T20W-4<X2@34[QSSHZ<./JU6"P%&A$$ 1C
MH>BN59,CRXF"]8>G]KP>,J'=A#&JVT6I R8"A?L5LL47S<PXV(K8PW?[7^A1
M@;$]H\YP.9H.(M<>$5XX6A'K5Y1<*^\V48F^8DW#R3QAE>UH]*8:+SK85,Y7
M"<$/^@2AZPK A5F952G=6D-# '=2R\[S4O8ZVS[BR>E[(4C@<TYD3W5[@_<5
M^_OV,-\1*%[&5HFP%,)MVJ7Y1!!,\X,Q^0?IX@&?2$:=57C9U5K!#^GWT++C
MVN0M-]^;NX_NJ@\0ON$Q!?/"9]!RW7JW)2"]VZ95G:@^'\,DY+3;64D>+."P
MM(=2"(]:QE:8B,<E/\\R+Y:=KJLS-V(48P:UJ&,D,^HTW::R.+D(DX?I"EOY
M)_J\]6&L8Z[/1#9:7<+0%*( Z=\7=/O3[T%QPC4AN$X,ZS]2-[5&T&BW1PT\
M[&B%!TIY/:4 _!MCIEZ7=]%W>5G%W>))<CYS_U4,/8SE#MRQ%8 WH'5!%G P
M=L>!1-MR(4!1=?WFN3D5P.]^^FG'V2GA.7R$:6DGO$@[MZ7]O,HII[+BX'X8
MYV3,U ;EX*O:BDH:^H_&B8^.Q9LNAE[3K*^UP[:R.JV7AL7S&KST%83VE/#+
MM@S.%P^.97#&^N.Z2FF3'W%3;D)#B;BOBJ*7/WF;W/<M:Y/5AS%7[)^G5?;0
M1UY!?CR_B[(!KNC!CLE7%U27[HO]><CSZO7BCB/ LP$7*#O'16'XHS.Z:H(9
M-,\.OZ_E26;0P* ZT%H+JB1,ET9=G6*YHP_'8$[85\'C6'$W$7T'AQ\0I"*Y
M\^I7HH -^2/@I&2'FH8FS\E7LKN0#W:#O*%3S"T#,X;?50#/,:7P.9=.HB4*
MR0N.*F.I595E@0(L=.U[M:F8&ME8M)RBU>7K\(P5D^7K\,"2[@JH_V25'^47
M1S!ZY#QUM\7+7J80Z. R\?QH<4KUO :ECQ++$6"5@=B#-+U>-FCT6<?O;>T1
M^ZWHC@"#Q!.KB[\C ^\@,NS)[<&3D&\(37O$(M3KC2\A27.U*3_]_X!Y'_9N
M9ST\?ZFR,WDE?JR:AUY00B1 N[2%9@M##V\M(A<)&ZN/O2%P!&S@+3;N[N7A
M+_JV?I^!<1T!D:0J\[A<%=P8BX&'R8'<Y:]4 UC4B0O7!,&]R8?8.\7Y+5J&
M3E#^/8C.;)B1J[?0+0-W1[+MI.\9E_F)F8ZTTEA_E?05?S1T,82[OK.@&[AK
M9'3Y78-RX>\:I_K?8E9"3D*.0($KW^:IJ-0H8-9'D=RB3-[+^%*]]/E$Z<XO
MU.%#U-)X#(;ZF][N98K"B;OGN2N6!<'/AKV5O3GF5BQ\%NY%/V7B.X0,=U 5
M,*<C>*9XD@!_RXQP6IV3N@-U=!"5,V^"" /^3H?]NP9H*F48G=K;/'&SVHCT
M*FI5B$D4L!FL^]8JD(GI54+3)1[YJQK;KZ(""@X*O@[NAW_%T/-HK'=4\0E9
M!N>6/@!:$=39&.8*$$4+S26[VS4BYLU9,[(:)*&?YPA\E3M@LMPLWRK><PL_
MB"3/7[)Z/I?__>8<3(6+.<0(%)_G]'84U@:Q*8#$#E6310$+/B[G+,(?X"2.
M@*8(^XMW C*![;^=/S3CGI8G>.Y'TN@2^SD"S=<9ED%_QZOW0XPPH#YJX(9>
M 5!"TFBQ$)K!.O7#N%V*_#1)M#J='8_?M-KUINS!\<R&PRK<B%#WXQ]N<5+B
MV!>WR/65+CUQ&Z!^(1R+-NBC0%63]\^PM"]/<ISE/WB)JLD1SB]@!LV*??;\
M.8!)9=J4V/DP(:NXXTN@^NT2$F[EE5 K(4:,Q\1UCCD%-O 'YE"X&U[/=K^/
M*GZG^Z09I,7GF>X81^SV6OJE2,_7+#.(89R JWR?9(+0@_S14#P/(MVO,EQO
M] AH?[/7)TE4.#MRY=LAQ^&U0TC+;\<:AX+\'W[G.0A^M.%YYM'*.[L*@?T-
M_*T-V2X7*\<.I='!!L!W\G0%V84.7*1A!>7I=F3O>FT8$U&YH.!K*#6P6?PA
MJ(9.ST["PQR!:4Y]ITK]L4^B;+!CMTQ+QLUAH(H7PGN[V&*QV^/[302Y7>A;
MY?/RGJAK/0<]S0(8)=9X'5)>RBK6SG^&&33JA,2'6[ID/="W<LE#3G&*HAH'
M7.\ORF'H$'\D:UP@[#,0VIK9<!'93\]?1 !?U16$TK#C\D2GJ0G)U3"_-DCH
M*N."+(N4^Z5@"D#;8KXJER;7+44.%QN?9'XL7/PF\Z>8!IB8"IJG[JJV=7Y[
M7G+["4^BL=AJ0?."(X:>06N]AY4IZ:-3JDVE\M>1Z#,>+4J+Q>= ?7H4''7*
M4G<\+*SP4V5\XB>M(O75R=0NPS ,K-7K[^W0%>_=3DJJG=38+O2N'FU<++09
MO*USS/?FMA3!JW4A%G +D<B$*JXBGT>G,?E]5$+%CEDV:HAI* ]MN?A;>.D5
M2#2CD?U@MM>Q!O*K]5-.M5C%E=]8__0$+F39%6 $6W LCA^[R:.L1EWIB^*$
MW2Y&(CR[V791C@ 5\WU*5MYGW/#B'<=.\Y,6_>OA_C6C5E,BB9Z^+$9+^@[R
M*H!_3\)4 IM%[MU4^V?GE9.P@LY\<:7%R$Q5 $,-EX[:8(P=;ED)X=Q7714)
MN'#CV\:[(3VJ2.TI2C-/IHI+"A)-:"&K0M&4TYPDYNMY;3''I^A5:W*/%R#A
MB@8^7L. #',T6=\P[P'"-!G;]OD%KI1Z?50O_+#J,2O-]3<B>T*Q@9\>97V,
MLY*<YI"<%V\%RTKDG-87VYM"2+[12X=<97VF1Y6Y(W^(A+_><?PQI93TF9O^
M"#!-6OO!?@3H96B0>V_])Z=3&=599.+$$%7V$V&60\75[.WUI9M>K8"_RL2+
MM%[*<E<FM<1MO%9-OU="94TP2NOKC%LR6E9=C%-) J7:E/,LEO#<RU6EB77-
MTCIBZPB ID0!Z31L)Z@H:Q5Y1_N)4#QE-!E#<H5+Q=JEN&0TU'N.5[A.;SRO
MM57[[VSIQ(I_*L?\RX#_)R2 !_YNKS'QU+^7 F^)1\!0U4 5BL;Z"##ZI %L
M\)SU"=@T.0+B,MH:Q%HGK.K[7\\L;& <,'Z::[F!K@]^Y(8D35LQ[2]9C6>&
M%EKGDEWQWL]*CE=:_/^6( G%".<C@& 6T\F6_ 0UMRFP'(;FQF=C)S<FI>E7
M:X2.:<,(E@YDR$5CVT@,_=J^@<(,;XF*WU-OWOK[.P5N^T< UF4I70#.)[;7
M1Y4'CD^%,#4CHHS8;%#7]Z_Q(( J%;AY1UIFH8F*:R*P]W^4=%*)0(6A)@7G
MD/9=]FTID"+Y9V/KJN858QR4G]I=!; (?*"SS=BH_Q$N<[<8T&$OYS!=6-/C
MJS8?MATR6A(,F#H__,.MP=PDH.C%G<*P@7ZC[*';=V:'[NWQ33YY+V6D>45&
MXPEG']E_II=<SS$+S91\K,RRL<QZY$SC_-GQIL1:8?6,1+BRFM'E>;2L6;U2
M7=P[ W-':M:@I ]I=R[F"K\IAK$E!QBH4G5"C'F-6,G2*2E^'<T7)]E2ED)G
M^=)KKP&?EGY,+9U)';5+DPU@;=TM&\5B>CJIDM'QR=HT5NDVRF,J1EQ]7^QA
M<6DL\-*A/!'W:?21T8;%[)ZT7<\8T+.^15M2P_+!HCW-<*OHBFO&W.7IROS'
MEZ?1"KV&E0*S&Y.56YK63SQ,1+>F-QVX5LPURK^^8<70QEAU/>NA\*KL[+.P
MVR/F3'QXQ*L OQB:Q_KAV*!5;8<SW@ A(_9-F.Z!X7*"R9)AJ>9^<_$17K#3
M[T&UKB^=;/M/GB-A#R5U)Z*C%A-T8-EA,$[Q02V:%P;7/5T^)5@^.$1_<(<\
M&7(>9?VL1SG$WL=HZW-[>2Q<2V?0S+:;+A:YW9#6HSH%8\8J$!,=%%'!YT7.
M0CU[;U*#QN&IO4@;:F NIXSAHLYV-BH'UT4J?MNU^Q)B-?*)\9B_0PPK+B^0
M%2X-7NFA4D25#CLKO/$KD?4>2'!@!A&=#+Z@'08J6NV<.O0![)TE&'4 _.RT
MFF;$=)W&VV%L4)\?AD'T:Q><[3L.KSYTD B&ZGS7M)E]4'3O)-\B'>!K/5X?
MO*Q+F@S9]N1I^)[-M-]'99?:=[75$)<]3T]H4YE?:$"-4O$[2(%R_?=;H.\G
MS#-D<GUI0'Z[+->"KXJ]T*-P.<.+D\6-,3Y,6;+XEN$T5SI=*[BC#*/_?Z%.
M_V6WTV+]OUU5@>CKX=3TK&JVZS!.I=J<"+PXD3>($/"E&' ??HN2!B*.)V^@
MOBJ]EZFA^_;82G(F6S5.=&4NY5@ &D]9;_\2B>?XD0M9T*7F^90;S/*Y=UMH
M"W/3Z7<L.Z!4K90$[<&?(\5Y*KCEB45(C]UX1I*%]GPJXK9O'WD(]S4<8;'R
MT_*9&CK>CK;FJ-7SK ^/YW2]25TV\FL-]L.D]YI5,][\>7PUCF^?D]#C^QU#
M4TOK7!I5%RS0W^VTE!J:<F*&X+!BTL7\68_"7+[@>M"'W*'YL$S9=HWY"T[3
MB3-2,?Q?HSG[*.12?'K?KUB&1O*&)I==\B8FZZGA-F\,UN=:"8)]ATZ%0Y'/
M"I@-%_\HZ_,?CI^3AST=4WNL*1W!O4%:Z&+BDY7X./%JO/6&T-L&_S/5G^J1
MP*S866"80W=GAP?1$. '51W\H40U$I9.^-Q8]H/E"[O,WB\Q5K&2T >!$3$_
M@ZPG?G>3*'Y#\-@*<N\(&=TA%J*2YXU<(8]<1!H'7S8L@O/7.UI0YF.1>ZG=
M?=AHM7H3PK1K'#/H+?*Z*.K,#?EJ'.Y;1SDW1,$IIVH"0SM^S3@"E551\\C(
MM=7@BA?O+'5GO5-FS\<^*G/H-CXY ,Z'U7GJ<,>N8>Y=D-WPXT!_5[6/=(!1
MF3K[9\9TPK(5APDC;GEA"WOZ22N*,$BZ07U9D.SP3Y#C^ M8_\[G(_YO7:'Z
M6A(1N05S^WEH.47DIRX3O!AQZV.R+!X^/&]DTNU?^3KPU$<)07 75-[Z4A5+
M5W5K^XRE+]X]UIRR1H[>]2H[Y=W)7UC[%M7_8N\]H)IJL_7Q U&P4"R@% $5
M%! 1:1:D1)$NTEMH"BJ0T'L/B!0IHE2- E%Z20)"I(-2%:23!*D"2HMT0@_Y
M)^HWWS=SY\Z=-7><F?]OW;7<YYQH<L[Q/>_9Y=G/WF]8;:]@=PU\P6NS%P-?
M(&P^V-1FFJ'>RZY?X[ZK&K.4 "7Z]^[P:%Z<%=_LW-7;'>D;&4L][":_4H
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MSOU5!]E[L_M#=UP/==_)F+-.<W;OT9S=Q+' @UL?+ @OX;F0O3)WMUZ]K*(
ML4:YR7.18<L[<A9!LLFTDBLO(^JLP7VC98/'*VHW\4C;B3EYDIT=:"W*I)@\
MT]T-QXN"Y*Y<->@K1U<(:*9'CI?P+XEZN!3U"\<9][U8U-+74L>4]>!B (G9
MP[?'RH;N&DV@W\P^JC<++/2& J,DOBI<>\?.ZPH>Q7FNR6P*8*)JHS+:0<HG
M8=P6GFT<JI*L3R,:$2V^4CW>!)#<N0ZR<;Z'+FWK_GW$;_RM).X_*B>F361B
M!Z4+?A32Z7N!.CQ^PJSFPY6X_ ?4D3*&]:87?OBM< XCWU.SCKG:61N6&/#
M*TG!V3 6VOX==S5Z)OJ6>I^/?[ENIY7/X2[^L7Q.C%8^I_SWE,\-_2R?N_.G
M\KG'W;22^3_:3>4KRIJB^KVGEVZ=#CI1A>,OC7FM#,8(+*:6Q!^E"S5;-(J
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ME\H\@:HT/WU^Z]EL49E-#6$A2Y8,Y#XBOD"!%FMJ8./1\.:B34/L'6+:XK=
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M@!#]2%(V5E&N0O:L>'^!WBFJWAM1!Y85#D)"$PM%)-5.7PDFH4,:^,_A0JR
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M3*F[#L#T;O0FF=W!$3^E+[$>[V1,:;-ZT^[=:%Q<<>8M2"/_!M.#?=EWHI=
M8)Z[&7 [D"QN/#VDO3]6)=;6#$\"K-%QC- 4J87J?.5(($\4X#ES\35S/T8'
MS)GV*5U.>.33>'>)+9*)5 BLY.O4'<9J_N/YJ__X)6S_(4E_.@I5CW1)0#(Q
M*W]K8I5NGJEH;2JXR#7C<<FD.'(4^YQS7Q'0R0@:D]/,.KL7<Z5Z8T)PN#+
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M:66Q<$2=0]96*3Q'K2L2:BY6-G1M[-.X*CS%U_7QMOZR$#VCQOTPX-438A?
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MZ!][>Y[&,9@$IC)U"&,]@JS?\IF%7CLI2*.RZ]4P\'F3;,"7?7&(1O8[S-#
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M9^W"8O]6O/_U%.]_.(Z)F[/C%$!CVRZNE?.V=)P<E1DZ-5]0D,D9IF#S[BH
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M0C6TN[D.&B>I.>'W1<.YLTD[D[\VFCMH/,6;[^.6Z.%MZTJBJ0N (&5(B1V
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M^J^9#ONZ\Z-8-QVQ>$6F"HS/2S/+6*!-)9+=CZY&_G'*M>HM-K;#K"M<*G
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MDH[7WG=)UTOCZ(/++\7)](WK4+$#/X>4ZE>@+,!XPS=/\<:OGU L_'82BM)
M2EI^#M,V>0X.!'715-BJ=I&? %)!=@2ZC!1S',J5-C?/T)' 5X>5822TB!U6
M'#O*^O=@X9GWEX$B0A-5!=,TF:U#G\\>7C;E_JP.+B40ZZ9U]^BU)]T_ 0,N
M38Q+#-!C8^PCEVVZP_:'K)ARVPND3\=XM[/ 9Y9:YB^CR #W*# )1ZIZ_1SE
MJ<"-M$^;+;(>S68_#J__>Q]3X\HLDM[9.+V$'=&":ZGG9QNP'*SEF*G1._.$
MX;2(&%$2W"<=*D[DX+H?FNY>J1.RM!5=! T!]T6H: 6GNY(9I]""!G^80;+N
M9!1)+J@D:@$8Z A1D'VWQ.=E;:DLS.B>#02JW BE,#7Z9ME<7G)I0,-XS0!<
M&K, X-PQ7,="EL B*(5 L1=+F8Y<(S"A-TP@V3*>V:7&M2(*2^8NW8W:!SM$
M2EP$C;?8N_Z+F:A,J"=X]HD=^"I2 P@LSF3B.W;[BNY=>A:)UK3?P/ BEP3L
MRX!>_0$?+YF87&=]H8JTEVRE=MH_V\LK@O5UW%[VO>7WZ\HI!8OUW(Z91)24
M[C\"]^[_?$X/+;BKNBQP@O?35P1FLCFJ;OP#UMONSNW5XR889/.E<U=VW[^*
M7G?^F=!W\:_UGB-V\M?PTH_&GP^(CBT KA%,).]4S18COO!O_6%:.)/*@%W/
M/]%Q9R<3^Q)D&\?@*EMLJE_2<;:3R,08!:[60R^S<XYY74K[<^+Y'X;:D3A6
M0>:^F#;QPU'[SH^0JA:U%BUV,$3)8=8%5V-(5?GIKATNJ1G2:J2?YK.D>?J[
M)EA7 A9-L#B">G*7G*^(<RMP\D\D4_VQO)5>BIFRIB\#RC"=H$4W;';"% V\
MB;6;(MFY4^@S+K]P5O_'A)Y_L*'"N[-MJ%(R4 6P#X7&B[E3?^/M)-3,S"X(
M_S_LO6= 4^FZ-KR0ID@1 144< 2D1$0I%FHL2),N1 ($%:0DTGL'NTA1$5 4
MB'0(240(O8B V.@D4:J U$@3 DCS32 49\_99][OFSE[[_/Z8R6+<0BPDO4\
M]W7?5YG8.0'Q5YF+QC!7652#]S#6SS5K/HQ1(6E+&')FIP9F\0RV"K9#)^-6
ML63#R\'TQ)!3_]J"]5]PO,$'#*%]J(^9X9^=?%8)I?C%5<LH1)G*9G[""G*,
M:9B3=*=/<3Y'S8[+>OE3<R1\0JT#_A6Q_$2(J6)^JD'!"A9A'O$"@[CJM^OG
M;9!N^B+<_%6TD:E%@03>^P/EI9+_\EI0OW8&KAD26 C>Q1>\A_@;JN@K?(BL
MMI>O&W<GG$#YH%6=W0*?;.LBUY#,\XI_.X"O,I^4I%?3[U8A4XF0"\O&SQ8L
M@5A=M#_7OR9]^1<K\E_+BCSI)&,B'Y^<-Y%_#*VAL\]R!.;;<_<QCYFX+-V'
MV:0J"QG&0$*!$<'J0>^80"Y"4C;GB"LAX^.GR+W">C+-)9)>3=QOL?JY5TSI
M1V!&W;8>TI#T5\XVLWK,AWOL]=I0%U&U!W&WXB_1"^ :O7H&,YS8G&(UGSQI
MX#@N2^<Q4&<[PTIPQTTUM =ID&#W=]ZJRC-I:RUDTSHSK_1VKR>2O>W57-(N
MHJ2YTG36]O:%#E3=E GKYN,99/MSM]]T@*]!"'QJ%_@*%892(X6Y#&O$"Q-X
M:]V.S.V-W^O1P,S!6#7Q05H7.EJBDE$T\I[OF3MR\Q,%N^>BGW13Q>B;[<G.
M7R*>X"XB?+*MKLBY)AF+%708I14=Y>T/.N2.^)1\[W-L$GQRK%ZNL2;%/V4R
MI/ENY3/+CKS@QZT>2<('"O>7;CU).)IY%3]P=+KKLL.Q:K-&=Z$]00YCX AM
M/'D/-)L9Y_4#N(WS9JL4LR04^Y*:)9\-X+S[R-D%)0NVFT [XUWCX2U$@]9[
M&ON*RCEFO12!D1&3>%!3V8?KP2%,6MT=[K'N!AVDC[D:"_-ZKJUE3@U]MF,M
M-J6^Q!L8M4\[G4? X:DA:)$I3O]^'H[ITKR \87!38L79^^X7M'%V1U,NE*I
M4'UA]I;A]9?G#@V!!81Z.2=I@)7XS*NHVSR!J61:Z$GYZ^#XM,_EI?R^%#CX
M+""JNW/K?".-G@H.B_V;5N/_U:E7/P ^/,V'6S9$:>M:U!7HU7H"5K!,=L1H
M\W+JU9_N'>U[,DH$H;^%F9_K\BBTM],X@V1GORQH1^U8=K]".T^>Z;(;ZBSZ
M 7!DL.32E::_I09*O>HJLY9K&Q8Z))CB#+G/=;BW%)!NO^J-&G[.60>2K#SS
MF"?F8(JPB^7^(/FMZ<UVG\SR4H0;(T,)HPE.#@";L93;F[[0IRQ CSV9]X'^
M T1^ VY?FPOB44%3GL8]$$3C1J\S!02=TGTDS]*4Q;8G#U_K^ ?R=)$_5HO^
M_SK>,AG'J4&!UV4YDR=Z"L(\3[:'MB&:H7OQ42@3$#3[)9+C:<F)-&_& @R3
M>YMKA,\TQZZVZU+5WOR?JS_--<AZ*K-3E::K^5 K)M0&/X<,\P_^P6J)=C[X
M$K'?7_V,KIR-8>2EV,_DL!-)UA5(]G!_.R<P_&V"@<UQID*1%JL'9E8$?);4
M 6^D]4.^[+#7T")M!8@)>#>J%J?F>TEW7TH#V4:&\8!/@Q QH*7XJ'4VF<W$
M4,C=Z&C:U\?U\!ZY,/-HEZ.4%?"J_XD4RVOZU7X3>1IR8:FP Y^M\*A//#LE
M;.E1S_&G+NS A'0Z[R-&?82I/ 5$T3Y,$4**B%B@?6-E*_M?Q.RN=,27QZ?N
M^.5I:@/SC75Z;G$$%Z7F#40[S0AZ-?&:N6=('"8DIQ[:\,J;COL8F% PF2#4
M9/4$(*NL.UN5&*[C8V1DRBH4?DRSNQJD?^MGCB?5N >2T;#J==HN4[@##0IG
M#='<KH+C8YXM5F,P4D6@A[3H*NZW@CI0^^.VFU:#JCQV!CH1!;/<X$ WF:,$
M$9^P>-E-GA9==:\NHC*!!"'!^KI5"J*ZRS;0=I&\0QZ!P]6FF='4QS]L)M$+
MS^-JO&(6M8@;1JBBRR-4YA^ Z2PQL*>>'&%&3_GE%VQY+P:,R,>6>\2M-]SN
M3:4D*XG1E0[CL7,51KYXE 7Y:I#23U/3J.Z?.;O(2.L,N" %0%'JA&=+&64/
MZ;Z4'9['SA)OD0));218=Z\@Y5X/\PK(7RHMRV7CG2Y%)#:7C6,\B&@WJ&<G
M]UZ%4L%$HHGC#*.+S^H<=4^''3/4F*0NW[!)EU+&</0(A)E745!:K=/2;X,M
M=/VM$7/->A4MYVC/!F)#;KKD][".SYUW8$*)@1CH]!C3E.86)67J^YG6O&]Y
M/.X/_+82:Y6U HW/>=+7NW>BS40&YBK-.XOQJ.LEE+\+T9+T_.TJ%,8JKP9=
M1?E?]XQ6<3*.@-=ESU_-]84\EJ16V_?^[)HH%'54TCE _(4DUS90058'M-;A
MPG'^=/H!>R.!SK[;S&B+QH4ST]?]JBX5Q056FGZZ#>T]Z+;EDN4-6;KF'\ K
M^/?Y@<DL?LLJ72_=#SH(J7F)7B4VL_R&RU$W3R"MH*=UG5W8%8@YL]"&+% -
M_(LL!_MWAV2T3T D?.]UY]9@/K%#!6E_EJQ 0\$.A!WER^]F#Y4TT!]&P0LJ
M83X6:\@87 ^F"A>F.[8N:BZ"JDHV0&,&MZ$95<E]%$B\7 _O2=LX1BVMKQ8<
M[AJ"\?8$DB,H,'#,YQD%?PL*D2!COK\3AZ[,46$<GR,HN_[K6Y0:]#WETP;[
M?;G^W$^+\D^WADSQ_QHY)WKWXB4"B"KG+%^6<]X.],#EK\=#_>YS\!^5J/RO
M/OYS=);_5VRFIY<EH%;70. ]=2F<5X@\J$_9QCVE^_N![UG\NKJ&7'OTF*\C
MIONV.IOQ#VQ?DB/!#N1RCO64Q!A\=]@\@[31[]:QH:!@'BH*MI#W4E]:5,9-
MV?RBD_X_2">E>\'ZC.<]?.YX4?W[V.$AEHQA1H"RT7;G<&6WS4$4HU_Q.H=,
M2W&;ON9\SNA]>?A&P;'E,*VN$MQ@>M>@Q0WO^EL!<\2D,RH-Y2P,WH+A'\=\
M^OVD:N<&"$6!_!F=^ ]>IDLJ1!*XWNFYJKQ3+\YI:9\J5QZSS^B!\VS'7%L+
M+#B/3;;%3VW^@#L& TF=O__<&ZT -D'(G ^=K*87'_RJ_:8>[1-_+\2>*(3S
MM@[?7,A+QAHT[=KJ7 ]G4,U,O*$($?1QT@%A\6;VBL3??*1UQ.CW:>SVA.;
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MCW@0^KCIXJ\$G[WTXN 4W7%1>[<I/6:>'\#FY_4=*3^ Z^=L1B%VE*5R1YG
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M.:="4B.@\U=FQ W,GC]ECD9-$J_] (BBA+(;X_G4 <!^=S>/Q/"6S9/UO#\
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M54UK,&L!OO=:!L^)!<--3QV@DUU<).P5"[:02:TNWG>1G/V"=4'*80+B03^
M[<TQU3N^+/9AGUA.)"<'9JG$G56TDUJ84HFCSY[RB]^?MUG]<CVAP&([J;&V
MF!7TKC[LLI# Q062,JDJPOEI*9UEIKEJ0//3&0SQ)-'R#N0 J"H09^KA:40*
MY"P1NH7D2$:7Z&_6C^%Q7-KNZ^=/^3'$U]+8A5R5.)4E+@WGI>=+;HP1B?4A
M%^H[H2K=8M?FWUL<2^#32B#?FDP3#>T37;RX,+A54$.U9]?E8ZP@S:VX)\^P
M"6ZZW&]E,X\2,;/PJ?9]5@U"V,20,\>X@5PC#0SAD OBB#G\V-QS)%LKZ*G
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MQ>,N-=QT7UQ?ZL6#5'8]\D=DM(R<OER N?SZH K5Z_A:.4'$GWZ%>Y_@]Q,
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M_H?/AOA6.LJN<L9:O_.A>FJ0H"IW:,49;4"2QQS3:_@V3>2=RBDPES[X. V
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MX1T!>S3G-IT+SE7\TTK>G_+FIK''FMJ2%OP1GZ8%CS84\@EF,;U5UG!44KK
MWV_R81"E;GG<TEO#:9.2U#%O#K?%_$!E4ZAY7TK6?EPQTVU$QT^@A\7RQ^!Y
M)#;89.>;3^V!RON_2_#L&LB&7A43AHXIJZ=M]N^6=LEZL*3..W6M\CL$9X>B
M/APPL1Z1J71?&WI@A.%8F,=OY\G?SI/_?G?YISM/.L\A;BXC*.7'KM!8)B)*
MA;U<+TMDMIP;$N#%5WN=8,59P<FHI,RP*5BO\@?'$_I'9)'XQ,2&^RQ]YRH:
M/UT2E38XI.7<R \,[0ECK?UF<LWDV?VOTBZZ6?5<9]ML)MF'D G M(NMG:^T
MLKTG]B,D4;W7?I;]+G2F4N1VGV@CJS/+7<:'@5*P]DXK)MXWP^1/,8$Z'D<,
MXV/XE[E?&CPQ?YML3[!X%^;!PY#HDB'Z_"M;'PDCL;?C! %-$.ME%8 &*K]<
M/!3-#0T0_@F85T$;6C_ZU!$AA2Q"KA0[OF%JY2*D=MWG5#B*6N16P&02ZB:P
MAR?]R_A,>P,/+8"H+Z44"6M0I#84/ RS0/<*!"5#I\5).^-:.5ZE,\IZN$V!
MW'8H#SPC"53'?N"X7+A?OP:P.O:#:$A=E5*C:UY\D/0U^G[?)E!)Y\#"HSRX
M[2SK\'E%_P67P,UL!?XH@9?@B\V!QW3,%E5U\<_\CG%J2NVG^'T.CH*.*,M8
MG2?L#00YM^LC:I&0Q)$&UWU6<K#._6'[BYB<X8,>,JRA!I_%F>JNDZHMM+(&
M"&G&+ZPM/)_V5#T->4E(@N,C-H. X[XYA3\VY+*A$J>T^X._M&A]U9/+F<BJ
M'B9A'_DMB6-0FW\"=2_]$4-1+-0%7YO9T_W/0@'C,=2?%$\V2;1!H"8' F(8
MOE2ND\1@]=8Y:S*=='\4':-W>'T-KKEBHOF,+I0!"W8'4\L!,7SE]8DB\C4R
MI '&M4RTV?&R>RGLNZVI/4Q)3Z1!V7810WRA?'RQ(K=K876<Q12_C(TT:YVA
M):7:B4_K<KI#IZ4L22?*9U\E;J]@(U#T,FY:54$UB-H4^QT80'%%$^,ANV*K
MF<44V+HX#U'QZ"H5U!W'N1$LACFXFJOZ>@)PHUV;AH5[8"+K 9- VZ=T9,2H
M<'QNUC+=X@];L75'\XCB'3#GH_B!S-GK,O>3NWB $8DRPOS+J,-JY>(,K8;*
MK8L3Z9R9*=3?_T=&)O_&P;#MI3#FX@@^)Z>.MQ&O^03EV:T-3$G;C1Z0VEKS
MU%45A\.REYD(!JK9TY+)!#<_N#B=Q[4SWPK9U8CJZ_"7.EIC4GOZ 6.@<DZK
MU>PD]DQ3QF:'*NVI[J?R$!^1"@\3R#MV8%M[H$U^[A6V),2=<J6/;<31DZ=/
M<QCIL]>% 6^B]T+SVO/QO-F4^^_EGJ5$-ST:!0OPF[\XG1_3P>1,P%UY-@L[
M\QUAI:(//>"$9G?>>F0 _K*Y=_\7?X2MD9J==:1]^Y&$>G$E.[ZT(1/"1![W
M(;,7I/Q:\OOTE#Z<#^6S/*0J@E'%ZY5;,%QAU'P\\A++D4QOA(%1$5 $?S=Y
MO3'IR(MZX I9_\,CM2ZL=6.OM$WQ-'9WDV,G#G#IHI:Q)O%/J%6&@$*$4\U7
M,<82^^DW.\18*D(&3V]#<5R&>?N?/#F*/G4#7GFY6 416=YJJL"'U9UTBN^7
MFH0=ST[1:L!?O1W=P;<#<^3UP!=_>"FEO<!ZL=S?CHG@MP.O.$.A02-2U<JK
M8W'1CX_^=Q4UOY4UOY4U_RG*&IZZC7!HI'XLFE/7K-C=I,8GI"+W7%F(#G(F
M-?/'B#=6E;!PQ%3.$<VUIW7\4LRS7D2\VX.HVC)'9^TC_<7Y!ZE=3A22Q:OK
M%WV-_X0/#23Y?\X_H8,DC:R)<[EC-(%-U5):7&4?(<3[ 071N/%KZD_ S*P=
M99S'0Q^@;1U7D!&(P!I&XI@=,Y.A!W2[$XY25])<^+# 6,( J8KD"!:ZG$?M
M_N$UM\;Q^*>+!;G;9:I.IZ)H.Y X(HR;*.AS,'ZQ ($O%\$K,OL*Q5/?N$?Y
M;=)RBRH:?V/U^1U5^3NJ\K\RJI)V;)D&15!ODZV!%N;N:U#-7';\7C\]%M7,
MWL(;=TI+AA>,GFR;@O#E=YYUVLF(;!,XEK]?98BI6&BO^2 (^;EF8W*-^<66
M?$9;EBSS Q/D1M:LG\!+FYQB+@.SN;KW5XX2HBB/7#^^P9@Q'=O]L)&UU![Y
MY2$[SGWBW)/= ^60TZWM+'K0BFT:;2??IGH 'C'WTR**=LN/+,W^=:UYY21E
MR!Y4SUVY;4\J=F:I:,C7\(T\"E1VG7U1=U%)*KJU7';2=B-BJ,2A)Y8MAO?]
M2 +;Z7-;]%@;4!]=;U8.$RT((=0IP177)LPN\R QMLF>7_)%5%S@(6RA]8SZ
M]QFL'-XA"?_UL2"'_R8W*RR#N2=6=9(KE+TF+!WPF4GNW21M:-.G#^=/2PBV
M%AW(;^BQKP[="!]+[K$_&^S*#P2_0AJJO"R D4;;.8I#&ET^2-UOG.9F:38I
M\S6MUM^ WD3;/)62,C<Z4GWG@Y3)8]*,JI90*T-OUZ'-]VI\J+4X389SK[?7
M=26AXR]D.+]]+7_+</Z#93C_T-?2=76XE*@Y&JEG].2DH \O1V8G+[Q\@$7E
MPT-L<EQ!?B'XTP\$UF_#P!,9K,BUK:?36/>X]#S_U/MT_T266+ICUUST1JT-
MUVW4;F&>1KP,BA]\I<3IHE\9_]6XI!SB=(I=:NM\=<&1*R^#!$H1/JZ!.LC]
M$9+R8-N'D)!3O1I:LORE&(%:[71-,D B2]UO*3]99/JCE*#!_,B(F1^(N\M3
M^,>-I%:".'K#H_ F\,9N=XI4^"3GE;9/19V@#R-XS0O>:*Z]K:]^U$62?,$=
M^RTQ3EU#[-^W/<NS3Q#0V$UMF?##[RI;N>#]"[KI\4Q'VD?=B:B#NS=FD<XP
M*)\*8_8V&L$;1+,<@L<VW$B+\!P#=1*3A&P.&"-"*R;*1_>\Y&<Q+FP3+;U_
M*4G'"RI]L\3X=;Z7YD1YMF1T2(7A*_*IZ%NQ:,VS9*ZQ(L=\7>-G"//;A\-F
MLAWNI-0JU%SIVMW$GO(, _CLJRW:5]:W/RW8(AIU;W\^/&E[?+KHGHSAKAWQ
ME_C4P?4<BIWY7YG#">G>7CK?GT7C[J#M]A\JBRLC"AQGXQ3G1J>RL:(SSN8T
M'>EI3\MRTAV+ *XD[0MBJ]S@/7M#6M7S.1:.[^WB+_]L_N3#F#C3FX-HJ3V]
M.4=92G4,"-9"4@^2;XKSX;U-?P)I8OC*&Q/.Y!ALHI_48H74$/8W;O*?AYLP
M'^5ZHDP 92%8& /@0\Y5K?Q3G2ZB!S_6 Z;.6V]_[-2UW(:L<)&M.R0Z=9YP
MU.#%P[O@AC,_@6OWK<=;97H=4((^\)$Q,X$(RS ?&_.K=DR-(I.';6K)GUM(
M;H>%03[NFX_>5R18I^3%FP\$"5UW/DABR6L3V.)7D%#Q%]03(P/MK8'['CWM
M6I @GEULMAS78TGD?0CB722QZM.^B."-\P"QCAOVM3()%3*D:JCO>C'?VOH_
M1FI,-//*[N3"LF$: TS4M@!C)B?G8HKW#!=C%20V8@NQAY+CLEX]<KRK9,=T
MYGCXC1CC48CN5(^3DE&I8V8,4.,@*R7!K,<:@>#7OZIY ??.HO,-"[C>]V!1
MVLW@BX@&#QF.TV-70@*/S1U,2S!WL\@/M6IQ?)T3)[3CSF7FE/R?@'K3PNT2
M* NWW85JSO8:O'R4A.EUK/;IV"WL;._:OFV_=$Q0@U%9S&AJMUMXFX#_"8MY
M5T05WN]8\].+4FS"FT\_M;U(!&_*?$XX6\*7/ZO1!( _PS-"4W:&C4''\S!Q
M.\$U3 J=AM353E/$&?X=XWO6;M!F<U?%R,B&N+V'S<\5I6PJVE*X\7N9RHDS
MEO=$C9[6[YL$IA(^E4Q47S6\!DI)GW-\%?$&S%.NEI*L8(Y%DD;YNU_CF 1S
M9;2:\+R6<:6G;VO>YP'((4-,3I^FLW-PPS4EU$;[CG?'P4^'QV&\U":K[I4_
MHE,9$?T$$HK8O'B[&\H27C./4XDB3Y*RP#_@"&':KG"#Q82E*?'SM#/-YW3+
MVAA]U^JW6NBW6NB_52WTC_R!;X<W-X'9#V>/2(E!"C2?60>9\?$FYFH_:@NQ
M8WKE9^V09<E8'CEA]8V"^.AGNWO_6?[)^5>+<0&%'()5U/4(G^Z_H2=JV>!4
M>+% :DB&';44,)+PQ".*Q$$SU<6KM1YM#A*26+,_F>'B\T!.4M0I/N1&>=F#
ML=(:.[3C?GFTV57LA_'W:6 -X)&TB^:[."[$-7\3QM730.UB)[_\!(ICMGIY
M+)F@F$@NZ84"E<=KU$:ZRN6JNXF61-C@DE9HB<U"0MM]O4MQ=+:GF#PV7+X&
M*CD*SR&>/)U_5-Q)']R_Y7@V$R<;R#*?45+A3#&#G%Z%;( I:5N*M<D!RX!G
MN&12A&F!/UE#@&Q+KL%")Z),B6_<&TBW8+@>H8)&D8_3O]U/?KN?_%]U/UDY
M\(Z/BK&\K]F=+:Z_V*-S14C<K2"+Z;V,X\E9VTA2VYS;JUNJW7$EJ;*8P7HB
M[&Z/U-R6_:?1FYU[0-\K!^$]Y1HIFQV[#TI].I?MH'F4;0K%U_6R9^8.M?#A
M??(@HGC<PB(IKLJV@Q7>?_&^ /5C'E4T.A(\#-[5^5G@_.-C Z4-;)9RKX.I
MY>A&?K>PKHGPDV>3H<",E&%I)Q=.1^\\=;G/\9=$KE;2$E'\5?JZCP)WSXN>
M'S80U4[<H!H&G) ];-S_),RR7+*>A^%^NV#NKECA6$45H7:YEU%O"^W0&ZV?
M1:I>S6!:>?4N(GX"(P^&S7#T:%-:C-E*C"GL'NVELNN>G)IKE&M47I=B.BFS
MAJ,$"2KZ-YTYG>R^')3-*K%.CH-UFSQ%+B)#0JBOOW4C*X-O5Q;U8:U[36Z;
M[R*=("RJGL)?C;)8K\:!!,^)C)^"3:90O^T)=7TG_.6>1Y[P5NH?I9!-2!?F
M[BVJ<#4'JOI.1I$)6.6[XPG3:CMI'E%3;U1_H"_9K^.2^#Q:AZ2 Y8:<5R"3
M@H45BLE2[@XO;(JBE;MT1G.RFH^TU9G[3UE$TC4Z]\.HLPA"DP9DA_T$D,\*
MG4FWP$+)CVAA;GDZVRA0?.>>ZW]!]>9NH ,F$/\5D@EXUX8ET.0>C5]BR%V0
M@<KC'6H7[H!.)<I1+F U&Q=[&Y\/93T*^RNAS__YXW5;P# &23OG1'ZY@EP1
MY+11#,?Y4Y8^T$JUC8+XT"9$EJ#4O4;J1,24[F)$R^O)>_X+PA8Y>:H3_@VQ
M=,'?JV9]J$7/,14:PM6\61O3,DU+:6$@QF:6Q9)M/N\W'M3:5',E0+3X#O=C
M':][H@[YPM6GL0(&3+6D3NTOVL^WF;J8P[07MN?7_@3.G!_C$B0ZGY@(.W?\
MHSC?X(#2RY(?.0_?N<H]))0?#;I]//F ^W2^H>G$2[.Q'QL 'R6^%^.0PA_Y
M6X^_P?QP+ZZ^=L$D(N[&-<;M@: %A:S7U[T.8PV;2-RB<#F8[B[A2Q<CI?(:
MG2/[S1M%6KB+#MJW0=\4/><X_\?E3O"*-.'DA!0IVP[-9JM[,VJW872MZ)!D
M&P_0"@X.XU-GY_?@8=#TEY4H#3)Z\.K9-U=CA%,8\";T1-&-B0UVZ@ZWHV*,
M6O48C#.>1CHOS2!1!X.<][S1U]'E,DMY;8S)$6=,V\[]\A@C!F#5AHH#64ZJ
M_3IZ'92W0#_NPB'$5?R)GMQBO.AS^%0GW,]I(/"8H -'O;DC@=P^0O+QDH-(
MN+R/81_QDUBL6(U.)?98DH8M-;Q_)Z?^!R2G;@TZ\RO:HZ'H',5;WSW\R$09
M8J"I<0(_TLKPLC[E:F9__H[J!)_ H[QCTI>N<<.<^\P$@^;07"+7M4KJ*KS(
M0O&#FN40$4?'Q006)4+^G*XN%YL+^&V3'7B+)WXF,>-&08WS+6:A6$FS''?T
M<69?(Z/60*NXOY@+6O.5T3X8Y" (9X4) P:Q'OZ1FB,?_+V<)XT%3TB<C7B1
MI_2Z_Z18 C"L>Y,QN4I;^;3 '/&]L\S7L!.R<#.!3_L<+C4S-9^KN#N;0XE\
M6A'8:7Y _^P7(82U3HC^[@_V02/\CMWW4Q/:U6-YWPZ]?0$!M6K,:@!:_U-1
MQVDCH<)"/6;-3H&LC%NF=?"D,,"J-K<Y68.'8=?MO&1O8TCS%[>W46^Q^F >
MB':1^NW4[[F'/Z>AW(T*]1AT+G$>LF_5VZ E/W=I1$W[AOWVYX-V"[DGP@"L
MX$-]_R83X'D-CQZ@">>33KV;E9V%9N-(^USP1O^'85_+A2@TA6;M4AVA=T5B
MFCH%F%0,,)G -Z?<CP!\U,+W=#QQ@4GD?>96<NFJF*^>^=PVA]U-.' Z-E*<
M*=1[!K-=G;+;'S[:H<30F]W.-1U$0MMBYF3R/$;)1VG1K3>\5\=Z(O\0,5B=
MAOY%113'F@*F0E*7Y#B-!4UZ=2*!215Z8JN%*AT[0%MO3SX+]?]E^UNJ?CD.
M!>^^$I "^**"*[]Y$$V$:3S8,VO"&#TMSR<>#7,S:MIXNB@F4/G,*K.C;7CQ
MP/QWR'U+R@S:KHZ.$Q!DZ1&N:*XSRT!![,WE %>)&Y+'FU.S6;6!]_2XUK:.
M$3IR /1A5V ">-=*@JN&T/6U,)38'M75D!1P_,>Z6?OIUXNCJD%_=']X5A4P
MV'.5M K[O=]YFECHC"6UB>R&#O;-MS6N<3Z"XDYITXST5C=RZ,DHS*N!* -6
M=%U,D%!-C^I-6+8]S1P9!ED;@V^NXW= +HJ1GYJC;M#B:P*5S=:  J1M6.44
M(;X+E:\&9;GE*:CAB3QEG"^[S/DH9%+R7P8+SO.C.GGSJSSOA[1 $W7@P-L5
MA@=R>^HLA\]825L6L\M=%&8!H7MN_MWYU=%IVS1OZ_%T7]U05%NZ=U&(*AE2
M..=%@>J)I/\/E@$&";N_4WM(2-@!&0K/,UL-_5^!^6:]>K>X(B((?IHYX65$
M70NOC1^Q$I/,=^.<"AGN]JH8F>_XD=MP4,#C@S_1E9*VK\BF9(86@=,H5T5=
M"EJQZ/+#BRFJL5.SP55+4 (M*P7-UXP_M^2CBOFS?507)&L@U#82,J>WCNA1
MA:]HJ+%T(;Y2UEG$+19R[(I&83"C:CEXMN5K(^MOHL=OHL=OHL?_@.BQE;;3
MR;#K9C%_;[GAI;.Z01;U-O!G)P9D#^,#5=WQ(G%=/3=8,4HZD\PSU_RJK2IV
MF$V@8^]?RS\Q^#**[QB417[NK1]EZKP7N9KP]?LY>-V"B('3$ *A,Y%B=52:
M44'JC-;9E,=(@IG=]U,;88BLHHF$'*8G:<Y<O,<V@W?YQ8TKE]1X=/$]/EP:
M+=F&#?WP19N@DVG_B-T%+.#9Y\"FD@.%LXOSC/QC8C\]O:1S.2F4EAA&2P45
M6%1%\4]7K06:!"4%T9:QT=(=Y%@RY.:2O-.)KC)I&0N#GIQ_M%S,*>CRH')1
MZ=3IYR>P1#1;ISD)/+9Y!03 =M$Y%84\R/&KJM,>X_S""[[4=U9XG>3D^/Z*
MOUP8Z1! 4>XRH2*&8:H['(6O\/F:[$=(F:NC( A)6K/U3"*T&AMV[PN65$!!
MU&];Y]G!D*SNO6S-P1M%R[W];IGNL.P0GS.;/*)CNG0&KJPH2[YY?,"8>]1U
MRU<;H"K,H$>IDP)DO@V7BLJ# M.4)0# RHY&I1C^*TU(Y(HS1]GP3Z 5=T5U
M[Z(D\&7)GB.MA#H!V!O<CXA8:?\)#X=7Z!0AK!H:/ 8[_V5X_+_\,-',G=5!
MX&EGZDL<W*8ZF;.=UC!A5\4F%I-SX+'"9>I$Y3(@$);QA=JTV/RZI'B%J1(A
MUDL7D\+*W<J]NG/D!43AQ*Q&_L&U87O51L$V&G$BIYU:;.=^N*!?Y9J%""(,
M7N"O8/DN<_ATOEBUHJ^#=1CX"J/+3)(_HM'OL _C]3>\_:4ION=O#@;K/)Y4
M:G\L<*,&\.<AQ"WJ._;M'(;Y]N:^ON&?!A'J4G)\X/?J!]ZQMI@<).*B@&;S
M.FHY+$8T(QN_/AR.W_%1]/;XBUP]UJ+=;N#ZW-3R26@[L^.@#+X@KRWSPF&+
M9Z&9L9(NX$C"N9TX7J<4G,7M(,-_3X&^E+R>/2)1:Q!XK-Y>BP/FAJGM/LH[
MTAY;N4#@RQU&Y^[28XV 9[V(1,13URZOKMU/N.-ZBP4:XAQ\&^6R)[#DZ17)
MAB7;+EJJJ!3-3C1(,/W?M4;X6\<RW2 V\WQ"]X)/<CK@+;/6M"-:E=?,+<!-
M@N)IZ3SLT'7S,S?=Q@)3M-S)-[)Z??D)T$)94ORDEPHUPB\D!+W]'NZ>CR);
M-TXU\%%O%')"=PL*"Y^M6O<%,' I?8G54QB]G&K"IK)MA6V 59D8U,">P%$G
M4XE'IEC\'60SC7T YESIW"W.KKA; %] :I5M#19>^:&&\Z/F) )277UZ78 )
MY,:PY>1$%76Y8YZ.FD#S?6OW6O#%TL+#EF--?C5IBRF,*5P6O5[BG,Y,M^VR
M\-$^9\<X>8?5A*=;568\K =DN?66P\)</JRO+FA7E!RUI[&>ZEV<2]^FB3R&
MW6DI1+T-TBCH'3]OAI_ >>I]>K(#+&L:X#&8=+3TYJLO82^<A1G3?*HPKLCQ
ML T?G9,5T!LQZ?I^7!6^.ZXY]9KR;%6$-!R&/[#M3")]&EJ4WOXZ-4"<;WK'
M R&Y\@!WGZ:?@!\DDDLHHHJ(@NK.Z;(ND"AVW-\"_"R[>7PF47Z0\&2A<&KA
M0H&;EKOOC.H**&3X=L)(9:=A,%,CX<%PE^2VQP)3%I$/_&>N[VIDJ:'MBBX]
MS48R!Q8FO'.G]5BEU$)G"Y00(B8379]-E*0:X1EI.7A9IVDTUP-<IWR=ZRO!
M$4*H^],#.8?-A,1.SEM;X_/GM+9\*"&A.;&Z$Q_FCG]JQTDO*/0_\X3H6.4\
MRRX2E*P!;*"F/KM=H))E&HI_OKA.&WK6H)%!KP.5"P(==W?A1G,>A1E+?L)*
M$:QUZILKME43;$#([X)N^M8B[(VL2MF!1ZT*1E%]7_SA_?TO;O.GVKA=42UD
M)U5MH P1.^3_:M-?L^9/>D%_=_"_._@_O8/_Q]T](K^_AOJ6UE2U!#1R\=8A
M5'F[-Q]Y.UV:F[47E_J5#?B16HT\^NG,0C%6N5CGWK%9K,-DJ;CL!4@X["=0
MUT-NE"N:<%EG7_%CBI9R95 9/%%'6Q9$,O(2K2GJ_E+091H FHMG\AX$*]RJ
M1DC&^+*&EU9X+Z8LEE/L^/EV:,<]NI5^YA?/%A:APFGB61H'(%"Q@9/:Q,Q&
ML5*JL:P3@^1^K/<$JD-[DU(IUFL1.[$:A.+5BRVF.UE0?\VJ\?K78=DGCY()
MY$9Y5ZW%9T6%B[FF$LM7L."SJ 70I_.4)G,G^N"LQK,,P_9X,!/=P"(WS;D4
M\0#_$VC# 3YQ]*;=#-I KLTS7?(%E:-8T7Q!\SR^EJX0 8:XOR%M%Y!A94:%
M2R2 /WR\-RS[@9((R_Z@8"'>-?N*,67=1=PB[E6'?]_IRR[XM*PZ:/3]]?=E
M8_^PENUBN;_]Y>6K'5/K@LAL= 7VQ%);-ZF[UL9?/1=+[]A'+L\_2J'V<U$0
MVEZV%P0KV$9M,G"^.U9L+;+X%4KH+?O3S/FVU+2?0!Z4!0FC[_KG&]*#1PU%
M_17L"_O1&^DQHVT?Z3R +*90^J9_;.-*\*BZHAHG"D-=G>]=6^R%A*RSM0BT
M3?]$+0]XG7+.+UW^\#:QWQTC"/9:DF0LPE==+8")Y-7]?HN?P&KX*/KR]?G"
M$3BEW6-MJE1OCKL]C699#AHU7J8  -/)&ZG_->W9I5W-+#+DVGIKBZLZ"<MV
MH!;+[J!ZK-%SZXU ?4/7F80VRMO2+2Q*/L-P3?;=WGJ!8_244=XW= : Q TW
MCS1!>S/,;B)XTXH7J->V%7]0/=8'<#6BCCJKOB']>CHUO4F-(.WK%8S<YQVY
MXFDA+CH]M^0'>G;9'!0(3;\THG8%7[#<PNMW<*FLV%=X(<=-\K=.42YB#2)?
M[5]IV,OGS\WW5K">6.0WGN'N,J6\@*KD*B[96< N%5%G!$GP/[OF2DK$&_MD
M;ZJY2/3J.JL3W!ZXI]5YMYZKABNA"%^=I.%&??5N6 @&NIF')TP_4?@1 2!W
M?':<]<R=*<45GG25>K]-+_['FRRQ-ML;E#YP@_M3O&/_<V:3MB<U+E<!+$LC
MZ4W2Y0U1T!E+]@[YIFPQ'*.B/"Y"R2B%QYUGY)_<OUKJQZ4\']."L'66[)NH
M#[R\\]R/!43SPFJ/SH)DI=DK/1NR'($,P_:M]>AZ(IFZI1+VV\;HZ87]RNLT
M#:2Q ''J0O$3T)YHH'Z*>4C@B\R*ZT/5ZI9]HSZQ<IVJ80+%[#]$[))7FYNQ
M3&=.F/Y+FC#=]:%K9;]>C[5AS3@3%KIBIRG/'D&+ D1:7JW"UY&P\NLZ=3L6
M?XZ5GMQ$C>9Q^R8@MF"93Y?;A<H&6='.\@S/B8G08F)4):* +G5HX=:B.V<6
M6"Y;:=HQM4S3G!\\;B[MU:<=^HO[RZBPVI./9U+7];;G<[?FLI@"EQOSZ$&*
M?;JVU1'Y%=L'F-OJEOU.05X>_;\23/R?/\[S8SM!V*6S?@<GUZJLH2K'O\](
MFO:)>M7U,)4N;]"[DI>-("0?!.IK\-[_94K\5V)&:,FBN8C9#5"LPACC%BYH
M?=L!DUZ1&OM6-\6<J=-<HI-<(0DG:DS*9^9?/:T>9$-T@Q1&)[RXS9W0,^%U
M8XT;O^]YU!%_.-CBW/6>X?,$UX0A'N@FM9!2CH.^1B("=CO-O.U\F+Z.GB<D
M"5Y8V(?DC9EX'<@H^:FE]U[T!L9C'&(G+[G$YO?I/N'>W8NIN\CC#^1*!IWB
M 7(.'3[SKP(<6F?6+PI=@6R1UM>S)06BBNV8-NO=/^AF'HE!!@DD#('\/SI
M&/+B#W7:,45."KXM<8 D=KL=[;,(*+1TLRF>3R8];)3+FKA/(?LCAJJ6F/\_
M""^3B<V5831- /J4[9_V "QWX?9XFR)JJ6D[#!;:O,Y2DL3%C\J++J_LH]A3
MEY13VA(2&DSK\^F9G<N,N6B6JXYTG\E"ALXY-8HK]7]AN9G&L_0C_=*>QVQ*
MM!#,2L4Q*D_5HD:ZRK=5"Q/;*\;7QH$*\<N9HJ++^^I7HTZN=N!2#7X*38A&
M#*J-S2Y.BI0&*Z0UY(U,Z2NVDA!#&>HB]NSI+#3P&,<R^9^80E<#W&ZDK-M
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M9<6XD32J[ZN_G3BI>QWLX*VVCBMP50?YER48/;W#V83K)JJOD2+.-%BUJ@_
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MKT=S/J.D'D$Q7")6+,$<P"1V.PGY/5&=XD(K3XMR"3$CPDO;FN)_L O&*!*
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M+FM.-T./]96]U>0WE6B_-,;YUYM6?^_89V\O!K)#4$9\U=)F:^T?P<'ZV!C
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MM2*=F/!?5E0@(HL9KI;91F.4993, QKRV[\0#N/K=R:BB92J?H5\ -8022#
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MA^,E/=,')JD./3QA;!Z[676UI@3.<KWN?GAT\*8@NL]7/^7<CLSR$X4@(N\
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M*'2OJDJ,VI,EW>]D@WS<>FS?Y1H=R["6?KU#''9FGS+/LBCBG).&(]YE1O.
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M2]K%?1LB",_PO**X><MTEOI$GZ;*T @L7SGV?4=:G/AU6T?@&A1V"V2!]/"
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M;2#M*IC8NTM<\[@X"XNZ&]>N:K[/&C4T\7):?\ ;&W/'0,/8 2 HR2=ONW0
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M(4,\5>'94Y2=F_4[S>QPG@#%EY]][JO'CT0W-VII8H=F@>T1M@_<IH'1,HG
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M^CLWQG#"XWB;,MI\:XYL"QC[V;('<6DVJG+!-"XU PMV]_99R% V/>#61-5
M62=*'JQ(26X$_]#K03261CNCC;T!G>:B)P6?.#X^YL$#8T'A]B?+/DN\YJJV
ME*YZ>*7(.ML2UM+@"Z%M1^\J1L-G)503OIP(3387N>\"-K?Z(A96W//!Y%2^
M:8]O) ].4=PP-@%]HHF'PIF63*4Q(#3U1)_>.4H.)V?=XK.8#@\Y\<%PC7Q(
MEI$O-_%2U8LG#T]VE(CL8TE;_UC>RC'NT6(C*:@3^> ^K0S_AY_@5_PW(>8Y
M_LV_&?]FWSGE/*KR10* W+"HRZO_J*W"[X76>(*UA5DU6 .U."I.N #OJ-J_
M.7H+@,OQM[3A\!58/P9U'='AU>C.U?1L!?6(S[5[Y!)/=^Y<$=(51&Z;\*^0
M\S-WH),>X.*LHV7B!HHU,XL/WW,!&/Z'RHYURE RUD;"WD[I$+Z)KR(.U)@?
M,P]H7-"4E'Q,WR?]8ASP9T7VGVR8%8&,+D@.L1'B9B<: U\T!NE7,GH=P/(W
MSVO*#QRNGH0S&I;W2/M. X82Y_'''+^_#<O]F^L\S[+^'P2 YI@__\&AO":J
MP.K(>>*W"N!\,_Z1B,0+M.:*WW/BQHIH*Q6U$6H9/:+K<SXU!VN;V,5\O*]1
M8>^AJDONTU6L%RT=#1MAZG]]$(41]I(3GP908!,/XY!_=D\<ZO)D4.L2EK"?
MJPIY>]W$,RL9-B4G7*8!=[#L^\I2[J%_E:YA4$@.PPA#TEH*ED(65$N>;#J.
MKQK/JF#O'$MX%7E5KXG;>(7"6&K^9$?P'A5!<*]_[.LPD.K;&L+*07_45AVW
M#)&+$F'$,*S.8ALUM,3 %2KM\S20 3:Q@]>":-0(W_#!$G]5_E#04,R=]:B1
M0BO$/=4KP=^!/0T31EUH"-J%?YVV0K??R?E)R+..0I/ ;<MVI1E530,GY0?J
MF-'8(OL/]5=T^^4_ZD_F"3R/WQ+5GC72^\W0>$RR_IF\]^/!O*$L7YR8WM/0
M4[[9/_1T/+4>[%E(/*]_36D)M4%W@F0^5':$I%K/XHQP8HY@94""M*)@N6!3
M9MSZ2U!ACE8S1ZOY7Z/5""@Y*SD)JJ*$>K^+E 3\T5'D+$U_)4((E,HPZ+:5
M(&DU36T]>UHE=[=NM$"%[]96@Z>'+E)*/IE&,1=Z]-KM#&U_B5X?_Q2<&V9;
MYR.!KBD3QR[X05E\!7ER]]KXNX*4TM!&E?*A3HEGZ 2IR;W'5X+;^N;<INXG
M?YQW<29VE:Z5>4 U4+UX8L6)=5-X0[.A<'S$:X:YL-N5L5,[%&(&474/GW]M
M%HALNISB=/RSZEO[D\5!=KZXA2ZP6T)BB<9W\ [8##UC8,1,9IF-\5#$:9:N
M+0W5VVF]\01I*649\R%$-PD?=_&7IW?2S(/W-5*@[2=8Q^=YH.,4[+.G WWQ
M&&GID,/1:6#1N*PD<]\<;6:.-C-'F_E7ILW\^M'?X>U74C.^3:8%[Q8]7VM,
MJ/ [6Y9R/:<",Y#]!8:X3QLE5</E$!D?%X2[VW42M^I)T^A^ BIVUQ.'AR=J
M=Y0-^3 :2;CB;=ASB<9_C+,QEI Y@^0Y@^0Y@^1_6X/DO^"8HZC\NU!4H /6
M\OI;I:E[<VGNUSMK\-F-YGDB$EW-S&QB?["3X,YIH'S#!4'$8I)+A.)9-,9U
MNX_C\VQ[$_U[T5-IP=I]#+/M^G&7ERVW]6G>4UD>H_' ]8W,\9"8%\%HA-E3
MM:<5UF%-*6<$;)N#KFVXM"PM6,MUS5&G)Z.HD!3?X!LXLA^=>'D[X!W7X]FB
MZ_OAG-/R/F_IQ#@1C2*A^Q7N2.T5H@75WCNO[EM2.__-G]\X2>595,EAC/2S
MIM.*8NH"9TVMS9E]5VE&S+X.5?(F&VV*H\M@8LDAPY1IP)4TGHE]<GNRJ>LB
M CLH[=#OPZ(#&,2/>BPFJC^%1?<C_2@"/YDHZ/OK$F*8>8FM:2;9F=<CFKKE
MFP>9?6MLSJL5WHUP18T9=\=EIML+W949S_8CO@N]?2CRR\/W3E)]JY OLM>>
MQ3M\ G_]J"(=81'1. U /VZ58'T9^)L;L:Z;Q_'56'(;.$27C6<*]++_6S/V
MK\^?^?7;=#9/NF)+#MN?- +?+A;\[9V6G_K>VP4T+J#O<MM?TO=EMQ1QCV'1
M=HG7Q%*%N\]3U,;^,D_1?R"3^F86LP%)AUZM99]]X:>5XQGIK1K[(-X"-2!H
MV1X")S5+E</>Z<B$F'/'?K+H0LAV1!4V?:"R3P35JV*[;K-TRZ3[M77JT.$S
MPR>D%R)>$#J4]00"BD;O<J5Q?S$A2>G6SKHXP#(,TRBYK.)K*;S7>JMJ^;&N
M1V35Y5O<M[7 930C.Z]ON5OANRFGXI,CI<2MHO#5TU;-4\6W+9G?GNN.+>G5
M7L<J@/4,"F,SS5(#OK6ON]9 <S@PL8-I#%9-'SET'?"R02"1N<CM"7PR]09:
MCX8LP5;8RQ5?!$L19..2RJA!ZS"2?"M>_">#!D<V+'23R]*YPT>$BMW@T(KR
M/4%R,A,>97B1:<Q4RM?KDX[GXT3SM,?+R[QHE<4&XZTEL?QA2/*E K!:16J=
M;I6(]X , V1W#"X2]HG3FK>J:,W!6"=P>FFK>-M$C(2=B+T$"]..&4L5K1#(
MF*>TSLY&+GW9@J;"_HK?^UQ'- "_'WE/P5*RC(8F4FK8 V=1:89#FT2?KF1?
MS+=F[BA:X#M8PY"AQ1>L:ZB]MHV_9OS.>2K/>2K_[WDJKP,B77:XK?2RL*R#
M+\]>3C*06+L:G)4+1 C[*<-ZK="W)9;&GS7[+/XU)T1KX[&D8.F<I#'(^V\>
MOG7)"Y<*?0]61JW(G8DG5$R91*<6)6'_.W?4<(>!)2ENQ-Y=\IT+\.74Q=\R
MLBNWBE#R2,% 1RY!K_,+E)P5M'BRCLJAP*#6<$/1V7 @[L <(6:.$#-'B/E7
M(\3\\C#4;-'8:*C:HB[P%KW ^ GL'7WBO@HJ,\L1C8BG3>JZ ",$BP4M<=\@
M9\*HRB*5TU(NG:D<>\_X\8MEE(V!\]L3V7;$ ;/LB %/KJL,VN9P#NMA:?2"
M83.^!3'UD>];/#6J3YY60PEY>-,STT6Q\$C>3_4#6QL$03%.@MDSA)8A+)_G
M@KM=Q%4&Y7"P&'&![ED.Q& SAOB,&:I9B25@"8*&&Q)I:'^S/O(%SCE/X)/3
M-/#2/B:Q1:*RASL2+[=U.:F3&0V %Z2:ANUK+CS =28V%[D'UCW2.<<GZ>1L
ML%UWJ0@?K%=LXRN#4"9\+"9$KHJM#B*;<& 8IU_:JG%H+?9>')K+F$ [:C,'
M*VH?T!TF=L[X$ZM?0<BZ&%_WRE2Z_I-+*"KZ#I961;G#/0?KF+W0\X,UCZG2
M3<9(XD-1K<8_2A8S+<&>LA<Q$'9EE*6#2G,H5%Y3,T'' ",./!]B1(YO$9X:
M"5Y%&C(D^7[BH$WD;7#WTL*6(+7,&!6XTZD]7-3EFSI7+[3=L.'._<-(X )7
M'61_F8O#!.\*Y*$N]DMY@J&4'<FS7(A]W4+U*"1*R=L76'=%88Q](B/'IB\5
M>OVU^]QKG@TQ_</K<73DL"HC%B>V< 9TT6B;)1D2/NH ;B2DV1M)BHZ2LY@Q
MX,;6!UFCV#@,3LSH)_]A7[-+6,I&__Q0L'9K#%3<\)%#;+%NYO!< #_568P6
MZE/?V6P7P0.!)&1/WF Q+)[K2KQ@Z2!7'627P,5A[H9J(O=28@KKE^8!MWFT
M%H0[C^H"^#U)9N4U;O.2V,DYBX=IV?,<B!%7>Q)I=TJ*GI>LN&!FQF&VO&+3
M7. +,#:'P04%+1=S.X/Y$FQK1EM\\(B%?JQ'5!^>*S%=\?MVUSV#86.RBR?0
M-7F#I;!:3]7V5(??9;^Q78ASLX.^$.2:NDS.@<MERC]=/?$(LL$W'2,TOZ""
M-RRDP3*I:$$5UY5U=@^33" D4-UMXH\I)ZD>.<A]_]-#;*9#JF\L9*#V!*S
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MQE<#$:>!BD2:W%,1B !6N_T%L]E+(ZA?:V:Y7-=K<A!C+NC?A'>@7\CB*(0
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M]BUZ;4ST6VS>!KHZULFHSTFP<1H OSG:0,^TJDB7I^DA1_0S#^Z)<_N1?;$
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M^2KD#HN2&(;]!;'=BV%LR;3L3<X)IZ 'M1*:2]? 7DK%UC!@Q+<J\5$_JSZ
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MD*W+UAT3#8)45;0 "XKUFV^,C2BX;WPNWK88":@=*0;%$LY;)T/HHLT0,%4
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M7.ZCVMHRF?^&V67=92^:O<5T;UG?8D4E1GFJQM8=4,'T09O%I,U>@(BD_G)
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M@G'\N7S^ESX26?V_9!]FQG#?4;Q[E$2=SK(]0;S7<V.SI&IWM?U)F7*,TJW
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M"+!0G+.=;3:B'?NXF8A&5MAET6RT[Q]*FM0TZ0?$#B^>EX"V:;EM>8X;33^
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M*A[QU-.M:"50[I&F82=!5!0MRC,+/IZH\CCXLVF;>Z[<>QT%\R%YPBYQ8#I
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M 8_6#E\2)FGC[=(*4E?FJJKPPOE))ZH8B->O#6A0BT.:F1]S74"]&*CR$N1
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M]+3;[4%"VISQJ+Z;;R8OHT=KL?[,2@?N&)']P0H-+[$BER!M.264;9.$RAO
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MI=FY:$7:'THOKJP<0+0-^E_TO%PA/']GM(HQYDS B(*>GFM'EX[&EXZ_5.>
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MNQWTP]C-$=>BM=F$2=G"-C>JJ^^,QN<-H)4LM^#/7-S]3L&#1:G%>UJW6+^
M_A&GJ--'*]I7TT2W8S1$P*LFC/N$-)FA\F_+)MS?L\AC[]LVUIUY>U15VD=%
MWG<7V761#Y*8WM KH+:*L3]+?@%F\5L1M=^1\SO7( ,UC43R\ QOX9@\]_D]
M>D;[GC\G@RFDN[VZ%K " Q9^58[4 +$+I&. ]B&YH4=\Z77Z'QF_QY%%=Q,E
MF5'=[OX2O>$_!+ISZO;,TQ)C5*HI*Q9MUY+)DEST/LV1!BA:[#S&;5X,,- !
M8%S!W\A W7^T^T[Q?V[ME:E<>%4>FR6A8]1IRR0F7U$ ^$HM@O@NH )Z^,2\
MS0/.XPK:1(%E2VSVH^?SL_AZ#1 96,<:4$H\IK>63^=%W,&,?AW<STT5Y2D&
MBW\VM#JY.@(M#@KO$J&WG:22:CEB@DW+'U*WN[X08@SZ*17?C1C/:!^\,OR%
M.7D:!80 .NR1:_! H\.#=0/!ZB '>L?(>+ENS#I='D61(+Y#GK_:5@":)/,)
M\VIHJR!#$;$@1A=)!D(9MD&.#2FGMTHD&N4=KJ=5:$BUA107'&\CKWF&K L&
MEE<=S5\7&Z-% ::(?]*IV']0\Q.%64&]2YR!V<QL'?;?+'IND!7_HA/K-NL@
M>2W1 1MSZRCPZ[#4G/5['3FUJ/=AW<R[5"(?KA^5YX14KV=0R*0-+H8 Z B+
M+4*M=8LR?U&4,5F,JC,^R[=\BWP[7%509_J_%NNSS=?6XTDY!6;VM(IJ/DVN
MK\B&SH,O_4=%6C,0WRR?<!@-5*]4J4F0U= &I<,WJ@N=ZD<K.:_@]J-6QX^N
M9V%>Q(DO]GJ73O"6BH+;5QL%ODI_9Y[5S(G\P'TBIR!DY,,3M9>BIS:8[HF"
M'PS*G0$X$!.'O4;GN5 Z @D8L?>LH+:ED../N"5]3W[3_66LE#T:VC:^(K_!
M]XD5-+L>9)8:VCM0Q'M*:3]MT=[E7CB0UY&X'X%6G%!3_ZKS'67B+GO;LM6/
M0HZ'U63%GHP:<MZ\[&QP]W0SYW,&QYF/I.=,L#Z!+?S.(EGYN>A3I1\OS6M6
MX^$P55=PK[\G(WVZB)-OQ:?7[.1!ND5[G]F,]>/S2T=E)E5_ L>B<L;5TG2R
M3R21+>61BYWD>>!SBCDJ*$@:?&,8Y80*^:@I_@ABZU5SST_=D 5WR +COEW/
M[K"+[$Y(GJF]@"HZ6@+QF MP,+]M\AV3 0?6*L#D^+%79!-'FJ@*=2'/$TMI
MT-6N%K(1,-A.4US(+NA1+ INY7N5XC'%/&LZ^@TZ_$J4#/W._V8#4)!8!J1A
MW![)4QO4XWC_G>IE!@=,IE9LOZ;R/\2%' *K;/=+W":#!-F:=,R,C&&\MP\Y
MNQJJP]+Z%CD]/^AM8":/[(/,(P!%;Q5"Q$R<^:S$5O(;*IIX>S=0OU9D$7&*
M\TP4J+I!D-7EFR;%D>RF43V;PB-E7K>B_\;.PXO,'F>'MPH?.7B06:?->=TO
M[B?@=6A64A@$?_TRE=SAPZ,!550_L:4.X^ TSZS^Y&C^40^&\V,GRZK2R3')
M%B&6!^;%.";.Y3>8S9//M_ &$"UKGXN(A2ZR 5- 1Z,.8[0<-O6@AO"9#9K[
M*R+&\L69R5VQ* TR+KRA87[U(F.R8\^;[Q;/V04\CNS#F,-@#/#)KX+QNY 3
MI/)9I>55;P0%^T@NQ@N  ]34_ZM:[U%>O=^V14BJ$!'C_;NE%^[,UZ^9$TYL
M'EPGK/TI.FS)^+WCGTKXC>3\:9]$[\7K"YV_HL%<+ ]>(53+NM*/[!.=/R;7
MR+^GNQC YI]FW:G_!ZO.'%'^KV#2XNQIQ<--.&65F?S0RL,RC.LPWF@# S1I
MFAEH3>PIEJ0[AMU%"_W%LQ&PY2N;IB0TGR;_M0G&_STWOH$;FS(6\&>SK< 9
M5AAG&0Z%=ZK#3HN6VH^F-V_VF8[ :SP28:>*BTFN'_/^3AV@_V?H_I?3$2\E
MF?3]Y5D7X=_A1_L_$^*+@MS$7/]V_M1_A,3^6O#ZWR]R%$E>:JE5?RB+_><0
M]=]) 1+W-P0/]?]>#?WWDJSF7R8[_:\GN52@ZK_8AA-FK?K/.3BFX_8[UL2?
MO0+QOWD%<E!_\@K@ \LLZ/^'>@6.<BH[__LR+7^7]!!Z?TYU_%>_^(>H>"Y)
MF^6&*ZA-D\> /YE9BZT=6?]U3(FKE$>A15_E26 ?C;>F-F6$I=F=)=''/VJM
MFJB 2X%^3]N""8(V&\PI7"B3H!C;XZNVP_/*";F[*<>YE'#TRC%Q9ZV8N _]
M-54<O'->A"M7\,7,-]Y<$8%*O&#)ENMY ^,*<8G-#P3J?BSW51FXK(!\AJ>]
M%Y^/&O1MV([$>#@F>NCBF*]C8!N1V ?0+FMDQ@T V\!4R'ZP!(SFXB*\^9=-
M']S! J+MV^7+9<.Q*B1?E*!:"!IZ?I5$J3*B=+8VU\:C?,77JL7@;H5JCITG
MT2$P!-CIEH5;;73?M'CTS=I<AK73(M_ZG5 <)X"-2T3<#28)*4&C_<OO=7PO
M!N>V;Q<0S'G\+CCX>UA-EK_TA9TNH[=]L2]QTS?.?,5K4B'U+<,CU6)P+.GV
MC3Z=E[I[)/:-\IX@W^\C7 0CB9HXD"IR)^9)=W ";3=8V6GC]OZ+[S^6$6];
MGYWBRCST?Z3"HV@PQJS7U3#H7.F0I"4*'I$+/TZ[,UOVK"K3@)U_I'=/GK#>
M56HY4O[MEMGF#1LBQ04Z<<7\27&]WU*._+\\GG\8.?__CY+TWQ)SNOJZOW*6
M_ZV+F/^+%?S/H;]:'NI_*OTJ\#= ?B&/;Q5PXV^",O'&P7O[?508R)EM8=/=
MDIS1LE\2IC*<:+$_U#P:2_[T(;>RF7AZ?R@<>7ZW&.R,:3L<LE\S/BANGL0Q
M8B%<^\;A3=H[N3^!$+2\:[G]BMGAMLA.Z:^/"^5.PZPY319GZD\$XNBK3,#)
MOS,]W7\7^O?ET_XL?/+D_@Y+_S//E1]-Z#\5[Z16I0(F _\>U?^MA.O_T\]=
M_=-)+O4?PX( 4HGO6K>NV7G=8]XPMJ(ADL2FI7+-O;3KUQN()L/S_A,1J*CA
M->$W#%B@=X/W1;?L]69$R1/4EQK(P[5EFYX22&.14K&$D&.J ^E.CJYKV!DK
M258/_(4#':[3_#L5(NO#X^5L/JAG#8];DWM"X((]/ZQ*%;)?*H1TK^]E-*3U
M*D&M6[Z>]/N(&%J_<GW5=!G6:[=^&,URQRK5;PO?&7]B5.<>G6RB7HY>G/:-
M[&E"GV /48WQ_".]HD6XU0*>=@K5[T3451)XLL^ >@^GH?>SF[BU<?7&,$8W
M8K@?51W)>,<N_#8O+1FO: X0KWW[7A:B/_O5-WMX!A'V](87O84!;\V<>OQ$
M,85!H,77SNMEV$1+-Z&V)3S!5J[<"Z5F$#UI=Q=];OGTN?63V</SFST_ =12
MR$@>TCSF2Y$@T4MV++SP,\\"QWB0EC,7$VI(<OL, UARM''^-<GQ<A%;9;D]
M-%\DTQL6'V_40@<"_000GRN(Z8&*R/EY$F_PN]6RG0 96X9/6(#H65K_0I?P
M\,K&,2VX_3;!PUU )U>R:L-FI?M'NN]G(5\8[W>',OSK<^R<LS]NWNX,O#A\
M9\K6M;OJ%+[B1'/&C;>C:!6-5?[1^S2D)ON7(8XF4>\P7Y?[XW5^ DUV=>L'
M"8+D$5!VJDST>#7(-F\G-7!"==^\2:N.^12,QP8+K+_5BEA+1&SQT7^4B:(<
M$2NQIJH3X5EV4 ]-R$6KQACF=*EWNXVHYNI8G:KG_$,0SK\XRDG]G5" D?5W
MYG0Q^>L"].\3=0KZU#^U')[>?P-=^>])D)MA8,@TJ_(DC&WNA64]-G]O5&S_
M]5/_ADVF5=3]QI''-C]^ G@@)&;G1_@D:_-8Q\&4W<5)@9L'/P%2:M#]YF88
M;_-!8\XD:[BGR&YT,/,/(8.C2XG?=#+V?SVXN_,U/,CXZ!:V&;7U9(5=\M)7
MFQ+P7.NC(?P$CA[B^_5/-7\"M"?#PY*^W:_<70"/:+UXO/^Z*-9*EWF2;?IS
MBWOSVE$B]N5X068L6A4)>2(2\JQ(H"Y4_$M[6;=?4B8>T/\S2M4$A"7_ZJ3^
M<_8C: I\ZUL_IG!A%Q(OV2A@"D43,<!\!?$G(-D^L3?,]XTL:<8.4/$DSP_.
M'BANI!$9G&U53JOM_.JX(+G/VQ50SE@R]'JXKWO@"AX(_^W+O,,3O^[9M%]1
M.-P^OY.QUT>3_Q-XK7WX<5G[AU#XRB%QKGG4\V!)K>KC_A!HT7X]^2=0L]=/
M'C>^_7!\< 7YB8&?@)L:&?X-&-T[:H1;\V_WC&3RZ!ZXJ579D]"J&F,M7)E'
M&5+]1^7SYMWG&N7?PGU%YYK47M=0O7/LHRG1\#T.%;Z$]/4@0O_<[:L&RA6(
M:PV7QN%4&+'[ LUZH>3O=73(@,>4 2/V(J2/LNJJ7<C@\!LXN(11DA5(K3KB
MK[8D2?['!H"N)C__GTK%2.?3DY*N%**%<M&^VGJ :'&VOR&1MCDND!7D@2DX
M*#A=7%2PY=F' 8B:4&[%Z:Q_X]2H3XY#SO[4:.'<1\^H%_]FO<+_5*(L^*,7
MZW\2'0LQ-\S;943]=I3?C.?EYL2?8E@#"=O(J?-J),YMT2\R[O^&(%&]?ZJ&
M6V!_G6<V<9PM;_1Y^:_=JSG](QV3_T=,SW\K*ALOW"IC)7&P@CJ0B."'*A9<
M90LQ#CS$I6=C-"M6G-E8SE/?7<'S>!<#Z7=!I:/.F8Z/& ()NRV<NC+5ITH7
ML+K[&K.W^F3SU]LP,'.([<62Z\^Z-D:KME15-&\6N=L-K42./GV+I+P].UWF
M4V/P-J3Y4UV4@E@.@K3AG-IF<>;6B'31Z6>U/%J,0"A?_J2V9,KM-_QF'><<
M-#NNVUGG?HLJ5]<_)))EQC1XLX_&[&(-JPM7]&7L@)X7NT7RTD7!<$7T? 7>
MU15;]:"]S@'&^\";O5XC9*XV_/AB U@>TC2@G@X8%3@%I?=*J?$4@UO6SG67
MM[AP#Q]<0$Q2I)?;LVIM7)D)(5%GA"Q[@43P8%5-P?WK/)NVIQ[D?J9QOQYD
M&9KG'%QA-EC.=LT40^F-F"W&?+A[P>)QU^G]2QL5UAO(F]'K%RP2QI5L+VW@
M7$J#[(3E\Q:MPF2^"]PT:Z:; -W$90];MQ8[WZ^$)2H]O>BT3@9[B:_W_$Q@
MM.""H.VJ\XRK.JJHH=M*Y<?. -E#H&$DPE'?<9ZB4;_5^!@A@Y>X''*WOL+U
M';M?A< &%[2[7S#;E5/N!P<DN%36MJ?ZPV#B/O%MD'Q'"T:',&(;%:_X$VB
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M5"M4]P89QFA@6I1?/X@?%D >>=:'4IT8';LNAN@2S<9VRU26Z-9(:'G)$,P
M#^1L#_PE9YWD:$OC48L<=,N+;WH49R",>Y: R=RZ[0T*%ZYHN\BKNMJ4<.HT
M-BU;=0>.]M(3J.(B\L1[]%N*X2'A;)8&5D8;<.JX-YCB-]BXCY"$JH]5S A
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M(289H$7KXY?E3;%GKC 8/676HT)OX7-$3;YKH*6[T6,#S\ZO:(!; QB/CZ+
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M7(#=6>41+:BJ7KYZR(]5G]T@5:VT"Y?YU,UMW>_&J>+/K/;ST(J+&3#?:"W
M4E\UQUU86>5?L7G(1!%U_GI %UIDXJX2MTL3<&*J.[Q$:GUN\TQ#J+ZOW75Y
M4O(+.^\!2&*HY@AK^,W*)X+M]R_CE"^E=:]U\+5E?[A_W1TLT-:.]18FG2@A
M'=KK%10K<@/K>;3*OR2A3U)"&?!_[[)/ZB3T'/6 >@GY,0V](9)\:=O0Q*V/
M*7Q04X1BTE$\LN4!]W7E4E_<C:!NX_L.7LFJ==*0-@T-1,/ZG=B>?.WV8O0=
MAV,DS]L7=Z$% 7_30S&ICP@!\+M[+W/E("H>.?B0FWL\5DX$I7#V1ZLF(;3]
M,G<Z#Y1N\-LX1!3J=#:*9;F/K]21TY\XK>TO&+L&WN>^^<H>LJ7Y1+^F DP\
MWT7Q$>MS[!T;K3B\OPF9:M43-,+GQDH&O50Q!+:YD3S,DTH 6XEI;Z%A)T2\
M:-CZ_I<P\<07W9L#J5'DUD2!>AV;HQ>*ST<I/Z+9\L\.T \4D4,?W1K,4\B;
ML)%FN0AT_S@_=DW3W?I#%L1N4-"1L-/R_F8+6EVZ^([B)_9-59& PR,WEZL9
M-L16X8:/'DU%D T-A#OZ(5S"K!CYEV^FO"2V(TM;] L:J1Z7ZW(X6HW>M:"Y
M4E:BMBOI1>!1]2(IHX=_\R1:2 N5<Z"Y;*9O>?8_A5^84DW=12DT]$(Q7.RR
M%/:P"X1$@\1C:@0758^VDK+.*#=(&?8-V[B^]_Y@ZK:*$ A>IH,?#_@O E[B
MQ#/$8*K<?,H9MX46+2(+67FDFU)X0O1RS9097XHO)>=PP%UQ-\CN-X.1%L:F
MAP)$(GB RB-T&Y"L(46&-D[\Y((#P1GYGT_A#>%=X.M2T=$!='+ L8,SI[:_
MB(+FY 18#.B"37-\3YW7X%,%)-(BW;QF*WY\M^_C5=!$\U/N?@V@W]Y^>\T>
MM2'"#\ C N0P]?2Y^\?(GA_B%6/N@?W[F7W[K'DMH;EW#D:2;V1Y&!ZOY\3K
MW>Y^M!GSO(5CKD<I9B;O4M)K_(>\Q,97%N;SY1&WI%FAV[R%"=6'G&N&[GZV
M76='I"E/RH%5-_C ABBHG&6Y):VAR4'JQ_W]U5:?P@G'S#"];I UIM6N29A3
M9/S6G0ILV*<JWKY:/L%4^S3WC%7.<-8#0YT[VVYXX9/E93Q:R=L.7GR.V+CM
M!QTUC9D4?H-VPK7 X"F+?E%1304;ON2\1!>@1';JP_5@Q<F4E1)"SQNZSZ"2
M6\T7.G;/X&\>;!J_]3%WMTKLOI"2%DYS=Y\CQ/&N.T.41L-(<JIRY982@&9C
MEWYE\ZLIF'A8ACV^-J(42?'T4ANU.YHQ%ND=D631<6OSD\!^V.H/E[-[2\JR
M8IJH+VW9R:UW-?T23D1=LX-UNT'2WDQ;11Z'I@;JK)>-BO-ZE350[,9ZN41X
MU$+RHIS']:7VC=TJA;<KS<!3/.XL6+:13H!_QCMJ6[(NH"0M,/;MU[?_-P7F
M6OT_+_R=TQ(8 7#_K3,\OU4H4K:O0-G1/SUP96+BV>\CX<1% *E5C#:;J\M"
MHO$2R,GH6LX3J=/(,4[]P>FE!>'FNX T+%3^I^Y!1D87$*P/Q+TN/JG,^$(9
M#$">;EX$HO/K*@_S^R,'7OW\FY;[)J07.7_?(@=/7Q%^=QBL3R(R__+2"A.3
M5AA].(0U\K.=8XS-G'OG=55"88ORWEGSI[XP 4_\[%8%>'_7Q[ ,SVTZNI*U
M(ABU2A1OT5'!5NNM#36I7K%B YD0B #@(**"14JSJ&#EP7+B.B;9%T_PAA?T
M7F$_L=G9[ =KZ&P*O_:UI_N.L=S6=9<LW4!U^X14&)$VW"XP+<!R/7-TSN<
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M>\&_=D&^/3B2$ G-A+RAZI9)I(7"^&=U205S_4NG<F38[/(LC*6;']_^B)/
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M@<@ -6^OG<\$,!VBT[8\!:8^5<6.JUF@TLQRZ-4=?(6,*V6W_IQ/?V_@*=P
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MJ#W$]H%=G45919BBH?!MWM9@1@'S3*/=M+'G7/*L($=&&?[T91</^9'MN>H
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MQA2HD\>N?N**ZW4)"VS>Q1_6 /^N(8WNUC,43E#U6J6_S]M*"/^<SK%[1U(
M,Q/U*$>Q0']Z'&S$.P5=;/TVB<[U_6_9LFR!^*M^A^?+%Y3AF- J81VHSC=:
MG?I.=!1GM(A6F,_OJ(%>/;2!X<U3*Z/$NH::80[AR_P$+:%[4QL;VM1['[;$
M3(AO *^$ *T[F2ZB\/R_X0#]'GS^T>GO.:KS>KQPM^/)JMX:\O_(W%!W=Y'K
M(=WIAG,=LE>&T"UR^M$@02E[>)QXK-.Z5P$?W,]?(P@7GLDY927X+CLT3DF7
MJ#)&*!YPO-5G&="*6).O.MRA.UB9U'B,@:3>R0=G=DM)>*],BC Y/:NOVZM
M[J]L!*EF$P^99Y/50WJ\*N8-KF'2X-X; (\;=<N68N-PT;%,G%7'ZS:U23Q
MTQ5KQN\9G(6G)7]]6X=HJWQE$-Q33MP:=X(@[\N*.(M(F)1]L:6K@=GAKFNB
M"SX9"S?F]Y1C^._*8OA2EJ3!?R7/,7[RW6BV_=I,QZI,6'43I3=0^_?M%(JL
M(6(8)W[4$/BR?^0G0IP_%^ J&R[%1ME3VNW-*4Q?".NQB#1B^-WY7-A#G#1X
M[/=1OZI7<D_UY%G',3)MK0@T8V# D29WA_K+W!$A$@DG JC?FGM0FJP'[/3Y
MTK97>8W6>'#G!O".>J_TBOT&(,YYY8?,0(KCPPB-4Y21 =W<*S:?.S[]<C>
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MS+ZP__B5?MBI/#NMU] 3:KGU&\#![=(;0+';#>"( $PN=O7FE<_6K-@U&L1
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MTN1,$QN$YN)[SH0SQ_>[[\Q\=\V<L^X?SZI>5-6F]JY=>^]?1>N+?"GHLLN
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M,C1Y=\Q.".MS<-):J8^MH8+1N(MK1!7VAM7!@ K'HG+I;8-?TLA)B=]SOBW
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MW8DP%0MJ$8N788\\%M%4; DZ(L\1LF=(LR_<TT,3[G]=;_/:D017;M;(<"G
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MU6=;RRA@\5)V&E4]#=1^6Y843";A=^E!%#6!?I+8NK?8,<2(2=S[2O8LT"F
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M*6L>I^@BG&X^4M#*.*1U^52HZ>?\D>0?FDML&_>FS )RDMJ5:+SR[,6?[#J
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M/V%D?NX4 VY-TDIX)GY4S]Q3YBWEX5-J--V-N'LTXT6[TF8:7A[?=:M:1-$
MVCF=<B%6U^AT!7A(DD_<R_'*G"H":J#ZK:T+5+I5G4Y5KM\['M<^\. .G/%)
MI:D#B^JW%I>QYX-9I&7T2,L/L"F47L_J%4 GYH0Y&7\Y5 (-"_[VI4R[_ H
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MWZ_)1^5"L@.[:-V[#DU6_IG)0XP N!EZ 162OS[J9&7U:)I!J<_S\%S;&1,
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MFN Z#UJ913QY3@$ #L*A4(3Q$9\_&<2M<?X_M [MV"X]@^KVY@F%?U!'$*A
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ML0[16/4V<.4R2:L-QT]&M/P^4XSX1T))MSA)K0OW[:X]#7R:FKO&Z?YHC&G
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M[EJT(%TPG]FGEQ,X!)[C"IYT1&)X5R*:&V]&G1^/TZU;X?M?CGCPE&J[&?P
M%T8OS,[0<7:TO9U83W#)WB4OBM%#8Z\2["I<K>%8Z1@HE:]">RH4]['2E?9Y
M!?]EI'WN.YW%*N6BIYI>1,CCS7=3PH?EXY5&KQNI@*=:]_6^ZY3M*,YY;S)O
MEWCRO>;6ZP-\[B&C"G/-6CS[F),3Y%J7MWFF9D7T6B<7UE>J\9 L>&$!"R#D
M6G2W*$K1N90KA.7^N-["_/EI X*E!%X'O9:JFT<PKL[*]1LGPQ6P%HR,7/S3
M9DX:9$'HY[\P(@>ZY\_-@J<H@XH*,CGUI7.]@H7Q*[0RCGD'%!;)9"MN#/J*
M+-#S]-T/2SJ4#UJN'.1D&_T_M\/&!AN :6S]I:+'NJ'.-1 -,@W?'ZB<T%)G
M^M'*O3M6<5=;1\^+UU#*E$52'U3Q)5TL%[I6UXGPU_G'N!W6-26TIVMT4+)4
MQ[4U[-,]? *:;,^;UP-7OS +[Z>I1Z901"=!%EG*; _BG&+;[7$K&U ZTMM)
MGAB2H]FMI[(X+#!>8E/?Y"]M=X5%.121W3-W2*9'WSTF')IWT[!E+RAFXQ7.
M)ZNW=K!9EZR(I3VF^JQ^WXU2\:-D#;2OO3> ;6 JVMQN3IH#]/7&LAPSG<-P
MZ,2:_*&VO\(;ZWBB<@M,3@I[A_%'WJWRUH[.&<T?=MMGAEOI(X=EZ+ZQ?3I#
MW1QT*;3THL24=17+S %9/>3G6YONCT'N^7RJ?)=[3U7[7(/-4"[<^]G2[O%H
M& V7WT58!U\"3DO@D]H^S"#GZT>P)[#I6 L,6]2DH15WHYM>YW[AT:''^4L<
MA K@NX4.V1,WOF1!H4@UW%@+^-!BGQ9LNU7>T)$]J6"H^T?%KLEQ8<?/NP.O
MQOJ*@E"SJAWRGN]06*KBL@3EY0\3,);4<5\3YLQ9&5!R>',D.J"V5:WI&]5(
MOE5J=.*-3[,<W'!Y/2W!&LX:T;#2Q(7Y**S3"IJO9R7_\[__T;AJ"8]ZLY^"
M>S<0)E[TDY]O2#5*+MI4!B)8@[98.NF2P'3994CN4D,3QSFL%A%> [?;D_%A
M7N%",A5_V% IJ[3 3FN-N.Y>(K]J(,2EMC<C777GA"R6/GI-.E[,V.X+Q2@A
M6)ZMJ3ZCM7#"J"#P:H5<_6R@IF#J6HOKVVB+R4O%HINKBV2+C_FD%2-I!"J:
M!:Q)EYLFAO6C(2E%0NJKFE8)A-.\D9%J$1.E/$35,-SFC]K4KVB?M:B-<LYX
M8[N9/<A_7QK(R "F)2$/0M04_&O-.#^HFYU<J+?_".PF]( V9/$,^6*<TN9A
M#''QY*$^VPMV4IYLEHJ0D([1(-U@6>U30UR?KMILGW'40N:^_;/KP#C7&WM=
M:%YR6XLP51J$6>J?_1S.[5N#P?O,K-5SM/6Q$LU"@9VT3RZB !?2T)BVAW4^
M_@MC'#SO,+:YB:-?HOFQVA=I91HT[\<IY77G@>NBQF)<G]PQK_ZFXS 814MR
MEEFU;QZ+$^MM86]>[PFS+7K\JIMZQW&:O%3%PIK0Z67?3?YBD#PP&F2RK.(+
M6[0IHJE!1OIBWQW\UD-33K9X=D-HK/RFV1%?6U^.;1%()B,YU.C-DENV']?J
M#7;VR0-MB9O  2':/YX0<6]_7;F*2Z+$FI9(W2)5KOG2[G4H7-NQRC%.H./7
M;Z$_RNM.]J(^&B0W+Q?7_=*=IPUKFVEEC]QE)'DZSN\T9O%&:$!+EF$DRVUU
MA#8$*^]M^!,/,8'"W&OZJVF=XQO=PXXUS)>58)HIKS:#6!13L>/D?3]P3[K>
M!)"W376ZUY:F7O-F(_+$3M&;$;'PB&#6-X_7-0=MG=&+=\VAF;7^LOMFGS_[
MHI,#@2\+9C:SY2;:4SZVFJ]_[\3:_DRZD;(?264H[^[MZ.[ICE3MF6M/0DN;
M]NYK+MLUBP7J:$8?:WB@M\@F3,\4EZ1#]FPI\$F=P*Q)CV9$JZY8H6M!G^-I
M?(_[XVHCD=+HKLE.XANKO4_.\A_'>3&=QBKO&ZFL3(.5B0[[N:_&.L2QQM+=
M,!X&3TV>!)Z65D2]K*JB=^F0Z"+ID+D<C?6BR%9IJJD:+;:A:K8YTSRP:?M(
M+$!G9N:ANFKL]#J\VWT)4PEE7G]^@+!MN,'6Y.LWY3?&G6J?-78EVX02(^..
M^8Y"!+:4)Z?K<VBHEE$;MZUA]^.=AIQVA;"?;1$-9W'KZ;//;LFN4#SQ& UH
MH#9VILB*X5)@./V0SYWPUM3Y$5?8?..C O;/:T+)_@V2F7KR^?I6?'7!YXFV
M]CJ/V%V9R!OS[[ DW^?W73O@MCZCL&GH6YW>I="CB@!C;UF7EN[7?<MI]_')
M!5EI/:&6=Q0#?*) !R!%!*]]V,_,<U,TQ,4,"&KP"X@)6G;<NW3.-G_(3Q71
M5PUY]@2$;+K%=-R5CB?YZ&DXWC-?[]P3,[\_C[80%X7. 0M,*E#\\H3R$E_S
MP<V07O.#YA7+6PJH@L@5O,8<LX0;BTW(T47KI>?XL.=7XOFW6:9.:%T$'0Z@
M\4X>O3T- Y&[1_D$<*@546*(F"ZY7H=P(GAEAD]?'B7Z7X<.QFI>B@CRMR9^
M>1QR42FYR'%!>MQ\N<,RF'F-MN&H=/ZQZJP8^V#].E)4&C:)L'"GL:?1S2Y$
M?"5U2_P4D;6>$G;ZG?=M7=,E$2#4%"/V@T7;!D$'9+#GHO(_.Y@TK/_/OZLY
M+UYJZP_Y.D!: 0>HLHR*8"-@(S:-XQ:PJ%67Y"V@1_:[YA7=7U_=5+7YH),,
MG_<'EWH9LNZ[B6M&3X1Q3?-!&ZVMXFGH2AM>,YK9:T0>4YT6W77Z J,H*U%"
MFY@&$ICW[:J7?&V]TQ!Q.48XVNL@G>+FT\J?;%[: $:;,A7^_G^P]]9A4?WM
MWN@H"@("HH2TBM(ATCD8M(!T@XI2(R6=HR#=+8UT#4,-0R/=(-T@W3%TSKP#
MJ+_?\^SGG'WM?:Y]SGO>Z_ECS=SK&Y]OKCO6NM>]DFU4Z*M-V@Z)GF.,:*R6
M1Y1\G5OHO'OKRLHW[Q;B;W;3PB*F/$V]_:WO1ATFC+FP%KR1PE93W#RVU)YX
M$\BLI';(LGR6K"UMG^P\I*%T1__>3S<)W>(6/:T^TOJ8N./Q _#H[6;BQDK?
M:Z_YD+<$"%>U"@Z?89AG^E6LQE9T/J.ATRKC*%/J$?V) [></G'R$V8:20]G
MBWWX45S\R3P669J!8,K7L!.MAAC7FDR)G$Y#JJ).\^O%)D*%F?Q3":E]UK%^
MD4'UY,YJMY_C-87<-_W:<M_^WHGJQ(%[<EG,P=IH_'P$#,%J8WZ%0L>[EI:6
M5ABA"A'B !E;IG44M37+E8",:INH))ODJTCL<%-\?U"OOMS:]+JIUE>HLQ)
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MW.:IS"C\XG%?N740%,N8+=]:WB'\K"UVO/)*O=9.Y.L^CZ9J[$.+HU!&?4Z
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MH_,.I@25=RKW0TMS[8$*+44%\R9=AAK$AT&?)T>J^RM VPQ/US5PVKO:6P&
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MSOG%\Q=5&&R5DH9  4[=<M%J_1QXB2X? NZ']F9U<#-_]W%PX%J"E#*7B(K
M'(F&/ZGN)L^6Q4VT,H:RB8D$^_L.=TQLV3>@ %L">PR7KVG6U#TGI=EBVKMQ
M>6J" C2&3,E?A(5HR;^(0U?Y*DU(UB5A@V")^4'Y%+7Z71@#5-DYC&T0N$Z
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MG!>UW*YN4(Y@#V,_W3%O"VN)0CK YR6$G/PB]A^D<K.'_$J.13KPSLM?-/:
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M=K4[4>AAC0Y\B+6W:V._QQ*OPG5]FNPZ'.R48(+GV+%,GO>90KT>-'W"G-G
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M3/5'XB?HUKGSP@?NL/5UQ>.^ L)W](G\PDB+DC:HDF]$"N?1AUW:YGFE==/
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M22YV>+M<[$D=Y% Y&ELH\56?G\Q[O%:J .[*I1*OU[0U6[M<%HVQL(+P^GW
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MYIFA/"D*/L</BPIFXT B#72\U:(E+_WTBI???7EU:)^R_"Y M^0UMK6KF>'
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ME*=[MX#>'Q\H*9- GH7WIPM4U!YRB&[8+$P 5Q\4 F'UMP"F0?GVBE[7O%N
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M2$0;<H.'>=_MOJ_5O=)M0= \B%K.O5OWX</QF0YU@A3(R?.9S.S4!U0%:@"
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M=K1><%68+L2:!P:+:V;(#A/_CWS%>>5PB=+EB)BH6/I]4 Q89!$,]200A&)
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M,,ZM,V_2H2(6:MM"K-;L9FQQG5/Z:7_!.N8$)%K8'C@A<EB")"L4E8IV)WY
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M+Z UQR^V C!%0K?4LJ$6:0];XM*;..J< /]B%&A4_$P3CDU2$8FR2T*4!!/
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M7UZI:O]_L?>647%M7;]G$1(@: CN!$^PX&Y)L""%2V$A0' +[BY! P1(<)=
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M'IJ_7MP#.#%K"YI7_\U]#\![W<MPBI*Y_6TG%6&V_<Y31Y_F[TZ9=1MOB[M
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MM'H9D%R"=G[,-'W5K"1$EIYIZMJMB0?!<S;D4=B[M 2PF]^3IY+7BC2D52-
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M9T/ >B.*/NUBE-25D1 61S3F7S<G75 P>21(*<FZ47[V(15\T9YL<YGTY5K
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MB^MJHGXPD'&[PUE5Q3^ ;4Z4;4JW$M[(^"@ZQ$ [D ,MQ>C(4T-D [S@MHO
MR\H7O%V7N*G5'J8G2(2WSX<.=29&QYS09&MNG#R+@2M%KDAN14RPY.P$<Z(]
M$E)1F&:3DQM0@\T91O4AX\]K?D\%3,"N.70*L_Y>D(-]@0_1&0%M]X @<]:A
MBV57D^S_H>F*_\;T25!T_I8P81ED5);R;E#1NS+'CLY+AW-(YY!Q+)ZKMP[<
M1V67#-%%NXD:!P -->PO4M 9!W+RZ8>>L .77SH.+P8QL:6"<&>K7K8UPB"!
MO/L5!69+"R."\ZKQDM+OS-ORZ,HP6Z49Z^DYZ!F6>)<(JA:;'&F$G9;FI-P.
M02U5W-/,LY6!W$H>XZ_POJ7+6Y.\)N^7)UKV@@"U<G0G%:/K3ZO47)I>C%8N
MJS/%R%H.D',/;O^U#/:JCGV.V_'FM6V!^.A%19FIY3NLR8HY=BD?"/>O>\"Z
M *JSR;Q\9;G?NJ0'IRGT<9RAM<G Z["?XK[Z0E5F=HO2Q07*^2M!SBL]I28*
M/,TL'.9IS#)\FK\GL1LU394K3!L2@]TISXR6EGHJX7G-+8;!&6K+M9'LN,J4
M@W8IBB;:2G-5W._J.JJA.]/%GHT='88FEAHNB%/RGCT;S-F]JJ>QP)9IR4=Y
MWC5"CJ_4#$N#)3IZ22VME^J<5=]#O&MA9]ZQH!E>$LW.VD3G)+=B4_\K3XKL
M*4O+RYU@J<B8$[B?1CTLMQ<V!;>GKE5[;WU-EGB4X=I]:AG0ZRS584_8:SQ;
MOXJ-CASAK,@T8]>)@9((%BAS6WR.[_5J0LC2CY:9R9<@YD2FL?B,!J#-<BG!
M_*[*):N]WVT]6\,QPD7XN,IHWZU'*@0<!,^VBUBM-_/VE[2Y%!RH9BF;N_%]
M67YI=A[&SIB KNR*\DH'=5:5&AV4V O73)NGJ-421&\GVF!I*:XX.\U@P.TZ
M7S9-"]%DDDY[X"' &\HL1J+AX<ZBF%0,9L66BS?J]>VM&8NKO9V,R0:TBOS@
MKVQL4ID[FS P^IG\5L9*J\_=9*<YU3V@Q/4F]BKR>^?C>T#2X, ]X.))XCU
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M^ TW79P9]ZR<,W!6;X6X\1: T!R(&MP"]34]$, \ZSWS%GBRF2"'OSL*\]E
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M[O3HK[9K_Y;(8<9X5ZRM$^[]:;WK#RQ</MM7V.1EX2+2H-;@W0)<3#?G>;=
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M,GK\@XJ=T^QMP?QW5\A,!=89#:GR$[B3>)?T^W;$AQ <N(Q#K]P&9DLK'+4
MDC@&9/WLLX,3O8DEYBOPSO+#;PB:DG58/;@4ETD'G2]/>R:#Q-\[TE@K3%[
M)94C@><G+K'Z2V@6"4S=STIM[84_SQG)$2O,^FB8^#^\!;#H.W)NC)?@.[!(
M8LG\S/,F\.Z\9#W&5YX8A)[.TP#]M/CIT%)K2/,9;OXM\/<A11U0B? XI;-
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MNX1.@.TZ8]S F][.9/$:CY6]1'[=4$!2%L6GXDO;V>5K?W _J66+YN+Z7=_
M,%KU2<5[<?K WGZNR^[6N!UC03]9N*=P%V( +D]2U1+0&6ALG?*R< Q9;]:8
MF#\1],#(E08T-J]ZTP=Q48MU:W^T5M>9^^<5ZO">R$/F,@0HGD=G9%=7K+TQ
MPV_EWM8MZ< M,VP^S]%@3?PX)YBDH:M^0!4N%F,S%.A2&Q69>7-1^E%8NRCN
M O,6:%&65WFOFR[((__0RM*L;T"V Y(>9LNTJ%7G*I/]2:3B;QT_]^ !@>8M
M0(]P%Q&\_D\WGJ(0OLW[>ZDA.QD",.=V<0 /.?YY4Q  AN]82J\_:EF^-7XM
MRYIQ1'_4LH)&0]11\^8DB>D3R;H8=VT9'%14;9'44)H\9QC]BZA:7]@RZWJZ
M;LH;IWH.8WE41 ;GO@]YT"6-%<RH2BBR6B6/P@0)A86H6$$_6 U:(XVW8O^N
M'T_Z@"*O2(3&N=KFB';"\P"_5=C36Z#+^6Y+4K)5G.5^APW<%:X<MH T4:T3
MN6M.B3*MN2XE1UJ%B3@I2?QG@7ZW@%YJ5Z4WR62QR)JL6)6&7BNGVN4P2E3M
MP'CFGA;;:2@)3EJX^%&G72,$R)!.8&7,>[MC9Y7W5!\"@,F/54/"!1S/IMYP
M;X$G G HY]J6):FGIEN=SF+@JW87L%Y(U/C-P:@JH39RE[)!0J+0%'Y2OJ;*
MT2#VF?4!T@*#]X/=48S:EE8WFUT@&RPA/@1:!QG]>L>Y,JLPH1)>\1>:DNC*
MJO26(W(MFG.:\G#;BK4GB9?8)4VO>:JE00[LM1+2G!7BCH.&M0\7VEW_*%"\
M^<N+$/^.J),.AF)F;EC[;X&++?"6P\3!7DRI(TT7Z%ORZ*=W*NA&S$AI."IH
M\QE\VWOG1RDWYP4XXI<W_HQWV7U$T;$JC5__6MZES&73_0)71XTOUX+H<4.Z
M1-Q%+H5/;^Z2FJTV 5]\;P'QJL %OB 31Q^-HS83N$7+U W<2S7^>3EV"W F
MPF]]CF[U&7^VC%H@[+\'UFW;2P7;G"X<;@I<'TI29^XKI3_YW7]U>;?+:NM#
MU%IYGVQ@1CN05MC#;>':$"2<6OA7GB9ZP.,6("S=S8,-]/<XTA?)K,H1P2-0
MJX7 H=R%TP'@D0!AUGB(2@N<!86V7RPLG!^EW9QGH?=;32<9E*"BY<GS_;Z6
M<RE^^ALN KER#U,+YN5S<L\3_[VK"Z5;P&_T^N6?MV,>6+(K\[4H7&?>@;U#
M%*[:^GL.H'PO]3CNY;J 2P#_:KC*K\MP],>.(1YC7SP?)).HM'FIH55/#03B
MIU$SIETO&RM.#;3AL^_FPOC*J)JC!:B?P"0IG_L83M".5;2MCSI>KJ7\*5YK
MA&P[QI')M-9<<O?3WWS!X1K= G_@Y?47[6] O-"(^1L4FP63OX$'HL59!C@E
M"_S_AL/FWI_L(^ EYUC-::;_^5A,@?%O$7IF8JA>:>$<$QWQ^YWO9XQN4?E'
M?Y0/H4\F.J+ZRPL9_XZ(TCDC"U0?)"AI68HF@&43Z2>#>"66J.'R6A]A"?Q]
MPJ;D=)SC=)R%O7 F=]1V?J0HL43SCS<($=)N ?2;%+B<(N6NZ*>-KRZ85O7T
MP\LHPLL N"ZT2^3!99^M_N>@_WY/([!=[.XD52=#KHR,NAI!8TJY^M.+R7UV
MBT9HN08B#@=@-6L]2:))9E4G]_J8\1W\72=)O]ZE2UUM[C.,ZOC'Q ]I]N-L
M @\WDO+J?4;J_[A^\?OZYG^Y_@>C_]L<W[%U!_3DUQ4=#K<9)?HT+QW>'9U/
M8M9H8AL(MJ\N^$._99A/]N[ZIK8IQ&]+DF7NQVX:'VZ\"6P7R0O\ ]VO*>[@
M!L)APZ?ZA3M;)WEI6]8:2> &[YKKQA\_[K>D1P?(?HF]&OZ/ZM<_KS+XC**B
MM0!6OZ5V)[X_WW_'IN*,?&6U_[Y^L4!AR7A0R'SR7_^S\']#2*.M_C#C6%$%
M,ZA($]A0L@=?_DGY2)<_,G@-EQSWK/@N3Y2%.@"CZ>J5G5..@#M_&DR=<215
ME%MV:)?9'R.075CN :2$".-Z?I(PN\/L0%ON?H13&>-)/POHG+C4+4#P&#@Z
M1]'9#PQ+O7!VYM0FB8?,P@9C\,9TUG@/:1D@[)_7Z,_"H9ND",4"3#1N.K4Y
MT"%2W>==0A,4ZQ*S1%^M:S?YVZMS(R8:Z)IBP#*00YE+[>K!KSF[E8LZD+2:
M;E?N*UF8J_C"CNQV7".;;2#96?G,L]C5&L:'L=S5(#1DJQU+4=<,<&X#'5B=
M@M=>_?-I22C)0V=#CKZ>SCV" OU)QS/TPMRS#]#$]#H["02#_OP?SWW'#)S8
M6!C?4H_MYW3Y#$5P.8QI-/ 4 UIXHRW61Q6X?Z;L97R#-S70PL\.NR]VHY99
M=NP=ONJS%F'%)D4L$/%_#/+/JSK*O]*@^9UHZMIY=E"-,-$'D^NT/^5Z'D"$
M[Z<(TRHG<D?MNP7,0;RL62J$.@7A?.MMK>'HBB%]78#-G)\4+*8$Q5\JF)Y^
ME4C_AM@X*A*PY8";5<@8+"/EQ!,B(U5-BQP\WV#/TZTTLQ++,*NP#@'F4J D
MT5G:-ERSJ&0TS(5C4$=(G"'<QL;K![",B*9SSDOA?94+6VYQJDV>MVOG-TAP
M'@T20;]Y<)8M.*E0D6:Z0I5=S='*;"LBGPPWSGERI1M@DC".6;E#]!L'MJ&'
MD>2+Y0 T2&2[+7*ZH2]$X_,%YDX Z5F!UI1#NF/YU2K9CA'NR4.T"J*?-"C+
M&"YGIUFXX HL6%VL^QQ]IR-*S9*\%+TUT6Y+R=I>Q&93Y\%*(%X6!EJ7H859
MAQ'5@F(94Y>R7P+^V<V3!FG;N"N^J:JGAI_5T)ZU$5P]&Y08FR';K ;)9Q*[
MLRD];QVAJ*(N&^-?GS:,,IREZZ%>;GJ/N>6GF1-E_W@VXL(=&H7P*8!WMI(T
M.'Q9HP_F<4ZOB],4*GZ\]G@2JIN$>"R>-+5@[2276Q+._I474M^^YEH87^0,
M"[N $L>B6*^(4?#+^'E"<XVY]V9,UW<AR_;V?C,)Q9F/_=FJR+%C\OBB?[2O
MDY5'J#>.1VI7,89 8PM+D>O.CZ$Y36<?2JA-QS^*)WT>0B>1\0@>>'(BYCP\
MQ9Z4'I-<\.E*!%9>4;:MC#.WF?Q(CK3"NB)#'.\)W50$=4[J!?7K]O\+JG'_
MBNY:TWC_;$WSK?E[/CGK7B#A#T%Z(KIQS0Q9UNSRSS^/N.[/ZWYG?P0;,M".
MT3=,.%2ICUT7>>?%G_YA1LZICT)>D[ZP[!K<_F)!.N-PD+.X@7(JJZB+X]GN
MK@LY':\4@S5ORA#1R.,\_M;TAZ59$2?[N&52.<^G^9C-ZBU>QTH2<59847(3
M@\,"S?0*R_6QWLVN'OF2.?*#N$/J/ U +RX0Y,GJ$#W6*D6Y/&KK>(&&V5EG
M0^W)#SQZM=_#]"&#+ 7F+EK%YW'\S5)4*Y'1]VVK0B##XSFF'H,=V#V,18+0
M^NTK.3>JD<U;X&]5.4<QMLX S-]1QJR/#LI=6GF]A^2N%_6#=_D0-/QW8^IG
M5TGL-!3P9 "-#4P\FN%)TYRLOXRW),6:UC$MJ/F,0%E)#)\$:8]+$>B!!<1Q
MG5 FB)287.@P=?B+<WPR],N[QO%ABJ:+V"!X)-'NU5/C(H'--T7\R>"QHL0<
M30S@X)4P#37$-ZWB7A;J\O8,KC[TAZ(MOGC<A[9MM%1,=:']C<%L5?"JY*L?
MCLF^[91&V$R"K.N>[**G<%G=-/MJG7)#SS-0B*V:?]KS9/IQ F-IP\UO]L_Z
M'LQ*#>)X,45\L.8_UY$^I$PUL4H]#@R!AT>JW<T%-3YU7Q+3&B3()7T-_=9A
M]ZTZ/]UU6FT,3AQF=FK&X2O%[9$#JVA4-HDTKT?QO?*';LJ#1(;"'O?3]0LA
MT8O)>)#OIE\7Y'[U+/S>T,T6<^:)O4DA7#FM0%KQ9 (?W:U']@U[='/T<7[V
M=VJYI1;^W>,^CF7#+@5*S".$)>W8255!XM<5B/45.+9].6>QT!<-%*E-WE>F
M*%WY!S,68D'E;V6^IUAZ9Y?87.QT^CI)QP\XZ&\1E/(\Z&=#TN;XV5;#7Y1G
M)6@Y""ZL'34-(XY^OV+&_ZF,U'I0+\H05W \^VF]3@^[;57AYS(:O.=]5L7V
M?>9#9*7M 0[@A)*FAA$5D)SO?I99YYVC2>1WO5]P(WL7B*-^^A\KQY%_*\Q[
MNWA/H9!CKVSW<$4Q+K9)F>/T*F178CLMD/4@[M[V14W2P(J>4=+)NG&KP$X/
M'\)V[%>(82PA=N+SA?WDC7?TE[(+(2&'D(%14=6[!NFHPO./6+X1>/'+@TY.
MX+@SWYPSE].. <X<1\H45.BS9-'C+%S53Y-N.Y([U<UAEKMX!S(<NQ6F!>EU
M(.>G"W.67RH>98C@</5<N!E1G[\P=^5A>C;^.+4VKFBKCB1U^3R/+ ?O$1.I
MX #@TU);8N:-EXQ5F"MSV:6?I^E(:.W<H#-ACW0/G0<;LG;%9)9C8#BOE#<7
M]O*)P(P]+?-1H9_ATAZ6]05X3BFOT_)=+4O?Y<#P,!K8#+Z>\:86WMBKWJ84
M5D1V[Q%5 1#%_FD[;$-8]WW7)^_P;V(E2MV-:9OB%*FK%#:S!.+=09Q]4 Y&
MEN;\<8X.*])Y-ED6LU3^!":0[,HC(=3FV)$KQFGU6%C';'^" ^;[<O!(,Z\]
M46TDHO[<=3Y.&_TRI1IJ:-=U30[K$,\#L^#Z9<;2J30_Y4:P KO%4\YVM^F&
M+5=0-JRVQ-$=T;91X ='KB#^.]Z><F:D3[Z7UKN3(VM2(MBOF!)8)\$QS1.E
MN-'V])?D?;PS) J'O=1OBU/$1=K\C9:5Q_CBW459L7#.LNZ=Q$< "5Y$?5Z^
MW1JV+@92A=-8(F\5KN=_KD,&,GO(\S;3JUMH=G3D%:N78"^%89)4+2W'->,)
M<LB]>V0=H6+B-9;-'4LGQ5'N%5LDQHVJCXC1WCOKH?4(?UM3**V6XG]O)ZV\
M%OQY#P+L;91K&)/K%X0NZ#[%J13@L<J36LHDVKHXG@UPB%O1%78@V!L:@P _
M"[,KKZ1+\^,*^#)]=)9 4WP([NX4LBV/P<YD]4C.T0*TVHVP6P!SQD@*)KY:
M86Z5H&2R[&GB3;1]KCX;X ;@ WV;VA_::NOK$] MY1(DFK-6(-]@K%L:WTF/
M9L/-7BX>$?5<"5=G]'3Y3+1T]:NR9J_.M/$AS,YO3SND/PK;.B#-I7^@N^^L
M7 ?CC'.GC>5X,MNP\:%;V;LNLOM- /-W' ,D\(EGKWBS!KBC_268.^M5[%%_
M][!4%JYFZX1=]3B.IS.EH@^)G3;SE7:V_))LGAW&YN67 :<,(4QVO@]%KI=M
M\U;;S\9)/H<\%7\B6Q?&-?>Z0 0F25U$6<1GNFRRY7/?B_^A2R:NS/?]F)09
M#!Z[]=2M#6#'^-'9T(ULR=[%%GAS=^*0)/H66+']HZ7V47*VX]F9\9L,'\PW
M&CU)B5Z4D,*F1\)/H[[*3R P%$IPV(F"(K-4'!YVJF2R<J\U-&'U$9%%I7]V
MLN'B3VOJ5\?^E$"2YR%\0:>EP5=]/CK+VIO[DC=>TWA.1M2NDMZ^AV%*A*BS
M6))3OIO5U)=!LIR'HL:NI%S_;;UA&C5Y8U4=+P:(JRG$4&R^P+*V 47AB&B]
M=I5CMG_*4Z9$\V6CRT"&$C4;OZ'#M[SPI@;5Y\WZ_6UO$*HGP>.CIFE>!@23
MV3[+)>)6'Z9(#TI^UU 7=B$G8W<EU+:K5[^3:)80<?>S#[< ?<M=YLQERA0F
M?2/GFWE*W( @B?^=5;S"KJ(]Q>#&_2@@^G5>J7.W[ 0E:.!C3UJGRXS'_8F-
M&VI8=.&\>A_6@I@UTHBHVHAX' /RG7:5>/%\L7,K_("-RY3G7=ZV3'8LF(%R
M_0.TG:DXM5\0@\S= >9BOR?@,XQ69(L>UNV\8'JCO>21:1NWPU5?JC\#OB<T
MX$F^%V<*QEBJ1<BGX>0UB TOUKT%+-.4)>/>?7_I:UE3P)"1VV=(T0B*UJ.P
M+EW#/B<=<&J5".J $B62XLM2')8W8OF3=UV=.VA/%7.RQ<)J<ZY+BAE@<7/%
MH:0GQ<70$_3Y2<M[XGK'QG_\O,P(%)?<HK^X> LH)<)*,<5RIP8E\"1^]Z/?
M]::W_?[)1O"V J>^[<483-G=TAT+KD>[U/>&IY1'3#FUJM\ZB&VVTN\G=0UT
MIJ@;H,BNV]@.[)]&V^>,+=4UF'RB!3 G)_S,S#D8$*5:Y.9*7J5^%Q#D0%*)
M<2S7,. MB4]M*MDLHC2R,P )692?DY<>+C/_5&$S.M1..!GN+:KE'G0UO.\A
MQ$1F_&0HW PJ1R55YDM2GPR527+*HG0VV(TL_N)(&?T<(0.L?X.?)O$P@E;@
ML)Q21DC14W;$AHV7O@N*R^QVR!;I,)%7NH4;Z#-P10:M>NM6IF57VJ/"0;77
M'G=.^D=Z\=?I74F5-5'R?ZB<BMAR"_SMPP>]H>E^">[&Y)%C@I6OCIC'Q(=I
MAZ$7>Y K9Z0:3'=5!1K @_ O7JZ(AYVDR^N)Y^3?SGP7MSG,.G;<^0>^BAC(
M<U,LNE<\JQNNO@2E9[]B4U%XO5[N,W941C<D4WW)$?U$L(YXYOV!-6)8VI*A
MA+PN-9'-0U:G Q<?GRF\Q7X."97)"M/Q26XVD?K#RFA\Y\D6+4C'A!]3GNTI
MC75#':J=R4<[9TG*_.C*3.JY= $:JT/4ZTQ/ZO%; ,]*#W9='JUB^KP9*F(.
M,LNU)@^(B*Y50^8XC75-]=F89"F.>?9$?/)^_M5)%E:.^7WLU\4Y%7DN <)/
M)_V81'7*/R7%*]D)=;.5I!+6AT)?6U":0 HL<GX\EV9_)%/S4,A)Q562TO(]
M']ZB=]+-T%KQH_/*-OZ\_6-+0]K=N178JL-1"8\7UA/O;YD6GYD8'/E']*:E
MK>R23S;P^4C51-30D&#$UJ:-8],FC[TWI[+6"F"KU^EKH2?ZNF;P7=-I>D^>
M?\)VGF:LIGZ":Z>S^)Z<8.FE!/)&+<C&F:IBB.RK1>2,)*677%2WC[!"^G:!
MR?JFGM']&(DEP8D9Z[E5+HD8#P+K9((MA4 &8#;;3F=(2J5ZI+2TPJ+IY?U$
M1<!C2 \X[/]_F'OKL"B_;G_X!J1$0.E&!:F1D&XP:)'N4D!J".D:F%$LNA1U
MJ)'N$>E66J53&H82D!ARZ'<&]/L\YYP_WO->YWK/[_<'UW4S>]_W7K%CK;W7
M_JSW*5ITY@6R4I-^ZRV.?O3:G\HW6CHDJ%1HGCE**"]>V+)X]BN!%.)&=YE;
MZH?]4(E [94TBPGF5V7[8^N7F^U@LFL3P1.9F$_&EU[%JA/F2]]X5O_\L(PF
MU$#5K^,]YVP*J$^T@7PI0/A^N6&C6.)ZQ*)8H@2LE-?.4?X;K,T36(Q79)$=
M\NG!D&F++]RE5FD]20XT2O/S4>67!66K<7 ZSB&YPSY!Y+*208<2OV=_5[9V
M#)B6Q]-47S=6(G6(Q]-F>X\@=\A42Z=D?JG7$V(9A IB;MZKO_9L]\?OSDM7
M87'VQ,N@LM[?#Y*S;U0YS\)[6@"_S()Z'G;J[J3R9ROMBM/V#EI.JV6:],V^
M1DC^LF8-9C8\:\FB&(=R#B,7O79VL"V)E5R^,HS71$F6[N*["XSXF[=WBR0:
M%385_$*.6TZ\IZ[$1IM^=$P?,;'J#KP@8Y^$QV%?"/C7U]"^:: 3W:[W4@WN
MVA=09,WK#M\^!2A5LOQW):Z4H6R;KS]\L+Q2%DWD )\?M; R]8^_VEB.DLP;
MFJ*$2("%.UFCN[*OON."22;[PV>;J@F<N,&E[+6"*_"I^G[9FP>D7,M3'9=M
M7=R34-7)1DW2EF7X=P.=.>\QZ"0]-%2'B&\TQ@1_[<]>)P=T,8Z<BZJWQ+=<
M0_:4#N!KRV5OW]:G.B4,];Y&W8:E%?3@C=9;HU/_GG76Y2\(,IX"?P\['UU\
M(MJK3@XX+F6'"HMLPC._<A4N=0#QQ_WZ(1X.^'[^,>[PN!4V?X(LWO+(T)*(
M#<?/]?MD!KDUQN;5XP]011,:B:+1G\046> )]IQ/5[6%:RX6[3Q^<:<1)B?R
MST+WLE9ONNW/LWTF %E!*_Q=YBR@_]Q!_(6'0BY]?K\&L';:AQC>'#N^05D'
MW)Q:&4\U+<FLU+Q#G40^J*[WP3S5U(N\W(MC"'9SJMXMZS$W8;1Z 2FQE-B-
M5DA?D!,?T!#((598.>YGVN%>Z>&YDS]LM7SU%/#)%0/N*=(N0XFALYM8UZOL
M)6B@GN(4:#N[YZ+BM-^&DCB*./>^L)9(=+/;/N/C4\"OA_@Z[X34NIJ&(O68
M%/V5I*0U6C?M#RV'R<W1ZA])CS>#E$P:%)9<%"]7ZGY]8S-4VO2I[\KMY0=*
MCQ=*'^UO;RK4=,I\$AD&?>$F+C1Y)M0K)??"J-.DW&VB<C>[H[$%7T1'$E7
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M#=X>"C>[]@4S^M7HHZ] *SZS4.\I 0$N_\=C'<^"P:&M6/_D;_C >636>?2
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M]AO DGEF)C)9ZLY/8 =I-3C)>#.)A]VGMN%^B?]:]N.NP6_'8'5:N:R"+JI
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M'AOE8%_&/A+P]PT[D(./';5M%UMC!;/%H?B\X=1AF4+O,94^EU?U<S]YY$A
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MRCZ9NB"=IT2C0WU4/[D#1'CGL65;B6C+T!*L!)%X^_7L*_L1+)G+;5K^W%#
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M[#D%Z**/]<Z0::S%9]2[^)V @?X<ZG%)OWPZX]F?::^4R%_9ZE#YQJUMNVL
M'-(HTZ1MIPSCG@D#LVV[#%TP]3SBRBGPQBIZKR#$J<ECCT/L6(_@PI*VG#12
MY+T6Z:._,9?,<%IK\!1 :?X_X.C]?_\)B($OCC888VJ#4(;^"DOYQ?F:]PY,
MVLZ= E^,@II. 6,?&#GX6&>]"UQ;3R%+L^A :.M>+^"E9^2J=* =CR_ZLPQ&
M\LXFP^,7'3]79L(NO$"__>H6@=&V.62R,^GM/??M6$]X\%5T9MYXAA*8K6U3
M[X^8Q^P4,V+YTO:K3Q:+[>3XB>8WPIRC6<:C]ZY4E7X?\3?H.>9+Q._II1XR
M 6\EU%@RB7R3H?:L%!P]N$;";>:SPS2B* R)2WK[YW!OI$T):\+YXQV[##MV
MQ/TG0Z!\HE>L-'TA<LKO]K.M1A8="(Q6A@+)628ZL,.Q_BT[$BM!Q,^/3)/V
M850N:Q82QVJ/O=,M]B,#!"S$CN_W'/-L3;/CPSNI[C'H<<LL!@EJXSI/ YI^
MH>GCU>!4U;[JT.G+!&0$W+7]RK]3D.65F7/N$%^6[GR/T7*1#TGV8FN%\HJZ
M:=?Z#MID*&GPI+="Y>AG!'I>X\,Z)8]"ERQD_;EQ[0@-YQ5G3IT=58UA1$KP
MPDWL3E!F9M^"#IH1JYK%*KLURX= >;ND)04Y<7W #_Y;=:L#E5;:9,A;^]Y>
MXDQY3@'U*:VYOGC<A#^HTI%S$D5GR;0IJ3OCE,T6NMYUNNE;W"\-;TQ/9K$%
M5BA#U!1_%E]PL(VN;L-?=W!(V>"#+=<\YCD3\91\)3VB)[NY$;/U@'KD=C3\
MIH_4O;MY).LP)AFY2$"M:O!HVR5+;OFC9KTLS0;X\GJ^^HO5:;_O+@'\'?LP
MTI*\I$7GD0VMN)8=<8)Q?S$9C"S^V@'Y!A>L=0;V'B=^*Z=?_/<Y#4Y]"]&^
MU2+L^Y]_Z-=6]04H[#1FU@31!N],&,Q&YN)>\)8OPLBCL<H[KH>D8Z? %&'B
M"74D\\GSO5-@_S/<B9^([Q_EK/]0Q_ZONC3V?Z_#ES>#I@BCL2I/@PY)<1,I
M$ 7!F62%S0B'MI-'?W^2X13X)C]U@J4KXH>1>?J:O4LW6:W H&H1*)19]@>H
MF$NYD.2>AP0J5?2N][6O%_(:9QCZ2DX!CJ.@HSV0>1C0<0J\M%8Y!6 !C;\V
M\:!(%G\50,;_H=;ZOZ]5_4=M^S]_$ C"M=NXR(Y'BR(;^@ 559BA_[N,M,_^
M\9!E=$P5MR)^Y&;H ",NZHPD5:^-Z9!+%959;[\ YU0&;(*^7,\*ZL6/E?9?
MCW3%N!J<JOE/5?#?52+_H:K( 4:>\0_&X:@L_M<S,N_?F?J/YQ+C'2V2 ,2;
M7".U>1-C96;?@N?&K'DX*B.>LHJN6U_;>]+!N?P-FAQ^0AWP-Z\?_9=NB&2=
M KWR5$?3!DA: IRC?KXU^A0 XS@RC8?LZ?ZK8( DA(KBZ78*++*3_J:PO>K_
M1?^_?_AON7-$Y]1SK_03SD*;>*-QBR\W0YSJSC-SJ'FVFF[;E:TC5<@O$?B'
M92K_B67?/^"[POC/KISQUI\=-T+?_RKI_Y1FT DU_-^E^3>=SWCPEW3[DRG\
MNX2(P7>$)/L5>:ZXJ<S6P.AR_LQ$TM,?_P=02P,$%     @ N8%N5#ED.^AS
M.P  Q$(  !(   !I;6<Q-S,X.#@T.%\Q-"YJ<&>]>P5<',VR[\"B@> 07)?@
M$"RX!P_NEF!!@SL$#P1W"^X:(+@%" 1W=_= @.!!=O=MOG._<[]SWSGWO7OO
M[[W97\UO>KJGMJN[J^I?U3.P!=@&@*,@(R\#(" "  +\!\"6 2D #04%%049
M#145%1T=[1$FP6-,# Q,$CQ\; (*4BI*"E)R<FHP.P,U+2L=.3DC'Q/K,TX>
M'AXJ!@$1?BYA=FX>KM],$-#1T3$Q,(D?/R;FHB&GX?HO'["O "X:@C["/ B!
M%D#$10#A(L!Z "IX/Y$1_CB ?SL0$$%(R"BH:.B/,. -&G  1 00"!$)A(R,
MA 2O]877 TBXR'@TG!(H^&HFJ+1.!%R!\7EH=)(U783JDS_!W*;.0>B/B)X0
MDY#2/V5@9&+FX7W.QR\@*/5"6D963EY!0U-+6T=73]_,_(V%I96UC8NKF[N'
MIY=W\/N0T ]AX1$)B4G)*:EI']/S"PJ+BDM*R\IKZ^H;&IN:6UJ[O_7T]O4/
M# Y-3<_,SLTO+"YM;FWO[.[M'WP_/#N_N+RZOOEU>_=;+@0 A/#G\4_EPH7+
MA8B$!$)"_2T7 J+'[P:X2,@TG"AX$FJH)D[XM%R!: 22\7DU7>ATW.H_"4V=
M)Q\1@7DVZ<]^B_:'9/]W@@7]MR3[NV#_+M<2@ E"@$\>"!<0 V[N&/,#'OV_
M)F:6\*FY-?F=L1G#3(_K<J<%W@5\&P$/X3"7<]GCF/V5"90 FE8<OZ0&^?H,
M45+&AW!4V??'=.='OZ86QYD2% T2,,^,3T&(TB)D%*TXOKV 87X$(_#_AV*\
M$M;0G\9MXBI2Y>:BG51M-SPBYAYX %MQC5Y2S>7!@/#,?KJ!QM>2F-$/7Z&N
MC40_$%J;J;YK8#;=@VJQ3>[2?7LOM<_1Q+TL3>()S-AB-0Y$1@$IMN35KYK9
M9Z3/#D<JL+B#,RU%9]F+FY2*#2OC>P>E=G.\(\=FJ9+JFJ*\Y3D9+@D<9F'
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MV+*C7<CQP3$_^"@"WA7,U;^)H9#I)QEQSGUCLMQ,MY[W":(B.^5FO9U^$'3
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M@^;Z&L"A)._$PC^]7<A'ZX,W*4V8E_9G4CXOU^UWNV\P0%R_K=B_/P(&=#)
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M$^E*;5L#J^T/0_*-'7[3#>=&<#RZGJUD]5T?WWH^[F6\%#'*AISJN10_HV@
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M.D[2@/$O00&:GZ.?N"(#6;UT]&:"2D109!76_J>ONOT/";;XOP!02P,$%
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MHRV:IQ1*^DF&"-N, TX[L'9U1S\-*CH0%.DZF)')D=GHJZ@TGZ<N<R?!0SC
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M_X/^(2 X-]X$?UWB_W\6W(=_ 5!+ P04    " "Y@6Y4 S('=E&9  !VL
M$@   &EM9S$W,S@X.#0X7S$V+FIP9[Q[!50>R[9FXZ[!/8$$=W<+\D,"P=W=
MW340(+AK<'>"NSL$=W</[CZ<<^^Y+[DS<][,K#>O67NM^NG=5?7MVEI=_3S[
MO J@2HB"1 $P<   >_D#GA< 80 6&AH&&@H6!@8&#@X6'A$#"1$! 1$7_14*
M!B$>,1$A'@$!"1D=.<D;&E(" @IV2AH&1A86%F)R3EX.)AXZ9A:F/SH!@X.#
M0T1 Q$%"PF%Z3?":Z?_Z>FX#T&#!0L'S(,#> .!H8!!H8,]= /'+/*' _KR
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M:-$G$%F4K;2L<6EV<3%)9A"E]U_Z\4\"HVV]NWPPSEQY='UBD2_/6N1A7_.
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M=- $'W]_EJ*[C@F"[4+$03^8X83AV,%Y4C"\[HR/G]_V]3".*"F)3F/ :@=
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M''K?8+&UG%<$U9HZO0R*E2"3/ ^G%7S]=:26*!8>[6/NP+:C(A=DI+Z(O?9
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ME% R4Y+ED_J11N417#X#',5#IKQ"9@O*%^<F]9DQXG2^$4K4$R8$4P*IY,^
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M>@)DQ)S*B+8DW&A-:L?#FW6.?19FR^]]B?25"+-P]*(T(F(&L:XF;"EP7ZY
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M#V D%,Z \-.<J.0F\I&PWL497,]*?C%C*>Q@,LE<A*<RRJF'K]?[X6_V79F
MIBU( 4,J.@^3%+XQ")[\TT6I8BF7=&MRQF[GA'8X"6T0@HD5$9G+GB:AREAI
M2.7$P<2&=WL(NYSQ$9:*YS$G&&6>HW#X1V_\[6C->)EQ^L")]Z1X4*SCLG)6
M\4#1D#G\Q_D _E$#M^7J[1.1J 1Y]NEI>;0BZEA)R4V*#6)+$\'@7HYH-Y4
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M^N5CJ5MV7P[/D#[/TN6G5L7BX\M3N7(T(=!:1:"6V2X<PD:HJB'HQI\'[0G
MI+(;EQH&[:<*^,2TRS5J'\&*BE5OES>20!TU(ZACH#-$8PA:U[1X_^SJ25QZ
M)512Y<Y)3;,)WST!.C$OVP0>QR\QN89&AYLMW2Z&"9GF%SRV';<3J(MJ]PE2
M_+T(O[W"\]/FE/M%#)RIKB4IAC1-P&J;8O8Y%ZDSV1)8WWKMU =/EA*2%M$7
MIW[55&^)&B%G">+%.T1ROK@LM$GYGTMFEX#Q=%0+O0.WYY>E9(5T0QNE/4!H
M?3JNWX,H,WU_E8%[8Y7=UAJIPV;LLJP^#"( 66@DI5D;^D8TR1G%MPGEQEC+
M3.N.#V926<Z69<72+_-LF#>4<"K-:,K1V/EO1NS&]X)GG$;R+9R<WJ\IZZ$V
ME%'Y^60,8[T-QTN(741O+F[->M&RLOZ9.H AQ.T;7/7Y^D_268H-^?-!!UG9
M!%#4L".Y4C<U>N:W,K>,9N^"E!8587]\)>'LI;KIV^1);P7HG: -&E?GNO+X
M\':UG&X[2[6(K FFRR\M=*N.68V\$O;N\5=:0(_.JH(1W1BSJ2^-1.I0)>T?
M0661[4P=@,>O"M^S+>AI$,S,W)ULSZEB2E^FCWQ28='-8'%9ZW=O1ET<=C["
MR[]2!]SC(/?M>L_SC]*D%"+X3D-2KK11&D@X""8A"%'V&V28(BZC>7[V30$M
MEYD6B? R,LB4:%$P"@73G4H&JD IU#IN]4XO9B&8Z&/B)/.P9NA''0;CQ@Y]
M^L[IZVP?W)5%A"AI)-:/EP-W'&'S,IAMQ 5>MMKAG,RXO>W[0RXPFN.7JH"'
MP\=DZI\*JN@Z]Y4T<+(T@VD):58"A[::$Y01F@;-21U,))4H&_5D_!<];A.0
MEY';>=)TRU 6X5#TEZG-%\)CUZZ'V[@N[C0AF"Q:6Q&K<A_.&@IW7<6)8 BP
MY6+9U<$N- VHC0>I?4=G7$.=_K85+!JN,_JZW/BQOXY_Y6<[40?_*%%_KT"/
M/$N4JUQ9.8W]2\XOL_E[[;!2=^;Y7/?PW\POR9CH<[HOV-"['#80Z^*GF+\)
M87\ .,ZKL&,XNT7!HAM$F(I%L>L:4Z2JW]I@;) ?%#= R3$(B8$V&XMW6C^U
MY1JF6FDE9_;(!^6^-R1Q><AX[>P&ONOQNB;Q# Z.,IMOI(HI2TN?@Q!B; BF
M#2KN_/;9;,6X _7#(CDEJ N1ML*T-M,WB#?HA#WH\,>@:Y&HJ.YA(R/\TV\/
M* D8,E7M,9LG\_/<.7[T)7*EYQ#WO'FA.!X>F%\!/2W,8"V93AT[QZ..4--E
M:<"FL9CB/8<HMP&Q9 <X>L5*C72F6#&'1U1\MA._<C' F"93/-SJYB1-(1$,
M<'^"B]J'#NO-]?'+[IAX$5I?K_#?=F6>PM4] 8+!OV5JZ7&UQY-!MZ3LB[FG
M2X9+W+JG'[M3/_@0T;C,DIIO3O$^DH0@AC&P.3FRK%%"$:K00\DX <30GV]*
M'>M3EM/M:!*86?"&!O%*R>7FHA*!4]-B=8L[]5>O#6O"/&U,%3T;3==9=GN"
M1>3@.%^ZC>I!7 ?G>O;(>._1Q?9)C.L><H8;.&Y:O>:&,IMPP'[DC3#B7C]U
MNZP%O26:09:N7.D4(B,E*+:(0DSW!1WQ>K&>[9538==[%U)1:XA<GO=9:"W^
M5)FO.7N?0,FOV@"0C\7/(/T#12KNRCY]F_E#]AQA'"1C6]8/N^H@&P^^<F[O
MP[+ 2;+AX9+][V0'BZP79' (V+VJ(K:$QQ>M"^\=7-RL'::G]0B)';H)%G5(
MXV7<=(K+%[MH*L6),_S"S=&.^_D@06]>3L&* Q#=YRT65FS&%@=1)8#EPR0O
M4&)=QLXD;1)5-(OJ+0I5E)'\*X>:\N[=F"7?Q!GR\2/$97XK?U.S_D'Z-:MB
M50'B DGJXMTL7;;1:,&PA9T/S;'4YXD>".525272]JCTQM;1;%:Q9UUYH0T=
M"/*XRU2/25TUI$75P6^8Z1X<[8KIB_LF7:?66_;VL?7,=V9$2%5LD-E_1P^T
M"/Y\ :W'-RVR\6+SR=,S&&@VA]!ZDG^(FF[**>+= J'09X>$_ <K_>!&KWM*
M"266W.N5*3/8JB)E7IB)KF)1"<-G&G&DS=!#?(2E<Z!EUM4[E3Q=_;8LAQHZ
M-(V,^IQ!69]ZUX5P,ZY+C4F1P1797@U-8=:':WY.53)5"F<O;_"U&@1$6T B
MPXD';>$U]![I=N\:ZVWN?Q.7FNBT')=^7HIU1$+\O.\R$R0TCXZGA@2Y+E9I
M;C@13+5Q9!-.5L]+0/&/6CU8!0!(SX9M=YV[U2W<J.;EOLX?WZ&^$/387WYP
M4[LNUFFI.N$&S3A5"7V+9H#(-01FY.2+2#L:[-BAQ8ZB62"SG+Y26(4(Q2C%
M(BF9$956)$29WZ6Q1]'JE;/>&A_^=IG\-<QR'M<]V0!Z8]!G;+)Y:-+B>-/D
MBW$Q*I9LX65CX]J(P%2.@E7X[MO[280HJ]-R^52IV@^EOY)*9DYQEM^BEWTX
MCGE8Q4 >Y8D,6&-P]."@CU_+8]_'*1>/ZL[\2JY)"M>W&UB[/][S+K[FLG[=
M++S33^ZW&X&KSQA6)0>V@U3[9KR/P6W4ZIUI'<OA=.+73:RL^B%D#?Y>7QP1
M&^#8=VNIRTBRG]"4@O$^CJU3&4)BTE.??5F]'[?<)S;8S=+,%FFLAFC!FO%N
M[3!:<?CS[982*%W7!J^GL!<$E"=J:]GMQ5Y,FCXR>%5OY2E6:KFTJ[!_(H7'
MH+$0ZA+$Z1:U$3%*X+7S-9XO-FDN+@@99?.@[]!9@G^$OW1)J+._H*!1QF=V
M<'&/Q)2]*XX8GHP=DWC4]^S8G^UCI^K\;.)!Y=2.F8MB?'$51^GYW9**-4V,
M2ESL&Q;SN>Y,]G;A])RTM$ORVN\N:\7N88Y1&B^%LOINP@&((YATY/< [W+Q
MJLDW-=H1<]T<.9^(C2^&^TU]?LO?'B.*7JD$FW%A\1;7](3N4]W"HJQB!1]K
M#UK 3%MAD7WG.ZLVDU_B-CP]<1<E.*+8DE]UIWL5'2QZG@,>5+,*LR?RF2%[
M>$>DD-TQY#O<L8I]+RN! T.KT%+C;JQ=OEE7:J79<)KXC_ N*"^1=Z+,SLKZ
M:R)U68$RT"2@PT 2/%(AT2;N36 BO[T_PWB4QJ^M+A/KJ3QBJ!-7[)C_Z\!Q
M)S>?5D*S!-3W7^'BHDBC$D:1HNW&#M8(CDL4NHO06/TP.I/Q:W]6QS!2E@R\
M7/WYJ; 8'_JY6Z6F'#B=IX"7,XAH4E0'#MQ[;,[<9/Q3Q:3.:X)BWB/9Z-W-
M15DW#SLN>FT_KX46C&0$;&BYWL2/-NS*2VY<^D(6I6_'%PT$G3/;NT,+.=0U
MK)QOL52\X./E1FQ6?A&T69Q^J$=E2X4%Y,K?+5WW[C_P]W)$3T>B-U8?U]95
MHD__:L:& IT:O'1? 1FUPDEAM=9@^Q4G0AEZL>KAE3E)M^V85,O]YS=9.?E3
M>;PO7_5 9MYX4U>4H@ZKMW+14%I02&Q>0W69BV^Y'XC$3]:,II4[<4"H).@%
M,?I5" *9*EK%R^^EG67JM;?.'&Z-?7<FX&NL2?_UG;)0HG<R@[YIFFVML:;^
M)T=Q2<5PTV(L"M;-NXR6\K%Q=S$[&3;I!RXC= RB,@(;Q[+#%'8I8^L$YQ@@
M$BF&2Z^*LC3F)PT2F1K!+^>07ES,KX?-DG'1[(VK[D4IK&T^!<N250O8Z-T6
M4Z4MGZD/X2S7JH2B-%NIVIHK?E;Y\=,TQ/:(4K_MH&1 B%YU.]J9B2PV$"@X
M]9.J>0(($>Z[5YMWUSXL33C,XWAJY"R^E^4QW1Y@RGEY'T.MSOAQ(RYS,J4C
M*N"[^Z!.+?%6V+6\\"SCEIX&X(;P+C0C-,O =WJ!QD',\'$TVL>B+O[7$(XV
MJZE)>\#&"(;?[6LO5JXO\75A?7@UZDH[_V-E2SJ!;'Y?CX<7](7[_E=[YQ44
MY;8EX)\@2;+ (8O0@M "$B5*4!I:)2HY"A*;G',3%"4W63(2FM@DR;9"DX-D
MR:! (TE!4. TT-"#MV;NS+'J3DU-W;HO,P__P_^PUUY[[;U"U5[U;15MJ>71
M5W5NW$_,O'*SV[Q,4Q^'=\/DD"D^+L75D17"O:5,^\(YOC/\D*<W7W>'74F;
MI7T0&#CS),BSR??1DLSU)_'%//3BP&A@7ZSIN-5^+"Z0*491<^?]QU-ZFBX9
M#%]R$':B.9/Y8V69+1\I \*!!-A^XS0#(\MNDV[*D\[,C&+GI56'_XPT\^N.
M?9OI]JT@KV=G-0;R ^FH_ZSKRQK@V1X?Z-G#&7 CIA@KPSH"CMO//<JV16V)
M6RY<+C9?*9Q%85C9!K#)=%I35PSC$Q2"^104B@1LD>T2H70,6^*FE;$]E]LD
M.9+"K?'7@#C$TDLL"C:3[]C7Z3>Y +DS*6$VPM,4LU+_Y(<*G^.(OKR-P@;S
MW*Q3DN6B14<T+]11-(TGV-.=@H\<26,\W22JJ\9$#5%S=M5Q]Q278S?[U::2
MVA 5IO"]^P]#EL]7&@XC GBO@ 1O0'H/%Q>OZ@[@OXZ#GTU)9C9:1KL/7.Z-
MZ*402 D-M17!DG"=/S+_'/BRU,\KD88JJ5QWU.[@@"7F1J4\<0$:'=$Y5RUB
M^=0J/(<1*@  LJ!DLDO:1NQ1I4B+)0N'/Q_(),^+-K)8IN*?FWIR;O"D;2!#
MW!U(5!=,:M%YK%8Y#2F0"9[9KFM:T]LR/'LJ:_HG6+2L2*+P^JNCSR[IQB[(
MY$_&<X%L$OS??)SS#F?'R"Q?**V1N!  XE^$.2>#O_[JD(6<IY 5@<2AU[L]
M55GY,()Q81Y)20=,F-=&L=)-<]>H5^]>2T)W8HO<1KQ,O*-BZ;<P;QML\^EF
M.?Q7+XN_6A./-K!C9.$C31_14B<K=*-V?&ZCRUD1S1KK]*%#_&DN*K)_X+M1
M-M+<[52Y\B5M@<VI?9:G8=H/=/ON+E8I04A3PB16=__Q(PXDL='U!+!UE30P
M%.%_VD=ZZBXDDB"E%^OK83J[F*%2EPVB+(1+E3"J@?D$K8@P7 GDS(&?/H$?
M>#<_E[X7224W?35:V,#?KB5,LAD!H2!>+IWK$_A )9<G?]BCXNM:V&)^GXW(
M>.\)HF[ ()'H_@E)AM)]O[K*K%(!AVP!R!OI]*,%UNMOHJ]9=8O?DNU7BL;3
MJ(N^J.+/7$K729;>N@8UMD:<U$=&GCEZF_:["M\3 U6N%7H(7(^DCL+#]'*3
MJIYH.<I?8[JD P"TP"]W_O@OO#%FR]I%2*$4E)OI7!3TBH_^I'@=IR<XV$1'
MZLO7PE_GTA!O<&K2)+?;:N]UEC?DGN[K>VY@%J4?(/[!X\]:,K+0M.F91%SH
M9'?L/M8H*ZC2@'C)8IUGN/G;3K<3.N1+AU+T80&=56%,15M\D9-F*25\(DUA
M]&8YFX4L:1QWD<Q6%K!V>$;L N^N!-VNQ1SQQR&ZA%-&N?&&Q@HB@^P2;<J+
M+-OD;, 1IV%N\-U[VO1&S RO[2Y%NX3E)!B_X/LZW_:.@;_.L?J0RY7CY?P-
M*Z$):C7>"(H1=VC_-\KOCUA:<Q,4Y"-1^M?M?>"*-,CPX)T\"]VT:.?E.&QX
M^+F'CIEI!3HNZ8T5V=/X?KN=R-%2K5RA4V*-+H;(E(2#VT,13,E:,BBF+'GJ
MR)*^RV1-S=&6\A/2(%+G0U:NGREYA_?=:$W8T(N,=:_C<K\5;,BRDI\5)<@?
M5J>%S_LB:&7XDT)MCU_P12;%-)K [,!\Q$IT"VIW>*.6\.B=QW&\?2D(Z82-
ME*RIF ^\XLD?,,U@62R/N[N0KTLRIP"''R,YB "8A!K5=G!XX-:1^M>%9XTI
M]JNBF]2HY99CH'PT)/< H%Q'K&.UN&SCHD(/@"\J#19P]_$MFTLUU.S$RT$9
M[2*^$/E<!=M)N7TUC^ M7%$F;A%]_B4JL8R9(WN'),(#S_OV),9MR4#6742\
MJP=C[$LEF#S,*<1NS"@%$C%:?II#9.8RDE)&^?V!$P*DIP'D5K^RUK[M3MW>
MB:'0(5H+]##PR47]9YUA4('Z>VLNT*@!42%_75(8)K:#OFWC;'V\6Z*A(=8C
MU25WC8M"SZ//*>.4MF^' ,#F^'?.W3+6;V>TGY[*N?Z)DAN>X:UW$7&LL?I9
M%/XP7!RBP4FK)&0 $2^EZ-T2IE!:89L4)P!O4Z,,E9$&0A4$P/_&*'#Z&($+
M[62D@)JGJR$DD]]<3:4O$L!!M)E?SHO5U4\69'T**J,,$'%91JSUSV(P/&D6
M$(D^LAIC;8_;D4@O'JBO)KO"Q%Z+G?Y0J-G$,:M*YY'[FT8"("HJH3IZ[TUM
MS@.JH3122 U8O)=.IR"'JO%Z@Y[Y7<^.X]HH"J])7PG\<R^6+._I]Z'IM:;1
M,6JR#N;[0F08R*(6)6;CO>.17/B;%OVW/T&F/C=*:/6)@EEDOT;HJY\B8]/8
MZZ "''RV#6"R*"-TT^. ."P,8>,UA4A\BPO,RNI[V#0YU*"JGO[0+=U09"<A
M4Z"V,B*]HD^UE'07<9%P6/ZI.)E^^ ISTT6)0 #6S]I.AT_ICO((@)A7>^AP
M[IWU3V(G,S6&^01@.)@ M,(O]LVP0 > #;^_48CJ3>.G=Q5.::;V2"B=>,=?
M\=EQNBV.%UR6-F5L]-23@H< W,_LRS1:[QGSV6QSG%\'WN_YI'ITVT\:7D6;
M%TM3<GA2C,A@MQ[-P<Y9FM.F)W4:H +.K4M#W)&@B6UNJK%#\/,LF*^!T?0M
M7L\"H0-69H@H!<X>\I'EV^#^$-E<6'HHO3V '<LWL3CL3^DIGQ=2:)>?G<GN
M,6%&1\E*F>ITV!/]Q)?7X9J5TU78G:;?)FJ.AA]G?8#3;G$+?!05%=GY'*QW
M3(1-2I71G6'E+@Y:13;MT8;#O#BWW,"2SFQW!S7ZMWJX#S%HRX9Q]?1SOSH/
MM/G*@35MC1-\*3CQPZ/"?8M(R>PK!HTCE,?Y#OA19G6]/9'($,6>Q?&!RP,9
MO@F:!=P;7(I?Y4^O=+5)7$;)B3:.J/*IVHF^^G+LE?B:/S'P7#E/=-YD_$M[
M[C<WZ.H2L2#;58/&133G'?5UP7'_2I7<(WZ48X[].N(&?E@/O<?_/"1 ^./8
MT+J&YX(MCW<?2:.2]I[6"^1BYDJ3G?5SBK2A.&XTN^+79Q:B\TY%0W#Y6>SA
M.XMYMY=-?[#X;;KTI7'6J_/3A_7Q)&%(E+1@8UKOBLJ![2;EE#"%0P+ WNE&
MY6__<,KD[/- NO0?1.S.O,%+'ELIIG+> R%! >"M83<0W1JH7E0<2?+TJJKV
MUKU'ABU/+HJR4J%<\W&!HZ/$< )P!<8-@6-7E'H1N!=J.@]@[/XDU:Z/\$X&
M$Y)'T;S22<[W* I$;A5$=1P-1N+TA0T[3T1*2LU-S8V[DX9;\^[I5!5'II/7
MK?TT\&49:2TF2JDP)OJZ48.;$JP.EE+XH2GU*1>47&8@+)<[*.^SM:/U40HL
MU<#0@; @%ZM*$EP,+I=9"I^)/)G.GT4UW_MT+^@U*<0W,94A,K'S(AZYHL'.
M^]HN04@^7N;XYYU[E -]BJ=YAP$^9VP#E)5&=5S*+7<3IW//HI$V9+W$TL^
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MU=W:\?WC^AL"\%\E58DR!4OLNY;;PT@MQ-O:P9XUL<5&Z9PDIQV/DM65R5%
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MDLFD(AF##DP[7\&&QC@H/>)RES;BQ;HB$KB*!&;9( C2+U((DR(D,"T'?K<
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MICG#BP.=OB$6]E+:=NNXN[_K1+QJ5O#I9PI= :O;M@Z#P53A:X;6Q#KFG$@
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MT?XGRY=Z*=B$]$A#\U"C'OA^I+L;4$B%1YAO%7*4U"B&.:Q>'HG-6/G^Y*Y
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MY:Z52E!XGV/]?H6</TE+2U7C5YHO!9AYTW."@@GH2:^]A+WEIE@C;8CQPCQ
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MO'N/1X_G^LZ\^^:^F;LSW\S.[+7_[%7VM];Z@Q_ ?P1H+ZFHJP 0 @" @!\
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MRQJCGU>0(2BH?ANLBZ^_Z2Z<ZHFYZJO'A X\.94A2\KAA/#)4;)9_E>%YC^
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MG46EZQW@1!:Z)7W*$>?P9.;*(._G2:64BK4'M0\O,Y\1UX<?(>6\+J:URT/
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M%54+H\EZ"@_*5S6Y"X6EU/@N8.35ZV3?A/8HU5Z+(6Z!\NM=<'U];;K->/Q
M5&*AQUB1U'T(GA)H(A*?I5RV$E$=ZJ9_;@?S?X:KVTXS[;C:& NQ<6);=%T5
M?]J#&IALI-7^+:GSPMG$;OHJ>?A-*_\'E#E1^AAZ@U3)1.B;FI%%!$I%*RGM
MGB>,WS;V!^2Q]!2O*$65@MJXAXD!SD]]=3%>79W5DVH-.$9'6??1:+]&[*[#
M?*=<BFI(O"L!1:^-.HFO4XA ([='A+O'L[R37S(+RFM!.:\U:5ZNTGK9>TJH
M'?S8Z7)#GV^-5Q8KC HQU+TEGRX*$^_8*T^RUR>:)6"&T27_WKCG:O4^RSTI
M!PL'ZXX))I\LAE_#XEX\_Q(H"#>M*4!T_?C1I\[SD^E9- .3<2+6#:=<1&9%
M?CUIM'2D&$]601;_'ED99GJTF://MKX46?MXA6.)@^?@0;XEZM.H3)H;N?NM
M1S[Z'A))<6D6]Z/U1U7P9G[5]P,_CE_>W*W<=X"'6!/ <7A62R"P#5P<$+#+
MV]UP2PP7!K'$#BD]L2-->Q^K&=U^1KF4W9=#CHR_ R!0[@ 3R<E'4;?R1HM7
M)])75#!A3HW,JE,'1WX<S:/B*J?ZAY4"Y2%6M#U!V'E]X_T49Q051D;4Y;L)
M3G9.+%#Z)3D66+FW6Z]8<1&<7 .Z^9E:@"]?KNZM)PW:56!]V?*0N)T24M6'
M$$09,UN=/I1 @2:=HB18T#/ZL(S;/M2BOYX64Q>B(7GS\8AQ:[@UT'T7B&\G
M[-PKV)[AQJ*5R?R%1GC5M()GCT>"M_27;2!3PV0/:):UDUI-A,9ORKL^*HM@
M6;!H/0]'Y'GI,'\TV/CUU?"^G9T?>MRS.\!'+WVQ*)M5M49A913KKK6@W=.B
M20G1"AN-2]B,_U$OU(\7#5YU\CWUEFD*ICTYTIO5RD>CZL7EP_#E#D @TDD#
MDY6(GT=*3&.>5Y]_C:64:>3 '"87H5=FC<A\]S[U><T:(<)//QWK?91JDW>)
M2&0*GVP AZ2*W.1I3/[M#[N W_DYD.I,Z<QNA'I9,&8^<E8DDD0I>N_!JB#J
MHNJ*V4<P3*S4X'&DF7V12V(C8T>18$3VOHT?>JQ>3\J5O2DA9*U^HLJ!QVCH
MA,<R#H=MP"TDV]6G0L4)URXUI<,6##FP#*?$)2X]/ZM^-;V_VGI4$K*_ >AG
M.?\>M*7PR<[.L/GZ<;UE08_0E;_F!]4,AINM$2L:69 2M\>!.!TI;=8P&/@N
M=D&W<721_<E\3I&-,4+=K!8L3+RM]^01)3=8A Y1+9^C.[$7R-(?0&E@T5AW
MO);(RKW>[ALO&<;I8M'<[-=49T:HX Q9NR0'*-;DV+M*<A2!$FOKX_6/E#E&
M\W"GKV*&];#+^92_3_FB9;OLZY37VRIJRI%T@HON  .F0[<M)2>DI_VVESDJ
M=X#XMM0;+_4-SNW8J0V+BTA%]GS02=^_^4G6OX(;/:'TVLO).\"\^@U%_9+'
M8<[?MW??2(?=*+TU,0N7L&S&#P(64S,_:YZ/?/!Y-GD62@-[(N>AAFT+02NC
MX]5<"EE>K,GJN0-4GXCL9G_.'^K#L5G*B".@9AH1.EST^8S&0O?YO,H0E&.!
M/^]T@@8>#V3@CHU.5ZLL+LZS#7G80MF?]^"1K:1?_UCYH 5I6^*L_LRKQ A9
MUUYUM!+4QA]/_+#]YZ9QLLBC)=3:GTPR-!N]=F2*&IHQ\_1AD\2LM+?)>91G
M0D<K; 2QF#3_"(C^.4;+A[5[:,Q-,D\A4CK[$O-=.?)Y8\?4'L]^Q2HX;/"B
MG\RM!<RV;7CBKPJ=.99\(4T@[]2)#16/#CW%)-V8U&Z5%$K\:GR0NB+>O6)3
MKR]PQ-@8HV5->Y+8AB6R4@GL&H#N,34&D#^/A>P .QB9*<_NMWW6A&PW- !U
MTVQYC':HT&#L;:E!T<VG88.$42RV:M/\G!5Z&KFRK6Y%J,# GCUB#H-/WBTH
MJ->E[O7YHXV-ACSGJO*N]F=F>-L7TY665M?J\D0.LWV2G,GY5<ZO=>.I[]T1
M$\)*/_&F,J;3>T8RZ'R5A6:3;DK?[IO<2@F,(9HS(T0D)M8E"2J8)$<W*NS4
M2)<DW#,O6<T\2=P]D7&$FI;5]^(*#32F'O&H?Q43EOH*F#T[8-VZ</E[EFY-
M@PI!P7$>]W0S4*H:/&:TU0$WBG]@0=&?L&61M*P$^3)Q2'?R?>+W]]_:X@?&
M^5T+H^E<QFC+P_._:+_E'C<^K+IEG)$I,M;?,N33#\BE/4SHDW\(\.IU3W]?
M(: >JIM:;9_*C@&+O'K*)5--6QY3;DM0@B=9_5C(HI"U71.A^[I;KC#5[VO3
MU.[B(Z([P$L'9B6HGGJ]2_B,@EHC  544NH]8.JMH#Y!--S/FB'?97Z)JT'W
MLTH+-*$17)_ZV?C4H)WUY_SL[*!/KIQ+@*.T%_-7CLH=D1&MR5L&N=+=9MVR
MF\^#K)'BJ2.C1PHR_:3=$TIOMROCC;<%>4GOO7_T6UAHG@PUX['7IG@ 7*]*
MPOL=_!,5TE.<3*2U^.-@9BQRI7&&HRU:W/VK\3;R[8H?+]'0@Y1F\QG%Z!&6
M-.JB 5IG<?/<H[A(O:ZK3'",K2-:[_H^ 9AF4Y(S)S_G6QP;VW-)UEO6;3YQ
M<80IF:<HEX&2-&+_?74<-R/\%55O0_17!=+:YV]B.N>41O>"C.5(<0A4W9$O
M-M\5(-8%JHEWFK]_M4&_'(A0"KZOPD0K%\.3;"&]9?/Z-REV/H_?^REEACTX
MB7\NK7R"#7Y;MFCC1EGAN YV??K*(?HFP$8[-],P]O 4)WNYQ-24)Z%L!%C8
M6S@K'[/>AS6XM):IEVJ3_=1$NLMKANWG<-AZ9F3K,/K\/FAP4D*ITC;^4K@Y
MN:>&KM0(.S!7UT25BP_DOS@5O.E1@'RIRMG=,".[K>*<$/.-DG[=X^ 9*,X,
M?FQ+10D1:!.TYS9^VY4 '0=@<$;FUUVU23G:H8^6&,)]=VXIOD[T)D3,?!HN
M?G4P\PQ**ASA;]^\-O,RN*?[)H=C0"9)_$B!5F3;.)1DBH+3P.$J='1(![[<
M 3?-J)*U6*<68#>WFF\E<AL5V56#T[70QSI65M:-4 ^U<ZE(Z?E_P$_KMUW9
M\1,?BI$Z$"]7,GRR*JIGFI]: ZH%3=F32Z8:3!X@)8^F63K>")('.71B9O58
MG)*N>'AI30O2FLH%O#@V"C-K:6NDE]$NTRC:@[;O46//'(4C8ZGT;OP)UNS(
M&EH9[RN#L.0[@!G:)16DI/,&\&^])Y==YB6O#F-HBZP8Z9]Q&0AH\>XO4OWC
MJ>N+MA_.KPLHANR8?--]I>I=\G===G07?8Q37AW]\"VK2M5$?&2#50IFT(KO
M76@^B36!.!+E[7G39SF?ZOSXQ'(P3A>_2"R &(9Y9M.!)%^\#?^<,#:Y^KCN
MEL9LV%^Z>H?O[<9)ND4V"B._J9(>MZ##BZX%(S^5P;PPI[.(F ]S%CE=-=E4
M/#S/<+):D*K!M$+O('6*%0<'&);)BF@NAYUK-W;4BO (J,0S8*%DP:N+=X,9
MPWTX?A;IZ[Z:AAPDD/K@3:\BQ.TT+WYWH>V5F)D"%@I?-^:]WRWUEUV=A+F3
M0/LRSFV8$TR%8]63A4X[>UVT-<]\;8VG<;*C[.!",T:*Q/H33"V-(=2L2\?B
MQR*"23YP3*TFN !5CV:A"NHG1?YX[;,'US!&.=;PXBP(3O8]6W?$C%V+$\'+
M].BA\,]?-W=<DDS]/-RX]^=@KQNVW[GNN<Q-"NAT?6(\"LK+VY%5F-X71"-/
M9PB81>D[[*M$E)C1,<.DZU+F.H4X]KA;2MK,-=43W-P\T$KA5E&I/=/3CRK3
MP-?L#(G78)<X92@$";0C#S>'" ;0.N5_!*2]#8E->Z#W4$XV#Y.4VCIXTV&%
M@%ZA:HNS!.^ID80K9P]\\+@8VH?!L>.O LY1"Y-\_3+L^  @T401+(R/8 :=
M_'@28)I5^:9IUJ[C$0:8)YG99N-Q3>:KGTF,B"V1E7+;!2&Q\"@NCP%[9($M
MX#CMPG$31CJHJ:H1_ M]]%H;$6(14*9OUIL?<<!=1"01VK<)L'!T@7P[]'=P
MX8V"]9 Y^^ _8HS,<'X[1VQ<22(?*K(7O%F4 R)#E?7.IHNP9?5,^\9_N2HX
M9KT@E-W=<V&XOH>Q8_217=/(<?&5QTJ3X1,N28'TAF6WP@FD=K-95)5@M[4E
M4:J4AK^%5SNGD3(BC$O01,NG[@X@!-5(';8&'Y=0]+F,.-?I*$>S-N-D1^00
MV7/O57%Q2TBEG"?F:=0,D*S%*JW4$$2-(^AO";];RM ^_EMN<)\%*(<*?CO!
M"75?P(.;([16=G1KA:5\0SL#&K]?46U85[*A"PYQ?YB9$%PN],ZX?C.;)G\!
M9!>2@DO> :@\\U:4>%J-;CJ<")*8!KZQV'N]B3/LSD^MC3D\1H/P2#W^J>*"
MAS@Z52W-G7GLB6E]&!(]18X(08&[^QYO.U(8?::3%C_TI5EI-.04#"MN1A]-
M[._EM%HUD'CA@,-9"T[J>.!(L0OJL(*CVO$2F^U$6E8Z^<KX>=HG!,7B<T;G
METV$S-\'@5,A1$S)+Z,Y/'*96,C*DO^Q(\58%:"R&GV'NP0IW#9)]8Q?@25V
M8)Z^V,U43H]IJAZ+BZZ/<S!QXJ29U/[)6/T["0%C![IEMYK)0*:N&:YFSYA"
MA9+([T1\\8 Q8P"FU%DJ;S0:XC$O 7>:7G0PVXG(TF8Q9TI^G?:3RM_13A;^
M>'17O4%5Y47LP<%/-.H6U)8/?7N$O3I3@8P*7W:H)'>W0UFAFR=JK,N(-7R1
M*C*0"H&J>"&Y&+=?SVX%X@NMM>'GC^;/ULE'/1-]5Q?JZNGI!1=!>X(#]OX=
MW_)DB96RELXV:?3(Y?1JPM(=<HT/SM0CG,?*#6T-/9-IVX9?^</\B3D28DK0
MSLH[CKZY?VH1BPZDD9L$[?,[T8^1;IQJWQC^WNA>NI,'@EE: 2_6XH3>#Z+E
MTGZHUD,HW0&8YL=N_'/6./MV?TD1 0? ;O>^E.T2>X@BL< 2ZW K'W2,C=T-
M3T5&IO??^'8<5_[XHU%> J_6D/+.!W%N86&SYW\0J..VW>R^JO Z;^1IPJV<
M^'2&T;*(,#0T4N;)Z5Y:0.E),[X#+.J/^(22?MKJ<CR6;9HP131L:L+?536Y
M/6*:D;,,4@-HN$7? 0PEY%8\8/Y*&!4-Q81$N<=#F^)*DBZ'QOLD4^R/TXVL
M,=U\X ]Y6O5*=F75WI$E2+SG%68%>XV*5!PB5!W?P&/Z.FRPHM4_'(E;DG92
MC"T;MY%RA I"B^X/H7 O#D5TJFXV_;V7ENM^I7QRQF )$\]#K&I !,LK7VCP
MR/T:AM?T!3S;CDT>FGC1#54J=R27Q#]9,6G65\>(*U!X)]@IOD9!DUT"<+4C
M;7U#W;G:W6'Y9FESG\[JVJC9O,F6_?_:&+OUTE15M<OZ[AG7Q*R3#/;-)V*$
M?2YQ:GBN IIZ6/+8$VCEX_>I/%O8H7N2Y7MAUH%XI9B6,#'SM*5%<G"HZ3H=
M;)\,1K&0]U6&MG_SG@!/-)5-9==F@1%2Y6M-K)\=+X$">L4'9$VCEM*..FGX
M?=G\T>([[_)4S=O&3-4-=VJP>Z]KG9:^KUVN\6$@18R&Z8)4AF"-1L$(.#.A
MU9/A@XMI9+Z)+<;YT?Q6_+9G1%%4.>H[_V-7P"IE-7IM6S/T +TWJR=>64S"
M7J:2>HS4#G9$P>.ADAH91NGUAO PMC[&GK_L\>DDL;! '$U[I$_9[*!M:K/'
M2$_<>DV_KJ1D1!%,PLO))U\HH7#[V4\C:5SO4?$EE/NXH[O01?.[?-C(@F-,
M$^#*%9IM[7JM%4]R==N<BC '/TE7[\$RGS"'U%<^$<1B[)0WYP^",H"62XO.
M?'VWR,4ZB+P75@VSH7LI0Q9X!>&1KP\=:?$#VCA=;MEFC65Q88:X_+:/XN:'
M>QZ53+HDF+K("8<70W1_\KC?/H4[PU\;"O_":PI2% V8C>P'DPYKRME@L?/H
M[V'J9O/I'/$BF8'FXE\5<C9<+L#N_6=?V@G@? BCU]GP2M7.%'I.ZX#&RZ Q
MV6WC,U*I'V0N#4ONOKP@<D7XN]$&!]S\]PFMN8B^8W5CSTH\X17TOJPJ6^$H
M:Y;:]B2_67YWD7Y,>LA]\?3;0:.UW*?"A@TQ4ED%UA/Z7$N';V/Y80#\]K,,
MKY6SIB-M.OIK0MV(N$6?3!J:TU[722UMAF:?T-&.KD A,P(;&)7#?$1+;5H4
MZ2C6P'>:,TS2(K8>/]Z]J#8>/'2&VA2A&*(GJ/NX6"SP$9\S$N504:GWP9NU
M>.\$I,,,38:G;;QPF!18>"<^;30N$GF?VLX\A0C,HG_])H+_18&Y"H 6E+Z^
M/E7_<(^HSV@P&R+A$)JQ3G'^Q8/D:")J(^6BT7C7(XZ:5J7[2C<#KT"&.T1^
M2#@MJY?<Z97+KM$SY*MOC8_4OU@_,S9[+J441$-O'\LY:EWN[>M@^-WM:]P*
MWK%WWEE<;6]-P7%,AT/:F)F9[S0]D?N0$EL+M%4B?E%-RD<%E_@P:,1GA"2;
M+F.+_'%S4\KQ@5U:AONW)D^IC;Q\T$\9.9+7J NI=P!&/]ZK@YQA/2AM^48
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M<X3G8<3:'8# 6*N1[I?-*A[J=??Q;KSMLRPIWK/$KPQYIPPG.;8AW0MB1W>
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M!H-S0K#TI=G:E !X$L]!\X,DF$W%*%S]C[SUWR&%8PE&.67P[TCRS52MZ .
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MO5A[?%'MY27@SK4V#!<_0$,9PK(H=^64B:!UFEE,*5&]!=[8?V*]S,X0/FF
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MF*D[[2OJKW!+VWT#_M[)YN;LQYFUPG$Y=F\IORA>(797E>I0K4#QDFM^\$O
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M/7Y"05*U)UK7:(X5R,(GZ )?C(26VJYN'!8])0%)=2JXM07)V1SR7W3'*[]
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MVYM!)?.&^J4E N&0C?2RLB)[5B?K=#XL55PA+A>!NY97T#;MI:X>:T.K0YA
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MIE$5S-QF"O69/C#C$D8Z!IR$ZW;(?.>HT956W9G9>2+?/P,V@+@S21$\W(\
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M?/OQY^=30L\\^M(C\+WU]$-// (3E,^\]C)(L#\%^;LO/@+-,S __Q0<,+X
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MF5S$(D!R'= NR$I@6$QCLV)]E8ZE 1ABV'6LKL3#,<TB01[ *+ O!J!$)\(
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M;G%>ZB.!_NV[Y4W6J#JMZB4+MDI?U (_W5I@:=,*VQJ_SSBMR9B\ T67P"N
MO(5;-H7C-PT)TZ:QL/X8P")<KQC=DK;DL)9-,/C &S-])$LBPO[S#RW<)_!2
M0#/)#]Z3&[21-/$PUQ7@/;"5-/J@5[TQUR0-,)";(?T*@GWS#XG+!R,U5WV8
MTALI0<Z R $LG2ZVVY EDC#=V!1>T2YU,'K26BQL&I&$L.FB83'UVE=:P 8,
MI;S]A^U9L]H)U2]["3@+1,MM,HUX'RM#E*'P'XKJGD)N0T!,9$9=Y$<T,T4&
M"D:>9$>N9$2NY$J%"$K>9$ON9$SN9$T^Y(H*Y4@=Y4<IY4X]9?0IS$D,,O)Y
M1(K2XU1N"2S_&!9"*RWM@&#4P#/!>+S50CSH&*'/(%8&LJ'G2&#"P,WGX+Y&
M$Z K<(QZ'<?$6$5HTU;LH-=QW==IU@T*:+3=V->N@$8#FL9>P@IK1-<5FJP"
MP,')VD]J)!9V+ !NKBUFM&>ZR)@_DN<"N"L#@(M\*(,K$,5'HPM5I#/<%;1D
MY<?U0S8Y(D5I,>#SO%@\\I=EJUYN&0VRR%N3M#@FS-.S'3=5$B>(=*Z1<R45
M3N&!*I(BM%M-LA(Z;6DK9-'&>;=UP[::79$BJ5+&RH J3(^C);AC,CF"FH'0
MF $#X0VDS5;$L,HMX0VH#0)1@]K1L;T92!"E'4&D=9(V5>&V;9UM_QH0LM2;
MEU;)=ZN2_:M3'GF1NC1I*M5:14I"2')AC8/IDOQ('K%C07XHV:05USR[/MDY
MV<PYAQ"[4.&=U2QL/CELAHK-P;0H3L&(Q ;<I2-LN9MLR&YL73$IS);LQT9L
MR_9LQN[LS?YLQR9MPY3,C.HHP)W4M./KU/24 &*VD)&M@ZDSN*H@[\N.Y$S0
M JK@@JF6TE@98KXJ0%O.O^C?O9C>MZ(+_\* [PVCL\!>"EA/YJZ\ZY->]A#@
M_UTK]Z0BY2.!$Y08VPN <$@+' R]K+ ]G4P+\=X*Q("AK/ OU2L 6>@EB2&!
MGKR^B[&LK!!&*W)OV?JCAH$V!8ZV^#NMD/_QM?+K%_Q.\-T"WMU6<-/0S7/)
M6Z[]MX_S2,FQ2_#"0@7\OP4CTP&A-Y$[T4>::]=Y$@84\29!L>E*4[B.D@K;
ML#N%#VRR!Q= L!E [\10#_^*M0SH/!QY%W"H$0"!/?A007^P:DHX0?78-_F0
M."-W$*',@_08(@@ $?L.HY6NVQI&FBV1:SF-&M0A'.S2&K"LP+C<,!;NL!L>
M'":L+@21L"]-4Q?UD?:P8T;\GN!9545,Q%O%8U7],F#Q"!T37%#!1$3?'44_
M]%C1Z\1]=%*)],6=]%2I=$/O'TC7'4WW<TKO=%?^=$P/]3]G]$P7=3YD[<#5
M8UG&GXTZ,QP+9%?_QF.*X+MEC: ZN@NTL.@/*EYP85!_1)AB8V@!168\$[P[
M&E H:C3GJ%9NS;09L(IK%HMLMD5'T\5L(L8A<C1;7-]RQK3/<I=;_ P .Y'/
M4D=YGM=,B[6T:"S$ZM?+RHI<6YLC(D@(QN"2>=AES8X#VL\"HJ ],F9D$Z0_
M0E9GH_"NR-N;9K? 2?/%R1!XDLBPQ2ZNAI #M#>R?"6P16L9[5)T^TJP\3"(
M_Q*[A!*59*>0#.L@"-<388'S(.\3&;@9T&^KOH_0R /_,_<?PA!M#1 5G '^
MX T1&(^8-Y&B)2>(#Y&+TS@E+*CH0LF":B5RVT@34WF9GJ35N5F.%!"Y_Q0G
MA__:/!<H';8W"3D/.Z:3E7H[T07LJ8-=3)EL7X%LV:4Z31D?-XQ52HDZ3%9L
M6-G[BNK[PZP O;H]&> 4.&$#$XF OR>(3,N'97 !T+W[EC>1!V Z2#Y\O[\?
MO)_=QKU[2:G[3_G\3HETRAS<A#@[AAH5OOZHSR6(IC)8]RN7##X6U1H9WEZM
M@=X@MJ*9W0\9IV+>WFH.;[FCW13/OJ  :(87LA#&--J+%2J#BWW/UX*^KFAY
M\^0*A;L]YMAYN\**ZD:,5E.^P;B&[L]>L/A?"-B+Y@\^;BF OYJLZ5,^5,.T
M\4=0W4Q.:W$9VJ<\!@8($AH*:"!!P6 !@@4H%/\D2,*AAFL$&1H42/'@0(<)
M,4J,2/#:P((:,#[\9_(DRI0J5_[3MX)$AB O5P31)[,F39<N808AL6+%SA49
M?/K$&63H4)HS:QIU>32G3*=2;]JD>;2H34I.D1;52C,F3ZM*G0(M&W:F/J\^
MK5Z-:1/LA !RY](M@W9%&[ISAQ2%(!><4IGYY+KH27.$7KEVKY91C-/*W)D9
M!@=PL39O8@-K?4I=&C6PS<\^*2D#BE,KTY=N=\;,8+-J$)E>4\>FS=4MU9^B
MR\9VO;3JZ* NS<:$FG.VTA6H@6IEZ?SYR0'-!E O,7UZ">K3!UB7SAW[=NW5
MKXOOOAT\=>_<L7#WWKW_?/KW[,-_'\#>?/SM^//;KQ_^_7[C]1?@>^WYDYA<
M#K"A7GIXZ,5@=PCJ)4-_]'4WA(1Z/4">@/=Q6)]_Z=7G(83Z?3ABB *F*&"!
M (9W7GG3W9<>C"22J"*#ZJ'7'4L&#210 2!1H!!(!?B(T$0_BG30D!DI5!!)
M4 Y4I$("(=2DCPD%V1"4$UF4T)%31B3E0A89=&!E#&WIEUPK9$1!/(@E.$-"
M(!D@UP@873&7/ANAZ0)(&K@P5P0SL.F/CQI@B.=#(%DA9P .L+#01&P&H ]D
M>,Z@YD,$/3J7I$XFY(!<$ PT9)R@SB"F!HKNU2>I 4"0Y H34.9/"@A921*G
M_Z?Z^I"9:@H))IE;9@F20$46&>RI"7D$9$/(CB0F12,YI":E0@+)$'3=JE04
M<^$:9=I-,XD55EKAPE04;D*A>Q13Z5:5;E24J)O4N%,IQ9E,G-F[+E=04?4O
M4CBMY94^^%YE+@D3\$.7/R[,Q%--+#PLES]64#4#.'+-D)9+L>;A+DT6SQ4Q
M3S8M*LM-+,SUC;U!H)F'6R2X &G&)/1;'%%?K7O<O/W^%%1N]2X%FM$_[P1O
M4O2^1572+S%5G,%C1?WTQ$B[-?2^39M6EK=A1]=,=NQ)EUU_%:*]G=EGN_WB
MVC1F=][<<VN'MMED>\=>WFA3-Y_;.I:=WGQX>Z>WX/]IJ_WWX7&[7;AW]60H
MUP>,LQ>!7D,POEVLDS]P=X4#P"'#Y'-]7EWCXCU.>." (TZWXI"'_CKHD,,.
M>.RLO[VVX^)AP3N-NNL-NWUU,ZXZ2]0J9*2U(R7[T:D6>0111QQ=6V:Q'CDO
MTO/:#^EE2!U5WZ6U&T%I9D:MJM\10>IO3ZG[34(_9J*M6J^^L^XW[SSS^C>)
MD?^L5 !+/22 #.&5_PZX$/7]#WX,Q @ &5B_[U&J?0R,7O@^ KZ*3*LCW7,6
M0\2WO/.53WL2@2 '#Z*0)K%O2"KD'TD6R,%MH>\:8@N;<H1#G)X4YS4$ U?/
MRK(4W+AD.4Q9&$Z<DL3?Y$3_*;-!SEMXDA35?*9H.30.;_:E1276:RM">XE-
M2!!&H>PL)_H@BAB_)D82I-$I/3,,:<#X1K+HK(U,:>/$:C,5-/X$7V%!CFQ<
M4AJOS(9=\3(.'0-F1=I,K(>_.4UGF!:OJ<7F:3K132,#:9JD\ 0K\&(+N59P
MP["I;D5Q,YM\5+<C]Z '1&DS$2O;0Q\5\8T_:4NEXF(9O.[8S96ZC)$L132=
M!Z I "/8T  ^L(RYC  .(OH ,_'TG^G,I0(E8(\S(24#&(F(<<YTQUR\*1Y8
MPC)M;?ME+'M9('2NDCZMG&9UVM:V_>2M/NM$SX[(V2%5!A-O+.E5183UH_^A
MKR+F_T.(F&2()5\9BZ!,VI[\I(5"^3&/@PTE(0(-0H%K?,]Y&]TH_;#T42D%
M2DA=XNB71N+"B P)I0HT*4=CVB6$R'1+"[34"A:B+8HP3Z0R!59&.$I"(E&@
MHS:]1DVA!$&2%I6C-L4HD<AGT"Z)='KP.Q(*Q^0L+;TOI&)"Z$*7I28R(4N@
M0*+2*+NEDW+51EW,B8I,F/.TH0S,-+ Q2[B 0S7:]"8UP,'KO"A!F\ B<C9>
MFYK.T$+(I^UL7EE+%[@PJ=BC)2<VXL+DSHR&UY]X<FK#J4G,.-N;S5RV.(A\
M"F?LBE>X?DU>E(3:9&_BFM3 !#9OL6T7/_G7JH'KDRGS3/\EK_96K-&K:0@3
M[$[2VBUY,FAXB!LGVHRG.-JY1SV_DUN.V%:[Q6$7;LV-[MM -SS0I6Z\N[.N
M>+-S#F:^" [+&,$VW08'.45@O7+QP/$&@ ^Y#.$ZV7D ,]NSNKX-P+X!.%TI
MS1M,\AH/=N:EW?!Z&6$=G=>_X37O.0G<.NB^,G#>_4_B-MP?L[%D@4OE(/NL
MNB3I876%NR+IM:1D48P^!%M9U6 '71P2:&&/A2*AWI. )$/M'70C5N)>2'AU
MY )"JX \A0CXJK5"#%YC3W+IE F3)!'LZ?C$T'LHD"^R8QP_3X _;@B7$>BL
M9"6YR<US\HO#Q+X>%Q0C:Q[K_5K_N*N"WKE9=N:6<IVSQ:J-*[5'Y V[>D86
MA%D683X#2U+4DC6_!F:*ABZ88XMB:-@$QVI;8YA<K0*;UAB,B* ERU1\N-;5
MAC$#CQTB#Q=6L."(IC5!@>(=Y:K)3O>UM[MU[*X+MLF:O$:VD 2:582]EDD7
MT2E><8M:>A@$1X-L+(&I(EH(G6W>-"?0SLGO>A(\H.#ACKGI/)R \!GN=0;(
M=R%ZCW[J6>Y]QO*=JL-E.2D,J>"54CP EDL%!L!,9S*NFL%CPUYDU&_Y5,!T
M%JIGN/.YMWMKM]X@XB:^71F>#.?W/\YLT8?FR>\"2=P]N,OX.K63/*#6*21W
M[JF, 2K2_[-^]7I'%8FVNGK1GB(T2%$-5K9^+.26(TE9& 3KS:O%)(7N><<"
M?:A!%7H^BGS)Z C%J?*TRF;H(;2L1E(@C[V>T#BKJ:,'3*A)4YJE+;F0Z!>I
MH-6QY74O";2A,<;JC+<JT14S]")'EF$!O,T2Q<+K*+CEV5>FXANL"4TG_^)-
MOZS(FX*YVFFHL2W2OG9$I.RKBUSSU]$VXTBC!"RQK$U+K1,KQ;@J [F5S*%,
MZ'I9R"(>]50L"V%UIEN!4='2P\ZBOQS?6J$U_O9&&U=;P(7J)OX5LI[?#7 ^
M$UB<N%4UJN=DXT.;6^.D5O LZ:;K\.8WA3]7P*]SG(5?V<L.Z_^MEH23KG=%
M7/Y;0@C<Z;\N=_76R^L.#W,!B,"$L0[B&-@'P,&B^,/GM V:]!?:/, RW1=V
M%4^.>(#I6 YYI1\WI==WV5_K&$[Y/1?^X5\ND1?N:!=],%<M81CZ>9AX"1/Z
M#<X _%..85 (0<_7F5GU'-F-3029I4\%K=FUS!B* 1E#]>"V9-FT;-6T9$E6
M65258 ^TY"!$857Z?- 40H2/Q)"=+4FF!$"-<<F6E8\& 1E$J%"PJ-W[U" 2
M(HN1V-3RU% 09H0.TMB2+-"='6%!D0FV: _>M<KS0!#=%9 ((2'VA"$%>-^W
M]-!KB-HF=9HGT80CVM5-8)MAW!:\@ SE\7%2$ZU%8&4%:R 6XD%%:Y!6HPU'
MRERB<3 %("7,[RUB;\T66%@?\#51:G@-5C215V31$1'?<(S1+1Z;T!324H1%
M7%W:ZE5;N0!,:F'%;#1;;/#:M#5;$WT-5-R5-!9%\;756L2:NS@2KA4;;VQ%
M;R&B2F 'P0G3NW63PI4@BOC2.1U/RN7(-?';+<%(NTU<*IF@@,T(,+E3B)S3
MQ@F<-*%7@=R'G(S =## 7)R#X92.,7&(NLWC #2<7'03O0$3+W&3Q 7D^*T(
M/I+'?K12+>U'1@K8NH$;.H((*KV(QL73+JD;=_^L'/,8RY28CQU2"\VQ'?KH
MY)OT'=DE5!T624\>RU=5U9& D!U:W4Q*"QXF8=I9R]*]STZ*59<D)0E=B1R2
MB4=5$ .!B8T-5%5"Y93!G%#:79'T"B NSTK%&)A12?.PW9@,"8\1Y4\F';/8
MU$[6'579X++P75;9F41%%3FB1"HRGV"U"ZH=)KJ,Q6$NS/7Y1+M06O#)%F&-
M5EP1S>R!XB3A8E!(S1#I#.5)IK@X7U4PYM+DQ"AJ36(>!VAPEK595FTMC&N]
M55Y=(FLMIM&XUM(@'A"%H_51C5CL7O.U%O-)']0@Y@])WP\!)[^HQB;62Q7)
MWFQ&S>4-)DK43MGTSCK_2E<$.I@L^8WLY(X(EIOA' ]UM0?_Q8W?!(YVT [^
M@=AYBLA[H@V:C !YH9=VH D>4 <<^)\)!$['9$@$N&"_L0T%RD4"#@Z(F0V#
M!L_Y45AW2N &/I<_HH[ZI:1YNIN\;5=ZYHAY2EB#+4X&JMQ**%#9<1F7I! (
M"5E65H]&\.']9%4.LE"7_62G*%WW2&'W?(^)O@D4?L_:S1"2#>(@QFC3E2'.
M?5D<4L]6+J&2^:4.[J@ <=F3N!V7_.6>\51>YN@3$@N3P.%5\13_@.&+%N(&
M=90'-4N770^5\:!'=0\)6*=)G")CK1IM.5)G45%0O(NT)5]A4E]H,-_1!*KG
M_WWB%;U>6WS1;RV6ST!B(SI1:?QB3%Q>7.V:<3!:3!R2#O$$:BC2716:&FV6
MIH7B*68-[GT%)&D2H]X$<BBC)EH6$ED-HGJ&*,)1))&1\@6&71E6)TUJ9X3&
M(KZFI'6&4LBI280.A95D2BH<+J7(AKY;*TU<?#A3R74'*K%C?KG?1^I2/FD7
M+XTD2&('>[D;B%@'10: B"P*NKH'923&,1$<>W2.7."#?$YD!:J'M>+K+ %D
MN<8;M,)CQ>T(B5A'.PT(=HA</+9(=L$CN+I2QJ7DMZ;-RM'<B[%=0TVE1Q4A
M#8D9E915'?)A^@!FS,78];AE1(7EUS5$3H;4W4&=M?^<)9M2U$#]W%A=B=T=
MG8^Y89@TRI*05?A<I=^1%$-Y[%)*)5"6Y5->%$)EX;08I0^B'?E8K,^F5$_Q
MG%/Z[,5^5<@"29.5G;%B$FF6BVN]JK#-YNU9$FAIGK =4MHB8V[H)B46G[\,
M5M2<WFFEIFPZIR==DM"D%C*61>M58^'IJMRV9A(M![U<UE-HEKS82V4JC-0$
MJ@[ID&PFC;2-(EWIIF+>RV0%*V:V&N\=;A5AWF?0*FQ,4A+Y5M?$J;%&8(,F
MSGQR6'BA3@!BH"JM)__QF[G-KHA-EW3Q*^) '(46Z+)"BG4 3T!"BH1,P-K$
MRA# P0/XGS$ICO1B3 *FQX'_!@ #6)@[V4W[:2",/)CYJ:.'K2"$AMAT6>#M
MJ(<SM<V$*=@&AF<'=EPWR>"?H8^8#ID(K>CTO&D&76D51@F-&BD&L>D)04N>
MU2A$$=D+08]01F&:62&1/DF*I=#?58N>Q=P5_L]5%J$*C94'E1V::9 :2J&S
MZ.C]1D^:I>B;60F<JJ'U3)G:X=B6 2D2WN\(6928K1V-2JF8LJYU@N-PX(:B
M&1N^R**^1)MA].VA_J;J1A+ 6)87A4:\D!JJAN.QE48LTM:C'1H@U2H=(1M;
M<1:^$(VI51LQHBHR9D5IZ"D3%?'6;-H6?>97;.*UL95A]&:A\<P4.=H2;6,B
M50UJ_Q@2UC@BIFE>%$F;&UN2%1O%).%&<1CK/S#(/)63/>H'Z]#3^?(K+ZDD
M=U KCNA.^G98"7Q<Q9F3*"\<2ZXDXT1L?>Q;MJK(?DT. 'J'P4G' P9 .C!.
M]0: /_#'N:*CLKHO+0$LQ6$D/\82*]M3*^6KBK#;B+8(Q$'HP)X(LT(D,UM@
MB5'L]O#L#,ELT)XLB\D/3UD=5&+96.+AVT7M3/DH4.+ELQ3E5GHE4=[=F_$*
M#ZYSF:QSSJ7LSHW=6](/5[5405!A0&%MVLEL/:_SG]$LSOW*VWV/T1DE_XHS
M05,A".EA\X@LQ?Z9DL ST98/4WJMG-HF<RB?O:@Q)3&>9__B1.!R(G( EO8M
M(FREBVK\5:[VILZ HR'I(F1:XW(DFF]BHBB6:JK%2\PD)C@:IZ[I$&T*WQNU
MEN,^GJ]E7Z4%7^<RVB*ZA*TMC!.3GJ&U]%47M:YNQ63%IBZ&4F[6=&BA7K$A
M=:#VUKT L76F,C$';X9J:_SU;@B.$WNNKP2:#1P 3_EN($H.-G:J+W?:;GE1
M!\+AR7K.%SY, /8ZY(&E1X#BP7;\&X(&3_M>6 D8V/6B%X669_G938C.+GG8
M#CJ*;PN^-H$1V/?*5X41=@;6KNO>KH@D3T-7[:]T<PUN$(XY[2#"CPV?8?_&
M$ D)I?BTV?;,* TF69#-9!(F*<[_]M@&P:AU8Z&*S1E$ZS"9FH\:NFF8:$0<
M%I#5NFC,P:%VGS#XA.'.0F56TNB8JO<6XIV7O'=#I/!*$917>31\?ZF3DIFQ
MWI4<\]:A1I$3'S(5C>X2XVFD%9L;Z>*I79$GAAK54-X;@5ZB3=$UDDRLF6(9
M.Y$2)4PR<AOF=7%-T\1L/.-J"1&C9>,4#]98+#4M*K*SY;B+CU83 Z,6&1Y<
M@_$5]68S9EX4([@X(B83:=(2A1HF\JTHM2YSE7)+1E>^ <B4<PB\"=@ZN=^6
MITA(KLCKFF,K!RP !T#XOS#18S)C1TO61S&-  MP!QM 2BW+R2_S#1PT S3A
MR<=1!H5XAX/(103_G*-%9ECVBDAVD)PGIQNR?CDNK6>_5KF_ZNLQTZ.$\4<S
MG(Y&@KD^51<Q\T>^.A-+>&P]>QW1WF%<8JS-BK16P>72OJ6HCU5%411!W^Q,
M5BQ-39V3[HIQ-^4W;PO-6F6JB]G-Y5W<)<F4 BV:$6U9"CO2#M5YN[H\4^G8
M!>U!NR'4MES*]IST^#/75HL%<\_.P;,;"KO3L>E"&.OA=HU?(2[W7;%?11X9
M)U:ZF-K9#DW,+.YO+IL@"586Z=7/9%+!1 7>AI(XKG4F2E%S0E:H4057 U$9
M-X6,ZZ*KJ5Z_KV+C25)H'/'S16YPW45J.?EE5B,M8J(B.9+37/QL 9MK_\ZF
MPC>NJ!V\%?EM,E91W Z%)$=HXI ?AW'O!=8K"UJ8"*;.@G7<H5,R_*FG[.(V
M"9Z2W<CV^LDK@GQ.G@? ?ZKC R(@>RQ@>/3G7HR8U\_VN9Z.^T$8\MZGB*[?
M>*7@\3!H>9Z]T$-.7VL8[EQ@:F\.#,J?\6"K@)68/9L=C\7A%OI] 4>)BQI9
M4#VWF<(01JWACTF9]]19XV/A%GH0";1!,1G3I@!9Y;/ _:S9XR=IG\%/XAL5
M!IL,J' ^>W.LE\P%!!P$";#^'M)PF[GW=Y<A_C8E  WA%/JDDH"$"-50&@IW
MQI+95U+T<A,A!WVMH_&:N0SC3S#JN[1%N.C&)?_QVE2\WIYJ/.SEM*-F%HD/
M.?4[_U'$@T,. :J9]!*_VA<Q$F7$PZ+-^!93D:01Q<1GJN2F8IVN0/M_C59#
M(D!D"))A11!]!1$&*2AP!8D5#X.0$.@PB,$5E/19M'A0H4*,#4%N],BQH,./
M%"5V/&CRH+*+!T&N%)@A9<85^CX:'-A19\:)!5<"M2CQ7U&C1Y$F55IT )8!
M3YT.*-%,*M6J3Y].Q6I5*U>J7)V6R$HUJM8!5LE*W=KT[%6Q5-^RO?K4:E2X
M7]7258O6;52[<ZWJA3J8[0=_ 1 G1NR/P5D\B<_!D?MT".2G]1!7&#O@'+C$
M6$&OK>HA\8/ ;=N*U=O_-6O;L'Q3WT6-5;79S5'GHO8Z6W=NK;A_K]XM-:QH
MXH1S[U;ME.Q2"AH*4""A@81TZM8I%+@&?7N!Z]>G5Y]>0#MWZAJZD__NO3IT
MZ./9:\C^_GGY\-B]ER?_G,3^ZN2[VZZ]\02$3CKKQ*MO!<48+*.\[.*)(  7
MTI-/O_D*: \[\P#DT#WQ./R/'P83\V<&Z_8+T4+M#@O "@-;A,"^[+;+3K\!
MYT.P/OG^>Y! %4'$L,8?]?O.QNB\>P[%Z*;3<;SGKE'O/Q4%S+"^[OBST$+^
MLJ1@J2_!+.JFABH:,R9*&A+H()K,#*JGG,B\":>,RK3H)C0-0I.C,G%":,Z-
M_R!B4Z$^:6)((H=LXFBFE.Z\R2 62"31@(IP&HJA/C'%<U T$<5(H199& A1
M1_O4B:!28<HT384H&E,G4=5<=846XU%S(TI4$DK10PMUB"*:-+J3))M8+8A5
M-F42M:.8$&)449V$79981T-JMMH^'6HTHVTW!>E23FUE*,QQE<(*MZ]4DZL9
ML>QZ*RYSSUI.+^9 0Y>N="5C+MW)_L)-77?O%6RP=9$C&+9XC2,8B^7V!4VR
M<R0L48; EEGL@8:;><"S $9X:N,)WH5CA,1&4)A=@*FJH#2$BV-+7]Y>;HO@
MO,X%;6&7=7L77H3WTIG=@%&CM[5STZUK8+UF9BOI?_\1YLO? 99BTL#SLHQR
M:JFQ:_))^ PD#^OPT//.:JOQRY#'][I&T3JKI29[O!7/_J^^ ]_.FCH2(E5L
M J\+V)B%%/LS\+X/V?M:<!ZSZU)KZO)63!^I S<\PXTAX#&Q&0"'+DG-SUY;
M;/901(]SM1?'$#S.H^,\2+ 1S-!LJZ<;^SS8D[PO/R7[VSQRSU\O/.RPR0V^
MJ%8+I?0BE_:<2*"($(+354QS);6C44?MR<]52:)HVY> "LFG8J'U5:A8.X*T
M<<0F/8BCDT[M?LQ#724_@WP0LX+8,JDOJ7N4'LK6IIH\M1,W"81]] L "UJE
M/5E]CT[-8LA)%F*]F!RK)A:?@5.N1,6]B!2/6"QAEO68EZT*ZF,F&;03\TB2
MDU1QSW\)X9;PA(>:$DC&+*\QCFW $AK9A$8K.+P*7'0X&=OLRU^LX5=6BHB7
M([K%:&'Y2VQ<PQ:S3$4R5)',5:IXEK3@!@Y69,L5=X,%R5PQ*F 4F%.N>,;0
MS*4$+4O-6IR"F[+8\#0_W,P4TP*;-LH0+T.\2V#ZM1D>AK%>4AS.< 8S_Y6E
MS X\V9D2B/0C(!3%CFK7 1W5M#8W2W)I/0&:&NNX5J0F?0>26#J/?=S3G<5%
M!P*)F<!V-/"-%@5@!3!"C NN9)[!)8B4:+,;V'!TGY$A)@7?T( &5C#, !B@
MDD4R&Y(<@!@952=&N1S0C,832BN=4I6=:\\SMR/))W%(DI@$C]CDD\X<(4ES
M[/RF)/-3)1QALW-:PE'7- !#<KD0?-3B4Y]"@JQH%<M[*L&3K1)BK$8=BD\*
M62"NN@>M;G4J>S/QB?B&$HW+B<]7$OU@G$384'XFRB DR-9&BN<G- F*6M4R
MU:#ZQU)L^;,A^N"HH?P$K4JI#T[Z^!ZR=K*I//\MY%<PI:BV!I74G&IK!<K
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M1?0A?\(>"@N:IIHD5%;,RV!./A*/Q 1J)'Z:P6)6X()9YJ%8-)E!&1+3!GU
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MGRJ5>2;(><V._]+@!","\UP#:GI&JLC@)-"TYR/*SID'PGQ!BQD%Z?[&$6<
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MMF=E2]A7I7&+TPK\)'C7911,P)8#3;F0F &LY<59<B(&L$).!3A085CP_E;
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MND:*3:0:*I-"@IL-13BP&0X3@_/:<347U8>5C62'=HVS6"5<'(.B:J+",0J
M=BNJ[A?-<IUK89N%-S>Q2K//DFR>"/N/^$(V:"F;V7[YUI,Z><VXB/8;38+_
M\K"ZF<I.'MF:5GO;)SVQ)%/RVLA/#PW72H93?;.4.^]\2;XPCE!^[C,C5UX4
MQ[=\TGSB=E&\^0?@?I.E>/6F;_06W)U' IO:VJ;+Y.4./0<M70"&$*$,V#,
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MG>>?)><@GEP![5A8?F;IC5;:[5S9Y6<WON4:75+@S(<K\+SAHQ/4A.#(E67
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MWE7/<I>,C(4D08(,Z'?3)-U_=O6S;*XA;-_QI6&]<[X-UO^<>R;W^4F.ED
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M],B+1/$4,F_T8%#=X0Z:E4>WJM#D\J.&>3%O4HS]AEZA5IU)3+4H=BL[FJE
M(K80MXA9..7_7K19*>->GM.<V!#;Q+8/(XOPTB*E*@4SIDY"2C3DP.]--!BC
M7K1.WM -GQNK6NJVYH1_9' WU09@R-Q#)9'>+2Y]%:1YK(692%('WDW*1@RF
M4@@L1<S$J1<?7LQD]A$Y/\P!/2Q]DQ1)1  I<U4Q"^ ]4>2D#.'+RB>=E1-*
M;#9G-=Y02702[AM+*PFZU9P5):S%.L>'XMJV5A#E@)M*_VZ+^K)FEM_-]MJR
M).X'[A\L.JL6FF9 ._\I&:8A9)$BE2$40.E:,X]-J'3A ^Y1W>KE&BHS:8[U
M".5F4,GG6(<5U'TX)7<B<4 <\PPN+*ZU=VY/?L9HKD -PP[JDT/:1?4FW=PL
MU,H9\OD7I?T2?(YL2TI9#]$.,O=6J:127),FVX2,B7KV#R(*LUEKBOJ1[(JL
M0:4T=/J=:9CA5X?:]QV1W;*H$.[Y[U3:A[-?+ML@']89GWLNDN-50,WH6%$1
M5W?BVNW&[ I880%'V$U&+G9@,I)W[)3-AU5HD,@0%S.AWLUU*#*6/N/K0DJ+
ME[X.N1@?%=>>%^4P*T467;\T.Z*1_*8ZIE](Y_0P6K!&I0KFU3IU_[J<\<3_
MHDR"*[5>9Q)UDF5U<)W?I^4BT"-C&!/6M"@]'%&Y&=!*]HC<!31V=C-):#1F
M#L]:BYLIJAS_V(D"-A>;E9G*:\U])GGT9)?[ZC?5G2@I[^P>,]248VL@>,T0
MB$R2VL9=GW-?"-UUT3[[SG:4.@NZZU3XGU"EGV([*O7(Q,H=Y(\=]<,P#5.4
M58E@]0/;5$V42)LB7;/2M*X]F ]_\2U?H0.!V,T#(X/I56W@E "K:4&:\>LE
M(,3*(QOQ>2(-&9-7X)@8'\^\>4M-+'L=+M<X(ZI9E:3MI8T[3 ,G;#<5\\Q/
M>=SQTGJA3PAN&&1^5LWN:=%EMB%)DM@R2QU1M/T]_[0XPWD89L6E46R07[+8
M\N2CI\0\?]J8VSV*6^+C2'S#N>CG_ZG/J#BYFF,S]3=]9V5]6)EQ$9@F<I8[
MMXNP4/3UR(IWXGF/G[L]!?KMX?P?:ZO$0NR.@RPF(=&V:6UP&Y>^H5#1/O4Q
M9=H6 M-^OGG7TG)_?4_))*8:12U;DU2]SA$04E6+]$?9 E+F/=&SJ@1A-FU1
M$GJX"*QWUY&R_V. \I\[0N'XL2 &NGQT H0_</X$.B X$)Q!!^ B'"PX4&%"
MA WQ(2SHSV!"@0T7+L2X\>-!@Q@A0O17<23#BQ5/^OOW$N9+C?@>9FSY<2!!
MFS;!T32X3"+.D3YU"A2(K__CT:)!"=($ZN^I3H0T3?8,Z;%I5HE$22;-N) F
MR;!4<=[TB' DT+,A?0Z,8'(D6()7_;T5FI,HTZ\'R5K=NO2M0J$D^=:%V])J
M7H]44PXN6G.@6K1SR=X,O)1LTJX:C0:-BU9C4(L9PQJTFS%F:M6K61<V&3:D
MT8>&']NE;94GUJ$7#>9%G-6A49N(]VY>ZA5G9LIS,ZHMF[/L2-N,'4XEZ'SN
M39RG2PI7JC%B8X\[OWNTZQ<X8:58.6/E"GXV0=L_.5=NZ5RPT?FT;7,.656J
MTVXC:CJC&!.M,<\>8HW!!F&2JB8(6_I,,L$ZPHLVV,:[Z#+'OG(+.K\$HPJ[
MT2+_?,HJ 3',J<+"M@/M(N<01*PMS?X;S"/)Y+,.MZI*(^XZB4@K2R2K0HHJ
M+I+P>TXW$#^B3D#"%KL*0\UL6C*G$94J2\.+(A1Q.>@4\TZ@UD8#9YFE3GH-
M32F99*ZJM5C*K\W0-ER3S-[:.RA-S@9B"4^+E#00NK-&*K+/\5[KC*/-/FM(
MM,%8 G2C/TULSR),%3U4I8,:\M2D-9^JK#>'/O2TNB3K7 C2#^\$"<Y6)\(S
M+ 5!4LF_"SE:]3#@+ QU1HT<''8U/R$E=,U==WWRSZ9"C7 HT-+LS$!392-*
M3R(S:A7..UD2E+!O\11,2&8W5'!.WK@LDKTI?56)U3J/FJUO,'CC]%4DXDI*
M*2)N?Y-(UD]I&FLRO68,U,9O2[U)R&97DLW0_\Z=*\LV^_UHH43G(I9CF&9-
MB3N; -VV6@BS1#9C-QERV-;2_.P3XBK#S>Y'[^R5JDE.[TPROA_/FK;0AENB
M#KR3:Z[3L4C=I=BA&K-K.-MOIW5V0K8L1KI-F\\]]MMYHYUP5>,0 GKB29T%
M^E,[*UYKMVK_62,*-C"A8LHSZQR0;"PO:7.M.-AT-(U'BBOS;;[# H/.-B /
M3W@YPN""T7%^BYIX+J NTTUE >]>.:P.<5LOPKFQBN[?=;O*=UN9I<-0*\56
M_HQ<ICEK<2^A&]>LKP-G.^]'%3ON&'7X]E:92&H_/'KT0VFZK+^]<I<MY.XJ
MM+AGC(TTJ<#)1(?.,?NJE3LA[)SR\RS8]-YM-XLT[\[DT!'7--_M\]2[+]EH
M2Y_G'.%CZD;K?FP613CJ3.>:)1?];:EZ'_H=Q_9W.2?I[UP\P5;=]A9!+SE,
M1]=S&> F9J3IS28T>8M/J?"&F>]TJ%9KP='*LM.?[)"G?N6*2(:*_Z*B"Y6J
M,25,G/U.=B'9Q4<[< /;_;R$N0GIJ#H?.<^.?O69O04P*WL1W_EFTY8R%4LV
M#3Q?IT@6G!\Z"F>H<ESH(B:YN%&D6HHRV:%\Z$-<,8=J,&*AR !C%MY8"D)Z
MNI/#1D:]*7'/6*&YT08UQ3*!+&.&M6)84D+EQMF4RF!%Q(N8%G47G57E4WK4
MGD32E+)8X>N1XUH@L009KK7=:T[P,6(5<8;'>U7MC;%YHR<W9+ZS0&I>B2.?
MA%BUQ0LEZI0S1-7+0@FPQR3$BN)RI?6>PZUT121--<H))Q\BJ\D)+6,F"D])
M K@82TWKEN8JX'_^YIUL?>A3\0'DKBXIL/_.V&24PWHGT^J52:W@TG1NVHS&
M;F)%O5!,<D Z'1WA2+*%F4ALCWD(VNBGO7YUYU%UHP@U2462M'E)D>C*&JY$
MMJ?@]5*:9E%EI\15OWD2S$/+9$O5RMC/2]'2CLIL6R3-EL21M*8K0"&:J_BF
ME,5IY"W[*9>1J&.A+<WP<W;;)+Z*!CKMS+ WY<P/E=;E)\0<2W]Y"UI+7*A3
MUVCK/I]["D\K]338V,6!^ME7_%1$'29J!7K_-!($5T0CB6$J.?9[$:?N,K[R
M(= ^X(BG@Z+H)" 2#3BZLZOG;*.Y+=7//%![F'&&TQ/\0'2ERPOA]]+RERF2
M*RQ>+>P*\=<TM0K_QW"%*B943PN^F,%.31PT;#\Q%DK'HC4R(=K06DHTS[DE
M-CZBY:E@WN)/J7#%/MP9;(.*EA2JU.RY68Q=\^(D)L.L!:& >^S<*J,C%/%+
M-%K]*)K\<[BC7H1\JN4DO>QJ)0FIJ;V3[4M^[&-%W(:)D=CAR7%RN]->/8Y.
M$$.O9FD&PE3-3%"0A%VF,)<^20Z/=@LJ5F/$N,=T<M&<;=+0'!OW4H3^T[3B
M*1(:%42][R%LC)0!C7FUBE7T%J56Z>P,(JGI'2O&CZ-CM&I3OQ8M<ED07E+2
M,.NRB<]RX8F9L7HEY4IY2+R*%R0H"964_14_<HXP*,MED$522"7,O1&A_Y2R
M7T4ZR3 DAS)EHSN=;V<6MW<!DUJ8G240+_BS719):Q<4L&_(DS*-6HF/>51H
MCJ&YSW$AN6V FJ:[E*,P#U7M-U,%V(^;VK(L1@E&BM12TTXI%"V;B8W3M*9]
M#AIID>IWF@6UGH[>H]>9=.LNT_H?:MNF'I2HVE8[H^9,J45/6NV+@@!2CS;)
M>]5>URY;@W*9XFH\.@PC3&W '-&L!*G'(K+T9(\SGL-JFS*%]9"\"Y,R?S\%
MZE</R:)J.]5O(F<D?64XK) ,K8@$F53D>C%ZC'23B'V('='9M&*$,:\,"0ZG
MH?5Z8*-=HF^P991R\H]4 $RO+-?X+/+8^JB6Q?^K5S7B'!%^O+>'43,2LS*]
ME"BGLQO^]&H8WE<F8E8A2%R<>K [/!O-]7&%TVZ*4LUSVXK<,HL6(",[))BQ
M^E3;=O&J;*DU\YS!-4@1A-' K3BDIM*SON_,R64(B'#[+?%4@;-+=&,W5[5R
M"N5%\?@Q:6@=ZEH/-2M/C:M U%G)^1"]91>J<\5RPD9J?9M(/9>__UK)?W6=
M7=I[>''#1):&.SVWOPWB-:^KNO/J]DG7GJ:;W2JSZFDU>5'/RMO?VDJ ?I6H
M=U076K6>\7^_^ZXO#/?36)-M,C4;?I'V*)[I,K*8145O7.Q4R0JVS4%)I9-(
MNW77)'3K:FZ'MK$)-4;_HVQPU<?Y./F$T<U%&DY%NA2<!=P31TOLYV&:']&B
MUC.7LWCIF_711GCWJ#$%F:[XR#TU2_7/%I,?*%X..9HFQZ6\;>+<Y9?4Q<9B
MR^":2J8"Y,32Y8S8[\R*IO\J:V<R3\76S&"\)6O82,#( Y-0*ZW$)ITT0P*G
MS?18J[8JS/;^BW*<C_R\24F"HNJ>I5>6AB;P+R: A5NL2M/0A)'H:,&F!EQN
MY6OL3Y]0+FQ2QY-N!5EJJ[F&KY<,QM_XQPEKBBJBI.P,I=AJ*=/P#(?PR)16
M<*A6J&1.9_N<!0=C)I,@CGN\@F4NS/QB3D%V:_CP"M'B:,%4Y8980\$L27"B
M_ZZN)D^R6L?A@L*\8,W> K%Y[D=[_B>%WB=(X,A(J$MYUN\[#L1;;D^=S*BV
MHHN(Q ]]D$Z@!&_8&-$Z'HEUTFWT[BS)]H(/52E?A,B)[&[K;$?<*F6J;BQB
M2$(''V1F-D<N> ="]B.RELVT$$2]?NM_P O7UH/]? 1+*N@_JNZT2H> UFV(
MY R' "-2F")N()&_ M$O\D(Y[,2TF F)?L6OA"=P2G&HHFNHU$C\=#&,G"TD
M&FL5]6QUOH1$)DZP?O$?AL2]DNK@V,JPY"9>'"#P9$_RGDM&!N=:;J,X!DIX
M,FC=3J4X&*\:7^[B L@_=.=S/F**P,IT!JZ"#$N"=O\D2.PKO;K,%E]/::J+
M\GY*H# %-C0+BN *[^3"]6"//K[,K>).-<Z$8:)IXMY$)$O0E?K$GIX*F4(0
M6&*GU RJ63:I#9V+3;+O^'I2ADY/"J\2$&$KH_P/H.2LJIS0(:R)F:@CX<CD
MP13,:%YK#&>"9=J(:FHJ4T*GIC#0HORO8F"FI*A&(P7R'^B%>ZR%I^PRR>I&
M/$S,T?B*S,[&]-SQ1F;F6NX%CS0- 1MLDY0GP83,S#:33U:P77CE+K(2^GC%
M*=&+6SJJ,[\19H[0/V)I:09%_=8L8Y"J4<K*V)*IDAS/I3"39,)FH4+",$/$
M]'A/ LN/8?RE.9YL5L"*=6S_,]4*;4WFD(QRC!4A"2F?1E<T+Y$$D&YXYG5H
MDI.X,"JXC;50R0:=R%36YFF\9JL($^XD:>SBYS$MYSC+$V/&#2>2KUWB1SEH
M1<E6<SQP:H^$23=G+X>R+;*X4AZ5(BJX(Z\X;HRL$5@P@M4N#^I $>>P(A%=
M+C6MJB(UD5VH\8: ZRHIK);RJO)>3,>T@N@ 9"X%Q<WV _BN47Z ;YSR@^3D
M"(%4"R]WZ]C4)2!_\3L<I4>VY.CJRKV"D2:9R>> R.= *Z]6E$,"[KY<B([
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M1+363B.IZB8;#!J5-F;F-"&#4M#8-JE@=UA/=8#:+DELB*4$S"1&)3T(C#:
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MU/M5+"4^U4T!3CSW=+_=%. "O *N=R<88[B&B5=-]?M$NY-VS?.2--EQ[.Q
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MX=$C\]C!?N,./_*R)Y(5#_^;IV\:%OQ8EF"Q02I*EY](F!G0@ +0 *:!J[_
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M5+1*NK82#(WD/+-3\@H1?#=V<TA:&47\,1<JJC1Y<JGF_W,SS'HAI(D "-"
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M/8PA8 &_W$0*#4*D2YGC38HH98U5U15CS,VL+16QF#%.F0#OC17K/3VJ=AL
M=JX[@Y6#(M]9^9%O09=_6Y?S@6(<^9LZ[:S&4+ZJ["/<Z0[WP9QXT15==(S[
MRE)C3J+2TB[">8\D:P&MLKF!> $3"(;C#H8B4)#EOJKF7FZU4NZK@N[I=H$B
MH&[KKN[I5N[CE@9,:3*<&UO1>DJDK2.I]>+MK!_BJS@=VN*!\]0F_VP.#)ZH
M,M.G^P!8'II(TT[E)+95%.P>>25)X MP^?;3H;%?>^P2I'J[W7N)"'B C!##
M9JU6.Y96U,443KEI"TCC#<_P"+AP-/[I++2:-.YIOQMQ!V#C:_U"UPU03TMJ
MABB)1BN/02[&_-D\328_6,6I3L7A\G8SP+H<_66.[D+<-+WM]*0S)&8O1"LY
M+2*L#<,\_4):]:$J9'X-Y\BD[!EA'5_*((LAA!@""BB <O5HN^ ,I',ML#0.
M.,6  AB8BKH7WSJN]S(=)[9@.E]7PF.-@DF3O;E8>QS2ZR#LX+URI5D> GFJ
M+ HH)MQDQW"N9FF,S;P,^U,=EM(T2"?G;?\$* [5:),#PM"FG%_;0;G9/T!'
MM#?UAW5DX2J#$:EI ;#!!CB2]2* (UJ/ 5NW]5F7]5K?]5OO]5SO=1K!!B^R
M&IO#!SBBV.71-5+OTL>4ZRQ2$F#\-?4<O@+A-__-K.I!(-J41-;CV_%&&:]F
MJ)R9E?YKS0U\S*2LDDPT-QYCJK<NM(=(I)CJ6TY9 0JP DZC+9G>7, ;\3%D
M8PW/':M!8TSQ<)S^W,\=<9WV\*+^=P>M25!S72O,K9)NI9X2Y\Y2HE14%!V4
MOQ7%:L7\\6M7DU/IYOTI.*C6Q?EU&[ZMDF'TY6O+T[N<.AZ91JT6<I4Q%VNR
M>6:>S_X!#HQR7GK_&0$II0 6R+?WXY_A4K<J6881&($AD $&8( '^( !>  8
M^  8P/H!8  V\  9P(,L[$!MGQ78=J(D,H'2. U7$UI1P@]LD2G6G&9JBEOL
M?+6[9$T_XCQS(ZC*<6!78KJ6J%,!+R]B[6#H673XIN7BT]0?!@SXK(MHWZZ7
M,S'<DP]L@Z.RXBI_.)L0N:H8J=0-<0#2-WT7,?W3QX?4#X#51_T-6?U\</T-
ML0<H@Y&THA&LXGRN&DYI4,+C>28FG^8!4=G0VTK'/#F_[#SA@HA&9J_F.4=$
M9BB^N&_,E+^,Y!*@Z0RQ^#WQ-F&=8+J.<PJC*JK2H>""6O(N;BM9,S]\_YB
M21D"3=O<: W#G+1C3-'PFUYCJ,=IJ >(#OQ&=!@QP@(_A @CO!CAH&$$@@XG
M"K3@\(4#?A$=9.3H,()&?Q$<+'/@CZ-)?/[ K6RITB1,< Y8^JLID^5-D_[P
ML30ILZ9.FC-/MAQ*%%R$FBN'QM3I<V52GCN5_IP*=2G0G3V!TG1)-6E-E5J)
MMCP)[A_:M&K7LFV+MN=-FTNW(CVZS.I0G#/O.@5WU^S4F&/%SIU;$JM4J5UO
M)IW9F"7/H&"'BE5),_'*OSYU8KBFX1H%#'29FKU+L^[6ED)/&JS AL& !R<>
M/(!A^P., 0QJ\YY-^T1L#WA&F-5I6:E+H9##%BX-.T'#9PTDALPUOGSOV)1$
MF9Y./E4YWLNI\7(%JYKH\;TPH2['"KBJU*.;4Y_6_^G6ZG>5R^)R-4KZIT_'
MY5?3?F6I]!)S!>95U$_PM11!5Q"*Q)*$[)V'TW=#*5@=<R:T$$P (8HX(HDE
M.B!-#"W$(,T(^)3X(HPQRCCCB \%TT(++DCC (TQQA #1_NM!Y=-!8JEG83@
M5.9>59ME9119_JVTY(3KS124?G'I!1Y^@CVY)5$5GN46F66BY9YE3@I)X6HY
M 4;8E43B=*0_0F:E5TT0!J4AD7)5."5R<3YY5%E'J23A2W1-]2<X*8P#$TH.
M>0121@PY@- +('4 DD6<\I/I"QT45- +GQ9DD46ECI#I0!B5.JH##G40:P24
MCC#2K1V--%))#HQT$J3NB/] %H95Z:EDGC^MF:RA@"ZZ'&%I]L<<2VM>22A5
M65(F'Z!T27LMH/,!9M.A<9EY;EOX%4>6@GCF=>UZ&7K['H-476FG3O76N56<
M?1$J9G@3GC=N<W%1!LX,&A0 W0-\!FB3=O B!:!((\APS@ ?Z/; ;K;MUC$#
M'7L,0VVV\4;R  -X4 $\7LV4*%<"8_B=/R-\1D$!)!@0+\UR$7P<LN'Q3-.Q
M6,;<['+\74?O?\X^U>"1RU)KDH0/:V>66V#ZY5Z<FEDE;7NH445>=Y!=9E-C
MI3%WGI-2/37M=G'[M[58=8GK3Q$M\-@CB2>F&(,)>_,]..%\1R -CL&\4+B(
MB)O_H)3;I4E<X,SY8NBDP85ME=C6I)U7F=D$-[F=7]Q!C*=B7YK6E#_HNIY6
M@VC3[.]3A&4FEV5\767Y?]LRK9772D6<%6%NEA?Z>I$M1BAJ01$OMZ_ QNI1
MK!9$I-&M#:TJ44.@;M]0!]V/\*E$IXX/_O@,4310K (Q-))&U&\4?V.^0NK/
M.!2XP)A9255E[]::9+"M7:5RG\.)_[ 30/,(STV8<0_;UB8VGR1P;5X9UX%\
MAK77N6Y+"LS.[E8#.;\DC2Q@D]OFQE8:-QFG@5_ZVFB8Y[GDI1!SDRD*"2AP
M#1)H@#K%6YU<"%@WJHV@ AI[P <8  /<*/%C,&BB$Y/(_S&.+9%D5LS8%=D@
M PVFD#S:Z4D$%N:9Z:AF02FI"^B:$T08:D4P>ZH/W1;SE+X\S7/-(Q9I*%B8
M_H"G0<Y+$TONXY0HX>E-%R)055)3M-.QCE&!*8R@EI9(;KTL6YD!TWZ*%Y@Y
M924"'V)< !QPHQ:8PQZ@/"4J280/7N"(%X(;'#Y^-*YW(<=V" (D@H92M:D]
MKUIMFL^0RD(T:$UM9AC<5S"IEA-^X6E,'#P75L!UMLSY<6+#<U B!?4P8NWR
M;=VJ9+& =BUK@2=)4)H*@@!$I"4A"R6[BM^M^#&]A7R*(>1+"#]&)9'MZ5-5
MI/HG]RS2S_85) *8FE[V$.HK>?_:#R2[DAY'\O& >4 @9ICK%\3(54NXQ4U:
M%6HA(9O"F*[H2SFYU!)9(&0G9'KP=/12SE">B:ZX 69NV +DG[R)K/'(2X8_
M&>*=@%:W]$00F_%Z&'^2]*#1$ T"%.!A :P0 (WJ$C)6PI/%<#-%)5*1 ;A)
MXCDX]H&PGB.)7@W9$[N:5I.13#8/4!D>,JC4<!:5!3STS K4J<QS&A"8)Z&<
MP.PUE\D($'*!M8R>HGDG)[&T+YFTX$Y62IK$KJM0SEQ+Z)!GR)J2+B;[26!J
M(C/"ORRI;EPC8#"!NBWZ*/"J?V%D67C'$E8NCG#^>$$K7YG*W9ZR RD*AFY[
M=*/$,G/_+*';HVSODD;E +:FA8P6OSHZMLJ5;BSC@L\ZD=.\ZDY%IN<Z6QMG
M&4"0,L\J_(G3#>-3F".1<)-[^@I9%&O=_JGK:LK[G.P^J)(14,=*NZ+41MR7
MJ5NM*B+A4U_X""*^!"=8?-Q3<*O*MZJ!D.\A!G8(]BHUO8U(:B3VVPY'6#"/
M;V27/.BT($J'B%)%17*]/G,,<]!KV*Y=T&[']2M]!UN>SM[)NV;"4.302"W_
M<84O<<E@W4 [-^7:+2S/1> +);,[KU#72(L!R[><&YX()"PZ^[NN&X&\E1%\
MH#8G8.(3P0I6!I#U-64]!YL?< X8D#6)560B%4O&F]H,8(O1_QU:VG[*@J=*
M1S2M[8]H(^FOZ/[40:-U<G$N%]M?:C:-7QF/F(5INJ[P9'4_/8E;WF84<[JT
MIT0E&Y3XT],R;G9 DYRC@9Q&'_96<I [!5<LW< XQ+FAMKS]=2IO% -?\PVW
MKDR6Z93)44#:.K;.35Z,)V3.:0)2-;G,D%PJZ5Y?,B^=LEV)C\M47C]E[E@:
MI=AI^2J@9SF/8LTTB;4B[6V8+F^GS14>L0CEKR%0X!LH::@\;V6K]W&O(/M<
M\/=(];U5D:I["F<X]UIEJ7U.#R,7B4!!IL=0#^=J5QPQBP@T$ TVX<Y"92M7
MO-J)F&;!FV+!_/0>QR/.0&5;7]C6J/_+2KU'RZ@DW&2"&:R+Q2T5W\EGX&TY
M>[4K)8+5\32)$A>LS7U,=KZ1LW,9 0]UJ $66/2F2OG3"#R@F[0V$3=O'BL#
M7L,&.*\][6D_.YS1'C*O/I%D7,T-R7PS@ KDA=GJI)<+;J:P* &J0$<C;C>I
MZ<(] F9#I*M23QY[6&$>KX4L7 V"! :I[C3[LFKI8AY/>SM]:RZ/ZHP*2>&%
M)L9?A2<5C)R _MYI".*./F!AS"<'=R(5=0#8OD\EXH9MVQ@$(W/F#=A>%'/[
M;9WQ:RXM85<\:UG"__$T%?RV"YWD/!S;Q^=M65H&)^WLXA$Y/K9S3")17ZB3
M3MGY,2-I>[[_D[9KN]R:H<M@-6O"[Q40)WK_=2BHQ,I C,H @H_XO, !ED%#
M*.#"'6#Y: ^#-2 ^68! #)C[2(K\3,3'R=-A>)@#X(.D3$LA#<^+F8UIE%==
ML)KF/)*DT1?GO-!]X=\@Q8?O,(E\B1:]V(3W?1]6V)B58!N4]0]<1$RF"58;
MI2#G,)GIE40 [9C\<<T3"AVG-1"36<4(7$,!$)H+S(Z[@(E)D%EM2!&;C=58
MO1F;K=TYP-DYM%T:JJ&;N1D9DM59D5T571%M[)WU%9T?(0<+1,=3'1>:=%%X
M&-X3*I_ST6#^)5T.%M:Z1(YUI2 ;91K4H9%FM4ZZ: EW2%Z6W9K3_YA06:S4
M8H"-MA@31DVAX2E5W)"<!%42HW@;4)C .! ;C01?</V>+1:;&[2 +,[(<"$-
MD_A.]"T%*%K6@N!+1HG4,7Z:EL",G?R=\0@*HE"+#!K63>P@6[0;JX6>4&G9
M>VA3M 6C.*70BGDC1G4+"K(:)X6)HL0:40S!-:S ORV40FE@@2$$0"E< KY
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MO*[*O*KONV;S^KZK/IJ ?+KONH9SNB8<Q+E*/%G<]+A/I6R<AQV&1(X !5
M92DPE323"M[$M.[4&C56$*VH3!#F<B3)M=D:7P46,L)JXHFL>,4D4< EY &&
MK4[AW?Q=R997,BD*X,Z+9A[RL> +392!=!":9[#_ $M E6<,R]+4203,F5@M
M$=NEX9,R[=-2K1(?<4TKL3O8= 6X0 5,K=56@-2NW9,"\9N]&56&H=WQ1LK(
M@ >OQ CH0PX!;0"P0)KZ* W'0]"P(%_NU>,-XY+DY-RN7NI=)B_)%YN@'Z[B
M484&5J0:+F:YC(RV7_&2%')))GEI"6%%)M7QD7$QZ]T XP)75['DBP6T@";/
M8B1?LF*;B(J JHS$4C \';X=JYQ83GRE(.L^4@P2"E$UG]A0S .IS0='[P W
M8=-M1P8/<.@5+^EX&A,^#7XEL'#FU^3>;*-=MJ#$!W@Q54PFGT_*Q$2"*ST^
M1(41I$& 3T"^JS=K<S:7_X$YT*O[QJLY(& *+#>\QB<#WB?"?<JYMJ<&HG.M
M9$JM;(0#D(/'_<K'#8$&K$!U9%8$*>CCV4X %;!F,TFC"I:@YC"F6>YO?V#]
MD<<#89=29+!]82;14>=W!B\B'SCS*E:+.M_H(-]5P*D(P8EX%(=Z>X9G;"'1
MWK &H'1UC$!L*%%19V57(C%/'_'3]C35YK2+UW2*3VU.RS10[_23*ND:>A6<
MQ5D3Y09NA&EL5 #,@2 )C)$&3$ H@4,?&OF7H7%&!7A>^.D7J9'%/F[K5?C1
M"-E@2*Y1E&:#J)\JLUJH12PB,U4IQX0@TPS4F.,_)ZHO\ZW1,$L<S^0M;]+
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MB2TV(Q$NRJ@AB$ARYYR%$M)55Y4*JM96&#[ =B9:'QB@VR;UH>!5H>KY"K$
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M,;!9$>[$'8SESWM&A%CXW!JVNC7G=VW+3/*B(AJVK&5^T].DR/0*0Z*A3#
M]1I=)YI6M.'0JWQC&L#41;6WG6>T^G*>:$E)-XI*+&%$V\L0*/""G7 )G(?+
MYN%P.<TBC6 (E3-!C((DN1UA-T;1[-R+?G2Y8KKH<HX#KS.M221KGNZ6%HB
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M;^3=S,%&XE=&XNW=OA-'EBF8XHV8UCE>8:0=E027WI,G$"??ID1UMKD>ZU.
MR2EBMW(0D4UD-X8AIT<84X[8G$I@O):4SJ-7CU$$ST=C*W15OF-5_W4N8MT'
M&M.X;-#&3_.60P/T#VLH:UYT(W&+5OD(&9<A@&"BI'(V:A^BI7IL G32IM/!
M1XFX1X<8B7TZ:8<0*"MH67IP:O.@@ZHVA*X,*J_03!"P%_-0D%,PM?J)BN+$
M]:1B4@:/H,328LG"DK[:HZ#-72Z4]C@0@^4*!(&&?)!'PV)3=BOCHF\H\9HS
M!9'&HYFW>TZOHE8&." 9L2:YDC%YDP7[1,;7L#/WL%.$L#\7<3P94^D-:46
ME%4W&-C0Q%YP1(GG=R X>F:.=?/&S +/%DVF A.T4AQE?M;'[:Z'> GTE5-[
MQ6;.U0*L#1UOM] IMEDKFJ-5<0-UL]4J,/^XUP76@U+?2WSECW3H-7+$BT?(
MCQO%<W.TTT7"47T]1]QBA/S@-4GNUSH[(/[RM7#J4SKO$YMWXE^]Y)RHJK*8
ML\P6])+89G#_BPW[RHH6M!#30O+8*5HQ%+5VPI>STK-!183]&_%F[Z\./$/1
MV P]FL(0]^.("* !LZ[<DDS!009<(ENJ15>DEH)@"LB"-@6*M(AY4@605L2/
M6,1]VFB+S(<[XH)T3(.2,F>M!6NUY2:,:HMC,#<I[@53F'DWF%4C6G<GQ@*C
M#5=[IZ/[1JRLXFW5YXX<0$Z#;6YIE=$*%!K/;J *[<'SJ=>&[V*NJ-&H@Q>A
M"#"B AH1!1P<&3?__KIFRD5+.)FP;VG;!IMT09FQL6G.'=N2';L,5+P-<E($
MQH%E?J,(F,.WQ*Y$-]*=5I4YE;>B;'6,%F-6)T6-=0A?;-5!!OR<WB2+ -R,
M2%:E51368BB7HY$K1Q3-_&J1MBI.F&I%Y3J:':":[>M#QHF6: F<[CE)6B2[
MY2U<R]%<CTE&Y,V<F\G<D/URTK$;S6M&O)6:TBN;V(O?Z@]?O:D>L^36NP2]
M!6UP?S5@3%22<MGA)D32%"[6.OK,QU;< 2.6'[KQ*/HV3TU:L3=@OA)O1C&V
MMJH[A&BM*02AW'(472WVN"K<N\J.%F,$@JY:8OHA9CKI;#IIB19IB9A'_TU\
MQ8DT)T5\""[^:(6L:1&H*)?%27MJ6J!0J&Z6J;O% Y#5XQ(1K_&#-#(=(:4&
MBDRV>AUFS/5X%)4MQ9;OL\V6W8&U,#P,384 $D#MOV>S2L65$_UL."/"&29N
M)U2V5E3P4%*,HRWD6FPGUOPV+HUF'E,6+/D]07FQ\5SL'[OL1]=S09ET?GJR
M2]DW0(\Y%-"B%"8.^1;?-2GQ@GS,MBHT<C,S@ A1Z8=,9>U/+3U.73LX\S[(
M5R5Y8G@064MEN[;,UQ2#[P?F%&_J,>LYXG($YH$-EBMV],^PJ=-;O:N<:V1&
MNC.Z/Z><Q]-RFIO<T 'VW9>7E%M&E'N]UBMUM.^]LNEU_[9DF_O9UD5D0BWS
M+OCKK5?9T6.PXM8VSO)J8@AO 9]<Q=@;8_F0*E'Q*#Y]M0L,\2;NYU7)P0!L
MS@[:U?ZT*D-;4;XX>5:K[D'0N#AD&;385@:"1GL8IF0*R')Z)P%"A8&! H<,
M')C"P! 5!A<V/ C1X, A$X90'"*"XH0)%2:XX^BB0H4\%=B<,\F&P;ES'Q@\
M. ?C XR8)Q[ &&!SP A_#L#YP^?3'S@'/_W]](G/:$^A1(D636K4)U&@3)$&
MG:J4Z5&E0Z46!;>,J].>$:[R#"HT@E&H/,^J;9NV+=NJ1K7^NXOW;E.T1/GZ
M+&L4L%>?785RA9J4K^&BRP@G3O_:N*=3H8G[?FT[]*S3PN 2<UU;]?'BR@%&
MM) 6(+5JU<%:.%@-&W93!_Q&C*B-^[;NVB_XY=X-O';P$1UT Q^>^_>+,N@,
M3#C8Q@"ZZ"):O(BM.D:1NHXC?\Z<N>]8QUJS)A4-.*MDKV<->UWJN6CZIE'A
M)BV[]"_2]N&S<LX+8( "#H@68&\M-=][@Q5EF67U&1A4>OU]Q19@DUG665V5
M*6987TDYY1EADAD5P 0.G(@B/Q'PXT!Q#NA6W LC+#?CC$.\8$X9)J!C0HXF
MO'#C$#F^8(*.YAQ9QHT^(MECDD<.84*01!JI(Y%27@GDE#*^L.6,91078P0R
MSAB!B\3_E3G"BR>.$(&:R[1YXC(H\C3$/"[XU!B#H&7()UUYEK=?>_BAM2!]
M07V8EED9XJ?G4DMYYUY17]$'8E0#7HHI7OPAZFAFF&'%GS\6@B:JB.!!*M2?
M;&&569Z&(@9H9?YX!QBLB Z&X*$=L@<.'@\P  ,##*!TC@<A??111QM1=!"S
M A&DD $%,12M00DI5-!&$STKT445<31$!1AUY(Y(([F3AP?I%LM2NRP%&]-,
M \#P0$T##*"?AI@9YJJ"=)EZ&5SI?179@NTY)1AW4)'EJ6A/?2<:?)3M&15D
MF=U*H%A@@:,65>)).M5[YBT6U,7[Y0<J6.7UM Q;GB[5GJQ;_XT55<?UE4>R
M@TN]<!IVJ;4&CL^I#76B<+8E9UMQ2 .G]&XR(@WUT\0)1S5P,I8QT'/00310
M=674XW,,P0!%WVC^6@955VKUI1;'A-W<X58O;\RRH7#%_7;(,_];UU[[+@SP
MJOYD2KB 6\6L<J<Q?Y:?I!=+^JFD'Q(V,%WP=24G=S#7W159>#=.J<I$S]9F
MFA&<R8\%+XA)7(U<WEA&EC?NV.,0.I9Q9)2X2P-DCT4^"63NO$>YG#F_WS@\
M[UC"_N-R/XX0^XQ=RMC!F*GC9H$#+]"6IO9KHEBT6G"VU90^WY!O&%6#A45^
MXI*KG#ZI;BUNU;Z!Z@WWVX.]5=7:D:+RU[C,%&Z >!%9H-(F,??4[7T*S I7
M#J0V^S6.?D=A7]X 9;.#1>J"@6*@ ZF"CV7,Y%<G88 'SH$N<VWD6Q<Q0#HH
MDI 45&0BS:JA0+"V$1><A"4I80.]3D*2&6;-6R)884<J@*YRL:$"+O  L=K5
M$I< ZU<YJ6(%I,*91D4E+%1I7U@NM*L$J@\N'"L/8N[WL*JP[W#Q,]4:RVBP
M2(T(4/'_&]#$0(8W^\7G,GVBSZUF53+_:,53A:D89F %'D!N+E&#U,JM1N0
M[\C*-+P06FM>@QV>O*AJOD&.<:!VF]HTS9.]\>1MFL:;$=@N:UR+#D1<61T3
M6'([ -1@A@15LLG<43.EVLMY%D.4@L$%0ZR:G)[BHR@P;BARPJ09><!!0 *B
MQ9B,*Q49$_BW]E1ECONYH&9NB3"T*'!N^[JF-4?%-EPIY43^Z-Z*VF2!-,V(
M-S%R'91TQ",>^>@%RI,=D?PI#1/03I^Q*Q(_?R0-X_'H=@9E7NRP9- ?E<%+
M]2QEF%8G(^VE:7OR_!Z;OB>^.>%C O,80=[,XJ!E C"7A'1/_]JH.3!(ME%?
M#PO=I\B9F;*,JI>8B>8 /=1(\F33F?]K2V,V)*%%GJQ1^;)F_(@"H:!*3&2L
MVDR(]%5(HWB 7L+ZP$K6E42/<&19WZ)ALP0BD(0XQ !)HH@+AO4!K[8D)2V1
M*P/B^@$V?(2%?.4%1T1@+I*<L +L<F*[7B*L7XV07C5YP !:5A<'ZL]O!8.9
M:&ZYL/]5E517U9S^\%B8RM9G/ Q25$T9<T!>"B5C.5.GS.*B/O^!IW'&Q$H"
M/S8WF/$*;P=:"^4^^)VXA$IG/N$9:GQ6A!;$IBF>I)K40(D;J37WN4=#3FZ6
MDR2L.>>5K6R.=+K6@C+XK!YB<Y0V8?\6%9:5MF.%S"H"N:.Q8=;/;HW$4'KE
MTLWUQ&UO?BG8%]/KT\+)+;[$A1S:%I0X^,UVM&[QE&<[Y3E#J3<Q[/VBB#X#
ME+ L6#*1!)\\E1;/BD)O.5EZZ)04:KPJP2[%MO,G[G[T.]T9+TLQSE(_D5=B
M@Z8@2\[CDNM:Y^/BZ&:3IU,3BSJ@)A3!"7SH<X &QA$>E<7VO& Q[\A\B[Z:
M,?B,$XX+%E$V3L61-K,&=IOBDA)@PA&J;?Y+KX(KV)^0S5&X<B'P_S G.:WX
MK3 +Q./!ZL?!S:R-,R :R@ALXI*5>-58*NR(MRKR+(%,0*UFC18Z$C(!'=J5
M)7;MM%UC<E?_-GA (^%:81$K -ARA21=.C2)2E32DI=045Z,Q<DYK"*QO;1M
MF%HV+5T\]LU>3W!$P$8?P$B[N,,1U[R?I>.%MS*@$3'JSXL!C8.^XQ3O;*9]
MAJG5'?<"*:B2)Y@-HXM_],MG^^A9SU@TS7&Q<\G4U$.3S6U=U9J&[WKGYD6?
MA-%P;&,[AFC-E0,A^'0&TAQ74J<%YA":"VCIF4'UDIQT5,_$[Y@AH-[4FACZ
MY7S6C<A]?3R=@%QOA'0%GC1GRBPRR]6C ):>HZI;M;!*YV2Z<I^3CWF7GG%0
MNG%Y7_E(I2EPZI[1'6 !?H#)=08%*(WY"5#:'71(4,H1\GK$(WY._S0.POB1
MD)@CC.7Y\T9>,H'K)NKC%PBY-Q<M3M*3+J87M8E%;.*'G.S>8? Y(!H4N)E2
M+<M@G(^3?L8TYMOZMJO H%0K T.DQ29U[&1:2N67LK8!<PZ:RD$^LA,3#V<J
MM-1I!_":9H'<Y\WM5$H-TF\TTR8XSF$3N9Y$7>HJUUZ5)1%I,>M:TMJ6M2A2
MDKNR9%C"C^OP>WC7Y,?:)0]P :EY(:Z-=(0DA$77":]O$MDGE@$GD(ECZ74O
MDV8E3QE'N:RBO.Z2[ZE2'^-V2O^%*/\ CN/FGY119.['0V99MZQ%(!;_2S9O
M<Q[IED#S=4'7)CJ+]&N2I3C/%H!DU&8@%/]HNB(IQF5)RI49MO%OT*5OU94<
M4J,T*G(;IW-=7K)*7 ,1WO5=!N!**G@0S5$=Z#!>1; =5X%2^^,5[_6 ['%S
MV^9_[(->$Y)+,_-9%+9?#&-@C=0^A;9ZE%=Y[=4V759G4AB$<L.$G]6#941E
MFZ%>U59(YE4V$BA?NQ84)D !)J!)[T0;V4,]MT$]6[(E12*'*@8D="@E+F8"
MO/-BPT-CLV,"<0 ,-! '+T8$@2@,)G8[*3:',!8[._9CU%-/'5 ;IX-D&U5D
M(@@^;0(G:V-A+P)EK))L^J4WFY$Y-[=K!=9DG>-:6!8H439L>>1,X]&% N2$
M G)XM+5E+,<9;Q'_@#[('?R3;@"S-WZ3-NPU&HBG94?!A%,&1Q@V7S^1 B<
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MAS+L87]%E511.3)8I'^MDE6\E)9JF1=UUA]+12A[A&R*A)<W%8OR57(RDW'
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M'.J583FV'M+(99.V8KM( 1R"C_R59#FV8X$L A278*O(=UF5++*B,%*7U=K
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MF@D0L+[<N=4@#6U:L%%EP\4L552U7NH=@.N=WE;-7E-=)6AJF[WPC<FL)A8
ML02[.MB W+,;1'/2UJUD6=;Q,0!ECE+3GX,;5Y[5#HLK(21K_Q/9I,3N^Y.
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MZ@E Y!%*JC*[-)CBB62S%1J>5+8JHCAD8@I9V L,T@%? :R1B]36"Y+E A,
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M(>B]MC8I&BP2 :]9P((G 1L"6+B"%71MA2=A8$QNG=_\#% _MK;U?FQUGV7
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MG^VHUI^\A]*D3--$VJ=D5M LH8*4(<U(WH15(6<E811&RM[AE(<]2':XB:)
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M&D4+&KT ($H7L[S &4W+-^CFRSE+'*!#'%B+-%S7"XQ<S>'+-21+(&K "HS
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M:-3CXER9ZAG.E_7-EQ4.V Y.XN!VZ\$!%FQ9[\$ &QSD!V0R<7C-A]:90YY
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M90BXL%+F9$[L[;:&*PD]2%"B0N,JC@A%P+1:9;(<P U7Q0&$\(O4C>6^J(R
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M@%;$H#9J!-?KCN)1223P!0. ':,B*E[Q _D&#Y[F/3_@:"SF'"HF#URI ES
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M,-X%1&J87*C,A*LO5>4Y2,BB;5(/;<6GDZX9H]#Q*H7S*N.9*]2$#_DPW2(
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M+8&QLR0*=3M#6K4U5=%7A)=1=K3Y*QUFB=^'OX<*:="3NMM$&AK@ F;C .2
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MA*-F%Z,U2K4/*D6]R1>S8LG.4S_/DT20;#/L*):Y9#^AYHY*1V]%E"[==JS
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MP"ZTL^!O1GLO@ $C@'MY)'1W&*E7$4Q*P7SO9G7O-J=/I!F[Q\/;YV^6@;I
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M=$_K,2EG3-CM&;TI:Y)KQ,\3H"C6VQ(4.9]Z]!M.P]@3LRV6B<U/8PGQ,]!
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M74,@V>2==AMA:1J0LA$E%7?=+33:11J9&>1%<])T%42WL11:GS$-Y< (#D3
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M;$ +S@I)R;]P3#*>M$QE@I89K6AF )A!TQFA]*_FG E@ZSKB^[HW+?KQ+SU
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M%MW/*:X&;C8/A8H?:/J=QT*H9-7M4M66#J;E9]ZMB*)BVRJ'1L =90; XKB
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M642%^<T]K@8MVF+5!JP6QJJ=R)(]GIDH2C#?B![X_*9%?JR:.EMSM$_ /J1
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M <.QC;G,8BH#;5[">((!G&-K0/K)$"@KL&M0X#0K*$,!S$*""<"R7-J[FGF
M5EAF)2V>01GF]2A:)^<T$H4=_<W_>*HVGQT1$2=?"6+YADB]W^$MBFMJ(D._
M9[VRL9-),>Q-]%;(I:,T#6A( 9[93# C<)C30 Y8)N%<( (+0>YQWM00@QA4
MA@9MDT)EB)"#'1S-"4FS0Q,:0H1 -\Y@H",?_"V0 V+@!KII)9)MB]X+XP2D
M7]&./BET"?I(\R-XM0YOPQL7886TR1<"5(IP!9>,;WF<=1'O.M]-";/NQD*
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M5[[HBR:EN;I9LKG7/>E#PHSSE4A%TLG@7N#A_DHC="TP9H!%(.#%J1S#+3>
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M93Z.695F";ZHRX;#;G>V]-V\7E0#^0TRJ3F[JW1_F*5J*YUL$0654D>5[]F
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M2M$F+[E)XZDJ\Z:>V2I.P@(,5=KE*,)!ZH3D8Y.@\)(F *7Q_U V,13?SM+
MGRGL;2>+3PQ1=L(P2415$_!+U&+E '0%S5G$X9&@G'6:-)FL8\<CU=Q(!J"2
MY"V2Y7I/TG9FL:&D$E%VFY4MW0>2'T%DA=IJ"S&!=;"-Y-*8U K8LP3CHJ\,
MJ30&4Z.H7+*P7!8J*D3B8 G3%;$^BBLH/_+DLP*%MI\ULIQW6V)64M,IFLVQ
M>AY;F'B:M<[C6<R&QO$3K(@YH+SD,GXODA1BF#:L\TFNF-UJSS*SQ;;XV0J
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MFBX)6B$C,F@^?=I1'!QMN/:V:_ 5EC<RKM5- "482*^YAT\K=$^[%ND'0_I
M:KYJCVN9/7(1B5[DT2@F8Q1.D"KV-;8V9B!1%<GCY(I9IZQ14M$-.*"6.L;E
M39.D *U+F)),GU3138@:>=KH(8=#G0&4V @+X@FMFX,-@A_]JI.<1&*./0I_
M[H1S-\E60DBIY'% [&:7V._-"CSEO:QW!LPUY1XQ1['Q[)I&EB^&%&^$$C*?
M5#X[/H2ZKZV;^=+,33N9]J&F3\@6Z]/^%1A]64Z'X^:?B<#L,>P$MH1@3QCG
MRN@Y]J87O2=3DY7ZIF;!2FXTL,&C;Y4K<8POL=N&9A&26S3;G.?)3U9V^3.>
M.*>Y%07]MO*#L72E4W@W2I:BY1,16X:N5[FVC.JV>5NS@\<^UFR./S-6L)WH
M4WCU,A#GB[O7OY9.,3E2T;>.7E:=)&=SZRS[M&3%X9",YR+\ &G4$E9P=3@^
M]QQFC+R5A57$BP.RK.L)8H?I%& [K%OIO>HYMHL]]_^J'N P_O&;W2'B=0Q]
M3H)F_]/)E6KX=2S!EN)JWS6!-_H1Y6]>,8S$3N/H0([\KH,YK"%(K$'*)W\Z
M'$A1%R5;BL%QNT#ZM\8@IJURJT0S)-<XN I,$W#*(Y@BLPZ\JIPXI%FA*6S9
MO)[ H5+#B?\K+_3@C0JDB$3:+2RILJ_H*"LCF7/#B8<[MVW2BQ39-X@YB9$B
M0:'"$G1[.,C!IGO1OF1Y'Q3Q/3[+-D3IP0>TD'B)JT=RG1+ZF^V!D< J)I7Z
MPM/P)2%#.'4QP1/T*W.:B8([GM<@G.9;%I;R&;0I.!=4-P\$ID.:0K9Q*LN+
M)D>;*"9[JE[)$6?S*D=A0MW_>C%?(RF]B;1KX:E6$ZRZ^BV.<!J@640?V1\Y
M= [(88RU^A1YD9L@=)R;L4#-NXVC AZ=X8R1\R9%1,&!42SS*3&$LCT4,BL6
M0Z:^8R.$NB:4\RPT"D12P:>FF21_<#G$NC#%V[1N@;HN@KC:,ZYD01,"^C<1
ML;#U8#?2.B/^0C#@\D'%<S4A[)N 21HW0@@TW)!RRJS<RB]NLIX*.:"O6I#!
MV X,:Z\Q])??R:.&6K?V&4?P^1#$T*U_S!]RFC:6 @[HD1O@NXO[V;D7L;CL
M AA'4@^* BC$\Y?;NY(UFCC@Z3L5FZ!J2[VCV1C'.1'^"98S64>?:$';.KR-
M8Q*Z_S,Y-[D=B/RCL/!$_Y@7;FHC]P(S6,,=$$.N#2./NUJ.(CH:+)HC$90W
M/>HEGNFNJ D=\AD1F9PP/3F\]GD\G,.8^_H/):*\UAJL% E+D=G$1=Q)VD)'
M[[N-E0BR\4.82\*;",L+H928@V$S'N0IA<R,!)L.L\&L^H,@\W,E?)M!;VG
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M,/S*#QIZ3M,;(?ZX'[S@C_*ZO9Z:.]W90N*L.Z-"RD5,1@<8 L2*G;QHO\/
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MB&E5JO^ED:>2E%*U?)F1L;TMGTAK9\"2QS-PM:]I^V*3888%H$WVBKT#"4
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M)5.H7H7WL,T@X4NZ<-7M 1Z\%4\7 NO&Q%S39&>*?$9MF)&=G42LH%*8S=#
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M7*D.0.IUB(#([[SAZO1O]O[2Q'=+#[^','T6"J^N4U7ETA7_J=\!!#YP_AR
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MY4[\HWDP+ *)92@C_P5V^NM71@T!)PID4@W#2*G^:E#H)"^ S@><H@1(RA+
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MI?,<<H152<.DN#*6G33<-=YIZ'B/HI4=3$G$H*N7ECD:5F=J5N>BH-4R\AL
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M[_UEUT+G$Q+7Q15@0#)(+H#*HK9@Y0[A_M.0*7/5+#B/(<G0YXK6 )</\=D
M5D1F^CS@:_PCOO$<'HJA7/@0B8:)<?XK.P)#@;5L+F9 R ;):,&NXAFQZ)F7
MI:W^@RZ(V4:?@S  Y?\L+3LK)R,@QW"DUHI5I3X[8WVT5L.:VJ'9;M3C03Y=
MP(@X73+/AJK@B7&PLJC12@VY#TJ[PY*"DB (84A.CTM #.J<<4[ >L&_T$@S
M=\\9WICS^<8M-ZSW,DPHE^KN!@T350-_1B'[Q[WH@6&&>:?=LC(:;%Q?3M,#
MVN*]CF"!,P/E,C !!]@W-TW+&MF&A+H&3R$6)L#*4X9>5M <D'/AU)+,--B_
M,)^&W%]@F,"I+:%OLM^;O-L&>8,""WNQ,[D)F56J<'(QZK;Z*C?TB.-A-G+6
M7%N:2A0@\?D0MGK7MI>NLRU(\BV7-,UX"W:(XA3PD]WMU4EE>B[5K2A8%>\2
ML#]W=NIRK>= 7S\^=N(ZBT-N3\P1E5?@3U((L6$RCGIJ[0)6#3%AZ+!;=!7)
M%]!H]CQ-N5L&7?7^AW<(Y44$A1J[59B5--#W"QA(6> J6Q!E><]1'):AB;SC
M*5NT)^89BZUP-9=[L*TD/"KTITV!41/TWMPN;5>K_!YR1',4A"PC^/M*B=83
MK-RDU.GUG3'7EB&WI!,;1Q34:\;J*OPJ:A(I@39A1,^"MKRL^EOVK9!J%FHB
M.$\J%.@6!>8."GQ50'Y^@":25C?I:A$_].!JP<CG%M^B39BNLL1JS5;]5C/'
M7UGV(WU0(!C]",T"[&'?NNX@.#UUE1JM=G;L*;ZVVA"9K1^W#MK:Z/Q5KB_E
M:,7?1)FB&/$#M5E.*QB@2;,0'D1O) GW44;.:'@OOWXP)*:VS!515C%JX6;R
M<5![F6^Z0="O ]R@X1[T$2<[Q$^B+IK2R8"9.EG[N F^_LA!8[2M/V.9"RI7
M?\F-BN,4!2N?I0KZF6P^2?C:#SZ):TM$!.R%%8_]E_UW%EE:].EQ;:F2_-#Y
MF<E54\H#LT]_!GFB!*FV3>ZS&@9P6-EL(2NB"B@,84LT7Y)'I7KP?]\TG5@X
MP5)API7 G^0[B]19AW?P2%=YXKZ>DX$7?'Y?O0:V=%TA6_-+TW.]@CUO_H:<
M"(9)?4MUE]XI#$<:_D+RSB/(1&LD/KEH;O?1</2'N_O=OZ4"U[X59=QUCR>(
M7MHY\".#9H"C+G5;:%S%Q_<%OPV(I>U_EP4>=6A"<%6J:-%GNO(G=YV4N3IT
M_JE4JF@3$E $/)5*$->"N&F^QGL)_.X4V<S>7GUU%I#/M5ULI0TRWP*[;OV?
MY7#)Y$C@$;KK?1ZZ"F11FQFI/L0N%*-MJO;\*[EH5G ?T9JMY^-G/GG.]8_B
M\O>NV3]P:N:E,WQ@/T4;>&JK2W$^\SE9G8_Q>1!XL_%()D%#)Z(A9Q!&@#QQ
M.5ES.<$O6@9:*7R5,/_J+4"UWH.4E &[]R&/19 IS2?E]72'/T3N+X[]-\2R
M0ZD\:G8$&^LT_MIP+X7*!QV(&/TFA)M,1+PDZ45.S+S>G.QL=O&^1K,VCGB1
MWT>&(:=IQ" MDB NC&E?3]G8[[-;'#G#'?MJ8'$"R_>M/WAO-VHH4;)&:91&
M7^=9#DC]>M[[=_'GR]L?2[EEP%0Q-_Y< N\5:W/)^)"(DIB2: #Y[*:PG(;L
M7E>9RI#.6,*,N\:E?!=8]'-7I(1(98 B-424U=4X(@MYDNCSPVT?[U*AWNQJ
M9-5OQVM+!A#RHKY#,#M\_Q:$-FK%[K&[W"ND+P9S 635X>_DA:NN21;)RJO/
M%M^'*U53?)QSZPP+[0U]DKQSVQ*F3:RU]R6L?=0W/J1&3([2CJSB:^IOFG\[
MK]CZW$3^*!,21E>%ROM0B;=4F__*L$I>#&=;$(OZ:R_'N84*>W8)!/+21=(J
M82 :,"GW/Z*&3G?NP+;=M_P2"A#Q*T<6*XJ;$WO;J8=-F>;YX-VHY?>U7O17
MWY2PY$>UF%2!E<.'R&N'NT"6UEUM$."(42L!J ;TRW#W40#\,UB6?\OIRT@2
MD@,M5#FH SQ;%3'04U;F5$NBUA=9.L!MIX*)(3-H3TH.I4Q:NMYYT6WNV%AR
M$@?9!]N,\YE"_(=%LI4'B KN1%Z?/XL<LK6\V?L[FDX[(ZD\$)?BLON?M-M<
MV:XA!^2E2L_(EJ[_TIE_L^D-_CJF/RW]U2IB:[.@.,]WE/@5R"1+X(/&9V)"
M5Y;&//]%Y?@)4&.C'\.6M:L@$J]_:N.OSO2Z6.E^N]$ZP7ZFJU95V5WWMK/'
M? 8+E$'>D#\E<\NHU U>7O)V 6.+\ROW]0+H&,2-N4O"R[T6T[5SI?I%V6*G
MJ)OD[0:M98C.D>Q;S@-#GU4NZI0J!EY\;[T$N*)M"(OL[Z)NKQ?:_ODVW7WC
M;$'U+/X@P4-7WY,7@5K.,!44.#FB=!#, 5=!#/.8J0J$U?%A A4M#IEA_.(9
ME:![9?Q@V7C^##5"&*;U;9R&1[P*X4/JC)$DHR(QE8\%CN=5I(:7K2.!BG^1
MW:"Y)/]R4E5JBJD;/,.7X3'I5$P%.2PT4>,U#/FCBN*9WH\98 +:6$+8*#DY
MR*T+-59CU>TS5A&&K)U)2AU5'4Z^6^.^\])I:]L55>I:"Y@&^7&&GC1W+EH%
MO>J\)*D'UGY<)$!)B26T2W^S.WASPB__S,15TD9[_D='?(CC,,D<\H82WPL$
M8L!F6E)\OXCQOE#*3Q++#^+Y\S#__4P.-HWY;1)YO\3W<F'2#-'[QLD2CF'Y
MSE6D0YD3G<Y^9<+A*,6>R/'8EWF%NXC=C\C*.%=J$K#O]^I2).4,F 0%E"ZC
MV""\!1BHR^20)T'5;K:4J3^?$WTTPB;RJB9Y4G@2&O/>]3L3Y8N.A:K.&TN8
MLN:"N*CK&V;7/TK]3@2-B$B["]\X=C5 #QKI5M=:1J-5UTJZB_X0QD'K5B:.
M\>@E82_9?CQSY_"RVMGV*4>YP))^3]Q-J]/!6 ZL^1@(>C*X65K)X>5Y24OY
MP1-WDE)@^VD#7C&F$(TOJ C50@Z>UGY<\8G;K"G1^IH))#Q]^6:P@\&G6O -
M4WWU*N3-&<./R0/9HI._81<X)<)_%U#KVW>&V0]SO7:UF7ZFO*40F2EL9+#/
MBL30/0S$0U3^<]B2(&<%YB!LZQ;G8Z""^HS?[^Z5?0R5_I'B@#EXP'F+C5/
M<(1N0>B= %PEWU+5-PF3*,XO2B<#$^1=]Y\ENN7TW$*V[CT5-R,O.#**=V,]
MI"SZUG2#9*VC_D_P([G *T&'7\TA?*?"Y&2$627:>83*@E_*&5Q?*!/=$7O\
M=P'RU3AH^0RX#/:#V*LC2+39BCO-L<P,[W2^Q90J';L/4 80,WOUE-M=!M#I
M6!XK-;U_J,"/$L:G.A PADYI_^"X9\R3(4"2CX$5C>(0]$T 0_2D&AX$*MN-
M@1+@. F(42#*1KYDXU@X017]V-K@K@19W91N41UE0*K_\[\5:.I77U[<_X6
MJ&GOL)CO9<H_^<IUB]YA%/![_N+*.=7!I5+[RA#0TFD%J+<Y+=7\GO>MNW#\
MZJVD?GO.7 T/\'!Q!!%M&VI3%M5PD%C">+Z':IO5CV0DM7,;/1;0>D=3!7##
M;=6%]G((RLF"PSAXJZ!9Y3>RPI#62KB2&^[N/MX""U7B&I2*.9/FFO-V+S\G
M;9W)E-R^$8)SPX>()[ZP)L^[P0^"F-4'**"11>_=!!W(%U$7%%$(WD)EC[D
M_D56X]FMY])O>.66>W"#WJ3B_+%\EHF!!N&/WY?_,CF$"W,9."7!*J6=YYWY
MDYD'6R4 &,9=T6.X&&L6S[QO<A@9_<"XX 6/<J3EF'4B$9US@_?]L$%'@[^!
M;PGQ[X0H,,K0Z1?1.X-?0L<+[=+/8CE9'QPJ=[Y!LE:,9!!*[M3;N=;HWX]=
MKGULJFW]!LE<H%PE0_,(\,H\3@^5!-<Z.0)LZ,P"(2@A;76B$$-0@U4*'<"
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M*?!:X(QT&3\SD4B6V0)..DL(<\**B[YSHC':O.08:WR?BUT-7WYC?F.L[<_
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M$+KA*T(:.[D.G&(T;7&1GX(+X)"Z1;4@I]G7L\Y9VW;,J35X1#[I>0/A&:"
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MS$-4T&J&?EN">$05ZIH($"V]?U_ZI-J1^^AXQN67:5F?,+"% 6!D":O&6(T
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MB45&'%OIV7A2E_C[O+]_KYFF^:YI%0R/:\2\U8AASM> M0]26TX3S]P_5-$
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MC)/NAOA8WGI[T"\6!ZJDZ?MR2B^VRPZ][_;ZW@.&R<2Q$[9,7^_ER9GB<1C
M2O6>1KLJD*]1L?L;E>>A_:(06]Q;'0%?OH74UHY+YZ10D@A="LSHCQ;>*1TW
MEXG71Q]R?UE+?G;!%H!K<9^S$GEW$8:XM9\>KVE#MJ5VN@#>O;RN7QJB7"LP
M5Y=;:@I3\<&!EV7X<')MUGYYKY"9A^_L8MSVL:80B+P*L;2Y1<*C]-#[NHP
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M_6*;?#6CTUPU?<BU$:-DO4"G _!QF#JX[-%^?#%B>B0$9JSKQ@Y50,UF5>'
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M-A)5 2%BA;<<6QM,D=I.+J/\RMB,U7:P(-J&Z5GOQ5$MN.X%YQ>N#I3K9$D
M\3Y&H$-)17:U*-#3B7 (+TUP6(W\5>NQ,/G"L)<)']RSK. ^4J;2WYX;QWK5
M?,B1@8QZ?2N]L=XT0 [_YI!4G"L:#KNMH/*6!9YC[T&R,<S(R</ 08T!$C6P
M71.!T)D.=8<Q6IMZM<HW2TMB9K=X#N3FZZ#!H\"NANE)2X]XP<1X8FG&VR?P
M(2PQOU5L<@\_PVM4-L,GE,S['E > P.3EM6@I]X:B'Z.RJ5VE(*AHK16R574
MQ-CI9G93.Y_K)UN&*T?DAMYINDTU5>'=)/"(4]/0+:%E7QW'IM4%"Q7X1Q'M
MFM !VTVQ0?7X5Q[K+B9>RV5 WS6MS[9N/F_#<?M&2%\T)8ZN&3M%^\N6S?F_
MJ9T\J"B('X\5CG()RZ[Y]8-LVD7'%VU4-;<>_Q,U?\,X4XSRY$MN)N-19EXU
MZF!\3:-IZ)WT^#YZA8O?JZ27(P5=Q#0'7"(Z3Q^#G.!$:X?;'"N870GNWG@4
M<HZ]T4UZ4<G;.C(<&T%CL"8F";J:Z?X\;&[NKY]&J.A"!RCN10X[4A*R$UV
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M;&5Z+*A:4RTJ4_X$9G-9 +\4/!]Q>&J/_2K>':C:G3I@1=S[-?!W<F:^9NH
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M:)[4]>XGR<A/19</%&@YXNWM.+IDS%5<M)..='"BNL:) 91F9)^S/7K:>+5
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M4HN[:!1 "-(, \'&.ORGU.1)ZS=FRS6'8Q8AI#+?'>R+GVK(WQU<5$0MGQ"
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MVL31M[?Y?;@E*:=* F7O)\7+=+IR7,7;E]%!Q)V5KUI!]4&.SOGO/-M1?,K
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MR-'9;$?Z,!2>P6:8N%BJX3ZO!8>;I.O%V?MQ;%O\O9WWFT<%_+<"=VXYZ6F
MZ(VG[-T1&-:>?B="\_,PV'86=?.O[I;^5Z'Z9.B4[>[\I*3OMQMP>1YP[U;N
MA'^&XT IK'7^+0-!+N;/A!3_>O\%7 "[;7S=4#THM/F%ZY3@7>CCF@P[WE!8
M:;I5?MCYF%.JD!NMO+']R:#@!T'HE(#^1^XLDO;H'^0IO5SW $X%[7%'!4&U
M)_/:3'6+,EA0JE?\16=Z1*/,SQ]+6NJI79=Q?4&[Y=+F[P)[+^%>: UZ6''*
M[L?V)^V_JS,15G=Y"4HYLDX$E7A*'-[&3\?V>5CT'N?0SQK7K3=>64BPDF<E
M4!#[15] 53T'=\V26.--%ZG(M>9TZ-)S%^[6T8L36<_LKZR%(TRFAVYCJ8*9
M3X6]N'O3UM5CH-H\T:6X+5LJ4MK4?EMZ[4<Y834R(Y.E%&)48$YYD%NJGK9K
MCM-UR>8CJE>6_"]_4 B([NZI=N &YR?VC;#*==G610<I$:-M0"B,]](0PGG+
MS(C-I'0I^X:QJ;$'SX3"W2?KXU26^AALV<D0J(\*$D8G2*:M#)#N+G'+OI^N
M)#U0W!$&28]ZTU@Z;"?BM-&,@6_J<ZE8.6*X]IG0B/<>*]2VU*<=R 9: =U.
M9DZCSFWA.1)1LFHM3SX+\6-XTXP[6;QVH%WEZ'SB^O5152M/^9'DSV6?NB?\
MO2FB]UL-["=-Z2H3-VS+](]W:Y<?+45#T,F\LM;$+OVH.E\6%W.3=M=FY):%
M^%27&AD=@L$Q]+67=E]0R=D@[BEVTAA&+[)EAAW?*J&L,D1K:[<-#'_%?[_@
MFH5$MQ/*_W)U?U=(%I2U?0PBG<L]K:^,8[;3NC3AQ>;_;K!EV\&;?WAI(F'+
MO6% #,\5"=GJ1$;$0146(T'^)$W,*&&.%LZ*[YD],YKJ>SR=(R :R?/#K50R
M"_Q5/6 =HJZ9U2-)XWQ"\/G,RB+SPOF.*?FSX]0IPYK'ESTQ7&MB]>,KJT&[
MTS+CI'ET7\1#27H]Z<]^%9=C?=1/I23II7@_H?:,)M)3>BWE!3X8 S%Z7TM:
MBHXT/Z_5!4X;!\5^RHD$ YM<WQN/.[J5LI5R-\:978MD%9'2)Y,7;T ;90P"
MYWC%,.SHSI5?18TF:!BE<9&/T 2[%Q=0G^9; 8[1(U[M;T@TI)E &FK*)\#Y
ML2J5'[-TZ ?7>^R;3*"G@XWY(!]<[IHQ:^ Z_:XU7#Q7+8TCRKB/U@E!($U8
MWX.1=!3A]U*_+T;0]1E &E$&1:$ ^4'G;]P1#EM!TC^&F51T5\Y*,VC"AP=A
MR?!?^2FY I<W.FOY8&N[K[,5RZ\1#>\!&P7Z\^6WH@(GN9*2:*%%V1G*?C(%
MH:AOU1!7?3,0)'V/XZ*K;> NM+N<CQ)C%51BD>[H=3Y);X0F+/9GNV*U7ZW#
MILMXK,2LK5E9L]DH"KW%HS>1 5>3!9=VE][Z"6GZY[P1K8ERE"]6P[N/LI\2
M,_ZK_? M78E(A*?6#*K^UF9W)H</MXTZ2/ 1[*/7LN =P<(%_D9; Z_HQK0/
MV)H%TL!8I-U>U.J(VH:PI:CV5JDH\ZTC&CL2=PG\R-_%-OX&3+]M=?_74CZ"
MRB68>P!*" 5%H>=<-YL2%C/48 '^54T)5;_8<PV7? /FD7]+K\/$I/+@"03<
M YPAH-^+I61^;_XZ:\Y_#?X9>7O^:\"D^/H>\,#F@8_< %B8ZU;^'M!\RVA6
M3F@MN@)3/%<PA*[]=M-9:0K^WR+S_ZGPFS.FX?1;)!$C73FN_H,$:F]0W]:T
M'NU1C6;]\9!#>AI>BSXKYW>%E=&D AU$@>9G?42T%6AB?'L46N8H_AT?U(_<
M>U9@_;BO02TX#G,2N53<^M,QI\:I,;38ZF72;P/D?RD=RG\%BK5<;KRBSA74
M?BLPO$=N-E1\Z'8\GR:0<WG^ X\AHO,\*7SP_UN^_WOW,G'^IN$+T]HT?T^-
MIYTH>K1'=YU7OB5N@/;/OJ7YS[JI^0#TN@^HJSX!^D5$(4_K@!+OVG;IKR4W
M;HY%SWN+(:/PMP3B>T3I/[[= Q:>1U7K^0Q1/]AO23H9^ED%7ED_[MRHKE='
MSL*&+E=]#F*EZ8FV(O"M[;^5>,D4^9@WW0/2I.\NN7_'ZVM[L.I]-F)\%IY%
M577< X1B[RX)5/^"//,OQ%^(OQ#_LXCQ1A%8:OA42HSI,#;1C>A[0(L"U>^S
M4=//.YM=0O8YS8/74Z4F,N+V0#/J]MC\MTF?'>]GLWMX#QAZ^'^+))59T)T;
MW>TQ8_Y?DOJ%^0OS%^8_%9-?&<<0G_Z,0/XOYWC32P,Q$A0(U]_PW_X^<7^O
M$ E$:OUMK<#W2J.Z7$T__U:4_N\5\KM?>+_P?N']3^$=POL" %B^:E2_S\:_
MZ<XU _D_6=[93'.OD[6HPS<"BJ&+X 9XU">.W,(X?SO]4F=Q.,+N ":J:BMX
M/.M'K[86"GIA8.OQUN>P\H;E'B ZZK,H> \( .U:^C A@+/JV2XTO0GO >E;
MHH<4]X#VJ#_]-%2]U)\E$H QQ3Q42ERRN;R+O0? +=S0_^GG&8%H_.U7AU\$
M?Q'\1? 7P5\$?Q'\1? 7P5\$?Q'\1?!_EN#GZ@O_I?Z=;U96!Q1Y7]J?L+_H
M%5E55U2FEQ/%^_EXP+^DO4?YWO+T'A"=J'8/*.OU.>'2G,A>IKHD<=*_NDF\
M!XCSI.J+8P?@//@"2G_Y L\_'8 ] 8X[7MJ=-4 ^L7"\"@S\Q9/"V#6%<H[-
M,J4)1_T@&&_&&=%W)_)MN"=<.'!;@TQ$W?.8E<.[5D["C"XQ??;X(60T)B8X
M7IBFY!(FHU7J%)'/0VNQX@MT9I*#F:UI/CHYA4>KW["!\G5WC"BT^&$SQJ:&
M*MJV6VWK$'M9OBD,+29%Y;&0\8/6*BMKRCX&#09Z6;6]QOEBA3S]F<Z8[Z9V
MY/9>W>;?,$\R9=D91X#6U3,[]#':Q?Q+TM?@9SB8S@*M'TLR#D42"S5FAFAO
MAQ+K&%A2"NG@\]2HR=S\VD=4YS1U-?K7YF;D$>X!SI)/1A7-'-X7C,WTX[7.
ML>987ZG-H0:&ED.)0M:LJ[]XC@4?!VU<N8^G3PLD)C*G&]1/$UUU'P\2[4AS
M[B,),.Z2\A8Z8:?:Y.OT$^GND#PKXA3@EY)21T&2V1"5>_P:>02X/@HA\["S
MXXGHM$V+'/G$2+]G_3QD+?01383(=5$,T8[D,,X(,&^,;2\[4G:WE%I69(7;
M!/E*V2%O05,J1E=S"%YTS@+'U[P!'DQ@.?.ZM3DB!U*99J(')L5#>E7^^D<P
M(1W7XRAFAKGT7**7TI(Z43+C>1:$PB)K SZ>J$/]IV J=%=K?=R=5UU?%B/$
M.'NK!.UF=E09NAEJSD@")"TOHF0%>!M=WE7TE4L_U= 2ZR\X2#L=<T7O$)"J
MS]OFT\J2:9\.1!-A;[2W- 5R!(F^?"''-,Y]@.GZN-.&MC31R3Z1,=>76>QJ
M,1(T=.#HT2ALN2&O 7-;^I3W3,7%N!D'3%)3 ZHC.5%K;&93*E>:3%#'8=@T
M>87D&'/Q3$,(OV',[5CW6X=50_ZL3IJB]X1*(3'LP)8?C:F^[A#L>^%@52*&
M.%3PK4\$2,=O)*#^E/>+CQ6GN'!\IWWKK%3XAP4YI4(2O3:UK'Q>]5>KVF06
MDE^W"#L:C[-W7?0MKOFF<Z^E;XYA+NXGQ0VX2 3OA 6N0 DUD8,NJ=XGEA_+
MKT*U4SGO!B4CMP===0<)=%%[S[(VT:K?3A+6$H83KC]Z:L2)&"IE,63HAA/>
M"^(,\9F("5J_<A]Q1')GW+WBS0=AI]KESW81G<,XD50RN<]^OBKB^Y_)/_N?
M #CPDL\E:77KU:7BAK[4Y* >T<,*4BS_L(+$W3F=6+FYW@-"\#^$TI?"_4QA
M2L5[$70GI:M^UTI[#QC^;@:,"O99-9WPV3G6O\6 .GEAB."_5)8D>/D/<PS_
M$X!@Y +[3MJ*ZZZ!:A64 A;%M@S) D$;PJ.Y"Q'PE&40CR)/"1[;6F"<@N78
M4+?UN+T$5:LP"RN?3\8^-5GQ97=?KC^@F)V;O0B3&V9E(5QX_2.VG]$US@2[
M R%<G6K9!@?3IC.J&-9#6]'^'LG/E%%@%3A?O]+HY2%66UM7'N\D;U]&,5H.
M(W=ZL>.O8Y?YHJ[YY#K(880GK&>,1Q[5ZC15]$UUB-2UIOIZM$.D\(M;$-:W
MK:$C"U;N7J,8_I+4G.,HN&.X&Q"I:#!,;1DV"Q+ J1MG">KEC Z_-LLUF79=
ME%SAG2Q]+YVXQBV/2$PFMC7D'JR4I*"=O5>@<U"-[F_I:6@+,";8+87;E'D]
M88/NFG:M>O@.7&A)^?:'EF"UVTL4-&)O2)_FQ1D,1N%&VOY.(*7L&<[*N4<B
M,4]JQD4E!55[0UH4;4FEK%OC^] VI+Z C>.\PV.+.5#^#4[]5%>1SD74DE2N
M4R%^@NE"( R978QJ,+\5>L#-%M"@-A$YD9H5@E"Y84 -MA,P"\LH/U18]X7&
M-%4E=&8&CJ0X[\ @>R+/IB27KBF>;4B!/AM%&*7(=& !MELN\QDY%66V/&X^
MK.=![.>?7BAB%7L'6X_X/X)?^71M+Y)5[*ER#_@DY7^W]3#$@.4WJBN.4.XZ
MQU3._ETM3U?:-YQVPW;#P' ?G),9,"%T4F-$9-K!$B6A,R+'S]>K>:L[9<5"
MNWAL'"M9ZYL/HG]*6'#K":ZF#XZGH4_>CD*.]J71R)*^Z&H_[WZ=<%U)A/8R
M.6DN-,S6\=(8]*ASE-XPJ&VS)3W"P#6]DZGT(NP:.(_LC^:G\HIXS3SWE4Y_
MJLM-^T:I=($XF#:E@;*>H"PNFS>*N"/J%1;J#1-\OW1#_476Z(XMK*K'9N.5
MH0[UXB(>M@J7)L(R<I!G3=7V'27>@K9]C,1+P%5D>KR)GNNU4MV1CM:J,HT1
MP?$HO#T:94:ZJC(: <$H<.0>H(Z>%IE4^;S6@S*_;*M*H]SDFE+$_*X56BE$
M? 9[]V4YJ)J!I_IQE>2@6AS#LTJ:BY"L[DFBFC0*M?$-W3+J>$;%9J/--(ZH
MUR.G8?)AFK3)2N^LCCX5Y7P0\.9F?+QF.=>(-+C3D?:\95P(R:=8'S6_OL;,
MI _#!"-2N"BU)M-N.2H@\<=V2<P 1=P+'6,,=N^F2:ILUQI,MJ^3,#*8/$VB
M8$U?"7RIM!TT@J_KT]0%Y7G'.A28M.(]'>^K-BCHM <\W.,=W6Y9K-]*:MG#
MFU2H&H.$83(2M_4-UG/Z;6FX)V^YZ.-6H\\\6DRP( ;WQ+E_>O&\PLK[R=:D
MNU<)Y=,1R1-H'4=?W08%MO .[T9W^T[7F5;_5(DS-&CU S,R]>PY#WLFCT=I
M5$VF0\VXIUJ!MJ<"9,2  QP;KTEDQJPI2R?2A.84/Y"@3\1V<L&;"QE YRY"
M44>'UJ$O$(@[K=1Y2M14,BLW<'PLG[7EF,S5]B&GNZ%K/8SN>K=,C1.2^8ZL
M(IS27?6J$1)S+1JL4[PRIW6@=*2PUMQ1+&W&)(F*0*SOH[5]1W"I/R4PF9Y.
MYW+ <3N7<A?_S;6CD]0EV,:XOF(,-M']NF1JX./YB\(;IN5-(>&<;: *3)Y+
MUQ\2[8M^O)("K<IG4%*6&Q)S$O# QG7%[E!@F8_'/YZ+9\PV-KDV.61L_5!V
M"E94A4($-9BSM0-96 96EQ]' GITG,IX2FN_WG$$=4 3$XAJI+8'-]?B909E
MOI*?(BJK!&1<.MG4Z9R@]XK,'9ZK$9'F"!0_XWT7 5"2PA)%R_58%I;##G!.
MRI+[L*]0,*@>CB>MF%&"?'3W*8EB/\HB4QB<4U$I06WWE;K8FP<Y;*4871']
M>5B1A8)SA9DAHL&/Z)1SDA("$MH2]X6\#@$9'H]4HB4*R%[>B"U [1T)3)[2
M3M:E1&?^AJMJLK1&^+1DB[&.>%6V]I2@1]>U!3T*OFMIK3K>5 KE.S/O[;*[
MTX&""(OO!<(=;FNE_/J&B/-2[<'^%K1L2GBOC&^12%AHJWS6-6^LBYKJ'2&&
MO#OEPL66:#SC%O!@N>Q"+JYL.C(-U4;U]N!ZO>EL9OF1_U>63$@UV&&UFDED
MJ9KA;*?M18Z(Z#T@E-R<R8J^_M@S5F2IUMI+X&2YZJI9?VR5B,^3Q:=47W.'
M-%S4L*JV[LLJWSG)K+#O/N"T>)XQ?>CBW:0^C&/[L3CS^T2[O&$-&12JOGHJ
M3%?8V.MAVA$>7>YY37X:I">V[OY)Z2I'\ZD%%T8KK\*D/,R3T:VI[2#L8CIW
M/-9QM[GCC@I>;8[NW9\]'3)=/50_(B</O$V)['/U^18^?I4>4OTPR(#.?')(
MX!0DM:-H\G"!E4V.BY%%="_QCA;B<1KH,U[H444"SZ=C9'[1OJ8#^2,K:.HR
M*,(T2][?OK.?W+\H-MI_*I+14#&UC^EMF<UGR@H:+? X7ZR%P$1:)OZVLY@=
M,6/:M%Y+RF3 K"0-D4H7(^JJ-.,W 0:43TS#ZLN$(?G-W]>CEWX@9]J*N)'X
MJG@=Z7G8"26J<\[*.="4ZD;5\_.TD.)%[%<__OGJ;(G8/WJBX)\$R+4!]X!5
MR]%[P,Z::*H7F3Z_J_Z=%)CMKD7U<G($LK9R1Z."1I]5A_S3*/"<^:/'HW?M
ML&B#,:>K8,<3PUU9[R(XQ/Q&T3WLCN#!(Q/=:!>]OO#I;M98L<B)_\(K1!EZ
M'G6A?H?_X("AW@,.ENX!I*)+^A>J=Y[4]X#6H!N+6_?T=X3_$,W\ZE1D@-E5
MF." ZK#LAN$>(()[#UCHN./V:6\]S+^YD+X'^&!?C)QN>WW6.'1GFO]CY8>&
M^2PI7AY&W=U1'67OC%^S5RR>J#?]L>X] .W!/4S_L41U>R.Z(CU9>&9H_'6S
MS/6/E?_ 9529ZFY[C_^(WM&?*M\P/?S!9^BCS_G/]Y>I]/*G Z)0LII7_EC[
M3PR+-"M6H5-B2WKT_*GZ'SGV^B6P7P+[);#_QP1F(=UQ@!;KEY\I,O@[D\IZ
MIP^-.NB@.L'4O]X=I0J:)T!!47SILY/Y>],Q_QLT_;]'7Y,T'B&7^5BR6$/(
M0@P V"S)D4R\_Z#WY<EDWW_>_4=<C_V4#?#_!1'^7S1=?@GLE\#^SPMLI>6/
M.WT.P#34PXG4677>,YDJB:\C_FFH6_,-6LN=T A@BM3/'4##?]D!Y'?]L&RW
MK/#VT3I M]^71LAS8[ZJ9<SN'B#ZV&>A^Z'9]7\Z<Q CV,^2]?Y[#)&__Q$:
M6HR:N,=']>.([_;&YBC[;\6"@JPV^;/DJ,N+Y+L[OHN1OQ7'WRH;T%XK]-S<
M*#RP379C_G=E2T;Z<KS;O)4[[^</O$<\R/=O91X"?(U'_U%3F!%;+>H>NB"D
M]6#%)X+J[\J2DH3P^M6S/D.="^='K=U1?RMF987!L<&L13>6;:XO%E:D_U94
M5I;T_;^ ->L+LZ_G+?212WMT@4\1D&RXA%;-(*I-AZ=[B2'(@==:6SEO59K)
MA+%'L].([%H*WKG\);.Z=,%-CPI<;12()M7994D^20?_2$E:*VQ73FIZ^3\0
M0M%95.YWL&6YQ:$ 32P>@JA8MT4CK?.SVK^F+UG;<2NUH=4Z"MV>E7\7O-_S
MXFF@%%.L*6PWORA&E%$YQ;2\5^37,/O_,VNEM4LY8Z(1>_'K\8F]B8'VTG(K
MH+(+TWL ]??:6[O$2Z#:Y/[:)M<<4[OW,T5.5]BIBH6:<S[:*E;\_L3B F[K
MJDOS/<!)--[M@FI95*PJZ7\H *:)"II?7?2_CS4UT)NQ4HCVYNYN)N?0TR7I
M'R(?@DR+X=G^\MN-F8?)P&,QOC,C3[/>C<M)DB(+ER2>FP3U$>+\-]D%U!4H
M=25+P)2YK&ZQ_X$@@0FX_QWZQ<9<CZ!Q<I?-AF4]D+N:Q/:R=S%-E%'%+K21
M).*O/_5D%6'GC23;LXSM 7QO[MV/LG^)!FT-OF%S6<I^SYH7JEC-8'K\H\MP
M-"P\?KCW/QH&SO\M9/+??ZS^ ];(](CK4IN4<_V%<LCBOG$^7MC1E_CWQZB?
M_X\=H[H'M7^YZ\\!)2*:2*A]NV+@&5;(>9Z]TDRM)_,#KHJ3ZPPS*O&$I\<5
MX6UY^;#3IO5^5J!L(FYQ"N$EZG)MM2*)Q=D] $OM78.8%U*5Q%.6'QSD&-A]
M37W#Z=5Q6;5C!Y)XKF<;UZ"OO/;M'&?)4R-<=T?*$FE$PR=/#0WN*-)58SP?
M[?M^BZI17)D9+>=AL1[PY!EY&KA-UU*;Q$"*L\#.V)DR*2M2G^\:\=X&W*3*
MFH#CDZ.-,J4][D'E(Z=3%:ZBK7M^">?G<'@WXOU$+"^[;BPO>-9JZ G"A_HK
M*#11]./2T;=1YI/T9_L3H3WV^7 I6&(E7,M[?(I'-T1*<W-S4](D?NM?^E?H
MBC;*P9^M;NA,5Y"/L,].7H]5F'RD))BRESTI2A=NOM[++WC<D:.QW8HC](K-
M\(>$;;OZ.C45&\1!C^#P+(HH"(*-NZ/T93%@SCBH!JYG67:Y@8*KDU1"[\7D
M?KJ2GT$2\4=[PJ5@E!<EHH] [L(;@:?8F);GSZ9IHV'\BH /TSO;V-RL3D3-
MS0N-!?@\TTUDA1>VNELCF(*J*&&FB!LI.!Z.&SR-V19W9#%]W8+86#K;W:\?
M[9M$F;_Y\CX->QCX!F*Z>(O=D?ZN-DE87M4,\77^)ZY!NVZ.;J:B<:<(:N7*
M,3/($>?6&?#" KR\E(- Q2H0&:]J$T\_/^EU#UAJZQKW9,B!><J/EE!#J(P:
M0E(7Z9@^D=T@:4UP#SVZ![P7#62N;FN(Z_+QJHXF='O!OUO/?:NO.9IW$91A
M:6?)>V 9+1/SPJ:^PUA4=Z+?LN&&4/1Q#M0JU9IE5(U?_%-_-4(4-(Y =D:]
M=L56$'@X&90Q832"$FB6\/PUSQT6@O'DU>1GUW3)N[8C)&A:J1[WTVSC\4(2
MDC*5NO%JL+2*@HHH<;^-D7$_C*:1O\=Z9;ZIJC/Q<%MKK_/LAXX""CIY(G;]
M%+:/7!-7.F]STSFRR8@DP:S,?R;"05W_L/]..MGF:H7MN/15PST@4/]8:,9G
MDL0GWE3_0N6$9#_^[PT#C^^N?)TVEQ0'/G.*:WK.*!=1P^_7S+-"3T/^PQ>E
M_PI.6C\F'#URDA_URXL@(!I'B/$1>IA'HPWI\!>90CPE@CJ!O"YH>+K9M#*;
M"X$*AL%A\;Q9W*:]9=L^,WM%MZ6*D)(NOUF[KUM1;Z9*@Z0B?RRSA0YO'[,E
MVA#J2"5CM;GJ#YR6?C3W1B9M@TI54<6ONRV\F^>UWADCZ8&H1/7 '/6$K]_;
M!I^,84\/A'ZF2SF@'KL"LGKVG]M-L-P#7K+.="UZR7?B7=@+4_='NT@E(D0,
MH#RA;([BT6^?QQA3[=3:3RY\52MK4=YY\!5MFO]JA< :-M9.JA^<>T0_B=NM
M]=87QW8 RVM(#TE\R8;0XESOV1%RMHL=19'.1YP2\(=7'U!6PH$*0_''>E!]
MKVZ%S"T]["/AEDP+JUR>UJDIMO3&#<.A[^EMXX0P]8 FA:4(%04^^6OJZ?U'
MO-[OVKZ)1@H ;3J^:W6\(3V885WV'T3HG[=K/'"\Z:)$G'C/[,E5*N;D@L_9
MAYU0:JN])LS0QQ46GSP*O7TYK,O40:KO>W)KHS3:>;RGHH:%46+/[M5X1V"F
M->9)D;/%Z_TT5I8Y$36+Z>U[)D*250\,*&MKT92.)]L8LV%CR'XV0\L3;\-)
M"%W8J3;Z$-PFL.;<3MX.:XB3AY_IXY.-H[SLYQ,S$ZUUZ'HLAY')S%?X5Z]?
M33@Q *E)(Y&7/MGMA,[%=HA058Q;.=I<2&W41TK"'1S*J'@I7G:9N(9UUN!L
MZ1&E0=<%0][G1<H:2?4"GF-:Z6PWZ)7YV!1V+&^]WVVJ6)\N27XD.D"E];TA
MI>B\IKFM<[B))._KRIRJ;--'7:V>]\\_RHXC&]X#)@GT[H;:K[K!*$'<( 2D
MOCFKI%6V0S86_S0OQLE 3_'<LB@>P7H>$I%O5A+*"B[/-0\[,H4;ENMN1;44
MJ+LWWJ)X,MFOA=X#\/ <HMIKPBWY>6<:Y \0JIILX"S<9\S5M;2*NC_'[%4Z
MUW"%GPXUBRU%H(LW5AU1MRG,-2$F6\@ROIQZ(XJ@7GIR#T"R3-HZ0NHN0Q=_
M%A@S'84QU2VS<Z&FCPER1X*4A0!A,KM[>2]J0J6^&I:'1Q66[%\*SRS(WRZ:
MNKY:$+/"Z'\>Y5!BF?,#-7R/TI=/3(N2[Q":;)RS!0.GI9\]@KE"9>"V8H?/
MOA53DD]P7]Y1BN5I[=AMGA^%RS]=JDI37&80TB_:XM/#JH1438P>:WL$UQ+:
MI!ZZ&2>56ESK-5[> SK@U)>'%D;N 3NQ/G(_W ^\:;<3!&*W?(P:0GU8GU'U
M\\^,UC%N=CPOI.EL?]#1?O^KH8ZD\W]4]YYK?PBJ2HRZB):ASPI=)/X9</7#
MY@_*WCTR][#!X_]K[[WCHFRR/]%&%$0RDG,2D"8(DB0CDD6" D*3%"2U3<Y!
M$"0U.4?)&;H)DJ/D)!D::7*&!IH<)"Z^LWOO_/9^9N:=G?W=W;UW_CC]J:JN
MYZFJ;YTZY]2I>JIVM ^VK48RTEQB'W_YVI"8ZE34LE?(?@/(^&%TNG #"//0
MZ!A5LE):)]7)O@&TY:1?^_%YS_O]]O[\W^'K*I7:")&L)H9K,M8;P!%5R/7E
M'PZNOXILO6GX_'??X6658"N^!#WR/GL3<VN:F/%>[/UV;/UU!*:)QD[5,(RX
M 3R(]C['Z[P!?/J+M^VO8L=%!M\/H<#;U$5-M1N 3&++;NL?'JV_CDG>UI?>
M3LY=ZI)3Z0:P\93BZNRWJ^VO(XA"%\Q!CE*%&X"_DM05UOM;HQ'[#V_67\7.
M)W@6W#K)-FX _P$QAO\8T\N=(?P_#AOHDS^1;4BDDQ*[ZA^@2+Q.FD@?M\GP
M#R'Z?O2/0:+LI*2/^S-X_XF7K9W1QU;]?['O_LW7_PHVP/_@UNG^ZPR@3Z1G
M7KR!ES+D6>?05\1TSO>AZRQT#KH3'9IQ0C$;3X?!K<TLWCV['M<H;\[3Y,.6
MAY=B*0:3Z^,ZFN'$C!IE'2!*^CHXUR/%-DCO$8VX[]]K>!/#;<O_OM3]WQ&]
M?W/6W\1F8$_B'O>?R/38[D_4*53C'[?M?>@_ FCY3XEF\]3W_Z@PEC]=;TQD
MZ(-_6'.3_\.Z]M]L_Z]A8_??6;%N 3%[;1 QG<I&T1+[^X]T']Q7'"1\5;5Y
MW!I:2-4K4A&I(4?VQ]4O=XJ]#H]S<FV:/U7&O? GU7AY!PJN[Z3I6;\/U8TH
MHQ)<1SZ>O'0!LU4*3AU]%5*B^FA<&>;"C^F#5ER7C/4Y$@7&CE6%O6X_)SNZ
MYG-MF^JO /;XW "494]?M8Y\Z^+T8N]"6L.*\(6W3Q$N$.)XD5WN'V9OZ)37
M80#'6!T224Y7IV#.F@&2YNY$4#HWC?,,.3SZPJ!\[)A;M,W,03+C[7,B4V.\
M>$F_.1^! KC*-;F0WTD+E]>W[6:;F),;P+>:J=-UROGC70.+E3O/L#/I-GTT
M]./F.[RP1M&N08WQ<W-J/!X]D*F,X"9<0F5D]60)KV"A0 &K>:V*8]T,=H]&
M/9$E1KZ<[2?.,]]X4:X$:N67AW(%L-B2=S.DOL*?6!WA19#W(HWBR)8IN/)]
MSR'V/DF;,1O]8:PXLC5ZO/WP6:S=#GK&\=V97K9.7T4[>A6BXON87%[@HK)]
M1)0G+UDT&K$T^M#N4=,XVS,\DS,?"3F 8Z6.Q.(0E64S1[S<6%;#SR"&@7B2
M@O:?IP)7-IW(3\&>\;QDL[-;W6M7:8,/6;YLUBYG9."C@"EJ=!9JBPC$CX-'
M]?TKE$C^1X?>=35P5'_+683)E7^QBJ6-!T&NI;4I"!QB#^>7U)F>?3I^DD&P
M!%UM%%NF@2A/OJBN WT9%\1]S7C(_),RRW=]PZ'3**535*OQO%'GH8#1%&>8
MXW8CH)V%OA*C2L[^W"9" *:BZ=N^?7H2/?M8:,#%VD2W[.E!S*L]^ERWHC,[
MM$W>TY>\[*%\ ,^B%8SN*H#CN(XPS'5>><0)N\RUE >=K<9OL</([P9$_=Q4
M<EEN(IA6*VN ZMI(SC7 ,JM">UE]G,0\3)HM,'.SZA(O/3(E QV**D>[Z4I\
M'V=$,[,I$<I-3[)7R5%$.%X4&ZCT5;4$G/3-#$+8JX%,^K;?7:@R".#0M4;L
M)9Q+E46@V$7!"B@K,2Y9 KH3T^<>X6Y=O#S HCQN5LXW9]!OC5$G%$E%CG$]
M0L>!F9_5.-TU)V!.C0\/<7&-1\;L1J,'\;='EM%YWB$2"GH[:$$: \+V>>N6
MNICMD[V :%V%P7EUJ:!S]=MN[W_K>OBR)1YL!RD S3YJT&>E(.^D?T,W[%(R
MA.?YW'>K=:@$_,F1)X:REXB(]5&05J@W<3<IQIR&/CII697WM;#=+Q?G&J&R
ME&!N="9?CPFFV"U/F'7NJ[3;!WW@=HV/WJNQL6YC_#DX.U>)@=30OPY<IGMJ
M.&XVMA".FD.+7(Z0C;,).0X*\[A#:TI=0]3V5DL<C 3\\[QY*-\_/U">@]Y[
M(F@!M^[OUGLTE^[MQEHQ=>7'8!F XH]62$OG]3SI%%;=;TXJ-J!AA9X,HA23
M%4G0F S)&4[ZQSG8JG)N 1%+!N^7NELCN+>^&1FJT?5R2KD6IV+^TLFT.J^*
M#\P;*##J7P5UAJ::1K\"8-:Q^?",Z,_%+'L):TW$O+R0./XZ$V0:S,O]XY-5
M>*Z#EOE95(:,ZSY#556E_2]^(]:[T\7KE+S'&03UT-5C!@:+>N=,B6S<AHAO
M@,FG(&G3<("\_!J=2+&V).]H%8YCT Y2$UFIJ0*)[=*2//'BP'2'KGHJ+8$5
M/U:%B.RNE]>7*<Z!@A8)U)\M X[S48;"8P(A0=MI8EO3N36ZN2"0 U/8_<44
MNJ?2=!)D?=YM*N9>L T7<O?8';"+N?@FF);JH3^=$HK*2VQ2^-UR<9A1.P6%
MCHN+^\=R5!O95VY^/#-I<DF/9;\9=>S\$?VNTEMN4AI'<[W4J=&<QIM)47%@
M_DYX&K39J>2]'(:K5C6&-EQ<"U1_CH#=_7#YPQG@D&X%V-@H42,\RU?;IZH/
M'[%FJJTR_@::Z3*)>CH<Z:'MTF%@> .0VZNM+T^<+JP+%POQ5Q_ >[&8B#GG
M(]H'##US*S1":2-35-T$KY/(!J=QI\; /Q)7CJBH=D'G-X @+G'!O!N A=7+
M+9LU+M,L-&-:JCI6+MG@)KW F*#'284B>L?:\QN7W6R;"7_&->N07K[)/GO[
M>2"27J@^'#G'%@U*8F1^A+25WS54(,68U-#OBEEN8M<>?U=./*>G:HL+NH)C
M4J82HF,0&;6W_0@R5'GH!=M93.B-/Q'!E8Y(-6Y!^(C>RJ6)1IM<2YVN'@4W
M#]NHX \J''C-FO3^Y:-?798AU)/*Y>,LT:#*YD>0K.K0QFCB\7LGNYO2=&1D
M/Q26=W".P#"EM*5'59&R B3/M;4BCPR:>@O&NMP_%>=;C;R8K'=:S<U^N65G
MK:TXADU >MP)<'+4H1=WRK5TUC.H&I],J$G05K(C#I])2"6>M-A0T]?:DJ+9
M2$@FFRM=;R32+5?Y\O5!+XVW8VGA#A2P40!_K7;FEV-%#8,GK1A-&\P^7.EV
ML'YMV^7B@*RO_\NURF<MB <?)'F/?2/).1M;MO#?%AW< $H$(G_V<605_'.;
MYC40Z]'3TN-P)DAT)QB83?"#*-);=%6@E [YUO5U>T1)KYUD9L';DO:^$ _E
MGRL L61I%P$=B;RS,?GQRH:M&X"0BL4V#H7=3*9"(*I*NWV)/,3;GI%O;EJL
M8TSV),7>UU$C6CVMT4&:SH"L=W.>N)).>6X-)50/'9UC$$2;^92X;OIXI.Y#
MRW-<YU4FCN]O:P/[E=8T][AGL)B>,,RP_Z%_25M(&X5:60<6JGE7>^TA0W$/
MS2G-=O1$U<(=PTRTJ1V!3GA#5/$/[3#"S&3&,R4L,'-^?_7\%HE3_U-RZD1-
MN/?">VIZ^^(PU.9\/RV.)W]YA^'E.+H2$7ZR=O 3J$16B25;&8I>KKZ?09 %
M76B4V7_ P>4IYI7#=3AM)1P$W\1X;]([XW?5&&JRI9<<$>%8C-O+K3VMT9!&
MJLNN C+S9GS2,[]AA_0130:&->WS-2/$681B7$&OQG-B?GR_ ;R]DT;@;@S=
M/%9]-20_9C;.NT8T_9P?[1U)-U0% &75>0EW(WDR[4\.0HIQR,F_RAVQ\?+S
M]7X8TG\0,+DD%.+D!L8)5/>EJ2&>GE7]V$M:X@Z8._H]$L)V.[Q(^K7KQ_!T
MQO21=4I?A%9]C<U9S[6_=D./BFT(0& 8L"FN5RXH:S6Q[CO ?<U': -N]'H?
M'95G-&0V8C@C48:UN0/[$6*3]LE>E'JC!+W0\BT /:H5/V=*2!LR$GN:=W=<
MAZ_H;%=IM(JJY*5+C<.TSR2#:0W_?>R+%X[%A4LP-ET!?U\'?E2G?W%&7RI>
MZKDFIA5T35QN&1?"1F>(O+\6HUY6"?(M)C86-K<\-W70;J2#*96>:7>K?WVD
M.\>WEL0R5=<01Y\6X"-L\=_=&?Z/Z)GDV?E$<DFZIY?5@ KU XZLR#8H1\8#
MV.D0(CJN^=?YJ!;);;8G5 (J$HUEY6T]_CA'=]\W3K9=L_A]3];=FPQZU_!Y
MV]2I^JNQN4I0<%^D]-: .X0)< RXDF,4;P?M,P3M7C)Y%$G&5B/X#;NJ U1L
M^"V,AY[RT_HZ]"Q#!\:L[W5W0!Z@Z-2T)R"-A8O""9&QH8K];1G?+\$_"P 8
M/@!2O 5/FLS.PDN>VE$X$Y)G;N7).[_:NM;+?5UZG*J)1@6[ D.K$7$7:K,T
MI&JA70T_D6SM^;YAL1PYYG=81C@O=FF@#>_E"V2BT3?),-IW&M,2B848:OHQ
MAE\AB]R&SQ93KDE2SA:UC([XB[3D9R"S\_15DPOF(E3'G:08*TC#)LCB_-WY
M,QWU,71+-48:6=5;*O_6R*\E-)2,*[2C%A7"/DY7$E5GZV]S1IAJ'BH\5,QZ
M(YY/]ZM4]SLK+5[X62XC?08#C!RS$Z>V=D^HSNL$&*NQ1%IO@7S:9(*'(U)J
MZ'N.KR9'49V;3)7)Y1_K*R^!;Y#UF5[,'.P$6?#&L1JP%$ @S3*Y:C282?K\
M@^9KFD4G9NVOI2BVA@HMAE^>N']*L/\V*_ RS43T:WEH:*I3J58&  L \'@
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M@LFLILV[F/LTZ%0 PV_YOEF*TDBE)?NA>6.S[S/]4!N<P[KN_'[]M?2\^;/
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M\%D)/V8RBX\2/B"@RO<@KOS+1Z<HVR8J':OT[W:OJ%6C0>UX3UB?SY3[%-P
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MP5")0=W"<HOL2.WZL]N>NW/9Z;$42O34[[CT"2*W$]$X.N L_B(!*E PWOS
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MDM#P[6%*)1]U>R('P<HL*?;P%(?(=!MX 3[8< %08/X<SXVG.JA&&QV3'4)
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M-],SPTODF\<SZZ*(K W;K,X_KY64U:6&-G;2ZJ(7@**J+=''R"PZG$&';P%
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ME70[[ZFH"$E,,<#XBJO<>U]NX64N _X<5S!M^<#8:]?)]"NW;3?M3I))-2A
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MU%ENFKQV8-F9R>@Y^Z4T_U Y8?BM8[4)2UE,GTP":01],DQFEDMFVDBC+A%
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M]>5GZ[$6U /YM%[8 <)<2L>(:9B1%:/;I#Y^AZZX\^#;3BB:)*90X48*;\Z
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M]JW9#J.-KUMVO*6<IYFO_T60.HBOXR/9TN#3&@[H1_D$3VNI;%6Y)"%6WLV
M2!U.MKJ=OG%E>D3I9UZEK#>#^^&RH8UIMPXDWPS.B'0PE>;D,[N=COV;D(N+
MB7#[H5 KP\_1F=B_-L%-OZ="&D#F.E<)*U6GS.)&NTI:9XLX=8QQ:KK=I4$[
MPIP2M+.B<8K^C*Q"./64V7%'I9NSKLPXUD\BM[ 0(7T/<%H6C\/X&4/(:0@C
MP1C,-7F6WKVR[1>A'<]QQ,*I\[S6WTM17/=U4N'PRFXEBZ'9>VA0'Q_ (LH_
M0*+VTG@9I P?0<8'D=!JPP<(?P)2FT!!Q5+ ?PAYK27!_$$XL<':7Q8-WC*'
MAZF^MG@QHX;7+O,,(6Z?7_,KKS5)/0F>:2I=E2A]6W+C2??]Z_Q[(C?"9\%-
M^]I]?H3MP3?:K>\[1S9M#E*>:A=F?H XH"#HAA$: ;QJPVOSP^'!BI6"R?2+
MN KR&"/@?LK][!0[MFOGP63=/VF"?Z"RUV9 65WTG"C@WQ=8+JUXPWJ#UH>B
M_>L\T_ G^EW4['0E888[5@D]X2PYN'ZXV/!J@HY-Y$MC?*T"36&__(I+R>SW
M.LG6 ]. ]4BFY/T-]&&*Y8MAVS*!1 DQCD/RVOO<*D.1RP91X?N'MLF#C34X
M4N-#2=43Y==LS\F&]JVI1\/!OJ>25IIJ\Y*0O_W5[TZY0+??=SX<X7'O*%#&
MZ4H6.4WB=.)YTV6,F&[)L]?))4H5;Y(W0CEB<)R#&[MM]R?\;EV8B.AIJF^'
M]884H(ZO4V*V9I(-I%V1BG^Q'#E :U?]%Q^='2D1YV;\%>E"US.[CLP5NB7[
MI$70E2D*IC:[05'I%[K'"B8QHZP[#Y<E;G&-TJML)690%!&6X&3[FLD"I:!O
MSOS4<>V#R$_V+:[\L5 ]T7F'_;X.E[]0^[ JFK'"I//$D\LL;_<3RO"D 5/4
MG[Y].L, L"8%J4D!AP"8-+&(2Q4*S9X,[-_,AS][VIHOKF:-A?@:A PB^&R\
MUDNV0?$F]2I6JIY82/9,V),O+3&2X?ADT%4C2.]A"_[%.PIPK=\$''H(>@B&
M5:?6*W6L*<A!O(+JHP+ #ZK?A)G7A77 I4[ /N:TI=N01*'J&03(T9S.(!X&
MD&-6P;Y?-:_1SEB)(%9S=5RBC#KB $Q<"3I\XQ\UF@T C 8;1IN&[HR*-=0/
M'8B;$%:SG4V%EP;^"=U_@HP\(4BM^6T!."XH(4Y%UOB6J3%9^ G9W<10W-BI
MS82CTK1EO&]0WXQ28S:EOZ?6:>)-MHC=9_0FFW\89TO;-WTV/I Y97D!L2PG
M6UVZGEK2T=C*U:;P>:3GR5IU-%B?"P]%9 _/TJ?KTS"J&-AN?1XNR%;?>WET
M1^CZ\<LOW@8\H1X/B2(4L@B%.$))G7#L((ZP2637B62C6O[!F3B' )P,EIR3
MLSD8UWG]H]-]FGSQ*[?$KWR;GRBP:+DI&G<&2A*TELX/FI;BV+M%.!K'!6*"
M:,5C&@OOUKU,\/? CLZ$M;OEM,QXOBIND2Z2'15MF_6(97C9X>,>$?=2U-4M
MJLH[ 2J1Y$E?SL2AXOIKLH*;H]*G)4ZP1E1JED@[!.+^0$7XZ_@_F92D$%_9
M *7_I;,M$!;@J0L5.7_77OW]OE7!UOKOL ZH/0)GV RZ?&)T69Y,]T)&$5-!
MDX!B>&+U?@4+T0<P,>A\(&)K8BBMLC.M4,+=N"S:Z 6-)/-U"UA3F56]7#+\
MMTWC][,W9UVA-K U"H+V43R\;VY5Z5.$)/*=0I:"/*M<QH*Z!15"\EV7582J
M)LN9U]-][EJ212A[@6D2*/!T KTJ0:;6!<F@@PBAK.P'R-9;J:12L2<5P,,D
M&(;!\$Q,CU'V@4"SP7IR-RCS/D?S)D,;$WAQZPQIU/ -:9D6%S1NZ.2W(SL5
M7Y#P1&5_QX'1M&O'A#!E&O>296P\Z<..5J"L=O3QP*H[.6J*/=\[.8N1'.=M
MF;?/'GKZ-._. 4-B&EMBVN44.=6,AKL=]WD(ESYTG,YBD#Z9J?LR4[6$CO?.
MA(JOA][N?.:OSYFZWZ\?R>*5 %\S:?A86[X"OF;=P9XL+"Z6N+*M=DI(2I\J
M20O(3]^T:KPY4ROPE78<(#H.J2L0T/W.!BHPL?S!L/7-AN&'?B,Z::4@M0?M
M?5"J"37M-G;'>PKE,GA*8THT1HM-*#_S_#&3>6)%$D)!21>&=6)V-I@'GF(E
M[2*+(PP53!*R:,:%D;D/$H@D -_=$.DN#&*/BM"@(K)(M'DAOCW85WR5 G^D
M*Z"^"V4V?[]C)1N7 CAD[G0LR5=1P,)Z(&*%'3<1R$-0M5]6VJVFT39',&PN
M7YY0JEU1,(8L&!>EYFBDREN/3GE;JZZU/CV@F>K6(MY!^S[^37H [;1)PT7(
ME9]GCL7YM"F]D0N'3J&I^,1P155;Z$,C:"@2^IC=.5GRAE3HNY8@NNDOK4L_
M%$4K:!C0]%NOP=I?0%94F,4A. 9PRX *-(J7%J+ 5J@TKA7 (1V$D'2/I#X3
M@E$_75'=4I]6/(&63I;*TZ96W=T-".X63G!3=]!M4>S!>!N1$[J1\CBK9O?G
MMA[QX[U\\II>IK@*89P=SN1.L['[7:WPU7YWQD^I:5[AQZ9VULEE])]2Q<DU
M+]F_ GQ.:RS<K0>[7AX46&!9#8:(P>ELB4\[< >7DC2'J:>VHHFZQ@9V)B+/
M' S2[&@B74W4EMHRCTV?[^ED?F^ _?/#0V?Q6;N\S.E?.5H,FD4,^<WY@S>Y
M,EW8(/=R4+JG2M-&Z%<"B6&,Y[NWS[/'SA8+Q)G0#J_RM -=_V43H)YH"4]7
M9!5*I>Y[5XI7S*R;>Y>0?IRI ?1ER2PFE<'#^UZQYQ7AU"-1!XR'7)5YQD/S
M3C:)A#?>Z7LLY8%B6P0A@@MS' I1-0J?Q4I_2"_OH7#, KFEJ0@*D?9/BU4Q
MBIUO4SJ/9:$DIT*:7;(Z1U+57E8['+"U!':H^/_#03P4"!?E]FM[Z<\Y,"<
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MYZ3&,9,B !E8,!OZ\*Z*CI*MOH3+RJ(^7_".M<)MTQJ;==_F]RPPLYYA5M/
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MQNNS0D&3ZR48PVHJMIQ__>T5)V-)%2N+WS;X.X:2]_>N?,(0&>,]J2=>0>H
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M!)P1S&HZR^,],>[]\1Y(^B#G:51)NXETBV.S%+;YY<\2C0/ITAY0G0I ',7
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M+Z)27AQ>I90"AWD?/:9(/\;R5XK3+;BF+H8,+2C(K)/BV/;IIK^EMA/F/KH
MS0BD5VZ<ZU&9!GCP]J+Q#9R 0Q'XX#_CY^(9(_T">UVFH*ZT_52M'7K!FAZM
MSW$S&ZR/SUUF3FP$J;^'_S/1?D]]]J,+L7VC?4O.M,$N<Y^5\6.1X!9E)KY7
ML/W(9),P/ @P37XO""T!/RJ+9^*1^[S B.]/8!V$Y-"#9 #)J ZHO-KS+QW/
M&6\\/%>+UQ:G@/Y<^RF'+9E(TD95 861T7C*(I_3<AB6QK$35KGZ@)K#%3'G
M_@Y[Z?S."K';N9%GOM%3[33&)J9(9K-C"?85$8N/I^L5=;;1^2I<IU.5GR''
MJCDC8M>DK/F+K8>]3D=2HTN&0Z?DW4#&#1>,\//_6-50HEHA"L$KZY2Y=?'?
M>3W#0NV[<VKZSGK%-T1(79HV.0Q:]1JS"QPC&^&'&ZR-3O);0&4Y$#:A$(@:
M]QGC+%00-X84Y6T12TP,&/L'R''Q\K7606/BC-B)0CIF]'YA!J8H<LSZI@LL
MAS;/$]]8,MCXGA]P@\TVH*'1?)PS\<R ,%2H%W0K=R"G]-<3Z%1Q&3,PW<JP
MP':R?DFBEODCO3A/+4G2.Z&D^E05 Y<Z1I2V: !09.)E5?=[Z+ZD!"FNW>=%
M M'(7SCO*I:<IP8R[6T<D*^QNJ_1/4.6VB0-+I+U.Q7ILECN5)0^;^(E8W&Z
M)'(D!2Y?"=!8)(ZGP!4Z@'3]<&7Y%*V!KD)*T@(M?W$1[:-^VIG!% H]T/4+
M:9XG%76'GX#7;%)KW9A^U$)T:*/RS]BNT],F8 DDQD&9#5>2%SY-^61(^>(*
MTCO!C9BXY,;P; JU'&2R#WX,\KU>TR/;#,%3K[8]9;@"Q+3O#YI\,!7XG7WE
M].S-93&XS[_]W.F*MLI:$GMFYRQB%\>8Y'%%2S8S9N[*E\.937+[&@#H%T'/
M5<(XPO:6<28Q$!Z'.,F\-,#%_[=,,B7.%O4^E%][?H'$ -@HBG@:D#.,6:AS
MB<UI65.>[89\C0&R]GT.+24>08FOSW!Z5:OG_@';>'.O^?7'UKF\&X?FH-X%
M;U&K<:V\F<1WHM/K>..-7!3[?V'.0;'.H6T*!C.>(4\6+!N[VNR][A[OM;]V
MBIK?P_M\"FX3#9SW%'=C67@T-IO!T90QIP%9%-@&7HMYPFIN[3=6J"?<R,6E
M?-^Z(3Z2V#/-&?=?C@%E7+J(RVQ?A?%"Y9XMR#KT*0I;G%K5%QC](1V87!32
M%T=;E .$!0+B[E?:2-WG22ZPT3]9@D4L(2C< 4BU .SRCR_%[6=)0E:3^<V<
MEQHTM^L'@+<6!AL:;0OCN7TV#+6T2@*;#:_9PV]KE,CP0G[_7:[A+JW0*U7X
M_V %\[8]!1O7 DQB\OZ9T\9HDON#>:,3X@:;J _W@>)<24^NVJN1><E9?M[2
MEKXU?"]'^ K77L^D'!6+/UI:3)D]FUHYE:X2=WW%(S-9FBK\@:X>)^,38"S^
M!"DI!Y+,VF(<A6Q@WLZ[T;_J3O*20[L@M]]D"?Q;9#A(>;SWK:V_ OHN8INZ
MK%7=\J8><N7=[\<7+.V?F_'MZ=J=+5?^^^5VGBUH>/=*OQQCO(SV_9O//JKM
M_#=RK _]&OW:C91(_QJ;= EB1+*@O\#1>#+XLQ5:")]P>1Z$1@Y"KBR0%(M(
M/W#Q@+Z'%R@:HP60W+Z<'"[^+X"&[BH8("$O*)Y588 !HM=AFNN<]'LR/DYK
MLUB&1"=FIM-&96_$H^QKQ<YJ9EZ3'J>%15ZC-T_;WN]UVF^H*M69I=QXAJBW
M^+_ME HLGGJ*YXZB+$<$7N2A'NCU:^7=&-Q353KCN?V)NSU8_#H+L:V:=*<@
M[GS#?<_YJC2("763R#.NZU^<UU68?=!P/Y*;;8$+U0%\L AEEF_(3FF,7^QC
MFQ(W6N$R.N*R2O>11<>_2;1FQ-HRH[Y'#7@S3GW8&2[<'>;\<)]HM0BU6VDL
MX4ERBI@DQ!C8*10'/I6H5OEX&1C/\TU9LO+6@($2^YV.R7H;HJ'"<HL#0*_D
M=O, "U3<K^-_%)QE6!,,%X;7&S!@I#2C&T:'Q!B-Q.@41X. A(BHH!O=W>6
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ME04N21TR#K.@L+[3:]_Z;AH<?Y--7YW$I@^^,W3,SG)Y3F6*'XYB&5BU8@1
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MAH;FAD^=V1)+I\)"[QT>(36"_N4V1A@@&FPR65R'XEC=-UE?D06U_.Q /W3
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MU*(C.RD:6'O=5/X0CX:06+2'K-;Q+-7Q3(>SK._',W-*."URL\Y-TZ?'V7?
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MPI63\>F2[>FDX>PH2C8777:+(3A1-(_GE5DO!/HM^+5CF[%XSA5Q/*\*7;X
M&F0G6L!C.3=#,9Q(,!1N+=S>AM\RXT4:E<AG%D4%6A\D"":8 8O:K.GKBA%0
M6R8TH]9(23V*"6)4ZNIK>PZTZSUR(+]BZ)8J"YY&3J(8NU.1#G5.953GB%:Z
M/@P3*7%EYA5CMF]E#M2EK,YE,[6J9J?J/'6U9\2UWU< :0-^/D*>&B&S2GO,
MM'KLU=6L0Z])T]?*Y_(;$OD+JH&^7IPSXDQ[TX@$-,4PC?[T,\4B#>I,Y?DK
M5S\[T(+QW#,G?Z2F^6HGL:4E78^ ;>K.7 24)3%G'3PRAP4,$]DL8 $XJT"-
M#0:E&TVXF<VR44YS*[]A0J#TXZVFX\!A *^=%6_B7& 1?4.*N9\2-@A+]%J&
M<2ZFM89YKH_ZA<21N=5HW)O&3[Y?]UH^O@%@@/3KMP'\T>R[R*)J9B4@>Q>Y
M'6+"EX=F%]A$V@.2)1E$I),C5.*$]6LZK;P^F]:P^<?)'Q$8(K$ARU24\]C9
MC:]#HEA0+YCG+IQ'%"N3\$@ZF'P[)OU74S8<%:H]4:/!0]7.,Y%&*<"$P53Z
M6ID("5A%$./S>DBP/KR'S.*,#8DD0W"V,%BUXOE8BONAZ-5XX,H5."N0F1:4
M:A7\[-?NA5(:5B'8FZ%_@S42(%_=P=)#99AI@JB1H:Z?3D4/9;P @]N;TB=/
M?MWH&/>B8N_:1L/0N@13W;MCU!,9]5Z%WD&%/XM@)?MQWG&"+)$(3!J34/FF
M2QO$.)XHZ(_?.DG/T$[!W!J"?'^B00Z5]5&2$05 1;&X7P9/OS.)EXMH]@J/
M=@@!=?[3_&HVF_W9_N LJ[#7::+F*<.@4KOL,,/IP\.LM</<DX:I>5ESSM29
MON'+([)7;&?-,?NOT30C+:DY^WTSVMX5T\:YZ_MYKON((<K\03[].Y_%51^Z
MTB.ZQ'W %T*1](C-^3:31HBM[O1B3VJI;4BIK.^R]@B#:N+%,IYQ*6YG:0WE
M&/#9(2GS#42L<B;0V<JHTFO$.2OD;<F(RZ]JT$F@*P7JVI.(:IUVZ_!U[Y"[
MRJ5X=9#Q_52KAV2XQV+F-3*66^FZZ4:KB!ON4K\GIY_^I5%Q3^.)]0PT:L^2
M [SAZ0Q@<[;Q,@?PMPIQ#\]MM!T']Y.V9-'@K'"F-G/>3IO +#]>U2^6B3#(
M1QIOPBBG:U;C";M/,,D[6-_LU>+.1Z)U<9+UY1M6NUV-Y^P\4 =>2Z;K/%^N
MJR0%Y CQ.]!S9NE?TJ+9?@CGE!>ZM#BZ%T<6^&;.@!)FS .V+BN&8FD6< D.
M4R!Z#,M@.A#V>$:((YD]#\ N8'+!=U+;(<G@K%C3B9D4$<W[C(O[K+5K:FDB
M[T5[EH U7Z+"HD"23<FN8S5#7@$)/O[1-QK$%S?[Z9_\AMC)$[$2<H?CY*W^
MR/2K"\)]^ QQ,ARZB#5_0X-.H1\0M^+4B% ?*L('T#TU>6KUS74I2#.&^/)D
MEXUIW-7SD>L]W#/J$'S6@+&'P+@M_D";&I> 1CC3H'\Y%(JO/*-U_YXJ!-HN
MZ#4]D6!>T)@Z2TT3N:@RE4/*?NV*<^OV!O15&U"L=<69F5,,="FO7Q DM'OB
MD%U;0_-+=]T-E%\M_5P=4KUE("=Z^%<K^!5Y;, Q0T:8G#J+._JX9< 39K7V
MS>P[\@(ZO0SZ:@K1:0,E_B?;F-R9J9#L;>,LT9#=<?,31,B8+,PF##;6:3QK
M!\KMM-#:+[!/@-M)A0>^,MS.A[M)62-]$7*6UJ*,>OD8FR_;154Y-DKJ^()4
M/)<]WM12WPU:RI/(\!)C)VI49@O%_9/JN((O:TL5?+SO1,,[>#!6$GP-TUN=
MUQH%[;NJ<L2JJN2J'D.K6GP?XJBH?Q+=(=(LC$UDGO:U55^3-SO57T98Y5C8
MTB--U:^[9 ,O;:+-;@W$;*'9+6T^9 U05HJA($^.*P#:W\^>DDD<<M3Z$G&_
M+'I(%HE!5]],;P84D6MU3;S)7 @)TH<W7=^$%+)E35Q8MMK /<@LX_9<CPX:
M3PJLYS:"S8&<O]H#&]KQ# Y(F$- )+JU?FZ+BXM7QBH@@&8Y?6H3GD3T/F!U
M)@032,Q^0DQ]A)A<SSU:6H@:F1LDA$C!/C'G$/QSW>HRC;$?RX"00?O>0M(K
MM3-=Z<#J,PMO]DDV=\@^BI#V/QQ]["RQ*VKAY>(6-WC#2_:8P/[Z1-3M46JT
M5_*$9*HKIQ3"VC=[3.%VA.J.B ([LV).D)L.]EX&<=2#QF9!UL6GW,N;5^;[
M&C,ODQ6><NM&P$L?,D3;.VXB(D;:)78>'NM( /N@D?)4,'NIAM\X*@/ ? ,7
M!Q/1IB0#?Y_$WP_*WAV\Z!D=&H=U:K)3Y((EORXO/>WP*GH(1NC2_(.$-3OB
M;OWM_4T;^H6(RGIG$+@#DCZQEK/MU.@MU8[;S+L5#]<*M^+)G$53M<^"<V>"
M3>L-35#[YA1E\R1#K<IO,ZAJ\V&[Z8\-64=JVM"0O.>&9!$\3'%_ELG2<M80
M_FE;YT-"M7>CKLR;HHC 0F%U&X#*PJ]./9:"!0TC&]WGMN:MMOUAI60IVX#/
M]A9/'2(S'8.G(U,9'=U_+">T.B:)K?B-K"AU.<4XN;21G,N,J@!S1F>I#TN*
M5W^GKO89N4/H[X:J5*,FN*B?[U:CH5]&JD]&/-9#4"KFM?/1ZQ\_<\VGF?E7
M7^R!-@AQ5$H##0K:L O5N+)_R0L#]/JBWA+YD4=3G D/Y-@DV_#W;F:%XRNE
MF=SUZ1.$XC[8^X'^#0R@<8D#./H(3$H ZY<V :*7P3,?V?#Z7/T#B=S=G=QG
M@;_:6?!"2"R5ISP)SUUH#>:%# *(^O(-LMB-KE$+97&PL+C7W16&HL76T1_Q
M8"&FED6*&O7QJM^-*B&A)"+=H!]3Q4IJ*<T1.(9FK7'4]T3RR'# )-A/ 8X<
M)LPG\<+_G'=@6$4T02ZJMB(+YX)QCX"&:*07 6#ZC(I85B5*)-68JL=,:02C
ML\U2!E=%)-BRM9\[W/49BX_\]+<7!-751]1<N8#H#A3N@A )5+ KD7V)J#CO
MK?0\[PSS\\PKE#%A !K\VNWRVEE.P(M9$?BY R)'8G#'BUH3=^]\[.XX]9=%
ME'R;6K'E)]];0[Q$ O3N;XVLVJ%-!U "MS;FL- (P!P!.![O3F4'![P:E&"<
MNISAC6U;ELFK_?O82[LJ.:'JD>;HFGOAV-B[S;+TK2PCD1_S8XIIM9\WIZMY
MW^1CS&8'[:9X]C5'*+E-E%R46<[VLTH;3-XR)V0!&=H->=T-^>])R]*5FK(?
MABJ:Z<B\A)M)5>^S@48YZ:XVU@C)%4NWUHC)V;(:%?\:IHM_56S.OX2]M*01
M$BEF=,OA4FE#X'+(^PN[X*=(G4B[_GV&I9PWHCOENHE,#K[.,:UT,U(5T;\,
MB^M<[+M 63^JZE\^[!FY TQSIXZX,:6]XYZX*T)_;\.7_F/BO1\[K.\8:]=;
MWZ\ 8RZSQL;+LX^\8<@[97L)Z&VD$NI54!Z 6(4!\U;@E?W;7E4#/,9?N#W?
M62C\RXN;8P#<"D!$)_RPQ_MO2#W\8OFS:U.)9L7V@N?*  ?@?%])H$OD_M8N
ME<'=$V#^;Z!CN</GTTU_(20,0)PCV5S]RZOYE_>TS,*_'M]9#^X2[Q K9[O!
M2PO7:%VF7W\)@'!N0)UIK2NCM318*O,F-V(0&5P-GMK8/2ZF<Q02>E&.G@=<
M()%*[$QPM+\#LSU &"8$ZN-R5O2_12P4'GHAHKLI:HA[Z<^@TP'O=T(C%XFR
M5W>I)?'J=]9ZZW&3E?"R2568*$&;\XD$2_Q?5%]&EC^U@0#VHH(]*L3+@N*U
ML3 U@,SG_T@CYGUK=BUND)#M>ZGA<L;<<C8A0JWQ1GD0&-40S E"\&5G!.KK
M5\'\;M8U]_ [OXK ?N_BI:MJ@63AZ<\:/[,?G2Y>459[C50+_:8-"'@@6UI\
M1SY'4CTJCIJYU3OH/8+H <80SZ^D:)X(TSNB-1+0R.?)]XYHXQ%C@=_>]0R#
MDQVU3^,0:&T -S:'$/\ P2;M/HX'\D'INZ0NH@&YFS5P5)?.;._Q@'%FB=;=
M[;;<;=,049L:V7V6A8E"9HQ4V*L-W^ER6<T(G\TY$>ML/B/89[/</<-LE-)Z
MM8;BIJ$&ZV6M3/JS1K4&9T'J'/U<X]!C @=Q <9T.-3!S$RQ"0-XO4N^QEP0
M*^,(U.NY.3ES*QK]&?@L>.<O_^]+,]?"XIB/>->&C[SH4YBQCA8#1R2V,,YK
MZS%QG1MLOR7=.=_[*"?.-)BH:UING-*%/;$^O2SD]CV#7B(L64/QR;64._^0
MV("ZH>>APCHY$E\'^-)ALM^J@DIT^2<9#]ZHNG]X_'XE\RMM*-[_-C@MA5=O
M1=_L==O+>PGA?=M:HT87-B7>Y^%WYE0_E<L[AT-P4 X2.]>X&+0#CZ,K=K8#
MB8NU$1@E;J8HFB1R^.5L\/4$:(RI_[D:P)#,YX<13N6I<A9"]#B;UG#QN):0
M4F].2=9PH8E'C B^+(1(JJ3'N%=6+=_62)9FFN)D.N<)HI9K+^:;)=?@7L"D
MNH*7QF:&_'V["77.JA(2]%+4T6CI>)C79E$Q81#$ )C!Q<L;"[@,PJ >>0QQ
M^JAC"Y0!)'>4R_7_6:>O5N*0@N-H@^E+S<3P4>[&"L51[J2JW%1Z,K'&J,X?
MV027++Z^8<S2L(I/:/)EG\-RMZ[&7^?6[G)-8O0=3VMN:1O\M?[DLRK@@I%^
MUD?($+E.;B.A; Q1^BQL&I>QD 5CC#X8K$($H<0);OBGT,3+ )1D :\1.Z-[
M\^/>31 )3L_6YC;[;#WI,A",'9Y\K(X\(H?V,FZCAU'&PS3<P 5.)$%H-AH=
MSY+4A0YGTNS"#W<M&5/!W?,1?"3FZ^.T$532.55Q=$;K1?B8]ODL",SV@-50
M!-<;!!$XVVS71THBJF$H?J=R^9Y?)RCP[+$: /+\A&?Q%, F^^=)+QL9%4]G
M;:V#95]C-?PR(?#T:%"L6*5CA+,X^AB'M#0A#-%'8[ A^HR&-H83VMHZQ']X
M/WP.G>#7XX6"#?P95'O$:9-@YNBVV0MR@D]\6XJ031N#(</9@0Z1[OW?YF Z
MCXJKWU'!R4'@MG]PD0Z&;AP.-B9:+$OY5_@]XTP/N_3P=J;,O[M8OO;_L,__
M(@WDR%/K&XLLP.M ZU@@2J^8V"$ZEA3&,WW+A%@;MUO6N8:K:\#[1DW%#Y8.
M6@Q4.-VOMH[<=V)^KW_)/63D;.EJTM+9,J$T=43O6NKQM6M_!YDGV?V(N5)H
M*"<X>9[H36(L2 ] &PST%\"84.[3@1;Y94SFH_%=)'#(=8/RMX<P]6\:^HA(
M.Q)[$E6=^M,2D95?L7D*T'J]3X+5*//SV^XFOSW.BDI")/(BCB^/2GK=Z1_*
MTF<_AN/QV1>(FG&!Q9>[7.$I0XKFEY)DK[-<"C]G3HF<2P&P2**>F:+$QQU!
M\&?[W!78T<2/IB8LOM@L@1J14HWJ!LWKDN K6C;)'P$@[D0Z(W[S.5DK>U-9
M,593%QZ;9,ZW@LX$,S.O-JB6%B0.&2,"UA#>+JP9KN$)R<O!:+%DV:HDB\7N
MX9(KXJ$S/N*ZD0T&NR7QJNN1=,Y[<; /*?'WPW*!RL%49'&8.TD-E:#'/8#T
MYC+@01;"E . W*%M "59 H-)#@CI;3I2)VXD:4L49KO+%4^AW('A*6P5WFT<
M36EXF-(1VJ'3RZ'UBYF,,\> P-.#1QRM*T1.@!!, #-(WW0"4VR#3GO_M75]
M,^CPK#ZWV=UYP?V%(1$4JBU'+S[+L\B%MXFR)$-Y)Y?_L2#"5?L(_@][77I=
MT0G!9"I8X0C+--$=QQ=#]2*!W;KQQ@NJ[IM034#9&#[J=7YC"U0F $@?08N[
MU(9%(,\A^WM)R9BC*<3U@&6\ZFC\#55:B[:S/I(+]?A9X&)-:2<?_2:/?'82
M@_L":!!N>]#.UT>#XHZ(A$1"TJ466B#2F23D%>88^UXF=";-\5T-M+<@\Y8K
M&PUX=:1;42":BAS$Q\,[JF&>P22H?$K0HNB18UP)@ )-!=!/M4%%9"W:HKE,
M>],N,+/?8T:D+*3H;0<?Y:YP.-W%"J6:F2L5; L71XO?@=D03M;>:CZY,_4M
M!<09[GX0^$-X\=UC1ZW-ERD!HL(6+I!/HIL%7]I_Q.XUI[G<9^!\F;##%-1X
MQ>5HK*AK+U0^\MGDA<K-DK^@CT2X!<%W>[.D7_NC0J4F];JNR,;DD;<JC1H6
MB.VDS:CXJ:"_H(.L:#RLQ4?#XA4#P7>W<%Q_ZP4'A9@BDN*A'U&>R9H%5K?J
M\_D%'I$O&ZQ9W>D3J?K*GJMM8P^[7( <$3SMT?'(&&+@.J;SC%'$$E3RY+$J
M# H 290"8KA\^% \J,L,9T&(DYL/3C?L?@:Q,"VHV.C[>*'V;G#FMN/-LK.6
MCSXM9I:IBZA$)2J=KBO!HJ.@3D[#DX1[O3<7=/>TQE)%W/Q;^^RUL"XY66H@
M[]*Q\<._76E[)28N?D1F3MH0[Q0DP*V QK#7-JI,BTQUF=ID_94Z)-OBF8!.
MX-:711BBXE I1BA/ECF^(67Z0ICJ3=?R'F<CP1D S#;G)MXUP/^1/;H17TEB
MOSMN^%0/"[-_=>!P&LRA\X9?YNYRT\.67Q*A#W]7P1I4X0(K;P&.;2V%[UL[
MI(<<(41 0N3[6YU;N(%)U-\N&&VCK;7[4G\5##+MT0ST@\8Q#![%Q7'CZJ$V
M)7!\3J;A<"M4]P@XY5BD6*UUH0JZB@<S+!,@E\8_=T0S5'3#=N,'6M$^."Q0
M((&4_&!?%B;S7^<621T(4<Y]&2S)]1@3<>=J#.A J7>]H%Z=S5"5\I[^A:%^
M6OC,2\? G<V@[G/^99@A-A#G[+8@CDKD\-FX^@X4:/^S[.DCEZ@; LW!++_K
MG@7D#J!XJ0:[AW] W-'HV@UAC:'N)*>&;BR7 K54O6VGM9-U._+4"O';_FEA
M?<:E*.'2QT<J2MI9LL6W7[C%'J9*O%P9RWJ&-=,YP3._K/5Y(KEH]R0J^T1K
M<_!QGY.GN5W/.X[O6I"8L%P%0YI2T4_=A-C;4E=XMIWT+I83_TGQ3+\8??C/
MGR(]S$6N)A+(F']_2"-))78?R<?CC#U+3B+5M9,A/^=*X2</XG/TO8J%<+5
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MELU:EA,C#QO/NW7JL>PV'%]W.!;>Z%XE<7I6Z_ZSQ'E6J_?K)N?F;4+@QJ5
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M]@L#-))?)I47[2I/ R7EM!E00?IMCW'[H,$P!YLW63!?U20,Q&W63/.$L0?
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M#?H+R'![/CR++=C' #IUBDQ'2WICP!6FEJYA)C&4X4DL_:<<1)&2Y/HRW Q
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M$62.R 4]8LI(,W9F3EDA7P3-%T*<"U[+>P5;OWO]L5#6L3']L,U)=2Y\&A#
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MR<O/31,!*>6735'7>F5>YAQ U%'\&2-) 9^?SX25SE;]UF& <)+$S.%P</Z
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MM&2Z"=+.-]\%X:'T3=6Z0Z8<;"W-,7D(I.-X\&.=/+T55!L;=; %4EF1S!^
M4O6G6PT-9;:X<&CPS,=F=F10:YV S*RJ?+IN<DLG%*?3#)GRRE61$9O,5:E)
MA^RV7KDBVLHE0?V ]UW3-G<U* +L%-"M_[:+TV^?MMF-OB*-X7+!<COHA^#?
MW7I<\IEY].%^$#\%= ]D'F+5'\L31,)_R_+FX4ANP!#(3-5QH%_2F0J^)^U&
MW4+#4E[&"N_)4L$R*@46-F,J%#@<[E2%TZ.(5\5:0C7>..I@C-[XZ4K)5?&
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M]18)406GUYG"JK:H29'D]:/)DTHIG:\GVB?/<I%29:1SO>G*L$9&I"7S:36
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MW]/VE/=FA8O[_]'$!)S6_WR%"2!,E_FPW<.@AU3H'^. :C%+2LT ZCVZ)EW
MBMLYF)3=W(F4-]^H06HD3S-HV'<Z+BP)[WD> IN7-#,B=9PM#U?U[Y,;)<:N
M;F42%W]O(4G( %NITVD[8 &E<]2B?8K?<KNO4=,Y\MFD/-P[>XT6\B#J0!<F
M?8+:KY^>2YU.788K="YQ47+^(*OS.K4@2+;,O/,0RVPKD9E+\ 2)9TAPO ><
MPP,[E9L)SF-RF00:5T&0X\\8R,9V;U*Q<H:O$J!R7KB5+!GVF+R@E>X/GKO"
MY.+<TZ._)M,S)+MC!]S=/,[^@)N9X0:/'G=;+)F33'M%S<=FT@V]@R7M%O+D
MJO-_\KW#CQ,LG0Y(WZ%A=*C33/@^+2EY'-YK+&.)JF6A=X$:AX;A\?/P^$+K
M=*__U17[30A;GRXU].8<__.9/+W'96+YBM^I5AG&?S\;84^93UMEZ.])/$1*
M[/U8)NGB5A;?HBD7@#P$33DGN"B79#5QZ:CR6(B88S@#0"?<C5#(HN^N'RBE
MSB9I5IY]MZY1T3XA%5Z;\HY9?]VU(J?QBEFW0&3SR1<?UE&$G>$""S^"(G)_
M+H.$-,V4)PI?/[O^O*'QJ:S/QXJZ=]XJ]6V9OJTUZCY_/MSZ<?F>XNTEW694
M'2SL^>96]]NPSF74G^C;@X$L*YV'?FT;71/[W#;BAO%,#?ZM.=6Y3-T)E3:G
MFW.V31J&LT=+\^.FA.N6;B[NOW[6:"UV:-_V*_"WMC.C-QY=^[52_4>=S<P>
MNR957D,!KMZ'F7#O?NZ+US*E# JF7?]\XZ4@=>]G\E<0?R=B\*[89I!P'W1:
MI?/^UE,3.;@N8OWAWY^?VIX<@HKXQ0Z@L>[,-.=P0.CC0U,$Y:) <#9*;@>7
M)4NO%>Y8ITES+<^3U^6#VE5MI>=G+B;V*.#2R70+GZ+"13!<1<T.YJ KX]\<
MK*3ND2.@MR1:&:.JK%_X 6[A/">4@CJ@616 T62 <(A"E6MK=@@K[I * 8[5
M(@@XY]V%R3IOJFKZ,^#4'*;( I\,,^BENEJN>S3-<R$&PUPX,?LI\8\X2G+U
MHWO+"S=I%H]Y))%$S-SDRGA<:B&5S4#5IMT%*#_4#6#+;L18Q>ZB$%A(%]<[
MM+->J>.'AA39%:&M.F"DP<TR!GA$[5ZV03/H>GR#NO^I1*;D=->U(-@*G$<8
MDN\IR+1>A,!(O30TPZ++':0! RG 1[(3R8;K%M(QT^E<6&:G\(ZZ2!!U2/_A
M)I/ER"6*D*2DJ,JZ)^7K420%J-T8N1O55W"%'UO^2'D:0(# <%R ]),\F]N]
MX"GE/TOE+[\L%#Y =YST-)Z K2A/H]IA'('H<(O4TT?ZUZ+5D1%,P7FR(;];
M"JYF]9OJZE? NN0\=75/,?S0UL(3SM]BCL;?<@<6PKGD8[2<*74=M#[[N(^"
M)#_J$@J #?6^XMH8TI0FU_ W[LXD76BY*'4ETO47H<&<&O^BE[6N_[9LW#%&
MU_W*QT^1>L8/VV/: S4_NBBI&+_\'6HX'*'.0+R]MZ)*PO:[+9U<G9A[1T&B
MOLJ <,UUP,9 0+(YMOHGKDGV.\7V+(]9O;M>O.\;=\#T^?C^/QHO9>%=%R$O
M9,;@_UC/(:^.6, .X%B*)2\@YJHP)-LYDY'"%=*9MB))SYC281AYYTYKR1(7
M@;Q"B/3,&,%YL1"1#+.4@;=D&!%<"RKJ\^3,^+?M#DU''+LE;B6%L'#04YR[
MY$]UT,BW<SS(+I4*C\!JU@=";=FCI+P&M;Q^KE=5>FU-+[E9XYH<T4-&'"<@
MT2P1Q<#:[ QS DDM)E_4W(/:%IH^[MAZUDQ ,TD#Q!-K8(?R"4_%WL[ZG^OI
MDJNYP^6S<XWX@/8@[$"A54&P8N5.NH.G8/%,ZP*>2D8*DH*$ LN&9()Y&0[L
M,UG60L-WXY8S3G(A3C<P-.D$N^O6G+?$-YM*O:-4 7D$A@$U@:J5M&2=6E^6
M\HXIP[M/I\=FOST>\:64@EGIRO]/H^KCZJ+1T=KN3[<FK\/*N7"A)=<6N#Y'
M6/-[C;>T6_W,]WJ^UC(8FDAV8ZM.R2F$Z!LC!2@MW(3I0&,?<:"(A<^K )N'
M6[B^F&ZNH31P.A:^.[CM]C2.E]3K9?QH^/H[\NRU[PMDM<'JKT6+_7O*S1=.
M+,4R@LJ0S08MCS+W>7@W'6S5M8DO=VF[T:1YQR3V<>NKPZWN-\R,(T[XMK[5
M.N8M5NRYJ/C2Z).GT#U)VZ,UCY63(U0=XU#QR)1?:T+G[IPX7BMIUH?/2I0D
MT:$5693M**3,BR3_GZ!5TZT,V]24@8O_30:9O]]!RDB^CTI^P3+CQ^)OB,=R
MPYX7/RBY>)&J^>OX(7&V#]1R'0:IGX9@4;X(W4TF"5*8<[I27C 49R-=QA_,
M,Z0L[;^SSAK=)W>1T^GW7O8#_:GU;!&G\[WZ\X),C]:B\L7Y(?6S=AN^VS5E
M@[Y*^' P9J59#.I'NJ#S;ARNX7RJ>KX@7\/\@/-1V+P 3+< 354X3^PT$8#-
M AH0UR.ABP JL%/-3LC5XRI.$JV;D31)#+P0WS.*P#"1PMG^KK6W)62W$W</
MA5+<K%"#T@0U#?H!=>_S=)I2S7]V>@0+Q),#3'C"7I!+K@6B%&1!PG=9)=:T
M''L8#M/HXZ[JU7RP_Z8[5-*Q]&C]>LVCT3W)$KTMIF*)!?Q$VCO,[G^9V'4Y
MF0G>,X(AA[QCQ4Y#*4D9C4CIQKY^'J0(O57"WYT,V61 XX @QXEI@N;":^4:
MQ]89:8&9"^_44T&S5:'*0K6S%]+!JI$Q6@4UP?G/Q#MK-T(U-VJP-E/9J0R(
M+PCNM0GUVH25(IXQ[!'JK4])G?4(^[#=1D12P8+BQ$)MHTK<1WXZTABF3FZ%
M-K^+-K17>%6M&9=]P) 6IJ-OVW)MHJWQ,]B^KJ6Y5:\Y6M %N21;AZYQ$KP8
MV6Z/%!@7>(T9>C5\0&?QXR+&BKP>>X:M<JU@&G4QVCA9P*3^/>I<J_'NBC'L
MD7!A@6GO^\YI!5-Q==./K.ZJ.G-%AV3%+^:6GY(J>-V&@J8+0Z)K;ZE?LLY"
MZJGK4 OI^OV[ 0B^ZPQ5?A4(93"%U@'&":O0+JLH]=NGVVAT]FTRW295QR;[
MQ(>B1[9I];8^* &?\(RJ$U)9L$5(C0-;SN'6%_NX .G;[$_MJUE<]=\?E2YE
MAN/^?8P:1M5M#V]MPSQ&LS<A:RY>/+%JE/!N+JD6Y,REHX)M-A>S!TVY&%U[
MV*2JH*%2D2DWRX]$5(:C KE0\LGOP2$H.@]A?]+5_LE@.%S8DPK9!/((LS@V
M ^7:[LX&%;6&>&=ROVCDC-:.^(@&B!QL@459E !/\%'+1$B 8%3 [[R\RZ%H
MO#U04KU%\*).< -$KETOI;?X?L\X'LH[GAN!Z03_&P4"1ZG2_,4C\(V @-XH
M3+MH4+<&UIP'W1V1-;21_WX2U*_&MU\)_K[!WY0'H2'">23D]H=(W7Q$F)-<
MLN8S<^<9E-/<KB[$43-:63,,WXJ*>S=3D@E6[90KR:R2+M:!WU@8E8=\M6GH
MRP$?)NOIB<']8N>Y-M.)GZ%!4XBONF +/8C;1^1),NROJS8X#)26K]F199+I
M1%EQ$LK7C%.$"ARS^H_[.0%O\4)>X?1E^Y>9\:?3O[7VY+836,9)<\^Y]CK5
M;AV+TQT$VS,Q\>A?L4++$Z>2%7A G9#$PS.C0;B<)DJMRJF]?-.["J;5#Y,X
M#Y.$/IDI":5H"*7,*JQMS+W=LS+A(VB'M!W6MA\>\ON2MC-P#N=^4W[XG4P]
M!*]JA4!9$ILM4[5H!VGI]&#)K!@K;\4/)4)WRBY\,*??H:,^N:+N5IW(6%SF
MM[-WXVHR&[>D(E VCP0=N8J?@S&_^TZ5Q9$$%!FXX0'<-NU+,.\+ _CF#.("
M).<=A_,@N 0#(4%0PE0'0#T9($=2-:X(IBLJ+*TA9S3B<2'#(YCDY@? QE!.
M*AEYJFC5)7'5,90P:1:EG.$"I#N,H^2/<5%1\*)4)93H "KF)+0ZP+M>Z9??
M$43%R,X[#C0J0*1]N=B?(3B]3,C&J!P;/Z8%QE_>(#2>]$^G"JZ/8*B 6_ZV
M*+^H^\^N-6,O(W":=V &A&4 V4ND1SU4F0TY=$G-U 3'<Z"K<G!<8TI4+AQ1
M-?JA$E.,7-357HH+#61 $<N-I^5/R@XB)35G_)QF@&E]X2D#E8YYU2F$;. L
M*BPV+Q"B7!";R)65_B9G_DUU0\V7'^?O42QWH=;%)MK9G)OMKHDT!X[M<[Z*
MPZ$\)J9CIAAW#&82.A#?MK7+0U',#E03$O>V0XCX'ONDX-5P_D%?6X&9 L-6
MLL'EZ!<R4(QF$UJ8A4EQ.QW8I&-X^OGC@KBRS]K#K:$1EU\KVY)E;,,^?*0D
M1YZIS3J5EHN;FT.=^QB./;6,:4M)C$S&?>KD69GQJQ]V]0^)S R9SM=U0\1O
M""6<U5+OD6\SWQ8SA;A3!;ZO*<*(SBZ6LL,W0X&;P2YXM0190QB-M$YC'X;&
M=4D:A]OL&MJ"CK*KA>@VV?MRZ^D%;'HU6_/^A=UK,UF+BIF1\QO)J-]C&<2(
M<=3"!<:PA<S*A9%ABY%<=RQ['CZ6#3\*P(,8(E4E7YM1< [87?;)80 0'$6X
M;E)A^ &H%L@5K^'131TUMT9MBQ]FR@N>/@(K.9.DL.;$XHE=?N9>\LQ)(:-0
M*\2U*+O0"^,]21(AC1>)@I6R.+\F>:)1 0^C K#VC+,9 =@+VBIA'PA:8 ^'
M2^.0@?&/<'=),+YX1Q*?-RO81T6*,CV\GT[6ZF)'GQQHZ0ZX.UM1OPP9Y7@:
M<9&+CC*CLT'BZ6E?HN1,,S&+$MC+-S4K);2VN+,'8F>EX_4C/M=+7];U_I]O
MQ^I*06KL!\E'$NME5I3""7.'O;2E;OFFV,SB6UVDU]0?C"*=N2<0 7!39X,K
M7OJ2'?Z"^-RK.^HTLGX3Q?>X?>9)&SE^X#?^__+^S:8SZ;GDGU,'KXN=OI9_
M\'A8\$U[ \6PX(:IEHIHHRPQ Q[N8,!"OM5EHPBKCC+L<RW\F3@W]%HG><*+
M\B^:G(@7?B"6^,^2/%K,0W05G7=.Y'TS59TQ7RL651-9T;AF-JBPLOEV>9%U
MMLHS=5M/=,"VAUN#MKE&U3VUAJA/75%Y)[IZSM4!F+_\SD?0,D*G[']:$"\B
M^"Z IMQ,TUU/]U&T-5QGA<,$_(8_9'<1L+]HI8K6E<,9_X0=)]I./1C^-)SD
M<.#71O-)/_PR',\4T )C^MOC3<Y 5[]XS7,QE(PO?E082,-.< 03".)Z H*!
M7 F0-<>%A.%7C\ #>3@0QI5T1/5T"#R*XZ+KZOB4ZN2YX;9M?-B:A%0==SE8
MD9116_>[)-]_8XN:[';:VIF@A* 7C;2*N_SWQ&>TM,B>NO..<39%U)W*R\K&
M."V6I]4(XQ_#SGU:LX?([;9K[";GJ#B04)C%R8INCX$HW)@P%F%Q8/EK0!$(
MNSAY?(*'W%6:17#^3=QM%[$,7<_#E(PB-P80&W+LK[7>2 ;H&*,^D11,F--Y
M>\FWXVEN6QGRR"+D5ZCV[=Y(6&0,PK<&7\F0(M>@?&=R>?-E$&%3L9R'HW ?
MGAKD5D8=)5OJ'N2304_.TTZ[ _K_;3(.O;S1D1X;&^DMDB7*/]>4UQ7?'/Q>
M^[$]^%JND4'8;06K%ZI9F ;<196@E^0PW9*)("M\.ZH.G2_0$7BY/=#3!)MT
M:I9'D;Y#_FA/V;$\A5 H^EM[#UQG(C 3GO$PHA1OTIJ5+*X3N>^"F?B)Y/K+
M8@VWS&Z=/N$;TWVP<+]A5XD@^\;A1SV.+J6^,S=]!&/4:7@KQBU#6'I4%^WG
M:>NR\O*CM%Y_Q0_I#A57I&QAMRO01E*%+AFN/?2*8.^VU:K_5./&U3/'ZD=4
M)%LDP?ZIZZ*9ZQB>-W;UPC=R9,)#NDPW!XX@"7!JX-N?X-?F89X%FX& H#1(
MPAF49\APD0WYFL8YOZ.#0,@[VY_\SO]9Z/EO#"ICAXH[D^2F@4PV0B3_FKRI
MJI4!F<QGY-.X;KH9IR-^H63'"S_>*8K4^"4JA],8%_0O>N@G"L-LB$XO-T5\
MD/(F[7*T=_LXF5]^W6MF.^T<;;DHZD?E2M<F8QKO>LY1!5L#9!@2V JY1UX&
M:!\>9%=)Q!R$Y1W1P&X^EN<2PVV"-Z\'#6M[OO6Y]JG6FP@29@?@8LO(FE.9
M(5Z( *?9O=G*1"XB3UZK%J0G1?7)"JWW])H;O:01&:C<_&JN9Z6+V1MPR/?D
M\&C",0">OS(_K8RP<_,]5S8C#<J1(@FD@E"RF@+MKVI$5^0 +K+*[(6.&UED
M05_PE@'_[RC/MP-LWQ$;/!?!WQ2&?P']_'QPKJP@9.%Y8N5_WRDOZ,C@.Y$'
MC<+R*\66QCHZXHC/8TTZ7N>N-.B1>VKRQ.X8;6HF7[ ZHYI4.%)9]"W2M.Y]
M$B@&![]@WO+>+.>?V9+;C7D]T5^6H@J'1857DT=54B_+?IA2$>=_H]J<O^'_
M.^VP8#2Q_EUXS$U15:8ER0H?;IESY[WC_U%TY_],.(X?P'=O9F-S#HNYEW-N
M(LWFF"M'<A3><^:JI&M)M<O,V5P1R5Q%J48J2K6Y&I$C%5+-53K>[RA)I^_G
M^S\\7X_'Z_73RX"ZR_W\WCYJ[D<J=?E_"KSJ%;Q"EKE%D&P*8V+$XMZ>V7M&
M89[W?WB>(I;/.F&W.?R7/GO8_\6J7\6105I=!$8<38 %ZB([Z;7 84A*&,(U
MH$['D(COW[G%$AX/T\Q4)Y8YP"?[0C<;7T Q<E\R7_RGEEEWDS@R_AM4( NR
MH'^V(,@34-! H"+WF98?F<#5^6LOACYGGFSR^"Z=1!WX^<A::&PYI^PJT2P:
M#:Y=_06<&L_YZ>=Z*_KBW$\_5<A:_YF3WG!Z#/K2ML?V9+J][.DC,GZ(COG[
M#4XT@@#8DY56\V-"#?U O*)J' R-DYF#S@.QQ))B6E L%Q8_QC_,2AQ[6&S@
M6^62K#3?"T3[52:))\8P5%?&5'?N3<23:G3Z^J+;V\3BVFUG9KIQNBT337[5
M1L^2E:^,J.F$+I*QX(](E[!LS_N#=..S32Y"-7/3<V[R.AY&9DV(L!9_G1A3
MHY&D,(O-LR*7TS^W?U 533WXIT%SZ=[7=]SJ?/V5I&)]ZXMN3BFWQ0N@;,7+
M^T=G;)&9I)@V3Z\W:UC]+WFM87&MB+UW.T:(J/"&<)8S_"(NYM6V/Z\ZKBV/
MNFHH&T?-=B9/7SHE)%L]APV]-U84MYTF _&GIV^DA@F%SANK"W."%XG1K-NK
M'\=WT&ZXNF9^7WVSH_F@3M&?;XH;'R_?$)]:6X6_SOPBL2*<0,Y:U;(_Z29%
M<Y:**[2S9'[-XNPY5D7T,0T3 2_G5<+QNA.R^$<!/(-,QGS>S!:17L%+2>?\
MT=FHG*BB],!T@*.+/7!!S@DY'7?6Y3\&4^"SWFF ]W4]'U]F'+@):"Q1\4M>
MDMMY46Q8\><"ID?N3PC@4N57YO2HBPV7%(!(OC286)VA9*6(W;Y&WZ<8GC3&
M@6E^>K]/J-E(]T,Z;)Q(JM><I0^C<[<ADQL=1 O+B@[A>5N==R0AH4<OED >
M&U9 E&B8IJJ\E)8088H[YKIFT ?Y9M@JI:6M7=BOT9BU5BR?TCQ^52.ED]!#
M<.ADYFA2<2PO,+F;R99K!KCMOS760:?8FZ6M>*,8G][.[+?J6^D1D3N8>T/5
M&]4X&I[+;UGR$>F&/7>)D2)SC=$ZP,B#7P-"&#*GN3H;0T%E !^2^^@]/HK^
M*X,PI3,=4ABUDM6FH9[::B6?V+V9[@U3FP)18,L,#-6^@DF&MIC?P9N813-T
MOPX_$F3>O)IOIM2G9_OT-]J,D&5CB_"\;!4XX7W/*E!SCR"8ATR:XGAJYB)4
MV,]V]9($6CHH"B:2Y"$;@6#M1., Y;JH/K@.[5K/Y8S2OF"5)_-S0&UB!X:#
MK<#5\70C.@F.<QSY WQYKNG%C?F"?>..\WF//CJ&$;/&>I;.QUT_\>["X2**
MPEGU_UB:)^X-S" _:NKUB5;U7#LU*2H'$-IZ0D!?=+WO <:B!8/0AK$("0WR
M'##N%Q-XBV,]4<?Z58'@RO/:G?-%ECN=%POVGCFU4+;O(.T]SWGGO6^9#22-
ML.?O-D7L+[V?7U'>AB2X2K^]VOMF8V/]7>WF^OU\DD5KDH=#]D?M105X%[Z/
M'G5E[\A_&8"[3[8;LX7@*(4/8:Z;JY\/+3X5PK!3DE_[ ]!*-ER$*^G.^T"9
M^ZQ3\8G,1J9*Q#ZJ^I6Y'$>N-E273_TD)SA]&D?0>7!Y.V7R;!9ON7=]X]&.
M;],Q2J52PK??Z;F*UAC>$9IV>A*5&M&'4?^G$J8=3736!BT<I],&K'B/7'ZO
M%!7%0QJL>K *YCU%A0HB"NY66W;F,%;[(Z/&Z'=2]F\AH"A4VN .RO7:XQ-?
MAMG:9.K1(L?N4ZJX,*F8?L3;SV8Y&-JC<NG$&L>_H4RY>I.?[N/2$AQP2H\-
M>[MJ[ I%!N98>PH5FH![C:X$Y6=,U@O'B-Y!*<%]'2HJIX6H8XV";7?'^ATN
M:IBH5:;LONQ3WD)/, T;3ZEN-WEFF.&!B=[Z7UB>#0?C+G)]Q;\>\7H*8$*(
M!1WL;@2BR=#MVT5\73[=KA80=H<I MF$%\F/#B+OA6*XQT_)1S >LQ'N0K)-
M&CT*O/=%9RR [$+Z6 =U#@]ECMW(]J<#]*,&%>UE/'2?;SVU,US3VIZK3K-%
MF.$H<F_I+*=A5D)M>K]QN-C:)' .:EX]/9KB:5,!9>]SMJ%BA@&@<(S_%8K-
MC%F:%=R5X$_P?BG&5=IO\FP;=0V2B!S%'DT0*XV ]EZ1*-+FGBGB^] N?%_W
MBSGJ'4X#!%WLH/7V6R4(03XT9JH0?IL$WUM&#JD0#<1JI*('?)ZW%41]BM-Y
M&?XX&G1S+XZ]XD)F][%".^K^1"5O7Y&3#NZ$%9:W-D>OY*K19)$H)@P3* /:
MI!V[<_:9)%%'*T*CV8UE@8$E>&1'!'G<AAB.L0[F",!O7$8M7,:6-:,%'+U%
M0PNPS(WLL;1WQ*+BSE#YI]A3OM$CT<_;AY^Y993G3_</D9OFOI(WN(';%!=?
M'!'DA[T._\Y>JE>_N?#J6JJ&5O3ZQ1?B C07'G_RNAI)AE@^*5'#M48O;6K.
M-: ZS6^%RECJC'4FS]%<V^#[/]*:8V S1Q)G1/[-L-[W.^_]+4\.YK_6<%"'
M#)NS_MGT*7&:0'C9F"WP\"J>6^X:4X+Q]=AJ6M]O!)$/V',6VX2O]0B<SE7*
MJ#\FX%/_712Y?)V.R6Y/ZO\<21Q\D_P5/8K07JU\Y/RV"USPH+3>JHKO:8D<
MYX>LU2NW\#VGYHIT$OKT]57E%,@S3XIF.AOU?B!H_F,&VJ;W#7QW>9>&^$R4
M&TPG>Z>\A_R63A@]Y'ZPZ7H/44VR(YH"C!VSF?ZZPETF[^.-S3J"SS&5)LT/
M=S5'PUX&=1>HJ."/IOF@YZ<JJR8OV4/CRV3UFRHB<;_#D:"B@\-Z(15\JEW8
MLRL7DP^'7AYZZX"=,/WOAP_Z+1ZR30<Y#AT00LF(7G<\[S,PW:W>JO/:G8%^
M:$H=,P(9.2*&K5_01TG 1(SDCCO)<CA>5[[K%3E4@:7*?[P3L15#Z>(2VEY&
MX8^326XH31)+3KRH:RIX!>/=0M@9Z,7A%Z8P\4PKS*=)5(R4@G(M1I=#GR$H
M]_M&$XUN5LF!]UV>/W\U5,VV 8V^O*7YIWH'LX/5N#LY]1G;,62,;2V, <^3
M$90)$N**5:$*A\@FX\C%?)'[?OW[M&G[V+.WT7IR$QBOCLL+)!>1#,KH%"-=
MVQ#:-UC0T4T!4#Y>Q/,PNPA-;?X];SH*&OKGXI?1SM]O7Q# &K;::TJW+!-I
M3 UUH7;$UV"\]IZS9HJ,6=3Y@RZ+/]"EL#+_)2,QA_2<SK.+!%T=OI5M;N'V
M:[C:#7>^)5V.3$=CB+>_EHRZK+CI_$2WDN^-/48H3HJR#YKU0..F_XO*$W"J
MJ:^_//\^I>DC .X-U_^:3W?[\X+>(9W1 [N$'CS[1N>,H>B,X=B)2@?&^G>&
M7?:>YN_FC*]RS4O Z<!8^2GF#;B+F0AJ*#KQ[1VCR.'$-Z^31<?/5-^*-)2%
M3\!!Q?O.:'3"&&.DNQ4GT1BPEH@A^7XZSR[KT?$HH'X >(6-QFQ"-1,@MWHS
M;U1DO@&=K(SA<O4A;H 3SW+.; L_8T9@:HC"4T70"&+6]H'LR.;P* 0/Y C_
M>H=-[&0\)\$C5H[KCT.*$I/@ CW+>.K6^D0=D,[A<XEA(01HB3;]=@ZZA/!+
MUR-DD4#GN?]P<X]==]^]2,BJS#D,TRM$:$<V>OX3DJ.EIZ?5XYFJHIVIMB\N
M?E^&@1?WV)8X Z\FG%<+(L>E9\N)(X#]&WE!UO&E[L"3?;27J_HO=6D=E0;&
M]0;9MBD7CX'*CQA&UGM?-C**[DE)R##ZNN+]A);:86]\)=[X^A'C<(!OYKSQ
MJ?G4VUPBGT+L?>XK=D\KF2>6L8LJZC>+=HQM3:4IV=H@.P7HZQA8)\GF+DG>
M%B!_5[:_L220Q?2_&>O?3H%V6F/F&T$?!D!P&PW,-_ 7GI8Z'3*&"?AQ6\EH
M!:2< /I3KQJT@GF-@7'H@>K]%FLJ,"O9_[B2;R^8ORD!OV2#7HN4EO4M>^O-
MKMT$4D06%A@P#@[Q8B)K P.(%1E@ .FAM9G2+2#NII6Z\BXK.X;+'68MN7P'
M/(1B&%(H..)U]&Q%.LK\,&IF\4@^/=N]=/?N%\"#@4>E=/D# )C/U]UQ(F"D
M86@<1B%A##0OA&=H@,#%B%U@^PP-)?0JZ=5QK($'3'T.K". #)$0Y].!_U4J
MF=9M!FD#(!@@1#4'KH/1N")Q+=8%M2P!5;X[-VE8&B16-3T[7Y.KI30 2 %6
M*QE5;[&OOG[>Z</D><Z*N96L6$T.4B-'*JLHY=S1,DW7,F6:6T\#&"L@3QF0
M*C*O35;5$6B&8C6(&+5785AE,4!;!+N-0?#$@"?@[5@9^'F7IC2C)I0%IZ;+
M<?==Z&2I&HQ=F-/?Y8EQ:5_(N$3E6!(@+$*D:9?6'3?A0CMH,A9,%@AWY#K?
MW+WW%P@2)!(:8:!C@-A+7P]>#1+>R]7ZLK762N3X;=<."S)'2ZU6\QO(>%^Q
MRPJ^>,[<[%PIBPZ+$+N:THL5@8%3/ZI09/4C;9L-+C,Q.WXV+.O5[&#"M40(
MBDQSX#W0?#WCU^YM%)&9A-KD%-%$V-?DV,4@'M9Z?BO&2@8L%,+^0^CG'MOB
M"$HZLIX8SM7%E/#CGE-WK\?#K"\[EU'7QZEN!H2 2PF*&3KQ1AXJL0GQQQ+W
MA^JE#U'? ',)\[H.!MJ%)DGV(7I5?+T4^WBKM7U';:G%V_(/..9OF_#,.Z;O
M #*PUC-P5;K2;&)0P/.Z[&.8'9]<&DH3KAO4JWDW'/,>##?ZPT0G9X#V6?LT
MK%U-#0;N#VYMMC4^.@$>RBO,:C<608CW[8G=*FGYP6D# .C6]#1!^S6']+27
M0PH<\M;JC*UE>N<-K#;WBS#P1S+D]714-/WL^K+?3<'^<7>3N>?^';&F?Y,$
MD#I'$T+]M]X#\*\'+*Y8=,9 3#'0R7FE[K"R2$%QMUSPZ"%S- >I%<BX6FRQ
MZ6FNY@ 8.('@59!PV4&JRN:F;23.PC]+];5$\B$##!@O!YDF%Z^O[42/;7L8
MO*UGOLRVPDI+5AO.@I.]0&[JX.M"\V5"B"<&+I)U1+[OV)E?_K<2YOS4)BT"
ME))[3HV)4I/=NBV0^[MRKE%T-%JU(J8<MDXXIH51H"?<'A)5'CH/T2'!+.CJ
M6-8=599]O-C>A1!VU@E!2K]^Y"O)!@<VO'5!UTDM&ZCZ1+<$\L$2JKK9]3<#
MH20&!)'PE<Z:E5>[AN;4G@!WK.KO<)6!#<L/*C%K@F1@IQ70UCWG*TXT@)F@
M&"&,L&XQTZ3B(8SJE%?UJ:M!$2 ]#A & /*T7+UP586"!=[]B.,)&M&<@T0Z
M2241HOO#7'-OX-?02(HP:.;R/1? O8W;&0XFI8HL^[4C#<IB!S* ^RGUKEE0
MM\.,LCT!GQ\4I45'+,A#***8-F=@YT><A=C,2Q.V,'CJR][3!^K$6)%XXID8
MU7HOL5C%E8[0"G5Y+0)9)2!&L3'N>? ![XQG%/,MGN;R^4+YO5IZB0V*6*@V
M&<K 0)69():0E[J1=W$/M2+/LV9C4[=TB,K/RUD)2OR\2O!>H_X!:I_>N R;
MU]GY-L?[4P)S8\O.<XE\D]P%2>)^F(Z*M799<VXI3>_00*YU/#5I4==ZC7)X
M33>].2_'WJMACX'#\$ G/]\8I&#SQ8LSJ>=CK5]M9,B(O^HSKW]1S;OVDD%D
M<$'UHN&?,46;%<,Z6W"]"F@TW.=FJ/%^2B'#6K&U,?5,3^&#T&NOFXD%)=>6
MFH&+246O/UP;"+F^@]2I;V732;CQ!G,C.A!YJT#^%V._F[()*]#TFM(!%["@
MLSZ42E!XJ"2R$#0J+!W /-,T';/<B@S6]C0?HP?<-#4S^ "Z\\P2<G2OVXIY
M9'K0'^XVHF@3& . 1#(/1;1I?FRW4#JJ]8P=I$=P;-" ;"1L^\L+>GQB)X7I
M_-POP$A8R]*']+27:?66]=P$#;-=R3GPZ3'S:7JYV<TC.^5!M'?0NV2;D.QR
M\UTF,G&(H0 5RD?MW@?<[0"/D@<U I 'A-#$:MM3[W=394=3\V$Z)$C\U= D
M,7@> \HE*)C+8 >$41EW:CQ?*2O1%5W2G^H0%#A,RHU/)!N&Z^]@R7AY]YNK
M]Y[4.6!GE-8@SX-( 73T<Q7-NKYQY2!F%_&%LC(&:BYZ[B+,X+*Z9M]GHIJX
M%<X/%)X"]NK&U"GO6K"&] @=3OY+$G\$CM$14_TJ#);ZTO%-%XUQ4,I8K*4,
MM)!\6D72?6)5+8 %MR9 >/]R-A) $Z:03\KF1N('3]K5&+*0&$+LR +NJ.J]
M6_^23F'OR1\^;S06<_):QJU7TRK%8$]AXPZY0'(^7%R#]1B[&",[I$6Z^+GZ
MH.0/IA^L/KO[U6-GM;UH,6@X'?1=SE(,ZO,-,/$*B%CE?$]\::K;2\4@HNZ3
M*")!)M7"[O=Q&[;^OLQ]YA1J;'?_YK6<HL[^?V.T?2/[E"8N<Y8O!:CI9&U<
M7EJ5[3^7$VO4Y^:2F/TA,3PK-V_F#2\S/N8WY2ANX-?]EI8-O1I-??=CE^HR
M]0^'Y!_JHY$>Y.V.-2"SK]0D;@F9WS0XDT;SUS/H^'DE_,LC?JMT4"J-KT]Y
M\,%H8&AQ(BFU\[9/S7!A+=Y7:%8T3QN2E U=<?&+L@!] D#U5H;T)<@L$GRT
M<?PVZH;GK;=MGZ!C$/]Q6\:UB;N^"3!PL1PG?5A)WWGI"*F/HF&U(OC.5AT#
M05!BR_,W+=52(*,KIF[B]#\\D!<@&&'G<M7*XI42.!(PTF=N,4:O^S-19XII
M^S-1BO, *8=MNYA=AP:@<P ?C=(17V,A+A'F3[]D_.X_(*8>WJA6'0WZ.+9B
M/KUB3C[>L?D#[9F."FH"!WW\--9G;9ENXQ]FDL@\>D$L=YN)RAH#OKRX*]<#
M:0) Q@DWH8GPI][ZH;OT%70"84,D3.(]NUPR)DEL9TZP/V2%=0M26Q=_7E^Q
MCW=X^^E:4"T9],SWD)8@:N:5BED5N,*[[.._I /[IQY&5;[5JE-+?GAR54XZ
M46+,@U>8OG+4!)>U@71DH&OW-*U%T+<0M(/)?91ZK(5(8WHD*H!U;V8:1"&
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M3$^1+ +>G6&].-._4Y.V4\+3.7@)J)G%1-N2_YXH<A2PF"VL8XY!EOLABN*
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M>-B9M9<Z2Q%C<JSN2XS"8852LG^QB#NZWEG!W&'V!D 0/CT$<=675S1NN3'
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M8!ZFG\1_2@(BLX*IG*2'(\(I]<'9AC!4QQ!H@CLB/4K(/$L!0*!;5G!U$E5
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M28@ZTW:6G?3M+^(V@"Z+OUAE% S_Y[7J94H,(R9@6]%NPB5BGOYQM;<2'_7
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MGDS#$"![JC@K5%O[(>2P*ZLFLEWZ%6V(K5:9 $0SVP8D03$8D""J_M&ZM'>
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MYF*.%!X.613H?3XRT_\RD^PFT@_X& %Q8E0,C TBR]T=(ZB7H]D*/(K7@Z'
M_[_I!*#AP A+=3T.!643;I_(5%MS(SC()',8J"6@?Z=6D _$)XT1\$D&6,UW
MBV ]JJ#,W&J4ZRN6].";M!61+K.?XYKLN="-08 *X<JA!Z3P6X H379IR!5[
MI:,HCKB<P2!RHEC>E?()Q43V 50T*'LB563%;AXLA;>K,6S3Y?OR%B FCQQ%
MYUNP@4:;3+EIAE'\E%+PA009%8-REA'U\+;&I5V>X$<*P%3X8H4/>U<MX5,(
M_5W%-^OD+S1<D42+:-O8I5:H!!]H 5Q7*1##@4^T]!1'ADE50\RC:I060O%H
MZ=,>M-:<3TE./Y\^R_U)DONH">[^@&S( 1PYAIA^!Q#F?#J!N#\;DG&:?TDG
M 'G9B186!RP;\6N=[GWNV2O.$8@;1-9Y5B "L->=/M^5\Y42]C0BP(.,W;&9
MJD&_P'N5O>8?T]JB)!MX$!1)DE%M3\9D[3C!95$(BN/YA'PKPWP$)5^NYE%;
MU?/$J(:].L/WQEEEAB9+Z->X4[ 3,X&A:(70RS(NTGI(D^NS4^<4)#JDQ"B?
MNN./IP76R+@WR&6781V<3=+4%A-$M3)$Y?*7+!_')X1<W-\0^EAE_/YN@?5,
MP_Y%Y+]O#;GKH;:Z7@-L!OZ3-XZB.+3MS<&$22@9X<-0E,B@WAB=,:R=:&=A
M_+E:&'5Y+!B_VEB8FWHCI1NSUD72CG* .5XXE%;NUZD(3[P4<H*\.D=UXBJU
M.10A#09A#!E?-XAGFI)*)Z\2]C0(JTZD@/5VC>0X%.P"Y4*K.E')6"Z1J>^Q
MWB^E7G..LCW,>)4N".C/HBA-/HGG.5G9*TT/?3,5\!XP]EQ.-T:*L=^D9^J+
M4U$ 8$:TDF=GZV_\('J-I#[(-\'R31QEZP3VYDH4%'5P?'W%!")0BL]"[=KC
M^P!4<7)++T!40Z"T^<K@CWL$C7(UTP$Q72O71U&?H"AUPV+6YITW:O=M3_YH
MJT!JPZP7CD9S6(8+$2(3S V#3''O.O&;_)/1?/EF =9F )U>==+&SI0!T/:1
MZQ:?]OF%[4F-# ^)&O*-_WL4<0[3"4[[X-]:S[S^3H0# $<?H^>*?#J1=T=T
M.NL$$TT%IC(.W:TQH4>_D8];%<5\''56C:5H70AHY4FU\H9?1TIQ>D%5#Q2P
M!:\^(-T^?!9+[OU\*R!A;$_^&B)Z5@5G'"\(<SKW45*% Y!^T$I/BA[%A76+
MY?.QN:\4G&O^:TW7$[T<(+4O330C8;QUC%.O^\GDQ/64FK);&@5-F@4R?TUO
M>83>8&M?\WR>=$9;.T^J=:;+C*707?C^:J0SH4#T[I_6A,"R5N''IKXNHE79
M_M!\^8WC_Q*]Y<<+SM]SX0[%3_B2+N*D6 0= 2Z(#6MD.:\-1[^@K-\>M6E\
M%_A9HQ<U\9)W-^W&^V*)K91EYP@>]>4-_I;/1O%4Z-LC+N^@Q?-Y;J=)ZJ-N
M_GSJ1Y4ABW[2CL*D-L;=7DA&8"EE#NNBZ)M?C'3A<X>M;=6)W>0MK8Y]V=21
MZ] ]=$KPBWZ&G/]-Q^D51QT(Z2_[.7=(FY@YA;L4WE/\E/,TGIZRZN^V@.M0
M([R2A6PXC0XZP9DFDRM/,&Y31+>/!+T%<BQ(G&Q_Z0UL$ZB%&S#0D$6.'O4+
MSMQ; &GO2L#[*-CT 1.-X:'K$3'HU]=WE,7H?)>OQN%+&THXL!U2SG'Y4DS5
MA<-2^BE7F%%Q3$FTOF]NW3Z&'RR8(GWH'4SH 8"9]@0FR; ^EO[<DGD1TB>N
MQ<^,O],QLE.AJE2$D& [922.G1Q8@-#MH,<$,  ?0N1]+<)F+(B< UA WS/4
M.*3*!L36NDG<"ZS*<=./_!UU9-?0K&KO7S_)RUM[Y]%O[K<B*CO_V6)::/E%
M%AR(_R"_<.[NCNJ_=V(;&4BZZ7A'_+O)U:$_:O@*CM[-$^=\G?O[:F3#GEQ-
M4S-U0FHO)NL'-(@+RJ2611NAGZ9%I9\L!_02 K6.7B>0%<Q.>HE9/TD.?-YR
MU_"<K8LV^:*&4YF8LQ?1/O]:S,7^9EK"<. Y\W&%UF2K=UKJDCHJLFV9"FL<
M'X M6?$B<MP&LCN4SAF**(1IX$<8KG;DA'?C41H)"7=;&/:O&&3%[<G^HY.#
M#+D($@K%L" "Y&F'#BU4N"3-'SUZ1=+@I:/!B)*_'4X'ZG"2Y"J$#&<!#TL,
M?;O!TRXGH3#B>B0PVD9W#YW(;U)DQD0,7#3]]<WVBS8'[.9OW*BE-TL'1*5=
MGJ:3S7R#=?WM5KEL--?>G$CQ W[_*RIV/>@F*C%LTC4K^ ' H7]H:Y@1T%Y.
M(((,Z$S)=-:>.:BAUMJ5ITL6U2,/\D$77QVSX:JA*'@<J^4OH$5K^,O$RD^X
MA+>[G/9EEO/NZ?::>P1T70*3]SV8\N:5LA%AWN0MR(CW^]5_RO"7A,AT"57:
M85PG7W-!H- ,1-\$86WLW+DE/#,R(H(4'6 G+0%0Z6>H]<6=/1DW"OLZ?&='
MY9C^N*EI3[Y-0" "= ]PQ>.'UH#GKO(;T%\1="("7569I*];2267%:V2<(Z+
M(5+0BY\.R=*3Y2[^"9_$'CFG+R-W &?Q51.Y>L8I*N!29*W-/UD/=H9S/LX-
M6/R_R40\__%455XBF.?D?:=RCQDP00V[4Q' P;:5EG.47QLBRVJ:HPOZ:.,-
M1+.[HYQ_G LZU@)N^H\;[/M4%ZF0.S7;3I>^S2[3;G&FBY]*47@X>V;63.8J
M2L';0#__5=!#K>J:1G\IXFWDP]VHCC3;M;.WFR%7K5\9:BH[EERK[N\/35#(
M1\C>99;@;DE.P.L8>$2?@!#-!CEW*QO9_ABC:);;7B@\^ 4AFZBC^;"P2G*[
MZJQ1^ ,2Z)&,2K! J02 +E=57>19ZQ%W6#<.L9D+TV*.0I_[,8\%6W,7BB%P
M);NG >POD_]^608:I(/0Z)M-=BP$ $@"+&4ZPW,=5#RJ2?L2ET3]ZN/EQW9T
M87)[V3?8\K^VE\NNY862TK]]I2P,NH1D]]/5-%Q1%XH*E5:P[\LFY$:*(PLD
MVV9DZXS]@V,Q.N(SED5&B+,F;"@\--1H[+<#F.UM;V+DB;!K\6RR;*G+EDPM
MS,K:%Q@1/6,ZF(6TL[,>'2T-!W>Y5"[S[F%TT%JR3/\(;N2CS.M2;X)-](9R
M/Q9T7'#A_$Z-F3>PY=*4!V1&7)1D3Y4\KF;=B%T+D+?._<Q L3V4U^*KU>PW
M"F7-8N?@)OB(T9J(WM>#?RTNTY-61HHD/%34AI%F#E((LHF:@ %_>C/H6=V5
M_3N?YA^$R^UEI.]^71V[:''^P7[ZCV<%B6]4&N 7=E]H[F&3/Y#=Q%5L K$:
M.61;>8B$'"R&_U VC 2$VDR0VOFR@;F-64KH%#X+DI'HH8"QS543@3YMFK+=
M>5U[V'YK.>Y+__;; LD'FW-!MQSD(M,OW)>]'W[AP:_&36:.W".7)(=-?#1#
M1!5+$Q[<P%=Q<F'XW2]4G45%J2%LZ,=D!Q5J,#]+*3V7I_)VVD8\7Y%(\V99
MY*VI3:+7.H7L<^ZC9H=%:P#O(:*[2Q?K#]9BMP&)XI9+ %'>TC</4?'HY1D[
MB3:,N(M$7WF]BY7]]JRKOGVWE[.$!^^)I]7C\GIGMP.TI[[DTS+B_D$GOC_Q
MLG]0\<3-9 A3[)96]/U)D/V!O9[9(VI'3WL?ULP"%T?Y'=GVL\1HG@Z,0;:0
MGL?*?+KTW!'\W\Z+6. GWQ?V,@=^L$F([][_OS0G/;5_?>AV_;G5:C6VM%X;
MZ0UZ\^F=S+1-L5 5_"H"N&3U+AY;P#K+^/8X]TUGW[(BUY'Y&$,D.(2'+Z"L
M(L+G79^\O>CI+N_6/(K70]M0RD;!$D8F((E7A?"!7)? N+?&#NRJM8N'NQ;'
M0;+^' &+$/4:AVJLA"U!HST"<@MD;DP^+Y':!( ^F,,:[^%]"@%,J%KGC5RD
MWXT=8:T8>Y?]Z=K!& @[7$#::+_JSXTJ<NB'@R7\XR6'"^5L<O<K#A4N"*'-
M^??VUK%ZMDN9&NKE4@[9]WO71"^=+&D@ZW+Z=?)*#5-TR"+R=:E065EV QY=
MW88>WK%4J0\7,^MVC"BB!CNJEZH9T($7R$+1MU+^T:(:<%D"XJU\BBD)5GW2
M]A]-U*#SK56HP,E.^\^[T\!0N'%QGGIQ>/(6Z(J5*:.>&!'%_/?<#-4N2M)L
MEFLH1IA,S"86ZB)/;/'PSC1DQ (%J6=7G5S.RC&D+QG%)3(O.;_55%_4.:3<
M/%.8NTW6B"&X!(W/GG== -D(R9"1(/YYGV@.>4V$K*-#D<1.@W!4-9CD<Q+2
ME::&(]!(]"H7\>0JL @SVL@PNK2T<YNO_CW:94]I;J:(FZNNSDRTQ;_U2DTA
MJGR*OVKK68X7*2#6(198%)=X\L7.088.L9V"HGEA/.AVJC$S!7[EDA(>)2QL
MYW2Q5*(P*:%DU#S U1U1>PB*FI=@_(PYJAT-JN]^VN:X;\-KG3*G>1ZJ$U D
MY5_8.-=AI*GG<V/#0Q1[I--AT3E@/#FP"W.D+5A7W^^<J-+M+A]N]$]G_TSU
M2N[<G$ED5N=A3UQY'46S48?F[)?7=?&.LY^.=(5;%,RYHL2:;VI\VHGZWUAP
MC<95*V"%TVE-YZ-?K(&:/?:&:>_60[07GCV$IV:FK=T^5DI<."@=16!G<4J3
M*/X#Q&FP =6UX:1@+W,(%UMHD15?JBX=@)>H]BQJ[00K7QG0Y(6QK2;PB@@@
M91U& ,)!#9*GHJF_0DJ*XO_/D<I/M@A[ADD:Y6C4]\D_\?4@JJ6KMZJ,9J,O
M^=[-%ZJAN)L,ETU2*99V':\/0" %7'1EMQK,RU^16BADUE@/JE<N9!+">#*-
MKU*B[B+LE+J6L@S;($FA);H^R3M]I)+!5 =.,*I*%M8J3\$&D6I>D1(/WL*&
MBE6B#9Z8HQ=K1WUT0H5Q.$B!Q:U@@<'#VX]A@Z'9:BB@O$'),&ZCJ_\^+]/X
M'- 5!@D'/BJW.QM"@QSO!8!FV8.RMP'DJ&*3@OO16G*70\F(/:E:9L ""+)[
MT37R<AQLW99U/J[ML9D-#6(&(</)7 =39QXBSB"L:90I!&QRRL2P2_&V_C.G
MVU9&#"=_%&:\72GJ6U,_V#5JOY>&IVL)6:IO:3Q]^DI6L66EC%:T(]W'':FD
M#L'IC$!LN=.BM@ \QB/:2-6R$>E!:#;T7:?^^(2[,+LV1!R_\S#$>4OZ9U^=
MY/!N=F!-8_[]43S.TC''4'BK0HN6B;,@C9+3FS+<?1QT^&V'#%0D)""Z6GM4
M'NS=?R,U.H&W5(BF9;\'+UX9K78[5:T?-"<5R3'/NNX*%!4?"\2TU65UA+=T
M5-[J>JI_OD4/VBPZU90IHY00L/?>#Y_O>S?LW?7=T X?:^\C@HV*5@5E S?S
MC8F2CF]W')[J^,+R'S=Y^334/;V^[X?3G# :U*99X4XYT(%8%_UV]^78I/?O
M]J>;^7X/=K)N[E]<KROK?L_;P'BDB\V5PCX!!V4[@/AHFHK$E:JARY],+K@!
M(TYVI/:<+,G<=V1N_%5O\J$WA)Q: AXE*P2K]#/SJVU[@&@B66F5<+^&3=9*
M/6T?%L$3D2V!2)CD,M$EXUF';33!2>A'WLE1S_*QF:)<M('+J#*LP)$OHX^&
MP>=Q2<R#@S(,F6'8ZVSO,J5^C&8TFZ!P_P[AK8.88E\[^DRC5"@W(LD#P5K9
M^;K%W8.SHHVGQV&@AO*G21$$''=(J9 C)7O9!O7V-0]MOEF> Q]*-:;'*9EJ
M7[I4-V0>5\66G^V"Q9;SK$RYO-@O^ ?=X0+9>2Y,6_A7S $.-G%$L.4Z\+9O
M_IJ+]W&'\-8#U8^#0<J:N<=VJ2M!$\1_B+WT8?1L2?8^"/E>E YS7\E]F$0\
MB? TG',G[U2(S0(*WN3'RGUT6T/ZY&;!=TVIBP'_OM%S2]IO;JL&NS_ 4O(:
MY6&^;DF9N3:8,I, .AP*@LT#O].)<7IX?/8SN1N$F=@$_W"Z)1_47Z=W3^5?
M]Z@,N$N*,N9SZ1]B6%+Q?R_._+G7!M19!:(9TPDG4;P]12T"4$*!,_OM7BWP
M*/<_E:FIA^/&H'3<^"8 VC$@TFE0BAES(](:4'JA4;S2A!-7C'0]S!$>&EE7
MAMN]J$Z79:$!Z*Q:4T.?L*P*1_O9U/49T EH1E;5+U2ENX??K\(J.G3ZS+N9
MX)89/'16L.[5._:XN 7R8 Q\<*S<M1UAG>=I<-UKM.5BB6:M^_6+@Q-SKKH3
M#YWF#-;+N@D71YWJ7L?4K;USC\(=IA<=^Y5'VT&4P8=I(+U0_/3")3=WJ=C%
MC>D&G#/8B]0HVQZNU^%&BA)- $0D $1)7] 2[>"H)<5QYOO1$[+6@ ]&P+/]
M0L5-K>/L)2EKCI;PDZ(U8T_&6JBX&R;U4PBE.\.Q?#3 '=Z'NT_Z#)427V(+
MU<Z(0\P9+R]E:Y9W))OSX@.7I6\P)(.7I?MYR.*38-02M)\D\I OFX*[]9 L
MPOZ@*%LJD0VP^)@?@QK!2.9HFNNO]RWK1(2E%H=&LX&G' Z=6NNX-;&A.&DB
MF8E?LP4*I=2Z!)P5(^ UC?=)!LB3[ :#>>$_<P)47X*8K",,GBQ>=<C8_YJQ
M,RG-F0&=IQ'BEQ0'PTR6>?%TV-T2I*SH3:FL#T;F=AE&0&EGVMVVG"U3P%F"
M';'FPU<%OH(_33(J6?)EPIM>?:;P!J$.*#FE#S/'P6 TJ#E)[&7<@>'#>__6
MQ.L.-;% T[^%+KICZKK/;@Z."@^F X8%X2"NJ<BFL"B=)Y+^$9QYV#$^OB4;
M &'S(.4K3G0>Q=S X#U\EZ Q^/#PG\ZW>Z^O[;A&#\]_*2CYO\28W=%L_WK*
MN4HB*V)J4%3Z1R+*V*W-=K-,))YCO7,2M-GV:N>"0##+!I3D1\4#ODGMI4SE
M#@YFPSCPSD)EJ?;GVQZ/<L5HFQK/!(2Z?GODD/U34_O'C5 ?CQB1N'5?'<V*
M]"&_D'>7WA;ZT-8K$^VK$O)@E=Y'<-=G6B,KA 8B5I%@IKWU8F= LWVY:8N'
M^YCGC>DG@P8^U.N/,9&S75F()B>/OX,>C4Y[7C?RYI[G(4\8(H<2S;]$U']N
M/\8E/T,Y')O;K(=T+"AHN2O L)C\ALN&$MIZE/W9C5PW,(>!?@&1W$>,=,YY
MG4CAKN(P!5LZ=)#N9U"B-2<E!(#Q9DE$ 4]&@^2S!1MU,"%JZ58A"5.M!;,%
MRN6TK@AX2+9#@E88=G'8Q)\'_WSB>O8JMI\'=Z:!;6C1;>71J%!\NI:BC1#Z
M>A@]1XNB)[A$NLN,%8DJZ=\/R5>JI\ Q_&0?"BRA7+%BV2B%)#+(2ZT*TQM<
MQN(?Q7S,_\Q>UF(W8+A&DCNM+=TXL0G>[6[AAT%Q"#Q9S%+-.#JS)W/Y=,DC
MPK(VF"3<$UTS0CDGB-& $#S8S*$'4J6M:@R4R\7+I3 W2:2[Z1\R',)E\R5E
M-]YG.#..[^!UC!H@C)Z3OV#]DWQ9B+I8NI>5%J/=B*93#?N^P++>SK5.N2#2
MUO1?FYUSVS[GJ,-!6X=-;_? NRJ"VB,<NX\$C\D<O=EC^Q'N,FGW'7;;N4;#
MX.(L"X\3+3Y.9;-S^[T4/H:Z+%_;+4\"$\U$&W&V *>\0)*C*#=W59 ].6 S
MGBORD>_4]<6LZ33@1^Y/ZK>]YU/!QR6"^$=,<R*(-[L*TTD@+&X/AMM3 %Q(
M?&O=!BERC7#J3C;98Z$:3X?I[AQL))E-?8A4CC=CH>")$GLVW&1B16I,$RVW
M4V;O^0E0LRS\SXD2C]OCXP7[[ES?M\7E #9"5NT/;WK/&>G63'Y[+ OUA!B6
MU^B>*/*POF@V5:;[Q$NWDNT-D\")*5U/R!E+,'EGD0/U3M:T.EQB[>1QI&H,
MH6^/4"VJ>+AN<="PHFK34_"NXJ]&TLIM^'T/I,GF8:DAC^%"Y&)[D.OCLM'U
M^8TAU.]0V.<A=SUA"(4&TFP74W8*S?^4N@)9Q,2JE(MAM58;=&"4%^QPG=@(
MCC!<-,FNPL)M[C@U:1E+29&=.[Z>GVE<''I3@6^T##BKL'1J,XP:VH!)&[]A
M2Q:KTDI*R6ZK$Z"Q2](J+JVPR;U;9WQ:M1J7503+Z:5(>KFDI7O&&4]X5?[+
M,]MJ-9^E]>*$XLLN[Y.B44N)M*28>&UIH#NV,.PFB+G2F7_5-_.]@(94.H[T
M.22RR^O"QB%7Q?\9;-#1W97:U)8Z1LIP=_<8 .!:7 SCF[*1X(_=./#GL+1M
MO!Q\2NT9 P$?>*D3;FH4*CE/2B_Y8$(#'BG8,OJ50#W?<]>=Y6T/5FY^ADRL
MN"MJ['_SQ]=)R2-7WLM7\110*_(JQ@$58)UPGJ('#SZ'$TW^DAW;:0N*&?@8
M?>%=FQ.6EONKSRD[URD= (??O2"Q*#!P+:X[&2)375PU./)ZU*F-_:=38V>!
M!7PIV N[,W6![DC"0$BK86@JST2>82@"@.-1%2SJ'Y#3K\VVT LC Q@(H1U.
M@BUE_3+]/FCL=&D0ELUV9ELYY?X\^';45J_:68M4<K7YIPX5I)'V0X<--/_(
M>QV==WGPWW3?'/,GT?H!!^CL,4=71^M%&YU33H[?#'_0C=[HB&Y_Z6?$FU4\
M+>8\M;8>?%,>W:% K?=DU/\,*&%#HM5RK5I%!SM8(K[2CQ8&PVFW2Z6T:-%F
M2.6AI^(M<P8G#CS)LATXY?4<%=![^\F<KT@.M"H170VJG&+G6>VY5H#^V?_-
MU<\W:R;DE_6[^99P!:_TBP@+>R^B;NT9Z\G9K*/^)SR>N^[YUM@W/6E_3#2\
MPGX>U)C7V(,^ZE"9L@)5^IB%^LUW!Z74]P6FKC?3V(:AC!,<J;G08L,&E9(&
MW ;YOVG@S>OTGA-HEZBT]>>6_MO2^_7V^88W.ZPH4I85?;]F&.#.?\ZYJ<]2
M, 1 =-I.E33>TFF#]-/$4X2^ISDYY/S,%)XLX6RFLYHJ< 4K6J#0=D-2Y1",
M3C%%&:O^>*Q_+^R69-RZPVFQ$!YT]C.639/LVY(. W4_  BW8S-(+U)UEO55
M1%)AQ5=[<7<C 8F;*6+.3-&J&:0S S$O5*2R)%9YH!OO%1^240^!_B<:;@=4
M*<0S^X=(F/@EY.Q]@FFM B9Y[XCA6;\5G&G5(UE+OO^7J_M>%ONH@_U_*_J]
M!_C+F8HGDS$!0F(7]AS&2\YU'_BU-KQ-*!]__',$#<00JE52D/-"I&6H6.M9
M^((EJ$H/IH4K%@,&OC#6<QO4WR+]\A4.A;X<\L0-!_&&3CL6AYCGUJ3F?)RB
M9;RD/8#EIMCD1J4/,#@CK59EGKC:([+?_6\.JE^#QO^?%QHT.2VT,@*Z,?NK
MD5I<#H9:9M(J!F@];RG+7PU[E,K?M,$[<_,]2'#WDU8U4A$?!@R<GL14L/7O
MEOVLF8>A>B]LY>KO@?]VLF.A[:/*U%_YP3.1P;_ZRR[>'GQ4>=@IN^U[<P3A
MP\N]L!]E!T(N4;+A%Y+A\)3^88N)*Q;>3E&^==!79O(DZJ^T^M]6\Z$9\^\%
M3LVI>PJX>8F2Q[=2F\XQ]LFC17\EAO46NC_WJ-_0#7'PFT]Y<NK '1$9N<=5
M9VIEW[54Z,ZV2EN]2WTA\<D"*I>P']J2IGL)5.D%LTCPLT<XE7@R"%.)]V::
M=8/?9E3WC97;OJN5E7L^969+Y@91_YF8T/6:&YJ8S[O\TNG@RKN.+QJDW\RE
MG]*TL!^EN+'ZU26:>#E'MK5TC4M^CY98?!ZF1'B4_X-BWWK#K<[R-0E@S5.R
MW1(3?!+S7Q*;(*\^;EA]3 8D_A7S??TN('3UZ.MW<0_!HN%[-T*$8D)Q^>X7
MH#:@_*6_8FU\$,=VPPJX<?NW6.-KD"E#NNOWQV8A5"H(:R/<:*B3-M^W\9-#
M**F3?BC<*+4%2P7!02R)>&![!,^*]U>H<DBF")"(,CI5S#Q?:R2?-K[BNB6<
M'>FJ A%(0@O8RD.K](VBSUM+D[)5#.DR?'\)6:4M=%_$:U#P.>YI%7GS6UX_
M*&G^CQ1V ?*%=5^MEL1V>4VF /]_L<JN3]7]!A1\*](2F077PIHW1O(KD&8/
M@>91#=V9N..QVHH3.'GP5VBW$#5,0AKP4-/8 (DM;994L9\XO"WZ0CX-ZML6
MZT?Z<ZWWSZ/S?YBYT=!?<TV O8JI1Q!?TMR+HM%4U)\'<^!ML 0J='SMFC-@
MV:Y*31^/+23P:)0LN**#OPE<0E15.KV3]ZUAB,^V;ZS"$@"C:&5*(R->N,(9
MDK#";FXR0>$%>&-YZ^ JPE4R1I'='%^5"&+)ZF"QCR570"5 :05BM#4PPKU=
MK)'*5( Z(E4B:LQS-^=TP<TH1M6! G/#0(R^UP9Q0:#A*.W98;J0^P,W70N+
M^9HK&-":?"#&L+DRC<D-[HCZX%QAS12YT':AQ0& #SA.J=+/;]Q%67>O3>G[
M]I5_W%YGP'3"!A.9F2,,_%[LBX=%^RWV1WY,V)U/M&,EBOF?H:F9G@R!O]O[
MCW+9<N:+59\TQEVI[1SOU_:'/WVJC*8'8S^^S$LPFJ:5B^G?12:\$^O_'KB\
M\^W]^??'5=U_;?U8_WURZ@WP%7!!Y=SJ?Q;U3-'GS^K/(>8M7C-$&K5Q_XC?
M\*L[_3%@1 *Z?"6GGCX?\Z,N]7/,[NNS[YE/!G/T\@\!Z<_V,5\A3+W>JYU1
MGZ\ZFOKT@$A=T=0!N:.E,B2+*=3D=[,IQ#>B'_GB>!8Z$OXHP$HB66V;1)4(
MV.%%2@SF!5R&A8GGK(KYPX^[)BIT(X(O\W^FLDSNOLH[7G?F\]CQA),IFPX<
M9BHOCY,-BM4Q/6^DIZ//JOF6#=4TP!<2XCKY@PJ]G:%%>_LT$[_:7YU//+/>
M5MGI28'UEB?&7(OC;D[(UBNIQV#_G_X=5X\MF':TQ]FLZ,$OEW.&VE500$$;
M$XL?E(T:Y?*U'7R>CVJJT&ELN5/IWQXKA>62[; F<.D1D]#!T&L$8W9#@GH1
M'5APSR[X:V9+VYGQ#VWU7>/M5UWCQP=EC>FA+B*CW%FR8!3[9U@I"Y;OJE09
M#$(:,(,SQS3O\AK;H)<]3A5#4?\(DV":Y1XF!IH,QJ3FJ12"B('T(]<MS=L3
MIH<F+=6;3@VM,0#=XF8L#X%F"!?',KRVP<V6#5KX"NWH+9PY7N^5QAJ!F5 9
MF9*QHZUR=E9;:._C35<R=J8.52QUFT?$^L$@1)<#,&J<"CR4+7D H<:&'Q0S
M]X=8H=182$- J9QCICV!C+3B;#(EC!NF!:[F]L(%@(Z2=R9:C %9('OZA*1)
MVJ*?4N2),@V546?M>0,>V2@U*HWULX2%S!;R[ZNI.$*\O%7L[>6]^7(290%=
M/<I>*!WL/$#"W:D^</OIU5:;$/"?'FQD2MXG].Y9PT'6L0)CB,]F17NOK43N
MS?^>?3UQF#9P>.E9$8CX\PY ;._O#PG>/2 :RECB'\I_QI"Q/(R'W]HC/_T\
M6*RZG>U^BB)=U=U]6?NQT,D.Y"6=^%9=%:'+-A\7/Q@]I_*!"!3'@ Z=#=ZM
M PZU[=\U*4%*0#B*SZ_NMTYO.+]]JO[7 H$D(>5Q#HWA8(N.9RDG-YS321P0
M?WP\2W=;[7P5'+=M<\M.A!-V-IK(4?9,HFK%2V+L%]0WRF>RYLAJ\O\T"S9&
MMR!/?GJ*%$"NR&^K6T\BR"EU;T?0\5R0?VQQLGB[IE%&NTOA',]FG"BQ# "[
MQ5$N)K[4N.HZOP[S=N2+J<#'/?)GS7.DRJ$*D6T'R>-*Z5@?7;%WMUR(RU#C
MW $8NS17;-H+9L<%P 5H6*"H.FIQERVR)Z"Q]TTL014)($)!M9A$N@!=3V<:
M]B86'D['*_:&L466"8]<X@%5(Q@'JX!$E$3GDF)W.A,MP+'H#QE0GP6&> B.
M%:#2%)RTF6D6R6$%1 @51W6@JOVT&UZ<#](W<OFB?=,PHT0UV(U$>_/@T%RY
M*KY"R"A,IGB^>]]<06TOG$I8P;'"^VF7]*_[PB!/@;'-LR!B#\#T[591\$1A
M%/$V3RG:V;1LANAU64@=\L\N;NZ8B*ZD 0U2MGR.IH-E':;Y2E%JV583$[*5
M'NV$Y9CLJWE+BAV@YV,IO.Y]HSBQ^$B0=)E)C^?K,5,3 DB%P1!1GQ-76UMQ
MD0P4[O7?5B)S8W4[0Y_O6*V*\2 D^@LG[&;_=R"PJW_E2EPR(^<^^\1M>Q(?
MZ<S+E&L#0I=7"LCIC, Q^>;T3OT37TN.E%V$M!J7E:(^Q"L"GS@-BZ"J&#$S
MST!J$"8T:($1]5T L*'C% -VV4A'G!O&9EA_^E1^F&U._U/'"S?CPL6 #Y(/
M?&AQ.#-7\"I>&5\^I&%N^E#L95#(LV=?UUMZ[7-1\N//7C_U:=6-JV4<D?J-
M_1 I9UHFJ;JH\^S@7[4J8OS/PF\4,!;@W;+O)IDL&:7^[/P?@"B> <*8_VQ=
MPERUQ$9XJ>[?55+FWSJ@TH4NW&RRWZ(Z%AA&213&C%+4][S@%/?")69Q-.?O
M-CJ/HM6%E/-1^P.X=0B@,)V6O+:B:/MSO^$-->06&+_3Z6BO97TX[<;+)J5Z
M[>%8I5,YU)0KUN:WBF+BM^"'J%?4W(X[SC#%S7<6FC65=9U\SI0E7XY8UCVJ
MZ\*.TJ@:IT+,) _-*#AV:ZX0E2R'$.ZUJ.(<L\)UUS=:%2?1I('7PC:2E=Y<
M\=<43ML,T$LD7V)..&!1-9^;7*V/6K7.=K[@*9IQ UG5#XM2<E8K# 1[8V_!
M=PC\Q=Q0J?N7C'52E>K</LAI=,]7"+YKCD?"U:O4).W:6N1"2'UB+Y./OBA<
M-8F)R4[KPJ$-2-HR(4+7![*G]FJ?ST69=_%S"6NSJ!#XC@G;!-)KWH@)R1U0
M0C^?.G[P;'T2G:]I@/.FJH&?XK]AM4U+@,;!H Z9 M:$ 0QIL@""J/LIP(WX
M'1762LI< -^"<0GHO[#Q>F1MX[:Q9&[,DO3U.)TAA10/4>5< ;)%AR\['0@*
M,I@ =3C?,WP8BI2_' K/PX*['I+VN>VMF-!+F/NWVK-UXGT)$6=?'A>?J;:S
MV47K6&9"&)L[O8\R$GYGB7[;T%H:TDLTX0P4TJ\^4ZCLW.F'9A\5G]@T#.+B
M1.3<W^S"#NZ,G/H'H$__OQNTLM$%HZ_?3@!CCS)R_CU0)V*T(+A#XC*O*U%-
M#?<2F78R51B;7,9GK['Q,S__J>@W2_WZ03T?<5FJ^FI)I9&O9V&83=D#GHGP
M1/D2&>GN'?1U<L?P1M"K>'DNZ/;Y;!W[!M17GJEP=%OVG&14"+BPZV<6:H@;
ME53T^\W-@R!WK?O2'C17 QN R/B^S(]5N"LV,>1O'$=6[Z%SQ..G+BEO>.+_
M$/ A\U%&W93X<H:RP.YW@UJPAOWZ#/5HMQUZ694,HZ*\J,@N53&!'=5<U;D9
M#UC&(:*IKE$X,PU5S"[U\+QR E%U_A9#TPL?<\E!EPY2_NIP) 5$I!S2H*J?
MFHLZ23QT4$HC%:*< E/^CP"F+FMHHQW]^I0>)VGZ[WD!1\D0/RFMHU\=0[R4
M+KQU#/\:C;_DQ M%U;S-M@!  P_E)'\7(R;F$#DYAP^!PP IYT9%,BQ]7U)2
M('ZB+9MBN8YB+8RX$1SX%B]7@$.$>HB6$1(OT'-'"(F%EHE%M+B<M;R)2W$Y
M?="NMT8.9D>^E,7]+H_[UR$Q1&C4PO5JX4(Y])Q>#O@C"/2?EV$2SNML$RQ]
MP.(9'J)(@*0UN2@,@=8O)0BC(#X$")D&*:!!1N )PM1".X8!U$]4)T=OT]3D
M:IB80Q/X#<%7782H60D\MNDM/VUJ34I>2S1=HI^08IU:6H 7< M?1<$ %NY?
MW@*SA:8&=B5?^X 3>\F&V2709\F&L33XLA;DY>IITTV#*"XL:AI>V05M*TLY
MQ4B2YZ7T10-[>9!Y BR*YVM'RBF1!!O@B)I"J")M_YIWAHDD>!H-CGWO8;6N
M,#5PCD2R"64>39.C%?4<^V5W]EHH^.<0UK!![KJ,N7T)&.R=;R $U59:HD*M
MGW\+XK(4] F0*T] ,RSYA]_I)Y? JIOR0VV27YZBI86@3UK@(4WZM9R,:8!L
M5"CH>FGY-2;6AV_[ 8S-MT^#8&0]MC"%WVVFO&4=$?^\[T';,T0WH-8F#)'G
M<@H=_UP269*#PJ0ES!6^WK8%.\">/3WF*007\X^Y>LI,5<IQG_B_WB, 7Y>@
MNQ&RGNCSC:&R$)]C:2,*XE!%N6&P?&^H8BKX02G(8S,[H4NKD*BIE:HADZAA
M-\MV(T19]ZE\6(HZ\%7% (;7-8W\S+1;7(PPQMA]G,FTC\C4&:W[LT1=WU(#
M4<)%EJD!/FK;DN%OEO 6K9%FU,A=1/CR6(2U8Z0;SUZ>HA*:K1+2JAXS>,7:
M$B_T5%?Q.I2<'>;==B@M.VOV;L/L^J&)4B55ZV@6+#L<JQ69V1A7I77IK98,
M4?N2K_9IG29.2J[H4%XA/+\I-ZZ%E'=K+>^N;^(MAANGKXF+C8/(%41'(KNK
MXFH7\CXO0ZDB*4G<! .&*0F,5/@'L;F';<$!D.#C1.$:E/1/;IB'*(X@0CJ%
M"$('JG!<'A,-Z4TGZ>"K9U9<3^NA[J2X?(%<79YW#=UT3P>W";!M0PNNFPY0
M!S1$@(883[?-MEE0.#!^&^Q<;.&P97"<<ZGFM&[0!M3>&[3&0!0)S9RR$ 8,
MA,_S$H%_>_;&U1E+2-2F@>+ZJ=UNERV(;Y]SJ7$)_.7PB>=KUWRN%@W$GHYA
ME,5LHF*FB5&;*#N:V!3:5U]7AEZ2X$ X'"J79NF9.OWM[)*,S&LT4.A<&Y%X
MS#Q1ZM_C9\&^Y=3UL[\KY..\+78&TJ0W@=T^[<8T^/O(2S 3X!5$0+UGY8TF
MZ84?\O0]86(>&OSRN(1PQ=KX%BB;LW^D#_1]Z&;A*32*!B<G&GY^*RN>9/W(
M&WM:&MPXAMF^ZO^QQ?\L0DQD[JC8]'4MP.W AJI_&N3M>8#T2AOQ+'/[F8JW
MX=8=/4</2]ZX+7^@7"U4>.>83I+,YL"!5#F9PPTRK+MR7\YT@4FU[GQ_F,;Y
MV=O';B1)[EX]WX0A6^#(#QLN_QOJE,]6RDD!L3%9=O@&E+^R=HIZ3 J%0+37
MGU4['G%%UX=EVQ>Q#Z/N&:'Z)<TA:[\*I;M.B8YSW*FS'>WSU*C?D:PW&J40
M4NQ<,7;'J6K+9'7<LKHV6Z7^49\F$2]2P_)B4SPBV G#K(:]_0WF8>RC/NI)
M4??_(RC3V5E>EE>4-#395$?_+B4V-5K-HW%R3#.F*OHX7BML.;IBL+%DM3&Y
MR\DL]D&&:>+JU[@]6'Q22>Z5A</[[N59 XS?<)+(.;XA/,/TS93#AY))*\G&
M.;ZFA-:WM2U=U(<M"W #1O)4B4\O#9A.,+'V $%<DP]"0?*,5G4_GO1MTS
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MM"P=81%;MBA%"43QJRV(P@M"^@8YCW1$$#4D!AN(P0"2)@2W+61S@"O"!V(
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M"((@6(2. :,@, ,'? $'K,!%:*3_15BX9\ C,'H!"1P",/JB!WR!0,A %'S
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M$(<3_*(HE$(S"*;P#$\B-(,B_*(UB$+]A$"#&$']!$$6:,\HM ;^%-  A<!
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M76.:Y9.6-*8V3*R]28CO*]Z4W_+V-TWU7>^!TWNE!A?XDO_MUGU/M=\)SW?
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MF9/YG)Y9W>C",3HOW@!*)0:/W[C-@L*C7!6Q5?' !9XW.99T*70 !1C %E"
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MO)TG8J%[WW;%*'9<9,+;*U%C =I;14/ZKO V6([6F"+8YS<W=0M"T*Z<\3_
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M^\*KAXL&]M!I;\ U]4SQA;K1HIOCZ7V$6ST37F9=Z0,J\L2[YCBMX+,7TJ]
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M^17Y_+M<\H]S0_EMTZ8[&FYF'\I4,WS+>+B0W*2D/%F0%DRLB ?!'Z8-O-T
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MO\(3M_:20W'L'_Y!JFWO=.<] @J0D7E[O;7DL.I;2ZDM*)8["?_32ZU"\[4
M+^6*QE5J\+3!D]?[R: *T*V2^Y-FKFN.?K?XQ <35HB&FV&&5]7"_F%.3VTD
M(0E7CC,T3_"*;,F9ZXW<'?&E4C]DM^QSGGR9@-?9/ES3BJHV,7OPL.1=>UE-
M]+WHCZ'S!-9@+);>,5Z38?@KN9[2494P_?6Q^@^C18/;BW<%< XB80?9-7^B
M&3;3M7W2;MZW"JFX62B"OK9A#OR8B*&Z^$Z-*8DJKL= "SX%X9OWG^7)HFDY
M_=2X\LP2#CN" BBBHYV@0R1B$KB;$XG,*$UN\Q3L6Q6Y#0KOLHG(U)&O?^E\
MC#D^IFF12$-#<S@LTW(HT/%.F$**Y;AO.1;'RB@J%/"[==X%::+'C85=>;Q1
M@4[J!>Q!F"7T*/?K5_K/SW":I% QZ[RLLLU,X0D8-.]IRQ *P^!8LOG1+P8O
M,7^[Q8+ 9\#.;,.HC/[,:W^K&V]8CR\;UO>T<(BHIII,I7(WV7TGPF;R!\PD
MF^U!Y!Q4*34A6#XT289&9MXVZV]:Z><'Z>3#@A ,"^5!;,#F+0W+T'>,F0CD
M>3)C-0+Y?834G9SD.V&KI9PQBE4L@Q#Z>H04GF(TKY[JORLNX'!@GQV^.\^7
M-= ,6%P"9J$=V 2R*"=.,@Z;X'TM5//"INXK^N#A?FY;,'LBYGJ-1GAF+'DD
M2\587TQT6 @XB^V#D$!GU'#Z'\K7A)N>C5KK)Z^;I@R,L"39+[#IQ?AG/R&=
M3-O.([+1&AX\RVR=,NVS]/919\^E3&]5ERZ)S:)?S^2<!'<46J\9-;1"!C3*
MDXJUW+PS\K4! 3B@=#=[01J2H;A UW%6%TAWU6?.9#WVR&[V*)8*I[_C+VQ[
MN]4WE_-Z8^?*Y@O!C*+4^+'["#G1["\&*0_[0'WA;!<)R"<?<[PJI3 ?TWG$
M?$\G/K!Q/:9[X"<"<K<'PX<I(^$;$Z]-=_M#^ W8:FIB[@8:_FW9^(U*AR)8
MS7M12JPYNN'DD+LH2Y5T4@<,#9Z##CZZ3Z"^S("U)L6PJ,_%EBWMH7*.TPZP
M \S_ +-_<0<J[ZGM9^.[3T?W['B)3'LP8>,W/CI@&WC&'QP)<,*1;1507022
MR'A HPU^II43J_F/J?#3L(4'N,3LF9[6UK-)L(G$UPDIDZ7!SNE)S%*8P/NY
M\4RY?XP1,(1=: Q9!RGS!&L(8H_Q)X7OQYKI4]?;Z1X[Y*%=\TUY4[<=)Y<E
M0,*8XBIYZG"2N6>M=&O!F(J@;\S_2MD,EE8#NS%I:B%&6=@+Y%6L+2QTB$])
MOUZ53^=6D%P:%[8W++:WJ]V6*+26Y*H4*=!(6G&35 3O $M%R$N35[*2$>SC
M^-B*G54FYDE6F+7">W"$ J6[:BT35UR$HFFK^J*I^PF[!_H=IYG/H7I/J/JW
M7,U<SC17^C*W<DAT"^E7.FJ]>*QL*I(G$5F@L_'CT4:5SZRV"_8N#Y8I)Z=0
M).%W'-9I9]F6!AI]0;TBD2.W;@O-G5"?T3X7-B\MT;E<T4QIOD.<UO CQ#?B
M29W.W/&QL_<T-"_EB;>&O:JVMA9HX;D6#U['C*'ER'[?C"&L#=*L59M<\?DW
M =BE3UZRX2EI*#S_&PNU,+6CN048!/&9GU3GJG/2)K/,A;6Z1!?VJEY&#M\P
M"98NCGI?U14>C#TOC*=PVBR$YBX>("W0Z17GMKT^.M2LY)"_XV.9"%SC;(#3
M #45YZO7FYDX(HOP?!;/3FCWQ[$1;7<F"X]:M(=?-A<;Z?K,5!PVSB@(;>)>
MWA&^;9;J"D<@^;,8'G8"8ME>-._HOCS01765(X%[CWZ2^C9_XO)\%QR6B11P
M!0"3J*^UJ<%9@?4F+?TC%  K66:-O9ZC+(4IO;6\IX?&77>]#:?5HX@5M^C5
MR=#T%XI8]K(=JH4D9QDG5E:9K-<[*5!AYP\RSD]J&M64*R49:B5]]2G+@&/%
M3%/,M6))^MEI)5F\4WJ-7%KC5K&#4[X>9DN<K,];IJ4X*=LR[ ]^3E,X\ES8
M;?[L@.QA?&PO4$H\N\L7"U^71Y[-N,OFK!?X V\<$ZIW#UI / 4]!$KTQX,,
M@W4J7J(T9KF1M,&QYKD!\GDF7KTGOI"*564CO?'0=C6=#&F>9L\:J\)*M%Y?
M+OAN5E!A$%+F0EW\O$;1R-+6D\]=\"JR?]E/TP0T]ZO/J/'P_#@3Y<#'^VM^
MIK3GJ4H.J0+5\]5OFV3/>&L"ULEB)T?6<J+I6&YII/_G#!B9HBKT"E"S:O-5
MNC\,/41]T.1]=JZY:/0/\V"1R4#GO::9B\>O($UJYH:'VOT]O,9/UP3A:_UZ
MIAG--(Z@D?K>)A8&;T*O!A\19^GZWOE3Z7P]%UM,7,.AB,.4>/&CQ?DAE^U;
M14H/F77?\]4I:,$",P+Q>@2,)T*K,F?/:T@_Z$ZU?GIX73X5Q4B:8-($?Q&L
M0@[1F "?>F;PP$,.DUFW !N\"_V*E-, ZWT@S"MY>U'4;U1SI!,CV(1A>VQ_
MMB)RSJ>XN*_S*<RQ^)T"A6]NB3!%"B6XE.[VQ>2=4H*IA!44+0IT%T'4TA\O
MCIR9BMD,BQG8O2/7O9W#LTJKC-PYG!ZB:6).*)]:RY3)!!-T:B7#=IE?Q-8Y
M":3>S#QA^G#IJ?%,?:9J68"&4&B9L< 9V4_-,W!<A2Q>.3#(>P -14H_ TCC
MB!=O?%HX52EXB'\LAS46<TW8. K*XO_@!"@GM0%<%G8FY^)4U$JL;:XM>/LK
MKGV:,<><V3-_58-5G@/?.T77@")=:/O7JFH:S1I7++HO+?]F,_+"(^_-M_NG
MN0_^)MC5,=>W:6VM2;XM'\"*/HW3SX_'C8-+9O4\/E=? P2Z@5;5L\T%V3__
M^%\6&#]93DRJ0*L/)-P*P"BRR"D_0Y3T 6^_;F2RECNOT\D]*R5- D"J^V\1
M;6*9K.19<-4LU@G5'YN^&1/J;.F7)4]5BBW#3Y.8KJVF4+IWAOSC'6H'HKSH
M^5IC1"F])_VU=U0I"5(:D8/4?9^8JH7<Y?F;-S[-5G]Z)>ID":]X?6>/*1,!
M^$I-H0V0+KYP_"8D%FGU8&= V'*X15JB4INFP]9YM5S?2%KXSBD3BLB/^BN^
M0OYUI=I8'"F=BF1*#^-.YVS1.K,<?+1'T2>NL;PG[).*XW9.IK\65N%6DZZ<
MX L>(?A+,@?'G[DEKY.PI_IKQ%()#L:FA1W)1Q]%CS!Q_]5)7P?'7.?;:YWH
M/E4'KP'HI%/G93">@@[V2N=S=PS/E+]X:OO\VFJZW6.MS[_ H F%X)V2>.U^
MQ^G20!R9BW!(B+<H D\D[S!SP(#N\@9:5//2; $8,]9;"PL7UF:-.XW^$38U
M9R6AY2=:&T_M76OV+HSLI &"'027;D+<FKF3-L[IX#U>F[BAK7J'*?J*58J$
M1M.FGJ -NT^0H[X(TZD@QB]BFKSZM+],[\=2#\G#BW.=JAZG^UX8'VE:#8O_
MX2%I XXPR47[S:' \6T_'5H4R@*??VB9^=#,V:"]G]"PWNV[:9!C$B?9,F#\
MNNQ](3YRS>,91NKM>G^6^\13<W(Y]:L;FB-JR%$&U7R.T#R3=W]>WTEJ$9G[
MLO.9W?(?0.%5H8S-ATPG8EBP9!.7X*B>4 "8>JN_FJYE;CPLOCEHB6MD]'4<
M8@30V[5E<?^BD<II]M&[J9\]SS>]S"J]9C-)P!I)!N4/21W)>[<)%=F$!P^&
M4UHK%KKX#$X80"PM,XF6>G0E+]?RHWIN.U<T3I#OC4N<RYFGIJB^I)K9]5N:
M@<5(T2) M/H5_P-R],L(?_QO17HEV>;?;M*_3#6'.Z?=MQL:%"7*@[@+RI&%
MWXN?,9;2 >4)),7[+9$"7_?]RSW+/0NK/%/P=4G=*UEM0U2&:6VY@?O,_R7=
M$RT^1=]#7#9BAY[%K3][-%O-I2JEAB7!J*VBHQ]"/]AFQ)R,0,UDO,H>E3;4
M$>ZA5/,_6>14M-D=ZA).S"G7>)ZP#/+#QT[%Q_V]"YWQ"?I-L+5N8J)>HJ1V
M+LDOT:+!4+YI7]5#[62<>>V;E5O'2V^<1?[47-1:PKU[7_+"ORS?5 Y_$*30
MQ]FHV')Q"TC>WO)8M@H4Y3VGY:&>B1FG:1LQD:#/*?PF1X]#WZBA(P%4DQ8/
M<D=-Z/\FF,6"O9.:V/D"1S]F7D$9KOKSK*]^Z0;EZ0\XM<4L/!SUA6HEE<8;
M-:'_Z6!,]/GYNU+>^7QBPB[N/7]D*(WI^D\V0\&]A_ [0;<!6;-[?T?5B/*%
M24*FM4!GV3NO*9G/KR RIE^.-L5^<F88X0=47#P (6S8T!$-GOJ:F%E_?M')
M<OQ>&^,MVUS^LL79H_+>QYP% PBVX9]B:Q-6"Z??BZYD)KZM3,^>28V>72^=
M26)E7_XG?+-_++G1J''0G_+(*:9N3XE"/(W-]'O*OM<G?;?>?9I- &GQ+4"^
M&(#!>(@3I\$/$<Q4[O"!3:SD'48:NT1Q$%*2Y@S&<NWX+#8=*>.TW(VH&J-&
M*I2>W<1L/^60A0SG*)CQ9<B&#L-Z441B+'7,J  E\W)<CJQIE5UF@(& 617+
M5K=)%92&Q\*LG5.UPJE!GJ=@Z\J/A#RQHF&>;J%8!T(QQ8%<2#R0IYK1ZF6V
M>'R5^./S^$O#/YP_X>^:Q[J1O*SL/?[</7EGN%GOP&H#EREM6-W.KT>?5O4+
MEM$E6U<4AT(L=Y7\)3]C:_R-)3F_,A?)KK%7X>1[RO)^3$,FV3D8D $2]IE)
M"2S_*9E&)^L32/<UMDRX=WN#7[;'<($"'GZY_6"!?M5RB75K*E)X6 KCSI;G
M-RE!D<N8?WKG3_OF=_"4[R^[5'X+[!![:KR4!\_NR:\I#GI1XV;%;./PC*JG
MMM'1);'?IOP ,%^_TP06TWG4,$)MF9!(YSL/2*%KU092TIOH T=8W%-;$UC$
ME_T(T#5D5369:J%>;P8\Q9@[>1P30$C(DT[428%B)743H(6 B3BZ>G1Y-/I;
M?)DP9=MN+&V_PO\!$D#MOP$*'I)<2,V*JJPHRX88^M*A+"EJP 5HU)H@"Q$D
MD("787CQDY<+ B4T4(]X&50.0W=*=- _"1W&4$$3!907COYT $4H+N &1!B-
M01'&3W_XDQ<\8E"K@150@//_H#6I3))+B"HJZ*&**$(2H29E[5(B)"]P(%AA
M'>"%C6+_25;999EMUMEGD_62#(5LE7-:-;-LX-4X+5H2H5>O_5;<B&R-($HR
M4$A5+1'PL(>!=QEP%UYYY9VW!7OGQ>A>>^Z%U]]X]^WW7WW]Y?==@N-EE[<8
M8E S37.WW39;;]+<=LJ'UYRV7(H,8I-B)W?%.%=M:YUR21[Z*1.<E:&PH<XT
MT_1VRR01*NCC80:\KJ^ZA!32GKER+@Z-"MF)(#]4#$$*,T-0^."'<3KC2H50
M,DFZC6N2*HTIR@P1!P8LT&)$$48@B0&2K]C3*C8W0@![*K&G^FZ_#SP:4*,!
M[:8N_[&1?-Z;.(Y4>,\?)V)K\&><ZR;P0,:N8PDX_&0ZRI7*4&D#E<J/,N0\
M\V)#(A]#K$X*J<D,N2 H9;Y2)C;G.*/M*[%"Z.$Y>W2<B1O@?@#:P)R10]QW
MO@SCBR-[ G<CD\$S:?!NC@C#NVZ.3'*\Z-HSW(H<-"Y01NJH6]?*>"0(=^,]
M-T(1BC5R+GA:^Z\BR]"EMNB^[O#B/-KK+K]]#YJ!XI\K'&?H=28__-W%+3<P
M&O5Z(Z(.?8I$H=+  U-PH@C>@ @:Z(&+;C2C&[ #.#2J40^ 0#V6L(,==.-;
M=1C#%[L%+6<-$)D+K>3"D4%L7-S25:QJQC&8Y3!615 9F?_ @2-<Q>J%=>)A
MG2B&$#R@@#=X$ $OY/"!1#7(5( "E)\<8"E 4=&*IJ)BI?S4Q4;)X5$_2,%V
M/L0A&8GH@2]2(Q$X%:@;Y&!A*(!5R&I&+8(D25K9DMFK/I9$&:II6Q-QB#<D
M)2Q"L2%8X[$!M" 926<-$5</*U?&KL2F6Y'KACHLV;5LM2HZJL6)]6K!@-YU
M2IZDLEZH5&6]WH5*=YW27Z^,)0-L24N\%6Q>L5286G*  DI2[)*93%*;;A7(
M3,()AJ'\9*RJY$R'W*H@"]G6K<0$CGZ,264"T:2YBH@M-E7$?B>I'W50 A?[
M$28DA.%(CUJ2GQQ0QC*5D8(A/K'_/:ZXKFI'4<I22I.4#>3##3" A%D.JHAL
M$*Y[MI$*-*I2E;AYYP(<+&&14C@DE00OH_]!X3#^ A;"Y8-!0UJ,.0NSD<?\
MP#>&L$SE1F>9*QB":EU1&UC<@ 30U>$*GP ="N(RGG$$I:9(4(8XU  Z-8@C
M*B&(BGMV@\ !5)0ET/MH@3 JEP,1""1UD<!?WO.<P%Q 9\?!Z$=7*E7O-" 3
MXC'=YCC3NH+"0'SU$1_YQD$.NGV KQ\0ZCYS]!VJ7I0Z$F*>7:SZ$2&9M3G/
M<4(^Q(J$"Y3$;@9J9_T^D%:UTJ0!-UI@BT)T@Q;!" M$D* :740$-X"H+2Y)
MGTM$  51_VF@?1EZ+6'S(B3%3.@X([$2G+ADD6_2ZE93TM*2$F+-C'T)2I8T
MV4-LH+)M=K,!RK6A0SI)32O-RDXAI(F>1" I,EJ*416% @QNT)9))<I/A/*3
MH/KD* FXUU1A#!04:/0#V;I(@6T,T6FQ$%]4U5%FE#1D!'9UQ^#>T8C8VF0E
MF8D0&S32 146%B^R*$D-2[*952)9,5\H,B0]+)K@K%.!8W8!==&$70#[5[SP
M]2]WM5)@^:+7OEZ,$5Z^V&#P6J4]?DD3ACVIP<[%V XYB4/L,K=C2J;DPPYB
MD-\:UYI1RB803Y R,MT 34>\9($'^;_E(<ZKUTD<.YUW%WNDC_^$4>W-9(Q"
M.<M5Y@KB4 ]ZOK(!T8B.,CY-PCA4 (4L)#0;D-  /[_"-C<T(VR*V ,DN) 6
M[TC@,<J;'\_$/)+*DMEOSK-'*-PS4L(!)A3*8TRGA?0_B[IY $>9\^B49AE#
MK*X^:Q.+.#ZCC$'D( HV (($?NW7"VA&;88HS5&28@BGBB43*IB65(?Q ^ 8
MSJK#2US^_-:\O1 &(X%#GFKZ)UG&'"YHIY84[EB]V9DT>QP_<,X^8:"">-LU
MISG]3";25NJ3V* !-AB&#?RJOJ\$MC<2&*'R>&:WNJP0?_.[B[7O%@HW#,X]
M[GD.$M"@._E!''%M84>ZU=VB#8Y(1&[_E)$'/3A;%X&H0SOY-0K&XY*4]X#@
MDUZUSN[6.[Z@<(4<X>&K!C"!*MN,Q,(=I XMF> B9PED,N1!EJ6K,G"<B<HQ
M<_"N:CC()3:Q5.P=E!4O@-^3KU$#<93 HKH81BHVR+Y;O*)[99MR$87H13**
M((Q$!"D\C)(F%T!!<VM&$'#=L%='/U=VORFRPY-A48H<3R,OL&')/VM'&IN2
MG"KB*C=9,V3)98@U;5;#"#/)(0QKXB!VR<J>%$S'JGSQN]#P>M6C4O7PHF4M
M87G[>05Y)L%,$S*Y]2;F?MYHM#KD!.!0IN3#X01P2'[S5T8!Y2O_^<N'/ARD
M#X[L0__ZW->F_S;)%'Z5L8,'?1RZ$2W)@.L,KS#3\6J0KFJWP4K .U&@)RJX
M &M4&"4,S:[U5T3*"79JIHSM!_I$J+0'"X0 !I  !L0!=,) ')@*=L:"*A)*
M$6IN)FS <1IDL3Y"-1[KKAXK$_(AU)Y#!"$KK![+XL3''XR'<!!.<1Z$,-C,
M &>"GI"-S_9,<QH*"<+"WJ" ;G@ "#JB?N;+=%#G >.LGNY)#3Z#'-3M"$CH
M!\BAJT[*'M[CL590-40P  EJU%S0"=RC!,GP.2 +X]JOL+QJ_M2--[1"&9)
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M[/A+15*11BSJ'K'@!RH*1;CA @Z!S5!N.^Z1"/+3-U:*X=ARYS9N,9#LR ;
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MZ="Q0">R03J1W ,FBF#7.>'"S5?5,EP[K$&$".K)3"#3?H*W"7'7#XA+YOZ
M_/7SZZ^OWP3_#8@?@/?Q ,X)X/2CH(+@A-"#! -XHUY[[;&'(8851N">ABX
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MBQ)! =UOQKC86_W0%6FB0N^STZ+5K0Y&\,M1CGXPG=[!R V[PQ&._,(&$8B
M5BC@DJ*\ 2E("4IZSCN?\S)DK#)=4(2#>@\9Y& G.['!3N_CQ9]>"$,_5:M"
M^^%0HB!5O@PFRH3TP1((.22F,U7H E,Z"AXL=2H&E&5399$ $U/5J1:@ 51-
M5.*EEKA$3F4QB4]T8A11):HC4@H%,PRB#P5%)B]U283Y06-\!.7!"]TP4>J9
MX?G:A,'XV. $#5)0A,"D/3-AB0SS<9-Z0(>>\S!D/ PACU0>.1',I$PN+?@)
M1]AU_X48R"M>D.C*0 9QA16\9"=MD(D+0G&7F>1D9U?XB$=XXDHIC$09'TA;
M;C CD:>\)BVATV5LS@*;IY@&<YC+A#(^(YZI)!(AFI% )-DAH*.@(B27_$0;
MBF(/&V0S/RV1 BIX-DI4\&0DD>F!&PSADHZXTF :N0(2\ 8P'JB-'?,#C6?.
M$I[QA.<U6H$-5R['N61ZCF1K@4AGZ/F629KN(O8@1TH>2I/ J( <#I%H8@*'
MEW'L31F0"=Q=:"(.-X2@7IFX &YP>4S.G$6?_5RI,CTS.=-HS"L!597%H@*Q
MUZ#G9'!9J$4:P*+DY XZ['##<BX0U/S!*#I(DLYOJ,/4Z?]@@0ACP (6W&#2
M6Y).-(E,9.B: DRPGND]]_D2&8)UU@P.,@(]U"&;W-0A.(Z/0\QJ4().0*/[
M> E#A<QC#<ED1C5Z"!I'\4861-"_]_D&"B*(CG7J)U4-,*DW\+L1_(R4@MJ<
M[6P"I&R)'OB_!$I'.A)Y8(Y,Q L13.HH,9  7>4#*3)=2TV&U%*6<#A(,FVH
M4&5]CPWB-*<XL2%.PXBA<6'H'K_"L7PUK(BBFAO$!F PN1N\4IET%:CH>G %
M131*#$CP*4_!RE2>(E6G#,+%4\$JO)P:[ZA*HZGPKE<$>*#5!6B8J^<^+XZX
MG<"&Y'-!ZLEQ6+#-'ENIA:PS\<#_KGG-(*\P%%TV(DIDS73;PR(&E>.)1VQG
M>XLMD5*TC>@+7HI0!21488-.OM,&W70)S\ IRTQ\5,8A8$G1KF$T@[7$$!J5
M,0.* @U%F$ NBW/8A@WB+8*"CGF@$QE--)8)<I",PN(AF9%#9@_:_$ 9'RY*
M%W(@A1Q$H<M%X4%'8*POGKAD)$\6*2G"H"]U'NTGA@#,!?I&$Z(HS#83P3*W
M-D,Y<6G-(! )64(8P+6!%(3*"I%-HV/CN2S7AAUD5A@9/@ P90CE!X*AB;^$
M\@%E(.9?A$LE7DX]DQGCI ?F+(F>Z;(XK3'ZSU73:2,-G1 5= 5SXWB-H;5%
M-4%/[6SL_X!"I7'# _K=P#BT6S9S8!>[VK7H?O=+@52MS4#>B-;:,<)"#S:
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MHZ6PO0!-).3[(Y+ *@<9(/W+*O_&XHVMFD-V2"/-88\8&2OV4,DA80_O6$!
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M\0E('KRS>?$H7H-L62")(MS^I.:![<S>B&V75[^AP2UQ.YY \<)0Z1@#&I"
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M4RS8>/G$272;@;'A"3G+NN#+'7883'31CGP(1_5-\*")7$U:H-45 XU'ZDA
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MD3A ,BMS1= :]3B -KO3[JJR/1BP#51?^&!!/X!#"C!5BS! %O3##7 !-,0
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M,$.C2 /);@/(N?X LU?X^68(@9+B*S;C[6 %]W0/.$X5+PA+,S0# Z  OMM
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M_PNV#;TQ8>^,V%80IK303@5NI]UQ'+NM\J]X  @MD1!^L+GA_C .*(T3T'_
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M?DCB4JP5"R(3F5R V'V7]$8=$/S)>\GX#2VI1'V793X?*>PH[F':"^TZ!$/
MXY]$9#?&SN72@@%EJ<5HJ^7\R48D)@* P .BH"4.02]^!C!DAA?HK=Y8!N%,
M@PB@ +A$1@Z"ZS(^\ >("]\N*664BV4*KC( #^=:H@76+;;(J.5@[BVZC@"Q
M[6(V9$;.KK:(J9ZT8CI CI>H@Q=*[FM6YRUR0W2BQK;&;N-R+"%6K"PJQ,D\
MP 5X8#_^PV_.<"(N[$$P3' 69\,,IPP5A&_L@032B24N  ^L$"TPCMQ4)#W^
MZS<TA\!L)-Q,[$749G7.#3W_K V6LM#B"*;'>*1[TL3/\*]VX$3TSJQVDN2D
MI&AXXH?WCL=]\B[*^,RA_$\H6 KTG*=6" W,Z"=17I'9LNQV1 ][/&L6T2_3
M(L(3,R\4C6<4T\==8())L&AW#*W*#,@-3"^ILB<9,6L6+VV ?.QZI*=1Z =,
M#(A-*J47*4KSF@R#IJBC+L#,4C'+;M&(_B\C'.+6L$4"@."MHL $HD >N>_Z
M3  :X)'[$(('$"*%HH(A/D /:&K3J.>I JC0),"Q*BI]?B#^)"NL-BHFJJC.
M^,\4DTCUH*T@:6+.*F*V$B8LSN[<9LL/:\QL]!#<;.O$QNC%+*[CJ XF\0#$
M0BP&_[+@!J-+,-C!-(C+& 3I9*!@9CZFD43&+_R"+VRFWI2K!PXIWQR#""IC
M&-#INU0"#RX 1GQ#[9;)VGC#;4I28F[-;"XNE<RK;2* +_XB.D1."KD#H&"G
M+?FI"%&$G?Y0:K %-QC !2+ R81@F@1$G!1'PPP$,'N.F@3SYXK./B0B,'T.
MG7*.)<C@$RH'=.()=C!N::#&MLP++@UP:JIF$6%IG[PNP !F.5BG8(1$L3:E
M_\XJIHJQ)ABORB@"3W($#1;-_2SJ%P.%#'Y*IT0 ?;CA \ID\%P*HAJ+5%8/
MRZ0*-47/(HDO_R"BJH;$>MQ$41Z(@QZKHX:GUIZ(#([@?/\HRD_(P4= "HDN
M"Z'J12?X)Q,>)1_>Y/4@J':HRA1+:K$Z!35KRO 4"].&2GS(81AC8J=RTTH:
M8!BX@8G^1#S1+UX([_7P94YRI4_TTJWZ,0H:@/OF$4/W\=7\\:U.*):V15=>
M:AM9CSY'E%P\(R3\A!<>4A0[3R(G*/BV,5XDHJKNQ#J);/1X3?6HSC-3*\:8
M2;TFL #CBT1VHRW5*Y]6++Z**0!C  \6(L3PH+=D!F@8:61LQC%<A@CB!VA"
MAC6"JY,RXS(N "GK#=](4)!20S,N@!NR( 94),1RD.6NSCP(L3.+4&KHT@!A
MB[YZA32=I@C)0.1P:>1Z:2V!J<;_V"N6])+F;L-J.$=)C\.-V.9%9B0'6X+!
M1&!PVG##\N.;$N=P" <PA6["^,9O[ $/A, Q%TP(E$.6.,Z,L#+ME(9@(BXD
M1<L[6&ET,(X])%5M"+%UX$EM^H4KY6)WS/$9R6<27S$CJ]& PN=-/H <&+)<
MMI-5W(<7P!-5S(5)KBR+&NK/%)307-%6D!4=8].#B"(V!4U3P+5W_D_U^@1*
ME <FCD! 8X,O +2CWH4RQHRE$,6+<I'9EC'/,D&!+,W9%$C30D\Z!RTC&2A[
MM.A@ES4CR"'OM/->P2M?&U+W* .!=H>JCH@2;^=,-$)7T. (JN*$+-1"+W0?
MY3'Z8 TA_[ %B!;"!KCE(1)VVJ;QH:)1B1R HZ!@6V%B12_(!B2 &SS/27[
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M/-75-0N(>Y UJ URT[P'9(GY*K]MEJXFQ]:6YI1CX[BV);&2;2^.H'Q#8'C
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MR'@Z2F@'DY>3)ZE*)#5L8TF0I+TSRM F)"G533HRQBK),$@BP /YIJ@E_C0
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M%O$1RF-IB1@45*)&A4=U='5SVM,H-51!(ND19)9T*L$#*- 0/+>&$0!D<-@
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M4<-A-M,5$$I>K>EAG<DWS66<K],X#7:?;UM9Q_A>P.59I>,Q#-B@U 5L\^4
MKL$A4! 7' (7J'$?V%DZF/<Q& ,VRDF9AY2!C_\Y,_,'@ 4W?X0#,:+CNZ,+
M? 98&!>@G]AV%K.P 1W0 1N %/[8 6O  FIP 03Y [: O7RP 5R1 7PP!]WZ
M 2#0 01)<)=P"02)!M^ # 2)%(/0 7Q@#27P ]&UM[='6JO%.+[A/2=JAW()
M8FZ$M#^*/$68/$%;@BA(M$R6*GRH9D4;$5ZB<^H#!#9P4@-B1F#J*SHH=+YR
M.0$"(";00S?IP2(+$8@I@D6%8MG#KVCZ@3^Z+V&;$XG2M5-W53:@LSI+A;"1
MA6S&9X V<C#W$40I$3=JI]FC4 F<L*<"!#G0+7@B 3W4Q5Y\L044+05D @S@
MQ6;L0\;R+ Q0I8&(1GO_*8) $K%@),=&E49P;&A>9"."5J6%.!(ZFL<T B\S
M2\>->:4>=!FZQ$KR-EW U%WR]ANZB8^MRDS)Q*O)\4[.EDR\*#?1(2*O^!61
MR(_;H1W2>$B=RCK!6EH$ZEV6MZBURITN\JZ]Z(JW=W&A,SN<+&W,51RW=!M[
ME*EYU*?I%1842&RWD6K*:DV,%&M+<1JH4;MPT1JI\<S1S"&HX0#U%D_BMTC'
M)&\>QLBL:IJLDTV$.Q@5\AO=>3K0M4D7( 8=8 'PBPPL$!@9, 3V, CU"P)J
M8 ]9@ QJX+X?\ '(L 'VH SL.PS/( 1EH 8E8!3@6P8;< D?\ ,9H 9' ;[V
M_\#02X$.69#1<S"OZ0H8PIHRH\8ZGF$7'8223()%+]<]"9MR,]<203)B4(=T
M,!?'A"9'@XRP,+9G-R(!%%LFO.(_351$(C!2O@)T&UL^%!M$2_1#[C/47)R2
M>062@A@2/#V7;?905 )H)VE17P8I<92"4(EF-P%V7D?$.SMV(V?%< 2#:8K5
M8"1!:N=7"<-D2^)#+L L+B F?9V& X$'Y1,!=59 >" $R7(MBMTL)) #4#01
M_676,%BD*NC'\;)07IBU:+O'578P_C+9.;S#8'N$#DP1J0.+=Z-<%U*?#R9>
M <K:K/F[G,LTK,6=G>F="TAAH]4ZYO>XQY==ZC=\\/^'.Y/ZK-D)O+LSFOGX
M6743N:"EG+,76[+YNJ7)O!A6@8MA-M:6#X]5,\2]SFLK?!QV?+G31[7(S8N#
MG?AT ;<K'N*Q&L_,(:WQ%JOQ _1] P;WF="M@)@+C,H)W5?#H+Q;M^:,8:T5
M6LGEW;#)B,@G 0A)-57#,C\@!@I)OA\@ B60,2"0!0AY%M]0X2 PT2%^& EI
MX20.P&(@ O.%#A.2D"YP">^1D(^+C*NY?/B4WK0E1CN:6!ED1CR*,+)"PW;5
MUI!7IT=(AEL%>2R&=#K*5=@#!'6& B@ U%*. A\PY8: PN:S@^6SHE5>%RU0
MY5QL T)8*Y#'*#W:0H@9/5@:>\?\ M<VT4)O1Y=+[B0E1[83(0'TM2E5:87_
M60A#>0BE9UI&3]+&B[:R3SI&E_:A!-M7.O'H+48D*AK&]E#"6P*$%S$ .H$0
M!-0J;;HH=XB(+!G:@ZZR-Y?F7MV2,Z818+B86QA&1_(C+1=Y"Z-/GE3)Q>1)
MPQLATHC)G(%ZTX@9(CW,NT=,GO2*D2&.D;/,EN1:_.BKT#'+T';KR$R.FU2I
MEUI(RDB:UZV-G81=U;%NCJC-R7Y*P%%+PI$)H.E[)@**O?CKA?N-S %-F]1[
M\\8<[.T:] T7W' !02>R#9">0# ,1P >;#$(UJR0NZ3-D*1LW!%L%)=NH)SL
MW\SMA3/OO'.-4,$ O2D6(.#OO(:0%T!P&8 "*2#1_U !O@!] 1E0%],;T&)@
M <@ OX/0SOA+\Q?P\47QC_AK 2*@!BB/!O*J<>Q!3*?<C>@]%G =@UL%YTVJ
M)']XLH2NTD?)0 7KTULX02P!AG/DL)&'5X@5 3]4/B=<0$76H502R(]7*9 6
MI N#TUKO]7L8@WW'U59642DGZBFI#U:I*3<K=EVVPX-GE^E"EWSIE3H=1DA'
M)$O"P!5E8X@W$F.E)RE<V.+2 &I@ LM3+U$9$F>TY*9R,$,[EY!V<F+F9D@W
MR&+8E0QT0?6R*EB=0O="+UL]<S=]1KJR/#'T8,+IF9'KNA2):JJ)V_BJ>;?7
MW#Q3-/G8,^V5FG'3<?+Y>__J#9[1K6'#29^-&S<2"'O6YS6JG6N^86'GA^.Q
M)-O-YWSKO(")(;J%,6U.X _65F%[D\C4S5G Z5Z/Z5X7 KVM]I\ ,6R8A L_
MV/V \N.&0FX2&@R &%&BQ G#N!EDI^S@P0O#T$BP)W#8!Y$?0DH8*?!C2($D
M/8)L.?*D0) H7XJ$Z1(EFI@H==I#*6'E0*(A308U.M.D1YI ?]A:2I+D#Q F
MJ7X85(+G!Q!J/D"]4-7>U0M0[;&\>C;DTZEFSP[+VK+$CZ4J:]HM*9+GP)DW
M=\8DXZU!A,&#R4P@0SA"!#*#!4?PAGA 8<:*R4PFG+@!8LK>&C-&;'F"-\6/
M(R?_%CQZ F3'AD]#7OU8,^C*E"F#)G-X]N?7MAE+\/!PHL0&$B0,GXCB4X//
ME'7[?JW[L&C&@SG7MLSX] #)A0<D_LQ[]?/JBIEC#NR8NF'+MQ_FUDWXP@4'
M].O7I_]/_W[^_\Z'9@Y Q1!#+#[#!$00O.XN<RXS!ZW;S3?F!B1MPL)VPR,&
MY"0":L.(8L #0L6RBZ^WW C[;D0+%Y.PLM%0FZ"!"F=CKT7=!/1-L\3,<S"T
M'0\\T<+$<'1P-M)TY)'&"%"RQZ4F!0)JKY* @E*GE7:RB<HJAZ$RRJ9<XE(J
MIO9Z,B^:>"I3RC2)8BHO*IG\2\LPV5Q3I:+@+'-.H7SB_Q)/F^ZZT\R4H+1I
MT)3D[/*HO:3TR$M #RUT3BK!) DIFQ35*R5&,P5S()X8R"<3-S)Q(A]/13J5
M*# ?[:G/.?N4DJ0RJ91R*RV?G-1.6#%"R"!NCHC 0V$'B, &@PS2B!UV0*H4
M32>%(M15,+6$%M97M]H25UGY;-/+5Z\U5-=,GZS)V:HB18,KJT"X (T2A!A&
MB#F\0N>#LBYH\MQ%X+W7'A;4&*M>JCKR5XUA+LB@(UO@50.90<Z$T]57R0T4
MJ"Z#ZC,"'U]4[; *<7L0-  (0/>_ST;+3#+=,/OXP(\-!/G P4*.+T;S=B/9
MP@I3? ]% W'&[46-/YX@PPD\;& 87H1M_^"3"T3T;KJ8-7NM0"1S?CG ('E<
M$<?O<#12-"6ML[DTCW7V&<+)$K/AOOGHXX4-7B[HKS]B#8/01[I;QIJQ^'*[
M[K/LW&--N^X$1\TROG=+LH$HU !"6)"$;<$#(/2VN[R[6<[1N0.QN[!OK_,&
MKSWLPD/9L;Y#,VVSQK:^D;;+5\OQNO=,3Z\R,K3\""^^2&(4S*'X E[6<*,Z
MJ5:84,78I=R)I\G,3BN="5KC3U+**$Y9RGU/BX/'OE">CA=4IBG;K$O\07^?
MWE!&[]J33?/KVDM,N[IG::F<6&(?_Y3$M&EYZMUP0JG$X00T6.PO->D>^?)T
M)9;$A"_],]-=H/_7E/$YT"4;T8@(V,& 874P(L8ZEC(,LBJ]_$E+Y?.?^ KE
M/1:B"E6_2\D!NZ0^!.Y/53%L($QJ\@,Q((,/R.A !_B@AK),I2K#^$$&D/$,
M'?R +1>H%Q+-,@QT6* #(@@)&M#!ASD,8BQ5^1X(.C '$?#D!W- QA!@D8.]
MZ# IZBLA]=Z7Q>/QID'D81!MP@.D$35'CYN3S>4$69X(?<YIL.L9S93DQ]:
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M*W7FSKE9DYK4W9B*49"#+'RBY%EPP01L8(\!K" +V7 !S,4=I!314F,G Q)
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M[;4WRK5305,_?%3KX3%FW#WV4=,] U0Z*D0T]L-=$^)N;$0D-J$T)'!''88
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M;,L<V46Q_!*M)#D-'JC>7^ZE_BBGD'5GI0LO6I(XZ4BH"XDG\=JPZ^SL]F1
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M[96FX:/,W7N8B9H9D$2)K!ZN2?98GE86K4LA)13[#^ 5[03X0*%T\'WXH80
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M[\U\-W'.T=-CKIV]N3W+TR/[$Y=/_YP3)VXRR2<3)_QQ(A,W#$P0P0$++/!
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M-"1UTI5AA^SL?+Z:[*2Y=BWYNV<#K^S6L.Z0,N;5GIZWUZ2V1WL0.K#&G@M
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M'\#A!(@@)P=" TY '/OA!'(T1AF (D) (L4Q!5SF1V.T'E/@W*+*(C0 ''H
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M]J-G4<V6(<TBHM5556VKM5R>L'+56E0E K8VJCX[=UKDL(*I*]6VD@ $-<K
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M3B<WK62#Y5[[ LKDQ;95=TC?@;?W+NB $"#7R>P 81:'T _7:,<@X;OS.D
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M%%#&.3#.<$P4\2,_Z[DN5RN01.*0L8%'\J'/ )$!(3">[  !/-"N:7,2%,@
M("C%<6P0!D '7A0O8_1'^OR^_CJ1,A'']#JU')$E[Y!1ZTF_ZK"F1YDOZ=(W
MW_$/[8&PS!":YNBB_Z5<4B7]J24+K#_K,^EXPB9;4JNL*)^9-,=[H/U9(S]C
MCM50($O4LSGS0]9@(#$:1""\(R53#=1 ,3;LL6&Q##GCLRE24PK31%*Q#3:\
MHT"CJ0H#-*#PGQ2$,3-\B,2$(HHA3,,LC+,**[_@!IV@H$*CM$K[&"T]Q#1"
M#4'EF1>3"B%;(<-RL7-1H2N*,4%#M#Z=PH,ZU1/R3-&(02,CQ,V0,KQ0" >,
MK==YGES#K6>;G4\$UD3B3?B, !;H4..)@ U@@;XQ)5%:&P-)4!MHT.ZR#AOX
MA@NHQV"%UA<( P\E Q#%-PU)1EX<2=F$$1DQU_2@D&_5GG'MK 0+M6<CD/]Y
MZJ\$TR5:\B7X/#<5@;K3*9)C>BX!39+*,2W6HC8O,8)+:  S"(0988!O4 /[
M:U@RZ$<A*(L.R('UD(%@]#\@L(6,S<<&8($YX .*'  &( L+Z #C! )EC  )
M.-FR"%'RXE#]:  0E=B1]3^3Y8-%N)%OF"HUR$>8'< &.%HL\=@.> 'NG /Z
MZU#K@%FU, /QHUB2E0'[,P,!@5D\.%ED$(*5O3\&C3W?Q+W28ZW?&E9'HCW4
MRJU7RYM(08\6@3@18[&7&9F_HCRD(\V]&KN9>YJB)*&O\Q7'VJFVU NEO,-B
M49=;$<U7A3O-?"#'(A8>@YF4"Y8LK4RC"KF["I;_"9,IPBJJ:6$7O;.[F(JK
MI_P?:.$QQ?.JI!A-L)-2/"P9MZJKHYFK#Y ,CH$B7I@ PVP !F '$>C=R?"8
MGHN9FBJ6P(J5Q&TIAHE=H7+>/&*:5V$5MHRLH8J\B0,\D8*-5H%*I>I;ZBW=
MI1&JRG6:DB++<XF:S^ :S(G?V3F>75+;A=M'>A/(T M),Q!.W#*"%V 4^9LJ
M[:3:5A1.+.G".2A:'@!@*'$!%I"1E6U9IVT CT6&"@[9GK5'!(8<6S#.(V#9
M[H-9"Y@#L?T&I)4_9*!(KP5;/"!A/I!:*&F A*1?#W!:+%%A&9 1F)TJ/@C1
MHX59$1#&CTS@^<,#$%@<$\IY+4=:L/J,7V,3/>U@QX%%'8+_+=A_F)[OPJW=
MZ0X=V( !< %;Y,X,X /K, -KA-E+R! Q!@)OD &G#>.&M8=9"-KJ>%A8<H&&
M/5KB7%#VNP @0.$^+EM5[%#&V0 +X &8Y=H[=MH(> %K%%?AC  0F ,;L $0
M(#]D!($5\ 8S<&00((%-AD;9LX=,1D8QV.$,@>,(& !(?M$UC@ \L #U#&-D
M\#]P,J1B!4 )W9IO!#4A_;SF')MDZ]7W3!#DFA'F0*%,9*.J0 HK;2,U@F:1
M&SJ0D,%9=3/&TXR\U5PR0M.?&,3X82-=X:.ZN@M=R0D2HQ\8PK#^R8J.,B$5
M(J-(_$$F"R!9U2 '.HU$=<P7S,$0_RQ4%7,)TBBQ)<32" -"H.)!E.&+MI,,
M;I" PE0B,CB"R'C#L/J!XT!H1RP*/N)!YQ"B+X7G&IJST-@X,!.)=<8@.QNI
M(T0@EA.CGB *A%;<Y-"B0H-F!4+5^!G"-2T(1.D>%]T:_4(4L]' 5>*M#-TW
M1J+/^!,"4$.!'ZZ.%S"#5G8!+V /$+WJ.8@"G9WD2K:!!+W%"7B!$+T.3$8!
MJK9C2.;.66!D"^W?\=H 2Q97$2B?6>8!&_!'8]1(AXUC/4Y:6XCEO-[K [01
M#NTF%&C8 6!E5Y8!;3019)P#%\!D0!YL-K;%!A#9#^WJNTD>Q\E7Z#&_,!F<
MTA'897* ZO_#XB2!#U.Z/?SHG@3E@:<5@8N= XXU1A! @8SD6.YDT=F&1^B$
MV>@D@^74$A!P ?;3QP=A@-T^@A)0XO.4CQ>P/^N> XC;:N/&;BR9[8G41S(0
M8QY@ #% VG[D;66,K_@@;Z1=/XTT1MS>C@LPX_CX[IG-;2'&#O93ZT^K'-_;
M-WF2'F-+/5BB3=WK8D+QS9(,18CS.ZQT2H1ZNX]0F<02F;6\7<;*W8F:N+ZE
M**."WLNE2BYSS0X\FIYC3>O]","3N?--RR$#7RVJ*T6;*-DM%</U.*(JN<A<
M-!J$\>^%*\\U7?7%RI#Y.@L'2\'Z7O8-N;_<73:KPQ^X@"-H@#C_)(P)\#\)
MD !N*+.)@2(KY,FH21F0>=[DO1D3V\G'5=^W"MTAQZAO47.[0O.[DY^D6]^/
MPEYI <OS??,Z9SREK/&HC BN:=L;Z38) =+<0I!?M1SOXKUZ[&(9.-F6;<4B
M/F[A'@0@* +C"5D4J$5];  7$ /_ P';#MG%$4];.(3M!N\8R  >D  Q..OZ
MDC_Z*XM\Y$Y-QPZ)!>3W[LZ)Y! 0&(25+6(&F 44*'92OA&<]8[O_N[X6$Y%
M1@?P;F7N],<0+N*,E !HCP_Q]M&*]*W@46\!WQ$)&)(J#E#6-MBZY1K: F;M
M,0(S8 \R:&L@8-'N^& ;\&MM1 $74 NU_Z"_#;"!\F:/66[9?Q=.NNX &6@0
M<R4#1$8&%I D\.A?:H<E_891,D"!$FB P*!C?M_X^%AN\8-&\;L :D64>O_'
M%*%C\EM1\LOXAL76W<[6"QB/\9QL"&TG%PV4#@&G"\1/"CFW"JR]^44NL<&W
MY^'3K7@-FWNQY_"C)7PQ.5LCEP(A+H*SUCAI+_NS:&[ZH^M,&[S$#$H-?([2
M.+N? S(7NP R/I32UU2ZQ_1F'G/"8?FQ&(+"$"N((4 &*D-$4JT?*K2%,JSF
M,SQ!2IM!K9#GK 2ABQ:!+E?,'[@!LZ.8MB.S'_#RA2 TENKF28M55*UIPJ<B
M5]W$$#J*"5/I#_]D4[6OU3%Z,UNM,RL5(G-.:!$$7W A%2^",X+H+W=W+U"$
M0-!)O^\:$]2*T>WHW_#C;#:>]/GKOOB0ZJGJ@$,P!(OE3A  @C"VQBR 6-A1
MVL7N#AY@T?TVK^P(SE9J9>'*^ ZP/V1  1LP]KY&@8*OOY85@NYDCS_F=+F9
M&@YE/8! 4:((BDL-&D2P\>U"A W(^,AH0(:,C5D7@-A"@9 !"!0N#)*)  0$
MD @(3Y(9,"&E1)4L39H,.4'B!)@28PZ02.;"!0<]Y?3\^6\HT:)&C89$F!0F
M&:41R*QLD-,F"#Y\+'28,X<' S$HGC8 @8?!-Q0A)73TL"5"A $A16;_,#LA
MRZ6V;+T]#4D&A%:NWS[@]3:![U;!8&4(F:@8X1%T7\FLJ&L2(PH2=1%BM('Q
M$.:,,;;J74D9:E+*#4Q'B"&93%<40.+B16NV 4>Y2TF;Q*OT9(2H;DU.]8;0
MF]ZI+X4_K0F5J5.IPYM&0"X5.F_J-I,/RXYFF 1[V;\/^_!=O(3LY;>']SX,
M/9KRW;FK_^"]O/ST\+/7MV^_?G?W\]73=]][[VE7'G[_<=>>/?[MEYY[ZX&G
MGWSYU;>=@>*!1V![X7U'((7J*:C?>@::9P]Y"P*(8('J<=?BB/&YN&*)!4+(
MX7<;"LBBA/.%^"*'(.0 H(TXC@C?#[9<<)^ _PD:R!Z#&,IH8W\V%BD>E/!5
M> $Y["C#S@]<>LG.#3_\,*8(RGS9Y0]0?/G#!=MM>)Z'( YHXHSY];=@B_QY
M=R6&4$X))9$/\L?A>5B"1^&-=38I09P0=B>H@03:1Y\].+YW9::+AJCA>-ZA
M5V25>H8HGH4@PD=B>0@]=1UO3$W@UG K2?>48%#I9AQ"*^4UU735+?5K!($(
MD=<%'>!ATD=LA32 26+,\94-($B QR6D9282"#P$DBQT9+QFEFHPA1MN<DDU
ML$BQBDTT$[0H#&!#1AA=,(!L=#7+K+FL>17N=#:]L.Y)&P02P05UG=417FY5
MM55KX4X4;C:717#$MO\3&48:;KNUNIQ3M_YF&&\V^,0+&P[XY%-/1[',<FXP
M\7J2KTSU%I(+8MA@EPT9X&'#''A$;(MF<4D4!3J'H,#'(>QZ8\\L9@V0M$;L
MHL26+7@ <33-$8BUU+#K A>2#5Y)A((%&AD\APTHS%'23EOY?$AT3J,P[5<-
MX,4:"#&T*A7=3<\B-QE),]0 VPW8HW4#/$0;$A!D+P6R4C$S]19O-TT.U>4Q
MQ4S<RU#-G)3'-#M%^6TU#W#BA1QBN"!Z=NK9.GFI;F<GE8Z"IR=^X_%>8W:N
M#Z.GZ[C_+I[P5@I/?/#E)1^\H!'6'B#QRFO7H?._.TH\>:%J?V.&RR=ZO.W_
MOL/.O'^3 F]B\J]GK_OXY@]IZ/7')[@[^!WJ'OP/Z"0)?)%V3FD[%U@(^(@W
MOD<9R':G6MUW_(<B$E6/>@FT!T_4!*8RM8D=[&"3EZ#@D^DUSW[F*5ZBJI<J
M\"GP?MLQGNR6QYX6#<^!5](3B2R$'MDU+WHN+"#V-E0^&]F.?D&T4HT B#W>
M!<AZJKO>$=W'O"5>#W=@N4Y2W(*K*:XDBZ0[ETVJF!3!5(=TN2(-KUB0&.!L
MH&W>2-K2\C(XD R.#Q<PF]O89H.0J L$4?#<1K1&N*?8<6=RPQM,!H"88 '2
M((#LP"$XPC>?H8!M*V!:XM"6M;H]+5@A,2/,]H('_\-9@&^&VXI$;A*!JUW2
M!HY!""3I"$A2V@0O,1.=3:PX =T@,HS>"$K*+L"+H+0LF$7AXJSZ9DSH"*<!
M,GA!7DPB S, H2\-, ,S]S4:%B@R!GQP#=%,LHAL;C-I/!!.-%'0FL_P8"(,
M:-QN#KFY?36 !<R,YSQM4; &?(.4($A,/!O' C,(1P8RR D(1, <?VU&*?+,
MR3\'T(*R1"PN33$7<KZ5N; !)XRW,=W&F$4YCDTD;*PZ'6^08U+?6#0"D *5
M]VJ4IP/USD=*JE&AB"A3)\$HB:E24:3"%R$19@^F,WW4A%I$J?S0CE!"!12*
M\/>AW07H5!SJD9*(ZM/WW/^0192:D:7NQ#NJXBBK0EUI[^1S5._\0 P6X,,&
M2F"-67Q@$!W@ S)8@-8YT-4#:)B%!>8PB!^ 0#['HNL/[/&#;VQ@KD/H$XM.
M!+VN3@E2"F)0^Z04'YZ0Z4OL$ &;R,23"S2UJY6B4Z>^:K^G+DE.^8OI@%K4
MHQ25$$.3S1&-RNHB1H&*0'4R(9686L+O2:JI^7&2B*+DV$WYKE3:0=&L0E*K
ME"H%-]]ZKE,Z.E+F/&5FU5E)3A!CDVB:P9L@B<'9R"L!D6A%(R  : -LL163
MX*$#9LB)<KS1FJ904SC_A(M9F*-,(1@GBQ?@PP?L]:ZPY !<&8GGM2;P&==D
M1)W_7B'#U;Z5$S*8,25-D0'"E/D"ALX7G9.)2VON*Q);+&V?37%OSO3"'+=P
MEV.;VZY>J&,#GI2L)R>[@!R$Z6/,X3(WG<,H0AB'AR#C@0\B ($:^-"!%Y"A
M::N,  ,LDA(S/&0.<F. 8ZIHAK4V;G =6"LROI(UN:%@KG-% :^XR\E;GHO+
M4W/6"[(RT)"6("MJ4!L9&+=6/.B (8:TRD 1DD86Q"0A"Q&)12X\ "Q#Q"W^
MHO+>VI*X01(STV2DI7-P]<67W?+3A/QH%UTU1CCORKKG,@X,E2H_37$O5$XT
MSZ-:VL#5/8C6+1T?$)^GO.W]NH?"#BJIP!.](=9/V/XK_V+KGOC;9+,/A23:
M7A-EVVL>_N=/Z<&0 9V]P_S-#D50\E.KX]?#Z:'A H&]P"RRL)UOI* ,@YB#
M"-# 9!.M&P1)NH M/H 6-91!!&>[P!P6^X,Y)*E#H5JA_.Y'H^XPP(1![!ZT
M;PVG71]*A#>,4?FXQT3_X2Y]\&-X]X0X*42Q3N(U9.+L=C<^D>=N=> VZL)[
MQ_#KM>>%[K/V@Y1G)[/J>G[-EE_^DD=,+_:FDT3&B]+_A;<88Y>0SJ%BS1*-
M-S,(X5\1B*\08O5E/C2N(4XN<]>X9I4] R%B8OBD,8%0%H0,@ 6$Q@M'5L#'
M9AT2)B#; %VW*1:Q!\)I<GMT5O_.1N6G82:3?$<T&1\]A[D^I%BL&L B^LJ"
MWR0M*V4&5UPJ8A9P69EK#]DS#Z9^T=/_ICFMXJ,L\S:,G_ 2F#X6IK-HC-V8
MS5+3)X876ZHSE;; G5G-W!S3(\<6*]8X7U:,SL?:A4SET,Q9LFJ5L]C23.HC
M\_BW27VO0MI)E3@+F54TYA2OV%Q=&?-6DZ-B33+7_G,=)VSO?PE(>>7\+78T
M4ZC2S\8M)*6I[@ECP=3L9$]8855_H(?T]!:=(-$(65M2S8<#XL].G1#0+<JB
MT% $2B $:9O&,0J3"*"H0,KM1.!6[4<(A@H&QLBX32!2$8E,F8I0)2"3X,][
M&%:_\9O_"$30,(" ,@Q""9C0D8@'8'T OR7)!Y0 FMB"#@HAZT3@\\#@^/#'
M;+%6;I6@$](<H3QA3OF.354*59%@C+S4;B4@2^U(<?5(G)3*:CD)6.G6?=A4
MIUR*A@R(&L94"K869"%1" 95A.#)3[U@CUB@@=3?%.&-<VW:C!&3%DE7@)6?
M_3&?K2A'^\7*1$17W_R&K5!?Q[1*=@E?MEB'8FS-] 5+[1T32%5?\MW%%*7B
MMUQ?4[@%*691]7$B=%0?*5K?\N4-%P%?+EZ %]S&<-@>QYB436C1Y30 +_72
M+_78[ 63*V).%:T$20$?TN&-X(FBTQEB3&".<?R&QFB,&W74_S2&E")F46B(
M6DS<GTXTA6ZHXSIF8["XX^7DC>C<!J>EXZW RD:=VD:5(_RI(SFZ"OM%&=5Y
M#"+="JK!&!DU#93$#G MS\Y!" WYC@B1D!/-6D0J#_MLG/G(&O&<R@R%G,^Q
M4!-1#\EIY+>%7 Q>SP.F$ O>#Z]Y9&0]$$?NS@-&R/G,%O!LI,OY"?UX)+;U
MW \QT>ZHVP<<29)( ,%AA06(0 J4P.RD6V 9EKX-PB48#PNHP0?H6U4F2:@T
M6YSH#DG&' EUF__13T5.G$W:6DTVD$-.6[*5Y,]=)/P\R,99Y+DUX*W=3U!%
MU@X"D Y%&\R=D$3ZY)YPR/JTE$,V6__1>2&I%.!,AM;KE"2H!1FI$9),H*.C
MW43N70Y+:.9 TH3SV=_HM$3F?":GO>,790& [4J0 1DMA5K5 =G+L I*$(<7
M54TI%9+,8(XQ!1B[9&,7C>8[*F)TE0TC-<4+F$%M2I?\N>/&R.8_B@V.\<0O
MI8P#.&,P99=2_%YTQ8I2/!>I*9A&H)]X4DYWGLM)4$ZMT-AYEM\Q1>*WE*86
M(8?]30Z,Z=TDIM3HN-CE?-3TW>8V=E1_NA]]PMBIN:/(P)AQX)_I1$78@,Z!
MEE]U\0J-(!5+RN ;^DA4\<Y/SI1C,56>4!:=9-MH;=4@3B8$V4]I.=98Y:$&
M(N8.UM"3Q$?Z;GVHBLC@"07@P^5<98'A;BE@&0+@C'1HC80(&-;'N+&($![E
M,*25")0!#RJ#")2 %1IA518A.M0'")!)OU%0O[E63)VA3FT(GZR(:!D@8^D4
MBI:(]&"*CHHE_YG@8WU*F=Y'&R:1_JT(DW8H@LP.4L%@C[:6B"QI8^E(1<JA
M4>4I!V+@\QP7;.D6@F2<=HA,@:Y?*<(BQ\!$=,#BIB5'ITJ'+*Z:^_6*C$5'
MJ/HGKX@,\T73M=18S)BB/Y(&2 VHWJG>YBS'KD9BKA)H_>$*K7 7K](GKV9.
MZ$R "\R5!7S8^YWC+0'K/M;$&$U=E#4 &_!"RNR8'/C$=O\&TW'FC6?2)FCN
M(W%0#F:*SDR<CJSZWL; YC<&AVW.(W#$$I'UWDM8G=6E:[@N9!5I5&]$9]/E
MBC%%XU3 &9P]9S3NH[X2[*?-IM,A'2*58^H5Z$SDC3=0&^]DH/+$Y0.1$/BP
MY,V9)5M.G$HN4%ZN5L9^W,@92K3M4!25H?$DD/GXSP+5CNJD8+(IIL1E;+@%
M)6#"3TJ6B,R"ST>:6X 84?-$%O,X2 K^D'P0H1$.P[PEB1GXU3#8@A"\'KT1
MG C@VP?8FQH,PPV<#5>"%A':)65^;,W2SEN6V_=X[$]!"-'6I5H2+5W.K,<!
M#Q$AS\\JG,6-4-#"CD@";KFEI>__M \#J:6WV=!/R2S#!2H,M1!/MB3V.";'
MR:SN3&Y0NH>"A)'4X9)V)5IZ1B.$FBL?D8Y,Z 9L3H3H&JO5Y>:%=5&XOL5U
MG&.^'FN;,9TV%BOG?)KH<.86>>=I$E."GLM'(=)LKJYMJJ[>.0LN_><Q>::O
M4&R^:LY.. "V*J,O>6O+<-^N1BB%WJJP^.=TO,1R2$[O26*40:*N&FPPBJ:T
MHN. ZJJ,+:1ZTDRM/N)MJ!_Z5=1\SA+"?J<;36,#0-UTF$ZT:M0QFF;39=3Q
M6H=4J*<V(H13(6F.=!5J96B&9."HI.F;RDB,5M6FX(@%OHBCHBB.<MN2J*!/
M5<BD,DA5_UEP:0EIK8W5&=*@D,JH@R#JDKSHG/)6:>$I!_<A^40M7%T*"SS$
M!JQ!%D!I!HR9&GC'&B"#&O#;$(I!5@P"E(KI !WJ"6U5G,;P7_J(62UJRA%1
MBH+;$RJ)H(H5H8[0!;/6AH2D$EEA<57)@:!/&9NAH335G;!IROEA!5*)]1A;
M!,$(3(4QE9PI!D[;_BT@;0T(P:IO G=,^^DF%DU10JYG)V,7^*9$A)ZOZ26'
MP<**.XKR%GE.12DD=&VCS.SJ\&;:Z56HI]ZNK*H:A9*&/E)'^&J:ZD%'=,Q$
M<-RF\5JH=;39Z2SE,GY6MW;O4<"N]1HO:,KNL0YC+/FC_)(G)?_CHT&2YRW9
MG^S.4G#,'V:RWNV>WV_>9BX19*?.&.J2KC_Z2K@JZ /S+NDDJ'3B!.A$;W%^
M9@3T5 DET Q!86)V;D2VT,OR:%$J9LF>K$DN'$W&X1'Q)0GIT/ 44,[]E,S-
M;%*A7!S[SPJ[+0O"I$&;I+1I= 1]9+&-($\V,OS CD'?K$F;)0#9PTT'CZP=
M\DVSB W<-(GPM!GJCJQ!81H7I="ZSL%!'EUM\<?VI D5H-N^GA@D7!E> /_X
M90*J;?J$6\9.'$9RK,/A#K4MF^T$;>!&&\/QFMS:$/549!K;D$W'Y5'?Y KF
MCV 6Y910'$7_$.>@+CKJG82>+R[;*Z?_U5[>!*_&Y%ZI6>C=93-X,C8[5^SY
M!F=H=N.,<5]FDF[-M&\WW\3&I)XX_Z[Z/K8FP<HEZC,MFY*GV:8PD\$O8:>.
M.8#)/+/+X&M^1O#"XI,(X 8ZL6\VBW(Y@8L$#$"5/<;4F51UG$0T;86O@( B
M"8MN ,%Y;<Z(W0T7\6]UK< <1 'T;5A6.)D%7!ZFDC93Z KZ06/2(3>GVJKZ
MTO)D"Z-([:]N1]T48;<[,^!3+6D7CJGW1!9>6E;&6>"/4NJ=OI2#3&!E+;3_
M-8H?%W(&_P>?!D@,SHE]<$^B4CAM-8@+4HH@PI9L\2F>4&0CXQ1E<16+I&$<
M6T]$]\DA/YP$_Q;)TA:I(!O54'=N7'K*4L4/H*" +: !3XL ,M3;(Q.<B$IR
M>SSI!]>'$.K(&%[5!=8@F0X7EB#(&8OA ?VW:$76E6 H%D9JXL80DA;J"=;6
MF>K("J&X7@=N]3S5 =(Q!WK'2$6H<$"=_AKP)XNN<FL:.B?'@GZS/1_ON>CC
M;GAC?&.F:],W>I)K?&_?INDGHYL4:=#78'O1 =>R[[Y?11D'R/ S%1UH29D.
M.0-P+$_1C?52R91,;1^%/R_Z@XK.U9P+VZ3= >_B@.Z,:R >610.)8.Z7F!$
MM"@%1I3 063:V*#-H(L-XJFFU %L3,@Z(@6,]47 "PQ[Y$!=^O[F4O_,)CC'
M*F"C6C^.;FJK)F CDM49<ZU+^FO:)F>2 8\:YO=(D!_#)1"-I F)Y,Q)KD(S
M\LK6[?^P$$N']%$774?SK,8%+K)E[J&8]0L96U"6]...T%I_'-UN+$K/STSR
MD,-G-./*SU^F]+7MS@RZ-4MZ+%';^T=GG/^YD&'Q3P.IR]H"5O\PIM!>,;'Y
M'-JBG%L.G;\ST<VIM5^>M.)F[D_.+,"'Y8=6G$(/O,.!\+OO)4L;]0=/9$FJ
M/+W/($HK3VY8]KU>1^6X<^H6K_GYH[@6:&+WS;B/<W,4Z.>DJL**KW5-YS;_
M\^;PN3R?7C]S/<+:[J:)JW=>D?FE:B[KZ[/_KN-3 $7*'+[LJ7I1F&*FYNKT
M24?7*$4,9$ Z"2^N/L5F,$!&\%="1B\_LD;!G5$#N( 12,;IP5,I-\7F?\5]
MFFM](\1G%$%\QU-BY&8#Z$ .,/HT0NCZ#JN> S]]XP9R! ?@ZV-RDZ<L/O:P
M*@=R9AI35#@C>V@=8A5O:>CMG# <%G*&)FJ/QGB#/!"@[G"42U49#\F3*/EB
MCNE1N?B8TW#*Z;"Y=6C5VQ1RD;E^2+B!?SB. K*1 L2P81\$#D,S3((]A/8^
MV$N(\*# AA(5(C2X$**$B!8)7DPH86#!A@\+&GPX$N/$AS]T$ 3Y@86:83_F
MS+$@ @T("W,&"9S3_V$.P1\@-@ =(L$6T!\_OA$<U*$#GS7#+H"8&!$-R((D
M.V95R/5KP:P8MRJ<:%+AP9,"O;(%N?&LUY<B!2;L6A8DR;EK3YH-25&BV)<5
M30X,NU'M7XI:+]8U2[BCQ;$/]88D,R%" S(#&D0@T_GR9C(1O('F3+ISZ<R9
M![#^['G":- 3O*WV%ILT9M"[3^_VW"#V[=RH5Y,1/GMT:-V]5W<N?EKUYMF_
M/9\NWF# Z]#(82<O'KIY\=O:8^/&GIIU:M^@/8-7?EE\;.3KKY.F#M_YY^RY
MI?^^X.""_P24PP%>_CD0P0057#!![3B3;;3RO$G.O @RLP4/[U"8 XC+%O_A
M(ZHH1@-B#F1 %((,(#+ XQMD.M@ "!"$,+$#/ 8P@H7:&L"#A<QDBX!$/&1H
M0+,7/"A!,Q*!ZD (%7]",0(6?F)A1! \B*K&"#\T443/0.!C#C4X7(TU,X3H
M+@(>RS,C*BJ!G ./I&K,; (VYV"A,R"^42/$Y$X[33H(BRO/Q_# ZPQ1"YUK
M0$<=!]51T$5#.[2Y'\D;QJ&(",I4,H$8J@O3O"R:RZ&0-/)T4Y!*Y92MD$H]
MM:ZLQHKH(U91+:G354\E*-7$ F.LH%4)BDC7DE[=2%B(;B7UK8] M374:(W-
M:RQ=-6U5,4PCHRNP3Z/U]J)DM[IHV& I<]6E3VW_+1966)55E[%/3Y576FUQ
MU0A?>Z?]5J,/0+@@4YHNR$FF0>8(\%^#8K(GA4L^N&".#>PQ^&&KT/!WX%FR
M*$.9.43XP1:7%E*UH8Y@=:C4P()-5ZM/-XU,Y)$;2]G4:&&VR-A>S45Y6WF1
M/3DR9",C>62L/MHH6GPY/79ECD+="&AIX675'LTBC'0_1"M,5+,(<+/4/+ C
M_;'K\0!MSVM+TRX4T>S*(X/LVBZ;$.VMR4:S:^QD8XY1O%O3[&\=H9M ;]=\
M;'0UW KMCVO/\,ZLT;DA'VT\X\)C&\V[+^M[;MG&,]2\80#D!<#2 ;R P=15
M_Z<[S(S#;,*WN=.L 1#P_V@.8A[(8.&%UDBXA$@0<K PBSEX. ($%(;Y1H(!
M)!#C$N*-CT$,'CIC000 !T#XO[>34Q&/%W@ DH4+HN=!>.EY8"#YSV3H/0+;
M(Y!@#FLL=,'X!GAO#0_@&Q#C3#) F*,(<-L-"U#TM1A80WV](\,+7I"B#  O
M37.P0938Q[OW98!]D$K4:TRSP=D]#CZ:J]!VJN.;X>AM4=!!3V< Y;K.& 9G
MM'),7AZ3DK24Y"R%@=E7>)@1L;BE5&>A#$,((S.XP'!4/21)6VK5*EX5!HES
M@>%(F)@IK>10BHV!(5C0XD--^>4NY\+($K5RK2,&C23<:HO(TBBK6ITK74C$
ME4C"LD/'_X!*)6/TBV @4Y$<CD6(10S)6;JR$C$L:0Y\^($]+O"-"Q@$'4L)
MV3"X$3*'@. ''YB#,F9BE:HTY *V %BT0#"(3S8FC4#DB!\K DA,-2:')6E+
M%W^UQE8":Y9>*5>KG(4TD\QR(4.CF<C0>$-L.0LOV;KC0^2B&+A\A8DXK.&]
M2A6>U+BP.*U36VP81QWAJ :%(/0-I8!CG+9QL#YB,]P&Y2.>%6KO@^A4VSFQ
MV<YLLJ=QV"&4=D)SG&R2,W/6'-1 9S< W'P3.((+X=L&9:D-WB9 ;!B=@"X@
MA]5=5$%ZN]L&;1.;!UE()TNR )B L"'=P0T$+K >W,C @UF@P/\>L[B B@X!
MI!6-Q@:.;%^&8M2A"MG 8Q[ @S<N( 04(,D&5DO1O_1T 2"ESSM $,-0R9#3
M"YB4I2G=D U&0S^?_N@%_3O-AJ*PH0Y%8*L,6)%G5(0"LL+-I$#-T(^^=L_G
ML!!PG:&-YUQS'OOD]6Z@(QN%!$57<B*N >.:C+U8A31OO0I<,KN5N0Z2,BM*
M]HCZ"HS.J/7#>>E,9J6Z5KR(YBE8^=)<4NM9U.PRV9.IJF6=Q59BDC5,G,EV
M+HBA&;Z(!2S/5LNWZ[J9TI[XM,FJRR6]U>)C119$-:*K:;4LR;Q@.Q"KV$,A
M]CB(")*QJ36H 6/VH,E/+&"!080WE!7_>V15 $:3D2+#E/_B&;D, ]O,U@QJ
M.%/6$QE#-'=IUB(N2QDRG2NJI)FJ6. Z2&1L931[[<6R3Q3MTUH[X'JAK+6@
MXI>LYLBKQTK@:G+CYM80*V*Z(6IO=_M:A<R&'H9RM*YZM1Q>&RK0L*TM42^V
MC^3TIIO'H1AS<%/41FL,FN0 %%$GGASDK'F:$5:*;9%RG&9&?+4@C_#&*\R,
M/OY3H/^P@1<"PNB862=/%L=3/AAJ300&D+LL@"B1R+! _U: I3F@  BVP',&
M4.# /C<@SX<@@P?,,( L%-JA#!"#"%#0(R/@8071\TR=;7+GMA*5#[H#C3?0
MAX+,M#4;';! _U3X,&<71.\R,=(=<>R'HMV@ 'BPE@T#OK'G/I.!UA>(P27@
M@SP\ZWE2;HM."]_SFN_X>)Q83K%GHM/.Z(1'-8:BE#K?0I:Q $94Q?W++,NU
M%K=LT8;+Y&&U%;.M+E8FCL!2"=3&?<.KW%&8U,I7'%7BQ[\@4Y:,R6.]HUA@
MR0P1,''1",HZA4><>=C@@ZRO'OM"0V7]4(OY'M>W<=7,A=\,,'Q4&;PUGIAZ
M:^4D("LD0ECB$N&)G)%6*4-%1-[)ATUR* ^;PR*' 0)EM'RZ'9XX+8O6%SD:
M#9CUI1D@!4E+?'?Q*DO4XQ0Q0O2,0':.\"YB-%,YQ1X6LH_;!CDTLURH<?I<
M1MB"%>AT&B? ^Q!;H+$3#:NA34('J>>OS.9Q=GK<'ATGFW*NH<V4%>5-P@'*
M46IO\6_>!AW8\)WL:(K.IET'J-[0_6^03Y2AQAE.U5R>QNQ\6)@E*B  D?]Y
MS'IE<N>*K$W;L90,6\V?D-F<F?]YV@9ZML%+9U]3!J"CSP.(:4US&H5 W([*
M= M2 \S0 !W8 -;6>[U-46 #/C=@JQ4B$0JP8P_<GWHS%AH-'I!$&GN P'K/
M(6#?(V $&:0>27!K:TS[#"3<P[IK0#W$[O<.Y'R*V,JS\\X'NV:WY8 G;/8N
M-!YO  '+;N9+93Y,7Q##M*#I6= HM28KP%*%729++8#+9F:&:(8F5.!E60YL
M6Q;LN,B-N6*%LDS+C4;0L1CL+EK%6C8NOQ(LVS30L=R% 1DKMGZ(75QI+CRL
M95ZF4Y3F!R&.!LL"XQ0.AV[KX12#:C!&P[0+! K_)B@T200P)28D(+V& F#2
M"V)P F,HQAZ"P )RP%\^(%UTIB/@I5J \,*&9C)HQF5DZ<&T:%<B+%SR!5S\
MJUA0BVE2BU6>J&0 # ]+*PZGA5AB9MO&Q0,;ZY>(9ITP)V] B,3DCN_JSVWB
M"?%L;-FFXU"D+!*W9LC2(^\B,9^@C,HZ1W+<(T+R!@"EK/3ZYA1%T9I^9.Q\
MI*ZRS''@YD&R1GL,2IW(#FYBC PZSP&\S,LL"O0N*CN"L:'.*9QDHP$PI#E0
MP )XX +XP-,^ VXB+3FN$048P!8. 1Q1@--J[3/R[,_,!/SR0S=L8-$B( S4
MX 4B0'S(( ;6@*6\40*2_R<":.T#Z(ZM@"U%Q  %O!'U[-%X/F,%).CPK@=%
MQJ-VAB<&[BPSMBK0.F,?"Q(;*])XVDJ$,L?']*, B6/P+"\][L-U+(4Y/H<[
M@O$7UVD D(:0U&B(\D5IQD@M[,W;%@XPGJDGV\CAEHY61 LH*R*-)F);WNW;
MDM(HQTT.L0VX:"8EN,59CK!FTNTP?F6+P@*&D :96FOK:,ADI$GKDH@LVN@I
MLR60]&*/KM)I8N4H[<V): F+B"@P/(Z1,J#;4 9B@$(9%&(-D$$F<@(H1$"\
MKHLI"&(-PB2]AB$P^6 #UB +8JX,M.B/]*WHD'(QN(67I@F(# PM!H,LMD4T
M1_^3*\^MCJ#((YR+X%()M0:I*2WSA[0-WYQ.WHJ(WT0%X 2":]S&KCX'G,(.
M/W2#-HSLR5 (()LM$U^'R%Z'.'!CA"HGQD 2VCR*<HZ33,8#V6K1KMA)H;Y.
M<?ICV?S)G')QVMKI/#\C)-G)H1HRH& '[FR@= ($0"3J\Y)Q=<X);')Q:ZS#
M?4+#K ; #( G]?C@JBR@SX!@%@Y&02^ #+Z!IYY/]V;A$&(##_C@_)@L_N;
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M\LBD\BB/3#@((/L7;_&#_(QS/_&).ISCV6C1@QIJVK8#\*SS;@&P._G3,VS
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M-8TUG"Z0202%-5+7&+HX_)=)-;*T$EMA6>)*L+F.U585$,6?*9AQQK;F4&2
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M2WRBA !'3#+%_6;HX\H71[AC9OYI3&2"&CJHLP3L72"' ^WU[$!^1/\73=_
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M"&S(')2X(GQ"'9Q!"&O$_*/0BOM0)"3#?S/!$S6[(=11!D/*FGRX9/) X9K
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MG#<'Y#<JU4H!C*\N94FSJU^WI< =7,(@[/_2'S52$[O:'VLW'P-#"?:N*8U
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M,*B%0(7$6/0JLYS%R)BD67]:V8R<2XIU8C=HZ'0>@ N NF^[3!L8 'M8VPM
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M4;>*A-R<$9Y]'L-X#KI$S-J@:WH55%*@1KW.F7@)6(W.SO]G;$QB?$8P.D'
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M9_?U9I$V7M\R*C]684]2*GTR:O].,24E-M1*=4 )F293ERJ3:@BM.$2OU/^
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MQ1=&,Q(0WW5ZAQ9 031](7A*\U6&1=!"0WA@.SB&U9=!-3*'%]0A\11%79B
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MY?\A[;#=*'#8;*[+2/?V;[JV,^;I2*L)%8OCD\[^QCM+-SL_5SR9<3TS.3X
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MR(PC)U"\>+$B3),L-88DXVUBS@8#,.:<L#-"3(892=;\:/1CT*-D:/8<.7)
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M5A*M8WVN,U)1AGQQQD!]X-<6%6%3F2)Y4")4J4,\3 $LJY,6$(84NG(2MS(
M2Z5.!;:2)M%4" :1Q[)3U))2SF([*F<^$G4H.SD P.>3_P8!3M/2>D[&0@8U
M>DD"*/LW>@I64'&F>D6!D3(600YT9OJW?#098&BF4)!75%,%%Y.W4%I)?SD1
M0":40,HG4OHW%,$S5 ZI8=Z 18-6-:_&5X311G[&1C$D37-42R'0#XLW#"D
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M?TQ[7P 3R",)=B\[ D19 D&GG,TM"85T4QWNF":=^%4/.ZW+#X-\U* <%;!
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M/)6U$>VD+39ZW_=:48#Y8]=QBME(Y-%EK_X"=[,(S3L[DCDWVV>X'G9UB,%
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M63U)6R=GZN :Q+HA0SD6[9MHW[[]J+GN\V9X?'K?Z)V)\?&IVC=.J@X:WAJ
MXQC1K3YG\Z:[==HT3',-_O<N(7M-('5'P?QHVF]2V4#C*42GD5D=&\W19<VH
MJ\V\E&&XR#CK[GPLV*>4?5+O]7"=3WN#92=JVLY/JO&,1)C^@'*SGJ&JIF%G
MZ=UX6&VQ@8">F=R0%16MJOQ"Z (X3'%)U3^KWT[2'BJWD]URL^%S" K0C=(>
ME&(4<^TDT()^\3#[ZKA%^$37]>7U75XG33RNP9VWV<N7>>/P'-<S0&'N,V_*
M=)R4\68,)XP5@\CXSP=;V< !CB>:8R%[QT^47U["VIEISL)# <^+P--G#^+1
M%+18WS:TGIX[WHPE*Z,T ENJ]*M(ES16+$XE_8I@,TLN!#TV$Z-'LP8K+)#;
M<6"UX0/*Z=Y=AW6%^V1K)-2WRA)T%#CH'6, >UCHX)%VB,,COF6L^!T0(AQN
M=.X$AN-"G^QV(()UH>?VR/3:5XV90N%.S11L?,6-JY)JA@T+$:=D94;PA7-I
M&8Z3G5-OXPC*G>1(V\*3A"&E:C=5VHHM\R""VZ$MM-C.C#'?7"OFEJ-33VQ6
M5,HJZ]S2V2B?.7'T ([^. T%C@V_E;4.ULFUUYHD)W@;NVGYE>(;D6ZTM^_)
M1?'<S/S"?+F3:1BDNRD(?CU:LVDZN+6EY9$BJN"73PJL UBLP@N"OCM0I"PZ
M3AOV(T;KF#K<Z]K?S"E\^"!SR^Y[,5/$;-<B4B<7JIJ>GW'YDH)M0#*-WR6Y
M%XN5=B)1<I-DWB%2A7KM*41<!YN2!FHR%MAV84-Z-3;-Q^SNN\.ODA&[(?,'
M#(9'':VQ<;F./ E#[-UMGY^JRMSMUX_0A1.K!+,.;LV]?<;L/Q*8PWXW?UVT
ME.5#S!9.GZY$IGM Q9-GMYZ%S\\+)Z8U8;S'BO"V&BR#!HAR?TB;,6QQSA$H
MWQ'/87QP[2TN;;,35'RG'Q'F#CZ'W$<;;<AQ!"6D,RL/G5\D-L!Q"XHU6.DB
M58PCDM("%((7 IAY.$-)*9R9$S$,RU(1MXI#IFZ.9D6YC3UM(;=^<,3LH%QY
M34MPIT(I_+B-RY%-E>LZ'QMX&HRV,>6%D,UZ%BL7=QE?BI>JI7Q3"D6=F0$:
M6*S83A)@75[*Y^OLCU]B#B&$=O)""46BIVR8D06&M@M@S-ZY] K-PF,ZQ[<U
M8X0#%1FFQ=\AQ(ISJPF'6X&?VKQL!1(?TFD?SRKR=]KJ^[EM)L)4"A&*'W0'
MMP10P/</KO-)+Z.9XO'@I(V+SHPGZ0(;0PFP>(POKAYWJW89BZE27MQ[2A5U
MCX_I[DC$JF2F5H$V@F=G*?^ZC4GRWJ.LQ7?016IZ;XCN/ACWI-H(3\YI5Z?#
M_L@GK:)8M<9Q:/^<0TM_1%QVH>O:&5&<!T-X;[WZT])'C5':Y<#WR\2*]EV?
M"C]UOU2.E6C<YO:F/3$Q_V9:&CL5U&B^XG#W\#28<DF28Z>MP_]0N>0A\@49
MX5>%4!N&/3%2PY2=_7LP)P4]_Y%$3K)+O'KQ0N^8KB4+TYNFY?.$RF.9]T:\
M#_8%'W><C JP*VD>><*DS#UOH'DG(0HX]T2KG5[LS0/I-/V153JBQU03ULQS
M"LR@A[0?V<U!/7^,"!#8AA^#X90D*, # I-:=>NE4#%\Z_=[O$5..7B"HTB7
M'<H9V<C;J-3R:L:6"9W_MCEJ3/VH:(DLMX7O0\YQ.=@W/SF8$ROO/B^$@P)L
M;><[$D.HQ%& 6]!C",'*#C29.7(Y9BGFVZ*#3GRX OEP]"2L J&L*8G_/K>1
M7$8O.0.\$+*SOMS8YB"T?,?RQ%$W6@I6X(S-4TR#&Z,\$WH^%QJZV]EOQU$W
MBF1=TXV-<3%.L![*:E5B7,,KQ*5G/"<&^[M94PZ(DB2^RZH,SY[K1T0DV)Z7
MH;56-DS:944^T-L^1F?Z V\,37=6D+*]0LAQ-"_-ACXZB48!-[B.SP8@JVV%
MBK)G7R2-WO>S[VCZ6LU+N(Y-R_%)+Y;&O_;YANW^:L, %(K RG)UD1(ZBJ..
M8(M1(Q>-:>I/#\GXR0O51(08[;%4G'O*GEM^&DYH9<O^Z.-6X5LK9C%O;6/%
M\8TU7*#"XJZ_CPA!1J6X9WOUYOTY<=#XG<=K,"W\%TWCZQ;=Q?K6XQ2 B(B$
M%Q@K<B<:*5,#A>]"SHE$MR29K(1$A?R[2EZ&6\4_P)069KO"'+GM&]$AD*>>
MD[=WUZ?(4W"G]O$G.9/]VP"UVR259,,MS,J9JPB)0)EB:S5Y-\)JTI5[*_92
MKIV2R56%5LVZ!4L1;UZPA,PK3NIG.BX%[U-^P'&!JKIM]WJXA%" 7Q_ZN'N%
MF)Y>%R1S-E>7ZS[&:A87_'@__R2D1[G2@HIV,D_@Z65Z\O:[!X7[K1#"4B^F
M%EBU?UWOF0*VQSNY&Y2L3(446J!9\"G#00-\%7) ;MCRIX!B$90K/!JJ-H2\
MPGC)RDKB<%*S?"">-<;O!M$BK&"U :^TQY7TT(VYNI)C7R9<55!RK(7>?66G
M$#+'G<305^7BQ3)H;8(7HB5LQKJ,4XX9>0*3WE4VJ!T2../@N)5\N=K,@CFL
MO'RDHR?%8>:CV(!AYI*&ZJLBNBC$G9W2-_Y#TTSK<61FARRU/>V&^"G-^YG%
M-<I/;HU')7\:ZQL]GHW4F:;?99@)%!3>2C5SO7N^67^>=ZW#NR%93',[6)))
M>9Z!74FBM,8U_:V?3F(-M\@E=V,4\(@][5&=2(&-3^M.1T#AC]6.*)R]#.D9
MSC:Y*^!<B0"KD>](FA/+<9)HO5ZG\VF=>.7%3+Q](US702,\64?ZER23N-]T
MWA=K+J3VBSMXN.3!IV:":UT<Z<NK-;Z_O'>;["9SJ[*J"PF&!%L!W><D: _C
MK(L+A,!3T!Z?^<Z0G@B]N",OTXZ)M!MKL#C8?J[@R7=NFH=W L.E;C,H>SY=
M>"L[9UBU@P*D80)*HO.$AAJ\O/=M<>)KVYHF^;\2US0RVT$8M>81YH)<?(\S
M/.ZMZU4!H<3#2.=8QOP8H^=+3I>WFY5/*;D;-D[13N;*1O1),=JUO  ?+J?
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M^5?>%3 %!Y/(!O^6ZS64^(V5.$ZMW;D]1!.]5M.:NG)>&T*Q^#8<<P$>$K=
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M.(I3TRMNU[V%1QZ1=5>:0Y\0MVS39)DEQ$L7J3U&^31J:8S$W0\W'_Z'F5U
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M^JK,35:PE@JT;_"/&J_TAQNZ/.\JGC11NC%J2"!'"E&*?\A(2WU>;:SPX^L
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M:7Z%1 ,(&8'%[EO ??6!A*%;@'Z-XRT@P>PC[$L[D-/W37H)C>.?W>R:5$"
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MCH11)T1XF.+G1ZK6JLHOAP#BO%(IU@>P7$-"#A3(?[X*^*.6I:%L][I5>?\
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M\K%B4O>"<C&[@8?F;GS!%3134\YKO*BT/_7W"N3HOZ(D!-7_JLAM"AQI?BP
MN7$%;>NV^*)G1NHMX*;Z=U*B2=G-^E50OO#07XO32?]6W]; WEY@;Q01[@4U
M<NQ/XL^+RWQ=IY/H&H'E>:>Z#$=(J#+7K[VW_9(4'<XO@:?W./KLT=9O55\Y
MQU6)MOZN>,;?><P=1%DE.'D"<9J1!=O=J;^IT8)"ZY]U8T,H.C2^/RN]!;2
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MKBULRDM;]<'B%G6N(EWL7C#AS=T8X-+#.M_8B(4[J7?B\Z*(P#%B;UG1YR^
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MY'.1TAG+1"N<^)G:%.[^])=.6K*L-%M9$,H9A!5:7HT9W61V"?AVW0^#= 3
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M0:AK*@,(R4N  .0"8W*JN4Z[IS6L1<B2F<R-'+2@;-=9LI!> >X;"W1P^TM
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M>8B=JL>$\@G[P^P1BQ[EWD$3ADQI/#QX,=-]^%@ U^B+:GONG]_E^=XGH'+
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MLTU\'81+/79X<@D@(7D@F)A^BJRIAKX]5_B4O3 U.VV<4A>T@BM;?.MSFY3
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MWQ8#8@"] 6CI7GSMG8[MNMYK$&[[C;K1^B\.5TR;K=8WV+I:CRD_'_.?)<8
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MCO9^XYC=JRK#X=$I75V#0[-# %)")#1+CPH(PP!@*U1T<1T?I(WY'M:^WL
M*?UC5QWHJ&J25>%=\4YVS+%B0RO;$D [0Z1GLTW2#624S9F",2$_3HK-%9Z
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M7?F_6@OIWX^=;S*$-%]#A#/1,^6O>_K3"BHVH' 7$*M(;1?XT=!<9_V87>W
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M^YPF]\'Y^1WA+.=;GK"X].UG<9J3NZ].E_N\%Q&WY@MK37<R;0A#GGQ-TDH
M?\F.T9H20_10'/GD/AM[D=B5<>ER&XUKGD/1O&>_1!1D]D9DUFJY<QKXV8%6
MZGSPM20*I1'.A,<O%0XB3I4W0TBG$F6X2<;D>NN-M>.?-82_36"5>-NZO*$7
M!VXX8;M,6LI>'12PCX*1GJ5SJ^B&(>TS43)P\:5J,=&R"/*".:4(Z=?I]8Q>
M)%E=(&Z%CH\(JR9V%H:/,8T?)^4\KB;IZ\H;KWTF)K%T/'A_,$#$3>6HW^A.
M Y=&E56Y\G0=7Q2AB7%K]KO=-.^A<GE+'FZ%EL8Z<T?'&&"4XN.6*_,<!J <
M_Y)EWI\/#2<LS8]C88JG(4I!1(A&J)2:H6Z4#O##Q!6Z,(!*3>D-Z6@^L?.>
M'V]:RVUX'O:#*>H?_IT@VPR:Q?&^ZG#*QYK^ASM+91,1=PG.:\QX\0WCT8FO
M03T%PBC;<_17Q[Z$3-BS$K)U<L;+>N%W$#X@3E MB<2-'N2R(_$W$D>W4QI)
MOU-8)6!@OW+CQ;A+$>Y>BXUA<_(G,+'^3)?E9N@+UW9[[XUM3Q0L'D'O57IR
MJ6G;O(Y:)ISN/F^>\"058T2U2V%_40O;G&/C'/F<TTVD<<=;#- I4Q(.'%D)
MO\^'..'$(!05>DOD;.,Y>;L(G4C>;GUP;797%>)9V$FJ\ZWE;H!NWWB* ?96
MDCMJRIN,3B$85O/SUR[)0W*^\ 9PI@2W=;RB>U'GAPL\(-Y;G2(XEH3;)Y(/
MUNSO--*_0713R5#+XWKA/[]B@_188?D1L/L1L/OG W:_A_Z#*PFT.&<G'#[,
M?]A[/^D;->DGA2]KLTO^))"=8M.6Z3'VDFL^_UVFOZ'*S_E[/V4:925+LOX1
M^8?DWVH'U :^Q5Z8/UR<P@#YX .S4MV?$XW41D[]@?T\_LQTRAR,1();#[6E
MOY_'G(AU/L-\4) H6RT(8E,BHRB[@NK*3\FN)78D5=-;0W::XAZ_1V+^F8FP
M+!FQB0'NHW*B?E5+QE -_!%Y;?]3]$NVJQWD>]#RVL"I?Y$(/M65B@&N3A\O
M?8"E5& !NXMBBR)+?WPW]?/F$S4]6ZVDGF33I:^_J6W@CA[&OM%*)'.1W'=_
M8D*>*4W7(YX<&RO]K%>VA.3/=M' $!0!AX9MOU_3-6I81WTV8S?;.8',L)TC
M5\P=^3Z/RAA^\0X?2[XHR[XG]I(.=N5 \107$!]O8/^[L*=TW9\_ORM92?NS
M7#2&Y6<C"=\(&%H"#$=K2@SKZV"?(P3[')K_[UB9"%^;<A":1-N]"&2CKK0)
M\0ID>:_ZC\2[?RD'5L_-_J6Z,6#W5-0?4:'Y+8I>2ONM0*S/!8?S>T&P9OST
M7BYZ0RN=]JO<2OEWVTC_$W3CKZ1XY?A?B?DK\9[AWPN"<V55C_/1)Z::][]J
MO7R )2_?O,E9VR^"<I!+J>JSG,QV8@,#U7'*?*&SMRS"U[O02" CWITY4;7M
M?H?MH12PW8%OH[!"U,'RWD&G-W&$+:O]D36PEW&JUR 9Q0$EP  ]8 S E(X!
MYLQS98@#&X4?AK^60H4IR&=^()0V,9=@[!,#72G+=*$Y[:LI8FKU+M0\.F;N
MP(_!+?=,*@MZ^V[%B<X5F@C<NG>5XMQS(-]2W29"9XOW5E5<,9WXZ-/].^*P
MO%1^K$D=RY&-Q\WA9W8]^FNX4.G%-/PCB@$#2$%0T3$8(""UQ /&4J""I@"_
M@JQP8X"(/@R $& $D[HRLWZ"$8"F?:71YK*\F_AJTG?,'2Q<".+ZYMC]PW#F
MK&&'@7%O3Y/'Y\".E'US[-B1%ITG@\;1$K.RP@=YXRKT2+W]AV2B35+M]3MJ
M\_3Q *LA3I^:'(')^?<79*1H5Y]YJ.E4%0:5$%'<)T=GGE</+2HP]!M@8;S/
MWTWEZ*)3H>_"J4X96[?^_/SSJ?J;5!(#!1Z3_W<YRR-S.NZ>$L*2TH&MFH I
MGNN%;S:B&(,7-4)3^FH]QM]5!EGYNY-75_F.T6KP%PN'X'BI13/C1E30' VK
MW,:N0+>J"YKAZ#YV*T1]1;^58?U.T=O(X%U5%<O2( Q R/T)M$N) =J?09!Q
M7%B8LO(M']:6^*Y-'C2(F3-:> FQG_?V[KZCWO^3V']75>G;T6>>ZS>*1UH2
M(7AV+(=7&5_\],M]=Q"\)=6%*+$@<TF%[U6(6(",SBX5>Z"VI&W)+YN/&>W7
M[_HLV$E?IGX[\[(9$/W_7LOG?3%M$@7[I08:JL/65]G)[RP6+X0=2&796I$_
MK;L6IU-2/5TBID#5^F;5LQ_ID6[W@9I?35=T., VC/B0?JP<8KISX 2I=I@L
M__J-9:40F;$S2R.XPN>X0<=L6QMT,M-\!Y;Q#J;TCN=W!?(E3Y.WK4$OU@BD
M*SP44G&XOL [E@$'S=SU 7GF(=VYD"]T;XN)OF*#A,J]\<0 KD6@=*['^&[2
M:GVEB;?TRX2N6$PXD'I[J6YG]GBWH<SV5$__)2NXDE9QSM37=C7IFOV!9:)[
M1WS#/M'K3#A_O**UZ!&[=SFR<K8R_>QU\'CV5:N("Y('ASK)?=7L1#+=&B7Z
MN81O"ZY:AE$_Q@V>.:)SIGNJ).Y1*DUV__\V&2JUD)&SC/;W<X.]O8.<Y%"?
M=@P%:A"&^M(VN'Z^&L2AHKSAKR%L\AEX;]1TX[K];:$D=\BJTH='^[38_#I-
MV^DWO>\1B;)'8@"?F%GZ(T(,L% "12F)N#,BY4=8!EM4\BYZ'D:E?Z[V'%33
MX)^TNC?$,)T);GC!$\%@K4-BMP:Z KUW*I"=61^+\.R*]YIV45.3R2-Z_I#A
M=Z$VK49)NQY#[RK.2G C[>C-QM=X2;8XY,,&FZV>N@OUN$I=]>W:Y6Q8Q6LT
M3LYPM$P,2/_\EI;HYQ+!?W5Y_X\NB7]E>?[HDOB?0/]\_$P$Y#_&;BY!4DEZ
MXSA(G8N!MFNZ!K05,>$\5V/5(!JSKQULV^FUR,!'D!"V">UXN=$%.7<D]LMV
M^N<ZQK[0@+E;)[<NZYA< TV(%:)%I4W4="=(,F Q2+\<P:B9W.7@<,89_53Z
M#3@$,3F8.FNH?VS52$&YZ"W/**F(/H)/9PDL@R_O61QH7;EKT61FR00<B'')
M9N% MW(J0?8S-G5G>^,-$"8AV<$U+&C;26M2)Y$C.(C4:'J>^R*SKQB(<P:G
MP.!0:\69\NI,\D,OR'F'@CLS2Y&+SP[&BK,F^?P9Q#\5<AY&@+;B6I"MCGU(
MWY9N$3G.\OG>Q%"(M)[/9LN,#4]K#C)>=\1+?_PXFCFR7=S=@Z3^W%9>W?DI
M><!\\M%E)E #V0U)T$7M0\TM[S@#T"/H8"RNLLFQ* _Z F <5C![>&Z/C0%O
M<(3^%C*Y/@[J,T]YR7^3HQVW^U4$69*GYP*$VWE5XC*R8VY:->PV-/9]6?QB
MF2GCV^2/8?LJF<9[ C!G'Y^ZS,P)G<FKCLRW0\7#;#9%O6%@;MY.4_O.Q.([
M-WAOW03-L<J_N)4BD3P(62!UP0 &C%BC4,D5BL=I8T-&(/F,YBISAGRS&Y_-
M"VXQ/LZ^8(ZA)Y)\_:S),+" CL+K-<&^-NL -CX:4X TSDX49Q+R*1%!@D(_
M2S[85T%?+]X+\S6ZVKO.6//0PH[L08G7Z&BLY)97&LC763OK:Q$5/.SD- ;8
MU@.C;WP4NX.0E;JB-"!J&V%DT$DM\S8@'(>!BNF#M3CT:%>XGN06G-E_TY:$
M=)RM0SKQ<RYYDVG4U03+UJPN\TDQZ5PBPL:#L7"<8-*+@<Z48BP2X_Z%B2B1
MC"^Y2-]/'7A<??>J:]_0%$G4GS)?O=5)K20S,3XU+FUS=N%]UF738?Q:LJT'
M$A;EY8.NNH5.-EM5=96/FHJM\=7EQ8%\;E(DH1Z\.<YPTO]&V9.Q/OW*!Z]V
M)U\3=!>J?-8N'T4ZW.ZQ9![(6W]4&MG.SM":\+QK?GMW8\2^4 3I,[_!KM<;
M&I7.'QG J!7QR(<,IPL06Q;>&(L,5%1E1LK/*08\B9>J?%-C3A4]4L18</-<
MF.6,FWDN,F".M49\-MI<>]3!%GWON6C*U8C&">*D!6UJ>%AC.7CL(BRR!3&>
M)R,LQ$KWD-'$+PL@W9,87-,+#<M80^28"0H>2/$5?PGF,9@7%I>5ZN_+$5K$
M70XC09IK(@QWBW1RBE22GF4\(G_AV+ZPL+/5D(Z@]+$#GS.4IMW.&!4)=-1Y
M\TATYC4!PX1V#5.!]TPMU^:F<'3+YZJ:SZD3CU^GA:JH"Y,O0$A=C4WG7.+E
M;/<BUX>JP]["0A:+>NR 1^G-3$OX*:X\")JQ9;^%\NH7!X(<#%S*BM?H69DK
M9_UFV,L+\&?!?@4E%A1+V]N"@>;+ZM>M[[!Q6<N)G^68]F6ORV=P,<.1)H\'
M^=LJZDX1AABK^#X6_E:,)_'J4K,JU10S(B-Q5MXBK<YK[8YU7OO"]01CJBX=
MY\$M$M@^5GC$J!:'/IWE:B][@/O8[6L9>WGVB)FVL[[.M+XA7JCDTEG-_84"
M/N]F6_#YO2\W&AL0#4XYNOJ?;[P^?&EP79!O&&^ U64(MS<K1\NY)3:KK7=D
M3=!!.>TEQZ7<U^)R9PH&/;0#7+]VTZGJ1]=<P@ R\D;C1DR((+0,3.4(KG)"
MQ22MY#%#^M[W;M19+3Q>H9X]5+/;G?1IKLSWH],IGR8^1<SW6^.3[S0/^J'4
M]"S?I=@X\1._[)Z4 9_$U9K/:KWG=J6)7AQI-V6_Z^!\J<)X/,&=G&S7'O<-
MLC7KL*HN.2-;_</M)X]$-U\&TS>\1 ['7=!X+85G+;5AR!WP!$**NETE%SHO
M/C<NW<6+0\"SFF"*R,, 9/K2IG/Y6E.GQ\D<U/' 4A6(^YR&]4<DG[#?'\L*
M=&\6'QVD-U3 MCVU/3\K$/_L0(CB0'7U@Q+U>%M'ZW,SN1FO%[P\NX5B<%#0
MGIRKX:,XWVPG&_-;3L2179LIY>>LE?&_A+KQZ>WHM9$XO@N$0^F0U1H0RJD[
MF6L.T4-#39(7J<9NZKHCKJD8CE+MDRVRX\"F_JJLQP-Y"RTK3H^NFT?;K0L.
MQ=A#SUFY3SO8O+03C.?O$]N.>:#'>WOAZ+P-+ ZQA0]I6T[# ,,3D*YW+BD2
M;][EK(GZU$5EJKC9'U_U)*R$(4G<!V?IKB(VJ^<4N]FFGEE8Q)8UFS^7XXRL
M?R1BW!^:Y%6@+D>2\K0PT10.#MP]UAIXW&]I+'TZMD^:"U]=#M]Z==60Q*N.
MR4AG*CVZ^B73ES>O6)+NQ+PZBAPH+'!V]]4X]EPOK@R<TJ6DTN#@6V=?CD+0
MY<[1DZU^7-.V8J$,)_.GD4D6/L[M<7,^BMN%!(+'Q_F[U\$;G&_C-^@?[?"$
M15+O8RW,HF1GA*/85HGT/H2O>TH,RGVKW#38.&$IPTH?9\^0? EZ'@/,,J%[
MZ] 3Z*'MFJAM].2219=3"WI/94XEM/#Y'D4O?[QO.4_6\;WVQHLRMW/MZQD8
M7\;UQRMZK@UH=T5/D2"TJI\+7%[GXF)X;7FQD\UK?L#R:IRW$H*B=C9$Z96#
M$*G\)8OHL4<*"71W6%'N41+]5;BK;&P9,:Y5&9&F[D%%E@_E;R_?<@!LDI_/
MU;G6(F1JB8M>AIBK;_?-?O#:J*\W;M7+5JAWHY5V_3)'3PI&AJE';VYKC^B\
M39U\$^ "2"0>#Q<@%37<\&<CUH[R=NY).&D^?O'%:UP31Z+BY!GKI.>4&E@(
M1L<P+*:?]2I:]_'.6PXMZ\@/+^L)_P][[QW0U);U#1^*5 %!0(H0!!0%$140
MD1)0$0&17J1%!51 I F$&A"E24= D-Y[Z""]25-Z4WKO):&&$)(OEGNO=^9]
MYYEY'^^],_/YQ_(<P\[9>Y_LO=9OE;W6R'ZLV6U*&E84IW"?)N4;,^,3,<[O
M0CC!P\JWK^S6S0>8."EQ2.SX[M6H(,,KG-)']&4R31F[WY^P]10K'6:2\.+R
M1;,JVH4J%-G?_]"5</:VG)BLL$I8;?$OV3#^ "+XU;>6]9LB>]W^[K^D03 $
M3UD<T46977^C7+;WVCFH&0=(<'-,PF[%W36KSQ4&TZ&F-8]XQ2X][!B&!GSL
MLI^^3-07U]C7IDFTT,8WS_J2AA[*.R6:K) C\1J3&T!Q8>NDG-J6\#*6 .F%
M.7G%,*6COX\_[Q1EK:7C95"LK.$V_:NU%9+O(T);48(XX(2+$K9, /M"YW?!
M5>&HAU-L @U#_EM?-#]M#>6]QWNBG0@/5>QYB:'*N.^"30K_QIXS/WX4HY ,
M?;G/]T5YEHV9<UWM?;+Z>K_V84+:I6P2>!UD+P V3'.0H0-BW-[+?OK>Y=30
M5<]=F]M2\^^9IB7GX;WCT3C@6<WF<1Q0 MI7348UIRAQ7W'-8@GWY.]Z'SC1
MR>OJ%;SGV+,/6%73(H1QP$OB0ADANX'@R[*1=8]+5>GM.8XX!B26\RM,K&[G
M1(=J+ZF,R;\LN]JU9WS@/G+#+ [A%0!W/E50&W2R/SJG*N'!T#7+BZRDZ<!3
MB4..#]X@M1HB$F0:.HU/B%D)&<$'^6(ERU(8&(N)FBM%X*-0&QU/[.C'TQRW
M/))]1F@Q54B(0C.G IT<*XDLP:N B<&3Q]PQ#%E9D.%/,M:A%PS/:JDR<,<Z
M7B*5J-"2%9-)7M@0.LW(IV"M(L=#\;)V>U6+N(M=#BG29#.Z)/A(\RA]H=M*
MF='EBS6V//M)J1+2.]DP2F>Q?G$%\YW."V=7.JXJ<(;H!:[!TZIL:+.'PI,S
MUW3,(MW.RFH:#FX*;Q_**;JD&30T''_SOI1WO"%P6%W&1BQ/W$(;)9/Q<:@2
M[;)BC]59>U19R%I:X!<$NZ W^!RC:#]I;BH:%K?RH>[)7>[)B+?-NUZ7X4G+
M?A&3,,\U@;5S<P&S0PXZ5V.?]*G>OJD<?]=&?3)GBO0>?7XGA>)14O^^BWD+
MTC,L+M+&)E0O_!CM)K+/W\AOHJ2[ZN[>FK$L1?$X@--GYO&D>GYSL8R]D]D]
M@MB-.5:H--&'**F7<;>BWI<CP5Y#/<;Z-K>XFVH)[$'B+B9ZA_7YIEQ]LDU+
MAERJ<N,+]23?F7!)Q>]/MML5;UIX/#E1C/2,D&C,;Z"X12G'=4B#23S$4:L:
M]OVA_+YZ+1WW')E+HG3: S=']8^3:*H%U6YQ]&;6\D4BUXJ$E,C&Y 7G1F@*
M958^T(#=B+$,O5HOG?4'% >J2$*\=C6MO*QP@.+QASA >G@O*E*,0WRNJGGR
M1HDP#=6E&.X7N6=!CPY;.Y?,PKC*#/.(ALH.!.O&'Z,T'#+(1 PJQQ\]G^:?
M36N3:A:?[1##(SV>R;&2IY!C.NM!)XN[]\4_+6ZZ]*YZ-DM&9B>M%9%VA<U!
MOM]\O68??G?X=Z 0);4)/XQ2W7]G+UAGR%]I3D%J*':>^&C >:JG1S&<R.,J
MQ^2*]E[#B&W.\V#1RF"=&L1#[%5TW($EY("B*B#QO"+!)G&^:2QK_P>+^3N0
MX=('=2#O"8\]EETX,33!62WA[ 90&A1W;E)6<?2U$RUZQB[7<)H]AG5AAR5(
M95X&''330+X@M'6'#P<$LM2B)!SO(?E'$^[337TL$:PSOA<@^2+=8"6;-!G5
MVY@UZ4*P-FBF?].YXND3:>LKP0NDX*!U QHS\RQHH=[&].:Y];23D:^WV%HE
M -"!Z0KVPGAE^;:_Y_JHM,6<X4':?9J%Q))JJL66J-L)&?3L1H5D#-XSO&ZW
M:1+XT4[*!XO:AV=0%ZS-=R6+*3H/WKF%X8#J4B*T%E4N"J:.2$T/,J *.2PN
M6-]L9EA>2LIQ0 9/6:9IC*7O=59CJ'3TBI;L>!><>)>&B]C(HYEH@WY4V!QH
M1=E,12 9/>]76 X.0.7(Q<NG9PW7+&W6))8+LMF(ZM!@SY1P_2O,C'):AH5M
MNERBBSVEF?VKG[.7W/JGS9W?&9ITCKRXY"8R6M<Y?VLC!X;7ES-;Y=O=Y7TK
M9O$8"0H;5W?0K!D#[?9K72$,8[!O*\8B\'-,_]94M(L^/:M: [[K=; M&V9V
M,(D#7%0ZW%)D]+\U$,^"K-/L+P4\/<3+N_Y+@U^>;!-_1D7+^6N+0-[!_08L
M.BF&X.^[/KY H:XQ_JW!+R.8EU)-S-W[VH#]VPA^#O&7(0)ZL.9$5P;YHAGM
M#U*BK&(VRM_&<<O8Z/_P$ V]?[/Q_P>\XC]@B)G?8B_4L5_;*?GS-[HE'*IP
M[HO>(BR>1^.WK#I# J]49R09U?8[P5\>X)?]]Q.)^\]]"_^A0_3L/8"B613@
MJ#U8PYY&>L@AYR9IB]Q'P?P?GK]EK<#TBX]MUW;^;0<:_Q%3^T\8XB_Y99]^
MZ^06(YCK$=?[9KV^-BVBBS_%V1\VQ"_!%?UQ7QNG<=M-UMU@_<RQ^MT\OSDO
MLFX8O7C-3$;*UL$+_MHL\6+!_V%NSO]=+^;G$'\.\><0_T.'*/VKWWHA&P=,
MC[@H&C8%G?T"QOKSC7$ .P[PR9Y;^_MB"HM?BRDP3(\S%<7QJ>3W!]_^%%1W
M8H79 ?2:![L'OY=K.$42>I _,;P09J](>)!X[J)U=+13V B8)9(O7E3)(ZID
MW^R \\;<I6.TA$Z@L#P) DK\O+1B4$D:YO;OCNVV*207A+T\J-N +QQ2[RDV
MBV&?N[.J31)"SO$8!]CV!?8^DZC-&??2X5TV$"BYHUY<!4??\O!C2S8GE<S6
M"KPU(%)^D\8",?9*2(E:V^1CP[4C--B]V1KDE%E+];DD ;\D;LN!1[)E(PUH
MK;=:D1A(-_O\[:+^2;_\DE-GO)=HRX^NT( 0O -FHX3C=7L]2N0C5\G&&8:-
MG!CT0/-[6O&#;A@)Y&-7IOX9A:9[::- 05!%R?G]G("J#JOE<<*J@5[EPIJ2
M8Y<BE-O)64N3G@&[6XG4"Y3"&QT)G.\S]&_Z,;,\-.8JXQXL@:XWVUVY'6%S
M[][3@B7KW%JNO>=2V_<='[*1ZDU5>C6P"$7A ._LK:VK+1LDKP,G_:R;)<H.
M;F:\J2@@&H]7C27ST;X7<1L(W'\($9&FU-.3(3S"(DM&OAAB!5%:NGO.'YH)
M$([6$I6VF<VY"&"O#D"V1\%;)V1NN]E>2:M?IUT,][=F'%I59C0N"0H'G,XS
M8P3U4I[=J5I1@)W-USWJ!0T2)-CBUNKKGX0=%3\E)*%NJAF\FE]IN)$Y>3^4
MF0^U(3N]**]<DDZCA+#W$N)G552(8:[N.:=\U&[U;;2C7>U.[6(G9[D.TN)%
M+!^+7?Q3A5:RDG*+D:,=K4I,.U08Y+*!_[0_1*6K4O!<0NK9!]JCUR*/Y)%!
M>=*;N6W:]72*:P?[S8VKN]?-3]C*/72?TGKB>^=FYV04<OP(YDQU]U:K1?9Z
M^-X]_0W968?']+9<H=&:I<]<N0T@RTV]!A4^]R+)7I3P\E9#B:?+6F:VFW/L
M8WD'5I["J$?U]&\GM?N$,)!&,@40HK<QIYT+M(@ZJMFA:(3I)?2YK#.QY-X!
M8YK["R.'5&U:)"2L99RHG+LG%4R>8'23&ZA7<8"I?T%\"&'>?>@6$%=?93\E
MXK,=>%CFWKDW,WN"$7>8IT8T/,GF+\\\+#64I^M5%JG4C7\_I4]5U+*F.2+'
M6=BB94=_'"$6/5T&/X&4==L6()5E3+& GN/OKMV<AO G/?G$++$_OS=HA5AO
MOFCVTN9AMG[S#I+CD1R%>Y?;I73 Z)G@\J:3^CB#\!L^"PJEE*(VBW-MQ-['
M@QCZ7X*DF\ L)Q_D$H.H,%96\&,]Q9=H'.B=IMXP;:K?/3*RT< 5/^,BNG4%
M$?>"L>?]]/5((@?+VI49HH ; -CG@&\THZZD&(#3(R%NE8H9T#25JJ)>Y_<.
MJ?RL>T@_/T?&=B=]^EE6]\U3Q9/M6@V=%*;A-0]-W"\$7H!PV.XGH_MS>.IB
M.0;/RJS%W)O7#><%=?@[L$$?D%2 _7  <C\9-B@*BQI40J1AKWOC@.7*N ^:
MIGQ1M4;.0HC8TLF#!VO3Z@4;G"'C]TNC L-'J"557?AZTQ.+Y=MJ&:8@3#4S
M3SYG_"7& =TA6B6#?^,H5%.[RU/0*[->QYHJ0W+S7-2$5>QS0I=J5=/ AK@C
M_HQLMNR:*CN7RKP-N1PM+ZS9NT9OY0Y/YF1"G$5#>B#;-I7=(MUEX([*V]>C
M>ASNN72W/&_FG"^[S-$G<;9VR955.T:V^=+CB8)ASS(;OPU2_!AJO;,[F7!
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MZNW.]5QI3[]-&L.[!< HYJ-AX/=L^O2OZ/JHCTT]]"I6.K(X0&MB5_,(FO+
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M';DYW0\5P?E^OK.NG*@2")7)!1DCJ9J*L_GYS!M]+G/H#0 '+&N*U(VJS/?
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MX(]_EX-<-]&[J:T66E-7L\<$QP'+O3C@H<YB]0582Y()#H LXH#$&?C5Q)"
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M,8JJ$'<N"(W#=,'-'3+XOZ.2W\:N@H2UR?' C^>?5E5['A&9@)[N"#6C%CI
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MVZW-I% \8(F^//F.7V*A\ /M83R1'-8 <M(+]\\"I06(P/H>3D)V8W'O[I^
MPL#[.H?F9P11<G;-(/POI3&?_U(:0Y?\&_SW;P;( EW"$*S/2V%,(#J)V%!_
MQD7(*4V5V-E^[*G!8 LM;"4;"CO:A\7!<Q0IM\$=N[1SP3F_NI^G+1+5%&=1
M^3_5'SLTYFL<+U^JKGD:O"\CZ4]:?,P^1>J.;FA/.9!4X\QUR8KCB;Q,[H^S
M>7IF$(WIZ3S)D$(KII+4A<"2;4FM'BPZ;WGQ+_PB/RRC7WSV<=/N;#[;+76P
M3@+QE23BC$YU;J;@]M&V"L=4>/-U#+1S[#WT&BI59W3>7:+!_U8'^(6..^-^
M2[3?=>]%4Q^YT#8O\Y/OJ0(>-:3-"N)RFSL!&9NHGBY7+WA[L/$DE3_T>K!'
MMRR*O%FIK>WD2J!"]%/]BA&I4[$CH:+=LMSS00)](NI3[DA?7%CV#&7::><>
M3U=<'J(1'2JG>'TA]%-9")/B[]DM*_-2_9SSTZX3@W]-#$=S0Q!81:@0Y=GV
MWO_IW?!'4^7EBPG(NUU.3M7/&0Z%G^ORC[$[JW!^PBFBVNVTRV!0=81WG-I:
MSFU&UT]" M>2T!DJQ5(@U@U._@P[-P*'J>HC#X_SEN0CDL/Q,AZ<Q/HQ>B]"
MJVJT:S(?-)WF^NW.]HTK'/;.M1U"C+8"+A%&[&I F#HK D<M(I[CF)2R]2"/
M)+.Q#"0M+B?5P_0AE620V3':)4N%E\MN7(;)"(*0Z:LX6:^O7GDA'3(Q3V2C
M=#TTT%;8XL-E_BDAPTQJ'*/:4IG %J+ZY_'QZRZ1T=DB;_$WQCPT5UP4;$/&
MH@)] D+0NNWS7/7&AN4K5;5^)#'H>[Y].]=X76=8^W;3=X768!$+(!B2/ /A
M:UPLZG9>8'WW!G+)(C8Y8G'%!<0!8G?=6KC:^$PVHE&"MVSY@YC4FF&ZNKP8
M*_@ZSPDR?%& .'O*C^!6*1=X4^!%%^G(9;HOWG3*>@E$_<4<>CB]1,QZ1PJ.
M,]S$_Z&$I1SL>N37QGPM$D$:ED]1;G#.?XS_>C@PAGJYQYG5G6(S>[0*#\RJ
MTUB_$S;YLO+"?TEK/87]$6FN!KJE/=:E4DHAR4[WEA1%5< #W4W3XX_%TU F
MV@7[$XE98ZT3J[MM1V=@A]/S)8,.8]@5A-&6@OOLV/,!_KA-Y^ -C/!5+D"5
MW)?2LMGK%X:JN+^^N3B?F8\YT.3MH?6+O-@BBU-RX(3?/9J5@)W@/]#9@@9-
M*$MZZ>K4VEDF;&&*VZ":0>8#D2$8FSI8]+QPQDTNU$!N4O0R_5P\]CE$T%^N
M[ZA_DK^C)?2Q5\E]A>]EKDI-'RNUW6H$.1^P,_61$'V*^;!XN,S%F9F%?8JJ
MB1!-F12J$Q$%$W$W/N;<][W29W+<[>)KTW#_-'-)MF,!<Z?P>\;DEO9GY<T/
MCWIKO=(L5U_*R;.']-SM83^K:1=CU%D2H]2">JUI#\BG\,7':'=K]&HI82PP
MY("BYY_4Z?EK,$:[9>7ZL37!W2XO7^BO]9PU*Q_OP49K&FD)"G'HF +6SH\'
MN!:4ON&^7=A<@4VZCG%.K( Y8"N>?[8\'6 ;?= &##<AFM$32.I.YAGY,&F6
MN3G"/L7%=,%$P\F)Y8<6]POR13%E&<Q#A&.\:+9'R\$H"V".]4_"):^#F;&/
M1;\MU;G5YD$LQC[VDY?%$49RC7:+V@"E7% /)O-CK!YWT_:_2XC)D<9IG>\N
M?Y^0*%YY+4S]4*+[B@!QT[ R'\:RT^"]K:,'RJ2.@MW@9D6=_"*GJJ+;D+-I
MJ-_4DE-H_>_W\+*">$?/8N.JEX:_;T1$-^Z7^EPA\3F\T336]@3JA(3>0U]N
MC-N2(+[V@>-Y'G'N)T_NJ8Q;\X&*0DMA*3@63.2)!T_;>E)S4)REY7J"TDDQ
M) *>I2A=6ABA*%NXU<O@7T#S^XL+XYED;.XE"/D!*-9#T-'-&"7>OW]GUIWD
MDOQQ&W8+#[26Z?SVNP4KO!UVSMMJQ3%A8@M^4 +N'";],O*_WZX;H^[C4;?=
MEPN]XZ6.OY?:B&RB9&YM9H3//NL7((Z&D/O1C7J'WS59EV.F"SIUZG+SL7F7
MOU%Q:F23Z6@7#D]D>;+P=!PG'1 )Q"Q=_5V67Y/&%*DGL$@G>;5MQ44HUOPM
M[JH^B5T(U_K'XEC<D&G^7Q\ALW0CW3-":FWL2-O"V>$G2\&QF6JO_!,JRTUS
MZD:A'(<W6PH>*2\:WB:R!Z_I=ZN2!G=RDC&./U9AGZ]>!%-BPA_+GA5\.'Z?
MDTUQNL]/7$C>JE_P/GMSGG,L-"S9Z=CW45>[D^W*T>H[Z6S"\X7",;=5T(H5
M/TKM?[CR"#X#_W3CXNPL9@6;?3I+G\L)E!^@;PVXAEK+/M[EUX5"/X=2O/]@
MR*BD>CF".VC<@W%DY*]V>C)1]9'#\\%'G?&L@UV^F36-IE2Y%QW)7$?$32\W
M(2!%H6S"L(U>IZZ8=C3\2-RE^RZ9KTO9Z<9?[7;XS^E1\.][6=)3OK#;$3QA
MS^;8(Q^'.<>I4RE' JW#?HS(/<HY;=?<33Q@DZZW/]>X"1:*<PY[J1!D?/C7
ME/'5?M;[%9<UVTBSRRT?8UR1'/K+0_7#N]AV+3XF.Q?=)W=H$X_*<R*!SI%&
M,'(/U+>VZ?.LJ;'!X[16>-'G]:O,J?09PMW"HDVC /@KQ^IK J+9D#8IB\ 3
MU@W_+E=SU)=&QG4R6,78&Z[EH50GSIE*TV@&(MT'HVX7;./&]M\?&75\VGEW
M:>4L\^E121)AJC_O=8A=V6(6<58.OQI??_I$BPX/+ BT!B2/&[=QE%7IHX(K
M[P71T#T$6-@S=+3^5^LG]==#_S7Y]EY"K@KG.> U!UMI1@^ICU;U^NG7'SM+
MXE#[7V!O8='0QVIO^A\^W-FXW]_VW].*]7^O%JPL5(N9($A$2\V,[F!QH];Z
MZ:C_HCCUW(R/K_X%PZ,KZBW(:' GZBYUI>UQ&O(E.E9ZC"0*1L;H^7"LS.VS
M @4%2V.)(;.5?>WWD2.>1/VBK$O%#@B=F(8"G8*M1]['B8X'W/,_/HE;],?Y
M!,V7CZBP&H'"JF(I$3\<<Q'^Z:SF/]T/./9_=;MT'C.6$"!F '9%U;35>#XU
M&<IU2K>5O.W_Q2*%GV<14N;!\(B4F1"N4]O AR1XH*^N!5,/03[!<.,",T__
M5(PS$SP@T<?L#3;;<&&JF$3'8]^7:W<R+"$_G1-3>(X97;9&$6?3N^6[2[7!
MJN&1>M1E"W%>TM(,1#TU[0N7&Y<LLS5JV0/YXL1,+H9_70@55HR55C4\JZZH
M"IZ\+$_;'L2L7,MQL37 0'37<,3M J;C#WE:<[!K$CRR9]U'RDWP5>50'*-8
M,&2## \DNL+0[@@"T,RQ@N8DL&$"*^!;PP-+FT^1&L&6\:9N)I)QJN=Z<["]
M^IV-K$L51W!2+]].R7?NIH(4[P)[/O;+<X8F!<.4A5PB@=7#O7!EVM%RQ7-3
MZH6?)#0V-A])W+CDY2#W-R?N%#T#!%@ -X:JO\SV%;,&Y)Q0Y^1-ZQ+$1<$<
M#X%I1J6]N$HJJ+K1<U#LYL^L.RPU/G;X W9C@DR(\_@5G8OW2UVC%C7@Q3:.
M<EA15_$6E ELG\!XD_4@[\$E5ZRPT&L6RYI@N9>FE=W9#+9RP(NGA-%^E<8#
M%!OS_,$L[N^ON\15VN$!KUZ]^)#^.!CY5$[@K4-3T$/4\2=AJ1+8-T28*+TO
MA!\NK%6ZZ]F*8T=+[YMMG7DB7M-)T+5DWK!0Y:$4(IJ(73>E8B#JP@/M^2B-
M"R+(_FLGG&A>"-(I>'?&Q>YQ(A[0X8OO6?D)K<@)Y*KZ5EU18^Q[V\XQR[R!
M78!68YA:T.>O@IQ<H2"Z *J_1/6P??ZWM/QC*8OOF8]\P?FN[U E;5KB279V
MANS(PB3XBC'CKQ$51K<+F1]:W[1UE$>O&;MMLFLRV$[%%,Z7$?R9JQ&<X+[(
MH4]/3^IY&^Y[B]':O0<_K8C*+#,?];N5LZ$_Y%1@7V',\_[KG?<'<H<V$ FL
M#I0 )1_2D$,P1=_MC4F(C7TK'5A^X0UKS[QE3,%'..86(4ZB!DH-_0LT]?)L
M!^/%R890%65; L3,QJC8<*RZIP/"A)GN!4CV,D_KAFPQ5>RK,2GSRQC7CJ^G
M]6:))/0>2:NS/LBT!(5CZ09"Y!TR]0)WI#9?-_59?KA07!K?SW^P I9\<1-Q
MS>F:QNN)X1&5RZZ(O2"L_!)TI6GB<*]JEN<E+TSY7GNP)HL^<0EXL)Y- "@U
MI_'2OHO6G<8#WU\%3!P[SAOLF<K\[@[89#W/A><[/E9A'.U&*,F['<4RE3 G
M<,\&K,DL*_GHFP4M7I"V[S\\DXZ=3G]#$C[H.7O%^21MN;BL7^"2T$<[,9'Y
M^:VKZP2<Q>A1EBI=561;%55FPHBN60JG,UC$VJTE2)P*$9F&,A EYV*<U%!G
MM:-5,[Y/EBE'X#\[ABM78KNK[7("Q=UC+V.<S))^%-LSC3UP_: BL'MDS979
M.2$$#FNF'ENC:\M6,:'1^+0G0.(K?Z.^7H"(\?\"!&-($8:_ _&]AK/2O_"T
M!IUT4^SSC<7B?A0+M7(R8<$S)I9ZV=Z;&BXO+C V^?3B=@$[R 8LCJ4B3")[
M<F$'^,IS[36U;)6!.&>I6('EZ5^16R-,_X6]]PZ+,MD2AU^"($B4H$AH) L"
M@@3)B)*39"0K(!E$<FQ $4$R@DK.46B4G)'4()*3Y)Q3-[&!IOMKG;EW9^;>
MW>_N_N:FW?FC'AZZWJHZ5>?4B55U!+1E"<, '8T _/2\[_'OW1!7"(5^3@+$
M[BC)-5JI8(7_40 C70%^%J@W;] UB?Z22HCJD-D>]_7I96A#$LUC: ++(7N#
M<68 C0#?U%T6_I*U)<WPV^%!M^QHI6'^S^>]V/VN0;=Z[F#?6Q7;P;ES]M5Y
M>'3Y]U5Q_UN/Z:W6>V$,&NHZ-&"B">:$\;YHVM,J_^%_RS1IC!QS10/;IJ0;
MHIX=CL79+ZP^6C*"OHY]G279D0UI4Z5:NOF^9D_]P;.Y7"FA=L!/R^0N?*B-
M^$)P9. EHBE0N7J?&.4\?G^E.A)GTZ3^*Y4R'Y9T%WLZ) [I! &1(UHUAG7E
M/*_=HZ,1P1:<=UZ/OAVE:8T-NN29NM\B6C/\P:PRT87B_H66,LX@.86)UE0^
M1.)Z1=KKTZ.ZK&D;CT3_-PX[YAS+3-&W#IB/4^Y^!BD=@(F0;+!N3RLU/U/E
MV[:7I3^IK2S(BB4E/](GN1TIP67X*];MBK7_Y'V^>O9&0FUP&57BA$[\18G/
MO9+QASM)^88;$Y:5&=9GVSOF#\TE8')>!Y*9C:Z(XGE:=4+/E[-G_#@D:6YX
M:_UEM_2T7M(\5D11C"&*^OTO>KZ8]?1>E4V5MBSUZP^2\\WKZA!-%L*LL#6I
M$K!O^MIT3ZOB1X \4[.A]9?)(3!:%7734IX=Z B*!N[G^(3\(D%$/DYS(Q-&
M%LJ,HH'-)31PW63Q\3:H^7SC:7>&"/YLE^#\["]<7AF^5["-D"(#<W%BK*7W
M[1F>ZN$%2+K!KKY"',OLOR(X^@9/V[5:/G<VU=?K$AV-S_>\W?[,\#+<Z&$O
M2U62TPRP3&?UO-]?A&I[0K@#3#QM0R!4='O<M!"U=R%XZC;I#MG%S\?,-$AK
M'.'%SB@4^?F-5PS6M69YYRDA4F?<EDCLV:,&#]I*KZ>K0R*^8-/1&M)7*%$T
M\&)(-V1KH-[ +9T)-X[V?:2P"%1E#N!WCG(QJ8*];BGS]&B];&QR/7)?PS(^
MZU%03. >-JF_/HHI0-)_[%+5*T%F-H^D F4+\Y15P</1M*HSH;$G0EXWJIQ4
MS%PAR2AN3T<'B@X/X2**2]RRX7 IA]7=J)(%]?ZP-20(GDG/)1.B-KI5PNYC
MW?:TQZ$\X0'PH#FFD\YJO>.9-8[38L<L0JZ\?A$\22+A7+IZJHO?;'I"8HL&
M#C$6/M6S5$EXRFS$;E8]M9-3[@0%)8#\QMUU<UJ8K$$"W_=);5- TQ[=" 8O
MXU('G, *BJ<^ LZK1:(VHB]C5;KW!HZ(TUR[A@;:DKA))F;O50U')@:<X-'S
M6<A<NOQTYF$?RW'Q;J0)0R+QXS'34(*JFO"[?#@["@W\?F.!J/4B$%$C^[H!
M3U B3QU+]$VBCDL!P6,VK)71Z3%!:J*'VQBMX7 R*M2$[:,RMZGJR([#X%W.
MO*.'*K=P<>*EO?F0FR4(KJS-:VHU!1'WE)K*P@PM6Z>DX05FTR(X[+C#)K<1
M/<*3<Z];7*+*.@@2;,S0@($/0!L-'.$G[DC2;,XPPAF>\V25R!-V[#T>R7K]
MR(UF2OT.LS@)_KW1 /'N10@R\LCTB%C]G(;; XP+7I(!GYY_/]%F,"_YZXCN
MF =,'G6?'0U ,&M$E8ZSZ(%\I8@&3#^B@35N(_9FR G]+G@+LTBG_)P[*&%P
MYXNTPS,0*FBDQ9<0#<3,'*,^0]! %E,Z4=1K"+.O\G!K7(4NV?LM\1QQ?Y;A
M6KPF.%OWO<JJ_NU#YMQTR;LA*@_)@MJ2A1-<NB0V?1;?AN0^UZ\86Y#!, LR
M%>FS6%Z5-+<Y<*TMM)4W]%3W=7KNZY(NEDLX?$%SU]TF%!VR.5C,XB(;?!X'
MB/BY+R[HA7[0[-8;<O/YP?S/$[2(L(#E!PSA8-'-1L*UTXZX$EOS!X.0K86$
M\:?'9.*V^L)JTEV?!:^$HVZK'B&88,F+6_ @RT1]J='49KPE0")PI2[JI??Q
M*W'Y].[\S9B6C_7O*JP7OAG+>5#T7NS#">P_3"?E_[4_T'CV,^B$+ W5]-U=
MJENM_LOK8M-(<LP281C:YI'Z^05KG,]N*U9PDMQ>H9JZ-Z4=MSP23U?5)\^3
M[,IHQ=],5N7>$M7K::(2%Y$,7E2N>ZDK5!L>Y4+TXJDR7>WY7:D8AHHUDTN(
MIDR>YPZ6D*]''NX#K^H'*#IC@P&<O:![#$CS*-\'^!\&3 5\%>!S<-T&W$1S
M5:KXQ$_2JQP[BA>2GC>+Z=$C5OM]0"V3]')]S4>?-MY>X9\RYDO17=!<N=-W
M$4\="*P#;3_ NP*UT)KKOL*\<BT(\ M_9G5"V(K 6?'+,H6>-I0ZGJZH@ WJ
MX#O;>JH#'XZ)!U59LCU: J2.;,M@S&K6XB(%MD1\1T4QU^##3(?(J:B6  F3
MOU/^O?_6X<^?O4EWA4\_'_S]$L3_/0KVSPE0'_STU-YO+.%/-Y'JV;:B6Z<2
M\1-&QI,=%DE?Q.(ES:IOWIF.&ZKR!L;^_T?(^6 +&A=E1>4L>S595,:">=VG
MSR@K;S\/7RSAP-ZF@GKB0\&PY+M^O$=.WQJ_=%;O(WLF ]& A7F.N\!OM!L+
MJ="#8#BE*.%T=N*;C-"7MZL[J#SH$6?U[N+]> W_TJ<7;6T,G";T56^==ZY)
MU8-;<C4U],R5=EH/4H1[F!8LS[^=%<K/')_JG@, @ -H&&DEQ=6),M,R_JWW
M]__WW>/_/U#^N\'E6[[W!I[ \J)V&,;?7WYX8;MH<6=I%>=\%-</@.1MOD(D
MS4'A'B&?/\DZJ U430;)G 2<+]WTMG@F9D$(K%,5(U7GHP?4;^J>1D NRS2+
M%D$>R^/C#X7-SR% \YX\3.^F;6-?30F_9?D8;T\W%\6;40P*KG5Z)2!%HIB]
M60EZ0KU'7>DD"'KVD24J/O+6^,'9K,'.CV?1</#;4\F'?,USVRT+!-9BE%@5
M&3E+2"YV*(C3'1Q1Q<R#7XI*O:@(+%@?FXA37BZWCU,*IE%_C(TSC#.63S4Q
M($W'_JJ18LV$;<S1S6>R04GL=43=* T9XT2&'):,-\>NL>[SS$E/G_L5@\4,
M>D'C2EE*=\UCU5D L5/="$JLU=.Q%E+2S=J>T0(WKX+L8]Z&T1OFA*25#])&
MZR3854+D!KD%)MUC,BI"'\M%![5A13X%^N;UK-.)U"][*LO!C0M;"R=":;#V
MEK4J%?;7P!D+]3.K<U1URDFF9-V4GF>?)D*DWEFB=+9<'^!CS4>]\,8/*8G=
M<V'+<J/%B\@#F,C#R;(:Y;42=]<R \17VR4E8=K'>JET<.**MB*B) MB$NU;
M.SEJ<UX;M^QX[R,,YZ3()^0+;?0FWHP&A[W9EXEH+8S6>KJYN:[IJXIXY+9
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M7/!FU'^9D.]_6%3>GC_,&_KNE+#&NOY=9@['T_TDGW]70XGY3\_Z*/XI7AX
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M!<7@Q7DP:/G!\&@3'-84M9?#_8ZD'@V8(@@ANKP_](K!R,[?4SAB^TAAU)3
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M=QQM:1,PKRUQ="'W>WST NU+!'8OV+B/*77?"J_1W<AX5XH_!(0]\/Y&@K,
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M'/UP^',3WOG9$^XA\-CY*NHYJ[L4H>#S?,^''[*?#7[K6MX;%Z.-1P/C 6C
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M/J1ONK9IP?&Q)CH_'%N_2L6CK\+S;:N]5)O7Q !XX$A%;B;P-O3NT,ZI)L(
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MW7PAO(F.__-.'??.\$+XL>XL_G>T>.:,</)Z!9O%V4.;BLYV!]J[=[H0ML!
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M$H>D<S@:9G>.,-2@-ODC@?TO(1#_B7BIG(,-TUS1Q"CGIQSY\+&SM_QR*G(
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M-9</KSC\I#I:4QLJ7X*2X5T#FO(7[C0(6;ER(/@>:GOD2Q0Z.G43 ]@;+[Q
M]+VJ<!,"O$>PXF^64T_WI-/$$YR]D9)]QELZ\XRH]:JEK94;RRJ%+%\MM5-9
M8*=*/0:--2>WFP)+^='>2.P!9'SOH%)<\6RP1A^S!+#FW^!(.DHBF3\6%2[
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M1DK4K3\/:W^]0Y]L2$"&GKZS:TISVV@G.M@#^9\BT(#9<XI(L1MM;%^K');
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M476CV ;*:X"\DLZS>1X4G]=[;._$T[B&2J_/\%0[&7@8 ,WB)="E-CI=T20
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M,FU63V\SFE%?QDYPF?_U'?RPDUE^<:.3O,[@)6 0XC["&3DW/2_#HC1GQR#
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M(-2%'N#AIYZ:&^":JC%Z2Y?)?L9/ZJF?:TI*7XT]''?LLT133W 'M0<Q EJ
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ME43<_5G6;>3NP\WO:MRV+4//_)UPE=P<",Q6SW0RN2E%-@(ME^#.G1+<B_U
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M_J^MI;;6'2X<I-PB/[*)$048N>O1G.DK%2CY=,GZX;Q X,'#U\2IGF%/WLA
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M_B45 X8:A\QI;D8Z>__4[;+RMJ>,U2*=B0/PO<N'BN!00"1LJ)'$]J%29X+
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MLR9SY^O_E&L6QYC#,_2.)C;"Y6BL24IO1&"8>.Z^[:O9CW*]\KWX(1,/>E"
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M#)&9L(H.[9/*,-*N3/,XKAR 'X8_)NR7"SC8B'IL2[<QS&[=2/O@#05FZA8
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M9B*]K#7%CB<(Z4F--6(8O*;\AG5NBF"#VF\\RKF!$L&1!??^70V3@ (8S*,
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MG);3*R 15+2U8[8[1MI 6T?7\H$Z/(5R Z#LA4SUHDGJSXW.&P;:\<9K#3T
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MD[/ZOZ?1CD3M_Z@$QO7'TZ-L-3*_W_QF[A_BLL@>6F,!\$6<1LRE/NZWWGN
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M)WQ!ZS3TC7X(W01SKQO30Y(4RIPD+;N7B/I(@&V+?_!MZ@#[@Y>K&D-7H)_
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MO\H^$E!:X<2S^!0[GPKB62(<+2OA%+N5U'$$:A'.B_C,6G/3U(CD\X< :3E
M(B0[SYK>('81!]9*T]77SKNQ[%O)=KM@>*LY'3CY:< \0X'[%N]2A(7IHTYV
M&SIMYMF("VG$G!\K3^*"$L[UYAE,ZMSI*59RY&K/+E814%P&D)NJI0UE0[;Q
M2^UK%_-HHZX%R*XYCD:W :J/R_]SDE%U<;,UL3D2=;NLVTS;W<W]ZLEFIQ1)
MYK6M-X4K";F;(VXZ)@KL6NIM#J16M;X.WW(7CU54V8 EOYMU^(A&E I+0\*I
MZ(:AF:F>!^;Y9A,6^'QKH)9^J>YJCKOJPY -=TUE!04SP;.4C=X P4KQYW#/
MD;J1_629-4G=*?6NB7E9$CGA+VS%'("?BHHBVT[:Q?TGUE/R\(?!WQKK*LM#
MQ6:D/H8>QZJ-K=,;Y"D.'G!+?B94K$PV;5I-(4Z[6*:F^)5*^1:>;"='6MKY
MC,^#K36D"<;#PO7"14I-K_2O>I^8B!?0!\%R5KD9K"3"L]]%107-FT6Z2B <
MZ=(NOM4PCA?/4#)VB1%]U+'F1,O\BGD^^9]^'DWZ;Q[Q@F[,I^'0GSE&9*EH
M?HD@"/PEH. 7,Z!!"Q6>@06>N:^K5SQAI3,]O0?9:NR!%[-'?FG(@S&BMC,\
MXA/MJNF]^V^5OPO$7-F[KIIVM7'[([#I2[<.G6S '\QQFY*N.8NWJ5!9F#7_
M7C2(&HWW=AP)7PZQ+7MKLCAV-P&\/_#@"A:(>(7N>8JZ.D^[?UJO^Z FP:SV
M]F$YNT.V#!9HY+K]HY)2LA6-E@$'\MX126"1"T.&^JVUS4"U8W]99L2.LIP(
M,WF2>K1B@EH2]S:]F=;!S''('$9<KZY!N-PO]C,#>U.OTY82QC#.JSTV5RYS
MY=#3AG:W\)GV6_^P61.(QB@21H1:M$&ZCXPX7>K\%$O$U%+%=NS[ F_,F_BS
M=AUWGH'-.:5M$3OX-34:1MSJ#7-W-1#,?)JF';(1?,^[A>[-J/&#/+8ZT &L
M,SK"(M*C_4D_"5S8%T:6'U25-U97:O*PQD5=F2$(.65]2D&;\I26BS7^N;3?
MFC7":]W?!>KL\/&Q,K<84862$-Y!Y(1I_8["Q*)XC(_H5_L"A5CT^L*D9.1G
M0]WOFS,+'9]MOPF^_/"\H81ZVW+VF2W+U;E![PH"HP6YEX:<VK*5.N&%M3$4
M3]5H88^(\4. 0_"?.VD^0<G1-D,'/GSS[?"'(<UVY.V[[\,B*,.8<DGPCN!@
M ^O,$1D"RZ6V2?FAK9'5QW&ZGXLBO$@_YAO"A!&N7R?X/LO,Y, E)SLK=)73
MFDQ=",Y=LL"'SHT&\DNISH=J,-KP%%Y3*GH.)\'KT#NIN F1&3Y@<DXA&A'2
MMVZYJ9H^*6=IE_4IOB3/\-I)E"QZ;T:\*,*/>V:J,"C9Q;V[VG;>0_&; .65
M,^YE$ -:M1$9%Z-]D7/CT]TWI%9+\DY$=#:7)/:I]EU_37^K1TW^O;6OLVPV
M[EF X/[UNLFV1B*TS 39<'LH_MBT;OL ;%M_X&%:3*ZC6&_>JBPI2GHV-G-2
MIM&#AT)OZA[%^2 UE@C! "<%A@BB.PXR65H?1[^FDDH]\4AS__RM_[G),Q^!
M9B$>N 6?["5"APMBRX/"^U/ ,U1CJ_6<*IG>.IGM82RQ;/'V>%WI^=,QL=G8
MP7+OU?D9VC4#F>%"[Y5T?]8NW2^,0';)AU)R 0?Q^8:WHR_((*V)[L5#"$M;
M[[;H3"WNJ@B_Z&\RK[2BO1^BGF6M)!(D+KV&V<1O9%B[1M7$&5-2\2@1L;M)
M>QG[X52&( S(\ +*N3M&>ZFNUE["DM6V,\P[7=6!2/R HX*[!'81Q3%?T#:<
MVI(@4%81<V] -]CXP8.Z.+T4RG X?M61\-9;0"MUW9 &#4FW%M71'T[)V9N4
M@5MDA.7+C#M [^^3[,(N>]-B9I!DAP5GC0L^'^]RQ!U*3_J4UIGOIH$@J&2$
MCVA[@L2+FA<TCKR?)1HG+C].;C5AT#[1W&[9#I'@")3B2=0_*TIG7Q>LMF"[
M4\41401:U:N,K"/&Z=G2;6&&$X:VI^JUYAV[AYML9YDIY;#9QD#P3@+*0]AP
M$_;9+CISMZ%[R6?Z>!H2!WC.O&I@7646:$SI5:EH"%$TWM/^SLK)QN)8'BDU
M:J@'\L/00[]<^:@WC</IL\K>EUWCA_;\]E\O.5>=:/G(GO?@A^O3;-)?"RJE
MCSF,>6<&/P*G0^0!:%/!2 %'ZX3$.H9NZ$4%ONA-@70V%L@3R$L 2@(@(_UK
M9L:EY#PR.U 1A_P"-W4Q.AQB^%/*8-0%F#(JNY#I2I/H1IBF=3$O&]OP7BT6
M8"(S%+?0^3#-C+P6GT$UHBP9:/[ 25;,K/F CFHEE5$8M7U@*ZI<&24ELN.3
M'G)D*0%%I(%15( S%B#>U_B$.NEYKQ34RE I$^B[C9'2VA7>@EXN8IZ<6ZID
MI2"NO+7C=8L$>L<Z!D67X1/;4IG8^N8-O]DNXAIT,=$QRF>L^ =3-$1>&M"=
M"3X9NIEO?BH>BU^E3HL)L<!?C@P^?..#.*.@ [@/XZ)>SICWX.3DZ'#YKGD
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MF2$+6H/0]2,L8&JUCF&"=DKW0];'H(*RS!K(7,Q]OCC<JC[" BOCW&-H$RS
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M%>E%;66>\UJ*+PA 7Z1N7PK>6[&NVJEL7_I<'-3;*N(\)737?F+62!]NV^5
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M?Y:)C_/G>  %.0D#L'93 YRO_]_><7A%]7_/QFBOX  =Z\Y,C$]<819I% X
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M6"J)^])I2+0+=;3S7# Z.E/O>/&:IXT*2C:\>KR$SE7SJ5U"&<.1#G/<LM.
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M5@FV7 I@(1<R>%+156=JJ!:3\.I1A9=+'[3PB]4QCSFEA!!TT6'CL"BY6Z=
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M[::-BO"XD3T<X>XE"*7:D&>.B_2_B_90&K77:=>,/'DN&'])WQ_UB+J55\Z
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M$B \0PTY42O\9/S"0"4WZMOHM3&*&P]B+MV7EAP&;X+?7@#VA6U 1VLP[%>
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M1]#74^5AXWAX592#U%ULBYD_!X:X<E+JRH1*>?43S1!.&33% YQU3F1]HH?
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MBV>R%7E9QO18-D%!C<!XT1,^\,5B4(9]6OX<(5P5;ND7E?[\DP,_BT!?-WS
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MH5_^_%MY5I$P45I+Q.VBM_]9G?!/M-$B_>P_^JI2V&'^36@>-K3YBYZ-S@7
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MH-P/HZ7A3ML2@1LF_ ^ZK=YTIY4]XGH@>1\\?T?96?*C#&(8MDCE=0$PY+P
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MC_1["&EA+6PWOTX\@_'C/,$ RMYVZ ?SE6$ 'J<E0+A<V4_D\"/I!2-><5'
M<HP_,0*B?+)(BB10.53+I#T];5]QZ;S[ 9_VZ1*I=_[ZFN"C.3?@)RS<',<
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M$[*JJ2R_[<#-^(&OY2*:@G562,B3HHV'4@$1)8]?%!1!\.+=?4I^OJTV+R<
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M1F+KOG^=MQX7^[GZEB2Z7")E=X@FM365R--0E^/=<:^'KV.PMU*3CE8*M?4
M'+D\Y@8S@7T1E'RU+C.^>TJM==7UC46IR7TO=RK\4EUE;+<\BG_QQ2^7L^.2
M56:SZ#9Z)QG0IHYJ(8Y+W78[/1&WA$*)\5;J3&G3B#U)BSDG0 >8T+4E(TGD
M4I/8UD@VO7UO5OE GN%KS++BC15@I,]LZ.;^1'V(V@2GD+$HSRZWA?<[U=5*
MXD\>\QL*D&SQ?&M0X/16#0;0NOO.6[KY@3"=>ZW/< ]?,RI:AA+<4[^M,&XV
M<1)AKSS+^'C4"40%2@?1-N/J!?E@GUT(1C$W-ZVT)EU0>@NDP"[*-"NT17=7
MY5H KNTR6^(PL6 72C+TR47_LP43C#[5ZXOX$__=[6XAQP\>Q]<YET2:5 ZK
M'I^;7LW<8OX.&CP&'A1=4R-2?EQ>?QUW8#06Z:ZPC&;@Q6>@.7*Z!8(JG]TZ
M52&P%RV_Y0 WE-/LL%_*IVMS1['73^/ &^X=-F3#54Y_UO(\2H']M*:QS&A>
M@:73)7-,26@AY X6 MVU*RGLZK79$JT?UJ[C-?B,[\GGPQ:-I2-UM[:4F(Q>
MH_H4Z4WL-J@7B61*/'5'%<=8DG68(KR?2=OW@/*$>!WZ<5HA+5CZFP_! %C!
M5\9N)N2'O9[=L%V]YU<<<GA+/M=78<OT;J^PCK<E^> <A;:%G)^!T8R5/@)+
M4<(MB0*#%I)S4?RXYN+Y & *;T;26D.:SS[UEQ5]//XLDE3;RQ)1TI>QBE/\
M(H19'G@-7H=G 8\^(K[%_(BPRQ%H:LVYM0H!=DCR;1M/!D@Q;K8J!3V?L+H_
M.IL7+9K*\EICE+44&.VY>9(?].L7<-26Q-UAD@B[<@C %B)%YD0&F6!/B<RV
M&L0/]A+?C":KS6SZB[\JCW_]1NH['9A&+\C6('ZM'D'EV.58/M=WF_W>)\_;
M.-N= %_V54'_RW<-AN/@%2YO#, 8ZW:>"IWDA%AP?TN?UA_DZ)?0P.&,;H\
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M*'%U9$JAD=BA$2MB)\@TYV!^S894<.1LX'D?8]@3/GW^@\9%&I!Z/%*S&&&
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M/<P L7*0&)KA6YQNRXRE=F]WP+P<F[8<PJHXQVOQ!\MM-9DE;U6S%(H2%=Z
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MD*>%VAJ463A&ZFW0VT:><<J5<>HA_8T5<2O&S1Y,OO!8Z1WB)5^[BHQO>KK
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M+ZA2DV4YA5_2GK3[K>KW"*YB;++B[-<J/ZOV&>6H+12G?('Y9(3GM7/Y'Q!
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M\J/WS.AM,[ <[TC\B<^-B)6_>J9@6QBH!K1*@[EFA) U*<C%4-'*<A"2,S%
ME0\;R7W8&RJK$_9E=*HJ7AGNM/\X7&<E2*&\([X^=0JSQ/[@'+CV58(%P99J
M9VT0!MZ9%2?NN]V8ZR-Y*)7)SC;*7"F_S3*XUP)U>H\*$#J1_.UY!Y$J+0D-
M9"/]=5QK<\JRZJ*4W HR.WAJH.K3XB/@8UU (*_,O@J6QP![ZY0.8AQ*LFN'
M]AB#WL^?Z<O@$U]Q"@1,1OK%=U:VTM_GS,9+*JKN.'2FDZJK@"AC(6XBUFRN
M07"BN3CFF=4^YZ>BO-*SWX^'*GC!A)/%!C.MEC;DQ66O1!Y*AP9E!#21"Y&-
M:4[]*]">\5^KV)M>6Q/=T^-='48B0ZVX G&75S_*+_1'EA=^HR=L-Z>.C[TT
MSJ5=-C$\Y;A(4ITV(F9/F3DW*9N0D..X89XB\ 2RF6[>21NJ@9RL1-XS0B\<
M)&<=B7W[$A+'"TKN;6+=XH4\Z#A0""9IH%:R$=OUU16.":-DX&VA[\*C-UCU
M([>%97LF;#^KOBDU'C^C/A\OT(D0N+@](+5M8N8M]Q[< ;L(P !F(=>Y)J4F
MZH>%:#/(V2(&8#.N#@=2P[-7:E@C1UJ6=E6NW)<K]'%#(4Q0)+EWE*='Q,[J
MJ!N6,G@&3YFC6QVRSNZ$%^4>KJ,O8#8_ZB,T1HMA9J+A")88OP]O0M_=:/<9
M1R0KJ[JV&03G 06)^107:>QIV$X&AI/., !Z.],IO[NU\9!)(^)?<CL#=]27
M@/0M=:GZ(Y!?4M0;L34(N][$JK>1-.0X$*(T^HZ<G!J<;7IBR(KL2./V-\B&
MO8FE,P; D@>94@)_@:DBO;%>E2X> S":Q0!D;8\YH!=<LN@6)50[Z33.GMOO
MZB7_<]DB?V\^+I2S3B@Y_G \Z\R0%TV':@4DRJ_>1H?D%?8TC_%*/.C0**VS
M=+;."(\-_/?V,?^IA+*LUF]EK04-[OE<8<:U?HD!-&F32_[U2I;Y\Q^Z*98R
M>NUY^4 %AKR M%YH_CEY!%J!*_B/V.4S5O^MKUZ,L_^MJ')>JO1CC7]$D;>_
M[!MJC/VE)!OK#](%#*#8]-RV7/_O-94U_LUI_?_'=N-O"49Z<E88 -WREEWR
MWXW)3?<OQX^6YE=1/0B9=SS?%BMS_VM)91W)WU8T]-].V/FG%NT=:I_!/Z=*
MHQ$-8[H)/!1*:7@T1!N84YWSB\[?N$/]. LOFRQTFY$C$T^7BO".#%U9V7^[
MGO8_HOUS))7./U4\R!#_\9^JS/Z54V.0H%70CEGSL9X"E2XH$%]23BH<T!_2
M6D-;UBWXX$DJ69X'4W8!Q^-3W#L<RO^5M_LK^Q O G?A^4S]!Y>3J7,VZJ-'
M)<W.1'U/#=]G)@@,+YLUH1D_D?ZK2L0Y*IQ.\J\3Y*) NJ[^X <#4BQ#NNJ<
MVU[6?M]41ZR.^AF$V'(Z&54H8X7UY%?XOP<A1_/_*]41_PMZDPG%LOA4G=PA
MR]OUFI=O[5<-M9@CR2U>0#R]EDOVN_1@R$1=8^+6Q)D ,SHV:.)WE_6/VWMR
MGI,!$G<;N*XLVU=&6^UOW?ZI$%F;HM@-2NOPR_B54L,@&<Q#ZNF KTE97O^8
M2>YV ?=R$]!?;!**W%I;Z.Q4*;*N/#N^^,9*[,A?I0_"I<V-7*)'DI1THLD6
MH!B #,<^RA7%0=\.)B@6=+PS;_M$V$- Q0%8YF+?;'0\="<HM>5S=1)PO&P;
MZ:[Z9.%R_A?A88C6*8P/B04&O. K1PR@#-O]%B+KN4T*,8DBX1GAKW<Q /.P
MP95I#*#AXXL_?&^S>X$"Z*HW JF0(IYN*ZRQ%D1R,RZS/J9DI5OU(.Z ?KBL
MG*UCGU";3NC0_,+*:N'3>[E'_]&M@1*G[F$F!T#FA_]=;_2N75\=$\,!M&W[
MFL[JEAV?9[-%$\ Q,A8RO8R^B1S^]9P@E73-UZ-]!AR\.^4DX[HQ(+V^D0F.
M>HEL)'QW>2<&5_F^R"I;N#B@ZD8!\J9I6^I==U.2'NK>$.<(UG2? F@S#GV\
M,;(?ZQ"3!="UE>@@I:UOP-S_L[?U<FQ=O+A[ KM<6[RDUOMJ!.FVI3\C55]C
M2^@B=LT(YWCQ'SE1SBWZ(R+L4-G=J10BOL#[7>0V1$<!SI=?A?44I5_^<\9(
M:XTCS;Q$&*>7'M'[_%[WMFH@R8.5Z^5+[?'/V;Y$Z=2V+>%L>8+_6Q#U?PNB
M_D^T_T9!U-30)Y44#7AC]KMF">\7>V9I%/6_D::+ %/\)X,A+3P(^DL<6PCR
M%BM2;U106YG"S"=?LF[B5QT%B1)AE]-P5[:^>CHHVR2H=69^[)9D S1/]7?9
M\EEQ#N)7("%()_A('+LXG<YA  ]-9I=,+T@%H9=+X*]%R]2U..L0@A-50_5#
M.U7O')-9N3,KXV/#&FZ7NM?A9P8]AX^RGT#AO;OR\Q8VQ<L+A0PL2H,^)"9V
M62B31N_1ZT+[UQ6%U*5')*V_<([R>DFZFS8-'F6FT37*>7(VDDN\. ]^714H
M$H; N1$/W/)SG*@W-3HT,J$ZN"[?R[_O^$;NQ@S3>583)XXDX%1P;!28F5'W
MX J1&[:7L^@H<=_Y^$,XN8-D;] UA\I39'7^;#^-01_?_&Q<<(+0-"/4B/CS
M-:]467T&<'HCSYY[J:$L?&M")^&6MIC8"</DPV4HO0+\C8KX2]+U%S$>YK,K
MH>\X0:Q2WWU];<KBFW:M88!O"$@$R^<:6Y*67"139226%_G>@!B,#_MQ;4V<
MVPI9PVLJ'"@SWKJ?4RY=\\WDSC!(9BB0/#MZXE3P<GFFSF4=X9=?;#>AFX#/
M^=9D2Y#!9T0QVW^UUFK([TT-A-YS9EOVQ\CJ2.R$IQ!;EOTQ$TW)W7Q*)BKB
MA3K-D=6=?8::R,>>K_7)A)_*= VN:HG:O0:-"^H!#S" CLO$\/U]AH; $:%@
MABTS>=Q8YX&7$Z81:.9M,5 XCV"OH1THD.B;P<NYTKGP3A$SL;@9V%>#):]X
M\A6OQ?;:& N[._%DC+M+47L.5$K:G_(X\W*'#N-2L("XY2<R'V%G5YZPAJ"N
M<CU^>E 0Z74CC>02+8@=Q 5K&,]D U=+DGWE&2?[>9Q"C18OBYGD9,7R_FBN
M$:*:4HH-6<(1P+0HQP],95=QN^W;\()X6S9)VON4/ C.<Z\944QITA'X.";2
M5;96G'I[CB3H\ET>RABQK7YK<YNS<-VH-P87L%1*V[T#@M7KC)> Y.0\:1?;
M><CFGIM05Q5K22B0X4NC7MXSE*)#5ON2C\B6M-.<[4T)M-6:@%U A))58)-X
MJ6&<'3<MQ@11N%*&V6%-L"XMOD20B3D" P@3&PA 1/3S3\PT+P6]F4@0YO1@
M+!V@O)-U5F#/U73*SM$MU!BA1V!ACY=(!K;S]EQ +$46*&K?U];:\.P&+QN=
MPK!/TNS"DK#'$7K<IRD= !$"H,NQ]]N/;_,\[W1!ZL!_E97K.ZQ'=C%_0H4*
M1 ?%>DJE1MENF+"'M-%1).I42,<]A:X][12GU1,YI^5H]5%!1"R2F[2Z^Y+7
M.9+Y&822^W<HK3-?#C_6MP;]\A$=WR]O).KUSE-[DUSRW8$!@$<!P!G2,S:5
M1'H@\ KAR;Q3^H;32B2?NK_&1+SV%^<]@:6S!=4 BJ#WMO/A@\1S6VHI%O(W
M.NG/OW_'.=GS#2CV6FK@GNT6#K*(%6(QJU5BEHHH3P1_(QXH4.LB9JJIFT 9
M%O(D35*<NSC%Y T,;Q2(:&  VT*9/*V#Y*W$23,2'WU)G[W!^E_9>Y?:C<0H
M=2NXKX/^OOF;8,^Z3$;",I_U7"<G 0Q@ N8P@E+-V&:@)E)>>,-*+6P/N5I9
M0L=_?I5="VSR$4<D:[6<;[,4E9@37<U:L5I$+T5WPH1.=%-]\7)S#1<-2<VK
MHEX_/VVF:CX_+;G7!KZ=,7$Z6ZS,I;>3 0_ZTM#?2!00E[R<OWY8\DU^&"8A
M"N?+,9AGF>^[]3!@%6H;JV2&/S_*2FN;D30<4"_G.0]MWS7;TCU<G'G)4AJO
M^RJFRM+H2-Z4"CA1'YNOA*4W)10(4+1#'8=D?/$'W9%!_K+86\WB>B)&  6M
MVJ-"J9N'3PH17-S'FN.O?@5./)JF^DBEU-1[+T&",#H%_=F58^I.1_AA/00Q
MCTJ$W@^A<9I]^/!-O+!$"E+BSNE'^K;]^TQ[]DJOZ>?M/ \OV;)W[])+3_A5
M%RJD6R<:?"\MRW?X5O&XV>(3 -55 F[" $@2VR@X<FR=LX3;_#9']_H#NCHM
MFJ5"+A HM4/WZ_K5Q1!-:@LK03;]GLHO_*[-\]$+GT4YC&Y)<"SWF[8MB)97
M?HU=Z"KZ8-@F(B(;U78$22SW*O?I3-M.E*(=SQPK)F5-XFWB;(I?,3MA.#^%
MN1Y0A#E*:*6K^_J2D?32]C[%O?UTB3UEY?CXP8OX$S-W0;V;RY#08>0[UUR;
M899V)%7,=U2,59K(EC>B[@#[1.9?JL9>\)S?K/.D1^Y!#!QL<$YNDJ]+$2"_
M"!5VE?4;4,)KXU;#K8](Y4^82E%.OE4ER_IU<6I#Y00;.@:&=C:/I)?9E?.9
M1';;-6T* [S"CVBI$;NHF2*EPF9+\NA)?@D2*?3=>""GO H _*!GW(_3[MQ#
M;<9;SL)Q^*[\3^&Q!%!J&OU$;C+.GIO>)Z0>HGYREG2RC8NZ">5;K&7WL/.0
M/9)D-(WRO,#@O#W98&MW5'[:RC87?Y?R/8U7\C1P X2P7M<%SFS [A^<MT?I
M+IR)G/["CM,/8K9(I@Z!\^#A0%".P+[)4/1/QAI>2_-/32LDVZI8FS'X'T0K
M_Z[^]T?RQM&-%H+T$:.Q,'M7[#3\"/*'Y)<,"#Z=AJDJTE'S06/PR=7!;)(U
M6?6 GQ/O(O) Z+CL'9UC<(G03:,R"N>V-F*XN\5@A;:?^W8J?CF3.SQLQ_AS
M^?<5-M GZ#$A!M!4J:TU[)]*4?[0'O[-&]#'7/N=%&<IP\45^1E&6H(!(-:R
M'.ITR#^]LOCE?Z-Z8_?XWL5;5&'<I-MHMNTM!T7F69F'31T$\D4*:ZJ/MYK.
MB8-3C]3+_I(XE&E2T[/R.V]&ZJ]Y,U%>B-/4\)J]Y)*M^[PS-OWDY7V?TCWG
M2F^W$<(O#PU<F>.;SFZSEWQU.:_121X+D.V_H=CL=4/['G2@"DKON:UU4%)H
M;V=Q\WL8)YT%U7#8 $*DE5@Y9Z<$E#89[?/F=S+05RPKH<8 GI9L-YFPU!VJ
M?90\/7FAP.G!A7_W,8%_@7?<8)_=Q]^,YJ&O +I*&/U12]@SH/+ $2V'A?27
M5QC ]/W$3@B)0QFMO"JK:H6&4U[V'LL*M[S\^'ZGZX6N7NNULCT]?*$^;[;(
M7JAN=OPU;KZX7@D^##Q9WIM*8CMBJV=#JLKP0O?NTP->L5AOKS%1@\<,DN?-
M>I5BT*"3J]KJ)+LPG:_S-7'UA12(XH]KF7!OZ[?VK#6?30K) OEW\#JIFFA%
MZ9.=38B0 04SJIE(/W%O)NO)6WAG\HOEBW')4X-]WGH9R/.VRI3[0VD-I>&W
M6&)7S1G=69QTH*]$+^1T1D-I'%NBZ+5&R[>G><JV>[7M[ M&F[INS=7=D/.:
M?W_N[^.>CRS4J2YO"!P0#"?F>X[?M.Y$LPHM]B+2YK+'FEW^5DUV243VG*UP
MB>["S=Z[_&IJ .!8+&A9^V8/1VNY>H38Z7CK-QRBSY+D3V]1-S+_Z/!ZMZN=
MADQ'5)GR^)(M7_TT3*-';I"GEOU&!3U(GHZ*!<Z*F.>O"#;>Q]YUN;T>K+6)
MRO?Q1A@.$EB_,'W9CAO;[?(C1BRVBKVSE :54;(U"<S/J,M405;SC?+L":G8
M63A31=F;5]Y422"JJEB3(,J,V=XWZN]LYR%7=5Y3>$]4 QED*QZ"H25N7=N^
M'Z*[DGM_'H!F*JD7VZPIZ+QY!2F($5&J+YUNE-T=J;U@5LRT879_)JW_-?I&
MP%B<=I)7&JV<YWYH ]>"BLO0!E_6DRWG]9YO*>I.Q !?>;_X")M#E?8GQZ"D
M/8ZL0;[>&P (.6#LZAFH0<-H_8.$J0VB%Q0K>.20WI1RP[52$E^RN?-BOSS/
M=-;FW;U%X^[5V9;:Y-+OMPM/;_23(Y(&V_M-MCR,'[$5[6( 'Y.!7;X#?J:M
M]&%%VZ;A)H\#Y6P<$-4O7'05[[[V\DG3_GT7O:\^QB.G1"I7]#OW*?1,3%,;
MNSZF.OC460&C0XY*<IO1O&6'Q@%N&D0[TN\/[GV'E!$[0=37OQX2=(B%?,
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MSLTS<]7*O<CW*UI )PR'^J>K]:>71OOY%\ 4!P&ENQRN":E[5J]H/R6Z! G
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MG,]EXAE?!>#B+F/3.^?R'X":%4Y8)O3/R]! /U0GO%4![WWG[M5W&FI"-:H
MX(K;_FT.A3N2VBSGG3P/]K^Q_H7V7&I[]DST\R3GXLR FY%U^FYOT89>+YEB
M(\'C&^]"R=BR5X$Y C@(</Z*%"S(4/X.*;'48/ZN@*=P2>&MTU%O"C0%BRCU
M@P]>!U.M#J<%L+2$")V7>>V<,6R]VJKAD:3L(XP&KEYWEX)G##(KKG]S,L@5
M[V7M% /[5]+VOG,];SUL67/ZXA<E94T498*S<O9!$XEQ4W8*5MQJ^?)MV2.8
MHX5PP5/I";I>1ZZ_[I]L;;Q'%*"!6T^2#V? RV:9)=B]GK]4@:T9]?WME,@9
MKM-YECVH2\[O)WC\Y]/L_SE'Z/Q$B16QIR.=(]D8X^R^X/3!85Y,8F8_31.]
MAJ(D>7SVQ<DY%R?G_.N>G/-SKNV'AT$6G7ZNY]]0CVHK&NKWF$U!APT07MVK
MY 0"3MA)OT3H@Y'BF-F[\].B#T4#*?P>I)+$@DX 5 CQ>:XZU$ ZWS22VC(U
MW*B/L4LF99$<.X\H223$,$L\7%)970U[19\8,:L%+U6P>-,OB_7J&26>IFIU
MI \><KT\/6?#DW_$T)1\VU(&G^[%%_(K;L3-+%$0X5.*':F!G44>/=-R)V*;
MV(3+=B>12A.F(VJ$Y3T],^,V(8]OI!QNLCU@&,6F;=2C9J#LN]'_O78HQ+C2
M857CB*'!P-.DUAD:ZB[BE.+LOV0<VEVZ5QHA[UOV(1$FU#:?).E!_2R!JO#6
MFZS VZ&51@Y$)$,TEG?SL.;59DF12ASI18'SL8;O9$-$EEA2Z*T5AF[(V\TP
M#I3IWMMC&<$FS.MH[9P9M_H8N0\I:V>:J0LIZ3^H%7Y\._:3R=L5G[Z&;(6%
MR[J9'3.;Q KS6S^T KS>&JHM\SDS8_MDD)[C@4.=Y;<R9P+S9*UX2M4%!B+P
M]=:=F89L$DZ#<O5,73U3)&J+RKXQ&KCTY<VYVM[]3OG0NIX$:9?KG*Q565*O
M;2RS53-\K4TEBEKB ?,IJJP!*8<&HGQS(9-<YV0Q.VH)#C$^6R4E%>4ZAM=:
MLL7<"$H>!YMU>_] _M$IL]:GKE_D^@(9Q?A]?7ECJU]@#@:BQW,[R"!!R"$*
M#9S>$\[9_822$#8Y=[(ZOU(K\',/EN$QW! %=H"<KE#NFU7O@AN=!#$NG>5:
M1+P1'L4R&?7K=JR&G3:L(^R96JD@G2H-DJ12DO<T._X%XJU8_N8.+&_56;6[
MQ'9]\$[M%X>IET=J;!;H4=HZ,UU^A#3SBM(@GY!#\;(#SIG0S-D.HYK!M]MT
M,$X^@I7]6UEEQ65?@[^7EOO/@+<EJ21."'3"7S=TP9,#HIMI<(1=*Z-TXN]8
M<U/WZKA9 T?D"VC@#SL!'KB2*ND.!@_^5ERX;%WEQ<_V)\]!D>W@K0#4T!>D
MT2"+((UG]OMN(*29":N);M%D [.2%2@;A=X.:;_%GFZMZB^!O&M[5HZ] B%&
MK*C#VY+%8KPJ[LNQQ,<;<B@683%%#F&-BK&O:IO6]9L237GNDB..J7,5$6Y/
M_)4YM,23HA@*RSM(5H(&LJA*L72.0VIXDEC[C$IQ;O\PZ:ZP&V\0!1GVH7#+
M[/F4S>;<6QV,\YQ-5%631()I.P)986P*;_.<Z%WHU+XB@A>:23XX!$R&&$E2
M69UM6$+H1ON4)R4<0'$V1'9W[,J?$(&95,#SU'V".ZCF02<3D;I.!KN-@9)%
M\]>XO32>\7G.R2KW)Z7%EH8">)XNEH,G',7$O]3YP,N]*?U+\?A6QT0*]4R!
MMF,QA3WL,8)A?[R"0:/[S*:)6Y* 9\QM%4.#F]5E84??W62][RO02LU!'/Q)
M]J$?^=GQ2VN?+S?-D0C,/*8U3&W<T-O-1LK"9Q(M;[GE&%5Y3PAX&UA/?HB0
MDL'./H1>39"KO[;1RZA\>_JP\:;T\4>X>")*E9_&#6L#A&>O:)XZ9;:3S+-[
MQ)+RA-FS(+E#W72!GH+DVALGX;=(?/5%S]7F&'#R6L(GF<%!V?[- \2)MG.L
MZ&G$ W#@<N%PIK&!^-ND7AVX6F64L*RY ^'K!P^_"QV)X8DG?[;JVK5J*=9V
MD2F_+WY_A9FY8C26_52]4L'JZ@\I]O>&L;S#S"\:4%>RN0+XF#\\3;B76(S]
M>6$8JW>47#3T;0.\%\]9ZJQ5N,96CJQ^?$%^5/!JVWQT!/[Z<SR84(^\FTEP
MZ8F#/OZZH_5=TXQW'Q2'XST-P'2&NP41E[(Q%B WL"6GDHYA9S#@(%=/LL&]
M3O$]S^YM.R';HBU!A'1?Y(;>+/RXE;*.=1!JR=5R2R-K(N\&.=93WZFDDT+_
MC<<#7)G[E@?5[('@>LZJ!\B.O!?:$N:@."LBZR]VY7P$X)M/[[\AP=\=]=E&
MBN7*N9D0"L2SQS,Y-[;0K9@>M!NN[21X5+3JWY@<(]0]*B[235O0"(RP"?O6
M*+Y(<QS4#2%>M95=%@_-*OWLQ)]+>K(0Q[3: -<G<M97W/7/EYGA_.%7:#EF
M+9+D]K57 ?+TF-YS1D0!>SVV+ULC== XE,Q1D1I0^V&3H?@>)OE$[U)V \A/
M.-'0"+?[9_ JLE<:#4 KT<!GC[N29#"&%^+:?QD/5:0:(TET_W4;>5OO*N9.
MWI]W/D&I?I.\32OB]8]XR?IOX9?XYE86TJU^"+/:9BK2C_T?)NFOA09&\Q6?
M/EUO<($V9K0%9->Y3GF'IX7O%K(O. 2,U=C8PT0L%5ET0ARHP+D)QZ=L.O?R
M<>.0-(-'&F9:P3?/%X,)[A\H1H>?K7JJ=KFK_;29]4_G01B;.2U,G@.7Y=<2
MQZ/QR&?PK9ZX!?-0"</7Q;56_$9T?G;''Y+:1<-?B5UU:^712$^Z$_1F1&;L
M962;!,-<WT\=ARN%"(6NGFJ9QM:;1#'3ON)YHAF=Y(MC G4?@03:;[TB-<_=
ML&S;4;IZ;Y3*.ATP<IR#BP#BOJLB%J2R)1^[S;]H2MQ]P$5>E>=IH+JN$S91
M]!>KQDH=+Z1#_^?F)N:W2E7_VJ_:M3U&(H@0Q+@'AVC@W ,-; ;KU+<6\+A9
MD1/NA5ALI^G(AF&S-NJ<SF$C1BM5[":;[:X'+5 MA1S*DG&#O3-@F/L)X%GA
M91YLG&#)]]H>(3K94[M1\YI[S8PPNJ3QY6K(+X$N]N+ROE*W!Z)=NFQMN!TB
M:162HO:+!'VIDA,_2"A_LF BQ[!PA6QNZ/5+DBWDYV/I0,-%V=$ OI3_#2 -
M-1;/V46'G5SS[FS.DU%=55( F@(2,*TJ_#97J_7X1J>Y36AQ,P]]H5B[I^MU
MK8GVEMEKYL+NY0I'VL[&2E$>23R$.>OXKR *6L?:>;1R0W>=S"\W7?<I;J/S
M+-.;E>C?NGUCTE3@6@?>35BY)&/8R:7TR,V/#(KPKL;CZ'7XAE.1[-7,.BUZ
MV!7UM<'"*W9)*^%::Y[W(1WIIAA_8 WCF2Y"'T'%$*V8S@S-.H=DH8*C FBE
M&EP$ DSSY.UN+X<4?_ITF]1S)0Y;J(/^=$],K$3[>)9,5-;C2UFTK!7QTL3^
M8VI-*J<5(9 7>0[<"B6%:?CI 1H8'ZE]I4LH7?GM[-F$:DCTBE/"T:JVF%T4
MKS)5>:F!<[)7#25FK7Y.VY5-;9^M;5<=@O\>;./A0G=*=-SJ)OV^5,/]<:JN
M:<FU.C-D>,BFS?>*E5,CM8]8*FQ> !7@F%GPL\#6\G*P+ER@CBX_MD+Q!OGN
MAQ@W6 G&*Q2Z!36?O<[?>\TT0.';&1^W@&CO33P>P\0;LMN\;>RS*Q7^RTSD
M+?>[J->C6 T@V"I;!_0, XJ<Y=$OB;Q\&$2,E/!V(MA<0%*X\>[WX:H#L]+0
M=>Y212G\LL!1HL40*\:C1J%#(;%O.^[&\QF[XMZ<*6P5=\^ZG)C2O?N2&@[
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M88/8R%SP+X3^KHFD\._2FQ<2+R1>2+R0>"'QOTWBTE]LT_X8-SOE'!YH-O'
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MYH]8]0C=1P]C\2F>L)3<[4"I'F0N7M<WC6X4M@QRUJ2W&[K>RY?[>'V8+.7
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MH]%AJ%L'-$)<O\;0:]W^X)<6YE/"ZPR:@E@+&R][2.O?4R^!-$WV058&E=!
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MS4P!LMKI1Z5*B_P#=F:<6<SP=?]M^ :Y'NP$@O=NS4)J*5$A6GL@_/6C4\K
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M6?F9PD2MS;[%^,X@_VK9?L$H,NX0#1050^X_!$G^Z;5$_FE#*2>#[)38UT*
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M'?>!3H(L8_>,W]]:I#I^]_!U2XXL?>Y4BP#<"D2G0X(N1F *8H+FI?>9!PC
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MKK7Q[ICO&9Z@!5JCF&E#F_MQKTW3G0J4=J3G\E53P\-/6=0QSZ6Q01]1LQ!
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M0)GOPN<[[CV4$$ 6Y2F7'QB* "K ,RS@5.T*6 (R$!G#6PO^/'S&@ZQ3$H8
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M8%,D S[U;X>9!X50*11P\*O3D5[&63O;VW1&7^'DK=[+)PH7%.C4A/C)4P@
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M.4' ,)F+,,7=4WD&ML8OTHME83MX'K3;8N'GF1'&IV]<8FY-D7$TOG4%TDK
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MN;.?/,YW/X_!\?CLO,3PVB?L42Y-XPA$BOHX&@XR\/X?Q+UU7)/_WS9\$C)
M0I"N(:"H@$A);V 0%HB!DB(M)2 =(R24F(" HC!0$!1ATMW2'3*:C=&Y$6/
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M>Z<J($B^RT7_R[,"R?=BT=BC@C"#X+%,QDT(W?(=YS^:Q;JRG?U<.Q5;J[G
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M)L.,->6O9F2,T&1A81'VS29NA*6H/<%V4^][8JHBSS?5?:3."W?PM0>7K5
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M'S9H5"&_</"H_#YE]0  97+O(%OUXC_BS9&V()O/,VC[ZCQFV .E7:-_-!@
MJ^?S"EVM2LK25N>TA4Y]T1>ON&$HKT\Z =RRA/QGJ,!,-[GI&P7X<A;I.J1Q
MZ_-:(Y61//=&W>;UE/!@7=6\N4>'N(D'QS=LJX_#QI2@NS:E-%LI?]5A9A93
M /A)M\/YAHX'NS0M)+-24V3D80SW%$[1*+=H)A-QM)#V,YC>7%\R4DG0[IF1
M8%T'TTJ5CA:IA#BZU3K96D9TSSLCH=G2RFDM[!,)_9S60CSM@">:&E8_N]+K
M4Z8+2]8Q(&L>&H("YF195NHO%H?U/XS7E\&DVS/&&WL"+?3Q[I&:<D\RI(>=
M2Q&1$[^_(AQ9"ZJ?Z$?/:7U1]\>/'*&,S?;AT/FK*-A:E\&"EI#D/V=>_+_E
M +5):%E2J!+L\,#@F*'.(^2BR8J)5^R69DY$0>T0BT;"U;P>A4^<((W?7Y]^
M?Q+-S*"O>4+7T_-$^H\*9?GLR]=SYA/ZN+56]9$G\3!XF8'(\UL8)'.K[-B2
M.E]HV::FY_&(\'&4AKL6?[WRR#P1CF>;O#T8DL@X9M)RWBR\O_^,./3\&D([
M[9!G:$)=747F67\JBY. _0 +^X*93\ML5'D]6]'.TC@$*3_G&"4F=_R+L$?5
M,6?,ZX!K/I["Z9_VC9:Z(Z\DX)<9#+:1PBBR6JM,]EL'$YM.B>@'9N:7[_.+
MYSV4E,1OS-0ESC$6%N14?*!KO<CE!?V5_13>535) :+JN4:DT\9WI<YK&WV^
MY?M(V4+N;:-'<%4FFSIZ*:POB>MP;XHPU*_F=[F@MOM\G(I,BI$.=GMW&53G
M7Q>XE*D/PZW-%2\O8F9^;QK-&'KPZ,VWH2;8#1DA8V+UL?_W0/26OQ'?/\@O
MZN\T,[!8>P)__QJNXE7!;OZ:N8[^G,^S 9V(8#L)#S,1<C*5\C?OX=I)1.JK
MVU^4):L^K.?S56ZI;@]UD?5B/3<SMS#_5C&>20(DZK-;V$[F1KV"+M/84X!
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M3@]KM*6+O-\'S6I"/L?5U[&_KE6VS6^NH5_9^>I9U-0BB]8^C!7 PSF('^?
MKW?5X\X=-7-FGTX^BQEVI2L<9;FL+UZN]O)<#2S\BLG7=(QI]YV[7:L#!1C?
MQ,5SL1OGJQI=QT&Y@0.@1(OZO%DNI7Q-D6O""X0OG@Z%ZJ!WX?U6\;D_>_V?
M!3(./F)4?I[:KU;\X4G8@0?-R DZ*<1^O.;:6UR7-*)4"!.I-;(%GZ//#OY<
M'Y')3D/LB0'_DCG#<?7S6#/W@Z<TBYV-2!L\G/1:@ (<A[M"=TV-X_\97R)
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MW)O.6>_R@0>QI_P%EFJY,7JU@IB](6R5\B5;1YN/=KWK+R";=R_3QN?FO'Q
MLY,:N36+<?OU\>.=.P9CDU>VNW\F+7 R=P%K Z=C\0FQJ($4_[B4+(=+ZYOH
MC*G8@R(]?G_[O!]P+E_9&WBOG_#[%1 /%EU/CI,7V;7&5(5]1>/][6H7+4/D
M>,^!.:HEOXQ'0M^[:[$30_%W-V=-RH9(XMZ)U9R2B2JC]Z0^G;C1H=I>X0&R
MMG@W=Q H*#HR+G"T+NW*S'+I..J%R/C<S\"SN(;KN)RQ^FMG%[:7;(:Q^T\I
M@)<N<+0WC[+R<R/4",:X3&HL3VB.]<G+?3($10>>^#/XA^I>+#K_#/ZI,69"
MRT:!<:\L+:A,T2FH8H,CFG",Z)X,_[3DWNOSDF;G41*!OUZ.BLY,EJD+@BN_
M\MU[[&[_-)PN7Q(9HRL+$KO-\Y;'6NAR9J<D<[Z990R9UZ%>ND:Y=;ZXX2E=
M+R.]?GS$NST(28"J NA^,=YJX.R7J9S7%?YY&VQA'H5TW:7I(5GA(Z*BRVZI
ML\H_S)AI"3X8/B'AW3ZMV3B)JC<H0AKC%M-%RG!I+7?LF\T=PS@;CX>,^4GL
MVS\VC#$BX5Z8=T.* ^7R/[KE:AUJQ\U"M%D\F(1V.^B&J@U8'64P4.:6W&G+
MF+SUA'[$_#MU>=/D[I>@/V/2!8GFR-RP0..\Y33\%7WW\BM^OH\7KKI_VC7B
M(TVK><\'E/5]L[*W)DQ^G/0M<$>HSM.P#^QJ2H6/[++3D^[[U/QLH !W7QL'
M$L:-)SL,5ULR,D)PJNW<,4XXSC[U9*<"?\=,%J9X]:>QNE\WVG=: ;_]N%H#
MWA@-;]F-EI./)U1$IT<^5YAY=TI@9^JVYF1)2=-NY#KX#C=61'Y@72;XO&,U
M ]RYJ(6C/+R;15^ZMS)%\A,FM#< %;T+VZ  [):.%K $0AZI0=ENHY[8T;^D
M)1+P=WI'=PY&2EZS//(F>ZU!Z'"6I#-JYKVIA*C)P(/::;)!:L4"'=]4D)1X
M*Y@%BI' !YKL$]K'20VR^V"[V?2HH\EVRQS G_N?.?W=PT4-'S0%(-YYJ?=R
MMB((WE7UA-0OV=/'G<HW!:U#:>;1IK9T/]ZJYW8L3[+ORIAXC'!L:E$(A_?5
MEC2J91%]L$?3LN;3;BPMZ]MZ+<P_!"]('F7;(P@E%AA,$#N9HX%UW!'L<*0[
M_@[YL<1NO4A3WATU6B5SZPX.VOH(:EO/GJ<M<IV SGZ3'B[%_L%#]U["6&P:
ML(DP^GD+7*&Y43QA#760SX.+U)3$_]ZQ_$4!>$R)R%8=4[$[<3^>,9KA%SUN
M0=1M/@4!A\9^O(WJ]]RKW4[=QL'<9:Y6'.\^A@]5L;^N9DC/)N;>PI$CG,5I
MQVD$8Q2Z-END#>['-61N:(%O/(&U1U0<>UC.7_1_+M8N\)GE8@BP2YNN)83X
ME<[@QN$K<CCT6^!6'J&?^7RGW?U$4)5@R'[K"R@HT,7:RHXL^-O>] G]#\+0
M3>]O_0\D=E7G_>?C*_O+C)GFD!$"[*^1YQI8E>)V:VO?/OU2D7]A-?B5_P#(
M,N_Y1'"R#2IU_Z?I9,3THAZ:5K/.X.>:!8V;! 7@)%_*6:B5ETF\'>^[(!H;
M;Y#E'("N"#2^YX)CGK;M147;IF@$C15<!?>4P"[N-K 1K6_BRA$$S8MC.C\\
M)6(]ML&/7*ETPSN3[1K6]E.%!>T3\4=B$]NJ".:[O$ZRF&[F* SHC6(JSK8P
M06;]E,6$QIMG*5H_,.F?Y,-16]:QN_M(O:KRL.U14Z?WB0YGC1)UL!<;]^B-
MDU<;:!5K/I!Z%1Y5%E_KC'_\JC&([0%V+0T8(Z9BXV1OXEK)"+< KHGD*1WZ
M-[PLALHL/;K3C?WU[GM"47]--LO_B>MOUCS=TD_X=C;QD'2)T_$=?5Q17%=X
M@V9G.U^[21$:' 7#A4]9WCK^1I@MNW@)TK^P,6%PI*OI0!=*W*, 9WK%R74(
MJ@1$.@XVS(-RJ3]<"CMD+-1M;V"#8I3K2ZK(HT>\XUBYC2/HAQI)U3[,FPWI
M#7*GM9M+#2Q)H+V&KX]!X<\N9>?_Z*Z_9@(MU;,0^YIE+M2JPC2\=]K%-4OT
MKOYX,Y7<21;UW .-H:[][UYLI4Y?<<PB'"L;11B>_N"R)9[QT#2:L=/L>!04
MIGIX- #ZX1O^:\(XTEEDS:@F7HSK_9S,3I>NK? =WZUF<[6=7Q:0.OS# 3$5
M 7U^?,N=\^(.AU)RA(.@&RZ/ ^F+WJ"O9!7VNS.2&5U^72>?_7A@_&W%WSP^
M)O>&5:[IV;H?UY@$O/<EM@VJ%D,T8OXQV8PD3 '$=$(IP--)V#%/V9\/ 5BS
MYS%5,)^&%@7!>RA BHCK\1%L@J]M=K0Z"&Q [AR45IQ5[CTZ6_K"[Z/WUEB6
M9^PG>V$%+2'E-DOV_A^^.NHUCR?T2P\"1V_PGY._/+;5WA4<\MO@U8S:\)8&
MU"W+TJS=#>90(\;Y\YZ\?5SVGJ@[7!MAYA_GUQ!=S[*LUOH+]4BA]^O4S<GH
MN&NM22BF-M5=T0!#D'TA,>8F;@9Q=C'71^A\?C+\Q>R9W8>K!@<K%F=QFZ,[
M;5 N>[S00+%IB\*TGNX-NX[K_>#C%[FCU>K@D!2YVP)'YAESE[7'62NC$Z9L
M2HSS' ZO(#(=BU8.;8M-)W-QR$>:G9KZ^XHTBY8B#?-,V3!4-Y5[*>7B/K9Y
M"R B-UX^68H7OMD9F'7Z5/US]FIC5#PCH=^_YX]YB=X1)]=;4@#MO)?(B#1H
MC ;'E^>TCLY>#&4T.=$,3]BUGA@8R8V] 39KG;":T.9JI>ZZJ6OWY, EII$G
MQOL![$_0IPP5))3(FSG%Y,7.<9=/5RPHA7/\>*F'OW_@U!=(U6[^H4%C^L71
M^5O?GY?,MF5S<+D?,,_T>+2#K[+7^>>4E?)X%YF:7G_;Q/DJ7I'O(5TF;8@&
M"(LDQ1,L":P&Q_PR02"+ &Q#)!B7MO9BU7(2;+U=D,(NNSYC]Z)GO ]_O/E^
MPR)"2\0*CR)?CY$]8I(DQZ14LT?>%,04QO^@N7\ZC/W:3MEC_&PXE8$J#9X9
M#IXF0"\NV.]H(!14'IE9OR#OFQ$*V$\NPW!Q1-=NO2/="4A/3N#T1V7;URM)
M\?5_HF:"#;"(!DY7%R4EJ+7S9/>E9H-W>E+GZ9!:=Q7:=!0LKSY9O6(2D5E3
M4A,6X*&PV"IJNY+QN5CC'KJ.MW6T6?/NU$&'G'#/=>D\3;JG\U[H,-65M)T/
MP< OL_>!.LL9<#L^LE4K )T#M:K7!#U'W<+%3=Q<ULO0PSZY7OB"FU=T262Z
M0SC.O_Z=;*I^J<!'<4N_FW_8$RFP,<#^S8+&_\">W+3 &B35^K*A>NG9H'K?
MC9:/T==N8HR#R0P&0FAX@;]QJ^DW2:)CGG[N[>)?%DH?YEX$W\%JA*^%!+W^
M016Q@8+#M=KY_=^>K,H[[DQ!/\@?7'U@IZG';\2DD6'@OU)[ 4VL5<?H#%S:
M/&U48><QB1G+,?V>+!U$ =0 3#U#RV=(LF_3TR!'N[/[A3:/Z\UK/$GJH7WJ
M6,W\H;)9#D<+P>'YVI%-; 2W1]&FX#SD39T^!="4ZBN3#55S1NF8RSZN++HS
MSM')FUZQ['.!M/.H%!ZFIEDP-/5\(J+O:\MWC@5QD?$FR=PZP*\]W$LAGV1=
M.C)/"RVSZ+XT%+R)_L4^PKQG^5>JZNM,X,6(6A>W.4W9>S%W']N\N5$2W\-U
M -"SR*-/J;,M5D,%?"W)G%1F DDF]!>[)MCL!"(5-@EMNCN9; 'H!E+26,/:
MHN6BU$!^!LXRXL]FM;AM1TOG(XMQ 0/EKFWROK,-]=:7'>BZ@E66&7:TRT;G
MZ+QB#CR.OKP%S8]1@/JX%YZKO#!.DC;&7'Q)3- FTD-OE6G'INV%_'<V=;1_
MJ,4&5IQZL8QV1<>9DRYWLD/[7^AA10[:-/$6YCA)+;O*$0UM>=8W#;8A;]D>
M8S[!;[-^@6Z _0%"Z8TX;JI #_FCSY<OC/Q?RD]$$/^\RX#5=TT??R>16[ZX
M9@/-;RW^C0(XZHD0-9]GY"J".>OE)DRODUU33ST$:?"]=0O.^*'77XDTQR,B
M1/'PJ-G;*59NY_82+_28]MB(^':LRJO%E\'1LI$X7['%[?G9DVLQKQZ/7@.E
M+F2JB@:VJZK#MA*TA'M]<]OO,%AYYA(C9Y3/?R/X38.F1!>8($?O[<>,RT:,
MKPQ8F'2[>'+>H?]NI#=E^U@D\PVPJ,&!#5)O3=.LXI4KS,[CF9L> \V I$%>
M&I_@*_I8A.#*#/?@)<$-N?HO8O*FIOFV%>@0/= 9[57?E=!>CS1D8_JYU87Y
M8:5;,5S6B(MZO[IJ=T&B6)%LA']P DY6I_2#S6\EP8^X7(B);&+<^HM;P=<-
M&0P:"QA>9E  RV3FYL'C%$YM0?+3'MUG-(:0JA]NKRG MG$!;&/R -4P::IM
M[\1=5JK/PG%>#ZL=8:@&2(7A=5O8B?H:ECQUQT4$F&SW<?MXQ9(5F8!'K6B)
M1/S9+-E"%[]&UDK3/0YL((=;5/WC4$L QE1K;_6-Z(JZD>&+&?F1VL4A=W(Q
M\R@GR!<-=]XOC&JK5Q@F27TQJYG^I72:XTBI\JGY)QR;.N#7B7V#^1]==4DV
MB6FHP/5Z]==\3=)S;0Y=\-N"]79I]UW1HX$3[*'^K(VIAG@NS"L/R7$K&<1,
M8-.G8QIFA37$S:Y_#1C;XAD=>#+1ZN+">8W^)J?*@-4#MA!F3*TC;OC/*N&8
M6)V=H  V1QI,O,D$-P5OE%V?#TO0^LL-K=.!9DXY1,^\H(_>)W7.7?3CV.(_
M?L%>I)G_GBC(%GWX$'LB="_G?>I,5<*S ^^-?MPF2&4KEH T^6]YV'-+VI?C
MA;'5%D7NSSX6BR?*JKL-;-X_6 S1Y#7'\R1CZB"W>N]NJMPSEA+!U%];SA]!
M[ S5!^%<OWK!8KW3/H7H$O+';2<,IJ?X0@]#+>#9@1R#&ZXIV$<CE[RN"!O"
M+_ 1^I@T-5<7EIKS3-M&R>)#>WRE"Y%ZV:8JZTT&;P&MEDLT=#\W'>@"Y@04
M2! 4;2RBN(C$P%1X$NV-S)U83DM/[UT_U4\(/:]O\U Z1ZNC<RGA\,W>VD<'
M-QF[LLI8??J.P8ZXP7>QIV!T%KH!.,ZA6RE.POX.HIKB*6,W6\CT_+!DX"6"
MCT^YQ6G4B/G#&='XJ"5NWB;8@601#-73T/-HZ[7&^1EQG,. " 7H#"IBJ-JN
ML,D"J?NP5>Z15@U.$"W)'.SLYZ@NJVPC(9OJLF2WO-L,=C+9I8C]7Z97ZL\7
MX96^*R>+93H"'?IO\8B\-DADG4%SL/P0R?3K#7='=X%IE^.]_,N<.M/$5=VL
MK8,W$_5%92/K=L5UH9+E'[P[!6,CP4L-S[>G#="05/?+00K&5277?I^+O@VE
M2Q;']P(OP9P:[KG$@!:4=X)9ZZ5\3\%K7(R-I0&1)W^N@U3ZC>36XCW1=J&:
M7]-A!5/B8M,;;V;%!9/UIV9OHX,9"AT0=+OFD$75/:GQ/<XHR*,F+F?/*5I]
MD7$*P+Q+_!S/EW@^P3J.ZZ)8[ FZ3+J?F>R(8$GJ<[ HHP 5;DN65XTSB%\P
M422)#-D8"_+8$31U@8Q=G]SY20$"?-=VD5<SV2\3UZ@T\4;J\:LD"G"CVQ3&
M!)M_OTP!"),40%?3_']F!OGUG#@JY12;X2L9K/]-0):X'>^GEG@OV:TDP>OB
MZ_+H>/\N0OQA$&JY+6%! <:H4+9K]G""6-%" 7#OB,]V=(Z,QX.'2_9G+(YK
MS$V_Z@1OJNU_MZ#'P?YLLSCA-ED_OCA52K9/6L!>S(]UA4ZO9>S2^+1!MR6<
MJ%?*6DD!!ETLW'#L9 VO_L,U]NWG>^;6!N310=G=6>6N(_/2MWX??9QG<CQC
M8[&:"F:S(8%,5!S1X!V$.095;-R.0XAW3Y:""?'^ PP-T1JF6433=0HPJ3QK
M>W1W2VK_[E$Y%OI2* B#&BU5W-!!/1K.;"A*[2U+]VD[NKD)ODK#O33+7ZN2
MAHP2_SU#-(V[(.$FW5K3*\\%V(N[B7IK.N7AZ&7=T*RL$G3G!L'AXY&80PXM
M8>$_&*2*G[PYSI:$O#IY-O[:\YY:9='JIWOH?+(7'"-8I>&#?\-J]QCFY>):
MTO$*%UM$C\93 !DVIS$-4TQEK3&F.UWL2:R(XR/]L,WS7=H@?OZ5^+JUDXU0
M-BO<]?T*D.'1R_V+><AYOV"3,'V^*<\D>%>(?+"*H\Y.,\]AF%A*4>6)L?BK
MT*X7L)EQ"\^L7BB<%("9-'UK,M,UP?=)]:B3>=,#-N,<>Q2?7A^*9XOCC0[4
M#,KN:>)<%0OMVAR;?E@T2T]'-+Z AD8ZH=,?+9)6&US\,K>UCI132UWI=RJ7
M,C/9]M[))S]E3J"R3$M5HNLQF8>D7U4Z,G(<5^(F7<,$N2?Z(Y.MCD:EGY^O
M-TC0C *\T>#]3*P>T_TVB5!E$*^*CD@&93H+Q=>>TM54T!(@_#=Q..39_X_
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MRK9XAQYQ.RV1V#E>XCX\W:EB[,J\'X?IV(?Y5/5WFFZWY%[%]]G+DG)P9+G
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M)RW'C9_>@?I1MEJ<"&SO6^<RU\8V^DD,>$PFGP,V%74U<Y6#,;EST4L<3-V
MIV8;].BZF^#QSCDP/=%\4 <F.A4E("?/L_IF_.2) XPDJ?+7O GR \LJ 5V/
M R2A;#A500:<M8W\9\&7EPU50)@ZL(=<S \\R9=R3MP35*^O$$K2%U(LW6GC
M<C.ZY%.@@\2W9??>(\T6D9&6H/)[V+@./M.KFT.?9S;,-+VTR-X9>@5.01GF
MC6B%CK1(G,IMW+-8AP6J#5?8F5WG L>'Y'-G,\@Q5-PCNRA8Y.J8&/JQM!JC
M4]-1X+U;@QSAXDN)@U(9B4.EN)2VVA9N3"SLH_'F=ZYJ-R_[F)HE29W;PHTX
MF>4=9YNHO]@TL(?F:I+.6:^P.G8;#[XV3'E)/R5QX[$73[U8#EM1P0 [G/ZL
MN)'E=DF?RJF(B>*?7B4I-_OT*KYKLD1,$_=(9OOKXZ]'T%<SC2020Q^<" ^0
MMX&HC@W)URBRUCZZ]@Z]RSDU$/WE2<=;[WC$YS4VGN%3S8NCEH<PJ]AK9#=W
M,N\^&L(2J?_]!::18-NF*<>#"6-.VO:#[5N<+ Z(W SWQ1# .X^ L& IWV=V
MYP#]P49>:-;'.875\+L49BQG2SRJAVAN?BE^@5FK6_;)=P)S3B2(R+.6Z&-0
MYP"Q%9MP[<-6Y<B5&P_T[BY(Q2EF%6?!,3TV07$+PG 1LZY1"G>(J(U-*-_:
MXU-_6 @ 9I*QRM?,!8&>&RF[.-V)XD3377XT_EB>$THCL?2%Y: 4]I82%/ 3
M>/MP+^#$MT@7[4^#<^[OG&QP?9(JL)4CE+X90BLE_BHW )!9>)$5/!$7T,0@
M^-96X%=LH6!.UI/;<95'ALR,#BC;Y4M[ZX1(OZ ;LN/X!3JEVDGPUY&$4R,[
M[L\(M3J]']<-G6$SZ?_ <R(X70GCO=%S=G;@!B=81H@\VY^UC\;04%'<OD.(
MMWNF4)>'P8N06)& WF@\TR?L]F]8$J^H_ U+#-/+P@18&I@FP!*E[E80P7V\
MLKPF99JYZI=,'_5]IM;]LDATAK\KT2*,JGH/ XK:YV<P ;]1F5*\4WIH%D]A
MQQ/7X,'F[0QZK-PTNY%\S1UB5]]<&SG)M)LE?^4,I#A2_YM,R TWO;IF6.TI
M^,0][[L$5?3J1=>7^^N)1@];VZ1UZJE<4&2?:H=NL18J<9RANOS?$W799'%$
M=4.N\8LQVR'-3\R;M.P9N>C?6\SP\&#+\VV^E_E334'MUVN/[7!?:RMH_)=^
MG2!TE6;U88[+9Q+'3B;I\I<L-M/4KQ^$>>7-)K WA/<\=].>#JN3@(18_CXO
MG@Q=VJ?WL"%;267%G38W:>: QJ8:ED]!]49THX4OO-K*LTO$*&2?#@N4V+^J
M#^QY$'_WY2@D<#7/95X0<SEFB3'(.%?!.RI\:[$'(]EF>_:S=U#JF,;$BJ<=
M3//\.UQULM0]2UQ$A8QCEM=A59ZM%F5Z==V??O1UTY@]_2,C^(7X%56_JQ['
M>ZR;G3),>?.G]W'QW)5>--<J9OW*?H;-&;%\>K&4%>"-OCB!S\3<QJ.6!B?%
MOM5+.ME>5W+ T2V!X\M-AD4U()T((P/W5/N;M7$9;G=\*MF6CW^0B/]%QX\?
M(W<\,MHI%3D[IT!F\SV0,]!E1[#4&_SW2>)=T%_Z1@W\'%1BU.2*7G^62G0,
M@$HM^$*QVFJCKJF_7*6GML5N_<A.GE?_!,2U-CD:_B!NWUQS8E@ 9L4]W\=G
MR5? \6-E8?=Q@HL# N991ZMCR]KO$E^:G0,MRJ9=\6AY0OQY\92#/X,.EW#
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M=+_HQS3J4L]\("6R->,9C$OK^3]>50/J@!WQ74\Y<_G=8O2V^;@.1.XK0G#
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MAP:L=_LW-=5$<D4WU+K$ P^>N6#<:/_^5#/=<2T*'FB_CX5X'"XJT42$ZRZ
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MZ[<A'597LU3D7-H?+'FIB=$P^%:OPS.U6\E6DJQ!DG1KV=3R:]6V2\=CXU?
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MP_.,6.5LK* Y!7PX]+JJ^+^Y I#)UPW?+1GS+YB>DXY#]:J&4%@",K.<2TE
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MI^H=R?Y7K D9GA($B=[Z\%R8^JI9-F+&Q R64%"5J.40M,#DP?U23+51V8O
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MX\,G]69J3\D/<LZ=AY^8C5I9V1<:/K&R)NNT)R.,%=W,T0(%^CZ\ A*;W:\
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M[1<9Z&3D]&PU+B[Y3&'<*,(7J"_%SOD+/AD=;TM3TN#=W&1A(4W\&FZ]BJ=
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MEM4)>_R^$M$(CG"W#=>00F_^T4'$M<0-;I T5-41]#Y2G='A2+%28FEE1#^
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M0GKV #+#S$B%GX1@O#-O$=/74N[R2NUX7*B0;?J3]Y<!/U/(CMI3Y)"_!4V
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M?GN_G,X=SFXE<5T^N"RKSW",G1* [S3>:BR36S7*]D1""6"*)'1PG*BP=W*
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M[S".&AY6&8+5(DC6LI-U"TL+9?#H(M^B5G <R4V&S]YYWI>Z=LTGA5T7RTA
M4>+V852<&RZQO[(?E$91I#83]QO#4(64<77?V3V5P:+IWZ,-^,8O:S?<=031
MC0T_-S8O:U0V%MV2A<O;>V)J>7<Q?IN0T*<+;R9:U3;O!F:^N+RNCY.+ R$W
M^KT#_&T%;0H1ER9;%>KYS1UW/PO;75Z]=SLTHN(.26G. P&^G)3<4I=?]?SA
MX<*1\7@OZAV&'H0!,>=#*MR55/6@\4*ZS[%J08X?CZY7!?_68(CISZ2XUR%
M8GLP\P?A\9]$D.<M,*':'&3/BQB\0L-04A7TS$_CF\C7'1A/C//-">S+[(D*
M[SDJJRV>9Z.A,]&[:#BHA%NC.%E?KKLTA0WRYT,T86M4/7I86:[';1Z=T_0G
M3%.Y_)<U,'BWW(!D!>'Q_)W$/$\Z4\AI<(*J7(UN_-U 9M$@=DL?5%0=_JBH
M&D[%)OE,HE_%)DL6OQXZ\CG,RVV2\XO\\^GP%V"B]ON%2H:#6Q!FK?I-W!#&
M9>_6I^D5JN7H9QI0X-F'A<?<)D2F/QWCZ<]YJ-#RX]5IE@Q/P3,F#0R[_$!O
M1[E>.CS&*'+C6EFDG7T+K,0M?%=^"TS9Q,J3&Z==M"T@5(Y1[=D+CS[TK@I+
MLN1^^_A"W$L\T'U8>"K)B\#6O,I0T)]S*E3S<]^RF.W^Q!WD^Z1I-V AF9GL
MKQG%4]KC*A$)*?CU%$F:XO9C.[F\-A2HC@F&KHM"]Y'--" E^VGR&1H0\R*$
M6G,/LLMR=P%W&"\\/#E:$%F&[-3,0[N7N:*(0^B[9.O]#.)1*#<-</;UO_ 0
MLX)[U(9("1'8WA[L%W2H /RX?2%_O@?A-^NA_2]+FT!;4$[,A)E2[)KFXQ$7
MS:#\:"UBPB02?.F3X;?Q-[U!6]>S2'KO/72MB]^U\RTFD]N=^_,7_*YTED/M
M/Q=\FG1)N6_X;@ARD'YI?\@!69!%TY94/!XXQG4M?M$?L>%X+0;6Q/,QL3MW
M@#\MF66_1#_>]HN84?XA(EZ> YY="@A5VK#,G.(M-R3>8K54DAMN#@#"M1F8
MT^]P;36@^#>3H!.NR7%'+F1G6UB]@+K?_D5/&6.U*YBSJ*?)EZRSQ@=&%E6B
M%FJZ3H>+*Z?6<MM<@L0C1M9O&*2PA4[)4&)&W:@5Z WN>L0_5]C2R"$P%U2M
M28+AR"O+.9GS7^ZO,TR_+=U7N#_&2%\G41Z56/HZN>Q=#J:O4UPQB+=A.@%8
MSJHJA]" TS3@YL%;OVMS6VN%50LT@!6:AT"Y3V'P*)6V9%]D*\FE9$/%O<Q]
ML:S[H_%AR4:MP^:MPK6FP?+CMMZ1 6EOT>%R)"9;.FJ!:XWX!LBAM=ZQ+D^S
M,H<N_V@Y]E$!S\M6F1(4$QFJI9HS=C\M03+LCJF8U]F%6M&@)>95Z98M7-#0
MZ<T&BPN[ 8JYS>'8)-Y=QHN0#REL;Z8@X><UY2;+"LU_)'PD%GCGIK:\%%N;
M_L'79E1HAQ I(;*EIHXNJ8_B6^L4?F9G)'L\+2N6U7IJ **"[CQS"TK0>_^K
M]=N3VTL, D]?BQU/8]>??4UAQAK_O[3=&X-#$/1UC,[-1/5KH/=YI3VG<X(T
M247\*V?-I)\^Q(!6#ZO=D^Q6@]S2<DHC9-1"R?J:IIXY-,!I/Z/=]&3SGG)K
MV0"$GEXTIOOX\!!&S9O=W%D\+YUZ#Y\Q_E5%$B'H >[C_S9SS(;RPFMO$"*C
ME%I_$Q-K0E?ZRBI]S8N%O.<S\5M5.2JF9($TRQ'-(<M4[8^"\[^D)/1V[4)V
M8NYNC@?N/N/*6E+_O>T>$B-H_,I#KELCL0)XC/CWF6-+K[:8TY@@.7'_0[;F
MS85/GC67&60K==5<C5JJ53?%ABIL&AKZK^6^_/6+*7B(>UCPL>P)>IQ</EFO
MS=RI:7W"]G9072<+S/V82Q3LR].+PG7\0']1Y8_><ZSU%:T5O6F9ASIK4WEG
MA$=9$43B/:W#5B<ONDV6/'1DL98T/RW ?ZL1.#11?&UZN-+I>]P$BUYS:)WK
MZP62-7I.T,1TTNJ%&?M+&9X]>2M+T=\>#QA>[??"^+;GAT\P#-[_W.E(ZAR1
M<XP];7I$[70@WSQ.*?03>:]66[1'[V5<YOZGA<RGR9=?5RVW2'%WF222929A
ME%/"HM=-]ISP_K:/*=B\'91_I0]F5D<XZF!\SE_[W]Y =("Z]Z0>0_%'9WZC
MPW^6DDT[5:NQI^.0'CT=#-U-2$BU(I-1F9E?@4]A4O^K#-12*8%0Q?47\F[M
M,U3UV-XU%=U0/GD6::*O>5C02RQ0(_*I-1%;;Z$]OI(/]S#/!!HQ$DG2*AEW
M1(V,KI)VI4"U(@1H.%5DV=V*G)O0T';.6A#PGC]-9TSM'B.;R^$FQ>;FEQR<
M6+/+;51%]2(5+</H1)]\-#;LOVK#$HCMSS\1XT*MC.1?N8JYGR___#2'@5>[
MCI-]?NBGF12H^EDI50I^5.Q+[6=#U*/PRP8S2K_8O:1\ +^)Z06V)]?UZ)]2
MY;Z,.$9DW"\]?/>QV9B\0N^;Z#JV$KZMZJF*H3!@7I-K4L#M\(*84=A%Q=4Y
M@_GAXM^V^)C PP#D]D@_[+\JW1CJ*%<(HL0O<0R%[T_UN!SC-23D" B\S^U.
M$:$!$4_Y7<N(MVN\<Q>QJ48!)PR+H,J]&0-I/^!HL6[Q_I^=.L(</I\I,'*4
M)VMEMO.S5B5!A7-1\;:7EG\DK;I7M;GCHYT&RE52S,@..H5=+FI73.8\9.T\
M6^1V,2T93WH_!1Z5^A^P!J+=;F'Q2QF'CK>5Z?Q9ND&@U5K66G".B5*^'H#8
MEX@B@J>T,YW<<LQ'30=J)O*ONSZ\T@C\N,7@W6BTV.K?@+%V2U_L(RE_Y3P&
MKWN<PA;H[Y.E^+_F$%F>G-(RFHI,]PI(;;3V)YE*1"O%"F@%7]D^#O[0P:C5
M $/Z;E^5 J')7A/5$^/L\0Y2NR]:CKA:^('"F< E@E3QW7[K_Q]J1A,QHG;;
MLC'9Y]O0H/EUSZ?4&TVINJL#[X]4"28S0%]X]1B#DQ"\W6Z;./!H]5?3!T/7
M^E>G-%XE*$O/-B@$@_G F">;9E(IC&'_\XU=F#A>F^0*Y5()0TC,C"CL=.E&
M\EQ&>+0D\PI/YQCILAVZ3!ROO_+)_!&AK%FJ:B,R4=FH)Z1X$^O\*5#S]D6R
M^Q3T!/FUUYJ =E-OT)YF_'DIH9-//IY"5L#GE?#/;OYCO/G_I_D6U]& 4!_M
M,W O%]&>)][$G4<2+I_N,D6%=,B*;TW,?ZWWNWZ"89)4*4O.3M,M,A$63MA/
M X[8YT;KB^TO-(&7F[\:/4?X$@7NA*$XN3+NU[[]=/E8?H^X;[-D+TX;P'I_
M"I1V)/$,62:Y63OP1HZ-R0D^T0#DR!B__/\-M*]_[7^._0]KBO_:7_MK_W>:
MW7\"A9*EU=:C[Z8TH+%D-P'XBB,2:,#MVW>D:0"$?4M)Z1_-*G_MK_VUOR;_
M!U1@97;S[YVC =,C =<!'1>)"U?$8I9A@Y)4 F7A4R![GM'^Y$XGR8 &E$/5
MI5) *S$T (Y\%A"-6F-OHZ?0>^(T8 R2!+'#[-5NT!%)NQFZ'3K_U_^O_U__
MO_Y__?_Z__7_Z__7_Z__7_^__G_]__K_]?\_V?^2@[)Z"+FW[/&05%&10G+/
M31T(;?"_ 5!+ P04    " "Y@6Y42!'T"DLV!0 92P@ $0   &EM9S$W,S@X
M.#0X7S4N:G!G[+P'6)/;LC<>FB@"BA($A*W2(8(""4U%$"D)/8$$ D&ID@30
M4 6WBB*@H7>(@%)""2344,6&002"$"!!B@6D"VZ5LM6M? '=Y?3OG/]S[OU_
M]Y[P#)#W76UFK7=FS6_-O.O#ZR\!.V%F4#, #R\ P,/] :R/ DP 6[=L$=PB
ML%504'#;MJU"PN(BPMNW"TOMVKU#7%9ZWP^RTC(R^Q4TE/?+'927D5'153UX
M6!,,!N]3UC^FIW540QNLM=$(S[9MVX2W"TN*B$AJ'9 YH/5/?];O \2V;MLC
MJ<+'(P?@%>/A$^-9?P38QQVG ,_F!_#]P\/+QR^P17#K-J'MW +TG0!>'CX^
M7GX^ 0%^?N[=B]S[ 'XQ@5T'-(VW[+9W%Y0CB&M=22G8*G^BY@$0WO^3@K9'
MX-5M0A)[)*6D%9645535P! =73U] Y.3IF;F%E 8PL$1B7)R1GMZ>?N<\<7B
M@H)#0L/.AT=$78N.B;U^@YB:EIZ1F96=0RHL*B:7E):54VKKZND-C4W-+0_;
M'S$Z'G<^Z6(-# ZQ.<//1EY-3+Z>FIZ9G9M_]_[#\LKJVL\?/VWPQ0/@X_GU
M\U?Y$N/RQ<O/S\<ON,$7#V_81@$Q?H$#FEMV&=L+NA-VRVE=V2I^(J6@YL$V
M>6WX3T"/P'XA"07P*\5W&ZQM<O9_Q]C5?XFSWQC[G:\1@# ?#W?R^,0 QP$S
MLX7$M2="*H61_Z'_T/]HBOXT.+1]I22RG[4.8*M'H&(_J8?3LK[6X%EWCO?C
MT\2J^Y\_N_@ A<O(&@.&WFEL>DA4*>8Q%;?[>R1@6=6"SQB*D)ZGW9VCH1QG
M\1%'<GHFWUYZ1[%DTYY_F73(HD80AE][I=N;'O[W<DB^?0).A*E(UJ?;&PF(
M_Q>1HKHXX&HF4050^"\2N9@[=AAZXXLJP-Y4_+Y*(1'P5PEL;[3-TE1\HU"D
M2G%A]O9_,#5_E8RX+:%A*K=YB7^;! I3_\80-BG=CM?>$FJTW511'% /_TT6
M%KQ$&/JTN+TI8(/4#Q2!_[)WF*I*,2_K6Y'#O\X:?V$4]T)]ND^D1!3T6^U_
M1"I_/D*TB.*F8/XI@L/[__T+1*68+ Z85RE,[M4@JE!M[O^KZ^0_]!_Z?X7*
M3E&M[>ZA?45D#WWQX)#/7R[DD.8N+TBT@=J_2#1K[A617=PP,>7.7&N#[[X0
MSWV"C?[1(^_0\KFD&8,JH%$6EDA3(6XQC47-N;V&:V^EB]MPBV^?0Z 1G%+9
M1#.HJ3CBW\H<F?DOJ)K_*OJ#/OY;Q-73*B5_UT980LU\ 9OFB*B*C4S_O]#'
M_PI)%F9&&6W[UF<](!W.^LN!D+@68C>X/KT> /?)3(V4^&:?BGD],HFJD;^R
MG%[_]]B%]VT:*P%U1?&MW&6V13R]WN.O[Q]4-]KZ9_G8L%I"VJ:* /4_Z=7C
MFU52)4 MN2RJ*_Y;!/@75)B:;L=75D@TT6M1*:0?X?T[)OX_]!_Z'T$%E^B0
M$U^PM\'!]U;BW#)>?8USPY/7 97HY:H=R^C7C_S 80VGSCF.D+W7!#!5ZDN'
MOV^S_Q[QP+^;F):*[\[-\\3I(+W/+^[@4E<J&N^='U)<<,L-U9=2%+>W^G=S
M*% ,_JZRH:;J@']7+\:FXNG"*N+UW_2N,=<>?[_SURP%'% 8!;42*"2J\*B0
M_XY'!D-K;FA@.(]O(=&#>^5*]-]0TUP5*7G[FU]32#S-5=%V?\?]^.L$4_6]
MS9N:!S7ZYE!QOYW@MB?\ET6CN#UR#8K]KX[41H??-#D< /X+'W7#.TEG;9A$
MKDNC*&X'4,5RQ9*:233:3_[6)+>V$5=0:)B1(F_FQC>HD>AMUI_QJ/Z'+4-]
MS.^.GM&F'\1MDX<K^W2N]8;W;<CX6R_$O^.);;#KSBVYOY"(-M+YU;>62/U]
MG\+C6_Q?!"O80V$J/(/VI@=R,>+VZ+PK_XI;^A_Z#_V_1%SOAE1PJ;Y/VN#4
M)T85[*=U@&D5Y'=8+=!#1_K(Z*$FM45X[>>K-$[FFN1W9?-WE5AYR)IU8$N5
M"<:1,P[IFF\3.6L>I)][<=.Y&1K=-#]5-D=DXE/_T0[^_SM) U1*2#:^U3L*
M<]+,K $&F3E,*?#6B^)C)'LC1N&_P:TJVM25,6DD0(AXO\T_-EKQO^YZX? @
M(]'"FW^C2A8XW8X'RMB2!@;,JQ;F_4/GYP"6JWLE-W6U!5;+EV<086KP3ZA#
MQH:./W!;@"G>BS7>Z%) ':"!U?Z;>PUP'R]K8!LX!\RC*'[?6L^.E_7-T3&!
M,@$&1!]K*3#@DVH.N/E[4^+V)*ZTLL0'C+:;ZI*L2("+4B7$D.]RF$CE#J!D
M0WX;DQ3-%>H&']?4%=45-3<L[W82;$,H)M9/;IO,;38J?/%W46.+N9=G2X+,
M-ZX^][TM:&_T*U.;;?9BP[G7+%1]-XU+$/2;=-*?8WUYL-AO5_]T/L$#%E!N
MBV7ON8+@-KEA<\U\_S@YQ3QFOB6DTP;$ .L-2Q=E#0:\Z;=^0N::R/\*;^D_
MGM-_Z'\S_<_VG-*%![952#QIBU:^S7O?%A?V+(D<@,9.W9^@7?:6N3CR9,BB
M_\3,H57/.7/NG>!UP#/SS_7W-GZU443- M<!/H;I%[,_H>S 15]&1%,OMYK3
MC3M['>Z;XSS-B7,^ [#$C(R@LW5''<W"%#LZW">("B\'3)#%B85IX W?0LF7
MN_UF;NIKJS[>?C.L-E=A*_DRO\-$/EQK5 _WB>?>@I+07-/_^_??5*15/PF
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M#VP,.5/] TC.<03;@=J-E"M,)FDC#WR?K@T[ZI,PN#$;F7\A=&ZWS=]G)N1
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M[T>?>O"B.=.=*;H+]JHG^_.B.FR71-,7FZ?=RL3ETE$%2.>"G88+D0*1?<.
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MN.^W,R-W;5P(,L/6V_'5F6&;B\#W0\3'B)B'D1)<;EG?$XXWT](R-\+]R0R
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MR1Q)=ZG69X2YSN@L-]JU0T;G&E4H^E5Z5SVW >EG*H#WQUWIV&;IA\AC/$M
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M93E8^%8K9G#!5#[?SF\BPWNMU#_K>>N!5^N 5>SEZN//*E;?*3^K2]JN_./
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M'3M9NU*F4;7-K3YS56-/BN/; I42LLH+KIX[TVTXO8!:GLP"1LNG*/ICE35
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MEN/%$E55#K9+4'/,3/T3@(X'U.+S?:X$A7[_]"K(_&'5 V*X<5_@W2A6\.O
MYSNZFGB$\59S9]U99[X]9=&7"8&,R]5C;N,7Q*VC),#B$W4'E$5=.3USK0Y.
M-X1V<O;OPN;&!Q=WT&\L!4Q^,VFEDBDKPK^NI(U&AGZ )T[I*3,/45NG4>[$
MSB/Z^@V>WQ W6!F)VCJA_XXVP'[ZRPQI6TGPM(J"G&NX_*;2Y:X9L)@&#>X@
MLQS*-[BD6X"H,Z_P5S4\+S0W^$_&R__J0KG_KR^6R_N4"%^/*KO_:,G=5'3N
M*7,./B0M-WM=NJ#TE0Z"?=AYH?['E.'=J ;3D)+ !@OQ3&_W3./^;>T!:8R
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MJY%N1$)=4@E"&"S^B63GN,J22"KGX?/(+;7;-K843.D&[XK1)'&8=^#OC/H
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M1")Z0QCT/C_ )_9>ZNSQR;>N$B]AP9E/<8N>FD2(]?EE,)BN8MHM^@^P8KG
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MS_M/\D6]I)D]^B?1'Q-5JN>GF]@%^!=@ZIIYF=#B=.C6FL2/<YE41.J]C_U
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M$8>S0?J\DK40,A'T*W5HD0FH^*R9DOK%%YKAO?-#LC>A0^%L-YE8;.XAA*9
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M NB)1AWF<3K +I2O<MO)6AG45@"JK$/+3FZS^]O.9A<#+'FJN:WK=YJM^CB
M6=7<7IAUW\ /DY90__L0F).F+8M6%V=]S8E[Z*I3<ZH2,5M<$.M@BJ;N$-\Z
M^?,92G$54:0+;+TZ%,5CJ>M/,V[7>Q[B^EO'VQ-.4U2K&%*4S7HMY#1DS<#B
MS\3Q@5BM(2*'=E[[3(PO7"T<W>5YFE!3[*GN:QKP*CE ,?+;U0H5DV^:V2CS
MNBN_@''4(MMFYL85C2WPZVJ)NK+#3XYUM;T#-V-1 QC'[2:J65[C\5ER4+X]
MZU36K^NG;2B.1=Y595BCJJTGI[X0&K6@>#&-K5M)@SU-H]]%96$[S>M?%?!2
MJX[;<2IKJ/L)43C_?HRQPKR*H?JK9QT_H,PUER8^03L*',_M5.#L-S +$8FW
M4KO8O!LRCU"Y@V^W*("9@_E='.G,IJ3_Z(_30HV3HLIQK8TD!"-F^>SO^6_X
M)Y %S%S)=]X!>\R6SRV#W=%ERBR=E[F7H S5K%B0!1A</1@IJ;O=777O!^Q&
MZ:JE>32%4KIH)X]G-,UJ:2.ILR#\1.S5P88Y.-KBVN;\$_OLPDT59'M +'&M
MV!0B#:F:1*SJK ;A_?<\%R@A#Q3XD5R9!'F315:#>9&%$4Y(' C:SJ2A"191
M@?C1::.4-%J;K&Z;B8=COB2.93^M$#:\K$R!Z*BKUP;X-^6_E4'I2Q5XC<*R
M.H*_^X'SF-_00/=""D?G4-FG];TNP74SJ>O&70Q5MI27E\'(B55=*6;4-=;[
M0]JR$OO:/8E,/K?JF&4"*_7$$CN&&TG6W;:1 )P$?L_!X.2I6/O$IM"K7X1]
M$(L+ZB+@HH+&:6!YOL$MZ:@:%6:*7J=$<8$7P1!T*'N8L%,Q91$)L7YDO\DO
MN6QC/?VPFR0SL(\'RGP?P* ,-7DS'9LG:@U\-_HK#>OI[W98-<1K)-<Y*^<9
M6U\1I+(%) Q5*QRNY?-M&\.GL^8QH5,ULCPX]AH@>AE:E5JOV,M]/U+6&!F/
MU0@LO<ZJSEWF\859EN0S,3PXDM=AU?9J@$+P??$!7N07D?8=QW_3!KV:M*^7
M.+J&>W,5<,^D\5P9]F;=U5_ D_#X%\K4ZT)!/!_'N6$\J<)"X"<&;Z?;,//N
M11[RV_ )Y6@K5+7I\"MT:DD!O,&!.?=MACU$O^K:1T!.A=9]-X1QS(+[=(3D
M7C&@FR024?#V+LE',7E]*1MI=14J$XMJ'I>"Y.1 1ET7SM^7B,!=$D/JB[]Z
MX4R^3<;,Z0PK"E3)2]Z]N52U,$O9*-B/L>W=CPD&[2D(@XR(+DP2E*<W)LYD
MPEP*Z,,1^EC;#O]@H!. 9.6,,O3)3SLR_(SP?V.PA"=UVOX"QE,@J7BD$F9T
M;*'DL!.[C[W(>!I9'%2ISE>1F#Z^;FB-#)R5"H80GW8PODU5F6S$/7ESOK$#
M)E=TN4C*MRTE#?0C(('V?+,W1AQ S/ \[PO_.A:&4_.50L'.=0N: !],S)")
M)^KQPOF(QMY#?SL4#[2QL.?FS&59G&^3Z^=1QT;36IN?N"/Y2^])+L9 Y_LW
M?*"_10(- 6VK_K,ZGL#JQLP@<Y+W1/CII13>O%$)EX]U=ZWJ,$_\@7$UE^)A
M#TJ>8#G75B4<>+H.BO',VT=!!]30BB?EX/?3?^@J;\-;5%M+D<M_Z()0#;5_
MZ(Q_P,X4'"WBYT:.]!\^\"Y+5]R\AVBY=*BI2B"C"A:1\WIO$7_H8MPTS1-4
M^@^U6!?1E!3.$D"W2W#J(#,J+V)'AXC"%/($@*-3T+ $;Y22CP9Y4-G.V'3Q
M3;\6Y[S(*(\L_%?^;D4SZ?X;94I1?^87>4!40$EWXRSEVZ),2E_&TO1H]\+D
M_6_I'TEF,\^LM)WMK(-^K)EE? 21VH<,* RFCTQ;O9G,"C_F?_ .2'ZS9I:3
M9$"ZDG?E4^ID!&!DQ:,;;W>&:,65^MC6PFRL=,,?VN9KEE#1]1Q,>-BG5@/.
M.ZS#B]T.G+84" IMC\ 6F8_>IF J^8-U[5,VM/^""E+B__[AG__K.-/_IJ@U
M%AUO\:9QUO[C<?/_7P7M/N''23>5G\GTGZ R_Y'R?Z6A\^\FC/HT$R=R9'!V
MV,97T?@GI3GJ0KKF< .[E.'TJ8V=I2F6 QB[KR_$T;].]9[UD^#;P:@A<'*?
M&X+IP X"_SS]W$Q<4HDSS"ZU*?H9IUTJFDY:2UV2.9R=H:3^<"X/ +K\R"2$
MG3_VY2\P^0]=[^761OVSW@1JH4.;M9M'Y%I$U[4**6V\SB+'O-52B>,#99B2
M:GI[-C _>5@#\JKO4K]+J^R*Y4L=UZ,)S^'7AX1WM1J/*MZ+HQMMVY_B!XJK
MH^?*V[C1QAB%Y'AXW\8.9 OG>_[,%%4R_Q,=IV.37)HO I9E%M)E*A"ALE9>
M17($MSH1#,M>"L\U+FT_ZM]MN>+K)([T/=M7^!UV>DRGJSI6C=D'5MA3 I:)
M+=#K)A?W!U5$&3@!?$R2A,F\<D??\.G8^Q^)!IO:EYL!R)]/_)'9"8)C0(/5
MVS)2P BXUI2KIV+E:7)$#H@PNDJ1ZO,$\O"KM+>@-TM$>FR%-]R6J_AP_L9X
M&IAGU"!,Q@*+Q2.?G)K# ;NGV>XE4IJI,N_6L,64EZ*-*9??XC$/6*/W%=V$
MG0!DM4DAO),F8JY)_*Z6+(+LYS@XYD#]S,M==H5H<1*^ -:EQ$)(//YE:72$
MV_8;GQ '60(%="GLG@>$",HUP/3[N< UH-G(_A5!2)$JS-;@%DSY-^?6XF7X
M6JW3(6' RO)2D7( 3E_4+9H>3(9,OTH&.06=E$;C_-6>82P5VC042L'\'1S
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M"C0S45RMHJZGOO!N4JWP;ZZ3/\K_) 7[/FCRUD<J<XB[,$DZ:]4^-U:GHX/
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MV;U1G^]\@[5Y_O)%!:KDU.J4^_\%^YZ10<9_#'#DRA!T<F9+/.GW?/!]A;Y
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M?2>$1$1M*^\.4CZJ[9MJ.EV__B*9_K"@_OUJDO$[4 %_Z;" +F79/4A>7CO
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M4D[L",#W=1ZB&F>@(.('3!X&1^ 6N VC:SS2Y"Y^Y$BN[#KBN$?VF'=Z]R[
M20(LK=D(! P030BS9>R$//:\ZJQ$Y\63&O.[*B+-C_+K%".+QJ/>SAT1>AQ$
MD<[>VW6NR;3:"B=((BY$I_,[W"F"9/9N)Y(NM'YM7LHK  2X2/W]=:H=C/BM
M=ZBC\QL,?.NU,'\Y%XR"CJ%$BV)K_G&1+BAUNKY7(&F6*AS?TC14_B4M?FOU
M7.9WN?,6_:UF[LCX+Q!P_R/X=4FZQ9FI!;@8 "7?3N?M?J;Y24G:D4I2=DA6
MT"^-FO\^_RK_8#N'+I+H)ME[,P W=&OR>>!=,V_G7)%!Q@XO0-1FS]R.5P8B
M=@Y7)&'%W0*U>!I%N"FSW4Z]@ZFW$Z_!TBL/O$.6"507G@(04M#W[GY0,*CN
M["W8(QM$TVUD<%4"O2[G;FV"%^\ZIYJ Z9IR'U8ZID6#_>64_EGO_F( ;ZW#
MX?7]IVP318BPM!V%77KSUI2B^[FALDLVXU=ZD([A'Z9GQ-?YJO-=KG+O-I[T
MSLTC:;UV9-_HI)I,WTLG\,NYK:N&.(^\R)>X!%CCI< *_,.P^4=\'5M^4=\*
M^*TF?,N>R/CS0*6L OGWW7>_4,:^X%]8J'FA]HNP-A"O"7KCP9F<>KM3VTSK
M^5:).4-4);@6A#4U'<!IH)L=65%^\=#BC&D49G\=B$7D0:8HQ? D/2(/.26V
MUXV1B+Q5\.;VHD'1!__DD;5.6EBY%^(HC0GS^)Q;L& P:>*B=_C"9>EA6AK.
M.@W[59"_U\J GTV$';JE?2_0NKHXYL.<0-S@WN>XI[!"H=!"V4-@F,#)F"%3
M]0"B DTYG7!_6]V,V>W,BZ5<6,J*S!I>.P8MP>\I/6E?)^K1[]3B9RKYEE&I
MUMW]S015OICZ,UN5Z@OK_#T%X[<%Z%<H?ADR>W^T\76Z+4+V?'8%?#;2>'DA
M/(",?\?/N64?_-OF]O]UD#IIJ]_OO;*)V:-D=%F'7WA%:S\5%NZ1R'4@C&0P
MID,J[&GM; )\]J>O7[HRS$A\=[T@Z<E:KWR#[?HG  JR[$DQ]<3NT?KSX!*%
MC>G%"Q]4@E<F/P'N97\"W K.:]ZGMI4K;>Z SW50["? <SV?)Y<_<EU>7_(V
MD_6R'>#8_.$[:8Y)["OWQ97\TW8O4HP6DRCB6AT9YCDG-B!24B%L#T-N=!-$
M+%$/"Q<-EJM']8_A=1X%O3(D#7J=7XRQ;7_,+M7?<Y_^]RUNI0I]*\M]KL&S
MF-.[( F\?&5_/?.Y-5"<:7+0JR0OP-S',_KZ<-,8:TX)QO$!@ZPW/,0RV@?7
M&]< <QYGLU-\S>^:)-1BJC>F!S#5!RV1@")\B[%XCF4 EU(6IVC)']4 ?$FL
MXBJ#-O)[K?LR5WG2ODC;B!*28;#U>+HT+V2?O"QC9OPIK[SW754H79R#FNRB
MR61O1T) )ZTCP^MU7*1$OH PG.<8?IJ>&G ^8%N<*T( .B2%\5?G;5A4.(,O
M^#L\B.8+8_O)#[=E?9!RE #T^?NK'T/GK*#] \ZR3/#I^U>8<JYA*-_ 39;;
MQWCSUESME9+IBP9T7NFW=!3+ 5"[?ZZW6OE#B4E:@]YULDQBT;5&,UK&TRPC
M3+GGT_8WYO05>Z:&L-94+:CUX@R:-M3!V[R/4F<T+(I$G/3O<RV^7/P*0JBY
M!+@$=YM\H^AP,6A_1Z<AXU\! ,(+$5*BWM9]E92HN(O/NE'?8X-D.(FV\DPK
M"&*/;IXPT5]X>,E>\1, 7S32<'.#](L)W"58,<7^E;.]-K/^!-AEU#&R ?%Y
MS7=A)'>MVG>I8ROA\A83*Q#YRO*V^=\?2U0Y%? )L+] 6(947O+U_."Q#;NM
MM-=\; &\_;3E!1)E;PU&97SP9?9N7>=DH ^UPZAR4W.-31[*$E%XV7_%9T+[
M.48^I?EY(1?J[(/86<_A+?4)J%G;"T+1!9VJJ+>S7/DQ5I[P69^JWHJ5-]K_
M0ZP<.&*7>T0LA6'1P&'73E@4SM::[JXL(Q"V?%41%E05?2->/^^EOP<GT(!'
M+0L)N&W:ZXR4=^,HTS46FNHWB]RQ9MZA K@5=^M9H[K[FCYQW SFARET<VYP
MJ]13JX++L@:<K>!3*8"L\#4 .%G3@ EN.:A:%^AXW;4  M6H*B'@')VJ.R]G
M^I7]:3)BN[ON?%2IP%YOJ,WCK6P<PU?-<<PA <JY0>FM\CEQ6H;^X YO-[TQ
M-W,HH0WA!(NYT6^FL2M]B3IG:C^,_\0ZSM,Q @TW<[.&<[P*@RECKH6^PZEJ
M2]/G>AM9=K3QI1 (XD,F N^+VC28LQMN\#_1U1I"J,KW)N.BS)8S&)XU>+8G
MN7&$AL%0/0MB@%UY*F]*';6U&U]'BXJVU$#VAB'R'3E9)X^$)BY1V" >VBI.
MZ5#2?;:D3ESE8YHX<#?<D "N5-3$*E<=V>U@S+S8EBHL8A*553C8!4>C]V$-
MQ<"/;2\ 59# ZYXGKTUU)8> C*]QY,M5$WOT]<T7#5I@N?OI>B62@]C49N\_
MGT"IY#.7]V$PMNQ 1\.17;+$^_R(#%HJ, +ZV%PC[S-/DW/B#>9+)A8[+',%
ML"/#W?D$7?HZ;]PW6S9=IC8;K;A1XZR7A"PZ1:C\N%01FI9RTB-I #+-IU<+
MFN=O:WRRZ+W664*XS3F13O0_)A4[F7/<61-MTP0"41%1S6>B9"4R,UQLE>LQ
M"L<E,G*%MPDJ7JV!,J$/ V<,"<C*IB1D.(19+BZJL3Y:Y2Y*)QJDU*%M4D.L
M+A>'$L\NOSOZ>MJS*ZWN!5M4Y:"]<[E^GV.4V6@U=-]^L1@9KVG1H>O[A3\W
M=\GM:AW"#5[JU2(C ^WWF[.F0D(&VUW'#V(9?(E1V6TD_AJ_MY.R^S!5C79Y
MK6$QUEH=E1HFIE=Q$L:L$]6D0-P'-KEK4O!^>M]H5L$#SLT/F>DQ62K:YV\B
M("&[)S2>,+'?U!- IUSP"@^[R*P3VNM/DV R7HHN.K!HT'N$4N%89\)SUT&/
MTUU*]!!HP+9=@=AJZ.'*0"\D3;C5DKZS!]."QKK:K1(3"2,@HU&!A5EF[$8:
MO5=W^>H5BW%&2E/%#3JUH\P6D!2[SZ*+9.8R*YB5C$CO\Z*U454X?G6(UVZ_
MMI(&KY^56:9O(1?C_H1]7B&"#A'TS[L4&'9N"[TI[9*6&G6=JMZTH'//&.(*
M501FN8;32U=7<\-@N1V!N(8/=TT'L'[Y>P0@PZ]N-J&.R+N^";8MK3@$N)CG
MUF+G\7+,!#EE,+YS1J&YF#LUIHC?-:OG)QF?$O7:<D:?12]04UMEG*>L,$W!
MELZ <U#W2<GH,H/IOC#31TL&<&AAT&@\,DSB%>+,W?[6PEN(0"YZ\1S>D"\V
M>KP699>:</:,VE97T+<A$0\T_%.R%G2'?8M9%<2N9^Q@WB'P8_QZVZ.?*76;
M5A2PQA<^+90RS7M(YV&0,*\IXXLS#=-\HK%6DU 5J_N_Z\T[A/!3C0Q& 2)?
M9.?2ZC[4$.:=RKZTL3/#%72RZ@COK@;%4SK"? FX5P%L=N4\I;-7AGDOTM;
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M>CO/D"K[L!HW(/41IR+@'1 S),L65)3G*KHVX5JU*".!ODVOIT65@W8JF4;
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M5 5)HIX1RGTQ178S$WJO9#))KUS0''\:BEM"/A$/1XSF.8<5JP,&@-SF?/O
ME#(7Z7I+!\$--$_;B.+X ]F!E/G&N8RP*2C' ^^>!=P7+]@;M7K PEY=!CF-
MU8 &:Y7(=@#M,V];US*0T'7QTXDV&8>82IU- ;*&RCRHX-ORIZGBG2F UT5V
MNS'-ELGC"J5E'7-90F9>R[Z.Z?D._$/!%30AXP,V:Z27$U/Z!;A/!>:=W?-V
M ^ZK,!&I?-R2AHXTTX]YM<)!#L)J;%.PJ?0Z5!I<FND=%Z/I:"2J7#'YLLD7
MWOY$EUFV M,*$B&_?>?1<4D#FF7-I;#Z6:6T1TF.B8,/=RD)VX02%(-:;C1:
MWXQX;9RB../K('@_Q<67RJG,NUQJ8,V(1_7U4K%7$MQ[RGWML5?B:SR "&)6
M>2<_JZETI'HS/4[.:/S,FR8P0/8<?Q&IH,U[57_.S/?G^8>-=8<#08EEL)#R
MX%)\H]HULNHE3'L 6I^GFNKTO L++44U2FZVR_JE8B6DM65#:HI'M)C'8R/R
M$U5S%T RU:" ;8;N<![:+ZO\<O]K#P%/@\S1P39G"5Q$C"!S^ ,W*X)$M0ZK
MIA05>E0@S('#_B9@'I*>BWN*C*TYL+J^_G3I&]*>XEK9IGW<U:S-% YCJ?Q&
MBU.X.Q1@.ITH,/H>:J./(M)>[A^II_J+,Y&WW(#9N@2[*E<6Y2G+']E:B1C=
M?KC;QCQ_+T\XL:X!91VD57DX[EEL.C7=SCHD!NVT8NR^M4D'O52OQG4F9^?4
M%]-[NHJ^VTZB.1):J1YC'K+GQ60#\(&1,3QDW\+QWELB1V4Y&_DRNVQ8+6?,
M8PJ=2L<\"*>$(7WNIWV KS)5K3:#IRS(S_=#+5GE8/5.Q.58W%@Y="A*%WS1
M'ZT/P;LEHR&TECA@<H-.!+-@16EERQ>N5,!_B)D%47(;OXW&Z$GDO(!PM1;A
M#)#F_KUT@H-/GTI%PE*/D;B=4Q#57\VLX!/XL4GQTNP&-5#-->G(2%U=B?GJ
MIF]P5X>LD. %O=,8!!>XINZT%(L$S0,XA\6&;-&J\G$R,:;3QO)#H)!7KU$F
MRH#E("E!";A6$^=?4U!-]VG1.@=H2J!&&]KII:ATA@_0]<LU8<;-/E[FX8J!
MRIC))V^D9X^MF7AK=!YL/"Y[KH^CUR9W/&)#+FI!<TYN#:SKOOKV,<(O.."E
MEO$@^?//HSUT&=.>D B>P8'!BBR$'W!XNU;ZZ$"1L\>>Y3,Q6?]K!M5RB*2\
MGK#^.T]M'2-&K?2\0Z(DJ^5NHK;NH3;JK]&P5\@"SI[0C-];M<^;OVH]!EHM
M^S%Y4I&65S#@O@R[^0)K8&2.[=GBQW:"=\^-MK-;D>4D13VL8((!D\<,0"GT
MN^8Z+KR)HP'BF2(#-I_GNEWV0?/3^G.@A9_".@>9H7?;=5K4KNK.UO 7@750
M4OEU&BQ@>%JLC^/Y\#2EPUCVF#P ;9F11V^H*.]87']#_YC^02WIRDM1<G;<
M,KJ![C]HWT#R#I6-'6Y>NE%\KT[LC$!;7Y3T.Q$SS6+,#)[W7,D5?E:!]72]
MD!#E>0"I\^WW7A+&#@)Q1'(#&P:WUYK,@2C+((VI>\&E=JO;?;OL2]#REL+[
M\'.VN.V4S@[:C%DDKY7IH^3-%]& MRM6VC3'QY=#J7=0:F[XDX!8PVF1;S(]
M/*.;(C?5JE?LXC5PTRO#(+-#6>VROE\;3?07YDC'1CQR;D52P4FFMVHI'T"N
M1R><5$J*L^TW<$NUL?P4.-'T]J02\6F$A+]>X9)I7XD7EB_6R<F6E5.XB"L_
M!EMDD0T?LD$#9"!:4)'X+W%=81)'98S9J(#AX$K+_/]BH\I_U" N55CT[R?4
M;>1[JVPZB]QN:8TJIOO$3N/.3N0^TV  OT4 D0$N:&9,)(4DN&#K*[T;ZVM3
M,:*5R)$JD[ /O['OG\?CZPI>G4BGA7#'EJDW;J)?O6QP?2C\A2AM.Z_JVP P
M2OVT(W=*@W$H6YSSV[0->:58SQL]0"*K'EI(9+PDV%.S&H3K0$@,LR*@59H]
MP/\+9K<<V.$O<F.:>8%)</<[&XMQL"KK"]E-X;(:F\K' 0LW='[7 13]+7V=
M\!_FMO^$_;^!GF+U"%ZV/9D(/$X_1#RML<+Y@WA)NF"H]!=%NUFC"A''3TY*
M7!Y"U>*?T3ET>I800 'K?C>JY!,)B:.3E:#>:)E)NP?*GVP:VT]2&BI,@L7Z
MA47)\ST6:=\%><L:W8H7L>&)=T%3$Z^^A5<J?=XVY606V,7H:"6_TZN+3^W+
MXQ_0H?-:.63;_1':D)M0,*35VA[O;17,]E!V*N"XY&P7^KR$>,RO LN\%$2(
M1&[90/;&KAQ9[IT@9/4>OB24U=9PQ[S"0?:Z,0>H4L@;SL!!59;!/H'(11IO
MLK[3D.$^(2DM3#JW8@+T,F5P%Y0^"9\OMJXFRYA[=PTF6MIHNC^SY,8RCP<1
MPQ;FRSS)7OU:J,Y)%/;J592R)K>J+J>1Y%$U!J"N4(D;)42S/*S!R%SN%'QK
MU--1@7\(9F0!]B@K\(N,ZFAMD)%+Q5PGS?Z[ESDS]95#]I,71P 7[WA\9>D)
M,T:]*!@'O:DMF3\KR\<5_)<[K/[?L.+NG\172<N>.<N32]=%[[(JFW?>ZNW3
M!.W8("V9[P-PQ5L;6]^8)0:SIQ=%Q;X3$+2R=J>&NR?OT4GS[W[8D8PG'TW%
M?;F7((J.9%2.\;62FFPN]8(6&H=445MHH^QYA+%LNCPJYL6]Y>2 CN.Q]'Y'
M0UN:]7==+%,P0RMCN?J%FCKQ3H8*:@"AHY_X29#&30-?3W]NTV.&;XLY%[=P
MH\FO-]$QO:C[U0%'1*[!EBPV\'FA#K#NL5OO?(_R8(;M/MG1==1F:7_[=I<8
M>H3PBTTTJOEQ^ZV-S^]@.Y\SLMF!B^COLSN5!E4Y/1$8QY"\^!G.U>;AE%]L
MD1#9\;,Z&IO599B*)]$S%66@S[18>A^*N;Z/'K5_%/YT SORKB@.$-[.)21=
MP<)0CDX_EO,>8'6RT=G5HT96B>:O6J:B\1, [W@%0&I#KT[6S]SV!'P;A>(Z
M +K8UY1)A\)Q\Z3U4'O;*V;=E]V0UQ9:L+>BTM,NAK1$:+\2#JJT_-QN=XQZ
M66V4J?S"<O"3;)0X "0O]V0T%+PRHB6RSAN]_IO^U'X](('BOS YN  :_P*\
MS<Q8KJ?-*W$%.IYK.J0,6L!&9'P$+3!32AAS_O<F7U:W) :!K8NV/I25.W@8
M /HR-#N/?KEL$MC9 G5(.<EX)"^CV8#:]_A(PM#==$1(I='0IZ_Z1]!=VXSS
MD=@C3R7NH,MC)C1.#$<XEH3R9E!-;%:?RLC,!<G&)^-K?DM:=_^12_J'PO7@
M7VQV]VNMRG[\/YGR965TR@<%DV)/9G@90LY!LY:[Y9N0H-6S@Q7E&'A<26''
MQTQ.MLWY+=T@@M*(*8D#-#Q0> [Y)O^=H<X''%N&\=9%8";S;O&XSS% <M%2
MMZ@*Z>700:F##R_A-)_A7NP?\]*9:S]0QE('Z\>AJE3#\VPVM9:'0V1MO]L:
M*:9-;0-*]-C<](H*W50  ><Y&\JD<CE?CE>T7"^/+= W]P%"<&QYW/@$439"
M>1[T8-;?DE6 2,(VJ,D.^UKWNO#'!RNO!9>W*QN 2?$_@CX@')/W>05J?[\.
MY)1V67$#!\B]7Q%O08MJ,:&#S!QTRF5J%5 P55/XK.R."I?Y=HV2&>8EC4+S
MQV;GG)-M)=U;+=Q2$YP+HFS+^1J:^)G@/H4I&3J3K-^:!_I2L1S1VPQ$B1><
MKT14IGRN>G'B<G0W^T0=$&@2T?$81R=1J[<PW]+^Z6-QMM+7FD>]@=AR1(<
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M;#/0M>D&(!3>L,?V4LVYN"E]E3(JKZU O<]^*#_M."^[@9_=65/I;CK8]$6
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ME7(E9!1@PR^QV=Z:QE9?+4RJZ_1B;D,>\O-7:"I80Z\K.*!FHVY4ZLLZZ'X
MZAL[?EZ6RB]MEX[GOU^[)\6N]<'<_@:KJM)?3W4735RRJ92,.=\-N'(L8Z2]
M7T@TX$'1T:U-YM50[U/9P%?T=8FW?L"(T05KVF,XW:,P_NZ!F*0YUSLF;QG]
MN ?!Y.CS4W]!?D:?EI?UI89V#C)>^,>;#QITD4<KIP&T1:,GC$;8CO1JF)+L
M3,'^P:F8XSPICI,Z>$PVQ9R<A2DL>+S)H *N2.-U*@JJ6U&-:J7:LIC'Y@<]
MD2U8<^(IJ6"2T8>#][.6-?%J#*7 J:8"#]3D?=CR;+7AF_>0P!BV@_6H46O5
M$D?,=*P-ITJ)E9[5D]\)JPA6*>I,I"ZD^%XY.H5QMPZ(L5*U%U'!FOO)@9Y5
M!6'@B+\RN@D3Q7F4 5#4UEU-='\9L&;5)_B^X50Y]"I,R9B=LR0.U2[O"3JN
M6UXT43WA82V^U@^L'EE'LOD!>V9'_ZK . 0*?NH[LKQ48B7107U? L+06>GV
MP:!KJB0+$[K&H"HIY9AN*:FK9X'&R%UJDL?N?X W<0]V]!MH?N)!O@A"3!G@
M:9E]""ZX8AE84'G,2@>;;5MZ4U=PX2I_&6AF1<G1<7U_VQ.YT?V9G@-5;^G@
MJ,>UW1QX!<?TV5]LT@D8W*9)2',)+4 -TGS[S32"%^^0#='*_/ACA/DAZB"'
M,5FD]MY#TL&!]LDG0J]AR[73"-=.T& 17_!( 00(OG?'MHR-*J]Z"'=4<6_T
M0]#R_G4Y*(-X<Q%,]=WK2&R6.XX8$@"8S_<9E^#Z?>;5JKY%&V7+EGEXQMR'
MM0<+G!1O";(=NG%HC21D,Q*6/P7E,H9HU7#$V0+B;F>"#6DF\@ _::=X#&?[
M]J=10V),=)&_("2).KI6L@1[D-9+#6HTCV,#U]65&*]N;C3,F=FEWGRY20\F
ME9U%A=L2UVY>]X6L#$9XQB=40B>,9V^HY*=+M[F6MIZV\#EM 1I8/DMX3#,J
MF^;EP'\ R1J%:S UC5,T/47/9$WAO]CXH;-;CO?+J)+%'8A@_&+#"CS.(^>&
MR4DI7I*8!TBD^;5*8<YE%'\KA.;T55.E<[IZW(.; F?>*S+BMQIN3NG_J^TM
M?D6QQ6T]ECYBG&_P-+[-&%8P>B?=F!MU&P-G9#V8#Z?YGU*:150G#Z02C%J7
MS?1X;=.>V'&3#\5%DV2.KR3P9*/QC8SV_<O=#S9<SHM.-HM=(007QC9"SQ+&
M)+?"8>RW('#O\K-G'P6N6 7W+<\1HNGI$/QM#X/>F2:1JQ:&23S *V^NO#=#
MMVS>.&ME(!Z7OT<UGEEJ.3'4WM!51NWS&F3F3*U\%SM03HVBS%\3*K5-:=5X
M%3BO7O5^NP1BF_P.SP$J5>,<5\\.>\]:I>;C_DE3[;]E^]BRL/CO(OH7V7C_
MHTQFQ<K'J:A:E#1R1LXH]9C]U)87MCNS[K /$V:2;M&#GKCJ7WTEN"+Z\V?7
M_HD/9;KI.081?<DJ8[/^"+DAYF/'<*3G338DV<0C[\D3=;0W\-K3&-N1HAZ_
M#[[+!!4$EEJH_Z92NW&HT./I!)99/^/QZ'9P1=!G5HV;EYOUXT0UGQ!\D9"P
M4F11LS?E2(O!S2>=@G1ULQ,Z!KT.C,&0ZR<@HQZ;F:I1(.CE(3W 8,B!?<XB
MQ5:<>IR1M%U^-M$3;-0$X-]2YVYX9?>=KKWFS/4U$J-65XJ\-$]R0H15Y& I
M)8Y]7Z1<2(7>V&8UG-&4[6B2"JNYTYC1%U,0$ 1#=.(+\,, U3A3"-<0:#$?
M-_;^/X*M!WWM&R,[4Z+QK\^W,34K5,?H9P+UOP5C3.<#$+<[%N8KTL*NFS9,
MVX!>SDT2,=4"ASY4PK9*;,O$;D6WCB1K6B"&R5<UN-&N#G<T;GX@^V2+)&Q2
M:%B]%Y_J!;9)/1;IJ+"?:J(=6&'SLH)/R$T&7)#O0O_$]M.*F]%%-QN='F?5
M9O%.]Y2D-71T*"47[SH$D\IYQ_D!O)!6==N$-\0\49L0^HI:W.H^<JGY4PLF
M]#@2U+-R]@1NB@E56S>>"R X=8T!DLWB5D4H]'X.ZU$!^):-%UE2/@Z%@/7K
M2MP6+'"Y<S[-!]V?F"KWA7?68CS[<=YTS=I\4Y-NV@W2F1NUSL<3$'.YDT<!
M[_2_C.Z:=J;FZ.Q[QWJ--W]*SV;;;=O0+QJF<9](4/]@DH%=E?P15G5YAD'!
MPTRDK(5R8\,#Q:T9DL=(]1V:UE<37VE6Q1(><U<8RFF^,-)?I.WJ/=GSTZX\
M=4L%[,# >\C%R=05%(M$XQ9] S72(-&U*NJ4R9#Y+!>?G[?G28Y+E?.B,F;J
M)LAS722T>O;;,HOQ+,>G$B+D25AF.S!]^+(IJAEJQ;D6P[DM+9FP&3Q>9J)C
M_/O=5N=_LCXJX])>W1ZX[.4#PMTBMI#7N%=;3*ZS?X7]!$U](WS2]!EZT#GP
MP3%++,(@-S@TGXGQ^ED!/3G[J9$\I?NS%'K1J]7;BGYTDQ8R4]>;0EJP>_YD
MHOD#+.$9*"0@?=O>&60@B[V!L04<*//V@X^<8I[>\8!=*.,G7)/BEFGPY'RA
MO$L]I%X;N'=<RJ72>$0D+-S1J&#J5*]C? &<+X9S+4]B;LO8K D_D?>+[2;H
MHZCX+[;XJ#TF"75)*7K)T8BE=>DN,93?;" K)0(K\.,]J3T/_:"MH>7$SVUH
M[L3;^>M:R78TJV)!> WE+>I+>PJ+XE&P.<4L7F[T<+D$>+L,"R5D<NXN5]5H
M?3CPU#H6=PKA^0&DF*K7"<OWFK;0-7FDQC V$ZDI.K8,S,2'^:Z7'K]-_WY*
MA'JV@0( ^;M[I%PLY  L:8F1Y<HWX#^?NA)K64TTK2GQ$YRK!<=183-NN/FO
M9GK?"Y9,] !C8>_'N?FJ M0?/9EB;.?X,-4)-^T%\T-%5)PSR2J:J,44;W1B
MZ@(&(5GM_7WRL9VT]XR;>/-$JN=WC4N7[^3Q3+Y0 XORM!"\58[T)\/FSW'P
M$O/*"4'(2[QEW%_X>;=.7Z6BEAA<$G$RUDV*R7I'IW),JB_O1\,)S03+9EM9
M">,WUI"FXR9R@G' NF1U,5 :4C4KP75<J93 2X=S!@04O/%>G]WG.']>J?[]
M]H??(_[^^^\ I@EU)(^=PZV[7&S.RVH/(RU W>_0SQIB&%&-M"BJ#_.TR85.
M(AOZ%YO[4RX+KGE^6S-MTQ?754#EBF[\*KE<ZL=768T.1O4'X-24S,6WN"7/
M6:DC[NQFYGJR(/W#:O\QDW]+WQ.<JM"\E9?+[:>]\RXV  N= O08_&S:(%4:
M?W_T$/1'5,G]*Z[]U<BA<58CITXY%F<&;[#Q'=OJ_<05;1UX/[D/$1Q\(2>P
MY45P@9S2=1+03JYCH4CWD5H!KG3;0+-HD3!_,J6)IF!L^ $<#B]*R>/UB],+
M4)IH=I+;XCPK(^DX[)!UR/<)\V".O1P*MQ!%/.K*PTWVR!Q^[)#XSPE]@O]8
M#+V\S#\R:9#C&$OZ/J12FI$5$^O82K*KB6(U+]@.C6?^1:;9*H4&<R;$+5RZ
M[= O!MM^=Z)Z%QC_<FC<1>PJ=OODR:75C.#2$K[TH5BB@('NZQ$'N:O#M02U
M'O$GP)O^I/:PU?H_R4M>J^L"@LT76:!YM1]/ISH!*TRKZ"?S#?>P0X;>0,$$
MRN+[\LTF4;T@@=A8U^Y+H*&54YZN5+^M@\),X.#>4:-N^"WE(^1:QI7W$/D\
M)(+OJ:?I,^K%!G/(TZE%I= OF= \C[H9&#<P\_-:*6<SU.O$'0E^4H^O5M!9
MR'I[01&O%2QSGT_'MN'9*C58<@P*T<'*LD(!LH-^+>V WZ*YV7I6T9#6@9K"
MDF+I4R7$&4+*?$-O,?=\Q;MW"M7S+V.:8OWJ,3.16C=O51UP/M+TX[BEG?&6
M(^;$I!D*AC*-N^;^;$ZF2-M#2'2A9/F9C-2TP^"K;5J(=O2.4J"E&=8U_6KZ
MT3TH0A6^VXPXZ4KC_.US'Y7-O)W/8Y&L3YV$'<G*&E!C^C='J52JTF6;2S2@
ME!4EW&!B'/UC]H6'$G7 E K/4,J](%EN#2-RF:,GCB@MKFMZ!9V]4#7KZ^)D
M9N)QW/"]TPNIYC9@T9!_R^;O!@;>XKPS8)WAX\GJZ!'%>\K=>BKE]\6&DZW\
MR$P#GH[< PC_6>2"7%J)JCWG8\[#:C@@DL9)]#V:<)1JGQLSJ+@:\HOMB>)T
M:Q5Y'DL,-^)GM4Q:OSPCS6K^>FLX<%T=C2\\B69_6A>SN7O ^+$J4=-\JGT!
MMP_I%S1K=Y.[#\P7Q<FOJA0^TEP][(]U37)UV74W9F$LH2Y91[ICGE&QKZ+=
MZBZJK.T[L7Q/3F-F$)(-=YX:8!T9G]/I]-M/@";VN1UQ0.JD<=^KIDV;3,:S
M3&G2+<>D"B]<NKH$[-I\<HSLK791Q]G&AJ8?(47(+1O!'R.[L=TDV^) 3"(<
MD^&YYZG$(Z,,<FV15X9%=%E@"_E'2W>4E?V'7<9( B=AS"HZ7DD,A*GXQCLV
M?_LO0:.Q>C/C2Q5+@N/J^LMKE^\VTX69,>[,JRTAE2:#<Y<)-']PUL!)@6@K
MNL@+89('75BC0\9X2<-5(/]%VO#AW&- ;:L:(Y8&QN+%#KA%8:WLDD#AJ@=_
M-RKNI-WG;PEID:3@15'P@A>V?;!39@'W9C0W#J1R,&_$(4NNTRRT1-8=TA<W
M1DP+TZEF4[Y/[EM.W'6I0J=21IVAL[%W5#>SBTZHD4@#MVHWV)(?3B-DDP<R
M<^>;=?5&/WI +S )W^YCQ*^@C3'S*AL-MB;(XGS<[Y)30I!R4B&]O(,A7&%F
MM(I0F8'(@30QW0,T.&T I_I;UL-1HCG K174-G7+V%D#_R$+DKYMYWG"12BK
M9>#I<;'7>R,5.\/]6J@M1N/S[&+2.+SA#LTXP^UFU1"N>@VO1&R^2D-$5K!L
MA)FQB]AP:PIHL=$\5P JV>C1MR$7'*I>4)J?%W?[ ]',010-^>-SU*QL[GI'
M&(;DQ<FLMZMEK?KD?81FKV"7RVX+$H,?0U1N"S9W0E\'!>[&8FQ*0].$179<
M5FC@?B3-.C;F!401K* M6>__<>HM:" TNUZ\N%;9OU=GM1D:4F!_>)**:;PI
MH\3T+2I_",3Z:L2X0*M;W,,E"+Q=U36X>P&B$E-_'X[ )J_[I)LDU)[X,HH:
M)!_3@7[&7#L1WE"Q[!DP*SM0]K&1^#$?V;UB,>S]43XF$;HC>WX"O#FR3;N8
M<F.3"<@:*/[R_(O;O=F5*!D*:/+-]^=0H;P)^<.L)J& \WJ!(V.[%8C,VLM6
M>H"\#EXK Q2;SAO.@<86NQK:Q35F4@G^ ]GKEH<VZ&81LCB20\D?"45\FX9!
MZ@E2PLQ$I0:(18N#X-TG#\^=K?@ !I.*#Q?Y8WW.;1>1O <<['G#Z,'+Y6?5
M"8[./FKRYAUD0']OI8Q8BVE\.^=:["@F[_NQ3\BB_!KBW?8W&!BGGW0)1EJ/
M^)LR/2F[__T.:/Z5>(N_[&/'Q%)I=XOAY@_M?++G/3D[B ,&!WII96\L2@W=
M-++)+?DS6CO=%>G^G5NOUKP]^$Y4-$,OW\7,5,QV8:_$^MN?E6RTR_ AN1G4
MN=BR&MU345!/)2WD:6^O8[]A=N:_R346YC_D^Y?S)-GB;+@C("+K*1<OS9$>
M/2_5U),DP654//V.YW'M3L)2\.[/Q&2]/&^MXQ"Y@666AL.V<[(=-S/. B[N
M4]-_^"P@*>W^G[4/_)?GGOXKDQ&*G#X- $F<*./E\@[Y^=IIV)O5<)QVOJ]]
MK=*]I9IG =>:HPOQ7".%C%!69JLS<9TG"Y=B2,W0_$5&Y.G@4EE%7Z&3*8WJ
MZKZ"<=(CD3'5P=E^?2:U-DG^?V<(_V/E.7^W@T*5.Y(-(J$$Z+V GX5,]LH
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M3(3@U.86_";*$[4?J!AAW_Z#T7!LZ!A<YZB7Z9-@8GF<W5N2G+'QXG#FKLB
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MC[7\[YJUH-3?-/&+TP%8?,STS198^'BBE>7QAGC],CX][ZB'-6+_]'[^#^R
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M(?[SP' +LX-<AR/XT %<3!TO]W7W?^*Y&/Z#F,JWES3^GW8P_+^$C[QV$PY
M-E9]BUQ&R$9\AC;ASM<#DVO?R5 -2X)*:7C*A6X2"N27O[KNP[=6S$H*Z<0=
M8 NNN#&V]EG,USZDU/K4HPV$5=YM)5NTOH<?%-I/200.J5\J6@<FV< #D\->
M!HZ'YT]\O1%<6F!J9[PIX.%;I51^+EVR"U!X^+!4B5(>%_V]05>/B8G)ZE-<
M>-?3"J$-X9U/.^///%YO+-U)>_=#]">#_6OX6MNZ-G I?*5KK 6F\Y/!DC@?
M^IN@_H)ZGE+!*98'B>(:R^3.P_@D;9<?F[74Z5JH4(+H+1=<'IU8DLCA$U5
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MQTW.3G$S,U@,@SU"WOYJ ^KB+RNV,L,[FZ@=JE]+5<^XLWC;\B<W1JF*-K1
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M>1^_F#G'&5K>4IV%JM4#6G'5O2OO\/9UU?)))'\,--HN=:VHP,\#:@;/"--
M2L!.CY>X;:2!R=>7=BZEGYHG-%+8970!XR9*FD&\=L9+=OEHH&,_B]31EV4?
M9PZ]UZ(TN*![;X,O=](QQUI%5@SFU;R &<N\]^(Q6B\)2&6SIH^/-K4#N1SF
M5HTUZ"(K9H3\^[MO$=Y8/,_$=VIBKJBFBS+4)+]A29OI+']N*8#R0AMZN9OL
MLP.M6 1\Q5749/1K(?5Z%\4]9+-&B?N(>=: XW(V0:$^CX73B26_&OR!*LCW
M;#$]DSLPC9"\$)N+0.H4R+<;D%(Z(1+[B,E5VFVM(#XYT/6AW?1CA4Z@J/O
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MMF2.6)*^\>7[7/1E=9V_=:X !I"O W %OQC ,%,:X[WZ?<C&V,+#4:C@7SC
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MO+?TOTI%<AN];RFZ6_>M\QOFU\1, NB*N%<WL:/XSH<W[C7B!D<S39J?]ZF
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M#@XK_B$4!A'VP^)ZWE #M2Z)(!,;QSG]E*PRGWS[.4'V20U]Z)0]GF!5=/=
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MB$S<8R(;R/0@!T'+BIN@#V2?2Q8P[R>0STZHOF*36QQ6(U6+JJF>3C:(@RP
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MU2=C(7%SR?/R@'))DL&2KWF%.UC\'080IA\,G=*_G6IL=:78_OR6R<7<T%^
MV$FQ\L1'/]6O\J[_T&UTPVM=^OKU!WHH_W/L5H#H-B[PD:1->6I_M-:HE?EQ
M<58\\]QE0K9&GB)X&8O/LYW$;H+'!**N\WZ\65& 9*-[@<%-'5;4LQ/&8WRO
MN('%2F;>9DM'19'QR'J3I9.8-AFO'"*BZGZ 0D WRX*O0T)VT8,W1'C_[H^R
M!?B-FZX$/>"D:?+VUQZT=^>#IV<O*^%L/BP2X?J&^Z7I^KA-Y_:TI]GCCRNZ
M;F< %Q'S;FZ'HZ7K$L;&X>5=>V\>8EM\[M>H\<_=<$S/[[A-J)0?:',#KB*T
M[FRBO@@G/'#YAN)A72JU8)V(3UIJI(.(-=>Y8Q;VGD ZYUH43NBBTT<2Q>_9
MO*XF7%/RG6G!R4[#1(B^]5=VVD=:<$I"$N:R[EXQ&(H$C;,8Y:M%. '?7(2M
MF&6FH5WW,?CJ["&JP&L@Z\6T*,LR 0)BUI<$,.*<V5TUK-FQ-0LX^\EZ<3A=
M5]'JRCDO)KF,$A-=3N%1M7/"!G \0?CCCNW<39G5HBRY>'UO-+*#AFG-2Z\+
MA!U,2F$)&/D%D#HY;,OC;Y#2]9ZIZ)S*X=!CN0<":,5-S+EU2/_0N7U%T7,X
M6&-2:4%#,\RTKO.G/_&,IEN#P$U):40U/\[%3E=[Y(4VH\:IXPWVH/^X7\_Q
M9[^>5Q)LMA>-V7M>393N/?_/O"/<_[Q[S^_8'J:2W&^AL2)1*7%<(I_*Y+:7
M_%JIK\)K#YJ,+Z<6[8!O&02V7O%N[;GO^($$R43$QU,J_73U#]U@POKER@]F
M";ALA7$N@-*J;=AB8B8C)Y56M_VTQ(E1"]JW]N]!O1GCN<_4]P:1<)?KIS7X
MS)PJQJDK)B>_A9?9!;-Q@\%_WI ?_1Z=;>*;+D_U\(Y!1P6/5UPBN3EK\P"+
MK[^J:)A6T7536\6L>D*3Z)VV/?=#<G]_EMX0Z]+E5)<JPI]1?D7+U_[[&CX^
M;M2V9+7-_B-<Y6+DDO$F.,O5)0O?"[II2NX4J=;-SI?WE"4,3]A=\%#"<<7V
MV"G=3J/&64 ,-&TFFKC!M39AK[0U^+>=>X\)3KY4P<7^5/:[M,4$&/J[7OF+
MSXR<<3#I$4Q-ZO8H!'*>DR0"LQA;F/^\7>[NBII8+6=51XSFI6 @AB\6&SL&
MG8XK6>F*_'YVNYW)1%I/YKUNA*[KWL=8073:J]'WGAJH)OR4;/GU4>S:J!\/
MFWA3F6E[;=0[R:V@^IFS,U^G'<022LY9[,#CQ^T[EUA-@IH=)N_SDQ_H>CU\
MJPO2;FI\Q71_J:GE*+C;><<*#O=T4AWE*9_J;-Q&]GKQW*@J,[.L:/@BN KX
MX*#^I/1AQ+=RHC2^\#2K&>+3BZL!FPWB1=FZ)%\;_39%O6*MV4&P-'3P28#H
M*AQ=*G@R/=-"+TPR]M^_H'],?FGXAPF3H>,-WNR].9WN:WQ-#0%DIF8&E(7K
M#IWO5LGAP8\W)5>!,E)ZS=NC'(=+0H))3D$P^9S3G=_3VU95GAGH"='R":*=
MT9<R95G"Z&,VN=,[RC-^ J4^;AR!BLF[U\XE9I1Q3KC9//5T%6#)/CLE=0G8
M3$=':UT7U:TA-1U(M!52@]J3&RG*W_/V?U,!JO;FUNW&B3J[+>QR8/19!:)Q
M3G1=?BC_M=A MJPFO*D:W.47X%;KM2_,+Y?PTM,_MH[0&?[(9YHQ;XGO]UKI
M;:?KO/&_ &:-.TG^CN=G.\_-M*)'Y<7%P22D(5Q)9DB4)7Y-(J^9[=P_"AKD
M-BDE%)<LF:Q  'Z\%3'8I<Q:D\'6H(-FWZ0<T 6/F#M! ]>A'@Z< MW)#G'7
MUD:JZXZN=HIB)BT>4$>T$O_6O?2O1^.'\)RO#T)0NRJSF20?Q*Y+= 5*,)IQ
M+30Z]UGK580=0_07&($A-NF+.:*^'=@Y=&C3\GH5YVP>691BP5W&[@"(PKJ2
M>JUV'"SNK.Y\Q7@-G_ID*<% <KM8@+C6:O6IX+Q2Q8K#BUG[6N_EE@=YZ7+D
M.KZWMJ&5^N3E:>Y*\<]+2ZZ55F11BHJ;B!)[SJ8J:G84%EC<,W*@3_C-T>?X
M^<[",";RTY%!+JOZUSN[1ZC]%/4;5I6Q._'7R(9;_/VB1=>:U=/JHK8P"+I_
M+HX!'O5+ML<WW5BBFVON*@^E[GB*,;$GIYL:V'_Q@D/$M8*&>(-28!;;!Y4Z
M0P&+Y[[8[H\PU22HC AV6PX=[BQ6%^?:;%K/-7^='VNLV!07TP&6VT%LMM>L
M_(_Y8(]+G1PK;Z1&+G5>XR^ ^0=#WV2],%R@3^19.<-Y@]K>%Y:"<WM+BAE;
M[DH"Z\.$Z9I:IJ54_=/=!VBFY*;UZ^NWU'H1762H'EU+-M/PNXL0A^K/8Z]5
M0 559-44=40OYW3O"U,%V?CDRH*B(2#.VLMI^W6Y]4AZ\D>KX'2*@A9IQ"F>
MA+DN1J0)@J!Q;JEP*5G?,'[Q_+Q(QDE[T\K"V&Y?QY:2O/NJ\!ST O7P_;GD
MM5FT(4+PKE@5G(A<W3<2H0'J;MGKH\UTG\DRO3W,*1:U:!I<;3[59%G?HG9)
MG[U$!86/  [[@7 0IEPJ!_FYQ-/ V/1O.@\5A#D/)7")JK]+]2L?;N@48QOD
M-BWM<QJ"WO#1%9EVS#Q0#P56$F9/"V%K%KXHO>%;3QZY6< Z!B9UEG0W;J-3
MK 7Z[F307514,=&#GSGQ8SA.9&>!Y*07LC4OWNP@<K*B"7AFR1U>NR_3/TS>
MS7Y_FS"%#(.]9IW Y8W'21(#]_NEA.>:D:\_?PG)F(Z<8;O *D7BA"UG3O]5
M<>7_,X?N__X0X_Q=>OY_Q'_1R:[4)KEK3B>]E%'KOECQ;G98.CM]9 #Z,>N%
M[VE,S66O@, 8(6E/38:X@-*2HA1=_Y+%QM_UG_]_J/(GTO0+ $7?&VTF!(_^
MQ1>,6_&FYYT_^! ?<,C.]Y]Y@H\TR@/-S"B*+K486NG[ )X#."HC6C<VVKSI
M+)"O?/Y$(3,A#*I=>%;!U^!B.:_0"\G2\C:S&:#JRN#:]M18PP,G?J9J6PN4
MQ#31,6'6/K#X5M+'.;._B]CA>@DQ<T)?#ZX:DH4XSB>C/ORN9I=[M%<Q;?=3
MW6X=H<S8C0N#?F5<"]XG>]T/!_'9-GK%V\&2SU#.Y6 U;MK$D+VM,&X]H+29
MW+";O\A2[=F+FY@5@C0X+F:QR&9EHU<=,;OH]4QOTZDTV<9&'J^.V*P+E[A(
MACTK]&C1$$/GVHR,JX%J. R$5!Y62IH.R%=(Y\?K41, %H/ +H6:JJ?>0*</
M"%M616M_47I=+X=L,2!LY*,A/1A5\:;\.$$?D40//O&8HT08B]F^*\E(\ITH
M:EF0^5;F"N(;R%M38XW<._M4,+UCK=G*_1R5]=59*8>Q2SK8"5/USQ65/ *]
MZ0@C;2:ORS>5$#?WS2</T ZN!GQ@.5F&E31@C#:'(D@NI;&:85K*"&3?H50^
M&E=(,BL21M+Z3UJ.^*/.*(<S#>%G0"]J':HPR_*Q&A34BM4]U?RQXO9/J=OD
M<\?U0^/^*W(-&O]C<HWI/^0:R^MVV*O6^,X?9__7W!K_[<Z&[<?_\/(9A#,H
ME_7:^ZFVL4KY#*Y;^7N51E_8>G#VQCY1@7TX@+='T#E=5I#3G+.WU,@#:FZ-
M_=(]/BIAI=R3'H2GZHPXCTKHK ;)3W%_\Z;(V<+!FS;ZG%C ^@C)Y0HUWN[-
MXF# P8X(R?YO'WW\^IPE3<[H@D0\9A8;C(YSV:.X7)MZ.<G7>-N C)V=AE9M
M1%H6+E]S2?@<K/6](,)'4O[)34DZB(<]L57J2;^#J>F64P1F(3 TJQ:SL<>G
M93#7U-(*+G F<IR^@M:?QM./M%YZ9U%E3?(?498\15/?XB4^V&E!-,\B)&8\
M]_"'213(,5L2CL;GFI@?W9S) ;T<BMA.)#>N)ZG.:W %E'OK 8<UZ=AA@FGT
MP$&] UJ SH!;_O>K:E+3G%34Q'O&'G(3. L-(.QD4+&\+= ) RCR:EJ%7E Z
M/BW;_U[*]4&@C'(IU2-,[*0_&4^YE,S/I!<5:)L7(27]DLWP2?=<85X$Z!L@
M)UTJU^)U\0"$Z*08=WG5_.BINU*YE3F7\'9CR<2'\X5V>??24TY"ZZYLPB1R
MF9PF<](E'E$74^X"?GG+,N6D-5:"FN[1V;^[!GA$G?G9G8#XW8J*9<^5X_X4
M[]\)LQSA/[ZT5AO[H.+-)GPEEROZPB&B\P?8W /%IX(NS"M.YY,B&[99U^><
MI<&T+/B2*RQ,0#R&IG9)%X2#BK\Y \4X.ZL=<D_L%K!3;L1C\V;38/\NB@ !
MP-C)JD*2<S@H1Q($X*^,3=>M5!OI/C6\IIQ>OZL$?+T.8]GQM4]/5=NH-S>S
M["M**LA&VQF^E'KM5H+BBL.'%-GH"2?YH!\J9.V=+F8<5-/6:YTY@]V0YE9F
MVMFD4U3Q=XPJ?LX@YQ@OJ9"8V".I*]O?M.A.D'\'\\#UG2M?N&6Q<,NZ3(*Z
M,GE3+WD35I++-,=;&GYFBX0<.F/(*X<%[. 0HDN"4M*RLF+\L)_Y'A5+>36U
MS,*%?JU/IE8"%H_&<#2"$$V7>^;6$RXV9=?W"]GG";:428^[4G3T+"?=&P/
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M(7N<QK=5-R?Y'NJF.8.V1[U<SSSFQF,,\MO;K:!A9RAQT]B.5M,S=@T776+
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M&+Z++K-Y9\OQU]V",S3#K2AEZZ.!I/@>_+.G_02W<U5_14%FT4+FL0=6",/
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M(,5W@"="9PJ(,94D/?X-=UG]7W.7_Q6%A[1):!Z[_?AF";I)5S$#E3]\<;P
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M&5KF5ZZMQ12]UZ453FS$L?0#!3..01B6ZQ0EVM2LNI& )<S1<T#K3!PIP4,
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M$#>4\R%\O8J^'C=MNO_<7#!HQ[@!+5<+BJN>%1A4 O8=]<_:T7)W(YW%Q/^
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MQ*.!DJL\K?XVO+W>S)[SJ8&$Q@;E08(:0PP<[_'(*PK<"[A3U)F77T"C_9\
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M)JE4<$<_@>U+JH83GR)3=Y&%>\,65)6Q>4I6S17%_MNR J;F^TL2L99=RKU
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M>(%2[C*1==W7G[RTT2DY0)6_Z*)P\0JEQX"9<O@54+^'V7P$=@9>7_[4E N
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M05U,/FQ.OR$B482L?PEB5G&\Y&B075P5V*E3R\9L>C650I[YTRZU:MVD9NW
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MB!*^@JYHHLE1TSR4GX5EJ/U9*>N_'=OHIT2L'@_[<*_\WA!0J]2U\"T^3K#
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MZG-%BQ*2T=CEM^I7J2<J&"A6+FW>#,.PSDA+;W_*/2[40<BH3=6^^*/.^0:
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M29.FSW+MOJ-\*9O_R.7L@2"7.LL67\NH*7?T8S<1)JRPT=,QF4M="3Q#)"F
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MEU>U<@L(7P 4MM^U)79%84ND:NZK6>+$^?V5T[1VA2XB_?-/-(&G$5=+XXU
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MCP.-X.*X#,C8L:5LF"W_C^_4+X(C3WYQCP7T?S.*)4=_=8[]'S!D[OPJ9FP
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MYYKS6E?9RXY"94^DO0=SFV\?8$>N&7KQUWV@&[WUILOB4?),,:Y?JV".>=\
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MTNV,A^_THC@N9P/TB#/Z5<M ?Z+89[7,Y.!ARA!0OW \2)F?XZ],KK\LY^G
MZ>CNJL_IJ\TSMF%Y7_,WI:/)WP V=\J9<%@4L*=^C<5+&69JJ_H_%;1(9-W[
MU7?@WUUQ[/!?^^EL>;,_V%E_\Z__]GI4O .GYU>R*OHP$ESST +J2K5GRR\8
M>19E-!+?Y19'JSBA^_G0UO!0@+<:)PRW[SS.1O+_]*Q 'ER+:,]9-Z7?K;_I
M:CEE;6?8-P23(4'BHC%//5;IRR75-=X4\<+NTB_4#D'P4#2\UOSEGC3"WBQP
M >ZX0=Q+7@)BUFARO3]F+/[N/3!W"R/)C^EQBG93U=S5ZT1D<?*F.8P/_^)U
M\XX@R3X[)HGQ:A7IXH_!F.4JT1A'06$2=2KBO:8\4P_.C7LZC#F^(!^0%?6#
M96SHM,<H7_PX:Q ?Z%5HXQ7$0>US4V;#+<\%8;+Y@[IRM(>'S9!7COE%I.*,
MC2R?1,4WDQK2G ,&NO-NOTB4DN[OG?>M*-8IOLQ>55*X@J]1ATK)P5]Y2I0>
MDD\;Z0+O>/)[&[;3G8)\0E/&3'5HV="*\\2#9.<TZ%P$'^7 C<P5HGI7X"UU
M4M_4Z+YH+, F"ZWU@S#((%K9U_;?AE0?E<R,!_K:BU@]91+ +'_^/'O1?\%6
MG"S-@E@>TG8ZP#^*,\V>+.95?(E !1CA@<^';-M3[QR#C#^U-ZH*E/>RB\RX
M^/J0O%EAG_U'T[L4E7*5.'X4F$V6/:':..5FN '#I$D:=K6DLIN$5+"(ON4\
M92X3Z?+%95G(<XJ:'&L3LM91M82LI%\+/^%AHS96VZ0*2S9;4Q_8\>[= _#R
M!$'53E8($0[@OX'O<?9^+]R8^]0=[CR0X@MBLNG&J^1?#SFRT^7-)?(C3V3G
M%Y4;'97B3Y=>=":Q 2>'A2JD*]&TR'E_<KIHV/T,N. +J8"POJO[S6$Y%>I2
MUL7YCD]$,7$KH*0[C2:=0_=W+:OP4;8506&HXJ*UPH1*SU?6F-&)9QY'QJL*
M(:[I!O>>-WFH[9HYTB-0&&L3[C!C$U\S4SP#_V3&XX'ICC2RCS[]0LI:J.+1
M&3!J]];]R7_Z/3+_$D4Z_^.C<E,P\T^[\7O=:"XM3<%QHC\H_-K;6@(C&,8Z
MD/C%!1C5:J3T -+_T][UQ9_V>V:^G._NWS^_]R=7DG,>7_%TKJ)$IA+;#P_)
MNXA>D)XO5%4+"Y@.E%-?KG=QTTA/M9Z6#Q9+(%9;=K.7"9$B65-N#=K7^+>?
M(7^2Q_5XMPGQMM@&T+&3P15$9&+G2CK%A^Y[!2%JVNAC]E"GS0DH)NGB$A5G
M"O86UOUY]*AV(6:W6#<1@J0.,65PJ5!S/23KY"D6C^7O*>$"XHM=C8'VNF5,
MS=Q,/9;,8Q&T1U,F=?MT:7F_3E2EI)UL()R5[P0!<+FFM#Q5^GQW(Z<BT*2R
M ^[CWOWP\$2ZYPI4-G]2ZL6+AYUF36^X-T[<?SW\?NL.._RC># ]/OD>W?RL
MPBPGQMH9ZS0-6'>*A?''1C4#_0\<O1\,72&='RDCZ3C&]5+D\8[<Y/VXHK,$
MKV>DR N:5$R1DY>;5*-IY/R_W-8CN[=FG28JTU*;/[&FV@N&NZ15*V9SL@2;
MQ%<+'R_BZ4">(/"VFK=Q?@-H/(//?%$7\.QEUA*WF2,FZW1'@._ Q["&R\+#
M<D VHY99[Y1U,?7X/,@)^Z61'03ZUA6IC'N:S,[!;2[W,TQ4_J\1JG]=_Z%H
MQ7&-Y<\X1D2EKI&DZ^,42>(-L/_"3DV:37]_YF>J@=5369R776#!S'6!= RY
M$#JFEB)\:2[ZXD,;'<4A.'0MR^8R_6'?S.ON8$H-V[E:.9;Q>.4OK_%.UK.0
M]EY!M&1)2A.',B5Z7^8/4H;?=U(&ZCLI8^%W3L9WG(,^8U>0'5@(7ZKY0[=2
M=&#79.P\&@72W:/K8#I<Q?IH0S*S=^VOQNB,-T!*@"")S6"/?7,T:-%J 7O$
MG2+M%NM2X'&1!L(*10S<!AT49*]]5,C)HM>-=CUZL5#?.G3K%@SZ\\[SG6P!
MTP^ @0B;-(+KK0L=]NVKQK6]I@SGV!J7:QYJ[6)_$J44\3)L<4_1:M)?//.0
M%K1K]E2)Z335G)0HDMB&9'3K11.R$C2S@F11-R]/(CM MU47KK($<&)],O9C
MQMPJVC^8L EQFYW_XD0QE-K,=MQ)C>MZVO6HG-[#/SC!F\$Y<+&7VF6!H3TZ
MT;6?#GIN9<-KN9=N;G^[1E,\:+=\QD(*I-7 ^+@@I*_OS%W)WA_[,M_?(!7;
M1[8_ FX"GFW5FY' _W+6Q0Y3\'>6/*B=F\93<,/4&C/D$;\U>EHG:#=>K#B;
M[7;=B,VR]G);F^?2-.?1&5MADLOG9/280]FCUDZZX !YY8DCIWEN%^J0LQVR
M>\7JX@-RD6SGK*#R8^F><DNTZ'@%UNOU:Z4  6]&%=/\FS<MXJ\W/,W$M=>$
MQ>HZY+.%P=6,"> =-%32,*:9]UQW#L,T\\\L5]C3K0D4T;C]X,(<S7"A0LS'
MKX6:_7P&0$FNL76G&FZC$0#9'Z*:[W^\:8LZ_/&CE0R^X/R*3F1JPJ+I!FV\
M^G"D-6;9UMQBZ8,&Z +6/BOTD&GJ6%1A1C"%(F ]=D.I2*"4UKZX#+N"G6ZL
M^$+%%/CX]-8I-DUDX<+X6%.M>!3N7(U"0HR@%48321)+U9Q9:,G'VQ>%X-:,
M$:EGVL%0E8@5? /@Y3'.&W7:>5^+NW(#\=Q,].^"$C #LOBU082>Q/N!2):4
MK;E9L),O>9$8;12DS"F=:KRZ2G7=:D5W]\7, J/UO:%7N/1KP-*BZWU4VVSN
M:8FV,]L']0JQ##=!8POJ%_P7:N?TZ_-GI=M6WXC(H)MR\ &6ROKN)ND-Q_T%
MIC[..#8/$\6='[T<)L"K@X?)HPI>-$+8W7!::X$#JO 4;MUY 7IB[02.5D(L
MLO88)\6M*$I>B4T:/#<BFL.Q6I.'S(4RH_RY84:67K9&X2J)=H8.N?,!P!N/
M3,BS%!0=DXVA$ZTU/4V];(T1LP\IZI[E_HZ7\T]:7[O0N\KQ:CX"G>M0J=B&
MF'ND 'KQ]E+E$W_BA#7)"?J\2+UWSE8P!7;,(.WK;G#63;6+N&@,91?J=(LZ
MXMW.2 'J;^ZOHDC[4I-ZPNL+=+3(=Z<,[F$F9T_%<'O97>(AE&].5XL\\#DU
M3(Q&X/W>FL;&3',5'E\K^#@M-;>&:WWV7NS$G4W$%.6ECPA('U=0_E%&>R*O
M40(U8T9C30YP,&USTQX(=4OM.'-CS$=$[Y%*S[$;#S%-3ZD[+WSI5;@<(EBA
MH,!E:A!CDX4,JE6 DE)_2Q;L-KM(-HGSE7?Z!K"@UB.1RYCYHRI9H"8D+K(I
MOV[RM8%2@]DJH0N_:Z1I>E0\I?E(HT55;\HI^(N<V0"_BPKE*A[$N[\-66/N
M9!UK!GTX/<WI($BWSQPN&8@U94]TAAYGS1;BT@^OE]&S2CAXZ!S<'NN=ZU<*
M]=E.408#=Y:%+&AVD\5&W4$QM]#G1O(>K]]&A+9U%ZMV4T2DM5TC+Z1*(PV?
M-UY^J7Q_!H9?@.B.1^YH2S7)*CCG0V0#W=BG#3YT\*%UJ,R/$T+&HO-IV220
MA"WI-@'\8ZLI#IVL0A&!M2+P>?GW#]BZJV9.^-?/V!*B5(,U>5S^,O2TTC08
M($FEQN+B;W04/K!00_^]6^#HZ&(&9^+YK_S3-V$RF8$<*+7\GYM#CICHUJ8_
ML?KDH79?D=0B1TK$7!"R_Y3,%ZH8\!5"^5"*<:LE)+3#G.6!Q9KJV=OJMA/W
M3))W,TTB:>,?BX[.;DJ?':U/YAK$ \4#%F1#HS4J>P9CZHC1!MV#Q>N&;@,N
M]GX"R(+NE=, %42\&'O2W8K0VR*&4H?0<]<(GR1&LLI+]C,U(D19@%V[^A8]
M@.2^;*S,[R<M%G+@\;T6O5OWW,2"?,.M#U"5J?VLD]+87K>=NH:>A^ C.3E.
MV#HYOZO.0AP/U<Z Q #0U9KB2!U@ARL_IKT>,SVJ%,&/."N.PJHU,N](0$LF
ML?R9'/H7N^[O(9Y_OW+_(?V(*W_RCR/M&0F\_.]0P[\D\(:G(+\!B,1DK<^M
M-JV_/V- (CI94UMEBL6Z,"!P(Q@FW78S(LKK0>0-]6-.]2/5Z]H?1,EJ;@VO
M!-"O<IOM#NC+5:O:0\[X-Q,,L]?3$!-JR.Q>>7'7W0/&/=[:>FRM-K>B)KJ>
M7E!+C:JOCQB @08:/.^2(WE>-^$:O1<C3DI7L+>LXRUBT^[-_-5/EI"Y*-C\
M2R#O'".05X3@,ODWR3H_G&7'.[:3=?XR.?_M#OTWZ[\N]F;K=8F%YX]J89;G
MG U9G@3;?L5YBFJU>?A6/CP1ZL(<A70._8V5Y-U*%O5(H3V%6Y+YF GZWF*'
MVBJ"E T%+%@ ]K9,+A,/ECB1'5E.)+<JP@ '3-&LERGS9 )Q?0>QOW]=<22O
M\I$>KVCNOWQW_J])P?V?+*8<;$[C+T<H0+</?2%T(=QT[H&W(%1 U*UL.^>1
M,^]JY6Q6<[K5;E5$( S,RH?%I,45OI)*<K;VNTN8IQ53N<L==J2NW_S'ALEM
M'N?QY.CLAG>2A3 UAW:GRIG^*HT# ]5NST$#K@\<@IBG(*N&8AWF2W2;D;&#
M=2]HD>QYX34ISUPF ^BV[V=<@?3#M)[?D&M);S:@[<E9ZR?4X>-YX-R;BOA7
M!_/LL[H>/4@$D2SPF4N=[-5V$9"8Q55LV]D7O^=K[0^S0+=2>AH:%N'E)FS*
M\B8"*HC-FNCX_O+)#%;M:K#ZSP9<3I-%>ZK*(LZ$]=HGN\NJ4,Y,K(.P=''A
MH5?5QMQ,$]VN3V*QUUP#?'@]S(UPX[1<#"ZF$> R8.V/4,0%73:+BOM3)0(*
M$D@N3&-!@IAQ4GCL<4SES5M7S=L\,,1\ V$79NUNR/)]M9F2XIB+AYV>%@Z8
MB9JV^2@;Y5IIM@%\^+(*!PS&F:#?2W_.PE9[!MR[N&!N;N+/S:$B%T&7V0T=
M>3IC6BYNWACPM0C@$BV$NU=3RB$[6N/9BWU]T^^$;QD\Y6M2;IFN8I%6UXD(
M!!FHI=NC_<Z';N^*$#-MY)[RC!:(_E384KUO@)=[X]QS+#&[GC$P',YWC@[
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M:;1#S.W$CG.D7FK+.LZ.KSZ*-%;!7^8N O*!7_^T*MB3!QVW?'HPU_OS?8(
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MUK(CP;8)SYE),MR^&3\YF>>FM@;^O1P^9T^7 ,?Z,:].1MN19C:R<)K(#I0
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M-LEU9!V!S6MZZ<M%;I2L?.?X.=OV)U;V?/@A!;!4_1@1(W @9J40RQJQV/?
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M.TYI*/P4R/'\'42><.F>S>D1D(QM2(A;H4]_V2$1D!>%DO;TM/I<AUWI,RO
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MG0FY>-KI^I=B[=1[%P\JY?_%(5)6YW4^478C\TC*[*(MXMT+',_XYM.,17%
MU"[]:YQ*Y\ .\\ ?A'(]'3?73,8ECB'-M2[]2T\G1#.Y6A>-3P;X!$&?),PR
M$EX=E=G&=F_R-7==,QOB>ZHD86B^CEQZX8DSDH.?.\6#O?M,N"=DH*\IW&H1
MAO"<[>UA8;OF-^Q_XQ4(@A['*S9BJLXB2_=+2 +KW';J1<MKF?L)PNQV0L6]
M","!9-<T/8Q/[I!#.4ATVTA]4_SU;D/I)@O8AA?$K.>96NQ'2'714<*[K%X*
MIGT-(B7;.F$_NGUJ>W''S%RMU?YX>6X/,/2XB9RJD9?KL&/+8G-@W-RG:RNH
M\FN8[.<-Y&,8EY  G]&^4D>]B-@3!*67RU95E<<*)O %K_$%6'X1VW75QV .
M"UEF'=-&QOV-W$Z4WTQD S0A=J1%7D(W\GD24,U$*7KZYHM9?MF)0?3M KHC
MY\;P3\ #X66?()[N#;43)?.E'C[-E]P&R7E2;VWF_7>OQ$1+?N0LP%')=Y5*
M(]0.]M[^+I,62ITX 7IS/?QK<QUC75WZ%<3Z+?8+G7: 1$C6V!W]'HL8 GE4
M3V?2:L0Z2. Z.73TB B(40$U:1ZD$3N0WV8?JE5.3F,M6@C[5%REL:%3%V69
M(HTQ3NLF--KZOO8$C;I6SQB]H#R=_[P$<Z@_K'DGV=,/HE^>P7-0)&ON1!?A
M% (1WNMPS(+BH!%(U2G2O"<DWQ)AI ^F]2VN*G#T!$:3/QRJ XRV^? (("8"
M9CND,XWJ4L%]5V8!*=Y.K2%SX)(T,8.;PT*RUSS\K(S2R73%CK5O7U_N! S.
M.:]5IO!'=NP_F'+P //D=/%\\^A2,_GQHP&WIB4NG$]_$71DVU4)FSCX)"VE
MCEE<WN(4-0;B?&AB>"GG;V%RG);Q:=T,+O;2;S!.+?GB2[[:E\#Q&*_YP"R9
M9LM GD6(B;KXM%Z^N8G?51T.\UZ57RI+>>4>C&E6^ P$FC%Q*+'(?ELO&"^Y
M"W.*^4HJP<-B<%W!X_G>-QN[?(EI3[P8'IA#T]3X3XE%D<X0,M JE,,,C9Z+
MT.>=S2']^6;EEURX92 Z'>_<E;O$/B_JR!!*\V)+;2%R9>D5"UTY:B?X94/2
MFM-?=N_G^ []E^NW9UXXFA T7&?K0R[?7U%DF$F4J+)79>/$L6E:)#(FY=Q;
M><@=1^BAC> P5V1VI9,0LVD%70@U.RJ +ERHUCD5C!<S)]L>9B$ES#K6L=W_
M?/\S%HN5X,$FQ9M:*/C9G-P9<O]*BM\K,)P-<"E*\WLM1]Q(LS)E0Q.$R0.N
MV]A6*=!]K:VBM<75&,6!@ ='"'.;7T#@F+V% 93IHKU=SD(7L*3+_BZFTRG2
M.B:MF]=88 A-_!$@^,0+ID,?:](;%)*SD',):T@!<^)%@S#$%/ZKIO4%Q6^5
MJ44V2YB(1.T^EB7W?,9:@:.&]7: -+<2K_?UA@%*M=K=KN8S6I*L"?@>=1*@
M,Q]G>E^A)V1Q9:,'].BP:7-VZM[P;"%C2 WLHKGX?-N$%KF>7>L(W4RI_!['
M?2:/0*CSDP0F@/_[OFB%%T[%48.O]DL8P4AQCLK^ZW>H[!!9S;* HM6\EN#7
M6)+]@L\1IWZWDR>!0YSHM%R9INM\P(A7QQX]G,1Y(7?(I*N$%Y\7K=\I;]>1
MC;-U0]7.S. #=Z1>^"J]AWAYY8.G[]ZQ=_ZP9S)KCQR0'^D3-I"SXA)UA";,
M)Q_O8\<88ZL2>"/[H+Q1U3\@II_-B*G*T5!) ^W]C,56,A1NAYK.'J#O&:@/
M"FD/-W* -AQIC-YD/:ER]:&/M7R%QQG!PA$X[-BV&ZHPK^F -JHW+\=1)9&7
M:AY0T/9W[0,E7#/W,\PO.6N9'!9R!IC&Z@;GNP( YX #DQ(@!&4-]FN[K^K\
M!&/ *.&:)_H7$?0_K]._<RJ"*)<7C+Q5MJQQ<YY,W-]I%K%YO=_6*+*_7SF;
MW-/-_JG\BK=2/[^GN6/5OF[_UQ[Z7S'S_9U:D9/Y4Y4D.OS%T(I,O$93EU](
M>JX@$WKLE;"FCWUPR:7W58>*)56%R@\;&4,3O4#]PJ= )OF+X%1G[ -"8F=^
M/$1^GE=/&=2>MW+#MZ$UYC.+PA>]'/2(SF@MGOUBXD/HL@>K([Y&->=-D\5T
MK$.,>9^UWS]UC.^'WAI#S"U2P06K@2^WW^//4[Z!:G,V 0]^PQ?P;[\*ZKI1
MB1K6H<EC@"R8[.C5GUHS_V'32Y?X3ALV]IW& B[RZ\*N7^[9!8'-1*+;+?^_
M:Q"<ZYE 0XXY!XTH$;*PPD^=XH6<#P@0K#[0RV2=+#Y[U^B%NW8L;#IB\@07
M".?GG_>N!$$S59FFE>TR4YM'2JW=CG)#1KW4:;[2[-*])TYOSF*U=20>?C:Y
M(%E2#O;PN;<N8[7\4SC<EX4FA"]E-9*[TM*_]Z+V_\]G9OI?F\XB9LI65N_9
MSL0'GCWJ%Z@3^XPIY$ [,B'%UG1PS%H*I"7$ALX9%L)\$$[L3N7M,[7K%#:N
M5'>-UOGA^$#W0[_Y7T1$:(OO/  EASH(6S0C+6RUCW ;P6J,WHSQAQ:Z[I9'
MX*%;>LYBTR7VZ<U.3*BFE_T<=]<H\@6PS3D73^;.M8PE,DM_Y1GY[&X-Z%S>
M@)4 !EY:'<7IQ&S?T-(C[SN8H=<?&"&"Q%57V<0<L3ILF_U(5[ $,^4Q7AVN
MMU8*$C,;2Y)!211](%A@?SO<C(WFZ*7GM[("M2,5@?%=B(638>:*H->+*OG=
M88CV  [CKPJL5H'R'F=/=O-NX4>,TBZ=NE89#,C+W_VP'H1?!!,5LR.)#44N
M@Y$$2]+04#B+%*0J/@15:I?3@>A^\R>)3+KHW//^U,US;O45]Q)(E(XZ4S.A
M*9H)W5"4#YB' _S0:AVMH#[& ]ZN#&'9?7\!!N_VWY;L5@(]NJX,*O&3+5 &
MW;EQ_<X3P<1^B0LF5SU:>^ L,=M@7S+% .8'!]V[$V.:]J;!;+1^OV@3IGJ0
M,IOI&^P7 K*,^7V:7%ODHMYXU&0)3C/A$YPTU"1:L_AY;S[SD'\*^(P2ODP<
M<!2BG%O="2RTMS2ENW/G+\?P\V"FK$Q6/QMUY/'!;[N?_A!.I2\;>++RBKG.
MTG]U\W*$_5\;TLQ:+H/T[*?.KO3/7CT6)D.;'^##/\FAN]9>AM#4Y8O*P#EN
M>5N+H-ZC1DP(XK3$7YJ;=,?06:'NPMK-KA;PH"/FB.D+QF=G&0KF54>_5NI(
ML<_L5KY[Z\ [RT$:(-YBN3*7UV/.=3?2W7O=[0)HM_*)CW/2*>;5 %5OU'6\
M=P,_S+'>-1/G&&>3+#$ZTQWC](W[)C<[$Y-'$#HLH:Q@&ZGO[VRQ!;[R<2M(
M726XY(RR\2V=@4O@Z_CNL< F!BV6F,>\5LV<G+@/K);!U]'?R) 3,?W[:3'S
M1T+\^U"$!Q6*4/D3%#%(A2("_CVA"%"! B=%U_># ZAE@:)ELVX^[0CU3]/-
MG!/AV2%OIDPQ?_A Y# D$^ *&QK*A5;L"NG'S2 J3[\MJV3?J18QW"\0;/Z5
MOE[B!S:A\@.H,&5*^0.6@/?\@5;,]WVY&#3\0RSUVWO\R1_Z(1FC@+=V/DES
MV:A9FFPT'%*8Q_.PU3HST*G"\L*$W%?+CPLAW'2= ?NWA>*N_AJ2\5/@@U)-
MKK]%'7C1I@[ G-SYO$-Q8?>19?F!613._0/,8L+'R(0@(:+J*%K#6,FY=3 -
M05_0Q"H+S"!5GA,+ZH(E]CQ$O8WZ3H.[*MDN5OB@ V,%YT]/_O3J@F2#G@ F
MN"H-SP6[21J>K[9'L"*RS/1:V>_Z!X'F<ID$D_[^8<;?+IJ?$RMPB7D8N7H+
M6HGYQ*[^1)6JXZ%3N#6,VLPJ;=I2^I.'RPO'/VFD%OO<X&M;T=4"TV=FO\B*
M$#J"D^*@3?%SFPDL?K;Q\9 2/MS6BK;KZKMWV?1=--=4'X=M&LQ:"@.ZS%\1
MZ8_3%E<&)L[1-15YVI?8S#^.T<ON?T=S' @6LW&E^\KM<%0)!PQ5.\T)R+A6
M4'C*I1HW"Z&[?48SY21 2G #0P4[?M@>QRD016_SZO$9@847ZA=/[.?.-7VN
MXISB5:]Z@\E2LDA#/+EX/]HAXYY8O.Y&F"P_SUFU.$9,-B,2C52B-SL5"&R?
M+&^-T#X9QWBK9"FI+X#=*:I>MUY$(QW&X:^M: -18&6.BMM4<@?2MW336P%-
M,_,';@(K8WL7!B+.W_(V9<3\&S F?RS.OWT7FO^;FJT_G$BA2/&KAH::'+D5
MUNKBT5V6&]@*\U)8IT,+AW]^']67Z4_;*BL98V3:T7];IN0&V>%6,4YUDERV
M7__>5F$YGXE3Z1AX0E?YUY1=,$,E;QFX9WCW,K'CFFLJ?0;F6_39 .,+19@H
MEY&AXCC_P@1/I$ZUD#+;DJC7!QS?>6V)4]O(V@?ZYK>7L69N10]^$"QR/RVW
M-'OP=S9AF_TEI;.SPH]QSEN0YVW6)4W0$*I6Y3/[Y<\Z1C[H*OP5J74(O/!6
M:VTK)OCRH[1&!3D;4F+LW!4WB0XSYT^G1W6^TY S0]T[OEHU&JEE6Y!Q=H9"
MCLIX5V*0.F%021RVM+PI\/0X,F3$UM(>6J,TENAGE+0WR<MNUXZ)G>EO*-3;
MN(H3JE)D'AKP.FZN7,)[URJ^B]X'/]M(Z9SV15PU7QI@OSOU:#XVQO28<1'9
MZR6M-;+@XW Y=;25@:,U-+M\Y5P3M622E/$='"B"1-89.>GCQ97&K#"D Z@P
M!$>L;Y8@L*&N2Z.9J#13YG6.4;_+S,CFXG>:D ?"CZ*X] <W.MP V9P@=>_
MET)6-%ZX&QX^SD(SA;,Z)2SR>/\**U5DACPK8A KC6B@.J,XY?@[081P@\&H
M5L!@.B)JK"#6!" %ZT_39?*__A*7_W0H&IA$<.02K+]V>8"1<[E$CK34KNIC
MJR0<(MUDB>YM.1Z'V$,]X[4Z^$'D$_QLE(,]>.(Q^$EZ;H"*%)N1+$"IY,*
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M$]6Z6C^Y"WP,P>6C3B?=7@H"463_2=$58-W5&H?RE>*FVY]LVA55Q*VFKL7
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M-G[L**XKF(SQ'[\Z4RM)*EV]XLV<35SVCS)EI \(# P*M^*E/)Y'WSV3@]Z
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ME2Y26UBT5:4Z(=CC@U\]DI004*1X]% Y;#DOSR8:F5F6:AA)[DV651L%,^E
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M-ALE<?L8&G/#O>RBL>2RKN).7J9;1?#G0H>7;A,9N5#Q!!\H-WI&6S_OK#!
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M$+$]957? 982*.SH)<X_=4[A=I&^P$0"1Q*M0JE4_=)%[G7=QN2&V ".-]_
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M3.N>-_VJM0D408IN@&?B)HZ-.UWS\L"TX/3@.=8F<YGL$)BJCY\XJB!_XKQ
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M\QTA= PU<,92C]YF<R88\J+NMF-Q2/BY>*$:+S1"UOLS06C6-M20GW!J!O9
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M7NT1&,2-M5T#&0%=>S2@7V?CFNZ.6B3&5>40GC&* L$%#KHX92.$P-G=[RO
MU.M\.>7%%,W(I_C8HX77'N*XK0:?UP].FVD9BL<4KXA,#V:$ZE<*>Z >]D.=
M!427(/8;$NM?!L.37[G+GIWTAU?7R*M!@F/=VXXAEG$9K, ^U'4!@22_N>"S
MIII<E7,<1J/F(!(,F91^$-0[\9T)C3\(>97>[&0YS!_#@LPF2%804NLF,2*+
MS7GIY=:1G?R$7(U8_!G9@(69F%LEP2->O6FQH!&/Y!A3>WC1L3'" D#Q7AQR
MM60U*:WE60N8[P",T\^X+-VR%7PMV5@#G*VKR/Z[&/TWF]TSB(?1A7-;+ "%
MK2[?HV3IH"F5H.N#K%KNS'FC6]O54L_<,($G;CE^_GJ=:EK\2JA72I5GW0(N
M6:L7OEW?8SO0S(+06E#E#-I7\SRD0I[JHU<5 )W Y)VE9BXM-B.)\/:BL8X%
M+6-SOB!UH:WQI8I>VN$9^HT23_(^41TF9ZYT0@9G5Z\_&%,&&<W3$E0,W[,V
MV"*-PI+7<0KK197O@RQ+>ND&I)2$AZA[/C-WR?'D>D0XYTYG^TM.!)=%;!PW
M;R"F-D.=4XG*C5W\SG3-&SL#.H*/ 03I]==G?F<"S*];'0>OT09E2=2F8 !7
MKV((.L&"M'0%"@H@\(F43=V39$VI49K%_G%&^*\=++.$-VLVS=&/;F)\4$PA
M3Q"/UZALQ[Z$?0.-?<*\5?;MN]G:\\8^1^"V=OC/,L^3@3\;@:75<GLC1/"^
MO]L!4C2?3^L7]=Y_9_K1Z>LZRY\UBB[25FCX+J$IE_!?D:'&BM_2F# O;_V_
MHRB1V86.*028J0"4]R#40K\T<H0@BG^F+;TC61F1-FUE, +Q'(NT.U8;=UR)
MJAR$/>L9DK]')>V0^5-L9X+"A2\[]#8W<V59\4$2P*!\-G$%DF4K%W7X$N8X
M7J%C>2>PI*KI0+YKA(RV'CA1>$Q,CPY\JO2/]O;__]FZ_W*U0I]7G?>\A+B&
M@ZGOX.W??D4\/XE?O[!\ WSKX$&FSZ/0SE$@_WVT)R+4XKIT4+BWKDWKP_Z7
M)_SLDL\--LN)\.T6!UO)E\H*EYGJ(L'.#&YF<TBVW4C/=>0'ZB7?O] LA)=K
M+RV8JV])L9'MA+!@BNI<GU/KQH?/YK^'=!<5[)/Z0#E2$OH)XG,N_MUH@HKF
MC1B"--SCJ.9K:D# )+;RLYC^^8,AWBIZ+X85<[&5?;Z5A,FG'1CD:H%\O+4B
MRB9$U0_*J4]0Q;<!!><D),W2&)U%K;;3-G<+J:*P6YT%AY1Z6X_7+,?)GHLY
MM8^K%7[4X]PR*W(-LE=GW/;)2)RB$^A^<6YL.*M4;&. +$!-,EO<?0%I:\W-
MU:OFF;H6:6TU?&*."QE3JU"*")XYMY#^'&0/#&)B9<+?X)F.?W.J^G6C-1_<
MO3HDS4EHM7/=W/0%:Y!M!!V[$72NV2ZWQFEB)(9J?II@+!V3UFF704GH7 0B
MB>27GEJ+GH"VX);%W$ O6@AXSA0IED#HO<<.6\Q&8![4$>KH1"OQ\VT<=VW5
M9Q@\GDQPXKX("D(6IB0@UGP. 6<JD<^+W-??6;P11IOY'.*ZV01&VM<[^\I:
MYXZ=?>RQ1*E9EYM9.R:/OT8:^PB;S"\(&%K/*I*L #6,$*$[;$[-UA?T-SA4
MKH'ZS7M%\0TQHH.6QQ\@<TJFO8$]H%$35%V%V1/FCHMZ:TD<%W9C6#$: T])
M$ZW9$\VQH.P^ *7QBC.(*1[D'Z22(%/H%F)HI&.; $.5*9?/$")<>2W],[<"
M74<\EE?E\$NJ_6UBP0.!3:+[[(%U_=7KJG(XCZ>OFZ>J*]&H4<]X/_#3*Q:^
M6AQR:#@:** L'Z"XG9Y:!#K0?YL/EGJYS-,UU46+;?GR@RFA36LVW$TL:% W
MK$20Y!_:6/ @NS>G6:0NV</[J"G4T;Y<51[/OC^9AX8Q7]QR;%G,[&C5XH_*
M4N F^%8DD/U[S*U;2?9N?IA483:P@GUY\]-QFW)D;K0!5V%HL?D>9B22^/7<
M<@>&Y%,A!BQ0S#74\6_8K\G9SGX(Z7P@?=)I#[*YD<RA.XM9I,Z>",'SF%+V
M!JQ92>4D:;!%!PRN.))-LW"Z?F$XCF<5\E&VBM]HL!+,K)"L68*&WB>9*)NF
M$S5L 8=A9WG7P.#;N5>$023(C,V@A>?\LP$[*5<V:%HL">H=5RX=K;6XMC?[
M<Q1R14E!-P@[*1S0P*6EE*'L8YS:=4< UF!;K[T9N8X36[$3D !Y2(@&Z)KJ
M"STSN(W7KV-?SW6D:S(KKM62DWN0+3Z'(CZ],IE-[CL@78Q/?.7_I@P/M[VB
M6V('5]?<(IN;$*W- BR*,W/T)&-F]&VYA/#E_=] MW=JABS7%@H+@SAS3WW(
MX%ET4>0Q>:$06ZQ2DKE%=IQ8<7YK;Y![YKSP*[J-2XYON &[,TAL@ARYI=BK
MABH/K@I!B,UXAJS8B/)$2U=3MV(BCRN@AN_PPV/)(']4S.)BT-@*;$W9Y8%4
M (3,H]S()M+4H9".)^4A*P?,3QFLEF=T#RM10KW%;42EJ(&"3GV!RLZQIO5-
MLEJ#!AV-U#OSZ)/)?DA:$EM1-&2VIE1H>-9)Y+E$[]M[,SM*S4_2+9GJS46E
M/P*P:J]-F.UVZX"BR\&MIW)WNX^/W;F_!FDIPHI->Y>E:ANR^GO/SX(2Y/=Y
M[H!X362'=>\.KCW6J<B!+*1@@&Y<W5.9R^I8-,Z 35'OW)L9_'<FC=ZGK,%D
M+Z#1CM9.Z&PFK+)%#G?2J)5?$#!3*%Q).'1B"M^GZ1WB[]7PL.A'S3#%7D9[
M\AW@C6_*(XRC#(\(H7SO=PY7V3M-<=<T.,:L[\6TZ?-=NO05'@1Z5AU&GBVA
MI76S7=PR?;8$&4"[7K\6!LCV#FTJP9YV6+/6\+B0K V:!JL4KYQ:LT\K,K('
MD:#R8S/-DU\S&S3YRG!)<J+[GJ+*O 4<72-1_O*KZLPDQPE8><07LKGE8%CC
M&D2E%,=+QW3V<JA<V'GYJK*E'7=Y,&RK1]V6(&0*MFMNMD0#/1ECZ+9R+OBK
M<=HX7_S1Y,Y!5G)5_]08^V[_=&2;B3QNB<]K_XYZ%,B_E!6AP->2Y5H9&6DW
M+U/&U>TANR3"2]5*(*KA'RQ?(PS>)VP?B=M]G&Y&)'PLFZWRQCNIAEH@TUI3
M8I&3!*A[$4=]U7ULD$G^(L^Q>N2Y$*PN2/,\A8C!.1,O@EQS=-YV+_:,Y"PQ
MA5KEW(A_<=K:VDW).PIU;281;]I*@M8D8$*RM!;+!HG1$)Y;Q/&(8E]1LGW_
M94DE,F)H#5GU(X]T.U^4<T<<5L@4TP."FZWZ OMHKM!8Y+1KM$OZ_;0^B]).
M8+92O?ECW^K1<.XO?1^0ZW%0OC/<HU:IZIJ>*W@WK>6/"[-'H^.5]QBY=TQ;
MA[OQMT6;5@^\E'N*<X9B$",<E;..\.O:?H,_#P[\GK!Z:/R/^!/=VZ()U?%=
MQUBMRS(GW*21!]QOAL S?WYY5/I<L$_Z1_A)+#?O6WZX&-W899Q"T?GU1NL+
MW:KCGUNP2_LC'E47IAK"_EOHJ8?\G>G-Y&-"07[X>_O[CW?P9_X1?GI875%'
MJ'\2:)VEW$(WO__]: )DMFD#7*^P'8T*_'9"#IA$^\Z4X.W^5=-A[&=$ZM'-
MO<DCMN%]8*X\EPU-=^L#M<?_4(?_U,!$7>VERMX<I.K^^$M9CY\VB?WJ$@2X
MK 9I_",@U8]_^72H$ &\-R2ZMPU5& '495F\,[QEN2C"?'3QF8X\5\HFQ(!N
M/")1;=&Z>*/P$*=["8,["D>4[.1,;3:0CH*\K$WL]2GG9%DK@JZ=GC;9%2P#
MX_6#!MW>6P:,1VQTALY+?S6187%G+E-EFLJQ7"E>.P9R_)?!.4:%)^W_;U9X
M^I]>CG\G7M?\-[G<T1%+IM6+BKW266<*\X^)7!^,.U6KH?FLN6#]9]TE)_RD
M<6&$Y.KRI?SW-E7S:J.*<'R+1WS<+3^3UYE]QD?D//UK-@%:3]-PG3:"$>QI
M?./]Z@=//?0.FDFXPV:Z^G2! %$;VG?H.],A1K)2BQV\4*ME<1Z[^K)<'A,_
M(+\XZ68<H(?0E.<DN%WXQQ:S(*^H-%.\EGQY:C-O5+:EXM)[]A"L:)AZV="X
M;8>'=[#I"XO<2G$8TM/@=@2PAY!U*'Z(BSH&1XLY!5V!/B0&O +=[L]MQ<2B
MS:(VND_;-A@^Q3]1?13DTH8)5A!)>S8*O9%3=%;-:*2#$^!F+RP57^!DK!OG
M"6^&#QY]=V>0-;>A$)N4@3GG(<.H6,,HW\)D$FJJ-N_.G$51E<<"G5ENMM0&
MW2BIQ#VALIYE->3S1D9<4DDKL*A^2[L<#<T__Z,_;:JT:P3G.E;9B$IB-'PY
M_)(W$)U2+XU2T86LL5GK.G:I4\06SC]9I6(@"QBA:^7"6IKRHQ!\]/#J0-=G
M!Z>[408N]FGV'X02C(#UZ>T<.LT.L*-J:Y'@ZXJ""8Z?%Z'9;.W^LW'.X:_7
M[/H73C\91Z]41R5_H)Y&-^2I:7/MWCEQIYN55J'>WRXB!6G)1-T'?J!"G0ZF
M%]:7-1<]ZX*U^*C3&(E(][;]LP-8)GFTL88-,FWN_D'IXF4/HZRLAZ/MYKF:
M9HD6KT:(XQK@D9?>Y;YP6[\U:RD<>EE#/*Q66:A#\RGF,TO=BI3YJT1X:4U6
MU\[:VZLA:>]6LQ@MM7_LL879)7Y4862I8]00B[(8KCL;PZT(=RVL:TT91G7$
M?7RD,UGAP#KMF-+?9C NUEV4)$W..;US*@YR9]!C3",?B _NU\XO5PFF@A$[
MV46&'J?QM_/!><PH4F>7=ZGZ@74:-)681#!ZK=*STZO/$2(E:IP+31*0[M+2
MD*PZ?%D\XI8-<V*:9 )IWBIPO&_V&%*B_3-<HOH6SRJUS+@$,S=#]W;/GC,:
MF?NHD(OIRCN3:&=<^>&!L[4IW/=A_FR5FQH+_-R<F<0M*7!-?J)(B\W='+O%
M#G99RRRH(20)V3AB:!L7OMC@A)%YOV;%/VK>'^)3%UHLR_H&9[,'U.%A/4NW
MD7./CA\'D1D]N4*-LBKICI/%MK_"Q?N=:3%!U[3G6UGOGI/E=$N;/^M;M06R
M=/,%HS$7@FE9_,D@ EGPHR?7;S(<V9WO[\XL9?*@,-OZ(/;R8[M4:$F^Y> :
MQ!X-KT-: X>;NGU6DF:#0'T+QU*<_>'\RA<#<X#HOO7'L9QMWJW:#E)RW+CH
MK4(TV&[O4\P;%!.#Q+<#%:*,)K/JW]C> UZ#,'Q=8];%W5(<>'/S""E^H/R+
M!\O/I_B$0CYXV)5L$<CS(][/&\TGJ_G=].:KMWSS_6RU$ :K%0^(+2VX>+M3
M7/Y%=QS$].:UDX2O^O[9U/?V:[/!(X_)TCMZEFKMN(@5$I0@YEE9$I3R>+EC
MJ.(<Q?)+"UYL(<\PS6@?3('R-K HES8V;WWY*G*-1_VY&G0BHDN/8I%*'$W*
MY@U4UFKQF@<:!&*5SRL>K6E5L[\=K**.@8S0?0A+[K^I9?1_L&[U']>?G>$%
MOS/9OP)_9/O]J!OT@>'+CLU?A99"[&._-8;#R=(^-'WKN[L"=3<\!@?_G^\,
MGV^RPV*U6*P$;PE$G65C\M\L7NEF\PLM[C_P&KD*VN\?T.Q?^_'Z!PE5WNO0
MCM,MAIX>W1\XLOMO.J6'K>#BV"YVM&@RV45(EH&J2KM'GY*L$D>!\58).9D'
MV$6848^\VL3&+:N@96)D)A9&"%.*T12"TPSPLX?&@_[=^7OZ#&R9 >'_.DJ4
M\3=1(B3;F5_!S7_S^J,RZ/]]2<G,TF:_M=3[2VN]?UK&\>>=\8/&.R^:FO6I
MVK>$(?TEM@J3I:?--^!:""O-M;88$:X]>DB$Z+WM7!S&XUB(SU,A^(9 4SOD
MHLM63-VK0UIZ!$;? K3\8LA'#+KNWA<R>UY9E8XDV=HZX7:"[<='Q\>LCWC/
M#;1D0Y4/6O174#NY073OUMQ2(P9_JM-4)-^[<,W4U9P$7Y%6VKC=N K3QZ5E
MO+5ZG(%[>T76&DGR71$VMT.>3N$^AKL$4\RB/&]6_2BN,-=M2O*P5LY/,0V
ML@5KC@LH6H*MZ*9&69M(L3 SB'E<+"C?0\:F$'W373O;V>)]]Z/ PM=3O54R
M@Z0 ,.%CLQ)5.Y!XAWJP@L6$?"18VP@@9C8X2^,S;7RQ9@DWM+T=-8O-4>MY
M ".@7>\[UHWE]!0D'/_ CRY:U%)MI#K MMZ00AY'5'R@%MH<4%=)(QN.\Q^5
M9)7LK66TV-QK869P**C$6"X>,$?CL] Z2#*;<0('C@T_\KG/ZUJ*F+X8^EK
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M" K_8.'"FZ:K8/&:029&L(NY15)*OV1,[L&!7$+3==?31KM-J@?TNMD5>_?
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MM"S3&8E6V(>\0R=T 4U7;3-W$[GY@&U*^A?6!%B(2_P4\*B;=-T:4&_"*R+
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M=*44V0EC"Y14!7:V(+.T'F8^3<T<6^I!!I0TAOY(C&$H$7A QP]5 2(\UY[
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MOYXJ^=;I("1#6<TLE'J]@G7:$]"+0^@I\(!!K^X?K1\*RJF,1,YYK8<(,L^
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M'3@";5<GD&R?=[] +$F/R[_BM;H'SGZ 'N:SSRN_;TKRQ-<%)\+S:OMG6.5
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M0G\95;Z7O/F_(M<O6"8TO*@812HEN$4BI+&Z5+9[^_VV04/E4[/?4&G/M1D
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MZL$@):KUJ?AA!U74:@5%/?]<V;(1E6><.?3>]_C7B*'?]O8Z [U^)P^D>UK
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M'7.=0XKCJS%W8O4 :HA_$()FC+/4B'KZVNJB=Q0Z&2-!P6X,ZX]CY*9P$7G
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MV64",C^KIJDV;-SV&Z1$7_!4" /DO&IXO@0D'VO +UQ]<WO0Y/\=%7=8N/D
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M\?"8C_U(TK*+R]$?5=CE&B[GS\K.B?I,$Q_;D7<0+^X10F@N6H[[IQL$E$9
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M(CVQ_J7(@EDY\$?8':>0=Q:ZJ+TJT:]9F"MVKX1FP:/F+;4RU$YW'E@&(.R
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MH$<\7I +JVN+;Z"T%/V9%Q2%44IM2_UDF,$CQ!;F?" )8@6L/?$S..9VH-T
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M\8Q1*+V_T*Z;[/ VR<ZAUDH^>Q"XP57%;0U^N>Y7@E^[Q>/=Z<U*UG8*[*9
M/_+X.<=G\<I;D1C+1A$H:$,_T3!UUG>FALLEQB_55H5=+TZAD/+EM:LJ%B.>
ME2:1AO_G?YB6]1<RBHN[%YYA:S9V!Q2G9470BXNQ 7",O=YZZ,)VSN3T,P%<
MN&&*>F3\M'#J_$?P[+K<Z-*NI7?YG0<0,8Q>UJ!8RNCK B1B4M<>D$>&>A2!
M&+8J@U0%AQ-3<&9AK&=,N-[V]W@*3H^^[L':[0KKQG%N(! J5[=ET"BD:?F^
M\I;P*\=VBY_%^",1WFK<^+4%8&V<^@2$LM1!QU#<4YR)6ER9$93WNWW5R;&3
M;!ZJF12%G#AP/2.'?#S]JVNPC-FF1]2)1E'$*1'= 2S]$D!0FAN13LXDK=5W
M3R0N9A<,RK.QJJLI8I_HX.U'Z"H\F=5K!B3*HBD4!C'*\8+CFY?O::S!-F[J
M*SZZ#U+_2ZX5=GC7LYH1PR>R&0&AOSN"1T8IL%"T5=E',&F#/4FH E57L4:1
MY^)I*K%B6RM=28O.6O_Q/G$)O7E1V^3B.9N6%^6-@O86\BZ.IAW7X=9W;G)W
MD ,^O/HH]Q8Y@IZ%M'\*(Q=_U^7P(FC"6J_>T9AT6J:=?&:0<(0X$C]P1=J?
M<&?PF[6*QGZVU$[KOJ$H#ZD25-:/XHP]O</A+[OM.566;8ZWP(^OL$0G>PKB
M306G#V@SD^EJ*]&NZ2JDOK!PG5!@&*^8^)EC\,8YZ"<[D*HSAL1-;C,!1/ _
MD7RE]K"C1]1^_1<<!,LC6R6A%ABU<S!W^Z@3@JKR:C(_6%7#7UX=(D);<#=F
M.:6%T5=>*2]!?.GX7X[J+UWH#QTKJFC4,Q3C="0;I^X.8R!H]9SA6GV.EC9"
M(.DS[9,RH9@1O[<ZC<G0X(++>+>Y=)ON*:O2,_3KS2"Y."S$BM;CLE3=9#[T
M21QYS? O)5:[I9E2 2PQWQ%\6Y[.I9"D%PQ3(8%L\3[E[4D:AFZBJ"$NL]!\
M<6UC%QVTE:KGI)KX :;KIO:8-*X%K?3XD\17H>ZI#[Z]BMC&4>;+X#/!YSC7
MX"70XABJ-7'W4BEQ]^((;E$Q))5I?#8/7%T+HB;<.$Q*AW,%J\S^?NDJ"B#)
MHIU_?$(21:86MZG592N%5*GI++E5"A9'%F7'&-U*TR'7A,AUGDIL#]3XM?7>
M'TA*.6:_-_7IU5N)B0SNJQ3IHA_PGD#MW>>54\!^@SK5PVK,7?==Q]<@ D<3
M^L;&)Z&$!_,8/++QE-JD'EF1QU*.3[*;'\+TZ\_C&E;#'H_&. UO&#9)W\3<
MQD_19>19=( N1*?"O1D.,X2M #O&@RIQQP>(]!R_76;!5T4?:KUYUX+TL.,'
M=]Q7@JZ#8J<PG#9^MBW9CXU=,6E)$HQLYAG"DFS&5"(*\4]PH>1X[)MS .2$
MZ K[(?QX2@EEP8MEF:P1:5;ESP %N!=E/=(?DCW'<HON9+-T;31&:UJ^'WL[
M+<3BIJRZ-]?M'PX7?(AI>':\@BWJ9AL% :#75R6=D06Q&$2( $GY#^#<;=G&
MJ]"P)/SHV?LUP[^$O8;64NT:O*1\GNEQG='_A\*GR*_2;V#T;2_KU>FCLDUN
MGM'"7H(S^D5OF(Y/20LUH37:7$N.ME[8D%V0##0\>8'8AP@I+4,I*%W.>=DF
M'DJDD7Y]3IX43>5:'4]ZA!^IBU6W->(E$[5Q0KL*XW&2Z5_3C2I!-6@ _I(/
ME%FIS[< KN]>M<C8T'3X__#BVJY+:41_#%)F%;P$ N-+9CZ([)5E? 37E/?*
M.DL1?&8^J>O2P-JE/ASH2%_$(46=G7&N/&$UUOU12(EOUM(WJ,QGB1DI6?2,
M 2"&&)\ 4CEWIF#C^#9"%X[>#Q?,];,+^O!)KG&EBVO<D0(NP*S*9F)Z.NN9
MM7@=NDN9RXBM^1@8 'U@ZW&N6QL7VO4;[=*F$E)5/^9/$,FRV;-U+9BT+A0%
MAVN/JP$RC\&JX,BC+3NB];F 9R](B>Y:ZT,M1+1UY%Y(]>&2M-86J;%Y\IT'
MYT'QMW.67Z^=-W"&8-/P1N>>+90%!9[F+J;R"[+-ES(HQCR#-W_T^X?$"W>D
M$\)X/IRW@?/7"3@TH-(2V<B$JAZ?3.6[M7JY&K]Q_1N4M[9:P;FN5QE*%/M5
MAV>VA-'Z;Z3I%#%;7 ,6+D)<A,]';=X=&^-7,(OF-HXU#G;+&T*@"S08,T'
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M&T--,,_D<C^*8PPC6&,KMP(@@U7\1PUE$+/1*T[/$ 4OQ>8#4+%%^F9I!:3
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M.,$OBG5EAO $&Q-IM[H9&SISQ^::9Q-4H<AG>I_$KZN=]'R9V7P(,*Q<^0.
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MQJ[X$@KP9N;%PN5,<(D6A\1-B8%+_+'39LZ[9ZP-SY;Q%V<UQW,JU.KK/GQ
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M"5;C+38T 'H^?L#QT8*3;5N7#*$?**1/J^ZYVQ0(=L/Q)Z#_L>FFI"N;80Q
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M2;JJ,S&MQ ^IOE+7=5R)[KI5BGJP.L9ZFWS'D&EW_U'EF_:JT*H9>[>3#!3
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MA5L+8H<FY;*EM]BJL$>*\:A6)AQ[] HR=0775@>%M=1JYLGDU$IU-K3=RN7
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M5D(3XYB?>2KC?D'->*>Y/M&KB!O;.*"?<?CE1_*<@$1SC7I$1IWFG*/W&K?
M(GGPRKZ1@*H#(271#Y6SR<.E@)R4#(PM_,A@I3FXL\_*"DAUY,+]NL%/"A9$
MR!%_JBE;RB2?WU%:1K"]%F9T0;9T$LG?#P_DOZ FKGO74U$0/[/ N^/Q7TA;
M/499T^V[]S*6?R+E]) E!JWRMA>?<..ZQZI!)^A1E/V#NM-(;?_L1^&7AD/Q
MM9D*;)3V%B9MBEGI8.LU4X?[4WN<TG5%359XYPT&*?+3#IG\OG#HX=$''MY5
MKJ)/]'5UI1AP$S[L*1@[TU)FTB;:>?,6R=6F]D8*HR',_5(@%%E>F<1*C".S
M-*Z)-JL.U;3TH10KC?BZ)(@OEL^Y-K5-I*=%H+F\*,]IXO <_:\2K8[GJYHI
M4@0NTY4$Y<YB!NSFSJ2WI@W:"R@B8D/E UF&\&B-'K'-M,<RHC3Y6NN!VMA%
MW]V!K/NW)S&$<GG<)XJ%H:%^A7&IS\9-H6C?WL#W,YWF0FR?'-2_Q!Q,ZJ&)
MP@6\A-LG$FM3@,(5/%Z1G;T!EIM5+[M*'>;U/W*9G"M_/=/]]@$(XH$DV>NB
M3?\&=+=GFS,;9B68="6ZY^B1# _(J\X^?G03559CZ ."3(D"IS :392(?[G]
MM@^=UQRG,5,[WWAZ6KN/T_:VY!86 SL9<L%KC,4>W5+3/EO@T;XI/*I">F+8
M(AZ)*[3;<?5YB0N'D<,'9"@<]$<B ?8'6%]M.(CCPSNXL=>B;Z'T60C<B)B<
MC%N_N?TI%;MZTR>7!Z!47&!DE4.]/AQ@$_CU_A KB"B1__&2MDY80%\ MM%P
M9#/P(95;%UW:U#+ !^F&*_9&!#@R)DR*240S6R<T6Z>;TDPZ;5X<9F0E!8PE
M&E%&^F$"@#5R()_W)/=MD8?#X-I)R6DB)?1SX94-%HHIGLO'?HF/T\3$9[ +
M19%KR).&]6D&1)GP#"<.+YL^EVB=NP!<F'SRNEYS"3+M-5G8&$_+8]T,-H_7
ME3'$SC7I</YU@P?8R%[[#,6UV1^4':3N%7"=@;7[;=-5*8H/^[,2'=X+!#R!
MUWHB3TJ8@I6WX:JO?4L?5$!,=I>;50:)1!3+$C-?E<.)!#^Z?6)AI6)R&7[C
ML5BL:,=Q*%FN:-E&EHLFQJ(B#"ZY#[G6*\%2"SU;E-3[)U5+*(1M65HK#-=&
M4224;J!&SZ.HW9LZ;2? M=3=Z(@(=%[BP*S)6%R!IP(MY60S@VFLO;,?%WKD
M[ B#=A[Y4867A[*XK/*VN(!C5]:1 2"[NPP7^,%XL9R^HF-C3J R':Y$PD<T
MAJ_,RJ+I I+Z5UX^=MDW#HLK:E:)'V$^0[!G9<<@R+2<^W[@^@E?;H-!T /9
M'F,ST62]4[==.O.E,\X6I)UTO#R$&5#I=3?Q!BZSA4CTWRA$Y8"NH;:)I.@7
MJM42X\NWEAEP[_8,[-,#K ?5#*6$_[E0_ON*_5?D[XWCO8H_7E--A<U"Z-^
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MQ]+UBN)\*^<5*U$&*R!'MJQ8O#^CX3&C#7-'_1?M,*&#J+Z?7D\+72OC^V=
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MM+P;VYYF4]X#=$5CFO+U$LX6%^2YT2@:;V82R<B4/;:JPA/[10:4(&&R^JD
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M[_;O;7NQXL:'323%/?H9$:>="OI3KUJ[^$YD.,GQ^!UX78I^+ 6.JW*&IZ$
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MNEHG-C>E'<JVHJ3&/SI)EI"1"F>;:9@H29$*A^M-WJ\Z^H*+>&5/Q\):*A/
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MC6?^>2F%^R>K:^2YQ?L\&%FM-,J6M58??7U=RR^T-VLU>JF\!_X9$_<FU6(
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M6S(QF;,)DB$*BML+P7Z%[:Q1X^[NGVL9;>M<.W$26.?+7VI-20Y05X+?#J+
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MZ+!NJSON.@EP-)@%8%!7C>Z']V^[P"55%3D27/O?Z?ET);6,LG=51BPR= ?
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M7.7-'>P*ZA7?E,DOP/FZGVL;ECAI#;+OC6,B$V,?Z( #N)F!9BWT8F/_LU8
M;LOX%\!2)<-0MUW/0$M/_31&D+,791OYMN6W-3[F:5=,.M!N.;8>E !+L@F_
ML>YYD0P*5=258<CHR8<4/<0+_."+IY(UN^3FZ+FHDKZ^O4@=#V.^;SC]G2C:
M'/-FCIZHKDR^P =W OH$X.X93%Y8]+<CYZB4[CXM=B0$RWI.7RV_^YEZZ7\[
M9U6UY.99@8.(-H6YM Q<N6MG31PFPW UH:^N]PF=SJJ; Y;NSL4^+G%\D)$6
M11!&IAG#S73(O,PSP2SQ!?%2LS(40G)P(CC9V7V[$S_!^ (QU O2#  2-IH?
M.C$@2S32F1[?GOR/QM,-P9+_(6Q:>D<Y<RS5F AJ\K<F6$ ^QP+&.WHECT@"
M(^1/*R8NI756_(V43G4".[RVEC(F 7?-43V\RI2>UDN2$E;U\\#[D%FZB&TI
M];M4B<^'S56!E7E89RN'<)N-+QZ-?'\F'1?U ?W$\C>LM?(D\&5<)]L'\-PW
M+]2>D39UII_R)H^9.?L&EWUY6X?8X@X[!F0XQMKOB,??R+71ZL1,9U6!#S[S
MN:%['EL2>BGNUB0X_E35CT J&F7JB:FM8:^VC-=MMS$M($3OP&Z^B_^&1&\*
M7CI#U-W:90OD9J4*DT^X/4W5XW,4-?Y8CA!J=)"5=Q$X,O<UN+][IZH.IG1D
M$-NPD'.8$_;!KB'8*NUD@26:T"4_7CD6CI5GO_=&,Y)ORJ-HO@$X4.,AS<OT
M)*@I(/>6T"/IKI*VA@=CM V6GKGG*>TY!?\(9?OM5PGA) 4=_$,Q3RU0BP=Z
M90R^Z/VAH9O27*#\9Q\_920-F:<8[I7XRNSNLY]\<?NMKUH,#]<VU#Y6G2YB
M/<+&%_/'K(2[;%ICW/[6&JKB'#N80]]O(I32W<.],T:#P@17*[T,8(7&N5-X
M9_@&Q)LE"HPHS)'EKDK17<)G7.@#Y]YF$UFNL!F;:F!%K'(_=W[R"1,)Y=$]
M$ 6/JDU:X$BRL6T!.%L3HF[,A<F]S;ZAVVA#]Y<D"-0"901,RE/!&YBV>*R
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M0'N SV1M"-40F5 &HV5%2&H35<'JW5BD.&0G]_^FU?C?,"?R)SZGUHR ^>T
MOX&6]D]=_K1E:VT2:9 XBMSYQT6D(=.+M\^)*9D^<3^T@Z?7YR9"'MFVP=5\
M@;'VQO1I<ZT/J-L7SFEMQ _RG2[/*'YUU_'N,_+6C]WZ[B<0<\DGD%?BYZH
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M:P!22@  WP204@( ^ L 4DH  -\"D%(" /@K %)*  #?!)!2 @#X\P%22@
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M7;4GKU /+]?6.J\)=OJ^<-4^,1#?O$D]W+B(Z5Y039E_.!!WN1@2O76XY=O
MS>/]EXO%-FP1?W-5HYC=F[AA"UNK)VIL'?Z\0(!;@%N 6X!;@%N 6X!;@%N
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M!4JW9_4S O<686!%&..\=,8%_CC7L_]X@^PA97'G=/HAL>R?[7PD_1TL=0P
M\-WP[][V!0                                   . _ /KLK.R?"SI
M7##<3SN/;U'W6XO,BXN[B-$X_X-0&ZF-_'*0*6=(H\;U<QS_/@3BCX!J"B3N
M(N[\F]NF_Q&;W'XM3]BSKV4PVKI[X,]V/^?YQD<M^WE(HP#5\Z1_]Y:B
M -\*LW-V1N"NA/]1R_YN:,1_&1",0%G9&4F?=SC^8\<4'0!)_M,RQ7UCB!%G
MXP*5;0U$-S+\&NHR_^X\#1M7F?&O%I5:JL!_B'V_"JVAN#,U-(C_SS *
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MI,.R1TW</*A[V#KR",&[(C: J([:6_B64=94\&Y'+($C/+"*@3C5";'>/W)
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MWU:8VH;[E:=#O^4 UY=E.#2I@IR?)JUHJ7U=4@H X _BZJ?!_P=02P,$%
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MU#T!X.% ('@$$"(B L(CU_>1#R#@(.(^XY1$PE-]BTSMB,\5$/<9A4:JJI-
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M6B*"[*$VK5JF3\;J[#%V[4AY&Q*H%_?C1C-?X QCD]V>Z&EF8967^X@76<*
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M+QH4>1,5)D\,%%$$<5K8?!T<]2BP:^[L(U@FH\I>F]M?8]-<])COBI_BM<"
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MVE[,9?%-'-Q:U84<!'91?1(CCO+O@ N$D/Y,LLR.&N ))X6'LS!&DN]8O_O
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M_>C9*GZY?URP&BI^#_]'.I:/ JGM;B$>F<7+ARFO.=SU$15J+ERFN-F32*>
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M6KU_G2YD;*HEN+BAK6ZU=I3P\8]F%%V$47'TR/E95(<JE W-WPBZ(IV@&.>
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MR*+/(7S2]+=W7WY685>:9#SQVF-82X",*0.PY2!&M=J[!6.FXGMFFK]Z> '
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M0Z%33/=5G< P11!M",X7I G-E.'%F[0;/7#>UJ]*-X56/.*3-1;9X$DB,*V
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M29[8(#/Z:1:.0*<0TM#4PCF4-R+!G[1H7Y.:@TGW!887*36$%F-.W/R5J-A
MCNYOY#4NI0IC/\MH'+;62:A>\X[:MJ%E;DW%M+F#?SGN2KO9&BXE3]'_\K8R
M'WE?;82U@?WX=8ZW>>;?2&'UQF@ZQMCWMK1NV[:2D[@&T8!#G@V"PXRT3$^_
M.CF')OVP'6W.GSO-S/Q41S[.D]*2,,TK95*=8\\8FZ;F!5<%=(B)?DN(-]SB
MS6&(UXZ3D_>A@50L21<3/"*>]7=3II*APK<H-4%X:X!:Y"2:DS(3E;/Z6E-[
ML7+1T2U$#V*HH_,"L-+IWZ\(/STU+/L-FGP+8IO$X1XF1#H@%IKH*B@Y(O88
M8?$/7OAHU7,Q_MTB5W"$%@\L,&&SF'7P3$]-7N-K.6NT+5_72>QYWPQ&%IVM
MP9<U'Y(_\R/(ND>.OK(#?*@66CBI]L/;LQ.2B6:#P<ABXXJ 7*=148+O^!Z.
M-P 65FW*:%[9';JY<7)7AR<ZLN8?.>C.D58CD%TN8[=K<]]06>O//HH7=3X7
MN]3HEV(E8[ .YY=0)ONCNEX\?FYL_&YH;"/TE)V 6LU4-V"#ZX$4\^&^4AU.
M'C,5O4Y8UT8+&7PS..Y<L[6'''J-G'2(6-B(O-Z=S3SA\O+5F:=K^7[&QS?V
MSF2'R$S'-6%?@J+ILM_=D6JP(X:5J\3-31#[M\5;._F+"77-!-5SCM"-/G5C
M6V+/C &MI* '"]D7@$\L[GA/;)63'"7F'%Q$IE]/*JSXD>%VH<EU+<699U9.
M]*2\.7*+3FXG^&IJ2X+JB6@73+U@U80(*[9=4$=$78T]V,84-7;L)CJ\(0O,
M7+K9J_(R6M&$I\4^?W1\:\?73,(MOT!\/M:T3BC#G+<]1,/H/:5Z*$&5'G[]
M8$QH0PR9^.$JX^C<;3:9*P 95))@<%=?;P3V\W3C*>8_?CIW2&Y+OU$[XB=A
M<?9-R"!-MN9HGH[?1*I\XAXD#\C>9J,>_@J7FFPT+ZGO=4:=[_VUY6=)I1LN
MP40;_P/IB%N1J@-?F;O"6;IP;6F3.3A9T8733W;&0L?!HG8>=#6R@S=8J@AL
M6HL20!=<11+]\ZKMT"S>"_Q1U2)NKKP@-AP]Y/4IR^3S^S=R?H+O?^$D)WG9
M$M-YNMMK_HXFHDU,/ =02$QZ4;7\,PCYY4M3J LY(&>[!]ANE!'3\\7;U^)I
M+%-N<4(O@(&NCW -D@#:^<WZ^JYE%+YT1>(9C<"W^\C(F ([< GJ5"EO;##O
M?,-4>/TO=\J-HIK[KS[?QY++,,3,<55RGPT/ZQ#%"G_9K]JS"88\?<:3#650
M885K(S\4*)P,D6CHD4.#@R6H>S6N#946I6:JW%D6/X+LP^5(/S(A_\7L.7]:
M&U\7AH=U-../H':DA9!FC^C<2F! A+#!2BR1"Q:M\R(4\#<.U=54]M>"(JF7
M*YBYV.^Y;P4?.C\@+X*J\$]G*'[V8C"S1E-4O?XSH6!D6*9KK+N$H)>?;:Q4
M0^W*(5"X*;)>,AL#*)MP!Z\T&G4T=P82ZR#>3^G-;=8K,,U5565L=HZ762S5
M1N$R(STZ_U?-+L0O?9T,_M04_+[0.[#H2"M9$7W%XM(R7&=J'!DLGWI]9O /
MQ]T,'0T0GFB-[M!.4UZT:)G&CRX>[Q?L'6DN9AE<VT4H<7X@'?-H)]J)B>>H
MS_C1HRZ4/\50EQ),E!@-7M2567KD[3OLH1\.VGCY#MQHK0O/7H'H!UR/?1P*
ML5OU?\7.Z,O'M---">L@]TZ]"Q(5*]FP,S9MJPL]T4ZG ::/7;)!UQ/AV3.4
MC^5G1HY;<1SJ<)KP1K;/9P/WJZY?W%VI2D)@/Z2)HE#;NT6CA@#(A _&>$<9
MX/3SHPO]D63]E2*%:K;1J)!PFD^4E-L"AQ+4Q5+>'I4E@\[0.+45E47WL:AW
MB6R-$1%?-UJ^!8Y)2P%:!3>3T<397@#A/ITWM5O>F2IIWE:-G1E+<DZ 'V5)
M<8AM)W3T?^<F]7]Y]_@FF2>#*5I#.ZY72XL,&U=%QME@OKE_ U//<-B5.(D:
MD3,>1ZWM-=VIQ34H>8]Y>)#[JO5)O>>9<L'Q=V?G+-$I(Y*E6^KVI<0S0AJI
MF_(_EW%6JP?DFNLIQ*EL/\R&WDO'OQZ)T\A#=6Z(_XXYDQ\-Z)GW(]J"V5U7
M<US-^T:HU G)PW\!#FA,*2(6>>N!0$=S(%%E!6<_BCRQP+9*6:X'0&-.!9T$
M^H_GBT<^&FYY,]4H=+Z?,\):.P$8PDN4N#"$(U3_QL+U(1SA;H&X=\/?ZG2,
M[+WKZAN2Q80LE]+H5W@KI0"NJG[BYQ7\()<,$<F87R)UIV;8@9'22CW^/>5<
M"'')'(FFO[LU:\5Z-5[ON,7,3;/>/C2_XO*]K1S]@,PW)C'+\R19#:M<=@"O
ML65(IR[]G#T-3?;QN1:=L%0\O^Q+6>VXL,5[/-L3^:Q+_-Y^__VG%=Q=0U%"
M),D&0\%K($AE!;=)K^_O%UJS5W1'?*$),ZD\OB@+.PM:V';X$FSK(-BXR0ZV
M-97O-L]8I</HK'[-#*/U@^7%G[\E!G$E7 /@C2>?Z5QL"D=4A,\,Y!Y"Q2DV
M$>#JC-S>8>^B_%H.:X1I]U6*_+EQ1(/^0$?M;-]J?FJ\G%6R.JEHNB]5=SA+
M0#3@,Q+*V]>BDE76_>24$-'XO%Q#?=:V;RZU]9[,O9LIK.:6QZF,$?0H>/'7
ML],2E/,Y_6=8.NM2[FC)8 NV+D9OPQF^:PTKYN(#YM/&+1#) /X7]F*S>L77
M ZXL#2X?KG"^\XG6ZQ.JH!EE;G72R,Y:S9ZPFH= _.[*?I^FT*/4$[1D>3+Q
M+#URY@]OS?]%RZ$XM&N7ZOC>@BQX-)"ULR]83NR3OL)Q5BDVZ(N^3*8]"6:K
MG4C*&EJ^"SKP/[H&F!T\X_^]HDAOG:U \<1IQYZ1O>C:. UWD:7NJUZW;<KX
MWE1G*+7'6]'G)6GVJ@4%K4= 8&3(-;[1H?[W BC%*%1:,UFAE0X8OH2V5( .
M:&6*!:-Q9U'W!9%5(%SE%@>,(5I@X)<<M@7IN#F\$/Z/Z.@MDV_4X3B_W/P^
M0-A#'1+OCIJB1S]7-K#UBW%/D@@@9R6= G/S@UAL;XCOC3)!IC:9;+ "G0)C
M*>17)4 QXFD_259N.ZW/NGDH,LRR\+;0.8?/.*+UT3$#8JPUYR=-:;-2[MZ!
M7K+-=74QXQD&_E T"8 G0[#B7Q%#4RA6>3E#R,6P:@-2<5U7S%@JX97]*TGU
M(PQ")'.9\Z:H7*S"F2L$;.',,2M:IQQ&2HDOL0G.]EWP,\85^?AF5"GCJW?<
MXT!485*^UC5>VI(X<Q['(!4Q-UM/[?SOF7<_^]]74U4=2YDX*9V<,N-2A"2=
MZ6>\ *)Y7@ XRRM33DRMR4>25)6-OP/LF[&EG6(VXO]QO(-7"XWYMNMTLPRS
MC?JFSK9TJ 6L8W\$*4M17(3)ZQFS&Q84+5GQ.LN9TJ:Y=N6W2>EGB1)RO9K&
MC-O;:HF;F\CC2K0R1I]IV%7BIH<PL(O1$Q4=_Z+S6V[28-O>)JZM' +W>CR_
M["DRQ.!=:UHQ=P=5>O%D4OA+/ZA$ ]BKTWA;70;N@I$P/RFA(8FBBQ[!")$F
MOIP_]#7=EKI3)[SUVKE4Q8XWD[G&2ZFAR:V8\.U] :R\ /#8.!ROKEMF"+[9
MZ'VA54OQSDQW>.WDO!K@/@.$7%='5+*=.FS_FO$MJ=3XBD2W8U*F)/M_L?=6
M47$&79MH(Z%Q=T^P)+B[!PM!@CL)#IT&&G=+@. 6(%CC;L'='8(VVHV[NS02
M,OGNY\B_SISUS\5</'?OJJKUUK.U=NW:8DM7Y0R8_V>,J:NB2%UQLG@_V:<%
M+?9J#GAD;O^!908CI]"N PD.C%[4ISQ8I\LD"AW@JPJ$SZ5%<"+31YS" TA
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ME?$DY$B<H$E &P3@@@-G43ES7-O12P:]>A-D%AKI]P1,N)8OG<M'#E<;6A0
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MULR>BPKVKCW)MC6>T]>4X[S^/'<=E=S0VAB?&BW],U*9,42GW(IA3]O,*W5
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M[Z,3\4J!PW"?E,U5/$GQ."QAW,$(">UQ.Y$"FYUIP+BJ7Q&SU*=.-[K"0%9
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MV._05YLJR9:,U^(10Z*496*>WRWF!!]7Q*:)C7V-[=@>35S"]/E.WP+0BN:
MC-"\("&[*F/-"_5"2U")@Y*,TW$Y%I5UHOUO3_Q(Q7NF[T78-TQ<!4'^=8*3
M$5Q[L\4U4VZ+#<#&)I53>E"28[X7JX!Y0A,O .H1?+E]U?TOCG%Y"(^]SF#
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M92YVX&68[#JAZT*##NS)VMWU3YR[>P%G8UJ%RL[2[R8SJYQX(VD^R1RN':T
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MI^%[SH1<B>5=W<@3>[H?&C-O.H'"_[$T;ZX=Q2$SUMW?!S:%C>C65*7RPZ4
M[C^QM(+L9ZPO:J\PV9'I:IG3,!E""_9NR%\8W)RKM&;$DLA"@A(VN2,4OG.X
M7=A<E^HF[>OU?.FO&)W;2.%G[B+,L/4(IE^F7 #-M_J X/G7M<-G%-+^["\A
M#]KG]#W[X1#QICR:+%6@@=5/$204 3S+Z2,*[)H<UUSC:C@YU_!=]98B#Q @
M[Q=$?87UQ?XN.?/BCBKTK+_FGLVZ(S3>F63,H:?/9[!\->*+(F\<?3M!3=JH
M6Z';UQKB2EK5%*LQC(O5%+,O6P^*[6\?/7 GWB]0*@(D*"1<A*R?(67B^FBX
M)^?+4R'7 0N%7RK<#B8XQ$9$9+]4[^-00IL(4\+Y(:6A^3>HQ=1N<ED?CSJG
M<#NT.I)>7;>XIPH^NK!W[18PA8&&,4(^N^^]>;7'-5EIV%:#,;_+>ZTHNJ7G
M^3XQZPQ@T0.H^H/A^-GR4C:#BZ8O)LI&M(6?5"#:JC!E&V0/TE#58II)8;O)
M\O)]0FSW=)]Z=*!EYH>>"INF9E0X?.3$: <?CIH(^)47]XI5-&[;4&MOI/!$
MP:E,'Z#'^K-V]#]U!Y>^?5?#F@M$*1!6D&YYU&?((3G9,T8OBO$8ASB*FF W
M1>GVEC6>^EV$6.;$' A3![H? ).$4FWSIB;U/<1GHNGJLZ9/$C-7ELFE@![M
MJU87"^UR+RINKX6[K9_R1)UZYH,,"?5OY@U$@C2]/43)B"]MSYAIDL#Z!],[
M@VM3\XQ@JG+0P'[#N3&?Y&QV VYEDM4]YL%,YAY@]N^I,\B[[GNO_U0,:!EF
M)/#G1LN/D0)7_U:.M4L 6U% [(H0W'+3;,[>P>2NO(.>]!=Y1**@TG\?QNMA
M@_^51^H3LGCCJI@6F]K2'C>N+!P3&'6?K)!BV]<A=5OK#D?LP2KIJT^GBIMM
M-<FQ,B#.E=[=+=7@T#\*(QRV/?;&1Q>_2WH(3&A)_C?=Z3VEJ^1083D3:QM'
M-(V&L>CK7J7EB7J?BQE/*!$ZFR-\!PT7&RI.I$J_01'!5YMG<:F>K!DS6G,Z
MPAX/6UNF&3?\3/FPR:MC_W(0QC#/ZPAZ*G$>]Y =22P[5]D;)_,S"=7&A;'E
M%KY"5Y%?MS]E:OCB":F ^Y&S;&V34?D9!]X4>3;F3*$I+J,UK0NT,R6O_ ,*
M+V!461&_TR#-6B;?*\3I6TY(/!:Y8G$^ADFD7(^1PVA9V_E@QTNN2UMLY4<>
M7,NB*J>DQRH?V%BJ,PGV)FYXQ.X]YK?$^[]CX4(VY$>H&@M(96DM=%'Y$IHN
M9]VCV<1T@U4.L4Q"T1R*=[)Q.V?,AKD!X3O6C*F6)!*OWW[;*=K_9^7A*U>#
M;:O]WL$7&E>8.C&F^^WM*\[I[+WAB\((RE.YY82K238L1AR#WPBH""5>-77_
MOYE[.EL/+SN?MLIH[;VP-2Z>U"^9;"[XMGZY.G526QK(;/O+-W*>92%RT"Z7
M0R@$04(]<51"9"/90SX=%"X2E$=X.0]8^ONM&4.*BDH3B58MPB X)]0HMM'[
MN87L)SN-MV=S9)TH().:8-3'+ZG6MW86+,G:7H9DOM'\SN;5#1Z'HV#=+4G-
MCDB&+9P2IV+7,"[\1P9_7*%)&CD=YICPN2Q67G"WX-PG!79ZE2C8Q^D>D?A0
MKD("WQCC49_&X6?0$64AKX.;M M[W<X.U_3LO'4)IL ZR94FPK$S?X5IF;CL
M,W7(0[DU,M=^J^*-'Z\LS!Q,Y5!P507WE%2>;B'JOU03_>SV*5W<E:B-;7HE
M[5@IL=M>R @$+O'9*X9(9=Q&"QL8JX7NO>'^6@"\,-AM.I/$YIO]S(B_65O8
M1WSC,H-XK->6*FI%2&]?K,HT1?-HLFMG?,J14WQRX*7=_=*)"7RD1EJ*;^\Q
M(*K<H\R($*O=B!O]\SO;H?%$%)[J8:VA-JSY51_@9U:U7]3%7N+>]Y?!%ZSJ
MQVR6&IYO'?.NQ2=(OUN!B25\Z:=M&\^5;QA+(K0WH!VWP8+N&RO?;>+^YYTL
M2W$],3G^Q,_2!:#_H!T.P+V#FI^S;T!Y=!'?C0J-#;H>NKN)8'4.<B]J$4@5
M4!5*#E=A<FP=-WLD9W?5#0N?J='HF1+I#9I_HW:NXDE3HL/FYEP.CF%H-29+
MU=^9K1BK4?]--.0))9S*B?9/CU(GD<W.[%Y\BJM?U\B3+5]'<8C%6'OO%%N]
MX[H4DY6@^7UKOV#-CR:+QNL$9Q/BA/"2?DB\VD(2SP0'L?[0P/4$1].D!9TT
M;&D+)O!@TN&7YV<8+V6L[!UAWM7P9Z(AF"4GWFFJMY:-S,<^#^I2O,%W=&[S
M]FF6/PIZ<,D8)2 VP;\KB!)LT8H^.!AT=\ X':E7F..S7!#V7G'+#EWB]>F]
M/X-J.J=3/5W8GK.!P<!:]&IC6$LRSFYUO]1FCBP>)6]J.LX/_@TU8RW]OSZJ
M^7_[7YG6/U/_!5!+ P04    " "Y@6Y4:8N3"N]'  !=8   $0   &EM9S$W
M,S@X.#0X7S<N:G!G[+P%5%S-LBB\"1:"!7<)D$#0!/>!\.'!@GN"2X#@@UMP
MAP )'MP).CC!);@SN+N[S3SRG7O.)_?<L\ZY[]YW__?6OUFUUIY=W=5=U=4E
M+<"GX(O 8QD):0D X0$ (-S_ ? 90 QXB(*"BH+\$!45%0WMX2,,?$P,='0,
M$EP\;'P*4BI*"E)R<FHZ5GIJ&F9:<G(&GN?,+UYR<G)2T?,)\;(+LG)PLO\D
M@H"&AH:!CD&,B4G,_H3\"?N__,"_ S@/$2H?8",BT  /<! 0<1#@[0#5?3^1
M$7Y]@'][$!X@(B&CH#Y$>X1^7Z#J,?   1'Q 1(B,C(2TCW6XQX/(.$@XSYY
M*8J"I_0.E<86G]TG^NM#VE=E+01OA@_I. SL?-$>$1(1DY ^?4;/\)R1DXN;
MAY>/7^P7<0E)*6D99155-74-32U#(V,34S-S"WL'1R=GL(NKWT?_@,"@X)"8
MV$]Q\0F?OR1F9&9EY^3FY1>45U1654-J:NM:V]H[.KNZ>WI'1L?&)R:GIJ%+
MRRNK:^L;FUO;1\<GIV?G%Y=7US_Y0@ 0$?[Z_%V^<.[Y>H"$A(B$^I,OA ?.
M/PO@("$_>8F"*ZJ$^LX6CX;=YR'^J^BO92UHM!QO#@D,[(8?$=)Q+CT]^LG:
MKYS]<XSY_J<X^QMCO_$%!3 0$>X'#Q$'  'AMZ;+XM&?+(DT4&_&%B[EW*7A
M@&AHVLUVV5,XH ,'M(S=8 ,4T3P\S4M<1_1W**Q>!P6@WUY;,M(J HV(_D-L
MI"E6-ZN-5ZOELL(UQCVY!97?O:OZB5,.4$3IS,.!CY/M::?$M7"@*>_W/PI1
M0H22!:AK&^$ 6FDP:/.E/1SP4/K]#S5,?#=>)U%[-QB>/J[7D,$&[#KSM]<B
M4H;S#[N^ZQ>WSYKHX$!ZQ^#=F>3OWC4XE7:7II'[#W['>.3OWK^994ZWE:,G
M+1PF7L;"_(A %^-4O[V^'9;\_S+SQ3;^Y^@NRZ.<0<44E1BK+[I[6B/7+8P/
M/\%8$M0F,YNJ*ZJ)8AB#5?RAN262HI%K&KTJF?2$\3[Y@?^^0=3;SI\\E2TK
MH#;YY$QOO[1X/ _522FDLXRPC8YP047)NG3\$'4Y,OQ4U2B%DH;8-(8=I"1W
M(RS)F]7V)NUW$K^7+!HD" YL<OS*P%VI/ZBRB=Z",))RALS2SY;GW;?;WN8(
M+^9)L0*+"KU-TH%<\[LTPL\ZTZU&H>NT3]!]>4F8O1@'E',299BT/6EYL?^#
MD:NGL&E)=/JR1"; Y):DOT<6G/G,A,3-+_D=WZ+[]Z,I-?G\PWFY9_.2:9K5
MYB&1%=_SW'N2DZT0A6NV$FWS14]O$97Q_KY05R^-&2O5)K76/I%^ZFED4:"#
M\6T<$G3J3\V:)WX\5Y>N!I-G>MMQ[.UIB4WU0Y][M(Z-_Z,1'OV_5[_^WYM<
MZI:'H_KC559VVTPW5R6TLG:])78(LPV3\>KIM[1P(#K@ M:H /M8%4"#HY(U
M0FJ*R':]<3W*U#3J2:R[?6W5E)&8A5/<B_: DRYN\/UZL5=K6M-/633?7=H<
M%8 3924Z#/LW2Z7@@#_(XZ<0O&X.%U8D;Y_?'%QC:-]W.P .D I725[Y=B4-
MZT7#@4>>-S _0CAPL=3<&7FI?+%P2@R! \V8,$X/B\@3Y$B>C$9:&/[=Q1T*
M"QPX:/,*ISK,/6C>?&D#!SS);LVNQZG6T2EMQ%W_U 1H26'A?@@78+<\E\-G
M!: ^0L'YD-,_-O"'OF?NJ'A]9G9I)-CZ8P-_8F3B7L(O-$Y<F4;^T,*?^"A6
M@KTM6S]5S_IC$W_D0ROSMN7_9EF)'\+ G*48EWXJ,1H3-LQ9%CHH BJIJ&,A
M)J6VE"F'L;*C7U,P.U8"/S'Y?K#; %WN:=PS*N J[U6U5W'O=[$OAX2QYOVB
M"V>,X, H(HS++X6(U905<A.@?AEHBUP=OG1'"M68LUJ:A6FCD  ,6Y>3%!FZ
M=WYZH_LG/@2M+X6G-T[[G6D7]S:W"F>PLU#_/%3JC\8,L?3>D7D*3KYWT'VV
M:U[>#@TH>-5#9XWVJ !!T&'%YZS$2R<&VK54&GCJ(ZA9$T>79HE8Z;&2[-4
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MA31'ZJZG-_9;!L3[LEI'[J0?CS3!\DQ)1G8TG[<?^D].FI.KF;:Y6)LV'JE
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M-E:"(90K<E'OC"BD9J9N/%6'P*8=\7IT/G&BD*;0X#VCI:B+KKSB)+[5VO(
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MLO9+NJ_@@#Q$>\]3VE% MK02JE]<\"1HA4P&BT2*CDIG(C"P$GM7:G\U<>_
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M 3$QZ^P+FZ6##O&<2S'5D7UW;#R)9W(OK84G&6MF2&RC4%QHZ<E=U;-^.YI
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M+]VZIO0")N(^:Y.()TE)-]11933Z^1]5"U-W=<2.O#2>+XN;E6_:^JZRUK+
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M=#7'^^@ILP15PR,>B:)\ME7.0PY_X9:'3+>Z$H=-!9U!49K0LIV-NQ F+W?
M$;,YP8!9++WO ^+R,M,7IF7"8?=]UPEEGK\[JP0F(J$';P\B<M8A!V6X#>*9
MR@:WF@W:WA>N*SJF;LU\!W2Q0'X]_;^6(G]GF#S#@Y'Z$6TV2!NA>[PFN3\L
M&&-MYJ[^A $-V=AR^0"<]>Y1-AA9Z?U 3?Q(3<;WMNVDQY\+I.$<!X/*O8/K
M0JZNR!DDTQ;>H9#A_M@06@%U7;+99'@#UC=11( M?Y(.-5XOX>![]'&R9GB
M5$_7S#/J8-6(=XX7H;==A0O$ ZXX0L5H/FUU,E787K,RY4C<GDPA I?D1?$4
MNNCB5^^7635N\W)'/E*]!6UAG<G&04!GV9EQ=I(9$!B1&1+D/O:*'*"-*$\7
M'84,Z:MJ?,\"63+<\?%L&P-31$!%4A_DI._Z8?O"8+(B5;7<V15]=_0P<2X[
M!*_<H/VI1T<-&X96O7==9QOJ8LEJ;B4%Q%?(!Y+X]U9:P$PZI?V..XZ@A$M.
MF%MJ&"P[KDXN\>A1LL8'R,JP+@H"D=?1LXYUFV,!92;1D_XYJ3T#YPORQR.2
MN)Z\_2S+B5VRB@\@ O<EA?5=SDLYVT7(>EYZ,W3Z#D7X QJJ*KN'0M$4VI!,
M#^OP_T0M"OEP.#B8H#?PL>50I"DH,8^UOK6:/!;!>Y\>#<9C2[4#=SNR;8,Y
M7GG0#","SX_M.*&>'@X>@0&A W*H^@,\]LM%_$+L?F<T;,SNX,.\0?:P=\#C
M&D_\L%#= L+AM/TC,/BLG_BE-#V4!=J0KJAB@OI9D$]H*F>,R"3.:/<Y;(\)
MY#:<_N72M6;0^:)Q4 ,\H#@.L%>'YZ7GMC9O^!CJJ][Y%\04L[J.A(P&\7 _
M'WN%JQ4F)]^XV/&/Y]'=HB@5[$2K-I7ZS.S55)@-G.J(CTBS3)M&%=X=\TH(
M,H0\5I"?#5#V\9B3C4=XT=S3?Z_^8ET%%VY%FWV3]HE=VFM6,V:^BC?,OGSS
MR9W)FOF#A$&.$KTIRRM2TY:U\1=)))".?'L^Q=Z OED&X7G(BR4#W4+''JCO
MM4^SM/27FG>?)*JR+#1ZZ6.+C>I1U=%L4ZLKQ2M/37H<NF)%']4W?9Z?IH9D
M@1S(XP<67S@38KV-7_9ERTYVWQS//JW)8U DF$H-@_"SDB>EO"OY&P4TZ9,?
ML 2?F]IEN@-"IPS,Q9<;<AOB_-"AZK2\<V $J8D[P /E*F*>QYD(6*4<1+OU
MX9F+A\&VB=G/]YGQ/> FN3Z_6\\QD5B;=_F=R;6\BA1_Z7=/1B1GD\\'S)YL
MV"]X(;B#!Z5+MF[67!?"8#?C>.L7U]J9H 6.EZ1UOZ$H1^@?>0I])(A"WY'K
M@BA#["<5!XNB<\\&@%>QGN$YP(N5;EBEAJ2.V\;U.C/SR;$.33Y,2M!1ZEJ9
MC=B9]<H@;<L(@FWBS#6H>7IK8;L2[]!\&6HY@$Y!E!U>(X!)D+Z=Z/9,%O:3
MJH.G3*&O9*++PSG="+N5E[I<>]N]^T=]V<[6%F(?_J2C_M.3%Q6>ES5L[282
M:CZ3J3<&;\UDWS-/W8F'>3\S"FY4OG9;6J+S43D)Q.ARB/KU3R8#%T?ZS,;:
M75U/M!_1.B'3=T,P(<PD0?_A+!V+HS5;302'RD?.VR)9EK=KR)F2B #5]5:;
MR08P 'M9]G;0[5(M0;>:?[&;AW4J]1G908-;+MM_J2^V%L!*HA7*M>@ZYU]Y
M%ZE\6T>QM'?]VMJ75N_-SD#,LI!/Y(NJ&EB0.UY8EP8:^(T(0'JX4)4*4OLK
MO7ARJ5E#PWVU],>6.*Y6@M"@PD](TFL2#&03!+N@P 46?+R;22J> R30)2&@
MCXZN# M];+MT_>5L+$@!C+G_F=T.IJC94I*Y-C;3ZO)AN&3WX_%@+PL-0X9]
M).FKC D8M'V;P/U4]8*_&^I2"!4YYH/3I.>.GD681Q]N"-+A']3*O#&'D-#7
M\1PN/9_NW1.*:9>(N4"",+XL.W97/7!+[JNPI#)]29^.]$,WOK@+Y2TC8K"9
M"4T.11E85AAO35RWZWGG^ ]1:B'M'C$S5L:]+006;5L7'"S:J*':D_>QB\!*
M/2LK.??<2]AD++" %\VW-N70(@(&F"A"@=="-_MYL]-ZSXT@W/: YUU9J??^
M"^V!M'#'FX5+N-+*]EFGD?;G\6]:73()1DL^K<&JY961ZH,%L6,L\W*5,"M;
M@ B4;.70?@4=CM:^$X$1[ $]SO8@? >H!B(2H?-&3PEUG0<>AXG%B$^U[[++
M)!XTZ6;%#C@;/YBE'T7!]WUU07)9;W)O%/KN,I)0SP_2D8GBP>[M)&34*)@M
MK&.&_F:OBB$\9: 6>MQ_X1IJ(Z;"]<022W=1F8V8& E]YCGW8@\+MMDEC(/?
MH^5T^O%1;2KU\\D:QP63(KN65%AVH,<;I)UA%@[]4R$P0L!5:Z-<UN"&'4\9
MTI'L61OV)6N6VNB/_NL;HE\-ENQO4Z99Y14?EZ,+Q+A#Z!C->Z$S='3J>:,3
M9EKF<T:ITAIH\=UC<#2)V*6E"#D3QUD._K8,KL32!JM\QU93S9*H9U_>R,0W
MD_.D*Y:KL# WG1T\C4Z(1Y.KI2+*1;/W1(W5K4H9H)0>GQ*4-S(6[*O[7=;P
M%C,;)Y8PW;/:Q87INO7'R[N\ZO>-.U8EL#>RM3;PBJAM*^VKZ-/8C&$7(E"]
MWMY<4?V(P07R?J;.K6O-.LJQ<'S,POQM,6*U_\%<LLV3MZ1<_M\R@#84U0K-
M=(^2<." MNOE(Q@K.^YTJI9JSCRF\!^(MC,Z;7UL_-)@VV N5Z6]HT)26;U/
M*:I'L*A,HJN(-96Q_+41AZ8,4XQ2TX!RJBVI/&=<*^XZLU83XN:9S2_,>XVZ
M7_I,7J IZZ^;X)O0IN4^\/%6S%OJWF49\Z(O3F-P7 >&1[%I$5^7,5(YZ.HJ
M9ON F;#GZ30A:BM+!$[8\)&YPF(<7:,]%I2+-_'% TJ,80JW5%A(!JZ1#SO'
M'&HO%!IGWE33$AR#K%7HJ_H7<*JC(PF7<3;[=Z$@H#)-\O W0( UI1,!2ZZ#
M++# M#8#C3QA"E* /NZ#M#)(H"4"I2-*CT#!MY93OT#)H2,K7!K0[< M+;0'
MM .*O'S %SZ(_5-+0/6.'=J!Q3K-(<Z60;TZN[HLV>!JS,C%D.<@(?, [+QB
M5XI3T&4)TTMR!DL7V:(FMKI,5?%!LU%&VO))0YG4@'Q&F)CHJJ0[U>>ENL3[
M4HXG[S1%4SUTKWZ2/"OM6IIZ1R%NGG[).MV2MC9W*91U6+)1"]F:P3/8U,_.
MD%IIE,7O=RR9U_LMGYW/AM767YKT'<%@1'C$"8:_FT&Z^ZQ6SWX@?'KD]F!Z
M(I?X(>LVVOS@\@$L&[/X!';U#G!7#Y:#[,EPR*=;7 XGY:4O>QHK+:M@^0B_
MNOR;7A=*^+I^S5 3M[.S']<#T4I7N9V+%P-=.Y/+++B[;,<S$[VR W?&9H*U
MIRWV$(RJLU :IZ*"98))BFRRZ 79E,^!"<H\H*^;9]^O4(Y1HA_"Z^;S$8$Q
MY%WXSW>4)4^TX@$HK2XYAR>-XV)=:!+:I'F,,P]NWGU^)"K-].$;(2TEX\_D
M>G?IYJSX(X.%N>YY0PJ%NS]_P#1\^]CJMLORY0''_4KW5Z\$C/1>R0%B($6Y
M_Q;G X\KQ:O;\Z7!:;)':2I4*.;U6]9QU*&7ZP*=Z]3BUM^_S#OS>!IB'3+K
M'I?%TB?=ZBP^+(),%!F*#]M#Z'9+0A9]NK'IL\S1#8*L/C27V.:]JR)WDK/?
M>N,]K,WVB]#*LV;C-RG[-]/G/AC<,D!L9#]!3"N8Z,_ P\=./C:>,T_=<H8W
M&#5IA.-\W-L(C)"/$\&ZZ,)X&&=W<X9D6M\"V9R#'^E0[2[#EE34K&YTW8N4
MFV1ELU9F<%'8G4_]Q<SCF)3NK$8Y2"SNPLC(Y/L)X;4;L11Z-VUC2%[B()9T
M[1N[P!(1V-HYZ)"[WH]--7PLT3%=%3UZL94M9YL](RU6Z+/F&3L5L"I[*W2H
M C_LMB4>7"WI.?V_.*WJ_QM.6P(]C@T5#AU@W#/<]C,>B"F%3?,&BT!86:<C
M*(]P4DB5J:JPQW'2#;EMK+DI7)F5K=1PY6.XXE+5=23TQE[)7L MN?!!*>1?
M;XK]>_J;$$,;IVA?L"C=DV(GL;>?WK<_&Y#N5S_; +^.[8;Y1Z]5;!QQ2%&X
M'ZZ0M)NX-:8$FC><#=BVNG*];,"5;46O/GKDZ K?1\;0RB]9/-BEPM9SY:B>
M>W7/!CF*A(I,N[9M&J8*[H"<GKQ!==:Y<BC8':9=\VV>=S=!L7SG.HJL4;MU
MDAI%!*)RJ?*7RE3/B@V^GN -,?VFPJF118=-1#.-N-,OT[QP_.#)[5&=Z #B
MXX[4HC4K5G\&2N.2ZD*8\$=@T+ZDCZ"C-G7*@FN+.0 U->W/!]I>@#(CYDD+
MP<)RBO!N>#'U\+R)&=O/H #6>/"[CW[II7R/5-C9[QL196W08]:1Z@>M[!G&
M *X?N&WB81Q71Q&H-0_*"Y6#^I%.%RM/J#;%72$"Y<A7/Q+3]G8BP J:Z1A(
M34W$6OZCI*76^:X)+O!]=QP6A$^?)SE\E\?T,(Q_^VS(OTF32-7#XV@^G>*'
M_M83U.7OF@WI/!U(S(6Z\=IH1"M.TSF$A\NX;I':WD6%"#0$$@#DN6W=6"X&
MV1JO/,<34,H/ B;[4V!!E<@(622<Q1;,0*G=8YW[_7P1F#7'^S=">E7Q.@%#
M63+8^^AC:I$M..>ED2/3G_G).3'5I 02":OTZ% JK/WE42G,Q6+?AO4:EC@N
M._;0 +AJ@LQ,O&T,$[T:D^$-R*H Z;M@991(_YT]]U@?5A^A%_)9 I_N\>^_
M4)8(35W.<$LI7!QYZ/QB])(CR::&G@ ^1,?R!V?ZAG@XA8& SKRR<7!_=U/K
MAX4I*KQ#3-:!O6LT?NF0?=]^0#)85;? =]F?$AKY",ZFL\I1HI?RQAUR8U&Q
M"HESY/BH301N&D3"<;@,7!T+ I G1)10HPQ:Z*/0> L1(.-[#=HGYZ#725YX
M&&KO#T?/V5DB$ =&F"@PM H]OOG/:UJH,AK^TODS<MZ_W*M=GHPA?!5R=B#@
MW[PVXHHIEGJ'?7L.&<PG0K''M9TT>6K]B4(AYAMV<Z<=\!Z1WLYXEFOUZ7.[
MESO_1-I9ZD(TT_O# =/ 7TQ@I,%4N&Q;=$UY8FVO'E_Q39P(D*QL9"3^Z4UL
M<E;TJ;:ZG>B*IV;>' (VNE[2R==&H.>34N6987>#D%D6^(OHWH1"BUZ6Y0U'
MEVLS;AIW2,?$,?"YGJ!*1LA[?^>9WNC@\TRK%5MIB]#NX<X-/CSE#!00*OX[
M]\E^Z"'T_U%/X3LD6>I\?Q_$]@&!L9$LT16T?(L 1CF."\,\ ,(S\I=D,]O(
M]0/0W*GP+,D'2@H_2#2<V2B_?;>RS?M$P!YN"!<Z%-X>/B1($.H8P< 'NQGU
MS^N&,NK_I:UF!-]<433N61-=NU5;'>R68$1=R"'8PP@Q;]4M'UB=*W]=%3LV
MIES/J,6D[M5^UYH_L2,03V\N&NTZFS")D?\Y9>\2+?J4';5M'"%U<4B/G&._
M=BX1QU"*0#EDXW6XQK-DP()5;AQTHQ@BT(:T504"OM:+QF\U"J]:M*3U1=]V
MG3-0ZZ -O&$B2@0H[H/NLWB4G$!6$&3%%+=X_>4&W]6BCFMKG.<.G=0?VH0R
M.* OG5F/IW946')G978:]9/1[_P&#X#)STKC(R7=]VC,H8L^7(9Y>,03I99L
MVR@B<.]*!W23!+0(J4$B]JJ"/:@[ 664E-#88M[RS]#T;W0W=<MF45B3CKN?
M546WJ<F[?8)#:F6;>WR)P&_%<+[V\SG\L?8.^H3./Q390;\3ZN8_1[BWXHYG
MXR<"#*9LT>FS5M=PVEUX(<\W7?$M7,=7K<ED],2$A@1>Q65:#9*V2^E(F)?5
M#.:EJS=62DN?YKL"E\P*X'[VA$#[9&+-W :5X!])B K:P)_3Q9KHSB7N4F&O
M$%HIP>0FY6N4!S?HLJ2ETZE#)Z3>2O,E'%>+N7#IJ9G9J90LT[AAQ%HO.[3O
MF2L1B+Q*!&:=RW+?N%;[_K'AN&4V#G_2@? 9W;E/.3*%E=0EG*UG$R!-.+22
M^)L+A?T+MG#.1KNFQP<;V1XMQMZ9_'1%]$F-$\7N=)PW9^6RI)':-=$,^?!I
M910L&$RF*H^A*&'E#I"M1#G/PG=1#\$PQX!WGEB$/9@3+-UB2@3#[0P5$E&%
M>*/T+MMM3WDL&"'K\65]/'.!(\AH"FO<)$@$LBD0*![ECD8N@C,%$7C-11B!
MM<!7AN6YRZ;Y9WKCRCM2Z A'"[$CR"B\U)PN]0JYG@U=\]V?=$ZV!C\<BLS\
MMF3=I6I[7L=,2#IGU6/J!SWW'[*"KZ0Q$,#UT%N7#0M;'_%#K366A;.*B?;O
MV$6N+5ENX(6R6:%]9[GP5+IH>&AN=<+I$I/SUN&V;Z$SEMAN0K@8$9@VA\8;
MN)-CG_@4#- ^91[/(/7DW=.R[::IEEU"5H8P6WI/84Q=$:N@)#B9Z[@)-S S
ME 2D?[]S'H&I-PZQR/"+5$B$OOK(BA\^HC,%JZZ)AM\;0Q5&KZV'#C"4XLY.
MU.(62KW_EK?8RM8V.;I)'#9NQ::.>IM?>B)G64YKX5L&(4'K\^U/>>,@G:P+
M8]4OB_Z49V.%^&WZ\I!K:SQI?O<LK-I]CP%^C++ 0MFK)@G$D'<V;=<K1_@W
M,XV47LZWDRX  1VPZ#L_'VAD96)=][2-S2HZY6XNK_/9YW[<>J/W1'A)%:7%
MV7'G<FA?Q<XT<,P5#KM4"(5<^[@M7WIYW-LO^6HQ4UML;4@.>\*\'1!DXO4?
M;7$3R$PB\U3/+.*$Z8K$\_+J#+^RD'#?=JJU)$T.CU19I0K(5+^USXPH^Y2.
M?8 //'I4I"2M:H973W@NE2F/;C#QR25^_K.5E;I,&F,]S](R/\:<+..(_QP7
M5O(DYEFJ;G5W2CO@LB+'&-@SDJJ0TJ!^K9Y9BY&T(4R-KEJJU+*@,/$\;-VU
MZI--0=3\U\E!/?^A*PJ98>3R87S'*0&VPES_R>V%JT'U$VPX[<*A,Q415/Y#
MZ6,?R.5?/[\\77[\@DP.[63LW/@L4ZRCHZ_WQ-7/I[X52B7G/C$.*:A"?>+E
M:.Z4!*N+XVLNW'4UKER&::<8KP>C._(MY 7<A9O<3$DDXL*S= !?R>NG'VD?
MTZAM?7DS.S#D[SQ.9[D04ZD]P:S?+WI"3[)+I+UTF8D]()*^*3!.B1Q_+$P4
M>K.3"%#:;!.!+(+[IZ;.+S=<._;'RY&*Q<8-1*!=26#8U4U!5>3)W3)SARK*
MAEVG/9A5I!]7R[-&ZSH:NG;Q9=R]#.^ZD+7X,8O2]P4# M]N\9^*IMQH)C^B
M1_[KK>X >&2PWTO=F6=.*]9)9^K>T'A1&E)]O=P>00U!>C+AAL'\@JW";>@.
MNBI<;M_2[EJ?/9'O5!8=E7 ]SBMN+N&N VE]27I?'I2I$[Z[\;7@207F]<5'
M-KZK6SU>4ZBG^6,3J>^U^A:CW^,"?GJ@!.7IOQJV-=YM.U(";?&&'RG>3WQI
M/J%I?V;B9S^!O#7!/'X6-XIW9Z[1"I#"<VLFY#O\//W]U&O2KPR);%%U7[J+
MML@]>@SH3CO/2)H9GCE7J4PXR72O?XFL\]J0N]WP:<>;"2Q(SU=B)A/)XA%0
M+6!E$:;: +43N3'^8EG4UL/_?$X3/3R5K[XJ,WAT_%% !ZT,K.Y?]OCTCX-,
MA]&KE>]"CO^\ :SP^9$;L?/X<],K\22]^MKU0_4USU0K&YYJ8-:2-&+H:KKX
MD5+(?A7V^/OW8*7""CQ4EBV=5RZ7'Z?;4/:^_F5S?B%CY>5?BXDU]9F)B:V*
M=QEQ=[M%2CT\/[X*J,R..8U[)+<)OP0F&(X@U>J!8,79PB$^8=HBN2ZGM+[R
M.IGXDV( AQ\W;[56]D^HJ 4\+X%#N^B1S:5 *8Y+F>S=O,4;['[=<XM"U> .
M%EQDSL>;"Q9WI+==<QW]M#VHU$]1Q5P6=^C_A@FC9.6%R1M99).L>)J&/+ V
MU7$\62@U-J[]5="RD\>VRJKP5;F=+?=<QJ:6 &GO9B(PY3AE3^=QH^ADA92R
MR.39JX88+98AKSB&YLT2.F:IK8I)_K[-(CN:8@VNU3>?WF$T>7.+Q.KP412D
M9\JJR1I#8X'8,0FF$O'J2<-C4(A!_]]YM/@9W%'<N8YF_<FYL6IZ1IK]CN52
M+#M72X5##JVP FM@,.E+A\')5I'BEQ+:/GX5JP%FX?P<'F$ SGC H5STX=Q(
M\!#FNL[%4&O:M<D;+OMB0DZ_QMAOW3;WI<759^:3"<)59]+VC:Z)V'X+7AP*
MX>((6<Z.D92/EVCI7WKT6=ZY6JZAVMPE#2T^-J"E^=DC"L+GDA)NG:T*>*03
M2&+7SI?,/KLYN+89LSE @B<"2A]DUCH^9)<>Q]I8#(D*\R/=2QZ;FG>[NYV?
MN]F8KQ.M/C'XA4#?J>A<GANF,-- ">MVS&WWN9CDGQ&2/4I3V?+^QONDJALY
MF#TU"H5 M@%49\2&Y+D*M:SU2?U"<TL+Z;0HO]UD<@-R%\@[V$@L@'ZGNC?A
M:,WV.G6^HGS$V*9<V_:TI>J)=Q^#.Y7/-@^)?7FCN/)I\5_WZX*_CF,964_)
MX"]Z;GK>/OY!K./<,6E+5&O20"T4:ZS$!8:^.CB!&N0ZL\6@V#*]/RR"UXFR
MG2$"NRNO0'+084,0K)<3((W[S6KBOW*S5Z6I]YHNC/@L5=)HZT6,=6R5N+J6
MK)M#.-L-[.0USK=5AP),KCXZ]IIR?O>%"^Z;#T_*WG:N3\<DW51[*UIQPN)1
M ZT&?RR@^X=?Y[D-^[))_(LQ4P<TA]:R\U/'V:PY)XLN,NG;8?+IF7'4&,%"
M_)G D:*76-O5$=38;D943^DFC3AW@];;L,N8AI,<LF\E(:"-CG6V$H%O2",B
MT!R'P!MQH4J"E8F HH\-GJ4;3"Q&VE!.IV^?*A>VV3FMVI<&-[>8;20'R6^?
M:;))!0R\NF:?C^"U7VD>R7"=O]QZO7SH_$_QCK(.7Z/-[A[+)(VL##_BFT/#
M]>]@J%+')J#?NU2-:B5 BD%2N/9J^ANY!99YALB1NHQ?']T3LD+MIS\HM:UN
M<H[2F K<9:A0E^D\H]%KWOSO *[B\GQ>[LB^/O)3?V@W8\O ]>>Y6&W+_LD
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M_V6P"@P:P1!.P=W8/([MW:"4?W;=@U/BW)ZOI#1'M)U;'JVK"&83#%W2!N)
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M*L F$CU%D8IZR#I(RVVDC]G;H3 1P;]:$2C/?+ \0 K))DJ?RD[BS;]*?CL
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M?7261*LFSFN=?#RS\5D2750] .)R1M\Q'DJ0O@LVGS(%->R %GJJ\U;#G7\
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M,H%Y>WW(O1U6'9#PFIM;Q)\@/$+Q>/EU= RY*2*,.[^@,MN8H69P1.0+.FF
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M_NC[L.:-7'5*&AK>R."NY(\0B5]%;4Q=>Z@W4L;'>$D.K_+X(\QJ9L\F@[)
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MGL2-Y@T.1$&;;^M1'<]S]BN\M)OV#1G='(6$,Y]>B$@&J3/($\A-V&4R;V<
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M"Y\XI$"?SHNS8]]E:W3,U(AF @\8P<2-/,7 !?31SYM7C:SUH]8>O-41MX$
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M2[10UQE<#GC.KNVH=VX*(V2?^WP=JCY7Z%%>SV]/U<&JQ+*\:PP?75EV=)[
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MV<;1WKYJY&$8]>9LV-9XH"Y87IJ0+Y6.I O;&39#J(^1I>H/JWO18E&,?O[
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M#:/\"1SAO-8EB!%S]HRJBC*@*MLK6+ _B"K<F -">(B#_=G:N21,P!7"(%[
MKK+QQEO4VU:5<$Z _<MB]^#LQ%FMY3HX#/8O\;2(LS1AEVBT:00R<"\+MP.-
MX-OJ0MGU)"M>I'())W6?S<FR6(E&:V%6&50)( =H\DH.T)I?D^->V?Z5-H;\
M$\H3X#%;5KDCEB:R?*R.(0*Y\P!"U"->\MK^/JYPY'=+N-3^89H]A1X@O*C,
M5O '$2T;$2.&W"SJ@34L34#:'B7*P/M_"UNK\-5H,+CDP-.85;>Y^&_0^W_\
M>'S:L_@Z(89*RAQVT+KY>4^3F9&[U6?11AL3\[_Z>&+A0W=?D3EZI,3;O[YK
MP<2N\IB2<1)):ZF6WSUK7TLRTBI^U#.B8S",M <*+$;XEW!165^* O2#EV5[
M;#$(_(1%S6TT%O_*;H  ^O*7BU5010F ;+94E&7\79V_OV0'Q% +ZVK#^N<&
M^V]Y_EWB-FZ6//%:L0IZ @X'= "$IVX5C@U3 L?FL$K%<X1CM7C# .E& 7EW
M8EF2#-+VK_0"5$>9E9E>EE%2.6+(9X-MQASL$W$1CL/BI$NBN*]=8BU89>^V
M3GX%RG3?A[HTLBO>#9K0,0#XY/;^IVV*B?L2[):=[SB?Z"LAGW]Q>B#EWI+#
M3U!33GJGZ]20.7]2P+1M(>]P6D3)R;)6;Y*R3-0=\OHW</>/QN\Y>,VJL?4*
MIWY^]S#2XB6,-I3K1^/CS+;6I>OEX*/0<=/$@V5R.,0*>K?R$%PMC,2I=*3<
MOZ*"P!&,!0>;*K-IX+2PX<IX-NS?'/\E)'R-);?^UN"QG$;05=_?.K%%\M\D
M8SW9]EON?VW10(AP Q0-NF\)Z."6>NP#;6E!RW9 ^($G^30U=D#Q;$Y1M86[
MK  5;3"1!?[=TB" =K8@?!? -D#S*A%>^=M-68@"5)3'*GD7;DO'E6TL_U0\
M0,/+7F[QTD/"9$N+M\ 'WU5I8\X]\IO' .Y8& +53\=9_I*!H%^%6V(U+,TY
MA M,_H:_[2:B%7AVCZVF_JHBQ;:*"M)*X75%C+)I8>$ A@'M_0\8!-(VFO9_
MH(4UQSDNX44K6S9U?A9H@(2M46!08[XP8AB0&HU?E7@@IF\(Q\++4@ I P33
M"@ QECS%&@*H "",UQ8!8<*_WAIRC\!56.6"4<&FX-@"DU]89!\9-8ZM.X3T
MYP_<^_T\L_X+:\%3NO^]I;S.1-9ZIY:&_[/>Z<]DZH\OX<)3 0LFG=HXWE(G
MIB->CM.$,3E.?[5931U'8GJSJVLDJD,LC$!O GOS35'^-6P@*ERJ>]_+,;O\
M,B;'237X6,R,K91-_]?>AA"L6V]Y)EN42].E=9NAQ2#_&EB7IB+<4NI9Z<O1
M;82<&@[D,_O,X#5Q1J++.?U5LG4T138_;;T &#O;X9YE?B8>?N.0>6=-O%\S
M>RK?)8P79PA76VI]C;O:B@Z:..=JCP<!&)0/L-Z<':M<POVQPOFI('<>SB$6
MHD8![TS/9W3>;5SDH;EVB58FPSY7G;,2:*#T]4W5.(IWUW_MK8]>6X(?%K*P
M-=]A^Z(]FV:+VE'LW^N_ ZF0(7 <VRQR_^2Z=;"I/_HEAD!8U%\W.U@R=!1Z
MH^U&V"DY=N<S4^A])B(6; ?.YT"CU(PRPFH'X&.%0=SMZ*#N=_9'R7R))+M)
M2QP,#-ISGV8I,FH: =TE1E@FUDOD3=PAZWLC54FLHXA* AO?Z6[U6(*ITUYO
M #TS6-7O\DZ\]HS:5+DJ+OB*H?_]ZGZ#I/&Z92V?6:(PGVW\="(GU],5R\\U
MI>^?$H+P-$@M=\I>DNC+\>R:5M>@VH#IU+%"(?9OS%2E\^BKMS3*(;:P+CE^
M KD[U/N=W3Q-B\P]L$CFUK;;*W[=P-:YO?IJ-J(D]M:%_.>,BM2J\T=JD]*V
MD>-AF1=2Z,5)_$0XN)"/]][W7)4T-E*GB%>8ZW2;IZ=0I1&]8X.!2NO+=WU&
MDXYBF-PO.#+7:6 ],G+G6NWV4-G3*XR,VBM]^[P##V3SQ3,ZY;L9*55X;*5W
M:8VZ(J:Z,5FM7(K+#TD:SWCKU"9W+.1CG<XJWXP:+6SB;EFU!/_X7-3DC\]!
M*,^7[X(U<6,2(3B:@\IS^]87%\5)=W#K\O77K:=TO+DI:A347AF-6KW&E\]0
M1P@\+GN:7L8L6E":53\3\X0RI^*/ZBWJ97' ENQ90D3+6GC^ 75U!?_4H2QC
M1R$="X"(%4MN.*D6$L*0 64.4XE/)]<]%LFFV@Y:B]KBQ2<.O_X,WQ]5*\&/
M\_4GY%YU3U@NGT<S/Y7/2!!E($$5_?E[YSI0.CC\FV#"'!;EQ,4CXJMZI6B1
M)%9*C*O%95<M665;^TGB!B<MVV[(L4<J'D!S/ 3X4<^",O;_#9:>_'4)K+QU
M$[%R619@("O^529-PQV_@,<WEE?3'*X5*X7CTN;.L>:HPM/4?D6K?.,M@$R*
M@+FR, 'I8*U&<" DR^HB8:[#[%Y8\/82+IKP\Q%# :KPS;^MQVJ$]9E8"=??
M^W?\(&&$;\HP^\C?[FT$C(^B,,+ZSX<YO*Y;_,'_AL5&4 Z"_J\P$WAI8VG%
MN;7ITA*PGH85U+_T9L+_=VW-9)L62'7[_ODYM"LBOMP1SM\3V?O;666=QN:$
MT=>G+)EY"OWG_5(#V,)R2/^&-?^8K/U+AMD1=*^\_SB.%0G3-.12!./_GO5X
M2*,U.V+D/W7ZP;&VYBPW* 5;?'1 FK*=D.%?+YZY:%6T&%RK_9G(&6^14-$?
M.Z73ONMS34=;O$'4PV[;6,AY!:YDQ4-3950.R"LX*/8/1^A?)=&R&Y"<_P43
M_^RL;^P>[.$M$M* #S/_KA1U7O!V/$U6RD0K#\CUM_2&(?\K_H<'4(8LK_(6
M;<"LF??87R_R8G=CD;"_SXW_4YT([.)@E 9+5Q%_1SE\68HMH.99&8"FJ?UJ
MGO(_#"3^-G&S!LPH#<N_?^IX@^14\V&=$,L8N<Q4NRB8<'F<%/'I^H]6S!-=
M5HS\^M[ZD2=I.=8ZO*J/1/_J6S\E7RS2SB-?3**7?'^"'#!9C!]+#HW-'+3U
MWP'Q*H;^FN,A[:DZ][P'G LG"96P,*<K?Z4>90$>+@SYCXR& )YPN7 +X/U3
M00CZ\!]HQ &XO6/ D#SO%W]$Z6"MT?F2XUKTN),LW<#_(Q@JLVTCY%:.6'$'
ME@MO@D%76-_AY?)2@((L6>.Y,BP,A-P:X%&5*W[+S%:9> YC.N#7>^P3SF>Y
M\]2#X& 36:&M?[8#'U*!P4M%6:P$5FNTVI^M]9G#VY64H*,U5VU-C0##."^N
MWSR[+$%LO,W,S?$A]JJMX X?)14$^I1SS)%A.0<UF?<:Y7/.FYCZ)!6NNI_=
MFS20?L_V)^@!O.]%K3YY6/I*4%F*GUS5Y)(*UA ]K;"J9#95^ZPHX.$M7,V1
M"V,' ]&;#V.ZH,$7FGW-=.G/IR#X-3N) QAR$707Z"BD!6^##4.SP>6*3/:R
M%?@_.P4,2P'$0'H(_T+X+0%G8\V""P,JC0.<2M;8R!"T%7P1+4L9YC O_W=%
M(OZG$[[B-Z(" LBF8:*F"%(3OI+W3V=?[QPQ*@/ R#@8/FG("S=U&EOM=65<
M%7>Q3,]+5(A]Z-9'.9EQ)YR<]:R;_!/4=5EE++$;GM[J#&NTECS]])F4RM[4
M&Y2H'1&HAL\&L'*#A!<\K[^KV/NGO++P0 W 0[5UA'HO+?O"SXR$DW)&=]DA
MZ-J#5HX/J=8"1PFO[M ;EP\\^M)%BNC07]&\769K+N#(OV J06];?=7\X]6W
MZN[N@Y=C?]CK3\@&/SD+0TTNN%5^DQ?\WKUA*]'-^F.S7,8C:AEE+4:LS>X^
M:0!D-8T1F?XA9%=C$I>"'UUT)CTRR[3VPQ&?\UBC- WG8L4MJAX&C,^34A(K
M4"[SZ8?>TT/,^43X+MIBZY?=HMW%SFO6_["7C_!9_2PXZ_S5/ZXGJXM>#:4_
M_Q(S\_#)996!8FJ9GLK8*'L^I%%D M5:P]:;WS/:!X4XS!WO*OO$GH<L+$U'
M3S:-2+M&$RAR[P<S@7*L%ZEL?1E/%N"#48[H*;'HF.X-^QWI@AV1&_R*#@<$
M4!;57&[%]\L,PFL.+T/+4+$Y"%\6E\HA(%MDCC;42R($_-*F7MB)(JNVX,8G
M+C\X@K[P?JWFC>>WFAB\X=P8+JOQ(.13?%4-GU:A[<F7BK^=4ZZR+"P(#/;_
M)U#B@" 0P!L4D 5/$\X!-2)X_]GXL%ZSYV7]^@<)^Q_R0\NR*JKPA-@[/I^I
M%W""[YD\?_S0BTF(.O@KB.<T\>N&Z4C-YUXC)B*R?_7DJ_7=KPDM@CM#T>_>
M_8[JM?D'R0]!#ZTGW)E90HK?V.QV7EVO0Q[;AOO/NO0'394KA*W9_Y4M8RTI
M_R?[J\@*^N!8GCD>\%K_[\VA&DB)!?L<POG"@._D=>//LJR5?P6;_Q]961P8
M'-N(""_1AL1BA&PTH?Y&:%]=WI'K1I'<QK<&LK-<XH:(4*M*:/O!V-64MP:Y
MOH_1GD?DKD$^L5?KVEGUDLUV939@A^--(Q-W' <R7Y&JL5=J?M&]4GX,T+BU
M)XUZ)I(+<=8V1J)XFOJ6BX2#'PE!F&T/H5^/<\HVY+OH,-Z41?\)XD=WO^KS
M$.C>L--)9GL8>!:F[SG1?OS5C6=%"7=6&K6N&ZBQE.N<T$FB[41^\G2-QGW2
MH7-[L(8AEK\HF=/XK^*U.;R_ABA_DW;_,J>_C*ZFI046^5M__D%K_M[4_YD(
M?UJFK9@K"X^W?OQW;RH @TU (N[N%"_B( /'X6+R$^1*>2LM!K@ZE)G-0YNS
M=9[O'V]2R ?<N\T\='B5I93KU#W_XH@39\@?<3!2P7=GLJ7+5Q*2_EQ0^[>C
M12[_?8!I9Y3+-J$*'5P1>-SKK[W-@9"-!86)B$7;1D]XP$V.SXW,C7@HE96N
M*:^!V=343.9LXWWS!<LRQ)$@3<#ME?WM\O[K\7S6GP%0G(LP:%%%7DEYMV_^
M[A%S =1V*D@G9<S4"K%=60PJC VQ-/^/8!\$YYDMW)675:IIK5C6=5*9JG$:
M\MX?1%74R?I;%_N/>O&_PW=_#H)^V6]Q"^%N>=YLX0(C N>ET/A.Z>AB OX)
M6+?!-%;S<?88/=EIM(G7&C#B&I!-*P3]#QFMYQ)CC=R11I:&.RRV-%>YA+,L
M+^M7X1J&%26<?WH'O]*?4;C_3Z>\K)3A_X)4TX,-.6R$?28*XX-)J5I= TM4
MI;>Q-ZQ&^6KUD2N-12!U5Y*!\4@+PJ']HJ5=LU&&CN,M9/.)P]>:DL65![ -
MGT1MZZL/095?(@ZK%G2L\A(EH2%4V'$=P3O&$5T5.JX(@2NM1Z+-=WQ?G(=\
M1RETJ9TH58YSL7Z_F:N@%JQS-\$V>(=[XVV%D3>R\4YM=XNS3IBSUQ3Y%I=$
M.)3Z>^W'#ES7#]=;ZECEBC5^[BCL_33X"Y-X,KH_N_'];,W 8*9[0>5\0R,H
M5^3-)9& PXZDA>6V<<Q0ST,"Q.X']6JX\&C%@WL/5$^B3I@[ 6:4=.#$FNOJ
M7,;@O:?O-WE/OVTYY>GZ?E5\Y>MXD,S.?3]4FK?'52HE"PD(.RA5E!P<O49Z
MYN:FV"=75W1C^T3%29NHN!GD7:QUPP[7"BKQQ!NYSE'[$8;YPV?N@>2%2[9:
M>]KG'>:&S7;3XK$4U*[<6*I=J_'MZ>90Y>/]K>3J8ZI)S^D0;[!M4WN1MJ&]
M->Q'3AM_H:=PABHATKOY.B4R#-WT%@LFW^ %J'KZ[;Q+"N^C>\PL+?DP!\HJ
M>T=L4-7K(K+<^J=DB=('V.FP5"'?Z3V=A^FO@K(9U8M17H-"4HT+X\'AWKH'
M/SWJZ<,^#)]X0E[K<9"VN*0:V[KAU]<9E5/Q*/G01(^/)W;Q8Y%8A4HXXV#\
MSDPF='&"/X?5#M[UHZ971R%<O-N1S\3M-*H&L&UTL[-[T0_N,1%:LM!S[K;>
MD,MW2H/455(_)4I4/\"68Z:Y(D&3;HH5 Y.R[XXCDJ0QM?X%VCLIU-/.^?FK
M[@O5"T0%JW!F_A=L]X#O=-N\P]TK?KP1 ;9]L(#!IN/&Q:H=QZLK 9SLQAJ:
M5KXAIYO'F@]FNDY<KB43C8^$55?7/S8:@5S-=51112\9IQB;V]!OOGHCL:>9
M[+1-O"-YR+5;-[U'2W5[ .\K,K<"=/X'V,.263AYF01=L+Y@+%O)&WC$T?#*
M%MRH[0,<3$M$,>JN<U!.ES96][[9T\)/D)B\4S (: I\W#?[[<HQF]E,1JR,
MR7Z8*QV$IQU$;:.!]GE:=-C,:H:6OZ5+]Q;'2GN41Y2_S8JR^>0GE2H.*JTV
M(FQ8Z8PF"H,:;7#'S4%-X';JP0<H_:$W)02V.5Y6+6<^LFHY;AI[<!7&K]T?
M/(:X)A<K92);@?]G751DE?/OO97O?\?])NS7_HC!78[YS'].6G9^?/1XL'1P
M]>5:Z"T9Y/#8/8;XXW12U,B3$V/_W2Y?G<[+J(: "JHF+6:ATL["7>&+\.G4
MJR.O&Y8-MW<@$LK?OENPF#V\7L+C>P6E8]-8G ,Z*UQ E3Y>/!93]%UYF&OR
M)$US4*Z0&_!,RR$YL9H6+=:FJ+NVXAX'5TTW]8=^Y/S*-@4.@7]P0L1A03'[
M2L3!(+K_I)$Q2I= X&A&!.&?^'_('V8#JL-_D*'GG'@0NQ=24!TN?EQ('*1M
MTY8]*)=^  ?2QKJ-%1_?1"0Y6;//Y65SVN ,Q?!3RO*08DL@&U8;"]26D+ZO
M#QT%:J]^2H@\$U8IH,R&VEZQ9&Z- \''@O :T$-YK$"T$15PCU':UG8XW3P(
M**C2-KH,;$@%J2FA4!46>+8.:_'LA]XP.4\K'AM3#5;,;2L"0P.QJIN [\_J
MS>=>-5TU>_J"SJH.PG;!]@[\0_\2[ B>?<34GP82OE8UA-(2HL<*193'_"85
M>)Y]A3O'-IH@W$(%J8969?QX;Y=R"7G-@,&[4RKH6H"B3W\=C!YJ_CIE=WE%
MY.>$QT.Y2SA5#I#T^!NO,XQNTY/$TMZ,+.'0.G5FX%5$/7MGI:.'FOFG.MG5
M?=_7$ \>-E=I[H4GZ79=9.+]HXQA6!BS>,%@];T^94E?TD,>.2JDE!>K\\XX
MU6.__X+[Q;JG!PX\$5GZ/*0_="EW]JY20+N#:*36_4*^;CZTY)KMX\\T0S/H
MXCX!X91S8#/8F2)P['R!&G9J5$V7(>G 5;,GQS'RU3,X];RJ"KG?SZ3</^Y!
M%F6\K]Q$TC!71"D[0#Y)TK[@:R:?:4<U;>"X)H$2M_.]:OYX62)_B@T1DW"X
M.^P\,^KI#?FPLR<+FW?=K*DA:JD6Y-[U1C+OW$RNK;QVW;=SFZHL5Q#XV36(
MJ6'%A_SQ)&VL]=-?TM%- APO>BA>EPY28Z%1PP*+$\6Q$M2#BZ?NM+Q%1=_6
M&2D1*,NN. :)A2E#?&/Y1BVM(_$?'BY8<414\(&WY$0Q$6#<LVIMFUG<*4"X
MW,9*Y@IFH4?  .1<:["$*\-E^<=* ;;B"G=B/=2$>9&&VH!,PK*!)_D[V@K!
M95K"+[<!@X!R2"+.4 E0FO0#Q8"L/T9[ .UX9?'IPL?R 4_3V&.0QA$JT [P
M=JK:/H0_&TN<!]"ZM\&QRV,%54\ #8  "E5*W<\2)L5$)(3M:04A#HLT5!.V
MP8&L1ED8K4O8PN@M ?^M3I, =@YXPHZ4\""$L*YS&:606$!MQXHM$4G]!(XJ
M/(=P8RQ8$X9JWU["$0:0!5P=#539:)/R-W[>GX/1_T52Z>A$4QUOD"#<35M1
MW?^S\OG/9 H!=:(>R(WU;T ;O /G=@%N(K?_[?#ED^)G$AO($WVFN]D^,'K<
M)3EC!AXX74WT?G3Y]NL?"Q4_!K._$CH-OX0*OL3_!%V-O-QNN:1\(#+QD^NM
M2<BMI^<OAS*K?H(>Z-Z;Q.M+B7[-B?'A2E?3N5CG;9//&R:RL%=?INL(K.ON
MR(3N-TIP;7Z:;848T5&+)*9KK[L3<V:%8_Z?X@,6.-94'8!MO^<,\N*233CI
M9ZSW^>/[*UC3%.91MB":GN<A>JG#1H/+IGUEH9G(X7!'#F74RF25ED 1<23@
M(YL<1U/I&$1CMU!3_:?%3V)O$@Y7<L?MNI1;<?GL;+\I>#.F&??2JVF./JUI
M6OQN(KY29PW[\1@_)RQVN?*T/_N1A\^<OH9=Y%OS%DLG*6%L[9L_2*8XJ =A
M0E?(<DAE85M1A/5)\,Z5 .M]#PZ/RST]]E&DW-O7QY,:A@N/GV/+K7UC?\*/
MK^U$ZC>EPE"47<RH.P7S"C]Q.*?9729UY[>R^DUZYY6^#.CUOC'QE%+D\KK;
M4;G).->BYYZBS!,J(6PP+$8:943B5!.^60Z)12K3ML(L.! _Z_^_=3+4>95I
M2B:R>[!6K-"\&##ZS[&Q,!3 XVE_3D=J D.W_YBN! B(.&.3"5!8[,^9&3'\
MUJ=;18'4A'W_"/K@"<!S?#]@)2PR+7&_E2R;53_N#ZFR&F:9D/_YP=*_(V5#
M&G.V:"\BG%!1Y4.(I7BUOV9G7=IV[GRB2/?\0IO/)I,<X34F<AP[VS/4[[\0
MN@1-@,Y0E*JCFN8C>[G\7\K%< 7K[V]7J8MW#]BKFQ"RR>@XKL[O6C142Q=:
ML^=W7Y[PG;O-<$"O5],M=@=V5ZM?[G3;<[,VQV?0D5<TWE%MQ7G;7.$"(>&B
MZ0U20@K[>&5(E9F"E!GL@R6_6WD?S47FV5.K(#+8<YW]],ZVE@!'-G49?P/D
M/%3-C,:#>R,.'_T!99JJR1X[Q1>S7N<Z:C SYI@5X1&]Y-Y,N-Q7199T>)FT
M[O>4;=/QQA)S6:(9NA#UBMJZZ9CVY69_9O4K^R>/7BS[KNFO.Z<C??IHKM69
M'=TG#VN3HD[B%#X&'G)33$"V?Y=![*YZ6,<W2G9V#7%/?K4TD\O)E(I2Z=;3
M-[S](&8;>4=/GF&"K*./G_;-;7.WH?T<O<\=I;0']Q6#JR8"\U>GR"B!?6$T
M?\R>^V>\L0]V;YQR+XL>45CG/^1H7B8#-;!AQJ6\(@Z5CCOO?6>K-#9EE#J>
M.+[>,KA93'ZWK]LV='!#W/-A;6[RB@RC#2YC?GX@G'%[-B6 IS3B_,O;9'CH
MAY<]3Q>P<XW7;8.(F<@+S5.N"GZ4R&S'O/@CI_?4?/M2!^XX_3%^O<YT57$^
M^P+T3;/N(WA41.C8B4#_\TDW+>K,1J&A6(TUQQPD?'::4CXNMO<=@FB9+WAB
M+.RE]Q'T*XJ>V]3QA-H-BEEVZKB;_,7$]0I>&#L4\FQ!W.9A'?S]\J"Z*^YE
M:-&^08ZF]N]R(R4V5$\W B1L]\L'0+O63HN4??M"GOJP-G@UA5D8D?7Q:!#F
M@.YI=<TK[:+Y8_(5%N>_5D!%%]QKGAAC)2K8$Q8,=]9M#BQ"3MVE/-K_@GSK
MA(S.V/@30=OW&QL.;3NZO\9_)%\V_'K=C>O-9OS'.NG+.Q]KKAHXUNFVLB;$
MA[^=&E]Z?)!U4V3]3]"VG0@LS,:-G17(],1Y^V8T0]$3')IL6.DK<@E*(?2F
MVH]-V3)J:!12 F:W3!X]-<S.EDN.RLT2Z^\NV<,Q2S1XGQ;\6?4>7.=(GQ'B
MNGE2+]?YCN,[I$\'E^3PS-9B.J'ECP?=^[3RL@1 M?R61IR[]S0FR+=(FT&L
M$BM.;*>%X0@9(T(?F)H0)>U>U=N'$88F#XE:GY;E!< ,QIR#I*-]A3_U4U%C
M)518[EIQQAF.65)$AT&&/G*QMC%./(7DKMXGNN!ZGKS)-W/Y%6"**.YG!5^>
MHTR"DU:I)YML'NGPI@<J\&1/+JB)&JAY/C<<R:9>5/N14'OU&EG&::2CLT]D
M!-;F$0PJ'*NZE@J'-EALHZ)034J^DHZ66;#I?90&U+;IYL#0PR]],)>MAN]:
MPYA&>XKKJ_K)1YEOCTE>^1+JO8(P2#RGOQQ^U;12TBY9$A%,]5G&\^ F_:^Q
M/6 HCE\W/37H/JB4D7T(Y'B4&!&MDK6'DB#OHB'M-&^W!N=N6C\FJ)@N@G7D
M=\N\8'@(#=:T_+M 'V?%O_D*I2V'"JR"Q,+\=VB=CG:,+/D)XC\7_L>O$.83
MO[*%6\&8,Z$BJ;_6*CMFZ_4"CB#BKUXZR+7C70N&=8[!!>:+<TR.NH_HA=*6
M=.W? TM_].DE?K\^1J?_6SGT?RL<B]=3%KTY1YZX/Y=)]7LS1\X^'O\H;)H0
MU'\\&W:@]9G]W*C8J<DZ\P8Z9P9',^7PC-'0R8E9^W6I=.WTDUZ7EOWOE^?]
M$%\J'V%OGB19!JKME>1%D/<<"2F5C)F@==!QZI>0ZW&$?>Y7[IQM5%\\1]'H
M0>_1C<)<<.Q5H145F'=CWZY$:UWX/E \:/SAB0_F@IL3W[$8X;;XIHIL8]F8
MB7<!'WMXV=C)4F"I*,=C/6B>S$E4H/0E9'^QD)BN(VD1*?K$'/DJ+ ;2XX*=
MKW V%[!NAJPC)L%GDFKS27"=OB%/:M#KK!8LXU/J/DD'*CEMB-NA+?!0][.N
M8YB*^!-..3Z8K(BK">>J2U8_^P=RSJPP2R5$QT*%RQYHO54]%-3UX5F15(9,
M7D-0H/CAB#JOMA'[L5>8&^.ANVM.3DP4A7:M9>&E40\?4D^/J?'Q1=3L+!S@
M"ML?%BRNU70IZ CQC45@ZS.DCF+)C;,B3TW*$J]*46@ZSVO];NH7WF]H(KDL
M'/BR@6F+X9C[2KDT>MR>0]5Z59SM_D^09U'K,[N@T&Z@H^N1H54,_2NM,>X/
M;8\(&W<^D=S6.#@C$JYVH.U-H+]9 -^3OJC%QDEE"]$-C,5XO23GA#?X:^-2
MC$;A]XF/%A_Y^U9&ER$[:P]39)P<.+!POMRA"5)(A>C]#<Q8;\9U&2/7'W>\
M,HD>=KV=3Z2]P_;FP:U?-W$%H6U^O(^S<4*1=..Q;Q&WVW>Y,\9?RV.?-8T\
M[=K E-&_Z<"N.+1==]OE;9-+1N=?;9)*VQ6ZVVR28%DJ<KK=/0ORI,_S^(+Y
M4I=(.D/4:?5KIP: @TYKQOV3JD\.?=,7E50+;B,GC.P.9\)U%N+Z304B23LN
MGE5/4P&K/3J5XD#.BROD0 X@77G,*O:X+E<=#!T%L.W%PN;Y0='ILG%(;$/6
MGM;<P ">&Z?$4ANLC%H8!!+:*X3J]^S@ HC<"/BKDYTWLR4=\%''1;Y2JLL6
MIH*F5&\GGI!VVL#@*C :Q=XAA'R !-(1CP(P8V&!"G+:@^XQ1!?1YZN.L$IU
M,9MOO8V!;Q_E3U=-D($"GYF,=DQV..0J#ESUH>)WMSZS=EWHA>HZ5E#+N1(5
M,;<8 0QHD"H.2NZ-'%MJ:+#AP%&J4F^+XQ-Q2R[;\K#@5@*[1JE(_EBR6(B+
M^*5\>OT&VD<AMAISAKZ+&O!L_M'+:,K( D[ 4!%3T3R2*^R#R8NXSO=JKY%"
MS,250+ZJKY0%8J4IM[K*44A.<)=(5H]ZPVMM),;L5MYMGVL9'^M<QR @NPQ*
M+QIW-.E67AN*864FGXTS5:IU-?8^#Y:[VM_EU7:0,]AT*,JADU!(]YXE;KJG
MT3/"F:A*_V-VNRF/$;<-SV?,^\1NH+U+BNZ%=[)!&HWZ191'9^1%16CK"9H#
M01\34@ E.*B& Y3 NWUDC\D1Y"S4#42>WM-<Z:;7M=;$R9MLP, RQPX\4EAU
M6NH9']\;*M_T_LT+Y#II[W<$,^M+R#NUJ*'K/ZHOY;[Q2D@.N[7.PSKG_- Z
MS;V]]B>HZFQ%Y-ZD>TQM1IZPV,V*RWU=F\R:+Q>_(YFYJ-.L",GB76G6+!I!
M85=[S$^0])L%=\_ITW?'%SZ_V+IN7EKQZ[+3J\_<YT:_KUD74R _0=%C^TE1
M24:%B)IW54_&B8I3TXDEXN*!<9%LU"BM.._Z0R+Q9<ZJ(D?JC$;5V)6G6S1$
M=/@E')*;=JH:V"/ZGY#,>\>HQX.W98B_.N62\J$HG %_%$DV=IIT3<,PH:2C
M, UJY.SW*HLD:A0$[;;]YCDDI+-F%*76? R#,;N]NWZZC3+"<4)@(H0TT!-Y
MZY.WW\IX?FA"0#1ELHCGS5=**:9465X5L<K1T'69I>S.3-R%'$&1I0_S_0U"
M<:X&26H.:EV\8.:<1^3K1?ND2I<NNG1N&"GESDN!=3I*?%<&1U-;A8W)MH>-
M=)Q5-*4*MUU^A8GR*=TVYH,Q^ZH#%>TB'_6"#OL56I3NU%_V<5M(94%)-J$\
M[<KM=Q]E%\\USB2M\&30A/8MV) O,KUK_'T/ ["^0@+8YW8.EY&D2=6X4ZQB
MH#E'/=W8I+F+ZC*\K22N,$T5/0I#:7Q@-.66WE0/9WI[EG*Q ""7+M9[\$KX
MFT#'6Z8J^LM1B9^0*A]%8#,PL\?L]4ZQNF3XT;BOC0T+M8 E,;IAS/E](E1G
M+^TSYG10K7R\CB77T,10&T7##[M^+%54P?F9JWYK@)PWU5ZGXY& IZ,:EM[4
M<-@;6\T^%W"1B2I[LMUX%6EW2T4L^7L&4*5UZVV--]AU#KR@ZK&+CFHDIZ0U
MJC<OT^/<2OM)\-YL6[>#3*CP\8.J-9O;6@/19^2QH^D6@%US",78R!\2>89<
M8"OC"0RQ(PX RKN)2HF9&,2I)73*.(R>\(\@[[5)]\YT/%FI+CIT$FWNY2>/
MS3K"5Y?B> H_GWIPM(F2,V:=\@P.Q?<-(E?]SZ2WNX4E7!$Q4D4.$N0$KK3,
M)C&-BJ,G!'@F:P<[%<MY9NL<?CQ.35!7N3:7<!O\8*QO%[G4NR](;>IP1,VW
M-,H+=!L;O"\P^#,C@3V"W&^'V'5"^PCQ4],/E*0#[-Z[8#??:Z#<&]C6=M78
M,?KU@^%CNQ=2[G6[I_J5)R9)=58WB^\Y-4D^=;9*&MUV<0\@8X'X&WV#;MAY
M6>U)THY 12$Q]F1'J31HZ&['E?%C)#' K'7"U*"\,^PU4_X#\^<H.,"\IKE.
M0,ZLVKTWJC,<;S0N2)N8>1?(=^!7:V[AK(1L[GBN(K4<".&2#JE/MLDV7Y#'
M3@ R:*B/?$;_R*$TVM2VI,8IET(Z/T;.& )# )-0$<,9]QDS8EH@+G E_>W\
ML_I:_?JN#]=)BBRS>C"P&$ 4G_;A/ !17J^?%<SA"V=\7"+LT=U4M_2B+!_X
M]CS8YI2O9X'H.Y=-A7U/C4B5>@?E6D:279=K+NBP(+!3?]3">1_/6?2C\8\>
M27V!(2J;3_SR:&(I.+*$$F7]^F7% NP#TXU5MX8+CKN"=S80/S%,C8\0G(WF
MU*?;]61@:UK?*+D6'^)BVRP#AR:(P9ZS;[ ?>T<>'"_J).8P AD'5IT>-&N*
M]<(*X([[<<WG36?L'B,7DQ)YP5QJZO\U#ZNBA!/J[D[Q^/@OEF%&_[D,4R#'
M9N+_9T$Z0J=._D=0/5!K:"A77JN__O<PW*$7R"%RMQZ/6;.#_71;$BEC/ZQ[
M9.]KY(O<;RW$AU63O0XWO6TGB'N3HAP<*FLBK2+)EP*CP0905U03#UKANE[-
MF0\%](Z/$>FW[CD&=IS8+@.U+=_GNCPU=-3N)6_/6*C]&04UY]$PGWRVMF88
M?ICAF"/Z6((16G>@>= UMT=1<M7]_O0.KFY)1]QBWGVIECK3:Y:EHF98-GQV
MO#%N<>?BUHH$6Z=ACFK"S99L6S.Q2V-L>R$A2(VGFN'5E^\4R(3?T.%0\"U4
M^=@4$%^!R!0[!4,1V+'@6%Q$"?L55,H3/&>V%==1_'VBAN'C"1*YN"<4_SI#
MS GR"C<:HQ>[8*\8ETU15.BZBM"&87;S<[ZV9Q.7F>)=_@85];-B"MQ:,KEP
M:>_7!6>'+Z91>;EHPJX^=#7913FY91G99OX39"8#JZX3?-Y,[\CYOEIL5%OB
M_&P)X>\O[H-G&C";&?AA V8=HW/_^VWK>KN?6LFGC2O=09=QSU#@I>D?@S]6
M0S-9][G/O7@A-GU7T?#V73U,MNT:TW,Z[BMSDREY[U(G]O1VQ5)Z'DX',0YZ
M*L"E2$9:*P>WU2XP9@F2%TK;98^=%G@267%2E1ZZ#/5./3DQIZN*N6:%_2@Z
M)@?24WW8 V]U*FM,E=PQ40^%PX5W93I0(@>X[Y,Y'#MC: \K8+?4=RTR!_<%
MB,^\DPF1M&^_GA=^% HO/RS^$=678WJ1 W>.>"B@FZ)N_+17%9,4.Y>&_A:>
M,EESW*LKM.)1[)!8I=T'0UN*?4CCZ',><11M>Q[TO*K#I3%M#^67]!1&_2C
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M!XC6G4/UF,=BL(C9-87<B3Y'0MZH=:[*1!Q+N&?@B\68OEU%1IP%V9WOUGB
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MF)/5M;AY90D+Z$74&A$[[=R0X+ZS2\,HA%-1&.K=5?ACC_X\VX4:TN?YW]K
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M]J(??EWD<Q:,M=GDG 7(XO.CK\4:#V!5"M8O.>DMGSNF&O^\]#.\G"'^ZAM
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MYJYEHI$>OH&Q%D_E10DY'NY[B/Z=^$DR+'5VPB6(5-XF2^-V3+6UM@>^1N)
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M9O+:@,?H:I7J5&2>U)4NAC-/\+KT)VG:[^M%ON=UQO!J^>7;NL.V02%Q<4V
M.0L+]:1%#AR.YQ.]:2(9)-A68UZ#W]C8P$?-C\Z;7G\_7,!;^6GT5=/K>V:W
MG7*:1)O?R$!O&TW:D$L7-LQ)7"1A*,H_\S)BLG2]P;D'0NS-#[5I-*_I?O-V
M-9^&&'@L!>X@U:>(M9S'OPZ@SJ&91\;2]XY;G98C=U<Q02Y@3^M$6G ?FS 3
MMO7_$(MU.C-\_'8DOAEV)Z9UWOB92F21DC<:(V1[U>!.C=^;#,<"]OL8J7L
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MTG"\I!#K/I0FH%=^[:,#):O4HS+](/1BVJW?^Z'(CP]&_M</1K2SY$ R#,_
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M+.[Z6&AZ5 @1,5SI>_$V2!9*J8[K\6#1*#XX?JKI:.,BKI'=K?=1RNKA<S?
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MD6;PBKFZ_*MG\38(,4JGQYA,;N#YB1(+>=E;*"X:>+Z4?J<([!_O+[1^=,T
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MHN[,0 E[\.Y#.U<B_^6QY_^4F,,PVZ!<A?_+.PW]&S$0TE><L8L8]4^$/M@
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M 9P-T[]R*EM6FD+ H*R(&:HF [-38X4<S'>PZ,!__ CZA&1TJN$5F';+]NO
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MB504<TYO'"[S8<M>%?@+YFI5A>R]/FPZK?ZTPM&OTGF*9/DCJDJ()QWC#D<
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MQ\[W5&E<.U4#*^\D8#]])/OM40B;\#3EU]8BII'(C)8J%$/&N*Q+4JND?#3
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MASI$?\V9CD&E'2"QK',=YSWN*Z=#9:+'3V@_[#UI,M,\E/4)+)AZ#RQE.?;
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MT/HJ>XWQE]BS 7TH^JX8*W.DG]:#U@\).(LN0=_ TMM_ );@KD_;U:XW@N"
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MPY),0?6K&$?]-4>%[CALMI31;,Q5&!L*GM\RDG%+O6^NOG>_T<)EWGK1S+8
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M9\7\B9WQ * 7/V+BEUM \GLSG2LIZN_ ZW>UN((1=.>V Q7" ,VU76,/U<A
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MZ\)J;NAKUV97N](A>N6,5L%00#BLY^0JDS\HNOQYA-$'LI[:9=+'*:AG4[W
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M?$*_6W$\*R7,<9CGP0& ]FGL?!2GM 6$'&,:>L/>)C+^C(:_SUQ\7U?<BHT
MGVB-"Z3#>FGJ^;.F"IOY\66>:RKM8)DEC<O6HUI _9$MU<EF"OS)G0X =Q/
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M.)7Y(0%KJIG4W9EYEZF63)](=S"4??^U_XBOYE[G=^OCWS.N_ <*!XM_HW
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M_)^VGY)Z/N+<PFV*:JWJ'P_0Y-2OOAQ6YS0+LQ@#5=RO.8JFO&S>>#2(X
M'97DH/T4-SH/U*EY7.0,?UQ>'IT28P7LED@Y=B3>^0"0C[P9/A8R>5?P*GSJ
M@7VF"A-?E0/E'"-1KV6G+,<%$UC^BR/ZE9/>9T%8>&7E4SQ>4SSL*2#ZO])%
M_049_Z?M+P<920*4)/='T60]L%/R<+'I!M'SV5.$.?,ZE:#KV'%H39+&512@
M?_EL&$.T/W(U<9G@,\QC,V\/MN$A' -_9&W^IOTR4'Z\SE= ?X 9/XG63.R<
MI9=O@Z:$Z39<H]UC8?FC@Q4C-\>L@/UI#U3%A*"M/4;%<%0?V]?EF44=^L^0
MW?F72!0 *@26EK=^V5?) G#[?=#=<S(H34EJ),"'WO].=\(AD]@?T=B?1N#S
MM^:4+'( ,%A_AV,>.P"L.T#8@6-^ZX?B6<<.+PCUY3\ F(Y WW2!O[+Q^Q'Y
M]&(NF5<JQ$_YDN%WL@>UKC[_ VQL<<5?ETGMUP(1:I*\EG!#]DNG7 ;\SV O
MY(6DVTHBFD.Q*GR;]2GME2(,\".,K+FM;B:Q<A%MP)./S!]F@$5WY\3S+^^-
M&V>=J+'1Y/*7S%_?C@Y^XR?S$2L_9DP11KY?,N7 /M#;]8G"141^!CB[2&$S
M[,P'K;*\?ZX%0[L4E 51K*QVN%2Y:G&BDUO/'YZ\S' ?1?QBP8QF5O_3Z+&+
MR@+ J45&J_PI:7*8BWSLA9,MF"QOI=%1L8IW,)4Q:FJ)4Q.\0+D#@/NY# O=
M(1,)'1HE,0&*NP209I.Z&U=%S:*"U\1YGKKW^9!?\,S0+:WVJ(>=>$L3AU;&
M!+H6V>>LX-#H.H&-I\>ER(]8W#,().1^>#:5H1EQ1WW5PJ*T"IKC8<-W[YX6
M25NR0.=;V?LETS@I8?ILKIK$99+@NR_;6U<I;]5]9 M1!ZR*5#42BXL #%6<
M1F<O+ 456.^S1K^]00D4=4WBG7SHJPM[.2I,4U!GD#O#?KQ>4'#','NF\OQ@
MVFXQ:4_/J4.%Z*?$1)(T7!]TG_S;,Q1_*>TM'9VO9Z9F@,'C0RQ[.S;AY ;1
M"5*- )GY!EI(?HR,82*BK&'NXZ#Y>N8RY<?9VB.XA'E&%S5N>S[_LWG>YY4Z
M>:MPN0B'1@$N"*S&+<B0CO!H095R39*[_V6@0N0=LS#;JV%=01/JYS#<72*W
MG"OXJAG5HA\R2I".I 5T_O=#12=P?X:\\)F4/\<^.R6T.L'C'WS@@[O\FSK8
M/Y%?$B3'4^_$[^C%G_A">_F?%YL4R#8%[['MQ[_%@<;>7GHF16)S*--P=R]S
MO^3UA=>&7F-MDMC-<XNF%Y0F*MJ ?/0EI ]TMM,"[K]?RZW$PQ$U\WR=N,59
MZ [1(\FZQQYH:N<E:5EN#!2_CNJ43,%(BP2B)Y"&3YJJM*C_G@KKKV@_EM^<
M5YA/T.K+G*_NA=E<+]^[!5FM9RMYK^=\\;G@$2V28)MD1B&CA0*%S?.6]R-*
MUJBRK]ZC;@6%]$K$BW$D^,L-U]>W2?C;X=WLS;NM=G;Q+FK=T3=,\Y%\#^$G
MM CI;_J?[%X[ #Q_PM0$@GY[@!I_147_'[._',3EIK@M:(6F\#E?WZ';Z"R3
M&$21&MFZ9JL+E;AV.\U?P0NW>Z8S2!848L>+W:ORPG7Y\O6D(P;)0&V67;7=
MJV75 )TE7!#%F^P;R(+8T8ZBM*02CKMK$_=.&U0Y IB A/Y" X.>ZL1"0__1
MS&>XLC-ATJ F02!71MN044165]N??B_E@:$(!H%6+"?9@W>L<QR7+:S?+R:8
M(VFPKF5MGH8FR$PXTZZ&;>]A-40>;D;86B<+NEU+E"!8DV,4?8,.8LY9A5FC
MMV+;!_ H:_CM^^T6*BO"=?T*K*K>1)C=0N=M,1>8SQ@U;8@' +^' EP]4!^=
M8E?#LCE"[M>.,$S(I(2];X&X;/<Q834$;#_A3RL?67@"[5U72J=WWY)EB8V_
M\0V;HE]_M;@B3JD;TX8"+%AE*8^.4PC^GJXB.#'BB&/XVIO5[U .#UL6W'M]
MJ$8E]W^A1A7V1W>6@<#_[WC[MRG8AD@-":B)[\9)CL7S$3=G A#4X7P.TML%
M5"JGIJHPQR]^D:Y5HP^61EM IE(&'B9;]U*$V<?S!EU,2T_,O&SQ)LU?7KRN
MA\%RJOH1Y$$QO U1&SAV_56CETCP^$E&"3JW^=8PZ,7/=V8U( PBPC%&C[BP
MXPT[IC=,%QAF<&76])=C8?"Q"-B9@K-D@.4.&N,\72D29&;&8%[L$^YJ*&[1
MP/@12;5N=\%%EQR%8HH-\Z,SRV*I0J#>XGGZ(%%_4*L<?W[34_]G&+T>-]+I
M",>Z ):X;[]-K[+(.&"LXG,'%<_$;GQ?%X3=4^1VUR,%\UG=080B%_>F7Z9'
MG!8Q0\*]^Q:3^0_2:0L .3\FS/Z78<5D1@-_>[*X*<(ZJHI7 YCR640A)XB+
M1J,4^&3AKW951DL#W@9B,LT8.G.8B;&+C=#KJB;D$/9C\ S9=N+A]9EDCJ5<
MU2?NNA\E;C!>C5^$Y8[.,Z4%7.FZ+\ J*K%(^4 J*;[OG3&3GE-8#8 -D/EO
MJ6@CD?R;/OH=_C_'?XLIZ;]GV<30? =\_6]E7OA"M:GR!?'&_:<:*B 1@]+5
M,6ZV7)V'7"2F+(!E!P8KV;+[)1,R_?$\8E+TN-Z=FI@RVK+7,+N"+94WI\[[
MQA&L;M_6VJ,4#-*\ (MW&256 ?//:F$"F1]XIV02F8[9%F_S.4JAUC0IK"C,
MCJKW=LMQ7A 4W8^?V>$/ODN6?6L64F"UY:"YPGT%E,\FE)GY+!#2:/*K%O"'
MP^#?3>N*$'93@X[N,L"@6O&.:>.$-78M9]W.DXMRU9#1:PRQ6W<V#/#1=4UK
M/-.MOYSFGF'L[##OO?+M^6?/EWE\C;8; 6XZK5RFL48XY)ABR@,#OIPQ2]K'
M\I[#%6,N"?6=)%G@\&B30RF\(H<QR[BHY!I$2B.=9_:T9'86(O\.106:.MT.
MTW]5.A<]86D89Z4@8"QU>WT&:I]61BK=!H!K0Z29_Q'^R<+>%HV%4*7EE*;3
M/;;4BQ[*2!(@;*3WGSADFN,^HQVK5=(MH@LYUJ5/N7NA/&._,[Q7BZA5*&7C
M+BSM<5EAV7D!PC[ZAOM@=9\_=IQ?JJ<_V_Z*JJ?L1/2X<^>M"(\6W/695["[
MH<OMF+=W?:DAO\US(P?S8(+;!^!AF)CK2MKNHI?:??&Y_:!I:70>ZT.(,&JM
MC5T2 >10!R1>*CK>=>?>]0QL;\R@7*2@R*)./_$$V:HF[=:#DX[L_C+S*<<S
M>"+&5Y\*CX>\Q.^08)EE8=V&%8F(DK;K-;6.S8LLQ#Z,U!$6]\??[,&O]S0<
M55!P,A<;0 2Y7DN0?#N3+'AUCGF&=NT$(_F9%DEYQTJJFB*AB+YW+QV?HZ71
M1_\V?QRI1DB!8QM+,FP-?#:4F]H[O=)5@1%<=D]3+V\#."9S]DV@1N-$YXTW
MI([!RLZ[Z&<0>[7C[YSWR:R+HV<)("=BMZ!V5:4LZ7P/)7-=N1D6,1DF/BF?
M(N-?V52>L&^V"2-V]F5-UDLBX,_W4@@5_2P6.POSRK2B2 0$+L*";Q"4%<UV
M:G'+-E2FQ))[#^4V[BH^Q7:74\#+E[/2M,ZU>9IH;#S"LCM;$3+E96$3.8^A
M>A0XDDX.%:\5#-:AZ$QM>94\/'R90VU#W\H@M4C:NSW[#9FDF21G8%3])DC"
MOM"Q-E&[:6=BZ;P# -7[!_9X)YO81SC3_*A=(JI?-QKU04[2&\;#7/!IJ.PB
M)2'O-P!#$', R)5L1,3Y3N['#[S>I'3RY>6H."1E, ^M/2SO,/E6WE$TYG#8
MT6;P7]6,^KL]_-ZRWTY907MY!R-^!$C $L>Q T"!0_Y-JY3#R_4L@W>F=OIO
MAGYKF*O: GW3A<6(+QD.J:\U?DZ?A03^8'CWCRTF3HO :&""W56XV>;=D]-<
M=*GT!!_V0=U73!<P0GTGSZB^-^P>YNJZ6%A(#CL[IDE5[G%2@$4.UR[[5)N?
MP=?L^,7[NUFQGR6;ESK%I=2.YE-RB1_JJ1<>C^"YZUW2:\7.&MNFHQ/ EGU7
M8FR0"H1SK=(4DARKB"*;V5?G,ZCJ#>$$:'$I=NK#7S6<B44],[$J<&E('-:O
MNKJ!IC)O\.6BR3WT$CWYJC'%GU[(&R^[/]NW\&_"KICTHW1C(:].W[*VY$'9
M.C]HX>P!=$B<0=_23YT7H0A?-<S?@C=XDN)=T-6U8P\>G,"9H.%V)YZ>U>*>
M':2$F"ICITI(N+#3=<CH)!K[-B37B:;L@0"J?WJ7[G?]0Y&]_XK]=?JF*'F%
MOS__R7/,:**"6V8!)NYP@U7=R"%J3L-C^5N1X <.] 2:HB^E$/E5PC["G91[
MH#<E(G0"+L%YTEB#UX\/A9OGO(V9]D75\'#[NI^WK]L'DL:"0Z(%>3GMDV#O
M?5>"Q=FQNP[C>S8?6>8THE UON&-5!G>4Z6V<F8E0>;K:&KOVPLW@*@BF'GZ
M5B'/ #G.*7MNUO'.%+&_E$!67D"3TG]==?/GE@ ?&M"8(8CTJ:&,I:[@MI(Y
M?@2LM=1-;QSOK#PM1+B?.0 X^NH/%-L,*7$&$LQ"F/JAIYP"5L+>A@UQ,1%F
M *B^EIK^LI]%F47S7FTR"QZ%*PF@L#UKJ):G,6D2NP #CR5=FFR: ]0M4X>8
M%A$A1Z=[/_$FWK;9JRMY/^'V*C]"I"[?Y4X9.! HFE?"/,X9 [<7.:9&]Z$B
M'U1[5(XFYEA9IA,J\V[I)PC^$?XDI\(SSMIVHVW:+%G,1<_UL_2-."!JS8%Z
MR^H]4>N4O]S<Y>/NT@,V5>\Z;%QN@T:";P=H?ZX9CF_?BGJY?_'BW6;V.()I
MJ!3FU#&!4TA<X98N=%6?P&;9)/=X<<7L/9:/NX+>7<\I.DDZI6)#KY-(WJS(
MIUMZ1;=JQK62%D!F=3C9,]+\OQ8K"C+'*ZL1^M,^YGPEV0Y'M9JD$O@W@J']
M%F7*]53R\RW>NF/>1?Y?XGZZB)2S3-3#E3[D>F=9?6UQ_B9P:LG.[2I</D+&
M>53,BGF>IG3F98X0^84'2IJ0L,0>3^V;Y6V:,!I1UMRT9;;F6%O/!1CS6(1=
MS"V"JD[Q4@>&TXNU.SW@44&.D3UX<Z(12F4TPH@1=\1-@F">I)'[,_ZJ5K/#
M7,?.L<XWLFQ,R\^G+>V]7Q";0!WQ 6:^WYZC@NM4^)%726BDJ,]]EXGZ0S:*
M>NCO&NQVOS78R?UJL/OWV5^QP4Z7]P!@T+MC63OW:!9R@B/TAA &)HTQ>][N
MN0BK'HLJ7Q]+/DG2X9 /E-H%N78X8S<QKEU3@I;4)0CJ.UL5EW9PE6];<[*I
M_(("3DR'EZ03R@1AF/O6U4YG765ZC%KP=G._%$E00*)9#,\M\'R%)HNVCAE2
M<+P"-^ @;WF=%%1-?G[I131]W!ZHJ&SI>4CSJQTM\9<%<M*GA%1UC9_R%3\J
M?XE!KU.3"09$=G1CFQO8.59XKC/2$_ '26:K:$&KPR_T[L[$3F%2\@A*RX'#
MU9KUC UWF=',<\M2$VT*.;.+-0";R3]ISTAWT*B5GL6<6)8;?-@$QWFK.['B
MPA"H2[*=).+'B9I\YFN6-K)*Y["XAWO9=/V?DESXB,4A'5 '.NI3E'TG6!Y[
MB#DK8F1CQJY6SY3VLP\KQD*B'+I/!D&H&8I<PQ(TH]171:@0:%%]X1V<Y\:R
MTW7/.0%@\ZZ;X.J)F^5L9Z>K.:"?=IW%N7'4&2([5CN=XH-8!B;28(;AD>@-
M+OG<L"6;*&&%^ $;CN49WSC296J6)A;# I$KK*>#^ZMJF:*&Y1W[WYONXQ<6
M=L;RNFS)60./)R=9(SRI@Z<$<MO<CLVU$55,EP#<B^9I+CJ5Z_MMJ7+N+V%8
M^K'096G6CFDCC7%C<K\\<!*P<(U_8Y=CF'X4 _$+,>P8;W+VP\.9T7%I<(V?
M#)'%\"U<ZEO'NO)%FKEE-?+18/55P^6XNSZKV_TW-D.3+;G]YB%&F#'6P)C1
M9U[=",3-4=^2CO?##Z<F<"JC+Q_J?<;_+CG1/PJ(@C0_=5<-FJ^[DB;_J_'J
M;Q[-Q_F(9<3>8">)/R)ES\4'+G[Q2P:E/P7OTN#.]A=):!XV:@+E1WZO7O=,
MN:W2^K6F_3?J 3H2*. \9/Z2>%,UM*B$38E3=]6U0%QG6::AF7JGDR35YRG'
M8IBV"^U,'384>R/HD)&M;U#D>.B)0_(X !)]=8A2V 5I\#PV8-7P8LRI,%()
MP-P/3OC]9D)F Z=FE$%1?;L2L<2RH*HL-9:6,TH 1,0!X.[Y"BYP]W/6NF:_
M]QBGBN[N\[[:>E1W XM*_>4ZKBRA>6Z U1>*H\@SO*ZTSBRX9H1$)92D1UB8
M$D 8;#\FO 40F1U6<X^6IA:0-'JHM#JA%NV;+"2GV864WZX1C+$+7%\%2[9P
M[:]4CM )TE4[YV[.,%LC=:)1C)FGK9AAYG'Z27S.9: .) 8,4GYPSSX1CY8/
M !^D7Y-N8ZX'/]"=A0E_.,*I@MIX .[E[[ZM]J-#-W^1VO2_,;W:<B.[5VV:
M(#M3'&B,]0!P>BC("ABUK!ER3_8%<J5-HX&N@QO05"RG[]O=_N$L\F6/1'-U
M^8EC*$ NR-3465P?5C=:Q;)>S?&2&/&%PN2M'V!!<_V0_8;F;7OV?1NC-+=Y
MU+J/81W'+1WOVN[RJC;9EK@" 2#]!6XJ<46-D KF@F:EKL >@29XUJ.7LOF;
MI)^16B3)LTCLDBJZD&%VGW69ULZ_VI&EX':_V+$RIBSKLVUV,@5(%L#.!8W>
M(S/8_DYI  Z%T-05/\*,40N9XE7H)?7YIYG.F[\8+?[7VT\AM" ('>-22FW.
M1!B&F>U.[^"JYYT\$QJ\#.\ALC5//A[S/]=VBKB"M1K^UAL$)V^J(,3"I&M>
MNW18P$)''6B(!*J>,,]61D;3)V23R1@F;-VI?Q=_2.%<G8 N<R1X/*%O,L1K
M+^8^%< NGV6E+-VD6YN)+ M<6XNZJ:<G.J/((0M/Z['SON<$826 S!"YU( B
MN2TU"!X;)$UEE:)CPU8UF1#/&-Q&\)O+HZT0@4J[FA+^8&/L9'/^M1$;#MO*
M<]*O"LKJ$OA4=,.(D9A@<OI+./L41Q_0@\Z/;YQR&MW(Z\*.'-;)_\9)0D"_
M.-D +5]P:#"W-&0M-(.AG6S?8MB6/>.* ML U^>'3UF'"[ALXQ[!9>X659U
M#<;4>4Y)$S\=GFDOC#$(># @6UAABH=J"/Y/S3!0]LN)(8+(]07843E>0(=I
M$7Z1*;GZF.QVS][Y[@Z^EC9":6IF,[LR6_:^U8Z0+.N"M[>J\??UTRKK/5S0
M7$Q4*9V/%8N$'#A-<O#>O:FJ00>BQ7ML*9DNP\=Z3P8F.C',&4#7T:'*!O[2
MQY<4.][O@30TEAXI<LJ"U3_FN\FJ#3[M7T@S:24PU>(J#;UI=Y\09(^BU7(4
MRMO,I=:%, KDN?>/D[ &<@PZ'0 06L2-#%%[)1R;^-?:7U\[#DL!6V-GS3@V
MWB ^UY6;,\Z%GW((0E,?6V8\I+A+^>(?/=WY&/")==[@-_Z1E%_NT2_WZ+_J
M'NF-J/M(::[;0=B]QOSP#E'-R8['(]!-$;KSQAQAR[6T4 [12 %FC?I$W\MU
M$YL8X])^W$> _0*,[4B^W6FDBTGA5D ,6U65%O>%1L;K8S>GY?K,J;CV,M76
M"]SQOM=J!@^J*LU&D0_FU2D^HTF9H<SSP?#ZTU0(X#JVO@X5':UULYH=Y,]Y
MI)-+ YURT^=M$ZA%#K9,XGV]*H5VOFYX*$[J'(9VF:]V^DV]!Q+P1NSF?!1T
M$2M2Y6R8;&UC;Z\XWX:<#I(88Z 28)X9N.+[1GP6RJ!3!SY-(_]TZ,^ND?DQ
MOUSDTB(#'=O\D)QR1<1\@YPQ\_M=+0G'^ZDQX^SK,PIL72RCAI/M\- >"^(E
M_"ZZ^$&#=%)UA0CPQA,KM*\M2ZVI/KH^=%I#RN*VJ+F&Y#U*9K,[T6$KYNS6
M78U35\F.>!:$^O&<M2%G+_DH<WDYIL%R T-;I@!+#9B'8= ME^_O:$FYP"1\
MWO0U61T EG<42G"(>IX29Q:UQ@_XM;0*(;NGXP,JZOU2$!RV=.V-M5E36LJ,
MY6<M[D;OZWZ(];I!%Y<MG-VX\N"I^/IW;#CS"* \R7D=;;B%5EET?CO!K+[W
M6>))&*AD_PW=RTTO+>Z76,7L]NY2@@)KB=<10RS5J]I+=:W-$WN@4PA%EWW,
M&MI#SMNZC&G&6OF1TPS\[0%@E,Y\>WI'-_ANXB$?'E$'LXS=BX\VV'Y=H15*
M+[WD8UJU<W@4]:(/*\,5$=E*.!WC>>GYJEDPWJGHY[6<,_"]U!RYGC/:$QKG
MU4E2BH!_XO78J)UK=%1@PC\*\2-0O,^#OKCV#_/WEV^2BED1].HSN]%'E3]1
M+KB[3D^0HZ0;MLWS2>CMR2"E/SJKG&&G@:_\,EU[WN=QQYJ2A+O=$!AW1%,S
M+D/87?;@(A>^%:'1#AWEL_?J=X\X9^+O,AR0HKC%29D#BX9=^#"DK<4Y!,N$
M(XN>O*0GK<!/?D+1NEBCRH0GPGTUM@8E];:!426>?N$ENJ3>D@#=99)0__?
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M8? V[Q5XN^K>3,%J'9EW+UJERY<EQ954?*#29GSW-&F@0CPN,HX4^I,73[H
M_$)"_XI&M5QB1P#XL-_U(DI*5A'#OWSZ-O?I\X;5EU+3KL([=C4M\R*=(!PR
M-NY9@JJ-%VZ1/.1D*HAJ2$CELY?M]XV@^AS(M AIKZV'\J-:W'$8*Q:6IC!U
M''B43?J2E3LN:^ \5\A5K9/72XW\&S5_4O'27X_ D^9>6&O?Q[O]S9%]^9>B
M@:FZ$':2L07*\ IRF),P=L.%CH!)<FVJ$)W?6O;Z,>XQW)=Z,D2SVU]N@,T=
M86@_KE,6D@W:;+."(6 77?#[AH$Y9>L5*13QS=),^=<6/%/%:VVG-7+TXOE*
MBD?(9%7%@E<P%SJ]3]$("NYH$9E3664=T2TMD4Q;ACYCGC6+R+K_K(EXN.]A
MWFRRS9E&0CD@3"V[XEH'M'!T@4[MIH[>>L'&>%V-[?:[D>Y*>>IZ\J.Z16MH
MRV'F[OWVG/B"3Z(AO5[ZLB8G"?V)8"?(OGH_.MJ_UY@>$;_$?1Y^>_E*X:3R
MELW,>FX'G]04-KQ1)OI^^1#D1&EAWFO)>D!SOB+<P<E5_-43X86:'K?8>5C2
M:#458Z@' :1#JKS'GEOZ96ZE7FR]T!W4^N4+]?>9MK1--W>YYV(F#0+8&(-$
M3 ,IX.4)\W8%+@/E^2R-:.ZP=[T%]PSNB0_XGZMEA =Q?9#TS-B)*].E84+U
M+]N-QHP&>?514\^.P!];WN+S%WQE)QOQ5N)M!NK=<V=07_XN#_M;MJ1JT /<
M+GA#J^&T**1E3=@S1HDHMW]7-L<GU7"JS7N9(FOX(\4F!K8D/^KCCSK28<Q&
M)"PE12RIT%L5G \0IG^4V*M=X6-%8)7QOJ;8GKV8H'VKT.6F9HGW[%AA^&%U
MI2\H6BF:><%<!I$W]7LGEOGW$J>UW]JRT,RS6@> '/-,->V77SJR?L'/_Z()
MP+XE$*M^\S:5V%ZLMFDLH@1Z:[;3JE4_BE9ZC##,0*F7<,FS(]Z&J5;@>B/#
MMU0K7_JAC/N_U$NN\OXI\T @:"WXMVN'ENF5D^?5T$>-:6N6&*"J"[T' $H7
M9':HP:!'1U13!0ASXFF+RL.=3I*<B]=(;@NU<*YAA)XO/X@.7@1#9Q:P5_)2
M_-;15(U#VL[-#.$^N3S&VX%7;10$].\=!D,_N&&.GR@]C'WT?S:*5.%&9+U]
M3?&<T FF*!)F^GHS:AI:Z1'6^NQUIRS[7E:(7&$9<[[02OZQQM36B$.:+>)'
M.<+=(FVH(S9=WR_%OWO(?G.7/34C%.9Q3V$<0RF9GH;W]L<[2:)>X^'Y2 02
M$W  N(TM,-_:WX7W>5/OTE-LL(KO1]:J>S]A<KE<S!3@&T\YV7*7Y8AN18]%
MHC1ASNE JMT%!H/5!C4"SF=/[+RUZ6,L$&BJR,%+89*?TU)[BV<&CF^KJ%=<
M0R:*+M5E536_&_3(!" ,(R0F+T\(>U:G2YRM)ZE&=D1F*DX1P%0S2C;9#QMF
MR4R+$^8J%J"5-2$.Z>#3+D8UI*$/=27G^OM5NTZ/#@2P\Y\-8)[@;]T3,">D
M ??MQW\ROUJV_R']L\+(Y]O^<K+[-!9?]7.T/^AH[M1V5]=_5J#^%-4:< T
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M*B3)=2I\7^&S^%U>GI?06Q?\:VWU?]F_:"1TU8[HHPA<8#S_51JI4]E1>OD
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M6Q1)':JHE]I]24JOG!=XS(Z%>2SW::-2D :_@.W<TCD.SCA3^T+LO<(/4=C
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M$$@\W%CZCLD72%=WYE816'7!X819@D DNFPC:T^ZO:O*;_&*>LNN-9"P^</
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M+M>:P1A=K\TMRK8SHRX->1/0ZU_<I):EP<3,ETN1X7Q>'.#>CEUKW&KO?8E
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MY(;F":BIOY(Y4)W1-.!+K$G9ANR4\"%.B'$'1/[T&;@?:']?>7-&P*]$P<3
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MER)5YRJ./>(?N@6\56LOM,K"&C]@/9@QT&&,GXU6*MP"2HV+YEL7$Z+8D[:
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MA9U7[S<Z-L_T;ZYMPB/GJ;+$VQ#6FU:;IJ">?&Y\&KAH4H_%<PO QML7_!*
M%/IS$MLO1;@#D4QAY >RMX#=IDFSIRQ0[4D3=\@RK)' *KKB),*CCSC;*/"$
MQ#):>[9.'G817->OU^LJ1CV5#TZDH#2"=^9+QU6F"W2>A#Q>D:&_MP%^GV'3
M!:RI\YR6"!<O9ES[\[?SGVI_*WJ@KQ9GZ'4P_+% N:H<6U:DKZ=4.U\5DOF
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MM^B@I-JMF",+[N7+Z O-SBH/=3VR;="\6:_#."3$XU[KG<TW=C]EP(##67,
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M;'*DQT"]4H*BE"Y@)P@)-*LEIX^\^U#PTZ6TS5O#NV*M3JJ3^2*:\+.X@.;
M-<NU#JTAMK!A9Z[%MV/-(8Z)O1[/<0.V\X?;G+3='HAYWN&X!C<I";KE0;2
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M#W\/Z+WB\A1[/R&W&$3-?;U"GO*H_99'P.$;AH'V1?SNDRG\,=G?14?;M)Q
M? 6?$,#H=XP\/L;]V)&,+4!:C:EZPG6/Z >"<VDVH_1LHP1F<-.D^6<?1L4;
MUAN*!UB25[@0W3'<5?JP6E3/^\U ]G /1@%P..NXL-3H]QP<W9JO,^UE+,X5
M.W"06AE:;G$ KM1 QTB]0(YF6#U:)9ET:*8;XMQOK1>6F;)T@_00<NRF%(2;
MZ)'Z 4EG6O]F615EYUT^C1%K$(,$G-TR:PU3^_L,ADI*KX/N$BY'2@U,]GW<
M!+]*;RVG).UL 6C=+S41$WD@H5^2?M'?[KBS_KS4)(D?0!WZ%*EG]$W4WY'A
M(YR(!&\&S/1]SQ2,,?Q>V1LD7?9UJL2V>,5@\Q+$Q0*/^O>T _^Q7Z[IO\$X
MR5>+%=OYV'['P,?6JAHOB4!#U<F>F[LRGN#P56O)X9@FD[J@LW\CM?LHW34M
MU,VKV:<IJ9O(&B.81:_L<5<4> A_T_F*C8=I(K?*.]BB2Q-"EXPXUQ:<*E=S
M6.H*S\"5QE'=H)[X.?<J211]QN.771(\3,8=6DZ*0$@%\2D*YU-,30UDXE$G
M/,+/$+;TR;(*9?)=7K:YQCFW98XI %:[5^C@+HTMN30G2F7DR4S&]>MC2P2)
M\\ZE7B5JH@1J6Q>:;Y&]]=-^U;_SY2B:_L*#)J$.,)1KMF6HD^U)6;FAGW-*
M5B7QV@#37?4N694%3CIYQ>8Q?N+G4>9",92D@N-LA"T)U!:UA@\H5]S)1=^[
M]V'@Y#HDME6%QU;=%%1Q:(;(GN ,M#9/%>//@X;Q83C868-NJ :C80PE,+*0
M1F/AONH(46(\+0Y0(@ ;QHSOUE0]XCL*X<+[LR8;CMSQSI.#12NK;FD@A6]F
MY<'E8G0K*]S0I2V 8K,MFFU<_3/(J6P'Y/3+:.(?^[>,'_8Y,L[[@G92V%L\
M7W]^.I)_NZ)?H/Q1Y,N\?,?S\3YGR M3V3(=R#O:N:HIRN;)*^T[%%[S?+])
M^$E$49R2Q5(#\ X^<SKJ?<!:C[D(1>X)M!$UZ:\D2%!P>!F=&U+6Z<_>P-4N
M6AB;Z6>*H*S.=Y6N[DIBFXJ:">ILQ(9'1SK!XU?OU",RH/'=-VY@;'*%WX!S
M?0SE B(T6J3Z582L6#J%ZBZJ)*.UF\.$A_3?2:8]B*(I$SO[D9%H@)D0>&;>
M>3JKK_AX4$#(;LJPP@:*]FJ7KKB\@&+1;C7..F0J1C3.;N\/ 5@VX7$9LYSV
MK"5,\W67N\L.S4*N19M;3:N7-Y%EG;'B Y#I>@W^=C<4:E!A#AJ?I^=_,L!,
MP/2G O>VN,VOYB8.6X"_++9FI2,:0C2DMFBE3N:^\JEXCM@NGIL?^2Z6!DGC
M/@EP0X@^\6;]NE;%)=%=;.*<K8?/A^@M):.5*(.RU4GSUX(5NK5$T8JTQ\ -
M& -&=UVZM8Z3> $9D[Y-4U!7#';HX2*3JT"[? F:Z=4LI$[T$$X_(610+,*T
M5_8D,#668A>1>C+ O%\RFCA'EB6=>7H!]3HGD.G,B&Y6B[N,Y:R>_Y+/6@=7
M7/A(WA; ;#9:;XT<X%43:#!EG8#ZWR!I\XP'[0_57.)4$<RO1[Y)\)^G!!;Z
MJ)1+@@N>R-N)"#D<NO?Q;:@$VJC9(C\[ DEQ8MZK_DZA4!YXC[L3Y'K?1&-+
M-C<+:+@ 0"A]T=].R[T(3YN5VYS?A <';AJ!A%+\+DV2>HV?EZOFX]#^(KJM
M(-L3UUJU)K?61):'X)KU#3Q8\+Q6=0FW@*::D9#-0]]J%5VR;8PGB1C["]3!
M?H3]#8<R^+=GVMW9>&-$0J[8.WZP>U_#!-%NNT?>)^Z *D*)'&9* N5DS\8I
M*_<*OIBUS4^,8!J,Z QKS>F$IB2\0.0/)X&ZN[0SLEEKYZ\LVP7I)?.3B0]G
MLF.K'Y(:PKRB#3:C^:WE6!T3O 1J%,0;I+VP^<_8"T;Z5+RG]JEX!EW)C? Z
M(*@LOZI.%F'6Z;<4=^L0$I?1Q\IJ287'1*2."9%.INH9M4&.*M^))'4*B_!C
MN$IT%6[7I:7K?E3!>3G!G(6^ENA@ ;BL,T1"3I586HC#LOYDRKO"%?E434#=
M-,:=(?Q_V;:5+,)&#CIO*_>%=:E^!>Y$T]%\-[N@+?6])$>3:+?4UU+W-V"=
ML7^+&_<?^Z7];8BGX@@YZ^X=Z>L:3L4<L9&KL9&56,PN)(^G')4#JLKB:5#%
M]<8AB= A!(JCW/'MW0&=#B+;%'TI'^HVHLFJBLPYVSNJ%K#V#X;@>H3!DE>_
M-!1C,PD=UKME'$UWL> -<OB<G"3JS.6FX1K^A*P,5:6&3LX.N$7"&0?6?LXF
M,A]QKS:ZIR>8$@V3U4P5!Q7!6'$Z2J57#SWG4'N@35"&+FUW<;%&5M97;%L
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M?T2'_P+V8T2'U1T(+\44_^:<HX<6AY)_@"7X$A*H5Q44^RC8;?>66_YRLQS
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MSMAW8[!#UP[X+XX$$\>@S$X<CJ!J="1QD1]X9C I^/AFAXU_#M$2FGE&8>"
M#/S=QSYG2I<D^NM_@6SIA]C?DYY^VY(^^"H?-5?A!\FH"DO2R6OX<QUUI&R+
M<1=02N1U\8(JE](*+&SSQBK^]T6G?WKE?PW[V_3*OUM\^Z^<Q)X3J^Y>8')%
M F_Q58%-FNEFR6S]E$4*@/CN?<6)OU-GXY\BVU_"?DR1C;^>,13806/\7GVQ
MWS>0V@8$,\[<5[\+#L/:,&73S'48J/*GM5$"LYMG2DYK2P0NO%2<H>B+.K*
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M45.M-G.N+3(9%ZP$+82/=5!5.0)+:J WKE,%1>=YNZ@[_!%<W?AIY-(#DO<
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M_;HX:*R[\DQ/,K4A_"<H#/@RNLY$ D/+VG:#YXY0FRUBJIT?// E*$+E.+[
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M[1NKMG3?A8]6ZNV"I]*31MYI?0DF^SWKWQ;^(0BV;[+K0QP^:=1S=I>C8]>
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MI8J E_JJ]D@DB8]K>GS2J(%43/_(*]">Y=3XO*?^VP%>Q$F6:XB\6Q0Z@7L
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MW;"?*',W+\(VMGCJ9\]@SD]"5[OJIK&T(_RMY7P91@WW;!G.!9R-^'QI$+(
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M'9+4'%+]GY+@/Y/]:\DXOR6S>AZ4PP%[N+S_[HG;_J"7EL&"9<J'6Q\-^RN
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M>7*C6ICL <]Z[G,"ZM-78H-G/3G6I*\=KN>K;-==/OV2MLI=SO$E4QO9]0[
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MS#SBP7Q=$#(#:Q7;,I2)J'(S@=QG-*-;(QOH-:ZC1=X=GKT5<=@.D^G*%_K
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M=)5,@_9.[(B)@H*R;PW1-_,+UC4"=;%\BD)[;@13M<7/@#;4>_YQC(:_3^R
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M-?B9%)=FT'L1ZF;[[8Q?U/CU!,1JN 5A>\N&73&DCL<)U%>X"ZS?J"SYY3F
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MM"VR,7S$S9]8'/G9=G/?JP+ <\Q\_8[H8!L-,2^3ICBQ_ CWF#!TEMUIDT%
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MS2H\KX_;>HD_#%TB9+Z-5_[<@;2_!"QD'4NJ/>Q$.7_3&/W"=:"-CRJM'(#
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M4?R0]NQ;P@IF_@Z3HMDUYH'[;GPNS(\G1<*$\8">3;^DZ 7O/J\BPM4%6YT
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M<-9G'C5^L(J0$PG</?<\*RHQU0W//\,7A /><><:AX"R6;&Z?&A^BP4PF.N
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M+&3+20^$/+@@I30K5"4D'<:%\ZS$T !KP3 QN&A2Z):]4;15T,NLDK[[XI>
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M;8\K6AV[VP@GA-X)C)5X[E'4.K7*KA054+H.<%!CN'0H^3"U&P/X/H(:"$-
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M(OA$G)Z[T ,)!T^7')WC2A8":<B9MP+:(XZ+5D,63/@/NCVEE0[0MB&=<2"
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MLY0Z6)LE$%L74/Y16<"Q:TX6EAVM_K\!47+]N5'0S^'(QN/K/QD@K4:LHAJ
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MAI+KK.+Y%P)8[S\DZ)J0CJ*60^,O!@!-_(^ZGT&*:,B'!Z;:6Z24,PND?NN
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MEN!I#STV95_-ELW[[%U'6Q"'MJ"4U25T0B)?G))>3X+M4*%AL\%5Z7@1T(&
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M=+L88G]4YNMD]/AGJQWA1L*-A!O_>VX4A@B%!(1WAMUW#FD4ISB:HTR,<L!
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MO-EHO.4W#<6[3HI49K^P)ZN([C+IFUB\WX0;PI^<]\.'X_\>+K40M_X$#(;
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M3OP1UDN[_QM_3=H+*N'<"WH40[26@:SM=C)!+-_427!9""R,/T?AW]F#34#
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MI)39PEW <HLV61CN$[M_]LD+O^9S"LS\F4J]?.NU9ZTB2H$ -27 V)^[A9[
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M!0K=^P")KJBOUB4-$IM4.#A5RIFX[\TJ4GB1,RB5NE9[QV .Z4KW*)B[I-%
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M.QZ .$!8'W_%Q/\ME0O%^J]4+K[L$%4N_M-QE:AR\4\AJ0G9H7:*T%4C8H(
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M*,_%DUJ Y/3*6".>4,IDH!7W(NK)#CB<*S$*M;\F@86_&=P0%F+<20+9QYQ
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M M]H?.15CR2N0A!7(?ZKJQ D.UYD<5S#-A9>C.OS*D'<GC_H=W([L&&^@FU
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MN>OX/!3'UWM(MNFXC\L2.HL?PP=\OCO3^U^#9B=XI&M#>.G7OT+U=O+UAEL
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M@U%P08-TY,Y(7([D5>D@Y?E+4%RMLUD:JCGV((BS@!G.'1]6:L$1YKH%^&6
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M4F5+P&V?A.J428V=&N>@//G@/-&*8LU)^I)6ZE:D,GBZT?:]YL8]ZXU7Q<J
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M44J?57JF*R!)4H7+>4M=P3+"WKM?X!@'MMM=C?NR)Z*^8-JE:0E)/H<-E]U
M])8>?.OO&3WD2HEW%T.7M50E3K%.0CC._ %V3*R7_EWQ+:IHF"'H@_76]!Y<
M0D W.,JC2(;@4E<ON[Y;-/#M#[F]U(%KV4!L(.);[9=KUUH)W(37+$'5_CS>
M/LN"-&C87? %)'XYIY-/*SF.3$59VG6MW248"Z%_/ :99ZAZ4*;N>ML%"%F
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MBEI>D3G%[:!RE[GEVZR1]H,PF'<B:QO[7GSS4^13U<.SW(ND:7W6,F?^Z>5
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MQ@6)_R8CV:^A_UT14?AH.JK^P89HM:S#4K^/;.EV9/F#0<;2Z!%%(AC,N3!
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MGZVW&C?5,+%I/'&2O!#K41V@'];2[B./*'YLS?Y>7\<_Q9TQ4-(7='P/:UT
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M>G)Z75BER/=Y7'BTXUBW7;,_W?U]2E>T(=SUGPXJO]D)Q6)+2R\:/ G5V!M
M"^QGAT7<H?N;OO;GVA7Y>9*EE$>U+I U8'8N0*6D X<"WA6N3^P;>JU)"&_V
MD<D4C=D$;N;PS80WAR^K#1*725TF(ZG(X<OVUWT^,NA_^(\3%];UR2:&?*3%
M;]L)K$)O+[_W)DQVN(BS0.S>Z-=KP@@S;!,V5V?\T, [JFVV260DL4T8WX:0
M_.+ LKG.!5J+5HDQ>F[&I[1M.?PJ!%D1VAO#:5A;<)!=Y> M<AF9_\QICC,&
M[^.K \L $^DYE\19JODOGEB?A'=H&?D<V5IN4:G]>!Z+B:-KTS8&QS))DL%'
M5BY2"4!Y<I"W6"\XL%(%NN">9:UWO8<M!7(\]$%U^QQ"/C#<_0SHJ@[<!% E
M<A.B34II3I%ZZ]7=OO$/!KW,S"Y39+W.%;.YK,25]6$*K(.\S(U/6;:J.<.R
M-621)9Q6/!&MT*1A'.^?1=/F;3MA;O>"GIR/])P -B(:?W!<R)876D/KK5?U
M:5!DM_PDE-Z-6+B!*/IELSBL6MJ9L3QO[!.*,)TWROG--EK/5!@XEA0T^J<O
M.7[B)[XB$U\Q06^X_5>JD)OMF_-9 >LUDN,-7LP;8+QI9?35$"JA/&7RL& U
MT3C/E4F*1?N"S^^99'4%0D[4R@<!HWD:^^Q9UO.J)N)W,[RZ[AT]>8;\B))N
MX5-5LA4E 'FSG.W@^=T+J;6#UXP]HR?;Q\;JIX/.+E@8K.62U=C(L]'J16V(
M%G?D7O:E:H0=[U9ED]>&0BHK,=1#X8WL&=]Q;>9_H0[8#XS1T[+>DK,.^3*,
M./9O>8Q=5Z'FQJXD#MM'C"*;3_M"5AE0)*YJT__5D7QRVY&,L2I!?N.K<*?O
MW,CD_QL7X'\$VIK"@3128F:(@B1JKOA.LDCL9#!Y01/<"KM<FGR$V3O/M-9]
MA>&=G-OUQ/2RFM!Y3C(>/>+1.Q6KU2L=0X20X$U C'$4[EYU^DU#&N,15TFZ
MA9WA; T'S=W6)Q]TBO>,)3S FHN@='5R/%I!=!;Y-F=<I%CH<@B6=UGJG QL
M1;RG &<9MD=MYY)=W9?X*"<HS?BDYL/NM7R*KL=ZX'S4^<0EF3W4N),2;%_A
MM<H2ZU-LE(@9\M$4"_)7=ESRD=U3FQ]BTBSZ2CQ99%^3QU*0\[6)]V+(B@#G
MI2#EJE:)>V^E]?Q2] Y.[GN1)1*G=<2I=E=<WG'(V;0>Y3J%6L#%G47@1=['
M<I8:V_NX@ZV7=N:B%W;2J]II>;[&1.(3"T-J*HYPZR59MRBS?K"J?0Z82BQF
M78\793ZRLL74%QY7+DCF-=OTM)^C:C(BG'LJO+=U1]1_<DVKHD=Z?,P7LKJ^
M;*3Q5,[S.&P@],6D-ZQ7N_J^;>(?E9,]_/15BO##PM<:<10:-?)!PMF5O^GH
MB$A=V)] 6D.BRV\6["N'#2[R48?6W-P0?7U?D8Y)+^<*L\(2J5M[]K-?/D&C
MF3=;9,6AV5YVR83CPD:;II^*'O\'# -8=39=AT:SO<0$?-;(A>^PJ%I_UW[X
MC>Q6<N$>S+]2L>WOX8\2J%:\ZLB1L[NF8(I<GM[5%704_4Y6T[(]^9T65>0D
M7! M<H\*_-"\?JBA86UT/JMGQ$\R\B@M@E.<X1QCGR1=!XG59:)F$K9871IQ
M97TB;9V_ ^5,ZLG4"UL"-PY$YON;0#E*!CQX,(%T@,R$V;"FC0Z5[?]JI:CX
M_*VQKT?)W 2JY*27-/AFPS4V.B!L%8,''Y"^E28>-,I7AY))^7+8P<$WX;-H
MX(ETD-7=J\9$ET"WC++G)P5S#\PNO)#([=9O\JLZKP3H]+M:YMI)"?FQ2SU\
M-E)K4O#$S=$7TO1:5E/R(C ZG]$2+ 0F';0Y&'*_[C0Z:OFZV;J@+QOJ\XDF
M$YDS*DCGG?'E)U';YP48;9VIP^?VIO[]]FY_#?SYQ$G-W6K(WS1W0L03>F)+
M28QQ^_-.G>7KE^3',?2A0K6[565NC.*P'N(W'7H&=05+%<_.KC?(1*1A/4S]
MLGLHS@7M<&<?$[&A4E#_XRCA%@Z(_<\1W^ Z5CKVRH!:6PZJ1L(7!'AH484O
MX[7W%M+#%5#7VYO=9N#^PZH[3\W#38][SB]B+%[<#.EXZ:B^IR\-#?CJ9339
MV<@$WM#GRCJP#+O!P6'%3IH$6GD9NLZE4$Y\VLDV8)M:[C'+7=/ JYGB!4JY
M<T7GAOI_<@CYS:'E9S3F3_RE\&.B,;_"=UR9*N7?8UX_RN::^18N +P/>EY.
M..1HX<#W$' ./R;NJ&$4)92.DRTF7*,$@R>UE(86^I:V2<VL @=E3.$#/C;E
M]_3#\SD1'?IA[^F8()QZ.J"[=]6_)[Y67XGOF^^)+_TF@#/%B@>2FD)Z&T]B
MY/"M[)2"F^43G\,DHT?EF=<R/MMOM?9U;@](9\^"!'W8;D F]0[G"110"4!/
MHH8*AU[T@V6 2<Y!EN']<9'\"_M+VTWWI,Y4K';FEQ_1J-QJBKL^:^/KY8B3
MCZ7#FPLPI88^>X. /"7@_1\?4LFD(5BI<15^J'R_$("W\T@XA$<CGX358QC9
M"$H=N2U-UQR?6)W,B:R1??4FYQJX M*HH"RC,\62G,)"IY$4RZ*KBJ'2/M>G
M/ $X2K9+.VI8IBF[L9"E)1O.%,)/X4N1;*_VAI4:*4?K* F6(:IEWAL\E[]X
M5$'H:7J5[Y2Z<;:WF'^CZ4-WW4U@4,QOK1'"B8Z_S],I-A>"CUI.J,KL?0%;
M8"/H,13VB^[4[Q8;"2TW@_ R95J#K>Z&]3R/$!=[ K\[Q)%XK=<1CD(J1 WY
MAMSH;9(3A7>HUS$<S(E_R6Y9+)P6:CX%8;BM8%T>S5I7K'=1RM+6M9#*)L?>
M*,U*MI5-1L0E8Z?7L(&=U%*HK[CQO3MH1/.+$Y(4X:9ML@:*PL>@:6.PV2+]
ME:P/H6#=NX)\1R?A3P;I;0KVBD'",?ONG/7QTS%@"$VG,8,C7,X/H@'8?RJJ
M+SD35?]D57_B\ZMNV#NWL )B7F;, V*NE^WTMTU$NRG0O/95TN;:ZC>[\(W4
M(3XE%H.+_VP&9>>-NNC^'YJ-_RB6*U5G\"1O)]D168,^R:3X)!]9XDRU.O_N
MIYFX6UI\6S)*)PM"%EF\T.#I5JJ')!9Z..$MB6W>- $7P?T_(3>!$I4WP\0I
MP&UT??_XQDO-9:4.HAL^R2L>/-VVO1O"ZT;B@,6H:^&D76O18RBK\+7<K=U?
M#S??'%^^1W-E%.[W_>'*EFYKV[W^. 4W&S*1A#3=PB7/8.]B!2JGX'S#R-,E
M0SZRZ4*KRG*3N;/$.$'1.?Q>JE6KK=(PU(K'M"2R.F0E<;M.'5Q#FH&+3&Z'
MV][H9#YE$/YF> &C\O5'P__.F;INGVD+B:1NGU#@]R<T0&K?)B [MMWVT8?N
M0EL?\VTUAFP4-1N<MB2"';0 S[4LX)379%%]R1])U/<ZZ6KV5HMP^3TMQAZK
M-/+U#>IF(X0/IMW4'Q,FZ_RC*5S(51%;KI@W3))D+ 4*I[I.2BGI+F6!+G1Y
MAK[%LWH-)8@%#$!X$S<>WU^KBETS 9>*UO76G7"H6.WP#P'W;EB#7E?D=:Q5
MA4\Y$V=Q/*1F5Q/1WKFH*C/BP"2$MW8C)Z&?!85(6[J%7%H7Y)LB?MM5V?.4
M=:VJJ,])"QI8;ONN8O#()N"PF"G=+\RLK$R:8GV.K.L+N[K/-_C/A#H7-Z<*
M68X4644>L_2-B9SNR!0>V/^HA85.Y;W>496UP<6T9T,10F3/,8SG9HV31'8+
MEK6H=NV""?>9'K<N3B^X/,K:9XC,56$G32$P&JMG^=E^R[>DMQOS(J$.M+8)
M8%4V 1H?(FFNA/!6__8Y_YU=_G5;?\D^FO;2; SJ"*9G>\_B]IBRKP^@%K'J
M?"PK(91;;9'S%L5L3+3'!0TYAQJU]#9=9\.5R[;N6/C)Q7_B)_X!?BP7_S?Q
M WAX>NI]\]! N8QVGG0-)W1=\ON:MZV4?(%2+7OE.4L?&!%T ]EIP+!.@F7.
MA4)ZN&[ZV]RG\1ZMDHBW2+2!^7Q"<W)X383?4LNH\4Q,D\(M'XR58^IRJL+!
M$<45?#K2O.;V:=^$15R"6('*WI,Y ]4]6:<GI+7XQS>.;PC==.K)57B!DYAM
M+AC93]\UEA\1:$;INUWF%\KS.=SBNM27%"@(W\GE[Q.='OXJ"N-_4/C [RD\
MZ_UTTT-,<>@VISR:3SA9@F76>_[!=)!03?P!)G\RT@ ^5V9:>XR#BYFO.8G
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MUHW1SA_M1[>]/5+'669%W)6P:K6J&_M<<;L*+OEH:$-JBY"^%%E;"M4I#8^
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M=FFVEDB%32#S30&,SM4W!=A!CCLX\?ZN3NE+UO4AV.?;K;-0ME+Z:-L"63[
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M)TK2@.D D'!O#4/2YZ/%94Q;L[&1C<-?N^^[MHTEK3\ -, X-EMG%7=/NQP
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MXB.=YY&JOL2/T\M+IJ2IGM'O3XF@Y@HES9DIG986H72>[5K4A008L$3")O=
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M<!E.!+ER &!P$%@5)ZFJ9]AZ2NQ.LS,8M7 I;-SX(;F$** LNF03&CA>:]O
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MMNC"*37NX;>QI!:%+,^R8!PW<4KM-$_]W*OA^;+G.<ZCJ2[QAPJT"6>F_&'
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M^HPAQS\=,5D<*XT3LH.N8^CQ-O$\/5(@+&GD^%M#G>MA$'>=+3\ST=T'J0>
M^WX:RYHBCT]'&+]XF'87[NSI>P"HO!:KX*G@@14Q4^\;$ 6@4&O78;(=MUU%
M'[ITP,0*6XFP8.:3KL&6FHWG!CITUXYIW^(*$*/[0A[>#\[9?=M/([K378,"
MV'-<M'])P8>V9 7*<5/RN0:JA;[H(^B?<WWQI@)CM9+1>%X=WN(FWJY4 ROV
M5*<C=($^GO^<=5Y037.$$EH*^0<7YO](J=G_#K^F <3/_9I0JDD:"/_&[BMY
MP/_([0N[I;-GH2DR*GEYOP#\_*M6Z]8OFD]\QTO^\+F03A *)VGBJ7WR5>'
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MER$(9"E+S !5= #.5X :Q>DYR^[,"5SLG;D"P@+9-1NR7H2\/H6+$12VX?X
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M,+57'W)MY(1'KSJ:*AM;Y:8D<26EN(^%'M2S>(FD%_.]5D315R95R3>JOG@
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MH#1U+S;.X],I:B7"=]:/HK0(^I/E7'.CU<;U:S!M\P'+Q%?OJ0<,/W]F> D
M6M1@!=] 6ELN(7\L7N3%=<8EM#E_BF-P4TEKTF-./PA(=#*>,?)&):@A;W]E
MZ]@G4$-Y](NY;*<KJV8+V6T#-%6DVX@4Q0,&/HP/7BN<7H4ENMM7CHJE1"ZA
M"&V5CAG41([LX9;SAGZ^_+NCED(%#@0Y%=789E*.\RO1%#%-?CWU^]6JTE\
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MN=Y6LMYE-#+ #"I>XQBK :Z+F;X"P9C9)Z.'AQS0+!7S+Z@/J*UU.N$F(9L
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MK.-WN]V+"E]"6E!U=52I%!Y)P@0:UM<JGI3L%+EYM9>03=!OL23LL>S5X)N
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MT+$ON7QN$?-*5A9[>J"1[:EK0[-X:[[BG2T5(/O),="QP\PHF=_5EO>60P_
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M3L]\?_&W<5+8'9EQ;]L8R_@XS(_SXI5_^=M4!J)FC6@_3HJWJ.A&-[8&N_D
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M-]<#TCPY]>D4;(?>! M+Y)3Y&(:PTEP!UG7+ACH%#)![Q_G9BX;3ZNK<=QX
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MVG_'1F"$M)T!8!@F<I-YH=:4S8H$ZS01"+?!XF2N.57]CIQ+7T# &GX]PSC
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M/YRN[+*+=?M*9BKP@ZE<[%?M>TBFK0.0FNQ-I4/ 6F L8O] ;(][<]K5N\%
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M*4RI"ZB)<%\,>&%D4A*%U"'8J,K!+E;<Z:T?;2/W28<C DV)<N< 4BP3=*H
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MPI?Q6+V,N/*8B*@54.(';D!<X5-L:QR3R+%$D,2)[YB]-9<W0KW_F\C!@,Y
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M<6T/?1>N(!&/F)M$86#%]G;H\:NXE&VF\OHS_+(13=J>M]?\O[4=RMQHI?X
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M>H[@16/1=5I@(%V!DV'$1[DV)!S1O"A3!H=%+LNGT><EC;WN(43L656E*=L
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M/I@:EWQ_HR,T8'0K=1E*UB[!$VE?;:U+$:1A.5-@25VWMM1N) @]=C@SP/C
M0+*J-EC$I]@W?NM.7RH4^B?9HVU,OPG]=>?1JZ5@K<%(8.'22H:KVRJ*A<*L
MCKM;OV[>WP4ELAQK>H6*A\0J+V;:_I[G2%]+!!8X7&5WZCI9\%!U-4%'_5XK
MLRM=K#>7_!(P3^['"FJ?'&55%9A4V-1[=U=FL7IF?AA&\PYVL#*RF;&.ULNV
M>B*?_[C086]_I4^WBO$U%3ES/]2Z][?]]W3T,TY;]1.!$6,X(DV2H_X\(QP[
MH((2\J_II6H%-=*AKGDS.]R\MJ6T(J?6)9 LMF?__]E[U^:VC6U;]*^@=NUU
M;G(7I27)[Z1J5\ER'EXGME6VDG7O1Y!H4HA!@,%#,O/A_/8SQYRS7R HR8X<
MDPFJ]EZQ)!)H-+IGS\>88_@Q -@PGCF?=N:<#Z0NS]6\C:?%'THY2F25AF*7
M85*8%C;+CF.O@?:#13YL\DXB(V>5+%>=/S[8/&B0)=MGR.J1@2AB*4R?_\36
M1+D8O1Z">.!:GR<:NCDS*J1V[H3+]<MI_5[B#+!8,VZ 8K:R=QZ:4.Z=TZN(
M4ZH"UA=<]U)&M.=;T%;MX\TYZT&XN(GM:BHLK^ PA1UQ9E5"LO=&.%&KTFC'
M]*VI>Q6@\(W,GY.2[U,((W<HJSCVJ8Q9Q7YU##O8A2K86LZ>O(KR'-]9HS3F
M%N_MV"D#KD"6<V!>5*UJ> 8[#@.LXZX.LO?^1%$J%0A(+DTG79'BP+*D-ZP&
MV)4S,?'XC8J(A(G''N[T.AJJS06&8%=_3$DR"#E%*3V)U+(C:Y *FKU$F)K\
MK<MG[[FDA4:=ANFMH9""W%D^Q4\.T9H+*"J$T;J<8W 8;28)D2F/4W:NK\8&
M'9H)[-7F9-A%6$2.3V;68\U+GON-#)Z(N[!$S%#.<Q_ %.-Q,1X7'G%+<2GG
M$WX0-_.[N "_+?<UGA:??EJ\%<\_L+GLP \4F\1@D6VB+S)[!.>ZV'Z]>'V*
M+_E24"I%0Y^A\76FM&G,<EIP<:@UZ5(B&']&"=NJ$=H0SE2LM>HT6/UB0*.,
M0DX$(4?2'8#_4I@T:WF(9/53&I(')' <D*KL+#W6VB(N7#E.8(T5ZD=-C!E)
MDZL4 0,?G+>-+@"'O'WY[OSMP5G:/)OH#S1C*7V.OOW[>FF3):Q8 * !?<GQ
M(^$<XH.EX.Y2ATBP'U1=O&AHOD:X!Y"$\3083P-W&OQ<%M7,(4C/76Z0%O5F
MB6,\ _Y0Q&#SOW'&.D4R1K0R5;^SH$$[?3 />;*(MB"[OCUGI3((]LI!GLLG
M>?E0T'P6ZW#W4\UA#OKZLB)C&6:\HP2WG#LT7U<Y@]ND#J^2-1,K<S-!DFQ3
M0B?P_Y&]MVB*,#6UF6X3!Q^2/*N6;@/T!AX/(8/0M[I9#D'UK*;CX/0?4YP?
MDZ^#.>U%1=8BU^B5E6.W"\[*BRGQ>+8=@3LC!PI+&A+C'7=LHGJU"]H>GY"0
M]<G&,D"GREYQ?P.10):N>%M)"G2@<&*]$%LOO+XT[-4$9#] &COV"_\)[?FT
M72O+"AOH=^&1L%R)4GOQ>BB3B+X2W2)5G<FG')%&^&FK;9W W6)Z>YJ)[GTU
M6[>BI46#\DQ /_YTZHF F"%#:(A$0L7;!*Y3TAPSR$?_+>J+*RC087($5@..
M#0WJ@52B636-8>VO*3U!#GE'FD+QH_PV=0-V%H^.:,EB"%,D2WJKM(2WI.Z]
M.1IGSG"+QYOSE <:S%<\8A59/."6NP;F:^A6^R'B/8*&-B?NZ0@:V@?0T+YI
M;6K-RA]JOT@I$2;I8^JX7W ]#:IKGAPN\OF NJ;^WBZ_ 77-QT_NKJXY(@)Z
M'8<H!+?I0H"^;RST],)7L#>+-^>2=/Y\Y]+C^SJ61G=YT%WF5QR %/*8DA8"
M%? B_=+@2"O+@%6+"N]]])+YH'TT43.!QZ#OF"NS0_FPL47G+Y$/NR_MM'<K
M8S*+"GY+D63?!I^M9X5$AK\87I<'^&^":^\ZR\C+,L(+22)>0W6?: HLR";\
ML ?S1'1[(,V/)@O9'OL7\7%>7$9EVKZ:IYF#\L(L5/I'B\QIB\_8>#/3@L5@
M[TI0JDZ3!JV/3$2+AI!TG5SIV\)_$PB_"51I5=.%:B!DTX9\N6O.I6G;A]$A
M4Q"K%6[;SVAS=* <U,P3/[$C?>Q!MF#;D>8(Z&RXB:>B>2PK\$U<5<65E;!N
MD)B01E*03RD>&)&U$3(&BTAE909I&EUR-DX.!S!2M4IR[F6N,P,VBYHQQ:F6
MR4N#:<;SXQ%P(W][_^:9;S-'9N+*@-^JD1C;46T&B&9,*=]>\+U-CO?&K[9!
MGF=9L,"2?;V@[[33XE>(MM[2O",;B+9:BYN3,U$3>MK U6]&RLLY%GC=X1<F
M+.O<""^8=76]V3L500R";B+-/)1E"(QCIHRFA_4U#O8P$X\.%3ZZ+ P.YZ"0
M>,! %20WW+O57')V@_&Z>+=@"ZHX!48[N*&;:QX61/9T \XS2</MHJHR30G1
M"E^K0+J5%T?:KNI:M#,%O<$KT)CE,W._W4MCE/SWR+X\&[,O^["N]C3[(B'4
MC6'Q#D_L8/[EP9;\RX-;\R]/CP;S+Y\676U[\A%N,(97]Q9>O>2V<JX_:U^Y
MM(33_BBW=H+O>ER%P.K?'?E0]+Z.&7+K*<C%HP=CFG7I-QKCTX_HB8?/'?3#
MI^2\SRX[5+0W_-,>H6W(-N/ZOJ0DUJ-!BKI  O&D3>K;J$E,*GZH N8KYERR
M$G-V\!-R36=IZ[7NF*YOQ41X0J^ 85M'/&STGSAUV&JE=6.4G4M,^$F/!2!2
M?.UTH.1E(_8#P2;PO W>MB![N5'.=OD' K-;7'OI%,P;#LS\@WEAO4T?'@@\
M+V_;( BBPZKPKKCF\'0_7(,;(JEJBH/SW[5$GE*8U,V8=,]VU=AXP=9IA9V"
M[K#0Z[BQBZ#,1Y$EW,*1T,\Q,IE/R/U MO_RCJMJ8B'84\N&PJ$L.JC1N.K"
M%8T0G:5 33FM9Y>3(4S[A/%^:RE(1[^/'DCN38NLT!HP [Y;Y;V(8C^&]3.9
M$T2)98_GW%M&^X]#/4<PL1E!SBQFAE$2G%C@9BNHS^/7'*NY<%9PDGH)HZF/
M#_&D^[#53>3'P5E&KWJ,UGCVCH_&<&T?%M9>U3:YVUEY<NZM\O2'4*%?NE:Y
M&13N<MBC-!R6Z8A<C4U:)&'PRSDW22X\RP[L6L_NKEFHP?#_X>&OJ\5 ^*^_
MORG\?W@S_*(7_#]XL)/R09_?5$^KFKPW?:0GC^AR@$;GV;<#$[1"ZV2Y$*OM
MA[];4_8GV/EG=YCU+]40</O8AE(/IZ]^^F)YA$\;\3<47'0423. -<\8Q$O!
M<OKMG];L<"\3_^K%N[V;>)[R;(TT6X. M5F765TMS;Y-_?GK_9QZZ"3D<\[U
M4&Q=F@HO8OGYW(N[F+NMWL5^G+,[_-+_WT#('?2H7+T?ED3^&"7D5R_.-;V4
M+Y6-@;4J:E,87(31=ZC <SZMU%PM\YXN4L8YH"^ AN+H<7"CSXBE^T.K< Q(
M;Z7?XIAE]P/2\>W=9C!4LT:U@"]"XKKG7),XDYK$%WS70\/>]?AT/U[^FRM3
M7^7F>A]?[HB+WS2)LIES*?_1R:RR#YO4VXP5E//]SARIJ(8A^@_(4F$R("C2
M8TH]C%7XK,"6JO"ADL42;P/CZC6_,OM36F<,;Q0N]613S:LY3-Z4^@VYAW![
M<">U*>FHFG/O]'6/.=158(%3G2IKIW$-GVU^P,\V .!]M2XJ/&JB9;RP++?>
M?"RNNM(UM8M[L'';48YHB9L^)OIAD]!32_NN&O>#AX5D#/E@534YN_N09KF^
MK*0_OF688P*E*TRHJJW2K4/T+MJ0+6&^WH,)!:O$0"A>7E(!SOV 20OR\OJS
M?E/>@Z=E]&]-YR+U"C7HU<CKI;B&-$I]AR #DY>7R'8H:)J^KYP@B_Q-BI'!
M'$AQF-[S@FN(4@^-7JU]>YA9GJXLKZ61^/3%F7V+DVB]AR5_%9YS.82#.6#3
MM .N\BO,5IFYHKG!_\K2=,]%?VOI;K0+%FE>-E+8YT@--6-+I2PE__5*-Z9P
M&Z<E@V=CW@'[-/=#)OM7252.Q<I;BI7'8[%R'Q;6GD<7?(!N\M^,_N:.O>U/
M,R*G2=DMIT#SS)68,Y\U0=[')I!R\N# 6B-D\2'_AP<RL7\)=P7GI_13748,
M>DN>$=#&&W7M&'0%L&SF=>Y$T@X2=TRM-F&)H4M!1JI^VH(%8KG*.H&OK (&
M\!#1@B[DEGS\3TU[C7O$;5)/'\$C>';T#W[LKGC/P[8RMDT*D)&@M1@6]^01
M?U"]A5E +[)KK:2["//>/3/W7__S%DXP*OE>^0*+Y::5,/#V]V#R!XOLC[84
MV1_=6F1_\.CN' =WL+:?X]EWV][R:9IS_)RV+;>673E-3)O"ZX&569PS-+/.
M8()AV :3C)VT/X@@2&.%J$/KG5'<7S)0UB;R4Q_W^9#9!50!RQCR ,)T)*(N
M*D'R8W4-:JE)+Q*+Z/,] 3_;_<LT<Z%T3E'1C!'P(AOCY&7J:E%2%,RA;!PA
M8T; MJ]4:MR_.Q"07P";O/D'CDMY&'',=L7MB0CL?)J@I/'7U<J4>6JI/O7M
M36U$RTV,_A2=F9K)DWD!65"XIZ)J+^F53,$^]5%7!;.3*5C!YI0&M^1 /[C;
MMB=)JFECZBNI%YFT+M9HN%AH7H"G5HCS3#;X^IA,-((UC4?>%X\7/^7$NX 1
M.,!N6?=>M.:ZY)3;MH[&.M%>I@A.QA3!/J0(/MJ#>[S%@WM\FP?WX-F#'?/@
M]BQ@OF )M4*,:)]I<RV.SI6'77S_XM2Y=9&D&%P8.E@79MEVOW?+=)I4OU<+
MNNLL#^@H?WCCV"@#1X$F\+W1T/Q\3D.OM26'N^EJV/$2W60NK^RK'>)F2)(\
M;1V/+C],)=&[9U7O$3(I9T:26IY1.#%PJDKU%M%,5VWQ#:TXTJ4)@RZ:"'OK
M5&3C4!%B1E/.'' ^0CG=\[9R%*/N>< 7PJ^#O&E:(XU_@@F%<^15ME8AF!W7
MQE7%(L?,-VNY-BWE@^G=669-'X"'?IB<<]DEAX"?/&/.[8?J:](5YGEA)M$K
MT+8^^DHGGCPWP(&N0GUB+8M)"@/]8Z(9[Z1VM?"3_:LV<P015<W4\P#R2%\>
MNBDWV91I,-."HE<_[7W?..S> ZD^NPI#C,.5HX7I>[0\P,!OUG6[3-<:ED0=
MC_:)7>CB:)6;CZN+_,V2>R<?XS?MIBD-J&&V2(L&=6H7.%L)<T<G%)HHK<Q)
MW#L0^6%I;N-0YCN@M!U%KK8<'NJ&\B?CU%%/,M5O(GX":YPC^?(MBJ))I"BZ
M)2;SK$=2IV2FWFK:-:V= B?FJE*>]IN6L-,9[YEU\<? [B]1KY$2]7F0&7J1
MMNE8KMFQEWU?'!+ABSY'.S:;LJJ<F57[13?T^-KOGV1V%Q<E:$RB1+12+/ A
MZ+*/PE$G!]O,\;LYL3\?J9P.%OMLK>_:.+:]JYP<3'^*B<O8I&N^WI(\X:YV
ME'.2"9VS3!'K:F-_E&VM%('T%P\'*[=I?G^E:@5,YC=)G&+ N_.SQFL&>'W9
M+*<;U^Q?",T'QF6;EVCI(@NK41)Y0B!:0$0'9_\Z![W=>F6]!=$;&4#I-9Q(
M1PS$A=2E53ZD"[D0$E_[SX4?(-<)?"QS+<GX$$)HG3&3]?VOZ*)_\J*\ A$C
M#5 W+)F!:!<]N769OC#%;N\C]XYX001;AU[3..&?P^.T(-.,:R\11.#)T<&<
M7!VD!FKICRF3EV>/CEAWCE7<\D8":]E@WK%GP()X_PQ(L.]Q3G>V-D$UKQE7
M^3XOA*85B04* X+$3<]0C1[Z?J(-W.L\"T\K6CU_YJ[F@?_A/?V?BYW6/6-2
MAKV;U#_14'[2K+*+,U8 ][("^&"L /XE*X!/ME0 GPQ4 !^=//$5P(</'H\5
MP#]6 <PI)&,-N!(!K6OCB$!7'*%>538:3@01-+M4"3HVJ11\U4%[$Q<*CQ_3
M;\W[1N+%XT=)OEQV-+7P.>FZ.:+?93XSVH-#'\!/$A5S\OK*T&T*WR_C8K9?
M+GT0:.G],*,K[?4*(+_<^RVPK%YL?/;B^.$_DV55LGX>ZH.BN!>DFL,';')$
M^_TOE6G;U1)J!I4T;3JGB%N#W#LD ^(@23^E,W!@9X ?TJ;,^<V%7/I%)=S[
M,D@G89@7ML6LXI!:JY4:D-,U"D3@0ERI\#7;2C?&:?<==Z3U<L+-D"K,GB:/
MCR4\4]9___)H)9K?.A88&%_)YWTED9HYM\"AKL9HPKI:54+F2I]CLM7&.%.X
MT5JG#8=Q?G!\;9_CM7D>6E=XK(8:9<=4PWZF&O8O^!TS"I\GH_"EN+GN-*V@
M-/#MUH@^X0I64K/QY: QY["7.8>'8\YA'W(.-RRLP93#TRTIAZ=#*8>CXR#E
M</P1H.,O\>"[G' 8PE&\14W6H]:L0N/K*GEC ^*7&KZ7T F"O.H(!OF+Y)\
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M3'5*&645%4IML[I66'WS*(X-T55AY8P/N10=@N*)%P\9W:G/4V3XTAG2'7'
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M %R;UEW/HV=0K/GE[!1K4+B_VK#>S(T+S<K,$,GP+:95QOH0  !"16))GRM
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MT7)S&96ZC)K@:^>O'>W)UX<)786+@GDCGE[*'FM;=TM6*@JR4W;4S@6?7::
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MS[<TS/J^@S<-OFGR$MA@V[?>,/Z-"S6E64B*/@9[NJRX[\&3-20HJVM[7[(
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MP ;TLB%HJF3_58A'Q766UV]*\!JZ9LG0E9TP*<FB$BUJQF9_@$J(<F,:N.S
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M+&FEXKFV7(\[X+L\=SV_F L6IL:Z6X=,NH[ =Y)<NGU@"2;Q$MW[$SJHWDI
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M9*3R?@1VD$"7%6DO!S^0IB@+/P@WHFN;V8R6TVW=V%-S2]2\L*$L*OA5<<5
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M.(XH%&(\K]LA#3U&4%"1'8.Z!H,,* S,QCTS[IF=WC,K4W/?A@76VU8;1B\
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MI?7[R4V4@(YC(ZP.G=]YD)H_DBC1/E/L';@107A6RS,6>G*9P1#G!N"@N8X
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MU[EWI%-%8MS[/*F8)\E<.K!4B/5H5ZEU#X]1),^;9MXTISIWHS.(*\E!T2\
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MF3"E3W4*=$!(4L.>/Y-[3AWOL*GGE3ZO]%->Z0J.I?PMV^C88*^ED7 61'&
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M4A\Z]<YFUS?>KN_3+S[]-G[1*C/$JL#0;QKA:26&-(XTL@20RU\2TA6$-]+
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M!/F9Y,"-95+] B6#041.-P2YP=[WE_OPP=_T K0IX:(BW5[ZW:U<V>%6U#@
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MZ;_%+3%"+Y ? @?F_3+OEU/>+YU?UTN4.@U=1[*H*<<+N-\2GL\QZ(WE5!F
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M6QVW-!L1_!"91^Y_&H^TSGD#I#);H%VV^++%+WV+1SGS,!RE-0&:QW#V,?T
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M&E>%,YC07=%P4#<B="D1Y]%?^S:$GSFC?4N&TI<R:,.%A9S\AX;=J.QLBU;
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MC$=U9YDW%9U-[U/G?IQNMJ*'!-OD:2A?,K<U<(N[7#'Q/)HDQSFE,AM*64R
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MQ>:U.UW]B/_3K&[HE6ZEE20.TB[6QNZ:,]MC(]-#>.( EY Q(MG=Z>:-$3Z
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M]!U;*9N*R%%K):ZJ37!4YY%14UTXYS\ ZQH0[Q%ER0RD)$[XS]2N(2L(C,T
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M]@BXK^_T9D1#DJ,3H9>)L"N+6WZKK3[0=8R]F=0Q? ERPJ/.MX(&S9],MEE
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M1-A__?HF6WWS_";:W<RTQK&4398*UP\SS1D5.3^F*<WHB^;MH4/I#%B&"*J
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MUZ!;I=1 _)Q\ D#@IN%PH_*AWX:I>=A*E'@')L1/J3%0%.T/%O*,P60\WZV
M9R1RP?^'4\TS0G@:YLP7'E-JKO5I<)"T@Y-$[)ZIO5@8I:7_63J=^HT_.),7
M;?)C.JORNJKOK_;U/<,\>2B HVBYGGS?[PD+7V774,32U/=Z>+"?2J-:^@"%
MC!4>5E'>'#?R@B0W!7*P D/[M.G[AK;WZH!M>_3/U7H=28Q8VCCBL:Y,&J>>
M?SWW@UPTYM-O7: ,:Y-XVWX7!09H#S4B1:/*02H8]<U\:JEIY>0]N7:491JC
M]"@=R48):"@\:-EL6[1FA9S3'8H-)68%1$+NBB8OXRPJLD*E7RM:$^CQ8?T4
M!I(KUSZO&&; -B".CTDFXS&3_L=#HL<5&\K],G/*,Q>+Y2,@Q4-GCY9R>&Q;
M"P*B@\9WABREJR/!.Q-F.;CM28^/: 4&"9Y-*4KJ@B\*.X+>KR^LRBWPS(7T
M%BFD:T)@=>_\&1K/?_EV00Z++]B%8:R]@^<9BO9$:]4*']L!@_3IX18U,Z?/
M,UU*GLKF:;9Y#RW\38\XWA":RH.(N-3X6<BOA9)TD-AZ(ZXK&H'9UBNXOX$E
M&._T.$ZP9IAM4#XZ0N%Z,]202Y%A"8^[7T@9")*<V6[-9K9][CPV6YZ>R6G!
M.AF\L5OJJ[X5I22=NQ'R;$'MC(=2Z]U,:&_?EPW9M[*K,1"SDW%4>A9';LK*
M]$;AK77Q <S3SJ://6>XI-R?0%_GD+]V7E)!8;[3)@ZOA7"'TTSN348G>D1-
MR,6O+,Q<DQ=P&&@3S'Q<A8?#S:QS.HJFY:05X39D#)$B&O_X>'B0YV[[HMP:
MB4#$@*<Z).7J;\]_.!?2^%S%!T,^0(CK"YZ-CF[K*1C  MH;@_;^>P'M+93=
M'WI7L:,8=DJ>I?[5/"HKRFXCTF&>ATUPZ'$_W*('Z17(J=YRYB4TOMSAB DS
M0URAZ9.14OC+0P=)R7$[_U=5*]/&8A<7/(87+'D&?.)R\H?X2D)J6T! 6B6&
M'G/H\!*M'8*I($X\1@6\_=*$TH8]T^ 10S_1'G8<U[8KJ;_XE;-([WKU$@<C
M;H';9U/WIZ6H.&NLZBKJ=D2[ &Q?4I.MN"%4[ KG%8TCZDK/81(FU1,*D^D'
MU -/RV2F!I?\!F>&_!>^%U.)B[B.HA8;KR34[5#TT86S)3*Z@<;_BWZ@S0^Z
M0?A?7'.0T@53%_'GE:8HY@E(,Z37Z$ W4YLK2E/ P\GCZQT^'[?(_*N54GBV
M4D5T3,8+/S6_Q0AH[_NHR=9X$,-B]/JA/CD1P6M'CW_2\CDFQ$I%\]Y/E4\K
M65Z<[RF$,DLL/X%+C.H0G?#MR_] %SQ4?&: 6K'RI/I.D;IN.;:6@P#(PKJS
M_SE4A:(OW3K^C;C^W-4;2+>I&XS\KEPR=.)A<E(LHVLC+;A>_5,H)KA.632;
M_M RK5@[\8!19O#@\]D,+KS7%K7T8MVCSL,/UU==(=SJ*"EO_%5^1FF*R;)+
M9"KDW4N\K;AJ=[Y^'2O3 U@DMHO_-F1#WNFMB&'2PZZU^)(03D!@-* /(BF\
MV+/S,PX+(S&>).ZZ**+D>O7W\Q^8*"F([QLQR82OEGE?;?9>2#Y(?R)'%$[3
M/JI(3J/SWEUJ="E-/$UW%BN93\"%]D436 (MX.$8(V+>#IREF;<QJU (Q59B
MJ'2F@L M5IRC3[!,YYG60+2IYP"M445>6VY<V=1B]R$JA@KX)XBP1^XQ\FOJ
MQYAN<=G?3W-__XV%41@]R%2Z3$6M*-!VR 0%QRAC!I[V*^E"6 (YZ(C=5*?!
MYS;#4-)[VE1:DFM?4UT<6DERYMN^M-G20=%XSA_+D1&*RIS0',BVZ!S%\6X9
M67X_1//=1U(2$VT1-;&9C@2+ T4LQ[;"UIO3'"W]6>EI18AX7 ZO**+EBW W
MZ0IS1P&')2U_P I0]$.YQJT;=;'EL_(MH>;BB\C.Z-MD6RAF4QY'Y]8V4U ^
M%]!SVD/P"8,B*-@-<<O/LF,#T0U0>$FZ:!)) ;$GCY=ZP:G=%:=#W/^4806=
M4/@ I_SJA@X+CP/A7!)++OT\PQZ,P1_2!!-"]''HYE?1<^@:<@;:[I$2Q4KJ
MG+&XBA?X:9PRN$M'OCZB( (27*T< X?>J.TI_DH'AJ)MSY8@0!+[$#9BO4$_
M!^-MH_H(![ )5D2>1;Q".)_BRTDL-_A6L@@<]J=_]X6'^$H1]IEIY4$Y+@ %
M?0)]^>NR,"H\(-AJC.F9&G44O2^'W-,\Y&Z$Y$M"MG.>.LZ.4(74H@MBIQ)@
M??CYJWW=CSI$ZJ"BCC_'35HX4>EP>#SS3:\Y<:%4C\^'CO^([0F_D*]K0?[L
M8J \=^@KQL.$FV0IF68PK!$II M$/-]B4B-PV@.,5'2]"M3'3C-"4TO+"QXF
MU*6B&XU=J0U"1:,,/$RH;2X36KO"$YQFSD@&X@5V_O"(+*E\7WD(P"H63[<6
M6Z8 I%1Q?1!0Z+A&-)(P.D*\U/0PDPQU/A7TT;?.I)_8&QSX1W(_.*.=\\S2
M$3M71#F7H._]FAK4(-#4/0G'\RONOWPXW>BX@\UD]=+U9?%"K_(@E?Q7*=[N
M$=CR0K#=45 H>'&NXISH@&<OP+#L9<SPPK;8NQDFMI0 HC=?Q6,N\F_;KU:;
MTT:5Q#_*;NM.1TT(T,)HI1;[QOHP.SA@E'"+-^3>W.M6(9\*]<]5"2T:,^!9
M2'Q(-FY,>'&]^BNT0[-I+'AY.ASW]>9D8\5%6\MTPAH%8H2_4+70.3WOW &3
M%NL 4CI05(_!U%8$W@"SX9,"?\4I]/6C[I,.LWN=H;C/>?Y0@_R*CBLZQ/:*
MT7OV]>>?7_D@]I4B5>75\9@8GQ-;0R C$^'X&X#(B@O$R"(M>]27S4=Y'DKU
M=EE1KJ6L0EIQ\BLEPA!!8=XY3&#YCPA.WH\ ",++!K]PW6<W+_R,.$#,79,
M^_V#ZFT%&05Z"I\9'DMGB8#MU>CWQP^@@R08SL+TI0ZK^!^5+$:U/FI_9O/*
M1R,,NOQ^ @YIN!H.)>T4+3%@$DY]R\5J#1)Z@W<^PHBBD5A>*2[$T+V]+BA%
M3$'7#//$W?^SXBSN92?SC%%S9 SU9R4*.1)DA[<0HF D)+<0-!&2,/" )&[7
MESL4.'3^$".\)@=CG=MDX034JI>3YY9Y +S!5XQ'-M9QGV5F'F:9 2DM_[<6
M<'OH$O&M\?A_]!3\#!TLC2[PJXB,_@T13U\NB*<%\?2A=U7<=(U&M<-0M;FO
M0;039+<\QN1'KQ908\H(" FAQHD4 :::.?YS (G431>/H?EY#;X+#1VLDBX1
M#PIQ%JGSX(_550-<U;':.:[HD*Y7>:SX]J3=X-/=KA\F"_I!:IA!- WOF:=;
M)0B2P!V[;#R,*+KOLL,#B8&/=#G4\_,9V+R/GEC^H(7/)5W\E/[Q!Z\2C5VP
M=Y2G><(74Y8-*9WHL3N;^.XHL=LPZTMM?E-&>HK&E-[CO2O(#T@%R09E)H9B
M 'VT@%W;(=8?BX=(K=O%3E80,BALR#W)S".WI=LC918"LWNKK8V0>@,(GO"?
M&;)'"WZF]48+4B.%H16PUI>>(;M&YG7"G9>N?QUR3GW2;_]^<W7 D W&(66B
M3AH,)^G^M%ZX=SC >KWZNXQEAC5);T&:1JW.4ET-_BBL:ZB.*E5@,B@JQ53F
MZI#7E"SDHJG[\83LWXDHXGKE33B20V(M7;76K77"0HV&(PU1*/3HUD--]H;V
MN?9X]6S1]+E]:P(+S9T;)U*;8>I-]A_?8?(;[('*^AY+4=7 RT3D/PS0YI\=
M<#8M&_+C;<A :O*V+]^&DFD+UK<59'4&6\H[<8#ZN*>D$UFC^&0P277S_.]A
M(QG*(][L^>HOSY[?7'D==.Y6@QA"*A1T:/S4\_0L?^SFZV<RX_ZWE__WL__^
MXD]?_N&/&?\E"*F;6W?5;<YR9OSYF^=_N_JOSWZ_^NW-@4Z!W_'S/'MV]>7G
MG_WQR]5O_X+9^KJ\>G["%U[^JR_6Z]\QGT0;*D1^AGBB]^.;U_)<N T=V'V?
M]\) ^8>[35ON>/M7DL<-LA*?2< 6]J+\"<ECU[3H$##ERE ,.=^)]YG%E$>O
M- \#LT[AY.*:[O*R=W[PK3X<@/[IZLWK)>GY-20]/SH/Z9CN$L.FICX1M\I#
MX=5+:2=D<#SY>=4?Q\B:&9X ,"H$,_#(:"DJ:-DR'HL0S(JJNN,KO8YF1W.?
M<]Q'PW9O&)4)H/96^,:J#RC:NZ1BGWA.HF[048I  X\60HTTI:6D?U\WKVW<
M8<Z&4DY=N-;#>)L;TZ'(J-IL59Y0)[F9[]25@350/A.FVS'21E$L]M=9B\X>
M,&D_JSWNOV&*>J-9YKQ]>PH4'HQJNRLY=E@XBIDY,QU&9!3ECX+IMI$&YLS0
M(90AR\82GG[PDY8SU(A 9<1ADGNR3!9$ORNV/4.FC"(.E#[VRH87"U\H!?RH
M7=BDH25QC%QOD)08FVB@IC:49018]7N2Z4GB7<TP(49@XY8PC%26(>B]WQNL
M:>TJMRLZK3-8H27AH1S0P-BQI3Q;GG[=<-K^5-2@3LHA;/D/VFYZ^L)1G#MZ
M5_0C$^!@CNCZIM'QQ%W/?WC'XW@0?&8)CG7"M4Y'IN9U^$#'^^!>)NCTF0Q%
M$IG10&LR6ZFS1C:?-A[O'?\$]QEX8A;]ZOD1SX_(%[[$P)\T!N8<"-O@Q&A!
MWL:<W]+VXHT)/&&WK[>"L=@Q$Z9S/]L&!Y#$(T*34WG')*5RX.[TB,H"-'7M
M2L[[1B,-UBN+Z1O]F&+,TOP1>7B6&/43#[_Y;;EU!T;NY%)T0 ADNRIL*5>-
M3V;@;E#4OHUQ5UV_+3S90YZP)PM'CW8XZ:S[V7GJIWOE!:C[3L=VE)99HS<]
M'B1Z$TR5?=J!HELQ13\.V;^343AVQ14'F''R-FELP2(9QT-V80HL$?^!'.TX
M$//FM)H@SVIU8"-P>\:7Y?ZOG?8#(7OC*.>!'/]^K.H41<"ZC@-^B;[2?V=Z
M>AM883&-W,^F^!%GKV=/?W2)G'TZ9CCUA';?:9S :^J&&^G=691YC,4X3X]]
M<ZQ;5MP8S94=:N#^MO4QZ,<J1"#B18AIUJ 60+^&2F;K*V6.\K;ZH#Y6PISU
M:25LRIK&1P%@C&XW7ZMQHM(OAIQK,I#2U;+]-UHV'K0>VI%1^%$D% 6]OFH_
M3'PT[)6>6N+L\1?CM24C<1U2SN@8&25K^4:F2-N]U'2E*Q 3 "AOUYPF48@4
MG4Q&O>_VF%@@XX.<3@!_'<'5OQ^X[$^_7\!E"[CL8T>5/E'.=;Z9![S&=6M/
M9.PGEZ2WY)MA["<5F>.JNZ*I*YSU&&BU&41<1MB'ROR^53=]JRCI-CJ;UPX4
MHS%2=IIF4R@X59,W<'1()R:,0TUW9(P/40_)1;OJ4C?ZNW->:+_E4=LZ[.@!
M2-M+0>S<%HAS2 $8DW%9(Q%XU';/XKTN ]>NH<"I$\&W0$(Q)K>YE?D'SHNU
M6'6*X/I?\786^2@IF>WI\B4/%/:M\](%6800U3288DNAO=WG/U/<6/>)5;HP
M?][:<$=GO^<.A2 =]%*@3;]UZ;7"M_W$@FP.BD0+S6WP$9%^=>1 ZI-SXP44
MNO=H7EVG;^+!_O0)=F5^.' 4%K&EAW4UU2_E60Z"8?ST^;:H<PNA]-NC6^ 4
MR5H)X<=YB3@[B_2\;/^%WH8,!;F Y8U?A@294TL?(WH];C8!X(X(%(KJI[XY
M>5Q7FSR3#F)(L^_,MP>Z!?"7HV6/%CIRY/0R>2+7]*$&Q41)@-L@2!/);ZE4
MXH8+RD*(8403.L:D@+?$_M381K>@D+#"[D-.#=9NUZG7?,3PH0CIJ+A[S#%9
M$@:D^;:[I/\3_BHC'V&D5XZK6%=>;F*HJ[$I[@JIQC;\BDL]_L1IZ/GW),+Z
MY5P:K=NS>5:B\3X>QDB6H'H]7#&<<??AD9<"7+)HD@)HC'R1K^B\O4X"#+HS
M]P_X(TJ@>42*62C9E]0#W8-)UX1/F<N[*5'^NM4$75G[D;C3L6TSB1Q^TI+(
M%8,", >F='HRDL%;/9\VO(11%UJL4TE/^%Z+P'=I9].DA,LY5TB>H8WNQVH$
MJ"C1N@1]OB!5?)L#P!M1)IA+-(^B4*=-WM!J^H9A=(C1<PX.I E-Y$33%LJ7
M4#W*VYZ\B_2D]/R*/'*XR+$N4:9L@[@?2WR]D?$X_RP\="@>7DYEE=4M6K]^
MYV^;7E+-= ?#34.[8K.IFRW+0V>>$_6!<^S\R61W2O^3_LJ.EJ=1V4SEUA.]
M:#F:C-W!GTYA82>(_"8+I_Z.VI[6$R(:4\BR<_G,0N_W[WRD#!UR\&9Q?5O3
MY#13?^#D>.]D9H"$340_1#B;CK&M4\9A-ENRL5@WT!,GU\UM7A7M01KW,C$@
M5H(+A90%'0\OQ(6R&!UIL"K<6G\TI#@LN#G%^CA!/-,?>?78AO6F\00H><M<
M\'@5WVJ1AD>Q_7XV9#Z."O'^-/YK$'")7ZR<IV]W&YXC,C!.Q1MH)])1205&
MA8_(W2@O>?!#D0[2XLX6=_9V1%<IH.ZMRC?<*>*MG%(+#ELW[U2DQ!A3I&T"
M)2CQM*R3EE?1+TT&W4-NTW$R*&I:L98?MR3]'E]LZ=V+_7_X[,F:TML7DW_S
MYQ<@25J]<'(NTL9\$:+/%^ZN</>?L-:]H*X^6 -G A:HVH SN&'KV21P"W%Z
MG!JK,,0<F&*&%1XIE*2F@7S<T]\:Z8_ZFD&<F@BKJQ>,D*@!FF$4.JAM VX2
MY#*2MKU^S(WPE*,Q!0^4F)EK6-I!EV8V[W: _$4I7<\*NJ @,;.Y/8Z0\1;G
M1QK /F0[,$DLAAM1>)IT;H(%--LBGB=4>QY8JMS&V%K)/)A^ _I( ^D5$.I%
M-<.$D'GK$(0(J1GN66#'@*ZQH,L!KN1$^4@;&Y9\O"63LR)\KK4R5H<$7[/)
M-V*Q*J[@'/ &A@^''Q+J756K$)0=VB!R[YQDV85%W-$-I644&M^48\[+")5#
M7]P6TM=12%C4 QXH+W5:OQ.N-T17AT1J8RC(J9[/('*T">WGE,A*O_PD JG%
M?XS6[3GM790ULV3[):!\+^14[\B2AX+M=WES\KJ)1^@LA# [IPUR8I6KY]*$
M,N9;!C5PC*\ YZU254R-W[H&"$C0F=MY7?,^9!EM-X*M3@T4*%"V@O(,D_K"
MB"5V%,\Y.3:PF[VI)[';%^S9&'OVAP5[]M[8L\6+SH%R9 8^&9.4N>!L.(/F
MP3=]A?B-!?"XR]/J^)>,-X9!-O)&V3B "MBPT8CS %=M=$$/C4<5#&*>8B6(
M<";_<V'N;UO<V5WH-L)VP4;]_6?_\94RZ_S/KG1O'K%)H910[$Y7*,]AN^-K
M5\S[\Q5OQ2MZI$/[/X VX[N3&_= _W!?;+O]_WQV_=D?O_R/I[*3;:F*BI>%
M5^RM+G!F\>(U^:_??_['+S[[XQ^^_-,7__W?7W[^'^Q_WGSV^\\^\QXH>J?I
M75WJVOWFSR&=;S#.JL+UX&NJVEY)=7P:QA/9&F-SIO)5V-7T[/K_+[M[V=T7
ML781?2>=!-^]^ N?!]*!Q'%#D36&.G"0%%WGI&P6M-5HWZ,NNUK7S/1IR:N7
M302.1:>:BPK,T)!\J7UN?N!#<Y2<"GI">)2'?^/1-:OSX^23?P;[]V)IBZ5=
MLJ5-G",LP%*4BNCD?U[EMXUSTD*O5K'89VH(UF9LQVW_2'J5#Z?87)Z]^%[+
M1(/OP(+:Q806$[ID$YIH'4V4EG ,62?'2'MU_@8"ZWV;='94<4V&%H'^S!+D
MVU >.4L4AZ;DPSUZ+E_3M>MJ$JM:!]R,EW):K&^QODNV/M^'T3E]1H/0T849
M[2OE8T?Y=6@*"E+F6%).+@;1:459-3#8R'A.H@#4A,L8QZ;(.Y<8G)Y6@D4/
M)/ 8I3?NX[7A282KF\O3BMC+XYFBYK 8W&)P3]'@1BA/H,!<J9+R9$7'ND#-
M<2=:KR#4BILSTE]TE1BN-%B$?0M?$'OL3)T8G-E@6E5YAPWE<JUO2.K%T5H]
MUC7ZF3U,F#Y>;Q?C6HSKDHV+=[A70?/<;PD5TU1W'A0BH@!*%E6E8KU?05>+
M#D$CXFW[0I*W6%0MB(N,VO?A+%S;=R@*99S /J>SM;KE21348!+E[,8%.U<Z
MDT"N;.*K=8N ]0X3,5L?<WK&QX@8K2WK^YG'JYN48WQ+AS3 #F$.=.2;<&A#
M.0#T(ZIG/+KLXBD63W&I:_>;/X\I4Z7T8LGA%*=$A,M*AA: *U+NR:+Q5P)O
MYD 0NT_Y4D?LJ(O1+$9SR48S["M( >9<9R&NLQAKRV3S0.<.6=$+LT$\Q?NH
M<2B<G%!B08O><V$%GH6JKC:#>><9.\[(,G>%3&G1T8>HMRT:/NJ1VVH"&LT<
M]94P&2,]WN>P>=<(KU>6*),E@0*K;3N.Z3%9*CEL7T5%81T#87UA]@TL0,H3
M&5+R#;1JPR9+&)U@_:NE!KPXEB?A6&0>LNT2A8PT/K]%D6<F@ETV][*Y+W7M
M9'/SE""#OHQS>[K-X<^60$,1*$_/*!RHD8 >P=.W\N%L[ [QD9ABU:+1%I:+
M$CA[9GS)/)Z7TI<SW9().4\_AX[M) +A+5@]!3RP/@TXB/A<OM_7!YBVB%QI
M&"T'I"*+/=\.IZ8@IMKU.O>[>('%"URR%PA61MM;1 "\')?-Z5B<:".W>0#/
M-(Z,CPF&,<C6786>QZXNR_K^JC\N%K!8P"5;P!0XA8N-1R&PZ62JB?^Z[.5E
M+U_R7M;.G&3B?F.'+AWG_E;XH/BHK*M;Q[0G1;UMDR_5Z]8U=YXF2@:Q@MYM
M3%38Y8M=+'9QR7;!8[0-0X#1*G-2EO.4(#(V,R2;G,H?8#\HE0&*K--_?<>W
M9I-^GIQ.]9R6#&"QC:=O&T65*&NIRO2FS&5$/+_5E$'IOY!)*P$6J&7K9K&"
MQ0HNV@HV^[RZ=0J9G^ZG,O5G3R<!TZ?&D139@O9GF%C0*.0JNKZ/ISQ07BB]
M%VM8K.%2UPYHP#:B6$LKQ?E=7I0V%TR^__FIK($ ,JD,Y7F<E>P!)S#'5\P>
M#.F?ZSEK>(K#XY]]\45F_^\/ORS9::SL.=;O]&BS1P\5R EN1#+3%?6U.]7,
MUU.WH96NK)]*\ ^&:"GUG[_!:8'1"QL4OQ02AXOGR?ALX<GX=6LT?3I'YSL3
M[^:S& 53Q&6L-F!*PY5PC=9+I'N:/IQR8#*JA(&9/@1"J^BO<N5&U7*$C0S#
M8*Y1):=)!WB@J.#"7-T2BRZQZ,78? 0;3]17I\@*-1"=X:U,];BG+K"@7A>[
M>"IVH;LXV?P BVX"X%([^G1('3W;MB]D,X<&A?%-G6_Q/T#"!YT-YJP%T-0M
MTU6+(3Q!0^ 2 P583B@OL-\%:@9MGHA;GB6*FE0,F:)"^H\@W*!1W'W.6H,)
MCGM=OT&_2/^RF,IB*I=O*JGZ0U3Y1D9$J;A,!VC@5* 71"M#]N&6PV#9X4]E
MA\?E3H/IGBEW<M7Q>*R;+J&U3$TE^CZC'4/N8 6'N&&TF,IB*I=O*HQJGZ'V
M1PRU;?)[Z6O*))S 7 84U_ZT0/9QP/S8((:J5D77ID&6GC=LF(RP?/'-\Y<R
MH-:PJ*7HFTDB(RJT*_>F$#O#9Q?[6NSK\NV+3Q#$3;2SE_VZ[-=+WZ^QN!#+
MOIK0;^..?:<2L[^B?OVG:([^,,'2)^I.0:*OJ#:-$![-=\VGA: >;(HU#Y70
M$S7EUU5]O[K?.[X&BW ,?H#O>>UN1>J&MGI5L4XO_KER$H&O-2#H6:.0JXOZ
M-3]GM$64T&[V;MN7+F*?N%Z]C*4 TVD-?>Q(2KZEZ 4B(TQ!K[AV(<17RALE
M8.2XAZ61WWB>1KQ2SQ?LR>RG.HCR6SE&G/2]'(ZTAD8XO.;?\WJN7:V+3,_+
M8DOWO+I*<E5N8XG3B'$_AD$\XIY4V2P0^^S!5?>!50Z?;+OZ_>S\PTB4?7-'
M&U/LV?>PF1O*S]*.:9J\BKR))I$I5MK"YC^S'6GU<T)$>[R?__?[%Y]_GJW^
M]]D-_U_< /_3ZO_HOZU>^2F^EZ>6P@6#=HD?&>V]P&G*[LPB^W]6!:SZ96==
MMW )2,BW6\D.,A7ZT8:=OV^='>9NG@AD57G3D+V%]H:?NF^=>[WHT5V:T;RS
M$HKN^(&FR,3&ZZL.?$BTV6(2SYEL5C-='=W@3<=[33"*XZM?K\Q>9\0B(W:E
M*=6Y,'8U/I4S19],WJAQV\<^HFB, )]N!-["S9(VJ36JM)MAZN8]Q/7J)M2U
M]$"-M:ZA/[/ZZ]<W]+&[HL4WGQF33@@N)AX%5Q#F?3J"J[JZB@MKP_) N)DI
MS?9QH,.7^,GI!9#-;$7#/*K1W4*6C&6,(Z5AT3(T,7**6MHR#+EIH;L1'N=<
M_1/8?2;AX>%)CS49_<D"#=Y.''O$"*0HVAL+\:CHX> E/^K877S(6-]WVK"\
MC+L:_J1/V9D>8UD<^ "+V^E\X*#(2]M7PEA6NE:9>M2]XMXB7T&_.2AWC<XR
MG/7:1>2MR"4N5GALSSH*FT&8:75"WR[O?2=3Z"NNXD=2[BF.\PP;7.@7=FB/
M9LECWC9X,F_*J8RX5=ISG29"4B/PN+A8/MC[ Y-_P"G:J\.O^6?>E'EQB%$-
M/J R& .[02]5Z@/K:<7;:7]/?E(B;'V/[K;&;[<;5X'GRR3,C2*EU !<2(3L
M5T)(S7<S<[+ &T37T6$L_"]5+__WD2Y?O-M8<7,,65M+TQ:G]%3TS=A[B0"0
MFF]KU[(Q05:J<<EE9LP/%0,^Z&F3DPM15>LXCA_:\4C.U@\'XEJ5TRN=DF"%
MZ>9D?O#1-R()Q%3J,_@A_]BW?0XOYMS<MT*FHM\EV[<_A_@+PJ6K_%## ?E5
MX:2>6?'NZA)'3-0S')TUL4AO(#:2V#1\;Q"66(@@Q8WKU4M*?I2KUT&O>.J9
MQ#591%<%G6-_RUQ^@DOJ6UU/G6V+[W^LE3K!?"@%"/G%M;,S@ ,<VLJHK;;]
M@>6+7\Q,VF']>''OBRV\'H=L]A;YB)+_&0HH(_%"F$ !QGZL^%FW+@:#H]N_
M1!%6/K>>N@GL+2.T\+TP84@<3I/#-$.0&\IKG)5,ZR6&_(1IF*&OK7LSS9\#
M&HDE=*M<WY><N$%W)/[%**).BH'A89_"X; ,WHP';SY?!F]^W8,WGV)7Q8?C
MI).APY_KFF]#4#UW+<XW?,5"8F'ZH)0O%-7C6Q4VS3/AI<_\ M/8RSQ!QN>"
MC*M:F=YZ$_1+_4:+12,Y7"E+<3+0EW;IB !D_L2QR_>57F6[U-<_1,GU;ZZ"
M5@%K%S@GI1BWV5=T1[<G(!EC+%>DR&"*!QH+\0%^O?H+,F<*"VX?NFI%9W09
M57#\1BSIW]I-?K3)6+QV*4K-QB+0<S8V2=GY)RT^3?4"F!F3%L:'<+SI)@YS
M;Q,VA6MJSD6G;;;L3#ZZE-8OS5[>S8O;CCY3=8AV-J:VN5QEJ<S8$#*3 (D,
MZY"'*LF488DM2'9%5Z1$=L-%#KLLLK\"=P"^ .;<H \IBP RCATMRJ(DOH!Y
MG@Z8YU.8^AE1$,]A0Y_)FZTU+)*/R2F%/TV<?A[7((S(?#IMPVE%]U54HL,G
M?_.U;VZZ++#-Q7(NV7)HVVZ9KH1'_'/?!HH$O#RN1UHM<Z>CV ?+W_E*SFU9
MKW'<+5:P6,$E6T%Q )X"C/^TUTO?&<LE&FO1 :V2.(SR%C\[G)==K/A25"UE
M-/X*]F6DYK6GSB_K3>B4YC:TS"OYAR^_:NDH:>I##2TZ#[\K72YL1CC-@'T0
MB")9*:K[J!LK"S^W"%T9@R%-PRX#9A'BE/B_6Y=W^\4R%\N\9,OL:'.W/-#O
MWM!EVU8-"Q'6L[S]DID&'2!'B9%X7G_E^4>+ZG#H*\FT6,Q*\"[TX7L*"UMK
MBL!NLF%3IW5WH+@A<RJ+G;OJ]BR# T-;S&<QGTLVGTW=-"+8/;"??'4HZ#\D
MOX$!90(>*9T_NJ(!-/\9,C0S+3NL]*P9]EP59,BVB;:IXR*PU.DV]6V%.C!.
M(>T[2MO.S#?' )[T[^?L-K^E/[>=@MKYT41]U7[1GM=.P\6J+VAG+E;]@<H=
MX*+>#-%QM <D-/6R-(G 022 X,_)^WWMJ^1!UJ9O'RJ*^(A8*NKN30X4;V;X
MG!#1>G0LW=8?OK@ZN;PY>WL&7VN=OTG?VD^&;?)M?>P$33_UD&=P9]Q'TPZ;
M0HH:<H!W>8#0^B4^I>Z#\1KKD\=F,$#WEGYWX3M>W,>ENP^N3A:N9+SVA''/
MMPZ1\Y807>D%%41&UIV071Y[AHPNDY+O]6)>I0W5I$8]V5.57NQ,7VFJYZ4<
M:.C9-\":;4KXX;3U>KWZL>CV&L(Q55KH7:T.:,72+\@&\AVQ_)YI0G>3%<2H
MI74:E!-U2H7/G6T\FRD8R)^C(09#?%KG^9OG-SJS,L1T,Y[=M1#R+=I]6 G]
MS5W123&&>W:T+K>U(#QWP^:;Q:W^7T:#+*'G#:/I\'IT\.$LY"]I.$RL#3>X
MPR^?9IH0.\;F5P8XY-U1%J]=^7!?XGKUG%8)MY$I@:M8/:T:XSGDK$4!JN-M
MVE>;ND;[!!@_RA7HBV5^#&A"+']-F;H!SZ,1%%I7GTB\Y>->K_X:!Q738%_;
M&'O*)N*WCG__'L!/WIBO*-WIM3-[L[U#$6T+X*.^ZM]*I++YZOM7-Z_D?V^_
M^AUOK4+H/)XQ%(X?[B^^8_O-75[V <;ZPB2R_>6>_>6;%^%R,G#0UJ4"8L,(
MS-!,!)1:,J+25B/S>_\9+18M+[T[>2S^P]_P_?!$$_-+'"W1O](%Z+:,IT3N
M(,$SXY-84KSFEN>$&1/D_XLB'Y8>ASRWM-@XQL  1GWHR]N\"R'5/[[[-DN?
M;30-! >"897HU-%E&?VL*'!W1=<KQFE=U)YVV)[3K_YW?WGF%Q_*XBB[EH,+
MA*^IR@5^N V_# 5U+WU.7RJ+GRV+/:PQB\ \,.VIHL>#AZQZ<JKT?_--01ZM
MIM.R+['O.FN@^!\'Z(8'I/-5@C0^,2189\P[AL!&W\I&UPE!-KT4OG&\5GIV
MP'(%O"TB-KQ,0=),'HD_CQ.YV D\^A2ANH!AX'I:3U:U,55T'2QQU5W1U#QR
M1F?&OBB=O?!X2]B90T?<5EQA7Y5 $R=W08_*8T;,E=-JI2" Z'-99)'7D;T5
M+4"K1PB^@U_?]5Y _NU>D[^?3( =P/7EE:'&I9:>_"Y3Z^*?[V%5@_&@P4+<
MU24E"WE3H%;/F0\^=8@]\8P>$5=F_#C=-._!]#$;'_YCO2+)&@4E8UYT:L9Q
M73/ZO0-/ _D'N*YHR^[KDMD,F!E@AHZ!ET?/H5'[G8>>(XHEA=3,SB71%F3*
M)+OEK:-W"*"ATC9@WNNNV")&':Z)B-+P8S.H'6?9>!!1Q97)W1^*RCH[.[\N
M^*BP8?*R\/S#X>BV3DMHRBFH:^4+;NG:9/QRC9G=SB\_L,M8-R9]2$9W"W[[
M=MVW6HL+0PY="OSZXA'N_[4@W!>$^X?>5;]RO_@4?-U2_YBL?[#4(KW7L@@L
MO=_T*#71'5/FAU/OE:3_(>X-*0YBB7/IW;,XNRO:4=XJ$;.A!/]%YV;1G;))
MQ@ML7OVE*S,E+8^$\4>=KFLHP/1MZYM7^&5$U8T[<O*SVC;DP5>H&K!9()N4
M15#J%Q[3GZN.\  ]Y\]UDT8\/IB30E$7Q,FB.XT&-#FQ:$W53^KK?,O)^C[W
M7_W!,GC\\[?] :^HC?*O9]\^_R$LM])!X1^E:M^RW>[X4OKLG(:.W[EXHYA!
MC%]%R+ZE86GO8^9)+9H\]&TGPYKTYK=<+-.=QO7@-UU(DK0=D-Y-%-7[S2BL
M")R,0PDQBOM5#L?VU/ ASKU6Z7^,-U4RL^IUR*(A)/EB>B,4+=(7M46;68.6
M5JMO-,%!\6?+: @Q0'[_O*'F"U)*7!1]83INSU;KOK,4&Q-.R>P'_D(;CQED
M%N_]-+WWC2:MPU1UP(<1S>(*-]_\Z'S(4^>JR-G,KJR;\+_U?M@K-#Y9BKVK
M0?W.##Z-$N7,BM!1:6 R94;HTLYDO;$O&"3!,SU+1BN0+^;K\71+A- -U:ES
M#\-U;%?P'7L&O6DVCYAY8T!XP-XRI2=,H?>[1ZY40EFC]<T-_3=N1/V8_W3+
MCPS,L@:A+JYLC4[G"0X";MQ&=6Z4SC>;6@<#Y+3K3D>7*1_5&S[^^?C47_"X
M3]Q*<.">&]K7S@81P)FY^EUM)_24WQ2BN-:8[*0VJ$T.LJ6*V1QYY?+7;E76
MU2WH+T'=L[/SGYROZU"]!KTEHV/TZYU\G59!* ZVJR->/'F&GCM*(8*8JL2\
MF, A!/D$,?;"TW J"U7H#,ANCDBI/.L-%\>.@<X@/2???LN?)MC#\.-2O^:/
M:?^,68.,O@:%.I=+<!B(@LXP^&R,6^O8%'?8;A0]%K?R<$. E+P[O.! \J45
M1B1-A;;]9L[3E%_+EU'I<[=-?FBM1#M)^"/W$,,XEB/W:1ZYHX8Q9^N^H]$J
MMXHV@G#/1YR'+?G7-:KJZ]I<QWX4MG;@P K]'#9.3#?2OU?#-FA:)LA\:-JW
M,X(4$:&*401Z"F#L]Q%7<!;P[Y/D=*))::1// 9/Z]P9V=B(,27(W_$L\825
M=*J0:5BH@:2FW4[,@,:1CK]RS(<VX "\7CTST>!LA8ZCK1@"]#$ZBI%5.<Q;
MQ<TBM%:K4PH3 ("IE!"'4='Z!!L=0?J0AX'QXVHZ)-&8DOSYHSY^,^3EA+P@
M4+W\E6\Z9FO*O#0A'TTQ*$U<8MRJCJ1,.%T!O$!RNG-CO"/W%ZAB!]HH3,=3
M=G&2%/OO"6MAZT@9'C1TQ*D09U<I)<26MD;M*1T'M^&WX[9H_>,GP>!L^^/?
MO-SY84;J;31<T2L!LC&UPP0$">^8AM#1*$T(^@X._JEH#QP!:T  ^Y4PN_-:
MN3OVEV3#6X$V>A"&^<&M-E_W>3>.I,\QD::DJE+AT'ZM4;3J]IJ0!8+-TA?\
MGQ NN1S%"_ '&LV>'!ER8VW0%=:=[NFV1,<D+T\_NX54X=(LZ=TC#MZ)C\KG
M*)/2321UU<=E:^QDVQY_X]..S##'5E+0YES%C'G&$%5OM,XD/-_&MRTWZKY]
M^6R2I,9[ 447UQ16"X+ET#J0GF7>-G U9(]777] UH[Y"O#D1,,15N@J\R.R
M1'3G5O3+K[)@.C! W$T;)A(<\UUR.L??\%>S"_&0+BC1$Y4Z+J((RL'R#S]U
MR&NIB@A6#>>$=-(-L:>:I/#AX[*8]'3!T='QWS?X&627'AOHZ.2L3X^H2O@B
M+(*0B,5.5BG@!>'83BPOX*K842FG($*'KP,U\9DP=0@E5QC,R2A30QV"-ZMW
MGQS0O)MCMJ#$B*K30H9WR-XPN"PK!D.WO2NDC3 +C6AMT:49AE5IE3 Q?C[I
MX\EVGWC=J(/@'?BY43L#N49Q</0XV_A\P^7&YZ,_T<0QNNHC'&F#"E1X1584
M!TBYEIK1XXZVWS9N!X0SNY=51[D&I_]KNGT 1Z/9PM]-5,1":AT"9G@OC5(?
M/"4]";O'<X#%<U<H(]=H7TK(''QE; 62VDP];!:SIE->43BE&,9! 1@MH&#Q
MAF<8^-;=-HZW7XNTII4"4<A_-L[;?VCBJO9'^(VG4&E88"AC&,H7"PQE@:%\
MZ%V5^AOS:MX]R=$4\@O/>-Y7R@G'QRBWD?A8:#NNCFAR'[."<X&KKJZ.37%
M"R#*A<*YH\U>>&PIVO.\ 9#)_)02ONI)T*8QJXVC,J :Q%\!K(V+X&DX]N \
MS YWN[]Q\]EBY%:YHIEZ711;$1[6DPR0UZOOSQV@_X^]=^UQW+BVAO^*$. !
M;( SQS,^N3@#!)B,X\3/$\<#>TZ,]R,E42UZ*%(AQ6[K_/IWKWVIVL6+NN?B
M6.WPP\GQM"2R6*S:M2]KKS4)IG ^?&1UQF@/*"9T);VX7%/BW"8X:+60^"].
M)CL6/'W?SJ1KZ.V)?@7N;;B$F*?G5XQ[ QN0GI$7:0"'577,8;_N0G_$19K
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M'#35IS8Z#T%P&0,Q>>W(#(_%SWY:N6\:5<>>%*'FO-Z<H[24"*YMO[R?=7W
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MAI.)W.@*Q#ZJW:A9HJK7@D+H6B=3NGF[;ZJM=:>3K];VQY.R\<9T$MW-MN'
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M^-^I+5 0VDQ"EI,_0^PT9@/Y)<T8+2?+HSU9PDIDQBXAB N8^A!DS83%RN#
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M1-'J8[[*>E^N2]O+6(H(NI _Q YE4F<Z^D7Z*1 E#"F2M^2? A$TU4<-!P@
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MML$T69^K;TA*"D(^'^/VIA1_NJ#S\I>^Y;V-"E9;JF:\W,MV-VR@FCN,,]A
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M1FW$Q;)C2'IETW:X0Z*)#2O.:\REYM8Z[3B4SSJ].F:97D"AS5/I]RT9,#X
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M0)(^NG;7B _ \3HFE4(YM(N!30H9].!H3I4<$V)LMEPO*R6IM(08>PC%5NK
MS@+Z@W]@R\^>GRY"/L>:!$9;F'<GZ\X5?8IQ:Q?B#DVV6:(SG9#I:= (Q@\V
M=(/-DY:.SR8D4G*:B.-)[B[IM-;:IA^#Z5[\F*F:5V!N5QCXG-^AH16C!,M3
MJC)R;/NMQI-:9TF]G &\Y3SCH(!@MVA] <?U$M(N*O*6D\#-7=T-EOGT!7G/
M@$?&QJ4]YP[XD<BKR$##V">MS)!@]D()9V(7V5:6.L .8 4WE1?(SU,&?_8
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M:GT0)YV4W+E6*,\Y42SG1*O2RC+H*3_OGWS9T''X<L,'\;,O_O#9@$G)?R7
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MG1&@O<2 ]50992'A8%75F)H3!P:6!^-G2FW_J/,3F"P'NC91&LRYX*OGGRF
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M[+^]$QZV.&>),1)-,XD['9;B26C^9% HA:.75C3O-"7/Z6C5>W0?I$QD91#
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M4%H]TOE=K[ZD87% _?QYMJ*CZ0]R:#(!IQLH.":[?7]:;<&V9K?1XP@U7LV
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M8&?H%*7;.P>K4M8;"4Q]T5X6?V 3HM7L"6B=2M.J!L3H&*)M]BR5)_=3?(*
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MB5?E<P\QQF)7UA(CCW6-2>/_J(>Q#0S@#BS_HB"2>>D3H2@#E^7Q,>H*![G
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MCN%C+%?1@TH9YPHM#>GD@21H#L>#%?UP#B>K[$PPB[G4M]NROD0%WC8=PI/
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MD<=[>0YO8-=PH',$A_-6Y,7)$E&]R>,<H\.\7]<)MG:JA5#^BR&M<6V+I[?
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MOM,L$+9\X:9+=RQE]+>K)EL38A?32&69[H;Y7MFNX +8K'7['K;H8%-I8JW
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M\P>(TJ3I-ZR]]\QRLI*9YRG><4H:0*X]S^\UGE J"%-"5.HA,;:^H=Y"9]O
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M/3E]F+3_[BDO@OK*F!2@,:1P\%G@84+E5&'@_0K."CT=T6A&DHTG>YG)+>B
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MW,)_X3J&'(A88^H:"IHP41T.@V/_5I-,>H3/7/9PX,).P9;I'G?W'9+P(N-
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MEX&SD6Z>JO>5R V+MS8?]=6#)(V+C\R<ZBV:&958X'G2PRL'Y!38/Z:.P'K
MY/+>J5VC 9X5"P<.!VSM-LOVE9Z,L,#98Y#;TL0*MX&C8*[$P"\3W'V .FS:
MEEP-%]S:U&J->\>8+&!I2-(W=B1A>*V.#2BM4 E<6:'.THU5^!1P3$/6]"&@
M*U)P:@D.I5T2Q<,HH&S]#?2;D8L"YQR43B5U:T<V ]4)5DGN&X\<-C*?+Y3:
M3+M%G0.M+4)NP/.K-$$U2SF_@B0')8=_F[%<9CIRIA:8&K\[J E)3*H$'.V5
M@60K2,&%[FI"=V,7NOONT)WS'%S#8Q5[U3S/BMFCM8J6>R; 8%F!)J'R1AEZ
MNOA)P_A)*)9U'2?@X$=P\*&0BXBM3M!CM<.A_P7,54Q7!ZA:(/K@:Z"B V,_
MI:,]@"W-Y0ER='RW%A' .#RX$F$VPTSX\?$_VH(9!E0B)K 0Q&XUP#7 LV$R
M[(ZZH\'1\7'WL#OL8>84$O0W=. 4)&T=:G59307>BY\*;;22RFRG9Y-687ZQ
M<YRU=\N$NT '#D4(6D+%YXYY>0RK+_*(*7=!J:Y(F6#V,F@9Y/8A[:#JEB^9
M)8!6_[T_]6Q12QWU..K9DWHHJ(PZ<AH2FJ] &XYSM#7S5-EUZ :V2@@4P6S4
M/E2)3.'^=OI2_C^A(ZM+'I(9*M)*,)I,]E//$9 CH 83D.3\*^EPJ/8"&.Q"
M&MO?LDD$#K4=:C<:M>?L*Z^X>$ 5TAD(V11&M+6DC&)$.F2HT5]I3[JN;DVL
ML 6;Z$(#1P>.#AI-!\3B4WX)!@!YX)'#JS@GA6-)A4%U!X.J]?J.0W&'XHU&
M<6#Q;!()B>DAE#_@VQB.&@WF1F#]F<I9F*8,?L\#$W*K))%2%H+1[!TU.&IH
M&S6PD"TR71Y?<'TLV8H$TZEZ5!NO7+=)NDAT-K05I<(,**QM#"CTI8BII ;G
M%W(DT&P2" B7,:L!<5 $5-1KL->O]9EF/)C%L,1+5.H=?CO\;C!^SQE8IO#'
M1V\^>2-Y#$P]X)AE/N48=:,H0I*9@!U:LE$$O^7*F[/@:;9R:.[0O,EH/D,>
M;N?,:0^]CUDS5$: <$F3R%]ST)25/Y)2Q\14!&7#"X?V#NV;C/: \676)V*[
M+G70P6!XB%VJ7&^!7'^N*Z!6$C%*<7Z'Z@[5VX#J2GU1"9748<>W^\QI;+<8
MNV[PLSK%[QQN.]QN-FYC\1.Z7-"E&')8-)6ZP4=8H,Q5P1.58TE3>;4RE49
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M]*7*]6U>OO:JLJKF\R16KRI'JC&8-I^W&>7Z-.7Z7T< X8.+8)9@5$ ]?;"
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M.GS)?GS9__'EZQ_- %;K'5PB?-H['@Q(]V%S&MK7=S;.M7I/>E8,L$E2NE5
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M(B;QINFB#F@*:@J<"GI*,<./6"P5G*@OIQFV&HX%X@PK;T&[KC$-IGO!:)'
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M@VXJ41)FC#C"O]<'T,;93&G5]!9N-:02'@W3DK?]#/3J];H'_WN**/]2++>
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M28=.Z%_0UD-#[Q:W7#W\UK;J)*[BZM9>"[O; E/WY^IN_M5HO=$>J7T NB=
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MIV(M58LNF!<4SH >Q&!1B#F%+L7NR8BF>[E/X4'J#O:13.M1EK'EJD3M$U5
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M;UEI8Y"?(V)7GKZL+M();901:&I(K(2W"U)'WK/T*R\\YD+G3E,2HS%:E&+
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M:<<[ [H&<CS++P&HW@AIL7=,PAW9!\C;OY!NX6&D>5+T<50@]CP-9H";7KY
M:E8C*0(Z/I4DU47,2%+#\Y*G2^ ='<_>@P!-:,)AK(C#0*$W39.YFJ8<7<T(
MI \J$[ 1X#C9+%K!!W#<430G)J@9SE1,LYD7LA5.R!GP+WH:OH/#NYQ5MM@?
M^/;>$)%$G">Y-"N%U<&K\+MBD32<S ,</]/;@#UDP! 1EGI':Q!#P"/;9$$
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MH*S;ZBGQ>BIN30W4(NM&09%S;H26##K#!C]<Y6'#62!\ *JX%NC^)%\E)OV
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M0TXUT7*X#D).Q"@,.D;@4U2++L*@GSRA<$XA.3S(#(W+2E!-A!SK4LX PX>
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M4?&4&ZAY?J5NO+194&XQWV)^TS%?Y24#@@-&'_%?9LZL:@JRE"(!K9W2H_*
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M69 T'!I^QM$<W\A!)WM#.TE#,M26. D@5[KFY(D+98J!(4\LA1I(0;5X61#
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MG3K..1:3R83:M5%K:VZ+Z6"W#+QL ^PEEJM\OX0/1BUB$6[,MU0J24#<8(=
M=5/8I -OBP^MM&.R+&_5[%Q.XL7J:8D:DK&SO!)<C>GBNC1_F=1).,LTV\DT
M/X9)-!<QNPTV=9;M_@LDKJO"=W$^(R.D=S(84,<XS11+G1_*S^<](%Q-W87)
M,5>M\TJ1]JK\)]I1Z@)E2D=!0!M,BDPY*GCT0\I+R+LKJ9J=E1\:G8&OWE^X
M>?>&*A%I!K'*IH$_<U81_"]5XX,R%V-Y:]Z0O@(3$CP),P$L]<>!,+B;F43?
M32NHQG;**0/M<Q9(I]>=CHYZSI4 8YIZG+0@_6X']O<\R6'-87^_[V #LD:%
MW7!40026-Q-SR3N+Z8E1V'@#F \&9T/D#B:JJ._\L/#=KXN>P600J5[^TSCZ
M*JDV8YI1 Q-0>()[RCB%*I8$YC05B9]7;(J-/;C%&_BLF$D5"^IE8/91$#'P
M<,PK=5"G!;:7+(H14[G7+,I]+^QL(4N<-1FEF/$[=:;ZG%4^M4 >SH#/EEPF
M6[<R70!EXV\>!P%*-U+.N->UI47NOAK[@4W'4>4!5&#?U+W7KRS,=>DV=%\;
M45Q,T06F9I>WJO9GG6M@."HH LG!Z0!8U:;2_^';4,D9%EPLA8Q6R-1-QB>7
M8MYF(I_#@M@!LLKW>(PHUPV0O#H,:?,CY@B/;8[P=^<(6S6F#+G?HO H;]KV
M3G/="Z- ZB TFA_-H+NOFQ]*EZ,\R)1+VU)AG#)O_*(A$+7X(X? +DWYM-53
MF9Y7%'K7[H':*]&H[\VME'.^>208FFKUARD-&TM+4ZI+BU.I+C?[<U0K_$W0
MM2:;VZ8EV;2D9TU+ C('[A#P@#T.Y' CKY\&(^RS9=.R#P>%#S,MVS3C:I'9
ME!!@SU\LL"H;,+QN\%5((1'NYH:VNS0S#Y3=_ O]CN07=J=CKSP/SH3ER5F)
MC>! QOTTZ%*O.MQ!+E.QS83\=X9!#/RY+7RP%-9V"D-Q,7%'W:[K_$12@Q#]
MIV&._ ;Y84,=W2R2VS7 VF9#_"WM'?3PAC#BG@L47O.,IB?7T8V,0W*H&*O%
M$CN3H9(;K"VE64H[ $KK$8D!J?6Z!:T=U]':3(LZ2VB6T"RAF82F9O/IX6O4
M@[/4CVLP<(_[@WLB-F:3X7L<&D5&C%BM(C],]5B=>H^%6T0%U!8PC49UJQR,
ML70 *PKAF MJ  U7%P0JH[ 49=#=V$HB./>RZ.:E^![] CP09]I9*K94W%38
MF<Z+K43<&[LGO=Y#B5AWLN3%C:PV4%UERHF]4PE8&.;#(-0(E?X=/]I.T6H/
M8 P&?J$8S_TXP3AGZ&.Z'(W!F)?VRL=5<U!#P/B:ER?%VQ_$%7*F8+A_3?[P
ML!JTL77QUV2]4TRZ/'"89MCXRVD6JY:;($I8</3.-GWM*B-=8'4@^>=C =J7
MD:FY62[#I3:A"MMSK@)F/7!3_CI)I%ONZ;%SB@(H;UM5RF&>IAK57BB42K)=
M J+32&]:YV*!E6SO\_C\[RHYH&9;&$6XUZ_/Z0;E]YK)HP_:0T)9OADE@FE:
MI(0P^":?>Y3_S RRY7-:$CY!9Y>XER6*#:)X;_05,7EZ4IT0GK=1+<].R =9
M\4#&4DJ%FJD;2V,MN%UJ0^RA>16HI8O42'6;3NJG 3R]"PX,S_)P["\J=YH2
MR_2W/&8+RS[7SD<]=(H>Z>1(Q%#@XU-N,R=(%V1?['#W.* &F"$%BN'$7L[;
MJ4A/Y$?EOL**/#$W,]_D:VJS/R>_J,J:S"'_ALD205_(U%71SHGZIX?L_2S)
M)4UU9F/-2G^ THM:D0QCX]L[Q[?U0#I1J'*F0E8?<>8$>(U@5>TOGQ13J_W=
M'0%G\5C,6L%^RS/*<.8UE1'V4^^X Z_)/WXRTVV;L=8*,K@W=:>]1/"(HSIK
M<WB<+ZC>V4F=]=>N4KY:P_R^E')9N/T#CDS()T<5Z:)<ZDV/5=5<$)6AJK&X
M5TM&OD/8I084U_-1<^0#*6!&SVK)&HNJM%K(P+M[+93:5$2>C_C2DSX_1U.<
MHWF.%NG.NKE+B4AH+IG1HRV'Q9D+GN^19:+SAZ@\MG"M;TT@*IG!36.K"E4V
M'6\X#.YL&H&B&-,NX,9.NV?T^%$@UG"1IW/_F_3.V!_4ZQ(O5C^  P5BE<C3
M1&*Z>)I[V*@].:_]"M\/&\@S5K%(CJLR3_7OU4/PE)?GAM+K1D#/@Q'ZG/[K
M;>IM>:C7&8T']SS3[8Q&D_O6&73&W?M>MM-"C[BAWKC]&X+_B*M8H/CU,>'R
MYO7?PW)O ?\XZ_F4<Y_Q@S.<:H)3#14K9QZO<35/3!YUX94.#6-QRK0(6]ZF
M?FB"(PH\WB5=NMN*JIF*/#_>)6]8+*7!76HQX3FOKS\:N?H?@&/S[_&>M/==
M[F CZ[U\"P!S_.8OK_JO7I2@:@#1E(MYOIJ//4CL@Y3)?TUCY^U?W[.J%L7\
MYZ7PT9/!?UQ@=/_U3V^:38RMPX&G)\_'OY<& =5RO%9A>T,XWN_D@6.^=DZ6
M(O^WP=Z^<]<(U*-!9S+JPV8>>H119S"^YPRZ1]PIM7D"PQ%.];KWYG7?\F?+
MGQL$5,N?6X7M#>'/7Z)4!%;9;!<S>R&_"\"O28!_,8_^+I>'H]L6\/<ECW K
M:JZ?DKY:<$&M$O(6GH\/SUK.V10(4WBCL3QEW'?[W:%%_'8BOH6GA6>3X6D9
M\]Z,>= = F?N6LQO)^9;>%IX-AF>EC/OSYG'8W=H=>96.:7ZW8G;'W;=_JA/
MB'$@P&\,3;P3H2^#0#B_R-E7^&@_XCC06WIAX6"AVB2H6L&[-Y,!2(_&)Y8(
MVD\$%JH6JFV!JF78+^/#LE30)"JP4+50;0M4+<?>GV./QN[$ZM@M]' =G&.Q
M,33Q3MSXGG/1<7[-IJ&,K=^W";+!PO.EX6FE[-X<9=AS^\<CB_CM1'P+3PO/
M)L/3,F:;=/5C8KZ%IX5GD^%I.?/^G'DX<H=69VZ52^I _8&-H8FK&QDZKW_Q
M@^"-<P[LQ/D5]C25\;7K?.J\ZU@G;G-DA85JDZ!JY?#^<OC$[?:/+1&TGP@L
M5"U4VP)5R[!M#I:E @M5"]6V0-5R[.]P=0W<OM6Q6^CP.C@_8V-HXG^R9.%<
M"OAES,XMU[E<[.WC.KA[:ETDQ,+31I8:PEH&$_=X: -++45\"T\+SR;#TS)F
MFXSU8V*^A:>%9Y/A:3GS=WBH^F[7ZLRM\DT=J&.P,33Q]RA99,+Y+)/0GWVU
M&5A-$Q 6JDV"JA6^^Q</@E4T&%LB:#\16*A:J+8%JI9AVPPL2P46JA:J;8&J
MY=C?X=\Z=H=6QWY^+Q?\6TP#2?^Y#1@_&V_M=7<!1N^Y@='K[@.-)AWZ^>:+
M;A#H3L#K#285R"UR]^A*7$NFN",QAU.<BN!6K).S5\[;1L&X(8BU$I[GA]=Z
MF[T*NWDR2%0GMDY&73VQ53]/4N)T/.Z,QY.?[P/=XV#?> < .PJV&M!W0/AH
MT!GU"QCCOD\'G6$+4*V_+Z9Y_HU^A=H5G;K/E^CYR2H0Z]-Y(+_M<.8_LR3U
MYVM@-\"/ )[XLZ,D%7%Z1B<[@C,LD].I2"3^MA8.2_C@UO?2Q>EP)T1JB!JB
M(>6'!!4"V$-^?P?H3(A,3H;'\,]@..H=CWN]G\]H$KV^4^,RR_MI*-!>_?7+
MPD]P@GBV#)U8PJ%G:>*D"^G,LR!PKF,1IHXG4OA;^+%S(X),.M'<B5:I'X4)
M/R ]Q\MB(%CZX5J*V%E*D60Q?+'*XB3#1=+(.;^Z<":]8]>!H\P6CL\O F2$
M_YI',6QCN<I27"=)H]G7(T13CSZ582+PA8X?.E$6.W,_%.',%P$\"9M;PH4E
M'>=*2N>W"/9Z@F_#Y^ RB4,*W&/=CQRQ6L%^\9TR2.3M0L827Y(B6,[#,(.G
M/\M5%*>T0S^<(Y!I*[#V3,8A_A3^G0K<VIQ.E*SDS)_[,T<D2;94D+J53H;'
M@<<0BO@S!<2.D[,$P!_UO_NSAK%E#<UA#?U6LP;ID'WA3&40W3K)(KIEDA77
MU[&\1JX09LNIC!WY[\Q/UXZX%;&7 .6E )T013A1C11 [<@T@"(]/P86$\5
M$(L(64 8I8YP0K$$VI#?Y P8P VR&* ?&;M 0OC+=W(FZ46#GNOTN_U>'BMN
M .3.8^ IAIY3)>-:36?$!-1XO69_%9I1IX9_B2R-M#J+[P4T.>V>T>-'0!:
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M'9S-VAB*L!-FFRPB+#Q?&IY6V-K2HA\2\2T\+3R;#$_+F&W@J,DX;P-'+;&
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M?BG4CZ/Y7,8T;8]_13.K,"-NZV@-._9DOZ$&'P&DGN?S-+"Z&,0SSDG::<>
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M&CX?X,%3%RY@K6GL?^^T!0O0!P,4P(??_.75^-7C W?I>UX@[;"R)Q]6]O]
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MBX8=HWC_P[]IJMEY_OE+DR<6.Q__^6CL:Z_W-Q7'-L9IC_Z0WQ;^%"3"'WF
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M58--[ )AE*J-) 4?$]-Q%%:!*'0 C,$8C,$8C,$8C,$8C,$8C,%X/(Q1JC;
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M0W'8D)5_</("PB ,PB ,PB ,PB ,PB ,P@,BC.(P+.R-* V%+;% =&C:#1T
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M/$C&E2=89:N"ENPE^R$(U*N5/E?:X9._H13GM,)7=9-('?16C=JOO._7)29
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M(^V1B:1P>4FH=D9GJ;-<W-@7JQ>5ZZ^/!>N8T%P.L8.M>5,K++2*9/8%2.-
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M>&!>"Y50.^#8 !]1!:**"*,*H9VQ/@UQ@:::M*O52&&9(9G-6&%R0TMI^LA
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MS:N7S_;?/7^6'%T^5^LQ+[8>>8"H;O^YPA#CX,M>G<GEYBE)MPRDG::",>R
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M^?T\7KKZY\%\UK5$^Y[#VI>^KKU+.KF)\)20W8Q4@30.I"A2V%*1 @P@#@,
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M-CK/B#0>TG@C,P: !=AA@85\0[YA#  +L(,$"_F&?,,8 !9@!PD6\@WYAC$
M+, .$BSD&_(])&/H;<N/RPZ#S3ZVO-F'G9^<S-M;G-L_D^5I^-%_]K6M&O^M
M+3_"AU;OGI^V108-MMN)Q!$!:1Q(X=6QA==.&P"0 FG\2"'3D.F=-@ @!=+X
MD4*F(=,[;0! "J3Q(X5,0Z9WV@" %$CC1PJ9ADSOM $ *9#&CQ0R#9G>$0/
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MFZ;TK!WWV32ELU!B=+#+=M.44S]K="<B_G/[L\=&1%'Y88"-#RQ&H]CN#,8
ML  [2+"0;\@WC %@ 7:08"'?D&\8 \ "["#!0KXAWS &@ 7808*%?$.^80P
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M 7 D=22=/TD=FW9L^ED? $=21]+YD]2Q:<>FG_4!<"1U))T_21V;=FSZF1P
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M37027?<<_R2-\EF/YQN0WYG>/?<#^?V='MCL_CU&MU"4LML<K[DXM9\L28&
M^,M__I#\<.]NHQOV".D),9>%>3BS<$L&WV1Y_T>RQGL#M!$;*/>/YAJ\4=N)
MHUOL>SV'3J@\<&#I%L?LQ[+RNO-ZW;)*M'.,NCY] 14Z 76, NJ!VZTX:>04
M;<?''!^[#S[F.SYV/'SL8%KU;3KR?4^/MN>M6&L7MPXV>*JI+[QZ)1O68;0;
MDUP^EUTIV]L=NP=HV^N$U1V(?/N4N <@^]Z,N$?6NQRMCX+6,Z*L8QYN0SM:
MSU6QW,PTL"2T4>A;:9G3T',PH=2\&-"#Y*O=9(G?R\Y;UNTMU4OG!7&.I6/:
M[0]9&'.$U2ZS6:=K*FNO?\1L9G(%"*4*9,&4(GX>"JR2Y22G/"%^EE(>J3R1
M:;!=B^.S4#+!8A+%,B8T$@$IE)2DH"S/0JZ2(D^V:W$^-K4JNU^ OQ^VHC;)
M%EF>/V8MCN-X-]M_+DSK!/LSV.9.L#O!/@?!SOPP$TI$))%Y0*C/8Y+Y<42X
M#((@C91,V YD1I3E0:"BC$A!L3!71H0Q^+\X286?<I[$T8,)=AHMHBAU@GW^
M'&^O8+^O>)]SSCS*&I^*?ZS;3A<D>5WM-1(8!R^7TJNLUP:_Q;^Q6LE;MU)X
M9=5'#^NJ?>'\_L[O_^1]T<[O_T1H/2/*.N;A-K2C]5$%#<,#Z:6ATTNO6^+7
M$I[%2ZUD>O+K2E:M=";B3/B5(^D\2'J$;L(GY(B3U$]46D@B?*X(S8.$Y%&2
M$,EI%!4\"7WE'R+"-F6%!\&Y"Q8T>M3.,HX5.)(ZDCY#DCJ!]9@"2\0)#S.E
M2$)C2FC!,Y(G@4]2*B0-91'GV4Y*R&TB1P<76(D?.W'U.(S@(<(]SJQ^N%S<
MNB(ZDK.4K)5W,ZR=&W9^[D!'V-GY69WF<G?-):<T9(D(29KG*9C-24Y +0F(
ME(4?R2@) [$#+'\;4_M#7Q7["[+'-X8['J:7W,(/#I7TXOC#_/B#(ZPC['$1
MUDFTQY1H*N2\X'E.HB"1A-(H)CEE!4D*GM(@D$(%^2%L\?N3:.G!.J,Z[N!B
MW<_9*-?MC$C!,+D2VY# $=6^,^?BFHF4=22=!TF=RO*8*DO PCP!/8-(GBA"
M@R@A.0\RDJJ8A1GG?I =)-[]Z9PU\F?DAJ\FS/ @.@M=1($+)3PMIN!(ZD@Z
M?Y(ZT?68HBOT_3"4N21Y$7%"BSPF3')&@C#/F%0RRU5R"&O['D57L(CHH0QN
MQQ1<%/PY&]P?NG/9.%_5K*2J(^S\".N4ED<-$60J8&D@B @4 CUDH+XPY9.D
MH'E :1&$BAXDZ(W<<(@3G YPT @9C4T1AP:/A]%CTD.EGCN.,3^.X0CK"'M<
MA#V^ MK9B*W_\[^_AGY W6$X2E/417T?]_2\.F?5&7PWPNE@,XZVE5WKL4IX
MRY+I#L.@B=T29,>Y>>X5(>.!_<!/$J]A=MYV1V7'*ARK>$:;V%'YP2,=T8&4
MS,@IF==&.@;-TA3\]4KEI;/99L6Z'&'G1]@CC'[,AN\\=1#NE,=9E$087<D*
M0FF6DR*-4Y+S6+*"4IG+Z!"QF7<5;Y!QOY;FWW?59D''+ST_/RQ&=[B(XT/U
MWGBZK&TV>_26'3B>[LH<K]!QA'72_ G*2\8#'ODTP494*:&^2$F6%P%A?A )
MRM(T5#OR\C8)F/<@+[]5U)]'3D@^W6"8\U,\&-?XV,@5*T4/2&0B8#4F)GE\
MW31 ,AL:<^[MF8AB1])YD/0(]9K9<)TG[Z7P4\62/":)4C&AJ2])%O@YR<,H
M92RA61CLM H[C)?"\O/74DG@WL+B3IQ60B>;GFI6?AAHR$64'$H)>XHL;38[
MU'4)/6HQXTCJ)/>3DHTY2$)91 ')F0@)S?R8Y'G 22#BA 49HW&^ REX&(_$
M867CC7II^XD3D4?NH7#Y%'/@):><PRBZUENQ2U8LI?93,,Z;M1R=%\X%."OA
M[ @[/\(ZW>=1=1_0;UC"%(FR.,86XADILE22*/<%BWR>,[73".(P?H&>?WXT
M[!.4GE/#/'\9JQT.@_1TL)81CGW,CWTXPCK"'A=AG<![3(%7J"+C8<R(*G(P
M]I.(DZ*(?!+Y*HP2'BG_OM(/'DS@Q8LL])W(>Q*VOLM&F $^E$LXF)?PO15)
M"_A)-N,T8Q\&Z;7ULA3>YDYRQ']$XA^A=C0;9O7DDQ@B&5._D(3["(-%01EC
M,BY(E >%+T1,@R*]IU*+36"L R8M)-ECQF.N/9=A'"_Z_^ TS)\[SF8+NRR'
M9R*Q'/&=NN#4A1FJ"WD:R%RHA"0IS[#)M22YKPH29$4A.$T3EMU7I<E]J0OA
M(O8?-<?1*0P/JS \1-((/9 [B3IWTG5K_%YVGFZZO<8.7YMX;P/:KO/4SDJ#
MN0-AG1)Y1$O@5$FG2EZE2L8QSXK0]T$/E*A*@E*9@3Y(F,]YEE,,&\I#>)Y
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M;1?BB(P7SMPC*VX>T:[AB=O/N6"77B$]-">*9=F>RVW_W&A5%#5K!#Y(@.'
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MN(W"^D)[UOL(\VK=K&IC]]EC9)(V[$&:E4/O0725*(J*-),I22-3*!8A7F1
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ML6NI[T<J+DA >0)V;5$0ED0%B9.<J2AA5(H=U>>A#NOQ6KDS'Z4N!AQT)QT
M'VK^F@L=/?66LNL,&J2)K4Q1 9G&"9-[(=,T)T#WTKQI@-"/.N93?I;+R^=7
M#A #9Q"17Q!?9<@P0C"38I^1E"=I&/B<)NEA,E"GT>-W.MKDJA?O,0EU)UC_
M%*VBXS5\;\<>=E>U=Y&VNC,T?K/ (,(7N5Q.\E/&#)EO9*%X/V(])"^[GVR]
MN$8!L!FQTQQ^9.P2.$)] 5Q$?C;I(C8RPRI;+:"C$M.W754BMCLE! >'(2'
M;SU,:RCH,BBA^T,9QR)TO(</E/M*)K[R$\)\B@$/L-V8"A+"64*E[^<^9_E!
M2M1W^BV\KSOYZ]"=<[,/CNZX.B]?V)$S_H&^IE6*X_IS6N(# # C!I\MBAU
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M?#A$<I(.)NJTEVGT_W0$"/GY<KSDHXDVGB(_1E>D]D2>CN[]WESI]SZ*P1]
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MW=_#>1@WE?SZ0WX5 "L 'H.A% 6 I#1KZ^^Z5@"L %@-I6\ 2$NSMOZN:P7
M"H#54/H#@(<8UW/$J_KBV=^]K=7-05BOLV6\[O':IV#W2QX]W/_36X6NLJ[@
M4<&C*G25=>&R+DFR%3RJ0E=9]TC6)4FV@D=5Z"KK?DQE?\I<_3[DGTK9S?>#
M:4^:\._%Z-R,-_?PU5/6"B:'>N302U-$E7B/)%Z2?"N<5.6N$N^UQ$N2;X63
MJMQ5XKV6>$GRK7!2E;M*O']9L<L\T:9$5]=Y_EF%&W(K#)O*F1'TC^DD7#3I
M$?X(\R:F&WI&YJP65$I*[)<NV')LX*4'>/>07!XET7)6]O9IM=P9HP56H*S
MP)"BH!3#X*)(_\.:12)OCL&CR DJ$ &BE /&$ =#$ /GC55<4Z&"W)K*W4U,
MNV5TXT[&<&L^H%0?>@QW29I;X;L*MO^"+0<]*R_6<Y/Z;DT5IJI@^R78<B"E
MXG_%_[Y;4X6I*MA^";8<2*GX_[KR8IIICYG4X&P4P(PC8)@U8 /%F CFC*$W
M\V(J($-$T"")LL HLF!1=*!LU#2]A96Q-2]6'LKTL5I8>^CWVT._<;I:[2BI
M'26%46T)#F>5>(\D7I)\*YQ4Y:X2[[7$2Y)OA9.JW%7BO99X2?*M<%*5NTJ\
M?PFQVCY_Z$3Z#]/9V30?\-K8:>V=+Q'%JF!+$FP/B:$<L*DM'M48CMY+JDK<
M+\'V4(F/JFF#\6A84 @$<Q'2;Q2L3S\%)B6G)*K U,VF#19B0")0<,I@8#XB
M4,X1H,1;10@BU+*7;=K 9"!0;=JH(%$,2/16UB5)MBIQC5UJ[%*-H0ACZ*VL
M2Y)L5>(:N^QN$ .C7%CN 1..@&&&(84K!B@6ADE-%//D9NSB$//&2 &*!PN,
M, H*(0S><XJ,E40&4V.7UP@2>V\XKU6V Z''/X>_#YM/2;[)9D>A-J>72L+/
M$._##T2M"U'(0O30>RH'TIX?#U=C>P7&MGWD>@^M[M@7J5I+:0O10R,YJL#>
M2QH\HQ$LP0)8M 24]>G7@#BE4FE/_,W WC#%,%82N$GA/+/*@([, C%*"A(C
MC_J% WN9,)?O,K"O(/0*0*A2=@\6J5I+:0O10R,IAX5K-%F-K5+3<2Q2M9;2
M%J*'1G)4T21!!DM%)&"9_F'>4=""!% .1^*4%@;QK197QE.821U8I0(P*368
M0#UX&HSQ5'O%58TF*PB5LVV3[ZB@S&M!^:LK_FDZ-^-FM(MY9[59HZ2.KBK8
MVBI7'MS4YN=J##5JKDI<E&![J,1'%=4ZZ31"7J<(-4>UT:4(%0<,B$NO':-.
M6'PSJL6$6R^) (<\R1LW)5@N*: 0=9188QW(RT:U2@Z$4+7YN8)$*2#16UF7
M)-FJQ#5VJ;%+-88BC*&WLBY)LE6):^RRL]@E((J%X Z\XQZ82,&(=20 LYXR
M1A'A:*N_4Q#).34>C(L:&(T>M)86M-+:18PTY;C&+J\1).I)07T[*>BWT,YG
M(S</OG&F/6G"OQ>C\V1_]>2@.DR[/.HMP<VI$J\2/P*)5X2I^EXE7B5>$>8X
MI5\E7B5^[!*O"%/U_95(O!XY5'+F[6D9^7],)^&B28_P1Y@W<5%/'2H1R)XD
MV+HKIT=+T$.^.:H29'2.:B8L&(T9L( Y*,<#*$8#=\YKCNW6[%A'/4-!0@S(
M ]-(@\F'7U@=, J"D*#LRY8@R8!A>N@*9,6=\G&G;MTO>GFJA92S!#TTC'+(
M]D#MGM7 RC>P2D%%+T^UD'*6H(>&42FH&ECQ!E8IJ.CEJ192SA+TT#".*C]I
M)!'"L0 N>@Y,: K&A@@L45O@5#A!P\W\9%":"R49().'EC'K0=EH(01DE>+I
MFXK6_&3%G6(.P:HSRUYX9EG=75$HF^]L&",9$I[AS4\7=AQZAF_E6,M?2E_*
MZI\=N'YLN,+>*Z JYEHP2?X991&TXL)&;XT4<FNH;'31,"K!AD"!R6A L_23
M=B8X20RWFK^L?Z;E0')2XE#97N/8T3/*=B*E+DDUCDKRE>2/BN33TA O @-"
M" :F:.+W@"@09A&5+(08MV;L46^<YTBG[V@!C#D"BDL"P6A"K&+<:]?S.145
MQUX%HU22+VY)>F,<Y2![)?E:[#_\(I>TI*\2.2N9%;<DO3&.<N"NDEF-6.^-
M6%'$ 3&J09D@@06-0'G#0#/BD#.<LNW)BHHB@97A8 0A*6)-\:Z11.6=40H;
M0IVD+YR6QHH/&$$U9.T=I=SL']A;;T<?QBV6P.!/ZIBI@GW<I(\G";F'5-E;
MA:ZRKN!1P:,J=)5UX;(N2;(5/*I"5UGW2-8E2;:"1U7H*NL#;%%1W1]XTDS"
MFG@ZM,)7P5Y'<,SV >%/V@6Z%L>#UD?M?WFN ''?I;H;)]RH!ZSQA^#"J0VS
MAN)!0U N912ZY;%W*_P5$WS(ZA3-+WO;M/H"*W:@,Z<>LN;?CB;-_&2Z:,W$
MMW\MS1QK=\I!8IDCALE"S.[OX3R,&UR:O?5W7?=.?^5 8%V;"HE'"XFD-/OK
M[[I62'SM:U,A\1@@D99F?_U=UPJ)KWUM*B3V&Q*?.:ZKKNJ!L\:U_ECKC[T5
M;.T@.1:%KK*NX%'!HRITE77ALBY)LA4\JD)76?=(UB5)MH)'5>@JZUZ>S7 T
M^:=RIK3\8SH)%TUZA#_"O(GIAMIZ!$.A"<.=C8CI\PDSY5A.":.NZ@%9)6C"
M[9.N--4^_P\L)P$8"AR4#P$H)2Q&2[B3[N:D*RNB%")&$,IQ8);1]!TN0'.C
ML4?,!RQ?=M(5PP-$18F#KOJ,8L=.)W6[0&DKTAO3* ?6*\'OG.#+6=R"YC+W
MV5J/'38KD96V(KTQC7*PKA)9);)#KW%)*_H:8;,266DKTAO3* ?K*I'5E.M]
M*5>NJ::62%#8"F"2IY^8L4 QI<&PR#DC-U.NV"M.&=-@%5/ L-/I.XB P,8A
MQ;45#M>4:_]1K(_E[TO+VA0HYMUUGE0+7\DMRV=]G1+7JAR<.<0NIVI)+[)]
MK-<'I91C(<_PR?:]B-4=.ZP[%C%G'&N1W#&7W#$5-6B' CA$HN#"6<_U37>,
M!RFC=1ZP91%8L,DQ<\P %EQ'R3A)__7<'7OMV'7$_%&S+ 4M1F\,HAP<KV1>
MBP351E\93E;2*F@Q>F,0Y8!;):U*6M5&7QE.5M(J:#%Z8Q#E@%LEK9HVO:N*
M[1W13F%05 M@UFI0$GF( 9% C!0*F9MI4T8)081;8(A&8-(;T#Y:$)ICYH)B
M.HB:-NTU=KUL 3O];)*,OELOX"^+TS ;N?2['YW?(2D^%$)^<Z^H,+E%5OB(
M<?[326AB,K'F/-M8,XW-/+WRP_0TW>W%TL/5[]K&F?:D"?]>C-+'DBC;QDQ\
M,POM/,E\'OSV^Z.VL:9-[R38^/=BFC^SVL1]EKZ2;F(T:;+)G8?5ZVWS930_
M:2;3[DY,AS?&_]]%.S]-%QPVVS<ZFIR'Y;OINZ9-II^XX#2MG+_ZTU/;AMEY
MUI3UGQ]-SA;S=MA\6,Q&D\_=TUX$,VN;D)3$-S</GL+=DZXULLPU)+?=WE%1
MCI6!*NHY>)>;H%008#QFP+RU(3K)I!$W*8<JC7&D"H)G")@(%(Q)_W A/9+.
M"4XO*><\/=XET2QYIQNIC3]-N_\GGV9FTL8PFP7__C3):;[-05?,\_,O/]U+
M/7=4(X65B'$%7@D.+! 'RED"B6NM9TX1(;::PW;QC&3UC/@%GI$GFE=.)%]!
M:YZ;V3P8[!@XRX+0-*I@MRJNCWG&M>MP^9S_""9[#!DD_E>"EW].K@#AYPX(
M?@OIK[G1>-0A3OIM,<NX\+UI1VTGI+54VI\G\Z6@Z.[E8M.34R\).(<Q,$HY
M6.L$I%>E]]%AZT*I<OFXF'^,SQ<,NL45>\(+1>,T*OO^!ID-9Z'YDO\Y>DYA
M*+*@. *2X@]@A%-0QJ2X1'OGN/%.QWC3YI AP7C#@?*0\(MZ##:& )89K8A+
M$*YWRBFWQ34W#0G:X+(QY2BC#9.['A='IK"C"+"A"6*02_&;0!H0PHE%G=62
M[^5Q'T,O.WQ<;DRT@B#0-D^WH"+]A)0$3YRV6C/'W%:0^IC'/133[%!$+K+$
MN=8"1IP ,XR#"4R"L#PR'85Q3I4JHGM)YTDRFDR/GX":^5I^C0WS+R%,FG&6
M83N\[;Y?\L:NA?RW1?0I[/_/]/]/8J)+ UA=<DT 3.! @P=.4=+_!(&@)4H.
ME(E&\.2$,?DL1%SK_Z^SZ5F8S2]^'9O)_/W$_YC"Y+-L!%<9K4_I+WP_GKH_
MWC0A:>]93ES,%N&>E,_1IC%N'/7QH.7EPV8MY"Y<OY3P('ULOC/=?LJM7=/L
M'2LP,I)&3QGX%!_D"(" D4XF!;;2!A*$C6BO"OQ(M7U _DT\5V]7FM^;_-LU
MO0U7>CL)\[QRB?ARZFR5EHO3\7CZ)3'BVX+P>IV0[?*QMVWD,8OY=)WHSG>2
M[Q^]ZSX.8W,Q7<S?QM&?P;_[,O+SDW0#';RMOI >:FS.VO"V#6=F9N9AO=Y=
MG65Y[3>W[6HZ'[4CFUR)^<7;]37NV-NT_+-"##'3WV1-N2OOO[J_H4#B09^C
M\B$?HT-$'O)WT5 3W+O[*^,P^(*.5WI"Z:38T^:J6%]R:'8_#@HKY/BWS3K.
MX69O]V/)*OQ4^#D67:[PT[LE>_&C):L/>IA<SD-6\MO1)(6ZTT6;XN'VKY50
MCHU0COB(W$(L*#<ME7;N<3UUO#K)%=-ZJ/7E8!JJF-8_3*LG;O6O(_RGQ6PR
MFB]FX7I)JAZ[5>B>N2,6;SE&<9C)KG6GVX%WNA%,$2<>N.0,6/0:#+,$L#81
M<26UB%L=<@2)W#N79X-Y!TP'"M;J !XK&Y3Q(;DR#VZP^-MLVK8[V>Z&D2IC
M8FM)&EPAO8KWN,1;#J)6QGR-C.DBRN07P<J0>\H-!4TLAF D0R[]QZB]R9C.
M!H'S?@0G/ 7&B *KE <O@L%>"(Y(/ !CLMMV)%7(.:[!Y35_L'-@^+NQTYF9
M3V<7NT@>[#7G?;PF4P7;+\%6O^7  P;R(=C1)6]%H;P9E)$4Z=, @BE'%-*"
M1WS3;U%1.4R8@"@$3M^A*/DM7D/4G'DJ*8EBZV26%_!;U(!Q>>BY-B5I[U$!
M115L%6R_!%NI[;#4)JU3,6@#3!&40O*\\3]RGW]5EG"FK-Y*8DO,!:610W2)
MT!AC"HSQ$A#1 5.D$.;A -3&4PQ=J>W@0%&K^CV,RH-IP\ET[)O1Z=EL>MY-
M86AK0JM0IJWB+56\U9TYK#M#HM7160I*TN33B*C!LD"3IT*4)"I$H;?&Y"EA
M.!).@4<B#PV, 32C>51:B$9&':@]1*3.>:TPO +$J.*MXNVO>'O(=^50V/./
M"*F&452@6@O'^S.6/'1\D0"FEHT+9I(];Y"J2W#P)>@AX1]5@.L#9XJ8%-MZ
M98&Q@$'[8"$R%C7&$@<NMP+<((0TB*9/IBB7:61 *T/!,(FID(IX2@\0X%)\
M\&S]$[;QE:3N1X5!5; '!_>Z! =?@LJO!][4Q92.T3A FD5@!",P!@G 47.#
M*8E<\YO\ZK$D0@H'(O)$S/GP,^N-!BQYQ):B],LA6M2QJ/S:1PRJ!?3^92?N
M&M3\.5MSS>\5RN55O*6*M[I!AW6#M-36>!1!FUP3IYJ!SOOOHHJ4&>&#55L'
MY/A(L%%<@#(N[X?7R75*"@14:.]Y[C,\B!ND!IKNTA&JH%$J:%3Q5O'V5[R5
M\@[<":\-Q=A$,,A)8)Q*4(ZS1%\*(QHT9VKK%%G,$**16\#,"6#"6C""6N!"
MFTB%8<$__+R<77;",\XJY94!&K7-H$^!_'OG%J>+L<GG*OF0+NR6QPW68DAQ
M7%N+(<>^!#UTB<I!LF^/_HQF8:D@BA%04N1]B(&"=AX!HE0P+&C$>.M<]*<D
M*38XX<,&):2?QR'_D)RX]Z?3I.K_KWO]3@=O)[X=&2"U2]^NUG5*,]Q2S[6H
M1%=]C>-=@NIK5%_C'E\C#T5@GA@(#E%@RB>O@UL% @DM)558$K^+[%!1OH8D
MHGH:K]'3J"TH_5O,>\X*KYG?0GV:9XCW.C"2(>$9&/UTD<]9[Y=W68X-'68L
M]2.6LH=>ZE&Y@2)RC*)RH'4>E\6D!&VYAHBT<-XP@NS6),B=]L7\$G;CVHF!
MXK2,$N'7U;]_/E[/R:6*MQ3 +WTER@'LRMV5N^_E[JB))LQPX!P18%@[4(0Y
M<-1$1[ /VNPDA;-W[F8#20HYKZER]W-;@M+/)@GKN_5Z_K(X#;.12[_[T?D=
MDN)#(>0W]XH*DUMDA1\C*]$O^-_,EC;AS[,P:4,VHF9^$IJ+8&9M$Y+T?/,A
MN'!JPZRA>-#DX["[A$D^0[;Y8MK&G)W-IG\F0YN'\45S6UZ[G&?^R]&GW;E2
M J%H\U!BES";*K Y[2XQ-8HF  YJ:]P!,B08GW">\L"!48_!QA# ,J,5<5%8
MO879F]IS)T:+:QC-[]]\.;R[2%^F,C7I]7&6?#:'LF_U^/7>.2&EH ZL0A98
M3/\H+2EX@[6-5H6(V$V]ITIC').%!,]0\E4"!6-"GF,I/9+IBISN7^_1\.Z2
M49G*M-;[03,+[5E(MWR>D']XVTV_Y%U=\QUN<PV2_W"G'W6_;W";&_4HUV#+
MC7JYX^&?>&HUE*V#F&TL=U[8D\N2VYGY');>.)B8A/S6C+^8B_;=F^8_BE*!
M%_.D\T,G_7\2[%_"[<J4UFAK!?7,B.0GR'P(@DRX&Y$"K*Q/_H=VGFPU$C[%
MRWCO7-*V>?NKN<@^?_IUM@C^[R-C1^/1?!3:%"U^3/[J;..E#Z/6C:?M8A9^
M6,QF:7$_I7OX?CQU?[QI0@+HL[STZ3+W1%7[CA0.EBBRT[%_K#Z)8;.2>_/C
M,DIH.X^GDWNSDG&SL0 [(X*GW.TU&MBQUBN& T8DY/99 @P)GGP,9R%B3K7F
MSD>U=1KG8[3^/(GH=W<2_&(</L:5T-<R7VOZ2N ;\OZ43>.12OZ @%@\5\M7
M=M*;@'BMY6%3RZ>=EKN5EH^OI)[7N1VU>=O+-'8Q<YR.Q],OH\GGMP6Y0NND
M29<S6=_+:IWR<KPUB_ETG97*=Y+O'[WK/@YC<S%=S-_&T9_!O_LR\O.3= ,=
M/JZ^D!YJ;,[:\+8-9V9FYF&M EUR='GM-[?UQ9R/VE$GR8NWZVO<T1VS_+-"
M# D3WV3EN2M5M[J_H4 /^QQ5^"&?(T.M'W)!-%39HE[^!NF0D(=\, 4:MSS(
M5QJ7U*/[EO;:4:V*3'"J4IMYJUB36),0\[O_]8:\V8.(;WG$4D3^<C'F#4?M
M(0NWF50^W EZ_5BR"C\5?HY%ERO\]&[)]FXGU0<M(QWTD)7\=C1)P>YTT:;@
MN"UUXV4EE)?=_]</'"O$@G('1?E[PGJWNM5)KIA6,>UPF(8JIO4/T^JVU?ZU
M[?]X>C:>7H0 L["<NG95IEI7KNH6F./; E.Z>,LQD,/L:ZF;50[; !HX<YH9
M!-9+ RP@ X98#"I$11 3(?W_+C::KN'WMR7Z;O1AK#HS=K1C!<M"=JR4I,85
MUZMXCTN\Y<!JI<W72)M(&>NX,H"TIL ,LZ"\%A U]9@+E"ATBS:?LL?S96B3
M#"2I1Y<4@NMUCGN?X/^WT 8S<R==.L&'\S">=GNP=Y!4V&M>_'CMIPJV7X*M
MKLR!QU5($ID) :2D'!@G 9(_@D%;X;&-QA&NGY,!R-LS5GL$UF#Y?N(_7$'E
M>JO&+CT:J0]^)FU)6GQ4@%$%6P7;+\%6BCOP= ]D$2>2@6$^41S#''0>J8BH
M55[**"C=VG?[F&C](!2'!YH<_(".DO3X6,+UV@NP;Y3X=3:-H6V3O9AQ$T.M
M_!=+MU6\I8JW^C2']6EHC-(XHT#[[)]HA4!)X_,\)H]3$"ZL>%;8OC%+)/LU
MFY#Y4]AQL,X*F1!=D@8?(614\5;Q]E>\E? .2WA2!X&CC* I"< <$Y"XC$#P
MDN%@N95L)^>FOP#AX0'::7ZZ@D91 7RMM^\/&_X^<MW$Y5QN3Q\)[7PZ"<^,
MX6OFJZ1D^?$)]H=T,3L;U>I#\2>.;J[4GP1A5I6_Y\I_? *M,'W<@NTA7!]5
MG!DUQ5@R"GD\+3#%%6C-%&"LHK6".Q7<CHK%*V?V_<3_8^W*[CK49!S5&O&A
MD:+6B/L7:'93HVM*IE!FW=E18O>--:D+4<A"5)?HL"Z1=X$B;4W>WF:!&>O
M^CS+GWBC=?#88;2+6G.'N=NG5>S2'Q*XD,3[$P;QE*3T1XA'5;R%P'U=B$(6
MHO+N@7N\/$IK;"AH*1.'!JW!4&Z!.H2=)%(Y_:Q4Q$OR+JFTVULXJB7R/F4N
M/DWG9MR8&\<RU:1?<1S^),%^_23TWOA1Y9C,,X;X['L1JP]VX+V#CB?W202P
MT>>V0\? :&8 6RVIP8;AW>0^]NQ^#2CEARX$?5WKJ_-5";KO@JT$70FZG&4]
M?H)VF%OO9 !)HTL$;1-!RT2V,B+$B>=>FEWN"]@;01-Q\$Z-2M#/S8ZDG_,1
MP-^M5W)U$G;ZW8_.[W@U'S3_M"/5;Y/@[D]4WXL$\T/O^)QQBPUWU&%(:FN2
M46L#QDF9G' C=.=ZJZT=L8\]9_RWX$,XS4O\PW32&5'Z\==9B"%!@?]]/G5_
M? J/.E+\JXN\.@_\&:LL#L7U3SF)7@Z;*R$W&U)N+L7<='+>V6GA3[G+S;/"
MGWQ4_,N8;SG\_;[-9[YOGB'9Y!-P!MTQ\&8Q/YG.TK5\DXQFE%.8;5[F]3'Q
M/TQ/TT-=-*.)&R]\^M1MZW]4C@VS.*A@'6B/)3#&5<(F) !A2E#R4YBA>!>.
MS:=P>C:=F=G%C_]>C.87OY^866C?7R['-?>F[=[<]&M^_N6G>QT;2M5 2SH0
M&M_IWI2IKLWR8;,"EGVC?SEZ4TBJ&Q1/Y$RD)<!\3#X^9ARDX-*;B V5._'Q
M;YC"KV;V<?;[/$_>_I<9+\*O8=99QW6//_V8J3]]JOT8WW<>B?DP'8_-K%U]
M^KJU?)?D@%#OK.',S)KS+(7F[)*(.X0>9 M)?]6='#\FZR!0](B"Y8$!D\9
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M\;XBSH.!O%9Z;C$A*UE4GCHPVK@<K5HPSGL@)G L*.5(;W<5/0_C7[C2H^2
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M0)&=TOV^='][?GT%HO(V][WF,+DR[RM8@\J\AV1>CJ(UA$5PE.>NHVC !F4
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M?K^]NE.WH>Z9*:>+V68P>C/NW(X?GYVY>:*>5;)^FA)/.L#J%. R ,B+?BT
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MOV^J?8T^WCL-G;6ON09'.QI-;V@C_++0QQQ)';8>0=>N[?#5D28:J(H6<6O
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M,XA:K.'?ZKP 85G]?3XM\QS#?US4HU-_-@#6DG__D-[!^L@K=''EW97EY8U
MI;@W4(F/[]Z%[N?JR2H\S-,V!1%U+O"UG+*JSAF?GTGL6N>;UJ*5)7#G$N!:
M, [NKL,^(4XPN+LJ=U4PCA%CDM=6[7 )_!X_3X=V4H^O3D?A70Z1C/U@XRM"
M'M\=M^_YBECV=\8+8;5*[Q?B6EX.^0MY!:7!N)G 3S GU<6X#E.?$06X5X[C
M=EQ@\D#0RG&.8;NMTD(4N&N?AW.0JL;UE1VV#AZ,UD_/IUVGL#G,C>*D:F#"
M6@ZU8##7 SIM/]A40[0MS<9*2*_C4?E'W.^1WV:48:VD#\KB*9LBH80C1[!
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MG#F0[W5AF\D\\KK8!)FG%5P+K[N@RSYL@Z9?XG X/T$S>VH7$C5OFRSK'%@
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MX;(]NTDG@-O4GT<@]^8F1\@$PM?-9!:7[WA&_N.*$%O.,!BUX@^]2IUX*3I
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M;.U=7U/KMA)_[Z?P35_:Z0TA<$Y[#U/:"00ZF>$<F(33]CYUC"T331TKE9P
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MTO/.MS!ZI(BDMK!4A^$3C)W'?;R2;UM^U#0]W=T= -RO._/K_VL4HN57A_Q
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M;J2&4\O%LOJ:__/H4/27_P=02P,$%     @ N8%N5-V-U\(>FP  ?D4' !0
M  !V;W(M,C R,3$R,S%?;&%B+GAM;.R]Z7+DR+$F^G^>(F[KV*C:;K*[6-4:
M';6.SEAR:W$.BTGCTAJ-[)H,!"))J)% "D!RT=-/N,>"".R90&"IOC^D9I&
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M"7AHRI5"M,RDVLWV!3];,G\3KO7&1=7O(&/J9_*RYL?#3W%U0+_BX:FD4-U
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MPQJ2*^M?&C& )LX9O7ZNYG2J?GZ\;>S]8R>LP_M(:A'4T,N8.E;B@%;?)'-
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MNH8%A]$:9$=< 23<S3-3X4M#%Z6/3.C6;GT]][6N*RW3RL7=],9XC7&@M;J
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M"=1]"38E>FV%'AP$(I4*@+MD9B/7=;$TJ'TY6-_CC0ITH/B%1J>IS^'T]BG
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M3W%'%#1>S.3I[B;;2 _]"%'F&90('4AP,/SN&\ ^Q6H[#U>$;/#7&S3Y#0=
MY4.(5<<&X4? [,0\!*Y<U: /N"JO]W?BZAL+W&'I!#;7 6+4;2WL.;'6[Y0@
MB%[MUB\_W-W':%:^9ST<.\6V'NZ(I$@RD@/$L_J31-]%#]_=?2<%LJHEGSZ#
M.^HRU'M.XQ49T.Q7=V!2@1/R8>NQPV+I1=O#<RKYB'#[ZN:F''2A_U:-2_C
M[(]\:/*W-&8GYMH)$IN^A@$GQ]#3U0PYV5QLLQG2?INH&=J)&7(&G:'.&5H7
M4;RF/H $):-G&0I>;&I[4Y\O:96TR*A*VJ94:2QG"86+X3,*U:YVDF?X'^A
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M@:7%V-"*UV# ?AWS&FA3V@V8)U>SK)7W<-^38'#@;7?M;&@G:,^*S;<@0'D
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M?S437,@X11 DH6@N2)J?G\#6_)AJ10;;5-E>L'>\.PTJJJ;3X.PEKU&[V\W
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M=$&OK/O7J&.OL0ET3SM0D#V.X$*+,3:<5:.%MVJ!0[*#02;ZO7P ,M^29:X
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MML5]<1\,RW:FPC$UX3D*/'84<JWK.DIIAD_2CRJA#?);$72>H4A!M30$AM!
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MO:5Q^GX30'^FT(-\9MS%#PE=[X(K?]U)6Y?D.0*/I+T@4#2Y@91# "5FXY"
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M22\(LF&S;FS"$U426:A"YDP:H#E7$HN3<POMZ3B_)65.YB>P./,.1(=140(
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M\OEX03Y]_'3\%4]'R9U9E3;</FM8\;2PW@+^FJ;0\)C=/X#/X)V\/R30G%+
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M';/LK/?3B)E\':UBI#&(U7O*%I.?7C@N*NV=BOXX*2)I#5#OUP?SA@IL2C
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M&LHT%:#-0EL.;H0Z('F62(^H5<9NLYDB(PTJ;[=9!*GGH,*1)%E1>^H1D]I
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M !P#%TL0IB2 -L(D2PCZDCG_^ND$@3OX@W[2?! +/=>RTAW0&#"_Q\I)7C!
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M\G[H^@&H";C/$5K;0QRA=(#>Q?XK/%-OPT.NR86;^J_8O,0Y.7KYE+:#Y@K
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M6"?VXCQ,5S.VUI!G.,/FO-(RM2&K!+A87VU+HZ)^'^5><>IK()&><Y"ZCM<
M&BX2I8='\](78#W+P]QZ@U>(_?MP=K^"^"6R'EXM6D.O[K-!Y:Y'^,<WM-H@
M2K(8W#LH7&NYNL@2/P3)V)(UYM9/E!L?BI"N0,I%>@=]3PF++>#>?H2&NKF<
MOP$U6PEAI=8E1FTPV%.VW3KQ?KEZ\M>AOX(Z3)B>HC:SW>"+8.[',\3X(J"G
M=!/L/"[V%$7$=I8EI-$<!U]6)GX%7LKH]71_+'C%378G/(#&M *'.=Z&Q2R_
M./$? -<_.)DOU'- C*H(/\>.=_ H'3>;Q^F]?4[WV2!/+'4_4E^[8/OI<N/X
M,=:POP '_7N$Y\QA"<=5\4X69A=M9PEI5KP#@=U'-U>+;$V5CSD(V,Z,Y6NO
MZD.O>Y".BQVI3]8X/,GOIS-3&'EJXA>WU!"ZV59X"QNABQ(@V<[*C;BW\GWQ
M96YQ)62$' ESYX%]21G9YP2\JY;50U\9HD:<XLG3CW*_*C\Z[FVQB3R65_P1
M[8<"?^MKK_(40VS=@7%<K$0N_W&<$D*5RCJ7)",FE!1YN4#A6^GNNCF27B5,
M'HD^V"O0SEFG-=5F1NJQ2D<3[/LH!>(BLGA_<QFO!1;676Q-EQ."@IK*?AQ\
M>%S-<E6ORQV@0$'\^N58N;M\?,CAVXZ#ZBNM)SKOB^J\>=S?=53=9X(:$JDE
MZ^R*L^TG"TXW,S(%.I\SYV1H--+&Z7<@20"HI_?A,C*GDVX^)6] E>]XJ[:=
MK:J.]W4,!G4)$74ZXH0H+,1OKTC1)'Z$I5IR.NCB"V& 2[V2MW#KV*-BE8JV
M6S]W,R,?,H[07(-P?"%3C(543-B<%Q]28^A[)R R3=Z=)CF([CNNU?;6HIHE
M0;/3>G0%5GX(\/)C_R5#@U^ $/XP13ZNT7'\08' (>FIGP=[R/"[\ CZ/+5P
MAOG\L&_A >I(\6&BQ>9)\'WKX0PX 62WN^;+;0VCQ;=_GOO@V7D'R?FXF/\P
M<V%F9_706<*I.2E^O"2CBVXF%=B61K(,QO*M8[SFTR" 2UL\@!C;O,;%@-=.
M'$()ZC![GD>'UEP;ZS5GQ.,[>GO=3,?;BBK',59M.[N)/12:'PQIX\@+)_&3
MY:HQM7W^)X\]!3MK6]S7!"Q7UTGJ;YV46K.PT4B?WQNLD5C\"'91++L18GWU
M1:1',8#\GT=CP1G%#M0I7/Q6$NH&^)]!_G12;+GMQS,L,XC8<L7Z&O!V26PY
M]/;Z?-'%_7H)[[<U$-P63B?#2.TDG0"1G*0H4'!(G39;*$)LD!'BM5"[90Y5
MX>Z&A4H=(_;J87HH>S5@;G/[\33N<>A"6LM?WC_ZR1^7<'I^BOY&W59Z#_UO
MMBKOYV1H5;R_>:]?Q%8HW%W?/;C=P5W 2?+B,A/+<G47A>L[>(!X^>M0P2NR
MS5":XSOR  >Q];%ZZ,QP!IS811?9%7@%083)JWAZPSPW17HJBA<H'D POYB(
MG!P=!]-ZJ9-"V,3O=)'>^HW3HK(TI;DQ)CZQ=?!ZZ<MC!-XJYHTX"N%?\YK<
M0ES6>AAE[UB0K!/LL:SFT::0%S-<>-$.\H/HX:%L:-VF7+E\,J(&,\L3#<J!
MUC3$V5X53RY#D9CAS_+"-W*8=; H6EXY1 Y'0;.DY443Y#!CV#O[R 0_6IQX
M1M4ALK^/!JQN1ML"RC_/4$J9?0O8_C+#ULV87.#XTXPCSR)="KZS6B!I]2Z!
MFU4&.5MZB=NL-K0WT9<8SBH#U]I?0C5K"L(>A1*R:2L-77T;)8JS-B'E)"EA
MFS4'MO.EQ&E6%81\/"5<LT;0SH=4VGJGK2:H=6"5F/:J0>A*4"849O^,$R_.
M0?8=?:I4Y0N)*,A6]S4!JRRX\U< (\YRHK8?:SPLW $OVY_'5 H.C)$Y)U&:
M TVL,I]7QP_05MU$\9,3@*]A#)S _P<D/O2L,$I\M%<'PQ;S .CC"[J/A6X%
M.)1B;?OA0:RY,<9CQ)K*&T_N!GA9 ):KP_QRDR)D@TI^ZF*_O"74S5'M3'B'
MXJ@BH<-"[3=T'Q>RE3T4(VS[$4&I!#+&0V)*]4!:OX4PA['5UOZ8$,L*5_P8
M)1-KKOM!3L%XN%/DL&=F:>P\IG8&%JO3H0A Z[A:JBS'&%E98W&.([V)8BO&
MJO*CZ692=NF.3CC9E(NQF92&6$I@C$PX%Q0@:M\GZ>P7;TZ<D_D2DVZ"-,><
M49,DV^8_DU2_E7S$*+"JFUU=Q\)-_5=X +0&2')@ T"YWNZ": _ $XA??1>0
ME[((\&3@W] )ZT;K$-DF'P \+W,N$<=*]?=T7TSJRUBHYF[+W^<-LP&R)X;E
M[_[Z!%WYB33$>T+]95W&*-6-K+@+G >B+2'I@-9:N698K[M"\A'\#OSU!G+E
M NI#SCHGEV<0;U'8*20B%-SP"+E60G_LZYOJP<$%4_$D140[R<Y&U1DJP=]_
M<5+D5A838MN,I/OR$:E(1&%5RV4A.C(#G1F6BSW"^'*/'<MS'+0K&L8]PH;(
M:*"_6,(8)3E+*B94M)#5"B#>/6X,.N^0JA&ZD$:/AE0)TX?\D 8 428W@-,E
M7122&,B-IOL8DRPXT8UZ+)=-6F,I28!#B" &U?48XV4Q^NH>%49OS T%W[E8
M2 ZR%-&LW TA-9H!RU^$J>^AR<&C[AC.?/WN!ADDL!MX ""C7986ECK9JB@]
M?$CW,2A33J4UF5E^E;3#4!VM6G_%(/4+(G:1)7X(];2%Y_GYJF[#503'0O^X
M JGC!V.[>7 8"=KG*(33O(JVCA_2KAUB6ZUU60O?TQ>P?0$Q9=JG[11959M4
M ;<7W*9@VRPWPV[;$;\$N-^MH]=/'O Q='__$_KKQ_RO>*KPG]^N(:NG>R1Q
MQKLHST]T!>7OY:KVH\:\)3IJ(P(#'XDVMQK?10(DD;?3)\-D+PF\#IQXCQY<
M+5>881;O/JUX$KV]OB4<)W+O;.%?*\E!F2>;0$=]:<$?ELSC[?A[C<5(X)&
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M?K^Y1/U<]ES-LNXX:70$.IJW*)Q*3W9!>:>Y##=^SG),2W@%X&WF^H4I:!<
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M!XJ<A#UC2,!01LBW_"6/#( "RD,?CTU.[?]4,W;Q"_3'BY. ?___4$L#!!0
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MH54KWA4,]\YY6S'QD9%--/PV;EL5'1A]]@N-F)5F4E#$XU;GG*HK;C%:4G^
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M;>V<:W/B-A2&/[>_0I.=W4EFL+&Y9!>;9H8E9)I>DDQ@.]N/PI:Q9H7DRB)
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MDX4CB#T/LSE>IMFZI5O/[W[7K6?WS?L'4$L#!!0    ( +F!;E3+]G-];AT
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MQ..?'G__A3;X4]CY@V>OD$_6U:+0< MP1U$B7[=L-0;*5Z8BZC_<@XGPO\@
M0Y?T:<B%)]%W\,2]O6E4"AU=B:P&#B(U7\TL9MHW1DDL3\/3;S5,EN%-S/ &
M!XE6"JZ;R0BV6!IX$\A!=R-<[:P0.L%;$J5E7!7:1$NQCI#+SC)E%L3GZ'T:
M*U<<1_9<L/NP5!?+J(*])5X+/[?&Z_YF!'_&Q^D"=W5+5/_WXIE]^MD?1:7R
M>?2&CO3(2^^.EYX+8$D+>&? K:P*VM)200>#[46W3T+*72ZCJP*4N1147"D<
M.T/-#)G<4E1@9QG0%V=+555\C^ [+!^B8?F!H ."*IO5";YJ_$YFP-Q0*PLY
MW6Z$RKI(4P7KJ]25],/94?!74469%*:*'CURI^6S[_<CHMN;MWO_B\WN5J?A
MQWN]>0?W>_.^=T?\BIE76:R8J*SXQZ_@7[Y3U!4([IR.?:"6A&K,Q T"1I&(
M#/P&IDV<"8-VDU43M'Q?*VUI#"T[LA.%RGO,RCZ#+*2^X X-YA(]V@V+O^,8
MSF[#==!4K/V'N@E_BGOEGF@_UG)9@#[4HNB)_S7*E)BI3%5K6+"(11ZCC8D,
MH!G!E#)6,,)22IP6W!VPD"B';0(M!W2LV!KRZVBED??DI H"\R*-2%[#4@UR
M#^!<]?*K,^SNKZC^15TIV*YD%--WR%LNZMF?0#%(DZ%N7RU \*$E,&OY0)!R
M\_4FL]FP6@()VO9-@4@/Q3Y0JT3:T0(-#ARY,!*HV+YYX"0I/G&"[,I.)Y'
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ME[U?%A1%0)6I:>324%F0.-2T5XF]FY /0">.D0J; 7X%>Y!,VE!><L/G&&2
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M,3<S.#@X-#A?,"YJ<&=02P$"% ,4    " "Y@6Y4K.KC(:W4 @ 0%@4 $0
M            @ %!X0  :6UG,3<S.#@X-#A?,2YJ<&=02P$"% ,4    " "Y
M@6Y4_HNY)T!F P TY@8 $@              @ $=M@, :6UG,3<S.#@X-#A?
M,3 N:G!G4$L! A0#%     @ N8%N5"*>6#W(BP  Y\0  !(
M ( !C1P' &EM9S$W,S@X.#0X7S$Q+FIP9U!+ 0(4 Q0    ( +F!;E0Q8V:4
M8R8! "!S 0 2              "  86H!P!I;6<Q-S,X.#@T.%\Q,BYJ<&=0
M2P$"% ,4    " "Y@6Y4=UH;!VVJ  #4R0  $@              @ $8SP@
M:6UG,3<S.#@X-#A?,3,N:G!G4$L! A0#%     @ N8%N5#ED.^AS.P  Q$(
M !(              ( !M7D) &EM9S$W,S@X.#0X7S$T+FIP9U!+ 0(4 Q0
M   ( +F!;E2.)(9 [AD  .8C   2              "  5BU"0!I;6<Q-S,X
M.#@T.%\Q-2YJ<&=02P$"% ,4    " "Y@6Y4 S('=E&9  !VL   $@
M        @ %VSPD :6UG,3<S.#@X-#A?,38N:G!G4$L! A0#%     @ N8%N
M5 -+'Y"@*0  ;#L  !(              ( !]V@* &EM9S$W,S@X.#0X7S$W
M+FIP9U!+ 0(4 Q0    ( +F!;E2P[E";O!<  "(C   2              "
M <>2"@!I;6<Q-S,X.#@T.%\Q."YJ<&=02P$"% ,4    " "Y@6Y4S:5.RGC8
M  !2(0$ $@              @ &SJ@H :6UG,3<S.#@X-#A?,3DN:G!G4$L!
M A0#%     @ N8%N5./JO+N$9@( :&8" !$              ( !6X,+ &EM
M9S$W,S@X.#0X7S(N9VEF4$L! A0#%     @ N8%N5$-:T+ZJO0  APT! !(
M             ( !#NH- &EM9S$W,S@X.#0X7S(P+FIP9U!+ 0(4 Q0    (
M +F!;E06+PWA$-\# !7A P 1              "  >BG#@!I;6<Q-S,X.#@T
M.%\S+F=I9E!+ 0(4 Q0    ( +F!;E1:'91.@B8% #']!P 1
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M.%\X+FIP9U!+ 0(4 Q0    ( +F!;E15:VQ3!E,% $7E#  1
M  "  04O'@!I;6<Q-S,X.#@T.%\Y+FIP9U!+ 0(4 Q0    ( +F!;E3F %7=
M6O<$  '@/@ 0              "  3J"(P!V;W(M,C R,3$R,S$N:'1M4$L!
M A0#%     @ N8%N5-,^^(I6$P  ^]@  !               ( !PGDH '9O
M<BTR,#(Q,3(S,2YX<V102P$"% ,4    " "Y@6Y4Z+_-I&\-  "_O   %
M            @ %&C2@ =F]R+3(P,C$Q,C,Q7V-A;"YX;6Q02P$"% ,4
M" "Y@6Y4'Z#*LU@G   _W0( %               @ 'GFB@ =F]R+3(P,C$Q
M,C,Q7V1E9BYX;6Q02P$"% ,4    " "Y@6Y4W8W7PAZ;  !^10< %
M        @ %QPB@ =F]R+3(P,C$Q,C,Q7VQA8BYX;6Q02P$"% ,4    " "Y
M@6Y4C#\$X4A&  !>>P4 %               @ '!72D =F]R+3(P,C$Q,C,Q
M7W!R92YX;6Q02P$"% ,4    " "Y@6Y4AKT4W]D"  ">#@  #@
M    @ $[I"D =F]R+65X,C-?,2YH=&U02P$"% ,4    " "Y@6Y4D BO"#$(
M  "400  #@              @ % IRD =F]R+65X,S%?,2YH=&U02P$"% ,4
M    " "Y@6Y4+R.J[H0(  !C20  #@              @ &=KRD =F]R+65X
M,S%?,BYH=&U02P$"% ,4    " "Y@6Y4$B.!WHH%   ^3P  #@
M    @ %-N"D =F]R+65X,S)?,2YH=&U02P$"% ,4    " "Y@6Y4R_9S?6X=
M   6WP  #0              @ $#OBD =F]R+65X-%\S+FAT;5!+!08
..(  @ .4'  "<VRD    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
